PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Barckhausen, C; Roos, WP; Naumann, SC; Kaina, B				Barckhausen, C.; Roos, W. P.; Naumann, S. C.; Kaina, B.			Malignant melanoma cells acquire resistance to DNA interstrand cross-linking chemotherapeutics by p53-triggered upregulation of DDB2/XPC-mediated DNA repair	ONCOGENE			English	Article						metastatic melanoma; interstrand cross-links; p53; drug resistance; DDB2; XPC	NUCLEOTIDE EXCISION-REPAIR; DOUBLE-STRAND BREAKS; GROUP-C GENE; ANTICANCER DRUGS; GLIOMA-CELLS; O6-ALKYLGUANINE-DNA ALKYLTRANSFERASE; ALKYLATING-AGENTS; INDUCED APOPTOSIS; P53; FOTEMUSTINE	Malignant melanoma is a cancer characterized by high chemoresistance although p53 is rarely mutated. Here, we show that p53 wild-type melanoma cells acquire resistance to cell death induced by fotemustine (FM), which is a representative of alkylating DNA interstrand cross-linking agents used in melanoma therapy. We show that drug-induced resistance is a result of p53-dependent upregulation of the nucleotide excision repair (NER) genes xeroderma pigmentosum complementation group C (XPC) and damaged DNA-binding protein 2 (DDB2), which stimulate the repair of DNA interstrand cross-links (ICLs) arising from O-6-chloroethylguanine. Consequently, TP53 mutated cells are unable to repair ICLs, leading to prolonged ATM, ATR and checkpoint kinase 1 (CHK1) activation, and finally apoptosis. The roles of p53 and NER in ICL-triggered cell death were confirmed by knockdown of p53 and XPC. Upregulation of XPC and DDB2 in p53wt cells following a single drug treatment is a robust and sustained response that lasts for up to 1 week. Pretreatment with an inducing dose followed by a high and toxic dose of FM provoked an adaptive response as the killing outcome of the challenge dose was reduced. Upregulation of XPC and DDB2 was also observed in a melanoma mouse xenograft model following systemic administration of FM. Additionally, XPC and DDB2 induction occurred upon treatment with other cross-linking anticancer drugs, such as cisplatin and mafosfamide, indicating it is a general response of cancer cells to this group of chemotherapeutics. Collectively, the data indicate that p53-dependent upregulation of XPC and DDB2 is a key mechanism upon genotoxic stress, whereby melanoma cells acquire resistance towards DNA cross-linking agents. To our knowledge, this is the first demonstration of upregulation of NER following a single dose of a DNA interstrand cross-linker, which is a robust and long-lasting effect that impacts the killing response of cancer cells to subsequent treatments.	[Barckhausen, C.; Roos, W. P.; Naumann, S. C.; Kaina, B.] Johannes Gutenberg Univ Mainz, Med Ctr, Inst Toxicol, D-55131 Mainz, Germany	Johannes Gutenberg University of Mainz	Kaina, B (corresponding author), Johannes Gutenberg Univ Mainz, Med Ctr, Inst Toxicol, Obere Zahlbacher Str 67, D-55131 Mainz, Germany.	kaina@uni-mainz.de	Roos, Wynand/B-4846-2008; Kaina, Bernd/AAE-4692-2020	Roos, Wynand/0000-0002-0474-7414; 	DFG [KA724, RO3617]	DFG(German Research Foundation (DFG))	We gratefully acknowledge a gift of DDB2 antibodies from Dr Vesna Rapic- Otrin, University of Pittsburgh and Dr Beate Koberle for her help. We thank Rebekka Kitzinger for technical assistance, Georg Nagel for his help with animal experiments and Christian Henninger for helpful advice concerning tumor sample processing. Work was supported by DFG KA724 and RO3617.	Adimoolam S, 2002, P NATL ACAD SCI USA, V99, P12985, DOI 10.1073/pnas.202485699; Akkari YMN, 2000, MOL CELL BIOL, V20, P8283, DOI 10.1128/MCB.20.21.8283-8289.2000; Batista LFZ, 2007, CANCER RES, V67, P11886, DOI 10.1158/0008-5472.CAN-07-2964; Batista LFZ, 2009, MOL CANCER RES, V7, P237, DOI 10.1158/1541-7786.MCR-08-0428; Berdelle N, 2011, MOL CANCER THER, V10, P2224, DOI 10.1158/1535-7163.MCT-11-0534; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRENT TP, 1987, CANCER RES, V47, P3384; Carson C, 2012, PIGM CELL MELANOMA R, V25, P514, DOI 10.1111/j.1755-148X.2012.01010.x; CASTRESANA JS, 1993, INT J CANCER, V55, P562, DOI 10.1002/ijc.2910550407; Chehab NH, 1999, P NATL ACAD SCI USA, V96, P13777, DOI 10.1073/pnas.96.24.13777; CHEN JM, 1992, CARCINOGENESIS, V13, P1503; Chen ZW, 2003, CARCINOGENESIS, V24, P1111, DOI 10.1093/carcin/bgg051; Christmann M, 2001, INT J CANCER, V92, P123, DOI 10.1002/1097-0215(200102)9999:9999<::AID-IJC1160>3.3.CO;2-M; De Silva IU, 2000, MOL CELL BIOL, V20, P7980, DOI 10.1128/MCB.20.21.7980-7990.2000; DEVARY Y, 1991, MOL CELL BIOL, V11, P2804, DOI 10.1128/MCB.11.5.2804; DOLAN ME, 1989, CARCINOGENESIS, V10, P1613, DOI 10.1093/carcin/10.9.1613; Dumaz N, 1999, EMBO J, V18, P7002, DOI 10.1093/emboj/18.24.7002; FETY R, 1992, CANCER CHEMOTH PHARM, V31, P118, DOI 10.1007/BF00685097; Garbe C, 2010, EUR J CANCER, V46, P270, DOI 10.1016/j.ejca.2009.10.032; Grombacher T, 1998, ONCOGENE, V17, P845, DOI 10.1038/sj.onc.1202000; Haapajarvi T, 1999, CELL GROWTH DIFFER, V10, P163; Hayes MT, 1997, BIOCHEMISTRY-US, V36, P10646, DOI 10.1021/bi970791q; Hwang BJ, 1999, P NATL ACAD SCI USA, V96, P424, DOI 10.1073/pnas.96.2.424; Jaspers NGJ, 2007, AM J HUM GENET, V80, P457, DOI 10.1086/512486; Kaina B, 2007, DNA REPAIR, V6, P1079, DOI 10.1016/j.dnarep.2007.03.008; KLEEBERG UR, 1995, MELANOMA RES, V5, P195, DOI 10.1097/00008390-199506000-00009; LUBBE J, 1994, J INVEST DERMATOL, V102, P819, DOI 10.1111/1523-1747.ep12381544; Ludlum DB, 1986, IARC SCI PUBL, V70, P137; McHugh PJ, 2006, CELL CYCLE, V5, P1044, DOI 10.4161/cc.5.10.2763; Muller M, 1998, J EXP MED, V188, P2033, DOI 10.1084/jem.188.11.2033; Muniandy PA, 2009, J BIOL CHEM, V284, P27908, DOI 10.1074/jbc.M109.029025; Naumann SC, 2009, BRIT J CANCER, V100, P322, DOI 10.1038/sj.bjc.6604856; Padget K, 2000, BIOCHEM PHARMACOL, V59, P629, DOI 10.1016/S0006-2952(99)00372-X; Passagne I, 2003, J PHARMACOL EXP THER, V307, P816, DOI 10.1124/jpet.103.051938; Pavey S, 2004, ONCOGENE, V23, P4060, DOI 10.1038/sj.onc.1207563; PEGG AE, 1993, BIOCHEMISTRY-US, V32, P11998, DOI 10.1021/bi00096a009; Raschle M, 2008, CELL, V134, P969, DOI 10.1016/j.cell.2008.08.030; Rafferty JA, 1996, ONCOGENE, V12, P693; Roos W, 2004, ONCOGENE, V23, P359, DOI 10.1038/sj.onc.1207080; Roos WP, 2007, ONCOGENE, V26, P186, DOI 10.1038/sj.onc.1209785; Roos WP, 2011, CANCER RES, V71, P4150, DOI 10.1158/0008-5472.CAN-10-3498; Roos WP, 2009, DNA REPAIR, V8, P72, DOI 10.1016/j.dnarep.2008.09.003; Roos WP, 2009, MOL PHARMACOL, V76, P927, DOI 10.1124/mol.109.058131; Sasaki MS, 2004, CYTOGENET GENOME RES, V104, P28, DOI 10.1159/000077463; Soengas MS, 2001, NATURE, V409, P207, DOI 10.1038/35051606; Stark M, 2007, CANCER RES, V67, P2632, DOI 10.1158/0008-5472.CAN-06-4152; Tarhini AA, 2004, CURR OPIN ONCOL, V16, P161, DOI 10.1097/00001622-200403000-00014; Tellez CS, 2009, MELANOMA RES, V19, P146, DOI 10.1097/CMR.0b013e32832b274e; Thoma BS, 2005, NUCLEIC ACIDS RES, V33, P2993, DOI 10.1093/nar/gki610; Tian M, 2004, MOL CELL BIOL, V24, P1200, DOI 10.1128/MCB.24.3.1200-1205.2004; Tsaryk R, 2006, CANCER LETT, V239, P305, DOI 10.1016/j.canlet.2005.08.036; Usanova S, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-248; Wang QE, 2004, CARCINOGENESIS, V25, P1033, DOI 10.1093/carcin/bgh085; Wu YH, 2007, ONCOGENE, V26, P4761, DOI 10.1038/sj.onc.1210284; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129	55	55	55	1	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 10	2014	33	15					1964	1974		10.1038/onc.2013.141	http://dx.doi.org/10.1038/onc.2013.141			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AE9RK	23604128				2022-12-25	WOS:000334346300009
J	Ruckrich, T; Steinle, A				Rueckrich, Thomas; Steinle, Alexander			Attenuated Natural Killer (NK) Cell Activation through C-type Lectin-like Receptor NKp80 Is Due to an Anomalous Hemi-immunoreceptor Tyrosine-based Activation Motif (HemITAM) with Impaired Syk Kinase Recruitment Capacity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T-CELLS; IDENTIFICATION; DECTIN-1; CLEC-2; SUBSET; NKG2D; SPECIFICITY; MACROPHAGES; MECHANISMS; IMMUNITY	Cellular cytotoxicity is the hallmark of NK cells mediating both elimination of virus-infected or malignant cells, and modulation of immune responses. NK cytotoxicity is triggered upon ligation of various activating NK cell receptors. Among these is the C-type lectin-like receptor NKp80 which is encoded in the human Natural Killer Gene Complex (NKC) adjacent to its ligand, activation-induced C-type lectin (AICL). NKp80-AICL interaction promotes cytolysis of malignant myeloid cells, but also stimulates the mutual crosstalk between NK cells and monocytes. While many activating NK cell receptors pair with ITAM-bearing adaptors, we recently reported that NKp80 signals via a hemITAM-like sequence in its cytoplasmic domain. Here we molecularly dissect the NKp80 hemITAM and demonstrate that two non-consensus amino acids, in particular arginine 6, critically impair both hemITAM phosphorylation and Syk recruitment. Impaired Syk recruitment results in a substantial attenuation of cytotoxic responses upon NKp80 ligation. Reconstituting the hemITAM consensus or Syk overexpression resulted in robust NKp80-mediated responsiveness. Collectively, our data provide a molecular rationale for the restrained activation potential of NKp80 and illustrate how subtle alterations in signaling motifs determine subsequent cellular responses. They also suggest that non-consensus alterations in the NKp80 hemITAM, as commonly present among mammalian NKp80 sequences, may have evolved to dampen NKp80-mediated cytotoxic responses toward AICL-expressing cells.	[Rueckrich, Thomas; Steinle, Alexander] Goethe Univ Frankfurt, Inst Mol Med, D-60590 Frankfurt, Germany	Goethe University Frankfurt	Steinle, A (corresponding author), Goethe Univ Frankfurt, Inst Mol Med, Theodor Stern Kai 7, D-60590 Frankfurt, Germany.	alexander.steinle@kgu.de		Steinle, Alexander/0000-0001-5081-8503	German Research Council (DFG) [STE 828/6-1]	German Research Council (DFG)(German Research Foundation (DFG))	This work was supported by a grant of the German Research Council (DFG; STE 828/6-1) (to A. S.).	Ahrens S, 2012, IMMUNITY, V36, P635, DOI 10.1016/j.immuni.2012.03.008; Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727; Biassoni R, 2005, J IMMUNOL, V174, P5695, DOI 10.4049/jimmunol.174.9.5695; Bryceson YT, 2008, CURR OPIN IMMUNOL, V20, P344, DOI 10.1016/j.coi.2008.03.005; Bryceson YT, 2006, IMMUNOL REV, V214, P73, DOI 10.1111/j.1600-065X.2006.00457.x; Bryceson YT, 2011, J INNATE IMMUN, V3, P216, DOI 10.1159/000325265; Cerboni C, 2007, BLOOD, V110, P606, DOI 10.1182/blood-2006-10-052720; Cooper MA, 2004, TRENDS IMMUNOL, V25, P47, DOI 10.1016/j.it.2003.10.012; Dennehy KM, 2011, J IMMUNOL, V186, P657, DOI 10.4049/jimmunol.0904117; Fuller GLJ, 2007, J BIOL CHEM, V282, P12397, DOI 10.1074/jbc.M609558200; Herre J, 2004, BLOOD, V104, P4038, DOI 10.1182/blood-2004-03-1140; Hughes CE, 2010, BLOOD, V115, P2947, DOI 10.1182/blood-2009-08-237834; Huysamen C, 2008, J BIOL CHEM, V283, P16693, DOI 10.1074/jbc.M709923200; Kerrigan AM, 2011, TRENDS IMMUNOL, V32, P151, DOI 10.1016/j.it.2011.01.002; Kerrigan AM, 2010, IMMUNOL REV, V234, P335, DOI 10.1111/j.0105-2896.2009.00882.x; Kerrigan AM, 2009, J IMMUNOL, V182, P4150, DOI 10.4049/jimmunol.0802808; Kitamura T, 1998, INT J HEMATOL, V67, P351; Kuttruff S, 2009, BLOOD, V113, P358, DOI [10.1182/blood-2008-04-145615, 10.1182/blood-2008-03-145615]; Lanier LL, 2008, NAT IMMUNOL, V9, P495, DOI 10.1038/ni1581; Mavilio D, 2005, BLOOD, V106, P1718, DOI 10.1182/blood-2004-12-4762; Poulin LF, 2012, BLOOD, V119, P6052, DOI 10.1182/blood-2012-01-406967; Sancho D, 2012, ANNU REV IMMUNOL, V30, P491, DOI 10.1146/annurev-immunol-031210-101352; Sancho D, 2009, NATURE, V458, P899, DOI 10.1038/nature07750; Severin S, 2011, J BIOL CHEM, V286, P4107, DOI 10.1074/jbc.M110.167502; Smith-Garvin JE, 2009, ANNU REV IMMUNOL, V27, P591, DOI 10.1146/annurev.immunol.021908.132706; SONGYANG Z, 1995, NATURE, V373, P536, DOI 10.1038/373536a0; Spreu J, 2010, P NATL ACAD SCI USA, V107, P5100, DOI 10.1073/pnas.0913108107; Tam YK, 1999, HUM GENE THER, V10, P1359, DOI 10.1089/10430349950018030; Underhill DM, 2005, BLOOD, V106, P2543, DOI 10.1182/blood-2005-03-1239; Vitale M, 2001, EUR J IMMUNOL, V31, P233, DOI 10.1002/1521-4141(200101)31:1<233::AID-IMMU233>3.0.CO;2-4; Vivier E, 2008, NAT IMMUNOL, V9, P503, DOI 10.1038/ni1582; Vogler I, 2011, J INNATE IMMUN, V3, P227, DOI 10.1159/000324112; Waldhauer I, 2008, ONCOGENE, V27, P5932, DOI 10.1038/onc.2008.267; Welte S, 2006, NAT IMMUNOL, V7, P1334, DOI 10.1038/ni1402; Zhang JG, 2012, IMMUNITY, V36, P646, DOI 10.1016/j.immuni.2012.03.009	35	6	6	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2013	288	24					17725	17733		10.1074/jbc.M113.453548	http://dx.doi.org/10.1074/jbc.M113.453548			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	164AH	23609447	Green Published, hybrid			2022-12-25	WOS:000320380600062
J	Fan, YX; Wong, L; Marino, MP; Ou, W; Shen, Y; Wu, WJ; Wong, KK; Reiser, J; Johnson, GR				Fan, Ying-Xin; Wong, Lily; Marino, Michael P.; Ou, Wu; Shen, Yi; Wu, Wen Jin; Wong, Kwok-Kin; Reiser, Jakob; Johnson, Gibbes R.			Acquired Substrate Preference for GAB1 Protein Bestows Transforming Activity to ERBB2 Kinase Lung Cancer Mutants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; PHOSPHORYLATION SITES; DOCKING PROTEIN; EGFR MUTATIONS; ACTIVATION; RESISTANCE; DOMAIN; SPECIFICITY; GEFITINIB; MECHANISM	Activating mutations in the alpha C-beta 4 loop of the ERBB2 kinase domain, such as ERBB2(YVMA) and ERBB2(G776VC), have been identified in human lung cancers and found to drive tumor formation. Here we observe that the docking protein GAB1 is hyper-phosphorylated in carcinomas from transgenic mice and in cell lines expressing these ERBB2 cancer mutants. Using dominant negative GAB1 mutants lacking canonical tyrosine residues for SHP2 and PI3K interactions or lentiviral shRNA that targets GAB1, we demonstrate that GAB1 phosphorylation is required for ERBB2 mutant-induced cell signaling, cell transformation, and tumorigenesis. An enzyme kinetic analysis comparing ERBB2(YVMA) to wild type using physiologically relevant peptide substrates reveals that ERBB2(YVMA) kinase adopts a striking preference for GAB1 phosphorylation sites as evidenced by similar to 150-fold increases in the specificity constants (k(cat)/K-m) for several GAB1 peptides, and this change in substrate selectivity was predominantly attributed to the peptide binding affinities as reflected by the apparent K-m values. Furthermore, we demonstrate that ERBB2(YVMA) phosphorylates GAB1 protein similar to 70-fold faster than wild type ERBB2 in vitro. Notably, the mutation does not significantly alter the K-m for ATP or sensitivity to lapatinib, suggesting that, unlike EGFR lung cancer mutants, the ATP binding cleft of the kinase is not significantly changed. Taken together, our results indicate that the acquired substrate preference for GAB1 is critical for the ERBB2 mutant-induced oncogenesis.	[Fan, Ying-Xin; Wong, Lily; Johnson, Gibbes R.] US FDA, Div Therapeut Prot, Ctr Drug Evaluat & Res, Bethesda, MD 20892 USA; [Marino, Michael P.; Ou, Wu; Reiser, Jakob] US FDA, Div Cellular & Gene Therapies, Ctr Biol Evaluat & Res, Bethesda, MD 20892 USA; [Shen, Yi; Wu, Wen Jin] US FDA, Div Monoclonal Antibodies, Ctr Drug Evaluat & Res, Bethesda, MD 20892 USA; [Wong, Kwok-Kin] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA	US Food & Drug Administration (FDA); US Food & Drug Administration (FDA); US Food & Drug Administration (FDA); Harvard University; Harvard Medical School	Fan, YX (corresponding author), US FDA, Div Therapeut Prot, Ctr Drug Evaluat & Res, Bldg 29A,Rm 3B-20,8800 Rockville Pike, Bethesda, MD 20892 USA.	ying-xin.fan@fda.hhs.gov; gibbes.johnson@fda.hhs.gov		wong, kwok kin/0000-0001-6323-235X	NCI NIH HHS [R01 CA166480, P01 CA154303, R01 CA140594, R01 CA122794] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA166480, P01CA154303, R01CA140594, R01CA122794] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aertgeerts K, 2011, J BIOL CHEM, V286, P18756, DOI 10.1074/jbc.M110.206193; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; Cunnick JM, 2000, J BIOL CHEM, V275, P13842, DOI 10.1074/jbc.275.18.13842; Cunnick JM, 2001, J BIOL CHEM, V276, P24380, DOI 10.1074/jbc.M010275200; Deb TB, 1998, J BIOL CHEM, V273, P16643, DOI 10.1074/jbc.273.27.16643; Fan YX, 2008, J BIOL CHEM, V283, P1588, DOI 10.1074/jbc.M708116200; Fan YX, 2005, BIOCHEM J, V392, P417, DOI 10.1042/BJ20051122; Fan YX, 2004, J BIOL CHEM, V279, P38143, DOI 10.1074/jbc.M405760200; Fan YX, 1996, BIOCHEM J, V315, P97, DOI 10.1042/bj3150097; Felici A, 2010, J CELL BIOCHEM, V111, P310, DOI 10.1002/jcb.22695; Gazdar AF, 2004, TRENDS MOL MED, V10, P481, DOI 10.1016/j.molmed.2004.08.008; Greulich H, 2005, PLOS MED, V2, P1167, DOI 10.1371/journal.pmed.0020313; Gu HH, 2003, TRENDS CELL BIOL, V13, P122, DOI 10.1016/S0962-8924(03)00002-3; Hoeben A, 2013, INT J CANCER, V132, P1042, DOI 10.1002/ijc.27763; HolgadoMadruga M, 1996, NATURE, V379, P560, DOI 10.1038/379560a0; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Itoh M, 2000, MOL CELL BIOL, V20, P3695, DOI 10.1128/MCB.20.10.3695-3704.2000; Lehr S, 1999, BIOCHEMISTRY-US, V38, P151, DOI 10.1021/bi9818265; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Lu YH, 2001, JNCI-J NATL CANCER I, V93, P1852, DOI 10.1093/jnci/93.24.1852; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Mattoon DR, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-24; Mood K, 2006, MOL BIOL CELL, V17, P3717, DOI 10.1091/mbc.E06-03-0244; Nishida K, 2003, CANCER SCI, V94, P1029, DOI 10.1111/j.1349-7006.2003.tb01396.x; Ou W, 2012, HUM GENE THER METHOD, V23, P137, DOI 10.1089/hgtb.2012.054; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; Perera SA, 2009, P NATL ACAD SCI USA, V106, P474, DOI 10.1073/pnas.0808930106; Pluta K, 2005, J GENE MED, V7, P803, DOI 10.1002/jgm.712; Qiu C, 2008, STRUCTURE, V16, P460, DOI 10.1016/j.str.2007.12.016; Qiu C, 2009, BIOCHEMISTRY-US, V48, P6624, DOI 10.1021/bi900755n; SEGATTO O, 1990, New Biologist, V2, P187; Sharial MSNM, 2012, ANN ONCOL, V23, P3007, DOI 10.1093/annonc/mds200; Shattuck DL, 2008, CANCER RES, V68, P1471, DOI 10.1158/0008-5472.CAN-07-5962; Shigematsu H, 2005, CANCER RES, V65, P1642, DOI 10.1158/0008-5472.CAN-04-4235; Sithanandam G, 2005, AM J RESP CELL MOL, V33, P490, DOI 10.1165/rcmb.2005-0049OC; SONGYANG Z, 1995, NATURE, V373, P536, DOI 10.1038/373536a0; Sordella R, 2004, SCIENCE, V305, P1163, DOI 10.1126/science.1101637; Stephens P, 2004, NATURE, V431, P525, DOI 10.1038/431525b; Vu T, 2012, FRONT ONCOL, V2, P1, DOI 10.3389/fonc.2012.00062; TSOU CL, 1993, SCIENCE, V262, P380, DOI 10.1126/science.8211158; Wang SZE, 2006, CANCER CELL, V10, P25, DOI 10.1016/j.ccr.2006.05.023; Weinstein IB, 2008, CANCER RES, V68, P3077, DOI 10.1158/0008-5472.CAN-07-3293; Wohrle FU, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-22; Yamasaki S, 2003, ONCOGENE, V22, P1546, DOI 10.1038/sj.onc.1206284; Yart A, 2003, CURR CANCER DRUG TAR, V3, P177, DOI 10.2174/1568009033481976; Yun CH, 2008, P NATL ACAD SCI USA, V105, P2070, DOI 10.1073/pnas.0709662105; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013	51	5	8	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2013	288	23					16895	16904		10.1074/jbc.M112.434217	http://dx.doi.org/10.1074/jbc.M112.434217			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	163ZU	23612964	Green Published, hybrid			2022-12-25	WOS:000320378900062
J	Qi, WT; Fitchev, PS; Cornwell, ML; Greenberg, J; Cabe, M; Weber, CR; Roy, HK; Crawford, SE; Savkovic, SD				Qi, Wentao; Fitchev, Philip S.; Cornwell, Mona L.; Greenberg, Jordan; Cabe, Maleen; Weber, Christopher R.; Roy, Hemant K.; Crawford, Susan E.; Savkovic, Suzana D.			FOXO3 Growth Inhibition of Colonic Cells Is Dependent on Intraepithelial Lipid Droplet Density	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID SYNTHASE; FORKHEAD TRANSCRIPTION FACTORS; TUMOR-SUPPRESSOR; COLORECTAL-CANCER; PAT-PROTEINS; KAPPA-B; EXPRESSION; SIRT1; ACCUMULATION; DEACETYLASE	Forkhead transcription factor FOXO3 plays a critical role in suppressing tumor growth, in part, by increasing the cell cycle inhibitor p27kip1, and Foxo3 deficiency in mice results in marked colonic epithelial proliferation. Here, we show in Foxo3-deficient colonic epithelial cells a striking increase in intracytoplasmic lipid droplets (LDs), a dynamic organelle recently observed in human tumor tissue. Although the regulation and function of LDs in non-adipocytes is unclear, we hypothesize that the anti-proliferative effect of FOXO3 was dependent on lowering LD density, thus decreasing fuel energy in both normal and colon cancer cells. In mouse colonic tumors, we found an increased expression of LD coat protein PLIN2 compared with normal colonic epithelial cells. Stimulation of LD density in human colon cancer cells led to a PI3K-dependent loss of FOXO3 and a decrease in the negative regulator of lipid metabolism in Sirtuin6 (SIRT6). Foxo3 deficiency also led to a decrease in SIRT6, revealing the existence of LD and FOXO3 feedback regulation in colonic cells. In parallel, LD-dependent loss of FOXO3 led to its dissociation from the promoter and decreased expression of the cell cycle inhibitor p27kip1. Stimulation of LD density promoted proliferation in colon cancer cells, whereas silencing PLIN2 or overexpression of FOXO3 inhibited proliferation. Taken together, FOXO3and LDs might serve as new targets for therapeutic intervention of colon cancer.	[Qi, Wentao; Greenberg, Jordan; Cabe, Maleen; Roy, Hemant K.; Savkovic, Suzana D.] Northshore Univ HealthSyst Res Inst, Div Gastroenterol, Dept Med, Evanston, IL 60201 USA; [Fitchev, Philip S.; Cornwell, Mona L.; Crawford, Susan E.] St Louis Univ Sch Med, Dept Pathol, St Louis, MO 63104 USA; [Weber, Christopher R.] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA	NorthShore University Health System; Saint Louis University; University of Chicago	Savkovic, SD (corresponding author), 1001 Univ Pl,Rm 304, Evanston, IL 60201 USA.	SSavkovic@northshore.org	Roy, Hemant/AAC-9096-2020	Weber, Christopher/0000-0002-2117-3184	National Institutes of Health [NIHR01-CA160809]; NIHR01-CA64239; Crohn's and Colitis Foundation of America [CCFA 1953]; Northshore University Health System; University of Chicago Collaborative Grant;  [K08DK088953]; NATIONAL CANCER INSTITUTE [R01CA064239, R01CA160809] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061931, K08DK088953] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIHR01-CA64239; Crohn's and Colitis Foundation of America; Northshore University Health System; University of Chicago Collaborative Grant; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants NIHR01-CA160809 (to S.D.S.) and NIHR01-CA64239 (to S.E.C.), Senior Investigator Award CCFA 1953 from the Crohn's and Colitis Foundation of America (to S.D.S.), and Northshore University Health System and University of Chicago Collaborative Grant (to S.D.S. and C.R.W.), and K08DK088953 (to C.R.W.).	Accioly MT, 2008, CANCER RES, V68, P1732, DOI 10.1158/0008-5472.CAN-07-1999; Arden KC, 2006, EXP GERONTOL, V41, P709, DOI 10.1016/j.exger.2006.05.015; Beller M, 2010, FEBS LETT, V584, P2176, DOI 10.1016/j.febslet.2010.03.022; Bozza PT, 2010, PROSTAG LEUKOTR ESS, V82, P243, DOI 10.1016/j.plefa.2010.02.005; Brasaemle DL, 2007, J LIPID RES, V48, P2547, DOI 10.1194/jlr.R700014-JLR200; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Ciaparrone M, 1998, CANCER RES, V58, P114; Delpuech O, 2007, MOL CELL BIOL, V27, P4917, DOI 10.1128/MCB.01789-06; Dugail I, 2007, CELL MOL LIFE SCI, V64, P2452, DOI 10.1007/s00018-007-7277-6; GOCZE PM, 1994, CYTOMETRY, V17, P151, DOI 10.1002/cyto.990170207; Greenberg AS, 2008, CELL METAB, V7, P472, DOI 10.1016/j.cmet.2008.05.005; Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Gunter MJ, 2006, J NUTR BIOCHEM, V17, P145, DOI 10.1016/j.jnutbio.2005.06.011; Heid HW, 1998, CELL TISSUE RES, V294, P309, DOI 10.1007/s004410051181; Herber DL, 2010, NAT MED, V16, P880, DOI 10.1038/nm.2172; Hoogeboom D, 2008, J BIOL CHEM, V283, P9224, DOI 10.1074/jbc.M706638200; Hu MCT, 2004, CELL, V117, P225, DOI 10.1016/S0092-8674(04)00302-2; Huang YN, 2012, GENE, V502, P87, DOI 10.1016/j.gene.2012.04.052; Kim HS, 2010, CELL METAB, V12, P224, DOI 10.1016/j.cmet.2010.06.009; Kimmel AR, 2010, J LIPID RES, V51, P468, DOI 10.1194/jlr.R000034; Kops GJPL, 2002, NATURE, V419, P316, DOI 10.1038/nature01036; Kuhnlein RP, 2012, J LIPID RES, V53, P1430, DOI 10.1194/jlr.R024299; Lee RYN, 2001, CURR BIOL, V11, P1950, DOI 10.1016/S0960-9822(01)00595-4; Li JN, 2001, CANCER RES, V61, P1493; Lin L, 2004, IMMUNITY, V21, P203, DOI 10.1016/j.immuni.2004.06.016; Liu XY, 2011, P NATL ACAD SCI USA, V108, P1925, DOI 10.1073/pnas.1019619108; Londos C, 2005, BIOCHIMIE, V87, P45, DOI 10.1016/j.biochi.2004.12.010; Martin S, 2006, NAT REV MOL CELL BIO, V7, P373, DOI 10.1038/nrm1912; McIntosh AL, 2012, AM J PHYSIOL-CELL PH, V303, pC728, DOI 10.1152/ajpcell.00448.2011; Medema RH, 2000, NATURE, V404, P782, DOI 10.1038/35008115; Nosho K, 2009, MODERN PATHOL, V22, P922, DOI 10.1038/modpathol.2009.49; Phillips WA, 1998, CANCER, V83, P41, DOI 10.1002/(SICI)1097-0142(19980701)83:1<41::AID-CNCR6>3.0.CO;2-H; Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583; Potente M, 2005, J CLIN INVEST, V115, P2382, DOI 10.1172/JCI23126; Qi WT, 2011, AM J PHYSIOL-GASTR L, V300, pG264, DOI 10.1152/ajpgi.00416.2010; Rashid A, 1997, AM J PATHOL, V150, P201; Rodgers JT, 2007, P NATL ACAD SCI USA, V104, P12861, DOI 10.1073/pnas.0702509104; Santos-Rosa H, 2005, EMBO J, V24, P1931, DOI 10.1038/sj.emboj.7600672; Sapiro JM, 2009, J LIPID RES, V50, P1621, DOI 10.1194/jlr.M800614-JLR200; Sebastian C, 2012, CELL, V151, P1185, DOI 10.1016/j.cell.2012.10.047; Snoeks L, 2008, INFECT IMMUN, V76, P4677, DOI 10.1128/IAI.00227-08; Snoeks L, 2009, LAB INVEST, V89, P1053, DOI 10.1038/labinvest.2009.66; Straub BK, 2010, MODERN PATHOL, V23, P480, DOI 10.1038/modpathol.2009.191; Straub BK, 2008, HEPATOLOGY, V47, P1936, DOI 10.1002/hep.22268; Tao RY, 2011, J BIOL CHEM, V286, P14681, DOI 10.1074/jbc.M110.201061; Vereshchagina N, 2006, DEVELOPMENT, V133, P4731, DOI 10.1242/dev.02659; Wang SM, 1997, J CELL BIOCHEM, V67, P84, DOI 10.1002/(SICI)1097-4644(19971001)67:1<84::AID-JCB9>3.0.CO;2-S; WHITEHEAD RH, 1994, EPITHELIAL CELL BIOL, V3, P119; Wu MQ, 2012, MED ONCOL, V29, P3240, DOI 10.1007/s12032-012-0260-6; Yang JY, 2009, CLIN CANCER RES, V15, P752, DOI 10.1158/1078-0432.CCR-08-0124; You H, 2006, P NATL ACAD SCI USA, V103, P9051, DOI 10.1073/pnas.0600889103; Zhang KB, 2012, ENDOCRINOLOGY, V153, P631, DOI 10.1210/en.2011-1527; Zhou WB, 2003, CANCER RES, V63, P7330	54	41	43	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 7	2013	288	23					16274	16281		10.1074/jbc.M113.470617	http://dx.doi.org/10.1074/jbc.M113.470617			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	163ZU	23603907	Green Published, hybrid			2022-12-25	WOS:000320378900007
J	Santos, JS; Syeda, R; Montal, M				Santos, Jose S.; Syeda, Ruhma; Montal, Mauricio			Stabilization of the Conductive Conformation of a Voltage-gated K+ (Kv) Channel THE LID MECHANISM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-TYPE INACTIVATION; SHAKER POTASSIUM CHANNELS; SELECTIVITY FILTER; MOLECULAR TEMPLATE; ION CONDUCTION; PORE MODULE; SLOW INACTIVATION; CRYSTAL-STRUCTURE; BLOCKING PEPTIDE; GATING CHARGE	Voltage-gated K+ (Kv) channels are molecular switches that sense membrane potential and in response open to allow K+ ions to diffuse out of the cell. In these proteins, sensor and pore belong to two distinct structural modules. We previously showed that the pore module alone is a robust yet dynamic structural unit in lipid membranes and that it senses potential and gates open to conduct K+ with unchanged fidelity. The implication is that the voltage sensitivity of K+ channels is not solely encoded in the sensor. Given that the coupling between sensor and pore remains elusive, we asked whether it is then possible to convert a pore module characterized by brief openings into a conductor with a prolonged lifetime in the open state. The strategy involves selected probes targeted to the filter gate of the channel aiming to modulate the probability of the channel being open assayed by single channel recordings from the sensorless pore module reconstituted in lipid bilayers. Here we show that the premature closing of the pore is bypassed by association of the filter gate with two novel open conformation stabilizers: an antidepressant and a peptide toxin known to act selectively on Kv channels. Such stabilization of the conductive conformation of the channel is faithfully mimicked by the covalent attachment of fluorescein at a cysteine residue selectively introduced near the filter gate. This modulation prolongs the occupancy of permeant ions at the gate. It is this longer embrace between ion and gate that we conjecture underlies the observed stabilization of the conductive conformation. This study provides a new way of thinking about gating.	[Santos, Jose S.; Syeda, Ruhma; Montal, Mauricio] Univ Calif San Diego, Div Biol Sci, Neurobiol Sect, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Montal, M (corresponding author), Univ Calif San Diego, Div Biol Sci, Neurobiol Sect, 9500 Gilman Dr, La Jolla, CA 92093 USA.	mmontal@ucsd.edu			National Institutes of Health Grant [GM-49711]; University of California San Diego Grant [RK-174C]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049711] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California San Diego Grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM-49711 (to M. M.). This work was also supported by University of California San Diego Grant RK-174C (to M. M.).	Abenavoli A, 2009, J GEN PHYSIOL, V134, P219, DOI 10.1085/jgp.200910266; Ambriz-Rivas M, 2005, PFLUG ARCH EUR J PHY, V450, P255, DOI 10.1007/s00424-005-1411-9; Aqvist J, 2000, NATURE, V404, P881, DOI 10.1038/35009114; Armstrong Clay M, 2003, Sci STKE, V2003, pre10, DOI 10.1126/stke.2003.188.re10; BAUKROWITZ T, 1995, NEURON, V15, P951, DOI 10.1016/0896-6273(95)90185-X; Bayley H, 2008, MOL BIOSYST, V4, P1191, DOI 10.1039/b808893d; Berneche S, 2005, STRUCTURE, V13, P591, DOI 10.1016/j.str.2004.12.019; Berneche S, 2001, NATURE, V414, P73, DOI 10.1038/35102067; Bezanilla F, 2000, PHYSIOL REV, V80, P555, DOI 10.1152/physrev.2000.80.2.555; CHOI KL, 1991, P NATL ACAD SCI USA, V88, P5092, DOI 10.1073/pnas.88.12.5092; del Camino D, 2005, J GEN PHYSIOL, V126, P419, DOI 10.1085/jgp.200509385; DEMO SD, 1991, NEURON, V7, P743, DOI 10.1016/0896-6273(91)90277-7; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; FRENCH RJ, 1981, BIOPHYS J, V34, P271, DOI 10.1016/S0006-3495(81)84849-7; GOLDSTEIN SAN, 1992, BIOPHYS J, V62, P5, DOI 10.1016/S0006-3495(92)81760-5; GOLDSTEIN SAN, 1994, NEURON, V12, P1377, DOI 10.1016/0896-6273(94)90452-9; GRISSMER S, 1989, BIOPHYS J, V55, P203, DOI 10.1016/S0006-3495(89)82793-6; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; HOSHI T, 1991, NEURON, V7, P547, DOI 10.1016/0896-6273(91)90367-9; Islas LD, 1999, J GEN PHYSIOL, V114, P723, DOI 10.1085/jgp.114.5.723; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; Kiss L, 1998, BIOPHYS J, V74, P1840, DOI 10.1016/S0006-3495(98)77894-4; Koch ED, 2004, BIOPHYS J, V86, P191, DOI 10.1016/S0006-3495(04)74096-5; Laine M, 2003, NEURON, V39, P467, DOI 10.1016/S0896-6273(03)00468-9; Lee SY, 2009, PLOS BIOL, V7, P676, DOI 10.1371/journal.pbio.1000047; Liu Y, 1996, NEURON, V16, P859, DOI 10.1016/S0896-6273(00)80106-3; Liu Y, 1997, NEURON, V19, P175, DOI 10.1016/S0896-6273(00)80357-8; Loboda A, 2001, BIOPHYS J, V81, P905, DOI 10.1016/S0006-3495(01)75750-5; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Long SB, 2005, SCIENCE, V309, P903, DOI 10.1126/science.1116270; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; Loots E, 2000, J GEN PHYSIOL, V116, P623, DOI 10.1085/jgp.116.5.623; Loots E, 1998, J GEN PHYSIOL, V112, P377, DOI 10.1085/jgp.112.4.377; Lundby A, 2006, J GEN PHYSIOL, V128, P293, DOI 10.1085/jgp.200609573; Lyskov S, 2008, NUCLEIC ACIDS RES, V36, pW233, DOI 10.1093/nar/gkn216; MACKINNON R, 1989, SCIENCE, V245, P1382, DOI 10.1126/science.2476850; MACKINNON R, 1991, NATURE, V350, P232, DOI 10.1038/350232a0; MACKINNON R, 1988, NEURON, V1, P997, DOI 10.1016/0896-6273(88)90156-0; MATTESON DR, 1986, J GEN PHYSIOL, V87, P795, DOI 10.1085/jgp.87.5.795; MILLER C, 1995, NEURON, V15, P5, DOI 10.1016/0896-6273(95)90057-8; Morais-Cabral JH, 2001, NATURE, V414, P37, DOI 10.1038/35102000; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Naranjo D, 1996, NEURON, V16, P123, DOI 10.1016/S0896-6273(00)80029-X; Noskov SY, 2004, NATURE, V431, P830, DOI 10.1038/nature02943; Ogielska EM, 1995, BIOPHYS J, V69, P2449, DOI 10.1016/S0006-3495(95)80114-1; PANYI G, 1995, BIOPHYS J, V69, P896, DOI 10.1016/S0006-3495(95)79963-5; PARDO LA, 1992, P NATL ACAD SCI USA, V89, P2466, DOI 10.1073/pnas.89.6.2466; PARK CS, 1992, BIOCHEMISTRY-US, V31, P7749, DOI 10.1021/bi00149a002; PARK CS, 1992, NEURON, V9, P307, DOI 10.1016/0896-6273(92)90169-E; Pathak M, 2005, J GEN PHYSIOL, V125, P57, DOI 10.1085/jgp.200409197; Patlak JB, 1999, J GEN PHYSIOL, V113, P385, DOI 10.1085/jgp.113.3.385; Qin F, 2004, BIOPHYS J, V86, P1488, DOI 10.1016/S0006-3495(04)74217-4; Santos JS, 2006, J GEN PHYSIOL, V128, P283, DOI 10.1085/jgp.200609572; Santos JS, 2012, J BIOL CHEM, V287, P43063, DOI 10.1074/jbc.M112.415091; Santos JS, 2008, J GEN PHYSIOL, V132, P651, DOI 10.1085/jgp.200810077; Santos JS, 2004, MAGN RESON CHEM, V42, P105, DOI 10.1002/mrc.1327; Schmidt D, 2012, P NATL ACAD SCI USA, V109, P10352, DOI 10.1073/pnas.1204700109; Schoppa NE, 1998, J GEN PHYSIOL, V111, P271, DOI 10.1085/jgp.111.2.271; Schroeder I, 2007, J GEN PHYSIOL, V130, P83, DOI 10.1085/jgp.200709802; Seebohm G, 2003, J PHYSIOL-LONDON, V552, P369, DOI 10.1113/jphysiol.2003.046490; Shahidullah M, 2003, BIOPHYS J, V84, P928, DOI 10.1016/S0006-3495(03)74910-8; STOCKER M, 1994, P NATL ACAD SCI USA, V91, P9509, DOI 10.1073/pnas.91.20.9509; SWENSON RP, 1981, NATURE, V291, P427, DOI 10.1038/291427a0; Syeda R, 2012, P NATL ACAD SCI USA, V109, P16917, DOI 10.1073/pnas.1205592109; Thompson J, 2000, BIOPHYS J, V78, P2382, DOI 10.1016/S0006-3495(00)76782-8; Vaid M, 2009, CHANNELS, V3, P3, DOI 10.4161/chan.3.1.7369; Yohannan S, 2007, J MOL BIOL, V366, P806, DOI 10.1016/j.jmb.2006.11.081; Yu LP, 2005, BIOCHEMISTRY-US, V44, P15834, DOI 10.1021/bi051656d; ZAGOTTA WN, 1990, SCIENCE, V250, P568, DOI 10.1126/science.2122520; ZAGOTTA WN, 1994, J GEN PHYSIOL, V103, P279, DOI 10.1085/jgp.103.2.279; Zhou YF, 2003, J MOL BIOL, V333, P965, DOI 10.1016/j.jmb.2003.09.022; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009	73	7	7	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2013	288	23					16619	16628		10.1074/jbc.M113.468728	http://dx.doi.org/10.1074/jbc.M113.468728			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	163ZU	23609443	hybrid, Green Published			2022-12-25	WOS:000320378900038
J	Argasinski, K				Argasinski, Krzysztof			The Dynamics of Sex Ratio Evolution: From the Gene Perspective to Multilevel Selection	PLOS ONE			English	Article							MODELS	The new dynamical game theoretic model of sex ratio evolution emphasizes the role of males as passive carriers of sex ratio genes. This shows inconsistency between population genetic models of sex ratio evolution and classical strategic models. In this work a novel technique of change of coordinates will be applied to the new model. This will reveal new aspects of the modelled phenomenon which cannot be shown or proven in the original formulation. The underlying goal is to describe the dynamics of selection of particular genes in the entire population, instead of in the same sex subpopulation, as in the previous paper and earlier population genetics approaches. This allows for analytical derivation of the unbiased strategic model from the model with rigorous non-simplified genetics. In effect, an alternative system of replicator equations is derived. It contains two subsystems: the first describes changes in gene frequencies (this is an alternative unbiased formalization of the Fisher-Dusing argument), whereas the second describes changes in the sex ratios in subpopulations of carriers of genes for each strategy. An intriguing analytical result of this work is that the fitness of a gene depends on the current sex ratio in the subpopulation of its carriers, not on the encoded individual strategy. Thus, the argument of the gene fitness function is not constant but is determined by the trajectory of the sex ratio among carriers of that gene. This aspect of the modelled phenomenon cannot be revealed by the static analysis. Dynamics of the sex ratio among gene carriers is driven by a dynamic "tug of war'' between female carriers expressing the encoded strategic trait value and random partners of male carriers expressing the average population strategy (a primary sex ratio). This mechanism can be called "double-level selection''. Therefore, gene interest perspective leads to multi-level selection.	Jagiellonian Univ, Inst Environm Sci, Krakow, Poland	Jagiellonian University	Argasinski, K (corresponding author), Jagiellonian Univ, Inst Environm Sci, Krakow, Poland.	krzysztof.argasinski@uj.edu.pl	Argasinski, Krzysztof/C-4086-2013	Argasinski, Krzysztof/0000-0002-2376-5853	Polish Ministry of Science and Higher Education [N N304 2764 33]; statutory fund [DS/WBiNoZ/INoS' 757]	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); statutory fund	This work was supported by grant N N304 2764 33 (finished) from the Polish Ministry of Science and Higher Education and the statutory fund DS/WBiNoZ/INoS' 757. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1995, EVOLUTIONARY GAME TH; Argasinski K, 2006, MATH BIOSCI, V202, P88, DOI 10.1016/j.mbs.2006.04.007; Argasinski K, 2012, J THEOR BIOL, V309, P134, DOI 10.1016/j.jtbi.2012.05.025; BOMZE IM, 1983, J THEOR BIOL, V101, P19, DOI 10.1016/0022-5193(83)90271-0; Bomze IM, 1989, LECT NOTES EC MATH S, V324; Cressman R., 1992, LECT NOTES BIOMATHEM, V94, P1, DOI 10.1007/978-3-642-49981-4; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; DAMUTH J, 1988, BIOL PHILOS, V3, P407, DOI 10.1007/BF00647962; Edwards AWF, 2000, THEOR POPUL BIOL, V58, P255, DOI 10.1006/tpbi.2000.1482; ESHEL I, 1982, THEOR POPUL BIOL, V21, P430, DOI 10.1016/0040-5809(82)90028-4; ESHEL I, 1982, THEOR POPUL BIOL, V21, P440, DOI 10.1016/0040-5809(82)90029-6; Fisher R.A., 1930, GENETICAL THEORY NAT; Hofbauer J., 1988, THEORY EVOLUTION DYN; Hofbauer J, 1990, EVOLUTIONARY GAMES P; Karlin S., 1986, THEORETICAL STUDIES; Maynard Smith J., 1982, pi; Oster G., 1979, SOME MATH QUESTIONS, VX, P21; Seger J, 2002, SEX RATIOS: CONCEPTS AND RESEARCH METHODS, P2, DOI 10.1017/CBO9780511542053.002; Traulsen A, 2006, P NATL ACAD SCI USA, V103, P10952, DOI 10.1073/pnas.0602530103; Wade MJ, 2010, NATURE, V463, pE8, DOI 10.1038/nature08809; Weissing FJ, 1996, J MATH BIOL, V34, P533; Wilson DS, 2008, CURR DIR PSYCHOL SCI, V17, P6, DOI 10.1111/j.1467-8721.2008.00538.x; Wilson DS, 1997, AM NAT             S, V150, P1	23	7	7	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2013	8	4							e60405	10.1371/journal.pone.0060405	http://dx.doi.org/10.1371/journal.pone.0060405			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IK	23613725	Green Published, Green Submitted, gold			2022-12-25	WOS:000317907200007
J	Bennett, MR; Falkingham, P; Morse, SA; Bates, K; Crompton, RH				Bennett, Matthew R.; Falkingham, Peter; Morse, Sarita A.; Bates, Karl; Crompton, Robin H.			Preserving the Impossible: Conservation of Soft-Sediment Hominin Footprint Sites and Strategies for Three-Dimensional Digital Data Capture	PLOS ONE			English	Article							LAETOLI; TRACKWAYS; DEPOSITS; EXAMPLE; MODELS; BASIN; FOOT	Human footprints provide some of the most publically emotive and tangible evidence of our ancestors. To the scientific community they provide evidence of stature, presence, behaviour and in the case of early hominins potential evidence with respect to the evolution of gait. While rare in the geological record the number of footprint sites has increased in recent years along with the analytical tools available for their study. Many of these sites are at risk from rapid erosion, including the Ileret footprints in northern Kenya which are second only in age to those at Laetoli (Tanzania). Unlithified, soft-sediment footprint sites such these pose a significant geoconservation challenge. In the first part of this paper conservation and preservation options are explored leading to the conclusion that to 'record and digitally rescue' provides the only viable approach. Key to such strategies is the increasing availability of three-dimensional data capture either via optical laser scanning and/or digital photogrammetry. Within the discipline there is a developing schism between those that favour one approach over the other and a requirement from geoconservationists and the scientific community for some form of objective appraisal of these alternatives is necessary. Consequently in the second part of this paper we evaluate these alternative approaches and the role they can play in a 'record and digitally rescue' conservation strategy. Using modern footprint data, digital models created via optical laser scanning are compared to those generated by state-of-the-art photogrammetry. Both methods give comparable although subtly different results. This data is evaluated alongside a review of field deployment issues to provide guidance to the community with respect to the factors which need to be considered in digital conservation of human/hominin footprints.	[Bennett, Matthew R.] Bournemouth Univ, Sch Appl Sci, Poole BH12 5BB, Dorset, England; [Falkingham, Peter] Univ London Royal Vet Coll, Dept Comparat Biomed Sci, Struct & Mot Lab, London, England; [Morse, Sarita A.; Bates, Karl; Crompton, Robin H.] Univ Liverpool, Inst Aging & Chron Dis, Liverpool L69 3BX, Merseyside, England; [Falkingham, Peter] Brown Univ, Div Biol & Med, Dept Ecol & Evolutionary Biol, Providence, RI 02912 USA	Bournemouth University; University of London; University of London Royal Veterinary College; University of Liverpool; Brown University	Bennett, MR (corresponding author), Bournemouth Univ, Sch Appl Sci, Talbot Campus, Poole BH12 5BB, Dorset, England.	mbennett@bmth.ac.uk	Falkingham, Peter/C-7656-2014	Falkingham, Peter/0000-0003-1856-8377; Bennett, Matthew/0000-0002-3063-8844	Natural Environment Research Council in the UK [NE/H004246/1]; Marie Curie International Outgoing Fellowship within 7th European Framework Programme; NERC [NE/H004211/1, NE/H004246/1] Funding Source: UKRI; Natural Environment Research Council [NE/H004211/1, NE/H004246/1] Funding Source: researchfish	Natural Environment Research Council in the UK(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Marie Curie International Outgoing Fellowship within 7th European Framework Programme; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The work was funded by the Natural Environment Research Council in the UK under grant number NE/H004246/1 and forms a contribution to the African Footprint Programme. PF was supported by a Marie Curie International Outgoing Fellowship within the 7th European Framework Programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnew N, 1998, SCI AM, V279, P44, DOI 10.1038/scientificamerican0998-44; Agnew N., 2002, CONSERV MANAGE ARCHA, V5, P7; Agnew N, 2004, CONSERVATION MANAGEM, V6, P295; Aldhouse-Green S.H.R., 1992, ARCHAEOLOGIA CAMBREN, V149, P14; Andalo FA, 2011, IM CRIM DET PREV 201, P1; Anton SC, 2002, J HUM EVOL, V43, P773, DOI 10.1006/jhev.2002.0602; Aramayo SA, 2009, ICHNOS, V16, P25, DOI 10.1080/10420940802470714; Bates KT, 2008, PALAEONTOLOGY, V51, P999, DOI 10.1111/j.1475-4983.2008.00789.x; Bates KT, 2008, J GEOL SOC LONDON, V165, P115, DOI 10.1144/0016-76492007-033; BEHRENSMEYER AK, 1981, NATURE, V289, P167, DOI 10.1038/289167a0; Bennett MR, 2010, P GEOLOGIST ASSOC, V121, P66, DOI 10.1016/j.pgeola.2010.01.002; Bennett MR, 2009, SCIENCE, V323, P1197, DOI 10.1126/science.1168132; Bennett MR, 2009, GEOL SOC AM 104 ANN, V41, P120; Bennett MR., 1996, GEOLOGY YOUR DOORSTE; Berge C, 2006, CR PALEVOL, V5, P561, DOI 10.1016/j.crpv.2005.09.001; Breithaupt Brent H., 2004, Ichnos, V11, P11, DOI 10.1080/10420940490442296; Cleere H, 2005, ARCHAEOLOGICAL HERIT, V9; Crompton RH, 2012, J R SOC INTERFACE, V9, P707, DOI 10.1098/rsif.2011.0258; DAY MH, 1980, NATURE, V286, P385, DOI 10.1038/286385a0; Demas M, 2006, GETTY CONSERV INST S, P64; Falkingham PL, 2010, PALAIOS, V25, P356, DOI 10.2110/palo.2009.p09-164r; Falkingham PL, 2012, PALAEONTOL ELECTRON, V15; FEIBEL CS, 1989, AM J PHYS ANTHROPOL, V78, P595, DOI 10.1002/ajpa.1330780412; Furukawa Y, 2010, IEEE T PATTERN ANAL, V32, P1362, DOI 10.1109/TPAMI.2009.161; Furukawa Y, 2010, PROC CVPR IEEE, P1434, DOI 10.1109/CVPR.2010.5539802; Gonzalez A, 2009, ICHNOS, V16, P12, DOI 10.1080/10420940802470672; Huddart D, 2008, ICHNOS, V15, P232, DOI 10.1080/10420940802470599; Jaehong Ahn, 2010, 2010 Proceedings of 16th International Conference on Virtual Systems and Multimedia (VSMM 2010), P340, DOI 10.1109/VSMM.2010.5665935; Kim JY, 2008, ICHNOS, V15, P126, DOI 10.1080/10420940802467868; Kim KS, 2009, ICHNOS, V16, P1, DOI 10.1080/10420940802470623; Kinahan J., 1996, S AFR ARCHAEOL BULL, V51, P94; LEAKEY M.D., 1987, LAETOLI PLIOCENE SIT; LEAKEY MD, 1979, NATURE, V278, P317, DOI 10.1038/278317a0; LEAKEY MG, 1995, NATURE, V376, P565, DOI 10.1038/376565a0; Lockley M, 2008, ICHNOS, V15, P106, DOI 10.1080/10420940802467835; Meldrum DJ, 2011, J AFR EARTH SCI, V60, P1, DOI 10.1016/j.jafrearsci.2011.01.003; Morse SA, 2010, QUATERNARY SCI REV, V29, P2571, DOI 10.1016/j.quascirev.2010.03.012; Musiba C, 2008, ICHNOS, V15, P166, DOI 10.1080/10420940802470383; *NAT CONS COUNC, 1990, EARTH SCI CONS GREAT; Pataky TC, 2008, J BIOMECH, V41, P3085, DOI 10.1016/j.jbiomech.2008.08.001; Petti F.M., 2008, STUDI TRENTINI SC NA, V83, P303; Raichlen DA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009769; Remondino F, 2010, PHOTOGRAMM REC, V25, P266, DOI 10.1111/j.1477-9730.2010.00587.x; Roberts D, 2008, ICHNOS, V15, P190, DOI 10.1080/10420940802470482; Roberts G, 1996, ANTIQUITY, V70, P647, DOI 10.1017/S0003598X00083770; Schmincke HU, 2009, B VOLCANOL, V71, P479, DOI 10.1007/s00445-008-0235-9; Snavely N, 2008, INT J COMPUT VISION, V80, P189, DOI 10.1007/s11263-007-0107-3; Snavely N, 2006, ACM T GRAPHIC, V25, P835, DOI 10.1145/1141911.1141964; The Royal Society, 2012, SCI OPEN ENTERPRISE; Zimmer B, 2012, GEOL SOC AM 108 ANN, V44, P13	50	21	21	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2013	8	4							e60755	10.1371/journal.pone.0060755	http://dx.doi.org/10.1371/journal.pone.0060755			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IK	23613743	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000317907200013
J	Dominguez, LG; Velazquez, JLP; Galan, RF				Dominguez, Luis Garcia; Velazquez, Jose Luis Perez; Galan, Roberto Fernandez			A Model of Functional Brain Connectivity and Background Noise as a Biomarker for Cognitive Phenotypes: Application to Autism	PLOS ONE			English	Article							SPATIAL-ORGANIZATION; PREFRONTAL CORTEX; SPECTRUM DISORDER; COMPLEXITY; NETWORKS; SYNCHRONIZATION; SPECIFICITY; DYNAMICS	We present an efficient approach to discriminate between typical and atypical brains from macroscopic neural dynamics recorded as magnetoencephalograms (MEG). Our approach is based on the fact that spontaneous brain activity can be accurately described with stochastic dynamics, as a multivariate Ornstein-Uhlenbeck process (mOUP). By fitting the data to a mOUP we obtain: 1) the functional connectivity matrix, corresponding to the drift operator, and 2) the traces of background stochastic activity (noise) driving the brain. We applied this method to investigate functional connectivity and background noise in juvenile patients (n = 9) with Asperger's syndrome, a form of autism spectrum disorder (ASD), and compared them to age-matched juvenile control subjects (n = 10). Our analysis reveals significant alterations in both functional brain connectivity and background noise in ASD patients. The dominant connectivity change in ASD relative to control shows enhanced functional excitation from occipital to frontal areas along a parasagittal axis. Background noise in ASD patients is spatially correlated over wide areas, as opposed to control, where areas driven by correlated noise form smaller patches. An analysis of the spatial complexity reveals that it is significantly lower in ASD subjects. Although the detailed physiological mechanisms underlying these alterations cannot be determined from macroscopic brain recordings, we speculate that enhanced occipital-frontal excitation may result from changes in white matter density in ASD, as suggested in previous studies. We also venture that long-range spatial correlations in the background noise may result from less specificity (or more promiscuity) of thalamo-cortical projections. All the calculations involved in our analysis are highly efficient and outperform other algorithms to discriminate typical and atypical brains with a comparable level of accuracy. Altogether our results demonstrate a promising potential of our approach as an efficient biomarker for altered brain dynamics associated with a cognitive phenotype.	[Dominguez, Luis Garcia] Univ Toronto, Temerty Ctr Therapeut Brain Intervent, Ctr Addict & Mental Hlth, Toronto, ON, Canada; [Velazquez, Jose Luis Perez] Univ Toronto, Hosp Sick Children, Brain & Behav Ctr, Neurosci & Mental Hlth Programme,Div Neurol, Toronto, ON M5G 1X8, Canada; [Velazquez, Jose Luis Perez] Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A1, Canada; [Velazquez, Jose Luis Perez] Univ Toronto, Dept Paediat, Toronto, ON M5S 1A1, Canada; [Galan, Roberto Fernandez] Case Western Reserve Univ, Sch Med, Dept Neurosci, Cleveland, OH 44106 USA	University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; Case Western Reserve University	Galan, RF (corresponding author), Case Western Reserve Univ, Sch Med, Dept Neurosci, Cleveland, OH 44106 USA.	rfgalan@case.edu		Fernandez Galan, Roberto/0000-0003-1426-1917	Natural Sciences and Engineering Research Council of Canada [227059-2012]; Mt. Sinai Health Care Foundation; NSERC	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Mt. Sinai Health Care Foundation; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	This study was funded in part by a grant (number 227059-2012) of the Natural Sciences and Engineering Research Council of Canada, NSERC (JLPV) and a scholarship of The Mt. Sinai Health Care Foundation (RFG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnett L, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.051914; Belmonte MK, 2004, J NEUROSCI, V24, P9228, DOI 10.1523/JNEUROSCI.3340-04.2004; Boser BE, 1992, SUPPORT VECTOR MACHI; Bosl W, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-18; Buchman Timothy G, 2004, Curr Opin Crit Care, V10, P378, DOI 10.1097/01.ccx.0000139369.65817.b6; Buzsaki G., 2006, RHYTHMS BRAIN; Camargo A, 2008, SOURCE CODE BIOL MED, V3, DOI 10.1186/1751-0473-3-15; Cheng W, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00058; Cherkassky VL, 2006, NEUROREPORT, V17, P1687, DOI 10.1097/01.wnr.0000239956.45448.4c; Constantinidis C, 2001, J NEUROSCI, V21, P3646, DOI 10.1523/JNEUROSCI.21-10-03646.2001; deOliveira SC, 1997, J NEUROSCI, V17, P9248; Di Martino A, 2011, BIOL PSYCHIAT, V69, P847, DOI 10.1016/j.biopsych.2010.10.029; Dominguez LG, 2008, INT J BIFURCAT CHAOS, V18, P429; Galan RF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002148; Gardiner C W, 2004, HDB STOCHASTIC METHO; Garrett DD, 2011, J NEUROSCI, V31, P4496, DOI 10.1523/JNEUROSCI.5641-10.2011; Ghosh A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000196; Han S, 2012, NATURE; Herbert MR, 2005, NEUROSCIENTIST, V11, P417, DOI 10.1177/0091270005278866; Kohane IS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033224; Komiyama T, 2010, NATURE, V464, P1182, DOI 10.1038/nature08897; Kostelecki W, 2012, FRONTIERS I IN PRESS; Mattila ML, 2007, J AM ACAD CHILD PSY, V46, P636, DOI 10.1097/chi.0b013e318033ff42; McIntosh AR, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000106; Mizuno A, 2006, BRAIN RES, V1104, P160, DOI 10.1016/j.brainres.2006.05.064; Monk CS, 2009, NEUROIMAGE, V47, P764, DOI 10.1016/j.neuroimage.2009.04.069; Morgan JT, 2012, BRAIN RES, V1456, P72, DOI 10.1016/j.brainres.2012.03.036; Murias M, 2007, BIOL PSYCHIAT, V62, P270, DOI 10.1016/j.biopsych.2006.11.012; Perez-Velazquez JL, 2011, BRAIN BEHAV CONTINUU; Rippon G, 2007, INT J PSYCHOPHYSIOL, V63, P164, DOI 10.1016/j.ijpsycho.2006.03.012; Robinson PA, 1998, PHYS REV E, V58, P3557, DOI 10.1103/PhysRevE.58.3557; Robinson PA, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.021903; Sporns O, 2000, NEURAL NETWORKS, V13, P909, DOI 10.1016/S0893-6080(00)00053-8; Steinke GK, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002207; Teitelbaum A, 2012, AUTISM SPECTRUM DISO; Tononi G, 1999, P NATL ACAD SCI USA, V96, P3257, DOI 10.1073/pnas.96.6.3257; Travers BG, 2012, AUTISM RES, V5, P289, DOI 10.1002/aur.1243; Tsiaras V, 2011, COMPUT BIOL MED, V41, P1166, DOI 10.1016/j.compbiomed.2011.04.004; Uhlhaas PJ, 2007, BIOL PSYCHIAT, V62, P190, DOI 10.1016/j.biopsych.2007.05.023; Vaillancourt DE, 2002, NEUROBIOL AGING, V23, P1, DOI 10.1016/S0197-4580(01)00247-0; Vapnik V., 1998, STAT LEARNING THEORY; Velazquez JLP, 2009, INT J PSYCHOPHYSIOL, V73, P341, DOI 10.1016/j.ijpsycho.2009.05.009; Whiteley P., 2010, AUTISM INSIGHTS, V2010, P17, DOI DOI 10.4137/AUI.S3938; Yizhar O, 2011, NATURE, V477, P171, DOI 10.1038/nature10360; Zhou YA, 2010, COGN NEURODYNAMICS, V4, P275, DOI 10.1007/s11571-010-9126-9	45	21	21	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2013	8	4							e61493	10.1371/journal.pone.0061493	http://dx.doi.org/10.1371/journal.pone.0061493			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IK	23613864	Green Submitted, Green Published, gold			2022-12-25	WOS:000317907200059
J	Fernandez, MS; Garcia, RA; Fiorelli, L; Scolaro, A; Salvador, RB; Cotaro, CN; Kaiser, GW; Dyke, GJ				Fernandez, Mariela S.; Garcia, Rodolfo A.; Fiorelli, Lucas; Scolaro, Alejandro; Salvador, Rodrigo B.; Cotaro, Carlos N.; Kaiser, Gary W.; Dyke, Gareth J.			A Large Accumulation of Avian Eggs from the Late Cretaceous of Patagonia (Argentina) Reveals a Novel Nesting Strategy in Mesozoic Birds	PLOS ONE			English	Article							WATER-VAPOR CONDUCTANCE; DINOSAUR EGGS; GAS CONDUCTANCE; EGGSHELLS; NEUQUEN; CROCODYLIFORMES; ARCHOSAURIA; INCUBATION; SHELL	We report the first evidence for a nesting colony of Mesozoic birds on Gondwana: a fossil accumulation in Late Cretaceous rocks mapped and collected from within the campus of the National University of Comahue, Neuquen City, Patagonia (Argentina). Here, Cretaceous ornithothoracine birds, almost certainly Enanthiornithes, nested in an arid, shallow basinal environment among sand dunes close to an ephemeral water-course. We mapped and collected 65 complete, near-complete, and broken eggs across an area of more than 55 m(2). These eggs were laid either singly, or occasionally in pairs, onto a sandy substrate. All eggs were found apparently in, or close to, their original nest site; they all occur within the same bedding plane and may represent the product of a single nesting season or a short series of nesting attempts. Although there is no evidence for nesting structures, all but one of the Comahue eggs were half-buried upright in the sand with their pointed end downwards, a position that would have exposed the pole containing the air cell and precluded egg turning. This egg position is not seen in living birds, with the exception of the basal galliform megapodes who place their eggs within mounds of vegetation or burrows. This accumulation reveals a novel nesting behaviour in Mesozoic Aves that was perhaps shared with the non-avian and phylogenetically more basal troodontid theropods.	[Fernandez, Mariela S.] Consejo Nacl Invest Cient & Tecn, Inst Invest Biodiversidad & Medioambiente INIBIOM, San Carlos De Bariloche, Rio Negro, Argentina; [Garcia, Rodolfo A.] Univ Nacl Rio Negro, Museo Carlos Ameghino, Inst Invest Paleontol & Geol, Cipolletti, Rio Negro, Argentina; [Fiorelli, Lucas] Consejo Nacl Invest Cient & Tecn, CRILAR, Ctr Reg Invest Cientificas & Transferencia Tecnol, Anillaco, La Rioja, Argentina; [Scolaro, Alejandro] Univ Nacl Patagonia San Juan Bosco, Catedra Ecol, Puerto Madryn, Chubut, Argentina; [Scolaro, Alejandro] Consejo Nacl Invest Cient & Tecn, CENPAT, Puerto Madryn, Chubut, Argentina; [Salvador, Rodrigo B.] Univ Sao Paulo, Museu Zool, Sao Paulo, Brazil; [Cotaro, Carlos N.] Ctr Atom Bariloche, San Carlos De Bariloche, Rio Negro, Argentina; [Kaiser, Gary W.] Royal British Columbia Museum, Victoria, BC, Canada; [Dyke, Gareth J.] Univ Southampton, Natl Oceanog Ctr, Southampton, Hants, England	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidad Nacional de la Patagonia San Juan Bosco; Centro Nacional Patagonico (CENPAT); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidade de Sao Paulo; Comision Nacional de Energia Atomica (CNEA); Centro Atomico Bariloche; NERC National Oceanography Centre; University of Southampton	Dyke, GJ (corresponding author), Univ Southampton, Natl Oceanog Ctr, Southampton, Hants, England.	gareth.dyke@soton.ac.uk	Salvador, Rodrigo Brincalepe/F-7524-2012; Dyke, Gareth/AAJ-9320-2020	Salvador, Rodrigo Brincalepe/0000-0002-4238-2276; Dyke, Gareth/0000-0002-8390-7817	Jurassic Foundation; Secretaria de Gobierno de La Rioja; Consejo Federal de Ciencia y Tecnologia (COFECYT) [1198/06, LR02/06]	Jurassic Foundation; Secretaria de Gobierno de La Rioja; Consejo Federal de Ciencia y Tecnologia (COFECYT)	Funding was provided by the Jurassic Foundation (to RAG), the Secretaria de Gobierno de La Rioja and the Consejo Federal de Ciencia y Tecnologia (COFECYT) (SCTIP No1198/06 - Proyecto LR02/06). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarenga Herculano M.F., 1992, Natural History Museum of Los Angeles County Science Series, V36, P51; AR A, 1985, RESP PHYSIOL, V61, P1, DOI 10.1016/0034-5687(85)90024-6; AR A, 1974, CONDOR, V76, P153, DOI 10.2307/1366725; Badano L.A., 1982, Historia Natural (Corrientes), V2, P241; Barta Z, 1997, FUNCTIONAL ECOLOGY, V11, P656; Benton A.H., 1974, FIELD BIOL ECOLOGY; BOARD RG, 1982, BIOL REV, V57, P1, DOI 10.1111/j.1469-185X.1982.tb00362.x; Bonaparte J.F., 1991, REV MUSEO ARGENTINO, V4, P15; Brennan PLR, 2009, WILSON J ORNITHOL, V121, P506, DOI 10.1676/08-073.1; Caldwell MW, 2001, ACTA PALAEONTOL POL, V46, P203; Campbell B., 1985, DICT BIRDS; Carrano MT, 2008, J SYST PALAEONTOL, V6, P183, DOI 10.1017/S1477201907002246; Chiappe L. M., 2002, MESOZOIC BIRDS HEADS; CHIAPPE LM, 1994, J VERTEBR PALEONTOL, V14, P230, DOI 10.1080/02724634.1994.10011554; Chiappe Luis M., 1995, Courier Forschungsinstitut Senckenberg, V181, P55; Chinsamy A., 1992, Palaeontologia Africana, V29, P39; Clark JM, 2011, ZOOL J LINN SOC-LOND, V163, pS152, DOI 10.1111/j.1096-3642.2011.00719.x; Davies S.J.J.F., 2002, RATITES TINAMOUS; Deeming D.C., 2002, AVIAN INCUBATION BEH; Deeming DC, 2006, PALAEONTOLOGY, V49, P171, DOI 10.1111/j.1475-4983.2005.00536.x; Dunning J., 2008, CRC HDB AVIAN BODY M, V2nd; Dyke G, 2012, NATURWISSENSCHAFTEN, V99, P435, DOI 10.1007/s00114-012-0917-1; Elliott A, 1994, HDB BIRDS WORLD, P278; Fiorelli LE, 2010, AMEGHINIANA, V47, P387, DOI 10.5710/AMGH.v47i3.1; Fiorelli Lucas, 2008, Arquivos do Museu Nacional Rio de Janeiro, V66, P83; Fiorelli LE, 2012, CRETACEOUS RES, V35, P94, DOI 10.1016/j.cretres.2011.12.002; Fiorelli Lucas E., 2007, Arquivos do Museu Nacional (Rio de Janeiro), V65, P417; Folch A., 1992, P98; Garrido AC, 2011, REV MUSEO ARGENTINO, V12, P121; Grellet-Tinner G, 2006, PALAEOGEOGR PALAEOCL, V232, P294, DOI 10.1016/j.palaeo.2005.10.029; Grellet-Tinner G, 2002, J VERTEBR PALEONTOL, V22, P719, DOI 10.1671/0272-4634(2002)022[0719:AAEFTC]2.0.CO;2; Grellet-Tinner G, 2012, PALAIOS, V27, P35, DOI 10.2110/palo.2011.p11-061r; Hayward JL, 2000, PALAIOS, V15, P343, DOI 10.2307/3515541; Jackson FD, 2008, PALEOBIOLOGY, V34, P229, DOI 10.1666/0094-8373(2008)034[0229:COWVCI]2.0.CO;2; Jackson FD, 2010, J VERTEBR PALEONTOL, V30, P1142, DOI 10.1080/02724634.2010.483537; KIDWELL S M, 1986, Palaios, V1, P228, DOI 10.2307/3514687; Kidwell SM, 1993, PALEONTOLOGICAL SOC, V6, P275; Kidwell Susan M., 1993, Short Courses in Paleontology, V6, P1; LANCASTER D. A., 1964, CONDOR, V66, P253, DOI 10.2307/1365285; Leanza HA, 2004, CRETACEOUS RES, V25, P61, DOI 10.1016/j.cretres.2003.10.005; Longrich NR, 2012, NATURE, V488, P205, DOI 10.1038/nature11227; Martin R.E., 1999, TAPHONOMY PROCESS AP; Martinelli AG, 2008, CR PALEVOL, V7, P371, DOI 10.1016/j.crpv.2008.05.002; NORELL MA, 1995, NATURE, V378, P774, DOI 10.1038/378774a0; O'Connor JK, 2013, J SYST PALAEONTOL, V11, P889, DOI 10.1080/14772019.2012.690455; PAGANELLI CV, 1974, CONDOR, V76, P319, DOI 10.2307/1366345; SABATH K, 1991, Acta Palaeontologica Polonica, V36, P151; SALVADOR R. B., 2011, 22 C BRAS PAL AT, P742; Sánchez M.L., 2006, Rev. Asoc. Geol. Argent., V61, P236; Schreiber Elizabeth, 2002, BIOL MARINE BIRDS, DOI 10.1201/9781420036305; Schweitzer MH, 2002, J VERTEBR PALEONTOL, V22, P191, DOI 10.1671/0272-4634(2002)022[0191:LCAEWE]2.0.CO;2; Scolaro JA, 1985, CTR NACL PATAGONICO, V103, P1; SEYMOUR RS, 1979, PALEOBIOLOGY, V5, P1; Varricchio DJ, 2008, SCIENCE, V322, P1826, DOI 10.1126/science.1163245; Walters M, 1993, MANUAL IDENTIFICACIO; Wiersma P, 1996, HDB BIRDS WORLD, P411; Woodward A.S., 1896, ANALES MUSEO PLATA P, V4, P1; Woodward AS, 1901, P ZOOL SOC LOND, V1, P169; Zavalaga CB, 2009, BIRD CONSERV INT, V19, P175, DOI 10.1017/S0959270908008332; Zhou ZH, 2004, SCIENCE, V306, P653, DOI 10.1126/science.1100000	60	25	27	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2013	8	4							e61030	10.1371/journal.pone.0061030	http://dx.doi.org/10.1371/journal.pone.0061030			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IK	23613776	gold, Green Published, Green Accepted			2022-12-25	WOS:000317907200025
J	Laiho, A; Kotaja, N; Gyenesei, A; Sironen, A				Laiho, Asta; Kotaja, Noora; Gyenesei, Attila; Sironen, Anu			Transcriptome Profiling of the Murine Testis during the First Wave of Spermatogenesis	PLOS ONE			English	Article							MALE GERM-CELLS; GENE-EXPRESSION; MOUSE; DISCOVERY	Correct gene expression patterns form the basis for male germ cell differentiation and male fertility. Although previous studies have elucidated the importance of testis specific gene expression, the exact transcripts and comprehensive gene expression patterns remain unknown. Large scale sequencing techniques have enabled cost effective analysis of gene expression and isoform studies. Using the SOLiD 4 next-generation sequencing platform we have investigated the gene expression patterns at five different time points during the first wave on murine spermatogenesis. Our results highlight the upregulation of spermatogenesis related biological processes and associated cellular components. Elucidation of differential gene expression at important time points during the sperm development emphasizes the importance of correct timing of gene expression within biological processes. Differential gene level expression was analyzed with R/Bioconductor's Limma package and isoform analysis was conducted with the Cufflinks pipeline. At gene level total of 2494 differentially expressed genes were identified and Cufflinks characterized over 160 000 gene isoforms, of which 29% were novel transcripts assigned to known genes. Isoforms were detected for 57% of expressed genes and in a total over 26 000 genes were expressed in the testis. Differential promoter and transcription start site usage appears also to play a role in regulation of gene expression during spermatogenesis. Furthermore, we identified 947 upregulated long non-coding RNAs during the first wave of spermatogenesis. These RNAs appeared to be highly specific to different time points. Transcriptomic analysis of testis tissue samples is highly informative due to the large number of expressed genes and identified isoforms. Our study provides a very valuable basis for investigation of gene isoforms and regulation and factors contributing to male fertility.	[Laiho, Asta; Gyenesei, Attila] Univ Turku, Turku Ctr Biotechnol, Finnish Microarray & Sequencing Ctr, Turku, Finland; [Laiho, Asta; Gyenesei, Attila] Abo Akad Univ, Turku, Finland; [Sironen, Anu] Agrifood Res Finland, Jokioinen, Finland; [Kotaja, Noora] Univ Turku, Inst Biomed, Dept Physiol, Turku, Finland	University of Turku; Abo Akademi University; Natural Resources Institute Finland (Luke); University of Turku	Sironen, A (corresponding author), Agrifood Res Finland, Jokioinen, Finland.	anu.sironen@mtt.fi		Kotaja, Noora/0000-0003-1503-9170	Academy of Finland	Academy of Finland(Academy of Finland)	This study was funded by the Academy of Finland (http://www.aka.fi/eng). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BELLVE AR, 1977, J CELL BIOL, V74, P68, DOI 10.1083/jcb.74.1.68; Ben-Asher HW, 2010, MOL REPROD DEV, V77, P241, DOI 10.1002/mrd.21139; Chalmel F, 2007, P NATL ACAD SCI USA, V104, P8346, DOI 10.1073/pnas.0701883104; Chan WY, 2006, MOL CELL ENDOCRINOL, V250, P8, DOI 10.1016/j.mce.2005.12.018; Choudhury DR, 2010, BIOL REPROD, V83, P663, DOI 10.1095/biolreprod.110.084889; Eddy EM, 2002, RECENT PROG HORM RES, V57, P103, DOI 10.1210/rp.57.1.103; Eden E, 2007, PLOS COMPUT BIOL, V3, P508, DOI 10.1371/journal.pcbi.0030039; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; JEGOU B, 1992, BAILLIERE CLIN ENDOC, V6, P273, DOI 10.1016/S0950-351X(05)80151-X; Kokkinaki M, 2010, REPRODUCTION, V139, P1011, DOI 10.1530/REP-09-0566; Kotaja N, 2004, NAT METHODS, V1, P249, DOI 10.1038/nmeth1204-249; Lee TL, 2012, METHODS MOL BIOL, V825, P75, DOI 10.1007/978-1-61779-436-0_7; Lin YN, 2005, SEMIN REPROD MED, V23, P201, DOI 10.1055/s-2005-872448; Liu TD, 2012, REPROD DOMEST ANIM, V47, P724, DOI 10.1111/j.1439-0531.2011.01950.x; Meikar O, 2012, SUBCELL BIOCH, V61, P119; O'Shaughnessy PJ, 2008, REPRODUCTION, V135, P839, DOI 10.1530/REP-08-0012; O'Shaughnessy PJ, 2002, BIOL REPROD, V66, P966, DOI 10.1095/biolreprod66.4.966; OAKBERG EF, 1957, NATURE, V180, P1137, DOI 10.1038/1801137a0; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Rossi P, 2004, GENE EXPR PATTERNS, V4, P267, DOI 10.1016/j.modgep.2003.11.003; Ryser S, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-29; Sassone-Corsi P, 1998, INT J BIOCHEM CELL B, V30, P27, DOI 10.1016/S1357-2725(97)00093-9; Schlecht U, 2004, MOL BIOL CELL, V15, P1031, DOI 10.1091/mbc.E03-10-0762; Schultz N, 2003, P NATL ACAD SCI USA, V100, P12201, DOI 10.1073/pnas.1635054100; Shima JE, 2004, BIOL REPROD, V71, P319, DOI 10.1095/biolreprod.103.026880; Steger K, 1999, ANAT EMBRYOL, V199, P471, DOI 10.1007/s004290050245; Takahashi H, 2011, J TOXICOL SCI, V36, P559; Tanaka H, 2005, CELL MOL LIFE SCI, V62, P344, DOI 10.1007/s00018-004-4394-y; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; VERGOUWEN RPFA, 1993, J REPROD FERTIL, V99, P479, DOI 10.1530/jrf.0.0990479; Waclawska A, 2012, SYST BIOL REPROD MED; Wrobel G, 2005, REPRODUCTION, V129, P1, DOI 10.1530/rep.1.00408; Wu SM, 2004, GENOMICS, V84, P971, DOI 10.1016/j.ygeno.2004.08.018	33	93	96	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2013	8	4							e61558	10.1371/journal.pone.0061558	http://dx.doi.org/10.1371/journal.pone.0061558			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IK	23613874	Green Published, gold			2022-12-25	WOS:000317907200064
J	Murray, KA; Skerratt, LF; Garland, S; Kriticos, D; McCallum, H				Murray, Kris A.; Skerratt, Lee F.; Garland, Stephen; Kriticos, Darren; McCallum, Hamish			Whether the Weather Drives Patterns of Endemic Amphibian Chytridiomycosis: A Pathogen Proliferation Approach	PLOS ONE			English	Article							BATRACHOCHYTRIUM-DENDROBATIDIS INFECTION; CHYTRID FUNGUS; TEMPERATURE; DISEASE; PREVALENCE; DECLINES; SURVIVAL; CLIMATE; EXTINCTION; MORTALITY	The pandemic amphibian disease chytridiomycosis often exhibits strong seasonality in both prevalence and disease-associated mortality once it becomes endemic. One hypothesis that could explain this temporal pattern is that simple weather-driven pathogen proliferation (population growth) is a major driver of chytridiomycosis disease dynamics. Despite various elaborations of this hypothesis in the literature for explaining amphibian declines (e.g., the chytrid thermal-optimum hypothesis) it has not been formally tested on infection patterns in the wild. In this study we developed a simple process-based model to simulate the growth of the pathogen Batrachochytrium dendrobatidis (Bd) under varying weather conditions to provide an a priori test of a weather-linked pathogen proliferation hypothesis for endemic chytridiomycosis. We found strong support for several predictions of the proliferation hypothesis when applied to our model species, Litoria pearsoniana, sampled across multiple sites and years: the weather-driven simulations of pathogen growth potential (represented as a growth index in the 30 days prior to sampling; GI(30)) were positively related to both the prevalence and intensity of Bd infections, which were themselves strongly and positively correlated. In addition, a machine-learning classifier achieved similar to 72% success in classifying positive qPCR results when utilising just three informative predictors 1) GI(30), 2) frog body size and 3) rain on the day of sampling. Hence, while intrinsic traits of the individuals sampled (species, size, sex) and nuisance sampling variables (rainfall when sampling) influenced infection patterns obtained when sampling via qPCR, our results also strongly suggest that weather-linked pathogen proliferation plays a key role in the infection dynamics of endemic chytridiomycosis in our study system. Predictive applications of the model include surveillance design, outbreak preparedness and response, climate change scenario modelling and the interpretation of historical patterns of amphibian decline.	[Murray, Kris A.] EcoHlth Alliance, New York, NY USA; [Skerratt, Lee F.; Garland, Stephen] James Cook Univ, Sch Publ Hlth, Trop Med & Rehabil Sci & Amphibian Dis Ecol Grp, Townsville, Qld 4811, Australia; [Kriticos, Darren] CSIRO Ecosyst Sci, Canberra, ACT, Australia; [Kriticos, Darren] Cooperat Res Ctr Natl Plant Biosecur, Canberra, ACT, Australia; [McCallum, Hamish] Griffith Univ, Sch Environm, Nathan, Qld 4111, Australia	EcoHealth Alliance; James Cook University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Griffith University	Murray, KA (corresponding author), EcoHlth Alliance, New York, NY USA.	murray@ecohealthalliance.org	Skerratt, Lee Francis/L-2797-2013; McCallum, Hamish/E-1638-2013; Kriticos, Darren J/A-4170-2008; Murray, Kris/AAY-6137-2020	McCallum, Hamish/0000-0002-3493-0412; Kriticos, Darren J/0000-0003-2599-8105; Skerratt, Lee/0000-0003-3471-7512; Murray, Kris/0000-0002-8382-0674	Australian Research Council [DP0451402]; Australian Postgraduate Award; Australian Biosecurity CRC professional development award; Wildlife Preservation Society of Australia student research award; Australian Government Department of the Environment and Heritage [42/2004]; James Cook University - Griffith University Collaboration Grant	Australian Research Council(Australian Research Council); Australian Postgraduate Award(Australian Government); Australian Biosecurity CRC professional development award(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Wildlife Preservation Society of Australia student research award; Australian Government Department of the Environment and Heritage(Australian Government); James Cook University - Griffith University Collaboration Grant	Major funding for the project was supplied by Australian Research Council Discovery Grant DP0451402 to H. McCallum, R. Speare, A. Hyatt, and P. Daszak. K. Murray was supported by an Australian Postgraduate Award, an Australian Biosecurity CRC professional development award, and a Wildlife Preservation Society of Australia student research award. Funding by the Australian Government Department of the Environment and Heritage (tender 42/2004 on the epidemiology of chytridiomycosis) contributed to the cost of diagnostic testing, and we thank R. Campbell for some of the PCR analyses. K. Murray was partially supported while writing the manuscript by EcoHealth Alliance and a James Cook University - Griffith University Collaboration Grant to L. Skerratt, H. McCallum and J-M. Hero. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre SE, 2008, J WILDLIFE DIS, V44, P716, DOI 10.7589/0090-3558-44.3.716; Angilletta MJ, 2006, J THERM BIOL, V31, P541, DOI 10.1016/j.jtherbio.2006.06.002; Berger L, 2005, DIS AQUAT ORGAN, V68, P65, DOI 10.3354/dao068065; Berger L, 1998, P NATL ACAD SCI USA, V95, P9031, DOI 10.1073/pnas.95.15.9031; Berger L, 2004, AUST VET J, V82, P434, DOI 10.1111/j.1751-0813.2004.tb11137.x; Bielby J, 2008, CONSERV LETT, V1, P82, DOI 10.1111/j.1755-263X.2008.00015.x; Boyle DG, 2004, DIS AQUAT ORGAN, V60, P141, DOI 10.3354/dao060141; Boyle DG, 2003, DIS AQUAT ORGAN, V56, P59, DOI 10.3354/dao056059; Brem FMR, 2008, DIS AQUAT ORGAN, V81, P189, DOI 10.3354/dao01960; Briggs CJ, 2010, P NATL ACAD SCI USA, V107, P9695, DOI 10.1073/pnas.0912886107; Bustamante HM, 2010, INTEGR ZOOL, V5, P143, DOI 10.1111/j.1749-4877.2010.00197.x; Carey C, 2006, ECOHEALTH, V3, P5, DOI 10.1007/s10393-005-0006-4; Crawley MJ, 2005, STAT INTRO USING R; Cutler DR, 2007, ECOLOGY, V88, P2783, DOI 10.1890/07-0539.1; Fisher MC, 2009, ANNU REV MICROBIOL, V63, P291, DOI 10.1146/annurev.micro.091208.073435; Friedman J., 2001, ELEMENTS STAT LEARNI, DOI 10.1007/978-0-387-21606-5; Han BA, 2008, BEHAV ECOL SOCIOBIOL, V63, P241, DOI 10.1007/s00265-008-0655-8; Hero JM, 2004, LITORIA PEARSONIANA; Hyatt AD, 2007, DIS AQUAT ORGAN, V73, P175, DOI 10.3354/dao073175; Johnson ML, 2003, EMERG INFECT DIS, V9, P922; Johnson ML, 2005, DIS AQUAT ORGAN, V65, P181, DOI 10.3354/dao065181; Johnson ML, 2003, DIS AQUAT ORGAN, V57, P255, DOI 10.3354/dao057255; Kearney M, 2009, ECOL LETT, V12, P334, DOI 10.1111/j.1461-0248.2008.01277.x; Kriger KM, 2007, J ZOOL, V271, P352, DOI 10.1111/j.1469-7998.2006.00220.x; Kriger KM, 2007, CONSERV BIOL, V21, P1280, DOI 10.1111/j.1523-1739.2007.00777.x; Kriticos D. J., 2001, Weed risk assessment, P61; Kriticos DJ, 2010, ECOGRAPHY, V33, P115, DOI 10.1111/j.1600-0587.2009.06042.x; Longcore JE, 1999, MYCOLOGIA, V91, P219, DOI 10.2307/3761366; Maindonald J, 2007, DATA ANAL GRAPHICS U; Murphy PJ, 2011, DIS AQUAT ORGAN, V95, P31, DOI 10.3354/dao02336; Murray K., 2010, Ecology, V91, P1557, DOI 10.1890/09-1608.1; Murray KA, 2011, P ROY SOC B-BIOL SCI, V278, P1515, DOI 10.1098/rspb.2010.1872; Murray KA, 2011, J APPL ECOL, V48, P163, DOI 10.1111/j.1365-2664.2010.01890.x; Murray KA, 2010, CONSERV BIOL, V24, P900, DOI 10.1111/j.1523-1739.2010.01508.x; Murray KA, 2009, CONSERV BIOL, V23, P1242, DOI 10.1111/j.1523-1739.2009.01211.x; Muths E, 2008, BIOL CONSERV, V141, P1484, DOI 10.1016/j.biocon.2008.03.011; Ortiz-Santaliestra ME, 2011, CONSERV BIOL, V25, P975, DOI 10.1111/j.1523-1739.2011.01700.x; Phillips A, 2010, TASMANIAN CHYTRID MA; Piotrowski JS, 2004, MYCOLOGIA, V96, P9, DOI 10.2307/3761981; Pounds JA, 2006, NATURE, V439, P161, DOI 10.1038/nature04246; Puschendorf R, 2009, DIVERS DISTRIB, V15, P401, DOI 10.1111/j.1472-4642.2008.00548.x; R Development Core Team, 2012, R LANG ENV STAT COMP; Raffel TR, 2006, FUNCT ECOL, V20, P819, DOI 10.1111/j.1365-2435.2006.01159.x; Raffel TR, 2013, NAT CLIM CHANGE, V3, P146, DOI [10.1038/nclimate1659, 10.1038/NCLIMATE1659]; Retallick RWR, 2004, PLOS BIOL, V2, P1965, DOI 10.1371/journal.pbio.0020351; Ribas L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008408; Rohr JR, 2008, P NATL ACAD SCI USA, V105, P17436, DOI 10.1073/pnas.0806368105; Rohr JR, 2010, P NATL ACAD SCI USA, V107, P8269, DOI 10.1073/pnas.0912883107; Rowley JJL, 2007, DIS AQUAT ORGAN, V77, P1, DOI 10.3354/dao01830; SHELFORD VE, 1963, ECOLOGY N AM; Shoo LP, 2011, J APPL ECOL, V48, P487, DOI 10.1111/j.1365-2664.2010.01942.x; Skerratt LF, 2010, DIS AQUAT ORGAN, V92, P117, DOI 10.3354/dao02272; Skerratt LF, 2007, ECOHEALTH, V4, P125, DOI 10.1007/s10393-007-0093-5; Smith KG, 2009, ECOL LETT, V12, P1069, DOI 10.1111/j.1461-0248.2009.01363.x; Sutherst R W, 2007, CLIMEX VERSION 3 USE; SUTHERST RW, 1985, AGR ECOSYST ENVIRON, V13, P281, DOI 10.1016/0167-8809(85)90016-7; van der Ploeg RR, 1999, SOIL SCI SOC AM J, V63, P1055, DOI 10.2136/sssaj1999.6351055x; Venables W.N., 2002, MODERN APPL STAT S, V4th ed, DOI DOI 10.1007/978-0-387-21706-2; Voyles J, 2007, DIS AQUAT ORGAN, V77, P113, DOI 10.3354/dao01838; Wake DB, 2008, P NATL ACAD SCI USA, V105, P11466, DOI 10.1073/pnas.0801921105; Walker SF, 2010, ECOL LETT, V13, P372, DOI 10.1111/j.1461-0248.2009.01434.x; Wiener M., 2012, R NEWS, V2, P18; Woodhams DC, 2005, CONSERV BIOL, V19, P1449, DOI 10.1111/j.1523-1739.2005.004403.x; Woodhams DC, 2008, ECOLOGY, V89, P1627, DOI 10.1890/06-1842.1; [No title captured]	65	29	29	1	90	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2013	8	4							e61061	10.1371/journal.pone.0061061	http://dx.doi.org/10.1371/journal.pone.0061061			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IK	23613783	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000317907200027
J	Xu, HT; Zhang, XM; Christe, A; Ebner, L; Zhang, SX; Luo, ZL; Wu, Y; Li, Y; Tian, FZ				Xu, Haotong; Zhang, Xiaoming; Christe, Andreas; Ebner, Lukas; Zhang, Shaoxiang; Luo, Zhulin; Wu, Yi; Li, Yin; Tian, Fuzhou			Anatomic Pathways of Peripancreatic Fluid Draining to Mediastinum in Recurrent Acute Pancreatitis: Visible Human Project and CT Study	PLOS ONE			English	Article							RETROPERITONEUM; DISEASE; SPREAD; RESOLUTION; FASCIA	Background: In past reports, researchers have seldom attached importance to achievements in transforming digital anatomy to radiological diagnosis. However, investigators have been able to illustrate communication relationships in the retroperitoneal space by drawing potential routes in computerized tomography (CT) images or a virtual anatomical atlas. We established a new imaging anatomy research method for comparisons of the communication relationships of the retroperitoneal space in combination with the Visible Human Project and CT images. Specifically, the anatomic pathways of peripancreatic fluid extension to the mediastinum that may potentially transform into fistulas were studied. Methods: We explored potential pathways to the mediastinum based on American and Chinese Visible Human Project datasets. These drainage pathways to the mediastinum were confirmed or corrected in CT images of 51 patients with recurrent acute pancreatitis in 2011. We also investigated whether additional routes to the mediastinum were displayed in CT images that were not in Visible Human Project images. Principal Findings: All hypothesized routes to the mediastinum displayed in Visible Human Project images, except for routes from the retromesenteric plane to the bilateral retrorenal plane across the bilateral fascial trifurcation and further to the retrocrural space via the aortic hiatus, were confirmed in CT images. In addition, route 13 via the narrow space between the left costal and crural diaphragm into the retrocrural space was demonstrated for the first time in CT images. Conclusion: This type of exploration model related to imaging anatomy may be used to support research on the communication relationships of abdominal spaces, mediastinal spaces, cervical fascial spaces and other areas of the body.	[Xu, Haotong; Luo, Zhulin; Tian, Fuzhou] Chengdu Army Gen Hosp, Gen Surg Ctr Peoples Liberat Army, Postdoctoral Workstn, Chengdu, Sichuan, Peoples R China; [Xu, Haotong] North Sichuan Med Coll, Affiliated Hosp 2, Dept Radiol, Nanchong, Sichuan, Peoples R China; [Zhang, Xiaoming] North Sichuan Med Coll, Affiliated Hosp, Dept Radiol, Sichuan Key Lab Med Imaging, Nanchong, Sichuan, Peoples R China; [Christe, Andreas; Ebner, Lukas] Univ Bern, Inselspital, Dept Radiol, CH-3010 Bern, Switzerland; [Zhang, Shaoxiang; Wu, Yi; Li, Yin] Third Mil Med Univ, Coll Basic Med Sci, Dept Anat, Chongqing, Peoples R China	North Sichuan Medical University; North Sichuan Medical University; University of Bern; University Hospital of Bern; Army Medical University	Xu, HT (corresponding author), Chengdu Army Gen Hosp, Gen Surg Ctr Peoples Liberat Army, Postdoctoral Workstn, Chengdu, Sichuan, Peoples R China.	xuliangxman@hotmail.com; tfz3006@yahoo.com.cn		Xu, Haotong/0000-0001-6416-9970; Ebner, Lukas/0000-0001-5117-6047; Xu, Hao-tong/0000-0003-0352-1795	National Science Foundation of China [61190122, 81100480]; Military Medical and Health Research Foundation of China [08z012]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Military Medical and Health Research Foundation of China	This work was supported by the National Science Foundation of China (No. 61190122 and 81100480) (http://www.nsfc.gov.cn). This work was also supported by the Military Medical and Health Research Foundation of China (No. 08z012) (http://yy.yongyao.net/temp/yyks1.aspx?id=332245d6-2033-4e28-ad57-817c006aa882&ksid=111). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizenstein RI, 1997, AM J ROENTGENOL, V168, P639, DOI 10.2214/ajr.168.3.9057506; Ali T, 2009, PANCREAS, V38, pE26, DOI 10.1097/MPA.0b013e3181870ad5; BALL JB, 1982, COMPUT RADIOL, V6, P295, DOI 10.1016/0730-4862(82)90117-2; Bhasin DK, 2005, J PANCREAS, V6, P359; Daly KP, 2008, RADIOGRAPHICS, V28, P1571, DOI 10.1148/rg.286075141; DETROYER A, 1981, SCIENCE, V213, P237, DOI 10.1126/science.7244632; Goldstein LE, 2012, SCI TRANSL MED, V4; Gupta Ruchi, 2007, MedGenMed, V9, P8; Ishikawa K, 2006, EUR J RADIOL, V60, P445, DOI 10.1016/j.ejrad.2006.06.014; Lee SL, 2010, EMERG RADIOL, V17, P3, DOI 10.1007/s10140-009-0809-7; [李幼琼 LI Youqiong], 2007, [吉林大学学报. 医学版, Journal of Jilin Univeristy. Medicine edition], V33, P464; Liu ZY, 2008, EUR RADIOL, V18, P1611, DOI 10.1007/s00330-008-0935-8; Mallavarapu R, 2001, GASTROINTEST ENDOSC, V53, P367, DOI 10.1067/mge.2001.112367; MARX WJ, 1979, UROLOGY, V13, P1, DOI 10.1016/0090-4295(79)90002-5; Mediero A, 2012, SCI TRANSL MED, V4; Molmenti EP, 1996, RADIOLOGY, V200, P95, DOI 10.1148/radiology.200.1.8657951; Scialpi M, 2004, EUR J RADIOL, V50, P74, DOI 10.1016/j.ejrad.2003.11.020; SPITZER VM, 1995, VISIBLE HUMAN PROJEC; Tan CH, 2011, RADIOGRAPHICS, V31, P117, DOI 10.1148/rg.311105050; [U.S. Department of Health and Human Services], 2000, INT CLASS DIS; Wakefield S, 1996, POSTGRAD MED J, V72, P115, DOI 10.1136/pgmj.72.844.115; Xu HT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027166; Zhang M, 2002, OTOLARYNG HEAD NECK, V127, P452, DOI 10.1067/mhn.2002.129823; Zhang SX, 2006, CLIN ANAT, V19, P204, DOI 10.1002/ca.20273	24	55	60	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2013	8	4							e62025	10.1371/journal.pone.0062025	http://dx.doi.org/10.1371/journal.pone.0062025			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IK	23614005	Green Published, Green Submitted, gold			2022-12-25	WOS:000317907200115
J	Hossain, S; Yamamoto, H; Chowdhury, EH; Wu, X; Hirose, H; Haque, A; Doki, Y; Mori, M; Akaike, T				Hossain, Sharif; Yamamoto, Hirofumi; Chowdhury, Ezharul Hoque; Wu, Xin; Hirose, Hajime; Haque, Amranul; Doki, Yuichiro; Mori, Masaki; Akaike, Toshihiro			Fabrication and Intracellular Delivery of Doxorubicin/Carbonate Apatite Nanocomposites: Effect on Growth Retardation of Established Colon Tumor	PLOS ONE			English	Article							MESOPOROUS SILICA NANOPARTICLES; SENSITIVE POLYMERIC MICELLES; CARBONATE-APATITE; NANO-CRYSTALS; LIPOSOMAL DOXORUBICIN; DRUG-RELEASE; IN-VITRO; PH; CANCER; DNA	In continuing search for effective treatments of cancer, the emerging model aims at efficient intracellular delivery of therapeutics into tumor cells in order to increase the drug concentration. However, the implementation of this strategy suffers from inefficient cellular uptake and drug resistance. Therefore, pH-sensitive nanosystems have recently been developed to target slightly acidic extracellular pH environment of solid tumors. The pH targeting approach is regarded as a more general strategy than conventional specific tumor cell surface targeting approaches, because the acidic tumor microclimate is most common in solid tumors. When nanosystems are combined with triggered release mechanisms in endosomal or lysosomal acidic pH along with endosomolytic capability, the nanocarriers demonstrated to overcome multidrug resistance of various tumors. Here, novel pH sensitive carbonate apatite has been fabricated to efficiently deliver anticancer drug Doxorubicin (DOX) to cancer cells, by virtue of its pH sensitivity being quite unstable under an acidic condition in endosomes and the desirable size of the resulting apatite-DOX for efficient cellular uptake as revealed by scanning electron microscopy. Florescence microscopy and flow cytometry analyses demonstrated significant uptake of drug (92%) when complexed with apatite nanoparticles. In vitro chemosensitivity assay revealed that apatite-DOX nanoparticles executed high cytotoxicity in several human cancer cell lines compared to free drugs and consequently apatite-DOX-facilitated enhanced tumor inhibitory effect was observed in colorectal tumor model within BALB/cA nude mice, thereby shedding light on their potential applications in cancer therapy.	[Hossain, Sharif; Akaike, Toshihiro] Tokyo Inst Technol, Dept Biomol Engn, Grad Sch Biosci & Biotechnol, Midori Ku, Yokohama, Kanagawa 227, Japan; [Yamamoto, Hirofumi; Wu, Xin; Hirose, Hajime; Doki, Yuichiro; Mori, Masaki] Osaka Univ, Grad Sch Med, Dept Surg, Suita, Osaka, Japan; [Chowdhury, Ezharul Hoque] Monash Univ, Jeffrey Cheah Sch Med & Hlth Sci, Selangor, Malaysia; [Haque, Amranul] Univ Calif Davis, Dept Biomed Engn, Davis, CA 95616 USA	Tokyo Institute of Technology; Osaka University; Monash University; Monash University Sunway; University of California System; University of California Davis	Akaike, T (corresponding author), Tokyo Inst Technol, Dept Biomol Engn, Grad Sch Biosci & Biotechnol, Midori Ku, Yokohama, Kanagawa 227, Japan.	takaike@bio.titech.ac.jp	Hossain, Sharif/H-4578-2014; Chowdhury, Ezharul/Y-5249-2019	Chowdhury, Ezharul Hoque/0000-0002-5705-841X	Japan Society for the Promotion of Science (JSPS); Grants-in-Aid for Scientific Research [23220014] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The authors acknowledge that this work has been supported by the grant from Japan Society for the Promotion of Science (JSPS). However, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aryal S, 2010, ACS NANO, V4, P251, DOI 10.1021/nn9014032; Brannon-Peppas L, 2004, ADV DRUG DELIVER REV, V56, P1649, DOI 10.1016/j.addr.2004.02.014; Chowdhury EH, 2007, INT J NANOMED, V2, P101, DOI 10.2147/nano.2007.2.1.101; Chowdhury EH, 2007, EXPERT OPIN DRUG DEL, V4, P193, DOI 10.1517/17425247.4.3.193; Chowdhury EH, 2006, GENE, V376, P87, DOI 10.1016/j.gene.2006.02.028; Chowdhury EH, 2005, CURR GENE THER, V5, P669, DOI 10.2174/156652305774964613; Chowdlhury EH, 2005, BIOTECHNOL BIOENG, V90, P414, DOI 10.1002/bit.20398; David A, 2004, EUR J CANCER, V40, P148, DOI 10.1016/j.ejca.2003.07.001; Dharap SS, 2005, P NATL ACAD SCI USA, V102, P12962, DOI 10.1073/pnas.0504274102; Dharap SS, 2003, J CONTROL RELEASE, V91, P61, DOI 10.1016/S0168-3659(03)00209-8; Duncan R, 2003, NAT REV DRUG DISCOV, V2, P347, DOI 10.1038/nrd1088; Etrych T, 2001, J CONTROL RELEASE, V73, P89, DOI 10.1016/S0168-3659(01)00281-4; Farokhzad OC, 2009, ACS NANO, V3, P16, DOI 10.1021/nn900002m; Gillies ER, 2004, J AM CHEM SOC, V126, P11936, DOI 10.1021/ja0463738; Hossain S, 2011, THER DELIV, V2, P125, DOI 10.4155/TDE.10.109; Hossain S, 2010, J CONTROL RELEASE, V147, P101, DOI 10.1016/j.jconrel.2010.06.024; Hossain S, 2010, ANAL BIOCHEM, V397, P156, DOI 10.1016/j.ab.2009.10.019; Kim D, 2009, MOL PHARMACEUT, V6, P1353, DOI 10.1021/mp900021q; Kim D, 2008, PHARM RES-DORDR, V25, P2074, DOI 10.1007/s11095-008-9603-6; Ko J, 2007, J CONTROL RELEASE, V123, P109, DOI 10.1016/j.jconrel.2007.07.012; Kobayashi T, 2007, INT J PHARMACEUT, V329, P94, DOI 10.1016/j.ijpharm.2006.08.039; Kutsuzawa K, 2008, BIOMATERIALS, V29, P370, DOI 10.1016/j.biomaterials.2007.09.011; Kwon GS, 1998, CRIT REV THER DRUG, V15, P481; Lee CH, 2010, ANGEW CHEM INT EDIT, V49, P8214, DOI 10.1002/anie.201002639; Lee ES, 2005, J CONTROL RELEASE, V103, P405, DOI 10.1016/j.jconrel.2004.12.018; Lee ES, 2008, J CONTROL RELEASE, V129, P228, DOI 10.1016/j.jconrel.2008.04.024; Lee ES, 2008, ANGEW CHEM INT EDIT, V47, P2418, DOI 10.1002/anie.200704121; Lee ES, 2008, J CONTROL RELEASE, V132, P164, DOI 10.1016/j.jconrel.2008.05.003; Maeda H, 2001, ADV ENZYME REGUL, V41, P189, DOI 10.1016/S0065-2571(00)00013-3; MAEDA M, 1988, J AM CHEM SOC, V110, P7455, DOI 10.1021/ja00230a028; MATSUMURA Y, 1986, CANCER RES, V46, P6387; Meng HA, 2010, J AM CHEM SOC, V132, P12690, DOI 10.1021/ja104501a; Minotti G, 2004, PHARMACOL REV, V56, P185, DOI 10.1124/pr.56.2.6; Mohajer G, 2007, PHARM RES-DORDR, V24, P1618, DOI 10.1007/s11095-007-9277-5; Nishiyama N, 2003, CANCER RES, V63, P8977; Panyam J, 2003, ADV DRUG DELIVER REV, V55, P329, DOI 10.1016/S0169-409X(02)00228-4; Peer D, 2007, NAT NANOTECHNOL, V2, P751, DOI 10.1038/nnano.2007.387; POLLAKIS G, 1983, FEBS LETT, V155, P267, DOI 10.1016/0014-5793(82)80618-2; Rijcken CJF, 2007, J CONTROL RELEASE, V120, P131, DOI 10.1016/j.jconrel.2007.03.023; Singal PK, 1997, FASEB J, V11, P931, DOI 10.1096/fasebj.11.12.9337145; Singal PK, 1998, NEW ENGL J MED, V339, P900, DOI 10.1056/NEJM199809243391307; Stuart MAC, 2010, NAT MATER, V9, P101, DOI [10.1038/NMAT2614, 10.1038/nmat2614]; Szakacs G, 2006, NAT REV DRUG DISCOV, V5, P219, DOI 10.1038/nrd1984; Tada S, 2010, BIOMATERIALS, V31, P1453, DOI 10.1016/j.biomaterials.2009.10.016; Torchilin VP, 2005, NAT REV DRUG DISCOV, V4, P145, DOI 10.1038/nrd1632; Ulbrich K, 2004, ADV DRUG DELIVER REV, V56, P1023, DOI 10.1016/j.addr.2003.10.040; Vail DM, 2004, SEMIN ONCOL, V31, P16, DOI 10.1053/j.seminoncol.2004.08.002; Zhu YF, 2005, ANGEW CHEM INT EDIT, V44, P5083, DOI 10.1002/anie.200501500	48	31	32	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2013	8	4							e60428	10.1371/journal.pone.0060428	http://dx.doi.org/10.1371/journal.pone.0060428			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130DR	23613726	Green Submitted, Green Published, gold			2022-12-25	WOS:000317893400009
J	Ide, Y; Waki, M; Hayasaka, T; Nishio, T; Morita, Y; Tanaka, H; Sasaki, T; Koizumi, K; Matsunuma, R; Hosokawa, Y; Ogura, H; Shiiya, N; Setou, M				Ide, Yoshimi; Waki, Michihiko; Hayasaka, Takahiro; Nishio, Tomohisa; Morita, Yoshifumi; Tanaka, Hiroki; Sasaki, Takeshi; Koizumi, Kei; Matsunuma, Ryoichi; Hosokawa, Yuko; Ogura, Hiroyuki; Shiiya, Norihiko; Setou, Mitsutoshi			Human Breast Cancer Tissues Contain Abundant Phosphatidylcholine(36:1) with High Stearoyl-CoA Desaturase-1 Expression	PLOS ONE			English	Article							IMAGING MASS-SPECTROMETRY; CHOLINE PHOSPHOLIPID-METABOLISM; GROWTH-FACTOR RECEPTOR-2; FATTY-ACID SYNTHASE; IDENTIFICATION; AMPLIFICATION; CARBOXYLASE; CARCINOMAS; PROTEIN; LEVEL	Breast cancer is the leading cause of cancer and mortality in women worldwide. Recent studies have argued that there is a close relationship between lipid synthesis and cancer progression because some enzymes related to lipid synthesis are overexpressed in breast cancer tissues. However, lipid distribution in breast cancer tissues has not been investigated. We aimed to visualize phosphatidylcholines (PCs) and lysoPCs (LPCs) in human breast cancer tissues by performing matrix assisted laser desorption/ionization-imaging mass spectrometry (MALDI-IMS), which is a novel technique that enables the visualization of molecules comprehensively. Twenty-nine breast tissue samples were obtained during surgery and subjected to MALDI-IMS analysis. We evaluated the heterogeneity of the distribution of PCs and LPCs on the tissues. Three species [PC(32:1), PC(34:1), and PC(36:1)] of PCs with 1 mono-unsaturated fatty acid chain and 1 saturated fatty acid chain (MUFA-PCs) and one [PC(34:0)] of PCs with 2 saturated fatty acid chains (SFA-PC) were relatively localized in cancerous areas rather than the rest of the sections (named reference area). In addition, the LPCs did not show any biased distribution. The relative amounts of PC(36:1) compared to PC(36:0) and that of PC(36:1) to LPC(18:0) were significantly higher in the cancerous areas. The protein expression of stearoyl-CoA desaturase-1 (SCD1), which is a synthetic enzyme of MUFA, showed accumulation in the cancerous areas as observed by the results of immunohistochemical staining. The ratios were further analyzed considering the differences in expressions of the estrogen receptor (ER), human epidermal growth factor receptor 2 (HER2), and Ki67. The ratios of the signal intensity of PC(36:1) to that of PC(36:0) was higher in the lesions with positive ER expression. The contribution of SCD1 and other enzymes to the formation of the observed phospholipid composition is discussed.	[Ide, Yoshimi; Koizumi, Kei; Matsunuma, Ryoichi; Hosokawa, Yuko; Ogura, Hiroyuki; Shiiya, Norihiko] Hamamatsu Univ Sch Med, Dept Surg 1, Hamamatsu, Shizuoka 4312102, Japan; [Ide, Yoshimi; Waki, Michihiko; Hayasaka, Takahiro; Morita, Yoshifumi; Tanaka, Hiroki; Setou, Mitsutoshi] Hamamatsu Univ Sch Med, Dept Cell Biol & Anat, Hamamatsu, Shizuoka 4312102, Japan; [Nishio, Tomohisa] Hamamatsu Univ Sch Med, Dept Lab Med, Hamamatsu, Shizuoka 4312102, Japan; [Sasaki, Takeshi] Hamamatsu Univ Sch Med, Dept Anat & Neurosci, Hamamatsu, Shizuoka 4312102, Japan	Hamamatsu University School of Medicine; Hamamatsu University School of Medicine; Hamamatsu University School of Medicine; Hamamatsu University School of Medicine	Setou, M (corresponding author), Hamamatsu Univ Sch Med, Dept Cell Biol & Anat, Hamamatsu, Shizuoka 4312102, Japan.	setou@hama-med.ac.jp		Waki, Michihiko/0000-0002-3754-9780	Ministry of Education, Culture, Sports, Science and Technology of Japan; Health Labor Sciences Research Grant from a Ministry of Health, Labor and Welfare	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Health Labor Sciences Research Grant from a Ministry of Health, Labor and Welfare	This study was supported by grants-in-aid for the scientific research project "Machinery of bioactive lipids in homeostasis and diseases'' from the Ministry of Education, Culture, Sports, Science and Technology of Japan and Health Labor Sciences Research Grant from a Ministry of Health, Labor and Welfare. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Ejeh F, 2011, CARCINOGENESIS, V32, P650, DOI 10.1093/carcin/bgr028; Arita M, 2012, EXPT MED, V30, P406; Blancato J, 2004, BRIT J CANCER, V90, P1612, DOI 10.1038/sj.bjc.6601703; BOUGNOUX P, 1992, BREAST CANCER RES TR, V20, P185; Chansela P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033154; Chen JE, 2012, J BIOTECHNOL, V162, P28, DOI 10.1016/j.jbiotec.2012.05.009; Chenais B, 2012, INT J BREAST CANCER, V2012, DOI 10.1155/2012/712536; Cheng ASL, 2008, CANCER RES, V68, P1786, DOI 10.1158/0008-5472.CAN-07-5547; Chughtai K, 2013, J LIPID RES, V54, P333, DOI 10.1194/jlr.M027961; Cornett DS, 2007, NAT METHODS, V4, P828, DOI 10.1038/NMETH1094; de los Monteros AE, 2003, VET PATHOL, V40, P718, DOI 10.1354/vp.40-6-718; Ekroos K, 2003, J LIPID RES, V44, P2181, DOI 10.1194/jlr.D300020-JLR200; Glunde K, 2004, CANCER RES, V64, P4270, DOI 10.1158/0008-5472.CAN-03-3829; Hammond MEH, 2010, ARCH PATHOL LAB MED, V134, P907, DOI [10.1043/1543-2165-134.6.907, 10.1200/JCO.2009.25.6529, 10.1200/JOP.777003]; Hayasaka T, 2011, ANAL BIOANAL CHEM, V401, P183, DOI 10.1007/s00216-011-4778-9; Hayasaka T, 2009, LIPIDS, V44, P837, DOI 10.1007/s11745-009-3331-5; Hilvo M, 2011, CANCER RES, V71, P3236, DOI 10.1158/0008-5472.CAN-10-3894; Hishikawa D, 2008, P NATL ACAD SCI USA, V105, P2830, DOI 10.1073/pnas.0712245105; Holder AM, 2013, BREAST CANCER RES TR, V137, P319, DOI 10.1007/s10549-012-2354-4; Iorio E, 2010, CANCER RES, V70, P2126, DOI 10.1158/0008-5472.CAN-09-3833; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; KALLIONIEMI OP, 1992, P NATL ACAD SCI USA, V89, P5321, DOI 10.1073/pnas.89.12.5321; Katz-Brull R, 2002, CANCER RES, V62, P1966; Koizumi S, 2012, WORLD NEUROSURG, V77, P153, DOI 10.1016/j.wneu.2011.03.039; Luyimbazi D, 2010, MOL CANCER THER, V9, P2770, DOI 10.1158/1535-7163.MCT-09-0980; Mauvoisin D, 2011, BIOCHIMIE, V93, P78, DOI 10.1016/j.biochi.2010.08.001; Menendez JA, 2007, NAT REV CANCER, V7, P763, DOI 10.1038/nrc2222; Miyazaki M, 2001, J BIOL CHEM, V276, P39455, DOI 10.1074/jbc.M106442200; Moore S, 2005, INT J CANCER, V114, P563, DOI 10.1002/ijc.20773; Nishimura R, 2010, EXP THER MED, V1, P747, DOI 10.3892/etm.2010.133; Ntambi JM, 1999, J LIPID RES, V40, P1549; Opekarova M, 2003, BBA-BIOMEMBRANES, V1610, P11, DOI 10.1016/S0005-2736(02)00708-3; Podo F, 2007, CURR MED IMAGING, V3, P123, DOI 10.2174/157340507780619160; Rockett BD, 2011, J NUTR, V141, P1041, DOI 10.3945/jn.111.138750; Roongta UV, 2011, MOL CANCER RES, V9, P1551, DOI 10.1158/1541-7786.MCR-11-0126; Scaglia N, 2005, BBA-MOL CELL BIOL L, V1687, P141, DOI 10.1016/j.bbalip.2004.11.015; Scaglia N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006812; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Shindou H, 2009, J LIPID RES, V50, pS46, DOI 10.1194/jlr.R800035-JLR200; Shrivas K, 2011, ANAL CHEM, V83, P7283, DOI 10.1021/ac201602s; Shrivas K, 2010, ANAL CHEM, V82, P8800, DOI 10.1021/ac102422b; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Stingl J, 2007, NAT REV CANCER, V7, P791, DOI 10.1038/nrc2212; Sugiura Y, 2012, ANAL BIOANAL CHEM, V403, P1851, DOI 10.1007/s00216-012-5988-5; Sutphen R, 2004, CANCER EPIDEM BIOMAR, V13, P1185; Tavassoeli FA, 2003, PATHOLOGY GENETICS T; Waki ML, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026721; Wolff AC, 2007, ARCH PATHOL LAB MED, V131, P18, DOI 10.1043/1543-2165(2007)131[18:ASOCCO]2.0.CO;2; Yoon S, 2007, J BIOL CHEM, V282, P26122, DOI 10.1074/jbc.M702854200; Zhao Y, 2008, J BIOL CHEM, V283, P8258, DOI 10.1074/jbc.M710422200	50	96	99	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2013	8	4							e61204	10.1371/journal.pone.0061204	http://dx.doi.org/10.1371/journal.pone.0061204			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130DR	23613812	Green Published, gold, Green Submitted			2022-12-25	WOS:000317893400048
J	Iebba, V; Santangelo, F; Totino, V; Nicoletti, M; Gagliardi, A; De Biase, RV; Cucchiara, S; Nencioni, L; Conte, MP; Schippa, S				Iebba, Valerio; Santangelo, Floriana; Totino, Valentina; Nicoletti, Mauro; Gagliardi, Antonella; De Biase, Riccardo Valerio; Cucchiara, Salvatore; Nencioni, Lucia; Conte, Maria Pia; Schippa, Serena			Higher Prevalence and Abundance of Bdellovibrio bacteriovorus in the Human Gut of Healthy Subjects	PLOS ONE			English	Article							ESCHERICHIA-COLI STRAINS; PEDIATRIC-PATIENTS; BIOFILM COMMUNITIES; MICROBIOTA; PREY; DIVERSITY; PREDATION; DISEASE; GENE; IDENTIFICATION	Introduction: Members of the human intestinal microbiota are key players in maintaining human health. Alterations in the composition of gut microbial community (dysbiosis) have been linked with important human diseases. Understanding the underlying processes that control community structure, including the bacterial interactions within the microbiota itself, is essential. Bdellovibrio bacteriovorus is a gram-negative bacterium that preys other gram-negative species for survival, acting as a population-balancer. It was found in terrestrial/aquatic ecosystems, and in animal intestines, postulating its presence also in the human gut. Methods: The present study was aimed to evaluate, by end-point PCR and qPCR, the presence of B. bacteriovorus in intestinal and faecal biopsy specimens from 92 paediatric healthy subjects and patients, suffering from Inflammatory Bowel Diseases (IBD), Celiac disease and Cystic fibrosis (CF). Results: i) B. bacteriovorus was present and abundant only in healthy individuals, while it was heavily reduced in patients, as in the case of IBD and Celiac, while in CF patients and relative controls we observed comparable results; ii) B. bacteriovorus seemed to be mucosa-associated, because all IBD and Celiac biopsies (and related controls) were treated with mucus-removing agents, leaving only the mucosa-attached microflora; iii) B. bacteriovorus abundance was district-dependent, with a major preponderance in duodenum, and gradually decreasing up to rectum; iv) B. bacteriovorus levels significantly dropped in disease status, in duodenum and ileum. Conclusions: Results obtained in this study could represent the first step for new therapeutic strategies aimed to restore a balance in the intestinal ecosystem, utilizing Bdellovibrio as a probiotic.	[Iebba, Valerio; Santangelo, Floriana; Totino, Valentina; Gagliardi, Antonella; Nencioni, Lucia; Conte, Maria Pia; Schippa, Serena] Univ Roma La Sapienza, Dept Publ Hlth & Infect Dis, Rome, Italy; [De Biase, Riccardo Valerio] Univ Roma La Sapienza, Reg Cyst Fibrosis Ctr, Rome, Italy; [Cucchiara, Salvatore] Univ Roma La Sapienza, Dept Paediat & Infant Neuropsychiat, Rome, Italy; [Nicoletti, Mauro] Univ G dAnnunzio, Dept Biomed Sci, Chieti, Italy	Sapienza University Rome; Sapienza University Rome; Sapienza University Rome; G d'Annunzio University of Chieti-Pescara	Iebba, V (corresponding author), Univ Roma La Sapienza, Dept Publ Hlth & Infect Dis, Rome, Italy.	valerio.iebba@uniroma1.it	Nicoletti, Mauro/AAI-7702-2020; Iebba, Valerio/P-1194-2016; De Biase, Riccardo Valerio/AAA-8869-2020; Nencioni, Lucia/K-5988-2016; Cucchiara, Salvatore/K-1628-2016	Iebba, Valerio/0000-0002-0716-306X; Nencioni, Lucia/0000-0003-4427-4823; schippa, serena/0000-0003-1572-2623; Cucchiara, Salvatore/0000-0002-2939-9698	Cystic Fibrosis Regional Grant; Italian Minister for University and Research (MIUR)	Cystic Fibrosis Regional Grant; Italian Minister for University and Research (MIUR)(Ministry of Education, Universities and Research (MIUR))	This study was supported by Cystic Fibrosis Regional Grant, year 2004, and by Italian Minister for University and Research (MIUR) to Serena Schippa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atterbury RJ, 2011, APPL ENVIRON MICROB, V77, P5794, DOI 10.1128/AEM.00426-11; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chen H, 2012, MBIO, V3, DOI 10.1128/mBio.00051-12; Chow J, 2010, ADV IMMUNOL, V107, P243, DOI [10.1016/B978-0-12-381300-8.00008-3, 10.1016/S0065-2776(10)07001-X]; Chu WH, 2010, ZOONOSES PUBLIC HLTH, V57, P258, DOI 10.1111/j.1863-2378.2008.01224.x; Conte MP, 2006, GUT, V55, P1760, DOI 10.1136/gut.2005.078824; COTTER TW, 1992, J BACTERIOL, V174, P6018, DOI 10.1128/JB.174.19.6018-6024.1992; Cox MJ, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0011044, 10.1371/journal.pone.0008745]; Davidov Y, 2006, ENVIRON MICROBIOL, V8, P1667, DOI 10.1111/j.1462-2920.2006.01052.x; Di Cagno R, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-219; Dwidar M, 2012, BMB REP, V45, P71, DOI 10.5483/BMBRep.2012.45.2.71; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Fulthorpe RR, 2008, ISME J, V2, P901, DOI 10.1038/ismej.2008.55; GRAY KM, 1989, ARCH MICROBIOL, V152, P420, DOI 10.1007/BF00446922; Hobley L, 2006, APPL ENVIRON MICROB, V72, P6757, DOI 10.1128/AEM.00844-06; Iebba V, 2012, INFECT IMMUN, V80, P1408, DOI 10.1128/IAI.06181-11; Iebba V, 2011, DIGEST DIS, V29, P531, DOI 10.1159/000332969; Jurkevitch E, 2000, APPL ENVIRON MICROB, V66, P2365, DOI 10.1128/AEM.66.6.2365-2371.2000; Kadouri D, 2005, APPL ENVIRON MICROB, V71, P4044, DOI 10.1128/AEM.71.7.4044-4051.2005; KESSEL M, 1976, J BACTERIOL, V128, P477, DOI 10.1128/JB.128.1.477-480.1976; Kim HJ, 2008, P NATL ACAD SCI USA, V105, P18188, DOI 10.1073/pnas.0807935105; Lambert C, 2006, MOL MICROBIOL, V60, P274, DOI 10.1111/j.1365-2958.2006.05081.x; Lambert C, 2011, J BACTERIOL, V193, P3139, DOI 10.1128/JB.00224-11; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Macfarlane S, 2008, J CLIN GASTROENTEROL, V42, pS142, DOI 10.1097/MCG.0b013e31816207df; Macfarlane S, 2011, ADV APPL MICROBIOL, V75, P111, DOI 10.1016/B978-0-12-387046-9.00005-0; MARSH MN, 1980, GASTROENTEROLOGY, V79, P481; Nell S, 2010, NAT REV MICROBIOL, V8, P564, DOI 10.1038/nrmicro2403; Peng Zonghui, 2008, Weishengwu Xuebao, V48, P1425; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Rendulic S, 2004, SCIENCE, V303, P689, DOI 10.1126/science.1093027; RICHARDSON IR, 1990, J APPL BACTERIOL, V69, P134, DOI 10.1111/j.1365-2672.1990.tb02921.x; Rogosky AM, 2006, CURR MICROBIOL, V52, P81, DOI 10.1007/s00284-005-0038-6; Schippa S, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-175; Schippa S, 2009, INFLAMM BOWEL DIS, V15, P661, DOI 10.1002/ibd.20818; Schwiertz A, 2010, J PEDIATR-US, V157, P240, DOI 10.1016/j.jpeds.2010.02.046; Schwudke D, 2001, SYST APPL MICROBIOL, V24, P385, DOI 10.1078/0723-2020-00042; SEIDLER FJ, 1969, J BACTERIOL, V97, P912; SEIDLER RJ, 1968, J BACTERIOL, V95, P1952, DOI 10.1128/JB.95.5.1952-1955.1968; Shemesh Y, 2004, ENVIRON MICROBIOL, V6, P12, DOI 10.1046/j.1462-2920.2003.00530.x; Starr M P, 1975, Symp Soc Exp Biol, P93; Stenhammar L, 2006, ACTA PAEDIATR, V95, P1495, DOI 10.1080/08035250600636552; STOLP H, 1963, ANTON VAN LEE J M S, V29, P217, DOI 10.1007/BF02046064; Strauch E, 2007, FUTURE MICROBIOL, V2, P63, DOI 10.2217/17460913.2.1.63; Sullivan A, 2001, Lancet Infect Dis, V1, P101, DOI 10.1016/S1473-3099(01)00066-4; Swidsinski A, 2007, INFLAMM BOWEL DIS, V13, P963, DOI 10.1002/ibd.20163; Swidsinski A, 2007, GUT, V56, P343, DOI 10.1136/gut.2006.098160; Van Essche M, 2009, ENV MICROBIOL REP, V1, P228, DOI 10.1111/j.1758-2229.2009.00034.x; Vandecasteele SJ, 2002, BIOCHEM BIOPH RES CO, V291, P528, DOI 10.1006/bbrc.2002.6465; VARON M, 1978, APPL ENVIRON MICROB, V36, P11, DOI 10.1128/AEM.36.1.11-17.1978; Walker AW, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-7; Wen CQ, 2009, J APPL MICROBIOL, V106, P1154, DOI 10.1111/j.1365-2672.2008.04081.x; WESTERGAARD JM, 1977, APPL ENVIRON MICROB, V34, P506, DOI 10.1128/AEM.34.5.506-511.1977; Willing BP, 2010, GASTROENTEROLOGY, V139, P1844, DOI 10.1053/j.gastro.2010.08.049	54	74	77	0	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2013	8	4							e61608	10.1371/journal.pone.0061608	http://dx.doi.org/10.1371/journal.pone.0061608			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130DR	23613881	Green Published, Green Submitted, gold			2022-12-25	WOS:000317893400079
J	Liu, XL; Wei, X; Zheng, WW; Jiang, SH; Templeton, MR; He, GS; Qu, WD				Liu, Xiaolin; Wei, Xiao; Zheng, Weiwei; Jiang, Songhui; Templeton, Michael R.; He, Gengsheng; Qu, Weidong			An Optimized Analytical Method for the Simultaneous Detection of Iodoform, Iodoacetic Acid, and Other Trihalomethanes and Haloacetic Acids in Drinking Water	PLOS ONE			English	Article							DISINFECTION BY-PRODUCTS; CHROMATOGRAPHY-MASS-SPECTROMETRY; MAMMALIAN-CELL CYTOTOXICITY; HEADSPACE GAS-CHROMATOGRAPHY; SOLID-PHASE MICROEXTRACTION; LIQUID-CHROMATOGRAPHY; CAPILLARY-ELECTROPHORESIS; ANALYTICAL-CHEMISTRY; ION CHROMATOGRAPHY; GENOTOXICITY	An optimized method is presented using liquid-liquid extraction and derivatization for the extraction of iodoacetic acid (IAA) and other haloacetic acids (HAA(9)) and direct extraction of iodoform (IF) and other trihalomethanes (THM4) from drinking water, followed by detection by gas chromatography with electron capture detection (GC-ECD). A Doehlert experimental design was performed to determine the optimum conditions for the five most significant factors in the derivatization step: namely, the volume and concentration of acidic methanol (optimized values = 15%, 1 mL), the volume and concentration of Na2SO4 solution (129 g/L, 8.5 mL), and the volume of saturated NaHCO3 solution (1 mL). Also, derivatization time and temperature were optimized by a two-variable Doehlert design, resulting in the following optimized parameters: an extraction time of 11 minutes for IF and THM4 and 14 minutes for IAA and HAA(9); mass of anhydrous Na2SO4 of 4 g for IF and THM4 and 16 g for IAA and HAA(9); derivatization time of 160 min and temperature at 40 degrees C. Under optimal conditions, the optimized procedure achieves excellent linearity (R-2 ranges 0.9990-0.9998), low detection limits (0.0008-0.2 mu g/L), low quantification limits (0.008-0.4 mu g/L), and good recovery (86.6%-106.3%). Intra- and inter-day precision were less than 8.9% and 8.8%, respectively. The method was validated by applying it to the analysis of raw, flocculated, settled, and finished waters collected from a water treatment plant in China.	[Liu, Xiaolin; Wei, Xiao; Zheng, Weiwei; Jiang, Songhui; Qu, Weidong] Fudan Univ, Dept Environm Hlth, Sch Publ Hlth, Key Lab Publ Hlth & Safety,Minist Educ, Shanghai 200433, Peoples R China; [He, Gengsheng] Fudan Univ, Dept Nutr & Food Hyg, Minist Educ, Key Lab Publ Hlth & Safety, Shanghai 200433, Peoples R China; [Templeton, Michael R.] Univ London Imperial Coll Sci Technol & Med, Dept Civil & Environm Engn, London, England	Fudan University; Fudan University; Imperial College London	Qu, WD (corresponding author), Fudan Univ, Dept Environm Hlth, Sch Publ Hlth, Key Lab Publ Hlth & Safety,Minist Educ, Shanghai 200433, Peoples R China.	wdqu@fudan.edu.cn			National Natural Science Fund [30771770, 30972438, 81273035]; National Key Technology RD Program [2006BAI19B02]; National High-tech R&D Program of China (863 Program) [2008AA062501, 2013AA061804]; Shanghai Municipal Health Bureau [08GWD14]; Dawn Scholarship Project [07SG01]; Non-profit Foundation of National Health Ministry [2012BAJ25B05, 201002001]	National Natural Science Fund(National Natural Science Foundation of China (NSFC)); National Key Technology RD Program(National Key Technology R&D Program); National High-tech R&D Program of China (863 Program)(National High Technology Research and Development Program of China); Shanghai Municipal Health Bureau; Dawn Scholarship Project; Non-profit Foundation of National Health Ministry	This work was supported by grants from the National Natural Science Fund (No. 30771770, 30972438 & 81273035), National Key Technology R&D Program in the 11th Five-Year Plan (No. 2006BAI19B02), Key Project of National High-tech R&D Program of China (863 Program) (2008AA062501 & 2013AA061804), Shanghai Municipal Health Bureau Leading Academic Discipline Project (No. 08GWD14), Dawn Scholarship Project (No. 07SG01), and Non-profit Foundation of National Health Ministry (No. 2012BAJ25B05 & 201002001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allard S, 2012, J CHROMATOGR A, V1238, P15, DOI 10.1016/j.chroma.2012.03.020; [Anonymous], 1995, DETERMINATION CHLORI; Bezerra MA, 2008, TALANTA, V76, P965, DOI 10.1016/j.talanta.2008.05.019; Bove GE, 2007, INT J HEALTH GEOGR, V6, DOI 10.1186/1476-072X-6-18; Cardador MJ, 2008, J CHROMATOGR A, V1209, P61, DOI 10.1016/j.chroma.2008.09.033; Cardador MJ, 2010, J CHROMATOGR B, V878, P1824, DOI 10.1016/j.jchromb.2010.05.022; Cardador MJ, 2010, ANAL BIOANAL CHEM, V396, P1331, DOI 10.1007/s00216-009-3281-z; Chen CY, 2009, J CHROMATOGR SCI, V47, P67, DOI 10.1093/chromsci/47.1.67; Ferreira SLC, 2007, J CHROMATOGR A, V1158, P2, DOI 10.1016/j.chroma.2007.03.051; Ding YS, 2010, ELECTROPHORESIS, V31, P2602, DOI 10.1002/elps.200900496; Duan JM, 2011, ANAL METHODS-UK, V3, P1667, DOI 10.1039/c1ay05122a; Ferreira SLC, 2004, TALANTA, V63, P1061, DOI 10.1016/j.talanta.2004.01.015; Kargalioglu Y, 2002, TERATOGEN CARCIN MUT, V22, P113, DOI 10.1002/tcm.10010; Komulainen H, 2004, TOXICOLOGY, V198, P239, DOI 10.1016/j.tox.2004.01.031; Krasner SW, 2006, ENVIRON SCI TECHNOL, V40, P7175, DOI 10.1021/es060353j; Kristiana I, 2012, J CHROMATOGR A, V1225, P45, DOI 10.1016/j.chroma.2012.01.005; Meng LP, 2010, J CHROMATOGR A, V1217, P4873, DOI 10.1016/j.chroma.2010.04.074; Montesinos I, 2012, J CHROMATOGR A, V1248, P1, DOI 10.1016/j.chroma.2012.05.067; Rosero MM, 2012, WATER AIR SOIL POLL, V223, P667, DOI 10.1007/s11270-011-0891-9; Muellner MG, 2007, ENVIRON SCI TECHNOL, V41, P645, DOI 10.1021/es0617441; Narotsky MG, 2011, REPROD TOXICOL, V31, P59, DOI 10.1016/j.reprotox.2010.08.002; Pals JA, 2011, ENVIRON SCI TECHNOL, V45, P5791, DOI 10.1021/es2008159; Paull B, 2004, J CHROMATOGR A, V1046, P1, DOI [10.1016/j.chroma.2004.06.081, 10.1016/S0021-9673(04)01029-5]; Pavon JLP, 2008, ANAL CHIM ACTA, V629, P6, DOI 10.1016/j.aca.2008.09.042; Pavon JLP, 2008, J CHROMATOGR A, V1194, P103, DOI 10.1016/j.chroma.2008.04.037; Plewa MJ, 2008, ENVIRON SCI TECHNOL, V42, P955, DOI 10.1021/es071754h; Plewa MJ, 2011, ENVIRON SCI TECHNOL, V45, P4159, DOI 10.1021/es104284h; Plewa MJ, 2004, ENVIRON SCI TECHNOL, V38, P62, DOI 10.1021/es030477l; Plewa MJ, 2004, ENVIRON SCI TECHNOL, V38, P4713, DOI 10.1021/es049971v; Prieto-Blanco MC, 2012, TALANTA, V94, P90, DOI 10.1016/j.talanta.2012.02.061; Ranaivo PL, 2011, ANAL METHODS-UK, V3, P2873, DOI 10.1039/c1ay05398a; Richardson SD, 2002, ENVIRON SCI TECHNOL, V36, p198A, DOI 10.1021/es022308r; Richardson SD, 2008, ENVIRON SCI TECHNOL, V42, P8330, DOI 10.1021/es801169k; Richardson SD, 2007, MUTAT RES-REV MUTAT, V636, P178, DOI 10.1016/j.mrrev.2007.09.001; Rodriguez-Cabo T, 2012, TALANTA, V99, P846, DOI 10.1016/j.talanta.2012.07.041; Sa CSA, 2012, J ENVIRON SCI HEAL A, V47, P176, DOI 10.1080/10934529.2012.640246; Saraji M, 2009, J CHROMATOGR A, V1216, P1059, DOI 10.1016/j.chroma.2008.12.064; Sun AD, 2010, CLEAN-SOIL AIR WATER, V38, P353, DOI 10.1002/clen.200900211; U.S. EPA, 2003, 5523 US EPA; Villanueva CM, 2007, AM J EPIDEMIOL, V165, P148, DOI 10.1093/aje/kwj364; Wei JR, 2010, SCI TOTAL ENVIRON, V408, P4600, DOI 10.1016/j.scitotenv.2010.06.053; Wu FW, 2002, ANALYST, V127, P1318, DOI 10.1039/b204574e; Xie YF, 2002, J AM WATER WORKS ASS, V94, P115; Zhang HJ, 2011, ANAL CHIM ACTA, V706, P176, DOI 10.1016/j.aca.2011.07.040; Zhang SH, 2010, MUTAT RES-GEN TOX EN, V703, P174, DOI 10.1016/j.mrgentox.2010.08.014	46	10	10	2	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2013	8	4							e60858	10.1371/journal.pone.0060858	http://dx.doi.org/10.1371/journal.pone.0060858			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130DR	23613747	Green Submitted, Green Published, gold			2022-12-25	WOS:000317893400023
J	Lucas, SJ; Akpinar, BA; Kantar, M; Weinstein, Z; Aydinoglu, F; Safar, J; Simkova, H; Frenkel, Z; Korol, A; Magni, F; Cattonaro, F; Vautrin, S; Bellec, A; Berges, H; Dolezel, J; Budak, H				Lucas, Stuart J.; Akpinar, Bala Ani; Kantar, Melda; Weinstein, Zohar; Aydinoglu, Fatma; Safar, Jan; Simkova, Hana; Frenkel, Zeev; Korol, Abraham; Magni, Federica; Cattonaro, Federica; Vautrin, Sonia; Bellec, Arnaud; Berges, Helene; Dolezel, Jaroslav; Budak, Hikmet			Physical Mapping Integrated with Syntenic Analysis to Characterize the Gene Space of the Long Arm of Wheat Chromosome 1A	PLOS ONE			English	Article							GENOME; MAP; BARLEY; ORGANIZATION; EVOLUTION; SEQUENCE; PATTERNS; LOCI	Background: Bread wheat (Triticum aestivum L.) is one of the most important crops worldwide and its production faces pressing challenges, the solution of which demands genome information. However, the large, highly repetitive hexaploid wheat genome has been considered intractable to standard sequencing approaches. Therefore the International Wheat Genome Sequencing Consortium (IWGSC) proposes to map and sequence the genome on a chromosome-by-chromosome basis. Methodology/Principal Findings: We have constructed a physical map of the long arm of bread wheat chromosome 1A using chromosome-specific BAC libraries by High Information Content Fingerprinting (HICF). Two alternative methods (FPC and LTC) were used to assemble the fingerprints into a high-resolution physical map of the chromosome arm. A total of 365 molecular markers were added to the map, in addition to 1122 putative unique transcripts that were identified by microarray hybridization. The final map consists of 1180 FPC-based or 583 LTC-based contigs. Conclusions/Significance: The physical map presented here marks an important step forward in mapping of hexaploid bread wheat. The map is orders of magnitude more detailed than previously available maps of this chromosome, and the assignment of over a thousand putative expressed gene sequences to specific map locations will greatly assist future functional studies. This map will be an essential tool for future sequencing of and positional cloning within chromosome 1A.	[Lucas, Stuart J.; Akpinar, Bala Ani; Kantar, Melda; Weinstein, Zohar; Aydinoglu, Fatma; Budak, Hikmet] Sabanci Univ, Fac Engn & Nat Sci, Istanbul, Turkey; [Safar, Jan; Simkova, Hana; Dolezel, Jaroslav] Inst Expt Bot, Ctr Reg Hana Biotechnol & Agr Res, Olomouc, Czech Republic; [Frenkel, Zeev; Korol, Abraham] Univ Haifa, Inst Evolut, IL-31999 Haifa, Israel; [Magni, Federica; Cattonaro, Federica] Inst Appl Genom, Udine, Italy; [Vautrin, Sonia; Bellec, Arnaud; Berges, Helene] Ctr Natl Ressources Genom Vegetables, Inst Natl Rech Agron, Castanet Tolosan, France; [Lucas, Stuart J.; Budak, Hikmet] Sabanci Univ, Nanotechnol Res & Applicat Ctr, Istanbul, Turkey	Sabanci University; Czech Academy of Sciences; Institute of Experimental Botany of the Czech Academy of Sciences; University of Haifa; INRAE; Sabanci University	Budak, H (corresponding author), Sabanci Univ, Fac Engn & Nat Sci, Istanbul, Turkey.	budak@sabanciuniv.edu	Dolezel, Jaroslav/B-7716-2008; Lucas, Stuart J./AAW-5615-2020; Budak, Hikmet/S-5835-2017; Safar, Jan/G-1038-2014; Budak, Hikmet/F-4708-2010; Simkova, Hana/F-7734-2014; Budak, Hikmet/U-8517-2019; aydinoglu, fatma/AAU-2680-2020; Frenkel, Zeev/A-5589-2019	Dolezel, Jaroslav/0000-0002-6263-0492; Lucas, Stuart J./0000-0003-3059-7453; Budak, Hikmet/0000-0002-2556-2478; Budak, Hikmet/0000-0002-2556-2478; Simkova, Hana/0000-0003-4159-7619; Budak, Hikmet/0000-0002-2556-2478; aydinoglu, fatma/0000-0002-9974-045X; Weinstein, Zohar/0000-0002-7472-9297; Akpinar, Bala Ani/0000-0001-6863-7436; Frenkel, Zeev/0000-0003-0211-6966; BERGES, Helene/0000-0002-5492-1062	EU-FP7-TriticeaeGenome project; Sabanci University Internal Research Grant; Ministry of Education, Youth and Sports of the Czech Republic; European Regional Development Fund (Operational Programme Research and Development for Innovations) [ED0007/01/01]	EU-FP7-TriticeaeGenome project; Sabanci University Internal Research Grant(Sabanci University); Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); European Regional Development Fund (Operational Programme Research and Development for Innovations)	This work was supported by the EU-FP7-TriticeaeGenome project and a Sabanci University Internal Research Grant. HS, JS, and JD were supported by the Ministry of Education, Youth and Sports of the Czech Republic and the European Regional Development Fund (Operational Programme Research and Development for Innovations No. ED0007/01/01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbelbide M, 2006, THEOR APPL GENET, V112, P885, DOI 10.1007/s00122-005-0190-1; Ariyadasa R, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/184854; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Choulet F, 2010, PLANT CELL, V22, P1686, DOI 10.1105/tpc.110.074187; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Feuillet C, 2012, FUNCT INTEGR GENOMIC, V12, P573, DOI 10.1007/s10142-012-0300-5; Frenkel Z, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-584; Lucas SJ, 2012, FUNCT INTEGR GENOMIC, V12, P173, DOI 10.1007/s10142-011-0250-3; Luo MC, 2003, GENOMICS, V82, P378, DOI 10.1016/S0888-7543(03)00128-9; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; Mayer KFX, 2011, PLANT CELL, V23, P1249, DOI 10.1105/tpc.110.082537; McIntosh R.A., 2008, P 11 INT WHEAT GEN S; Nelson W, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp034; Nelson WM, 2005, PLANT PHYSIOL, V139, P27, DOI 10.1104/pp.105.061978; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Paux E, 2008, SCIENCE, V322, P101, DOI 10.1126/science.1161847; Paux E, 2010, PLANT BIOTECHNOL J, V8, P196, DOI 10.1111/j.1467-7652.2009.00477.x; Qi LL, 2004, GENETICS, V168, P701, DOI 10.1534/genetics.104.034868; Quraishi UM, 2009, FUNCT INTEGR GENOMIC, V9, P473, DOI 10.1007/s10142-009-0129-8; Roder MS, 1998, GENETICS, V149, P2007; Rustenholz C, 2011, PLANT PHYSIOL, V157, P1596, DOI 10.1104/pp.111.183921; Rustenholz C, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-714; Safar J, 2010, CYTOGENET GENOME RES, V129, P211, DOI 10.1159/000313072; Somers DJ, 2004, THEOR APPL GENET, V109, P1105, DOI 10.1007/s00122-004-1740-7; Sourdille Pierre, 2004, Functional & Integrative Genomics, V4, P12, DOI 10.1007/s10142-004-0106-1; Stephenson P, 1998, THEOR APPL GENET, V97, P946, DOI 10.1007/s001220050975; Vogel JP, 2010, NATURE, V463, P763, DOI 10.1038/nature08747; Wicker T, 2011, PLANT CELL, V23, P1706, DOI 10.1105/tpc.111.086629; You FM, 2007, BIOINFORMATICS, V23, P240, DOI 10.1093/bioinformatics/btl494	29	22	23	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2013	8	4							e59542	10.1371/journal.pone.0059542	http://dx.doi.org/10.1371/journal.pone.0059542			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130DR	23613713	Green Published, gold			2022-12-25	WOS:000317893400002
J	Nelissen, E; Mduma, E; Broerse, J; Ersdal, H; Evjen-Olsen, B; van Roosmalen, J; Stekelenburg, J				Nelissen, Ellen; Mduma, Estomih; Broerse, Jacqueline; Ersdal, Hege; Evjen-Olsen, Bjorg; van Roosmalen, Jos; Stekelenburg, Jelle			Applicability of the WHO Maternal Near Miss Criteria in a Low-Resource Setting	PLOS ONE			English	Article							MORBIDITY	Background: Maternal near misses are increasingly used to study quality of obstetric care. Inclusion criteria for the identification of near misses are diverse and studies not comparable. WHO developed universal near miss inclusion criteria in 2009 and these criteria have been validated in Brazil and Canada. Objectives: To validate and refine the WHO near miss criteria in a low-resource setting. Methods: A prospective cross-sectional study was performed in a rural referral hospital in Tanzania. From November 2009 until November 2011, all cases of maternal death (MD) and maternal near miss (MNM) were included. For identification of MNM, a local modification of the WHO near miss criteria was used, because most laboratory-based and some management-based criteria could not be applied in this setting. Disease-based criteria were added as they reflect severe maternal morbidity. In the absence of a gold standard for identification of MNM, the clinical WHO criteria were validated for identification of MD. Results: 32 MD and 216 MNM were identified using the locally adapted near miss criteria; case fatality rate (CFR) was 12.9%. WHO near miss criteria identified only 60 MNM (CFR 35.6%). All clinical criteria, 25% of the laboratory-based criteria and 50% of the management-based criteria could be applied. The threshold of five units of blood for identification of MNM led to underreporting of MNM. Clinical criteria showed specificity of 99.5% (95%CI: 99.4%-99.7%) and sensitivity of 100% (95%CI: 91.1%-100%). Some inclusion criteria did not contribute to the identification of cases and therefore may be eligible for removal. Conclusion: The applicability of the WHO near miss criteria depends on the local context, e.g. level of health care. The clinical criteria showed good validity. Lowering the threshold for blood transfusion from five to two units in settings without blood bank and addition of disease-based criteria in low-resource settings is recommended.	[Nelissen, Ellen; Mduma, Estomih; Ersdal, Hege] Haydom Lutheran Hosp, Mbulu, Manyara, Tanzania; [Nelissen, Ellen; Broerse, Jacqueline] Vrije Univ Amsterdam, Fac Earth & Life Sci, Athena Inst, Amsterdam, Netherlands; [Ersdal, Hege] Stavanger Univ Hosp, Stavanger Acute Med Fdn Educ & Res, Stavanger, Norway; [Evjen-Olsen, Bjorg] Univ Bergen, Ctr Int Hlth, Bergen, Norway; [Evjen-Olsen, Bjorg] Sorlandet Hosp, Dept Obstet & Gynaecol, Flekkefjord, Norway; [van Roosmalen, Jos] Leiden Univ, Med Ctr, Dept Obstet, Leiden, Netherlands; [van Roosmalen, Jos] Vrije Univ Amsterdam, Med Ctr, EMGO Inst Hlth & Care Res, Amsterdam, Netherlands; [Stekelenburg, Jelle] Leeuwarden Med Ctr, Dept Obstet & Gynaecol, Leeuwarden, Netherlands	Vrije Universiteit Amsterdam; Stavanger University Hospital; University of Bergen; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Vrije Universiteit Amsterdam; Medical Center Leeuwarden	Nelissen, E (corresponding author), Haydom Lutheran Hosp, Mbulu, Manyara, Tanzania.	ejtnelissen@gmail.com	Stekelenburg, Jelle/B-3129-2017	Stekelenburg, Jelle/0000-0002-2732-6620	Laerdal Foundation for Acute Medicine, Stavanger, Norway	Laerdal Foundation for Acute Medicine, Stavanger, Norway	EN received a stipend from the Laerdal Foundation for Acute Medicine, Stavanger, Norway (www.laerdalfoundation.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cecatti JG, 2011, REPROD HEALTH, V8, DOI 10.1186/1742-4755-8-22; Graham WJ, 2009, BEST PRACT RES CL OB, V23, P375, DOI 10.1016/j.bpobgyn.2009.01.017; Kaye DK, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-65; Lauritsen J, 2003, EPIDATA COMPREHENSIV; Lozano R, 2011, LANCET, V378, P1139, DOI 10.1016/S0140-6736(11)61337-8; Mantel GD, 1998, BRIT J OBSTET GYNAEC, V105, P985, DOI 10.1111/j.1471-0528.1998.tb10262.x; Morse Márcia Lait, 2011, Rev. bras. epidemiol., V14, P310, DOI 10.1590/S1415-790X2011000200012; Nyamtema AS, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-94; Olsen BE, 2002, ACTA OBSTET GYN SCAN, V81, P1101, DOI 10.1034/j.1600-0412.2002.811202.x; Pattinson RC, 2003, BJOG-INT J OBSTET GY, V110, P889, DOI 10.1111/j.1471-0528.2003.03044.x; Say Lale, 2004, Reprod Health, V1, P3, DOI 10.1186/1742-4755-1-3; Say L, 2009, BEST PRACT RES CL OB, V23, P287, DOI 10.1016/j.bpobgyn.2009.01.007; Souza JP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044129; Souza JP, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-286; Souza JP, 2010, B WORLD HEALTH ORGAN, V88, P113, DOI 10.2471/BLT.08.057828; [The United Republic of Tanzania Central Census Office NBoS President's Offices Planning and Privatisation], 2005, POP HOUS CENS VILL S; Tuncalp O, 2012, BJOG-INT J OBSTET GY, V119, P653, DOI 10.1111/j.1471-0528.2012.03294.x; van den Akker T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054805; van den Akker T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020776; van Roosmalen J, 2009, BEST PRACT RES CL OB, V23, P297, DOI 10.1016/j.bpobgyn.2009.01.004; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; World Health Organization (WHO), 2011, EV QUAL CAR SEV PREG	22	76	80	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2013	8	4							e61248	10.1371/journal.pone.0061248	http://dx.doi.org/10.1371/journal.pone.0061248			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130DR	23613821	Green Submitted, Green Published, gold			2022-12-25	WOS:000317893400052
J	Baines, AC; Adams, EJ; Zhang, B; Ginsburg, D				Baines, Andrea C.; Adams, Elizabeth J.; Zhang, Bin; Ginsburg, David			Disruption of the Sec24d Gene Results in Early Embryonic Lethality in the Mouse	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM; COPII VESICLE; PROTEIN-TRANSPORT; MEMBRANE-PROTEINS; SELECTIVE EXPORT; COAT; SUBUNIT; MUTATIONS; DATABASE; GOLGI	Transport of newly synthesized proteins from the endoplasmic reticulum (ER) to the Golgi is mediated by the coat protein complex COPII. The inner coat of COPII is assembled from heterodimers of SEC23 and SEC24. Though mice with mutations in one of the four Sec24 paralogs, Sec24b, exhibit a neural tube closure defect, deficiency in humans or mice has not yet been described for any of the other Sec24 paralogs. We now report characterization of mice with targeted disruption of Sec24d. Early embryonic lethality is observed in mice completely deficient in SEC24D, while a hypomorphic Sec24d allele permits survival to mid-embryogenesis. Mice haploinsufficient for Sec24d exhibit no phenotypic abnormality. A BAC transgene containing Sec24d rescues the embryonic lethality observed in Sec24d-null mice. These results demonstrate an absolute requirement for SEC24D expression in early mammalian development that is not compensated by the other three Sec24 paralogs. The early embryonic lethality resulting from loss of SEC24D in mice contrasts with the previously reported mild skeletal phenotype of SEC24D deficiency in zebrafish and restricted neural tube phenotype of SEC24B deficiency in mice. Taken together, these observations suggest that the multiple Sec24 paralogs have developed distinct functions over the course of vertebrate evolution.	[Baines, Andrea C.] Johns Hopkins Univ, Johns Hopkins Bayview Internal Med Residency Prog, Baltimore, MD USA; [Adams, Elizabeth J.; Ginsburg, David] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; [Zhang, Bin] Cleveland Clin Fdn, Lerner Res Inst, Genom Med Inst, Cleveland, OH 44195 USA; [Ginsburg, David] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Ginsburg, David] Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; [Ginsburg, David] Univ Michigan, Dept Pediat, Ann Arbor, MI 48109 USA; [Ginsburg, David] Univ Michigan, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA	Johns Hopkins University; University of Michigan System; University of Michigan; Cleveland Clinic Foundation; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Howard Hughes Medical Institute; University of Michigan System; University of Michigan	Ginsburg, D (corresponding author), Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA.	ginsburg@umich.edu		Ginsburg, David/0000-0002-6436-8942	National Institutes of Health [R01 HL039693, P01-HL057346]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL057346, R01HL039693, R01HL094505] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007315] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA013616] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institutes of Health Grants R01 HL039693 and P01-HL057346. DG is a Howard Hughes Medical Institute Investigator. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAHOU WF, 1988, BLOOD, V72, P308; Bickford LC, 2004, CURR OPIN STRUC BIOL, V14, P147, DOI 10.1016/j.sbi.2004.02.002; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; Boyadjiev SA, 2006, NAT GENET, V38, P1192, DOI 10.1038/ng1876; Budnik A, 2009, FEBS LETT, V583, P3796, DOI 10.1016/j.febslet.2009.10.038; Gelfand Y, 2007, NUCLEIC ACIDS RES, V35, pD80, DOI 10.1093/nar/gkl1013; Kanapin A, 2003, GENOME RES, V13, P1335, DOI 10.1101/gr.978703; KENDALL SK, 1995, GENE DEV, V9, P2007, DOI 10.1101/gad.9.16.2007; Khoriaty R, 2012, BLOOD, V120, P31, DOI 10.1182/blood-2012-01-292086; Krupp M, 2012, BIOINFORMATICS, V28, P1184, DOI 10.1093/bioinformatics/bts084; Kurihara T, 2000, MOL BIOL CELL, V11, P983, DOI 10.1091/mbc.11.3.983; Lang MR, 2006, NAT GENET, V38, P1198, DOI 10.1038/ng1880; Lee MCS, 2007, SEMIN CELL DEV BIOL, V18, P424, DOI 10.1016/j.semcdb.2007.06.007; Lee MCS, 2005, CELL, V122, P605, DOI 10.1016/j.cell.2005.07.025; Lee MCS, 2004, ANNU REV CELL DEV BI, V20, P87, DOI 10.1146/annurev.cellbio.20.010403.105307; Mancias JD, 2008, EMBO J, V27, P2918, DOI 10.1038/emboj.2008.208; Merte J, 2010, NAT CELL BIOL, V12, P41, DOI 10.1038/ncb2002; Miller E, 2002, EMBO J, V21, P6105, DOI 10.1093/emboj/cdf605; Miller EA, 2005, MOL BIOL CELL, V16, P3719, DOI 10.1091/mbc.E05-03-0262; Miller EA, 2003, CELL, V114, P497, DOI 10.1016/S0092-8674(03)00609-3; Ohisa S, 2010, DEV BIOL, V342, P85, DOI 10.1016/j.ydbio.2010.03.016; Palade G, 1975, SCIENCE, V189; Peng RW, 2000, J BIOL CHEM, V275, P11521, DOI 10.1074/jbc.275.15.11521; Richardson L, 2010, NUCLEIC ACIDS RES, V38, pD703, DOI 10.1093/nar/gkp763; Roberg KJ, 1999, J CELL BIOL, V145, P659, DOI 10.1083/jcb.145.4.659; Sarmah S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010367; Schwarz K, 2009, NAT GENET, V41, P936, DOI 10.1038/ng.405; Skarnes WC, 2000, METHOD ENZYMOL, V328, P592, DOI 10.1016/S0076-6879(00)28420-6; Stagg SM, 2006, NATURE, V439, P234, DOI 10.1038/nature04339; Stryke D, 2003, NUCLEIC ACIDS RES, V31, P278, DOI 10.1093/nar/gkg064; Tang BL, 1999, BIOCHEM BIOPH RES CO, V258, P679, DOI 10.1006/bbrc.1999.0574; Tao J, 2012, P NATL ACAD SCI; Van Keuren ML, 2009, TRANSGENIC RES, V18, P769, DOI 10.1007/s11248-009-9271-2; Wendeler MW, 2007, EMBO REP, V8, P258, DOI 10.1038/sj.embor.7400893; Westrick RJ, 2010, P NATL ACAD SCI USA, V107, P16904, DOI 10.1073/pnas.1012050107; Williams E., 2011, ADV PROTOCOLS ANIMAL, P377	36	30	30	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2013	8	4							e61114	10.1371/journal.pone.0061114	http://dx.doi.org/10.1371/journal.pone.0061114			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125TD	23596517	gold, Green Submitted, Green Published			2022-12-25	WOS:000317563300022
J	Ning, WW; Wang, YJ; Zhang, F; Wang, HY; Wang, F; Wang, XJ; Tang, HX; Liang, SP; Shi, XL; Liu, ZH				Ning, Weiwen; Wang, Yongjun; Zhang, Fan; Wang, Hengyun; Wang, Fan; Wang, Xiaojuan; Tang, Huaxin; Liang, Songping; Shi, Xiaoliu; Liu, Zhonghua			Beneficial Effects of Trypsin Inhibitors Derived from a Spider Venom Peptide in L-Arginine-Induced Severe Acute Pancreatitis in Mice	PLOS ONE			English	Article							MOUSE MODEL; EXPRESSION; ACTIVATION; INFLAMMATION; INJURY	HWTI is a 55-residue protein isolated from the venom of the spider Ornithoctonus huwena. It is a potent trypsin inhibitor and a moderate voltage-gated potassium channel blocker. Here, we designed and expressed two HWTI mutants, HWTI-mut1 and HWTI-mut2, in which the potassium channel inhibitory activity was reduced while the trypsin inhibitory activity of the wild type form (approximately 5 EPU/mg) was retained. Animal studies showed that these mutants were less toxic than HWTI. The effects of HWTI and HWTI-mut1 were examined in a mouse model of acute pancreatitis induced by intraperitoneal injection of a large dose of L-arginine (4 mg/kg, twice). Serum amylase and serum lipase activities were assessed, and pathological sections of the pancreas were examined. Treatment with HWTI and HWTI-mut1 significantly reduced serum amylase and lipase levels in a dose dependent manner. Compared with the control group, at 4 mg/kg, HWTI significantly reduced serum amylase level by 47% and serum lipase level by 73%, while HWTI-mut1 significantly reduced serum amylase level by 59% and serum lipase level by 72%. Moreover, HWTI and HWTI-mut1 effectively protected the pancreas from acinar cell damage and inflammatory cell infiltration. The trypsin inhibitory potency and lower neurotoxicity of HWTI-mut1 suggest that it could potentially be developed as a drug for the treatment of acute pancreatitis with few side effects.	[Ning, Weiwen; Zhang, Fan; Wang, Hengyun; Wang, Fan; Wang, Xiaojuan; Tang, Huaxin; Liang, Songping; Liu, Zhonghua] Hunan Normal Univ, Coll Life Sci, Changsha, Hunan, Peoples R China; [Wang, Yongjun; Shi, Xiaoliu] Cent S Univ, Xiangya Hosp 2, Dept Digest, Changsha, Hunan, Peoples R China	Hunan Normal University; Central South University	Shi, XL (corresponding author), Cent S Univ, Xiangya Hosp 2, Dept Digest, Changsha, Hunan, Peoples R China.	shixiaoliu61766@yahoo.com.cn; liuzh@hunnu.edu.cn		Shi, Xiaoliu/0000-0002-9759-2254	National 973 Program of China [2010CB529800]; National Nature Science Foundation of China [31071091, 30971570]; Xiamen Bioway Biotech Co., Ltd.	National 973 Program of China(National Basic Research Program of China); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Xiamen Bioway Biotech Co., Ltd.	This work was supported by grants from the National 973 Program of China (No. 2010CB529800), National Nature Science Foundation of China (No. 31071091; No. 30971570), and through funding received by Dr. Songping Liang from Xiamen Bioway Biotech Co., Ltd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aprotinin, EUROPEAN PHARMACOPOE; Benjakul S, 2000, J FOOD BIOCHEM, V24, P107, DOI 10.1111/j.1745-4514.2000.tb00689.x; Biczo G, 2010, PANCREAS, V39, P868, DOI 10.1097/MPA.0b013e3181d371f8; CARAWAY WT, 1959, AM J CLIN PATHOL, V32, P97, DOI 10.1093/ajcp/32.1_ts.97; Dawra R, 2007, AM J PHYSIOL-GASTR L, V292, pG1009, DOI 10.1152/ajpgi.00167.2006; Dawra R, 2011, GASTROENTEROLOGY, V141, P2210, DOI 10.1053/j.gastro.2011.08.033; ERLANGER BF, 1961, ARCH BIOCHEM BIOPHYS, V95, P271, DOI 10.1016/0003-9861(61)90145-X; Gaiser S, 2011, GUT, V60, P1379, DOI 10.1136/gut.2010.226175; GITLITZ PH, 1976, CLIN CHEM, V22, P1223; HIRANO T, 1993, ARCH SURG-CHICAGO, V128, P1322; HIRANO T, 1993, DIGEST DIS SCI, V38, P660, DOI 10.1007/BF01316797; Hirota M, 2006, J GASTROENTEROL, V41, P832, DOI 10.1007/s00535-006-1874-2; Inoue KI, 2005, MOL PHARMACOL, V67, P673, DOI 10.1124/mol.104.005967; Jacewicz D, 2010, SENSORS-BASEL, V10, P280, DOI 10.3390/s100100280; Ji BA, 2011, GASTROENTEROLOGY, V141, P1972, DOI 10.1053/j.gastro.2011.10.021; Jo YJ, 2008, INT IMMUNOPHARMACOL, V8, P959, DOI 10.1016/j.intimp.2008.02.014; Kakkar T, 1999, DRUG METAB DISPOS, V27, P756; Kanayama N, 1998, BBA-GEN SUBJECTS, V1381, P139, DOI 10.1016/S0304-4165(98)00022-1; Kitagawa M, 2007, J PANCREAS, V8, P518; Laukkarinen JM, 2007, GUT, V56, P1590, DOI 10.1136/gut.2007.124230; Li WZ, 2006, GLYCOBIOLOGY, V16, P1007, DOI 10.1093/glycob/cwl023; Liang SP, 2004, TOXICON, V43, P575, DOI 10.1016/j.toxicon.2004.02.005; Meiri N, 1997, P NATL ACAD SCI USA, V94, P4430, DOI 10.1073/pnas.94.9.4430; Nakamichi I, 2005, J CLIN INVEST, V115, P3007, DOI 10.1172/JCI24912; Nakamura H, 2008, GUT, V57, P788, DOI 10.1136/gut.2007.119370; Nathan JD, 2005, GASTROENTEROLOGY, V128, P717, DOI 10.1053/j.gastro.2004.11.052; Qiao SF, 2005, WORLD J GASTROENTERO, V11, P6216, DOI 10.3748/wjg.v11.i39.6216; Sah RP, 2012, CURR OPIN GASTROEN, V28, P507, DOI 10.1097/MOG.0b013e3283567f52; Sah RP, 2011, GUT, V60, P1305, DOI 10.1136/gut.2011.241703; SHIHABI ZK, 1971, CLIN CHEM, V17, P1150; SMEDLY LA, 1986, J CLIN INVEST, V77, P1233, DOI 10.1172/JCI112426; Smith M, 2010, INT J CLIN PRACT, V64, P84, DOI 10.1111/j.1742-1241.2008.01899.x; SPORMANN H, 1989, PATHOL RES PRACT, V184, P507, DOI 10.1016/S0344-0338(89)80143-8; TANI S, 1990, DIGEST DIS SCI, V35, P367, DOI 10.1007/BF01537416; Van Acker GJD, 2002, AM J PHYSIOL-GASTR L, V283, pG794, DOI 10.1152/ajpgi.00363.2001; Wu JJ, 2002, BIOCHEMISTRY-US, V41, P2844, DOI 10.1021/bi011367z; Yagci G, 2004, J GASTROENTEROL, V39, P268, DOI 10.1007/s00535-003-1287-4; Yuan CH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003414; Zhang ZQ, 2012, INFLAMMATION, V35, P605, DOI 10.1007/s10753-011-9352-2	39	7	8	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2013	8	4							e61049	10.1371/journal.pone.0061049	http://dx.doi.org/10.1371/journal.pone.0061049			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125TD	23613780	gold, Green Published, Green Submitted			2022-12-25	WOS:000317563300017
J	Cuzon, G; Bonnin, RA; Nordmann, P				Cuzon, Gaelle; Bonnin, Remy A.; Nordmann, Patrice			First Identification of Novel NDM Carbapenemase, NDM-7, in Escherichia coli in France	PLOS ONE			English	Article							METALLO-BETA-LACTAMASE; ENVIRONMENT	Background: The NDM-1 carbapenemase has been identified in 2008 in Enterobacteriaceae. Since then, several reports have emphasized its rapid dissemination throughout the world. The spread of NDM carbapenemases involve several bla(NDM) gene variants associated with various plasmids among several Gram negative species. Methodology: A multidrug-resistant E. coli isolate recovered from urine of a patient who had travelled to Burma has been characterized genetically and biochemically. Principal Findings: E. coli COU was resistant to all antibiotics tested except amikacin, tigecycline, fosfomycin, and chloramphenicol. Analysis of the antibiotic resistance traits identified a metallo-beta-lactamase, a novel NDM variant, NDM-7. It differs from NDM-4 by a single amino acid substitution sharing an identical extended spectrum profile towards carbapenems. The bla(NDM-7) gene was located on an untypeable conjugative plasmid and associated with a close genetic background similar to those described among the bla(NDM-1) genes. The isolate also harbours bla(CTXM-15) and bla(OXA-1) genes and belonged to ST167. Significance: This study highlights that spread of NDM producers correspond to spread of multiple blaNDM genes and clones and therefore will be difficult to control.	[Cuzon, Gaelle; Bonnin, Remy A.; Nordmann, Patrice] Hop Bicetre, AP HP, INSERM, U914,Fae Med Paris Sud,Serv Bacteriol Virol, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Nordmann, P (corresponding author), Hop Bicetre, AP HP, INSERM, U914,Fae Med Paris Sud,Serv Bacteriol Virol, Paris, France.	nordmann.patrice@bct.aphp.fr		Bonnin, Remy A./0000-0002-2307-3232	European Community [241742]	European Community(European Commission)	This work was funded by the European Community (7th Framework program FP7/2007-2013 under grant agreement no. 241742). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernabeu S, 2012, DIAGN MICR INFEC DIS, V74, P88, DOI 10.1016/j.diagmicrobio.2012.05.021; Bonnin RA, 2013, ANTIMICROB AGENTS CH, V57, P674, DOI 10.1128/AAC.01086-12; Bonnin RA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034752; Borgia S, 2012, CLIN INFECT DIS, V55, pE109, DOI 10.1093/cid/cis737; Carattoli A, 2012, ANTIMICROB AGENTS CH, V56, P783, DOI 10.1128/AAC.05116-11; Carattoli A, 2009, ANTIMICROB AGENTS CH, V53, P2227, DOI 10.1128/AAC.01707-08; Clinical and Laboratory Standards Institute (CLSI), 2012, M100S22 CLIN LAB S S; Dortet L, 2012, EMERG INFECT DIS, V18, P1540, DOI 10.3201/eid1809.120011; Ho PL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017989; Hornsey M, 2011, ANTIMICROB AGENTS CH, V55, P5952, DOI 10.1128/AAC.05108-11; Isozumi R, 2012, EMERG INFECT DIS, V18, P1383, DOI 10.3201/eid1808.111816; Jovcic B, 2011, ANTIMICROB AGENTS CH, V55, P3929, DOI 10.1128/AAC.00226-11; Kaase M, 2011, J ANTIMICROB CHEMOTH, V66, P1260, DOI 10.1093/jac/dkr135; Livermore DM, 2011, LANCET INFECT DIS, V11, P164, DOI 10.1016/S1473-3099(11)70048-2; Nordmann P, 2012, ANTIMICROB AGENTS CH, V56, P2184, DOI 10.1128/AAC.05961-11; Nordmann P, 2011, TRENDS MICROBIOL, V19, P588, DOI 10.1016/j.tim.2011.09.005; Nordmann P, 2011, EMERG INFECT DIS, V17, P1791, DOI 10.3201/eid1710.110655; Oteo J, 2009, INT J ANTIMICROB AG, V34, P173, DOI 10.1016/j.ijantimicag.2009.03.006; Poirel L, 2011, ANTIMICROB AGENTS CH, V55, P5403, DOI 10.1128/AAC.00585-11; Poirel L, 2011, ANTIMICROB AGENTS CH, V55, P4224, DOI 10.1128/AAC.00165-11; Poirel L, 2011, ANTIMICROB AGENTS CH, V55, P1821, DOI 10.1128/AAC.01761-10; Rimrang B, 2012, J ANTIMICROB CHEMOTH, V67, P2626, DOI 10.1093/jac/dks267; Tran HH, 2012, J CLIN MICROBIOL, DOI [10.1128/JCM.02322-12, DOI 10.1128/JCM.02322-12]; Walsh TR, 2011, LANCET INFECT DIS, V11, P355, DOI 10.1016/S1473-3099(11)70059-7; Williamson DA, 2012, INT J ANTIMICROB AG, V39, P529, DOI 10.1016/j.ijantimicag.2012.02.017; Wirth T, 2006, MOL MICROBIOL, V60, P1136, DOI 10.1111/j.1365-2958.2006.05172.x	26	72	76	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2013	8	4							e61322	10.1371/journal.pone.0061322	http://dx.doi.org/10.1371/journal.pone.0061322			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123JP	23593461	gold, Green Published, Green Submitted			2022-12-25	WOS:000317385300070
J	Dhahri, S; Ramonda, M; Marliere, C				Dhahri, Samia; Ramonda, Michel; Marliere, Christian			In-Situ Determination of the Mechanical Properties of Gliding or Non-Motile Bacteria by Atomic Force Microscopy under Physiological Conditions without Immobilization	PLOS ONE			English	Article							NANOMECHANICAL PROPERTIES; CELL-WALL; BACILLUS-SUBTILIS; FILAMENTOUS CYANOBACTERIA; MICROBIAL SURFACES; TURGOR PRESSURE; FIBRILLAR ARRAY; MOTILITY; AFM; ADHESION	We present a study about AFM imaging of living, moving or self-immobilized bacteria in their genuine physiological liquid medium. No external immobilization protocol, neither chemical nor mechanical, was needed. For the first time, the native gliding movements of Gram-negative Nostoc cyanobacteria upon the surface, at speeds up to 900 mu m/h, were studied by AFM. This was possible thanks to an improved combination of a gentle sample preparation process and an AFM procedure based on fast and complete force-distance curves made at every pixel, drastically reducing lateral forces. No limitation in spatial resolution or imaging rate was detected. Gram-positive and non-motile Rhodococcus wratislaviensis bacteria were studied as well. From the approach curves, Young modulus and turgor pressure were measured for both strains at different gliding speeds and are ranging from 20 +/- 3 to 105 +/- 5 MPa and 40 +/- 5 to 310 +/- 30 kPa depending on the bacterium and the gliding speed. For Nostoc, spatially limited zones with higher values of stiffness were observed. The related spatial period is much higher than the mean length of Nostoc nodules. This was explained by an inhomogeneous mechanical activation of nodules in the cyanobacterium. We also observed the presence of a soft extra cellular matrix (ECM) around the Nostoc bacterium. Both strains left a track of polymeric slime with variable thicknesses. For Rhodococcus, it is equal to few hundreds of nanometers, likely to promote its adhesion to the sample. While gliding, the Nostoc secretes a slime layer the thickness of which is in the nanometer range and increases with the gliding speed. This result reinforces the hypothesis of a propulsion mechanism based, for Nostoc cyanobacteria, on ejection of slime. These results open a large window on new studies of both dynamical phenomena of practical and fundamental interests such as the formation of biofilms and dynamic properties of bacteria in real physiological conditions.	[Dhahri, Samia; Marliere, Christian] Univ Montpellier 2, CNRS, Geosci Montpellier, Montpellier, France; [Ramonda, Michel] Univ Montpellier 2, Cent Technol Micro & Nanoelect, Lab Microscopie Champ Proche, Montpellier, France; [Marliere, Christian] Univ Paris 11, CNRS, Inst Sci Mol Orsay, Orsay, France	Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Marliere, C (corresponding author), Univ Montpellier 2, CNRS, Geosci Montpellier, Montpellier, France.	christian.marliere@u-psud.fr	DHAHRI, Samia/AAL-9269-2021; RAMONDA, Michel/C-2948-2019	Dague, Etienne/0000-0003-3290-9166	Agence Nationale de la Recherche (ANR, Paris, France) [ANR-10-ECOT-014-05]	Agence Nationale de la Recherche (ANR, Paris, France)(French National Research Agency (ANR))	This work was funded by the Agence Nationale de la Recherche (ANR, Paris, France) through the program ECOTECH_2011 (project BIOPHY No ANR-10-ECOT-014-05). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DG, 1999, J BACTERIOL, V181, P884, DOI 10.1128/JB.181.3.884-892.1999; Arfsten J, 2010, COLLOID SURFACE B, V79, P284, DOI 10.1016/j.colsurfb.2010.04.011; Arnoldi M, 2000, PHYS REV E, V62, P1034, DOI 10.1103/PhysRevE.62.1034; Auffret M, 2009, APPL ENVIRON MICROB, V75, P7774, DOI 10.1128/AEM.01117-09; Boal D., 2012, MECH CELL; Bolshakova AV, 2001, ULTRAMICROSCOPY, V86, P121, DOI 10.1016/S0304-3991(00)00075-9; Boulbitch A, 2000, J ELECTRON MICROSC, V49, P459, DOI 10.1093/oxfordjournals.jmicro.a023829; Boulbitch AA, 1998, PHYS REV E, V57, P2123, DOI 10.1103/PhysRevE.57.2123; Bruneel O, 2011, MICROB ECOL, V61, P793, DOI 10.1007/s00248-011-9808-9; BUSSCHER HJ, 1987, FEMS MICROBIOL LETT, V46, P165, DOI 10.1111/j.1574-6968.1987.tb02457.x; Cerf A, 2009, LANGMUIR, V25, P5731, DOI 10.1021/la9004642; Colville K, 2010, LANGMUIR, V26, P2639, DOI 10.1021/la902826n; Dague E, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/39/395102; Dague E, 2008, BIOPHYS J, V94, P656, DOI 10.1529/biophysj.107.116491; Deng Y, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.158101; Doktycz MJ, 2003, ULTRAMICROSCOPY, V97, P209, DOI 10.1016/S0304-3991(03)00045-7; Dorobantu LS, 2010, SCANNING, V32, P74, DOI 10.1002/sca.20177; Ducret A, 2012, P NATL ACAD SCI USA, V109, P10036, DOI 10.1073/pnas.1120979109; Dufrene YF, 2001, MICRON, V32, P153, DOI 10.1016/S0968-4328(99)00106-7; Dufrene YF, 2002, J BACTERIOL, V184, P5205, DOI 10.1128/JB.184.19.5205-5213.2002; Dupres V, 2010, TRENDS MICROBIOL, V18, P397, DOI 10.1016/j.tim.2010.06.004; Fantner GE, 2010, NAT NANOTECHNOL, V5, P280, DOI [10.1038/NNANO.2010.29, 10.1038/nnano.2010.29]; Fayolle F, 1998, BIOTECHNOL LETT, V20, P283, DOI 10.1023/A:1005390221856; Flemming HC, 2011, COLLOID SURFACE B, V86, P251, DOI 10.1016/j.colsurfb.2011.04.025; Francius G, 2008, J BACTERIOL, V190, P7904, DOI 10.1128/JB.01116-08; Gaboriaud F, 2005, J BACTERIOL, V187, P3864, DOI 10.1128/JB.187.11.3864-3868.2005; Gaboriaud F, 2008, LANGMUIR, V24, P10988, DOI 10.1021/la800258n; Gaboriaud F, 2008, COLLOID SURFACE B, V62, P206, DOI 10.1016/j.colsurfb.2007.10.004; Gaboriaud F, 2007, COLLOID SURFACE B, V54, P10, DOI 10.1016/j.colsurfb.2006.09.014; Galvez ME, 2012, GEOBIOLOGY, V10, P118, DOI 10.1111/j.1472-4669.2011.00316.x; Hanada Y, 2011, LAB CHIP, V11, P2109, DOI 10.1039/c1lc20101h; HENRICHSEN J, 1972, BACTERIOL REV, V36, P478, DOI 10.1128/MMBR.36.4.478-503.1972; Hoiczyk E, 1998, CURR BIOL, V8, P1161, DOI 10.1016/S0960-9822(07)00487-3; HOICZYK E, 1995, J BACTERIOL, V177, P2387, DOI 10.1128/jb.177.9.2387-2395.1995; Hoiczyk E, 2000, ARCH MICROBIOL, V174, P11, DOI 10.1007/s002030000187; Kailas L, 2009, ULTRAMICROSCOPY, V109, P775, DOI 10.1016/j.ultramic.2009.01.012; KASAS S, 1995, BIOPHYS J, V68, P1678, DOI 10.1016/S0006-3495(95)80344-9; Korstgens V, 2001, J MICROBIOL METH, V46, P9, DOI 10.1016/S0167-7012(01)00248-2; Levy R, 2002, NANOTECHNOLOGY, V13, P33, DOI 10.1088/0957-4484/13/1/307; Longo G, 2012, J MOL RECOGNIT, V25, P278, DOI 10.1002/jmr.2171; McBride MJ, 2001, ANNU REV MICROBIOL, V55, P49, DOI 10.1146/annurev.micro.55.1.49; MENDELSON NH, 1989, J BACTERIOL, V171, P1055, DOI 10.1128/jb.171.2.1055-1062.1989; Mendez-Vilas A, 2006, ANTON LEEUW INT J G, V89, P495, DOI 10.1007/s10482-005-9048-4; Meyer RL, 2010, ULTRAMICROSCOPY, V110, P1349, DOI 10.1016/j.ultramic.2010.06.010; Oxaran V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050989; Piveteau P, 2001, APPL MICROBIOL BIOT, V55, P369, DOI 10.1007/s002530000545; Polyakov P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018887; Raman A, 2011, NAT NANOTECHNOL, V6, P809, DOI [10.1038/nnano.2011.186, 10.1038/NNANO.2011.186]; Read N, 2007, J BACTERIOL, V189, P7361, DOI 10.1128/JB.00706-07; REICHENBACH H, 1981, ANNU REV MICROBIOL, V35, P339, DOI 10.1146/annurev.mi.35.100181.002011; Schaer-Zammaretti P, 2003, ULTRAMICROSCOPY, V97, P199, DOI 10.1016/S0304-3991(03)00044-5; Scheuring S, 2005, SCIENCE, V309, P484, DOI 10.1126/science.1110879; Tamulonis C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022084; THWAITES JJ, 1991, J BACTERIOL, V173, P197, DOI 10.1128/jb.173.1.197-203.1991; THWAITES JJ, 1989, INT J BIOL MACROMOL, V11, P201, DOI 10.1016/0141-8130(89)90069-X; Ulrich TA, 2009, CANCER RES, V69, P4167, DOI 10.1158/0008-5472.CAN-08-4859; Vadillo-Rodriguez V, 2003, LANGMUIR, V19, P2372, DOI 10.1021/la020658l; Volle CB, 2008, LANGMUIR, V24, P8102, DOI 10.1021/la8009354; Webb HK, 2011, J MICROBIOL METH, V86, P131, DOI 10.1016/j.mimet.2011.05.021; WHATMORE AM, 1990, J GEN MICROBIOL, V136, P2521, DOI 10.1099/00221287-136-12-2521; Wright CJ, 2006, SURF INTERFACE ANAL, V38, P1419, DOI 10.1002/sia.2506; Xu W, 1996, J BACTERIOL, V178, P3106, DOI 10.1128/jb.178.11.3106-3112.1996; Yao X, 1999, J BACTERIOL, V181, P6865, DOI 10.1128/JB.181.22.6865-6875.1999; Yao X, 2002, COLLOID SURFACE B, V23, P213, DOI 10.1016/S0927-7765(01)00249-1; Youderian P, 1998, CURR BIOL, V8, pR408, DOI 10.1016/S0960-9822(98)70264-7; Yu R, 2007, MOL MICROBIOL, V63, P454, DOI 10.1111/j.1365-2958.2006.05536.x; Zhavnerko G, 2012, INT J MYCOBACT, V1, P53, DOI 10.1016/j.ijmyco.2012.01.009	67	19	20	1	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2013	8	4							e61663	10.1371/journal.pone.0061663	http://dx.doi.org/10.1371/journal.pone.0061663			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123JP	23593493	Green Submitted, Green Published, gold			2022-12-25	WOS:000317385300079
J	Wang, MJ; Li, YC; Snyder, MA; Wang, HX; Li, F; Gao, WJ				Wang, Min-Juan; Li, Yan-Chun; Snyder, Melissa A.; Wang, Huaixing; Li, Feng; Gao, Wen-Jun			Group II Metabotropic Glutamate Receptor Agonist LY379268 Regulates AMPA Receptor Trafficking in Prefrontal Cortical Neurons	PLOS ONE			English	Article							POSITIVE ALLOSTERIC MODULATORS; MEDIAL TEMPORAL-LOBE; LONG-TERM DEPRESSION; MESSENGER-RNA EXPRESSION; METHYL-D-ASPARTATE; MGLUR2/3 AGONIST; EXCITATORY SYNAPSES; NMDA RECEPTORS; SYNAPTIC PLASTICITY; GLIAL LOCALIZATIONS	Group II metabotropic glutamate receptor (mGluR) agonists have emerged as potential treatment drugs for schizophrenia and other neurological disorders, whereas the mechanisms involved remain elusive. Here we examined the effects of LY379268 (LY37) on the expression and trafficking of the alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA) receptor subunits GluA1 and GluA2 in prefrontal neurons. We show that LY37 significantly increased the surface and total expression of both GluA1 and GluA2 subunits in cultured prefrontal neurons and in vivo. This effect was mimicked by the selective mGluR2 agonist LY395756 and was blocked by mGluR2/3 antagonist LY341495. Moreover, we found that both GluA1 and GluA2 subunits were colocalized with PSD95 but not synapsin I, suggesting a postsynaptic localization. Consistently, treatment with LY37 significantly increased the amplitude, but not frequency, of miniature excitatory postsynaptic currents. Further, actinomycin-D blocked LY37's effects, suggesting a transcriptional regulation. In addition, application of glycogen synthase kinase-3beta (GSK-3 beta) inhibitor completely blocked LY37's effect on GluA2 surface expression, whereas GSK-3 beta inhibitor itself induced decreases in the surface and total protein levels of GluA1, but not GluA2 subunits. This suggests that GSK-3 beta differentially mediates GluA1 and GluA2 trafficking. Further, LY37 significantly increased the phosphorylation, but not total protein, of extracellular signal-regulated kinase 1/2 (ERK1/2). Neither ERK1/2 inhibitor PD98059 alone nor PD98059 combined with LY37 treatment induced changes in GluA1 or GluA2 surface expression or total protein levels. Our data thus suggest that mGluR2/3 agonist regulates postsynaptic AMPA receptors by affecting the synaptic trafficking of both GluA1 and GluA2 subunits and that the regulation is likely through ERK1/2 signaling in GluA1 and/or both ERK1/2 and GSK-3 beta signaling pathways in the GluA2 subunit.	[Wang, Min-Juan; Li, Yan-Chun; Snyder, Melissa A.; Wang, Huaixing; Gao, Wen-Jun] Drexel Univ, Coll Med, Dept Neurobiol & Anat, Philadelphia, PA 19104 USA; [Wang, Min-Juan; Li, Feng] Sun Yat Sen Univ, Zhongshan Coll Med, Dept Neurobiol & Anat, Guangzhou 510275, Guangdong, Peoples R China	Drexel University; Sun Yat Sen University	Li, F (corresponding author), Sun Yat Sen Univ, Zhongshan Coll Med, Dept Neurobiol & Anat, Guangzhou 510275, Guangdong, Peoples R China.	lifeng@mail.sysu.edu.cn; wgao@drexelmed.edu	li, yan/GTI-4638-2022	Gao, Wen-Jun/0000-0002-8585-3082	National Institutes of Health (NIH) [R01MH085666]; 111 Project of China [B13037]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH085666] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); 111 Project of China; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work is supported by National Institutes of Health (NIH) R01MH085666 to W.J.Gao and the 111 Project of China, Grant No. B13037. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amitai N, 2010, EUR J PHARMACOL, V639, P67, DOI 10.1016/j.ejphar.2009.12.040; Barry MF, 2002, CURR OPIN NEUROBIOL, V12, P279, DOI 10.1016/S0959-4388(02)00329-X; Beneyto M, 2007, NEUROPSYCHOPHARMACOL, V32, P1888, DOI 10.1038/sj.npp.1301312; Beneyto M, 2006, SYNAPSE, V60, P585, DOI 10.1002/syn.20329; Benneyworth MA, 2007, MOL PHARMACOL, V72, P477, DOI 10.1124/mol.107.035170; Blumcke I, 1996, BRAIN RES, V736, P217; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Carlsson A, 1997, LIFE SCI, V61, P75, DOI 10.1016/S0024-3205(97)00228-2; Carter K, 2004, NEUROPHARMACOLOGY, V47, P1135, DOI 10.1016/j.neuropharm.2004.08.018; Cartmell J, 1999, J PHARMACOL EXP THER, V291, P161; Cartmell J, 2000, PSYCHOPHARMACOLOGY, V148, P423, DOI 10.1007/s002130050072; Cartmell J, 2001, NEUROPHARMACOLOGY, V40, P847, DOI 10.1016/S0028-3908(01)00034-X; Ceolin L, 2011, J NEUROSCI, V31, P6721, DOI 10.1523/JNEUROSCI.0418-11.2011; Conn PJ, 2008, MOL INTERV, V8, P99, DOI 10.1124/mi.8.2.7; Conn PJ, 2009, NAT REV DRUG DISCOV, V8, P41, DOI 10.1038/nrd2760; Conn PJ, 2009, TRENDS PHARMACOL SCI, V30, P25, DOI 10.1016/j.tips.2008.10.006; Conn PJ, 2009, NEUROPSYCHOPHARMACOL, V34, P248, DOI 10.1038/npp.2008.156; Conrad KL, 2008, NATURE, V454, P118, DOI 10.1038/nature06995; Coyle JT, 2003, ANN NY ACAD SCI, V1003, P318, DOI 10.1196/annals.1300.020; D'Onofrio M, 2001, J NEUROCHEM, V78, P435, DOI 10.1046/j.1471-4159.2001.00435.x; Derkach VA, 2007, NAT REV NEUROSCI, V8, P101, DOI 10.1038/nrn2055; Di Liberto V, 2011, NEUROPHARMACOLOGY, V61, P638, DOI 10.1016/j.neuropharm.2011.05.006; Dominguez C, 2005, J MED CHEM, V48, P3605, DOI 10.1021/jm040222y; Dracheva S, 2005, J NEUROSCI RES, V79, P868, DOI 10.1002/jnr.20423; Dunn KW, 2011, AM J PHYSIOL-CELL PH, V300, pC723, DOI 10.1152/ajpcell.00462.2010; EASTWOOD SL, 1995, MOL BRAIN RES, V29, P211, DOI 10.1016/0169-328X(94)00247-C; Eastwood SL, 1997, BIOL PSYCHIAT, V41, P636, DOI 10.1016/S0006-3223(96)00220-X; Endo S, 2003, NEUROPHARMACOLOGY, V45, P863, DOI 10.1016/S0028-3908(03)00210-7; Fell MJ, 2008, J PHARMACOL EXP THER, V326, P209, DOI 10.1124/jpet.108.136861; Fell MJ, 2012, NEUROPHARMACOLOGY, V62, P1473, DOI 10.1016/j.neuropharm.2011.06.007; Fraley ME, 2009, EXPERT OPIN THER PAT, V19, P1259, DOI 10.1517/13543770903045009; Glynn MW, 2006, NAT PROTOC, V1, P1287, DOI 10.1038/nprot.2006.220; Groc L, 2006, CELL TISSUE RES, V326, P423, DOI 10.1007/s00441-006-0254-9; Grosshans DR, 2002, NAT NEUROSCI, V5, P27, DOI 10.1038/nn779; Hammond JC, 2010, NEUROPSYCHOPHARMACOL, V35, P2110, DOI 10.1038/npp.2010.87; Harich S, 2007, PSYCHOPHARMACOLOGY, V192, P511, DOI 10.1007/s00213-007-0742-y; Harrison PJ, 2008, J PSYCHOPHARMACOL, V22, P308, DOI 10.1177/0269881108089818; Henley JM, 2011, TRENDS NEUROSCI, V34, P258, DOI 10.1016/j.tins.2011.02.004; Hermes MLHJ, 2011, J PHARMACOL EXP THER, V336, P840, DOI 10.1124/jpet.110.176149; Higgins GA, 2004, NEUROPHARMACOLOGY, V46, P907, DOI 10.1016/j.neuropharm.2004.01.018; Homayoun L, 2005, J NEUROPHYSIOL, V93, P1989, DOI 10.1152/jn.00875.2004; Howes OD, 2009, SCHIZOPHRENIA BULL, V35, P549, DOI 10.1093/schbul/sbp006; Hu JL, 2010, MOL BRAIN, V3, DOI 10.1186/1756-6606-3-20; Huang CC, 2008, NEUROPHARMACOLOGY, V54, P1071, DOI 10.1016/j.neuropharm.2008.02.013; Huang CC, 2007, J NEUROSCI, V27, P2958, DOI 10.1523/JNEUROSCI.4247-06.2007; Imre G, 2006, BRAIN RES BULL, V69, P338, DOI 10.1016/j.brainresbull.2006.01.010; Imre G, 2007, CNS DRUG REV, V13, P444; Javitt DC, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002804; Johnson MP, 2005, PSYCHOPHARMACOLOGY, V179, P271, DOI 10.1007/s00213-004-2099-9; Jones CA, 2011, PSYCHOPHARMACOLOGY, V214, P269, DOI 10.1007/s00213-010-1931-7; Jones N. C., 2011, INT J NEUROPSYCHOPH, V9, P1; Kessels HW, 2009, NEURON, V61, P340, DOI 10.1016/j.neuron.2009.01.015; Kinon BJ, 2011, J CLIN PSYCHOPHARM, V31, P349, DOI 10.1097/JCP.0b013e318218dcd5; Krivoy A, 2008, EUR NEUROPSYCHOPHARM, V18, P395, DOI 10.1016/j.euroneuro.2007.11.001; Krystal JH, 2005, PSYCHOPHARMACOLOGY, V179, P303, DOI 10.1007/s00213-004-1982-8; Lee HG, 2009, BRAIN RES, V1249, P244, DOI 10.1016/j.brainres.2008.10.055; Li Q, 2004, J NEUROSCI, V24, P4070, DOI 10.1523/JNEUROSCI.0346-04.2004; Li YC, 2010, J NEUROCHEM, V114, P62, DOI 10.1111/j.1471-4159.2010.06720.x; Li YC, 2009, J NEUROSCI, V29, P15551, DOI 10.1523/JNEUROSCI.3336-09.2009; Liu XB, 1998, J COMP NEUROL, V395, P450, DOI 10.1002/(SICI)1096-9861(19980615)395:4<450::AID-CNE3>3.0.CO;2-0; Lopez-Camarillo C, 2003, J BIOL CHEM, V278, P11273, DOI 10.1074/jbc.M211757200; Lopez-Rosas I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045966; Lorrain DS, 2003, NEUROSCIENCE, V117, P697, DOI 10.1016/S0306-4522(02)00652-8; Lu WY, 2001, NEURON, V29, P243, DOI 10.1016/S0896-6273(01)00194-5; Lyon L, 2011, NEUROPSYCHOPHARMACOL, V36, P2616, DOI 10.1038/npp.2011.145; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Meltzer HY, 1999, BIOL PSYCHIAT, V46, P1321, DOI 10.1016/S0006-3223(99)00255-3; Mezler M, 2010, CURR OPIN INVEST DR, V11, P833; Minzenberg MJ, 2012, TRENDS COGN SCI, V16, P35, DOI 10.1016/j.tics.2011.11.017; Moghaddam B, 1998, SCIENCE, V281, P1349, DOI 10.1126/science.281.5381.1349; Moghaddam B, 2004, PSYCHOPHARMACOLOGY, V174, P39, DOI 10.1007/s00213-004-1792-z; Moghaddam B, 2003, NEURON, V40, P881, DOI 10.1016/S0896-6273(03)00757-8; Niswender CM, 2010, ANNU REV PHARMACOL, V50, P295, DOI 10.1146/annurev.pharmtox.011008.145533; O'Connor JA, 2007, SCHIZOPHR RES, V97, P277, DOI 10.1016/j.schres.2007.09.022; Otani S, 2002, J NEUROSCI, V22, P3434; Palucha A, 2006, EXPERT OPIN INV DRUG, V15, P1545, DOI 10.1517/13543784.15.12.1545; Patil ST, 2007, NAT MED, V13, P1102, DOI 10.1038/nm1632; Petralia RS, 1996, NEUROSCIENCE, V71, P949, DOI 10.1016/0306-4522(95)00533-1; Petralia RS, 1996, J COMP NEUROL, V372, P356; Profaci CP, 2011, PSYCHOPHARMACOLOGY B; Recasens M, 2007, CURR DRUG TARGETS, V8, P651, DOI 10.2174/138945007780618544; Ritzen A, 2005, BASIC CLIN PHARMACOL, V97, P202, DOI 10.1111/j.1742-7843.2005.pto_156.x; Scannevin RH, 2000, NAT REV NEUROSCI, V1, P133, DOI 10.1038/35039075; Schlumberger C, 2009, BEHAV PHARMACOL, V20, P56, DOI 10.1097/FBP.0b013e3283242f57; Schoepp DD, 2001, J PHARMACOL EXP THER, V299, P12; Shipe WD, 2005, CURR OPIN DRUG DISC, V8, P449; Simpson EH, 2010, NEURON, V65, P585, DOI 10.1016/j.neuron.2010.02.014; Spinelli S, 2005, PSYCHOPHARMACOLOGY, V179, P292, DOI 10.1007/s00213-004-2126-x; Spooren WPJM, 2000, EUR J PHARMACOL, V397, pR1, DOI 10.1016/S0014-2999(00)00269-7; Stornetta RL, 2011, NEUROSCIENTIST, V17, P54, DOI 10.1177/1073858410365562; Swanson CJ, 2005, NAT REV DRUG DISCOV, V4, P131, DOI 10.1038/nrd1630; Tan HY, 2007, CEREB CORTEX, V17, pI171, DOI [10.1093/cercor/bhm069, 10.1093/cercor/hhm069]; Toda Mitsuru, 2007, Curr Psychiatry Rep, V9, P329, DOI 10.1007/s11920-007-0041-7; Wei J, 2010, J BIOL CHEM, V285, P26369, DOI 10.1074/jbc.M110.121376; Woolley ML, 2008, PSYCHOPHARMACOLOGY, V196, P431, DOI 10.1007/s00213-007-0974-x; Xi D, 2011, NEUROPSYCHOPHARMACOL, V36, P1260, DOI 10.1038/npp.2011.12; Yokoi M, 1996, SCIENCE, V273, P645, DOI 10.1126/science.273.5275.645	97	22	22	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2013	8	4							e61787	10.1371/journal.pone.0061787	http://dx.doi.org/10.1371/journal.pone.0061787			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123JP	23593498	Green Published, gold			2022-12-25	WOS:000317385300084
J	Collin, F; Thompson, RE; Jolliffe, KA; Payne, RJ; Maxwell, A				Collin, Frederic; Thompson, Robert E.; Jolliffe, Katrina A.; Payne, Richard J.; Maxwell, Anthony			Fragments of the Bacterial Toxin Microcin B17 as Gyrase Poisons	PLOS ONE			English	Article							MOLECULAR-WEIGHT ANTIBIOTICS; PLASMID CCDB PROTEIN; DNA GYRASE; ESCHERICHIA-COLI; INHIBITOR; BIOSYNTHESIS; CLEAVAGE; SEQUENCE; OXAZOLE	Fluoroquinolones are very important drugs in the clinical antibacterial arsenal; their success is principally due to their mode of action: the stabilisation of a gyrase-DNA intermediate (the cleavage complex), which triggers a chain of events leading to cell death. Microcin B17 (MccB17) is a modified peptide bacterial toxin that acts by a similar mode of action, but is unfortunately unsuitable as a therapeutic drug. However, its structure and mechanism could inspire the design of new antibacterial compounds that are needed to circumvent the rise in bacterial resistance to current antibiotics. Here we describe the investigation of the structural features responsible for MccB17 activity and the identification of fragments of the toxin that retain the ability to stabilise the cleavage complex.	[Collin, Frederic; Maxwell, Anthony] John Innes Ctr Plant Sci Res, Dept Biol Chem, Norwich NR4 7UH, Norfolk, England; [Thompson, Robert E.; Jolliffe, Katrina A.; Payne, Richard J.] Univ Sydney, Sch Chem, Sydney, NSW 2006, Australia	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; University of Sydney	Maxwell, A (corresponding author), John Innes Ctr Plant Sci Res, Dept Biol Chem, Norwich Res Pk, Norwich NR4 7UH, Norfolk, England.	tony.maxwell@jic.ac.uk	Jolliffe, Katrina/E-3834-2010; Payne, Richard/AAH-3666-2021; Jolliffe, Katrina/P-6282-2019; Collin, Frederic/N-5579-2015; Thompson, Robert/H-6605-2014	Jolliffe, Katrina/0000-0003-1100-4544; Jolliffe, Katrina/0000-0003-1100-4544; Collin, Frederic/0000-0002-6720-5444; Payne, Richard/0000-0002-3618-9226; Maxwell, Anthony/0000-0002-5756-6430	Norwich Research Park; BBSRC [BB/J016853/1, BB/J004561/1]; John Innes Foundation; APA scholarship; John Lamberton Research Scholarship; Biotechnology and Biological Sciences Research Council [BBS/E/J/00000201, BB/J016853/1] Funding Source: researchfish	Norwich Research Park; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); John Innes Foundation; APA scholarship; John Lamberton Research Scholarship; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	FC was supported by a studentship funded by the Norwich Research Park, and by grant BB/J016853/1 from BBSRC, and the work was also supported by grant BB/J004561/1 from BBSRC and the John Innes Foundation. RET is supported by an APA scholarship and a John Lamberton Research Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASENSIO C, 1976, BIOCHEM BIOPH RES CO, V69, P7, DOI 10.1016/S0006-291X(76)80264-1; BAQUERO F, 1978, J BACTERIOL, V135, P342, DOI 10.1128/JB.135.2.342-347.1978; BATES AD, 1993, DNA TOPOLOGY; BERNARD P, 1992, J MOL BIOL, V226, P735, DOI 10.1016/0022-2836(92)90629-X; BERNARD P, 1993, J MOL BIOL, V234, P534, DOI 10.1006/jmbi.1993.1609; Collin F, 2011, APPL MICROBIOL BIOT, V92, P479, DOI 10.1007/s00253-011-3557-z; Drlica K, 1997, MICROBIOL MOL BIOL R, V61, P377, DOI 10.1128/.61.3.377-392.1997; Edwards MJ, 2009, SCIENCE, V326, P1415, DOI 10.1126/science.1179123; GELLERT M, 1976, P NATL ACAD SCI USA, V73, P3872, DOI 10.1073/pnas.73.11.3872; GENILLOUD O, 1989, J BACTERIOL, V171, P1126, DOI 10.1128/jb.171.2.1126-1135.1989; Heddle JG, 2001, J MOL BIOL, V307, P1223, DOI 10.1006/jmbi.2001.4562; Maxwell A, 1999, METH MOL B, V94, P135; Maxwell A, 2003, CURR TOP MED CHEM, V3, P283, DOI 10.2174/1568026033452500; Milne JC, 1998, BIOCHEMISTRY-US, V37, P13250, DOI 10.1021/bi980996e; Pierrat OA, 2005, BIOCHEMISTRY-US, V44, P4204, DOI 10.1021/bi0478751; Pierrat OA, 2003, J BIOL CHEM, V278, P35016, DOI 10.1074/jbc.M304516200; Pong H, 1999, METH MOL B, V94, P163; REECE RJ, 1989, J BIOL CHEM, V264, P19648; Roy RS, 1999, CHEM BIOL, V6, P305, DOI 10.1016/S1074-5521(99)80076-3; Roy RS, 1998, BIOCHEMISTRY-US, V37, P4125, DOI 10.1021/bi9728250; Ruiz N, 2005, CELL, V121, P307, DOI 10.1016/j.cell.2005.02.014; Thompson RE, 2011, ORG LETT, V13, P680, DOI 10.1021/ol102916b; Videnov G, 1996, ANGEW CHEM INT EDIT, V35, P1503, DOI 10.1002/anie.199615031; Vos SM, 2011, NAT REV MOL CELL BIO, V12, P827, DOI 10.1038/nrm3228; YORGEY P, 1994, P NATL ACAD SCI USA, V91, P4519, DOI 10.1073/pnas.91.10.4519	25	26	26	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2013	8	4							e61459	10.1371/journal.pone.0061459	http://dx.doi.org/10.1371/journal.pone.0061459			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123IQ	23593482	Green Published, gold, Green Submitted			2022-12-25	WOS:000317382000050
J	Kuda, O; Pietka, TA; Demianova, Z; Kudova, E; Cvacka, J; Kopecky, J; Abumrad, NA				Kuda, Ondrej; Pietka, Terri A.; Demianova, Zuzana; Kudova, Eva; Cvacka, Josef; Kopecky, Jan; Abumrad, Nada A.			Sulfo-N-succinimidyl Oleate (SSO) Inhibits Fatty Acid Uptake and Signaling for Intracellular Calcium via Binding CD36 Lysine 164	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SCAVENGER RECEPTOR CD36; CHEMICAL CROSS-LINKING; ADIPOSE-TISSUE; OXIDIZED PHOSPHOLIPIDS; DENSITY-LIPOPROTEIN; SERUM-ALBUMIN; PROTEIN; SITE; IDENTIFICATION; INFLAMMATION	FAT/CD36 is a multifunctional glycoprotein that facilitates long-chain fatty acid (FA) uptake by cardiomyocytes and adipocytes and uptake of oxidized low density lipoproteins (oxLDL) by macrophages. CD36 also mediates FA-induced signaling to increase intracellular calcium in various cell types. The membrane-impermeable sulfo-N-hydroxysuccinimidyl (NHS) ester of oleate (SSO) irreversibly binds CD36 and has been widely used to inhibit CD36-dependent FA uptake and signaling to calcium. The inhibition mechanism and whether SSO modification of CD36 involves the FA-binding site remain unexplored. CHO cells expressing human CD36 were SSO-treated, and the protein was pulled down, deglycosylated, and resolved by electrophoresis. The CD36 band was extracted from the gel and digested for analysis by mass spectrometry. NHS derivatives react with primary or secondary amines on proteins to yield stable amide or imide bonds. Two oleoylated peptides, found only in SSO-treated samples, were identified with high contribution and confidence scores as carrying oleate modification of Lys-164. Lysine 164 lies within a predicted CD36 binding domain for FA and oxLDL. CHO cells expressing CD36 with mutated Lys-164 had impaired CD36 function in FA uptake and FA-induced calcium release from the endoplasmic reticulum, supporting the importance of Lys-164 for both FA effects. Furthermore, consistent with the importance of Lys-164 for oxLDL binding, SSO inhibited oxLDL uptake by macrophages. In conclusion, SSO accesses Lys-164 in the FA-binding site on CD36, and initial modeling of this site is presented. The data suggest competition between FA and oxLDL for access to the CD36 binding pocket.	[Kuda, Ondrej; Kopecky, Jan] Acad Sci Czech Republ, Inst Physiol, Vvi, CR-14220 Prague 4, Czech Republic; [Pietka, Terri A.; Abumrad, Nada A.] Washington Univ, Sch Med, Ctr Human Nutr, Dept Med, St Louis, MO 63110 USA; [Pietka, Terri A.; Abumrad, Nada A.] Washington Univ, Sch Med, Ctr Human Nutr, Dept Cell Biol, St Louis, MO 63110 USA; [Demianova, Zuzana; Kudova, Eva; Cvacka, Josef] Acad Sci Czech Republ, Inst Organ Chem & Biochem, Vvi, CR-16610 Prague 6, Czech Republic	Czech Academy of Sciences; Institute of Physiology of the Czech Academy of Sciences; Washington University (WUSTL); Washington University (WUSTL); Czech Academy of Sciences; Institute of Organic Chemistry & Biochemistry of the Czech Academy of Sciences	Kuda, O (corresponding author), Acad Sci Czech Republ, Inst Physiol, Vvi, Videnska 1083, CR-14220 Prague 4, Czech Republic.	kuda@biomed.cas.cz	Kopecky, Jan/B-8244-2012; Cvačka, Josef/A-6126-2014; Kudova, Eva/B-3155-2012; Kuda, Ondrej/B-7990-2012	Kopecky, Jan/0000-0001-8072-2035; Cvačka, Josef/0000-0002-3590-9009; Kudova, Eva/0000-0001-7131-5948; Kuda, Ondrej/0000-0001-7034-4536; demianova, zuzana/0000-0003-2822-2177	National Institutes of Health [DK033301, DK60022, P01 HL057278]; Czech Science Foundation [13-04449P]; EC Project DIABAT [HEALTH-F2-2011-278373]; Academy of Sciences of the Czech Republic [RVO 61388963]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL057278] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056341, R01DK033301, R01DK060022] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Czech Science Foundation(Grant Agency of the Czech Republic); EC Project DIABAT; Academy of Sciences of the Czech Republic(Czech Academy of Sciences); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK033301, DK60022, and P01 HL057278. This work was also supported by Czech Science Foundation Grant 13-04449P, EC Project DIABAT HEALTH-F2-2011-278373, and Academy of Sciences of the Czech Republic Grant RVO 61388963.	Abumrad NA, 2012, PHYSIOL REV, V92, P1061, DOI 10.1152/physrev.00019.2011; ASCH AS, 1993, SCIENCE, V262, P1436, DOI 10.1126/science.7504322; Baillie AGS, 1996, J MEMBRANE BIOL, V153, P75, DOI 10.1007/s002329900111; BARNWELL JW, 1989, J CLIN INVEST, V84, P765, DOI 10.1172/JCI114234; Berglund L, 1996, BBA-GENE STRUCT EXPR, V1309, P63, DOI 10.1016/S0167-4781(96)00143-1; Coort SLM, 2002, MOL CELL BIOCHEM, V239, P213, DOI 10.1023/A:1020539932353; Demers A, 2004, BIOCHEM J, V382, P417, DOI 10.1042/BJ20040036; Dramane G, 2012, J CLIN INVEST, V122, P2267, DOI 10.1172/JCI59953; Duttaroy A. K., 2004, CELLULAR PROTEINS TH, P3; El-Yassimi A, 2008, J BIOL CHEM, V283, P12949, DOI 10.1074/jbc.M707478200; ENDEMANN G, 1993, J BIOL CHEM, V268, P11811; Falomir-Lockhart LJ, 2006, J BIOL CHEM, V281, P13979, DOI 10.1074/jbc.M511943200; Febbraio M, 2001, J CLIN INVEST, V108, P785, DOI 10.1172/JCI200114006; Gao DT, 2010, J BIOL CHEM, V285, P4447, DOI 10.1074/jbc.M109.082800; GEFFEN I, 1989, EMBO J, V8, P2855, DOI 10.1002/j.1460-2075.1989.tb08433.x; Ghosh A, 2011, BLOOD, V117, P6355, DOI 10.1182/blood-2011-02-338582; Glatz JFC, 2010, PHYSIOL REV, V90, P367, DOI 10.1152/physrev.00003.2009; Gros J, 1999, J CELL SCI, V112, P3791; HARE JF, 1991, P NATL ACAD SCI USA, V88, P5902, DOI 10.1073/pnas.88.13.5902; HARMON CM, 1991, J MEMBRANE BIOL, V121, P261, DOI 10.1007/BF01951559; HARMON CM, 1993, J MEMBRANE BIOL, V133, P43; Hirano K, 2003, TRENDS CARDIOVAS MED, V13, P136, DOI 10.1016/S1050-1738(03)00026-4; Hoosdally SJ, 2009, J BIOL CHEM, V284, P16277, DOI 10.1074/jbc.M109.007849; Huang BX, 2005, BIOCHEM J, V387, P695, DOI 10.1042/BJ20041624; HUANG MM, 1991, P NATL ACAD SCI USA, V88, P7844, DOI 10.1073/pnas.88.17.7844; Kalkhof S, 2008, ANAL BIOANAL CHEM, V392, P305, DOI 10.1007/s00216-008-2231-5; Kar NS, 2008, J BIOL CHEM, V283, P8765, DOI 10.1074/jbc.M709195200; Kennedy DJ, 2011, CARDIOVASC RES, V89, P604, DOI 10.1093/cvr/cvq360; Kerkhoff C, 2001, BIOCHEMISTRY-US, V40, P241, DOI 10.1021/bi001791k; Koutsari C, 2012, DIABETES, V61, P329, DOI 10.2337/db11-0748; Koutsari C, 2011, DIABETES, V60, P2032, DOI 10.2337/db11-0154; Kuda O, 2011, J BIOL CHEM, V286, P17785, DOI 10.1074/jbc.M111.232975; Le Foll C, 2009, AM J PHYSIOL-REG I, V297, pR655, DOI 10.1152/ajpregu.00223.2009; Listenberger LL, 2003, P NATL ACAD SCI USA, V100, P3077, DOI 10.1073/pnas.0630588100; Love-Gregory L, 2008, HUM MOL GENET, V17, P1695, DOI 10.1093/hmg/ddn060; Love-Gregory L, 2011, CURR OPIN CLIN NUTR, V14, P527, DOI 10.1097/MCO.0b013e32834bbac9; Lundby A, 2012, CELL REP, V2, P419, DOI 10.1016/j.celrep.2012.07.006; Navazo MDP, 1996, J BIOL CHEM, V271, P15381, DOI 10.1074/jbc.271.26.15381; Naville D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030686; Nicholls HT, 2011, DIABETES, V60, P1100, DOI 10.2337/db10-1353; NICHOLSON AC, 1995, ARTERIOSCL THROM VAS, V15, P269, DOI 10.1161/01.ATV.15.2.269; Pepino MY, 2012, J LIPID RES, V53, P561, DOI 10.1194/jlr.M021873; Pohl J, 2005, MOL BIOL CELL, V16, P24, DOI 10.1091/mbc.E04-07-0616; Rasmussen JT, 1998, EUR J BIOCHEM, V257, P488, DOI 10.1046/j.1432-1327.1998.2570488.x; REED RG, 1986, J BIOL CHEM, V261, P5619; Riquelme CA, 2011, SCIENCE, V334, P528, DOI 10.1126/science.1210558; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Shilov IV, 2007, MOL CELL PROTEOMICS, V6, P1638, DOI 10.1074/mcp.T600050-MCP200; Silverstein RL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.272re3; Smith J, 2008, WESTERN HUM REV, V62, P36; Storch J, 2009, J LIPID RES, V50, pS126, DOI 10.1194/jlr.R800084-JLR200; Strohalm M, 2010, ANAL CHEM, V82, P4648, DOI 10.1021/ac100818g; Su X, 2009, TRENDS ENDOCRIN MET, V20, P72, DOI 10.1016/j.tem.2008.11.001; Sundaresan S, 2013, FASEB J, V27, P1191, DOI 10.1096/fj.12-217703; Tao NB, 1996, J BIOL CHEM, V271, P22315, DOI 10.1074/jbc.271.37.22315; Wagner SA, 2012, MOL CELL PROTEOMICS, V11, P1578, DOI 10.1074/mcp.M112.017905; Xiong Y, 2012, J CELL BIOL, V198, P155, DOI 10.1083/jcb.201202056	57	89	96	3	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 31	2013	288	22					15547	15555		10.1074/jbc.M113.473298	http://dx.doi.org/10.1074/jbc.M113.473298			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	156LA	23603908	Green Published, hybrid			2022-12-25	WOS:000319822300013
J	Voss, S; Hallstrom, T; Saleh, M; Burchhardt, G; Pribyl, T; Singh, B; Riesbeck, K; Zipfel, PF; Hammerschmidt, S				Voss, Sylvia; Hallstroem, Teresia; Saleh, Malek; Burchhardt, Gerhard; Pribyl, Thomas; Singh, Birendra; Riesbeck, Kristian; Zipfel, Peter F.; Hammerschmidt, Sven			The Choline-binding Protein PspC of Streptococcus pneumoniae Interacts with the C-terminal Heparin-binding Domain of Vitronectin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SURFACE PROTEIN; NASOPHARYNGEAL COLONIZATION; INTRASTRAIN VARIATION; MEDIATES ADHESION; ADHERENCE; FIBRONECTIN; VIRULENCE; RECEPTOR; INVASION; POLYSACCHARIDE	Adherence of Streptococcus pneumoniae is directly mediated by interactions of adhesins with eukaryotic cellular receptors or indirectly by exploiting matrix and serum proteins as molecular bridges. Pneumococci engage vitronectin, the human adhesive glycoprotein and complement inhibitor, to facilitate attachment to epithelial cells of the mucosal cavity, thereby modulating host cell signaling. In this study, we identified PspC as a vitronectin-binding protein interacting with the C-terminal heparin-binding domain of vitronectin. PspC is a multifunctional surface-exposed choline-binding protein displaying various adhesive properties. Vitronectin binding required the R domains in the mature PspC protein, which are also essential for the interaction with the ectodomain of the polymeric immunoglobulin receptor and secretory IgA. Consequently, secretory IgA competitively inhibited binding of vitronectin to purified PspC and to PspC-expressing pneumococci. In contrast, Factor H, which binds to the N-terminal part of mature PspC molecules, did not interfere with the PspC-vitronectin interaction. Using a series of vitronectin peptides, the C-terminal heparin-binding domain was shown to be essential for the interaction of soluble vitronectin with PspC. Binding experiments with immobilized vitronectin suggested a region N-terminal to the identified heparin-binding domain as an additional binding region for PspC, suggesting that soluble, immobilized, as well as cellularly bound vitronectin possesses different conformations. Finally, vitronectin bound to PspC was functionally active and inhibited the deposition of the terminal complement complex. In conclusion, this study identifies and characterizes (on the molecular level) the interaction between the pneumococcal adhesin PspC and the human glycoprotein vitronectin.	[Voss, Sylvia; Saleh, Malek; Burchhardt, Gerhard; Pribyl, Thomas; Hammerschmidt, Sven] Ernst Moritz Arndt Univ Greifswald, Interfac Inst Genet & Funct Gen, Dept Genet Microorganisms, D-17487 Greifswald, Germany; [Hallstroem, Teresia; Zipfel, Peter F.] Leibniz Inst Nat Product Res & Infect Biol, Hans Knoell Inst, Dept Infect Biol, D-07745 Jena, Germany; [Zipfel, Peter F.] Univ Jena, Inst Microbiol, D-07743 Jena, Germany; [Singh, Birendra; Riesbeck, Kristian] Lund Univ, Skane Univ Hosp, Dept Lab Med, SE-20502 Malmo, Sweden	Ernst Moritz Arndt Universitat Greifswald; Hans Knoll Institute (HKI); Friedrich Schiller University of Jena; Lund University; Skane University Hospital	Hammerschmidt, S (corresponding author), Ernst Moritz Arndt Univ Greifswald, Interfac Inst Genet & Funct Gen, Dept Genet Microorganisms, Friedrich Ludwig Jahn Str 15A, D-17487 Greifswald, Germany.	sven.hammerschmidt@uni-greifswald.de	Hammerschmidt, Sven/G-2598-2010; Singh, Birendra/H-3592-2011	Hammerschmidt, Sven/0000-0002-6382-6681; Riesbeck, Kristian/0000-0001-6274-6965; Singh, Birendra/0000-0002-7246-1442	Deutsche Forschungsgemeinschaft [DFG HA 3125/4-2, DFG-GRK840]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Grants DFG HA 3125/4-2 and the DFG-GRK840 from the Deutsche Forschungsgemeinschaft (to S. H.).	Agarwal V, 2010, J BIOL CHEM, V285, P23484, DOI 10.1074/jbc.M110.142703; Anderton JM, 2007, MICROB PATHOGENESIS, V42, P225, DOI 10.1016/j.micpath.2007.02.003; Asmat TM, 2012, MICROBIOL-SGM, V158, P771, DOI 10.1099/mic.0.053603-0; Attali C, 2008, INFECT IMMUN, V76, P466, DOI 10.1128/IAI.01261-07; Bagnoli F, 2008, J BACTERIOL, V190, P5480, DOI 10.1128/JB.00384-08; Barocchi MA, 2006, P NATL ACAD SCI USA, V103, P2857, DOI 10.1073/pnas.0511017103; Bergmann S, 2004, INFECT IMMUN, V72, P2416, DOI 10.1128/IAI.72.4.2416-2419.2004; Bergmann S, 2001, MOL MICROBIOL, V40, P1273, DOI 10.1046/j.1365-2958.2001.02448.x; Bergmann S, 2009, J CELL SCI, V122, P256, DOI 10.1242/jcs.035600; Brooks-Walter A, 1999, INFECT IMMUN, V67, P6533; Cartwright K, 2002, EUR J PEDIATR, V161, P188, DOI 10.1007/s00431-001-0907-3; Chia ES, 2000, INFECT IMMUN, V68, P1864, DOI 10.1128/IAI.68.4.1864-1870.2000; Chillakuri CR, 2010, FEBS LETT, V584, P3287, DOI 10.1016/j.febslet.2010.06.023; Dave S, 2004, J IMMUNOL, V173, P471, DOI 10.4049/jimmunol.173.1.471; Dieudonne-Vatran A, 2009, J IMMUNOL, V182, P7865, DOI 10.4049/jimmunol.0802376; Elm C, 2004, J BIOL CHEM, V279, P6296, DOI 10.1074/jbc.M310528200; Gamez G, 2012, CURR DRUG TARGETS, V13, P323, DOI 10.2174/138945012799424697; GASSON MJ, 1983, J BACTERIOL, V154, P1; Habermann BF, 1993, CURR OPIN CELL BIOL, V5, P864, DOI 10.1016/0955-0674(93)90036-P; Hartel T, 2011, INFECT IMMUN, V79, P44, DOI 10.1128/IAI.00855-10; Hallstrom T, 2011, J INFECT DIS, V204, P1065, DOI 10.1093/infdis/jir459; Hallstrom T, 2009, J IMMUNOL, V183, P2593, DOI 10.4049/jimmunol.0803226; Hammerschmidt S, 2005, INFECT IMMUN, V73, P4653, DOI 10.1128/IAI.73.8.4653-4667.2005; Hammerschmidt S, 1997, MOL MICROBIOL, V25, P1113, DOI 10.1046/j.1365-2958.1997.5391899.x; Hammerschmidt S, 2000, MOL MICROBIOL, V36, P726, DOI 10.1046/j.1365-2958.2000.01897.x; Hammerschmidt S, 2007, J IMMUNOL, V178, P5848, DOI 10.4049/jimmunol.178.9.5848; Haupt K, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000250; Hill DJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045452; Hilleringmann M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000026; Holmes AR, 2001, MOL MICROBIOL, V41, P1395, DOI 10.1046/j.1365-2958.2001.02610.x; Hyams C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024581; Hyams C, 2010, INFECT IMMUN, V78, P716, DOI 10.1128/IAI.01056-09; Iannelli F, 2002, GENE, V284, P63, DOI 10.1016/S0378-1119(01)00896-4; ICHIHARA Y, 1993, GENE, V130, P153, DOI 10.1016/0378-1119(93)90361-6; Janulczyk R, 2000, J BIOL CHEM, V275, P37257, DOI 10.1074/jbc.M004572200; Jensch I, 2010, MOL MICROBIOL, V77, P22, DOI 10.1111/j.1365-2958.2010.07189.x; Lin IH, 2012, GENOMICS, V100, P370, DOI 10.1016/j.ygeno.2012.08.001; LOWRANCE JH, 1988, INFECT IMMUN, V56, P2279, DOI 10.1128/IAI.56.9.2279-2285.1988; McNab R, 1996, INFECT IMMUN, V64, P4204, DOI 10.1128/IAI.64.10.4204-4210.1996; Nelson AL, 2007, MOL MICROBIOL, V66, P329, DOI 10.1111/j.1365-2958.2007.05908.x; Orihuela CJ, 2009, J CLIN INVEST, V119, P1638, DOI 10.1172/JCI36759; Papasergi S, 2010, J BIOL CHEM, V285, P7517, DOI 10.1074/jbc.M109.062075; Petit CM, 2001, FEMS MICROBIOL LETT, V200, P229, DOI 10.1111/j.1574-6968.2001.tb10720.x; Pracht D, 2005, INFECT IMMUN, V73, P2680, DOI 10.1128/IAI.73.5.2680-2689.2005; Preissner KT, 2011, SEMIN THROMB HEMOST, V37, P408, DOI 10.1055/s-0031-1276590; PREISSNER KT, 1991, ANNU REV CELL BIOL, V7, P275, DOI 10.1146/annurev.cellbio.7.1.275; Rennemeier C, 2007, FASEB J, V21, P3118, DOI 10.1096/fj.06-7992com; Romero-Steiner S, 2006, VACCINE, V24, P3224, DOI 10.1016/j.vaccine.2006.01.042; Rose L, 2008, J INFECT DIS, V198, P375, DOI 10.1086/589775; Shivshankar P, 2009, MOL MICROBIOL, V73, P663, DOI 10.1111/j.1365-2958.2009.06796.x; Singh B, 2011, MOL MICROBIOL, V81, P80, DOI 10.1111/j.1365-2958.2011.07678.x; Singh B, 2010, MOL MICROBIOL, V78, P545, DOI 10.1111/j.1365-2958.2010.07373.x; Tellier MC, 2000, J IMMUNOL, V164, P3236, DOI 10.4049/jimmunol.164.6.3236; Tettelin H, 2001, SCIENCE, V293, P498, DOI 10.1126/science.1061217; Vengadesan K, 2011, PROTEIN SCI, V20, P759, DOI 10.1002/pro.613; Voss S, 2012, MOL ORAL MICROBIOL, V27, P246, DOI 10.1111/j.2041-1014.2012.00654.x; Weiser JN, 1996, INFECT IMMUN, V64, P2240, DOI 10.1128/IAI.64.6.2240-2245.1996; Weiser JN, 1999, INFECT IMMUN, V67, P3690, DOI 10.1128/IAI.67.7.3690-3692.1999; Yamaguchi M, 2008, J BIOL CHEM, V283, P36272, DOI 10.1074/jbc.M807087200; Yuste J, 2010, INFECT IMMUN, V78, P283, DOI 10.1128/IAI.00541-09; Zhang JR, 2000, CELL, V102, P827, DOI 10.1016/S0092-8674(00)00071-4; Zipfel PF, 2008, VACCINE, V26, pI67, DOI 10.1016/j.vaccine.2008.11.015	62	56	58	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 31	2013	288	22					15614	15627		10.1074/jbc.M112.443507	http://dx.doi.org/10.1074/jbc.M112.443507			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	156LA	23603906	Green Published, Green Submitted, hybrid			2022-12-25	WOS:000319822300019
J	Hoffman, JM; Creevy, KE; Promislow, DEL				Hoffman, Jessica M.; Creevy, Kate E.; Promislow, Daniel E. L.			Reproductive Capability Is Associated with Lifespan and Cause of Death in Companion Dogs	PLOS ONE			English	Article							GONADECTOMY; MORTALITY; WOMEN; SEX; AGE; COHORT; COSTS; CASTRATION; LONGEVITY; SURVIVAL	Reproduction is a risky affair; a lifespan cost of maintaining reproductive capability, and of reproduction itself, has been demonstrated in a wide range of animal species. However, little is understood about the mechanisms underlying this relationship. Most cost-of-reproduction studies simply ask how reproduction influences age at death, but are blind to the subjects' actual causes of death. Lifespan is a composite variable of myriad causes of death and it has not been clear whether the consequences of reproduction or of reproductive capability influence all causes of death equally. To address this gap in understanding, we compared causes of death among over 40,000 sterilized and reproductively intact domestic dogs, Canis lupus familiaris. We found that sterilization was strongly associated with an increase in lifespan, and while it decreased risk of death from some causes, such as infectious disease, it actually increased risk of death from others, such as cancer. These findings suggest that to understand how reproduction affects lifespan, a shift in research focus is needed. Beyond the impact of reproduction on when individuals die, we must investigate its impact on why individuals die, and subsequently must identify the mechanisms by which these causes of death are influenced by the physiology associated with reproductive capability. Such an approach may also clarify the effects of reproduction on lifespan in people.	[Hoffman, Jessica M.; Promislow, Daniel E. L.] Univ Georgia, Dept Genet, Athens, GA 30602 USA; [Creevy, Kate E.] Univ Georgia, Coll Vet Med, Dept Small Anim Med & Surg, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Creevy, KE (corresponding author), Univ Georgia, Coll Vet Med, Dept Small Anim Med & Surg, Athens, GA 30602 USA.	creevy@uga.edu; promislow@uga.edu		Promislow, Daniel/0000-0001-7088-4495	National Institutes of Health [T32GM007103]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007103] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was partially supported by National Institutes of Health training grant T32GM007103. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartlett PC, 2010, PREV VET MED, V94, P264, DOI 10.1016/j.prevetmed.2010.01.007; Bernichtein S, 2008, ENDOCRINOLOGY, V149, P651, DOI 10.1210/en.2007-0925; Boyko AR, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000451; Breen M, 2009, TOP COMPANION ANIM M, V24, P113, DOI 10.1053/j.tcam.2009.03.002; Bryan JN, 2007, PROSTATE, V67, P1174, DOI 10.1002/pros.20590; CHAPMAN T, 1995, NATURE, V373, P241, DOI 10.1038/373241a0; COCHRAN WG, 1954, BIOMETRICS, V10, P417, DOI 10.2307/3001616; Cooley DM, 2002, CANCER EPIDEM BIOMAR, V11, P1434; Fernandez-Varon E, 2007, VET J, V174, P33, DOI 10.1016/j.tvjl.2006.08.001; Fettman MJ, 1997, RES VET SCI, V62, P131, DOI 10.1016/S0034-5288(97)90134-X; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Flatt T, 2011, EXP GERONTOL, V46, P369, DOI 10.1016/j.exger.2010.10.008; Fleming JM, 2011, J VET INTERN MED, V25, P187, DOI 10.1111/j.1939-1676.2011.0695.x; FOLSTAD I, 1992, AM NAT, V139, P603, DOI 10.1086/285346; Frank LA, 2003, DOMEST ANIM ENDOCRIN, V24, P43, DOI 10.1016/S0739-7240(02)00204-7; Gagnon A, 2009, AM J HUM BIOL, V21, P533, DOI 10.1002/ajhb.20893; Green J, 2011, LANCET ONCOL, V12, P785, DOI 10.1016/S1470-2045(11)70154-1; Greer KA, 2007, RES VET SCI, V82, P208, DOI 10.1016/j.rvsc.2006.06.005; Grumbach MM, 2000, J PEDIATR ENDOCR MET, V13, P1439; HAMILTON JB, 1969, J GERONTOL, V24, P395, DOI 10.1093/geronj/24.4.395; Helle S, 2002, SCIENCE, V296, P1085, DOI 10.1126/science.1070106; Hince M, 2008, CELL IMMUNOL, V252, P122, DOI 10.1016/j.cellimm.2007.10.007; HOPKINS SG, 1976, J AM VET MED ASSOC, V168, P1108; Hurt LS, 2006, POP STUD-J DEMOG, V60, P55, DOI 10.1080/00324720500436011; Klein SL, 2004, PARASITE IMMUNOL, V26, P247, DOI 10.1111/j.0141-9838.2004.00710.x; Kustritz MVR, 2007, JAVMA-J AM VET MED A, V231, P1665, DOI 10.2460/javma.231.11.1665; Li Y, 1996, J GERONTOL A-BIOL, V51, pB403, DOI 10.1093/gerona/51A.6.B403; McClelland EE, 2011, ARCH IMMUNOL THER EX, V59, P203, DOI 10.1007/s00005-011-0124-3; Min KJ, 2012, CURR BIOL, V22, pR792, DOI 10.1016/j.cub.2012.06.036; Neilson JC, 1997, J AM VET MED ASSOC, V211, P180; Nemeth N, 2012, CLIN HEMORHEOL MICRO, V50, P197, DOI 10.3233/CH-2011-1427; Partridge L, 2005, CELL, V120, P461, DOI 10.1016/j.cell.2005.01.026; PARTRIDGE L, 1985, NATURE, V316, P20, DOI 10.1038/316020a0; Penn DJ, 2007, P NATL ACAD SCI USA, V104, P553, DOI 10.1073/pnas.0609301103; Pinilla L, 1999, EUR J ENDOCRINOL, V140, P468, DOI 10.1530/eje.0.1400468; R Development Core Team, 2009, R FDN STAT COMP; REIF JS, 1992, AM J EPIDEMIOL, V135, P234, DOI 10.1093/oxfordjournals.aje.a116276; REZNICK D, 1985, OIKOS, V44, P257, DOI 10.2307/3544698; Ru G, 1998, VET J, V156, P31, DOI 10.1016/S1090-0233(98)80059-2; SALMERI KR, 1991, J AM VET MED ASSOC, V198, P1193; SCHNEIDER R, 1969, JNCI-J NATL CANCER I, V43, P1249; Sorenmo KU, 2000, J VET INTERN MED, V14, P266, DOI 10.1892/0891-6640(2000)014&lt;0266:EOSATO&gt;2.3.CO;2; Surveillance Epidemiology and End Results (SEER) Program, 2011, SEER STAT DAT POP TO; Tamas A, 2006, ENDOCRINE, V29, P275, DOI 10.1385/ENDO:29:2:275; Therneau T.M., 2012, PACKAGE SURVIVAL ANA; Urfer SR, 2008, VET REC, V163, P457, DOI 10.1136/vr.163.15.457; van Hagen MAE, 2005, AM J VET RES, V66, P1646, DOI 10.2460/ajvr.2005.66.1646; Venables W, 1997, J EDUC BEHAV STAT, V22, P244; White CR, 2011, J AM ANIM HOSP ASSOC, V47, P210, DOI 10.5326/JAAHA-MS-5621; Withrow SJ, 2010, ILAR J, V51, P208, DOI 10.1093/ilar.51.3.208	50	84	84	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2013	8	4							e61082	10.1371/journal.pone.0061082	http://dx.doi.org/10.1371/journal.pone.0061082			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IK	23613790	Green Published, Green Submitted, gold			2022-12-25	WOS:000317907200030
J	Torfadottir, JE; Valdimarsdottir, UA; Mucci, LA; Kasperzyk, JL; Fall, K; Tryggvadottir, L; Aspelund, T; Olafsson, O; Harris, TB; Jonsson, E; Tulinius, H; Gudnason, V; Adami, HO; Stampfer, M; Steingrimsdottir, L				Torfadottir, Johanna E.; Valdimarsdottir, Unnur A.; Mucci, Lorelei A.; Kasperzyk, Julie L.; Fall, Katja; Tryggvadottir, Laufey; Aspelund, Thor; Olafsson, Orn; Harris, Tamara B.; Jonsson, Eirikur; Tulinius, Hrafn; Gudnason, Vilmundur; Adami, Hans-Olov; Stampfer, Meir; Steingrimsdottir, Laufey			Consumption of Fish Products across the Lifespan and Prostate Cancer Risk	PLOS ONE			English	Article							FOOD FREQUENCY QUESTIONNAIRE; NORDIC COUNTRIES; FATTY FISH; DIET; MEN; METAANALYSIS; ASSOCIATION; MORTALITY; REYKJAVIK; VALIDITY	Objective: To examine whether fish and fish oil consumption across the lifespan is associated with a lower risk of prostate cancer. Design: The study was nested among 2268 men aged 67-96 years in the AGES-Reykjavik cohort study. In 2002 to 2006, dietary habits were assessed, for early life, midlife and later life using a validated food frequency questionnaire. Participants were followed for prostate cancer diagnosis and mortality through 2009 via linkage to nationwide cancer- and mortality registers. Adjusting for potential confounders, we used regression models to estimate odds ratios (ORs) and hazard ratios (HRs) for prostate cancer according to fish and fish oil consumption. Results: Among the 2268 men, we ascertained 214 prevalent and 133 incident prostate cancer cases, of which 63 had advanced disease. High fish consumption in early- and midlife was not associated with overall or advanced prostate cancer. High intake of salted or smoked fish was associated with a 2-fold increased risk of advanced prostate cancer both in early life (95% CI: 1.08, 3.62) and in later life (95% CI: 1.04, 5.00). Men consuming fish oil in later life had a lower risk of advanced prostate cancer [HR (95% CI): 0.43 (0.19, 0.95)], no association was found for early life or midlife consumption. Conclusions: Salted or smoked fish may increase risk of advanced prostate cancer, whereas fish oil consumption may be protective against progression of prostate cancer in elderly men. In a setting with very high fish consumption, no association was found between overall fish consumption in early or midlife and prostate cancer risk.	[Torfadottir, Johanna E.; Valdimarsdottir, Unnur A.; Fall, Katja; Aspelund, Thor; Olafsson, Orn] Univ Iceland, Ctr Publ Hlth Sci, Reykjavik, Iceland; [Torfadottir, Johanna E.] Univ Iceland, Sch Educ, Educ Res Inst, Reykjavik, Iceland; [Valdimarsdottir, Unnur A.; Mucci, Lorelei A.; Kasperzyk, Julie L.; Adami, Hans-Olov; Stampfer, Meir] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Mucci, Lorelei A.; Kasperzyk, Julie L.; Stampfer, Meir] Brigham & Womens Hosp, Dept Med, Channing Div Network Med, Boston, MA 02115 USA; [Mucci, Lorelei A.; Kasperzyk, Julie L.; Stampfer, Meir] Harvard Univ, Sch Med, Boston, MA USA; [Fall, Katja] Orebro Univ Hosp, Orebro, Sweden; [Tryggvadottir, Laufey; Tulinius, Hrafn] Iceland Canc Registry, Reykjavik, Iceland; [Harris, Tamara B.] NIA, Lab Epidemiol Demog & Biometry, Intramural Res Program, Bethesda, MD 20892 USA; [Jonsson, Eirikur] Landspitali Natl Univ Hosp Iceland, Dept Urol, Reykjavik, Iceland; [Adami, Hans-Olov] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Aspelund, Thor; Gudnason, Vilmundur] Iceland Heart Assoc, Kopavogur, Iceland; [Tryggvadottir, Laufey; Tulinius, Hrafn; Gudnason, Vilmundur] Univ Iceland, Fac Med, Reykjavik, Iceland; [Steingrimsdottir, Laufey] Univ Iceland, Landspitali Univ Hosp, Unit Nutr Res, Reykjavik, Iceland; [Steingrimsdottir, Laufey] Univ Iceland, Sch Hlth Sci, Fac Food Sci & Nutr, Reykjavik, Iceland	University of Iceland; University of Iceland; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Orebro University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Karolinska Institutet; Icelandic Heart Association; University of Iceland; Landspitali National University Hospital; University of Iceland; University of Iceland	Torfadottir, JE (corresponding author), Univ Iceland, Ctr Publ Hlth Sci, Reykjavik, Iceland.	jet@hi.is	Aspelund, Thor/K-7022-2019; Gudnason, Vilmundur/K-6885-2015; Fall, Katja/AAE-1876-2021; Gudnason, Vilmundur/AAE-7126-2019; Aspelund, Thor/C-5983-2008; Steingrimsdottir, Laufey/L-3150-2015	Aspelund, Thor/0000-0002-7998-5433; Gudnason, Vilmundur/0000-0001-5696-0084; Fall, Katja/0000-0002-3649-2639; Gudnason, Vilmundur/0000-0001-5696-0084; Aspelund, Thor/0000-0002-7998-5433; Tryggvadottir, Laufey/0000-0001-8067-9030; Valdimarsdottir, Unnur/0000-0001-5382-946X	Framfor (Progress); Icelandic organization; Nordic Health Whole Grain Food [NIH 5 T32 CA09001-36]; American Institute for Cancer Research; National Institute on Aging [N01-AG-1-2100]; Intramural Research Program of the National Institute on Aging, the Icelandic Heart Association; Althingi (the Icelandic Parliament); NATIONAL CANCER INSTITUTE [T32CA009001] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [N01AG012100] Funding Source: NIH RePORTER	Framfor (Progress); Icelandic organization; Nordic Health Whole Grain Food; American Institute for Cancer Research; National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Intramural Research Program of the National Institute on Aging, the Icelandic Heart Association; Althingi (the Icelandic Parliament); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Support was received from Framfor (Progress), an Icelandic organization that aims to fund research and education initiatives related to prostate cancer (to JET), the Icelandic Cancer Society (to JET), HELGA: Nordic Centre of Excellence, Nordic Health Whole Grain Food (to JET and JLK), in part by training grant NIH 5 T32 CA09001-36 (to JLK) and by the American Institute for Cancer Research (to JLK). This study was also funded in part by the National Institute on Aging contract N01-AG-1-2100, in part by the Intramural Research Program of the National Institute on Aging, the Icelandic Heart Association, and the Althingi (the Icelandic Parliament). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DD, 2010, NUTR J, V9, DOI 10.1186/1475-2891-9-50; Allen NE, 2004, CANCER CAUSE CONTROL, V15, P911, DOI 10.1007/s10552-004-1683-y; Amin M, 2008, CUAJ-CAN UROL ASSOC, V2, P510; ANDERSSON SO, 1995, CANCER EPIDEM BIOMAR, V4, P187; Andresdottir MB, 2003, AM J EPIDEMIOL, V158, P844, DOI 10.1093/aje/kwg222; Augustsson K, 2003, CANCER EPIDEM BIOMAR, V12, P64; Chavarro JE, 2008, AM J CLIN NUTR, V88, P1297, DOI 10.3945/ajcn.2008.26419; Chavarro JE, 2007, CANCER EPIDEM BIOMAR, V16, P1364, DOI 10.1158/1055-9965.EPI-06-1033; Dwyer JT, 1997, AM J CLIN NUTR, V65, P1153; Eysteinsdottir T, 2011, J NUTR HEALTH AGING, V15, P809, DOI 10.1007/s12603-011-0067-8; Eysteinsdottir T, 2012, NUTR J, V11, DOI 10.1186/1475-2891-11-12; Fang F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018625; Gilbert R, 2011, CANCER CAUSE CONTROL, V22, P319, DOI 10.1007/s10552-010-9706-3; Guillen MD, 2008, CRIT REV FOOD SCI, V48, P119, DOI 10.1080/10408390601177613; Gunnarsdottir I, 2008, INT J OBESITY, V32, P1105, DOI 10.1038/ijo.2008.64; Gunnarsdottir I, 2010, EUR J CLIN NUTR, V64, P958, DOI 10.1038/ejcn.2010.100; Gunnarsdottir I, 2012, PUBLIC HEALTH NUTR, V21, P1; Harris TB, 2007, AM J EPIDEMIOL, V165, P1076, DOI 10.1093/aje/kwk115; Hedelin M, 2007, INT J CANCER, V120, P398, DOI 10.1002/ijc.22319; Hrbacek J, 2012, UROL ONCOL; Icelandic Cancer Registry Homepage of the Icelandic Cancer Registry, 2006, ICELANDIC CANC REGIS; Jian L, 2004, BRIT J CANCER, V90, P1792, DOI 10.1038/sj.bjc.6601755; JONASSON JG, 2007, IARC SCI PUBL, V160, P312; Joshi AD, 2012, CANCER CAUSE CONTROL, V23, P405, DOI 10.1007/s10552-011-9889-2; Kvale R, 2007, JNCI-J NATL CANCER I, V99, P1881, DOI 10.1093/jnci/djm249; MILLS PK, 1989, CANCER, V64, P598, DOI 10.1002/1097-0142(19890801)64:3&lt;598::AID-CNCR2820640306&gt;3.0.CO;2-6; Mina K, 2008, NUTR CANCER, V60, P222, DOI 10.1080/01635580701684864; Moller B, 2002, EUR J CANCER PREV, V11, pS1; Mori M, 2009, MOL NUTR FOOD RES, V53, P191, DOI 10.1002/mnfr.200800285; Norrish AE, 1999, BRIT J CANCER, V81, P1238, DOI 10.1038/sj.bjc.6690835; OSINCHAK JE, 1992, FREE RADICAL BIO MED, V12, P35, DOI 10.1016/0891-5849(92)90056-M; Pawlega J, 1996, NEOPLASMA, V43, P61; Reese AC, 2009, J NUTRIGENET NUTRIGE, V2, P149, DOI 10.1159/000235565; Rolland-Cachera MF, 2006, INT J OBESITY, V30, pS11, DOI 10.1038/sj.ijo.0803514; Shui IM, 2012, JNCI-J NATL CANCER I, V104, P690, DOI 10.1093/jnci/djs189; Sigurjonsson J, 1943, SURVEY DIET HLTH ICE; Steingrimsdottir L, 1991, ICELANDIC NATL NUTR, VIII; Steingrimsdottir L, 2002, DIET ICELANDERS DIET; Szymanski KM, 2010, AM J CLIN NUTR, V92, P1223, DOI 10.3945/ajcn.2010.29530; Terry P, 2001, LANCET, V357, P1764, DOI 10.1016/S0140-6736(00)04889-3; Torfadottir JE, 2012, CANCER CAUSE CONTROL, V23, P941, DOI 10.1007/s10552-012-9965-2; Torfadottir JE, 2012, AM J EPIDEMIOL, V175, P144, DOI 10.1093/aje/kwr289; Truong-Minh P, 2009, PUBLIC HEALTH NUTR, V12, P609, DOI [10.1017/S1368980008003182, 10.1017/S136898000800182]; Yang YJ, 1999, CLIN BIOCHEM, V32, P405, DOI 10.1016/S0009-9120(99)00036-3	44	35	36	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2013	8	4							e59799	10.1371/journal.pone.0059799	http://dx.doi.org/10.1371/journal.pone.0059799			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IK	23613715	Green Submitted, Green Published, gold			2022-12-25	WOS:000317907200004
J	Chahine, NO; Blanchette, C; Thomas, CB; Lu, J; Haudenschild, D; Loots, GG				Chahine, Nadeen O.; Blanchette, Craig; Thomas, Cynthia B.; Lu, Jeffrey; Haudenschild, Dominik; Loots, Gabriela G.			Effect of Age and Cytoskeletal Elements on the Indentation-Dependent Mechanical Properties of Chondrocytes	PLOS ONE			English	Article							ATOMIC-FORCE MICROSCOPY; ARTICULAR-CARTILAGE EXPLANTS; KNEE-JOINT CARTILAGE; VISCOELASTIC PROPERTIES; CYTOCHALASIN-D; IN-VITRO; INTERMEDIATE FILAMENTS; DYNAMIC COMPRESSION; TENSILE PROPERTIES; CELLS	Articular cartilage chondrocytes are responsible for the synthesis, maintenance, and turnover of the extracellular matrix, metabolic processes that contribute to the mechanical properties of these cells. Here, we systematically evaluated the effect of age and cytoskeletal disruptors on the mechanical properties of chondrocytes as a function of deformation. We quantified the indentation-dependent mechanical properties of chondrocytes isolated from neonatal (1-day), adult (5-year) and geriatric (12-year) bovine knees using atomic force microscopy (AFM). We also measured the contribution of the actin and intermediate filaments to the indentation-dependent mechanical properties of chondrocytes. By integrating AFM with confocal fluorescent microscopy, we monitored cytoskeletal and biomechanical deformation in transgenic cells (GFP-vimentin and mCherry-actin) under compression. We found that the elastic modulus of chondrocytes in all age groups decreased with increased indentation (15-2000 nm). The elastic modulus of adult chondrocytes was significantly greater than neonatal cells at indentations greater than 500 nm. Viscoelastic moduli (instantaneous and equilibrium) were comparable in all age groups examined; however, the intrinsic viscosity was lower in geriatric chondrocytes than neonatal. Disrupting the actin or the intermediate filament structures altered the mechanical properties of chondrocytes by decreasing the elastic modulus and viscoelastic properties, resulting in a dramatic loss of indentation-dependent response with treatment. Actin and vimentin cytoskeletal structures were monitored using confocal fluorescent microscopy in transgenic cells treated with disruptors, and both treatments had a profound disruptive effect on the actin filaments. Here we show that disrupting the structure of intermediate filaments indirectly altered the configuration of the actin cytoskeleton. These findings underscore the importance of the cytoskeletal elements in the overall mechanical response of chondrocytes, indicating that intermediate filament integrity is key to the non-linear elastic properties of chondrocytes. This study improves our understanding of the mechanical properties of articular cartilage at the single cell level.	[Chahine, Nadeen O.] Hofstra North Shore LIJ Sch Med, Feinstein Inst Med Res, Manhasset, NY USA; [Blanchette, Craig; Thomas, Cynthia B.; Loots, Gabriela G.] Lawrence Livermore Natl Lab, Biosci & Biotechnol Div, Phys & Life Sci Directorate, Livermore, CA 94550 USA; [Lu, Jeffrey; Haudenschild, Dominik] Univ Calif Davis, Med Ctr, Dept Orthopaed Surg, Lawrence J Ellison Musculoskeletal Res Ctr, Sacramento, CA 95819 USA; [Loots, Gabriela G.] Univ Calif Merced, Sch Nat Sci, Merced, CA USA	Hofstra University; Northwell Health; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; University of California System; University of California Davis; University of California System; University of California Merced	Blanchette, C (corresponding author), Lawrence Livermore Natl Lab, Biosci & Biotechnol Div, Phys & Life Sci Directorate, Livermore, CA 94550 USA.	blanchette2@llnl.gov; loots1@llnl.gov	Chahine, Nadeen/O-5496-2015; Haudenschild, Dominik/B-2381-2008; Loots, Gabriela G/AGA-4868-2022; Chahine, Nadeen/AAF-9975-2019	Haudenschild, Dominik/0000-0001-9947-9864; Loots, Gabriela G/0000-0001-9546-5561; Chahine, Nadeen/0000-0002-0478-6042	Laboratory Directed Research and Development award from LLNL [09-LW-072]; NSF CAREER Award [1151605]; NIH/NIAMS [AR061038]; U.S. Department of Energy by Lawrence Livermore National Laboratory [DE-AC52-07NA27344]; Directorate For Engineering [1151605] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R03AR061038] Funding Source: NIH RePORTER	Laboratory Directed Research and Development award from LLNL; NSF CAREER Award(National Science Foundation (NSF)NSF - Office of the Director (OD)); NIH/NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); U.S. Department of Energy by Lawrence Livermore National Laboratory(United States Department of Energy (DOE)); Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by Laboratory Directed Research and Development award from LLNL (09-LW-072) (NOC, CB, CT, GGL), NSF CAREER Award 1151605 (NOC) and NIH/NIAMS AR061038 (DRH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work performed under the auspices of the U.S. Department of Energy by Lawrence Livermore National Laboratory under Contract DE-AC52-07NA27344.	AKIZUKI S, 1986, J ORTHOPAED RES, V4, P379, DOI 10.1002/jor.1100040401; Amanatullah DF, 2012, TISSUE ENG A; ARMSTRONG CG, 1982, J BONE JOINT SURG AM, V64, P88, DOI 10.2106/00004623-198264010-00013; Azeloglu EU, 2010, AM J PHYSIOL-HEART C, V298, pH853, DOI 10.1152/ajpheart.00427.2009; BUSCHMANN MD, 1995, J CELL SCI, V108, P1497; Butz KD, 2011, J BIOMECH, V44, P2667, DOI 10.1016/j.jbiomech.2011.08.005; Canal CE, 2008, J BIOMECH, V41, P3145, DOI 10.1016/j.jbiomech.2008.08.031; Chahine NO, 2007, EUR CELLS MATER, V13, P100, DOI 10.22203/eCM.v013a11; Choi JB, 2007, J BIOMECH, V40, P2596, DOI 10.1016/j.jbiomech.2007.01.009; Costa KD, 2006, J BIOMECH ENG-T ASME, V128, P176, DOI 10.1115/1.2165690; Costa Kevin D., 2006, V319, P331; Darling EM, 2006, OSTEOARTHR CARTILAGE, V14, P571, DOI 10.1016/j.joca.2005.12.003; Darling EM, 2009, CELL MOL BIOENG, V2, P395, DOI 10.1007/s12195-009-0077-3; Duan Wangping, 2011, Molecular & Cellular Biomechanics, V8, P253; Durrant LA, 1999, J ANAT, V194, P343, DOI 10.1046/j.1469-7580.1999.19430343.x; ECKERT BS, 1986, CELL MOTIL CYTOSKEL, V6, P15, DOI 10.1002/cm.970060104; Elliott CE, 1997, GENOMICS, V42, P115, DOI 10.1006/geno.1997.4724; Foisner R, 1995, J STRUCT BIOL, V115, P304, DOI 10.1006/jsbi.1995.1055; Guilak F, 1994, Osteoarthritis Cartilage, V2, P91, DOI 10.1016/S1063-4584(05)80059-7; Guilak F, 2000, J BIOMECH, V33, P1663, DOI 10.1016/S0021-9290(00)00105-6; Haudenschild DR, 2011, J ORTHOP RES, V29, P20, DOI 10.1002/jor.21198; Haudenschild Dominik R., 2009, Molecular & Cellular Biomechanics, V6, P135; HAYES WC, 1978, J BIOMECH, V11, P407, DOI 10.1016/0021-9290(78)90075-1; HODGE WA, 1986, P NATL ACAD SCI USA, V83, P2879, DOI 10.1073/pnas.83.9.2879; Holtzer H, 1982, Cold Spring Harb Symp Quant Biol, V46 Pt 1, P317; Hsieh CH, 2008, OSTEOARTHR CARTILAGE, V16, P480, DOI 10.1016/j.joca.2007.08.004; Hudelmaier M, 2001, ARTHRITIS RHEUM, V44, P2556, DOI 10.1002/1529-0131(200111)44:11<2556::AID-ART436>3.0.CO;2-U; Jones WR, 1999, J BIOMECH, V32, P119, DOI 10.1016/S0021-9290(98)00166-3; KEMPSON GE, 1968, NATURE, V220, P1127, DOI 10.1038/2201127b0; KORVER THV, 1992, J RHEUMATOL, V19, P905; KUETTNER KE, 1982, J CELL BIOL, V93, P743, DOI 10.1083/jcb.93.3.743; Lee B, 2010, J BIOMECH, V43, P469, DOI 10.1016/j.jbiomech.2009.09.053; Lee DA, 1997, J ORTHOP RES, V15, P181, DOI 10.1002/jor.1100150205; Leong Daniel J, 2011, Curr Osteoporos Rep, V9, P196, DOI 10.1007/s11914-011-0070-3; Levin AS, 2005, OSTEOARTHR CARTILAGE, V13, P488, DOI 10.1016/j.joca.2005.01.006; LIN DC, 1980, J CELL BIOL, V84, P455, DOI 10.1083/jcb.84.2.455; Loeser RF, 2000, BIORHEOLOGY, V37, P109; Maroudas, 1979, ADULT ARTICULAR CART, P219; McKinley TO, 2004, CLIN ORTHOP RELAT R, P44, DOI 10.1097/01.blo.0000131639.89143.26; McLean WHI, 1996, GENE DEV, V10, P1724, DOI 10.1101/gad.10.14.1724; Mow Van C., 1997, P113; MOW VC, 1980, J BIOMECH ENG-T ASME, V102, P73, DOI 10.1115/1.3138202; Na S, 2009, AM J PHYSIOL-CELL PH, V296, pC868, DOI 10.1152/ajpcell.00604.2008; Nikolic B, 1996, J CELL BIOL, V134, P1455, DOI 10.1083/jcb.134.6.1455; PARKKINEN JJ, 1992, J ORTHOPAED RES, V10, P610, DOI 10.1002/jor.1100100503; Pravincumar P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043938; Pritchard S, 2004, ANN BIOMED ENG, V32, P103, DOI 10.1023/B:ABME.0000007795.69001.35; SAGER PR, 1988, TOXICOLOGY, V49, P479, DOI 10.1016/0300-483X(88)90034-0; SAH RLY, 1989, J ORTHOPAED RES, V7, P619, DOI 10.1002/jor.1100070502; Salter DM, 2001, CLIN ORTHOP RELAT R, pS49; Schinagl RM, 1997, J ORTHOPAED RES, V15, P499, DOI 10.1002/jor.1100150404; SELDEN LA, 1980, BIOCHEM BIOPH RES CO, V95, P1854, DOI 10.1016/S0006-291X(80)80115-X; Sokolov I, 2006, NANOMED-NANOTECHNOL, V2, P31, DOI 10.1016/j.nano.2005.12.002; Steklov Nikolai, 2009, Molecular & Cellular Biomechanics, V6, P113; TELLAM R, 1982, BIOCHEMISTRY-US, V21, P3207, DOI 10.1021/bi00256a027; Trickey WR, 2006, J BIOMECH, V39, P78, DOI 10.1016/j.jbiomech.2004.11.006; Trickey WR, 2004, J ORTHOPAED RES, V22, P131, DOI 10.1016/S0736-0266(03)00150-5; TSAI MA, 1994, BIOPHYS J, V66, P2166, DOI 10.1016/S0006-3495(94)81012-4; URBAN JPG, 1994, BRIT J RHEUMATOL, V33, P901; URBANIK E, 1989, ARCH BIOCHEM BIOPHYS, V269, P181, DOI 10.1016/0003-9861(89)90098-2; Wang CCB, 2003, J BIOMECH, V36, P339, DOI 10.1016/S0021-9290(02)00417-7; Wang CCB, 2002, J BIOMECH ENG-T ASME, V124, P557, DOI 10.1115/1.1503795; Wei XC, 1998, OSTEOARTHR CARTILAGE, V6, P400, DOI 10.1053/joca.1998.0143; Wiche G, 1998, J CELL SCI, V111, P2477; Wong M, 1997, J ORTHOPAED RES, V15, P189, DOI 10.1002/jor.1100150206; Wu JZ, 1999, J BIOMECH, V32, P563, DOI 10.1016/S0021-9290(99)00034-2; Zahn JT, 2011, SMALL, V7, P1480, DOI 10.1002/smll.201100146	67	23	26	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2013	8	4							e61651	10.1371/journal.pone.0061651	http://dx.doi.org/10.1371/journal.pone.0061651			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130DR	23613892	Green Submitted, gold, Green Published			2022-12-25	WOS:000317893400086
J	Fernandez-Soto, P; Tirado, VV; Rodriguez, CC; Perez-Arellano, JL; Muro, A				Fernandez-Soto, Pedro; Velasco Tirado, Virginia; Carranza Rodriguez, Cristina; Luis Perez-Arellano, Jose; Muro, Antonio			Long-Term Frozen Storage of Urine Samples: A Trouble to Get PCR Results in Schistosoma spp. DNA Detection?	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; HAEMATOBIUM INFECTION; MANSONI; DIAGNOSIS; AMPLIFICATION; TUBERCULOSIS; STOOL; BLOOD; EGGS	Background: Human schistosomiasis remains a serious worldwide public health problem. At present, a sensitive and specific assay for routine diagnosis of schistosome infection is not yet available. The potential for detecting schistosome-derived DNA by PCR-based methods in human clinical samples is currently being investigated as a diagnostic tool with potential application in routine schistosomiasis diagnosis. Collection of diagnostic samples such as stool or blood is usually difficult in some populations. However, urine is a biological sample that can be collected in a non-invasive method, easy to get from people of all ages and easy in management, but as a sample for PCR diagnosis is still not widely used. This could be due to the high variability in the reported efficiency of detection as a result of the high variation in urine samples' storage or conditions for handling and DNA preservation and extraction methods. Methodology/Principal Findings: We evaluate different commercial DNA extraction methods from a series of long-term frozen storage human urine samples from patients with parasitological confirmed schistosomiasis in order to assess the PCR effectiveness for Schistosoma spp. detection. Patients urine samples were frozen for 18 months up to 7 years until use. Results were compared with those obtained in PCR assays using fresh healthy human urine artificially contaminated with Schistosoma mansoni DNA and urine samples from mice experimentally infected with S. mansoni cercariae stored frozen for at least 12 months before use. PCR results in fresh human artificial urine samples using different DNA based extraction methods were much more effective than those obtained when long-term frozen human urine samples were used as the source of DNA template. Conclusions/Significance: Long-term frozen human urine samples are probably not a good source for DNA extraction for use as a template in PCR detection of Schistosoma spp., regardless of the DNA method of extraction used.	[Fernandez-Soto, Pedro; Velasco Tirado, Virginia; Muro, Antonio] Univ Salamanca, Fac Farm, IBSAL CIETUS Inst Invest Biomed Salamanca Ctr Inv, E-37007 Salamanca, Spain; [Carranza Rodriguez, Cristina; Luis Perez-Arellano, Jose] Univ Las Palmas Gran Canaria, Fac Ciencias Salud, Dept Ciencias Med & Quirurgicas, Las Palmas Gran Canaria, Spain	University of Salamanca; Universidad de Las Palmas de Gran Canaria	Fernandez-Soto, P (corresponding author), Univ Salamanca, Fac Farm, IBSAL CIETUS Inst Invest Biomed Salamanca Ctr Inv, E-37007 Salamanca, Spain.	pfsoto@usal.es; ama@usal.es	Carranza, Cristina/K-9578-2016; PEREZ-ARELLANO, JOSE-LUIS/E-1565-2019	Velasco Tirado, Virginia/0000-0001-7175-1758; PEREZ-ARELLANO, JOSE-LUIS/0000-0002-2936-8242; Muro, Antonio/0000-0003-0244-4740	Junta de Castilla y Leon [SA116A08]	Junta de Castilla y Leon(Junta de Castilla y Leon)	Junta de Castilla y Leon (Ref. SA116A08). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Oliveira LMA, 2010, DIAGN MICR INFEC DIS, V68, P416, DOI 10.1016/j.diagmicrobio.2010.07.016; Allam AF, 2009, TROP MED INT HEALTH, V14, P316, DOI 10.1111/j.1365-3156.2009.02225.x; Bergmann AR, 2002, J CLIN MICROBIOL, V40, P4581, DOI 10.1128/JCM.40.12.4581-4584.2002; Bergquist R, 2009, TRENDS PARASITOL, V25, P151, DOI 10.1016/j.pt.2009.01.004; Berhe N, 2004, ACTA TROP, V92, P205, DOI 10.1016/j.actatropica.2004.06.011; Bio-Rad Laboratories, 1998, CHEL 100 CHEL 20 CHE; Botezatu I, 2000, CLIN CHEM, V46, P1078; Cannas A, 2008, INT J TUBERC LUNG D, V12, P146; Cannas A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006985; Deelman Leo E., 2002, Molecular Biology Today, V3, P51; Doenhoff MJ, 2004, TRENDS PARASITOL, V20, P35, DOI 10.1016/j.pt.2003.10.019; Enk Martin J, 2010, BMC Res Notes, V3, P115, DOI 10.1186/1756-0500-3-115; Enk MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038947; Fisa R, 2008, AM J TROP MED HYG, V78, P741, DOI 10.4269/ajtmh.2008.78.741; Freire N, 2003, MEM I OSWALDO CRUZ, V98, P783, DOI 10.1590/S0074-02762003000600013; Gobert GN, 2005, MOL CELL PROBE, V19, P250, DOI 10.1016/j.mcp.2005.01.006; Green C, 2009, LANCET INFECT DIS, V9, P505, DOI 10.1016/S1473-3099(09)70149-5; Jelinek, 1996, J Travel Med, V3, P160, DOI 10.1111/j.1708-8305.1996.tb00731.x; Kato-Hayashi N, 2010, EXP PARASITOL, V124, P325, DOI 10.1016/j.exppara.2009.11.008; King CH, 2010, ACTA TROP, V113, P95, DOI 10.1016/j.actatropica.2009.11.012; Kjetland EF, 2009, AM J TROP MED HYG, V81, P1050, DOI 10.4269/ajtmh.2009.09-0081; Kosinski KC, 2011, ACTA TROP, V118, P123, DOI 10.1016/j.actatropica.2011.02.006; Lardeux F, 2008, T ROY SOC TROP MED H, V102, P485, DOI 10.1016/j.trstmh.2008.02.006; LEBECH AM, 1992, J CLIN MICROBIOL, V30, P1646, DOI 10.1128/JCM.30.7.1646-1653.1992; Lichtenstein AV, 2001, ANN NY ACAD SCI, V945, P239; Lucena WA, 1998, T ROY SOC TROP MED H, V92, P290, DOI 10.1016/S0035-9203(98)91016-1; Mharakurwa S, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-103; Pontes LA, 2003, AM J TROP MED HYG, V68, P652, DOI 10.4269/ajtmh.2003.68.652; Pontes LA, 2002, AM J TROP MED HYG, V66, P157, DOI 10.4269/ajtmh.2002.66.157; Putaporntip C, 2011, CLIN MICROBIOL INFEC, V17, P1484, DOI 10.1111/j.1469-0691.2011.03507.x; Rabello ALT, 1997, CLIN INFECT DIS, V24, P304, DOI 10.1093/clinids/24.3.304; Saetun P, 2009, AM J PHYSIOL-RENAL, V296, pF1346, DOI 10.1152/ajprenal.90736.2008; Sandoval N, 2006, PARASITOLOGY, V133, P581, DOI 10.1017/S0031182006000898; Sandoval N, 2006, EXP PARASITOL, V114, P84, DOI 10.1016/j.exppara.2006.02.012; Sorgho H, 2005, ACTA TROP, V93, P169, DOI 10.1016/j.actatropica.2004.10.006; Stothard JR, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000938; Su YH, 2004, J MOL DIAGN, V6, P101, DOI 10.1016/S1525-1578(10)60497-7; Tang YW, 2005, J CLIN MICROBIOL, V43, P4830, DOI 10.1128/JCM.43.9.4830-4833.2005; ten Hove RJ, 2008, T ROY SOC TROP MED H, V102, P179, DOI 10.1016/j.trstmh.2007.10.011; Whitty CJM, 2000, T ROY SOC TROP MED H, V94, P531, DOI 10.1016/S0035-9203(00)90077-4; Wichmann D, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000422; Willard J M, 1998, Methods Mol Biol, V98, P9; Yang JL, 2008, WORLD J GASTROENTERO, V14, P2872, DOI 10.3748/wjg.14.2872; Zhu YC, 2005, ACTA TROP, V96, P130, DOI 10.1016/j.actatropica.2005.07.007	44	11	11	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2013	8	4							e61703	10.1371/journal.pone.0061703	http://dx.doi.org/10.1371/journal.pone.0061703			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130DR	23613907	gold, Green Published, Green Submitted			2022-12-25	WOS:000317893400095
J	Jones, RT; Sanchez, LG; Fierer, N				Jones, Ryan Thomas; Sanchez, Leticia Gonzales; Fierer, Noah			A Cross-Taxon Analysis of Insect-Associated Bacterial Diversity	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; ACYRTHOSIPHON-PISUM; GUT MICROBIOTA; PEA APHIDS; COMMUNITY; SYMBIONTS; ENDOSYMBIONTS; EVOLUTION; HINDGUT; SPACE	Although it is well known that plants and animals harbor microbial symbionts that can influence host traits, the factors regulating the structure of these microbial communities often remain largely undetermined. This is particularly true for insect-associated microbial communities, as few cross-taxon comparisons have been conducted to date. To address this knowledge gap and determine how host phylogeny and ecology affect insect-associated microbial communities, we collected 137 insect specimens representing 39 species, 28 families, and 8 orders, and characterized the bacterial communities associated with each specimen via 16S rRNA gene sequencing. Bacterial taxa within the phylum Proteobacteria were dominant in nearly all insects sampled. On average, the insect-associated bacterial communities were not very diverse, with individuals typically harboring fewer than 8 bacterial phylotypes. Bacterial communities also tended to be dominated by a single phylotype; on average, the most abundant phylotype represented 54.7% of community membership. Bacterial communities were significantly more similar among closely related insects than among less-related insects, a pattern driven by within-species community similarity but detected at every level of insect taxonomy tested. Diet was a poor predictor of bacterial community composition. Individual insect species harbored remarkably unique communities: the distribution of 69.0% of bacterial phylotypes was limited to unique insect species, whereas only 5.7% of phylotypes were detected in more than five insect species. Together these results suggest that host characteristics strongly regulate the colonization and assembly of bacterial communities across insect lineages, patterns that are driven either by co-evolution between insects and their symbionts or by closely related insects sharing conserved traits that directly select for similar bacterial communities.	[Jones, Ryan Thomas; Fierer, Noah] Univ Colorado, Cooperat Inst Res Environm Sci, Boulder, CO 80309 USA; [Sanchez, Leticia Gonzales] Univ Colorado, Miramontes Arts & Sci Program, Boulder, CO 80309 USA; [Fierer, Noah] Univ Colorado, Dept Ecol & Evolut Biol, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	Jones, RT (corresponding author), Montana State Univ, Dept Land Resources & Environm Sci, Bozeman, MT 59717 USA.	DrRyanJones@gmail.com		FIERER, NOAH/0000-0002-6432-4261	American Society for Microbiology Postdoctoral Fellowship	American Society for Microbiology Postdoctoral Fellowship	RTJ's salary was provided through an American Society for Microbiology Postdoctoral Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson KE, 2012, MOL ECOL, V21, P2282, DOI 10.1111/j.1365-294X.2011.05464.x; Andert J, 2010, FEMS MICROBIOL ECOL, V74, P439, DOI 10.1111/j.1574-6941.2010.00950.x; ARONSON AI, 1986, MICROBIOL REV, V50, P1; Ayres MP, 2000, ECOLOGY, V81, P2198, DOI 10.1890/0012-9658(2000)081[2198:NBOPFB]2.0.CO;2; Baumann P, 2005, ANNU REV MICROBIOL, V59, P155, DOI 10.1146/annurev.micro.59.030804.121041; Baumann P, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 1, THIRD EDITION, P403, DOI 10.1007/0-387-30741-9_16; Bourne DG, 2005, ENVIRON MICROBIOL, V7, P1162, DOI 10.1111/j.1462-2920.2005.00793.x; BRAND JM, 1975, NATURE, V254, P136, DOI 10.1038/254136a0; BUCHER GE, 1967, J INVERTEBR PATHOL, V9, P82, DOI 10.1016/0022-2011(67)90047-X; BULLA LA, 1975, ANNU REV MICROBIOL, V29, P163, DOI 10.1146/annurev.mi.29.100175.001115; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chandler JA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002272; Chandler SM, 2008, P ROY SOC B-BIOL SCI, V275, P565, DOI 10.1098/rspb.2007.1478; Colman D, MOL ECOLOGY; Costello EK, 2010, ISME J, V4, P1375, DOI 10.1038/ismej.2010.71; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Dale C, 2006, CELL, V126, P453, DOI 10.1016/j.cell.2006.07.014; DeSantis TZ, 2006, NUCLEIC ACIDS RES, V34, pW394, DOI 10.1093/nar/gkl244; Dillon RJ, 2004, ANNU REV ENTOMOL, V49, P71, DOI 10.1146/annurev.ento.49.061802.123416; Douglas AE, 2009, FUNCT ECOL, V23, P38, DOI 10.1111/j.1365-2435.2008.01442.x; Douglas AE, 2011, CELL HOST MICROBE, V10, P359, DOI 10.1016/j.chom.2011.09.001; Ferrari J, 2004, ECOL ENTOMOL, V29, P60, DOI 10.1111/j.1365-2311.2004.00574.x; Fierer N, 2008, P NATL ACAD SCI USA, V105, P17994, DOI 10.1073/pnas.0807920105; Forst S, 1997, ANNU REV MICROBIOL, V51, P47, DOI 10.1146/annurev.micro.51.1.47; Fraedrich SW, 2008, PLANT DIS, V92, P215, DOI 10.1094/PDIS-92-2-0215; Gaidos E, 2011, ENVIRON MICROBIOL, V13, P1138, DOI 10.1111/j.1462-2920.2010.02392.x; Geib SM, 2009, ENVIRON ENTOMOL, V38, P686, DOI 10.1603/022.038.0320; Hawlena H, ISME J; HOYT CP, 1971, NATURE, V230, P472, DOI 10.1038/230472a0; Janssen PH, 2006, APPL ENVIRON MICROB, V72, P1719, DOI 10.1128/AEM.72.3.1719-1728.2006; Jones RT, 2012, J MED ENTOMOL, V49, P492, DOI 10.1603/ME11244; Jones RT, 2011, APPL ENVIRON MICROB, V77, P8345, DOI 10.1128/AEM.05974-11; Jones RT, 2010, ISME J, V4, P223, DOI 10.1038/ismej.2009.111; Koch H, 2011, P NATL ACAD SCI USA, V108, P19288, DOI 10.1073/pnas.1110474108; Kunin V, 2010, ENVIRON MICROBIOL, V12, P118, DOI 10.1111/j.1462-2920.2009.02051.x; Lamelas A, 2011, APPL ENVIRON MICROB, V77, P4446, DOI 10.1128/AEM.00141-11; Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lozupone CA, 2007, P NATL ACAD SCI USA, V104, P11436, DOI 10.1073/pnas.0611525104; McCutcheon JP, 2007, P NATL ACAD SCI USA, V104, P19392, DOI 10.1073/pnas.0708855104; McCutcheon JP, 2011, CURR BIOL, V21, P1366, DOI 10.1016/j.cub.2011.06.051; McCutcheon JP, 2009, P NATL ACAD SCI USA, V106, P15394, DOI 10.1073/pnas.0906424106; McFall-Ngai M, 2007, NATURE, V445, P153, DOI 10.1038/445153a; McKenzie VJ, 2012, ISME J, V6, P588, DOI 10.1038/ismej.2011.129; Montllor CB, 2002, ECOL ENTOMOL, V27, P189, DOI 10.1046/j.1365-2311.2002.00393.x; Moran NA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036393; Muegge BD, 2011, SCIENCE, V332, P970, DOI 10.1126/science.1198719; Oliver KM, 2010, ANNU REV ENTOMOL, V55, P247, DOI 10.1146/annurev-ento-112408-085305; Oliver KM, 2003, P NATL ACAD SCI USA, V100, P1803, DOI 10.1073/pnas.0335320100; Osborne SE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000656; Osei-Poku J, MOL ECOLOGY; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Quince C, 2009, NAT METHODS, V6, P639, DOI [10.1038/NMETH.1361, 10.1038/nmeth.1361]; Rohwer F, 2002, MAR ECOL PROG SER, V243, P1, DOI 10.3354/meps243001; Scarborough CL, 2005, SCIENCE, V310, P1781, DOI 10.1126/science.1120180; Scott JJ, 2008, SCIENCE, V322, P63, DOI 10.1126/science.1160423; Sharon G, 2010, P NATL ACAD SCI USA, V107, P20051, DOI 10.1073/pnas.1009906107; Shigenobu S, 2011, CELL MOL LIFE SCI, V68, P1297, DOI 10.1007/s00018-011-0645-2; Six DL, 1998, ENVIRON ENTOMOL, V27, P1393, DOI 10.1093/ee/27.6.1393; Tanaka H, 2006, APPL MICROBIOL BIOT, V71, P907, DOI 10.1007/s00253-005-0215-3; Teixeira L, 2008, PLOS BIOL, V6, P2753, DOI 10.1371/journal.pbio.1000002; Tsuchida T, 2010, SCIENCE, V330, P1102, DOI 10.1126/science.1195463; Wang Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024767; Wegley L, 2007, ENVIRON MICROBIOL, V9, P2707, DOI 10.1111/j.1462-2920.2007.01383.x; Wilson ACC, 2010, INSECT MOL BIOL, V19, P249, DOI 10.1111/j.1365-2583.2009.00942.x; Wu D, 2006, PLOS BIOL, V4, P1079, DOI 10.1371/journal.pbio.0040188; Yildirim S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013963; Zinger L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024570	69	128	130	2	89	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2013	8	4							e61218	10.1371/journal.pone.0061218	http://dx.doi.org/10.1371/journal.pone.0061218			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130DR	23613815	Green Published, Green Submitted, gold			2022-12-25	WOS:000317893400049
J	Mets, OM; de Jong, PA; van Ginneken, B; Kruitwagen, CLJJ; Prokop, M; Oudkerk, M; Lammers, JWJ; Zanen, P				Mets, Onno M.; de Jong, Pim A.; van Ginneken, Bram; Kruitwagen, Cas L. J. J.; Prokop, Mathias; Oudkerk, Matthijs; Lammers, Jan-Willem J.; Zanen, Pieter			CT Air Trapping Is Independently Associated with Lung Function Reduction over Time	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; COMPUTED DENSITY; SCREENING TRIAL; EMPHYSEMA; MORTALITY; SMOKERS; IDENTIFICATION; MORPHOMETRY; PROJECTIONS; BURDEN	Purpose: We aimed to study the association between lung function decline and quantitative computed tomography (CT) air trapping. Materials and Methods: Current and former heavy smokers in a lung cancer screening trial underwent volumetric low-dose CT in inspiration and expiration. Spirometry was obtained at baseline and after 3 years. The expiratory to inspiratory ratio of mean lung density (E/I-ratio(MLD)) was used to quantify air trapping. CT emphysema was defined as voxels in inspiratory CT below -950 Hounsfield Unit. Linear mixed modeling was used to determine the association between CT air trapping and lung function. Results: We included 985 subjects with a mean age of 61.3 years. Independent of CT emphysema, CT air trapping was significantly associated with a reduction in forced expiratory volume in one second (FEV1) and the ratio of FEV1 over the forced vital capacity (FEV1/FVC); FEV1 declines with 33 mL per percent increase in CT air trapping, while FEV1/FVC declines 0.58% per percent increase (both p<0.001). CT air trapping further elicits accelerated loss of FEV1/FVC (additional 0.24% reduction per percent increase; p = 0.014). Conclusion: In a lung cancer screening cohort, quantitatively assessed air trapping on low-dose CT is independently associated with reduced lung function and accelerated decline of FEV1/FVC.	[Mets, Onno M.; de Jong, Pim A.] Univ Med Ctr Utrecht, Utrecht, Netherlands; [van Ginneken, Bram] Radboud Univ Nijmegen, Med Ctr, Diagnost Image Anal Grp, NL-6525 ED Nijmegen, Netherlands; [Kruitwagen, Cas L. J. J.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Prokop, Mathias] Radboud Univ Nijmegen, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Oudkerk, Matthijs] Univ Groningen, Univ Med Ctr Groningen, NL-9713 AV Groningen, Netherlands; [Lammers, Jan-Willem J.; Zanen, Pieter] Univ Med Ctr Utrecht, Div Heart & Lungs, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Radboud University Nijmegen; Utrecht University; Utrecht University Medical Center; Radboud University Nijmegen; University of Groningen; Utrecht University; Utrecht University Medical Center	Mets, OM (corresponding author), Univ Med Ctr Utrecht, Utrecht, Netherlands.	metsonno@gmail.com	de Jong, Pim A/G-7220-2014; Prokop, W.M./H-8081-2014; van Ginneken, Bram/A-3728-2012	de Jong, Pim A/0000-0003-4840-6854; van Ginneken, Bram/0000-0003-2028-8972; zanen, pieter/0000-0002-5318-8276; Prokop, Mathias/0000-0001-8157-8055; Oudkerk, Matthijs/0000-0003-2800-4110	Netherlands Organisation for Health Research and Development (ZonMw); Dutch Cancer Society Koningin Wilhelmina Fonds (KWF); Stichting Centraal Fonds Reserves van Voormalig Vrijwillige Ziekenfondsverzekeringen (RvvZ); Siemens Germany; Roche Diagnostics; Rotterdam Oncologic Thoracic Steering committee (ROTS); G.Ph.Verhagen Trust; Flemish League Against Cancer; Foundation Against Cancer; Erasmus Trust Fund	Netherlands Organisation for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development); Dutch Cancer Society Koningin Wilhelmina Fonds (KWF); Stichting Centraal Fonds Reserves van Voormalig Vrijwillige Ziekenfondsverzekeringen (RvvZ); Siemens Germany(Siemens AG); Roche Diagnostics; Rotterdam Oncologic Thoracic Steering committee (ROTS); G.Ph.Verhagen Trust; Flemish League Against Cancer; Foundation Against Cancer; Erasmus Trust Fund	The NELSON-trial was sponsored by: Netherlands Organisation for Health Research and Development (ZonMw); Dutch Cancer Society Koningin Wilhelmina Fonds (KWF); Stichting Centraal Fonds Reserves van Voormalig Vrijwillige Ziekenfondsverzekeringen (RvvZ); Siemens Germany; Roche Diagnostics; Rotterdam Oncologic Thoracic Steering committee (ROTS); G.Ph.Verhagen Trust, Flemish League Against Cancer, Foundation Against Cancer and Erasmus Trust Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Fiore MC, 2011, NEW ENGL J MED, V365, P1222, DOI 10.1056/NEJMcp1101512; FLETCHER C, 1977, BMJ-BRIT MED J, V1, P1645, DOI 10.1136/bmj.1.6077.1645; Gevenois PA, 1996, AM J RESP CRIT CARE, V154, P187, DOI 10.1164/ajrccm.154.1.8680679; GEVENOIS PA, 1995, AM J RESP CRIT CARE, V152, P653, DOI 10.1164/ajrccm.152.2.7633722; Hoesein FAAM, 2011, THORAX, V66, P782, DOI 10.1136/thx.2010.145995; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; McDonough JE, 2011, NEW ENGL J MED, V365, P1567, DOI 10.1056/NEJMoa1106955; Mets OM, 2012, LUNG, V190, P629, DOI 10.1007/s00408-012-9422-8; Mets OM, 2011, JAMA-J AM MED ASSOC, V306, P1775, DOI 10.1001/jama.2011.1531; Miller MR, 2005, EUR RESPIR J, V26, P153, DOI 10.1183/09031936.05.00034505; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; Nishimura M, 2012, AM J RESP CRIT CARE, V185, P44, DOI 10.1164/rccm.201106-0992OC; O'Donnell RA, 2004, THORAX, V59, P837, DOI 10.1136/thx.2003.019349; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Remy-Jardin M, 2002, RADIOLOGY, V222, P261, DOI 10.1148/radiol.2221001154; Schilham AMR, 2006, IEEE T MED IMAGING, V25, P451, DOI 10.1109/TMI.2006.871545; Tashkin DP, 2008, NEW ENGL J MED, V359, P1543, DOI 10.1056/NEJMoa0805800; van Iersel CA, 2007, INT J CANCER, V120, P868, DOI 10.1002/ijc.22134; van Rikxoort EM, 2009, MED PHYS, V36, P2934, DOI 10.1118/1.3147146; Vestbo J, 2011, NEW ENGL J MED, V365, P1184, DOI 10.1056/NEJMoa1105482; Yuan R, 2009, THORAX, V64, P944, DOI 10.1136/thx.2008.112433	22	10	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2013	8	4							e61783	10.1371/journal.pone.0061783	http://dx.doi.org/10.1371/journal.pone.0061783			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130DR	23613934	gold, Green Published, Green Submitted			2022-12-25	WOS:000317893400108
J	Owczarek-Lipska, M; Jagannathan, V; Drogemuller, C; Lutz, S; Glanemann, B; Leeb, T; Kook, PH				Owczarek-Lipska, Marta; Jagannathan, Vidhya; Droegemueller, Cord; Lutz, Sabina; Glanemann, Barbara; Leeb, Tosso; Kook, Peter H.			A Frameshift Mutation in the Cubilin Gene (CUBN) in Border Collies with Imerslund-Grasbeck Syndrome (Selective Cobalamin Malabsorption)	PLOS ONE			English	Article							DEFICIENCY; RECEPTOR; GENOME; AMNIONLESS; ANEMIA	Imerslund-Grasbeck syndrome (IGS) or selective cobalamin malabsorption has been described in humans and dogs. IGS occurs in Border Collies and is inherited as a monogenic autosomal recessive trait in this breed. Using 7 IGS cases and 7 non-affected controls we mapped the causative mutation by genome-wide association and homozygosity mapping to a 3.53 Mb interval on chromosome 2. We re-sequenced the genome of one affected dog at similar to 10 x coverage and detected 17 non-synonymous variants in the critical interval. Two of these non-synonymous variants were in the cubilin gene (CUBN), which is known to play an essential role in cobalamin uptake from the ileum. We tested these two CUBN variants for association with IGS in larger cohorts of dogs and found that only one of them was perfectly associated with the phenotype. This variant, a single base pair deletion (c.8392delC), is predicted to cause a frameshift and premature stop codon in the CUBN gene. The resulting mutant open reading frame is 821 codons shorter than the wildtype open reading frame (p.Q2798Rfs*3). Interestingly, we observed an additional nonsense mutation in the MRC1 gene encoding the mannose receptor, C type 1, which was in perfect linkage disequilibrium with the CUBN frameshift mutation. Based on our genetic data and the known role of CUBN for cobalamin uptake we conclude that the identified CUBN frameshift mutation is most likely causative for IGS in Border Collies.	[Owczarek-Lipska, Marta; Jagannathan, Vidhya; Droegemueller, Cord; Leeb, Tosso] Univ Bern, Inst Genet, Vetsuisse Fac, Bern, Switzerland; [Lutz, Sabina; Kook, Peter H.] Univ Zurich, Vetsuisse Fac, Clin Small Anim Internal Med, Zurich, Switzerland; [Glanemann, Barbara] Univ London, Royal Vet Coll, Dept Vet Clin Sci, N Mymms, Herts, England	University of Bern; University of Zurich; University of London; University of London Royal Veterinary College	Leeb, T (corresponding author), Univ Bern, Inst Genet, Vetsuisse Fac, Bern, Switzerland.	tosso.leeb@vetsuisse.unibe.ch	Jagannathan, Vidhya/P-1055-2019; Kook, P. H./AAO-9714-2020; Leeb, Tosso/G-3187-2014; Kook, Peter/A-7352-2018	Jagannathan, Vidhya/0000-0002-8155-0041; Leeb, Tosso/0000-0003-0553-4880; Kook, Peter/0000-0002-9492-3484; Drogemuller, Cord/0000-0001-9773-522X	Albert-Heim Foundation	Albert-Heim Foundation	This work was funded in part by a grant from the Albert-Heim Foundation. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aminoff M, 1999, NAT GENET, V21, P309, DOI 10.1038/6831; Andersen CBF, 2010, NATURE, V464, P445, DOI 10.1038/nature08874; Battersby IA, 2005, J SMALL ANIM PRACT, V46, P339, DOI 10.1111/j.1748-5827.2005.tb00330.x; Bishop MA, 2012, VET J, V191, P41, DOI 10.1016/j.tvjl.2011.05.008; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Drogemuller C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000579; Fordyce HH, 2000, J SMALL ANIM PRACT, V41, P407, DOI 10.1111/j.1748-5827.2000.tb03233.x; FYFE JC, 1991, PEDIATR RES, V29, P24, DOI 10.1203/00006450-199101000-00006; Fyfe JC, 2004, BLOOD, V103, P1573, DOI 10.1182/blood-2003-08-2852; Grasbeck R, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-17; He QC, 2005, BLOOD, V106, P1447, DOI 10.1182/blood-2005-03-1197; Lee SJ, 2002, SCIENCE, V295, P1898, DOI 10.1126/science.1069540; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lutz S, 2013, J AM ANIM HOSP ASSOC, V49, P197, DOI 10.5326/JAAHA-MS-5867; Lutz S, 2012, AM J VET RES, V73, P1194, DOI 10.2460/ajvr.73.8.1194; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Morgan LW, 1999, J AM ANIM HOSP ASSOC, V35, P392, DOI 10.5326/15473317-35-5-392; Nielsen MJ, 2012, NAT REV GASTRO HEPAT, V9, P345, DOI 10.1038/nrgastro.2012.76; Outerbridge CA, 1996, J VET INTERN MED, V10, P169; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Sly WS, 2006, P NATL ACAD SCI USA, V103, P15172, DOI 10.1073/pnas.0607053103; Tanner SM, 2003, NAT GENET, V33, P426, DOI 10.1038/ng1098	22	27	27	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2013	8	4							e61144	10.1371/journal.pone.0061144	http://dx.doi.org/10.1371/journal.pone.0061144			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130DR	23613799	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000317893400044
J	Shirazi, RH; Dickson, SL; Skibicka, KP				Shirazi, Rozita H.; Dickson, Suzanne L.; Skibicka, Karolina P.			Gut Peptide GLP-1 and Its Analogue, Exendin-4, Decrease Alcohol Intake and Reward	PLOS ONE			English	Article							GLUCAGON-LIKE PEPTIDE-1; ETHANOL-CONSUMPTION; GLUCAGON-LIKE-PEPTIDE-1 RECEPTOR; NUCLEUS-ACCUMBENS; RODENT MODELS; FOOD-INTAKE; BRAIN; AGONIST; NEURONS; MAINTENANCE	Glucagon-like-peptide-1 (GLP-1) is a gut-and neuro-peptide with an important role in the regulation of food intake and glucose metabolism. Interestingly, GLP-1 receptors (GLP-1R) are expressed in key mesolimbic reward areas (including the ventral tegmental area, VTA), innervated by hindbrain GLP-1 neurons. Recently GLP-1 has emerged as a potential regulator of food reward behavior, an effect driven by the mesolimbic GLP-1Rs. Its role in other reward behaviors remains largely unexplored. Since a considerable overlap has been suggested for circuitry controlling reward behavior derived from food and alcohol we hypothesized that GLP-1 and GLP-1Rs could regulate alcohol intake and alcohol reward. We sought to determine whether GLP-1 or its clinically safe stable analogue, Exendin-4, reduce alcohol intake and reward. To determine the potential role of the endogenous GLP-1 in alcohol intake we evaluated whether GLP-1R antagonist, Exendin 9-39, can increase alcohol intake. Furthermore, we set out to evaluate whether VTA GLP-1R activation is sufficient to reduce alcohol intake. Male Wistar rats injected peripherally with GLP-1 or Exendin-4 reduced their alcohol intake in an intermittent access two bottle free choice drinking model. Importantly, a contribution of endogenously released GLP-1 is highlighted by our observation that blockade of GLP-1 receptors alone resulted in an increased alcohol intake. Furthermore, GLP-1 injection reduced alcohol reward in the alcohol conditioned place preference test in mice. To evaluate the neuroanatomical substrate linking GLP-1 with alcohol intake/reward, we selectively microinjected GLP-1 or Exendin 4 into the VTA. This direct stimulation of the VTA GLP-1 receptors potently reduced alcohol intake. Our findings implicate GLP-1R signaling as a novel modulator of alcohol intake and reward. We show for the first time that VTA GLP-1R stimulation leads to reduced alcohol intake. Considering that GLP-1 analogues are already approved for clinical use, this places the GLP system as an exciting new potential therapeutic target for alcohol use disorders.	[Shirazi, Rozita H.; Dickson, Suzanne L.; Skibicka, Karolina P.] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Physiol, Gothenburg, Sweden	University of Gothenburg	Skibicka, KP (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Physiol, Gothenburg, Sweden.	Karolina.Skibicka@neuro.gu.se	Dickson, Suzanne L/U-4628-2019	Dickson, Suzanne/0000-0002-3822-5294	Swedish Research Council for Medicine [2011-3054, 2009-S266, 2012-1758]; European Commission [FP7-HEALTH-2009-241592, FP7-KBBE-2009-3-245009, FP7-KBBE-2010-4-266408]; Forskning och Utvecklingsarbete/Avtal om Lakarutbildning och Forskning Goteborg [ALFGBG-138741]; Swedish Foundation for Strategic Research [A305-188]; NovoNordisk Fonden; Novo Nordisk Fonden [NNF12OC1016479] Funding Source: researchfish	Swedish Research Council for Medicine; European Commission(European CommissionEuropean Commission Joint Research Centre); Forskning och Utvecklingsarbete/Avtal om Lakarutbildning och Forskning Goteborg; Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); NovoNordisk Fonden(Novo Nordisk Foundation); Novo Nordisk Fonden(Novo Nordisk Foundation)	This work was supported by the Swedish Research Council for Medicine (2011-3054 to KPS; 2009-S266 and 2012-1758 to SLD), European Commission Seventh Framework grants (FP7-HEALTH-2009-241592 (EurOCHIP); FP7-KBBE-2009-3-245009 (NeuroFAST); FP7-KBBE-2010-4-266408 (Full4Health)), Forskning och Utvecklingsarbete/Avtal om Lakarutbildning och Forskning Goteborg (ALFGBG-138741), the Swedish Foundation for Strategic Research to Sahlgrenska Center for Cardiovascular and Metabolic Research (A305-188), and NovoNordisk Fonden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abizaid A, 2009, J NEUROENDOCRINOL, V21, P787, DOI 10.1111/j.1365-2826.2009.01896.x; Alhadeff AL, 2012, ENDOCRINOLOGY, V153, P647, DOI 10.1210/en.2011-1443; Baraboi ED, 2011, AM J PHYSIOL-REG I, V301, pR1011, DOI 10.1152/ajpregu.00424.2010; Barrera JG, 2009, DIABETES, V58, P2820, DOI 10.2337/db09-0281; Bertilsson G, 2008, J NEUROSCI RES, V86, P326, DOI 10.1002/jnr.21483; Bradley DP, 2010, NUTRITION, V26, P243, DOI 10.1016/j.nut.2009.07.008; Davis JF, 2012, BIOL PSYCHIAT, V72, P354, DOI 10.1016/j.biopsych.2012.01.035; DiBattista D, 2003, ALCOHOL, V29, P173, DOI 10.1016/S0741-8329(03)00036-3; Dickson SL, 2012, J NEUROSCI, V32, P4812, DOI 10.1523/JNEUROSCI.6326-11.2012; Dickson SL, 2011, MOL CELL ENDOCRINOL, V340, P80, DOI 10.1016/j.mce.2011.02.017; Dossat AM, 2011, J NEUROSCI, V31, P14453, DOI 10.1523/JNEUROSCI.3262-11.2011; Erreger K, 2012, PHYSIOL BEHAV, V106, P574, DOI 10.1016/j.physbeh.2012.03.014; GOKE R, 1995, EUR J NEUROSCI, V7, P2294, DOI 10.1111/j.1460-9568.1995.tb00650.x; Gonzales RA, 2004, PHARMACOL THERAPEUT, V103, P121, DOI 10.1016/j.pharmthera.2004.06.002; Graham D.L., 2012, MOL PSYCHIAT; Harkavyi A, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-19; Hayes MR, 2010, PHYSIOL BEHAV, V100, P503, DOI 10.1016/j.physbeh.2010.02.029; Kanoski SE, 2012, NEUROPHARMACOLOGY, V62, P1916, DOI 10.1016/j.neuropharm.2011.12.022; Kinzig KP, 2002, J NEUROSCI, V22, P10470; Koole C, 2012, J BIOL CHEM, V287, P3659, DOI 10.1074/jbc.M111.309369; Larsen PJ, 1997, NEUROSCIENCE, V77, P257, DOI 10.1016/S0306-4522(96)00434-4; Li YZ, 2009, P NATL ACAD SCI USA, V106, P1285, DOI 10.1073/pnas.0806720106; Merchenthaler I, 1999, J COMP NEUROL, V403, P261, DOI 10.1002/(SICI)1096-9861(19990111)403:2<261::AID-CNE8>3.0.CO;2-5; Perry T, 2002, J PHARMACOL EXP THER, V300, P958, DOI 10.1124/jpet.300.3.958; Ploj K, 2002, BRAIN RES BULL, V59, P97, DOI 10.1016/S0361-9230(02)00844-4; Rinaman L, 1999, AM J PHYSIOL-REG I, V277, pR582, DOI 10.1152/ajpregu.1999.277.2.R582; Simms JA, 2008, ALCOHOL CLIN EXP RES, V32, P1816, DOI 10.1111/j.1530-0277.2008.00753.x; Skibicka KP, 2011, NEUROSCIENCE, V180, P129, DOI 10.1016/j.neuroscience.2011.02.016; Skibicka KP, 2012, ADDICT BIOL, V17, P95, DOI 10.1111/j.1369-1600.2010.00294.x; Stopponi S, 2011, BIOL PSYCHIAT, V69, P642, DOI 10.1016/j.biopsych.2010.12.010; TangChristensen M, 1996, AM J PHYSIOL-REG I, V271, pR848, DOI 10.1152/ajpregu.1996.271.4.R848; THORENS B, 1993, DIABETES, V42, P1678, DOI 10.2337/diabetes.42.11.1678; Toth K, 2011, GLUCAGON LIKE PEPTID; Turton MD, 1996, NATURE, V379, P69, DOI 10.1038/379069a0; Volkow ND, 2005, NAT NEUROSCI, V8, P555, DOI 10.1038/nn1452; Vrang N, 2003, AM J PHYSIOL-REG I, V285, pR470, DOI 10.1152/ajpregu.00732.2002; Williams DL, 2011, PHYSIOL BEHAV, V103, P557, DOI 10.1016/j.physbeh.2011.04.005; WISE RA, 1973, PSYCHOPHARMACOLOGIA, V29, P203, DOI 10.1007/BF00414034; Young AA, 1999, DIABETES, V48, P1026, DOI 10.2337/diabetes.48.5.1026	39	93	95	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2013	8	4							e61965	10.1371/journal.pone.0061965	http://dx.doi.org/10.1371/journal.pone.0061965			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130DR	23613987	Green Published, Green Submitted, gold			2022-12-25	WOS:000317893400135
J	Shryock, N; McBerry, C; Gonzalez, RMS; Janes, S; Costa, FTM; Aliberti, J				Shryock, Nathaniel; McBerry, Cortez; Gonzalez, Rosa Maria Salazar; Janes, Steven; Costa, Fabio T. M.; Aliberti, Julio			Lipoxin A(4) and 15-Epi-Lipoxin A(4) Protect against Experimental Cerebral Malaria by Inhibiting IL-12/IFN-gamma in the Brain	PLOS ONE			English	Article							IFN-GAMMA; FALCIPARUM-MALARIA; ADJUNCTIVE THERAPY; INTERFERON-GAMMA; IL-12 PRODUCTION; STABLE ANALOGS; T-CELLS; INFLAMMATION; ASPIRIN; IMMUNOPATHOLOGY	Cerebral malaria is caused by infection with Plasmodium falciparum and can lead to severe neurological manifestations and predominantly affects sub-Saharan African children. The pathogenesis of this disease involves unbalanced over-production of pro-inflammatory cytokines. It is clear that signaling though IL-12 receptor is a critical step for development of cerebral malaria, IL-12 genetic deficiency failed to show the same effect, suggesting that there is redundancy among the soluble mediators which leads to immunopathology and death. Consequently, counter-regulatory mediators might protect the host during cerebral malaria. We have previously showed that endogenously produced lipoxins, which are anti-inflammatory mediators generated by 5-lipoxygenase (5-LO)-dependent metabolism of arachidonic acid, limit host damage in a model of mouse toxoplasmosis. We postulated here that lipoxins might also play a counter-regulatory role during cerebral malaria. To test this hypothesis, we infected 5-LO-deficient hosts with P. berghei ANKA strain, which induces a mouse model of cerebral malaria (ECM). Our results show accelerated mortality concomitant with exuberant IL-12 and IFN-gamma production in the absence of 5-lipoxygenase. Moreover, in vivo administration of lipoxin to 5-LO-deficient hosts prevented early mortality and reduced the accumulation of CD8(+)IFN-gamma(+) cells in the brain. Surprisingly, WT animals treated with lipoxin either at the time of infection or 3 days post-inoculum also showed prolonged survival and diminished brain inflammation, indicating that although protective, endogenous lipoxin production is not sufficient to optimally protect the host from brain damage in cerebral malaria. These observations establish 5-LO/LXA(4) as a host protective pathway and suggest a new therapeutic approach against human cerebral malaria (HCM). (255 words).	[Shryock, Nathaniel; McBerry, Cortez; Gonzalez, Rosa Maria Salazar; Janes, Steven; Aliberti, Julio] Univ Cincinnati, Coll Med, Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH USA; [Costa, Fabio T. M.] Univ Estadual Campinas, Inst Biol, Dept Genet Evolut & Bioagents, Sao Paulo, Brazil	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Universidade de Sao Paulo; Universidade Estadual de Campinas	Aliberti, J (corresponding author), Univ Cincinnati, Coll Med, Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH USA.	julio.aliberti@cchmc.org	Costa, Fabio/E-1181-2012; Aliberti, Julio/I-7354-2013	Costa, Fabio/0000-0001-9969-7300; Aliberti, Julio/0000-0003-3420-8478	National Institutes of Health [AI 075038]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI075038] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by National Institutes of Health grant AI 075038 (JA, NS and CM). FTMC is a Conselho Nacional de Desenvolvimento Cientifico e Tecnologico fellow and is enrolled at the Programa Estrategico de Ciencia, Tecnologia & Inovacao nas Fundacoes Estaduais de Saude (PECTI/AM Saude) from Fundacao de Amparoa Pesquisa do Estado do Amazonas (Amazonas-Brazil). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achtman AH, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003515; Aliberti J, 2002, NAT IMMUNOL, V3, P76, DOI 10.1038/ni745; Aliberti J, 2005, NAT REV IMMUNOL, V5, P162, DOI 10.1038/nri1547; Aliberti J, 2002, J EXP MED, V196, P1253, DOI 10.1084/jem.20021183; Amani V, 2000, EUR J IMMUNOL, V30, P1646, DOI 10.1002/1521-4141(200006)30:6&lt;1646::AID-IMMU1646&gt;3.0.CO;2-0; Bafica A, 2005, J CLIN INVEST, V115, P1601, DOI 10.1172/JCI23949; Belnoue E, 2008, PARASITE IMMUNOL, V30, P544, DOI 10.1111/j.1365-3024.2008.01053.x; Bienvenu AL, 2008, ACTA TROP, V106, P104, DOI 10.1016/j.actatropica.2008.02.001; Birnbaum Y, 2007, PROSTAG OTH LIPID M, V83, P89, DOI 10.1016/j.prostaglandins.2006.10.003; Birnbaum Y, 2006, CIRCULATION, V114, P929, DOI 10.1161/CIRCULATIONAHA.106.629907; Charunwatthana P, 2009, CRIT CARE MED, V37, P516, DOI 10.1097/CCM.0b013e3181958dfd; Claser C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018720; Craig AG, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002401; Day N, 2007, AM J TROP MED HYG, V77, P29; de Miranda AS, 2011, NEUROSCI LETT, V491, P202, DOI 10.1016/j.neulet.2011.01.038; DEKOSSODO S, 1993, J IMMUNOL, V151, P4811; Dondorp AM, 2010, LANCET, V376, P1647, DOI 10.1016/S0140-6736(10)61924-1; Engwerda CR, 2002, J EXP MED, V195, P1371, DOI 10.1084/jem.20020128; Faiz MA, 2005, LANCET, V366, P717; Fauconnier M, 2012, J IMMUNOL, V188, P1905, DOI 10.4049/jimmunol.1101978; GRAU GE, 1995, SOZ PRAVENTIV MED, V40, P50, DOI 10.1007/BF01615662; GRAU GE, 1989, P NATL ACAD SCI USA, V86, P5572, DOI 10.1073/pnas.86.14.5572; GRAU GE, 1987, SCIENCE, V237, P1210, DOI 10.1126/science.3306918; Herb F, 2008, HUM MOL GENET, V17, P1052, DOI 10.1093/hmg/ddm378; Higgins SJ, 2011, EXPERT REV ANTI-INFE, V9, P803, DOI [10.1586/eri.11.96, 10.1586/ERI.11.96]; HOFFMAN SL, 1988, J INFECT DIS, V158, P325, DOI 10.1093/infdis/158.2.325; Hunt NH, 2003, TRENDS IMMUNOL, V24, P491, DOI 10.1016/S1471-4906(03)00229-1; Hunt NH, 2010, TRENDS PARASITOL, V26, P272, DOI 10.1016/j.pt.2010.03.006; Idro R, 2005, LANCET NEUROL, V4, P827, DOI 10.1016/S1474-4422(05)70247-7; John CC, 2008, PEDIATRICS, V122, pE92, DOI 10.1542/peds.2007-3709; John CC, 2008, AM J TROP MED HYG, V78, P198, DOI 10.4269/ajtmh.2008.78.198; John CC, 2010, EXPERT REV ANTI-INFE, V8, P997, DOI [10.1586/eri.10.90, 10.1586/ERI.10.90]; Keri JE, 2000, EUR J DERMATOL, V10, P617; Lau LS, 2011, J INFECT DIS, V204, P1989, DOI 10.1093/infdis/jir656; Maddox JF, 1997, J BIOL CHEM, V272, P6972, DOI 10.1074/jbc.272.11.6972; McBerry C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038384; Morris T, 2009, J IMMUNOL, V183, P2089, DOI 10.4049/jimmunol.0900477; Nie CQ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000369; Palmer CD, 2011, BIOCHEM SOC T, V39, P994, DOI 10.1042/BST0390994; Penet MF, 2008, P NATL ACAD SCI USA, V105, P1321, DOI 10.1073/pnas.0706867105; Planche T, 2005, CURR OPIN INFECT DIS, V18, P369, DOI 10.1097/01.qco.0000180161.38530.81; Prasad K, 2000, COCHRANE DB SYST REV; Rampengan T H, 1991, Paediatr Indones, V31, P59; Renia L, 2006, INT J PARASITOL, V36, P547, DOI 10.1016/j.ijpara.2006.02.007; Rudin W, 1997, AM J PATHOL, V150, P257; Rudin W, 1997, EUR J IMMUNOL, V27, P810, DOI 10.1002/eji.1830270403; Schwab JM, 2007, NATURE, V447, P869, DOI 10.1038/nature05877; Serghides L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027714; Serghides L, 2012, PPAR RES, V2012, P1, DOI 10.1155/2012/513865; Serhan CN, 2007, ANNU REV IMMUNOL, V25, P101, DOI 10.1146/annurev.immunol.25.022106.141647; Serhan CN, 2011, CURR TOP MED CHEM, V11, P629; SERHAN CN, 1995, BIOCHEMISTRY-US, V34, P14609, DOI 10.1021/bi00044a041; Takano T, 1998, J CLIN INVEST, V101, P819, DOI 10.1172/JCI1578; Togbe D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002608; Van den Steen PE, 2010, AM J RESP CRIT CARE, V181, P957, DOI 10.1164/rccm.200905-0786OC; Villegas-Mendez A, 2012, J IMMUNOL, V189, P968, DOI 10.4049/jimmunol.1200688; Villegas-Mendez A, 2011, J IMMUNOL, V187, P2885, DOI 10.4049/jimmunol.1100241; Walker J, 2011, SHOCK, V36, P410, DOI 10.1097/SHK.0b013e31822798c1; Willcox ML, 2001, LANCET, V357, P1881, DOI 10.1016/S0140-6736(00)04982-5; WYLER DJ, 1988, J INFECT DIS, V158, P320, DOI 10.1093/infdis/158.2.320	60	24	24	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2013	8	4							e61882	10.1371/journal.pone.0061882	http://dx.doi.org/10.1371/journal.pone.0061882			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130DR	23613965	gold, Green Published, Green Submitted			2022-12-25	WOS:000317893400127
J	Talukdar, FR; Ghosh, SK; Laskar, RS; Mondal, R				Talukdar, Fazlur Rahman; Ghosh, Sankar Kumar; Laskar, Ruhina Shirin; Mondal, Rosy			Epigenetic, Genetic and Environmental Interactions in Esophageal Squamous Cell Carcinoma from Northeast India	PLOS ONE			English	Article							PROMOTER HYPERMETHYLATION; CIGARETTE-SMOKE; DNA METHYLATION; RISK-FACTORS; CANCER-RISK; BETEL QUID; TOBACCO; POLYMORPHISMS; ALCOHOL; TUMORS	Background: Esophageal squamous cell carcinoma (ESCC) develops as a result of complex epigenetic, genetic and environmental interactions. Epigenetic changes like, promoter hypermethylation of multiple tumour suppressor genes are frequent events in cancer, and certain habit-related carcinogens are thought to be capable of inducing aberrant methylation. However, the effects of environmental carcinogens depend upon the level of metabolism by carcinogen metabolizing enzymes. As such key interactions between habits related factors and carcinogen metabolizing gene polymorphisms towards modulating promoter methylation of genes are likely. However, this remains largely unexplored in ESCC. Here, we studied the interaction of various habits related factors and polymorphism of GSTM1/GSTT1 genes towards inducing promoter hypermethylation of multiple tumour suppressor genes. Methodology/Principal Findings: The study included 112 ESCC cases and 130 age and gender matched controls. Conditional logistic regression was used to calculate odds ratios (OR) and multifactor dimensionality reduction (MDR) was used to explore high order interactions. Tobacco chewing and smoking were the major individual risk factors of ESCC after adjusting for all potential confounding factors. With regards to methylation status, significantly higher methylation frequencies were observed in tobacco chewers than non chewers for all the four genes under study (p<0.01). In logistic regression analysis, betel quid chewing, alcohol consumption and null GSTT1 genotypes imparted maximum risk for ESCC without promoter hypermethylation. Whereas, tobacco chewing, smoking and GSTT1 null variants were the most important risk factors for ESCC with promoter hypermethylation. MDR analysis revealed two predictor models for ESCC with promoter hypermethylation (Tobacco chewing/Smoking/Betel quid chewing/GSTT1 null) and ESCC without promoter hypermethylation (Betel quid chewing/Alcohol/GSTT1) with TBA of 0.69 and 0.75 respectively and CVC of 10/10 in both models. Conclusion: Our study identified a possible interaction between tobacco consumption and carcinogen metabolizing gene polymorphisms towards modulating promoter methylation of tumour suppressor genes in ESCC.	[Talukdar, Fazlur Rahman; Ghosh, Sankar Kumar; Laskar, Ruhina Shirin; Mondal, Rosy] Assam Univ, Dept Biotechnol, Silchar, Assam, India	Assam University	Ghosh, SK (corresponding author), Assam Univ, Dept Biotechnol, Silchar, Assam, India.	drsankarghosh@gmail.com	mondal, rosy/J-7808-2017; Talukdar, Fazlur Rahman/GWV-3782-2022; Talukdar, Fazlur Rahman/S-5928-2019	mondal, rosy/0000-0002-5556-0799; Talukdar, Fazlur Rahman/0000-0002-6558-5543; Laskar, Ruhina Shirin/0000-0001-6455-094X	Department of Biotechnology, Government of India (DBT) [BT/Med/NE-SFC/2009]	Department of Biotechnology, Government of India (DBT)(Department of Biotechnology (DBT) India)	The authors thank Department of Biotechnology, Government of India for providing infastructural support 380 (DBT grant number-BT/Med/NE-SFC/2009). The authors do not have any Extramural fund for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbdelRahman SZ, 1996, CANCER LETT, V107, P229, DOI 10.1016/0304-3835(96)04832-X; Akhtar S, 2012, EUR J CANCER, V48, P655, DOI 10.1016/j.ejca.2011.06.008; Brabender J, 2009, ANN SURG ONCOL, V16, P1378, DOI 10.1245/s10434-009-0356-1; Chen J, 2012, ASIAN PAC J CANCER P, V13, P5303, DOI 10.7314/APJCP.2012.13.10.5303; Ganesh B, 2009, CANCER EPIDEMIOL, V33, P431, DOI 10.1016/j.canep.2009.09.002; Gao CM, 2002, CANCER LETT, V188, P95, DOI 10.1016/S0304-3835(02)00115-5; Garg K, 2013, AM J SURG PATHOL, V37, P138, DOI 10.1097/PAS.0b013e31826cabbd; Ghosh SK, 2012, INT J GYNECOL OBSTET, V118, P72, DOI 10.1016/j.ijgo.2012.02.006; Hecht SS, 2003, NAT REV CANCER, V3, P733, DOI 10.1038/nrc1190; Herman JG, 2001, CURR PROTOC HUM GENE; Huang YP, 2011, INT J CANCER, V128, P2261, DOI 10.1002/ijc.25569; Huang Zhi-gang, 2004, Zhonghua Liu Xing Bing Xue Za Zhi, V25, P898; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2007, IARC Monogr Eval Carcinog Risks Hum, V89, P1; Jain M, 2006, CANCER LETT, V242, P60, DOI 10.1016/j.canlet.2005.10.034; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Jin YT, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-422; Kulkarni V, 2004, ORAL ONCOL, V40, P145, DOI 10.1016/S1368-8375(03)00143-X; Lee CH, 2005, INT J CANCER, V113, P475, DOI 10.1002/ijc.20619; Lee YC, 2011, CANCER PREV RES, V4, P1982, DOI 10.1158/1940-6207.CAPR-11-0096; Li B, 2011, EPIGENETICS-US, V6, P307, DOI 10.4161/epi.6.3.14182; Lima SCS, 2011, EPIGENETICS-US, V6, P1217, DOI 10.4161/epi.6.10.17199; Lin RK, 2010, J CLIN INVEST, V120, P521, DOI 10.1172/JCI40706; Liu R, 2010, J TOXICOL ENV HEAL A, V73, P471, DOI 10.1080/15287390903523394; Carvalho AL, 2011, CLIN CANCER RES, V17, P4782, DOI 10.1158/1078-0432.CCR-11-0324; Malik MA, 2010, NUTR CANCER, V62, P734, DOI 10.1080/01635581003605904; Mani S, 2012, EPIGENETICS-US, V7, P270, DOI 10.4161/epi.7.3.19306; Meng XY, 2012, J DIGEST DIS, V13, P208, DOI 10.1111/j.1751-2980.2012.00578.x; Nandakumar A, 2005, INT J CANCER, V116, P740, DOI 10.1002/ijc.21109; Phukan RK, 2001, BRIT J CANCER, V85, P661, DOI 10.1054/bjoc.2001.1920; Pulling LC, 2004, CANCER RES, V64, P3844, DOI 10.1158/0008-5472.CAN-03-2119; Pulling LC, 2001, CARCINOGENESIS, V22, P461, DOI 10.1093/carcin/22.3.461; Tahara T, 2011, HELICOBACTER, V16, P99, DOI 10.1111/j.1523-5378.2011.00821.x; Vuillemenot BR, 2006, MOL CANCER RES, V4, P267, DOI 10.1158/1541-7786.MCR-05-0218; Wacholder S, 2004, J NATL CANCER I, V96, P434, DOI 10.1093/jnci/djh075; Wu IC, 2006, EUR J CLIN INVEST, V36, P236, DOI 10.1111/j.1365-2362.2006.01621.x; Wu M, 2011, CANCER CAUSE CONTROL, V22, P649, DOI 10.1007/s10552-011-9737-4; Yang CX, 2005, WORLD J GASTROENTERO, V11, P2531, DOI 10.3748/wjg.v11.i17.2531; Ye F, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-93; Zendehdel K, 2009, CANCER CAUSE CONTROL, V20, P2031, DOI 10.1007/s10552-009-9399-7	39	56	58	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2013	8	4							e60996	10.1371/journal.pone.0060996	http://dx.doi.org/10.1371/journal.pone.0060996			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125TD	23596512	gold, Green Submitted, Green Published			2022-12-25	WOS:000317563300013
J	Wilson, JS; Jahner, JP; Williams, KA; Forister, ML				Wilson, Joseph S.; Jahner, Joshua P.; Williams, Kevin A.; Forister, Matthew L.			Ecological and Evolutionary Processes Drive the Origin and Maintenance of Imperfect Mimicry	PLOS ONE			English	Article							PIGEONS	Although the forces behind the evolution of imperfect mimicry remain poorly studied, recent hypotheses suggest that relaxed selection on small-bodied individuals leads to imperfect mimicry. While evolutionary history undoubtedly affects the development of imperfect mimicry, ecological community context has largely been ignored and may be an important driver of imperfect mimicry. Here we investigate how evolutionary and ecological contexts might influence mimetic fidelity in Mullerian and Batesian mimicry systems. In Batesian hoverfly systems we find that body size is not a strong predictor of mimetic fidelity. However, in Mullerian velvet ants we find a weak positive relationship between body size and mimetic fidelity when evolutionary context is controlled for and a much stronger relationship between community diversity and mimetic fidelity. These results suggest that reduced selection on small-bodied individuals may not be a major driver of the evolution of imperfect mimicry and that other factors, such as ecological community context, should be considered when studying the evolution of imperfect mimicry.	[Wilson, Joseph S.] Utah State Univ Tooele, Dept Biol, Tooele, UT USA; [Jahner, Joshua P.; Forister, Matthew L.] Univ Nevada, Dept Biol, Reno, NV 89557 USA; [Williams, Kevin A.] Utah State Univ, Dept Biol, Logan, UT 84322 USA; [Williams, Kevin A.] Univ Fed Parana, Dept Zool, BR-80060000 Curitiba, Parana, Brazil	Nevada System of Higher Education (NSHE); University of Nevada Reno; Utah System of Higher Education; Utah State University; Universidade Federal do Parana	Wilson, JS (corresponding author), Utah State Univ Tooele, Dept Biol, Tooele, UT USA.	joeswilson@gmail.com		Jahner, Joshua/0000-0001-8121-6783				Bain RS, 2007, P R SOC B, V274, P1949, DOI 10.1098/rspb.2007.0458; Bates HW., 1862, T LINN SOC LOND, V23, P495, DOI [DOI 10.1111/J.1096-3642.1860.TB00146.X, 10.1111/j.1096-3642.1860.tb00146.x]; Dasmahapatra KK, 2012, NATURE, V487, P94, DOI 10.1038/nature11041; DITTRICH W, 1993, P ROY SOC B-BIOL SCI, V251, P195, DOI 10.1098/rspb.1993.0029; DUNCAN C. J., 1965, BEHAVIOUR, V24, P269, DOI 10.1163/156853965X00066; DUNCAN CJ, 1963, PROC R SOC SER B-BIO, V158, P343, DOI 10.1098/rspb.1963.0052; Edmunds M, 2000, BIOL J LINN SOC, V70, P459; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Fox J., 2019, CAR COMPANION APPL R; GETTY T, 1985, AM NAT, V125, P239, DOI 10.1086/284339; Green PR, 1999, BEHAV PROCESS, V46, P97, DOI 10.1016/S0376-6357(99)00022-4; Hines HM, 2011, P NATL ACAD SCI USA, V108, P19666, DOI 10.1073/pnas.1110096108; Honkavaara J, 2002, OIKOS, V98, P505, DOI 10.1034/j.1600-0706.2002.980315.x; Ihalainen E, 2012, P ROY SOC B-BIOL SCI, V279, P2099, DOI 10.1098/rspb.2011.2360; Iserbyt A, 2011, P ROY SOC B-BIOL SCI, V278, P3116, DOI 10.1098/rspb.2011.0126; Jahner JP, 2012, EVOLUTION, V66, P818, DOI 10.1111/j.1558-5646.2011.01481.x; Johnstone RA, 2002, NATURE, V418, P524, DOI 10.1038/nature00845; MAGURRAN A. E., 2004, MEASURING BIOLOGICAL; Manley DG, 2007, ZOOTAXA, P1; Marek PE, 2009, P NATL ACAD SCI USA, V106, P9755, DOI 10.1073/pnas.0810408106; Muller F., 1879, T ENTOMOL SOC LOND, V1879, P20, DOI DOI 10.1093/beheco/arw009; OATEN A, 1975, B MATH BIOL, V37, P367, DOI 10.1016/S0092-8240(75)80037-1; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Penney HD, 2012, NATURE, V483, P461, DOI 10.1038/nature10961; R Development Core Team, 2011, R PROJ STAT COMP VER; RUST RW, 1983, GREAT BASIN NAT, V43, P403; Ruxton GD, 2004, AVOIDING ATTACK EVOL; Schoener TW, 2011, SCIENCE, V331, P426, DOI 10.1126/science.1193954; Sherratt TN, 2002, BEHAV ECOL, V13, P821, DOI 10.1093/beheco/13.6.821; Wilson JS, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2275	30	43	43	0	101	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2013	8	4							e61610	10.1371/journal.pone.0061610	http://dx.doi.org/10.1371/journal.pone.0061610			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123JP	23593490	Green Published, gold, Green Submitted			2022-12-25	WOS:000317385300077
J	Yu, SCY; Jiang, PY; Choy, KW; Chan, KCA; Won, HS; Leung, WC; Lau, ET; Tang, MHY; Leung, TY; Lo, YMD; Chiu, RWK				Yu, Stephanie C. Y.; Jiang, Peiyong; Choy, Kwong W.; Chan, Kwan Chee Allen; Won, Hye-Sung; Leung, Wing C.; Lau, Elizabeth T.; Tang, Mary H. Y.; Leung, Tak Y.; Lo, Yuk Ming Dennis; Chiu, Rossa W. K.			Noninvasive Prenatal Molecular Karyotyping from Maternal Plasma	PLOS ONE			English	Article							MONOGENIC DISEASES; DNA; FETAL; DIAGNOSIS; TRISOMY-21; ANEUPLOIDY	Fetal DNA is present in the plasma of pregnant women. Massively parallel sequencing of maternal plasma DNA has been used to detect fetal trisomies 21, 18, 13 and selected sex chromosomal aneuploidies noninvasively. Case reports describing the detection of fetal microdeletions from maternal plasma using massively parallel sequencing have been reported. However, these previous reports were either polymorphism-dependent or used statistical analyses which were confined to one or a small number of selected parts of the genome. In this report, we reported a procedure for performing noninvasive prenatal karyotyping at 3 Mb resolution across the whole genome through the massively parallel sequencing of maternal plasma DNA. This method has been used to analyze the plasma obtained from 6 cases. In three cases, fetal microdeletions have been detected successfully from maternal plasma. In two cases, fetal microduplications have been detected successfully from maternal plasma. In the remaining case, the plasma DNA sequencing result was consistent with the pregnant mother being a carrier of a microduplication. Simulation analyses were performed for determining the number of plasma DNA molecules that would need to be sequenced and aligned for enhancing the diagnostic resolution of noninvasive prenatal karyotyping to 2 Mb and 1 Mb. In conclusion, noninvasive prenatal molecular karyotyping from maternal plasma by massively parallel sequencing is feasible and would enhance the diagnostic spectrum of noninvasive prenatal testing.	[Yu, Stephanie C. Y.; Jiang, Peiyong; Chan, Kwan Chee Allen; Lo, Yuk Ming Dennis; Chiu, Rossa W. K.] Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Ctr Res Circulating Fetal Nucle Acids, Shatin, Hong Kong, Peoples R China; [Yu, Stephanie C. Y.; Jiang, Peiyong; Chan, Kwan Chee Allen; Lo, Yuk Ming Dennis; Chiu, Rossa W. K.] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Chem Pathol, Shatin, Hong Kong, Peoples R China; [Choy, Kwong W.; Leung, Tak Y.] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Obstet & Gynaecol, Shatin, Hong Kong, Peoples R China; [Won, Hye-Sung] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Obstet & Gynecol, Seoul, South Korea; [Leung, Wing C.] Kwong Wah Hosp, Kowloon, Hong Kong, Peoples R China; [Lau, Elizabeth T.; Tang, Mary H. Y.] Univ Hong Kong, Dept Obstet & Gynaecol, Tsan Yuk Hosp, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Prince of Wales Hospital; University of Ulsan; Asan Medical Center; Kwong Wah Hospital; University of Hong Kong	Chiu, RWK (corresponding author), Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Ctr Res Circulating Fetal Nucle Acids, Shatin, Hong Kong, Peoples R China.	rossachiu@cuhk.edu.hk	Lo, Yuk Ming Dennis/D-4468-2011; JIANG, Peiyong/AAZ-9898-2020; Chan, K.C. Allen/M-2930-2013; Choy, Richard/AAW-8230-2020	Lo, Yuk Ming Dennis/0000-0001-8746-0293; Chan, K.C. Allen/0000-0003-1780-1691; Choy, Richard/0000-0002-3616-6200; Jiang, Peiyong/0000-0003-4523-3476	University Grants Committee of the Government of the Hong Kong Special Administrative Region [AoE/M-04/06]; Hong Kong Research Grants Council General Research Fund [CUHK 463710]; Sequenom Inc.	University Grants Committee of the Government of the Hong Kong Special Administrative Region; Hong Kong Research Grants Council General Research Fund(Hong Kong Research Grants Council); Sequenom Inc.	This work was supported by University Grants Committee of the Government of the Hong Kong Special Administrative Region, under the Areas of Excellence Scheme (AoE/M-04/06); Hong Kong Research Grants Council General Research Fund (CUHK 463710); Sponsored Research Agreement from Sequenom Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bianchi DW, 2012, OBSTET GYNECOL, V119, P890, DOI 10.1097/AOG.0b013e31824fb482; Chan KCA, 2013, CLIN CHEM, V59, P211, DOI 10.1373/clinchem.2012.196014; Chen EZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021791; Chiu RWK, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.c7401; Chiu RWK, 2008, P NATL ACAD SCI USA, V105, P20458, DOI 10.1073/pnas.0810641105; Chiu RWK, 2001, CLIN CHEM, V47, P1607; Fan HC, 2012, NATURE, V487, P320, DOI 10.1038/nature11251; Fan HC, 2011, NAT BIOTECHNOL, V29, P51, DOI 10.1038/nbt.1739; Jensen TJ, 2012, CLIN CHEM, V58, P1148, DOI 10.1373/clinchem.2011.180794; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Lam KWG, 2012, CLIN CHEM, V58, P1467, DOI 10.1373/clinchem.2012.189589; Leung TY, 2011, ULTRASOUND OBST GYN, V38, P314, DOI 10.1002/uog.8988; Liao GJW, 2011, CLIN CHEM, V57, P92, DOI 10.1373/clinchem.2010.154336; Lo YMD, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001720; Lo YMD, 1997, LANCET, V350, P485, DOI 10.1016/S0140-6736(97)02174-0; Lo YMD, 2012, ANNU REV GENOM HUM G, V13, P285, DOI 10.1146/annurev-genom-090711-163806; Lun FMF, 2008, P NATL ACAD SCI USA, V105, P19920, DOI 10.1073/pnas.0810373105; Palomaki GE, 2012, GENET MED, V14, P296, DOI 10.1038/gim.2011.73; Palomaki GE, 2011, GENET MED, V13, P913, DOI 10.1097/GIM.0b013e3182368a0e; Peters BA, 2012, NATURE, V487, P190, DOI 10.1038/nature11236; Peters D, 2011, NEW ENGL J MED, V365, P1847, DOI 10.1056/NEJMc1106975; Swanton C, 2013, CLIN CHEM, V59, P6, DOI 10.1373/clinchem.2012.197053; Tsui NBY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048319; van den Oever JME, 2012, CLIN CHEM, V58, P699, DOI 10.1373/clinchem.2011.174698; Wapner RJ, 2012, NEW ENGL J MED, V367, P2175, DOI 10.1056/NEJMoa1203382; Zheng YWL, 2012, CLIN CHEM, V58, P549, DOI 10.1373/clinchem.2011.169318	26	66	89	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2013	8	4							e60968	10.1371/journal.pone.0060968	http://dx.doi.org/10.1371/journal.pone.0060968			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IK	23613765	gold, Green Published, Green Submitted			2022-12-25	WOS:000317907200021
J	Blignaut, M; Ellis, AG; Le Roux, JJ				Blignaut, Marguerite; Ellis, Allan G.; Le Roux, Johannes J.			Towards a Transferable and Cost-Effective Plant AFLP Protocol	PLOS ONE			English	Article							GENETIC DIVERSITY; POA-ANNUA; MOLECULAR MARKERS; GENOTYPING ERRORS; PATTERNS; AMPLIFICATION; METHYLATION; EVOLUTION; DENSITY; NUCLEAR	Amplified fragment length polymorphism (AFLP) is a powerful fingerprinting technique that is widely applied in ecological and population genetic studies. However, its routine use has been limited by high costs associated with the optimization of fluorescently labelled markers, especially for individual study systems. Here we develop a low-cost AFLP protocol that can be easily transferred between distantly related plant taxa. Three fluorescently labelled EcoRI-primers with anchors that target interspecifically conserved genomic regions were used in combination with a single non-labelled primer in our AFLP protocol. The protocol was used to genotype one gymnosperm, two monocot and three eudicot plant genera representing four invasive and four native angiosperm species (Pinus pinaster (Pinaceae), Pennisetum setaceum and Poa annua (Poaceae), Lantana camara (Verbenaceae), Bassia diffusa (Chenopodiaceae), Salvia lanceolata, Salvia africana-lutea, and Salvia africana-caerulea (Lamiaceae)). Highly polymorphic and reproducible genotypic fingerprints (between 37-144 polymorphic loci per species tested) were obtained for all taxa tested. Our single protocol was easily transferred between distantly related taxa. Measures of expected heterozygosity ranged from 0.139 to 0.196 for P. annua and from 0.168 to 0.272 for L. camara which compared well with previously published reports. In addition to ease of transferability of a single AFLP protocol, our protocol reduces costs associated with commercial kits by almost half. The use of highly conserved but abundant anchor sequences reduces the need for laborious screening for usable primers that result in polymorphic fingerprints, and appears to be the main reason for ease of transferability of our protocol between distantly related taxa.	[Blignaut, Marguerite; Le Roux, Johannes J.] Univ Stellenbosch, Ctr Invas Biol, ZA-7600 Stellenbosch, Western Cape, South Africa; [Ellis, Allan G.] Univ Stellenbosch, Dept Bot & Zool, ZA-7600 Stellenbosch, Western Cape, South Africa	Stellenbosch University; Stellenbosch University	Le Roux, JJ (corresponding author), Univ Stellenbosch, Ctr Invas Biol, ZA-7600 Stellenbosch, Western Cape, South Africa.	jleroux@sun.ac.za	; Ellis, Allan/H-1105-2011	Le Roux, Johannes/0000-0001-7911-9810; Ellis, Allan/0000-0001-6310-2870; Blignaut, Marguerite/0000-0001-7645-9780	South Africa's National Research Foundation (NRF Blue Skies Programme) [BS2008093000013]; DST-NRF Centre of Excellence for Invasion Biology; Working for Water (WfW) Programme through their collaborative project on "Research for Integrated Management of Invasive Alien Species"; Stellenbosch University's Central Analytical Facility; South African National Research Foundation's Blue Skies Programme; Stellenbosch University's Centre for Invasion Biology	South Africa's National Research Foundation (NRF Blue Skies Programme); DST-NRF Centre of Excellence for Invasion Biology(Department of Science & Technology (India)); Working for Water (WfW) Programme through their collaborative project on "Research for Integrated Management of Invasive Alien Species"; Stellenbosch University's Central Analytical Facility; South African National Research Foundation's Blue Skies Programme; Stellenbosch University's Centre for Invasion Biology	Funding was provided by South Africa's National Research Foundation (NRF Blue Skies Programme, grant no: BS2008093000013). This work was also partly supported by the DST-NRF Centre of Excellence for Invasion Biology and the Working for Water (WfW) Programme through their collaborative project on "Research for Integrated Management of Invasive Alien Species". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Stellenbosch University's Central Analytical Facility for their support as well as Dimitri Allastair Veldkornet (Nelson Mandela Metropolitan University) for supplying B. diffusa samples and Anton Pauw (Stellenbosch University) for Salvia samples. J.LeR acknowledges funding from the South African National Research Foundation's Blue Skies Programme and Stellenbosch University's Centre for Invasion Biology. We also thank David L. Roberts and two anonymous reviewers for their helpful comments on a previous draft of this manuscript.	Bachem CWB, 1996, PLANT J, V9, P745, DOI 10.1046/j.1365-313X.1996.9050745.x; Bensch S, 2005, MOL ECOL, V14, P2899, DOI 10.1111/j.1365-294X.2005.02655.x; Bonin A, 2007, MOL ECOL, V16, P3737, DOI 10.1111/j.1365-294X.2007.03435.x; Bonin A, 2005, METHOD ENZYMOL, V395, P145, DOI 10.1016/S0076-6879(05)95010-6; Bonin A, 2004, MOL ECOL, V13, P3261, DOI 10.1111/j.1365-294X.2004.02346.x; Chen XY, 2003, ENVIRON POLLUT, V124, P449, DOI 10.1016/S0269-7491(03)00042-3; Chwedorzewska KJ, 2008, POLAR BIOL, V31, P263, DOI 10.1007/s00300-007-0353-4; Da Y, 1999, ANIM BIOTECHNOL, V10, P25, DOI 10.1080/10495399909525919; De Riek J, 2001, THEOR APPL GENET, V103, P1254, DOI 10.1007/s001220100710; Despres L, 2003, MOL PHYLOGENET EVOL, V27, P185, DOI 10.1016/S1055-7903(02)00445-1; Dlugosch KM, 2007, MOL ECOL, V16, P4269, DOI 10.1111/j.1365-294X.2007.03508.x; Doyle J. J., 1987, PHYTOCHEMISTRY B, V19, P11, DOI DOI 10.2307/4119796; Fay MF, 2005, ANN BOT-LONDON, V95, P237, DOI 10.1093/aob/mci017; Hamrick JL, 1996, PHILOS T ROY SOC B, V351, P1291, DOI 10.1098/rstb.1996.0112; Haque S., 2004, PLANT TISSUE CULT, V14, P143; Le Roux J, 2009, ANN APPL BIOL, V154, P1, DOI 10.1111/j.1744-7348.2008.00280.x; Le Roux JJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000590; Lu YZ, 2008, PLANT CELL REP, V27, P1645, DOI 10.1007/s00299-008-0568-z; LYNCH M, 1994, MOL ECOL, V3, P91, DOI 10.1111/j.1365-294X.1994.tb00109.x; Mariette S, 2001, HEREDITY, V86, P469, DOI 10.1046/j.1365-2540.2001.00852.x; Mateescu RG, 2005, J HERED, V96, P847, DOI 10.1093/jhered/esi109; Mengistu LW, 2000, THEOR APPL GENET, V101, P70, DOI 10.1007/s001220051451; Meudt HM, 2007, TRENDS PLANT SCI, V12, P106, DOI 10.1016/j.tplants.2007.02.001; Mueller UG, 1999, TRENDS ECOL EVOL, V14, P389, DOI 10.1016/S0169-5347(99)01659-6; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pompanon F, 2005, NAT REV GENET, V6, P847, DOI 10.1038/nrg1707; Poulin J, 2005, DIVERS DISTRIB, V11, P241, DOI 10.1111/j.1366-9516.2005.00136.x; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Ray A, 2011, CONSERV GENET, P13; Reineke AR, 2011, NUCLEIC ACIDS RES, V39, P6029, DOI 10.1093/nar/gkr179; ReynaLopez GE, 1997, MOL GEN GENET, V253, P703, DOI 10.1007/s004380050374; Schlotterer C, 2004, NAT REV GENET, V5, P63, DOI 10.1038/nrg1249; Shaheen N, 2010, J MED PLANTS RES, V4, P148; Stolting KN, 2011, MOL ECOL RESOUR, V11, P494, DOI 10.1111/j.1755-0998.2010.02957.x; van Tienderen PH, 2002, TRENDS ECOL EVOL, V17, P577, DOI 10.1016/S0169-5347(02)02624-1; Vardien W, 2013, ECOGRAPHY, V36, P1032, DOI 10.1111/j.1600-0587.2012.00120.x; Vekemans X, 2002, MOL ECOL, V11, P139, DOI 10.1046/j.0962-1083.2001.01415.x; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Vuylsteke M, 1999, THEOR APPL GENET, V99, P921, DOI 10.1007/s001220051399; Vuylsteke M, 2007, NAT PROTOC, V2, P1387, DOI 10.1038/nprot.2007.175; Xiong LZ, 1999, MOL GEN GENET, V261, P439, DOI 10.1007/s004380050986; Zenger KR, 2006, J HERED, V97, P607, DOI 10.1093/jhered/esl044	42	14	14	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2013	8	4							e61704	10.1371/journal.pone.0061704	http://dx.doi.org/10.1371/journal.pone.0061704			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130DR	23613908	gold, Green Published			2022-12-25	WOS:000317893400096
J	Galatro, TFD; Uno, M; Oba-Shinjo, SM; Almeida, AN; Teixeira, MJ; Rosemberg, S; Marie, SKN				de Almeida Galatro, Thais Fernanda; Uno, Miyuki; Oba-Shinjo, Sueli Mieko; Almeida, Antonio Nogueira; Teixeira, Manoel J.; Rosemberg, Sergio; Marie, Suely Kazue N.			Differential Expression of ID4 and Its Association with TP53 Mutation, SOX2, SOX4 and OCT-4 Expression Levels	PLOS ONE			English	Article							LOOP-HELIX PROTEINS; CANCER STEM-CELLS; HUMAN ASTROCYTOMAS; GLIOBLASTOMA-MULTIFORME; DIFFUSE ASTROCYTOMAS; INITIATING CELLS; MUTANT P53; RT-PCR; TUMORS; GENE	Inhibitor of DNA Binding 4 (ID4) is a member of the helix-loop-helix ID family of transcription factors, mostly present in the central nervous system during embryonic development, that has been associated with TP53 mutation and activation of SOX2. Along with other transcription factors, ID4 has been implicated in the tumorigenic process of astrocytomas, contributing to cell dedifferentiation, proliferation and chemoresistance. In this study, we aimed to characterize the ID4 expression pattern in human diffusely infiltrative astrocytomas of World Health Organization (WHO) grades II to IV of malignancy (AGII-AGIV); to correlate its expression level to that of SOX2, SOX4, OCT-4 and NANOG, along with TP53 mutational status; and to correlate the results with the clinical end-point of overall survival among glioblastoma patients. Quantitative real time PCR (qRT-PCR) was performed in 130 samples of astrocytomas for relative expression, showing up-regulation of all transcription factors in tumor cases. Positive correlation was found when comparing ID4 relative expression of infiltrative astrocytomas with SOX2 (r = 0.50; p < 0.005), SOX4 (r = 0.43; p < 0.005) and OCT-4 (r = 0.39; p < 0.05). The results from TP53 coding exon analysis allowed comparisons between wild-type and mutated status only in AGII cases, demonstrating significantly higher levels of ID4, SOX2 and SOX4 in mutated cases (p < 0.05). This pattern was maintained in secondary GBM and further confirmed by immunohistochemistry, suggesting a role for ID4, SOX2 and SOX4 in early astrocytoma tumorigenesis. Combined hyperexpression of ID4, SOX4 and OCT-4 conferred a much lower (6 months) median survival than did hypoexpression (18 months). Because both ID4 alone and a complex of SOX4 and OCT-4 activate SOX2 transcription, it is possible that multiple activation of SOX2 impair the prognosis of GBM patients. These observational results of associated expression of ID4 with SOX4 and OCT-4 may be used as a predictive factor of prognosis upon further confirmation in a larger GBM series.	[de Almeida Galatro, Thais Fernanda; Uno, Miyuki; Oba-Shinjo, Sueli Mieko; Almeida, Antonio Nogueira; Teixeira, Manoel J.; Marie, Suely Kazue N.] Univ Sao Paulo, Dept Neurol, Sch Med, Sao Paulo, Brazil; [Uno, Miyuki; Oba-Shinjo, Sueli Mieko; Marie, Suely Kazue N.] ICESP, Ctr Translat Oncol, Sao Paulo, Brazil; [Rosemberg, Sergio] Univ Sao Paulo, Sch Med, Dept Pathol, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	Galatro, TFD (corresponding author), Univ Sao Paulo, Dept Neurol, Sch Med, Sao Paulo, Brazil.	thaisgalatro@usp.br	Galatro, Thais/J-7564-2016; de Almeida, Antonio Nogueira/A-2957-2016; Galatro, Thais/C-9934-2013; Marie, Suely Kazue Nagahashi/D-1870-2012; Oba-Shinjo, Sueli M./C-4017-2012; Uno, Miyuki/AAB-5486-2022	Galatro, Thais/0000-0002-3811-7680; de Almeida, Antonio Nogueira/0000-0002-0796-7025; Marie, Suely Kazue Nagahashi/0000-0003-4419-7928; Oba-Shinjo, Sueli M./0000-0002-1650-5973; 	Conselho Nacional de Pesquisa (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao Faculdade de Medicina (FFM); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [04/12133-6]; Ludwig Institute for Cancer	Conselho Nacional de Pesquisa (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao Faculdade de Medicina (FFM); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Ludwig Institute for Cancer	This study was supported by grants from Conselho Nacional de Pesquisa (CNPq), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Fundacao Faculdade de Medicina (FFM) and the tumor tissues bank of the Clinical Genomics Project supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, process #04/12133-6) and the Ludwig Institute for Cancer research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; BENEZRA R, 1990, CELL, V61, P49, DOI 10.1016/0092-8674(90)90214-Y; BENEZRA R, 1990, ANN NY ACAD SCI, V599, P1; Boiani M, 2005, NAT REV MOL CELL BIO, V6, P872, DOI 10.1038/nrm1744; Bonavia R, 2011, CANCER RES, V71, P4055, DOI 10.1158/0008-5472.CAN-11-0153; Chambers I, 2009, DEVELOPMENT, V136, P2311, DOI 10.1242/dev.024398; Dell'Orso S, 2010, ONCOTARGET, V1, P48, DOI 10.18632/oncotarget.108; Fontemaggi G, 2009, NAT STRUCT MOL BIOL, V16, P1086, DOI 10.1038/nsmb.1669; Freed-Pastor WA, 2012, GENE DEV, V26, P1268, DOI 10.1101/gad.190678.112; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Guo Y, 2011, HISTOPATHOLOGY, V59, P763, DOI 10.1111/j.1365-2559.2011.03993.x; Holmberg J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018454; Hur W, 2010, CARCINOGENESIS, V31, P1298, DOI 10.1093/carcin/bgq072; Iavarone A, 2004, CANCER LETT, V204, P189, DOI 10.1016/S0304-3835(03)00455-5; Iavarone A, 2006, TRENDS MOL MED, V12, P588, DOI 10.1016/j.molmed.2006.10.007; Ikushima H, 2011, J BIOL CHEM, V286, P41434, DOI 10.1074/jbc.M111.300863; Jeon HM, 2008, GENE DEV, V22, P2028, DOI 10.1101/gad.1668708; Jeon HM, 2011, CANCER RES, V71, P3410, DOI 10.1158/0008-5472.CAN-10-3340; Kawamura T, 2009, NATURE, V460, P1140, DOI 10.1038/nature08311; Kuzontkoski PM, 2010, ONCOGENE, V29, P3793, DOI 10.1038/onc.2010.147; Lin BY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010210; Lin TX, 2005, NAT CELL BIOL, V7, P165, DOI 10.1038/ncb1211; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Ma YH, 2008, J NEURO-ONCOL, V86, P31, DOI 10.1007/s11060-007-9439-7; Mallanna SK, 2012, J CELL PHYSIOL, V227, P27, DOI 10.1002/jcp.22721; Marie SKN, 2008, INT J CANCER, V122, P807, DOI 10.1002/ijc.23189; Martini M, 2013, CANCER-AM CANCER SOC, V119, P1004, DOI 10.1002/cncr.27821; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Norton JD, 2000, J CELL SCI, V113, P3897; Oba-Shinjo SM, 2005, MOL BRAIN RES, V140, P25, DOI 10.1016/j.molbrainres.2005.06.015; Ohgaki H, 2013, CLIN CANCER RES, V19, P764, DOI 10.1158/1078-0432.CCR-12-3002; Ohgaki H, 2011, BRAIN TUMOR PATHOL, V28, P177, DOI 10.1007/s10014-011-0029-1; Pan X, 2009, P NATL ACAD SCI USA, V106, P3788, DOI 10.1073/pnas.0810147106; Park Se-Jin, 2011, Lab Anim Res, V27, P333, DOI 10.5625/lar.2011.27.4.333; Perk J, 2005, NAT REV CANCER, V5, P603, DOI 10.1038/nrc1673; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Qu QH, 2009, J CELL PHYSIOL, V221, P5, DOI 10.1002/jcp.21862; Sampieri K, 2012, SEMIN CANCER BIOL, V22, P187, DOI 10.1016/j.semcancer.2012.03.002; Singh SK, 2003, CANCER RES, V63, P5821; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Uno M, 2006, INT J BIOL MARKER, V21, P50, DOI 10.1177/172460080602100108; Uno M, 2005, CANCER LETT, V224, P321, DOI 10.1016/j.canlet.2004.10.022; Uno M, 2011, CLINICS, V66, P1747, DOI 10.1590/S1807-59322011001000013; Valente V, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-17; Vandeputte DAA, 2002, GLIA, V38, P329, DOI 10.1002/glia.10076; Wu QO, 2005, MOL CANCER, V4, DOI 10.1186/1476-4598-4-16; Yuan XP, 2004, ONCOGENE, V23, P9392, DOI 10.1038/sj.onc.1208311; Yun K, 2004, DEVELOPMENT, V131, P5441, DOI 10.1242/dev.01430; Zeng WF, 2010, J CANCER, V1, P1	50	14	14	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2013	8	4							e61605	10.1371/journal.pone.0061605	http://dx.doi.org/10.1371/journal.pone.0061605			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130DR	23613880	gold, Green Published, Green Submitted			2022-12-25	WOS:000317893400078
J	Huntley, B; Allen, JRM; Collingham, YC; Hickler, T; Lister, AM; Singarayer, J; Stuart, AJ; Sykes, MT; Valdes, PJ				Huntley, Brian; Allen, Judy R. M.; Collingham, Yvonne C.; Hickler, Thomas; Lister, Adrian M.; Singarayer, Joy; Stuart, Anthony J.; Sykes, Martin T.; Valdes, Paul J.			Millennial Climatic Fluctuations Are Key to the Structure of Last Glacial Ecosystems	PLOS ONE			English	Article							EUROPEAN VEGETATION; ISOTOPE STAGE-3; ICE; VARIABILITY; MAMMOTHS; DYNAMICS; SOUTHERN; RECORDS; MODEL; AGES	Whereas fossil evidence indicates extensive treeless vegetation and diverse grazing megafauna in Europe and northern Asia during the last glacial, experiments combining vegetation models and climate models have to-date simulated widespread persistence of trees. Resolving this conflict is key to understanding both last glacial ecosystems and extinction of most of the mega-herbivores. Using a dynamic vegetation model (DVM) we explored the implications of the differing climatic conditions generated by a general circulation model (GCM) in "normal" and "hosing" experiments. Whilst the former approximate interstadial conditions, the latter, designed to mimic Heinrich Events, approximate stadial conditions. The "hosing" experiments gave simulated European vegetation much closer in composition to that inferred from fossil evidence than did the "normal" experiments. Given the short duration of interstadials, and the rate at which forest cover expanded during the late-glacial and early Holocene, our results demonstrate the importance of millennial variability in determining the character of last glacial ecosystems.	[Huntley, Brian; Allen, Judy R. M.; Collingham, Yvonne C.; Stuart, Anthony J.] Univ Durham, Sch Biol & Biomed Sci, Durham, England; [Hickler, Thomas] Senckenberg Gesell Nat Forsch, Biodivers & Climate Res Ctr BiK F, Frankfurt, Germany; [Hickler, Thomas] Goethe Univ Frankfurt, Dept Phys Geog, D-60054 Frankfurt, Germany; [Lister, Adrian M.] Nat Hist Museum, Dept Palaeontol, Palaeontol Res Div, London SW7 5BD, England; [Singarayer, Joy; Valdes, Paul J.] Univ Bristol, Sch Geog Sci, Bristol, Avon, England; [Sykes, Martin T.] Lund Univ, Geoctr 2, Dept Phys Geog & Ecosyst Sci, Lund, Sweden	Durham University; Senckenberg Biodiversitat & Klima- Forschungszentrum (BiK-F); Senckenberg Gesellschaft fur Naturforschung (SGN); Goethe University Frankfurt; Natural History Museum London; University of Bristol; Lund University	Huntley, B (corresponding author), Univ Durham, Sch Biol & Biomed Sci, Durham, England.	brian.huntley@durham.ac.uk	Valdes, Paul/T-2004-2019; Valdes, Paul/C-4129-2013; Hickler, Thomas/S-6287-2016	Valdes, Paul/0000-0002-1902-3283; Hickler, Thomas/0000-0002-4668-7552; Lister, Adrian/0000-0002-7985-138X	UK Natural Environment Research Council [NE/G00188X/1]; Natural Environment Research Council [NE/G006989/1, NE/D003105/2, NE/D003105/1, NE/G00188X/1, NE/G005982/1] Funding Source: researchfish; NERC [NE/G005982/1, NE/D003105/2, NE/D003105/1, NE/G006989/1, NE/G00188X/1] Funding Source: UKRI	UK Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The research reported was supported by grant NE/G00188X/1 awarded by the UK Natural Environment Research Council (http://www.nerc.ac.uk/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfano MJ, 2003, QUATERNARY RES, V59, P97, DOI 10.1016/S0033-5894(02)00012-1; Allen JRM, 2000, QUATERN INT, V73-4, P111, DOI 10.1016/S1040-6182(00)00068-9; Allen JRM, 2010, QUATERNARY SCI REV, V29, P2604, DOI 10.1016/j.quascirev.2010.05.031; BARD E, 1990, NATURE, V346, P456, DOI 10.1038/346456a0; Barnosky AD, 2004, SCIENCE, V306, P70, DOI 10.1126/science.1101476; Barron E, 2002, QUATERNARY RES, V58, P296, DOI 10.1006/qres.2002.2374; Bennike O, 2005, POLAR REC, V41, P305, DOI 10.1017/S003224740500464X; Bhagwat SA, 2008, J BIOGEOGR, V35, P464, DOI 10.1111/j.1365-2699.2007.01861.x; Binney HA, 2009, QUATERNARY SCI REV, V28, P2445, DOI 10.1016/j.quascirev.2009.04.016; BOND G, 1993, NATURE, V365, P143, DOI 10.1038/365143a0; Cramer W, 2001, GLOBAL CHANGE BIOL, V7, P357, DOI 10.1046/j.1365-2486.2001.00383.x; Davis MB, 1983, LATE QUATERNARY US V, V2, P166; Ehlers J., 2004, QUATERNARY GLACIATIO, V488; FAIRBANKS RG, 1989, NATURE, V342, P637, DOI 10.1038/342637a0; Graham RW, 1996, SCIENCE, V272, P1601; Guthrie RD, 2004, NATURE, V429, P746, DOI 10.1038/nature02612; Huntley B, 2003, QUATERNARY RES, V59, P195, DOI 10.1016/S0033-5894(02)00016-9; Huntley B., 1983, AN ATLAS OF PAST AND; Huntley B, 2013, GLOBAL ECOL BIOGEOGR, V22, P277, DOI 10.1111/j.1466-8238.2011.00751.x; Kienast F, 2011, QUATERNARY SCI REV, V30, P2134, DOI 10.1016/j.quascirev.2010.11.024; Kjellstrom E, 2010, BOREAS, V39, P436, DOI 10.1111/j.1502-3885.2010.00143.x; LISTER AM, 1995, NATURE, V378, P23, DOI 10.1038/378023a0; MacPhee R.D.E., 2005, BMC EVOLUTIONARY BIO, V5, P1; MARTINSON DG, 1987, QUATERNARY RES, V27, P1, DOI 10.1016/0033-5894(87)90046-9; Muller UC, 2003, QUATERNARY RES, V59, P235, DOI 10.1016/S0033-5894(03)00005-X; New M, 1999, J CLIMATE, V12, P829, DOI 10.1175/1520-0442(1999)012<0829:RTCSTC>2.0.CO;2; Parry M. L., 2007, CLIMATE CHANGE 2007, P23; Peltier WR, 2004, ANNU REV EARTH PL SC, V32, P111, DOI 10.1146/annurev.earth.32.082503.144359; Seidov D, 1999, GEOLOGY, V27, P23, DOI 10.1130/0091-7613(1999)027<0023:NADWCC>2.3.CO;2; Sher AV, 2005, QUATERNARY SCI REV, V24, P533, DOI 10.1016/j.quascirev.2004.09.007; Sher AV, 1997, NATO ASI SER SER I, V47, P319; Singarayer JS, 2010, QUATERNARY SCI REV, V29, P43, DOI 10.1016/j.quascirev.2009.10.011; Sitch S, 2003, GLOBAL CHANGE BIOL, V9, P161, DOI 10.1046/j.1365-2486.2003.00569.x; Smith B, 2001, GLOBAL ECOL BIOGEOGR, V10, P621, DOI 10.1046/j.1466-822X.2001.00256.x; Stuart AJ, 2012, QUATERNARY SCI REV, V51, P1, DOI 10.1016/j.quascirev.2012.06.007; Trenberth KE, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P235; VARTANYAN SL, 1993, NATURE, V362, P337, DOI 10.1038/362337a0; Williams JW, 2003, GLOBAL PLANET CHANGE, V35, P1, DOI 10.1016/S0921-8181(02)00088-7; Willis KJ, 2004, QUATERNARY SCI REV, V23, P2369, DOI 10.1016/j.quascirev.2004.06.002; Wolff EW, 2010, QUATERNARY SCI REV, V29, P2828, DOI 10.1016/j.quascirev.2009.10.013; Zazula GD, 2006, QUATERN INT, V142, P2, DOI 10.1016/j.quaint.2005.03.010	41	38	39	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2013	8	4							e61963	10.1371/journal.pone.0061963	http://dx.doi.org/10.1371/journal.pone.0061963			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130DR	23613985	Green Accepted, Green Submitted, Green Published, gold			2022-12-25	WOS:000317893400134
J	Jimenez-Fernandez, D; Landa, BB; Kang, S; Jimenez-Diaz, RM; Navas-Cortes, JA				Jimenez-Fernandez, Daniel; Landa, Blanca B.; Kang, Seogchan; Jimenez-Diaz, Rafael M.; Navas-Cortes, Juan A.			Quantitative and Microscopic Assessment of Compatible and Incompatible Interactions between Chickpea Cultivars and Fusarium oxysporum f. sp ciceris Races	PLOS ONE			English	Article							TOMATO ROOT COLONIZATION; PATHOGENIC RACE-0; INOCULUM DENSITY; WILT; RESISTANCE; INFECTION; STRAINS; IDENTIFICATION; ARIETINUM; RESPONSES	Background: Fusarium wilt caused by Fusarium oxysporum f. sp. ciceris, a main threat to global chickpea production, is managed mainly by resistant cultivars whose efficiency is curtailed by Fusarium oxysporum f. sp. ciceris races. Methodology: We characterized compatible and incompatible interactions by assessing the spatial-temporal pattern of infection and colonization of chickpea cvs. P-2245, JG-62 and WR-315 by Fusarium oxysporum f. sp. ciceris races 0 and 5 labeled with ZsGreen fluorescent protein using confocal laser scanning microscopy. Findings: The two races colonized the host root surface in both interactions with preferential colonization of the root apex and subapical root zone. In compatible interactions, the pathogen grew intercellularly in the root cortex, reached the xylem, and progressed upwards in the stem xylem, being the rate and intensity of stem colonization directly related with the degree of compatibility among Fusarium oxysporum f. sp. ciceris races and chickpea cultivars. In incompatible interactions, race 0 invaded and colonized 'JG-62' xylem vessels of root and stem but in 'WR-315', it remained in the intercellular spaces of the root cortex failing to reach the xylem, whereas race 5 progressed up to the hypocotyl. However, all incompatible interactions were asymptomatic. Conclusions: The differential patterns of colonization of chickpea cultivars by Fusarium oxysporum f. sp. ciceris races may be related to the operation of multiple resistance mechanisms.	[Jimenez-Fernandez, Daniel; Jimenez-Diaz, Rafael M.] Univ Cordoba, Coll Agr & Forestry, Campus Excelencia Internac Agroalimentario CeiA3, Cordoba, Spain; [Landa, Blanca B.; Jimenez-Diaz, Rafael M.; Navas-Cortes, Juan A.] CSIC, Inst Sustainable Agr IAS, Cordoba, Spain; [Kang, Seogchan] Penn State Univ, Dept Plant Pathol & Environm Microbiol, University Pk, PA 16802 USA	Universidad de Cordoba; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Agricultura Sostenible (IAS); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Navas-Cortes, JA (corresponding author), CSIC, Inst Sustainable Agr IAS, Cordoba, Spain.	j.navas@csic.es	Navas-Cortes, Juan A/H-3381-2014; Navas-Cortes, Juan A./M-2060-2019; Landa, Blanca B/K-9629-2014; Jimenez Diaz, Rafael/H-9159-2018	Navas-Cortes, Juan A/0000-0001-6480-1104; Landa, Blanca B/0000-0002-9511-3731; Jimenez Diaz, Rafael/0000-0003-2411-1955; Kang, Seogchan/0000-0003-2291-5634	Junta de Andalucia of Spain [AGR580]; European Social Fund; CICE [AGR-136]	Junta de Andalucia of Spain(Junta de Andalucia); European Social Fund(European Social Fund (ESF)); CICE	Financial support for this research was provided by grant AGR580 from "Consejeria de Economia, Innovacion y Ciencia (CICE),'' Junta de Andalucia of Spain and the European Social Fund and partially by grant AGR-136 from CICE and the European Social Fund. DJ-F was recipient of a fellowship from CICE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALCONERO R, 1968, PHYTOPATHOLOGY, V58, P1281; [Anonymous], FAOSTAT PROD STAT CR; Garcia-Sanchez MA, 2010, FUNGAL GENET BIOL, V47, P216, DOI 10.1016/j.fgb.2009.11.006; BHALLA MK, 1992, J PHYTOPATHOL, V135, P335, DOI 10.1111/j.1439-0434.1992.tb04319.x; Bolwerk A, 2003, MOL PLANT MICROBE IN, V16, P983, DOI 10.1094/MPMI.2003.16.11.983; CHI CC, 1964, PHYTOPATHOLOGY, V54, P434; Czymmek KJ, 2007, FUNGAL GENET BIOL, V44, P1011, DOI 10.1016/j.fgb.2007.01.012; CZYMMEK KJ, 1994, EXP MYCOL, V18, P275, DOI 10.1016/S0147-5975(06)80001-0; Dolar F. S., 1997, Journal of Turkish Phytopathology, V26, P11; Duyvesteijn RGE, 2005, MOL MICROBIOL, V57, P1051, DOI 10.1111/j.1365-2958.2005.04751.x; Fang XL, 2012, PLANT SOIL, V358, P71, DOI 10.1007/s11104-012-1205-8; FARQUHAR ML, 1989, CAN J PLANT PATHOL, V11, P221, DOI 10.1080/07060668909501103; GAO H, 1995, PHYSIOL MOL PLANT P, V46, P29, DOI 10.1006/pmpp.1995.1003; Garc-a-Limones C, 2009, PLANT BIOLOGY, V11, P194, DOI 10.1111/j.1438-8677.2008.00095.x; Gupta S, 2009, PHYTOPATHOLOGY, V99, P1245, DOI 10.1094/PHYTO-99-11-1245; Halila M. H., 1996, Phytopathologia Mediterranea, V35, P67; HAWARE MP, 1982, PLANT DIS, V66, P809, DOI 10.1094/PD-66-809; Heath MC, 2000, ANNU REV PHYTOPATHOL, V38, P443, DOI 10.1146/annurev.phyto.38.1.443; Hellens R, 2000, TRENDS PLANT SCI, V5, P446, DOI 10.1016/S1360-1385(00)01740-4; HOAGLAND D. R., 1938, Annual Report of the Smithsonian Institution, P461; Jimenez-Diaz R. M., 1993, Hodowla Roslin, Aklimatyzacja i Nasiennictwo, V37, P87; Jimenez-Diaz R. M., 1993, Breeding for stress tolerance in cool-season food legumes., P77; Jimenez-Diaz R.M., 1989, NATO ASI SERIES H, VH28, P113; Jimenez-Fernandez D, 2011, PHYTOPATHOLOGY, V101, P250, DOI 10.1094/PHYTO-07-10-0190; Jimenez-Gasco MD, 2003, PHYTOPATHOLOGY, V93, P200, DOI 10.1094/PHYTO.2003.93.2.200; Jimenez-Gasco MD, 2001, EUR J PLANT PATHOL, V107, P237, DOI 10.1023/A:1011294204630; Jimenez-Gasco MM, 2004, INT MICROBIOL, V7, P95; Jimenez-Gasco MM, 2002, PLANT PATHOL, V51, P72, DOI 10.1046/j.0032-0862.2001.x; Khang Chang Hyun, 2006, V344, P403, DOI 10.1385/1-59745-131-2:403; KRAFT JM, 1994, AGRONOMIE, V14, P561, DOI 10.1051/agro:19940901; Landa BB, 2004, PHYTOPATHOLOGY, V94, P946, DOI 10.1094/PHYTO.2004.94.9.946; Landa BB, 2004, PLANT PATHOL, V53, P341, DOI 10.1111/j.0032-0862.2004.01008.x; Li CY, 2011, EUR J PLANT PATHOL, V131, P327, DOI 10.1007/s10658-011-9811-5; Madden L.V., 2007, STUDY PLANT DIS EPID, DOI DOI 10.1094/9780890545058; Mandeel Q. A., 1994, Phytopathologia Mediterranea, V33, P137; Michielse CB, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000637; Mullins ED, 2001, PHYTOPATHOLOGY, V91, P173, DOI 10.1094/PHYTO.2001.91.2.173; Nahalkova J, 2008, FEMS MICROBIOL LETT, V286, P152, DOI 10.1111/j.1574-6968.2008.01241.x; Navas-Cortes JA, 2000, EUR J PLANT PATHOL, V106, P135, DOI 10.1023/A:1008727815927; Navas-Cortes JA, 2000, PHYTOPATHOLOGY, V90, P1269, DOI 10.1094/PHYTO.2000.90.11.1269; Navas-Cortes JA, 2007, PHYTOPATHOLOGY, V97, P564, DOI 10.1094/PHYTO-97-5-0564; Nelson P.E., 1981, FUNGAL WILT DIS PLAN, P51, DOI [10.1016/B978-0-12-464450-2.50008-5, DOI 10.1016/B978-0-12-464450-2.50008-5]; Nene Y. L., 1987, The Chickpea., P233; NYVALL RF, 1972, PHYTOPATHOLOGY, V62, P1419, DOI 10.1094/Phyto-62-1419; Olivain C, 1999, NEW PHYTOL, V141, P497, DOI 10.1046/j.1469-8137.1999.00365.x; Olivain C, 2006, APPL ENVIRON MICROB, V72, P1523, DOI 10.1128/AEM.72.2.1523-1531.2006; Pande S, 2006, PLANT DIS, V90, P1214, DOI 10.1094/PD-90-1214; PUHALLA JE, 1985, CAN J BOT, V63, P179, DOI 10.1139/b85-020; Ramirez-Suero M, 2010, EUR J PLANT PATHOL, V126, P517, DOI 10.1007/s10658-009-9560-x; RODRIGUEZGALVEZ E, 1995, PROTOPLASMA, V189, P61, DOI 10.1007/BF01280291; Sarrocco S, 2007, J PLANT PATHOL, V89, P47; Sharma KD, 2007, EUPHYTICA, V157, P1, DOI 10.1007/s10681-007-9401-y; Shehabu M, 2008, INT J PEST MANAGE, V54, P143, DOI 10.1080/09670870701780153; SMITH AK, 1985, CAN J PLANT PATHOL, V7, P28, DOI 10.1080/07060668509501510; Stevenson PC, 1997, PHYSIOL MOL PLANT P, V50, P167, DOI 10.1006/pmpp.1997.0082; TESSIER BJ, 1990, PHYTOPATHOLOGY, V80, P756, DOI 10.1094/Phyto-80-756; TRAPEROCASAS A, 1985, PHYTOPATHOLOGY, V75, P1146, DOI 10.1094/Phyto-75-1146; TURLIER MF, 1994, CAN J BOT, V72, P1605, DOI 10.1139/b94-198; van der Does HC, 2008, FUNGAL GENET BIOL, V45, P1257, DOI 10.1016/j.fgb.2008.06.002; Zvirin T, 2010, PLANT PATHOL, V59, P576, DOI 10.1111/j.1365-3059.2009.02225.x	60	31	33	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2013	8	4							e61360	10.1371/journal.pone.0061360	http://dx.doi.org/10.1371/journal.pone.0061360			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130DR	23613839	gold, Green Published			2022-12-25	WOS:000317893400057
J	Karunker, I; Rotem, O; Dori-Bachash, M; Jurkevitch, E; Sorek, R				Karunker, Iris; Rotem, Or; Dori-Bachash, Mally; Jurkevitch, Edouard; Sorek, Rotem			A Global Transcriptional Switch between the Attack and Growth Forms of Bdellovibrio bacteriovorus	PLOS ONE			English	Article							BACTERIUM BDELLOVIBRIO; ESCHERICHIA-COLI; DI-GMP; FLAGELLAR; SEQUENCE; CYCLE; RIBOSWITCHES; SALMONELLA; EXPRESSION; PROMOTERS	Bdellovibrio bacteriovorus is an obligate predator of bacteria ubiquitously found in the environment. Its life cycle is composed of two essential phases: a free-living, non-replicative, fast swimming attack phase (AP) wherein the predator searches for prey; and a non-motile, actively dividing growth phase (GP) in which it consumes the prey. The molecular regulatory mechanisms governing the switch between AP and GP are largely unknown. We used RNA-seq to generate a single-base-resolution map of the Bdellovibrio transcriptome in AP and GP, revealing a specific "AP" transcriptional program, which is largely mutually exclusive of the GP program. Based on the expression map, most genes in the Bdellovibrio genome are classified as "AP only" or "GP only". We experimentally generated a genome-wide map of 140 AP promoters, controlling the majority of AP-specific genes. This revealed a common sigma-like DNA binding site highly similar to the E. coli flagellar genes regulator sigma28 (FliA). Further analyses suggest that FliA has evolved to become a global AP regulator in Bdellovibrio. Our results also reveal a non-coding RNA that is massively expressed in AP. This ncRNA contains a c-di-GMP riboswitch. We suggest it functions as an intracellular reservoir for c-di-GMP, playing a role in the rapid switch from AP to GP.	[Karunker, Iris; Sorek, Rotem] Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel; [Rotem, Or; Dori-Bachash, Mally; Jurkevitch, Edouard] Hebrew Univ Jerusalem, Fac Agr Food & Environm, Dept Plant Pathol & Microbiol, IL-76100 Rehovot, Israel	Weizmann Institute of Science; Hebrew University of Jerusalem	Sorek, R (corresponding author), Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel.	rotem.sorek@weizmann.ac.il			ERC-StG program [260432]; Minerva Foundation; Deutsche Forschungsgemeinschaft; Israel Science Foundation [1290/08]	ERC-StG program; Minerva Foundation; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Israel Science Foundation(Israel Science Foundation)	RS was supported, in part, by the ERC-StG program (grant 260432), the Minerva Foundation, and by a DIP grant from the Deutsche Forschungsgemeinschaft. EJ was supported by the Israel Science Foundation (grant 1290/08). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert-Weissenberger C, 2010, J BACTERIOL, V192, P446, DOI 10.1128/JB.00610-09; Andre G, 2008, NUCLEIC ACIDS RES, V36, P5955, DOI 10.1093/nar/gkn601; Breaker R.R., 2012, COLD SPRING HARB PER, V4; Chilcott GS, 2000, MICROBIOL MOL BIOL R, V64, P694, DOI 10.1128/MMBR.64.4.694-708.2000; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dori-Bachash M, 2008, APPL ENVIRON MICROB, V74, P7152, DOI 10.1128/AEM.01736-08; Gophna U, 2006, TRENDS MICROBIOL, V14, P64, DOI 10.1016/j.tim.2005.12.008; Hengge R, 2009, NAT REV MICROBIOL, V7, P263, DOI 10.1038/nrmicro2109; HESPELL RB, 1973, J BACTERIOL, V113, P1280, DOI 10.1128/JB.113.3.1280-1288.1973; Hobley L, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002493; Jurkevitch E, 2000, APPL ENVIRON MICROB, V66, P2365, DOI 10.1128/AEM.66.6.2365-2371.2000; KESSEL M, 1976, J BACTERIOL, V128, P477, DOI 10.1128/JB.128.1.477-480.1976; Lambert C, 2006, MOL MICROBIOL, V60, P274, DOI 10.1111/j.1365-2958.2006.05081.x; Lambert C, 2003, ENVIRON MICROBIOL, V5, P127, DOI 10.1046/j.1462-2920.2003.00385.x; Lambert C, 2006, CURR OPIN MICROBIOL, V9, P639, DOI 10.1016/j.mib.2006.10.002; Lambert C, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-99; Lambert C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008599; Lenz G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028544; LIU XY, 1995, GENE, V164, P81, DOI 10.1016/0378-1119(95)00480-T; Loh E, 2009, CELL, V139, P770, DOI 10.1016/j.cell.2009.08.046; Mahmoud KK, 2010, MICROBIOL-SGM, V156, P1040, DOI 10.1099/mic.0.036137-0; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Pallen MJ, 2010, CURR OPIN MICROBIOL, V13, P625, DOI 10.1016/j.mib.2010.08.003; Prouty MG, 2001, MOL MICROBIOL, V39, P1595, DOI 10.1046/j.1365-2958.2001.02348.x; Sharma CM, 2010, NATURE, V464, P250, DOI 10.1038/nature08756; Shen L, 2006, J BACTERIOL, V188, P7364, DOI 10.1128/JB.01014-06; Sockett RE, 2004, NAT REV MICROBIOL, V2, P669, DOI 10.1038/nrmicro959; Sockett RE, 2009, ANNU REV MICROBIOL, V63, P523, DOI 10.1146/annurev.micro.091208.073346; Sorek R, 2010, NAT REV GENET, V11, P9, DOI 10.1038/nrg2695; Sudarsan N, 2008, SCIENCE, V321, P411, DOI 10.1126/science.1159519; Tamayo R, 2007, ANNU REV MICROBIOL, V61, P131, DOI 10.1146/annurev.micro.61.080706.093426; Toledo-Arana A, 2009, NATURE, V459, P950, DOI 10.1038/nature08080; van Vliet AHM, 2010, FEMS MICROBIOL LETT, V302, P1, DOI 10.1111/j.1574-6968.2009.01767.x; Waters LS, 2009, CELL, V136, P615, DOI 10.1016/j.cell.2009.01.043; Wozniak CE, 2008, J MOL BIOL, V379, P936, DOI 10.1016/j.jmb.2008.04.043; Wozniak CE, 2010, J BACTERIOL, V192, P4752, DOI 10.1128/JB.00093-10; Wurtzel O, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.11; Wurtzel O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015628; Wurtzel O, 2010, GENOME RES, V20, P133, DOI 10.1101/gr.100396.109; Yoder-Himes DR, 2009, P NATL ACAD SCI USA, V106, P3976, DOI 10.1073/pnas.0813403106	40	50	52	1	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2013	8	4							e61850	10.1371/journal.pone.0061850	http://dx.doi.org/10.1371/journal.pone.0061850			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130DR	23613952	Green Published, gold, Green Submitted			2022-12-25	WOS:000317893400119
J	Vivarelli, S; Lenzken, SC; Ruepp, MD; Ranzini, F; Maffioletti, A; Alvarez, R; Muhlemann, O; Barabino, SML				Vivarelli, Silvia; Lenzken, Silvia C.; Ruepp, Marc-David; Ranzini, Francesco; Maffioletti, Andrea; Alvarez, Reinaldo; Muehlemann, Oliver; Barabino, Silvia M. L.			Paraquat Modulates Alternative Pre-mRNA Splicing by Modifying the Intracellular Distribution of SRPK2	PLOS ONE			English	Article							PROTEIN-SPECIFIC KINASE; MAMMALIAN-CELLS; NUCLEAR IMPORT; SR PROTEINS; HNRNP A1; PHOSPHORYLATION; STRESS; CYCLE; LOCALIZATION; EXPRESSION	Paraquat (PQ) is a neurotoxic herbicide that induces superoxide formation. Although it is known that its toxic properties are linked to ROS production, the cellular response to PQ is still poorly understood. We reported previously that treatment with PQ induced genome-wide changes in pre-mRNA splicing. Here, we investigated the molecular mechanism underlying PQ-induced pre-mRNA splicing alterations. We show that PQ treatment leads to the phosphorylation and nuclear accumulation of SRPK2, a member of the family of serine/arginine (SR) protein-specific kinases. Concomitantly, we observed increased phosphorylation of SR proteins. Site-specific mutagenesis identified a single serine residue that is necessary and sufficient for nuclear localization of SRPK2. Transfection of a phosphomimetic mutant modified splice site selection of the E1A minigene splicing reporter similar to PQ-treatment. Finally, we found that PQ induces DNA damage and vice versa that genotoxic treatments are also able to promote SRPK2 phosphorylation and nuclear localization. Consistent with these observations, treatment with PQ, cisplatin or gamma-radiation promote changes in the splicing pattern of genes involved in DNA repair, cell cycle control, and apoptosis. Altogether, our findings reveal a novel regulatory mechanism that connects PQ to the DNA damage response and to the modulation of alternative splicing via SRPK2 phosphorylation.	[Vivarelli, Silvia; Lenzken, Silvia C.; Ranzini, Francesco; Maffioletti, Andrea; Alvarez, Reinaldo; Barabino, Silvia M. L.] Univ Milano Bicocca, Dipartimento Biotecnol & Biosci, Milan, Italy; [Ruepp, Marc-David; Muehlemann, Oliver] Univ Bern, Dept Chem & Biochem, Bern, Switzerland	University of Milano-Bicocca; University of Bern	Barabino, SML (corresponding author), Univ Milano Bicocca, Dipartimento Biotecnol & Biosci, Milan, Italy.	silvia.barabino@unimib.it	Ruepp, Marc-David/H-9916-2018; Barabino, Silvia/AAC-4674-2021; Vivarelli, Silvia/Z-3528-2019	Ruepp, Marc-David/0000-0003-3264-9800; Vivarelli, Silvia/0000-0001-9363-6523; Muhlemann, Oliver/0000-0003-0657-1368	Gottfried und Julia Bangerter-Rhyner-Stiftung; Vontobel-Stiftung; Swiss National Science Foundation [CRSII3-136222]	Gottfried und Julia Bangerter-Rhyner-Stiftung; Vontobel-Stiftung; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by grants from the Gottfried und Julia Bangerter-Rhyner-Stiftung and the Vontobel-Stiftung and by the Swiss National Science Foundation (CRSII3-136222). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barreau C, 2006, BIOCHIMIE, V88, P515, DOI 10.1016/j.biochi.2005.10.011; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; CACERES JF, 1994, SCIENCE, V265, P1706, DOI 10.1126/science.8085156; Cerqueira A, 2009, J CELL BIOL, V187, P773, DOI 10.1083/jcb.200903033; Cocheme HM, 2008, J BIOL CHEM, V283, P1786, DOI 10.1074/jbc.M708597200; Colwill K, 1996, EMBO J, V15, P265, DOI 10.1002/j.1460-2075.1996.tb00357.x; Cooper TA, 2009, CELL, V136, P777, DOI 10.1016/j.cell.2009.02.011; Ding JH, 2006, MOL BIOL CELL, V17, P876, DOI 10.1091/mbc.E05-10-0963; GUI JF, 1994, NATURE, V369, P678, DOI 10.1038/369678a0; Guil S, 2006, MOL CELL BIOL, V26, P5744, DOI 10.1128/MCB.00224-06; Heyd F, 2011, TRENDS BIOCHEM SCI, V36, P397, DOI 10.1016/j.tibs.2011.04.003; Jazayeri A, 2006, NAT CELL BIOL, V8, P37, DOI 10.1038/ncb1337; Jenny A, 1996, SCIENCE, V274, P1514, DOI 10.1126/science.274.5292.1514; Kuroyanagi N, 1998, BIOCHEM BIOPH RES CO, V242, P357, DOI 10.1006/bbrc.1997.7913; Labourier E, 1998, NUCLEIC ACIDS RES, V26, P2955, DOI 10.1093/nar/26.12.2955; Lai MC, 2003, EMBO J, V22, P1359, DOI 10.1093/emboj/cdg126; Lai MC, 2001, P NATL ACAD SCI USA, V98, P10154, DOI 10.1073/pnas.181354098; Lenzken SC, 2011, HUM MUTAT, V32, P168, DOI 10.1002/humu.21394; Long JC, 2009, BIOCHEM J, V417, P15, DOI 10.1042/BJ20081501; Mah LJ, LEUKEMIA, V24, P679; McCormack AL, 2005, J NEUROCHEM, V93, P1030, DOI 10.1111/j.1471-4159.2005.03088.x; Murray-Zmijewski F, 2006, CELL DEATH DIFFER, V13, P962, DOI 10.1038/sj.cdd.4401914; Nakagawa O, 2005, GENE DEV, V19, P2066, DOI 10.1101/gad.1338705; Neugebauer KM, 1997, GENE DEV, V11, P1148, DOI 10.1101/gad.11.9.1148; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Paillusson A, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni052; POPIELARZ M, 1993, NUCLEIC ACIDS RES, V21, P5144, DOI 10.1093/nar/21.22.5144; Schwerk C, 2005, MOL CELL, V19, P1, DOI 10.1016/j.molcel.2005.05.026; Shi YS, 2006, MOL CELL, V23, P819, DOI 10.1016/j.molcel.2006.07.022; Shin C, 2004, NAT REV MOL CELL BIO, V5, P727, DOI 10.1038/nrm1467; Stamm S, 2008, J BIOL CHEM, V283, P1223, DOI 10.1074/jbc.R700034200; van Oordt WV, 2000, J CELL BIOL, V149, P307, DOI 10.1083/jcb.149.2.307; Wang HY, 1998, J CELL BIOL, V140, P737, DOI 10.1083/jcb.140.4.737; Wiznerowicz M, 2003, J VIROL, V77, P8957, DOI 10.1128/JVI.77.16.8957-8951.2003; Wohlbold L, 2009, DNA REPAIR, V8, P1018, DOI 10.1016/j.dnarep.2009.04.009; Yu XC, 2004, MOL CELL BIOL, V24, P9478, DOI 10.1128/MCB.24.21.9478-9486.2004; Zhong XY, 2009, GENE DEV, V23, P482, DOI 10.1101/gad.1752109; Zhou ZH, 2012, MOL CELL, V47, P422, DOI 10.1016/j.molcel.2012.05.014	38	21	21	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2013	8	4							e61980	10.1371/journal.pone.0061980	http://dx.doi.org/10.1371/journal.pone.0061980			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130DR	23613995	Green Published, gold			2022-12-25	WOS:000317893400138
J	George, JA; Norris, SA; van Deventer, HE; Crowther, NJ				George, Jaya A.; Norris, Shane A.; van Deventer, Hendrik Emmanuel; Crowther, Nigel J.			The Association of 25 Hydroxyvitamin D and Parathyroid Hormone with Metabolic Syndrome in Two Ethnic Groups in South Africa	PLOS ONE			English	Article							VITAMIN-D STATUS; BONE-MINERAL DENSITY; PRIMARY HYPERPARATHYROIDISM; INSULIN-RESISTANCE; 25-HYDROXYVITAMIN D; US ADULTS; SERUM CONCENTRATIONS; DIABETES-MELLITUS; NATIONAL-HEALTH; MORBIDLY OBESE	Introduction: Though inconsistent, a number of studies have shown an association between vitamin D (25(OH) D) status, parathyroid hormone (PTH) and the metabolic syndrome (Met S). These have largely been carried out in Caucasians or black subjects living in high income countries. There no data on the relationship of 25(OH) D and PTH status with Met S in populations resident in Africa. The aims of this study were to evaluate if there was an association of 25(OH) D or PTH with Met S in non- Caucasian populations in South Africa, and whether these molecules explained ethnic differences in the prevalence of Met S and its individual components. Methods: We measured anthropometry, serum 25(OH) D and PTH levels and the components of Met S, plus related metabolic variables, in 374 African and 350 Asian Indian healthy adults from the greater Johannesburg metropolitan area. Results: Met S was diagnosed in 29% of the African and 46% of the Asian Indian subjects (p, 0.0001). Subjects with Met S had higher PTH than those without Met S, (p, 0.0001), whilst 25(OH) D levels were not significantly different (p = 0.50). In multivariate analysis, 25(OH) D was not associated with any components of the Met S however PTH was shown to be positively associated with systolic (p = 0.018) and diastolic (p = 0.005) blood pressures and waist circumference (p, 0.0001) and negatively associated with HOMA (p = 0.0008) levels. Logistic regression analysis showed that Asian Indian ethnicity (OR 2.24; 95% CIs 1.57, 3.18; p, 0.0001) and raised PTH (OR 2.48; 95% CIs 1.01, 6.08; p = 0.04; adjusted for 25(OH) D) produced an increased risk of Met S but 25(OH) D did not (OR 1.25; 95% CI 0.67, 2.24; p = 0.48). Conclusions: Plasma PTH but not 25(OH) D is an independent predictor of the Met S in African and Asian Indians in South Africa.	[George, Jaya A.; Crowther, Nigel J.] Natl Hlth Lab Serv, Dept Chem Pathol, Johannesburg, South Africa; [George, Jaya A.; Crowther, Nigel J.] Univ Witwatersrand, Johannesburg, South Africa; [Norris, Shane A.] Univ Witwatersrand, MRC, Dev Pathways Hlth Res Unit, Johannesburg, South Africa; [van Deventer, Hendrik Emmanuel] Lancet Labs, Johannesburg, South Africa	National Health Laboratory Service; University of Witwatersrand; University of Witwatersrand	George, JA (corresponding author), Natl Hlth Lab Serv, Dept Chem Pathol, Johannesburg, South Africa.	jaya.george@wits.ac.za	Norris, Shane/C-4664-2014	Norris, Shane/0000-0001-7124-3788; Crowther, Nigel/0000-0002-5766-1745; George, Jaya/0000-0001-8769-3505; George, Jaya/0000-0002-8741-8746	MRC [G1001333] Funding Source: UKRI; Medical Research Council [G1001333] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Arya V, 2004, OSTEOPOROSIS INT, V15, P56, DOI 10.1007/s00198-003-1491-3; Bajaj Mandeep, 2004, Curr Diab Rep, V4, P213, DOI 10.1007/s11892-004-0026-4; Bernini G, 1999, METABOLISM, V48, P298, DOI 10.1016/S0026-0495(99)90075-6; Cakir I, 2012, ENDOCRINE, V42, P419, DOI 10.1007/s12020-012-9627-x; Chang E, 2009, MOL CELL ENDOCRINOL, V307, P77, DOI 10.1016/j.mce.2009.03.024; Chiu KC, 2000, METABOLISM, V49, P1501, DOI 10.1053/meta.2000.17708; Chiu KC, 2004, AM J CLIN NUTR, V79, P820; Ferris WF, 2005, HORM METAB RES, V37, P695, DOI 10.1055/s-2005-870580; Ford ES, 2005, DIABETES CARE, V28, P1228, DOI 10.2337/diacare.28.5.1228; Frost M, 2010, CLIN ENDOCRINOL, V73, P573, DOI 10.1111/j.1365-2265.2010.03847.x; Goswami R, 2000, AM J CLIN NUTR, V72, P472; Grethen E, 2012, J CLIN ENDOCR METAB, V97, P1655, DOI 10.1210/jc.2011-2280; Grethen E, 2011, J CLIN ENDOCR METAB, V96, P1320, DOI 10.1210/jc.2010-2202; He JL, 2011, AM J HYPERTENS, V24, P911, DOI 10.1038/ajh.2011.73; Hjelmesaeth J, 2009, CARDIOVASC DIABETOL, V8, DOI 10.1186/1475-2840-8-7; Kamycheva E, 2004, EUR J CARDIOV PREV R, V11, P69, DOI 10.1097/01.hjr.0000114706.27531.01; Khaleeli AA, 2007, DIABETES-METAB RES, V23, P43, DOI 10.1002/dmrr.637; Lee DM, 2009, EUR J ENDOCRINOL, V161, P947, DOI 10.1530/EJE-09-0496; Little RR, 2003, CLIN CHEM LAB MED, V41, P1191, DOI 10.1515/CCLM.2003.183; Maetani M, 2009, NUTR CANCER, V61, P225, DOI 10.1080/01635580802455149; Majumdar V, 2011, INT J OBESITY, V35, P1131, DOI 10.1038/ijo.2010.232; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Misra A, 2004, NUTRITION, V20, P482, DOI 10.1016/j.nut.2004.01.020; Pepe J, 2005, OSTEOPOROSIS INT, V16, P805, DOI 10.1007/s00198-004-1757-4; PETTIFOR JM, 1978, BRIT MED J, V1, P826, DOI 10.1136/bmj.1.6116.826; Pilz S, 2010, EUR HEART J, V31, P1591, DOI 10.1093/eurheartj/ehq109; Popkin BM, 1998, NUTR REV, V56, P106; Procopio M, 2002, DIABETIC MED, V19, P958, DOI 10.1046/j.1464-5491.2002.00809.x; Puoane T, 2002, OBES RES, V10, P1038, DOI 10.1038/oby.2002.141; Querfeld U, 1999, J AM SOC NEPHROL, V10, P2158; Reinchr T, 2007, EUR J ENDOCRINOL, V157, P225, DOI 10.1530/EJE-07-0188; Reis JP, 2008, EUR J ENDOCRINOL, V159, P41, DOI 10.1530/EJE-08-0072; Reis JP, 2007, DIABETES CARE, V30, P1549, DOI 10.2337/dc06-2438; Richter LM, 2004, PAEDIATR PERINAT EP, V18, P290, DOI 10.1111/j.1365-3016.2004.00572.x; Roislien J, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-17; Ross AC, 2011, J AM DIET ASSOC, V111, P524, DOI 10.1016/j.jada.2011.01.004; Roth HJ, 2008, ANN CLIN BIOCHEM, V45, P153, DOI 10.1258/acb.2007.007091; Sambrook PN, 2004, J CLIN ENDOCR METAB, V89, P5477, DOI 10.1210/jc.2004-0307; Scragg R, 2004, DIABETES CARE, V27, P2813, DOI 10.2337/diacare.27.12.2813; Steyn K, 1996, HUM GENET, V98, P479, DOI 10.1007/s004390050243; Sukumar D, 2011, J BONE MINER RES, V26, P1339, DOI 10.1002/jbmr.318; Tassone F, 2009, DIABETIC MED, V26, P968, DOI 10.1111/j.1464-5491.2009.02804.x; TAYLOR WH, 1991, DIABETIC MED, V8, P683, DOI 10.1111/j.1464-5491.1991.tb01678.x; van Deventer HE, 2008, CLIN CHEM, V54, P1197, DOI 10.1373/clinchem.2007.099085; Waisberg R, 2011, HORM METAB RES, V43, P660, DOI 10.1055/s-0031-1283139; Zhao GX, 2010, J HYPERTENS, V28, P1821, DOI 10.1097/HJH.0b013e32833bc5b4	48	36	36	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2013	8	4							e61282	10.1371/journal.pone.0061282	http://dx.doi.org/10.1371/journal.pone.0061282			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125TD	23596520	gold, Green Published, Green Submitted			2022-12-25	WOS:000317563300027
J	Song, TT; Zhao, J; Ying, SH; Feng, MG				Song, Ting-Ting; Zhao, Jing; Ying, Sheng-Hua; Feng, Ming-Guang			Differential Contributions of Five ABC Transporters to Mutidrug Resistance, Antioxidion and Virulence of Beauveria bassiana, an Entomopathogenic Fungus	PLOS ONE			English	Article							NATURAL TOXIC COMPOUNDS; BOTRYTIS-CINEREA; BENZIMIDAZOLE RESISTANCE; DRUG-RESISTANCE; FUNGICIDES; EFFLUX; GROWTH; CONIDIATION; STRESS; BCATRB	Multidrug resistance (MDR) confers agrochemical compatibility to fungal cells-based mycoinsecticdes but mechanisms involved in MDR remain poorly understood for entomopathogenic fungi, which have been widely applied as biocontrol agents against arthropod pests. Here we characterized the functions of five ATP-binding cassette (ABC) transporters, which were classified to the subfamilies ABC-B (Mdr1), ABC-C (Mrp1) and ABC-G (Pdr1, Pdr2 and Pdr5) and selected from 54 full-size ABC proteins of Beauveria bassiana based on their main domain architecture, membrane topology and transcriptional responses to three antifungal inducers. Disruption of each transporter gene resulted in significant reduction in resistance to four to six of eight fungicides or antifungal drugs tested due to their differences in structure and function. Compared with wild-type and complemented (control) strains, disruption mutants of all the five transporter genes became significantly less tolerant to the oxidants menadione and H2O2 based on 22-41% and 10-31% reductions of their effective concentrations required for the suppression of 50% colony growth at 25 degrees C. Under a standardized spray, the killing actions of Delta Pdr5 and Delta Mrp1 mutants against Spodoptera litura second-instar larvae were delayed by 59% and 33% respectively. However, no significant virulence change was observed in three other delta mutants. Taken together, the examined five ABC transporters contribute differentially to not only the fungal MDR but antioxidant capability, a phenotype rarely associated with ABC efflux pumps in previous reports; at least some of them are required for the full virulence of B. bassiana, thereby affecting the fungal biocontrol potential. Our results indicate that ABC pump-dependent MDR mechanisms exist in entomopathogenic fungi as do in yeasts and human and plant pathogenic fungi.	[Song, Ting-Ting; Zhao, Jing; Ying, Sheng-Hua; Feng, Ming-Guang] Zhejiang Univ, Inst Microbiol, Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Song, Ting-Ting] Zhejiang Acad Agr Sci, Inst Hort, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Zhejiang Academy of Agricultural Sciences	Feng, MG (corresponding author), Zhejiang Univ, Inst Microbiol, Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China.	mgfeng@zju.edu.cn			Natural Science Foundation of China [30930018, 30971960]; Ministry of Science and Technology of China [2011AA10A204]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China)	Funding for this study was provided by the Natural Science Foundation of China (Grant Nos: 30930018 and 30971960) and the Ministry of Science and Technology of China (Grant No: 2011AA10A204). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade AC, 2000, MICROBIOL-SGM, V146, P1987, DOI 10.1099/00221287-146-8-1987; Bardas GA, 2010, PEST MANAG SCI, V66, P967, DOI 10.1002/ps.1968; Coleman JJ, 2011, MOL PLANT MICROBE IN, V24, P368, DOI 10.1094/MPMI-09-10-0198; Cowen LE, 2008, EUKARYOT CELL, V7, P747, DOI 10.1128/EC.00041-08; de Faria MR, 2007, BIOL CONTROL, V43, P237, DOI 10.1016/j.biocontrol.2007.08.001; Del Sorbo G, 2000, FUNGAL GENET BIOL, V30, P1, DOI 10.1006/fgbi.2000.1206; Ernst R, 2010, FEBS J, V277, P540, DOI 10.1111/j.1742-4658.2009.07485.x; Fang WG, 2004, J INVERTEBR PATHOL, V85, P18, DOI 10.1016/j.jip.2003.12.003; FENG MG, 1994, BIOCONTROL SCI TECHN, V4, P3, DOI 10.1080/09583159409355309; Gao QA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001264; Holmes AR, 2008, ANTIMICROB AGENTS CH, V52, P3851, DOI 10.1128/AAC.00463-08; Klein C, 2011, ESSAYS BIOCHEM, V50, P101, DOI [10.1042/bse0500101, 10.1042/BSE0500101]; Kovalchuk A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-177; Krattinger SG, 2009, SCIENCE, V323, P1360, DOI 10.1126/science.1166453; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Lamping E, 2010, FUNGAL GENET BIOL, V47, P127, DOI 10.1016/j.fgb.2009.10.007; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo XD, 2012, FUNGAL GENET BIOL, V49, P544, DOI 10.1016/j.fgb.2012.05.002; Ma ZH, 2005, PEST MANAG SCI, V61, P449, DOI 10.1002/ps.982; Ma ZH, 2003, APPL ENVIRON MICROB, V69, P7145, DOI 10.1128/AEM.69.12.7145-7152.2003; MAJCHROWICZ I, 1993, BIOCONTROL SCI TECHN, V3, P321, DOI 10.1080/09583159309355287; Morschhauser J, 2010, FUNGAL GENET BIOL, V47, P94, DOI 10.1016/j.fgb.2009.08.002; Roberts DW, 2004, ADV APPL MICROBIOL, V54, P1, DOI 10.1016/S0065-2164(04)54001-7; Schoonbeek H, 2001, MOL PLANT MICROBE IN, V14, P562, DOI 10.1094/MPMI.2001.14.4.562; Shi WB, 2005, APPL ENTOMOL ZOOL, V40, P659, DOI 10.1303/aez.2005.659; Song TT, 2012, J APPL MICROBIOL, V112, P175, DOI 10.1111/j.1365-2672.2011.05188.x; Stefanato FL, 2009, PLANT J, V58, P499, DOI 10.1111/j.1365-313X.2009.03794.x; Tanabe K, 2011, MOL MICROBIOL, V82, P416, DOI 10.1111/j.1365-2958.2011.07820.x; Tsao S, 2009, ANTIMICROB AGENTS CH, V53, P1344, DOI 10.1128/AAC.00926-08; Urban M, 1999, EMBO J, V18, P512, DOI 10.1093/emboj/18.3.512; Vermeulen T, 2001, PEST MANAG SCI, V57, P393, DOI 10.1002/ps.309; Wang J, 2013, ENVIRON MICROBIOL, V15, P967, DOI 10.1111/1462-2920.12044; Wang ZL, 2013, ENVIRON MICROBIOL, V15, P409, DOI 10.1111/j.1462-2920.2012.02848.x; Xiao GH, 2012, SCI REP-UK, V2, DOI 10.1038/srep00483; Xie XQ, 2013, ENVIRON MICROBIOL, V15, P447, DOI 10.1111/j.1462-2920.2012.02871.x; Xie XQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030298; Xie XQ, 2010, APPL MICROBIOL BIOT, V86, P1543, DOI 10.1007/s00253-010-2437-2; Zhang YJ, 2009, APPL ENVIRON MICROB, V75, P3787, DOI 10.1128/AEM.01913-08; Zolnerciks JK, 2011, ESSAYS BIOCHEM, V50, P43, DOI [10.1042/bse0500043, 10.1042/BSE0500043]; Zou G, 2006, ENVIRON MICROBIOL, V8, P2096, DOI 10.1111/j.1462-2920.2006.01086.x; Zwiers LH, 2000, FUNGAL GENET BIOL, V30, P115, DOI 10.1006/fgbi.2000.1209	41	21	21	2	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2013	8	4							e62179	10.1371/journal.pone.0062179	http://dx.doi.org/10.1371/journal.pone.0062179			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125TD	23596534	Green Submitted, Green Published, gold			2022-12-25	WOS:000317563300052
J	Qin, CX; Lan, XL; He, J; Xia, XT; Tian, YL; Pei, ZJ; Yuan, H; Zhang, YX				Qin, Chunxia; Lan, Xiaoli; He, Jiang; Xia, Xiaotian; Tian, Yueli; Pei, Zhijun; Yuan, Hui; Zhang, Yongxue			An In Vitro and In Vivo Evaluation of a Reporter Gene/Probe System hERL/F-18-FES	PLOS ONE			English	Article							VEGF GENE-THERAPY; BASIC EVALUATION; CELLS; BIODISTRIBUTION; ESTROGENS; DISEASE; TRACER	Purpose: To evaluate the feasibility of a reporter gene/probe system, namely the human estrogen receptor ligand binding domain (hERL)/16 alpha-[F-18] fluoro-17 beta-estradiol (F-18-FES), for monitoring gene and cell therapy. Methods: The recombinant adenovirus vector Ad5-hERL-IRES-VEGF (Ad-EIV), carrying a reporter gene (hERL) and a therapeutic gene (vascular endothelial growth factor, VEGF165) through an internal ribosome entry site (IRES), was constructed. After transfection of Ad-EIV into bone marrow mesenchymal stem cells (Ad-EIV-MSCs), hERL and VEGF165 mRNA and protein expressions were identified using Real-Time qRT-PCR and immunofluorescence. The uptake of F-18-FES was measured in both Ad-EIV-MSCs and nontransfected MSCs after different incubation time. Micro-PET/CT images were obtained at 1 day after injection of Ad-EIV-MSCs into the left foreleg of the rat. The right foreleg was injected with nontransfected MSCs, which served as self-control. Results: After transfection with Ad-EIV, the mRNA and protein expression of hERL and VEGF165 were successfully detected in MSCs, and correlated well with each other (R-2 = 0.9840, P<0.05). This indicated the reporter gene could reflect the therapeutic gene indirectly. Ad-EIV-MSCs uptake of F-18-FES increased with incubation time with a peak value of 9.13%+/- 0.33% at 150 min, which was significantly higher than that of the control group. A far higher level of radioactivity could be seen in the left foreleg on the micro-PET/CT image than in the opposite foreleg. Conclusion: These preliminary in vitro and in vivo studies confirmed that hERL/F-18-FES might be used as a novel reporter gene/probe system for monitoring gene and cell therapy. This imaging platform may have broad applications for basic research and clinical studies.	[Qin, Chunxia; Lan, Xiaoli; Xia, Xiaotian; Tian, Yueli; Pei, Zhijun; Yuan, Hui; Zhang, Yongxue] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Nucl Med, Wuhan 430074, Peoples R China; [He, Jiang] Univ Virginia, Sch Med, Dept Radiol & Med Imaging, Charlottesville, VA 22908 USA	Huazhong University of Science & Technology; University of Virginia	Lan, XL (corresponding author), Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Nucl Med, Wuhan 430074, Peoples R China.	LXL730724@hotmail.com	Xia, Xiaotian/GWK-0088-2022; qin, chunxia/GPG-1369-2022	Pei, Zhijun/0000-0001-6125-0626	National Nature Science Foundation of China [30970853, 81071200, 30830041]; China Postdoctoral Science Foundation [2005037194]; Hubei Province Science Fund for Distinguished Young Scholars [2010CDA094]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Hubei Province Science Fund for Distinguished Young Scholars	This study was supported by the National Nature Science Foundation of China (Grant Numbers: 30970853, 81071200 and 30830041), the China Postdoctoral Science Foundation (2005037194), and Hubei Province Science Fund for Distinguished Young Scholars (2010CDA094). The funders' websites are http://www.nsfc.gov.cn/Portal0/default152.htm for the National Nature Science Foundation of China, http://210.79.234.200/V1/Manage/Login.aspx for the China Postdoctoral Science Foundation, and http://www.hbstd.gov.cn/jh/default.jsp for Hubei Province Science Fund for Distinguished Young Scholars. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEATO M, 1995, CELL, V83, P851, DOI 10.1016/0092-8674(95)90201-5; Benard F, 2008, EUR J NUCL MED MOL I, V35, P1473, DOI 10.1007/s00259-008-0745-x; Blasberg Ronald G, 2002, Mol Imaging, V1, P280; Bonaros N, 2005, Minerva Cardioangiol, V53, P265; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; Freeman SM, 1997, LANCET, V349, P2, DOI 10.1016/S0140-6736(97)22001-5; Furukawa T, 2006, NUCL MED BIOL, V33, P145, DOI 10.1016/j.nucmedbio.2005.07.013; Gambhir SS, 1999, NUCL MED BIOL, V26, P481, DOI 10.1016/S0969-8051(99)00021-9; Hu J, 2011, J HUAZHONG U SCI-MED, V31, P693, DOI 10.1007/s11596-011-0584-z; Hu S, 2011, MOL IMAGING, V10, P227, DOI 10.2310/7290.2010.00051; Javazon EH, 2001, STEM CELLS, V19, P219, DOI 10.1634/stemcells.19-3-219; Kalil RAK, 2010, REV BRAS CIR CARDIOV, V25, P311, DOI 10.1590/S0102-76382010000300006; KIESEWETTER DO, 1984, J NUCL MED, V25, P1212; Kumar P, 2007, J PHARM PHARM SCI, V10, P256; KUMAR V, 1987, CELL, V51, P941, DOI 10.1016/0092-8674(87)90581-2; Lan XL, 2009, NUCL MED BIOL, V36, P207, DOI 10.1016/j.nucmedbio.2008.10.016; Likar Y, 2008, J NUCL MED, V49, P713, DOI 10.2967/jnumed.107.046425; Lohith TG, 2008, MOL IMAGING BIOL, V10, P245, DOI 10.1007/s11307-008-0149-0; Mankoff DA, 1997, NUCL MED BIOL, V24, P341, DOI 10.1016/S0969-8051(97)00002-4; Mankoff DA, 2001, J NUCL MED, V42, P679; Mansilla E, 2006, TRANSPL P, V38, P967, DOI 10.1016/j.transproceed.2006.02.053; MATHIAS CJ, 1987, NUCL MED BIOL, V14, P15, DOI 10.1016/0883-2897(87)90156-5; MCGUIRE AH, 1991, J NUCL MED, V32, P1526; Modarai B, 2008, ARTERIOSCL THROM VAS, V28, P1753, DOI 10.1161/ATVBAHA.108.170571; Mori T, 2006, NUCL MED BIOL, V33, P281, DOI 10.1016/j.nucmedbio.2005.11.002; Oh SJ, 2007, APPL RADIAT ISOTOPES, V65, P676, DOI 10.1016/j.apradiso.2006.06.016; Ozawa K, 2008, J AUTOIMMUN, V30, P121, DOI 10.1016/j.jaut.2007.12.008; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Roelants V, 2008, J NUCL MED, V49, P1836, DOI 10.2967/jnumed.108.052175; Romer J, 2001, APPL RADIAT ISOTOPES, V55, P631, DOI 10.1016/S0969-8043(00)00339-0; Romer J, 1999, NUCL MED BIOL, V26, P473, DOI 10.1016/S0969-8051(98)00098-5; Sasaki M, 2000, ANN NUCL MED, V14, P127, DOI 10.1007/BF02988592; Seimbille Y, 2002, STEROIDS, V67, P765, DOI 10.1016/S0039-128X(02)00025-9; Silva MCME, 2001, APPL RADIAT ISOTOPES, V54, P227; Stewart DJ, 2006, GENE THER, V13, P1503, DOI 10.1038/sj.gt.3302802; Takahashi N, 2007, EUR J NUCL MED MOL I, V34, P354, DOI 10.1007/s00259-006-0191-6; Takamatsu S, 2005, NUCL MED BIOL, V32, P821, DOI 10.1016/j.nucmedbio.2005.06.010; Wong GKY, 2011, BIOTECHNOL ADV, V29, P1, DOI 10.1016/j.biotechadv.2010.07.005; Zhang HW, 2011, J NUCL MED, V52, P123, DOI 10.2967/jnumed.110.079004	39	11	11	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2013	8	4							e61911	10.1371/journal.pone.0061911	http://dx.doi.org/10.1371/journal.pone.0061911			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123JP	23593502	Green Published, Green Submitted, gold			2022-12-25	WOS:000317385300088
J	Bose, A; Huhtaniemi, I; Singh, O; Pal, R				Bose, Anjali; Huhtaniemi, Ilpo; Singh, Om; Pal, Rahul			Synergistic Activation of Innate and Adaptive Immune Mechanisms in the Treatment of Gonadotropin-Sensitive Tumors	PLOS ONE			English	Article							HUMAN CHORIONIC-GONADOTROPIN; BACILLUS-CALMETTE-GUERIN; MYCOBACTERIUM-VACCAE SRL172; ACTIVE SPECIFIC IMMUNOTHERAPY; HUMAN DENDRITIC CELLS; BETA-SUBUNIT; MONOCLONAL-ANTIBODIES; CONTRACEPTIVE VACCINE; COLORECTAL-CANCER; IMPROVED SURVIVAL	Human chorionic gonadotropin (hCG) prolongs the secretion of progesterone from the corpus luteum, providing a critical stimulus for the sustenance of pregnancy. hCG (or individual subunits) is also secreted by a variety of trophoblastic and non-trophoblastic cancers and has been associated with poor prognosis. Early clinical studies have indicated merit in anti-hCG vaccination as potential immunotherapy, but anti-tumor efficacy is believed to be compromised by sub-optimal immunogenecity. In the present study, enhanced tumorigenesis was observed when SP2/O cells were subcutaneously injected in either male or female BALB/c x FVB/J(beta hCG/-) F1 transgenic mice, establishing the growth-promoting effects of the gonadotropin for implanted tumors in vivo. The utility of Mycobacterium indicus pranii (MIP) was evaluated, as an innate antitumor immunomodulator as well as adjuvant in mice. MIP elicited the secretion of the inflammatory cytokines IFN gamma, IL-6, IL-12p40, KC and TNF alpha from murine antigen presenting cells. When MIP was incorporated into an anti-hCG vaccine formulation previously employed in humans (a beta hCG-TT conjugate adsorbed on alum), elevated T cell recall proliferative and cytokine responses to hCG, beta hCG and TT were observed. MIP increased vaccine immunogenicity in mice of diverse genetic background (including in traditionally low-responder murine strains), leading to enhanced titres of bioneutralizing anti-hCG antibodies which exhibited cytotoxicity towards tumor cells. Individual administration of MIP and beta hCG-TT to BALB/c mice subcutaneously implanted with SP2/O cells resulted in anti-tumor effects; significantly, immunization with beta hCG-TT supplemented with MIP invoked synergistic benefits in terms of tumor volume, incidence and survival. The development of novel vaccine formulations stimulating both adaptive and innate anti-tumor immunity to induce collaborative beneficial effects may fill a niche in the adjunct treatment of hCG-sensitive tumors that are resistant to conventional therapy.	[Bose, Anjali; Singh, Om; Pal, Rahul] Natl Inst Immunol, Immunoendocrinol Lab, New Delhi 110067, India; [Huhtaniemi, Ilpo] Univ Turku, Dept Physiol, Turku, Finland; [Huhtaniemi, Ilpo] Univ London Imperial Coll Sci Technol & Med, Dept Reprod & Dev Biol, London, England	Department of Biotechnology (DBT) India; National Institute of Immunology (NII); University of Turku; Imperial College London	Singh, O (corresponding author), Natl Inst Immunol, Immunoendocrinol Lab, New Delhi 110067, India.	omsingh@gmail.com; rahul@nii.ac.in			Department of Biotechnology, Government of India [BT/PR/5861/Med/14/705/2005]	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	This work was supported by an extra-mural grant from the Department of Biotechnology, Government of India (BT/PR/5861/Med/14/705/2005) to OS and RP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025424; Cekan SZ, 1998, J CLIN LAB ANAL, V12, P60, DOI 10.1002/(SICI)1098-2825(1998)12:1<60::AID-JCLA10>3.0.CO;2-M; Chaudhuri D, 2009, CURR PHARM BIOTECHNO, V10, P166, DOI 10.2174/138920109787315114; Chaudhuri Prabir, 2003, J Indian Med Assoc, V101, P559; Crawford RAF, 1998, J CLIN PATHOL, V51, P685, DOI 10.1136/jcp.51.9.685; de Gruijl TD, 2008, CANCER IMMUNOL IMMUN, V57, P1569, DOI 10.1007/s00262-008-0536-z; Gillott DJ, 1996, BRIT J CANCER, V73, P323, DOI 10.1038/bjc.1996.56; Hanna MG, 2001, VACCINE, V19, P2576, DOI 10.1016/S0264-410X(00)00485-0; Henderson RA, 1997, J IMMUNOL, V159, P635; HERLYN D, 1982, P NATL ACAD SCI-BIOL, V79, P4761, DOI 10.1073/pnas.79.15.4761; Herr HW, 2008, J UROLOGY, V179, P53, DOI 10.1016/j.juro.2007.08.122; Hrouda D, 1998, BRIT J UROL, V82, P568; Hrouda D, 1998, BRIT J UROL, V82, P870; Huhtaniemi I, 2005, MOL CELL ENDOCRINOL, V234, P117, DOI 10.1016/j.mce.2004.10.013; JONES WR, 1988, LANCET, V1, P1295; KIPPS TJ, 1985, J EXP MED, V161, P1, DOI 10.1084/jem.161.1.1; Kuroda H, 1998, INT J CANCER, V76, P571, DOI 10.1002/(SICI)1097-0215(19980518)76:4<571::AID-IJC21>3.3.CO;2-P; Lambrecht BN, 2009, CURR OPIN IMMUNOL, V21, P23, DOI 10.1016/j.coi.2009.01.004; LAPTHORN AJ, 1994, NATURE, V369, P455, DOI 10.1038/369455a0; Lund T, 1998, REV REPROD, V3, P71, DOI 10.1530/ror.0.0030071; Lundin M, 2000, ANTICANCER RES, V20, P4949; Mandokhot A, 2000, CLIN EXP IMMUNOL, V122, P101, DOI 10.1046/j.1365-2249.2000.01351.x; Maraveyas A, 1999, ANN ONCOL, V10, P817, DOI 10.1023/A:1008307821189; Marrack P, 2009, NAT REV IMMUNOL, V9, P287, DOI 10.1038/nri2510; MORALES A, 1976, J UROLOGY, V116, P180, DOI 10.1016/S0022-5347(17)58737-6; Morse MA, 2011, CLIN CANCER RES, V17, P4844, DOI 10.1158/1078-0432.CCR-11-0891; Moulton HM, 2002, CLIN CANCER RES, V8, P2044; PAL R, 1990, AM J REPROD IMMUNOL, V22, P124, DOI 10.1111/j.1600-0897.1990.tb00654.x; Pal R, 2001, FERTIL STERIL, V76, P332, DOI 10.1016/S0015-0282(01)01897-0; Patel PM, 2008, EUR J CANCER, V44, P216, DOI 10.1016/j.ejca.2007.11.003; Rakshit S, 2012, INT J CANCER, V130, P865, DOI 10.1002/ijc.26099; REGELSON W, 1995, CANCER, V76, P1299, DOI 10.1002/1097-0142(19951015)76:8<1299::AID-CNCR2820760802>3.0.CO;2-L; Rulli SB, 2002, ENDOCRINOLOGY, V143, P4084, DOI 10.1210/en.2002-220490; Sachdeva R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051125; Sano K, 1999, AM J RESP CELL MOL, V20, P1260, DOI 10.1165/ajrcmb.20.6.3546; SINGH O, 1989, FERTIL STERIL, V52, P739; Stanford JL, 2008, EUR J CANCER, V44, P224, DOI 10.1016/j.ejca.2007.08.021; Sugino N, 2000, J CLIN ENDOCR METAB, V85, P4379, DOI 10.1210/jc.85.11.4379; Sur Prabir Kumar, 2003, J Indian Med Assoc, V101, P120; Szturmowicz M, 1999, TUMOR BIOL, V20, P99, DOI 10.1159/000030052; TALWAR GP, 1994, P NATL ACAD SCI USA, V91, P8532, DOI 10.1073/pnas.91.18.8532; Thurnher M, 1997, INT J CANCER, V70, P128; Tsuji S, 2000, INFECT IMMUN, V68, P6883, DOI 10.1128/IAI.68.12.6883-6890.2000; YAMAMURA Y, 1979, CANCER-AM CANCER SOC, V43, P1314, DOI 10.1002/1097-0142(197904)43:4<1314::AID-CNCR2820430420>3.0.CO;2-6; Zygmunt M, 2002, J CLIN ENDOCR METAB, V87, P5290, DOI 10.1210/jc.2002-020642	45	6	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2013	8	4							e61288	10.1371/journal.pone.0061288	http://dx.doi.org/10.1371/journal.pone.0061288			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130FG	23593454	gold, Green Submitted, Green Published			2022-12-25	WOS:000317898000121
J	Gisch, N; Kohler, T; Ulmer, AJ; Muthing, J; Pribyl, T; Fischer, K; Lindner, B; Hammerschmidt, S; Zahringer, U				Gisch, Nicolas; Kohler, Thomas; Ulmer, Artur J.; Muething, Johannes; Pribyl, Thomas; Fischer, Kathleen; Lindner, Buko; Hammerschmidt, Sven; Zaehringer, Ulrich			Structural Reevaluation of Streptococcus pneumoniae Lipoteichoic Acid and New Insights into Its Immunostimulatory Potency	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STAPHYLOCOCCUS-AUREUS; TEICHOIC-ACIDS; GROUP-B; GANGLIOSIDES; FORSSMAN; RECEPTOR; GLYCOSPHINGOLIPIDS; PRELIPOPROTEINS; BIOSYNTHESIS; RECOGNITION	Streptococcus pneumoniae is a Gram-positive human pathogen with a complex lipoteichoic acid (pnLTA) structure. Because the current structural model for pnLTA shows substantial inconsistencies, we reinvestigated purified and, more importantly, O-deacylated pnLTA, which is most suitable for NMR spectroscopy and electrospray ionization-MS spectrometry. We analyzed pnLTA of nonencapsulated pneumococcal strains D39 Delta cps and TIGR4 Delta cps, respectively. The data obtained allowed us to (re) define (i) the position and linkage of the repeating unit, (ii) the putative alpha-GalpNAc substitution at the ribitiol 5-phosphate (Rib-ol-5-P), and (iii) the length of (i. e. the number of repeating units in) the pnLTA chain. We here also describe for the first time that the terminal sugar residues in the pnLTA (Forssman disaccharide; alpha-D-GalpNAc-(1 -> 3)-beta-D-GalpNAc-(1 ->)), responsible for the cross-reactivity with anti-Forssman antigen antibodies, can be heterogeneous with respect to its degree of phosphorylcholine substitution in both O-6-positions. To assess the proinflammatory potency of pnLTA, we generated a (lipopeptide-free) Delta lgt mutant of strain D39 Delta cps, isolated its pnLTA, and showed that it is capable of inducing IL-6 release in human mononuclear cells, independent of TLR2 activation. This finding was quite in contrast to LTA of the Staphylococcus aureus SA113 Delta lgt mutant, which did not activate human mononuclear cells in our experiments. Remarkably, this is also contrary to various other reports showing a proinflammatory potency of S. aureus LTA. Taken together, our study refines the structure of pnLTA and indicates that pneumococcal and S. aureus LTAs differ not only in their structure but also in their bioactivity.	[Gisch, Nicolas; Lindner, Buko; Zaehringer, Ulrich] Leibniz Ctr Med & Biosci, Res Ctr Borstel, Div Immunochem, D-23845 Borstel, Germany; [Ulmer, Artur J.] Leibniz Ctr Med & Biosci, Res Ctr Borstel, Div Innate Immun, D-23845 Borstel, Germany; [Fischer, Kathleen] Leibniz Ctr Med & Biosci, Res Ctr Borstel, Div Struct Biochem, D-23845 Borstel, Germany; [Fischer, Kathleen] German Ctr Lung Res, Airway Res Ctr North, D-23845 Borstel, Germany; [Kohler, Thomas; Pribyl, Thomas; Hammerschmidt, Sven] Ernst Moritz Arndt Univ Greifswald, Dept Genet Microorganisms, Interfac Inst Genet & Funct Gen, D-17487 Greifswald, Germany; [Muething, Johannes] Univ Munster, Inst Hyg, D-48149 Munster, Germany	Forschungszentrum Borstel; Forschungszentrum Borstel; Forschungszentrum Borstel; Ernst Moritz Arndt Universitat Greifswald; University of Munster	Gisch, N (corresponding author), Leibniz Ctr Med & Biosci, Res Ctr Borstel, Div Immunochem, Pk Allee 1-40, D-23845 Borstel, Germany.	ngisch@fz-borstel.de	Hammerschmidt, Sven/G-2598-2010	Hammerschmidt, Sven/0000-0002-6382-6681; Gisch, Nicolas/0000-0003-3260-5269	Deutsche Forschungsgemeinschaft [(ZA 149/6-1, HA 3125/2-1]; cluster of excellence "Inflammation at Interfaces"	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); cluster of excellence "Inflammation at Interfaces"	This work was supported by Deutsche Forschungsgemeinschaft (ZA 149/6-1 and HA 3125/2-1) and the cluster of excellence "Inflammation at Interfaces."	BEHR T, 1992, EUR J BIOCHEM, V207, P1063, DOI 10.1111/j.1432-1033.1992.tb17143.x; Bergmann S, 2006, MICROBIOL-SGM, V152, P295, DOI 10.1099/mic.0.28610-0; BETHKE U, 1986, J IMMUNOL METHODS, V89, P111, DOI 10.1016/0022-1759(86)90038-4; BETHKE U, 1987, J IMMUNOL, V138, P4329; BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P77; Bui NK, 2012, ANAL BIOCHEM, V421, P657, DOI 10.1016/j.ab.2011.11.026; COURTNEY HS, 1986, INFECT IMMUN, V51, P414, DOI 10.1128/IAI.51.2.414-418.1986; CUNDELL DR, 1995, NATURE, V377, P435, DOI 10.1038/377435a0; Debarry J, 2007, J ALLERGY CLIN IMMUN, V119, P1514, DOI 10.1016/j.jaci.2007.03.023; Dehus O, 2011, IMMUNOBIOLOGY, V216, P24, DOI 10.1016/j.imbio.2010.03.008; Denapaite D, 2012, MICROB DRUG RESIST, V18, P344, DOI 10.1089/mdr.2012.0026; Draing C, 2006, J BIOL CHEM, V281, P33849, DOI 10.1074/jbc.M602676200; Elling L, 1999, GLYCOCONJUGATE J, V16, P327, DOI 10.1023/A:1007039825505; Farhat K, 2008, J LEUKOCYTE BIOL, V83, P692, DOI 10.1189/jlb.0807586; Fischer W, 1997, MICROB DRUG RESIST, V3, P309, DOI 10.1089/mdr.1997.3.309; FISCHER W, 1983, EUR J BIOCHEM, V133, P523, DOI 10.1111/j.1432-1033.1983.tb07495.x; FISCHER W, 1993, EUR J BIOCHEM, V215, P851, DOI 10.1111/j.1432-1033.1993.tb18102.x; FISCHER W, 2000, STREPTOCOCCUS PNEUMO, P155; Gamez G, 2012, CURR DRUG TARGETS, V13, P323, DOI 10.2174/138945012799424697; Hashimoto M, 2006, J IMMUNOL, V177, P3162, DOI 10.4049/jimmunol.177.5.3162; HAVARSTEIN LS, 1995, P NATL ACAD SCI USA, V92, P11140, DOI 10.1073/pnas.92.24.11140; Heissigerova H, 2003, GLYCOBIOLOGY, V13, P377, DOI 10.1093/glycob/cwg042; Henneke P, 2005, J IMMUNOL, V174, P6449, DOI 10.4049/jimmunol.174.10.6449; Houliston RS, 2009, GLYCOBIOLOGY, V19, P153, DOI 10.1093/glycob/cwn117; HUMMELL DS, 1985, INFECT IMMUN, V47, P384, DOI 10.1128/IAI.47.2.384-387.1985; Jin MS, 2007, CELL, V130, P1071, DOI 10.1016/j.cell.2007.09.008; Kadioglu A, 2008, NAT REV MICROBIOL, V6, P288, DOI 10.1038/nrmicro1871; Kang JY, 2009, IMMUNITY, V31, P873, DOI 10.1016/j.immuni.2009.09.018; Kinjo Y, 2011, NAT IMMUNOL, V12, P966, DOI 10.1038/ni.2096; KUNDU SK, 1978, J LIPID RES, V19, P390; LEDEEN RW, 1982, METHOD ENZYMOL, V83, P139; LOOS M, 1986, INFECT IMMUN, V53, P595, DOI 10.1128/IAI.53.3.595-599.1986; Lopez R, 2004, INT MICROBIOL, V7, P163; LOWRY OH, 1954, J BIOL CHEM, V207, P1; Lynch NJ, 2004, J IMMUNOL, V172, P1198, DOI 10.4049/jimmunol.172.2.1198; Morath S, 2002, J EXP MED, V195, P1635, DOI 10.1084/jem.20020322; Morath S, 2001, J EXP MED, V193, P393, DOI 10.1084/jem.193.3.393; Morr M, 2002, EUR J IMMUNOL, V32, P3337, DOI 10.1002/1521-4141(2002012)32:12<3337::AID-IMMU3337>3.0.CO;2-I; Muthing J, 2012, GLYCOBIOLOGY, V22, P849, DOI 10.1093/glycob/cws009; Pedersen CM, 2010, ANGEW CHEM INT EDIT, V49, P2585, DOI 10.1002/anie.200906163; Petit CM, 2001, FEMS MICROBIOL LETT, V200, P229, DOI 10.1111/j.1574-6968.2001.tb10720.x; Radin JN, 2005, INFECT IMMUN, V73, P7827, DOI 10.1128/IAI.73.12.7827-7835.2005; Rennemeier C, 2007, FASEB J, V21, P3118, DOI 10.1096/fj.06-7992com; SAITO T, 1971, J LIPID RES, V12, P257; Schmidt RR, 2011, ORG BIOMOL CHEM, V9, P2040, DOI 10.1039/c0ob00794c; Seo HS, 2008, J BACTERIOL, V190, P2379, DOI 10.1128/JB.01795-07; Stoll H, 2005, INFECT IMMUN, V73, P2411, DOI 10.1128/IAI.73.4.2411-2423.2005; UENO K, 1978, J LIPID RES, V19, P863; Voss S, 2012, MOL ORAL MICROBIOL, V27, P246, DOI 10.1111/j.2041-1014.2012.00654.x; Weidenmaier C, 2008, NAT REV MICROBIOL, V6, P276, DOI 10.1038/nrmicro1861; Zahringer U, 2008, IMMUNOBIOLOGY, V213, P205, DOI 10.1016/j.imbio.2008.02.005	51	67	69	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 31	2013	288	22					15654	15667		10.1074/jbc.M112.446963	http://dx.doi.org/10.1074/jbc.M112.446963			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	156LA	23603911	Green Published, hybrid			2022-12-25	WOS:000319822300022
J	Khelaifia, S; Raoult, D; Drancourt, M				Khelaifia, Saber; Raoult, Didier; Drancourt, Michel			A Versatile Medium for Cultivating Methanogenic Archaea	PLOS ONE			English	Article							NUTRITIONAL-REQUIREMENTS; SP-NOV; METHANOBREVIBACTER-ARBORIPHILICUS; METHANOSPHAERA-STADTMANAE; METHANOTHRIX-CONCILII; HUNGATE TECHNIQUE; CARBON-MONOXIDE; HUMAN FECES; GEN-NOV; BACTERIA	Background: Methanobrevibacter smithii, Methanobrevibacter oralis, Methanosphaera stadtmanae, Methanomassilicoccus luminyensis and Methanobrevibacter arboriphilicus have been cultured from human digestive microbiota. Each one of these fastidious methanogenic archaea requires a specific medium for its growth, hampering their routine isolation and the culture. Methodology/Principal Findings: A new culture medium here referred as SAB medium was optimized and tested to cultivate methanogens associated with human microbiota, as well as two mesophile methanogens Methanobacterium beijingense and Methanosaeta concilii. It was further tested for the isolation of archaea from 20 human stool specimens including 10 specimens testing positive for PCR detection of M. smithii. After inoculating 10(5) colony-forming-unit archaea/mL or 1 g stool specimen in parallel in SAB medium and reference DSMZ medium in the presence of negative controls, growth of archaea was determined by optical microscopy and the measurement of methane production by gas chromatography. While the negative controls remained sterile, all tested archaea grew significantly more rapidly in SAB medium than in reference medium in 1-3 days (P<0.05, Student test). Among PCR-positive stool specimens, 10/10 grew in the SAB medium, 6/10 in DSMZ 119 medium, 5/10 in DSMZ 322 medium and 3/10 in DSMZ 334 c medium. Four out of ten PCR-negative stool specimens grew after a 3-week incubation in the SAB-medium whereas no growth was detected in any of the reference media. 16S rRNA gene sequencing yielded 99-100% sequence similarity with reference M. smithii except for one specimen that yielded 99-100% sequence similarity with reference Methanobrevibacter millerae. Conclusions/Significance: SAB medium allows for the versatile isolation and growth of methanogenic archaea associated with human gut microbiota including the archaea missed by inoculation of reference media. Implementation of the SAB medium in veterinary and medical microbiology laboratories will ease the routine culture-based detection of methanogenic archaea in clinical and environmental specimens.	[Khelaifia, Saber; Raoult, Didier; Drancourt, Michel] Aix Marseille Univ, URMITE, CNRS UMR63 7278, IRD 198,Inserm 1095, F-13005 Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD)	Drancourt, M (corresponding author), Aix Marseille Univ, URMITE, CNRS UMR63 7278, IRD 198,Inserm 1095, F-13005 Marseille, France.	Michel.Drancourt@univmed.fr	RAOULT, Didier/A-8434-2008	RAOULT, Didier/0000-0002-0633-5974; Khelaifia, Saber/0000-0002-9303-3893				ASAKAWA S, 1993, INT J SYST BACTERIOL, V43, P683, DOI 10.1099/00207713-43-4-683; BALCH WE, 1979, MICROBIOL REV, V43, P260, DOI 10.1128/MMBR.43.2.260-296.1979; BELAY N, 1990, J CLIN MICROBIOL, V28, P1666, DOI 10.1128/JCM.28.7.1666-1668.1990; Bringuier A, 2012, J CLIN MICR IN PRESS; BRYANT MP, 1972, AM J CLIN NUTR, V25, P1324; BRYANT MP, 1971, ADV CHEM SER, P23; de Macario EC, 2009, INT J MED MICROBIOL, V299, P99, DOI 10.1016/j.ijmm.2008.06.011; DIEKERT G, 1981, J BACTERIOL, V148, P459, DOI 10.1128/JB.148.2.459-464.1981; Dridi Bedis, 2012, BMC Res Notes, V5, P238, DOI 10.1186/1756-0500-5-238; Dridi B, 2012, INT J SYST EVOL MICR, V62, P1902, DOI 10.1099/ijs.0.033712-0; Dridi B, 2011, J ANTIMICROB CHEMOTH, V66, P2038, DOI 10.1093/jac/dkr251; Dridi B, 2011, ANAEROBE, V17, P56, DOI 10.1016/j.anaerobe.2011.03.001; FERRARI A, 1994, CURR MICROBIOL, V29, P7, DOI 10.1007/BF01570184; Fricke WF, 2006, J BACTERIOL, V188, P642, DOI 10.1128/JB.188.2.642-658.2006; HAMMEL KE, 1984, J BACTERIOL, V157, P975, DOI 10.1128/JB.157.3.975-978.1984; HARTZELL PL, 1986, P NATL ACAD SCI USA, V83, P6726, DOI 10.1073/pnas.83.18.6726; HENSGENS CMH, 1994, ARCH MICROBIOL, V162, P143; Hungate R.E., 1969, METHODS MICROBIOLO B, P117, DOI [DOI 10.1016/S0580-9517(08)70503-8, 10.1016/S0580-9517(08)70503-8]; JARRELL KF, 1988, CAN J MICROBIOL, V34, P557, DOI 10.1139/m88-095; Lepp PW, 2004, P NATL ACAD SCI USA, V101, P6176, DOI 10.1073/pnas.0308766101; Ma K, 2005, INT J SYST EVOL MICR, V55, P325, DOI 10.1099/ijs.0.63254-0; MILLER TL, 1985, ARCH MICROBIOL, V141, P116, DOI 10.1007/BF00423270; MILLER TL, 1974, APPL MICROBIOL, V27, P985, DOI 10.1128/AEM.27.5.985-987.1974; MILLER TL, 1982, APPL ENVIRON MICROB, V43, P227, DOI 10.1128/AEM.43.1.227-232.1982; Moore JM, 2005, ANTIMICROB AGENTS CH, V49, P1236, DOI 10.1128/AAC.49.3.1236-1237.2005; MURRAY PA, 1985, APPL ENVIRON MICROB, V50, P49, DOI 10.1128/AEM.50.1.49-55.1985; PATEL GB, 1988, CAN J MICROBIOL, V34, P73, DOI 10.1139/m88-013; PATEL GB, 1990, INT J SYST BACTERIOL, V40, P79, DOI 10.1099/00207713-40-1-79; Rother M, 2004, P NATL ACAD SCI USA, V101, P16929, DOI 10.1073/pnas.0407486101; Scherer P, 1981, ACTA BIOTECHNOL, V1, P57, DOI DOI 10.1002/ABIO.370010108; TANNER RS, 1988, APPL ENVIRON MICROB, V54, P625, DOI 10.1128/AEM.54.3.625-628.1988; TAYLOR CD, 1974, J BACTERIOL, V120, P974, DOI 10.1128/JB.120.2.974-975.1974; Wang QH, 1999, BIOMASS BIOENERG, V16, P407, DOI 10.1016/S0961-9534(99)00016-1; Wolfe RS, 2010, ANAEROBE, V16, P216, DOI 10.1016/j.anaerobe.2009.11.005; Yamabe K, 2008, FEMS MICROBIOL LETT, V287, P69, DOI 10.1111/j.1574-6968.2008.01304.x; Zhang HS, 2009, P NATL ACAD SCI USA, V106, P2365, DOI 10.1073/pnas.0812600106	36	58	58	3	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2013	8	4							e61563	10.1371/journal.pone.0061563	http://dx.doi.org/10.1371/journal.pone.0061563			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IK	23613876	Green Submitted, Green Published, gold			2022-12-25	WOS:000317907200065
J	Asnaghi, V; Chiantore, M; Mangialajo, L; Gazeau, F; Francour, P; Alliouane, S; Gattuso, JP				Asnaghi, Valentina; Chiantore, Mariachiara; Mangialajo, Luisa; Gazeau, Frederic; Francour, Patrice; Alliouane, Samir; Gattuso, Jean-Pierre			Cascading Effects of Ocean Acidification in a Rocky Subtidal Community	PLOS ONE			English	Article							URCHIN PARACENTROTUS-LIVIDUS; INCREASED ATMOSPHERIC CO2; SEAWATER ACIDIFICATION; SEA-URCHINS; ELEVATED CO2; ALGAL ASSEMBLAGES; CORALLINE ALGAE; CLIMATE-CHANGE; LIGURIAN SEA; CALCIFICATION	Temperate marine rocky habitats may be alternatively characterized by well vegetated macroalgal assemblages or barren grounds, as a consequence of direct and indirect human impacts (e. g. overfishing) and grazing pressure by herbivorous organisms. In future scenarios of ocean acidification, calcifying organisms are expected to be less competitive: among these two key elements of the rocky subtidal food web, coralline algae and sea urchins. In order to highlight how the effects of increased pCO(2) on individual calcifying species will be exacerbated by interactions with other trophic levels, we performed an experiment simultaneously testing ocean acidification effects on primary producers (calcifying and non-calcifying algae) and their grazers (sea urchins). Artificial communities, composed by juveniles of the sea urchin Paracentrotus lividus and calcifying (Corallina elongata) and non-calcifying (Cystoseira amentacea var stricta, Dictyota dichotoma) macroalgae, were subjected to pCO(2) levels of 390, 550, 750 and 1000 mu atm in the laboratory. Our study highlighted a direct pCO(2) effect on coralline algae and on sea urchin defense from predation (test robustness). There was no direct effect on the non-calcifying macroalgae. More interestingly, we highlighted diet-mediated effects on test robustness and on the Aristotle's lantern size. In a future scenario of ocean acidification a decrease of sea urchins' density is expected, due to lower defense from predation, as a direct consequence of pH decrease, and to a reduced availability of calcifying macroalgae, important component of urchins' diet. The effects of ocean acidification may therefore be contrasting on well vegetated macroalgal assemblages and barren grounds: in the absence of other human impacts, a decrease of biodiversity can be predicted in vegetated macroalgal assemblages, whereas a lower density of sea urchin could help the recovery of shallow subtidal rocky areas affected by overfishing from barren grounds to assemblages dominated by fleshy macroalgae.	[Asnaghi, Valentina; Chiantore, Mariachiara] DiSTAV Univ Genoa, Genoa, Italy; [Asnaghi, Valentina; Mangialajo, Luisa; Francour, Patrice] Univ Nice Sophia Antipolis, EA ECOMERS 4228, Nice, France; [Gazeau, Frederic; Alliouane, Samir; Gattuso, Jean-Pierre] CNRS INSU, Lab Oceanog Villefranche, Villefranche Sur Mer, France; [Gazeau, Frederic; Alliouane, Samir; Gattuso, Jean-Pierre] Univ Paris 06, Observ Oceanol Villefranche, Villefranche Sur Mer, France	UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite	Asnaghi, V (corresponding author), DiSTAV Univ Genoa, Genoa, Italy.	valentina.asnaghi@unige.it	Gattuso, Jean-Pierre/E-6631-2010; Asnaghi, Valentina/AFT-8900-2022; Gazeau, Frédéric/G-3050-2011; Gattuso, Jean-Pierre/AAG-8643-2019; Chiantore, Mariachiara/C-7070-2017	Gattuso, Jean-Pierre/0000-0002-4533-4114; Gazeau, Frédéric/0000-0001-8807-4597; Gattuso, Jean-Pierre/0000-0002-4533-4114; Mangialajo, Luisa/0000-0002-0225-8625; Chiantore, Mariachiara/0000-0002-5862-1470; Francour, Patrice/0000-0002-8489-1319; Asnaghi, Valentina/0000-0003-1659-2613	European Community [211384, 222492]; "Mediterranean Sea Acidification under a changing climate" project (MedSeA) [265103]; Universita Italo-francese	European Community(European Commission); "Mediterranean Sea Acidification under a changing climate" project (MedSeA); Universita Italo-francese	This work is a contribution to the "European Project on Ocean Acidification" (EPOCA) which received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement no 211384 and to the "Mediterranean Sea Acidification under a changing climate" project (MedSeA) under grant agreement no 265103. VA mobility was funded by "Universita Italo-francese" (Bando Vinci 2010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Sea urchin juveniles were reared in the CNR-IBF marine facility in Camogli (Italy), in the framework of the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement no 222492 project (ENRICH); authors are thankful to Davide Privitera and Enrico Cantamessa for the sea urchins juveniles rearing and to Laura Negretti for the SEM images. Authors are particularly thankful to the Academic Editor, Tasman Crowe, and also to the anonymous reviewers, for their accurate review of the manuscript and precious suggestions for its improvement.	Airoldi L, 2003, OCEANOGR MAR BIOL, V41, P161; Andersson A. J., 2011, OCEAN ACIDIFICATION, P122; Anthony KRN, 2008, P NATL ACAD SCI USA, V105, P17442, DOI 10.1073/pnas.0804478105; Arenas F, 2006, ECOLOGY, V87, P2851, DOI 10.1890/0012-9658(2006)87[2851:TIOMAA]2.0.CO;2; Asnaghi V, 2009, MAR ECOL-EVOL PERSP, V30, P505, DOI 10.1111/j.1439-0485.2009.00346.x; Ballesteros E, 2007, MAR POLLUT BULL, V55, P172, DOI 10.1016/j.marpolbul.2006.08.038; Barry B, 2010, GUIDE BEST PRACTICES, P53; Beardall J, 1998, BOT MAR, V41, P113, DOI 10.1515/botm.1998.41.1-6.113; BOROWITZKA MA, 1987, CRIT REV PLANT SCI, V6, P1, DOI 10.1080/07352688709382246; Browman Howard I., 2008, Marine Ecology Progress Series, V373, P199, DOI 10.3354/meps07868; Budenbender J, 2011, MAR ECOL PROG SER, V441, P79, DOI 10.3354/meps09405; Bulleri F, 2009, OIKOS, V118, P269, DOI 10.1111/j.1600-0706.2008.16955.x; Bulleri F, 2002, MAR ECOL PROG SER, V243, P101, DOI 10.3354/meps243101; Byrne M, 2011, P ROY SOC B-BIOL SCI, V278, P2376, DOI 10.1098/rspb.2010.2404; CARNEVALI MDC, 1991, B ZOOL, V58, P1, DOI 10.1080/11250009109355726; Coleman MA, 2003, J EXP MAR BIOL ECOL, V282, P67, DOI 10.1016/S0022-0981(02)00442-2; Coma R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022017; Connell SD, 2005, MAR ECOL PROG SER, V289, P53, DOI 10.3354/meps289053; Connell SD, 2010, P ROY SOC B-BIOL SCI, V277, P1409, DOI 10.1098/rspb.2009.2069; Cornwall CE, 2012, J PHYCOL, V48, P137, DOI 10.1111/j.1529-8817.2011.01085.x; De Beer D, 2001, PLANT CELL ENVIRON, V24, P1209, DOI 10.1046/j.1365-3040.2001.00772.x; Diaz-Pulido G, 2011, ECOL LETT, V14, P156, DOI 10.1111/j.1461-0248.2010.01565.x; Dickson A. G., 2007, PICES SPECIAL PUBLIC, DOI DOI 10.1159/000331784; Dupont S, 2010, ECOTOXICOLOGY, V19, P449, DOI 10.1007/s10646-010-0463-6; EBERT TA, 1980, B MAR SCI, V30, P467; Falkenberg L, 2012, OECOLOGIA, P1; Falkenberg LJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033841; GAO K, 1993, MAR BIOL, V117, P129, DOI 10.1007/BF00346434; GAO K, 1991, J APPL PHYCOL, V3, P355, DOI 10.1007/BF00026098; Gattuso J.-P., 2011, OCEAN ACIDIFICATION, P1; Gattuso JP, 1999, AM ZOOL, V39, P160; Guidetti P, 2007, MAR ENVIRON RES, V63, P168, DOI 10.1016/j.marenvres.2006.08.002; Guidetti P, 2005, MAR BIOL, V147, P797, DOI 10.1007/s00227-005-1611-z; Hall-Spencer JM, 2008, NATURE, V454, P96, DOI 10.1038/nature07051; Halpern BS, 2008, OCEAN COAST MANAGE, V51, P203, DOI 10.1016/j.ocecoaman.2007.08.002; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Hurd CL, 2009, J PHYCOL, V45, P1236, DOI 10.1111/j.1529-8817.2009.00768.x; Johnson VR, 2012, GLOBAL CHANGE BIOL, V18, P2792, DOI 10.1111/j.1365-2486.2012.02716.x; Jokiel PL, 2008, CORAL REEFS, V27, P473, DOI 10.1007/s00338-008-0380-9; Keeling C. D., 2009, ATMOSPHERIC CO2 RECO; Kleypas J. A., 2006, CORAL REEFS CLIMATE, V61, P73, DOI DOI 10.1029/61CE06; Kroeker KJ, 2011, P NATL ACAD SCI USA, V108, P14515, DOI 10.1073/pnas.1107789108; Kroeker KJ, 2010, ECOL LETT, V13, P1419, DOI 10.1111/j.1461-0248.2010.01518.x; Kubler JE, 1999, PLANT CELL ENVIRON, V22, P1303, DOI 10.1046/j.1365-3040.1999.00492.x; Kuffner IB, 2008, NAT GEOSCI, V1, P114, DOI 10.1038/ngeo100; Kurihara H, 2004, MAR ECOL PROG SER, V274, P161, DOI 10.3354/meps274161; Kurihara H, 2008, MAR ECOL PROG SER, V373, P275, DOI 10.3354/meps07802; Lavigne H., 2010, SEACARB SEAWATER CAR; Levitan DR, 2007, EVOLUTION, V61, P2007, DOI 10.1111/j.1558-5646.2007.00150.x; LEVITAN DR, 1991, MAR BIOL, V111, P431, DOI 10.1007/BF01319415; Maggi E, 2011, ECOLOGY, V92, P1399, DOI 10.1890/10-1323.1; Mangialajo L, 2008, MAR ECOL PROG SER, V358, P63, DOI 10.3354/meps07400; Mangialajo L, 2007, MAR POLLUT BULL, V55, P30, DOI 10.1016/j.marpolbul.2006.08.022; Martin S, 2011, J EXP BIOL, V214, P1357, DOI 10.1242/jeb.051169; Martin S, 2009, GLOBAL CHANGE BIOL, V15, P2089, DOI 10.1111/j.1365-2486.2009.01874.x; Miles H, 2007, MAR POLLUT BULL, V54, P89, DOI 10.1016/j.marpolbul.2006.09.021; Moulin L, 2011, MAR POLLUT BULL, V62, P48, DOI 10.1016/j.marpolbul.2010.09.012; Nelson WA, 2009, MAR FRESHWATER RES, V60, P787, DOI 10.1071/MF08335; Nisumaa A.-M., 2010, EARTH SYSTEM SCI DAT, V3, P109; O'Donnell MJ, 2010, MAR ECOL PROG SER, V398, P157, DOI 10.3354/meps08346; Orr J.C., 2011, OCEAN ACIDIFICATION, V1, P41; Portner H. O., 2011, OCEAN ACIDIFICATION; Porzio L, 2011, J EXP MAR BIOL ECOL, V400, P278, DOI 10.1016/j.jembe.2011.02.011; Ragazzola F, 2012, GLOBAL CHANGE BIOL, V18, P2804, DOI 10.1111/j.1365-2486.2012.02756.x; Ruitton S, 2000, ESTUAR COAST SHELF S, V50, P217, DOI 10.1006/ecss.1999.0546; Russell BD, 2009, GLOBAL CHANGE BIOL, V15, P2153, DOI 10.1111/j.1365-2486.2009.01886.x; Russell BD, 2012, MAR BIOL, P1; Sala E, 1998, OIKOS, V82, P425, DOI 10.2307/3546364; Sala E, 1997, MAR BIOL, V129, P531, DOI 10.1007/s002270050194; Sala E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032742; Semesi IS, 2009, ESTUAR COAST SHELF S, V84, P337, DOI 10.1016/j.ecss.2009.03.038; Shirayama Y, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002618; SMITH AD, 1979, MAR BIOL, V52, P217, DOI 10.1007/BF00398135; Solomon S., 2007, CLIMATE CHANGE 2007; STRATHMANN RR, 1981, PALEOBIOLOGY, V7, P400, DOI 10.1017/S0094837300004693; Stumpp M, 2011, COMP BIOCHEM PHYS A, V160, P320, DOI 10.1016/j.cbpa.2011.06.023; Stumpp M, 2011, COMP BIOCHEM PHYS A, V160, P331, DOI 10.1016/j.cbpa.2011.06.022; Widdicombe S, 2008, J EXP MAR BIOL ECOL, V366, P187, DOI 10.1016/j.jembe.2008.07.024; Wootton JT, 2008, P NATL ACAD SCI USA, V105, P18848, DOI 10.1073/pnas.0810079105; Zou DH, 2005, AQUACULTURE, V250, P726, DOI 10.1016/j.aquaculture.2005.05.014; Zou DH, 2009, PHYCOLOGIA, V48, P510, DOI 10.2216/08-99.1	81	58	58	1	189	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2013	8	4							e61978	10.1371/journal.pone.0061978	http://dx.doi.org/10.1371/journal.pone.0061978			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130DR	23613994	Green Published, Green Submitted, gold			2022-12-25	WOS:000317893400137
J	Jaquiery, AL; Oliver, MH; Landon-Lane, N; Matthews, SJ; Harding, JE; Bloomfield, FH				Jaquiery, Anne L.; Oliver, Mark H.; Landon-Lane, Nina; Matthews, Samuel J.; Harding, Jane E.; Bloomfield, Frank H.			Unpredictable Feeding Impairs Glucose Tolerance in Growing Lambs	PLOS ONE			English	Article							INSULIN SENSITIVITY; PERICONCEPTIONAL UNDERNUTRITION; CIRCADIAN OSCILLATORS; GROWTH-HORMONE; PLASMA-INSULIN; FOOD SECURITY; RESPONSES; CORTISOL; OBESITY; MEALS	Irregular eating is associated with insulin resistance and metabolic disease in adults but may affect young, growing children differently. We investigated the metabolic effects of unpredictable feeding in female juvenile lambs randomly assigned to receive, for six weeks, maintenance feed given twice daily in equal portions (Control Group, C; n = 24) or the same weekly feed amount in aliquots of variable size at unpredictable times (Unpredictable Group, U; n = 21). Intravenous glucose tolerance tests (IVGTT), insulin tolerance tests (ITT), and measurement of diurnal plasma cortisol concentrations were performed pre and post the dietary intervention. Groups were compared using t test and RM ANOVA. Weight gain was similar in both groups (C 18+/-2%; U 16+/-2% of initial body weight). Glucose area under the curve (AUC) was unchanged in C (AUC pre 818+/-34, post 801+/-33 mmol.min.l(-1)), but increased by 20% in U (pre 830+/-25, post 1010+/-19 mmol.min.l(-1); p<0.0001), with an inadequate insulin response to glucose load (log(AUC insulin first 40 minutes) post intervention C 1.49+/-0.04 vs U 1.36+/-0.04 ng.min.ml(-1); p = 0.03). Insulin tolerance and diurnal variation of plasma cortisol concentrations were not different between groups. Unpredictable feeding impairs insulin response to glucose in growing lambs despite high quality food and normal weight gain. Irregular eating warrants investigation as a potentially remediable risk factor for disordered glucose metabolism.	[Jaquiery, Anne L.; Oliver, Mark H.; Landon-Lane, Nina; Matthews, Samuel J.; Harding, Jane E.; Bloomfield, Frank H.] Univ Auckland, Liggins Inst, Auckland 1, New Zealand; [Jaquiery, Anne L.] Univ Auckland, Waikato Clin Sch, Hamilton, New Zealand; [Bloomfield, Frank H.] Univ Auckland, Dept Paediat Child & Youth Hlth, Auckland 1, New Zealand; [Jaquiery, Anne L.; Oliver, Mark H.; Bloomfield, Frank H.] Liggins Inst, Gravida Natl Ctr Growth & Dev, Auckland, New Zealand	University of Auckland; University of Auckland; University of Auckland; University of Auckland	Jaquiery, AL (corresponding author), Univ Auckland, Liggins Inst, Auckland 1, New Zealand.	a.jaquiery@auckland.ac.nz	Harding, Jane E/J-5853-2015	Harding, Jane E/0000-0003-2697-1422; Oliver, Mark/0000-0002-0359-2297; Bloomfield, Frank/0000-0001-6424-6577	Health Research Council of NZ; National Research Centre for Growth and Development; University of Auckland	Health Research Council of NZ(Health Research Council of New Zealand); National Research Centre for Growth and Development; University of Auckland	Funding support for this study was contributed to by the Health Research Council of NZ (www.hrc.govt.nz); the National Research Centre for Growth and Development (www.nrcgd.org.nz); and the University of Auckland summer student scheme (www.auckland.ac.nz). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BASSETT JM, 1974, AUST J BIOL SCI, V27, P167, DOI 10.1071/BI9740167; Bertram R, 2007, AM J PHYSIOL-ENDOC M, V293, pE890, DOI 10.1152/ajpendo.00359.2007; Buxton OM, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003200; Buxton OM, 2010, DIABETES, V59, P2126, DOI 10.2337/db09-0699; Castillo MR, 2004, AM J PHYSIOL-REG I, V287, pR551, DOI 10.1152/ajpregu.00247.2004; CHALLIS JRG, 1989, ENDOCR REV, V10, P182, DOI 10.1210/edrv-10-2-182; Clarke SD, 2012, AM J PHYSIOL-REG I, V303, pR1071, DOI 10.1152/ajpregu.00036.2012; Cobelli C, 2007, AM J PHYSIOL-ENDOC M, V293, pE1, DOI 10.1152/ajpendo.00421.2006; Dallman MF, 2004, ENDOCRINOLOGY, V145, P2633, DOI 10.1210/en.2004-0037; Damiola F, 2000, GENE DEV, V14, P2950, DOI 10.1101/gad.183500; Drummond S, 1996, EUR J CLIN NUTR, V50, P779; Farshchi HR, 2004, EUR J CLIN NUTR, V58, P1071, DOI 10.1038/sj.ejcn.1601935; Froy O, 2007, FRONT NEUROENDOCRIN, V28, P61, DOI 10.1016/j.yfrne.2007.03.001; Gatenby SJ, 1997, BRIT J NUTR, V77, pS7, DOI 10.1079/BJN19970100; Gatford KL, 2004, AM J PHYSIOL-ENDOC M, V286, pE1050, DOI 10.1152/ajpendo.00340.2003; Gonzalez LA, 2009, J ANIM SCI, V87, P2709, DOI 10.2527/jas.2008-1709; Gross RS, 2012, PEDIATRICS, V130, P254, DOI 10.1542/peds.2011-3588; Heart E, 2007, AM J PHYSIOL-ENDOC M, V292, pE1295, DOI 10.1152/ajpendo.00648.2006; HEITMANN RN, 1987, J NUTR, V117, P1174, DOI 10.1093/jn/117.6.1174; Henry BA, 2003, J NEUROENDOCRINOL, V15, P697, DOI 10.1046/j.1365-2826.2003.01049.x; Herath CB, 1999, EXP PHYSIOL, V84, P559, DOI 10.1017/S0958067099018722; HONMA KI, 1983, AM J PHYSIOL, V245, pR339, DOI 10.1152/ajpregu.1983.245.3.R339; Jaquiery AL, 2006, J PHYSIOL-LONDON, V572, P109, DOI 10.1113/jphysiol.2006.105734; Jaquiery AL, 2009, OBSTET GYNECOL, V114, P869, DOI 10.1097/AOG.0b013e3181b8fb86; Keski-Rahkonen A, 2003, EUR J CLIN NUTR, V57, P842, DOI 10.1038/sj.ejcn.1601618; Koopmans SJ, 2005, PHYSIOL BEHAV, V84, P497, DOI 10.1016/j.physbeh.2005.01.017; Oliver MH, 2005, PEDIATR RES, V57, P591, DOI 10.1203/01.PDR.0000155942.18096.9C; Oliver MH, 2002, PEDIATR RES, V52, P516, DOI [10.1203/01.PDR.0000028852.63989.11, 10.1203/00006450-200210000-00010]; OLIVER MH, 1993, PEDIATR RES, V34, P62, DOI 10.1203/00006450-199307000-00015; Parnell WR, 2001, NEW ZEAL MED J, V114, P141; Rush E, 2007, ASIA PAC J CLIN NUTR, V16, P448; Scheer FAJL, 2009, P NATL ACAD SCI USA, V106, P4453, DOI 10.1073/pnas.0808180106; Schibler U, 2003, J BIOL RHYTHM, V18, P250, DOI 10.1177/0748730403018003007; Sierra-Johnson J, 2008, OBESITY, V16, P1302, DOI 10.1038/oby.2008.203; Smith KJ, 2010, AM J CLIN NUTR, V92, P1316, DOI 10.3945/ajcn.2010.30101; Stevens A, 2010, ENDOCRINOLOGY, V151, P3652, DOI 10.1210/en.2010-0094; Taylor E, 2004, AM J HEALTH BEHAV, V28, P242, DOI 10.5993/AJHB.28.3.5; Toda Masahiro, 2004, Environ Health Prev Med, V9, P27, DOI 10.1265/ehpm.9.27; VANCAUTER E, 1994, J CLIN ENDOCR METAB, V79, P1797, DOI 10.1210/jc.79.6.1797; VANCAUTER E, 1992, AM J PHYSIOL, V262, pE467, DOI 10.1152/ajpendo.1992.262.4.E467; Vidarsdottir S, 2007, DIABETES, V56, P2547, DOI 10.2337/db07-0193; Yayou K, 2009, J VET MED SCI, V71, P431, DOI 10.1292/jvms.71.431	42	4	4	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2013	8	4							e61040	10.1371/journal.pone.0061040	http://dx.doi.org/10.1371/journal.pone.0061040			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130DR	23613779	Green Submitted, Green Published, gold			2022-12-25	WOS:000317893400037
J	Rinnenthal, JL; Bornchen, C; Radbruch, H; Andresen, V; Mossakowski, A; Siffrin, V; Seelemann, T; Spiecker, H; Moll, I; Herz, J; Hauser, AE; Zipp, F; Behne, MJ; Niesner, R				Rinnenthal, Jan Leo; Boernchen, Christian; Radbruch, Helena; Andresen, Volker; Mossakowski, Agata; Siffrin, Volker; Seelemann, Thomas; Spiecker, Heinrich; Moll, Ingrid; Herz, Josephine; Hauser, Anja E.; Zipp, Frauke; Behne, Martin J.; Niesner, Raluca			Parallelized TCSPC for Dynamic Intravital Fluorescence Lifetime Imaging: Quantifying Neuronal Dysfunction in Neuroinflammation	PLOS ONE			English	Article							RESONANCE ENERGY-TRANSFER; SINGLE DENDRITIC SPINES; 2-PHOTON MICROSCOPY; CELL INVASION; DEEP TISSUE; TIME-DOMAIN; TROPONIN-C; FRET; PHOTON; LOCALIZATION	Two-photon laser-scanning microscopy has revolutionized our view on vital processes by revealing motility and interaction patterns of various cell subsets in hardly accessible organs (e.g. brain) in living animals. However, current technology is still insufficient to elucidate the mechanisms of organ dysfunction as a prerequisite for developing new therapeutic strategies, since it renders only sparse information about the molecular basis of cellular response within tissues in health and disease. In the context of imaging, Forster resonant energy transfer (FRET) is one of the most adequate tools to probe molecular mechanisms of cell function. As a calibration-free technique, fluorescence lifetime imaging (FLIM) is superior for quantifying FRET in vivo. Currently, its main limitation is the acquisition speed in the context of deep-tissue 3D and 4D imaging. Here we present a parallelized time-correlated single-photon counting point detector (p-TCSPC) (i) for dynamic single-beam scanning FLIM of large 3D areas on the range of hundreds of milliseconds relevant in the context of immune-induced pathologies as well as (ii) for ultrafast 2D FLIM in the range of tens of milliseconds, a scale relevant for cell physiology. We demonstrate its power in dynamic deep-tissue intravital imaging, as compared to multi-beam scanning time-gated FLIM suitable for fast data acquisition and compared to highly sensitive single-channel TCSPC adequate to detect low fluorescence signals. Using p-TCSPC, 256 x 256 pixel FLIM maps (300 x 300 mu m(2)) are acquired within 468 ms while 131 x 131 pixel FLIM maps (75 x 75 mu m(2)) can be acquired every 82 ms in 115 mu m depth in the spinal cord of CerTN L15 mice. The CerTN L15 mice express a FRET-based Ca-biosensor in certain neuronal subsets. Our new technology allows us to perform time-lapse 3D intravital FLIM (4D FLIM) in the brain stem of CerTN L15 mice affected by experimental autoimmune encephalomyelitis and, thereby, to truly quantify neuronal dysfunction in neuroinflammation.	[Rinnenthal, Jan Leo; Mossakowski, Agata; Hauser, Anja E.; Niesner, Raluca] German Rheumatism Res Ctr, Berlin, Germany; [Radbruch, Helena; Siffrin, Volker; Herz, Josephine; Zipp, Frauke; Niesner, Raluca] Max Delbruck Ctr Mol Med, Berlin, Germany; [Boernchen, Christian; Moll, Ingrid; Behne, Martin J.] Univ Med Ctr Hamburg Eppendorf, Dept Dermatol & Venerol, Hamburg, Germany; [Rinnenthal, Jan Leo; Radbruch, Helena; Mossakowski, Agata; Herz, Josephine; Hauser, Anja E.; Niesner, Raluca] Charite, D-13353 Berlin, Germany; [Andresen, Volker; Spiecker, Heinrich] LaVis Biotec GmbH, Bielefeld, Germany; [Seelemann, Thomas] LaVis, Gottingen, Germany; [Andresen, Volker; Zipp, Frauke] Johannes Gutenberg Univ Mainz, Dept Neurol, D-55122 Mainz, Germany	Deutsches Rheuma-Forschungszentrum (DRFZ); Helmholtz Association; Max Delbruck Center for Molecular Medicine; University of Hamburg; University Medical Center Hamburg-Eppendorf; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Johannes Gutenberg University of Mainz	Niesner, R (corresponding author), German Rheumatism Res Ctr, Berlin, Germany.	niesner@drfz.de	Siffrin, Volker/AAR-3632-2021; Zipp, Frauke/C-9968-2015	Zipp, Frauke/0000-0002-1231-1928; Siffrin, Volker/0000-0002-1532-2868; Hauser, Anja Erika/0000-0002-7725-9526; Mossakowski, Agata/0000-0001-5792-4501; Andresen, Volker/0000-0002-8960-6599; Radbruch, Helena/0000-0001-6941-3397	Deutsche Forschungsgemeinschaft [NI 1167/2-1, SFB-TRR 43]; Berlin-Brandenburg School for Regenerative Therapies [GSC 203]; Charite - University Hospital, Berlin under grant Rahel-Hirsch fellowship; Marie-Curie grant [MC-IRG 6675]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Berlin-Brandenburg School for Regenerative Therapies; Charite - University Hospital, Berlin under grant Rahel-Hirsch fellowship; Marie-Curie grant(European Commission)	The authors acknowledge the Deutsche Forschungsgemeinschaft under grant NI 1167/2-1 to RN and SFB-TRR 43 to FZ, the Berlin-Brandenburg School for Regenerative Therapies GSC 203 for HR and the Charite - University Hospital, Berlin under grant Rahel-Hirsch fellowship for RN for financial support. This work was partially funded through a Marie-Curie grant (MC-IRG 6675 to MB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andresen V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050915; Bajenoff M, 2007, TRENDS IMMUNOL, V28, P346, DOI 10.1016/j.it.2007.06.005; Bakker GJ, 2012, METHOD ENZYMOL, V504, P109, DOI 10.1016/B978-0-12-391857-4.00005-7; Becker W, 2006, MICROSC RES TECHNIQ, V69, P186, DOI 10.1002/jemt.20251; Becker W, 2004, MICROSC RES TECHNIQ, V63, P58, DOI 10.1002/jemt.10421; Behne MJ, 2011, ARCH DERMATOL RES, V303, P103, DOI 10.1007/s00403-010-1113-9; Breart B, 2008, J CLIN INVEST, V118, P1390, DOI 10.1172/JCI34388; Caccia M, 2008, EUR BIOPHYS J BIOPHY, V37, P979, DOI 10.1007/s00249-008-0323-y; Cahalan MD, 2008, ANNU REV IMMUNOL, V26, P585, DOI 10.1146/annurev.immunol.24.021605.090620; Celli A, 2010, BIOPHYS J, V98, P911, DOI 10.1016/j.bpj.2009.10.055; Chen Y, 2003, DIFFERENTIATION, V71, P528, DOI 10.1111/j.1432-0436.2003.07109007.x; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Digman MA, 2008, BIOPHYS J, V94, pL14, DOI 10.1529/biophysj.107.120154; Ducros M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004418; Elangovan M, 2003, METHODS, V29, P58, DOI 10.1016/S1046-2023(02)00283-9; Elson D, 2004, PHOTOCH PHOTOBIO SCI, V3, P795, DOI 10.1039/b316456j; Fruhwirth GO, 2011, CHEMPHYSCHEM, V12, P442, DOI 10.1002/cphc.201000866; Geiger A, 2012, BIOPHYS J, V102, P2401, DOI 10.1016/j.bpj.2012.03.065; Gratton E, 2003, J BIOMED OPT, V8, P381, DOI 10.1117/1.1586704; Gu M, 2000, ADV OPTICAL IMAGING; Hanson KM, 2002, BIOPHYS J, V83, P1682, DOI 10.1016/S0006-3495(02)73936-2; Hauser AE, 2007, IMMUNITY, V26, P655, DOI 10.1016/j.immuni.2007.04.008; Heim N, 2004, J BIOL CHEM, V279, P14280, DOI 10.1074/jbc.M312751200; Heim N, 2007, NAT METHODS, V4, P127, DOI 10.1038/nmeth1009; Helmchen F, 2005, NAT METHODS, V2, P932, DOI 10.1038/NMETH818; Herz J, 2010, BIOPHYS J, V98, P715, DOI 10.1016/j.bpj.2009.10.035; Hoffmann B, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2937829; Hopt A, 2001, BIOPHYS J, V80, P2029, DOI 10.1016/S0006-3495(01)76173-5; Jares-Erijman EA, 2003, NAT BIOTECHNOL, V21, P1387, DOI 10.1038/nbt896; Jo JA, 2004, P ANN INT IEEE EMBS, V26, P1271; Krishnan RV, 2003, J BIOMED OPT, V8, P362, DOI 10.1117/1.1577574; Kumar S, 2007, OPT EXPRESS, V15, P12548, DOI 10.1364/OE.15.012548; Lee KCB, 2001, BIOPHYS J, V81, P1265, DOI 10.1016/S0006-3495(01)75784-0; Lee SJR, 2009, NATURE, V458, P299, DOI 10.1038/nature07842; Levitt JA, 2009, CURR OPIN BIOTECH, V20, P28, DOI 10.1016/j.copbio.2009.01.004; Magde D, 2002, PHOTOCHEM PHOTOBIOL, V75, P327, DOI 10.1562/0031-8655(2002)075<0327:FQYATR>2.0.CO;2; Magde D, 1999, PHOTOCHEM PHOTOBIOL, V70, P737, DOI 10.1111/j.1751-1097.1999.tb08277.x; McGinty J, 2009, OPT LETT, V34, P2772, DOI 10.1364/OL.34.002772; Murakoshi H, 2008, BRAIN CELL BIOL, V36, P31, DOI 10.1007/s11068-008-9024-9; Niesner R, 2007, BIOPHYS J, V93, P2519, DOI 10.1529/biophysj.106.102459; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Nitsch R, 2000, LANCET, V356, P827, DOI 10.1016/S0140-6736(00)02659-3; Periasamy A, 2001, J BIOMED OPT, V6, P287, DOI 10.1117/1.1383063; Peter M, 2005, BIOPHYS J, V88, P1224, DOI 10.1529/biophysj.104.050153; Roszik J, 2009, CYTOM PART A, V75A, P761, DOI 10.1002/cyto.a.20747; Siffrin V, 2010, IMMUNITY, V33, P424, DOI 10.1016/j.immuni.2010.08.018; Soloviev VY, 2007, APPL OPTICS, V46, P7384, DOI 10.1364/AO.46.007384; STRICKLER SJ, 1962, J CHEM PHYS, V37, P814, DOI 10.1063/1.1733166; Timpson P, 2011, CANCER RES, V71, P747, DOI 10.1158/0008-5472.CAN-10-2267; Tsien R. Y, 2009, COLD SPRING HARB PRO, V2009, DOI 10.1101/PDB.TOP57,pdb.top57; Vitali M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015820; Wahl M, 2008, REV SCI INSTRUM, V79, DOI 10.1063/1.3055912; Zipfel Warren R., 2003, Nature Biotechnology, V21, P1369, DOI 10.1038/nbt899	53	57	57	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2013	8	4							e60100	10.1371/journal.pone.0060100	http://dx.doi.org/10.1371/journal.pone.0060100			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130DR	23613717	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000317893400005
J	Wu, R; Wang, XR; Lin, Y; Ma, YQ; Liu, G; Yu, XM; Zhong, SL; Liu, B				Wu, Rui; Wang, Xiaoran; Lin, Yan; Ma, Yiqiao; Liu, Gang; Yu, Xiaoming; Zhong, Silin; Liu, Bao			Inter-Species Grafting Caused Extensive and Heritable Alterations of DNA Methylation in Solanaceae Plants	PLOS ONE			English	Article							RNA; ROOTSTOCK; MOBILE; DRM; METHYLTRANSFERASES; INHERITANCE; MOVEMENT; PATTERNS	Background: Grafting has been extensively used to enhance the performance of horticultural crops. Since Charles Darwin coined the term "graft hybrid" meaning that asexual combination of different plant species may generate products that are genetically distinct, highly discrepant opinions exist supporting or against the concept. Recent studies have documented that grafting enables exchanges of both RNA and DNA molecules between the grafting partners, thus providing a molecular basis for grafting-induced genetic variation. DNA methylation is known as prone to alterations as a result of perturbation of internal and external conditions. Given characteristics of grafting, it is interesting to test whether the process may cause an alteration of this epigenetic marker in the grafted organismal products. Methodology/Principal Findings: We analyzed relative global DNA methylation levels and locus-specific methylation patterns by the MSAP marker and locus-specific bisulfite-sequencing in the seed plants (wild-type controls), self-and hetero-grafted scions/rootstocks, selfed progenies of scions and their seed-plant controls, involving three Solanaceae species. We quantified expression of putative genes involved in establishing and/or maintaining DNA methylation by q-(RT)-PCR. We found that (1) hetero-grafting caused extensive alteration of DNA methylation patterns in a locus-specific manner, especially in scions, although relative methylation levels remain largely unaltered; (2) the altered methylation patterns in the hetero-grafting-derived scions could be inherited to sexual progenies with some sites showing further alterations or revisions; (3) hetero-grafting caused dynamic changes in steady-state transcript abundance of genes encoding for a set of enzymes functionally relevant to DNA methylation. Conclusions/Significance: Our results demonstrate that inter-species grafting in plants could produce extensive and heritable alterations in DNA methylation. We suggest that these readily altered, yet heritable, epigenetic modifications due to interspecies hetero-grafting may shed one facet of insight into the molecular underpinnings for the still contentious concept of graft hybrid.	[Wu, Rui; Wang, Xiaoran; Liu, Gang; Yu, Xiaoming; Zhong, Silin; Liu, Bao] NE Normal Univ, Minist Educ MOE, Key Lab Mol Epigenet, Changchun, Jilin Province, Peoples R China; [Lin, Yan; Ma, Yiqiao] Jilin Acad Vegetables & Flowers, Changchun Changchun, Jilin Province, Peoples R China; [Wu, Rui] Carnegie Inst Sci, Dept Plant Biol, Stanford, CA 94305 USA; [Zhong, Silin] Cornell Univ, Boyce Thompson Inst Plant Res, Ithaca, NY 14853 USA	Northeast Normal University - China; Carnegie Institution for Science; Cornell University; Boyce Thompson Institute for Plant Research	Zhong, SL (corresponding author), NE Normal Univ, Minist Educ MOE, Key Lab Mol Epigenet, Changchun, Jilin Province, Peoples R China.	silin.zhong@googlemail.com; baoliu@nenu.edu.cn	zhong, silin/O-7029-2015; Yu, Xiaomi ng/GXN-0004-2022	zhong, silin/0000-0002-0198-7383; Yu, Xiaomi ng/0000-0003-1564-4549; zakaria, seyed moein/0000-0002-0086-1279; Liu, Bao/0000-0001-5481-1675	National Natural Science Foundation of China [30900783]; Programme for Introducing Talents to Universities [B07017]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Programme for Introducing Talents to Universities	This work was supported by the National Natural Science Foundation of China (http://www.nsfc.gov.cn(#30900783) and the Programme for Introducing Talents to Universities (http://www.safea.gov.cn)(#B07017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albacete A, 2009, PLANT CELL ENVIRON, V32, P928, DOI 10.1111/j.1365-3040.2009.01973.x; Bai SL, 2011, J EXP BOT, V62, P4561, DOI 10.1093/jxb/err163; Buhtz A, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-64; Burge GK, 2002, PLANT CELL TISS ORG, V70, P13, DOI 10.1023/A:1016088621471; Cao XF, 2002, CURR BIOL, V12, P1138, DOI 10.1016/S0960-9822(02)00925-9; Cao XF, 2002, P NATL ACAD SCI USA, V99, P16491, DOI 10.1073/pnas.162371599; Cao XF, 2003, CURR BIOL, V13, P2212, DOI 10.1016/j.cub.2003.11.052; Chinnusamy V, 2009, CURR OPIN PLANT BIOL, V12, P133, DOI 10.1016/j.pbi.2008.12.006; Clearwater MJ, 2004, J EXP BOT, V55, P1371, DOI 10.1093/jxb/erh137; Darwin CR., 1868, VARIATION ANIMALS PL, DOI DOI 10.1371/journal.pbio.0040088; Dong ZY, 2006, THEOR APPL GENET, V113, P196, DOI 10.1007/s00122-006-0286-2; Dunoyer P, 2010, SCIENCE, V328, P912, DOI 10.1126/science.1185880; Feng SH, 2010, SCIENCE, V330, P622, DOI 10.1126/science.1190614; Gehring M, 2007, BBA-GENE STRUCT EXPR, V1769, P276, DOI 10.1016/j.bbaexp.2007.01.009; Haroldsen VM, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00039; Huang Y, 2013, SCI HORTIC-AMSTERDAM, V149, P80, DOI 10.1016/j.scienta.2012.02.009; Kidwell Kimberlee K., 1992, P1; Kim M, 2001, SCIENCE, V293, P287, DOI 10.1126/science.1059805; Kubota C, 2008, HORTSCIENCE, V43, P1664, DOI 10.21273/HORTSCI.43.6.1664; Liu YS, 2010, HEREDITY, V104, P1, DOI 10.1038/hdy.2009.115; Liu YS, 2006, ADV GENET, V56, P101, DOI 10.1016/S0065-2660(06)56003-1; Lucas WJ, 2001, NAT REV MOL CELL BIO, V2, P849, DOI 10.1038/35099096; Mahfouz MM, 2010, PLANT SIGNAL BEHAV, V5, P806, DOI 10.4161/psb.5.7.11695; Molnar A, 2010, SCIENCE, V328, P872, DOI 10.1126/science.1187959; Morales-Ruiz T, 2006, P NATL ACAD SCI USA, V103, P6853, DOI 10.1073/pnas.0601109103; Mudge K., 2009, Horticultural Reviews, V35, P437; Napoli C, 1996, PLANT PHYSIOL, V111, P27, DOI 10.1104/pp.111.1.27; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; ReynaLopez GE, 1997, MOL GEN GENET, V253, P703, DOI 10.1007/s004380050374; Rivero RM, 2003, J SCI FOOD AGR, V83, P1315, DOI 10.1002/jsfa.1541; Rouphael Y, 2010, SCI HORTIC-AMSTERDAM, V127, P172, DOI 10.1016/j.scienta.2010.09.001; Rusk N, 2009, NAT METHODS, V6, P484, DOI 10.1038/nmeth0709-484; Stegemann S, 2012, P NATL ACAD SCI USA, V109, P2434, DOI 10.1073/pnas.1114076109; Stegemann S, 2009, SCIENCE, V324, P649, DOI 10.1126/science.1170397; Taller J, 1998, THEOR APPL GENET, V97, P705, DOI 10.1007/s001220050946; Thyssen G, 2012, P NATL ACAD SCI USA, V109, P2439, DOI 10.1073/pnas.1114297109; Tsaballa A, 2012, SCI HORTICULTURAE; Tsaballa A, 2013, SCI HORTIC-AMSTERDAM, V149, P2, DOI 10.1016/j.scienta.2012.06.018; Venema JH, 2008, ENVIRON EXP BOT, V63, P359, DOI 10.1016/j.envexpbot.2007.12.015; Wang MB, 2001, RNA, V7, P16, DOI 10.1017/S1355838201001224; Wang Yan, 2011, Yichuan, V33, P585, DOI 10.3724/SP.J.1005.2011.00585; Yoo BC, 2004, PLANT CELL, V16, P1979, DOI 10.1105/tpc.104.023614; Zhang HM, 2011, CURR OPIN PLANT BIOL, V14, P142, DOI 10.1016/j.pbi.2011.02.003; Zhao XX, 2007, PLANT SCI, V172, P930, DOI 10.1016/j.plantsci.2007.01.002; Zhu JH, 2007, CURR BIOL, V17, P54, DOI 10.1016/j.cub.2006.10.059	45	75	85	3	103	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2013	8	4							e61995	10.1371/journal.pone.0061995	http://dx.doi.org/10.1371/journal.pone.0061995			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130DR	23614002	Green Submitted, Green Published, gold			2022-12-25	WOS:000317893400144
J	McWhorter, TJ; Pinshow, B; Karasov, WH; Tracy, CR				McWhorter, Todd J.; Pinshow, Berry; Karasov, William H.; Tracy, Christopher R.			Paracellular Absorption Is Relatively Low in the Herbivorous Egyptian Spiny-Tailed Lizard, Uromastyx aegyptia	PLOS ONE			English	Article							PASSIVE ABSORPTION; SMALL-INTESTINE; NUTRIENT ABSORPTION; TRANSPORT; GLUCOSE; THERMOREGULATION; DIGESTION; AGAMIDAE; SUGARS; BLOOD	mAbsorption of small water-soluble nutrients in vertebrate intestines occurs both by specific, mediated transport and by nonspecific, passive, paracellular transport. Although it is apparent that paracellular absorption represents a significant route for nutrient absorption in many birds and mammals, especially small, flying species, its importance in ectothermic vertebrates has not previously been explored. Therefore, we measured fractional absorption (e) and absorption rate of three paracellular probes (arabinose, L-rhamnose, cellobiose) and of 3-O-methyl D-glucose (absorbed by both mediated and paracellular pathways) by the large herbivorous lizard, Uromastyx aegyptia, to explore the relative importance of paracellular and mediated transport in an ectothermic, terrestrial vertebrate. Fractional absorption of 3-O-methyl D-glucose was high (e = 0.7360.04) and similar to other vertebrates; e of the paracellular probes was relatively low (arabinose e = 0.3160.03, Lrhamnose e = 0.1960.02, and cellobiose e = 0.146 +/- 0.02), and decreased with molecular mass, a pattern consistent with other vertebrates. Paracellular absorption accounted for approximately 24% of total 3-O-methyl D-glucose uptake, indicating low reliance on this pathway for these herbivorous lizards, a pattern similar to that found in other terrestrial vertebrates, and different from small flying endotherms (both birds and bats).	[McWhorter, Todd J.] Univ Adelaide, Sch Anim & Vet Sci, Adelaide, SA, Australia; [McWhorter, Todd J.; Karasov, William H.] Univ Wisconsin, Dept Forest & Wildlife Ecol, Madison, WI USA; [Pinshow, Berry; Tracy, Christopher R.] Ben Gurion Univ Negev, Mitrani Dept Desert Ecol, Jacob Blaustein Inst Desert Res, Midreshet Ben Gurion, Israel; [Tracy, Christopher R.] Charles Darwin Univ, Res Inst Environm & Livelihoods, Darwin, NT 0909, Australia; [Tracy, Christopher R.] Univ Melbourne, Dept Zool, Parkville, Vic 3052, Australia	University of Adelaide; University of Wisconsin System; University of Wisconsin Madison; Ben Gurion University; Charles Darwin University; University of Melbourne	Tracy, CR (corresponding author), Calif State Univ Fullerton, Dept Biol Sci, Fullerton, CA 92634 USA.	ctracy@fullerton.edu	McWhorter, Todd/E-5760-2017	McWhorter, Todd/0000-0002-4746-4975	National Science Foundation (USA) [IBN-0216709]; Australian Research Council [LP0882478]; Blaustein Center for Scientific Cooperation (CRT); Direct For Biological Sciences [1025886] Funding Source: National Science Foundation	National Science Foundation (USA)(National Science Foundation (NSF)); Australian Research Council(Australian Research Council); Blaustein Center for Scientific Cooperation (CRT); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Funding for this project was provided by the National Science Foundation (USA) (IBN-0216709 to WHK), the Australian Research Council (LP0882478 to CRT), and by a Blaustein post-doctoral fellowship from the Blaustein Center for Scientific Cooperation (CRT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOUSKILA A, 1985, ISRAEL J ZOOL, V33, P122; Caviedes-Vidal E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001425; Caviedes-Vidal E, 2007, P NATL ACAD SCI USA, V104, P19132, DOI 10.1073/pnas.0703159104; Chang MH, 2004, J EXP BIOL, V207, P3109, DOI 10.1242/jeb.01154; CHANG RLS, 1975, BIOPHYS J, V15, P861, DOI 10.1016/S0006-3495(75)85862-0; Chediack JG, 2006, J COMP PHYSIOL B, V176, P303, DOI 10.1007/s00360-005-0052-9; Chediack JG, 2003, J COMP PHYSIOL B, V173, P187, DOI 10.1007/s00360-002-0314-8; CHRISTIAN KA, 1984, HERPETOLOGICA, V40, P205; Cunningham Peter, 2000, Zoology in the Middle East, V21, P37; Cunningham Peter L., 2009, HERPETOZOA, V22, P91; DIAMOND J, 1991, NEWS PHYSIOL SCI, V6, P92, DOI 10.1152/physiologyonline.1991.6.2.92; DIAMOND JM, 1967, J GEN PHYSIOL, V50, P2061, DOI 10.1085/jgp.50.8.2061; Dzialowski EM, 2001, PHYSIOL BIOCHEM ZOOL, V74, P679, DOI 10.1086/322929; El-Toubi M. R., 1959, Bulletin of the Faculty of Science Cairo, VNo. 34, P13; FINE KD, 1993, GASTROENTEROLOGY, V105, P1117, DOI 10.1016/0016-5085(93)90957-E; FOLEY WJ, 1992, J ZOOL, V226, P387, DOI 10.1111/j.1469-7998.1992.tb07486.x; Friedman MH, 1987, PRINCIPLES AND MODEL; Galli G, 2004, J EXP BIOL, V207, P1471, DOI 10.1242/jeb.00912; GRIGG GC, 1976, PHYSIOL ZOOL, V49, P24, DOI 10.1086/physzool.49.1.30155674; Guard C.L., 1980, COMP PHYSL PRIMITIVE, P43; Hopfer U., 1987, PHYSL GASTROINTESTIN, P1499; IVERSON JB, 1980, J MORPHOL, V163, P79, DOI 10.1002/jmor.1051630110; Karasov W.H., 1990, Studies in Avian Biology, P391; KARASOV WH, 1986, J COMP PHYSIOL B, V156, P599, DOI 10.1007/BF00691047; Karasov WH., 1997, HDB COMP PHYSL, P409, DOI 10.1002/cphy.cp130107; Karasov WH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032417; Karasov WH, 2011, AM J PHYSIOL-REG I, V301, pR276, DOI 10.1152/ajpregu.00600.2010; Lane JS, 1999, AM J PHYSIOL-GASTR L, V276, pG789, DOI 10.1152/ajpgi.1999.276.3.G789; Lavin SR, 2007, J EXP BIOL, V210, P2754, DOI 10.1242/jeb.006114; LOO JCK, 1968, J PHARM SCI, V57, P918, DOI 10.1002/jps.2600570602; McWhorter TJ, 2007, AM J PRIMATOL, V69, P1399, DOI 10.1002/ajp.20443; MOTULSKY HJ, 1987, FASEB J, V1, P365, DOI 10.1096/fasebj.1.5.3315805; PAPPENHEIMER JR, 1993, AM J PHYSIOL, V265, pG409, DOI 10.1152/ajpgi.1993.265.3.G409; PAPPENHEIMER JR, 1987, J MEMBRANE BIOL, V100, P123, DOI 10.1007/BF02209145; Pencek RR, 2002, J NUTR, V132, P1929, DOI 10.1093/jn/132.7.1929; SCHWARTZ RM, 1995, GASTROENTEROLOGY, V109, P1206, DOI 10.1016/0016-5085(95)90580-4; Seebacher F, 2005, J COMP PHYSIOL B, V175, P533, DOI 10.1007/s00360-005-0007-1; Seebacher F, 2000, J THEOR BIOL, V203, P97, DOI 10.1006/jtbi.1999.1067; Sibly R.M., 1981, P109; Smith EN, 1978, AMERICAN JOURNAL OF, V4, pR160; SMULDERS AP, 1971, J MEMBRANE BIOL, V5, P297, DOI 10.1007/BF01957348; Sokal RR, 1995, BIOMETRY; Stevens CE, 1995, COMPARATIVE PHYSIOLO; THROCKMORTON G, 1973, COPEIA, P431; Tracy CR, 2007, J EXP BIOL, V210, P1726, DOI 10.1242/jeb.02766; TROYER K, 1984, PHYSIOL ZOOL, V57, P1; UHING MR, 1995, J CLIN INVEST, V95, P2799, DOI 10.1172/JCI117984; WAGNER JG, 1963, J PHARM SCI, V52, P610, DOI 10.1002/jps.2600520629; Warner A. C. I., 1981, Nutrition Abstracts and Reviews, B, V51, P789; WEATHERS WW, 1971, AM J PHYSIOL, V221, P704, DOI 10.1152/ajplegacy.1971.221.3.704; WELLING PG, 1986, PHARMACOKINETICS PRO; Wilms TM, 2011, J ARID ENVIRON, V75, P636, DOI 10.1016/j.jaridenv.2011.02.003; Wilms TM, 2010, SALAMANDRA, V46, P131; Wilms Thomas M., 2009, Bonner Zoologische Beitraege, V56, P55; Wilms TM, 2007, FAUNA ARAB SER, V23, P435	55	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2013	8	4							e61869	10.1371/journal.pone.0061869	http://dx.doi.org/10.1371/journal.pone.0061869			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125TD	23596529	gold, Green Published, Green Submitted			2022-12-25	WOS:000317563300042
J	Prohaszka, Z; Munthe-Fog, L; Ueland, T; Gombos, T; Yndestad, A; Forhecz, Z; Skjoedt, MO; Pozsonyi, Z; Gustavsen, A; Janoskuti, L; Karadi, I; Gullestad, L; Dahl, CP; Askevold, ET; Fust, G; Aukrust, P; Mollnes, TE; Garred, P				Prohaszka, Zoltan; Munthe-Fog, Lea; Ueland, Thor; Gombos, Timea; Yndestad, Arne; Foerhecz, Zsolt; Skjoedt, Mikkel-Ole; Pozsonyi, Zoltan; Gustavsen, Alice; Janoskuti, Livia; Karadi, Istvan; Gullestad, Lars; Dahl, Christen P.; Askevold, Erik T.; Fuest, George; Aukrust, Pal; Mollnes, Tom E.; Garred, Peter			Association of Ficolin-3 with Severity and Outcome of Chronic Heart Failure	PLOS ONE			English	Article							BINDING LECTIN ENGAGEMENT; NECROSIS-FACTOR-ALPHA; COMPLEMENT ACTIVATION; SERUM; POLYMORPHISM; MECHANISMS; EXPRESSION; CLEARANCE; PATHWAY; PROTEIN	Background: Inflammatory mechanisms involving complement activation has been shown to take part in the pathophysiology of congestive heart failure, but the initiating mechanisms are unknown. We hypothesized that the main initiator molecules of the lectin complement pathway mannose-binding lectin (MBL), ficolin-2 and ficolin-3 were related to disease severity and outcome in chronic heart failure. Methods and Results: MBL, ficolin-2 and ficolin-3 plasma concentrations were determined in two consecutive cohorts comprising 190 patients from Hungary and 183 patients from Norway as well as controls. Disease severity and clinical parameters were determined at baseline, and all-cause mortality was registered after 5-years follow-up. In univariate analysis a low level of ficolin-3, but not that of MBL or ficolin-2, was significantly associated with advanced heart failure (New York Heart Association Class IV, p<0.001 for both cohorts) and showed inverse correlation with B-type natriuretic peptide (BNP) levels (r = -0.609, p<0.001 and r = -0.467, p<0.001, respectively). In multivariable Cox regression analysis, adjusted for age, gender and BNP, decreased plasma ficolin-3 was a significant predictor of mortality (HR 1.368, 95% CI 1.052-6.210; and HR 1.426, 95% CI 1.013-2.008, respectively). Low ficolin-3 levels were associated with increased complement activation product C3a and correspondingly decreased concentrations of complement factor C3. Conclusions: This study provides evidence for an association of low ficolin-3 levels with advanced heart failure. Concordant results from two cohorts show that low levels of ficolin-3 are associated with advanced heart failure and outcome. The decrease of ficolin-3 was associated with increased complement activation.	[Prohaszka, Zoltan; Gombos, Timea; Foerhecz, Zsolt; Pozsonyi, Zoltan; Janoskuti, Livia; Karadi, Istvan; Fuest, George] Semmelweis Univ, Dept Internal Med 3, H-1085 Budapest, Hungary; [Prohaszka, Zoltan; Gombos, Timea; Foerhecz, Zsolt; Pozsonyi, Zoltan; Janoskuti, Livia; Karadi, Istvan; Fuest, George] Hungarian Acad Sci, Res Grp Inflammat Biol & Immunogen, Budapest, Hungary; [Munthe-Fog, Lea; Skjoedt, Mikkel-Ole; Garred, Peter] Univ Copenhagen, Fac Hlth Sci, Rigshosp, Lab Mol Med,Dept Clin Immunol,Sect 7631, DK-1168 Copenhagen, Denmark; [Ueland, Thor; Yndestad, Arne; Dahl, Christen P.; Askevold, Erik T.; Aukrust, Pal] Univ Oslo, Fac Med, Rikshosp, Res Inst Internal Med,Oslo Univ Hosp, N-0316 Oslo, Norway; [Yndestad, Arne; Gullestad, Lars; Dahl, Christen P.; Askevold, Erik T.] Univ Oslo, Fac Med, Rikshosp, Ctr Heart Failure Res,Oslo Univ Hosp, N-0316 Oslo, Norway; [Gustavsen, Alice; Mollnes, Tom E.] Univ Oslo, Fac Med, Rikshosp, Dept Immunol,Oslo Univ Hosp, N-0316 Oslo, Norway; [Gullestad, Lars; Dahl, Christen P.; Askevold, Erik T.] Univ Oslo, Fac Med, Rikshosp, Dept Cardiol,Oslo Univ Hosp, N-0316 Oslo, Norway; [Aukrust, Pal] Univ Oslo, Fac Med, Rikshosp, Sect Clin Immunol & Infect Dis,Oslo Univ Hosp, N-0316 Oslo, Norway	Semmelweis University; Hungarian Academy of Sciences; Rigshospitalet; University of Copenhagen; University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway	Garred, P (corresponding author), Univ Copenhagen, Fac Hlth Sci, Rigshosp, Lab Mol Med,Dept Clin Immunol,Sect 7631, DK-1168 Copenhagen, Denmark.	garred@post5.tele.dk	Prohászka, Zoltán/F-2191-2010; Mollnes, Tom/ABI-5183-2020; Pozsonyi, Zoltán/AAD-3278-2020	Prohászka, Zoltán/0000-0003-1761-7982; Skjodt, Mikkel-Ole/0000-0003-1306-6482; Munthe-Fog, Lea/0000-0003-1345-176X; Pozsonyi, Zoltan/0000-0002-3098-2434; Karadi, Istvan/0000-0002-8253-2654; Garred, Peter/0000-0002-2876-8586	Danish Medical Research Council; Novo Nordisk Research Foundation; Sven Andersen Research Foundation; Research Foundation of The Capital Region of Denmark, Rigshospitalet; Hungarian Research Fund [NF72689]; Hungarian Ministry of Welfare [ETT 229/2006]	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Novo Nordisk Research Foundation(Novo Nordisk Foundation); Sven Andersen Research Foundation; Research Foundation of The Capital Region of Denmark, Rigshospitalet; Hungarian Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Hungarian Ministry of Welfare	This work was supported by the Danish Medical Research Council, The Novo Nordisk Research Foundation, The Sven Andersen Research Foundation, the Research Foundation of The Capital Region of Denmark, Rigshospitalet and The Hungarian Research Fund (NF72689), and the Hungarian Ministry of Welfare (ETT 229/2006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aukrust P, 2001, CIRCULATION, V104, P1494, DOI 10.1161/hc3801.096353; Bay JT, 2013, CLIN IMMUNOL, V146, P240, DOI 10.1016/j.clim.2013.01.005; Clark DJ, 2001, AM HEART J, V141, P684, DOI 10.1067/mhj.2001.113758; Fust G, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-185; GARRED P, 1992, CLIN EXP IMMUNOL, V90, P517; GARRED P, 1992, EUR J IMMUNOGENET, V19, P403, DOI 10.1111/j.1744-313X.1992.tb00083.x; Garred P, 2009, MOL IMMUNOL, V46, P2737, DOI 10.1016/j.molimm.2009.05.005; Gombos T, 2012, CLIN RES CARDIOL, V101, P607, DOI 10.1007/s00392-012-0432-6; Gout E, 2010, J BIOL CHEM, V285, P6612, DOI 10.1074/jbc.M109.065854; Hein E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015443; Honore C, 2008, MOL IMMUNOL, V45, P2782, DOI 10.1016/j.molimm.2008.02.005; Honore C, 2007, ARTHRITIS RHEUM, V56, P1598, DOI 10.1002/art.22564; Hummelshoj T, 2008, MOL IMMUNOL, V45, P1623, DOI 10.1016/j.molimm.2007.10.006; Imai N, 2006, NEPHROL DIAL TRANSPL, V21, P2589, DOI 10.1093/ndt/gfl210; Jensen ML, 2007, MOL IMMUNOL, V44, P856, DOI 10.1016/j.molimm.2006.04.002; Kaslow RA, 1996, NAT MED, V2, P405, DOI 10.1038/nm0496-405; Kim HJ, 2007, J PROTEOME RES, V6, P735, DOI 10.1021/pr060489g; Kostin S, 2003, CIRC RES, V92, P715, DOI 10.1161/01.RES.0000067471.95890.5C; Krarup A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000623; Li RX, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003224; Ma YJ, 2013, J INNATE IMMUN, V5, P242, DOI 10.1159/000345356; McMurray JJV, 2012, EUR J HEART FAIL, V14, P803, DOI 10.1093/eurjhf/hfs105; Munthe-Fog L, 2007, SCAND J IMMUNOL, V65, P383, DOI 10.1111/j.1365-3083.2007.01915.x; Munthe-Fog L, 2008, MOL IMMUNOL, V45, P2660, DOI 10.1016/j.molimm.2007.12.012; Munthe-Fog L, 2009, NEW ENGL J MED, V360, P2637, DOI 10.1056/NEJMoa0900381; Nauta AJ, 2003, EUR J IMMUNOL, V33, P2853, DOI 10.1002/eji.200323888; Ogden CA, 2001, J EXP MED, V194, P781, DOI 10.1084/jem.194.6.781; Oliveira GHM, 2006, AM J CARDIOL, V97, P1626, DOI 10.1016/j.amjcard.2005.12.056; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Wang CC, 2007, CLIN CHEM, V53, P42, DOI 10.1373/clinchem.2007.074401; Whelan RS, 2010, ANNU REV PHYSIOL, V72, P19, DOI 10.1146/annurev.physiol.010908.163111; Wrigley BJ, 2011, EUR J HEART FAIL, V13, P1161, DOI 10.1093/eurjhf/hfr122; Zimmermann O, 2007, EUR J HEART FAIL, V9, P51, DOI 10.1016/j.ejheart.2006.04.001; Zwaka TP, 2002, AM J PATHOL, V161, P449, DOI 10.1016/S0002-9440(10)64201-0	34	27	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2013	8	4							e60976	10.1371/journal.pone.0060976	http://dx.doi.org/10.1371/journal.pone.0060976			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125TD	23596511	Green Published, gold, Green Submitted			2022-12-25	WOS:000317563300012
J	Venit, T; Dzijak, R; Kalendova, A; Kahle, M; Rohozkova, J; Schmidt, V; Rulicke, T; Rathkolb, B; Hans, W; Bohla, A; Eickelberg, O; Stoeger, T; Wolf, E; Yildirim, AO; Gailus-Durner, V; Fuchs, H; de Angelis, MH; Hozak, P				Venit, Tomas; Dzijak, Rastislav; Kalendova, Alzbeta; Kahle, Michal; Rohozkova, Jana; Schmidt, Volker; Ruelicke, Thomas; Rathkolb, Birgit; Hans, Wolfgang; Bohla, Alexander; Eickelberg, Oliver; Stoeger, Tobias; Wolf, Eckhard; Yildirim, Ali Oender; Gailus-Durner, Valerie; Fuchs, Helmut; de Angelis, Martin Hrabe; Hozak, Pavel			Mouse Nuclear Myosin I Knock-Out Shows Interchangeability and Redundancy of Myosin Isoforms in the Cell Nucleus	PLOS ONE			English	Article							ACTIN; TRANSCRIPTION; MYO1C; IDENTIFICATION; MEMBRANE; INSULIN; MUTATIONS; TRANSPORT; NETWORK; COMPLEX	Background: Nuclear myosin I (NM1) is a nuclear isoform of the well-known "cytoplasmic" Myosin 1c protein (Myo1c). Located on the 11th chromosome in mice, NM1 results from an alternative start of transcription of the Myo1c gene adding an extra 16 amino acids at the N-terminus. Previous studies revealed its roles in RNA Polymerase I and RNA Polymerase II transcription, chromatin remodeling, and chromosomal movements. Its nuclear localization signal is localized in the middle of the molecule and therefore directs both Myosin 1c isoforms to the nucleus. Methodology/Principal Findings: In order to trace specific functions of the NM1 isoform, we generated mice lacking the NM1 start codon without affecting the cytoplasmic Myo1c protein. Mutant mice were analyzed in a comprehensive phenotypic screen in cooperation with the German Mouse Clinic. Strikingly, no obvious phenotype related to previously described functions has been observed. However, we found minor changes in bone mineral density and the number and size of red blood cells in knock-out mice, which are most probably not related to previously described functions of NM1 in the nucleus. In Myo1c/NM1 depleted U2OS cells, the level of Pol I transcription was restored by overexpression of shRNA-resistant mouse Myo1c. Moreover, we found Myo1c interacting with Pol II. The ratio between Myo1c and NM1 proteins were similar in the nucleus and deletion of NM1 did not cause any compensatory overexpression of Myo1c protein. Conclusion/Significance: We observed that Myo1c can replace NM1 in its nuclear functions. Amount of both proteins is nearly equal and NM1 knock-out does not cause any compensatory overexpression of Myo1c. We therefore suggest that both isoforms can substitute each other in nuclear processes.	[Venit, Tomas; Dzijak, Rastislav; Kalendova, Alzbeta; Kahle, Michal; Rohozkova, Jana; Hozak, Pavel] ASCR, Inst Mol Genet, Dept Biol Cell Nucleus, Vvi, Prague, Czech Republic; [Schmidt, Volker; Ruelicke, Thomas] Univ Vet Med Vienna, Inst Lab Anim Sci & Biomodels Austria, Vienna, Austria; [Rathkolb, Birgit; Hans, Wolfgang; Gailus-Durner, Valerie; Fuchs, Helmut; de Angelis, Martin Hrabe] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, German Mouse Clin, Inst Expt Genet, Neuherberg, Germany; [Bohla, Alexander; Eickelberg, Oliver; Stoeger, Tobias; Yildirim, Ali Oender] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Comprehens Pneumol Ctr, German Mouse Clin, Neuherberg, Germany; [Bohla, Alexander; Eickelberg, Oliver; Stoeger, Tobias; Yildirim, Ali Oender] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Lung Biol & Dis, Neuherberg, Germany; [Rathkolb, Birgit; Wolf, Eckhard] Univ Munich, Chair Mol Anim Breeding & Biotechnol, Gene Ctr, Munich, Germany; [de Angelis, Martin Hrabe] Tech Univ Munich, Chair Expt Genet, Ctr Life & Food Sci Weihenstephan, Freising Weihenstephan, Germany; [Venit, Tomas] Charles Univ Prague, Fac Sci, Prague, Czech Republic	Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences; University of Veterinary Medicine Vienna; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; Technical University of Munich; Charles University Prague	Hozak, P (corresponding author), ASCR, Inst Mol Genet, Dept Biol Cell Nucleus, Vvi, Prague, Czech Republic.	hozak@img.cas.cz	Fuchs, Helmut/M-7347-2014; Rohozkova, Jana/G-3525-2014; Stöger, Tobias/M-9861-2014; Hozak, Pavel/AAB-5359-2021; Dzijak, Rastislav/G-6181-2014; Gailus-Durner, Valerie/M-7337-2014; Kahle, Michal/K-9936-2016; Hozak, Pavel/J-4182-2014; Venit, Tomas/G-3534-2014; de Angelis, Martin Hrabe/F-5531-2012; Rathkolb, Birgit/F-7041-2013; Dzijak, Rastislav/AGI-4423-2022; Eickelberg, Oliver/A-5461-2013	Fuchs, Helmut/0000-0002-5143-2677; Stöger, Tobias/0000-0002-2790-0389; Hozak, Pavel/0000-0003-1901-1394; Kahle, Michal/0000-0002-3854-0390; Hozak, Pavel/0000-0003-1901-1394; de Angelis, Martin Hrabe/0000-0002-7898-2353; Dzijak, Rastislav/0000-0003-1141-7736; Eickelberg, Oliver/0000-0001-7170-0360; Wolf, Eckhard/0000-0002-0430-9510; Yildirim, Ali Onder/0000-0003-1969-480X; IICT, DA/0000-0002-2456-1721; Kalendova, Alzbeta/0000-0003-2557-5807; Petrusova, Jana/0000-0002-4942-255X	Grant Agency of Czech Republic [204/09/4048, P305/11/2232]; Technology Agency of Czech Republic [TE01010118]; Ministry of Education, Youth and Sports of the Czech Republic [LH12143]; institutional grant [AV0Z50520514]; Grant Agency of the Charles University [253189]; Austrian Federal Ministry of Science and Research (BM.W_Fa, GEN-AU II/III "Austromouse"); European Community [EUMODIC LSHG-2006-037188]; Bundesministerium fur Bildung und Forschung [NGFN-Plus: 01GS0850, 01GS0851, Infrafrontier 01KX1012]	Grant Agency of Czech Republic(Grant Agency of the Czech Republic); Technology Agency of Czech Republic; Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); institutional grant; Grant Agency of the Charles University; Austrian Federal Ministry of Science and Research (BM.W_Fa, GEN-AU II/III "Austromouse"); European Community(European Commission); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF))	This study has been supported by the Grant Agency of Czech Republic (Reg. No. 204/09/4048 and Reg. No. P305/11/2232, http://www.gacr.cz/), by the Technology Agency of Czech Republic (Reg. No. TE01010118, http://www.tacr.cz/), by the Ministry of Education, Youth and Sports of the Czech Republic (Reg. No. LH12143, http://www.msmt.cz/), by the institutional grant AV0Z50520514 (www.img.cas.cz), by the Grant Agency of the Charles University (Reg. No. 253189, www.cuni.cz) and by the Austrian Federal Ministry of Science and Research (BM.W_Fa, GEN-AU II/III "Austromouse", http://www.bmwf.gv.at). Phenotyping of NM1 KO mice in the German Mouse Clinic has been supported by grants from the European Community (EUMODIC LSHG-2006-037188, http://www.eumodic.org/) and from the Bundesministerium fur Bildung und Forschung (NGFN-Plus: 01GS0850, 01GS0851; Infrafrontier 01KX1012, http://www.bmbf.de/) to the GMC and to the German Center for Diabetes Research (DZD e.V.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrosino C, 2010, MOL CELL PROTEOMICS, V9, P1352, DOI 10.1074/mcp.M900519-MCP200; Arif E, 2011, MOL CELL BIOL, V31, P2134, DOI 10.1128/MCB.05051-11; Aslinia F, 2006, CLIN MED RES, V4, P236, DOI 10.3121/cmr.4.3.236; Barylko B, 2005, ACTA BIOCHIM POL, V52, P373; Bose A, 2002, NATURE, V420, P821, DOI 10.1038/nature01246; Bose A, 2004, MOL CELL BIOL, V24, P5447, DOI 10.1128/MCB.24.12.5447-5458.2004; Chuang CH, 2006, CURR BIOL, V16, P825, DOI 10.1016/j.cub.2006.03.059; Diefenbach TJ, 2002, J CELL BIOL, V158, P1207, DOI 10.1083/jcb.200202028; Dzijak R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030529; Ferron M, 2010, CELL, V142, P296, DOI 10.1016/j.cell.2010.06.003; Fomproix N, 2004, EXP CELL RES, V294, P140, DOI 10.1016/j.yexcr.2003.10.028; Fuchs H, 2011, METHODS, V53, P120, DOI 10.1016/j.ymeth.2010.08.006; Fulzele K, 2010, CELL, V142, P309, DOI 10.1016/j.cell.2010.06.002; Gailus-Durner Valerie, 2009, V530, P463, DOI 10.1007/978-1-59745-471-1_25; GILLESPIE PG, 1993, NEURON, V11, P581, DOI 10.1016/0896-6273(93)90071-X; Gillespie PG, 2001, J CELL BIOL, V155, P703, DOI 10.1083/jcb.200110032; Grummt I, 2006, CURR OPIN GENET DEV, V16, P191, DOI 10.1016/j.gde.2006.02.001; Hofmann WA, 2006, BIOCHEM CELL BIOL, V84, P418, DOI 10.1139/O06-069; Ihnatovych I, 2012, CYTOSKELETON, V69, P555, DOI 10.1002/cm.21040; Kahle M, 2007, HISTOCHEM CELL BIOL, V127, P139, DOI 10.1007/s00418-006-0231-0; Kysela K, 2005, HISTOCHEM CELL BIOL, V124, P347, DOI 10.1007/s00418-005-0042-8; Leneuve P, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng021; McConnell RE, 2010, TRENDS CELL BIOL, V20, P418, DOI 10.1016/j.tcb.2010.04.004; McGowan KA, 2008, NAT GENET, V40, P963, DOI 10.1038/ng.188; Nambiar R, 2009, P NATL ACAD SCI USA, V106, P11972, DOI 10.1073/pnas.0901641106; Nowak G, 1997, J BIOL CHEM, V272, P17176, DOI 10.1074/jbc.272.27.17176; Obrdlik A, 2010, FASEB J, V24, P146, DOI 10.1096/fj.09-135863; Percipalle P, 2006, EMBO REP, V7, P525, DOI 10.1038/sj.embor.7400657; Pestic-Dragovich L, 2000, SCIENCE, V290, P337, DOI 10.1126/science.290.5490.337; Philimonenko VV, 2010, HISTOCHEM CELL BIOL, V134, P243, DOI 10.1007/s00418-010-0732-8; Philimonenko VV, 2004, NAT CELL BIOL, V6, P1165, DOI 10.1038/ncb1190; REIZES O, 1994, P NATL ACAD SCI USA, V91, P6349, DOI 10.1073/pnas.91.14.6349; Schenten D, 2002, EUR J IMMUNOL, V32, P3152, DOI 10.1002/1521-4141(200211)32:11<3152::AID-IMMU3152>3.0.CO;2-2; Simon DN, 2011, NAT REV MOL CELL BIO, V12, P695, DOI 10.1038/nrm3207; Sokac AM, 2006, DEV CELL, V11, P629, DOI 10.1016/j.devcel.2006.09.002; Stauffer EA, 2005, NEURON, V47, P541, DOI 10.1016/j.neuron.2005.07.024; WAGNER MC, 1992, J CELL BIOL, V119, P163, DOI 10.1083/jcb.119.1.163; Wang FS, 1996, SCIENCE, V273, P660, DOI 10.1126/science.273.5275.660; Willig TN, 1999, BLOOD, V94, P4294; Ye J, 2008, GENE DEV, V22, P322, DOI 10.1101/gad.455908; Zadro C, 2009, BBA-MOL BASIS DIS, V1792, P27, DOI 10.1016/j.bbadis.2008.10.017	41	25	25	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2013	8	4							e61406	10.1371/journal.pone.0061406	http://dx.doi.org/10.1371/journal.pone.0061406			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123JA	23593477	gold, Green Published, Green Submitted			2022-12-25	WOS:000317383200056
J	Xia, L; Huang, W; Tian, D; Chen, Z; Zhang, L; Li, Y; Hu, H; Liu, J; Chen, Z; Tang, G; Dou, J; Sha, S; Xu, B; Liu, C; Ma, J; Zhang, S; Li, M; Fan, D; Nie, Y; Wu, K				Xia, L.; Huang, W.; Tian, D.; Chen, Z.; Zhang, L.; Li, Y.; Hu, H.; Liu, J.; Chen, Z.; Tang, G.; Dou, J.; Sha, S.; Xu, B.; Liu, C.; Ma, J.; Zhang, S.; Li, M.; Fan, D.; Nie, Y.; Wu, K.			ACP5, a direct transcriptional target of FoxM1, promotes tumor metastasis and indicates poor prognosis in hepatocellular carcinoma	ONCOGENE			English	Article						Forkhead box M1; tartrate-resistant acid phosphatase 5; hepatocellular carcinoma; metastasis; transcriptional regulation	RESISTANT ACID-PHOSPHATASE; FORKHEAD BOX M1B; FOCAL-ADHESION KINASE; HUMAN BREAST-CANCER; BONE METASTASES; UP-REGULATION; SERUM MARKER; HEPATITIS-B; EXPRESSION; 5B	Tartrate-resistant acid phosphatase 5 (ACP5), which is essential for bone resorption and osteoclast differentiation, promotes cell motility through the modulation of focal adhesion kinase phosphorylation. However, whether ACP5 contributes to the metastasis and progression of hepatocellular carcinoma (HCC) remains unknown. In this paper, a complementary DNA microarray, serial deletion, site-directed mutagenesis and a chromatin immunoprecipitation assays confirmed that ACP5 is a direct transcriptional target of Forkhead box M1 (FoxM1). ACP5 expression was markedly higher in HCC tissues compared with adjacent noncancerous tissues. ACP5 overexpression was correlated with microvascular invasion, poor differentiation and higher tumor-node-metastasis stage. HCC patients with positive ACP5 expression had poorer prognoses than those with negative ACP5 expression. A multivariate analysis revealed that ACP5 expression was an independent and significant risk factor for disease recurrence and reduced-patient survival following curative resection. Transwell assays and an orthotopic metastatic model showed that the upregulation of ACP5 promoted HCC invasion and lung metastasis, whereas ACP5 knockdown inhibited these processes. The knockdown of ACP5 significantly attenuated FoxM1-enhanced invasion and lung metastasis. Immunohistochemistry revealed that ACP5 expression was positively correlated with FoxM1 expression in human HCC tissues, and their coexpression was associated with poor prognoses. In summary, ACP5 is a direct transcriptional and functional target of FoxM1. This novel FoxM1/ACP5 signaling pathway promotes HCC metastasis and may be a candidate biomarker for prognosis and a target for new therapies.	[Xia, L.; Huang, W.; Chen, Z.; Zhang, L.; Hu, H.; Liu, J.; Chen, Z.; Tang, G.; Dou, J.; Sha, S.; Xu, B.; Liu, C.; Ma, J.; Zhang, S.; Li, M.; Fan, D.; Nie, Y.; Wu, K.] Fourth Mil Med Univ, State Key Lab Canc Biol, Xian 710032, Shaanxi Provinc, Peoples R China; [Tian, D.] Fourth Mil Med Univ, Xijing Hosp Digest Dis, Xian 710032, Shaanxi Provinc, Peoples R China; [Li, Y.] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Gastroenterol, Wuhan 430074, Hubei Province, Peoples R China; [Xia, L.; Huang, W.] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada	Air Force Military Medical University; Air Force Military Medical University; Huazhong University of Science & Technology; University of British Columbia	Nie, Y (corresponding author), Fourth Mil Med Univ, State Key Lab Canc Biol, Xian 710032, Shaanxi Provinc, Peoples R China.	yongznie@fmmu.edu.cn; wu_kaichun@yahoo.cn	Huang, Wenjie/G-1778-2017; meng, li/GVT-2063-2022		National Natural Science Foundation of China [81272652, 81172290, 91129723, 81090270, 81090273, 81120108005]; National Key and Basic Research Development Program of China [2010CB529302, 2010CB529306]; National Municipal Science and Technology Project [2009ZX09103-667, 2009ZX09301-009-RC06]; Chinese Postdoctoral Science Foundation [20100471776, 201104757]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key and Basic Research Development Program of China(National Basic Research Program of China); National Municipal Science and Technology Project; Chinese Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This study was supported by combined grants from the National Natural Science Foundation of China (No. 81272652, No. 81172290, No. 91129723, No.81090270, No.81090273 and No.81120108005), the National Key and Basic Research Development Program of China (No. 2010CB529302 and 2010CB529306), the National Municipal Science and Technology Project (2009ZX09103-667 and 2009ZX09301-009-RC06) and the Chinese Postdoctoral Science Foundation (No. 20100471776 and No.201104757).	Adams LM, 2007, CELL BIOL INT, V31, P191, DOI 10.1016/j.cellbi.2006.09.022; Bao B, 2011, J CELL BIOCHEM, V112, P2296, DOI 10.1002/jcb.23150; Calvisi DF, 2009, GUT, V58, P679, DOI 10.1136/gut.2008.152652; Capeller B, 2003, ANTICANCER RES, V23, P1011; Chao TY, 2005, CLIN CANCER RES, V11, P544; Dai B, 2007, ONCOGENE, V26, P6212, DOI 10.1038/sj.onc.1210443; EDMONDSON HA, 1954, CANCER-AM CANCER SOC, V7, P462, DOI 10.1002/1097-0142(195405)7:3<462::AID-CNCR2820070308>3.0.CO;2-E; El-Serag HB, 2008, GASTROENTEROLOGY, V134, P1752, DOI 10.1053/j.gastro.2008.02.090; El-Serag HB, 2011, NEW ENGL J MED, V365, P1118, DOI 10.1056/NEJMra1001683; Gusarova GA, 2007, J CLIN INVEST, V117, P99, DOI 10.1172/JCI27527; Halleen JM, 2001, CLIN CHEM, V47, P597; Honig A, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-199; Huang C, 2012, CANCER RES, V72, P655, DOI 10.1158/0008-5472.CAN-11-3102; Kalinichenko VV, 2004, GENE DEV, V18, P830, DOI 10.1101/gad.1200704; Laoukili J, 2007, BBA-REV CANCER, V1775, P92, DOI 10.1016/j.bbcan.2006.08.006; Li Y, 2012, NAT REV GASTRO HEPAT, V9, P32, DOI 10.1038/nrgastro.2011.196; Lyubimova NV, 2004, B EXP BIOL MED+, V138, P77, DOI 10.1007/BF02694481; McLean GW, 2005, NAT REV CANCER, V5, P505, DOI 10.1038/nrc1647; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Park HJ, 2011, EMBO MOL MED, V3, P21, DOI 10.1002/emmm.201000107; Raychaudhuri P, 2011, CANCER RES, V71, P4329, DOI 10.1158/0008-5472.CAN-11-0640; Scott KL, 2011, CANCER CELL, V20, P92, DOI 10.1016/j.ccr.2011.05.025; Sun HC, 2011, CANCER LETT, V306, P214, DOI 10.1016/j.canlet.2011.03.009; Wang IC, 2008, J BIOL CHEM, V283, P20770, DOI 10.1074/jbc.M709892200; Wang XH, 2002, P NATL ACAD SCI USA, V99, P16881, DOI 10.1073/pnas.252570299; Wang XH, 2001, P NATL ACAD SCI USA, V98, P11468, DOI 10.1073/pnas.201360898; Wang ZW, 2007, CANCER RES, V67, P8293, DOI 10.1158/0008-5472.CAN-07-1265; Wu YY, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-158; Xia LM, 2012, CARCINOGENESIS, V33, P2250, DOI 10.1093/carcin/bgs249; Xia LM, 2012, J HEPATOL, V57, P600, DOI 10.1016/j.jhep.2012.04.020; Xia LM, 2012, J IMMUNOL, V188, P753, DOI 10.4049/jimmunol.1101652; Yang JD, 2010, NAT REV GASTRO HEPAT, V7, P448, DOI 10.1038/nrgastro.2010.100; Zenger S, 2011, CLIN EXP METASTAS, V28, P65, DOI 10.1007/s10585-010-9358-4	33	30	31	0	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 13	2014	33	11					1395	1406		10.1038/onc.2013.90	http://dx.doi.org/10.1038/onc.2013.90			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AD0SD	23604121				2022-12-25	WOS:000332943500007
J	Eckle, T; Hughes, K; Ehrentraut, H; Brodsky, KS; Rosenberger, P; Choi, DS; Ravid, K; Weng, TT; Xia, Y; Blackburn, MR; Eltzschig, HK				Eckle, Tobias; Hughes, Kelly; Ehrentraut, Heidi; Brodsky, Kelley S.; Rosenberger, Peter; Choi, Doo-Sup; Ravid, Katya; Weng, Tingting; Xia, Yang; Blackburn, Michael R.; Eltzschig, Holger K.			Crosstalk between the equilibrative nucleoside transporter ENT2 and alveolar Adora2b adenosine receptors dampens acute lung injury	FASEB JOURNAL			English	Article						A(2B); dipyridamole; hypoxia-inducible factor; CD73; CD39; apyrase; ecto-nucleotidase	HYPOXIA-INDUCIBLE FACTOR; CEREBRAL-BLOOD-FLOW; HIF-1-DEPENDENT REPRESSION; EXTRACELLULAR ADENOSINE; TRANSGENIC MOUSE; IMAGE-ANALYSIS; ATP RELEASE; KAPPA-B; INFLAMMATION; MECHANISM	The signaling molecule adenosine has been implicated in attenuating acute lung injury (ALI). Adenosine signaling is terminated by its uptake through equilibrative nucleoside transporters (ENTs). We hypothesized that ENT-dependent adenosine uptake could be targeted to enhance adenosine-mediated lung protection. To address this hypothesis, we exposed mice to high-pressure mechanical ventilation to induce ALI. Initial studies demonstrated time-dependent repression of ENT1 and ENT2 transcript and protein levels during ALI. To examine the contention that ENT repression represents an endogenous adaptive response, we performed functional studies with the ENT inhibitor dipyridamole. Dipyridamole treatment (1 mg/kg; EC50=10 M) was associated with significant increases in ALI survival time (277 vs. 395 min; P<0.05). Subsequent studies in gene-targeted mice for Ent1 or Ent2 revealed a selective phenotype in Ent2(-/-) mice, including attenuated pulmonary edema and improved gas exchange during ALI in conjunction with elevated adenosine levels in the bronchoalveolar fluid. Furthermore, studies in genetic models for adenosine receptors implicated the A(2B) adenosine receptor (Adora2b) in mediating ENT-dependent lung protection. Notably, dipyridamole-dependent attenuation of lung inflammation was abolished in mice with alveolar epithelial Adora2b gene deletion. Our newly identified crosstalk pathway between ENT2 and alveolar epithelial Adora2b in lung protection during ALI opens possibilities for combined therapies targeted to this protein set.	[Eckle, Tobias; Hughes, Kelly; Ehrentraut, Heidi; Brodsky, Kelley S.; Eltzschig, Holger K.] Univ Colorado, Sch Med, Mucosal Inflammat Program, Dept Anesthesiol, Aurora, CO 80045 USA; [Rosenberger, Peter] Univ Hosp, Dept Anesthesiol & Intens Care Med, Tubingen, Germany; [Choi, Doo-Sup] Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, Coll Med, Rochester, MN USA; [Ravid, Katya] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA; [Ravid, Katya] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA; [Weng, Tingting; Xia, Yang; Blackburn, Michael R.] Univ Texas Med Sch Houston, Dept Biochem & Mol Biol, Houston, TX USA	University of Colorado System; University of Colorado Anschutz Medical Campus; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Mayo Clinic; Boston University; Boston University; University of Texas System; University of Texas Health Science Center Houston	Eltzschig, HK (corresponding author), Univ Colorado, Sch Med, Mucosal Inflammat Program, Dept Anesthesiol, 12700 E 19th Ave,Mailstop B112,Res Complex 2,Room, Aurora, CO 80045 USA.	holger.eltzschig@ucdenver.edu	Eckle, Tobias/AAE-6705-2020; Choi, Doo-Sup/G-9474-2012	Eckle, Tobias/0000-0002-6065-4669; Choi, Doo-Sup/0000-0002-6796-9938; Blackburn, Michael/0000-0002-1394-9966; Ravid, Katya/0000-0002-9918-3024	U.S. National Heart Institute [R01-DK097075, R01-HL0921, R01-DK083385, R01-HL098294, P01-HL114457-01, K08-HL102267, R01-HL070952]; Crohn's and Colitis Foundation of America; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070952, K08HL102267, R01HL098294, P01HL114457] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK083385, R01DK097075] Funding Source: NIH RePORTER	U.S. National Heart Institute; Crohn's and Colitis Foundation of America; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors acknowledge Kristann Magee, Stephanie Bonney, and Megan Bonney for technical assistance. This research was supported by U.S. National Heart Institute grants R01-DK097075, R01-HL0921, R01-DK083385, R01-HL098294, and P01-HL114457-01 to H. K. E.; K08-HL102267 to T. E.; and R01-HL070952 to M. R. B.; and by a Crohn's and Colitis Foundation of America grant to H.K.E.	Aherne CM, 2012, GUT, V61, P695, DOI 10.1136/gutjnl-2011-300012; Alva JA, 2006, DEV DYNAM, V235, P759, DOI 10.1002/dvdy.20643; Blackburn MR, 2000, J EXP MED, V192, P159, DOI 10.1084/jem.192.2.159; Cagnina RE, 2009, AM J PHYSIOL-LUNG C, V297, pL467, DOI 10.1152/ajplung.90553.2008; Casanello P, 2005, CIRC RES, V97, P16, DOI 10.1161/01.RES.0000172568.49367.f8; Chaudary N, 2004, CARDIOVASC RES, V61, P780, DOI 10.1016/j.cardiores.2003.11.031; Choi DS, 2004, NAT NEUROSCI, V7, P855, DOI 10.1038/nn1288; CRONSTEIN BN, 1994, ADV EXP MED BIOL, V370, P411; Cronstein BN, 1997, RHEUM DIS CLIN N AM, V23, P739, DOI 10.1016/S0889-857X(05)70358-6; CRONSTEIN BN, 1993, J CLIN INVEST, V92, P2675, DOI 10.1172/JCI116884; CRONSTEIN BN, 1991, P NATL ACAD SCI USA, V88, P2441, DOI 10.1073/pnas.88.6.2441; Cummins EP, 2008, GASTROENTEROLOGY, V134, P156, DOI 10.1053/j.gastro.2007.10.012; Cummins EP, 2006, P NATL ACAD SCI USA, V103, P18154, DOI 10.1073/pnas.0602235103; Cummins EP, 2005, PFLUG ARCH EUR J PHY, V450, P363, DOI 10.1007/s00424-005-1413-7; Dixon BS, 2009, NEW ENGL J MED, V360, P2191, DOI 10.1056/NEJMoa0805840; Eckle T, 2008, AM J PHYSIOL-LUNG C, V295, pL718, DOI 10.1152/ajplung.90298.2008; Eckle T, 2008, J CLIN INVEST, V118, P3301, DOI 10.1172/JCI34203; Eckle T, 2008, CIRCULATION, V118, P166, DOI 10.1161/CIRCULATIONAHA.107.758516; Eckle T, 2008, BLOOD, V111, P2024, DOI 10.1182/blood-2007-10-117044; Eckle T, 2007, J IMMUNOL, V178, P8127, DOI 10.4049/jimmunol.178.12.8127; Eckle T, 2007, CIRCULATION, V115, P1581, DOI 10.1161/CIRCULATIONAHA.106.669697; Eckle T, 2012, NAT MED, V18, P774, DOI 10.1038/nm.2728; Eckle T, 2009, PHYSIOLOGY, V24, P298, DOI 10.1152/physiol.00022.2009; Eltzschig HK, 2004, BRIT MED BULL, V70, P71, DOI 10.1093/bmb/ldh025; Eltzschig HK, 2005, J EXP MED, V202, P1493, DOI 10.1084/jem.20050177; Eltzschig HK, 2008, TRENDS CARDIOVAS MED, V18, P103, DOI 10.1016/j.tcm.2008.01.006; Eltzschig HK, 2006, CIRC RES, V99, P1100, DOI 10.1161/01.RES.0000250174.31269.70; Eltzschig HK, 2006, METH MOL B, V341, P73; Eltzschig HK, 2006, BLOOD, V108, P1602, DOI 10.1182/blood-2006-02-001016; Eltzschig HK, 2012, NEW ENGL J MED, V367, P2322, DOI 10.1056/NEJMra1205750; Eltzschig HK, 2011, NAT MED, V17, P1391, DOI 10.1038/nm.2507; Eltzschig HK, 2011, NEW ENGL J MED, V364, P656, DOI 10.1056/NEJMra0910283; Eltzschig HK, 2009, ANESTHESIOLOGY, V111, P904, DOI 10.1097/ALN.0b013e3181b060f2; Faigle M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002801; Grenz A, 2008, PLOS MED, V5, P968, DOI 10.1371/journal.pmed.0050137; Grenz A, 2012, J CLIN INVEST, V122, P693, DOI 10.1172/JCI60214; Grenz A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014812; Hart ML, 2008, GASTROENTEROLOGY, V135, P1739, DOI 10.1053/j.gastro.2008.07.064; Hart ML, 2008, FASEB J, V22, P2784, DOI 10.1096/fj.07-103911; Hart ML, 2008, ARTERIOSCL THROM VAS, V28, P1477, DOI 10.1161/ATVBAHA.108.169219; Hart ML, 2011, J IMMUNOL, V186, P4367, DOI 10.4049/jimmunol.0903617; Hart ML, 2010, J IMMUNOL, V184, P4017, DOI 10.4049/jimmunol.0901851; Hart ML, 2009, J IMMUNOL, V182, P3965, DOI 10.4049/jimmunol.0802193; Herridge MS, 2011, NEW ENGL J MED, V364, P1293, DOI 10.1056/NEJMoa1011802; Jackson EK, 2013, AM J PHYSIOL-RENAL, V304, pF49, DOI 10.1152/ajprenal.00571.2012; Jackson EK, 2010, HYPERTENSION, V56, P151, DOI 10.1161/HYPERTENSIONAHA.110.152454; Jackson EK, 2009, J BIOL CHEM, V284, P33097, DOI 10.1074/jbc.M109.053876; Kim HH, 2008, J CEREBR BLOOD F MET, V28, P1285, DOI 10.1038/jcbfm.2008.24; KO KR, 1990, AM J PHYSIOL, V259, pH1703, DOI 10.1152/ajpheart.1990.259.6.H1703; Koeppen M, 2013, MUCOSAL IMMUNOL, V6, P762, DOI 10.1038/mi.2012.114; Koeppen M., 2011, JOVE-J VIS EXP, V51, P2525; Koeppen M, 2012, ANESTHESIOLOGY, V116, P1245, DOI 10.1097/ALN.0b013e318255793c; Lahm A, 2004, ARCH ORTHOP TRAUM SU, V124, P431, DOI 10.1007/s00402-004-0701-6; Lehr HA, 1997, J HISTOCHEM CYTOCHEM, V45, P1559, DOI 10.1177/002215549704501112; Loffler M, 2007, ARTERIOSCL THROM VAS, V27, P1004, DOI 10.1161/ATVBAHA.106.126714; Lu Q, 2010, AM J PHYSIOL-LUNG C, V298, pL755, DOI 10.1152/ajplung.00330.2009; Martin TR, 2002, J CLIN INVEST, V110, P1603, DOI 10.1172/JCI200217302; Morabito L, 1998, J CLIN INVEST, V101, P295, DOI 10.1172/JCI1554; Morote-Garcia JC, 2008, BLOOD, V111, P5571, DOI 10.1182/blood-2007-11-126763; Morote-Garcia JC, 2009, GASTROENTEROLOGY, V136, P607, DOI 10.1053/j.gastro.2008.10.037; Ohta A, 2001, NATURE, V414, P916, DOI 10.1038/414916a; Okubo Tadashi, 2004, J Biol, V3, P11, DOI 10.1186/jbiol3; Oliver KM, 2012, J BIOL CHEM, V287, P14004, DOI 10.1074/jbc.M112.347971; Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669; Reutershan J, 2009, FASEB J, V23, P473, DOI 10.1096/fj.08-119701; Rosenberger P, 2009, NAT IMMUNOL, V10, P195, DOI 10.1038/ni.1683; Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333; Sacco RL, 2008, NEW ENGL J MED, V359, P1238, DOI 10.1056/NEJMoa0805002; Schingnitz U, 2010, J IMMUNOL, V184, P5271, DOI 10.4049/jimmunol.0903035; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Sitkovsky M, 2005, NAT REV IMMUNOL, V5, P712, DOI 10.1038/nri1685; Sitkovsky MV, 2008, BLOOD, V111, P5424, DOI 10.1182/blood-2008-03-143990; Sitkovsky MV, 2004, ANNU REV IMMUNOL, V22, P657, DOI 10.1146/annurev.immunol.22.012703.104731; Taylor CT, 2008, J PHYSIOL-LONDON, V586, P4055, DOI 10.1113/jphysiol.2008.157669; Taylor CT, 2011, J PHYSIOL-LONDON, V589, P797, DOI 10.1113/jphysiol.2010.201467; Taylor CT, 2010, PHYSIOLOGY, V25, P272, DOI 10.1152/physiol.00029.2010; Thiel M, 2005, PLOS BIOL, V3, P1088, DOI 10.1371/journal.pbio.0030174; Tsukamoto H, 2012, BLOOD, V119, P4554, DOI 10.1182/blood-2011-09-375899; Van Linden A, 2007, EXPERT OPIN BIOL TH, V7, P1437, DOI 10.1517/14712598.7.9.1437; WAKAMIYA M, 1995, P NATL ACAD SCI USA, V92, P3673, DOI 10.1073/pnas.92.9.3673; Ward JL, 2000, J BIOL CHEM, V275, P8375, DOI 10.1074/jbc.275.12.8375; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; Yang D, 2006, J CLIN INVEST, V116, P1913, DOI 10.1172/JCI27933; Yao SYM, 1997, J BIOL CHEM, V272, P28423, DOI 10.1074/jbc.272.45.28423; Zhou Y, 2011, J IMMUNOL, V186, P1097, DOI 10.4049/jimmunol.1002907; Zhou Y, 2009, J IMMUNOL, V182, P8037, DOI 10.4049/jimmunol.0900515	86	74	75	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2013	27	8					3078	3089		10.1096/fj.13-228551	http://dx.doi.org/10.1096/fj.13-228551			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	292BT	23603835	Green Published			2022-12-25	WOS:000329877600015
J	Magne, J; Aminoff, A; Sundelin, JP; Mannila, MN; Gustafsson, P; Hultenby, K; Wernerson, A; Bauer, G; Listenberger, L; Neville, MJ; Karpe, F; Boren, J; Ehrenborg, E				Magne, Joelle; Aminoff, Anna; Sundelin, Jeanna Perman; Mannila, Maria Nastase; Gustafsson, Peter; Hultenby, Kjell; Wernerson, Annika; Bauer, Greta; Listenberger, Laura; Neville, Matt J.; Karpe, Fredrik; Boren, Jan; Ehrenborg, Ewa			The minor allele of the missense polymorphism Ser251Pro in perilipin 2 (PLIN2) disrupts an alpha-helix, affects lipolysis, and is associated with reduced plasma triglyceride concentration in humans	FASEB JOURNAL			English	Article						lipid droplets; lipid accumulation; lipid metabolism; HEK293 cells; macrophages	DIFFERENTIATION-RELATED PROTEIN; CYTOSOLIC LIPID DROPLETS; LOW-DENSITY-LIPOPROTEIN; HUMAN MACROPHAGES; HIGH-RISK; SECRETION; INSULIN; TRIACYLGLYCEROL; METABOLISM; INCREASES	Perilipin 2 (PLIN2) is the most abundant lipid droplet (LD)-associated protein in nonadipose tissue, and its expression correlates with intracellular lipid accumulation. Here we identified a missense polymorphism, Ser251Pro, that has major effect on protein structure and function, along with an influence on human plasma triglyceride concentration. The evolutionarily conserved Ser251Pro polymorphism was identified with the ClustalW program. Structure modeling using 3D-JigSaw and the Chimera package revealed that the Pro251 allele disrupts a predicted -helix in PLIN2. Analyses of macrophages from individuals carrying Ser251Pro variants and human embryonic kidney 293 (HEK293) cells stably transfected with either of the alleles demonstrated that the Pro251 variant causes increased lipid accumulation and decreased lipolysis. Analysis of LD size distribution in stably transfected cells showed that the minor Pro251 allele resulted in an increased number of small LDs per cell and increased perilipin 3 protein expression levels as compared with cells carrying the major Ser251 allele. Genotyping of 2113 individuals indicated that the Pro251 variant is associated with decreased plasma triglyceride and very low-density lipoprotein concentrations. Altogether, these data provide the first evidence of a polymorphism in PLIN2 that affects PLIN2 function and may influence the development of metabolic and cardiovascular diseases.	[Magne, Joelle; Aminoff, Anna; Mannila, Maria Nastase; Gustafsson, Peter; Ehrenborg, Ewa] Karolinska Univ Hosp, Atherosclerosis Res Unit, Ctr Mol Med, Dept Med, SE-17176 Stockholm, Sweden; [Hultenby, Kjell] Karolinska Inst, Div Clin Res Ctr, Dept Lab Med, Stockholm, Sweden; [Wernerson, Annika] Karolinska Inst, Div Renal Med, Dept Clin Sci Technol & Intervent, Stockholm, Sweden; [Sundelin, Jeanna Perman; Boren, Jan] Univ Gothenburg, Wallenberg Lab, Sahlgrenska Ctr Cardiovasc & Metab Res, Gothenburg, Sweden; [Bauer, Greta; Listenberger, Laura] St Olaf Coll, Dept Biol & Chem, Northfield, MN 55057 USA; [Neville, Matt J.; Karpe, Fredrik] Univ Oxford, Radcliffe Dept Med, OCDEM, Oxford, England; [Neville, Matt J.; Karpe, Fredrik] Oxford Univ Hosp Trust, Oxford Biomed Res Ctr, Natl Inst Hlth Res, OCDEM,Churchill Hosp, Oxford, England	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska Institutet; University of Gothenburg; Saint Olaf College; University of Oxford; Oxford University Hospitals NHS Foundation Trust; University of Oxford	Ehrenborg, E (corresponding author), Karolinska Univ Hosp, Atherosclerosis Res Unit, Ctr Mol Med, L8 03, SE-17176 Stockholm, Sweden.	ewa.ehrenborg@ki.se		Saliba-Gustafsson, Peter/0000-0002-7807-9009; Ehrenborg, Ewa/0000-0003-1993-2468; magne, joelle/0000-0003-0316-4046; Karpe, Fredrik/0000-0002-2751-1770; Wernerson, Annika/0000-0003-2792-0010	Swedish Research Council [12659]; Swedish Heart-Lung Foundation; Swedish Diabetes Foundation; Swedish Foundation for Strategic Research; Karolinska Institutet Funds; Research Corporation for Science Advancement; Novo Nordisk Fonden [NNF13OC0004973] Funding Source: researchfish	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Swedish Diabetes Foundation; Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Karolinska Institutet Funds; Research Corporation for Science Advancement(Research Corporation for Science Advancement); Novo Nordisk Fonden(Novo Nordisk Foundation)	The authors thank professor Mai-Lis Hellenius (Karolinska Institutet) for clinical expertise and Olivera Werngren (Karolinska Institutet) and Anastasia Hains (St. Olaf College) for excellent technical support. This work was supported by the Swedish Research Council (grant no. 12659), the Swedish Heart-Lung Foundation, the Swedish Diabetes Foundation, the Swedish Foundation for Strategic Research, Karolinska Institutet Funds, and the Research Corporation for Science Advancement. The authors declare no conflicts of interest.	ANDERSSON M, 1994, J LIPID RES, V35, P535; Bell M, 2008, DIABETES, V57, P2037, DOI 10.2337/db07-1383; Bickel PE, 2009, BBA-MOL CELL BIOL L, V1791, P419, DOI 10.1016/j.bbalip.2009.04.002; Bosma M, 2012, DIABETES, V61, P2679, DOI 10.2337/db11-1402; Bostrom P, 2007, NAT CELL BIOL, V9, P1286, DOI 10.1038/ncb1648; Brasaemle DL, 2007, J LIPID RES, V48, P2547, DOI 10.1194/jlr.R700014-JLR200; Brasaemle DL, 1997, J LIPID RES, V38, P2249; Buers I, 2009, ARTERIOSCL THROM VAS, V29, P767, DOI 10.1161/ATVBAHA.108.182675; Bulankina AV, 2009, J CELL BIOL, V185, P641, DOI 10.1083/jcb.200812042; Chang BHJ, 2010, J LIPID RES, V51, P2132, DOI 10.1194/jlr.M004515; Chapman MJ, 2011, EUR HEART J, V32, P1345, DOI 10.1093/eurheartj/ehr112; Chong BM, 2011, J BIOL CHEM, V286, P23254, DOI 10.1074/jbc.M110.217091; Contreras-Moreira B, 2002, BIOINFORMATICS, V18, P1141, DOI 10.1093/bioinformatics/18.8.1141; Faleck DM, 2010, AM J PHYSIOL-ENDOC M, V299, pE249, DOI 10.1152/ajpendo.00646.2009; Gibbons GF, 2000, BBA-MOL CELL BIOL L, V1483, P37, DOI 10.1016/S1388-1981(99)00182-1; Hickenbottom SJ, 2004, STRUCTURE, V12, P1199, DOI 10.1016/j.str.2004.04.021; Homan R, 1998, J CHROMATOGR B, V708, P21, DOI 10.1016/S0378-4347(97)00651-8; Imai Y, 2012, PHYSIOL GENOMICS, V44, P1125, DOI 10.1152/physiolgenomics.00045.2012; Jenkins CM, 2004, J BIOL CHEM, V279, P48968, DOI 10.1074/jbc.M407841200; Johansen CT, 2011, J LIPID RES, V52, P189, DOI 10.1194/jlr.R009720; Krahmer N, 2011, CELL METAB, V14, P504, DOI 10.1016/j.cmet.2011.07.013; Larigauderie G, 2004, ARTERIOSCL THROM VAS, V24, P504, DOI 10.1161/01.ATV.0000115638.27381.97; Larigauderie G, 2006, FEBS J, V273, P3498, DOI 10.1111/j.1742-4658.2006.05357.x; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Ledmyr H, 2002, J LIPID RES, V43, P51; Lehner R, 2012, ARTERIOSCL THROM VAS, V32, P1087, DOI 10.1161/ATVBAHA.111.241497; Li L, 2006, J LIPID RES, V47, P67, DOI 10.1194/jlr.M500424-JLR200; Listenberger LL, 2007, J LIPID RES, V48, P2751, DOI 10.1194/jlr.M700359-JLR200; Listenberger LL, 2007, CURR PROTOC CELL BIO, DOI [DOI 10.1002/0471143030.CB2402S35, 10.1002/0471143030.cb2402s35]; Llorente-Cortes V, 2007, J LIPID RES, V48, P2133, DOI 10.1194/jlr.M700039-JLR200; Magnusson B, 2006, ARTERIOSCL THROM VAS, V26, P1566, DOI 10.1161/01.ATV.0000223345.11820.da; Manolio TA, 2010, NEW ENGL J MED, V363, P166, DOI 10.1056/NEJMra0905980; McIntosh AL, 2012, AM J PHYSIOL-CELL PH, V303, pC728, DOI 10.1152/ajpcell.00448.2011; Nakamura N, 2003, BIOCHEM BIOPH RES CO, V306, P333, DOI 10.1016/S0006-291X(03)00979-3; Narayanaswami V, 2010, COMP BIOCHEM PHYS A, V155, P123, DOI 10.1016/j.cbpa.2009.09.009; Nuotio K, 2007, STROKE, V38, P1791, DOI 10.1161/STROKEAHA.106.478867; Paul A, 2008, CIRC RES, V102, P1492, DOI 10.1161/CIRCRESAHA.107.168070; Perman JC, 2011, J CLIN INVEST, V121, P2625, DOI 10.1172/JCI43068; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rader DJ, 2005, CELL METAB, V1, P223, DOI 10.1016/j.cmet.2005.03.005; Robenek H, 2006, J CELL SCI, V119, P4215, DOI 10.1242/jcs.03191; Rydberg EK, 2003, ATHEROSCLEROSIS, V170, P245, DOI 10.1016/S0021-9150(03)00302-2; Spencer C, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001337; Sztalryd C, 2003, J CELL BIOL, V161, P1093, DOI 10.1083/jcb.200210169; Sztalryd C, 2006, J BIOL CHEM, V281, P34341, DOI 10.1074/jbc.M602497200; Tan GD, 2006, DIABETOLOGIA, V49, P158, DOI 10.1007/s00125-005-0044-z; Tansey JT, 2003, J BIOL CHEM, V278, P8401, DOI 10.1074/jbc.M211005200; VANHOOF G, 1995, FASEB J, V9, P736, DOI 10.1096/fasebj.9.9.7601338; Wang XK, 1999, FEBS LETT, V462, P145, DOI 10.1016/S0014-5793(99)01521-5; Watts GF, 2011, HEART, V97, P350, DOI 10.1136/hrt.2010.204990; WIGGINS D, 1992, BIOCHEM J, V284, P457, DOI 10.1042/bj2840457; Wolins NE, 2006, FEBS LETT, V580, P5484, DOI 10.1016/j.febslet.2006.08.040; Wolins NE, 2001, J BIOL CHEM, V276, P5101, DOI 10.1074/jbc.M006775200; Zechner R, 2009, J LIPID RES, V50, P3, DOI 10.1194/jlr.R800031-JLR200	54	30	30	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2013	27	8					3090	3099		10.1096/fj.13-228759	http://dx.doi.org/10.1096/fj.13-228759			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	292BT	23603836				2022-12-25	WOS:000329877600016
J	Qiu, X; Dong, S; Qiao, F; Lu, S; Song, Y; Lao, Y; Li, Y; Zeng, T; Hu, J; Zhang, L; Zhang, L; Fan, H				Qiu, X.; Dong, S.; Qiao, F.; Lu, S.; Song, Y.; Lao, Y.; Li, Y.; Zeng, T.; Hu, J.; Zhang, L.; Zhang, L.; Fan, H.			HBx-mediated miR-21 upregulation represses tumor-suppressor function of PDCD4 in hepatocellular carcinoma	ONCOGENE			English	Article						hepatocellular carcinoma; hepatitis B virus X protein; PDCD4; miR-21	VIRUS-X-PROTEIN; HEPATITIS-B; GENE-EXPRESSION; CDNA MICROARRAY; DOWN-REGULATION; KAPPA-B; ACTIVATION; TRANSLATION; HEPATOCARCINOGENESIS; DEGRADATION	The hepatitis B virus (HBV) X protein (HBx) has a key role in the molecular pathogenesis of HBV-related hepatocellular carcinoma (HCC). However, the mechanism of HBx-mediated hepatocarcinogenesis remains to be elucidated. In this study, we aimed to better understand the effects of HBx on gene-expression profiles that participate in hepatocarcinogenesis and the mechanism by which HBx regulates these genes. Differentially expressed genes between L02-HBx and L02-Vector control cells were identified by microarray and validated using quantitative real-time PCR. HBx upregulates 456 genes and downregulates 843 genes, including programmed cell death 4 (PDCD4). PDCD4 was downregulated in clinical HCC specimens and the downregulation of PDCD4 in HCC is correlated with HBx. Furthermore, overexpression experiments in HCC cells proved that PDCD4 has strong tumor-suppressive effects both in vitro and in vivo, and may induce cell apoptosis to suppress the development of HCC. HBx induces expression of DNA methyltransferases (DNMTs), but failed to change the methylation status of the PDCD4 promoter. HBx downregulates PDCD4 expression at least partially through miR-21. Taken together, this study reported for the first time that HBx downregulates PDCD4 and upregulates miR-21 expression. The overexpression of PDCD4 could suppress tumorigenicity. The deregulation of PDCD4 by HBx through miR-21 represents a potential novel mechanism of the downregulation of PDCD4 in HBV-related HCC and provides new insights into HCC development.	[Qiu, X.; Qiao, F.; Song, Y.; Lao, Y.; Hu, J.; Fan, H.] Southeast Univ, Dept Med Genet & Dev Biol, Sch Med, Key Lab Dev Genes & Human Dis,Minist Educ, Nanjing 210009, Jiangsu, Peoples R China; [Dong, S.] Univ Hong Kong, Dept Clin Oncol, Hong Kong, Hong Kong, Peoples R China; [Lu, S.] Nanjing Med Univ, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China; [Li, Y.; Zeng, T.] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol Southern China, Guangzhou 510275, Guangdong, Peoples R China; [Zhang, L.] Shandong Univ, Sch Med, Dept Immunol, Jinan 250100, Peoples R China; [Zhang, L.] Southeast Univ, Affiliated Zhongda Hosp, Nanjing 210009, Jiangsu, Peoples R China	Southeast University - China; University of Hong Kong; Nanjing Medical University; State Key Lab Oncology South China; Sun Yat Sen University; Shandong University; Southeast University - China	Fan, H (corresponding author), Southeast Univ, Dept Med Genet & Dev Biol, Sch Med, Key Lab Dev Genes & Human Dis,Minist Educ, 87 Dingjiaqiao Rd, Nanjing 210009, Jiangsu, Peoples R China.	fanh@seu.edu.cn			National Natural Science Foundation of China [30470950, 91229107]; National 973 Basic Research Program of China [2013CB911302]; Innovative Scientific Research Projects for College Graduates of Jiangsu Province [CXZZ_0137]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National 973 Basic Research Program of China(National Basic Research Program of China); Innovative Scientific Research Projects for College Graduates of Jiangsu Province	This work was supported by The National Natural Science Foundation of China, no. 30470950, National 973 Basic Research Program of China 2013CB911302, National Natural Science Foundation of China, no. 91229107 and in part by Innovative Scientific Research Projects for College Graduates of Jiangsu Province, no. CXZZ_0137. We thank Professor Guan Xinyuan in the Univrsity of Hong Kong for providing the HBx construct, Dr Olubunmi Afonja in New York University for providing the PDCD4 construct and Dr Heike Allgayer in the University of Heidelberg for providing the PDCD4 promoter constructs.	Asangani IA, 2008, ONCOGENE, V27, P2128, DOI 10.1038/sj.onc.1210856; Buendia MA, 2000, SEMIN CANCER BIOL, V10, P185; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Dorrello NV, 2006, SCIENCE, V314, P467, DOI 10.1126/science.1130276; Fan H, 2007, EUR J GASTROEN HEPAT, V19, P952, DOI 10.1097/MEG.0b013e3282c3a89e; Frankel LB, 2008, J BIOL CHEM, V283, P1026, DOI 10.1074/jbc.M707224200; Gao F, 2009, J CELL MOL MED, V13, P4257, DOI 10.1111/j.1582-4934.2008.00497.x; Hajjou M, 2005, J MED VIROL, V77, P57, DOI 10.1002/jmv.20427; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Hilliard A, 2006, J IMMUNOL, V177, P8095, DOI 10.4049/jimmunol.177.11.8095; Huang JZ, 2003, WORLD J GASTROENTERO, V9, P84, DOI 10.3748/wjg.v9.i1.84; Jansen AP, 2005, CANCER RES, V65, P6034, DOI 10.1158/0008-5472.CAN-04-2119; Kong GY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019518; Kusano N, 1999, HEPATOLOGY, V29, P1858, DOI 10.1002/hep.510290636; Ladeiro Y, 2008, HEPATOLOGY, V47, P1955, DOI 10.1002/hep.22256; Lankat-Buttgereit B, 2003, BIOL CELL, V95, P515, DOI 10.1016/j.biolcel.2003.09.003; Lee JO, 2005, ONCOGENE, V24, P6617, DOI 10.1038/sj.onc.1208827; Leupold JH, 2012, BIOSCIENCE REP, V32, P281, DOI 10.1042/BSR20110045; Li J, 2010, BMC EVOL BIOL, V10, DOI [10.1186/1471-2148-10-68, 10.1186/1471-2407-10-354]; Lok AS, 2001, GASTROENTEROLOGY, V120, P1828, DOI 10.1053/gast.2001.24839; LUBER B, 1993, RES VIROLOGY, V144, P311, DOI 10.1016/S0923-2516(06)80047-6; Lupberger J, 2007, WORLD J GASTROENTERO, V13, P74, DOI 10.3748/wjg.v13.i1.74; Matsuhashi Sachiko, 1997, Research Communications in Biochemistry and Cell and Molecular Biology, V1, P109; Murakami Y, 2006, ONCOGENE, V25, P2537, DOI 10.1038/sj.onc.1209283; Okabe H, 2001, CANCER RES, V61, P2129; Ozaki I, 2000, CANCER RES, V60, P6519; Ozturk M, 1999, SEMIN LIVER DIS, V19, P235, DOI 10.1055/s-2007-1007113; Park IY, 2007, GASTROENTEROLOGY, V132, P1476, DOI 10.1053/j.gastro.2007.01.034; Schmid T, 2008, CANCER RES, V68, P1254, DOI 10.1158/0008-5472.CAN-07-1719; Si ML, 2007, ONCOGENE, V26, P2799, DOI 10.1038/sj.onc.1210083; Soejima K, 2003, ONCOGENE, V22, P4723, DOI 10.1038/sj.onc.1206510; Talotta F, 2009, ONCOGENE, V28, P73, DOI 10.1038/onc.2008.370; Tan A, 2008, LIVER INT, V28, P175, DOI 10.1111/j.1478-3231.2007.01652.x; Tanaka Y, 2006, ONCOGENE, V25, P633, DOI 10.1038/sj.onc.1209093; Tsai CN, 2002, P NATL ACAD SCI USA, V99, P10084, DOI 10.1073/pnas.152059399; Wang Q, 2008, ONCOGENE, V27, P1527, DOI 10.1038/sj.onc.1210793; Wang YL, 2004, HEPATOLOGY, V39, P318, DOI 10.1002/hep.20076; Wang Y, 2010, J HEPATOL, V53, P57, DOI 10.1016/j.jhep.2009.12.043; Yang HS, 2001, ONCOGENE, V20, P669, DOI 10.1038/sj.onc.1204137; Yoshinaga H, 1999, PATHOL INT, V49, P1067, DOI 10.1046/j.1440-1827.1999.00995.x; YU MW, 1994, CRIT REV ONCOL HEMAT, V17, P71, DOI 10.1016/1040-8428(94)90020-5; Zhang H, 2006, ONCOGENE, V25, P6101, DOI 10.1038/sj.onc.1209634; Zhang S, 2009, J EXP CLIN CANC RES, V28, P1; Zhang X, 2010, CANCER SCI, V101, P2163, DOI 10.1111/j.1349-7006.2010.01664.x; Zhang XY, 2009, HEPATOLOGY, V50, P490, DOI 10.1002/hep.23008; Zheng DL, 2009, J HEPATOL, V50, P377, DOI 10.1016/j.jhep.2008.10.019	47	95	105	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 4	2013	32	27					3296	3305		10.1038/onc.2013.150	http://dx.doi.org/10.1038/onc.2013.150			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	176JZ	23604124				2022-12-25	WOS:000321301600009
J	Sasaki, H; Toda, T; Furukawa, T; Mawatari, Y; Takaesu, R; Shimizu, M; Wada, R; Kato, D; Utsugi, T; Ohtsu, M; Murakami, Y				Sasaki, Hitoshi; Toda, Takanori; Furukawa, Toru; Mawatari, Yuki; Takaesu, Rika; Shimizu, Masashi; Wada, Ryohei; Kato, Dai; Utsugi, Takahiko; Ohtsu, Masaya; Murakami, Yasufumi			alpha-1,6-Fucosyltransferase (FUT8) Inhibits Hemoglobin Production during Differentiation of Murine and K562 Human Erythroleukemia Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR GATA-1; MOUSE EMBRYOS LACKING; CDNA CLONE SET; ERYTHROID-DIFFERENTIATION; ERYTHROPOIETIN RECEPTOR; GENE-EXPRESSION; HEMATOPOIETIC-CELLS; INITIAL ANNOTATION; DOWN-REGULATION; DEFICIENT MICE	Erythropoiesis results from a complex combination of the expression of several transcription factor genes and cytokine signaling. However, the overall view of erythroid differentiation remains unclear. First, we screened for erythroid differentiation- related genes by comparing the expression profiles of high differentiation-inducible and low differentiation-inducible murine erythroleukemia cells. We identified that overexpression of alpha-1,6-fucosyltransferase (Fut8) inhibits hemoglobin production. FUT8 catalyzes the transfer of a fucose residue to N-linked oligosaccharides on glycoproteins via an alpha-1,6 linkage, leading to core fucosylation in mammals. Expression of Fut8 was down-regulated during chemically induced differentiation of murine erythroleukemia cells. Additionally, expression of Fut8 was positively regulated by c-Myc and c-Myb, which are known as suppressors of erythroid differentiation. Second, we found that FUT8 is the only fucosyltransferase family member that inhibits hemoglobin production. Functional analysis of FUT8 revealed that the donor substrate-binding domain and a flexible loop play essential roles in inhibition of hemoglobin production. This result clearly demonstrates that core fucosylation inhibits hemoglobin production. Third, FUT8 also inhibited hemoglobin production of human erythroleukemia K562 cells. Finally, a short hairpin RNA study showed that FUT8 down-regulation induced hemoglobin production and increase of transferrin receptor/ glycophorin A-positive cells in human erythroleukemia K562 cells. Our findings define FUT8 as a novel factor for hemoglobin production and demonstrate that core fucosylation plays an important role in erythroid differentiation.	[Sasaki, Hitoshi; Toda, Takanori; Furukawa, Toru; Mawatari, Yuki; Takaesu, Rika; Shimizu, Masashi; Wada, Ryohei; Kato, Dai; Ohtsu, Masaya; Murakami, Yasufumi] Tokyo Univ Sci, Fac Ind Sci & Technol, Dept Biol Sci & Technol, Tokyo 1258585, Japan; [Sasaki, Hitoshi; Toda, Takanori; Furukawa, Toru; Mawatari, Yuki; Takaesu, Rika; Shimizu, Masashi; Wada, Ryohei; Utsugi, Takahiko; Murakami, Yasufumi] Tokyo Univ Sci, Genome & Drug Res Ctr, Chiba 2700101, Japan; [Utsugi, Takahiko; Murakami, Yasufumi] Bio Matrix Res Inc, Chiba 2700101, Japan	Tokyo University of Science; Tokyo University of Science	Murakami, Y (corresponding author), Tokyo Univ Sci, Fac Ind Sci & Technol, Dept Biol Sci & Technol, Katsushika Ku, 3-1,Niijyuku 6 Chome, Tokyo 1258585, Japan.	yasufumi@rs.noda.tus.ac.jp	Furukawa, Toru/AAF-5596-2021	Furukawa, Toru/0000-0002-1083-2324	Bio Matrix Research Inc.	Bio Matrix Research Inc.	This work was supported by Bio Matrix Research Inc.	ANDERSSON LC, 1979, NATURE, V278, P364, DOI 10.1038/278364a0; Athanasiou M, 2000, LEUKEMIA, V14, P439, DOI 10.1038/sj.leu.2401689; Athanasiou M, 1996, CELL GROWTH DIFFER, V7, P1525; Bany-Laszewicz U, 2004, CELL MOL BIOL LETT, V9, P145; Bartunek P, 2003, ONCOGENE, V22, P1927, DOI 10.1038/sj.onc.1206281; BENDAVID Y, 1990, P NATL ACAD SCI USA, V87, P1332, DOI 10.1073/pnas.87.4.1332; BURGER PE, 1994, BLOOD, V83, P1808; Di Pietro R, 2007, J CELL BIOCHEM, V100, P1070, DOI 10.1002/jcb.21106; FRIEND C, 1971, P NATL ACAD SCI USA, V68, P378; FUJITA H, 1991, J BIOL CHEM, V266, P17494; Fujiwara Y, 1996, P NATL ACAD SCI USA, V93, P12355, DOI 10.1073/pnas.93.22.12355; FUKUDA Y, 1994, BLOOD, V83, P1662; Ghaffari S, 2001, BLOOD, V98, P2948, DOI 10.1182/blood.V98.10.2948; Ihara H, 2007, GLYCOBIOLOGY, V17, P455, DOI 10.1093/glycob/cwl079; IKAWA Y, 1976, GANN, V67, P767; Jayapal S, 2010, J BIOL CHEM, V285, P40252, DOI 10.1074/jbc.M110.181073; Kaneko K, 2009, FEBS J, V276, P1370, DOI 10.1111/j.1742-4658.2009.06878.x; KANEKOISHINO T, 1988, MOL CELL BIOL, V8, P5545, DOI 10.1128/MCB.8.12.5545; Kargul GJ, 2001, NAT GENET, V28, P17, DOI 10.1038/ng0501-17; Kieran MW, 1996, P NATL ACAD SCI USA, V93, P9126, DOI 10.1073/pnas.93.17.9126; Kumar MS, 2011, BLOOD, V118, P4666, DOI 10.1182/blood-2010-12-324715; LACHMAN HM, 1984, NATURE, V310, P592, DOI 10.1038/310592a0; Li W, 2008, GLYCOBIOLOGY, V18, P114, DOI 10.1093/glycob/cwm107; Lin CS, 1996, GENE DEV, V10, P154, DOI 10.1101/gad.10.2.154; LOZZIO CB, 1975, BLOOD, V45, P321, DOI 10.1182/blood.V45.3.321.321; Ma B, 2006, GLYCOBIOLOGY, V16, p158R, DOI 10.1093/glycob/cwl040; MARKS PA, 1987, ANN NY ACAD SCI, V511, P246, DOI 10.1111/j.1749-6632.1987.tb36252.x; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Ney PA, 2000, BLOOD, V96, P3675, DOI 10.1182/blood.V96.12.3675.h8003675_3675_3680; Nosaka T, 1999, EMBO J, V18, P4754, DOI 10.1093/emboj/18.17.4754; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Pang CJ, 2012, MOL CELL BIOL, V32, P2628, DOI 10.1128/MCB.00104-12; Rekhtman N, 1999, GENE DEV, V13, P1398, DOI 10.1101/gad.13.11.1398; RUTHERFORD T, 1981, P NATL ACAD SCI-BIOL, V78, P348, DOI 10.1073/pnas.78.1.348; Rylski M, 2003, MOL CELL BIOL, V23, P5031, DOI 10.1128/MCB.23.14.5031-5042.2003; SCOTT EW, 1994, SCIENCE, V265, P1573, DOI 10.1126/science.8079170; Siatecka M, 2011, BLOOD, V118, P2044, DOI 10.1182/blood-2011-03-331371; Starck J, 2003, MOL CELL BIOL, V23, P1390, DOI 10.1128/MCB.23.4.1390-1402.2003; Takahashi T, 2000, GLYCOBIOLOGY, V10, P503, DOI 10.1093/glycob/10.5.503; Tanaka TS, 2000, P NATL ACAD SCI USA, V97, P9127, DOI 10.1073/pnas.97.16.9127; TODOKORO K, 1988, P NATL ACAD SCI USA, V85, P8900, DOI 10.1073/pnas.85.23.8900; VanBuren V, 2002, GENOME RES, V12, P1999, DOI 10.1101/gr.633802; Wang XC, 2005, P NATL ACAD SCI USA, V102, P15791, DOI 10.1073/pnas.0507375102; Wang XC, 2006, J BIOL CHEM, V281, P2572, DOI 10.1074/jbc.M510893200; WEISS MJ, 1995, P NATL ACAD SCI USA, V92, P9623, DOI 10.1073/pnas.92.21.9623; Welch JJ, 2004, BLOOD, V104, P3136, DOI 10.1182/blood-2004-04-1603; WITTHUHN BA, 1993, CELL, V74, P227, DOI 10.1016/0092-8674(93)90414-L; Wojda U, 2002, BLOOD, V99, P3005, DOI 10.1182/blood.V99.8.3005.h8003005_3005_3013; WU H, 1995, CELL, V83, P59, DOI 10.1016/0092-8674(95)90234-1; Yamaguchi Y, 2000, GLYCOBIOLOGY, V10, P637, DOI 10.1093/glycob/10.6.637; YOSHIDA M, 1987, CANCER RES, V47, P3688; Zhao W, 2006, BLOOD, V107, P907, DOI 10.1182/blood-2005-06-2516	52	11	12	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2013	288	23					16839	16847		10.1074/jbc.M113.459594	http://dx.doi.org/10.1074/jbc.M113.459594			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	163ZU	23609441	Green Published, hybrid			2022-12-25	WOS:000320378900056
J	Hong, XX; Carmichael, GG				Hong, Xiao-Xiao; Carmichael, Gordon G.			Innate Immunity in Pluripotent Human Cells ATTENUATED RESPONSE TO INTERFERON-beta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYONIC STEM-CELLS; PROTEIN-TYROSINE-PHOSPHATASE; ALPHA-INDUCED APOPTOSIS; CYTOKINE SIGNALING-1; PROMOTES SURVIVAL; MESSENGER-RNAS; SELF-RENEWAL; KAPPA-B; ACTIVATION; STAT3	Type I interferon (IFN-alpha/beta) binds to cell surface receptors IFNAR1 and IFNAR2 and triggers a signaling cascade that leads to the transcription of hundreds of IFN-stimulated genes. This response is a crucial component in innate immunity in that it establishes an "antiviral state" in cells and protects them against further damage. Previous work demonstrated that, compared with their differentiated counterparts, pluripotent human cells have a much weaker response to cytoplasmic double-stranded RNA(dsRNA) and are only able to produce a minimal amount of IFN-beta. Weshow here that human embryonic stem cells (hESCs) and human induced pluripotent stem cells (hiPSCs) also exhibit an attenuated response to IFN-beta. Even though all known type I IFN signaling components are expressed in these cells, STAT1 phosphorylation is greatly diminished upon IFN-beta treatment. This attenuated response correlates with a high expression of suppressor of cytokine signaling 1 (SOCS1). Upon differentiation of hESCs into trophoblasts, cells acquire the ability to respond to IFN-beta, and this is accompanied by a significant induction of STAT1 phosphorylation as well as a decrease in SOCS1 expression. Furthermore, SOCS1 knockdown in hiPSCs enhances their ability to respond to IFN-beta. Taken together, our results suggest that an attenuated cellular response to type I IFNs may be a general feature of pluripotent human cells and that this is associated with high expression of SOCS1.	[Hong, Xiao-Xiao; Carmichael, Gordon G.] Univ Connecticut, Ctr Hlth, Dept Genet & Dev Biol, Farmington, CT 06030 USA	University of Connecticut	Carmichael, GG (corresponding author), Univ Connecticut, Ctr Hlth, Dept Genet & Dev Biol, 400 Farmington Ave, Farmington, CT 06030 USA.	carmichael@nso2.uchc.edu			State of Connecticut under the Connecticut Stem Cell Research Grants Program	State of Connecticut under the Connecticut Stem Cell Research Grants Program	This work was supported by an Established Investigator award from the State of Connecticut under the Connecticut Stem Cell Research Grants Program (to G. G. C.).	Alexander WS, 2004, ANNU REV IMMUNOL, V22, P503, DOI 10.1146/annurev.immunol.22.091003.090312; Babon JJ, 2008, J MOL BIOL, V381, P928, DOI 10.1016/j.jmb.2008.06.038; Barca O, 2003, J NEUROIMMUNOL, V139, P155, DOI 10.1016/S0165-5728(03)00160-7; Brysha M, 2001, J BIOL CHEM, V276, P22086, DOI 10.1074/jbc.M102737200; Chen LL, 2010, CELL CYCLE, V9, P3552, DOI 10.4161/cc.9.17.12792; Chen LL, 2009, MOL CELL, V35, P467, DOI 10.1016/j.molcel.2009.06.027; Chin YE, 1997, MOL CELL BIOL, V17, P5328, DOI 10.1128/MCB.17.9.5328; Chung CD, 1997, SCIENCE, V278, P1803, DOI 10.1126/science.278.5344.1803; Daheron L, 2004, STEM CELLS, V22, P770, DOI 10.1634/stemcells.22-5-770; Dumitru R, 2012, MOL CELL, V46, P573, DOI 10.1016/j.molcel.2012.04.002; Fujimoto M, 2003, TRENDS IMMUNOL, V24, P659, DOI 10.1016/j.it.2003.10.008; Gao SM, 2013, EXP HEMATOL, V41, P261, DOI 10.1016/j.exphem.2012.10.012; Gonzalez-Navajas JM, 2012, NAT REV IMMUNOL, V12, P125, DOI 10.1038/nri3133; Humphrey RK, 2004, STEM CELLS, V22, P522, DOI 10.1634/stemcells.22-4-522; Ilangumaran S, 2004, SEMIN IMMUNOL, V16, P351, DOI 10.1016/j.smim.2004.08.015; Ilangumaran S, 2002, J IMMUNOL, V169, P5010, DOI 10.4049/jimmunol.169.9.5010; Irie-Sasaki J, 2001, NATURE, V409, P349, DOI 10.1038/35053086; ISAACS A, 1957, PROC R SOC SER B-BIO, V147, P258, DOI 10.1098/rspb.1957.0048; Kubo M, 2003, NAT IMMUNOL, V4, P1169, DOI 10.1038/ni1012; Kumar A, 1997, SCIENCE, V278, P1630, DOI 10.1126/science.278.5343.1630; Lee J, 2012, CELL, V151, P547, DOI 10.1016/j.cell.2012.09.034; Li YZ, 2005, J BIOL CHEM, V280, P10001, DOI 10.1074/jbc.M410972200; Liu B, 2004, NAT IMMUNOL, V5, P891, DOI 10.1038/ni1104; Ma Y., 2012, CURR PROTOC STEM CEL; Matsuda T, 1999, EMBO J, V18, P4261, DOI 10.1093/emboj/18.15.4261; Myers MP, 2001, J BIOL CHEM, V276, P47771, DOI 10.1074/jbc.C100583200; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Platanias LC, 1996, J BIOL CHEM, V271, P278, DOI 10.1074/jbc.271.1.278; Raz R, 1999, P NATL ACAD SCI USA, V96, P2846, DOI 10.1073/pnas.96.6.2846; Ruuth K, 2001, BIOCHEM BIOPH RES CO, V284, P583, DOI 10.1006/bbrc.2001.5025; Shultz LD, 1997, TRENDS BIOTECHNOL, V15, P302, DOI 10.1016/S0167-7799(97)01060-3; Simoncic PD, 2002, CURR BIOL, V12, P446, DOI 10.1016/S0960-9822(02)00697-8; Sironi JJ, 2004, J BIOL CHEM, V279, P4066, DOI 10.1074/jbc.M307774200; Soloaga A, 2003, EMBO J, V22, P2788, DOI 10.1093/emboj/cdg273; Svoboda P, 2000, DEVELOPMENT, V127, P4147; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Thyrell L, 2004, J BIOL CHEM, V279, P24152, DOI 10.1074/jbc.M312219200; Uddin S, 1999, J BIOL CHEM, V274, P30127, DOI 10.1074/jbc.274.42.30127; UDDIN S, 1995, J BIOL CHEM, V270, P15938, DOI 10.1074/jbc.270.27.15938; Uddin S, 2000, BIOCHEM BIOPH RES CO, V270, P158, DOI 10.1006/bbrc.2000.2402; Wang YJ, 2000, MOL CELL BIOL, V20, P4505, DOI 10.1128/MCB.20.13.4505-4512.2000; WHYATT LM, 1993, MOL CELL BIOL, V13, P7971, DOI 10.1128/MCB.13.12.7971; Wianny F, 2000, NAT CELL BIOL, V2, P70, DOI 10.1038/35000016; Xu RH, 2002, NAT BIOTECHNOL, V20, P1261, DOI 10.1038/nbt761; Xu RH, 2005, NAT METHODS, V2, P185, DOI 10.1038/NMETH744; Yang CL, 2001, J BIOL CHEM, V276, P47277, DOI 10.1074/jbc.M105396200; Yang L, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r16; Zeng H, 2009, STEM CELLS, V27, P2435, DOI 10.1002/stem.192; Zhang JY, 2000, SEMIN IMMUNOL, V12, P361, DOI 10.1006/smim.2000.0223	50	45	46	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 31	2013	288	22					16196	16205		10.1074/jbc.M112.435461	http://dx.doi.org/10.1074/jbc.M112.435461			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	156LA	23599426	Green Published, hybrid			2022-12-25	WOS:000319822300070
J	Bellon, JR; Schmid, F; Capone, DL; Dunn, BL; Chambers, PJ				Bellon, Jennifer R.; Schmid, Frank; Capone, Dimitra L.; Dunn, Barbara L.; Chambers, Paul J.			Introducing a New Breed of Wine Yeast: Interspecific Hybridisation between a Commercial Saccharomyces cerevisiae Wine Yeast and Saccharomyces mikatae	PLOS ONE			English	Article							TARTARIC ACID-ESTERS; VOLATILE COMPOSITION; VITIS-VINIFERA; HYBRIDS; FERMENTATION; EVOLUTION; STRAINS; KUDRIAVZEVII; DIVERSITY; FLAVOR	Interspecific hybrids are commonplace in agriculture and horticulture; bread wheat and grapefruit are but two examples. The benefits derived from interspecific hybridisation include the potential of generating advantageous transgressive phenotypes. This paper describes the generation of a new breed of wine yeast by interspecific hybridisation between a commercial Saccharomyces cerevisiae wine yeast strain and Saccharomyces mikatae, a species hitherto not associated with industrial fermentation environs. While commercially available wine yeast strains provide consistent and reliable fermentations, wines produced using single inocula are thought to lack the sensory complexity and rounded palate structure obtained from spontaneous fermentations. In contrast, interspecific yeast hybrids have the potential to deliver increased complexity to wine sensory properties and alternative wine styles through the formation of novel, and wider ranging, yeast volatile fermentation metabolite profiles, whilst maintaining the robustness of the wine yeast parent. Screening of newly generated hybrids from a cross between a S. cerevisiae wine yeast and S. mikatae (closely-related but ecologically distant members of the Saccharomyces sensu stricto clade), has identified progeny with robust fermentation properties and winemaking potential. Chemical analysis showed that, relative to the S. cerevisiae wine yeast parent, hybrids produced wines with different concentrations of volatile metabolites that are known to contribute to wine flavour and aroma, including flavour compounds associated with non-Saccharomyces species. The new S. cerevisiae x S. mikatae hybrids have the potential to produce complex wines akin to products of spontaneous fermentation while giving winemakers the safeguard of an inoculated ferment.	[Bellon, Jennifer R.; Capone, Dimitra L.; Chambers, Paul J.] Australian Wine Res Inst, Glen Osmond, SA, Australia; [Bellon, Jennifer R.; Schmid, Frank] Univ Adelaide, Sch Agr & Wine, Glen Osmond, SA, Australia; [Dunn, Barbara L.] Stanford Univ, Dept Genet, Stanford, CA 94305 USA	Australian Wine Research Institute; University of Adelaide; Stanford University	Bellon, JR (corresponding author), Australian Wine Res Inst, Glen Osmond, SA, Australia.	Jenny.Bellon@awri.com.au	Capone, Dimitra/ABC-7444-2020	Capone, Dimitra/0000-0003-4424-0746; Dunn, Barbara/0000-0002-7041-0035	Australia's grape-growers and winemakers through their investment body the Grape and Wine Research Development Corporation; Australian Government	Australia's grape-growers and winemakers through their investment body the Grape and Wine Research Development Corporation(Australian Grape and Wine Authority); Australian Government(Australian GovernmentCGIAR)	This work was financially supported by Australia's grape-growers and winemakers through their investment body the Grape and Wine Research Development Corporation (http://www.gwrdc.com.au/site/page.cfm), with matching funds from the Australian Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams KL, 2005, CURR OPIN PLANT BIOL, V8, P135, DOI 10.1016/j.pbi.2005.01.001; Ausubel FM, 1994, CURRENT PROTOCOLS MO; Bellon JR, 2011, APPL MICROBIOL BIOT, V91, P603, DOI 10.1007/s00253-011-3294-3; Borneman AR, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001287; Borneman AR, 2012, GENOME RES, V18, P1610; Bradbury JE, 2006, ANTON LEEUW INT J G, V89, P27, DOI 10.1007/s10482-005-9006-1; Chambers P.J., 2009, YEAST BIOTECHNOLOGY, P433, DOI [10.1007/978-1-4020-8292-4_20, DOI 10.1007/978-1-4020-8292-4_20]; Delneri D, 2003, NATURE, V422, P68, DOI 10.1038/nature01418; Dunn B, 2008, GENOME RES, V18, P1610, DOI 10.1101/gr.076075.108; Dunn B, 2012, GENOME RES, V22, P908, DOI 10.1101/gr.130310.111; Egli CM, 1998, J APPL MICROBIOL, V85, P779, DOI 10.1046/j.1365-2672.1998.00521.x; Esteve-Zarzoso B, 1999, GENETICS, V70, P41; FLAVELL RB, 1989, GENOME, V31, P963, DOI 10.1139/g89-168; FLEET GH, 1984, APPL ENVIRON MICROB, V48, P1034, DOI 10.1128/AEM.48.5.1034-1038.1984; Gerstein AC, 2006, PLOS GENET, V2, P1396, DOI 10.1371/journal.pgen.0020145; Gonzalez SS, 2006, FEMS YEAST RES, V6, P1221, DOI 10.1111/j.1567-1364.2006.00126.x; Groth G, 1999, INT J SYST BACTERIOL, V49, P1933; GUNGE N, 1972, GENETICS, V70, P41; Hanssen HP, 1981, FLAVOUR 81, P547; HERRAIZ T, 1990, AM J ENOL VITICULT, V41, P313; Howell KS, 2004, LETT APPL MICROBIOL, V38, P315, DOI 10.1111/j.1472-765X.2004.01486.x; Kellis M, 2003, NATURE, V423, P241, DOI 10.1038/nature01644; King ES, 2008, J AGR FOOD CHEM, V56, P10829, DOI 10.1021/jf801695h; Libkind D, 2011, P NATL ACAD SCI USA, V108, P14539, DOI 10.1073/pnas.1105430108; Masneuf I, 1998, APPL ENVIRON MICROB, V64, P3887; MORTIMER RK, 1994, YEAST, V10, P1543, DOI 10.1002/yea.320101203; Naumov GI, 2000, INT J SYST EVOL MICR, V50, P1931, DOI 10.1099/00207713-50-5-1931; Nissen TL, 1997, MICROBIOL-UK, V143, P203, DOI 10.1099/00221287-143-1-203; NOBLE AC, 1994, PHYSIOL BEHAV, V56, P1251, DOI 10.1016/0031-9384(94)90373-5; NOBLE AC, 1984, AM J ENOL VITICULT, V35, P110; ONG BY, 1978, J CHROMATOGR, V157, P345, DOI 10.1016/S0021-9673(00)92352-5; Perez-Traves L, 2012, INT J FOOD MICROBIOL, V156, P102, DOI 10.1016/j.ijfoodmicro.2012.03.008; Pontes O, 2004, P NATL ACAD SCI USA, V101, P18240, DOI 10.1073/pnas.0407258102; Pretorius IS, 2000, YEAST, V16, P675, DOI 10.1002/1097-0061(20000615)16:8<675::AID-YEA585>3.0.CO;2-B; Prior B. A., 1997, YEAST SUGAR METABOLI, P313; Romano P, 2003, INT J FOOD MICROBIOL, V86, P169, DOI 10.1016/S0168-1605(03)00290-3; ROMEYER FM, 1983, J AGR FOOD CHEM, V31, P346, DOI 10.1021/jf00116a040; Saison D, 2009, FOOD CHEM, V114, P1206, DOI 10.1016/j.foodchem.2008.10.078; SALMON JM, 1989, APPL ENVIRON MICROB, V55, P953, DOI 10.1128/AEM.55.4.953-958.1989; Salmon JM, 1997, J FERMENT BIOENG, V83, P253, DOI 10.1016/S0922-338X(97)80988-9; Scanes K. T., 1998, South African Journal for Enology and Viticulture, V19, P17; Scannell DR, 2011, G3-GENES GENOM GENET, V1, P11, DOI 10.1534/g3.111.000273; Schuetz M., 1993, Chemie Mikrobiologie Technologie der Lebensmittel, V15, P73; SCHUTZ M, 1993, J APPL BACTERIOL, V75, P551, DOI 10.1111/j.1365-2672.1993.tb01594.x; Siebert TE, 2005, ANAL BIOANAL CHEM, V381, P937, DOI 10.1007/s00216-004-2992-4; Soden A., 2000, Australian Journal of Grape and Wine Research, V6, P21, DOI 10.1111/j.1755-0238.2000.tb00158.x; SOMERS TC, 1985, J SCI FOOD AGR, V36, P1275, DOI 10.1002/jsfa.2740361212; SOMERS TC, 1991, VITIS, V30, P189; Spencer John F. T., 1996, V53, P39; Winge O, 1938, CR LAB CARLSBERG SER, V22, P235; Yamada Y., 1993, B JFCC, V9, P95; Zambonelli C., 1993, Annali di Microbiologia ed Enzimologia, V43, P217	52	64	63	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2013	8	4							e62053	10.1371/journal.pone.0062053	http://dx.doi.org/10.1371/journal.pone.0062053			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IK	23614011	Green Submitted, Green Published, gold			2022-12-25	WOS:000317907200118
J	Kong, FJ; Chen, SP; Cheng, Y; Ma, LL; Lu, HS; Zhang, HH; Hu, WW				Kong, Feijuan; Chen, Shuping; Cheng, Yuan; Ma, Leilei; Lu, Huishun; Zhang, Honghai; Hu, Wenwen			Minocycline Attenuates Cognitive Impairment Induced by Isoflurane Anesthesia in Aged Rats	PLOS ONE			English	Article							HUNTINGTONS-DISEASE; GENERAL-ANESTHESIA; POSTNATAL MEMORY; ALZHEIMERS-DISEASE; NONCARDIAC SURGERY; LEARNING-DEFICITS; OXIDE ANESTHESIA; FETAL EXPOSURE; DYSFUNCTION; INJURY	Postoperative cognitive dysfunction (POCD) is a clinical phenomenon characterized by cognitive deficits in patients after anesthesia and surgery, especially in geriatric surgical patients. Although it has been documented that isoflurane exposure impaired cognitive function in several aged animal models, there are few clinical interventions and treatments available to prevent this disorder. Minocycline has been well established to exert neuroprotective effects in various experimental animal models and neurodegenerative diseases. Therefore, we hypothesized that pretreatment with minocycline attenuates isoflurane-induced cognitive decline in aged rats. In the present study, twenty-month-old rats were administered minocycline or an equal volume of saline by intraperitoneal injection 12 h before exposure to isoflurane. Then the rats were exposed to 1.3% isoflurane for 4 h. Two weeks later, spatial learning and memory of the rats were examined using the Morris Water Maze. We found that pretreatment with minocycline mitigated isoflurane-induced cognitive deficits and suppressed the isoflurane-induced excessive release of IL-1 beta and caspase-3 in the hippocampal CA1 region at 4 h after isoflurane exposure, as well as the number of TUNEL-positive nuclei. In addition, minocycline treatment also prevented the changes of synaptic ultrastructure in the hippocampal CA1 region induced by isoflurane. In conclusion, pretreatment with minocycline attenuated isoflurane-induced cognitive impairment in aged rats.	[Kong, Feijuan; Chen, Shuping; Cheng, Yuan; Zhang, Honghai] Nanjing Med Univ, Hangzhou Peoples Hosp 1, Dept Anesthesiol, Hangzhou, Zhejiang, Peoples R China; [Ma, Leilei] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Anesthesiol, Hangzhou 310003, Zhejiang, Peoples R China; [Lu, Huishun; Hu, Wenwen] Zhejiang Univ, Sch Med, Womens Hosp, Dept Anesthesiol, Hangzhou 310003, Zhejiang, Peoples R China	Nanjing Medical University; Zhejiang University; Zhejiang University	Kong, FJ (corresponding author), Nanjing Med Univ, Hangzhou Peoples Hosp 1, Dept Anesthesiol, Hangzhou, Zhejiang, Peoples R China.	kongfeijuan@163.com; lig08010915@163.com			Medical and Health Research Fund of Health Department of Zhejiang Provincial, China [2010KYA129]	Medical and Health Research Fund of Health Department of Zhejiang Provincial, China	The work was supported by Medical and Health Research Fund of Health Department of Zhejiang Provincial, China (NO. 2010KYA129). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abildstrom H, 2000, ACTA ANAESTH SCAND, V44, P1246, DOI 10.1034/j.1399-6576.2000.441010.x; ARONSON AL, 1980, J AM VET MED ASSOC, V176, P1061; Baranov D, 2009, ANESTH ANALG, V108, P1627, DOI 10.1213/ane.0b013e318199dc72; Bekker Alex Y, 2003, Best Pract Res Clin Anaesthesiol, V17, P259, DOI 10.1016/S1521-6896(03)00005-3; Blum D, 2004, NEUROBIOL DIS, V17, P359, DOI 10.1016/j.nbd.2004.07.012; Bonelli RM, 2003, NEUROLOGY, V60, P883, DOI 10.1212/01.WNL.0000049936.85487.7A; Choi Y, 2007, NEUROPSYCHOPHARMACOL, V32, P2393, DOI 10.1038/sj.npp.1301377; Clergue F, 1999, ANESTHESIOLOGY, V91, P1509, DOI 10.1097/00000542-199911000-00045; Culley DJ, 2004, ANESTHESIOLOGY, V100, P309, DOI 10.1097/00000542-200402000-00020; Culley DJ, 2003, ANESTH ANALG, V96, P1004, DOI 10.1213/01.ANE.0000052712.67573.12; Diguet E, 2004, EXP NEUROL, V189, P1, DOI 10.1016/j.expneurol.2004.05.016; Fang M, 2003, J BIOL CHEM, V278, P36669, DOI 10.1074/jbc.M303520200; Grasshoff C, 2007, TOXICOLOGY, V229, P206, DOI 10.1016/j.tox.2006.10.017; Gruart A, 2006, J NEUROSCI, V26, P1077, DOI 10.1523/JNEUROSCI.2834-05.2006; Izquierdo I, 1999, BEHAV BRAIN RES, V103, P1, DOI 10.1016/S0166-4328(99)00036-4; Jevtovic-Todorovic V, 2003, J NEUROSCI, V23, P876, DOI 10.1523/jneurosci.23-03-00876.2003; Kong FJ, 2012, BIOCHEM PHARMACOL, V84, P558, DOI 10.1016/j.bcp.2012.06.001; Kong FJ, 2011, EUR J PHARMACOL, V670, P168, DOI 10.1016/j.ejphar.2011.08.050; Li YJ, 2007, NEUROPHARMACOLOGY, V53, P942, DOI 10.1016/j.neuropharm.2007.09.005; Lin DW, 2011, NEUROPHARMACOLOGY, V61, P1354, DOI 10.1016/j.neuropharm.2011.08.011; Lunardi N, 2010, NEUROTOX RES, V17, P179, DOI 10.1007/s12640-009-9088-z; Mawhinney LJ, 2012, BRAIN RES, V1431, P23, DOI 10.1016/j.brainres.2011.11.004; Moller JT, 1998, LANCET, V351, P857, DOI 10.1016/S0140-6736(97)07382-0; Monk TG, 2008, ANESTHESIOLOGY, V108, P18, DOI 10.1097/01.anes.0000296071.19434.1e; Newman MF, 2001, NEW ENGL J MED, V344, P395, DOI 10.1056/NEJM200102083440601; Nicholson DA, 2004, J NEUROSCI, V24, P7648, DOI 10.1523/JNEUROSCI.1725-04.2004; Palazuelos J, 2009, BRAIN, V132, P3152, DOI 10.1093/brain/awp239; Planel E, 2007, J NEUROSCI, V27, P3090, DOI 10.1523/JNEUROSCI.4854-06.2007; Ramaiah Ramesh, 2009, Anesthesiol Clin, V27, P485, DOI 10.1016/j.anclin.2009.07.011; Rasmussen LS, 2003, ACTA ANAESTH SCAND, V47, P260, DOI 10.1034/j.1399-6576.2003.00057.x; Sametsky EA, 2010, NEUROBIOL AGING, V31, P813, DOI 10.1016/j.neurobiolaging.2008.05.029; Sanderson DJ, 2009, BEHAV BRAIN RES, V201, P103, DOI 10.1016/j.bbr.2009.01.038; Smith DL, 2003, ANN NEUROL, V54, P186, DOI 10.1002/ana.10614; Steinmetz J, 2009, ANESTHESIOLOGY, V110, P548, DOI 10.1097/ALN.0b013e318195b569; Stirling DP, 2004, J NEUROSCI, V24, P2182, DOI 10.1523/JNEUROSCI.5275-03.2004; Szymanska A, 2006, EXP NEUROL, V197, P189, DOI 10.1016/j.expneurol.2005.09.011; Tao YX, 2004, MOL INTERV, V4, P215, DOI 10.1124/mi.4.4.5; Terrando N, 2010, P NATL ACAD SCI USA, V107, P20518, DOI 10.1073/pnas.1014557107; Terrando N, 2010, CRIT CARE, V14, DOI 10.1186/cc9019; Thompson JV, 2008, BRAIN RES, V1200, P58, DOI 10.1016/j.brainres.2008.01.057; Valentim AM, 2010, ANESTHESIOLOGY, V113, P1099, DOI 10.1097/ALN.0b013e3181f79c7c; WILLIAMSRUSSO P, 1995, JAMA-J AM MED ASSOC, V274, P44, DOI 10.1001/jama.274.1.44; Wu DC, 2002, J NEUROSCI, V22, P1763, DOI 10.1523/JNEUROSCI.22-05-01763.2002; Wu X, 2012, NEUROBIOL AGING, V33, P1364, DOI 10.1016/j.neurobiolaging.2010.11.002; Yrjanheikki J, 1999, P NATL ACAD SCI USA, V96, P13496, DOI 10.1073/pnas.96.23.13496; Zhang YY, 2012, ANN NEUROL, V71, P687, DOI 10.1002/ana.23536; Ziff EB, 1997, NEURON, V19, P1163, DOI 10.1016/S0896-6273(00)80409-2	47	51	53	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2013	8	4							e61385	10.1371/journal.pone.0061385	http://dx.doi.org/10.1371/journal.pone.0061385			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IK	23613842	Green Published, Green Submitted, gold			2022-12-25	WOS:000317907200052
J	Kuniholm, MH; Parrinello, CM; Anastos, K; Augenbraun, M; Plankey, M; Nowicki, M; Peters, M; Golub, ET; Lurain, N; Landay, AL; Strickler, HD; Kaplan, RC				Kuniholm, Mark H.; Parrinello, Christina M.; Anastos, Kathryn; Augenbraun, Michael; Plankey, Michael; Nowicki, Marek; Peters, Marion; Golub, Elizabeth T.; Lurain, Nell; Landay, Alan L.; Strickler, Howard D.; Kaplan, Robert C.			Hepatitis C Viremia Is Associated with Cytomegalovirus IgG Antibody Levels in HIV-Infected Women	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; SIMPLE NONINVASIVE INDEX; DWELLING OLDER-ADULTS; CD8(+) T-CELLS; ATHEROSCLEROSIS RISK; SIGNIFICANT FIBROSIS; IMMUNE-RESPONSES; VIRUS-INFECTION; ALL-CAUSE; DISEASE	Background: Individuals with HIV infection exhibit high cytomegalovirus (CMV) IgG levels, but there are few data regarding the association of hepatitis C virus (HCV) with the immune response against CMV. Methods: Associations of HCV with CMV seropositivity and CMV IgG levels were studied in 635 HIV-infected women, 187 of whom were HCV-seropositive, with adjustment in multivariable models for age, race/ethnicity, and HIV disease characteristics. Eighty one percent of the women reported receipt of highly active antiretroviral therapy (HAART) prior to or at CMV testing. Results: In adjusted models women with chronic HCV had higher CMV IgG levels than those without HCV RNA (beta = 2.86, 95% CI:0.89 - 4.83; P = 0.004). The association of HCV RNA with CMV IgG differed by age (P-interaction = 0.0007), with a strong association observed among women in the low and middle age tertiles (<= 45.3 years of age; beta = 6.21, 95% CI: 3.30 - 9.11, P < .0001) but not among women in the high age tertile. CMV IgG levels were not associated with non-invasive measures of liver disease, APRI and FIB-4, or with HCV RNA level and adjustment for Epstein-Barr virus (EBV) IgG levels did not affect the association between HCV and CMV. Conclusions: CMV IgG levels are higher in HCV/HIV co-infected women than in HIV mono-infected women. Further research on the association of HCV with CMV IgG is indicated because prior studies have found CMV IgG to be associated with morbidity and mortality in the general population and subclinical carotid artery disease in HIV-infected patients.	[Kuniholm, Mark H.; Parrinello, Christina M.; Anastos, Kathryn; Strickler, Howard D.; Kaplan, Robert C.] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10467 USA; [Anastos, Kathryn] Montefiore Med Ctr, Dept Med, Bronx, NY 10467 USA; [Augenbraun, Michael] Suny Downstate Med Ctr, Dept Med, Brooklyn, NY 11203 USA; [Plankey, Michael] Georgetown Univ, Med Ctr, Dept Med, Washington, DC 20007 USA; [Nowicki, Marek] Univ So Calif, Dept Med, Los Angeles, CA USA; [Peters, Marion] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Golub, Elizabeth T.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Lurain, Nell; Landay, Alan L.] Rush Univ, Med Ctr, Dept Immunol Microbiol, Chicago, IL 60612 USA; [Landay, Alan L.] Univ Utrecht, Div Pharmacol, Utrecht Inst Pharmaceut Sci, Fac Sci, Utrecht, Netherlands	Yeshiva University; Albert Einstein College of Medicine; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; Georgetown University; University of Southern California; University of California System; University of California San Francisco; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Rush University; Utrecht University	Kuniholm, MH (corresponding author), Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10467 USA.	mark.kuniholm@einstein.yu.edu			National Center for Research Resources CTSA [UL1RR025750, KL2RR025749, TL1RR025748]; National Institute of Allergy and Infectious Diseases [UO1-AI-35004, UO1-AI-31834, UO1-AI-34994, UO1-AI-34989, UO1-AI-34993, UO1-AI-42590]; Eunice Kennedy Shriver National Institute of Child Health and Human Development [UO1-HD-32632]; National Cancer Institute; National Institute on Drug Abuse; National Institute on Deafness and Other Communication Disorders; National Center for Research Resources (UCSF-CTSI) [UL1 RR024131]; Einstein-Montefiore Center for AIDS Research [5P30AI051519-08];  [R01HL095140];  [1R01HL083760-01]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U01HD032632] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR025749, TL1RR025748, UL1RR025750, UL1RR024131] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095140, R01HL083760] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI042590, U01AI034989, U01AI035004, U01AI031834, P30AI051519, U01AI034994, U01AI034993] Funding Source: NIH RePORTER	National Center for Research Resources CTSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)NIH National Center for Research Resources (NCRR)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); National Center for Research Resources (UCSF-CTSI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Einstein-Montefiore Center for AIDS Research; ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding for the current project was provided in part by grants R01HL095140 and 1R01HL083760-01 (to R. C. K.) in addition to National Center for Research Resources CTSA grants UL1RR025750, KL2RR025749 and TL1RR025748. Clinical data and specimens used in this study were collected by the Women's Interagency HIV Study (WIHS) Collaborative Study Group with centers (Principal Investigators) at New York City/Bronx Consortium (Kathryn Anastos); Brooklyn, NY (Howard Minkoff); Washington DC, Metropolitan Consortium (Mary Young); The Connie Wofsy Study Consortium of Northern California (Ruth Greenblatt); Los Angeles County/Southern California Consortium (Alexandra Levine); Chicago Consortium (Mardge Cohen); Data Coordinating Center (Stephen Gange). The WIHS is funded by the National Institute of Allergy and Infectious Diseases (UO1-AI-35004, UO1-AI-31834, UO1-AI-34994, UO1-AI-34989, UO1-AI-34993, and UO1-AI-42590) and by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (UO1-HD-32632). The study is co-funded by the National Cancer Institute, the National Institute on Drug Abuse, and the National Institute on Deafness and Other Communication Disorders. Funding is also provided by the National Center for Research Resources (UCSF-CTSI Grant Number UL1 RR024131). This research was also supported in part by the Einstein-Montefiore Center for AIDS Research (5P30AI051519-08). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Harthi L, 2006, J INFECT DIS, V193, P1202, DOI 10.1086/500843; Barkan SE, 1998, EPIDEMIOLOGY, V9, P117, DOI 10.1097/00001648-199803000-00004; Bate SL, 2010, CLIN INFECT DIS, V50, P1439, DOI 10.1086/652438; Bugianesi E, 2012, J HEPATOL, V56, pS56, DOI 10.1016/S0168-8278(12)60007-5; Cannon MJ, 2010, REV MED VIROL, V20, P202, DOI 10.1002/rmv.655; Chak E, 2011, LIVER INT, V31, P1090, DOI 10.1111/j.1478-3231.2011.02494.x; CONVERSE PJ, 1990, CLIN EXP IMMUNOL, V82, P559, DOI 10.1111/j.1365-2249.1990.tb05490.x; Deayton JR, 2004, LANCET, V363, P2116, DOI 10.1016/S0140-6736(04)16500-8; El Din NGB, 2011, J GASTROEN HEPATOL, V26, P55, DOI 10.1111/j.1440-1746.2010.06319.x; El-Kamary SS, 2011, CLIN INFECT DIS, V53, P150, DOI 10.1093/cid/cir306; Guiltinan AM, 2008, AM J EPIDEMIOL, V167, P743, DOI 10.1093/aje/kwm370; Gupta CK, 1996, BIOLOGICALS, V24, P41, DOI 10.1006/biol.1996.0004; Gutierrez J, 1997, MICROBIOS, V90, P151; Jackson SE, 2011, VIRUS RES, V157, P151, DOI 10.1016/j.virusres.2010.10.031; Kaplan RC, 2008, AIDS, V22, P1615, DOI 10.1097/QAD.0b013e328300581d; Kuparinen T, 2012, GENES IMMUN, V13, P184, DOI 10.1038/gene.2011.71; Lachmann R, 2012, J VIROL, V86, P1001, DOI 10.1128/JVI.00873-11; Leng SX, 2011, EXP GERONTOL, V46, P679, DOI 10.1016/j.exger.2011.04.002; McGovern BH, 2007, CLIN INFECT DIS, V44, P431, DOI 10.1086/509580; MUSIANI M, 1988, J CLIN PATHOL, V41, P722, DOI 10.1136/jcp.41.7.722; Naeger DM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008886; Nieto FJ, 1996, CIRCULATION, V94, P922, DOI 10.1161/01.CIR.94.5.922; Parrinello CM, 2012, J INFECT DIS, V205, P1788, DOI 10.1093/infdis/jis276; Pawelec G, 2009, REV MED VIROL, V19, P47, DOI 10.1002/rmv.598; Razonable RR, 2008, WORLD J GASTROENTERO, V14, P4849, DOI 10.3748/wjg.14.4849; Roberts ET, 2010, AM J EPIDEMIOL, V172, P363, DOI 10.1093/aje/kwq177; Ryan EJ, 2011, J VIRAL HEPATITIS, V18, P601, DOI 10.1111/j.1365-2893.2011.01453.x; Simanek AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016103; Sinzger C, 2008, CURR TOP MICROBIOL, V325, P63; Sorlie PD, 2000, ARCH INTERN MED, V160, P2027, DOI 10.1001/archinte.160.13.2027; Sterling RK, 2006, HEPATOLOGY, V43, P1317, DOI 10.1002/hep.21178; Strandberg TE, 2009, JAMA-J AM MED ASSOC, V301, P380, DOI 10.1001/jama.2009.4; Sylwester AW, 2005, J EXP MED, V202, P673, DOI 10.1084/jem.20050882; Tabll A, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-343; Thimme R, 2011, FEMS MICROBIOL REV; Thursz M, 2011, SEMIN LIVER DIS, V31, P115, DOI 10.1055/s-0031-1276642; Vescovini R, 2007, J IMMUNOL, V179, P4283, DOI 10.4049/jimmunol.179.6.4283; Wai CT, 2003, HEPATOLOGY, V38, P518, DOI 10.1053/jhep.2003.50346; Yonkers NL, 2011, J INFECT DIS, V203, P635, DOI 10.1093/infdis/jiq101	39	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2013	8	4							e61973	10.1371/journal.pone.0061973	http://dx.doi.org/10.1371/journal.pone.0061973			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IK	23613990	Green Submitted, Green Published, gold			2022-12-25	WOS:000317907200112
J	Liu, ZJ; Wang, BS; Nadler, T; Liu, GJ; Sun, T; Huang, CM; Zhou, QH; Zhou, J; Que, TC; Wang, ZM; Roos, C; Li, M				Liu, Zhijin; Wang, Boshi; Tilo Nadler; Liu, Guangjian; Sun, Tao; Huang, Chengming; Zhou, Qihai; Zhou, Jiang; Que, Tengcheng; Wang, Ziming; Roos, Christian; Li, Ming			Relatively Recent Evolution of Pelage Coloration in Colobinae: Phylogeny and Phylogeography of Three Closely Related Langur Species	PLOS ONE			English	Article							POPULATION-GROWTH; TRACHYPITHECUS-LEUCOCEPHALUS; STATISTICAL TESTS; GENETIC DIVERSITY; JAPANESE MACAQUE; KARST HILLS; DNA; NEUTRALITY; DISPERSAL; GUANGXI	To understand the evolutionary processes leading to the diversity of Asian colobines, we report here on a phylogenetic, phylogeographical and population genetic analysis of three closely related langurs, Trachypithecus francoisi, T. poliocephalus and T. leucocephalus, which are all characterized by different pelage coloration predominantly on the head and shoulders. Therefore, we sequenced a 395 bp long fragment of the mitochondrial control region from 178 T. francoisi, 54 T. leucocephalus and 19 T. poliocephalus individuals, representing all extant populations of these three species. We found 29 haplotypes in T. francoisi, 12 haplotypes in T. leucocephalus and three haplotypes in T. poliocephalus. T. leucocephalus and T. poliocephalus form monophyletic clades, which are both nested within T. francoisi, and diverged from T. francoisi recently, 0.46-0.27 (T. leucocephalus) and 0.50-0.25 million years ago (T. poliocephalus). Thus, T. francoisi appears as a polyphyletic group, while T. leucocephalus and T. poliocephalus are most likely independent descendents of T. francoisi that are both physically separated from T. francoisi populations by rivers, open sea or larger habitat gaps. Since T. francoisi populations show no variability in pelage coloration, pelage coloration in T. leucocephalus and T. poliocephalus is most likely the result of new genetic mutations after the split from T. francoisi and not of the fixation of different characters derived from an ancestral polymorphism. This case study highlights that morphological changes for example in pelage coloration can occur in isolated populations in relatively short time periods and it provides a solid basis for studies in related species. Nevertheless, to fully understand the evolutionary history of these three langur species, nuclear loci should be investigated as well.	[Liu, Zhijin; Wang, Boshi; Liu, Guangjian; Huang, Chengming; Li, Ming] Chinese Acad Sci, Inst Zool, Key Lab Anim Ecol & Conservat Biol, Beijing, Peoples R China; [Liu, Zhijin; Roos, Christian] Leibniz Inst Primate Res, German Primate Ctr, Primate Genet Lab, Gottingen, Germany; [Wang, Boshi; Liu, Guangjian] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China; [Sun, Tao; Huang, Chengming; Zhou, Qihai; Zhou, Jiang] Guangxi Normal Univ, Coll Life Sci, Guilin, Peoples R China; [Roos, Christian] Leibniz Inst Primate Res, German Primate Ctr, Gene Bank Primates, Gottingen, Germany; [Que, Tengcheng] Guangxi Rescue & Res Ctr Rare & Endangered Wild A, Guangxi Zhuang Autonomous Reg Forestry Dept, Nanning, Peoples R China; [Wang, Ziming] South China Agr Univ, Coll Anim Sci, Guangzhou, Guangdong, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; Deutsches Primatenzentrum (DPZ); Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Guangxi Normal University; Deutsches Primatenzentrum (DPZ); South China Agricultural University	Roos, C (corresponding author), Leibniz Inst Primate Res, German Primate Ctr, Primate Genet Lab, Gottingen, Germany.	croos@dpz.eu; lim@ioz.ac.cn			Natural Science Foundation of China [30970376, 30860050, 30560023]; Foundation of Chinese Academy of Sciences [KSCX3-IOZ-1001, KSCX2-EW-Q-7-2]; Guangxi Nature Science Foundation [0991095]; Monitoring and Conservation of Langur Project of State Forestry Administration of China; German Primate Center	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation of Chinese Academy of Sciences(Chinese Academy of Sciences); Guangxi Nature Science Foundation; Monitoring and Conservation of Langur Project of State Forestry Administration of China; German Primate Center	This project was supported by the Natural Science Foundation of China (No. 30970376, No. 30860050 and No. 30560023), Foundation of Chinese Academy of Sciences (KSCX3-IOZ-1001 and KSCX2-EW-Q-7-2), Guangxi Nature Science Foundation (No. 0991095), the Monitoring and Conservation of Langur Project of State Forestry Administration of China and the German Primate Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1963, GUANGX FOR BUR CONF, P32; Avise John C., 2004, P1; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bleisch B, 2008, IUCN 2011 1; Bouzat JL, 1998, CONSERV BIOL, V12, P836, DOI 10.1046/j.1523-1739.1998.97164.x; Bradley BJ, 2008, EVOL ANTHROPOL, V17, P97, DOI 10.1002/evan.20164; Brandon-Jones D, 2004, INT J PRIMATOL, V25, P97, DOI 10.1023/B:IJOP.0000014647.18720.32; Butzer KW, 1964, ENV ARCHAEOLOGY; Chang J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050286; CHAPPELL J, 1974, GEOL SOC AM BULL, V85, P553, DOI 10.1130/0016-7606(1974)85<553:GOCTHP>2.0.CO;2; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; CRANDALL KA, 1993, GENETICS, V134, P959; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Dupanloup I, 2002, MOL ECOL, V11, P2571, DOI 10.1046/j.1365-294X.2002.01650.x; Durka W, 2005, MOL ECOL, V14, P1697, DOI 10.1111/j.1365-294X.2005.02521.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; FU YX, 1993, GENETICS, V133, P693; Fu YX, 1997, GENETICS, V147, P915; Gathorne-Hardy FJ, 2002, BIOL J LINN SOC, V75, P453, DOI 10.1046/j.1095-8312.2002.00031.x; Gorog AJ, 2004, BIOL J LINN SOC, V81, P91, DOI 10.1111/j.1095-8312.2004.00281.x; Groves CP, 2001, SMITHSONIAN; GUSTAFSON S, 1987, ANAL BIOCHEM, V165, P294, DOI 10.1016/0003-2697(87)90272-7; HARPENDING HC, 1993, CURR ANTHROPOL, V34, P483, DOI 10.1086/204195; HARPENDING HC, 1994, HUM BIOL, V66, P591; Hayaishi S, 2006, PRIMATES, V47, P158, DOI 10.1007/s10329-005-0169-1; Hu Yan-Ling, 2004, Chinese Journal of Zoology, V39, P109; Huang C, 2002, WHITE HEADED LANGUR; Huang CM, 2002, BIOL CONSERV, V104, P221, DOI 10.1016/S0006-3207(01)00168-9; Huelsenbeck JP, 2004, SYST BIOL, V53, P904, DOI 10.1080/10635150490522629; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jin T, 2009, AM J PRIMATOL, V71, P206, DOI 10.1002/ajp.20637; Kleiman DG, 2004, GRZIMEKS ANIMAL LIFE, V14; Kuhner MK, 1998, GENETICS, V149, P429; KUMAR S, 2001, MEGA2 MOL EVOLUTIONA; Lampert KP, 2003, MOL ECOL, V12, P3325, DOI 10.1046/j.1365-294X.2003.02016.x; Li YB, 2007, ORYX, V41, P38, DOI 10.1017/S0030605307001500; Liedigk Rasmus, 2009, Vietnamese Journal of Primatology, V1, P1; Liu Z, 2007, MOL ECOL, V16, P3334, DOI 10.1111/j.1365-294X.2007.03383.x; Lu LR, 1991, CHINESE J ZOOL, V9, P67; Macey JR, 1998, MOL PHYLOGENET EVOL, V9, P80, DOI 10.1006/mpev.1997.0440; MANTEL N, 1967, CANCER RES, V27, P209; Marmi J, 2004, MOL PHYLOGENET EVOL, V30, P676, DOI 10.1016/S1055-7903(03)00247-1; Miller KG, 2005, SCIENCE, V310, P1293, DOI 10.1126/science.1116412; Modolo L, 2008, MOL ECOL, V17, P4027, DOI 10.1111/j.1365-294X.2008.03890.x; Nei M, 1986, MOL EVOLUTIONARY GEN; Osterholz M, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-58; Perelman P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001342; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Pusey A.E., 1987, P250; Que TC, 2011, CHINESE J VET MED, V47, P21; Que Teng-cheng, 2007, Zoological Research, V28, P225; Rambaut A., 2006, FIGTREE TREE FIGURE; Rambaut A, 2007, TRACER MCMC TRADE AN; Ramos-Onsins SE, 2002, MOL BIOL EVOL, V19, P2092, DOI 10.1093/oxfordjournals.molbev.a004034; Roos Christian, 2007, Vietnamese Journal of Primatology, V1, P41; Roos C, 2008, MOL PHYLOGENET EVOL, V47, P629, DOI 10.1016/j.ympev.2008.03.006; Rousset F, 1997, GENETICS, V145, P1219; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Sambrook J., 1989, MOL CLONING LAB MANU, V2; SMOUSE PE, 1986, SYST ZOOL, V35, P627, DOI 10.2307/2413122; Swofford D. L., 2003, PAUP PHYLOGENETIC AN; TAJIMA F, 1989, GENETICS, V123, P585; TAYLOR AC, 1994, MOL ECOL, V3, P277, DOI 10.1111/j.1365-294X.1994.tb00068.x; Thalmann O, 2004, MOL ECOL, V13, P321, DOI 10.1046/j.1365-294X.2003.02070.x; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Voris HK, 2000, J BIOGEOGR, V27, P1153, DOI 10.1046/j.1365-2699.2000.00489.x; WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018; Wang DZ, 2005, PRIMATES, V46, P219, DOI 10.1007/s10329-004-0122-8; Wang W, 1997, INT J PRIMATOL, V18, P305, DOI 10.1023/A:1026378215222; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Wilting A, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-15; Wisely SM, 2002, J HERED, V93, P231, DOI 10.1093/jhered/93.4.231; Woodruff DS, 2010, BIODIVERS CONSERV, V19, P919, DOI 10.1007/s10531-010-9783-3; WU XH, 1989, MOUNTAIN RES, V7, P75; Zhang YW, 2001, J MOL EVOL, V52, P516, DOI 10.1007/s002390010182; Zinner D, 2013, LYNX, V3	76	17	20	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2013	8	4							e61659	10.1371/journal.pone.0061659	http://dx.doi.org/10.1371/journal.pone.0061659			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IK	23613895	Green Submitted, Green Published, gold			2022-12-25	WOS:000317907200071
J	Wang, AX; Wu, JW; Zhou, Y; Guo, XH; Luo, YX; Wu, SL; Zhao, XQ				Wang, Anxin; Wu, Jianwei; Zhou, Yong; Guo, Xiuhua; Luo, Yanxia; Wu, Shouling; Zhao, Xingquan			Measures of Adiposity and Risk of Stroke in China: A Result from the Kailuan Study	PLOS ONE			English	Article							BODY-MASS INDEX; CORONARY-HEART-DISEASE; ABDOMINAL ADIPOSITY; ISCHEMIC-STROKE; WAIST CIRCUMFERENCE; CARDIOVASCULAR-DISEASE; OBESITY MEASURES; HIP RATIO; WOMEN; MEN	Objective: The objective of this study was to explore the association between adiposity and risk of incident stroke among men and women. Methods: We studied the relationship between adiposity and stroke among 94,744 participants (18-98 years old) in the Kailuan study. During a follow-up of 4 years, 1,547 ischemic or hemorrhagic strokes were recorded. Measurements of adiposity included body mass index (BMI), waist circumference (WC), waist-to-hip ratio (WHpR), and waist-to-height ratio (WHtR). Hazard ratios (HRs) with 95% confidence intervals (CIs) were calculated from Cox regression models and each model fit was assessed using -2log-likelihood. Results: Every measurement of adiposity was associated with the risk for total stroke and ischemic stroke, but not for hemorrhagic stroke. After adjusting for confounders and intermediates, the HR (comparing the mean of the highest quintile with that of the lowest quintile) for total stroke was 1.34(1.13-1.60) for BMI, 1.26(1.06-1.52) for WC, 1.29(1.08-1.56) for WHpR, and 1.38(1.15-1.66) for WHtR. The HR for ischemic stroke was 1.52(1.24-1.88) for BMI, 1.46(1.17-1.81) for WC, 1.40(1.12-1.74) for WHpR, and 1.62(1.29-2.04) for WHtR. The model fit for each of the indices was similar. Conclusions: Adiposity increases the total risk of stroke and ischemic stroke, but not of hemorrhagic stroke. No clinically meaningful differences among the associations between BMI, WC, WHpR, and WHtR and stroke incidence were identified in this study.	[Wang, Anxin; Wu, Jianwei; Zhou, Yong; Zhao, Xingquan] Capital Med Univ, Beijing Tiantan Hosp, Dept Neurol, Beijing, Peoples R China; [Wang, Anxin; Guo, Xiuhua; Luo, Yanxia] Capital Med Univ, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Beijing, Peoples R China; [Wu, Shouling] Hebei United Univ, Kailuan Hosp, Dept Cardiol, Tangshan, Peoples R China	Capital Medical University; Capital Medical University; North China University of Science & Technology	Wu, SL (corresponding author), Hebei United Univ, Kailuan Hosp, Dept Cardiol, Tangshan, Peoples R China.	drwusl@163.com; zxq@vip.163.com	Wu, Jian/AAU-5221-2020; Wang, Anxin/AAD-4073-2021; Wu, Jian/AAU-5221-2020	Wu, Jian/0000-0001-9933-7364; Wu, Jian/0000-0002-3394-1507	National Natural Science Foundation of China [81202279]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by a grant from the National Natural Science Foundation of China (Grant No. 81202279). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1989, Stroke, V20, P1407; [Anonymous], STROKE, V34, P1450; Baik I, 2000, AM J EPIDEMIOL, V152, P264, DOI 10.1093/aje/152.3.264; Bodenant M, 2011, STROKE, V42, P2872, DOI 10.1161/STROKEAHA.111.614099; Cui RZ, 2005, STROKE, V36, P1377, DOI 10.1161/01.STR.0000169925.57251.4e; de Koning L, 2007, EUR HEART J, V28, P850, DOI 10.1093/eurheartj/ehm026; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; Folsom AR, 2000, ARCH INTERN MED, V160, P2117, DOI 10.1001/archinte.160.14.2117; Furukawa Y, 2010, STROKE, V41, P550, DOI 10.1161/STROKEAHA.109.569145; Gelber RP, 2008, J AM COLL CARDIOL, V52, P605, DOI 10.1016/j.jacc.2008.03.066; Hsieh SD, 1995, INTERNAL MED, V34, P1147, DOI 10.2169/internalmedicine.34.1147; Hu G, 2007, ARCH INTERN MED, V167, P1420, DOI 10.1001/archinte.167.13.1420; Kurth T, 2005, CIRCULATION, V111, P1992, DOI 10.1161/01.CIR.0000161822.83163.B6; Kurth T, 2002, ARCH INTERN MED, V162, P2557, DOI 10.1001/archinte.162.22.2557; Liu LP, 2011, STROKE, V42, P3651, DOI 10.1161/STROKEAHA.111.635755; Liu M, 2007, LANCET NEUROL, V6, P456, DOI 10.1016/S1474-4422(07)70004-2; Olsen TS, 2008, NEUROEPIDEMIOLOGY, V30, P93, DOI 10.1159/000118945; Reeder BA, 1997, CAN MED ASSOC J, V157, pS39; Rexrode KM, 1998, JAMA-J AM MED ASSOC, V280, P1843, DOI 10.1001/jama.280.21.1843; Rexrode KM, 1997, JAMA-J AM MED ASSOC, V277, P1539, DOI 10.1001/jama.277.19.1539; Scherbakov N, 2011, STROKE, V42, P3646, DOI 10.1161/STROKEAHA.111.619163; Suk SH, 2003, STROKE, V34, P1586, DOI 10.1161/01.STR.0000075294.98582.2F; Vemmos K, 2011, STROKE, V42, P30, DOI 10.1161/STROKEAHA.110.593434; Walker SP, 1996, AM J EPIDEMIOL, V144, P1143, DOI 10.1093/oxfordjournals.aje.a008892; Wang YF, 2005, AM J CLIN NUTR, V81, P555; Wang YJ, 2012, CNS NEUROSCI THER, V18, P93, DOI 10.1111/j.1755-5949.2011.00290.x; Winter Y, 2008, STROKE, V39, P3145, DOI 10.1161/STROKEAHA.108.523001; Wu SL, 2012, INT J CARDIOL, V157, P75, DOI 10.1016/j.ijcard.2010.12.019; Yatsuya H, 2010, J EPIDEMIOL, V20, P347, DOI 10.2188/jea.JE20090186; Yatsuya H, 2010, STROKE, V41, P417, DOI 10.1161/STROKEAHA.109.566299; Zhang XL, 2007, ARCH INTERN MED, V167, P886, DOI 10.1001/archinte.167.9.886; Zhang XL, 2009, STROKE, V40, P1098, DOI 10.1161/STROKEAHA.108.539692; Zhao D, 2008, STROKE, V39, P1668, DOI 10.1161/STROKEAHA.107.502807; WHO TECH REP SER, V894, pR1	34	63	65	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2013	8	4							e61665	10.1371/journal.pone.0061665	http://dx.doi.org/10.1371/journal.pone.0061665			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IK	23613897	Green Published, gold, Green Submitted			2022-12-25	WOS:000317907200072
J	Garcia-Vidal, C; Labori, M; Viasus, D; Simonetti, A; Garcia-Somoza, D; Dorca, J; Gudiol, F; Carratala, J				Garcia-Vidal, Carolina; Labori, Maria; Viasus, Diego; Simonetti, Antonella; Garcia-Somoza, Dolors; Dorca, Jordi; Gudiol, Francesc; Carratala, Jordi			Rainfall Is a Risk Factor for Sporadic Cases of Legionella pneumophila Pneumonia	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; LEGIONNAIRES-DISEASE; OUTBREAK; UPDATE; WATER	It is not known whether rainfall increases the risk of sporadic cases of Legionella pneumonia. We sought to test this hypothesis in a prospective observational cohort study of non-immunosuppressed adults hospitalized for community-acquired pneumonia (1995-2011). Cases with Legionella pneumonia were compared with those with non-Legionella pneumonia. Using daily rainfall data obtained from the regional meteorological service we examined patterns of rainfall over the days prior to admission in each study group. Of 4168 patients, 231 (5.5%) had Legionella pneumonia. The diagnosis was based on one or more of the following: sputum (41 cases), antigenuria (206) and serology (98). Daily rainfall average was 0.556 liters/m(2) in the Legionella pneumonia group vs. 0.328 liters/m(2) for non-Legionella pneumonia cases (p = 0.04). A ROC curve was plotted to compare the incidence of Legionella pneumonia and the weighted median rainfall. The cut-off point was 0.42 (AUC 0.54). Patients who were admitted to hospital with a prior weighted median rainfall higher than 0.42 were more likely to have Legionella pneumonia (OR 1.35; 95% CI 1.02-1.78; p = .03). Spearman Rho correlations revealed a relationship between Legionella pneumonia and rainfall average during each two-week reporting period (0.14; p = 0.003). No relationship was found between rainfall average and non-Legionella pneumonia cases (-0.06; p = 0.24). As a conclusion, rainfall is a significant risk factor for sporadic Legionella pneumonia. Physicians should carefully consider Legionella pneumonia when selecting diagnostic tests and antimicrobial therapy for patients presenting with CAP after periods of rainfall.	[Garcia-Vidal, Carolina; Labori, Maria; Viasus, Diego; Simonetti, Antonella; Gudiol, Francesc; Carratala, Jordi] Univ Barcelona, Dept Infect Dis, Hosp Univ Bellvitge, IDIBELL Inst Invest Biomed Bellvitge, Barcelona, Spain; [Garcia-Vidal, Carolina; Gudiol, Francesc; Carratala, Jordi] REIPI Spanish Network Res Infect Dis, Madrid, Spain; [Garcia-Somoza, Dolors] Hosp Univ Bellvitge, Dept Microbiol, Barcelona, Spain; [Dorca, Jordi] Hosp Univ Bellvitge, Dept Resp Med, Barcelona, Spain	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona	Garcia-Vidal, C (corresponding author), Univ Barcelona, Dept Infect Dis, Hosp Univ Bellvitge, IDIBELL Inst Invest Biomed Bellvitge, Barcelona, Spain.	carolgv75@hotmail.com	Simonetti, Antonella F./AFN-2321-2022; Viasus, Diego/HDN-6634-2022; Carratala, Jordi/AAC-2639-2020; Dorca, Jordi/Q-3617-2016; Carratalà, Jordi/B-8410-2011	Carratala, Jordi/0000-0003-3209-2563; Dorca, Jordi/0000-0002-8137-878X; Carratalà, Jordi/0000-0003-3209-2563; Garcia-Somoza, Dolores/0000-0002-4363-8499; Simonetti, Antonella Francesca/0000-0002-7707-082X; Garcia-Vidal, Carolina/0000-0002-8915-0683; Viasus, Diego/0000-0001-8408-3947	Ministerio de Sanidad y Consumo, Instituto de Salud Carlos III [FIS 10/01318]; Ministerio de Ciencia e Innovacion, Instituto de Salud Carlos III; European Development Regional Fund (ERDF) [REIPI RD06/0008]; Instituto de Salud Carlos III, Madrid, Spain; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL)	Ministerio de Sanidad y Consumo, Instituto de Salud Carlos III(Instituto de Salud Carlos III); Ministerio de Ciencia e Innovacion, Instituto de Salud Carlos III(Instituto de Salud Carlos IIIMinistry of Science and Innovation, Spain (MICINN)Spanish Government); European Development Regional Fund (ERDF)(European Commission); Instituto de Salud Carlos III, Madrid, Spain(Instituto de Salud Carlos III); Institut d'Investigacio Biomedica de Bellvitge (IDIBELL)	This study was supported by research grants from the Ministerio de Sanidad y Consumo, Instituto de Salud Carlos III (FIS 10/01318) and Ministerio de Ciencia e Innovacion, Instituto de Salud Carlos III-co-financed by the European Development Regional Fund (ERDF) "A way to achieve Europe", Spanish Network for Research in Infectious Diseases (REIPI RD06/0008). Dr CGV is the recipient of a Juan de la Cierva research grant from the Instituto de Salud Carlos III, Madrid, Spain. Dr DV is the recipient of a research grant from the Institut d'Investigacio Biomedica de Bellvitge (IDIBELL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baron EJ, 2007, MANUAL OF CLINICAL MICROBIOLOGY, 9TH ED, P1; Benson RF, 2000, J CLIN MICROBIOL, V38, P2763, DOI 10.1128/JCM.38.7.2763-2765.2000; Carratala J, 2010, CURR OPIN INFECT DIS, V23, P152, DOI 10.1097/QCO.0b013e328336835b; DONDERO TJ, 1980, NEW ENGL J MED, V302, P365, DOI 10.1056/NEJM198002143020703; FALCO V, 1991, CHEST, V100, P1007, DOI 10.1378/chest.100.4.1007; Fields BS, 2002, CLIN MICROBIOL REV, V15, P506, DOI 10.1128/CMR.15.3.506-526.2002; Fisman DN, 2005, J INFECT DIS, V192, P2066, DOI 10.1086/498248; Garcia-Fulgueiras A, 2003, EMERG INFECT DIS, V9, P915; Garcia-Vidal Carolina, 2006, Expert Rev Anti Infect Ther, V4, P995, DOI 10.1586/14787210.4.6.995; Gudiol C, 2009, TRANSPL INFECT DIS, V11, P78, DOI 10.1111/j.1399-3062.2008.00337.x; Hicks LA, 2007, EPIDEMIOL INFECT, V135, P811, DOI 10.1017/S0950268806007552; Isenberg HD, 1992, CLIN MICROBIOLOGY PR; Keller DW, 1996, CLIN INFECT DIS, V22, P257, DOI 10.1093/clinids/22.2.257; Malan AK, 2003, J CLIN MICROBIOL, V41, P3060, DOI 10.1128/JCM.41.7.3060-3063.2003; Neil K, 2008, CLIN INFECT DIS, V47, P591, DOI 10.1086/590557; Paul M, 2012, CLIN MICROBIOL INFEC, V18, P925, DOI 10.1111/j.1469-0691.2012.03972.x; Plouffe JF, 1999, CURR OPIN INFECT DIS, V12, P127, DOI 10.1097/00001432-199904000-00004; Rello J, 2003, CHEST, V123, P174, DOI 10.1378/chest.123.1.174; Roson B, 2004, ARCH INTERN MED, V164, P502, DOI 10.1001/archinte.164.5.502; Sakamoto R, 2009, EMERG INFECT DIS, V15, P1295, DOI 10.3201/eid1508.090317; SANDEN GN, 1992, APPL ENVIRON MICROB, V58, P2001, DOI 10.1128/AEM.58.6.2001-2004.1992; Sopena N, 2007, J AM GERIATR SOC, V55, P114, DOI 10.1111/j.1532-5415.2006.01021.x; STOUT JE, 1992, NEW ENGL J MED, V326, P151, DOI 10.1056/NEJM199201163260302; Straus WL, 1996, ARCH INTERN MED, V156, P1685, DOI 10.1001/archinte.156.15.1685; Vergis EN, 2000, SEMIN RESP CRIT CARE, V21, P295, DOI 10.1055/s-2000-9934; Viasus D, 2013, MEDICINE, V92, P51, DOI 10.1097/MD.0b013e31827f6104	26	41	42	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2013	8	4							e61036	10.1371/journal.pone.0061036	http://dx.doi.org/10.1371/journal.pone.0061036			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130DR	23613778	Green Published, gold, Green Submitted			2022-12-25	WOS:000317893400036
J	Lapidus, N; de Lamballerie, X; Salez, N; Setbon, M; Delabre, RM; Ferrari, P; Moyen, N; Gougeon, ML; Vely, F; Leruez-Ville, M; Andreoletti, L; Cauchemez, S; Boelle, PY; Vivier, E; Abel, L; Schwarzinger, M; Legeas, M; Le Cann, P; Flahault, A; Carrat, F				Lapidus, Nathanael; de Lamballerie, Xavier; Salez, Nicolas; Setbon, Michel; Delabre, Rosemary M.; Ferrari, Pascal; Moyen, Nanikaly; Gougeon, Marie-Lise; Vely, Frederic; Leruez-Ville, Marianne; Andreoletti, Laurent; Cauchemez, Simon; Boelle, Pierre-Yves; Vivier, Eric; Abel, Laurent; Schwarzinger, Michael; Legeas, Michele; Le Cann, Pierre; Flahault, Antoine; Carrat, Fabrice			Factors Associated with Post-Seasonal Serological Titer and Risk Factors for Infection with the Pandemic A/H1N1 Virus in the French General Population	PLOS ONE			English	Article							A H1N1 2009; INFLUENZA-VIRUS; CIGARETTE-SMOKING; HOUSEHOLD TRANSMISSION; ELIMINATING BIAS; RESPONSES; SEROCONVERSION; INHIBITION; PREVALENCE; SURVIVAL	The CoPanFlu-France cohort of households was set up in 2009 to study the risk factors for infection by the pandemic influenza virus (H1N1pdm) in the French general population. The authors developed an integrative data-driven approach to identify individual, collective and environmental factors associated with the post-seasonal serological H1N1pdm geometric mean titer, and derived a nested case-control analysis to identify risk factors for infection during the first season. This analysis included 1377 subjects (601 households). The GMT for the general population was 47.1 (95% confidence interval (CI): 45.1, 49.2). According to a multivariable analysis, pandemic vaccination, seasonal vaccination in 2009, recent history of influenza-like illness, asthma, chronic obstructive pulmonary disease, social contacts at school and use of public transports by the local population were associated with a higher GMT, whereas history of smoking was associated with a lower GMT. Additionally, young age at inclusion and risk perception of exposure to the virus at work were identified as possible risk factors, whereas presence of an air humidifier in the living room was a possible protective factor. These findings will be interpreted in light of the longitudinal analyses of this ongoing cohort.	[Lapidus, Nathanael; Delabre, Rosemary M.; Ferrari, Pascal; Boelle, Pierre-Yves; Flahault, Antoine; Carrat, Fabrice] Inst Natl Sante & Rech Med, UMR S 707, Paris, France; [Lapidus, Nathanael; Delabre, Rosemary M.; Ferrari, Pascal; Boelle, Pierre-Yves; Carrat, Fabrice] Univ Paris 06, UMR S 707, Paris, France; [de Lamballerie, Xavier; Salez, Nicolas; Setbon, Michel; Moyen, Nanikaly] Aix Marseille Univ, UMR D 190, Unite Virus Emergents, Marseille, France; [de Lamballerie, Xavier; Salez, Nicolas; Setbon, Michel; Moyen, Nanikaly] Inst Rech Dev, Marseille, France; [de Lamballerie, Xavier; Moyen, Nanikaly] Hop Marseille, Virol Lab, Pole Hosp Microbiol & Malad Infect, Marseille, France; [de Lamballerie, Xavier; Setbon, Michel; Moyen, Nanikaly; Legeas, Michele; Le Cann, Pierre; Flahault, Antoine] Ecole Hautes Etud Sante Publ, Rennes, France; [Gougeon, Marie-Lise] Inst Pasteur, Antiviral Immun Biotherapy & Vaccine Unit, Paris, France; [Vely, Frederic; Vivier, Eric] Univ Mediterranee UM 631, Ctr Immunol Marseille Luminy, Marseille, France; [Vely, Frederic; Vivier, Eric] Inst Natl Sante & Rech Med, UMR S 631, Paris, France; [Vely, Frederic; Vivier, Eric] CNRS, UMR6102, Marseille, France; [Vely, Frederic; Vivier, Eric] Hop Conception, Hop Marseille, Marseille, France; [Leruez-Ville, Marianne; Abel, Laurent] Univ Paris 05, Sorbonne Paris Cite, EA 36 20, Paris, France; [Leruez-Ville, Marianne] AP HP, Hop Necker, Virol Lab, Paris, France; [Andreoletti, Laurent] Ctr Hosp Univ, Unite Virol Med & Mol, Reims, France; [Andreoletti, Laurent] DAT PPCIDH, IFR 53, EA 4303, Fac Med, Reims, France; [Cauchemez, Simon] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, MRC, Ctr Outbreak Anal & Modeling, London, England; [Boelle, Pierre-Yves; Carrat, Fabrice] Hop St Antoine, AP HP, Unite Sante Publ, F-75571 Paris, France; [Abel, Laurent] Inst Natl Sante & Rech Med, U550, Lab Genet Humaine Malad Infect, Paris, France; [Abel, Laurent] Rockefeller Univ, Rockefeller Branch, Lab Human Genet Infect Dis, New York, NY 10021 USA; [Schwarzinger, Michael] Univ Paris Diderot, Sorbonne Paris Cite, UMR 738, Paris, France; [Schwarzinger, Michael] INSERM, Equipe ATIP AVENIR, UMR 738, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Aix-Marseille Universite; Institut de Recherche pour le Developpement (IRD); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU de Reims; Universite de Reims Champagne-Ardenne; Imperial College London; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Rockefeller University; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm)	Lapidus, N (corresponding author), Inst Natl Sante & Rech Med, UMR S 707, Paris, France.	lapidus@u707.jussieu.fr	Abel, Laurent/H-8888-2017; LE CANN, Pierre/K-1854-2015; Vély, Frédéric/HHM-3894-2022; Vivier, Eric/F-8939-2010; Andreoletti, Laurent/AAQ-2756-2020; Schwarzinger, Michael/F-7367-2011; Carrat, Fabrice/AAU-8480-2020; Lapidus, N./AAT-4479-2020	Abel, Laurent/0000-0001-7016-6493; Vivier, Eric/0000-0001-7022-8287; Schwarzinger, Michael/0000-0002-0573-6856; Carrat, Fabrice/0000-0002-8672-7918; Lapidus, N./0000-0002-4837-1068; Vely, Frederic/0000-0002-1682-0949; Boelle, Pierre-Yves/0000-0002-5367-8232; LE CANN, PIERRE/0000-0001-5329-4311; ANDREOLETTI, LAURENT/0000-0002-7440-8880	Institut de Microbiologie et Maladies Infectieuses (IMMI-AVIESAN); Institut de Sante Publique (ISP-AVIESAN); French Ministry of Health and Assistance Publique Hopitaux de Paris - PHRC [AOM10199]; French Ministry of research; Institut de Recherche en Sante Publique (IReSP - TGIR); MRC [G0600719, MR/K010174/1] Funding Source: UKRI; Medical Research Council [MR/K010174/1B, G0600719B, G0600719, MR/K010174/1] Funding Source: researchfish	Institut de Microbiologie et Maladies Infectieuses (IMMI-AVIESAN); Institut de Sante Publique (ISP-AVIESAN); French Ministry of Health and Assistance Publique Hopitaux de Paris - PHRC; French Ministry of research(Ministry of Research, FranceEuropean Commission); Institut de Recherche en Sante Publique (IReSP - TGIR); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was supported by the Institut de Microbiologie et Maladies Infectieuses (IMMI-AVIESAN), the Institut de Sante Publique (ISP-AVIESAN), the French Ministry of Health and Assistance Publique Hopitaux de Paris - PHRC 2010 #AOM10199, the French Ministry of research and the Institut de Recherche en Sante Publique (IReSP - TGIR 2009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achonu C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026427; Adamson WE, 2011, EUROSURVEILLANCE, V16, P5; Allwinn R, 2010, MED MICROBIOL IMMUN, V199, P117, DOI 10.1007/s00430-010-0143-4; Arcavi L, 2004, ARCH INTERN MED, V164, P2206, DOI 10.1001/archinte.164.20.2206; Bandaranayake D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013211; Bansal S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009360; Bougneres P, 2008, J EXP MED, V205, P2953, DOI 10.1084/jem.20082622; CAREY V, 1993, BIOMETRIKA, V80, P517, DOI 10.2307/2337173; Carrat F, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-301; Cauchemez S, 2011, P NATL ACAD SCI USA, V108, P2825, DOI 10.1073/pnas.1008895108; CDC, FLU ACT SURV REP SUR; Chao DY, 2011, INT J INFECT DIS, V15, pE695, DOI 10.1016/j.ijid.2011.05.012; Chen MIC, 2010, JAMA-J AM MED ASSOC, V303, P1383, DOI 10.1001/jama.2010.404; Monsalvo AC, 2011, NAT MED, V17, P195, DOI 10.1038/nm.2262; Cowling BJ, 2010, CLIN INFECT DIS, V51, P1370, DOI 10.1086/657311; Delangue J, 2011, CLIN MICROBIOL INFEC; Dellagi K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025738; Deng Y, 2011, EPIDEMIOL INFECT, V139, P52, DOI 10.1017/S0950268810002189; Garcia-Garcia L, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3928; Gilbert GL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012562; Goldstein E, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-211; Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453; Horvath KM, 2011, AM J RESP CELL MOL, V45, P237, DOI 10.1165/rcmb.2010-0190OC; Hsu ACY, 2012, RESPIROLOGY, V17, P1166, DOI 10.1111/j.1440-1843.2012.02200.x; Insee, 2011, DEF METH STAT BLOCK; Juhn YJ, 2012, ALLERGY ASTHMA IMMUN, V4, P122, DOI 10.4168/aair.2012.4.3.122; KARK JD, 1982, NEW ENGL J MED, V307, P1042, DOI 10.1056/NEJM198210213071702; Kelly HA, 2011, VACCINE, V29, P6419, DOI 10.1016/j.vaccine.2011.03.055; Kesic MJ, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-82; Kloepfer KM, 2012, AM J RESP CRITICAL C; Lapidus N, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-417; Lau LLH, 2012, EPIDEMIOLOGY, V23, P531, DOI 10.1097/EDE.0b013e31825588b8; Lee DH, 2010, AM J INFECT CONTROL, V38, pE43, DOI 10.1016/j.ajic.2010.05.017; Lemaitre M, 2010, CLIN MICROBIOL INFEC; Lerdsamran H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016164; Lim WY, 2011, EMERG INFECT DIS, V17, P1455, DOI 10.3201/eid1708.101270; Lumley T, 2010, POSTSTRATIFICATION R, P147; MACKENZIE JS, 1976, J HYG-CAMBRIDGE, V77, P409, DOI 10.1017/S0022172400055790; McLeish NJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020358; Mian MF, 2008, J LEUKOCYTE BIOL, V83, P774, DOI 10.1189/jlb.0707481; Mian MF, 2009, MOL IMMUNOL, V46, P821, DOI 10.1016/j.molimm.2008.09.007; Miller E, 2010, LANCET, V375, P1100, DOI 10.1016/S0140-6736(09)62126-7; Morgan OW, 2010, EMERG INFECT DIS, V16, P631, DOI 10.3201/eid1604.091658; Myatt TA, 2010, ENVIRON HEALTH-GLOB, V9, DOI 10.1186/1476-069X-9-55; Nauta JJP, 2006, BIOLOGICALS, V34, P183, DOI 10.1016/j.biologicals.2005.09.001; Nougairede A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009214; Papenburg J, 2010, CLIN INFECT DIS; Patel CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010746; Pebody R, 2011, VACCINE, V29, P2613, DOI 10.1016/j.vaccine.2011.01.046; Potter GE, 2012, ANN APPL STAT, V6, P1, DOI 10.1214/11-AOAS505; Puig-Barbera J, 2010, VACCINE, V28, P7460, DOI 10.1016/j.vaccine.2010.09.042; RUBIN DB, 1991, STAT MED, V10, P585, DOI 10.1002/sim.4780100410; Schafer JL, 1997, ANAL INCOMPLETE MULT, V1st, DOI 10.1201/9781439821862; Sentiweb, SENT NETW FRANC WEEK; Shaman J, 2009, P NATL ACAD SCI USA, V106, P3243, DOI 10.1073/pnas.0806852106; Siev D, 2007, BIOLOGICALS, V35, P149, DOI 10.1016/j.biologicals.2006.06.002; Sikora C, 2010, J CLIN VIROL, V49, P90, DOI 10.1016/j.jcv.2010.06.015; Skowronski DM, 2010, CAN MED ASSOC J, V182, P1851, DOI 10.1503/cmaj.100910; Skowronski DM, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000258; Storey JD, 2004, J R STAT SOC B, V66, P187, DOI 10.1111/j.1467-9868.2004.00439.x; Tandale BV, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-255; Tian LL, 2011, PREV MED, V52, P71, DOI 10.1016/j.ypmed.2010.10.006; Kerkhove MD, 2013, INFLUENZA OTHER RESP, V7, P872, DOI 10.1111/irv.12074; Wang M, 2011, PLOS ONE, V6, P1, DOI DOI 10.1371/J0URNAL.P0NE.0016809; WOOD JM, 1994, VACCINE, V12, P167, DOI 10.1016/0264-410X(94)90056-6; Wu JT, 2010, CLIN INFECT DIS, V51, P1184, DOI 10.1086/656740; Wu WX, 2011, AM J PHYSIOL-LUNG C, V300, pL821, DOI 10.1152/ajplung.00267.2010; Xu C, 2011, J NANOMATER, V2011, DOI 10.1155/2011/201834; Zimmer SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011601	70	15	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2013	8	4							e60127	10.1371/journal.pone.0060127	http://dx.doi.org/10.1371/journal.pone.0060127			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130DR	23613718	Green Published, Green Submitted, gold			2022-12-25	WOS:000317893400006
J	Li, F; Chen, TA; Hu, SL; Lin, JK; Hu, R; Feng, H				Li, Fei; Chen, Tunan; Hu, Shengli; Lin, Jiangkai; Hu, Rong; Feng, Hua			Superoxide Mediates Direct Current Electric Field-Induced Directional Migration of Glioma Cells through the Activation of AKT and ERK	PLOS ONE			English	Article							PROSTATE-CANCER CELLS; ENDOTHELIAL-CELLS; HYDROGEN-PEROXIDE; OXIDATIVE STRESS; EPITHELIAL-CELLS; INVASION; CYTOSKELETON; CHEMOTAXIS	Direct current electric fields (DCEFs) can induce directional migration for many cell types through activation of intracellular signaling pathways. However, the mechanisms that bridge extracellular electrical stimulation with intracellular signaling remain largely unknown. In the current study, we found that a DCEF can induce the directional migration of U87, C6 and U251 glioma cells to the cathode and stimulate the production of hydrogen peroxide and superoxide. Subsequent studies demonstrated that the electrotaxis of glioma cells were abolished by the superoxide inhibitor N-acetyl-l-cysteine (NAC) or overexpression of mitochondrial superoxide dismutase (MnSOD), but was not affected by inhibition of hydrogen peroxide through the overexpression of catalase. Furthermore, we found that the presence of NAC, as well as the overexpression of MnSOD, could almost completely abolish the activation of Akt, extracellular-signal-regulated kinase (Erk) 1/2, c-Jun N-terminal kinase (JNK), and p38, although only JNK and p38 were affected by overexpression of catalase. The presenting of specific inhibitors can decrease the activation of Erk1/2 or Akt as well as the directional migration of glioma cells. Collectively, our data demonstrate that superoxide may play a critical role in DCEF-induced directional migration of glioma cells through the regulation of Akt and Erk1/2 activation. This study provides novel evidence that the superoxide is at least one of the "bridges" coupling the extracellular electric stimulation to the intracellular signals during DCEF-mediated cell directional migration.	[Li, Fei; Chen, Tunan; Hu, Shengli; Lin, Jiangkai; Hu, Rong; Feng, Hua] Third Mil Med Univ, Southwest Hosp, Dept Neurosurg, Chongqing, Peoples R China	Army Medical University	Feng, H (corresponding author), Third Mil Med Univ, Southwest Hosp, Dept Neurosurg, Chongqing, Peoples R China.	fenghua8888@yahoo.com.cn	Feng, Hua/AAX-4121-2021; Hu, Rong/GWV-5159-2022	Feng, Hua/0000-0003-4489-9217; 	National Natural Science Foundation of China [30670506, 30973494]; Natural Science Foundation Project of CQ Chongqing Science & Technology Commission [cstc2012jjB0081]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation Project of CQ Chongqing Science & Technology Commission	This work was supported by National Natural Science Foundation of China (30670506 and 30973494), http://isisn.nsfc.gov.cn/egrantweb/ and Natural Science Foundation Project of CQ Chongqing Science & Technology Commission (cstc2012jjB0081), http://www.ctin.ac.cn/Class.aspx?clsId = 226. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Augustyniak A, 2010, FREE RADICAL RES, V44, P1216, DOI 10.3109/10715762.2010.508495; Borgens R B, 1988, Adv Neurol, V47, P547; Brown SB, 2008, THESCIENTIFICWORLDJO, V8, P1280, DOI 10.1100/tsw.2008.158; Campetelli A, 2012, CYTOSKELETON, V69, P601, DOI 10.1002/cm.21047; CARTER WO, 1994, J LEUKOCYTE BIOL, V55, P253; Castano AP, 2006, NAT REV CANCER, V6, P535, DOI 10.1038/nrc1894; Chernyavsky AI, 2005, J BIOL CHEM, V280, P39220, DOI 10.1074/jbc.M504407200; Chi AS, 2007, EXPERT OPIN THER TAR, V11, P473, DOI 10.1517/14728222.11.4.473; Chiarugi P, 2007, CELL SIGNAL, V19, P672, DOI 10.1016/j.cellsig.2006.11.009; Connor KM, 2007, CANCER RES, V67, P10260, DOI 10.1158/0008-5472.CAN-07-1204; Djamgoz MBA, 2001, J CELL SCI, V114, P2697; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Guo AH, 2010, J INVEST DERMATOL, V130, P2320, DOI 10.1038/jid.2010.96; Hattori Hidenori, 2010, Commun Integr Biol, V3, P278; Hattori H, 2010, P NATL ACAD SCI USA, V107, P3546, DOI 10.1073/pnas.0914351107; Huang CW, 2009, BIOSENS BIOELECTRON, V24, P3510, DOI 10.1016/j.bios.2009.05.001; Huo YA, 2009, EXP EYE RES, V89, P876, DOI 10.1016/j.exer.2009.07.012; Huttenlocher A, 2007, NEW ENGL J MED, V356, P2; Iglesias PA, 2008, CURR OPIN CELL BIOL, V20, P35, DOI 10.1016/j.ceb.2007.11.011; Jiang HJ, 2002, PHOTOCHEM PHOTOBIOL, V76, P224, DOI 10.1562/0031-8655(2002)076<0224:SAOTPQ>2.0.CO;2; Kiewert C, 2010, BRAIN RES, V1312, P101, DOI 10.1016/j.brainres.2009.11.068; Kitaoka T, 2002, STROKE, V33, P3012, DOI 10.1161/01.STR.0000037673.17260.1B; Kumar B, 2008, CANCER RES, V68, P1777, DOI 10.1158/0008-5472.CAN-07-5259; Kurzwelly D, 2010, ADV TECH STAND NEURO, V35, P80; Li F, 2012, FREE RADICAL BIO MED, V52, P1888, DOI 10.1016/j.freeradbiomed.2012.02.047; Li F, 2011, FREE RADICAL RES, V45, P1154, DOI 10.3109/10715762.2011.604321; Li J, 2011, LAB CHIP, V11, P1298, DOI 10.1039/c0lc00371a; Li L, 2008, STEM CELLS, V26, P2193, DOI 10.1634/stemcells.2007-1022; Li XF, 2002, J VASC RES, V39, P391, DOI 10.1159/000064517; McCaig CD, 2005, PHYSIOL REV, V85, P943, DOI 10.1152/physrev.00020.2004; Monti Barbara, 2009, Curr Mol Pharmacol, V2, P95; Mycielska ME, 2004, J CELL SCI, V117, P1631, DOI 10.1242/jcs.01125; Myhre O, 2003, BIOCHEM PHARMACOL, V65, P1575, DOI 10.1016/S0006-2952(03)00083-2; Nakada M, 2007, CELL MOL LIFE SCI, V64, P458, DOI 10.1007/s00018-007-6342-5; Novo E, 2011, J HEPATOL, V54, P964, DOI 10.1016/j.jhep.2010.09.022; Ozkucur N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006131; Okoh V, 2011, BBA-REV CANCER, V1815, P115, DOI 10.1016/j.bbcan.2010.10.005; Poonnoose SI, 2000, SURG NEUROL, V54, P194, DOI 10.1016/S0090-3019(00)00280-9; Pu J, 2007, J CELL SCI, V120, P3395, DOI 10.1242/jcs.002774; Rajnicek AM, 2008, BIOMATERIALS, V29, P2082, DOI 10.1016/j.biomaterials.2008.01.015; Sato MJ, 2007, BIOSYSTEMS, V88, P261, DOI 10.1016/j.biosystems.2006.06.008; Saudemont A, 2009, CELL CYCLE, V8, P3307, DOI 10.4161/cc.8.20.9692; Song L, 2006, J CELL BIOL, V175, P607, DOI 10.1083/jcb.200602149; Tait MJ, 2007, BRIT J NEUROSURG, V21, P496, DOI 10.1080/02688690701449251; Yan XL, 2009, BIOELECTROMAGNETICS, V30, P29, DOI 10.1002/bem.20436; Yao L, 2011, TISSUE ENG PART B-RE, V17, P143, DOI [10.1089/ten.teb.2010.0561, 10.1089/ten.TEB.2010.0561]; Zhao M, 2002, FASEB J, V16, P857, DOI 10.1096/fj.01-0811fje; Zhao M, 2006, NATURE, V442, P457, DOI 10.1038/nature04925; Zhao M, 2009, SEMIN CELL DEV BIOL, V20, P674, DOI 10.1016/j.semcdb.2008.12.009; Zohrabian VM, 2009, ANTICANCER RES, V29, P119	50	34	35	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2013	8	4							e61195	10.1371/journal.pone.0061195	http://dx.doi.org/10.1371/journal.pone.0061195			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130DR	23613809	gold, Green Submitted, Green Published			2022-12-25	WOS:000317893400046
J	Manley, NC; Caso, JR; Works, MG; Cutler, AB; Zemlyak, I; Sun, GH; Munhoz, CD; Chang, S; Sorrells, SF; Ermini, FV; Decker, JH; Bertrand, AA; Dinkel, KM; Steinberg, GK; Sapolsky, RM				Manley, Nathan C.; Caso, Javier R.; Works, Melissa G.; Cutler, Andrew B.; Zemlyak, Ilona; Sun, Guohua; Munhoz, Carolina D.; Chang, Sydney; Sorrells, Shawn F.; Ermini, Florian V.; Decker, Johannes H.; Bertrand, Anthony A.; Dinkel, Klaus M.; Steinberg, Gary K.; Sapolsky, Robert M.			Derivation of Injury-Responsive Dendritic Cells for Acute Brain Targeting and Therapeutic Protein Delivery in the Stroke-Injured Rat	PLOS ONE			English	Article							CEREBRAL-ARTERY OCCLUSION; MESENCHYMAL STEM-CELLS; ISCHEMIC BRAIN; IN-VIVO; NEUROTROPHIC FACTOR; GENE-THERAPY; INTRAVENOUS-INJECTION; FUSION PROTEIN; EXPRESSION; CHEMOATTRACTANT	Research with experimental stroke models has identified a wide range of therapeutic proteins that can prevent the brain damage caused by this form of acute neurological injury. Despite this, we do not yet have safe and effective ways to deliver therapeutic proteins to the injured brain, and this remains a major obstacle for clinical translation. Current targeted strategies typically involve invasive neurosurgery, whereas systemic approaches produce the undesirable outcome of non-specific protein delivery to the entire brain, rather than solely to the injury site. As a potential way to address this, we developed a protein delivery system modeled after the endogenous immune cell response to brain injury. Using ex-vivo-engineered dendritic cells (DCs), we find that these cells can transiently home to brain injury in a rat model of stroke with both temporal and spatial selectivity. We present a standardized method to derive injury-responsive DCs from bone marrow and show that injury targeting is dependent on culture conditions that maintain an immature DC phenotype. Further, we find evidence that when loaded with therapeutic cargo, cultured DCs can suppress initial neuron death caused by an ischemic injury. These results demonstrate a non-invasive method to target ischemic brain injury and may ultimately provide a way to selectively deliver therapeutic compounds to the injured brain.	[Manley, Nathan C.; Caso, Javier R.; Works, Melissa G.; Zemlyak, Ilona; Chang, Sydney; Sorrells, Shawn F.; Ermini, Florian V.; Decker, Johannes H.; Bertrand, Anthony A.; Dinkel, Klaus M.; Sapolsky, Robert M.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Manley, Nathan C.; Sun, Guohua; Steinberg, Gary K.; Sapolsky, Robert M.] Stanford Univ, Sch Med, Dept Neurosurg, Stanford, CA 94305 USA; [Manley, Nathan C.; Sun, Guohua; Steinberg, Gary K.; Sapolsky, Robert M.] Stanford Univ, Sch Med, Stanford Stroke Ctr, Stanford, CA 94305 USA; [Manley, Nathan C.; Sun, Guohua; Steinberg, Gary K.; Sapolsky, Robert M.] Stanford Univ, Sch Med, Stanford Inst Neuroinnovat & Translat Neurosci, Stanford, CA 94305 USA; [Cutler, Andrew B.] Stanford Univ, Sch Med, Dept Bioengn, Stanford, CA 94305 USA; [Munhoz, Carolina D.] Univ Sao Paulo, Inst Biomed Sci, Dept Pharmacol, Sao Paulo, Brazil; [Steinberg, Gary K.; Sapolsky, Robert M.] Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Universidade de Sao Paulo; Stanford University	Manley, NC (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.	nmanley@stanford.edu	Caso, Javier R/G-2243-2017; Munhoz, Carolina Demarchi/N-7219-2014	Caso, Javier R/0000-0001-8622-749X; Munhoz, Carolina Demarchi/0000-0002-8656-5234; Cutler, Andrew/0000-0003-4064-1139; Steinberg, Gary/0000-0001-6374-1058; Sorrells, Shawn/0000-0002-0010-6628	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS058784] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS058784] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ajmo CT, 2008, J NEUROSCI RES, V86, P2227, DOI 10.1002/jnr.21661; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Belayev L, 1996, STROKE, V27, P1616, DOI 10.1161/01.STR.27.9.1616; Binder DK, 2004, GROWTH FACTORS, V22, P123, DOI 10.1080/08977190410001723308; Breckpot K, 2003, J GENE MED, V5, P654, DOI 10.1002/jgm.400; Brissette-Storkus CS, 2002, J LEUKOCYTE BIOL, V71, P941; Brooke SM, 1999, NEUROSCI LETT, V267, P21, DOI 10.1016/S0304-3940(99)00315-8; Cao GD, 2002, J NEUROSCI, V22, P5423; COUCHIE D, 1986, J NEUROCHEM, V47, P1255; Creusot RJ, 2009, BLOOD, V113, P6638, DOI 10.1182/blood-2009-02-204321; Dietz GPH, 2004, MOL CELL NEUROSCI, V27, P85, DOI 10.1016/j.mcn.2004.03.005; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; Donnini S, 2009, CELL CYCLE, V8, P1271, DOI 10.4161/cc.8.8.8301; Gelderblom M, 2009, STROKE, V40, P1849, DOI 10.1161/STROKEAHA.108.534503; Grauer O, 2002, HISTOCHEM CELL BIOL, V117, P351, DOI 10.1007/s00418-002-0384-4; Hicks A, 2009, ACTA NEUROBIOL EXP, V69, P1; Hsich G, 2002, HUM GENE THER, V13, P579, DOI 10.1089/10430340252837198; Ju KL, 2008, EXP NEUROL, V210, P602, DOI 10.1016/j.expneurol.2007.12.008; Kilic E, 2006, FRONT BIOSCI-LANDMRK, V11, P1716, DOI 10.2741/1917; Kostulas N, 2002, STROKE, V33, P1129, DOI 10.1161/hs0402.105379; Lazovic J, 2005, STROKE, V36, P2226, DOI 10.1161/01.STR.0000182255.08162.6a; Lebson L, 2010, J NEUROSCI, V30, P9651, DOI 10.1523/JNEUROSCI.0329-10.2010; Lee HJ, 2010, J NEUROSCI RES, V88, P3282, DOI 10.1002/jnr.22474; Lee ST, 2008, BRAIN, V131, P616, DOI 10.1093/brain/awm306; MULLEN CA, 1992, P NATL ACAD SCI USA, V89, P33, DOI 10.1073/pnas.89.1.33; Munhoz CD, 2010, J NEUROSCI, V30, P13690, DOI 10.1523/JNEUROSCI.0303-09.2010; Naldini L, 1996, P NATL ACAD SCI USA, V93, P11382, DOI 10.1073/pnas.93.21.11382; Nomura T, 2005, NEUROSCIENCE, V136, P161, DOI 10.1016/j.neuroscience.2005.06.062; Omori Y, 2008, BRAIN RES, V1236, P30, DOI 10.1016/j.brainres.2008.07.116; Pardridge WM, 2012, METHOD ENZYMOL, V503, P269, DOI 10.1016/B978-0-12-396962-0.00011-2; de Lima MCP, 2005, CNS NEUROL DISORD-DR, V4, P453, DOI 10.2174/1568007054546144; Ransohoff RM, 2003, NAT REV IMMUNOL, V3, P569, DOI 10.1038/nri1130; Reichmann G, 2002, J NEUROIMMUNOL, V129, P125, DOI 10.1016/S0165-5728(02)00184-4; Sallusto F, 1998, EUR J IMMUNOL, V28, P2760, DOI 10.1002/(SICI)1521-4141(199809)28:09<2760::AID-IMMU2760>3.0.CO;2-N; Sapolsky RM, 2003, NAT REV NEUROSCI, V4, P61, DOI 10.1038/nrn1006; Schilling M, 2009, NEUROSCIENCE, V161, P806, DOI 10.1016/j.neuroscience.2009.04.025; Schwarze SR, 1999, SCIENCE, V285, P1569, DOI 10.1126/science.285.5433.1569; Singh MH, 2010, NEUROSCI LETT, V469, P179, DOI 10.1016/j.neulet.2009.11.067; Tanaka S, 2004, STROKE, V35, P1968, DOI 10.1161/01.STR.0000133685.59556.a7; Wang Q, 2007, J NEUROIMMUNOL, V184, P53, DOI 10.1016/j.jneuroim.2006.11.014; White E, 2012, BRIT J NEUROSURG, DOI [10.3109/Br.J.Neurosurg.02688697.2012.671972, DOI 10.3109/BR.J.NEUROSURG.02688697.2012.671972]; Wilson NS, 2004, BLOOD, V103, P2187, DOI 10.1182/blood-2003-08-2729; Wu Dafang, 2005, NeuroRx, V2, P120, DOI 10.1602/neurorx.2.1.120; Xu XH, 2006, LIFE SCI, V78, P704, DOI 10.1016/j.lfs.2005.05.080; Yamagami S, 1999, J LEUKOCYTE BIOL, V65, P744, DOI 10.1002/jlb.65.6.744; Yilmaz A, 2010, CLIN SCI, V118, P147, DOI 10.1042/CS20090154; Zhang RL, 1998, BRAIN RES, V785, P207, DOI 10.1016/S0006-8993(97)01343-7; Zhang Y, 2001, BRAIN RES, V889, P49, DOI 10.1016/S0006-8993(00)03108-5	48	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2013	8	4							e61789	10.1371/journal.pone.0061789	http://dx.doi.org/10.1371/journal.pone.0061789			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130DR	23613937	gold, Green Published, Green Submitted			2022-12-25	WOS:000317893400111
J	Michaloglou, C; Lehmann, W; Martin, T; Delaunay, C; Hueber, A; Barys, L; Niu, HL; Billy, E; Wartmann, M; Ito, M; Wilson, CJ; Digan, ME; Bauer, A; Voshol, H; Christofori, G; Sellers, WR; Hofmann, F; Schmelzle, T				Michaloglou, Chrysiis; Lehmann, Waltraut; Martin, Typhaine; Delaunay, Clara; Hueber, Andreas; Barys, Louise; Niu, Honglin; Billy, Eric; Wartmann, Markus; Ito, Moriko; Wilson, Christopher J.; Digan, Mary Ellen; Bauer, Andreas; Voshol, Hans; Christofori, Gerhard; Sellers, William R.; Hofmann, Francesco; Schmelzle, Tobias			The Tyrosine Phosphatase PTPN14 Is a Negative Regulator of YAP Activity	PLOS ONE			English	Article							YES-ASSOCIATED PROTEIN; HIPPO SIGNALING PATHWAY; CELL-PROLIFERATION; ORGAN SIZE; WW DOMAIN; TUMOR-SUPPRESSOR; DROSOPHILA; APOPTOSIS; ANGIOMOTIN; JUNCTIONS	The Hippo (Hpo) pathway is a novel signaling pathway that controls organ size in Drosophila and mammals and is deregulated in a variety of human cancers. It consists of a set of kinases that, through a number of phosphorylation events, inactivate YAP, a transcriptional co-activator that controls cellular proliferation and apoptosis. We have identified PTPN14 as a YAP-binding protein that negatively regulates YAP activity by controlling its localization. Mechanistically, we find that the interaction of ectopic YAP with PTPN14 can be mediated by the respective WW and PPxY motifs. However, the PTPN14 PPxY motif and phosphatase activity appear to be dispensable for the negative regulation of endogenous YAP, likely suggesting more complex mechanisms of interaction and modulation. Finally, we demonstrate that PTPN14 downregulation can phenocopy YAP activation in mammary epithelial cells and synergize with YAP to induce oncogenic transformation.	[Michaloglou, Chrysiis; Lehmann, Waltraut; Martin, Typhaine; Delaunay, Clara; Hueber, Andreas; Barys, Louise; Billy, Eric; Wartmann, Markus; Ito, Moriko; Bauer, Andreas; Voshol, Hans; Hofmann, Francesco; Schmelzle, Tobias] Novartis Inst BioMed Res, Basel, Switzerland; [Wilson, Christopher J.; Sellers, William R.] Novartis Inst BioMed Res, Cambridge, MA USA; [Niu, Honglin; Digan, Mary Ellen] Novartis Inst BioMed Res, Ctr Prote Chem, Cambridge, MA USA; [Christofori, Gerhard] Univ Basel, Dept Biomed, Inst Biochem & Genet, Basel, Switzerland	Novartis; Novartis; Novartis; University of Basel	Schmelzle, T (corresponding author), Novartis Inst BioMed Res, Basel, Switzerland.	tobias.schmelzle@novartis.com		Wilson, Christopher/0000-0002-9146-522X; Billy, Eric/0000-0002-8859-0089	Novartis AG	Novartis AG	All research costs were covered by Novartis AG. No additional external funding was received for this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basu S, 2003, MOL CELL, V11, P11, DOI 10.1016/S1097-2765(02)00776-1; Boggiano JC, 2012, DEV CELL, V22, P695, DOI 10.1016/j.devcel.2012.03.013; BORK P, 1994, TRENDS BIOCHEM SCI, V19, P531, DOI 10.1016/0968-0004(94)90053-1; Camargo FD, 2007, CURR BIOL, V17, P2054, DOI 10.1016/j.cub.2007.10.039; Chan SW, 2011, J BIOL CHEM, V286, P7018, DOI 10.1074/jbc.C110.212621; Chen HI, 1997, J BIOL CHEM, V272, P17070, DOI 10.1074/jbc.272.27.17070; CHEN HI, 1995, P NATL ACAD SCI USA, V92, P7819, DOI 10.1073/pnas.92.17.7819; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Fotia AB, 2004, J BIOL CHEM, V279, P28930, DOI 10.1074/jbc.M402820200; Gaffney CJ, 2012, GENE, V509, P215, DOI 10.1016/j.gene.2012.08.025; Genevet A, 2011, BIOCHEM J, V436, P213, DOI 10.1042/BJ20110217; Huang J.M., 2012, ONCOGENE; Huang JB, 2005, CELL, V122, P421, DOI 10.1016/j.cell.2005.06.007; Ito M, 2011, CLIN CANCER RES, V17, P416, DOI 10.1158/1078-0432.CCR-10-2050; Jiang SW, 2000, DNA CELL BIOL, V19, P507, DOI 10.1089/10445490050128430; Lai ZC, 2005, CELL, V120, P675, DOI 10.1016/j.cell.2004.12.036; Levy D, 2008, MOL CELL, V29, P350, DOI 10.1016/j.molcel.2007.12.022; Liu X., 2012, ONCOGENE; Mauviel A, 2012, ONCOGENE, V31, P1743, DOI 10.1038/onc.2011.363; Miller E, 2012, CHEM BIOL, V19, P955, DOI 10.1016/j.chembiol.2012.07.005; Oka T, 2012, ONCOGENE, V31, P128, DOI 10.1038/onc.2011.216; Overholtzer M, 2006, P NATL ACAD SCI USA, V103, P12405, DOI 10.1073/pnas.0605579103; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Paramasivam M, 2011, MOL BIOL CELL, V22, P3725, DOI 10.1091/mbc.E11-04-0300; Poernbacher I, 2012, CURR BIOL, V22, P389, DOI 10.1016/j.cub.2012.01.019; Schlegelmilch K, 2011, CELL, V144, P782, DOI 10.1016/j.cell.2011.02.031; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Tao WF, 1999, NAT GENET, V21, P177, DOI 10.1038/5960; Varelas X, 2012, TRENDS CELL BIOL, V22, P88, DOI 10.1016/j.tcb.2011.10.002; Wadham C, 2003, MOL BIOL CELL, V14, P2520, DOI 10.1091/mbc.E02-09-0577; Wang WQ, 2012, GENE DEV, V26, P1959, DOI 10.1101/gad.192955.112; Wang WQ, 2011, J BIOL CHEM, V286, P4364, DOI 10.1074/jbc.C110.205401; Wang ZH, 2004, SCIENCE, V304, P1164, DOI 10.1126/science.1096096; Webb C, 2011, BIOCHEMISTRY-US, V50, P3300, DOI 10.1021/bi2001888; Wee S, 2008, P NATL ACAD SCI USA, V105, P13057, DOI 10.1073/pnas.0802655105; Wiederschain D, 2009, CELL CYCLE, V8, P498, DOI 10.4161/cc.8.3.7701; Wu S, 2003, CELL, V114, P445, DOI 10.1016/S0092-8674(03)00549-X; Yu FX, 2012, CELL, V150, P780, DOI 10.1016/j.cell.2012.06.037; Zhao B, 2011, NAT CELL BIOL, V13, P877, DOI 10.1038/ncb2303; Zhao B, 2011, GENE DEV, V25, P51, DOI 10.1101/gad.2000111; Zhao B, 2008, CURR OPIN CELL BIOL, V20, P638, DOI 10.1016/j.ceb.2008.10.001	41	64	66	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2013	8	4							e61916	10.1371/journal.pone.0061916	http://dx.doi.org/10.1371/journal.pone.0061916			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130DR	23613971	Green Submitted, gold, Green Published			2022-12-25	WOS:000317893400129
J	Oshimoto, A; Wakabayashi, Y; Garske, A; Lopez, R; Rolen, S; Flowers, M; Arevalo, N; Restrepo, D				Oshimoto, Arisa; Wakabayashi, Yoshihiro; Garske, Anna; Lopez, Roberto; Rolen, Shane; Flowers, Michael; Arevalo, Nicole; Restrepo, Diego			Potential Role of Transient Receptor Potential Channel M5 in Sensing Putative Pheromones in Mouse Olfactory Sensory Neurons	PLOS ONE			English	Article							NARIS OCCLUSION ALTERS; MARKER PROTEIN; ELECTRO-OLFACTOGRAM; MICROVILLOUS CELLS; ADENYLYL-CYCLASE; ODOR DEPRIVATION; TRANSDUCTION; SYSTEM; TRPM5; IMMUNOREACTIVITY	Based on pharmacological studies of chemosensory transduction in transient receptor potential channel M5 (TRPM5) knockout mice it was hypothesized that this channel is involved in transduction for a subset of putative pheromones in mouse olfactory sensory neurons (OSNs). Yet, in the same study an electroolfactogram (EOG) in the mouse olfactory epithelium showed no significant difference in the responses to pheromones (and odors) between wild type and TRPM5 knockout mice. Here we show that the number of OSNs expressing TRPM5 is increased by unilateral naris occlusion. Importantly, EOG experiments show that mice lacking TRPM5 show a decreased response in the occluded epithelia to putative pheromones as opposed to wild type mice that show no change upon unilateral naris occlusion. This evidence indicates that under decreased olfactory sensory input TRPM5 plays a role in mediating putative pheromone transduction. Furthermore, we demonstrate that cyclic nucleotide gated channel A2 knockout (CNGA2-KO) mice that show substantially decreased or absent responses to odors and pheromones also have elevated levels of TRPM5 compared to wild type mice. Taken together, our evidence suggests that TRPM5 plays a role in mediating transduction for putative pheromones under conditions of reduced chemosensory input.	[Oshimoto, Arisa; Garske, Anna; Lopez, Roberto; Rolen, Shane; Flowers, Michael; Arevalo, Nicole; Restrepo, Diego] Univ Colorado, Sch Med, Dept Cell & Dev Biol, Neurosci Program, Aurora, CO 80045 USA; [Oshimoto, Arisa; Garske, Anna; Lopez, Roberto; Rolen, Shane; Flowers, Michael; Arevalo, Nicole; Restrepo, Diego] Univ Colorado, Sch Med, Rocky Mt Taste & Smell Ctr, Aurora, CO USA; [Wakabayashi, Yoshihiro] Natl Inst Agrobiol Sci, Neurobiol Lab, Tsukuba, Ibaraki, Japan	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; National Institute of Agrobiological Sciences - Japan	Restrepo, D (corresponding author), Univ Colorado, Sch Med, Dept Cell & Dev Biol, Neurosci Program, Aurora, CO 80045 USA.	diego.restrepo@ucdenver.edu			NIH;  [UL1RR025780]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025780] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS099042] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The NIH has funded this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Drs. Ernesto Salcedo, John Thompson, and David Gire for discussions; the use of the PCR core at University of Colorado Anschutz Medical Campus and Umarani Pugazhenthi for running the Q-RTPCR experiments; Dr. David Gire for helping with MATLAB programming. Q-RTPCR was performed under University of Colorado Cancer Center facilities partially funded by UL1RR025780.	Angely CJ, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-26; Axel R, 2005, ANGEW CHEM INT EDIT, V44, P6110, DOI 10.1002/anie.200501726; BAKALYAR HA, 1990, SCIENCE, V250, P1403, DOI 10.1126/science.2255909; Baum MJ, 2012, FRONT NEUROANAT, V6, DOI 10.3389/fnana.2012.00020; Billig GM, 2011, NAT NEUROSCI, V14, P763, DOI 10.1038/nn.2821; Brunet LJ, 1996, NEURON, V17, P681, DOI 10.1016/S0896-6273(00)80200-7; BRUNJES PC, 1985, BRAIN RES BULL, V14, P233, DOI 10.1016/0361-9230(85)90088-7; BRUNJES PC, 1991, DEV BRAIN RES, V62, P239, DOI 10.1016/0165-3806(91)90171-E; BRUNJES PC, 1994, BRAIN RES REV, V19, P146; Buck LB, 2005, ANGEW CHEM INT EDIT, V44, P6128, DOI 10.1002/anie.200501120; Clapp TR, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-7; Coppola DM, 2012, J MOL NEUROSCI, V47, P604, DOI 10.1007/s12031-011-9690-4; Coppola DM, 2006, HISTOL HISTOPATHOL, V21, P487, DOI 10.14670/HH-21.487; Curran-Everett D, 2000, AM J PHYSIOL-REG I, V279, pR1, DOI 10.1152/ajpregu.2000.279.1.R1; Damak S, 2006, CHEM SENSES, V31, P253, DOI 10.1093/chemse/bjj027; FARBMAN AI, 1980, DEV BIOL, V74, P205, DOI 10.1016/0012-1606(80)90062-7; FARBMAN AI, 1988, J NEUROSCI, V8, P3290; Gold GH, 1999, ANNU REV PHYSIOL, V61, P857, DOI 10.1146/annurev.physiol.61.1.857; Hansen A, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-115; He J, 2012, EUR J NEUROSCI; JONES DT, 1989, SCIENCE, V244, P790, DOI 10.1126/science.2499043; KANG JS, 1991, J GEN PHYSIOL, V98, P699, DOI 10.1085/jgp.98.4.699; Kang N, 2009, EUR J NEUROSCI, V29, P624, DOI 10.1111/j.1460-9568.2009.06638.x; Kimbell JS, 1997, TOXICOL APPL PHARM, V145, P388, DOI 10.1006/taap.1997.8206; KLEENE SJ, 1991, J NEUROSCI, V11, P3624; KURAHASHI T, 1990, J PHYSIOL-LONDON, V430, P355, DOI 10.1113/jphysiol.1990.sp018295; Kwak J, 2010, P ROY SOC B-BIOL SCI, V277, P2417, DOI 10.1098/rspb.2010.0162; Lin WH, 2008, J NEUROPHYSIOL, V99, P1451, DOI 10.1152/jn.01195.2007; Lin W, 2007, P NATL ACAD SCI USA, V104, P2471, DOI 10.1073/pnas.0610201104; Lin WH, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-114; Lin WH, 2004, J NEUROSCI, V24, P3703, DOI 10.1523/JNEUROSCI.0188-04.2004; LOWE G, 1993, NATURE, V366, P283, DOI 10.1038/366283a0; LOWE G, 1989, P NATL ACAD SCI USA, V86, P5641, DOI 10.1073/pnas.86.14.5641; Ma MH, 2007, CRIT REV BIOCHEM MOL, V42, P463, DOI 10.1080/10409230701693359; Mirich JM, 2001, DEV BRAIN RES, V127, P77, DOI 10.1016/S0165-3806(01)00101-8; Mombaerts P, 2006, ANNU REV CELL DEV BI, V22, P713, DOI 10.1146/annurev.cellbio.21.012804.093915; Munger SD, 2009, ANNU REV PHYSIOL, V71, P115, DOI 10.1146/annurev.physiol.70.113006.100608; NAKAMURA T, 1987, NATURE, V325, P442, DOI 10.1038/325442a0; Oliva AM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011359; Reisert J, 2007, J PHYSIOL-LONDON, V585, P731, DOI 10.1113/jphysiol.2007.142471; Reisert J, 2011, J GEN PHYSIOL, V138, P303, DOI 10.1085/jgp.201110645; Schild D, 1998, PHYSIOL REV, V78, P429, DOI 10.1152/physrev.1998.78.2.429; Scott JW, 2002, MICROSC RES TECHNIQ, V58, P152, DOI 10.1002/jemt.10133; Shepherd G.M., 2004, SYNAPTIC ORG BRAIN, P159; Spehr M, 2006, J NEUROSCI, V26, P1961, DOI 10.1523/JNEUROSCI.4939-05.2006; Stephan AB, 2009, P NATL ACAD SCI USA, V106, P11776, DOI 10.1073/pnas.0903304106; Thompson JA, 2012, J COMP NEUROL, V520, P1819, DOI 10.1002/cne.23015; Waggener CT, 2007, NEUROSCI LETT, V427, P112, DOI 10.1016/j.neulet.2007.09.013; Waguespack AM, 2005, BRAIN RES, V1044, P1, DOI 10.1016/j.brainres.2005.02.047; Wang Z, 2007, MOL NEUROBIOL, V35, P317, DOI 10.1007/s12035-007-0014-1; Wong ST, 2000, NEURON, V27, P487, DOI 10.1016/S0896-6273(00)00060-X; Zhang YF, 2003, CELL, V112, P293, DOI 10.1016/S0092-8674(03)00071-0	52	11	11	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2013	8	4							e61990	10.1371/journal.pone.0061990	http://dx.doi.org/10.1371/journal.pone.0061990			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130DR	23613997	gold, Green Published, Green Submitted			2022-12-25	WOS:000317893400139
J	Palar, K; Martin, A; Camacho, MLO; Derose, KP				Palar, Kartika; Martin, Alexis; Oropeza Camacho, Martha Lidia; Derose, Kathryn Pitkin			Livelihood Experiences and Adherence to HIV Antiretroviral Therapy among Participants in a Food Assistance Pilot in Bolivia: A Qualitative Study	PLOS ONE			English	Article							ART ADHERENCE; HIV/AIDS; BARRIERS; PEOPLE; HEALTH; CHALLENGES; FRAMEWORK; STIGMA; AIDS; ERA	Introduction: Health and development organizations increasingly promote livelihood interventions to improve health and economic outcomes for people living with HIV (PLHIV) receiving treatment with antiretroviral therapy (ART). In-depth understanding about how PLHIV make labor decisions in the context of treatment for HIV - and treatment decisions in the context of their livelihoods - is essential to guiding intervention design and developing hypotheses for future research on livelihoods and ART. However, few studies have explored the perspectives of PLHIV regarding integration of livelihoods and ART in urban, resource-limited settings. Methods: Qualitative interviews explored the livelihood experiences of food insecure ART patients in four Bolivian cities (n = 211). Topics included work-related barriers to ART adherence, HIV-related barriers to work, and economic coping mechanisms. Themes were identified using content coding procedures, with two coders to maximize reliability. Results: Participants reported complex economic lives often characterized by multiple economic activities, including both formal and informal labor. They struggled to manage ART treatment and livelihoods simultaneously, and faced a range of interpersonal and structural barriers. In particular, lack of HIV status disclosure, stigma, and discrimination were highly salient issues for study participants and likely to be unique to people with HIV, leading to conflict around requesting time off for clinic visits, resentment from co-workers about time off, and difficulties adhering to medication schedules. In addition, health system issues such as limited clinic hours or drug shortages exacerbated the struggle to balance economic activities with HIV treatment adherence. Conclusions: Improved policy-level efforts to enforce existing anti-discrimination laws, reduce HIV-related stigma, and expand health services accessibility could mitigate many of the barriers discussed by our participants, improve adherence, and reduce the need for livelihoods interventions.	[Palar, Kartika] RAND Corp, Pardee RAND Grad Sch, Santa Monica, CA USA; [Palar, Kartika] Univ Calif Los Angeles, Fielding Sch Publ Hlth, Los Angeles, CA USA; [Martin, Alexis] Reg Off Latin Amer & Caribbean, World Food Program, Panama City, Panama; [Oropeza Camacho, Martha Lidia] Bolivia Country Off, World Food Program, La Paz, Bolivia; [Derose, Kathryn Pitkin] RAND Corp, Santa Monica, CA USA	RAND Corporation; Pardee RAND Graduate School; University of California System; University of California Los Angeles; RAND Corporation	Palar, K (corresponding author), RAND Corp, Pardee RAND Grad Sch, Santa Monica, CA USA.	kpalar@ucla.edu			OPEC Fund for International Development (OFID); Pardee RAND Graduate School; Agency for Healthcare Research and Quality (AHRQ) [T32HS00046]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [T32HS000046] Funding Source: NIH RePORTER	OPEC Fund for International Development (OFID); Pardee RAND Graduate School; Agency for Healthcare Research and Quality (AHRQ)(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	This study was funded by a grant from the OPEC Fund for International Development (OFID) to the UN World Food Program Regional Office for Latin America and the Caribbean, and by a dissertation award to KP from the Pardee RAND Graduate School. Preparation of this manuscript was supported by grant number T32HS00046 from the Agency for Healthcare Research and Quality (AHRQ). The content is solely the responsibility of the authors and does not necessarily represent the official views of OFID, the Pardee RAND Graduate School, or AHRQ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altheide D. L, 1996, QUALITATIVE MEDIA AN; Anema Aranka, 2009, Curr HIV/AIDS Rep, V6, P224, DOI 10.1007/s11904-009-0030-z; [Anonymous], 2006, AIDS ECOLOGY POVERTY; [Anonymous], 1991, SUSTAINABLE RURAL LI; Beard J, 2009, AIDS CARE, V21, P1343, DOI 10.1080/09540120902889926; Crush J, 2011, FOOD SECUR, V3, P347, DOI 10.1007/s12571-011-0137-0; Erah PO, 2008, AFR J PHARM PHARMACO, V2, P145; Frega R, 2010, FOOD NUTR BULL, V31, pS292, DOI 10.1177/15648265100314S402; Gillespie S, 2005, INT FOOD POLICY RES; Haering S. A., 2009, COMMUNITY FOOD SECUR; Hardon AP, 2007, AIDS CARE, V19, P658, DOI 10.1080/09540120701244943; Holmes K, 2011, GLOB PUBLIC HEALTH, V6, P447, DOI 10.1080/17441692.2010.515235; Kadiyala S, 2009, J DEV EFFECT, V1, P470, DOI 10.1080/19439340903370469; Kagee A, 2011, GLOB PUBLIC HEALTH, V6, P83, DOI 10.1080/17441691003796387; Krippendorff K., 2004, CONTENT ANAL INTRO I, V2nd ed; Mahajan AP, 2008, AIDS, V22, pS67, DOI 10.1097/01.aids.0000327438.13291.62; Martin A, 2011, HIV AIDS POLICY FOOD; Melgar-Quinonez H., 2010, Seguranca Alimentar e Nutricional, V17, P48; Miles M. B., 2019, QUALITATIVE DATA ANA, V4th; Mills EJ, 2006, PLOS MED, V3, P2039, DOI 10.1371/journal.pmed.0030438; Pearson CR, 2006, JAIDS-J ACQ IMM DEF, V43, pS134, DOI 10.1097/01.qai.0000248339.82567.17; Rachlis BS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018948; Roopnaraine T, 2012, AIDS CARE, V24, P649, DOI 10.1080/09540121.2011.630349; Samuels FA, 2011, AIDS CARE, V23, P748, DOI 10.1080/09540121.2010.532535; Smallman Shawn, 2007, AIDS PANDEMIC LATIN; Sprague L, 2011, AJAR-AFR J AIDS RES, V10, P311, DOI 10.2989/16085906.2011.637730; Strauss AL, 1998, BASICS QUALITATIVE R, V2nd; The World Bank, 2007, HIV AIDS NUTR FOOD S; Tirivayi N, 2011, LABOUR SUPPLY RESPON; Tirivayi N, 2011, SOC SCI MED, V73, P685, DOI 10.1016/j.socscimed.2011.06.056; United Nations Development Programme, 2010, REG HUM DEV REP LAT; Weber R. P., 1990, BASIC CONTENT ANAL, V2nd; Weiser S, 2003, JAIDS-J ACQ IMM DEF, V34, P281, DOI 10.1097/00126334-200311010-00004; Yager JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026117	34	7	7	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2013	8	4							e61935	10.1371/journal.pone.0061935	http://dx.doi.org/10.1371/journal.pone.0061935			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	130DR	23613976	Green Submitted, gold, Green Published			2022-12-25	WOS:000317893400131
J	Papworth, S; Milner-Gulland, EJ; Slocombe, K				Papworth, Sarah; Milner-Gulland, E. J.; Slocombe, Katie			Hunted Woolly Monkeys (Lagothrix poeppigii) Show Threat-Sensitive Responses to Human Presence	PLOS ONE			English	Article							ALARM CALL; PRIMATE; BEHAVIOR; DIANA; PREDATORS	Responding only to individuals of a predator species which display threatening behaviour allows prey species to minimise energy expenditure and other costs of predator avoidance, such as disruption of feeding. The threat sensitivity hypothesis predicts such behaviour in prey species. If hunted animals are unable to distinguish dangerous humans from non-dangerous humans, human hunting is likely to have a greater effect on prey populations as all human encounters should lead to predator avoidance, increasing stress and creating opportunity costs for exploited populations. We test the threat sensitivity hypothesis in wild Poeppigi's woolly monkeys (Lagothrix poeppigii) in Yasuni National Park, Ecuador, by presenting human models engaging in one of three behaviours "hunting", "gathering" or "researching". These experiments were conducted at two sites with differing hunting pressures. Visibility, movement and vocalisations were recorded and results from two sites showed that groups changed their behaviours after being exposed to humans, and did so in different ways depending on the behaviour of the human model. Results at the site with higher hunting pressure were consistent with predictions based on the threat sensitivity hypothesis. Although results at the site with lower hunting pressure were not consistent with the results at the site with higher hunting pressure, groups at this site also showed differential responses to different human behaviours. These results provide evidence of threat-sensitive predator avoidance in hunted primates, which may allow them to conserve both time and energy when encountering humans which pose no threat.	[Papworth, Sarah; Milner-Gulland, E. J.] Imperial Coll, Div Ecol & Evolut, Ascot, Berks, England; [Papworth, Sarah] Imperial Coll, Ctr Environm Policy, Kensington, England; [Slocombe, Katie] Univ York, Dept Psychol, York YO10 5DD, N Yorkshire, England	Imperial College London; Imperial College London; University of York - UK	Papworth, S (corresponding author), Imperial Coll, Div Ecol & Evolut, Silwood Pk Campus, Ascot, Berks, England.	sarah.papworth06@imperial.ac.uk	Slocombe, Katie E/B-8788-2016	Slocombe, Katie E/0000-0002-7310-1887; Papworth, Sarah/0000-0002-8746-1912; Milner-Gulland, E.J./0000-0003-0324-2710	UK Natural Environment Research Council; Economic and Social Research Council; Company of Biologists; Royal Society; Society of Experimental Biology	UK Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Company of Biologists; Royal Society(Royal Society of London); Society of Experimental Biology	This work was supported by a UK Natural Environment Research Council and Economic and Social Research Council interdisciplinary studentship. Fieldwork costs were supplemented with a travel grant from the Company of Biologists and Society of Experimental Biology. EJMG acknowledges the support of a Royal Society Wolfson Research Merit Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold K, 2008, BEHAV ECOL SOCIOBIOL, V62, P549, DOI 10.1007/s00265-007-0479-y; Bates LA, 2007, CURR BIOL, V17, P1938, DOI 10.1016/j.cub.2007.09.060; BISHOP TD, 1992, BEHAV ECOL SOCIOBIOL, V31, P133, DOI 10.1007/BF00166346; Boersma P., 2013, PRAAT DOING PHONETIC; Bshary R, 2001, BEHAV ECOL SOCIOBIOL, V50, P251, DOI 10.1007/s002650100354; COOK M, 1985, J ABNORM PSYCHOL, V94, P591, DOI 10.1037/0021-843X.94.4.591; Croes BM, 2007, BIOTROPICA, V39, P257, DOI 10.1111/j.1744-7429.2006.00247.x; da Silva Maria N.F., 2005, Neotropical Primates, V13, P31, DOI 10.1896/1413-4705.13.2.31; Derby AM, 2008, THESIS STONY BROOK U; Di Fiore A, 2005, INT J PRIMATOL, V26, P1137, DOI 10.1007/s10764-005-6462-4; Di Fiore A, 2003, AM J PRIMATOL, V59, P47, DOI 10.1002/ajp.10065; Di Fiore A, 2009, BEHAVIOUR, V146, P437, DOI 10.1163/156853909X426345; Dindo M, 2008, P ROY SOC B-BIOL SCI, V275, P187, DOI 10.1098/rspb.2007.1318; Ferrari Stephen F., 2009, P251, DOI 10.1007/978-0-387-78705-3_10; Franzen M, 2006, ENVIRON CONSERV, V33, P36, DOI 10.1017/S0376892906002712; Gil-da-Costa R, 2003, P ROY SOC B-BIOL SCI, V270, P605, DOI 10.1098/rspb.2002.2281; Gil-da-Costa R, 2007, DEV PRIMATOL-PROG PR, P289, DOI 10.1007/978-0-387-34810-0_14; Griffin AS, 2003, ANIM BEHAV, V66, P485, DOI 10.1006/anbe.2003.2207; Griffin AS, 2004, LEARN BEHAV, V32, P131; Halekoh U, 2006, J STAT SOFTW, V15, P1, DOI 10.18637/jss.v015.i02; Hardin J.W., 2002, GEN ESTIMATING EQUAT; HELFMAN GS, 1989, BEHAV ECOL SOCIOBIOL, V24, P47, DOI 10.1007/BF00300117; Kone I, 2004, EFFET BRACONNAGE QUE; Kuhn M, 2011, CONTRACT COLLECTION; Lind J, 2005, BEHAV ECOL, V16, P945, DOI 10.1093/beheco/ari075; Maldonado Rodriguez AM, 2010, THESIS OXFORD BROOKE; Mena P, 2000, BIOL RESOURCE MANAGE, P57; Mitlermeier R.A., 1987, Monographs in Primatology, V9, P109; Morand S, 2005, GENOME, V48, P273, DOI 10.1139/G04-125; Papworth S, 2008, BIOL LETTERS, V4, P472, DOI 10.1098/rsbl.2008.0299; Papworth SK, 2012, METHODS ECOL EVOL, V3, P584, DOI 10.1111/j.2041-210X.2012.00189.x; Papworth SK, 2012, THESIS IMPERIAL COLL; PERES C A, 1991, Oryx, V25, P89; Puttlitz MH, 1999, ETHOLOGY, V105, P449, DOI 10.1046/j.1439-0310.1999.00416.x; R Core Development Team, 2011, R LANG ENV STAT COMP; Rendall D, 2000, J COMP PSYCHOL, V114, P36, DOI 10.1037/0735-7036.114.1.36; RIVAL L, 1993, MAN, V28, P635, DOI 10.2307/2803990; SLOBODCHIKOFF CN, 1991, ANIM BEHAV, V42, P713, DOI 10.1016/S0003-3472(05)80117-4; Stankowich T, 2006, BEHAV ECOL, V17, P246, DOI 10.1093/beheco/arj020; Urbani B., 2005, J ANTHROPOL SCI, V83, P89; Whiten A, 2000, COGNITIVE SCI, V24, P477; Yost J. A., 1983, ADAPTIVE RESPONSES N; Zuberbuhler K, 2007, DEV PRIMATOL-PROG PR, P3, DOI 10.1007/978-0-387-34810-0_1; Zuberbuhler K, 2002, J HUM EVOL, V43, P873, DOI 10.1006/jhev.2002.0605; Zuberbuhler K, 1999, ETHOLOGY, V105, P477, DOI 10.1046/j.1439-0310.1999.00396.x; Zuberbuhler K, 2000, COGNITION, V76, P195, DOI 10.1016/S0010-0277(00)00079-2; Zuberbuhler K, 1997, ANIM BEHAV, V53, P589, DOI 10.1006/anbe.1996.0334	47	29	29	0	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2013	8	4							e62000	10.1371/journal.pone.0062000	http://dx.doi.org/10.1371/journal.pone.0062000			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	130DR	23614003	Green Published, gold, Green Submitted			2022-12-25	WOS:000317893400145
J	Peterson, MP; Rosvall, KA; Choi, JH; Ziegenfus, C; Tang, HX; Colbourne, JK; Ketterson, ED				Peterson, Mark P.; Rosvall, Kimberly A.; Choi, Jeong-Hyeon; Ziegenfus, Charles; Tang, Haixu; Colbourne, John K.; Ketterson, Ellen D.			Testosterone Affects Neural Gene Expression Differently in Male and Female Juncos: A Role for Hormones in Mediating Sexual Dimorphism and Conflict	PLOS ONE			English	Article							EXPERIMENTALLY-ELEVATED TESTOSTERONE; DARK-EYED JUNCOS; AVIAN LIFE HISTORIES; SONG CONTROL NUCLEI; BRAIN AROMATASE; FUNCTIONAL GENOMICS; SEASONAL-CHANGES; EXOGENOUS TESTOSTERONE; REPRODUCTIVE SUCCESS; MELOSPIZA-MELODIA	Despite sharing much of their genomes, males and females are often highly dimorphic, reflecting at least in part the resolution of sexual conflict in response to sexually antagonistic selection. Sexual dimorphism arises owing to sex differences in gene expression, and steroid hormones are often invoked as a proximate cause of sexual dimorphism. Experimental elevation of androgens can modify behavior, physiology, and gene expression, but knowledge of the role of hormones remains incomplete, including how the sexes differ in gene expression in response to hormones. We addressed these questions in a bird species with a long history of behavioral endocrinological and ecological study, the dark-eyed junco (Junco hyemalis), using a custom microarray. Focusing on two brain regions involved in sexually dimorphic behavior and regulation of hormone secretion, we identified 651 genes that differed in expression by sex in medial amygdala and 611 in hypothalamus. Additionally, we treated individuals of each sex with testosterone implants and identified many genes that may be related to previously identified phenotypic effects of testosterone treatment. Some of these genes relate to previously identified effects of testosterone-treatment and suggest that the multiple effects of testosterone may be mediated by modifying the expression of a small number of genes. Notably, testosterone-treatment tended to alter expression of different genes in each sex: only 4 of the 527 genes identified as significant in one sex or the other were significantly differentially expressed in both sexes. Hormonally regulated gene expression is a key mechanism underlying sexual dimorphism, and our study identifies specific genes that may mediate some of these processes.	[Peterson, Mark P.; Rosvall, Kimberly A.; Ketterson, Ellen D.] Indiana Univ, Dept Biol, Ctr Integrat Study Anim Behav, Bloomington, IN 47405 USA; [Choi, Jeong-Hyeon; Tang, Haixu; Colbourne, John K.] Indiana Univ, Ctr Genom & Bioinformat, Bloomington, IN USA; [Choi, Jeong-Hyeon] Ctr Canc, Dept Biostat, Augusta, GA USA; [Ziegenfus, Charles] James Madison Univ, Dept Math, Harrisonburg, VA 22807 USA; [Colbourne, John K.] Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; James Madison University; University of Birmingham	Peterson, MP (corresponding author), Indiana Univ, Dept Biol, Ctr Integrat Study Anim Behav, Bloomington, IN 47405 USA.	petersmp@indiana.edu	Colbourne, John K/L-7748-2014; Choi, Justin/F-8792-2014; Rosvall, Kimberly/GQB-1395-2022	Colbourne, John K/0000-0002-6966-2972; 	National Science Foundation [ACI-0338618l, CNS-0521433, ABI-1062432, OCI-0451237, OCI-0535258, OCI-0504075, IOS-0820055, DGE-0504627]; Indiana METACyt Initiative; Lilly Endowment, Inc.; Shared University Research grants from IBM, Inc.; Indiana University; National Institutes of Health [T32-HD049336]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD049336] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); Indiana METACyt Initiative; Lilly Endowment, Inc.; Shared University Research grants from IBM, Inc.; Indiana University; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This material is based upon work supported by the National Science Foundation under Grant Numbers: ACI-0338618l, CNS-0521433, ABI-1062432, OCI-0451237, OCI-0535258, and OCI-0504075. This research was supported in part by the Indiana METACyt Initiative. The Indiana METACyt Initiative of Indiana University is supported in part by Lilly Endowment, Inc. This work was supported in part by Shared University Research grants from IBM, Inc. to Indiana University. This work was further funded by Indiana University, and the National Science Foundation (IOS-0820055 and DGE-0504627) and the National Institutes of Health (T32-HD049336). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMSKI J, 1995, BIOCHEM J, V311, P437, DOI 10.1042/bj3110437; Adkins-Regan E, 1999, HORM BEHAV, V35, P63, DOI 10.1006/hbeh.1998.1497; Alexa A., 2019, TOPGO ENRICHMENT ANA; Alexa A, 2006, BIOINFORMATICS, V22, P1600, DOI 10.1093/bioinformatics/btl140; ARCHER J, 1991, BRIT J PSYCHOL, V82, P1, DOI 10.1111/j.2044-8295.1991.tb02379.x; ARNOLD AP, 1975, J EXP ZOOL, V191, P309, DOI 10.1002/jez.1401910302; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Aubin-Horth N, 2007, MOL ECOL, V16, P1349, DOI 10.1111/j.1365-294X.2007.03249.x; Belfer I, 2007, GENES BRAIN BEHAV, V6, P473, DOI 10.1111/j.1601-183X.2006.00275.x; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berthold AA., 1849, ARCH ANAT PHYSIOL, P42; Black MP, 2005, P ROY SOC B-BIOL SCI, V272, P2435, DOI 10.1098/rspb.2005.3210; Brenowitz EA, 2004, ANN NY ACAD SCI, V1016, P560, DOI 10.1196/annals.1298.006; BRUNNER HG, 1993, SCIENCE, V262, P578, DOI 10.1126/science.8211186; Canoine V, 2007, DEV NEUROBIOL, V67, P57, DOI 10.1002/dneu.20296; Casto JM, 2001, AM NAT, V157, P408, DOI 10.1086/319318; Cawthorn JM, 1998, ANIM BEHAV, V56, P617, DOI 10.1006/anbe.1998.0849; CHANDLER CR, 1994, ANIM BEHAV, V47, P1445, DOI 10.1006/anbe.1994.1191; Cheviron ZA, 2011, CONDOR, V113, P483, DOI 10.1525/cond.2011.100201; Clotfelter ED, 2004, HORM BEHAV, V46, P171, DOI 10.1016/j.yhbeh.2004.03.003; Clotfelter ED, 2007, ETHOLOGY, V113, P18, DOI 10.1111/j.1439-0310.2006.01286.x; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cox RM, 2009, J EVOLUTION BIOL, V22, P1586, DOI 10.1111/j.1420-9101.2009.01772.x; Cox RM, 2009, AM NAT, V173, P176, DOI 10.1086/595841; Cushing BS, 2008, J NEUROSCI, V28, P10399, DOI 10.1523/JNEUROSCI.1928-08.2008; De Luca MA, 2012, NEUROPHARMACOLOGY, V63, P161, DOI 10.1016/j.neuropharm.2011.10.018; De Ridder E, 2002, AUK, V119, P487, DOI 10.1642/0004-8038(2002)119[0487:SALTEO]2.0.CO;2; Delph LF, 2004, EVOLUTION, V58, P1936, DOI 10.1111/j.0014-3820.2004.tb00481.x; Drnevich J, 2012, P NATL ACAD SCI USA, V109, P17245, DOI 10.1073/pnas.1200655109; Ellegren H, 2007, NAT REV GENET, V8, P689, DOI 10.1038/nrg2167; Enstrom DA, 1997, ANIM BEHAV, V54, P1135, DOI 10.1006/anbe.1997.0555; Fan W, 1997, NATURE, V385, P165, DOI 10.1038/385165a0; Farooqi IS, 2000, J CLIN INVEST, V106, P271, DOI 10.1172/JCI9397; Fedorka KM, 2004, NATURE, V429, P65, DOI 10.1038/nature02492; Forlano PM, 2006, FRONT NEUROENDOCRIN, V27, P247, DOI 10.1016/j.yfrne.2006.05.002; Gerlach NM, 2013, HORMONES BE IN PRESS; Greives TJ, 2006, FUNCT ECOL, V20, P812, DOI 10.1111/j.1365-2435.2006.01167.x; Hau M, 2010, P ROY SOC B-BIOL SCI, V277, P3203, DOI 10.1098/rspb.2010.0673; Hawrylycz MJ, 2012, NATURE, V489, P391, DOI 10.1038/nature11405; Holmes A, 2003, NEUROPSYCHOPHARMACOL, V28, P1031, DOI 10.1038/sj.npp.1300164; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6; Jia R, 2008, PHYSIOL BEHAV, V95, P56, DOI 10.1016/j.physbeh.2008.04.015; Ketterson E.D., 2001, P19; Ketterson ED, 1996, IBIS, V138, P70; Ketterson ED, 2005, AM NAT, V166, pS85, DOI 10.1086/444602; KETTERSON ED, 1991, HORM BEHAV, V25, P489, DOI 10.1016/0018-506X(91)90016-B; KETTERSON ED, 1992, AM NAT, V140, P980, DOI 10.1086/285451; Ketterson ED, 2009, INTEGR COMP BIOL, V49, P365, DOI 10.1093/icb/icp057; KRINER E, 1991, ETHOLOGY, V87, P37; LANDE R, 1980, EVOLUTION, V34, P292, DOI 10.1111/j.1558-5646.1980.tb04817.x; Leibowitz SF, 2005, NEUROPEPTIDES, V39, P327, DOI 10.1016/j.npep.2004.12.022; Lephart ED, 1996, BRAIN RES REV, V22, P1; Lopez J, 2011, 20112 CGB, V2; Lord LD, 2009, HORM BEHAV, V56, P519, DOI 10.1016/j.yhbeh.2009.09.002; Lu XY, 2005, P NATL ACAD SCI USA, V102, P874, DOI 10.1073/pnas.0408891102; Maklakov AA, 2008, CURR BIOL, V18, P1062, DOI 10.1016/j.cub.2008.06.059; Mank JE, 2007, AM NAT, V169, P142, DOI 10.1086/510103; MARLER CA, 1988, BEHAV ECOL SOCIOBIOL, V23, P21, DOI 10.1007/BF00303053; McGlothlin JW, 2007, AM NAT, V170, P864, DOI 10.1086/522838; McGlothlin JW, 2010, AM NAT, V175, P687, DOI 10.1086/652469; McGlothlin JW, 2004, P ROY SOC B-BIOL SCI, V271, P1377, DOI 10.1098/rspb.2004.2741; Meitzen J, 2008, GEN COMP ENDOCR, V157, P259, DOI 10.1016/j.ygcen.2008.03.014; Meitzen J, 2009, HORM BEHAV, V55, P217, DOI 10.1016/j.yhbeh.2008.10.006; Miller A. H., 1941, University of California Publications in Zoology, V44, P173; Mitchell DGV, 2011, BEHAV BRAIN RES, V217, P215, DOI 10.1016/j.bbr.2010.10.030; Miziorko HM, 2011, ARCH BIOCHEM BIOPHYS, V505, P131, DOI 10.1016/j.abb.2010.09.028; Mokkonen M, 2012, J ANIM ECOL, V81, P277, DOI 10.1111/j.1365-2656.2011.01903.x; Moller AP, 2005, BEHAV ECOL SOCIOBIOL, V58, P534, DOI 10.1007/s00265-005-0962-2; Mukai M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008182; Naurin S, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-37; NOLAN V, 1992, CONDOR, V94, P364, DOI 10.2307/1369209; Nolan V. Jr, 2002, Birds of North America, V716, P1; NOTTEBOHM F, 1980, BRAIN RES, V189, P429, DOI 10.1016/0006-8993(80)90102-X; O'Neal DM, 2008, HORM BEHAV, V54, P571, DOI 10.1016/j.yhbeh.2008.05.017; Ono H, 2009, GEN COMP ENDOCR, V163, P2, DOI 10.1016/j.ygcen.2008.11.017; Oppliger A, 2004, CAN J ZOOL, V82, P1713, DOI 10.1139/Z04-152; Pedretti A, 2009, BBA-BIOMEMBRANES, V1788, P973, DOI 10.1016/j.bbamem.2009.02.007; Pertwee RG, 2008, BRIT J PHARMACOL, V153, P199, DOI 10.1038/sj.bjp.0707442; Peterson MP, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-305; Phillips DJ, 1998, FRONT NEUROENDOCRIN, V19, P287, DOI 10.1006/frne.1998.0169; Plant TM, 2008, J NEUROENDOCRINOL, V20, P719, DOI 10.1111/j.1365-2826.2008.01708.x; Prasad NG, 2006, J GENET, V85, P161, DOI 10.1007/BF02935325; Pruitt KD, 2009, NUCLEIC ACIDS RES, V37, pD32, DOI 10.1093/nar/gkn721; Raouf SA, 1997, P ROY SOC B-BIOL SCI, V264, P1599, DOI 10.1098/rspb.1997.0223; Reed WL, 2006, AM NAT, V167, P667, DOI 10.1086/503054; Reichard DG, 2012, WILSON J ORNITHOL, V124, P614, DOI 10.1676/11-189.1; Renn SCP, 2008, J EXP BIOL, V211, P3041, DOI 10.1242/jeb.018242; RICE WR, 1984, EVOLUTION, V38, P735, DOI 10.1111/j.1558-5646.1984.tb00346.x; Rice WR, 2001, J EVOLUTION BIOL, V14, P685, DOI 10.1046/j.1420-9101.2001.00319.x; Rinn JL, 2005, TRENDS GENET, V21, P298, DOI 10.1016/j.tig.2005.03.005; Risold PY, 1997, BRAIN RES REV, V24, P197, DOI 10.1016/S0165-0173(97)00007-6; Rosvall KA, 2012, P ROY SOC B-BIOL SCI, V279, P3547, DOI 10.1098/rspb.2012.0442; Rosvall KA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054120; Rowan W, 1925, NATURE, V115, P494, DOI 10.1038/115494b0; Rustay NR, 2005, NEUROPEPTIDES, V39, P239, DOI 10.1016/j.npep.2004.12.026; Schoech SJ, 1998, HORM BEHAV, V34, P1, DOI 10.1006/hbeh.1998.1455; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; SEARCY WA, 1988, ECOLOGY, V69, P85, DOI 10.2307/1943163; Smith GT, 1997, J NEUROSCI, V17, P6001; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Soma KK, 1999, J NEUROBIOL, V41, P176, DOI 10.1002/(SICI)1097-4695(19991105)41:2<176::AID-NEU2>3.3.CO;2-U; Soma KK, 1999, J COMP NEUROL, V409, P224; Soma KK, 2003, J NEUROBIOL, V56, P209, DOI 10.1002/neu.10225; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Thompson RR, 1998, BRAIN BEHAV EVOLUT, V51, P215; Tramontin AD, 2001, GEN COMP ENDOCR, V122, P1, DOI 10.1006/gcen.2000.7597; Tsutsui K, 2000, BIOCHEM BIOPH RES CO, V275, P661, DOI 10.1006/bbrc.2000.3350; UENO N, 1987, P NATL ACAD SCI USA, V84, P8282, DOI 10.1073/pnas.84.23.8282; van Doorn GS, 2009, ANN NY ACAD SCI, V1168, P52, DOI 10.1111/j.1749-6632.2009.04573.x; Van Duyse E, 2002, HORM BEHAV, V41, P178, DOI 10.1006/hbeh.2001.1747; van Nas A, 2009, ENDOCRINOLOGY, V150, P1235, DOI 10.1210/en.2008-0563; Vishnivetskaya GB, 2007, AGGRESSIVE BEHAV, V33, P1, DOI 10.1002/ab.20161; Voigt C, 2007, DEV NEUROBIOL, V67, P1560, DOI 10.1002/dneu.20528; Whitehead A, 2006, MOL ECOL, V15, P1197, DOI 10.1111/j.1365-294X.2006.02868.x; Whittaker DJ, 2011, J CHEM ECOL, V37, P1349, DOI 10.1007/s10886-011-0050-1; Wikelski M, 1999, J COMP PHYSIOL A, V185, P463, DOI 10.1007/s003590050407; Wiley CJ, 2003, HORM BEHAV, V43, P554, DOI 10.1016/S0018-506X(03)00066-7; WINGFIELD JC, 1984, GEN COMP ENDOCR, V56, P417, DOI 10.1016/0016-6480(84)90084-4; Wolf WL, 2004, ANIM BEHAV, V67, P93, DOI 10.1016/j.anbehav.2003.02.009; Xu XH, 2012, CELL, V148, P596, DOI 10.1016/j.cell.2011.12.018; Yang X, 2006, GENOME RES, V16, P995, DOI 10.1101/gr.5217506; Yonehara K, 2003, J REPROD DEVELOP, V49, P547, DOI 10.1262/jrd.49.547; Yonehara K, 2002, NEUROSCI LETT, V334, P107, DOI 10.1016/S0304-3940(02)01114-X; Zhang DP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005816; Zysling DA, 2006, HORM BEHAV, V50, P200, DOI 10.1016/j.yhbeh.2006.03.004	126	40	42	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2013	8	4							e61784	10.1371/journal.pone.0061784	http://dx.doi.org/10.1371/journal.pone.0061784			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130DR	23613935	Green Published, gold, Green Submitted			2022-12-25	WOS:000317893400109
J	White, MM; McCorkle, DC; Mullineaux, LS; Cohen, AL				White, Meredith M.; McCorkle, Daniel C.; Mullineaux, Lauren S.; Cohen, Anne L.			Early Exposure of Bay Scallops (Argopecten irradians) to High CO2 Causes a Decrease in Larval Shell Growth	PLOS ONE			English	Article							CARBON-DIOXIDE CONCENTRATIONS; OYSTER SACCOSTREA-GLOMERATA; OCEAN ACIDIFICATION; ELEVATED PCO(2); CRESOL PURPLE; SEAWATER; FUTURE; SURVIVAL; IMPACT; PH	Ocean acidification, characterized by elevated pCO(2) and the associated decreases in seawater pH and calcium carbonate saturation state (Omega), has a variable impact on the growth and survival of marine invertebrates. Larval stages are thought to be particularly vulnerable to environmental stressors, and negative impacts of ocean acidification have been seen on fertilization as well as on embryonic, larval, and juvenile development and growth of bivalve molluscs. We investigated the effects of high CO2 exposure (resulting in pH = 7.39, Omega(ar) = 0.74) on the larvae of the bay scallop Argopecten irradians from 12 h to 7 d old, including a switch from high CO2 to ambient CO2 conditions (pH = 7.93, Omega(ar) = 2.26) after 3 d, to assess the possibility of persistent effects of early exposure. The survival of larvae in the high CO2 treatment was consistently lower than the survival of larvae in ambient conditions, and was already significantly lower at 1 d. Likewise, the shell length of larvae in the high CO2 treatment was significantly smaller than larvae in the ambient conditions throughout the experiment and by 7 d, was reduced by 11.5%. This study also demonstrates that the size effects of short-term exposure to high CO2 are still detectable after 7 d of larval development; the shells of larvae exposed to high CO2 for the first 3 d of development and subsequently exposed to ambient CO2 were not significantly different in size at 3 and 7 d than the shells of larvae exposed to high CO2 throughout the experiment.	[White, Meredith M.] Massachusetts Inst Technol Woods Hole Oceanog Ins, Woods Hole, MA USA; [White, Meredith M.; Mullineaux, Lauren S.] Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA; [McCorkle, Daniel C.; Cohen, Anne L.] Woods Hole Oceanog Inst, Dept Geol & Geophys, Woods Hole, MA 02543 USA	Massachusetts Institute of Technology (MIT); Woods Hole Oceanographic Institution; Woods Hole Oceanographic Institution	White, MM (corresponding author), Bigelow Lab Ocean Sci, East Boothbay, ME USA.	meredith@whoi.edu		White, Meredith/0000-0001-8113-9618; Mullineaux, Lauren/0000-0002-8932-2625	Woods Hole Oceanographic Institution Interdisciplinary Award through NOAA (National Oceanic and Admosphereic Administration) Sea Grant [NA10OAR4170083]; National Defense Science and Engineering Graduate Fellowship through the American Society for Engineering Education	Woods Hole Oceanographic Institution Interdisciplinary Award through NOAA (National Oceanic and Admosphereic Administration) Sea Grant; National Defense Science and Engineering Graduate Fellowship through the American Society for Engineering Education	This work was funded by a Woods Hole Oceanographic Institution Interdisciplinary Award to Mullineaux & McCorkle; and awards to Mullineaux & White, to McCorkle, and to Cohen & McCorkle through NOAA (National Oceanic and Admosphereic Administration) Sea Grant #NA10OAR4170083. White was funded through a National Defense Science and Engineering Graduate Fellowship through the American Society for Engineering Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2004, HATCHERY CULTURE BIV; Barber Bruce J., 2006, Developments in Aquaculture and Fisheries Science, V35, P357; Belding DL, 1910, REPORT SCALLOP FISHE, P238; Borges AV, 2010, LIMNOL OCEANOGR, V55, P346, DOI 10.4319/lo.2010.55.1.0346; Cai WJ, 2011, NAT GEOSCI, V4, P766, DOI [10.1038/ngeo1297, 10.1038/NGEO1297]; Cai WJ, 1998, LIMNOL OCEANOGR, V43, P657, DOI 10.4319/lo.1998.43.4.0657; Chou WC, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL038475; CLAYTON TD, 1993, DEEP-SEA RES PT I, V40, P2115, DOI 10.1016/0967-0637(93)90048-8; Dai MH, 2006, MAR CHEM, V102, P159, DOI 10.1016/j.marchem.2005.09.020; Diaz RJ, 2008, SCIENCE, V321, P926, DOI 10.1126/science.1156401; Dickson A. G., 2007, PICES SPECIAL PUBLIC, DOI DOI 10.1159/000331784; DICKSON AG, 1987, DEEP-SEA RES, V34, P1733, DOI 10.1016/0198-0149(87)90021-5; Doney SC, 2009, ANNU REV MAR SCI, V1, P169, DOI 10.1146/annurev.marine.010908.163834; Feely RA, 2004, SCIENCE, V305, P362, DOI 10.1126/science.1097329; Feely RA, 2010, ESTUAR COAST SHELF S, V88, P442, DOI 10.1016/j.ecss.2010.05.004; Feely RA, 2009, OCEANOGRAPHY, V22, P36, DOI 10.5670/oceanog.2009.95; Gazeau F, 2010, BIOGEOSCIENCES, V7, P2051, DOI 10.5194/bg-7-2051-2010; Gazeau F, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028554; Gazeau F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023010; Gilbert D, 2010, BIOGEOSCIENCES, V7, P2283, DOI 10.5194/bg-7-2283-2010; GREEN MA, 1993, LIMNOL OCEANOGR, V38, P331, DOI 10.4319/lo.1993.38.2.0331; Green MA, 1998, LIMNOL OCEANOGR, V43, P18, DOI 10.4319/lo.1998.43.1.0018; Hofmann GE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028983; Howarth R, 2011, FRONT ECOL ENVIRON, V9, P18, DOI 10.1890/100008; Kurihara H, 2007, AQUAT BIOL, V1, P91, DOI 10.3354/ab00009; Kurihara H, 2009, AQUAT BIOL, V4, P225, DOI 10.3354/ab00109; Lee SW, 2006, B MAR SCI, V78, P309; Liu XW, 2011, ENVIRON SCI TECHNOL, V45, P4862, DOI 10.1021/es200665d; Lohbeck KT, 2012, NAT GEOSCI, V5, P346, DOI [10.1038/NGEO1441, 10.1038/ngeo1441]; McCorkle DC, 2012, OC SCI M SALT LAK CI; MEHRBACH C, 1973, LIMNOL OCEANOGR, V18, P897, DOI 10.4319/lo.1973.18.6.0897; Miller AW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005661; Orr JC, 2005, NATURE, V437, P681, DOI 10.1038/nature04095; Parker LM, 2010, MAR BIOL, V157, P2435, DOI 10.1007/s00227-010-1508-3; Parker LM, 2009, GLOBAL CHANGE BIOL, V15, P2123, DOI 10.1111/j.1365-2486.2009.01895.x; Pechenik J.A., 1987, P551; Pierrot DE., 2006, MS EXCEL PROGRAM DEV, DOI [10.3334/CDIAC/otg.CO2SYS_XLS_CDIAC105a, DOI 10.3334/CDIAC/OTG.CO2SYS_XLS_CDIAC105A]; Rabalais NN, 2002, ANNU REV ECOL SYST, V33, P235, DOI 10.1146/annurev.ecolsys.33.010802.150513; SASTRY A. N., 1965, BULL MAR SCI GULF CARIBBEAN, V15, P417; Smith P, 2007, AR4 CLIMATE CHANGE 2007: MITIGATION OF CLIMATE CHANGE, P497; Sunda WG, 2012, ENVIRON SCI TECHNOL, V46, P10651, DOI 10.1021/es300626f; Sunday JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022881; Talmage SC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026941; Talmage SC, 2010, P NATL ACAD SCI USA, V107, P17246, DOI 10.1073/pnas.0913804107; Talmage SC, 2009, LIMNOL OCEANOGR, V54, P2072, DOI 10.4319/lo.2009.54.6.2072; THORSON G, 1950, BIOL REV, V25, P1, DOI 10.1111/j.1469-185X.1950.tb00585.x; Van Colen C, 2010, MAR POLLUT BULL, V60, P178, DOI 10.1016/j.marpolbul.2009.09.028; Van Colen C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044655; Waldbusser GG, 2011, ESTUAR COAST, V34, P221, DOI 10.1007/s12237-010-9307-0; Watson SA, 2009, J SHELLFISH RES, V28, P431, DOI 10.2983/035.028.0302; Weiss IM, 2002, J EXP ZOOL, V293, P478, DOI 10.1002/jez.90004; Widdicombe S, 2008, J EXP MAR BIOL ECOL, V366, P187, DOI 10.1016/j.jembe.2008.07.024; WIDMAN JC, 2001, MANUAL HATCHERY CULT	53	70	73	2	92	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2013	8	4							e61065	10.1371/journal.pone.0061065	http://dx.doi.org/10.1371/journal.pone.0061065			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125TD	23596514	Green Published, Green Submitted, gold			2022-12-25	WOS:000317563300018
J	Jaiswal, R; Luk, F; Dalla, PV; Grau, GER; Bebawy, M				Jaiswal, Ritu; Luk, Frederick; Dalla, Penelope V.; Grau, Georges Emile Raymond; Bebawy, Mary			Breast Cancer-Derived Microparticles Display Tissue Selectivity in the Transfer of Resistance Proteins to Cells	PLOS ONE			English	Article							P-GLYCOPROTEIN; HORIZONTAL TRANSFER; TUMOR XENOGRAFTS; LIPID RAFTS; MICROVESICLES; EXPRESSION; MEDIATORS; MECHANISM; DOMINANCE	Microparticles (MPs) play a vital role in cell communication by facilitating the horizontal transfer of cargo between cells. Recently, we described a novel "non-genetic" mechanism for the acquisition of multidrug resistance (MDR) in cancer cells by intercellular transfer of functional P-gp, via MPs. MDR is caused by the overexpression of the efflux transporters P-glycoprotein (P-gp) and Multidrug Resistance-Associated Protein 1 (MRP1). These transporters efflux anticancer drugs from resistant cancer cells and maintain sublethal intracellular drug concentrations. By conducting MP transfer experiments, we show that MPs derived from DX breast cancer cells selectively transfer P-gp to malignant MCF-7 breast cells only, in contrast to VLB100 leukaemic cell-derived MPs that transfer P-gp and MRP1 to both malignant and non-malignant cells. The observed transfer selectivity is not the result of membrane restrictions for intercellular exchange, limitations in MP binding to recipient cells or the differential expression of the cytoskeletal protein, Ezrin. CD44 (isoform 10) was found to be selectively present on the breast cancer-derived MPs and not on leukaemic MPs and may contribute to the observed selective transfer of P-gp to malignant breast cells observed. Using the MCF-7 murine tumour xenograft model we demonstrated the stable transfer of P-gp by MPs in vivo, which was found to localize to the tumour core as early as 24 hours post MP exposure and to remain stable for at least 2 weeks. These findings demonstrate a remarkable capacity by MPs to disseminate a stable resistant trait in the absence of any selective pressure.	[Jaiswal, Ritu; Luk, Frederick; Dalla, Penelope V.; Bebawy, Mary] Univ Technol Sydney, Grad Sch Hlth, Sch Pharm, Sydney, NSW 2007, Australia; [Jaiswal, Ritu; Grau, Georges Emile Raymond] Univ Sydney, Sydney Med Sch, Vasc Immunol Unit, Sydney, NSW 2006, Australia; [Jaiswal, Ritu; Grau, Georges Emile Raymond] Univ Sydney, Bosch Inst, Sydney, NSW 2006, Australia	University of Technology Sydney; University of Sydney; University of Sydney	Bebawy, M (corresponding author), Univ Technol Sydney, Grad Sch Hlth, Sch Pharm, Sydney, NSW 2007, Australia.	mary.bebawy@uts.edu.au	Grau, Georges/AGR-7139-2022	Grau, Georges/0000-0002-0442-0462; Dalla, Penelope/0000-0003-3612-784X; Jaiswal, Ritu/0000-0002-8691-1352; Bebawy, Mary/0000-0003-2606-921X	New South Wales Cancer Council; National Health and Medical Research Council [APP1007613]	New South Wales Cancer Council(Cancer Council New South Wales); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This research was supported by grants to M.B and G.E.R.G. from the New South Wales Cancer Council and National Health and Medical Research Council (APP1007613). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Nedawi K, 2009, CELL CYCLE, V8, P2014, DOI 10.4161/cc.8.13.8988; Bebawy M, 2001, BRIT J CANCER, V85, P1998, DOI 10.1054/bjoc.2001.2184; Bebawy M, 2009, LEUKEMIA, V23, P1643, DOI 10.1038/leu.2009.76; BECK WT, 1979, CANCER RES, V39, P2070; Bergsmedh A, 2001, P NATL ACAD SCI USA, V98, P6407, DOI 10.1073/pnas.101129998; Bianco F, 2005, J IMMUNOL, V174, P7268, DOI 10.4049/jimmunol.174.11.7268; Coldwell KE, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn439; Coltel N, 2006, MICROBES INFECT, V8, P2305, DOI 10.1016/j.micinf.2006.04.006; DAVEY RA, 1995, LEUKEMIA RES, V19, P275, DOI 10.1016/0145-2126(94)00159-8; del Conde I, 2005, BLOOD, V106, P1604, DOI 10.1182/blood-2004-03-1095; Deregibus MC, 2007, BLOOD, V110, P2440, DOI 10.1182/blood-2007-03-078709; Distler JHW, 2006, AUTOIMMUNITY, V39, P683, DOI 10.1080/08916930601061538; Donmez Y, 2011, CANCER CHEMOTH PHARM, V67, P823, DOI 10.1007/s00280-010-1385-y; FOLEY GE, 1965, CANCER, V18, P522, DOI 10.1002/1097-0142(196504)18:4<522::AID-CNCR2820180418>3.0.CO;2-J; Fu D, 2007, AM J PHYSIOL-CELL PH, V292, pC1543, DOI 10.1152/ajpcell.00068.2006; Ghetie MA, 2004, BLOOD, V104, P178, DOI 10.1182/blood-2003-12-4255; Graves LE, 2004, CANCER RES, V64, P7045, DOI 10.1158/0008-5472.CAN-04-1800; Jaiswal R, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-37; Jaiswal R, 2012, FASEB J, V26, P420, DOI 10.1096/fj.11-186817; Levchenko A, 2005, P NATL ACAD SCI USA, V102, P1933, DOI 10.1073/pnas.0401851102; Li YC, 2005, NEUROSCI RES, V53, P298, DOI 10.1016/j.neures.2005.07.006; Luciani F, 2002, BLOOD, V99, P641, DOI 10.1182/blood.V99.2.641; Mack M, 2000, NAT MED, V6, P769, DOI 10.1038/77498; MacKenzie A, 2001, IMMUNITY, V15, P825, DOI 10.1016/S1074-7613(01)00229-1; MIMNAUGH EG, 1991, BIOCHEM PHARMACOL, V42, P391, DOI 10.1016/0006-2952(91)90727-M; Mittelbrunn M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1285; Muller I, 2003, FASEB J, V17, P476, DOI 10.1096/fj.02-0574fje; Pasquier J, 2012, J BIOL CHEM, V287, P7374, DOI 10.1074/jbc.M111.312157; Sherer NM, 2008, TRENDS CELL BIOL, V18, P414, DOI 10.1016/j.tcb.2008.07.003; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Smalley DM, 2007, THROMB HAEMOSTASIS, V97, P67, DOI 10.1160/TH06-02-0066; Supino R, 2001, HISTOL HISTOPATHOL, V16, P719, DOI 10.14670/HH-16.719; ULLMANN CAD, 1991, ANTICANCER RES, V11, P1379; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Watkins SC, 2005, IMMUNITY, V23, P309, DOI 10.1016/j.immuni.2005.08.009	35	85	88	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2013	8	4							e61515	10.1371/journal.pone.0061515	http://dx.doi.org/10.1371/journal.pone.0061515			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123JP	23593486	Green Published, gold			2022-12-25	WOS:000317385300076
J	Li, T; Wang, Q; Chen, FH; Li, X; Luo, S; Fang, HL; Wang, DH; Li, Z; Hou, XJ; Wang, H				Li, Tao; Wang, Qin; Chen, Fanghong; Li, Xiang; Luo, Sen; Fang, Huali; Wang, Dehui; Li, Zhan; Hou, Xiaojun; Wang, Hui			Biochemical Characteristics of New Delhi Metallo-beta-Lactamase-1 Show Unexpected Difference to Other MBLs	PLOS ONE			English	Article							METALLO-BETA-LACTAMASE; PSEUDOMONAS-AERUGINOSA; ANTIBIOTIC-RESISTANCE; CHELATION-THERAPY; CRYSTAL-STRUCTURE; MECHANISM; NDM-1; INHIBITION; REVEALS	New Delhi metallo-beta-lactamase (NDM-1) is a new metallo-beta-lactamase (MBL) that has recently emerged as a global threat because it confers bacteria with resistance to almost all clinically used beta-lactam antibiotics. To determine the molecular basis of this threat, NDM-1 was purified from Escherichia coli TransB (DE3) carrying cloned blaNDM-1 gene by an anion-exchange chromatography step followed by a gel permeation chromatography step. The purified enzyme was stable even in extremely alkaline buffer (pH 11) and reached its highest activity at a low temperature (15 degrees C), which was different from other MBLs. The 50% inhibition concentration of EDTA against NDM-1 was 412 nM, which showed that NDM-1 was more susceptible to EDTA than other MBLs. The effects of zinc on NDM-1 differed between cephem and carbapenem complexes, but inhibition at high Zn2+ concentration was observed for all of tested beta-lactam compounds.	[Li, Tao; Wang, Qin; Chen, Fanghong; Li, Xiang; Luo, Sen; Fang, Huali; Wang, Dehui; Li, Zhan; Hou, Xiaojun; Wang, Hui] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogens & Biosecur, Beijing, Peoples R China	Beijing Institute of Microbiology & Epidemiology	Wang, H (corresponding author), Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogens & Biosecur, Beijing, Peoples R China.	geno0109@vip.sina.com			National Natural Science Foundation of China [81072677]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by National Natural Science Foundation of China (No. 81072677). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki N, 2010, ANTIMICROB AGENTS CH, V54, P4582, DOI 10.1128/AAC.00511-10; Bebrone C, 2009, ANTIMICROB AGENTS CH, V53, P4464, DOI 10.1128/AAC.00288-09; Bhattacharya A, 2007, NEUROTOXICOLOGY, V28, P686, DOI 10.1016/j.neuro.2007.03.007; Bounaga S, 1998, BIOCHEM J, V331, P703, DOI 10.1042/bj3310703; Garcia-Saez I, 2008, J MOL BIOL, V375, P604, DOI 10.1016/j.jmb.2007.11.012; Guo Y, 2011, PROTEIN CELL, V2, P384, DOI 10.1007/s13238-011-1055-9; Juan C, 2008, ANTIMICROB AGENTS CH, V52, P3589, DOI 10.1128/AAC.00465-08; Kim SK, 2009, CHEM BIOL DRUG DES, V74, P343, DOI 10.1111/j.1747-0285.2009.00879.x; Kim Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024621; King D, 2011, PROTEIN SCI, V20, P1484, DOI 10.1002/pro.697; Kumarasamy KK, 2010, LANCET INFECT DIS, V10, P597, DOI 10.1016/S1473-3099(10)70143-2; Lin-Tan DT, 2007, NEPHROL DIAL TRANSPL, V22, P2924, DOI 10.1093/ndt/gfm342; Materon IC, 2003, ANTIMICROB AGENTS CH, V47, P2040, DOI 10.1128/AAC.47.6.2040-2042.2003; Murphy TA, 2003, ANTIMICROB AGENTS CH, V47, P582, DOI 10.1128/AAC.47.2.582-587.2003; Nordmann P, 2002, CLIN MICROBIOL INFEC, V8, P321, DOI 10.1046/j.1469-0691.2002.00401.x; Park H, 2005, J AM CHEM SOC, V127, P4232, DOI 10.1021/ja042607b; Poirel L, 2010, ANTIMICROB AGENTS CH, V54, P2420, DOI 10.1128/AAC.01456-09; Rolain JM, 2010, CLIN MICROBIOL INFEC, V16, P1699, DOI 10.1111/j.1469-0691.2010.03385.x; Walsh TR, 2005, CLIN MICROBIOL REV, V18, P306, DOI 10.1128/CMR.18.2.306-325.2005; Wang ZG, 1999, BIOCHEMISTRY-US, V38, P10013, DOI 10.1021/bi990356r; Wang ZG, 1999, CURR OPIN CHEM BIOL, V3, P614, DOI 10.1016/S1367-5931(99)00017-4; Yong D, 2009, ANTIMICROB AGENTS CH, V53, P5046, DOI 10.1128/AAC.00774-09; Zhang HM, 2011, FASEB J, V25, P2574, DOI 10.1096/fj.11-184036	23	20	23	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2013	8	4							e61914	10.1371/journal.pone.0061914	http://dx.doi.org/10.1371/journal.pone.0061914			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123JP	23593503	gold, Green Published, Green Submitted			2022-12-25	WOS:000317385300089
J	Sheridan, J; Mack, DR; Amre, DK; Israel, DM; Cherkasov, A; Li, HF; Grimard, G; Steiner, TS				Sheridan, Jared; Mack, David R.; Amre, Devendra K.; Israel, David M.; Cherkasov, Artem; Li, Huifang; Grimard, Guy; Steiner, Theodore S.			A Non-Synonymous Coding Variant (L616F) in the TLR5 Gene Is Potentially Associated with Crohn's Disease and Influences Responses to Bacterial Flagellin	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; INFLAMMATORY-BOWEL-DISEASE; CANADIAN CHILDREN; DEFICIENT MICE; RECEPTOR; COLITIS; SUSCEPTIBILITY; PROTECTS; TOLL-LIKE-RECEPTOR-5; RADIATION	Background and Objectives: Although numerous studies have implicated TLR5, or its ligands, bacterial flagellins, in the pathogenesis of Crohn's disease (CD), genome-wide association studies (GWAS) have not reported associations with the TLR5 gene. We aimed to examine potential CD-associated TLR5 variants and assess whether they modified inflammatory responses to bacterial flagellins. Methods and Principal Results: A two-stage study was carried out. In stage 1, we genotyped tagging single-nucleotide polymorphisms (tag-SNPs) in the TLR5 gene in a sample of CD cases (<20 years of age, N = 566) and controls (N = 536). Single SNP and haplotype analysis was carried out. In Stage 2, we assessed the functional significance of potential CD-associated variant(s) vis-a-vis effects on the inflammatory response to bacterial flagellin using HEK293T cells. We observed marginal association between a non-synonymous coding SNP rs5744174 (p = 0.05) and CD. Associations between SNP rs851139 that is in high linkage disequilibrium (LD) with SNP rs5744174 were also suggested (p = 0.07). Haplotype analysis revealed that a 3 marker haplotype was significantly associated with CD (p = 0.01). Functional studies showed that the risk allele (616F) (corresponding to the C allele of SNP rs5744174) conferred significantly greater production of CCL20 in response to a range of flagellin doses than the comparator allele (616L). Conclusions: Our findings suggest that a non-synonymous coding variation in the TLR5 gene may confer modest susceptibility for CD.	[Sheridan, Jared; Steiner, Theodore S.] Vancouver Hosp, Div Infect Dis, Vancouver, BC, Canada; [Sheridan, Jared; Steiner, Theodore S.] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; [Mack, David R.] Childrens Hosp Eastern Ontario, Div Gastroenterol, Ottawa, ON K1H 8L1, Canada; [Amre, Devendra K.; Grimard, Guy] CHU Ste Justine, Res Ctr, Montreal, PQ, Canada; [Amre, Devendra K.; Grimard, Guy] Univ Montreal, Dept Pediat, Montreal, PQ H3C 3J7, Canada; [Israel, David M.] British Columbia Childrens Hosp, Div Gastroenterol Hepatol & Nutr, Vancouver, BC, Canada; [Cherkasov, Artem; Li, Huifang] Vancouver Coastal Res Inst, Prostate Ctr, Vancouver, BC, Canada	University of British Columbia; University of British Columbia; University of Ottawa; Children's Hospital of Eastern Ontario; Universite de Montreal; Universite de Montreal; BC Childrens Hospital; University of British Columbia; Vancouver Coastal Health Research Institute	Amre, DK (corresponding author), CHU Ste Justine, Res Ctr, Montreal, PQ, Canada.	devendra.amre@umontreal.ca; tsteiner@mail.ubc.ca	Cherkasov, Artem/A-2134-2012; AMRE, DEVENDRA K/D-4988-2015	Steiner, Ted/0000-0002-3136-6668	Canadian Institutes of Health Research (CIHR-IBD NET GRANT, Institute of Infection and Immunity); Fonds de la Recherche en Sante du Quebec (FRSQ), Quebec	Canadian Institutes of Health Research (CIHR-IBD NET GRANT, Institute of Infection and Immunity)(Canadian Institutes of Health Research (CIHR)); Fonds de la Recherche en Sante du Quebec (FRSQ), Quebec(Fonds de la Recherche en Sante du Quebec)	This work was supported by the Canadian Institutes of Health Research (CIHR-IBD NET GRANT, Institute of Infection and Immunity). Dr. Amre was supported by a research salary award from the Fonds de la Recherche en Sante du Quebec (FRSQ), Quebec. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amre DK, 2010, ALIMENT PHARM THER, V31, P1186, DOI 10.1111/j.1365-2036.2010.04294.x; Amre DK, 2009, ALIMENT PHARM THER, V29, P1025, DOI 10.1111/j.1365-2036.2009.03953.x; Amre DK, 2008, AM J GASTROENTEROL, V103, P615, DOI 10.1111/j.1572-0241.2007.01661.x; Amre DK, 2010, HUM GENET, V128, P131, DOI 10.1007/s00439-010-0835-2; Amre DK, 2009, AM J GASTROENTEROL, V104, P2824, DOI 10.1038/ajg.2009.430; Amre DK, 2009, INFLAMM BOWEL DIS, V15, P501, DOI 10.1002/ibd.20785; Burdelya LG, 2008, SCIENCE, V320, P226, DOI 10.1126/science.1154986; Burdelya LG, 2012, INT J RADIAT ONCOL, V83, P228, DOI 10.1016/j.ijrobp.2011.05.055; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Carlson CS, 2004, AM J HUM GENET, V74, P106, DOI 10.1086/381000; Carvalho FA, 2012, GUT, V61, P373, DOI 10.1136/gut.2011.240556; Gewirtz AT, 2006, AM J PHYSIOL-GASTR L, V290, pG1157, DOI 10.1152/ajpgi.00544.2005; Glocker EO, 2009, NEW ENGL J MED, V361, P2033, DOI 10.1056/NEJMoa0907206; Hardenberg G, 2012, INFLAMM BOWEL DIS, V18, P85, DOI 10.1002/ibd.21738; Himmel ME, 2008, IMMUNOLOGY, V125, P145, DOI 10.1111/j.1365-2567.2008.02939.x; Honko AN, 2005, IMMUNOL RES, V33, P83, DOI 10.1385/IR:33:1:083; Ivison SM, 2007, BIOCHEM BIOPH RES CO, V352, P936, DOI 10.1016/j.bbrc.2006.11.132; Ivison SM, 2010, INFLAMM BOWEL DIS, V16, P401, DOI 10.1002/ibd.21097; Lodes MJ, 2004, J CLIN INVEST, V113, P1296, DOI 10.1172/JCI200420295; Shen C, 2008, INFLAMM BOWEL DIS, V14, P1641, DOI 10.1002/ibd.20645; Targan SR, 2005, GASTROENTEROLOGY, V128, P2020, DOI 10.1053/j.gastro.2005.03.046; Vijay-Kumar M, 2008, J IMMUNOL, V180, P8280, DOI 10.4049/jimmunol.180.12.8280; Vijay-Kumar M, 2007, J CLIN INVEST, V117, P3909, DOI 10.1172/JCI33084; Yoon SI, 2012, SCIENCE, V335, P859, DOI 10.1126/science.1215584; Zhou KF, 2012, J STRUCT BIOL, V177, P402, DOI 10.1016/j.jsb.2011.12.002	25	22	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2013	8	4							e61326	10.1371/journal.pone.0061326	http://dx.doi.org/10.1371/journal.pone.0061326			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123JA	23593463	Green Published, Green Submitted, gold			2022-12-25	WOS:000317383200051
J	Crescenzi, E; Raia, Z; Pacifico, F; Mellone, S; Moscato, F; Palumbo, G; Leonardi, A				Crescenzi, Elvira; Raia, Zelinda; Pacifico, Francesco; Mellone, Stefano; Moscato, Fortunato; Palumbo, Giuseppe; Leonardi, Antonio			Down-regulation of Wild-type p53-induced Phosphatase 1 (Wip1) Plays a Critical Role in Regulating Several p53-dependent Functions in Premature Senescent Tumor Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-DAMAGE; MITOTIC CATASTROPHE; ANTICANCER DRUGS; CANCER-THERAPY; GROWTH ARREST; P53; EXPRESSION; DEATH; PPM1D; AMPLIFICATION	Premature or drug-induced senescence is a major cellular response to chemotherapy in solid tumors. The senescent phenotype develops slowly and is associated with chronic DNA damage response. We found that expression of wild-type p53induced phosphatase 1 (Wip1) is markedly down-regulated during persistent DNA damage and after drug release during the acquisition of the senescent phenotype in carcinoma cells. We demonstrate that down-regulation of Wip1 is required for maintenance of permanent G2 arrest. In fact, we show that forced expression of Wip1 in premature senescent tumor cells induces inappropriate re-initiation of mitosis, uncontrolled polyploid progression, and cell death by mitotic failure. Most of the effects of Wip1 may be attributed to it sability to dephosphorylate p53 at Ser15 and to inhibit DNA damage response. However, we also uncover a regulatory pathway whereby suppression of p53 Ser15 phosphorylation is associated with enhanced phosphorylation at Ser46, increased p53 protein levels, and induction of Noxa expression. On the whole, our data indicate that downregulation of Wip1 expression during premature senescence plays a pivotal role in regulating several p53-dependent aspects of the senescent phenotype.	[Crescenzi, Elvira; Pacifico, Francesco; Mellone, Stefano; Moscato, Fortunato] CNR, Ist Endocrinol & Oncol Sperimentale, I-80131 Naples, Italy; [Raia, Zelinda; Palumbo, Giuseppe; Leonardi, Antonio] Univ Naples Federico II, Dipartimento Biol & Patol Cellulare & Mol, I-80131 Naples, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto per Endocrinologia e Oncologia "Gaetano Salvatore" (IEOS-CNR); University of Naples Federico II	Leonardi, A (corresponding author), Univ Naples Federico II, Dipartimento Biol & Patol Cellulare & Mol, Via S Pansini 5, I-80131 Naples, Italy.	leonardi@unina.it	leonardi, antonio/A-2887-2009; Pacifico, Francesco/AAX-3958-2020; Palumbo, Giuseppe/N-3136-2016	leonardi, antonio/0000-0001-8636-9623; Pacifico, Francesco/0000-0001-9563-3596; CRESCENZI, ELVIRA/0000-0002-9258-8053; Palumbo, Giuseppe/0000-0001-9380-8436	MIUR [2008CCPKRP]; Firb/Merit Grant [RBNE08YYBM_002]	MIUR(Ministry of Education, Universities and Research (MIUR)); Firb/Merit Grant	This work was supported by MIUR Grant 2008CCPKRP (to A.L.) and Firb/Merit Grant RBNE08YYBM_002 (to A.L. and G.P.).	Aylon Y, 2011, MOL ONCOL, V5, P315, DOI 10.1016/j.molonc.2011.07.007; Batchelor E, 2008, MOL CELL, V30, P277, DOI 10.1016/j.molcel.2008.03.016; Beausejour CM, 2003, EMBO J, V22, P4212, DOI 10.1093/emboj/cdg417; Bulavin DV, 2002, NAT GENET, V31, P210, DOI 10.1038/ng894; Cairney CJ, 2012, DRUG DISCOV TODAY, V17, P269, DOI 10.1016/j.drudis.2012.01.019; Castellino RC, 2008, J NEURO-ONCOL, V86, P245, DOI 10.1007/s11060-007-9470-8; Chang BD, 2002, P NATL ACAD SCI USA, V99, P389, DOI 10.1073/pnas.012602599; Chang BD, 1999, CANCER RES, V59, P3761; Choi J, 2000, GENOMICS, V64, P298, DOI 10.1006/geno.2000.6134; Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301; Crescenzi E, 2011, ONCOGENE, V30, P2707, DOI 10.1038/onc.2011.1; Crescenzi E, 2008, CLIN CANCER RES, V14, P1877, DOI 10.1158/1078-0432.CCR-07-4298; Davoli T, 2010, CELL, V141, P81, DOI 10.1016/j.cell.2010.01.031; de Bruin EC, 2008, CANCER TREAT REV, V34, P737, DOI 10.1016/j.ctrv.2008.07.001; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Fiscella M, 1997, P NATL ACAD SCI USA, V94, P6048, DOI 10.1073/pnas.94.12.6048; Galluzzi L, 2012, CELL DEATH DIFFER, V19, P107, DOI 10.1038/cdd.2011.96; Gire V, 1998, MOL CELL BIOL, V18, P1611, DOI 10.1128/MCB.18.3.1611; Green DR, 2009, NATURE, V458, P1127, DOI 10.1038/nature07986; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; Hirasawa A, 2003, CLIN CANCER RES, V9, P1995; Kawabe T, 2004, MOL CANCER THER, V3, P513; Komarov PG, 1999, SCIENCE, V285, P1733, DOI 10.1126/science.285.5434.1733; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610; Lee JS, 2009, STEM CELLS, V27, P1963, DOI 10.1002/stem.121; Li J, 2002, NAT GENET, V31, P133, DOI 10.1038/ng888; Lindqvist A, 2009, EMBO J, V28, P3196, DOI 10.1038/emboj.2009.246; Lowe J, 2012, FRONT BIOSCI-LANDMRK, V17, P1480, DOI 10.2741/3999; Lu XB, 2005, GENE DEV, V19, P1162, DOI 10.1101/gad.1291305; Lu XB, 2008, CANCER METAST REV, V27, P123, DOI 10.1007/s10555-008-9127-x; Lu XB, 2007, CANCER CELL, V12, P342, DOI 10.1016/j.ccr.2007.08.033; Mansilla S, 2006, CELL CYCLE, V5, P53, DOI 10.4161/cc.5.1.2267; Meek DW, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000950; Mirzayans R, 2005, RADIAT RES, V163, P53, DOI 10.1667/RR3280; Nardella C, 2011, NAT REV CANCER, V11, P503, DOI 10.1038/nrc3057; Oda K, 2000, CELL, V102, P849, DOI 10.1016/S0092-8674(00)00073-8; Puca R, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-85; Salminen A, 2012, CELL SIGNAL, V24, P835, DOI 10.1016/j.cellsig.2011.12.006; Schmitt CA, 2002, CELL, V109, P335, DOI 10.1016/S0092-8674(02)00734-1; Sedelnikova OA, 2004, NAT CELL BIOL, V6, P168, DOI 10.1038/ncb1095; Seo YW, 2003, J BIOL CHEM, V278, P48292, DOI 10.1074/jbc.M308785200; Sluss HK, 2004, MOL CELL BIOL, V24, P976, DOI 10.1128/MCB.24.3.976-984.2004; te Poele RH, 2002, CANCER RES, V62, P1876; Ugalde AP, 2011, EMBO J, V30, P2219, DOI 10.1038/emboj.2011.124; Vakifahmetoglu H, 2008, CELL DEATH DIFFER, V15, P1153, DOI 10.1038/cdd.2008.47; Vitale I, 2011, NAT REV MOL CELL BIO, V12, P384, DOI 10.1038/nrm3115; Wang YC, 1999, ONCOGENE, V18, P2643, DOI 10.1038/sj.onc.1202632; Wang YC, 1998, ONCOGENE, V17, P1923, DOI 10.1038/sj.onc.1202113; Wu ZQ, 2002, MOL CELL BIOL, V22, P2441, DOI 10.1128/MCB.22.8.2441-2449.2002; Young ARJ, 2009, EMBO REP, V10, P228, DOI 10.1038/embor.2009.22	51	21	23	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2013	288	23					16212	16224		10.1074/jbc.M112.435149	http://dx.doi.org/10.1074/jbc.M112.435149			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	163ZU	23612976	Green Published, hybrid			2022-12-25	WOS:000320378900002
J	Croak, BM; Crowther, MS; Webb, JK; Shine, R				Croak, Benjamin M.; Crowther, Mathew S.; Webb, Jonathan K.; Shine, Richard			Movements and Habitat Use of an Endangered Snake, Hoplocephalus bungaroides (Elapidae): Implications for Conservation	PLOS ONE			English	Article							LIFE-HISTORY TRAITS; THREATENED SNAKE; SOUTHEASTERN AUSTRALIA; EASTERN AUSTRALIA; SYMPATRIC SNAKES; STEPHENSII ELAPIDAE; ARTIFICIAL ROCKS; SPATIAL ECOLOGY; SELECTION; SERPENTES	A detailed understanding of how extensively animals move through the landscape, and the habitat features upon which they rely, can identify conservation priorities and thus inform management planning. For many endangered species, information on habitat use either is sparse, or is based upon studies from a small part of the species' range. The broad-headed snake (Hoplocephalus bungaroides) is restricted to a specialized habitat (sandstone outcrops and nearby forests) within a small geographic range in south-eastern Australia. Previous research on this endangered taxon was done at a single site in the extreme south of the species' geographic range. We captured and radio-tracked 9 adult broad-headed snakes at sites in the northern part of the species' distribution, to evaluate the generality of results from prior studies, and to identify critical habitat components for this northern population. Snakes spent most of winter beneath sun-warmed rocks then shifted to tree hollows in summer. Thermal regimes within retreat-sites support the hypothesis that this shift is thermally driven. Intervals between successive displacements were longer than in the southern snakes but dispersal distances per move and home ranges were similar. Our snakes showed non-random preferences both in terms of macrohabitat (e. g., avoidance of some vegetation types) and microhabitat (e.g., frequent use of hollow-bearing trees). Despite many consistencies, the ecology of this species differs enough between southern and northern extremes of its range that managers need to incorporate information on local features to most effectively conserve this threatened reptile.	[Croak, Benjamin M.; Crowther, Mathew S.; Shine, Richard] Univ Sydney, Sch Biol Sci A08, Camperdown, NSW, Australia; [Webb, Jonathan K.] Univ Technol Sydney, Sch Environm, Broadway, NSW, Australia	University of Sydney; University of Technology Sydney	Croak, BM (corresponding author), Univ Sydney, Sch Biol Sci A08, Camperdown, NSW, Australia.	bencroak@gmail.com	Crowther, Mathew/M-7406-2013	Crowther, Mathew/0000-0001-8968-1161; Webb, Jonathan/0000-0003-4822-6829; Croak, Benjamin/0000-0003-4191-5891	Australian research council Linkage grant [LP0776647]; Australian Reptile Park	Australian research council Linkage grant(Australian Research Council); Australian Reptile Park	Australian research council Linkage grant: number LP0776647 awarded to professor Richard Shine. Linkage Contributors: NSW National parks and wildlife: http://www.nationalparks.nsw.gov.au/; Forests NSW: http://www.forests.nsw.gov.au/; The Hawkesbury/Nepean catchment authority: http://www.hn.cma.nsw.gov.au/; Zoos Victoria: http://www.zoo.org.au/; The Australian Reptile Park: http://www.reptilepark.com.au/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts. Australian Reptile Park provided funding for this study. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	[Anonymous], 2010, COMPLETE GUIDE REPTI; Bonin MC, 2012, CORAL REEFS, V31, P287, DOI 10.1007/s00338-011-0843-2; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Caughley G., 1995, CONSERVATION BIOL TH; Cogger H, 2000, REPTILES AMPHIBIANS; Cooke Steven J., 2008, Endangered Species Research, V4, P165, DOI 10.3354/esr00063; Croak BM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037982; Croak BM, 2010, RESTOR ECOL, V18, P428, DOI 10.1111/j.1526-100X.2008.00476.x; Croak BM, 2008, ANIM BEHAV, V76, P1875, DOI 10.1016/j.anbehav.2008.08.011; Dirzo R, 2003, ANNU REV ENV RESOUR, V28, P137, DOI 10.1146/annurev.energy.28.050302.105532; Dubey S, 2011, ECOL EVOL, V1, P218, DOI 10.1002/ece3.25; Fitzgerald M, 2005, AUSTRAL ECOL, V30, P465, DOI 10.1111/j.1442-9993.2005.01489.x; Fitzgerald M, 2002, COPEIA, P321, DOI 10.1643/0045-8511(2002)002[0321:RSOHUB]2.0.CO;2; Fitzgerald M, 2002, AUSTRAL ECOL, V27, P537, DOI 10.1046/j.1442-9993.2002.01214.x; Gaston K.J., 1994, RARITY, P1; Gibbons P, 2002, BIOL CONSERV, V103, P1, DOI 10.1016/S0006-3207(01)00109-4; Gibbons P., 2002, TREE HOLLOWS WILDLIF, DOI [10.1071/9780643090033, DOI 10.1071/9780643090033]; Gibson L, 2011, NATURE, V478, P378, DOI 10.1038/nature10425; Gillies CS, 2006, J ANIM ECOL, V75, P887, DOI 10.1111/j.1365-2656.2006.01106.x; Greer A. E., 1997, BIOL EVOLUTION AUSTR; HARRIS S, 1990, MAMMAL REV, V20, P97, DOI 10.1111/j.1365-2907.1990.tb00106.x; Hucke-Gaete R, 2004, P ROY SOC B-BIOL SCI, V271, pS170, DOI 10.1098/rsbl.2003.0132; Julliard R, 2004, GLOBAL CHANGE BIOL, V10, P148, DOI 10.1111/j.1365-2486.2003.00723.x; Keogh JS, 2000, J ZOOL, V252, P317, DOI 10.1017/S0952836900000054; Keogh SJ, 2003, CONSERV GENET, V4, P57, DOI 10.1023/A:1021823423944; Krefft G., 1869, SNAKES AUSTR ILLUSTR; McCulloch C. E., 2001, GEN LINEAR MIXED MOD; Mills MGL, 2004, WILDLIFE BIOL, V10, P177, DOI 10.2981/wlb.2004.024; Munday PL, 2004, GLOBAL CHANGE BIOL, V10, P1642, DOI 10.1111/j.1365-2486.2004.00839.x; Pike David A., 2011, Ecological Management & Restoration, V12, P110, DOI 10.1111/j.1442-8903.2011.00582.x; PINHEIRO JC, 2011, NLME LINEAR NONLINEA, V3, P1, DOI DOI 10.1371/J0URNAL.P0NE.0018860; Pringle RM, 2003, ECOLOGY, V84, P2668, DOI 10.1890/02-0482; Sanders KL, 2008, J EVOLUTION BIOL, V21, P682, DOI 10.1111/j.1420-9101.2008.01525.x; SHINE R, 1989, Australian Zoologist, V25, P65; Shine R, 1998, WILDLIFE RES, V25, P285, DOI 10.1071/WR97022; Shine R, 2012, ADV STUD BEHAV, V44, P1, DOI 10.1016/B978-0-12-394288-3.00001-0; Sumner J, 2010, CONSERV GENET, V11, P747, DOI 10.1007/s10592-009-9863-7; Webb JK, 1997, BIOL CONSERV, V81, P21, DOI 10.1016/S0006-3207(96)00160-7; Webb JK, 2002, ORYX, V36, P170, DOI 10.1017/S0030605302000248; Webb JK, 2003, AUSTRAL ECOL, V28, P601, DOI 10.1046/j.1442-9993.2003.t01-1-01316.x; Webb JK, 1998, PHYSIOL ZOOL, V71, P680, DOI 10.1086/515979; Webb JK, 2002, ECOL RES, V17, P59, DOI 10.1046/j.1440-1703.2002.00463.x; Webb JK, 2000, BIOL CONSERV, V92, P93, DOI 10.1016/S0006-3207(99)00056-7; Webb JK, 1997, BIOL CONSERV, V82, P203, DOI 10.1016/S0006-3207(97)00032-3; Webb JK, 2008, J WILDLIFE MANAGE, V72, P1394, DOI 10.2193/2007-515; Webb JK, 1998, ANIM CONSERV, V1, P185, DOI 10.1111/j.1469-1795.1998.tb00028.x; White G.C., 1990, ANAL WILDLIFE RADIO	47	13	15	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2013	8	4							e61711	10.1371/journal.pone.0061711	http://dx.doi.org/10.1371/journal.pone.0061711			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JR	23613912	Green Submitted, Green Published, gold			2022-12-25	WOS:000317911500062
J	Chu, AHY; Moy, FM				Chu, Anne H. Y.; Moy, Foong Ming			Joint Association of Sitting Time and Physical Activity with Metabolic Risk Factors among Middle-Aged Malays in a Developing Country: A Cross-Sectional Study	PLOS ONE			English	Article							BODY-MASS INDEX; SEDENTARY BEHAVIORS; LIFE-STYLE; ADULTS; OVERWEIGHT; INACTIVITY; OBESITY	Background: Prolonged sitting is associated with increased weight and higher risks for abdominal obesity, dyslipidaemia, hyperglycaemia and hypertension among the adult population. This has been well documented in the West, but studies on these associations are lacking in developing countries, including Malaysia. Objective: This cross-sectional study aimed to examine the joint association of sitting time and physical activity with metabolic risk factors among middle-aged working adults. Methodology: A total of 686 Malay men and women participated (mean age 45.9 +/- 6.5 years). Metabolic syndrome was diagnosed from the modified NCEP ATP III criteria. Self-reported sitting time was obtained with the validated Malay version of the International Physical Activity Questionnaire. Participants were asked about their time spent sitting during travel in a motor vehicle, e. g., car, motorcycle or bus, over the preceding 7 days. Logistic regression was used to estimate the odds ratio with the confidence interval for the combined effects of sitting quartiles and physical activity categories with metabolic risk factors. Results/Significance: The prevalence of metabolic syndrome among our participants was 31.9%. Their average total sitting time (including transportation) was 7.6 +/- 2.4 h/day. After we adjusted for gender and educational level, higher sitting quartiles and physically inactive groups were associated with higher odds for metabolic syndrome compared with the referent group (sitting <6 h/day and physically active). In the physically active stratum, the odds for metabolic syndrome in participants who sat >= 9.3 h/day was 3.8 times that of participants who sat <6 h/day. Both higher sitting quartiles and insufficient physical activity were associated with adverse effects on abdominal obesity, hypertriglyceridemia and hyperglycaemia. Conclusion: In joint analyses of sitting time and physical activity, higher sitting time and insufficient physical activity were deleteriously associated with odds for metabolic risk factors in middle-aged Malay men and women.	[Chu, Anne H. Y.; Moy, Foong Ming] Univ Malaya, Fac Med, Julius Ctr, Dept Social & Prevent Med, Kuala Lumpur, Malaysia	Universiti Malaya	Chu, AHY (corresponding author), Univ Malaya, Fac Med, Julius Ctr, Dept Social & Prevent Med, Kuala Lumpur, Malaysia.	anne.chu.hy@gmail.com	Moy, Foong Ming/B-7899-2010; Stefanadis, Christodoulos/ABH-2232-2020	Moy, Foong Ming/0000-0002-0306-4419; Stefanadis, Christodoulos/0000-0001-5974-6454	University of Malaya [PV065/2011A]; MOHE HIR [STeMM-E000010-20001]	University of Malaya(Universiti Malaya); MOHE HIR	This study was supported by research grants from the University of Malaya (PV065/2011A) and the MOHE HIR grant (STeMM-E000010-20001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almselati A.S.I., 2011, SOC SCI, V6, P24, DOI [10.3923/sscience.2011.24.33, DOI 10.3923/SSCIENCE.2011.24.33]; Bauman A, 2011, AM J PREV MED, V41, P228, DOI 10.1016/j.amepre.2011.05.003; Bauman A, 2009, INT J BEHAV NUTR PHY, V6, DOI 10.1186/1479-5868-6-21; Bertrais S, 2005, OBES RES, V13, P936, DOI 10.1038/oby.2005.108; Bey L, 2003, J PHYSIOL-LONDON, V551, P673, DOI 10.1113/jphysiol.2003.045591; Broekhuizen LN, 2011, EUR J CARDIOV PREV R, V18, P209, DOI 10.1177/1741826710389397; Chu AHY, 2012, ASIA PAC J IN PRESS; Dunton GF, 2009, INT J OBESITY, V33, P1427, DOI 10.1038/ijo.2009.174; Edwardson CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034916; Gill JMR, 2011, DIABETES CARE, V34, P1214, DOI 10.2337/dc10-2313; Hamilton MT, 2004, EXERC SPORT SCI REV, V32, P161; Healy GN, 2008, DIABETES CARE, V31, P369, DOI 10.2337/dc07-1795; Hoehner CM, 2012, AM J PREV MED, V42, P571, DOI 10.1016/j.amepre.2012.02.020; Hu G, 2004, HYPERTENSION, V43, P25, DOI 10.1161/01.HYP.0000107400.72456.19; Katzmarzyk PT, 2009, MED SCI SPORT EXER, V41, P998, DOI 10.1249/MSS.0b013e3181930355; Liao Y, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-131; Mabry RM, 2012, OBESITY, V20, P2290, DOI 10.1038/oby.2012.26; Mohamud WNW, 2011, DIABETES RES CLIN PR, V91, P239, DOI 10.1016/j.diabres.2010.11.025; Moy FM, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-678; Organization WH, 1998, WELLB MEAS PRIM HLTH; Owen N, 2011, AM J PREV MED, V41, P189, DOI 10.1016/j.amepre.2011.05.013; Pitsavos C, 2005, EUR J CARDIOV PREV R, V12, P151, DOI 10.1097/00149831-200504000-00010; Salmon J, 2000, INT J OBESITY, V24, P600, DOI 10.1038/sj.ijo.0801203; Sisson SB, 2009, METAB SYNDR RELAT D, V7, P529, DOI 10.1089/met.2009.0023; Sugiyama T, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-35; Thorp AA, 2011, AM J PREV MED, V41, P207, DOI 10.1016/j.amepre.2011.05.004; Thorp AA, 2010, DIABETES CARE, V33, P327, DOI 10.2337/dc09-0493; US Department of Health and Human Services, 2008, PHYS ACT GUID AM; van Uffelen JGZ, 2010, AM J PREV MED, V39, P379, DOI 10.1016/j.amepre.2010.05.024; Wan Rabiah WO, 2011, WORLD J MANAG, V3, P109	30	21	23	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2013	8	4							e61723	10.1371/journal.pone.0061723	http://dx.doi.org/10.1371/journal.pone.0061723			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IK	23613917	Green Published, Green Submitted, gold			2022-12-25	WOS:000317907200078
J	Dey, I; Beck, PL; Chadee, K				Dey, Indranil; Beck, Paul L.; Chadee, Kris			Lymphocytic Colitis Is Associated with Increased Pro-Inflammatory Cytokine Profile and Up Regulation of Prostaglandin Receptor EP4	PLOS ONE			English	Article							COLONIC EPITHELIAL-CELLS; MICROSCOPIC COLITIS; COLLAGENOUS COLITIS; EXPRESSION; E-2; RISK; PERMEABILITY; POLYMORPHISM; MECHANISMS; TRANSPORT	Microscopic colitis (MC) is comprised of two entities, lymphocytic (LC) and collagenous colitis. Up to 20% of patients with chronic diarrhea that have a normal appearing colonoscopy will be diagnosed with MC. Since MC was first described less than 40 years ago, little is known about the mechanisms involved in disease pathogenesis. Nonsteroidal anti-inflammatory drugs are associated with an increased risk of MC and some reports suggest a dysregulation in prostaglandin production. Recent genome wide screens have found an association between prostaglandin receptor EP4 expression and inflammatory bowel disease; however, EP4 expression has never been studied in MC. The aim of this study was to assess colonic mucosal inflammatory cytokine profiles in patients with LC and to assess expression of the prostaglandin receptor EP4. Colonic mucosal biopsies were obtained from patients undergoing colonoscopy for investigation of diarrhea and in those undergoing colon cancer screening. Following histological assessment, expression of cytokines and the prostaglandin receptor EP4 was analyzed using real-time reverse transcriptase-PCR and immunohistochemistry. Patients with LC had markedly increased mRNA expression for TNF-alpha, IFN-gamma and IL-8 compared to normal controls (p < 0.001). No significant differences were noted for IL-1 beta, IL-4, IL-10 or IL-12/23. Interestingly, those with LC had increased EP4 receptor expression, which positively correlated with increased TNF-alpha expression. This is the first report to demonstrate that LC is associated with increased TNF-alpha, INF-gamma and IL-8 concurrent with a marked up-regulation of EP4. These findings add to our knowledge on the pathogenesis of LC and may give rise to possible new therapeutic and/or diagnostic tools in the management of MC.	[Dey, Indranil; Chadee, Kris] Univ Calgary, Hlth Sci Ctr, Dept Microbiol, Snyder Inst Chron Inflammat, Calgary, AB, Canada; [Dey, Indranil; Chadee, Kris] Univ Calgary, Hlth Sci Ctr, Dept Immunol, Snyder Inst Chron Inflammat, Calgary, AB, Canada; [Dey, Indranil; Chadee, Kris] Univ Calgary, Hlth Sci Ctr, Dept Infect Dis, Snyder Inst Chron Inflammat, Calgary, AB, Canada; [Beck, Paul L.] Univ Calgary, Hlth Sci Ctr, Div Gastroenterol, Snyder Inst Chron Inflammat, Calgary, AB, Canada	University of Calgary; University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Calgary; University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Calgary; University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Calgary; University of Manitoba; Children's Hospital Research Institute of Manitoba	Chadee, K (corresponding author), Univ Calgary, Hlth Sci Ctr, Dept Microbiol, Snyder Inst Chron Inflammat, Calgary, AB, Canada.	kchadee@ucalgary.ca			Crohn's and Colitis Foundation of Canada; Canadian Institutes of Health Research (CIHR); CAG-Axcan Pharma-CIHR; Axcan Pharma	Crohn's and Colitis Foundation of Canada; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CAG-Axcan Pharma-CIHR; Axcan Pharma	This work was supported by grants from the Crohn's and Colitis Foundation of Canada (KC and PLB), the Canadian Institutes of Health Research (CIHR) (KC) and a CAG-Axcan Pharma-CIHR Research and Fellowship Award to ID. PLB is an Alberta Heritage Foundation for Medical Research Scholar. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The commercial funder Axcan Pharma provided salary support only in the form of a fellowship to ID. This commercial funder does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Abdo AA, 2003, CAN J GASTROENTEROL, V17, P425, DOI 10.1155/2003/404857; Baert F, 1999, GUT, V45, P375, DOI 10.1136/gut.45.3.375; Beaugerie L, 2005, ALIMENT PHARM THER, V22, P277, DOI 10.1111/j.1365-2036.2005.02561.x; Bohr J, 1996, GUT, V39, P73, DOI 10.1136/gut.39.1.73; Bohr J, 1996, GUT, V39, P846, DOI 10.1136/gut.39.6.846; BRAEGGER CP, 1994, ANN ALLERGY, V72, P135; Burgel N, 2002, GASTROENTEROLOGY, V123, P433, DOI 10.1053/gast.2002.34784; Chande N, 2005, SCAND J GASTROENTERO, V40, P343, DOI 10.1080/00365520510011623; Chang FJ, 2005, ADV ANAT PATHOL, V12, P203, DOI 10.1097/01.pap.0000175115.63165.6b; Cindoruk M, 2002, J CLIN GASTROENTEROL, V34, P237, DOI 10.1097/00004836-200203000-00008; Cosme R, 2000, HUM IMMUNOL, V61, P684, DOI 10.1016/S0198-8859(00)00131-2; Dey I, 2006, BRIT J PHARMACOL, V149, P611, DOI 10.1038/sj.bjp.0706923; Dey I, 2009, BRIT J PHARMACOL, V156, P475, DOI 10.1111/j.1476-5381.2008.00056.x; El-Salhy M, 2012, WORLD J GASTROENTERO, V18, P6070, DOI 10.3748/wjg.v18.i42.6070; Fernandez-Banares F, 2007, AM J GASTROENTEROL, V102, P324, DOI 10.1111/j.1572-0241.2006.00902.x; GUSTAFSONSVARD C, 1993, SCAND J GASTROENTERO, V28, P323, DOI 10.3109/00365529309090250; Hendel J, 1997, AM J GASTROENTEROL, V92, P1170; Jarnerot G, 2001, SCAND J GASTROENTERO, V36, P959, DOI 10.1080/003655201750305486; Jiang GL, 2007, J PHARMACOL EXP THER, V320, P22, DOI 10.1124/jpet.106.111146; Kabashima K, 2002, J CLIN INVEST, V109, P883, DOI 10.1172/JCI14459; KANDEMIR O, 1995, DIS COLON RECTUM, V38, P1097, DOI 10.1007/BF02133986; Kaplan GG, 2008, TRANSPLANTATION, V85, P48, DOI 10.1097/01.tp.0000298001.66377.a2; Koskela RM, 2008, EUR J GASTROEN HEPAT, V20, P276, DOI 10.1097/MEG.0b013e3282f2468d; Koskela RM, 2011, EUR J GASTROEN HEPAT, V23, P607, DOI 10.1097/MEG.0b013e328346f5be; Kunikata T, 2002, DIGEST DIS SCI, V47, P894, DOI 10.1023/A:1014725024519; Lazenby AJ, 2005, SEMIN DIAGN PATHOL, V22, P295, DOI 10.1053/j.semdp.2006.04.006; Lejeune M, 2010, AM J PHYSIOL-GASTR L, V299, pG1097, DOI 10.1152/ajpgi.00280.2010; Libioulle C, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030058; MARTIN M, 1994, KIDNEY INT, V45, P150, DOI 10.1038/ki.1994.18; Nitta M, 2002, SCAND J IMMUNOL, V56, P66, DOI 10.1046/j.1365-3083.2002.01096.x; Olesen M, 2004, GUT, V53, P536, DOI 10.1136/gut.2003.023440; Olesen M, 2004, GUT, V53, P346, DOI 10.1136/gut.2003.014431; Pardi DS, 2007, GUT, V56, P504, DOI 10.1136/gut.2006.105890; RASKMADSEN J, 1983, DIGEST DIS SCI, V28, P1141, DOI 10.1007/BF01295815; RIDDELL RH, 1992, GUT, V33, P683, DOI 10.1136/gut.33.5.683; Ruemmele F M, 1998, Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi, V39, P1; Sheibanie AF, 2007, J IMMUNOL, V178, P8138, DOI 10.4049/jimmunol.178.12.8138; Singer II, 1998, GASTROENTEROLOGY, V115, P297, DOI 10.1016/S0016-5085(98)70196-9; Soderholm JD, 2002, GUT, V50, P307, DOI 10.1136/gut.50.3.307; Srivastava V, 2012, EUR J IMMUNOL, V42, P912, DOI 10.1002/eji.201141965; Stahle-Backdahl M, 2000, SCAND J GASTROENTERO, V35, P742, DOI 10.1080/003655200750023426; Sugi K, 2001, GASTROENTEROLOGY, V120, P1393, DOI 10.1053/gast.2001.24045; Sun Y, 2004, GUT, V53, P362, DOI 10.1136/gut.2003.015867; Tagkalidis PP, 2007, J CLIN PATHOL, V60, P382, DOI 10.1136/jcp.2005.036376; Wallace JL, 2001, GASTROENTEROL CLIN N, V30, P971, DOI 10.1016/S0889-8553(05)70223-5; Warren BF, 2002, HISTOPATHOLOGY, V40, P374, DOI 10.1046/j.1365-2559.2002.01341.x; Williams JJ, 2008, CLIN GASTROENTEROL H, V6, P35, DOI 10.1016/j.cgh.2007.10.031; Yu Y, 1998, J IMMUNOL, V161, P3746	48	18	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2013	8	4							e61891	10.1371/journal.pone.0061891	http://dx.doi.org/10.1371/journal.pone.0061891			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IK	23613969	Green Published, Green Submitted, gold			2022-12-25	WOS:000317907200101
J	Dooley, FD; Nair, SP; Ward, PD				Dooley, Frederick D.; Nair, Suven P.; Ward, Peter D.			Increased Growth and Germination Success in Plants following Hydrogen Sulfide Administration	PLOS ONE			English	Article							OXIDATIVE-PHOSPHORYLATION; SEED-GERMINATION; PHOTOSYNTHESIS; MITOCHONDRIA; CONSUMPTION; TOLERANCE; LIFE	This study presents a novel way of enhancing plant growth through the use of a non-petroleum based product. We report here that exposing either roots or seeds of multicellular plants to extremely low concentrations of dissolved hydrogen sulfide at any stage of life causes statistically significant increases in biomass including higher fruit yield. Individual cells in treated plants were smaller (similar to 13%) than those of controls. Germination success and seedling size increased in, bean, corn, wheat, and pea seeds while time to germination decreases. These findings indicated an important role of H2S as a signaling molecule that can increase the growth rate of all species yet tested. The increased crop yields reported here has the potential to effect the world's agricultural output.	[Dooley, Frederick D.; Nair, Suven P.; Ward, Peter D.] Univ Washington, Dept Biol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Dooley, FD (corresponding author), Univ Washington, Dept Biol, Seattle, WA 98195 USA.	fdd@u.washington.edu			NASA Astrobiology Institute	NASA Astrobiology Institute	The authors declare no competing financial interest; funding was provided by the Directors Discretionary Fund from the NASA Astrobiology Institute and the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aon MA, 2006, BBA-MOL BASIS DIS, V1762, P232, DOI 10.1016/j.bbadis.2005.06.008; Attene-Ramos MS, 2006, MOL CANCER RES, V4, P9, DOI 10.1158/1541-7786.MCR-05-0126; Chen J, 2011, J EXP BOT, V62, P4481, DOI 10.1093/jxb/err145; COHEN Y, 1986, APPL ENVIRON MICROB, V51, P398, DOI 10.1128/AEM.51.2.398-407.1986; Doeller JE, 2005, ANAL BIOCHEM, V341, P40, DOI 10.1016/j.ab.2005.03.024; Dooley FD, 2013, AQUAT BOT, V105, P7, DOI 10.1016/j.aquabot.2012.10.007; Erwin D. H, 1993, GREAT PALEOZOIC CRIS; Fenchel T., 1995, ECOLOGY EVOLUTION AN; Garcia-Mata C, 2010, NEW PHYTOL, V188, P977, DOI 10.1111/j.1469-8137.2010.03465.x; Hancock JT, 2011, NUTR NAT RES, V6, P1; JARVIS B, 1995, J APPL BACTERIOL, V79, pS5; Kimura H, 2002, MOL NEUROBIOL, V26, P13, DOI 10.1385/MN:26:1:013; KRAUSE GH, 1991, ANNU REV PLANT PHYS, V42, P313, DOI 10.1146/annurev.pp.42.060191.001525; Kump LR, 2005, GEOLOGY, V33, P397, DOI 10.1130/G21295.1; Li L, 2008, CIRCULATION, V117, P2351, DOI 10.1161/CIRCULATIONAHA.107.753467; Lisjak M, 2011, PLANT SIGNAL BEHAV, V6, P1444, DOI 10.4161/psb.6.10.17104; Lloyd D, 2005, TRENDS BIOCHEM SCI, V30, P373, DOI 10.1016/j.tibs.2005.05.005; LLOYD D, 1981, J GEN MICROBIOL, V126, P167; Lloyd D, 2006, TRENDS MICROBIOL, V14, P456, DOI 10.1016/j.tim.2006.08.003; Lloyd D, 2006, FEBS LETT, V580, P2830, DOI 10.1016/j.febslet.2006.02.066; Mancardi D, 2009, BBA-BIOENERGETICS, V1787, P864, DOI 10.1016/j.bbabio.2009.03.005; Mascaro O, 2009, J EXP MAR BIOL ECOL, V373, P26, DOI 10.1016/j.jembe.2009.03.001; Miller DL, 2007, P NATL ACAD SCI USA, V104, P20618, DOI 10.1073/pnas.0710191104; Miroshnichenko ML, 2006, EXTREMOPHILES, V10, P85, DOI 10.1007/s00792-005-0489-5; Nagai Y, 2004, FASEB J, V18, P557, DOI 10.1096/fj.03-1052fje; Napoli A. M., 2006, HOSP PHYS, V42, P47; OREN A, 1979, BIOCHIM BIOPHYS ACTA, V546, P270, DOI 10.1016/0005-2728(79)90045-8; POWELL MA, 1986, SCIENCE, V233, P563, DOI 10.1126/science.233.4763.563; Raven JA, 1995, ANN BOT, V79, P79; Roth Mark B, 2005, Sci Am, V292, P48; Searcy DG, 2004, ANAL BIOCHEM, V324, P269, DOI 10.1016/j.ab.2003.09.037; THOMPSON CR, 1978, ENVIRON SCI TECHNOL, V12, P550, DOI 10.1021/es60141a001; Wang R, 2003, ANTIOXID REDOX SIGN, V5, P493, DOI 10.1089/152308603768295249; Wang YQ, 2012, PLANT SOIL, V351, P107, DOI 10.1007/s11104-011-0936-2; Ward P., 2007, GREEN SKY GLOBAL WAR; Ward PD, 2006, SCI AM, V295, P64, DOI 10.1038/scientificamerican1006-64; Yong R, 2001, COMP BIOCHEM PHYS B, V129, P129, DOI 10.1016/S1096-4959(01)00309-8; Zhang H, 2008, J INTEGR PLANT BIOL, V50, P1518, DOI 10.1111/j.1744-7909.2008.00769.x; Zhang H, 2010, J INTEGR PLANT BIOL, V52, P556, DOI 10.1111/j.1744-7909.2010.00946.x; Zhao WM, 2002, AM J PHYSIOL-HEART C, V283, pH474, DOI 10.1152/ajpheart.00013.2002	41	80	85	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2013	8	4							e62048	10.1371/journal.pone.0062048	http://dx.doi.org/10.1371/journal.pone.0062048			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IK	23614010	gold, Green Published, Green Submitted			2022-12-25	WOS:000317907200117
J	Islam, MR; Arslan, I; Attia, J; McEvoy, M; McElduff, P; Basher, A; Rahman, W; Peel, R; Akhter, A; Akter, S; Vashum, KP; Milton, A				Islam, Md. Rafiqul; Arslan, Iqbal; Attia, John; McEvoy, Mark; McElduff, Patrick; Basher, Ariful; Rahman, Waliur; Peel, Roseanne; Akhter, Ayesha; Akter, Shahnaz; Vashum, Khanrin P.; Milton, Abul Hasnat			Is Serum Zinc Level Associated with Prediabetes and Diabetes?: A Cross-Sectional Study from Bangladesh	PLOS ONE			English	Article							INSULIN-RESISTANCE; GLOBAL PREVALENCE; SUPPLEMENTATION; DISEASE; PROJECTIONS; PREVENTION; YEAR-2000; GLUCOSE	Aims: To determine serum zinc level and other relevant biological markers in normal, prediabetic and diabetic individuals and their association with Homeostasis Model Assessment (HOMA) parameters. Methods: This cross-sectional study was conducted between March and December 2009. Any patient aged >= 30 years attending the medicine outpatient department of a medical university hospital in Dhaka, Bangladesh and who had a blood glucose level ordered by a physician was eligible to participate. Results: A total of 280 participants were analysed. On fasting blood sugar results, 51% were normal, 13% had prediabetes and 36% had diabetes. Mean serum zinc level was lowest in prediabetic compared to normal and diabetic participants (mean differences were approximately 65 ppb/L and 33 ppb/L, respectively). In multiple linear regression, serum zinc level was found to be significantly lower in prediabetes than in those with normoglycemia. Beta cell function was significantly lower in prediabetes than normal participants. Adjusted linear regression for HOMA parameters did not show a statistically significant association between serum zinc level, beta cell function (P = 0.07) and insulin resistance (P = 0.08). Low serum zinc accentuated the increase in insulin resistance seen with increasing BMI. Conclusion: Participants with prediabetes have lower zinc levels than controls and zinc is significantly associated with beta cell function and insulin resistance. Further longitudinal population based studies are warranted and controlled trials would be valuable for establishing whether zinc supplementation in prediabetes could be a useful strategy in preventing progression to Type 2 diabetes.	[Islam, Md. Rafiqul; Attia, John; McEvoy, Mark; McElduff, Patrick; Peel, Roseanne; Vashum, Khanrin P.; Milton, Abul Hasnat] Univ Newcastle, Sch Med & Publ Hlth, CCEB, New Lambton Hts, NSW, Australia; [Basher, Ariful] Govt Bangladesh, Minist Hlth & Family Welf, Mymensingh Med Coll, Dept Med, Mymensingh, Bangladesh; [Arslan, Iqbal; Rahman, Waliur] BSMMU, Dept Biochem, Dhaka, Bangladesh; [Akhter, Ayesha] Tairunnessa Mem Med Coll, Dept Obstet & Gynaecol, Dhaka, Bangladesh; [Akter, Shahnaz] ICMH, Dept Paediat, Dhaka, Bangladesh	University of Newcastle; Mymensingh Medical College; Bangabandhu Sheikh Mujib Medical University (BSMMU)	Milton, A (corresponding author), Univ Newcastle, Sch Med & Publ Hlth, CCEB, New Lambton Hts, NSW, Australia.	milton.hasnat@newcastle.edu.au	Peel, Roseanne/G-7726-2013; Attia, John R/F-5376-2013	Peel, Roseanne/0000-0001-9912-3198; Attia, John R/0000-0001-9800-1308; Vashum-Johnston, Khanrin/0000-0003-0433-4000; McEvoy, Mark/0000-0002-5505-5557	Directorate General Health Services, Ministry of Health and Family Welfare, Government of the People's Republic of Bangladesh	Directorate General Health Services, Ministry of Health and Family Welfare, Government of the People's Republic of Bangladesh	The study was funded by the Directorate General Health Services, Ministry of Health and Family Welfare, Government of the People's Republic of Bangladesh. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arsenault JE, 2010, J NUTR, V140, P1683, DOI 10.3945/jn.110.123059; Baig Ayaz, 2007, J Ayub Med Coll Abbottabad, V19, P25; Balaz M, 2012, ICE ECE 2012, P1196; BEGINHEICK N, 1985, DIABETES, V34, P179, DOI 10.2337/diabetes.34.2.179; Beletate V, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005525.pub2; Benja M, 2012, BMC PUBLIC HLTH, V12; Benjamin SM, 2003, DIABETES CARE, V26, P645, DOI 10.2337/diacare.26.3.645; Berry C, 2007, J AM COLL CARDIOL, V49, P631, DOI 10.1016/j.jacc.2006.09.046; Boyd R, 2005, EMERG MED J, V22, P177, DOI 10.1136/emj.2003.011619; Brender JR, 2010, J AM CHEM SOC, V132, P8973, DOI 10.1021/ja1007867; Chausmer AB, 1998, J AM COLL NUTR, V17, P109, DOI 10.1080/07315724.1998.10718735; CHEN M-D, 1991, Kaohsiung Journal of Medical Sciences, V7, P628; Chen MD, 1997, BIOL TRACE ELEM RES, V60, P123, DOI 10.1007/BF02783315; COULSTON L, 1980, DIABETES, V29, P665, DOI 10.2337/diabetes.29.8.665; Dhingra U, 2009, J HEALTH POPUL NUTR, V27, P632; DIMARTINO G, 1993, J MED, V24, P177; Ferrannini E, 1997, J CLIN INVEST, V100, P1166, DOI 10.1172/JCI119628; Haase H, 2008, EXP GERONTOL, V43, P394, DOI 10.1016/j.exger.2007.12.002; HUANG XF, 1995, J BIOL CHEM, V270, P20417, DOI 10.1074/jbc.270.35.20417; Kongsbak K, 2006, J NUTR, V136, P2262, DOI 10.1093/jn/136.8.2262; Marreiro Dilina N., 2004, Arq Bras Endocrinol Metab, V48, P234, DOI 10.1590/S0004-27302004000200005; Nathan DM, 2007, DIABETES CARE, V30, P753, DOI 10.2337/dc07-9920; Ognjanovic S, 2012, INT J OBES LOND; Rathmann W, 2004, DIABETES CARE, V27, P2568, DOI 10.2337/diacare.27.10.2568; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; Roussel AM, 2003, J AM COLL NUTR, V22, P316, DOI 10.1080/07315724.2003.10719310; Simon SF, 2001, EXP BIOL MED, V226, P43, DOI 10.1177/153537020122600107; Sun Q, 2009, DIABETES CARE, V32, P629, DOI 10.2337/dc08-1913; Trirogoff ML, 2007, AM J CLIN NUTR, V86, P1642, DOI 10.1093/ajcn/86.5.1642; Twigg SM, 2007, MED J AUSTRALIA, V186, P461, DOI 10.5694/j.1326-5377.2007.tb00998.x; Ukropec J, 2010, DIABETOLOGIA, V53, P899, DOI 10.1007/s00125-010-1683-2; Wiernsperger N, 2010, WIERNSPERGER RAPIN D, V2; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292	35	30	32	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2013	8	4							e61776	10.1371/journal.pone.0061776	http://dx.doi.org/10.1371/journal.pone.0061776			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IK	23613929	Green Published, gold			2022-12-25	WOS:000317907200084
J	Vincze, O; Szekely, T; Kupper, C; AlRashidi, M; Amat, JA; Tico, AA; Burgas, D; Burke, T; Cavitt, J; Figuerola, J; Shobrak, M; Montalvo, T; Kosztolanyi, A				Vincze, Orsolya; Szekely, Tamas; Kuepper, Clemens; AlRashidi, Monif; Amat, Juan A.; Tico, Araceli Argueelles; Burgas, Daniel; Burke, Terry; Cavitt, John; Figuerola, Jordi; Shobrak, Mohammed; Montalvo, Tomas; Kosztolanyi, Andraa			Local Environment but Not Genetic Differentiation Influences Biparental Care in Ten Plover Populations	PLOS ONE			English	Article							CHARADRIUS-ALEXANDRINUS; PARENTAL CARE; SEXUAL CONFLICT; EVOLUTION; KENTISH; HERITABILITY; DIVERGENCE	Social behaviours are highly variable between species, populations and individuals. However, it is contentious whether behavioural variations are primarily moulded by the environment, caused by genetic differences, or a combination of both. Here we establish that biparental care, a complex social behaviour that involves rearing of young by both parents, differs between closely related populations, and then test two potential sources of variation in parental behaviour between populations: ambient environment and genetic differentiation. We use 2904 hours behavioural data from 10 geographically distinct Kentish (Charadrius alexandrinus) and snowy plover (C. nivosus) populations in America, Europe, the Middle East and North Africa to test these two sources of behavioural variation. We show that local ambient temperature has a significant influence on parental care: with extreme heat (above 40 degrees C) total incubation (i.e. % of time the male or female incubated the nest) increased, and female share (% female share of incubation) decreased. By contrast, neither genetic differences between populations, nor geographic distances predicted total incubation or female's share of incubation. These results suggest that the local environment has a stronger influence on a social behaviour than genetic differentiation, at least between populations of closely related species.	[Vincze, Orsolya] Univ Babes Bolyai, Hungarian Dept Biol & Ecol, Evolutionary Ecol Grp, R-3400 Cluj Napoca, Romania; [Vincze, Orsolya; Kosztolanyi, Andraa] Univ Debrecen, Dept Evolutionary Zool & Human Biol, MTA DE Lendulet Behav Ecol Res Grp, H-4012 Debrecen, Hungary; [Szekely, Tamas; Tico, Araceli Argueelles] Univ Bath, Dept Biol & Biochem, Biodivers Lab, Bath BA2 7AY, Avon, England; [Kuepper, Clemens; Burke, Terry] Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England; [AlRashidi, Monif] Univ Hail, Coll Sci, Dept Biol, Hail, Saudi Arabia; [Amat, Juan A.; Figuerola, Jordi] Estac Biol Donana CSIC, Dept Wetland Ecol, Seville, Spain; [Burgas, Daniel] Univ Helsinki, Dept Biosci, Helsinki, Finland; [Cavitt, John] Weber State Univ, Dept Zool, Avian Ecol Lab, Ogden, UT 84408 USA; [Shobrak, Mohammed] Taif Univ, Coll Sci, Dept Biol, At Taif, Saudi Arabia; [Montalvo, Tomas] Agencia Salut Publ Barcelona, Serv Vigilancia & Control Plagues Urbanes, Barcelona, Spain	Babes Bolyai University from Cluj; University of Debrecen; University of Bath; University of Sheffield; University Ha'il; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); University of Helsinki; Utah System of Higher Education; Weber State University; Taif University; Public Health Agency of Barcelona	Vincze, O (corresponding author), Univ Babes Bolyai, Hungarian Dept Biol & Ecol, Evolutionary Ecol Grp, R-3400 Cluj Napoca, Romania.	orsolya.vincze@vocs.unideb.hu	Küpper, Clemens/D-8116-2011; Kosztolanyi, Andras/B-8008-2016; Vincze, Orsolya/AEQ-1159-2022; , Mohammed/AAQ-4157-2021; Szekely, Tamas/I-7089-2016; Figuerola, Jordi/B-7917-2008; Burke, Terry/B-3196-2011	Küpper, Clemens/0000-0002-1507-8033; Kosztolanyi, Andras/0000-0002-9109-5871; Vincze, Orsolya/0000-0001-5789-2124; , Mohammed/0000-0002-6053-8289; Szekely, Tamas/0000-0003-2093-0056; Figuerola, Jordi/0000-0002-4664-9011; Burke, Terry/0000-0003-3848-1244; Montalvo Porro, Tomas/0000-0002-9060-3205; Amat, Juan A./0000-0003-1685-1056; Burgas, Daniel/0000-0003-3512-8365	NERC, UK; DAAD; CONACyT, Mexico; university of Hail and Saudi Wildlife Authority; Spanish Ministry of Science and Innovation/EU-ERDF [CGL2009-11445]; Spanish Ministries of Education and Science/EU-ERDF [PB95-0110]; Science and Innovation/EU-ERDF [CGL2011-24230]; US Fish and Wildlife Service Region 6; Tides Foundation; Weber State University; BirdLife-Rio Tinto partnership; Eccles Foundation; Hungarian Scientific Research Fund [OTKA K81953]; Hungarian Academy of Sciences ("Lendulet'') [LP2012-37/2012]; Leverhulme Research Fellowship [RF/2/RFG/2005/0279]; National Geographic Society [CRE 8403-08]; NERC [NBAF010001] Funding Source: UKRI; Natural Environment Research Council [NBAF010001] Funding Source: researchfish	NERC, UK(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); DAAD(Deutscher Akademischer Austausch Dienst (DAAD)); CONACyT, Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); university of Hail and Saudi Wildlife Authority; Spanish Ministry of Science and Innovation/EU-ERDF; Spanish Ministries of Education and Science/EU-ERDF; Science and Innovation/EU-ERDF; US Fish and Wildlife Service Region 6; Tides Foundation; Weber State University; BirdLife-Rio Tinto partnership; Eccles Foundation; Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Hungarian Academy of Sciences ("Lendulet''); Leverhulme Research Fellowship(Leverhulme Trust); National Geographic Society(National Geographic Society); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The genetic analyses were funded by NERC, UK and carried out at NBAF Sheffield (reference numbers: 140, 183, 184). CK was supported by DAAD. AAT was supported by a Ph.D. grant from CONACyT, Mexico. MA was supported by university of Hail and Saudi Wildlife Authority. JF is currently supported by Spanish Ministry of Science and Innovation/EU-ERDF (CGL2009-11445). Generalitat de Catalunya and Autoritat Portuaria del Port de Barcelona supported field work in Llobregat. JAA received funding from the Spanish Ministries of Education and Science/EU-ERDF (PB95-0110) and Science and Innovation/EU-ERDF (CGL2011-24230). The Consejeria de Medio Ambiente of the Junta de Andalucia authorized field work at Fuente de Piedra. JC received funding from the US Fish and Wildlife Service Region 6, Tides Foundation, Weber State University, the BirdLife-Rio Tinto partnership and the Eccles Foundation. AK was supported by the Hungarian Scientific Research Fund (OTKA K81953) and the Hungarian Academy of Sciences ("Lendulet'' LP2012-37/2012). TS was supported by Leverhulme Research Fellowship (RF/2/RFG/2005/0279) and National Geographic Society (CRE 8403-08). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonzo SH, 2010, TRENDS ECOL EVOL, V25, P99, DOI 10.1016/j.tree.2009.07.012; AlRashidi M, 2011, ANIM BEHAV, V82, P235, DOI 10.1016/j.anbehav.2011.04.019; AlRashidi M, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-1; Amat JA, 2004, BEHAV ECOL SOCIOBIOL, V56, P26, DOI 10.1007/s00265-004-0758-9; Bennett P. M., 2002, OX ECOL EV; Bleakley BH, 2010, SOCIAL BEHAV GENES E, P271; Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; Brown JL, 2010, AM NAT, V175, P436, DOI 10.1086/650727; Charmantier A, 2007, P R SOC B, V274, P1757, DOI 10.1098/rspb.2007.0012; Clutton-Brock T.H., 1991, EVOLUTION PARENTAL C, DOI DOI 10.104641420-9101.1992.5040719.X; Covas R, 2012, P ROY SOC B-BIOL SCI, V279, P1531, DOI 10.1098/rspb.2011.1785; Ersts P, 2011, GEOGRAPHIC DISTANCE; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fraga Rosendo M., 1996, Ardeola, V43, P69; Freckleton RP, 2009, P ROY SOC B-BIOL SCI, V276, P21, DOI 10.1098/rspb.2008.0905; Funk WC, 2007, CONSERV GENET, V8, P1287, DOI 10.1007/s10592-006-9278-7; Ghalambor CK, 2001, SCIENCE, V292, P494, DOI 10.1126/science.1059379; Harrison F, 2009, J EVOLUTION BIOL, V22, P1800, DOI 10.1111/j.1420-9101.2009.01792.x; Houston AI, 2005, TRENDS ECOL EVOL, V20, P33, DOI 10.1016/j.tree.2004.10.008; Jennions Michael D., 2010, P343; Kosztolanyi A, 2002, J FIELD ORNITHOL, V73, P199, DOI 10.1648/0273-8570-73.2.199; Kosztolanyi A, 2009, BIRD STUDY, V56, P244, DOI 10.1080/00063650902792106; Kupper C, 2012, MOL ECOL, V21, P5864, DOI 10.1111/mec.12064; Kupper C, 2009, AUK, V126, P839, DOI 10.1525/auk.2009.08174; Kupper C, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-502; Lessells CM, 1999, MG BEH ECOL, P75; MacColl ADC, 2003, EVOLUTION, V57, P2191; Mank JE, 2005, EVOLUTION, V59, P1570; Martin TE, 2007, EVOLUTION, V61, P2558, DOI 10.1111/j.1558-5646.2007.00204.x; McGraw Lisa, 2010, P271; McNamara JM, 2000, J THEOR BIOL, V205, P605, DOI 10.1006/jtbi.2000.2093; Moore Allen J., 2010, P538; MOUSSEAU TA, 1987, HEREDITY, V59, P181, DOI 10.1038/hdy.1987.113; Piersma T., 1996, HDB BIRDS WORLD, P384; Price T, 2008, SPECIATION BIRDS; Queller DC, 2009, PHILOS T R SOC B, V364, P3143, DOI 10.1098/rstb.2009.0095; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rankin DJ, 2007, TRENDS ECOL EVOL, V22, P643, DOI 10.1016/j.tree.2007.07.009; Regan E, 2005, HORMONES ANIMAL SOCI; Reynolds JD, 2002, PHILOS T R SOC B, V357, P269, DOI 10.1098/rstb.2001.0930; Rheindt FE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026995; Rittinghaus H, 1961, DER SEEREGENPFEIFER; Robinson GE, 2008, SCIENCE, V322, P896, DOI 10.1126/science.1159277; Smiseth PT, 2012, EVOLUTION OF PARENTAL CARE, P1; Sokolowski MB, 2010, SOCIAL BEHAV GENES E, P271; Szekely T, 2008, UNPUBLISHED REPORT; Szekely T, 2013, J EVOLUTION BIOL IN; Szekely Tamas, 1996, Current Ornithology, V13, P271; Tallamy DW, 2001, ANNU REV ENTOMOL, V46, P139, DOI 10.1146/annurev.ento.46.1.139; Thomas GH, 2007, ADV STUD BEHAV, V37, P279, DOI 10.1016/S0065-3454(07)37006-X; Trillmich F, 2010, ANIMAL BEHAVIOUR: EVOLUTION AND MECHANISMS, P267, DOI 10.1007/978-3-642-02624-9_10; Trivers RL, 1972, SEXUAL SELECTION DES, P136; van Dijk R, 2008, ENCY LIFE SCI; Walling CA, 2008, P NATL ACAD SCI USA, V105, P18430, DOI 10.1073/pnas.0803146105; WEBB DR, 1987, CONDOR, V89, P874, DOI 10.2307/1368537; Wells DK., 2007, ECOLOGY BEHAV AMPHIB; Westneat DF, 2011, AM NAT, V178, P652, DOI 10.1086/662173; Wilson E.O., 1975, P1; Wolf JBW, 2010, MOL ECOL, V19, P162, DOI 10.1111/j.1365-294X.2009.04471.x	59	33	35	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2013	8	4							e60998	10.1371/journal.pone.0060998	http://dx.doi.org/10.1371/journal.pone.0060998			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IK	23613768	Green Submitted, Green Accepted, gold, Green Published			2022-12-25	WOS:000317907200023
J	Dai, N; Wang, WY; Patterson, SE; Bleecker, AB				Dai, Ning; Wang, Wuyi; Patterson, Sara E.; Bleecker, Anthony B.			The TMK Subfamily of Receptor-Like Kinases in Arabidopsis Display an Essential Role in Growth and a Reduced Sensitivity to Auxin	PLOS ONE			English	Article							PROTEIN-KINASE; ETHYLENE RECEPTOR; CELL ELONGATION; GENE ENCODES; SIZE CONTROL; ERECTA GENE; EXPRESSION; FAMILY; BINDING; DOMAIN	Mechanisms that govern the size of plant organs are not well understood but believed to involve both sensing and signaling at the cellular level. We have isolated loss-of-function mutations in the four genes comprising the transmembrane kinase TMK subfamily of receptor-like kinases (RLKs) in Arabidopsis. These TMKs have an extracellular leucine-rich-repeat motif, a single transmembrane region, and a cytoplasmic kinase domain. While single mutants do not display discernable phenotypes, unique double and triple mutant combinations result in a severe reduction in organ size and a substantial retardation in growth. The quadruple mutant displays even greater severity of all phenotypes and is infertile. The kinematic studies of root, hypocotyl, and stamen filament growth reveal that the TMKs specifically control cell expansion. In leaves, TMKs control both cell expansion and cell proliferation. In addition, in the tmk double mutants, roots and hypocotyls show reduced sensitivity to applied auxin, lateral root induction and activation of the auxin response reporter DR5: GUS. Thus, taken together with the structural and biochemical evidence, TMKs appear to orchestrate plant growth by regulation of both cell expansion and cell proliferation, and as a component of auxin signaling.	[Dai, Ning; Wang, Wuyi; Bleecker, Anthony B.] Univ Wisconsin, Dept Bot, Madison, WI USA; [Dai, Ning; Wang, Wuyi; Bleecker, Anthony B.] Univ Wisconsin, Genet Lab, Madison, WI 53706 USA; [Patterson, Sara E.] Univ Wisconsin, Dept Hort, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Dai, N (corresponding author), Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA.	ning@molbio.mgh.harvard.edu; spatters@wisc.edu			Department of Energy [DE-FG02-91ER20029]	Department of Energy(United States Department of Energy (DOE))	This project was funded by a Department of Energy grant (DE-FG02-91ER20029) to ABB and SEP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Azpiroz R, 1998, PLANT CELL, V10, P219, DOI 10.1105/tpc.10.2.219; Beemster GTS, 1998, PLANT PHYSIOL, V116, P1515, DOI 10.1104/pp.116.4.1515; Bleecker AB, 2000, ANNU REV CELL DEV BI, V16, P1, DOI 10.1146/annurev.cellbio.16.1.1; CHANG C, 1992, PLANT CELL, V4, P1263, DOI 10.1105/tpc.4.10.1263; Cho HS, 2000, MOL CELLS, V10, P317; Cho SK, 2008, P NATL ACAD SCI USA, V105, P15629, DOI 10.1073/pnas.0805539105; Clark SE, 2001, NAT REV MOL CELL BIO, V2, P276, DOI 10.1038/35067079; Clark SE, 1997, CELL, V89, P575, DOI 10.1016/S0092-8674(00)80239-1; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cockcroft CE, 2000, NATURE, V405, P575, DOI 10.1038/35014621; Croxdale J, 1992, DEV BIOL, V93, P1078; de Lorenzo L, 2009, PLANT CELL, V21, P668, DOI 10.1105/tpc.108.059576; De Smet I, 2009, NAT CELL BIOL, V11, P1166, DOI 10.1038/ncb1009-1166; Donnelly PM, 1999, DEV BIOL, V215, P407, DOI 10.1006/dbio.1999.9443; Escobar-Restrepo JM, 2007, SCIENCE, V317, P656, DOI 10.1126/science.1143562; Gao FB, 1997, J CELL BIOL, V138, P1367, DOI 10.1083/jcb.138.6.1367; Gendreau E, 1997, PLANT PHYSIOL, V114, P295, DOI 10.1104/pp.114.1.295; Guo HQ, 2009, P NATL ACAD SCI USA, V106, P7648, DOI 10.1073/pnas.0812346106; HAJDUKIEWICZ P, 1994, PLANT MOL BIOL, V25, P989, DOI 10.1007/BF00014672; Hall AE, 1999, PLANT PHYSIOL, V121, P291, DOI 10.1104/pp.121.1.291; He ZH, 2000, SCIENCE, V288, P2360, DOI 10.1126/science.288.5475.2360; Hematy K, 2008, CURR OPIN PLANT BIOL, V11, P321, DOI 10.1016/j.pbi.2008.02.008; Hematy K, 2007, CURR BIOL, V17, P922, DOI 10.1016/j.cub.2007.05.018; HEMERLY A, 1995, EMBO J, V14, P3925, DOI 10.1002/j.1460-2075.1995.tb00064.x; Hua J, 1998, CELL, V94, P261, DOI 10.1016/S0092-8674(00)81425-7; Jones AM, 1998, SCIENCE, V282, P1114, DOI 10.1126/science.282.5391.1114; KAPLAN DR, 1991, BIOSCIENCE, V41, P693, DOI 10.2307/1311764; Kohorn BD, 2009, PLANT J, V60, P974, DOI 10.1111/j.1365-313X.2009.04016.x; Lally D, 2001, PLANT CELL, V13, P1317, DOI 10.1105/tpc.13.6.1317; Lee JS, 2012, GENE DEV, V26, P126, DOI 10.1101/gad.179895.111; Leslie ME, 2010, DEVELOPMENT, V137, P467, DOI 10.1242/dev.041335; Lewers KS, 2001, GENOME, V44, P1057, DOI 10.1139/gen-44-6-1057; Li JM, 1997, CELL, V90, P929, DOI 10.1016/S0092-8674(00)80357-8; Matsubayashi Y, 2002, SCIENCE, V296, P1470, DOI 10.1126/science.1069607; Mizukami Y, 2000, P NATL ACAD SCI USA, V97, P942, DOI 10.1073/pnas.97.2.942; O'Malley RC, 2005, PLANT J, V41, P651, DOI 10.1111/j.1365-313X.2004.02331.X; Oh MH, 2009, P NATL ACAD SCI USA, V106, P658, DOI 10.1073/pnas.0810249106; Pfaffl M, 1998, EXP CLIN ENDOCR DIAB, V106, P514, DOI 10.1055/s-0029-1212026; Polymenis M, 1999, CURR OPIN GENET DEV, V9, P76, DOI 10.1016/S0959-437X(99)80011-2; Robertson SC, 2000, TRENDS GENET, V16, P265, DOI 10.1016/S0168-9525(00)02021-7; SCHALLER GE, 1993, FEBS LETT, V333, P306, DOI 10.1016/0014-5793(93)80676-L; Sessions A, 2002, PLANT CELL, V14, P2985, DOI 10.1105/tpc.004630; Shinohara H, 2012, PLANT J, V70, P845, DOI 10.1111/j.1365-313X.2012.04934.x; Shiu S.H., 2001, STKE, V2001, pR, DOI DOI 10.1126/SCISIGNAL.1132001RE22; Shiu SH, 2001, P NATL ACAD SCI USA, V98, P10763, DOI 10.1073/pnas.181141598; Shiu SH, 2001, THESIS U WISCONSIN M; Shpak ED, 2004, DEVELOPMENT, V131, P1491, DOI 10.1242/dev.01028; Steinwand BJ, 2010, PLANT PHYSIOL, V153, P479, DOI 10.1104/pp.110.155887; Stenvik GE, 2008, PLANT CELL, V20, P1805, DOI 10.1105/tpc.108.059139; THOMPSON CJ, 1987, EMBO J, V6, P2519, DOI 10.1002/j.1460-2075.1987.tb02538.x; Torii KU, 1996, PLANT CELL, V8, P735, DOI 10.1105/tpc.8.4.735; Uchida N, 2012, P NATL ACAD SCI USA, V109, P6337, DOI 10.1073/pnas.1117537109; Ulmasov T, 1997, PLANT CELL, V9, P1963, DOI 10.1105/tpc.9.11.1963; van der Knaap E, 1999, PLANT PHYSIOL, V120, P559, DOI 10.1104/pp.120.2.559; VANDERGEER P, 1994, ANNU REV CELL BIOL, V10, P251, DOI 10.1146/annurev.cellbio.10.1.251; Wang WY, 2003, P NATL ACAD SCI USA, V100, P352, DOI 10.1073/pnas.0237085100; Xu SL, 2008, PLANT CELL, V20, P3065, DOI 10.1105/tpc.108.063354; Yokoyama R, 1998, PLANT J, V15, P301, DOI 10.1046/j.1365-313X.1998.00203.x	59	61	71	4	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2013	8	4							e60990	10.1371/journal.pone.0060990	http://dx.doi.org/10.1371/journal.pone.0060990			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130DR	23613767	Green Submitted, Green Published, gold			2022-12-25	WOS:000317893400032
J	Gomez-Ospina, N; Panagiotakos, G; Portmann, T; Pasca, SP; Rabah, D; Budzillo, A; Kinet, JP; Dolmetsch, RE				Gomez-Ospina, Natalia; Panagiotakos, Georgia; Portmann, Thomas; Pasca, Sergiu P.; Rabah, Dania; Budzillo, Agata; Kinet, Jean Pierre; Dolmetsch, Ricardo E.			A Promoter in the Coding Region of the Calcium Channel Gene CACNA1C Generates the Transcription Factor CCAT	PLOS ONE			English	Article							C-TERMINUS; RECEPTORS	The C-terminus of the voltage-gated calcium channel Ca(v)1.2 encodes a transcription factor, the calcium channel associated transcriptional regulator (CCAT), that regulates neurite extension and inhibits Ca(v)1.2 expression. The mechanisms by which CCAT is generated in neurons and myocytes are poorly understood. Here we show that CCAT is produced by activation of a cryptic promoter in exon 46 of CACNA1C, the gene that encodes Ca(V)1.2. Expression of CCAT is independent of Ca(v)1.2 expression in neuroblastoma cells, in mice, and in human neurons derived from induced pluripotent stem cells (iPSCs), providing strong evidence that CCAT is not generated by cleavage of Ca(V)1.2. Analysis of the transcriptional start sites in CACNA1C and immune-blotting for channel proteins indicate that multiple proteins are generated from the 3' end of the CACNA1C gene. This study provides new insights into the regulation of CACNA1C, and provides an example of how exonic promoters contribute to the complexity of mammalian genomes.	[Gomez-Ospina, Natalia; Panagiotakos, Georgia; Portmann, Thomas; Pasca, Sergiu P.; Budzillo, Agata; Dolmetsch, Ricardo E.] Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA; [Kinet, Jean Pierre] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Kinet, Jean Pierre] Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA; [Rabah, Dania] Biogen Idec Inc, Cambridge, MA USA	Stanford University; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Biogen	Dolmetsch, RE (corresponding author), Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA.	ricardo.dolmetsch@stanford.edu	Pasca, Sergiu/AAY-3949-2021	Pasca, Sergiu/0000-0002-3216-3248; Gomez-Ospina, Natalia/0000-0002-6740-1154; PANAGIOTAKOS, GEORGIA/0000-0001-9444-2480; Budzillo, Agata/0000-0002-2723-3272; Budzillo, Agata/0000-0002-1762-435X	NINDS [R01NS048564-04]; Child Health Research Institute at Stanford; Maosbacher Fund; JDH Research Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048564] Funding Source: NIH RePORTER	NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Child Health Research Institute at Stanford; Maosbacher Fund; JDH Research Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This project was funded by generous support from the NINDS (R01NS048564-04), the Child Health Research Institute at Stanford, the Maosbacher Fund, and the JDH Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cox B, 2006, NAT PROTOC, V1, P1872, DOI 10.1038/nprot.2006.273; Gomez-Ospina N, 2006, CELL, V127, P591, DOI 10.1016/j.cell.2006.10.017; Graef IA, 1999, NATURE, V401, P703, DOI 10.1038/44378; Hardingham GE, 1999, NEURON, V22, P789, DOI 10.1016/S0896-6273(00)80737-0; Hulme JT, 2005, P NATL ACAD SCI USA, V102, P5274, DOI 10.1073/pnas.0409885102; Hulme JT, 2004, J MOL CELL CARDIOL, V37, P625, DOI 10.1016/j.yjmcc.2004.04.014; Mao ZX, 1999, SCIENCE, V286, P785, DOI 10.1126/science.286.5440.785; MORGAN JI, 1986, NATURE, V322, P552, DOI 10.1038/322552a0; MURPHY TH, 1991, NEURON, V7, P625, DOI 10.1016/0896-6273(91)90375-A; Nurminsky DI, 1998, NATURE, V396, P572, DOI 10.1038/25126; Schroder E, 2009, CIRC RES, V104, P1373, DOI 10.1161/CIRCRESAHA.108.191387; SHENG M, 1990, NEURON, V4, P571, DOI 10.1016/0896-6273(90)90115-V; Warren L, 2006, P NATL ACAD SCI USA, V103, P17807, DOI 10.1073/pnas.0608512103; WEI XY, 1994, J BIOL CHEM, V269, P1635; Yazawa M, 2011, NATURE, V471, P230, DOI 10.1038/nature09855; ZAFRA F, 1990, EMBO J, V9, P3545, DOI 10.1002/j.1460-2075.1990.tb07564.x; Zhang SC, 2001, NAT BIOTECHNOL, V19, P1129, DOI 10.1038/nbt1201-1129	17	25	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2013	8	4							e60526	10.1371/journal.pone.0060526	http://dx.doi.org/10.1371/journal.pone.0060526			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130DR	23613729	gold, Green Published, Green Submitted			2022-12-25	WOS:000317893400012
J	Kurihara, T; Yamada, H; Inoue, K; Iwai, K; Hatta, M				Kurihara, Takeo; Yamada, Hideaki; Inoue, Ken; Iwai, Kenji; Hatta, Masayuki			Impediment to Symbiosis Establishment between Giant Clams and Symbiodinium Algae Due to Sterilization of Seawater	PLOS ONE			English	Article							TRIDACNA-CROCEA; LARVAL; GROWTH; ZOOXANTHELLAE; DIVERSITY; NUTRITION; SURVIVAL; ECOLOGY; METAMORPHOSIS; REQUIREMENTS	To survive the juvenile stage, giant clam juveniles need to establish a symbiotic relationship with the microalgae Symbiodinium occurring in the environment. The percentage of giant clam juveniles succeeding in symbiosis establishment ("symbiosis rate") is often low, which is problematic for seed producers. We investigated how and why symbiosis rates vary, depending on whether giant clam seeds are continuously reared in UV treated or non treated seawater. Results repeatedly demonstrated that symbiosis rates were lower for UV treated seawater than for non treated seawater. Symbiosis rates were also lower for autoclaved seawater and 0.2-mu m filtered seawater than for non treated seawater. The decreased symbiosis rates in various sterilized seawater suggest the possibility that some factors helping symbiosis establishment in natural seawater are weakened owing to sterilization. The possible factors include vitality of giant clam seeds, since additional experiments revealed that survival rates of seeds reared alone without Symbiodinium were lower in sterilized seawater than in non treated seawater. In conclusion, UV treatment of seawater was found to lead to decreased symbiosis rates, which is due possibly to some adverse effects common to the various sterilization techniques and relates to the vitality of the giant clam seeds.	[Kurihara, Takeo] Seikai Natl Fisheries Res Inst, Ariake Yatsushiro Ctr, Nagasaki, Japan; [Yamada, Hideaki] Seikai Natl Fisheries Res Inst, Res Ctr Subtrop Fisheries, Okinawa, Japan; [Inoue, Ken] Okinawa Prefectural Fisheries & Ocean Res Ctr, Ishigaki Branch, Okinawa, Japan; [Iwai, Kenji] Okinawa Prefectural Sea Farming Ctr, Okinawa, Japan; [Hatta, Masayuki] Ochanomizu Univ, Dept Biol, Tokyo 112, Japan	Japan Fisheries Research & Education Agency (FRA); Japan Fisheries Research & Education Agency (FRA); Ochanomizu University	Kurihara, T (corresponding author), Seikai Natl Fisheries Res Inst, Ariake Yatsushiro Ctr, Nagasaki, Japan.	takeo@affrc.go.jp			Fisheries Research Institute [1BA104]	Fisheries Research Institute	The source of funding: the General Research Project of Fisheries Research Institute, 2006-2010, No. 1BA104, "Elucidation of the factors causing the decrease of resources in tropical aquaculture." The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker AC, 2003, ANNU REV ECOL EVOL S, V34, P661, DOI 10.1146/annurev.ecolsys.34.011802.132417; Belda-Baillie CA, 1999, J EXP MAR BIOL ECOL, V241, P207, DOI 10.1016/S0022-0981(99)00079-9; BERTNESS MD, 1993, AM NAT, V142, P718, DOI 10.1086/285567; Brostrom G., 2008, GLMMML GEN LINEAR MO; Chihara M., 1997, ILLUSTRATED GUIDE MA; Coffroth MA, 2005, PROTIST, V156, P19, DOI 10.1016/j.protis.2005.02.004; CRAWFORD CM, 1986, AQUACULTURE, V58, P281, DOI 10.1016/0044-8486(86)90094-3; Crawley M. J, 2002, STAT COMPUTING INTRO; Croft MT, 2005, NATURE, V438, P90, DOI 10.1038/nature04056; DeBoer TS, 2012, MAR ECOL PROG SER, V444, P117, DOI 10.3354/meps09413; EDMUNDS PJ, 1986, MAR BIOL, V92, P339, DOI 10.1007/BF00392674; Eisenhauer N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034517; Ellis S, 1998, SPAWNING EARLY LARVA, P55; Ferrier-Pages C, 1998, MICROBIAL ECOL, V35, P46, DOI 10.1007/s002489900059; Fisheries Research Agency, 2011, FISH RES AG GUID EXP; FITT WK, 1984, AQUACULTURE, V39, P181, DOI 10.1016/0044-8486(84)90265-5; FITT WK, 1986, AQUACULTURE, V55, P5, DOI 10.1016/0044-8486(86)90051-7; FITT WK, 1981, BIOL BULL, V161, P213, DOI 10.2307/1540800; Gosling E, 2003, BIVALVE MOLLUSCS BIO; Halaj J, 2001, AM NAT, V157, P262, DOI 10.1086/319190; HAWKINS AJS, 1995, J EXP MAR BIOL ECOL, V190, P263, DOI 10.1016/0022-0981(95)00044-R; HESLINGA GA, 1984, AQUACULTURE, V39, P197, DOI 10.1016/0044-8486(84)90266-7; Hirose E, 2006, MAR BIOL, V148, P551, DOI 10.1007/s00227-005-0119-x; Iwai K., 2005, REP OKINAWA FISH RES, V15, P174; Iwai K, 2006, BIOL STATUS AQUACULT, P27; JAMESON SC, 1976, PAC SCI, V30, P219; Jorquera MA, 2002, AQUACULTURE, V207, P213, DOI 10.1016/S0044-8486(01)00766-9; KINZIE RA, 1979, BIOL BULL-US, V156, P315, DOI 10.2307/1540920; KLUMPP DW, 1994, MAR ECOL PROG SER, V115, P103, DOI 10.3354/meps115103; Kurihara T, 2012, J SHELLFISH IN PRESS; Kurihara Takeo, 2011, Plankton & Benthos Research, V6, P51; Kurihara Takeo, 2010, Plankton & Benthos Research, V5, P11; LABARBERA M, 1975, Malacologia, V15, P69; LaJeunesse TC, 2001, J PHYCOL, V37, P866, DOI 10.1046/j.1529-8817.2001.01031.x; Meunpol O, 2003, AQUACULTURE, V220, P437, DOI 10.1016/S0044-8486(02)00586-0; Mingoa-Licuanan S.S., 2007, GIANT CLAM HATCHERY; MORSE DE, 1991, BIOL BULL, V181, P104, DOI 10.2307/1542493; MORSE DE, 1988, J EXP MAR BIOL ECOL, V116, P193, DOI 10.1016/0022-0981(88)90027-5; Murakoshi M, 1991, AQUACULTURE TROPICAL, V360, P257; Negri AP, 2001, MAR ECOL PROG SER, V223, P121, DOI 10.3354/meps223121; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Ribes M, 2003, MAR ECOL PROG SER, V257, P13, DOI 10.3354/meps257013; Ritola O, 2002, AQUACULTURE, V210, P1, DOI 10.1016/S0044-8486(01)00823-7; Rowan R, 1998, J PHYCOL, V34, P407, DOI 10.1046/j.1529-8817.1998.340407.x; Sims A, 2012, ECOL ENG, V40, P100, DOI 10.1016/j.ecoleng.2011.12.021; Venn AA, 2008, J EXP BOT, V59, P1069, DOI 10.1093/jxb/erm328	46	6	6	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2013	8	4							e61156	10.1371/journal.pone.0061156	http://dx.doi.org/10.1371/journal.pone.0061156			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130DR	23613802	gold, Green Published, Green Submitted			2022-12-25	WOS:000317893400045
J	Li, SX; Li, B; Jiang, HR; Wang, Y; Qu, ML; Duan, HY; Zhou, QJ; Shi, WY				Li, Suxia; Li, Bin; Jiang, Haoran; Wang, Yao; Qu, Mingli; Duan, Haoyun; Zhou, Qingjun; Shi, Weiyun			Macrophage Depletion Impairs Corneal Wound Healing after Autologous Transplantation in Mice	PLOS ONE			English	Article							ALLOGRAFT-REJECTION; DENDRITIC CELLS; GROWTH-FACTORS; IN-VITRO; NEUTROPHIL INFILTRATION; INDUCED KERATITIS; SMOOTH MUSCLE; RATS; NEOVASCULARIZATION; INFLAMMATION	Purpose: Macrophages have been shown to play a critical role in the wound healing process. In the present study, the role of macrophages in wound healing after autologous corneal transplantation was investigated by depleting local infiltrated macrophages. Methods: Autologous corneal transplantation model was used to induce wound repair in Balb/c mice. Macrophages were depleted by sub-conjunctival injections of clodronate-containing liposomes (Cl2MDP-LIP). The presence of CD11b(+) F4/80(+) macrophages, alpha-smooth muscle actin(+) (alpha-SMA(+)) myofibroblasts, CD31(+) vascular endothelial cells and NG(2)(+) pericytes was examined by immunohistochemical and corneal whole-mount staining 14 days after penetrating keratoplasty. Peritoneal macrophages were isolated from Balb/c mice and transfused into conjunctiva to examine the recovery role of macrophages depletion on wound healing after autologous corneal transplantation. Results: Sub-conjunctival Cl2MDP-LIP injection significantly depleted the corneal resident phagocytes and infiltrated macrophages into corneal stroma. Compared with the mice injected with PBS-liposome, the Cl2MDP-LIP-injected mice showed few inflammatory cells, irregularly distributed extracellular matrix, ingrowth of corneal epithelium into stroma, and even the detachment of donor cornea from recipient. Moreover, the number of macrophages, myofibroblasts, endothelial cells and pericytes was also decreased in the junction area between the donor and recipient cornea in macrophage-depleted mice. Peritoneal macrophages transfusion recovered the defect of corneal wound healing caused by macrophages depletion. Conclusions: Macrophage depletion significantly impairs wound healing after autologous corneal transplantation through at least partially impacting on angiogenesis and wound closure.	[Li, Suxia] Qingdao Univ, Qingdao 266071, Peoples R China; [Li, Suxia; Li, Bin; Jiang, Haoran; Wang, Yao; Qu, Mingli; Duan, Haoyun; Zhou, Qingjun; Shi, Weiyun] Shandong Acad Med Sci, Shandong Eye Inst, Shandong Prov Key Lab Ophthalmol, Qingdao, Peoples R China	Qingdao University; Shandong First Medical University & Shandong Academy of Medical Sciences; University of Jinan	Zhou, QJ (corresponding author), Shandong Acad Med Sci, Shandong Eye Inst, Shandong Prov Key Lab Ophthalmol, Qingdao, Peoples R China.	qjzhou2000@hotmail.com; weiyunshi@163.com			National Natural Science Foundation of China [81170816, 81170815]; Shandong Natural Science Foundation [ZR2010HQ019, ZR2012 HQ006, ZR2010HQ011]; Taishan Scholar Program, Jinan, China [20081148]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shandong Natural Science Foundation(Natural Science Foundation of Shandong Province); Taishan Scholar Program, Jinan, China	This work was partially supported by the National Natural Science Foundation of China(81170816 & 81170815) and Shandong Natural Science Foundation (ZR2010HQ019, ZR2012 HQ006, ZR2010HQ011). Weiyun Shi and Qingjun Zhou are partially supported by the Taishan Scholar Program (20081148), Jinan, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auerbach R, 2003, CLIN CHEM, V49, P32, DOI 10.1373/49.1.32; Barrientos S, 2008, WOUND REPAIR REGEN, V16, P585, DOI 10.1111/j.1524-475X.2008.00410.x; Barron L, 2011, AM J PHYSIOL-GASTR L, V300, pG723, DOI 10.1152/ajpgi.00414.2010; Baum CL, 2005, DERMATOL SURG, V31, P674; Behm B, 2012, J EUR ACAD DERMATOL, V26, P812, DOI 10.1111/j.1468-3083.2011.04415.x; Bikbova G, 2012, CURR DIABETES REV, V8, P294, DOI 10.2174/157339912800840479; Carlson EC, 2006, INVEST OPHTH VIS SCI, V47, P241, DOI 10.1167/iovs.04-0741; Carlson EC, 2007, J BIOL CHEM, V282, P35502, DOI 10.1074/jbc.M705823200; Chen L, 2007, ARCH OPHTHALMOL-CHIC, V125, P783, DOI 10.1001/archopht.125.6.783; Chinnery HR, 2008, IMMUNOLOGY, V125, P541, DOI 10.1111/j.1365-2567.2008.02868.x; Chung ES, 2009, AM J PATHOL, V175, P1984, DOI 10.2353/ajpath.2009.080515; Cunnusamy K, 2011, J IMMUNOL, V186, P6737, DOI 10.4049/jimmunol.1100101; Cursiefen C, 2004, J CLIN INVEST, V113, P1040, DOI 10.1172/JCI200420465; Daniels JT, 2000, INVEST OPHTH VIS SCI, V41, P3754; Delavary BM, 2011, IMMUNOBIOLOGY, V216, P753, DOI 10.1016/j.imbio.2011.01.001; Forbes A, 2007, J APPL PHYSIOL, V103, P637, DOI 10.1152/japplphysiol.00995.2006; Hu JZ, 2009, INVEST OPHTH VIS SCI, V50, P2087, DOI 10.1167/iovs.07-1237; Hunter MM, 2010, GASTROENTEROLOGY, V138, P1395, DOI 10.1053/j.gastro.2009.12.041; Hussain S, 2012, J LEUKOCYTE BIOL, V91, P571, DOI 10.1189/jlb.0711351; Ishida Y, 2008, J IMMUNOL, V180, P569, DOI 10.4049/jimmunol.180.1.569; Jang HS, 2008, TRANSPLANTATION, V85, P447, DOI 10.1097/TP.0b013e318160f0d1; JESTER JV, 1995, INVEST OPHTH VIS SCI, V36, P809; Jin YP, 2009, INVEST OPHTH VIS SCI, V50, P4743, DOI 10.1167/iovs.08-2462; Karamichos D, 2010, INVEST OPHTH VIS SCI, V51, P1382, DOI 10.1167/iovs.09-3860; Khallou-Laschet J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008852; Koh TJ, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399411001943; KR FA, 2005, WOUND HEAL; Kurahashi K, 2009, AM J PHYSIOL-LUNG C, V296, pL198, DOI 10.1152/ajplung.90472.2008; Kurosaka H, 1998, INVEST OPHTH VIS SCI, V39, P699; Lin M, 2007, J LEUKOCYTE BIOL, V81, P786, DOI 10.1189/jlb.0806502; Liu Y, 2002, J EXP MED, V195, P259, DOI 10.1084/jem.20010838; Lu L, 2012, AM J NEPHROL, V35, P181, DOI 10.1159/000335582; Lu PR, 2009, CORNEA, V28, P562, DOI 10.1097/ICO.0b013e3181930bcd; Lucas T, 2010, J IMMUNOL, V184, P3964, DOI 10.4049/jimmunol.0903356; MAJNO G, 1971, SCIENCE, V173, P548, DOI 10.1126/science.173.3996.548; Mast Bruce A., 1996, Wound Repair and Regeneration, V4, P411, DOI 10.1046/j.1524-475X.1996.40404.x; Murray LA, 2011, INT J BIOCHEM CELL B, V43, P154, DOI 10.1016/j.biocel.2010.10.013; Nakao S, 2007, AM J PATHOL, V171, P1058, DOI 10.2353/ajpath.2007.070172; Porcheray F, 2005, CLIN EXP IMMUNOL, V142, P481, DOI 10.1111/j.1365-2249.2005.02934.x; Probst HC, 2005, CLIN EXP IMMUNOL, V141, P398, DOI 10.1111/j.1365-2249.2005.02868.x; Qi F, 2008, TRANSPLANTATION, V86, P1267, DOI 10.1097/TP.0b013e318188d433; Schiechl G, 2011, J CLIN INVEST, V121, P1692, DOI 10.1172/JCI42540; Slegers TPAM, 2004, TRANSPLANTATION, V77, P1641, DOI 10.1097/01.TP.0000129410.89410.F2; Slegers TPAM, 2003, CURR EYE RES, V26, P73, DOI 10.1076/ceyr.26.2.73.14510; Slegers TPAM, 2000, INVEST OPHTH VIS SCI, V41, P2239; VANDERVEEN G, 1994, INVEST OPHTH VIS SCI, V35, P3505; vanKlink F, 1996, INVEST OPHTH VIS SCI, V37, P1271; VANROOIJEN N, 1994, J IMMUNOL METHODS, V174, P83; Werner S, 2003, PHYSIOL REV, V83, P835, DOI 10.1152/physrev.2003.83.3.835; West-Mays JA, 2006, INT J BIOCHEM CELL B, V38, P1625, DOI 10.1016/j.biocel.2006.03.010; Xu HP, 2007, INVEST OPHTH VIS SCI, V48, P2162, DOI 10.1167/iovs.06-0783	51	35	39	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2013	8	4							e61799	10.1371/journal.pone.0061799	http://dx.doi.org/10.1371/journal.pone.0061799			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130DR	23613940	gold, Green Submitted, Green Published			2022-12-25	WOS:000317893400112
J	Yu, HW; Fischer, G; Ferhatovic, L; Fan, F; Light, AR; Weihrauch, D; Sapunar, D; Nakai, H; Park, F; Hogan, QH				Yu, Hongwei; Fischer, Gregory; Ferhatovic, Lejla; Fan, Fan; Light, Alan R.; Weihrauch, Dorothee; Sapunar, Damir; Nakai, Hiroyuki; Park, Frank; Hogan, Quinn H.			Intraganglionic AAV6 Results in Efficient and Long-Term Gene Transfer to Peripheral Sensory Nervous System in Adult Rats	PLOS ONE			English	Article							ADENOASSOCIATED VIRAL VECTORS; DORSAL-ROOT GANGLION; VIRUS SEROTYPE 6; NOCICEPTIVE NEURONS; SPINAL-CORD; INTRATHECAL INJECTION; TRANSGENE EXPRESSION; IMMUNE-RESPONSES; NEUROPATHIC PAIN; DIFFERENT ROUTES	We previously demonstrated safe and reliable gene transfer to the dorsal root ganglion (DRG) using a direct microinjection procedure to deliver recombinant adeno-associated virus (AAV) vector. In this study, we proceed to compare the in vivo transduction patterns of self-complementary (sc) AAV6 and AAV8 in the peripheral sensory pathway. A single, direct microinjection of either AAV6 or AAV8 expressing EGFP, at the adjusted titer of 2 x 10(9) viral particle per DRG, into the lumbar (L) 4 and L5 DRGs of adult rats resulted in efficient EGFP expression (48 +/- 20% for AAV6 and 25 +/- 4% for AAV8, mean +/- SD) selectively in sensory neurons and their axonal projections 3 weeks after injection, which remained stable for up to 3 months. AAV6 efficiently transfers EGFP to all neuronal size groups without differential neurotropism, while AAV8 predominantly targets large-sized neurons. Neurons transduced with AAV6 penetrate into the spinal dorsal horn (DH) and terminate predominantly in superficial DH laminae, as well as in the dorsal columns and deeper laminae III-V. Only few AAV8-transduced afferents were evident in the superficial laminae, and spinal EGFP was mostly present in the deeper dorsal horn (lamina III-V) and dorsal columns, with substantial projections to the ventral horn. AAV6-mediated EGFP-positive nerve fibers were widely observed in the medial plantar skin of ipsilateral hindpaws. No apparent inflammation, tissue damage, or major pain behaviors were observed for either AAV serotype. Taken together, both AAV6 and AAV8 are efficient and safe vectors for transgene delivery to primary sensory neurons, but they exhibit distinct functional features. Intraganglionic delivery of AAV6 is more uniform and efficient compared to AAV8 in gene transfer to peripheral sensory neurons and their axonal processes.	[Yu, Hongwei; Fischer, Gregory; Weihrauch, Dorothee; Hogan, Quinn H.] Med Coll Wisconsin, Dept Anesthesiol, Milwaukee, WI 53226 USA; [Ferhatovic, Lejla; Sapunar, Damir] Univ Split, Sch Med, Dept Anat Histol & Embryol, Split, Croatia; [Fan, Fan] Univ Mississippi, Med Ctr, Dept Pharmacol & Toxicol, Jackson, MS 39216 USA; [Light, Alan R.] Univ Utah, Dept Anesthesiol, Salt Lake City, UT USA; [Light, Alan R.] Univ Utah, Dept Neurobiol, Salt Lake City, UT USA; [Light, Alan R.] Univ Utah, Dept Anat, Salt Lake City, UT USA; [Nakai, Hiroyuki] Oregon Hlth & Sci Univ, Portland, OR 97201 USA; [Park, Frank] Med Coll Wisconsin, Dept Physiol & Med, Milwaukee, WI 53226 USA; [Hogan, Quinn H.] Zablocki Vet Affairs Med Ctr, Milwaukee, WI USA	Medical College of Wisconsin; University of Split; University of Mississippi; University of Mississippi Medical Center; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Oregon Health & Science University; Medical College of Wisconsin	Yu, HW (corresponding author), Med Coll Wisconsin, Dept Anesthesiol, Milwaukee, WI 53226 USA.	hyu@mcw.edu	Yu, Hongwei/L-3754-2017; Park, Frank/I-4590-2019; Sapunar, Damir/E-7247-2010	Yu, Hongwei/0000-0002-5607-0628; Park, Frank/0000-0003-2324-2937; Sapunar, Damir/0000-0002-8352-4402	VA Rehabilitation Research and Development [3690-03]	VA Rehabilitation Research and Development	This study was funded in part by the VA Rehabilitation Research and Development grant 3690-03 (//www.research.va.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Asokan A, 2012, MOL THER, V20, P699, DOI 10.1038/mt.2011.287; Ayuso E, 2010, GENE THER, V17, P503, DOI 10.1038/gt.2009.157; Belmonte C, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-14; Beutler AS, 2009, GENE THER, V16, P461, DOI 10.1038/gt.2009.23; Beutler AS, 2010, MOL THER, V18, P670, DOI 10.1038/mt.2010.41; Beutler AS, 2005, CURR OPIN MOL THER, V7, P431; Bevan AK, 2011, MOL THER, V19, P1971, DOI 10.1038/mt.2011.157; Boutin S, 2010, HUM GENE THER, V21, P704, DOI 10.1089/hum.2009.182; Chen J, 2006, MOL THER, V13, P260, DOI 10.1016/j.ymthe.2005.10.006; Cordier L, 2001, HUM GENE THER, V12, P205, DOI 10.1089/104303401750061267; Davidson BL, 2003, NAT REV NEUROSCI, V4, P353, DOI 10.1038/nrn1104; DIXON WJ, 1980, ANNU REV PHARMACOL, V20, P441, DOI 10.1146/annurev.pa.20.040180.002301; Fang X, 2005, J NEUROSCI, V25, P4868, DOI 10.1523/JNEUROSCI.0249-05.2005; Federici T, 2012, GENE THER, V19, P852, DOI 10.1038/gt.2011.130; Fischer G, 2011, J NEUROSCI METH, V199, P43, DOI 10.1016/j.jneumeth.2011.04.021; Glatzel W, 2000, P NATL ACAD SCI USA, V97, P442, DOI 10.1073/pnas.97.1.442; Grieger JC, 2006, NAT PROTOC, V1, P1412, DOI 10.1038/nprot.2006.207; Hammond DL, 2004, J COMP NEUROL, V475, P575, DOI 10.1002/cne.20209; Hirai T, 2012, HUM GENE THER METHOD, V23, P119, DOI 10.1089/hgtb.2012.035; Hogan Q, 2004, ANESTHESIOLOGY, V101, P476, DOI 10.1097/00000542-200408000-00030; Hollis ER, 2010, MOL THER, V18, P1496, DOI 10.1038/mt.2010.97; Homs J, 2011, GENE THER, V18, P622, DOI 10.1038/gt.2011.7; Hunt SP, 2001, NAT REV NEUROSCI, V2, P83, DOI 10.1038/35053509; Iwamoto N, 2009, J GENE MED, V11, P498, DOI 10.1002/jgm.1325; Jacques SJ, 2012, MOL CELL NEUROSCI, V49, P464, DOI 10.1016/j.mcn.2012.03.002; Jooss K, 1998, J VIROL, V72, P4212, DOI 10.1128/JVI.72.5.4212-4223.1998; Julius D, 2001, NATURE, V413, P203, DOI 10.1038/35093019; Kim J, 2009, BIOCHEM BIOPH RES CO, V388, P73, DOI 10.1016/j.bbrc.2009.07.120; Klein RL, 2008, MOL THER, V16, P89, DOI 10.1038/sj.mt.6300331; Lin SW, 2007, J CLIN INVEST, V117, P3958, DOI 10.1172/JCI33138; Lock M, 2010, HUM GENE THER, V21, P1259, DOI 10.1089/hum.2010.055; Martino AT, 2011, BLOOD, V117, P6459, DOI 10.1182/blood-2010-10-314518; Mason MRJ, 2010, MOL THER, V18, P715, DOI 10.1038/mt.2010.19; Mingozzi F, 2009, BLOOD, V114, P2077, DOI 10.1182/blood-2008-07-167510; Pfirrmann CWA, 2001, RADIOLOGY, V221, P704, DOI 10.1148/radiol.2213001635; Qu G, 2007, J VIROL METHODS, V140, P183, DOI 10.1016/j.jviromet.2006.11.019; Rapti K, 2012, MOL THER, V20, P73, DOI 10.1038/mt.2011.177; Rogers GL, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00194; Ruscheweyh R, 2007, J COMP NEUROL, V502, P325, DOI 10.1002/cne.21311; Samad OA, 2012, MOL THERAPY J AM SOC; SAMULSKI RJ, 1989, J VIROL, V63, P3822, DOI 10.1128/JVI.63.9.3822-3828.1989; Schaffer DV, 2008, ANNU REV BIOMED ENG, V10, P169, DOI 10.1146/annurev.bioeng.10.061807.160514; Snyder BR, 2011, HUM GENE THER, V22, P1129, DOI 10.1089/hum.2011.008; Sommer JM, 2003, MOL THER, V7, P122, DOI 10.1016/S1525-0016(02)00019-9; Storek B, 2008, P NATL ACAD SCI USA, V105, P1055, DOI 10.1073/pnas.0708003105; Sun J, 2009, DNA CELL BIOL, V28, P233, DOI 10.1089/dna.2009.0862; Todd A. J., 2006, WALL MELZACKS TXB PA, P73; Towne C, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-52; Tsujino H, 2000, MOL CELL NEUROSCI, V15, P170, DOI 10.1006/mcne.1999.0814; Urabe M, 2006, MOL THER, V13, P823, DOI 10.1016/j.ymthe.2005.11.024; Ussher JE, 2010, HUM GENE THER, V21, P1675, DOI 10.1089/hum.2010.087; Van Vliet Kim M., 2008, V437, P51, DOI 10.1007/978-1-59745-210-6_2; Vasileva A, 2005, NAT REV MICROBIOL, V3, P837, DOI 10.1038/nrmicro1266; Vulchanova L, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-31; Wang Z, 2003, GENE THER, V10, P2105, DOI 10.1038/sj.gt.3302133; Weeratna RD, 2001, GENE THER, V8, P1872, DOI 10.1038/sj.gt.3301602; Wright JF, 2008, GENE THER, V15, P840, DOI 10.1038/gt.2008.65; Wu HE, 2010, J PAIN, V11, P280, DOI 10.1016/j.jpain.2009.07.011; Xu QH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032581; Xu Y, 2003, P NATL ACAD SCI USA, V100, P6204, DOI 10.1073/pnas.0930324100; Xu Y, 2003, HUM GENE THER, V14, P897, DOI 10.1089/104303403765701187; Yu HW, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-63; Zeltner N, 2010, GENE THER, V17, P872, DOI 10.1038/gt.2010.27; Zolotukhin S, 1999, GENE THER, V6, P973, DOI 10.1038/sj.gt.3300938	64	19	20	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2013	8	4							e61266	10.1371/journal.pone.0061266	http://dx.doi.org/10.1371/journal.pone.0061266			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130DR	23613824	Green Published, Green Submitted, gold			2022-12-25	WOS:000317893400053
J	Aparicio, R; Neyen, C; Lemaitre, B; Busturia, A				Aparicio, Ricardo; Neyen, Claudine; Lemaitre, Bruno; Busturia, Ana			dRYBP Contributes to the Negative Regulation of the Drosophila Imd Pathway	PLOS ONE			English	Article							PEPTIDOGLYCAN RECOGNITION PROTEIN; DEATH EFFECTOR DOMAIN; KAPPA-B KINASE; IMMUNE-RESPONSE; BACTERIAL-INFECTION; ANTIBACTERIAL IMMUNITY; INDUCIBLE EXPRESSION; INNATE IMMUNITY; CASPASE DREDD; FACTOR RELISH	The Drosophila humoral innate immune response fights infection by producing antimicrobial peptides (AMPs) through the microbe-specific activation of the Toll or the Imd signaling pathway. Upon systemic infection, the production of AMPs is both positively and negatively regulated to reach a balanced immune response required for survival. Here, we report the function of the dRYBP (drosophila Ring and YY1 Binding Protein) protein, which contains a ubiquitin-binding domain, in the Imd pathway. We have found that dRYBP contributes to the negative regulation of AMP production: upon systemic infection with Gram-negative bacteria, Diptericin expression is up-regulated in the absence of dRYBP and down-regulated in the presence of high levels of dRYBP. Epistatic analyses using gain and loss of function alleles of imd, Relish, or skpA and dRYBP suggest that dRYBP functions upstream or together with SKPA, a member of the SCF-E3-ubiquitin ligase complex, to repress the Imd signaling cascade. We propose that the role of dRYBP in the regulation of the Imd signaling pathway is to function as a ubiquitin adaptor protein together with SKPA to promote SCF-dependent proteasomal degradation of Relish. Beyond the identification of dRYBP as a novel component of Imd pathway regulation, our results also suggest that the evolutionarily conserved RYBP protein may be involved in the human innate immune response.	[Aparicio, Ricardo; Busturia, Ana] CSIC, Ctr Biol Mol Severo Ochoa, Madrid, Spain; [Aparicio, Ricardo; Busturia, Ana] Univ Autonoma Madrid, Madrid, Spain; [Neyen, Claudine; Lemaitre, Bruno] Ecole Polytech Fed Lausanne, Global Hlth Inst, Sch Life Sci, Lausanne, Switzerland	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Autonomous University of Madrid; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Busturia, A (corresponding author), CSIC, Ctr Biol Mol Severo Ochoa, Madrid, Spain.	abusturia@cbm.uam.es	Lemaitre, Bruno/T-8146-2019	Lemaitre, Bruno/0000-0001-7970-1667; Aparicio, Ricardo/0000-0003-3670-0466; Neyen, Claudine/0000-0002-9870-5548	Direccion General de Investigacion [BFU2008-01154]; Program of the Ministerio de Ciencia e Innovacion [CSD 2007-00008]; Fundacion Ramon Areces to the Centro de Biologia Molecular Severo Ochoa; National Research Fund Luxembourg (AFR) [08/037]; Bettencourt-Schueller Foundation; ERC Advanced Grant; Swiss National Fund [3100A0-12079/1]	Direccion General de Investigacion(Spanish Government); Program of the Ministerio de Ciencia e Innovacion; Fundacion Ramon Areces to the Centro de Biologia Molecular Severo Ochoa; National Research Fund Luxembourg (AFR)(Luxembourg National Research Fund); Bettencourt-Schueller Foundation; ERC Advanced Grant(European Research Council (ERC)); Swiss National Fund(Swiss National Science Foundation (SNSF))	This work was supported by grants from the Direccion General de Investigacion (BFU2008-01154) to A. B, the Consolider Ingenio 2010 Program of the Ministerio de Ciencia e Innovacion (CSD 2007-00008) to A. B., by an institutional grant from the Fundacion Ramon Areces to the Centro de Biologia Molecular Severo Ochoa, by the National Research Fund Luxembourg (AFR Postdoctoral Grant 08/037) to C.N., by the Bettencourt-Schueller Foundation to B. L., by the ERC Advanced Grant to C.N. and B. L., and the Swiss National Fund (3100A0-12079/1) to B. L. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal K, 2008, BMB REP, V41, P267, DOI 10.5483/BMBRep.2008.41.4.267; Aggarwal K, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000120; Arrigoni R, 2006, FEBS LETT, V580, P6233, DOI 10.1016/j.febslet.2006.10.027; Beinke S, 2002, J BIOL CHEM, V277, P24162, DOI 10.1074/jbc.M201576200; Bejarano F, 2005, MECH DEVELOP, V122, P1118, DOI 10.1016/j.mod.2005.06.001; Bocca SN, 2001, BIOCHEM BIOPH RES CO, V286, P357, DOI 10.1006/bbrc.2001.5394; Charroux B, 2010, FLY, V4, P40, DOI 10.4161/fly.4.1.10810; Chinchore Y, 2012, P NATL ACAD SCI USA, V109, pE605, DOI 10.1073/pnas.1110666109; Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; Choe KM, 2002, SCIENCE, V296, P359, DOI 10.1126/science.1070216; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; Danen-van Oorschot AAAM, 2004, CELL DEATH DIFFER, V11, P564, DOI 10.1038/sj.cdd.4401391; De Gregorio E, 2001, P NATL ACAD SCI USA, V98, P12590, DOI 10.1073/pnas.221458698; De Gregorio E, 2002, EMBO J, V21, P2568, DOI 10.1093/emboj/21.11.2568; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Dushay MS, 2000, GENE, V246, P49, DOI 10.1016/S0378-1119(00)00041-X; Ferrandon D, 2007, NAT REV IMMUNOL, V7, P862, DOI 10.1038/nri2194; Garcia E, 1999, EMBO J, V18, P3404, DOI 10.1093/emboj/18.12.3404; Georgel P, 2001, DEV CELL, V1, P503, DOI 10.1016/S1534-5807(01)00059-4; Gonzalez I, 2008, GENETICS, V179, P1373, DOI 10.1534/genetics.107.082966; Gonzalez I, 2009, CELL RES, V19, P747, DOI 10.1038/cr.2009.29; Gottar M, 2002, NATURE, V416, P640, DOI 10.1038/nature734; Guntermann S, 2009, DEV COMP IMMUNOL, V33, P127, DOI 10.1016/j.dci.2008.07.021; Hatakeyama S, 1999, P NATL ACAD SCI USA, V96, P3859, DOI 10.1073/pnas.96.7.3859; Hattori K, 1999, J BIOL CHEM, V274, P29641, DOI 10.1074/jbc.274.42.29641; Hedengren M, 1999, MOL CELL, V4, P827, DOI 10.1016/S1097-2765(00)80392-5; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Khush RS, 2002, CURR BIOL, V12, P1728, DOI 10.1016/S0960-9822(02)01214-9; Kim M, 2006, P NATL ACAD SCI USA, V103, P16358, DOI 10.1073/pnas.0603238103; Kleino A, 2008, J IMMUNOL, V180, P5413, DOI 10.4049/jimmunol.180.8.5413; Kwon D, 2012, NUCLEIC ACIDS RES, V40, pD331, DOI 10.1093/nar/gkr1149; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Leulier F, 2000, EMBO REP, V1, P353, DOI 10.1093/embo-reports/kvd073; Leulier F, 2003, NAT IMMUNOL, V4, P478, DOI 10.1038/ni922; Leulier F, 2002, CURR BIOL, V12, P996, DOI 10.1016/S0960-9822(02)00873-4; Leulier F, 2006, MOL CELL BIOL, V26, P7821, DOI 10.1128/MCB.00548-06; Lhocine N, 2008, CELL HOST MICROBE, V4, P147, DOI 10.1016/j.chom.2008.07.004; Lu YR, 2001, GENE DEV, V15, P104, DOI 10.1101/gad.856901; Maillet F, 2008, CELL HOST MICROBE, V3, P293, DOI 10.1016/j.chom.2008.04.002; Meinander A, 2012, EMBO J, V31, P2770, DOI 10.1038/emboj.2012.121; Naitza S, 2002, IMMUNITY, V17, P575, DOI 10.1016/S1074-7613(02)00454-5; Novak RL, 2008, CANCER GENE THER, V15, P713, DOI 10.1038/cgt.2008.25; Paquette N, 2010, MOL CELL, V37, P172, DOI 10.1016/j.molcel.2009.12.036; Paredes JC, 2011, IMMUNITY, V35, P770, DOI 10.1016/j.immuni.2011.09.018; Park HH, 2007, ANNU REV IMMUNOL, V25, P561, DOI 10.1146/annurev.immunol.25.022106.141656; Pirity MK, 2005, MOL CELL BIOL, V25, P7193, DOI 10.1128/MCB.25.16.7193-7202.2005; Schickling O, 2001, CELL DEATH DIFFER, V8, P1157, DOI 10.1038/sj.cdd.4400928; Schlisio S, 2002, EMBO J, V21, P5775, DOI 10.1093/emboj/cdf577; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; Schwartz YB, 2007, NAT REV GENET, V8, P9, DOI 10.1038/nrg1981; Shembade N, 2009, EMBO J, V28, P513, DOI 10.1038/emboj.2008.285; Silverman N, 2000, GENE DEV, V14, P2461, DOI 10.1101/gad.817800; Stoven S, 2000, EMBO REP, V1, P347, DOI 10.1093/embo-reports/kvd072; Thevenon D, 2009, CELL HOST MICROBE, V6, P309, DOI 10.1016/j.chom.2009.09.007; Tsichritzis T, 2007, DEVELOPMENT, V134, P2605, DOI 10.1242/dev.02859; Tsuda M, 2005, EMBO REP, V6, P1082, DOI 10.1038/sj.embor.7400537; Tzou P, 2000, IMMUNITY, V13, P737, DOI 10.1016/S1074-7613(00)00072-8; Uvell H, 2007, TRENDS GENET, V23, P342, DOI 10.1016/j.tig.2007.05.003; WICKER C, 1990, J BIOL CHEM, V265, P22493; Willems AR, 1999, PHILOS T ROY SOC B, V354, P1533, DOI 10.1098/rstb.1999.0497; Zaidman-Remy A, 2006, IMMUNITY, V24, P463, DOI 10.1016/j.immuni.2006.02.012; Zheng LX, 2001, J BIOL CHEM, V276, P31945, DOI 10.1074/jbc.M102799200; Zhou R, 2005, J BIOL CHEM, V280, P34048, DOI 10.1074/jbc.M506655200	63	24	27	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2013	8	4							e62052	10.1371/journal.pone.0062052	http://dx.doi.org/10.1371/journal.pone.0062052			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125TD	23596533	Green Published, gold			2022-12-25	WOS:000317563300047
J	Elfert, S; Weise, A; Bruser, K; Biniossek, ML; Jagle, S; Senghaas, N; Hecht, A				Elfert, Susanne; Weise, Andreas; Bruser, Katja; Biniossek, Martin L.; Jaegle, Sabine; Senghaas, Niklas; Hecht, Andreas			Acetylation of Human TCF4 (TCF7L2) Proteins Attenuates Inhibition by the HBP1 Repressor and Induces a Conformational Change in the TCF4:: DNA Complex	PLOS ONE			English	Article							TRANSCRIPTION FACTOR HBP1; BETA-CATENIN; DEPENDENT PHOSPHORYLATION; MASS-SPECTROMETRY; BINDING PROTEIN; GENE-EXPRESSION; C-MYC; CBP; TARGET; P300	The members of the TCF/LEF family of DNA-binding proteins are components of diverse gene regulatory networks. As nuclear effectors of Wnt/beta-catenin signaling they act as assembly platforms for multimeric transcription complexes that either repress or activate gene expression. Previously, it was shown that several aspects of TCF/LEF protein function are regulated by post-translational modification. The association of TCF/LEF family members with acetyltransferases and deacetylases prompted us to investigate whether vertebrate TCF/LEF proteins are subject to acetylation. Through co-expression with p300 and CBP and subsequent analyses using mass spectrometry and immunodetection with anti-acetyllysine antibodies we show that TCF4 can be acetylated at lysine K-150 by CBP. K-150 acetylation is restricted to TCF4E splice variants and requires the simultaneous presence of beta-catenin and the unique TCF4E C-terminus. To examine the functional consequences of K-150 acetylation we substituted K-150 with amino acids representing the non-acetylated and acetylated states. Reporter gene assays based on Wnt/beta-catenin-responsive promoter regions did not indicate a general role of K-150 acetylation in transactivation by TCF4E. However, in the presence of CBP, non-acetylatable TCF4E with a K150R substitution was more susceptible to inhibition by the HBP-1 repressor protein compared to wild-type TCF4E. Acetylation of K-150 using a bacterial expression system or amino acid substitutions at K-150 alter the electrophoretic properties of TCF4E:: DNA complexes. This result suggests that K-150 acetylation leads to a conformational change that may also represent the mechanism whereby acetylated TCF4E acquires resistance against HBP1. In summary, TCF4 not only recruits acetyltransferases but is also a substrate for these enzymes. The fact that acetylation affects only a subset of TCF4 splice variants and is mediated preferentially by CBP suggests that the conditional acetylation of TCF4E is a novel regulatory mechanism that diversifies the transcriptional output of Wnt/b-catenin signaling in response to changing intracellular signaling milieus.	[Elfert, Susanne; Weise, Andreas; Bruser, Katja; Biniossek, Martin L.; Jaegle, Sabine; Senghaas, Niklas; Hecht, Andreas] Univ Freiburg, Inst Mol Med & Cell Res, D-79106 Freiburg, Germany; [Jaegle, Sabine; Senghaas, Niklas; Hecht, Andreas] Univ Freiburg, Fac Biol, D-79106 Freiburg, Germany; [Hecht, Andreas] Univ Freiburg, BIOSS Ctr Biol Signalling Studies, Freiburg, Germany	University of Freiburg; University of Freiburg; University of Freiburg	Hecht, A (corresponding author), Univ Freiburg, Inst Mol Med & Cell Res, Hugstetter Str 55, D-79106 Freiburg, Germany.	andreas.hecht@mol-med.uni-freiburg.de		Hecht, Andreas/0000-0003-2262-2575	German Research Foundation (Deutsche Forschungsgemeinschaft, DFG) [He2004/8-1, CRC-850/B5]; Albert-Ludwigs-University Freiburg (Open Access Publishing program)	German Research Foundation (Deutsche Forschungsgemeinschaft, DFG)(German Research Foundation (DFG)); Albert-Ludwigs-University Freiburg (Open Access Publishing program)	This work was supported by the German Research Foundation (Deutsche Forschungsgemeinschaft, DFG;http://www.dfg.de) grant He2004/8-1 and CRC-850/B5 to AH. Publication fees for this article were covered by funding from the DFG and the Albert-Ludwigs-University Freiburg (Open Access Publishing program; http://www.ub.uni-freiburg.de/go/oapf). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arce L, 2006, ONCOGENE, V25, P7492, DOI 10.1038/sj.onc.1210056; Archbold HC, 2012, ACTA PHYSIOL, V204, P74, DOI 10.1111/j.1748-1716.2011.02293.x; Atcha FA, 2007, MOL CELL BIOL, V27, P8352, DOI 10.1128/MCB.02132-06; Aulehla A, 2003, DEV CELL, V4, P395, DOI 10.1016/S1534-5807(03)00055-8; Bedford DC, 2010, EPIGENETICS-US, V5, P9, DOI 10.4161/epi.5.1.10449; Berasi SP, 2004, MOL CELL BIOL, V24, P3011, DOI 10.1128/MCB.24.7.3011-3024.2004; Billin AN, 2000, MOL CELL BIOL, V20, P6882, DOI 10.1128/MCB.20.18.6882-6890.2000; Black JC, 2006, MOL CELL, V23, P809, DOI 10.1016/j.molcel.2006.07.018; BLUM H, 1987, ELECTROPHORESIS, V8, P93, DOI 10.1002/elps.1150080203; Brunner E, 1997, NATURE, V385, P829, DOI 10.1038/385829a0; Ceschin DG, 2011, GENE DEV, V25, P1132, DOI 10.1101/gad.619211; Chang MV, 2008, CURR BIOL, V18, P1877, DOI 10.1016/j.cub.2008.10.047; Chen YC, 2010, ONCOGENE, V29, P3067, DOI 10.1038/onc.2010.97; Duval A, 2000, CANCER RES, V60, P3872; ECKNER R, 1994, GENE DEV, V8, P869, DOI 10.1101/gad.8.8.869; Escamilla-Powers JR, 2010, J BIOL CHEM, V285, P4847, DOI 10.1074/jbc.M109.074856; Galceran J, 1999, GENE DEV, V13, P709, DOI 10.1101/gad.13.6.709; Gay F, 2003, GENE DEV, V17, P717, DOI 10.1101/gad.1042403; Gregorieff A, 2004, EMBO J, V23, P1825, DOI 10.1038/sj.emboj.7600191; GROSSCHEDL R, 1994, TRENDS GENET, V10, P94, DOI 10.1016/0168-9525(94)90232-1; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Hecht A, 2000, EMBO J, V19, P1839, DOI 10.1093/emboj/19.8.1839; Hecht A, 2003, J BIOL CHEM, V278, P3776, DOI 10.1074/jbc.M210081200; Henderson BR, 2002, J BIOL CHEM, V277, P24258, DOI 10.1074/jbc.M110602200; Hikasa H, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.185280; Hikasa H, 2010, DEV CELL, V19, P521, DOI 10.1016/j.devcel.2010.09.005; Hoppler S, 2007, J CELL SCI, V120, P385, DOI 10.1242/jcs.03363; Howng SL, 2004, INT J ONCOL, V25, P1685; Ishitani T, 2003, MOL CELL BIOL, V23, P1379, DOI 10.1128/MCB.23.4.1379-1389.2003; Kalkhoven E, 2004, BIOCHEM PHARMACOL, V68, P1145, DOI 10.1016/j.bcp.2004.03.045; Korinek V, 1998, NAT GENET, V19, P379, DOI 10.1038/1270; Kumar SR, 2009, CANCER RES, V69, P3736, DOI 10.1158/0008-5472.CAN-08-3232; Levy L, 2004, MOL CELL BIOL, V24, P3404, DOI 10.1128/MCB.24.8.3404-3414.2004; Leymarie N, 2002, ANAL CHEM, V74, P4124, DOI 10.1021/ac0255835; Li H, 2010, ONCOGENE, V29, P5083, DOI 10.1038/onc.2010.252; Li HL, 2011, BREAST CANCER RES TR, V126, P565, DOI 10.1007/s10549-010-0954-4; Li J, 2007, EMBO J, V26, P2284, DOI 10.1038/sj.emboj.7601667; Lickert H, 2000, DEVELOPMENT, V127, P3805; LIN RL, 1995, CELL, V83, P599, DOI 10.1016/0092-8674(95)90100-0; Liu F, 2005, DEVELOPMENT, V132, P5375, DOI 10.1242/dev.02152; Love JJ, 2004, BIOCHEMISTRY-US, V43, P8725, DOI 10.1021/bi049591m; Ma H, 2005, ONCOGENE, V24, P3619, DOI 10.1038/sj.onc.1208433; Mahmoudi T, 2009, EMBO J, V28, P3329, DOI 10.1038/emboj.2009.285; Merrill BJ, 2004, DEVELOPMENT, V131, P263, DOI 10.1242/dev.00935; Miyabayashi T, 2007, P NATL ACAD SCI USA, V104, P5668, DOI 10.1073/pnas.0701331104; Miyagishi M, 2000, J BIOL CHEM, V275, P35170, DOI 10.1074/jbc.C000258200; Mohan RD, 2010, NUCLEIC ACIDS RES, V38, P1135, DOI 10.1093/nar/gkp1097; Mosimann C, 2009, NAT REV MOL CELL BIO, V10, P276, DOI 10.1038/nrm2654; Najdi R, 2009, ONCOGENE, V28, P4133, DOI 10.1038/onc.2009.271; Nazwar TA, 2009, J NEUROSCI RES, V87, P1532, DOI 10.1002/jnr.21989; Neumann H, 2009, MOL CELL, V36, P153, DOI 10.1016/j.molcel.2009.07.027; Nguyen H, 2009, NAT GENET, V41, P1068, DOI 10.1038/ng.431; Olsen JV, 2004, MOL CELL PROTEOMICS, V3, P608, DOI 10.1074/mcp.T400003-MCP200; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Roel G, 2002, CURR BIOL, V12, P1941, DOI 10.1016/S0960-9822(02)01280-0; Sachdev S, 2001, GENE DEV, V15, P3088, DOI 10.1101/gad.944801; Sampson EM, 2001, EMBO J, V20, P4500, DOI 10.1093/emboj/20.16.4500; Shiina H, 2003, CLIN CANCER RES, V9, P2121; Shitashige M, 2010, CANCER RES, V70, P5024, DOI 10.1158/0008-5472.CAN-10-0306; Sun YN, 2000, P NATL ACAD SCI USA, V97, P12613, DOI 10.1073/pnas.220158597; Takemaru KI, 2000, J CELL BIOL, V149, P249, DOI 10.1083/jcb.149.2.249; Teo JL, 2010, ADV DRUG DELIVER REV, V62, P1149, DOI 10.1016/j.addr.2010.09.012; Tevosian SG, 1997, GENE DEV, V11, P383, DOI 10.1101/gad.11.3.383; TURNER DL, 1994, GENE DEV, V8, P1434, DOI 10.1101/gad.8.12.1434; Valenta T, 2003, NUCLEIC ACIDS RES, V31, P2369, DOI 10.1093/nar/gkg346; vandeWetering M, 1996, MOL CELL BIOL, V16, P745; vandeWetering M, 1997, CELL, V88, P789, DOI 10.1016/S0092-8674(00)81925-X; VANGENDEREN C, 1994, GENE DEV, V8, P2691, DOI 10.1101/gad.8.22.2691; VERBEEK S, 1995, NATURE, V374, P70, DOI 10.1038/374070a0; Waltzer L, 1998, NATURE, V395, P521, DOI 10.1038/26785; Wang WB, 2012, NUCLEIC ACIDS RES, V40, P981, DOI 10.1093/nar/gkr818; Weise A, 2010, NUCLEIC ACIDS RES, V38, P1964, DOI 10.1093/nar/gkp1197; Wolf D, 2002, J BIOL CHEM, V277, P25562, DOI 10.1074/jbc.M201196200; Yamada M, 2006, J BIOL CHEM, V281, P20749, DOI 10.1074/jbc.M602089200; Yamamoto H, 2003, EMBO J, V22, P2047, DOI 10.1093/emboj/cdg204; Yang XJ, 2008, MOL CELL, V31, P449, DOI 10.1016/j.molcel.2008.07.002; Yao CJ, 2005, LEUKEMIA, V19, P1958, DOI 10.1038/sj.leu.2403918; Ye F, 2009, NAT NEUROSCI, V12, P829, DOI 10.1038/nn.2333; Zhuma T, 1999, EMBO J, V18, P6396, DOI 10.1093/emboj/18.22.6396	79	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2013	8	4							e61867	10.1371/journal.pone.0061867	http://dx.doi.org/10.1371/journal.pone.0061867			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125TD	23613959	gold, Green Published, Green Submitted			2022-12-25	WOS:000317563300041
J	Kramer, BH; Schaible, R				Kramer, Boris H.; Schaible, Ralf			Life Span Evolution in Eusocial Workers-A Theoretical Approach to Understanding the Effects of Extrinsic Mortality in a Hierarchical System	PLOS ONE			English	Article							DIVISION-OF-LABOR; SOCIAL INSECTS; AGE POLYETHISM; HONEY-BEE; ANT; LONGEVITY; REPRODUCTION; HYMENOPTERA; QUEENS; GROWTH	While the extraordinary life span of queens and division of labor in eusocial societies have been well studied, it is less clear which selective forces act on the short life span of workers. The disparity of life span between the queen and the workers is linked to a basic issue in sociobiology: How are the resources in a colony allocated between colony maintenance and reproduction? Resources for somatic maintenance of the colony can either be invested into quality or quantity of workers. Here, we present a theoretical optimization model that uses a hierarchical trade-off within insect colonies and extrinsic mortality to explain how different aging phenotypes could have evolved to keep resources secure in the colony. The model points to the significance of two factors. First, any investment that would generate a longer intrinsic life span for workers is lost if the individual dies from external causes while foraging. As a consequence, risky environments favor the evolution of workers with a shorter life span. Second, shorter-lived workers require less investment than long-lived ones, allowing the colony to allocate these resources to sexual reproduction or colony growth.	[Kramer, Boris H.; Schaible, Ralf] Max Planck Inst Demog Res, Lab Evolutionary Biodemog, Rostock, Mecklenburg Wes, Germany	Max Planck Society	Kramer, BH (corresponding author), Max Planck Inst Demog Res, Lab Evolutionary Biodemog, Rostock, Mecklenburg Wes, Germany.	kramer@demogr.mpg.de	Kramer, Boris/AAO-3183-2021		Max-Planck-Institute	Max-Planck-Institute(Foundation CELLEX)	The Max-Planck-Institute for Demographic Research funded this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amdam GV, 2005, AGEING RES REV, V4, P398, DOI 10.1016/j.arr.2005.03.007; Amdam GV, 2004, EXP GERONTOL, V39, P767, DOI 10.1016/j.exger.2004.02.010; Amdam GV, 2002, J THEOR BIOL, V216, P209, DOI 10.1006/jtbi.2002.2545; Anderson C, 2001, BEHAV ECOL, V12, P534, DOI 10.1093/beheco/12.5.534; Batra S. W. T., 1966, Indian Journal of Entomology, V28, P375; Boomsma JJ, 2009, PHILOS T R SOC B, V364, P3191, DOI 10.1098/rstb.2009.0101; BOURKE AFG, 1988, Q REV BIOL, V63, P291, DOI 10.1086/415930; Bourke AFG, 2007, ANNU REV ECOL EVOL S, V38, P103, DOI 10.1146/annurev.ecolsys.38.091206.095528; Brian M. V., 1978, PRODUCTION ECOLOGY A; CALABI P, 1989, J INSECT PHYSIOL, V35, P643, DOI 10.1016/0022-1910(89)90127-3; Carey James R., 2000, P1; Carey JR, 2001, EXP GERONTOL, V36, P713, DOI 10.1016/S0531-5565(00)00237-0; Chapuisat M, 2002, P ROY SOC B-BIOL SCI, V269, P909, DOI 10.1098/rspb.2002.1962; Chittka Lars, 2009, Communicative & Integrative Biology, V2, P151; Evans JD, 1999, P NATL ACAD SCI USA, V96, P5575, DOI 10.1073/pnas.96.10.5575; FRANKS NR, 1993, ANIM BEHAV, V45, P197, DOI 10.1006/anbe.1993.1021; GADGIL M, 1970, American Naturalist, V104, P1, DOI 10.1086/282637; Galliot B, 2002, INT J DEV BIOL, V46, P39; Gompertz B, 1825, PHILOS T ROY SOC LON, V31, P513, DOI [10.1098/rstl.1825.0026, DOI 10.1098/RSTL.1825.0026]; Gorbunova V, 2008, AGE, V30, P111, DOI 10.1007/s11357-008-9053-4; GREENE A, 1984, J KANSAS ENTOMOL SOC, V57, P545; Hartmann A, 2003, EVOLUTION, V57, P2424, DOI 10.1111/j.0014-3820.2003.tb00254.x; Heinze J, 2008, GERONTOLOGY, V54, P160, DOI 10.1159/000122472; Heylighen F, 2000, COMPLEXITY, V6; Hoelldobler B., 2008, SUPERORGANISM BEAUTY, Vi, P1; Hoffman EA, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-23; HOLLDOBLER B, 1977, NATURWISSENSCHAFTEN, V64, P8, DOI 10.1007/BF00439886; Holldobler B., 1990, pi; HOLMES DJ, 1994, J MAMMAL, V75, P224, DOI 10.2307/1382255; JEANNE RL, 1986, MONIT ZOOL ITAL, V20, P119; Jemielity S, 2005, AGE, V27, P241, DOI 10.1007/s11357-005-2916-z; Jerome CA, 1998, BEHAV ECOL, V9, P301, DOI 10.1093/beheco/9.3.301; KASPARI M, 1995, AM NAT, V145, P610, DOI 10.1086/285758; Keller L, 1997, NATURE, V389, P958, DOI 10.1038/40130; KIRKWOOD TBL, 1977, NATURE, V270, P301, DOI 10.1038/270301a0; Lee RD, 2003, P NATL ACAD SCI USA, V100, P9637, DOI 10.1073/pnas.1530303100; MACEVICZ S, 1976, BEHAV ECOL SOCIOBIOL, V1, P265, DOI 10.1007/BF00300068; Medawar P., 1952, UNSOLVED PROBLEM BIO; Michod RE, 2006, P NATL ACAD SCI USA, V103, P9113, DOI 10.1073/pnas.0601080103; Moorad JA, 2010, CURR BIOL, V20, pR406, DOI 10.1016/j.cub.2010.03.016; Moret Y, 2000, SCIENCE, V290, P1166, DOI 10.1126/science.290.5494.1166; ODONNELL S, 1995, EXPERIENTIA, V51, P749, DOI 10.1007/BF01941274; ODONNELL S, 1995, BEHAV ECOL, V6, P269, DOI 10.1093/beheco/6.3.269; Omholt Stig W, 2004, Sci Aging Knowledge Environ, V2004, ppe28, DOI 10.1126/sageke.2004.26.pe28; Oster G.F., 1978, Monographs in Population Biology, pi; Parker JD, 2004, P NATL ACAD SCI USA, V101, P3486, DOI 10.1073/pnas.0400222101; Parker JD, 2010, MYRMECOL NEWS, V13, P103; Poitrineau K, 2009, INSECT SOC, V56, P119, DOI 10.1007/s00040-009-0004-6; PORTER SD, 1981, BEHAV ECOL SOCIOBIOL, V9, P247, DOI 10.1007/BF00299879; PORTER SD, 1988, J INSECT PHYSIOL, V34, P1127, DOI 10.1016/0022-1910(88)90215-6; PORTER SD, 1986, ANN ENTOMOL SOC AM, V79, P723, DOI 10.1093/aesa/79.4.723; PORTER SD, 1985, BEHAV ECOL SOCIOBIOL, V16, P323, DOI 10.1007/BF00295545; ROBINSON GE, 1992, ANNU REV ENTOMOL, V37, P637, DOI 10.1146/annurev.en.37.010192.003225; Roff Derek A., 1992; Rueppell O, 2007, EXP GERONTOL, V42, P1020, DOI 10.1016/j.exger.2007.06.002; Rueppell O, 2007, CURR BIOL, V17, pR274, DOI 10.1016/j.cub.2007.02.015; Rueppell O, 2009, EXP GERONTOL, V44, P447, DOI 10.1016/j.exger.2009.04.003; Schmid-Hempel P., 1998, Parasites in social insects.; SCHMIDHEMPEL P, 1993, CAN ENTOMOL, V125, P129, DOI 10.4039/Ent125129-1; Schreiber K.F., 1969, ERDKUNDE, P280; Seifert B, 2007, DIE AMEISEN MITTEL U; Shattuck MR, 2010, P NATL ACAD SCI USA, V107, P4635, DOI 10.1073/pnas.0911439107; SOLIS CR, 1990, FUNCT ECOL, V4, P531, DOI 10.2307/2389321; Stearns S.C., 1992, pi; Stearns SC, 2000, P NATL ACAD SCI USA, V97, P3309, DOI 10.1073/pnas.060289597; STREHLER BL, 1960, SCIENCE, V132, P14, DOI 10.1126/science.132.3418.14; Team RDC, 2010, R LANG ENV STAT COMP; Tofilski A, 2006, J THEOR BIOL, V238, P527, DOI 10.1016/j.jtbi.2005.06.008; Tofilski A, 2002, BEHAV ECOL SOCIOBIOL, V51, P234, DOI [10.1007/s00265-001-0429-z, 10.1007/S00265-001-0429-Z]; TOHME G, 1978, CR ACAD SCI D NAT, V286, P961; Tsuji K, 1996, NATURWISSENSCHAFTEN, V83, P577; Wheller WM, 1911, J MORPHOL, V22, P307; WILLIAMS GC, 1957, EVOLUTION, V11, P398, DOI 10.1111/j.1558-5646.1957.tb02911.x; Wilson E.O., 1971, INSECT SOC; WILSON EO, 1983, BEHAV ECOL SOCIOBIOL, V14, P47, DOI 10.1007/BF00366655	75	26	26	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2013	8	4							e61813	10.1371/journal.pone.0061813	http://dx.doi.org/10.1371/journal.pone.0061813			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125TD	23596527	Green Submitted, Green Published, gold			2022-12-25	WOS:000317563300038
J	Palaniyandi, S; Radhakrishnan, SV; Karlsson, FJ; Stokes, KY; Kittan, N; Huber, E; Hildebrandt, GC				Palaniyandi, Senthilnathan; Radhakrishnan, Sabarinath Venniyil; Karlsson, Fridrik J.; Stokes, Karen Y.; Kittan, Nicolai; Huber, Elisabeth; Hildebrandt, Gerhard C.			Murine Cytomegalovirus Immediate-Early 1 Gene Expression Correlates with Increased GVHD after Allogeneic Hematopoietic Cell Transplantation in Recipients Reactivating from Latent Infection	PLOS ONE			English	Article							VERSUS-HOST-DISEASE; BONE-MARROW-TRANSPLANTATION; BRONCHIOLITIS OBLITERANS SYNDROME; RISK-FACTORS; MODEL; LUNGS; TRANSCRIPTION; REPLICATION; RECURRENCE; MORBIDITY	The success of allogeneic (allo) hematopoietic cell transplantation (HCT) is limited by its treatment related complications, mostly graft versus host disease (GVHD) and fungal and viral infections. CMV reactivation after HCT has been associated with increased morbidity and mortality, and a causal relation between GVHD, immunosuppressive therapy and vice versa has been postulated. Using a low GVHD severity murine HCT model, we assessed the role of MCMV reactivation and GVHD development. BALB/c mice were infected with either murine CMV (MCMV) or mock and monitored for 25 weeks to establish latency, followed by sublethal irradiation conditioning and infusion of bone marrow plus splenocytes from either syngeneic (syn) BALB/c or allo B10.D2 donors. Engraftment of allo donor cells was confirmed by PCR for D2Mit265 gene product size. Day+100 mortality and overall GVHD severity in allo MCMV pre-infected recipients was higher than in allo mock controls. Pathologic changes of lung and liver GVHD in immediate-early gene 1 (IE1) positive recipients were significantly increased compared to mock controls, and were only slightly increased in IE1 negative. No significant gut injury was seen in any group. Aggravated lung injury in IE1 positive recipients correlated with higher BAL cell counts both for total cells and for CD4+ T cells when compared with mock controls, and also with protein expression of lung IFN-gamma and liver TNF. No evidence for CMV specific morphologic changes was seen on histopathology in any organ of IE1 positive recipients, suggesting that CMV reactivation is related to increased GVHD severity but does not require active CMV disease, strengthening the concept of a reciprocal relationship between CMV and GVHD.	[Palaniyandi, Senthilnathan; Radhakrishnan, Sabarinath Venniyil; Karlsson, Fridrik J.; Kittan, Nicolai; Hildebrandt, Gerhard C.] Louisiana State Univ, Dept Med, Div Hematol & Oncol, Feist Weiller Canc Ctr,Hlth Sci Ctr Shreveport, Shreveport, LA 71105 USA; [Palaniyandi, Senthilnathan; Hildebrandt, Gerhard C.] Univ Utah, Sch Med, Dept Med, Div Hematol & Hematol Malignancies, Salt Lake City, UT USA; [Stokes, Karen Y.] Louisiana State Univ, Dept Mol & Cellular Physiol, Ctr Mol & Tumor Virol, Hlth Sci Ctr Shreveport, Shreveport, LA 71105 USA; [Huber, Elisabeth] Univ Regensburg, Dept Pathol, Sch Med, D-93053 Regensburg, Germany	Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Utah System of Higher Education; University of Utah; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; University of Regensburg	Hildebrandt, GC (corresponding author), Louisiana State Univ, Dept Med, Div Hematol & Oncol, Feist Weiller Canc Ctr,Hlth Sci Ctr Shreveport, Shreveport, LA 71105 USA.	Gerhard.hildebrandt@hci.utah.edu		Palaniyandi, Senthilnathan/0000-0002-9611-0321	Louisiana State University Health Sciences Center (LSUHSC) Shreveport Feist Weiller Cancer Center; COBRE from the National Institute of General Medical Sciences of the National Institutes of Health [GM103433]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103433] Funding Source: NIH RePORTER	Louisiana State University Health Sciences Center (LSUHSC) Shreveport Feist Weiller Cancer Center; COBRE from the National Institute of General Medical Sciences of the National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work was funded by Louisiana State University Health Sciences Center (LSUHSC) Shreveport Feist Weiller Cancer Center. KS was supported by the COBRE Grant GM103433 from the National Institute of General Medical Sciences of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALTHESEN M, 1993, J VIROL, V67, P5360, DOI 10.1128/JVI.67.9.5360-5366.1993; Bate SL, 2010, CLIN INFECT DIS, V50, P1439, DOI 10.1086/652438; BOSTROM L, 1988, TRANSPLANTATION, V46, P548, DOI 10.1097/00007890-198810000-00016; Broers AEC, 2000, BLOOD, V95, P2240, DOI 10.1182/blood.V95.7.2240.007k08_2240_2245; Cantoni N, 2010, BIOL BLOOD MARROW TR, V16, P1309, DOI 10.1016/j.bbmt.2010.03.020; Cook CH, 2002, J INFECT DIS, V185, P1395, DOI 10.1086/340508; Cooke KR, 1998, J CLIN INVEST, V102, P1882, DOI 10.1172/JCI4285; Cooke KR, 1996, BLOOD, V88, P3230, DOI 10.1182/blood.V88.8.3230.bloodjournal8883230; D'Agaro P., 2000, Haematologica, V85, P54; Defabianis P, 2010, EUR J PAEDIATR DENT, V11, P31; DORSCHHASLER K, 1985, P NATL ACAD SCI USA, V82, P8325, DOI 10.1073/pnas.82.24.8325; El-Amouri IS, 2010, CLIN EXP IMMUNOL, V162, P379, DOI 10.1111/j.1365-2249.2010.04241.x; George B, 2010, TRANSPL INFECT DIS, V12, P322, DOI 10.1111/j.1399-3062.2010.00504.x; Ghazal P, 2005, J VIROL, V79, P7182, DOI 10.1128/JVI.79.11.7182-7194.2005; Gratama JW, 2008, CYTOM PART B-CLIN CY, V74B, P211, DOI 10.1002/cyto.b.20420; GRATAMA JW, 1987, LANCET, V1, P471; Gribaudo G, 1996, VIRUS RES, V45, P15, DOI 10.1016/0168-1702(96)01356-1; Hill GR, 1998, J CLIN INVEST, V102, P115, DOI 10.1172/JCI3132; HO M, 1990, REV INFECT DIS, V12, pS701; Hummel M, 2001, J VIROL, V75, P4814, DOI 10.1128/JVI.75.10.4814-4822.2001; Jackson SE, 2011, VIRUS RES, V157, P151, DOI 10.1016/j.virusres.2010.10.031; JORDAN MC, 1977, J GEN VIROL, V37, P419, DOI 10.1099/0022-1317-37-2-419; Kanda Y, 2010, BONE MARROW TRANSPL, V45, P1325, DOI 10.1038/bmt.2009.337; Kaplan DH, 2004, J IMMUNOL, V173, P5467, DOI 10.4049/jimmunol.173.9.5467; KEIL GM, 1985, J VIROL, V54, P422, DOI 10.1128/JVI.54.2.422-428.1985; Koffron AJ, 1998, J VIROL, V72, P95, DOI 10.1128/JVI.72.1.95-103.1998; Kurz S, 1997, J VIROL, V71, P2980, DOI 10.1128/JVI.71.4.2980-2987.1997; Kurz SK, 1999, J VIROL, V73, P8612, DOI 10.1128/JVI.73.10.8612-8622.1999; Ljungman P, 2003, BLOOD, V102, P4255, DOI 10.1182/blood-2002-10-3263; Marquardt A, 2011, J GEN VIROL, V92, P1279, DOI 10.1099/vir.0.029827-0; Meijer E, 2002, CLIN INFECT DIS, V35, P703, DOI 10.1086/342332; Olkinuora H, 2011, SCAND J IMMUNOL, V73, P586, DOI 10.1111/j.1365-3083.2011.02530.x; Osarogiagbon RU, 2000, BIOL BLOOD MARROW TR, V6, P280, DOI 10.1016/S1083-8791(00)70010-3; Paraskeva M, 2011, AM J TRANSPLANT, V11, P2190, DOI 10.1111/j.1600-6143.2011.03663.x; Peggs KS, 2004, INT J BIOCHEM CELL B, V36, P695, DOI 10.1016/j.biocel.2003.08.008; Peppercorn A, 2008, JAMA-J AM MED ASSOC, V300, P2367, DOI 10.1001/jama.2008.696; Poutsiaka DD, 2011, BONE MARROW TRANSPL, V46, P300, DOI 10.1038/bmt.2010.112; Rawlinson WD, 1996, J VIROL, V70, P8833, DOI 10.1128/JVI.70.12.8833-8849.1996; Reddehase MJ, 2008, CURR TOP MICROBIOL, V325, P315; Reeves M, 2008, CURR TOP MICROBIOL, V325, P297; Seckert CK, 2009, J VIROL, V83, P8869, DOI 10.1128/JVI.00870-09; Sengsayadeth SM, 2012, BIOL BLOOD MARROW TR, V18, P1479, DOI 10.1016/j.bbmt.2012.03.008; Shlomchik WD, 2007, NAT REV IMMUNOL, V7, P340, DOI 10.1038/nri2000; Stinski MF, 2008, MED MICROBIOL IMMUN, V197, P223, DOI 10.1007/s00430-007-0069-7; STJOHN RC, 1990, CHEST, V98, P600, DOI 10.1378/chest.98.3.600; Takebayashi K, 2011, INFLAMM BOWEL DIS, V17, P268, DOI 10.1002/ibd.21447; Tang QY, 2003, J VIROL, V77, P1357, DOI 10.1128/JVI.77.2.1357-1367.2003; Toze CL, 2012, BRIT J HAEMATOL, V158, P174, DOI 10.1111/j.1365-2141.2012.09170.x; VERDONCK LF, 1987, EXP HEMATOL, V15, P864; Wang LR, 2008, BONE MARROW TRANSPL, V42, P673, DOI 10.1038/bmt.2008.238; Zekri ARN, 2004, TRANSPL IMMUNOL, V13, P305, DOI 10.1016/j.trim.2004.10.001	51	9	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2013	8	4							e61841	10.1371/journal.pone.0061841	http://dx.doi.org/10.1371/journal.pone.0061841			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125TD	23596528	Green Published, gold, Green Submitted			2022-12-25	WOS:000317563300040
J	Kang, J; Xu, LM; Yang, SF; Yu, WD; Liu, S; Xin, Y; Ma, YF				Kang, Jian; Xu, Liming; Yang, Shufeng; Yu, Wendan; Liu, Shuo; Xin, Yi; Ma, Yufang			Effect of Phosphoglucosamine Mutase on Biofilm Formation and Antimicrobial Susceptibilities in M. smegmatis glmM Gene Knockdown Strain	PLOS ONE			English	Article							IDENTIFICATION; MYCOBACTERIA; RESISTANCE; PLATE; ASSAY	UDP-N-acetylglucosamine (UDP-GlcNAc) is a direct glycosyl donor of linker unit (L-Rhamnose-D-GlcNAc) and an essential precursor of peptidoglycan in mycobacteria. Phosphoglucosamine mutase (GlmM) is involved in the formation of glucosamine-1-phosphate from glucosamine-6-phosphate, the second step in UDP-GlcNAc biosynthetic pathway. We have demonstrated that GlmM protein is essential for the growth of M. smegmatis. To facilitate the analysis of the GlmM protein function in mycobacteria, a tetracycline inducible M. smegmatis glmM gene knockdown strain was constructed by using an antisense RNA technology. After induction with 20 ng/ml tetracycline, the expression of GlmM protein in glmM gene knockdown strain was significantly decreased, resulting in a decline of cell growth. The morphological changes of glmM gene knockdown strain induced with 20 ng/ml tetracycline have been observed by scanning electron microscope and transmission electron microscope. Furthermore, insufficient GlmM protein reduced the biofilm formation and increased the sensitivity to isoniazid and ethambutol in M. smegmatis, indicating that GlmM protein had effect on the biofilm formation and the senstivity to some anti-tuberculosis drugs targeting the cell wall. These results provide a new insight on GlmM functions in mycobacteria, suggesting that GlmM could be a potential target for development of new anti-tuberculosis drug.	[Kang, Jian; Xu, Liming; Yang, Shufeng; Yu, Wendan; Liu, Shuo; Ma, Yufang] Dalian Med Univ, Dept Biochem & Mol Biol, Dalian, Peoples R China; [Xin, Yi] Dalian Med Univ, Dept Biotechnol, Dalian, Peoples R China; [Xin, Yi; Ma, Yufang] Liaoning Prov Core Lab Glycobiol & Glycoengn, Dalian, Peoples R China	Dalian Medical University; Dalian Medical University	Ma, YF (corresponding author), Dalian Med Univ, Dept Biochem & Mol Biol, Dalian, Peoples R China.	yufang_ma@hotmail.com			National Basic Research Program of China [2012CB518803]; National Natural Science Foundation of China [30970067]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program of China (2012CB518803; http://www.973.gov.cn/English/Index.aspx), and the National Natural Science Foundation of China (30970067; http://www.nsfc.gov.cn/Portal0/default166.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blokpoel MCJ, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni023; Brennan PJ, 2003, TUBERCULOSIS, V83, P91, DOI 10.1016/S1472-9792(02)00089-6; CHEN WP, 1993, NUCLEIC ACIDS RES, V21, P2260, DOI 10.1093/nar/21.9.2260; Daffe M, 1998, ADV MICROB PHYSIOL, V39, P131; Dinadayala P, 2006, J BIOL CHEM, V281, P20027, DOI 10.1074/jbc.M603395200; Dye C, 2002, J INFECT DIS, V185, P1197, DOI 10.1086/339818; Gandhi NR, 2006, LANCET, V368, P1575, DOI 10.1016/S0140-6736(06)69573-1; Jolly L, 1999, EUR J BIOCHEM, V262, P202, DOI 10.1046/j.1432-1327.1999.00373.x; Jolly L, 1997, J BACTERIOL, V179, P5321, DOI 10.1128/jb.179.17.5321-5325.1997; Klein DJ, 2006, SCIENCE, V313, P1752, DOI 10.1126/science.1129666; Li S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042769; Liu XD, 2009, ORAL MICROBIOL IMMUN, V24, P272, DOI 10.1111/j.1399-302X.2009.00503.x; MENGINLECREULX D, 1994, J BACTERIOL, V176, P5788, DOI 10.1128/JB.176.18.5788-5795.1994; MenginLecreulx D, 1996, J BIOL CHEM, V271, P32, DOI 10.1074/jbc.271.1.32; MENGINLECREULX D, 1993, J BACTERIOL, V175, P6150, DOI 10.1128/JB.175.19.6150-6157.1993; Ojha A, 2005, CELL, V123, P861, DOI 10.1016/j.cell.2005.09.012; Palomino JC, 2002, ANTIMICROB AGENTS CH, V46, P2720, DOI 10.1128/AAC.46.8.2720-2722.2002; Qu H, 2007, FEMS MICROBIOL LETT, V275, P237, DOI 10.1111/j.1574-6968.2007.00890.x; RAETZ CRH, 1986, ANNU REV GENET, V20, P253, DOI 10.1146/annurev.ge.20.120186.001345; Recht J, 2000, J BACTERIOL, V182, P4348, DOI 10.1128/JB.182.15.4348-4351.2000; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Shimazu K, 2008, FEMS IMMUNOL MED MIC, V53, P166, DOI 10.1111/j.1574-695X.2008.00410.x; Thomason MK, 2010, ANNU REV GENET, V44, P167, DOI 10.1146/annurev-genet-102209-163523; Zhang WL, 2008, INT J BIOCHEM CELL B, V40, P2560, DOI 10.1016/j.biocel.2008.05.003; Zhang Y, 2003, INT J TUBERC LUNG D, V7, P6	25	11	11	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2013	8	4							e61589	10.1371/journal.pone.0061589	http://dx.doi.org/10.1371/journal.pone.0061589			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123IQ	23593488	Green Published, Green Submitted, gold			2022-12-25	WOS:000317382000051
J	Banerjee, A; Wu, Y; Banerjee, R; Li, Y; Yan, HG; Sharkey, TD				Banerjee, Aparajita; Wu, Yan; Banerjee, Rahul; Li, Yue; Yan, Honggao; Sharkey, Thomas D.			Feedback Inhibition of Deoxy-D-xylulose-5-phosphate Synthase Regulates the Methylerythritol 4-Phosphate Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							1-DEOXY-D-XYLULOSE 5-PHOSPHATE SYNTHASE; NON-MEVALONATE PATHWAY; DEOXYXYLULOSE PHOSPHATE-PATHWAY; ISOPRENOID BIOSYNTHESIS; ISOPENTENYL DIPHOSPHATE; TERPENOID BIOSYNTHESIS; ESCHERICHIA-COLI; HIGHER-PLANTS; MEP PATHWAY; SYNECHOCOCCUS-LEOPOLIENSIS	The 2-C-methyl-D-erythritol 4-phosphate (MEP) pathway leads to the biosynthesis of isopentenyl diphosphate (IDP) and dimethylallyl diphosphate (DMADP), the precursors for isoprene and higher isoprenoids. Isoprene has significant effects on atmospheric chemistry, whereas other isoprenoids have diverse roles ranging from various biological processes to applications in commercial uses. Understanding the metabolic regulation of the MEP pathway is important considering the numerous applications of this pathway. The 1-deoxy-D-xylulose-5-phosphate synthase (DXS) enzyme was cloned from Populus trichocarpa, and the recombinant protein (PtDXS) was purified from Escherichia coli. The steady-state kinetic parameters were measured by a coupled enzyme assay. An LC-MS/MS-based assay involving the direct quantification of the end product of the enzymatic reaction, 1-deoxy-D-xylulose 5-phosphate (DXP), was developed. The effect of different metabolites of the MEP pathway on PtDXS activity was tested. PtDXS was inhibited by IDP and DMADP. Both of these metabolites compete with thiamine pyrophosphate for binding with the enzyme. An atomic structural model of PtDXS in complex with thiamine pyrophosphate and Mg2+ was built by homology modeling and refined by molecular dynamics simulations. The refined structure was used to model the binding of IDP and DMADP and indicated that IDP and DMADP might bind with the enzyme in a manner very similar to the binding of thiamine pyrophosphate. The feedback inhibition of PtDXS by IDP and DMADP constitutes an important mechanism of metabolic regulation of the MEP pathway and indicates that thiamine pyrophosphate-dependent enzymes may often be affected by IDP and DMADP.	[Banerjee, Aparajita; Wu, Yan; Banerjee, Rahul; Li, Yue; Yan, Honggao; Sharkey, Thomas D.] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA	Michigan State University	Yan, HG (corresponding author), Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA.	yanh@msu.edu; tsharkey@msu.edu	BANERJEE, RAHUL/Q-7260-2019; Sharkey, Thomas/ABF-1317-2020; Sharkey, Thomas D/B-4032-2009; Banerjee, Aparajita/ABC-8383-2020	BANERJEE, RAHUL/0000-0002-3547-4746; Sharkey, Thomas/0000-0002-4423-3223; Sharkey, Thomas D/0000-0002-4423-3223; Banerjee, Aparajita/0000-0001-5711-4998; Banerjee, Rahul/0000-0002-6681-1047	National Science Foundation [IOS-0950574, CHE-0957201]; Division Of Chemistry [0957201] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Division Of Chemistry(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported by National Science Foundation Grants IOS-0950574 (to T. D. S.) and CHE-0957201 (to H. Y.).	Adam P, 2002, P NATL ACAD SCI USA, V99, P12108, DOI 10.1073/pnas.182412599; Altincicek B, 2000, FEMS MICROBIOL LETT, V190, P329, DOI 10.1111/j.1574-6968.2000.tb09307.x; Altincicek B, 2002, FEBS LETT, V532, P437, DOI 10.1016/S0014-5793(02)03726-2; [Anonymous], 2008, AMBER 10; Argyrou A, 2004, BIOCHEMISTRY-US, V43, P4375, DOI 10.1021/bi049974k; Arigoni D, 1997, P NATL ACAD SCI USA, V94, P10600, DOI 10.1073/pnas.94.20.10600; Bailey AM, 2002, GLYCOBIOLOGY, V12, P813, DOI 10.1093/glycob/cwf100; Bitok JK, 2012, ACS CHEM BIOL, V7, P1702, DOI 10.1021/cb300243w; Bouvier F, 1998, PLANT PHYSIOL, V117, P1423, DOI 10.1104/pp.117.4.1423; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Cordoba E, 2009, J EXP BOT, V60, P2933, DOI 10.1093/jxb/erp190; DellaPenna D, 2006, ANNU REV PLANT BIOL, V57, P711, DOI 10.1146/annurev.arplant.56.032604.144301; Dubey VS, 2003, J BIOSCIENCES, V28, P637, DOI 10.1007/BF02703339; Eisenreich W, 2004, CELL MOL LIFE SCI, V61, P1401, DOI 10.1007/s00018-004-3381-z; Eisenreich W, 1996, P NATL ACAD SCI USA, V93, P6431, DOI 10.1073/pnas.93.13.6431; Eisenreich W, 1998, CHEM BIOL, V5, pR221, DOI 10.1016/S1074-5521(98)90002-3; Enfissi EMA, 2005, PLANT BIOTECHNOL J, V3, P17, DOI 10.1111/j.1467-7652.2004.00091.x; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Estevez JM, 2001, J BIOL CHEM, V276, P22901, DOI 10.1074/jbc.M100854200; Eubanks LM, 2003, BIOCHEMISTRY-US, V42, P1140, DOI 10.1021/bi0205303; Feurle J, 1998, J CHROMATOGR A, V803, P111, DOI 10.1016/S0021-9673(97)01214-4; Gong YF, 2006, PLANTA MED, V72, P329, DOI 10.1055/s-2005-916234; Guevara-Garcia A, 2005, PLANT CELL, V17, P628, DOI 10.1105/tpc.104.028860; Hahn FM, 2001, J BACTERIOL, V183, P1, DOI 10.1128/JB.183.1.1-11.2001; Hale I, 2012, MEDCHEMCOMM, V3, P418, DOI 10.1039/c2md00298a; Han YS, 2003, J CHROMATOGR A, V986, P291, DOI 10.1016/S0021-9673(02)02016-2; Harker M, 1999, FEBS LETT, V448, P115, DOI 10.1016/S0014-5793(99)00360-9; HAWKINS CF, 1989, FEBS LETT, V255, P77, DOI 10.1016/0014-5793(89)81064-6; Hemmerlin A, 2003, J BIOL CHEM, V278, P26666, DOI 10.1074/jbc.M302526200; Hunter WN, 2007, J BIOL CHEM, V282, P21573, DOI 10.1074/jbc.R700005200; Kuzuyama T, 2000, J BACTERIOL, V182, P891, DOI 10.1128/JB.182.4.891-897.2000; Lange BM, 1998, P NATL ACAD SCI USA, V95, P2100, DOI 10.1073/pnas.95.5.2100; Li ZR, 2013, PLANT CELL ENVIRON, V36, P429, DOI 10.1111/j.1365-3040.2012.02584.x; Li ZR, 2011, PLANT PHYSIOL, V155, P1037, DOI 10.1104/pp.110.167551; Lichtenthaler HK, 1997, PHYSIOL PLANTARUM, V101, P643, DOI 10.1111/j.1399-3054.1997.tb01049.x; Lichtenthaler HK, 1997, FEBS LETT, V400, P271, DOI 10.1016/S0014-5793(96)01404-4; Lois LM, 2000, PLANT J, V22, P503, DOI 10.1046/j.1365-313x.2000.00764.x; Lois LM, 1998, P NATL ACAD SCI USA, V95, P2105, DOI 10.1073/pnas.95.5.2105; Matthews PD, 2000, APPL MICROBIOL BIOT, V53, P396, DOI 10.1007/s002530051632; Miller B, 2000, FEBS LETT, V481, P221, DOI 10.1016/S0014-5793(00)02014-7; Miller B, 1999, FEBS LETT, V460, P485, DOI 10.1016/S0014-5793(99)01397-6; Morris WL, 2006, J EXP BOT, V57, P3007, DOI 10.1093/jxb/erl061; Patel H, 2012, J AM CHEM SOC, V134, P18374, DOI 10.1021/ja307315u; Phillips MA, 2008, TRENDS PLANT SCI, V13, P619, DOI 10.1016/j.tplants.2008.09.003; Querol J, 2001, ANAL BIOCHEM, V296, P101, DOI 10.1006/abio.2001.5234; Rodriguez-Concepcion M, 2002, PLANT PHYSIOL, V130, P1079, DOI 10.1104/pp.007138; Rodriguez-Concepcion Manuel, 2006, Phytochemistry Reviews, V5, P1, DOI 10.1007/s11101-005-3130-4; Rohdich F, 2003, P NATL ACAD SCI USA, V100, P1586, DOI 10.1073/pnas.0337742100; Rohdich F, 2002, P NATL ACAD SCI USA, V99, P1158, DOI 10.1073/pnas.032658999; Rohmer M, 1996, J AM CHEM SOC, V118, P2564, DOI 10.1021/ja9538344; ROHMER M, 1993, BIOCHEM J, V295, P517, DOI 10.1042/bj2950517; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sacchettini JC, 1997, SCIENCE, V277, P1788, DOI 10.1126/science.277.5333.1788; Schwender J, 1997, FEBS LETT, V414, P129, DOI 10.1016/S0014-5793(97)01002-8; Schwender J, 1996, BIOCHEM J, V316, P73, DOI 10.1042/bj3160073; Sharkey TD, 2008, ANN BOT-LONDON, V101, P5, DOI 10.1093/aob/mcm240; Sharkey TD, 2013, EVOLUTION, V67, P1026, DOI 10.1111/evo.12013; Shi GB, 2012, BIOORGAN MED CHEM, V20, P4303, DOI 10.1016/j.bmc.2012.05.060; Sprenger GA, 1997, P NATL ACAD SCI USA, V94, P12857, DOI 10.1073/pnas.94.24.12857; Takahashi S, 1998, PSYCHIAT CLIN NEUROS, V52, P1; Wanke M, 2001, ACTA BIOCHIM POL, V48, P663; Wiberley AE, 2009, PLANT CELL ENVIRON, V32, P939, DOI 10.1111/j.1365-3040.2009.01980.x; WINTER H, 1994, PLANTA, V193, P530, DOI 10.1007/BF02411558; Wolfertz M, 2004, PLANT PHYSIOL, V135, P1939, DOI 10.1104/pp.104.043737; Wolfertz M, 2003, PLANT CELL ENVIRON, V26, P1357, DOI 10.1046/j.0016-8025.2003.01059.x; Xiang S, 2007, J BIOL CHEM, V282, P2676, DOI 10.1074/jbc.M610235200; Zeidler JG, 1997, Z NATURFORSCH C, V52, P15	67	121	127	1	93	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2013	288	23					16926	16936		10.1074/jbc.M113.464636	http://dx.doi.org/10.1074/jbc.M113.464636			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	163ZU	23612965	Green Published, hybrid			2022-12-25	WOS:000320378900065
J	He, FZ; Luo, JQ; Luo, ZY; Fan, L; He, YJ; Zhu, DL; Gao, JP; Deng, S; Wang, Y; Qian, YS; Zhou, HH; Chen, XP; Zhang, W				He, Fazhong; Luo, Jianquan; Luo, Zhiying; Fan, Lan; He, Yijing; Zhu, Dingliang; Gao, Jinping; Deng, Sheng; Wang, Yan; Qian, Yuesheng; Zhou, Honghao; Chen, Xiaoping; Zhang, Wei			The KCNH2 Genetic Polymorphism (1956, C > T) Is a Novel Biomarker That Is Associated with CCB and alpha,beta-ADR Blocker Response in EH Patients in China	PLOS ONE			English	Article							PROTEIN-KINASE-A; POTASSIUM CHANNELS; RAPID COMPONENT; ANGIOTENSIN-II; GUINEA-PIG; K+ CURRENT; HERG; INHIBITION; CURRENTS; SURFACE	Background: KCNH2 (hERG) potassium channels have an integral role in regulating the excitability of smooth muscle cells. Some pathways driven by angiotensin II, nitric oxide and adrenergic receptors blocker are involved in modulating the properties of KCNH2 potassium channels. And these pathways are closely related to blood pressure regulation. Therefore, we hypothesized that KCNH2 genetic polymorphisms may affect blood pressure response to the antihypertensive drug therapies. Materials and Methods: To evaluate the interactions between KCNH2 genetic polymorphisms and individual blood pressure response to antihypertensive drugs, 370 subjects with essential hypertension (EH) were studied. In evaluating the interactions between KCNH2 genetic polymorphisms and drug response to blood pressure, multivariable ANOVA analysis followed by Bonferroni correction were carried out. Results: There were statistically significant interactions between KCNH2 (1956, C>T) polymorphism and DBP change (P = 0.010), MAP change (P = 0.014) on azelnidipine or nitrendipine therapy patients at the end of 6 weeks. We found that the KCNH2 (1956, C>T) polymorphism was associated with the hypotensive effects of alpha, beta-ADR blockers of DBP change at the end of 4 and 6 weeks' treatment in an age- and gender-dependent manner (P = 0.007 and 0.019, respectively). Similar results were also observed for changes in MAP at the end of 4 and 6 weeks (P-values were 0.035 and 0.078, respectively). While patients who received imidapril, candesartan and irbesartan therapy, no significant difference in drug response among KCNH2(1956, C>T) genotype was observed. Conclusion: We have reported for the first time that KCNH2 (1956, C>T) polymorphism is associated with efficacy of antihypertensive drugs CCBs and ADR blockers, and may serve as a novel biomarker for individualized therapy for certain antihypertensive drugs.	[He, Fazhong; Luo, Jianquan; Luo, Zhiying; Fan, Lan; He, Yijing; Zhou, Honghao; Chen, Xiaoping; Zhang, Wei] Cent South Univ, Pharmacogenet Res Inst, Inst Clin Pharmacol, Hunan Key Lab Pharmacogenet, Changsha, Hunan, Peoples R China; [Zhu, Dingliang; Gao, Jinping; Wang, Yan; Qian, Yuesheng] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Shanghai Inst Hypertens, Shanghai 200030, Peoples R China; [Deng, Sheng] Cent South Univ, Dept Pharm, Xiangya Hosp, Changsha, Hunan, Peoples R China	Central South University; Shanghai Jiao Tong University; Central South University	Chen, XP (corresponding author), Cent South Univ, Pharmacogenet Res Inst, Inst Clin Pharmacol, Hunan Key Lab Pharmacogenet, Changsha, Hunan, Peoples R China.	chenxp74@hotmail.com; yjsd2003@163.com	Luo, Jianquan/AAE-7795-2019	Deng, Sheng/0000-0002-8313-6522	National Scientific Foundation of China [81273595, 30901834, 81001476]; Scientific Foundation of Hunan [11K073, 10JJ4020]; "863'' Project [2012AA02A518];  [NCET-10-0843]	National Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Foundation of Hunan; "863'' Project(National High Technology Research and Development Program of China); 	This work was supported by the National Scientific Foundation of China (No. 81273595, 30901834, 81001476), the Scientific Foundation of Hunan (No. 11K073, 10JJ4020), and the "863'' Project (No. 2012AA02A518) and NCET-10-0843. The funders had no role in study design, data collection and analysis, decision to publish.	Acosta E, 2007, J NEUROPHYSIOL, V98, P79, DOI 10.1152/jn.01103.2006; Aiba T, 2010, CARDIOVASC RES, V85, P454, DOI 10.1093/cvr/cvp324; Akbarali HI, 1999, AM J PHYSIOL-CELL PH, V277, pC1284, DOI 10.1152/ajpcell.1999.277.6.C1284; Ando F, 2011, J MEMBRANE BIOL, V241, P31, DOI 10.1007/s00232-011-9360-z; Arcangeli A, 1995, J PHYSIOL-LONDON, V489, P455, DOI 10.1113/jphysiol.1995.sp021065; Best JM, 2011, AM J PHYSIOL-CELL PH, V300, pC1023, DOI 10.1152/ajpcell.00288.2010; Caballero R, 2001, MOL PHARMACOL, V59, P825, DOI 10.1124/mol.59.4.825; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Chun YS, 2010, J NEUROCHEM, V112, P1286, DOI 10.1111/j.1471-4159.2009.06545.x; Dupuis DS, 2005, BASIC CLIN PHARMACOL, V96, P123, DOI 10.1111/j.1742-7843.2005.pto960206.x; Guo J, 2011, MOL PHARMACOL, V79, P806, DOI 10.1124/mol.110.069419; Hattori K, 2007, J VASC SURG, V46, P116, DOI 10.1016/j.jvs.2007.03.044; Johnson JP, 1999, J GEN PHYSIOL, V113, P565, DOI 10.1085/jgp.113.4.565; Johnson JP, 2001, J NEUROSCI, V21, P4143, DOI 10.1523/JNEUROSCI.21-12-04143.2001; Jury J, 1996, AM J PHYSIOL-GASTR L, V270, pG932, DOI 10.1152/ajpgi.1996.270.6.G932; Koyama Y, 2007, CARDIOVASC DRUG THER, V21, P69, DOI 10.1007/s10557-007-6008-4; Krishnan Y, 2012, BBA-MOL CELL RES, V1823, P1273, DOI 10.1016/j.bbamcr.2012.05.012; Lin JJ, 2008, BIOCHEM CELL BIOL, V86, P405, DOI [10.1139/O08-118, 10.1139/o08-118]; Massaeli H, 2010, J BIOL CHEM, V285, P27259, DOI 10.1074/jbc.M110.124909; Mizuno K, 2011, BRAIN RES, V1414, P10, DOI 10.1016/j.brainres.2011.07.057; Moreno I, 2003, J PHARMACOL EXP THER, V304, P862, DOI 10.1124/jpet.102.042325; Moric-Janiszewska E, 2011, ARCH MED SCI, V7, P941, DOI [10.5114/aoms.2011.26604, 10.5114/AOMS.2011.26604]; Oshiro C, 2010, PHARMACOGENET GENOM, V20, P775, DOI 10.1097/FPC.0b013e3283349e9c; Rebsamen MC, 1997, AM J PHYSIOL-ENDOC M, V273, pE922, DOI 10.1152/ajpendo.1997.273.5.E922; Ridley JM, 2008, J PHYSIOL PHARMACOL, V59, P395; Sanguinetti MC, 2006, NATURE, V440, P463, DOI 10.1038/nature04710; Sarzani R, 2006, J HYPERTENS, V24, P479, DOI 10.1097/01.hjh.0000209984.28735.fd; Sroubek J, 2011, J BIOL CHEM, V286, P21927, DOI 10.1074/jbc.M110.201699; Sun T, 2011, J BIOL CHEM, V286, P6751, DOI 10.1074/jbc.M110.198408; Taglialatela M, 1997, P NATL ACAD SCI USA, V94, P11698, DOI 10.1073/pnas.94.21.11698; Thomas D, 2004, N-S ARCH PHARMACOL, V369, P462, DOI 10.1007/s00210-004-0931-8; Tutor AS, 2006, MOL BIOL CELL, V17, P4666, DOI 10.1091/mbc.E06-05-0422; Ueno K, 2012, HYPERTENS RES, V35, P245, DOI 10.1038/hr.2011.189; Wang S, 2009, EUR J PHARMACOL, V608, P1, DOI 10.1016/j.ejphar.2009.02.017; Wang YH, 2008, BRIT J PHARMACOL, V154, P429, DOI 10.1038/bjp.2008.95; Wu ZY, 2011, J BIOL CHEM, V286, P22186, DOI 10.1074/jbc.M110.198853; Yao EH, 2008, AM J HYPERTENS, V21, P1062, DOI 10.1038/ajh.2008.233; Zhang ST, 1999, CIRC RES, V84, P989, DOI 10.1161/01.RES.84.9.989; Zhang XH, 2010, BRIT J PHARMACOL, V161, P872, DOI 10.1111/j.1476-5381.2010.00916.x; Zhou QL, 2010, AM J PHYSIOL-HEART C, V298, pH1710, DOI 10.1152/ajpheart.01246.2009	40	7	8	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2013	8	4							e61317	10.1371/journal.pone.0061317	http://dx.doi.org/10.1371/journal.pone.0061317			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JR	23613831	gold, Green Published, Green Submitted			2022-12-25	WOS:000317911500027
J	Lawrence, AJ; Patel, B; Morris, RG; MacKinnon, AD; Rich, PM; Barrick, TR; Markus, HS				Lawrence, Andrew J.; Patel, Bhavini; Morris, Robin G.; MacKinnon, Andrew D.; Rich, Philip M.; Barrick, Thomas R.; Markus, Hugh S.			Mechanisms of Cognitive Impairment in Cerebral Small Vessel Disease: Multimodal MRI Results from the St George's Cognition and Neuroimaging in Stroke (SCANS) Study	PLOS ONE			English	Article							DIFFUSION TENSOR; ALZHEIMERS-DISEASE; CADASIL; LESIONS; LEUKOARAIOSIS; MICROBLEEDS; DYSFUNCTION; PROGRESSION; PROFILES; DEMENTIA	Cerebral small vessel disease (SVD) is a common cause of vascular cognitive impairment. A number of disease features can be assessed on MRI including lacunar infarcts, T2 lesion volume, brain atrophy, and cerebral microbleeds. In addition, diffusion tensor imaging (DTI) is sensitive to disruption of white matter ultrastructure, and recently it has been suggested that additional information on the pattern of damage may be obtained from axial diffusivity, a proposed marker of axonal damage, and radial diffusivity, an indicator of demyelination. We determined the contribution of these whole brain MRI markers to cognitive impairment in SVD. Consecutive patients with lacunar stroke and confluent leukoaraiosis were recruited into the ongoing SCANS study of cognitive impairment in SVD (n = 115), and underwent neuropsychological assessment and multimodal MRI. SVD subjects displayed poor performance on tests of executive function and processing speed. In the SVD group brain volume was lower, white matter hyperintensity volume higher and all diffusion characteristics differed significantly from control subjects (n = 50). On multi-predictor analysis independent predictors of executive function in SVD were lacunar infarct count and diffusivity of normal appearing white matter on DTI. Independent predictors of processing speed were lacunar infarct count and brain atrophy. Radial diffusivity was a stronger DTI predictor than axial diffusivity, suggesting ischaemic demyelination, seen neuropathologically in SVD, may be an important predictor of cognitive impairment in SVD. Our study provides information on the mechanism of cognitive impairment in SVD.	[Lawrence, Andrew J.; Patel, Bhavini; Barrick, Thomas R.; Markus, Hugh S.] St Georges Univ London, Stroke & Dementia Res Ctr, London, England; [Morris, Robin G.] Inst Psychiat, Dept Psychol, London SE5 8AF, England; [MacKinnon, Andrew D.; Rich, Philip M.] St Georges Healthcare NHS Trust, Dept Neuroradiol, Atkinson Morley Reg Neurosci Ctr, London, England	St Georges University London; University of London; King's College London; St Georges University London	Lawrence, AJ (corresponding author), St Georges Univ London, Stroke & Dementia Res Ctr, London, England.	alawrenc@sgul.ac.uk; hmarkus@sgul.ac.uk		Lawrence, Andrew/0000-0002-1420-3381; Barrick, Thomas/0000-0003-1783-3650	English National Institute of Health Research Clinical Stroke Research Network; NIH; Wellcome Trust [081589]	English National Institute of Health Research Clinical Stroke Research Network; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission)	Recruitment to the study was supported by the English National Institute of Health Research Clinical Stroke Research Network. We thank Lalit Kalra and Tony Rudd for help with recruitment. We also thank Thomas Willis for assistance with neuropsychological assessment and Ai Wern Chung for assistance with MRI analysis. We acknowledge the Neuroergonomics Research Team of the University of Iowa's Department of Neurology for the use of their Grooved Pegboard normative data, obtained in their NIH-sponsored research.; This research was funded by the Wellcome Trust (grant number 081589). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AWAD IA, 1986, STROKE, V17, P1090, DOI 10.1161/01.STR.17.6.1090; BAMFORD J, 1991, LANCET, V337, P1521, DOI 10.1016/0140-6736(91)93206-O; BASSER PJ, 1994, J MAGN RESON SER B, V103, P247, DOI 10.1006/jmrb.1994.1037; Burzynska AZ, 2010, NEUROIMAGE, V49, P2104, DOI 10.1016/j.neuroimage.2009.09.041; Charlton RA, 2006, NEUROLOGY, V66, P1523, DOI 10.1212/01.wnl.0000216270.02610.7e; Charlton RA, 2006, NEUROLOGY, V66, P217, DOI 10.1212/01.wnl.0000194256.15247.83; Cordonnier C, 2009, STROKE, V40, P94, DOI 10.1161/STROKEAHA.108.526996; Della Nave R, 2007, AM J NEURORADIOL, V28, P1313, DOI 10.3174/ajnr.A0555; Dormann CF, 2012, ECOGRAPHY IN PRESS; Duering M, 2011, BRAIN, V134, P2366, DOI 10.1093/brain/awr169; Englund E, 2002, CEREBROVASC DIS, V13, P11, DOI 10.1159/000049144; FAZEKAS F, 1987, AM J ROENTGENOL, V149, P351, DOI 10.2214/ajr.149.2.351; FISHER CM, 1969, ACTA NEUROPATHOL, V12, P1, DOI 10.1007/BF00685305; Grassiot B, 2009, J NEUROL, V256, P1397, DOI 10.1007/s00415-009-5108-4; Grimaud J, 1996, MAGN RESON IMAGING, V14, P495, DOI 10.1016/0730-725X(96)00018-5; Holtmannspotter M, 2005, STROKE, V36, P2559, DOI 10.1161/01.STR.0000189696.70989.a4; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; JUNQUE C, 1990, ARCH NEUROL-CHICAGO, V47, P151, DOI 10.1001/archneur.1990.00530020047013; Khan U, 2007, J NEUROL NEUROSUR PS, V78, P702, DOI 10.1136/jnnp.2006.103549; Nagahama Y, 2003, DEMENT GERIATR COGN, V16, P103, DOI 10.1159/000070683; NEEMAN M, 1991, MAGNET RESON MED, V21, P138, DOI 10.1002/mrm.1910210117; Nelson H., 1991, NATL ADULT READING T; Nitkunan A, 2008, STROKE, V39, P1999, DOI 10.1161/STROKEAHA.107.507475; Nitkunan A, 2011, STROKE, V42, P133, DOI 10.1161/STROKEAHA.110.594267; O'Sullivan M, 2004, J NEUROL NEUROSUR PS, V75, P441, DOI 10.1136/jnnp.2003.014910; O'Sullivan M, 2001, NEUROLOGY, V57, P632, DOI 10.1212/WNL.57.4.632; O'Sullivan M, 2010, STROKE, V41, pS154, DOI 10.1161/STROKEAHA.110.595314; Pantoni L, 2010, LANCET NEUROL, V9, P689, DOI 10.1016/S1474-4422(10)70104-6; Patel B, STROKE; Patel B, 2011, INT J STROKE, V6, P47, DOI 10.1111/j.1747-4949.2010.00552.x; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Sachdev PS, 2004, NEUROLOGY, V63, P1618, DOI 10.1212/01.WNL.0000142964.83484.DE; Schmidt R, 2010, STROKE, V41, pE402, DOI 10.1161/STROKEAHA.109.576629; Seo SW, 2007, STROKE, V38, P1949, DOI 10.1161/STROKEAHA.106.477315; Shiee N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037049; Smith EE, 2011, NEUROLOGY, V76, P1492, DOI 10.1212/WNL.0b013e318217e7c8; Smith EE, 2012, LANCET NEUROL, V11, P272, DOI 10.1016/S1474-4422(11)70307-6; Smith SM, 2002, NEUROIMAGE, V17, P479, DOI 10.1006/nimg.2002.1040; Song SK, 2003, NEUROIMAGE, V20, P1714, DOI 10.1016/j.neuroimage.2003.07.005; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604; Viswanathan A, 2010, NEUROBIOL AGING, V31, P1629, DOI 10.1016/j.neurobiolaging.2008.09.001; Werring DJ, 2004, BRAIN, V127, P2265, DOI 10.1093/brain/awh253; Wheeler-Kingshott CAM, 2009, MAGN RESON MED, V61, P1255, DOI 10.1002/mrm.21965; Zhou AH, 2009, J INT NEUROPSYCH SOC, V15, P898, DOI 10.1017/S1355617709990816	44	93	110	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2013	8	4							e61014	10.1371/journal.pone.0061014	http://dx.doi.org/10.1371/journal.pone.0061014			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JR	23613774	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000317911500014
J	Qu, S; Olafsrud, SM; Meza-Zepeda, LA; Saatcioglu, F				Qu, Su; Olafsrud, Solveig Mjelstad; Meza-Zepeda, Leonardo A.; Saatcioglu, Fahri			Rapid Gene Expression Changes in Peripheral Blood Lymphocytes upon Practice of a Comprehensive Yoga Program	PLOS ONE			English	Article							PRACTITIONERS; EXERCISE; MEDICINE; HEALTH	One of the most common integrative medicine (IM) modalities is yoga and related practices. Previous work has shown that yoga may improve wellness in healthy people and have benefits for patients. However, the mechanisms of how yoga may positively affect the mind-body system are largely unknown. Here we have assessed possible rapid changes in global gene expression profiles in the peripheral blood mononuclear cells (PBMCs) in healthy people that practiced either a comprehensive yoga program or a control regimen. The experimental sessions included gentle yoga postures, breathing exercises, and meditation (Sudarshan Kriya and Related Practices - SK&P) compared with a control regimen of a nature walk and listening to relaxing music. We show that the SK&P program has a rapid and significantly greater effect on gene expression in PBMCs compared with the control regimen. These data suggest that yoga and related practices result in rapid gene expression alterations which may be the basis for their longer term cell biological and higher level health effects.	[Qu, Su; Saatcioglu, Fahri] Univ Oslo, Dept Biosci, Oslo, Norway; [Olafsrud, Solveig Mjelstad; Meza-Zepeda, Leonardo A.] Oslo Univ Hosp, Inst Canc Res, Dept Tumor Biol, Oslo, Norway; [Olafsrud, Solveig Mjelstad; Meza-Zepeda, Leonardo A.] Univ Oslo, Genom Core Facil, Dept Biosci, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo	Saatcioglu, F (corresponding author), Univ Oslo, Dept Biosci, Oslo, Norway.	fahris@ibv.uio.no	Meza-Zepeda, Leonardo Andres/CAG-5229-2022	Meza-Zepeda, Leonardo Andres/0000-0003-3056-212X	Norwegian Cancer Society; Coffral Ltd	Norwegian Cancer Society(Norwegian Cancer Society); Coffral Ltd	This work was supported by grants from the Norwegian Cancer Society and Coffral Ltd to FS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astin JA, 2003, J AM BOARD FAM PRACT, V16, P131, DOI 10.3122/jabfm.16.2.131; Barnes Patricia M, 2008, Natl Health Stat Report, P1; Bhatia M., 2003, Indian Journal of Physiology and Pharmacology, V47, P157; Black D.S., 2012, PSYCHONEUROENDOCRINO; Breitling R, 2004, FEBS LETT, V573, P83, DOI 10.1016/j.febslet.2004.07.055; Cole SW, 2010, PSYCHONEUROENDOCRINO, V35, P955, DOI 10.1016/j.psyneuen.2010.06.008; Dusek JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002576; Dysvik B, 2001, BIOINFORMATICS, V17, P369, DOI 10.1093/bioinformatics/17.4.369; Garland EL, 2009, HEALTH SOC WORK, V34, P191, DOI 10.1093/hsw/34.3.191; GLASER R, 1986, BEHAV NEUROSCI, V100, P675, DOI 10.1037/0735-7044.100.5.675; Janakiramaiah N, 2000, J AFFECT DISORDERS, V57, P255, DOI 10.1016/S0165-0327(99)00079-8; Kim J, 2010, NATURE, V464, P1048, DOI 10.1038/nature08895; Kjellgren Anette, 2007, BMC Complement Altern Med, V7, P43, DOI 10.1186/1472-6882-7-43; Klokk TI, 2007, CANCER RES, V67, P5221, DOI 10.1158/0008-5472.CAN-06-4728; Kuntsevich V, 2010, MT SINAI J MED, V77, P559, DOI 10.1002/msj.20214; Li QZ, 2005, J ALTERN COMPLEM MED, V11, P29, DOI 10.1089/acm.2005.11.29; Marks PW, 1998, J CELL SCI, V111, P2129; Nahin Richard L, 2009, Natl Health Stat Report, P1; NIEMAN DC, 1995, INT J SPORTS MED, V16, P404, DOI 10.1055/s-2007-973028; Orange JS, 2008, NAT REV IMMUNOL, V8, P713, DOI 10.1038/nri2381; Pilkington K, 2005, J AFFECT DISORDERS, V89, P13, DOI 10.1016/j.jad.2005.08.013; Pullen PR, 2008, J CARD FAIL, V14, P407, DOI 10.1016/j.cardfail.2007.12.007; Ross A, 2010, J ALTERN COMPLEM MED, V16, P3, DOI 10.1089/acm.2009.0044; Shankar SSR, 2010, PATANJALI YOGA SUTRA; Sharma H, 2003, BIOL PSYCHOL, V63, P281, DOI 10.1016/S0301-0511(03)00071-1; Sharma H, 2008, J PSYCHOSOM RES, V64, P213, DOI 10.1016/j.jpsychores.2007.07.003; SHINKAI S, 1992, INT J SPORTS MED, V13, P452, DOI 10.1055/s-2007-1021297; SHIVDASANI RA, 1995, P NATL ACAD SCI USA, V92, P8690, DOI 10.1073/pnas.92.19.8690; Shivdasani RA, 2001, STEM CELLS, V19, P397, DOI 10.1634/stemcells.19-5-397; Snyderman R, 2002, ARCH INTERN MED, V162, P395, DOI 10.1001/archinte.162.4.395; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Yeung KY, 2001, BIOINFORMATICS, V17, P763, DOI 10.1093/bioinformatics/17.9.763	32	48	48	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2013	8	4							e61910	10.1371/journal.pone.0061910	http://dx.doi.org/10.1371/journal.pone.0061910			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IK	23613970	gold, Green Published			2022-12-25	WOS:000317907200102
J	Gineste, C; Le Fur, Y; Vilmen, C; Le Troter, A; Pecchi, E; Cozzone, PJ; Hardeman, EC; Bendahan, D; Gondin, J				Gineste, Charlotte; Le Fur, Yann; Vilmen, Christophe; Le Troter, Arnaud; Pecchi, Emilie; Cozzone, Patrick J.; Hardeman, Edna C.; Bendahan, David; Gondin, Julien			Combined MRI and P-31-MRS Investigations of the ACTA1(H40Y) Mouse Model of Nemaline Myopathy Show Impaired Muscle Function and Altered Energy Metabolism	PLOS ONE			English	Article							ALPHA-ACTIN GENE; MAGNETIC-RESONANCE-SPECTROSCOPY; SERUM-RESPONSE FACTOR; SKELETAL-MUSCLE; CONGENITAL MYOPATHIES; MUSCULAR-DYSTROPHY; MUTATIONS; BIOENERGETICS; DISEASE; FIBERS	Nemaline myopathy (NM) is the most common disease entity among non-dystrophic skeletal muscle congenital diseases. Mutations in the skeletal muscle a-actin gene (ACTA1) account for,25% of all NM cases and are the most frequent cause of severe forms of NM. So far, the mechanisms underlying muscle weakness in NM patients remain unclear. Additionally, recent Magnetic Resonance Imaging (MRI) studies reported a progressive fatty infiltration of skeletal muscle with a specific muscle involvement in patients with ACTA1 mutations. We investigated strictly noninvasively the gastrocnemius muscle function of a mouse model carrying a mutation in the ACTA1 gene (H40Y). Skeletal muscle anatomy (hindlimb muscles and fat volumes) and energy metabolism were studied using MRI and 31 Phosphorus magnetic resonance spectroscopy. Skeletal muscle contractile performance was investigated while applying a force-frequency protocol (from 1-150 Hz) and a fatigue protocol (80 stimuli at 40 Hz). H40Y mice showed a reduction of both absolute (240%) and specific (225%) maximal force production as compared to controls. Interestingly, muscle weakness was associated with an improved resistance to fatigue (+ 40%) and an increased energy cost. On the contrary, the force frequency relationship was not modified in H40Y mice and the extent of fatty infiltration was minor and not different from the WT group. We concluded that the H40Y mouse model does not reproduce human MRI findings but shows a severe muscle weakness which might be related to an alteration of intrinsic muscular properties. The increased energy cost in H40Y mice might be related to either an impaired mitochondrial function or an alteration at the cross-bridges level. Overall, we provided a unique set of anatomic, metabolic and functional biomarkers that might be relevant for monitoring the progression of NM disease but also for assessing the efficacy of potential therapeutic interventions at a preclinical level.	[Gineste, Charlotte; Le Fur, Yann; Vilmen, Christophe; Le Troter, Arnaud; Pecchi, Emilie; Cozzone, Patrick J.; Bendahan, David; Gondin, Julien] Aix Marseille Univ, CNRS, Ctr Resonance Magnet Biol & Med, Unite Mixte Rech, Marseille, France; [Hardeman, Edna C.] Univ New S Wales, Sch Med Sci, Sydney, NSW, Australia	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; University of New South Wales Sydney	Gondin, J (corresponding author), Aix Marseille Univ, CNRS, Ctr Resonance Magnet Biol & Med, Unite Mixte Rech, Marseille, France.	julien.gondin@univ-amu.fr	GONDIN, Julien/D-6877-2019; Bendahan, David/AAU-1420-2020	Hardeman, Edna/0000-0003-1649-7712	ERA-NET E-Rare; French Ministry of Higher Education and Research; Association Franc, aise contre les Myopathies (AFM)	ERA-NET E-Rare; French Ministry of Higher Education and Research; Association Franc, aise contre les Myopathies (AFM)(Association Francaise contre les Myopathies)	This work was funded by the ERA-NET E-Rare "European research projects on rare diseases''(grant NEMMYOP). Charlotte GINESTE was supported by a fellowship from the French Ministry of Higher Education and Research and by the Association Franc, aise contre les Myopathies (AFM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACHTEN E, 1990, J APPL PHYSIOL, V68, P644, DOI 10.1152/jappl.1990.68.2.644; Agrawal PB, 2004, ANN NEUROL, V56, P86, DOI 10.1002/ana.20157; Baligand C, 2011, NMR BIOMED, V24, P281, DOI 10.1002/nbm.1587; Bang ML, 2009, FASEB J, V23, P4117, DOI 10.1096/fj.09-137729; BARCLAY CJ, 1993, J PHYSIOL-LONDON, V472, P61, DOI 10.1113/jphysiol.1993.sp019937; Bendahan D, 2002, REV NEUROL-FRANCE, V158, P527; Charvet C, 2006, MOL CELL BIOL, V26, P6664, DOI 10.1128/MCB.00138-06; Clarkson E, 2004, J PATHOL, V204, P407, DOI 10.1002/path.1648; Cole MA, 2002, NEUROMUSCULAR DISORD, V12, P247, DOI 10.1016/S0960-8966(01)00278-4; Crawford K, 2002, MOL CELL BIOL, V22, P5887, DOI 10.1128/MCB.22.16.5887-5896.2002; D'Antona G, 2006, J PHYSIOL-LONDON, V570, P611, DOI 10.1113/jphysiol.2005.101642; Giannesini B, 2004, MAGN RESON MATER PHY, V17, P210, DOI 10.1007/s10334-004-0080-6; Giannesini B, 2010, MAGN RESON MED, V64, P262, DOI 10.1002/mrm.22386; Gineste C, 2013, NEUROMUSCUL DISORD; Gondin J, 2006, MED SCI SPORT EXER, V38, P1147, DOI 10.1249/01.mss.0000222843.04510.ca; Gordon AM, 2000, PHYSIOL REV, V80, P853, DOI 10.1152/physrev.2000.80.2.853; HENRIKSEN O, 1994, ACTA RADIOL, V35, P96; Hunter SK, 2001, J APPL PHYSIOL, V91, P2686, DOI 10.1152/jappl.2001.91.6.2686; Jungbluth H, 2004, NEUROMUSCULAR DISORD, V14, P779, DOI 10.1016/j.nmd.2004.08.005; Jungbluth H, 2001, NEUROMUSCULAR DISORD, V11, P35, DOI 10.1016/S0960-8966(00)00167-X; Laing NG, 2009, HUM MUTAT, V30, P1267, DOI 10.1002/humu.21059; Lanza IR, 2011, J MAGN RESON IMAGING, V34, P1143, DOI 10.1002/jmri.22733; Lawlor MW, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-23; Le Fur Y, 2010, MAGN RESON MATER PHY, V23, P23, DOI 10.1007/s10334-009-0186-y; Liu M, 2007, P NATL ACAD SCI USA, V104, P371, DOI 10.1073/pnas.0609870104; Marston S, 2004, NEUROMUSCULAR DISORD, V14, P167, DOI 10.1016/j.nmd.2003.11.003; MOON RB, 1973, J BIOL CHEM, V248, P7276; Nguyen MAT, 2011, BRAIN, V134, P3513, DOI 10.1093/brain/awr274; Nguyen MAT, 2008, ADV EXP MED BIOL, V642, P66; North KN, 1997, J MED GENET, V34, P705, DOI 10.1136/jmg.34.9.705; Nowak KJ, 1999, NAT GENET, V23, P208, DOI 10.1038/13837; Nunes PM, 2012, AM J PHYSIOL-ENDOC M, V303, pE71, DOI 10.1152/ajpendo.00597.2011; Ochala J, 2008, J PHYSIOL-LONDON, V586, P2993, DOI 10.1113/jphysiol.2008.153650; Ochala J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045923; Ochala J, 2010, NEUROMUSCULAR DISORD, V20, P98, DOI 10.1016/j.nmd.2009.11.010; Ottenheijm CAC, 2011, HUM MOL GENET, V20, P2015, DOI 10.1093/hmg/ddr084; Ottenheijm CAC, 2010, J STRUCT BIOL, V170, P334, DOI 10.1016/j.jsb.2009.11.013; PARK JH, 1987, P NATL ACAD SCI USA, V84, P8976, DOI 10.1073/pnas.84.24.8976; Positano V, 2009, J MAGN RESON IMAGING, V29, P677, DOI 10.1002/jmri.21699; Quijano-Roy S, 2011, SEMIN PEDIATR NEUROL, V18, P221, DOI 10.1016/j.spen.2011.10.003; Ravenscroft G, 2011, BRAIN, V134, P1101, DOI 10.1093/brain/awr004; Ravenscroft G, 2011, NEUROMUSCULAR DISORD, V21, P31, DOI 10.1016/j.nmd.2010.08.005; Sanoudou D, 2003, P NATL ACAD SCI USA, V100, P4666, DOI 10.1073/pnas.0330960100; Sanoudou D, 2001, TRENDS MOL MED, V7, P362, DOI 10.1016/S1471-4914(01)02089-5; Schnell C, 2000, NEUROMUSCULAR DISORD, V10, P307, DOI 10.1016/S0960-8966(99)00123-6; Sparrow JC, 2003, NEUROMUSCULAR DISORD, V13, P519, DOI 10.1016/S0960-8966(03)00101-9; Torriani M, 2012, SKELETAL RADIOL, V41, P437, DOI 10.1007/s00256-011-1240-1; Truett GE, 2000, BIOTECHNIQUES, V29, P52, DOI 10.2144/00291bm09; Visegrady B, 2010, BIOCHEM J, V427, P41, DOI 10.1042/BJ20091641; Wallgren-Pettersson C, 2004, NEUROMUSCULAR DISORD, V14, P461, DOI 10.1016/j.nmd.2004.03.006; Wallgren-Pettersson C, 2011, SEMIN PEDIATR NEUROL, V18, P230, DOI 10.1016/j.spen.2011.10.004; Walter G, 2005, MAGN RESON MED, V54, P1369, DOI 10.1002/mrm.20721; Wang CH, 2012, J CHILD NEUROL, V27, P363, DOI 10.1177/0883073812436605; Wary C, 2012, NMR BIOMED, V25, P1160, DOI 10.1002/nbm.2785; YOUNKIN DP, 1987, NEUROLOGY, V37, P165, DOI 10.1212/WNL.37.1.165	55	14	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2013	8	4							e61517	10.1371/journal.pone.0061517	http://dx.doi.org/10.1371/journal.pone.0061517			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130DR	23613869	gold, Green Submitted, Green Published			2022-12-25	WOS:000317893400072
J	Hu, ZH; Zhou, J; Wang, HB; Zhang, M; Li, SG; Huang, YZ; Wu, J; Li, ZW; Zhou, L; Zheng, SS				Hu, Zhenhua; Zhou, Jie; Wang, Haibo; Zhang, Min; Li, Shaogang; Huang, Yuzhou; Wu, Jian; Li, Zhiwei; Zhou, Lin; Zheng, Shusen			Survival in Liver Transplant Recipients with Hepatitis B- or Hepatitis C-Associated Hepatocellular Carcinoma: The Chinese Experience from 1999 to 2010	PLOS ONE			English	Article							NATURAL-HISTORY; VIRAL-INFECTION; VIRUS-INFECTION; GENE-EXPRESSION; RECURRENCE; CIRRHOSIS; RISK; PROPHYLAXIS; PROGRESSION; MICROARRAY	Background: Hepatitis B virus-associated hepatocellular carcinoma (HBV-HCC) and hepatitis C virus (HCV)-HCC are the main indications for liver transplantation. We compared differences in survival outcomes between these two conditions. Methods and Findings: The China Liver Transplant Registry (CLTR) contains data collated from all transplants performed in 86 liver transplantation centers across China. We analyzed CLTR data from January 1999 to December 2010. In all, 7,658 patients (7,162 with HBV-HCC and 496 with HCV-HCC) were included in this study. Clinical characteristics were compared between the HBV-HCC and HCV-HCC groups; Kaplan-Meier analysis was used to calculate the overall, tumor-free and hepatitis-free survival rates. The 1-year, 3-year and 5-year overall survival was significantly higher in HBV-HCC recipients than in HCV-HCC recipients (76.65%, 56.61% and 49.10% vs. 64.59%, 42.78% and 39.20%, respectively; P<0.001). The corresponding tumor-free survival rates (63.55%, 47.37%, 40.99% vs. 56.84%, 38.04%, 35.66%, respectively) and hepatitis-free survival rates (75.49%, 54.84%, 47.34% vs. 63.87%, 42.15%, 39.33%, respectively) were both superior in HBV-HCC recipients (both P<0.001). Multivariate analyses identified hepatitis, preoperative alpha-fetoprotein (AFP) level, size of largest tumor, number of tumor nodules, TNM stage, vascular invasion and preoperative model for end-stage liver disease (MELD) score as independent predictors of overall, tumor-free and hepatitis-free survival. Conclusions: Survival outcomes after liver transplantation were significantly better in HBV-HCC patients than in HCV-HCC patients. This finding may be used to guide donor liver allocation in transplantation programs.	[Hu, Zhenhua; Zhou, Jie; Zhang, Min; Wu, Jian; Li, Zhiwei; Zhou, Lin; Zheng, Shusen] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Hepatobiliary & Pancreat Surg, Hangzhou 310003, Zhejiang, Peoples R China; [Hu, Zhenhua; Zhou, Jie; Zhang, Min; Wu, Jian; Li, Zhiwei; Zhou, Lin; Zheng, Shusen] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Minist Publ Hlth,Key Lab Combined Multiorgan Tran, Hangzhou 310003, Zhejiang, Peoples R China; [Hu, Zhenhua; Zhou, Jie; Zhang, Min; Wu, Jian; Li, Zhiwei; Zhou, Lin; Zheng, Shusen] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Key Lab Organ Transplantat, Hangzhou 310003, Zhejiang, Peoples R China; [Wang, Haibo; Li, Shaogang; Huang, Yuzhou] China Liver Transplant Registry, Hong Kong, Hong Kong, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University	Zheng, SS (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Hepatobiliary & Pancreat Surg, Hangzhou 310003, Zhejiang, Peoples R China.	shusenzheng@zju.edu.cn			National Natural Science Foundation of China [31140004]; National Basic Research Program of China (973 Program) [2009CB522403]; Foundation for Innovative Research Groups of the National Natural Science Foundation of China [81121002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); Foundation for Innovative Research Groups of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China [grant number 31140004]; the National Basic Research Program of China (973 Program) [grant number 2009CB522403]; and the Foundation for Innovative Research Groups of the National Natural Science Foundation of China [grant number 81121002]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belli LS, 2012, DIG LIVER DIS; Berenguer M, 2000, HEPATOLOGY, V32, P852, DOI 10.1053/jhep.2000.17924; Berenguer M, 2000, J HEPATOL, V32, P673, DOI 10.1016/S0168-8278(00)80231-7; Berenguer M, 2002, LIVER TRANSPLANT, V8, pS14, DOI 10.1053/jlts.2002.35781; Bozorgzadeh A, 2007, LIVER TRANSPLANT, V13, P807, DOI 10.1002/lt.21054; Burra P, 2009, DIGEST LIVER DIS, V41, P350, DOI 10.1016/j.dld.2008.09.018; Castello G, 2010, CLIN IMMUNOL, V134, P237, DOI 10.1016/j.clim.2009.10.007; Chisari FV, 2005, NATURE, V436, P930, DOI 10.1038/nature04076; Cholongitas E, 2011, LIVER TRANSPLANT, V17, P1176, DOI 10.1002/lt.22354; Chun J, 2010, AM J TRANSPLANT, V10, P1649, DOI 10.1111/j.1600-6143.2010.03162.x; Custer B, 2004, J CLIN GASTROENTEROL, V38, pS158, DOI 10.1097/00004836-200411003-00008; DIBISCEGLIE AM, 1994, J CLIN GASTROENTEROL, V19, P222, DOI 10.1097/00004836-199410000-00011; Farazi PA, 2006, NAT REV CANCER, V6, P674, DOI 10.1038/nrc1934; Faria LC, 2008, GASTROENTEROLOGY, V134, P1890, DOI 10.1053/j.gastro.2008.02.064; Feray C, 1999, GASTROENTEROLOGY, V117, P619, DOI 10.1016/S0016-5085(99)70454-3; Firpi RJ, 2002, LIVER TRANSPLANT, V8, P1000, DOI 10.1053/jlts.2002.34968; Forman LM, 2002, GASTROENTEROLOGY, V122, P889, DOI 10.1053/gast.2002.32418; Gane EJ, 2008, LIVER TRANSPLANT, V14, pS36, DOI 10.1002/lt.21646; Han SH, 2011, CLIN TRANSPLANT, V25, pE152, DOI 10.1111/j.1399-0012.2010.01349.x; Iizuka N, 2002, CANCER RES, V62, P3939; JOHNSON RJ, 1990, KIDNEY INT, V37, P663, DOI 10.1038/ki.1990.32; Kim W, 2003, CLIN CANCER RES, V9, P5493; Lai CL, 2003, LANCET, V362, P2089, DOI 10.1016/S0140-6736(03)15108-2; Lee JP, 2010, NEPHROL DIAL TRANSPL, V25, P2772, DOI 10.1093/ndt/gfq093; Li MR, 2011, DIGESTION, V84, P134, DOI 10.1159/000324197; Liu J, 2007, LANCET, V369, P1582, DOI 10.1016/S0140-6736(07)60723-5; Mazzaferro V, 1996, NEW ENGL J MED, V334, P693, DOI 10.1056/NEJM199603143341104; Miyagawa S, 1996, HEPATOLOGY, V24, P307; Neuveut C, 2010, J HEPATOL, V52, P594, DOI 10.1016/j.jhep.2009.10.033; Okabe H, 2001, CANCER RES, V61, P2129; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Parkin DM, 2006, INT J CANCER, V118, P3030, DOI 10.1002/ijc.21731; Rehermann B, 2005, NAT REV IMMUNOL, V5, P215, DOI 10.1038/nri1573; Saab S, 2009, LIVER TRANSPLANT, V15, P1525, DOI 10.1002/lt.21882; Schlitt HJ, 1999, J CLIN ONCOL, V17, P324, DOI 10.1200/JCO.1999.17.1.324; Seehofer D, 2005, TRANSPLANTATION, V80, pS120, DOI 10.1097/01.tp.0000186919.00303.ec; SHIRATORI Y, 1995, HEPATOLOGY, V22, P1027, DOI 10.1002/hep.1840220403; Sievert W, 2011, LIVER INT, V31, P61, DOI 10.1111/j.1478-3231.2011.02540.x; Stroffolini T, 1998, J HEPATOL, V29, P944, DOI 10.1016/S0168-8278(98)80122-0; Waki K, 2011, TRANSPLANTATION, V92, P809, DOI 10.1097/TP.0b013e31822d4dc3; WEINER A, 1995, P NATL ACAD SCI USA, V92, P2755, DOI 10.1073/pnas.92.7.2755; WONG PYN, 1995, AM J GASTROENTEROL, V90, P29; Yataco M, 2010, ANN TRANSPL, V15, P27; Yi NJ, 2007, LIVER TRANSPLANT, V13, P451, DOI 10.1002/lt.21043; Zheng SS, 2008, TRANSPLANTATION, V85, P1726, DOI 10.1097/TP.0b013e31816b67e4; Zimmerman MA, 2007, TRANSPL P, V39, P3276, DOI 10.1016/j.transproceed.2007.07.085	46	16	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2013	8	4							e61620	10.1371/journal.pone.0061620	http://dx.doi.org/10.1371/journal.pone.0061620			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130DR	23613886	Green Published, Green Submitted, gold			2022-12-25	WOS:000317893400082
J	Huong, LT; Kobayashi, M; Nakata, M; Shioi, G; Miyachi, H; Honjo, T; Nagaoka, H				Huong, Le Thi; Kobayashi, Maki; Nakata, Mikiyo; Shioi, Go; Miyachi, Hitoshi; Honjo, Tasuku; Nagaoka, Hitoshi			In Vivo Analysis of Aicda Gene Regulation: A Critical Balance between Upstream Enhancers and Intronic Silencers Governs Appropriate Expression	PLOS ONE			English	Article							INDUCED-CYTIDINE-DEAMINASE; NF-KAPPA-B; CLASS-SWITCH RECOMBINATION; ACTIVATION-INDUCED DEAMINASE; SOMATIC HYPERMUTATION; AID EXPRESSION; CONSTITUTIVE EXPRESSION; TRANSCRIPTION FACTOR; IMMUNE-RESPONSE; CELLS	The Aicda gene encodes activation-induced cytidine deaminase (AID). Aicda is strongly transcribed in activated B cells to diversify immunoglobulin genes, but expressed at low levels in various other cells in response to physiological or pathological stimuli. AID's mutagenic nature has been shown to be involved in tumor development. Here, we used a transgenic strategy with bacterial artificial chromosomes (BACs) to examine the in vivo functions of Aicda regulatory elements, which cluster in two regions: in the first intron (region 2), and approximately 8-kb upstream of the transcription start site (region 4). Deleting either of these regions completely abolished the expression of Aicda-BAC reporters, demonstrating these elements' critical roles. Furthermore, we found that selectively deleting two C/EBP-binding sites in region 4 inactivated the enhancer activity of the region despite the presence of intact NF-kappa B-, STAT6- and Smad-binding sites. On the other hand, selectively deleting E2F- and c-Myb-binding sites in region 2 increased the frequency of germinal-center B cells in which the Aicda promoter was active, indicating that E2F and c-Myb act as silencers in vivo. Interestingly, the silencer deletion did not cause ectopic activation of the Aicda promoter, indicating that Aicda activation requires enhancer-specific stimulation. In summary, precise regulation of the Aicda promoter appears to depend on a coordinated balance of activities between enhancer and silencer elements.	[Huong, Le Thi; Kobayashi, Maki; Nakata, Mikiyo; Honjo, Tasuku] Kyoto Univ, Grad Sch Med, Dept Immunol & Genom Med, Kyoto, Japan; [Nagaoka, Hitoshi] Gifu Univ, Grad Sch Med, Dept Mol Pathobiochem, Gifu, Japan; [Shioi, Go] RIKEN Ctr Dev Biol, Lab Anim Resources & Genet Engn, Kobe, Hyogo, Japan; [Miyachi, Hitoshi] Kyoto Univ, Inst Virus Res, Reprod Engn Team, Kyoto 606, Japan	Kyoto University; Gifu University; RIKEN; Kyoto University	Nagaoka, H (corresponding author), Gifu Univ, Grad Sch Med, Dept Mol Pathobiochem, Gifu, Japan.	nagaokh@gifu-u.ac.jp	Honjo, Tasuku/N-4470-2016		Ministry of Education, Culture, Sports, Science and Technology of Japan; KAKENHI [17002015]; Takeda Science Foundation (HN);  [11016207]; Grants-in-Aid for Scientific Research [23659151] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Takeda Science Foundation (HN); ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Supported by the Ministry of Education, Culture, Sports, Science and Technology of Japan, KAKENHI Grant-in-AID for Special Promoted Research 17002015 (TH), Grant-in-AID for Sicentific Research 11016207 (HN), and Takeda Science Foundation (HN) (http://www.takeda-sci.or.jp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen J, 2005, J BIOL CHEM, V280, P16354, DOI 10.1074/jbc.M411134200; Crouch EE, 2007, J EXP MED, V204, P1145, DOI 10.1084/jem.20061952; Epeldegui M, 2007, MOL IMMUNOL, V44, P934, DOI 10.1016/j.molimm.2006.03.018; Fagarasan S, 2002, SCIENCE, V298, P1424, DOI 10.1126/science.1077336; Fan J, 2010, J VIROL, V84, P7278, DOI 10.1128/JVI.02239-09; Frolov MV, 2004, J CELL SCI, V117, P2173, DOI 10.1242/jcs.01227; Gonda H, 2003, J EXP MED, V198, P1427, DOI 10.1084/jem.20030802; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Honjo T, 2012, ADV CANCER RES, V113, P1, DOI 10.1016/B978-0-12-394280-7.00001-4; Ishikawa C, 2011, CARCINOGENESIS, V32, P110, DOI 10.1093/carcin/bgq222; JACOB J, 1991, J EXP MED, V173, P1165, DOI 10.1084/jem.173.5.1165; Kato L, 2012, P NATL ACAD SCI USA, V109, P2479, DOI 10.1073/pnas.1120791109; Kotani A, 2005, P NATL ACAD SCI USA, V102, P4506, DOI 10.1073/pnas.0500830102; Kuraoka M, 2011, P NATL ACAD SCI USA, V108, P11560, DOI 10.1073/pnas.1102571108; Kwon K, 2008, IMMUNITY, V28, P751, DOI 10.1016/j.immuni.2008.04.014; LALMANACHGIRARD AC, 1993, J EXP MED, V177, P1215, DOI 10.1084/jem.177.4.1215; LECLAIR KP, 1992, P NATL ACAD SCI USA, V89, P8145, DOI 10.1073/pnas.89.17.8145; Liu M, 2008, NATURE, V451, P841, DOI 10.1038/nature06547; Luche H, 2007, EUR J IMMUNOL, V37, P43, DOI 10.1002/eji.200636745; Machida K, 2004, P NATL ACAD SCI USA, V101, P4262, DOI 10.1073/pnas.0303971101; Mao CC, 2004, IMMUNITY, V20, P133, DOI 10.1016/S1074-7613(04)00019-6; Matsumoto Y, 2007, NAT MED, V13, P470, DOI 10.1038/nm1566; MATSUSAKA T, 1993, P NATL ACAD SCI USA, V90, P10193, DOI 10.1073/pnas.90.21.10193; Meyers G, 2011, P NATL ACAD SCI USA, V108, P11554, DOI 10.1073/pnas.1102600108; Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Nagaoka H, 2002, J EXP MED, V195, P529, DOI 10.1084/jem.20012144; Nagaoka H, 2010, INT IMMUNOL, V22, P227, DOI 10.1093/intimm/dxq023; Okazaki I, 2003, J EXP MED, V197, P1173, DOI 10.1084/jem.20030275; Park SR, 2009, NAT IMMUNOL, V10, P540, DOI 10.1038/ni.1725; Park SR, 2012, CYTOKINE; Pavri R, 2010, CELL, V143, P122, DOI 10.1016/j.cell.2010.09.017; Petersen S, 2001, NATURE, V414, P660, DOI 10.1038/414660a; Poli V, 1998, J BIOL CHEM, V273, P29279, DOI 10.1074/jbc.273.45.29279; Qin HY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029141; Ramiro AR, 2004, CELL, V118, P431, DOI 10.1016/j.cell.2004.08.006; Ramji DP, 2002, BIOCHEM J, V365, P561, DOI 10.1042/BJ20020508; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; Sayegh CE, 2003, NAT IMMUNOL, V4, P586, DOI 10.1038/ni923; Takahashi Y, 2001, IMMUNITY, V14, P181, DOI 10.1016/S1074-7613(01)00100-5; Takai A, 2009, ONCOGENE, V28, P469, DOI 10.1038/onc.2008.415; Takeda K, 1997, J MOL MED-JMM, V75, P317, DOI 10.1007/s001090050117; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Takizawa M, 2008, J EXP MED, V205, P1949, DOI 10.1084/jem.20081007; Tran TH, 2010, NAT IMMUNOL, V11, P148, DOI 10.1038/ni.1829; Ueda Y, 2007, J IMMUNOL, V178, P3593, DOI 10.4049/jimmunol.178.6.3593; Yadav A, 2006, MOL IMMUNOL, V43, P529, DOI 10.1016/j.molimm.2005.05.007; Yamane A, 2011, NAT IMMUNOL, V12, P62, DOI 10.1038/ni.1964	48	6	6	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2013	8	4							e61433	10.1371/journal.pone.0061433	http://dx.doi.org/10.1371/journal.pone.0061433			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130DR	23613851	gold, Green Submitted, Green Published			2022-12-25	WOS:000317893400065
J	Furst, CM; Morgelin, M; Vadstrup, K; Heinegard, D; Aspberg, A; Blom, AM				Furst, Camilla Melin; Morgelin, Matthias; Vadstrup, Kasper; Heinegard, Dick; Aspberg, Anders; Blom, Anna M.			The C-Type Lectin of the Aggrecan G3 Domain Activates Complement	PLOS ONE			English	Article							INHIBITOR C4B-BINDING PROTEIN; COLLAGEN-INDUCED ARTHRITIS; EXTRACELLULAR-MATRIX; FACTOR-H; RHEUMATOID-ARTHRITIS; PROTEOGLYCANS; C1Q; CARTILAGE; VERSICAN; BINDING	Excessive complement activation contributes to joint diseases such as rheumatoid arthritis and osteoarthritis during which cartilage proteins are fragmented and released into the synovial fluid. Some of these proteins and fragments activate complement, which may sustain inflammation. The G3 domain of large cartilage proteoglycan aggrecan interacts with other extracellular matrix proteins, fibulins and tenascins, via its C-type lectin domain (CLD) and has important functions in matrix organization. Fragments containing G3 domain are released during normal aggrecan turnover, but increasingly so in disease. We now show that the aggrecan CLD part of the G3 domain activates the classical and to a lesser extent the alternative pathway of complement, via binding of C1q and C3, respectively. The complement control protein (CCP) domain adjacent to the CLD showed no effect on complement initiation. The binding of C1q to G3 depended on ionic interactions and was decreased in D2267N mutant G3. However, the observed complement activation was attenuated due to binding of complement inhibitor factor H to CLD and CCP domains. This was most apparent at the level of deposition of terminal complement components. Taken together our observations indicate aggrecan CLD as one factor involved in the sustained inflammation of the joint.	[Furst, Camilla Melin; Blom, Anna M.] Lund Univ, Dept Lab Med, Div Med Prot Chem, Malmo, Sweden; [Morgelin, Matthias] Lund Univ, Dept Clin Sci, Div Infect Med, Lund, Sweden; [Vadstrup, Kasper; Aspberg, Anders] Univ Copenhagen, Dept Biol, Copenhagen, Denmark; [Heinegard, Dick] Lund Univ, Dept Clin Sci, Rheumatol Sect, Lund, Sweden	Lund University; Lund University; University of Copenhagen; Lund University	Blom, AM (corresponding author), Lund Univ, Dept Lab Med, Div Med Prot Chem, Malmo, Sweden.	anna.blom@med.lu.se	Blom, Anna/AFS-7369-2022; Blom, Anna/B-9607-2009	Blom, Anna/0000-0002-1348-1734; Vadstrup, Kasper/0000-0002-4041-0536; Aspberg, Anders/0000-0002-6588-6944; Melin Furst, Camilla/0000-0001-5487-4270	Swedish Research Council [K2012-66X-14928-09-5, K2011-52X-05668-32-3]; National Board of Health and Welfare	Swedish Research Council(Swedish Research CouncilEuropean Commission); National Board of Health and Welfare	This study was supported by grants from the Swedish Research Council (K2012-66X-14928-09-5, K2011-52X-05668-32-3, http://vr.se), the National Board of Health and Welfare (http://www.socialstyrelsen.se/english), the Foundations of Osterlund (http://www. alfredosterlundsstiftelse.se), Greta and Johan Kock (http://www.kockskastiftelsen.se), King Gustav Vs 80th Anniversary, Knut and Alice Wallenberg (http://www. wallenberg. com/kaw), Inga-Britt and Arne Lundberg (http://www.lundbergsstiftelsen.se), Lundbeck (http://www. lundbeckincgrants. com), Carlsberg (http://www. carlsbergfondet. dk), Gigtforeningen (http://www.gigtforeningen.dk) and a grant from the Ska ne University Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aspberg A, 1999, J BIOL CHEM, V274, P20444, DOI 10.1074/jbc.274.29.20444; Aspberg A, 1997, P NATL ACAD SCI USA, V94, P10116, DOI 10.1073/pnas.94.19.10116; Aspberg A, 2012, J HISTOCHEM CYTOCHEM, V60, P987, DOI 10.1369/0022155412464376; BING DH, 1982, P NATL ACAD SCI-BIOL, V79, P4198, DOI 10.1073/pnas.79.13.4198; Blom AM, 2003, MOL IMMUNOL, V39, P547, DOI 10.1016/S0161-5890(02)00213-4; BOHNSACK JF, 1985, P NATL ACAD SCI USA, V82, P3824, DOI 10.1073/pnas.82.11.3824; DAHLBACK B, 1983, BIOCHEM J, V209, P847, DOI 10.1042/bj2090847; Day JM, 2004, J BIOL CHEM, V279, P12511, DOI 10.1074/jbc.M400242200; Dudhia J, 1996, BIOCHEM J, V313, P933, DOI 10.1042/bj3130933; ENGEL J, 1987, METHOD ENZYMOL, V145, P3; Ferreira VP, 2010, IMMUNOBIOLOGY, V215, P932, DOI 10.1016/j.imbio.2010.02.002; Groeneveld TWL, 2005, J IMMUNOL, V175, P4715, DOI 10.4049/jimmunol.175.7.4715; Happonen KE, 2012, IMMUNOBIOLOGY, V217, P1088, DOI 10.1016/j.imbio.2012.07.013; Happonen KE, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3694; Happonen KE, 2010, ARTHRITIS RHEUM-US, V62, P3574, DOI 10.1002/art.27720; Happonen KE, 2009, J IMMUNOL, V182, P1518, DOI 10.4049/jimmunol.182.3.1518; Hein E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015443; HEINEGARD D, 1987, METHOD ENZYMOL, V144, P319; Heinegard D, 2009, INT J EXP PATHOL, V90, P575, DOI 10.1111/j.1365-2613.2009.00695.x; Isogai Z, 2002, J BIOL CHEM, V277, P4565, DOI 10.1074/jbc.M110583200; Kiani C, 2002, CELL RES, V12, P19, DOI 10.1038/sj.cr.7290106; Kojouharova M, 2010, MOL IMMUNOL, V47, P2154, DOI 10.1016/j.molimm.2010.05.011; Lundell A, 2004, STRUCTURE, V12, P1495, DOI 10.1016/j.str.2004.05.021; Munthe-Fog L, 2007, SCAND J IMMUNOL, V65, P383, DOI 10.1111/j.1365-3083.2007.01915.x; Munthe-Fog L, 2008, MOL IMMUNOL, V45, P2660, DOI 10.1016/j.molimm.2007.12.012; Okroj M, 2007, ANN MED, V39, P517, DOI 10.1080/07853890701477546; Olin AI, 2001, J BIOL CHEM, V276, P1253, DOI 10.1074/jbc.M006783200; PAULSSON M, 1987, BIOCHEM J, V245, P763, DOI 10.1042/bj2450763; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Sjoberg A, 2005, J BIOL CHEM, V280, P32301, DOI 10.1074/jbc.M504828200; Sjoberg AP, 2009, TRENDS IMMUNOL, V30, P83, DOI 10.1016/j.it.2008.11.003; Sjoberg AP, 2008, MOL IMMUNOL, V45, P3213, DOI 10.1016/j.molimm.2008.02.023; Sjoberg AP, 2007, J BIOL CHEM, V282, P10894, DOI 10.1074/jbc.M610256200; Sjoberg AP, 2009, MOL IMMUNOL, V46, P830, DOI 10.1016/j.molimm.2008.09.018; Sjolander J, 2012, J BIOL CHEM, V287, P10824, DOI 10.1074/jbc.M111.244285; Song H, 2007, J IMMUNOL, V179, P7860, DOI 10.4049/jimmunol.179.11.7860; Stattin EL, 2010, AM J HUM GENET, V86, P126, DOI 10.1016/j.ajhg.2009.12.018; TENNER AJ, 1981, J IMMUNOL, V127, P648; Tompson SW, 2009, AM J HUM GENET, V84, P72, DOI 10.1016/j.ajhg.2008.12.001; Trouw LA, 2007, J BIOL CHEM, V282, P28540, DOI 10.1074/jbc.M704354200; VERTEL BM, 1994, BIOCHEM J, V301, P211, DOI 10.1042/bj3010211; Wang Q, 2011, NAT MED, V17, P1674, DOI 10.1038/nm.2543; WANG Y, 1995, P NATL ACAD SCI USA, V92, P8955, DOI 10.1073/pnas.92.19.8955	43	16	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2013	8	4							e61407	10.1371/journal.pone.0061407	http://dx.doi.org/10.1371/journal.pone.0061407			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125TD	23596522	Green Published, gold, Green Submitted			2022-12-25	WOS:000317563300029
J	Sole, RV; Valverde, S				Sole, Ricard V.; Valverde, Sergi			Before the Endless Forms: Embodied Model of Transition from Single Cells to Aggregates to Ecosystem Engineering	PLOS ONE			English	Article							DIFFERENTIAL ADHESION; MORPHOGENESIS; EXTINCTION; ORGANISMS; EVOLUTION; END; DIVERSIFICATION; ADAPTATION; RECOVERIES; MOVEMENT	The emergence of complex multicellular systems and their associated developmental programs is one of the major problems of evolutionary biology. The advantages of cooperation over individuality seem well known but it is not clear yet how such increase of complexity emerged from unicellular life forms. Current multicellular systems display a complex cell-cell communication machinery, often tied to large-scale controls of body size or tissue homeostasis. Some unicellular life forms are simpler and involve groups of cells cooperating in a tissue-like fashion, as it occurs with biofilms. However, before true gene regulatory interactions were widespread and allowed for controlled changes in cell phenotypes, simple cellular colonies displaying adhesion and interacting with their environments were in place. In this context, models often ignore the physical embedding of evolving cells, thus leaving aside a key component. The potential for evolving pre-developmental patterns is a relevant issue: how far a colony of evolving cells can go? Here we study these pre-conditions for morphogenesis by using CHIMERA, a physically embodied computational model of evolving virtual organisms in a pre-Mendelian world. Starting from a population of identical, independent cells moving in a fluid, the system undergoes a series of changes, from spatial segregation, increased adhesion and the development of generalism. Eventually, a major transition occurs where a change in the flow of nutrients is triggered by a sub-population. This ecosystem engineering phenomenon leads to a subsequent separation of the ecological network into two well defined compartments. The relevance of these results for evodevo and its potential ecological triggers is discussed.	[Sole, Ricard V.; Valverde, Sergi] Univ Pompeu Fabra, ICREA Complex Syst Lab, Barcelona, Spain; [Sole, Ricard V.] Santa Fe Inst, Santa Fe, NM 87501 USA; [Sole, Ricard V.; Valverde, Sergi] UPF CSIC, Inst Biol Evolut, Barcelona, Spain; [Sole, Ricard V.; Valverde, Sergi] C Foscari Univ Venice, European Ctr Living Technol, Venice, Italy	ICREA; Pompeu Fabra University; The Santa Fe Institute; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UPF - Institut de Biologia Evolutiva (IBE); Pompeu Fabra University; Universita Ca Foscari Venezia	Sole, RV (corresponding author), Univ Pompeu Fabra, ICREA Complex Syst Lab, Barcelona, Spain.	ricard.sole@upf.edu	Solé, Ricard/I-3379-2015; Valverde, Sergi/J-3275-2012	Valverde, Sergi/0000-0002-2150-9610; Sole, Ricard/0000-0001-6974-1008	James McDonnell Foundation; Fundacion Marcelino Botin; Santa Fe Institute;  [FIS2004-05422]; ICREA Funding Source: Custom	James McDonnell Foundation; Fundacion Marcelino Botin; Santa Fe Institute; ; ICREA(ICREA)	This work has been supported by grants of the James McDonnell Foundation (RVS, SV), Fundacion Marcelino Botin (RVS, SV), FIS2004-05422 (RVS) and by the Santa Fe Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bell N., 2005, P 2005 ACM SIGGRAPH, P77, DOI DOI 10.1145/1073368.1073379; Benton MJ, 2003, TRENDS ECOL EVOL, V18, P358, DOI 10.1016/S0169-5347(03)00093-4; Bonner J.T., 2001, 1 SIGNALS EVOLUTION, DOI [10.1515/9781400830589, DOI 10.1515/9781400830589]; CARROLL SB, 2005, ENDLESS FORMS MOST B; Chen ZQ, 2012, NAT GEOSCI, V5, P375, DOI [10.1038/NGEO1475, 10.1038/ngeo1475]; Coen E, 2004, P NATL ACAD SCI USA, V101, P4728, DOI 10.1073/pnas.0306308101; Cummings FW, 2006, INT J DEV BIOL, V50, P193, DOI 10.1387/ijdb.052058fc; Doursat R., 2008, ORGANIC COMPUTING, P167, DOI DOI 10.1007/978-3-540-77657-4_8; EGGENBERGER P, 1997, COM ADAP SY, P205; Eldredge N., 1985, UNFINISHED SYNSIS; Ericson C., 2005, REAL TIME COLLISION; Erwin DH, 2001, P NATL ACAD SCI USA, V98, P5399, DOI 10.1073/pnas.091092698; Erwin DH, 1998, TRENDS ECOL EVOL, V13, P344, DOI 10.1016/S0169-5347(98)01436-0; ERWIN DH, 1994, NATURE, V367, P231, DOI 10.1038/367231a0; Erwin DH, 2008, TRENDS ECOL EVOL, V23, P304, DOI 10.1016/j.tree.2008.01.013; Erwin DH, 2012, EVOL ECOL, V26, P417, DOI 10.1007/s10682-011-9505-7; Fedonkin M. A., 2007, RISE ANIMALS EVOLUTI, DOI [10.1017/S0016756808005645, DOI 10.1017/S0016756808005645]; Forgacs G, 2005, BIOLOGICAL PHYSICS OF THE DEVELOPING EMBRYO, P1, DOI 10.1017/CBO9780511755576; Fujimoto K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002772; GLAZIER JA, 1993, PHYS REV E, V47, P2128, DOI 10.1103/PhysRevE.47.2128; GRANER F, 1992, PHYS REV LETT, V69, P2013, DOI 10.1103/PhysRevLett.69.2013; Greig D, 2002, SCIENCE, V298, P1773, DOI 10.1126/science.1076374; Grosberg RK, 2007, ANNU REV ECOL EVOL S, V38, P621, DOI 10.1146/annurev.ecolsys.36.102403.114735; Hastings A, 2007, ECOL LETT, V10, P153, DOI 10.1111/j.1461-0248.2006.00997.x; Hogeweg P, 2000, ARTIF LIFE, V6, P85, DOI 10.1162/106454600568339; Hogeweg P, 2000, J THEOR BIOL, V203, P317, DOI 10.1006/jtbi.2000.1087; Jones CG, 1997, ECOLOGY, V78, P1946, DOI 10.1890/0012-9658(1997)078[1946:PANEOO]2.0.CO;2; JONES CG, 1994, OIKOS, V69, P373, DOI 10.2307/3545850; Kaandorp JA, 2008, P ROY SOC B-BIOL SCI, V275, P2569, DOI 10.1098/rspb.2008.0746; King N, 2004, DEV CELL, V7, P313, DOI 10.1016/j.devcel.2004.08.010; Knoll AH, 2011, ANNU REV EARTH PL SC, V39, P217, DOI 10.1146/annurev.earth.031208.100209; LENSKI RE, 1994, P NATL ACAD SCI USA, V91, P6808, DOI 10.1073/pnas.91.15.6808; Lipps J.H., 1992, ORIGIN EARLY EVOLUTI; McShea DW, 2001, PALEOBIOLOGY, V27, P405, DOI 10.1666/0094-8373(2001)027<0405:THSOOA>2.0.CO;2; Muller GB, 2007, NAT REV GENET, V8, P943, DOI 10.1038/nrg2219; Newman SA, 2006, INT J DEV BIOL, V50, P289, DOI 10.1387/ijdb.052049sn; Newman SA, 2008, PHYS BIOL, V5, DOI 10.1088/1478-3975/5/1/015008; Newman TJ, 2005, MATH BIOSCI ENG, V2, P613, DOI 10.3934/mbe.2005.2.613; Niklas K.J., 1997, EVOLUTIONARY BIOL PL; Palsson E, 2000, P NATL ACAD SCI USA, V97, P10448, DOI 10.1073/pnas.97.19.10448; Palsson E, 2001, FUTURE GENER COMP SY, V17, P835, DOI 10.1016/S0167-739X(00)00062-5; Pfeifer R, 2007, SCIENCE, V318, P1088, DOI 10.1126/science.1145803; Queller DC, 2000, PHILOS T R SOC B, V355, P1647, DOI 10.1098/rstb.2000.0727; Queller DC., 1997, Q REV BIOL, V72, P184, DOI [10.1086/419766, DOI 10.1086/419766]; Rainey PB, 1998, NATURE, V394, P69, DOI 10.1038/27900; Ratcliff WC, 2012, P NATL ACAD SCI USA, V109, P1595, DOI 10.1073/pnas.1115323109; Rokas A, 2008, CURR OPIN GENET DEV, V18, P472, DOI 10.1016/j.gde.2008.09.004; Roopnarine PD, 2006, PALEOBIOLOGY, V32, P1; Sandersius SA, 2008, PHYS BIOL, V5, DOI 10.1088/1478-3975/5/1/015002; Savill NJ, 1997, J THEOR BIOL, V184, P229, DOI 10.1006/jtbi.1996.0237; Sebe-Pedros A, 2010, P NATL ACAD SCI USA, V107, P10142, DOI 10.1073/pnas.1002257107; Sims Karl, 1994, Artificial Life, V1, P353, DOI 10.1162/artl.1994.1.4.353; Sole R., 2011, PHASE TRANSITIONS; Sole RV, 2003, INT J DEV BIOL, V47, P685; Sole RV, 2002, PHILOS T R SOC B, V357, P697, DOI 10.1098/rstb.2001.0987; Szathmary E, 1995, MAJOR TRANSITIONS EV; Ten Tusscher K. H., 2011, PLOS COMPUT BIOL, V7, DOI [DOI 10.1371/JOURNAL.PCBI.1002208, 10.1371/journal.pcbi.1002208]; TRAVISANO M, 1995, SCIENCE, V267, P87, DOI 10.1126/science.7809610; Yedid G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037233	59	13	13	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2013	8	4							e59664	10.1371/journal.pone.0059664	http://dx.doi.org/10.1371/journal.pone.0059664			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125TD	23596506	Green Published, gold, Green Submitted			2022-12-25	WOS:000317563300002
J	Abdullah, A; Deris, S; Mohamad, MS; Anwar, S				Abdullah, Afnizanfaizal; Deris, Safaai; Mohamad, Mohd Saberi; Anwar, Sohail			An Improved Swarm Optimization for ParameterA Estimation and Biological Model Selection	PLOS ONE			English	Article							DIFFERENTIAL EVOLUTION; GLOBAL OPTIMIZATION; SYSTEMS BIOLOGY; ALGORITHMS; EFFICIENT	One of the key aspects of computational systems biology is the investigation on the dynamic biological processes within cells. Computational models are often required to elucidate the mechanisms and principles driving the processes because of the nonlinearity and complexity. The models usually incorporate a set of parameters that signify the physical properties of the actual biological systems. In most cases, these parameters are estimated by fitting the model outputs with the corresponding experimental data. However, this is a challenging task because the available experimental data are frequently noisy and incomplete. In this paper, a new hybrid optimization method is proposed to estimate these parameters from the noisy and incomplete experimental data. The proposed method, called Swarm-based Chemical Reaction Optimization, integrates the evolutionary searching strategy employed by the Chemical Reaction Optimization, into the neighbouring searching strategy of the Firefly Algorithm method. The effectiveness of the method was evaluated using a simulated nonlinear model and two biological models: synthetic transcriptional oscillators, and extracellular protease production models. The results showed that the accuracy and computational speed of the proposed method were better than the existing Differential Evolution, Firefly Algorithm and Chemical Reaction Optimization methods. The reliability of the estimated parameters was statistically validated, which suggests that the model outputs produced by these parameters were valid even when noisy and incomplete experimental data were used. Additionally, Akaike Information Criterion was employed to evaluate the model selection, which highlighted the capability of the proposed method in choosing a plausible model based on the experimental data. In conclusion, this paper presents the effectiveness of the proposed method for parameter estimation and model selection problems using noisy and incomplete experimental data. This study is hoped to provide a new insight in developing more accurate and reliable biological models based on limited and low quality experimental data.	[Abdullah, Afnizanfaizal; Deris, Safaai; Mohamad, Mohd Saberi] UTM, Fac Comp, Artificial Intelligence & Bioinformat Grp AIBIG, Johor Baharu, Malaysia; [Anwar, Sohail] Penn State Univ, Altoona, PA USA	Universiti Teknologi Malaysia; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University	Abdullah, A (corresponding author), UTM, Fac Comp, Artificial Intelligence & Bioinformat Grp AIBIG, Johor Baharu, Malaysia.	afnizanfaizal@utm.my; saberi@utm.my	MOHAMAD, MOHD SABERI/AAA-1929-2022; Abdullah, Afnizanfaizal/E-8709-2013; Mohamad, Mohd Saberi/J-3201-2014; Abdullah, Afnizanfaizal/AAI-9429-2020	MOHAMAD, MOHD SABERI/0000-0002-1079-4559; Abdullah, Afnizanfaizal/0000-0002-0280-565X; Mohamad, Mohd Saberi/0000-0002-1079-4559; Abdullah, Afnizanfaizal/0000-0002-0280-565X	Malaysia Ministry of Science, Technology and Innovation (MOSTI) [07-05-MGI-GMB011]; Research Management Centre (RMC), Universiti Teknologi Malaysia (UTM) [73744]; Universiti Teknologi Malaysia; Research University Grant (RUG) [Q.J130000.2507.04H16]	Malaysia Ministry of Science, Technology and Innovation (MOSTI)(Ministry of Energy, Science, Technology, Environment and Climate Change (MESTECC), Malaysia); Research Management Centre (RMC), Universiti Teknologi Malaysia (UTM); Universiti Teknologi Malaysia; Research University Grant (RUG)	This research was supported by a grant from Malaysia Ministry of Science, Technology and Innovation (MOSTI), organized by Malaysia Genome Institute (MGI) project number 07-05-MGI-GMB011 entitled "Design and Development of Microbial Cell Factories for Biomolecules Production and Secretion" and managed by Research Management Centre (RMC), Universiti Teknologi Malaysia (UTM) grant number 73744. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to express gratitude to the editor and reviewers for helpful suggestions and Universiti Teknologi Malaysia for sponsoring this research.; This research was supported by Research University Grant (RUG), project number Q.J130000.2507.04H16, and managed by Research Management Centre (RMC), Universiti Teknologi Malaysia (UTM). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullah A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056310; Abdullah A, 2009, PROCEEDINGS OF THE 2009 INTERNATIONAL CONFERENCE ON COMPUTER TECHNOLOGY AND DEVELOPMENT, VOL 1, P230, DOI 10.1109/ICCTD.2009.168; Abdullahl Afnizanfaizal, 2013, International Journal of Computer Information Systems and Industrial Management Applications, V5, P571; Ashyraliyev M, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-83; Balsa-Canto E, 2008, IET SYST BIOL, V2, P163, DOI 10.1049/iet-syb:20070069; Balsa-Canto E, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-26; Balsa-Canto E, 2012, ADV EXP MED BIOL, V736, P409, DOI 10.1007/978-1-4419-7210-1_24; Besozzi D, 2009, LECT NOTES COMPUT SC, V5483, P116, DOI 10.1007/978-3-642-01184-9_11; Buhry L, 2011, NEURAL COMPUT, V23, P2599, DOI 10.1162/NECO_a_00170; Bujara M, 2010, BIOTECHNOL BIOENG, V106, P376, DOI 10.1002/bit.22666; Chen Y.M., 2012, INT J COMPUT SCI ISS, V9, P1; Chou IC, 2009, MATH BIOSCI, V219, P57, DOI 10.1016/j.mbs.2009.03.002; COSTA PJ, 1994, IEEE T AERO ELEC SYS, V30, P525, DOI 10.1109/7.272275; Slezak DF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013283; Germani A, 2003, 42ND IEEE CONFERENCE ON DECISION AND CONTROL, VOLS 1-6, PROCEEDINGS, P886; Glover F, 2000, CONTROL CYBERN, V29, P653; Goldber D. E., 1988, Machine Learning, V3, P95, DOI 10.1023/A:1022602019183; Kennedy J, 1995, 1995 IEEE INTERNATIONAL CONFERENCE ON NEURAL NETWORKS PROCEEDINGS, VOLS 1-6, P1942, DOI 10.1109/icnn.1995.488968; Kim J, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2010.119; Lages NF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032749; Lam AYS, 2010, IEEE T EVOLUT COMPUT, V14, P381, DOI 10.1109/TEVC.2009.2033580; Le Novere N, 2006, NUCLEIC ACIDS RES, V34, pD689, DOI 10.1093/nar/gkj092; Lillacci G, 2012, INT J ROBUST NONLIN, V22, P1065, DOI 10.1002/rnc.2794; Lillacci G, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000696; Lloyd-Smith JO, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000180; Miao HY, 2009, BIOMETRICS, V65, P292, DOI 10.1111/j.1541-0420.2008.01059.x; Raue A, 2011, IET SYST BIOL, V5, P120, DOI 10.1049/iet-syb.2010.0061; Rodriguez-Fernandez M, 2006, BIOSYSTEMS, V83, P248, DOI 10.1016/j.biosystems.2005.06.016; Rodriguez-Fernandez M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-483; Runarsson TP, 2000, IEEE T EVOLUT COMPUT, V4, P284, DOI 10.1109/4235.873238; Storn R, 1997, J GLOBAL OPTIM, V11, P341, DOI 10.1023/A:1008202821328; Sun JY, 2012, IEEE ACM T COMPUT BI, V9, P185, DOI 10.1109/TCBB.2011.63; Sun XD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003758; Tashkova K, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-159; Tutkun N, 2009, EXPERT SYST APPL, V36, P3342, DOI 10.1016/j.eswa.2008.01.060; Veening JW, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.18; Yang XS, 2009, LECT NOTES COMPUT SC, V5792, P169, DOI 10.1007/978-3-642-04944-6_14; Zeng NY, 2012, IEEE ACM T COMPUT BI, V9, P321, DOI 10.1109/TCBB.2011.140; Zheng YT, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/541609	39	10	10	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2013	8	4							e61258	10.1371/journal.pone.0061258	http://dx.doi.org/10.1371/journal.pone.0061258			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123JA	23593445	Green Published, Green Submitted, gold			2022-12-25	WOS:000317383200047
J	Khan, MAH; Liu, J; Kumar, G; Skapek, SX; Falck, JR; Imig, JD				Khan, Md Abdul Hye; Liu, Jing; Kumar, Ganesh; Skapek, Stephen X.; Falck, John R.; Imig, John D.			Novel orally active epoxyeicosatrienoic acid (EET) analogs attenuate cisplatin nephrotoxicity	FASEB JOURNAL			English	Article						chemotherapeutics; acute kidney injury; eicosanoids	SOLUBLE EPOXIDE HYDROLASE; ENDOPLASMIC-RETICULUM STRESS; RENAL INJURY; KIDNEY; INHIBITION; APOPTOSIS; CELLS; MECHANISMS; EXPRESSION; PROTECTS	Nephrotoxicity severely limits the use of the anticancer drug cisplatin. Oxidative stress, inflammation, and endoplasmic reticulum (ER) stress contribute to cisplatin-induced nephrotoxicity. We developed novel orally active epoxyeicosatrienoic acid (EET) analogs and investigated their prophylactic effect in cisplatin-induced nephrotoxicity in rats. Cisplatin-induced nephrotoxicity was manifested by increases in blood urea nitrogen, plasma creatinine, urinary N-acetyl--(d)-glucosaminidase activity, kidney injury molecule 1, and histopathology. EET analogs (10 mg/kg/d) attenuated cisplatin-induced nephrotoxicity by reducing these renal injury markers by 40-80% along with a 50-70% reduction in renal tubular cast formation. This attenuated renal injury is associated with reduced oxidative stress, inflammation, and ER stress evident from reduction in related biomarkers and in the renal expression of genes involved in these pathways. Moreover, we demonstrated that the attenuated nephrotoxicity correlated with decreased apoptosis that is associated with 50-90% reduction in Bcl-2 protein family mediated proapoptotic signaling, reduced renal caspase-12 expression, and a 50% reduction in renal caspase-3 activity. We further demonstrated in vitro that the protective activity of EET analogs does not compromise the anticancer effects of cisplatin. Collectively, our data provide evidence that EET analogs attenuate cisplatin-induced nephrotoxicity by reducing oxidative stress, inflammation, ER stress, and apoptosis without affecting the chemotherapeutic effects of cisplatin.	[Khan, Md Abdul Hye; Imig, John D.] Med Coll Wisconsin, Dept Pharmacol & Toxicol, Milwaukee, WI 53226 USA; [Imig, John D.] Med Coll Wisconsin, Cardiovasc Ctr, Milwaukee, WI 53226 USA; [Liu, Jing; Skapek, Stephen X.] Univ Texas SW Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA; [Kumar, Ganesh; Falck, John R.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA	Medical College of Wisconsin; Medical College of Wisconsin; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Imig, JD (corresponding author), Med Coll Wisconsin, Dept Pharmacol & Toxicol, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	jdimig@mcw.edu	Falck, John R/B-3030-2011	Falck, John R/0000-0002-9219-7845; Imig, John/0000-0002-9668-2899; Khan, Md Abdul Hye/0000-0001-5940-9300	U.S. National Institutes of Health (NIH) [HL59699, DK38226]; Robert A. Welch Foundation [GL625910]; NIH [DK38226, GM31278]; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059699, R29HL059699] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK038226] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031278] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert A. Welch Foundation(The Welch Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	These studies were supported by U.S. National Institutes of Health (NIH) grants HL59699 and DK38226 to J.D.I.; Robert A. Welch Foundation grant GL625910 and NIH grants GM31278 and DK38226 to J.R.F.; and a postdoctoral fellowship from the Midwest Affiliate of the American Heart Association to Md.A.H.K.	Batchu SN, 2011, BRIT J PHARMACOL, V162, P897, DOI 10.1111/j.1476-5381.2010.01093.x; Benoehr P, 2005, J AM SOC NEPHROL, V16, P452, DOI 10.1681/ASN.2004030225; Bongers ML, 2012, PHARMACOECONOMICS, V30, P17, DOI 10.2165/11595000-000000000-00000; Breckenridge DG, 2003, ONCOGENE, V22, P8608, DOI 10.1038/sj.onc.1207108; Cribb AE, 2005, DRUG METAB REV, V37, P405, DOI 10.1080/03602530500205135; El-Beshbishy HA, 2011, EUR J PHARMACOL, V668, P278, DOI 10.1016/j.ejphar.2011.06.051; Elmarakby AA, 2011, AM J PHYSIOL-REG I, V301, pR1307, DOI 10.1152/ajpregu.00759.2010; Falck JR, 2009, J MED CHEM, V52, P5069, DOI 10.1021/jm900634w; Falck JR, 2003, BIOORG MED CHEM LETT, V13, P4011, DOI 10.1016/j.bmcl.2003.08.060; Faubel S, 2007, J PHARMACOL EXP THER, V322, P8, DOI 10.1124/jpet.107.119792; Gross GJ, 2008, AM J PHYSIOL-HEART C, V294, pH2838, DOI 10.1152/ajpheart.00186.2008; Hanigan MH, 2005, AM J PHYSIOL-RENAL, V288, pF125, DOI 10.1152/ajprenal.00041.2003; Imig JD, 2009, US Patent, Patent No. [7,550,617, 7550617]; Imig JD, 2012, PHYSIOL REV, V92, P101, DOI 10.1152/physrev.00021.2011; Imig JD, 2010, FRONT PHYSIOL, V1, DOI 10.3389/fphys.2010.00157; Imig JD, 2010, J CARDIOVASC PHARM, V56, P329, DOI 10.1097/FJC.0b013e3181e96e0c; Imig JD, 2009, NAT REV DRUG DISCOV, V8, P794, DOI 10.1038/nrd2875; Inagi R, 2009, NEPHRON EXP NEPHROL, V112, pE1, DOI 10.1159/000210573; Jia ZJ, 2011, KIDNEY INT, V79, P77, DOI 10.1038/ki.2010.331; Kaergel E, 2002, HYPERTENSION, V40, P273, DOI 10.1161/01.HYP.0000029240.44253.5E; King Lorraine M, 2005, Pharmacogenet Genomics, V15, P7, DOI 10.1097/01213011-200501000-00002; Kintzel PE, 2001, DRUG SAFETY, V24, P19, DOI 10.2165/00002018-200124010-00003; Levy AR, 2011, CURR MED RES OPIN, V27, P2253, DOI 10.1185/03007995.2011.633989; Lieberthal W, 1996, AM J PHYSIOL-RENAL, V270, pF700, DOI 10.1152/ajprenal.1996.270.4.F700; Liu L, 2011, J PHARMACOL EXP THER, V339, P451, DOI 10.1124/jpet.111.180505; Liu YM, 2012, J PHARMACOL EXP THER, V341, P725, DOI 10.1124/jpet.111.191247; Ma H, 2010, CLIN EXP PHARMACOL P, V37, P460, DOI 10.1111/j.1440-1681.2009.05323.x; Mandic A, 2003, J BIOL CHEM, V278, P9100, DOI 10.1074/jbc.M210284200; Manhiani M, 2009, AM J PHYSIOL-RENAL, V297, pF740, DOI 10.1152/ajprenal.00098.2009; Marino JP, 2009, CURR TOP MED CHEM, V9, P452, DOI 10.2174/156802609788340805; Miller RP, 2010, TOXINS, V2, P2490, DOI 10.3390/toxins2112490; Morisseau C, 2005, ANNU REV PHARMACOL, V45, P311, DOI 10.1146/annurev.pharmtox.45.120403.095920; Mukhopadhyay P, 2012, FREE RADICAL BIO MED, V52, P497, DOI 10.1016/j.freeradbiomed.2011.11.001; Node K, 1999, SCIENCE, V285, P1276, DOI 10.1126/science.285.5431.1276; Olearczyk JJ, 2009, CLIN SCI, V116, P61, DOI 10.1042/CS20080039; Pabla N, 2008, KIDNEY INT, V73, P994, DOI 10.1038/sj.ki.5002786; Park MS, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V134858; Parrish AR, 2009, CELL BIOL TOXICOL, V25, P217, DOI 10.1007/s10565-008-9071-0; Perazella MA, 2010, SEMIN NEPHROL, V30, P570, DOI 10.1016/j.semnephrol.2010.09.005; Peyrou M, 2007, TOXICOL SCI, V99, P346, DOI 10.1093/toxsci/kfm152; Rabik CA, 2008, J PHARMACOL EXP THER, V327, P442, DOI 10.1124/jpet.108.141291; Ramesh G, 2002, J CLIN INVEST, V110, P835, DOI 10.1172/JCI200215606; Sanchez-Gonzalez PD, 2011, CRIT REV TOXICOL, V41, P803, DOI 10.3109/10408444.2011.602662; Seubert JM, 2007, PROSTAG OTH LIPID M, V82, P50, DOI 10.1016/j.prostaglandins.2006.05.017; Sodhi K, 2009, J PHARMACOL EXP THER, V331, P906, DOI 10.1124/jpet.109.157545; Wang D, 2005, NAT REV DRUG DISCOV, V4, P307, DOI 10.1038/nrd1691; Wei Q, 2007, KIDNEY INT, V72, P53, DOI 10.1038/sj.ki.5002256; Yang BC, 2001, MOL PHARMACOL, V60, P310, DOI 10.1124/mol.60.2.310; Zhang B, 2007, KIDNEY INT, V72, P37, DOI 10.1038/sj.ki.5002242; Zhao G, 2012, HUM GENE THER, V23, P688, DOI 10.1089/hum.2011.135; Zhao G, 2012, J LIPID RES, V53, P456, DOI 10.1194/jlr.M017319	51	60	62	0	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2013	27	8					2946	2956		10.1096/fj.12-218040	http://dx.doi.org/10.1096/fj.12-218040			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	292BT	23603837	Green Published			2022-12-25	WOS:000329877600003
J	Cusimano, MD; Sharma, B; Lawrence, DW; Ilie, G; Silverberg, S; Jones, R				Cusimano, Michael D.; Sharma, Bhanu; Lawrence, David W.; Ilie, Gabriela; Silverberg, Sarah; Jones, Rochelle			Trends in North American Newspaper Reporting of Brain Injury in Ice Hockey	PLOS ONE			English	Article							CONCUSSION; CHILDREN; IMPACT; HEAD; NHL	The frequency and potential long-term effects of sport-related traumatic brain injuries (TBI) make it a major public health concern. The culture within contact sports, such as ice hockey, encourages aggression that puts youth at risk of TBI such as concussion. Newspaper reports play an important role in conveying and shaping the culture around health-related behaviors. We qualitatively studied reports about sport-related TBI in four major North American newspapers over the last quarter-century. We used the grounded-theory approach to identify major themes and then did a content analysis to compare the frequency of key themes between 1998-2000 and 2009-2011. The major themes were: perceptions of brain injury, aggression, equipment, rules and regulations, and youth hockey. Across the full study period, newspaper articles from Canada and America portrayed violence and aggression that leads to TBI both as integral to hockey and as an unavoidable risk associated with playing the game. They also condemned violence in ice hockey, criticized the administrative response to TBI, and recognized the significance of TBI. In Canada, aggression was reported more often recently and there was a distinctive shift in portraying protective equipment as a solution to TBI in earlier years to a potential contributing factor to TBI later in the study period. American newspapers gave a greater attention to 'perception of risks' and the role of protective equipment, and discussed TBI in a broader context in the recent time period. Newspapers from both countries showed similar recent trends in regards to a need for rule changes to curb youth sport-related TBI. This study provides a rich description of the reporting around TBI in contact sport. Understanding this reporting is important for evaluating whether the dangers of sport-related TBI are being appropriately communicated by the media.	[Cusimano, Michael D.; Sharma, Bhanu; Lawrence, David W.; Ilie, Gabriela; Silverberg, Sarah; Jones, Rochelle] Univ Toronto, St Michaels Hosp, Keenan Res Ctr, Div Neurosurg,Dept Surg,Injury Prevent Res Off, Toronto, ON M5B 1W8, Canada	University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto	Cusimano, MD (corresponding author), Univ Toronto, St Michaels Hosp, Keenan Res Ctr, Div Neurosurg,Dept Surg,Injury Prevent Res Off, Toronto, ON M5B 1W8, Canada.	injuryprevention@smh.ca	Cusimano, Michael/X-4059-2019; Ilie, Gabriela/AAM-9122-2021; Cusimano, Michael/GWR-1025-2022; Meijer, Anna/K-5118-2016	Cusimano, Michael/0000-0002-9989-0650	Canadian Institutes of Health Research Strategic Team Grant in Applied Injury Research [TIR-103946]; Ontario Neurotrauma Foundation	Canadian Institutes of Health Research Strategic Team Grant in Applied Injury Research(Canadian Institutes of Health Research (CIHR)); Ontario Neurotrauma Foundation	This research was supported by the Canadian Institutes of Health Research Strategic Team Grant in Applied Injury Research # TIR-103946, and the Ontario Neurotrauma Foundation. The authors have completed this study on behalf of the Canadian Brain Injury and Violence Research Team. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali SH, 2006, URBAN STUD, V43, P491, DOI 10.1080/00420980500452458; Anderson C. A., 2007, SAGE HDB SOCIAL PSYC, P296; Anderson CA, 2002, ANNU REV PSYCHOL, V53, P27, DOI 10.1146/annurev.psych.53.100901.135231; Audit Bureau of Circulations, 2011, AV CIRC TOP 25 US DA; BANDURA A, 1978, J COMMUN, V28, P12, DOI 10.1111/j.1460-2466.1978.tb01621.x; Bazarian JJ, 2006, ACAD EMERG MED, V13, P31, DOI 10.1197/j.aem.2005.07.038; Benson BW, 2011, CAN MED ASSOC J, V183, P905, DOI 10.1503/cmaj.092190; Bergeron LR, 2002, FAM SOC-J CONTEMP H, V83, P547, DOI 10.1606/1044-3894.48; Bowen Anne Phelan, 2003, J Emerg Nurs, V29, P287, DOI 10.1067/men.2003.90; Boxer P, 2009, J YOUTH ADOLESCENCE, V38, P417, DOI 10.1007/s10964-008-9335-2; Cantor J, 2000, J ADOLESCENT HEALTH, V27, P30, DOI 10.1016/S1054-139X(00)00129-4; Chapman S, 2005, MED J AUSTRALIA, V183, P247, DOI 10.5694/j.1326-5377.2005.tb07029.x; Council on Communications and Media, 2011, Pediatrics, V128, P201, DOI 10.1542/peds.2011-1066; Cusimano MD, 2009, CAN J NEUROL SCI, V36, P315, DOI 10.1017/S0317167100007046; Faul M, 2010, TRAUMATIC BRAIN INJU, DOI DOI 10.15620/CDC.5571; Flick U., 2000, QUALITATIVE RES TEXT, DOI [10.4135/9781849209731.n5, DOI 10.4135/9781849209731.N5]; Gee CJ, 2011, BEHAVIORAL SPORT PSYCHOLOGY: EVIDENCE-BASED APPROACHES TO PERFORMANCE ENHANCEMENT, P199, DOI 10.1007/978-1-4614-0070-7_12; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Herman Edward S, 2002, MANUFACTURING CONSEN; Iyengar S., 1991, IS ANYONE RESPONSIBL; Jordan Amy B, 2008, Adolesc Med State Art Rev, V19, P431; Katz E., 1955, PERSONAL INFLUENCE P; Kepner T, 2012, NY TIMES; Kirsh S. J., 2010, MEDIA YOUTH DEV PERS; LordMaes J, 1996, J LEARN DISABIL, V29, P609, DOI 10.1177/002221949602900605; Lupton D, 1998, SOC SCI MED, V46, P947, DOI 10.1016/S0277-9536(97)10013-2; Macciocchi SN, 1996, NEUROSURGERY, V39, P510, DOI 10.1097/00006123-199609000-00014; Marchie A, 2003, CAN MED ASSOC J, V169, P124; McFaull SR., 2011, OPEN MED, V5, P57; McGuire W.J., 2001, PUBLIC COMMUNICATION, V3rd ed., P22, DOI DOI 10.4135/9781452233260.N2; Morse JM, 1998, QUAL HEALTH RES, V8, P147, DOI 10.1177/104973239800800201; National Center for Injury Prevention & Control, 2003, REP C MILD TRAUM BRA; Newspapers Canada, 2011, DAIL NEWSP CIRC PROV; Patton M.Q., 2002, QUALITATIVE RES EVAL, P688; Putnam J. M., 2007, American Journal of Health Studies, V22, P130; Rabadi MH, 2001, CLIN J SPORT MED, V11, P194, DOI 10.1097/00042752-200107000-00011; Sheldon JP, 2001, RES Q EXERCISE SPORT, V72, P304, DOI 10.1080/02701367.2001.10608965; Smith AM, 2000, AM SOC TEST MATER, V1341, P199, DOI 10.1520/STP15240S; Stevens ST, 2006, J SCI MED SPORT, V9, P238, DOI 10.1016/j.jsams.2006.03.025; Strauss AL, 1998, BASICS QUALITATIVE R, V2nd; Tesch R, 1991, QUALITATIVE HLTH RES, V1, P309, DOI [10.1177/104973239100100303, DOI 10.1177/104973239100100303]; Ward-Smith Peggy, 2005, J Neurosci Nurs, V37, P92; Wennberg RA, 2003, CAN J NEUROL SCI, V30, P206, DOI 10.1017/S0317167100002596; Wennberg RA, 2008, CAN J NEUROL SCI, V35, P647, DOI 10.1017/S031716710000946X; Wetjen NM, 2010, J AM COLL SURGEONS, V211, P553, DOI 10.1016/j.jamcollsurg.2010.05.020; WIDMEYER WN, 1984, J PSYCHOL, V117, P77, DOI 10.1080/00223980.1984.9923661; Youl PH, 2009, INT J CANCER, V124, P1963, DOI 10.1002/ijc.24154	47	29	29	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2013	8	4							e61865	10.1371/journal.pone.0061865	http://dx.doi.org/10.1371/journal.pone.0061865			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	130IK	23613957	gold, Green Published			2022-12-25	WOS:000317907200095
J	Law, J; Jovel, J; Patterson, J; Ford, G; O'keefe, S; Wang, WW; Meng, B; Song, DY; Zhang, Y; Tian, ZJ; Wasilenko, ST; Rahbari, M; Mitchell, T; Jordan, T; Carpenter, E; Mason, AL; Wong, GKS				Law, John; Jovel, Juan; Patterson, Jordan; Ford, Glenn; O'keefe, Sandra; Wang, Weiwei; Meng, Bo; Song, Deyong; Zhang, Yong; Tian, Zhijian; Wasilenko, Shawn T.; Rahbari, Mandana; Mitchell, Troy; Jordan, Tracy; Carpenter, Eric; Mason, Andrew L.; Wong, Gane Ka-Shu			Identification of Hepatotropic Viruses from Plasma Using Deep Sequencing: A Next Generation Diagnostic Tool	PLOS ONE			English	Article							TT-VIRUS; DNA VIRUSES; GENETIC DIVERSITY; HEPATITIS; INFECTION; EVOLUTION; PREDOMINANCE; CIRCOVIRUS; VIROPHAGE; CHILDREN	We conducted an unbiased metagenomics survey using plasma from patients with chronic hepatitis B, chronic hepatitis C, autoimmune hepatitis (AIH), non-alcoholic steatohepatitis (NASH), and patients without liver disease (control). RNA and DNA libraries were sequenced from plasma filtrates enriched in viral particles to catalog virus populations. Hepatitis viruses were readily detected at high coverage in patients with chronic viral hepatitis B and C, but only a limited number of sequences resembling other viruses were found. The exception was a library from a patient diagnosed with hepatitis C virus (HCV) infection that contained multiple sequences matching GB virus C (GBV-C). Abundant GBV-C reads were also found in plasma from patients with AIH, whereas Torque teno virus (TTV) was found at high frequency in samples from patients with AIH and NASH. After taxonomic classification of sequences by BLASTn, a substantial fraction in each library, ranging from 35% to 76%, remained unclassified. These unknown sequences were assembled into scaffolds along with virus, phage and endogenous retrovirus sequences and then analyzed by BLASTx against the non-redundant protein database. Nearly the full genome of a heretofore-unknown circovirus was assembled and many scaffolds that encoded proteins with similarity to plant, insect and mammalian viruses. The presence of this novel circovirus was confirmed by PCR. BLASTx also identified many polypeptides resembling nucleo-cytoplasmic large DNA viruses (NCLDV) proteins. We re-evaluated these alignments with a profile hidden Markov method, HHblits, and observed inconsistencies in the target proteins reported by the different algorithms. This suggests that sequence alignments are insufficient to identify NCLDV proteins, especially when these alignments are only to small portions of the target protein. Nevertheless, we have now established a reliable protocol for the identification of viruses in plasma that can also be adapted to other patient samples such as urine, bile, saliva and other body fluids.	[Law, John; Jovel, Juan; Patterson, Jordan; Ford, Glenn; O'keefe, Sandra; Wang, Weiwei; Meng, Bo; Wasilenko, Shawn T.; Rahbari, Mandana; Mitchell, Troy; Jordan, Tracy; Mason, Andrew L.; Wong, Gane Ka-Shu] Univ Alberta, Dept Med, Edmonton, AB, Canada; [Carpenter, Eric; Wong, Gane Ka-Shu] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada; [Song, Deyong; Zhang, Yong; Tian, Zhijian; Wong, Gane Ka-Shu] BGI Shenzhen, Shenzhen, Guangdong, Peoples R China	University of Alberta; University of Alberta; Beijing Genomics Institute (BGI)	Mason, AL (corresponding author), Univ Alberta, Dept Med, Edmonton, AB, Canada.	andrew.mason@ualberta.ca; gane@ualberta.ca	WONG, Gane Ka-Shu/G-5784-2013; Mason, Andrew/D-2938-2013	WONG, Gane Ka-Shu/0000-0001-6108-5560; Mason, Andrew/0000-0002-0470-9522	Alberta Innovates Technology Futures; Alberta Innovates Health Solutions	Alberta Innovates Technology Futures; Alberta Innovates Health Solutions	This research was supported by Alberta Innovates Technology Futures (GKSW), Alberta Innovates Health Solutions (ALM, WW), and computing resources provided by WestGrid and Compute/Calcul Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allander T, 2001, P NATL ACAD SCI USA, V98, P11609, DOI 10.1073/pnas.211424698; Arslan D, 2011, P NATL ACAD SCI USA, V108, P17486, DOI 10.1073/pnas.1110889108; BARRESINOUSSI F, 1983, SCIENCE, V220, P868, DOI 10.1126/science.6189183; Berzsenyi MD, 2009, J GASTROEN HEPATOL, V24, P1407, DOI 10.1111/j.1440-1746.2009.05920.x; Bhattarai N, 2012, TRENDS MICROBIOL, V20, P124, DOI 10.1016/j.tim.2012.01.004; Blinkova O, 2010, J GEN VIROL, V91, P74, DOI 10.1099/vir.0.015446-0; Breitbart M, 2012, ANNU REV MAR SCI, V4, P425, DOI 10.1146/annurev-marine-120709-142805; Charlton M, 1998, HEPATOLOGY, V28, P839, DOI 10.1002/hep.510280335; CHOO QL, 1989, SCIENCE, V244, P359, DOI 10.1126/science.2523562; Colson P, 2012, INTERVIROLOGY, V55, P321, DOI 10.1159/000336562; Colson Philippe, 2011, Genome Biol Evol, V3, P737, DOI 10.1093/gbe/evr048; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; DANE DS, 1970, LANCET, V1, P695; Delwart E, 2012, CURR OPIN VIROL, V2, P344, DOI 10.1016/j.coviro.2012.02.012; Delwart E, 2012, VIRUS RES, V164, P114, DOI 10.1016/j.virusres.2011.11.021; FEINSTONE SM, 1973, SCIENCE, V182, P1026, DOI 10.1126/science.182.4116.1026; Feng HC, 2008, SCIENCE, V319, P1096, DOI 10.1126/science.1152586; Fischer MG, 2011, SCIENCE, V332, P231, DOI 10.1126/science.1199412; Ge XY, 2011, J GEN VIROL, V92, P2646, DOI 10.1099/vir.0.034108-0; George SL, 2006, J INFECT DIS, V193, P451, DOI 10.1086/499435; Gish R G, 2001, Clin Liver Dis, V5, P287, DOI 10.1016/S1089-3261(05)70167-7; Jones MS, 2005, J VIROL, V79, P8230, DOI 10.1128/JVI.79.13.8230-8236.2005; Koonin EV, 2010, INTERVIROLOGY, V53, P284, DOI 10.1159/000312913; Kundu S, 2012, J VIROL, V86, P5221, DOI 10.1128/JVI.06504-11; La Scola B, 2003, SCIENCE, V299, P2033; La Scola B, 2008, NATURE, V455, P100, DOI 10.1038/nature07218; Lemoine M, 2012, CURR OPIN INFECT DIS, V25, P10, DOI 10.1097/QCO.0b013e32834ef599; Li LL, 2011, J GEN VIROL, V92, P768, DOI 10.1099/vir.0.028704-0; Li LL, 2010, J VIROL, V84, P6955, DOI 10.1128/JVI.00501-10; Li LL, 2010, J VIROL, V84, P1674, DOI 10.1128/JVI.02109-09; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Maggi F, 2003, J VIROL, V77, P2418, DOI 10.1128/JVI.77.4.2418-2425.2003; Minot S, 2012, P NATL ACAD SCI USA, V109, P3962, DOI 10.1073/pnas.1119061109; Minot S, 2011, GENOME RES, V21, P1616, DOI 10.1101/gr.122705.111; Nishizawa T, 1997, BIOCHEM BIOPH RES CO, V241, P92, DOI 10.1006/bbrc.1997.7765; Novais RC, 2011, J MICROBIOL METH, V86, P1, DOI 10.1016/j.mimet.2011.04.006; Palacios G, 2008, NEW ENGL J MED, V358, P991, DOI 10.1056/NEJMoa073785; Pasarica M, 2007, ADV FOOD NUTR RES, V52, P61, DOI 10.1016/S1043-4526(06)52002-9; Peiris JSM, 2003, LANCET, V361, P1319, DOI 10.1016/S0140-6736(03)13077-2; Phan TG, 2012, J VIROL, V86, P11024, DOI 10.1128/JVI.01427-12; Phan TG, 2012, J GEN VIROL, V93, P1356, DOI 10.1099/vir.0.041731-0; Polgreen PM, 2003, MICROBES INFECT, V5, P1255, DOI 10.1016/j.micinf.2003.08.006; Quail Michael A, 2009, Curr Protoc Hum Genet, VChapter 18, DOI 10.1002/0471142905.hg1802s62; Raoult D, 2004, SCIENCE, V306, P1344, DOI 10.1126/science.1101485; Remmert M, 2012, NAT METHODS, V9, P173, DOI [10.1038/NMETH.1818, 10.1038/nmeth.1818]; Rosario K, 2009, J GEN VIROL, V90, P2418, DOI 10.1099/vir.0.012955-0; Shibayama T, 2001, AIDS, V15, P563, DOI 10.1097/00002030-200103300-00004; Simmonds P, 2002, J MED MICROBIOL, V51, P455, DOI 10.1099/0022-1317-51-6-455; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Tarailo-Graovac M., 2009, CURR PROTOC BIOINFOR, V25, p4.10.11, DOI 10.1002/0471250953.bi0410s25; Thomas V, 2011, ENVIRON MICROBIOL, V13, P1454, DOI 10.1111/j.1462-2920.2011.02446.x; Touinssi M, 2001, J CLIN VIROL, V21, P135, DOI 10.1016/S1386-6532(01)00157-3; Van Etten JL, 2010, ANNU REV MICROBIOL, V64, P83, DOI 10.1146/annurev.micro.112408.134338; Wylie KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0027735; Xu BL, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002369; Yutin N, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-223; zur Hausen H, 2009, CURR TOP MICROBIOL, V331, P109	57	46	50	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2013	8	4							e60595	10.1371/journal.pone.0060595	http://dx.doi.org/10.1371/journal.pone.0060595			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IK	23613733	Green Submitted, gold, Green Published			2022-12-25	WOS:000317907200009
J	Lee, S; Kim, CH; Kim, DG; Kim, HG; Lee, PS; Myung, H				Lee, Serin; Kim, Cheol-Hu; Kim, Dae-Gun; Kim, Han-Guen; Lee, Phill-Seung; Myung, Hyun			Remote Guidance of Untrained Turtles by Controlling Voluntary Instinct Behavior	PLOS ONE			English	Article								Recently, several studies have been carried out on the direct control of behavior in insects and other lower animals in order to apply these behaviors to the performance of specialized tasks in an attempt to find more efficient means of carrying out these tasks than artificial intelligence agents. While most of the current methods cause involuntary behavior in animals by electronically stimulating the corresponding brain area or muscle, we show that, in turtles, it is also possible to control certain types of behavior, such as movement trajectory, by evoking an appropriate voluntary instinctive behavior. We have found that causing a particular behavior, such as obstacle avoidance, by providing a specific visual stimulus results in effective control of the turtle's movement. We propose that this principle may be adapted and expanded into a general framework to control any animal behavior as an alternative to robotic probes.	[Lee, Serin; Kim, Han-Guen; Myung, Hyun] Korea Adv Inst Sci & Technol, Dept Civil & Environm Engn, Taejon 305701, South Korea; [Kim, Cheol-Hu; Kim, Dae-Gun; Lee, Phill-Seung] Korea Adv Inst Sci & Technol, Div Ocean Syst Engn, Taejon 305701, South Korea	Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST)	Lee, PS (corresponding author), Korea Adv Inst Sci & Technol, Div Ocean Syst Engn, Taejon 305701, South Korea.	phillseung@kaist.edu; hmyung@kaist.ac.kr	Myung, Hyun/C-1698-2011; Lee, Phill-Seung/C-1725-2011	Myung, Hyun/0000-0002-5799-2026; 	IT Convergence Campus Fund of KAIST [G04100066]; Korea Ministry of Land, Transport, and Maritime Affairs (MLTM); Korea Institute of Energy Technology Evaluation and Planning (KETEP) [20114030200040]; Korean Ministry of Knowledge Economy	IT Convergence Campus Fund of KAIST; Korea Ministry of Land, Transport, and Maritime Affairs (MLTM); Korea Institute of Energy Technology Evaluation and Planning (KETEP); Korean Ministry of Knowledge Economy(Ministry of Trade, Industry & Energy (MOTIE), Republic of Korea)	This research was supported by the IT Convergence Campus Fund of KAIST (G04100066), the Korea Ministry of Land, Transport, and Maritime Affairs (MLTM) as U-City Master and Doctor Course Grant Program, and a grant from Human Resources Development (No. 20114030200040) of the Korea Institute of Energy Technology Evaluation and Planning (KETEP) funded by the Korean Ministry of Knowledge Economy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbib MA, 1987, DEPTH DETOURS ESSAY, P129; ARNOLD K, 1987, VISION RES, V27, P1501, DOI 10.1016/0042-6989(87)90159-3; Britt WR, 2010, PERS UBIQUIT COMPUT, V15, P61; Card G, 2008, CURR BIOL, V18, P1300, DOI 10.1016/j.cub.2008.07.094; Daly DC, 2010, IEEE J SOLID-ST CIRC, V45, P153, DOI 10.1109/JSSC.2009.2034433; Krause J, 2011, TRENDS ECOL EVOL, V26, P369, DOI 10.1016/j.tree.2011.03.015; Robie AA, 2010, J EXP BIOL, V213, P2494, DOI 10.1242/jeb.041749; Sato H, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00199; Straw AD, 2011, J R SOC INTERFACE, V8, P395, DOI 10.1098/rsif.2010.0230; Straw AD, 2010, CURR BIOL, V20, P1550, DOI 10.1016/j.cub.2010.07.025; Talwar SK, 2002, NATURE, V417, P37, DOI 10.1038/417037a; Tsang WM, 2010, IEEE MEMS 2010 HONG, P39; VERHEIJEN F J, 1973, Netherlands Journal of Sea Research, V7, P53, DOI 10.1016/0077-7579(73)90032-X; WITHERINGTON BE, 1991, BIOL CONSERV, V55, P139, DOI 10.1016/0006-3207(91)90053-C	14	5	5	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2013	8	4							e61798	10.1371/journal.pone.0061798	http://dx.doi.org/10.1371/journal.pone.0061798			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IK	23613939	gold, Green Published, Green Submitted			2022-12-25	WOS:000317907200087
J	Makarov, VV; Skurat, EV; Semenyuk, PI; Abashkin, DA; Kalinina, NO; Arutyunyan, AM; Solovyev, AG; Dobrov, EN				Makarov, Valentin V.; Skurat, Eugeny V.; Semenyuk, Pavel I.; Abashkin, Dmitry A.; Kalinina, Natalya O.; Arutyunyan, Alexsandr M.; Solovyev, Andrey G.; Dobrov, Eugeny N.			Structural Lability of Barley Stripe Mosaic Virus Virions	PLOS ONE			English	Article							TRIPLE GENE BLOCK; MOVEMENT PROTEIN-BINDING; RAY FIBER DIFFRACTION; CIRCULAR-DICHROISM; COAT PROTEIN; IN-VITRO; ELECTRON-MICROSCOPY; SECONDARY STRUCTURE; RNA; RESOLUTION	Virions of Barley stripe mosaic virus (BSMV) were neglected for more than thirty years after their basic properties were determined. In this paper, the physicochemical characteristics of BSMV virions and virion-derived viral capsid protein (CP) were analyzed, namely, the absorption and intrinsic fluorescence spectra, circular dichroism spectra, differential scanning calorimetry curves, and size distributions by dynamic laser light scattering. The structural properties of BSMV virions proved to be intermediate between those of Tobacco mosaic virus (TMV), a well-characterized virus with rigid rod-shaped virions, and flexuous filamentous plant viruses. The BSMV virions were found to be considerably more labile than expected from their rod-like morphology and a distant sequence relation of the BSMV and TMV CPs. The circular dichroism spectra of BSMV CP subunits incorporated into the virions, but not subunits of free CP, demonstrated a significant proportion of beta-structure elements, which were proposed to be localized mostly in the protein regions exposed on the virion outer surface. These beta-structure elements likely formed during virion assembly can comprise the N- and C-terminal protein regions unstructured in the non-virion CP and can mediate inter-subunit interactions. Based on computer-assisted structure modeling, a model for BSMV CP subunit structural fold compliant with the available experimental data was proposed.	[Makarov, Valentin V.; Semenyuk, Pavel I.; Kalinina, Natalya O.; Arutyunyan, Alexsandr M.; Solovyev, Andrey G.; Dobrov, Eugeny N.] Moscow MV Lomonosov State Univ, AN Belozersky Inst Physicochem Biol, Moscow, Russia; [Makarov, Valentin V.; Skurat, Eugeny V.] Moscow MV Lomonosov State Univ, Dept Biol, Moscow, Russia; [Semenyuk, Pavel I.; Abashkin, Dmitry A.] Moscow MV Lomonosov State Univ, Fac Bioengn & Bioinformat, Moscow, Russia	Lomonosov Moscow State University; Lomonosov Moscow State University; Lomonosov Moscow State University	Dobrov, EN (corresponding author), Moscow MV Lomonosov State Univ, AN Belozersky Inst Physicochem Biol, Moscow, Russia.	endobrov@gmail.com	Arutyunyan, Alexander/G-8654-2012; Semenyuk, Pavel I/E-2974-2012; Abashkin, Dmitry/AAN-1045-2021; Solovyev, Andrey/AAB-6683-2022	Semenyuk, Pavel I/0000-0001-7759-6445; Abashkin, Dmitry/0000-0001-6659-9851; Solovyev, Andrey/0000-0001-6284-9155; Skurat, Eugene/0000-0003-1128-8786	Russian Foundation for Basic Research [12-04-01472-a]	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR))	The work was supported by grant 12-04-01472-a from the Russian Foundation for Basic Research (http://www.rfbr.ru). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	[Anonymous], [No title captured]; ATABEKOV I. G., 1966, BIOKHIMIYA, V31, P157; Atabekov J, 1971, ASS APPL BIOL, V68; ATABEKOV JG, 1968, VIROLOGY, V36, P620, DOI 10.1016/0042-6822(68)90193-1; ATABEKOV JG, 1970, VIROLOGY, V41, P519, DOI 10.1016/0042-6822(70)90172-8; BLOOMER AC, 1978, NATURE, V276, P362, DOI 10.1038/276362a0; Butler PJG, 1999, PHILOS T ROY SOC B, V354, P537, DOI 10.1098/rstb.1999.0405; CHAPMAN S, 1992, VIROLOGY, V191, P223, DOI 10.1016/0042-6822(92)90183-P; Cheng LP, 2011, P NATL ACAD SCI USA, V108, P1373, DOI 10.1073/pnas.1014995108; CITOVSKY V, 1992, PLANT CELL, V4, P397, DOI 10.1105/tpc.4.4.397; Clare DK, 2010, J STRUCT BIOL, V171, P303, DOI 10.1016/j.jsb.2010.06.011; DELEAGE G, 1993, COMPUT APPL BIOSCI, V9, P197; DOBROV EN, 1972, J GEN VIROL, V16, P161, DOI 10.1099/0022-1317-16-2-161; DOLJA VV, 1991, VIROLOGY, V184, P79, DOI 10.1016/0042-6822(91)90823-T; FRAENKELCONRAT H, 1957, VIROLOGY, V4, P1, DOI 10.1016/0042-6822(57)90038-7; Ge P, 2011, P NATL ACAD SCI USA, V108, P9637, DOI 10.1073/pnas.1018104108; GOODMAN RM, 1975, VIROLOGY, V68, P287, DOI 10.1016/0042-6822(75)90272-X; GUTTENPLAN JB, 1973, BIOCHIM BIOPHYS ACTA, V322, P294, DOI 10.1016/0005-2795(73)90305-X; HOMER RB, 1975, BIOCHIM BIOPHYS ACTA, V378, P296, DOI 10.1016/0005-2787(75)90117-3; Jackson AO, 2009, ANNU REV PHYTOPATHOL, V47, P385, DOI 10.1146/annurev-phyto-080508-081733; Kalinina NO, 2001, J GEN VIROL, V82, P2569, DOI 10.1099/0022-1317-82-10-2569; KISELEV N. A., 1966, BIOKHIMIYA, V31, P670; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Makarov VV, 2009, J GEN VIROL, V90, P3022, DOI 10.1099/vir.0.013862-0; Morozov SY, 2003, J GEN VIROL, V84, P1351, DOI 10.1099/vir.0.18922-0; NAMBA K, 1989, J MOL BIOL, V208, P307, DOI 10.1016/0022-2836(89)90391-4; Nemykh MA, 2008, VIROLOGY, V373, P61, DOI 10.1016/j.virol.2007.11.024; Orlov VN, 1998, FEBS LETT, V433, P307, DOI 10.1016/S0014-5793(98)00924-7; Perez-Iratxeta C, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-25; PETTY ITD, 1989, VIROLOGY, V171, P342, DOI 10.1016/0042-6822(89)90601-6; Rodionova NP, 2003, J MOL BIOL, V333, P565, DOI 10.1016/j.jmb.2003.08.058; Sachse C, 2007, J MOL BIOL, V371, P812, DOI 10.1016/j.jmb.2007.05.088; Sreerama N, 2004, PROTEIN SCI, V13, P100, DOI 10.1110/ps.03258404; STUBBS G, 1977, NATURE, V267, P216, DOI 10.1038/267216a0; TIKCHONENKO TI, 1966, J MOL BIOL, V18, P58, DOI 10.1016/S0022-2836(66)80076-1; Verchot J, 1998, J VIROL, V72, P8316, DOI 10.1128/JVI.72.10.8316-8320.1998; Verchot-Lubicz J, 2010, MOL PLANT MICROBE IN, V23, P1231, DOI 10.1094/MPMI-04-10-0086; WANG H, 1994, J MOL BIOL, V239, P371, DOI 10.1006/jmbi.1994.1379; Wolf M, 2010, P NATL ACAD SCI USA, V107, P6298, DOI 10.1073/pnas.0914604107; Yang SQ, 2012, J MOL BIOL, V422, P263, DOI 10.1016/j.jmb.2012.05.032; Zhang X, 2008, P NATL ACAD SCI USA, V105, P1867, DOI 10.1073/pnas.0711623105	41	15	15	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2013	8	4							e60942	10.1371/journal.pone.0060942	http://dx.doi.org/10.1371/journal.pone.0060942			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IK	23613760	Green Submitted, Green Published, gold			2022-12-25	WOS:000317907200018
J	Umemura, A; Oeda, T; Hayashi, R; Tomita, S; Kohsaka, M; Yamamoto, K; Sawada, H				Umemura, Atsushi; Oeda, Tomoko; Hayashi, Ryutaro; Tomita, Satoshi; Kohsaka, Masayuki; Yamamoto, Kenji; Sawada, Hideyuki			Diagnostic Accuracy of Apparent Diffusion Coefficient and I-123-Metaiodobenzylguanidine for Differentiation of Multiple System Atrophy and Parkinson's Disease	PLOS ONE			English	Article							CARDIAC SYMPATHETIC-NERVE; PURE AUTONOMIC FAILURE; MYOCARDIAL SCINTIGRAPHY; DEGENERATION; MRI; I-123-MIBG; PATHOLOGY	Background: It is often hard to differentiate Parkinson's disease (PD) and parkinsonian variant of multiple system atrophy (MSA-P), especially in the early stages. Cardiac sympathetic denervation and putaminal rarefaction are specific findings for PD and MSA-P, respectively. Purpose: We investigated diagnostic accuracy of putaminal apparent diffusion coefficient (ADC) test for MSA-P and I-123-metaiodobenzylguanidine (MIBG) scintigram for PD, especially in early-stage patients. Methods: The referral standard diagnosis of PD and MSA-P were the diagnostic criteria of the United Kingdom Parkinson's Disease Society Brain Bank Criteria and the second consensus criteria, respectively. Based on the referral standard criteria, diagnostic accuracy [area under the receiver-operator characteristic curve (AUC), sensitivity and specificity] of the ADC and MIBG tests was estimated retrospectively. Diagnostic accuracy of these tests performed within 3 years of symptom onset was also investigated. Results: ADC and MIBG tests were performed on 138 patients (20 MSA and 118 PD). AUC was 0.95 and 0.83 for the ADC and MIBG tests, respectively. Sensitivity and specificity were 85.0% and 89.0% for MSA-P diagnosis by ADC test and 67.0% and 80.0% for PD diagnosis by MIBG test. When these tests were restricted to patients with disease duration <= 3 years, the sensitivity and specificity were 75.0% and 91.4% for the ADC test (MSA-P diagnosis) and 47.7% and 92.3% for the MIBG test (PD diagnosis). Conclusions: Both tests were useful in differentiating between PD and MSA-P, even in the early stages. In early-stage patients, elevated putaminal ADC was a diagnostic marker for MSA-P. Despite high specificity of the MIBG test, careful neurological history and examinations were required for PD diagnosis because of possible false-negative results.	[Umemura, Atsushi; Oeda, Tomoko; Hayashi, Ryutaro; Tomita, Satoshi; Kohsaka, Masayuki; Yamamoto, Kenji; Sawada, Hideyuki] Natl Utano Hosp, Clin Res Ctr, Kyoto, Japan; [Umemura, Atsushi; Oeda, Tomoko; Hayashi, Ryutaro; Tomita, Satoshi; Kohsaka, Masayuki; Yamamoto, Kenji; Sawada, Hideyuki] Natl Utano Hosp, Dept Neurol, Kyoto, Japan		Sawada, H (corresponding author), Natl Utano Hosp, Clin Res Ctr, Kyoto, Japan.	sawada@unh.hosp.go.jp	Umemura, Atsushi/ABC-4716-2021; Yamamoto, Kenji/AAD-8766-2019	Umemura, Atsushi/0000-0001-8557-6014; Yamamoto, Kenji/0000-0003-1240-6369; Tomita, Satoshi/0000-0003-4410-6539; Sawada, Hideyuki/0000-0002-5909-3366	National Hospital Organization	National Hospital Organization	This study was supported by grants-in-aid from the National Hospital Organization. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Daniel S E, 1993, J Neural Transm Suppl, V39, P165; Druschky A, 2000, J NEUROL SCI, V175, P3, DOI 10.1016/S0022-510X(00)00279-3; Fujishiro H, 2008, ACTA NEUROPATHOL, V116, P269, DOI 10.1007/s00401-008-0398-7; Gilman S, 2008, NEUROLOGY, V71, P670, DOI 10.1212/01.wnl.0000324625.00404.15; Hughes AJ, 2002, BRAIN, V125, P861, DOI 10.1093/brain/awf080; Ito M, 2007, J NEUROL NEUROSUR PS, V78, P722, DOI 10.1136/jnnp.2006.104075; Iwanaga K, 1999, NEUROLOGY, V52, P1269, DOI 10.1212/WNL.52.6.1269; Kashihara K, 2006, J NUCL MED, V47, P1099; Kollensperger M, 2007, MOVEMENT DISORD, V22, P1771, DOI 10.1002/mds.21614; Konagaya M, 1999, J NEUROL, V246, P142, DOI 10.1007/s004150050323; KONAGAYA M, 1994, J NEUROL NEUROSUR PS, V57, P1528, DOI 10.1136/jnnp.57.12.1528; Kraft E, 1999, ARCH NEUROL-CHICAGO, V56, P225, DOI 10.1001/archneur.56.2.225; LEBIHAN D, 1992, AM J ROENTGENOL, V159, P591, DOI 10.2214/ajr.159.3.1503032; Mitsui J, 2006, J NEUROL SCI, V243, P101, DOI 10.1016/j.jns.2005.11.034; Nagayama H, 2005, J NEUROL NEUROSUR PS, V76, P249, DOI 10.1136/jnnp.2004.037028; Nagayama H, 2008, MOVEMENT DISORD, V23, P1055, DOI 10.1002/mds.22031; Orimo S, 1999, J NEUROL NEUROSUR PS, V67, P189, DOI 10.1136/jnnp.67.2.189; Orimo S, 2002, J NEUROL NEUROSUR PS, V73, P776, DOI 10.1136/jnnp.73.6.776; Orimo S, 2007, BRAIN PATHOL, V17, P24, DOI 10.1111/j.1750-3639.2006.00032.x; Orimo S, 2007, ACTA NEUROPATHOL, V113, P81, DOI 10.1007/s00401-006-0160-y; Orimo Satoshi, 2004, Rinsho Shinkeigaku, V44, P827; Parkkinen L, 2007, CLIN NEUROPATHOL, V26, P276; Saiki S, 2004, J NEUROL SCI, V220, P105, DOI 10.1016/j.jns.2004.02.018; Sawada H, 2005, JAMA-J AM MED ASSOC, V293, P932, DOI 10.1001/jama.293.8.932-c; Sawada H, 2009, EUR J NEUROL, V16, P174, DOI 10.1111/j.1468-1331.2008.02372.x; Schocke MFH, 2002, NEUROLOGY, V58, P575, DOI 10.1212/WNL.58.4.575; Schrag A, 1998, J NEUROL NEUROSUR PS, V65, P65, DOI 10.1136/jnnp.65.1.65; Seppi K, 2006, MOVEMENT DISORD, V21, P847, DOI 10.1002/mds.20843; SOLANKI KK, 1992, NUCL MED COMMUN, V13, P513, DOI 10.1097/00006231-199207000-00006; Takatsu H, 2000, JAMA-J AM MED ASSOC, V284, P44, DOI 10.1001/jama.284.1.44; Tolosa E, 2006, LANCET NEUROL, V5, P75, DOI 10.1016/S1474-4422(05)70285-4; Tomlinson CL, 2010, MOVEMENT DISORD, V25, P2649, DOI 10.1002/mds.23429; von Lewinski F, 2007, J NEUROL, V254, P1184, DOI 10.1007/s00415-006-0496-1; Watanabe H, 2002, BRAIN, V125, P1070, DOI 10.1093/brain/awf117	34	28	28	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2013	8	4							e61066	10.1371/journal.pone.0061066	http://dx.doi.org/10.1371/journal.pone.0061066			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IK	23613784	gold, Green Submitted, Green Published			2022-12-25	WOS:000317907200028
J	D'Amici, S; Ceccarelli, S; Vescarelli, E; Romano, F; Frati, L; Marchese, C; Angeloni, A				D'Amici, Sirio; Ceccarelli, Simona; Vescarelli, Enrica; Romano, Ferdinando; Frati, Luigi; Marchese, Cinzia; Angeloni, Antonio			TNF alpha Modulates Fibroblast Growth Factor Receptor 2 Gene Expression through the pRB/E2F1 Pathway: Identification of a Non-Canonical E2F Binding Motif	PLOS ONE			English	Article							P38(MAPK) SIGNALING PATHWAY; SMOOTH-MUSCLE-CELLS; INFLAMMATORY CYTOKINES; PROMOTER REGION; WOUND REPAIR; CANCER; PROLIFERATION; PROTEIN; RB; TRANSCRIPTION	Interactions between epithelium and mesenchyme during wound healing are not fully understood, but Fibroblast Growth Factors (FGFs) and their receptors FGFRs are recognized as key elements. FGFR2 gene encodes for two splicing transcript variants, FGFR2-IIIb or Keratinocyte Growth Factor Receptor (KGFR) and FGFR2-IIIc, which differ for tissue localization and ligand specificity. Proinflammatory cytokines play an essential role in the regulation of epithelial-mesenchymal interactions, and have been indicated to stimulate FGFs production. Here we demonstrated that upregulation of FGFR2 mRNA and protein expression is induced by the proinflammatory cytokines Tumor Necrosis Factor-alpha, Interleukin-1 beta and Interleukin 2. Furthermore, we found that TNF alpha determines FGFR2 transcriptional induction through activation of pRb, mediated by Raf and/or p38 pathways, and subsequent release of the transcription factor E2F1. Experiments based on FGFR2 promoter serial deletions and site-directed mutagenesis allowed us to identify a minimal responsive element that retains the capacity to be activated by E2F1. Computational analysis indicated that this element is a non-canonical E2F responsive motif. Thus far, the molecular mechanisms of FGFR2 upregulation during wound healing or in pathological events are not known. Our data suggest that FGFR2 expression can be modulated by local recruitment of inflammatory cytokines. Furthermore, since alterations in FGFR2 expression have been linked to the pathogenesis of certain human cancers, these findings could also provide elements for diagnosis and potential targets for novel therapeutic approaches.	[D'Amici, Sirio; Ceccarelli, Simona; Vescarelli, Enrica; Frati, Luigi; Marchese, Cinzia] Univ Roma La Sapienza, Dept Expt Med, I-00185 Rome, Italy; [Romano, Ferdinando] Univ Roma La Sapienza, Dept Publ Hlth & Infect Dis, Rome, Italy; [Angeloni, Antonio] Univ Roma La Sapienza, Dept Expt Med, Rome, Italy	Sapienza University Rome; Sapienza University Rome; Sapienza University Rome	Angeloni, A (corresponding author), Univ Roma La Sapienza, Dept Expt Med, Rome, Italy.	antonio.angeloni@uniroma1.it	Ceccarelli, Simona/J-4086-2018; Angeloni, Antonio/J-9392-2018; Frati, Luigi/ABI-7437-2020; Marchese, Cinzia/J-1323-2018	Ceccarelli, Simona/0000-0001-8789-7719; Angeloni, Antonio/0000-0003-4969-9548; MARCHESE, CINZIA/0000-0002-9280-8917	Regione Molise, Italy [B81J09001360002]	Regione Molise, Italy	This study was supported by grants from Regione Molise - Conv. 17/07 (B81J09001360002), Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APPLETON I, 1994, J ROY SOC MED, V87, P500; AVIVI A, 1992, ONCOGENE, V7, P1957; Barrientos S, 2008, WOUND REPAIR REGEN, V16, P585, DOI 10.1111/j.1524-475X.2008.00410.x; BASILICO C, 1992, ADV CANCER RES, V59, P115, DOI 10.1016/S0065-230X(08)60305-X; Becker M, 2000, BIOCHEM BIOPH RES CO, V276, P493, DOI 10.1006/bbrc.2000.3483; CHEDID M, 1994, J BIOL CHEM, V269, P10753; CHUNG LWK, 1993, SEMIN CANCER BIOL, V4, P183; Cottoni F, 2009, J DERMATOL SCI, V53, P65, DOI 10.1016/j.jdermsci.2008.07.012; Cullen K J, 1992, Cancer Treat Res, V61, P413; Dailey L, 2005, CYTOKINE GROWTH F R, V16, P233, DOI 10.1016/j.cytogfr.2005.01.007; Dasgupta P, 2004, MOL CELL BIOL, V24, P9527, DOI 10.1128/MCB.24.21.9527-9541.2004; Davis R, 2012, CELL CYCLE, V11, P109, DOI 10.4161/cc.11.1.18473; Donjacour A A, 1991, Cancer Treat Res, V53, P335; Ekuni D, 2006, J PERIODONTAL RES, V41, P340, DOI 10.1111/j.1600-0765.2006.00881.x; Fernandes DJ, 2004, BRIT J PHARMACOL, V142, P1182, DOI 10.1038/sj.bjp.0705809; Finch PW, 2006, JNCI-J NATL CANCER I, V98, P812, DOI 10.1093/jnci/djj228; FINCH PW, 1989, SCIENCE, V245, P752, DOI 10.1126/science.2475908; FUSENIG NE, 1994, KERATINOCYTE HDB, P71; GAILIT J, 1994, CURR OPIN CELL BIOL, V6, P717, DOI 10.1016/0955-0674(94)90099-X; Gartside MG, 2009, MOL CANCER RES, V7, P41, DOI 10.1158/1541-7786.MCR-08-0021; HELIN K, 1993, MOL CELL BIOL, V13, P6501, DOI 10.1128/MCB.13.10.6501; JOHNSON DE, 1993, ADV CANCER RES, V60, P1; Kanai M, 2009, GENE, V438, P49, DOI 10.1016/j.gene.2009.03.004; Katoh M, 2008, INT J ONCOL, V33, P233, DOI 10.3892/ijo_00000001; Katoh Y, 2009, INT J MOL MED, V23, P307, DOI 10.3892/ijmm_00000132; KREK W, 1994, CELL, V78, P161, DOI 10.1016/0092-8674(94)90582-7; LUGER TA, 1995, ALLERGY, V50, P292, DOI 10.1111/j.1398-9995.1995.tb01151.x; Luger TA, 1996, J DERMATOL SCI, V13, P5, DOI 10.1016/0923-1811(95)00485-8; Maas-Szabowski N, 1999, J CELL SCI, V112, P1843; MACKENZIE IC, 1994, KERATINOCYTE HDB, P243; MARCHESE C, 1995, J EXP MED, V182, P1369, DOI 10.1084/jem.182.5.1369; McClellan KA, 2007, CELL CYCLE, V6, P2917, DOI 10.4161/cc.6.23.4997; McEwen DG, 1998, J BIOL CHEM, V273, P5349, DOI 10.1074/jbc.273.9.5349; NATHAN C, 1991, J CELL BIOL, V113, P981, DOI 10.1083/jcb.113.5.981; NEVINS JR, 1992, SCIENCE, V258, P424; Nurcombe V, 2000, J BIOL CHEM, V275, P30009, DOI 10.1074/jbc.M003038200; Palmieri C, 2003, J ENDOCRINOL, V177, P65, DOI 10.1677/joe.0.1770065; PARKINS C S, 1991, British Journal of Neurosurgery, V5, P289, DOI 10.3109/02688699109005189; Pollock J, 2002, NEUROPHARMACOLOGY, V42, P93, DOI 10.1016/S0028-3908(01)00163-0; Read MA, 1997, J BIOL CHEM, V272, P2753, DOI 10.1074/jbc.272.5.2753; Rotolo S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002528; Rubin J S, 1995, EXS, V74, P191; SAITO H, 1992, BIOCHEM BIOPH RES CO, V183, P688, DOI 10.1016/0006-291X(92)90537-U; Samaniego F, 1997, J IMMUNOL, V158, P1887; Samaniego F, 1998, AM J PATHOL, V152, P1433; SAWHNEY N, 1992, CANCER, V70, P2115, DOI 10.1002/1097-0142(19921015)70:8<2115::AID-CNCR2820700818>3.0.CO;2-K; SCOTT RJ, 1991, J PATHOL, V165, P173, DOI 10.1002/path.1711650213; Scuderi N, 2008, BIOMATERIALS, V29, P1620, DOI 10.1016/j.biomaterials.2007.12.024; Skroza N, 2008, J DERMATOL SCI, V51, P53, DOI 10.1016/j.jdermsci.2008.02.004; Slansky JE, 1996, CURR TOP MICROBIOL, V208, P1; SMOLA H, 1993, J CELL BIOL, V122, P417, DOI 10.1083/jcb.122.2.417; SMOLA H, 1994, TOXICOL IN VITRO, V8, P641, DOI 10.1016/0887-2333(94)90034-5; St Bernard R, 2005, ENDOCRINOLOGY, V146, P1145, DOI 10.1210/en.2004-1134; Sun A, 2007, J CELL BIOCHEM, V102, P1400, DOI 10.1002/jcb.21609; Sun FY, 2009, J BIOL CHEM, V284, P3136, DOI 10.1074/jbc.M808992200; Tammali R, 2010, ENDOCRINOLOGY, V151, P2140, DOI 10.1210/en.2010-0160; Tang AM, 1996, J DERMATOL SCI, V11, P41, DOI 10.1016/0923-1811(95)00418-1; Tashiro E, 2003, ONCOGENE, V22, P5630, DOI 10.1038/sj.onc.1206636; Tashiro E, 2003, CANCER RES, V63, P424; Wang S, 1999, EMBO J, V18, P1559, DOI 10.1093/emboj/18.6.1559; Werner S, 2003, PHYSIOL REV, V83, P835, DOI 10.1152/physrev.2003.83.3.835; WERNER S, 1994, J INVEST DERMATOL, V103, P469, DOI 10.1111/1523-1747.ep12395564; Werner S, 1998, CYTOKINE GROWTH F R, V9, P153, DOI 10.1016/S1359-6101(98)00010-0; WERNER S, 1992, P NATL ACAD SCI USA, V89, P6896, DOI 10.1073/pnas.89.15.6896; Yamamoto T, 1998, ACTA DERM-VENEREOL, V78, P99; Yeste-Velasco M, 2009, NEUROCHEM INT, V54, P99, DOI 10.1016/j.neuint.2008.10.004; Yoshimura A, 2006, CANCER SCI, V97, P439, DOI 10.1111/j.1349-7006.2006.00197.x; Zhu XG, 2010, AM J PATHOL, V176, P2333, DOI 10.2353/ajpath.2010.091049	68	21	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2013	8	4							e61491	10.1371/journal.pone.0061491	http://dx.doi.org/10.1371/journal.pone.0061491			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130DR	23613863	Green Published, gold, Green Submitted			2022-12-25	WOS:000317893400070
J	Gautam, A; Bhattacharya, J				Gautam, Archana; Bhattacharya, Jayanta			Evidence that Vpu Modulates HIV-1 Gag-Envelope Interaction towards Envelope Incorporation and Infectivity in a Cell Type Dependent Manner	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; MATRIX DOMAIN; PARTICLE RELEASE; MEDIATED ENHANCEMENT; PRIMARY MACROPHAGES; INDIAN PATIENTS; MESSENGER-RNAS; PROTEIN; CD4; ENV	The HIV-1 Vpu is required for efficient virus particle release from the plasma membrane and intracellular CD4 degradation in infected cells. In the present study, we found that the loss of virus infectivity as a result of envelope (Env) incorporation defect caused by a Gag matrix (MA) mutation (L30E) was significantly alleviated by introducing a start codon mutation in vpu. Inactivation of Vpu partially restored the Env incorporation defect imposed by L30E substitution in MA. This effect was found to be comparable in cell types such as 293T, HeLa, NP2 and GHOST as well as in peripheral blood mononuclear cells (PBMC) and monocyte- derived macrophages (MDM). However, in HeLa cells BST-2 knockdown was found to further alleviate the effect of Vpu inactivation on infectivity of L30E mutant. Our data demonstrated that the impaired infectivity of virus particles due to Env incorporation defect caused by MA mutation was modulated by start codon mutation in Vpu.	[Gautam, Archana; Bhattacharya, Jayanta] Natl AIDS Res Inst, Dept Mol Virol, Pune, Maharashtra, India	Indian Council of Medical Research (ICMR); ICMR - National AIDS Research Institute (NARI)	Bhattacharya, J (corresponding author), Translat Hlth Sci & Technol Inst, Dept Biotechnol, Int AIDS Vaccine Initiat, HVTR Lab, Phase 3 Gurgaon, Gurgaon, Haryana, India.	bhattacharya.jayanta@gmail.com			Indian Council of Medical Research, New Delhi	Indian Council of Medical Research, New Delhi(Indian Council of Medical Research (ICMR))	AG is supported by a Senior Research Fellowship from the Indian Council of Medical Research, New Delhi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi A, 2001, INT J MOL MED, V8, P641; BALLIET JW, 1994, VIROLOGY, V200, P623, DOI 10.1006/viro.1994.1225; Bhattacharya J, 2006, J VIROL, V80, P5292, DOI 10.1128/JVI.01469-05; Brandano L, 2012, J VIROL, V86, P2347, DOI 10.1128/JVI.06047-11; Callahan MA, 1998, J VIROL, V72, P8461; Cortes MJ, 2002, J BIOL CHEM, V277, P1770, DOI 10.1074/jbc.M109807200; Dejucq N, 2000, J GEN VIROL, V81, P2899, DOI 10.1099/0022-1317-81-12-2899; Deora A, 2000, VIROLOGY, V269, P305, DOI 10.1006/viro.1999.0094; DORFMAN T, 1994, J VIROL, V68, P1689, DOI 10.1128/JVI.68.3.1689-1696.1994; Dutta S, 2008, BIOCHEMISTRY-US, V47, P10123, DOI 10.1021/bi800758a; FACKE M, 1993, J VIROL, V67, P4972; FREED EO, 1995, J VIROL, V69, P1984, DOI 10.1128/JVI.69.3.1984-1989.1995; Freed EO, 1996, J VIROL, V70, P341, DOI 10.1128/JVI.70.1.341-351.1996; FREED EO, 1995, J VIROL, V69, P3949, DOI 10.1128/JVI.69.6.3949-3954.1995; Garrus JE, 2001, CELL, V107, P55, DOI 10.1016/S0092-8674(01)00506-2; Gharu L, 2011, VIRUS RES, V158, P216, DOI 10.1016/j.virusres.2011.04.003; Goidin D, 2001, ANAL BIOCHEM, V295, P17, DOI 10.1006/abio.2001.5171; Handley MA, 2001, VIROLOGY, V291, P198, DOI 10.1006/viro.2001.1166; Harila K, 2006, J VIROL, V80, P3765, DOI 10.1128/JVI.80.8.3765-3772.2006; Harila K, 2007, VIROLOGY, V369, P299, DOI 10.1016/j.virol.2007.08.009; Joshi A, 2009, J VIROL, V83, P5375, DOI 10.1128/JVI.00109-09; KAWAMURA M, 1994, J GEN VIROL, V75, P2427, DOI 10.1099/0022-1317-75-9-2427; KLIMKAIT T, 1990, J VIROL, V64, P621, DOI 10.1128/JVI.64.2.621-629.1990; Lama J, 1999, CURR BIOL, V9, P622, DOI 10.1016/S0960-9822(99)80284-X; Lee YH, 1997, VIROLOGY, V237, P46, DOI 10.1006/viro.1997.8711; Levesque K, 2003, J BIOL CHEM, V278, P28346, DOI 10.1074/jbc.M300327200; Long EM, 2002, AIDS RES HUM RETROV, V18, P567, DOI 10.1089/088922202753747914; MALDARELLI F, 1993, J VIROL, V67, P5056, DOI 10.1128/JVI.67.8.5056-5061.1993; Mansouri M, 2009, J VIROL, V83, P9672, DOI 10.1128/JVI.00597-09; Martin-Serrano J, 2001, NAT MED, V7, P1313, DOI 10.1038/nm1201-1313; Miyagi E, 2009, P NATL ACAD SCI USA, V106, P2868, DOI 10.1073/pnas.0813223106; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Neil Stuart J. D., 2006, PLoS Pathogens, V2, DOI 10.1371/jounral.ppat.0020039; Nydegger S, 2006, J CELL BIOL, V173, P795, DOI 10.1083/jcb.200508165; Pacyniak E, 2005, AIDS RES HUM RETROV, V21, P379, DOI 10.1089/aid.2005.21.379; Pelchen-Matthews A, 2003, J CELL BIOL, V162, P443, DOI 10.1083/jcb.200304008; Perez-Caballero D, 2009, CELL, V139, P499, DOI 10.1016/j.cell.2009.08.039; Peters PJ, 2004, J VIROL, V78, P6915, DOI 10.1128/JVI.78.13.6915-6926.2004; REICIN AS, 1995, J VIROL, V69, P642, DOI 10.1128/JVI.69.2.642-650.1995; Richards KH, 2007, J GEN VIROL, V88, P2780, DOI 10.1099/vir.0.83120-0; Ringe R, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-76; Ruiz A, 2010, VIROLOGY, V408, P89, DOI 10.1016/j.virol.2010.08.031; Schubert U, 1999, J VIROL, V73, P887, DOI 10.1128/JVI.73.2.887-896.1999; SCHWARTZ S, 1990, J VIROL, V64, P5448, DOI 10.1128/JVI.64.11.5448-5456.1990; SCHWARTZ S, 1992, MOL CELL BIOL, V12, P207, DOI 10.1128/MCB.12.1.207; Stephens EB, 2002, VIROLOGY, V293, P252, DOI 10.1006/viro.2001.1244; Strack B, 2003, CELL, V114, P689, DOI 10.1016/S0092-8674(03)00653-6; STREBEL K, 1989, J VIROL, V63, P3784, DOI 10.1128/JVI.63.9.3784-3791.1989; Van Damme N, 2008, CELL MICROBIOL, V10, P1040, DOI 10.1111/j.1462-5822.2007.01101.x; Varthakavi V, 2006, TRAFFIC, V7, P298, DOI 10.1111/j.1600-0854.2005.00380.x; Varthakavi V, 2003, P NATL ACAD SCI USA, V100, P15154, DOI 10.1073/pnas.2433165100; VINCENT MJ, 1995, VIROLOGY, V213, P639, DOI 10.1006/viro.1995.0035; WANG CT, 1993, J VIROL, V67, P7067, DOI 10.1128/JVI.67.12.7067-7076.1993; WILLEY RL, 1992, J VIROL, V66, P7193, DOI 10.1128/JVI.66.12.7193-7200.1992; Willey SJ, 2003, J VIROL, V77, P6138, DOI 10.1128/JVI.77.11.6138-6152.2003; YU XF, 1992, J VIROL, V66, P4966, DOI 10.1128/JVI.66.8.4966-4971.1992	56	2	2	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2013	8	4							e61388	10.1371/journal.pone.0061388	http://dx.doi.org/10.1371/journal.pone.0061388			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130DR	23613843	Green Published, gold, Green Submitted			2022-12-25	WOS:000317893400059
J	Moreau, MP; Bruse, SE; Jornsten, R; Liu, YS; Brzustowicz, LM				Moreau, Michael P.; Bruse, Shannon E.; Jornsten, Rebecka; Liu, Yushi; Brzustowicz, Linda M.			Chronological Changes in MicroRNA Expression in the Developing Human Brain	PLOS ONE			English	Article							NEURONAL DIFFERENTIATION; SCHIZOPHRENIA; RNA; ADULT; LET-7; MORPHOGENESIS; INDIVIDUALS; CORTEX	Objective: MicroRNAs (miRNAs) are endogenously expressed noncoding RNA molecules that are believed to regulate multiple neurobiological processes. Expression studies have revealed distinct temporal expression patterns in the developing rodent and porcine brain, but comprehensive profiling in the developing human brain has not been previously reported. Methods: We performed microarray and TaqMan-based expression analysis of all annotated mature miRNAs (miRBase 10.0) as well as 373 novel, predicted miRNAs. Expression levels were measured in 48 post-mortem brain tissue samples, representing gestational ages 14-24 weeks, as well as early postnatal and adult time points. Results: Expression levels of 312 miRNAs changed significantly between at least two of the broad age categories, defined as fetal, young, and adult. Conclusions: We have constructed a miRNA expression atlas of the developing human brain, and we propose a classification scheme to guide future studies of neurobiological function.	[Moreau, Michael P.; Brzustowicz, Linda M.] Rutgers State Univ, Dept Genet, Piscataway, NJ 08854 USA; [Bruse, Shannon E.; Liu, Yushi] Lovelace Resp Res Inst, Albuquerque, NM USA; [Jornsten, Rebecka] Univ Gothenburg, Gothenburg, Sweden; [Jornsten, Rebecka] Chalmers Univ Technol, S-41296 Gothenburg, Sweden	Rutgers State University New Brunswick; Lovelace Respiratory Research Institute; University of Gothenburg; Chalmers University of Technology	Moreau, MP (corresponding author), Rutgers State Univ, Dept Genet, Piscataway, NJ 08854 USA.	moreau@biology.rutgers.edu	Liu, Yushi/A-1533-2014	Liu, Yushi/0000-0003-4185-4187	National Institutes of Mental Health [R01 MH80429]; National Alliance for Research on Schizophrenia and Depression (NARSAD)/Staglin Family Music Festival Schizophrenia Research Award [T32 MH019957]; Ruth L. Kirschstein National Research Service Award; Swedish Research Council; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH019957, R01MH080429] Funding Source: NIH RePORTER	National Institutes of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Alliance for Research on Schizophrenia and Depression (NARSAD)/Staglin Family Music Festival Schizophrenia Research Award(NARSAD); Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swedish Research Council(Swedish Research CouncilEuropean Commission); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by grant R01 MH80429 from the National Institutes of Mental Health and the National Alliance for Research on Schizophrenia and Depression (NARSAD)/Staglin Family Music Festival Schizophrenia Research Award (LMB), T32 MH019957, the Ruth L. Kirschstein National Research Service Award (MPM), and the Swedish Research Council (RJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral PP, 2008, MAMM GENOME, V19, P454, DOI 10.1007/s00335-008-9136-7; Balu DT, 2009, NEUROSCI BIOBEHAV R, V33, P232, DOI 10.1016/j.neubiorev.2008.08.007; Banizs B, 2005, DEVELOPMENT, V132, P5329, DOI 10.1242/dev.02153; BEVERIDGE NJ, 2008, HUM MOL GENET; Davis TH, 2008, J NEUROSCI, V28, P4322, DOI 10.1523/JNEUROSCI.4815-07.2008; Fiore Roberto, 2007, ScientificWorldJournal, V7, P167; Friedlander MR, 2008, NAT BIOTECHNOL, V26, P407, DOI 10.1038/nbt1394; Giraldez AJ, 2005, SCIENCE, V308, P833, DOI 10.1126/science.1109020; Hansen T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000873; Hebert SS, 2009, TRENDS NEUROSCI; Hornstein E, 2006, NAT GENET, V38, pS20, DOI 10.1038/ng1803; Huang RS, 2011, RNA BIOL, V8, P692, DOI 10.4161/rna.8.4.16029; Johnson CD, 2007, CANCER RES, V67, P7713, DOI 10.1158/0008-5472.CAN-07-1083; Kocerha J, 2009, P NATL ACAD SCI USA, V106, P3507, DOI 10.1073/pnas.0805854106; Krichevsky AM, 2003, RNA, V9, P1274, DOI 10.1261/rna.5980303; Krichevsky AM, 2006, STEM CELLS, V24, P857, DOI 10.1634/stemcells.2005-0441; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luikart BW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019077; Lukiw WJ, 2007, NEUROREPORT, V18, P297, DOI 10.1097/WNR.0b013e3280148e8b; Makeyev EV, 2007, MOL CELL, V27, P435, DOI 10.1016/j.molcel.2007.07.015; Marcet B, 2011, NAT CELL BIOL, V13, P693, DOI 10.1038/ncb2241; Martinez NJ, 2009, BIOESSAYS; Miller BH, 2012, P NATL ACAD SCI USA, V109, P3125, DOI 10.1073/pnas.1113793109; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Miska EA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r68; Moreau MP, 2011, BIOL PSYCHIAT, V69, P188, DOI 10.1016/j.biopsych.2010.09.039; Perkins DO, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r27; Peter ME, 2009, CELL CYCLE, V8, P843, DOI 10.4161/cc.8.6.7907; Podolska A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014494; Redshaw N, 2009, BRAIN RES, V1250, P20, DOI 10.1016/j.brainres.2008.11.020; Roush S, 2008, TRENDS CELL BIOL, V18, P505, DOI 10.1016/j.tcb.2008.07.007; Schaefer A, 2007, J EXP MED, V204, P1553, DOI 10.1084/jem.20070823; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; Sempere LF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r13; Smirnova L, 2005, EUR J NEUROSCI, V21, P1469, DOI 10.1111/j.1460-9568.2005.03978.x; Strauss WM, 2006, MAMM GENOME, V17, P833, DOI 10.1007/s00335-006-0025-7; Tonelli DD, 2008, DEVELOPMENT, V135, P3911, DOI 10.1242/dev.025080; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498	39	34	36	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2013	8	4							e60480	10.1371/journal.pone.0060480	http://dx.doi.org/10.1371/journal.pone.0060480			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130DR	23613727	Green Published, gold, Green Submitted			2022-12-25	WOS:000317893400010
J	Salvador, AC; Baptista, I; Barros, AS; Gomes, NCM; Cunha, A; Almeida, A; Rocha, SM				Salvador, Angelo C.; Baptista, Ines; Barros, Antonio S.; Gomes, Newton C. M.; Cunha, Angela; Almeida, Adelaide; Rocha, Silvia M.			Can Volatile Organic Metabolites Be Used to Simultaneously Assess Microbial and Mite Contamination Level in Cereal Grains and Coffee Beans?	PLOS ONE			English	Article							2-DIMENSIONAL GAS-CHROMATOGRAPHY; FLIGHT MASS-SPECTROMETRY; SOLID-PHASE MICROEXTRACTION; ASTIGMATID MITES; FUNGAL VOLATILES; ACTIVE COMPOUNDS; ELECTRONIC NOSE; POWERFUL TOOL; IDENTIFICATION; FOOD	A novel approach based on headspace solid-phase microextraction (HS-SPME) combined with comprehensive two-dimensional gas chromatography-time-of-flight mass spectrometry (GCxGC-ToFMS) was developed for the simultaneous screening of microbial and mite contamination level in cereals and coffee beans. The proposed approach emerges as a powerful tool for the rapid assessment of the microbial contamination level (ca. 70 min versus ca. 72 to 120 h for bacteria and fungi, respectively, using conventional plate counts), and mite contamination (ca. 70 min versus ca. 24 h). A full-factorial design was performed for optimization of the SPME experimental parameters. The methodology was applied to three types of rice (rough, brown, and white rice), oat, wheat, and green and roasted coffee beans. Simultaneously, microbiological analysis of the samples (total aerobic microorganisms, moulds, and yeasts) was performed by conventional plate counts. A set of 54 volatile markers was selected among all the compounds detected by GCxGC-ToFMS. Principal Component Analysis (PCA) was applied in order to establish a relationship between potential volatile markers and the level of microbial contamination. Methylbenzene, 3-octanone, 2-nonanone, 2-methyl-3-pentanol, 1-octen-3-ol, and 2-hexanone were associated to samples with higher microbial contamination level, especially in rough rice. Moreover, oat exhibited a high GC peak area of 2-hydroxy-6-methylbenzaldehyde, a sexual and alarm pheromone for adult mites, which in the other matrices appeared as a trace component. The number of mites detected in oat grains was correlated to the GC peak area of the pheromone. The HS-SPME/GCxGC-ToFMS methodology can be regarded as the basis for the development of a rapid and versatile method that can be applied in industry to the simultaneous assessment the level of microbiological contamination and for detection of mites in cereals grains and coffee beans.	[Salvador, Angelo C.; Barros, Antonio S.; Rocha, Silvia M.] Univ Aveiro, Dept Chem, QOPNA, P-3800 Aveiro, Portugal; [Baptista, Ines; Gomes, Newton C. M.; Cunha, Angela; Almeida, Adelaide] Univ Aveiro, Dept Biol, P-3800 Aveiro, Portugal; [Baptista, Ines; Gomes, Newton C. M.; Cunha, Angela; Almeida, Adelaide] Univ Aveiro, CESAM, P-3800 Aveiro, Portugal	Universidade de Aveiro; Universidade de Aveiro; Universidade de Aveiro	Rocha, SM (corresponding author), Univ Aveiro, Dept Chem, QOPNA, Campus Univ Santiago, P-3800 Aveiro, Portugal.	smrocha@ua.pt	Cunha, Angela/AAC-3830-2019; Gomes, Newton CM/F-7430-2012; Gomes, Newton Carlos Marcial/AAV-4603-2021; Gomes, Newton Carlos Marcial/K-3211-2015; Barros, António S./B-5847-2009; Baptista, Maria I/F-8163-2014; Almeida, Adelaide/D-9899-2011; Cunha, Angela/E-9537-2011; Baptista, Inês/O-5555-2019	Cunha, Angela/0000-0002-9118-3521; Gomes, Newton CM/0000-0003-1934-0091; Gomes, Newton Carlos Marcial/0000-0003-1934-0091; Gomes, Newton Carlos Marcial/0000-0003-1934-0091; Barros, António S./0000-0002-9103-5852; Baptista, Maria I/0000-0003-4798-0192; Almeida, Adelaide/0000-0002-8422-8664; Cunha, Angela/0000-0002-9118-3521; Baptista, Inês/0000-0003-4798-0192; Rocha, Silvia/0000-0002-0396-3019; Salvador, Angelo C./0000-0003-4573-5847	Research Unit 62/94, QOPNA [PEst-C/QUI/UI0062/2011]; Research Unit CESAM (FCT-Fundacao para a Ciencia e Tecnologia); Sistema de Incentivos a Investigacao e Desenvolvimento Tecnologico, Portugal	Research Unit 62/94, QOPNA; Research Unit CESAM (FCT-Fundacao para a Ciencia e Tecnologia); Sistema de Incentivos a Investigacao e Desenvolvimento Tecnologico, Portugal	Authors thank the Research Unit 62/94, QOPNA (project PEst-C/QUI/UI0062/2011) and to the Research Unit CESAM (FCT-Fundacao para a Ciencia e Tecnologia - http://www.fct.pt/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Samples supplying, which not includes any financial support: The samples were supplied through the Project QREN No 1561 (Development of an equipment to determine the level of fungal contamination in food matrices and related materials, supported by Sistema de Incentivos a Investigacao e Desenvolvimento Tecnologico, Portugal).	Adahchour M, 2006, TRAC-TREND ANAL CHEM, V25, P438, DOI 10.1016/j.trac.2006.03.002; Adahchour M, 2006, TRAC-TREND ANAL CHEM, V25, P540, DOI 10.1016/j.trac.2006.04.004; Adams R.P., 1995, IDENTIFICATION ESSEN; [Anonymous], 1987, 327711987 NP I PORT; Blanco C, 1997, J ALLERGY CLIN IMMUN, V99, P308, DOI 10.1016/S0091-6749(97)70047-2; Bokhari F. M., 2009, ADV BIOL RES, V3, P71; BORJESSON T, 1992, APPL ENVIRON MICROB, V58, P2599; BORJESSON T, 1989, CEREAL CHEM, V66, P300; Campeol E, 2003, J AGR FOOD CHEM, V51, P1994, DOI 10.1021/jf026025u; Cantergiani E, 2001, EUR FOOD RES TECHNOL, V212, P648, DOI 10.1007/s002170100305; Carrapiso AI, 2002, J AGR FOOD CHEM, V50, P6453, DOI 10.1021/jf025526c; Chevance FFV, 1999, J AGR FOOD CHEM, V47, P5151, DOI 10.1021/jf990515d; CURTIS RF, 1981, J STORED PROD RES, V17, P197, DOI 10.1016/0022-474X(81)90006-0; Dhanda J.S., 2003, SASKATCHEWAN SPECIAL; Engel E, 2002, J AGR FOOD CHEM, V50, P6459, DOI 10.1021/jf025579u; Eyres G, 2005, J SEP SCI, V28, P1061, DOI 10.1002/jssc.200500012; Ho L, 2004, LITERARY REV, V47, P101; Humston EM, 2010, J CHROMATOGR A, V1217, P1963, DOI 10.1016/j.chroma.2010.01.069; Irfan-Ul-Haq, 2007, 8th African Crop Science Society Conference, El-Minia, Egypt, 27-31 October 2007, P2205; ISO, 2003, 48332003 ISO; Jelen H, 1998, FOOD REV INT, V14, P391, DOI 10.1080/87559129809541170; Johanningsmeier SD, 2011, J FOOD SCI, V76, pC168, DOI 10.1111/j.1750-3841.2010.01918.x; Jolliffe, 2002, PRINCIPAL COMPONENT; Jordan MJ, 2002, J AGR FOOD CHEM, V50, P5386, DOI 10.1021/jf020297f; Kai M, 2009, APPL MICROBIOL BIOT, V81, P1001, DOI 10.1007/s00253-008-1760-3; Kataoka H, 2000, J CHROMATOGR A, V880, P35, DOI 10.1016/S0021-9673(00)00309-5; Korpi A, 2009, CRIT REV TOXICOL, V39, P139, DOI [10.1080/10408440802291497 , 10.1080/10408440802291497]; KUWAHARA Y, 1992, APPL ENTOMOL ZOOL, V27, P253, DOI 10.1303/aez.27.253; Leffingwell J. C., 2005, ELECT J ENV AGR FOOD, V4, P899; LEQUERE JL, 1990, J AGR FOOD CHEM, V38, P3, DOI 10.1021/jf00091a001; Machiels D, 2003, TALANTA, V60, P755, DOI 10.1016/S0039-9140(03)00133-4; Magan N, 2000, J STORED PROD RES, V36, P319, DOI 10.1016/S0022-474X(99)00057-0; Mottram DS, 1998, INT J FOOD SCI TECH, V33, P19, DOI 10.1046/j.1365-2621.1998.00155.x; Nieminen T, 2008, LWT-FOOD SCI TECHNOL, V41, P2051, DOI 10.1016/j.lwt.2007.11.009; Noba S, 2009, J AGR FOOD CHEM, V57, P6036, DOI 10.1021/jf900546p; OConnor BM, 2009, EXP APPL ACAROL, V49, P125, DOI 10.1007/s10493-009-9270-2; Olsen AR, 2001, REGUL TOXICOL PHARM, V33, P363, DOI 10.1006/rtph.2001.1472; Pasanen AL, 1996, ANALYST, V121, P1949, DOI 10.1039/an9962101949; Perestrelo R, 2011, J AGR FOOD CHEM, V59, P3186, DOI 10.1021/jf104219t; Perestrelo R, 2010, J CHROMATOGR A, V1217, P3441, DOI 10.1016/j.chroma.2010.03.027; Perkowski J, 2008, INT J FOOD MICROBIOL, V126, P127, DOI 10.1016/j.ijfoodmicro.2008.05.028; Peshin SS, 2002, ACTA PHARMACOL SIN, V23, P193; Pino JA, 2005, J AGR FOOD CHEM, V53, P2213, DOI 10.1021/jf0402633; Priestap HA, 2003, PHYTOCHEMISTRY, V63, P221, DOI 10.1016/S0031-9422(02)00751-3; Rasanen RM, 2010, BUILD ENVIRON, V45, P2184, DOI 10.1016/j.buildenv.2010.03.018; Rocha SM, 2007, J CHROMATOGR A, V1161, P292, DOI 10.1016/j.chroma.2007.05.093; Ruppert EE, 1994, INVERTEBRATE ZOOLOGY; Ruther J, 2000, J CHEM ECOL, V26, P1205, DOI 10.1023/A:1005484027559; Rychlik M., 1998, COMPILATION ODOR THR, P63; Schnurer J, 1999, FUNGAL GENET BIOL, V27, P209, DOI 10.1006/fgbi.1999.1139; Schuchardt S, 2009, J BASIC MICROB, V49, P350, DOI 10.1002/jobm.200800152; Semwal AD, 1996, FOOD CHEM, V57, P233, DOI 10.1016/0308-8146(95)00208-1; Silva I, 2010, J CHROMATOGR A, V1217, P5511, DOI 10.1016/j.chroma.2010.06.050; Sotomayor JA, 2004, J AGR FOOD CHEM, V52, P5418, DOI 10.1021/jf0496245; SUNESSON AL, 1995, APPL ENVIRON MICROB, V61, P2911, DOI 10.1128/AEM.61.8.2911-2918.1995; Tan W, 1999, J MICROBIOL METH, V37, P87, DOI 10.1016/S0167-7012(99)00052-4; Thind BB, 2001, EXP APPL ACAROL, V25, P203, DOI 10.1023/A:1010647519044; Triqui R, 2003, J AGR FOOD CHEM, V51, P7540, DOI 10.1021/jf0348166; TSUBOUCHI H, 1987, MYCOPATHOLOGIA, V97, P111, DOI 10.1007/BF00436848; VANDENDOOL H, 1963, J CHROMATOGR, V11, P463, DOI 10.1016/S0021-9673(01)80947-X; Wenke K, 2010, PLANTA, V231, P499, DOI 10.1007/s00425-009-1076-2; Whitfield FB, 1998, INT J FOOD SCI TECH, V33, P31, DOI 10.1046/j.1365-2621.1998.00156.x; Wihlborg R, 2008, J MICROBIOL METH, V75, P244, DOI 10.1016/j.mimet.2008.06.011; Zhou MX, 1999, J AGR FOOD CHEM, V47, P3941, DOI 10.1021/jf990428l	64	20	20	2	96	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2013	8	4							e59338	10.1371/journal.pone.0059338	http://dx.doi.org/10.1371/journal.pone.0059338			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130DR	23613710	Green Published, gold, Green Submitted			2022-12-25	WOS:000317893400001
J	He, XZ; Yang, YL; Zhi, F; Moore, ML; Kang, XZ; Chao, DM; Wang, R; Balboni, G; Salvadori, S; Kim, DH; Xia, Y				He, Xiaozhou; Yang, Yilin; Zhi, Feng; Moore, Meredith L.; Kang, Xuezhi; Chao, Dongman; Wang, Rong; Balboni, Gianfranco; Salvadori, Severo; Kim, Dong H.; Xia, Ying			delta-Opioid Receptor Activation Modified MicroRNA Expression in the Rat Kidney under Prolonged Hypoxia	PLOS ONE			English	Article							K+ HOMEOSTASIS; MU; HIF-1-ALPHA; PROTECTS; CELLS; IMMATURE; NEURONS; INFLUX; DEATH; VEGF	Hypoxic/ischemic injury to kidney is a frequently encountered clinical problem with limited therapeutic options. Since microRNAs are differentially involved in hypoxic/ischemic events and delta-opioid receptor (DOR) activation is known to protect against hypoxic/ischemic injury, we speculated on the involvement of DOR activation in altering the microRNA (miRNA) expression in kidney under hypoxic condition. We selected 31 miRNAs based on microarray data for quantitative PCR analysis. Among them, 14 miRNAs were significantly altered after prolonged hypoxia, DOR activation or a combination of both. We found that 1) DOR activation alters miRNA expression profiles in normoxic conditions; 2) hypoxia differentially alters miRNA expression depending on the duration of hypoxia; and 3) DOR activation can modify hypoxia-induced changes in miRNA expression. For example, 10-day hypoxia reduced the level of miR-212 by over 70%, while DOR activation could mimic such reduction even in normoxic kidney. In contrast, the same stress increased miR-29a by >100%, which was reversed following DOR activation. These first data suggest that hypoxia comprehensively modifies the miRNA profile within the kidney, which can be mimicked or modified by DOR activation. Ascertaining the targeted pathways that regulate the diverse cellular and molecular functions of miRNA may provide new insights into potential therapies for hypoxic/ischemic injury of the kidney.	[He, Xiaozhou; Yang, Yilin; Zhi, Feng; Wang, Rong] Soochow Univ, Clin Coll 3, Res Inst Modern Med, Changzhou, Jiangsu, Peoples R China; [Moore, Meredith L.; Chao, Dongman; Kim, Dong H.; Xia, Ying] Univ Texas Med Sch Houston, Dept Neurosurg, Houston, TX USA; [Kang, Xuezhi] Shanghai Res Ctr Acupuncture & Meridians, Lab Mol Neurol, Shanghai, Peoples R China; [Chao, Dongman; Xia, Ying] Yale Univ, Sch Med, Dept Pediat, New Haven, CT 06510 USA; [Balboni, Gianfranco] Univ Cagliari, Dept Life & Environm Sci, Cagliari, Italy; [Salvadori, Severo] Univ Ferrara, Dept Pharmaceut Sci, I-44100 Ferrara, Italy	Soochow University - China; University of Texas System; University of Texas Health Science Center Houston; Yale University; University of Cagliari; University of Ferrara	Xia, Y (corresponding author), Univ Texas Med Sch Houston, Dept Neurosurg, Houston, TX USA.	Ying.Xia@UTH.TMC.edu	Kang, Xuezhi/L-6719-2016; Gianfranco, Balboni/K-1503-2019	Kang, Xuezhi/0000-0002-0582-2244; Kim, Dong/0000-0002-1523-6396; SALVADORI, Severo/0000-0002-8224-2358	National Institutes of Health [HD-034852, AT004422]; National Science Foundation of China [31071046]; Changzhou Science Development Project [CS20102010]; Changzhou Health Bureau [ZD201007]; National Basic Research Project [09CB522901, 12CB518502]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD034852] Funding Source: NIH RePORTER; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE [R01AT004422] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Changzhou Science Development Project; Changzhou Health Bureau; National Basic Research Project(National Basic Research Program of China); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine)	Supported by National Institutes of Health (HD-034852 and AT004422), National Science Foundation of China (31071046), Changzhou Science Development Project (CS20102010), Changzhou Health Bureau (ZD201007), and National Basic Research Project (09CB522901; 12CB518502). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bodnar R J, 1998, Expert Opin Investig Drugs, V7, P485, DOI 10.1517/13543784.7.4.485; Bondeva T, 2009, KIDNEY INT, V75, P605, DOI 10.1038/ki.2008.603; Borlongan CV, 2004, FRONT BIOSCI-LANDMRK, V9, P3392, DOI 10.2741/1490; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Cascio S, 2010, J CELL PHYSIOL, V224, P242, DOI 10.1002/jcp.22126; Chao D, 2009, CELL MOL LIFE SCI, V66, P1105, DOI 10.1007/s00018-009-8759-5; Chao DM, 2008, CEREB CORTEX, V18, P2217, DOI 10.1093/cercor/bhm247; Chao DM, 2007, J CELL PHYSIOL, V212, P60, DOI 10.1002/jcp.21000; Chao DM, 2007, J CEREBR BLOOD F MET, V27, P356, DOI 10.1038/sj.jcbfm.9600352; Chao DM, 2012, EXP NEUROL, V236, P228, DOI 10.1016/j.expneurol.2012.05.006; Chao DM, 2010, PROG NEUROBIOL, V90, P439, DOI 10.1016/j.pneurobio.2009.12.007; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Cui Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025872; Feng YA, 2011, CHINESE J PHYSIOL, V54, P118, DOI 10.4077/CJP.2011.AMM047; Gonsalves CS, 2010, J IMMUNOL, V184, P3878, DOI 10.4049/jimmunol.0902594; He Y, 2010, J NEUROSCI, V30, P10251, DOI 10.1523/JNEUROSCI.2419-10.2010; Hempel C, 2011, AM J PATHOL, V179, P1939, DOI 10.1016/j.ajpath.2011.06.027; Heyman SN, 2008, AM J NEPHROL, V28, P998, DOI 10.1159/000146075; Hulsmans M, 2011, FASEB J, V25, P2515, DOI 10.1096/fj.11-181149; Israel Y, 2005, PEPTIDES, V26, P1167, DOI 10.1016/j.peptides.2005.01.017; Kang XZ, 2009, CELL MOL LIFE SCI, V66, P3505, DOI 10.1007/s00018-009-0136-x; Kato S, 2011, J NEUROSCI RES, V89, P1566, DOI 10.1002/jnr.22702; Kriegel AJ, 2012, PHYSIOL GENOMICS, V44, P237, DOI 10.1152/physiolgenomics.00141.2011; Lei Z, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007629; Li J, 2010, ONCOGENE, V29, P2550, DOI 10.1038/onc.2010.14; Liang MY, 2009, AM J PHYSIOL-RENAL, V297, pF553, DOI 10.1152/ajprenal.00045.2009; Liu CG, 2004, P NATL ACAD SCI USA, V101, P9740, DOI 10.1073/pnas.0403293101; Luna C, 2009, MOL VIS, V15, P2488; Ma MC, 2005, J BIOL CHEM, V280, P16208, DOI 10.1074/jbc.M408055200; MARTINEZBALLARIN E, 1986, REV ESP FISIOL, V42, P319; Nangaku M, 2007, J MOL MED, V85, P1325, DOI 10.1007/s00109-007-0278-y; Olaru AV, 2011, INFLAMM BOWEL DIS, V17, P221, DOI 10.1002/ibd.21359; Patel HH, 2006, AM J PHYSIOL-HEART C, V291, pH344, DOI 10.1152/ajpheart.01100.2005; Polytarchou C, 2011, CANCER RES, V71, P4720, DOI 10.1158/0008-5472.CAN-11-0365; Saito A, 2011, AM J PHYSIOL-REG I, V300, pR340, DOI 10.1152/ajpregu.00640.2009; Tang FC, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gnj009; Tang YM, 2008, ALCOHOL CLIN EXP RES, V32, P355, DOI 10.1111/j.1530-0277.2007.00584.x; Thomson JM, 2004, NAT METHODS, V1, P47, DOI 10.1038/NMETH704; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; White NMA, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-65; Wu QF, 2013, FASEB J, V27, P522, DOI 10.1096/fj.12-213439; Xia Y, 1999, NEUROSCIENCE, V94, P1231, DOI 10.1016/S0306-4522(99)00375-9; XIA Y, 1993, PEDIATR RES, V34, P634, DOI 10.1203/00006450-199311000-00015; XIA Y, 1995, BRAIN RES, V675, P224, DOI 10.1016/0006-8993(95)00079-6; XIA Y, 1997, AM J PHYSIOL-REG I, V273, pR1734; Xiong YJ, 2010, HEPATOLOGY, V51, P836, DOI 10.1002/hep.23380; Yang YL, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-55; Ye YM, 2011, PHYSIOL GENOMICS, V43, P534, DOI 10.1152/physiolgenomics.00130.2010; Zhang JH, 2006, STROKE, V37, P1094, DOI 10.1161/01.STR.0000206444.29930.18; Zhang JH, 2000, BRAIN RES, V885, P143, DOI 10.1016/S0006-8993(00)02906-1; Zheng H, 2010, J BIOL CHEM, V285, P21994, DOI 10.1074/jbc.M110.112607	51	19	19	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2013	8	4							e61080	10.1371/journal.pone.0061080	http://dx.doi.org/10.1371/journal.pone.0061080			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125TD	23596515	Green Published, Green Submitted, gold			2022-12-25	WOS:000317563300019
J	Palige, K; Linde, J; Martin, R; Bottcher, B; Citiulo, F; Sullivan, DJ; Weber, J; Staib, C; Rupp, S; Hube, B; Morschhauser, J; Staib, P				Palige, Katja; Linde, Joerg; Martin, Ronny; Boettcher, Bettina; Citiulo, Francesco; Sullivan, Derek J.; Weber, Johann; Staib, Claudia; Rupp, Steffen; Hube, Bernhard; Morschhaeuser, Joachim; Staib, Peter			Global Transcriptome Sequencing Identifies Chlamydospore Specific Markers in Candida albicans and Candida dubliniensis	PLOS ONE			English	Article							STAIB AGAR; GENE; MORPHOGENESIS; GROWTH; UME6; NRG1; EPIDEMIOLOGY; FLUCONAZOLE; GERMINATION; INFECTIONS	Candida albicans and Candida dubliniensis are pathogenic fungi that are highly related but differ in virulence and in some phenotypic traits. During in vitro growth on certain nutrient-poor media, C. albicans and C. dubliniensis are the only yeast species which are able to produce chlamydospores, large thick-walled cells of unknown function. Interestingly, only C. dubliniensis forms pseudohyphae with abundant chlamydospores when grown on Staib medium, while C. albicans grows exclusively as a budding yeast. In order to further our understanding of chlamydospore development and assembly, we compared the global transcriptional profile of both species during growth in liquid Staib medium by RNA sequencing. We also included a C. albicans mutant in our study which lacks the morphogenetic transcriptional repressor Nrg1. This strain, which is characterized by its constitutive pseudohyphal growth, specifically produces masses of chlamydospores in Staib medium, similar to C. dubliniensis. This comparative approach identified a set of putatively chlamydospore-related genes. Two of the homologous C. albicans and C. dubliniensis genes (CSP1 and CSP2) which were most strongly upregulated during chlamydospore development were analysed in more detail. By use of the green fluorescent protein as a reporter, the encoded putative cell wall related proteins were found to exclusively localize to C. albicans and C. dubliniensis chlamydospores. Our findings uncover the first chlamydospore specific markers in Candida species and provide novel insights in the complex morphogenetic development of these important fungal pathogens.	[Palige, Katja; Boettcher, Bettina; Staib, Peter] Hans Knoell Inst, Leibniz Inst Nat Prod Res & Infect Biol, Jr Res Grp Fundamental Mol Biol Pathogen Fungi, Jena, Germany; [Linde, Joerg] Hans Knoell Inst, Leibniz Inst Nat Prod Res & Infect Biol, Jena, Germany; [Martin, Ronny] Hans Knoell Inst, Ctr Innovat Competence Sept, Res Grp Fungal Sept, Leibniz Inst Nat Prod Res & Infect Biol, Jena, Germany; [Citiulo, Francesco; Hube, Bernhard] Hans Knoell Inst, Leibniz Inst Nat Prod Res & Infect Biol, Jena, Germany; [Citiulo, Francesco; Sullivan, Derek J.] Univ Dublin, Sch Dent Sci, Trinity Coll Dublin, Dublin, Ireland; [Citiulo, Francesco; Sullivan, Derek J.] Univ Dublin, Dublin Dent Univ Hosp, Trinity Coll Dublin, Dublin, Ireland; [Weber, Johann] Univ Lausanne, Lausanne Genom Technol Facil, Ctr Integrat Gen, Lausanne, Switzerland; [Staib, Claudia] Univ Wurzburg, Dept Obstet & Gynecol, D-97070 Wurzburg, Germany; [Rupp, Steffen] Fraunhofer Inst Interfacial Engn & Biotechnol, Stuttgart, Germany; [Hube, Bernhard] Univ Jena, Jena, Germany; [Hube, Bernhard] Jena Univ Hosp, Ctr Sepsis Control & Care, Jena, Germany; [Morschhaeuser, Joachim] Univ Wurzburg, Inst Mol Infect Biol, D-97070 Wurzburg, Germany; [Staib, Peter] Dept Res & Dev, Wurzburg, Germany	Hans Knoll Institute (HKI); Hans Knoll Institute (HKI); Hans Knoll Institute (HKI); Hans Knoll Institute (HKI); Trinity College Dublin; Trinity College Dublin; University of Lausanne; University of Wurzburg; Fraunhofer Gesellschaft; Friedrich Schiller University of Jena; Friedrich Schiller University of Jena; University of Wurzburg	Staib, P (corresponding author), Hans Knoell Inst, Leibniz Inst Nat Prod Res & Infect Biol, Jr Res Grp Fundamental Mol Biol Pathogen Fungi, Jena, Germany.	Peter.Staib@hki-jena.de	Morschhäuser, Joachim/AFS-2547-2022; Morschhäuser, Joachim/E-2918-2013; Sullivan, Derek/A-8269-2008	Morschhäuser, Joachim/0000-0003-4227-8687; Morschhäuser, Joachim/0000-0003-4227-8687; Sullivan, Derek/0000-0003-0195-9697; Citiulo, Francesco/0000-0003-2322-6742; Hube, Bernhard/0000-0002-6028-0425	Deutsche Forschungsgemeinschaft (DFG) [STA 1147/1-1]; Hans Knoell Institute	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Hans Knoell Institute	This work was supported by the Deutsche Forschungsgemeinschaft (DFG grant STA 1147/1-1) and the Hans Knoell Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Monge R, 2003, EUKARYOT CELL, V2, P351, DOI 10.1128/EC.2.2.351-361.2003; Ausubel F. M., 1988, CURRENT PROTOCOLS MO; Banerjee M, 2008, MOL BIOL CELL, V19, P1354, DOI 10.1091/mbc.E07-11-1110; BERNHARDT E, 1946, MYCOLOGIA, V38, P228, DOI 10.2307/3755067; Braun BR, 2001, EMBO J, V20, P4753, DOI 10.1093/emboj/20.17.4753; CHABASSE D, 1988, ANN BIOL CLIN-PARIS, V46, P817; Citiulo F, 2009, FEMS YEAST RES, V9, P1051, DOI 10.1111/j.1567-1364.2009.00533.x; COLE GT, 1991, CAN J MICROBIOL, V37, P637, DOI 10.1139/m91-108; de Groot PWJ, 2003, YEAST, V20, P781, DOI 10.1002/yea.1007; Dignard D, 2006, EUKARYOT CELL, V5, P192, DOI 10.1128/EC.5.1.192-202.2006; Fell JW, 1984, YEASTS TAXONOMIC STU, P893; Fitzpatrick DA, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-290; Gelis S, 2012, FUNGAL GENET BIOL, V49, P322, DOI 10.1016/j.fgb.2012.01.010; GILLUM AM, 1984, MOL GEN GENET, V198, P179, DOI 10.1007/BF00328721; Hecker M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-262; Jackson AP, 2009, GENOME RES, V19, P2231, DOI 10.1101/gr.097501.109; JANSONS VK, 1970, J BACTERIOL, V104, P910, DOI 10.1128/JB.104.2.910-921.1970; Kohler GA, 1997, J BACTERIOL, V179, P2331; Lan CY, 2002, P NATL ACAD SCI USA, V99, P14907, DOI 10.1073/pnas.232566499; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Melo NR, 2008, ANTIMICROB AGENTS CH, V52, P3718, DOI 10.1128/AAC.00446-08; MILLON L, 1994, J CLIN MICROBIOL, V32, P1115, DOI 10.1128/JCM.32.4.1115-1118.1994; Morschhauser J, 1999, MYCOSES, V42, P29, DOI 10.1046/j.1439-0507.1999.00259.x; Murad AMA, 2001, EMBO J, V20, P4742, DOI 10.1093/emboj/20.17.4742; Nantel A, 2002, MOL BIOL CELL, V13, P3452, DOI 10.1091/mbc.E02-05-0272; Nobile CJ, 2003, MICROBIOL-SGM, V149, P3629, DOI 10.1099/mic.0.26640-0; O'Connor L, 2010, EUKARYOT CELL, V9, P1383, DOI 10.1128/EC.00042-10; Odds FC, 1988, CANDIDA CANDIDOSIS R; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pfaller MA, 2001, J CLIN MICROBIOL, V39, P3254, DOI 10.1128/JCM.39.9.3254-3259.2001; Reuss O, 2004, GENE, V341, P119, DOI 10.1016/j.gene.2004.06.021; Sonneborn A, 1999, INFECT IMMUN, V67, P5514, DOI 10.1128/IAI.67.10.5514-5517.1999; STAIB F, 1987, ZBL BAKT-INT J MED M, V266, P167; Staib F, 2001, MYCOSES, V44, P23, DOI 10.1046/j.1439-0507.2001.00621.x; Staib P, 1999, MYCOSES, V42, P521, DOI 10.1046/j.1439-0507.1999.00516.x; Staib P, 2005, MOL MICROBIOL, V55, P637, DOI 10.1111/j.1365-2958.2004.04414.x; Staib P, 2005, MYCOSES, V48, P50, DOI 10.1111/j.1439-0507.2004.01085.x; Staib P, 2007, MYCOSES, V50, P1, DOI 10.1111/j.1439-0507.2006.01308.x; Sullivan DJ, 2004, FEMS YEAST RES, V4, P369, DOI 10.1016/S1567-1356(03)00240-X; SULLIVAN DJ, 1995, MICROBIOL-UK, V141, P1507, DOI 10.1099/13500872-141-7-1507; TASCHDJIAN CL, 1953, MYCOLOGIA, V45, P474, DOI 10.1080/00275514.1953.12024286; Tsong AE, 2003, CELL, V115, P389, DOI 10.1016/S0092-8674(03)00885-7; Zeidler U, 2009, FEMS YEAST RES, V9, P126, DOI 10.1111/j.1567-1364.2008.00459.x	43	17	21	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2013	8	4							e61940	10.1371/journal.pone.0061940	http://dx.doi.org/10.1371/journal.pone.0061940			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125TD	23613980	Green Published, gold			2022-12-25	WOS:000317563300044
J	Park, SJ; Kim, YH; Huh, JW; Lee, SR; Kim, SH; Kim, SU; Kim, JS; Jeong, KJ; Kim, KM; Kim, HS; Chang, KT				Park, Sang-Je; Kim, Young-Hyun; Huh, Jae-Won; Lee, Sang-Rae; Kim, Sang-Hyun; Kim, Sun-Uk; Kim, Ji-Su; Jeong, Kang-Jin; Kim, Kyoung-Min; Kim, Heui-Soo; Chang, Kyu-Tae			Selection of New Appropriate Reference Genes for RT-qPCR Analysis via Transcriptome Sequencing of Cynomolgus Monkeys (Macaca fascicularis)	PLOS ONE			English	Article							INTERNAL REFERENCE GENES; PCR; GENOME; MODEL; CDNAS; IDENTIFICATION; NORMALIZATION; DIVERGENCE; MACAQUES; PRIMATES	In the investigation of the expression levels of target genes, reverse transcription quantitative real-time polymerase chain reaction (RT-qPCR) is the most accurate and widely used method. However, a normalization step is a prerequisite to obtain accurate quantification results from RT-qPCR data. Therefore, many studies regarding the selection of reference genes have been carried out. Recently, these studies have involved large-scale gene analysis methods such as microarray and next generation sequencing. In our previous studies, we analyzed large amounts of transcriptome data from the cynomolgus monkey. Using a modification of this large-scale transcriptome sequencing dataset, we selected and compared 12 novel candidate reference genes (ARFGAP2, ARL1, BMI1, CASC3, DDX3X, MRFAP1, ORMDL1, RSL24D1, SAR1A, USP22, ZC3H11A, and ZRANB2) and 4 traditionally used reference genes (ACTB, GAPDH, RPS19, and YWHAZ) in 13 different whole-body tissues by the 3 well-known programs geNorm, NormFinder, and BestKeeper. Combined analysis by these 3 programs showed that ADP-ribosylation factor GTPase activating protein 2 (ARFGAP2), morf4 family associated protein 1 (MRFAP1), and ADP-ribosylation factor-like 1 (ARL1) are the most appropriate reference genes for accurate normalization. Interestingly, 4 traditionally used reference genes were the least stably expressed in this study. For this reason, selection of appropriate reference genes is vitally important, and large-scale analysis is a good method for finding new candidate reference genes. Our results could provide reliable reference gene lists for future studies on the expression of various target genes in the cynomolgus monkey.	[Park, Sang-Je; Kim, Young-Hyun; Huh, Jae-Won; Lee, Sang-Rae; Kim, Sang-Hyun; Kim, Sun-Uk; Kim, Ji-Su; Jeong, Kang-Jin; Kim, Kyoung-Min; Chang, Kyu-Tae] Korea Res Inst Biosci & Biotechnol, Natl Primate Res Ctr, Chungbuk, South Korea; [Park, Sang-Je; Kim, Heui-Soo] Pusan Natl Univ, Coll Nat Sci, Dept Biol Sci, Pusan, South Korea; [Kim, Young-Hyun; Huh, Jae-Won; Kim, Kyoung-Min; Chang, Kyu-Tae] Univ Sci & Technol, Korea Res Inst Biosci & Biotechnol, Natl Primate Res Ctr, Chungbuk, South Korea	Korea Research Institute of Bioscience & Biotechnology (KRIBB); Pusan National University; Korea Research Institute of Bioscience & Biotechnology (KRIBB)	Kim, HS (corresponding author), Pusan Natl Univ, Coll Nat Sci, Dept Biol Sci, Pusan, South Korea.	khs307@pusan.ac.kr; changkt@kribb.re.kr	Kim, Heui-Soo/ABF-3773-2021	Kim, Heui-Soo/0000-0002-5226-6594; Lee, Sang-Rae/0000-0001-8400-5973	Korea Research Institute of Bioscience and Biotechnology Research Initiative Program [KGM4241231]	Korea Research Institute of Bioscience and Biotechnology Research Initiative Program	This research was supported by a Grant from the Korea Research Institute of Bioscience and Biotechnology Research Initiative Program (KGM4241231). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn K, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-78; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Carlsson HE, 2004, AM J PRIMATOL, V63, P225, DOI 10.1002/ajp.20054; Chang Z, 2010, ANAL BIOCHEM, V406, P214, DOI 10.1016/j.ab.2010.07.021; Cheng WC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017347; De Pablos V, 2009, NEUROSCI LETT, V463, P37, DOI 10.1016/j.neulet.2009.07.069; Demidenko NV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019434; Gibbs RA, 2007, SCIENCE, V316, P222, DOI 10.1126/science.1139247; Heo JH, 2011, J ALZHEIMERS DIS, V25, P517, DOI 10.3233/JAD-2011-102079; Higgs S, 2010, J CLIN INVEST, V120, P657, DOI 10.1172/JCI42392; Huh JW, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-163; Maccoux LJ, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-62; Noriega NC, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-47; Osada N, 2005, MOL BIOL EVOL, V22, P1976, DOI 10.1093/molbev/msi187; Osada N, 2002, BMC GENOMICS, V3, DOI 10.1186/1471-2164-3-36; Osada N, 2001, GENE, V275, P31, DOI 10.1016/S0378-1119(01)00665-5; Osada Naoki, 2009, BMC Res Notes, V2, P199, DOI 10.1186/1756-0500-2-199; Osada N, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-90; Park SJ, 2012, MOL BIOTECH IN PRESS; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Race B, 2009, EMERG INFECT DIS, V15, P1366, DOI 10.3201/eid1509.090253; Register TC, 2009, AM J PRIMATOL, V71, P766, DOI 10.1002/ajp.20722; Rozen S, 2000, Methods Mol Biol, V132, P365; Taylor K, 2010, J IMMUNOTOXICOL, V7, P114, DOI 10.1080/15476910903213539; Uchida A, 2012, BRAIN, V135, P833, DOI 10.1093/brain/awr348; Uno Y, 2008, FEBS LETT, V582, P351, DOI 10.1016/j.febslet.2007.12.031; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Yan GM, 2011, NAT BIOTECHNOL, V29, P1019, DOI 10.1038/nbt.1992; Yperman J, 2004, J HEART VALVE DIS, V13, P848; Zhou K, 2011, BMC MOL BIOL, V12, DOI 10.1186/1471-2199-12-18	31	19	20	4	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2013	8	4							e60758	10.1371/journal.pone.0060758	http://dx.doi.org/10.1371/journal.pone.0060758			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125TD	23613744	Green Submitted, gold, Green Published			2022-12-25	WOS:000317563300008
J	Jones, BM; Iglesias-Rodriguez, MD; Skipp, PJ; Edwards, RJ; Greaves, MJ; Young, JR; Elderfield, H; O'Connor, CD				Jones, Bethan M.; Iglesias-Rodriguez, M. Debora; Skipp, Paul J.; Edwards, Richard J.; Greaves, Mervyn J.; Young, Jeremy R.; Elderfield, Henry; O'Connor, C. David			Responses of the Emiliania huxleyi Proteome to Ocean Acidification	PLOS ONE			English	Article							EXPRESSED SEQUENCE TAGS; MESSENGER-RNA; GENE-EXPRESSION; CO2 CONCENTRATION; ELEVATED PCO(2); CARBON-DIOXIDE; CALCIFICATION; SEAWATER; GROWTH; COCCOLITHOPHORES	Ocean acidification due to rising atmospheric CO2 is expected to affect the physiology of important calcifying marine organisms, but the nature and magnitude of change is yet to be established. In coccolithophores, different species and strains display varying calcification responses to ocean acidification, but the underlying biochemical properties remain unknown. We employed an approach combining tandem mass-spectrometry with isobaric tagging (iTRAQ) and multiple database searching to identify proteins that were differentially expressed in cells of the marine coccolithophore species Emiliania huxleyi (strain NZEH) between two CO2 conditions: 395 (similar to current day) and similar to 1340 p.p.m.v. CO2. Cells exposed to the higher CO2 condition contained more cellular particulate inorganic carbon (CaCO3) and particulate organic nitrogen and carbon than those maintained in present-day conditions. These results are linked with the observation that cells grew slower under elevated CO2, indicating cell cycle disruption. Under high CO2 conditions, coccospheres were larger and cells possessed bigger coccoliths that did not show any signs of malformation compared to those from cells grown under present-day CO2 levels. No differences in calcification rate, particulate organic carbon production or cellular organic carbon: nitrogen ratios were observed. Results were not related to nutrient limitation or acclimation status of cells. At least 46 homologous protein groups from a variety of functional processes were quantified in these experiments, of which four (histones H2A, H3, H4 and a chloroplastic 30S ribosomal protein S7) showed down-regulation in all replicates exposed to high CO2, perhaps reflecting the decrease in growth rate. We present evidence of cellular stress responses but proteins associated with many key metabolic processes remained unaltered. Our results therefore suggest that this E. huxleyi strain possesses some acclimation mechanisms to tolerate future CO2 scenarios, although the observed decline in growth rate may be an overriding factor affecting the success of this ecotype in future oceans.	[Jones, Bethan M.; Iglesias-Rodriguez, M. Debora] Univ Southampton, Natl Oceanog Ctr Southampton, Southampton, Hants, England; [Iglesias-Rodriguez, M. Debora; Skipp, Paul J.; Edwards, Richard J.] Univ Southampton, Inst Life Sci, Southampton, Hants, England; [Iglesias-Rodriguez, M. Debora] Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA; [Skipp, Paul J.; Edwards, Richard J.; O'Connor, C. David] Univ Southampton, Ctr Prote Res, Southampton, Hants, England; [Skipp, Paul J.; Edwards, Richard J.; O'Connor, C. David] Univ Southampton, Ctr Biol Sci, Southampton, Hants, England; [Greaves, Mervyn J.; Elderfield, Henry] Univ Cambridge, Dept Earth Sci, Cambridge CB2 3EQ, England; [Young, Jeremy R.] UCL, Dept Earth Sci, London, England; [O'Connor, C. David] Xian Jiaotong Liverpool Univ, Dept Biol Sci, Suzhou, Peoples R China	NERC National Oceanography Centre; University of Southampton; University of Southampton; University of California System; University of California Santa Barbara; University of Southampton; University of Southampton; University of Cambridge; University of London; University College London; Xi'an Jiaotong-Liverpool University	Jones, BM (corresponding author), Rutgers State Univ, Dept Earth & Environm Sci, Newark, NJ 07102 USA.	bmj38@andromeda.rutgers.edu	Edwards, Richard/C-8755-2011	Edwards, Richard/0000-0002-3645-5539; Greaves, Mervyn/0000-0001-8014-8627; Young, Jeremy/0000-0001-9320-9804	Natural Environment Research Council (NERC) PhD studentship [NER/S/A2006/14211]; European Community's Seventh Framework Programme (FP7) [211384]	Natural Environment Research Council (NERC) PhD studentship; European Community's Seventh Framework Programme (FP7)	BMJ was supported in part by a Natural Environment Research Council (NERC) PhD studentship (NER/S/A2006/14211). This work is a contribution to the "European Project on Ocean Acidification'' (EPOCA), which received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement no. 211384. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; AKEDO Y, 1992, BIOCHEM BIOPH RES CO, V187, P814, DOI 10.1016/0006-291X(92)91269-V; Anderson L, 1997, ELECTROPHORESIS, V18, P533, DOI 10.1002/elps.1150180333; Bala G, 2005, J CLIMATE, V18, P4531, DOI 10.1175/JCLI3542.1; Ramos JBE, 2010, BIOGEOSCIENCES, V7, P177, DOI 10.5194/bg-7-177-2010; Barsnes H, 2009, NAT BIOTECHNOL, V27, P598, DOI 10.1038/nbt0709-598; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Beaufort L, 2011, NATURE, V476, P80, DOI 10.1038/nature10295; Bortoluzzi S, 2001, BIOINFORMATICS, V17, P1152, DOI 10.1093/bioinformatics/17.12.1152; Caldeira K, 2003, NATURE, V425, P365, DOI 10.1038/425365a; Carvalho RN, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-159; Chen GA, 2002, MOL CELL PROTEOMICS, V1, P304, DOI 10.1074/mcp.M200008-MCP200; Chiang PK, 1996, FASEB J, V10, P471, DOI 10.1096/fasebj.10.4.8647346; Choi YW, 2008, PROTEOMICS, V8, P2665, DOI 10.1002/pmic.200700689; Crawfurd KJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026695; Daines AM, 2003, CURR ORG CHEM, V7, P1625, DOI 10.2174/1385272033486279; Davey NE, 2006, NUCLEIC ACIDS RES, V34, P3546, DOI 10.1093/nar/gkl486; de Villiers S, 2002, GEOCHEM GEOPHY GEOSY, V3, DOI 10.1029/2001GC000169; DICKSON AG, 1990, J CHEM THERMODYN, V22, P113, DOI 10.1016/0021-9614(90)90074-Z; DICKSON AG, 1987, DEEP-SEA RES, V34, P1733, DOI 10.1016/0198-0149(87)90021-5; Dietz KJ, 2001, J EXP BOT, V52, P1969, DOI 10.1093/jexbot/52.363.1969; El-Sayed NM, 2005, SCIENCE, V309, P404, DOI 10.1126/science.1112181; El-Sayed NM, 2005, SCIENCE, V309, P409, DOI 10.1126/science.1112631; Evans TG, 2012, PHILOS T R SOC B, V367, P1733, DOI 10.1098/rstb.2012.0019; Fargo DC, 2001, PLANT CELL, V13, P207, DOI 10.1105/tpc.13.1.207; Fiorini S, 2011, J PHYCOL, V47, P1281, DOI 10.1111/j.1529-8817.2011.01080.x; Flynn KJ, 2010, J PHYCOL, V46, P1, DOI 10.1111/j.1529-8817.2009.00756.x; FRANKIGNOULLE M, 1994, LIMNOL OCEANOGR, V39, P458, DOI 10.4319/lo.1994.39.2.0458; Guillard R.R.L., 1975, CULTURE MARINE INVER, P29, DOI [10.1007/978-1-4615-8714-9_3, DOI 10.1007/978-1-4615-8714-9_3]; GUILLARD RR, 1962, CAN J MICROBIOL, V8, P229, DOI 10.1139/m62-029; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; Hoppe CJM, 2011, J EXP MAR BIOL ECOL, V406, P54, DOI 10.1016/j.jembe.2011.06.008; Iglesias-Rodriguez MD, 2008, SCIENCE, V320, P336, DOI 10.1126/science.1154122; Irie T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013436; Jones BM, 2011, MAR BIOTECHNOL, V13, P496, DOI 10.1007/s10126-010-9320-0; Kegel JU, 2010, EUR J PHYCOL, V45, P1, DOI 10.1080/09670260903349900; Kim JM, 2006, LIMNOL OCEANOGR, V51, P1629, DOI 10.4319/lo.2006.51.4.1629; Kolber ZS, 1998, BBA-BIOENERGETICS, V1367, P88, DOI 10.1016/S0005-2728(98)00135-2; Kultz D, 2003, J EXP BIOL, V206, P3119, DOI 10.1242/jeb.00549; Kurosu M, 2010, MOLECULES, V15, P1531, DOI 10.3390/molecules15031531; Langer G, 2009, BIOGEOSCIENCES, V6, P2637, DOI 10.5194/bg-6-2637-2009; Langer G, 2006, GEOCHEM GEOPHY GEOSY, V7, DOI 10.1029/2005GC001227; Lefebvre SC, 2010, J PHYCOL, V46, P123, DOI 10.1111/j.1529-8817.2009.00793.x; LUBBEN M, 1995, BBA-BIOENERGETICS, V1229, P1, DOI 10.1016/0005-2728(94)00174-4; MEHRBACH C, 1973, LIMNOL OCEANOGR, V18, P897, DOI 10.4319/lo.1973.18.6.0897; Meshi T, 2000, PLANT MOL BIOL, V43, P643, DOI 10.1023/A:1006421821964; MILLIMAN JD, 1993, GLOBAL BIOGEOCHEM CY, V7, P927, DOI 10.1029/93GB02524; Mosavi LK, 2004, PROTEIN SCI, V13, P1435, DOI 10.1110/ps.03554604; NOVICK A, 1950, P NATL ACAD SCI USA, V36, P708, DOI 10.1073/pnas.36.12.708; OHLROGGE JB, 1979, P NATL ACAD SCI USA, V76, P1194, DOI 10.1073/pnas.76.3.1194; Orr JC, 2005, NATURE, V437, P681, DOI 10.1038/nature04095; Pandhal J, 2007, J PROTEOME RES, V6, P996, DOI 10.1021/pr060460c; Petrackova D, 2010, J MEMBRANE BIOL, V233, P73, DOI 10.1007/s00232-010-9226-9; Phadtare S, 2004, CURR ISSUES MOL BIOL, V6, P125; Pierrot D., 2006, ORNLCDIAC105A; Raven J, 2005, OCEAN ACIDIFICATION; Richier S, 2011, MAR BIOL, V158, P551, DOI 10.1007/s00227-010-1580-8; Ridgwell A, 2009, BIOGEOSCIENCES, V6, P2611, DOI 10.5194/bg-6-2611-2009; Riebesell U, 2000, NATURE, V407, P364, DOI 10.1038/35030078; Rokitta SD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052212; Sasaki T, 1999, PLANT BIOLOGY, V1, P68, DOI 10.1055/s-2007-978490; Schoepp-Cothenet B, 2009, P NATL ACAD SCI USA, V106, P8549, DOI 10.1073/pnas.0813173106; Shi D, 2009, BIOGEOSCIENCES, V6, P1199, DOI 10.5194/bg-6-1199-2009; Smith HEK, 2012, P NATL ACAD SCI USA, V109, P8845, DOI 10.1073/pnas.1117508109; Tian Q, 2004, MOL CELL PROTEOMICS, V3, P960, DOI 10.1074/mcp.M400055-MCP200; Tortell PD, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032583; Vizcaino JA, 2010, NUCLEIC ACIDS RES, V38, pD736, DOI 10.1093/nar/gkp964; Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185; von Dassow P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-r114; Wahlund TM, 2004, MICROPALEONTOLOGY, V50, P145, DOI 10.2113/50.Suppl_1.145; Wahlund TM, 2004, MAR BIOTECHNOL, V6, P278, DOI 10.1007/s10126-003-0035-3; WESTBROEK P, 1993, GLOBAL PLANET CHANGE, V8, P27, DOI 10.1016/0921-8181(93)90061-R; YOUNG JR, 1991, MAR MICROPALEONTOL, V18, P5, DOI 10.1016/0377-8398(91)90004-P; Zeebe R. E., 2001, CO2 SEAWATER EQUILIB; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005; Zondervan I, 2002, J EXP MAR BIOL ECOL, V272, P55, DOI 10.1016/S0022-0981(02)00037-0	76	34	35	4	105	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2013	8	4							e61868	10.1371/journal.pone.0061868	http://dx.doi.org/10.1371/journal.pone.0061868			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123JP	23593500	Green Submitted, gold, Green Published, Green Accepted			2022-12-25	WOS:000317385300086
J	Grayson, AR; Walsh, EM; Cameron, MJ; Godec, J; Ashworth, T; Ambrose, JM; Aserlind, AB; Wang, H; Evan, GI; Kluk, MJ; Bradner, JE; Aster, JC; French, CA				Grayson, A. R.; Walsh, E. M.; Cameron, M. J.; Godec, J.; Ashworth, T.; Ambrose, J. M.; Aserlind, A. B.; Wang, H.; Evan, G. I.; Kluk, M. J.; Bradner, J. E.; Aster, J. C.; French, C. A.			MYC, a downstream target of BRD-NUT, is necessary and sufficient for the blockade of differentiation in NUT midline carcinoma	ONCOGENE			English	Article						BRD4; NUT; MYC; epigenetic; differentiation; fusion oncogene	SQUAMOUS-CELL CARCINOMA; SET ENRICHMENT ANALYSIS; C-MYC; POOR-PROGNOSIS; IN-VIVO; INDUCED APOPTOSIS; BET BROMODOMAINS; STEM-CELLS; GENE; REARRANGEMENT	NUT midline carcinoma (NMC) is an aggressive type of squamous cell carcinoma that is defined by the presence of BRD-NUT fusion oncogenes, which encode chimeric proteins that block differentiation and maintain tumor growth. BRD-NUT oncoproteins contain two bromodomains whose binding to acetylated histones is required for the blockade of differentiation in NMC, but the mechanisms by which BRD-NUT act remain uncertain. Here, we provide evidence that MYC is a key downstream target of BRD4-NUT. Expression profiling of NMCs shows that the set of genes whose expression is maintained by BRD4-NUT is highly enriched for MYC upregulated genes, and MYC and BRD4-NUT protein expression is strongly correlated in primary NMCs. More directly, we find that BRD4-NUT associates with the MYC promoter and is required to maintain MYC expression in NMC cell lines. Moreover, both siRNA knockdown of MYC and a dominant-negative form of MYC, omomyc, induce differentiation of NMC cells. Conversely, differentiation of NMC cells induced by knockdown of BRD4-NUT is abrogated by enforced expression of MYC. Together, these findings suggest that MYC is a downstream target of BRD4-NUT that is required for maintenance of NMC cells in an undifferentiated, proliferative state. Our findings support a model in which dysregulation of MYC by BRD-NUT fusion proteins has a central role in the pathogenesis of NMC.	[Grayson, A. R.; Walsh, E. M.; Cameron, M. J.; Ashworth, T.; Ambrose, J. M.; Aserlind, A. B.; Wang, H.; Kluk, M. J.; Aster, J. C.; French, C. A.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Grayson, A. R.; Walsh, E. M.; Cameron, M. J.; Ashworth, T.; Ambrose, J. M.; Aserlind, A. B.; Wang, H.; Kluk, M. J.; Bradner, J. E.; Aster, J. C.; French, C. A.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Godec, J.] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA 02115 USA; [Godec, J.] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Evan, G. I.] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England; [Bradner, J. E.] Dana Farber Canc Inst, Dept Adult Oncol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; University of Cambridge; Harvard University; Dana-Farber Cancer Institute	French, CA (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA.	cfrench@partners.org			Samuel Waxman Cancer Research Foundation; US National Institutes of Health [1R01CA124633]; Adolescent and Young Adult Gap Fund; American Association for Cancer Research [10-20-03-FREN]; NATIONAL CANCER INSTITUTE [R01CA124633] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007627] Funding Source: NIH RePORTER	Samuel Waxman Cancer Research Foundation; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Adolescent and Young Adult Gap Fund; American Association for Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the Samuel Waxman Cancer Research Foundation (CAF and JEB), the US National Institutes of Health grant 1R01CA124633 (CAF), the Adolescent and Young Adult Gap Fund (CAF and JEB), and the American Association for Cancer Research grant 10-20-03-FREN. We would like to thank Dr Nicholas Haining for assistance with GSEA. Many thanks to Dr Paola Dal Cin for providing fluorescent in situ hybridization probes, and to Mr Dan Shea for his assistance with fluorescent in situ hybridization photomicrographs. High-throughput siRNA assays were performed at the Institute of Chemistry and Cell Biology, Longwood Campus (ICCB-L, http://iccb.med.harvard.edu/).	AbouElella A, 1996, MODERN PATHOL, V9, P95; Acosta JC, 2008, MOL CELL BIOL, V28, P7286, DOI 10.1128/MCB.00752-08; Akervall J, 2003, CLIN CANCER RES, V9, P1750; Arnold I, 2001, CURR BIOL, V11, P558, DOI 10.1016/S0960-9822(01)00154-3; Barrans S, 2010, J CLIN ONCOL, V28, P3360, DOI 10.1200/JCO.2009.26.3947; Bauer DE, 2012, CLIN CANCER RES, V18, P5773, DOI 10.1158/1078-0432.CCR-12-1153; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; FIELD JK, 1989, ONCOGENE, V4, P1463; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Flores I, 2004, ONCOGENE, V23, P5923, DOI 10.1038/sj.onc.1207796; French CA, 2008, ONCOGENE, V27, P2237, DOI 10.1038/sj.onc.1210852; French CA, 2003, CANCER RES, V63, P304; Gandarillas A, 1997, GENE DEV, V11, P2869, DOI 10.1101/gad.11.21.2869; Gomez-Casares MT, 2013, ONCOGENE, V32, P2239, DOI 10.1038/onc.2012.246; Haack H, 2009, AM J SURG PATHOL, V33, P984, DOI 10.1097/PAS.0b013e318198d666; Ince TA, 2007, CANCER CELL, V12, P160, DOI 10.1016/j.ccr.2007.06.013; Kluk MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033813; Knoepfler PS, 2006, EMBO J, V25, P2723, DOI 10.1038/sj.emboj.7601152; Lin CH, 2009, EMBO J, V28, P3157, DOI 10.1038/emboj.2009.254; Lin YJ, 2008, PROTEIN SCI, V17, P2174, DOI 10.1110/ps.037580.108; Mertz JA, 2011, P NATL ACAD SCI USA, V108, P16669, DOI 10.1073/pnas.1108190108; Mossafa H, 2006, LEUKEMIA LYMPHOMA, V47, P1885, DOI 10.1080/10428190600687547; Murphy DJ, 2008, CANCER CELL, V14, P447, DOI 10.1016/j.ccr.2008.10.018; Pelengaris S, 1999, MOL CELL, V3, P565, DOI 10.1016/S1097-2765(00)80350-0; Pelengaris S, 2002, CELL, V109, P321, DOI 10.1016/S0092-8674(02)00738-9; Pellakuru LG, 2012, AM J PATHOL, V181, P560, DOI 10.1016/j.ajpath.2012.04.021; Reynoird N, 2010, EMBO J, V29, P2943, DOI 10.1038/emboj.2010.176; Savage KJ, 2009, BLOOD, V114, P3533, DOI 10.1182/blood-2009-05-220095; Schuhmacher M, 2001, NUCLEIC ACIDS RES, V29, P397, DOI 10.1093/nar/29.2.397; Schwartz BE, 2011, CANCER RES, V71, P2686, DOI 10.1158/0008-5472.CAN-10-3513; Senapedis WT, 2011, MOL BIOL CELL, V22, P1791, DOI 10.1091/mbc.E10-10-0854; Soucek L, 2004, CELL DEATH DIFFER, V11, P1038, DOI 10.1038/sj.cdd.4401443; Soucek L, 2002, CANCER RES, V62, P3507; Soucek L, 2008, NATURE, V455, P679, DOI 10.1038/nature07260; Stelow EB, 2008, AM J SURG PATHOL, V32A, P828, DOI 10.1097/PAS.0b013e31815a3900; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Subramanian A, 2007, BIOINFORMATICS, V23, P3251, DOI 10.1093/bioinformatics/btm369; Toretsky JA, 2003, AM J CLIN ONCOL-CANC, V26, P300, DOI 10.1097/00000421-200306000-00019; Varlakhanova NV, 2010, DIFFERENTIATION, V80, P9, DOI 10.1016/j.diff.2010.05.001; Varlakhanova NV, 2009, CANCER RES, V69, P7487, DOI 10.1158/0008-5472.CAN-08-4832; Watt FM, 2008, NAT REV CANCER, V8, P234, DOI 10.1038/nrc2328; Yan JP, 2011, J BIOL CHEM, V286, P27663, DOI 10.1074/jbc.M111.246975; YOUNG J, 1994, ONCOGENE, V9, P1053; Yu DN, 2005, ANN NY ACAD SCI, V1059, P145, DOI 10.1196/annals.1339.047; Zuber J, 2011, NATURE, V478, P524, DOI 10.1038/nature10334	45	113	116	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 27	2014	33	13					1736	1742		10.1038/onc.2013.126	http://dx.doi.org/10.1038/onc.2013.126			7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AE9QY	23604113	Green Accepted			2022-12-25	WOS:000334344700013
J	Wei, L; Wu, J; Liu, H; Yang, HL; Rong, MQ; Li, DS; Zhang, PH; Han, JY; Lai, R				Wei, Lin; Wu, Jing; Liu, Han; Yang, Hailong; Rong, Mingqiang; Li, Dongsheng; Zhang, Pinghu; Han, Junyou; Lai, Ren			A mycobacteriophage-derived trehalose-6,6 '-dimycolate-binding peptide containing both antimycobacterial and anti-inflammatory abilities	FASEB JOURNAL			English	Article						Mycobacterium tuberculosis; cord factor; immunoregulative effects; cytokine; mouse model	TUBERCULOSIS; GENE; EXPRESSION; INITIATION; GRANULOMA	Bacteriophages, the viruses of eubacteria, have developed unique mechanisms to interact with their host bacteria. They have been viewed as potential antibacterial therapeutics. Mycobacteriophage-derived compounds may interact with Mycobacterium tuberculosis (MTB) and/or its components, such as the cord factor, trehalose-6,6'-dimycolate (TDM), which is the most abundant glycolipid produced on the surface of MTB. TDM emulsion injected intravenously into mice induces lung immunopathology that mimics many aspects of MTB infection. Thus, TDM is an important target for anti-MTB agent development. On the basis of genomics information of mycobacteriophages, 200 peptides were synthesized. Their effects on MTB, their interactions with TDM, and anti-inflammatory activities were tested. One of them (PK34) showed MTB-killing activity with a minimal inhibitory concentration of 50 g/ml and TDM-binding ability. In a mouse model, PK34 showed comparable ability to clear MTB as rifampin did in vivo. It also exerted strong activity to inhibit MTB or TDM-induced inflammation in vivo. PK34 significantly inhibited inflammatory cytokines secretions by inactivating MAPK and PKB signals while it maintained certain proinflammatory cytokine production. It is possible to prospect for TDM-binding and/or anti-MTB peptides by mining the mycobacteriophages genome. In addition to its direct MTB-killing ability, PK34 might be a useful adjunct in the treatment of granulomatous inflammation occurring during mycobacterial infection or a template for developing antituberculosis (TB) agents because of its immunoregulative effects. As a TDM-binding peptide, PK34 may be a promising tool to study TDM's interactions with corresponding receptors and signal pathways.	[Wei, Lin; Wu, Jing; Liu, Han; Yang, Hailong; Rong, Mingqiang; Li, Dongsheng; Lai, Ren] Chinese Acad Sci, Key Lab Anim Models & Human Dis Mech, Kunming, Peoples R China; [Wei, Lin; Wu, Jing; Liu, Han; Yang, Hailong; Rong, Mingqiang; Li, Dongsheng; Lai, Ren] Kunming Inst Zool, Kunming, Peoples R China; [Wei, Lin; Lai, Ren] Nanjing Agr Univ, Minist Agr, Key Lab Microbiol Engn Agr Environm, Life Sci Coll, Nanjing, Jiangsu, Peoples R China; [Wu, Jing; Liu, Han] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China; [Zhang, Pinghu] China Pharmaceut Univ, Jiangsu Ctr New Drug Screening, Nanjing, Jiangsu, Peoples R China; [Zhang, Pinghu] China Pharmaceut Univ, Natl Drug Screening Lab, Nanjing, Jiangsu, Peoples R China; [Han, Junyou] Jilin Univ, Changchun 130023, Peoples R China	Chinese Academy of Sciences; Chinese Academy of Sciences; Kunming Institute of Zoology; Ministry of Agriculture & Rural Affairs; Nanjing Agricultural University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; China Pharmaceutical University; China Pharmaceutical University; Jilin University	Han, JY (corresponding author), 32 East Jiaochang Rd, Kunming 650223, Yunnan, Peoples R China.	han_junyou@126.com; rlai@mail.kiz.ac.cn	yang, hailong/GXH-9625-2022; Wei, Lin/AAE-3043-2022	Wei, Lin/0000-0003-3359-2471	Chinese National Natural Science Foundation [30830021, 31025025, 31070701, 31000960, U1132601]; Ministry of Science and Technology [2010CB529800, 2009ZX09103-1/091, 2011ZX09102-002-10]; Ministry of Agriculture [2009ZX08009-159B]; Yunnan Province [Y103951111]	Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Ministry of Agriculture(Gida Tarim Ve Hayvancilik Bakanligi); Yunnan Province	This work was supported by the Chinese National Natural Science Foundation (30830021, 31025025, 31070701, 31000960, 31025025, U1132601), the Ministry of Science and Technology (2010CB529800, 2009ZX09103-1/091, 2011ZX09102-002-10), the Ministry of Agriculture (2009ZX08009-159B), and Yunnan Province (Y103951111).	BEKIERKUNST A, 1969, J BACTERIOL, V100, P95, DOI 10.1128/JB.100.1.95-102.1969; BLOOM BR, 1992, SCIENCE, V257, P1055, DOI 10.1126/science.257.5073.1055; Centers for Disease Control and Prevention (CDC), 2006, MMWR Morb Mortal Wkly Rep, V55, P301; Chan J, 2004, CLIN IMMUNOL, V110, P2, DOI 10.1016/S1521-6616(03)00210-9; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Co DO, 2004, CLIN IMMUNOL, V113, P130, DOI 10.1016/j.clim.2004.08.012; Cooper AM, 2008, IMMUNOL REV, V226, P191, DOI 10.1111/j.1600-065X.2008.00702.x; Figueiredo R, 2009, BIOORGAN MED CHEM, V17, P503, DOI 10.1016/j.bmc.2008.12.006; Geisel RE, 2005, J IMMUNOL, V174, P5007, DOI 10.4049/jimmunol.174.8.5007; Hatfull GF, 2010, ANNU REV MICROBIOL, V64, P331, DOI 10.1146/annurev.micro.112408.134233; Haydel SE, 2010, PHARMACEUTICALS-BASE, V3, P2268, DOI 10.3390/ph3072268; Hunter RL, 2006, ANN CLIN LAB SCI, V36, P371; Kim JH, 2008, FREE RADICAL BIO MED, V45, P885, DOI 10.1016/j.freeradbiomed.2008.06.019; Leal IS, 1999, INFECT IMMUN, V67, P5747, DOI 10.1128/IAI.67.11.5747-5754.1999; Lee WB, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002614; Li JX, 2007, MOL CELL PROTEOMICS, V6, P882, DOI 10.1074/mcp.M600334-MCP200; Liu J, 2004, NAT BIOTECHNOL, V22, P185, DOI 10.1038/nbt932; Loeffler JM, 2001, SCIENCE, V294, P2170, DOI 10.1126/science.1066869; Ma YF, 2010, GENOMICS, V95, P66, DOI 10.1016/j.ygeno.2009.09.004; MALLORY JB, 1990, J BIOL CHEM, V265, P13297; Matsunaga I, 2009, J EXP MED, V206, P2865, DOI 10.1084/jem.20092533; McNerney R, 2005, J APPL MICROBIOL, V99, P223, DOI 10.1111/j.1365-2672.2005.02596.x; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nechaev S, 1999, J MOL BIOL, V289, P815, DOI 10.1006/jmbi.1999.2782; Odegrip R, 2000, J VIROL, V74, P4057, DOI 10.1128/JVI.74.9.4057-4063.2000; Ojaniemi M, 2003, EUR J IMMUNOL, V33, P597, DOI 10.1002/eji.200323376; ORSINI G, 1993, J BACTERIOL, V175, P85, DOI 10.1128/JB.175.1.85-93.1993; Paige C, 2010, CELL MICROBIOL, V12, P301, DOI 10.1111/j.1462-5822.2009.01424.x; Raviglione MC, 2007, NEW ENGL J MED, V356, P656, DOI 10.1056/NEJMp068273; Schoolnik GK, 2004, NAT BIOTECHNOL, V22, P505, DOI 10.1038/nbt0504-505; Schuch R, 2002, NATURE, V418, P884, DOI 10.1038/nature01026; Welsh KJ, 2010, TRANSL RES, V156, P207, DOI 10.1016/j.trsl.2010.06.001; Yoong P, 2006, J BACTERIOL, V188, P2711, DOI 10.1128/JB.188.7.2711-2714.2006	33	16	18	0	22	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2013	27	8					3067	3077		10.1096/fj.13-227454	http://dx.doi.org/10.1096/fj.13-227454			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	292BT	23603838				2022-12-25	WOS:000329877600014
J	Polyak, MJ; Vivithanaporn, P; Maingat, FG; Walsh, JG; Branton, W; Cohen, EA; Meeker, R; Power, C				Polyak, Maria J.; Vivithanaporn, Pornpun; Maingat, Ferdinand G.; Walsh, John G.; Branton, William; Cohen, Eric A.; Meeker, Rick; Power, Christopher			Differential type 1 interferon-regulated gene expression in the brain during AIDS: interactions with viral diversity and neurovirulence	FASEB JOURNAL			English	Article						HIV-1; FIV; type 1 interferon; tetherin; CD317; BST-2; microglia	FELINE IMMUNODEFICIENCY VIRUS; ENHANCES MACROPHAGE TROPISM; IN-SITU HYBRIDIZATION; AFRICAN-GREEN MONKEYS; NERVOUS-SYSTEM; LENTIVIRUS INFECTION; MESSENGER-RNA; ENVELOPE GLYCOPROTEIN; NUCLEOTIDE-SEQUENCE; MOLECULAR-CLONING	The lentiviruses, human and feline immunodeficiency viruses (HIV-1 and FIV, respectively), infect the brain and cause neurovirulence, evident as neuronal injury, inflammation, and neurobehavioral abnormalities with diminished survival. Herein, different lentivirus infections in conjunction with neural cell viability were investigated, concentrating on type 1 interferon-regulated pathways. Transcriptomic network analyses showed a preponderance of genes involved in type 1 interferon signaling, which was verified by increased expression of the type 1 interferon-associated genes, Mx1 and CD317, in brains from HIV-infected persons (P < 0.05). Leukocytes infected with different strains of FIV or HIV-1 showed differential Mx1 and CD317 expression (P < 0.05). In vivo studies of animals infected with the FIV strains, FIVch or FIVncsu, revealed that FIVch-infected animals displayed deficits in memory and motor speed compared with the FIVncsu-and mock-infected groups (P < 0.05). TNF-alpha, IL-1 beta, and CD40 expression was increased in the brains of FIVch-infected animals; conversely, Mx1 and CD317 transcript levels were increased in the brains of FIVncsu-infected animals, principally in microglia (P < 0.05). Gliosis and neuronal loss were evident among FIVch-infected animals compared with mock-and FIVncsu-infected animals (P < 0.05). Lentiviral infections induce type 1 interferon-regulated gene expression in microglia in a viral diversity-dependent manner, representing a mechanism by which immune responses might be exploited to limit neurovirulence.-Polyak, M. J., Vivithanaporn, P., Maingat, F. G., Walsh, J. G., Branton, W., Cohen, E. A., Meeker, R., Power, C. Differential type 1 interferon- regulated gene expression in the brain during AIDS: interactions with viral diversity and neurovirulence.	[Polyak, Maria J.; Maingat, Ferdinand G.; Walsh, John G.; Branton, William; Power, Christopher] Univ Alberta, Dept Med, Edmonton, AB, Canada; [Vivithanaporn, Pornpun] Mahidol Univ, Fac Sci, Dept Pharmacol, Bangkok 10400, Thailand; [Cohen, Eric A.] Univ Montreal, Inst Rech Clin Montreal, Montreal, PQ, Canada; [Cohen, Eric A.] Univ Montreal, Dept Microbiol & Immunol, Montreal, PQ H3C 3J7, Canada; [Meeker, Rick] Univ N Carolina, Dept Neurol, Durham, NC USA	University of Alberta; Mahidol University; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; Universite de Montreal; University of North Carolina	Power, C (corresponding author), Univ Alberta, Dept Med Neurol, HMRC 6-11, Edmonton, AB, Canada.	chris.power@ualberta.ca		Branton, William/0000-0002-3259-2544; Power, Christopher/0000-0002-5131-9711	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	C.P. and E.A.C. hold Canada Research Chairs (Tier 1) in Neurological Infection and Immunity and Human Retrovirology, respectively. C.P. is an Alberta Innovates Health Solutions (AIHS) Senior Scholar. J.G.W. is an AIHS Fellow. These studies were supported by the Canadian Institutes of Health Research (to C.P. and E.A.C.).	Acharjee S, 2011, BRAIN, V134, P3209, DOI 10.1093/brain/awr242; Afkhami-Goli A, 2009, J NEUROVIROL, V15, P139, DOI 10.1080/13550280802534763; Andrew AJ, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-80; Arts JHE, 2007, FOOD CHEM TOXICOL, V45, P1856, DOI 10.1016/j.fct.2007.04.001; Barrett BS, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002596; BEEBE AM, 1994, J VIROL, V68, P3080, DOI 10.1128/JVI.68.5.3080-3091.1994; Blasius AL, 2006, J IMMUNOL, V177, P3260, DOI 10.4049/jimmunol.177.5.3260; Boche D, 1996, J NEUROVIROL, V2, P377, DOI 10.3109/13550289609146903; Bosinger SE, 2009, J CLIN INVEST, V119, P3556, DOI 10.1172/JCI40115; Broussard SR, 2001, J VIROL, V75, P2262, DOI 10.1128/JVI.75.5.2262-2275.2001; Brown JN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003664; BROWN WC, 1991, J VIROL, V65, P3359, DOI 10.1128/JVI.65.6.3359-3364.1991; BRUNNER D, 1989, J VIROL, V63, P5483, DOI 10.1128/JVI.63.12.5483-5488.1989; CALLANAN JJ, 1992, VET IMMUNOL IMMUNOP, V35, P3, DOI 10.1016/0165-2427(92)90116-8; Cao W, 2009, J EXP MED, V206, P1603, DOI 10.1084/jem.20090547; Celestino M, 2012, J VIROL, V86, P6688, DOI 10.1128/JVI.07037-11; Cheney KM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013521; Clements JE, 2008, J NEUROVIROL, V14, P309, DOI 10.1080/13550280802132832; Clements JE, 1996, CLIN MICROBIOL REV, V9, P100, DOI 10.1128/CMR.9.1.100; Cocka L., 2012, 19 C RETR OPP INF; Dietrich I, 2011, J VIROL, V85, P5840, DOI 10.1128/JVI.00071-11; Dionne KR, 2011, J NEUROVIROL, V17, P314, DOI 10.1007/s13365-011-0038-1; DOW SW, 1992, VET IMMUNOL IMMUNOP, V35, P23, DOI 10.1016/0165-2427(92)90118-A; Dube M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000856; Dube M, 2009, J VIROL, V83, P4574, DOI 10.1128/JVI.01800-08; Dunfee RL, 2007, VIROLOGY, V367, P222, DOI 10.1016/j.virol.2007.05.029; Dunfee RL, 2006, P NATL ACAD SCI USA, V103, P15160, DOI 10.1073/pnas.0605513103; Elder JH, 2010, CURR HIV RES, V8, P73, DOI 10.2174/157016210790416389; ENGLISH RV, 1993, J VIROL, V67, P5175, DOI 10.1128/JVI.67.9.5175-5186.1993; Erikson E, 2011, P NATL ACAD SCI USA, V108, P13688, DOI 10.1073/pnas.1101684108; Fadel HJ, 2011, VET IMMUNOL IMMUNOP, V143, P179, DOI 10.1016/j.vetimm.2011.06.002; Fletcher NF, 2008, VET IMMUNOL IMMUNOP, V123, P134, DOI 10.1016/j.vetimm.2008.01.028; Fletcher NF, 2011, VET J, V188, P260, DOI 10.1016/j.tvjl.2010.03.022; Fritz-French C, 2012, CYTOKINE GROWTH F R, V23, P7, DOI 10.1016/j.cytogfr.2012.01.001; Gandhi N, 2009, AIDS RES HUM RETROV, V25, P691, DOI 10.1089/aid.2008.0299; Gannon P, 2011, CURR OPIN NEUROL, V24, P275, DOI 10.1097/WCO.0b013e32834695fb; Giunta Brian, 2007, Critical Reviews in Neurobiology, V19, P79; Gonzalez-Scarano F, 2005, NAT REV IMMUNOL, V5, P69, DOI 10.1038/nri1527; Gupta RK, 2009, P NATL ACAD SCI USA, V106, P20889, DOI 10.1073/pnas.0907075106; Hauser H, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-85; Huang JH, 2011, J INFECT DIS, V204, P1557, DOI 10.1093/infdis/jir616; Huang JH, 2010, J VIROL, V84, P9463, DOI 10.1128/JVI.01009-10; Hughes R, 2012, REV MED VIROL, V22, P257, DOI 10.1002/rmv.1708; Jacquelin B, 2009, J CLIN INVEST, V119, P3544, DOI 10.1172/JCI40093; Jia B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000429; Johnston JB, 2000, J VIROL, V74, P7211, DOI 10.1128/JVI.74.16.7211-7220.2000; Johnston JB, 2002, J VIROL, V76, P2622, DOI 10.1128/JVI.76.6.2622-2633.2002; Johnston JB, 2002, J VIROL, V76, P3626, DOI 10.1128/JVI.76.8.3626-3636.2002; Kaul M, 2006, CURR HIV RES, V4, P307, DOI 10.2174/157016206777709384; Kenyon JC, 2011, VIRUSES-BASEL, V3, P2192, DOI 10.3390/v3112192; Kirchhoff F, 2010, CELL HOST MICROBE, V8, P55, DOI 10.1016/j.chom.2010.06.004; Kolenda-Roberts HM, 2007, FRONT BIOSCI-LANDMRK, V12, P3668, DOI 10.2741/2343; KUIKEN CL, 1995, J GEN VIROL, V76, P175, DOI 10.1099/0022-1317-76-1-175; Kupzig S, 2003, TRAFFIC, V4, P694, DOI 10.1034/j.1600-0854.2003.00129.x; Lederer S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000296; Liberatore RA, 2011, P NATL ACAD SCI USA, V108, P18097, DOI 10.1073/pnas.1113694108; Lichterfeld M, 2012, J LEUKOCYTE BIOL, V91, P27, DOI 10.1189/jlb.0811442; Liner KJ, 2007, J NEUROVIROL, V13, P291, DOI 10.1080/13550280701422383; MacKinnon CD, 2007, J NEUROPHYSIOL, V97, P4368, DOI 10.1152/jn.01136.2006; Maingat F, 2010, J IMMUNOL, V184, P1566, DOI 10.4049/jimmunol.0902575; Maingat F, 2009, J NEUROSCI, V29, P8429, DOI 10.1523/JNEUROSCI.5818-08.2009; Mandl JN, 2008, NAT MED, V14, P1077, DOI 10.1038/nm.1871; Mankowski JL, 1997, J VIROL, V71, P6055, DOI 10.1128/JVI.71.8.6055-6060.1997; Mankowski JL, 2002, J INFECT DIS, V186, pS199, DOI 10.1086/344938; Medzhitov R, 2012, SCIENCE, V335, P936, DOI 10.1126/science.1214935; Miller C, 2011, VET IMMUNOL IMMUNOP, V143, P282, DOI 10.1016/j.vetimm.2011.06.006; Moore RA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019838; Na H, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-44; Neil S, 2009, J INTERF CYTOK RES, V29, P569, DOI 10.1089/jir.2009.0077; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Neil SJD, 2007, CELL HOST MICROBE, V2, P193, DOI 10.1016/j.chom.2007.08.001; NOVOTNEY C, 1990, AIDS, V4, P1213, DOI 10.1097/00002030-199012000-00005; Ohtomo T, 1999, BIOCHEM BIOPH RES CO, V258, P583, DOI 10.1006/bbrc.1999.0683; OLMSTED RA, 1989, P NATL ACAD SCI USA, V86, P2448, DOI 10.1073/pnas.86.7.2448; OLMSTED RA, 1989, P NATL ACAD SCI USA, V86, P8088, DOI 10.1073/pnas.86.20.8088; Park KM, 2010, CELL SIGNAL, V22, P977, DOI 10.1016/j.cellsig.2010.01.010; PAVLOVIC J, 1993, CIBA F SYMP, V176, P233; Peng G, 2006, J EXP MED, V203, P41, DOI 10.1084/jem.20051512; Power C, 1998, J VIROL, V72, P9109, DOI 10.1128/JVI.72.11.9109-9115.1998; Power C, 1995, CURR TOP MICROBIOL, V202, P89; Power C, 1998, J VIROL, V72, P9045, DOI 10.1128/JVI.72.11.9045-9053.1998; Power C, 2004, J NEUROVIROL, V10, P113, DOI 10.1080/13550280490270815; POWER C, 1994, J VIROL, V68, P4643, DOI 10.1128/JVI.68.7.4643-4649.1994; Power C, 2002, CAN J NEUROL SCI, V29, P19, DOI 10.1017/S0317167100001682; Power C, 2001, TRENDS NEUROSCI, V24, P162, DOI 10.1016/S0166-2236(00)01737-9; Pulliam L, 2011, AIDS, V25, P1721, DOI 10.1097/QAD.0b013e328349f022; Rho MB, 1995, BRAIN BEHAV IMMUN, V9, P366, DOI 10.1006/brbi.1995.1034; Robertson K, 2009, NEUROPSYCHOL REV, V19, P232, DOI 10.1007/s11065-009-9096-z; Sauter D, 2009, CELL HOST MICROBE, V6, P409, DOI 10.1016/j.chom.2009.10.004; Schoggins JW, 2011, CURR OPIN VIROL, V1, P519, DOI 10.1016/j.coviro.2011.10.008; Smith JA, 2012, BRAIN RES BULL, V87, P10, DOI 10.1016/j.brainresbull.2011.10.004; TALBOTT RL, 1989, P NATL ACAD SCI USA, V86, P5743, DOI 10.1073/pnas.86.15.5743; TOMPKINS MB, 1991, J AM VET MED ASSOC, V199, P1311; TORTEN M, 1991, J VIROL, V65, P2225, DOI 10.1128/JVI.65.5.2225-2230.1991; TYOR WR, 1992, ANN NEUROL, V31, P349, DOI 10.1002/ana.410310402; TYOR WR, 1995, J ACQ IMMUN DEF SYND, V9, P379; Van Damme N, 2008, CELL HOST MICROBE, V3, P245, DOI 10.1016/j.chom.2008.03.001; Van Damme N, 2008, CELL MICROBIOL, V10, P1040, DOI 10.1111/j.1462-5822.2007.01101.x; van Marle G, 2005, J NEUROVIROL, V11, P107, DOI 10.1080/13550280590922838; van Marle G, 2002, AIDS, V16, P1905, DOI 10.1097/00002030-200209270-00007; Vivithanaporn P, 2010, NEUROLOGY, V75, P1150, DOI 10.1212/WNL.0b013e3181f4d5bb; Vivithanaporn P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012856; Weed MR, 2003, J NEUROVIROL, V9, P452, DOI 10.1080/13550280390218751; Wesselingh SL, 1997, J NEUROIMMUNOL, V74, P1, DOI 10.1016/S0165-5728(96)00160-9; WESSELINGH SL, 1993, ANN NEUROL, V33, P576, DOI 10.1002/ana.410330604; Wesselingh SL, 2000, METH MOL B, V123, P323; Wesselingh SL, 2001, CURR OPIN NEUROL, V14, P375, DOI 10.1097/00019052-200106000-00018; WESSELINGH SL, 1994, ADV NEUROIMMUNOL, V4, P199, DOI 10.1016/S0960-5428(06)80258-5; Witwer KW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008129; YAMAMOTO JK, 1989, J AM VET MED ASSOC, V194, P213; Zaritsky LA, 2012, J IMMUNOL, V188, P3876, DOI 10.4049/jimmunol.1103024; Zhang FW, 2009, CELL HOST MICROBE, V6, P54, DOI 10.1016/j.chom.2009.05.008; Zhang KY, 2003, J VIROL, V77, P6899, DOI 10.1128/JVI.77.12.6899-6912.2003; Zhang KY, 2001, VIROLOGY, V283, P19, DOI 10.1006/viro.2001.0876; Zhu Y, 2009, FASEB J, V23, P2928, DOI 10.1096/fj.08-128819; Zink MC, 2006, CURR HIV RES, V4, P293; Zink MC, 1997, AM J PATHOL, V151, P793	117	17	17	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2013	27	7					2829	2844		10.1096/fj.13-227868	http://dx.doi.org/10.1096/fj.13-227868			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	277TA	23608145	Green Accepted			2022-12-25	WOS:000328841000031
J	Zhu, H; Moriasi, CM; Zhang, M; Zhao, Y; Zou, MH				Zhu, Huaiping; Moriasi, Cate M.; Zhang, Miao; Zhao, Yu; Zou, Ming-Hui			Phosphorylation of Serine 399 in LKB1 Protein Short Form by Protein Kinase C xi Is Required for Its Nucleocytoplasmic Transport and Consequent AMP-activated Protein Kinase (AMPK) Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PEUTZ-JEGHERS-SYNDROME; TUMOR-SUPPRESSOR; ENDOTHELIAL-CELLS; GLUCOSE-TRANSPORT; SPLICE VARIANT; MUSCLE-CELLS; IN-VIVO; ZETA; POLARITY; GROWTH	Two splice variants of LKB1 exist: LKB1 long form (LKB1L) and LKB1 short form (LKB1S). In a previous study, we demonstrated that phosphorylation of Ser-428/431 (in LKB1L) by protein kinase C xi (PKC xi) was essential for LKB1-mediated activation of AMP-activated protein kinase (AMPK) in response to oxidants or metformin. Paradoxically, LKB1S also activates AMPK although it lacks Ser-428/431. Thus, we hypothesized that LKB1S contained additional phosphorylation sites important in AMPK activation. Truncation analysis and site-directed mutagenesis were used to identify putative PKC xi phosphorylation sites in LKB1S. Substitution of Ser-399 to alanine did not alter the activity of LKB1S, but abolished peroxynitrite-and metformin-induced activation of AMPK. Furthermore, the phosphomimetic mutation (S399D) increased the phosphorylation of AMPK and its downstream target phospho-acetyl-coenzyme A carboxylase (ACC). PKC xi-dependent phosphorylation of Ser-399 triggered nucleocytoplasmic translocation of LKB1S in response to metformin or peroxynitrite treatment. This effect was ablated by pharmacological and genetic inhibition of PKC xi, by inhibition of CRM1 activity and by substituting Ser-399 with alanine (S399A). Overexpression of PKC xi up-regulated metformin-mediated phosphorylation of both AMPK (Thr-172) and ACC (Ser-79), but the effect was ablated in the S399A mutant. We conclude that, similar to Ser-428/431 (in LKB1L), Ser-399 (in LKB1S) is a PKC xi-dependent phosphorylation site essential for nucleocytoplasmic export of LKB1S and consequent AMPK activation.	[Zhu, Huaiping; Moriasi, Cate M.; Zhang, Miao; Zhao, Yu; Zou, Ming-Hui] Univ Oklahoma Hlth Sci Ctr, Dept Med, Sect Mol Med, Oklahoma City, OK 73104 USA; [Zou, Ming-Hui] Univ Oklahoma Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73104 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center	Zou, MH (corresponding author), Univ Oklahoma Hlth Sci Ctr, Dept Med, Sect Mol Med, BSEB 306A,941,Stanton L Young Blvd, Oklahoma City, OK 73104 USA.	ming-hui-zou@ouhsc.edu			National Institutes of Health [HL079584, HL080499, HL074399, HL089920, HL096032, HL105157, HL110488]; American Diabetes Association; Warren Chair of the University of Oklahoma Health Sciences Center; National Established Investigator Award of the American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL074399, R01HL080499, R01HL079584, R01HL089920, R01HL105157, R01HL096032, R01HL110488] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); Warren Chair of the University of Oklahoma Health Sciences Center; National Established Investigator Award of the American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL079584, HL080499, HL074399, HL089920, HL096032, HL105157, and HL110488) (to M. H. Z.). This work was also supported by a Research Award from the American Diabetes Association and funds from the Warren Chair of the University of Oklahoma Health Sciences Center (to M. H. Z.).; A recipient of the National Established Investigator Award of the American Heart Association.	Alessi DR, 2006, ANNU REV BIOCHEM, V75, P137, DOI 10.1146/annurev.biochem.75.103004.142702; Baas AF, 2003, EMBO J, V22, P3062, DOI 10.1093/emboj/cdg292; Barnes AP, 2007, CELL, V129, P549, DOI 10.1016/j.cell.2007.03.025; Boudeau J, 2003, FEBS LETT, V546, P159, DOI 10.1016/S0014-5793(03)00642-2; Boudeau J, 2003, EMBO J, V22, P5102, DOI 10.1093/emboj/cdg490; Canto C, 2004, J BIOL CHEM, V279, P12260, DOI 10.1074/jbc.M308554200; Collins SP, 2000, BIOCHEM J, V345, P673, DOI 10.1042/0264-6021:3450673; Denison FC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028306; Denison FC, 2009, J BIOL CHEM, V284, P67, DOI 10.1074/jbc.M806153200; Dorfman J, 2008, MOL BIOL CELL, V19, P1614, DOI 10.1091/mbc.E07-05-0454; Fogarty S, 2009, J BIOL CHEM, V284, P77, DOI 10.1074/jbc.M806152200; Forcet C, 2005, HUM MOL GENET, V14, P1283, DOI 10.1093/hmg/ddi139; Grifoni D, 2007, ONCOGENE, V26, P5960, DOI 10.1038/sj.onc.1210389; Hemminki A, 1998, NATURE, V391, P184, DOI 10.1038/34432; Hezel AF, 2008, ONCOGENE, V27, P6908, DOI 10.1038/onc.2008.342; Hirai T, 2003, J BIOCHEM, V133, P1, DOI 10.1093/jb/mvg017; HUANG WD, 1994, P NATL ACAD SCI USA, V91, P8960, DOI 10.1073/pnas.91.19.8960; Jansen M, 2009, PHYSIOL REV, V89, P777, DOI 10.1152/physrev.00026.2008; Jishage K, 2002, P NATL ACAD SCI USA, V99, P8903, DOI 10.1073/pnas.122254599; Liu LZ, 2006, MOL BIOL CELL, V17, P2322, DOI 10.1091/mbc.E05-10-0969; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Mirouse V, 2011, FEBS LETT, V585, P981, DOI 10.1016/j.febslet.2010.12.025; Real E, 2007, J IMMUNOL, V179, P5649, DOI 10.4049/jimmunol.179.9.5649; Rowan A, 2000, J PATHOL, V192, P203; Sanchez-Cespedes M, 2007, ONCOGENE, V26, P7825, DOI 10.1038/sj.onc.1210594; Sanchez-Cespedes M, 2002, CANCER RES, V62, P3659; Sapkota GP, 2001, J BIOL CHEM, V276, P19469, DOI 10.1074/jbc.M009953200; Shackelford DB, 2009, NAT REV CANCER, V9, P563, DOI 10.1038/nrc2676; Shaw Reuben J, 2008, Biochem J, V416, pe1, DOI 10.1042/BJ20082023; Shelly M, 2007, CELL, V129, P565, DOI 10.1016/j.cell.2007.04.012; Smith DP, 1999, HUM MOL GENET, V8, P1479, DOI 10.1093/hmg/8.8.1479; Song P, 2008, J BIOL CHEM, V283, P12446, DOI 10.1074/jbc.M708208200; Tiainen M, 2002, HUM MOL GENET, V11, P1497, DOI 10.1093/hmg/11.13.1497; Towler MC, 2008, BIOCHEM J, V416, P1, DOI 10.1042/BJ20081447; Vaahtomeri K, 2011, FEBS LETT, V585, P944, DOI 10.1016/j.febslet.2010.12.034; Woods A, 2003, CURR BIOL, V13, P2004, DOI 10.1016/j.cub.2003.10.031; Xie Z, 2008, CIRCULATION, V117, P952, DOI 10.1161/CIRCULATIONAHA.107.744490; Xie ZL, 2009, MOL CELL BIOL, V29, P3582, DOI 10.1128/MCB.01417-08; Xie ZL, 2006, J BIOL CHEM, V281, P6366, DOI 10.1074/jbc.M511178200; Ylikorkala A, 2001, SCIENCE, V293, P1323, DOI 10.1126/science.1062074; Zou MH, 2004, J BIOL CHEM, V279, P43940, DOI 10.1074/jbc.M404421200	41	22	24	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2013	288	23					16495	16505		10.1074/jbc.M112.443580	http://dx.doi.org/10.1074/jbc.M112.443580			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	163ZU	23612973	Green Published, hybrid			2022-12-25	WOS:000320378900026
J	Bump, JK; Murawski, CM; Kartano, LM; Beyer, DE; Roell, BJ				Bump, Joseph K.; Murawski, Chelsea M.; Kartano, Linda M.; Beyer, Dean E., Jr.; Roell, Brian J.			Bear-Baiting May Exacerbate Wolf-Hunting Dog Conflict	PLOS ONE			English	Article							HUMAN-CARNIVORE CONFLICT; WOLVES; DEPREDATION; WISCONSIN; PREDATION; ATTACKS	Background: The influence of policy on the incidence of human-wildlife conflict can be complex and not entirely anticipated. Policies for managing bear hunter success and depredation on hunting dogs by wolves represent an important case because with increasing wolves, depredations are expected to increase. This case is challenging because compensation for wolf depredation on hunting dogs as compared to livestock is less common and more likely to be opposed. Therefore, actions that minimize the likelihood of such conflicts are a conservation need. Methodology/Principal Findings: We used data from two US states with similar wolf populations but markedly different wolf/hunting dog depredation patterns to examine the influence of bear hunting regulations, bear hunter to wolf ratios, hunter method, and hunter effort on wolf depredation trends. Results indicated that the ratio of bear hunting permits sold per wolf, and hunter method are important factors affecting wolf depredation trends in the Upper Great Lakes region, but strong differences exist between Michigan and Wisconsin related in part to the timing and duration of bear-baiting (i.e., free feeding). The probability that a wolf depredated a bear-hunting dog increases with the duration of bear-baiting, resulting in a relative risk of depredation 2.12-7.22x greater in Wisconsin than Michigan. The net effect of compensation for hunting dog depredation in Wisconsin may also contribute to the difference between states. Conclusions/Significance: These results identified a potential tradeoff between bear hunting success and wolf/bear-hunting dog conflict. These results indicate that management options to minimize conflict exist, such as adjusting baiting regulations. If reducing depredations is an important goal, this analysis indicates that actions aside from (or in addition to) reducing wolf abundance might achieve that goal. This study also stresses the need to better understand the relationship among baiting practices, the effect of compensation on hunter behavior, and depredation occurrence.	[Bump, Joseph K.; Murawski, Chelsea M.] Michigan Technol Univ, Sch Forest Resources & Environm Sci, Houghton, MI 49931 USA; [Beyer, Dean E., Jr.; Roell, Brian J.] Michigan Dept Nat Resources, Wildlife Div, Marquette, MI USA; [Kartano, Linda M.] Univ Helsinki, Helsinki, Finland	Michigan Technological University; University of Helsinki	Bump, JK (corresponding author), Michigan Technol Univ, Sch Forest Resources & Environm Sci, Houghton, MI 49931 USA.	jkbump@mtu.edu			Michigan Tech Summer Undergraduate Research Fellowship (SURF); Actions for Transatlantic Links and Academic Networks for Training and Integrated Studies (ATLANTIS) fellowship; Ecosystem Science Center at Michigan Tech	Michigan Tech Summer Undergraduate Research Fellowship (SURF); Actions for Transatlantic Links and Academic Networks for Training and Integrated Studies (ATLANTIS) fellowship; Ecosystem Science Center at Michigan Tech	Funding for this research was provided by a Michigan Tech Summer Undergraduate Research Fellowship (SURF) to CMM, an Actions for Transatlantic Links and Academic Networks for Training and Integrated Studies (ATLANTIS) fellowship to LMK, and the Ecosystem Science Center at Michigan Tech. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwala M, 2010, BIOL CONSERV, V143, P2945, DOI 10.1016/j.biocon.2010.05.003; Bangs EE, 2005, CONSERV BIOL SER, V9, P340; BEYER D, 2006, REV SOCIAL BIOL SCI; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Breck S., 2004, Sheep & Goat Research Journal, V19, P41; Bulte EH, 2005, J WILDLIFE MANAGE, V69, P14, DOI 10.2193/0022-541X(2005)069&lt;0014:WCWDMB&gt;2.0.CO;2; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Cameron AC., 2013, REGRESSION ANAL COUN, V2nd ed, DOI 10.1017/CBO9781139013567; Dhuey B, 2009, BLACK BEAR HUNTER QU; Dickman AJ, 2011, P NATL ACAD SCI USA, V108, P13937, DOI 10.1073/pnas.1012972108; Edge Justin L., 2011, Human-Wildlife Interactions, V5, P66; FRITTS SH, 1989, WILDLIFE SOC B, V17, P121; Harper EK, 2005, WILDLIFE SOC B, V33, P888, DOI 10.2193/0091-7648(2005)33[888:COWDIM]2.0.CO;2; Hosmer DW, 2000, APPL LOGISTIC REGRES, P492; Kojola I, 2002, WILDLIFE SOC B, V30, P498; Kojola I, 2004, WILDLIFE BIOL, V10, P01; MDNR, 2011, MICH BEAR HUNT DIG; Mech L. David, 2003, P1; Mech LD, 2001, WILDLIFE SOC B, V29, P70; Mladenoff DJ, 2009, RECOVERY OF GRAY WOLVES IN THE GREAT LAKES REGION OF THE UNITED STATES, P119, DOI 10.1007/978-0-387-85952-1_8; Musiani M, 2004, BIOSCIENCE, V54, P50, DOI 10.1641/0006-3568(2004)054[0050:TPOWPP]2.0.CO;2; Naughton-Treves L, 2003, CONSERV BIOL, V17, P1500, DOI 10.1111/j.1523-1739.2003.00060.x; Potvin MJ, 2005, J WILDLIFE MANAGE, V69, P1660, DOI 10.2193/0022-541X(2005)69[1660:MAHAFW]2.0.CO;2; Roell BJ, 2009, 3498 MICH DEP NAT RE; Rogers LL, 1987, 8210144 US FISH WILD, V82; Ruid DB, 2009, RECOVERY OF GRAY WOLVES IN THE GREAT LAKES REGION OF THE UNITED STATES, P279, DOI 10.1007/978-0-387-85952-1_18; THIEL RP, 1981, AM MIDL NAT, V106, P401, DOI 10.2307/2425178; Treves A, 2004, CONSERV BIOL, V18, P114, DOI 10.1111/j.1523-1739.2004.00189.x; Treves A, 2003, CONSERV BIOL, V17, P1491, DOI 10.1111/j.1523-1739.2003.00059.x; Treves A, 2002, WILDLIFE SOC B, V30, P231; Treves A, 2011, BIOSCIENCE, V61, P451, DOI 10.1525/bio.2011.61.6.7; Treves A, 2009, BIODIVERS CONSERV, V18, P4003, DOI 10.1007/s10531-009-9695-2; Treves A, 2009, CONSERV BIOL, V23, P1577, DOI 10.1111/j.1523-1739.2009.01242.x; USFWS, 2011, FED REGISTER, V76, P81666; Vanak AT, 2009, MAMMAL REV, V39, P265, DOI 10.1111/j.1365-2907.2009.00148.x; Vucetich JA, 2011, J ANIM ECOL, V80, P1236, DOI 10.1111/j.1365-2656.2011.01855.x; WDNR, 2012, PUBWM197 WDNR; WDNR, 2011, WISC ANN WOLF DAM PA; Woodroffe R., 2005, PEOPLE WILDLIFE CONF; Wydeven A.P., 2009, RECOVERY GRAY WOLVES	40	7	7	0	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2013	8	4							e61708	10.1371/journal.pone.0061708	http://dx.doi.org/10.1371/journal.pone.0061708			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IK	23613910	gold, Green Published, Green Submitted			2022-12-25	WOS:000317907200075
J	Lee, JY; Jeong, W; Lim, W; Lim, CH; Bae, SM; Kim, J; Bazer, FW; Song, G				Lee, Jin-Young; Jeong, Wooyoung; Lim, Whasun; Lim, Chul-Hong; Bae, Seung-Min; Kim, Jinyoung; Bazer, Fuller W.; Song, Gwonhwa			Hypermethylation and Post-Transcriptional Regulation of DNA Methyltransferases in the Ovarian Carcinomas of the Laying Hen	PLOS ONE			English	Article							PROMOTER METHYLATION; GENE-EXPRESSION; CANCER; MODEL; TUMORS; PROTEINS; TIME	DNA methyltransferases (DNMTs) are key regulators of DNA methylation and have crucial roles in carcinogenesis, embryogenesis and epigenetic modification. In general, DNMT1 has enzymatic activity affecting maintenance of DNA methylation, whereas DNMT3A and DNMT3B are involved in de novo methylation events. Although DNMT genes are well known in mammals including humans and mice, they are not well studied in avian species, especially the laying hen which is recognized as an excellent animal model for research on human ovarian carcinogenesis. Results of the present study demonstrated that expression of DNMT1, DNMT3A and DNMT3B genes was significantly increased, particularly in the glandular epithelia (GE) of cancerous ovaries, but not normal ovaries. Consistent with this result, immunoreactive 5-methylcytosine protein was predominantly abundant in nuclei of stromal and GE cells of cancerous ovaries, but it was also found that, to a lesser extent, in nuclei of stromal cells of normal ovaries. Methylation-specific PCR analysis detected hypermethylation of the promoter regions of the tumor suppressor genes in the initiation and development of chicken ovarian cancer. Further, several microRNAs, specifically miR-1741, miR-16c, and miR-222, and miR-1632 were discovered to influence expression of DNMT3A and DNMT3B, respectively, via their 3'-UTR which suggests post-transcriptional regulation of their expression in laying hens. Collectively, results of the present study demonstrated increased expression of DNMT genes in cancerous ovaries of laying hens and post-transcriptional regulation of those genes by specific microRNAs, as well as control of hypermethylation of the promoters of tumor suppressor genes.	[Lee, Jin-Young; Jeong, Wooyoung; Lim, Whasun; Lim, Chul-Hong; Bae, Seung-Min; Bazer, Fuller W.; Song, Gwonhwa] Seoul Natl Univ, WCU Biomodulat Major, Dept Agr Biotechnol, Seoul, South Korea; [Kim, Jinyoung] Dankook Univ, Dept Anim Resources Sci, Cheonan, South Korea; [Bazer, Fuller W.] Texas A&M Univ, Ctr Anim Biotechnol & Genom, College Stn, TX USA; [Bazer, Fuller W.] Texas A&M Univ, Dept Anim Sci, College Stn, TX 77843 USA	Seoul National University (SNU); Dankook University; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Song, G (corresponding author), Seoul Natl Univ, WCU Biomodulat Major, Dept Agr Biotechnol, Seoul, South Korea.	ghsong@snu.ac.kr	Lim, Whasun/AAP-3156-2020; Bazer, Fuller/AAF-4317-2021; Song, Gwonhwa/H-3647-2015; gwonhwa, song/H-3208-2015	Lim, Whasun/0000-0002-1328-0465; Bazer, Fuller/0000-0002-5823-5086; 	World Class University program [R31-10056]; National Research Foundation of Korea (NRF) [2010-0013078]; Ministry of Education, Science, and Technology; Next-Generation BioGreen 21 Program [PJ008142]; Rural Development Administration, Republic of Korea	World Class University program; National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Next-Generation BioGreen 21 Program(Rural Development Administration (RDA), Republic of Korea); Rural Development Administration, Republic of Korea(Rural Development Administration (RDA), Republic of Korea)	This research was funded by the World Class University program (R31-10056) and by Basic Science Research Program (2010-0013078) through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science, and Technology, and also by a grant from the Next-Generation BioGreen 21 Program (No. PJ008142), Rural Development Administration, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson GL, 2010, JNCI-J NATL CANCER I, V102, P26, DOI 10.1093/jnci/djp438; Barua A, 2009, INT J GYNECOL CANCER, V19, P531, DOI 10.1111/IGC.0b013e3181a41613; Ellinger J, 2008, J UROLOGY, V179, P346, DOI 10.1016/j.juro.2007.08.091; Esteller M, 2007, HUM MOL GENET, V16, pR50, DOI 10.1093/hmg/ddm018; FATHALLA MF, 1971, LANCET, V2, P163; Garzon R, 2006, TRENDS MOL MED, V12, P580, DOI 10.1016/j.molmed.2006.10.006; Jackson E, 2007, GYNECOL ONCOL, V104, P192, DOI 10.1016/j.ygyno.2006.07.024; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Jair KW, 2006, CANCER RES, V66, P682, DOI 10.1158/0008-5472.CAN-05-1980; Johnson KA, 2009, CANCER PREV RES, V2, P97, DOI 10.1158/1940-6207.CAPR-08-0244; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Jones PA, 2001, SCIENCE, V293, P1068, DOI 10.1126/science.1063852; Kurihara Y, 2008, DEV BIOL, V313, P335, DOI 10.1016/j.ydbio.2007.10.033; Laird PW, 2010, NAT REV GENET, V11, P191, DOI 10.1038/nrg2732; Lan J, 2010, ACTA BIOCH BIOPH SIN, V42, P243, DOI 10.1093/abbs/gmq015; Lee JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034215; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Lim W, 2012, EXP BIOL MED, V237, P150, DOI 10.1258/ebm.2011.011250; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Roa JC, 2005, REV MED CHILE, V133, P874; Robertson KD, 1999, NUCLEIC ACIDS RES, V27, P2291, DOI 10.1093/nar/27.11.2291; Robertson KD, 2002, ONCOGENE, V21, P5361, DOI 10.1038/sj.onc.1205609; Rodriguez-Burford C, 2001, GYNECOL ONCOL, V81, P373, DOI 10.1006/gyno.2001.6191; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Smith ER, 2008, LANCET ONCOL, V9, P1108, DOI 10.1016/S1470-2045(08)70281-X; Socha MJ, 2009, NEOPLASIA, V11, P126, DOI 10.1593/neo.81146; Song GH, 2006, ENDOCRINOLOGY, V147, P3478, DOI 10.1210/en.2006-0122; Stakleff KDS, 2003, INT J GYNECOL CANCER, V13, P405, DOI 10.1046/j.1525-1438.2003.13317.x; Stammer K, 2008, GYNECOL ONCOL, V109, P115, DOI 10.1016/j.ygyno.2007.12.030; Stec I, 2000, FEBS LETT, V473, P1, DOI 10.1016/S0014-5793(00)01449-6; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Vanderhyden Barbara C, 2003, Reprod Biol Endocrinol, V1, P67, DOI 10.1186/1477-7827-1-67; Yang HJ, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-212	34	15	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2013	8	4							e61658	10.1371/journal.pone.0061658	http://dx.doi.org/10.1371/journal.pone.0061658			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IK	23613894	gold, Green Submitted, Green Published			2022-12-25	WOS:000317907200070
J	Lee, YL; Chen, CW; Liu, FH; Huang, YW; Huang, HM				Lee, Yueh-Lun; Chen, Chih-Wei; Liu, Fu-Hwa; Huang, Yu-Wen; Huang, Huei-Mei			Aclacinomycin A Sensitizes K562 Chronic Myeloid Leukemia Cells to Imatinib through p38MAPK-Mediated Erythroid Differentiation	PLOS ONE			English	Article							CHRONIC MYELOGENOUS LEUKEMIA; CYTOGENETIC RESPONSES; STEM-CELLS; GROWTH-INHIBITION; APOPTOSIS; CANCER; ACTIVATION; INDUCTION; ANTHRACYCLINES; DEGRADATION	Expression of oncogenic Bcr-Abl inhibits cell differentiation of hematopoietic stem/progenitor cells in chronic myeloid leukemia (CML). Differentiation therapy is considered to be a new strategy for treating this type of leukemia. Aclacinomycin A (ACM) is an antitumor antibiotic. Previous studies have shown that ACM induced erythroid differentiation of CML cells. In this study, we investigate the effect of ACM on the sensitivity of human CML cell line K562 to Bcr-Abl specific inhibitor imatinib (STI571, Gleevec). We first determined the optimal concentration of ACM for erythroid differentiation but not growth inhibition and apoptosis in K562 cells. Then, pretreatment with this optimal concentration of ACM followed by a minimally toxic concentration of imatinib strongly induced growth inhibition and apoptosis compared to that with simultaneous co-treatment, indicating that ACM-induced erythroid differentiation sensitizes K562 cells to imatinib. Sequential treatment with ACM and imatinib induced Bcr-Abl down-regulation, cytochrome c release into the cytosol, and caspase-3 activation, as well as decreased Mcl-1 and Bcl-xL expressions, but did not affect Fas ligand/Fas death receptor and procaspase-8 expressions. ACM/imatinib sequential treatment-induced apoptosis was suppressed by a caspase-9 inhibitor and a caspase-3 inhibitor, indicating that the caspase cascade is involved in this apoptosis. Furthermore, we demonstrated that ACM induced erythroid differentiation through the p38 mitogen-activated protein kinase (MAPK) pathway. The inhibition of erythroid differentiation by p38MAPK inhibitor SB202190, p38MAPK dominant negative mutant or p38MAPK shRNA knockdown, reduced the ACM/imatinib sequential treatment-mediated growth inhibition and apoptosis. These results suggest that differentiated K562 cells induced by ACM-mediated p38MAPK pathway become more sensitive to imatinib and result in down-regulations of Bcr-Abl and anti-apoptotic proteins, growth inhibition and apoptosis. These results provided a potential management by which ACM might have a crucial impact on increasing sensitivity of CML cells to imatinib in the differentiation therapeutic approaches.	[Lee, Yueh-Lun] Taipei Med Univ, Coll Med, Dept Microbiol & Immunol, Taipei, Taiwan; [Chen, Chih-Wei] Chi Mei Med Ctr, Dept Neurosurg, Taipei, Taiwan; [Liu, Fu-Hwa] Acad Sinica, Inst Mol Biol, Taipei, Taiwan; [Huang, Yu-Wen; Huang, Huei-Mei] Taipei Med Univ, Coll Med, Grad Inst Med Sci, Taipei, Taiwan	Taipei Medical University; Chi Mei Hospital; Academia Sinica - Taiwan; Taipei Medical University	Huang, HM (corresponding author), Taipei Med Univ, Coll Med, Grad Inst Med Sci, Taipei, Taiwan.	cmbhhm@tmu.edu.tw			National Science Council of Taiwan [NSC 99-2320-B-038-005-MY3]; Chi Mei Medical Center of Taiwan [98CM-TMU-02-3]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Chi Mei Medical Center of Taiwan	This study was supported by research grants from the National Science Council of Taiwan (NSC 99-2320-B-038-005-MY3) and the Chi Mei Medical Center of Taiwan (98CM-TMU-02-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aichberger KJ, 2005, BLOOD, V105, P3303, DOI 10.1182/blood-2004-02-0749; Akgul C, 2009, CELL MOL LIFE SCI, V66, P1326, DOI 10.1007/s00018-008-8637-6; Alvira D, 2011, J BIOL CHEM, V286, P32313, DOI 10.1074/jbc.M111.249060; ANDO S, 1986, CANCER TREAT REP, V70, P835; Aries A, 1996, BLOOD, V87, P2885, DOI 10.1182/blood.V87.7.2885.bloodjournal8772885; CHAIRES JB, 1990, BIOCHEMISTRY-US, V29, P6145, DOI 10.1021/bi00478a006; Chen KC, 2010, J CELL PHYSIOL, V222, P625, DOI 10.1002/jcp.21979; Chen R, 2006, CANCER RES, V66, P10959, DOI 10.1158/0008-5472.CAN-06-1216; Clarkson B, 2003, LEUKEMIA, V17, P1211, DOI 10.1038/sj.leu.2402912; Corbin AS, 2011, J CLIN INVEST, V121, P396, DOI 10.1172/JCI35721; Crews LA, 2012, CURR HEMATOL MALIG R, V7, P125, DOI 10.1007/s11899-012-0121-6; Deininger MWN, 2000, BLOOD, V96, P3343, DOI 10.1182/blood.V96.10.3343; DREXLER HG, 1994, LEUKEMIA RES, V18, P919, DOI 10.1016/0145-2126(94)90103-1; FigueiredoPereira ME, 1996, J BIOL CHEM, V271, P16455, DOI 10.1074/jbc.271.28.16455; Graham SM, 2002, BLOOD, V99, P319, DOI 10.1182/blood.V99.1.319; Hajji N, 2005, MUTAT RES-GEN TOX EN, V583, P26, DOI 10.1016/j.mrgentox.2005.01.012; Hersey P, 2003, J CELL PHYSIOL, V196, P9, DOI 10.1002/jcp.10256; Holyoake T, 1999, BLOOD, V94, P2056, DOI 10.1182/blood.V94.6.2056; Holyoake TL, 2001, BRIT J HAEMATOL, V113, P11, DOI 10.1046/j.1365-2141.2001.02558.x; Huang HM, 2004, BIOCHEM BIOPH RES CO, V320, P1247, DOI 10.1016/j.bbrc.2004.06.083; Huang HM, 2009, J CELL PHYSIOL, V218, P568, DOI 10.1002/jcp.21627; Huang HM, 2010, J CELL PHYSIOL, V223, P687, DOI 10.1002/jcp.22074; Huttemann M, 2011, MITOCHONDRION, V11, P369, DOI 10.1016/j.mito.2011.01.010; Jakubowska J, 2008, EUR J PHARMACOL, V596, P41, DOI 10.1016/j.ejphar.2008.08.021; Jeannesson P, 1997, LEUKEMIA LYMPHOMA, V26, P575, DOI 10.3109/10428199709050893; Jiang X, 2007, LEUKEMIA, V21, P926, DOI 10.1038/sj.leu.2404609; Kantarjian H, 2002, NEW ENGL J MED, V346, P645, DOI 10.1056/NEJMoa011573; Kaufmann SH, 2000, EXP CELL RES, V256, P42, DOI 10.1006/excr.2000.4838; Larsen AK, 2003, PHARMACOL THERAPEUT, V99, P167, DOI 10.1016/S0163-7258(03)00058-5; Lavrik IN, 2012, CELL DEATH DIFFER, V19, P36, DOI 10.1038/cdd.2011.155; Li QF, 2007, ONCOGENE, V26, P7904, DOI 10.1038/sj.onc.1210587; LOZZIO CB, 1975, BLOOD, V45, P321, DOI 10.1182/blood.V45.3.321.321; Mauro MJ, 2006, HAEMATOL-HEMATOL J, V91, P152; Minotti G, 2004, PHARMACOL REV, V56, P185, DOI 10.1124/pr.56.2.6; Moosavi MA, 2007, INT J BIOCHEM CELL B, V39, P1685, DOI 10.1016/j.biocel.2007.04.016; Morceau F, 2006, CANCER LETT, V240, P203, DOI 10.1016/j.canlet.2005.09.014; Nitiss JL, 1997, CANCER RES, V57, P4564; Paschka P, 2003, LEUKEMIA, V17, P1687, DOI 10.1038/sj.leu.2403033; Peng C, 2007, BLOOD, V110, P678, DOI 10.1182/blood-2006-10-054098; Sawyers CL, 2002, BLOOD, V99, P3530, DOI 10.1182/blood.V99.10.3530; Sundman-Engberg B, 1998, CANCER CHEMOTH PHARM, V42, P17, DOI 10.1007/s002800050779; Talpaz M, 2002, BLOOD, V99, P1928, DOI 10.1182/blood.V99.6.1928; Tamura K, 2000, CELL, V102, P221, DOI 10.1016/S0092-8674(00)00027-1; Wang Z, 2006, APOPTOSIS, V11, P1851, DOI 10.1007/s10495-006-9529-6; Witt O, 2000, BLOOD, V95, P2391, DOI 10.1182/blood.V95.7.2391.007k21_2391_2396; Yu CR, 2003, CANCER RES, V63, P2118; Yu CR, 2002, CANCER RES, V62, P188	47	12	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2013	8	4							e61939	10.1371/journal.pone.0061939	http://dx.doi.org/10.1371/journal.pone.0061939			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IK	23613979	Green Published, Green Submitted, gold			2022-12-25	WOS:000317907200107
J	Du, QZ; Pan, W; Tian, JX; Li, BL; Zhang, DQ				Du, Qingzhang; Pan, Wei; Tian, Jiaxing; Li, Bailian; Zhang, Deqiang			The UDP-Glucuronate Decarboxylase Gene Family in Populus: Structure, Expression, and Association Genetics	PLOS ONE			English	Article							SOLID WOOD PROPERTIES; COTTON FIBER; LINKAGE DISEQUILIBRIUM; ACID DECARBOXYLASE; CELL-WALL; NUCLEOTIDE DIVERSITY; NATURAL-POPULATIONS; BLACK COTTONWOOD; CANDIDATE GENES; TREMULA L.	In woody crop plants, the oligosaccharide components of the cell wall are essential for important traits such as bioenergy content, growth, and structural wood properties. UDP-glucuronate decarboxylase (UXS) is a key enzyme in the synthesis of UDP-xylose for the formation of xylans during cell wall biosynthesis. Here, we isolated a multigene family of seven members (PtUXS1-7) encoding UXS from Populus tomentosa, the first investigation of UXSs in a tree species. Analysis of gene structure and phylogeny showed that the PtUXS family could be divided into three groups (PtUXS1/4, PtUXS2/5, and PtUXS3/6/7), consistent with the tissue-specific expression patterns of each PtUXS. We further evaluated the functional consequences of nucleotide polymorphisms in PtUXS1. In total, 243 single-nucleotide polymorphisms (SNPs) were identified, with a high frequency of SNPs (1/18 bp) and nucleotide diversity (pi(T) = 0.01033, theta(W=)0.01280). Linkage disequilibrium (LD) analysis showed that LD did not extend over the entire gene (r(2)<0.1, P<0.001, within 700 bp). SNP- and haplotype-based association analysis showed that nine SNPs (Q <0.10) and 12 haplotypes (P<0.05) were significantly associated with growth and wood property traits in the association population (426 individuals), with 2.70% to 12.37% of the phenotypic variation explained. Four significant single-marker associations (Q <0.10) were validated in a linkage mapping population of 1200 individuals. Also, RNA transcript accumulation varies among genotypic classes of SNP10 was further confirmed in the association population. This is the first comprehensive study of the UXS gene family in woody plants, and lays the foundation for genetic improvements of wood properties and growth in trees using genetic engineering or marker-assisted breeding.	[Du, Qingzhang; Pan, Wei; Tian, Jiaxing; Li, Bailian; Zhang, Deqiang] Beijing Forestry Univ, Coll Biol Sci & Technol, Natl Engn Lab Tree Breeding, Beijing, Peoples R China; [Du, Qingzhang; Pan, Wei; Tian, Jiaxing; Li, Bailian; Zhang, Deqiang] Beijing Forestry Univ, Coll Biol Sci & Technol, Minist Educ, Key Lab Genet & Breeding Forest Trees & Ornamenta, Beijing, Peoples R China	Beijing Forestry University; Beijing Forestry University	Zhang, DQ (corresponding author), Beijing Forestry Univ, Coll Biol Sci & Technol, Natl Engn Lab Tree Breeding, Beijing, Peoples R China.	DeqiangZhang@bjfu.edu.cn			Beijing Forestry University [BLYJ201201]; State Key Basic Research Program of China [2012CB114506]; National Natural Science Foundation of China [31170622, 30872042]	Beijing Forestry University; State Key Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Specific Program in Graduate Science and Technology Innovation of Beijing Forestry University (No. BLYJ201201), the State Key Basic Research Program of China (No. 2012CB114506), and the Project of the National Natural Science Foundation of China (Nos. 31170622, 30872042). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson M, 2010, PLANT SCI, V178, P61, DOI 10.1016/j.plantsci.2009.11.003; Al-Ghazi Y, 2009, PLANT CELL PHYSIOL, V50, P1364, DOI 10.1093/pcp/pcp084; Andersen JR, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-2; Aschan G, 2001, TREES-STRUCT FUNCT, V15, P431, DOI 10.1007/s004680100120; Bar-Peled M, 2001, P NATL ACAD SCI USA, V98, P12003, DOI 10.1073/pnas.211229198; Beaulieu J, 2011, GENETICS, V188, P197, DOI 10.1534/genetics.110.125781; Bindschedler LV, 2007, PHYTOCHEMISTRY, V68, P2635, DOI 10.1016/j.phytochem.2007.08.029; Brown GR, 2004, P NATL ACAD SCI USA, V101, P15255, DOI 10.1073/pnas.0404231101; Chung BYW, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-120; Collard BCY, 2008, PHILOS T R SOC B, V363, P557, DOI 10.1098/rstb.2007.2170; DALESSANDRO G, 1977, BIOCHEM J, V162, P267, DOI 10.1042/bj1620267; Dillon SK, 2010, GENETICS, V185, P1477, DOI 10.1534/genetics.110.116582; Dillon SK, 2012, NEW PHYTOL, V195, P596, DOI 10.1111/j.1469-8137.2012.04200.x; Djerbi S, 2004, CELLULOSE, V11, P301, DOI 10.1023/B:CELL.0000046408.84510.06; Du QZ, 2013, NEW PHYTOL, V197, P763, DOI 10.1111/nph.12072; Du QZ, 2012, J HERED, V103, P853, DOI 10.1093/jhered/ess061; Duan JB, 2003, HUM MOL GENET, V12, P205, DOI 10.1093/hmg/ddg055; Dvornyk V, 2002, MOL BIOL EVOL, V19, P179, DOI 10.1093/oxfordjournals.molbev.a004070; Eckert AJ, 2009, GENETICS, V182, P1289, DOI 10.1534/genetics.109.102350; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Geisler-Lee J, 2006, PLANT PHYSIOL, V140, P946, DOI 10.1104/pp.105.072652; Gonzalez-Martinez SC, 2007, GENETICS, V175, P399, DOI 10.1534/genetics.106.061127; Gonzalez-Martinez SC, 2006, NEW PHYTOL, V170, P227, DOI 10.1111/j.1469-8137.2006.01686.x; Greene CS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005639; Guerra FP, 2013, NEW PHYTOL, V197, P162, DOI 10.1111/nph.12003; Haigler CH, 2005, PHYSIOL PLANTARUM, V124, P285, DOI 10.1111/j.1399-3054.2005.00480.x; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; Harper AD, 2002, PLANT PHYSIOL, V130, P2188, DOI 10.1104/pp.009654; Higuchi T., 1997, BIOCH MOL BIOL WOOD, P1, DOI [10.1007/978-3-642-60469-0_1, DOI 10.1007/978-3-642-60469-0_1, 10.1007/978-3-642-60469-0]; HILL W G, 1968, Theoretical and Applied Genetics, V38, P226, DOI 10.1007/BF01245622; Ingvarsson PK, 2008, GENETICS, V178, P2217, DOI 10.1534/genetics.107.082354; Ingvarsson PK, 2005, GENETICS, V169, P945, DOI 10.1534/genetics.104.034959; Jacob-Wilk D, 2006, P NATL ACAD SCI USA, V103, P12191, DOI 10.1073/pnas.0605098103; Kien ND, 2009, ANN FOREST SCI, V66, DOI 10.1051/forest/2009064; Krutovsky KV, 2005, GENETICS, V171, P2029, DOI 10.1534/genetics.105.044420; Kurek I, 2002, P NATL ACAD SCI USA, V99, P11109, DOI 10.1073/pnas.162077099; Li LG, 2006, CRIT REV PLANT SCI, V25, P215, DOI 10.1080/07352680600611519; Lin ZG, 2012, MOL BIOL EVOL, V29, P81, DOI 10.1093/molbev/msr143; Lu JL, 2008, MOL GENET GENOMICS, V279, P563, DOI 10.1007/s00438-008-0333-6; MEINERT MC, 1977, PLANT PHYSIOL, V59, P1088, DOI 10.1104/pp.59.6.1088; Miyamoto Y, 2007, NAT GENET, V39, P529, DOI 10.1038/2005; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Neale DB, 2011, NAT REV GENET, V12, P111, DOI 10.1038/nrg2931; Neale DB, 2004, TRENDS PLANT SCI, V9, P325, DOI 10.1016/j.tplants.2004.05.006; Nordborg M, 2002, NAT GENET, V30, P190, DOI 10.1038/ng813; Pan YX, 2010, J PLANT BIOL, V53, P367, DOI 10.1007/s12374-010-9124-9; Pattathil S, 2005, PLANTA, V221, P538, DOI 10.1007/s00425-004-1471-7; Persson S, 2005, P NATL ACAD SCI USA, V102, P8633, DOI 10.1073/pnas.0503392102; Pfanz H, 2008, TREES-STRUCT FUNCT, V22, P137, DOI 10.1007/s00468-007-0196-1; Plomion C, 2001, PLANT PHYSIOL, V127, P1513, DOI 10.1104/pp.010816; Reiter WD, 2001, PLANT MOL BIOL, V47, P95, DOI 10.1023/A:1010671129803; Rethmeier N, 1997, PLANT J, V12, P895, DOI 10.1046/j.1365-313X.1997.12040895.x; Ritland K, 1996, GENET RES, V67, P175, DOI 10.1017/S0016672300033620; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Sari-Gorla M, 1999, THEOR APPL GENET, V99, P289, DOI 10.1007/s001220051234; Saveyn A, 2010, PLANT CELL ENVIRON, V33, P1949, DOI 10.1111/j.1365-3040.2010.02197.x; Sexton TR, 2012, PLANT PHYSIOL, V158, P531, DOI 10.1104/pp.111.181602; Sexton TR, 2010, AUST FORESTRY, V73, P254, DOI 10.1080/00049158.2010.10676336; Shakil Ahmed, 2011, Pakistan Journal of Phytopathology, V23, P86; Sivamani E, 2006, PLANT MOL BIOL, V60, P225, DOI 10.1007/s11103-005-3853-z; Slavov GT, 2012, NEW PHYTOL, V196, P713, DOI 10.1111/j.1469-8137.2012.04258.x; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Strasser R, 2000, FEBS LETT, V472, P105, DOI 10.1016/S0014-5793(00)01443-5; Suzuki K, 2004, ARCH BIOCHEM BIOPHYS, V431, P169, DOI 10.1016/j.abb.2004.08.029; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Teskey RO, 2008, NEW PHYTOL, V177, P17, DOI 10.1111/j.1469-8137.2007.02286.x; Thumma BR, 2009, GENETICS, V183, P1153, DOI 10.1534/genetics.109.106591; Thumma BR, 2005, GENETICS, V171, P1257, DOI 10.1534/genetics.105.042028; Tian JX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053116; Tsankov AM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000414; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Varshney RK, 2009, TRENDS BIOTECHNOL, V27, P522, DOI 10.1016/j.tibtech.2009.05.006; Vilela C, 2003, MOL MICROBIOL, V49, P859, DOI 10.1046/j.1365-2958.2003.03622.x; Wegrzyn JL, 2010, NEW PHYTOL, V188, P515, DOI 10.1111/j.1469-8137.2010.03415.x; Wheatley ER, 2002, PHYTOCHEMISTRY, V61, P771, DOI 10.1016/S0031-9422(02)00399-0; Ye ZH, 2006, TRENDS PLANT SCI, V11, P162, DOI 10.1016/j.tplants.2006.02.001; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Yu Q, 2006, TREE GENET GENOMES, V2, P98, DOI 10.1007/s11295-005-0032-y; Zeng YC, 1997, J BIOL CHEM, V272, P31340, DOI 10.1074/jbc.272.50.31340; Zhang DQ, 2011, TREE GENET GENOMES, V7, P443, DOI 10.1007/s11295-010-0346-2; Zhang DQ, 2010, MOL GENET GENOMICS, V284, P105, DOI 10.1007/s00438-010-0552-5; Zhang QS, 2005, PLANT PHYSIOL, V138, P131, DOI 10.1104/pp.104.057869	82	26	29	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2013	8	4							e60880	10.1371/journal.pone.0060880	http://dx.doi.org/10.1371/journal.pone.0060880			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130DR	23613749	gold, Green Submitted, Green Published			2022-12-25	WOS:000317893400024
J	Lorente, N; Preau, M; Vernay-Vaisse, C; Mora, M; Blanche, J; Otis, J; Passeron, A; Le Gall, JM; Dhotte, P; Carrieri, MP; Suzan-Monti, M; Spire, B				Lorente, Nicolas; Preau, Marie; Vernay-Vaisse, Chantal; Mora, Marion; Blanche, Jerome; Otis, Joanne; Passeron, Alain; Le Gall, Jean-Marie; Dhotte, Philippe; Carrieri, Maria Patrizia; Suzan-Monti, Marie; Spire, Bruno		ANRS-DRAG Study Grp	Expanding Access to Non-Medicalized Community-Based Rapid Testing to Men Who Have Sex with Men: An Urgent HIV Prevention Intervention (The ANRS-DRAG Study)	PLOS ONE			English	Article							RISK; BEHAVIOR; UNAWARE; AWARE	Background: Little is known about the public health benefits of community-based, non-medicalized rapid HIV testing offers (CBOffer) specifically targeting men who have sex with men (MSM), compared with the standard medicalized HIV testing offer (SMOffer) in France. This study aimed to verify whether such a CBOffer, implemented in voluntary counselling and testing centres, could improve access to less recently HIV-tested MSM who present a risk behaviour profile similar to or higher than MSM tested with the SMOffer. Method: This multisite study enrolled MSM attending voluntary counselling and testing centres' during opening hours in the SMOffer. CBOffer enrolees voluntarily came to the centres outside of opening hours, following a communication campaign in gay venues. A self-administered questionnaire was used to investigate HIV testing history and sexual behaviours including inconsistent condom use and risk reduction behaviours (in particular, a score of "intentional avoidance" for various at-risk situations was calculated). A mixed logistic regression identified factors associated with access to the CBOffer. Results: Among the 330 participants, 64% attended the CBOffer. Percentages of inconsistent condom use in both offers were similar (51% CBOffer, 50% SMOffer). In multivariate analyses, those attending the CBOffer had only one or no test in the previous two years, had a lower intentional avoidance score, and met more casual partners in saunas and backrooms than SMOffer enrolees. Conclusion: This specific rapid CBOffer attracted MSM less recently HIV-tested, who presented similar inconsistent condom use rates to SMOffer enrolees but who exposed themselves more to HIV-associated risks. Increasing entry points for HIV testing using community and non-medicalized tests is a priority to reach MSM who are still excluded.	[Lorente, Nicolas; Preau, Marie; Mora, Marion; Blanche, Jerome; Carrieri, Maria Patrizia; Suzan-Monti, Marie; Spire, Bruno] Inst Natl Sante & Rech Med U912 SESSTIM, Marseille, France; [Lorente, Nicolas; Mora, Marion; Blanche, Jerome; Carrieri, Maria Patrizia; Suzan-Monti, Marie; Spire, Bruno] Aix Marseille Univ, IRD, UMR S912, Marseille, France; [Lorente, Nicolas; Preau, Marie; Mora, Marion; Blanche, Jerome; Carrieri, Maria Patrizia; Suzan-Monti, Marie; Spire, Bruno] Observ Reg Sante Prov Alpes Cote Azur, Marseille, France; [Preau, Marie] Univ Lyon 2, Grpe Rech Psychol Sociale, Lyon, France; [Vernay-Vaisse, Chantal] Conseil Gen Bouches Rhone, Marseille, France; [Otis, Joanne] Univ Quebec, Chaire Rech Canada Educ Sante, Montreal, PQ H3C 3P8, Canada; [Passeron, Alain; Spire, Bruno] Conseil Gen Alpes Maritimes, Nice, France; [Le Gall, Jean-Marie] Aides, Pantin, France; [Dhotte, Philippe] Ctr Informat Depistage & Diagnost Infect Sexuelle, Ctr Informat & Depistage Anonyme & Gratuit, CMS, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; Universite Lyon 2; University of Quebec; University of Quebec Montreal	Lorente, N (corresponding author), Inst Natl Sante & Rech Med U912 SESSTIM, Marseille, France.	nicolas.lorente@inserm.com	Lorente, Nicolas/AAB-5279-2019; Spire, Bruno/F-5546-2013	Lorente, Nicolas/0000-0002-5320-1493; Spire, Bruno/0000-0002-3546-8020; Carrieri, Patrizia/0000-0002-6794-4837	French Agence Nationale de Recherche sur le Sida et les hepatitis virales (ANRS)	French Agence Nationale de Recherche sur le Sida et les hepatitis virales (ANRS)	The study was supported by the French Agence Nationale de Recherche sur le Sida et les hepatitis virales (ANRS, http://www.anrs.fr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey AC, 2009, SEX TRANSM INFECT, V85, P145, DOI 10.1136/sti.2008.032359; Branson B., 2006, REVISED RECOMMENDATI; Brewer DD, 2006, SEX TRANSM DIS, V33, P250, DOI 10.1097/01.olq.0000194595.90487.ed; Cazein F., 2011, Bulletin Epidemiologique Hebdomadaire, P446; Champenois K, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000693; Cubaynes MH, 2010, PLAN NATIONAL DE LUT; d'Almeida KW, 2012, ARCH INTERN MED, V172, P12, DOI 10.1001/archinternmed.2011.535; Dufour A, 2000, CAN J PUBLIC HEALTH, V91, P345, DOI 10.1007/BF03404804; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Greacen T, 2012, AIDS CARE IN PRESS; Greacen T, 2012, SEX TRANSM INFECT, V88, P368, DOI 10.1136/sextrans-2011-050405; Hall HI, 2012, AIDS, V26, P893, DOI 10.1097/QAD.0b013e328351f73f; Kline P., 1999, HDB PSYCHOL TESTING; Koo DJ, 2006, AM J PUBLIC HEALTH, V96, P962, DOI 10.2105/AJPH.2006.089235; Le Vu S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039872; Lee SS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031072; Lorente N, 2012, AIDS CARE IN PRESS; Marks G, 2005, JAIDS-J ACQ IMM DEF, V39, P446, DOI 10.1097/01.qai.0000151079.33935.79; MILLER W, 2002, PREPARING PEOPLE CHA; Obermeyer CM, 2007, AM J PUBLIC HEALTH, V97, P1762, DOI 10.2105/AJPH.2006.096263; Philip SS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012662; Schwarcz S, 2011, AIDS CARE, V23, P892, DOI 10.1080/09540121.2010.534436; Sullivan PS, 2009, AIDS, V23, P1153, DOI 10.1097/QAD.0b013e32832baa34; Supervie V, 2012, THE CASE OF FRANCE; Vallabhaneni S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045718; Velter A, 2012, AIDS BEHAV; Velter A, 2010, PREVAGAY 2009 SURVEY; WHO, 2011, PREVENTION AND TREAT	28	28	28	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2013	8	4							e61225	10.1371/journal.pone.0061225	http://dx.doi.org/10.1371/journal.pone.0061225			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	130DR	23613817	Green Published, gold			2022-12-25	WOS:000317893400050
J	Skar, H; Albert, J; Leitner, T				Skar, Helena; Albert, Jan; Leitner, Thomas			Towards Estimation of HIV-1 Date of Infection: A Time-Continuous IgG-Model Shows That Seroconversion Does Not Occur at the Midpoint between Negative and Positive Tests	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; ENZYME-IMMUNOASSAY; TYPE-1 INCIDENCE; DYNAMICS; ALGORITHM; DIAGNOSIS; ASSAY; ANTIBODIES; PROGRESS; COHORT	Estimating date of infection for HIV-1-infected patients is vital for disease tracking and informed public health decisions, but is difficult to obtain because most patients have an established infection of unknown duration at diagnosis. Previous studies have used HIV-1-specific immunoglobulin G (IgG) levels as measured by the IgG capture BED enzyme immunoassay (BED assay) to indicate if a patient was infected recently, but a time-continuous model has not been available. Therefore, we developed a logistic model of IgG production over time. We used previously published metadata from 792 patients for whom the HIV-1-specific IgG levels had been longitudinally measured using the BED assay. To account for patient variability, we used mixed effects modeling to estimate general population parameters. The typical patient IgG production rate was estimated at r = 6.72[ approximate 95% CI 6.17,7.33] x 10(-3) OD-n units day(-1), and the carrying capacity at K = 1.84[ 1.75,1.95] OD-n units, predicting how recently patients seroconverted in the interval boolean AND t = (31,711) days. Final model selection and validation was performed on new BED data from a population of 819 Swedish HIV-1 patients diagnosed in 2002-2010. On an appropriate subset of 350 patients, the best model parameterization had an accuracy of 94% finding a realistic seroconversion date. We found that seroconversion on average is at the midpoint between last negative and first positive HIV-1 test for patients diagnosed in prospective/cohort studies such as those included in the training dataset. In contrast, seroconversion is strongly skewed towards the first positive sample for patients identified by regular public health diagnostic testing as illustrated in the validation dataset. Our model opens the door to more accurate estimates of date of infection for HIV-1 patients, which may facilitate a better understanding of HIV-1 epidemiology on a population level and individualized prevention, such as guidance during contact tracing.	[Skar, Helena; Leitner, Thomas] Los Alamos Natl Lab, Theoret Biol & Biophys Grp, Los Alamos, NM 87545 USA; [Albert, Jan] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden; [Albert, Jan] Karolinska Univ Hosp, Clin Microbiol, Stockholm, Sweden	United States Department of Energy (DOE); Los Alamos National Laboratory; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Leitner, T (corresponding author), Los Alamos Natl Lab, Theoret Biol & Biophys Grp, Los Alamos, NM 87545 USA.	tkl@lanl.gov			National Institutes of Health (NIH) [1R01AI087520]; Swedish Research Council [623-2011-1100]; Swedish International Development Cooperation Agency [SWE-2006-018]; EU [QLK2-CT-2001-01344]; EHR [LSHP-CT-2006-518211]; CHAIN;  [K2008-56X-09935-17-3];  [K2001-56X-0095-20-6;]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI087520] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish International Development Cooperation Agency; EU(European Commission); EHR; CHAIN; ; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by a grant from the National Institutes of Health (NIH) (grant no. 1R01AI087520), a postdoctoral fellowship from the Swedish Research Council to H. S. (623-2011-1100) and grants no. K2008-56X-09935-17-3, K2001-56X-0095-20-6; a grant from the Swedish International Development Cooperation Agency (grant no. SWE-2006-018); and the EU projects: SPREAD (QLK2-CT-2001-01344); EHR (LSHP-CT-2006-518211) and CHAIN (FP7/ 2007-2013) `` Collaborative HIV and Anti-HIV Drug Resistance Network'' grant agreement no. 223131. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaeus A, 1997, AIDS, V11, P199, DOI 10.1097/00002030-199702000-00010; Antinori A, 2011, HIV MED, V12, P61, DOI 10.1111/j.1468-1293.2010.00857.x; Atun R, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001045; Babiker A, 2000, LANCET, V355, P1131, DOI 10.1016/S0140-6736(00)02061-4; Batzing-Feigenbaum J, 2011, HIV MED, V12, P269, DOI 10.1111/j.1468-1293.2010.00879.x; Bannister WP, 2008, JAIDS-J ACQ IMM DEF, V48, P324, DOI 10.1097/QAI.0b013e31817ae5c0; Barin F, 2005, J CLIN MICROBIOL, V43, P4441, DOI 10.1128/JCM.43.9.4441-4447.2005; Bates D., 2011, PACKAGE LME4 LINEAR, V1; Busch MP, 2010, AIDS, V24, P2763, DOI 10.1097/QAD.0b013e32833f1142; Cohen MS, 2011, NEW ENGL J MED, V364, P1943, DOI 10.1056/NEJMra1011874; Dobbs T, 2004, J CLIN MICROBIOL, V42, P2623, DOI 10.1128/JCM.42.6.2623-2628.2004; Duong YT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033328; Fiebig EW, 2003, AIDS, V17, P1871, DOI 10.1097/00002030-200309050-00005; Fisher M, 2007, AIDS, V21, P2309, DOI 10.1097/QAD.0b013e3282ef9fed; Guy R, 2009, LANCET INFECT DIS, V9, P747, DOI 10.1016/S1473-3099(09)70300-7; Hallett TB, 2011, CURR OPIN HIV AIDS, V6, P102, DOI 10.1097/COH.0b013e328343bfdb; Hargrove J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049661; Hargrove JW, 2008, AIDS, V22, P511, DOI 10.1097/QAD.0b013e3282f2a960; Janssen RS, 1998, JAMA-J AM MED ASSOC, V280, P42, DOI 10.1001/jama.280.1.42; Karita E, 2007, AIDS, V21, P403, DOI 10.1097/QAD.0b013e32801481b7; Karlsson A, 2012, PLOS ONE IN PRESS; Kitahata MM, 2009, NEW ENGL J MED, V360, P1815, DOI 10.1056/NEJMoa0807252; Laeyendecker O, 2012, J INFECT DIS; Le Vu S, 2008, EUROPEAN COMMUNICABL, V13; Lodi S, 2011, CLIN INFECT DIS, V53, P817, DOI 10.1093/cid/cir494; Marks G, 2005, JAIDS-J ACQ IMM DEF, V39, P446, DOI 10.1097/01.qai.0000151079.33935.79; McDougal JS, 2006, AIDS RES HUM RETROV, V22, P945, DOI 10.1089/aid.2006.22.945; Meyer PS, 1999, TECHNOL FORECAST SOC, V61, P209, DOI 10.1016/S0040-1625(99)00022-0; Monforte AD, 2011, ANTIVIR THER, V16, P1103, DOI 10.3851/IMP1883; Murphy G, 2008, EUROPEAN COMMUNICABL, V13; Murphy G, 2008, EURO SURVEILL, V13; Parekh BS, 2011, AIDS RES HUM RETROV, V27, P265, DOI 10.1089/aid.2010.0159; Parekh BS, 2002, AIDS RES HUM RETROV, V18, P295, DOI 10.1089/088922202753472874; Park SY, 2011, AIDS, V25, pF13, DOI 10.1097/QAD.0b013e328349f089; Perelson AS, 1996, SCIENCE, V271, P1582, DOI 10.1126/science.271.5255.1582; Porter K, 2003, LANCET, V362, P1267, DOI 10.1016/S0140-6736(03)14570-9; R Development Core Team, 2003, R LANG ENV STAT COMP; Ragonnet-Cronin M, 2012, J INFECT DIS, V206, P756, DOI 10.1093/infdis/jis411; Remis RS, 2009, AIDS, V23, P493, DOI 10.1097/QAD.0b013e328323ad5f; ROUGHGARDEN J, 1974, AM NAT, V108, P649, DOI 10.1086/282941; Sabin CA, 2010, AIDS, V24, P723, DOI 10.1097/QAD.0b013e328333fa0f; Sarkar D., 2019, NLME LINEAR NONLINEA; Sharma U, 2011, AIDS RES HUMAN RETRO; Shouse R. L., 2009, Morbidity and Mortality Weekly Report, V58, P661; Skar H, 2011, J VIROL, V85, P510, DOI 10.1128/JVI.01413-10; Sommen C, 2011, BIOMETRICS, V67, P467, DOI 10.1111/j.1541-0420.2010.01473.x; Song RG, 2006, BIOMETRICS, V62, P838, DOI 10.1111/j.1541-0420.2006.00536.x; UNAIDS/ WHO Working Group on Global HIV/ AIDS and STI Surveillance, 2011, US ASS REC INF EST H; Vercauteren J, 2009, J INFECT DIS, V200, P1503, DOI 10.1086/644505; VONGEGERFELT A, 1991, VIROLOGY, V185, P162, DOI 10.1016/0042-6822(91)90764-3; White EW, 2010, SEX TRANSM INFECT, V86, P506, DOI 10.1136/sti.2009.037481; Zoufaly A, 2012, HIV MED, V13, P172, DOI 10.1111/j.1468-1293.2011.00958.x	52	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2013	8	4							e60906	10.1371/journal.pone.0060906	http://dx.doi.org/10.1371/journal.pone.0060906			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130DR	23613753	Green Published, gold, Green Submitted			2022-12-25	WOS:000317893400027
J	Tan, YV; Abad, C; Wang, YQ; Lopez, R; Waschek, JA				Tan, Yossan-Var; Abad, Catalina; Wang, Yuqi; Lopez, Robert; Waschek, James A.			Pituitary Adenylate Cyclase Activating Peptide Deficient Mice Exhibit Impaired Thymic and Extrathymic Regulatory T Cell Proliferation during EAE	PLOS ONE			English	Article							VASOACTIVE-INTESTINAL-PEPTIDE; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; CENTRAL-NERVOUS-SYSTEM; MULTIPLE-SCLEROSIS; POLYPEPTIDE PACAP; INFLAMMATORY DISEASE; GENE-EXPRESSION; DENDRITIC CELLS; SENSORY NEURONS; IMMUNE-SYSTEM	We have shown that mice deficient in pituitary adenylate cyclase-activating polypeptide (PACAP, gene name ADCYAP1) manifest enhanced sensitivity to experimental autoimmune encephalomyelitis (EAE), supporting the anti-inflammatory actions described for this neuropeptide. In addition to an increased proinflammatory cytokine response in these mice, a reduction in regulatory T cell (Treg) abundance in the lymph nodes (LN) was observed, suggesting altered Treg kinetics. In the present study, we compared in PACAP deficient (KO) vs. wild type mice the abundances and rates of proliferation FoxP3(+) Tregs in three sites, the LN, central nervous system (CNS) and thymus and the relative proportions of Th1, Th2, and Th17 effector subsets in the LN and CNS. Flow cytometry analyses revealed a decrease in Treg proliferation and an increased T effector/Tregs ratio in the LN and CNS of PACAP KO mice. In the thymus, the primary site of do novo natural Treg production, the total numbers and proliferative rates of FoxP3(+) Tregs were significantly reduced. Moreover, the expression of IL-7, a cytokine implicated in thymic Treg expansion during EAE, failed to increase at the peak of the disease in the thymus and LN of PACAP KO mice. In addition to these Treg alterations, a specific reduction of Th2 cells (about 4-fold) was observed in the lymph nodes in PACAP KO mice, with no effects on Th1 and Th17 subsets, whereas in the CNS, Th1 and Th17 cells were increased and Th2 decreased. Our results suggest that endogenous production of the neuropeptide PACAP protects against EAE by modulating Treg expansion and Th subsets at multiple sites.	[Tan, Yossan-Var; Abad, Catalina; Wang, Yuqi; Lopez, Robert; Waschek, James A.] Univ Calif Los Angeles, David Geffen Sch Med, Semel Inst, Dept Psychiat, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Waschek, JA (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Semel Inst, Dept Psychiat, Los Angeles, CA 90095 USA.	JWaschek@mednet.ucla.edu		Abad, Catalina/0000-0001-9144-9310	National Multiple Sclerosis Society [RG3928, RG4859, TA3048]; National Institutes of Health [HD04612, CA-16042, AI-28697]; Alpha Omega Alpha Carolyn L. Kuckein Student Research Fellowship; JCCC; UCLA AIDS Institute; David Geffen School of Medicine at UCLA; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD004612] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA016042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI028697] Funding Source: NIH RePORTER	National Multiple Sclerosis Society(National Multiple Sclerosis Society); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alpha Omega Alpha Carolyn L. Kuckein Student Research Fellowship; JCCC; UCLA AIDS Institute; David Geffen School of Medicine at UCLA(University of California System); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Multiple Sclerosis Society grants RG3928, RG4859, and TA3048, and National Institutes of Health grant HD04612. R.L. was supported by an Alpha Omega Alpha Carolyn L. Kuckein Student Research Fellowship. Flow cytometry was performed in the University of California at Los Angeles (UCLA) Jonsson Comprehensive Cancer Center (JCCC) and Center for AIDS Research Flow Cytometry Core Facility that is supported by National Institutes of Health awards CA-16042 and AI-28697, and by the JCCC, the UCLA AIDS Institute, and the David Geffen School of Medicine at UCLA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad C, 2006, CURR TOP MED CHEM, V6, P151, DOI 10.2174/156802606775270288; Abad C, 2002, NEUROIMMUNOMODULAT, V10, P177, DOI 10.1159/000067180; Armstrong BD, 2008, NEUROSCIENCE, V151, P63, DOI 10.1016/j.neuroscience.2007.09.084; Armstrong BD, 2004, NEUROSCIENCE, V129, P93, DOI 10.1016/j.neuroscience.2004.06.085; Banham AH, 2006, TRENDS IMMUNOL, V27, P541, DOI 10.1016/j.it.2006.10.002; Beaudet MM, 1998, J NEUROBIOL, V36, P325, DOI 10.1002/(SICI)1097-4695(19980905)36:3<325::AID-NEU2>3.0.CO;2-Y; Beyersdorf N, 2006, IMMUNOLOGY, V119, P441, DOI 10.1111/j.1365-2567.2006.02455.x; Bilate AM, 2011, ANN REV IMMUNOL; Bodor J, 2012, EUR J IMMUNOL, V42, P1375, DOI 10.1002/eji.201141578; Brudvik KW, 2011, BRIT J PHARMACOL, V5, P411; Chen X, 2009, J IMMUNOL, V183, P6135, DOI 10.4049/jimmunol.0901576; Cheng GY, 2011, IMMUNOL REV, V241, P63, DOI 10.1111/j.1600-065X.2011.01004.x; Delgado M, 1999, J BIOL CHEM, V274, P31930, DOI 10.1074/jbc.274.45.31930; Delgado M, 2005, J IMMUNOL, V175, P7311, DOI 10.4049/jimmunol.175.11.7311; Delgado M, 2004, FASEB J, V18, P1453, DOI 10.1096/fj.04-1548fje; Delgado M, 1999, J NEUROIMMUNOL, V96, P167, DOI 10.1016/S0165-5728(99)00023-5; Delgado M, 2002, FASEB J, V16, P1844, DOI 10.1096/fj.02-0248fje; Delgado M, 2003, J LEUKOCYTE BIOL, V73, P155, DOI 10.1189/jlb.0702372; Delgado M, 2001, Arch Physiol Biochem, V109, P372, DOI 10.1076/apab.109.4.372.4240; Delgado M, 2000, ANN NY ACAD SCI, V921, P68; Delgado M, 2004, PHARMACOL REV, V56, P249, DOI 10.1124/pr.56.2.7; Fernandez-Martin A, 2006, EUR J IMMUNOL, V36, P318, DOI 10.1002/eji.200535430; Fletcher JM, 2010, CLIN EXP IMMUNOL, V162, P1, DOI 10.1111/j.1365-2249.2010.04143.x; GAYTAN F, 1994, CELL TISSUE RES, V276, P223, DOI 10.1007/s004410050084; Hoyer KK, 2008, IMMUNOL REV, V226, P19, DOI 10.1111/j.1600-065X.2008.00697.x; Jadidi-Niaragh F, 2011, SCAND J IMMUNOL, V74, P1, DOI 10.1111/j.1365-3083.2011.02536.x; Kato H, 2004, MULT SCLER J, V10, P651, DOI 10.1191/1352458504ms1096oa; Kohm AP, 2002, J IMMUNOL, V169, P4712, DOI 10.4049/jimmunol.169.9.4712; Korn T, 2007, NAT MED, V13, P423, DOI 10.1038/nm1564; Lang TJ, 2004, CLIN IMMUNOL, V113, P224, DOI 10.1016/j.clim.2004.05.011; Lelievre V, 2006, REGUL PEPTIDES, V137, P58, DOI 10.1016/j.regpep.2006.04.024; Lourenco EV, 2011, AUTOIMMUNITY, V44, P33, DOI 10.3109/08916931003782155; Ma A, 2006, ANNU REV IMMUNOL, V24, P657, DOI 10.1146/annurev.immunol.24.021605.090727; McColl SR, 2004, LAB INVEST, V84, P1418, DOI 10.1038/labinvest.3700155; McGeachy MJ, 2005, J IMMUNOL, V175, P3025, DOI 10.4049/jimmunol.175.5.3025; Mei Q, 1998, NEUROPEPTIDES, V32, P527, DOI 10.1016/S0143-4179(98)90081-6; Mucida D, 2010, ADV IMMUNOL, V107, P139, DOI [10.1016/S0065-2776(10)07007-0, 10.1016/B978-0-12-381300-8.00005-8]; Nance DM, 2007, BRAIN BEHAV IMMUN, V21, P736, DOI 10.1016/j.bbi.2007.03.008; O'Connor RA, 2007, J IMMUNOL, V179, P958, DOI 10.4049/jimmunol.179.2.958; Pettersson LME, 2004, J COMP NEUROL, V471, P85, DOI 10.1002/cne.20015; Reglodi D, 2011, CURR PHARM DESIGN, V17, P962, DOI 10.2174/138161211795589355; Reyes JL, 2011, CELL IMMUNOL, V267, P77, DOI 10.1016/j.cellimm.2010.11.006; Ring S, 2007, J IMMUNOL METHODS, V326, P10, DOI 10.1016/j.jim.2007.06.007; Schrempf W, 2007, AUTOIMMUN REV, V6, P469, DOI 10.1016/j.autrev.2007.02.003; Serezani CH, 2008, AM J RESP CELL MOL, V39, P127, DOI 10.1165/rcmb.2008-0091TR; Shalev I, 2011, SEMIN IMMUNOL, V23, P282, DOI 10.1016/j.smim.2011.04.003; Tan YV, 2011, ASN NEURO, V3, P195, DOI 10.1042/AN20110024; Tan YV, 2009, P NATL ACAD SCI USA, V106, P2012, DOI 10.1073/pnas.0812257106; Vaudry D, 2000, PHARMACOL REV, V52, P269; Vaudry D, 2009, PHARMACOL REV, V61, P283, DOI 10.1124/pr.109.001370; Vendetti S, 2002, J IMMUNOL, V169, P6231, DOI 10.4049/jimmunol.169.11.6231; Vendetti S, 2006, J LEUKOCYTE BIOL, V80, P880, DOI 10.1189/jlb.0106072; Vizzard MA, 2000, J COMP NEUROL, V420, P335; Wainwright Derek A, 2008, J Neurodegener Regen, V1, P31; Wallin HJ, 2003, NEUROSCIENCE, V120, P325, DOI 10.1016/S0306-4522(03)00118-0; Zelenay S, 2010, J IMMUNOL, V185, P3829, DOI 10.4049/jimmunol.1001281; Zhang XM, 2004, INT IMMUNOL, V16, P249, DOI 10.1093/intimm/dxh029; Zhang YZ, 1998, NEUROREPORT, V9, P2833, DOI 10.1097/00001756-199808240-00027; Zhou XR, 1999, J NEUROSCI RES, V57, P953, DOI 10.1002/(SICI)1097-4547(19990915)57:6<953::AID-JNR21>3.0.CO;2-R	59	13	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2013	8	4							e61200	10.1371/journal.pone.0061200	http://dx.doi.org/10.1371/journal.pone.0061200			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130DR	23613811	Green Submitted, Green Published, gold			2022-12-25	WOS:000317893400047
J	Kalisvaart, JP; Goossens, J				Kalisvaart, Joke P.; Goossens, Jeroen			Influence of Retinal Image Shifts and Extra-Retinal Eye Movement Signals on Binocular Rivalry Alternations	PLOS ONE			English	Article							AMBIGUOUS PATTERNS; PERCEPTION; SACCADES; NEURONS; DYNAMICS; BLINKS	Previous studies have indicated that saccadic eye movements correlate positively with perceptual alternations in binocular rivalry, presumably because the foveal image changes resulting from saccades, rather than the eye movement themselves, cause switches in awareness. Recently, however, we found evidence that retinal image shifts elicit so-called onset rivalry and not percept switches as such. These findings raise the interesting question whether onset rivalry may account for correlations between saccades and percept switches. We therefore studied binocular rivalry when subjects made eye movements across a visual stimulus and compared it with the rivalry in a 'replay' condition in which subjects maintained fixation while the same retinal displacements were reproduced by stimulus displacements on the screen. We used dichoptic random-dot motion stimuli viewed through a stereoscope, and measured eye and eyelid movements with scleral search-coils. Positive correlations between retinal image shifts and perceptual switches were observed for both saccades and stimulus jumps, but only for switches towards the subjects' preferred eye at stimulus onset. A similar asymmetry was observed for blink-induced stimulus interruptions. Moreover, for saccades, amplitude appeared crucial as the positive correlation persisted for small stimulus jumps, but not for small saccades (amplitudes < 1 degrees). These findings corroborate our tenet that saccades elicit a form of onset rivalry, and that rivalry is modulated by extra-retinal eye movement signals.	[Kalisvaart, Joke P.; Goossens, Jeroen] Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, Dept Cognit Neurosci,Sect Biophys, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen	Goossens, J (corresponding author), Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, Dept Cognit Neurosci,Sect Biophys, NL-6525 ED Nijmegen, Netherlands.	j.goossens@donders.ru.nl	Goossens, Jeroen/D-7311-2010	Goossens, Jeroen/0000-0001-5522-3437	Netherlands Organisation for Scientific Research (ALW VIDI) [864.06.005]; Radboud University Nijmegen Medical Centre	Netherlands Organisation for Scientific Research (ALW VIDI); Radboud University Nijmegen Medical Centre	This work was supported by Netherlands Organisation for Scientific Research grant 864.06.005 (ALW VIDI) and the Radboud University Nijmegen Medical Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AERTSEN AMHJ, 1989, J NEUROPHYSIOL, V61, P900, DOI 10.1152/jn.1989.61.5.900; Alais D, 2010, CURR BIOL, V20, P1362, DOI 10.1016/j.cub.2010.06.015; Blake R, 2003, NEURON, V39, P869, DOI 10.1016/S0896-6273(03)00495-1; BLAKE RR, 1971, J EXP PSYCHOL, V88, P327, DOI 10.1037/h0030877; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Carter O, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000343; Chong SC, 2006, VISION RES, V46, P1794, DOI 10.1016/j.visres.2005.10.031; COLLEWIJN H, 1975, VISION RES, V15, P447, DOI 10.1016/0042-6989(75)90098-X; Einhauser W, 2004, EUR J NEUROSCI, V20, P2811, DOI 10.1111/j.1460-9568.2004.03722.x; Freeman AW, 2005, J NEUROPHYSIOL, V94, P4412, DOI 10.1152/jn.00557.2005; Gawne TJ, 2002, J NEUROPHYSIOL, V88, P2178, DOI 10.1152/jn.00151.200; GEORGESON MA, 1984, VISION RES, V24, P1311, DOI 10.1016/0042-6989(84)90186-X; GERSTEIN GL, 1960, BIOPHYS J, V1, P15, DOI 10.1016/S0006-3495(60)86872-5; Goossens HHLM, 2010, J NEUROPHYSIOL, V103, P1685, DOI 10.1152/jn.00788.2009; Goossens HHLM, 2000, J NEUROPHYSIOL, V83, P3430, DOI 10.1152/jn.2000.83.6.3430; HALLETT PE, 1976, VISION RES, V16, P107, DOI 10.1016/0042-6989(76)90084-5; Ito J, 2003, PERCEPTION, V32, P681, DOI 10.1068/p5052; Kalisvaart JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020017; Kalisvaart JP, 2011, J VIS, V11, P1, DOI DOI 10.1167/11.1.20.[; Klink PC, 2008, J VISION, V8, DOI 10.1167/8.5.16; LACK LC, 1971, PERCEPT PSYCHOPHYS, V10, P38, DOI 10.3758/BF03205765; Leopold DA, 2002, NAT NEUROSCI, V5, P605, DOI 10.1038/nn0602-851; Mamassian P, 2005, J VISION, V5, P361, DOI 10.1167/5.4.7; McDougall W., 1903, MIND, V12, P473, DOI [DOI 10.1093/MIND/XII.4.473, 10.1093/mind/XII.4.473]; Melcher D, 2005, CURR BIOL, V15, P1745, DOI 10.1016/j.cub.2005.08.044; Noest AJ, 2007, J VISION, V7, DOI 10.1167/7.8.10; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; PERKEL DH, 1967, BIOPHYS J, V7, P419, DOI 10.1016/S0006-3495(67)86597-4; PHEIFFER CH, 1956, AM J PSYCHOL, V69, P452, DOI 10.2307/1419051; PRITCHARD RM, 1958, Q J EXP PSYCHOL, V10, P77, DOI 10.1080/17470215808416259; Ross J, 2004, NAT NEUROSCI, V7, P65, DOI 10.1038/nn1163; SABRIN HW, 1983, PERCEPT PSYCHOPHYS, V34, P155, DOI 10.3758/BF03211341; SABRIN HW, 1980, PERCEPT PSYCHOPHYS, V28, P150, DOI 10.3758/BF03204341; SCOTTO MA, 1990, PERCEPT MOTOR SKILL, V70, P1059; Sundareswara R, 2008, J VIS, V8, P11; van Boxtel JJA, 2008, J VISION, V8, DOI 10.1167/8.5.17; van Dam LCJ, 2006, VISION RES, V46, P787, DOI 10.1016/j.visres.2005.10.011; van Dam LCJ, 2005, VISION RES, V45, P2417, DOI 10.1016/j.visres.2005.03.013; van Dam LCJ, 2006, J VISION, V6, P1172, DOI 10.1167/6.11.3; Ventura V, 2005, J NEUROPHYSIOL, V94, P2940, DOI 10.1152/jn.00645.2004; Wilson HR, 2003, P NATL ACAD SCI USA, V100, P14499, DOI 10.1073/pnas.2333622100	42	6	6	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2013	8	4							e61702	10.1371/journal.pone.0061702	http://dx.doi.org/10.1371/journal.pone.0061702			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123JP	23593494	Green Published, gold, Green Submitted			2022-12-25	WOS:000317385300080
J	Seelig, E; Keller, U; Klarhofer, M; Scheffler, K; Brand, S; Holsboer-Trachsler, E; Hatzinger, M; Bilz, S				Seelig, Eleonora; Keller, Ulrich; Klarhoefer, Markus; Scheffler, Klaus; Brand, Serge; Holsboer-Trachsler, Edith; Hatzinger, Martin; Bilz, Stefan			Neuroendocrine Regulation and Metabolism of Glucose and Lipids in Primary Chronic Insomnia: A Prospective Case-Control Study	PLOS ONE			English	Article							OBSTRUCTIVE SLEEP-APNEA; INSULIN SENSITIVITY; AXIS ACTIVITY; PROTON MR; PREVALENCE; CORTISOL; OBESITY; SPECTROSCOPY; RESTRICTION; OVERWEIGHT	Objectives: To investigate the relation between primary chronic insomnia and insulin sensitivity, visceral adiposity, non alcoholic fatty liver disease and neuroendocrine hormones. Materials and Methods: In a case-controlled, prospective clinical trial 13 women with primary chronic insomnia according to DSM-IV criteria were compared to 12 healthy controls matched for age, sex, BMI, body composition and menopausal status. All participants had a sleep assessment including polysomnographic studies and neuropsychiatric evaluation. Insulin sensitivity was evaluated using the euglycaemic hyperinsulinemic clamp. Hepatic fat content, visceral adipose tissue and intramyocellular lipid accumulation were assessed using magnetic resonance imaging and spectroscopy. The hormonal stress axis was evaluated by measurements of midnight and early morning salivary cortisol, urinary catecholamines and plasma metanephrines. Body composition was determined using body impedance analysis and indirect calorimetry. Results: Although the diagnosis of primary chronic insomnia was made by established clinical criteria, standard polysomongraphic studies failed to identify altered sleep continuity and architecture when compared to matched controls. However, women with primary chronic insomnia showed significantly higher midnight salivary cortisol concentrations (1.46 vs. 0.76 nmol/l, p = 0.02), indicating dysregulation of the hypothalamo-pituitary-adrenal (HPA) axis. Plasma glucose and lipid concentrations, insulin sensitivity, hepatic and intramyocellular fat content, visceral adipose tissue mass and body composition did not differ between the two groups. Conclusion: Healthy women with clinically diagnosed primary chronic insomnia demonstrate a dysregulation of circadian cortisol secretion despite normal sleep continuity and architecture. Increased midnight cortisol levels, however, were not associated with impaired metabolism of glucose and lipids.	[Seelig, Eleonora; Keller, Ulrich] Univ Basel Hosp, CH-4031 Basel, Switzerland; [Klarhoefer, Markus; Scheffler, Klaus] Univ Basel Hosp, Inst Radiol, CH-4031 Basel, Switzerland; [Scheffler, Klaus] Max Planck Inst Biol Cybernet, MRC Dept, D-72076 Tubingen, Germany; [Brand, Serge; Holsboer-Trachsler, Edith; Hatzinger, Martin] Univ Basel, Hosp Psychiat, Ctr Affect Stress & Sleep Disorders, Basel, Switzerland; [Bilz, Stefan] Kantonsspital St Gallen, St Gallen, Switzerland	University of Basel; University of Basel; Max Planck Society; University of Basel	Seelig, E (corresponding author), Univ Basel Hosp, CH-4031 Basel, Switzerland.	seelige@uhbs.ch	Brand, Serge/H-7159-2019	Brand, Serge/0000-0003-2175-2765; Scheffler, Klaus/0000-0001-6316-8773; Bilz, Stefan/0000-0002-7716-2791	University Hospital Basel	University Hospital Basel	The study has been funded by the University Hospital Basel. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boesch C, 2006, NMR BIOMED, V19, P968, DOI 10.1002/nbm.1096; Brand S, 2011, NEUROPSYCHOBIOLOGY, V64, P15, DOI 10.1159/000322456; Buckley TM, 2005, J CLIN ENDOCR METAB, V90, P3106, DOI 10.1210/jc.2004-1056; Buxton OM, 2010, DIABETES, V59, P2126, DOI 10.2337/db09-0699; Cappuccio FP, 2010, DIABETES CARE, V33, P414, DOI 10.2337/dc09-1124; DEFRONZO RA, 1979, AM J PHYSIOL, V237, pE214; Flegal KM, 1998, INT J OBESITY, V22, P39, DOI 10.1038/sj.ijo.0800541; Gottlieb DJ, 2005, ARCH INTERN MED, V165, P863, DOI 10.1001/archinte.165.8.863; Han Kuem Sun, 2012, Exp Neurobiol, V21, P141, DOI 10.5607/en.2012.21.4.141; Harsch IA, 2004, AM J RESP CRIT CARE, V169, P156, DOI 10.1164/rccm.200302-206OC; HOLSBOER F, 1988, NEUROENDOCRINOLOGY, V48, P32, DOI 10.1159/000124986; Keckeis M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009444; Knutson KL, 2007, SLEEP MED REV, V11, P163, DOI 10.1016/j.smrv.2007.01.002; Krystal AD, 2008, SLEEP MED, V9, pS10, DOI 10.1016/S1389-9457(08)70011-X; Kumari M, 2009, J CLIN ENDOCR METAB, V94, P4801, DOI 10.1210/jc.2009-0555; Leproult R, 1997, SLEEP, V20, P865; LONGO R, 1995, JMRI-J MAGN RESON IM, V5, P281, DOI 10.1002/jmri.1880050311; Machann J, 2004, DIABETES OBES METAB, V6, P239, DOI 10.1111/j.1462-8902.2004.00339.x; Nedeltcheva AV, 2009, J CLIN ENDOCR METAB, V94, P3242, DOI 10.1210/jc.2009-0483; Ogden CL, 2002, JAMA-J AM MED ASSOC, V288, P1728, DOI 10.1001/jama.288.14.1728; Ohayon MM, 1997, J PSYCHIATR RES, V31, P333, DOI 10.1016/S0022-3956(97)00002-2; Plat L, 1999, J CLIN ENDOCR METAB, V84, P3082, DOI 10.1210/jc.84.9.3082; Rafalson L, 2010, ANN EPIDEMIOL, V20, P883, DOI 10.1016/j.annepidem.2010.05.002; Rechtschaffen A, 1968, BETHESDA NIH PUBL, V204; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Spiegel K, 1999, LANCET, V354, P1435, DOI 10.1016/S0140-6736(99)01376-8; Spiegel K, 2009, NAT REV ENDOCRINOL, V5, P253, DOI 10.1038/nrendo.2009.23; Staels B, 2006, NAT MED, V12, P54, DOI 10.1038/nm0106-54; Steer RA, 1999, GEN HOSP PSYCHIAT, V21, P106, DOI 10.1016/S0163-8343(98)00070-X; Szczepaniak LS, 1999, AM J PHYSIOL-ENDOC M, V276, pE977, DOI 10.1152/ajpendo.1999.276.5.E977; Tasali E, 2008, CHEST, V133, P496, DOI 10.1378/chest.07-0828; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; West SD, 2006, THORAX, V61, P945, DOI 10.1136/thx.2005.057745	33	33	35	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2013	8	4							e61780	10.1371/journal.pone.0061780	http://dx.doi.org/10.1371/journal.pone.0061780			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123JP	23593497	Green Accepted, Green Published, gold			2022-12-25	WOS:000317385300083
J	Guenther, GG; Liu, G; Ramirez, MU; McMonigle, RJ; Kim, SM; McCracken, AN; Joo, Y; Ushach, I; Nguyen, NL; Edinger, AL				Guenther, G. G.; Liu, G.; Ramirez, M. U.; McMonigle, R. J.; Kim, S. M.; McCracken, A. N.; Joo, Y.; Ushach, I.; Nguyen, N. L.; Edinger, A. L.			Loss of TSC2 confers resistance to ceramide and nutrient deprivation	ONCOGENE			English	Article						TSC2; mTOR; nutrient transporters; 4F2hc; GLUT1; ceramide	ACTIVATED PROTEIN-KINASE; TUBEROUS SCLEROSIS COMPLEX; TSC1-TSC2 COMPLEX; AMINO-ACIDS; INDUCED APOPTOSIS; CELL-GROWTH; TRANSLATIONAL CONTROL; TRANSPORTER PROTEINS; TSC2-NULL CELLS; MESSENGER-RNA	Nutrient stress that produces quiescence and catabolism in normal cells is lethal to cancer cells, because oncogenic mutations constitutively drive anabolism. One driver of biosynthesis in cancer cells is the mammalian target of rapamycin complex 1 (mTORC1) signaling complex. Activating mTORC1 by deleting its negative regulator tuberous sclerosis complex 2 (TSC2) leads to hypersensitivity to glucose deprivation. We have previously shown that ceramide kills cells in part by triggering nutrient transporter loss and restricting access to extracellular amino acids and glucose, suggesting that TSC2-deficient cells would be hypersensitive to ceramide. However, murine embryonic fibroblasts (MEFs) lacking TSC2 were highly resistant to ceramide-induced death. Consistent with the observation that ceramide limits access to both amino acids and glucose, TSC2(-/-) MEFs also had a survival advantage when extracellular amino acids and glucose were both reduced. As TSC2(-/-) MEFs were resistant to nutrient stress despite sustained mTORC1 activity, we assessed whether mTORC1 signaling might be beneficial under these conditions. In low amino acid and glucose medium, and following ceramide-induced nutrient transporter loss, elevated mTORC1 activity significantly enhanced the adaptive upregulation of new transporter proteins for amino acids and glucose. Strikingly, the introduction of oncogenic Ras abrogated the survival advantage of TSC2(-/-) MEFs upon ceramide treatment most likely by increasing nutrient demand. These results suggest that, in the absence of oncogene-driven biosynthetic demand, mTORC1-dependent translation facilitates the adaptive cellular response to nutrient stress.	[Guenther, G. G.; Liu, G.; Ramirez, M. U.; McMonigle, R. J.; Kim, S. M.; McCracken, A. N.; Joo, Y.; Ushach, I.; Nguyen, N. L.; Edinger, A. L.] Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92697 USA	University of California System; University of California Irvine	Edinger, AL (corresponding author), Univ Calif Irvine, Dept Dev & Cell Biol, 2128 Nat Sci 1, Irvine, CA 92697 USA.	aedinger@uci.edu	Liu, Gang/B-7635-2012	Ushach, Irina/0000-0002-3223-4202; Kim, Seong Min/0000-0001-8328-8211	NIH [R01-GM089919]; American Cancer Society grant from the Army Medical Research & Materiel Command [120976-RSG-11-111-01-CDD, W81XWH-11-1-0535]; UCI CORCL [SIIG-1-2007-2008]; National Cancer Institute [T32CA009054]; NATIONAL CANCER INSTITUTE [T32CA009054] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM089919] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society grant from the Army Medical Research & Materiel Command; UCI CORCL; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by NIH R01-GM089919, American Cancer Society grant 120976-RSG-11-111-01-CDD, W81XWH-11-1-0535 from the Army Medical Research & Materiel Command, and SIIG-1-2007-2008 from the UCI CORCL to ALE. GGG and ANM were supported by grant number T32CA009054 from the National Cancer Institute.	Aronova S, 2008, CELL METAB, V7, P148, DOI 10.1016/j.cmet.2007.11.015; Avruch J, 2009, AM J PHYSIOL-ENDOC M, V296, pE592, DOI 10.1152/ajpendo.90645.2008; Bain PJ, 2002, J NUTR, V132, P3023, DOI 10.1093/jn/131.10.3023; Bhaskar PT, 2009, MOL CELL BIOL, V29, P5136, DOI 10.1128/MCB.01946-08; Bhattacharyya SN, 2006, CELL, V125, P1111, DOI 10.1016/j.cell.2006.04.031; Brugarolas JB, 2003, CANCER CELL, V4, P147, DOI 10.1016/S1535-6108(03)00187-9; Choo AY, 2010, MOL CELL, V38, P487, DOI 10.1016/j.molcel.2010.05.007; Curatolo P, 2008, LANCET, V372, P657, DOI 10.1016/S0140-6736(08)61279-9; Dazert E, 2011, CURR OPIN CELL BIOL, V23, P744, DOI 10.1016/j.ceb.2011.09.003; Dibble CC, 2012, MOL CELL, V47, P535, DOI 10.1016/j.molcel.2012.06.009; DOBROWSKY RT, 1993, J BIOL CHEM, V268, P15523; Duran RV, 2012, EMBO REP, V13, P121, DOI 10.1038/embor.2011.257; Edinger AL, 2004, ONCOGENE, V23, P5654, DOI 10.1038/sj.onc.1207738; Edinger AL, 2002, MOL BIOL CELL, V13, P2276, DOI 10.1091/mbc.01-12-0584; Fernandez J, 2001, J BIOL CHEM, V276, P12285, DOI 10.1074/jbc.M009714200; Gaccioli F, 2006, J BIOL CHEM, V281, P17929, DOI 10.1074/jbc.M600341200; Gao XS, 2002, NAT CELL BIOL, V4, P699, DOI 10.1038/ncb847; Gazzola RF, 2001, FEBS LETT, V490, P11; Guenther GG, 2008, P NATL ACAD SCI USA, V105, P17402, DOI 10.1073/pnas.0802781105; Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Harrington LS, 2004, J CELL BIOL, V166, P213, DOI 10.1083/jcb.200403069; Huang JX, 2008, MOL CELL BIOL, V28, P4104, DOI 10.1128/MCB.00289-08; Huang J, 2008, BIOCHEM J, V412, P179, DOI 10.1042/BJ20080281; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Jewell JL, 2013, NAT REV MOL CELL BIO, V14, P133, DOI 10.1038/nrm3522; Kanai Y, 1998, J BIOL CHEM, V273, P23629, DOI 10.1074/jbc.273.37.23629; Kang YJ, 2011, CELL DEATH DIFFER, V18, P133, DOI 10.1038/cdd.2010.82; Kaper F, 2006, CANCER RES, V66, P1561, DOI 10.1158/0008-5472.CAN-05-3375; Kim E, 2008, NAT CELL BIOL, V10, P935, DOI 10.1038/ncb1753; Kim J, 2011, ANNU REV BIOCHEM, V80, P1001, DOI 10.1146/annurev-biochem-062209-094414; Kim SG, 2013, MOL CELL, V49, P172, DOI 10.1016/j.molcel.2012.10.003; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Lacher MD, 2010, ONCOGENE, V29, P6543, DOI 10.1038/onc.2010.393; Le Stunff H, 2007, J BIOL CHEM, V282, P34372, DOI 10.1074/jbc.M703329200; Li BH, 2010, CANCER CELL, V17, P469, DOI 10.1016/j.ccr.2010.03.019; Manel N, 2003, CELL, V115, P449, DOI 10.1016/S0092-8674(03)00881-X; Matsumoto S, 2002, GENETICS, V161, P1053; Menon S, 2008, Oncogene, V27 Suppl 2, pS43, DOI 10.1038/onc.2009.352; Ng S, 2011, AUTOPHAGY, V7, P1173, DOI 10.4161/auto.7.10.16681; Nobukuni T, 2005, P NATL ACAD SCI USA, V102, P14238, DOI 10.1073/pnas.0506925102; Ogretmen B, 2004, NAT REV CANCER, V4, P604, DOI 10.1038/nrc1411; Ogretmen B, 2002, J BIOL CHEM, V277, P12960, DOI 10.1074/jbc.M110699200; Park NS, 2008, ANTICANCER RES, V28, P2649; Parkhitko A, 2011, P NATL ACAD SCI USA, V108, P12455, DOI 10.1073/pnas.1104361108; Pende M, 2004, MOL CELL BIOL, V24, P3112, DOI 10.1128/MCB.24.8.3112-3124.2004; Roccio M, 2006, ONCOGENE, V25, P657, DOI 10.1038/sj.onc.1209106; Rosales KR, 2011, BIOCHEM J, V439, P299, DOI 10.1042/BJ20110853; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Schubert KM, 2000, J BIOL CHEM, V275, P13330, DOI 10.1074/jbc.275.18.13330; Shah OJ, 2006, MOL CELL BIOL, V26, P6425, DOI 10.1128/MCB.01254-05; Shaw RJ, 2004, CANCER CELL, V6, P91, DOI 10.1016/j.ccr.2004.06.007; Short JD, 2008, CANCER RES, V68, P6496, DOI 10.1158/0008-5472.CAN-07-5756; Tee AR, 2003, CURR BIOL, V13, P1259, DOI 10.1016/S0960-9822(03)00506-2; Teske BF, 2011, METHOD ENZYMOL, V490, P333, DOI 10.1016/B978-0-12-385114-7.00019-2; Tremblay F, 2007, P NATL ACAD SCI USA, V104, P14056, DOI 10.1073/pnas.0706517104; Wek RC, 2006, BIOCHEM SOC T, V34, P7, DOI 10.1042/BST0340007; Yecies JL, 2011, J MOL MED, V89, P221, DOI 10.1007/s00109-011-0726-6; Yuan HX, 2013, MOL CELL, V49, P379, DOI 10.1016/j.molcel.2013.01.019; Zhang HH, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0006189, 10.1371/journal.pone.0007826]; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505; Zhou HL, 1998, J BIOL CHEM, V273, P16568, DOI 10.1074/jbc.273.26.16568	64	15	15	1	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 3	2014	33	14					1776	1787		10.1038/onc.2013.139	http://dx.doi.org/10.1038/onc.2013.139			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AE9RE	23604129	Green Accepted			2022-12-25	WOS:000334345500004
J	Hong, WMC; Amara, SG				Hong, Weimin C.; Amara, Susan G.			Differential targeting of the dopamine transporter to recycling or degradative pathways during amphetamine- or PKC-regulated endocytosis in dopamine neurons	FASEB JOURNAL			English	Article						ubiquitination; internalization; endosome sorting; fluorescence imaging	RECEPTOR TRAFFICKING; SURFACE EXPRESSION; XENOPUS OOCYTES; CELL-LINES; MEMBRANE; INTERNALIZATION; MICROSCOPY; MECHANISM; BINDING; METHAMPHETAMINE	The dopamine transporter (DAT) clears the extracellular dopamine released during neurotransmission and is a major target for both therapeutic and addictive psychostimulant amphetamines. Amphetamine exposure or activation of protein kinase C (PKC) by the phorbol ester PMA has been shown to down-regulate cell surface DAT. However, in dopamine neurons, the trafficking itinerary and fate of internalized DAT has not been elucidated. By monitoring surface-labeled DAT in transfected dopamine neurons from embryonic rat mesencephalic cultures, we find distinct sorting and fates of internalized DAT after amphetamine or PMA treatment. Although both drugs promote DAT internalization above constitutive endocytosis in dopamine neurons, PMA induces ubiquitination of DAT and leads to accumulation of DAT on LAMP1-positive endosomes. In contrast, after amphetamine exposure DAT is sorted to recycling endosomes positive for Rab11 and the transferrin receptor. Furthermore, quantitative assessment of DAT recycling using an antibody-feeding assay reveals that significantly less DAT returns to the surface of dopamine neurons after internalization by PMA, compared with vehicle or amphetamine treatment. These results demonstrate that, in neurons, the DAT is sorted differentially to recycling and degradative pathways after psychostimulant exposure or PKC activation, which may allow for either the transient or sustained inhibition of DAT during dopamine neurotransmission.	[Hong, Weimin C.; Amara, Susan G.] Univ Pittsburgh, Dept Neurobiol, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Amara, SG (corresponding author), NIMH, Ctr Dr, 10 Ctr Dr,Room 4N222, Bethesda, MD 20814 USA.	susan.amara@nih.gov		Amara, Susan/0000-0001-8914-1106	American Recovery and Reinvestment Act funds; U.S. National Institutes of Health [DA07595]; NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002946] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R37DA007595, R01DA007595] Funding Source: NIH RePORTER	American Recovery and Reinvestment Act funds; U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The authors thank Yong-Jian Liu, Alexander Sorkin, Willi Halfter, Geoff Murdoch, Mee Choi, Linton Traub, Ora Weisz, Gerald Apodaca, and Katy Baty (University of Pittsburgh, Pittsburgh, PA, USA) for valuable suggestions or various DNA constructs and antibodies. The authors also appreciate critiques from Spencer Watts, Mads Larsen, Ethan Block, Jie Jiang, and other members of the S.G.A. laboratory. This work was supported by American Recovery and Reinvestment Act funds and a U.S. National Institutes of Health grant (DA07595) to S.G.A.	Baker R., 1995, NEURAL CELL CULTURE, P25; Blot Vincent, 2008, V457, P347, DOI 10.1007/978-1-59745-261-8-26; Bogdanov Y, 2006, EMBO J, V25, P4381, DOI 10.1038/sj.emboj.7601309; Boudanova E, 2008, NEUROPHARMACOLOGY, V54, P605, DOI 10.1016/j.neuropharm.2007.11.007; Carvelli L, 2002, J NEUROCHEM, V81, P859, DOI 10.1046/j.1471-4159.2002.00892.x; Chi LM, 2003, J PHARMACOL EXP THER, V307, P729, DOI 10.1124/jpet.103.055095; Cremona ML, 2011, NAT NEUROSCI, V14, P469, DOI 10.1038/nn.2781; Daniels GM, 1999, J BIOL CHEM, V274, P35794, DOI 10.1074/jbc.274.50.35794; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; Doolen S, 2001, J PHARMACOL EXP THER, V296, P931; Eriksen J, 2010, J BIOL CHEM, V285, P27289, DOI 10.1074/jbc.M110.131003; Fleckenstein AE, 1997, J PHARMACOL EXP THER, V282, P834; Fleckenstein AE, 2007, ANNU REV PHARMACOL, V47, P681, DOI 10.1146/annurev.pharmtox.47.120505.105140; Foster JD, 2008, J NEUROCHEM, V105, P1683, DOI 10.1111/j.1471-4159.2008.05262.x; Furman CA, 2009, J NEUROSCI, V29, P3328, DOI 10.1523/JNEUROSCI.5386-08.2009; Garcia BG, 2005, MOL PHARMACOL, V68, P102, DOI 10.1124/mol.104.009092; German CL, 2012, J NEUROCHEM, V123, P288, DOI 10.1111/j.1471-4159.2012.07875.x; Holton KL, 2005, NAT NEUROSCI, V8, P881, DOI 10.1038/nn1478; Hong WC, 2010, J BIOL CHEM, V285, P32616, DOI 10.1074/jbc.M110.150565; Jiang M, 2006, NAT PROTOC, V1, P695, DOI 10.1038/nprot.2006.86; Johnson LA, 2005, NEUROPHARMACOLOGY, V49, P750, DOI 10.1016/j.neuropharm.2005.08.018; Kantor L, 1998, J PHARMACOL EXP THER, V284, P592; Loder MK, 2003, J BIOL CHEM, V278, P22168, DOI 10.1074/jbc.M301845200; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Matthies HJG, 2010, J NEUROSCI, V30, P7863, DOI 10.1523/JNEUROSCI.4574-09.2010; Melikian HE, 1999, J NEUROSCI, V19, P7699; MELLMAN I, 1984, J CELL BIOL, V98, P1163, DOI 10.1083/jcb.98.4.1163; Miranda M, 2007, MOL BIOL CELL, V18, P313, DOI 10.1091/mbc.E06-08-0704; Moron JA, 2003, J NEUROSCI, V23, P8480; Mortensen OV, 2008, MOL BIOL CELL, V19, P2818, DOI 10.1091/mbc.E07-09-0980; Park M, 2004, SCIENCE, V305, P1972, DOI 10.1126/science.1102026; Rao A, 2012, FASEB J, V26, P1921, DOI 10.1096/fj.11-196113; Rao A, 2011, MOL CELL NEUROSCI, V46, P148, DOI 10.1016/j.mcn.2010.08.016; Sakrikar D, 2012, J NEUROSCI, V32, P5385, DOI 10.1523/JNEUROSCI.6033-11.2012; Saunders C, 2000, P NATL ACAD SCI USA, V97, P6850, DOI 10.1073/pnas.110035297; Scott DB, 2004, J NEUROSCI, V24, P7096, DOI 10.1523/JNEUROSCI.0780-04.2004; Sekine-Aizawa Y, 2004, P NATL ACAD SCI USA, V101, P17114, DOI 10.1073/pnas.0407563101; Sorkina T, 2005, TRAFFIC, V6, P157, DOI 10.1111/j.1600-0854.2005.00259.x; Sorkina T, 2003, J BIOL CHEM, V278, P28274, DOI 10.1074/jbc.M210652200; Sorkina T, 2006, J NEUROSCI, V26, P8195, DOI 10.1523/JNEUROSCI.1301-06.2006; Sulzer D, 2011, NEURON, V69, P628, DOI 10.1016/j.neuron.2011.02.010; Tang TTT, 2010, J BIOL CHEM, V285, P20975, DOI 10.1074/jbc.M110.102210; Wanat MJ, 2008, J PHYSIOL-LONDON, V586, P2157, DOI 10.1113/jphysiol.2007.150078; Wheeler D. S., 2011, NEUROSCIENCE; Zhu SJ, 1997, J PHARMACOL EXP THER, V282, P1358	45	46	47	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2013	27	8					2995	3007		10.1096/fj.12-218727	http://dx.doi.org/10.1096/fj.12-218727			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	292BT	23612789	Green Published			2022-12-25	WOS:000329877600008
J	Ehteshami, M; Nijhuis, M; Bernatchez, JA; Ablenas, CJ; McCormick, S; de Jong, D; Jochmans, D; Gotte, M				Ehteshami, Maryam; Nijhuis, Monique; Bernatchez, Jean A.; Ablenas, Christopher J.; McCormick, Suzanne; de Jong, Dorien; Jochmans, Dirk; Goette, Matthias			Formation of a Quaternary Complex of HIV-1 Reverse Transcriptase with a Nucleotide-competing Inhibitor and Its ATP Enhancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; DEPENDENT PRIMER UNBLOCKING; DRUG-RESISTANCE; POLYMERASE TRANSLOCATION; DNA-POLYMERASE; ZIDOVUDINE RESISTANCE; MOLECULAR-MECHANISMS; ANALOG INHIBITORS; RATCHET MODEL; MUTATIONS	Nucleotide-competing reverse transcriptase inhibitors were shown to bind reversibly to the nucleotide-binding site of the reverse transcriptase (RT) enzyme of human immunodeficiency virus type 1 (HIV-1). Here, we show that the presence of ATP can enhance the inhibitory effects of the prototype compound INDOPY-1. We employed a combination of cell-free and cell-based assays to shed light on the underlying molecular mechanism. Binding studies and site-specific footprinting experiments demonstrate the existence of a stable quaternary complex with HIV-1 RT, its nucleic acid substrate, INDOPY-1, and ATP. The complex is frozen in the post-translocational state that usually accommodates the incoming nucleotide substrate. Structure-activity relationship studies show that both the base and the phosphate moieties of ATP are elements that play important roles in enhancing the inhibitory effects of INDOPY-1. In vitro susceptibility measurements with mutant viruses containing amino acid substitutions K70G, V75T, L228R, and K219R in the putative ATP binding pocket revealed unexpectedly a hypersusceptible phenotype with respect to INDOPY-1. The same mutational cluster was previously shown to reduce susceptibility to the pyrophosphate analog phosphonoformic acid. However, in the absence of INDOPY-1, ATP can bind and act as a pyrophosphate donor under conditions that favor formation of the pre-translocated RT complex. We therefore conclude that the mutant enzyme facilitates simultaneous binding of INDOPY-1 and ATP to the post-translocated complex. Based on these data, we propose a model in which the bound ATP traps the inhibitor, which, in turn, compromises its dissociation.	[Ehteshami, Maryam; McCormick, Suzanne; Goette, Matthias] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ H3A 2B4, Canada; [Bernatchez, Jean A.; Ablenas, Christopher J.; Goette, Matthias] McGill Univ, Dept Biochem, Montreal, PQ H3A 2B4, Canada; [Goette, Matthias] McGill Univ, Dept Med, Montreal, PQ H3A 2B4, Canada; [Nijhuis, Monique; de Jong, Dorien] Univ Med Ctr Utrecht, Dept Med Microbiol, NL-3584 CX Utrecht, Netherlands; [Jochmans, Dirk] Univ Louvain, Rega Inst Med Res, B-3000 Louvain, Belgium	McGill University; McGill University; McGill University; Utrecht University; Utrecht University Medical Center; KU Leuven	Gotte, M (corresponding author), McGill Univ, Dept Microbiol & Immunol, Duff Med Bldg D-6,3775 Univ St, Montreal, PQ H3A 2B4, Canada.	matthias.gotte@mcgill.ca	JOCHMANS, DIRK/T-6223-2017	JOCHMANS, DIRK/0000-0002-9265-6028; Bernatchez, Jean/0000-0002-8309-1627	Canadian Institutes of Health Research, Tibotec; Netherlands Organisation for Scientific Research VIDI [91796349]; Canadian Institutes of Health Research doctoral research award; Fonds de la Recherche en Sante du Quebec; Canadian Institutes of Health Research Strategic Training Initiative in Chemical Biology	Canadian Institutes of Health Research, Tibotec(Canadian Institutes of Health Research (CIHR)); Netherlands Organisation for Scientific Research VIDI(Netherlands Organization for Scientific Research (NWO)); Canadian Institutes of Health Research doctoral research award(Canadian Institutes of Health Research (CIHR)); Fonds de la Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec); Canadian Institutes of Health Research Strategic Training Initiative in Chemical Biology(Canadian Institutes of Health Research (CIHR))	This work was supported in part by the Canadian Institutes of Health Research, Tibotec, and Netherlands Organisation for Scientific Research VIDI Grant 91796349.; Recipient of a Canadian Institutes of Health Research doctoral research award. Present address: Dept. of Pediatrics, Emory University/Veterans Affairs Medical Hospital, Decatur, GA 30033.; Recipient of a doctoral training award from the Fonds de la Recherche en Sante du Quebec and supported by the Canadian Institutes of Health Research Strategic Training Initiative in Chemical Biology.; Recipient of a career award from the Fonds de la Recherche en Sante du Quebec. To whom correspondence should be addressed: McGill University, Dept. of Microbiology and Immunology, Duff Medical Bldg. (D-6), 3775 University St., Montreal, Quebec H3A 2B4, Canada. Tel.: 514-398-1365; Fax: 514-398-7052; E-mail: matthias.gotte@mcgill.ca.	ARTS EJ, 1994, J BIOL CHEM, V269, P14672; Auger A, 2011, J BIOL CHEM, V286, P29575, DOI 10.1074/jbc.M111.268235; Basavapathruni A, 2007, FASEB J, V21, P3795, DOI 10.1096/fj.07-8697rev; Boucher CAB, 1996, ANTIMICROB AGENTS CH, V40, P2404, DOI 10.1128/AAC.40.10.2404; Boyer PL, 2001, J VIROL, V75, P4832, DOI 10.1128/JVI.75.10.4832-4842.2001; Bradshaw D, 2007, ANTIMICROB AGENTS CH, V51, P4489, DOI 10.1128/AAC.00687-07; Cases-Gonzalez CE, 2000, J BIOL CHEM, V275, P19759, DOI 10.1074/jbc.M910361199; Cauchon E, 2011, J BIOMOL SCREEN, V16, P518, DOI 10.1177/1087057111402201; Ehteshami M, 2008, J BIOL CHEM, V283, P29904, DOI 10.1074/jbc.M804882200; Ehteshami M, 2008, AIDS REV, V10, P224; Feng JY, 1999, BIOCHEMISTRY-US, V38, P9440, DOI 10.1021/bi990709m; Gao GX, 1997, P NATL ACAD SCI USA, V94, P407, DOI 10.1073/pnas.94.2.407; Gotte M, 2006, CURR PHARM DESIGN, V12, P1867, DOI 10.2174/138161206776873626; Goldschmidt V, 2004, INT J BIOCHEM CELL B, V36, P1687, DOI 10.1016/j.biocel.2004.02.028; Gotte M, 1999, J BIOL CHEM, V274, P11159, DOI 10.1074/jbc.274.16.11159; Gotte Matthias, 2004, Expert Rev Anti Infect Ther, V2, P707, DOI 10.1586/14789072.2.5.707; Hammond JL, 2001, ANTIMICROB AGENTS CH, V45, P1621, DOI 10.1128/AAC.45.6.1621-1628.2001; Huang HF, 1998, SCIENCE, V282, P1669, DOI 10.1126/science.282.5394.1669; Jochmans D, 2008, VIRUS RES, V134, P171, DOI 10.1016/j.virusres.2008.01.003; Jochmans D, 2006, J VIROL, V80, P12283, DOI 10.1128/JVI.00889-06; Kisic M, 2011, J BIOL CHEM, V286, P20615, DOI 10.1074/jbc.M111.226100; LEGRICE SFJ, 1990, EUR J BIOCHEM, V187, P307, DOI 10.1111/j.1432-1033.1990.tb15306.x; Marchand B, 2004, INT J BIOCHEM CELL B, V36, P1823, DOI 10.1016/j.biocel.2004.02.029; Marchand B, 2003, J BIOL CHEM, V278, P35362, DOI 10.1074/jbc.M304262200; Marchand B, 2007, ANTIMICROB AGENTS CH, V51, P2911, DOI 10.1128/AAC.00314-07; Marchand B, 2007, J BIOL CHEM, V282, P3337, DOI 10.1074/jbc.M607710200; Mathiesen S, 2007, ANTIVIR THER, V12, P335; MELLORS JW, 1995, ANTIMICROB AGENTS CH, V39, P1087, DOI 10.1128/AAC.39.5.1087; Menendez-Arias L, 2008, VIRUS RES, V134, P124, DOI 10.1016/j.virusres.2007.12.015; Meyer PR, 2003, J VIROL, V77, P3871, DOI 10.1128/JVI.77.6.3871-3877.2003; Meyer PR, 2002, ANTIMICROB AGENTS CH, V46, P1540, DOI 10.1128/AAC.46.5.1540-1545.2002; Meyer PR, 1999, MOL CELL, V4, P35, DOI 10.1016/S1097-2765(00)80185-9; Meyer PR, 1998, P NATL ACAD SCI USA, V95, P13471, DOI 10.1073/pnas.95.23.13471; Ray AS, 2003, BIOCHEMISTRY-US, V42, P8831, DOI 10.1021/bi034435l; Sarafianos SG, 1999, CHEM BIOL, V6, pR137, DOI 10.1016/S1074-5521(99)80071-4; Sarafianos SG, 2003, J BIOL CHEM, V278, P16280, DOI 10.1074/jbc.M212911200; Sarafianos SG, 2002, EMBO J, V21, P6614, DOI 10.1093/emboj/cdf637; Sarafianos SG, 2009, J MOL BIOL, V385, P693, DOI 10.1016/j.jmb.2008.10.071; Scarth B, 2011, J MOL BIOL, V405, P349, DOI 10.1016/j.jmb.2010.10.009; Sluis-Cremer N, 2008, VIRUS RES, V134, P147, DOI 10.1016/j.virusres.2008.01.002; Smith AJ, 2005, ANTIMICROB AGENTS CH, V49, P1761, DOI 10.1128/AAC.49.5.1761-1769.2005; TACHEDJIAN G, 1995, VIROLOGY, V212, P58, DOI 10.1006/viro.1995.1453; TISDALE M, 1993, P NATL ACAD SCI USA, V90, P5653, DOI 10.1073/pnas.90.12.5653; Tu XY, 2010, NAT STRUCT MOL BIOL, V17, P1202, DOI 10.1038/nsmb.1908; van Maarseveen NM, 2006, J VIROL METHODS, V133, P185, DOI 10.1016/j.jviromet.2005.11.008; Wainberg MA, 1996, AIDS, V10, pS3, DOI 10.1097/00002030-199612005-00002; Zahn KE, 2011, J BIOL CHEM, V286, P25246, DOI 10.1074/jbc.M111.248864; Zhang ZJ, 2006, ANTIMICROB AGENTS CH, V50, P2772, DOI 10.1128/AAC.00127-06	48	14	14	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2013	288	24					17336	17346		10.1074/jbc.M112.433441	http://dx.doi.org/10.1074/jbc.M112.433441			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	164AH	23598281	Green Published, hybrid			2022-12-25	WOS:000320380600027
J	Jha, KN; Coleman, AR; Wong, L; Salicioni, AM; Howcroft, E; Johnson, GR				Jha, Kula N.; Coleman, Alyssa R.; Wong, Lily; Salicioni, Ana M.; Howcroft, Elizabeth; Johnson, Gibbes R.			Heat Shock Protein 90 Functions to Stabilize and Activate the Testis-specific Serine/Threonine Kinases, a Family of Kinases Essential for Male Fertility	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHAPERONE MACHINERY; HSP90 FUNCTION; GERM-CELLS; IN-VIVO; DEGRADATION; MOUSE; GELDANAMYCIN; EXPRESSION; PROTEASOME; INHIBITOR	Spermiogenesis is characterized by a profound morphological differentiation of the haploid spermatid into spermatozoa. The testis-specific serine/ threonine kinases (TSSKs) comprise a family of post-meiotic kinases expressed in spermatids, are critical to spermiogenesis, and are required for male fertility in mammals. To explore the role of heat shock protein 90 (HSP90) in regulation of TSSKs, the stability and catalytic activity of epitope-tagged murine TSSKs were assessed in 293T and COS-7 cells. TSSK1, -2, -4, and -6 (small serine/threonine kinase) were all found to associate with HSP90, and pharmacological inhibition of HSP90 function using the highly specific drugs 17-AAG, SNX-5422, or NVP-AUY922 reduced TSSK protein levels in cells. The attenuation of HSP90 function abolished the catalytic activities of TSSK4 and -6 but did not significantly alter the specific activities of TSSK1 and -2. Inhibition of HSP90 resulted in increased TSSK ubiquitination and proteasomal degradation, indicating that HSP90 acts to control ubiquitin-mediated catabolism of the TSSKs. To study HSP90 and TSSKs in germ cells, a mouse primary spermatid culture model was developed and characterized. Using specific antibodies against murine TSSK2 and -6, it was demonstrated that HSP90 inhibition resulted in a marked decrease of the endogenous kinases in spermatids. Together, our findings demonstrate that HSP90 plays a broad and critical role in stabilization and activation of the TSSK family of protein kinases.	[Jha, Kula N.; Coleman, Alyssa R.; Wong, Lily; Howcroft, Elizabeth; Johnson, Gibbes R.] US FDA, Div Therapeut Prot, Ctr Drug Evaluat & Res, Bethesda, MD 20892 USA; [Salicioni, Ana M.] Univ Massachusetts, Dept Vet & Anim Sci, Amherst, MA 01003 USA	US Food & Drug Administration (FDA); University of Massachusetts System; University of Massachusetts Amherst	Jha, KN (corresponding author), US FDA, Div Therapeut Prot, Ctr Drug Evaluat & Res, 29 Lincoln Dr,Bldg 29A,HFD 122, Bethesda, MD 20892 USA.	kula.jha@fda.hhs.gov; gibbes.johnson@fda.hhs.gov	Salicioni, Ana Maria/ABD-8384-2021	Salicioni, Ana Maria/0000-0002-8951-3587	A.R.C	A.R.C(Fondation ARC pour la Recherche sur le CancerAustralian Research Council)	This work was supported in part by an appointment of A.R.C. to the ORISE Research Participation Program at the Center for Drug Evaluation and Research (CDER) administered by the Oak Ridge Institute for Science and Education through an agreement between the United States Department of Energy and CDER.	An WG, 2000, CELL GROWTH DIFFER, V11, P355; Baker MA, 2011, J PROTEOME RES, V10, P1004, DOI 10.1021/pr1007224; Baldo B, 2012, J BIOL CHEM, V287, P1406, DOI 10.1074/jbc.M111.294801; Basso AD, 2002, J BIOL CHEM, V277, P39858, DOI 10.1074/jbc.M206322200; Belle A, 2006, P NATL ACAD SCI USA, V103, P13004, DOI 10.1073/pnas.0605420103; BELLVE AR, 1993, METHOD ENZYMOL, V225, P84; BLAGOSKLONNY MV, 1995, ONCOGENE, V11, P933; Bucko-Justyna M, 2005, FEBS J, V272, P6310, DOI 10.1111/j.1742-4658.2005.05018.x; Chandarlapaty S, 2008, CLIN CANCER RES, V14, P240, DOI 10.1158/1078-0432.CCR-07-1667; Cheng CY, 2002, PHYSIOL REV, V82, P825, DOI 10.1152/physrev.00009.2002; Ciechanover A, 1998, EMBO J, V17, P7151, DOI 10.1093/emboj/17.24.7151; Eddy EM, 1998, CURR TOP DEV BIOL, V37, P141; Ehrlich ES, 2009, P NATL ACAD SCI USA, V106, P20330, DOI 10.1073/pnas.0810571106; Escalier D, 2003, MOL REPROD DEV, V66, P190, DOI 10.1002/mrd.10346; Faresse N, 2010, AM J PHYSIOL-RENAL, V299, pF1462, DOI 10.1152/ajprenal.00285.2010; Grad I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015770; GRISWOLD MD, 1995, BIOL REPROD, V52, P211, DOI 10.1095/biolreprod52.2.211; Jha KN, 2010, J BIOL CHEM, V285, P35180, DOI 10.1074/jbc.M110.134767; KIERSZENBAUM AL, 1975, J CELL BIOL, V65, P258, DOI 10.1083/jcb.65.2.258; La Salle S, 2009, METHODS MOL BIOL, V558, P279, DOI 10.1007/978-1-60761-103-5_17; Lewis J, 2000, J BIOL CHEM, V275, P10519, DOI 10.1074/jbc.275.14.10519; Li YH, 2011, MOL HUM REPROD, V17, P42, DOI 10.1093/molehr/gaq071; Lim KL, 2005, J NEUROSCI, V25, P2002, DOI 10.1523/JNEUROSCI.4474-04.2005; LUTHMAN H, 1983, NUCLEIC ACIDS RES, V11, P1295, DOI 10.1093/nar/11.5.1295; Marubayashi S, 2010, J CLIN INVEST, V120, P3578, DOI 10.1172/JCI42442; Meacham GC, 2001, NAT CELL BIOL, V3, P100, DOI 10.1038/35050509; Meng LH, 1999, P NATL ACAD SCI USA, V96, P10403, DOI 10.1073/pnas.96.18.10403; Ogurtsov AY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003599; Ortega S, 2003, NAT GENET, V35, P25, DOI 10.1038/ng1232; Panaretou B, 1998, EMBO J, V17, P4829, DOI 10.1093/emboj/17.16.4829; Pedersen AG, 1997, ISMB-97 - FIFTH INTERNATIONAL CONFERENCE ON INTELLIGENT SYSTEMS FOR MOLECULAR BIOLOGY, PROCEEDINGS, P226; Pratt WB, 2003, EXP BIOL MED, V228, P111, DOI 10.1177/153537020322800201; Rajan A, 2012, CLIN CANCER RES, V18, P2344, DOI 10.1158/1078-0432.CCR-11-2425; SCHULTE TW, 1995, J BIOL CHEM, V270, P24585, DOI 10.1074/jbc.270.41.24585; Segnitz B, 1997, J BIOL CHEM, V272, P18694, DOI 10.1074/jbc.272.30.18694; Shang P, 2010, J CELL SCI, V123, P331, DOI 10.1242/jcs.059949; Sosnik J, 2009, J CELL SCI, V122, P2741, DOI 10.1242/jcs.047225; Spiridonov NA, 2005, MOL CELL BIOL, V25, P4250, DOI 10.1128/MCB.25.10.4250-4261.2005; Taipale M, 2012, CELL, V150, P987, DOI 10.1016/j.cell.2012.06.047; Tikhomirov O, 2000, J BIOL CHEM, V275, P26625, DOI 10.1074/jbc.M003114200; van de Kooij B, 2013, J BIOL CHEM, V288, P6617, DOI 10.1074/jbc.M112.448209; Wandinger SK, 2008, J BIOL CHEM, V283, P18473, DOI 10.1074/jbc.R800007200; Waza M, 2005, NAT MED, V11, P1088, DOI 10.1038/nm1298; Wu JY, 2000, NAT GENET, V25, P448, DOI 10.1038/78153; Xu BF, 2008, DEV BIOL, V319, P211, DOI 10.1016/j.ydbio.2008.03.047; Young JC, 2001, J CELL BIOL, V154, P267, DOI 10.1083/jcb.200104079	46	27	27	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2013	288	23					16308	16320		10.1074/jbc.M112.400978	http://dx.doi.org/10.1074/jbc.M112.400978			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	163ZU	23599433	Green Published, hybrid			2022-12-25	WOS:000320378900010
J	Poon, WW; Carlos, AJ; Aguilar, BL; Berchtold, NC; Kawano, CK; Zograbyan, V; Yaopruke, T; Shelanski, M; Cotman, CW				Poon, Wayne W.; Carlos, Anthony J.; Aguilar, Brittany L.; Berchtold, Nicole C.; Kawano, Crystal K.; Zograbyan, Vahe; Yaopruke, Tim; Shelanski, Michael; Cotman, Carl W.			beta-Amyloid (A beta) Oligomers Impair Brain-derived Neurotrophic Factor Retrograde Trafficking by Down-regulating Ubiquitin C-terminal Hydrolase, UCH-L1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; BDNF KNOCKOUT MICE; AXONAL-TRANSPORT; ALZHEIMERS-DISEASE; HIPPOCAMPAL-NEURONS; CORTICAL-NEURONS; TRANSGENIC MICE; DEGRADATION; EXPRESSION; PROTEASOME	We previously found that BDNF-dependent retrograde trafficking is impaired in AD transgenic mouse neurons. Utilizing a novel microfluidic culture chamber, we demonstrate that A beta oligomers compromise BDNF-mediated retrograde transport by impairing endosomal vesicle velocities, resulting in impaired downstream signaling driven by BDNF/TrkB, including ERK5 activation, and CREB-dependent gene regulation. Our data suggest that a key mechanism mediating the deficit involves ubiquitin C-terminal hydrolase L1 (UCH-L1), a deubiquitinating enzyme that functions to regulate cellular ubiquitin. A beta-induced deficits in BDNF trafficking and signaling are mimicked by LDN (an inhibitor of UCH-L1) and can be reversed by increasing cellular UCH-L1 levels, demonstrated here using a transducible TAT-UCH-L1 strategy. Finally, our data reveal that UCH-L1 mRNA levels are decreased in the hippocampi of AD brains. Taken together, our data implicate that UCH-L1 is important for regulating neurotrophin receptor sorting to signaling endosomes and supporting retrograde transport. Further, our results support the idea that in AD, A beta may downregulate UCH-L1 in the AD brain, which in turn impairs BDNF/TrkB-mediated retrograde signaling, compromising synaptic plasticity and neuronal survival.	[Poon, Wayne W.; Carlos, Anthony J.; Aguilar, Brittany L.; Berchtold, Nicole C.; Kawano, Crystal K.; Zograbyan, Vahe; Yaopruke, Tim; Cotman, Carl W.] Univ Calif Irvine, Inst Memory Impairments & Neurol Disorders, Irvine, CA 92697 USA; [Shelanski, Michael] Columbia Univ, Dept Pathol, New York, NY 10032 USA; [Shelanski, Michael] Columbia Univ, Taub Inst, New York, NY 10032 USA	University of California System; University of California Irvine; Columbia University; Columbia University	Poon, WW (corresponding author), Univ Calif Irvine, Inst Memory Impairments & Neurol Disorders, 1259 Gillespie NRF, Irvine, CA 92697 USA.	wpoon@uci.edu		Aguilar, Brittany/0000-0002-9966-2834; Poon, Wayne/0000-0003-0625-3968	National Institutes of Health [AG016573, AG000538, AG00096]; NATIONAL INSTITUTE ON AGING [P01AG000538, P50AG016573, T32AG000096] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants AG016573 and AG000538 (to C. W. C) and AG00096 (to A. J. C.).	Almeida CG, 2006, J NEUROSCI, V26, P4277, DOI 10.1523/JNEUROSCI.5078-05.2006; Alwan HAJ, 2003, J BIOL CHEM, V278, P35781, DOI 10.1074/jbc.M301326200; Arevalo JC, 2006, NEURON, V50, P549, DOI 10.1016/j.neuron.2006.03.044; Berchtold NC, 2008, P NATL ACAD SCI USA, V105, P15605, DOI 10.1073/pnas.0806883105; Blurton-Jones M, 2004, J COMP NEUROL, V468, P347, DOI 10.1002/cne.10989; Cartier AE, 2009, J NEUROSCI, V29, P7857, DOI 10.1523/JNEUROSCI.1817-09.2009; Cataldo AM, 2004, NEUROBIOL AGING, V25, P1263, DOI 10.1016/j.neurobiolaging.2004.02.027; Causing CG, 1997, NEURON, V18, P257, DOI 10.1016/S0896-6273(00)80266-4; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; Cribbs DH, 1996, NEUROSCIENCE, V75, P173, DOI 10.1016/0306-4522(96)80001-P; De Felice FG, 2008, NEUROBIOL AGING, V29, P1334, DOI 10.1016/j.neurobiolaging.2007.02.029; Decker H, 2010, J NEUROSCI, V30, P9166, DOI 10.1523/JNEUROSCI.1074-10.2010; Delcroix JD, 2003, NEURON, V39, P69, DOI 10.1016/S0896-6273(03)00397-0; Devon RS, 2006, P NATL ACAD SCI USA, V103, P9595, DOI 10.1073/pnas.0510197103; ESCANDON E, 1994, J NEUROSCI, V14, P2054; Garzon DJ, 2007, J NEUROSCI, V27, P2628, DOI 10.1523/JNEUROSCI.5053-06.2007; Geetha T, 2008, TRAFFIC, V9, P1146, DOI 10.1111/j.1600-0854.2008.00751.x; Genoud C, 2004, J NEUROSCI, V24, P2394, DOI 10.1523/JNEUROSCI.4040-03.2004; Georgieva MV, 2011, J NEUROCHEM, V117, P479, DOI 10.1111/j.1471-4159.2011.07218.x; Gong B, 2006, CELL, V126, P775, DOI 10.1016/j.cell.2006.06.046; Grimes ML, 1996, J NEUROSCI, V16, P7950; Guerreiro RJ, 2011, BIOCHEM SOC T, V39, P910, DOI 10.1042/BST0390910; Haglund K, 2003, TRENDS BIOCHEM SCI, V28, P598, DOI 10.1016/j.tibs.2003.09.005; Hartmann M, 2001, EMBO J, V20, P5887, DOI 10.1093/emboj/20.21.5887; Heerssen HM, 2004, NAT NEUROSCI, V7, P596, DOI 10.1038/nn1242; Her LS, 2008, J NEUROSCI, V28, P13662, DOI 10.1523/JNEUROSCI.4144-08.2008; Hiruma H, 2003, J NEUROSCI, V23, P8967; Howe CL, 2004, J NEUROBIOL, V58, P207, DOI 10.1002/neu.10323; Hsia AY, 1999, P NATL ACAD SCI USA, V96, P3228, DOI 10.1073/pnas.96.6.3228; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Hsieh H, 2006, NEURON, V52, P831, DOI 10.1016/j.neuron.2006.10.035; Jack CR, 2010, LANCET NEUROL, V9, P119, DOI 10.1016/S1474-4422(09)70299-6; Kim HJ, 2012, ACS CHEM NEUROSCI, V3, P433, DOI 10.1021/cn3000026; Kohara K, 2001, SCIENCE, V291, P2419, DOI 10.1126/science.1057415; KORTE M, 1995, P NATL ACAD SCI USA, V92, P8856, DOI 10.1073/pnas.92.19.8856; Lauwers E, 2009, J CELL BIOL, V185, P493, DOI 10.1083/jcb.200810114; Lee S, 2011, J NEUROSCI, V31, P7817, DOI 10.1523/JNEUROSCI.6412-10.2011; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Levkowitz G, 1998, GENE DEV, V12, P3663, DOI 10.1101/gad.12.23.3663; Longva KE, 2002, J CELL BIOL, V156, P843, DOI 10.1083/jcb.200106056; Lue LF, 1999, AM J PATHOL, V155, P853, DOI 10.1016/S0002-9440(10)65184-X; Martinez A, 1998, J NEUROSCI, V18, P7336; McLean CA, 1999, ANN NEUROL, V46, P860, DOI 10.1002/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M; Minichiello L, 1999, NEURON, V24, P401, DOI 10.1016/S0896-6273(00)80853-3; Miyake S, 1998, P NATL ACAD SCI USA, V95, P7927, DOI 10.1073/pnas.95.14.7927; Moises T, 2009, BIOCHEM BIOPH RES CO, V387, P360, DOI 10.1016/j.bbrc.2009.07.032; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; Naslund J, 2000, JAMA-J AM MED ASSOC, V283, P1571, DOI 10.1001/jama.283.12.1571; Osaka H, 2003, HUM MOL GENET, V12, P1945, DOI 10.1093/hmg/ddg211; Pang PT, 2004, SCIENCE, V306, P487, DOI 10.1126/science.1100135; Park YY, 2010, J CELL SCI, V123, P619, DOI 10.1242/jcs.061481; Patterson SL, 1996, NEURON, V16, P1137, DOI 10.1016/S0896-6273(00)80140-3; Peng SY, 2005, J NEUROCHEM, V93, P1412, DOI 10.1111/j.1471-4159.2005.03135.x; Philippidou P, 2011, P NATL ACAD SCI USA, V108, P852, DOI 10.1073/pnas.1015981108; Piper RC, 2011, TRENDS CELL BIOL, V21, P647, DOI 10.1016/j.tcb.2011.08.007; Poon WW, 2011, NEUROBIOL AGING, V32, P821, DOI 10.1016/j.neurobiolaging.2009.05.012; Pozzo-Miller LD, 1999, J NEUROSCI, V19, P4972; Rui YF, 2006, J NEUROSCI, V26, P10480, DOI 10.1523/JNEUROSCI.3231-06.2006; Ryu KY, 2008, P NATL ACAD SCI USA, V105, P4016, DOI 10.1073/pnas.0800096105; Salehi A, 2006, NEURON, V51, P29, DOI 10.1016/j.neuron.2006.05.022; Snyder EM, 2005, NAT NEUROSCI, V8, P1051, DOI 10.1038/nn1503; Taylor AM, 2005, NAT METHODS, V2, P599, DOI 10.1038/NMETH777; Taylor AM, 2003, LANGMUIR, V19, P1551, DOI 10.1021/la026417v; Thien CBF, 2001, NAT REV MOL CELL BIO, V2, P294, DOI 10.1038/35067100; Tong LQ, 2004, J NEUROSCI, V24, P6799, DOI 10.1523/JNEUROSCI.5463-03.2004; Tyler WJ, 2002, LEARN MEMORY, V9, P224, DOI 10.1101/lm.51202; Valdez G, 2005, J NEUROSCI, V25, P5236, DOI 10.1523/JNEUROSCI.5104-04.2005; Vossel KA, 2010, SCIENCE, V330, P198, DOI 10.1126/science.1194653; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Wang XL, 2010, NEURODEGENER DIS, V7, P56, DOI 10.1159/000283484; Watanabe T, 2012, J NEUROSCI, V32, P3352, DOI 10.1523/JNEUROSCI.5659-11.2012; Watson FL, 1999, J NEUROSCI, V19, P7889; Watson FL, 2001, NAT NEUROSCI, V4, P981, DOI 10.1038/nn720; Wilkinson KD, 2000, SEMIN CELL DEV BIOL, V11, P141, DOI 10.1006/scdb.2000.0164; WILKINSON KD, 1989, SCIENCE, V246, P670, DOI 10.1126/science.2530630; Xu BJ, 2000, NEURON, V26, P233, DOI 10.1016/S0896-6273(00)81153-8; Yi JJ, 2007, PHARMACOL REV, V59, P14, DOI 10.1124/pr.59.1.4	77	82	83	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2013	288	23					16937	16948		10.1074/jbc.M113.463711	http://dx.doi.org/10.1074/jbc.M113.463711			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	163ZU	23599427	Green Published, hybrid			2022-12-25	WOS:000320378900066
J	Boucias, DG; Kariithi, HM; Bourtzis, K; Schneider, DI; Kelley, K; Miller, WJ; Parker, AG; Abd-Alla, AMM				Boucias, Drion G.; Kariithi, Henry M.; Bourtzis, Kostas; Schneider, Daniela I.; Kelley, Karen; Miller, Wolfgang J.; Parker, Andrew G.; Abd-Alla, Adly M. M.			Transgenerational Transmission of the Glossina pallidipes Hytrosavirus Depends on the Presence of a Functional Symbiome	PLOS ONE			English	Article							GLAND HYPERTROPHY VIRUS; WHITEFLY BEMISIA-TABACI; CIRCULATIVE TRANSMISSION; MUTUALIST WIGGLESWORTHIA; SECONDARY ENDOSYMBIONT; SODALIS-GLOSSINIDIUS; MORSITANS-MORSITANS; BUCHNERA GROEL; DNA VIRUS; TSETSE	The vertically transmitted endosymbionts (Sodalis glossinidius and Wigglesworthia glossinidia) of the tsetse fly (Diptera: Glossinidae) are known to supplement dietary deficiencies and modulate the reproductive fitness and the defense system of the fly. Some tsetse fly species are also infected with the bacterium, Wolbachia and with the Glossina hytrosavirus (GpSGHV). Laboratory-bred G. pallidipes exhibit chronic asymptomatic and acute symptomatic GpSGHV infection, with the former being the most common in these colonies. However, under as yet undefined conditions, the asymptomatic state can convert to the symptomatic state, leading to detectable salivary gland hypertrophy (SGH(+)) syndrome. In this study, we investigated the interplay between the bacterial symbiome and GpSGHV during development of G. pallidipes by knocking down the symbionts with antibiotic. Intrahaemocoelic injection of GpSGHV led to high virus titre (10(9) virus copies), but was not accompanied by either the onset of detectable SGH(+), or release of detectable virus particles into the blood meals during feeding events. When the F-1 generations of GpSGHV-challenged mothers were dissected within 24 h post-eclosion, SGH(+) was observed to increase from 4.5% in the first larviposition cycle to >95% in the fourth cycle. Despite being sterile, these F-1 SGH(+) progeny mated readily. Removal of the tsetse symbiome, however, suppressed transgenerational transfer of the virus via milk secretions and blocked the ability of GpSGHV to infect salivary glands of the F-1 progeny. Whereas GpSGHV infects and replicates in salivary glands of developing pupa, the virus is unable to induce SGH(+) within fully differentiated adult salivary glands. The F-1 SGH(+) adults are responsible for the GpSGHV-induced colony collapse in tsetse factories. Our data suggest that GpSGHV has co-evolved with the tsetse symbiome and that the symbionts play key roles in the virus transmission from mother to progeny.	[Boucias, Drion G.] Univ Florida, Dept Entomol & Nematol, Gainesville, FL 32611 USA; [Boucias, Drion G.; Kariithi, Henry M.; Bourtzis, Kostas; Parker, Andrew G.; Abd-Alla, Adly M. M.] Joint FAO IAEA Programme Nucl Tech Food & Agr, Insect Pest Control Lab, Vienna, Austria; [Kariithi, Henry M.] Wageningen Univ, Virol Lab, NL-6700 AP Wageningen, Netherlands; [Schneider, Daniela I.; Miller, Wolfgang J.] Med Univ Vienna, Ctr Anat & Cell Biol, Labs Genome Dynam, Vienna, Austria; [Kelley, Karen] Univ Florida, ICBR Electron Microscope Facil, Gainesville, FL USA	State University System of Florida; University of Florida; International Atomic Energy Agency; Wageningen University & Research; Medical University of Vienna; State University System of Florida; University of Florida	Boucias, DG (corresponding author), Univ Florida, Dept Entomol & Nematol, Gainesville, FL 32611 USA.	pathos@ufl.edu	Miller, Wolfgang J/E-5716-2015	Miller, Wolfgang J/0000-0002-5044-6276; Parker, Andrew Gordon/0000-0001-8187-1278; Schneider, Daniela/0000-0002-7740-8827; ABD-ALLA, Adly/0000-0001-7540-4462; Kariithi, Henry/0000-0002-9250-9108	Austrian Science Fund (FWF) [P 22634] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF))		Abd-Alla A, 2007, J VIROL METHODS, V139, P143, DOI 10.1016/j.jviromet.2006.09.018; Abd-Alla AMM, 2008, J VIROL, V82, P4595, DOI 10.1128/JVI.02588-07; Abd-Alla AMM, 2010, VIRUS RES, V150, P103, DOI 10.1016/j.virusres.2010.03.001; Abd-Alla AMM, 2009, ARCH VIROL, V154, P909, DOI 10.1007/s00705-009-0398-5; Abd-Alla AMM, 2009, VIRUS RES, V139, P48, DOI 10.1016/j.virusres.2008.10.006; Aksoy S, 2000, PARASITOL TODAY, V16, P114, DOI 10.1016/S0169-4758(99)01606-3; AKSOY S, 1995, INT J SYST BACTERIOL, V45, P848, DOI 10.1099/00207713-45-4-848; Alam U, 2012, APPL ENVIRON MICROB, V78, P4627, DOI 10.1128/AEM.00806-12; Alam U, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002415; [Anonymous], 2010, R LANG ENV STAT COMP; Attardo GM, 2008, J INSECT PHYSL, V54, P1; Baier T, 2007, COMPUTATION STAT, V22, P91, DOI 10.1007/s00180-007-0023-6; Belda E, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-449; Caljon G, 2009, INSECT BIOCHEM MOLEC, V39, P332, DOI 10.1016/j.ibmb.2009.01.010; Cheng Q, 1999, INSECT MOL BIOL, V8, P125, DOI 10.1046/j.1365-2583.1999.810125.x; Dale C, 1999, INT J SYST BACTERIOL, V49, P267, DOI 10.1016/S0020-7519(01)00151-5; Dyck V.A., 2006, STERILE INSECT TECHN; Feldmann U, 2005, STERILE INSECT TECHNIQUE: PRINCIPLES AND PRACTICE IN AREA-WIDE INTEGRATED PEST MANAGEMENT, P701, DOI 10.1007/1-4020-4051-2_27; Feldmann U, 1994, TECHNIQUES INSECT RE, P449; Filichkin SA, 1997, J VIROL, V71, P569, DOI 10.1128/JVI.71.1.569-577.1997; Geden C, 2011, J MED ENTOMOL, V48, P1128, DOI 10.1603/ME11021; Geden CJ, 2011, J VECTOR ECOL, V36, P231, DOI 10.1111/j.1948-7134.2011.00163.x; Gottlieb Y, 2010, J VIROL, V84, P9310, DOI 10.1128/JVI.00423-10; Haine ER, 2008, P ROY SOC B-BIOL SCI, V275, P353, DOI 10.1098/rspb.2007.1211; Haines LR, 2002, INSECT BIOCHEM MOLEC, V32, P1429, DOI 10.1016/S0965-1748(02)00063-2; Hedges LM, 2008, SCIENCE, V322, P702, DOI 10.1126/science.1162418; Hendrichs J, 2005, STERILE INSECT TECHNIQUE: PRINCIPLES AND PRACTICE IN AREA-WIDE INTEGRATED PEST MANAGEMENT, P563, DOI 10.1007/1-4020-4051-2_22; Hogenhout SA, 2000, J VIROL, V74, P4541, DOI 10.1128/JVI.74.10.4541-4548.2000; HOLMES PH, 1988, OUTLOOK AGR, V17, P54, DOI 10.1177/003072708801700203; Hu CY, 2008, PLOS NEGLECT TROP D, V2, P3; JAENSON TGT, 1986, ENTOMOL EXP APPL, V41, P265, DOI 10.1007/BF00221256; Jeyaprakash A, 2000, INSECT MOL BIOL, V9, P393, DOI 10.1046/j.1365-2583.2000.00203.x; Jordan A, 1986, TRYPANOSOMIASIS CONT; JURA WGZO, 1993, INSECT SCI APPL, V14, P383, DOI 10.1017/S1742758400014909; Kariithi HM, 2013, J INVERTEBR PATHOL, V112, pS123, DOI 10.1016/j.jip.2012.04.016; Kariithi HM, 2013, J GEN VIROL, V94, P193, DOI 10.1099/vir.0.047423-0; Klassen W, 2005, STERILE INSECT TECHNIQUE: PRINCIPLES AND PRACTICE IN AREA-WIDE INTEGRATED PEST MANAGEMENT, P3, DOI 10.1007/1-4020-4051-2_1; Leak SGA., 1998, TSETSE BIOL ECOLOGY, DOI [10.1079/9780851993003.0000, DOI 10.1079/9780851993003.0000]; Lietze VU, 2009, J INVERTEBR PATHOL, V101, P49, DOI 10.1016/j.jip.2009.02.007; Lietze VU, 2007, APPL ENVIRON MICROB, V73, P6811, DOI 10.1128/AEM.02694-06; Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042; Morin S, 2000, VIROLOGY, V276, P404, DOI 10.1006/viro.2000.0549; Morin S, 1999, VIROLOGY, V256, P75, DOI 10.1006/viro.1999.9631; Mutika GN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042188; NOGGE G, 1981, PARASITOLOGY, V82, P101; ODINDO MO, 1981, INSECT SCI APPL, V2, P219, DOI 10.1017/S1742758400001089; ONEILL SL, 1993, MED VET ENTOMOL, V7, P377, DOI 10.1111/j.1365-2915.1993.tb00709.x; Osborne SE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000656; Pais R, 2008, APPL ENVIRON MICROB, V74, P5965, DOI 10.1128/AEM.00741-08; Rances E, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002548; Rio RVM, 2012, MBIO, V3, DOI 10.1128/mBio.00240-11; Rose TM, 1998, NUCLEIC ACIDS RES, V26, P1628, DOI 10.1093/nar/26.7.1628; Sang RC, 1997, J INVERTEBR PATHOL, V69, P253, DOI 10.1006/jipa.1996.4629; Saridaki A, 2010, CURR OPIN MICROBIOL, V13, P67, DOI 10.1016/j.mib.2009.11.005; Scarborough CL, 2005, SCIENCE, V310, P1781, DOI 10.1126/science.1120180; Schneider D, 2012, FRONT MICROBIOL SER, P149; Schneider DI, 2013, J INVERTEBR PATHOL, V112, pS104, DOI 10.1016/j.jip.2012.03.024; Sokal R. R, 1981, BIOMETRY; Teixeira L, 2008, PLOS BIOL, V6, P2753, DOI 10.1371/journal.pbio.1000002; Teixeira LAF, 2009, J ECON ENTOMOL, V102, P1108, DOI 10.1603/029.102.0332; Van den Bossche P, 2010, TRENDS PARASITOL, V26, P236, DOI 10.1016/j.pt.2010.02.010; VANDENHEUVEL JFJM, 1994, J GEN VIROL, V75, P2559, DOI 10.1099/0022-1317-75-10-2559; VandenHeuvel JFJM, 1997, J VIROL, V71, P7258, DOI 10.1128/JVI.71.10.7258-7265.1997; Vreysen MJB, 2013, J INVERTEBR PATHOL, V112, pS15, DOI 10.1016/j.jip.2012.07.026; Vreysen MJB, 2000, J ECON ENTOMOL, V93, P123, DOI 10.1603/0022-0493-93.1.123; Wang JW, 2013, J INVERTEBR PATHOL, V112, pS32, DOI 10.1016/j.jip.2012.03.028; Wang JW, 2009, P NATL ACAD SCI USA, V106, P12133, DOI 10.1073/pnas.0901226106; Weiss BL, 2006, APPL ENVIRON MICROB, V72, P7013, DOI 10.1128/AEM.01507-06; Weiss BL, 2012, J IMMUNOL, V188, P3395, DOI 10.4049/jimmunol.1103691; Weiss BL, 2008, P NATL ACAD SCI USA, V105, P15088, DOI 10.1073/pnas.0805666105; Wu M, 2004, PLOS BIOL, V2, P327, DOI 10.1371/journal.pbio.0020069; [No title captured]	72	24	24	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2013	8	4							e61150	10.1371/journal.pone.0061150	http://dx.doi.org/10.1371/journal.pone.0061150			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JR	23613801	Green Published, gold, Green Submitted			2022-12-25	WOS:000317911500020
J	Komori, R; Kobayashi, T; Matsuo, H; Kino, K; Miyazawa, H				Komori, Rie; Kobayashi, Takanobu; Matsuo, Hikaru; Kino, Katsuhito; Miyazawa, Hiroshi			Csn3 Gene Is Regulated by All-Trans Retinoic Acid during Neural Differentiation in Mouse P19 Cells	PLOS ONE			English	Article							EMBRYONAL CARCINOMA-CELLS; NEURONAL DIFFERENTIATION; STEM-CELLS; DEVELOPMENTAL EXPRESSION; INHIBITS GLIOGENESIS; MOLECULAR CHAPERONES; NUCLEAR RECEPTORS; SELECTIVE RAR; CANCER-CELLS; X-RECEPTOR	kappa-Casein (CSN3) is known to play an essential role in controlling the stability of the milk micelles. We found that the expression of Csn3 was induced by all-trans retinoic acid (ATRA) during neural differentiation in P19 embryonal carcinoma cells from our study using DNA microarray. In this paper, we describe the detailed time course of Csn3 expression and the induction mechanism of Csn3 transcription activation in this process. The Csn3 expression was induced rapidly and transiently within 24 h of ATRA treatment. Retinoic acid receptor (RAR)-specific agonists were used in expression analysis to identify the RAR subtype involved upregulation of Csn3; a RAR alpha-specific agonist mimicked the effects of ATRA on induction of Csn3 expression. Therefore, RAR alpha may be the RAR subtype mediating the effects of ATRA on the induction of Csn3 gene transcription in this differentiation-promoting process of P19 cells. We found that the promoter region of Csn3 contained a typical consensus retinoic acid response element (RARE), and this RARE was necessary for ATRA-dependent transcriptional regulation. We confirmed that RAR alpha bound to this RARE sequence in P19 cells. These findings indicated that the Csn3 expression is upregulated via ATRA-bound RAR alpha and binding of this receptor to the RARE in the Csn3 promoter region. This will certainly serve as a first step forward unraveling the mysteries of induction of Csn3 in the process of neural differentiation.	[Komori, Rie; Kobayashi, Takanobu; Matsuo, Hikaru; Kino, Katsuhito; Miyazawa, Hiroshi] Tokushima Bunri Univ, Kagawa Sch Pharmaceut Sci, Sanuki, Kagawa, Japan	Tokushima Bunri University	Miyazawa, H (corresponding author), Tokushima Bunri Univ, Kagawa Sch Pharmaceut Sci, Sanuki, Kagawa, Japan.	miyazawah@kph.bunri-u.ac.jp			Tokushima Bunri University	Tokushima Bunri University	This work was supported by research grants from Tokushima Bunri University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansems M, 2010, BBA-REV CANCER, V1806, P193, DOI 10.1016/j.bbcan.2010.05.001; BAIN G, 1994, BIOESSAYS, V16, P343, DOI 10.1002/bies.950160509; Balmer JE, 2002, J LIPID RES, V43, P1773, DOI 10.1194/jlr.R100015-JLR200; Bastien J, 2004, GENE, V328, P1, DOI 10.1016/j.gene.2003.12.005; BOUILLET P, 1995, DEV BIOL, V170, P420, DOI 10.1006/dbio.1995.1226; Calabrese V, 2002, DEV NEUROSCI-BASEL, V24, P1, DOI 10.1159/000064941; CastroObregon S, 1996, FEBS LETT, V381, P93, DOI 10.1016/0014-5793(96)00088-9; Chambon P, 1996, FASEB J, V10, P940, DOI 10.1096/fasebj.10.9.8801176; Cheng YH, 2008, J CLIN ENDOCR METAB, V93, P1915, DOI 10.1210/jc.2007-1536; Comin A, 2008, J DAIRY SCI, V91, P4022, DOI 10.3168/jds.2007-0546; DE LUCA LM, 1991, FASEB J, V5, P2924; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Finley MFA, 1996, J NEUROSCI, V16, P1056; Germain P, 2006, PHARMACOL REV, V58, P685, DOI 10.1124/pr.58.4.2; Germain P, 2006, PHARMACOL REV, V58, P712, DOI 10.1124/pr.58.4.4; Heinitz K, 2006, J NEUROCHEM, V98, P1930, DOI 10.1111/j.1471-4159.2006.04015.x; HEYMAN RA, 1992, CELL, V68, P397, DOI 10.1016/0092-8674(92)90479-V; Hohjoh H, 2007, BIOCHEM BIOPH RES CO, V362, P360, DOI 10.1016/j.bbrc.2007.07.189; Houdek Z, 2011, FOLIA BIOL-PRAGUE, V57, P162; Humphreys DT, 1999, J BIOL CHEM, V274, P6875, DOI 10.1074/jbc.274.11.6875; Husmann M, 2000, BIOCHEM J, V352, P763, DOI 10.1042/0264-6021:3520763; Iosefson O, 2012, CELL STRESS CHAPERON, V17, P57, DOI 10.1007/s12192-011-0285-3; Jing XT, 2009, CELL MOL NEUROBIOL, V29, P55, DOI 10.1007/s10571-008-9295-9; JONESVILLENEUVE EMV, 1983, MOL CELL BIOL, V3, P2271, DOI 10.1128/MCB.3.12.2271; JONESVILLENEUVE EMV, 1982, J CELL BIOL, V94, P253, DOI 10.1083/jcb.94.2.253; JONK LJC, 1994, DEV BIOL, V161, P604, DOI 10.1006/dbio.1994.1056; Kang SW, 2005, EXP CELL RES, V309, P305, DOI 10.1016/j.yexcr.2005.06.012; Kumar P, 2010, J BIOL CHEM, V285, P37521, DOI 10.1074/jbc.M110.132795; Laperriere D, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-23; Lefebvre P, 2005, VITAM HORM, V70, P199, DOI 10.1016/S0083-6729(05)70007-8; Lin BZ, 2000, MOL CELL BIOL, V20, P957, DOI 10.1128/MCB.20.3.957-970.2000; MANGELSDORF DJ, 1995, CELL, V83, P841, DOI 10.1016/0092-8674(95)90200-7; MANGELSDORF DJ, 1992, GENE DEV, V6, P329, DOI 10.1101/gad.6.3.329; MCBURNEY MW, 1982, DEV BIOL, V89, P503, DOI 10.1016/0012-1606(82)90338-4; MCBURNEY MW, 1993, INT J DEV BIOL, V37, P135; MCBURNEY MW, 1982, NATURE, V299, P165, DOI 10.1038/299165a0; MORASSUTTI DJ, 1994, NEUROSCIENCE, V58, P753, DOI 10.1016/0306-4522(94)90452-9; Morgan PE, 2005, J AGR FOOD CHEM, V53, P2670, DOI 10.1021/jf048329h; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; NEWCOMER ME, 1993, P NATL ACAD SCI USA, V90, P9223, DOI 10.1073/pnas.90.19.9223; Nishino J, 2004, EMBO J, V23, P1998, DOI 10.1038/sj.emboj.7600202; Niwa H, 2002, MOL CELL BIOL, V22, P1526, DOI 10.1128/MCB.22.5.1526-1536.2002; Nuka S, 1997, CELL STRUCT FUNCT, V22, P27, DOI 10.1247/csf.22.27; PERLMANN T, 1993, GENE DEV, V7, P1411, DOI 10.1101/gad.7.7b.1411; Piu F, 2005, BIOCHEM PHARMACOL, V71, P156, DOI 10.1016/j.bcp.2005.10.025; Reynolds JN, 1996, MOL BRAIN RES, V35, P11, DOI 10.1016/0169-328X(95)00172-O; Satoh J, 2009, NEUROPATH APPL NEURO, V35, P16, DOI 10.1111/j.1365-2990.2008.00947.x; Shang YF, 1999, J BIOL CHEM, V274, P18005, DOI 10.1074/jbc.274.25.18005; Shekar PC, 2006, P NATL ACAD SCI USA, V103, P8000, DOI 10.1073/pnas.0601611103; Shen J, 2006, J ORTHOP RES, V24, P1128, DOI 10.1002/jor.20131; STARNAUD R, 1993, MOL CELL BIOL, V13, P1590, DOI 10.1128/MCB.13.3.1590; Suzuki Y, 1999, BLOOD, V93, P4264, DOI 10.1182/blood.V93.12.4264.412k27_4264_4276; Tang K, 2002, BIOCHEM BIOPH RES CO, V293, P167, DOI 10.1016/S0006-291X(02)00215-2; Ulrich H, 2006, CELL PROLIFERAT, V39, P281, DOI 10.1111/j.1365-2184.2006.00385.x; Voronova A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019174; WAUGH DF, 1956, J AM CHEM SOC, V78, P4576, DOI 10.1021/ja01599a017; Willander H, 2011, FEBS J, V278, P3893, DOI 10.1111/j.1742-4658.2011.08209.x; Wu JB, 2009, J BIOL CHEM, V284, P16723, DOI 10.1074/jbc.M901779200; Yerbury JJ, 2007, FASEB J, V21, P2312, DOI 10.1096/fj.06-7986com; ZHANG XK, 1992, NATURE, V358, P587, DOI 10.1038/358587a0	60	13	14	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2013	8	4							e61938	10.1371/journal.pone.0061938	http://dx.doi.org/10.1371/journal.pone.0061938			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IK	23613978	Green Published, gold, Green Submitted			2022-12-25	WOS:000317907200106
J	Lampert, EJ; Choudhury, KR; Hostage, CA; Petrella, JR; Doraiswamy, PM				Lampert, Erika J.; Choudhury, Kingshuk Roy; Hostage, Christopher A.; Petrella, Jeffrey R.; Doraiswamy, P. Murali		Alzheimer's Dis Neuroimaging Initi	Prevalence of Alzheimer's Pathologic Endophenotypes in Asymptomatic and Mildly Impaired First-Degree Relatives	PLOS ONE			English	Article							MATERNAL FAMILY-HISTORY; NORMAL ADULTS; DISEASE; ASSOCIATION; ATROPHY; VOLUME; RISK; MRI	Objective: A positive family history (FH) is a risk factor for late-onset Alzheimer's disease (AD). Our aim was to examine the effects of FH on pathological and neuronal loss biomarkers across the cognitive spectrum. Design: Cross-sectional analyses of data from a national biomarker study. Setting: The Alzheimer's Disease Neuroimaging Initiative national study. Patients: 257 subjects (ages 55-89), divided into cognitively normal (CN), mild cognitive impairment (MCI), and AD groups, with CSF and FH data. Outcome Measures: Cerebrospinal fluid (CSF) A beta 42, tau, and tau/A beta 42 ratio, MRI-measured hippocampal volumes. Statistics: Univariate and multivariate analyses. Results: In MCI, CSF A beta 42 was lower (p = .005), t-tau was higher (p = 0.02) and t-tau/A beta 42 ratio was higher (p = 0.002) in FH+ than FH- subjects. A significant residual effect of FH on pathologic markers in MCI remained after adjusting for ApoE4 (p < 0.05). Among CN, 47% of FH+ exhibited "pathologic signature of AD'' (CSF t-tau/A beta 42 ratio >0.39) versus 21% of FH- controls (p = 0.03). The FH effect was not significant in AD subjects. Hippocampal and intracranial volumes did not differ between FH+ and FH- subjects in any group. Conclusions: A positive family history of late-onset AD is associated with a higher prevalence of an abnormal cerebral beta-amyloid and tau protein phenotype in MCI. The unexplained genetic heritability in family history is about the half the size of the ApoE4 effect. Longitudinal studies are warranted to more definitively examine this issue.	[Lampert, Erika J.; Doraiswamy, P. Murali] Duke Univ, Dept Psychiat, Med Ctr, Durham, NC 27706 USA; [Choudhury, Kingshuk Roy; Hostage, Christopher A.; Petrella, Jeffrey R.] Duke Univ, Med Ctr, Dept Radiol, Durham, NC 27710 USA; [Doraiswamy, P. Murali] Duke Univ, Med Ctr, Duke Inst Brain Sci, Durham, NC USA	Duke University; Duke University; Duke University	Doraiswamy, PM (corresponding author), Duke Univ, Dept Psychiat, Med Ctr, Durham, NC 27706 USA.	murali.doraiswamy@duke.edu		Lampert, Erika/0000-0001-9406-5371	National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering; National Institutes of Health (NIH) [P30 AG010129, K01 AG030514]; Amorfix Life Sciences Ltd.; AstraZeneca; Bayer HealthCare; BioClinica, Inc.; Biogen Idec Inc.; Bristol-Myers Squibb Company; Eisai Inc.; Elan Pharmaceuticals Inc.; Eli Lilly and Company; F. Hoffmann-La Roche Ltd; GE Healthcare; Innogenetics, N.V.; IXICO Ltd.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC; Medpace, Inc.; Merck Co., Inc.; Meso Scale Diagnostics, LLC.; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Servier; Synarc Inc.; Takeda Pharmaceutical Company; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000128] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG010129, K01AG030514] Funding Source: NIH RePORTER	National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)NIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Amorfix Life Sciences Ltd.; AstraZeneca(AstraZeneca); Bayer HealthCare(Bayer AGBayer Healthcare Pharmaceuticals); BioClinica, Inc.; Biogen Idec Inc.(Biogen); Bristol-Myers Squibb Company(Bristol-Myers Squibb); Eisai Inc.(Eisai Co Ltd); Elan Pharmaceuticals Inc.; Eli Lilly and Company(Eli Lilly); F. Hoffmann-La Roche Ltd(Hoffmann-La Roche); GE Healthcare(General ElectricGE Healthcare); Innogenetics, N.V.; IXICO Ltd.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC(Johnson & JohnsonJohnson & Johnson USA); Medpace, Inc.; Merck Co., Inc.(Merck & Company); Meso Scale Diagnostics, LLC.; Novartis Pharmaceuticals Corporation(Novartis); Pfizer Inc.(Pfizer); Servier(Servier); Synarc Inc.; Takeda Pharmaceutical Company(Takeda Pharmaceutical Company Ltd); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The Alzheimer's Disease Neuroimaging Initiative (ADNI) is funded by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from the following: Abbott; Alzheimer's Association; Alzheimer's Drug Discovery Foundation; Amorfix Life Sciences Ltd.; AstraZeneca; Bayer HealthCare; BioClinica, Inc.; Biogen Idec Inc.; Bristol-Myers Squibb Company; Eisai Inc.; Elan Pharmaceuticals Inc.; Eli Lilly and Company; F. Hoffmann-La Roche Ltd and its affiliated company Genentech, Inc.; GE Healthcare; Innogenetics, N.V.; IXICO Ltd.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC; Medpace, Inc.; Merck & Co., Inc.; Meso Scale Diagnostics, LLC.; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Servier; Synarc Inc.; and Takeda Pharmaceutical Company. This research was also supported by National Institutes of Health (NIH) grants P30 AG010129 and K01 AG030514. The funding referred to above was not provided directly to any of the study authors but was given to the Northern California Research Institute (UCSF) and overall PI of ADNI (who is not an author of this study) through the NIH foundation and NIH, which in turn awarded a subcontract to PMD. The funders (ADNI) had a direct role in study design and data collection. The funders had no role in data analyses or decision to publish. All other funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The Alzheimer's Disease Neuroimaging Initiative is funded by Amorfix Life Sciences Ltd.; AstraZeneca; Bayer HealthCare; BioClinica, Inc.; Biogen Idec Inc.; Bristol-Myers Squibb Company; Eisai Inc.; Elan Pharmaceuticals Inc.; Eli Lilly and Company; F. Hoffmann-La Roche Ltd and its affiliated company Genentech, Inc.; GE Healthcare; Innogenetics, N.V.; IXICO Ltd.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC; Medpace, Inc.; Merck & Co., Inc.; Meso Scale Diagnostics, LLC.; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Servier; Synarc Inc.; and Takeda Pharmaceutical Company. PMD owns stock in Sonexa and Clarimedix, whose products are not discussed here. Jeffrey Petrella is on the neuroradiology advisory board of Janssen Alzheimer Immunotherapy. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Andrawis JP, 2012, NEUROBIOL AGING, V33, P856, DOI 10.1016/j.neurobiolaging.2010.07.020; Bateman RJ, 2012, NEW ENGL J MED, V367, P795, DOI 10.1056/NEJMoa1202753; Biffi A, 2010, ARCH NEUROL-CHICAGO, V67, P677, DOI 10.1001/archneurol.2010.108; Castellano JM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002156; Cupples LA, 2004, GENET MED, V6, P192, DOI 10.1097/01.GIM.0000132679.92238.58; Fleisher AS, 2013, NEUROBIOL AGING, V34, P1, DOI 10.1016/j.neurobiolaging.2012.04.017; Han X, 2006, NEUROIMAGE, V32, P180, DOI 10.1016/j.neuroimage.2006.02.051; Honea RA, 2010, NEUROLOGY, V74, P113, DOI 10.1212/WNL.0b013e3181c918cb; Honea RA, 2012, J ALZHEIMERS DIS, V31, P659, DOI 10.3233/JAD-2012-120676; Honea RA, 2011, NEUROLOGY, V76, P822, DOI 10.1212/WNL.0b013e31820e7b74; Jack CR, 2010, LANCET NEUROL, V9, P119, DOI 10.1016/S1474-4422(09)70299-6; Kim S, 2011, NEUROLOGY, V76, P69, DOI 10.1212/WNL.0b013e318204a397; Lewczuk P, 2010, MOL PSYCHIATR, V15, P138, DOI 10.1038/mp.2008.84; Mayeux R, 2012, COLD SPRING HARB PER, V2; Mosconi L, 2009, NEUROLOGY, V72, P513, DOI 10.1212/01.wnl.0000333247.51383.43; Mosconi L, 2007, P NATL ACAD SCI USA, V104, P19067, DOI 10.1073/pnas.0705036104; Mosconi L, 2013, NEUROBIOL AGING, V34, P22, DOI 10.1016/j.neurobiolaging.2012.03.002; Okonkwo OC, 2012, NEUROLOGY, V78, P1769, DOI 10.1212/WNL.0b013e3182583047; Potkin SG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006501; Schuff N, 2009, BRAIN, V132, P1067, DOI 10.1093/brain/awp007; Shaw LM, 2009, ANN NEUROL, V65, P403, DOI 10.1002/ana.21610; SILVERMAN JM, 1994, ARCH GEN PSYCHIAT, V51, P577; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P280, DOI 10.1016/j.jalz.2011.03.003; Tanzi RE, 2012, COLD SPRING HARB PER, V2; Weiner MW, 2010, ALZHEIMERS DEMENT, V6, P202, DOI 10.1016/j.jalz.2010.03.007; Xiong CJ, 2011, ARCH NEUROL-CHICAGO, V68, P1313, DOI 10.1001/archneurol.2011.208	26	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2013	8	4							e60747	10.1371/journal.pone.0060747	http://dx.doi.org/10.1371/journal.pone.0060747			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IK	23613741	gold, Green Published, Green Submitted			2022-12-25	WOS:000317907200012
J	Langfelder, P; Mischel, PS; Horvath, S				Langfelder, Peter; Mischel, Paul S.; Horvath, Steve			When Is Hub Gene Selection Better than Standard Meta-Analysis?	PLOS ONE			English	Article							COEXPRESSION NETWORK ANALYSIS; CELL-PROLIFERATION; DNA METHYLATION; REGULATED GENES; EXPRESSION DATA; DISCOVERY; PROTEIN; ASSOCIATION; MODULES; IDENTIFICATION	Since hub nodes have been found to play important roles in many networks, highly connected hub genes are expected to play an important role in biology as well. However, the empirical evidence remains ambiguous. An open question is whether (or when) hub gene selection leads to more meaningful gene lists than a standard statistical analysis based on significance testing when analyzing genomic data sets (e.g., gene expression or DNA methylation data). Here we address this question for the special case when multiple genomic data sets are available. This is of great practical importance since for many research questions multiple data sets are publicly available. In this case, the data analyst can decide between a standard statistical approach (e.g., based on meta-analysis) and a co-expression network analysis approach that selects intramodular hubs in consensus modules. We assess the performance of these two types of approaches according to two criteria. The first criterion evaluates the biological insights gained and is relevant in basic research. The second criterion evaluates the validation success (reproducibility) in independent data sets and often applies in clinical diagnostic or prognostic applications. We compare meta-analysis with consensus network analysis based on weighted correlation network analysis (WGCNA) in three comprehensive and unbiased empirical studies: (1) Finding genes predictive of lung cancer survival, (2) finding methylation markers related to age, and (3) finding mouse genes related to total cholesterol. The results demonstrate that intramodular hub gene status with respect to consensus modules is more useful than a meta-analysis p-value when identifying biologically meaningful gene lists (reflecting criterion 1). However, standard meta-analysis methods perform as good as (if not better than) a consensus network approach in terms of validation success (criterion 2). The article also reports a comparison of meta-analysis techniques applied to gene expression data and presents novel R functions for carrying out consensus network analysis, network based screening, and meta analysis.	[Langfelder, Peter; Horvath, Steve] Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA 90024 USA; [Mischel, Paul S.] Univ Calif Los Angeles, Dept Pathol & Lab Med, Los Angeles, CA USA; [Horvath, Steve] Univ Calif Los Angeles, Dept Human Genet & Biostat, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Horvath, S (corresponding author), Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA 90024 USA.	shorvath@mednet.ucla.edu			National Institutes of Health [1R01DA030913-01, P50CA092131]; UCLA AIDS Institute and UCLA Center for AIDS Research [AI28697]; UCLA Clinical and Translational Science Institute; NCRR and NCATS [UL1TR000124]; NATIONAL CANCER INSTITUTE [P50CA092131] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI028697] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA030913] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCLA AIDS Institute and UCLA Center for AIDS Research; UCLA Clinical and Translational Science Institute; NCRR and NCATS; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was funded in part by National Institutes of Health grants 1R01DA030913-01 and P50CA092131; UCLA AIDS Institute and UCLA Center for AIDS Research (AI28697) (http://aidsinstitute.ucla.edu/); the UCLA Clinical and Translational Science Institute (http://www.ctsi.ucla.edu/); NCRR and NCATS (UL1TR000124). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts S, 2006, NAT BIOTECHNOL, V24, P537, DOI 10.1038/nbt1203; Aggarwal A, 2006, CANCER RES, V66, P232, DOI 10.1158/0008-5472.CAN-05-2232; Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Allen JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029348; Almaas E, 2007, J EXP BIOL, V210, P1548, DOI 10.1242/jeb.003731; Alter O, 2000, P NATL ACAD SCI USA, V97, P10101, DOI 10.1073/pnas.97.18.10101; [Anonymous], 2010, R LANG ENV STAT COMP; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barabasi AL, 2003, SCI AM, V288, P60, DOI 10.1038/scientificamerican0503-60; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Bell CG, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-33; Bennett BJ, 2010, GENOME RES, V20, P281, DOI 10.1101/gr.099234.109; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Breitling R, 2004, FEBS LETT, V573, P83, DOI 10.1016/j.febslet.2004.07.055; Butte AJ, 2000, P NATL ACAD SCI USA, V97, P12182, DOI 10.1073/pnas.220392197; Cahan P, 2007, GENE, V401, P12, DOI 10.1016/j.gene.2007.06.016; Cai CC, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-589; Campain A, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-408; Carlson MRJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-40; Choi JK, 2003, BIOINFORMATICS, V19, pi84, DOI 10.1093/bioinformatics/btg1010; Cuzick J, 2011, LANCET ONCOL, V12, P245, DOI 10.1016/S1470-2045(10)70295-3; Dawson JA, 2012, BIOINFORMATICS, V28, P1939, DOI 10.1093/bioinformatics/bts268; de la Fuente A, 2010, TRENDS GENET, V26, P326, DOI 10.1016/j.tig.2010.05.001; Dong J, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-24; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fisher R. A., 1954, STAT METHODS RES WOR, DOI DOI 10.1007/BF01603396; Fuller TF, 2007, MAMM GENOME, V18, P463, DOI 10.1007/s00335-007-9043-3; Gargalovic PS, 2006, P NATL ACAD SCI USA, V103, P12741, DOI 10.1073/pnas.0605457103; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Ghazalpour A, 2006, PLOS GENET, V2, P1182, DOI 10.1371/journal.pgen.0020130; Gibbs JR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000952; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Hahn MW, 2005, MOL BIOL EVOL, V22, P803, DOI 10.1093/molbev/msi072; Han JDJ, 2004, NATURE, V430, P88, DOI 10.1038/nature02555; Hong FX, 2008, BIOINFORMATICS, V24, P374, DOI 10.1093/bioinformatics/btm620; Horvath S, 2006, P NATL ACAD SCI USA, V103, P17402, DOI 10.1073/pnas.0608396103; Horvath S, 2011, WEIGHTED NETWORK ANALYSIS: APPLICATIONS IN GENOMICS AND SYSTEMS BIOLOGY, P1, DOI 10.1007/978-1-4419-8819-5; Horvath S, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000117; Huang Y, 2007, BIOINFORMATICS, V23, pI222, DOI 10.1093/bioinformatics/btm222; ISOLA J, 1992, J NATL CANCER I, V84, P1109, DOI 10.1093/jnci/84.14.1109; Ivliev AE, 2010, CANCER RES, V70, P10060, DOI 10.1158/0008-5472.CAN-10-2465; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Kaufman L., 1990, FINDING GROUPS DATA, DOI 10.1002/9780470316801; Keller MP, 2008, GENOME RES, V18, P706, DOI 10.1101/gr.074914.107; Killmann F., 2001, EC QUAL CONTROL, V16, P17, DOI [DOI 10.1515/EQC.2001.17, 10.1515/EQC.2001.17]; Koyuturk M, 2006, J COMPUT BIOL, V13, P1299, DOI 10.1089/cmb.2006.13.1299; Langfelder P, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-54; Langfelder P, 2008, BIOINFORMATICS, V24, P719, DOI 10.1093/bioinformatics/btm563; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Langfelder P, 2012, J STAT SOFTW, V46, P1; Langfelder P, 2012, BBA-MOL CELL BIOL L, V1821, P435, DOI 10.1016/j.bbalip.2011.07.014; Langfelder P, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001057; Larsson O, 2006, OMICS, V10, P381, DOI 10.1089/omi.2006.10.381; Lee HK, 2004, GENOME RES, V14, P1085, DOI 10.1101/gr.1910904; Li W, 2011, SHANDONG COTTON, P1; LIPPONEN PK, 1995, J CANCER RES CLIN, V121, P44, DOI 10.1007/BF01202728; Liptak T., 1958, MAGYAR TUD AKAD MAT, V3, P171; Lo JC, 2007, SCIENCE, V316, P285, DOI 10.1126/science.1137221; Margolin AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S7; Mason MJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-327; Miller JA, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-322; Miller JA, 2010, P NATL ACAD SCI USA, V107, P12698, DOI 10.1073/pnas.0914257107; Mosley JD, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-11; Mosteller F., 1954, HDB SOCIAL PSYCHOL, VI, P289; Normand SLT, 1999, STAT MED, V18, P321, DOI 10.1002/(SICI)1097-0258(19990215)18:3<321::AID-SIM28>3.0.CO;2-P; Oldham MC, 2008, NAT NEUROSCI, V11, P1271, DOI 10.1038/nn.2207; Oldham MC, 2006, P NATL ACAD SCI USA, V103, P17973, DOI 10.1073/pnas.0605938103; Parkinson H, 2011, NUCLEIC ACIDS RES, V39, pD1002, DOI 10.1093/nar/gkq1040; Parmigiani G, 2002, J ROY STAT SOC B, V64, P717, DOI 10.1111/1467-9868.00358; Pihur V, 2008, GENOMICS, V92, P400, DOI 10.1016/j.ygeno.2008.05.003; Presson AP, 2009, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-95; Rakyan VK, 2010, GENOME RES, V20, P434, DOI 10.1101/gr.103101.109; Ramasamy A, 2008, PLOS MED, V5, P1320, DOI 10.1371/journal.pmed.0050184; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Rhodes DR, 2002, CANCER RES, V62, P4427; Roepman P, 2009, CLIN CANCER RES, V15, P284, DOI 10.1158/1078-0432.CCR-08-1258; Shedden K, 2008, NAT MED, V14, P822, DOI 10.1038/nm.1790; Shockley KR, 2009, PHYSIOL GENOMICS, V39, P172, DOI 10.1152/physiolgenomics.90350.2008; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Storey JD, 2004, J R STAT SOC B, V66, P187, DOI 10.1111/j.1467-9868.2004.00439.x; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Stouffer S, 1949, STUDIES SOCIAL PSYCH, V1; Stuart JM, 2003, SCIENCE, V302, P249, DOI 10.1126/science.1087447; Takeuchi T, 2006, J CLIN ONCOL, V24, P1679, DOI 10.1200/JCO.2005.03.8224; Teschendorff AE, 2010, GENOME RES, V20, P440, DOI 10.1101/gr.103606.109; Tomida S, 2009, J CLIN ONCOL, V27, P2793, DOI 10.1200/JCO.2008.19.7053; van Nas A, 2009, ENDOCRINOLOGY, V150, P1235, DOI 10.1210/en.2008-0563; Wang Y, 2006, BIOINFORMATICS, V22, P2413, DOI 10.1093/bioinformatics/btl396; Whitlock MC, 2005, J EVOLUTION BIOL, V18, P1368, DOI 10.1111/j.1420-9101.2005.00917.x; Wilcox R. R., 2011, INTRO ROBUST ESTIMAT; Wolfe CJ, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-227; Yip AM, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-22; Zaykin DV, 2011, J EVOLUTION BIOL, V24, P1836, DOI 10.1111/j.1420-9101.2011.02297.x; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128; Zhang J, 2010, BMC BIOINFORMATICS, V11, DOI [10.1186/1471-2105-11-S9-S5, 10.1186/1471-2105-11-s9-s5]; [No title captured], DOI DOI 10.1093/nar/gkp967	99	178	180	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2013	8	4							e61505	10.1371/journal.pone.0061505	http://dx.doi.org/10.1371/journal.pone.0061505			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IK	23613865	gold, Green Submitted, Green Published			2022-12-25	WOS:000317907200060
J	Lin, YJ; Lee, MH; Yang, HI; Jen, CL; You, SL; Wang, LY; Lu, SN; Liu, J; Chen, CJ				Lin, Yu-Ju; Lee, Mei-Hsuan; Yang, Hwai-I; Jen, Chin-Lan; You, San-Lin; Wang, Li-Yu; Lu, Sheng-Nan; Liu, Jessica; Chen, Chien-Jen			Predictability of Liver-Related Seromarkers for the Risk of Hepatocellular Carcinoma in Chronic Hepatitis B Patients	PLOS ONE			English	Article							VIRUS-INFECTION; PREDICTIVE SCORE; CIRRHOSIS; FIBROSIS; DISEASE; EPIDEMIOLOGY; LAMIVUDINE; CARRIERS; MARKERS; LEVEL	Background: Hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC) is a major global health problem. A few risk calculators have been developed using mainly HBV seromarkers as predictors. However, serum HBV DNA level, HBV genotype, and mutants are not routinely checked in regular health examinations. This study aimed to assess the predictability of HCC risk in chronic hepatitis B patients, using a combination of liver-related seromarkers combined with or without HBV seromarkers. Methods: A prospective cohort of 1,822 anti-HCV-seronegative chronic HBV carriers was included in this study. Liver-related seromarkers including aspartate aminotransferase (AST), alanine aminotransferase (ALT), alpha-fetoprotein (AFP), gamma-glutamyltransferase (GGT), total bilirubin, total protein, albumin, serum globulins, apolipoprotein A1, and apolipoprotein B were examined. Hazard ratios of HCC with 95% confidence intervals were estimated using Cox proportional hazards regression models. Regression coefficients of seromarkers significantly associated with HCC risk in multivariate analyses were used to create integer risk scores. The predictability of various risk models were assessed by area under receiver operating characteristic curves (AUROCs). Results: During a median follow-up of 5.9 years, 48 newly-developed HCC cases were ascertained. Elevated serum levels of ALT (>= 28 U/L), AFP (>= 5 ng/mL), and GGT (>= 41 U/L), an increased AST/ALT ratio (AAR, >= 1), and lowered serum levels of albumin (<= 4.1 g/dL) and alpha-1 globulin (<= 0.2 g/dL) were significantly associated with an increased HCC risk (P<0.05) in multivariate analysis. The risk model incorporating age, gender, AAR, and serum levels of ALT, AFP, GGT, albumin, and alpha-1 globulin had an AUROC of 0.89 for predicting 6-year HCC incidence. The AUROC was 0.91 after the addition of HBV seromarkers into the model, and 0.83 for the model without liver-related seromarkers, with the exception of ALT. Conclusion: Liver-related seromarkers may be combined into useful risk models for predicting HBV-related HCC risk.	[Lin, Yu-Ju] Natl Yang Ming Univ, Sch Life Sci, Inst Microbiol & Immunol, Taipei 112, Taiwan; [Lin, Yu-Ju; Lee, Mei-Hsuan; Yang, Hwai-I; Jen, Chin-Lan; You, San-Lin; Liu, Jessica; Chen, Chien-Jen] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan; [Lee, Mei-Hsuan] Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan; [Yang, Hwai-I] China Med Univ, Coll Med, Grad Inst Clin Med Sci, Taichung, Taiwan; [Yang, Hwai-I] China Med Univ Hosp, Mol & Genom Epidemiol Ctr, Taichung, Taiwan; [Wang, Li-Yu] MacKay Med Coll, Sch Med, Taipei, Taiwan; [Lu, Sheng-Nan] Kaohsiung Chang Gung Mem Hosp, Dept Internal Med, Kaohsiung, Taiwan; [Chen, Chien-Jen] Natl Taiwan Univ, Coll Publ Hlth, Grad Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan	National Yang Ming Chiao Tung University; Academia Sinica - Taiwan; National Yang Ming Chiao Tung University; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; Mackay Medical College; Chang Gung Memorial Hospital; National Taiwan University	Chen, CJ (corresponding author), Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan.	chencj@gate.sinica.edu.tw	Chen, Chien-Jen/N-4723-2019; Chen, Chien-Jen/C-6976-2008; Yang, Hwai-I/A-9470-2008; Lee, Mei-Hsuan/J-8880-2015	Yang, Hwai-I/0000-0002-3433-942X; Lee, Mei-Hsuan/0000-0002-0222-2251; You, San-Lin/0000-0002-3192-3356	Department of Health, Executive Yuan, Taipei, Taiwan; Bristol-Myers Squibb Co., USA; Academia Sinica, Taipei, Taiwan; National Health Research Institutes, Chunan, Taiwan [NHRI-EX98-9806PI]; Bristol-Myers Squibb Co.	Department of Health, Executive Yuan, Taipei, Taiwan; Bristol-Myers Squibb Co., USA(Bristol-Myers Squibb); Academia Sinica, Taipei, Taiwan(Academia Sinica - Taiwan); National Health Research Institutes, Chunan, Taiwan(National Health Research Institutes - Taiwan); Bristol-Myers Squibb Co.(Bristol-Myers Squibb)	Supported by research grants from Department of Health, Executive Yuan, Taipei, Taiwan; Bristol-Myers Squibb Co., USA; Academia Sinica, Taipei, Taiwan; and National Health Research Institutes (NHRI-EX98-9806PI), Chunan, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The funder, Bristol-Myers Squibb Co., supported the testing of serum levels of HBV DNA for this study. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Aghemo A, 2012, J HEPATOL, V57, P1326, DOI 10.1016/j.jhep.2012.06.025; Baranova A, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-91; Bruix J, 2001, J HEPATOL, V35, P421, DOI 10.1016/S0168-8278(01)00130-1; Chan HLY, 2004, GUT, V53, P1494, DOI 10.1136/gut.2003.033324; Chen CJ, 2011, J GASTROEN HEPATOL, V26, P628, DOI 10.1111/j.1440-1746.2011.06695.x; Chen CJ, 2009, HEPATOLOGY, V49, pS72, DOI 10.1002/hep.22884; Chen CJ, 2006, JAMA-J AM MED ASSOC, V295, P65, DOI 10.1001/jama.295.1.65; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; El-Serag HB, 2012, GASTROENTEROLOGY, V142, P1264, DOI 10.1053/j.gastro.2011.12.061; ERIKSSON S, 1986, NEW ENGL J MED, V314, P736, DOI 10.1056/NEJM198603203141202; Fattovich G, 2004, GASTROENTEROLOGY, V127, pS35, DOI 10.1053/j.gastro.2004.09.014; Fung J, 2008, LIVER INT, V28, P1408, DOI 10.1111/j.1478-3231.2008.01784.x; Giannini E, 2003, ARCH INTERN MED, V163, P218, DOI 10.1001/archinte.163.2.218; Grimes DA, 2005, LANCET, V365, P1500, DOI 10.1016/S0140-6736(05)66422-7; Iloeje UH, 2006, GASTROENTEROLOGY, V130, P678, DOI 10.1053/j.gastro.2005.11.016; Imbert-Bismut F, 2001, LANCET, V357, P1069, DOI 10.1016/S0140-6736(00)04258-6; Kao JH, 2003, GASTROENTEROLOGY, V124, P327, DOI 10.1053/gast.2003.50053; Liaw YF, 2004, NEW ENGL J MED, V351, P1521, DOI 10.1056/NEJMoa033364; Morgan TR, 2004, GASTROENTEROLOGY, V127, pS87, DOI 10.1053/j.gastro.2004.09.020; Ott JJ, 2012, VACCINE, V30, P2212, DOI 10.1016/j.vaccine.2011.12.116; Peng CY, 2012, J HEPATOL; SAWABU N, 1983, CANCER, V51, P327, DOI 10.1002/1097-0142(19830115)51:2<327::AID-CNCR2820510227>3.0.CO;2-C; Sullivan LM, 2004, STAT MED, V23, P1631, DOI 10.1002/sim.1742; Wong VWS, 2010, J CLIN ONCOL, V28, P1660, DOI 10.1200/JCO.2009.26.2675; Yang HI, 2002, NEW ENGL J MED, V347, P168, DOI 10.1056/NEJMoa013215; Yang HI, 2011, LANCET ONCOL, V12, P568, DOI 10.1016/S1470-2045(11)70077-8; Yang HI, 2010, J CLIN ONCOL, V28, P2437, DOI 10.1200/JCO.2009.27.4456; Yang JD, 2010, NAT REV GASTRO HEPAT, V7, P448, DOI 10.1038/nrgastro.2010.100; Yuen MF, 2007, ANTIVIR THER, V12, P1295; Yuen MF, 2009, J HEPATOL, V50, P80, DOI 10.1016/j.jhep.2008.07.023	30	33	36	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2013	8	4							e61448	10.1371/journal.pone.0061448	http://dx.doi.org/10.1371/journal.pone.0061448			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IK	23613855	Green Published, Green Submitted, gold			2022-12-25	WOS:000317907200057
J	Qiu, R; Chen, C; Jiang, H; Shen, LB; Wu, M; Liu, CY				Qiu, Rong; Chen, Chao; Jiang, Hong; Shen, Libing; Wu, Min; Liu, Chunyu			Large Genomic Region Free of GWAS-Based Common Variants Contains Fertility-Related Genes	PLOS ONE			English	Article							WIDE ASSOCIATION; PROJECT; TRAITS; HUMANS	DNA variants, such as single nucleotide polymorphisms (SNPs) and copy number variants (CNVs), are unevenly distributed across the human genome. Currently, dbSNP contains more than 6 million human SNPs, and whole-genome genotyping arrays can assay more than 4 million of them simultaneously. In our study, we first questioned whether published genome-wide association studies (GWASs) assays cover all regions well in the genome. Using dbSNP build 135 data, we identified 50 genomic regions longer than 100 Kb that do not contain any common SNPs, i.e., those with minor allele frequency (MAF)>= 1%. Secondly, because conserved regions are generally of functional importance, we tested genes in those large genomic regions without common SNPs. We found 97 genes and were enriched for reproduction function. In addition, we further filtered out regions with CNVs listed in the Database of Genomic Variants (DGV), segmental duplications from Human Genome Project and common variants identified by personal genome sequencing (UCSC). No region survived after those filtering. Our analysis suggests that, while there may not be many large genomic regions free of common variants, there are still some "holes" in the current human genomic map for common SNPs. Because GWAS only focused on common SNPs, interpretation of GWAS results should take this limitation into account. Particularly, two recent GWAS of fertility may be incomplete due to the map deficit. Additional SNP discovery efforts should pay close attention to these regions.	[Qiu, Rong; Wu, Min] Cent S Univ, Sch Informat Sci & Engn, Changsha, Hunan, Peoples R China; [Qiu, Rong; Wu, Min] Hunan Engn Lab Adv Control & Intelligent Automat, Changsha, Hunan, Peoples R China; [Chen, Chao; Liu, Chunyu] Univ Illinois, Dept Psychiat, Chicago, IL 60612 USA; [Chen, Chao; Liu, Chunyu] Univ Illinois, Inst Human Genet, Chicago, IL USA; [Jiang, Hong] Cent S Univ, Xiangya Hosp, Dept Neurol, Changsha, Hunan, Peoples R China; [Shen, Libing] Fudan Univ, Sch Life Sci, Shanghai 200433, Peoples R China; [Liu, Chunyu] Cent S Univ, State Key Lab Med Genet China, Changsha, Hunan, Peoples R China	Central South University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Central South University; Fudan University; Central South University	Chen, C (corresponding author), Univ Illinois, Dept Psychiat, Chicago, IL 60612 USA.	chenchaor@gmail.com; liucy@uic.edu	Liu, chunyu/Q-3901-2017		National Basic Research Program (973 Program) [2012CB944601, 2012CB517902]; New Century Excellent Talents in University [NCET-10-0836]; National Natural Science Foundation of China [61125301, 30971585, 30871354, 30710303061, 30400262, 81271260]	National Basic Research Program (973 Program)(National Basic Research Program of China); New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by National Basic Research Program (973 Program) (No. 2012CB944601, 2012CB517902, to Hong Jiang), New Century Excellent Talents in University (No. NCET-10-0836, to Hong Jiang), National Natural Science Foundation of China (No. 61125301 to Min Wu; No. 30971585, 30871354, 30710303061, 30400262, 81271260, to Hong Jiang). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aissani B, 2006, OBESITY, V14, P1605, DOI 10.1038/oby.2006.185; Bailey JA, 2001, GENOME RES, V11, P1005, DOI 10.1101/gr.GR-1871R; BURGOYNE PS, 1992, CELL, V71, P391, DOI 10.1016/0092-8674(92)90509-B; Chengmo Yang, 2011, Proceedings 2011 Design, Automation & Test in Europe; Choi J, 2007, INT J UROL, V14, P431, DOI 10.1111/j.1442-2042.2007.01741.x; Costantini M, 2006, GENOME RES, V16, P536, DOI 10.1101/gr.4910606; Costantini M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-146; Fernandes S, 2002, MOL HUM REPROD, V8, P286, DOI 10.1093/molehr/8.3.286; Hu ZB, 2012, NAT GENET, V44, P183, DOI 10.1038/ng.1040; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jiang RH, 2003, PHARMACOGENOMICS, V4, P779; Kleiman SE, 2011, FERTIL STERIL, V95, P2297, DOI 10.1016/j.fertnstert.2011.03.020; Kosova G, 2012, AM J HUM GENET, V90, P950, DOI 10.1016/j.ajhg.2012.04.016; Krausz C, 2007, ARCH ANDROLOGY, V53, P125, DOI 10.1080/01485010701271786; Lardone MC, 2007, MOL HUM REPROD, V13, P705, DOI 10.1093/molehr/gam057; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; McVean GAT, 2004, SCIENCE, V304, P581, DOI 10.1126/science.1092500; Nannya Y, 2007, HUM MOL GENET, V16, P2494, DOI 10.1093/hmg/ddm205; Oliver JL, 2004, NUCLEIC ACIDS RES, V32, pW287, DOI 10.1093/nar/gkh399; Repping S, 2003, NAT GENET, V35, P247, DOI 10.1038/ng1250; Wang WYS, 2005, NAT REV GENET, V6, P109, DOI 10.1038/nrg1522; Zhu QQ, 2011, AM J HUM GENET, V88, P458, DOI 10.1016/j.ajhg.2011.03.008	22	3	3	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2013	8	4							e61917	10.1371/journal.pone.0061917	http://dx.doi.org/10.1371/journal.pone.0061917			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IK	23613972	Green Submitted, gold, Green Published			2022-12-25	WOS:000317907200103
J	Wang, XL; Dai, HP; Wang, Q; Wang, QR; Xu, Y; Wang, Y; Sun, AN; Ruan, J; Chen, SN; Wu, DP				Wang, Xiuli; Dai, Haiping; Wang, Qian; Wang, Qinrong; Xu, Yang; Wang, Ying; Sun, Aining; Ruan, Jia; Chen, Suning; Wu, Depei			EZH2 Mutations Are Related to Low Blast Percentage in Bone Marrow and-7/del(7q) in De Novo Acute Myeloid Leukemia	PLOS ONE			English	Article							METHYLTRANSFERASE GENE EZH2; B-CELL LYMPHOMAS; MYELODYSPLASTIC SYNDROMES; PROGNOSTIC IMPACT; DNMT3A MUTATIONS; SOMATIC MUTATIONS; CLASSIFICATION; IDH2; FLT3; TET2	The purpose of the present work was to determine the incidence and clinical implications of somatic EZH2 mutations in 714 patients with de novo acute myelogenous leukemia by sequencing the entire coding region. EZH2 mutations were identified in 13/714 (1.8%) of AML patients were found to be more common in males (P = 0.033). The presence of EZH2 mutations was significantly associated with lower blast percentage (21-30%) in bone marrow (P < 0.0001) and -7/del(7q) (P = 0.025). There were no differences in the incidence of mutation in 13 genes, ASXL1, CBL, c-KIT, DNMT3A, FLT3, IDH1, IDH2, MLL, NPM1, NRAS, RUNX1, TET2, and WT1, between patients with and without EZH2 mutations. No difference in complete remission, event-free survival, or overall survival was observed between patients with and without EZH2 mutation (P > 0.05). Overall, these results showed EZH2 mutation in de novo acute myeloid leukemia as a recurrent genetic abnormality to be associated with lower blast percentage in BM and -7/del(7q).	[Wang, Xiuli; Dai, Haiping; Wang, Qian; Wang, Qinrong; Xu, Yang; Wang, Ying; Sun, Aining; Ruan, Jia; Chen, Suning; Wu, Depei] Soochow Univ, Affiliated Hosp 1, Minist Hlth, Key Lab Thrombosis & Hemostasis,Jiangsu Inst Hema, Suzhou, Peoples R China; [Ruan, Jia] Weill Cornell Med Coll, Dept Med, Div Hematol Oncol, New York, NY USA	Soochow University - China; Cornell University	Chen, SN (corresponding author), Soochow Univ, Affiliated Hosp 1, Minist Hlth, Key Lab Thrombosis & Hemostasis,Jiangsu Inst Hema, Suzhou, Peoples R China.	chensuning@sina.com; wudepei@medmail.com.cn	Xu, Yang/GOH-1228-2022	Xu, Yang/0000-0003-4643-2098	National Key Scientific Projects of China [2011CB933501]; Priority Academic Program Development of Jiangsu Higher Education Institutions; Jiangsu Province's Key Provincial Talents Program; National Natural Science Foundation of China [81070416]; Jiangsu Province Natural Science Foundation [BK2010204]; Jiangsu Province Natural Science Fund for Distinguished Young Scholars; Foundation of Jiangsu Province Health Department [H200915]	National Key Scientific Projects of China; Priority Academic Program Development of Jiangsu Higher Education Institutions; Jiangsu Province's Key Provincial Talents Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Province Natural Science Foundation(Natural Science Foundation of Jiangsu Province); Jiangsu Province Natural Science Fund for Distinguished Young Scholars; Foundation of Jiangsu Province Health Department	This work was supported in part by grants from National Key Scientific Projects of China (2011CB933501), http: //www.nsfc.gov.cn/Portal0/default152.htm; the Priority Academic Program Development of Jiangsu Higher Education Institutions, Jiangsu Province's Key Provincial Talents Program, the National Natural Science Foundation of China (81070416), http: //www.ec.js.edu.cn/; Jiangsu Province Natural Science Foundation (BK2010204); Jiangsu Province Natural Science Fund for Distinguished Young Scholars; and Foundation of Jiangsu Province Health Department (H200915), http: //www.most.gov.cn/tztg/index. htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bacher U, 2005, ANN HEMATOL, V84, P785, DOI 10.1007/s00277-005-1099-0; BENNETT JM, 1982, BRIT J HAEMATOL, V51, P189, DOI 10.1111/j.1365-2141.1982.tb08475.x; Boissel N, 2006, LEUKEMIA, V20, P965, DOI 10.1038/sj.leu.2404188; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Chou WC, 2010, BLOOD, V116, P4086, DOI 10.1182/blood-2010-05-283291; Delhommeau F, 2009, NEW ENGL J MED, V360, P2289, DOI 10.1056/NEJMoa0810069; Ernst T, 2010, NAT GENET, V42, P722, DOI 10.1038/ng.621; Greenberg P, 2000, J CLIN ONCOL, V18, P3447; Grimwade D, 2001, BLOOD, V98, P1312, DOI 10.1182/blood.V98.5.1312; Haase D, 2007, BLOOD, V110, P4385, DOI 10.1182/blood-2007-03-082404; Huh YO, 2002, LEUKEMIA, V16, P2249, DOI 10.1038/sj.leu.2402704; Jaffe E. S., 2008, WHO CLASSIFICATION T; Ley TJ, 2010, NEW ENGL J MED, V363, P2424, DOI 10.1056/NEJMoa1005143; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; Morin RD, 2010, NAT GENET, V42, P181, DOI 10.1038/ng.518; Nikoloski G, 2010, NAT GENET, V42, P665, DOI 10.1038/ng.620; Patel JP, 2012, NEW ENGL J MED, V366, P1079, DOI 10.1056/NEJMoa1112304; Rocquain J, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-401; Shiah HS, 2002, LEUKEMIA, V16, P196, DOI 10.1038/sj.leu.2402352; Sneeringer CJ, 2010, P NATL ACAD SCI USA, V107, P20980, DOI 10.1073/pnas.1012525107; Stegelmann F, 2011, LEUKEMIA, V25, P1217, DOI 10.1038/leu.2011.77; Tefferi A, 2010, LEUKEMIA, V24, P1302, DOI 10.1038/leu.2010.113; Thol F, 2010, BLOOD, V116, P614, DOI 10.1182/blood-2010-03-272146; Walter MJ, 2011, LEUKEMIA, V25, P1153, DOI 10.1038/leu.2011.44	24	34	36	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2013	8	4							e61341	10.1371/journal.pone.0061341	http://dx.doi.org/10.1371/journal.pone.0061341			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IK	23613835	Green Published, gold, Green Submitted			2022-12-25	WOS:000317907200049
J	Jin, SH; Ma, XM; Han, P; Wang, B; Sun, YG; Zhang, GZ; Li, YJ; Hou, BK				Jin, Shang-Hui; Ma, Xin-Mei; Han, Ping; Wang, Bo; Sun, Yan-Guo; Zhang, Gui-Zhi; Li, Yan-Jie; Hou, Bing-Kai			UGT74D1 Is a Novel Auxin Glycosyltransferase from Arabidopsis thaliana	PLOS ONE			English	Article							INDOLE-3-BUTYRIC ACID; GLUCOSYLTRANSFERASE; IDENTIFICATION; PROTEIN; MUTANT; BIOSYNTHESIS; HOMEOSTASIS; TRANSPORT; GROWTH; GENE	Auxin is one type of phytohormones that plays important roles in nearly all aspects of plant growth and developmental processes. The glycosylation of auxins is considered to be an essential mechanism to control the level of active auxins. Thus, the identification of auxin glycosyltransferases is of great significance for further understanding the auxin regulation. In this study, we biochemically screened the group L of Arabidopsis thaliana glycosyltransferase superfamily for enzymatic activity toward auxins. UGT74D1 was identified to be a novel auxin glycosyltransferase. Through HPLC and LC-MS analysis of reaction products in vitro by testing eight substrates including auxins and other compounds, we found that UGT74D1 had a strong glucosylating activity toward indole-3-butyric acid [IBA], indole-3-propionic acid [IPA], indole-3-acetic acid [IAA] and naphthaleneacetic acid [NAA], catalyzing them to form corresponding glucose esters. Biochemical characterization showed that this enzyme had a maximum activity in HEPES buffer at pH 6.0 and 37 degrees C. In addition, the enzymatic activity analysis of crude protein and the IBA metabolite analysis from transgenic Arabidopsis plants overexpressing UGT74D1 gene were also carried out. Experimental results indicated that over-production of the UGT74D1 in plants indeed led to increased level of the glucose conjugate of IBA. Moreover, UGT74D1 overexpression lines displayed curling leaf phenotype, suggesting a physiological role of UGT74D1 in affecting the activity of auxins. Our current data provide a new target gene for further genetic studies to understand the auxin regulation by glycosylation in plants.	[Jin, Shang-Hui; Ma, Xin-Mei; Han, Ping; Wang, Bo; Sun, Yan-Guo; Zhang, Gui-Zhi; Li, Yan-Jie; Hou, Bing-Kai] Educ Minist China, Key Lab Plant Cell Engn & Germplasm Innovat, Jinan, Shandong, Peoples R China; [Jin, Shang-Hui; Ma, Xin-Mei; Han, Ping; Wang, Bo; Sun, Yan-Guo; Zhang, Gui-Zhi; Li, Yan-Jie; Hou, Bing-Kai] Shandong Univ, Sch Life Sci, Jinan 250100, Shandong, Peoples R China	Shandong University	Hou, BK (corresponding author), Educ Minist China, Key Lab Plant Cell Engn & Germplasm Innovat, Jinan, Shandong, Peoples R China.	bkhou@sdu.edu.cn			National Natural Science Foundation of China [90917006, 30971543]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by grants from the National Natural Science Foundation of China (No. 90917006 and No. 30971543 to B. K. H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bajguz A, 2009, PHYTOCHEMISTRY, V70, P957, DOI 10.1016/j.phytochem.2009.05.006; Bandurski RS, 1995, PLANT HORMONES, P118; Bartel B, 2001, J PLANT GROWTH REGUL, V20, P198, DOI 10.1007/s003440010025; Benjamins R, 2008, ANNU REV PLANT BIOL, V59, P443, DOI 10.1146/annurev.arplant.58.032806.103805; Bowles D, 2006, ANNU REV PLANT BIOL, V57, P567, DOI 10.1146/annurev.arplant.57.032905.105429; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; COHEN JD, 1982, ANNU REV PLANT PHYS, V33, P403, DOI 10.1146/annurev.pp.33.060182.002155; de Carbonnel M, 2010, PLANT PHYSIOL, V152, P1391, DOI 10.1104/pp.109.150441; EPSTEIN E, 1993, PHYSIOL PLANTARUM, V88, P382, DOI 10.1111/j.1399-3054.1993.tb05513.x; Grubb CD, 2004, PLANT J, V40, P893, DOI 10.1111/j.1365-313X.2004.02261.x; Hou BK, 2004, J BIOL CHEM, V279, P47822, DOI 10.1074/jbc.M409569200; Jackson RG, 2002, PLANT J, V32, P573, DOI 10.1046/j.1365-313X.2002.01445.x; Jackson RG, 2001, J BIOL CHEM, V276, P4350, DOI 10.1074/jbc.M006185200; Kazan K, 2009, TRENDS PLANT SCI, V14, P373, DOI 10.1016/j.tplants.2009.04.005; Kieffer M, 2010, CURR OPIN PLANT BIOL, V13, P12, DOI 10.1016/j.pbi.2009.10.006; Li Y, 2001, J BIOL CHEM, V276, P4338, DOI 10.1074/jbc.M007447200; Lim EK, 2004, EMBO J, V23, P2915, DOI 10.1038/sj.emboj.7600295; Lim EK, 2002, J BIOL CHEM, V277, P586, DOI 10.1074/jbc.M109287200; Lim EK, 2001, J BIOL CHEM, V276, P4344, DOI 10.1074/jbc.M007263200; Liu X, 2012, PLANT PHYSIOL, V158, P1988, DOI 10.1104/pp.111.191288; Ljung K, 2002, PLANT MOL BIOL, V50, P309, DOI 10.1023/A:1016024017872; Ludwig-Muller J, 2011, J EXP BOT, V62, P1757, DOI 10.1093/jxb/erq412; Ludwig-Muller J, 2000, PLANT GROWTH REGUL, V32, P219, DOI 10.1023/A:1010746806891; LUDWIGMULLER J, 1995, PHYSIOL PLANTARUM, V94, P651, DOI 10.1111/j.1399-3054.1995.tb00980.x; LUDWIGMULLER J, 1993, PLANT GROWTH REGUL, V13, P179, DOI 10.1007/BF00024260; LUDWIGMULLER J, 1993, PLANT GROWTH REGUL, V13, P189, DOI 10.1007/BF00024261; Oono Y, 1998, PLANT CELL, V10, P1649, DOI 10.1105/tpc.10.10.1649; Park JE, 2007, J BIOL CHEM, V282, P10036, DOI 10.1074/jbc.M610524200; Poupart J, 2005, PLANT PHYSIOL, V139, P1460, DOI 10.1104/pp.105.067967; Rampey RA, 2004, PLANT PHYSIOL, V135, P978, DOI 10.1104/pp.104.039677; Rashotte AM, 2003, PLANT PHYSIOL, V133, P761, DOI 10.1104/pp.103.022582; Ross J, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2001-2-2-reviews3004; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Strader Lucia C, 2010, Plant Physiol, V153, P1577, DOI 10.1104/pp.110.157461; Strader LC, 2011, PLANT CELL, V23, P984, DOI 10.1105/tpc.111.083071; Strader LC, 2011, MOL PLANT, V4, P477, DOI 10.1093/mp/ssr006; SZERSZEN JB, 1994, SCIENCE, V265, P1699, DOI 10.1126/science.8085154; Tam YY, 2000, PLANT PHYSIOL, V123, P589, DOI 10.1104/pp.123.2.589; Tognetti VB, 2010, PLANT CELL, V22, P2660, DOI 10.1105/tpc.109.071316; Ulmasov T, 1999, P NATL ACAD SCI USA, V96, P5844, DOI 10.1073/pnas.96.10.5844; Vanneste S, 2009, CELL, V136, P1005, DOI 10.1016/j.cell.2009.03.001; Woodward AW, 2005, ANN BOT-LONDON, V95, P707, DOI 10.1093/aob/mci083; Zhang HR, 2008, PLANT CELL, V20, P1879, DOI 10.1105/tpc.108.061150; Zolman BK, 2007, PLANT MOL BIOL, V64, P59, DOI 10.1007/s11103-007-9134-2; Zolman BR, 2008, GENETICS, V180, P237, DOI 10.1534/genetics.108.090399; Zolman BK, 2001, J BIOL CHEM, V276, P31037, DOI 10.1074/jbc.M104679200; Zolman BK, 2001, PLANT PHYSIOL, V127, P1266, DOI 10.1104/pp.010550; Zolman BK, 2000, GENETICS, V156, P1323	48	70	76	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2013	8	4							e61705	10.1371/journal.pone.0061705	http://dx.doi.org/10.1371/journal.pone.0061705			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130DR	23613909	Green Published, gold, Green Submitted			2022-12-25	WOS:000317893400097
J	Papazi, A; Kotzabasis, K				Papazi, Aikaterini; Kotzabasis, Kiriakos			"Rational" Management of Dichlorophenols Biodegradation by the Microalga Scenedesmus obliquus	PLOS ONE			English	Article							PHENOLIC-COMPOUNDS; RHODOCOCCUS-CHLOROPHENOLICUS; POLYCHLORINATED PHENOLS; CHLORINATED PHENOLS; TETRASELMIS-MARINA; 2,4-DICHLOROPHENOL DEGRADATION; 4-CHLOROPHENOL DEGRADATION; PHOTOSYNTHETIC BACTERIA; AQUEOUS-SOLUTION; O-CHLOROPHENOL	The microalga Scenedesmus obliquus exhibited the ability to biodegrade dichlorophenols (dcps) under specific autotrophic and mixotrophic conditions. According to their biodegradability, the dichlorophenols used can be separated into three distinct groups. Group I (2,4-dcp and 2,6 dcp - no meta-substitution) consisted of quite easily degraded dichlorophenols, since both chloride substituents are in less energetically demanding positions. Group II (2,3-dcp, 2,5-dcp and 3,4-dcp - one meta-chloride) was less susceptible to biodegradation, since one of the two substituents, the meta one, required higher energy for C-Cl-bond cleavage. Group III (3,5-dcp - two meta-chlorides) could not be biodegraded, since both chlorides possessed the most energy demanding positions. In general, when the dcp-toxicity exceeded a certain threshold, the microalga increased the energy offered for biodegradation and decreased the energy invested for biomass production. As a result, the biodegradation per cell volume of group II (higher toxicity) was higher, than group I (lower toxicity) and the biodegradation of dichlorophenols (higher toxicity) was higher than the corresponding monochlorophenols (lower toxicity). The participation of the photosynthetic apparatus and the respiratory mechanism of microalga to biodegrade the group I and the group II, highlighted different bioenergetic strategies for optimal management of the balance between dcp-toxicity, dcp-biodegradability and culture growth. Additionally, we took into consideration the possibility that the intermediates of each dcp-biodegradation pathway could influence differently the whole biodegradation procedures. For this reason, we tested all possible combinations of phenolic intermediates to check cometabolic interactions. The present contribution bring out the possibility of microalgae to operate as "smart" bioenergetic "machines", that have the ability to continuously "calculate" the energy reserves and "use" the most energetically advantageous dcp-biodegradation strategy. We tried to manipulate the above fact, changing the energy reserves and as a result the chosen strategy, in order to take advantage of their abilities in detoxifying the environment.	[Papazi, Aikaterini; Kotzabasis, Kiriakos] Univ Crete, Dept Biol, Iraklion, Crete, Greece	University of Crete	Kotzabasis, K (corresponding author), Univ Crete, Dept Biol, Voutes Univ Campus, Iraklion, Crete, Greece.	kotzab@biology.uoc.gr	Kotzabasis, Kiriakos/AAP-1448-2021	Kotzabasis, Kiriakos/0000-0002-1002-6365				APAJALAHTI JHA, 1987, J BACTERIOL, V169, P5125, DOI 10.1128/jb.169.11.5125-5130.1987; APAJALAHTI JHA, 1987, J BACTERIOL, V169, P675, DOI 10.1128/jb.169.2.675-681.1987; APAJALAHTI JHA, 1986, APPL MICROBIOL BIOT, V25, P62; Bishop NL, 1971, PREPARATION PHOTOSYN, P130; Boyd EM, 2001, CHEMOSPHERE, V43, P157, DOI 10.1016/S0045-6535(00)00266-6; BOYD SA, 1984, APPL ENVIRON MICROB, V47, P272, DOI 10.1128/AEM.47.2.272-277.1984; Caldeira M, 1999, APPL MICROBIOL BIOT, V52, P722, DOI 10.1007/s002530051584; CASSADY CJ, 1994, ORG MASS SPECTROM, V29, P30, DOI 10.1002/oms.1210290106; Catalkaya EC, 2003, ENVIRON SCI POLLUT R, V10, P113, DOI 10.1065/espr2002.10.135; Guedes AC, 2011, BIOTECHNOL PROGR, V27, P1218, DOI 10.1002/btpr.649; Chinalia A.F., 2007, TERR AQUAT ENV TOXIC, V1, P24; Chu J., 1973, Developments in Industrial Microbiology, V14, P264; Czaplicka M, 2006, J HAZARD MATER, V134, P45, DOI 10.1016/j.jhazmat.2005.10.039; DELIEU T, 1981, NEW PHYTOL, V89, P165, DOI 10.1111/j.1469-8137.1981.tb07480.x; Dong Yi-hua, 2011, Yingyong Shengtai Xuebao, V22, P1280; ENSLEY HE, 1994, ENVIRON TOXICOL CHEM, V13, P325, DOI 10.1002/etc.5620130217; Fahr K, 1999, FEMS MICROBIOL LETT, V175, P127, DOI 10.1111/j.1574-6968.1999.tb13611.x; FRAGIADAKIS A, 1981, CHEMOSPHERE, V10, P1315, DOI 10.1016/0045-6535(81)90049-7; Gaffron H, 1939, BIOL ZENTRALBL, V43, P402; Gomes JRB, 2003, J PHYS CHEM A, V107, P869, DOI 10.1021/jp026707k; HAGGBLOM MM, 1988, APPL ENVIRON MICROB, V54, P3043; Hu Xiao-min, 2010, Huanjing Kexue, V31, P1672; HULZEBOS EM, 1993, ENVIRON TOXICOL CHEM, V12, P1079, DOI 10.1002/etc.5620120614; Ivanov VL, 2011, HIGH ENERG CHEM+, V45, P210, DOI 10.1134/S0018143911030064; KNACKMUSS HJ, 1978, ARCH MICROBIOL, V117, P1, DOI 10.1007/BF00689343; LAMAR RT, 1990, APPL ENVIRON MICROB, V56, P3519, DOI 10.1128/AEM.56.11.3519-3526.1990; LIU JQ, 1992, ENVIRON POLLUT, V75, P273, DOI 10.1016/0269-7491(92)90127-V; Lo KV, 1998, ENVIRON TECHNOL, V19, P91, DOI 10.1080/09593331908616659; Logothetis K, 2004, J PLANT PHYSIOL, V161, P715, DOI 10.1078/0176-1617-00942; Lovell CR, 2002, MAR ECOL PROG SER, V229, P11, DOI 10.3354/meps229011; Mandal S, 2009, APPL MICROBIOL BIOT, V84, P281, DOI 10.1007/s00253-009-1935-6; Mars AE, 1997, J BACTERIOL, V179, P4530, DOI 10.1128/jb.179.14.4530-4537.1997; Nakagawa A, 2006, BIOSCI BIOTECH BIOCH, V70, P525, DOI 10.1271/bbb.70.525; Pan L, 2010, IND ENG CHEM RES, V49, P8526, DOI 10.1021/ie100841w; Papazi A, 2008, J BIOTECHNOL, V135, P366, DOI 10.1016/j.jbiotec.2008.05.009; Papazi A, 2007, J BIOTECHNOL, V129, P706, DOI 10.1016/j.jbiotec.2007.02.021; Papazi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049037; Perez RR, 1997, BIORESOURCE TECHNOL, V60, P207, DOI 10.1016/S0960-8524(97)00022-9; Petroutsos D, 2008, PHYTOCHEMISTRY, V69, P707, DOI 10.1016/j.phytochem.2007.09.002; Petroutsos D, 2007, J APPL PHYCOL, V19, P485, DOI 10.1007/s10811-007-9160-0; Petroutsos D, 2007, AQUAT TOXICOL, V85, P192, DOI 10.1016/j.aquatox.2007.09.007; RAVANEL P, 1985, ECOTOX ENVIRON SAFE, V9, P300, DOI 10.1016/0147-6513(85)90048-X; RAVANEL P, 1989, ECOTOX ENVIRON SAFE, V18, P337, DOI 10.1016/0147-6513(89)90027-4; Rodriguez I, 1996, J CHROMATOGR A, V721, P297, DOI 10.1016/0021-9673(95)00795-4; ROY S, 1994, ENVIRON TOXICOL CHEM, V13, P763, DOI 10.1002/etc.5620130511; SABER DL, 1985, APPL ENVIRON MICROB, V50, P1512, DOI 10.1128/AEM.50.6.1512-1518.1985; Schafer TE, 1999, J BIOMED MATER RES, V45, P192, DOI 10.1002/(SICI)1097-4636(19990605)45:3<192::AID-JBM5>3.3.CO;2-1; Semple KT, 1996, APPL ENVIRON MICROB, V62, P1265, DOI 10.1128/AEM.62.4.1265-1273.1996; SENGER H, 1986, PHYSIOL PLANTARUM, V68, P119, DOI 10.1111/j.1399-3054.1986.tb06605.x; Sharma HA, 1997, ENVIRON TOXICOL CHEM, V16, P346, DOI [10.1002/etc.5620160233, 10.1897/1551-5028(1997)016&lt;0346:ACOTTA&gt;2.3.CO;2]; SPAIN JC, 1988, APPL ENVIRON MICROB, V54, P1399, DOI 10.1128/AEM.54.6.1399-1404.1988; Staples CA, 1998, CHEMOSPHERE, V36, P2149, DOI 10.1016/S0045-6535(97)10133-3; STEIERT JG, 1987, APPL ENVIRON MICROB, V53, P907, DOI 10.1128/AEM.53.5.907-910.1987; Strasser BJ, 1995, PHOTOSYNTHESIS: FROM LIGHT TO BIOSPHERE, VOL 5, P977; Talano MA, 2012, ENVIRON SCI POLLUT R, V19, P2202, DOI 10.1007/s11356-011-0724-9; TISSUT M, 1987, ECOTOX ENVIRON SAFE, V13, P32, DOI 10.1016/0147-6513(87)90040-6; TOMASI I, 1995, J BACTERIOL, V177, P307, DOI 10.1128/jb.177.2.307-311.1995; Tsuji N, 2003, BIOTECHNOL LETT, V25, P241, DOI 10.1023/A:1022333406348; Uchida M, 2003, J SOLUTION CHEM, V32, P19, DOI 10.1023/A:1022980614320; von Sonntag C, 2008, WATER SCI TECHNOL, V58, P1015, DOI 10.2166/wst.2008.467; Wang CC, 2000, CHEMOSPHERE, V41, P447, DOI 10.1016/S0045-6535(99)00263-5; Webb MD, 2001, SOIL BIOL BIOCHEM, V33, P1903, DOI 10.1016/S0038-0717(01)00115-8; Wu Wei-zhong, 2008, Huanjing Kexue, V29, P3185; Zertal A, 2001, J PHOTOCH PHOTOBIO A, V146, P37, DOI 10.1016/S1010-6030(01)00534-2; Zhao BX, 2007, PHOTOCHEM PHOTOBIOL, V83, P642, DOI 10.1562/2006-09-05-RA-1030	66	29	29	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2013	8	4							e61682	10.1371/journal.pone.0061682	http://dx.doi.org/10.1371/journal.pone.0061682			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130DR	23613903	Green Submitted, Green Published, gold			2022-12-25	WOS:000317893400091
J	Tinnikov, AA; Samuels, HH				Tinnikov, Alexander A.; Samuels, Herbert H.			A Novel Cell Lysis Approach Reveals That Caspase-2 Rapidly Translocates from the Nucleus to the Cytoplasm in Response to Apoptotic Stimuli	PLOS ONE			English	Article							SELECTIVELY MODULATES APOPTOSIS; BREAST-CANCER CELLS; DNA-DAMAGE RESPONSE; ESTROGEN-RECEPTOR; ACTIVATION; DEATH; LOCALIZATION; INHIBITION; PRODOMAIN; COMPLEX	Unlike other caspases, caspase-2 appears to be a nuclear protein although immunocytochemical studies have suggested that it may also be localized to the cytosol and golgi. Where and how caspase-2 is activated in response to apoptotic signals is not clear. Earlier immunocytochemistry studies suggest that caspase-2 is activated in the nucleus and through cleavage of BID leads to increased mitochondrial permeability. More recent studies using bimolecular fluorescence complementation found that caspase-2 oligomerization that leads to activation only occurs in the cytoplasm. Thus, apoptotic signals may lead to activation of caspase-2 which may already reside in the cytoplasm or lead to release of nuclear caspase-2 to the extranuclear cytoplasmic compartment. It has not been possible to study release of nuclear caspase-2 to the cytoplasm by cell fractionation studies since cell lysis is known to release nuclear caspase-2 to the extra-nuclear fraction. This is similar to what is known about unliganded nuclear estrogen receptor-alpha (ER alpha) when cells are disrupted. In this study we found that pretreatment of cells with N-ethylmaleimide (NEM), which alkylates cysteine thiol groups in proteins, completely prevents redistribution of caspase-2 and ER alpha from the nucleus to the extra-nuclear fraction when cells are lysed. Using this approach we provide evidence that apoptotic signals rapidly leads to a shift of caspase-2 from the nucleus to the extra-nuclear fraction, which precedes the detection of apoptosis. These findings are consistent with a model where apoptotic signals lead to a rapid shift of caspase-2 from the nucleus to the cytoplasm where activation occurs.	[Tinnikov, Alexander A.; Samuels, Herbert H.] NYU, Sch Med, Dept Biochem & Mol Pharmacol, New York, NY USA	New York University	Samuels, HH (corresponding author), NYU, Sch Med, Dept Biochem & Mol Pharmacol, New York, NY USA.	herbert.samuels@nyumc.org			New York State Peter T. Rowley Breast Cancer Research Award [C026592]	New York State Peter T. Rowley Breast Cancer Research Award	This work was supported by a New York State Peter T. Rowley Breast Cancer Research Award (C026592) (to HHS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baliga BC, 2003, J BIOL CHEM, V278, P4899, DOI 10.1074/jbc.M211512200; Benjamin CW, 1998, MOL PHARMACOL, V53, P446, DOI 10.1124/mol.53.3.446; Bouchier-Hayes L, 2010, J CELL MOL MED, V14, P1212, DOI 10.1111/j.1582-4934.2010.01037.x; Bouchier-Hayes L, 2010, CELL CYCLE, V9, P12, DOI 10.4161/cc.9.1.10477; Bouchier-Hayes L, 2009, MOL CELL, V35, P830, DOI 10.1016/j.molcel.2009.07.023; Cande C, 2002, J CELL SCI, V115, P4727, DOI 10.1242/jcs.00210; Chauvier D, 2005, APOPTOSIS, V10, P1243, DOI 10.1007/s10495-005-1681-x; Cohen GM, 1997, BIOCHEM J, V326, P1, DOI 10.1042/bj3260001; Colussi PA, 1999, IMMUNOL CELL BIOL, V77, P58, DOI 10.1046/j.1440-1711.1999.00788.x; Colussi PA, 1998, J BIOL CHEM, V273, P24535, DOI 10.1074/jbc.273.38.24535; Das S, 2007, CANCER RES, V67, P1775, DOI 10.1158/0008-5472.CAN-06-4034; Dorstyn L, 2012, CELL DEATH DIFFER, V19, P1288, DOI 10.1038/cdd.2012.36; FORSLING ML, 1968, J PHYSIOL-LONDON, V194, P535, DOI 10.1113/jphysiol.1968.sp008422; Gottardi CJ, 2004, J CELL BIOL, V167, P339, DOI 10.1083/jcb.200402153; Guo Y, 2002, J BIOL CHEM, V277, P13430, DOI 10.1074/jbc.M108029200; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Ho LH, 2009, P NATL ACAD SCI USA, V106, P5336, DOI 10.1073/pnas.0811928106; Kamada S, 2005, J BIOL CHEM, V280, P857, DOI 10.1074/jbc.C400538200; Krumschnabel G, 2009, CELL DEATH DIFFER, V16, P195, DOI 10.1038/cdd.2008.170; Kudo N, 1999, P NATL ACAD SCI USA, V96, P9112, DOI 10.1073/pnas.96.16.9112; Kumar S, 2009, NAT REV CANCER, V9, P897, DOI 10.1038/nrc2745; Lahm A, 2003, CELL DEATH DIFFER, V10, P10, DOI 10.1038/sj.cdd.4401203; Li DS, 2004, MOL CELL BIOL, V24, P3838, DOI 10.1128/MCB.24.9.3838-3848.2004; Mancini M, 2000, J CELL BIOL, V149, P603, DOI 10.1083/jcb.149.3.603; Manzl C, 2009, J CELL BIOL, V185, P291, DOI 10.1083/jcb.200811105; Nonclercq D, 2007, J MOL ENDOCRINOL, V39, P105, DOI 10.1677/JME-07-0040; O'Reilly LA, 2002, CELL DEATH DIFFER, V9, P832, DOI 10.1038/sj.cdd.4401033; Paroni G, 2002, J BIOL CHEM, V277, P15147, DOI 10.1074/jbc.M112338200; Paroni G, 2001, J BIOL CHEM, V276, P21907, DOI 10.1074/jbc.M011565200; PRESS MF, 1989, AM J PATHOL, V135, P857; Rehm M, 2002, J BIOL CHEM, V277, P24506, DOI 10.1074/jbc.M110789200; Ren KQ, 2012, J BIOL CHEM, V287, P14792, DOI 10.1074/jbc.M112.347625; SAMUELS HH, 1973, P NATL ACAD SCI USA, V70, P3488, DOI 10.1073/pnas.70.12.3488; SAMUELS HH, 1979, ENDOCRINOLOGY, V105, P80, DOI 10.1210/endo-105-1-80; Shikama Y, 2001, EXP CELL RES, V264, P315, DOI 10.1006/excr.2000.5153; Sohn D, 2011, CELL DEATH DIFFER, V18, P1664, DOI 10.1038/cdd.2011.34; Sugimoto K, 1998, BLOOD, V91, P1407, DOI 10.1182/blood.V91.4.1407; Taylor RC, 2008, NAT REV MOL CELL BIO, V9, P231, DOI 10.1038/nrm2312; Tinnikov AA, 2009, CANCER RES, V69, P1375, DOI 10.1158/0008-5472.CAN-08-2896; Troy CM, 2003, CELL DEATH DIFFER, V10, P101, DOI 10.1038/sj.cdd.4401175; Wang XD, 2001, GENE DEV, V15, P2922; Yeung KT, 2011, MOL CELL BIOL, V31, P2287, DOI 10.1128/MCB.01381-10; Yoshida H, 2003, CELL STRUCT FUNCT, V28, P3	43	11	12	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2013	8	4							e61085	10.1371/journal.pone.0061085	http://dx.doi.org/10.1371/journal.pone.0061085			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125TD	23596516	gold, Green Published, Green Submitted			2022-12-25	WOS:000317563300020
J	Franzellitti, S; Fabbri, E				Franzellitti, Silvia; Fabbri, Elena			Cyclic-AMP Mediated Regulation of ABCB mRNA Expression in Mussel Haemocytes	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; MYTILUS-GALLOPROVINCIALIS; P-GLYCOPROTEIN; MULTIDRUG-RESISTANCE; SEROTONIN-RECEPTOR; DEFENSE-MECHANISM; CAMP; 5-HT; MXR; GENES	Background: The multixenobiotic resistance system (MXR) allows aquatic organisms to cope with their habitat despite high pollution levels by over-expressing membrane and intracellular transporters, including the P-glycoprotein (Pgp). In mammals transcription of the ABCB1 gene encoding Pgp is under cAMP/PKA-mediated regulation; whether this is true in mollusks is not fully clarified. Methodology/Principal Findings: cAMP/PKA regulation and ABCB mRNA expression were assessed in haemocytes from Mediterranean mussels (Mytilus galloprovincialis) exposed in vivo for 1 week to 0.3 ng/L fluoxetine (FX) alone or in combination with 0.3 ng/L propranolol (PROP). FX significantly decreased cAMP levels and PKA activity, and induced ABCB mRNA down-regulation. FX effects were abolished in the presence of PROP. In vitro experiments using haemocytes treated with physiological agonists (noradrenaline and serotonin) and pharmacological modulators (PROP, forskolin, dbcAMP, and H89) of the cAMP/PKA system were performed to obtain clear evidence about the involvement of the signaling pathway in the transcriptional regulation of ABCB. Serotonin (5-HT) decreased cAMP levels, PKA activity and ABCB mRNA expression but increased the mRNA levels for a putative 5-HT1 receptor. Interestingly, 5-HT1 was also over-expressed after in vivo exposures to FX. 5-HT effects were counteracted by PROP. Forskolin and dbcAMP increased PKA activity as well as ABCB mRNA expression; the latter effect was abolished in the presence of the PKA inhibitor H89. Conclusions: This study provides the first direct evidence for the cAMP/PKA-mediated regulation of ABCB transcription in mussels.	[Franzellitti, Silvia; Fabbri, Elena] Univ Bologna, Interdept Ctr Environm Sci Res, Ravenna, Italy; [Fabbri, Elena] Univ Bologna, Dept Biol Geol & Environm Sci, Bologna, Italy	University of Bologna; University of Bologna	Franzellitti, S (corresponding author), Univ Bologna, Interdept Ctr Environm Sci Res, Ravenna, Italy.	silvia.franzellitti@unibo.it		Franzellitti, Silvia/0000-0001-6104-7812; FABBRI, Elena/0000-0002-9957-8202	Ministry of Education and Scientific Research (MIUR-RFO )	Ministry of Education and Scientific Research (MIUR-RFO )	The research has been granted by Ministry of Education and Scientific Research (MIUR-RFO 2009) to E.F. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER BS, 1987, J PHARM PHARMACOL, V39, P664, DOI 10.1111/j.2042-7158.1987.tb03452.x; Angers A, 1998, J NEUROSCI, V18, P5586; Ashton D, 2004, SCI TOTAL ENVIRON, V333, P167, DOI 10.1016/j.scitotenv.2004.04.062; Banni M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018904; Bard SM, 2000, AQUAT TOXICOL, V48, P357, DOI 10.1016/S0166-445X(00)00088-6; Bardales JR, 2008, FEBS J, V275, P4479, DOI 10.1111/j.1742-4658.2008.06591.x; Bardales JR, 2011, ACTA HISTOCHEM, V113, P743, DOI 10.1016/j.acthis.2010.11.002; Buratti S, 2013, ENVIRON TOXICOL, V28, P451, DOI 10.1002/tox.20739; Canesi L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019803; Cao A, 2004, FISH SHELLFISH IMMUN, V16, P215, DOI 10.1016/S1050-4648(03)00080-9; Cao A, 2007, INT IMMUNOPHARMACOL, V7, P1395, DOI 10.1016/j.intimp.2007.07.008; Chekmenev DS, 2005, NUCLEIC ACIDS RES, V33, pW432, DOI 10.1093/nar/gki441; Ciacci C, 2011, FISH SHELLFISH IMMUN, V31, P1026, DOI 10.1016/j.fsi.2011.09.002; Ciocan CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022326; Cubero-Leon E, 2012, ENVIRON SCI POLLUT R, V19, P2728, DOI 10.1007/s11356-012-0772-9; Cubero-Leon E, 2010, AQUAT TOXICOL, V98, P178, DOI 10.1016/j.aquatox.2010.02.007; Dailianis S, 2007, ARCH ENVIRON CON TOX, V52, P371, DOI 10.1007/s00244-006-0073-8; DeVane CL, 1999, CELL MOL NEUROBIOL, V19, P443, DOI 10.1023/A:1006934807375; Dondero F, 2005, GENE, V345, P259, DOI 10.1016/j.gene.2004.11.031; Ericson H, 2010, AQUAT TOXICOL, V99, P223, DOI 10.1016/j.aquatox.2010.04.017; Eufemia NA, 2000, AQUAT TOXICOL, V49, P89, DOI 10.1016/S0166-445X(99)00068-5; Fabbri E, 2006, AQUAT TOXICOL, V76, P59, DOI 10.1016/j.aquatox.2005.09.007; Fabbri E, 2010, J EXP ZOOL PART A, V313A, P179, DOI 10.1002/jez.592; Farcy E, 2009, CELL STRESS CHAPERON, V14, P371, DOI 10.1007/s12192-008-0091-8; Fent K, 2006, AQUAT TOXICOL, V76, P122, DOI 10.1016/j.aquatox.2005.09.009; Fong PP, 2003, J EXP ZOOL PART A, V298A, P67, DOI 10.1002/a.10279; Franzellitti S, 2006, BIOCHEM BIOPH RES CO, V351, P719, DOI 10.1016/j.bbrc.2006.10.089; Franzellitti S, 2011, COMP BIOCHEM PHYS C, V154, P377, DOI 10.1016/j.cbpc.2011.07.006; Franzellitti S, 2011, AQUAT TOXICOL, V101, P299, DOI 10.1016/j.aquatox.2010.11.001; Franzellitti S, 2010, COMP BIOCHEM PHYS C, V152, P24, DOI 10.1016/j.cbpc.2010.02.010; Gonzalez-Riopedre M, 2009, MOL CELL BIOCHEM, V332, P243, DOI 10.1007/s11010-009-0197-z; Grabe N., 2002, SILICO BIOL, V2, P1; Hannon J, 2008, BEHAV BRAIN RES, V195, P198, DOI 10.1016/j.bbr.2008.03.020; Hiemke C, 2000, PHARMACOL THERAPEUT, V85, P11, DOI 10.1016/S0163-7258(99)00048-0; Huggett DB, 2002, ARCH ENVIRON CON TOX, V43, P229, DOI 10.1007/s00244-002-1182-7; Humphries JE, 2003, INTEGR COMP BIOL, V43, P305, DOI 10.1093/icb/43.2.305; Idriss HT, 2000, J PHYSIOL-LONDON, V524, P629, DOI 10.1111/j.1469-7793.2000.00629.x; Lacoste A, 2001, GEN COMP ENDOCR, V122, P252, DOI 10.1006/gcen.2001.7643; Lacoste A, 2001, J CELL SCI, V114, P3557; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Martin-Diaz L, 2009, AQUAT TOXICOL, V94, P177, DOI 10.1016/j.aquatox.2009.06.015; Minier C, 2000, AQUAT TOXICOL, V50, P167, DOI 10.1016/S0166-445X(99)00104-6; Oakes Ken D., 2010, Integrated Environmental Assessment and Management, V6, P524, DOI 10.1002/ieam.77; PEROUTKA SJ, 1994, NEUROPHARMACOLOGY, V33, P319, DOI 10.1016/0028-3908(94)90060-4; PEROUTKA SJ, 1994, NEUROCHEM INT, V25, P533, DOI 10.1016/0197-0186(94)90151-1; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Plows LD, 2005, INT J PARASITOL, V35, P293, DOI 10.1016/j.ijpara.2004.11.012; ROHLFF C, 1995, CELL SIGNAL, V7, P431, DOI 10.1016/0898-6568(95)00018-K; Rohlff C, 1998, INT J ONCOL, V12, P383; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schug J., 2008, CURR PROTOC BIOINFOR, V21, DOI DOI 10.1002/0471250953.BI0206S21; Scotto K W, 2001, Mol Interv, V1, P117; Smital T, 2011, ECOTOX ENVIRON SAFE, V74, P844, DOI 10.1016/j.ecoenv.2010.11.010; SUGAMORI KS, 1993, P NATL ACAD SCI USA, V90, P11, DOI 10.1073/pnas.90.1.11; Sukhai M, 2000, J PHARM PHARM SCI, V3, P268; Thomas KV, 2004, MAR POLLUT BULL, V49, P436, DOI 10.1016/j.marpolbul.2004.02.028; Tierney AJ, 2001, COMP BIOCHEM PHYS A, V128, P791, DOI 10.1016/S1095-6433(00)00320-2; TINAJERO JC, 1993, ENDOCRINOLOGY, V133, P257, DOI 10.1210/en.133.1.257; Tiu SHK, 2005, GENE, V353, P41, DOI 10.1016/j.gene.2005.03.037; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Varotto L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054602; Vasskog T, 2008, J CHROMATOGR A, V1185, P194, DOI 10.1016/j.chroma.2008.01.063; Weir MR, 2009, POSTGRAD MED, V121, P90, DOI 10.3810/pgm.2009.05.2007; Zaja R, 2006, COMP BIOCHEM PHYS C, V143, P103, DOI 10.1016/j.cbpc.2005.12.009; Zhang LL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035484	65	29	29	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2013	8	4							e61634	10.1371/journal.pone.0061634	http://dx.doi.org/10.1371/journal.pone.0061634			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123JP	23593491	Green Published, gold, Green Submitted			2022-12-25	WOS:000317385300078
J	Furnari, MA; Jobes, ML; Nekrasova, T; Minden, A; Wagner, GC				Furnari, Melody A.; Jobes, Michelle L.; Nekrasova, Tanya; Minden, Audrey; Wagner, George C.			Functional Deficits in Pak5, Pak6 and Pak5/Pak6 Knockout Mice	PLOS ONE			English	Article							P21-ACTIVATED PROTEIN-KINASE; TARGETED DISRUPTION; ACTIN CYTOSKELETON; BRAIN	The p21-activated kinases are effector proteins for Rho-family GTPases. PAK4, PAK5, and PAK6 are the group II PAKs associated with neurite outgrowth, filopodia formation, and cell survival. Pak4 knockout mice are embryonic lethal, while Pak5, Pak6, and Pak5/Pak6 double knockout mice are viable and fertile. Our previous work found that the double knockout mice exhibit locomotor changes and learning and memory deficits. We also found some differences with Pak5 and Pak6 single knockout mice and the present work further explores the potential differences of the Pak5 knockout and Pak6 knockout mice in comparison with wild type mice. The Pak6 knockout mice were found to weigh significantly more than the other genotypes. The double knockout mice were found to be less active than the other genotypes. The Pak5 knockout mice and the double knockout mice performed worse on the rotorod test. All the knockout genotypes were found to be less aggressive in the resident intruder paradigm. The double knockout mice were, once again, found to perform worse in the active avoidance assay. These results indicate, that although some behavioral differences are seen in the Pak5 and Pak6 single knockout mice, the double knockout mice exhibit the greatest changes in locomotion and learning and memory.	[Furnari, Melody A.; Jobes, Michelle L.] Rutgers State Univ, Joint Program Toxicol, Piscataway, NJ USA; [Nekrasova, Tanya; Minden, Audrey] Rutgers State Univ, Susan Lehman Cullman Lab Canc Res, Dept Biol Chem, Ernesto Mario Sch Pharm, Piscataway, NJ USA; [Wagner, George C.] Rutgers State Univ, Dept Psychol, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University New Brunswick	Wagner, GC (corresponding author), Rutgers State Univ, Dept Psychol, Piscataway, NJ 08854 USA.	gcwagner@rci.rutgers.edu			 [ES007148];  [ES05022]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007148] Funding Source: NIH RePORTER	; ; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Supported in part by ES007148 and ES05022. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abo A, 1998, EMBO J, V17, P6527, DOI 10.1093/emboj/17.22.6527; Arias-Romero LE, 2008, BIOL CELL, V100, P97, DOI 10.1042/BC20070109; Bagrodia S, 1999, TRENDS CELL BIOL, V9, P350, DOI 10.1016/S0962-8924(99)01618-9; Dan C, 2002, MOL CELL BIOL, V22, P567, DOI 10.1128/MCB.22.2.567-577.2002; Daniels RH, 1999, TRENDS BIOCHEM SCI, V24, P350, DOI 10.1016/S0968-0004(99)01442-5; Fan WQ, 2005, DIABETES, V54, P1000, DOI 10.2337/diabetes.54.4.1000; Jaffer ZM, 2002, INT J BIOCHEM CELL B, V34, P713, DOI 10.1016/S1357-2725(01)00158-3; Knaus UG, 1998, INT J BIOCHEM CELL B, V30, P857, DOI 10.1016/S1357-2725(98)00059-4; Lee SR, 2002, MOL ENDOCRINOL, V16, P85, DOI 10.1210/me.16.1.85; Li XF, 2003, MOL CELL BIOL, V23, P7134, DOI 10.1128/MCB.23.20.7134-7142.2003; Nekrasova T, 2008, DEV BIOL, V322, P95, DOI 10.1016/j.ydbio.2008.07.006; Pandey A, 2002, ONCOGENE, V21, P3939, DOI 10.1038/sj.onc.1205478; Qu J, 2003, MOL CELL BIOL, V23, P7122, DOI 10.1128/MCB.23.20.7122-7133.2003; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Sells MA, 1997, TRENDS CELL BIOL, V7, P162, DOI 10.1016/S0962-8924(97)01003-9; Soosairajah J, 2005, EMBO J, V24, P473, DOI 10.1038/sj.emboj.7600543; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Vadlamudi RK, 2003, CANCER METAST REV, V22, P385, DOI 10.1023/A:1023729130497; Wells CM, 2010, BIOCHEM J, V425, P465, DOI 10.1042/BJ20091173; Yang F, 2001, J BIOL CHEM, V276, P15345, DOI 10.1074/jbc.M010311200; Zito K, 2004, NEURON, V44, P321, DOI 10.1016/j.neuron.2004.09.022	21	21	22	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2013	8	4							e61321	10.1371/journal.pone.0061321	http://dx.doi.org/10.1371/journal.pone.0061321			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130FG	23593460	Green Published, gold, Green Submitted			2022-12-25	WOS:000317898000124
J	Zhu, X; Guo, Y; Yao, S; Yan, Q; Xue, M; Hao, T; Zhou, F; Zhu, J; Qin, D; Lu, C				Zhu, X.; Guo, Y.; Yao, S.; Yan, Q.; Xue, M.; Hao, T.; Zhou, F.; Zhu, J.; Qin, D.; Lu, C.			Synergy between Kaposi's sarcoma-associated herpesvirus (KSHV) vIL-6 and HIV-1 Nef protein in promotion of angiogenesis and oncogenesis: role of the AKT signaling pathway	ONCOGENE			English	Article						KSHV vIL-6; angiogenesis; tumorigenesis; signal pathway	LYTIC CYCLE REPLICATION; IMMUNODEFICIENCY-VIRUS REPLICATION; IN-VITRO; T-CELLS; TYPE-1; ACTIVATION; AIDS; INFECTION; GP130; INDUCTION	Kaposi's sarcoma-associated herpesvirus (KSHV) is the cause of Kaposi's sarcoma (KS), which is the most common AIDS-associated malignancy. KS is characterized by neovascularization and spindle cell proliferation. The interaction between HIV-1 and KSHV has a central role in promoting the aggressive manifestations of KS in AIDS patients; however, the pathogenesis underlying AIDS-related KS (AIDS-KS) remains unknown. Herein, we examined the potential of HIV-1 negative factor (Nef) to impact KSHV viral interleukin-6 (vIL-6)-induced angiogenesis and tumorigenesis. In vitro experiments showed that exogenous Nef penetrated vIL-6-expressing endothelial cells. Both internalized and ectopic expression of Nef in endothelial cells and fibroblasts synergized with vIL-6 to promote vascular tube formation and cell proliferation. Using a chicken chorioallantoic membrane (CAM) model, we demonstrated that Nef synergistically promotes vIL-6-induced angiogenesis and tumorigenesis. Animal experiments further showed that Nef facilitates vIL-6-induced angiogenesis and tumor formation in athymic nu/nu mice. Mechanistic studies indicated that Nef synergizes with vIL-6 to enhance angiogenesis and tumorigenesis by activating the AKT pathway in the CAM model, as well as nude mice. LY294002, a specific inhibitor of phosphatidylinositol-3-kinase (PI3K), significantly impaired the ability of Nef to promote vIL-6-induced tumorigenesis in an allograft model of nude mice. Our data provide first-line evidence that Nef may contribute to the pathogenesis underlying AIDS-KS in synergy with vIL-6. These novel findings also suggest that targeting the PI3K/AKT signal may be a potentially effective therapeutic approach in AIDS-KS patients.	[Zhu, X.; Lu, C.] Nanjing Med Univ, State Key Lab Reprod Med, Nanjing 210029, Jiangsu, Peoples R China; [Zhu, X.; Lu, C.] Nanjing Med Univ, Key Lab Pathogen Biol Jiangsu Prov, Nanjing 210029, Jiangsu, Peoples R China; [Zhu, X.; Guo, Y.; Yan, Q.; Xue, M.; Hao, T.; Zhou, F.; Qin, D.; Lu, C.] Nanjing Med Univ, Dept Microbiol & Immunol, Nanjing 210029, Jiangsu, Peoples R China; [Zhu, X.] Jiangsu Prov Hosp Tradit Chinese Med, Dept Lab Med, Nanjing, Jiangsu, Peoples R China; [Yao, S.] Quzhou Coll Technol, Sch Med, Quzhou, Peoples R China; [Zhu, J.] Univ Pittsburgh, Inst Canc, Canc Virol Program, Pittsburgh, PA USA	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing University of Chinese Medicine; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Lu, C (corresponding author), Nanjing Med Univ, Dept Microbiol & Immunol, Nanjing 210029, Jiangsu, Peoples R China.	diqin@njmu.edu.cn; clu@njmu.edu.cn		yuanyuan, guo/0000-0002-5122-8545	National Basic Research Program of China (973 Program) [2011CB504803]; National Natural Science Foundation of China [81171552, 30972619, 30900064, 31270199]; Ph.D Programs Foundation of Ministry of Education of China [20123234110006]; Natural Science Foundation of Ministry of Education of Jiangsu Province [10KJA310032, 09KJB310007]; Research Fund for the Doctoral Program of Higher Education of China (New Teacher Fund) [20093234120004]; China Postdoctoral Science Foundation [2012M511304]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ph.D Programs Foundation of Ministry of Education of China(Ministry of Education, China); Natural Science Foundation of Ministry of Education of Jiangsu Province; Research Fund for the Doctoral Program of Higher Education of China (New Teacher Fund); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by grants from the National Basic Research Program of China (973 Program) (2011CB504803), National Natural Science Foundation of China (81171552, 30972619, 30900064, 31270199), the Ph.D Programs Foundation of Ministry of Education of China (20123234110006), Natural Science Foundation of Ministry of Education of Jiangsu Province (great project 10KJA310032 and grant 09KJB310007), Research Fund for the Doctoral Program of Higher Education of China (New Teacher Fund, grant 20093234120004) and China Postdoctoral Science Foundation (2012M511304).	AIKEN C, 1994, CELL, V76, P853, DOI 10.1016/0092-8674(94)90360-3; Akula SM, 2003, J VIROL, V77, P7978, DOI 10.1128/JVI.77.14.7978-7990.2003; Aoki Y, 1999, BLOOD, V93, P4034, DOI 10.1182/blood.V93.12.4034.412k38_4034_4043; Aoki Y, 2000, J HEMATOTH STEM CELL, V9, P137, DOI 10.1089/152581600319351; BERAL V, 1990, LANCET, V335, P123, DOI 10.1016/0140-6736(90)90001-L; Blagoveshchenskaya AD, 2002, CELL, V111, P853, DOI 10.1016/S0092-8674(02)01162-5; Blum L, 1997, AIDS, V11, P1653; Boshoff C, 2001, PHILOS T R SOC B, V356, P517, DOI 10.1098/rstb.2000.0778; BOVI PD, 1986, CANCER RES, V46, P6333; Caby MP, 2005, INT IMMUNOL, V17, P879, DOI 10.1093/intimm/dxh267; Cerimele F, 2001, J VIROL, V75, P2435, DOI 10.1128/JVI.75.5.2435-2443.2001; CESARMAN E, 1995, NEW ENGL J MED, V332, P1186, DOI 10.1056/NEJM199505043321802; CHANG Y, 1994, SCIENCE, V266, P1865, DOI 10.1126/science.7997879; Chen XY, 2009, NEOPLASIA, V11, P1272, DOI 10.1593/neo.09494; Choi J, 2005, J VIROL, V79, P11194, DOI 10.1128/JVI.79.17.11194-11204.2005; Choi J, 2005, J VIROL, V79, P264, DOI 10.1128/JVI.79.1.264-276.2005; Cullen BR, 1998, CELL, V93, P685, DOI 10.1016/S0092-8674(00)81431-2; Ensoli B, 1996, EUR J CANCER PREV, V5, P410; ENSOLI B, 1993, J VIROL, V67, P277, DOI 10.1128/JVI.67.1.277-287.1993; Fujii Y, 1996, FEBS LETT, V393, P93, DOI 10.1016/0014-5793(96)00859-9; Ganem D, 2006, ANNU REV PATHOL-MECH, V1, P273, DOI 10.1146/annurev.pathol.1.110304.100133; Greenway AL, 2003, J BIOSCIENCES, V28, P323, DOI 10.1007/BF02970151; Guo HG, 2004, J VIROL, V78, P9336, DOI 10.1128/JVI.78.17.9336-9342.2004; GUY B, 1990, VIROLOGY, V176, P413, DOI 10.1016/0042-6822(90)90011-F; GUY B, 1987, NATURE, V330, P266, DOI 10.1038/330266a0; Hanna Z, 1998, CELL, V95, P163, DOI 10.1016/S0092-8674(00)81748-1; Harrington W, 1997, LANCET, V349, P774; He JCJ, 2004, J CLIN INVEST, V114, P643, DOI 10.1172/JCI200421004; Husain M, 2005, AIDS, V19, P1975, DOI 10.1097/01.aids.0000191918.42110.27; Junkin M, 2011, BIOMATERIALS, V32, P1848, DOI 10.1016/j.biomaterials.2010.11.009; KAAYA EE, 1995, J ACQ IMMUN DEF SYND, V10, P295; KESTLER HW, 1991, CELL, V65, P651, DOI 10.1016/0092-8674(91)90097-I; Leonard JA, 2011, J VIROL, V85, P6867, DOI 10.1128/JVI.00229-11; Linnemann T, 2002, VIROLOGY, V294, P246, DOI 10.1006/viro.2002.1365; Macreadie IG, 1998, J BIOMED SCI, V5, P203, DOI 10.1007/BF02253470; Marecki JC, 2006, AM J RESP CRIT CARE, V174, P437, DOI 10.1164/rccm.200601-005OC; Meads MB, 2004, J BIOL CHEM, V279, P51793, DOI 10.1074/jbc.M407382200; Merat R, 2002, INT J CANCER, V97, P791, DOI 10.1002/ijc.10086; Mercader M, 2000, AM J PATHOL, V156, P1961, DOI 10.1016/S0002-9440(10)65069-9; Mocroft A, 1998, ARCH INTERN MED, V158, P491, DOI 10.1001/archinte.158.5.491; Molden J, 1997, J BIOL CHEM, V272, P19625, DOI 10.1074/jbc.272.31.19625; Moore PS, 1996, SCIENCE, V274, P1739, DOI 10.1126/science.274.5293.1739; Morris VA, 2008, J VIROL, V82, P8771, DOI 10.1128/JVI.00766-08; Morris VA, 2012, VIROLOGY, V428, P112, DOI 10.1016/j.virol.2012.03.013; Mullberg J, 2000, J IMMUNOL, V164, P4672, DOI 10.4049/jimmunol.164.9.4672; Peter F, 1998, IMMUNITY, V9, P433, DOI 10.1016/S1074-7613(00)80626-3; Qiao XG, 2006, NAT IMMUNOL, V7, P302, DOI 10.1038/ni1302; Qin D, 2008, CELL MICROBIOL, V10, P713, DOI 10.1111/j.1462-5822.2007.01079.x; Qin D, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-240; Raymond AD, 2011, AIDS RES HUM RETROV, V27, P167, DOI 10.1089/aid.2009.0170; Strathdee S A, 1996, AIDS, V10 Suppl A, pS51, DOI 10.1097/00002030-199601001-00008; Suthaus J, 2011, EUR J CELL BIOL, V90, P495, DOI 10.1016/j.ejcb.2010.10.016; Tang Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031652; Varthakavi V, 1999, J VIROL, V73, P10329, DOI 10.1128/JVI.73.12.10329-10338.1999; Voelkel NF, 2008, AIDS, V22, pS49, DOI 10.1097/01.aids.0000327516.55041.01; Wan XY, 1999, J VIROL, V73, P8268, DOI 10.1128/JVI.73.10.8268-8278.1999; Wolf D, 2001, NAT MED, V7, P1217, DOI 10.1038/nm1101-1217; Xu WF, 2009, NAT IMMUNOL, V10, P1008, DOI 10.1038/ni.1753; Zeng Y, 2007, J VIROL, V81, P2401, DOI 10.1128/JVI.02024-06; Zhou F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053145; Zhu TS, 2011, CANCER RES, V71, P6061, DOI 10.1158/0008-5472.CAN-10-4269; Zhu XL, 2011, J MOL BIOL, V410, P1035, DOI 10.1016/j.jmb.2011.03.055	62	51	53	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 10	2014	33	15					1986	1996		10.1038/onc.2013.136	http://dx.doi.org/10.1038/onc.2013.136			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AE9RK	23604117				2022-12-25	WOS:000334346300011
J	Reyes, D; Ballare, C; Castellano, G; Soronellas, D; Bago, JR; Blanco, J; Beato, M				Reyes, D.; Ballare, C.; Castellano, G.; Soronellas, D.; Bago, J. R.; Blanco, J.; Beato, M.			Activation of mitogen- and stress-activated kinase 1 is required for proliferation of breast cancer cells in response to estrogens or progestins	ONCOGENE			English	Article						breast cancer; xenografts; estrogen receptor; progesterone receptor; T47D; hormone signaling	NF-KAPPA-B; PROGESTERONE-RECEPTOR; HISTONE H3; GENE-REGULATION; PHOSPHORYLATION; PROTEIN; PATHWAY; MSK1; INDUCTION; ESTRADIOL	Growth of breast cancers is often dependent on ovarian steroid hormones making the tumors responsive to antagonists of hormone receptors. However, eventually the tumors become hormone independent, raising the need to identify downstream targets for the inhibition of tumor growth. One possibility is to focus on the signaling mechanisms used by ovarian steroid hormones to induce breast cancer cell proliferation. Here we report that the mitogen- and stress-activated kinase 1 (MSK1) could be a potential druggable target. Using the breast cancer cell line T47D, we show that estrogens (E2) and progestins activate MSK1, which forms a complex with the corresponding hormone receptor. Inhibition of MSK1 activity with H89 or its depletion by MSK1 short hairpin RNAs (shRNAs) specifically abrogates cell proliferation in response to E2 or progestins without affecting serum-induced cell proliferation. MSK1 activity is required for the transition from the G1- to the S-phase of the cell cycle and inhibition of MSK1 compromises both estradiol- and progestin-dependent induction of cell cycle genes. ChIP-seq experiments identified binding of MSK1 to progesterone receptor-binding sites associated with hormone-responsive genes. MSK1 recruitment to epigenetically defined enhancer regions supports the need of MSK1 as a chromatin remodeler in hormone-dependent regulation of gene transcription. In agreement with this interpretation, expression of a histone H3 mutated at S10 eliminates the hormonal effect on cell proliferation and on induction of relevant target genes. Finally, we show that E2- or progestin-dependent growth of T47D cells xenografted in immunodefficient mice is inhibited by depletion of MSK1, indicating that our findings are not restricted to cultured cells, and that MSK1 plays an important role for hormone-dependent breast cancer growth in a more physiological context.	[Reyes, D.; Ballare, C.; Castellano, G.; Soronellas, D.; Beato, M.] CRG, Barcelona 08003, Spain; [Reyes, D.; Ballare, C.; Castellano, G.; Soronellas, D.; Beato, M.] UPF, Barcelona, Spain; [Bago, J. R.; Blanco, J.] CIBER BBN, CSIC ICCC, Cardiovasc Res Ctr, Barcelona, Spain	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Pompeu Fabra University; CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Institut Catala de Ciencies Cardiovasculars (ICCC)	Beato, M (corresponding author), CRG, Doctor Aiguader 88, Barcelona 08003, Spain.	miguel.beato@crg.eu	BAGO, JULI R/M-3526-2018; Beato, Miguel/B-5564-2015; Reyes, Diana/GSI-6210-2022; Reyes Garau, Diana/ABF-9958-2021; Reyes, Diana/A-9441-2017; Blanco, Jeronimo/H-2764-2015; Ballare, Cecilia/F-2593-2016	BAGO, JULI R/0000-0002-2862-4048; Beato, Miguel/0000-0002-2878-2222; Reyes Garau, Diana/0000-0002-9746-6485; Blanco, Jeronimo/0000-0003-3765-0640; Ballare, Cecilia/0000-0002-9442-807X; Castellano, Giancarlo/0000-0002-5715-7733	Spanish government [BMC 2003-02902, 2010-15313, CSD2006-00049]; European Union (IP HEROIC); Catalan government (AGAUR); fellowship from the Spanish Ministry of Science	Spanish government(Spanish GovernmentEuropean Commission); European Union (IP HEROIC); Catalan government (AGAUR)(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)); fellowship from the Spanish Ministry of Science	We thank Luciano Di Croce, CRG, for providing the expression vector for histone H3, the CRG ultrasequencing facility and Dr Juan Valcarcel for help with the manuscript. The experimental work has been supported by grants from the Spanish government (BMC 2003-02902 and 2010-15313; CSD2006-00049), the European Union (IP HEROIC) and the Catalan government (AGAUR). DR was the recipient of a fellowship from the Spanish Ministry of Science.	Allred DC, 2001, ENDOCR-RELAT CANCER, V8, P47, DOI 10.1677/erc.0.0080047; Arthur JSC, 2004, J NEUROSCI, V24, P4324, DOI 10.1523/JNEUROSCI.5227-03.2004; Ballare C, 2003, MOL CELL BIOL, V23, P1994, DOI 10.1128/MCB.23.6.1994-2008.2003; Ballare C, 2013, MOL CELL, V49, P67, DOI 10.1016/j.molcel.2012.10.019; Banks E, 2003, LANCET, V362, P419, DOI 10.1016/S0140-6736(03)14065-2; BEATO M, 1995, CELL, V83, P851, DOI 10.1016/0092-8674(95)90201-5; BLOBEL GA, 1995, MOL CELL BIOL, V15, P3147; Boonyaratanakornkit V, 2001, MOL CELL, V8, P269, DOI 10.1016/S1097-2765(01)00304-5; Cerillo G, 1998, J STEROID BIOCHEM, V67, P79, DOI 10.1016/S0960-0760(98)00078-8; Chang S, CANC INVEST, V29, P240; CLARKE CL, 1990, J BIOL CHEM, V265, P12694; Clarke R, 2003, ONCOGENE, V22, P7316, DOI 10.1038/sj.onc.1206937; Cui KR, 2009, CELL STEM CELL, V4, P80, DOI 10.1016/j.stem.2008.11.011; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Deak M, 1998, EMBO J, V17, P4426, DOI 10.1093/emboj/17.15.4426; Drobic B, NUCL ACIDS RES, V38, P3196; Drobic B, 2010, NUCLEIC ACIDS RES, V38, P3196, DOI 10.1093/nar/gkq030; Foidart JM, 1998, FERTIL STERIL, V69, P963, DOI 10.1016/S0015-0282(98)00042-9; Harrell JC, 2007, CANCER RES, V67, P10582, DOI 10.1158/0008-5472.CAN-07-1655; Hewitt SC, 2005, ANNU REV PHYSIOL, V67, P285, DOI 10.1146/annurev.physiol.67.040403.115914; Hirota T, 2005, NATURE, V438, P1176, DOI 10.1038/nature04254; Khan SA, 1998, J NATL CANCER I, V90, P37, DOI 10.1093/jnci/90.1.37; Kushner PJ, 2000, J STEROID BIOCHEM, V74, P311, DOI 10.1016/S0960-0760(00)00108-4; Kuukasjarvi T, 1996, J CLIN ONCOL, V14, P2584, DOI 10.1200/JCO.1996.14.9.2584; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lauper N, 1998, ONCOGENE, V17, P2637, DOI 10.1038/sj.onc.1202477; Lavoie JN, 1996, J BIOL CHEM, V271, P20608, DOI 10.1074/jbc.271.34.20608; Lochner A, 2006, CARDIOVASC DRUG REV, V24, P261, DOI 10.1111/j.1527-3466.2006.00261.x; LYDON JP, 1995, GENE DEV, V9, P2266, DOI 10.1101/gad.9.18.2266; Migliaccio A, 1996, EMBO J, V15, P1292, DOI 10.1002/j.1460-2075.1996.tb00471.x; Migliaccio A, 1998, EMBO J, V17, P2008, DOI 10.1093/emboj/17.7.2008; NANDI S, 1958, J NATL CANCER I, V21, P1039; Vicent GP, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000567; Prigent C, 2003, J CELL SCI, V116, P3677, DOI 10.1242/jcs.00735; Ritchie ME, 2007, BIOINFORMATICS, V23, P2700, DOI 10.1093/bioinformatics/btm412; Sancho M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000227; Sassone-Corsi P, 1999, SCIENCE, V285, P886, DOI 10.1126/science.285.5429.886; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Strutt H, 1999, METH MOL B, V119, P455; Subtil-Rodriguez A, 2008, MOL CELL BIOL, V28, P3830, DOI 10.1128/MCB.01217-07; Thomson S, 1999, SEMIN CELL DEV BIOL, V10, P205, DOI 10.1006/scdb.1999.0302; Vermeulen L, 2003, EMBO J, V22, P1313, DOI 10.1093/emboj/cdg139; Vicent GP, GENES DEV, V25, P845; Vicent GP, 2006, MOL CELL, V24, P367, DOI 10.1016/j.molcel.2006.10.011; Vicent Guillermo P, 2009, Nucl Recept Signal, V7, pe008, DOI 10.1621/nrs.07008; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; Weinstein-Oppenheimer CR, 2002, CANCER BIOL THER, V1, P256, DOI 10.4161/cbt.77; Wiggin GR, 2002, MOL CELL BIOL, V22, P2871, DOI 10.1128/MCB.22.8.2871-2881.2002; WILSON JE, 1972, BIOCHIM BIOPHYS ACTA, V276, P568, DOI 10.1016/0005-2744(72)91022-4; Wright RHG, 2012, GENE DEV, V26, P1972, DOI 10.1101/gad.193193.112	50	25	25	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 20	2014	33	12					1570	1580		10.1038/onc.2013.95	http://dx.doi.org/10.1038/onc.2013.95			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AD4TS	23604116				2022-12-25	WOS:000333244200010
J	Sergeeva, OA; Chen, B; Haase-Pettingell, C; Ludtke, SJ; Chiu, W; King, JA				Sergeeva, Oksana A.; Chen, Bo; Haase-Pettingell, Cameron; Ludtke, Steven J.; Chiu, Wah; King, Jonathan A.			Human CCT4 and CCT5 Chaperonin Subunits Expressed in Escherichia coli Form Biologically Active Homo-oligomers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROUP-II CHAPERONIN; GAMMA-D CRYSTALLIN; CRYO-EM STRUCTURE; BINDING-SITES; IN-VITRO; MOLECULAR CHAPERONES; FOLDING CYCLE; COMPLEX; PROTEIN; TRIC/CCT	Chaperonins are a family of chaperones that encapsulate their substrates and assist their folding in an ATP-dependent manner. The ubiquitous eukaryotic chaperonin, TCP-1 ring complex (TRiC), is a hetero-oligomeric complex composed of two rings, each formed from eight different CCT (chaperonin containing TCP-1) subunits. Each CCT subunit may have distinct substrate recognition and ATP hydrolysis properties. We have expressed each human CCT subunit individually in Escherichia coli to investigate whether they form chaperonin-like double ring complexes. CCT4 and CCT5, but not the other six CCT subunits, formed high molecular weight complexes within the E. coli cells that sedimented about 20S in sucrose gradients. When CCT4 and CCT5 were purified, they were both organized as two back-to-back rings of eight subunits each, as seen by negative stain and cryo-electron microscopy. This morphology is consistent with that of the hetero-oligomeric double-ring TRiC purified from bovine testes and HeLa cells. Both CCT4 and CCT5 homo-oligomers hydrolyzed ATP at a rate similar to human TRiC and were active as assayed by luciferase refolding and human gamma D-crystallin aggregation suppression and refolding. Thus, both CCT4 and CCT5 homo-oligomers have the property of forming 8-fold double rings absent the other subunits, and these complexes carry out chaperonin reactions without other partner subunits.	[Sergeeva, Oksana A.; Haase-Pettingell, Cameron; King, Jonathan A.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Chen, Bo; Ludtke, Steven J.; Chiu, Wah] Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Chen, Bo; Ludtke, Steven J.] Baylor Coll Med, Natl Ctr Macromol Imaging, Houston, TX 77030 USA	Massachusetts Institute of Technology (MIT); Baylor College of Medicine; Baylor College of Medicine	King, JA (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave 68-330, Cambridge, MA 02139 USA.	jaking@mit.edu	; Ludtke, Steven/A-4478-2008	Sergeeva, Oksana/0000-0002-4830-0518; Ludtke, Steven/0000-0002-1903-1574	National Institutes of Health [PN2EY016525, R01EY015834, P41GM103832]; NATIONAL EYE INSTITUTE [R01EY015834, PN2EY016525] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103832] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Common Fund Grants PN2EY016525, R01EY015834, and P41GM103832.	Acosta-Sampson L, 2010, J MOL BIOL, V401, P134, DOI 10.1016/j.jmb.2010.05.067; Bigotti MG, 2008, ARCH BIOCHEM BIOPHYS, V474, P331, DOI 10.1016/j.abb.2008.03.015; BRAIG K, 1994, NATURE, V371, P578, DOI 10.1038/371578a0; Chen DH, 2006, STRUCTURE, V14, P1711, DOI 10.1016/j.str.2006.09.010; CHENG MY, 1990, NATURE, V348, P455, DOI 10.1038/348455a0; Cong Y, 2012, EMBO J, V31, P720, DOI 10.1038/emboj.2011.366; Cong Y, 2010, P NATL ACAD SCI USA, V107, P4967, DOI 10.1073/pnas.0913774107; Dekker C, 2011, EMBO J, V30, P3078, DOI 10.1038/emboj.2011.208; Douglas NR, 2011, CELL, V144, P240, DOI 10.1016/j.cell.2010.12.017; Feldman DE, 2003, MOL CELL, V12, P1213, DOI 10.1016/S1097-2765(03)00423-4; Ferreyra RG, 2000, METH MOL B, V140, P153; Finnigan GC, 2012, NATURE, V481, P360, DOI 10.1038/nature10724; Flaugh SL, 2005, PROTEIN SCI, V14, P571, DOI 10.1110/ps.041111405; FRYDMAN J, 1992, EMBO J, V11, P4767, DOI 10.1002/j.1460-2075.1992.tb05582.x; Frydman J, 2001, ANNU REV BIOCHEM, V70, P603, DOI 10.1146/annurev.biochem.70.1.603; Glynn SE, 2009, CELL, V139, P744, DOI 10.1016/j.cell.2009.09.034; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; HEYN MP, 1975, BIOPHYS CHEM, V3, P35, DOI 10.1016/0301-4622(75)80035-4; Horwich AL, 2007, ANNU REV CELL DEV BI, V23, P115, DOI 10.1146/annurev.cellbio.23.090506.123555; Hynes GM, 2000, J BIOL CHEM, V275, P18985, DOI 10.1074/jbc.M910297199; Kalisman N, 2012, P NATL ACAD SCI USA, V109, P2884, DOI 10.1073/pnas.1119472109; KIKUCHI Y, 1975, J MOL BIOL, V99, P695, DOI 10.1016/S0022-2836(75)80180-X; KIM S, 1994, TRENDS BIOCHEM SCI, V19, P543, DOI 10.1016/0968-0004(94)90058-2; Knee KM, 2013, CELL STRESS CHAPERON, V18, P137, DOI 10.1007/s12192-012-0357-z; Knee KM, 2011, PROTEIN SCI, V20, P30, DOI 10.1002/pro.531; Kosinski-Collins MS, 2003, PROTEIN SCI, V12, P480, DOI 10.1110/ps.0225503; Kubota H, 1999, EUR J BIOCHEM, V262, P492, DOI 10.1046/j.1432-1327.1999.00405.x; Leitner A, 2012, STRUCTURE, V20, P814, DOI 10.1016/j.str.2012.03.007; LEWIS VA, 1992, NATURE, V358, P249, DOI 10.1038/358249a0; Liou AKF, 1997, EMBO J, V16, P4311, DOI 10.1093/emboj/16.14.4311; Llorca O, 1999, NATURE, V402, P693, DOI 10.1038/45294; Llorca O, 2001, J STRUCT BIOL, V135, P205, DOI 10.1006/jsbi.2001.4359; Llorca O, 2000, EMBO J, V19, P5971, DOI 10.1093/emboj/19.22.5971; Machida K, 2012, PROTEIN EXPRES PURIF, V82, P61, DOI 10.1016/j.pep.2011.11.010; Martin-Benito J, 2004, P NATL ACAD SCI USA, V101, P17410, DOI 10.1073/pnas.0405070101; Martin-Benito J, 2007, EMBO REP, V8, P252, DOI 10.1038/sj.embor.7400894; Moreau KL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037256; Munoz IG, 2011, NAT STRUCT MOL BIOL, V18, P14, DOI 10.1038/nsmb.1971; Neirynck K, 2006, J MOL BIOL, V355, P124, DOI 10.1016/j.jmb.2005.10.051; Pappenberger G, 2006, J MOL BIOL, V360, P484, DOI 10.1016/j.jmb.2006.05.003; Pereira JH, 2012, EMBO J, V31, P731, DOI 10.1038/emboj.2011.468; Pereira JH, 2010, J BIOL CHEM, V285, P27958, DOI 10.1074/jbc.M110.125344; Reissmann S, 2007, NAT STRUCT MOL BIOL, V14, P432, DOI 10.1038/nsmb1236; Reissmann S, 2012, CELL REP, V2, P866, DOI 10.1016/j.celrep.2012.08.036; Roobol A, 1999, EUR J CELL BIOL, V78, P21, DOI 10.1016/S0171-9335(99)80004-1; ROOBOL A, 1995, J CELL SCI, V108, P1477; Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013; Satish L, 2011, CELL STRESS CHAPERON, V16, P675, DOI 10.1007/s12192-011-0274-6; Scheres SHW, 2012, NAT METHODS, V9, P853, DOI 10.1038/nmeth.2115; Sontag EM, 2013, P NATL ACAD SCI USA, V110, P3077, DOI 10.1073/pnas.1222663110; Spiess C, 2006, MOL CELL, V24, P25, DOI 10.1016/j.molcel.2006.09.003; Tam S, 2006, NAT CELL BIOL, V8, P1155, DOI 10.1038/ncb1477; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Tang YC, 2006, CELL, V125, P903, DOI 10.1016/j.cell.2006.04.027; Thulasiraman V, 2000, METH MOL B, V140, P169; Thulasiraman V, 1999, EMBO J, V18, P85, DOI 10.1093/emboj/18.1.85; Trent JD, 1997, P NATL ACAD SCI USA, V94, P5383, DOI 10.1073/pnas.94.10.5383; YAFFE MB, 1992, NATURE, V358, P245, DOI 10.1038/358245a0; Zhang JJ, 2010, NATURE, V463, P379, DOI 10.1038/nature08701; Zhang QH, 2012, J BIOL CHEM, V287, P20625, DOI 10.1074/jbc.M112.341487	60	39	41	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2013	288	24					17734	17744		10.1074/jbc.M112.443929	http://dx.doi.org/10.1074/jbc.M112.443929			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	164AH	23612981	Green Published, hybrid			2022-12-25	WOS:000320380600063
J	Chen, Y; Decker, KF; Zheng, DL; Matkovich, SJ; Jia, L; Dorn, GW				Chen, Yun; Decker, Keith F.; Zheng, Dali; Matkovich, Scot J.; Jia, Li; Dorn, Gerald W., II			A Nucleus-targeted Alternately Spliced Nix/Bnip3L Protein Isoform Modifies Nuclear Factor kappa B (NF kappa B)-mediated Cardiac Transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; PROGRAMMED CELL-DEATH; ENDOPLASMIC-RETICULUM CA2+; BCL-2 FAMILY-MEMBERS; MITOCHONDRIAL APOPTOSIS; HEART-FAILURE; C-ELEGANS; NIX; MICE; CARDIOMYOPATHY	Several Bcl2 family proteins are expressed both as mitochondrial-targeted full-length and as cytosolic truncated alternately spliced isoforms. Recombinantly expressed shorter Bcl2 family isoforms can heterotypically bind to and prevent mitochondrial localization of their full-length analogs, thus suppressing their activity by sequestration. This "sponge" role requires 1:1 expression stoichiometry; absent this an alternate role is suggested. Here, RNA sequencing revealed coordinate regulation of BH3-only protein Nix/Bnip3L (Nix) and its alternately spliced soluble form (sNix) in hearts, but relative sNix/Nix expression of similar to 1:10. Accordingly, we examined other putative functions of sNix. Although Nix expressed in H9c2 rat myoblasts localized to mitochondria, sNix showed variable cytoplasmic and nuclear distribution. Tumor necrosis factor alpha (TNF alpha) induced rapid and complete sNix nucleoplasmic translocation concomitant with nuclear translocation of the p65/RelA subunit of NF kappa B. sNix co-localized and co-precipitated with p65/RelA after TNF alpha stimulation; TNF alpha-induced sNix nuclear translocation did not occur in p65/RelA null murine embryonic fibroblasts. ChIP sequencing of TNF alpha-stimulated H9c2 cells revealed sNix suppression of p65/RelA binding to a subset of weaker DNA binding sites, accounting for its ability to alter gene expression in cultured cells and in vivo mouse hearts. These findings reveal TNF alpha-stimulated cytoplasmic-nuclear shuttling of the alternately spliced non-mitochondrial Nix isoform and uncover a role for sNix as a modulator of TNF alpha/NF kappa B-stimulated cardiac gene expression. Transcriptional co-regulation of sNix and Nix, combined with sNix posttranslational regulation by TNF alpha, comprises a previously unknown mechanism for molecular cross-talk between extrinsic death receptor and intrinsic mitochondrial apoptosis pathways.	[Chen, Yun; Decker, Keith F.; Zheng, Dali; Matkovich, Scot J.; Jia, Li; Dorn, Gerald W., II] Washington Univ, Ctr Pharmacogenom, Dept Med, Sch Med, St Louis, MO 63110 USA	Washington University (WUSTL)	Jia, L (corresponding author), Washington Univ, Ctr Pharmacogenom, Campus Box 8220,660 S Euclid Ave, St Louis, MO 63110 USA.	ljia@dom.wustl.edu; gdorn@dom.wustl.edu	li, jia/GVT-7587-2022; Matkovich, Scot J/B-9077-2009; Jia, li/GPW-8015-2022; Zheng, Dali/J-2973-2019; Matkovich, Scot J/AFP-0908-2022; Zheng, Dali/B-4577-2012	Matkovich, Scot J/0000-0002-7398-6857; Zheng, Dali/0000-0003-2345-4040; Matkovich, Scot J/0000-0002-7398-6857; Zheng, Dali/0000-0003-2345-4040	National Institutes of Health through the NHLBI [R01 HL059888]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059888] Funding Source: NIH RePORTER	National Institutes of Health through the NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 HL059888 through the NHLBI (to G.W.D.).	Aronow BJ, 2001, PHYSIOL GENOMICS, V6, P19, DOI 10.1152/physiolgenomics.2001.6.1.19; BEG AA, 1995, NATURE, V376, P167, DOI 10.1038/376167a0; Bergmann MW, 2001, J MOL CELL CARDIOL, V33, P1223, DOI 10.1006/jmcc.2001.1385; BOISE LH, 1993, CELL, V74, P597, DOI 10.1016/0092-8674(93)90508-N; BOYD JM, 1994, CELL, V79, P341, DOI 10.1016/0092-8674(94)90202-X; Ceconi C, 1998, PROG CARDIOVASC DIS, V41, P25, DOI 10.1016/S0033-0620(98)80028-5; Chang NC, 2010, EMBO J, V29, P606, DOI 10.1038/emboj.2009.369; Chen G, 1999, J BIOL CHEM, V274, P7, DOI 10.1074/jbc.274.1.7; Chen Y, 2010, P NATL ACAD SCI USA, V107, P9035, DOI 10.1073/pnas.0914013107; Cizeau J, 2000, ONCOGENE, V19, P5453, DOI 10.1038/sj.onc.1203929; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; DAngelo DD, 1997, P NATL ACAD SCI USA, V94, P8121, DOI 10.1073/pnas.94.15.8121; Decker KF, 2012, NUCLEIC ACIDS RES, V40, P10765, DOI 10.1093/nar/gks888; Diwan A, 2008, CIRCULATION, V117, P396, DOI 10.1161/CIRCULATIONAHA.107.727073; Diwan A, 2007, P NATL ACAD SCI USA, V104, P6794, DOI 10.1073/pnas.0610666104; Diwan A, 2009, J CLIN INVEST, V119, P203, DOI 10.1172/JCI36445; Dorn GW, 2010, CELL CYCLE, V9, P3442, DOI 10.4161/cc.9.17.12944; Dorn GW, 2010, J CARDIOVASC TRANSL, V3, P374, DOI 10.1007/s12265-010-9174-x; ELLIS HM, 1986, CELL, V44, P817, DOI 10.1016/0092-8674(86)90004-8; Fujimoto K, 2010, J CLIN INVEST, V120, P4031, DOI 10.1172/JCI44011; Galvez AS, 2006, J BIOL CHEM, V281, P1442, DOI 10.1074/jbc.M509056200; Gordon JW, 2011, CIRC RES, V108, P1122, DOI 10.1161/CIRCRESAHA.110.226928; Higuchi Y, 2004, CIRCULATION, V109, P1892, DOI 10.1161/01.CIR.0000124227.00670.AB; HOCKENBERY D, 1990, NATURE, V348, P334, DOI 10.1038/348334a0; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kim H, 2009, MOL CELL, V36, P487, DOI 10.1016/j.molcel.2009.09.030; Kitsis RN, 2010, P NATL ACAD SCI USA, V107, P9031, DOI 10.1073/pnas.1003827107; Klee M, 2009, EMBO J, V28, P1757, DOI 10.1038/emboj.2009.90; Kubota T, 2001, J MOL CELL CARDIOL, V33, P1331, DOI 10.1006/jmcc.2001.1393; Matkovich SJ, 2010, CIRC RES, V106, P1459, DOI 10.1161/CIRCRESAHA.110.217513; Mercatante DR, 2001, J BIOL CHEM, V276, P16411, DOI 10.1074/jbc.M009256200; Minn AJ, 1996, J BIOL CHEM, V271, P6306, DOI 10.1074/jbc.271.11.6306; Nelson DE, 2004, SCIENCE, V306, P704, DOI 10.1126/science.1099962; Oakes SA, 2003, BIOCHEM PHARMACOL, V66, P1335, DOI 10.1016/S0006-2952(03)00482-9; Sakata Y, 1998, CIRCULATION, V97, P1488; Sandoval H, 2008, NATURE, V454, P232, DOI 10.1038/nature07006; Schweers RL, 2007, P NATL ACAD SCI USA, V104, P19500, DOI 10.1073/pnas.0708818104; Scorrano L, 2003, BIOCHEM BIOPH RES CO, V304, P437, DOI 10.1016/S0006-291X(03)00615-6; Scorrano L, 2003, SCIENCE, V300, P135, DOI 10.1126/science.1081208; Syed F, 2004, CIRC RES, V95, P1200, DOI 10.1161/01.RES.0000150366.08972.7f; TANAKA S, 1993, J BIOL CHEM, V268, P10920; TSUJIMOTO Y, 1986, P NATL ACAD SCI USA, V83, P5214, DOI 10.1073/pnas.83.14.5214; Wajant H, 2003, CELL DEATH DIFFER, V10, P45, DOI 10.1038/sj.cdd.4401189; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Whelan RS, 2010, ANNU REV PHYSIOL, V72, P19, DOI 10.1146/annurev.physiol.010908.163111; Yussman MG, 2002, NAT MED, V8, P725, DOI 10.1038/nm719	46	13	13	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 31	2013	288	22					15455	15465		10.1074/jbc.M113.452342	http://dx.doi.org/10.1074/jbc.M113.452342			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	156LA	23603904	hybrid, Green Published			2022-12-25	WOS:000319822300004
J	Schram, E; Bierman, S; Teal, LR; Haenen, O; van de Vis, H; Rijnsdorp, AD				Schram, Edward; Bierman, Stijn; Teal, Lorna R.; Haenen, Olga; van de Vis, Hans; Rijnsdorp, Adriaan D.			Thermal Preference of Juvenile Dover Sole (Solea solea) in Relation to Thermal Acclimation and Optimal Growth Temperature	PLOS ONE			English	Article							TURBOT SCOPHTHALMUS-MAXIMUS; FINAL PREFERENDUM; CLIMATE-CHANGE; FISH; SENEGALENSIS; ECTOTHERMS; PHYSIOLOGY; CONVERSION; TOLERANCE; ECOLOGY	Dover sole (Solea solea) is an obligate ectotherm with a natural thermal habitat ranging from approximately 5 to 27 degrees C. Thermal optima for growth lie in the range of 20 to 25 degrees C. More precise information on thermal optima for growth is needed for cost-effective Dover sole aquaculture. The main objective of this study was to determine the optimal growth temperature of juvenile Dover sole (Solea solea) and in addition to test the hypothesis that the final preferendum equals the optimal growth temperature. Temperature preference was measured in a circular preference chamber for Dover sole acclimated to 18, 22 and 28 degrees C. Optimal growth temperature was measured by rearing Dover sole at 19, 22, 25 and 28 degrees C. The optimal growth temperature resulting from this growth experiment was 22.7 degrees C for Dover sole with a size between 30 to 50 g. The temperature preferred by juvenile Dover sole increases with acclimation temperature and exceeds the optimal temperature for growth. A final preferendum could not be detected. Although a confounding effect of behavioural fever on temperature preference could not be entirely excluded, thermal preference and thermal optima for physiological processes seem to be unrelated in Dover sole.	[Schram, Edward; Bierman, Stijn; Teal, Lorna R.; van de Vis, Hans; Rijnsdorp, Adriaan D.] Wageningen UR, IMARES, Ijmuiden, Netherlands; [Haenen, Olga] Wageningen UR, Cent Vet Inst, Lelystad, Netherlands; [Rijnsdorp, Adriaan D.] Wageningen UR, Aquaculture & Fisheries Grp, Wageningen, Netherlands	Wageningen University & Research; Wageningen University & Research; Wageningen University & Research	Schram, E (corresponding author), Wageningen UR, IMARES, Ijmuiden, Netherlands.	edward.schram@wur.nl	Rijnsdorp, Adriaan/A-4217-2008; Teal, Lorna R/C-8972-2009	Rijnsdorp, Adriaan/0000-0003-0785-9662; 	Dutch ministry of Economics, Agriculture and Innovation	Dutch ministry of Economics, Agriculture and Innovation	The study was partly funded by the Dutch ministry of Economics, Agriculture and Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	AEBISCHER NJ, 1993, ECOLOGY, V74, P1313, DOI 10.2307/1940062; AITCHISON J, 1982, J ROY STAT SOC B MET, V44, P139; Aitchison J, 1986, STAT ANAL COMPOSITIO; Angilletta MJ, 2002, J THERM BIOL, V27, P249, DOI 10.1016/S0306-4565(01)00094-8; Austin B, 1999, BACTERIAL FISH PATHO, P63; AUSTRENG E, 1987, AQUACULTURE, V60, P157, DOI 10.1016/0044-8486(87)90307-3; Barrow GI, 1993, COWAN STEELS MANUAL, P94; Bayarri MJ, 2004, PHYSIOL BEHAV, V81, P577, DOI 10.1016/j.physbeh.2004.02.001; BEITINGER TL, 1979, AM ZOOL, V19, P319; Berghahn R, 2000, MAR ECOL PROG SER, V192, P277, DOI 10.3354/meps192277; Bjornsson B, 2001, ICES J MAR SCI, V58, P29, DOI 10.1006/jmsc.2000.0986; Bowman JP, 1998, INT J SYST BACTERIOL, V48, P1037, DOI 10.1099/00207713-48-3-1037; CerdaCuellar M, 1997, INT J SYST BACTERIOL, V47, P58, DOI 10.1099/00207713-47-1-58; COVERT JB, 1977, NATURE, V267, P43, DOI 10.1038/267043a0; Fonds M., 1976, European Marine Biology Symposium, P109; Holmstrom C, 1999, FEMS MICROBIOL ECOL, V30, P285, DOI 10.1111/j.1574-6941.1999.tb00656.x; Horwood JW, 1998, J MAR BIOL ASSOC UK, V78, P345, DOI 10.1017/S0025315400040133; Howell BR, 1997, AQUACULTURE, V155, P355, DOI 10.1016/S0044-8486(97)00103-8; HUEY RB, 1979, AM ZOOL, V19, P357; Imsland AK, 2003, REV FISH BIOL FISHER, V13, P379, DOI 10.1007/s11160-004-1632-6; Imsland AK, 2001, AQUACULTURE, V198, P353, DOI 10.1016/S0044-8486(01)00507-5; Irvin DN, 1973, THESIS U LIVERPOOL; JOBLING M, 1981, J FISH BIOL, V19, P439, DOI 10.1111/j.1095-8649.1981.tb05847.x; KELLOGG RL, 1983, T AM FISH SOC, V112, P424, DOI 10.1577/1548-8659(1983)112<424:RBOTFG>2.0.CO;2; LAGARDERE JP, 1987, J FISH BIOL, V30, P91, DOI 10.1111/j.1095-8649.1987.tb05735.x; Manly BFJ., 2017, RANDOMIZATION MONTE, DOI 10.1201/9781315273075; Myrick CA, 2004, T AM FISH SOC, V133, P427, DOI 10.1577/02-154; Oliveira CCV, 2013, FISH PHYSIOL BIOCHEM, V39, P479, DOI 10.1007/s10695-012-9713-2; Portner HO, 2007, SCIENCE, V315, P95, DOI 10.1126/science.1135471; REYNOLDS WW, 1976, NATURE, V259, P41, DOI 10.1038/259041a0; REYNOLDS WW, 1979, AM ZOOL, V19, P211; Rijnsdorp AD, 2009, ICES J MAR SCI, V66, P1570, DOI 10.1093/icesjms/fsp056; Schram E, 2006, AQUACULTURE, V252, P339, DOI 10.1016/j.aquaculture.2005.07.011; Schuurman T, 2004, J CLIN MICROBIOL, V42, P734, DOI 10.1128/JCM.42.2.734-740.2004; Sugita H, 2006, LETT APPL MICROBIOL, V43, P336, DOI 10.1111/j.1472-765X.2006.01943.x; Teal LR, 2012, GLOBAL CHANGE BIOL, V18, P3291, DOI 10.1111/j.1365-2486.2012.02795.x; TSUCHIDA S, 1995, J THERM BIOL, V20, P35, DOI 10.1016/0306-4565(94)00024-D; Woodhead P. M. J., 1964, Helgolander Wissenschaftliche Meeresuntersuchungen, V10, P328, DOI 10.1007/BF01626117	38	26	26	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2013	8	4							e61357	10.1371/journal.pone.0061357	http://dx.doi.org/10.1371/journal.pone.0061357			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JR	23613837	Green Submitted, Green Published, gold			2022-12-25	WOS:000317911500031
J	Tati, S; Jang, WS; Li, R; Kumar, R; Puri, S; Edgerton, M				Tati, Swetha; Jang, Woong Sik; Li, Rui; Kumar, Rohitashw; Puri, Sumant; Edgerton, Mira			Histatin 5 Resistance of Candida glabrata Can Be Reversed by Insertion of Candida albicans Polyamine Transporter-Encoding Genes DUR3 and DUR31	PLOS ONE			English	Article							SALIVARY HISTATIN-5; ANTIFUNGAL AGENTS; CELL-WALL; FUNGICIDAL ACTIVITY; BIOFILM RESISTANCE; PROTEOMIC ANALYSIS; DRUG-RESISTANCE; AMPHOTERICIN-B; PROTEINS; BINDING	Candida albicans and Candida glabrata are predominant fungi associated with oral candidiasis. Histatin 5 (Hst 5) is a small cationic human salivary peptide with high fungicidal activity against C. albicans, however many strains of C. glabrata are resistant. Since Hst 5 requires fungal binding to cell wall components prior to intracellular translocation, reduced Hst 5 binding to C. glabrata may be the reason for its insensitivity. C. glabrata has higher surface levels of beta-1,3-glucans as compared with C. albicans; however these differences did not account for reduced Hst 5 uptake and killing in C. glabrata. Similarly, the biofilm matrix of C. glabrata contained significantly higher levels of beta-1,3-glucans compared with C. albicans, but it did not reduce the percentage of Hst 5 positive fungal cells in the biofilm. Hst 5 enters C. albicans cell through polyamine transporters Dur3p and Dur31p that are uncharacterized in C. glabrata. C. glabrata strains expressing CaDur3 and CaDur31 had two-fold higher killing and uptake of Hst 5. Thus, neither C. glabrata cell surface or biofilm matrix beta-1,3-glucan levels affected Hst 5 toxicity; rather the crucial rate limiting step is reduced uptake that can be overcome by expression of C. albicans Dur proteins in C. glabrata.	[Tati, Swetha; Jang, Woong Sik; Li, Rui; Kumar, Rohitashw; Puri, Sumant; Edgerton, Mira] SUNY Buffalo, Dept Oral Biol, Buffalo, NY 14260 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Edgerton, M (corresponding author), SUNY Buffalo, Dept Oral Biol, Buffalo, NY 14260 USA.	edgerto@buffalo.edu	Kumar, Rohitashw/D-1968-2014; Puri, Sumant/H-4323-2012; Puri, Sumant/ABF-4209-2021	Kumar, Rohitashw/0000-0001-8695-3555; 	National Institute of Dental and Craniofacial Research, National Institutes of Health, USA [R01DE010641]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [T32DE023526, R01DE010641] Funding Source: NIH RePORTER	National Institute of Dental and Craniofacial Research, National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by grant R01DE010641 (ME) from the National Institute of Dental and Craniofacial Research, National Institutes of Health, USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Al-Fattani MA, 2004, ANTIMICROB AGENTS CH, V48, P3291, DOI 10.1128/AAC.48.9.3291-3297.2004; Al-Fattani MA, 2006, J MED MICROBIOL, V55, P999, DOI 10.1099/jmm.0.46569-0; Baillie GS, 2000, J ANTIMICROB CHEMOTH, V46, P397, DOI 10.1093/jac/46.3.397; Cormack BP, 1999, GENETICS, V151, P979; de Groot PWJ, 2008, EUKARYOT CELL, V7, P1951, DOI 10.1128/EC.00284-08; Ferrari S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017589; Ferrari S, 2011, ANTIMICROB AGENTS CH, V55, P1852, DOI 10.1128/AAC.01271-10; Ferrari S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000268; Fidel PL, 1999, CLIN MICROBIOL REV, V12, P80, DOI 10.1128/CMR.12.1.80; Fidel PL, 1996, J INFECT DIS, V173, P425, DOI 10.1093/infdis/173.2.425; FONZI WA, 1993, GENETICS, V134, P717; Helmerhorst EJ, 2001, P NATL ACAD SCI USA, V98, P14637, DOI 10.1073/pnas.141366998; Helmerhorst EJ, 2005, YEAST, V22, P705, DOI 10.1002/yea.1241; Helmerhorst EJ, 2006, ANTIMICROB AGENTS CH, V50, P1100, DOI 10.1128/AAC.50.3.1100-1103.2006; Helmerhorst EJ, 1999, ANTIMICROB AGENTS CH, V43, P702, DOI 10.1128/AAC.43.3.702; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Jain N, 2007, APPL ENVIRON MICROB, V73, P1697, DOI 10.1128/AEM.02439-06; Jang WS, 2008, ANTIMICROB AGENTS CH, V52, P497, DOI 10.1128/AAC.01199-07; Jang WS, 2010, MOL MICROBIOL, V77, P354, DOI 10.1111/j.1365-2958.2010.07210.x; Joly S, 2004, J CLIN MICROBIOL, V42, P1024, DOI 10.1128/JCM.42.3.1024-1029.2004; Keppler-Ross S, 2010, EUKARYOT CELL, V9, P1776, DOI 10.1128/EC.00156-10; Konopka K, 2010, ANTON LEEUW INT J G, V97, P413, DOI 10.1007/s10482-010-9417-5; Koshlukova SE, 1999, J BIOL CHEM, V274, P18872, DOI 10.1074/jbc.274.27.18872; Kumar R, 2011, J BIOL CHEM, V286, P43748, DOI 10.1074/jbc.M111.311175; Lewis RE, 2002, ANTIMICROB AGENTS CH, V46, P3499, DOI 10.1128/AAC.46.11.3499-3505.2002; Li XWS, 2006, J BIOL CHEM, V281, P22453, DOI 10.1074/jbc.M604064200; Penha CVLY, 2010, BRAZ J MED BIOL RES, V43, P1203, DOI 10.1590/S0100-879X2010007500125; Lowman DW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027614; Ma B, 2009, MOL CELL BIOL, V29, P4067, DOI 10.1128/MCB.01461-08; Mayer FL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002592; Mochon AB, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000190; Nett J, 2007, ANTIMICROB AGENTS CH, V51, P510, DOI 10.1128/AAC.01056-06; OPPENHEIM FG, 1988, J BIOL CHEM, V263, P7472; Pfaller MA, 2007, CLIN MICROBIOL REV, V20, P133, DOI 10.1128/CMR.00029-06; RAJ PA, 1990, J BIOL CHEM, V265, P3898; Raj PA, 1998, BIOPOLYMERS, V45, P51, DOI 10.1002/(SICI)1097-0282(199801)45:1<51::AID-BIP5>3.0.CO;2-Y; Rogers PD, 2006, J ANTIMICROB CHEMOTH, V58, P434, DOI 10.1093/jac/dkl221; Sanglard D, 1999, ANTIMICROB AGENTS CH, V43, P2753, DOI 10.1128/AAC.43.11.2753; Sanglard D, 2001, ANTIMICROB AGENTS CH, V45, P1174, DOI 10.1128/AAC.45.4.1174-1183.2001; Seneviratne CJ, 2010, PROTEOMICS, V10, P1444, DOI 10.1002/pmic.200900611; Sorgo AG, 2010, YEAST, V27, P661, DOI 10.1002/yea.1775; Sun JNN, 2008, MOL MICROBIOL, V70, P1246, DOI 10.1111/j.1365-2958.2008.06480.x; Taff HT, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002848; Thein ZM, 2007, ARCH ORAL BIOL, V52, P761, DOI 10.1016/j.archoralbio.2007.01.009; Tsai HY, 1997, BBA-GEN SUBJECTS, V1336, P367, DOI 10.1016/S0304-4165(97)00076-7; Wisplinghoff H, 2004, CLIN INFECT DIS, V39, P309, DOI 10.1086/421946; XU T, 1991, INFECT IMMUN, V59, P2549, DOI 10.1128/IAI.59.8.2549-2554.1991	47	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2013	8	4							e61480	10.1371/journal.pone.0061480	http://dx.doi.org/10.1371/journal.pone.0061480			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JR	23613860	gold, Green Submitted, Green Published			2022-12-25	WOS:000317911500041
J	Bathen, TF; Geurts, B; Sitter, B; Fjosne, HE; Lundgren, S; Buydens, LM; Gribbestad, IS; Postma, G; Giskeodegard, GF				Bathen, Tone F.; Geurts, Brigitte; Sitter, Beathe; Fjosne, Hans E.; Lundgren, Steinar; Buydens, Lutgarde M.; Gribbestad, Ingrid S.; Postma, Geert; Giskeodegard, Guro F.			Feasibility of MR Metabolomics for Immediate Analysis of Resection Margins during Breast Cancer Surgery	PLOS ONE			English	Article							MAGNETIC-RESONANCE-SPECTROSCOPY; HR-MAS SPECTROSCOPY; TISSUE; PROFILES; PROGNOSIS; PROSTATE; METABOLITES; PREDICTION; BIOMARKERS; LACTATE	In this study, the feasibility of high resolution magic angle spinning (HR MAS) magnetic resonance spectroscopy (MRS) of small tissue biopsies to distinguish between tumor and non-involved adjacent tissue was investigated. With the current methods, delineation of the tumor borders during breast cancer surgery is a challenging task for the surgeon, and a significant number of re-surgeries occur. We analyzed 328 tissue samples from 228 breast cancer patients using HR MAS MRS. Partial least squares discriminant analysis (PLS-DA) was applied to discriminate between tumor and non-involved adjacent tissue. Using proper double cross validation, high sensitivity and specificity of 91% and 93%, respectively was achieved. Analysis of the loading profiles from both principal component analysis (PCA) and PLS-DA showed the choline-containing metabolites as main biomarkers for tumor content, with phosphocholine being especially high in tumor tissue. Other indicative metabolites include glycine, taurine and glucose. We conclude that metabolic profiling by HR MAS MRS may be a potential method for on-line analysis of resection margins during breast cancer surgery to reduce the number of re-surgeries and risk of local recurrence.	[Bathen, Tone F.; Gribbestad, Ingrid S.; Giskeodegard, Guro F.] Norwegian Univ Sci & Technol NTNU, Fac Med, Dept Circulat & Med Imaging, Trondheim, Norway; [Bathen, Tone F.; Gribbestad, Ingrid S.; Giskeodegard, Guro F.] St Olavs Univ Hosp, Trondheim, Norway; [Geurts, Brigitte; Buydens, Lutgarde M.; Postma, Geert] Radboud Univ Nijmegen, Inst Mol & Mat, NL-6525 ED Nijmegen, Netherlands; [Sitter, Beathe] Sor Trondelag Univ Coll, Dept Technol, Trondheim, Norway; [Fjosne, Hans E.] St Olavs Univ Hosp, Dept Surg, Trondheim, Norway; [Lundgren, Steinar] St Olavs Univ Hosp, Dept Oncol, Trondheim, Norway; [Lundgren, Steinar] Norwegian Univ Sci & Technol NTNU, Fac Med, Dept Canc Res & Mol Med, Trondheim, Norway	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Radboud University Nijmegen; Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU)	Bathen, TF (corresponding author), Norwegian Univ Sci & Technol NTNU, Fac Med, Dept Circulat & Med Imaging, Trondheim, Norway.	tone.f.bathen@ntnu.no	Sitter, Beathe/ABC-3892-2021; Buydens, Lutgarde M.C./D-4338-2012	Sitter, Beathe/0000-0003-1786-6380; 	Liaison Committee between the Central Norway Regional Health Authority (RHA); Norwegian University of Science and Technology (NTNU)	Liaison Committee between the Central Norway Regional Health Authority (RHA); Norwegian University of Science and Technology (NTNU)	This study was supported by the Liaison Committee between the Central Norway Regional Health Authority (RHA) and the Norwegian University of Science and Technology (NTNU). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerstaff E, 2003, J CELL BIOCHEM, V90, P525, DOI 10.1002/jcb.10659; Atkins J, 2012, J SURG RES, V177, P109, DOI 10.1016/j.jss.2012.03.045; Bathen TF, 2007, BREAST CANCER RES TR, V104, P181, DOI 10.1007/s10549-006-9400-z; Bathen TF, 2010, CANCER RES, V70, P6692, DOI 10.1158/0008-5472.CAN-10-0437; BLOOM HJG, 1957, BRIT J CANCER, V11, P359, DOI 10.1038/bjc.1957.43; Borgan E, 2013, MOL ONCOL, V7, P130, DOI 10.1016/j.molonc.2012.10.005; Cancer Registry of Norway, 2011, CANC NORW 2009 CANC; Cao MD, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-39; Martinez-Bisbal MC, 2009, NMR BIOMED, V22, P199, DOI 10.1002/nbm.1304; Chong IG, 2005, CHEMOMETR INTELL LAB, V78, P103, DOI 10.1016/j.chemolab.2004.12.011; Eilers PHC, 2004, ANAL CHEM, V76, P404, DOI 10.1021/ac034800e; Fiehn O, 2002, PLANT MOL BIOL, V48, P155, DOI 10.1023/A:1013713905833; Giskeodegard GF, 2012, NMR BIOMED, V25, P1271, DOI 10.1002/nbm.2798; Giskeodegard GF, 2010, ANAL CHIM ACTA, V683, P1, DOI 10.1016/j.aca.2010.09.026; Giskeodegard GF, 2010, J PROTEOME RES, V9, P972, DOI 10.1021/pr9008783; Glunde K, 2011, NAT REV CANCER, V11, P835, DOI 10.1038/nrc3162; Good P, 2000, PERMUTATION TESTS PR; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Keun HC, 2003, ANAL CHIM ACTA, V490, P265, DOI 10.1016/S0003-2670(03)00094-1; Li M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025563; Locasale JW, 2011, NAT GENET, V43, P869, DOI 10.1038/ng.890; Lovrics PJ, 2009, AM J SURG, V197, P740, DOI 10.1016/j.amjsurg.2008.03.007; Lyng H, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-11; MASSART DL, 1997, HDB CHEMOMETRICS Q B; Mistry M, 2011, BRIT J CANCER, V105, P1795, DOI 10.1038/bjc.2011.430; Moestue SA, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-433; Piotto Martial, 2012, J Med Case Rep, V6, P22, DOI 10.1186/1752-1947-6-22; Savorani F, 2010, J MAGN RESON, V202, P190, DOI 10.1016/j.jmr.2009.11.012; Seierstad T, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-33; Sitter B, 2002, NMR BIOMED, V15, P327, DOI 10.1002/nbm.775; Sitter B, 2006, NMR BIOMED, V19, P30, DOI 10.1002/nbm.992; Sitter B, 2004, J NEUROSCI RES, V77, P762, DOI 10.1002/jnr.20123; Sitter B, 2004, MAGN RESON MATER PHY, V16, P174, DOI 10.1007/s10334-003-0025-5; Sitter B, 2010, NMR BIOMED, V23, P424, DOI 10.1002/nbm.1478; Sitter B, 2009, PROG NUCL MAG RES SP, V54, P239, DOI 10.1016/j.pnmrs.2008.10.001; Swanson MG, 2006, MAGN RESON MED, V55, P1257, DOI 10.1002/mrm.20909; Tessem MB, 2008, MAGN RESON MED, V60, P510, DOI 10.1002/mrm.21694; Tessem MB, 2010, J PROTEOME RES, V9, P3664, DOI 10.1021/pr100176g; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Westerhuis JA, 2008, METABOLOMICS, V4, P81, DOI 10.1007/s11306-007-0099-6; Wold S, 2001, CHEMOMETR INTELL LAB, V58, P109, DOI 10.1016/S0169-7439(01)00155-1; Wu CL, 2003, MAGNET RESON MED, V50, P1307, DOI 10.1002/mrm.10645; Yakoub D, 2010, CANCER RES, V70, P9129, DOI 10.1158/0008-5472.CAN-10-1566	43	48	49	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2013	8	4							e61578	10.1371/journal.pone.0061578	http://dx.doi.org/10.1371/journal.pone.0061578			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IK	23613877	Green Published, gold, Green Submitted			2022-12-25	WOS:000317907200066
J	Behringer, V; Borchers, C; Deschner, T; Mostl, E; Selzer, D; Hohmann, G				Behringer, Verena; Borchers, Claudia; Deschner, Tobias; Moestl, Erich; Selzer, Dieter; Hohmann, Gottfried			Measurements of Salivary Alpha Amylase and Salivary Cortisol in Hominoid Primates Reveal Within-Species Consistency and Between-Species Differences	PLOS ONE			English	Article							MASS-SPECTROMETRY; MOUNTAIN GORILLAS; LOWLAND GORILLAS; LOPE RESERVE; PAN-PANISCUS; STRESS; DIET; CHIMPANZEES; MONKEYS; GABON	Salivary alpha amylase (sAA) is the most abundant enzyme in saliva. Studies in humans found variation in enzymatic activity of sAA across populations that could be linked to the copy number of loci for salivary amylase (AMY1), which was seen as an adaptive response to the intake of dietary starch. In addition to diet dependent variation, differences in sAA activity have been related to social stress. In a previous study, we found evidence for stress-induced variation in sAA activity in the bonobos, a hominoid primate that is closely related to humans. In this study, we explored patterns of variation in sAA activity in bonobos and three other hominoid primates, chimpanzee, gorilla, and orangutan to (a) examine if within-species differences in sAA activity found in bonobos are characteristic for hominoids and (b) assess the extent of variation in sAA activity between different species. The results revealed species-differences in sAA activity with gorillas and orangutans having higher basal sAA activity when compared to Pan. To assess the impact of stress, sAA values were related to cortisol levels measured in the same saliva samples. Gorillas and orangutans had low salivary cortisol concentrations and the highest cortisol concentration was found in samples from male bonobos, the group that also showed the highest sAA activity. Considering published information, the differences in sAA activity correspond with differences in AMY1 copy numbers and match with general features of natural diet. Studies on sAA activity have the potential to complement molecular studies and may contribute to research on feeding ecology and nutrition.	[Behringer, Verena; Borchers, Claudia; Deschner, Tobias; Hohmann, Gottfried] Max Planck Inst Evolutionary Anthropol, Dept Primatol, Leipzig, Germany; [Moestl, Erich] Univ Vet Med, Dept Biomed Sci Biochem, Vienna, Austria; [Selzer, Dieter] Univ Giessen, Working Grp Wildlife Biol, D-35390 Giessen, Germany	Max Planck Society; University of Veterinary Medicine Vienna; Justus Liebig University Giessen	Behringer, V (corresponding author), Max Planck Inst Evolutionary Anthropol, Dept Primatol, Leipzig, Germany.	verena_behringer@eva.mpg.de	Behringer, Verena/AAE-9054-2022; Moreira, Nei/AAK-1357-2020	Behringer, Verena/0000-0001-6338-7298; Moreira, Nei/0000-0002-9236-667X	University Giessen; Max Planck Society; University of Veterinary Medicine Vienna	University Giessen; Max Planck Society(Max Planck Society); University of Veterinary Medicine Vienna	This research was supported by the University Giessen, the Max Planck Society, and University of Veterinary Medicine Vienna. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anestis SF, 2006, PHYSIOL BEHAV, V89, P287, DOI 10.1016/j.physbeh.2006.06.010; Baayen R. H., 2008, ANAL LINGUISTIC DATA; Baayen RH, 2011, ANAL LINGUISTICS DAT; Bates D., 2011, PACKAGE LME4 LINEAR, V1; BAUM BJ, 1993, ANN NY ACAD SCI, V694, P17; Behringer V, 2011, HALTUNGSBEDINGTE EIN; Behringer V, 2012, PHYSIOL BEHAV, V105, P476, DOI 10.1016/j.physbeh.2011.09.005; Behringer V, 2009, PRIMATES, V50, P190, DOI 10.1007/s10329-008-0121-2; BENARYEH H, 1990, ARCH ORAL BIOL, V35, P929, DOI 10.1016/0003-9969(90)90075-L; CHAUNCEY HH, 1963, ARCH ORAL BIOL, V8, P615, DOI 10.1016/0003-9969(63)90076-1; Clauss M, 2008, COMP BIOCHEM PHYS A, V150, P274, DOI 10.1016/j.cbpa.2008.03.012; CONKLINBRITTAIN NL, 2000, APES CHALLENGES 21 C; Cross N, 2004, DEV PSYCHOBIOL, V45, P134, DOI 10.1002/dev.20023; Cunningham AJ, 2010, 23 IPS KYOT; da Costa G, 2008, J CHEM ECOL, V34, P376, DOI 10.1007/s10886-007-9413-z; Dobson AJ., 2008, INTRO GEN LINEAR MOD, DOI 10.1201/9780367807849; Doran-Sheehy D, 2009, AM J PHYS ANTHROPOL, V140, P727, DOI 10.1002/ajpa.21118; Elder CM, 2001, PRIMATES, V42, P345, DOI 10.1007/BF02629625; Furtbauer I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026144; GALDIKAS BMF, 1988, INT J PRIMATOL, V9, P1, DOI 10.1007/BF02740195; Ganas J, 2008, AM J PRIMATOL, V70, P927, DOI 10.1002/ajp.20584; Goymann W, 2004, ANIM BEHAV, V67, P591, DOI 10.1016/j.anbehav.2003.08.007; Granger DA, 2007, ANN NY ACAD SCI, V1098, P122, DOI 10.1196/annals.1384.008; Higham JP, 2010, PHYSIOL BEHAV, V101, P601, DOI 10.1016/j.physbeh.2010.09.003; Hohmann G, 2003, BEHAVIOUR, V140, P1389, DOI 10.1163/156853903771980648; Hohmann Gottfried, 2006, P123; Hohmann G, 2010, AM J PHYS ANTHROPOL, V141, P476, DOI 10.1002/ajpa.21168; JUNQUEIRA LCU, 1973, AN ACAD BRAS CIENC, V45, P629; Kimura T, 2007, J AM ASSOC LAB ANIM, V46, P33; Kivlighan KT, 2006, PSYCHONEUROENDOCRINO, V31, P703, DOI 10.1016/j.psyneuen.2006.01.007; Knott CD, 1998, INT J PRIMATOL, V19, P1061, DOI 10.1023/A:1020330404983; Koolhaas JM, 1999, NEUROSCI BIOBEHAV R, V23, P925, DOI 10.1016/S0149-7634(99)00026-3; Kuhar CW, 2005, ANIM WELFARE, V14, P187; Kutsukake N, 2009, AM J PRIMATOL, V71, P696, DOI 10.1002/ajp.20708; Lawrence Herenia P, 2002, J Can Dent Assoc, V68, P170; LEIGHTON M, 1993, INT J PRIMATOL, V14, P257, DOI 10.1007/BF02192635; Luca F, 2010, ANNU REV NUTR, V30, P291, DOI 10.1146/annurev-nutr-080508-141048; Lutz CK, 2000, AM J PRIMATOL, V52, P93, DOI 10.1002/1098-2345(200010)52:2<93::AID-AJP3>3.3.CO;2-2; MALENKY RK, 1991, AM J PRIMATOL, V23, P153, DOI 10.1002/ajp.1350230303; Mandel AL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013352; Mau M, 2010, J MED PRIMATOL, V39, P187, DOI 10.1111/j.1600-0684.2010.00407.x; Mau M, 2011, AM J PRIMATOL, V73, P896, DOI 10.1002/ajp.20958; Mau M, 2009, AM J PRIMATOL, V71, P663, DOI 10.1002/ajp.20701; MCGEACHIN RL, 1982, COMP BIOCHEM PHYS A, V72, P267, DOI 10.1016/0300-9629(82)90045-7; MILTON K, 1981, AM NAT, V117, P496, DOI 10.1086/283730; Nater UM, 2009, PSYCHONEUROENDOCRINO, V34, P486, DOI 10.1016/j.psyneuen.2009.01.014; Palme R, 1997, Z SAUGETIERKD, V62, P192; PARISH AR, 1994, ETHOL SOCIOBIOL, V15, P157, DOI 10.1016/0162-3095(94)90038-8; Perry GH, 2007, NAT GENET, V39, P1256, DOI 10.1038/ng2123; Rodman Peter S., 2002, P77; ROGERS ME, 1990, OECOLOGIA, V84, P326, DOI 10.1007/BF00329756; Rohleder N, 2006, PSYCHOPHYSIOLOGY, V43, P645, DOI 10.1111/j.1469-8986.2006.00457.x; Samuelson LC, 1996, MOL BIOL EVOL, V13, P767, DOI 10.1093/oxfordjournals.molbev.a025637; SCANNAPIECO FA, 1993, CRIT REV ORAL BIOL M, V4, P301, DOI 10.1177/10454411930040030701; Schielzeth H, 2010, METHODS ECOL EVOL, V1, P103, DOI 10.1111/j.2041-210X.2010.00012.x; Silk JB, 2002, EVOL ANTHROPOL, V11, P221, DOI 10.1002/evan.10038; Smiley T, 2010, J ZOO WILDLIFE MED, V41, P201, DOI 10.1638/2009-0015R.1; Takai N, 2007, ANN NY ACAD SCI, V1098, P510, DOI 10.1196/annals.1384.014; Tutin CEG, 1997, AM J PRIMATOL, V42, P1, DOI 10.1002/(SICI)1098-2345(1997)42:1<1::AID-AJP1>3.0.CO;2-0; WILLIAMSON EA, 1990, AM J PRIMATOL, V21, P265, DOI 10.1002/ajp.1350210403; Wilson GM, 2006, GENOME RES, V16, P173, DOI 10.1101/gr.4456006; WRANGHAM RW, 1983, BIOTROPICA, V15, P217, DOI 10.2307/2387832; WRANGHAM RW, 1991, PHILOS T ROY SOC B, V334, P171, DOI 10.1098/rstb.1991.0106; Yamagiwa J, 2006, PRIMATES, V47, P74, DOI 10.1007/s10329-005-0147-7; YOUNG JA, 1981, AUST J EXP BIOL MED, V59, P1, DOI 10.1038/icb.1981.1; ZAKOWSKI JJ, 1985, CRC CR REV CL LAB SC, V21, P283, DOI 10.3109/10408368509165786	66	29	30	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2013	8	4							e60773	10.1371/journal.pone.0060773	http://dx.doi.org/10.1371/journal.pone.0060773			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IK	23613746	Green Published, gold, Green Submitted			2022-12-25	WOS:000317907200014
J	Mima, J; Koshino, A; Oka, K; Uchida, H; Hieda, Y; Nohara, K; Kogo, M; Chai, Y; Sakai, T				Mima, Junko; Koshino, Aya; Oka, Kyoko; Uchida, Hitoshi; Hieda, Yohki; Nohara, Kanji; Kogo, Mikihiko; Chai, Yang; Sakai, Takayoshi			Regulation of the Epithelial Adhesion Molecule CEACAM1 Is Important for Palate Formation	PLOS ONE			English	Article							MEDIAL EDGE EPITHELIUM; FETAL MOUSE PALATE; CYTOPLASMIC DOMAIN; CLEFT-PALATE; IN-VITRO; CELLS; EXPRESSION; FATE; DEFECTS; ISOFORMS	Cleft palate results from a mixture of genetic and environmental factors and occurs when the bilateral palatal shelves fail to fuse. The objective of this study was to search for new genes involved in mouse palate formation. Gene expression of murine embryonic palatal tissue was analyzed at various developmental stages before, during, and after palate fusion using GeneChip (R) microarrays. Ceacam1 was one of the highly up-regulated genes during palate formation, and this was confirmed by quantitative real-time PCR. Immunohistochemical staining showed that CEACAM1 was present in prefusion palatal epithelium and was degraded during fusion. To investigate the developmental role of CEACAM1, function-blocking antibody was added to embryonic mouse palate in organ culture. Palatal fusion was inhibited by this function-blocking antibody. To investigate the subsequent developmental role of CEACAM1, we characterized Ceacam1-deficient (Ceacam1(-/-)) mice. Epithelial cells persisted abnormally at the midline of the embryonic palate even on day E16.0, and palatal fusion was delayed in Ceacam1(-/-) mice. TGF beta 3 expression, apoptosis, and cell proliferation in palatal epithelium were not affected in the palate of Ceacam1(-/-) mice. However, CEACAM1 expression was retained in the remaining MEE of TGF beta-deficient mice. These results suggest that CEACAM1 has roles in the initiation of palatal fusion via epithelial cell adhesion.	[Mima, Junko; Koshino, Aya; Uchida, Hitoshi; Nohara, Kanji; Sakai, Takayoshi] Osaka Univ, Dept Oral Facial Disorders, Grad Sch Dent, Suita, Osaka, Japan; [Mima, Junko; Kogo, Mikihiko] Osaka Univ, Grad Sch Dent, Dept Oral & Maxillofacial Surg 1, Suita, Osaka, Japan; [Oka, Kyoko] Fukuoka Dent Coll, Dept Oral Growth & Dev, Sect Pediat Dent, Fukuoka, Japan; [Hieda, Yohki] Osaka Dent Univ, Dept Biol, Kuzuha, Osaka, Japan; [Chai, Yang] Univ So Calif, Ctr Craniofacial Mol Biol, Ostow Sch Dent, Los Angeles, CA 90033 USA	Osaka University; Osaka University; Fukuoka Dental College (FDC); University of Southern California	Sakai, T (corresponding author), Osaka Univ, Dept Oral Facial Disorders, Grad Sch Dent, Suita, Osaka, Japan.	sakai@dent.osaka-u.ac.jp	Kogo, Mikihiko/ABD-7080-2020; Sakai, Takayoshi/L-1456-2019	Kogo, Mikihiko/0000-0002-4556-2491; Sakai, Takayoshi/0000-0003-4348-4896	Japan Society for the Promotion of Science (JSPS) [21390534, 21659466]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE014078] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [24659890, 24390452] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for Challenging Exploratory Research (21659466) and Scientific Research (B) (21390534) from the Japan Society for the Promotion of Science (JSPS) to T.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carette M J, 1992, Epithelial Cell Biol, V1, P119; Chai Y, 2006, DEV DYNAM, V235, P2353, DOI 10.1002/dvdy.20833; Chou MJ, 2004, ANAT EMBRYOL, V208, P19, DOI 10.1007/s00429-004-0379-0; Choudhary B, 2009, GENESIS, V47, P115, DOI 10.1002/dvg.20466; Cuervo R, 2004, DEVELOPMENT, V131, P15, DOI 10.1242/dev.00907; DVEKSLER GS, 1993, J VIROL, V67, P1; FERGUSON MWJ, 1988, DEVELOPMENT, V103, P41; FITZPATRICK DR, 1990, DEVELOPMENT, V109, P585; Geiger B., 2011, COLD SPRING HARBOR P, V3; GODFRAIND C, 1995, LAB INVEST, V73, P615; Gritli-Linde A, 2007, DEV BIOL, V301, P309, DOI 10.1016/j.ydbio.2006.07.042; Horst AK, 2006, J CLIN INVEST, V116, P1596, DOI 10.1172/JCI24340; HSIEH JT, 1995, CANCER RES, V55, P190; Jalali A, 2012, DEV GROWTH DIFFER, V54, P633, DOI 10.1111/j.1440-169X.2012.01364.x; JOHNSTON MC, 1995, CRIT REV ORAL BIOL M, V6, P25, DOI 10.1177/10454411950060010301; KAARTINEN V, 1995, NAT GENET, V11, P415, DOI 10.1038/ng1295-415; Leung N, 2006, ONCOGENE, V25, P5527, DOI 10.1038/sj.onc.1209541; Martinez-Alvarez C, 2000, DEV BIOL, V220, P343, DOI 10.1006/dbio.2000.9644; Nawshad A, 2007, J CELL SCI, V120, P1646, DOI 10.1242/jcs.003129; Oka K, 2012, J HISTOCHEM CYTOCHEM, V60, P57, DOI 10.1369/0022155411427059; Oshima M, 1996, DEV BIOL, V179, P297, DOI 10.1006/dbio.1996.0259; Sanford LP, 1997, DEVELOPMENT, V124, P2659; Sani FV, 2005, DEV BIOL, V285, P490, DOI 10.1016/j.ydbio.2005.07.027; SHIOTA K, 1990, ACTA ANAT, V137, P59; SHULER C F, 1991, International Journal of Developmental Biology, V35, P463; SHULER CF, 1992, DEV BIOL, V154, P318, DOI 10.1016/0012-1606(92)90071-N; Stern N, 2005, J IMMUNOL, V174, P6692, DOI 10.4049/jimmunol.174.11.6692; Sundberg U, 2004, J CELL SCI, V117, P1091, DOI 10.1242/jcs.00944; Takahara S, 2004, INT J DEV BIOL, V48, P39, DOI 10.1387/ijdb.15005573; Takigawa T, 2004, INT J DEV BIOL, V48, P307, DOI 10.1387/ijdb.041840tt; TANIGUCHI K, 1995, ARCH HISTOL CYTOL, V58, P191, DOI 10.1679/aohc.58.191; Taya Y, 1999, DEVELOPMENT, V126, P3869; Wagener C, 2000, EXP CELL RES, V261, P19, DOI 10.1006/excr.2000.5038; Xu X, 2006, DEV BIOL, V297, P238, DOI 10.1016/j.ydbio.2006.05.014; Yokoyama S, 2007, ONCOGENE, V26, P7637, DOI 10.1038/sj.onc.1210577	35	13	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2013	8	4							e61653	10.1371/journal.pone.0061653	http://dx.doi.org/10.1371/journal.pone.0061653			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IK	23613893	gold, Green Published, Green Submitted			2022-12-25	WOS:000317907200069
J	Rath, BA; Yousef, KP; Katzenstein, DK; Shafer, RW; Schutte, C; von Kleist, M; Merigan, TC				Rath, Barbara A.; Yousef, Kaveh Pouran; Katzenstein, David K.; Shafer, Robert W.; Schuette, Christof; von Kleist, Max; Merigan, Thomas C.			In Vitro HIV-1 Evolution in Response to Triple Reverse Transcriptase Inhibitors & In Silico Phenotypic Analysis	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; ACTIVE ANTIRETROVIRAL THERAPY; DRUG-RESISTANCE; NONNUCLEOSIDE INHIBITORS; CONFERS RESISTANCE; INFECTED PATIENTS; LAMIVUDINE MONOTHERAPY; NUCLEOSIDE INHIBITORS; REPLICATION CAPACITY; PROTEASE INHIBITOR	Background: Effectiveness of ART regimens strongly depends upon complex interactions between the selective pressure of drugs and the evolution of mutations that allow or restrict drug resistance. Methods: Four clinical isolates from NRTI-exposed, NNRTI-naive subjects were passaged in increasing concentrations of NVP in combination with 1 mu M 3 TC and 2 mu M ADV to assess selective pressures of multi-drug treatment. A novel parameter inference procedure, based on a stochastic viral growth model, was used to estimate phenotypic resistance and fitness from in vitro combination passage experiments. Results: Newly developed mathematical methods estimated key phenotypic parameters of mutations arising through selective pressure exerted by 3 TC and NVP. Concentrations of 1 mu M 3 TC maintained the M184V mutation, which was associated with intrinsic fitness deficits. Increasing NVP concentrations selected major NNRTI resistance mutations. The evolutionary pathway of NVP resistance was highly dependent on the viral genetic background, epistasis as well as stochasticity. Parameter estimation indicated that the previously unrecognized mutation L228Q was associated with NVP resistance in some isolates. Conclusion: Serial passage of viruses in the presence of multiple drugs may resemble the selection of mutations observed among treated individuals and populations in vivo and indicate evolutionary preferences and restrictions. Phenotypic resistance estimated here "in silico" from in vitro passage experiments agreed well with previous knowledge, suggesting that the unique combination of "wet-" and "dry-lab" experimentation may improve our understanding of HIV-1 resistance evolution in the future.	[Rath, Barbara A.] Charite Univ Med Ctr, Dept Pediat, Div Pneumonol Immunol, Berlin, Germany; [Yousef, Kaveh Pouran; Schuette, Christof; von Kleist, Max] Free Univ Berlin, Dept Math & Comp Sci, Berlin, Germany; [Rath, Barbara A.; Katzenstein, David K.; Shafer, Robert W.; Merigan, Thomas C.] Stanford Univ, Med Ctr, Ctr AIDS Res, Stanford, CA 94305 USA	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Stanford University	Rath, BA (corresponding author), Charite Univ Med Ctr, Dept Pediat, Div Pneumonol Immunol, Berlin, Germany.	Barbara.Rath@gmail.com	Merigan, Thomas/AGQ-7464-2022; von Kleist, Max/K-3023-2016	von Kleist, Max/0000-0001-6587-6394; katzenstein, david/0000-0002-8593-4560	National Cancer Institute [CA59039]; National Institutes of Health [8R01 EB002784-28]; DFG research center MATHEON through project "Modeling, Simulation and Therapy Optimization for Infectious Diseases" [A21]; NATIONAL CANCER INSTITUTE [R01CA059039] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB002784] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DFG research center MATHEON through project "Modeling, Simulation and Therapy Optimization for Infectious Diseases"(German Research Foundation (DFG)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	The laboratory work was supported by grant CA59039 from the National Cancer Institute and 8R01 EB002784-28 from the National Institutes of Health. KYP and MvK acknowledge financial support from the DFG research center MATHEON through project A21 "Modeling, Simulation and Therapy Optimization for Infectious Diseases". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen LJS, 2011, INTRO STOCHASTIC PRO, Vxxiv; Arora P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000305; Bacheler L, 2001, J VIROL, V75, P4999, DOI 10.1128/JVI.75.11.4999-5008.2001; Bazzoli C, 2010, CLIN PHARMACOKINET, V49, P17, DOI 10.2165/11318110-000000000-00000; Bennett DE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004724; Bonate PL, 2011, PHARMACOKINETIC-PHARMACODYNAMIC MODELING AND SIMULATION, SECOND EDITION, P1, DOI 10.1007/978-1-4419-9485-1; Bonate PL, 2006, PHARMACOKINETIC PHAR; Bonhoeffer S, 2004, SCIENCE, V306, P1547, DOI 10.1126/science.1101786; Bosch RJ, 2003, AIDS, V17, P2395, DOI 10.1097/00002030-200311070-00016; Breen MS, 2012, NATURE, V490, P535, DOI 10.1038/nature11510; Buckheit RW, 2004, EXPERT OPIN INV DRUG, V13, P933, DOI 10.1517/13543784.13.8.933; Campbell TB, 2005, CLIN INFECT DIS, V41, P236, DOI 10.1086/430709; Castagna A, 2006, AIDS, V20, P795, DOI 10.1097/01.aids.0000218542.08845.b2; Chou R, 2006, LANCET, V368, P1503, DOI 10.1016/S0140-6736(06)69638-4; Cohen J, 2011, SCIENCE, V334, P1614, DOI 10.1126/science.334.6063.1614; Cong ME, 2007, J VIROL, V81, P3037, DOI 10.1128/JVI.02712-06; de Ronde A, 2001, J VIROL, V75, P595, DOI 10.1128/JVI.75.2.595-602.2001; DHHS, 2012, GUID US ANT AG HIV 1; Engblom S, 2006, APPL MATH COMPUT, V180, P498, DOI 10.1016/j.amc.2005.12.032; ESNOUF R, 1995, NAT STRUCT BIOL, V2, P303, DOI 10.1038/nsb0495-303; Fisher EJ, 2001, AIDS, V15, P1695, DOI 10.1097/00002030-200109070-00013; Frank M, 2011, ANTIMICROB AGENTS CH, V55, P5529, DOI 10.1128/AAC.00741-11; Gardiner CW, 2004, HDB STOCHASTIC METHO, Vxvii; Gatanaga H, 2010, ANTIMICROB AGENTS CH, V54, P1596, DOI 10.1128/AAC.01480-09; Gianotti N, 2008, J MED VIROL, V80, P201, DOI 10.1002/jmv.21085; Gillespie DT, 1992, MARKOV PROCESSES INT; Goon A, 1962, FUNDAMENTALS STAT; Goudsmit J, 1997, J VIROL, V71, P4479, DOI 10.1128/JVI.71.6.4479-4484.1997; Herman BD, 2010, J BIOL CHEM, V285, P12101, DOI 10.1074/jbc.M109.096529; Hogg RV, 2013, INTRO MATH STAT, Vx; Johnson Victoria A, 2011, Top Antivir Med, V19, P156; Katzenstein DA, 2003, AIDS, V17, P821, DOI 10.1097/00002030-200304110-00007; Kepler TB, 1998, P NATL ACAD SCI USA, V95, P11514, DOI 10.1073/pnas.95.20.11514; Martinez JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018375; Martinez-Cajas JL, 2008, DRUGS, V68, P43, DOI 10.2165/00003495-200868010-00004; Martinez-Picado J, 2002, AIDS, V16, P895, DOI 10.1097/00002030-200204120-00009; Melikian GL, 2012, ANTIMICROB AGENTS CH, V56, P2305, DOI 10.1128/AAC.05487-11; MERLUZZI VJ, 1990, SCIENCE, V250, P1411, DOI 10.1126/science.1701568; NIJHUIS M, 1995, BIOTECHNIQUES, V19, P178; Norris JR, 1998, MARKOV CHAINS, Vxvi; North TW, 2010, J VIROL, V84, P2913, DOI 10.1128/JVI.02356-09; Palmer S, 1999, AIDS, V13, P661, DOI 10.1097/00002030-199904160-00006; Perelson AS, 1999, SIAM REV, V41, P3, DOI 10.1137/S0036144598335107; Petropoulos CJ, 2000, ANTIMICROB AGENTS CH, V44, P920, DOI 10.1128/AAC.44.4.920-928.2000; Rath BA, 2012, VIRUSES-BASEL, V4, P1212, DOI 10.3390/v4081212; Reekie J, 2010, HIV MED, V11, P469, DOI 10.1111/j.1468-1293.2009.00816.x; Ren JS, 2008, VIRUS RES, V134, P157, DOI 10.1016/j.virusres.2007.12.018; Rhee SY, 2003, NUCLEIC ACIDS RES, V31, P298, DOI 10.1093/nar/gkg100; Schapiro JM, 1996, ANN INTERN MED, V124, P1039, DOI 10.7326/0003-4819-124-12-199606150-00003; Sharma PL, 2004, CURR TOP MED CHEM, V4, P895, DOI 10.2174/1568026043388484; Shulman N, 2001, AIDS, V15, P1125, DOI 10.1097/00002030-200106150-00007; Shulman NS, 2004, AIDS, V18, P1781, DOI 10.1097/00002030-200409030-00006; Sierra-Aragon S, 2012, INTERVIROLOGY, V55, P84, DOI 10.1159/000331995; Sluis-Cremer N, 2007, ANTIMICROB AGENTS CH, V51, P48, DOI 10.1128/AAC.00683-06; SPENCE RA, 1995, SCIENCE, V267, P988, DOI 10.1126/science.7532321; Tang MW, 2012, DRUGS, V72, pE1, DOI 10.2165/11633630-000000000-00000; von Kleist M, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002359; von Kleist M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018204; von Kleist M, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000720; Weinreich DM, 2005, EVOLUTION, V59, P1165; Winters MA, 1998, J CLIN INVEST, V102, P1769, DOI 10.1172/JCI4948; Winters MA, 1998, J VIROL, V72, P5303, DOI 10.1128/JVI.72.6.5303-5306.1998; Yerly S, 1998, J VIROL, V72, P3520, DOI 10.1128/JVI.72.5.3520-3523.1998	63	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2013	8	4							e61102	10.1371/journal.pone.0061102	http://dx.doi.org/10.1371/journal.pone.0061102			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IK	23613794	gold, Green Submitted, Green Published			2022-12-25	WOS:000317907200032
J	Wilmers, CC; Wang, YW; Nickel, B; Houghtaling, P; Shakeri, Y; Allen, ML; Kermish-Wells, J; Yovovich, V; Williams, T				Wilmers, Christopher C.; Wang, Yiwei; Nickel, Barry; Houghtaling, Paul; Shakeri, Yasaman; Allen, Maximilian L.; Kermish-Wells, Joe; Yovovich, Veronica; Williams, Terrie			Scale Dependent Behavioral Responses to Human Development by a Large Predator, the Puma	PLOS ONE			English	Article							RESOURCE SELECTION; SPATIAL AUTOCORRELATION; LANDSCAPE; ECOLOGY; CARNIVORE; MOVEMENT; PATTERNS; WILDLIFE; COUGARS; PREY	The spatial scale at which organisms respond to human activity can affect both ecological function and conservation planning. Yet little is known regarding the spatial scale at which distinct behaviors related to reproduction and survival are impacted by human interference. Here we provide a novel approach to estimating the spatial scale at which a top predator, the puma (Puma concolor), responds to human development when it is moving, feeding, communicating, and denning. We find that reproductive behaviors (communication and denning) require at least a 4 x larger buffer from human development than non-reproductive behaviors (movement and feeding). In addition, pumas give a wider berth to types of human development that provide a more consistent source of human interference (neighborhoods) than they do to those in which human presence is more intermittent (arterial roads with speeds >35 mph). Neighborhoods were a deterrent to pumas regardless of behavior, while arterial roads only deterred pumas when they were communicating and denning. Female pumas were less deterred by human development than males, but they showed larger variation in their responses overall. Our behaviorally explicit approach to modeling animal response to human activity can be used as a novel tool to assess habitat quality, identify wildlife corridors, and mitigate human-wildlife conflict.	[Wilmers, Christopher C.; Wang, Yiwei; Nickel, Barry; Houghtaling, Paul; Shakeri, Yasaman; Kermish-Wells, Joe; Yovovich, Veronica] Univ Calif Santa Cruz, Dept Environm Studies, Ctr Integrated Spatial Res, Santa Cruz, CA 95064 USA; [Allen, Maximilian L.] Victoria Univ, Sch Biol Sci, Wellington, New Zealand; [Williams, Terrie] Univ Calif Santa Cruz, Ecol & Evolutionary Biol Dept, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz; Victoria University Wellington; University of California System; University of California Santa Cruz	Wilmers, CC (corresponding author), Univ Calif Santa Cruz, Dept Environm Studies, Ctr Integrated Spatial Res, Santa Cruz, CA 95064 USA.	cwilmers@ucsc.edu	Allen, Maximilian/ABG-9307-2020	Allen, Maximilian/0000-0001-8976-889X	NSF [0963022]; Gordon and Betty Moore Foundation; Nature Conservancy, Midpeninsula Regional Open Space District, UC Santa Cruz; Felidae Conservation Fund; Direct For Biological Sciences [0963022] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Nature Conservancy, Midpeninsula Regional Open Space District, UC Santa Cruz; Felidae Conservation Fund; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Funding was provided by NSF grant #0963022, as well as by the Gordon and Betty Moore Foundation, The Nature Conservancy, Midpeninsula Regional Open Space District, UC Santa Cruz and the Felidae Conservation Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DR., 2002, PRACTICAL INFORM THE, DOI DOI 10.1007/B97636; Beale CM, 2010, ECOL LETT, V13, P246, DOI 10.1111/j.1461-0248.2009.01422.x; BEIER P, 1993, CONSERV BIOL, V7, P94, DOI 10.1046/j.1523-1739.1993.07010094.x; BEIER P, 1995, J WILDLIFE MANAGE, V59, P228, DOI 10.2307/3808935; BEIER P, 1995, J MAMMAL, V76, P1056, DOI 10.2307/1382599; Beier P, 2008, CONSERV BIOL, V22, P836, DOI 10.1111/j.1523-1739.2008.00942.x; Berger J, 2007, BIOL LETTERS, V3, P620, DOI 10.1098/rsbl.2007.0415; Beyer HL, 2010, PHILOS T R SOC B, V365, P2245, DOI 10.1098/rstb.2010.0083; Bivand R, 2006, GEOGR ANAL, V38, P23, DOI 10.1111/j.0016-7363.2005.00672.x; Borcard D, 2002, ECOL MODEL, V153, P51, DOI 10.1016/S0304-3800(01)00501-4; Boyce MS, 1999, TRENDS ECOL EVOL, V14, P268, DOI 10.1016/S0169-5347(99)01593-1; Breitenmoser U, 1998, BIOL CONSERV, V83, P279, DOI 10.1016/S0006-3207(97)00084-0; Brown JS, 2004, ECOL LETT, V7, P999, DOI 10.1111/j.1461-0248.2004.00661.x; Burdett CL, 2010, ECOSPHERE, V1, DOI 10.1890/ES10-00005.1; Crooks K. R., 2006, CONNECTIVITY CONSERV; Crooks KR, 1999, NATURE, V400, P563, DOI 10.1038/23028; Crooks KR, 2002, CONSERV BIOL, V16, P488, DOI 10.1046/j.1523-1739.2002.00386.x; Davies N. B., 1981, INTRO BEHAV ECOLOGY; DeStefano S, 2003, FRONT ECOL ENVIRON, V1, P95, DOI 10.1890/1540-9295(2003)001[0095:ETEOSW]2.0.CO;2; Dickson BG, 2005, J WILDLIFE MANAGE, V69, P264, DOI 10.2193/0022-541X(2005)069&lt;0264:IOVTAR&gt;2.0.CO;2; Dickson BG, 2002, J WILDLIFE MANAGE, V66, P1235, DOI 10.2307/3802956; Dormann CF, 2007, GLOBAL ECOL BIOGEOGR, V16, P129, DOI 10.1111/j.1466-8238.2006.00279.x; Elbroch LM, 2012, MAMM BIOL, V77, P377, DOI 10.1016/j.mambio.2012.02.010; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; Fischer J, 2007, GLOBAL ECOL BIOGEOGR, V16, P265, DOI 10.1111/j.1466-8238.2007.00287.x; Gillies CS, 2006, J ANIM ECOL, V75, P887, DOI 10.1111/j.1365-2656.2006.01106.x; Griffith DA, 2006, ECOLOGY, V87, P2603, DOI 10.1890/0012-9658(2006)87[2603:SMIETF]2.0.CO;2; Hebblewhite M, 2008, J APPL ECOL, V45, P834, DOI 10.1111/j.1365-2664.2008.01466.x; Hosmer DavidW., 2000, APPL LOGISTIC REGRES; Hurst JL, 2004, BIOESSAYS, V26, P1288, DOI 10.1002/bies.20147; Johnson CJ, 2006, J WILDLIFE MANAGE, V70, P347, DOI 10.2193/0022-541X(2006)70[347:RSFBOU]2.0.CO;2; Kertson BN, 2011, ECOL APPL, V21, P2866, DOI 10.1890/11-0947.1; Knopff KH, 2009, J WILDLIFE MANAGE, V73, P586, DOI 10.2193/2008-294; LEGENDRE P, 1993, ECOLOGY, V74, P1659, DOI 10.2307/1939924; Logan AL, 2001, DESERT PUMA EVOLUTIO; Manly B.F.J., 2002, RESOURCE SELECTION A; Mcrae BH, 2008, ECOLOGY, V89, P2712, DOI 10.1890/07-1861.1; Mosser A, 2009, ECOL LETT, V12, P1050, DOI 10.1111/j.1461-0248.2009.01359.x; Naughton-Treves L, 1998, CONSERV BIOL, V12, P156, DOI 10.1046/j.1523-1739.1998.96346.x; Penrod K., 2006, S COAST MISSING LINK; Peres-Neto PR, 2010, GLOBAL ECOL BIOGEOGR, V19, P174, DOI 10.1111/j.1466-8238.2009.00506.x; Soulu M., 1999, CONTINENTAL CONSERVA; Treves A, 2003, CONSERV BIOL, V17, P1491, DOI 10.1111/j.1523-1739.2003.00059.x; Tuomainen U, 2011, BIOL REV, V86, P640, DOI 10.1111/j.1469-185X.2010.00164.x; Valeix M, 2012, J APPL ECOL, V49, P73, DOI 10.1111/j.1365-2664.2011.02099.x; WITH KA, 1995, ECOLOGY, V76, P2446, DOI 10.2307/2265819	46	130	132	0	134	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2013	8	4							e60590	10.1371/journal.pone.0060590	http://dx.doi.org/10.1371/journal.pone.0060590			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IK	23613732	Green Published, gold, Green Submitted			2022-12-25	WOS:000317907200008
J	Buchbinder, R; Staples, MP; Shanahan, EM; Roos, JF				Buchbinder, Rachelle; Staples, Margaret P.; Shanahan, E. Michael; Roos, Juliana F.			General Practitioner Management of Shoulder Pain in Comparison with Rheumatologist Expectation of Care and Best Evidence: An Australian National Survey	PLOS ONE			English	Article							HOSPITAL-BASED RHEUMATOLOGY; BACK-PAIN; MUSCULOSKELETAL PROBLEMS; ORTHOPEDIC SERVICES; FROZEN SHOULDER; HEALTH-CARE; DISORDERS; REFERRALS; ADULTS; INTENTIONS	Objectives: To determine whether current care for common shoulder problems in Australian general practice is in keeping with rheumatologist expectations and the best available evidence. Methods: We performed a mailed survey of a random sample of 3500 Australian GPs and an online survey of all 270 rheumatologists in Australia in June 2009. Each survey included four vignettes (first presentation of shoulder pain due to rotator cuff tendinopathy, acute rotator cuff tear in a 45 year-old labourer and early and later presentation of adhesive capsulitis). For each vignette, GPs were asked to indicate their management, rheumatologists were asked to indicate appropriate primary care, and we determined best available evidence from relevant Cochrane and other systematic reviews and published guidelines. Results: Data were available for at least one vignette for 614/3500 (17.5%) GPs and 64 (23.8%) rheumatologists. For first presentation of rotator cuff tendinopathy, 69% and 82% of GPs and 50% and 56% rheumatologists would order a shoulder X-ray and ultrasound respectively (between group comparisons P = 0.004 and P<0001). Only 66% GPs and 60% rheumatologists would refer to an orthopaedic surgeon for the acute rotator cuff tear. For adhesive capsulitis, significantly more rheumatologists recommended treatments of known benefit (e.g. glucocorticoid injection (56% versus 14%, P<0.0001), short course of oral glucocorticoids (36% versus 6%, p<0.0001) and arthrographic distension of the glenohumeral joint (41% versus 19%, P<0.0001). Conclusions: There is a mismatch between the stated management of common shoulder problems encountered in primary care by GPs, rheumatologist expectations of GP care and the available evidence.	[Buchbinder, Rachelle; Staples, Margaret P.; Roos, Juliana F.] Monash Univ, Cabrini Hlth, Monash Dept Clin Epidemiol, Melbourne, Vic 3004, Australia; [Buchbinder, Rachelle; Staples, Margaret P.; Roos, Juliana F.] Monash Univ, Sch Publ Hlth & Prevent Med, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia; [Shanahan, E. Michael] Repatriat Gen Hosp, Dept Rheumatol, Adelaide, SA, Australia	Cabrini Health; Monash University; Monash University; Flinders University South Australia	Buchbinder, R (corresponding author), Monash Univ, Cabrini Hlth, Monash Dept Clin Epidemiol, Victoria, Melbourne, Vic 3004, Australia.	rachelle.buchbinder@monash.edu	Shanahan, Michael/ABE-5543-2020; Buchbinder, Rachelle/G-2952-2011	Buchbinder, Rachelle/0000-0002-0597-0933; Roos, Juliana F./0000-0002-9054-6597	Shepherd Foundation; Australian National Health & Medical Research Council Practitioner Fellowship	Shepherd Foundation; Australian National Health & Medical Research Council Practitioner Fellowship	The Shepherd Foundation funded this study. RB is supported in part by an Australian National Health & Medical Research Council Practitioner Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albright J, 2001, PHYS THER, V81, P1719; American Academy of Orthopaedic Surgeons, 1999, CLIN GUID SHOULD PAI; American Academy of Orthopaedic Surgeons, 2010, AM AC ORTH SURG CLIN; AMPCo, 1997, MED MAST AUSTR; [Anonymous], 1978, MAIL TELEPHONE SURVE; Australian Acute Musculoskeletal Pain Guidelines Group, 2003, EV BAS MAN AC MUSC P; Australian Institute of Health and Welfare and Commonwealth Department of Health and Family Services, 1997, 1 AIHW DHFS COMM DEP; Australian Medical Workforce Advisory Committee, 2005, 20052 AMWAC; Australian Rheumatology Association, ADV TRAIN RHEUM; Awerbuch MS, 2008, MED J AUSTRALIA, V188, P50, DOI 10.5694/j.1326-5377.2008.tb01507.x; BINDER AI, 1984, ANN RHEUM DIS, V43, P361, DOI 10.1136/ard.43.3.361; BRIDGMAN JF, 1972, ANN RHEUM DIS, V31, P69, DOI 10.1136/ard.31.1.69; Britt H, 2001, AUSTR I HLTH WELFARE, V7; Broadhurst NA, 2007, BMC FAM PRACT, V8, DOI 10.1186/1471-2296-8-12; Broadhurst Norman, 2004, Aust Fam Physician, V33, P668; Broadhurst Norman A, 2004, Aust Fam Physician, V33, P861; Buchbinder R, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007005; Buchbinder R, 2001, BRIT MED J, V322, P1516, DOI 10.1136/bmj.322.7301.1516; Buchbinder R, 2001, SPINE, V26, P2535, DOI 10.1097/00007632-200112010-00005; Buchbinder R, 2006, COCHRANE DB SYST REV, V4, DOI DOI 10.1002/14651858.CD006189; Buchbinder R., 2003, COCHRANE DB SYST REV, V2003, pCD004016, DOI [DOI 10.1002/14651858.CD004016, 10.1002/14651858.CD004016]; Buchbinder R, 2009, SPINE, V34, P1218, DOI 10.1097/BRS.0b013e318195d688; Bussieres AE, 2007, J MANIP PHYSIOL THER, V30, P617, DOI 10.1016/j.jmpt.2007.10.003; Charles J, 2007, AUST FAM PHYSICIAN, V36, P392; Coghlan JA, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005619.pub2; Cumpston M, 2009, COCHRANE DB SYST REV, V3; Eccles MP, 2006, IMPLEMENT SCI, V1, DOI 10.1186/1748-5908-1-28; Expert Rheumatology Group, 2010, THER GUID RHEUM VERS; Favejee MM, 2011, BRIT J SPORT MED, V45, P49, DOI 10.1136/bjsm.2010.071431; FELSON DT, 1985, ARTHRITIS RHEUM, V28, P1156, DOI 10.1002/art.1780281012; Geraets Jacques J X R, 2009, Ned Tijdschr Geneeskd, V153, pA164; Glazier RH, 1996, J RHEUMATOL, V23, P351; Glazier RH, 1998, CAN MED ASSOC J, V158, P1037; Godin G, 2008, IMPLEMENT SCI, V3, DOI 10.1186/1748-5908-3-36; Green S, 1998, BRIT MED J, V316, P354, DOI 10.1136/bmj.316.7128.354; Green S, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005319; Green S, 2003, Cochrane Database Syst Rev, pCD004258; Hand C, 2008, J SHOULDER ELB SURG, V17, P231, DOI 10.1016/j.jse.2007.05.009; Hrisos S, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-37; Jansen JJM, 2000, MED EDUC, V34, P66; Johol P, 2008, AUST FAM PHYSICIAN, V37, P263; Linsell L, 2006, RHEUMATOLOGY, V45, P215, DOI 10.1093/rheumatology/kei139; Little P, 2004, BMJ-BRIT MED J, V328, P444, DOI 10.1136/bmj.38013.644086.7C; Loebenberg Mark I, 2006, Bull Hosp Jt Dis, V63, P137; Medicare Australia, 2011, MED IT REP MED AUSTR; MILGROM C, 1995, J BONE JOINT SURG BR, V77B, P296, DOI 10.1302/0301-620X.77B2.7706351; Murphy RJ, 2010, CLIN EVID; National Health and Medical Research Council, RES TRANSL FAC; Patel S, 2011, J EVAL CLIN PRACT, V17, P118, DOI 10.1111/j.1365-2753.2010.01377.x; Perrot S, 2006, EUR J PAIN, V10, P185, DOI 10.1016/j.ejpain.2005.03.004; Rao C, 2005, RHEUMATOLOGY, V44, P1332, DOI 10.1093/rheumatology/kei020; REEVES B, 1975, SCAND J RHEUMATOL, V4, P193, DOI 10.3109/03009747509165255; Solomon DH, 2001, J RHEUMATOL, V28, P2090; Speed CA, 2005, RHEUMATOLOGY, V44, P469, DOI 10.1093/rheumatology/keh504; vanderHeijden GJMG, 1997, BRIT MED J, V315, P25, DOI 10.1136/bmj.315.7099.25; vanderHeijden GJMG, 1996, BRIT J GEN PRACT, V46, P309; vanderWindt DAWM, 1996, BRIT J GEN PRACT, V46, P519; VIERHOUT WPM, 1995, LANCET, V346, P990, DOI 10.1016/S0140-6736(95)91686-5; Watson J, 2008, RHEUMATOLOGY, V47, P1795, DOI 10.1093/rheumatology/ken360; Zwolsman S, 2012, BRIT J GEN PRACT, V62, DOI 10.3399/bjgp12X652382	60	32	32	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2013	8	4							e61243	10.1371/journal.pone.0061243	http://dx.doi.org/10.1371/journal.pone.0061243			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130DR	23613818	gold, Green Published, Green Submitted			2022-12-25	WOS:000317893400051
J	Castanheira, MF; Herrera, M; Costas, B; Conceicao, LEC; Martins, CIM				Castanheira, Maria Filipa; Herrera, Marcelino; Costas, Benjamin; Conceicao, Luis E. C.; Martins, Catarina I. M.			Can We Predict Personality in Fish? Searching for Consistency over Time and across Contexts	PLOS ONE			English	Article							STRESS-COPING STYLES; TROUT ONCORHYNCHUS-MYKISS; RAINBOW-TROUT; BEHAVIORAL SYNDROMES; HERITABLE VARIATION; DISEASE RESISTANCE; NEURAL PLASTICITY; CORTISOL; EVOLUTIONARY; INDICATORS	The interest in animal personality, broadly defined as consistency of individual behavioural traits over time and across contexts, has increased dramatically over the last years. Individual differences in behaviour are no longer recognised as noise around a mean but rather as adaptive variation and thus, essentially, raw material for evolution. Animal personality has been considered evolutionary conserved and has been shown to be present in all vertebrates including fish. Despite the importance of evolutionary and comparative aspects in this field, few studies have actually documented consistency across situations in fish. In addition, most studies are done with individually housed fish which may pose additional challenges when interpreting data from social species. Here, we investigate, for the first time in fish, whether individual differences in behavioural responses to a variety of challenges are consistent over time and across contexts using both individual and grouped-based tests. Twenty-four juveniles of Gilthead seabream Sparus aurata were subjected to three individual-based tests: feed intake recovery in a novel environment, novel object and restraining and to two group-based tests: risk-taking and hypoxia. Each test was repeated twice to assess consistency of behavioural responses over time. Risk taking and escape behaviours during restraining were shown to be significantly consistent over time. In addition, consistency across contexts was also observed: individuals that took longer to recover feed intake after transfer into a novel environment exhibited higher escape attempts during a restraining test and escaped faster from hypoxia conditions. These results highlight the possibility to predict behaviour in groups from individual personality traits.	[Castanheira, Maria Filipa; Herrera, Marcelino; Conceicao, Luis E. C.; Martins, Catarina I. M.] Univ Algarve, CCMAR CIMAR LA, Ctr Ciencias Mar, Faro, Portugal; [Herrera, Marcelino] IFAPA Agua del Pino, Inst Invest & Formac Agr & Pesquera, Cartaya, Spain; [Costas, Benjamin] Univ Porto, CIIMAR CIMAR LA, Ctr Interdisciplinar Invest Marinha & Ambiental, P-4100 Oporto, Portugal	Universidade do Algarve; Universidade do Porto	Castanheira, MF (corresponding author), Univ Algarve, CCMAR CIMAR LA, Ctr Ciencias Mar, Faro, Portugal.	mcastanheira@ualg.pt	Conceicao, Luis E.C./H-6257-2011; Herrera, Marcelino/AAV-4163-2020; Herrera, Marcelino/J-7771-2016; Costas, Benjamín/F-9350-2010	Conceicao, Luis E.C./0000-0001-6102-2068; Herrera, Marcelino/0000-0002-9371-156X; Herrera, Marcelino/0000-0002-9371-156X; Costas, Benjamín/0000-0003-3758-0849	European Commission [265957 COPEWELL]; European Social Fund of Andalusia; Foundation for Science and Technology, Portugal [SFRH/BPD/77210/2011]	European Commission(European CommissionEuropean Commission Joint Research Centre); European Social Fund of Andalusia; Foundation for Science and Technology, Portugal(Portuguese Foundation for Science and Technology)	This research project has been supported by the European Commission under the 7th Framework Programme FP7-KBBE-2010-4 Contract no.: 265957 COPEWELL. MH post-doc contract was supported by the Operational Programme of the European Social Fund 2007-2013 of Andalusia. BC post-doc contract was supported by the Foundation for Science and Technology, Portugal, through the grant SFRH/BPD/77210/2011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves RN, 2010, AQUACULTURE, V299, P57, DOI 10.1016/j.aquaculture.2009.11.014; Arends RJ, 1999, J ENDOCRINOL, V163, P149, DOI 10.1677/joe.0.1630149; Barazi-Yeroulanos L, 2010, SYNTHESIS MEDITERRAN; Barreto RE, 2011, J BIOSCIENCES, V36, P851, DOI 10.1007/s12038-011-9111-4; Basic D, 2012, PHYSIOL BEHAV, V105, P1175, DOI 10.1016/j.physbeh.2011.12.021; BENUS RF, 1991, EXPERIENTIA, V47, P1008, DOI 10.1007/BF01923336; Bolhuis JE, 2005, ANIM BEHAV, V69, P1085, DOI 10.1016/j.anbehav.2004.09.013; Brelin D, 2005, ANN NY ACAD SCI, V1040, P239, DOI 10.1196/annals.1327.033; Budaev S.V., 2002, J ICHTHYOL+, V42, P189; Careau V, 2008, OIKOS, V117, P641, DOI 10.1111/j.0030-1299.2008.16513.x; Champagne DL, 2010, BEHAV BRAIN RES, V214, P332, DOI 10.1016/j.bbr.2010.06.001; Ruiz-Gomez MD, 2011, PHYSIOL BEHAV, V102, P317, DOI 10.1016/j.physbeh.2010.11.023; FEVOLDEN SE, 1993, AQUACULTURE, V109, P215, DOI 10.1016/0044-8486(93)90164-T; FEVOLDEN SE, 1992, AQUACULTURE, V104, P19, DOI 10.1016/0044-8486(92)90134-7; Frost AJ, 2007, P ROY SOC B-BIOL SCI, V274, P333, DOI 10.1098/rspb.2006.3751; Galhardo L, 2012, BIOL LETTERS, V8, P936, DOI 10.1098/rsbl.2012.0500; Galhardo Leonor, 2009, ARBS Annual Review of Biomedical Sciences, V11, P1; Huntingford F, 2005, BEHAVIOUR, V142, P1207, DOI 10.1163/156853905774539382; Huntingford FA, 2010, J FISH BIOL, V76, P1576, DOI 10.1111/j.1095-8649.2010.02582.x; Irwin S, 1999, COMP BIOCHEM PHYS C, V124, P27, DOI 10.1016/S0742-8413(99)00043-2; Johansen IB, 2012, COMP BIOCHEM PHYS D, V7, P161, DOI 10.1016/j.cbd.2012.01.002; Koolhaas JM, 2010, FRONT NEUROENDOCRIN, V31, P307, DOI 10.1016/j.yfrne.2010.04.001; Koolhaas JM, 1999, NEUROSCI BIOBEHAV R, V23, P925, DOI 10.1016/S0149-7634(99)00026-3; Laursen DC, 2011, APPL ANIM BEHAV SCI, V132, P211, DOI 10.1016/j.applanim.2011.03.011; LeBlanc S, 2012, AM J PHYSIOL-REG I, V302, pR184, DOI 10.1152/ajpregu.00196.2011; MacKenzie S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005314; Martins CIM, 2012, BEHAVIOUR, V149, P215, DOI 10.1163/156853912X634430; Martins CIM, 2012, FISH PHYSIOL BIOCHEM, V38, P17, DOI 10.1007/s10695-011-9518-8; Martins CIM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028084; Martins CIM, 2011, APPL ANIM BEHAV SCI, V133, P109, DOI 10.1016/j.applanim.2011.05.001; Martins CIM, 2011, APPL ANIM BEHAV SCI, V130, P135, DOI 10.1016/j.applanim.2010.12.007; Martins CIM, 2011, AQUACULTURE, V312, P192, DOI 10.1016/j.aquaculture.2010.12.035; Silva PIM, 2010, APPL ANIM BEHAV SCI, V124, P75, DOI 10.1016/j.applanim.2010.01.008; Overli O, 2006, PHYSIOL BEHAV, V87, P506, DOI 10.1016/j.physbeh.2005.11.012; Overli O, 2002, J EXP BIOL, V205, P391; Overli O, 2007, NEUROSCI BIOBEHAV R, V31, P396, DOI 10.1016/j.neubiorev.2006.10.006; Raleigh R.F., 1984, FWSOBS821060; Reale D, 2007, BIOL REV, V82, P291, DOI 10.1111/j.1469-185X.2007.00010.x; Reale D, 2010, PHILOS T R SOC B, V365, P3937, DOI 10.1098/rstb.2010.0222; Reebs SG, 2000, ANIM BEHAV, V59, P403, DOI 10.1006/anbe.1999.1314; Reig AC, 2001, INFLUENCIA TEMPERATU; Sih A, 2004, TRENDS ECOL EVOL, V19, P372, DOI 10.1016/j.tree.2004.04.009; Sorensen C, 2013, GEN COMP ENDOCR, V181, P25, DOI 10.1016/j.ygcen.2012.12.003; Toms CN., 2010, INT J COMPPSYCHOL, V23, P1, DOI DOI 10.1002/CPMO.17; van de Nieuwegiessen PG, 2008, APPL ANIM BEHAV SCI, V115, P233, DOI 10.1016/j.applanim.2008.05.008; van Erp-van der Kooij E, 2003, PHYSIOL BEHAV, V78, P479, DOI 10.1016/S0031-9384(03)00002-7	46	85	86	0	106	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2013	8	4							e62037	10.1371/journal.pone.0062037	http://dx.doi.org/10.1371/journal.pone.0062037			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130DR	23614007	Green Published, Green Submitted, gold			2022-12-25	WOS:000317893400147
J	Dong, LX; Li, ZG; Leffler, NR; Asch, AS; Chi, JT; Yang, LV				Dong, Lixue; Li, Zhigang; Leffler, Nancy R.; Asch, Adam S.; Chi, Jen-Tsan; Yang, Li V.			Acidosis Activation of the Proton-Sensing GPR4 Receptor Stimulates Vascular Endothelial Cell Inflammatory Responses Revealed by Transcriptome Analysis	PLOS ONE			English	Article							NF-KAPPA-B; GENE-EXPRESSION; METABOLIC-ACIDOSIS; CEREBRAL-ISCHEMIA; PH SENSOR; DISEASE; REPERFUSION; DEFICIENT; STRESS; STROKE	Acidic tissue microenvironment commonly exists in inflammatory diseases, tumors, ischemic organs, sickle cell disease, and many other pathological conditions due to hypoxia, glycolytic cell metabolism and deficient blood perfusion. However, the molecular mechanisms by which cells sense and respond to the acidic microenvironment are not well understood. GPR4 is a proton-sensing receptor expressed in endothelial cells and other cell types. The receptor is fully activated by acidic extracellular pH but exhibits lesser activity at the physiological pH 7.4 and minimal activity at more alkaline pH. To delineate the function and signaling pathways of GPR4 activation by acidosis in endothelial cells, we compared the global gene expression of the acidosis response in primary human umbilical vein endothelial cells (HUVEC) with varying level of GPR4. The results demonstrated that acidosis activation of GPR4 in HUVEC substantially increased the expression of a number of inflammatory genes such as chemokines, cytokines, adhesion molecules, NF-kappa B pathway genes, and prostaglandin-endoperoxidase synthase 2 (PTGS2 or COX-2) and stress response genes such as ATF3 and DDIT3 (CHOP). Similar GPR4-mediated acidosis induction of the inflammatory genes was also noted in other types of endothelial cells including human lung microvascular endothelial cells and pulmonary artery endothelial cells. Further analyses indicated that the NF-kappa B pathway was important for the acidosis/GPR4-induced inflammatory gene expression. Moreover, acidosis activation of GPR4 increased the adhesion of HUVEC to U937 monocytic cells under a flow condition. Importantly, treatment with a recently identified GPR4 antagonist significantly reduced the acidosis/GPR4-mediated endothelial cell inflammatory response. Taken together, these results show that activation of GPR4 by acidosis stimulates the expression of a wide range of inflammatory genes in endothelial cells. Such inflammatory response can be suppressed by GPR4 small molecule inhibitors and hold potential therapeutic value.	[Dong, Lixue; Li, Zhigang; Leffler, Nancy R.; Asch, Adam S.; Yang, Li V.] E Carolina Univ, Brody Sch Med, Dept Oncol, Greenville, NC 27858 USA; [Dong, Lixue; Li, Zhigang; Leffler, Nancy R.; Asch, Adam S.; Yang, Li V.] E Carolina Univ, Brody Sch Med, Dept Internal Med, Greenville, NC USA; [Yang, Li V.] E Carolina Univ, Brody Sch Med, Dept Anat & Cell Biol, Greenville, NC USA; [Asch, Adam S.; Yang, Li V.] UNC Lineberger Comprehens Canc Ctr, Chapel Hill, NC USA; [Chi, Jen-Tsan] Duke Univ, Inst Genome Sci & Policy, Durham, NC USA; [Chi, Jen-Tsan] Duke Univ, Dept Mol Genet & Microbiol, Durham, NC USA	University of North Carolina; East Carolina University; University of North Carolina; East Carolina University; University of North Carolina; East Carolina University; University of North Carolina; University of North Carolina Chapel Hill; Duke University; Duke University	Yang, LV (corresponding author), E Carolina Univ, Brody Sch Med, Dept Oncol, Greenville, NC 27858 USA.	yangl@ecu.edu	Chi, Jen-Tsan/AAI-4125-2020; LI, ZHIGANG/M-4572-2017	Chi, Jen-Tsan/0000-0003-3433-903X; LI, ZHIGANG/0000-0001-8291-3652; Yang, Li/0000-0002-8654-4927	American Heart Association [11SDG5390021]; Brody Brothers Endowment Fund; Golfers against Cancer; North Carolina Biotechnology Center; ECU Internal Medicine Startup Funds; National Institutes of Health [R01CA125618]; Doris Duke Charitable Foundation; NATIONAL CANCER INSTITUTE [R01CA125618] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); Brody Brothers Endowment Fund; Golfers against Cancer; North Carolina Biotechnology Center; ECU Internal Medicine Startup Funds; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by research grants from the American Heart Association (11SDG5390021), Brody Brothers Endowment Fund, Golfers against Cancer, North Carolina Biotechnology Center, and ECU Internal Medicine Startup Funds (to L.V.Y.). J.T.C. acknowledged the support from National Institutes of Health (R01CA125618) and Doris Duke Charitable Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beg AA, 1996, SCIENCE, V274, P782, DOI 10.1126/science.274.5288.782; BEG AA, 1995, GENE DEV, V9, P2736, DOI 10.1101/gad.9.22.2736; Benson V, 2007, CURR MOL MED, V7, P219, DOI 10.2174/156652407780059131; BRIEHL RW, 1973, J MOL BIOL, V80, P445, DOI 10.1016/0022-2836(73)90415-4; BRUGNARA C, 1989, BLOOD, V74, P487; Castellone RD, 2011, CANC LETT; Cha SH, 2005, MOL CELLS, V19, P232; Chang JT, 2006, BIOINFORMATICS, V22, P2926, DOI 10.1093/bioinformatics/btl483; Chen AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027586; Chen JLY, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001093; Chen JLY, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000293; Colotta F, 2009, CARCINOGENESIS, V30, P1073, DOI 10.1093/carcin/bgp127; Firth PG, 2005, BRIT J ANAESTH, V95, P287, DOI 10.1093/bja/aei129; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Hoffmann E, 2002, J LEUKOCYTE BIOL, V72, P847; Huang J, 2006, SURG NEUROL, V66, P232, DOI 10.1016/j.surneu.2005.12.028; Hunt JF, 2000, AM J RESP CRIT CARE, V161, P694, DOI 10.1164/ajrccm.161.3.9911005; Kellum JA, 2000, CRIT CARE, V4, P6, DOI 10.1186/cc644; Kinsey GR, 2008, NEPHRON EXP NEPHROL, V109, pE102, DOI 10.1159/000142934; Lardner A, 2001, J LEUKOCYTE BIOL, V69, P522; Liu YL, 2008, CYTOKINE, V44, P108, DOI 10.1016/j.cyto.2008.06.016; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ludwig MG, 2003, NATURE, V425, P93, DOI 10.1038/nature01905; Lum H, 2003, AM J PHYSIOL-HEART C, V285, pH1786, DOI 10.1152/ajpheart.00359.2003; Milbauer LC, 2008, BLOOD, V111, P3872, DOI 10.1182/blood-2007-06-097188; Mitchell BL, 2007, J NATL MED ASSOC, V99, P300; Muller WA, 2003, TRENDS IMMUNOL, V24, P327, DOI 10.1016/S1471-4906(03)00117-0; Nowik M, 2008, PHYSIOL GENOMICS, V32, P322, DOI 10.1152/physiolgenomics.00160.2007; Oeckinghaus A, 2011, NAT IMMUNOL, V12, P695, DOI 10.1038/ni.2065; Okpala H, 2006, CURR OPIN HEMATOL, V13, P40, DOI 10.1097/01.moh.0000190108.62414.06; Rezkalla SH, 2002, CIRCULATION, V105, P656, DOI 10.1161/hc0502.102867; Ribatti D, 2002, J HEMATOTH STEM CELL, V11, P81, DOI 10.1089/152581602753448559; Sheridan FM, 1996, CIRCULATION, V93, P1784, DOI 10.1161/01.CIR.93.10.1784; Siesjo BK, 1996, ADV NEUROL, V71, P209; Sughrue ME, 2004, INFLAMM RES, V53, P497, DOI 10.1007/s00011-004-1282-0; Sun XM, 2010, J AM SOC NEPHROL, V21, P1745, DOI 10.1681/ASN.2009050477; Takeshita K, 2003, AM J RESP CELL MOL, V29, P124, DOI 10.1165/rcmb.2002-0126OC; Tang XH, 2012, CANCER RES, V72, P491, DOI 10.1158/0008-5472.CAN-11-2076; Taracido IC, 2009, United States patent application, Patent No. [12/468,706, 12468706]; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wongdee K, 2009, MOL CELL BIOCHEM, V321, P173, DOI 10.1007/s11010-008-9931-1; Wyder L, 2011, ANGIOGENESIS, V14, P533, DOI 10.1007/s10456-011-9238-9; Xiong ZG, 2004, CELL, V118, P687, DOI 10.1016/j.cell.2004.08.026; Yang L. V., 2012, CANC PREVENTION MECH, P3, DOI DOI 10.5772/28692; Yang LV, 2007, MOL CELL BIOL, V27, P1334, DOI 10.1128/MCB.01909-06; Yellon DM, 2007, NEW ENGL J MED, V357, P1121, DOI 10.1056/NEJMra071667; Zhang KZ, 2008, NATURE, V454, P455, DOI 10.1038/nature07203	47	71	71	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2013	8	4							e61991	10.1371/journal.pone.0061991	http://dx.doi.org/10.1371/journal.pone.0061991			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130DR	23613998	Green Submitted, Green Published, gold			2022-12-25	WOS:000317893400140
J	Li, RS; Wu, Q; Zhao, Y; Jin, WB; Yuan, XF; Wu, XP; Tang, YC; Zhang, J; Tan, XY; Bi, F; Liu, JN				Li, Ruishu; Wu, Qiong; Zhao, Yue; Jin, Wenbo; Yuan, Xinfang; Wu, Xiaopeng; Tang, Yanchun; Zhang, Jing; Tan, Xiangyang; Bi, Feng; Liu, Jian-Ning			The Novel Pro-Osteogenic Activity of NUCB2(1-83)	PLOS ONE			English	Article							OSTEOPOROSIS; NESFATIN-1	NUCB2(1-83) has been recently reported as an anorexigenic and anti-hyperglycemic peptide. Here we report that NUCB2(1-83) promotes osteogenesis. It was found after two months of once-a-day intravenous injection of NUCB2 1-83, bone mineral density of femora and lumbar vertebrae were increased in ovariectomized rats. NUCB2(1-83) also increased the alkaline phosphatase activity and promoted mineralization in mouse MC3T3-E1 preosteoblastic cell line. When either both Arg(60) and Arg(63) or Ser(72) were mutated to Ala, the pro-osteogenic activity was completely lost, indicating that these residues are structurally important for its biological function. Furthermore, it encumbered osteoclastic differentiation of RAW 264.7 macrophage. It also excluded any possibility of the effect caused by contaminants or experimental faults, and demonstrated that the pro-osteogenic activity observed was a specific effect of NUCB2(1-83) itself. These findings warranted that further studies on NUCB2(1-83) would be valuable for the treatment of bone metabolic diseases especially for osteoporosis.	[Li, Ruishu; Wu, Qiong; Zhao, Yue; Liu, Jian-Ning] Nanjing Univ, Inst Mol Med, Nanjing 210008, Jiangsu, Peoples R China; [Zhao, Yue; Jin, Wenbo; Yuan, Xinfang; Wu, Xiaopeng; Tang, Yanchun; Zhang, Jing; Tan, Xiangyang; Bi, Feng; Liu, Jian-Ning] Landing Labs, Suzhou, Peoples R China	Nanjing University	Bi, F (corresponding author), Landing Labs, Suzhou, Peoples R China.	fengbi@live.com; jianningliu2000@yahoo.com	Wu, Qiong/GPX-8246-2022					Akune T, 2004, J CLIN INVEST, V113, P846, DOI 10.1172/JCI200419900; Cummings SR, 2002, LANCET, V359, P1761, DOI 10.1016/S0140-6736(02)08657-9; ERLEBACHER A, 1995, CELL, V80, P371, DOI 10.1016/0092-8674(95)90487-5; Goebel M, 2009, BRAIN RES, V1300, P114, DOI 10.1016/j.brainres.2009.08.082; [Li Rui-Shu 李睿书], 2010, [南京大学学报. 自然科学版, Journal of Nanjing University], V46, P85; Melton LJ, 2004, J BONE MINER RES, V19, P1055, DOI 10.1359/JBMR.040316; Melton LJ, 2001, OSTEOPOROSIS, P557, DOI [10.1016/B978-012470862-4/50022-2, DOI 10.1016/B978-012470862-4/50022-2]; Merali Z, 2008, PSYCHOPHARMACOLOGY, V201, P115, DOI 10.1007/s00213-008-1252-2; MINKIN C, 1982, CALCIFIED TISSUE INT, V34, P285, DOI 10.1007/BF02411252; Oh-I S, 2006, NATURE, V443, P709, DOI 10.1038/nature05162; Petersson U, 2004, BONE, V34, P949, DOI 10.1016/j.bone.2004.01.019; Raisz LG, 2005, J CLIN INVEST, V115, P3318, DOI 10.1172/JCI27071; Sambrook P, 2006, LANCET, V367, P2010, DOI 10.1016/S0140-6736(06)68891-0; Su YJ, 2010, BIOCHEM BIOPH RES CO, V391, P1039, DOI 10.1016/j.bbrc.2009.12.014; SUDO H, 1983, J CELL BIOL, V96, P191, DOI 10.1083/jcb.96.1.191	15	23	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2013	8	4							e61619	10.1371/journal.pone.0061619	http://dx.doi.org/10.1371/journal.pone.0061619			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125TD	23613885	Green Published, Green Submitted, gold			2022-12-25	WOS:000317563300033
J	Told, R; Palkovits, S; Haslacher, H; Frantal, S; Schmidl, D; Boltz, A; Lasta, M; Kaya, S; Werkmeister, RM; Garhofer, G; Schmetterer, L				Told, Reinhard; Palkovits, Stefan; Haslacher, Helmuth; Frantal, Sophie; Schmidl, Doreen; Boltz, Agnes; Lasta, Michael; Kaya, Semira; Werkmeister, Rene M.; Garhoefer, Gerhard; Schmetterer, Leopold			Alterations of Choroidal Blood Flow Regulation in Young Healthy Subjects with Complement Factor H Polymorphism	PLOS ONE			English	Article							C-REACTIVE PROTEIN; HY402H GENE POLYMORPHISM; MACULAR DEGENERATION; ISOMETRIC-EXERCISE; MYOCARDIAL-INFARCTION; FOVEAL REGION; RISK-FACTORS; ACTIVATION; AMD; NEOVASCULARIZATION	A common polymorphism in the complement factor H gene (rs1061170, Y402H) is associated with a high risk of age-related macular degeneration (AMD). In the present study we hypothesized that healthy young subjects homozygous for the high-risk haplotype (CC) show abnormal choroidal blood flow (ChBF) regulation decades before potentially developing the disease. A total of 100 healthy young subjects were included in the present study, of which 4 subjects were excluded due to problems with genotyping or blood flow measurements. ChBF was measured continuously using laser Doppler flowmetry while the subjects performed isometric exercise (squatting) for 6 minutes. The increase in ChBF was less pronounced than the response in ocular perfusion pressure (OPP), indicating for some degree of choroidal blood flow regulation. Eighteen subjects were homozygous for C, 47 subjects were homozygous for T and 31 subjects were heterozygous (CT). The increase in OPP during isometric exercise was not different between groups. By contrast the increase in ChBF was more pronounced in subjects homozygous for the high risk C allele (p = 0.041). This was also evident from the pressure/flow relationship, where the increase in ChBF in homozygous C carriers started at lower OPPs as compared to the other groups. Our data indicate that the regulation of ChBF is abnormal in rs1061170 CC carriers. So far this polymorphism has been linked to age related macular degeneration (AMD) mainly via inflammatory pathways associated with the complement system dysfunction. Our results indicate that it could also be related to vascular factors that have been implicated in AMD pathogenesis.	[Told, Reinhard; Palkovits, Stefan; Schmidl, Doreen; Boltz, Agnes; Lasta, Michael; Kaya, Semira; Garhoefer, Gerhard; Schmetterer, Leopold] Med Univ Vienna, Dept Clin Pharmacol, Vienna, Austria; [Haslacher, Helmuth] Med Univ Vienna, Dept Lab Med, Vienna, Austria; [Told, Reinhard; Boltz, Agnes; Werkmeister, Rene M.; Schmetterer, Leopold] Med Univ Vienna, Ctr Med Phys & Biomed Engn, Vienna, Austria; [Frantal, Sophie] Med Univ Vienna, Ctr Med Stat Informat & Intelligence Syst, Vienna, Austria	Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; Medical University of Vienna	Schmetterer, L (corresponding author), Med Univ Vienna, Dept Clin Pharmacol, Vienna, Austria.	leopold.schmetterer@meduniwien.ac.at	Haslacher, Helmuth/D-4233-2013	Haslacher, Helmuth/0000-0003-4605-2503; Schmidl, Doreen/0000-0001-5664-7768; Told, Reinhard/0000-0003-2046-7081; Schmetterer, Leopold/0000-0002-7189-1707	Austrian Science Fund (FWF) [P 21406]	Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This study was supported by the Austrian Science Fund (FWF, project P 21406). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DH, 2010, PROG RETIN EYE RES, V29, P95, DOI 10.1016/j.preteyeres.2009.11.003; Bergeron-Sawitzke J, 2009, EUR J HUM GENET, V17, P1190, DOI 10.1038/ejhg.2009.23; Boltz A, 2010, SPEKTRUM AUGENHEILKD, V24, P296, DOI 10.1007/s00717-010-0445-3; Boltz A, 2010, INVEST OPHTH VIS SCI, V51, P4220, DOI 10.1167/iovs.09-4968; Chakravarthy U, 2010, BMC OPHTHALMOL, V10, DOI 10.1186/1471-2415-10-31; Chen J, 2012, NAT MED, V18, P658, DOI 10.1038/nm.2761; Ciulla TA, 2002, BRIT J OPHTHALMOL, V86, P209, DOI 10.1136/bjo.86.2.209; Clark SJ, 2010, BIOCHEM SOC T, V38, P1342, DOI 10.1042/BST0381342; Coleman AL, 2008, OPHTHALMOLOGY, V115, P18, DOI 10.1016/j.ophtha.2007.04.016; Donoso LA, 2010, SURV OPHTHALMOL, V55, P227, DOI 10.1016/j.survophthal.2009.11.001; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; FRIEDMAN E, 1995, OPHTHALMOLOGY, V102, P640, DOI 10.1016/S0161-6420(95)30974-8; Fuchsjager-Mayrl G, 2003, INVEST OPHTH VIS SCI, V44, P728, DOI 10.1167/iovs.02-0372; Geiser MH, 1999, KLIN MONATSBL AUGENH, V214, P285, DOI 10.1055/s-2008-1034795; Geiser MH, 2000, CURR EYE RES, V21, P669, DOI 10.1076/0271-3683(200008)21:2;1-V;FT669; Goverdhan SV, 2008, EYE, V22, P849, DOI 10.1038/sj.eye.6702830; Grunwald JE, 1998, INVEST OPHTH VIS SCI, V39, P385; Grunwald JE, 2005, INVEST OPHTH VIS SCI, V46, P1033, DOI 10.1167/iovs.04-1050; Hageman GS, 2001, PROG RETIN EYE RES, V20, P705, DOI 10.1016/S1350-9462(01)00010-6; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Ho L, 2011, ARCH OPHTHALMOL-CHIC, V129, P758, DOI 10.1001/archophthalmol.2011.141; Jylhava J, 2009, CLIN EXP IMMUNOL, V155, P53, DOI 10.1111/j.1365-2249.2008.03752.x; Jylhava J, 2009, EXP GERONTOL, V44, P297, DOI 10.1016/j.exger.2008.10.006; Kardys I, 2006, J AM COLL CARDIOL, V47, P1568, DOI 10.1016/j.jacc.2005.11.076; Kassoff A, 2001, ARCH OPHTHALMOL-CHIC, V119, P1417, DOI 10.1001/archopht.119.10.1417; Klein ML, 2008, OPHTHALMOLOGY, V115, P1019, DOI 10.1016/j.ophtha.2008.01.036; Klein R, 2009, ARCH OPHTHALMOL-CHIC, V127, P193, DOI 10.1001/archophthalmol.2008.551; Luksch A, 2003, INVEST OPHTH VIS SCI, V44, P734, DOI 10.1167/iovs.02-0177; Machalinska A, 2012, ACTA OPHTHALMOL, V90, P695, DOI 10.1111/j.1755-3768.2011.02295.x; Metelitsina TI, 2008, INVEST OPHTH VIS SCI, V49, P358, DOI 10.1167/iovs.07-0526; Metelitsina TI, 2006, BRIT J OPHTHALMOL, V90, P342, DOI 10.1136/bjo.2005.082974; Mullins RF, 2000, FASEB J, V14, P835, DOI 10.1096/fasebj.14.7.835; Pauleikhoff D, 1999, ARCH OPHTHALMOL-CHIC, V117, P1353, DOI 10.1001/archopht.117.10.1353; Polska E, 2003, MICROVASC RES, V65, P39, DOI 10.1016/S0026-2862(02)00010-9; Pournaras CJ, 2006, INVEST OPHTH VIS SCI, V47, P1581, DOI 10.1167/iovs.05-0434; Reynolds R, 2009, INVEST OPHTH VIS SCI, V50, P5818, DOI 10.1167/iovs.09-3928; Riva CE, 1997, INVEST OPHTH VIS SCI, V38, P2338; RIVA CE, 1994, INVEST OPHTH VIS SCI, V35, P4273; ROBINSON F, 1986, INVEST OPHTH VIS SCI, V27, P722; Schaumberg DA, 2007, ARCH OPHTHALMOL-CHIC, V125, P300, DOI 10.1001/archopht.125.3.300; Schmidl D, 2011, EXP EYE RES, V93, P141, DOI 10.1016/j.exer.2010.09.002; Thakkinstian A, 2006, HUM MOL GENET, V15, P2784, DOI 10.1093/hmg/ddl220; Tong Y, 2010, MOL VIS, V16, P1958; Uretmen O, 2003, OPHTHALMOLOGICA, V217, P137, DOI 10.1159/000068559; Vinores SA, 2006, J CELL PHYSIOL, V206, P749, DOI 10.1002/jcp.20525; Voick KA, 2008, AM J HYPERTENS, V21, P533, DOI 10.1038/ajh.2007.81; von Leithner PL, 2009, AM J PATHOL, V175, P412, DOI 10.2353/ajpath.2009.080927; Wegscheider BJ, 2007, OPHTHALMOLOGY, V114, P738, DOI 10.1016/j.ophtha.2006.07.048; Weismann D, 2011, NATURE, V478, P76, DOI 10.1038/nature10449; WOLZT M, 1995, BRIT J CLIN PHARMACO, V39, P347, DOI 10.1111/j.1365-2125.1995.tb04462.x; Zee RYL, 2006, ATHEROSCLEROSIS, V187, P332, DOI 10.1016/j.atherosclerosis.2005.09.009; Zhou JL, 2006, P NATL ACAD SCI USA, V103, P16182, DOI 10.1073/pnas.0604255103	52	14	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2013	8	4							e60424	10.1371/journal.pone.0060424	http://dx.doi.org/10.1371/journal.pone.0060424			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125TD	23596508	gold, Green Published, Green Submitted			2022-12-25	WOS:000317563300005
J	Wong, IOL; Cowling, BJ; Leung, GM; Schooling, CM				Wong, Irene O. L.; Cowling, Benjamin J.; Leung, Gabriel M.; Schooling, C. Mary			Age-Period-Cohort Projections of Ischaemic Heart Disease Mortality by Socio-Economic Position in a Rapidly Transitioning Chinese Population	PLOS ONE			English	Article							EPIDEMIOLOGIC TRANSITION; CARDIOVASCULAR-DISEASES; TEMPORAL VARIATION; CANCER INCIDENCE; RISK-FACTORS; TRENDS; RATES; FORECASTS; MODELS; STROKE	Background: With economic development and population aging, ischaemic heart disease (IHD) is becoming a leading cause of mortality with widening inequalities in China. To forewarn the trends in China we projected IHD trends in the most economically developed part of China, i.e., Hong Kong. Methods: Based on sex-specific IHD mortality rates from 1976 to 2005, we projected mortality rates by neighborhood-level socio-economic position (i.e., low- or high-income groups) to 2020 in Hong Kong using Poisson age-period-cohort models with autoregressive priors. Results: In the low-income group, age-standardized IHD mortality rates among women declined from 33.3 deaths in 1976-1980 to 19.7 per 100,000 in 2016-2020 (from 55.5 deaths to 34.2 per 100,000 among men). The rates in the high-income group were initially higher in both sexes, particularly among men, but this had reversed by the end of the study periods. The rates declined faster for the high-income group than for the low-income group in both sexes. The rates were projected to decline faster in the high-income group, such that by the end of the projection period the high-income group would have lower IHD mortality rates, particularly for women. Birth cohort effects varied with sex, with a marked upturn in IHD mortality around 1945, i.e., for the first generation of men to grow up in a more economically developed environment. There was no such upturn in women. Birth cohort effects were the main drivers of change in IHD mortality rates. Conclusion: IHD mortality rates are declining in Hong Kong and are projected to continue to do so, even taking into account greater vulnerability for the first generation of men born into a more developed environment. At the same time social disparities in IHD have reversed and are widening, partly as a result of a cohort effect, with corresponding implications for prevention.	[Wong, Irene O. L.; Cowling, Benjamin J.; Leung, Gabriel M.; Schooling, C. Mary] Univ Hong Kong, Li Ka Shing Fac Med, Sch Publ Hlth, Lifestyle & Life Course Epidemiol Grp, Hong Kong, Hong Kong, Peoples R China; [Schooling, C. Mary] CUNY Hunter Coll, Sch Publ Hlth, New York, NY 10021 USA	University of Hong Kong; City University of New York (CUNY) System; Hunter College (CUNY)	Schooling, CM (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Sch Publ Hlth, Lifestyle & Life Course Epidemiol Grp, Hong Kong, Hong Kong, Peoples R China.	cms1@hkucc.hku.hk	Cowling, Benjamin John/C-4263-2009	Cowling, Benjamin John/0000-0002-6297-7154; Schooling, Mary/0000-0001-9933-5887; Leung, Gabriel/0000-0002-2503-6283	Census and Statistics Department of the Government of the Hong Kong Special Administrative Region; Health and Health Services Research Fund; Food and Health Bureau; Government of the HK Special Administrative Region, China [08090861]; MedImmune Inc.	Census and Statistics Department of the Government of the Hong Kong Special Administrative Region; Health and Health Services Research Fund; Food and Health Bureau; Government of the HK Special Administrative Region, China; MedImmune Inc.(AstraZenecaMedimmune)	We thank the Census and Statistics Department of the Government of the Hong Kong Special Administrative Region for their support and for facilitating data access, although they have no role in the design, analysis, interpretation or decision to submit for publication. The authors thank Roger Chung for technical support. We also thank Elaine Lau, Cindy Lin and Rita Hou for their support in data retrieval and data management. The authors thank the Editor and the reviewer for their helpful comments and suggestions that greatly improved the final revision of this paper.; This project was supported by the Health and Health Services Research Fund; Food and Health Bureau; Government of the HK Special Administrative Region, China (Grant number: 08090861). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; C. Mary Schooling is a PLOS ONE Editorial Board member. Benjamin J. Cowling is a PLOS ONE Editorial Board member. He has received research funding from MedImmune Inc., and consults for Crucell NV. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.	AHMAD O, 2001, 31 GPE WHO; Bonneux L, 2003, EUR J PUBLIC HEALTH, V13, P226, DOI 10.1093/eurpub/13.3.226; Bray I, 2002, J ROY STAT SOC C-APP, V51, P151, DOI 10.1111/1467-9876.00260; Chen FN, 2010, AM SOCIOL REV, V75, P126, DOI 10.1177/0003122409359165; Chu LW, 2008, J AM GERIATR SOC, V56, P1286, DOI 10.1111/j.1532-5415.2008.01746.x; Chung RY, 2010, AM J EPIDEMIOL, V171, P345, DOI 10.1093/aje/kwp378; CLAYTON D, 1987, STAT MED, V6, P449, DOI 10.1002/sim.4780060405; CLAYTON D, 1987, STAT MED, V6, P469, DOI 10.1002/sim.4780060406; Gelman A., 1992, STAT SCI, V7, P457, DOI [DOI 10.1214/SS/1177011136, 10.1214/ss/1177011136]; Gonzalez MA, 1998, INT J EPIDEMIOL, V27, P350, DOI 10.1093/ije/27.3.350; Haase CL, 2012, J CLIN ENDOCR METAB, V97, pE248, DOI 10.1210/jc.2011-1846; He J, 2005, NEW ENGL J MED, V353, P1124, DOI 10.1056/NEJMsa050467; Holford T R, 1992, Stat Methods Med Res, V1, P317, DOI 10.1177/096228029200100306; HOLFORD TR, 1991, ANNU REV PUBL HEALTH, V12, P425, DOI 10.1146/annurev.pu.12.050191.002233; Huovinen E, 2006, INT J EPIDEMIOL, V35, P1246, DOI 10.1093/ije/dyl128; Janus ED, 2000, DIABETIC MED, V17, P741, DOI 10.1046/j.1464-5491.2000.00376.x; Jhun HJ, 2011, J KOREAN MED SCI, V26, P637, DOI 10.3346/jkms.2011.26.5.637; Lau EW, 2012, ANN EPIDEMIOL, V22, P285, DOI 10.1016/j.annepidem.2012.01.009; Lawlor DA, 2002, LANCET, V360, P1818, DOI 10.1016/S0140-6736(02)11769-7; Lawlor DA, 2001, BRIT MED J, V323, P541, DOI 10.1136/bmj.323.7312.541; Liu J, 2004, JAMA-J AM MED ASSOC, V291, P2591, DOI 10.1001/jama.291.21.2591; Ma E, 2008, CIRC J, V72, P966, DOI 10.1253/circj.72.966; MARMOT MG, 1976, AM J EPIDEMIOL, V104, P225, DOI 10.1093/oxfordjournals.aje.a112296; Fernandez-Balsells MM, 2010, J CLIN ENDOCR METAB, V95, P2560, DOI 10.1210/jc.2009-2575; Mirzaei M, 2009, HEART, V95, P740, DOI 10.1136/hrt.2008.154856; Moran A, 2010, CIRC-CARDIOVASC QUAL, V3, P243, DOI 10.1161/CIRCOUTCOMES.109.910711; Peltonen M, 1997, EUR HEART J, V18, P1307; R Development Core Team, 2005, R LANG ENV STAT COMP; Schooling CM, 2010, J EPIDEMIOL COMMUN H, V64, DOI 10.1136/jech.2008.086553; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Studer M, 2005, ARCH INTERN MED, V165, P725, DOI 10.1001/archinte.165.7.725; Taylor R, 2012, J EPIDEMIOL COMMUN H, V66, DOI 10.1136/jech.2010.109538; Tiwari RC, 2005, J R STAT SOC C-APPL, V54, P919, DOI 10.1111/j.1467-9876.2005.00518.x; Tobias Martin, 2006, N Z Med J, V119, pU1932; Tsang S., 2004, MODERN HIST HONG KON; Voight BF, 2012, LANCET N AM EDITION; Wong IOL, 2007, INT J CANCER, V121, P1556, DOI 10.1002/ijc.22731; World Health Organization [WHO], 1992, WORLD HLTH STAT ANN; Wu YF, 2006, CIRCULATION, V114, P2217, DOI 10.1161/CIRCULATIONAHA.105.607499; Yang Y, 2008, DEMOGRAPHY, V45, P387, DOI 10.1353/dem.0.0000; YANO K, 1979, AM J EPIDEMIOL, V109, P440, DOI 10.1093/oxfordjournals.aje.a112702; Yusuf S, 2001, CIRCULATION, V104, P2746, DOI 10.1161/hc4601.099487; Zhao D, 2008, STROKE, V39, P1668, DOI 10.1161/STROKEAHA.107.502807	43	10	12	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2013	8	4							e61495	10.1371/journal.pone.0061495	http://dx.doi.org/10.1371/journal.pone.0061495			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	123JA	23593484	Green Published, gold			2022-12-25	WOS:000317383200058
J	Khan, DH; He, SH; Yu, J; Winter, S; Cao, WG; Seiser, C; Davie, JR				Khan, Dilshad H.; He, Shihua; Yu, Jenny; Winter, Stefan; Cao, Wenguang; Seiser, Christian; Davie, James R.			Protein Kinase CK2 Regulates the Dimerization of Histone Deacetylase 1 (HDAC1) and HDAC2 during Mitosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOPOISOMERASE-II-ALPHA; BREAST-CANCER CELLS; TRANSCRIPTION FACTORS; PHOSPHORYLATION; ACETYLATION; CHROMATIN; SP3; DNA	Histone deacetylase 1 (HDAC1) and HDAC2 are components of corepressor complexes that are involved in chromatin remodeling and regulation of gene expression by regulating dynamic protein acetylation. HDAC1 and -2 form homo- and heterodimers, and their activity is dependent upon dimer formation. Phosphorylation of HDAC1 and/or HDAC2 in interphase cells is required for the formation of HDAC corepressor complexes. In this study, we show that during mitosis, HDAC2 and, to a lesser extent, HDAC1 phosphorylation levels dramatically increase. When HDAC1 and -2 are displaced from the chromosome during metaphase, they dissociate from each other, but each enzyme remains in association with components of the HDAC corepressor complexes Sin3, NuRD, and CoREST as homodimers. Enzyme inhibition studies and mutational analyses demonstrated that protein kinase CK2-catalyzed phosphorylation of HDAC1 and -2 is crucial for the dissociation of these two enzymes. These results suggest that corepressor complexes, including HDAC1 or HDAC2 homodimers, might target different cellular proteins during mitosis.	[Khan, Dilshad H.; He, Shihua; Cao, Wenguang; Davie, James R.] Univ Manitoba, Manitoba Inst Child Hlth, Winnipeg, MB R3E 3P4, Canada; [Winter, Stefan; Seiser, Christian] Med Univ Vienna, Vienna Bioctr, Max F Perutz Labs, A-1030 Vienna, Austria; [Yu, Jenny] Univ Texas MD Anderson Canc Ctr, Houston, TX 77054 USA	University of Manitoba; Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); University of Texas System; UTMD Anderson Cancer Center	Davie, JR (corresponding author), Manitoba Inst Child Hlth, 715 McDermot Ave,Rm 600A, Winnipeg, MB R3E 3P4, Canada.	davie@cc.umanitoba.ca		Seiser, Christian/0000-0002-7046-9352; Davie, James/0000-0002-0420-6888	Canadian Institutes of Health Research Grant [MOP-9186]; Canada Research Chair; Manitoba Health Research Council/CancerCare Manitoba studentship; FWF; Austrian Science Fund (FWF) [P22340]; Genome Research in Austria (GEN-AU) project "Epigenetic Regulation of Cell Fate Decisions" (BM: WF); Austrian Science Fund (FWF) [P 22340] Funding Source: researchfish	Canadian Institutes of Health Research Grant(Canadian Institutes of Health Research (CIHR)); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); Manitoba Health Research Council/CancerCare Manitoba studentship; FWF(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Genome Research in Austria (GEN-AU) project "Epigenetic Regulation of Cell Fate Decisions" (BM: WF); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by Canadian Institutes of Health Research Grant MOP-9186, a Canada Research Chair (to J. R. D.), and a Manitoba Health Research Council/CancerCare Manitoba studentship (to D. K.).; Fellow of the Vienna Biocenter International Ph.D. program supported by the FWF.; Work in the laboratory of C. S. was supported by the Austrian Science Fund (FWF) Grant P22340 and the Genome Research in Austria (GEN-AU) project "Epigenetic Regulation of Cell Fate Decisions" (BM: WF).	Brunmeir R, 2009, INT J DEV BIOL, V53, P275, DOI 10.1387/ijdb.082649rb; Chuang C, 2010, J PROTEOME RES, V9, P4554, DOI 10.1021/pr100281h; De Ruijter AJM, 2003, BIOCHEM J, V370, P737, DOI 10.1042/BJ20021321; Delcuve GP, 2012, CLIN EPIGENETICS, V4, DOI 10.1186/1868-7083-4-5; Escargueil AE, 2000, J BIOL CHEM, V275, P34710, DOI 10.1074/jbc.M005179200; Escargueil AE, 2007, BIOCHEM J, V403, P235, DOI 10.1042/BJ20061460; Galasinski SC, 2002, J BIOL CHEM, V277, P19618, DOI 10.1074/jbc.M201174200; Guan JS, 2009, NATURE, V459, P55, DOI 10.1038/nature07925; He SH, 2006, J CELL SCI, V119, P1063, DOI 10.1242/jcs.02829; He SH, 2005, MOL BIOL CELL, V16, P4073, DOI 10.1091/mbc.e05-05-0388; Hnilicova J, 2011, NUCLEUS-PHILA, V2, P182, DOI 10.4161/nucl.2.3.15876; Jurkin J, 2011, CELL CYCLE, V10, P406, DOI 10.4161/cc.10.3.14712; Kruhlak MJ, 2001, J BIOL CHEM, V276, P38307; Luo Y, 2009, J BIOL CHEM, V284, P34901, DOI 10.1074/jbc.M109.038356; Marshall GM, 2010, ONCOGENE, V29, P5957, DOI 10.1038/onc.2010.332; Patzlaff JS, 2010, EXP CELL RES, V316, P2123, DOI 10.1016/j.yexcr.2010.05.003; Pflum MKH, 2001, J BIOL CHEM, V276, P47733, DOI 10.1074/jbc.M105590200; Samuel SK, 1998, CANCER RES, V58, P3004; Segre CV, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/690848; Sun JM, 2007, J BIOL CHEM, V282, P33227, DOI 10.1074/jbc.M703549200; Sun JM, 2002, J BIOL CHEM, V277, P35783, DOI 10.1074/jbc.C200378200; Taplick J, 2001, J MOL BIOL, V308, P27, DOI 10.1006/jmbi.2001.4569; Tsai SC, 2002, J BIOL CHEM, V277, P31826, DOI 10.1074/jbc.M204149200; Upadhyay AK, 2008, CURR CANCER DRUG TAR, V8, P741, DOI 10.2174/156800908786733405; Wang WP, 2008, GENETICS, V179, P1823, DOI 10.1534/genetics.108.091959; Winter S, 2008, EMBO J, V27, P88, DOI 10.1038/sj.emboj.7601954; Zhou HL, 2011, P NATL ACAD SCI USA, V108, pE627, DOI 10.1073/pnas.1103344108	27	41	42	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2013	288	23					16518	16528		10.1074/jbc.M112.440446	http://dx.doi.org/10.1074/jbc.M112.440446			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	163ZU	23612983	hybrid, Green Published			2022-12-25	WOS:000320378900028
J	Steiner, CC; Ryder, OA				Steiner, Cynthia C.; Ryder, Oliver A.			Characterization of Prdm9 in Equids and Sterility in Mules	PLOS ONE			English	Article							HYBRID STERILITY; GENE; MEIOSIS; EQUUS; METHYLTRANSFERASE; PHYLOGENIES; DROSOPHILA; MEISETZ; HINNY	Prdm9 (Meisetz) is the first speciation gene discovered in vertebrates conferring reproductive isolation. This locus encodes a meiosis-specific histone H3 methyltransferase that specifies meiotic recombination hotspots during gametogenesis. Allelic differences in Prdm9, characterized for a variable number of zinc finger (ZF) domains, have been associated with hybrid sterility in male house mice via spermatogenic failure at the pachytene stage. The mule, a classic example of hybrid sterility in mammals also exhibits a similar spermatogenesis breakdown, making Prdm9 an interesting candidate to evaluate in equine hybrids. In this study, we characterized the Prdm9 gene in all species of equids by analyzing sequence variation of the ZF domains and estimating positive selection. We also evaluated the role of Prdm9 in hybrid sterility by assessing allelic differences of ZF domains in equine hybrids. We found remarkable variation in the sequence and number of ZF domains among equid species, ranging from five domains in the Tibetan kiang and Asiatic wild ass, to 14 in the Grevy's zebra. Positive selection was detected in all species at amino acid sites known to be associated with DNA-binding specificity of ZF domains in mice and humans. Equine hybrids, in particular a quartet pedigree composed of a fertile mule showed a mosaic of sequences and number of ZF domains suggesting that Prdm9 variation does not seem by itself to contribute to equine hybrid sterility.	[Steiner, Cynthia C.; Ryder, Oliver A.] San Diego Zoo Global, San Diego Zoo Inst Conservat Res, Div Genet, Escondido, CA USA	Zoological Society of San Diego	Steiner, CC (corresponding author), San Diego Zoo Global, San Diego Zoo Inst Conservat Res, Div Genet, Escondido, CA USA.	csteiner@sandiegozoo.org			National Science Foundation Grant for the Mammalian Tree of Life (AToL) project [DEB-0629811]	National Science Foundation Grant for the Mammalian Tree of Life (AToL) project	This work has been funded by a National Science Foundation Grant for the Mammalian Tree of Life (AToL) project, Grant number DEB-0629811. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkan C, 2011, NAT METHODS, V8, P61, DOI 10.1038/NMETH.1527; Allen WR, 1997, J HERED, V88, P384, DOI 10.1093/oxfordjournals.jhered.a023123; Baudat F, 2010, SCIENCE, V328, P690; BENIRSCHKE K, 1964, J HERED, V55, P31, DOI 10.1093/oxfordjournals.jhered.a107283; Berg IL, 2011, P NATL ACAD SCI USA, V108, P12378, DOI 10.1073/pnas.1109531108; CHANDLEY AC, 1974, CYTOGENET CELL GENET, V13, P330, DOI 10.1159/000130284; CHOO Y, 1994, P NATL ACAD SCI USA, V91, P11168, DOI 10.1073/pnas.91.23.11168; Cordingley JE, 2009, ANIM CONSERV, V12, P505, DOI 10.1111/j.1469-1795.2009.00294.x; Coyne JA, 2004, SPECIATION, V37; Drummond A. J., 2006, GENEIOUS V1 2 1; Dzur-Gejdosova M, 2012, EVOLUTION, V66, P3321, DOI 10.1111/j.1558-5646.2012.01684.x; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Flachs P, 2010, PLOS GENET, V8; Fog CK, 2012, BIOESSAYS, V34, P50, DOI 10.1002/bies.201100107; Fumasoni I, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-187; Grey C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001176; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hayashi K, 2005, NATURE, V438, P374, DOI 10.1038/nature04112; Hayashi K, 2006, CELL CYCLE, V5, P615, DOI 10.4161/cc.5.6.2572; Henry M., 1995, BIOL REPROD, V52, P273, DOI [10.1093/biolreprod/52.monograph_series1.273, DOI 10.1093/BIOLREPROD/52.MONOGRAPH_SERIES1.273]; Horie T, 1959, B NAT I AGRIC SCI CH, V8, P143; HULBERT RC, 1996, HORSES TIME, P11; Johnson NA, 2010, TRENDS GENET, V26, P317, DOI 10.1016/j.tig.2010.04.005; Laurie CC, 1997, GENETICS, V147, P937; LINDSAY EH, 1980, NATURE, V287, P135, DOI 10.1038/287135a0; MADDISON D, 2005, MACCLADE 4 08; Masly JP, 2006, SCIENCE, V313, P1448, DOI 10.1126/science.1128721; Mihola O, 2009, SCIENCE, V323, P373, DOI 10.1126/science.1163601; Miyamoto T, 2008, J ASSIST REPROD GEN, V25, P553, DOI 10.1007/s10815-008-9270-x; Muller HJ, 1942, BIOL S, V6, P71; Munoz-Fuentes V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025498; Oliver PL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000753; Parvanov ED, 2010, SCIENCE, V327, P835, DOI 10.1126/science.1181495; PEREZ DE, 1995, GENETICS, V140, P201; Phadnis N, 2009, SCIENCE, V323, P376, DOI 10.1126/science.1163934; Ponting CP, 2011, TRENDS GENET, V27, P165, DOI 10.1016/j.tig.2011.02.001; Presgraves DC, 2010, NAT REV GENET, V11, P175, DOI 10.1038/nrg2718; RONG R, 1988, CYTOGENET CELL GENET, V47, P134, DOI 10.1159/000132531; RYDER OA, 1985, J HERED, V76, P379; Segurel L, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001211; SHORT RV, 1974, CYTOGENET CELL GENET, V13, P465, DOI 10.1159/000130300; SMITH GP, 1976, SCIENCE, V191, P528, DOI 10.1126/science.1251186; Steiner CC, 2012, MOL PHYLOGENET EVOL, V65, P573, DOI 10.1016/j.ympev.2012.07.010; Swofford D.L., 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/j.0014-3820.2002.tb00191.x; Thomas JH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008505; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wang BM, 2009, SCIENCE, V326, P871, DOI 10.1126/science.1177627; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555	48	29	30	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2013	8	4							e61746	10.1371/journal.pone.0061746	http://dx.doi.org/10.1371/journal.pone.0061746			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JR	23613924	Green Submitted, Green Published, gold			2022-12-25	WOS:000317911500063
J	Fenn, S; Schiller, CB; Griese, JJ; Duerr, H; Imhof-Jung, S; Gassner, C; Moelleken, J; Regula, JT; Schaefer, W; Thomas, M; Klein, C; Hopfner, KP; Kettenberger, H				Fenn, Sebastian; Schiller, Christian B.; Griese, Julia J.; Duerr, Harald; Imhof-Jung, Sabine; Gassner, Christian; Moelleken, Joerg; Regula, Joerg Thomas; Schaefer, Wolfgang; Thomas, Markus; Klein, Christian; Hopfner, Karl-Peter; Kettenberger, Hubert			Crystal Structure of an Anti-Ang2 CrossFab Demonstrates Complete Structural and Functional Integrity of the Variable Domain	PLOS ONE			English	Article							IGG; SYSTEM	Bispecific antibodies are considered as a promising class of future biotherapeutic molecules. They comprise binding specificities for two different antigens, which may provide additive or synergistic modes of action. There is a wide variety of design alternatives for such bispecific antibodies, including the "CrossMab'' format. CrossMabs contain a domain crossover in one of the antigen-binding (Fab) parts, together with the "knobs-and-holes'' approach, to enforce the correct assembly of four different polypeptide chains into an IgG-like bispecific antibody. We determined the crystal structure of a hAng-2-binding Fab in its crossed and uncrossed form and show that C(H)1-C-L-domain crossover does not induce significant perturbations of the structure and has no detectable influence on target binding.	[Fenn, Sebastian; Duerr, Harald; Imhof-Jung, Sabine; Gassner, Christian; Moelleken, Joerg; Regula, Joerg Thomas; Schaefer, Wolfgang; Kettenberger, Hubert] Roche Dignost GmbH, pRED, Large Mol Res, Penzberg, Germany; [Thomas, Markus] Roche Diagnost GmbH, pRED, Discovery Oncol, Penzberg, Germany; [Klein, Christian] Roche Glycart AG, pRED, Discovery Oncol, Schlieren, Switzerland; [Schiller, Christian B.; Griese, Julia J.; Hopfner, Karl-Peter] Univ Munich, Gene Ctr, Dept Biochem, Munich, Germany	Roche Holding; Roche Holding; University of Munich	Hopfner, KP (corresponding author), Univ Munich, Gene Ctr, Dept Biochem, Munich, Germany.	hopfner@lmb.uni-muenchen.de; hubert.kettenberger@roche.com	Klein, Christian/G-1336-2010; Hopfner, Karl-Peter/B-6864-2014; Griese, Julia Johanna/GQB-0023-2022	Klein, Christian/0000-0001-7594-7280; Hopfner, Karl-Peter/0000-0002-4528-8357; Griese, Julia Johanna/0000-0003-3686-3062; Regula, Joerg Thomas/0000-0002-7343-1077				Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Atwell S, 1997, J MOL BIOL, V270, P26, DOI 10.1006/jmbi.1997.1116; Bostrom J, 2009, SCIENCE, V323, P1610, DOI 10.1126/science.1165480; Bricogne G, 2011, BUSTER VERSION; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Carter P, 2001, J IMMUNOL METHODS, V248, P7, DOI 10.1016/S0022-1759(00)00339-2; Demarest SJ, 2008, CURR OPIN DRUG DISC, V11, P675; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Ewert S, 2003, J MOL BIOL, V325, P531, DOI 10.1016/S0022-2836(02)01237-8; Feige MJ, 2009, MOL CELL, V34, P569, DOI 10.1016/j.molcel.2009.04.028; Garber E, 2007, BIOCHEM BIOPH RES CO, V355, P751, DOI 10.1016/j.bbrc.2007.02.042; Ionescu RM, 2008, J PHARM SCI-US, V97, P1414, DOI 10.1002/jps.21104; Jefferis R, 1998, IMMUNOL REV, V163, P59, DOI 10.1111/j.1600-065X.1998.tb01188.x; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Klein C, 2012, MABS, V4; Kolfschoten MV, 2007, SCIENCE, V317, P1554, DOI 10.1126/science.1144603; Kontermann R, 2012, MABS, V4; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Merchant AM, 1998, NAT BIOTECHNOL, V16, P677, DOI 10.1038/nbt0798-677; MILSTEIN C, 1983, NATURE, V305, P537, DOI 10.1038/305537a0; PADLAN EA, 1994, MOL IMMUNOL, V31, P169, DOI 10.1016/0161-5890(94)90001-9; Ridgway JBB, 1996, PROTEIN ENG, V9, P617, DOI 10.1093/protein/9.7.617; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schaefer W, 2011, P NATL ACAD SCI USA, V108, P11187, DOI 10.1073/pnas.1019002108; Schneider EL, 2012, J MOL BIOL, V415, P699, DOI 10.1016/j.jmb.2011.11.036; Schroeder HW, 2010, J ALLERGY CLIN IMMUN, V125, pS41, DOI 10.1016/j.jaci.2009.09.046; Stanfield RL, 2006, J MOL BIOL, V357, P1566, DOI 10.1016/j.jmb.2006.01.023; Stubenrauch K, 2010, DRUG METAB DISPOS, V38, P84, DOI 10.1124/dmd.109.029751; Sturniolo T, 1999, NAT BIOTECHNOL, V17, P555, DOI 10.1038/9858; Suhrer SJ, 2009, NUCLEIC ACIDS RES, V37, pW539, DOI 10.1093/nar/gkp411; SURESH MR, 1986, METHOD ENZYMOL, V121, P210; WILLIAMSON AR, 1976, ANNU REV BIOCHEM, V45, P467, DOI 10.1146/annurev.bi.45.070176.002343	35	24	39	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2013	8	4							e61953	10.1371/journal.pone.0061953	http://dx.doi.org/10.1371/journal.pone.0061953			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IK	23613981	Green Published, gold, Green Submitted			2022-12-25	WOS:000317907200108
J	Quiles, F; Fernandez-Rodriguez, J; Mosca, R; Feliubadalo, L; Tornero, E; Brunet, J; Blanco, I; Capella, G; Pujana, MA; Aloy, P; Monteiro, A; Lazaro, C				Quiles, Francisco; Fernandez-Rodriguez, Juana; Mosca, Roberto; Feliubadalo, Lidia; Tornero, Eva; Brunet, Joan; Blanco, Ignacio; Capella, Gabriel; Angel Pujana, Miquel; Aloy, Patrick; Monteiro, Alvaro; Lazaro, Conxi			Functional and Structural Analysis of C-Terminal BRCA1 Missense Variants	PLOS ONE			English	Article							BREAST-CANCER; PROTEIN MUTATIONS; CLASSIFICATION	Germline inactivating mutations in BRCA1 and BRCA2 genes are responsible for Hereditary Breast and Ovarian Cancer Syndrome (HBOCS). Genetic testing of these genes is available, although approximately 15% of tests identify variants of uncertain significance (VUS). Classification of these variants into pathogenic or non-pathogenic type is an important challenge in genetic diagnosis and counseling. The aim of the present study is to functionally assess a set of 7 missense VUS (Q1409L, S1473P, E1586G, R1589H, Y1703S, W1718L and G1770V) located in the C-terminal region of BRCA1 by combining in silico prediction tools and structural analysis with a transcription activation (TA) assay. The in silico prediction programs gave discrepant results making its interpretation difficult. Structural analysis of the three variants located in the BRCT domains (Y1703S, W1718L and G1770V) reveals significant alterations of BRCT structure. The TA assay shows that variants Y1703S, W1718L and G1770V dramatically compromise the transcriptional activity of BRCA1, while variants Q1409L, S1473P, E1586G and R1589H behave like wild-type BRCA1. In conclusion, our results suggest that variants Y1703S, W1718L and G1770V can be classified as likely pathogenic BRCA1 mutations.	[Quiles, Francisco; Fernandez-Rodriguez, Juana; Feliubadalo, Lidia; Tornero, Eva; Brunet, Joan; Blanco, Ignacio; Capella, Gabriel; Lazaro, Conxi] Catalan Inst Oncol, Bellvitge Inst Biomed Res, Girona Inst Biomed Res,ICO IDIBELL,ICO IdIBGI,ICO, Hereditary Canc Program,Germans Trial & Pujol Res, Barcelona, Spain; [Mosca, Roberto; Aloy, Patrick] IRB Barcelona, Joint IRB BSC Program Computat Biol, Barcelona, Spain; [Angel Pujana, Miquel] Catalan Inst Oncol ICO, Bellvitge Inst Biomed Res IDIBELL, Translat Res Lab, Breast Canc Unit, Barcelona, Spain; [Aloy, Patrick] ICREA, Barcelona, Spain; [Monteiro, Alvaro] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Canc Epidemiol Program, Tampa, FL 33612 USA	Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Universitat de Girona; Girona University Hospital Dr. Josep Trueta; Institut d'Investigacio Biomedica de Girona (IDIBGI); Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); ICREA; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida	Lazaro, C (corresponding author), Catalan Inst Oncol, Bellvitge Inst Biomed Res, Girona Inst Biomed Res,ICO IDIBELL,ICO IdIBGI,ICO, Hereditary Canc Program,Germans Trial & Pujol Res, Barcelona, Spain.	clazaro@iconcologia.net	Feliubadalo, Lidia/G-4577-2016; Blanco, Ignacio/AAN-5426-2021; Pujana, Miquel Angel/N-3127-2014; Aloy, Patrick/AAB-3538-2019; Blanco, Ignacio/D-2565-2013; Capella, Gabriel/I-1879-2015; Monteiro, Alvaro N. A./A-7566-2009; GARCIA, CONXI LAZARO/Q-2410-2016; Brunet, Joan/C-5292-2018	Feliubadalo, Lidia/0000-0002-1736-0112; Blanco, Ignacio/0000-0002-7414-7481; Pujana, Miquel Angel/0000-0003-3222-4044; Blanco, Ignacio/0000-0002-7414-7481; Capella, Gabriel/0000-0002-4669-7320; Monteiro, Alvaro N. A./0000-0002-8448-4801; GARCIA, CONXI LAZARO/0000-0002-7198-5906; Mosca, Roberto/0000-0002-3244-1885; Brunet, Joan/0000-0003-1945-3512; Aloy, Patrick/0000-0002-3557-0236; FERNANDEZ RODRIGUEZ, JUANA/0000-0002-7760-5804	Spanish Ministry of Health ISCIII FIS [PI10/01422, PI09/02483, PI12/01528]; RETICC [RD06/0020/1051, RD06/0020/1050, RD12/0036/008, RD12/0036/0031]; AGAUR Catalan Government Agency [2009-SGR293, 2009-SGR290]; Spanish Association Against Cancer [AECC 2010]; Fundacion Eugenio Rodriguez Pascual grant; NATIONAL CANCER INSTITUTE [P30CA076292] Funding Source: NIH RePORTER; ICREA Funding Source: Custom	Spanish Ministry of Health ISCIII FIS(Spanish Government); RETICC; AGAUR Catalan Government Agency; Spanish Association Against Cancer; Fundacion Eugenio Rodriguez Pascual grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); ICREA(ICREA)	This work was funded by: the Spanish Ministry of Health ISCIII FIS grants PI10/01422, PI09/02483 and PI12/01528, RETICC grants RD06/0020/1051, RD06/0020/1050, RD12/0036/008 and RD12/0036/0031; the AGAUR Catalan Government Agency grants 2009-SGR293 and 2009-SGR290; the Spanish Association Against Cancer (AECC 2010); and the Fundacion Eugenio Rodriguez Pascual grant 2012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Balmain A, 2003, NAT GENET, V33, P238, DOI 10.1038/ng1107; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bromberg Y, 2007, NUCLEIC ACIDS RES, V35, P3823, DOI 10.1093/nar/gkm238; Capriotti E, 2006, BIOINFORMATICS, V22, P2729, DOI 10.1093/bioinformatics/btl423; Capriotti E, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S2-S6; Carvalho MA, 2007, CANCER RES, V67, P1494, DOI 10.1158/0008-5472.CAN-06-3297; Carvalho MA, 2007, INT J BIOCHEM CELL B, V39, P298, DOI 10.1016/j.biocel.2006.08.002; Clark SL, 2012, COMPUT STRUCT BIOTEC, V1, DOI 10.5936/csbj.201204005; Feliubadalo L, 2012, EUROPEAN J IN PRESS; Frank TS, 2002, J CLIN ONCOL, V20, P1480, DOI 10.1200/JCO.20.6.1480; FUTREAL PA, 1994, SCIENCE, V266, P120, DOI 10.1126/science.7939630; Glover JNM, 2006, FAM CANCER, V5, P89, DOI 10.1007/s10689-005-2579-z; Gonzalez-Perez A, 2011, AM J HUM GENET, V88, P440, DOI 10.1016/j.ajhg.2011.03.004; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Kurian AW, 2010, CURR OPIN OBSTET GYN, V22, P72, DOI 10.1097/GCO.0b013e328332dca3; Lee MS, 2010, CANCER RES, V70, P4880, DOI 10.1158/0008-5472.CAN-09-4563; Li MX, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003143; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Millot GA, 2012, HUM MUTAT, V33, P1526, DOI 10.1002/humu.22150; Mirkovic N, 2004, CANCER RES, V64, P3790, DOI 10.1158/0008-5472.CAN-03-3009; Olatubosun A, 2012, HUM MUTAT, V33, P1166, DOI 10.1002/humu.22102; Phelan CM, 2005, J MED GENET, V42, P138, DOI 10.1136/jmg.2004.024711; Reva B, 2011, NUCLEIC ACIDS RES, V39, pE118, DOI 10.1093/nar/gkr407; Spurdle AB, 2012, HUM MUTAT, V33, P2, DOI 10.1002/humu.21628; Tavtigian SV, 2006, J MED GENET, V43, P295, DOI 10.1136/jmg.2005.033878; Thusberg J, 2011, HUM MUTAT, V32, P358, DOI 10.1002/humu.21445; Williams RS, 2003, J BIOL CHEM, V278, P53007, DOI 10.1074/jbc.M310182200; Williams RS, 2001, NAT STRUCT BIOL, V8, P838, DOI 10.1038/nsb1001-838; Zhang F, 2009, MOL CANCER RES, V7, P1110, DOI 10.1158/1541-7786.MCR-09-0123	30	13	13	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2013	8	4							e61302	10.1371/journal.pone.0061302	http://dx.doi.org/10.1371/journal.pone.0061302			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IK	23613828	Green Submitted, Green Published, gold			2022-12-25	WOS:000317907200045
J	Sanchez-Diaz, PC; Hsiao, TH; Chang, JC; Yue, D; Tan, MMC; Chen, HIH; Tomlinson, GE; Huang, YF; Chen, YD; Hung, JY				Sanchez-Diaz, Patricia C.; Hsiao, Tzu-Hung; Chang, Judy C.; Yue, Dong; Tan, Mimi C.; Chen, Hung-I Harry; Tomlinson, Gail E.; Huang, Yufei; Chen, Yidong; Hung, Jaclyn Y.			De-Regulated MicroRNAs in Pediatric Cancer Stem Cells Target Pathways Involved in Cell Proliferation, Cell Cycle and Development	PLOS ONE			English	Article							GENE; NETWORKS; PLAYER	Background: microRNAs (miRNAs) have been implicated in the control of many biological processes and their deregulation has been associated with many cancers. In recent years, the cancer stem cell (CSC) concept has been applied to many cancers including pediatric. We hypothesized that a common signature of deregulated miRNAs in the CSCs fraction may explain the disrupted signaling pathways in CSCs. Methodology/Results: Using a high throughput qPCR approach we identified 26 CSC associated differentially expressed miRNAs (DEmiRs). Using BCmicrO algorithm 865 potential CSC associated DEmiR targets were obtained. These potential targets were subjected to KEGG, Biocarta and Gene Ontology pathway and biological processes analysis. Four annotated pathways were enriched: cell cycle, cell proliferation, p53 and TGF-beta/BMP. Knocking down hsa-miR-21-5p, hsa-miR-181c-5p and hsa-miR-135b-5p using antisense oligonucleotides and small interfering RNA in cell lines led to the depletion of the CSC fraction and impairment of sphere formation (CSC surrogate assays). Conclusion: Our findings indicated that CSC associated DEmiRs and the putative pathways they regulate may have potential therapeutic applications in pediatric cancers.	[Sanchez-Diaz, Patricia C.; Hsiao, Tzu-Hung; Chang, Judy C.; Tan, Mimi C.; Chen, Hung-I Harry; Tomlinson, Gail E.; Huang, Yufei; Chen, Yidong; Hung, Jaclyn Y.] Univ Texas Hlth Sci Ctr San Antonio, Greehey Childrens Canc Res Inst, San Antonio, TX 78229 USA; [Tomlinson, Gail E.; Hung, Jaclyn Y.] Univ Texas Hlth Sci Ctr San Antonio, Dept Pediat, Div Hematol & Oncol, San Antonio, TX 78229 USA; [Chen, Yidong] Univ Texas Hlth Sci Ctr San Antonio, Dept Epidemiol & Biostat, San Antonio, TX 78229 USA; [Yue, Dong; Huang, Yufei] Univ Texas San Antonio, Dept Elect & Comp Engn, San Antonio, TX USA; [Tomlinson, Gail E.; Chen, Yidong; Hung, Jaclyn Y.] Univ Texas Hlth Sci Ctr San Antonio, Canc Therapy & Res Ctr, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas at San Antonio (UTSA); Cancer Therapy & Research Center; University of Texas System; University of Texas Health San Antonio	Chen, YD (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Greehey Childrens Canc Res Inst, San Antonio, TX 78229 USA.	cheny8@uthscsa.edu; hungj@uthscsa.edu	Tomlinson, Gail/AAR-9776-2020; Huang, Yufei/AAU-2891-2021		Cancer Prevention and Research Institute of Texas (CPRIT) [RP101195]; National Institutes of Health [NIH-NCI P30CA54174, NIH-NCATS UL1TR000149]; Semp Russ Foundation of the San Antonio Area Foundation; Greehey Graduate Fellowship in Children's Health; Ambassadors' Circle Fund of the Greehey Children's Cancer Research Institute; CTRC at UTHSCSA [NIH-NCI P30CA54174]; NATIONAL CANCER INSTITUTE [P30CA054174] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000149] Funding Source: NIH RePORTER	Cancer Prevention and Research Institute of Texas (CPRIT); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Semp Russ Foundation of the San Antonio Area Foundation; Greehey Graduate Fellowship in Children's Health; Ambassadors' Circle Fund of the Greehey Children's Cancer Research Institute; CTRC at UTHSCSA; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Semp Russ Foundation of the San Antonio Area Foundation (awarded to JYH), Cancer Prevention and Research Institute of Texas (CPRIT, RP101195; awarded to GET and YC), National Institutes of Health (NIH-NCI P30CA54174; awarded to CTRC at UTHSCSA, YC and NIH-NCATS UL1TR000149; awarded to CTSA at UTHSCSA, YC), the Greehey Graduate Fellowship in Children's Health (awarded to JCC) and the Ambassadors' Circle Fund of the Greehey Children's Cancer Research Institute funded part of this work. FACS was done in the Flow Cytometry Shared Resource Facility, which is supported by NIH-NCI P30CA54174 (CTRC at UTHSCSA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anton R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026257; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Chen TTL, 2009, PEDIATR BLOOD CANCER, V53, P1040, DOI 10.1002/pbc.22187; Cho S, 2011, NUCLEIC ACIDS RES, V39, pD158, DOI 10.1093/nar/gkq1094; Creighton CJ, 2008, RNA, V14, P2290, DOI 10.1261/rna.1188208; DeSano JT, 2009, AAPS J, V11, P682, DOI 10.1208/s12248-009-9147-7; Ernst A, 2010, ONCOGENE, V29, P3411, DOI 10.1038/onc.2010.83; Flicek P, 2012, NUCLEIC ACIDS RES, V40, pD84, DOI 10.1093/nar/gkr991; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Hatfield SD, 2005, NATURE, V435, P974, DOI 10.1038/nature03816; Hatfield S, 2008, CELL TISSUE RES, V331, P57, DOI 10.1007/s00441-007-0530-3; Ibarra I, 2007, GENE DEV, V21, P3238, DOI 10.1101/gad.1616307; Ji JF, 2009, HEPATOLOGY, V50, P472, DOI 10.1002/hep.22989; Karginov FV, 2007, P NATL ACAD SCI USA, V104, P19291, DOI 10.1073/pnas.0709971104; Katoh M, 2007, CLIN CANCER RES, V13, P4042, DOI 10.1158/1078-0432.CCR-06-2316; Kim J, 2012, MICRORNA 148A NOVEL; Nagel R, 2008, CANCER RES, V68, P5795, DOI 10.1158/0008-5472.CAN-08-0951; Nam S, 2008, NUCLEIC ACIDS RES, V36, pD159, DOI 10.1093/nar/gkm829; Rhodes DR, 2007, NEOPLASIA, V9, P166, DOI 10.1593/neo.07112; Scotting PJ, 2005, NAT REV CANCER, V5, P481, DOI 10.1038/nrc1633; Shirdel EA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017429; Smith At, 2012, ONCOGENE; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tomlins SA, 2007, NAT GENET, V39, P41, DOI 10.1038/ng1935; Tsang JS, 2010, MOL CELL, V38, P140, DOI 10.1016/j.molcel.2010.03.007; Ulitsky I, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq570; Xiao FF, 2009, NUCLEIC ACIDS RES, V37, pD105, DOI 10.1093/nar/gkn851; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054; Yue D, 2013, BMC GENOMICS; Yue D, 2010, 2010 ACM INT C BIOIN, P214; Yue D, 2012, IEEE SIGNAL PROC MAG, V29, P77, DOI 10.1109/MSP.2011.943013; Zhang BH, 2006, J CELL PHYSIOL, V209, P266, DOI 10.1002/jcp.20713; Zheng Q, 2008, NUCLEIC ACIDS RES, V36, pW358, DOI 10.1093/nar/gkn276	34	45	45	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2013	8	4							e61622	10.1371/journal.pone.0061622	http://dx.doi.org/10.1371/journal.pone.0061622			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IK	23613887	Green Published, Green Submitted, gold			2022-12-25	WOS:000317907200067
J	Schippa, S; Iebba, V; Santangelo, F; Gagliardi, A; De Biase, RV; Stamato, A; Bertasi, S; Lucarelli, M; Conte, MP; Quattrucci, S				Schippa, Serena; Iebba, Valerio; Santangelo, Floriana; Gagliardi, Antonella; De Biase, Riccardo Valerio; Stamato, Antonella; Bertasi, Serenella; Lucarelli, Marco; Conte, Maria Pia; Quattrucci, Serena			Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Allelic Variants Relate to Shifts in Faecal Microbiota of Cystic Fibrosis Patients	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; PEDIATRIC-PATIENTS; GUT MICROBIOTA; BACTERIA; DISEASE; GENE; CONSEQUENCES; PATHOGENESIS; SEQUENCE; SAMPLES	Introduction: In this study we investigated the effects of the Cystic Fibrosis Transmembrane conductance Regulator (CFTR) gene variants on the composition of faecal microbiota, in patients affected by Cystic Fibrosis (CF). CFTR mutations (F508del is the most common) lead to a decreased secretion of chloride/water, and to mucus sticky secretions, in pancreas, respiratory and gastrointestinal tracts. Intestinal manifestations are underestimated in CF, leading to ileum meconium at birth, or small bowel bacterial overgrowth in adult age. Methods: Thirty-six CF patients, fasting and under no-antibiotic treatment, were CFTR genotyped on both alleles. Faecal samples were subjected to molecular microbial profiling through Temporal Temperature Gradient Electrophoresis and species-specific PCR. Ecological parameters and multivariate algorithms were employed to find out if CFTR variants could be related to the microbiota structure. Results: Patients were classified by two different criteria: 1) presence/absence of F508del mutation; 2) disease severity in heterozygous and homozygous F508del patients. We found that homozygous-F508del and severe CF patients exhibited an enhanced dysbiotic faecal microbiota composition, even within the CF cohort itself, with higher biodiversity and evenness. We also found, by species-specific PCR, that potentially harmful species (Escherichia coli and Eubacterium biforme) were abundant in homozygous-F508del and severe CF patients, while beneficial species (Faecalibacterium prausnitzii, Bifidobacterium spp., and Eubacterium limosum) were reduced. Conclusions: This is the first report that establishes a link among CFTR variants and shifts in faecal microbiota, opening the way to studies that perceive CF as a 'systemic disease', linking the lung and the gut in a joined axis.	[Schippa, Serena; Iebba, Valerio; Santangelo, Floriana; Gagliardi, Antonella; Conte, Maria Pia] Univ Roma La Sapienza, Microbiol Unit, Publ Hlth & Infect Dis Dept, Rome, Italy; [De Biase, Riccardo Valerio; Stamato, Antonella; Bertasi, Serenella; Quattrucci, Serena] Univ Roma La Sapienza, Paediat & Infant Neuropsychiat Dept, Reg Cyst Fibrosis Ctr, Rome, Italy; [Lucarelli, Marco] Univ Roma La Sapienza, Dept Haematol & Cellular Biotechnol, Rome, Italy	Sapienza University Rome; Sapienza University Rome; Sapienza University Rome	Iebba, V (corresponding author), Univ Roma La Sapienza, Microbiol Unit, Publ Hlth & Infect Dis Dept, Rome, Italy.	valerio.iebba@uniroma1.it	Lucarelli, Marco/AAC-1667-2019; Iebba, Valerio/P-1194-2016; De Biase, Riccardo Valerio/AAA-8869-2020; Chiang, Tzen-Yuh/F-7383-2014; Chiang, Yu-Chung/E-9143-2011	Iebba, Valerio/0000-0002-0716-306X; Lucarelli, Marco/0000-0002-5538-2494; schippa, serena/0000-0003-1572-2623	Cystic Fibrosis Lazio Regional Center, Italy; MIUR Italian Minister for Research	Cystic Fibrosis Lazio Regional Center, Italy; MIUR Italian Minister for Research	This study was funded by Cystic Fibrosis Lazio Regional Center, Italy, and MIUR Italian Minister for Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adlerberth I, 2008, NESTLE NUTR WORKS SE, V62, P13, DOI 10.1159/000146245; Ahmed N, 2003, GUT, V52, P1159, DOI 10.1136/gut.52.8.1159; Biasucci G, 2010, EARLY HUM DEV, V86, pS13, DOI 10.1016/j.earlhumdev.2010.01.004; Borowitz D, 2002, J PEDIATR GASTR NUTR, V35, P246, DOI 10.1097/00005176-200209000-00004; Boucher RC, 2002, ADV DRUG DELIVER REV, V54, P1359, DOI 10.1016/S0169-409X(02)00144-8; Casaccia G, 2003, PEDIATR SURG INT, V19, P75, DOI 10.1007/s00383-002-0781-8; Castellani C, 2008, J CYST FIBROS, V7, P179, DOI 10.1016/j.jcf.2008.03.009; Chow J, 2010, ADV IMMUNOL, V107, P243, DOI [10.1016/B978-0-12-381300-8.00008-3, 10.1016/S0065-2776(10)07001-X]; Chow J, 2010, CELL HOST MICROBE, V7, P265, DOI 10.1016/j.chom.2010.03.004; Conte MP, 2006, GUT, V55, P1760, DOI 10.1136/gut.2005.078824; Cox MJ, 2010, DCPT, V5; Davis PB, 1996, AM J RESP CRIT CARE, V154, P1229, DOI 10.1164/ajrccm.154.5.8912731; De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; Duytschaever G, 2011, APPL ENVIRON MICROB, V77, P8015, DOI 10.1128/AEM.05933-11; Frank DN, 2011, INFLAMM BOWEL DIS, V17, P179, DOI 10.1002/ibd.21339; Fridge JL, 2007, J PEDIATR GASTR NUTR, V44, P212, DOI 10.1097/MPG.0b013e31802c0ceb; GIBSON LE, 1959, PEDIATRICS, V23, P545; Goddard AF, 2012, P NATL ACAD SCI USA, V109, P13769, DOI 10.1073/pnas.1107435109; Harper-Owen R, 1999, J CLIN MICROBIOL, V37, P1469, DOI 10.1128/JCM.37.5.1469-1473.1999; Iebba V, 2012, INFECT IMMUN, V80, P1408, DOI 10.1128/IAI.06181-11; Iebba V, 2011, DIGEST DIS, V29, P531, DOI 10.1159/000332969; Keely S, 2012, MUCOSAL IMMUNOL, V5, P7, DOI 10.1038/mi.2011.55; Khachatryan ZA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003064; Le Blay G, 2007, LETT APPL MICROBIOL, V45, P252, DOI 10.1111/j.1472-765X.2007.02178.x; Lee JM, 2012, DCPT, V2012; Lees CW, 2011, GUT, V60, P1739, DOI 10.1136/gut.2009.199679; LEWISTON N, 1987, CHEST, V91, P878, DOI 10.1378/chest.91.6.878; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Li M, 2008, P NATL ACAD SCI USA, V105, P2117, DOI 10.1073/pnas.0712038105; Lucarelli M, 2006, ANAL BIOCHEM, V353, P226, DOI 10.1016/j.ab.2006.03.022; Marzorati M, 2008, ENVIRON MICROBIOL, V10, P1571, DOI 10.1111/j.1462-2920.2008.01572.x; Matsuki T, 2002, APPL ENVIRON MICROB, V68, P5445, DOI 10.1128/AEM.68.11.5445-5451.2002; MOORE WEC, 1995, APPL ENVIRON MICROB, V61, P3202, DOI 10.1128/AEM.61.9.3202-3207.1995; Nubel U, 1996, J BACTERIOL, V178, P5636; Packey CD, 2009, CURR OPIN INFECT DIS, V22, P292, DOI 10.1097/QCO.0b013e32832a8a5d; Pezzulo AA, 2012, NATURE, V487, P109, DOI 10.1038/nature11130; Rogers GB, 2010, GUT MICROBES, V1, P85, DOI 10.4161/gmic.1.2.11350; Roh H, 2011, J BACTERIOL, V193, P307, DOI 10.1128/JB.01217-10; Rowntree RK, 2003, ANN HUM GENET, V67, P471, DOI 10.1046/j.1469-1809.2003.00028.x; Schippa S, 2012, CAN J MICROBIOL, V58, P426, DOI [10.1139/W2012-007, 10.1139/w2012-007]; Schippa S, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-175; Schwiertz A, 2000, APPL ENVIRON MICROB, V66, P375, DOI 10.1128/AEM.66.1.375-382.2000; SOKOL H, 2008, DCPT, V105, P16731, DOI DOI 10.1073/PNAS.0804812105; TIZZANO EF, 1995, ANN INTERN MED, V123, P305, DOI 10.7326/0003-4819-123-4-199508150-00009; Wang RF, 1996, APPL ENVIRON MICROB, V62, P1242, DOI 10.1128/AEM.62.4.1242-1247.1996; Wiuf C, 2001, GENET RES, V78, P41, DOI 10.1017/S0016672301005195; Zoetendal EG, 1998, APPL ENVIRON MICROB, V64, P3854; Zoetendal Erwin G, 2004, Curr Issues Intest Microbiol, V5, P31	48	70	70	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2013	8	4							e61176	10.1371/journal.pone.0061176	http://dx.doi.org/10.1371/journal.pone.0061176			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IK	23613805	gold, Green Submitted, Green Published			2022-12-25	WOS:000317907200035
J	Vercauteren, J; Beheydt, G; Prosperi, M; Libin, P; Imbrechts, S; Camacho, R; Clotet, B; De Luca, A; Grossman, Z; Kaiser, R; Sonnerborg, A; Torti, C; Van Wijngaerden, E; Schmit, JC; Zazzi, M; Geretti, AM; Vandamme, AM; Van Laethem, K				Vercauteren, Jurgen; Beheydt, Gertjan; Prosperi, Mattia; Libin, Pieter; Imbrechts, Stijn; Camacho, Ricardo; Clotet, Bonaventura; De Luca, Andrea; Grossman, Zehava; Kaiser, Rolf; Sonnerborg, Anders; Torti, Carlo; Van Wijngaerden, Eric; Schmit, Jean-Claude; Zazzi, Maurizio; Geretti, Anna-Maria; Vandamme, Anne-Mieke; Van Laethem, Kristel			Clinical Evaluation of Rega 8: An Updated Genotypic Interpretation System That Significantly Predicts HIV-Therapy Response	PLOS ONE			English	Article							RESISTANCE INTERPRETATION SYSTEMS; DRUG-RESISTANCE; ANTIRETROVIRAL TREATMENT; HIV-1-INFECTED PATIENTS; VIROLOGICAL RESPONSE; DISTINCT SYSTEMS; RECOMMENDATIONS; VALIDATION; ALGORITHMS; OUTCOMES	Introduction: Clinically evaluating genotypic interpretation systems is essential to provide optimal guidance in designing potent individualized HIV-regimens. This study aimed at investigating the ability of the latest Rega algorithm to predict virological response on a short and longer period. Materials & Methods: 9231 treatment changes episodes were extracted from an integrated patient database. The virological response after 8, 24 and 48 weeks was dichotomized to success and failure. Success was defined as a viral load below 50 copies/ml or alternatively, a 2 log decrease from the baseline viral load at 8 weeks. The predictive ability of Rega version 8 was analysed in comparison with that of previous evaluated version Rega 5 and two other algorithms (ANRS v2011.05 and Stanford HIVdb v6.0.11). A logistic model based on the genotypic susceptibility score was used to predict virological response, and additionally, confounding factors were added to the model. Performance of the models was compared using the area under the ROC curve (AUC) and a Wilcoxon signed-rank test. Results: Per unit increase of the GSS reported by Rega 8, the odds on having a successful therapy response on week 8 increased significantly by 81% (OR = 1.81, CI = [1.76-1.86]), on week 24 by 73% (OR = 1.73, CI = [1.69-1.78]) and on week 48 by 85% (OR = 1.85, CI = [1.80-1.91]). No significant differences in AUC were found between the performance of Rega 8 and Rega 5, ANRS v2011.05 and Stanford HIVdb v6.0.11, however Rega 8 had the highest sensitivity: 76.9%, 76.5% and 77.2% on 8, 24 and 48 weeks respectively. Inclusion of additional factors increased the performance significantly. Conclusion: Rega 8 is a significant predictor for virological response with a better sensitivity than previously, and with rules for recently approved drugs. Additional variables should be taken into account to ensure an effective regimen.	[Vercauteren, Jurgen; Beheydt, Gertjan; Libin, Pieter; Imbrechts, Stijn; Vandamme, Anne-Mieke; Van Laethem, Kristel] Katholieke Univ Leuven, Rega Inst Med Res, Louvain, Belgium; [Prosperi, Mattia] Univ Manchester, Northwest Inst Biohlth Informat, Manchester, Lancs, England; [Camacho, Ricardo] Ctr Hosp Lisboa Ocidental, Lisbon, Portugal; [Clotet, Bonaventura] IRSICAIXA Fdn, Retrovirol Lab, Badalona, Spain; [De Luca, Andrea] Univ Cattolica Sacro Cuore, Ist Clin Malattie Infett, Rome, Italy; [Grossman, Zehava] Chaim Sheba Med Ctr, IL-52621 Tel Hashomer, Israel; [Kaiser, Rolf] Univ Cologne, Inst Virol, D-50931 Cologne, Germany; [Sonnerborg, Anders] Karolinska Inst, Dept Med, Div Infect Dis, Stockholm, Sweden; [Torti, Carlo] Univ Brescia, Inst Infect & Trop Dis, Brescia, Italy; [Van Wijngaerden, Eric] Katholieke Univ Leuven Hosp, Dept Internal Med, Louvain, Belgium; [Schmit, Jean-Claude] Ctr Rech Publ Sante, Lab Retrovirol, Luxembourg, Luxembourg; [Zazzi, Maurizio] Univ Siena, Dept Mol Biol, I-53100 Siena, Italy; [Geretti, Anna-Maria] Royal Free Hampstead Natl Hlth Serv Trust, Dept Virol, London, England; [Camacho, Ricardo] Univ Nova Lisboa, Inst Higiene & Med Trop, P-1200 Lisbon, Portugal; [Grossman, Zehava] Tel Aviv Univ, Sch Publ Hlth, IL-69978 Tel Aviv, Israel	KU Leuven; University of Manchester; Centro Hospitalar de Lisboa Ocidental, EPE; Universidade de Lisboa; Institut de Recerca de la Sida - IrsiCaixa; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Chaim Sheba Medical Center; University of Cologne; Karolinska Institutet; University of Brescia; Flanders Institute for Biotechnology (VIB); KU Leuven; University Hospital Leuven; Luxembourg Institute of Health; University of Siena; Universidade Nova de Lisboa; Institute of Hygiene & Tropical Medicine - UNL; Tel Aviv University	Vercauteren, J (corresponding author), Katholieke Univ Leuven, Rega Inst Med Res, Louvain, Belgium.	jurgen.vercauteren@rega.kuleuven.be	Vercauteren, Jurgen/P-7676-2019; Sönnerborg, Anders/W-2011-2019; Van Wijngaerden, Eric/AAB-9187-2021; Vandamme, Anne-Mieke/I-4127-2012; Camacho, Ricardo J/I-7629-2012; Van Laethem, Kristel/R-6282-2016; De Luca, Andrea/G-8810-2011; Zazzi, Maurizio/K-3422-2018	Vercauteren, Jurgen/0000-0003-0698-4736; Sönnerborg, Anders/0000-0001-8928-3374; Van Wijngaerden, Eric/0000-0001-8926-099X; Vandamme, Anne-Mieke/0000-0002-6594-2766; Camacho, Ricardo J/0000-0002-9129-3237; Van Laethem, Kristel/0000-0001-6036-2271; De Luca, Andrea/0000-0002-9561-9193; Zazzi, Maurizio/0000-0002-0344-6281; Geretti, Anna Maria/0000-0002-3670-6588	European Community [223131]; Fonds Wetenschappelijk Onderzoek (FWO) [G.0611.09]; Interuniversity Attraction Poles Programme, Belgian State, Belgian Science Policy [IAP-VI P6/41]; Medical Research Council (MRC) [MR/K006665/1]; Institute for the Promotion of Innovation through Sciences and Technology in Flanders (IWT); Medical Research Council [MC_PC_13042, MR/K006665/1] Funding Source: researchfish; MRC [MR/K006665/1] Funding Source: UKRI	European Community(European Commission); Fonds Wetenschappelijk Onderzoek (FWO)(FWO); Interuniversity Attraction Poles Programme, Belgian State, Belgian Science Policy(Belgian Federal Science Policy Office); Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Institute for the Promotion of Innovation through Sciences and Technology in Flanders (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The research leading to the results has received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under the project "Collaborative HIV and Anti-HIV Drug Resistance Network (CHAIN)'' - grant agreement no 223131 and was also supported by the Fonds Wetenschappelijk Onderzoek (FWO) grant G.0611.09 and a grant from the Interuniversity Attraction Poles Programme, Belgian State, Belgian Science Policy (IAP-VI P6/41). MP from the University of Manchester's Health Research Center (HeRC) was funded by the Medical Research Council (MRC) grant MR/K006665/1. The data used for this study originated from several cohorts and hospitals: EuResist (IST-2004-027173; www.euresist.org), Virolab (IST-FP6-027446; www.virolab.org), University Hospitals Leuven (Leuven, Belgium), Chaim Sheba Medical Center (Tel-Hashomer, Israel) and Hospital Egas Moniz (Lisbon, Portugal). GB was funded by a Ph.D grant of the Institute for the Promotion of Innovation through Sciences and Technology in Flanders (IWT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmann A, 2009, J INFECT DIS, V199, P999, DOI 10.1086/597305; De Luca A, 2004, ANTIVIR THER, V9, P743; De Luca A, 2003, CURR OPIN INFECT DIS, V16, P573, DOI 10.1097/00001432-200312000-00010; De Luca A, 2011, ANTIVIR THER, V16, P489, DOI 10.3851/IMP1799; de Oliveira T, 2005, BIOINFORMATICS, V21, P3797, DOI 10.1093/bioinformatics/bti607; Fox ZV, 2007, AIDS, V21, P2033, DOI 10.1097/QAD.0b013e32825a69e4; Frentz D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011505; Helm M, 2007, EUR J MED RES, V12, P231; Hemelaar J, 2006, AIDS, V20, pW13, DOI 10.1097/01.aids.0000247564.73009.bc; Katlama C, 1996, JAMA-J AM MED ASSOC, V276, P118, DOI 10.1001/jama.276.2.118; Libin P, 2007, 5 EUR HIV DRUG RES W; Liu TF, 2006, CLIN INFECT DIS, V42, P1608, DOI 10.1086/503914; Meynard JL, 2002, AIDS, V16, P727, DOI 10.1097/00002030-200203290-00008; Mocroft A, 1998, LANCET, V352, P1725, DOI 10.1016/S0140-6736(98)03201-2; Prosperi MCF, 2009, ANTIVIR THER, V14, P433; Rhee SY, 2009, J INFECT DIS, V200, P453, DOI 10.1086/600073; Staszewski S, 1997, AIDS, V11, P477, DOI 10.1097/00002030-199704000-00011; Thompson MA, 2010, JAMA-J AM MED ASSOC, V304, P321, DOI 10.1001/jama.2010.1004; Van Laethem K, 2002, ANTIVIR THER, V7, P123; Vandamme AM, 2011, AIDS REV, V13, P77; Vercauteren J, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-12; Vercauteren J, 2006, ANTIVIR RES, V71, P335, DOI 10.1016/j.antiviral.2006.05.003; Wilson LE, 2009, CLIN INFECT DIS, V48, P214, DOI 10.1086/595701; Zazzi M, 2009, J ANTIMICROB CHEMOTH, V64, P616, DOI 10.1093/jac/dkp252	24	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2013	8	4							e61436	10.1371/journal.pone.0061436	http://dx.doi.org/10.1371/journal.pone.0061436			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IK	23613852	Green Published, gold, Green Submitted			2022-12-25	WOS:000317907200055
J	Wen, HC; Kao, C; Hsu, RC; Huo, YN; Ting, PC; Chen, LC; Hsu, SP; Juan, SH; Lee, WS				Wen, Heng-Ching; Kao, Chieh; Hsu, Ruei-Chi; Huo, Yen-Nien; Ting, Pei-Ching; Chen, Li-Ching; Hsu, Sung-Po; Juan, Shu-Hui; Lee, Wen-Sen			Thy-1-Induced Migration Inhibition in Vascular Endothelial Cells through Reducing the RhoA Activity	PLOS ONE			English	Article							HUMAN THY-1; FOCAL ADHESIONS; ANGIOGENESIS; BINDING; GTPASES; MECHANISM; PROLIFERATION; FIBROBLASTS; ACTIVATION; EXPRESSION	Our previous study indicated that Thy-1, which is expressed on blood vessel endothelium in settings of pathological and a specific of physiological, but not during embryonic, angiogenesis, may be used as a marker for angiogenesis. However, the function of Thy-1 during angiogenesis is still not clear. Here, we demonstrate that knock-down of the endogenous Thy-1 expression by Thy-1 siRNA transfection promoted the migration of human umbilical vein endothelial cells (HUVEC). In contrast, treatment with interleukin-1 beta (IL-1 beta) or phorbol-12-myristate-13-acetate (PMA) increased the level of Thy-1 protein and reduced the migration of HUVEC. These effects were abolished by pre-transfection of HUVEC with Thy-1 siRNA to knock-down the expression of Thy-1. Moreover, over-expression of Thy-1 by transfection of HUVEC with Thy-1 pcDNA3.1 decreased the activity of RhoA and Rac-1 and inhibited the adhesion, migration and capillary-like tube formation of these cells. These effects were prevented by co-transfection of the cell with constitutively active RhoA construct (RhoA V14). On the other hand, pre-treatment with a ROCK (a kinase associated with RhoA for transducing RhoA signaling) inhibitor, Y27632, abolished the RhoA V14-induced prevention effect on the Thy-1-induced inhibition of endothelial cell migration and tube formation. Taken together, these results indicate that suppression of the RhoA-mediated pathway might participate in the Thy-1-induced migration inhibition in HUVEC. In the present study, we uncover a completely novel role of Thy-1 in endothelial cell behaviors.	[Wen, Heng-Ching; Hsu, Ruei-Chi; Huo, Yen-Nien; Ting, Pei-Ching; Chen, Li-Ching; Lee, Wen-Sen] Taipei Med Univ, Grad Inst Med Sci, Coll Med, Taipei, Taiwan; [Kao, Chieh] Taipei Med Univ, Coll Med, Grad Inst Cell & Mol Biol, Taipei, Taiwan; [Hsu, Sung-Po; Juan, Shu-Hui; Lee, Wen-Sen] Taipei Med Univ, Coll Med, Sch Med, Dept Physiol, Taipei, Taiwan; [Lee, Wen-Sen] Taipei Med Univ Hosp, Canc Res Ctr, Taipei, Taiwan	Taipei Medical University; Taipei Medical University; Taipei Medical University; Taipei Medical University; Taipei Medical University Hospital	Lee, WS (corresponding author), Taipei Med Univ, Grad Inst Med Sci, Coll Med, Taipei, Taiwan.	wslee@tmu.edu.tw	Hsu, Sung-Po/I-8383-2019	HSU, SUNG-PO/0000-0001-7527-9040	National Science Council of the Republic of China [NSC 93-2320-B-038-018, NSC 94-2320-B-038-005]	National Science Council of the Republic of China(Ministry of Science and Technology, Taiwan)	This work was supported by research grants from the National Science Council of the Republic of China (NSC 93-2320-B-038-018, NSC 94-2320-B-038-005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABEDI H, 1995, CARDIOVASC RES, V30, P544, DOI 10.1016/0008-6363(95)00092-5; ADES EW, 1992, J INVEST DERMATOL, V99, P683, DOI 10.1111/1523-1747.ep12613748; Barker TH, 2004, EXP CELL RES, V295, P488, DOI 10.1016/j.yexcr.2004.01.026; Bellon G, 2004, CRIT REV ONCOL HEMAT, V49, P203, DOI 10.1016/j.critrevonc.2003.10.004; Bouterfa HL, 2000, ANTICANCER RES, V20, P2761; Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653; Choi J, 2005, BIOCHEM BIOPH RES CO, V331, P557, DOI 10.1016/j.bbrc.2005.04.006; CRAIG W, 1993, J EXP MED, V177, P1331, DOI 10.1084/jem.177.5.1331; Fryer BH, 2005, CANCER LETT, V229, P13, DOI 10.1016/j.canlet.2004.12.009; GRANT DS, 1992, J CELL PHYSIOL, V153, P614, DOI 10.1002/jcp.1041530324; Gupta MK, 2003, WORLD J GASTROENTERO, V9, P1144, DOI 10.3748/wjg.v9.i6.1144; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Ho PY, 2004, INT J CANCER, V111, P51, DOI 10.1002/ijc.20039; KALEBIC T, 1983, SCIENCE, V221, P281, DOI 10.1126/science.6190230; Lee WS, 1998, CIRC RES, V82, P845; Liu HJ, 2005, BIOCHEM BIOPH RES CO, V336, P709, DOI 10.1016/j.bbrc.2005.08.149; Mason JC, 1996, J IMMUNOL, V157, P874; McTaggart SJ, 2006, CELL MOL LIFE SCI, V63, P255, DOI 10.1007/s00018-005-5298-6; Meerovitch K, 2003, VASC PHARMACOL, V40, P77, DOI 10.1016/S1537-1891(02)00339-7; Munoz-Chapuli R, 2004, CELL MOL LIFE SCI, V61, P2224, DOI 10.1007/s00018-004-4070-7; Pilorget A, 2005, J CEREBR BLOOD F MET, V25, P1171, DOI 10.1038/sj.jcbfm.9600117; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Rikitake Y, 2005, CIRC RES, V97, P1232, DOI 10.1161/01.RES.0000196564.18314.23; Saalbach A, 1999, CELL TISSUE RES, V298, P307, DOI 10.1007/s004419900079; Saalbach A, 2000, J INVEST DERMATOL, V115, P882, DOI 10.1046/j.1523-1747.2000.00104.x; Saalbach A, 2005, ONCOGENE, V24, P4710, DOI 10.1038/sj.onc.1208559; Saalbach A, 2002, MICROVASC RES, V64, P86, DOI 10.1006/mvre.2002.2401; Saalbach A, 2008, EUR J IMMUNOL, V38, P1391, DOI 10.1002/eji.200737901; Seabra MC, 1998, CELL SIGNAL, V10, P167, DOI 10.1016/S0898-6568(97)00120-4; Tse AKW, 2005, BIOCHEM PHARMACOL, V70, P1443, DOI 10.1016/j.bcp.2005.08.011; Uchima Y, 2004, PANCREAS, V29, P123, DOI 10.1097/00006676-200408000-00007; VanAelst L, 1997, GENE DEV, V11, P2295, DOI 10.1101/gad.11.18.2295; Wetzel A, 2004, J IMMUNOL, V172, P3850, DOI 10.4049/jimmunol.172.6.3850; Wu MH, 2005, J PHYSIOL-LONDON, V569, P359, DOI 10.1113/jphysiol.2005.096537	35	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2013	8	4							e61506	10.1371/journal.pone.0061506	http://dx.doi.org/10.1371/journal.pone.0061506			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IK	23613866	gold, Green Published, Green Submitted			2022-12-25	WOS:000317907200061
J	Zou, HC; Fairley, CK; Guy, R; Bilardi, J; Bradshaw, CS; Garland, SM; Sze, JK; Afrizal, A; Chen, MY				Zou, Huachun; Fairley, Christopher K.; Guy, Rebecca; Bilardi, Jade; Bradshaw, Catriona S.; Garland, Suzanne M.; Sze, Jun Kit; Afrizal, Afrizal; Chen, Marcus Y.			Automated, Computer Generated Reminders and Increased Detection of Gonorrhoea, Chlamydia and Syphilis in Men Who Have Sex with Men	PLOS ONE			English	Article							ASYMPTOMATIC SYPHILIS; NEISSERIA-GONORRHOEAE; AUSTRALIA; RISK; CHINA	Background: Guidelines recommend frequent screening of men who have sex with men (MSM) for sexually transmissible infections (STIs) but few interventions have demonstrated increased testing and detection of bacterial STIs among MSM in controlled studies. Methods: We used automated text message and email reminders generated by computer assisted self-interview (CASI) to remind MSM to retest for syphilis. We compared clinic visits, STI testing and detection rates over 12 month between men receiving reminders (reminder group) and men not offered the reminders (concurrent control group). Results: Men who chose 3-monthly reminders had more clinic visits (median 3 vs 1) and higher testing rates for pharyngeal gonorrhoea (67.0% vs 33.6%), rectal gonorrhoea (62.7% vs 31.1%), urethral chlamydia (67.3% vs 39.3%), rectal chlamydia (62.9% vs 31.3%), syphilis (67.0% vs 39.3%) and HIV (64.9% vs 36.7%) (all p < 0.001) than concurrent controls, within 12 months after their first visit. Also, men receiving reminders had a higher combined testing rate for all the aforementioned STIs at a same visit (55.7% vs 25.5%, p < 0.001) compared with concurrent controls. This association remained after adjusting for differences in characteristics between the two groups (adjusted odds ratio: 1.77, 95% confidence interval: 1.51-2.08). Men receiving reminders also had a higher detection rate of: rectal gonorrhoea (3.7% vs 1.2%, p = 0.001), urethral chlamydia (3.1% vs 1.4%, p = 0.027), rectal chlamydia (6.6% vs 2.8%, p < 0.001), and early, latent syphilis (1.7% vs 0.4%, p = 0.008) compared with concurrent controls. Conclusion: This is the first study to demonstate that a fully automated reminder system using CASI was associated with increased detection of bacterial STIs among MSM.	[Zou, Huachun; Fairley, Christopher K.; Bradshaw, Catriona S.; Chen, Marcus Y.] Univ Melbourne, Sch Populat Hlth, Sexual Hlth Unit, Melbourne, Vic, Australia; [Fairley, Christopher K.; Bradshaw, Catriona S.; Sze, Jun Kit; Afrizal, Afrizal; Chen, Marcus Y.] Alfred Hlth, Melbourne Sexual Hlth Ctr, Melbourne, Vic, Australia; [Guy, Rebecca] Univ New S Wales, Kirby Inst, Sydney, NSW, Australia; [Bilardi, Jade] Monash Univ, Dept Epidemiol & Preventat Med, Melbourne, Vic 3004, Australia; [Garland, Suzanne M.] Royal Womens Hosp, Dept Microbiol & Infect Dis, Melbourne, Vic, Australia; [Garland, Suzanne M.] Univ Melbourne, Dept Obstet & Gynaecol, Melbourne, Vic, Australia; [Garland, Suzanne M.] Murdoch Childrens Res Inst, Melbourne, Vic, Australia	University of Melbourne; University of New South Wales Sydney; Kirby Institute; Monash University; University of Melbourne; Murdoch Children's Research Institute	Chen, MY (corresponding author), Univ Melbourne, Sch Populat Hlth, Sexual Hlth Unit, Melbourne, Vic, Australia.	mchen@mshc.org.au	Zou, Huachun/AAU-6097-2020	Christopher, Fairley/0000-0001-9081-1664; bradshaw, catriona/0000-0002-6643-5678; Guy, Rebecca/0000-0002-2929-4634; Bilardi, Jade/0000-0003-0461-2605				[Anonymous], EURO SURVEILL; Baker J, 2009, AIDS PATIENT CARE ST, V23, P585, DOI 10.1089/apc.2008.0277; Bernstein KT, 2010, JAIDS-J ACQ IMM DEF, V53, P537, DOI 10.1097/QAI.0b013e3181c3ef29; Bissessor M, 2011, J CLIN MICROBIOL, V49, P4304, DOI 10.1128/JCM.05341-11; Bissessor M, 2011, CLIN INFECT DIS, V53, P57, DOI 10.1093/cid/cir271; Bissessor M, 2010, JAIDS-J ACQ IMM DEF, V55, P211, DOI 10.1097/QAI.0b013e3181e583bf; Van der Meer JTM, 2009, SEX TRANSM DIS, V36, P84, DOI 10.1097/OLQ.0b013e318186debb; Centers for Disease Control and Prevention, HIV US OV; Gray RT, 2010, SEX TRANSM DIS, V37, P298, DOI 10.1097/OLQ.0b013e3181ca3c0a; Guy R, 2012, SEX TRANSM INFECT; Guy RJ, 2011, SEX HEALTH, V8, P319, DOI 10.1071/SH10095; Hoare A, 2012, SEX HEALTH, V9, P144, DOI 10.1071/SH10145; HUTT DM, 1986, ANN INTERN MED, V104, P655, DOI 10.7326/0003-4819-104-5-655; McNamee KM, 2008, SEX TRANSM INFECT, V84, P565, DOI 10.1136/sti.2008.030874; Ministry of Health People's Republic of China, 2010, 2009 EST HIV AIDS EP; National Centre in HIV Epidemiology and Clinical Research, 2009, FIN TECHN REP PHAS A; Park J, 2012, SEX TRANSM DIS, V39, P482, DOI 10.1097/OLQ.0b013e3182495e2f; The Kirby Institute, HIV VIR HEP SEX TRAN; Vodstrcil LA, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-158; Vodstrcil LA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018456; WALLIN J, 1979, BRIT MED J, V1, P1462, DOI 10.1136/bmj.1.6176.1462; Workowski Kimberly A, 2010, MMWR Recomm Rep, V59, P1; Zou HC, 2012, AIDS BEHAV, V16, P1717, DOI 10.1007/s10461-012-0225-y; Zou HC, 2012, SEX TRANSM DIS, V39, P382, DOI 10.1097/OLQ.0b013e318248e3ff; Zou HC, 2010, JAIDS-J ACQ IMM DEF, V53, pS81, DOI 10.1097/QAI.0b013e3181c7dd2b	25	48	48	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2013	8	4							e61972	10.1371/journal.pone.0061972	http://dx.doi.org/10.1371/journal.pone.0061972			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IK	23613989	Green Published, gold			2022-12-25	WOS:000317907200111
J	Kim, JE; Bunderson, BR; Croasdell, A; Reed, KM; Coulombe, RA				Kim, Ji Eun; Bunderson, Brett R.; Croasdell, Amanda; Reed, Kent M.; Coulombe, Roger A., Jr.			Alpha-Class Glutathione S-Transferases in Wild Turkeys (Meleagris gallopavo): Characterization and Role in Resistance to the Carcinogenic Mycotoxin Aflatoxin B-1	PLOS ONE			English	Article							BUTYLATED HYDROXYTOLUENE CHEMOPREVENTION; FUNCTIONAL-CHARACTERIZATION; PROMOTER HYPERMETHYLATION; CYTOCHROME-P450 3A37; MOLECULAR-CLONING; GENE; EXPRESSION; POLYMORPHISM; LIVER; SUSCEPTIBILITY	Domestic turkeys (Meleagris gallopavo) are one of the most susceptible animals known to the toxic effects of the mycotoxin aflatoxin B-1 (AFB(1)), a potent human hepatocarcinogen, and universal maize contaminant. We have demonstrated that such susceptibility is associated with the inability of hepatic glutathione S-transferases (GSTs) to detoxify the reactive electrophilic metabolite exo-AFB(1)-8,9-epoxide (AFBO). Unlike their domestic counterparts, wild turkeys, which are relatively AFB(1)-resistant, possess hepatic GST-mediated AFBO conjugating activity. Here, we characterized the molecular and functional properties of hepatic alpha-class GSTs (GSTAs) from wild and domestic turkeys to shed light on the differences in resistance between these closely related strains. Six alpha-class GST genes (GSTA) amplified from wild turkeys (Eastern and Rio Grande subspecies), heritage breed turkeys (Royal Palm) and modern domestic (Nicholas strain) turkeys were sequenced, and catalytic activities of heterologously-expressed recombinant enzymes determined. Alpha-class identity was affirmed by conserved GST domains and four signature motifs. All GSTAs contained single nucleotide polymorphisms (SNPs) in their coding regions: GSTA1.1 (5 SNPs), GSTA1.2 (7), GSTA1.3 (3), GSTA2 (3), GSTA3 (1) and GSTA4 (2). E. coli-expressed GSTAs possessed varying activities toward GST substrates 1-chloro-2,4-dinitrobenzene (CDNB), 1,2-dichloro-4-nitrobenzene (DCNB), ethacrynic acid (ECA), cumene hydroperoxide (CHP). As predicted by their relative resistance, livers from domestic turkeys lacked detectable GST-mediated AFBO detoxification activity, whereas those from wild and heritage birds possessed this critical activity, suggesting that intensive breeding and selection resulted in loss of AFB(1)-protective alleles during domestication. Our observation that recombinant tGSTAs detoxify AFBO, whereas their hepatic forms do not, implies that the hepatic forms of these enzymes are down-regulated, silenced, or otherwise modified by one or more mechanisms. These data may inform of possible molecular mechanisms of resistance to AFB(1), and may also have the benefit of identifying genetic markers which could be used to enhance AFB(1) resistance in modern domestic strains.	[Kim, Ji Eun; Bunderson, Brett R.; Croasdell, Amanda; Coulombe, Roger A., Jr.] Utah State Univ, Dept Anim Dairy & Vet Sci, Logan, UT 84322 USA; [Kim, Ji Eun; Bunderson, Brett R.; Croasdell, Amanda; Coulombe, Roger A., Jr.] Utah State Univ, Interdept Grad Toxicol Program, Logan, UT 84322 USA; [Reed, Kent M.] Univ Minnesota, Coll Vet Med, Dept Vet & Biomed Sci, St Paul, MN 55108 USA	Utah System of Higher Education; Utah State University; Utah System of Higher Education; Utah State University; University of Minnesota System; University of Minnesota Twin Cities	Coulombe, RA (corresponding author), Utah State Univ, Dept Anim Dairy & Vet Sci, Logan, UT 84322 USA.	roger@usu.edu	Coulombe, Roger A/G-7523-2012		National Resources Institute from the United States Department of Agriculture Cooperative State Research, Education, and Extension Service Animal Genome program [2004-35205-14217, 2007-35205-17880]; Utah Agricultural Experiment Station; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007026] Funding Source: NIH RePORTER	National Resources Institute from the United States Department of Agriculture Cooperative State Research, Education, and Extension Service Animal Genome program; Utah Agricultural Experiment Station; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study was supported in part by National Resources Institute competitive grants 2004-35205-14217 and 2007-35205-17880 from the United States Department of Agriculture Cooperative State Research, Education, and Extension Service Animal Genome program (http://www.csrees.usda.gov/funding/rfas/nri_rfa.html), and by the Utah Agricultural Experiment Station (http://uaes.usu.edu/) where it is published as paper number 8482. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AliOsman F, 1997, J BIOL CHEM, V272, P10004; Andersson L, 2001, NAT REV GENET, V2, P130, DOI 10.1038/35052563; Aslam ML, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-391; Blount W. P., 1961, J BRIT TURKEY FEDERA, V9; BORROZ KI, 1991, TOXICOL LETT, V58, P97, DOI 10.1016/0378-4274(91)90195-C; Chaves LD, 2011, HEREDITY, V107, P40, DOI 10.1038/hdy.2010.153; Chaves LD, 2010, IMMUNOGENETICS, V62, P465, DOI 10.1007/s00251-010-0451-2; Cho HR, 2011, INT J IMMUNOGENET, V38, P145, DOI 10.1111/j.1744-313X.2010.00987.x; Coles BF, 2005, METHOD ENZYMOL, V401, P9, DOI 10.1016/S0076-6879(05)01002-5; COULOMBE RA, 1993, J DAIRY SCI, V76, P880, DOI 10.3168/jds.S0022-0302(93)77414-7; EATON DL, 1994, ANNU REV PHARMACOL, V34, P135, DOI 10.1146/annurev.pa.34.040194.001031; Eaton DL, 1999, TOXICOL SCI, V49, P156, DOI 10.1093/toxsci/49.2.156; Esteller M, 1998, CANCER RES, V58, P4515; ESTEP JE, 1990, TOXICOLOGY, V64, P179, DOI 10.1016/0300-483X(90)90134-3; Gross-Steinmeyer K, 2010, TOXICOL SCI, V116, P422, DOI 10.1093/toxsci/kfq135; Guarisco JA, 2008, FOOD CHEM TOXICOL, V46, P3727, DOI 10.1016/j.fct.2008.09.050; Guarisco JA, 2008, TOXICOL APPL PHARM, V227, P339, DOI 10.1016/j.taap.2007.11.017; Habig W H, 1981, Methods Enzymol, V77, P398; HABIG WH, 1974, J BIOL CHEM, V249, P7130; Hartman S, 2006, POULTRY SCI, V85, P1791, DOI 10.1093/ps/85.10.1791; Hayes JD, 2005, ANNU REV PHARMACOL, V45, P51, DOI 10.1146/annurev.pharmtox.45.120403.095857; Hayes JD, 1995, CRIT REV BIOCHEM MOL, V30, P445, DOI 10.3109/10409239509083491; Ilic Z, 2010, TOXICOL APPL PHARM, V242, P241, DOI 10.1016/j.taap.2009.10.008; Kim JE, 2011, TOXICOL SCI, V124, P45, DOI 10.1093/toxsci/kfr212; Kim JE, 2010, GENE, V452, P45, DOI 10.1016/j.gene.2009.11.001; Klein PJ, 2003, FOOD CHEM TOXICOL, V41, P671, DOI 10.1016/S0278-6915(02)00332-0; Klein PJ, 2002, TOXICOL APPL PHARM, V182, P11, DOI 10.1006/taap.2002.9433; Klein PJ, 2002, COMP BIOCHEM PHYS C, V132, P193, DOI 10.1016/S1532-0456(02)00065-0; Klein PJ, 2000, TOXICOL APPL PHARM, V165, P45, DOI 10.1006/taap.2000.8926; LAWRENCE RA, 1976, BIOCHEM BIOPH RES CO, V71, P952, DOI 10.1016/0006-291X(76)90747-6; Lecomte T, 2006, CLIN CANCER RES, V12, P3050, DOI 10.1158/1078-0432.CCR-05-2076; Lee JS, 2007, VIRCHOWS ARCH, V450, P637, DOI 10.1007/s00428-007-0421-8; Liu Y, 2010, ENVIRON HEALTH PERSP, V118, P818, DOI 10.1289/ehp.0901388; Low WY, 2007, GENETICS, V177, P1363, DOI 10.1534/genetics.107.075838; Mock KE, 2002, MOL ECOL, V11, P643, DOI 10.1046/j.1365-294X.2002.01467.x; Muira WM, 2008, P NATL ACAD SCI USA, V105, P17312, DOI 10.1073/pnas.0806569105; Quist CF, 2000, J WILDLIFE DIS, V36, P436, DOI 10.7589/0090-3558-36.3.436; Rawal S, 2009, CYTOGENET GENOME RES, V125, P67, DOI 10.1159/000218748; Rawal S, 2011, TOXICOL APPL PHARM, V254, P349, DOI 10.1016/j.taap.2011.05.010; Rawal S, 2010, RES VET SCI, V89, P325, DOI 10.1016/j.rvsc.2010.04.011; Rawal S, 2010, CHEM RES TOXICOL, V23, P1322, DOI 10.1021/tx1000267; Reed Kent M., 2009, V3, P143, DOI 10.1007/978-3-540-73835-0_6; Schweitzer SH, 2001, J WILDLIFE DIS, V37, P657, DOI 10.7589/0090-3558-37.3.657; Smith EJ, 2005, BIOCHEM GENET, V43, P35, DOI 10.1007/s10528-005-1065-5; Soller M, 1998, REV SCI TECH OIE, V17, P329, DOI 10.20506/rst.17.1.1102; Speller CF, 2010, P NATL ACAD SCI USA, V107, P2807, DOI 10.1073/pnas.0909724107; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Yip SSM, 2006, CHEM RES TOXICOL, V19, P30, DOI 10.1021/tx050233+; Zhong S, 2002, CLIN CANCER RES, V8, P1087	49	14	14	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2013	8	4							e60662	10.1371/journal.pone.0060662	http://dx.doi.org/10.1371/journal.pone.0060662			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130DR	23613737	Green Published, Green Submitted, gold			2022-12-25	WOS:000317893400018
J	O'Meara, CP; Armitage, CW; Harvie, MCG; Timms, P; Lycke, NY; Beagley, KW				O'Meara, Connor P.; Armitage, Charles W.; Harvie, Marina C. G.; Timms, Peter; Lycke, Nils Y.; Beagley, Kenneth W.			Immunization with a MOMP-Based Vaccine Protects Mice against a Pulmonary Chlamydia Challenge and Identifies a Disconnection between Infection and Pathology	PLOS ONE			English	Article							OUTER-MEMBRANE PROTEIN; NECROSIS-FACTOR-ALPHA; MALTOSE-BINDING PROTEIN; DENDRITIC CELLS; IFN-GAMMA; ESCHERICHIA-COLI; CHOLERA-TOXIN; T-CELL; TRANSCUTANEOUS IMMUNIZATION; MUCOSAL IMMUNITY	Chlamydia pneumoniae is responsible for up to 20% of community acquired pneumonia and can exacerbate chronic inflammatory diseases. As the majority of infections are either mild or asymptomatic, a vaccine is recognized to have the greatest potential to reduce infection and disease prevalence. Using the C. muridarum mouse model of infection, we immunized animals via the intranasal (IN), sublingual (SL) or transcutaneous (TC) routes, with recombinant chlamydial major outer membrane protein (MOMP) combined with adjuvants CTA1-DD or a combination of cholera toxin/CpG-oligodeoxynucleotide (CT/CpG). Vaccinated animals were challenged IN with C. muridarum and protection against infection and pathology was assessed. SL and TC immunization with MOMP and CT/CpG was the most protective, significantly reducing chlamydial burden in the lungs and preventing weight loss, which was similar to the protection induced by a previous live infection. Unlike a previous infection however, these vaccinations also provided almost complete protection against fibrotic scarring in the lungs. Protection against infection was associated with antigen-specific production of IFN gamma, TNF alpha and IL-17 by splenocytes, however, protection against both infection and pathology required the induction of a similar pro-inflammatory response in the respiratory tract draining lymph nodes. Interestingly, we also identified two contrasting vaccinations capable of preventing infection or pathology individually. Animals IN immunized with MOMP and either adjuvant were protected from infection, but not the pathology. Conversely, animals TC immunized with MOMP and CTA1-DD were protected from pathology, even though the chlamydial burden in this group was equivalent to the unimmunized controls. This suggests that the development of pathology following an IN infection of vaccinated animals was independent of bacterial load and may have been driven instead by the adaptive immune response generated following immunization. This identifies a disconnection between the control of infection and the development of pathology, which may influence the design of future vaccines.	[O'Meara, Connor P.; Armitage, Charles W.; Harvie, Marina C. G.; Timms, Peter; Beagley, Kenneth W.] Queensland Univ Technol, IHBI, Brisbane, Qld 4001, Australia; [Lycke, Nils Y.] Univ Gothenburg, Mucosal Immunobiol & Vaccine Ctr MIVAC, Gothenburg, Gotaland, Sweden	Queensland University of Technology (QUT); University of Gothenburg	Beagley, KW (corresponding author), Queensland Univ Technol, IHBI, Brisbane, Qld 4001, Australia.	k2.beagley@qut.edu.au	Beagley, Kenneth/J-1129-2012	Beagley, Kenneth/0000-0003-3112-6557; O'Meara, Connor/0000-0002-2007-8126; Armitage, Charles/0000-0002-3859-5172; Timms, Peter/0000-0002-1682-0025	Australian Research Council; Biovitrum [LP0884020]	Australian Research Council(Australian Research Council); Biovitrum	This work was funded by the Australian Research Council and Biovitrum (LP0884020). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agren LC, 1999, J IMMUNOL, V162, P2432; Agren LC, 1997, J IMMUNOL, V158, P3936; Akhiani AA, 2006, SCAND J IMMUNOL, V63, P97, DOI 10.1111/j.1365-3083.2005.01713.x; ALDOUS MB, 1992, J INFECT DIS, V166, P646, DOI 10.1093/infdis/166.3.646; Andersen CS, 2007, INFECT IMMUN, V75, P408, DOI 10.1128/IAI.01290-06; Atamas SP, 2003, CYTOKINE GROWTH F R, V14, P537, DOI 10.1016/S1359-6101(03)00060-1; Bai H, 2009, J IMMUNOL, V183, P5886, DOI 10.4049/jimmunol.0901584; Bai Y, 2011, P NATL ACAD SCI USA, V108, P18406, DOI 10.1073/pnas.1115348108; Berry LJ, 2004, INFECT IMMUN, V72, P1019, DOI 10.1128/IAI.72.2.1019-1028.2004; Bos JD, 2005, SKIN IMMUNE SYSTEM C, P3; CALDWELL HD, 1981, INFECT IMMUN, V31, P1161, DOI 10.1128/IAI.31.3.1161-1176.1981; Choi AH, 2002, VACCINE, V20, P1733, DOI 10.1016/S0264-410X(02)00043-9; Clementsen P, 2002, J INVEST ALLERG CLIN, V12, P73; Cuburu N, 2007, VACCINE, V25, P8598, DOI 10.1016/j.vaccine.2007.09.073; Cunningham KA, 2009, J REPROD IMMUNOL; Cunningham KA, 2011, AM J REPROD IMMUNOL, V65, P118, DOI 10.1111/j.1600-0897.2010.00894.x; Czerkinsky C, 1999, IMMUNOL REV, V170, P197, DOI 10.1111/j.1600-065X.1999.tb01339.x; CZERKINSKY C, 2010, CURR TOP MICROBIOL I; De Filette M, 2006, VACCINE, V24, P544, DOI 10.1016/j.vaccine.2005.08.061; Eriksson AM, 2004, J IMMUNOL, V173, P3310, DOI 10.4049/jimmunol.173.5.3310; Fernandez S, 2007, INFECT IMMUN, V75, P1359, DOI 10.1128/IAI.00486-06; Fichorova RN, 1999, BIOL REPROD, V60, P508, DOI 10.1095/biolreprod60.2.508; Fox JD, 2001, PROTEIN SCI, V10, P622, DOI 10.1110/ps.45201; Frech SA, 2008, LANCET, V371, P2019, DOI 10.1016/S0140-6736(08)60839-9; Fujihashi K, 2004, MECH AGEING DEV, V125, P889, DOI 10.1016/j.mad.2004.05.009; Gabr MA, 2011, J ORTHOP RES, V29, P1, DOI 10.1002/jor.21206; Grayston JT, 2000, J INFECT DIS, V181, pS402, DOI 10.1086/315596; HAMMERSCHLAG MR, 1992, CLIN INFECT DIS, V14, P178, DOI 10.1093/clinids/14.1.178; Han Q, 2011, P NATL ACAD SCI US; Hickey DK, 2009, VACCINE, V27, P6217, DOI 10.1016/j.vaccine.2009.08.001; Hickey DK, 2005, CURR MOL MED, V5, P599, DOI 10.2174/1566524054863906; Igietseme Joseph U., 1993, Regional Immunology, V5, P317; Igietseme JU, 1996, J LEUKOCYTE BIOL, V59, P656, DOI 10.1002/jlb.59.5.656; Igietseme JU, 1999, IMMUNOLOGY, V98, P510, DOI 10.1046/j.1365-2567.1999.00926.x; Jupelli M, 2008, J IMMUNOL, V180, P4148, DOI 10.4049/jimmunol.180.6.4148; Karande P, 2009, J CONTROL RELEASE; KUO CC, 1993, J INFECT DIS, V167, P841, DOI 10.1093/infdis/167.4.841; Kushwaha A, 2001, PARASITE IMMUNOL, V23, P435, DOI 10.1046/j.1365-3024.2001.00390.x; Lawrence CW, 2004, J IMMUNOL, V173, P1209, DOI 10.4049/jimmunol.173.2.1209; Lezzi G, 1998, IMMUNITY, V8, P89, DOI 10.1016/S1074-7613(00)80461-6; Lu CX, 2012, VACCINE, V30, P475, DOI 10.1016/j.vaccine.2011.10.059; Lu H, 1999, INFECT IMMUN, V67, P1763; Lund FE, 2002, J IMMUNOL, V169, P5236, DOI 10.4049/jimmunol.169.9.5236; Mascarell L, 2009, CLIN EXP ALLERGY, V39, P1910, DOI 10.1111/j.1365-2222.2009.03337.x; Mattsson J, 2011, J IMMUNOL, V187, P3641, DOI 10.4049/jimmunol.1101107; McNeal MM, 2007, VACCINE, V25, P6224, DOI 10.1016/j.vaccine.2007.05.065; Miyairi I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033781; Moore T, 2002, IMMUNOLOGY, V105, P213, DOI 10.1046/j.0019-2805.2001.01354.x; Murthy AK, 2004, CELL IMMUNOL, V230, P56, DOI 10.1016/j.cellimm.2004.09.002; Mutsch M, 2004, NEW ENGL J MED, V350, P896, DOI 10.1056/NEJMoa030595; O'Garra A, 1998, IMMUNITY, V8, P275, DOI 10.1016/S1074-7613(00)80533-6; Pal S, 2008, INFECT IMMUN, V76, P5581, DOI 10.1128/IAI.00574-08; Penttila JM, 1998, INFECT IMMUN, V66, P5113; Perry LL, 1999, J IMMUNOL, V162, P3541; Robinson CM, 2003, J INTERF CYTOK RES, V23, P413, DOI 10.1089/107999003322277829; Sanchez J, 2011, INDIAN J MED RES, V133, P153; Simmons M, 2001, AM J TROP MED HYG, V65, P159, DOI 10.4269/ajtmh.2001.65.159; Simmons M, 2001, AM J TROP MED HYG, V65, P420, DOI 10.4269/ajtmh.2001.65.420; Skelding KA, 2006, VACCINE, V24, P355, DOI 10.1016/j.vaccine.2005.07.104; Steinman RM, 2006, CURR TOP MICROBIOL, V311, P17; Su H, 1996, P NATL ACAD SCI USA, V93, P11143, DOI 10.1073/pnas.93.20.11143; SUMMERSGILL JT, 1995, INFECT IMMUN, V63, P2801, DOI 10.1128/IAI.63.7.2801-2803.1995; Sun GF, 2009, VACCINE, V27, P5020, DOI 10.1016/j.vaccine.2009.05.008; Sundling C, 2008, J GEN VIROL, V89, P2954, DOI 10.1099/vir.0.2008/005470-0; Villegas E, 2010, J MED MICROBIOL, V59, P1267, DOI 10.1099/jmm.0.020362-0; Visweswaraiah A, 2002, VACCINE, V20, P3209, DOI 10.1016/S0264-410X(02)00247-5; Wagner H, 2004, TRENDS IMMUNOL, V25, P381, DOI 10.1016/j.it.2004.04.011; Williams DM, 1997, INFECT IMMUN, V65, P2876, DOI 10.1128/IAI.65.7.2876-2882.1997; Yang X, 1999, J IMMUNOL, V162, P1010; Yang X, 1996, J IMMUNOL, V156, P4338; Yang X, 1998, J IMMUNOL, V161, P1439; Yu H, 2010, INFECT IMMUN, V78, P2272, DOI 10.1128/IAI.01374-09; Yuzawa S, 2012, FEMS IMMUNOL MED MIC; Zhao XY, 2003, J EXP MED, V197, P153, DOI 10.1084/jem.20021109; Zygmunt BM, 2009, J IMMUNOL, V183, P6933, DOI 10.4049/jimmunol.0901144	75	26	28	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2013	8	4							e61962	10.1371/journal.pone.0061962	http://dx.doi.org/10.1371/journal.pone.0061962			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130DR	23613984	Green Published, gold, Green Submitted			2022-12-25	WOS:000317893400133
J	Rompala, GR; Zsiros, V; Zhang, S; Kolata, SM; Nakazawa, K				Rompala, Gregory R.; Zsiros, Veronika; Zhang, Shuqin; Kolata, Stefan M.; Nakazawa, Kazu			Contribution of NMDA Receptor Hypofunction in Prefrontal and Cortical Excitatory Neurons to Schizophrenia-Like Phenotypes	PLOS ONE			English	Article							PREPULSE INHIBITION; WORKING-MEMORY; SPATIAL WORKING; CORTEX; STARTLE; KETAMINE; DEFICITS; HIPPOCAMPUS; ANTAGONIST; IMPAIRMENT	Pharmacological and genetic studies support a role for NMDA receptor (NMDAR) hypofunction in the etiology of schizophrenia. We have previously demonstrated that NMDAR obligatory subunit 1 (GluN1) deletion in corticolimbic interneurons during early postnatal development is sufficient to confer schizophrenia-like phenotypes in mice. However, the consequence of NMDAR hypofunction in cortical excitatory neurons is not well delineated. Here, we characterize a conditional knockout mouse strain (CtxGluN1 KO mice), in which postnatal GluN1 deletion is largely confined to the excitatory neurons in layer II/III of the medial prefrontal cortex and sensory cortices, as evidenced by the lack of GluN1 mRNA expression in in situ hybridization immunocytochemistry as well as the lack of NMDA currents with in vitro recordings. Mutants were impaired in prepulse inhibition of the auditory startle reflex as well as object-based short-term memory. However, they did not exhibit impairments in additional hallmarks of schizophrenia-like phenotypes (e g. spatial working memory, social behavior, saccharine preference, novelty and amphetamine-induced hyperlocomotion, and anxiety-related behavior). Furthermore, upon administration of the NMDA receptor antagonist, MK-801, there were no differences in locomotor activity versus controls. The mutant mice also showed negligible levels of reactive oxygen species production following chronic social isolation, and recording of miniature-EPSC/IPSCs from layer II/III excitatory neurons in medial prefrontal cortex suggested no alteration in GABAergic activity. All together, the mutant mice displayed cognitive deficits in the absence of additional behavioral or cellular phenotypes reflecting schizophrenia pathophysiology. Thus, NMDAR hypofunction in prefrontal and cortical excitatory neurons may recapitulate only a cognitive aspect of human schizophrenia symptoms.	[Rompala, Gregory R.; Zsiros, Veronika; Zhang, Shuqin; Kolata, Stefan M.; Nakazawa, Kazu] NIMH, Unit Genet Cognit & Behav, NIH, Dept Hlth & Human Serv, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Nakazawa, K (corresponding author), NIMH, Unit Genet Cognit & Behav, NIH, Dept Hlth & Human Serv, Bethesda, MD 20892 USA.	nakazawk@mail.nih.gov	Nakazawa, Kazutoshi/J-6195-2015	Nakazawa, Kazutoshi/0000-0001-5699-9093	Intramural Research Program of NIMH, National Institutes of Health; NATIONAL INSTITUTE OF MENTAL HEALTH [K22MH099164, ZIAMH002895] Funding Source: NIH RePORTER	Intramural Research Program of NIMH, National Institutes of Health; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported by the Intramural Research Program of NIMH, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbarian S, 2006, BRAIN RES REV, V52, P293, DOI 10.1016/j.brainresrev.2006.04.001; Alkam T, 2011, BEHAV BRAIN RES, V220, P185, DOI 10.1016/j.bbr.2011.01.039; Amitai N, 2010, BIOL PSYCHIAT, V68, P5, DOI 10.1016/j.biopsych.2010.03.004; Bakshi VP, 1999, J PHARMACOL EXP THER, V288, P643; Bannerman DM, 2006, PSYCHOPHARMACOLOGY, V188, P552, DOI 10.1007/s00213-006-0403-6; Behrens MM, 2007, SCIENCE, V318, P1645, DOI 10.1126/science.1148045; Belforte JE, 2010, NAT NEUROSCI, V13, P76, DOI 10.1038/nn.2447; Berretta N, 1996, J NEUROPHYSIOL, V76, P1089, DOI 10.1152/jn.1996.76.2.1089; Bickel S, 2008, NEUROPSYCHOPHARMACOL, V33, P1680, DOI 10.1038/sj.npp.1301536; Bigelow NO, 2006, SCHIZOPHR RES, V83, P257, DOI 10.1016/j.schres.2005.12.856; BRAFF DL, 1990, ARCH GEN PSYCHIAT, V47, P181; Carlen M, 2012, MOL PSYCHIATR, V17, P537, DOI 10.1038/mp.2011.31; COYLE JT, 1993, SCIENCE, V262, P689, DOI 10.1126/science.7901908; Cravens CJ, 2006, EUR J NEUROSCI, V24, P1771, DOI 10.1111/j.1460-9568.2006.05044.x; Deacon RMJ, 2003, BEHAV BRAIN RES, V139, P139, DOI 10.1016/S0166-4328(02)00225-5; Dillon GM, 2008, NEUROBIOL LEARN MEM, V90, P426, DOI 10.1016/j.nlm.2008.05.008; Do KQ, 2009, CURR OPIN NEUROBIOL, V19, P220, DOI 10.1016/j.conb.2009.05.001; Duncan GE, 2004, BEHAV BRAIN RES, V153, P507, DOI 10.1016/j.bbr.2004.01.008; Elvevag B, 2000, CRIT REV NEUROBIOL, V14, P1; Eyles DW, 2002, SCHIZOPHR RES, V57, P27, DOI 10.1016/S0920-9964(01)00299-7; Fendt M, 2001, PSYCHOPHARMACOLOGY, V156, P216, DOI 10.1007/s002130100794; Filion DL, 2003, BIOL PSYCHOL, V64, P283, DOI 10.1016/S0301-0511(03)00077-2; Fradley RL, 2005, BEHAV BRAIN RES, V163, P257, DOI 10.1016/j.bbr.2005.05.012; Fukaya M, 2003, P NATL ACAD SCI USA, V100, P4855, DOI 10.1073/PNAS.0830996100; Gil V, 2010, CEREB CORTEX, V20, P1769, DOI 10.1093/cercor/bhp246; Gisquet-Verrier P, 2006, NEUROSCIENCE, V141, P585, DOI 10.1016/j.neuroscience.2006.04.009; Glausier JR, 2012, NEUROSCIENCE; Hauser TA, 2009, BIOCHEM PHARMACOL, V78, P803, DOI 10.1016/j.bcp.2009.05.030; Heekeren K, 2004, NEUROPSYCHOBIOLOGY, V49, P88, DOI 10.1159/000076416; Iwasato T, 2000, NATURE, V406, P726, DOI 10.1038/35021059; Jackson ME, 2004, P NATL ACAD SCI USA, V101, P8467, DOI 10.1073/pnas.0308455101; JAVITT DC, 1991, AM J PSYCHIAT, V148, P1301; Jiang Z, 2013, BIOL PSYCHIAT; Jinde S, 2009, EUR J NEUROSCI, V30, P1036, DOI 10.1111/j.1460-9568.2009.06896.x; Karlsgodt KH, 2011, BIOL PSYCHIAT, V69, P28, DOI 10.1016/j.biopsych.2010.09.012; KRYSTAL JH, 1994, ARCH GEN PSYCHIAT, V51, P199, DOI 10.1001/archpsyc.1994.03950030035004; Lahti AC, 2001, NEUROPSYCHOPHARMACOL, V25, P455, DOI 10.1016/S0893-133X(01)00243-3; Laurent A, 1999, PSYCHIAT RES, V89, P147, DOI 10.1016/S0165-1781(99)00109-2; Lee S, 2012, NAT NEUROSCI, V15, P308, DOI 10.1038/nn.2999; Lewis DA, 2005, NAT REV NEUROSCI, V6, P312, DOI 10.1038/nrn1648; Lewis DA, 2004, PSYCHOPHARMACOLOGY, V174, P143, DOI 10.1007/s00213-003-1673-x; Li L, 2002, HEARING RES, V168, P98, DOI 10.1016/S0378-5955(02)00356-8; Li L, 2009, NEUROSCI BIOBEHAV R, V33, P1157, DOI 10.1016/j.neubiorev.2009.02.001; Lisman JE, 1998, NAT NEUROSCI, V1, P273, DOI 10.1038/1086; MacQueen DA, 2011, NEUROBIOL LEARN MEM, V95, P57, DOI 10.1016/j.nlm.2010.11.004; Malkesman O, 2010, BIOL PSYCHIAT, V67, P864, DOI 10.1016/j.biopsych.2009.10.018; Matus-Amat P, 2007, BEHAV NEUROSCI, V121, P721, DOI 10.1037/0735-7044.121.4.721; MCDOWD JM, 1993, SCHIZOPHRENIA BULL, V19, P733, DOI 10.1093/schbul/19.4.733; Mirjana C, 2004, NEUROPSYCHOPHARMACOL, V29, P1637, DOI 10.1038/sj.npp.1300479; Moghaddam B, 1997, J NEUROSCI, V17, P2921; Mohn AR, 1999, CELL, V98, P427, DOI 10.1016/S0092-8674(00)81972-8; Murphy ER, 2005, PSYCHOPHARMACOLOGY, V179, P99, DOI 10.1007/s00213-004-2068-3; Murray AJ, 2011, NAT NEUROSCI, V14, P297, DOI 10.1038/nn.2751; Nakazawa K, 2012, NEUROPHARMACOLOGY, V62, P1574, DOI 10.1016/j.neuropharm.2011.01.022; Niewoehner B, 2007, EUR J NEUROSCI, V25, P837, DOI 10.1111/j.1460-9568.2007.05312.x; OLNEY JW, 1995, ARCH GEN PSYCHIAT, V52, P998; Plappert CF, 2006, BEHAV NEUROSCI, V120, P16, DOI 10.1037/0735-7044.120.1.16; Rebsam A, 2002, J NEUROSCI, V22, P8541; Roskam S, 2006, INT J PSYCHOPHYSIOL, V60, P10, DOI 10.1016/j.ijpsycho.2005.04.004; Sarnyai Z, 2000, P NATL ACAD SCI USA, V97, P14731, DOI 10.1073/pnas.97.26.14731; Sawtell NB, 2003, NEURON, V38, P977, DOI 10.1016/S0896-6273(03)00323-4; Steele RJ, 1999, HIPPOCAMPUS, V9, P118, DOI 10.1002/(SICI)1098-1063(1999)9:2<118::AID-HIPO4>3.0.CO;2-8; Tsien JZ, 1996, CELL, V87, P1327, DOI 10.1016/S0092-8674(00)81827-9; Ultanir SK, 2007, P NATL ACAD SCI USA, V104, P19553, DOI 10.1073/pnas.0704031104; van den Buuse M, 2010, SCHIZOPHRENIA BULL, V36, P246, DOI 10.1093/schbul/sbp132; Volk DW, 2010, CURR TOP BEHAV NEURO, V4, P485, DOI 10.1007/7854_2010_44; Wang J, 2001, CEREB CORTEX, V11, P452, DOI 10.1093/cercor/11.5.452; Weisstaub NV, 2006, SCIENCE, V313, P536, DOI 10.1126/science.1123432	68	36	36	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2013	8	4							e61278	10.1371/journal.pone.0061278	http://dx.doi.org/10.1371/journal.pone.0061278			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	130DR	23613827	Green Published, gold, Green Submitted			2022-12-25	WOS:000317893400054
J	Schaap, MWH; van Oostrom, H; Doornenbal, A; Baars, AM; Arndt, SS; Hellebrekers, LJ				Schaap, Manon W. H.; van Oostrom, Hugo; Doornenbal, Arie; Baars, Annemarie M.; Arndt, Saskia S.; Hellebrekers, Ludo J.			Predictability of Painful Stimulation Modulates the Somatosensory-Evoked Potential in the Rat	PLOS ONE			English	Article							CORTICAL RESPONSES; NOXIOUS STIMULI; CORTEX; ANXIETY; UNPLEASANTNESS; PERCEPTION; ATTENTION; MODELS; SYSTEM; FEAR	Somatosensory-evoked potentials (SEPs) are used in humans and animals to increase knowledge about nociception and pain. Since the SEP in humans increases when noxious stimuli are administered unpredictably, predictability potentially influences the SEP in animals as well. To assess the effect of predictability on the SEP in animals, classical fear conditioning was applied to compare SEPs between rats receiving SEP-evoking electrical stimuli either predictably or unpredictably. As in humans, the rat's SEP increased when SEP-evoking stimuli were administered unpredictably. These data support the hypothesis that the predictability of noxious stimuli plays a distinctive role in the processing of these stimuli in animals. The influence of predictability should be considered when studying nociception and pain in animals. Additionally, this finding suggests that animals confronted with (un) predictable noxious stimuli can be used to investigate the mechanisms underlying the influence of predictability on central processing of noxious stimuli.	[Schaap, Manon W. H.; van Oostrom, Hugo; Doornenbal, Arie; Hellebrekers, Ludo J.] Univ Utrecht, Fac Vet Med, Dept Clin Sci Compan Anim, Utrecht, Netherlands; [Schaap, Manon W. H.; van Oostrom, Hugo; Arndt, Saskia S.; Hellebrekers, Ludo J.] Rudolf Magnus Inst Neurosci, NL-3508 TA Utrecht, Netherlands; [Baars, Annemarie M.; Arndt, Saskia S.] Univ Utrecht, Fac Vet Med, Dept Anim Sci & Soc, Utrecht, Netherlands	Utrecht University; Utrecht University; Utrecht University Medical Center; Utrecht University	Schaap, MWH (corresponding author), Univ Utrecht, Fac Vet Med, Dept Clin Sci Compan Anim, Utrecht, Netherlands.	m.schaap@uu.nl		Peeters-Schaap, Manon/0000-0001-6147-1226	Utrecht University	Utrecht University	This work was supported by Utrecht University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARENDTNIELSEN L, 1988, J NEUROSCI METH, V24, P117, DOI 10.1016/0165-0270(88)90054-4; Banoub M, 2003, ANESTHESIOLOGY, V99, P716, DOI 10.1097/00000542-200309000-00029; Bromm B, 1998, ELECTROEN CLIN NEURO, V107, P227, DOI 10.1016/S0013-4694(98)00075-3; Carlsson K, 2006, NEUROIMAGE, V32, P1804, DOI 10.1016/j.neuroimage.2006.05.027; FIELD A., 2009, DESCOBRINDO ESTATIST, V2; Grillon C, 2008, PSYCHOPHARMACOLOGY, V199, P421, DOI 10.1007/s00213-007-1019-1; Handy TC, 2005, EVENT RELATED POTENT; Iannetti GD, 2008, J NEUROPHYSIOL, V100, P815, DOI 10.1152/jn.00097.2008; Kakigi R, 2000, J CLIN NEUROPHYSIOL, V17, P295, DOI 10.1097/00004691-200005000-00007; Kalliomaki J, 1998, PAIN, V77, P323, DOI 10.1016/S0304-3959(98)00115-8; Kenntner-Mabiala R, 2008, BIOL PSYCHOL, V78, P114, DOI 10.1016/j.biopsycho.2008.01.007; KOLPAKOV VG, 1977, BEHAVIOUR, V62, P190, DOI 10.1163/156853977X00108; Legrain V, 2012, NEUROPHYSIOL CLIN, V42, P325, DOI 10.1016/j.neucli.2012.06.003; Legrain V, 2011, PROG NEUROBIOL, V93, P111, DOI 10.1016/j.pneurobio.2010.10.005; MINEKA S, 1978, J ABNORM PSYCHOL, V87, P256, DOI 10.1037/0021-843X.87.2.256; Mogil JS, 2010, PAIN, V151, P12, DOI 10.1016/j.pain.2010.07.015; Mogil JS, 2009, NAT REV NEUROSCI, V10, P283, DOI 10.1038/nrn2606; Moseley GL, 2003, AUST J PHYSIOTHER, V49, P263, DOI 10.1016/S0004-9514(14)60142-2; Murrell JC, 2006, J VET PHARMACOL THER, V29, P325, DOI 10.1111/j.1365-2885.2006.00758.x; Ohara S, 2004, PAIN, V110, P318, DOI 10.1016/j.pain.2004.04.009; Oka S, 2010, J PAIN, V11, P239, DOI 10.1016/j.jpain.2009.07.009; OVERMIER JB, 1983, LEARN MOTIV, V14, P324, DOI 10.1016/0023-9690(83)90020-6; Paxinos G., 2005, RAT BRAIN STEREOTAXI, V5th Edn, DOI 10.1016/c2009-0-63235-9; RESCORLA RA, 1988, AM PSYCHOL, V43, P151, DOI 10.1037/0003-066X.43.3.151; Rhudy JL, 2000, PAIN, V84, P65, DOI 10.1016/S0304-3959(99)00183-9; Schaap MWH, 2011, ILAR J, V52, P32; SELIGMAN ME, 1968, J COMP PHYSIOL PSYCH, V66, P402, DOI 10.1037/h0026355; Silbert SC, 2003, J NEUROSCI, V23, P34; Stienen PJ, 2006, BRAIN RES BULL, V70, P203, DOI 10.1016/j.brainresbull.2006.06.003; Stienen PJ, 2004, BRAIN RES, V1030, P256, DOI 10.1016/j.brainres.2004.10.014; Truini A, 2007, PAIN, V131, P341, DOI 10.1016/j.pain.2007.06.023; Truini A, 2004, EXP BRAIN RES, V155, P120, DOI 10.1007/s00221-003-1785-x; Valentini E, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00143; van Oostrom H, 2005, BRAIN RES PROTOC, V15, P14, DOI 10.1016/j.brainresprot.2005.02.001; van Oostrom H, 2007, BRAIN RES BULL, V71, P404, DOI 10.1016/j.brainresbull.2006.10.009; van Oostrom H, 2011, VET J, V190, P338, DOI 10.1016/j.tvjl.2010.11.025; Villemure C, 2002, PAIN, V95, P195, DOI 10.1016/S0304-3959(02)00007-6; Wang AL, 2010, J NEUROPHYSIOL, V104, P2116, DOI 10.1152/jn.01088.2009; Wang JY, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-34; Warbrick T, 2006, PSYCHOPHYSIOLOGY, V43, P481, DOI 10.1111/j.1469-8986.2006.00425.x	40	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2013	8	4							e61487	10.1371/journal.pone.0061487	http://dx.doi.org/10.1371/journal.pone.0061487			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	130DR	23613862	gold, Green Published, Green Submitted			2022-12-25	WOS:000317893400069
J	Gaia, M; Pagnier, I; Campocasso, A; Fournous, G; Raoult, D; La Scola, B				Gaia, Morgan; Pagnier, Isabelle; Campocasso, Angelique; Fournous, Ghislain; Raoult, Didier; La Scola, Bernard			Broad Spectrum of Mimiviridae Virophage Allows Its Isolation Using a Mimivirus Reporter	PLOS ONE			English	Article							GIANT; AMEBAS; VIRUS	The giant virus Mimiviridae family includes 3 groups of viruses: group A (includes Acanthamoeba polyphaga Mimivirus), group B (includes Moumouvirus) and group C (includes Megavirus chilensis). Virophages have been isolated with both group A Mimiviridae (the Mamavirus strain) and the related Cafeteria roenbergensis virus, and they have also been described by bioinformatic analysis of the Phycodnavirus. Here, we found that the first two strains of virophages isolated with group A Mimiviridae can multiply easily in groups B and C and play a role in gene transfer among these virus subgroups. To isolate new virophages and their Mimiviridae host in the environment, we used PCR to identify a sample with a virophage and a group C Mimiviridae that failed to grow on amoeba. Moreover, we showed that virophages reduce the pathogenic effect of Mimivirus (plaque formation), establishing its parasitic role on Mimivirus. We therefore developed a co-culture procedure using Acanthamoeba polyphaga and Mimivirus to recover the detected virophage and then sequenced the virophage's genome. We present this technique as a novel approach to isolating virophages. We demonstrated that the newly identified virophages replicate in the viral factories of all three groups of Mimiviridae, suggesting that the spectrum of virophages is not limited to their initial host.	[Gaia, Morgan; Pagnier, Isabelle; Campocasso, Angelique; Fournous, Ghislain; Raoult, Didier; La Scola, Bernard] Aix Marseille Univ, URMITE, Inserm 1095, UM63,CNRS 7278,IRD 198, Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD)	La Scola, B (corresponding author), Aix Marseille Univ, URMITE, Inserm 1095, UM63,CNRS 7278,IRD 198, Marseille, France.	bernard.la-scola@univ-amu.fr	LA SCOLA, Bernard/P-6477-2016; RAOULT, Didier/A-8434-2008	LA SCOLA, Bernard/0000-0001-8006-7704; RAOULT, Didier/0000-0002-0633-5974; Pagnier, Isabelle/0000-0002-1724-3450				Arslan D, 2011, P NATL ACAD SCI USA, V108, P17486, DOI 10.1073/pnas.1110889108; Boyer M, 2011, P NATL ACAD SCI USA, V108, P10296, DOI 10.1073/pnas.1101118108; Desnues C, 2010, INTERVIROLOGY, V53, P293, DOI 10.1159/000312914; Desnues C, 2012, NAT REV MICROBIOL, V10, P234, DOI 10.1038/nrmicro2676-c3; Fischer MG, 2012, NAT REV MICROBIOL, V10, P78, DOI 10.1038/nrmicro2676-c1; Fischer MG, 2011, SCIENCE, V332, P231, DOI 10.1126/science.1199412; Iyer LA, 2006, VIRUS RES, V117, P156, DOI 10.1016/j.virusres.2006.01.009; Krupovic M, 2012, NAT REV MICROBIOL, V10, P78, DOI 10.1038/nrmicro2676-c2; La Scola B, 2003, SCIENCE, V299, P2033; La Scola B, 2008, NATURE, V455, P100, DOI 10.1038/nature07218; La Scola B, 2010, INTERVIROLOGY, V53, P344, DOI 10.1159/000312919; Pagnier I, 2008, ENVIRON MICROBIOL, V10, P1135, DOI 10.1111/j.1462-2920.2007.01530.x; Raoult D, 2004, SCIENCE, V306, P1344, DOI 10.1126/science.1101485; Raoult D, 2010, INTERVIROLOGY, V53, P321, DOI 10.1159/000312917; ROWBOTHAM TJ, 1983, J CLIN PATHOL, V36, P978, DOI 10.1136/jcp.36.9.978; Suzan-Monti M, 2006, VIRUS RES, V117, P145, DOI 10.1016/j.virusres.2005.07.011; Xiao CA, 2005, J MOL BIOL, V353, P493, DOI 10.1016/j.jmb.2005.08.060; Yau S, 2011, P NATL ACAD SCI USA, V108, P6163, DOI 10.1073/pnas.1018221108; Zhang XZ, 2012, P NATL ACAD SCI USA, V109, P18431, DOI 10.1073/pnas.1211702109	19	45	49	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2013	8	4							e61912	10.1371/journal.pone.0061912	http://dx.doi.org/10.1371/journal.pone.0061912			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125TD	23596530	Green Published, gold			2022-12-25	WOS:000317563300043
J	Hanberry, BB; Palik, BJ; He, HS				Hanberry, Brice B.; Palik, Brian J.; He, Hong S.			Winning and Losing Tree Species of Reassembly in Minnesota's Mixed and Broadleaf Forests	PLOS ONE			English	Article							WHITE-TAILED DEER; UNDERSTOREY VEGETATION; DYNAMICS; REGENERATION; FIRE; HOMOGENIZATION; COMMUNITIES; ECOSYSTEMS; SUCCESSION; MANAGEMENT	We examined reassembly of winning and losing tree species, species traits including shade and fire tolerance, and associated disturbance filters and forest ecosystem types due to rapid forest change in the Great Lakes region since 1850. We identified winning and losing species by changes in composition, distribution, and site factors between historical and current surveys in Minnesota's mixed and broadleaf forests. In the Laurentian Mixed Forest, shade-intolerant aspen replaced shade-intolerant tamarack as the most dominant tree species. Fire-tolerant white pine and jack pine decreased, whereas shade-tolerant ashes, maples, and white cedar increased. In the Eastern Broadleaf Forest, fire-tolerant white oaks and red oaks decreased, while shade-tolerant ashes, American basswood, and maples increased. Tamarack, pines, and oaks have become restricted to sites with either wetter or sandier and drier soils due to increases in aspen and shade-tolerant, fire-sensitive species on mesic sites. The proportion of shade-tolerant species increased in both regions, but selective harvest reduced the applicability of functional groups alone to specify winners and losers. Harvest and existing forestry practices supported aspen dominance in mixed forests, although without aspen forestry and with fire suppression, mixed forests will transition to a greater composition of shade-tolerant species, converging to forests similar to broadleaf forests. A functional group framework provided a perspective of winning and losing species and traits, selective filters, and forest ecosystems that can be generalized to other regions, regardless of species identity.	[Hanberry, Brice B.; He, Hong S.] Univ Missouri, Dept Forestry, Columbia, MO 65211 USA; [Palik, Brian J.] US Forest Serv, USDA, No Res Stn, Grand Rapids, MN USA	University of Missouri System; University of Missouri Columbia; United States Department of Agriculture (USDA); United States Forest Service	Hanberry, BB (corresponding author), Univ Missouri, Dept Forestry, Columbia, MO 65211 USA.	hanberryb@missouri.edu		Palik, Brian/0000-0003-0300-9644; Hanberry, Brice/0000-0001-8657-9540; He, Hong S./0000-0002-3983-2512	National Fire Plan, USDA Forest Service	National Fire Plan, USDA Forest Service	Funding from the National Fire Plan, USDA Forest Service. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Augustine DJ, 1998, J WILDLIFE MANAGE, V62, P1165, DOI 10.2307/3801981; BEERS TW, 1966, J FOREST, V64, P691; Bergeron Y, 2000, ECOLOGY, V81, P1500, DOI 10.1890/0012-9658(2000)081[1500:SASDIT]2.0.CO;2; Bergeron Yves, 2002, Dendrochronologia, V20, P175, DOI 10.1078/1125-7865-00015; Bond WJ, 2005, NEW PHYTOL, V165, P525, DOI 10.1111/j.1469-8137.2004.01252.x; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Briske DD, 2003, J APPL ECOL, V40, P601, DOI 10.1046/j.1365-2664.2003.00837.x; Chapin FS, 1996, J VEG SCI, V7, P347, DOI 10.2307/3236278; Clark JS, 1997, J ECOL, V85, P377, DOI 10.2307/2960510; Cleland David T., 1997, P181; Cote SD, 2004, ANNU REV ECOL EVOL S, V35, P113, DOI 10.1146/annurev.ecolsys.35.021103.105725; COTTAM G, 1949, ECOLOGY, V30, P271, DOI 10.2307/1932609; CROW TR, 1988, FOREST SCI, V34, P19; Cutler DR, 2007, ECOLOGY, V88, P2783, DOI 10.1890/07-0539.1; Fei SL, 2007, FOREST SCI, V53, P473; Fei SL, 2011, FOREST ECOL MANAG, V262, P1370, DOI 10.1016/j.foreco.2011.06.030; Fei SL, 2009, CAN J FOREST RES, V39, P1444, DOI 10.1139/X09-065; Fralish JS, 2009, AM MIDL NAT, V162, P418, DOI 10.1674/0003-0031-162.2.418; Friedman SK, 2005, ECOL APPL, V15, P726, DOI 10.1890/04-0748; Friedman SK, 2001, J ECOL, V89, P538, DOI 10.1046/j.1365-2745.2001.00578.x; Fule PZ, 2009, FOREST ECOL MANAG, V258, P1200, DOI 10.1016/j.foreco.2009.06.015; Girardin MP, 2002, CAN J FOREST RES, V32, P206, DOI [10.1139/x01-185, 10.1139/X01-185]; Grime JP, 1998, J ECOL, V86, P902, DOI 10.1046/j.1365-2745.1998.00306.x; Hanberry BB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041337; Hedl R, 2010, DIVERS DISTRIB, V16, P267, DOI 10.1111/j.1472-4642.2010.00637.x; Hutchinson TF, 2008, CAN J FOREST RES, V38, P1184, DOI 10.1139/X07-216; Jackson SM, 2000, CAN J FOREST RES, V30, P605, DOI 10.1139/x99-242; Kuiters AT, 2002, BIOL CONSERV, V105, P65, DOI 10.1016/S0006-3207(01)00204-X; Leadbitter P, 2002, FOREST CHRON, V78, P522, DOI 10.5558/tfc78522-4; LORIMER CG, 1994, J ECOL, V82, P227, DOI 10.2307/2261291; McKinney ML, 1999, TRENDS ECOL EVOL, V14, P450, DOI 10.1016/S0169-5347(99)01679-1; MLADENOFF DJ, 1993, CONSERV BIOL, V7, P889, DOI 10.1046/j.1523-1739.1993.740889.x; Myking T, 2011, FORESTRY, V84, P61, DOI 10.1093/forestry/cpq044; Niinemets U, 2006, ECOL MONOGR, V76, P521, DOI 10.1890/0012-9615(2006)076[0521:TTSDAW]2.0.CO;2; Niklasson M, 2002, J VEG SCI, V13, P765, DOI 10.1111/j.1654-1103.2002.tb02106.x; Nowacki GJ, 2008, BIOSCIENCE, V58, P123, DOI 10.1641/B580207; Odion DC, 2010, J ECOL, V98, P96, DOI 10.1111/j.1365-2745.2009.01597.x; Palmer SCF, 2004, FOREST ECOL MANAG, V192, P251, DOI 10.1016/j.foreco.2004.01.038; Pinto F, 2008, CAN J FOREST RES, V38, P1842, DOI 10.1139/X08-034; Povak NA, 2008, CAN J FOREST RES, V38, P2880, DOI 10.1139/X08-118; R Core Team, 2021, R LANG ENV STAT COMP; Rooney TP, 2003, FOREST ECOL MANAG, V181, P165, DOI 10.1016/S0378-1127(03)00130-0; Rossell CR, 2005, FOREST ECOL MANAG, V210, P415, DOI 10.1016/j.foreco.2005.02.035; Russell FL, 2001, AM MIDL NAT, V146, P1, DOI 10.1674/0003-0031(2001)146[0001:EOWTDO]2.0.CO;2; Sappington JM, 2007, J WILDLIFE MANAGE, V71, P1419, DOI 10.2193/2005-723; Schulte LA, 2007, LANDSCAPE ECOL, V22, P1089, DOI 10.1007/s10980-007-9095-5; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Strandberg B, 2005, FOREST ECOL MANAG, V211, P318, DOI 10.1016/j.foreco.2005.02.051; Svenning JC, 2002, BIOL CONSERV, V104, P133, DOI 10.1016/S0006-3207(01)00162-8; Tybirk K, 1999, FOREST ECOL MANAG, V114, P97, DOI 10.1016/S0378-1127(98)00384-3; Van Calster H, 2007, FOREST ECOL MANAG, V241, P258, DOI 10.1016/j.foreco.2007.01.007; von Oheimb G, 2007, ACTA OECOL, V31, P229, DOI 10.1016/j.actao.2006.12.001; White C.A., 1983, HIST RECTANGULAR SUR	53	20	20	2	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2013	8	4							e61709	10.1371/journal.pone.0061709	http://dx.doi.org/10.1371/journal.pone.0061709			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125TD	23613911	gold, Green Published, Green Submitted			2022-12-25	WOS:000317563300034
J	Suzuki, T; Ukai, A; Honma, M; Adachi, N; Nohmi, T				Suzuki, Tetsuya; Ukai, Akiko; Honma, Masamitsu; Adachi, Noritaka; Nohmi, Takehiko			Restoration of Mismatch Repair Functions in Human Cell Line Nalm-6, Which Has High Efficiency for Gene Targeting	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; HOMOLOGOUS RECOMBINATION; DNA-DAMAGE; IN-VITRO; CATALYTIC SUBUNIT; TUMOR-CELLS; HUMAN REV7; RECOGNITION; MECHANISMS; PROFICIENT	Gene targeting is a powerful approach in reverse genetics. The approach has been hampered in most of human cell lines, however, by the poor targeting efficiency. Nalm-6, a human pre-B acute lymphoblastic leukemia cell line, exhibits exceptionally high gene targeting efficiency and is used in DNA repair and the related research fields. Nonetheless, usage of the cell line is still limited partly because it lacks expression of MSH2, a component of mismatch repair complex, which leads to increased genome instability. Here, we report successful restoration of MSH2 expression in Nalm-6 cells and demonstrate that the recovery does not affect the high targeting efficiency. We recovered the expression by introduction of cDNA sequences corresponding to exons 9 to 16 at downstream of exon 8 of the MSH2 gene. Endogenous exons 9 to 16 were deleted in the cell line. The MSH2 expression substantially reduced spontaneous HPRT mutation frequency. Moreover, gene targeting efficiency in the MSH2-expressing cells was similar to that in the MSH2-lacking cells. In fact, we generated heterozygously REV3L knockout and the catalytically dead mutants in the MSH2-proficient Nalm-6 cells with efficiency of 20-30%. The established cell line, Nalm-6-MSH+, is useful for reverse genetics in human cells.	[Suzuki, Tetsuya; Ukai, Akiko; Honma, Masamitsu; Nohmi, Takehiko] Natl Inst Hlth Sci, Div Genet & Mutagenesis, Setagaya Ku, Tokyo, Japan; [Nohmi, Takehiko] Natl Inst Hlth Sci, Biol Safety Res Ctr, Setagaya Ku, Tokyo, Japan; [Adachi, Noritaka] Yokohama City Univ, Grad Sch Nanobiosci, Yokohama, Kanagawa 232, Japan	National Institute of Health Sciences - Japan; National Institute of Health Sciences - Japan; Yokohama City University	Nohmi, T (corresponding author), Natl Inst Hlth Sci, Div Genet & Mutagenesis, Setagaya Ku, Tokyo, Japan.	nohmi@nihs.go.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT) [18201010, 22241016]; Ministry of Health, Labour and Welfare, Japan (MHLW) [H21-Food-General-009]; Japan Health Science Foundation [KHB1007]	Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare, Japan (MHLW)(Ministry of Health, Labour and Welfare, Japan); Japan Health Science Foundation	This work was supported by grants-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT, 18201010; MEXT, 22241016), the Ministry of Health, Labour and Welfare, Japan (MHLW, H21-Food-General-009), the Japan Health Science Foundation (KHB1007); for cancer research from MHLW (20 designated-8) and the Food Safety Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi N, 2006, DNA CELL BIOL, V25, P19, DOI 10.1089/dna.2006.25.19; Adachi Noritaka, 2008, V435, P17, DOI 10.1007/978-1-59745-232-8_2; ALBERT H, 1995, PLANT J, V7, P649, DOI 10.1046/j.1365-313X.1995.7040649.x; Arakawa H, 2001, BMC Biotechnol, V1, P7, DOI 10.1186/1472-6750-1-7; Elliott B, 2001, MOL CELL BIOL, V21, P2671, DOI 10.1128/MCB.21.8.2671-2682.2001; FURTH EE, 1981, ANAL BIOCHEM, V110, P1, DOI 10.1016/0003-2697(81)90103-2; Gan GN, 2008, CELL RES, V18, P174, DOI 10.1038/cr.2007.117; Gibbs PEM, 1998, P NATL ACAD SCI USA, V95, P6876, DOI 10.1073/pnas.95.12.6876; Hanafusa T, 2010, GENES CELLS, V15, P281, DOI 10.1111/j.1365-2443.2009.01380.x; Holt SM, 2009, MUTAT RES-GEN TOX EN, V674, P123, DOI 10.1016/j.mrgentox.2008.09.014; Honma M, 2003, ENVIRON MOL MUTAGEN, V42, P288, DOI 10.1002/em.10201; Iiizumi S, 2006, BIOTECHNIQUES, V41, P311, DOI 10.2144/000112233; Klug A, 2010, ANNU REV BIOCHEM, V79, P213, DOI 10.1146/annurev-biochem-010909-095056; KOI M, 1994, CANCER RES, V54, P4308; Kurosawa A, 2008, DNA CELL BIOL, V27, P55, DOI 10.1089/dna.2007.0649; Lange SS, 2011, NAT REV CANCER, V11, P96, DOI 10.1038/nrc2998; Li GM, 2008, CELL RES, V18, P85, DOI 10.1038/cr.2007.115; Li JL, 2000, GENETICS, V156, P809; Lin WS, 1999, MUTAT RES-DNA REPAIR, V433, P89, DOI 10.1016/S0921-8777(98)00065-2; Lorge E, 2010, MUTAT RES-GEN TOX EN, V702, P199, DOI 10.1016/j.mrgentox.2010.03.002; Macpherson P, 2005, NUCLEIC ACIDS RES, V33, P5094, DOI 10.1093/nar/gki813; Marti TM, 2002, J CELL PHYSIOL, V191, P28, DOI 10.1002/jcp.10077; Matheson EC, 2003, CARCINOGENESIS, V24, P31, DOI 10.1093/carcin/24.1.31; Murakumo Y, 2000, J BIOL CHEM, V275, P4391, DOI 10.1074/jbc.275.6.4391; Nomura Y, 2007, GENES CELLS, V12, P1111, DOI 10.1111/j.1365-2443.2007.01124.x; O'Brien V, 2006, CARCINOGENESIS, V27, P682, DOI 10.1093/carcin/bgi298; Porteus MH, 2005, NAT BIOTECHNOL, V23, P967, DOI 10.1038/nbt1125; RIELE HT, 1992, P NATL ACAD SCI USA, V89, P5128, DOI 10.1073/pnas.89.11.5128; Shahar OD, 2012, ONCOGENE, V31, P3495, DOI 10.1038/onc.2011.516; So S, 2007, DNA CELL BIOL, V26, P517, DOI 10.1089/dna.2007.0578; Umar A, 1997, CANCER RES, V57, P3949; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842; Wang HX, 1999, J BIOL CHEM, V274, P16894, DOI 10.1074/jbc.274.24.16894; Yamada M, 1997, NUCLEIC ACIDS RES, V25, P491, DOI 10.1093/nar/25.3.491; Yamazoe M, 2004, DNA REPAIR, V3, P1175, DOI 10.1016/j.dnarep.2004.03.039; ZHANG LS, 1995, MUTAT RES LETT, V347, P105, DOI 10.1016/0165-7992(95)00027-5	36	10	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2013	8	4							e61189	10.1371/journal.pone.0061189	http://dx.doi.org/10.1371/journal.pone.0061189			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125TD	23596518	Green Submitted, Green Published, gold			2022-12-25	WOS:000317563300024
J	Langenfeld, E; Hong, CC; Lanke, G; Langenfeld, J				Langenfeld, Elaine; Hong, Charles C.; Lanke, Gandhi; Langenfeld, John			Bone Morphogenetic Protein Type I Receptor Antagonists Decrease Growth and Induce Cell Death of Lung Cancer Cell Lines	PLOS ONE			English	Article							BRONCHIAL EPITHELIAL-CELLS; OVARIAN-CANCER; TUMOR-GROWTH; CYCLE ARREST; EXPRESSION; ACTIVATION; CARCINOMA; APOPTOSIS; DIFFERENTIATION; BMP-2	Bone morphogenetic proteins (BMPs) are highly conserved morphogens that are essential for normal development. BMP-2 is highly expressed in the majority of non-small cell lung carcinomas (NSCLC) but not in normal lung tissue or benign lung tumors. The effects of the BMP signaling cascade on the growth and survival of cancer cells is poorly understood. We show that BMP signaling is basally active in lung cancer cell lines, which can be effectively inhibited with selective antagonists of the BMP type I receptors. Lung cancer cell lines express alk2, alk3, and alk6 and inhibition of a single BMP receptor was not sufficient to decrease signaling. Inhibition of more than one type I receptor was required to decrease BMP signaling in lung cancer cell lines. BMP receptor antagonists and silencing of BMP type I receptors with siRNA induced cell death, inhibited cell growth, and caused a significant decrease in the expression of inhibitor of differentiation (Id1, Id2, and Id3) family members, which are known to regulate cell growth and survival in many types of cancers. BMP receptor antagonists also decreased clonogenic cell growth. Knockdown of Id3 significantly decreased cell growth and induced cell death of lung cancer cells. H1299 cells stably overexpressing Id3 were resistant to growth suppression and induction of cell death induced by the BMP antagonist DMH2. These studies suggest that BMP signaling promotes cell growth and survival of lung cancer cells, which is mediated through its regulation of Id family members. Selective antagonists of the BMP type I receptors represents a potential means to pharmacologically treat NSCLC and other carcinomas with an activated BMP signaling cascade.	[Langenfeld, Elaine; Lanke, Gandhi; Langenfeld, John] UMDNJ Robert Wood Johnson Med Sch, Div Thorac Surg, Dept Surg, New Brunswick, NJ USA; [Langenfeld, Elaine; Lanke, Gandhi; Langenfeld, John] UMDNJ Robert Wood Johnson Med Sch, Dept Surg, New Brunswick, NJ USA; [Hong, Charles C.] Vanderbilt Univ, Sch Med, Vet Affairs TVHS, Nashville, TN 37212 USA; [Hong, Charles C.] Vanderbilt Univ, Sch Med, Div Cardiovasc Med, Nashville, TN 37212 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Vanderbilt University; Vanderbilt University	Langenfeld, J (corresponding author), UMDNJ Robert Wood Johnson Med Sch, Div Thorac Surg, Dept Surg, New Brunswick, NJ USA.	langenje@umdnj.edu	Lanke, Gandhi/T-5727-2019	Lanke, Gandhi/0000-0002-5577-2257	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL104040] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL104040] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Alani RM, 2001, P NATL ACAD SCI USA, V98, P7812, DOI 10.1073/pnas.141235398; Attisano L, 2002, SCIENCE, V296, P1646, DOI 10.1126/science.1071809; Beck SE, 2007, CELL SIGNAL, V19, P1465, DOI 10.1016/j.cellsig.2007.01.017; Chang H, 1999, DEVELOPMENT, V126, P1631; Chen SS, 2011, BLOOD, V117, P862, DOI 10.1182/blood-2010-05-284638; Gray MJ, 2008, ONCOGENE, V27, P7192, DOI 10.1038/onc.2008.356; Gupta GP, 2007, P NATL ACAD SCI USA, V104, P19506, DOI 10.1073/pnas.0709185104; Hao J, 2010, ACS CHEM BIOL, V5, P245, DOI 10.1021/cb9002865; Hao JJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002904; Izumi M, 2001, J BIOL CHEM, V276, P31133, DOI 10.1074/jbc.M101463200; KE Y, 1988, DIFFERENTIATION, V38, P60, DOI 10.1111/j.1432-0436.1988.tb00592.x; Kiesslich T, 2011, CURR PHARM BIOTECHNO, P24; Kishimoto Y, 1997, DEVELOPMENT, V124, P4457; Korchynskyi O, 2002, J BIOL CHEM, V277, P4883, DOI 10.1074/jbc.M111023200; Langenfeld EM, 2006, ONCOGENE, V25, P685, DOI 10.1038/sj.onc.1209110; Langenfeld EM, 2005, MOL CANCER RES, V3, P679, DOI 10.1158/1541-7786.MCR-05-0124; Langenfeld EM, 2005, ANN THORAC SURG, V80, P1028, DOI 10.1016/j.athoracsur.2005.03.094; Langenfeld EM, 2004, MOL CANCER RES, V2, P141; Langenfeld EM, 2003, CARCINOGENESIS, V24, P1445, DOI 10.1093/carcin/bgg100; Langenfeld EM, 2005, ONCOGENE; Lavery K, 2008, J BIOL CHEM, V283, P20948, DOI 10.1074/jbc.M800850200; Lawson KA, 1999, GENE DEV, V13, P424, DOI 10.1101/gad.13.4.424; Le Page C, 2009, J OVARIAN RES, V2, DOI 10.1186/1757-2215-2-4; Leite M, 1999, ANAL CELL PATHOL, V19, P139, DOI 10.1155/1999/176515; Li B, 2009, INT J CANCER, V125, P2576, DOI 10.1002/ijc.24675; Lin JZ, 2010, CLIN CANCER RES, V16, P77, DOI 10.1158/1078-0432.CCR-08-2362; Ling MT, 2006, DIFFERENTIATION, V74, P481, DOI 10.1111/j.1432-0436.2006.00083.x; Mern DS, 2010, BRIT J CANCER, V103, P1237, DOI 10.1038/sj.bjc.6605897; Mern DS, 2010, BREAST CANCER RES TR, V124, P623, DOI 10.1007/s10549-010-0810-6; Miyazaki H, 2004, ONCOGENE, V23, P9326, DOI 10.1038/sj.onc.1208127; Nickel J, 2009, CYTOKINE GROWTH F R, V20, P367, DOI 10.1016/j.cytogfr.2009.10.022; Noetzel E, 2008, Pathologe, V29 Suppl 2, P319, DOI 10.1007/s00292-008-1038-7; Nohe A, 2002, J BIOL CHEM, V277, P5330, DOI 10.1074/jbc.M102750200; Okada H, 2004, NAT REV CANCER, V4, P592, DOI 10.1038/nrc1412; Park Y, 2010, MED ONCOL, V27, P1192, DOI 10.1007/s12032-009-9358-x; Pizette S, 2001, DEVELOPMENT, V128, P4463; Ponz-Sarvise M, 2011, CLIN CANCER RES, V17, P4155, DOI 10.1158/1078-0432.CCR-10-3381; Raida M, 2005, J CANCER RES CLIN, V131, P741, DOI 10.1007/s00432-005-0024-1; Raida M, 2005, INT J ONCOL, V26, P1465; Ramirez RD, 2004, CANCER RES, V64, P9027, DOI 10.1158/0008-5472.CAN-04-3703; Rollin J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004158; Rosendahl A, 2002, AM J RESP CELL MOL, V27, P160, DOI 10.1165/ajrcmb.27.2.4779; Rothhammer T, 2007, ONCOGENE, V26, P4158, DOI 10.1038/sj.onc.1210182; Rothschild SI, LUNG, V71, P306; Shepherd TG, 2008, GENE, V414, P95, DOI 10.1016/j.gene.2008.02.015; Soda H, 1998, ANTI-CANCER DRUG, V9, P327, DOI 10.1097/00001813-199804000-00006; Sountoulidis A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041460; Sugimori K, 2005, J BONE MINER METAB, V23, P411, DOI 10.1007/s00774-005-0622-7; Swarbrick A, 2005, ONCOGENE, V24, P381, DOI 10.1038/sj.onc.1208188; Swarbrick A, 2008, P NATL ACAD SCI USA, V105, P5402, DOI 10.1073/pnas.0801505105; Tada A, 1998, ONCOL REP, V5, P1137; Umetani N, 2005, ONCOGENE, V24, P4721, DOI 10.1038/sj.onc.1208538; Yang X, 1999, DEVELOPMENT, V126, P1571; Ye L, FRONT, V16, P865; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Yu PB, 2008, NAT MED, V14, P1363, DOI 10.1038/nm.1888; Yuen HF, 2008, MODERN PATHOL, V21, P1436, DOI 10.1038/modpathol.2008.94; Yui PB, 2008, NAT CHEM BIOL, V4, P33, DOI 10.1038/nchembio.2007.54; Zhang JW, 2005, DEV BIOL, V284, P1, DOI 10.1016/j.ydbio.2005.05.009; Zou HY, 1997, GENE DEV, V11, P2191, DOI 10.1101/gad.11.17.2191	60	39	39	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2013	8	4							e61256	10.1371/journal.pone.0061256	http://dx.doi.org/10.1371/journal.pone.0061256			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123JP	23593444	Green Published, Green Submitted, gold			2022-12-25	WOS:000317385300067
J	Roberts, RA; Shen, T; Allen, IC; Hasan, W; DeSimone, JM; Ting, JPY				Roberts, Reid A.; Shen, Tammy; Allen, Irving C.; Hasan, Warefta; DeSimone, Joseph M.; Ting, Jenny P. Y.			Analysis of the Murine Immune Response to Pulmonary Delivery of Precisely Fabricated Nano- and Microscale Particles	PLOS ONE			English	Article							AMORPHOUS SILICA PARTICLES; NLRP3 INFLAMMASOME; DRUG-DELIVERY; NANOPARTICLES; ACTIVATION; CELLS; SIZE; RELEASE; NALP3; SHAPE	Nanomedicine has the potential to transform clinical care in the 21st century. However, a precise understanding of how nanomaterial design parameters such as size, shape and composition affect the mammalian immune system is a prerequisite for the realization of nanomedicine's translational promise. Herein, we make use of the recently developed Particle Replication in Non-wetting Template (PRINT) fabrication process to precisely fabricate particles across and the nano- and micro-scale with defined shapes and compositions to address the role of particle design parameters on the murine innate immune response in both in vitro and in vivo settings. We find that particles composed of either the biodegradable polymer poly(lactic-co-glycolic acid) (PLGA) or the biocompatible polymer polyethylene glycol (PEG) do not cause release of pro-inflammatory cytokines nor inflammasome activation in bone marrow-derived macrophages. When instilled into the lungs of mice, particle composition and size can augment the number and type of innate immune cells recruited to the lungs without triggering inflammatory responses as assayed by cytokine release and histopathology. Smaller particles (80x320 nm) are more readily taken up in vivo by monocytes and macrophages than larger particles (6 mu m diameter), yet particles of all tested sizes remained in the lungs for up to 7 days without clearance or triggering of host immunity. These results suggest rational design of nanoparticle physical parameters can be used for sustained and localized delivery of therapeutics to the lungs.	[Roberts, Reid A.; Ting, Jenny P. Y.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC USA; [Shen, Tammy; DeSimone, Joseph M.] Univ N Carolina, Eshelman Sch Pharm, Chapel Hill, NC 27515 USA; [Allen, Irving C.] Virginia Polytech Inst & State Univ, Virginia Maryland Reg Coll Vet Med, Dept Biomed Sci & Pathobiol, Blacksburg, VA 24061 USA; [Hasan, Warefta; DeSimone, Joseph M.] Univ N Carolina, Dept Chem, Chapel Hill, NC USA; [DeSimone, Joseph M.; Ting, Jenny P. Y.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [DeSimone, Joseph M.] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC USA; [DeSimone, Joseph M.] Univ N Carolina, Carolina Ctr Canc Nanotechnol Excellence, Chapel Hill, NC USA; [DeSimone, Joseph M.] N Carolina State Univ, Dept Chem & Biomol Engn, Raleigh, NC 27695 USA; [DeSimone, Joseph M.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC USA; [DeSimone, Joseph M.] Univ N Carolina, Inst Adv Mat, Chapel Hill, NC USA; [DeSimone, Joseph M.] Univ N Carolina, Inst Nanomed, Chapel Hill, NC USA; [DeSimone, Joseph M.] Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst Canc Res, New York, NY 10021 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Virginia Polytechnic Institute & State University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; North Carolina State University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Memorial Sloan Kettering Cancer Center	DeSimone, JM (corresponding author), Univ N Carolina, Eshelman Sch Pharm, Chapel Hill, NC 27515 USA.	desimone@email.unc.edu; jpyting@gmail.com		Allen, Irving/0000-0001-9573-5250	National Institutes of Health [8-VP1-CA174425-04, U19-AI077437, U54 AI057157]; NC Tracs [100K1202]; NATIONAL CANCER INSTITUTE [DP1CA174425, P30CA016086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI077437, U54AI057157] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK092355] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NC Tracs; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health grants 8-VP1-CA174425-04 (awarded to Joseph M. DeSimone), U19-AI077437 and U54 AI057157 (Jenny P.Y. Ting) and NC Tracs 100K1202 (Joseph M. DeSimone and Jenny P.Y. Ting). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen IC, 2006, AM J PHYSIOL-LUNG C, V291, pL1005, DOI 10.1152/ajplung.00174.2006; Allen IC, 2009, IMMUNITY, V30, P556, DOI 10.1016/j.immuni.2009.02.005; Bachmann MF, 2010, NAT REV IMMUNOL, V10, P787, DOI 10.1038/nri2868; Barnes PJ, 2008, NAT REV IMMUNOL, V8, P183, DOI 10.1038/nri2254; Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; Bershteyn A, 2012, J CONTROL RELEASE, V157, P354, DOI 10.1016/j.jconrel.2011.07.029; Canelas DA, 2009, WIRES NANOMED NANOBI, V1, P391, DOI 10.1002/wnan.40; Capriotti AL, 2012, J PROTEOMICS, V75, P1924, DOI 10.1016/j.jprot.2012.01.003; Chan JM, 2010, METHODS MOL BIOL, V624, P163, DOI 10.1007/978-1-60761-609-2_11; Chen K, 2012, BIOMACROMOLECULES, V13, P2748, DOI 10.1021/bm3007242; Choi HS, 2010, NAT BIOTECHNOL, V28, P1300, DOI 10.1038/nbt.1696; Chu KS, 2012, NANOMEDICINE; Dailey LA, 2006, TOXICOL APPL PHARM, V215, P100, DOI 10.1016/j.taap.2006.01.016; Danhier F, 2012, J CONTROL RELEASE, V161, P505, DOI 10.1016/j.jconrel.2012.01.043; Demento SL, 2010, J IMMUNOL, V185, P2989, DOI 10.4049/jimmunol.1000768; Demento SL, 2009, VACCINE, V27, P3013, DOI 10.1016/j.vaccine.2009.03.034; Dhar S, 2011, P NATL ACAD SCI USA, V108, P1850, DOI 10.1073/pnas.1011379108; Dobrovolskaia MA, 2007, NAT NANOTECHNOL, V2, P469, DOI 10.1038/nnano.2007.223; Dobrovolskaia MA, 2009, NAT NANOTECHNOL, V4, P411, DOI [10.1038/nnano.2009.175, 10.1038/NNANO.2009.175]; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Dunn SS, 2012, J AM CHEM SOC, V134, P7423, DOI 10.1021/ja300174v; Enlow EM, 2011, NANO LETT, V11, P808, DOI 10.1021/nl104117p; Fahmy TM, 2007, AAPS J, V9, pE171, DOI 10.1208/aapsj0902019; Garcia A, 2012, J DRUG DELIV, V2012, DOI 10.1155/2012/941243; Gebril A, 2012, EXPERT REV VACCINES, V11, P1139, DOI [10.1586/ERV.12.81, 10.1586/erv.12.81]; Getts DR, 2012, NAT BIOTECHNOL, V30, P1217, DOI 10.1038/nbt.2434; Gratton SEA, 2008, P NATL ACAD SCI USA, V105, P11613, DOI 10.1073/pnas.0801763105; Guzman J, 1997, POLYMER, V38, P5227, DOI 10.1016/S0032-3861(97)00039-6; Hasan W, 2012, NANO LETT, V12, P287, DOI 10.1021/nl2035354; Holgado MA, 2011, CURR DRUG TARGETS, V12, P1096; Hubbell JA, 2009, NATURE, V462, P449, DOI 10.1038/nature08604; Jain RA, 2000, BIOMATERIALS, V21, P2475, DOI 10.1016/S0142-9612(00)00115-0; Jeong W, 2010, NANOMEDICINE-UK, V5, P633, DOI 10.2217/NNM.10.34; Karmali PP, 2011, EXPERT OPIN DRUG DEL, V8, P343, DOI 10.1517/17425247.2011.554818; Kasturi SP, 2011, NATURE, V470, P543, DOI 10.1038/nature09737; Kircher MF, 2012, NAT MED, V18, P829, DOI 10.1038/nm.2721; Leuschner F, 2011, NAT BIOTECHNOL, V29, P1005, DOI 10.1038/nbt.1989; Lu JM, 2009, EXPERT REV MOL DIAGN, V9, P325, DOI 10.1586/ERM.09.15; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Merkel TJ, 2011, P NATL ACAD SCI USA, V108, P586, DOI 10.1073/pnas.1010013108; Moon JJ, 2012, P NATL ACAD SCI USA, V109, P1080, DOI 10.1073/pnas.1112648109; Moon JJ, 2011, NAT MATER, V10, P243, DOI 10.1038/NMAT2960; Morishige T, 2010, PHARMAZIE, V65, P596, DOI 10.1691/ph.2010.9408; Morishige T, 2012, ARCH TOXICOL; Morishige T, 2010, BIOMATERIALS, V31, P6833, DOI 10.1016/j.biomaterials.2010.05.036; Nicolete R, 2011, INT IMMUNOPHARMACOL, V11, P1557, DOI 10.1016/j.intimp.2011.05.014; Park J, 2012, NAT MAT; Park J, 2011, MOL PHARMACEUT, V8, P143, DOI 10.1021/mp100203a; Parrott MC, 2012, J AM CHEM SOC, V134, P7978, DOI 10.1021/ja301710z; Parrott MC, 2010, J AM CHEM SOC, V132, P17928, DOI 10.1021/ja108568g; Perry JL, 2011, ACCOUNTS CHEM RES, V44, P990, DOI 10.1021/ar2000315; Petros RA, 2008, J AM CHEM SOC, V130, P5008, DOI 10.1021/ja801436j; Pulendran B, 2011, NAT IMMUNOL, V12, P509, DOI 10.1038/ni.2039; Qiao Y, 2012, FEBS LETT, V586, P1022, DOI 10.1016/j.febslet.2012.02.045; Rice-Ficht AC, 2010, CURR OPIN MICROBIOL, V13, P106, DOI 10.1016/j.mib.2009.12.001; Rolland JP, 2005, J AM CHEM SOC, V127, P10096, DOI 10.1021/ja051977c; Roy I, 2010, NANOMED-NANOTECHNOL, V6, P237, DOI 10.1016/j.nano.2009.07.001; Sayes CM, 2011, METHODS MOL BIOL, V726, P313, DOI 10.1007/978-1-61779-052-2_20; Schijns VEJC, 2011, EXPERT REV VACCINES, V10, P539, DOI [10.1586/erv.11.21, 10.1586/ERV.11.21]; Sharp FA, 2009, P NATL ACAD SCI USA, V106, P870, DOI 10.1073/pnas.0804897106; Stephan MT, 2012, BIOMATERIALS, V33, P5776, DOI 10.1016/j.biomaterials.2012.04.029; Tsai SE, 2010, IMMUNITY, V32, P568, DOI 10.1016/j.immuni.2010.03.015; Vaine CA, 2013, J IMMUNOL; Wang J, 2010, J AM CHEM SOC, V132, P11306, DOI 10.1021/ja1043177; Willingham SB, 2009, J IMMUNOL, V183, P2008, DOI 10.4049/jimmunol.0900138; Yang W, 2008, INT J PHARMACEUT, V356, P239, DOI 10.1016/j.ijpharm.2008.02.011; Yazdi AS, 2010, P NATL ACAD SCI USA, V107, P19449, DOI 10.1073/pnas.1008155107; Zolnik BS, 2010, ENDOCRINOLOGY, V151, P458, DOI 10.1210/en.2009-1082	68	47	47	2	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2013	8	4							e62115	10.1371/journal.pone.0062115	http://dx.doi.org/10.1371/journal.pone.0062115			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123JP	23593509	gold, Green Published, Green Submitted			2022-12-25	WOS:000317385300093
J	Yoshino, N; Endo, M; Kanno, H; Matsukawa, N; Tsutsumi, R; Takeshita, R; Sato, S				Yoshino, Naoto; Endo, Masahiro; Kanno, Hiroyuki; Matsukawa, Naomi; Tsutsumi, Reiko; Takeshita, Ryosuke; Sato, Shigehiro			Polymyxins as Novel and Safe Mucosal Adjuvants to Induce Humoral Immune Responses in Mice	PLOS ONE			English	Article							MAST-CELLS; INHALED COLISTIN; IN-VIVO; HISTAMINE; MUTANT; PEPTIDES; RELEASE; ANTIGEN; PROTEIN; NEPHROTOXICITY	There is currently an urgent need to develop safe and effective adjuvants for enhancing vaccine-induced antigen-specific immune responses. We demonstrate here that intranasal immunization with clinically used polypeptide antibiotics, polymyxin B (PMB) and colistin (CL), along with ovalbumin (OVA), increases OVA-specific humoral immune responses in a dose-dependently manner at both mucosal and systemic compartments. Enhanced immunity by boosting was found to persist during 8 months of observation. Moreover, mice intranasally immunized with OVA plus various doses of PMB or CL showed neither inflammatory responses in the nasal cavity and olfactory bulbs nor renal damages, compared to those given OVA alone. These data suggest that polymyxins may serve as novel and safe mucosal adjuvants to induce humoral immune responses. The polymyxin adjuvanticity was found to be independent of endotoxins liberated by its bactericidal activity, as indicated by similar enhancing effects of PMB in lipopolysaccharide (LPS)-hyporesponsive and LPS-susceptible mice. However, despite the presence of preexisting anti-PMB antibodies, we observed no reduction in the adjuvant function of polymyxins when they were given intranasally. Furthermore, the titers of OVA-specific Abs in mice intranasally immunized with OVA plus PMB or CL were significantly higher than those in mice administered with polymyxin analogues, such as polymyxin B nonapeptide and colistin methanesulfonate. The levels of released beta-hexosaminidase and histamine in mast cell culture supernatants stimulated by PMB or CL were also significantly higher than those stimulated by their analogues. These results suggest that both the hydrophobic carbon chain and hydrophilic cationic cyclic peptide contribute to the mucosal adjuvanticity of PMB and CL.	[Yoshino, Naoto; Endo, Masahiro; Matsukawa, Naomi; Tsutsumi, Reiko; Sato, Shigehiro] Iwate Med Univ, Sch Med, Dept Microbiol, Div Infect Dis & Immunol, Morioka, Iwate, Japan; [Kanno, Hiroyuki] Iwate Med Univ, Sch Med, Dept Pathol, Div Leading Pathophysiol, Morioka, Iwate, Japan; [Takeshita, Ryosuke] Iwate Med Univ, Sch Med, Dept Obstet & Gynecol, Morioka, Iwate, Japan	Iwate Medical University; Iwate Medical University; Iwate Medical University	Yoshino, N (corresponding author), Iwate Med Univ, Sch Med, Dept Microbiol, Div Infect Dis & Immunol, Morioka, Iwate, Japan.	nyoshino@iwate-med.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; MEXT; Grants-in-Aid for Scientific Research [23790543] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for Young Scientists (B) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan and the MEXT-Supported Program for the Strategic Research Foundation at Private Universities, 2010-2014. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALVING CR, 1993, IMMUNOBIOLOGY, V187, P430, DOI 10.1016/S0171-2985(11)80355-4; Amaral MM, 2007, J IMMUNOL, V179, P3425, DOI 10.4049/jimmunol.179.6.3425; Andreu D, 1998, BIOPOLYMERS, V47, P415, DOI 10.1002/(SICI)1097-0282(1998)47:6<415::AID-BIP2>3.0.CO;2-D; APPELMELK BJ, 1992, ANAL BIOCHEM, V207, P311, DOI 10.1016/0003-2697(92)90017-2; Ascarateil S, 2006, VACCINE S2, P83; BEVERIDGE EG, 1967, BRIT J PHARM CHEMOTH, V29, P125, DOI 10.1111/j.1476-5381.1967.tb01946.x; BUSHBY SRM, 1955, BRIT J PHARM CHEMOTH, V10, P215, DOI 10.1111/j.1476-5381.1955.tb00085.x; Cameotra SS, 1998, APPL MICROBIOL BIOT, V50, P520, DOI 10.1007/s002530051329; Caron G, 2001, J IMMUNOL, V166, P6000, DOI 10.4049/jimmunol.166.10.6000; CHIHARA S, 1973, AGR BIOL CHEM TOKYO, V37, P2455, DOI 10.1080/00021369.1973.10861030; CLEMENTS JD, 1988, VACCINE, V6, P269, DOI 10.1016/0264-410X(88)90223-X; Cunningham S, 2001, ARCH DIS CHILD, V84, P432, DOI 10.1136/adc.84.5.432; ELLIS HV, 1970, J PHARMACOL EXP THER, V175, P627; ELSON CO, 1984, J IMMUNOL, V132, P2736; Falagas ME, 2010, PEDIATR PULM, V45, P1135, DOI 10.1002/ppul.21302; Falagas ME, 2005, CLIN INFECT DIS, V40, P1333, DOI 10.1086/429323; FEKETY FR, 1962, ANN INTERN MED, V57, P214, DOI 10.7326/0003-4819-57-2-214; Finlay BB, 2004, NAT REV MICROBIOL, V2, P497, DOI 10.1038/nrmicro908; GALLI SJ, 1982, J CELL BIOL, V95, P435, DOI 10.1083/jcb.95.2.435; GALLO RL, 1994, P NATL ACAD SCI USA, V91, P11035, DOI 10.1073/pnas.91.23.11035; Gudmundsson GH, 1999, J IMMUNOL METHODS, V232, P45, DOI 10.1016/S0022-1759(99)00152-0; Hagiwara Y, 2006, J IMMUNOL, V177, P3045, DOI 10.4049/jimmunol.177.5.3045; Hancock RD, 2001, COORDIN CHEM REV, V212, P1, DOI 10.1016/S0010-8545(00)00418-5; Hashizume H, 2008, STUD NAT PROD CHEM, V35, P693; Hodson ME, 2002, EUR RESPIR J, V20, P658, DOI 10.1183/09031936.02.00248102; Iosifidis E, 2010, EUR J PEDIATR, V169, P867, DOI 10.1007/s00431-009-1137-3; ITO J, 1969, ACTA PATHOL JAPON, V19, P55; Jawdat DM, 2006, J IMMUNOL, V177, P1755, DOI 10.4049/jimmunol.177.3.1755; JENSEN T, 1987, J ANTIMICROB CHEMOTH, V19, P831, DOI 10.1093/jac/19.6.831; John ALS, 2012, NAT MATER, V11, P250, DOI [10.1038/NMAT3222, 10.1038/nmat3222]; KATZ R, 1963, Med Ann Dist Columbia, V32, P408; Katz SL, 2001, CHEST, V119, P250, DOI 10.1378/chest.119.1.250; Kawamoto S, 2011, BIOSCI BIOTECH BIOCH, V75, P140, DOI 10.1271/bbb.100541; Ketavarapu JM, 2008, P NATL ACAD SCI USA, V105, P9313, DOI 10.1073/pnas.0707636105; KOCH-WESER J, 1970, Annals of Internal Medicine, V72, P857; KOSARIC N, 1992, PURE APPL CHEM, V64, P1731, DOI 10.1351/pac199264111731; Kweon MN, 2002, J INFECT DIS, V186, P1261, DOI 10.1086/344526; LEE C, 1977, ANESTH ANALG, V56, P373; Li J, 2005, INT J ANTIMICROB AG, V25, P11, DOI 10.1016/j.ijantimicag.2004.10.001; Littlewood JM, 2000, RESP MED, V94, P632, DOI 10.1053/rmed.2000.0834; Lycke N, 1997, RES IMMUNOL, V148, P504, DOI 10.1016/S0923-2494(98)80144-2; McLachlan JB, 2008, NAT MED, V14, P536, DOI 10.1038/nm1757; McLachlan JB, 2003, NAT IMMUNOL, V4, P1199, DOI 10.1038/ni1005; Moldoveanu Z, 2005, MUCOSAL IMMUNOLOGY, 3RD EDITION, P1841, DOI 10.1016/B978-012491543-5/50110-8; Montero A, 2002, ANTIMICROB AGENTS CH, V46, P1946, DOI 10.1128/AAC.46.6.1946-1952.2002; Mutsch M, 2004, NEW ENGL J MED, V350, P896, DOI 10.1056/NEJMoa030595; Ohmura M, 2001, VACCINE, V20, P756, DOI 10.1016/S0264-410X(01)00412-1; Orinska Z, 2005, BLOOD, V106, P978, DOI 10.1182/blood-2004-07-2656; PARRATT JR, 1957, J PHYSIOL-LONDON, V137, P179, DOI 10.1113/jphysiol.1957.sp005805; Qureshi ST, 1999, J EXP MED, V189, P615, DOI 10.1084/jem.189.4.615; Rescigno M, 1998, J EXP MED, V188, P2175, DOI 10.1084/jem.188.11.2175; Risso A, 1998, CELL IMMUNOL, V189, P107, DOI 10.1006/cimm.1998.1358; ROSENSTREICH DL, 1975, J IMMUNOL, V115, P777; Saita T, 1999, BIOL PHARM BULL, V22, P1257; SAWYER JG, 1988, INFECT IMMUN, V56, P693, DOI 10.1128/IAI.56.3.693-698.1988; SCHWARTZ BENJAMIN S., 1959, ANTIBIOT ANN, V7, P41; SCHWARTZ LB, 1981, J IMMUNOL, V126, P2071; Shelburne CP, 2009, CELL HOST MICROBE, V6, P331, DOI 10.1016/j.chom.2009.09.004; Sousa CRE, 1999, J IMMUNOL, V162, P6552; STANSLY PG, 1947, B JOHNS HOPKINS HOSP, V81, P43; TALLGREN LG, 1965, ACTA MED SCAND, V177, P717; Tamura S, 1996, J IMMUNOL, V156, P3892; Tough DF, 1997, J EXP MED, V185, P2089, DOI 10.1084/jem.185.12.2089; VOITENKO VG, 1990, AGENTS ACTIONS, V30, P153, DOI 10.1007/BF01969025; WU HY, 1993, INFECT IMMUN, V61, P314, DOI 10.1128/IAI.61.1.314-322.1993; Yamamoto S, 1997, P NATL ACAD SCI USA, V94, P5267, DOI 10.1073/pnas.94.10.5267; Yoshino N, 2012, EXP ANIM TOKYO, V61, P407, DOI 10.1538/expanim.61.407; Yoshino N, 2009, VACCINE, V27, P4808, DOI 10.1016/j.vaccine.2009.05.081	68	21	23	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2013	8	4							e61643	10.1371/journal.pone.0061643	http://dx.doi.org/10.1371/journal.pone.0061643			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123JA	23593492	gold, Green Published, Green Submitted			2022-12-25	WOS:000317383200062
J	Hill, KS; Erdogan, E; Khoor, A; Walsh, MP; Leitges, M; Murray, NR; Fields, AP				Hill, K. S.; Erdogan, E.; Khoor, A.; Walsh, M. P.; Leitges, M.; Murray, N. R.; Fields, A. P.			Protein kinase C alpha suppresses Kras-mediated lung tumor formation through activation of a p38 MAPK-TGF beta signaling axis	ONCOGENE			English	Article						tumor suppressor; lung adenocarcinoma; bronchio-alveolar stem cells; p38 MAPK; Wilm's Tumor 1 gene; inhibitors of DNA Binding (Id)	ANTISENSE OLIGONUCLEOTIDE INHIBITOR; SMOOTH-MUSCLE-CELLS; TRANSFORMED GROWTH; K-RAS; MOUSE MODELS; PKC-IOTA; CANCER; SENESCENCE; MICE; EXPRESSION	Protein kinase C alpha (PKC alpha) can activate both pro- and anti-tumorigenic signaling depending upon cellular context. Here, we investigated the role of PKC alpha in lung tumorigenesis in vivo. Gene expression data sets revealed that primary human non-small lung cancers (NSCLC) express significantly decreased PKC alpha levels, indicating that loss of PKC alpha expression is a recurrent event in NSCLC. We evaluated the functional relevance of PKC alpha loss during lung tumorigenesis in three murine lung adenocarcinoma models (LSL-Kras, LA2-Kras and urethane exposure). Genetic deletion of PKC alpha resulted in a significant increase in lung tumor number, size, burden and grade, bypass of oncogene-induced senescence, progression from adenoma to carcinoma and a significant decrease in survival in vivo. The tumor promoting effect of PKC alpha loss was reflected in enhanced Kras-mediated expansion of bronchio-alveolar stem cells (BASCs), putative tumor-initiating cells, both in vitro and in vivo. LSL-Kras/Prkca(-/-) mice exhibited a decrease in phospho-p38 MAPK in BASCs in vitro and in tumors in vivo, and treatment of LSL-Kras BASCs with a p38 inhibitor resulted in increased colony size indistinguishable from that observed in LSL-Kras/Prkca(-/-) BASCs. In addition, LSL-Kras/Prkca(-/-) BASCs exhibited a modest but reproducible increase in TGF beta 1 mRNA, and addition of exogenous TGF beta 1 to LSL-Kras BASCs results in enhanced growth similar to untreated BASCs from LSL-Kras/Prkca(-/-) mice. Conversely, a TGF beta R1 inhibitor reversed the effects of PKC alpha loss in LSL-Kras/Prkca(-/-) BASCs. Finally, we identified the inhibitors of DNA binding (Id) Id1-3 and the Wilm's Tumor 1 as potential downstream targets of PKC alpha-dependent tumor suppressor activity in vitro and in vivo. We conclude that PKC alpha suppresses tumor initiation and progression, at least in part, through a PKC alpha-p38MAPK-TGF beta signaling axis that regulates tumor cell proliferation and Kras-induced senescence. Our results provide the first direct evidence that PKC alpha exhibits tumor suppressor activity in the lung in vivo.	[Hill, K. S.; Erdogan, E.; Walsh, M. P.; Murray, N. R.; Fields, A. P.] Mayo Clin, Dept Canc Biol, Jacksonville, FL 32224 USA; [Khoor, A.] Mayo Clin, Dept Pathol, Jacksonville, FL 32224 USA; [Leitges, M.] Oslo Biotechnol Ctr, Oslo, Norway	Mayo Clinic; Mayo Clinic	Fields, AP (corresponding author), Mayo Clin, Dept Canc Biol, Griffin Canc Res Bldg,Rm 212,4500 San Pablo Rd, Jacksonville, FL 32224 USA.	fields.alan@mayo.edu	Leitges, Michael/AAN-1953-2021	Leitges, Michael/0000-0003-4203-6995; Hill, Kristen/0000-0003-3757-2822	National Cancer Institute [R01 CA081436-16, R01 CA140290-03]; NATIONAL CANCER INSTITUTE [R01CA081436, R01CA140290, P30CA015083] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors thank Brandy Edenfield for immunohistochemical staining procedures, Capella Weems for technical assistance, Justin Weems and Dr Lee Jamieson for animal husbandry and members of the Fields laboratory for support, encouragement and critical review of the manuscript. This work was supported in part by grants from the National Cancer Institute (R01 CA081436-16 to APF and R01 CA140290-03 to NRM). APF is the Monica Flynn Jacoby Endowed Professor of Cancer Research.	Advani R, 2004, CANCER-AM CANCER SOC, V100, P321, DOI 10.1002/cncr.11909; Bivona TG, 2006, MOL CELL, V21, P481, DOI 10.1016/j.molcel.2006.01.012; Cacace AM, 1996, ONCOGENE, V13, P2517; CASTAGNA M, 1982, J BIOL CHEM, V257, P7847; Collado M, 2010, NAT REV CANCER, V10, P51, DOI 10.1038/nrc2772; Dalgaard P, 2008, STAT COMPUT SER, P1, DOI 10.1007/978-0-387-79054-1_1; Dean N, 1996, CANCER RES, V56, P3499; Dehan E, 2007, LUNG CANCER, V56, P175, DOI 10.1016/j.lungcan.2006.12.010; Eder AM, 2005, P NATL ACAD SCI USA, V102, P12519, DOI 10.1073/pnas.0505641102; Erdogan E, 2006, J BIOL CHEM, V281, P28450, DOI 10.1074/jbc.M606054200; Fasbender A, 1998, J CLIN INVEST, V102, P184, DOI 10.1172/JCI2732; Fields AP, 2007, BIOCHEM SOC T, V35, P996, DOI 10.1042/BST0350996; Fields Alan P, 2003, Methods Mol Biol, V233, P519; Fields AP, 2008, ADV ENZYME REGUL, V48, P166, DOI 10.1016/j.advenzreg.2007.11.014; Galvez AS, 2009, MOL CELL BIOL, V29, P104, DOI 10.1128/MCB.01294-08; Geiger T, 1998, ANTI-CANCER DRUG DES, V13, P35; Grossman SA, 2005, NEURO-ONCOLOGY, V7, P32, DOI 10.1215/S1152851703000353; Grunert S, 2003, NAT REV MOL CELL BIO, V4, P657, DOI 10.1038/nrm1175; Hao F, 2011, J BIOL CHEM, V286, P18104, DOI 10.1074/jbc.M110.208488; Hou J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010312; Hsieh YH, 2007, CANCER RES, V67, P4320, DOI 10.1158/0008-5472.CAN-06-2486; Iwasa H, 2003, GENES CELLS, V8, P131, DOI 10.1046/j.1365-2443.2003.00620.x; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Jamieson L, 1999, J BIOL CHEM, V274, P3927, DOI 10.1074/jbc.274.7.3927; Johnson L, 2001, NATURE, V410, P1111, DOI 10.1038/35074129; Justilien V, 2010, PROTEIN KINASE C IN CANCER SIGNALING AND THERAPY, P455, DOI 10.1007/978-1-60761-543-9_23; KIKKAWA U, 1983, J BIOL CHEM, V258, P1442; Kikuchi K, 2013, ONCOGENE, V32, P286, DOI 10.1038/onc.2012.46; Kim CFB, 2005, CELL, V121, P823, DOI 10.1016/j.cell.2005.03.032; Leitges M, 2002, MOL ENDOCRINOL, V16, P1203; Lindschau C, 2003, HYPERTENSION, V42, P335, DOI 10.1161/01.HYP.0000087839.72582.DD; Luo XP, 2005, ENDOCRINOLOGY, V146, P1097, DOI 10.1210/en.2004-1377; MALKINSON AM, 1985, J NATL CANCER I, V75, P971, DOI 10.1093/jnci/75.5.971; MISCHAK H, 1993, J BIOL CHEM, V268, P6090; Murray NR, 1997, J BIOL CHEM, V272, P27521, DOI 10.1074/jbc.272.44.27521; Murray NR, 2004, J CELL BIOL, V164, P797, DOI 10.1083/jcb.200311011; Nakagawa M, 2005, J BIOL CHEM, V280, P33926, DOI 10.1074/jbc.M505748200; Nazarenko I, 2010, MOL CANCER RES, V8, P919, DOI 10.1158/1541-7786.MCR-09-0358; Nikitin AY, 2004, CANCER RES, V64, P2307, DOI 10.1158/0008-5472.CAN-03-3376; Oliva JL, 2008, J BIOL CHEM, V283, P5466, DOI 10.1074/jbc.M707576200; Oster H, 2006, CANCER RES, V66, P6955, DOI 10.1158/0008-5472.CAN-06-0268; Paz-Ares L, 2006, J CLIN ONCOL, V24, P1428, DOI 10.1200/JCO.2005.04.3299; Pysz MA, 2009, EXP CELL RES, V315, P1415, DOI 10.1016/j.yexcr.2009.02.002; Reddig PJ, 1999, CANCER RES, V59, P5710; Reddig PJ, 2000, CANCER RES, V60, P595; Regala RP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026439; Regala RP, 2009, CANCER RES, V69, P7603, DOI 10.1158/0008-5472.CAN-09-2066; Regala RP, 2005, CANCER RES, V65, P8905, DOI 10.1158/0008-5472.CAN-05-2372; Regala RP, 2005, J BIOL CHEM, V280, P31109, DOI 10.1074/jbc.M505402200; Sanchez-Palencia A, 2011, INT J CANCER, V129, P355, DOI 10.1002/ijc.25704; Scotti ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030509; Scotti ML, 2010, CANCER RES, V70, P2064, DOI 10.1158/0008-5472.CAN-09-2684; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Stallings-Mann M, 2006, CANCER RES, V66, P1767, DOI 10.1158/0008-5472.CAN-05-3405; Tanaka Y, 2003, J BIOL CHEM, V278, P33753, DOI 10.1074/jbc.M303313200; Tossidou I, 2009, CELL PHYSIOL BIOCHEM, V24, P627, DOI 10.1159/000257518; Tuveson DA, 2004, CANCER CELL, V5, P375, DOI 10.1016/S1535-6108(04)00085-6; Ventura JJ, 2007, NAT GENET, V39, P750, DOI 10.1038/ng2037; Vicent S, 2010, J CLIN INVEST, V120, P3940, DOI 10.1172/JCI44165; Wang WP, 2002, MOL CELL BIOL, V22, P3389, DOI 10.1128/MCB.22.10.3389-3403.2002; Yang Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002220; Zhang L, 2006, CANCER RES, V66, P4627, DOI 10.1158/0008-5472.CAN-05-4527	64	33	35	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 17	2014	33	16					2134	2144		10.1038/onc.2013.147	http://dx.doi.org/10.1038/onc.2013.147			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AF3GH	23604119	Green Accepted			2022-12-25	WOS:000334599100012
J	Chaganti, LK; Kuppili, RR; Bose, K				Chaganti, Lalith K.; Kuppili, Raja Reddy; Bose, Kakoli			Intricate structural coordination and domain plasticity regulate activity of serine protease HtrA2	FASEB JOURNAL			English	Article						PDZ; serine protease domain; dynamics	DEGS PROTEASE; ACTIVATION; BINDING; PROTEINS; PDZ; IDENTIFICATION; RECOGNITION; TEMPERATURE; INHIBITOR; EFFICIENT	HtrA2, a complex trimeric pyramidal mitochondrial serine protease that regulates critical biological functions and diseases, including apoptosis and cancer, is a promising therapeutic target. It promotes apoptosis through multiple pathways, complex mechanisms of which are still elusive. The existing model of activation that emphasizes relative intramolecular movements between C-terminal PDZ and protease domains (PDZ-protease collapse in inactive and resting states) has not been able to unambiguously demonstrate dynamics of its actions. Using structure-guided design, molecular biology and protein biochemistry, we obtained various combinations of HtrA2 domains and mutants. Conformational changes and stability were characterized using molecular dynamics simulation and spectroscopic tools while functional enzymology delineated their roles in regulating enzyme catalysis. Quantitative Forster resonance energy transfer showed lesser intramolecular PDZ-protease distance in trimeric HtrA2 compared to its inactive monomeric counterpart (approximate to 21 and approximate to 22.3 angstrom, respectively, at 37 degrees C). Our findings highlight importance of N-terminal region, oligomerization, and intricate intermolecular PDZ-protease interaction in proper active-site formation, enzyme-substrate complex stabilization, and hence HtrA2 functions. These observations redefine the existing activation model and showcase a unique example of how precise interdomain coordination, plasticity, and intermolecular contacts lead to distinct functional properties and hence provide new insights into HtrA2 structure, function, and dynamics.	[Chaganti, Lalith K.; Kuppili, Raja Reddy; Bose, Kakoli] Tata Mem Hosp, Adv Ctr Treatment Res & Educ Canc ACTREC, Kharghar 410210, Navi Mumbai, India	Tata Memorial Centre (TMC); Advance Centre for Treatment, Research & Education in Cancer (ACTREC); Tata Memorial Hospital	Bose, K (corresponding author), Tata Mem Hosp, ACTREC, Sect 22, Integrated Biophys & Struct Biol Lab, Kharghar 410210, Navi Mumbai, India.	kbose@actrec.gov.in			DBT; Department of Biotechnology (DBT), Government of India	DBT(Department of Biotechnology (DBT) India); Department of Biotechnology (DBT), Government of India(Department of Biotechnology (DBT) India)	The authors thank Avani Solanki for help with protein purification and Pruthvi Raj Bejugam, Siddharth Gurdasani, and Nitu Singh for their intellectual inputs and critical feedback on the manuscript. The authors are grateful to Dr. Manoj K. Bhat (National Centre for Cell Science, Pune, India) for providing reagents and Dr. Sanjib Senapati, (Indian Institute of Technology, Madras, India) for help with MD simulations. The authors also acknowledge the facility provided by DBT-sponsored Distributed Information Sub Centre (DISC) of the Biotechnology Information System Network (BTISnet) at the Advanced Centre for Treatment, Research, and Education in Cancer, where in silico studies have been carried out. The project is funded by a grant from the Department of Biotechnology (DBT), Government of India.	Baldi A, 2008, PHARMACOGENOMICS, V9, P1069, DOI 10.2217/14622416.9.8.1069; Bejugam PR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055416; Bhuiyan MS, 2009, CURR DRUG TARGETS, V10, P372, DOI 10.2174/138945009787846399; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; CALHOUN DB, 1983, BIOCHEMISTRY-US, V22, P1526, DOI 10.1021/bi00276a002; Clausen T, 2011, NAT REV MOL CELL BIO, V12, P152, DOI 10.1038/nrm3065; de Castro IP, 2011, MOL NEUROBIOL, V43, P80, DOI 10.1007/s12035-010-8150-4; Doyle DA, 1996, CELL, V85, P1067, DOI 10.1016/S0092-8674(00)81307-0; EFTINK MR, 1981, ARCH BIOCHEM BIOPHYS, V209, P706, DOI 10.1016/0003-9861(81)90332-5; Gavathiotis E, 2012, NAT CHEM BIOL, V8, P639, DOI [10.1038/NCHEMBIO.995, 10.1038/nchembio.995]; Hasenbein S, 2010, J MOL BIOL, V397, P957, DOI 10.1016/j.jmb.2010.02.027; Hegde R, 2002, J BIOL CHEM, V277, P432, DOI 10.1074/jbc.M109721200; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Jiang JS, 2008, P NATL ACAD SCI USA, V105, P11939, DOI 10.1073/pnas.0805464105; Kelly SM, 2005, BBA-PROTEINS PROTEOM, V1751, P119, DOI 10.1016/j.bbapap.2005.06.005; Krojer T, 2002, NATURE, V416, P455, DOI 10.1038/416455a; Krojer T, 2008, P NATL ACAD SCI USA, V105, P7702, DOI 10.1073/pnas.0803392105; Krojer T, 2010, NAT STRUCT MOL BIOL, V17, P844, DOI 10.1038/nsmb.1840; Lakowicz J.R., 2006, PRINCIPLES FLUORESCE, P443; Li WY, 2002, NAT STRUCT BIOL, V9, P436, DOI 10.1038/nsb795; Liang JJ, 2006, PROTEIN SCI, V15, P1619, DOI 10.1110/ps.062216006; LIPINSKA B, 1989, J BACTERIOL, V171, P1574, DOI 10.1128/jb.171.3.1574-1584.1989; Martins LM, 2003, J BIOL CHEM, V278, P49417, DOI 10.1074/jbc.M308659200; Mauldin RV, 2013, NAT CHEM BIOL, V9, P90, DOI [10.1038/nchembio.1135, 10.1038/NCHEMBIO.1135]; Meltzer M, 2009, RES MICROBIOL, V160, P660, DOI 10.1016/j.resmic.2009.07.012; Merdanovic M, 2010, NAT STRUCT MOL BIOL, V17, P837, DOI 10.1038/nsmb.1839; Nam MK, 2006, EXP MOL MED, V38, P36, DOI 10.1038/emm.2006.5; Polur I, 2010, HISTOL HISTOPATHOL, V25, P599, DOI 10.14670/HH-25.599; Roy S, 2000, BIOCHEMISTRY-US, V39, P4603, DOI 10.1021/bi992328e; Singh N, 2011, ARCH BIOCHEM BIOPHYS, V516, P85, DOI 10.1016/j.abb.2011.10.007; Sohn J, 2007, CELL, V131, P572, DOI 10.1016/j.cell.2007.08.044; Sohn J, 2009, STRUCTURE, V17, P1411, DOI 10.1016/j.str.2009.07.017; Sohn J, 2009, MOL CELL, V33, P64, DOI 10.1016/j.molcel.2008.12.017; Suzuki Y, 2004, CELL DEATH DIFFER, V11, P208, DOI 10.1038/sj.cdd.4401343; Suzuki Y, 2001, MOL CELL, V8, P613, DOI 10.1016/S1097-2765(01)00341-0; Suzuki Y, 2001, J BIOL CHEM, V276, P27058, DOI 10.1074/jbc.M102415200; Walsh NP, 2003, CELL, V113, P61, DOI 10.1016/S0092-8674(03)00203-4; WANG CK, 1986, J MOL BIOL, V191, P509, DOI 10.1016/0022-2836(86)90145-2; Wang WG, 2003, MOL CELL BIOL, V23, P2171, DOI 10.1128/MCB.23.6.2171-2181.2003; Wrase R, 2011, P NATL ACAD SCI USA, V108, P10490, DOI 10.1073/pnas.1101084108; Wu G, 2000, NATURE, V408, P1008, DOI 10.1038/35050012; Zhang XF, 2004, BIOCHEMISTRY-MOSCOW+, V69, P687, DOI 10.1023/B:BIRY.0000033743.09806.1a; Zumbrunn J, 1996, FEBS LETT, V398, P187, DOI 10.1016/S0014-5793(96)01229-X; Zurawa-Janicka D, 2010, EXPERT OPIN THER TAR, V14, P665, DOI 10.1517/14728222.2010.487867	44	23	23	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2013	27	8					3054	3066		10.1096/fj.13-227256	http://dx.doi.org/10.1096/fj.13-227256			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	292BT	23608143				2022-12-25	WOS:000329877600013
J	Hamilton, BS; Whittaker, GR				Hamilton, Brian S.; Whittaker, Gary R.			Cleavage Activation of Human-adapted Influenza Virus Subtypes by Kallikrein-related Peptidases 5 and 12	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEMAGGLUTININ CLEAVAGE; PROTEOLYTIC ACTIVATION; CANCER PROGRESSION; PROTEASES TMPRSS2; SERINE PROTEASES; MEMBRANE-FUSION; A VIRUSES; GLYCOPROTEIN; EXPRESSION; VIRULENCE	A critical step in the influenza virus replication cycle is the cleavage activation of the HA precursor. Cleavage activation of influenza HA enables fusion with the host endosome, allowing for release of the viral genome into the host cell. To date, studies have determined that HA activation is driven by trypsin-like host cell proteases, as well as yet to be identified bacterial proteases. Although the number of host proteases that can activate HA is growing, there is still uncertainty regarding which secreted proteases are able to support multicycle replication of influenza. In this study, we have determined that the kallikrein-related peptidases 5 and 12 are secreted from the human respiratory tract and have the ability to cleave and activate HA from the H1, H2, and H3 subtypes. Each peptidase appears to have a preference for particular influenza subtypes, with kallikrein 5 cleaving the H1 and H3 subtypes most efficiently and kallikrein 12 cleaving the H1 and H2 subtypes most efficiently. Cleavage analysis using HA cleavage site peptide mimics revealed that the amino acids neighboring the arginine cleavage site affect cleavage efficiency. Additionally, the thrombolytic zymogens plasminogen, urokinase, and plasma kallikrein have all been shown to cleave and activate influenza but are found circulating mainly as inactive precursors. Kallikrein 5 and kallikrein 12 were examined for their ability to activate the thrombolytic zymogens, and both resulted in activation of each zymogen, with kallikrein 12 being a more potent activator. Activation of the thrombolytic zymogens may therefore allow for both direct and indirect activation of the HA of human-adapted influenza viruses by kallikrein 5 and kallikrein 12.	[Whittaker, Gary R.] Cornell Univ, Coll Vet Med, Dept Microbiol & Immunol, Ithaca, NY 14853 USA; Univ Rochester, Med Ctr, New York Ctr Excellence Influenza Res & Surveilla, Rochester, NY 14627 USA	Cornell University; University of Rochester	Whittaker, GR (corresponding author), Cornell Univ, Coll Vet Med, Dept Microbiol & Immunol, Ithaca, NY 14853 USA.	grw7@cornell.edu			National Institutes of Health [R01 AI48678]; United States Department of Health and Human Services from the NIAID Centers of Excellence for Influenza Research and Surveillance [HHSN266200700008C]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI048678] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Health and Human Services from the NIAID Centers of Excellence for Influenza Research and Surveillance; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 AI48678 and United States Department of Health and Human Services Contract HHSN266200700008C from the NIAID Centers of Excellence for Influenza Research and Surveillance.	Ahmed R, 2007, NAT IMMUNOL, V8, P1188, DOI 10.1038/ni1530; BELIN D, 1985, EUR J BIOCHEM, V148, P225, DOI 10.1111/j.1432-1033.1985.tb08829.x; Bertram S, 2010, J VIROL, V84, P10016, DOI 10.1128/JVI.00239-10; Bottcher E, 2009, VACCINE, V27, P6324, DOI 10.1016/j.vaccine.2009.03.029; Bottcher-Friebertshauser E, 2010, J VIROL, V84, P5605, DOI 10.1128/JVI.00140-10; Bottcher E, 2006, J VIROL, V80, P9896, DOI 10.1128/JVI.01118-06; Chaipan C, 2009, J VIROL, V83, P3200, DOI 10.1128/JVI.02205-08; Chu VC, 2004, P NATL ACAD SCI USA, V101, P18153, DOI 10.1073/pnas.0405172102; Chutinimitkul S, 2010, J VIROL, V84, P11802, DOI 10.1128/JVI.01136-10; Deryugina EI, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/564259; Emami N, 2007, MOL ONCOL, V1, P269, DOI 10.1016/j.molonc.2007.09.003; Hamilton BS, 2012, J VIROL, V86, P10579, DOI 10.1128/JVI.00306-12; Hooper JD, 2001, J BIOL CHEM, V276, P857, DOI 10.1074/jbc.R000020200; Kesic MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035108; KIDO H, 1992, J BIOL CHEM, V267, P13573; Korbakis D, 2009, CLIN CHEM, V55, P904, DOI 10.1373/clinchem.2008.103788; Medina RA, 2011, NAT REV MICROBIOL, V9, P590, DOI 10.1038/nrmicro2613; Michael IP, 2006, J BIOL CHEM, V281, P12743, DOI 10.1074/jbc.M600326200; Michael IP, 2005, J BIOL CHEM, V280, P14628, DOI 10.1074/jbc.M408132200; Nelson MI, 2007, NAT REV GENET, V8, P196, DOI 10.1038/nrg2053; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; Oshansky CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021183; Pappas C, 2008, P NATL ACAD SCI USA, V105, P3064, DOI 10.1073/pnas.0711815105; Planque C, 2008, CLIN CANCER RES, V14, P1355, DOI 10.1158/1078-0432.CCR-07-4117; Renne T, 1999, J BIOL CHEM, V274, P25777, DOI 10.1074/jbc.274.36.25777; SCHEIBLAUER H, 1992, J INFECT DIS, V166, P783, DOI 10.1093/infdis/166.4.783; Schnitzler SU, 2009, VIRUS GENES, V39, P279, DOI 10.1007/s11262-009-0404-8; Sharma JN, 2002, CURR MED RES OPIN, V18, P10, DOI 10.1185/03007990212500093; Shaw JLV, 2007, CLIN CHEM, V53, P1423, DOI 10.1373/clinchem.2007.088104; Shulla A, 2011, J VIROL, V85, P873, DOI 10.1128/JVI.02062-10; Steinhauer DA, 1999, VIROLOGY, V258, P1, DOI 10.1006/viro.1999.9716; STEINHAUER DA, 1991, VIROLOGY, V184, P445, DOI 10.1016/0042-6822(91)90867-B; Sun XJ, 2010, J VIROL, V84, P8683, DOI 10.1128/JVI.00797-10; Suzuki Y, 2000, J VIROL, V74, P11825, DOI 10.1128/JVI.74.24.11825-11831.2000; TASHIRO M, 1987, NATURE, V325, P536, DOI 10.1038/325536a0; Taubenberger JK, 1998, P NATL ACAD SCI USA, V95, P9713, DOI 10.1073/pnas.95.17.9713; Thoennes S, 2008, VIROLOGY, V370, P403, DOI 10.1016/j.virol.2007.08.035; Tumpey TM, 2009, ANNU REV MICROBIOL, V63, P79, DOI 10.1146/annurev.micro.091208.073359; Watanabe Y, 2012, TRENDS MICROBIOL, V20, P11, DOI 10.1016/j.tim.2011.10.003; WILEY DC, 1987, ANNU REV BIOCHEM, V56, P365, DOI 10.1146/annurev.bi.56.070187.002053; Yousef GM, 2000, GENOMICS, V69, P331, DOI 10.1006/geno.2000.6346	41	34	34	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2013	288	24					17399	17407		10.1074/jbc.M112.440362	http://dx.doi.org/10.1074/jbc.M112.440362			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	164AH	23612974	Green Published, hybrid			2022-12-25	WOS:000320380600032
J	Yang, DR; Ding, XF; Luo, J; Shan, YX; Wang, RH; Lin, SJ; Li, GH; Huang, CK; Zhu, J; Chen, Y; Lee, SO; Chang, C				Yang, Dong-Rong; Ding, Xian-Fan; Luo, Jie; Shan, Yu-Xi; Wang, Ronghao; Lin, Shin-Jen; Li, Gonghui; Huang, Chiung-Kuei; Zhu, Jin; Chen, Yuhchyau; Lee, Soo Ok; Chang, Chawnshang			Increased Chemosensitivity via Targeting Testicular Nuclear Receptor 4 (TR4)-Oct4-Interleukin 1 Receptor Antagonist (IL1Ra) Axis in Prostate Cancer CD133(+) Stem/Progenitor Cells to Battle Prostate Cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOXANTRONE PLUS PREDNISONE; TUMOR-INITIATING CELLS; STEM-CELLS; DOCETAXEL; RESISTANT; CHEMOTHERAPY; THERAPY; ABIRATERONE; APOPTOSIS; 1ST-LINE	Prostate cancer (PCa) stem/progenitor cells are known to have higher chemoresistance than non-stem/progenitor cells, but the underlying molecular mechanism remains unclear. We found the expression of testicular nuclear receptor 4 (TR4) is significantly higher in PCa CD133(+) stem/progenitor cells compared with CD133(+) non-stem/progenitor cells. Knockdown of TR4 levels in the established PCa stem/progenitor cells and the CD133(+) population of the C4-2 PCa cell line with lentiviral TR4 siRNA led to increased drug sensitivity to the two commonly used chemotherapeutic drugs, docetaxel and etoposide, judging from significantly reduced IC50 values and increased apoptosis in the TR4 knockdown cells. Mechanism dissection studies found that suppression of TR4 in these stem/progenitor cells led to down-regulation of Oct4 expression, which, in turn, down-regulated the IL-1 receptor antagonist (IL1Ra) expression. Neutralization experiments via adding these molecules into the TR4 knockdown PCa stem/progenitor cells reversed the chemoresistance, suggesting that the TR4-Oct4-IL1Ra axis may play a critical role in the development of chemoresistance in the PCa stem/progenitor cells. Together, these studies suggest that targeting TR4 may alter chemoresistance of PCa stem/progenitor cells, and this finding provides the possibility of targeting TR4 as a new and better approach to overcome the chemoresistance problem in PCa therapeutics.	[Yang, Dong-Rong; Ding, Xian-Fan; Luo, Jie; Wang, Ronghao; Lin, Shin-Jen; Huang, Chiung-Kuei; Zhu, Jin; Chen, Yuhchyau; Chang, Chawnshang] Univ Rochester Med Ctr, George Whipple Lab Canc Res, Dept Pathol, Rochester, NY 14642 USA; [Yang, Dong-Rong; Ding, Xian-Fan; Luo, Jie; Wang, Ronghao; Lin, Shin-Jen; Huang, Chiung-Kuei; Zhu, Jin; Chen, Yuhchyau; Chang, Chawnshang] Univ Rochester Med Ctr, George Whipple Lab Canc Res, Dept Urol, Rochester, NY 14642 USA; [Yang, Dong-Rong; Ding, Xian-Fan; Luo, Jie; Wang, Ronghao; Lin, Shin-Jen; Huang, Chiung-Kuei; Zhu, Jin; Chen, Yuhchyau; Chang, Chawnshang] Univ Rochester Med Ctr, George Whipple Lab Canc Res, Dept Radiat Oncol, Rochester, NY 14642 USA; [Yang, Dong-Rong; Ding, Xian-Fan; Luo, Jie; Wang, Ronghao; Lin, Shin-Jen; Huang, Chiung-Kuei; Zhu, Jin; Chen, Yuhchyau; Chang, Chawnshang] Univ Rochester Med Ctr, Wilmot Canc Ctr, Rochester, NY 14642 USA; [Yang, Dong-Rong; Shan, Yu-Xi; Zhu, Jin; Lee, Soo Ok] Soochow Univ, Affiliated Hosp 2, Dept Urol, Suzhou 215004, Peoples R China; [Ding, Xian-Fan; Li, Gonghui] Zhejiang Univ, Sir Run Run Shaw Hosp, Dept Urol, Hangzhou 310016, Zhejiang, Peoples R China; [Chang, Chawnshang] China Med Univ Hosp, Sex Hormone Res Ctr, Taichung 404, Taiwan	University of Rochester; University of Rochester; University of Rochester; University of Rochester; Soochow University - China; Zhejiang University; China Medical University Taiwan; China Medical University Hospital - Taiwan	Lee, SO (corresponding author), Soochow Univ, Affiliated Hosp 2, Dept Urol, Suzhou 215004, Peoples R China.	soook_lee@urmc.rochester.edu; chang@urmc.rochester.edu	Luo, Jie/AAG-3091-2019	Chang, Chawnshang/0000-0001-8510-3516	National Institutes of Health [CA122840, CA156700]; George Whipple Professorship Endowment; Taiwan Department of Health Clinical Trial; Research Center of Excellence Grant [DOH99-TD-B-111-004]; National Basic Research Program of China [2012CB518304]; Pao Yu-Kong Chair Professorship [201006]; NATIONAL CANCER INSTITUTE [R01CA122840, R01CA156700] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); George Whipple Professorship Endowment; Taiwan Department of Health Clinical Trial; Research Center of Excellence Grant; National Basic Research Program of China(National Basic Research Program of China); Pao Yu-Kong Chair Professorship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA122840 and CA156700. This work was also supported by the George Whipple Professorship Endowment, a Taiwan Department of Health Clinical Trial, Research Center of Excellence Grant DOH99-TD-B-111-004 (to China Medical University), National Basic Research Program of China Grant 2012CB518304, and Pao Yu-Kong Chair Professorship 201006.	Beer TM, 2008, CANCER, V112, P326, DOI 10.1002/cncr.23163; Berthold DR, 2008, J CLIN ONCOL, V26, P242, DOI 10.1200/JCO.2007.12.4008; Caffo O, 2010, UROL ONCOL-SEMIN ORI, V28, P152, DOI 10.1016/j.urolonc.2008.07.033; CHANG CS, 1994, P NATL ACAD SCI USA, V91, P6040, DOI 10.1073/pnas.91.13.6040; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; Colloca G, 2012, MED ONCOL, V29, P776, DOI 10.1007/s12032-011-9855-6; Crea F, 2009, EPIGENOMICS-UK, V1, P63, DOI 10.2217/EPI.09.4; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Dinarello CA, 2010, CANCER METAST REV, V29, P317, DOI 10.1007/s10555-010-9229-0; Duhagon MA, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-324; Fan XL, 2012, UROL ONCOL-SEMIN ORI, V30, P314, DOI 10.1016/j.urolonc.2010.03.019; Frame FM, 2012, ADV EXP MED BIOL, V720, P105, DOI 10.1007/978-1-4614-0254-1_9; Gan L, 2011, PROSTATE, V71, P1158, DOI 10.1002/pros.21331; Greco SJ, 2007, STEM CELLS, V25, P3143, DOI 10.1634/stemcells.2007-0351; Harper LJ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-166; Hawley SA, 2002, DIABETES, V51, P2420, DOI 10.2337/diabetes.51.8.2420; Heidenreich A, 2013, ANN ONCOL, V24, P329, DOI 10.1093/annonc/mds505; Heidenreich A, 2013, EUR UROL, V63, P977, DOI 10.1016/j.eururo.2012.08.058; Hwang C, 2012, THER ADV MED ONCOL, V4, P329, DOI 10.1177/1758834012449685; James ND, 2012, LANCET ONCOL, V13, P549, DOI 10.1016/S1470-2045(12)70088-8; Kawasaki BT, 2009, PROSTATE, V69, P827, DOI 10.1002/pros.20931; Kim E, 2007, BIOCHEM BIOPH RES CO, V361, P323, DOI 10.1016/j.bbrc.2007.06.168; Kim E, 2011, DIABETES, V60, P1493, DOI 10.2337/db10-0393; Klarmann GJ, 2009, CLIN EXP METASTAS, V26, P433, DOI 10.1007/s10585-009-9242-2; Lee YF, 2011, AM J PHYSIOL-ENDOC M, V301, pE91, DOI 10.1152/ajpendo.00701.2010; Linn Douglas E, 2010, Genes Cancer, V1, P908, DOI 10.1177/1947601910388271; Liu S, 2011, J BIOL CHEM, V286, P38103, DOI 10.1074/jbc.M111.259523; Liu T, 2010, MOL CELL BIOCHEM, V340, P265, DOI 10.1007/s11010-010-0426-5; Loriot Y, 2010, EUR J CANCER, V46, P1770, DOI 10.1016/j.ejca.2010.04.010; Maitland NJ, 2005, BJU INT, V96, P1219, DOI 10.1111/j.1464-410X.2005.05744.x; Malik Babar, 2012, Front Biosci (Elite Ed), V4, P2142; Matsumoto A, 2009, INT J UROL, V16, P687, DOI 10.1111/j.1442-2042.2009.02341.x; Mezynski J, 2012, ANN ONCOL, V23, P2943, DOI 10.1093/annonc/mds119; Michels J, 2006, CANCER-AM CANCER SOC, V106, P1041, DOI 10.1002/cncr.21695; Mimeault M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031919; Morrison R, 2011, J ONCOL, V2011, DOI 10.1155/2011/941876; Nakabayashi M, 2008, BJU INT, V101, P308, DOI 10.1111/j.1464-410X.2007.07331.x; Reuter CWM, 2010, WORLD J UROL, V28, P391, DOI 10.1007/s00345-010-0527-5; Rosenberg JE, 2009, J CLIN ONCOL, V27, P2772, DOI 10.1200/JCO.2008.19.8002; Ross RW, 2008, CANCER-AM CANCER SOC, V112, P521, DOI 10.1002/cncr.23195; Ryan CJ, 2013, NEW ENGL J MED, V368, P138, DOI 10.1056/NEJMoa1209096; Seruga B, 2011, J CLIN ONCOL, V29, P3686, DOI 10.1200/JCO.2010.34.3996; Shyr CR, 2009, ENDOCRINOLOGY, V150, P2454, DOI 10.1210/en.2008-1165; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Smith DC, 2011, UROLOGY, V77, P1172, DOI 10.1016/j.urology.2010.12.043; Sternberg CN, 2013, ANN ONCOL, V24, P1017, DOI 10.1093/annonc/mds585; Tannock IF, 2004, NEW ENGL J MED, V351, P1502, DOI 10.1056/NEJMoa040720; Thomas S, 2005, CANCER BIOL THER, V4, P1226, DOI 10.4161/cbt.4.11.2093; Tsai LL, 2011, J ORAL PATHOL MED, V40, P621, DOI 10.1111/j.1600-0714.2011.01015.x; Wang XQ, 2010, HEPATOLOGY, V52, P528, DOI 10.1002/hep.23692; Wen KM, 2013, CANCER LETT, V333, P56, DOI 10.1016/j.canlet.2013.01.009; Yan H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024397; Yan SJ, 2012, CELL MOL BIOL LETT, V17, P309, DOI 10.2478/s11658-012-0012-9; Yap TA, 2012, EXPERT REV ANTICANC, V12, P1129, DOI [10.1586/era.12.88, 10.1586/ERA.12.88]; Yin ST, 2012, APOPTOSIS, V17, P388, DOI 10.1007/s10495-011-0687-9; Zhang LL, 2012, J CANCER RES CLIN, V138, P675, DOI 10.1007/s00432-011-1146-2	56	49	51	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2013	288	23					16476	16483		10.1074/jbc.M112.448142	http://dx.doi.org/10.1074/jbc.M112.448142			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	163ZU	23609451	Green Published, hybrid			2022-12-25	WOS:000320378900024
J	Yan, C; Ding, XC; Wu, LY; Yu, MG; Qu, P; Du, H				Yan, Cong; Ding, Xinchun; Wu, Lingyan; Yu, Menggang; Qu, Peng; Du, Hong			Stat3 Downstream Gene Product Chitinase 3-Like 1 Is a Potential Biomarker of Inflammation-induced Lung Cancer in Multiple Mouse Lung Tumor Models and Humans	PLOS ONE			English	Article							MYELOID-SPECIFIC EXPRESSION; II EPITHELIAL-CELLS; ALVEOLAR; ACTIVATION	Over-activation of the signal transducers and activators of the transcription 3 (Stat3) pathway in lung alveolar type II (AT II) epithelial cells induces chronic inflammation and adenocarcinoma in the lung of CCSP-rtTA/(tetO) 7-CMV-Stat3C bitransgenic mice. One of Stat3 downstream genes products, chitinase 3-like 1 (CHI3L1) protein, showed increased concentration in both bronchioalveolar lavage fluid (BALF) and blood of doxycycline-treated CCSP-rtTA/(tetO) 7-CMV-Stat3C bitransgenic mice. When tested in other inflammation-induced lung cancer mouse models, the CHI3L1 protein concentration was also highly increased in BALF and blood of these models with tumors. Immunohistochemical staining showed strong staining of CHI3L1 protein around tumor areas in these mouse models. Analysis of normal objects and lung cancer patients revealed a significant elevation of CHI3L1 protein concentration in human serum samples from all categories of lung cancers. Furthermore, recombinant CHI3L protein stimulated proliferation and growth of Lewis lung cancer cells. Therefore, secretory CHI3L1 plays an important role in inflammation-induced lung cancer formation and potentially serve as a biomarker for lung cancer prediction. Based on our previous publication and this work, this is the first animal study linking overexpression of CHI3L1 to various lung tumor mouse models. These models will facilitate identification of additional biomarkers to predict and verify lung cancer under various pathogenic conditions, which normally cannot be done in humans.	[Yan, Cong; Ding, Xinchun; Wu, Lingyan; Qu, Peng; Du, Hong] Indiana Univ Sch Med, Dept Pathol & Lab Med, Indianapolis, IN 46202 USA; [Yan, Cong; Ding, Xinchun; Wu, Lingyan; Qu, Peng] Indiana Univ Sch Med, Ctr Immunobiol, Indianapolis, IN USA; [Yan, Cong; Ding, Xinchun; Wu, Lingyan; Du, Hong] Indiana Univ Sch Med, IU Simon Canc Ctr, Indianapolis, IN USA; [Yu, Menggang] Univ Wisconsin, Dept Biostat & Med Informat, Madison, WI USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; University of Wisconsin System; University of Wisconsin Madison	Yan, C (corresponding author), Indiana Univ Sch Med, Dept Pathol & Lab Med, Indianapolis, IN 46202 USA.	coyan@iupui.edu	ding, xinchun/P-5490-2017		NIH [CA138759, CA152099, HL087001]; NATIONAL CANCER INSTITUTE [P30CA082709, R01CA152099, R01CA138759] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087001] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding was provided by NIH CA138759, CA152099 (C. Yan) and HL087001 (H. Du). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Churg A, 2003, AM J RESP CRIT CARE, V167, P1083, DOI 10.1164/rccm.200212-1396OC; Kawada M, 2012, ONCOGENE, V31, P3111, DOI 10.1038/onc.2011.498; Lee CG, 2011, ANNU REV PHYSIOL, V73, P479, DOI 10.1146/annurev-physiol-012110-142250; Lee CG, 2009, J EXP MED, V206, P1149, DOI 10.1084/jem.20081271; Letuve S, 2008, J IMMUNOL, V181, P5167, DOI 10.4049/jimmunol.181.7.5167; Li Y, 2007, CANCER RES, V67, P8494, DOI 10.1158/0008-5472.CAN-07-0647; Li Y, 2011, CANCER RES, V71, P5488, DOI 10.1158/0008-5472.CAN-10-4225; Libreros S, 2012, INT J CANCER, V131, P377, DOI 10.1002/ijc.26379; Matsuura H, 2011, AM J RESP CELL MOL, V44, P777, DOI 10.1165/rcmb.2010-0081OC; Morris DG, 2003, NATURE, V422, P169, DOI 10.1038/nature01413; Qu P, 2011, BLOOD, V117, P4476, DOI 10.1182/blood-2010-07-298380; Qu P, 2009, CANCER RES, V69, P7252, DOI 10.1158/0008-5472.CAN-09-0577; Qu P, 2009, LUNG CANCER, V63, P341, DOI 10.1016/j.lungcan.2008.05.025; Qu P, 2009, J IMMUNOL, V182, P1648, DOI 10.4049/jimmunol.182.3.1648; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Thorn I, 2012, CANCER, V116, P4114; Wu LY, 2011, AM J PATHOL, V179, P2131, DOI 10.1016/j.ajpath.2011.06.028; Yan C, 2012, SCI CHINA LIFE SCI, V55, P576, DOI 10.1007/s11427-012-4339-2	18	9	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2013	8	4							e61984	10.1371/journal.pone.0061984	http://dx.doi.org/10.1371/journal.pone.0061984			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JR	23613996	Green Published, Green Submitted, gold			2022-12-25	WOS:000317911500075
J	Lee, SI; Kim, DS; Lee, HJ; Cha, HJ; Kim, EC				Lee, Sang-Im; Kim, Duck-Su; Lee, Hwa-Jeong; Cha, Hee-Jae; Kim, Eun-Cheol			The Role of Thymosin Beta 4 on Odontogenic Differentiation in Human Dental Pulp Cells	PLOS ONE			English	Article							MINERAL TRIOXIDE AGGREGATE; FOCAL ADHESION KINASE; ODONTOBLASTIC DIFFERENTIATION; HEME OXYGENASE-1; EXPRESSION; GROWTH; MIGRATION; SIALOPHOSPHOPROTEIN; SIALOPROTEIN; PROTEINS	We recently reported that overexpression of thymosin beta-4 (T beta 4) in transgenic mice promotes abnormal hair growth and tooth development, but the role of T beta 4 in dental pulp regeneration was not completely understood. The aim of this study was to investigate the role of T beta 4 on odontoblastic differentiation and the underlying mechanism regulating pulp regeneration in human dental pulp cells (HDPCs). Our results demonstrate that mRNA and protein expression of T beta 4 is upregulated during odontogenic differentiation in HDPCs. Transfection with T beta 4 siRNA decreases OM-induced odontoblastic differentiation by decreasing alkaline phosphatase (ALP) activity, mRNA expression of differentiation markers, and calcium nodule formation. In contrast, Tb4 activation with a T beta 4 peptide promotes these processes by enhancing the phosphorylation of p38, JNK, and ERK mitogen-activated protein kinases (MAPKs), bone morphogenetic protein (BMP) 2, BMP4, phosphorylation of Smad1/5/8 and Smad2/3, and expression of transcriptional factors such as Runx2 and Osterix, which were blocked by the BMP inhibitor noggin. The expression of integrin receptors alpha 1, alpha 2, alpha 3, and beta 1 and downstream signaling molecules including phosphorylated focal adhesion kinase (p-FAK), p-paxillin, and integrin-linked kinase (ILK) were increased by T beta 4 peptide in HDPCs. ILK siRNA blocked T beta 4-induced odontoblastic differentiation and activation of the BMP and MAPK transcription factor pathways in HDPCs. In conclusion, this study demonstrates for the first time that T beta 4 plays a key role in odontoblastic differentiation of HDPCs and activation of T beta 4 could provide a novel mechanism for regenerative endodontics.	[Lee, Sang-Im; Lee, Hwa-Jeong; Kim, Eun-Cheol] Kyung Hee Univ, Sch Dent, Dept Maxillofacial Tissue Regenerat, Seoul, South Korea; [Lee, Sang-Im; Lee, Hwa-Jeong; Kim, Eun-Cheol] Kyung Hee Univ, Sch Dent, Inst Oral Biol, Seoul, South Korea; [Kim, Duck-Su] Kyung Hee Univ, Sch Dent, Dept Conservat Dent, Seoul, South Korea; [Cha, Hee-Jae] Kosin Univ, Coll Med, Dept Parasitol & Genet, Pusan, South Korea	Kyung Hee University; Kyung Hee University; Kyung Hee University	Kim, EC (corresponding author), Kyung Hee Univ, Sch Dent, Dept Maxillofacial Tissue Regenerat, Seoul, South Korea.	eckim@khu.ac.kr	Cha, Hee-Jae/AFO-8772-2022; Kim, Duck-Su/AAT-9050-2021		National Research Foundation of Korea (NRF); Korea government (MEST) [2012R1A5A2051384]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korea government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MEST) (No, 2012R1A5A2051384). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhter M, 2005, HISTOCHEM CELL BIOL, V124, P207, DOI 10.1007/s00418-005-0040-x; Bock-Marquette I, 2004, NATURE, V432, P466, DOI 10.1038/nature03000; Butler WT, 2003, CONNECT TISSUE RES, V44, P171, DOI 10.1080/03008200390152287; Cha HJ, 2010, INT J DEV BIOL, V54, P135, DOI 10.1387/ijdb.082735hc; Chan CP, 2005, ARCH ORAL BIOL, V50, P469, DOI 10.1016/j.archoralbio.2004.10.005; Chen S, 2009, J DENT RES, V88, P904, DOI 10.1177/0022034509342873; Choi BD, 2012, INT J MOL MED, V29, P841, DOI 10.3892/ijmm.2012.913; Goldberg Michel, 2006, Dent Clin North Am, V50, P277, DOI 10.1016/j.cden.2005.11.008; Grant D S, 1999, Angiogenesis, V3, P125, DOI 10.1023/A:1009041911493; GRANT DS, 1995, J CELL SCI, V108, P3685; Hwang YC, 2008, J MOL HISTOL, V39, P153, DOI 10.1007/s10735-007-9148-8; Kim EC, 2012, J ENDODONT, V38, P769, DOI 10.1016/j.joen.2012.03.014; Kim JJ, 2012, J ENDODONT, V38, P899, DOI 10.1016/j.joen.2012.04.006; Kim SJ, 2010, J ENDODONT, V36, P1326, DOI 10.1016/j.joen.2010.04.011; Kim YS, 2010, J ENDODONT, V36, P1824, DOI 10.1016/j.joen.2010.08.020; Kitagawa M, 2007, ARCH ORAL BIOL, V52, P727, DOI 10.1016/j.archoralbio.2007.02.006; Lee SY, 2012, J DENT RES, V91, P407, DOI 10.1177/0022034511436113; Lee SY, 2012, J ENDODONT, V38, P405, DOI 10.1016/j.joen.2011.12.025; Lee SK, 2010, J ENDODONT, V36, P1537, DOI 10.1016/j.joen.2010.04.027; Lee SK, 2010, LIFE SCI, V86, P107, DOI 10.1016/j.lfs.2009.11.013; Liu H, 2006, METHOD ENZYMOL, V419, P99, DOI 10.1016/S0076-6879(06)19005-9; Malinda KM, 1997, FASEB J, V11, P474, DOI 10.1096/fasebj.11.6.9194528; Matsubara T, 2005, J BONE MINER RES, V20, P399, DOI 10.1359/JBMR.041117; Matsuo K, 2012, OR SURG OR MED OR PA, V114, P17, DOI 10.1016/j.tripleo.2011.05.025; Min KS, 2008, J ENDODONT, V34, P666, DOI 10.1016/j.joen.2008.03.009; Min KS, 2010, J ENDODONT, V36, P447, DOI 10.1016/j.joen.2009.11.021; Min KS, 2009, ORAL SURG ORAL MED O, V108, pE82, DOI 10.1016/j.tripleo.2009.05.022; Miyazono K, 2005, CYTOKINE GROWTH F R, V16, P251, DOI 10.1016/j.cytogfr.2005.01.009; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Papagerakis P, 2002, BONE, V30, P377, DOI 10.1016/S8756-3282(01)00683-4; Parsons JT, 2003, J CELL SCI, V116, P1409, DOI 10.1242/jcs.00373; Philp D, 2003, FASEB J, V17, P385, DOI 10.1096/fj.03-0244fje; Philp D, 2004, MECH AGEING DEV, V125, P113, DOI 10.1016/j.mad.2003.11.005; Qin W, 2012, J ENDODONT, V38, P66, DOI 10.1016/j.joen.2011.09.025; Qiu FY, 2009, J CARDIOVASC PHARM, V53, P209, DOI 10.1097/FJC.0b013e318199f326; SAFER D, 1991, J BIOL CHEM, V266, P4029; Salasznyk RM, 2007, EXP CELL RES, V313, P22, DOI 10.1016/j.yexcr.2006.09.013; Santra M, 2012, GLIA, V60, P1826, DOI 10.1002/glia.22400; Schneider GB, 2001, J DENT RES, V80, P1540, DOI 10.1177/00220345010800061201; Sloan AJ, 2007, ORAL DIS, V13, P151, DOI 10.1111/j.1601-0825.2006.01346.x; Tokura Y, 2011, J BIOCHEM, V149, P43, DOI 10.1093/jb/mvq115; Wan DC, 2007, J BIOL CHEM, V282, P26450, DOI 10.1074/jbc.M703282200; Yamakoshi Y, 2009, J ORAL BIOSCI, V51, P134, DOI 10.2330/joralbiosci.51.134; Yasuda Y, 2008, J ENDODONT, V34, P1057, DOI 10.1016/j.joen.2008.06.007; YOHAY DA, 1994, J CELL PHYSIOL, V158, P467, DOI 10.1002/jcp.1041580311; Zhang W, 2005, TISSUE ENG, V11, P357, DOI 10.1089/ten.2005.11.357	46	28	31	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2013	8	4							e61960	10.1371/journal.pone.0061960	http://dx.doi.org/10.1371/journal.pone.0061960			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IK	23613983	Green Published, gold, Green Submitted			2022-12-25	WOS:000317907200109
J	Khan, HAA; Akram, W; Shad, SA; Lee, JJ				Khan, Hafiz Azhar Ali; Akram, Waseem; Shad, Sarfraz Ali; Lee, Jong-Jin			Insecticide Mixtures Could Enhance the Toxicity of Insecticides in a Resistant Dairy Population of Musca domestica L	PLOS ONE			English	Article							ARMIGERA HUBNER LEPIDOPTERA; ORGANOPHOSPHATE INSECTICIDES; PIPERONYL BUTOXIDE; COTTON BOLLWORM; HOUSE-FLIES; PYRETHROIDS; DIPTERA; POTENTIATION/ANTAGONISM; COMBINATIONS; MANAGEMENT	House flies, Musca domestica L., are important pests of dairy operations worldwide, with the ability to adapt wide range of environmental conditions. There are a number of insecticides used for their management, but development of resistance is a serious problem. Insecticide mixtures could enhance the toxicity of insecticides in resistant insect pests, thus resulting as a potential resistance management tool. The toxicity of bifenthrin, cypermethrin, deltamethrin, chlorpyrifos, profenofos, emamectin benzoate and fipronil were assessed separately, and in mixtures against house flies. A field-collected population was significantly resistant to all the insecticides under investigation when compared with a laboratory susceptible strain. Most of the insecticide mixtures like one pyrethroid with other compounds evaluated under two conditions (1:1-"A" and LC50: LC50-"B") significantly increased the toxicity of pyrethroids in the field population. Under both conditions, the combination indices of pyrethroids with other compounds, in most of the cases, were significantly below 1, suggesting synergism. The enzyme inhibitors, PBO and DEF, when used in combination with insecticides against the resistant population, toxicities of bifenthrin, cypermethrin, deltamethrin and emamectin were significantly increased, suggesting esterase and monooxygenase based resistance mechanism. The toxicities of bifenthrin, cypermethrin and deltamethrin in the resistant population of house flies could be enhanced by the combination with chlorpyrifos, profenofos, emamectin and fipronil. The findings of the present study might have practical significance for resistance management in house flies.	[Khan, Hafiz Azhar Ali; Shad, Sarfraz Ali] Bahauddin Zakariya Univ, Dept Entomol, Multan, Pakistan; [Akram, Waseem] Univ Agr Faisalabad, Dept Agri Entomol, Faisalabad, Pakistan; [Lee, Jong-Jin] Chonbuk Natl Univ, Chonju, South Korea	Bahauddin Zakariya University; University of Agriculture Faisalabad; Jeonbuk National University	Khan, HAA (corresponding author), Bahauddin Zakariya Univ, Dept Entomol, Multan, Pakistan.	azhar_naturalist@yahoo.com	Khan, Hafiz Azhar Ali/AAI-7476-2021	Khan, Hafiz Azhar Ali/0000-0002-7209-4750	Higher Education Commission, Pakistan	Higher Education Commission, Pakistan(Higher Education Commission of Pakistan)	The authors thank the Higher Education Commission, Pakistan for providing PhD merit scholarship to HAAK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad M, 2004, PESTIC BIOCHEM PHYS, V80, P31, DOI 10.1016/j.pestbp.2004.06.002; Ahmad M, 2009, PEST MANAG SCI, V65, P266, DOI 10.1002/ps.1681; Ahmad M, 2007, J ECON ENTOMOL, V100, P886, DOI 10.1603/0022-0493(2007)100[886:AOPWOI]2.0.CO;2; Ahmad Mushtaq, 2009, Acta Entomologica Sinica, V52, P631; Ahmad M, 2009, CROP PROT, V28, P264, DOI 10.1016/j.cropro.2008.11.001; ASCHER KRS, 1986, PHYTOPARASITICA, V14, P101, DOI 10.1007/BF02980896; Attique MNR, 2006, J APPL ENTOMOL, V130, P122, DOI 10.1111/j.1439-0418.2006.01035.x; Bryne F. J., 1991, PEST BIOCH PHYSL, V40, P198; Cakir G, 2008, ACTA VET BRNO, V77, P467, DOI 10.2754/avb200877030467; Cetin H, 2010, EKOLOJI, V19, P27, DOI 10.5053/ekoloji.2010.754; CHAPMAN RB, 1980, PESTIC SCI, V11, P600, DOI 10.1002/ps.2780110607; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Corbel V, 2004, PEST MANAG SCI, V60, P375, DOI 10.1002/ps.809; CORBETT J R, 1974, P330; CURTIS CF, 1985, B ENTOMOL RES, V75, P259, DOI 10.1017/S0007485300014346; Denholm I., 1998, PHILOS T R SOC B, V353, P1673; ELGUINDY MA, 1983, PESTIC SCI, V14, P246, DOI 10.1002/ps.2780140306; Gunning RV, 1999, PESTIC BIOCHEM PHYS, V63, P50, DOI 10.1006/pest.1998.2388; Hemingway J, 2000, ANNU REV ENTOMOL, V45, P371, DOI 10.1146/annurev.ento.45.1.371; Islam M. Z., 2002, PAKISTAN J BIOL SCI, V5, P299; Kaufman PE, 2006, J AGR URBAN ENTOMOL, V23, P195; Kaufman PE, 2010, PEST MANAG SCI, V66, P290, DOI 10.1002/ps.1872; Keddis M. E., 1986, B ENTOMOL SOC EGYPT, V14, P251; Khan HAA, 2013, ECOTOXICOL IN PRESS; Khan HAA, 2012, PARASITOL RES, V111, P1165, DOI 10.1007/s00436-012-2947-1; KULKARNI AP, 1980, PHARMACOL THERAPEUT, V8, P379, DOI 10.1016/0163-7258(80)90054-6; Liu NN, 2000, J ECON ENTOMOL, V93, P1269, DOI 10.1603/0022-0493-93.4.1269; Martin T, 2003, J ECON ENTOMOL, V96, P468, DOI 10.1603/0022-0493-96.2.468; Montella IR, 2012, MEM I OSWALDO CRUZ, V107, P437, DOI 10.1590/S0074-02762012000400001; Phokela A., 1999, Pesticide Research Journal, V11, P62; ROUSH RT, 1993, PARASITOL TODAY, V9, P174, DOI 10.1016/0169-4758(93)90141-2; Tian L, 2011, INT J BIOL SCI, V7, P902, DOI 10.7150/ijbs.7.902; Usmani KA, 2001, J ECON ENTOMOL, V94, P868, DOI 10.1603/0022-0493-94.4.868; Wang XP, 2006, PHYSIOL ENTOMOL, V31, P190, DOI 10.1111/j.1365-3032.2006.00508.x; Ware GW, 2000, PESTICIDE BOOK	35	40	44	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2013	8	4							e60929	10.1371/journal.pone.0060929	http://dx.doi.org/10.1371/journal.pone.0060929			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130DR	23613758	gold, Green Submitted, Green Published			2022-12-25	WOS:000317893400030
J	Liang, LF; Wang, CT; Sun, XF; Liu, L; Li, M; Witz, C; Williams, D; Griffith, J; Skorupski, J; Haddad, G; Gill, J; Wang, WH				Liang, Lifeng; Wang, Cassie T.; Sun, Xiaofang; Liu, Lian; Li, Man; Witz, Craig; Williams, Daniel; Griffith, Jason; Skorupski, Josh; Haddad, Ghassan; Gill, Jimmy; Wang, Wei-Hua			Identification of Chromosomal Errors in Human Preimplantation Embryos with Oligonucleotide DNA Microarray	PLOS ONE			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; IN-VITRO FERTILIZATION; BODY ARRAY CGH; GENETIC DIAGNOSIS; SINGLE CELLS; YOUNG-WOMEN; ANEUPLOIDY; AGE; ABNORMALITIES; MOSAICISM	A previous study comparing the performance of different platforms for DNA microarray found that the oligonucleotide (oligo) microarray platform containing 385K isothermal probes had the best performance when evaluating dosage sensitivity, precision, specificity, sensitivity and copy number variations border definition. Although oligo microarray platform has been used in some research fields and clinics, it has not been used for aneuploidy screening in human embryos. The present study was designed to use this new microarray platform for preimplantation genetic screening in the human. A total of 383 blastocysts from 72 infertility patients with either advanced maternal age or with previous miscarriage were analyzed after biopsy and microarray. Euploid blastocysts were transferred to patients and clinical pregnancy and implantation rates were measured. Chromosomes in some aneuploid blastocysts were further analyzed by fluorescence insitu hybridization (FISH) to evaluate accuracy of the results. We found that most (58.1%) of the blastocysts had chromosomal abnormalities that included single or multiple gains and/or losses of chromosome(s), partial chromosome deletions and/or duplications in both euploid and aneuploid embryos. Transfer of normal euploid blastocysts in 34 cycles resulted in 58.8% clinical pregnancy and 54.4% implantation rates. Examination of abnormal blastocysts by FISH showed that all embryos had matching results comparing microarray and FISH analysis. The present study indicates that oligo microarray conducted with a higher resolution and a greater number of probes is able to detect not only aneuploidy, but also minor chromosomal abnormalities, such as partial chromosome deletion and/or duplication in human embryos. Preimplantation genetic screening of the aneuploidy by DNA microarray is an advanced technology used to select embryos for transfer and improved embryo implantation can be obtained after transfer of the screened normal embryos.	[Liang, Lifeng; Wang, Cassie T.; Witz, Craig; Williams, Daniel; Griffith, Jason; Skorupski, Josh; Haddad, Ghassan; Gill, Jimmy; Wang, Wei-Hua] Houston Fertil Inst, Houston, TX USA; [Liang, Lifeng; Sun, Xiaofang] Guangzhou Med Univ, Hosp 3, Guangzhou, Guangdong, Peoples R China; [Liu, Lian; Li, Man] Pacgenomics Inc, Village Med Ctr, Thousand Oaks, CA USA	Guangzhou Medical University	Wang, WH (corresponding author), Houston Fertil Inst, Houston, TX USA.	wangweihua11@yahoo.com			Third Hospital Affiliated to Guangzhou Medical University	Third Hospital Affiliated to Guangzhou Medical University	This study was supported by a grant from the Third Hospital Affiliated to Guangzhou Medical University. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfarawati S, 2011, HUM REPROD, V26, P1560, DOI 10.1093/humrep/der068; Asan, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-r95; Baart EB, 2006, HUM REPROD, V21, P223, DOI 10.1093/humrep/dei291; Baart EB, 2007, HUM REPROD, V22, P980, DOI 10.1093/humrep/del484; Chang H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021097; Chiang T, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.094367; Clark MJ, 2011, NAT BIOTECHNOL, V29, P908, DOI 10.1038/nbt.1975; Colls P, 2009, REPROD BIOMED ONLINE, V19, P532, DOI 10.1016/j.rbmo.2009.05.002; Fiegler H, 2006, GENOME RES, V16, P1566, DOI 10.1101/gr.5630906; Fiorentino F, 2011, HUM REPROD, V26, P1925, DOI 10.1093/humrep/der082; Geigl JB, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp526; Geraedts J, 2011, HUM REPROD, V26, P3173, DOI 10.1093/humrep/der294; Gutierrez-Mateo C, 2004, HUM REPROD, V19, P2859, DOI 10.1093/humrep/deh515; Hardarson T, 2008, HUM REPROD, V23, P2806, DOI 10.1093/humrep/den217; Harper JC, 2010, FERTIL STERIL, V94, P1173, DOI 10.1016/j.fertnstert.2010.04.064; Harper-Stromberg E, 2011, BIOINFORMATICS, V27, P1052; Hassold T, 2001, NAT REV GENET, V2, P280, DOI 10.1038/35066065; Hehir-Kwa JY, 2007, DNA RES, V14, P1, DOI 10.1093/dnares/dsm002; Hellani A, 2008, REPROD BIOMED ONLINE, V17, P841, DOI 10.1016/S1472-6483(10)60413-0; Jessberger R, 2012, EMBO REP, V13, P539, DOI 10.1038/embor.2012.54; Johnson DS, 2010, MOL HUM REPROD, V16, P944, DOI 10.1093/molehr/gaq062; Jones KT, 2008, HUM REPROD UPDATE, V14, P143, DOI 10.1093/humupd/dmm043; Jones KT, 2012, EXP CELL RES, V318, P1394, DOI 10.1016/j.yexcr.2012.02.012; Lewis R, 2011, HUMAN GENETICS CONCE; Li M, 2005, FERTIL STERIL, V84, P1395, DOI 10.1016/j.fertnstert.2005.04.068; Li XM, 2008, CURR GENOMICS, V9, P466, DOI 10.2174/138920208786241199; Liu PF, 2011, CELL, V146, P888, DOI 10.1016/j.cell.2011.07.042; Liu Y, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.096826; Magli MC, 2011, HUM REPROD, V26, P3181, DOI 10.1093/humrep/der295; Mastenbroek S, 2007, NEW ENGL J MED, V357, P9, DOI 10.1056/NEJMoa067744; Mukaida T, 2006, HUM REPROD, V21, P3246, DOI 10.1093/humrep/del285; Munne S, 2004, PRENATAL DIAG, V24, P638, DOI 10.1002/pd.957; Munne Santiago, 2002, Reprod Biomed Online, V4, P223; Northrop LE, 2010, MOL HUM REPROD, V16, P590, DOI 10.1093/molehr/gaq037; Pacchierotti F, 2007, ENVIRON RES, V104, P46, DOI 10.1016/j.envres.2006.12.001; Platteau P, 2005, FERTIL STERIL, V84, P319, DOI 10.1016/j.fertnstert.2005.02.019; Racowsky C, 2010, J ASSIST REPROD GEN, V27, P437, DOI 10.1007/s10815-010-9443-2; Rius M, 2011, FERTIL STERIL, V95, P413, DOI 10.1016/j.fertnstert.2010.07.1051; Rubio C, 2003, HUM REPROD, V18, P182, DOI 10.1093/humrep/deg015; Schoolcraft WB, 2010, FERTIL STERIL, V94, pS23, DOI 10.1016/j.fertnstert.2010.07.090; Scott RT, 2012, FERTIL STERIL, V97, P870, DOI 10.1016/j.fertnstert.2012.01.104; Selesniemi K, 2011, P NATL ACAD SCI USA, V108, P12319, DOI 10.1073/pnas.1018793108; Staessen C, 2008, HUM REPROD, V23, P2818, DOI 10.1093/humrep/den367; Treff NR, 2010, FERTIL STERIL, V94, P2017, DOI 10.1016/j.fertnstert.2010.01.052; Vanneste Evelyne, 2012, Frontiers in Genetics, V3, P44, DOI 10.3389/fgene.2012.00044; Voullaire L, 2002, MOL HUM REPROD, V8, P1035, DOI 10.1093/molehr/8.11.1035; Yang ZH, 2012, MOL CYTOGENET, V5, DOI 10.1186/1755-8166-5-24	47	15	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2013	8	4							e61838	10.1371/journal.pone.0061838	http://dx.doi.org/10.1371/journal.pone.0061838			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130DR	23613950	Green Published, Green Submitted, gold			2022-12-25	WOS:000317893400116
J	Mohamed, S; Raimondo, A; Penaranda, G; Camus, C; Ouzan, D; Ravet, S; Bourliere, M; Khiri, H; Dukan, P; Olive, D; Halfon, P				Mohamed, Sofiane; Raimondo, Audrey; Penaranda, Guillaume; Camus, Claire; Ouzan, Denis; Ravet, Sophie; Bourliere, Marc; Khiri, Hacene; Dukan, Patrick; Olive, Daniel; Halfon, Philippe			Dried Blood Spot Sampling for Hepatitis B Virus Serology and Molecular Testing	PLOS ONE			English	Article							NATURAL-HISTORY; FILTER-PAPER; INFECTION; MANAGEMENT; RISK; QUANTIFICATION; AMPLIFICATION; SURVEILLANCE; VACCINATION; PREVALENCE	Background & Aims: Dried blood spots (DBS) on filter paper have been successfully used to diagnose and monitor several infectious diseases. The aim was to investigate the performance of DBS in hepatitis B virus (HBV) diagnosis using commercial tests in comparison to standard methods. Methods: Paired DBS and plasma samples were collected from 200 patients: 100 patients with HBsAg negative status and 100 patients with HBsAg positive status. In the latter patient, HBeAg reactivity was tested. Ten samples of anti-HBs were collected from people vaccinated against HBV. We also studied 50 patients with positive HBV DNA viral load in plasma and 10 HBV DNA negative patients. HBV genotypes and gene polymerase mutations were determined in 10 randomly selected HBV-infected patients. The DBS sample consisted of 50 mu L of whole blood, i.e. a 12-mm paper card. Results: The sensitivity thresholds of HBsAg and anti-HBs antibody were 0.30+/-0.08 IU/mL and 18.11+/-6.05 IU/mL, respectively, for DBS with 98% sensitivity and 100% specificity. Sensitivity was 98% and specificity 100% for the detection of HBV DNA on a blotter, considering an HBV DNA threshold of 914.1+/-157.8 IU/ml. Ten patients had an HBeAg positive status in plasma, all were detected positive using DBS. HBV genotyping and mutation detection were successfully performed on DBS, with full concordance between the 10 paired DBS and plasma samples. Conclusion: This study shows DBS is a reliable alternative to plasma specimens for quantifying and detecting HBsAg, anti-HBs, HBeAg and genotyping. DBS may increase the opportunities for HBV testing and treatment follow-up in hard-to-reach individuals.	[Mohamed, Sofiane; Penaranda, Guillaume; Camus, Claire; Khiri, Hacene; Halfon, Philippe] Lab Alphabio, Marseille, France; [Raimondo, Audrey; Ravet, Sophie] CDL Pharma, Marseille, France; [Ouzan, Denis] Inst Arnault Tzanck, St Laurent Du Var, France; [Bourliere, Marc] Hop St Joseph, Dept Hepatogastroenterol, Marseille, France; [Dukan, Patrick; Halfon, Philippe] Hop Ambroise Pare, Marseille, France; [Mohamed, Sofiane; Olive, Daniel] Inst Paoli Calmettes, Lab Immunol Tumeurs, Marseille, France; [Mohamed, Sofiane; Olive, Daniel] Inst Paoli Calmettes, Ctr INSERM Rech Cancerol, Marseille, France	UNICANCER; Institut Paoli-Calmette (IPC); Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Institut Paoli-Calmette (IPC)	Halfon, P (corresponding author), Lab Alphabio, Marseille, France.	philippe.halfon@alphabio.fr		PENARANDA, Guillaume/0000-0002-7461-4254				Beck IA, 2001, J CLIN MICROBIOL, V39, P29, DOI 10.1128/JCM.39.1.29-33.2001; Bertagnolio S, 2010, AIDS REV, V12, P195; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Brugal MT, 2009, EUR ADDICT RES, V15, P171, DOI 10.1159/000220345; Chanbancherd P, 1999, J CLIN MICROBIOL, V37, P804, DOI 10.1128/JCM.37.3.804-806.1999; Chevaliez S, 2012, GASTROENTEROLOGY, V142, P1303, DOI 10.1053/j.gastro.2012.02.027; Fattovich G, 2003, SEMIN LIVER DIS, V23, P47, DOI 10.1055/s-2003-37590; Forbi JC, 2010, ANN AFR MED, V9, P44, DOI 10.4103/1596-3519.62625; Ganem D, 2004, NEW ENGL J MED, V350, P1118, DOI 10.1056/NEJMra031087; Goldstein ST, 2002, J INFECT DIS, V185, P713, DOI 10.1086/339192; GUPTA BP, 1992, J CLIN MICROBIOL, V30, P1913, DOI 10.1128/JCM.30.8.1913-1916.1992; Hadziyannis SJ, 2006, SEMIN LIVER DIS, V26, P130, DOI 10.1055/s-2006-939751; Halfon P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033000; Hoofnagle JH, 2007, HEPATOLOGY, V45, P1056, DOI 10.1002/hep.21627; Ibrahim SA, 2006, EPIDEMIOL INFECT, V134, P79, DOI 10.1017/S0950268805004620; Jardi R, 2004, HEPATOLOGY, V40, P133, DOI 10.1002/hep.20275; Kassak K, 2011, SEX HEALTH, V8, P229, DOI 10.1071/SH10080; Komas NP, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-226; Lampertico P, 2012, GUT, V61, P18, DOI 10.1136/gutjnl-2012-302085; Liaw YF, 2005, SEMIN LIVER DIS, V25, P40, DOI 10.1055/s-2005-915649; Lok ASF, 2007, HEPATOLOGY, V45, P507, DOI 10.1002/hep.21513; Lukacs Z, 2005, CLIN CHEM LAB MED, V43, P141, DOI 10.1515/CCLM.2005.023; Mahfoud Z, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-96; McMahon BJ, 2004, SEMIN LIVER DIS, V24, P17, DOI 10.1055/s-2004-828674; Mei JV, 2001, J NUTR, V131, p1631S, DOI 10.1093/jn/131.5.1631S; Mendy M, 2005, J VIRAL HEPATITIS, V12, P642, DOI 10.1111/j.1365-2893.2005.00641.x; Neumaier M, 1998, CLIN CHEM, V44, P12; Ott JJ, 2012, VACCINE, V30, P2212, DOI 10.1016/j.vaccine.2011.12.116; Papatheodoridis G, 2012, J HEPATOL, V57, P167, DOI 10.1016/j.jhep.2012.02.010; Snijdewind IJM, 2012, ANTIVIR RES, V93, P309, DOI 10.1016/j.antiviral.2011.12.011; Snow-Lampart A, 2011, HEPATOLOGY, V53, P763, DOI 10.1002/hep.24078; Tappin DM, 1998, EPIDEMIOL INFECT, V121, P387, DOI 10.1017/S0950268898001393; Therrell BL, 1996, BIOCHEM MOL MED, V57, P116, DOI 10.1006/bmme.1996.0017; Tuaillon E, 2010, HEPATOLOGY, V51, P752, DOI 10.1002/hep.23407; Vallejo F, 2008, J SUBST ABUSE TREAT, V34, P398, DOI 10.1016/j.jsat.2007.07.003; Viljoen J, 2010, JAIDS-J ACQ IMM DEF, V55, P290, DOI 10.1097/QAI.0b013e3181edaaf5; Villar LM, 2011, J MED VIROL, V83, P1522, DOI 10.1002/jmv.22138; Whelan J, 2012, VACCINE, V30, P5651, DOI 10.1016/j.vaccine.2012.06.080	38	45	46	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2013	8	4							e61077	10.1371/journal.pone.0061077	http://dx.doi.org/10.1371/journal.pone.0061077			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130DR	23613788	Green Published, Green Submitted, gold			2022-12-25	WOS:000317893400039
J	Shi, ZH; Ganzenmuller, S; Muller, HJ				Shi, Zhuanghua; Ganzenmueller, Stephanie; Mueller, Hermann J.			Reducing Bias in Auditory Duration Reproduction by Integrating the Reproduced Signal	PLOS ONE			English	Article							PERCEIVED DURATION; PERCEPTION; TIME; INTERVAL; MOTOR; MECHANISMS; RANGE; DISTORTIONS; INFORMATION; COMBINATION	Duration estimation is known to be far from veridical and to differ for sensory estimates and motor reproduction. To investigate how these differential estimates are integrated for estimating or reproducing a duration and to examine sensorimotor biases in duration comparison and reproduction tasks, we compared estimation biases and variances among three different duration estimation tasks: perceptual comparison, motor reproduction, and auditory reproduction (i.e. a combined perceptual-motor task). We found consistent overestimation in both motor and perceptual-motor auditory reproduction tasks, and the least overestimation in the comparison task. More interestingly, compared to pure motor reproduction, the overestimation bias was reduced in the auditory reproduction task, due to the additional reproduced auditory signal. We further manipulated the signal-to-noise ratio (SNR) in the feedback/comparison tones to examine the changes in estimation biases and variances. Considering perceptual and motor biases as two independent components, we applied the reliability-based model, which successfully predicted the biases in auditory reproduction. Our findings thus provide behavioral evidence of how the brain combines motor and perceptual information together to reduce duration estimation biases and improve estimation reliability.	[Shi, Zhuanghua; Ganzenmueller, Stephanie; Mueller, Hermann J.] Ludwig Maximilians Univ Munchen, Dept Psychol, Munich, Germany; [Ganzenmueller, Stephanie] Ludwig Maximilians Univ Munchen, Grad Sch Syst Neurosci, Munich, Germany; [Mueller, Hermann J.] Univ London, Birkbeck Coll, Dept Psychol Sci, London, England	University of Munich; University of Munich; University of London; Birkbeck University London	Shi, ZH (corresponding author), Ludwig Maximilians Univ Munchen, Dept Psychol, Munich, Germany.	shi@psy.lmu.de	Shi, Zhuanghua/J-2236-2019	Shi, Zhuanghua/0000-0003-2388-6695	German DFG project [SH-166]	German DFG project(German Research Foundation (DFG))	The work is supported by German DFG project SH-166 (http://gepris.dfg.de/gepris/OCTOPUS/?context=projekt&id=194001222&language=en&module=gepris&task=showDetail). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alais D, 2004, CURR BIOL, V14, P257, DOI 10.1016/j.cub.2004.01.029; Alais D, 2010, SEEING PERCEIVING, V23, P3, DOI 10.1163/187847510X488603; Angrilli A, 1997, PERCEPT PSYCHOPHYS, V59, P972, DOI 10.3758/BF03205512; Aschersleben G, 2001, EXP BRAIN RES, V136, P331, DOI 10.1007/s002210000562; Binda P, 2009, J NEUROSCI, V29, P13147, DOI 10.1523/JNEUROSCI.3723-09.2009; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Bueti D, 2008, J COGNITIVE NEUROSCI, V20, P204, DOI 10.1162/jocn.2008.20017; Bueti D, 2008, J COGNITIVE NEUROSCI, V20, P1054, DOI 10.1162/jocn.2008.20060; Bueti D, 2011, FRONT INTEGR NEUROSC, V5, DOI 10.3389/fnint.2011.00034; Bueti D, 2010, PERCEPTION, V39, P81, DOI 10.1068/p6405; Buhusi CV, 2005, NAT REV NEUROSCI, V6, P755, DOI 10.1038/nrn1764; Burge J, 2010, J NEUROSCI, V30, P7714, DOI 10.1523/JNEUROSCI.6427-09.2010; Burr D, 2009, EXP BRAIN RES, V198, P49, DOI 10.1007/s00221-009-1933-z; Chen KM, 2009, ACTA PSYCHOL, V130, P225, DOI 10.1016/j.actpsy.2008.12.008; CHURCH RM, 1984, ANN NY ACAD SCI, V423, P566, DOI 10.1111/j.1749-6632.1984.tb23459.x; Cicchini GM, 2012, J NEUROSCI, V32, P1056, DOI 10.1523/JNEUROSCI.3411-11.2012; Coull JT, 2004, SCIENCE, V303, P1506, DOI 10.1126/science.1091573; Di Luca M, 2009, J VISION, V9, DOI 10.1167/9.12.7; Ernst M. O., 2011, SENSORY CUE INTEGRAT, P224, DOI 10.1093/acprof:oso/9780195387247.003.0012; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; Gamache PL, 2010, EUR J NEUROSCI, V31, P1908, DOI 10.1111/j.1460-9568.2010.07197.x; Ganzenmuler S, 2012, FRONT INTEGR NEUROSC, V6, DOI 10.3389/fnint.2012.00095; Ghahramani Z, 1997, ADV PSYCHOL, V119, P117; Gibbon J, 1997, CURR OPIN NEUROBIOL, V7, P170, DOI 10.1016/S0959-4388(97)80005-0; GOLDSTON.S, 1968, PERCEPT MOTOR SKILL, V26, P755, DOI 10.2466/pms.1968.26.3.755; Gori M, 2008, CURR BIOL, V18, P694, DOI 10.1016/j.cub.2008.04.036; Gu BM, 2011, LECT NOTES ARTIF INT, V6789, P67, DOI 10.1007/978-3-642-21478-3_6; Hartcher-O'Brien J, 2011, J EXP PSYCHOL HUMAN, V37, P1383, DOI 10.1037/a0024234; Iordanescu L, 2013, PSYCHON B REV, V20, P108, DOI 10.3758/s13423-012-0330-y; IVRY RB, 1995, J EXP PSYCHOL HUMAN, V21, P3, DOI 10.1037/0096-1523.21.1.3; Jancke L, 2000, COGNITIVE BRAIN RES, V10, P51, DOI 10.1016/S0926-6410(00)00022-7; Jantzen KJ, 2005, NEUROIMAGE, V25, P1031, DOI 10.1016/j.neuroimage.2004.12.029; Jazayeri M, 2010, NAT NEUROSCI, V13, P1020, DOI 10.1038/nn.2590; Jones LA, 2009, Q J EXP PSYCHOL, V62, P2171, DOI 10.1080/17470210902782200; KEELE SW, 1985, ACTA PSYCHOL, V60, P173, DOI 10.1016/0001-6918(85)90054-X; Kording KP, 2004, NATURE, V427, P244, DOI 10.1038/nature02169; Kuschel M, 2010, IEEE T HAPTICS, V3, P234, DOI 10.1109/ToH.2010.9; Landy M.S., 2011, SENSORY CUE INTEGRAT, P5, DOI [10.1093/acprof:oso/9780195387247.003.0001, DOI 10.1093/ACPROF:OSO/9780195387247.003.0001]; Ley I, 2009, J EXP PSYCHOL HUMAN, V35, P1005, DOI 10.1037/a0015021; Macmillan N. A., 2005, DETECTION THEORY USE; Matthews WJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019815; Matthews WJ, 2011, J EXP PSYCHOL HUMAN, V37, P303, DOI 10.1037/a0019961; Meegan DV, 2000, NAT NEUROSCI, V3, P860, DOI 10.1038/78757; Morrone MC, 2005, NAT NEUROSCI, V8, P950, DOI 10.1038/nn1488; Oruc I, 2003, VISION RES, V43, P2451, DOI 10.1016/S0042-6989(03)00435-8; Pariyadath V, 2008, J VISION, V8, DOI 10.1167/8.16.11; Park J, 2003, EXP BRAIN RES, V149, P527, DOI 10.1007/s00221-003-1376-x; Petzschner FH, 2011, J NEUROSCI, V31, P17220, DOI 10.1523/JNEUROSCI.2028-11.2011; Shi Z, 2012, FRONT INTEGR NEUROSC, V6, P1; Shi ZH, 2010, EXP BRAIN RES, V203, P723, DOI 10.1007/s00221-010-2286-3; Takahashi K, 2012, ATTEN PERCEPT PSYCHO, V74, P1623, DOI 10.3758/s13414-012-0347-3; TEGHTSOONIAN R, 1978, PERCEPT PSYCHOPHYS, V24, P305, DOI 10.3758/BF03204247; Tomassini A, 2011, FRONT INTEGR NEUROSC, V5, DOI 10.3389/fnint.2011.00051; TREISMAN M, 1963, PSYCHOL MONOGR, V77, P1, DOI 10.1037/h0093864; van Wassenhove V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001437; WALKER JT, 1981, J EXP PSYCHOL HUMAN, V7, P1327, DOI 10.1037/0096-1523.7.6.1327; Wearden JH, 2003, TIME AND MIND II: INFORMATION PROCESSING PERSPECTIVES, P21; Wearden JH, 1998, Q J EXP PSYCHOL-B, V51, P97; WELCH RB, 1980, PSYCHOL BULL, V88, P638, DOI 10.1037/0033-2909.88.3.638; WING AM, 1973, PERCEPT PSYCHOPHYS, V14, P5, DOI 10.3758/BF03198607; Witten IB, 2005, NEURON, V48, P489, DOI 10.1016/j.neuron.2005.10.020; Yarrow K, 2003, CURR BIOL, V13, P1134, DOI 10.1016/S0960-9822(03)00413-5; Yarrow K, 2001, NATURE, V414, P302, DOI 10.1038/35104551; Zaidel A, 2011, J NEUROSCI, V31, P13949, DOI 10.1523/JNEUROSCI.2732-11.2011; Zatorre RJ, 2007, NAT REV NEUROSCI, V8, P547, DOI 10.1038/nrn2152	65	21	21	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2013	8	4							e62065	10.1371/journal.pone.0062065	http://dx.doi.org/10.1371/journal.pone.0062065			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	130DR	23614014	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000317893400150
J	Suzuki, J; Kuwahara, M; Tofukuji, S; Imamura, M; Kato, F; Nakayama, T; Ohara, O; Yamashita, M				Suzuki, Junpei; Kuwahara, Makoto; Tofukuji, Soichi; Imamura, Masashi; Kato, Fuminori; Nakayama, Toshinori; Ohara, Osamu; Yamashita, Masakatsu			A Novel Small Compound SH-2251 Suppresses Th2 Cell-Dependent Airway Inflammation through Selective Modulation of Chromatin Status at the Il5 Gene Locus	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; HISTONE MODIFICATIONS; TYPE-2 IMMUNITY; ALLERGIC-ASTHMA; LYMPHOID-CELLS; CONTROL REGION; IN-VIVO; DIFFERENTIATION; INNATE; LUNG	IL-5 is a key cytokine that plays an important role in the development of pathological conditions in allergic inflammation. Identifying strategies to inhibit IL-5 production is important in order to establish new therapies for treating allergic inflammation. We found that SH-2251, a novel thioamide-related small compound, selectively inhibits the differentiation of IL-5-producing Th2 cells. SH-2251 inhibited the induction of active histone marks at the Il5 gene locus during Th2 cell differentiation. The recruitment of RNA polymerase II, and following expression of the Th2 cell-specific intergenic transcripts around the Il5 gene locus was also inhibited. Furthermore, Th2 cell-dependent airway inflammation in mice was suppressed by the oral administration of SH-2251. Gfi1, a transcriptional repressor, was identified as a downstream target molecule of SH-2251 using a DNA microarray analysis. The Gfi1 expression dramatically decreased in SH-2251-treated Th2 cells, and the SH-2251-mediated inhibition of IL-5-producing Th2 cell differentiation was restored by transduction of Gfi1. Therefore, our study unearthed SH-2251 as a novel therapeutic candidate for allergic inflammation that selectively inhibits active histone marks at the Il5 gene locus.	[Suzuki, Junpei] Chiba Univ, Grad Sch Pharmaceut Sci, Dept Pharmacogen, Chuo Ku, Chiba, Japan; [Suzuki, Junpei; Kuwahara, Makoto; Tofukuji, Soichi; Ohara, Osamu; Yamashita, Masakatsu] Kazusa DNA Res Inst, Dept Human Genome Res, Kisarazu, Chiba, Japan; [Tofukuji, Soichi; Nakayama, Toshinori] Chiba Univ, Grad Sch Med, Dept Immunol, Chuo Ku, Chiba, Japan; [Imamura, Masashi; Kato, Fuminori] Ishihara Sangyo Kaisha Ltd, Cent Res Inst, Kusatsu, Shiga, Japan; [Nakayama, Toshinori] Japan Sci & Technol Agcy, CREST, Chuo Ku, Chiba, Japan; [Yamashita, Masakatsu] Ehime Univ, Grad Sch Med, Dept Immunol, Toon, Ehime, Japan; [Yamashita, Masakatsu] Japan Sci & Technol Agcy, PRESTO, Toon, Ehime, Japan	Chiba University; Kazusa DNA Research Institute; Chiba University; Ishihara Sangyo Kaisha Ltd; Japan Science & Technology Agency (JST); Ehime University; Japan Science & Technology Agency (JST)	Yamashita, M (corresponding author), Kazusa DNA Res Inst, Dept Human Genome Res, Kisarazu, Chiba, Japan.	yamamasa@m.ehime-u.ac.jp	Nakayama, Toshinori/E-1067-2017; Ohara, Osamu/G-5448-2015	Nakayama, Toshinori/0000-0002-1434-2007; Ohara, Osamu/0000-0002-3328-9571; Tofukuji, Soichi/0000-0003-4599-4937	Global COE Program (Global Center for Education and Research in Immune System Regulation and Treatment); Ministry of Education, Culture, Sports, Science and Technology (Japan) [23390075]; JST PRESTO (Japan)	Global COE Program (Global Center for Education and Research in Immune System Regulation and Treatment)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science and Technology (Japan)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JST PRESTO (Japan)	This work was supported by the Global COE Program (Global Center for Education and Research in Immune System Regulation and Treatment), JST PRESTO (Japan), and by grants from the Ministry of Education, Culture, Sports, Science and Technology (Japan) (Grants-in-Aid: Scientific Research (B) #23390075). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abonia JP, 2011, EXPERT REV CLIN IMMU, V7, P411, DOI [10.1586/ECI.11.27, 10.1586/eci.11.27]; Adcock IM, 2008, LANCET, V372, P1073, DOI 10.1016/S0140-6736(08)61449-X; Agarwal S, 2000, IMMUNITY, V12, P643, DOI 10.1016/S1074-7613(00)80215-0; Ansel KM, 2006, ANNU REV IMMUNOL, V24, P607, DOI 10.1146/annurev.immunol.23.021704.115821; Ballantyne SJ, 2007, J ALLERGY CLIN IMMUN, V120, P1324, DOI 10.1016/j.jaci.2007.07.051; Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22; Bartemes KR, 2012, J IMMUNOL, V188, P1503, DOI 10.4049/jimmunol.1102832; Bosnjak B, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-114; Cosio BG, 2004, AM J RESP CRIT CARE, V170, P141, DOI 10.1164/rccm.200305-659OC; Duan ZJ, 2005, MOL CELL BIOL, V25, P10338, DOI 10.1128/MCB.25.23.10338-10351.2005; Foster PS, 1996, J EXP MED, V183, P195, DOI 10.1084/jem.183.1.195; Gauvreau GM, 2009, CLIN EXP ALLERGY, V39, P1297, DOI 10.1111/j.1365-2222.2009.03325.x; Haldar P, 2009, NEW ENGL J MED, V360, P973, DOI 10.1056/NEJMoa0808991; Halim TYF, 2012, IMMUNITY, V36, P451, DOI 10.1016/j.immuni.2011.12.020; Holgate ST, 2008, CLIN EXP ALLERGY, V38, P872, DOI 10.1111/j.1365-2222.2008.02971.x; Hurst SD, 2002, J IMMUNOL, V169, P443, DOI 10.4049/jimmunol.169.1.443; Ikutani M, 2012, J IMMUNOL, V188, P703, DOI 10.4049/jimmunol.1101270; Ito K, 2002, AM J RESP CRIT CARE, V166, P392, DOI 10.1164/rccm.2110060; Khan AU, 2005, FRONT BIOSCI-LANDMRK, V10, P866, DOI 10.2741/1580; Kouro T, 2009, INT IMMUNOL, V21, P1303, DOI 10.1093/intimm/dxp102; Kuwahara M, 2012, NAT IMMUNOL, V13, P778, DOI 10.1038/ni.2362; Lee GR, 2005, NAT IMMUNOL, V6, P42, DOI 10.1038/ni1148; Lee GR, 2003, IMMUNITY, V19, P145, DOI 10.1016/S1074-7613(03)00179-1; Montoya-Durango DE, 2008, J BIOL CHEM, V283, P32056, DOI 10.1074/jbc.M802320200; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Moroy T, 2011, SEMIN IMMUNOL, V23, P368, DOI 10.1016/j.smim.2011.08.006; Nakayama T, 2008, CURR OPIN IMMUNOL, V20, P265, DOI 10.1016/j.coi.2008.03.011; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Northrup DL, 2011, IMMUNITY, V34, P830, DOI 10.1016/j.immuni.2011.06.002; Poon AH, 2012, CLIN EXP ALLERGY, V42, P625, DOI 10.1111/j.1365-2222.2012.03983.x; Rothenberg ME, 2006, ANNU REV IMMUNOL, V24, P147, DOI 10.1146/annurev.immunol.24.021605.090720; Saleque S, 2007, MOL CELL, V27, P562, DOI 10.1016/j.molcel.2007.06.039; Schwenger GTF, 2001, J BIOL CHEM, V276, P48502, DOI 10.1074/jbc.M107836200; Shinnakasu R, 2008, J BIOL CHEM, V283, P28216, DOI 10.1074/jbc.M804174200; Suzuki A, 2010, J IMMUNOL, V184, P4510, DOI 10.4049/jimmunol.0903426; Tanaka S, 2011, NAT IMMUNOL, V12, P77, DOI 10.1038/ni.1966; Taniguchi M, 2010, INT IMMUNOL, V22, P1, DOI 10.1093/intimm/dxp104; Terashima A, 2008, J EXP MED, V205, P2727, DOI 10.1084/jem.20080698; Wei L, 2010, IMMUNITY, V32, P840, DOI 10.1016/j.immuni.2010.06.003; Wilson CB, 2009, NAT REV IMMUNOL, V9, P91, DOI 10.1038/nri2487; Yamashita M, 2005, J BIOL CHEM, V280, P29409, DOI 10.1074/jbc.M502333200; Yamashita M, 2002, J BIOL CHEM, V277, P42399, DOI 10.1074/jbc.M205876200; Yamashita M, 2008, J EXP MED, V205, P1109, DOI 10.1084/jem.20072000; Zhu JF, 2002, IMMUNITY, V16, P733, DOI 10.1016/S1074-7613(02)00317-5; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212	45	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2013	8	4							e61785	10.1371/journal.pone.0061785	http://dx.doi.org/10.1371/journal.pone.0061785			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130DR	23613936	gold, Green Submitted, Green Published			2022-12-25	WOS:000317893400110
J	Woehler, A				Woehler, Andrew			Simultaneous Quantitative Live Cell Imaging of Multiple FRET-Based Biosensors	PLOS ONE			English	Article							RESONANCE ENERGY-TRANSFER; YELLOW FLUORESCENT PROTEINS; LIVING CELLS; DYNAMIC-RANGE; MICROSCOPY; COORDINATION; ACTIVATION; EXCITATION; REPORTERS; ACCEPTORS	We have developed a novel method for multi-color spectral FRET analysis which is used to study a system of three independent FRET-based molecular sensors composed of the combinations of only three fluorescent proteins. This method is made possible by a novel routine for computing the 3-D excitation/emission spectral fingerprint of FRET from reference measurements of the donor and acceptor alone. By unmixing the 3D spectrum of the FRET sample, the total relative concentrations of the fluorophores and their scaled FRET efficiencies are directly measured, from which apparent FRET efficiencies can be computed. If the FRET sample is composed of intramolecular FRET sensors it is possible to determine the total relative concentration of the sensors and then estimate absolute FRET efficiency of each sensor. Using multiple tandem constructs with fixed FRET efficiency as well as FRET-based calcium sensors with novel fluorescent protein combinations we demonstrate that the computed FRET efficiencies are accurate and changes in these quantities occur without crosstalk. We provide an example of this method's potential by demonstrating simultaneous imaging of spatially colocalized changes in [Ca2+], [cAMP], and PKA activity.	[Woehler, Andrew] Deutsch Forsch Gemeinschaft Res Ctr Nanoscopy & M, Gottingen, Germany; [Woehler, Andrew] Max Planck Inst Biophys Chem, Dept Membrane Biophys, D-37077 Gottingen, Germany	Max Planck Society	Woehler, A (corresponding author), Deutsch Forsch Gemeinschaft Res Ctr Nanoscopy & M, Gottingen, Germany.	awoehle@gwdg.de		Woehler, Andrew/0000-0001-5157-9313	Deutsche Forschungsgemeinschaft (DFG) through the DFG-Research Center of Nanoscale Microscopy and Molecular Physiology of the Brain	Deutsche Forschungsgemeinschaft (DFG) through the DFG-Research Center of Nanoscale Microscopy and Molecular Physiology of the Brain	Work was funded by the Deutsche Forschungsgemeinschaft (DFG) through the DFG-Research Center of Nanoscale Microscopy and Molecular Physiology of the Brain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai HW, 2008, NAT METHODS, V5, P401, DOI [10.1038/nmeth.1207, 10.1038/NMETH.1207]; Allen MD, 2008, ANGEW CHEM INT EDIT, V47, P500, DOI 10.1002/anie.200703493; Clamme JP, 2005, CHEMPHYSCHEM, V6, P74, DOI 10.1002/cphc.200400261; Galperin E, 2004, NAT METHODS, V1, P209, DOI 10.1038/NMETH720; Gambin Y, 2010, MOL BIOSYST, V6, P1540, DOI 10.1039/c003024d; Goedhart J, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1738; Gordon GW, 1998, BIOPHYS J, V74, P2702, DOI 10.1016/S0006-3495(98)77976-7; Guizar-Sicairos M, 2008, OPT LETT, V33, P156, DOI 10.1364/OL.33.000156; Hohng S, 2004, BIOPHYS J, V87, P1328, DOI 10.1529/biophysj.104.043935; Hoppe A, 2002, BIOPHYS J, V83, P3652, DOI 10.1016/S0006-3495(02)75365-4; Hoppe AD, 2004, MOL BIOL CELL, V15, P3509, DOI 10.1091/mbc.E03-11-0847; Jensen JB, 2009, J GEN PHYSIOL, V133, P347, DOI 10.1085/jgp.200810075; Komatsu N, 2011, MOL BIOL CELL, V22, P4647, DOI 10.1091/mbc.E11-01-0072; Koushik SV, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008031; Lakowicz JR, 1999, PRINCIPLES FLUORESCE; Lam AJ, 2012, NAT METHODS, V9, P1005, DOI [10.1038/NMETH.2171, 10.1038/nmeth.2171]; Landa LR, 2005, J BIOL CHEM, V280, P31294, DOI 10.1074/jbc.M505657200; Lee NK, 2007, BIOPHYS J, V92, P303, DOI 10.1529/biophysj.106.093211; Machacek M, 2009, NATURE, V461, P99, DOI 10.1038/nature08242; Mank M, 2008, NAT METHODS, V5, P805, DOI 10.1038/NMETH.1243; Mehta K, 2009, PROTEOMICS, V9, P5371, DOI 10.1002/pmic.200800494; Nagai T, 2004, P NATL ACAD SCI USA, V101, P10554, DOI 10.1073/pnas.0400417101; Neher R, 2004, J MICROSC-OXFORD, V213, P46, DOI 10.1111/j.1365-2818.2004.01262.x; Neher RA, 2004, MICROSC RES TECHNIQ, V64, P185, DOI 10.1002/jemt.20078; Newman RH, 2011, CHEM REV, V111, P3614, DOI 10.1021/cr100002u; Ni Q, 2006, METHODS, V40, P279, DOI 10.1016/j.ymeth.2006.06.013; Ni QA, 2011, NAT CHEM BIOL, V7, P34, DOI 10.1038/NCHEMBIO.478; Piljic A, 2008, ACS CHEM BIOL, V3, P156, DOI 10.1021/cb700247q; Ponsioen B, 2004, EMBO REP, V5, P1176, DOI 10.1038/sj.embor.7400290; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Sun YS, 2010, BIOPHYS J, V99, P1274, DOI 10.1016/j.bpj.2010.06.004; Thaler C, 2006, CYTOM PART A, V69A, P904, DOI 10.1002/cyto.a.20267; Ulbrich MH, 2007, NAT METHODS, V4, P319, DOI 10.1038/NMETH1024; Welch CM, 2011, NAT REV MOL CELL BIO, V12, P749, DOI 10.1038/nrm3212; Wlodarczyk J, 2008, BIOPHYS J, V94, P986, DOI 10.1529/biophysj.107.111773; Woehler A, 2010, BIOPHYS J, V99, P2344, DOI 10.1016/j.bpj.2010.07.053; Youvan D. C., 1997, BIOTECHNOLOGY, V3, P1; Zeug A, 2012, BIOPHYSICAL IN PRESS; Zhang J, 2001, P NATL ACAD SCI USA, V98, P14997, DOI 10.1073/pnas.211566798	39	26	26	3	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2013	8	4							e61096	10.1371/journal.pone.0061096	http://dx.doi.org/10.1371/journal.pone.0061096			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130DR	23613792	gold, Green Accepted, Green Published, Green Submitted			2022-12-25	WOS:000317893400042
J	Miller, JE; Pedersen, LH; Vestergaard, M; Olsen, J				Miller, Jessica E.; Pedersen, Lars Henning; Vestergaard, Mogens; Olsen, Jorn			Maternal Use of Antibiotics and the Risk of Childhood Febrile Seizures: A Danish Population-Based Cohort	PLOS ONE			English	Article							URINARY-TRACT-INFECTIONS; NATIONAL HOSPITAL REGISTER; PRENATAL EXPOSURE; FETAL-BRAIN; INTRAUTERINE INFLAMMATION; EPIDEMIOLOGIC RESEARCH; MENTAL-RETARDATION; PREGNANCY; DISORDERS; EPILEPSY	Objective: In a large population-based cohort in Denmark to examine if maternal use of antibiotics during pregnancy, as a marker of infection, increases the risk of febrile seizures in childhood in a large population-based cohort in Denmark. Methods: All live-born singletons born in Denmark between January 1, 1996 and September 25, 2004 and who were alive on the 90th day of life were identified from the Danish National Birth Registry. Diagnoses of febrile seizures were obtained from the Danish National Hospital Register and maternal use of antibiotics was obtained from the National Register of Medicinal Product Statistics. Hazard ratios (HR) and 95% confidence intervals (95% CI) were estimated by Cox proportional hazard regression models. Results: We followed 551,518 singletons for up to 5 years and identified a total of 21,779 children with a diagnosis of febrile seizures. Slightly increased hazard ratios were observed among most exposure groups when compared to the unexposed group, ex. HR 1.08 95% CI: 1.05-1.11 for use of any systemic antibiotic during pregnancy. Conclusion: We found weak associations between the use of pharmacologically different antibiotics during pregnancy and febrile seizures in early childhood which may indicate that some infections, or causes or effects of infections, during pregnancy could affect the fetal brain and induce susceptibility to febrile seizures.	[Miller, Jessica E.; Olsen, Jorn] Univ Calif Los Angeles, Sch Publ Hlth, Dept Epidemiol, Los Angeles, CA 90024 USA; [Pedersen, Lars Henning] Aarhus Univ Hosp, Inst Clin Med, Dept Obstet & Gynecol, DK-8000 Aarhus, Denmark; [Vestergaard, Mogens] Univ Aarhus, Res Unit Gen Practice, Aarhus, Denmark; [Vestergaard, Mogens] Univ Aarhus, Dept Gen Practice, Aarhus, Denmark; [Pedersen, Lars Henning; Olsen, Jorn] Aarhus Univ, Inst Publ Hlth, Dept Epidemiol, Aarhus, Denmark	University of California System; University of California Los Angeles; Aarhus University; Aarhus University; Aarhus University; Aarhus University	Miller, JE (corresponding author), Univ Calif Los Angeles, Sch Publ Hlth, Dept Epidemiol, Los Angeles, CA 90024 USA.	jemille@ucla.edu	Olsen, Jørn/F-8801-2015; Vestergaard, Mogens/M-9333-2014	Olsen, Jørn/0000-0001-7462-5140; Vestergaard, Mogens/0000-0001-8830-2174; Miller, Jessica/0000-0002-1806-1894				Andersen AMN, 2002, LANCET, V360, P1552, DOI 10.1016/S0140-6736(02)11518-2; Andersen TF, 1999, DAN MED BULL, V46, P263; Bell MJ, 2002, J NEUROSCI RES, V70, P570, DOI 10.1002/jnr.10423; Burd I, 2012, AM J REPROD IMMUNOL, V67, P287, DOI 10.1111/j.1600-0897.2012.01110.x; Christensen B, 2001, INT J ANTIMICROB AG, V17, P283, DOI 10.1016/S0924-8579(00)00349-6; Clarke MC, 2009, AM J PSYCHIAT, V166, P1025, DOI 10.1176/appi.ajp.2009.08010031; Connolly AM, 1999, UROL CLIN N AM, V26, P779, DOI 10.1016/S0094-0143(05)70218-4; Greenland S, 1999, EPIDEMIOLOGY, V10, P37, DOI 10.1097/00001648-199901000-00008; Grether JK, 1997, JAMA-J AM MED ASSOC, V278, P207, DOI 10.1001/jama.278.3.207; Hallas J, 2001, PHARMACOEPIDEM DR S, V10, P619, DOI 10.1002/pds.638; HAUSER WA, 1994, EPILEPSIA, V35, pS1, DOI 10.1111/j.1528-1157.1994.tb05932.x; Hornig M, 2001, MENT RETARD DEV D R, V7, P200, DOI 10.1002/mrdd.1028; Kenyon S, 2008, LANCET, V372, P1319, DOI 10.1016/S0140-6736(08)61203-9; Knudsen LB, 1998, DAN MED BULL, V45, P221; Knudsen LB, 1998, DAN MED BULL, V45, P320; McDermott S, 2000, OBSTET GYNECOL, V96, P113, DOI 10.1016/S0029-7844(00)00823-1; McDermott S, 2001, J FAM PRACTICE, V50, P433; Nahmias AJ, 2006, CLIN DEV IMMUNOL, V13, P167, DOI 10.1080/17402520600801745; Nicolle LE, 2000, J ANTIMICROB CHEMOTH, V46, P35, DOI 10.1093/jac/46.suppl_1.35; Patterson PH, 2009, BEHAV BRAIN RES, V204, P313, DOI 10.1016/j.bbr.2008.12.016; Patterson PH, 2002, CURR OPIN NEUROBIOL, V12, P115, DOI 10.1016/S0959-4388(02)00299-4; Schnarr J, 2008, EUR J CLIN INVEST, V38, P50, DOI 10.1111/j.1365-2362.2008.02009.x; Sun Y, 2008, PEDIATRICS, V121, pE1100, DOI 10.1542/peds.2007-2316; Sun YL, 2011, PAEDIATR PERINAT EP, V25, P53, DOI 10.1111/j.1365-3016.2010.01143.x; Urakubo A, 2001, SCHIZOPHR RES, V47, P27, DOI 10.1016/S0920-9964(00)00032-3; Vestergaard M, 2002, EPIDEMIOLOGY, V13, P282, DOI 10.1097/00001648-200205000-00008; Vestergaard M, 2006, J CLIN EPIDEMIOL, V59, P61, DOI 10.1016/j.jclinepi.2005.05.008; Vestergaard M, 2005, PEDIATRICS, V116, P1089, DOI 10.1542/peds.2004-2210; Vestergaard M, 2007, AM J EPIDEMIOL, V165, P911, DOI 10.1093/aje/kwk086; Vestergaard M, 2009, BRAIN DEV-JPN, V31, P372, DOI 10.1016/j.braindev.2008.11.012	30	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2013	8	4							e61148	10.1371/journal.pone.0061148	http://dx.doi.org/10.1371/journal.pone.0061148			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125TD	23613800	Green Published, Green Submitted, gold			2022-12-25	WOS:000317563300023
J	Matsunaga, Y; Fukuyama, S; Okuno, T; Sasaki, F; Matsunobu, T; Asai, Y; Matsumoto, K; Saeki, K; Oike, M; Sadamura, Y; Machida, K; Nakanishi, Y; Kubo, M; Yokomizo, T; Inoue, H				Matsunaga, Yuko; Fukuyama, Satoru; Okuno, Toshiaki; Sasaki, Fumiyuki; Matsunobu, Takehiko; Asai, Yukari; Matsumoto, Koichiro; Saeki, Kazuko; Oike, Masahiro; Sadamura, Yukari; Machida, Kentaro; Nakanishi, Yoichi; Kubo, Masato; Yokomizo, Takehiko; Inoue, Hiromasa			Leukotriene B-4 receptor BLT2 negatively regulates allergic airway eosinophilia	FASEB JOURNAL			English	Article						asthma; CD4(+) T cell; interleukin-13; 12(S)-hydroxyheptadeca-5Z; 8E; 10E-trienoic acid	EXHALED BREATH CONDENSATE; T-CELL RECRUITMENT; MAST-CELLS; EXPERIMENTAL ASTHMA; HYPERRESPONSIVENESS; ANTAGONIST; ACTIVATION; RESPONSES; EXPRESSION; IL-13	Leukotriene B-4 (LTB4) has been implicated in the pathogenesis of allergic diseases. BLT2, a low-affinity LTB4 receptor, is activated by LTB4 and 12(S)-hydroxyheptadeca-5Z,8E,10E-trienoic acid (12-HHT). Although the high-affinity LTB4 receptor BLT1 has been shown to exert proinflammatory roles, the role of BLT2 in allergic inflammation has not been clarified. To study the function of BLT2 in development of asthma, we used mice model of ovalbumin (OVA)-induced allergic airway disease. The 12-HHT levels were elevated in bronchoalveolar lavage (BAL) fluids of OVA-sensitized/challenged wild-type mice. BLT2-deficient mice exhibited enhanced eosinophilia in BAL fluids after OVA exposure. Interleukin (IL)-13 levels in BAL fluids and IL-13-producing CD4(+) T cells in the lungs were elevated in BLT2-deficient mice compared to wild-type mice, whereas the levels of IL-4, IL-5, and interferon (IFN)- in BAL fluids and serum OVA-specific IgE were comparable. Transfection of BLT2-specific small interfering RNA enhanced IL-13 production in CD4(+) T cells in vitro. Expression of BLT2 mRNA in CD4(+) T cells was significantly reduced in patients with asthma compared to healthy control subjects. These findings indicate that BLT2 has a protective role in allergic airway inflammation and that diminished BLT2 expression in CD4(+) T cells may contribute to the pathophysiology of asthma.Matsunaga, Y., Fukuyama, S., Okuno, T., Sasaki, F., Matsunobu, T., Asai, Y., Matsumoto, K., Saeki, K., Oike, M., Sadamura, Y., Machida, K., Nakanishi, Y., Kubo, M., Yokomizo, T., Inoue, H. Leukotriene B-4 receptor BLT2 negatively regulates allergic airway eosinophilia.	[Matsunaga, Yuko; Fukuyama, Satoru; Asai, Yukari; Matsumoto, Koichiro; Nakanishi, Yoichi; Inoue, Hiromasa] Kyushu Univ, Grad Sch Med Sci, Res Inst Dis Chest, Fukuoka 812, Japan; [Okuno, Toshiaki; Sasaki, Fumiyuki; Matsunobu, Takehiko; Saeki, Kazuko; Yokomizo, Takehiko] Kyushu Univ, Grad Sch Med Sci, Dept Med Biochem, Fukuoka 812, Japan; [Oike, Masahiro] Kyushu Univ, Grad Sch Med Sci, Dept Pharmacol, Fukuoka 812, Japan; [Okuno, Toshiaki; Yokomizo, Takehiko] Juntendo Univ, Sch Med, Dept Biochem, Tokyo 113, Japan; [Sadamura, Yukari; Machida, Kentaro; Inoue, Hiromasa] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Pulm Med, Kagoshima 8908520, Japan; [Kubo, Masato] RIKEN Yokohama Inst, Res Ctr Allergy & Immunol, Lab Signal Network, Yokohama, Kanagawa, Japan; [Kubo, Masato] Tokyo Univ Sci, Res Inst Biol Sci, Div Biotechnol, Chiba, Japan	Kyushu University; Kyushu University; Kyushu University; Juntendo University; Kagoshima University; RIKEN; Tokyo University of Science	Inoue, H (corresponding author), Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Pulm Med, 8-35-1 Sakuragaoka, Kagoshima 8908520, Japan.	inoue-pulm@umin.net	Kubo, Masato/A-5918-2016; Yokomizo, Takehiko/P-5673-2016	Yokomizo, Takehiko/0000-0002-5219-1553	Japan Society for the Promotion of Science (JSPS); JSPS; Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan; National Institute of Biomedical Innovation, Japan	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Institute of Biomedical Innovation, Japan(National Institute of Biomedical Innovation)	The authors thank Prof. Junichi Miyazaki (Osaka University, Osaka, Japan) for providing an expression vector pCXN2 and Ms. Ayako Hashizume, Ms. Makiko Kogo, and Ms. Asami Harumatsu for their technical assistance. This work was supported by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (JSPS), a Grant-in-Aid for Challenging Exploratory Research from JSPS, and a Grant-in-Aid for Scientific Research on Innovative Areas from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan, and by the National Institute of Biomedical Innovation, Japan.	Aratake Y, 2012, FASEB J, V26, P4068, DOI 10.1096/fj.12-212050; Becker M, 2011, J IMMUNOL, V186, P7225, DOI 10.4049/jimmunol.1100676; Bousquet J, 2000, AM J RESP CRIT CARE, V161, P1720, DOI 10.1164/ajrccm.161.5.9903102; Cho KJ, 2010, J IMMUNOL, V185, P6329, DOI 10.4049/jimmunol.1001213; Cho KJ, 2010, AM J RESP CELL MOL, V42, P294, DOI 10.1165/rcmb.2008-0445OC; Evans DJ, 1996, THORAX, V51, P1178, DOI 10.1136/thx.51.12.1178; Fish SC, 2005, J IMMUNOL, V174, P7716, DOI 10.4049/jimmunol.174.12.7716; GOETZL EJ, 1984, J CLIN IMMUNOL, V4, P79, DOI 10.1007/BF00915039; Goodarzi K, 2003, NAT IMMUNOL, V4, P965, DOI 10.1038/ni972; Gronke L, 2008, PULM PHARMACOL THER, V21, P409, DOI 10.1016/j.pupt.2007.10.007; Grunig G, 1998, SCIENCE, V282, P2261, DOI 10.1126/science.282.5397.2261; Hanazawa T, 2000, AM J RESP CRIT CARE, V162, P1273, DOI 10.1164/ajrccm.162.4.9912064; Iizuka Y, 2005, J BIOL CHEM, V280, P24816, DOI 10.1074/jbc.M413257200; Iizuka Y, 2010, FASEB J, V24, P4678, DOI 10.1096/fj.10-165050; Jaffe JS, 1996, AM J RESP CELL MOL, V15, P473, DOI 10.1165/ajrcmb.15.4.8879181; Kaur D, 2006, ALLERGY, V61, P1047, DOI 10.1111/j.1398-9995.2006.01139.x; Kibe A, 2003, AM J RESP CRIT CARE, V167, P50, DOI 10.1164/rccm.2110084; Kita Y, 2005, ANAL BIOCHEM, V342, P134, DOI 10.1016/j.ab.2005.03.048; Kostikas K, 2005, CHEST, V127, P1553, DOI 10.1378/chest.127.5.1553; Kuniyeda K, 2007, J BIOL CHEM, V282, P3998, DOI 10.1074/jbc.M610540200; Lundeen KA, 2006, J IMMUNOL, V177, P3439, DOI 10.4049/jimmunol.177.5.3439; Matsumoto K, 2005, RESPIROLOGY, V10, P18, DOI 10.1111/j.1440-1843.2005.00647.x; Matsunaga Y, 2010, AM J RESP CRIT CARE, V181; Medoff BD, 2006, AM J PHYSIOL-LUNG C, V290, pL170, DOI 10.1152/ajplung.00212.2005; Meurs H, 2008, EUR RESPIR J, V32, P487, DOI 10.1183/09031936.00023608; Miki K, 2010, J PHARMACOL SCI, V113, P387, DOI 10.1254/jphs.10124FP; Miyahara N, 2005, AM J RESP CRIT CARE, V172, P161, DOI 10.1164/rccm.200502-205OC; Montuschi P, 2003, THORAX, V58, P585, DOI 10.1136/thorax.58.7.585; Ohnishi Hiroshi, 2008, Allergol Int, V57, P291, DOI 10.2332/allergolint.08-RAI-0019; Okuno T, 2008, J EXP MED, V205, P759, DOI 10.1084/jem.20072329; Richards I. M., 1991, ANN N Y ACAD SCI, V629, P428; Rockwell CE, 2010, CYTOKINE, V51, P12, DOI 10.1016/j.cyto.2010.03.018; SILBAUGH SA, 1992, EUR J PHARMACOL, V223, P57, DOI 10.1016/0014-2999(92)90818-O; Silkoff PE, 2001, CHEST, V119, P1049, DOI 10.1378/chest.119.4.1049; Tager AM, 2003, NAT IMMUNOL, V4, P982, DOI 10.1038/ni970; Tager AM, 2003, PROSTAG LEUKOTR ESS, V69, P123, DOI 10.1016/S0952-3278(03)00073-5; Terawaki K, 2005, J IMMUNOL, V175, P4217, DOI 10.4049/jimmunol.175.7.4217; Tsai M, 2005, CHEM IMMUNOL ALLERGY, V87, P179, DOI 10.1159/000087644; Umetsu DT, 2002, NAT IMMUNOL, V3, P715, DOI 10.1038/ni0802-715; Wills-Karp M, 1998, SCIENCE, V282, P2258, DOI 10.1126/science.282.5397.2258; WOLLERT PS, 1993, SURGERY, V114, P191; Yokomizo T, 2000, J EXP MED, V192, P421, DOI 10.1084/jem.192.3.421; Yokomizo T, 2001, J BIOL CHEM, V276, P12454, DOI 10.1074/jbc.M011361200; Zuyderduyn S, 2008, EUR RESPIR J, V32, P265, DOI 10.1183/09031936.00051407	44	36	36	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2013	27	8					3306	3314		10.1096/fj.12-217000	http://dx.doi.org/10.1096/fj.12-217000			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	292BT	23603839				2022-12-25	WOS:000329877600035
J	Salewski, J; Escobar, FV; Kaminski, S; von Stetten, D; Keidel, A; Rippers, Y; Michael, N; Scheerer, P; Piwowarski, P; Bartl, F; Frankenberg-Dinkel, N; Ringsdorf, S; Gartner, W; Lamparter, T; Mroginski, MA; Hildebrandt, P				Salewski, Johannes; Escobar, Francisco Velazquez; Kaminski, Steve; von Stetten, David; Keidel, Anke; Rippers, Yvonne; Michael, Norbert; Scheerer, Patrick; Piwowarski, Patrick; Bartl, Franz; Frankenberg-Dinkel, Nicole; Ringsdorf, Simone; Gaertner, Wolfgang; Lamparter, Tilman; Mroginski, Maria Andrea; Hildebrandt, Peter			Structure of the Biliverdin Cofactor in the Pfr State of Bathy and Prototypical Phytochromes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PSEUDOMONAS-AERUGINOSA BACTERIOPHYTOCHROME; RESONANCE RAMAN-SPECTROSCOPY; P-FR PHOTOTRANSFORMATION; MOLECULAR-DYNAMICS; GROUND-STATE; AGROBACTERIUM-TUMEFACIENS; TETRAPYRROLE CHROMOPHORE; BACTERIAL PHYTOCHROMES; ASPERGILLUS-NIDULANS; SPECTRAL PROPERTIES	Phytochromes act as photoswitches between the red-and farred absorbing parent states of phytochromes (Pr and Pfr). Plant phytochromes display an additional thermal conversion route from the physiologically active Pfr to Pr. The same reaction pattern is found in prototypical biliverdin-binding bacteriophytochromes in contrast to the reverse thermal transformation in bathy bacteriophytochromes. However, the molecular origin of the different thermal stabilities of the Pfr states in prototypical and bathy bacteriophytochromes is not known. Weanalyzed the structures of the chromophore binding pockets in the Pfr states of various bathy and prototypical biliverdin-binding phytochromes using a combined spectroscopic-theoretical approach. For the Pfr state of the bathy phytochrome from Pseudomonas aeruginosa, the very good agreement between calculated and experimental Raman spectra of the biliverdin cofactor is in line with important conclusions of previous crystallographic analyses, particularly the ZZEssa configuration of the chromophore and its mode of covalent attachment to the protein. The highly homogeneous chromophore conformation seems to be a unique property of the Pfr states of bathy phytochromes. This is in sharp contrast to the Pfr states of prototypical phytochromes that display conformational equilibria between two sub-states exhibiting small structural differences at the terminal methine bridges A-B and C-D. These differences may mainly root in the interactions of the cofactor with the highly conserved Asp-194 that occur via its carboxylate function in bathy phytochromes. The weaker interactions via the carbonyl function in prototypical phytochromes may lead to a higher structural flexibility of the chromophore pocket opening a reaction channel for the thermal (ZZE -> ZZZ) Pfr to Pr back-conversion.	[Salewski, Johannes; Escobar, Francisco Velazquez; Kaminski, Steve; von Stetten, David; Keidel, Anke; Rippers, Yvonne; Michael, Norbert; Mroginski, Maria Andrea; Hildebrandt, Peter] Tech Univ Berlin, Inst Chem, D-10623 Berlin, Germany; [von Stetten, David] European Synchrotron Radiat Facil, Struct Biol Grp, F-38043 Grenoble, France; [Scheerer, Patrick; Piwowarski, Patrick; Bartl, Franz] Charite, Inst Med Phys & Biophys CCO, D-10117 Berlin, Germany; [Scheerer, Patrick] Charite, AG Prot Xray Crystallog, D-10117 Berlin, Germany; [Piwowarski, Patrick; Bartl, Franz] Charite, AG Spect, D-10117 Berlin, Germany; [Frankenberg-Dinkel, Nicole] Ruhr Univ Bochum, AG Physiol Mikroorganismen, D-44780 Bochum, Germany; [Ringsdorf, Simone; Gaertner, Wolfgang] Max Planck Inst Chem Energiekonvers, D-45470 Mulheim, Germany; [Lamparter, Tilman] Karlsruher Inst Technol, Inst Allgemeine Bot, D-76131 Karlsruhe, Germany	Technical University of Berlin; European Synchrotron Radiation Facility (ESRF); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Ruhr University Bochum; Max Planck Society; Helmholtz Association; Karlsruhe Institute of Technology	Mroginski, MA (corresponding author), Tech Univ Berlin, Inst Chem, Sekr PC 14,Str 17 Juni 135, D-10623 Berlin, Germany.	andrea.mroginski@tu-berlin.de; Hildebrandt@tu-berlin.de	Hildebrandt, Peter/J-5658-2014; Frankenberg-Dinkel, Nicole/C-1058-2011; Lamparter, Tilman/E-4421-2013	Hildebrandt, Peter/0000-0003-1030-5900; Frankenberg-Dinkel, Nicole/0000-0002-7757-6839; Kaminski, Steve/0000-0002-0047-8819; Scheerer, Patrick/0000-0001-5028-2075; Lamparter, Tilman/0000-0003-4327-9737; Gartner, Wolfgang/0000-0002-6898-7011; von Stetten, David/0000-0001-7906-9788; Velazquez Escobar, Francisco/0000-0003-0365-8118	Deutsche Forschungsgemeinschaft [Sfb1078 (B5), Sfb1078 (B6), Sfb1078 (C3)]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant Sfb1078 (B5, B6, and C3).	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; [Anonymous], 2007, MATH STAT METASTATIS; BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; Blumenstein A, 2005, CURR BIOL, V15, P1833, DOI 10.1016/j.cub.2005.08.061; Borucki B, 2005, J BIOL CHEM, V280, P34358, DOI 10.1074/jbc.M505493200; Borucki B, 2009, BIOCHEMISTRY-US, V48, P6305, DOI 10.1021/bi900436v; Brandt S, 2008, J BIOL CHEM, V283, P34605, DOI 10.1074/jbc.M805506200; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Buchan DWA, 2010, NUCLEIC ACIDS RES, V38, pW563, DOI 10.1093/nar/gkq427; Buckler DR, 2002, STRUCTURE, V10, P153, DOI 10.1016/S0969-2126(01)00706-7; Chen Y, 2012, FEBS J, V279, P40, DOI 10.1111/j.1742-4658.2011.08397.x; Christie JM, 2005, HANDBOOK OF PHOTOSENSORY RECEPTORS, P277, DOI 10.1002/352760510X.ch13; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Essen LO, 2008, P NATL ACAD SCI USA, V105, P14709, DOI 10.1073/pnas.0806477105; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; FODOR SPA, 1990, BIOCHEMISTRY-US, V29, P11141, DOI 10.1021/bi00502a018; Freer LH, 2012, J PHYS CHEM B, V116, P10571, DOI 10.1021/jp302637u; HILDEBRANDT P, 1992, BIOCHEMISTRY-US, V31, P7957, DOI 10.1021/bi00149a029; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Hughes J, 1997, NATURE, V386, P663, DOI 10.1038/386663a0; Hughes J, 2010, BIOCHEM SOC T, V38, P710, DOI 10.1042/BST0380710; Inomata K, 2006, J BIOL CHEM, V281, P28162, DOI 10.1074/jbc.M603983200; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Karniol B, 2003, P NATL ACAD SCI USA, V100, P2807, DOI 10.1073/pnas.0437914100; Kehoe DM, 1996, SCIENCE, V273, P1409, DOI 10.1126/science.273.5280.1409; Kim PW, 2012, BIOCHEMISTRY-US, V51, P619, DOI 10.1021/bi2017365; Kneip C, 1999, BIOCHEMISTRY-US, V38, P15185, DOI 10.1021/bi990688w; Lamparter T, 2002, P NATL ACAD SCI USA, V99, P11628, DOI 10.1073/pnas.152263999; Lamparter T, 2001, EUR J BIOCHEM, V268, P4720, DOI 10.1046/j.1432-1327.2001.02395.x; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lindner I, 1998, ANGEW CHEM INT EDIT, V37, P1843, DOI 10.1002/(SICI)1521-3773(19980803)37:13/14<1843::AID-ANIE1843>3.0.CO;2-W; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; MANITTO P, 1980, J CHEM SOC CHEM COMM, P178, DOI 10.1039/c39800000178; MARTYNA GJ, 1994, J CHEM PHYS, V101, P4177, DOI 10.1063/1.467468; Montgomery BL, 2002, TRENDS PLANT SCI, V7, P357, DOI 10.1016/S1360-1385(02)02304-X; Mroginski MA, 2011, J MOL STRUCT, V993, P15, DOI 10.1016/j.molstruc.2011.02.038; Mroginski MA, 2010, CHEMPHYSCHEM, V11, P1265, DOI 10.1002/cphc.200900895; Mroginski MA, 2007, BIOPHYS J, V93, P1885, DOI 10.1529/biophysj.107.108878; Mroginski MA, 2011, J PHYS CHEM B, V115, P1220, DOI 10.1021/jp108265h; Mroginski MA, 2009, BIOPHYS J, V96, P4153, DOI 10.1016/j.bpj.2009.02.029; Murgida DH, 2007, BIOPHYS J, V93, P2410, DOI 10.1529/biophysj.107.108092; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Quest B, 2007, FEBS J, V274, P2088, DOI 10.1111/j.1742-4658.2007.05751.x; Rockwell NC, 2010, CHEMPHYSCHEM, V11, P1172, DOI 10.1002/cphc.200900894; Rockwell NC, 2009, P NATL ACAD SCI USA, V106, P6123, DOI 10.1073/pnas.0902370106; Rottwinkel G, 2010, J BACTERIOL, V192, P5124, DOI 10.1128/JB.00672-10; Scheerer P, 2010, CHEMPHYSCHEM, V11, P1090, DOI 10.1002/cphc.200900913; Schmidt P, 1998, PHOTOCHEM PHOTOBIOL, V68, P754, DOI 10.1111/j.1751-1097.1998.tb02541.x; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Schwinte P, 2008, BIOPHYS J, V95, P1256, DOI 10.1529/biophysj.108.131441; Senn HM, 2007, CURR OPIN CHEM BIOL, V11, P182, DOI 10.1016/j.cbpa.2007.01.684; Sharda S, 2007, EUR BIOPHYS J BIOPHY, V36, P815, DOI 10.1007/s00249-007-0171-1; Sherwood P, 2003, J MOL STRUC-THEOCHEM, V632, P1, DOI 10.1016/S0166-1280(03)00285-9; Song C, 2013, PHOTOCHEM PHOTOBIOL, V89, P259, DOI 10.1111/php.12029; Song C, 2012, MOL PLANT, V5, P698, DOI 10.1093/mp/sss017; Song C, 2011, P NATL ACAD SCI USA, V108, P3842, DOI 10.1073/pnas.1013377108; Tasler R, 2005, FEBS J, V272, P1927, DOI 10.1111/j.1742-4658.2005.04623.x; THUMMLER F, 1992, PLANT MOL BIOL, V20, P1003, DOI 10.1007/BF00028888; von Stetten D, 2008, ANGEW CHEM INT EDIT, V47, P4753, DOI 10.1002/anie.200705716; von Stetten D, 2007, J BIOL CHEM, V282, P2116, DOI 10.1074/jbc.M608878200; Wagner JR, 2008, J BIOL CHEM, V283, P12212, DOI 10.1074/jbc.M709355200; Wagner JR, 2007, J BIOL CHEM, V282, P12298, DOI 10.1074/jbc.M611824200; Wilde A, 1997, FEBS LETT, V406, P89, DOI 10.1016/S0014-5793(97)00248-2; Yang X, 2008, P NATL ACAD SCI USA, V105, P14715, DOI 10.1073/pnas.0806718105; Yang X, 2007, P NATL ACAD SCI USA, V104, P12571, DOI 10.1073/pnas.0701737104; Yang XJ, 2011, NATURE, V479, P428, DOI 10.1038/nature10506; Yang XJ, 2009, P NATL ACAD SCI USA, V106, P15639, DOI 10.1073/pnas.0902178106; Yeh KC, 1998, P NATL ACAD SCI USA, V95, P13976, DOI 10.1073/pnas.95.23.13976; Yeh KC, 1997, SCIENCE, V277, P1505, DOI 10.1126/science.277.5331.1505	71	51	51	0	54	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2013	288	23					16800	16814		10.1074/jbc.M113.457531	http://dx.doi.org/10.1074/jbc.M113.457531			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	163ZU	23603902	hybrid, Green Published			2022-12-25	WOS:000320378900053
J	Babcock, JT; Nguyen, HB; He, YJ; Hendricks, JW; Wek, RC; Quilliam, LA				Babcock, Justin T.; Nguyen, Hoa B.; He, Yujun; Hendricks, Jeremiah W.; Wek, Ronald C.; Quilliam, Lawrence A.			Mammalian Target of Rapamycin Complex 1 (mTORC1) Enhances Bortezomib-induced Death in Tuberous Sclerosis Complex (TSC)-null Cells by a c-MYC-dependent Induction of the Unfolded Protein Response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRESS-RESPONSE; GENE-PRODUCTS; TSC2; ACTIVATION; EXPRESSION; KINASE; PERK; RHEB; TRANSLATION; DOWNSTREAM	Many factors, including duration and intensity of the unfolded protein response (UPR), dictate whether cells will adapt to endoplasmic reticulum stress or undergo apoptosis. In tuberous sclerosis (TSC), elevation of mammalian target of rapamycin complex 1 (mTORC1) activity has been proposed to compound the induction of UPR transcription factors ATF4 and CHOP, suggesting that the UPR could be targeted to eradicate TSC1/2-null cells during patient therapy. Here we report that control of c-MYC translation by mTORC1 plays a key role in determining whether TSC2-null Elt3 rat leiomyoma cells apoptose in response to UPR induction by the proteasome inhibitor bortezomib. Although bortezomib induces eukaryotic initiating factor 2 alpha phosphorylation, mTORC1 activity was also required for downstream induction of the UPR transcription factors ATF4 and CHOP by a mechanism involving increased expression of c-MYC. Although bortezomib-induced c-MYC transcription was resistant to rapamycin treatment, mTORC1 activity was required for efficient c-MYC translation. c-MYC subsequently bound to the ATF4 promoter, suggesting direct involvement of an mTORC1/c-MYC-driven signaling pathway in the activation of the UPR. Consistent with this notion, exogenously expressed c-MYC reversed the ability of rapamycin to prevent bortezomib-induced CHOP and ATF4 expression as well as apoptosis. These findings indicate that the induction of ATF4/CHOP expression occurs via mTORC1 regulation of c-MYC and that this signaling pathway is a major determinant in the ability of bortezomib to induce apoptosis.	[Babcock, Justin T.; Nguyen, Hoa B.; He, Yujun; Hendricks, Jeremiah W.; Wek, Ronald C.; Quilliam, Lawrence A.] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington	Quilliam, LA (corresponding author), Indiana Univ Sch Med, Dept Biochem & Mol Biol, 635 Barnhill Dr,MS4075, Indianapolis, IN 46202 USA.	lquillia@iupui.edu	Quilliam, Lawrence/B-6447-2015; Quilliam, Lawrence/Q-4987-2019		United States Department of Defense [W81XWH1110355]; LAM foundation; DeVault Gift Estate; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049164] Funding Source: NIH RePORTER	United States Department of Defense(United States Department of Defense); LAM foundation; DeVault Gift Estate; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the United States Department of Defense Award W81XWH1110355 and The LAM foundation (to L. A. Q.).; Supported by a student fellowship awarded by the DeVault Gift Estate.	Armstrong JL, 2010, J BIOL CHEM, V285, P6091, DOI 10.1074/jbc.M109.014092; Benvenuto G, 2000, ONCOGENE, V19, P6306, DOI 10.1038/sj.onc.1204009; Castro AF, 2003, J BIOL CHEM, V278, P32493, DOI 10.1074/jbc.C300226200; Chen SQ, 2010, CANCER RES, V70, P4318, DOI 10.1158/0008-5472.CAN-09-4428; Choo AY, 2008, P NATL ACAD SCI USA, V105, P17414, DOI 10.1073/pnas.0809136105; Crino PB, 2006, NEW ENGL J MED, V355, P1345, DOI 10.1056/NEJMra055323; Dey S, 2010, J BIOL CHEM, V285, P33165, DOI 10.1074/jbc.M110.167213; Di Nardo A, 2009, J NEUROSCI, V29, P5926, DOI 10.1523/JNEUROSCI.0778-09.2009; Duvel K, 2010, MOL CELL, V39, P171, DOI 10.1016/j.molcel.2010.06.022; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; Hosoi H, 1998, MOL PHARMACOL, V54, P815, DOI 10.1124/mol.54.5.815; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Jiang HY, 2005, J BIOL CHEM, V280, P14189, DOI 10.1074/jbc.M413660200; Kang YJ, 2011, CELL DEATH DIFFER, V18, P133, DOI 10.1038/cdd.2010.82; Kumar R, 2003, J CEREBR BLOOD F MET, V23, P462, DOI 10.1097/01.WCB.0000056064.25434.CA; Li ZR, 2003, P NATL ACAD SCI USA, V100, P8164, DOI 10.1073/pnas.1332764100; Liang SH, 2006, BIOCHEM J, V393, P201, DOI 10.1042/BJ20050374; Lin CY, 2012, CELL, V151, P56, DOI 10.1016/j.cell.2012.08.026; Marciniak SJ, 2006, PHYSIOL REV, V86, P1133, DOI 10.1152/physrev.00015.2006; Nawrocki ST, 2008, BLOOD, V112, P2917, DOI 10.1182/blood-2007-12-130823; Nie ZQ, 2012, CELL, V151, P68, DOI 10.1016/j.cell.2012.08.033; Nikiforov MA, 2007, P NATL ACAD SCI USA, V104, P19488, DOI 10.1073/pnas.0708380104; Ozean U, 2008, MOL CELL, V29, P541, DOI [10.1016/j.moicel.2007.12.023, 10.1016/j.molcel.2007.12.023]; Palam LR, 2011, J BIOL CHEM, V286, P10939, DOI 10.1074/jbc.M110.216093; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Tee AR, 2003, CURR BIOL, V13, P1259, DOI 10.1016/S0960-9822(03)00506-2; Tee AR, 2002, P NATL ACAD SCI USA, V99, P13571, DOI 10.1073/pnas.202476899; Teske BF, 2011, MOL BIOL CELL, V22, P4390, DOI 10.1091/mbc.E11-06-0510; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; WALKER C, 1992, CARCINOGENESIS, V13, P25, DOI 10.1093/carcin/13.1.25; Woo CW, 2009, NAT CELL BIOL, V11, P1473, DOI 10.1038/ncb1996; Yecies JL, 2011, CANCER RES, V71, P2815, DOI 10.1158/0008-5472.CAN-10-4158; Yin XY, 2003, ONCOGENE, V22, P6151, DOI 10.1038/sj.onc.1206641; Zeller KI, 2006, P NATL ACAD SCI USA, V103, P17834, DOI 10.1073/pnas.0604129103; Zhang HB, 2003, J CLIN INVEST, V112, P1223, DOI 10.1172/JCI200317222; Zhang Y, 2003, NAT CELL BIOL, V5, P578, DOI 10.1038/ncb999	39	28	31	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 31	2013	288	22					15687	15698		10.1074/jbc.M112.431056	http://dx.doi.org/10.1074/jbc.M112.431056			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	156LA	23612979	hybrid, Green Published			2022-12-25	WOS:000319822300025
J	Li, YY; Tsun, A; Gao, ZM; Han, ZJ; Gao, YY; Li, ZY; Lin, F; Wang, Y; Wei, G; Yao, ZJ; Li, B				Li, Yangyang; Tsun, Andy; Gao, Zhimei; Han, Zhijun; Gao, Yayi; Li, Zhiyuan; Lin, Fang; Wang, Yan; Wei, Gang; Yao, Zhengju; Li, Bin			60-kDa Tat-interactive Protein (TIP60) Positively Regulates Th-inducing POK (ThPOK)-mediated Repression of Eomesodermin in Human CD4(+) T Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE ACETYLTRANSFERASE; GENE-EXPRESSION; C-KROX; THPOK; LINEAGE; BET; ACETYLATION; DIFFERENTIATION; SUPPRESSION; COMMITMENT	The abundant expression of IFN gamma in Th-inducing POK (ThPOK)-deficient CD4(+) T cells requires the activation of Eomesodermin (Eomes); however, the underlying mechanism of this phenomenon remains unclear. Here we report that ThPOK binds directly to the promoter region of the Eomes gene to repress its expression in CD4(+) T cells. We identified the histone acetyltransferase TIP60 as a co-repressor of ThPOK-target genes, where ectopically expressed TIP60 increased ThPOK protein stability by promoting its acetylation at its Lys(360) residue to then augment the transcriptional repression of Eomes. Moreover, knockdown of endogenous TIP60 abolished the stabilization of ThPOK in CD4(+) T cells, which led to the transcriptional activation of Eomes and increased production of IFN gamma. Our results reveal a novel pathway by which TIP60 and ThPOK synergistically suppresses Eomes function and IFN gamma production, which could contribute to the regulation of inflammation.	[Li, Yangyang; Tsun, Andy; Gao, Zhimei; Gao, Yayi; Li, Zhiyuan; Lin, Fang; Yao, Zhengju; Li, Bin] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Pasteur Shanghai, Key Lab Mol Virol & Immunol,Unit Mol Immunol, Shanghai 200025, Peoples R China; [Han, Zhijun; Wang, Yan] Chinese Acad Sci, Shanghai Inst Biol Sci, Chinese Acad Sci Max Planck Soc MPG Partner Inst, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Le Reseau International des Instituts Pasteur (RIIP); Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Li, B (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Pasteur Shanghai, Key Lab Mol Virol & Immunol,Unit Mol Immunol, 411 Hefei Rd, Shanghai 200025, Peoples R China.	binli@sibs.ac.cn	li, zhiyuan/HGD-9581-2022; lI, Bin/AAR-4966-2021	lI, Bin/0000-0002-7640-8884	National Institutes of Health-National Science Foundation of China [81161120417]; National Science Foundation of China [30972702, 31170825, 81270083, 31150110337, 31200646, 31200647, 81271835]; Shanghai Rising Star Program [10QA1407900]; Novo Nordisk-Chinese Academy of Sciences Foundation; Sanofi-Aventis-Shanghai Institutes for Biological Sciences scholarship program; Knowledge Innovation Program of Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences [2010KIP205, 2012KIP204]	National Institutes of Health-National Science Foundation of China; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Rising Star Program; Novo Nordisk-Chinese Academy of Sciences Foundation; Sanofi-Aventis-Shanghai Institutes for Biological Sciences scholarship program; Knowledge Innovation Program of Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences(Knowledge Innovation Program of the Chinese Academy of SciencesChinese Academy of Sciences)	This work was supported, in whole or in part, by National Institutes of Health-National Science Foundation of China Collaborative Grant 81161120417. This work was also supported by National Science Foundation of China Grants 30972702, 31170825, 81270083, 31150110337, 31200646, 31200647, and 81271835; Shanghai Rising Star Program 10QA1407900; the Novo Nordisk-Chinese Academy of Sciences Foundation; the Sanofi-Aventis-Shanghai Institutes for Biological Sciences scholarship program, and the Knowledge Innovation Program of Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Grants 2010KIP205 and 2012KIP204.	Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247; Carpenter AC, 2012, IMMUNITY, V37, P622, DOI 10.1016/j.immuni.2012.06.019; Chen JZ, 2009, CELL IMMUNOL, V254, P85, DOI 10.1016/j.cellimm.2008.09.001; Egawa T, 2008, NAT IMMUNOL, V9, P1131, DOI 10.1038/ni.1652; Endo Y, 2011, IMMUNITY, V35, P733, DOI 10.1016/j.immuni.2011.08.017; GALERA P, 1994, P NATL ACAD SCI USA, V91, P9372, DOI 10.1073/pnas.91.20.9372; Galera P, 1996, J BIOL CHEM, V271, P21331, DOI 10.1074/jbc.271.35.21331; Gordon SM, 2012, IMMUNITY, V36, P55, DOI 10.1016/j.immuni.2011.11.016; Gorrini C, 2007, NATURE, V448, P1063, DOI 10.1038/nature06055; Goswami R, 2011, J IMMUNOL, V186, P3283, DOI 10.4049/jimmunol.1003049; He X, 2005, NATURE, V433, P826, DOI 10.1038/nature03338; He X, 2008, IMMUNITY, V28, P346, DOI 10.1016/j.immuni.2008.02.006; Ichiyama K, 2011, IMMUNITY, V34, P741, DOI 10.1016/j.immuni.2011.02.021; Ikura T, 2000, CELL, V102, P463, DOI 10.1016/S0092-8674(00)00051-9; Intlekofer AM, 2005, NAT IMMUNOL, V6, P1236, DOI 10.1038/ni1268; Jenkinson SR, 2007, J EXP MED, V204, P267, DOI 10.1084/jem.20061982; Kamine J, 1996, VIROLOGY, V216, P357, DOI 10.1006/viro.1996.0071; Kimura A, 1998, GENES CELLS, V3, P789, DOI 10.1046/j.1365-2443.1998.00229.x; Li B, 2007, P NATL ACAD SCI USA, V104, P4571, DOI 10.1073/pnas.0700298104; Lin SY, 2012, SCIENCE, V336, P477, DOI 10.1126/science.1217032; Muroi S, 2008, NAT IMMUNOL, V9, P1113, DOI 10.1038/ni.1650; Narayanan S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010636; Patel JH, 2004, MOL CELL BIOL, V24, P10826, DOI 10.1128/MCB.24.24.10826-10834.2004; Pearce EL, 2003, SCIENCE, V302, P1041, DOI 10.1126/science.1090148; Rui JX, 2012, J IMMUNOL, V189, P1380, DOI 10.4049/jimmunol.1201077; Sliva D, 1999, BIOCHEM BIOPH RES CO, V263, P149, DOI 10.1006/bbrc.1999.1083; Sun YL, 2005, P NATL ACAD SCI USA, V102, P13182, DOI 10.1073/pnas.0504211102; Takemoto N, 2006, J IMMUNOL, V177, P7515, DOI 10.4049/jimmunol.177.11.7515; Tang Y, 2006, MOL CELL, V24, P827, DOI 10.1016/j.molcel.2006.11.021; Vignali DAA, 2008, NAT REV IMMUNOL, V8, P523, DOI 10.1038/nri2343; von Herrath MG, 2003, NAT REV IMMUNOL, V3, P223, DOI 10.1038/nri1029; Wang L, 2010, EUR J IMMUNOL, V40, P2385, DOI 10.1002/eji.201040534; Wang L, 2008, IMMUNITY, V29, P876, DOI 10.1016/j.immuni.2008.09.019; Xiao H, 2003, J BIOL CHEM, V278, P11197, DOI 10.1074/jbc.M210816200; Yagi R, 2010, IMMUNITY, V32, P507, DOI 10.1016/j.immuni.2010.04.004; Yamagata K, 2009, BIOCHEM BIOPH RES CO, V390, P1355, DOI 10.1016/j.bbrc.2009.10.156; Yamamoto T, 1997, J BIOL CHEM, V272, P30595, DOI 10.1074/jbc.272.49.30595; Yang Y, 2008, J IMMUNOL, V181, P8700, DOI 10.4049/jimmunol.181.12.8700; Zhang JW, 2007, J CLIN INVEST, V117, P871, DOI 10.1172/JCI31860; Zhang M, 2010, J IMMUNOL, V185, P3960, DOI 10.4049/jimmunol.1001462	40	14	15	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 31	2013	288	22					15537	15546		10.1074/jbc.M112.430207	http://dx.doi.org/10.1074/jbc.M112.430207			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	156LA	23609452	hybrid, Green Published			2022-12-25	WOS:000319822300012
J	Lu, CX; Kumar, PA; Sun, JH; Aggarwal, A; Fan, Y; Sperling, MA; Lumeng, CN; Menon, RK				Lu, Chunxia; Kumar, P. Anil; Sun, Jinhong; Aggarwal, Anjali; Fan, Yong; Sperling, Mark A.; Lumeng, Carey N.; Menon, Ram K.			Targeted Deletion of Growth Hormone (GH) Receptor in Macrophage Reveals Novel Osteopontin-mediated Effects of GH on Glucose Homeostasis and Insulin Sensitivity in Diet-induced Obesity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADIPOSE-TISSUE; BINDING-PROTEINS; INFLAMMATION; LIPOPOLYSACCHARIDE; INFILTRATION; STIMULATION; DEFICIENCY; METABOLISM; RESISTANCE; SECRETION	We investigated GH action on macrophage (M Phi) by creating a M Phi-specific GH receptor-null mouse model (MacGHR KO). On a normal diet (10% fat), MacGHR KO and littermate controls exhibited similar growth profiles and glucose excursions on intraperitoneal glucose (ipGTT) and insulin tolerance (ITT) tests. However, when challenged with high fat diet (HFD, 45% fat) for 18 weeks, MacGHR KO mice exhibited impaired ipGTT and ITT compared with controls. In MacGHR KO, adipose-tissue (AT) M Phi abundance was increased with skewing toward M1 polarization. Expression of pro-inflammatory cytokines (IL1 beta, TNF-alpha, IL6, and osteopontin (OPN)) were increased in MacGHR KO AT stromal vascular fraction (SVF). In MacGHR KO AT, crown-like-structures were increased with decreased insulin-dependent Akt phosphorylation. The abundance of phosphorylated NF-kappa B and of OPN was increased in SVF and bone-marrow-derived M Phi in MacGHR KO. GH, acting via an NF-kappa B site in the distal OPN promoter, inhibited the OPN promoter. Thus in diet-induced obesity (DIO), lack of GH action on the M Phi exerts an unexpected deleterious effect on glucose homeostasis by accentuating AT inflammation and NF-kappa B-dependent activation of OPN expression. These novel results in mice support the possibility that administration of GH could have salutary effects on DIO-associated chronic inflammation and insulin resistance in humans.	[Lu, Chunxia; Kumar, P. Anil; Sun, Jinhong; Aggarwal, Anjali; Lumeng, Carey N.; Menon, Ram K.] Univ Michigan, Dept Pediat & Communicable Dis, Ann Arbor, MI 48109 USA; [Lumeng, Carey N.; Menon, Ram K.] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Fan, Yong; Sperling, Mark A.] Univ Pittsburgh, Sch Med, Dept Pediat, Pittsburgh, PA 15224 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Lu, CX (corresponding author), Univ Michigan, Sch Med, D1205 MPB-SPC 5718,1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.	rammenon@umich.edu	Aggarwal, Anjali/AAD-2800-2020	Pasupulati, Anil Kumar/0000-0001-9467-7650; Lumeng, Carey/0000-0003-0303-6204	National Institutes of Health [DK49845, P60DK-20572 Center]; D.R.E.A.M. Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020572, P30DK020572, R29DK049845, R56DK049845, R01DK049845, R01DK090262] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008322] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); D.R.E.A.M. Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by grants from the National Institutes of Health (DK49845 (to R. K. M.) and P60DK-20572 Center) and the D.R.E.A.M. Foundation.	BLOCH CA, 1987, J PEDIATR-US, V110, P481, DOI 10.1016/S0022-3476(87)80522-X; Chapman J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013959; Clayton PE, 2000, GROWTH HORM IGF RES, V10, P306, DOI 10.1054/ghir.2000.0175; Clemmons DR, 2010, CURR OPIN ENDOCRINOL, V17, P377, DOI 10.1097/MED.0b013e32833b6bc7; DENHARDT DT, 1993, FASEB J, V7, P1475, DOI 10.1096/fasebj.7.15.8262332; DiPietro LA, 1998, J CLIN INVEST, V101, P1693, DOI 10.1172/JCI1020; Fan Y, 2009, J BIOL CHEM, V284, P19937, DOI 10.1074/jbc.M109.014308; Fujisaka S, 2009, DIABETES, V58, P2574, DOI 10.2337/db08-1475; Haeffner A, 1997, J IMMUNOL, V158, P1310; HOCHBERG Z, 1992, ENDOCRINOLOGY, V131, P430, DOI 10.1210/en.131.1.430; Hull KL, 1996, CELL TISSUE RES, V286, P69, DOI 10.1007/s004410050676; Johansen T, 2005, GROWTH HORM IGF RES, V15, P55, DOI 10.1016/j.ghir.2004.11.006; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Kaplan SA, 2007, J CLIN ENDOCR METAB, V92, P4529, DOI 10.1210/jc.2007-0526; Kiefer FW, 2010, DIABETES, V59, P935, DOI 10.2337/db09-0404; List EO, 2013, MOL ENDOCRINOL, V27, P524, DOI 10.1210/me.2012-1330; Liu ZH, 2002, ANN CLIN LAB SCI, V32, P164; Lu CX, 2010, ENDOCRINOLOGY, V151, P2189, DOI 10.1210/en.2009-1194; Makimura H, 2008, J CLIN ENDOCR METAB, V93, P4254, DOI 10.1210/jc.2008-1333; Mantovani A, 2006, BLOOD, V108, P408, DOI 10.1182/blood-2006-05-019430; Maurer M, 2004, INT J BIOCHEM CELL B, V36, P1882, DOI 10.1016/j.biocel.2003.10.019; Mavalli MD, 2010, J CLIN INVEST, V120, P4007, DOI 10.1172/JCI42447; Moller N, 2009, ENDOCR REV, V30, P152, DOI 10.1210/er.2008-0027; Newbern D, 2011, CURR OPIN ENDOCRINOL, V18, P409, DOI 10.1097/MED.0b013e32834c800d; Nomiyama T, 2007, J CLIN INVEST, V117, P2877, DOI 10.1172/JCI31986; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; RASMUSSEN MH, 1995, J CLIN ENDOCR METAB, V80, P796, DOI 10.1210/jc.80.3.796; RASMUSSEN MH, 1995, J CLIN ENDOCR METAB, V80, P1407, DOI 10.1210/jc.80.4.1407; Rasmussen MH, 2008, OBESITY, V16, P1516, DOI 10.1038/oby.2008.249; Rasmussen MH, 2006, EUR J ENDOCRINOL, V155, P575, DOI 10.1530/eje.1.02246; Rittling SR, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399411001839; SCHULTZ RM, 1976, CANCER RES, V36, P1641; Smith JR, 2000, BIOMED SCI INSTRUM, V395, P111; Standal T, 2004, EXP ONCOL, V26, P179; TATRO JB, 1987, ENDOCRINOLOGY, V120, P373, DOI 10.1210/endo-120-1-373; Thirone ACP, 1999, ENDOCRINOLOGY, V140, P55, DOI 10.1210/en.140.1.55; Tripathi A, 2007, MOL IMMUNOL, V44, P3185, DOI 10.1016/j.molimm.2007.01.024; VELDHUIS JD, 1991, J CLIN ENDOCR METAB, V72, P51, DOI 10.1210/jcem-72-1-51; Vijayakumar A, 2012, DIABETES, V61, P94, DOI 10.2337/db11-0814; Wang KX, 2008, CYTOKINE GROWTH F R, V19, P333, DOI 10.1016/j.cytogfr.2008.08.001; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102; Wilson E., 2012, OXIDATIVE M IN PRESS; Yakar S, 1999, P NATL ACAD SCI USA, V96, P7324, DOI 10.1073/pnas.96.13.7324; Yakar Shoshana, 2005, Pediatr Endocrinol Rev, V3, P11; Zeyda M, 2007, IMMUNOL LETT, V112, P61, DOI 10.1016/j.imlet.2007.07.003; Zeyda M, 2011, ENDOCRINOLOGY, V152, P2219, DOI 10.1210/en.2010-1328; Zhao W, 2011, J IMMUNOL, V186, P3173, DOI 10.4049/jimmunol.1003626	48	45	46	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 31	2013	288	22					15725	15735		10.1074/jbc.M113.460212	http://dx.doi.org/10.1074/jbc.M113.460212			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	156LA	23595986	hybrid, Green Published			2022-12-25	WOS:000319822300028
J	Hart, R; Stanley, P; Chakravarty, P; Hogg, N				Hart, Rosie; Stanley, Paula; Chakravarty, Probir; Hogg, Nancy			The Kindlin 3 Pleckstrin Homology Domain Has an Essential Role in Lymphocyte Function-associated Antigen 1 (LFA-1) Integrin-mediated B Cell Adhesion and Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN-LIKE DOMAIN; TALIN HEAD; LEUKOCYTE ADHESION; DEFICIENCY-III; IN-VIVO; ACTIVATION; BINDING; RECEPTOR; STABILIZATION; MUTATIONS	The protein kindlin 3 is mutated in the leukocyte adhesion deficiency III (LAD-III) disorder, leading to widespread infection due to the failure of leukocytes to migrate into infected tissue sites. To gain understanding of how kindlin 3 controls leukocyte function, we have focused on its pleckstrin homology (PH) domain and find that deletion of this domain eliminates the ability of kindlin 3 to participate in adhesion and migration of B cells mediated by the leukocyte integrin lymphocyte function-associated antigen 1 (LFA-1). PH domains are often involved in membrane localization of proteins through binding to phosphoinositides. We show that the kindlin 3 PH domain has binding affinity for phosphoinositide PI(3,4,5)P-3 over PI(4,5)P-2. It has a major role in membrane association of kindlin 3 that is enhanced by the binding of LFA-1 to intercellular adhesion molecule 1 (ICAM-1). A splice variant, kindlin 3-IPRR, has a four-residue insert in the PH domain at a critical site that influences phosphoinositide binding by enhancing binding to PI(4,5)P-2 as well as by binding to PI(3,4,5)P-3. However kindlin 3-IPRR is unable to restore the ability of LAD-III B cells to adhere to and migrate on LFA-1 ligand ICAM-1, potentially by altering the dynamics or PI specificity of binding to the membrane. Thus, the correct functioning of the kindlin 3 PH domain is central to the role that kindlin 3 performs in guiding lymphocyte adhesion and motility behavior, which in turn is required for a successful immune response.	[Hart, Rosie; Stanley, Paula; Hogg, Nancy] Canc Res United Kingdom London Res Inst, Leukocyte Adhes Lab, London WC2A 3LY, England; [Chakravarty, Probir] Canc Res United Kingdom London Res Inst, Bioinformat & Biostat Unit, London WC2A 3LY, England	Cancer Research UK; Cancer Research UK	Hogg, N (corresponding author), Canc Res United Kingdom London Res Inst, Leukocyte Adhes Lab, London WC2A 3LY, England.	nancy.hogg@cancer.org.uk		chakravarty, probir/0000-0003-1146-8824				Alon R, 2007, IMMUNITY, V26, P17, DOI 10.1016/j.immuni.2007.01.002; Anthis NJ, 2011, TRENDS BIOCHEM SCI, V36, P191, DOI 10.1016/j.tibs.2010.11.002; Bledzka K, 2012, J BIOL CHEM, V287, P24585, DOI 10.1074/jbc.M111.336743; Blomberg N, 1999, TRENDS BIOCHEM SCI, V24, P441, DOI 10.1016/S0968-0004(99)01472-3; Bouaouina M, 2012, J BIOL CHEM, V287, P6979, DOI 10.1074/jbc.M111.330845; Cronin TC, 2004, EMBO J, V23, P3711, DOI 10.1038/sj.emboj.7600388; DRANSFIELD I, 1992, J CELL BIOL, V116, P219, DOI 10.1083/jcb.116.1.219; DRANSFIELD I, 1989, EMBO J, V8, P3759, DOI 10.1002/j.1460-2075.1989.tb08552.x; Elliott PR, 2010, STRUCTURE, V18, P1289, DOI 10.1016/j.str.2010.07.011; Etzioni A, 2004, CURR OPIN ALLERGY CL, V4, P485, DOI 10.1097/00130832-200412000-00003; Evans R, 2009, J CELL SCI, V122, P215, DOI 10.1242/jcs.019117; Feigelson SW, 2011, BLOOD, V117, P7042, DOI 10.1182/blood-2010-12-322859; Feng C, 2012, J BIOL CHEM, V287, P10714, DOI 10.1074/jbc.M111.299594; Goult BT, 2010, EMBO J, V29, P1069, DOI 10.1038/emboj.2010.4; Goult BT, 2009, J MOL BIOL, V394, P944, DOI 10.1016/j.jmb.2009.09.061; Hogg N, 2011, NAT REV IMMUNOL, V11, P416, DOI 10.1038/nri2986; Hyduk SJ, 2011, J IMMUNOL, V187, P4360, DOI 10.4049/jimmunol.1003725; Isakoff SJ, 1998, EMBO J, V17, P5374, DOI 10.1093/emboj/17.18.5374; Kahner BN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034056; Kim M, 2003, SCIENCE, V301, P1720, DOI 10.1126/science.1084174; Kinashi T, 2005, NAT REV IMMUNOL, V5, P546, DOI 10.1038/nri1646; Kinashi T, 2007, ADV IMMUNOL, V93, P185, DOI 10.1016/S0065-2776(06)93005-3; Klarlund JK, 2000, J BIOL CHEM, V275, P32816, DOI 10.1074/jbc.M002435200; Kuijpers TW, 2009, BLOOD, V113, P4740, DOI 10.1182/blood-2008-10-182154; Larjava H, 2008, EMBO REP, V9, P1203, DOI 10.1038/embor.2008.202; Lefort CT, 2012, BLOOD, V119, P4275, DOI 10.1182/blood-2011-08-373118; Legate KR, 2011, EMBO J, V30, P4539, DOI 10.1038/emboj.2011.332; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; Liu JM, 2011, J BIOL CHEM, V286, P43334, DOI 10.1074/jbc.M111.295352; Liu Y, 2012, PROTEIN CELL, V3, P434, DOI 10.1007/s13238-012-2046-1; Ma YQ, 2008, J CELL BIOL, V181, P439, DOI 10.1083/jcb.200710196; Malinin NL, 2010, BLOOD, V115, P4011, DOI 10.1182/blood-2009-10-239269; Malinin NL, 2009, NAT MED, V15, P313, DOI 10.1038/nm.1917; McDowall A, 2010, BLOOD, V115, P4834, DOI 10.1182/blood-2009-08-238709; Meves A, 2009, TRENDS CELL BIOL, V19, P504, DOI 10.1016/j.tcb.2009.07.006; Miller MJ, 2002, SCIENCE, V296, P1869, DOI 10.1126/science.1070051; Mory A, 2008, BLOOD, V112, P2591, DOI 10.1182/blood-2008-06-163162; Moser M, 2008, NAT MED, V14, P325, DOI 10.1038/nm1722; Moser M, 2009, SCIENCE, V324, P895, DOI 10.1126/science.1163865; Moser M, 2009, NAT MED, V15, P300, DOI 10.1038/nm.1921; Mueller KL, 2004, J IMMUNOL, V173, P2222, DOI 10.4049/jimmunol.173.4.2222; Perera HD, 2011, STRUCTURE, V19, P1664, DOI 10.1016/j.str.2011.08.012; Qu H, 2011, J CELL SCI, V124, P879, DOI 10.1242/jcs.076976; Raab M, 2011, J BIOL CHEM, V286, P29663, DOI 10.1074/jbc.M111.222661; Saltel F, 2009, J CELL BIOL, V187, P715, DOI 10.1083/jcb.200908134; Sanchez-Martin L, 2004, J BIOL CHEM, V279, P16194, DOI 10.1074/jbc.M400905200; Smith DF, 2006, J LEUKOCYTE BIOL, V80, P1491, DOI 10.1189/jlb.0306227; Svensson L, 2009, NAT MED, V15, P306, DOI 10.1038/nm.1931; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; van de Vijver E., 2012, BLOOD CELL MOL DIS, V48, P53; Ward SG, 2009, BIOCHEM J, V418, P13, DOI 10.1042/BJ20081969; Ye F, 2010, J CELL BIOL, V188, P157, DOI 10.1083/jcb.200908045; Zhang TT, 2009, IMMUNOL REV, V232, P255, DOI 10.1111/j.1600-065X.2009.00838.x	53	29	30	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 24	2013	288	21					14852	14862		10.1074/jbc.M112.434621	http://dx.doi.org/10.1074/jbc.M112.434621			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	151HU	23595985	hybrid, Green Published			2022-12-25	WOS:000319452100017
J	Dovere, L; Fera, S; Grasso, M; Lamberti, D; Gargioli, C; Muciaccia, B; Lustri, AM; Stefanini, M; Vicini, E				Dovere, Lisa; Fera, Stefania; Grasso, Margherita; Lamberti, Dante; Gargioli, Cesare; Muciaccia, Barbara; Lustri, Anna Maria; Stefanini, Mario; Vicini, Elena			The Niche-Derived Glial Cell Line-Derived Neurotrophic Factor (GDNF) Induces Migration of Mouse Spermatogonial Stem/Progenitor Cells	PLOS ONE			English	Article							STEM-CELLS; HEPARAN-SULFATE; UNDIFFERENTIATED SPERMATOGONIA; PROTEIN; VASP; CHEMOATTRACTANT; EXPRESSION; RECEPTOR; CULTURE	In mammals, the biological activity of the stem/progenitor compartment sustains production of mature gametes through spermatogenesis. Spermatogonial stem cells and their progeny belong to the class of undifferentiated spermatogonia, a germ cell population found on the basal membrane of the seminiferous tubules. A large body of evidence has demonstrated that glial cell line-derived neurotrophic factor (GDNF), a Sertoli-derived factor, is essential for in vivo and in vitro stem cell self-renewal. However, the mechanisms underlying this activity are not completely understood. In this study, we show that GDNF induces dose-dependent directional migration of freshly selected undifferentiated spermatogonia, as well as germline stem cells in culture, using a Boyden chamber assay. GDNF-induced migration is dependent on the expression of the GDNF co-receptor GFRA1, as shown by migration assays performed on parental and GFRA1-transduced GC-1 spermatogonial cell lines. We found that the actin regulatory protein vasodilator-stimulated phosphoprotein (VASP) is specifically expressed in undifferentiated spermatogonia. VASP belongs to the ENA/VASP family of proteins implicated in actin-dependent processes, such as fibroblast migration, axon guidance, and cell adhesion. In intact seminiferous tubules and germline stem cell cultures, GDNF treatment up-regulates VASP in a dose-dependent fashion. These data identify a novel role for the niche-derived factor GDNF, and they suggest that GDNF may impinge on the stem/progenitor compartment, affecting the actin cytoskeleton and cell migration.	[Dovere, Lisa; Fera, Stefania; Lamberti, Dante; Muciaccia, Barbara; Lustri, Anna Maria; Stefanini, Mario; Vicini, Elena] Univ Roma La Sapienza, Fdn Pasteur Cenci Bolognetti, Dept Anat Histol Forens & Orthopaed Sci, Sect Histol & Med Embryol, Rome, Italy; [Grasso, Margherita] Univ Trento, Ctr Integrat Biol, Trento, Italy; [Gargioli, Cesare] Univ Roma Tor Vergata, Dept Biol, I-00173 Rome, Italy	Fondazione Cenci Bolognetti; Sapienza University Rome; University of Trento; University of Rome Tor Vergata	Vicini, E (corresponding author), Univ Roma La Sapienza, Fdn Pasteur Cenci Bolognetti, Dept Anat Histol Forens & Orthopaed Sci, Sect Histol & Med Embryol, Rome, Italy.	elena.vicini@uniroma1.it	lamberti, dante/AAB-8791-2020	lamberti, dante/0000-0001-9852-4934; Grasso, Margherita/0000-0001-9749-5908; Gargioli, Cesare/0000-0003-1742-3969; Vicini, Elena/0000-0003-0399-0145	Italian Ministry of University (FIRB) [RBIN06E9Z8_008]; Sapienza University (Ateno)	Italian Ministry of University (FIRB)(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB)); Sapienza University (Ateno)	This work was supported by grants from Italian Ministry of University (FIRB, grant number: RBIN06E9Z8_008) and Sapienza University (Ateno 2011) to E. V. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnett MW, 2002, J CELL SCI, V115, P4495, DOI 10.1242/jcs.00114; Bespalov MM, 2011, J CELL BIOL, V192, P153, DOI 10.1083/jcb.201009136; Chiarini-Garcia H, 2001, BIOL REPROD, V65, P1179, DOI 10.1095/biolreprod65.4.1179; Corallini S, 2006, REPRODUCTION, V132, P887, DOI 10.1530/REP-06-0062; De Rooij DG, 2000, J ANDROL, V21, P776; Ferranti F, 2012, INT J ANDROL, V35, P758, DOI 10.1111/j.1365-2605.2012.01267.x; Gargioli C, 2008, NAT MED, V14, P973, DOI 10.1038/nm.1852; Grasso M, 2012, REPRODUCTION, V143, P325, DOI 10.1530/REP-11-0385; Grisanti L, 2009, STEM CELLS, V27, P3043, DOI 10.1002/stem.206; Harbeck B, 2000, J BIOL CHEM, V275, P30817, DOI 10.1074/jbc.M005066200; Hofmann MC, 2008, MOL CELL ENDOCRINOL, V288, P95, DOI 10.1016/j.mce.2008.04.012; HOFMANN MC, 1992, EXP CELL RES, V201, P417, DOI 10.1016/0014-4827(92)90291-F; Johnston DS, 2011, BIOL REPROD, V85, P763, DOI 10.1095/biolreprod.110.087676; Kadirkamanathan V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035182; Kanatsu-Shinohara M, 2003, BIOL REPROD, V69, P612, DOI 10.1095/biolreprod.103.017012; Kanatsu-Shinohara M, 2005, BIOL REPROD, V72, P985, DOI 10.1095/biolreprod.104.036400; Klein AM, 2010, CELL STEM CELL, V7, P214, DOI 10.1016/j.stem.2010.05.017; Krause M, 2003, ANNU REV CELL DEV BI, V19, P541, DOI 10.1146/annurev.cellbio.19.050103.103356; Kubota H, 2003, P NATL ACAD SCI USA, V100, P6487, DOI 10.1073/pnas.0631767100; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Meng XJ, 2000, SCIENCE, V287, P1489, DOI 10.1126/science.287.5457.1489; Nagano M, 1999, BIOL REPROD, V60, P1429, DOI 10.1095/biolreprod60.6.1429; Naughton CK, 2006, BIOL REPROD, V74, P314, DOI 10.1095/biolreprod.105.047365; Neel NF, 2009, J CELL SCI, V122, P1882, DOI 10.1242/jcs.039057; Okada Y, 1999, INT J CANCER, V81, P67, DOI 10.1002/(SICI)1097-0215(19990331)81:1<67::AID-IJC13>3.0.CO;2-V; Paratcha G, 2006, MOL CELL NEUROSCI, V31, P505, DOI 10.1016/j.mcn.2005.11.007; Parkash V, 2008, J BIOL CHEM, V283, P35164, DOI 10.1074/jbc.M802543200; Phillips BT, 2010, PHILOS T R SOC B, V365, P1663, DOI 10.1098/rstb.2010.0026; REINHARD M, 1992, EMBO J, V11, P2063, DOI 10.1002/j.1460-2075.1992.tb05264.x; REINHARD M, 1995, EMBO J, V14, P1583, DOI 10.1002/j.1460-2075.1995.tb07146.x; Rickard SM, 2003, GLYCOBIOLOGY, V13, P419, DOI 10.1093/glycob/cwg046; Rottner K, 1999, NAT CELL BIOL, V1, P321, DOI 10.1038/13040; Sato T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028367; Simon L, 2010, STEM CELLS, V28, P1882, DOI 10.1002/stem.508; Tang MJ, 1998, J CELL BIOL, V142, P1337, DOI 10.1083/jcb.142.5.1337; VANKEULEN CJG, 1975, CELL TISSUE KINET, V8, P543, DOI 10.1111/j.1365-2184.1975.tb01240.x; Yoshida S, 2007, SCIENCE, V317, P1722, DOI 10.1126/science.1144885; Young HM, 2001, DEV BIOL, V229, P503, DOI 10.1006/dbio.2000.0100	38	30	35	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2013	8	4							e59431	10.1371/journal.pone.0059431	http://dx.doi.org/10.1371/journal.pone.0059431			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JR	23613711	Green Published, gold, Green Submitted			2022-12-25	WOS:000317911500001
J	Kim, JW; Chun, EJ; Choi, SI; Park, DJ; Kim, HH; Bang, SM; Kim, MJ; Lee, JH; Lee, MS; Lee, JO; Kim, YJ; Kim, JH; Lee, JS; Lee, KW				Kim, Jin Won; Chun, Eun Ju; Choi, Sang Il; Park, Do Joong; Kim, Hyung-Ho; Bang, Soo-Mee; Kim, Min Jeong; Lee, Ju-Hee; Lee, Moon-Soo; Lee, Jeong-Ok; Kim, Yu Jung; Kim, Jee Hyun; Lee, Jong Seok; Lee, Keun-Wook			A Prospective Study on the Incidence of Postoperative Venous Thromboembolism in Korean Gastric Cancer Patients: An Inquiry into the Application of Western Guidelines to Asian Cancer Patients	PLOS ONE			English	Article							DEEP-VEIN THROMBOSIS; CLINICAL-PRACTICE GUIDELINES; MAJOR ORTHOPEDIC-SURGERY; MOLECULAR-WEIGHT HEPARIN; PULMONARY-EMBOLISM; RISK-FACTORS; COLORECTAL-CANCER; RATES; PROPHYLAXIS; THROMBOPROPHYLAXIS	Several Western guidelines recommend the routine use of pharmacologic thromboprophylaxis for cancer surgery patients to prevent venous thromboembolism (VTE). However, the necessity of routine pharmacologic perioperative thromboprophylaxis in Asian gastric cancer (GC) patients has not been clearly determined. To determine the necessity of routine perioperative pharmacologic thromboprophylaxis in Korean gastric cancer patients, the incidence of postoperative VTE was prospectively evaluated in gastric cancer patients receiving surgery. Among 610 GC patients who had received surgery, 375 patents underwent routine duplex Doppler ultrasonography (DUS) on days 5-12 following surgery to detect VTE and then VTE-related symptoms and signs were checked at 4 weeks after surgery (cohort A). The 235 patients that declined DUS were registered to cohort B and the occurrence of postoperative VTE was retrospectively analyzed. In cohort A, symptomatic or asymptomatic VTE until 4 weeks after surgery was detected in 9 patients [2.4%; 95% confidence interval (CI); 0.9-3.9]. Tumor stage was a significant factor related to VTE development [stage I, 1.4%; stage II/III, 2.4%; stage IV, 9.7% (P = 0.008)]. In multivariate analysis, patients with stage IV had a higher postoperative VTE development [odds ratio, 8.18 (95% CI, 1.54-43.42)] than those with stage I. In cohort B, a low incidence of postoperative VTE was reaffirmed; only one postoperative VTE case (0.4%) was observed. In conclusion, the incidence of postoperative VTE in Korean GC patients was only 2.4%. Risk-stratified applications of perioperative pharmacologic thromboprophylaxis are thought to be more appropriate than the routine pharmacologic thromboprophylaxis in Korean GC patients receiving surgery.	[Kim, Jin Won; Bang, Soo-Mee; Kim, Min Jeong; Lee, Jeong-Ok; Kim, Yu Jung; Kim, Jee Hyun; Lee, Jong Seok; Lee, Keun-Wook] Seoul Natl Univ, Coll Med, Dept Internal Med, Bundang Hosp, Seoul 151, South Korea; [Chun, Eun Ju; Choi, Sang Il] Seoul Natl Univ, Coll Med, Dept Radiol, Bundang Hosp, Seoul, South Korea; [Park, Do Joong; Kim, Hyung-Ho; Lee, Ju-Hee; Lee, Moon-Soo] Seoul Natl Univ, Coll Med, Dept Surg, Bundang Hosp, Seoul, South Korea; [Lee, Moon-Soo] Eulji Univ Hosp, Dept Surg, Taejon, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Eulji University	Lee, KW (corresponding author), Seoul Natl Univ, Coll Med, Dept Internal Med, Bundang Hosp, Seoul 151, South Korea.	hmodoctor@snubh.org	Kim, Hyung Ho/J-5451-2012; Kim, Hyung-Ho/AAG-3720-2019	Kim, Hyung-Ho/0000-0002-8916-0048	Seoul National University Bundang Hospital Research Fund [02-2010-037]; Sanofi-Aventis; Sanofi-Aventis Korea Co., Ltd	Seoul National University Bundang Hospital Research Fund; Sanofi-Aventis(Sanofi-Aventis); Sanofi-Aventis Korea Co., Ltd(Sanofi-Aventis)	This study was partially supported by research grants from the Seoul National University Bundang Hospital Research Fund (02-2010-037) and Sanofi-Aventis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have the following interests. This study was partly funded by Sanofi-Aventis Korea Co., Ltd in the form of research funding to Keun-Wook Lee. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Ahn HS, 2011, BRIT J SURG, V98, P255, DOI 10.1002/bjs.7310; Ahn HS, 2011, GASTRIC CANCER, V14, P178, DOI 10.1007/s10120-011-0012-x; Alcalay A, 2006, J CLIN ONCOL, V24, P1112, DOI 10.1200/JCO.2005.04.2150; ANDERSON FA, 1991, ARCH INTERN MED, V151, P933, DOI 10.1001/archinte.151.5.933; APPELMAN PT, 1987, RADIOLOGY, V163, P743, DOI 10.1148/radiology.163.3.3554343; Buchberg B, 2011, ARCH SURG-CHICAGO, V146, P739, DOI 10.1001/archsurg.2011.127; Chew HK, 2007, J CLIN ONCOL, V25, P70, DOI 10.1200/JCO.2006.07.4393; Chew HK, 2006, ARCH INTERN MED, V166, P458; Choi S, 2011, THROMB HAEMOSTASIS, V106, P1084, DOI 10.1160/TH11-07-0505; Clarke-Pearson DL, 2003, OBSTET GYNECOL, V101, P157, DOI 10.1016/S0029-7844(02)02444-4; CRONAN JJ, 1988, RADIOLOGY, V168, P101, DOI 10.1148/radiology.168.1.2967984; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Gaitini D, 2006, J CLIN ULTRASOUND, V34, P289, DOI 10.1002/jcu.20236; Geerts WH, 2008, CHEST, V133, p381S, DOI 10.1378/chest.08-0656; Gould MK, 2012, CHEST, V141, pE227S, DOI 10.1378/chest.11-2297; Heit JA, 2000, ARCH INTERN MED, V160, P809, DOI 10.1001/archinte.160.6.809; HISAMICHI S, 1988, CANCER DETECT PREV, V11, P323; Hosono S, 2006, WORLD J GASTROENTERO, V12, P7676, DOI 10.3748/wjg.v12.i47.7676; INADA K, 1983, AM J SURG, V145, P775, DOI 10.1016/0002-9610(83)90138-1; Jang MJ, 2011, J THROMB HAEMOST, V9, P85, DOI 10.1111/j.1538-7836.2010.04108.x; Jeong O, 2011, J GASTRIC CANCER, V11, P69, DOI 10.5230/jgc.2011.11.2.69; Jeong O, 2010, ANN SURG ONCOL, V17, P2363, DOI 10.1245/s10434-010-1032-1; Jung HC, 2003, KOREAN J GASTROENTER, V41, P72; Khorana AA, 2008, BLOOD, V111, P4902, DOI 10.1182/blood-2007-10-116327; Khorana AA, 2007, ONCOLOGIST, V12, P1361, DOI 10.1634/theoncologist.12-11-1361; Khorana AA, 2009, J CLIN ONCOL, V27, P4919, DOI 10.1200/JCO.2009.22.3214; Kim DH, 2012, J SURG ONCOL, V105, P26, DOI 10.1002/jso.22026; Kim HH, 2010, ANN SURG, V251, P417, DOI 10.1097/SLA.0b013e3181cc8f6b; Kim IG, 2004, J KOREAN SOC VASC SU, V20, P237; Lee EH, 2011, CANCER RES TREAT, V43, P141, DOI 10.4143/crt.2011.43.3.141; Lee JH, 2005, SURG ENDOSC, V19, P168, DOI 10.1007/s00464-004-8808-y; Lee KW, 2010, J THROMB HAEMOST, V8, P540, DOI 10.1111/j.1538-7836.2009.03731.x; Leizorovicz A, 2005, J THROMB HAEMOST, V3, P28, DOI 10.1111/j.1538-7836.2004.01094.x; Levitan N, 1999, MEDICINE, V78, P285, DOI 10.1097/00005792-199909000-00001; Liew Ngoh Chin, 2003, Asian J Surg, V26, P154, DOI 10.1016/S1015-9584(09)60375-4; Lyman GH, 2007, J CLIN ONCOL, V25, P5490, DOI 10.1200/JCO.2007.14.1283; Mandala M, 2010, ANN ONCOL, V21, pv274, DOI 10.1093/annonc/mdq199; Mismetti P, 2001, BRIT J SURG, V88, P913, DOI 10.1046/j.0007-1323.2001.01800.x; Mukherjee D, 2008, J GASTROINTEST SURG, V12, P2015, DOI 10.1007/s11605-008-0600-1; Nguyen NT, 2007, ANN SURG, V246, P1021, DOI 10.1097/SLA.0b013e31815792d8; Oh SY, 2008, THROMB RES, V122, P485, DOI 10.1016/j.thromres.2007.12.015; Piovella F, 2005, J THROMB HAEMOST, V3, P2664, DOI 10.1111/j.1538-7836.2005.01621.x; Sakon M, 2006, J THROMB HAEMOST, V4, P581, DOI 10.1111/j.1538-7836.2006.01786.x; Silverstein MD, 1998, ARCH INTERN MED, V158, P585, DOI 10.1001/archinte.158.6.585; White RH, 2003, THROMB HAEMOSTASIS, V90, P446, DOI 10.1160/TH03-03-0152; Yoon HM, 2012, J AM COLL SURGEONS, V214, P88, DOI 10.1016/j.jamcollsurg.2011.09.018	46	17	19	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2013	8	4							e61968	10.1371/journal.pone.0061968	http://dx.doi.org/10.1371/journal.pone.0061968			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IK	23613988	gold, Green Published, Green Submitted			2022-12-25	WOS:000317907200110
J	Onmus-Leone, F; Hang, J; Clifford, RJ; Yang, Y; Riley, MC; Kuschner, RA; Waterman, PE; Lesho, EP				Onmus-Leone, Fatma; Hang, Jun; Clifford, Robert J.; Yang, Yu; Riley, Matthew C.; Kuschner, Robert A.; Waterman, Paige E.; Lesho, Emil P.			Enhanced De Novo Assembly of High Throughput Pyrosequencing Data Using Whole Genome Mapping	PLOS ONE			English	Article							PROVIDENCIA-STUARTII; CLINICAL ISOLATE; SEQUENCE; STRAIN; VALIDATION; BLA(NDM-1); DIVERSITY; OUTBREAK; ERA	Despite major advances in next-generation sequencing, assembly of sequencing data, especially data from novel microorganisms or re-emerging pathogens, remains constrained by the lack of suitable reference sequences. De novo assembly is the best approach to achieve an accurate finished sequence, but multiple sequencing platforms or paired-end libraries are often required to achieve full genome coverage. In this study, we demonstrated a method to assemble complete bacterial genome sequences by integrating shotgun Roche 454 pyrosequencing with optical whole genome mapping (WGM). The whole genome restriction map (WGRM) was used as the reference to scaffold de novo assembled sequence contigs through a stepwise process. Large de novo contigs were placed in the correct order and orientation through alignment to the WGRM. De novo contigs that were not aligned to WGRM were merged into scaffolds using contig branching structure information. These extended scaffolds were then aligned to the WGRM to identify the overlaps to be eliminated and the gaps and mismatches to be resolved with unused contigs. The process was repeated until a sequence with full coverage and alignment with the whole genome map was achieved. Using this method we were able to achieved 100% WGRM coverage without a paired-end library. We assembled complete sequences for three distinct genetic components of a clinical isolate of Providencia stuartii: a bacterial chromosome, a novel bla(NDM-1) plasmid, and a novel bacteriophage, without separately purifying them to homogeneity.	[Onmus-Leone, Fatma; Clifford, Robert J.; Riley, Matthew C.; Waterman, Paige E.; Lesho, Emil P.] Walter Reed Army Inst Res, Multidrug Resistant Organism Surveillance Network, Silver Spring, MD USA; [Hang, Jun; Yang, Yu; Kuschner, Robert A.] Walter Reed Army Inst Res, Viral Dis Branch, Silver Spring, MD USA	United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR)	Onmus-Leone, F (corresponding author), Walter Reed Army Inst Res, Multidrug Resistant Organism Surveillance Network, Silver Spring, MD USA.	Fatma.Onmus-Leone.ctr@us.army.mil; Jun.Hang.ctr@us.army.mil		Clifford, Robert/0000-0001-8888-897X	United States Army Medical Command [09-050, 11-035]; Global Emerging Infections Surveillance and Response System, a Division of the Armed Forces Health Surveillance Center [C0709_12_WR, I0361_12_WR]	United States Army Medical Command; Global Emerging Infections Surveillance and Response System, a Division of the Armed Forces Health Surveillance Center	This study was supported by the United States Army Medical Command Policies 09-050 and 11-035, and was partially funded by grants C0709_12_WR and I0361_12_WR from the Global Emerging Infections Surveillance and Response System, a Division of the Armed Forces Health Surveillance Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048228; Chain PSG, 2009, SCIENCE, V326, P236, DOI 10.1126/science.1180614; Chandry PS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041615; Chaudhuri RR, 2008, NUCLEIC ACIDS RES, V36, pD543, DOI 10.1093/nar/gkm928; Clarridge JE, 2013, J CLIN MICROBIOL, V51, P224, DOI 10.1128/JCM.02423-12; Clifford RJ, 2012, J BACTERIOL, V194, P3736, DOI 10.1128/JB.00615-12; Fey PD, 2012, J CLIN MICROBIOL, V50, P3063, DOI 10.1128/JCM.01320-12; Garcia-Martinez J, 1999, J MICROBIOL METH, V36, P55, DOI 10.1016/S0167-7012(99)00011-1; Giongo A, 2010, STAND GENOMIC SCI, V2, P309, DOI 10.4056/sigs.972221; Hasan NA, 2012, P NATL ACAD SCI USA, V109, pE2010, DOI 10.1073/pnas.1207359109; Hongoh Y, 2011, METHODS MOL BIOL, V733, P25, DOI 10.1007/978-1-61779-089-8_2; Hu B, 2011, BRIEF FUNCT GENOMICS, V10, P322, DOI 10.1093/bfgp/elr042; Jackson SA, 2012, APPL ENVIRON MICROB, V78, P1601, DOI 10.1128/AEM.07464-11; Koser CU, 2012, NEW ENGL J MED, V366, P2267, DOI 10.1056/NEJMoa1109910; Lavigne JP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034294; Lefebure T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037607; Lin JY, 1999, SCIENCE, V285, P1558, DOI 10.1126/science.285.5433.1558; Loman NJ, 2012, NAT BIOTECHNOL, V30, P562, DOI 10.1038/nbt0612-562f; Mc Gann P, 2012, ANTIMICROB AGENTS CH, V56, P1673, DOI 10.1128/AAC.05604-11; Metzker Michael L, 2010, Nat Rev Genet, V11, P31, DOI 10.1038/nrg2626; Nagarajan N, 2008, BIOINFORMATICS, V24, P1229, DOI 10.1093/bioinformatics/btn102; Nagarajan N, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-242; Narzisi G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019175; Neely RK, 2011, BIOPOLYMERS, V95, P298, DOI 10.1002/bip.21579; Park J, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-545; Petrosino JF, 2009, CLIN CHEM, V55, P856, DOI 10.1373/clinchem.2008.107565; Poirel L, 2011, ANTIMICROB AGENTS CH, V55, P5403, DOI 10.1128/AAC.00585-11; Poirel L, 2011, J ANTIMICROB CHEMOTH, V66, P304, DOI 10.1093/jac/dkq428; Ramirez MS, 2011, ANTIMICROB AGENTS CH, V55, P1520, DOI 10.1128/AAC.01595-10; Reslewic S, 2005, APPL ENVIRON MICROB, V71, P5511, DOI 10.1128/AEM.71.9.5511-5522.2005; Riley MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027085; Riley MC, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-252; Saunders MP, 2010, EPIDEMIOL INFECT, P1; Schwan WR, 2010, MICROBIOL-SGM, V156, P2124, DOI 10.1099/mic.0.033977-0; Shukla SK, 2012, J CLIN MICROBIOL, V50, P3526, DOI 10.1128/JCM.01168-12; Shukla SK, 2009, J BACTERIOL, V191, P5717, DOI 10.1128/JB.00325-09; Storey S. A., 2011, Morbidity and Mortality Weekly Report, V60, P756; Thomas Torsten, 2012, Microb Inform Exp, V2, P3, DOI 10.1186/2042-5783-2-3; Tompkins TA, 2012, J BACTERIOL, V194, P6349, DOI 10.1128/JB.01638-12; Triscari-Barberi T, 2012, J BACTERIOL, V194, P4426, DOI 10.1128/JB.00722-12; Turner PC, 2012, J IND MICROBIOL BIOT, V39, P629, DOI 10.1007/s10295-011-1052-2; Walsh TR, 2011, LANCET INFECT DIS, V11, P355, DOI 10.1016/S1473-3099(11)70059-7; Welch JS, 2011, HEMATOL-AM SOC HEMAT, P30, DOI 10.1182/asheducation-2011.1.30; Yi H, 2012, J BACTERIOL, V194, P3742, DOI 10.1128/JB.00641-12; Yoo M, 2012, J BACTERIOL, V194, P4440, DOI 10.1128/JB.00844-12; Zhang XJ, 2012, BIOTECHNIQUES, V53, P61, DOI 10.2144/0000113891; Zhou S, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-278	47	26	26	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2013	8	4							e61762	10.1371/journal.pone.0061762	http://dx.doi.org/10.1371/journal.pone.0061762			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IK	23613926	Green Submitted, Green Published, gold			2022-12-25	WOS:000317907200083
J	Zhao, XM; Wang, ZQ; Shu, SH; Wang, WJ; Xu, HJ; Ahn, YJ; Wang, M; Hu, XB				Zhao, Xin-Mei; Wang, Zhang-Qian; Shu, Shao-Hua; Wang, Wen-Juan; Xu, Hai-Jie; Ahn, Young-Joon; Wang, Mo; Hu, Xuebo			Ethanol and Methanol Can Improve Huperzine A Production from Endophytic Colletotrichum gloeosporioides ES026	PLOS ONE			English	Article							PICHIA-PASTORIS; PROMISING DRUG; SOLID-STATE; HEAT-SHOCK; FERMENTATION; SERRATA; FUNGUS; RESPIRATION; ALKALOIDS; CULTURE	Huperzine A (HupA) is a plant alkaloid that is of great interest as a therapeutic candidate for the treatment of Alzheimer's disease. However, the current production of HupA from plants in large quantity is unsustainable because the plant resource is scarce and the content of HupA in plants is extremely low. Surprisingly, this compound was recently found to be produced by various endophytic fungi, which are much more controllable than the plants due to simpler genetics and ease of manipulation. However, it might be due to the innate properties of endophytic symbiosis, that production of this chemical in large quantity from endophytes has not yet been put into practice. Endophytic Colletotrichum gloeosporioides ES026 was previously isolated from a HupA producing plant and the fungi also proved to produce HupA. In this study, various fermentation conditions were tried to optimize the production of HupA from C. gloeosporioides ES026. Optimization of these parameters resulted in a 25.58% increase in HupA yield. Potato extracts supplemented with glucose or sucrose but not maltose facilitated HupA producing from the fungi. A final concentration of 0.5-2% ethanol stimulated the growth of fungi while methanol with the same treatment slightly inhibited the growth. However, both methanol and ethanol greatly increased the HupA production with the highest yield of HupA (51.89% increment) coming from ethanol treatment. Further analysis showed that both ethanol and methanol were strong inducers of HupA production, while ethanol was partially used as a carbon source during fermentation. It was noticed that the color of that ethanol treated mycelia gradually became dark while methanol treated ones stayed grey during fermentation. The present study sheds light on the importance of optimizing the fermentation process, which, combined with effective inducers, maximizes production of chemicals of important economic interest from endophytic fungi.	[Zhao, Xin-Mei; Shu, Shao-Hua; Wang, Wen-Juan; Xu, Hai-Jie; Wang, Mo; Hu, Xuebo] Huazhong Agr Univ, Coll Plant Sci & Technol, Inst Med Plant, Wuhan, Peoples R China; [Zhao, Xin-Mei] Xinyang Normal Univ, Coll Life Sci, Xinyang, Henan, Peoples R China; [Wang, Zhang-Qian; Ahn, Young-Joon] Seoul Natl Univ, Dept Agr Biotechnol, WCU Biomodulat Major, Seoul, South Korea	Huazhong Agricultural University; Xinyang Normal University; Seoul National University (SNU)	Wang, M (corresponding author), Huazhong Agr Univ, Coll Plant Sci & Technol, Inst Med Plant, Wuhan, Peoples R China.	wangmo@mail.hzau.edu.cn; xuebohu@mail.hzau.edu.cn			Science and Technology of the People's Republic of China [2011DFA31290]; National Natural Science Foundation of China [81202870]	Science and Technology of the People's Republic of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Science and Technology of the People's Republic of China (Grant No. 2011DFA31290) and National Natural Science Foundation of China (Grant No. 81202870). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnaud H, 2000, TETRAHEDRON, V56, P3181; Cai MH, 2011, BIORESOURCE TECHNOL, V102, P3584, DOI 10.1016/j.biortech.2010.10.052; Cai MH, 2012, MAR BIOTECHNOL  0128; Castilho LR, 2000, BIOCHEM ENG J, V4, P239, DOI 10.1016/S1369-703X(99)00052-2; Cheng DH, 1996, NEUROREPORT, V8, P97, DOI 10.1097/00001756-199612200-00020; DAVIS EN, 1976, APPL ENVIRON MICROB, V32, P303, DOI 10.1128/AEM.32.2.303-305.1976; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; Foricher Y, 2000, TETRAHEDRON LETT, V41, P2007, DOI 10.1016/S0040-4039(00)00085-X; Goodger JQD, 2008, BIOCHEM SYST ECOL, V36, P612, DOI 10.1016/j.bse.2008.05.006; Holker U, 2005, CURR OPIN MICROBIOL, V8, P301, DOI 10.1016/j.mib.2005.04.006; Ju Zan, 2009, Fudan Xuebao (Yixueban), V36, P445; Kaneko S, 1997, TETRAHEDRON-ASYMMETR, V8, P829, DOI 10.1016/S0957-4166(97)00048-7; Kern KA, 2009, PLANT PHYSIOL BIOCH, V47, P1095, DOI 10.1016/j.plaphy.2009.07.002; Koshiba T, 2009, ORG LETT, V11, P5354, DOI 10.1021/ol9022408; Li Jing, 2007, Yingyong Shengtai Xuebao, V18, P376; Li W., 2007, CHIN MED BIOTECHNOL, V2, P254; Lim WH, 2010, PHARM BIOL, V48, P1073, DOI 10.3109/13880209.2010.485619; LIU JS, 1986, ACTA CHIM SINICA, V44, P1035; LIU JS, 1986, CAN J CHEM, V64, P837, DOI 10.1139/v86-137; Liu XJ, 2012, BIOPROC BIOSYST ENG, V35, P739, DOI 10.1007/s00449-011-0654-4; Luo HM, 2010, PHYSIOL PLANTARUM, V139, P1, DOI 10.1111/j.1399-3054.2009.01339.x; Ma XQ, 2008, PHYTOCHEMISTRY, V69, P2022, DOI 10.1016/j.phytochem.2008.04.017; Ma XQ, 2007, J ETHNOPHARMACOL, V113, P15, DOI 10.1016/j.jep.2007.05.030; Ma XQ, 2006, J ETHNOPHARMACOL, V104, P54, DOI 10.1016/j.jep.2005.08.042; Ma XQ, 2005, J AGR FOOD CHEM, V53, P1393, DOI 10.1021/jf048193n; Ma XQ, 2004, NAT PROD REP, V21, P752, DOI 10.1039/b409720n; ODUMERU JA, 1992, J IND MICROBIOL, V10, P111, DOI 10.1007/BF01583843; Ostergaard S, 2000, MICROBIOL MOL BIOL R, V64, P34, DOI 10.1128/MMBR.64.1.34-50.2000; QIAN BC, 1995, ACTA PHARM SINIC, V16, P396; QIAN LG, 1989, TETRAHEDRON LETT, V30, P2089, DOI 10.1016/S0040-4039(01)93719-0; Saikkonen K, 2004, TRENDS PLANT SCI, V9, P275, DOI 10.1016/j.tplants.2004.04.005; Sakaki T, 2001, YEAST, V18, P679, DOI 10.1002/yea.720; STIERLE A, 1993, SCIENCE, V260, P214, DOI 10.1126/science.8097061; Strobel G, 2003, MICROBIOL MOL BIOL R, V67, P491, DOI 10.1128/MMBR.67.4.491-502.2003; Szypula W, 2005, PLANT SCI, V168, P1443, DOI 10.1016/j.plantsci.2004.12.021; Tang XC, 1996, ACTA PHARM SINIC, V17, P481; Tang YJ, 2009, BIORESOURCE TECHNOL, V100, P1852, DOI 10.1016/j.biortech.2008.10.005; VERDUYN C, 1992, YEAST, V8, P501, DOI 10.1002/yea.320080703; Wang Ya, 2011, Mycosystema, V30, P255; Ward J, 2006, TETRAHEDRON LETT, V47, P553, DOI 10.1016/j.tetlet.2005.11.037; Wiley J, 1971, BIOTECHNOL BIOENG, V13, P923; XIA Y, 1989, J AM CHEM SOC, V111, P4116, DOI 10.1021/ja00193a062; XU SS, 1995, ACTA PHARM SINIC, V16, P391; ZEUTHEN ML, 1988, J GEN MICROBIOL, V134, P1375; [张磊 Zhang Lei], 2005, [中草药, Chinese Traditional and Herbal Drugs], V36, P1422; Zhang W, 2003, J IND MICROBIOL BIOT, V30, P57, DOI 10.1007/s10295-002-0012-2; Zhang ZB, 2011, WORLD J MICROB BIOT, V27, P479, DOI 10.1007/s11274-010-0476-6; Zhu D, 2010, J APPL MICROBIOL, V109, P1469, DOI 10.1111/j.1365-2672.2010.04777.x	48	35	39	4	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2013	8	4							e61777	10.1371/journal.pone.0061777	http://dx.doi.org/10.1371/journal.pone.0061777			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IK	23613930	Green Published, Green Submitted, gold			2022-12-25	WOS:000317907200085
J	Sai, E; Shimada, K; Yokoyama, T; Sato, S; Miyazaki, T; Hiki, M; Tamura, Y; Aoki, S; Watada, H; Kawamori, R; Daida, H				Sai, Eiryu; Shimada, Kazunori; Yokoyama, Takayuki; Sato, Shuji; Miyazaki, Tetsuro; Hiki, Makoto; Tamura, Yoshifumi; Aoki, Shigeki; Watada, Hirotaka; Kawamori, Ryuzo; Daida, Hiroyuki			Association between Myocardial Triglyceride Content and Cardiac Function in Healthy Subjects and Endurance Athletes	PLOS ONE			English	Article							ANKLE VASCULAR INDEX; INSULIN-RESISTANCE; ARTERIAL STIFFNESS; LIPID-ACCUMULATION; DIASTOLIC FUNCTION; SKELETAL-MUSCLE; EPICARDIAL FAT; HUMAN OBESITY; HUMAN HEART; EXERCISE	Ectopic fat accumulation plays important roles in various metabolic disorders and cardiovascular diseases. Recent studies reported that myocardial triglyceride (TG) content measured by proton magnetic resonance spectroscopy (H-1-MRS) is associated with aging, diabetes mellitus, and cardiac dysfunction. However, myocardial TG content in athletes has not yet been investigated. We performed H-1-MRS and cardiac magnetic resonance imaging in 10 male endurance athletes and 15 healthy male controls. Serum markers and other clinical parameters including arterial stiffness were measured. Cardiopulmonary exercise testing was also performed. There were no significant differences in clinical characteristics including age, anthropometric parameters, blood test results, or arterial stiffness between the two groups. Peak oxygen uptakes, end-diastolic volume (EDV), end-systolic volume (ESV), left ventricular (LV) mass, peak ejection rates and peak filling rates were significantly higher in the athlete group than in the control group (all P, 0.02). Myocardial TG content was significantly lower in the athlete group than in the control group (0.60 +/- 0.20 vs. 0.89 +/- 0.41%, P < 0.05). Myocardial TG content was negatively correlated with EDV (r = -0.47), ESV (r = -0.64), LV mass (r = -0.44), and epicardial fat volume (r = 0.47) (all P < 0.05). In conclusion, lower levels of myocardial TG content were observed in endurance athletes and were associated with morphological changes related to physiological LV alteration in athletes, suggesting that metabolic imaging for measurement of myocardial TG content by H-1-MRS may be a useful technique for noninvasively assessing the "athlete's heart''.	[Sai, Eiryu; Shimada, Kazunori; Yokoyama, Takayuki; Miyazaki, Tetsuro; Hiki, Makoto; Daida, Hiroyuki] Juntendo Univ, Dept Cardiol, Grad Sch Med, Tokyo, Japan; [Shimada, Kazunori; Tamura, Yoshifumi; Watada, Hirotaka; Kawamori, Ryuzo; Daida, Hiroyuki] Juntendo Univ, Sportol Ctr, Grad Sch Med, Tokyo, Japan; [Sato, Shuji] Juntendo Univ Hosp, Dept Radiol, Tokyo, Japan; [Tamura, Yoshifumi; Watada, Hirotaka; Kawamori, Ryuzo] Juntendo Univ, Sch Med, Dept Med Metab & Endocrinol, Tokyo 113, Japan; [Aoki, Shigeki] Juntendo Univ, Dept Radiol, Grad Sch Med, Tokyo, Japan	Juntendo University; Juntendo University; Juntendo University; Juntendo University; Juntendo University	Shimada, K (corresponding author), Juntendo Univ, Dept Cardiol, Grad Sch Med, Tokyo, Japan.	shimakaz@juntendo.ac.jp	Tamura, Yoshifumi/AFK-2430-2022	Watada, Hirotaka/0000-0001-5961-1816; Tamura, Yoshifumi/0000-0002-1685-7821	Sportology Research Center; Ministry of Education, Culture, Sports, Science and Technology of Japan; Mizuno Sports Promotion Foundation	Sportology Research Center; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Mizuno Sports Promotion Foundation	This work was partially supported by the Sportology Research Center grant from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and a grant from the Mizuno Sports Promotion Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand SS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022112; ATS, 2003, AM J RESP CRIT CARE, V167, P211, DOI 10.1164/rccm.167.2.211; Bilet L, 2011, BASIC RES CARDIOL, V106, P307, DOI 10.1007/s00395-010-0144-x; Britton KA, 2011, CIRCULATION, V124, pE837, DOI 10.1161/CIRCULATIONAHA.111.077602; Bugger H, 2010, CARDIOVASC RES, V88, P229, DOI 10.1093/cvr/cvq239; Chai JW, 2011, J MAGN RESON IMAGING, V33, P464, DOI 10.1002/jmri.22462; Chess DJ, 2008, CARDIOVASC RES, V79, P269, DOI 10.1093/cvr/cvn074; Chiu HC, 2001, J CLIN INVEST, V107, P813, DOI 10.1172/JCI10947; Christoffersen C, 2003, ENDOCRINOLOGY, V144, P3483, DOI 10.1210/en.2003-0242; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; DENHOLLANDER JA, 1994, MAGN RESON MED, V32, P175, DOI 10.1002/mrm.1910320205; Felblinger J, 1999, MAGN RESON MED, V42, P903, DOI 10.1002/(SICI)1522-2594(199911)42:5<903::AID-MRM10>3.0.CO;2-N; Gandy SJ, 2008, J MAGN RESON IMAGING, V28, P359, DOI 10.1002/jmri.21401; Gibson AL, 2008, AM J CLIN NUTR, V87, P332, DOI 10.1093/ajcn/87.2.332; Goodpaster BH, 2001, J CLIN ENDOCR METAB, V86, P5755, DOI 10.1210/jc.86.12.5755; Hammer S, 2008, J CLIN ENDOCR METAB, V93, P497, DOI 10.1210/jc.2007-2015; Iozzo P, 2011, DIABETES CARE, V34, pS371, DOI 10.2337/dc11-s250; Kankaanpaa M, 2006, J CLIN ENDOCR METAB, V91, P4689, DOI 10.1210/jc.2006-0584; Kavazis AN, 2008, AM J PHYSIOL-HEART C, V294, pH928, DOI 10.1152/ajpheart.01231.2007; Lopaschuk GD, 2010, PHYSIOL REV, V90, P207, DOI 10.1152/physrev.00015.2009; McGavock JM, 2006, ANN INTERN MED, V144, P517, DOI 10.7326/0003-4819-144-7-200604040-00011; McGavock JM, 2007, CIRCULATION, V116, P1170, DOI 10.1161/CIRCULATIONAHA.106.645614; Nelson AJ, 2009, J CARDIOVASC MAGN R, V11, DOI 10.1186/1532-429X-11-15; Newsom SA, 2011, METABOLISM, V60, P852, DOI 10.1016/j.metabol.2010.08.004; Nishitani M, 2011, J CARDIOL, V58, P173, DOI 10.1016/j.jjcc.2011.05.001; Oleinikov VE, 2010, TERAPEVT ARKH, V82, P68; Ren J, 2010, J MOL MED, V88, P993, DOI 10.1007/s00109-010-0663-9; Roth SM, 2012, MED SCI SPORT EXER, V44, P809, DOI 10.1249/MSS.0b013e31824f28b6; Satoh N, 2008, HYPERTENS RES, V31, P1921, DOI 10.1291/hypres.31.1921; SCHICK F, 1993, MAGN RESON MED, V29, P158, DOI 10.1007/BF01769418; Schrauwen-Hinderling VB, 2010, J CLIN ENDOCR METAB, V95, P1932, DOI 10.1210/jc.2009-2076; Sharma S, 2004, FASEB J, V18, P1692, DOI 10.1096/fj.04-2263com; Solomon TPJ, 2008, J APPL PHYSIOL, V104, P1313, DOI 10.1152/japplphysiol.00890.2007; Summers SA, 2006, PROG LIPID RES, V45, P42, DOI 10.1016/j.plipres.2005.11.002; Szczepaniak LS, 2003, MAGN RESON MED, V49, P417, DOI 10.1002/mrm.10372; Tamura Y, 2005, J CLIN ENDOCR METAB, V90, P3191, DOI 10.1210/jc.2004-1959; TURINSKY J, 1990, J BIOL CHEM, V265, P16880; Unger RH, 2003, ANNU REV PHYSIOL, V65, P333, DOI 10.1146/annurev.physiol.65.092101.142622; Utz W, 2011, HEART, V97, P1585, DOI 10.1136/hrt.2011.224451; van der Meer RW, 2008, EUR HEART J, V29, P1516, DOI 10.1093/eurheartj/ehn207; ZEHENDER M, 1990, AM HEART J, V119, P1378, DOI 10.1016/S0002-8703(05)80189-9; Zhou YT, 2000, P NATL ACAD SCI USA, V97, P1784, DOI 10.1073/pnas.97.4.1784	42	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2013	8	4							e61604	10.1371/journal.pone.0061604	http://dx.doi.org/10.1371/journal.pone.0061604			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130DR	23613879	Green Published, gold, Green Submitted			2022-12-25	WOS:000317893400077
J	Salomon, D; Gonzalez, H; Updegraff, BL; Orth, K				Salomon, Dor; Gonzalez, Herman; Updegraff, Barrett L.; Orth, Kim			Vibrio parahaemolyticus Type VI Secretion System 1 Is Activated in Marine Conditions to Target Bacteria, and Is Differentially Regulated from System 2	PLOS ONE			English	Article							AGROBACTERIUM-TUMEFACIENS; UNITED-STATES; EXPRESSION; VIRULENCE; REQUIRES; PROTEIN; LOCUS; OYSTERS; PH	Vibrio parahaemolyticus is a marine bacterium that thrives in warm climates. It is a leading cause of gastroenteritis resulting from consumption of contaminated uncooked shellfish. This bacterium harbors two putative type VI secretion systems (T6SS). T6SSs are widespread protein secretion systems found in many Gram-negative bacteria, and are often tightly regulated. For many T6SSs studied to date, the conditions and cues, as well as the regulatory mechanisms that control T6SS activity are unknown. In this study, we characterized the environmental conditions and cues that activate both V. parahaemolyticus T6SSs, and identified regulatory mechanisms that control T6SS gene expression and activity. We monitored the expression and secretion of the signature T6SS secreted proteins Hcp1 and Hcp2, and found that both T6SSs are differentially regulated by quorum sensing and surface sensing. We also showed that T6SS1 and T6SS2 require different temperature and salinity conditions to be active. Interestingly, T6SS1, which is found predominantly in clinical isolates, was most active under warm marine-like conditions. Moreover, we found that T6SS1 has anti-bacterial activity under these conditions. In addition, we identified two transcription regulators in the T6SS1 gene cluster that regulate Hcp1 expression, but are not required for immunity against self-intoxication. Further examination of environmental isolates revealed a correlation between the presence of T6SS1 and virulence of V. parahaemolyticus against other bacteria, and we also showed that different V. parahaemolyticus isolates can outcompete each other. We propose that T6SS1 and T6SS2 play different roles in the V. parahaemolyticus lifestyles, and suggest a role for T6SS1 in enhancing environmental fitness of V. parahaemolyticus in marine environments when competing for a niche in the presence of other bacterial populations.	[Salomon, Dor; Gonzalez, Herman; Updegraff, Barrett L.; Orth, Kim] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Orth, K (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA.	kim.orth@utsouthwestern.edu	Orth, Kim/AAV-4421-2021	Orth, Kim/0000-0002-0678-7620; Salomon, Dor/0000-0002-2009-9453	National Institutes of Health-AID [R01-AI056404]; Welch Research Foundation [I-1561]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI056404] Funding Source: NIH RePORTER	National Institutes of Health-AID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Research Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	KO, BS, HG, and DS are supported by National Institutes of Health-AID grant R01-AI056404 and grant I-1561 from the Welch Research Foundation. KO is a Burroughs Welcome Investigator in Pathogenesis of Infectious Disease and a W. W. Caruth, Jr. Biomedical Scholar. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagwell CE, 1998, APPL ENVIRON MICROB, V64, P4276; Basler M, 2012, NATURE, V483, P182, DOI 10.1038/nature10846; Bernard CS, 2010, J BACTERIOL, V192, P3850, DOI 10.1128/JB.00370-10; Bingle LEH, 2008, CURR OPIN MICROBIOL, V11, P3, DOI 10.1016/j.mib.2008.01.006; Boyd EF, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-110; Boyer F, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-104; Broberg CA, 2011, MICROBES INFECT, V13, P992, DOI 10.1016/j.micinf.2011.06.013; Cascales E, 2008, EMBO REP, V9, P735, DOI 10.1038/embor.2008.131; Daniels NA, 2000, J INFECT DIS, V181, P1661, DOI 10.1086/315459; DePaola A, 2003, APPL ENVIRON MICROB, V69, P1521, DOI 10.1128/AEM.69.3.1521-1526.2003; DePaola A, 2000, APPL ENVIRON MICROB, V66, P4649, DOI 10.1128/AEM.66.11.4649-4654.2000; EAGON RG, 1962, J BACTERIOL, V83, P736, DOI 10.1128/JB.83.4.736-737.1962; English G, 2012, MOL MICROBIOL; Escobar MA, 2003, TRENDS PLANT SCI, V8, P380, DOI 10.1016/S1360-1385(03)00162-6; Fukui T, 2005, BIOCHEMISTRY-US, V44, P9825, DOI 10.1021/bi050311s; Furukawa Y, 2006, J ENVIRON QUAL, V35, P1939, DOI 10.2134/jeq2005.0482; Gamble MD, 2011, APPL ENVIRON MICROB, V77, P3703, DOI 10.1128/AEM.02897-10; Gode-Potratz CJ, 2011, J BACTERIOL, V193, P4224, DOI 10.1128/JB.00432-11; Gode-Potratz CJ, 2011, MOL MICROBIOL, V79, P240, DOI 10.1111/j.1365-2958.2010.07445.x; Hachani A, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.193045; Hood RD, 2010, CELL HOST MICROBE, V7, P25, DOI 10.1016/j.chom.2009.12.007; Ishikawa T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006734; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Kimata N, 2004, MICROBIAL ECOL, V47, P41, DOI 10.1007/s00248-003-1032-9; Lesic B, 2009, MICROBIOL-SGM, V155, P2845, DOI 10.1099/mic.0.029082-0; Ma AT, 2009, CELL HOST MICROBE, V5, P234, DOI 10.1016/j.chom.2009.02.005; Ma L., 2012, THESCIENTIFICWORLDJO, V2012, P1, DOI DOI 10.1100/2012/982140; MacIntyre DL, 2010, P NATL ACAD SCI USA, V107, P19520, DOI 10.1073/pnas.1012931107; Martinez-Urtaza J, 2008, APPL ENVIRON MICROB, V74, P265, DOI 10.1128/AEM.01307-07; Mattinen L, 2007, PROTEOMICS, V7, P3527, DOI 10.1002/pmic.200600759; Matz C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020275; McCarter LL, 1998, J BACTERIOL, V180, P3166, DOI 10.1128/JB.180.12.3166-3173.1998; Miyata ST, 2011, INFECT IMMUN, V79, P2941, DOI 10.1128/IAI.01266-10; Morris JG, 2003, CLIN INFECT DIS, V37, P272, DOI 10.1086/375600; Mougous JD, 2006, SCIENCE, V312, P1526, DOI 10.1126/science.1128393; Newton A, 2012, CLIN INFECT DIS, V54, pS391, DOI 10.1093/cid/cis243; O'Grady EP, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-441; Park KS, 2004, INFECT IMMUN, V72, P6659, DOI 10.1128/IAI.72.11.6659-6665.2004; Pukatzki S, 2006, P NATL ACAD SCI USA, V103, P1528, DOI 10.1073/pnas.0510322103; Pukatzki S, 2007, P NATL ACAD SCI USA, V104, P15508, DOI 10.1073/pnas.0706532104; Ritchie JM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002593; Ritchie JM, 2009, CURR TOP MICROBIOL, V337, P37, DOI 10.1007/978-3-642-01846-6_2; Russe AB, 2012, CELL HOST MICROBE, V11, P538, DOI 10.1016/j.chom.2012.04.007; Russell AB, 2011, NATURE, V475, P343, DOI 10.1038/nature10244; Sana TG, 2012, J BIOL CHEM, V287, P27095, DOI 10.1074/jbc.M112.376368; Schwarz S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001068; Senderovich Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008607; Shalom G, 2007, MICROBIOL-SGM, V153, P2689, DOI 10.1099/mic.0.2007/006585-0; Suarez G, 2010, J BACTERIOL, V192, P155, DOI 10.1128/JB.01260-09; UNE T, 1977, MICROBIOL IMMUNOL, V21, P349, DOI 10.1111/j.1348-0421.1977.tb00300.x; Unterweger D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048320; Waters CM, 2005, ANNU REV CELL DEV BI, V21, P319, DOI 10.1146/annurev.cellbio.21.012704.131001; Whitaker WB, 2010, APPL ENVIRON MICROB, V76, P4720, DOI 10.1128/AEM.00474-10; Wu CF, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002938; Yu Y, 2012, ARCH MICROBIOL; Yuan ZC, 2008, J BACTERIOL, V190, P494, DOI 10.1128/JB.01387-07; Zheng J, 2007, MOL MICROBIOL, V66, P1192, DOI 10.1111/j.1365-2958.2007.05993.x; Zheng J, 2010, P NATL ACAD SCI USA, V107, P21128, DOI 10.1073/pnas.1014998107	58	128	139	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2013	8	4							e61086	10.1371/journal.pone.0061086	http://dx.doi.org/10.1371/journal.pone.0061086			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130DR	23613791	Green Submitted, Green Published, gold			2022-12-25	WOS:000317893400041
J	Deng, XF; Dong, YM; Yi, QH; Huang, Y; Zhao, D; Yang, YB; Tijssen, P; Qiu, JM; Liu, KY; Li, Y				Deng, Xuefeng; Dong, Yanming; Yi, Qianhui; Huang, Yu; Zhao, Dan; Yang, Yongbo; Tijssen, Peter; Qiu, Jianming; Liu, Kaiyu; Li, Yi			The Determinants for the Enzyme Activity of Human Parvovirus B19 Phospholipase A2 (PLA2) and Its Influence on Cultured Cells	PLOS ONE			English	Article							VP1 UNIQUE REGION; NONSTRUCTURAL PROTEIN; CAPSID PROTEIN; KAPPA-B; INFECTION; APOPTOSIS; VIRUS; A(2); NS1; REPLICATION	Human parvovirus B19 (B19V) is the causative agent of erythema infectiosum in humans. B19 infection also causes severe disease manifestations, such as chronic anemia in immunocompromised patients, aplastic crisis in patients with a high turnover rate of red blood cells, and hydrops fetalis in pregnant women. Although a secreted phospholipase A2 (PLA2) motif has been identified in the unique region of the B19V minor capsid protein VP1(VP1u), the determinants for its enzyme activity and its influences on host cells are not well understood. The purpose of this study was to investigate the contribution of the PLA2 motif and other regions of the VP1u to the PLA2 activity, to determine the cellular localization of the VP1u protein, and to examine the effects of VP1u on cellular cytokines. We found that in addition to the critical conserved and non-conserved amino acids within the VP1u PLA2 motif, amino acid residues outside the VP1u PLA2 motif are also important for the PLA2 activity. VP1u and various mutants all revealed a nucleo-cytoplasmic distribution. UT7-Epo cells treated with prokaryotic expressed VP1u or mutant proteins with PLA2 activity released a large amount of free fatty acid (FFA), and the cell morphological change occurred dramatically. However, neither free fatty acid nor cell morphology change occurred for cells treated with the mutants without PLA2 activity. The wild type and the VP1u mutants with the PLA2 activity also activated TNF-alpha promoter and upregulated the transcription activity of NF-kappa B in transfected cells. In addition, we found that the amino acids outside the PLA2 domain are critical for the viral PLA2 activity, and that these tested VP1u mutants did not affect the localization of the VP1u protein.	[Deng, Xuefeng; Dong, Yanming; Yi, Qianhui; Huang, Yu; Zhao, Dan; Yang, Yongbo; Liu, Kaiyu; Li, Yi] Cent China Normal Univ, Coll Life Sci, Wuhan, Peoples R China; [Li, Yi] Wuhan Bioengn Inst, Bioengn Dept, Wuhan, Peoples R China; [Tijssen, Peter] Univ Quebec, INRS Inst Armand Frappier, Laval, PQ, Canada; [Qiu, Jianming] Univ Kansas, Med Ctr, Dept Microbiol Mol Genet & Immunol, Kansas City, KS 66103 USA	Central China Normal University; University of Quebec; Institut national de la recherche scientifique (INRS); University of Kansas; University of Kansas Medical Center	Liu, KY (corresponding author), Cent China Normal Univ, Coll Life Sci, Wuhan, Peoples R China.	liukaiyuccnu@126.com; johnli2668@hotmail.com	DENG, XUEFENG/E-1936-2016		National Natural Science Foundation of China [30670081]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded by the National Natural Science Foundation of China (30670081) (http://www.nsfc.gov.cn/Portal0/default166.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter P, 2006, BIOCHEM BIOPH RES CO, V339, P180, DOI 10.1016/j.bbrc.2005.10.195; ANDERSON MJ, 1983, LANCET, V1, P1378; ANDERSON MJ, 1984, J HYG-CAMBRIDGE, V93, P85, DOI 10.1017/S0022172400060964; Balsinde J, 1999, ANNU REV PHARMACOL, V39, P175, DOI 10.1146/annurev.pharmtox.39.1.175; Bemelmans MHA, 1996, CRIT REV IMMUNOL, V16, P1; Brown KE, 1997, ADV PEDIATR INFECT D, V13, P101; Brown KE, 1997, ANNU REV MED, V48, P59; Canaan S, 2004, J BIOL CHEM, V279, P14502, DOI 10.1074/jbc.M312630200; Chen AY, 2010, J VIROL, V84, P12385, DOI 10.1128/JVI.01229-10; Chen AY, 2010, BLOOD, V115, P1070, DOI 10.1182/blood-2009-04-215756; COSSART YE, 1975, LANCET, V1, P72; Dennis EA, 1997, TRENDS BIOCHEM SCI, V22, P1, DOI 10.1016/S0968-0004(96)20031-3; Dorsch S, 2002, J VIROL, V76, P2014, DOI 10.1128/JVI.76.4.2014-2018.2002; Drechsler MD, 2008, IMMUNOBIOLOGY, V213, P511, DOI 10.1016/j.imbio.2007.12.003; Filippone C, 2008, VIROLOGY, V374, P444, DOI 10.1016/j.virol.2008.01.002; Hsu TC, 2004, SCAND J INFECT DIS, V36, P570, DOI 10.1080/00365540410016230; Li Y, 2001, J GEN VIROL, V82, P2821, DOI 10.1099/0022-1317-82-11-2821; Lindblom A, 2005, CLIN INFECT DIS, V41, P1201, DOI 10.1086/444503; Lou S, 2012, J VIROL, V86, P10748, DOI 10.1128/JVI.01007-12; Lu J, 2006, J INFECT DIS, V193, P582, DOI 10.1086/499599; Lunardi C, 2008, AUTOIMMUN REV, V8, P116, DOI 10.1016/j.autrev.2008.07.005; Luo Y, 2011, J VIROL, V85, P8046, DOI 10.1128/JVI.00831-11; Lupescu A, 2006, J VIROL, V80, P11370, DOI 10.1128/JVI.01041-06; Moffatt S, 1996, J VIROL, V70, P8485, DOI 10.1128/JVI.70.12.8485-8491.1996; Moffatt S, 1998, J VIROL, V72, P3018, DOI 10.1128/JVI.72.4.3018-3028.1998; Murakami M, 1997, CRIT REV IMMUNOL, V17, P225, DOI 10.1615/CritRevImmunol.v17.i3-4.10; Poole BD, 2004, J VIROL, V78, P7775, DOI 10.1128/JVI.78.14.7775-7783.2004; ROSENFELD SJ, 1992, J CLIN INVEST, V89, P2023, DOI 10.1172/JCI115812; Schowengerdt KO, 1997, CIRCULATION, V96, P3549; Sun YN, 2009, J VIROL, V83, P3956, DOI 10.1128/JVI.02569-08; Tzang BS, 2007, CLIN CHIM ACTA, V378, P59, DOI 10.1016/j.cca.2006.10.016; Tzang BS, 2011, MOL IMMUNOL, V48, P1518, DOI 10.1016/j.molimm.2011.04.013; Venkatakrishnan B, 2013, J VIROLOGY; Wu DY, 2003, J BIOL CHEM, V278, P10983, DOI 10.1074/jbc.M207470200; Young NS, 2004, NEW ENGL J MED, V350, P586, DOI 10.1056/NEJMra030840; Zadori Z, 2001, DEV CELL, V1, P291, DOI 10.1016/S1534-5807(01)00031-4; Zhi N, 2004, VIROLOGY, V318, P142, DOI 10.1016/j.virol.2003.09.011	37	12	16	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2013	8	4							e61440	10.1371/journal.pone.0061440	http://dx.doi.org/10.1371/journal.pone.0061440			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125TD	23596524	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000317563300031
J	Doi, Y; Takeuchi, H; Horiuchi, H; Hanyu, T; Kawanokuchi, J; Jin, SJ; Parajuli, B; Sonobe, Y; Mizuno, T; Suzumura, A				Doi, Yukiko; Takeuchi, Hideyuki; Horiuchi, Hiroshi; Hanyu, Taketo; Kawanokuchi, Jun; Jin, Shijie; Parajuli, Bijay; Sonobe, Yoshifumi; Mizuno, Tetsuya; Suzumura, Akio			Fingolimod Phosphate Attenuates Oligomeric Amyloid beta-Induced Neurotoxicity via Increased Brain-Derived Neurotrophic Factor Expression in Neurons	PLOS ONE			English	Article							SPHINGOSINE 1-PHOSPHATE RECEPTORS; CENTRAL-NERVOUS-SYSTEM; SPINAL-CORD-INJURY; MULTIPLE-SCLEROSIS; FULL-LENGTH; ADULT-RAT; SYNAPTIC PLASTICITY; ALZHEIMERS-DISEASE; AXONAL-TRANSPORT; MESSENGER-RNA	The neurodegenerative processes that underlie Alzheimer's disease are mediated, in part, by soluble oligomeric amyloid beta, a neurotoxic protein that inhibits hippocampal long-term potentiation, disrupts synaptic plasticity, and induces the production of reactive oxygen species. Here we show that the sphingosine-1-phosphate (S1P) receptor (S1PR) agonist fingolimod phosphate (FTY720-P)-a new oral drug for multiple sclerosis-protects neurons against oligomeric amyloid beta-induced neurotoxicity. We confirmed that primary mouse cortical neurons express all of the S1P receptor subtypes and FTY720-P directly affects the neurons. Treatment with FTY720-P enhanced the expression of brain-derived neurotrophic factor (BDNF) in neurons. Moreover, blocking BDNF-TrkB signaling with a BDNF scavenger, TrkB inhibitor, or ERK1/2 inhibitor almost completely ablated these neuroprotective effects. These results suggested that the neuroprotective effects of FTY720-P are mediated by upregulated neuronal BDNF levels. Therefore, FTY720-P may be a promising therapeutic agent for neurodegenerative diseases, such as Alzheimer's disease.	[Doi, Yukiko; Takeuchi, Hideyuki; Horiuchi, Hiroshi; Hanyu, Taketo; Kawanokuchi, Jun; Jin, Shijie; Parajuli, Bijay; Sonobe, Yoshifumi; Mizuno, Tetsuya; Suzumura, Akio] Nagoya Univ, Environm Med Res Inst, Dept Neuroimmunol, Chikusa Ku, Nagoya, Aichi 464, Japan	Nagoya University	Takeuchi, H (corresponding author), Nagoya Univ, Environm Med Res Inst, Dept Neuroimmunol, Chikusa Ku, Furo Cho, Nagoya, Aichi 464, Japan.	htake@riem.nagoya-u.ac.jp	Bijay, Parajuli/AAT-5590-2021; Parajuli, Bijay/G-2961-2015	Parajuli, Bijay/0000-0003-3813-113X; Horiuchi, Hiroshi/0000-0001-9008-2027; Takeuchi, Hideyuki/0000-0001-5912-7581	Advanced Research for Medical Products Mining Program of the National Institute of Biomedical Innovation (NIBIO); Ministry of Education, Culture, Sports, Science and Technology of Japan; Ministry of Health, Labour and Welfare of Japan	Advanced Research for Medical Products Mining Program of the National Institute of Biomedical Innovation (NIBIO); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported in part by the Advanced Research for Medical Products Mining Program of the National Institute of Biomedical Innovation (NIBIO); a Grant-in-Aid for the global COE program from the Ministry of Education, Culture, Sports, Science and Technology of Japan; and grants from the Ministry of Health, Labour and Welfare of Japan. he funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADACHI K, 1995, BIOORG MED CHEM LETT, V5, P853, DOI 10.1016/0960-894X(95)00127-F; Brinkmann V, 2002, J BIOL CHEM, V277, P21453, DOI 10.1074/jbc.C200176200; Brinkmann V, 2007, PHARMACOL THERAPEUT, V115, P84, DOI 10.1016/j.pharmthera.2007.04.006; Brinkmann V, 2010, NAT REV DRUG DISCOV, V9, P883, DOI 10.1038/nrd3248; Choi JW, 2011, P NATL ACAD SCI USA, V108, P751, DOI 10.1073/pnas.1014154108; Chun J, 2010, CLIN NEUROPHARMACOL, V33, P91, DOI 10.1097/WNF.0b013e3181cbf825; Cohen JA, 2011, ANN NEUROL, V69, P759, DOI 10.1002/ana.22426; Conner JM, 1997, J NEUROSCI, V17, P2295; Dahlgren KN, 2002, J BIOL CHEM, V277, P32046, DOI 10.1074/jbc.M201750200; De Felice FG, 2007, J BIOL CHEM, V282, P11590, DOI 10.1074/jbc.M607483200; Deogracias R, 2012, P NATL ACAD SCI USA, V109, P14230, DOI 10.1073/pnas.1206093109; Deshpande A, 2006, J NEUROSCI, V26, P6011, DOI 10.1523/JNEUROSCI.1189-06.2006; Dev KK, 2008, PHARMACOL THERAPEUT, V117, P77, DOI 10.1016/j.pharmthera.2007.08.005; Doi Y, 2009, AM J PATHOL, V175, P2121, DOI 10.2353/ajpath.2009.090418; Drake CT, 1999, J NEUROSCI, V19, P8009; Ferrer I, 1999, J NEUROPATH EXP NEUR, V58, P729, DOI 10.1097/00005072-199907000-00007; Harada J, 2004, J NEUROCHEM, V88, P1026, DOI 10.1046/j.1471-4159.2003.02219.x; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Kaneider NC, 2004, FASEB J, V18, P1309, DOI 10.1096/fj.03-1050fje; Kemppainen S, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.11.006; Kimura A, 2007, STEM CELLS, V25, P115, DOI 10.1634/stemcells.2006-0223; Koponen E, 2004, MOL CELL NEUROSCI, V26, P166, DOI 10.1016/j.mcn.2004.01.006; Lu Y, 2008, NEUROBIOL LEARN MEM, V89, P312, DOI 10.1016/j.nlm.2007.08.018; Mandala S, 2002, SCIENCE, V296, P346, DOI 10.1126/science.1070238; Manelli AM, 2007, NEUROBIOL AGING, V28, P1139, DOI 10.1016/j.neurobiolaging.2006.05.024; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Minichiello L, 2009, NAT REV NEUROSCI, V10, P850, DOI 10.1038/nrn2738; Miron VE, 2010, AM J PATHOL, V176, P2682, DOI 10.2353/ajpath.2010.091234; Mizuno M, 2003, LEARN MEMORY, V10, P108, DOI 10.1101/lm.56003; Mizuno T, 2011, AM J PATHOL, V179, P2016, DOI 10.1016/j.ajpath.2011.06.011; Noda H, 2013, J NEUROIMMUNOL; Norimatsu Y, 2012, AM J PATHOL, V180, P1625, DOI 10.1016/j.ajpath.2011.12.012; Osinde M, 2007, NEUROPHARMACOLOGY, V52, P1210, DOI 10.1016/j.neuropharm.2006.11.010; Pelletier D, 2012, NEW ENGL J MED, V366, P339, DOI 10.1056/NEJMct1101691; PHILLIPS HS, 1991, NEURON, V7, P695, DOI 10.1016/0896-6273(91)90273-3; Pinschewer DD, 2000, J IMMUNOL, V164, P5761, DOI 10.4049/jimmunol.164.11.5761; Rex CS, 2007, J NEUROSCI, V27, P3017, DOI 10.1523/JNEUROSCI.4037-06.2007; Selkoe DJ, 2008, BEHAV BRAIN RES, V192, P106, DOI 10.1016/j.bbr.2008.02.016; SOPPET D, 1991, CELL, V65, P895, DOI 10.1016/0092-8674(91)90396-G; Takeuchi H, 2005, J BIOL CHEM, V280, P10444, DOI 10.1074/jbc.M413863200; Walsh DM, 2012, PROG MOL BIOL TRANSL, V107, P101, DOI 10.1016/B978-0-12-385883-2.00012-6; Yan Q, 1997, J COMP NEUROL, V378, P135; Yan Q, 1997, NEUROSCIENCE, V78, P431, DOI 10.1016/S0306-4522(96)00613-6; Yoshii A, 2010, DEV NEUROBIOL, V70, P304, DOI 10.1002/dneu.20765	44	76	80	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2013	8	4							e61988	10.1371/journal.pone.0061988	http://dx.doi.org/10.1371/journal.pone.0061988			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123JP	23593505	Green Submitted, gold, Green Published			2022-12-25	WOS:000317385300091
J	Mai, ZH; Peng, ZL; Wu, SH; Zhang, JL; Chen, L; Liang, HY; Bai, D; Yan, GM; Ai, H				Mai, Zhihui; Peng, Zhuli; Wu, Sihan; Zhang, Jinglan; Chen, Lin; Liang, Huangyou; Bai, Ding; Yan, Guangmei; Ai, Hong			Single Bout Short Duration Fluid Shear Stress Induces Osteogenic Differentiation of MC3T3-E1 Cells via Integrin beta 1 and BMP2 Signaling Cross-Talk	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; OSTEOBLAST DIFFERENTIATION; ALKALINE-PHOSPHATASE; BONE-FORMATION; FLOW; EXPRESSION; PROTEIN; MECHANOTRANSDUCTION; OSTEOPONTIN; ACTIVATION	Fluid shear stress plays an important role in bone osteogenic differentiation. It is traditionally believed that pulsed and continuous stress load is more favorable for fracture recovery and bone homeostasis. However, according to our clinical practice, we notice that one single stress load is also sufficient to trigger osteogenic differentiation. In the present study, we subject osteoblast MC3T3-E1 cells to single bout short duration fluid shear stress by using a parallel plate flow system. The results show that 1 hour of fluid shear stress at 12 dyn/cm(2) promotes terminal osteogenic differentiation, including rearrangement of F-actin stress fiber, up-regulation of osteogenic genes expression, elevation of alkaline phosphatase activity, secretion of type I collagen and osteoid nodule formation. Moreover, collaboration of BMP2 and integrin beta 1 pathways plays a significant role in such differentiation processes. Our findings provide further experimental evidence to support the notion that single bout short duration fluid shear stress can promote osteogenic differentiation.	[Mai, Zhihui; Peng, Zhuli; Chen, Lin; Liang, Huangyou; Ai, Hong] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Stomatol, Guangzhou 510275, Guangdong, Peoples R China; [Wu, Sihan; Yan, Guangmei] Sun Yat Sen Univ, Zhongshan Sch Med, Dept Pharmacol, Guangzhou 510275, Guangdong, Peoples R China; [Zhang, Jinglan] Guangdong Prov Stomatol Hosp, Dept Pediat Dent, Guangzhou, Guangdong, Peoples R China; [Bai, Ding] Sichuan Univ, West China Hosp Stomatol, Dept Stomatol, Chengdu 610064, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Southern Medical University - China; Sichuan University	Ai, H (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 3, Dept Stomatol, Guangzhou 510275, Guangdong, Peoples R China.	aih_zssy09@126.com		Bai, Ding/0000-0002-5058-4329	National Science Foundation of China [81070860]; Science and Technology Planning Project of Guangdong Province, China [2011B080701070]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Planning Project of Guangdong Province, China	This research is supported by National Science Foundation of China (81070860) and Science and Technology Planning Project of Guangdong Province, China (2011B080701070) (http://pro.gdstc.gov.cn and https://isis.nsfc.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcantara EH, 2011, J NUTR BIOCHEM, V22, P1055, DOI 10.1016/j.jnutbio.2010.09.003; Assoian RK, 2001, CURR OPIN GENET DEV, V11, P48, DOI 10.1016/S0959-437X(00)00155-6; Ban Y, 2011, TISSUE CELL, V43, P311, DOI 10.1016/j.tice.2011.06.003; BINDERMA.I, 1974, J CELL BIOL, V61, P427, DOI 10.1083/jcb.61.2.427; Chen JH, 2010, J BIOMECH, V43, P108, DOI 10.1016/j.jbiomech.2009.09.016; Chen Y, 2007, J CELL BIOCHEM, V102, P52, DOI 10.1002/jcb.21275; Chevallay B, 2000, ACELLULAR MINERAL DE, P204; Cohen MM, 2002, AM J MED GENET, V109, P87, DOI 10.1002/ajmg.10289; Danen EHJ, 2001, J CELL PHYSIOL, V189, P1, DOI 10.1002/jcp.1137; DODDS RA, 1993, J BONE MINER RES, V8, P261; Dunlop JWC, 2009, CALCIFIED TISSUE INT, V85, P45, DOI 10.1007/s00223-009-9242-x; Fritton SP, 2009, ANNU REV FLUID MECH, V41, P347, DOI 10.1146/annurev.fluid.010908.165136; Irvine R, 2004, J Orthod, V31, P303, DOI 10.1179/146531204225020606; Irvine R, 2004, J ORTHODONTICS, V31, P300; Jacobs CR, 1998, J BIOMECH, V31, P969, DOI 10.1016/S0021-9290(98)00114-6; Jikko A, 1999, J BONE MINER RES, V14, P1075, DOI 10.1359/jbmr.1999.14.7.1075; Kamiya N, 2011, BIOFACTORS, V37, P75, DOI 10.1002/biof.139; Kanzaki S, 2011, PHARMACOL REP, V63, P1222, DOI 10.1016/S1734-1140(11)70642-9; Khosla S, 2008, J CLIN INVEST, V118, P421, DOI 10.1172/JCI33612; Komori T, 2006, J CELL BIOCHEM, V99, P1233, DOI 10.1002/jcb.20958; Kreke MR, 2005, BONE, V36, P1047, DOI 10.1016/j.bone.2005.03.008; Kurokouchi K, 2001, J BIOL CHEM, V276, P13499, DOI 10.1074/jbc.M003795200; Lai CF, 2005, J BONE MINER RES, V20, P330, DOI 10.1359/JBMR.041013; Luppen CA, 2008, GROWTH FACTORS, V26, P226, DOI 10.1080/08977190802277880; Mathews S, 2012, DIFFERENTIATION, V84, P185, DOI 10.1016/j.diff.2012.05.001; Matsubara T, 2008, J BIOL CHEM, V283, P29119, DOI 10.1074/jbc.M801774200; Mulhall H, 2011, J TISSUE ENG REGEN M, V5, P629, DOI 10.1002/term.355; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Ogasawara A, 2001, J BIOL CHEM, V276, P7048, DOI 10.1074/jbc.M008070200; Park JS, 2010, BIOMATERIALS, V31, P6239, DOI 10.1016/j.biomaterials.2010.05.002; Patel M, 2011, BIOTECHNOL LETT, V33, P1481, DOI 10.1007/s10529-011-0570-3; Pavlidis D, 2009, EUR J ORTHODONT, V31, P565, DOI 10.1093/ejo/cjp053; PEAD MJ, 1988, J BONE MINER RES, V3, P647; Qing W, 2012, J BIOMED BIOTECHNOL, V2012, DOI 10.1155/2012/ 410879.84; Riddle RC, 2009, J ORTHOP RES, V27, P143, DOI 10.1002/jor.20723; Sailhan F, 2011, OSTEOPOROSIS INT, V22, P2011, DOI 10.1007/s00198-011-1613-2; Saunders MM, 2003, BONE, V32, P350, DOI 10.1016/S8756-3282(03)00025-5; Sotobori T, 2006, EXP CELL RES, V312, P3927, DOI 10.1016/j.yexcr.2006.08.024; Sumanasinghe RD, 2006, TISSUE ENG, V12, P3459, DOI 10.1089/ten.2006.12.3459; Taylor D, 2007, NAT MATER, V6, P263, DOI 10.1038/nmat1866; Wenstrup RJ, 2006, J BIOL CHEM, V281, P12888, DOI 10.1074/jbc.M511528200; Yan Y., 2012, PLOS ONE, V7, P35709; You J, 2001, J BIOL CHEM, V276, P13365, DOI 10.1074/jbc.M009846200; Yourek G, 2010, REGEN MED, V5, P713, DOI 10.2217/RME.10.60	44	25	28	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2013	8	4							e61600	10.1371/journal.pone.0061600	http://dx.doi.org/10.1371/journal.pone.0061600			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123JA	23593489	gold, Green Submitted, Green Published			2022-12-25	WOS:000317383200061
J	Yang, JB; Singh, V; Cha, BY; Chen, TE; Sarker, R; Murtazina, R; Jin, S; Zachos, NC; Patterson, GH; Tse, CM; Kovbasnjuk, O; Li, XH; Donowitz, M				Yang, Jianbo; Singh, Varsha; Cha, Boyoung; Chen, Tian-E; Sarker, Rafiquel; Murtazina, Rakhilya; Jin, Shi; Zachos, Nicholas C.; Patterson, George H.; Tse, C. Ming; Kovbasnjuk, Olga; Li, Xuhang; Donowitz, Mark			NHERF2 Protein Mobility Rate Is Determined by a Unique C-terminal Domain That Is Also Necessary for Its Regulation of NHE3 Protein in OK Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NA+/H+ EXCHANGER ISOFORM; ILEAL BRUSH-BORDER; PLASMA-MEMBRANE; CA2+-DEPENDENT INHIBITION; SCAFFOLDING PROTEINS; DEPENDENT MECHANISM; BINDING PARTNERS; 2-PHOTON FRAP; H+ EXCHANGER; LIPID RAFTS	Na+/H+ exchanger regulatory factor (NHERF) proteins are a family of PSD-95/Discs-large/ZO-1 (PDZ)-scaffolding proteins, three of which (NHERFs 1-3) are localized to the brush border in kidney and intestinal epithelial cells. All NHERF proteins are involved in anchoring membrane proteins that contain PDZ recognition motifs to form multiprotein signaling complexes. In contrast to their predicted immobility, NHERF1, NHERF2, and NHERF3 were all shown by fluorescence recovery after photobleaching/confocal microscopy to be surprisingly mobile in the microvilli of the renal proximal tubule OK cell line. Their diffusion coefficients, although different among the three, were all of the same magnitude as that of the transmembrane proteins, suggesting they are all anchored in the microvilli but to different extents. NHERF3 moves faster than NHERF1, and NHERF2 moves the slowest. Several chimeras and mutants of NHERF1 and NHERF2 were made to determine which part of NHERF2 confers the slower mobility rate. Surprisingly, the slower mobility rate of NHERF2 was determined by a unique C-terminal domain, which includes a nonconserved region along with the ezrin, radixin, moesin (ERM) binding domain. Also, this C-terminal domain of NHERF2 determined its greater detergent insolubility and was necessary for the formation of larger multiprotein NHERF2 complexes. In addition, this NHERF2 domain was functionally significant in NHE3 regulation, being necessary for stimulation by lysophosphatidic acid of activity and increased mobility of NHE3, as well as necessary for inhibition of NHE3 activity by calcium ionophore 4-Br-A23187. Thus, multiple functions of NHERF2 require involvement of an additional domain in this protein.	[Yang, Jianbo; Singh, Varsha; Cha, Boyoung; Chen, Tian-E; Sarker, Rafiquel; Murtazina, Rakhilya; Jin, Shi; Zachos, Nicholas C.; Tse, C. Ming; Kovbasnjuk, Olga; Li, Xuhang; Donowitz, Mark] Johns Hopkins Univ, Sch Med, Dept Med, Div Gastroenterol, Baltimore, MD 21205 USA; [Donowitz, Mark] Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA; [Patterson, George H.] Natl Inst Biomed Imaging & Bioengn, Biophoton Sect, NIH, Bethesda, MD 20892 USA	Johns Hopkins University; Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)	Donowitz, M (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Div Gastroenterol & Hepatol, 925 Ross Res Bldg,720 Rutland Ave, Baltimore, MD 21205 USA.	mdonowit@jhmi.edu	Patterson, George/ABI-4751-2020; Zachos, Nicholas/GWC-7914-2022; Yang, Jianbo/G-1254-2013	Jin, Shi/0000-0003-0177-5716	National Institutes of Health from NIDDK [R01DK26523, R01DK61765, P01DK072084, K08DK088950]; National Institutes of Health [P30DK089502]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [ZIAEB000071] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK089502, P01DK072084, R01DK026523, K08DK088950, R01DK061765] Funding Source: NIH RePORTER	National Institutes of Health from NIDDK; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by National Institutes of Health Grants R01DK26523, R01DK61765, P01DK072084, and K08DK088950 from NIDDK.; We thank John Gibas and Molee Chakraborty (Johns Hopkins University) for technical assistance. We thank Dr. Chris Yun (Emory University) for providing rabbit polyclonal antibody against NHERF2 and plasmid pcDNA3.1-LPA5R. We thank Dr. Jerrold Turner (University of Chicago) for providing the Caco-2/bbe cell line. We acknowledge use of the Kudsi Imaging Core Facility of the Conte Hopkins Digestive Disease Basic and Translational Research Core Center (supported by National Institutes of Health Grant P30DK089502).	Ardura JA, 2011, PHARMACOL REV, V63, P882, DOI 10.1124/pr.110.004176; Ardura JA, 2011, J BIOL CHEM, V286, P35020, DOI 10.1074/jbc.M111.264978; BERRYMAN M, 1995, J CELL BIOL, V131, P1231, DOI 10.1083/jcb.131.5.1231; BRANT SR, 1995, AM J PHYSIOL-CELL PH, V269, pC198, DOI 10.1152/ajpcell.1995.269.1.C198; Brown JW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009406; Cha B, 2006, MOL BIOL CELL, V17, P2661, DOI 10.1091/mbc.E05-09-0843; Cha BY, 2010, J CELL SCI, V123, P2434, DOI 10.1242/jcs.056713; Cha BY, 2004, J CELL SCI, V117, P3353, DOI 10.1242/jcs.01180; Chen MM, 2010, J PHYSIOL-LONDON, V588, P5049, DOI 10.1113/jphysiol.2010.198721; Cinar A, 2007, J PHYSIOL-LONDON, V581, P1235, DOI 10.1113/jphysiol.2007.131722; COLE JA, 1989, AM J PHYSIOL, V256, pF672, DOI 10.1152/ajprenal.1989.256.4.F672; Coscoy S, 2002, P NATL ACAD SCI USA, V99, P12813, DOI 10.1073/pnas.192084599; Cotton LM, 2010, MOL REPROD DEV, V77, P114, DOI 10.1002/mrd.21122; Donowitz M, 2005, J PHYSIOL-LONDON, V567, P3, DOI 10.1113/jphysiol.2005.090399; Donowitz M, 2007, PHYSIOL REV, V87, P825, DOI 10.1152/physrev.00030.2006; Ellenberg J, 1997, J CELL BIOL, V138, P1193, DOI 10.1083/jcb.138.6.1193; Finnerty CM, 2004, J CELL SCI, V117, P1547, DOI 10.1242/jcs.01038; Garbett D, 2012, J CELL BIOL, V198, P195, DOI 10.1083/jcb.201204008; Haggie PM, 2004, J BIOL CHEM, V279, P5494, DOI 10.1074/jbc.M312445200; Han W, 2006, J BIOL CHEM, V281, P1461, DOI 10.1074/jbc.M509786200; Itoh K, 2002, J IMMUNOL, V168, P541, DOI 10.4049/jimmunol.168.2.541; Karthikeyan S, 2002, J BIOL CHEM, V277, P18973, DOI 10.1074/jbc.M201507200; Kim JH, 2002, J BIOL CHEM, V277, P23714, DOI 10.1074/jbc.M200835200; LaLonde DP, 2010, MOL BIOL CELL, V21, P1519, DOI 10.1091/mbc.E10-01-0008; Lange K, 2011, J CELL PHYSIOL, V226, P896, DOI 10.1002/jcp.22302; Lee HJ, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-8; Lee-Kwon W, 2003, AM J PHYSIOL-CELL PH, V285, pC1527, DOI 10.1152/ajpcell.00017.2003; Lee-Kwon W, 2003, J BIOL CHEM, V278, P16494, DOI 10.1074/jbc.M300580200; Li XH, 2004, J PHYSIOL-LONDON, V556, P791, DOI 10.1113/jphysiol.2004.060921; Li XH, 2001, J PHYSIOL-LONDON, V537, P537, DOI 10.1111/j.1469-7793.2001.00537.x; Lin R, 2011, GASTROENTEROLOGY, V140, P560, DOI 10.1053/j.gastro.2010.10.042; Lin SB, 2010, GASTROENTEROLOGY, V138, P649, DOI 10.1053/j.gastro.2009.09.055; Lissner S, 2010, AM J PHYSIOL-GASTR L, V299, pG907, DOI 10.1152/ajpgi.00191.2010; Mavrakis M., 2008, CURR PROTOC CELL BIO; McKinney SA, 2009, NAT METHODS, V6, P131, DOI [10.1038/NMETH.1296, 10.1038/nmeth.1296]; Morales FC, 2007, MOL CELL BIOL, V27, P2527, DOI 10.1128/MCB.01372-06; Murtazina R, 2006, J BIOL CHEM, V281, P17845, DOI 10.1074/jbc.M601740200; Murtazina R, 2011, AM J PHYSIOL-CELL PH, V301, pC126, DOI 10.1152/ajpcell.00311.2010; Padanyi R, 2010, J BIOL CHEM, V285, P31704, DOI 10.1074/jbc.M110.164137; Romero G, 2011, ADV PHARMACOL, V62, P279, DOI 10.1016/B978-0-12-385952-5.00003-8; Sarker R, 2011, AM J PHYSIOL-CELL PH, V300, pC771, DOI 10.1152/ajpcell.00119.2010; Schultheis PJ, 1998, NAT GENET, V19, P282, DOI 10.1038/969; Seidler U, 2009, ANN NY ACAD SCI, V1165, P249, DOI 10.1111/j.1749-6632.2009.04046.x; Terawaki S, 2006, STRUCTURE, V14, P777, DOI 10.1016/j.str.2006.01.015; Tyska MJ, 2002, BIOPHYS J, V82, P1869, DOI 10.1016/S0006-3495(02)75537-9; Wade JB, 2003, AM J PHYSIOL-CELL PH, V285, pC1494, DOI 10.1152/ajpcell.00092.2003; Waharte F, 2005, BIOPHYS J, V88, P1467, DOI 10.1529/biophysj.104.049619; Weinman EJ, 2009, AM J PHYSIOL-RENAL, V297, pF1560, DOI 10.1152/ajprenal.90657.2008; Weinman EJ, 2003, BIOCHEMISTRY-US, V42, P12662, DOI 10.1021/bi035244l; WEINMAN EJ, 1995, J CLIN INVEST, V95, P2143, DOI 10.1172/JCI117903; Weinman EJ, 2001, AM J PHYSIOL-RENAL, V281, pF374, DOI 10.1152/ajprenal.2001.281.2.F374; Yun CC, 2002, J BIOL CHEM, V277, P7676, DOI 10.1074/jbc.M107768200; Yun CHC, 1998, J BIOL CHEM, V273, P25856, DOI 10.1074/jbc.273.40.25856; Zachos NC, 2008, CELL PHYSIOL BIOCHEM, V22, P693, DOI 10.1159/000185553; Zhu XJ, 2011, J BIOL CHEM, V286, P34486, DOI 10.1074/jbc.M111.230219	55	11	11	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2013	288	23					16960	16974		10.1074/jbc.M113.470799	http://dx.doi.org/10.1074/jbc.M113.470799			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	163ZU	23612977	hybrid, Green Published			2022-12-25	WOS:000320378900068
J	Bi, D; Toyama, K; Lemaitre, V; Takai, J; Fan, F; Jenkins, DP; Wulff, H; Gutterman, DD; Park, F; Miura, H				Bi, Dan; Toyama, Kazuyoshi; Lemaitre, Vincent; Takai, Jun; Fan, Fan; Jenkins, David P.; Wulff, Heike; Gutterman, David D.; Park, Frank; Miura, Hiroto			The Intermediate Conductance Calcium-activated Potassium Channel KCa3.1 Regulates Vascular Smooth Muscle Cell Proliferation via Controlling Calcium-dependent Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CA2+-ACTIVATED K+ CHANNELS; UP-REGULATION; PHENOTYPIC MODULATION; TRANSCRIPTION FACTOR; GENE-EXPRESSION; GROWTH-FACTOR; CA2+; BLOCKADE; IKCA1; DIFFERENTIATION	The intermediate conductance calcium-activated potassium channel KCa3.1 contributes to a variety of cell activation processes in pathologies such as inflammation, carcinogenesis, and vascular remodeling. We examined the electrophysiological and transcriptional mechanisms by which KCa3.1 regulates vascular smooth muscle cell (VSMC) proliferation. Platelet-derived growth factor-BB (PDGF)-induced proliferation of human coronary artery VSMCs was attenuated by lowering intracellular Ca2+ concentration ([Ca2+](i)) and was enhanced by elevating [Ca2+](i). KCa3.1 blockade or knockdown inhibited proliferation by suppressing the rise in [Ca2+](i) and attenuating the expression of phosphorylated cAMP-response element-binding protein (CREB), c-Fos, and neuron-derived orphan receptor-1 (NOR-1). This antiproliferative effect was abolished by elevating [Ca2+](i). KCa3.1 overexpression induced VSMC proliferation, and potentiated PDGF-induced proliferation, by inducing CREB phosphorylation, c-Fos, and NOR-1. Pharmacological stimulation of KCa3.1 unexpectedly suppressed proliferation by abolishing the expression and activity of KCa3.1 and PDGF beta-receptors and inhibiting the rise in [Ca2+](i). The stimulation also attenuated the levels of phosphorylated CREB, c-Fos, and cyclin expression. After KCa3.1 blockade, the characteristic round shape of VSMCs expressing high l-caldesmon and low calponin-1 (dedifferentiation state) was maintained, whereas KCa3.1 stimulation induced a spindle-shaped cellular appearance, with low l-caldesmon and high calponin-1. In conclusion, KCa3.1 plays an important role in VSMC proliferation via controlling Ca2+-dependent signaling pathways, and its modulation may therefore constitute a new therapeutic target for cell proliferative diseases such as atherosclerosis.	[Bi, Dan; Lemaitre, Vincent; Takai, Jun; Miura, Hiroto] Univ Nevada, Sch Med, Dept Physiol & Cell Biol, Reno, NV 89557 USA; [Toyama, Kazuyoshi; Fan, Fan; Gutterman, David D.; Park, Frank; Miura, Hiroto] Med Coll Wisconsin, Dept Med, Milwaukee, WI 53226 USA; [Toyama, Kazuyoshi; Fan, Fan; Gutterman, David D.; Park, Frank; Miura, Hiroto] Med Coll Wisconsin, Ctr Cardiovasc, Milwaukee, WI 53226 USA; [Jenkins, David P.; Wulff, Heike] Univ Calif Davis, Dept Pharmacol, Davis, CA 95616 USA	Nevada System of Higher Education (NSHE); University of Nevada Reno; Medical College of Wisconsin; Medical College of Wisconsin; University of California System; University of California Davis	Miura, H (corresponding author), Univ Nevada, Sch Med, Dept Physiol & Cell Biol, 1664 N Virginia St,MS0575, Reno, NV 89557 USA.	hmiura@medicine.nevada.edu	wulff, Heike/Z-2056-2019; Park, Frank/I-4590-2019	Park, Frank/0000-0003-2324-2937	National Institutes of Health [RO1HL080173, HL080173-02S1, P20 RR018751, P20 GM103513, RO1 GM076063, P01 HL68769, RO1 DK090123]; Advancing a Healthier Wisconsin grant from the Medical College of Wisconsin; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018751] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL068769, R01HL113612, R01HL080173] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK090123] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103513, R01GM076063] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Advancing a Healthier Wisconsin grant from the Medical College of Wisconsin; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1HL080173, HL080173-02S1, P20 RR018751, and P20 GM103513 (to H. M.); RO1 GM076063 (to H. W.); P01 HL68769 (to D. D. G.); and RO1 DK090123 (to F. P.). This work was also supported by an Advancing a Healthier Wisconsin grant from the Medical College of Wisconsin.	Barlow CA, 2006, J PHYSIOL-LONDON, V570, P59, DOI 10.1113/jphysiol.2005.098426; Berkefeld H, 2010, PHYSIOL REV, V90, P1437, DOI 10.1152/physrev.00049.2009; BERRIDGE MJ, 1995, BIOESSAYS, V17, P491, DOI 10.1002/bies.950170605; BOONSTRA J, 1981, J CELL PHYSIOL, V107, P75, DOI 10.1002/jcp.1041070110; Brugnara C, 1996, J CLIN INVEST, V97, P1227, DOI 10.1172/JCI118537; Cheong A, 2005, MOL CELL, V20, P45, DOI 10.1016/j.molcel.2005.08.030; Choi J, 2006, CIRC RES, V98, P1273, DOI 10.1161/01.RES.0000223059.19250.91; Chou CC, 2008, EXPERT REV MOL DIAGN, V8, P179, DOI 10.1586/14737159.8.2.179; DESDOUETS C, 1995, MOL CELL BIOL, V15, P3301; Dolmetsch RE, 1997, NATURE, V386, P855, DOI 10.1038/386855a0; Feske S, 2007, NAT REV IMMUNOL, V7, P690, DOI 10.1038/nri2152; Ghanshani S, 2000, J BIOL CHEM, V275, P37137, DOI 10.1074/jbc.M003941200; Grgic I, 2005, ARTERIOSCL THROM VAS, V25, P704, DOI 10.1161/01.ATV.0000156399.12787.5c; Hollenbeck ST, 2004, J VASC SURG, V40, P351, DOI 10.1016/j.jvs.2004.03.047; Kaplan-Albuquerque N, 2005, CIRC RES, V97, P427, DOI 10.1161/01.RES.0000179776.40216.a9; Koegel H, 2003, J BIOL CHEM, V278, P3323, DOI 10.1074/jbc.M208914200; Kohler R, 2003, CIRCULATION, V108, P1119, DOI 10.1161/01.CIR.0000086464.04719.DD; Koledova VV, 2006, CIRC RES, V98, P1240, DOI 10.1161/01.RES.0000225860.41648.63; Martinez-Gonzalez J, 2003, CIRC RES, V92, P96, DOI 10.1161/01.ES.0000050921.53008.47; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; McAllister J, 2008, BIOCHEM PHARMACOL, V75, P956, DOI 10.1016/j.bcp.2007.10.019; MIANO JM, 1993, AM J PATHOL, V142, P715; Neylon CB, 1999, CIRC RES, V85, pE33, DOI 10.1161/01.RES.85.9.e33; Neylon CB, 2002, VASC PHARMACOL, V38, P35, DOI 10.1016/S1537-1891(02)00124-6; Pardo LA, 1999, EMBO J, V18, P5540, DOI 10.1093/emboj/18.20.5540; Park F, 2000, NAT GENET, V24, P49, DOI 10.1038/71673; Pena TL, 1999, J MEMBRANE BIOL, V172, P249, DOI 10.1007/s002329900601; Pulver RA, 2004, CIRC RES, V94, P1351, DOI 10.1161/01.RES.0000127618.34500.FD; Raicu M, 2000, FUNDAM CLIN PHARM, V14, P477, DOI 10.1111/j.1472-8206.2000.tb00430.x; ROTHMAN A, 1994, J BIOL CHEM, V269, P6399; Rouzaire-Dubois B, 2000, PFLUG ARCH EUR J PHY, V440, P881, DOI 10.1007/s004240000371; Saito T, 2002, CLIN EXP PHARMACOL P, V29, P324, DOI 10.1046/j.1440-1681.2002.03652.x; Sankaranarayanan A, 2009, MOL PHARMACOL, V75, P281, DOI 10.1124/mol.108.051425; Shepherd MC, 2007, AM J RESP CELL MOL, V37, P525, DOI 10.1165/rcmb.2006-0358OC; Si H, 2006, BRIT J PHARMACOL, V148, P909, DOI 10.1038/sj.bjp.0706793; Sirois MG, 1997, CIRCULATION, V95, P669, DOI 10.1161/01.CIR.95.3.669; Strobaek D, 2004, BBA-BIOMEMBRANES, V1665, P1, DOI 10.1016/j.bbamem.2004.07.006; Sun D, 2003, AM J PHYSIOL-GASTR L, V285, pG12, DOI 10.1152/ajpgi.00513.2002; Sylvester AM, 1998, J CLIN INVEST, V101, P940, DOI 10.1172/JCI1630; Tao R, 2008, AM J PHYSIOL-CELL PH, V295, pC1409, DOI 10.1152/ajpcell.00268.2008; Terata Y, 2003, PHARMACOLOGY, V68, P169, DOI 10.1159/000070455; Tharp DL, 2008, ARTERIOSCL THROM VAS, V28, P1084, DOI 10.1161/ATVBAHA.107.155796; Tharp DL, 2006, AM J PHYSIOL-HEART C, V291, pH2493, DOI 10.1152/ajpheart.01254.2005; Tolic-Norrelykke IM, 2005, J BIOMECH, V38, P1405, DOI 10.1016/j.jbiomech.2004.06.027; Toyama K, 2008, J CLIN INVEST, V118, P3025, DOI 10.1172/JCI30836; Wamhoff BR, 2004, CIRC RES, V95, P406, DOI 10.1161/01.RES.0000138582.36921.9e; Wulff H, 2000, P NATL ACAD SCI USA, V97, P8151, DOI 10.1073/pnas.97.14.8151; Wulff H, 2004, J IMMUNOL, V173, P776, DOI 10.4049/jimmunol.173.2.776; Wulff H, 2007, CURR MED CHEM, V14, P1437, DOI 10.2174/092986707780831186; Wulff Heike, 2010, Expert Rev Clin Pharmacol, V3, P385, DOI 10.1586/ecp.10.11; Yamashita M, 2006, FEBS J, V273, P3585, DOI 10.1111/j.1742-4658.2006.05365.x	51	60	63	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 31	2013	288	22					15843	15853		10.1074/jbc.M112.427187	http://dx.doi.org/10.1074/jbc.M112.427187			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	156LA	23609438	Green Published, hybrid			2022-12-25	WOS:000319822300038
J	LeBlanc, GA; Wang, YH; Holmes, CN; Kwon, G; Medlock, EK				LeBlanc, Gerald A.; Wang, Ying H.; Holmes, Charisse N.; Kwon, Gwijun; Medlock, Elizabeth K.			A Transgenerational Endocrine Signaling Pathway in Crustacea	PLOS ONE			English	Article							ENVIRONMENTAL SEX DETERMINATION; METHYL FARNESOATE; DAPHNIA-MAGNA; BISPHENOL-A; EXPOSURE; GENE; TRANSFORMER; EXPRESSION; EVOLUTION	Background: Environmental signals to maternal organisms can result in developmental alterations in progeny. One such example is environmental sex determination in Branchiopod crustaceans. We previously demonstrated that the hormone methyl farnesoate could orchestrate environmental sex determination in the early embryo to the male phenotype. Presently, we identify a transcription factor that is activated by methyl farnesoate and explore the extent and significance of this transgenerational signaling pathway. Methodology/Principal Findings: Several candidate transcription factors were cloned from the water flea Daphnia pulex and evaluated for activation by methyl farnesoate. One of the factors evaluated, the complex of two bHLH-PAS proteins, dappuMet and SRC, activated a reporter gene in response to methyl farnesoate. Several juvenoid compounds were definitively evaluated for their ability to activate this receptor complex (methyl farnesoate receptor, MfR) in vitro and stimulate male sex determination in vivo. Potency to activate the MfR correlated to potency to stimulate male sex determination of offspring (pyriproxyfen>methyl farnesoate>methoprene, kinoprene). Daphnids were exposed to concentrations of pyriproxyfen and physiologic responses determined over multiple generations. Survivial, growth, and sex of maternal organisms were not affected by pyriproxyfen exposure. Sex ratio among offspring (generation 2) were increasingly skewed in favor of males with increasing pyriproxyfen concentration; while, the number of offspring per brood was progressively reduced. Female generation 2 daphnids were reared to reproductive maturity in the absence of pyriproxyfen. Sex ratios of offspring (generation 3) were not affected in this pyriproxyfen lineage, however, the number of offspring per brood, again, was significantly reduced. Conclusions: Results reveal likely components to a hormone/receptor signaling pathway in a crustacean that orchestrates transgenerational modifications to important population metrics (sex ratios, fecundity of females). A model is provided that describes how these signaling processes can facilitate population sustainability under normal conditions or threaten sustainability when perturbed by environmental chemicals.	[LeBlanc, Gerald A.; Wang, Ying H.; Holmes, Charisse N.; Kwon, Gwijun; Medlock, Elizabeth K.] N Carolina State Univ, Dept Environm & Mol Toxicol, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University	LeBlanc, GA (corresponding author), N Carolina State Univ, Dept Environm & Mol Toxicol, Raleigh, NC 27695 USA.	Gerald_leblanc@ncsu.edu	Kakaley, Elizabeth Medlock/AAG-1897-2019		US EPA STAR [RD-83273901]; NSF [IOS-0744210]; NIEHS [ES7046]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007046] Funding Source: NIH RePORTER	US EPA STAR(United States Environmental Protection Agency); NSF(National Science Foundation (NSF)); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	A US EPA STAR grant RD-83273901 and NSF grant IOS-0744210 was given to GAL. CNH was supported in part by NIEHS grant ES7046. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALDWIN WS, 1994, ENVIRON TOXICOL CHEM, V13, P1013, DOI 10.1002/etc.5620130702; Barnthouse LW, 2009, ENVIRON TOXICOL CHEM, V23, P500; Betancourt AM, 2010, ENVIRON HEALTH PERSP, V118, P1614, DOI 10.1289/ehp.1002148; Bowden RM, 2000, P ROY SOC B-BIOL SCI, V267, P1745, DOI 10.1098/rspb.2000.1205; BULL JJ, 1981, HEREDITY, V47, P173, DOI 10.1038/hdy.1981.74; BURTIS KC, 1989, CELL, V56, P997, DOI 10.1016/0092-8674(89)90633-8; Colbourne JK, 2011, SCIENCE, V331, P555, DOI 10.1126/science.1197761; Finley KD, 1998, NEURON, V21, P1363, DOI 10.1016/S0896-6273(00)80655-8; HEBERT PDN, 1978, BIOL REV, V53, P387, DOI 10.1111/j.1469-185X.1978.tb00860.x; Ho SM, 2006, CANCER RES, V66, P5624, DOI 10.1158/0008-5472.CAN-06-0516; HOSHIJIMA K, 1991, SCIENCE, V252, P833, DOI 10.1126/science.1902987; Janzen FJ, 2006, J EVOLUTION BIOL, V19, P1775, DOI 10.1111/j.1420-9101.2006.01138.x; Jones G, 2006, FEBS J, V273, P4983, DOI 10.1111/j.1742-4658.2006.05498.x; Kato Y, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001345; Kato Y, 2010, GENOMICS, V95, P160, DOI 10.1016/j.ygeno.2009.12.005; KORPELAINEN H, 1990, BIOL REV, V65, P147, DOI 10.1111/j.1469-185X.1990.tb01187.x; Laudet V, 2002, NUCL RECEPTOR FACTSB; Laufer H, 2001, AM ZOOL, V41, P442, DOI 10.1668/0003-1569(2001)041[0442:UCLFMF]2.0.CO;2; LeBlanc GA, 1999, SETAC TECH PUBLICAT, P23; Li M, 2011, P NATL ACAD SCI USA, V108, P638, DOI 10.1073/pnas.1013914108; Minelli A, 2006, TRENDS ECOL EVOL, V21, P474, DOI 10.1016/j.tree.2006.06.017; Morgan CP, 2011, J NEUROSCI, V31, P11748, DOI 10.1523/JNEUROSCI.1887-11.2011; O'Kane CJ, 1999, CURR BIOL, V9, pR289, DOI 10.1016/S0960-9822(99)80181-X; Olmstead AW, 2007, INT J BIOL SCI, V3, P77; Olmstead AW, 2003, ENVIRON HEALTH PERSP, V111, P919, DOI 10.1289/ehp.5982; Olmstead AW, 2002, J EXP ZOOL, V293, P736, DOI 10.1002/jez.10162; Olmstead AW, 2001, J EXP ZOOL, V290, P148, DOI 10.1002/jez.1044; Olmstead AW, 2001, TOXICOL SCI, V62, P268, DOI 10.1093/toxsci/62.2.268; Paland S, 2006, SCIENCE, V311, P990, DOI 10.1126/science.1118152; Partch CL, 2010, J CELL PHYSIOL, V223, P553, DOI 10.1002/jcp.22067; Rider CV, 2005, J EXP BIOL, V208, P15, DOI 10.1242/jeb.01343; SAAL FSV, 1989, J ANIM SCI, V67, P1824; Tatarazako N, 2003, CHEMOSPHERE, V53, P827, DOI 10.1016/S0045-6535(03)00761-6; Thomson SA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-500; VERHULST EC, 2010, GEN DEV, V20, P376, DOI DOI 10.1016/J.GDE.2010.05.001; Wang HY, 2005, AQUAT TOXICOL, V74, P193, DOI 10.1016/j.aquatox.2005.05.010; Wang YH, 2011, TOXICOL SCI, V123, P71, DOI 10.1093/toxsci/kfr154; Wang YH, 2009, MOL CELL ENDOCRINOL, V309, P109, DOI 10.1016/j.mce.2009.05.016; Warner DA, 2007, P ROY SOC B-BIOL SCI, V274, P883, DOI 10.1098/rspb.2006.0105; Wei J, 2011, ENDOCRINOLOGY, V152, P3049, DOI 10.1210/en.2011-0045; WILSON TG, 1986, DEV BIOL, V118, P190, DOI 10.1016/0012-1606(86)90087-4; Xu JM, 2003, MOL ENDOCRINOL, V17, P1681, DOI 10.1210/me.2003-0116; Zhang XA, 2011, J MOL ENDOCRINOL, V46, pR11, DOI 10.1677/JME-10-0053	43	30	30	2	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2013	8	4							e61715	10.1371/journal.pone.0061715	http://dx.doi.org/10.1371/journal.pone.0061715			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IK	23613913	Green Published, Green Submitted, gold			2022-12-25	WOS:000317907200076
J	Puvanesuaran, VR; Noordin, R; Balakrishnan, V				Puvanesuaran, Vignesh R.; Noordin, Rahmah; Balakrishnan, Venugopal			Genotyping of Toxoplasma gondii Isolates from Wild Boars in Peninsular Malaysia	PLOS ONE			English	Article							INFECTION; SPECIFICITY; ANTIBODIES; RESPONSES; CHICKENS; SHEEP; MICE; PIGS; DOGS	Toxoplasma gondii is a parasitic protozoan that infects nearly one-third of the world population. The present study was done to isolate and genotype T. gondii from wild boar from forests of Pahang, Malaysia. A total of 30 wild boars' blood, heads and hearts were obtained for this study and 30 (100.0%) were found to be seropositive when assayed with modified agglutination test (MAT >= 6). The positive samples were inoculated into mice and T. gondii was only isolated from samples that had strong seropositivity (MAT >= 1:24). The isolates were subjected to PCR-RFLP analysis and all the Peninsular Malaysia isolates of T. gondii are of clonal type I.	[Puvanesuaran, Vignesh R.; Noordin, Rahmah; Balakrishnan, Venugopal] Univ Sains Malaysia, Inst Res Mol Med INFORMM, George Town, Malaysia	Universiti Sains Malaysia	Balakrishnan, V (corresponding author), Univ Sains Malaysia, Inst Res Mol Med INFORMM, George Town, Malaysia.	venu201278@gmail.com	Puvanesuaran, Vignesh R./E-4995-2012; Noordin, Rahmah/A-8277-2011; Balakrishnan, Venugopal/E-4774-2012	Puvanesuaran, Vignesh R./0000-0003-3957-8363; Noordin, Rahmah/0000-0001-7583-0752; Balakrishnan, Venugopal/0000-0002-4874-600X	Universiti Sains Malaysia Research University Grant Scheme [1001/CIPPM/813027]; National Science Fellowship [MOSTI/BMI/TAJ/1-1/2 Jld. 19 (121)]	Universiti Sains Malaysia Research University Grant Scheme(Universiti Sains Malaysia); National Science Fellowship(Ministry of Energy, Science, Technology, Environment and Climate Change (MESTECC), Malaysia)	The study was funded Universiti Sains Malaysia Research University Grant Scheme (1001/CIPPM/813027) and the first author received the National Science Fellowship (MOSTI/BMI/TAJ/1-1/2 Jld. 19 (121)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander J., 2006, MALAYSIA BRUNEI SING; Bokken GCAM, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-36; Chandrawathani P, 2008, TROP BIOMED, V25, P257; Choi WY, 1997, J INFECT DIS, V175, P1280, DOI 10.1086/593702; Cong W, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-110; Dubey JP, 2007, VET PARASITOL, V146, P347, DOI 10.1016/j.vetpar.2007.03.008; DUBEY JP, 1987, EQUINE VET J, V19, P337, DOI 10.1111/j.2042-3306.1987.tb01426.x; Dubey JP, 1997, VET PARASITOL, V71, P307, DOI 10.1016/S0304-4017(97)00016-2; Dubey JP, 1998, VET PARASITOL, V74, P75, DOI 10.1016/S0304-4017(97)00135-0; Herrmann DC, 2010, INT J PARASITOL, V40, P285, DOI 10.1016/j.ijpara.2009.08.001; Hisaeda H, 1997, J IMMUNOL, V159, P2375; Hoff J, 2000, LAB ANIMAL, V29, P47; HOWE DK, 1995, J INFECT DIS, V172, P1561, DOI 10.1093/infdis/172.6.1561; Hrda S, 2000, J PARASITOL, V86, P657, DOI 10.1645/0022-3395(2000)086[0657:TNOTGI]2.0.CO;2; Katzer F, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-121; Mazzariol S, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-20; Nimir Amal, 2010, J Clin Med Res, V2, P117, DOI 10.4021/jocmr2010.06.375w; Puvanesuaran VR, 2012, EUR REV MED PHARMACO, V16, P1179; Puvanesuaran V. R., 2012, INT J PHARM PHARM SC, V4, P220; RAJAMANICKAM C, 1990, TROP ANIM HEALTH PRO, V22, P61, DOI 10.1007/BF02243502; Shaapan RM, 2008, VET PARASITOL, V153, P359, DOI 10.1016/j.vetpar.2008.02.016; Sreekumar C, 2003, VET PARASITOL, V118, P187, DOI 10.1016/j.vetpar.2003.10.018; Su CL, 2002, P NATL ACAD SCI USA, V99, P10753, DOI 10.1073/pnas.172117099; Tomavo S, 2001, INT J PARASITOL, V31, P1023, DOI 10.1016/S0020-7519(01)00193-X	24	16	16	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2013	8	4							e61730	10.1371/journal.pone.0061730	http://dx.doi.org/10.1371/journal.pone.0061730			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IK	23613920	Green Published, gold, Green Submitted			2022-12-25	WOS:000317907200079
J	Aravindan, S; Delma, CR; Thirugnanasambandan, SS; Herman, TS; Aravindan, N				Aravindan, Sheeja; Delma, Caroline R.; Thirugnanasambandan, Somasundaram S.; Herman, Terence S.; Aravindan, Natarajan			Anti-Pancreatic Cancer Deliverables from Sea: First-Hand Evidence on the Efficacy, Molecular Targets and Mode of Action for Multifarious Polyphenols from Five Different Brown-Algae	PLOS ONE			English	Article							NF-KAPPA-B; ENDOTHELIAL GROWTH-FACTOR; EXPRESSION; INHIBITION; CELL; ANTIOXIDANT; CARCINOGENESIS; ANGIOGENESIS; EXTRACT; STAT3	Pancreatic cancer (PC) remains the fourth leading cause of cancer death with an unacceptable survival that has remained relatively unchanged over the past 25 years. The presence of occult or clinical metastases at the time of diagnosis together with the lack of effective chemotherapies pose a dire need for designing new and targeted therapeutic deliverables that favors the clinical outcome. Herein, we investigated the anti-tumorigenic potential of polyphenols from five different brown-algae in human PC cells (MiaPaCa-2, Panc-1, BXPC-3 and Panc-3.27). Total anti-oxidant capacity (TAC) analysis on stepwise polyphenol separations with increasing polarity (Hexane-DCM-EA-methanol) identified high levels of TAC in DCM and EA extractions across all seaweeds assessed. All DCM and EA separated polyphenols induced a dose-dependent and sustained (time-independent) inhibition of cell proliferation and viability. Further, these polyphenols profoundly enhanced DNA damage (acridine orange/Ethidium bromide staining and DNA fragmentation) in all the cell lines investigated. More importantly, luciferase reporter assay revealed a significant inhibition of NF kappa B transcription in cells treated with polyphenols. Interestingly, QPCR analysis identified a differential yet definite regulation of pro-tumorigenic EGFR, VEGFA, AKT, hTERT, kRas, Bcl2, FGF alpha and PDGF alpha transcription in cells treated with DCM and EA polyphenols. Immunoblotting validates the inhibitory potential of seaweed polyphenols in EGFR phosphorylation, kRas, AurK beta and Stat3. Together, these data suggest that intermediate polarity based fractions of seaweed polyphenols may significantly potentiate tumor cell killing and may serve as potential drug deliverable for PC cure. More Studies dissecting out the active constituents in potent fractions, mechanisms of action and synergism, if any, are warranted and are currently in process.	[Aravindan, Sheeja; Delma, Caroline R.; Herman, Terence S.; Aravindan, Natarajan] Univ Oklahoma, Hlth Sci Ctr, Dept Radiat Oncol, Oklahoma City, OK 73190 USA; [Aravindan, Sheeja; Delma, Caroline R.; Thirugnanasambandan, Somasundaram S.] Annamalai Univ, Ctr Adv Study Marine Biol, Dept Marine Sci, Parangipettai, India	University of Oklahoma System; University of Oklahoma Health Sciences Center; Annamalai University	Aravindan, N (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Radiat Oncol, Oklahoma City, OK 73190 USA.	naravind@ouhsc.edu	Aravindan, Natarajan/M-3203-2013	Aravindan, Natarajan/0000-0001-9150-3911; Thirugnanasambandan, Somasundaram/0000-0002-0820-365X; Aravindan, Sheeja/0000-0002-4810-789X	Department of Radiation Oncology at University of Oklahoma Health Sciences Center; Government of India, Department of Science and Technology [BT/PR11535/AAQ/03/431/2008]	Department of Radiation Oncology at University of Oklahoma Health Sciences Center; Government of India, Department of Science and Technology(Department of Science & Technology (India))	The authors are supported by research development funds from the Department of Radiation Oncology at University of Oklahoma Health Sciences Center to N. Aravindan and, Government of India, Department of Science and Technology (DBT Sanction Order No. & Date: BT/PR11535/AAQ/03/431/2008; 17.09.2009) grant (Evaluation of Polyphenols and Polysaccharides from Phaeophytes against Oxidative Stress and Cancer Progression for Drug Development) to T. Somasundaram. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre AJ, 2003, GENE DEV, V17, P3112, DOI 10.1101/gad.1158703; Algul H, 2002, J GASTROINTEST CANC, V31, P71, DOI 10.1385/IJGC:31:1-3:71; Allen E, 2011, CLIN CANCER RES, V17, P5299, DOI 10.1158/1078-0432.CCR-10-2847; Aravindan N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029705; Aravindan N, 2011, INT J RADIAT ONCOL, V79, P1206, DOI 10.1016/j.ijrobp.2010.10.058; Aronchik I, 2010, CANCER RES, V70, P4961, DOI 10.1158/0008-5472.CAN-09-3349; Biliran H, 2007, CLIN CANCER RES, V13, P2811, DOI 10.1158/1078-0432.CCR-06-1844; Boeck S, 2012, BRIT J CANCER; Boopathy NS, 2010, J ONCOL, V2010, DOI 10.1155/2010/214186; Cai YZ, 2004, LIFE SCI, V74, P2157, DOI 10.1016/j.lfs.2003.09.047; Carbone C, 2012, EXPERT OPIN THER TAR, V16, pS1, DOI 10.1517/14728222.2011.645806; Cascinu S, 2006, ANN ONCOL, V17, pV148, DOI 10.1093/annonc/mdj971; Chakravarthy A Bapsi, 2012, Gastrointest Cancer Res, V5, P112; Collins MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049707; Collisson EA, 2011, NAT MED, V17, P500, DOI 10.1038/nm.2344; Compagni A, 2000, CANCER RES, V60, P7163; Cunningham D, 2010, GUT, V59, P1454, DOI 10.1136/gut.2010.220954; Frozza COD, 2013, FOOD CHEM TOXICOL, V52, P137, DOI 10.1016/j.fct.2012.11.013; Deorukhkar A, 2010, PANCREAS, V39, P1277, DOI 10.1097/MPA.0b013e3181dd63e1; El-Hariry I, 2001, INT J CANCER, V94, P652, DOI 10.1002/ijc.1515; Fahy BN, 2003, BRIT J CANCER, V89, P391, DOI 10.1038/sj.bjc.6601037; Fujimoto K, 1998, EUR J CANCER, V34, P1439, DOI 10.1016/S0959-8049(98)00069-0; Fujioka S, 2003, CLIN CANCER RES, V9, P346; FUJITA Y, 1989, JPN J CANCER RES, V80, P503, DOI 10.1111/j.1349-7006.1989.tb01666.x; Greten FR, 2002, GASTROENTEROLOGY, V123, P2052, DOI 10.1053/gast.2002.37075; Halliwell B, 2007, CARDIOVASC RES, V73, P341, DOI 10.1016/j.cardiores.2006.10.004; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; Hoffmann AC, 2008, NEOPLASIA, V10, P674, DOI 10.1593/neo.08292; Huang ZQ, 2011, CURR PHARM DESIGN, V17, P2221, DOI 10.2174/138161211796957427; Institute NC, 2012, FAST STATS AN INTERA; Jayasooriya RGPT, 2012, ONCOL REP, V27, P541, DOI 10.3892/or.2011.1501; Kagawa S, 2012, J SURG RES, V178, P758, DOI 10.1016/j.jss.2012.05.065; Kanda M, 2012, GASTROENTEROLOGY, V142, P730, DOI 10.1053/j.gastro.2011.12.042; Kang K, 2003, ARCH PHARM RES, V26, P286, DOI 10.1007/BF02976957; Kim SK, 2011, ADV FOOD NUTR RES, V64, P225, DOI 10.1016/B978-0-12-387669-0.00017-X; Kumari A, 2009, ANN SURG ONCOL, V16, P1051, DOI 10.1245/s10434-009-0333-8; Liu An, 2011, Zhongguo Zhong Yao Za Zhi, V36, P3167; Liu A, 2011, ONCOL REP, V26, P81, DOI 10.3892/or.2011.1257; Liu F, 2012, PHYTOMEDICINE, V19, P797, DOI 10.1016/j.phymed.2012.03.015; Madhusoodhanan R, 2009, CANCER BIOL THER, V8, P765, DOI 10.4161/cbt.8.9.8105; Makita H, 1996, CANCER RES, V56, P4904; Maniati E, 2011, J CLIN INVEST, V121, P4685, DOI 10.1172/JCI45797; Mans D R, 2000, Oncologist, V5, P185, DOI 10.1634/theoncologist.5-3-185; Muerkoster S, 2003, INT J CANCER, V104, P469, DOI 10.1002/ijc.10963; Ogawa T, 2002, CANCER GENE THER, V9, P633, DOI 10.1038/sj.cgt.7700478; Ohuchida K, 2006, CLIN CANCER RES, V12, P2066, DOI 10.1158/1078-0432.CCR-05-1821; Perugini RA, 2000, J SURG RES, V90, P39, DOI 10.1006/jsre.2000.5833; Prieto P, 1999, ANAL BIOCHEM, V269, P337, DOI 10.1006/abio.1999.4019; Sahraei M, 2012, ONCOGENE, V31, P4935, DOI 10.1038/onc.2011.651; Scholz A, 2003, GASTROENTEROLOGY, V125, P891, DOI 10.1016/S0016-5085(03)01064-3; Sclabas GM, 2005, CANCER-AM CANCER SOC, V103, P2485, DOI 10.1002/cncr.21075; Sclabas Guido M, 2003, Int J Gastrointest Cancer, V33, P15, DOI 10.1385/IJGC:33:1:15; Shah SA, 2001, J GASTROINTEST SURG, V5, P603, DOI 10.1016/S1091-255X(01)80102-5; Singh A, 2009, CANCER CELL, V15, P489, DOI 10.1016/j.ccr.2009.03.022; Siveke JT, 2012, ONCOTARGET, V3, P1262; Society AC, 2012, CANCER FACTS FIGURES; Spada PDS, 2008, J MED FOOD, V11, P144, DOI 10.1089/jmf.2007.598; Surh YJ, 2010, CANCER PREV RES, V3, P1379, DOI 10.1158/1940-6207.CAPR-10-0251; Tan J, 2012, EXP CLIN TRANSPLANT, V10, P386, DOI 10.6002/ect.2011.0157; TANAKA T, 1994, ONCOL REP, V1, P1139; TANAKA T, 1993, CARCINOGENESIS, V14, P1321, DOI 10.1093/carcin/14.7.1321; Torrisani J, 2008, B CANCER, V95, P503, DOI 10.1684/bdc.2008.0632; Veeraraghavan J, 2011, PANCREAS, V40, P1107, DOI 10.1097/MPA.0b013e31821f677d; Veeraraghavan J, 2011, J BIOL CHEM, V286, P21588, DOI 10.1074/jbc.M110.193755; Vezzosi D, 2006, CLIN ENDOCRINOL, V64, P63, DOI 10.1111/j.1365-2265.2005.02417.x; Walsh N, 2012, INVEST NEW DRUGS; Wei DY, 2003, ONCOGENE, V22, P319, DOI 10.1038/sj.onc.1206122; Wijesinghe WAJP, 2012, FITOTERAPIA, V83, P6, DOI 10.1016/j.fitote.2011.10.016; Yang JI, 2012, MOLECULES, V17, P7241, DOI 10.3390/molecules17067241; Yeh JJ, 2007, EXPERT OPIN THER TAR, V11, P673, DOI 10.1517/14728222.11.5.673; Yuan YV, 2006, FOOD CHEM TOXICOL, V44, P1144, DOI 10.1016/j.fct.2006.02.002; Zavoral M, 2011, WORLD J GASTROENTERO, V17, P2897, DOI 10.3748/wjg.v17.i24.2897; Zhang RL, 2012, MOLECULES, V17, P8419, DOI 10.3390/molecules17078419; Zhang ZQ, 2006, INT J ONCOL, V29, P185; Zhang ZY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027441; Zhong YQ, 2010, J DIGEST DIS, V11, P176, DOI 10.1111/j.1751-2980.2010.00433.x; Zhou J, 2011, TECHNOL CANCER RES T, V10, P361, DOI 10.7785/tcrt.2012.500213	77	28	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2013	8	4							e61977	10.1371/journal.pone.0061977	http://dx.doi.org/10.1371/journal.pone.0061977			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130DR	23613993	Green Published, gold, Green Submitted			2022-12-25	WOS:000317893400136
J	Duncan, JS; Fritzsch, B				Duncan, Jeremy S.; Fritzsch, Bernd			Continued Expression of GATA3 Is Necessary for Cochlear Neurosensory Development	PLOS ONE			English	Article							INNER-EAR MORPHOGENESIS; SPIRAL GANGLION NEURONS; HAIR CELL FATE; SENSORY EPITHELIA; MOLECULAR-BASIS; NERVOUS-SYSTEM; NULL MICE; MOUSE EAR; ORGAN; GENE	Hair cells of the developing mammalian inner ear are progressively defined through cell fate restriction. This process culminates in the expression of the bHLH transcription factor Atoh1, which is necessary for differentiation of hair cells, but not for their specification. Loss of several genes will disrupt ear morphogenesis or arrest of neurosensory epithelia development. We previously showed in null mutants that the loss of the transcription factor, Gata3, results specifically in the loss of all cochlear neurosensory development. Temporal expression of Gata3 is broad from the otic placode stage through the postnatal ear. It therefore remains unclear at which stage in development Gata3 exerts its effect. To better understand the stage specific effects of Gata3, we investigated the role of Gata3 in cochlear neurosensory specification and differentiation utilizing a LoxP targeted Gata3 line and two Cre lines. Foxg1(Cre):Gata3(f/f) mice show recombination of Gata3 around E8.5 but continue to develop a cochlear duct without differentiated hair cells and spiral ganglion neurons. qRT-PCR data show that Atoh1 was down-regulated but not absent in the duct whereas other hair cell specific genes such as Pou4f3 were completely absent. In addition, while Sox2 levels were lower in the Foxg1(Cre):Gata3(f/f) cochlea, Eya1 levels remained normal. We conclude that Eya1 is unable to fully upregulate Atoh1 or Pou4f3, and drive differentiation of hair cells without Gata3. Pax2-Cre:Gata3(f/f) mice show a delayed recombination of Gata3 in the ear relative to Foxg1(Cre):Gata3(f/f). These mice exhibited a cochlear duct containing patches of partially differentiated hair cells and developed only few and incorrectly projecting spiral ganglion neurons. Our conditional deletion studies reveal a major role of Gata3 in the signaling of prosensory genes and in the differentiation of cochlear neurosenory cells. We suggest that Gata3 may act in combination with Eya1, Six1, and Sox2 in cochlear prosensory gene signaling.	[Duncan, Jeremy S.; Fritzsch, Bernd] Univ Iowa, Dept Biol, Iowa City, IA 52242 USA	University of Iowa	Duncan, JS (corresponding author), Univ Iowa, Dept Biol, Iowa City, IA 52242 USA.	jeremyduncan@jhmi.edu	; Duncan, Jeremy/K-7230-2013	Fritzsch, Bernd/0000-0002-4882-8398; Duncan, Jeremy/0000-0002-5555-3273	National Institutes of Health [R01DC005590, P30 DC 010362]; Evelyn Hart Watson Fellowship; University of Iowa Office of the Vice President for Research (OVPR); College of Liberal Arts and Sciences; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005590, P30DC010362] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Evelyn Hart Watson Fellowship; University of Iowa Office of the Vice President for Research (OVPR); College of Liberal Arts and Sciences; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by a National Institutes of Health grant R01DC005590 (to B. F.) and P30 DC 010362. J.S.D was supported by an Evelyn Hart Watson Fellowship. The authors thank the University of Iowa Office of the Vice President for Research (OVPR) and the College of Liberal Arts and Sciences for their support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed M, 2012, DEVELOPMENT, V139, P1965, DOI 10.1242/dev.071670; Ahmed M, 2012, DEV CELL, V22, P377, DOI 10.1016/j.devcel.2011.12.006; Ali A, 2007, HUM MOL GENET, V16, P265, DOI 10.1093/hmg/ddl454; Alvarado DM, 2009, DEV DYNAM, V238, P3093, DOI 10.1002/dvdy.22149; Moreno-Pelayo MA, 2008, JARO-J ASSOC RES OTO, V9, P202, DOI 10.1007/s10162-008-0116-0; Appler JM, 2013, J NEUROSCI, V33, P3679, DOI 10.1523/JNEUROSCI.4703-12.2013; Bermingham NA, 1999, SCIENCE, V284, P1837, DOI 10.1126/science.284.5421.1837; Bok JW, 2007, INT J DEV BIOL, V51, P521, DOI 10.1387/ijdb.072381jb; Bouchard M, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-89; Brigande JV, 2000, P NATL ACAD SCI USA, V97, P11700, DOI 10.1073/pnas.97.22.11700; Burton Q, 2004, DEV BIOL, V272, P161, DOI 10.1016/j.ydbio.2004.04.024; Bustin SA, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-74; Camarero G, 2003, DEV BIOL, V262, P242, DOI 10.1016/S0012-1606(03)00387-7; Camarero G, 2002, HEARING RES, V170, P2, DOI 10.1016/S0378-5955(02)00447-1; Chai RJ, 2011, JARO-J ASSOC RES OTO, V12, P455, DOI 10.1007/s10162-011-0267-2; Chang W, 2004, DEVELOPMENT, V131, P4201, DOI 10.1242/dev.01292; Chang WI, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000050; Chen P, 2002, DEVELOPMENT, V129, P2495; Cole LK, 2000, J COMP NEUROL, V424, P509, DOI 10.1002/1096-9861(20000828)424:3<509::AID-CNE8>3.0.CO;2-Q; Daudet N, 2007, DEVELOPMENT, V134, P2369, DOI 10.1242/dev.001842; Duncan J, 2011, JOVE-J VIS EXP, DOI 10.3791/2451; Duncan JS, 2011, INT J DEV BIOL; Fekete DM, 2002, CURR OPIN NEUROBIOL, V12, P35, DOI 10.1016/S0959-4388(02)00287-8; Fischer M, 2000, NAT NEUROSCI, V3, P887, DOI 10.1038/78791; Fritzsch B, 2000, NEUROREPORT, V11, pR35, DOI 10.1097/00001756-200011270-00013; Fritzsch B, 2005, BRAIN RES BULL, V66, P249, DOI 10.1016/j.brainresbull.2005.05.016; Fritzsch B, 2005, DEV DYNAM, V233, P570, DOI 10.1002/dvdy.20370; Fritzsch B, 2001, DEV GENES EVOL, V211, P388, DOI 10.1007/s004270100166; Fritzsch B, 2006, BIOESSAYS, V28, P1181, DOI 10.1002/bies.20502; Fritzsch B, 2013, EVOL DEV, V15, P63, DOI 10.1111/ede.12015; GEORGE KM, 1994, DEVELOPMENT, V120, P2673; Grocott T, 2012, DEV BIOL, V370, P3, DOI 10.1016/j.ydbio.2012.06.028; Gross J, 2010, HEARING RES, V261, P9, DOI 10.1016/j.heares.2009.12.017; Grote D, 2006, DEVELOPMENT, V133, P53, DOI 10.1242/dev.02184; Grote D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000316; Groves AK, 2012, DEVELOPMENT, V139, P245, DOI 10.1242/dev.067074; Hatini V, 1999, DEV DYNAM, V215, P332, DOI 10.1002/(SICI)1097-0177(199908)215:4<332::AID-AJA5>3.3.CO;2-I; Haugas M, 2012, HEARING RES, V283, P151, DOI 10.1016/j.heares.2011.10.010; Hebert JM, 2000, DEV BIOL, V222, P296, DOI 10.1006/dbio.2000.9732; Home P, 2009, J BIOL CHEM, V284, P28729, DOI 10.1074/jbc.M109.016840; Huh SH, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001231; Jahan I, 2013, HEARING RES, V297, P30, DOI 10.1016/j.heares.2012.11.008; Jahan I, 2010, CELL TISSUE RES, V341, P95, DOI 10.1007/s00441-010-0984-6; Karis A, 2001, J COMP NEUROL, V429, P615, DOI 10.1002/1096-9861(20010122)429:4<615::AID-CNE8>3.0.CO;2-F; Kelly MC, 2012, J NEUROSCI, V32, P6699, DOI 10.1523/JNEUROSCI.5420-11.2012; Kersigo J, 2011, GENESIS, V49, P326, DOI 10.1002/dvg.20714; Kiernan AE, 2001, P NATL ACAD SCI USA, V98, P3873, DOI 10.1073/pnas.071496998; Kiernan AE, 2005, NATURE, V434, P1031, DOI 10.1038/nature03487; Kiernan AE, 2006, PLOS GENET, V2, P27, DOI 10.1371/journal.pgen.0020004; Kopecky BJ, 2012, J MICROSC-OXFORD, V248, P292, DOI 10.1111/j.1365-2818.2012.03673.x; Kopecky B, 2012, DEV DYNAM, V241, P465, DOI 10.1002/dvdy.23736; Kopecky B, 2011, DEV DYNAM, V240, P1373, DOI 10.1002/dvdy.22620; Ladher RK, 2005, GENE DEV, V19, P603, DOI 10.1101/gad.1273605; Lanford RJ, 2000, JARO-J ASSOC RES OTO, V1, P161, DOI 10.1007/sl01620010023; Lawoko-Kerali G, 2002, J COMP NEUROL, V442, P378, DOI 10.1002/cne.10088; Lillevali K, 2006, MECH DEVELOP, V123, P415, DOI 10.1016/j.mod.2006.04.007; Liu ZY, 2012, J NEUROSCI, V32, P6600, DOI 10.1523/JNEUROSCI.0818-12.2012; Lu CC, 2011, J NEUROSCI, V31, P10903, DOI 10.1523/JNEUROSCI.2358-11.2011; Ma QF, 2000, JARO-J ASSOC RES OTO, V1, P129, DOI 10.1007/s101620010017; Maklad A, 2010, CELL TISSUE RES, V340, P303, DOI 10.1007/s00441-010-0944-1; Masuda M, 2012, DEV BIOL, V372, P68, DOI 10.1016/j.ydbio.2012.09.002; Matei V, 2005, DEV DYNAM, V234, P633, DOI 10.1002/dvdy.20551; Milo M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007144; Neves J, 2011, DEVELOPMENT, V138, P735, DOI 10.1242/dev.060657; Nichols DH, 2008, CELL TISSUE RES, V334, P339, DOI 10.1007/s00441-008-0709-2; Oh SH, 1996, J NEUROSCI, V16, P6463; Ohyama T, 2004, GENESIS, V38, P195, DOI 10.1002/gene.20017; Ohyama T, 2010, J NEUROSCI, V30, P15044, DOI 10.1523/JNEUROSCI.3547-10.2010; Pan N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030358; Pan N, 2011, HEARING RES, V275, P66, DOI 10.1016/j.heares.2010.12.002; PANDOLFI PP, 1995, NAT GENET, V11, P40, DOI 10.1038/ng0995-40; Pauley S, 2003, DEV DYNAM, V227, P203, DOI 10.1002/dvdy.10297; Pauley S, 2006, DEV DYNAM, V235, P2470, DOI 10.1002/dvdy.20839; Pirvola U, 2000, J NEUROSCI, V20, P6125, DOI 10.1523/JNEUROSCI.20-16-06125.2000; Pirvola U, 2004, DEV BIOL, V273, P350, DOI 10.1016/j.ydbio.2004.06.010; Puligilla C, 2007, DEV DYNAM, V236, P1905, DOI 10.1002/dvdy.21192; Ramain P, 2000, MOL CELL, V6, P781, DOI 10.1016/S1097-2765(05)00079-1; Richardson GP, 2008, CURR OPIN OTOLARYNGO, V16, P458, DOI 10.1097/MOO.0b013e32830e20c4; Rivolta MN, 1998, J NEUROCYTOL, V27, P637, DOI 10.1023/A:1006951813063; Ruben RJ, 1967, ACTA OTO LARYNGOLOGI, V220, P221; Simmons D, 2011, SPRINGER HANDB AUDIT, V38, P187, DOI 10.1007/978-1-4419-7070-1_7; Soukup GA, 2009, DEV BIOL, V328, P328, DOI 10.1016/j.ydbio.2009.01.037; van der Wees J, 2004, NEUROBIOL DIS, V16, P169, DOI 10.1016/j.nbd.2004.02.004; Van Esch H, 2000, NATURE, V406, P419, DOI 10.1038/35019088; Yamashita M, 2002, J BIOL CHEM, V277, P42399, DOI 10.1074/jbc.M205876200; Yang JM, 2012, J NEUROSCI, V32, P3712, DOI 10.1523/JNEUROSCI.6093-11.2012; Yang T, 2011, HEARING RES, V278, P21, DOI 10.1016/j.heares.2011.03.002; Zhao LD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023729; Zheng JL, 2000, NAT NEUROSCI, V3, P580, DOI 10.1038/75753; Zou D, 2008, HUM MOL GENET, V17, P3340, DOI 10.1093/hmg/ddn229	90	69	69	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2013	8	4							e62046	10.1371/journal.pone.0062046	http://dx.doi.org/10.1371/journal.pone.0062046			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130DR	23614009	Green Submitted, Green Published, gold			2022-12-25	WOS:000317893400149
J	Li, XG; Liu, BA				Li, Xiaogang; Liu, Biao			A 2-Year Field Study Shows Little Evidence That the Long-Term Planting of Transgenic Insect-Resistant Cotton Affects the Community Structure of Soil Nematodes	PLOS ONE			English	Article							GENETICALLY-MODIFIED MAIZE; THURINGIENSIS SUBSP KURSTAKI; BACILLUS-THURINGIENSIS; BT COTTON; CRY3BB1 PROTEIN; MICROBIAL COMMUNITY; MODIFIED CROPS; HONEY-BEES; CORN; ARTHROPODS	Transgenic insect-resistant cotton has been released into the environment for more than a decade in China to effectively control the cotton bollworm (Helicoverpa armigera) and other Lepidoptera. Because of concerns about undesirable ecological side-effects of transgenic crops, it is important to monitor the potential environmental impact of transgenic insect-resistant cotton after commercial release. Our 2-year study included 1 cotton field where non-transgenic cotton had been planted continuously and 2 other cotton fields where transgenic insect-resistant cotton had been planted for different lengths of time since 1997 and since 2002. In 2 consecutive years (2009 and 2010), we took soil samples from 3 cotton fields at 4 different growth stages (seedling, budding, boll-forming and boll-opening stages), collected soil nematodes from soil with the sugar flotation and centrifugation method and identified the soil nematodes to the genus level. The generic composition, individual densities and diversity indices of the soil nematodes did not differ significantly between the 2 transgenic cotton fields and the non-transgenic cotton field, but significant seasonal variation was found in the individual densities of the principal trophic groups and in the diversity indices of the nematodes in all 3 cotton fields. The study used a comparative perspective to monitor the impact of transgenic insect-resistant cotton grown in typical 'real world' conditions. The results of the study suggested that more than 10 years of cultivation of transgenic insect-resistant cotton had no significant effects-adverse or otherwise-on soil nematodes. This study provides a theoretical basis for ongoing environmental impact monitoring of transgenic plants.	[Li, Xiaogang; Liu, Biao] Minist Environm Protect China, Nanjing Inst Environm Sci, Nanjing, Jiangsu, Peoples R China; [Li, Xiaogang] Chinese Acad Sci, Inst Soil Sci, Key Lab Soil Environm & Pollut Remediat, Nanjing, Jiangsu, Peoples R China	Chinese Academy of Sciences; Institute of Soil Science, CAS	Liu, BA (corresponding author), Minist Environm Protect China, Nanjing Inst Environm Sci, Nanjing, Jiangsu, Peoples R China.	85287064@163.com	li, xiaogang/ABH-2977-2020		National Special Transgenic Project [2011ZX08012-005, 2013ZX08012-005]; National Science and Technology Pillar Program [2013BAD11B01]; Jiangsu Province Science Foundation for Youths [BK2012498]	National Special Transgenic Project; National Science and Technology Pillar Program; Jiangsu Province Science Foundation for Youths	This research was jointly supported by the National Special Transgenic Project (2011ZX08012-005; 2013ZX08012-005), the National Science and Technology Pillar Program (No. 2013BAD11B01), the Jiangsu Province Science Foundation for Youths (BK2012498). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad A, 2005, ENVIRON ENTOMOL, V34, P385, DOI 10.1603/0046-225X-34.2.385; Al-Deeb MA, 2003, ENVIRON ENTOMOL, V32, P859, DOI 10.1603/0046-225X-32.4.859; Andersson HC, 2011, EFSA J, V9, DOI 10.2903/j.efsa.2011.2316; ANDRASSY I, 1992, Fundamental and Applied Nematology, V15, P187; Bartsch D, 2010, BIOTECH AGR FOREST, V64, P575, DOI 10.1007/978-3-642-02391-0_27; Bitzer RJ, 2005, ENVIRON ENTOMOL, V34, P1346, DOI 10.1603/0046-225X(2005)034[1346:BACSOE]2.0.CO;2; Blair J.M., 1996, SOIL SCI SOC AM J, V49, P283; Bongers T, 1999, TRENDS ECOL EVOL, V14, P224, DOI 10.1016/S0169-5347(98)01583-3; BONGERS T, 1990, OECOLOGIA, V83, P14, DOI 10.1007/BF00324627; Chelinho S, 2011, ECOTOX ENVIRON SAFE, V74, P2002, DOI 10.1016/j.ecoenv.2011.07.015; Chen LZ, 2011, J PEST SCI, V84, P9, DOI 10.1007/s10340-010-0319-0; Choudhary B., 2013, BT COTTON INDIA COUN; Committee of handbook of soil fauna research methods, 1998, HDB SOIL FAUNA RES M; Cortet J, 2007, PEDOBIOLOGIA, V51, P207, DOI 10.1016/j.pedobi.2007.04.001; Coz I, 2008, J ENVIRON QUAL, V37, P647, DOI 10.2134/jeq2007.0352; Devare M, 2007, SOIL BIOL BIOCHEM, V39, P2038, DOI 10.1016/j.soilbio.2007.03.004; Dong DF, 2008, CAN J SOIL SCI, V88, P115, DOI 10.4141/CJSS07014; Duan JJ, 2010, BIOL LETTERS, V6, P74, DOI 10.1098/rsbl.2009.0612; Duan JJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001415; Duc C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025014; Ferris H, 2001, APPL SOIL ECOL, V18, P13, DOI 10.1016/S0929-1393(01)00152-4; Fliessbach A, 2012, BIOL FERT SOILS, V48, P315, DOI 10.1007/s00374-011-0625-6; Graef F, 2005, ENVIRON MONIT ASSESS, V111, P1, DOI 10.1007/s10661-005-8044-5; Green J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030973; Griffiths BS, 2006, J ENVIRON QUAL, V35, P734, DOI 10.2134/jeq2005.0344; Griffiths BS, 2005, PLANT SOIL, V275, P135, DOI 10.1007/s11104-005-1093-2; Guo XM, 2003, GUIDANCE SEED INTRO; Gupta VVSR, 2004, ECOLOGICAL IMPACTS G; Han P, 2012, ECOTOXICOLOGY, V21, P2214, DOI 10.1007/s10646-012-0976-2; Han P, 2010, ECOTOXICOLOGY, V19, P1452, DOI 10.1007/s10646-010-0530-z; Head G, 2002, ENVIRON ENTOMOL, V31, P30, DOI 10.1603/0046-225X-31.1.30; Hoss S, 2011, SCI TOTAL ENVIRON, V409, P2674, DOI 10.1016/j.scitotenv.2011.03.041; Hofs J. -L., 2008, International Journal of Tropical Insect Science, V28, P211, DOI 10.1017/S1742758408201682; Hopkins DW, 2003, EUR J SOIL SCI, V54, P793, DOI 10.1046/j.1351-0754.2003.0563.x; Hutchison WD, 2010, SCIENCE, V330, P222, DOI 10.1126/science.1190242; Icoz I, 2008, TRANSGENIC RES, V17, P609, DOI 10.1007/s11248-007-9133-8; JENKINS W. R., 1964, PLANT DIS REP, V48, P692; Karuri HW, 2010, AFR J AGR RES, V5, P1889; Knox OGG, 2007, EUPHYTICA, V154, P83, DOI 10.1007/s10681-006-9272-7; Koskella J, 1997, APPL ENVIRON MICROB, V63, P3561, DOI 10.1128/AEM.63.9.3561-3568.1997; Lang A, 2006, MONITORING ENV EFFEC; Lee L, 2003, APPL ENVIRON MICROB, V69, P4111, DOI 10.1128/AEM.69.7.4111-4115.2003; Li GP, 2011, CROP PROT, V30, P1573, DOI 10.1016/j.cropro.2011.08.015; [李克梅 LI Kemei], 2009, [西北农业学报, Acat Agriculturae Boreali-Occidentalis Sinica], V18, P273; Li XG, 2012, J ENVIRON MONITOR, V14, P1055, DOI 10.1039/c2em10378h; Li XG, 2011, PLANT SOIL, V339, P247, DOI 10.1007/s11104-010-0572-2; Liang WJ, 2009, SOIL BIOL BIOCHEM, V41, P883, DOI 10.1016/j.soilbio.2008.06.018; Lilley AK, 2006, TRENDS BIOTECHNOL, V24, P9, DOI 10.1016/j.tibtech.2005.11.005; Lingaraju S, 2012, CURR SCI INDIA, V103, P926; Liu BA, 2009, ECOTOX ENVIRON SAFE, V72, P1163, DOI 10.1016/j.ecoenv.2009.02.002; Lu YH, 2012, NATURE, V487, P362, DOI 10.1038/nature11153; MAGURRAN A. E., 2004, MEASURING BIOLOGICAL; Manachini B., 2002, Bollettino di Zoologia Agraria e di Bachicoltura, V34, P85; Manachini B, 2003, BIODIVERSITY IMPLICA; Manachini Barbara, 2004, IOBC-WPRS Bulletin, V27, P103; Marvier M, 2007, SCIENCE, V316, P1475, DOI 10.1126/science.1139208; Moser T, 2004, ECOTOXICOLOGY, V13, P61, DOI 10.1023/B:ECTX.0000012405.90160.21; Naranjo SE, 2005, ENVIRON ENTOMOL, V34, P1193, DOI 10.1603/0046-225X(2005)034[1193:LAOTEO]2.0.CO;2; Parmelee RW, 1997, ENVIRON TOXICOL CHEM, V16, P1212, DOI [10.1002/etc.5620160616, 10.1897/1551-5028(1997)016&lt;1212:DTEOPO&gt;2.3.CO;2]; Pen-Mouratov S, 2005, NEMATOLOGY, V7, P179, DOI 10.1163/1568541054879476; Powell JR, 2009, J APPL ECOL, V46, P388, DOI 10.1111/j.1365-2664.2009.01617.x; Priestley AL, 2009, TRANSGENIC RES, V18, P425, DOI 10.1007/s11248-008-9234-z; Robinson A. F., 2007, INTEGRATED MANAGEMEN, P149; Rose R, 2007, APIDOLOGIE, V38, P368, DOI 10.1051/apido:2007022; Rose R, 2007, ENVIRON ENTOMOL, V36, P1254, DOI 10.1603/0046-225X(2007)36[1254:EOIALB]2.0.CO;2; Sanvido O, 2007, J VERBRAUCH LEBENSM, V2, P37, DOI 10.1007/s00003-007-0292-6; SANVIDO O, 2006, ART SCHRIFTENREIHE, V1, P1; Sanvido Olivier, 2005, Environmental Biosafety Research, V4, P13, DOI 10.1051/ebr:2005008; Saxena D, 2001, SOIL BIOL BIOCHEM, V33, P1225, DOI 10.1016/S0038-0717(01)00027-X; Sims SR, 1997, J AGR FOOD CHEM, V45, P1502, DOI 10.1021/jf960647w; State Council of China, 2001, REG SAF AGR GEN MOD; Stotzky G, 2004, PLANT SOIL, V266, P77; Tapp H, 1998, SOIL BIOL BIOCHEM, V30, P471, DOI 10.1016/S0038-0717(97)00148-X; Wada S, 2008, MICROBES ENVIRON, V23, P331, DOI 10.1264/jsme2.ME08534; Wang R., 1989, Acta Phytopathologica Sinica, V19, P205; Wei JZ, 2003, P NATL ACAD SCI USA, V100, P2760, DOI 10.1073/pnas.0538072100; Wolfenbarger LL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002118; Xu Y, 2012, J INTEGR AGR, V11, P1493, DOI 10.1016/S2095-3119(12)60149-X; YEATES GW, 1993, J NEMATOL, V25, P315; Yu HL, 2011, J INTEGR PLANT BIOL, V53, P520, DOI 10.1111/j.1744-7909.2011.01047.x; Zughart W, 2008, EUPHYTICA, V164, P845, DOI 10.1007/s10681-007-9475-6	81	21	28	2	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2013	8	4							e61670	10.1371/journal.pone.0061670	http://dx.doi.org/10.1371/journal.pone.0061670			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130DR	23613899	gold, Green Submitted, Green Published			2022-12-25	WOS:000317893400088
J	Lin, JH; Chiu, SC; Lin, YC; Cheng, JC; Wu, HS; Salemi, M; Liu, HF				Lin, Jih-Hui; Chiu, Shu-Chun; Lin, Yung-Cheng; Cheng, Ju-Chien; Wu, Ho-Sheng; Salemi, Marco; Liu, Hsin-Fu			Exploring the Molecular Epidemiology and Evolutionary Dynamics of Influenza A Virus in Taiwan	PLOS ONE			English	Article							PHYLOGENETIC ANALYSIS; GENOME ANALYSIS; H3N2; REASSORTMENT; REVEALS; H1N1; RECOMBINATION; SURVEILLANCE; CIRCULATION; INFERENCE	The evolution and population dynamics of human influenza in Taiwan is a microcosm of the viruses circulating worldwide, which has not yet been studied in detail. We collected 343 representative full genome sequences of human influenza A viruses isolated in Taiwan between 1979 and 2009. Phylogenetic and antigenic data analysis revealed that H1N1 and H3N2 viruses consistently co-circulated in Taiwan, although they were characterized by different temporal dynamics and degrees of genetic diversity. Moreover, influenza A viruses of both subtypes underwent internal gene reassortment involving all eight segments of the viral genome, some of which also occurred during non-epidemic periods. The patterns of gene reassortment were different in the two subtypes. The internal genes of H1N1 viruses moved as a unit, separately from the co-evolving HA and NA genes. On the other hand, the HA and NA genes of H3N2 viruses tended to segregate consistently with different sets of internal gene segments. In particular, as reassortment occurred, H3HA always segregated as a group with the PB1, PA and M genes, while N2NA consistently segregated with PB2 and NP. Finally, the analysis showed that new phylogenetic lineages and antigenic variants emerging in summer were likely to be the progenitors of the epidemic strains in the following season. The synchronized seasonal patterns and high genetic diversity of influenza A viruses observed in Taiwan make possible to capture the evolutionary dynamic and epidemiological rules governing antigenic drift and reassortment and may serve as a "warning" system that recapitulates the global epidemic.	[Lin, Jih-Hui; Chiu, Shu-Chun; Wu, Ho-Sheng] Ctr Dis Control, Res & Diagnost Ctr, Taipei, Taiwan; [Lin, Yung-Cheng; Liu, Hsin-Fu] Natl Taiwan Ocean Univ, Inst Biosci & Biotechnol, Keelung, Taiwan; [Cheng, Ju-Chien] China Med Univ, Dept Med Lab Sci & Biotechnol, Taichung, Taiwan; [Wu, Ho-Sheng] Taipei Med Univ, Sch Med Lab Sci & Biotechnol, Taipei, Taiwan; [Salemi, Marco] Univ Florida, Dept Pathol Immunol & Lab Med, Gainesville, FL USA; [Salemi, Marco] Univ Florida, Emerging Pathogens Inst, Gainesville, FL USA; [Liu, Hsin-Fu] Mackay Mem Hosp, Dept Med Res, Taipei City, Taiwan; [Liu, Hsin-Fu] Natl Yang Ming Univ, Inst Publ Hlth, Taipei 112, Taiwan; [Liu, Hsin-Fu] Natl Taipei Univ Nursing & Hlth Sci, Ctr Gen Educ, Taipei, Taiwan	Centers For Disease Control - Taiwan; National Taiwan Ocean University; China Medical University Taiwan; Taipei Medical University; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Mackay Memorial Hospital; National Yang Ming Chiao Tung University; National Taipei University of Nursing & Health Science (NTUNHS)	Wu, HS (corresponding author), Ctr Dis Control, Res & Diagnost Ctr, Taipei, Taiwan.	wuhs@cdc.gov.tw; salemi@pathology.ufl.edu; hsinfu@ms1.mmh.org.tw	Liu, Hsin-Fu/AAR-5960-2020	Liu, Hsin-Fu/0000-0003-0082-2269	Centers for Diseases Control, Taiwan [DOH96-DC2402]; Mackay Memorial Hospital, Taiwan [MMH-9925, -10017]	Centers for Diseases Control, Taiwan; Mackay Memorial Hospital, Taiwan	This study was supported by Centers for Diseases Control, Taiwan (grant DOH96-DC2402) and in part by Mackay Memorial Hospital, Taiwan (grant MMH-9925 and -10017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahl J, 2011, P NATL ACAD SCI USA, V108, P19359, DOI 10.1073/pnas.1109314108; BEAN WJ, 1980, NATURE, V284, P638, DOI 10.1038/284638a0; BEARE AS, 1980, INFECT IMMUN, V28, P753; BUONAGURIO DA, 1986, SCIENCE, V232, P980, DOI 10.1126/science.2939560; Cox NJ, 2000, ANNU REV MED, V51, P407, DOI 10.1146/annurev.med.51.1.407; Delport W, 2010, BIOINFORMATICS, V26, P2455, DOI 10.1093/bioinformatics/btq429; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2002, GENETICS, V161, P1307; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Ghedin E, 2005, NATURE, V437, P1162, DOI 10.1038/nature04239; GHENDON Y, 1981, J GEN VIROL, V56, P303, DOI 10.1099/0022-1317-56-2-303; Grenfell BT, 2004, SCIENCE, V303, P327, DOI 10.1126/science.1090727; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Gulati U, 2002, J VIROL, V76, P12274, DOI 10.1128/JVI.76.23.12274-12280.2002; Holmes EC, 2005, PLOS BIOL, V3, P1579, DOI 10.1371/journal.pbio.0030300; Kang S, 2010, J CLIN MICROBIOL, V48, P2177, DOI 10.1128/JCM.00209-10; KENDAL AP, 1978, AM J EPIDEMIOL, V108, P308, DOI 10.1093/oxfordjournals.aje.a112624; KENDAL AP, 1979, AM J EPIDEMIOL, V110, P449, DOI 10.1093/oxfordjournals.aje.a112826; Koelle K, 2006, SCIENCE, V314, P1898, DOI 10.1126/science.1132745; Pond SLK, 2006, MOL BIOL EVOL, V23, P1891, DOI 10.1093/molbev/msl051; Lin JH, 2008, J MED VIROL, V80, P316, DOI 10.1002/jmv.21074; Lin YP, 2004, VIRUS RES, V103, P47, DOI 10.1016/j.virusres.2004.02.011; Lindstrom SE, 1998, J VIROL, V72, P8021, DOI 10.1128/JVI.72.10.8021-8031.1998; Minin VN, 2008, MOL BIOL EVOL, V25, P1459, DOI 10.1093/molbev/msn090; Nelson MI, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000012; Nelson MI, 2007, PLOS PATHOG, V3, P1220, DOI 10.1371/journal.ppat.0030131; Nelson MI, 2006, PLOS PATHOG, V2, P1144, DOI 10.1371/journal.ppat.0020125; Nelson MI, 2007, NAT REV GENET, V8, P196, DOI 10.1038/nrg2053; Nelson MI, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000133; Poon AFY, 2008, BIOINFORMATICS, V24, P1949, DOI 10.1093/bioinformatics/btn313; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rambaut A, 2008, NATURE, V453, P615, DOI 10.1038/nature06945; RAYMOND FL, 1986, VIROLOGY, V148, P275, DOI 10.1016/0042-6822(86)90325-9; Russell CA, 2008, SCIENCE, V320, P340, DOI 10.1126/science.1154137; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Shih ACC, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-63; Smith DJ, 2006, SCIENCE, V312, P392, DOI 10.1126/science.1122665; Smith DJ, 2004, SCIENCE, V305, P371, DOI 10.1126/science.1097211; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tseng RK, 1996, JPN J MED SCI BIOL, V49, P77, DOI 10.7883/yoken1952.49.77; WILSON IA, 1990, ANNU REV IMMUNOL, V8, P737, DOI 10.1146/annurev.iy.08.040190.003513; Wong KKY, 2011, J CLIN VIROL, V51, P266, DOI 10.1016/j.jcv.2011.05.013; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088	45	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2013	8	4							e61957	10.1371/journal.pone.0061957	http://dx.doi.org/10.1371/journal.pone.0061957			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130DR	23613982	Green Published, Green Submitted, gold			2022-12-25	WOS:000317893400132
J	Ghosh, A; Dutt, A; Ghosh, M; Bhargava, P; Rao, S				Ghosh, Amitabha; Dutt, Aparna; Ghosh, Madhura; Bhargava, Pallavi; Rao, Sulakshana			Using the Revised Diagnostic Criteria for Frontotemporal Dementia in India: Evidence of an Advanced and Florid Disease	PLOS ONE			English	Article							LOBAR DEGENERATION; ALZHEIMERS-DISEASE; BEHAVIORAL VARIANT; CONSENSUS; ACCURACY; SENSITIVITY; SYMPTOMS; DECLINE	Background: The International Consortium (FTDC) that revised the diagnostic criteria for behavioural variant frontotemporal dementia (bvFTD) did not have an Asian representation. Whether the revised criteria are equally useful in the early detection of Asian bvFTD patients therefore remains largely unexplored. Earlier studies have indicated differences in clinical manifestations in Indian and other Asian bvFTD patients when compared to western groups. There is an urgent need for clarification, given the projected exponential rise in dementia in these countries and the imminent clinical trials on bvFTD. Objective: To assess how Indian bvFTD patients fulfil the FTDC criteria, hypothesizing that our patients might present differently early in the illness. Method: In a hospital-based retrospective observational study, we assessed 48 probable bvFTD patients, diagnosed according to the FTDC criteria, for the speed with which these criteria were fulfilled, the frequency of individual symptoms and their order of appearance during the illness. Results: Most of our patients presented with moderate to severe dementia, in spite of having relatively short onset to diagnosis times. Patients on average took 1.4 years from onset to meet the FTDC criteria, with 90% of them presenting with four or more symptoms at diagnosis. Disinhibition was the commonest symptom and the first symptom in most patients. Conclusion: With most patients presenting with advanced and florid disease, the FTDC criteria have little additional impact in early identification of bvFTD in India. Modifying the criteria further could allow detection of Indian patients early enough for their inclusion in future clinical trials.	[Ghosh, Amitabha] Apollo Gleneagles Hosp, Dept Neurol, Kolkata, India; Apollo Gleneagles Hosp, Cognit Neurol Unit, Kolkata, India		Ghosh, A (corresponding author), Apollo Gleneagles Hosp, Dept Neurol, Kolkata, India.	amitabha.ghosh@yahoo.co.in						Blair M, 2007, DEMENT GERIATR COGN, V23, P406, DOI 10.1159/000101908; Borroni B, 2008, EUR J NEUROL, V15, P1412, DOI 10.1111/j.1468-1331.2008.02338.x; Chow TW, 2006, DEMENT GERIATR COGN, V22, P194, DOI 10.1159/000094870; Das G, 2013, PARKINSONISM RELAT D, V19, P487, DOI 10.1016/j.parkreldis.2012.11.015; Das SK, 2006, NEUROL ASIA, V199, P37; Dua T, 2012, DEMENTIA PUBLIC HLTH; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Garcin B, 2009, NEUROLOGY, V73, P1656, DOI 10.1212/WNL.0b013e3181c1dee7; Ghosh A, 2013, J NEUROL, V260, P861, DOI 10.1007/s00415-012-6722-0; Ghosh A, 2010, J NEUROL NEUROSUR PS, V81, P154, DOI 10.1136/jnnp.2008.160416; Heaton R.K., 1993, WISCONSIN CARD SORTI; Hokoishi K, 2001, DEMENT GERIATR COGN, V12, P393, DOI 10.1159/000051286; Ikeda M, 2004, DEMENT GERIATR COGN, V17, P265, DOI 10.1159/000077151; Jeong Y, 2005, J NUCL MED, V46, P233; Josephs KA, 2011, BRAIN, V134, P432, DOI 10.1093/brain/awq348; Krueger CE, 2010, ALZ DIS ASSOC DIS, V24, P43, DOI 10.1097/WAD.0b013e3181a6f101; Le Ber I, 2006, BRAIN, V129, P3051, DOI 10.1093/brain/awl288; McNeill R, 2007, J NEUROL NEUROSUR PS, V78, P350, DOI 10.1136/jnnp.2006.106054; Mendez MF, 2007, ARCH NEUROL-CHICAGO, V64, P830, DOI 10.1001/archneur.64.6.830; Mendez MF, 2002, J NEUROPSYCH CLIN N, V14, P424, DOI 10.1176/appi.neuropsych.14.4.424; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Neary D, 1998, NEUROLOGY, V51, P1546, DOI 10.1212/WNL.51.6.1546; Papatriantafyllou JD, 2009, ALZ DIS ASSOC DIS, V23, P77, DOI 10.1097/WAD.0b013e318182d874; Pasquier F, 1999, DEMENT GERIATR COGN, V10, P10, DOI 10.1159/000051206; Pasquier F, 2004, DEMENT GERIATR COGN, V17, P253, DOI 10.1159/000077148; Piguet O, 2009, NEUROLOGY, V72, P732, DOI 10.1212/01.wnl.0000343004.98599.45; Pijnenburg YAL, 2008, DEMENT GERIATR COGN, V25, P157, DOI 10.1159/000112852; Rao S.L., 2004, NIMHANS NEUROPSYCHOL; Rascovsky K, 2005, NEUROLOGY, V65, P397, DOI 10.1212/01.wnl.0000171343.43314.6e; Rascovsky K, 2011, BRAIN, V134, P2456, DOI 10.1093/brain/awr179; Ratnavalli E, 2002, NEUROLOGY, V58, P1615, DOI 10.1212/WNL.58.11.1615; Ren Ru-Jing, 2012, Int J Alzheimers Dis, V2012, P587215, DOI 10.1155/2012/587215; Roberson ED, 2005, NEUROLOGY, V65, P719, DOI 10.1212/01.wnl.0000173837.82820.9f; Rohrer JD, 2009, NEUROLOGY, V73, P1451, DOI 10.1212/WNL.0b013e3181bf997a; Sheng B, 2009, INT PSYCHOGERIATR, V21, P392, DOI 10.1017/S104161020800817X; Shimomura T, 1998, LANCET, V352, P623, DOI 10.1016/S0140-6736(05)79578-7; Shinagawa S, 2009, J NEUROL NEUROSUR PS, V80, P1413, DOI 10.1136/jnnp.2008.165332; Srikanth S, 2005, J NEUROL SCI, V236, P43, DOI 10.1016/j.jns.2005.04.014; Stevens M, 1998, NEUROLOGY, V50, P1541, DOI 10.1212/WNL.50.6.1541; Wada-Isoe K, 2012, DEMENT GER COGN D EX, V2, P381, DOI 10.1159/000342972	40	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2013	8	4							e60999	10.1371/journal.pone.0060999	http://dx.doi.org/10.1371/journal.pone.0060999			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125TD	23596513	Green Published, gold, Green Submitted			2022-12-25	WOS:000317563300014
J	Gu, C; Liu, QZ; Yang, YN; Zhang, SJ; Khan, MA; Wu, J; Zhang, SL				Gu, Chao; Liu, Qing-Zhong; Yang, Ya-Nan; Zhang, Shu-Jun; Khan, Muhammad Awais; Wu, Jun; Zhang, Shao-Ling			Inheritance of Hetero-Diploid Pollen S-Haplotype in Self-Compatible Tetraploid Chinese Cherry (Prunus pseudocerasus Lindl)	PLOS ONE			English	Article							F-BOX GENE; MULTIPLE SEQUENCE ALIGNMENT; PRIMARY STRUCTURAL FEATURES; NICOTIANA-ALATA; SOUR CHERRY; SWEET CHERRY; TUBE GROWTH; MOLECULAR CHARACTERIZATION; INCOMPATIBILITY ALLELES; PART MUTATION	The breakdown of self-incompatibility, which could result from the accumulation of non-functional S-haplotypes or competitive interaction between two different functional S-haplotypes, has been studied extensively at the molecular level in tetraploid Rosaceae species. In this study, two tetraploid Chinese cherry (Prunus pseudocerasus) cultivars and one diploid sweet cherry (Prunus avium) cultivar were used to investigate the ploidy of pollen grains and inheritance of pollen-S alleles. Genetic analysis of the S-genotypes of two intercross-pollinated progenies showed that the pollen grains derived from Chinese cherry cultivars were hetero-diploid, and that the two S-haplotypes were made up of every combination of two of the four possible S-haplotypes. Moreover, the distributions of single S-haplotypes expressed in self-and intercross-pollinated progenies were in disequilibrium. The number of individuals of the two different S-haplotypes was unequal in two self-pollinated and two intercross-pollinated progenies. Notably, the number of individuals containing two different S-haplotypes (S-1- and S-5-, S-5- and S-8-, S-1- and S-4- haplotype) was larger than that of other individuals in the two self-pollinated progenies, indicating that some of these hetero-diploid pollen grains may have the capability to inactivate stylar S-RNase inside the pollen tube and grow better into the ovaries.	[Gu, Chao; Yang, Ya-Nan; Zhang, Shu-Jun; Wu, Jun; Zhang, Shao-Ling] Nanjing Agr Univ, Coll Hort, Nanjing, Jiangsu, Peoples R China; [Gu, Chao] Chinese Acad Sci, Wuhan Bot Garden, Key Lab Plant Germplasm Enhancement & Specialty A, Wuhan, Hubei, Peoples R China; [Liu, Qing-Zhong] Pomol Inst Shandong, Key Lab Fruit Biotechnol Breeding Shandong, Tai An, Shandong, Peoples R China; [Khan, Muhammad Awais] Univ Illinois, Dept Nat Resource & Environm Sci, Urbana, IL USA	Nanjing Agricultural University; Chinese Academy of Sciences; Wuhan Botanical Garden, CAS; University of Illinois System; University of Illinois Urbana-Champaign	Wu, J (corresponding author), Nanjing Agr Univ, Coll Hort, Nanjing, Jiangsu, Peoples R China.	wujun@njau.edu.cn; slzhang@njau.edu.cn		Khan, Muhammad Awais/0000-0002-0424-7727; zhang, shaoling/0000-0002-1835-1824; Gu, Chao/0000-0002-4381-6910	National Natural Science Foundation of China [31071759, 31201604]; National Department Public Benefit Research Foundation [2009030044]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Department Public Benefit Research Foundation	This work was supported by the National Natural Science Foundation of China (31071759 and 31201604) and the National Department Public Benefit Research Foundation (2009030044). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON MA, 1986, NATURE, V321, P38, DOI 10.1038/321038a0; Boskovic RI, 2006, THEOR APPL GENET, V112, P315, DOI 10.1007/s00122-005-0130-0; BREWBAKER JL, 1954, GENETICS, V39, P307; BREWBAKER JL, 1960, GENETICS, V45, P699; Chawla B, 1997, THEOR APPL GENET, V95, P992, DOI 10.1007/s001220050652; Crane MB, 1942, J GENET, V43, P31, DOI 10.1007/BF02982745; De Nettancourt D, 1974, POLYPLOIDY INDUCED M, P77; de Nettancourt D., 1977, INCOMPATIBILITY ANGI; Deshaies RJ, 1999, ANNU REV CELL DEV BI, V15, P435, DOI 10.1146/annurev.cellbio.15.1.435; Goldraij A, 2006, NATURE, V439, P805, DOI 10.1038/nature04491; Golz JF, 1999, GENETICS, V152, P1123; Golz JF, 2000, ANN BOT-LONDON, V85, P95, DOI 10.1006/anbo.1999.1060; Gu C, 2010, TREE GENET GENOMES, V6, P579, DOI 10.1007/s11295-010-0273-2; Hauck NR, 2006, J HERED, V97, P514, DOI 10.1093/jhered/esl029; Hauck NR, 2006, GENETICS, V172, P1191, DOI 10.1534/genetics.105.049395; Hauck NR, 2002, SEX PLANT REPROD, V15, P39, DOI 10.1007/s00497-002-0136-6; Herrero M, 1996, SEX PLANT REPROD, V9, P343, DOI 10.1007/BF02441953; Huang SX, 2008, PLANT CELL REP, V27, P1075, DOI 10.1007/s00299-008-0528-7; HULSKAMP M, 1995, PLANT CELL, V7, P57, DOI 10.1105/tpc.7.1.57; Ikeda K, 2005, SEX PLANT REPROD, V17, P289, DOI 10.1007/s00497-004-0240-x; Ikeda K, 2004, SEX PLANT REPROD, V16, P235, DOI 10.1007/s00497-003-0200-x; Kao TH, 2004, PLANT CELL, V16, pS72, DOI 10.1105/tpc.016154; Lai Z, 2002, PLANT MOL BIOL, V50, P29, DOI 10.1023/A:1016050018779; LEWIS D, 1947, HEREDITY, V1, P85, DOI 10.1038/hdy.1947.5; Marchese A, 2007, J EXP BOT, V58, P4347, DOI 10.1093/jxb/erm322; MCCLURE BA, 1990, NATURE, V347, P757, DOI 10.1038/347757a0; MCCLURE BA, 1989, NATURE, V342, P955, DOI 10.1038/342955a0; Moriya Y, 2007, PLANT CELL REP, V26, P345, DOI 10.1007/s00299-006-0254-y; Nettancourt, 2001, INCOMPATIBILITY INCO; Okada K, 2008, PLANT MOL BIOL, V66, P389, DOI 10.1007/s11103-007-9277-1; PANDEY KK, 1968, GENETICA, V39, P257, DOI 10.1007/BF02324469; PANDEY KK, 1965, NATURE, V206, P792, DOI 10.1038/206792a0; Qi Bi shu, 2000, J AGR U HEBEI, V23, P49; Qi YJ, 2011, TREE GENET GENOMES, V7, P685, DOI 10.1007/s11295-011-0366-6; Qiao H, 2004, PLANT CELL, V16, P2307, DOI 10.1105/tpc.104.024919; Qu HY, 2007, NEW PHYTOL, V174, P524, DOI 10.1111/j.1469-8137.2007.02069.x; ROYO J, 1994, P NATL ACAD SCI USA, V91, P6511, DOI 10.1073/pnas.91.14.6511; Sanzol J, 2009, PLANT CELL REP, V28, P457, DOI 10.1007/s00299-008-0645-3; Sassa H, 1996, MOL GEN GENET, V250, P547; Sassa H, 2010, SEX PLANT REPROD, V23, P39, DOI 10.1007/s00497-009-0111-6; Shen D, 1996, FRUIT TREE THREMMATO, P142; Sijacic P, 2004, NATURE, V429, P302, DOI 10.1038/nature02523; Singh DP, 2002, PLANT CELL, V14, P3133, DOI 10.1105/tpc.003046; Sonneveld T, 2005, PLANT CELL, V17, P37, DOI 10.1105/tpc.104.026963; Sonneveld T, 2001, THEOR APPL GENET, V102, P1046, DOI 10.1007/s001220000525; Stout AB, 1942, SCIENCE, V96, P257, DOI 10.1126/science.96.2489.257-a; Tao R, 1997, PLANT CELL PHYSIOL, V38, P304, DOI 10.1093/oxfordjournals.pcp.a029167; Tao R, 1999, J AM SOC HORTIC SCI, V124, P224, DOI 10.21273/JASHS.124.3.224; Tao R, 2007, PLANT MOL BIOL, V63, P109, DOI 10.1007/s11103-006-9076-0; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; THOMPSON KF, 1972, HEREDITY, V28, P1, DOI 10.1038/hdy.1972.1; Tsukamoto T, 2005, PLANT MOL BIOL, V57, P141, DOI 10.1007/s11103-004-6852-6; Tsukamoto T, 2008, J EXP BOT, V59, P3169, DOI 10.1093/jxb/ern172; Tsukamoto T, 2006, PLANT MOL BIOL, V62, P371, DOI 10.1007/s11103-006-9026-x; Ushijima K, 1998, MOL GEN GENET, V260, P261, DOI 10.1007/s004380050894; Ushijima K, 2004, PLANT J, V39, P573, DOI 10.1111/j.1365-313X.2004.02154.x; Ushijima K, 2003, PLANT CELL, V15, P771, DOI 10.1105/tpc.009290; Vilanova S, 2006, PLANT PHYSIOL, V142, P629, DOI 10.1104/pp.106.083865; Wang Y, 2003, PLANT MOL BIOL, V53, P565, DOI 10.1023/B:PLAN.0000019068.00034.09; Wolters-Arts M, 1998, NATURE, V392, P818, DOI 10.1038/33929; Wu J, 2009, J HORTIC SCI BIOTECH, V84, P645, DOI 10.1080/14620316.2009.11512580; Wu J, 2011, SEX PLANT REPROD, V24, P23, DOI 10.1007/s00497-010-0148-6; Wu JY, 2010, PLANT J, V63, P1042, DOI 10.1111/j.1365-313X.2010.04301.x; Wunsch A, 2004, SEX PLANT REPROD, V17, P203, DOI 10.1007/s00497-004-0234-8; Xue YB, 1996, PLANT CELL, V8, P805, DOI 10.1105/tpc.8.5.805; Zhang SL, 2007, SEX PLANT REPROD, V20, P1, DOI 10.1007/s00497-006-0037-1	67	9	9	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2013	8	4							e61219	10.1371/journal.pone.0061219	http://dx.doi.org/10.1371/journal.pone.0061219			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125TD	23596519	Green Submitted, Green Published, gold			2022-12-25	WOS:000317563300025
J	Vaudo, JJ; Heithaus, MR				Vaudo, Jeremy J.; Heithaus, Michael R.			Microhabitat Selection by Marine Mesoconsumers in a Thermally Heterogeneous Habitat: Behavioral Thermoregulation or Avoiding Predation Risk?	PLOS ONE			English	Article							JUVENILE LEMON SHARKS; TOP-PREDATOR; TIGER SHARK; NEGAPRION-BREVIROSTRIS; SUBTROPICAL EMBAYMENT; VERTICAL MIGRATION; GALEOCERDO-CUVIER; SEA-TURTLES; GROWTH; TEMPERATURE	Habitat selection decisions by consumers has the potential to shape ecosystems. Understanding the factors that influence habitat selection is therefore critical to understanding ecosystem function. This is especially true of mesoconsumers because they provide the link between upper and lower tropic levels. We examined the factors influencing microhabitat selection of marine mesoconsumers - juvenile giant shovelnose rays (Glaucostegus typus), reticulate whiprays (Himantura uarnak), and pink whiprays (H. fai) - in a coastal ecosystem with intact predator and prey populations and marked spatial and temporal thermal heterogeneity. Using a combination of belt transects and data on water temperature, tidal height, prey abundance, predator abundance and ray behavior, we found that giant shovelnose rays and reticulate whiprays were most often found resting in nearshore microhabitats, especially at low tidal heights during the warm season. Microhabitat selection did not match predictions derived from distributions of prey. Although at a course scale, ray distributions appeared to match predictions of behavioral thermoregulation theory, fine-scale examination revealed a mismatch. The selection of the shallow nearshore microhabitat at low tidal heights during periods of high predator abundance (warm season) suggests that this microhabitat may serve as a refuge, although it may come with metabolic costs due to higher temperatures. The results of this study highlight the importance of predators in the habitat selection decisions of mesoconsumers and that within thermal gradients, factors, such as predation risk, must be considered in addition to behavioral thermoregulation to explain habitat selection decisions. Furthermore, increasing water temperatures predicted by climate change may result in complex trade-offs that might have important implications for ecosystem dynamics.	[Vaudo, Jeremy J.; Heithaus, Michael R.] Florida Int Univ, Dept Biol Sci, North Miami, FL USA	State University System of Florida; Florida International University	Vaudo, JJ (corresponding author), Florida Int Univ, Dept Biol Sci, North Miami, FL USA.	jeremy.vaudo@fiu.edu	Heithaus, Michael/AAF-9914-2020	Heithaus, Michael/0000-0002-3219-1003	Presidential Fellowship from Florida International University; Dissertation Year Fellowship from Florida International University; National Geographic Expeditions Council; National Science Foundation [OCE0526065, OCE0745606]; Florida International University's College of Arts and Sciences; Directorate For Geosciences [0745606] Funding Source: National Science Foundation	Presidential Fellowship from Florida International University; Dissertation Year Fellowship from Florida International University; National Geographic Expeditions Council; National Science Foundation(National Science Foundation (NSF)); Florida International University's College of Arts and Sciences; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This project was funded by a Presidential Fellowship and Dissertation Year Fellowship from Florida International University to JJV, a grant from the National Geographic Expeditions Council to JJV, National Science Foundation grants OCE0526065 and OCE0745606 to MRH, and Florida International University's College of Arts and Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramsky Z, 2005, J ANIM ECOL, V74, P567, DOI 10.1111/j.1365-2656.2005.00956.x; ADOLPH SC, 1990, ECOLOGY, V71, P315, DOI 10.2307/1940271; ANDREN H, 1990, ECOLOGY, V71, P1796, DOI 10.2307/1937587; Armstrong MP, 1997, FISH B-NOAA, V95, P414; Barletta M, 2005, J FISH BIOL, V66, P45, DOI 10.1111/j.0022-1112.2005.00582.x; Barton BT, 2009, ECOL LETT, V12, P1317, DOI 10.1111/j.1461-0248.2009.01386.x; Barton BT, 2009, ECOLOGY, V90, P2346, DOI 10.1890/08-2254.1; Black R., 1990, P245; BREWER DT, 1995, ESTUAR COAST SHELF S, V40, P577, DOI 10.1006/ecss.1995.0039; Brown BR, 2003, NATURE, V421, P495, DOI 10.1038/421495a; Brown JS, 2004, ECOL LETT, V7, P999, DOI 10.1111/j.1461-0248.2004.00661.x; Burkholder DA, J ANIM ECOL; Bush A, 2002, J EXP MAR BIOL ECOL, V278, P157, DOI 10.1016/S0022-0981(02)00332-5; Carlson JK, 2012, J FISH BIOL, V80, P1749, DOI 10.1111/j.1095-8649.2011.03193.x; Claramunt RM, 2005, T AM FISH SOC, V134, P1048, DOI 10.1577/T04-075.1; CORTES E, 1992, ENVIRON BIOL FISH, V35, P205, DOI 10.1007/BF00002195; Creel S, 2007, SCIENCE, V315, P960, DOI 10.1126/science.1135918; Di Santo V, 2011, J FISH BIOL, V78, P195, DOI 10.1111/j.1095-8649.2010.02853.x; Diaz JA, 2005, HERPETOL J, V15, P295; Diaz RJ, 2008, SCIENCE, V321, P926, DOI 10.1126/science.1156401; Dowd WW, 2006, FISH B-NOAA, V104, P323; DUNHAM AE, 1989, PHYSIOL ZOOL, V62, P335, DOI 10.1086/physzool.62.2.30156174; Eby LA, 2002, CAN J FISH AQUAT SCI, V59, P952, DOI 10.1139/F02-067; Economakis AE, 1998, ENVIRON BIOL FISH, V51, P129, DOI 10.1023/A:1007416813214; Eklov P, 1997, CAN J FISH AQUAT SCI, V54, P1520, DOI 10.1139/cjfas-54-7-1520; Ferretti F, 2010, ECOL LETT, V13, P1055, DOI 10.1111/j.1461-0248.2010.01489.x; Frisk MG, 2008, ECOL APPL, V18, P234, DOI 10.1890/06-1392.1; HARRIS JE, 1952, J MAR BIOL ASSOC UK, V31, P269, DOI 10.1017/S002531540005298X; Harter SL, 2006, ESTUAR COAST, V29, P318, DOI 10.1007/BF02782000; Heithaus MR, 2007, ISR J ECOL EVOL, V53, P355, DOI 10.1560/IJEE.53.3.355; Heithaus MR, 2008, TRENDS ECOL EVOL, V23, P202, DOI 10.1016/j.tree.2008.01.003; Heithaus MR, 2007, J ANIM ECOL, V76, P837, DOI 10.1111/j.1365-2656.2007.01260.x; Heithaus MR, 2012, MAR FRESHWATER RES, V63, P1039, DOI 10.1071/MF12024; Heithaus MR, 2009, LIMNOL OCEANOGR, V54, P472, DOI 10.4319/lo.2009.54.2.0472; Herczeg G, 2008, OECOLOGIA, V155, P1, DOI 10.1007/s00442-007-0886-9; Hight BV, 2007, J EXP MAR BIOL ECOL, V352, P114, DOI 10.1016/j.jembe.2007.07.021; Hofmann N, 2003, J FISH BIOL, V63, P1295, DOI 10.1046/j.1095-8649.2003.00252.x; HUEY RB, 1976, Q REV BIOL, V51, P363, DOI 10.1086/409470; Hutto R.L., 1985, P455; Last PR, 2009, SHARKS RAYS AUSTR; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Lotze HK, 2006, SCIENCE, V312, P1806, DOI 10.1126/science.1128035; Matern SA, 2000, ENVIRON BIOL FISH, V58, P173, DOI 10.1023/A:1007625212099; MCLAREN IA, 1963, J FISH RES BOARD CAN, V20, P685, DOI 10.1139/f63-046; MITTELBACH G, 1986, ENVIRON BIOL FISH, V16, P159, DOI 10.1007/BF00005168; Morris DW, 2003, OECOLOGIA, V136, P1, DOI 10.1007/s00442-003-1241-4; MORRISSEY JF, 1993, ENVIRON BIOL FISH, V38, P311, DOI 10.1007/BF00007524; Mull CG, 2010, GEN COMP ENDOCR, V166, P379, DOI 10.1016/j.ygcen.2009.12.009; Myers RA, 2007, SCIENCE, V315, P1846, DOI 10.1126/science.1138657; Nelson EH, 2004, ECOLOGY, V85, P1853, DOI 10.1890/03-3109; PAINE RT, 1966, AM NAT, V100, P65, DOI 10.1086/282400; Papastamatiou YP, 2009, ECOLOGY, V90, P996, DOI 10.1890/08-0491.1; Rahmstorf S, 2007, SCIENCE, V316, P709, DOI 10.1126/science.1136843; Ripple WJ, 2004, BIOSCIENCE, V54, P755, DOI 10.1641/0006-3568(2004)054[0755:WATEOF]2.0.CO;2; Ritchie EG, 2009, ECOL LETT, V12, P982, DOI 10.1111/j.1461-0248.2009.01347.x; SALINI JP, 1990, MAR BIOL, V105, P363, DOI 10.1007/BF01316307; Saoud IP, 2008, AQUAC RES, V39, P491, DOI 10.1111/j.1365-2109.2007.01903.x; Schofield G, 2009, J ANIM ECOL, V78, P14, DOI 10.1111/j.1365-2656.2008.01454.x; Semeniuk CAD, 2006, ETHOLOGY, V112, P33, DOI 10.1111/j.1439-0310.2006.01108.x; Semeniuk CAD, 2005, BEHAV ECOL, V16, P417, DOI 10.1093/beheco/ari005; Simpfendorfer CA, 2001, ENVIRON BIOL FISH, V61, P37, DOI 10.1023/A:1011021710183; Sims DW, 2006, J ANIM ECOL, V75, P176, DOI 10.1111/j.1365-2656.2005.01033.x; Sims DW, 1996, J MAR BIOL ASSOC UK, V76, P479, DOI 10.1017/S002531540003068X; Speed CW, 2012, MAR ECOL PROG SER, V463, P231, DOI 10.3354/meps09864; Stephens D.W., 1986, pi; STEVENS JD, 1989, AUST J MAR FRESH RES, V40, P129; VANBLARICOM GR, 1982, ECOL MONOGR, V52, P283, DOI 10.2307/2937332; Vaudo JJ, 2011, MAR ECOL PROG SER, V425, P247, DOI 10.3354/meps08988; Vaudo JJ, 2009, MAR BIOL, V156, P2579, DOI 10.1007/s00227-009-1282-2; Wallman HL, 2006, ENVIRON BIOL FISH, V75, P259, DOI 10.1007/s10641-006-0025-1; Ward AJW, 2010, J FISH BIOL, V76, P2287, DOI 10.1111/j.1095-8649.2010.02576.x; Wearmouth VJ, 2012, ECOL MONOGR, V82, P351, DOI 10.1890/11-2052.1; Webb JK, 2005, OIKOS, V110, P515, DOI 10.1111/j.0030-1299.2005.13722.x; WELLS F E, 1985, Records of the Western Australian Museum, V12, P47; WERNER EE, 1979, ECOLOGY, V60, P256, DOI 10.2307/1937653; Wetherbee BM, 2007, MAR ECOL PROG SER, V343, P283, DOI 10.3354/meps06920; White WT, 2004, MAR BIOL, V144, P439, DOI 10.1007/s00227-003-1218-1; WIEDERHOLM AM, 1987, OIKOS, V48, P28, DOI 10.2307/3565684; Wirsing AJ, 2008, MAR MAMMAL SCI, V24, P1, DOI 10.1111/j.1748-7692.2007.00167.x; Wirsing AJ, 2006, MAR BIOL, V149, P961, DOI 10.1007/s00227-006-0278-4; WURTSBAUGH WA, 1988, NATURE, V333, P846, DOI 10.1038/333846a0	81	23	23	1	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2013	8	4							e61907	10.1371/journal.pone.0061907	http://dx.doi.org/10.1371/journal.pone.0061907			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123JP	23593501	gold, Green Published, Green Submitted			2022-12-25	WOS:000317385300087
J	Yano, M; Yamamoto, T; Nishimura, N; Gotoh, T; Watanabe, K; Ikeda, K; Garan, Y; Taguchi, R; Node, K; Okazaki, T; Oike, Y				Yano, Masato; Yamamoto, Tadashi; Nishimura, Naotaka; Gotoh, Tomomi; Watanabe, Ken; Ikeda, Kazutaka; Garan, Yohei; Taguchi, Ryo; Node, Koichi; Okazaki, Toshiro; Oike, Yuichi			Increased Oxidative Stress Impairs Adipose Tissue Function in Sphingomyelin Synthase 1 Null Mice	PLOS ONE			English	Article							CELLULAR-RESPONSES; LIPID RAFTS; CERAMIDE; PROTEIN; DEFICIENCY; APOPTOSIS; MITOCHONDRIA; TRAFFICKING; ADIPOCYTES; METABOLISM	Sphingomyelin synthase 1 (SMS1) catalyzes the conversion of ceramide to sphingomyelin. Here, we found that SMS1 null mice showed lipodystrophic phenotype. Mutant mice showed up-regulation of plasma triglyceride concentrations accompanied by reduction of white adipose tissue (WAT) as they aged. Lipoprotein lipase (LPL) activity was severely reduced in mutant mice. In vivo analysis indicated that fatty acid uptake in WAT but not in liver decreased in SMS1 null compared to wild-type mice. In vitro analysis using cultured cell revealed that SMS1 depletion reduced fatty acid uptake. Proteins extracted from WAT of mutant mice were severely modified by oxidative stress, and up-regulation of mRNAs related to apoptosis, redox adjustment, mitochondrial stress response and mitochondrial biogenesis was observed. ATP content of WAT was reduced in SMS1 null mice. Blue native gel analysis indicated that accumulation of mitochondrial respiratory chain complexes was reduced. These results suggest that WAT of SMS1 null mice is severely damaged by oxidative stress and barely functional. Indeed, mutant mice treated with the anti-oxidant N-acetyl cysteine (NAC) showed partial recovery of lipodystrophic phenotypes together with normalized plasma triglyceride concentrations. Altogether, our data suggest that SMS1 is crucial to control oxidative stress in order to maintain WAT function.	[Yano, Masato; Yamamoto, Tadashi; Nishimura, Naotaka; Gotoh, Tomomi; Garan, Yohei; Oike, Yuichi] Kumamoto Univ, Fac Life Sci, Dept Mol Genet, Kumamoto, Japan; [Yamamoto, Tadashi; Node, Koichi] Saga Univ, Dept Cardiovasc Med, Saga 840, Japan; [Watanabe, Ken] Natl Ctr Geriatr & Gerontol, Dept Bone & Joint Dis, Tokyo, Japan; [Ikeda, Kazutaka; Taguchi, Ryo] Univ Tokyo, Grad Sch Med, Dept Metabolome, Tokyo, Japan; [Ikeda, Kazutaka; Taguchi, Ryo] CREST, JST, Tokyo, Japan; [Okazaki, Toshiro] Tottori Univ, Fac Med, Div Clin Lab Med & Hematol Oncol, Tottori 680, Japan	Kumamoto University; Saga University; National Center for Geriatrics & Gerontology; University of Tokyo; Japan Science & Technology Agency (JST); Tottori University	Yano, M (corresponding author), Kumamoto Univ, Fac Life Sci, Dept Mol Genet, Kumamoto, Japan.	myano@gpo.kumamoto-u.ac.jp; oike@gpo.kumamoto-u.ac.jp	Watanabe, Ken/I-3960-2013	Watanabe, Ken/0000-0003-0664-3915	Ministry of Education, Science, Technology, Sports and Culture of Japan [19790215, 23590340, 22116009]; Japan Society for the Promotion of Science [22659156]; Takeda Science Foundation; Inamori Foundation	Ministry of Education, Science, Technology, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takeda Science Foundation(Takeda Science Foundation (TSF)); Inamori Foundation	This work was supported by grants-in-aid 19790215 (to MY) and 23590340 (to MY), and 22116009 (to YO) from the Ministry of Education, Science, Technology, Sports and Culture of Japan, by a grant-in-aid 22659156 (to YO) from the Japan Society for the Promotion of Science, and by grants-in-aid from the Takeda Science Foundation (to MY) and Inamori Foundation (to MY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldridge JE, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000874; Alvarez SE, 2007, TRENDS ENDOCRIN MET, V18, P300, DOI 10.1016/j.tem.2007.07.005; Baker BM, 2011, TRENDS BIOCHEM SCI, V36, P254, DOI 10.1016/j.tibs.2011.01.004; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Choksi KB, 2004, BBA-MOL BASIS DIS, V1688, P95, DOI 10.1016/j.bbadis.2003.11.007; Dabbeni-Sala F, 2001, FASEB J, V15, P164, DOI 10.1096/fj.00-0129com; Dong LL, 2012, INT IMMUNOL, V24, P327, DOI 10.1093/intimm/dxs008; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; Fajas L, 1998, CURR OPIN CELL BIOL, V10, P165, DOI 10.1016/S0955-0674(98)80138-5; Futerman AH, 2004, EMBO REP, V5, P777, DOI 10.1038/sj.embor.7400208; Fyrst H, 2010, NAT CHEM BIOL, V6, P489, DOI [10.1038/NCHEMBIO.392, 10.1038/nchembio.392]; Garg A, 2009, BBA-MOL CELL BIOL L, V1791, P507, DOI 10.1016/j.bbalip.2008.12.014; Grimsrud PA, 2008, J BIOL CHEM, V283, P21837, DOI 10.1074/jbc.R700019200; Hailemariam TK, 2008, ARTERIOSCL THROM VAS, V28, P1519, DOI 10.1161/ATVBAHA.108.168682; Hanada K, 2003, NATURE, V426, P803, DOI 10.1038/nature02188; Hanada K, 2009, BBA-MOL CELL BIOL L, V1791, P684, DOI 10.1016/j.bbalip.2009.01.006; Hannun YA, 2002, J BIOL CHEM, V277, P25847, DOI 10.1074/jbc.R200008200; Hannun YA, 1996, SCIENCE, V274, P1855, DOI 10.1126/science.274.5294.1855; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Haughey NJ, 2010, BBA-MOL CELL BIOL L, V1801, P878, DOI 10.1016/j.bbalip.2010.05.003; Ikeda K, 2009, J CHROMATOGR B, V877, P2639, DOI 10.1016/j.jchromb.2009.03.047; Klemm DJ, 2001, J BIOL CHEM, V276, P28430, DOI 10.1074/jbc.M103382200; Lefterova MI, 2009, TRENDS ENDOCRIN MET, V20, P107, DOI 10.1016/j.tem.2008.11.005; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Liu J, 2009, CIRC RES, V105, P295, DOI 10.1161/CIRCRESAHA.109.194613; Lu MH, 2012, J PHYSIOL-LONDON, V590, P4029, DOI 10.1113/jphysiol.2012.235846; Mao CG, 2008, BBA-MOL CELL BIOL L, V1781, P424, DOI 10.1016/j.bbalip.2008.06.002; Menaldino DS, 2003, PHARMACOL RES, V47, P373, DOI 10.1016/S1043-6618(03)00054-9; Milhas D, 2010, FEBS LETT, V584, P1887, DOI 10.1016/j.febslet.2009.10.058; Mitsutake S, 2011, J BIOL CHEM, V286, P28544, DOI 10.1074/jbc.M111.255646; Miyaji M, 2005, J EXP MED, V202, P249, DOI 10.1084/jem.20041685; Nunes AF, 2005, FASEB J, V19, P166, DOI 10.1096/fj.05-4106fje; Oike Y, 2005, NAT MED, V11, P400, DOI 10.1038/nm1214; Park JH, 2006, BBA-BIOMEMBRANES, V1758, P2133, DOI 10.1016/j.bbamem.2006.08.019; Pettus BJ, 2002, BBA-MOL CELL BIOL L, V1585, P114, DOI 10.1016/S1388-1981(02)00331-1; Rao RP, 2007, P NATL ACAD SCI USA, V104, P11364, DOI 10.1073/pnas.0705049104; RICHTER C, 1995, BBA-MOL BASIS DIS, V1271, P67, DOI 10.1016/0925-4439(95)00012-S; Schagger H, 2000, EMBO J, V19, P1777, DOI 10.1093/emboj/19.8.1777; Separovic D, 2008, EXP CELL RES, V314, P1860, DOI 10.1016/j.yexcr.2008.02.008; Simha V, 2009, CURR OPIN LIPIDOL, V20, P300, DOI 10.1097/MOL.0b013e32832d4a33; Simons K, 2010, NAT REV MOL CELL BIO, V11, P688, DOI 10.1038/nrm2977; Singh NR, 2007, FREE RADICAL RES, V41, P1078, DOI 10.1080/10715760701487674; Tafesse FG, 2006, J BIOL CHEM, V281, P29421, DOI 10.1074/jbc.R600021200; Usui S, 2002, J LIPID RES, V43, P805; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Voshol PJ, 2009, BBA-MOL CELL BIOL L, V1791, P479, DOI 10.1016/j.bbalip.2008.12.015; Wang T, 2010, OBESITY, V18, P1493, DOI 10.1038/oby.2009.456; Wang X, 2009, J CELL BIOL, V184, P143, DOI 10.1083/jcb.200807176; White UA, 2010, MOL CELL ENDOCRINOL, V318, P10, DOI 10.1016/j.mce.2009.08.023; Wymann MP, 2008, NAT REV MOL CELL BIO, V9, P162, DOI 10.1038/nrm2335; Yamaoka S, 2004, J BIOL CHEM, V279, P18688, DOI 10.1074/jbc.M401205200; Yano M, 2007, EXP CELL RES, V313, P3767, DOI 10.1016/j.yexcr.2007.07.031; Yano M, 2011, J BIOL CHEM, V286, P3992, DOI 10.1074/jbc.M110.179176; Zeidan YH, 2007, TRENDS MOL MED, V13, P327, DOI 10.1016/j.molmed.2007.06.002; Zheng W, 2006, BBA-BIOMEMBRANES, V1758, P1864, DOI 10.1016/j.bbamem.2006.08.009	55	31	33	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2013	8	4							e61380	10.1371/journal.pone.0061380	http://dx.doi.org/10.1371/journal.pone.0061380			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123JP	23593476	Green Submitted, Green Published, gold			2022-12-25	WOS:000317385300075
J	Jiang, WX; Nakayama, Y; Sequeira, JM; Quadros, EV				Jiang, Wenxia; Nakayama, Yasumi; Sequeira, Jeffrey M.; Quadros, Edward V.			Mapping the functional domains of TCblR/CD320, the receptor for cellular uptake of transcobalamin-bound cobalamin	FASEB JOURNAL			English	Article						vitamin B-12; cytoplasmic domain; calcium-binding domain; LDLR-A; Hek293 cells; Qdots	DENSITY-LIPOPROTEIN RECEPTOR; LIGAND-BINDING DOMAIN; CYSTEINE-RICH REPEAT; MONOCLONAL-ANTIBODIES; VITAMIN B12; PROTEIN RAP; CELLS; 1ST; ENDOCYTOSIS; TRANSPORT	The membrane receptor TCblR/CD320 binds transcobalamin (TC) saturated with vitamin B-12 [cobalamin (Cbl)] and mediates cellular uptake of the vitamin. The specificity of TC for Cbl and of the receptor for TC-Cbl ensures efficient uptake of Cbl into cells. The high-affinity interaction of TCblR with TC-Cbl (K-a=10 nM(-1)) was investigated using deletions and mutations of amino acid sequences in TCblR. Only the extracellular region (aa 32-229) is needed for TC-Cbl binding, but the N-glycosylation sites (N126, N195, and N213) are of no importance for this function. Deleting the cysteine-rich region (aa 95-141) that separates the two low-density lipoprotein receptor type A (LDLR-A) domains does not affect TC-Cbl binding (K-a = 19-24 nM(-1)). The two LDLR-A domains (aa 54-89 and 132-167) with the negatively charged acidic residues involved in Ca2+ binding are critical determinants of ligand binding. The cytoplasmic tail is apparently crucial for internalization of the ligand. Within this region, the RPLGLL motif and the PDZ binding motifs (QERL/KESL) appear to be involved in initiating and completing the process of ligand internalization. Mutations and deletions of these regions involved in binding and internalization of TC-Cbl are likely to produce the biochemical and clinical phenotype of Cbl deficiency.	[Jiang, Wenxia] Suny Downstate Med Ctr, Sch Grad Studies, Brooklyn, NY 11203 USA; [Nakayama, Yasumi; Sequeira, Jeffrey M.; Quadros, Edward V.] Suny Downstate Med Ctr, Dept Med, Brooklyn, NY 11203 USA; [Quadros, Edward V.] Suny Downstate Med Ctr, Dept Cell Biol, Brooklyn, NY 11203 USA	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center	Quadros, EV (corresponding author), Suny Downstate Med Ctr, Box 20,450 Clarkson Ave, Brooklyn, NY 11203 USA.	edward.quadros@downstate.edu			U.S. National Institutes of Health [DK064732]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK064732, R01DK064732] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by U.S. National Institutes of Health grant DK064732 (to E.V.Q.).	AMAGASAKI T, 1990, BLOOD, V76, P1380; Andersen OM, 2000, J BIOL CHEM, V275, P21017, DOI 10.1074/jbc.M000507200; BIERI S, 1995, BIOCHEMISTRY-US, V34, P13059, DOI 10.1021/bi00040a017; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Brown MS, 1997, NATURE, V388, P629, DOI 10.1038/41672; Bu GJ, 2001, INT REV CYTOL, V209, P79; CANNATA JJB, 1965, J BIOL CHEM, V240, P3249; COOPER BA, 1961, NATURE, V191, P393, DOI 10.1038/191393a0; DIGIROLAMO PM, 1975, ARCH BIOCHEM BIOPHYS, V168, P386, DOI 10.1016/0003-9861(75)90267-2; ESSER V, 1988, J BIOL CHEM, V263, P13282; Fass D, 1997, NATURE, V388, P691, DOI 10.1038/41798; Fyfe JC, 2004, BLOOD, V103, P1573, DOI 10.1182/blood-2003-08-2852; HALL CA, 1984, J LAB CLIN MED, V103, P70; Jiang WX, 2011, DRUG DELIV, V18, P74, DOI 10.3109/10717544.2010.509745; Kurniawan ND, 2000, PROTEIN SCI, V9, P1282, DOI 10.1110/ps.9.7.1282; LETOURNEUR F, 1992, CELL, V69, P1143, DOI 10.1016/0092-8674(92)90636-Q; Moestrup SK, 1996, P NATL ACAD SCI USA, V93, P8612, DOI 10.1073/pnas.93.16.8612; Nourry Claire, 2003, Sci STKE, V2003, pRE7; Quadros EV, 2010, HUM MUTAT, V31, P924, DOI 10.1002/humu.21297; Quadros EV, 2009, BLOOD, V113, P186, DOI 10.1182/blood-2008-05-158949; Quadros EV, 2005, BIOCHEM BIOPH RES CO, V327, P1006, DOI 10.1016/j.bbrc.2004.12.103; Quadros EV, 1999, AM J PHYSIOL-GASTR L, V277, pG161, DOI 10.1152/ajpgi.1999.277.1.G161; QUADROS EV, 1994, ARCH BIOCHEM BIOPHYS, V308, P192, DOI 10.1006/abbi.1994.1027; Ratschmann R, 2009, MOL GENET METAB, V98, P285, DOI 10.1016/j.ymgme.2009.06.003; SENNETT C, 1981, ANNU REV BIOCHEM, V50, P1053, DOI 10.1146/annurev.bi.50.070181.005201; VANDRIEL IR, 1987, J BIOL CHEM, V262, P17443; WEISSBACH H, 1966, FED PROC, V25, P1649	27	13	13	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2013	27	8					2988	2994		10.1096/fj.13-230185	http://dx.doi.org/10.1096/fj.13-230185			7	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	292BT	23603833	Green Published			2022-12-25	WOS:000329877600007
J	Varkey, J; Mizuno, N; Hegde, BG; Cheng, NQ; Steven, AC; Langen, R				Varkey, Jobin; Mizuno, Naoko; Hegde, Balachandra G.; Cheng, Naiqian; Steven, Alasdair C.; Langen, Ralf			alpha-Synuclein Oligomers with Broken Helical Conformation Form Lipoprotein Nanoparticles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-DENSITY-LIPOPROTEINS; APOLIPOPROTEIN-A-I; FAMILIAL PARKINSONS-DISEASE; PULSED ESR MEASUREMENTS; FATTY-ACIDS; TRANSGENIC MICE; MEMBRANE INTERACTIONS; UNILAMELLAR VESICLES; HIPPOCAMPAL-NEURONS; SECONDARY STRUCTURE	alpha-Synuclein (alpha S) is a membrane-binding protein with sequence similarity to apolipoproteins and other lipid-carrying proteins, which are capable of forming lipid-containing nanoparticles, sometimes referred to as "discs." Previously, it has been unclear whether alpha S also possesses this property. Using cryo-electron microscopy and light scattering, we found that alpha S can remodel phosphatidylglycerol vesicles into nanoparticles whose shape (ellipsoidal) and dimensions (in the 7-10-nm range) resemble those formed by apolipoproteins. The molar ratio of alpha S to lipid in nanoparticles is similar to 1:20, and alpha S is oligomeric (including trimers and tetramers). Similar nanoparticles form when alpha S is added to vesicles of mitochondrial lipids. This observation suggests a mechanism for the previously reported disruption of mitochondrial membranes by alpha S. Circular dichroism and four-pulse double electron electron resonance experiments revealed that in nanoparticles alpha S assumes a broken helical conformation distinct from the extended helical conformation adopted when alpha S is bound to intact vesicles or membrane tubules. We also observed alpha S-dependent tubule and nanoparticle formation in the presence of oleic acid, implying that alpha S can interact with fatty acids and lipids in a similar manner. alpha S-related nanoparticles might play a role in lipid and fatty acid transport functions previously attributed to this protein.	[Varkey, Jobin; Langen, Ralf] Univ So Calif, Zilkha Neurogenet Inst, Los Angeles, CA 90033 USA; [Mizuno, Naoko] Max Planck Inst Biochem, Dept Struct Cell Biol, D-82152 Martinsried, Germany; [Hegde, Balachandra G.] PES Inst Technol, Bangalore, Karnataka, India; [Mizuno, Naoko; Cheng, Naiqian; Steven, Alasdair C.] NIAMS, Struct Biol Lab, NIH, Bethesda, MD 20892 USA	University of Southern California; Max Planck Society; PES University; National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)	Steven, AC (corresponding author), NIAMS, Struct Biol Lab, NIH, Bethesda, MD 20892 USA.	stevena@mail.nih; langen@usc.edu	Varkey, Jobin/I-5845-2019; Hegde, Balachandra/GPS-6028-2022; Mizuno, Naoko/AAY-1926-2021	Mizuno, Naoko/0000-0002-1594-2821	National Institutes of Health [2 R01 M063915]; Intramural Research Program of the NIAMS; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIAAR041157, ZIAAR027015] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intramural Research Program of the NIAMS; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 2 R01 M063915 (to R. L.) and by the Intramural Research Program of the NIAMS.	Abeliovich A, 2000, NEURON, V25, P239, DOI 10.1016/S0896-6273(00)80886-7; Assayag K, 2007, AM J PATHOL, V171, P2000, DOI 10.2353/ajpath.2007.070373; Auluck PK, 2010, ANNU REV CELL DEV BI, V26, P211, DOI 10.1146/annurev.cellbio.042308.113313; Bartels T, 2011, NATURE, V477, P107, DOI 10.1038/nature10324; Ben Gedalya T, 2009, TRAFFIC, V10, P218, DOI 10.1111/j.1600-0854.2008.00853.x; Beyer K, 2007, CELL BIOCHEM BIOPHYS, V47, P285, DOI 10.1007/s12013-007-0014-9; Bisaglia M, 2009, FASEB J, V23, P329, DOI 10.1096/fj.08-119784; Bodner CR, 2009, J MOL BIOL, V390, P775, DOI 10.1016/j.jmb.2009.05.066; Borbat P, 2006, J AM CHEM SOC, V128, P10004, DOI 10.1021/ja063122l; Brasaemle DL, 2007, J LIPID RES, V48, P2547, DOI 10.1194/jlr.R700014-JLR200; Bulankina AV, 2009, J CELL BIOL, V185, P641, DOI 10.1083/jcb.200812042; Cabin DE, 2002, J NEUROSCI, V22, P8797; Castagnet PI, 2005, J NEUROCHEM, V94, P839, DOI 10.1111/j.1471-4159.2005.03247.x; Catte A, 2006, BIOPHYS J, V90, P4345, DOI 10.1529/biophysj.105.071456; Chiang YW, 2005, J MAGN RESON, V172, P279, DOI 10.1016/j.jmr.2004.10.012; Cole NB, 2002, J BIOL CHEM, V277, P6344, DOI 10.1074/jbc.M108414200; Davidson WS, 2007, J BIOL CHEM, V282, P22249, DOI 10.1074/jbc.R700014200; Davidson WS, 1998, J BIOL CHEM, V273, P9443, DOI 10.1074/jbc.273.16.9443; De Franceschi G, 2011, J BIOL CHEM, V286, P22262, DOI 10.1074/jbc.M110.202937; Der-Sarkissian A, 2003, J BIOL CHEM, V278, P37530, DOI 10.1074/jbc.M305266200; Devi L, 2008, J BIOL CHEM, V283, P9089, DOI 10.1074/jbc.M710012200; DeWitt DC, 2013, BIOCHEMISTRY-US, V52, P2385, DOI 10.1021/bi4002369; Drescher M, 2008, CHEMBIOCHEM, V9, P2411, DOI 10.1002/cbic.200800238; Drescher M, 2008, J AM CHEM SOC, V130, P7796, DOI 10.1021/ja801594s; Drescher M, 2010, J AM CHEM SOC, V132, P4080, DOI 10.1021/ja909247j; Fauvet B, 2012, J BIOL CHEM, V287, P28243, DOI 10.1074/jbc.M112.383711; Fauvet B, 2012, J BIOL CHEM, V287, P15345, DOI 10.1074/jbc.M111.318949; Ferreon ACM, 2009, P NATL ACAD SCI USA, V106, P5645, DOI 10.1073/pnas.0809232106; Fujita Y, 2006, ACTA NEUROPATHOL, V112, P261, DOI 10.1007/s00401-006-0114-4; Georgieva ER, 2008, J AM CHEM SOC, V130, P12856, DOI 10.1021/ja804517m; Golovko MY, 2009, MOL CELL BIOCHEM, V326, P55, DOI 10.1007/s11010-008-0008-y; Golovko MY, 2005, BIOCHEMISTRY-US, V44, P8251, DOI 10.1021/bi0502137; Gosavi N, 2002, J BIOL CHEM, V277, P48984, DOI 10.1074/jbc.M208194200; Gu FF, 2010, J BIOL CHEM, V285, P4652, DOI 10.1074/jbc.M109.069914; Halliday GM, 2005, BRAIN, V128, P2654, DOI 10.1093/brain/awh584; HUANG C, 1978, P NATL ACAD SCI USA, V75, P308, DOI 10.1073/pnas.75.1.308; Ibanez P, 2004, LANCET, V364, P1169, DOI 10.1016/S0140-6736(04)17104-3; IWAI A, 1995, NEURON, V14, P467, DOI 10.1016/0896-6273(95)90302-X; Jao CC, 2004, P NATL ACAD SCI USA, V101, P8331, DOI 10.1073/pnas.0400553101; Jao CC, 2008, P NATL ACAD SCI USA, V105, P19666, DOI 10.1073/pnas.0807826105; Jeschke G, 2006, APPL MAGN RESON, V30, P473, DOI 10.1007/BF03166213; Jones MK, 2011, BIOCHEMISTRY-US, V50, P2249, DOI 10.1021/bi101301g; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Lee MK, 2002, P NATL ACAD SCI USA, V99, P8968, DOI 10.1073/pnas.132197599; Lee SJ, 2008, ACTA NEUROBIOL EXP, V68, P509; Li L, 2004, J MOL BIOL, V343, P1293, DOI 10.1016/j.jmb.2004.09.017; Lokappa SB, 2011, J BIOL CHEM, V286, P21450, DOI 10.1074/jbc.M111.224055; Ludtke SJ, 2010, METHODS MOL BIOL, V673, P157, DOI 10.1007/978-1-60761-842-3_9; Lucke C, 2006, J LIPID RES, V47, P1714, DOI 10.1194/jlr.M600003-JLR200; Martin LJ, 2006, J NEUROSCI, V26, P41, DOI 10.1523/JNEUROSCI.4308-05.2006; Meredith GE, 2002, BRAIN RES, V956, P156, DOI 10.1016/S0006-8993(02)03514-X; Mishra VK, 1998, BIOCHEMISTRY-US, V37, P10313, DOI 10.1021/bi980042o; MISHRA VK, 1995, J BIOL CHEM, V270, P1602, DOI 10.1074/jbc.270.4.1602; Mizuno N, 2012, J BIOL CHEM, V287, P29301, DOI 10.1074/jbc.M112.365817; Murphy DD, 2000, J NEUROSCI, V20, P3214, DOI 10.1523/JNEUROSCI.20-09-03214.2000; Nakamura K., 2013, NEUROTHERAP IN PRESS; Nakamura K, 2011, J BIOL CHEM, V286, P20710, DOI 10.1074/jbc.M110.213538; Nakamura K, 2008, J NEUROSCI, V28, P12305, DOI 10.1523/JNEUROSCI.3088-08.2008; Nemani VM, 2010, NEURON, V65, P66, DOI 10.1016/j.neuron.2009.12.023; Newhouse Y, 2005, ACTA CRYSTALLOGR F, V61, P981, DOI 10.1107/S1744309105032410; Norris EH, 2004, CURR TOP DEV BIOL, V60, P17; Outeiro TF, 2003, SCIENCE, V302, P1772, DOI 10.1126/science.1090439; Pandey AP, 2011, J PHYS CHEM B, V115, P5886, DOI 10.1021/jp1121917; Perrin RJ, 2001, J BIOL CHEM, V276, P41958, DOI 10.1074/jbc.M105022200; Peters-Libeu CA, 2007, J LIPID RES, V48, P1035, DOI 10.1194/jlr.M600545-JLR200; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Rao JN, 2010, J AM CHEM SOC, V132, P8657, DOI 10.1021/ja100646t; SEGREST JP, 1992, J LIPID RES, V33, P141; Shaikh TR, 2008, NAT PROTOC, V3, P1941, DOI 10.1038/nprot.2008.156; Sharon R, 2001, P NATL ACAD SCI USA, V98, P9110, DOI 10.1073/pnas.171300598; Sharon R, 2003, NEURON, V37, P583, DOI 10.1016/S0896-6273(03)00024-2; Sharon R, 2003, J BIOL CHEM, V278, P49874, DOI 10.1074/jbc.M309127200; Silva RAGD, 2008, P NATL ACAD SCI USA, V105, P12176, DOI 10.1073/pnas.0803626105; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Song DD, 2004, EXP NEUROL, V186, P158, DOI 10.1016/S0014-4886(03)00342-X; Stichel CC, 2007, HUM MOL GENET, V16, P2377, DOI 10.1093/hmg/ddm083; TERTOV VV, 1985, BIOCHEM BIOPH RES CO, V128, P1196, DOI 10.1016/0006-291X(85)91067-8; Tofaris GK, 2007, CELL MOL LIFE SCI, V64, P2194, DOI 10.1007/s00018-007-7217-5; Trexler AJ, 2009, BIOCHEMISTRY-US, V48, P2304, DOI 10.1021/bi900114z; Ulmer TS, 2005, J BIOL CHEM, V280, P9595, DOI 10.1074/jbc.M411805200; Uversky VN, 2001, J BIOL CHEM, V276, P44284, DOI 10.1074/jbc.M105343200; Uversky VN, 2002, NEUROTOXICOLOGY, V23, P527, DOI 10.1016/S0161-813X(02)00067-0; Varkey J, 2010, J BIOL CHEM, V285, P32486, DOI 10.1074/jbc.M110.139576; Wang GF, 2010, PROTEIN SCI, V19, P1686, DOI 10.1002/pro.449; Wang WJ, 2011, APPL CATAL B-ENVIRON, V108, P108, DOI 10.1016/j.apcatb.2011.08.015; Weinreb PH, 1996, BIOCHEMISTRY-US, V35, P13709, DOI 10.1021/bi961799n; Westphal CH, 2013, J BIOL CHEM, V288, P1829, DOI 10.1074/jbc.M112.418871; Willingham S, 2003, SCIENCE, V302, P1769, DOI 10.1126/science.1090389; Withers GS, 1997, DEV BRAIN RES, V99, P87, DOI 10.1016/S0165-3806(96)00210-6; Xie WL, 2012, J NEUROCHEM, V122, P404, DOI 10.1111/j.1471-4159.2012.07769.x	90	56	56	1	43	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2013	288	24					17620	17630		10.1074/jbc.M113.476697	http://dx.doi.org/10.1074/jbc.M113.476697			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	164AH	23609437	hybrid, Green Published			2022-12-25	WOS:000320380600053
J	Furuya, F; Shimura, H; Asami, K; Ichijo, S; Takahashi, K; Kaneshige, M; Oikawa, Y; Aida, K; Endo, T; Kobayashi, T				Furuya, Fumihiko; Shimura, Hiroki; Asami, Keiichi; Ichijo, Sayaka; Takahashi, Kazuya; Kaneshige, Masahiro; Oikawa, Yoichi; Aida, Kaoru; Endo, Toyoshi; Kobayashi, Tetsuro			Ligand-bound Thyroid Hormone Receptor Contributes to Reprogramming of Pancreatic Acinar Cells into Insulin-producing Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL-GROWTH-FACTOR; BETA-CELLS; FACTOR-ALPHA; GUINEA-PIG; IN-VITRO; METAMORPHOSIS; ACTIVATION; EXPRESSION; GENE; PROLIFERATION	One goal of diabetic regenerative medicine is to instructively convert mature pancreatic exocrine cells into insulin-producing cells. We recently reported that ligand-bound thyroid hormone receptor alpha (TR alpha) plays a critical role in expansion of the beta-cell mass during postnatal development. Here, we used an adenovirus vector that expresses TR alpha driven by the amylase 2 promoter (AdAmy2TR alpha) to induce the reprogramming of pancreatic acinar cells into insulin-producing cells. Treatment with L-3,5,3-triiodothyronine increases the association of TR alpha with the p85 alpha subunit of phosphatidylinositol 3-kinase (PI3K), leading to the phosphorylation and activation of Akt and the expression of Pdx1, Ngn3, and MafA in purified acinar cells. Analyses performed with the lectin-associated cell lineage tracing system and the Cre/loxP-based direct cell lineage tracing system indicate that newly synthesized insulin-producing cells originate from elastase-expressing pancreatic acinar cells. Insulin-containing secretory granules were identified in these cells by electron microscopy. The inhibition of p85 alpha expression by siRNA or the inhibition of PI3K by LY294002 prevents the expression of Pdx1, Ngn3, and MafA and the reprogramming to insulin-producing cells. In immunodeficient mice with streptozotocin-induced hyperglycemia, treatment with AdAmy2TR alpha leads to the reprogramming of pancreatic acinar cells to insulin-producing cells in vivo. Our findings suggest that ligand-bound TR alpha plays a critical role in beta-cell regeneration during postnatal development via activation of PI3K signaling.	[Furuya, Fumihiko; Asami, Keiichi; Ichijo, Sayaka; Takahashi, Kazuya; Kaneshige, Masahiro; Aida, Kaoru; Endo, Toyoshi; Kobayashi, Tetsuro] Univ Yamanashi, Dept Internal Med 3, Yamanashi 4093898, Japan; [Shimura, Hiroki] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Environm Med, Yamanashi 4093898, Japan; [Oikawa, Yoichi] Saiseikai Cent Hosp, Dept Internal Med, Tokyo 1080073, Japan	University of Yamanashi; University of Yamanashi; Tokyo Saiseikai Central Hospital	Kobayashi, T (corresponding author), 1110 Shimokato,Chou Shi, Yamanashi 4093898, Japan.	tetsurou@yamanashi.ac.jp			The Japan Society for the Promotion of Science (JSPS) KAKENHI [24591359]	The Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by The Japan Society for the Promotion of Science (JSPS) KAKENHI Grant 24591359.	Baeyens L, 2005, DIABETOLOGIA, V48, P49, DOI 10.1007/s00125-004-1606-1; Baeyens L, 2009, GASTROENTEROLOGY, V136, P1750, DOI 10.1053/j.gastro.2009.01.047; BOLLIN E, 1973, DEV BIOL, V31, P185, DOI 10.1016/0012-1606(73)90329-1; Brown DD, 2005, P NATL ACAD SCI USA, V102, P12455, DOI 10.1073/pnas.0505989102; CHIN WW, 1994, THYROID, V4, P389, DOI 10.1089/thy.1994.4.389; Cras-Meneur C, 2001, DIABETES, V50, P1571, DOI 10.2337/diabetes.50.7.1571; Das B, 2002, P NATL ACAD SCI USA, V99, P12230, DOI 10.1073/pnas.182430599; DeMatteo RP, 1997, J SURG RES, V72, P155, DOI 10.1006/jsre.1997.5096; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; Edlund H, 1998, DIABETES, V47, P1817, DOI 10.2337/diabetes.47.12.1817; Furuya F, 2006, P NATL ACAD SCI USA, V103, P1780, DOI 10.1073/pnas.0510849103; Furuya F, 2010, J BIOL CHEM, V285, P24477, DOI 10.1074/jbc.M109.100222; Gradwohl G, 2000, P NATL ACAD SCI USA, V97, P1607, DOI 10.1073/pnas.97.4.1607; Gu GQ, 2002, DEVELOPMENT, V129, P2447; GUMUCIO DL, 1985, J BIOL CHEM, V260, P3483; Hafezi-Moghadam A, 2002, NAT MED, V8, P473, DOI 10.1038/nm0502-473; HANAICHI T, 1986, J ELECTRON MICROSC, V35, P304; Heit JJ, 2006, ANNU REV CELL DEV BI, V22, P311, DOI 10.1146/annurev.cellbio.22.010305.104425; Heremans Y, 2002, J CELL BIOL, V159, P303, DOI 10.1083/jcb.200203074; Hiroi Y, 2006, P NATL ACAD SCI USA, V103, P14104, DOI 10.1073/pnas.0601600103; Jensen J, 2004, DEV DYNAM, V229, P176, DOI 10.1002/dvdy.10460; LAZAR MA, 1993, ENDOCR REV, V14, P184, DOI 10.1210/er.14.2.184; Li L, 2003, AM J PHYSIOL-ENDOC M, V285, pE577, DOI 10.1152/ajpendo.00120.2003; Marsh-Armstrong N, 2004, P NATL ACAD SCI USA, V101, P165, DOI 10.1073/pnas.2136755100; MAYLIEPFENNINGER MF, 1979, J CELL BIOL, V80, P77, DOI 10.1083/jcb.80.1.77; Means AL, 2005, DEVELOPMENT, V132, P3767, DOI 10.1242/dev.01925; Minami K, 2005, P NATL ACAD SCI USA, V102, P15116, DOI 10.1073/pnas.0507567102; Minami K, 2008, J BIOL CHEM, V283, P13753, DOI 10.1074/jbc.M710034200; Miyatsuka T, 2006, GENE DEV, V20, P1435, DOI 10.1101/gad.1412806; Mukhi S, 2008, P NATL ACAD SCI USA, V105, P8962, DOI 10.1073/pnas.0803569105; Murtaugh LC, 2003, ANNU REV CELL DEV BI, V19, P71, DOI 10.1146/annurev.cellbio.19.111301.144752; Sakaguchi Y, 1996, ENDOCRINOLOGY, V137, P4744, DOI 10.1210/en.137.11.4744; SAMUELS HH, 1979, ENDOCRINOLOGY, V105, P80, DOI 10.1210/endo-105-1-80; Schwitzgebel VM, 2000, DEVELOPMENT, V127, P3533; Sen LY, 2002, AM J PHYSIOL-HEART C, V283, pH2119, DOI 10.1152/ajpheart.00326.2002; Shifrin AL, 2001, GENE THER, V8, P1480, DOI 10.1038/sj.gt.3301544; Shih A, 2004, ENDOCRINOLOGY, V145, P1708, DOI 10.1210/en.2003-0742; STERN PH, 1985, J CLIN INVEST, V76, P2016, DOI 10.1172/JCI112202; Sun ZQ, 2000, AM J PHYSIOL-ENDOC M, V278, pE302, DOI 10.1152/ajpendo.2000.278.2.E302; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	40	26	32	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 31	2013	288	22					16155	16166		10.1074/jbc.M112.438192	http://dx.doi.org/10.1074/jbc.M112.438192			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	156LA	23595988	Green Published, hybrid			2022-12-25	WOS:000319822300066
J	Chadli, FK; Nazih, H; Krempf, M; Nguyen, P; Ouguerram, K				Chadli, Fatima Kasbi; Nazih, Hassane; Krempf, Michel; Nguyen, Patrick; Ouguerram, Khadija			Omega 3 Fatty Acids Promote Macrophage Reverse Cholesterol Transport in Hamster Fed High Fat Diet	PLOS ONE			English	Article							FISH-OIL; DENSITY-LIPOPROTEIN; EFFLUX CAPACITY; ESTER TRANSFER; ACYLTRANSFERASE ACTIVITY; EICOSAPENTAENOIC ACID; J774 MACROPHAGES; APOLIPOPROTEIN-E; HDL-CHOLESTEROL; BILE-ACID	The aim of this study was to investigate macrophage reverse cholesterol transport (RCT) in hamster, a CETP-expressing species, fed omega 3 fatty acids (v3PUFA) supplemented high fat diet (HFD). Three groups of hamsters (n = 6/group) were studied for 20 weeks: 1) control diet: Control, 2) HFD group: HF and 3) HFD group supplemented with omega 3PUFA (EPA and DHA): HF omega 3. In vivo macrophage-to-feces RCT was assessed after an intraperitoneal injection of H-3-cholesterol-labelled hamster primary macrophages. Compared to Control, HF presented significant (p < 0.05) increase in body weight, plasma TG (p<0.01) and cholesterol (p<0.001) with an increase in VLDL TG and in VLDL and LDL cholesterol (p<0.001). Compared to HF, HF omega 3 presented significant decrease in body weight. HF omega 3 showed less plasma TG (p<0.001) and cholesterol (p<0.001) related to a decrease in VLDL TG and HDL cholesterol respectively and higher LCAT activity (p<0.05) compared to HF. HF omega 3 showed a higher fecal bile acid excretion (p<0.05) compared to Control and HF groups and higher fecal cholesterol excretion (p<0.05) compared to HF. This increase was related to higher gene expression of ABCG5, ABCA1 and SR-B1 in HF omega 3 compared to Control and HF groups (<0.05) and in ABCG1 and CYP7A1 compared to HF group (p<0.05). A higher plasma efflux capacity was also measured in HF omega 3 using H-3-cholesterol labeled Fu5AH cells. In conclusion, EPA and DHA supplementation improved macrophage to feces reverse cholesterol transport in hamster fed HFD. This change was related to the higher cholesterol and fecal bile acids excretion and to the activation of major genes involved in RCT.	[Chadli, Fatima Kasbi; Krempf, Michel; Ouguerram, Khadija] UN Inst Thorax, INSERM, CNRS, IRS,UMR 1087,UMR 6291, Nantes, France; [Chadli, Fatima Kasbi; Nguyen, Patrick] UNAM Univ, Oniris Nutr & Endocrinol Unit, Natl Coll Vet Med Food Sci & Engn, Nantes, France; [Chadli, Fatima Kasbi; Nazih, Hassane; Krempf, Michel; Nguyen, Patrick; Ouguerram, Khadija] CHU Nantes, CRNH, Human Nutr Res Ctr Nantes, F-44035 Nantes 01, France; [Nazih, Hassane] Univ Nantes, Fac Pharm, MMS Lab Biochim 2160, F-44035 Nantes, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Ecole Nationale Veterinaire, Agroalimentaire et de l'Alimentation Nantes-Atlantique; Nantes Universite; CHU de Nantes; Nantes Universite	Ouguerram, K (corresponding author), UN Inst Thorax, INSERM, CNRS, IRS,UMR 1087,UMR 6291, Nantes, France.	khadija.ouguerram@univ-nantes.fr		Krempf, Michel/0000-0002-4353-9511; Nazih, Hassan/0000-0002-3607-295X	CRNH (Centre de Recherche en Nutrition Humaine, Nantes); research program NUPEM by Region Pays de la Loire	CRNH (Centre de Recherche en Nutrition Humaine, Nantes); research program NUPEM by Region Pays de la Loire(Region Pays de la Loire)	This work was supported by CRNH (Centre de Recherche en Nutrition Humaine, Nantes) and research program NUPEM supported by Region Pays de la Loire. The omega 3 polyunsaturated fatty acids were provided by Pierre Fabre Sante. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBEY M, 1990, ARTERIOSCLEROSIS, V10, P85, DOI 10.1161/01.ATV.10.1.85; Alvaro A, 2010, J NUTR BIOCHEM, V21, P518, DOI 10.1016/j.jnutbio.2009.02.010; Berard AM, 2004, FEBS LETT, V559, P125, DOI 10.1016/S0014-5793(04)00049-3; BERNARD DW, 1991, J BIOL CHEM, V266, P710; Briand F, 2010, CURR OPIN INVEST DR, V11, P289; Calabresi Laura, 2006, Curr Atheroscler Rep, V8, P163, DOI 10.1007/s11883-006-0054-4; Castro-Perez J, 2011, J LIPID RES, V52, P1965, DOI 10.1194/jlr.M016410; Chen JN, 2012, ATHEROSCLEROSIS, V221, P397, DOI 10.1016/j.atherosclerosis.2012.01.005; DAVIDSON WS, 1995, J BIOL CHEM, V270, P5882, DOI 10.1074/jbc.270.11.5882; Degoma EM, 2008, J AM COLL CARDIOL, V51, P2199, DOI 10.1016/j.jacc.2008.03.016; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fournier N, 2001, ATHEROSCLEROSIS, V157, P315, DOI 10.1016/S0021-9150(00)00730-9; Ginsberg HN, 2006, OBESITY, V14, p41S, DOI 10.1038/oby.2006.281; Harris W, 2010, CURR OPIN CLIN NUTR, V13, P125, DOI 10.1097/MCO.0b013e3283357242; Harrison N, 2005, CURR MED RES OPIN, V21, P95, DOI 10.1185/030079904X17956; Hassanali Z, 2010, DIABETES OBES METAB, V12, P139, DOI 10.1111/j.1463-1326.2009.01130.x; Holzer M, 2012, J LIPID RES, V53, P1618, DOI 10.1194/jlr.M027367; Ji Y, 1997, J BIOL CHEM, V272, P20982, DOI 10.1074/jbc.272.34.20982; Jonkers IJAM, 2006, J NUTR, V136, P987, DOI 10.1093/jn/136.4.987; Kasbi Chadli F, 2011, BR J NUTR, V16, P1; le Morvan V, 2002, LIPIDS, V37, P767, DOI 10.1007/s11745-002-0959-2; Lecker JL, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-186; Mathur SN, 2007, J LIPID RES, V48, P395, DOI 10.1194/jlr.M600325-JLR200; MAZZONE T, 1994, J LIPID RES, V35, P1345; Montoya MT, 2002, AM J CLIN NUTR, V75, P484, DOI 10.1093/ajcn/75.3.484; NAGASAKI T, 1977, CLIN CHIM ACTA, V75, P371; Nishimoto T, 2009, ARTERIOSCL THROM VAS, V29, P1502, DOI 10.1161/ATVBAHA.109.187252; Ntambi JM, 2002, P NATL ACAD SCI USA, V99, P11482, DOI 10.1073/pnas.132384699; Okuno M, 1997, J NUTR, V127, P1752, DOI 10.1093/jn/127.9.1752; Ottestad I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042550; Ouguerram K, 2006, BRIT J NUTR, V96, P100, DOI 10.1079/BJN20061806; Ouguerram K, 2002, METABOLISM, V51, P5, DOI 10.1053/meta.2002.29006; Ozasa H, 2011, ATHEROSCLEROSIS, V219, P141, DOI 10.1016/j.atherosclerosis.2011.07.113; PARKS JS, 1989, J BIOL CHEM, V264, P2545; Pawar A, 2003, J BIOL CHEM, V278, P40736, DOI 10.1074/jbc.M307973200; Piquer BR, 2006, METABOLISM, V55, P980, DOI 10.1016/j.metabol.2006.03.006; Rossmeisl M, 2009, OBESITY, V17, P1023, DOI 10.1038/oby.2008.602; Rousset X, 2009, CURR OPIN ENDOCRINOL, V16, P163, DOI 10.1097/MED.0b013e328329233b; SAKAI N, 1995, ATHEROSCLEROSIS, V114, P139, DOI 10.1016/0021-9150(94)05477-Z; Sheril A, 2009, ATHEROSCLEROSIS, V204, P136, DOI 10.1016/j.atherosclerosis.2008.08.021; Skulas-Ray AC, 2011, AM J CLIN NUTR, V93, P243, DOI 10.3945/ajcn.110.003871; Spady DK, 1999, J LIPID RES, V40, P1384; STORLIEN LH, 1987, SCIENCE, V237, P885, DOI 10.1126/science.3303333; Sugano M, 1997, BBA-LIPID LIPID MET, V1346, P17, DOI 10.1016/S0005-2760(97)00013-1; Tanigawa H, 2007, CIRCULATION, V116, P1267; Tchoua U, 2008, CARDIOVASC RES, V77, P732, DOI 10.1093/cvr/cvm087; Thomas TR, 2004, METABOLISM, V53, P749, DOI 10.1016/j.metabol.2003.12.019; Treguier M, 2011, EUR J CLIN INVEST; Uehara Y, 2007, ATHEROSCLEROSIS, V191, P11, DOI 10.1016/j.atherosclerosis.2006.04.018; Vaysse-Boue C, 2007, LIPIDS, V42, P717, DOI 10.1007/s11745-007-3074-0; Vergeer M, 2010, DIABETES CARE, V33, P869, DOI 10.2337/dc09-1562; von Eckardstein A, 2011, CURR OPIN LIPIDOL, V22, P26, DOI 10.1097/MOL.0b013e3283412279; Wang LJ, 2012, BBA-MOL CELL BIOL L, V1821, P964, DOI 10.1016/j.bbalip.2012.03.004; Yokoyama M, 2007, LANCET, V369, P1090, DOI 10.1016/S0140-6736(07)60527-3; Yvan-Charvet L, 2007, J CLIN INVEST, V117, P3900, DOI 10.1172/JCI33372; Zhang L, 2009, J ATHEROSCLER THROMB, V16, P463, DOI 10.5551/jat.No1347; Zhang YZ, 2005, J CLIN INVEST, V115, P2870, DOI 10.1172/JCI25327; ZILVERSMIT DB, 1983, J LIPID RES, V24, P297	58	37	37	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2013	8	4							e61109	10.1371/journal.pone.0061109	http://dx.doi.org/10.1371/journal.pone.0061109			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JR	23613796	Green Published, gold, Green Submitted			2022-12-25	WOS:000317911500018
J	Favoino, E; Digiglio, L; Cuomo, G; Favia, IE; Racanelli, V; Valentini, G; Perosa, F				Favoino, Elvira; Digiglio, Liboria; Cuomo, Giovanna; Favia, Isabella E.; Racanelli, Vito; Valentini, Gabriele; Perosa, Federico			Autoantibodies Recognizing the Amino Terminal 1-17 Segment of CENP-A Display Unique Specificities in Systemic Sclerosis	PLOS ONE			English	Article							FINE-SPECIFICITY; NUCLEAR AUTOANTIGENS; B ANTIBODIES; FIBROBLASTS; SCLERODERMA; GENERATION; RITUXIMAB; FEATURES; DISEASE; FRENCH	Centromere-associated protein A (CENP-A), a common autoimmune target in a subset of systemic sclerosis patients, appears to have no role to explain why its corresponding auto-antibodies are more frequently found in the limited than the diffuse form of systemic sclerosis. Therefore, we investigated the fine specificity of anti-CENP-A antibodies as a first step to understanding their role in systemic sclerosis pathology. We focused on the amino-terminal portion of CENP-A spanning amino acids 1 to 17 (Ap(1-17)), which represents, along with Ap(17-30), an immunodominant epitope of the protein. Peptide Ap(1-17) was used to purify antibodies from 8 patients with systemic sclerosis. Anti-Ap(1-17) antibodies specifically reacted with human CENP-A but did not cross-react with CENP-B or Ap(17-30). Panning of a phage display peptide library with anti-Ap(1-17) antibodies from 2 patients identified two novel, partially overlapping motifs, <(5)Rx(st)xKP(10)> and <(9)KPxxPxR(15)> as the result of the alignment of specific phage clone insert sequences. Anti-Ap(1-17) IgG from the 8 patients had different reactivities to isolated phage clone insert sequences. Scanning the Swiss-Prot database revealed a large number of different types of proteins containing the two Ap(1-17) antigenic motifs. These data show that anti-CENP-A(1-17) antibodies are generated independently from anti-CENP-B antibodies and display great heterogeneity in their specificity by recognizing different motifs within that peptide sequence. This finding, along with the widespread interspecies and human tissue distribution of the two motifs, suggests that the number of motif-expressing proteins which can be the potential target of these antibodies is markedly higher than that estimated from the peptide-based epitope spreading model.	[Favoino, Elvira; Digiglio, Liboria; Favia, Isabella E.; Racanelli, Vito; Perosa, Federico] Univ Bari, Sch Med, Dept Internal Med DIMO, Bari, Italy; [Cuomo, Giovanna; Valentini, Gabriele] Univ Naples 2, Dept Clin & Expt Internal Med, Naples, Italy	Universita degli Studi di Bari Aldo Moro; Universita della Campania Vanvitelli	Perosa, F (corresponding author), Univ Bari, Sch Med, Dept Internal Med DIMO, Bari, Italy.	federico.perosa@uniba.it	Racanelli, Vito/J-8511-2018; Favoino, Elvira/D-4804-2014	Racanelli, Vito/0000-0002-8639-1940; VALENTINI, Gabriele/0000-0002-7852-9137; Perosa, Federico/0000-0002-4072-4244; Favoino, Elvira/0000-0002-4664-1394; Cuomo, Giovanna/0000-0002-4292-3589	Apulia region [BIOTECNOTER 2011-12]; University of Bari, Medical School	Apulia region; University of Bari, Medical School	This work was supported by a grant BIOTECNOTER 2011-12 from Apulia region and by a grant from University of Bari, Medical School. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbarali Y, 2006, J AUTOIMMUN, V27, P272, DOI 10.1016/j.jaut.2006.10.001; [Anonymous], 1980, ARTHRITIS RHEUM, V23, P581, DOI 10.1002/art.1780230510; Arnett FC, 2010, ANN RHEUM DIS, V69, P822, DOI 10.1136/ard.2009.111906; De Palma R, 2006, CLIN EXP IMMUNOL, V144, P169, DOI 10.1111/j.1365-2249.2006.03041.x; Disis ML, 2004, J CLIN IMMUNOL, V24, P571, DOI 10.1023/B:JOCI.0000040928.67495.52; GIORDANO M, 1986, J RHEUMATOL, V13, P911; Gu YS, 2008, SEMIN ARTHRITIS RHEU, V38, P132, DOI 10.1016/j.semarthrit.2007.10.010; Hanke K, 2010, J RHEUMATOL, V37, P2548, DOI 10.3899/jrheum.100402; Henault J, 2004, ARTHRITIS RHEUM-US, V50, P3265, DOI 10.1002/art.20515; Herzenberg LA, 1997, P NATL ACAD SCI USA, V94, P1967, DOI 10.1073/pnas.94.5.1967; Hudson M, 2012, J RHEUMATOL, V39, P787, DOI 10.3899/rheum.111133; Hudson M, 2010, MEDICINE, V89, P159, DOI 10.1097/MD.0b013e3181dde28d; Kaveri SV, 2012, AUTOIMMUN REV, V11, P792, DOI 10.1016/j.autrev.2012.02.006; Mahler M, 2000, J MOL MED-JMM, V78, P460, DOI 10.1007/s001090000128; Mahler M, 2002, ARTHRITIS RHEUM, V46, P1866, DOI 10.1002/art.10330; Mahler M, 2001, J MOL MED, V79, P722, DOI 10.1007/s001090100258; Mahler M, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3029; Mannoor K, 2013, AUTOIMMUNITY, DOI [103109/089169342012748753, DOI 10.3109/08916934 2012 748753]; Mehra S, 2013, AUTOIMMUN REV, V12, P340, DOI 10.1016/j.autrev.2012.05.011; Meyer OC, 2007, J RHEUMATOL, V34, P104; Mitri GM, 2003, ARTHRITIS RHEUM-US, V48, P203, DOI 10.1002/art.10760; Muro Y, 2000, CLIN EXP IMMUNOL, V120, P218, DOI 10.1046/j.1365-2249.2000.01189.x; Perosa F, 2006, BLOOD, V107, P1070, DOI 10.1182/blood-2005-04-1769; PEROSA F, 1988, HUM IMMUNOL, V23, P255, DOI 10.1016/0198-8859(88)90061-4; Perosa F, 2003, J IMMUNOL, V171, P1918, DOI 10.4049/jimmunol.171.4.1918; Perosa F, 2007, J IMMUNOL, V179, P7967, DOI 10.4049/jimmunol.179.11.7967; Perosa F, 2010, CLIN IMMUNOL, V137, P60, DOI 10.1016/j.clim.2010.06.008; Racanelli V, 2011, AUTOIMMUN REV, V10, P503, DOI 10.1016/j.autrev.2011.03.001; REVEILLE JD, 1992, J CLIN INVEST, V89, P1208, DOI 10.1172/JCI115704; Scussel-Lonzetti L, 2002, MEDICINE, V81, P154, DOI 10.1097/00005792-200203000-00005; Senecal JL, 2005, J RHEUMATOL, V32, P1643; Servettaz A, 2006, CLIN IMMUNOL, V120, P212, DOI 10.1016/j.clim.2006.02.006; STEEN VD, 1988, ARTHRITIS RHEUM, V31, P196, DOI 10.1002/art.1780310207; Tamby MC, 2006, EUR RESPIR J, V28, P799, DOI 10.1183/09031936.06.00152705; Vanderlugt CL, 2002, NAT REV IMMUNOL, V2, P85, DOI 10.1038/nri724; Varga J, 2007, J CLIN INVEST, V117, P557, DOI 10.1172/JCI31139; WEINER ES, 1991, ARTHRITIS RHEUM, V34, P68, DOI 10.1002/art.1780340111	37	10	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2013	8	4							e61453	10.1371/journal.pone.0061453	http://dx.doi.org/10.1371/journal.pone.0061453			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JR	23613856	Green Published, Green Submitted, gold			2022-12-25	WOS:000317911500038
J	Galicia, G; Boulianne, B; Pikor, N; Martin, A; Gommerman, JL				Galicia, Georgina; Boulianne, Bryant; Pikor, Natalia; Martin, Alberto; Gommerman, Jennifer L.			Secondary B Cell Receptor Diversification Is Necessary for T Cell Mediated Neuro-Inflammation during Experimental Autoimmune Encephalomyelitis	PLOS ONE			English	Article							MYELIN OLIGODENDROCYTE GLYCOPROTEIN; CYTIDINE DEAMINASE AID; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; REMITTING MULTIPLE-SCLEROSIS; CEREBROSPINAL-FLUID; CLONAL EXPANSION; SOMATIC HYPERMUTATION; PLASMA-CELLS; ANTIBODY; BRAIN	Background: Clinical studies of B cell depletion in Multiple Sclerosis (MS) have revealed that B Lymphocytes are involved in the neuro-inflammatory process, yet it remains unclear how B cells can exert pro- and anti-inflammatory functions during MS. Experimental Autoimmune Encephalomyelitis (EAE) is an animal model of MS whereby myelin-specific T cells become activated and subsequently migrate to the Central Nervous System (CNS) where they perform pro-inflammatory functions such as cytokine secretion. Typically EAE is induced by immunization of mice of a susceptible genetic background with peptide antigen emulsified in Complete Freund's Adjuvant. However, novel roles for B-lymphocytes in EAE may also be explored by immunization with full-length myelin oligodendrocyte glycoprotein (MOG) that contains the B cell conformational epitope. Here we show that full length MOG immunization promotes a chronic disease in mice that depends on antigen-driven secondary diversification of the B cell receptor. Methods: Activation-Induced Deaminase (AID) is an enzyme that is essential for antigen-driven secondary diversification of the B cell receptor. We immunized AID(-/-) mice with the extracellular domain (amino acids 1-120) of recombinant human MOG protein (rhMOG) and examined the incidence and severity of disease in AID(-/-) versus wild type mice. Corresponding with these clinical measurements, we also evaluated parameters of T cell activation in the periphery and the CNS as well as the generation of anti-MOG antibodies (Ab). Conclusions: AID(-/-) mice exhibit reduced severity and incidence of EAE. This suggests that the secondary diversification of the B cell receptor is required for B cells to exert their full encephalogenic potential during rhMOG-induced EAE, and possibly also during MS.	[Galicia, Georgina; Boulianne, Bryant; Pikor, Natalia; Martin, Alberto; Gommerman, Jennifer L.] Univ Toronto, Dept Immunol, Toronto, ON, Canada	University of Toronto	Gommerman, JL (corresponding author), Univ Toronto, Dept Immunol, Toronto, ON, Canada.	jen.gommerman@utoronto.ca		Galicia, Georgina/0000-0003-4316-6986; Gommerman, Jennifer/0000-0003-4576-6168; Martin, Alberto/0000-0002-0795-0418; Pikor, Natalia/0000-0002-6564-4232	Canadian Institutes for Health [89783]; MS Society of Canada; Faculty of Medicine flow cytometry core facility	Canadian Institutes for Health(Canadian Institutes of Health Research (CIHR)); MS Society of Canada; Faculty of Medicine flow cytometry core facility	This work was supported by a Canadian Institutes for Health Research grant to AM (MOG# 89783), an operating grant from the MS Society of Canada to JG, and a post-doctoral fellowship from the MS Society of Canada to GR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the Faculty of Medicine flow cytometry core facility and Dionne White for their support. We also thank Maribel Berru for technical help and Dr. Nancy Ruddle (Yale University) for providing the rhMOG construct.	Baranzini SE, 1999, J IMMUNOL, V163, P5133; Bransteitter R, 2003, P NATL ACAD SCI USA, V100, P4102, DOI 10.1073/pnas.0730835100; Burgoon MP, 2005, P NATL ACAD SCI USA, V102, P7245, DOI 10.1073/pnas.0502323102; Colombo M, 2000, J IMMUNOL, V164, P2782, DOI 10.4049/jimmunol.164.5.2782; deLuca LES, 2010, J IMMUNOL, V184, P3174, DOI 10.4049/jimmunol.0902881; Di Noia J, 2002, NATURE, V419, P43, DOI 10.1038/nature00981; Di Pauli F, 2010, J NEUROL SCI, V288, P147, DOI 10.1016/j.jns.2009.09.016; Fillatreau S, 2002, NAT IMMUNOL, V3, P944, DOI 10.1038/ni833; Gilden DH, 2005, LANCET NEUROL, V4, P195, DOI 10.1016/S1474-4422(05)01017-3; Giuliani F, 2005, J NEUROIMMUNOL, V158, P213, DOI 10.1016/j.jneuroim.2004.09.006; Harp C, 2007, J NEUROIMMUNOL, V183, P189, DOI 10.1016/j.jneuroim.2006.10.020; Hauser SL, 2008, NEW ENGL J MED, V358, P676, DOI 10.1056/NEJMoa0706383; Henderson APD, 2009, ANN NEUROL, V66, P739, DOI 10.1002/ana.21800; Hjelmstrom P, 1998, J IMMUNOL, V161, P4480; Jiang CC, 2012, AUTOIMMUNITY, V45, P440, DOI 10.3109/08916934.2012.682668; KABAT EA, 1948, AM J MED, V4, P653, DOI 10.1016/S0002-9343(48)90389-1; Kappos L, 2011, LANCET, V378, P1779, DOI 10.1016/S0140-6736(11)61649-8; Kuenz B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002559; Kuerten S, 2008, CLIN IMMUNOL, V129, P256, DOI 10.1016/j.clim.2008.07.016; Lovato L, 2011, BRAIN, V134, P534, DOI 10.1093/brain/awq350; Lucchinetti C, 2000, ANN NEUROL, V47, P707, DOI 10.1002/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q; Lyons JA, 1999, EUR J IMMUNOL, V29, P3432, DOI 10.1002/(SICI)1521-4141(199911)29:11<3432::AID-IMMU3432>3.0.CO;2-2; Lyons JA, 2002, EUR J IMMUNOL, V32, P1905, DOI 10.1002/1521-4141(200207)32:7<1905::AID-IMMU1905>3.0.CO;2-L; Marta CB, 2005, P NATL ACAD SCI USA, V102, P13992, DOI 10.1073/pnas.0504979102; Martin A, 2002, NATURE, V415, P802, DOI 10.1038/nature714; Matsushita T, 2008, J CLIN INVEST, V118, P3420, DOI 10.1172/JCI36030; Monson NL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017103; Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Obermeier B, 2008, NAT MED, V14, P688, DOI 10.1038/nm1714; Owens GP, 1998, ANN NEUROL, V43, P236, DOI 10.1002/ana.410430214; Petersen-Mahrt SK, 2002, NATURE, V418, P99, DOI 10.1038/nature00862; PRINEAS JW, 1978, LAB INVEST, V38, P409; Qin YF, 2003, LAB INVEST, V83, P1081, DOI 10.1097/01.LAB.0000077008.24259.0D; Qin YF, 1998, J CLIN INVEST, V102, P1045, DOI 10.1172/JCI3568; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; Ritchie AM, 2004, J IMMUNOL, V173, P649, DOI 10.4049/jimmunol.173.1.649; Sekiguchi Y, 2009, IMMUNOL LETT, V122, P145, DOI 10.1016/j.imlet.2008.08.009; Serafini B, 2004, BRAIN PATHOL, V14, P164, DOI 10.1111/j.1750-3639.2004.tb00049.x; SINDIC CJM, 1994, J NEUROIMMUNOL, V54, P75, DOI 10.1016/0165-5728(94)90233-X; Sun Y, 2013, AUTOIMMUNITY; von Budingen HC, 2002, P NATL ACAD SCI USA, V99, P8207, DOI 10.1073/pnas.122092499; WALSH MJ, 1985, CLIN IMMUNOL IMMUNOP, V35, P313, DOI 10.1016/0090-1229(85)90092-3; Wu GF, 2011, J AUTOIMMUN, V36, P56, DOI 10.1016/j.jaut.2010.10.006; Yoshizaki A, 2012, NATURE; Zaheen A, 2009, BLOOD, V114, P547, DOI 10.1182/blood-2009-03-211763	46	10	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2013	8	4							e61478	10.1371/journal.pone.0061478	http://dx.doi.org/10.1371/journal.pone.0061478			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JR	23613859	Green Submitted, gold, Green Published			2022-12-25	WOS:000317911500040
J	Remuinan, MJ; Perez-Herran, E; Rullas, J; Alemparte, C; Martinez-Hoyos, M; Dow, DJ; Afari, J; Mehta, N; Esquivias, J; Jimenez, E; Ortega-Muro, F; Fraile-Gabaldon, MT; Spivey, VL; Loman, NJ; Pallen, MJ; Constantinidou, C; Minick, DJ; Cacho, M; Rebollo-Lopez, MJ; Gonzalez, C; Sousa, V; Angulo-Barturen, I; Mendoza-Losana, A; Barros, D; Besra, GS; Ballell, L; Cammack, N				Remuinan, Modesto J.; Perez-Herran, Esther; Rullas, Joaquin; Alemparte, Carlos; Martinez-Hoyos, Maria; Dow, David J.; Afari, Johnson; Mehta, Nalini; Esquivias, Jorge; Jimenez, Elena; Ortega-Muro, Fatima; Teresa Fraile-Gabaldon, Maria; Spivey, Vickey L.; Loman, Nicholas J.; Pallen, Mark J.; Constantinidou, Chrystala; Minick, Douglas J.; Cacho, Monica; Jose Rebollo-Lopez, Maria; Gonzalez, Carolina; Sousa, Veronica; Angulo-Barturen, Inigo; Mendoza-Losana, Alfonso; Barros, David; Besra, Gurdyal S.; Ballell, Lluis; Cammack, Nicholas			Tetrahydropyrazolo[1,5-a]Pyrimidine-3-Carboxamide and N-Benzyl-6 ',7 '-Dihydrospiro[Piperidine-4,4 '-Thieno[3,2-c]Pyran] Analogues with Bactericidal Efficacy against Mycobacterium tuberculosis Targeting MmpL3	PLOS ONE			English	Article							DRUG DISCOVERY; IDENTIFICATION; CANDIDATE; SQ109	Mycobacterium tuberculosis is a major human pathogen and the causative agent for the pulmonary disease, tuberculosis (TB). Current treatment programs to combat TB are under threat due to the emergence of multi-drug and extensively-drug resistant TB. As part of our efforts towards the discovery of new anti-tubercular leads, a number of potent tetrahydropyrazolo[1,5-a]pyrimidine-3-carboxamide (THPP) and N-benzyl-6',7'-dihydrospiro[piperidine-4,4'-thieno[3,2-c]pyran] (Spiro) analogues were recently identified against Mycobacterium tuberculosis and Mycobacterium bovis BCG through a high-throughput whole-cell screening campaign. Herein, we describe the attractive in vitro and in vivo anti-tubercular profiles of both lead series. The generation of M. tuberculosis spontaneous mutants and subsequent whole genome sequencing of several resistant mutants identified single mutations in the essential mmpL3 gene. This 'genetic phenotype' was further confirmed by a 'chemical phenotype', whereby M. bovis BCG treated with both the THPP and Spiro series resulted in the accumulation of trehalose monomycolate. In vivo efficacy evaluation of two optimized THPP and Spiro leads showed how the compounds were able to reduce >2 logs bacterial cfu counts in the lungs of infected mice.	[Remuinan, Modesto J.; Perez-Herran, Esther; Rullas, Joaquin; Alemparte, Carlos; Martinez-Hoyos, Maria; Esquivias, Jorge; Jimenez, Elena; Ortega-Muro, Fatima; Teresa Fraile-Gabaldon, Maria; Cacho, Monica; Jose Rebollo-Lopez, Maria; Gonzalez, Carolina; Sousa, Veronica; Angulo-Barturen, Inigo; Mendoza-Losana, Alfonso; Barros, David; Ballell, Lluis; Cammack, Nicholas] GlaxoSmithKline, Dis Developing World, Madrid, Spain; [Dow, David J.; Afari, Johnson; Mehta, Nalini; Spivey, Vickey L.] GlaxoSmithKline, Mol & Cellular Technol, Stevenage, Herts, England; [Loman, Nicholas J.; Pallen, Mark J.; Constantinidou, Chrystala; Besra, Gurdyal S.] Univ Birmingham, Sch Biosci, Edgbaston, England; [Minick, Douglas J.] GlaxoSmithKline, Dept Analyt Chem, Res Triangle Pk, NC USA	GlaxoSmithKline; GlaxoSmithKline; University of Birmingham; GlaxoSmithKline	Remuinan, MJ (corresponding author), GlaxoSmithKline, Dis Developing World, Madrid, Spain.	Modesto.b.remuinan@gsk.com	Loman, Nicholas/Z-1573-2019; Mendoza-Losana, Alfonso/AAF-4383-2021	Mendoza-Losana, Alfonso/0000-0003-2493-4118; Besra, Gurdyal/0000-0002-5605-0395; Ballell, Lluis/0000-0002-3029-1860; Gonzalez Cortes, Carolina/0000-0002-8103-8996; Loman, Nicholas/0000-0002-9843-8988; Pallen, Mark/0000-0003-1807-3657; Rowlands, Vicky/0000-0002-1352-938X; Alemparte, Carlos/0000-0001-5521-8304; Esquivias, Jorge/0000-0001-6050-5092	Global Alliance for TB Drug Development; European Union [261378]; European Regional Development Fund and Invest in Spain from the Ministry of Economy and Competition; MRC [MR/J014370/1] Funding Source: UKRI; Medical Research Council [MR/J014370/1] Funding Source: researchfish	Global Alliance for TB Drug Development; European Union(European Commission); European Regional Development Fund and Invest in Spain from the Ministry of Economy and Competition; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The research leading to these results has received funding from the Global Alliance for TB Drug Development, from the European Union's 7th framework program (FP7-2007-2013) under the Orchid grant agreement No. 261378 and has been co-financed by the European Regional Development Fund and Invest in Spain from the Ministry of Economy and Competition. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andries K, 2005, SCIENCE, V307, P223, DOI 10.1126/science.1106753; Ballell L, 2013, CHEMMEDCHEM, V8, P313, DOI 10.1002/cmdc.201200428; Berry M, 2009, EUR RESPIR REV, V18, P195, DOI 10.1183/09059180.00005209; Biava M, 2006, J MED CHEM, V49, P4946, DOI 10.1021/jm0602662; Blagg J., 2010, BURGERS MED CHEM DRU, P301, DOI DOI 10.1002/0471266949.BMC128; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Dobson G., 1985, CHEM METHODS BACTERI, P237; Dye C, 2010, SCIENCE, V328, P856, DOI 10.1126/science.1185449; Grzegorzewicz AE, 2012, NAT CHEM BIOL, V8, P334, DOI [10.1038/NCHEMBIO.794, 10.1038/nchembio.794]; Hill AP, 2010, DRUG DISCOV TODAY, V15, P648, DOI 10.1016/j.drudis.2010.05.016; Koul A, 2011, NATURE, V469, P483, DOI 10.1038/nature09657; La Rosa V, 2012, ANTIMICROB AGENTS CH, V56, P324, DOI 10.1128/AAC.05270-11; Maddry JA, 2009, TUBERCULOSIS, V89, P354, DOI 10.1016/j.tube.2009.07.006; Makarov V, 2009, SCIENCE, V324, P801, DOI 10.1126/science.1171583; Murray M, 2000, CURR DRUG METAB, V1, P67, DOI 10.2174/1389200003339270; Payne DJ, 2007, NAT REV DRUG DISCOV, V6, P29, DOI 10.1038/nrd2201; Pethe K, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1060; Protopopova M, 2005, J ANTIMICROB CHEMOTH, V56, P968, DOI 10.1093/jac/dki319; Rullas J, 2010, ANTIMICROB AGENTS CH, V54, P2262, DOI 10.1128/AAC.01423-09; Singh R, 2008, SCIENCE, V322, P1392, DOI 10.1126/science.1164571; Stanley SA, 2012, ACS CHEM BIOL, V7, P1377, DOI 10.1021/cb300151m; Stover CK, 2000, NATURE, V405, P962, DOI 10.1038/35016103; Tahlan K, 2012, ANTIMICROB AGENTS CH, V56, P1797, DOI 10.1128/AAC.05708-11; Varela C, 2012, CHEM BIOL, V19, P498, DOI 10.1016/j.chembiol.2012.03.006; WHO, 2011, WHO GLOBAL TUBERCULO	25	112	114	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2013	8	4							e60933	10.1371/journal.pone.0060933	http://dx.doi.org/10.1371/journal.pone.0060933			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IK	23613759	Green Published, gold, Green Submitted			2022-12-25	WOS:000317907200017
J	Laatikainen, LM; Sharp, T; Harrison, PJ; Tunbridge, EM				Laatikainen, Linda M.; Sharp, Trevor; Harrison, Paul J.; Tunbridge, Elizabeth M.			Sexually Dimorphic Effects of Catechol-O-Methyltransferase (COMT) Inhibition on Dopamine Metabolism in Multiple Brain Regions	PLOS ONE			English	Article							RAT PREFRONTAL CORTEX; VAL(158)MET GENOTYPE; PARKINSONS-DISEASE; MEMORY FORMATION; DEFICIENT MICE; RO 40-7592; TOLCAPONE; POLYMORPHISM; REWARD; COGNITION	The catechol-O-methyltransferase (COMT) enzyme metabolises catecholamines. COMT inhibitors are licensed for the adjunctive treatment of Parkinson's disease and are attractive therapeutic candidates for other neuropsychiatric conditions. COMT regulates dopamine levels in the prefrontal cortex (PFC) but plays a lesser role in the striatum. However, its significance in other brain regions is largely unknown, despite its links with a broad range of behavioural phenotypes hinting at more widespread effects. Here, we investigated the effect of acute systemic administration of the brain-penetrant COMT inhibitor tolcapone on tissue levels of dopamine, noradrenaline, and the dopamine metabolites 3,4-dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA). We examined PFC, striatum, hippocampus and cerebellum in the rat. We studied both males and females, given sexual dimorphisms in several aspects of COMT's function. Compared with vehicle, tolcapone significantly increased dopamine levels in the ventral hippocampus, but did not affect dopamine in other regions, nor noradrenaline in any region investigated. Tolcapone increased DOPAC and/or decreased HVA in all brain regions studied. Notably, several of the changes in DOPAC and HVA, particularly those in PFC, were more prominent in females than males. These data demonstrate that COMT alters ventral hippocampal dopamine levels, as well as regulating dopamine metabolism in all brain regions studied. They demonstrate that COMT is of significance beyond the PFC, consistent with its links with a broad range of behavioural phenotypes. Furthermore, they suggest that the impact of tolcapone may be greater in females than males, a finding which may be of clinical significance in terms of the efficacy and dosing of COMT inhibitors.	[Laatikainen, Linda M.; Harrison, Paul J.; Tunbridge, Elizabeth M.] Univ Oxford, Dept Psychiat, Oxford, England; [Sharp, Trevor] Univ Oxford, Dept Pharmacol, Oxford OX1 3QT, England	University of Oxford; University of Oxford	Tunbridge, EM (corresponding author), Univ Oxford, Dept Psychiat, Oxford, England.	elizabeth.tunbridge@psych.ox.ac.uk		Tunbridge, Elizabeth/0000-0002-2966-2281; Sharp, Trevor/0000-0001-7434-9713; Harrison, Paul/0000-0002-6719-1126	Medical Research Council (MRC) [G0700983]; Royal Society University Research Fellowship; UK Medical Research Council; Medical Research Council [G0700983] Funding Source: researchfish; MRC [G0700983] Funding Source: UKRI	Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Royal Society University Research Fellowship(Royal Society of London); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This research was supported by a Medical Research Council (MRC; www.mrc.ac.uk) project grant (G0700983) with additional funds provided by a Royal Society University Research Fellowship (www.royalsoc.ac.uk) awarded to EMT. LML was supported by a UK Medical Research Council studentship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACQUAS E, 1992, J NEUROCHEM, V59, P326, DOI 10.1111/j.1471-4159.1992.tb08907.x; Apud JA, 2007, NEUROPSYCHOPHARMACOL, V32, P1011, DOI 10.1038/sj.npp.1301227; Bannerman DM, 2004, NEUROSCI BIOBEHAV R, V28, P273, DOI 10.1016/j.neubiorev.2004.03.004; Barnett JH, 2007, AM J PSYCHIAT, V164, P142, DOI 10.1176/appi.ajp.164.1.142; Berridge KC, 1998, BRAIN RES REV, V28, P309, DOI 10.1016/S0165-0173(98)00019-8; Bertolino A, 2006, BIOL PSYCHIAT, V60, P1250, DOI 10.1016/j.biopsych.2006.03.078; Bilder RM, 2004, NEUROPSYCHOPHARMACOL, V29, P1943, DOI 10.1038/sj.npp.1300542; Budygin EA, 1999, EUR J PHARMACOL, V370, P125, DOI 10.1016/S0014-2999(99)00084-9; Ceravolo R, 2002, SYNAPSE, V43, P201, DOI 10.1002/syn.10034; Chen JS, 2011, J BIOL CHEM, V286, P34752, DOI 10.1074/jbc.M111.262790; Drabant EM, 2006, ARCH GEN PSYCHIAT, V63, P1396, DOI 10.1001/archpsyc.63.12.1396; Egan MF, 2001, P NATL ACAD SCI USA, V98, P6917, DOI 10.1073/pnas.111134598; Enoch MA, 2003, PSYCHIAT GENET, V13, P33, DOI 10.1097/00041444-200303000-00006; Farrell SM, 2012, BIOL PSYCHIAT, V71, P538, DOI 10.1016/j.biopsych.2011.12.023; Gan JO, 2010, NAT NEUROSCI, V13, P25, DOI 10.1038/nn.2460; Giakoumaki SG, 2008, NEUROPSYCHOPHARMACOL, V33, P3058, DOI 10.1038/npp.2008.82; Gogos JA, 1998, P NATL ACAD SCI USA, V95, P9991, DOI 10.1073/pnas.95.17.9991; Goldman-Rakic PS, 2000, BRAIN RES REV, V31, P295, DOI 10.1016/S0165-0173(99)00045-4; Goto Y, 2008, CEREB CORTEX, V18, P1407, DOI 10.1093/cercor/bhm172; Huotari M, 2002, EUR J NEUROSCI, V15, P246, DOI 10.1046/j.0953-816x.2001.01856.x; Jorga K, 2000, BRIT J CLIN PHARMACO, V49, P39, DOI 10.1046/j.1365-2125.2000.00113.x; Kaenmaki M, 2010, J NEUROCHEM, V114, P1745, DOI 10.1111/j.1471-4159.2010.06889.x; Laatikainen L, 2012, J PSYCHOPHARMACOL; Lapish CC, 2009, PSYCHOPHARMACOLOGY, V202, P521, DOI 10.1007/s00213-008-1342-1; Lewis DA, 2001, J COMP NEUROL, V432, P119, DOI 10.1002/cne.1092; Li YH, 1998, EUR J PHARMACOL, V356, P127, DOI 10.1016/S0014-2999(98)00524-X; Liljequist R, 1997, BEHAV BRAIN RES, V82, P195, DOI 10.1016/S0166-4328(97)80989-8; MAJ J, 1990, J NEURAL TRANSM-PARK, V2, P101, DOI 10.1007/BF02260898; Mannisto PT, 1999, PHARMACOL REV, V51, P593; Matsumoto M, 2003, NEUROSCIENCE, V116, P127, DOI 10.1016/S0306-4522(02)00556-0; Mier D, 2010, MOL PSYCHIATR, V15, P918, DOI 10.1038/mp.2009.36; Myohanen TT, 2010, J NEUROCHEM, V113, P1632, DOI 10.1111/j.1471-4159.2010.06723.x; PACKARD MG, 1989, PHARMACOL BIOCHEM BE, V33, P511, DOI 10.1016/0091-3057(89)90378-X; Papaleo F, 2008, J NEUROSCI, V28, P8709, DOI 10.1523/JNEUROSCI.2077-08.2008; Pooley EC, 2007, MOL PSYCHIAT; Schott BH, 2006, J NEUROSCI, V26, P1407, DOI 10.1523/JNEUROSCI.3463-05.2006; Sesack S R, 1998, Adv Pharmacol, V42, P171; Stumpenhorst K, 2012, J PSYCHOPHARMACOL, V26, pA64; Tunbridge EM, 2012, CNS NEUROL DISORD-DR, V11, P306; Tunbridge EM, 2006, BIOL PSYCHIAT, V60, P141, DOI 10.1016/j.biopsych.2005.10.024; Tunbridge EM, 2011, CURR TOP BEHAV NEURO, V8, P119, DOI 10.1007/7854_2010_97; Tunbridge EM, 2004, J NEUROSCI, V24, P5331, DOI 10.1523/JNEUROSCI.1124-04.2004; WESTERINK BHC, 1975, EUR J PHARMACOL, V33, P31, DOI 10.1016/0014-2999(75)90134-X; Wittmann BC, 2005, NEURON, V45, P459, DOI 10.1016/j.neuron.2005.01.010; Yacubian J, 2007, P NATL ACAD SCI USA, V104, P8125, DOI 10.1073/pnas.0702029104; Yavich L, 2007, J NEUROSCI, V27, P10196, DOI 10.1523/JNEUROSCI.0665-07.2007; Zubieta JK, 2003, SCIENCE, V299, P1240, DOI 10.1126/science.1078546; ZURCHER G, 1990, ADV NEUROL, V53, P497	48	49	49	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2013	8	4							e61839	10.1371/journal.pone.0061839	http://dx.doi.org/10.1371/journal.pone.0061839			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130DR	23613951	Green Published, gold, Green Submitted			2022-12-25	WOS:000317893400117
J	Marco-Rius, F; Caballero, P; Moran, P; de Leaniz, CG				Marco-Rius, Francisco; Caballero, Pablo; Moran, Paloma; Garcia de Leaniz, Carlos			Mixed-Effects Modelling of Scale Growth Profiles Predicts the Occurrence of Early and Late Fish Migrants	PLOS ONE			English	Article							SALMON SALMO-SALAR; WILD ATLANTIC SALMON; BROWN TROUT; COMPENSATORY GROWTH; ESTIMATING AGE; BODY-SIZE; EGG SIZE; SURVIVAL; POPULATION; MIGRATION	Fish growth is commonly used as a proxy for fitness but this is only valid if individual growth variation can be interpreted in relation to conspecifics' performance. Unfortunately, assessing individual variation in growth rates is problematic under natural conditions because subjects typically need to be marked, repeated measurements of body size are difficult to obtain in the field, and recaptures may be limited to a few time events which will generally vary among individuals. The analysis of consecutive growth rings (circuli) found on scales and other hard structures offers an alternative to mark and recapture for examining individual growth variation in fish and other aquatic vertebrates where growth rings can be visualized, but accounting for autocorrelations and seasonal growth stanzas has proved challenging. Here we show how mixed-effects modelling of scale growth increments (inter-circuli spacing) can be used to reconstruct the growth trajectories of sea trout (Salmo trutta) and correctly classify 89% of individuals into early or late seaward migrants (smolts). Early migrants grew faster than late migrants during their first year of life in freshwater in two natural populations, suggesting that migration into the sea was triggered by ontogenetic (intrinsic) drivers, rather than by competition with conspecifics. Our study highlights the profound effects that early growth can have on age at migration of a paradigmatic fish migrant and illustrates how the analysis of inter-circuli spacing can be used to reconstruct the detailed growth of individuals when these cannot be marked or are only caught once.	[Marco-Rius, Francisco; Moran, Paloma] Univ Vigo, Dept Bioquim Genet & Inmunol, Vigo 36310, Spain; [Caballero, Pablo] Xunta Galicia, Serv Conservac Nat, Conselleria Medio Rural, Pontevedra, Spain; [Garcia de Leaniz, Carlos] Swansea Univ, Dept BioSci, Swansea, W Glam, Wales	Universidade de Vigo; Swansea University	de Leaniz, CG (corresponding author), Swansea Univ, Dept BioSci, Swansea, W Glam, Wales.	c.garciadeleaniz@swansea.ac.uk	Caballero Javierre, Pablo/AHA-9013-2022; de Leaniz, Carlos Garcia/AAQ-4171-2020; Morán, Paloma/J-6877-2014	Caballero Javierre, Pablo/0000-0002-2541-7684; de Leaniz, Carlos Garcia/0000-0003-1650-2729; Morán, Paloma/0000-0002-3644-8507	Ministerio de Ciencia y Tecnologia [CGL2007-60572, CGL2010-14964]; Fondos FEDER [PGIDIT03PXIC30102PN, 2010/80]; Spanish Government [BES-2008-001973]	Ministerio de Ciencia y Tecnologia(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fondos FEDER(European Commission); Spanish Government(Spanish GovernmentEuropean Commission)	This work was funded by grants from Ministerio de Ciencia y Tecnologia (CGL2007-60572 and CGL2010-14964), and Fondos FEDER (PGIDIT03PXIC30102PN; Grupos de Referencia Competitiva, 2010/80). Francisco Marco-Rius was supported by a doctoral scholarship from the Spanish Government (BES-2008-001973). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Albert JS, 2012, EVOL BIOL, V39, P324, DOI 10.1007/s11692-011-9149-0; Ali M, 2003, FISH FISH, V4, P147, DOI 10.1046/j.1467-2979.2003.00120.x; Anderson JH, 2010, MOL ECOL, V19, P2562, DOI 10.1111/j.1365-294X.2010.04652.x; Angilletta MJ, 2011, INTEGR COMP BIOL, V51, P653, DOI 10.1093/icb/icr091; [Anonymous], 2010, R LANG ENV STAT COMP; Aubin-Horth N, 2002, CAN J FISH AQUAT SCI, V59, P1575, DOI [10.1139/f02-124, 10.1139/F02-124]; Bagenal T.B., 1978, IBP HDB, V3, P101; Bagliniere J., 1985, B FR PECHE PISCIC, V298, P69, DOI DOI 10.1051/KMAE:1985002; Beechie T, 2006, BIOL CONSERV, V130, P560, DOI 10.1016/j.biocon.2006.01.019; Bolnick DI, 2003, AM NAT, V161, P1, DOI 10.1086/343878; Bono LM, 2011, J FISH BIOL, V78, P1311, DOI 10.1111/j.1095-8649.2011.02932.x; Britton JR, 2004, FISHERIES MANAG ECOL, V11, P415, DOI 10.1111/j.1365-2400.2004.00421.x; Caballero Moran, 2012, TROUT PHYSL CONSERVA, P9; Ciborowski KL, 2007, CONSERV GENET, V8, P1355, DOI 10.1007/s10592-007-9286-2; Clutton-Brock T, 2010, TRENDS ECOL EVOL, V25, P562, DOI 10.1016/j.tree.2010.08.002; Consuegra S, 2005, CONSERV GENET, V6, P823, DOI 10.1007/s10592-005-9042-4; Consuegra S, 2002, MOL ECOL, V11, P2037, DOI 10.1046/j.1365-294X.2002.01592.x; Crozier LG, 2010, J ANIM ECOL, V79, P342, DOI 10.1111/j.1365-2656.2009.01641.x; De Leaniz CG, 2000, FISHERIES MANAG ECOL, V7, P489, DOI 10.1046/j.1365-2400.2000.00223.x; DeAngelis DL, 2005, ANNU REV ECOL EVOL S, V36, P147, DOI 10.1146/annurev.ecolsys.36.102003.152644; Dieterman DJ, 2012, ECOL FRESHW FISH, V21, P483, DOI 10.1111/j.1600-0633.2012.00567.x; Downes GM, 2009, DENDROCHRONOLOGIA, V27, P147, DOI 10.1016/j.dendro.2009.06.006; Einum S, 2002, AM NAT, V160, P756, DOI 10.1086/343876; Einum S, 2005, OECOLOGIA, V143, P203, DOI 10.1007/s00442-004-1793-y; Einum S, 2012, METHODS ECOL EVOL, V3, P438, DOI 10.1111/j.2041-210X.2011.00167.x; Elliott J.M., 1994, QUANTITATIVE ECOLOGY; English S, 2012, OECOLOGIA, V169, P143, DOI 10.1007/s00442-011-2192-9; Forseth T, 1999, J ANIM ECOL, V68, P783, DOI 10.1046/j.1365-2656.1999.00329.x; Fukaya K, 2010, J ANIM ECOL, V79, P1270, DOI 10.1111/j.1365-2656.2010.01727.x; Gagne S, 2008, J FISH BIOL, V73, P153, DOI 10.1111/j.1095-8649.2008.01922.x; Garcia de Leaniz C, 2007, BIOL REV, V82, P173, DOI 10.1111/j.1469-185X.2006.00004.x; Gross MR, 1998, J THEOR BIOL, V192, P445, DOI 10.1006/jtbi.1998.0665; Gross MR, 1996, TRENDS ECOL EVOL, V11, P92, DOI 10.1016/0169-5347(96)81050-0; Gurney WSC, 2003, ECOLOGY, V84, P2777, DOI 10.1890/02-0536; Hinrichsen HH, 2007, FISH OCEANOGR, V16, P207, DOI 10.1111/j.1365-2419.2007.00425.x; Hogan F, 2010, J FISH BIOL, V76, P2502, DOI 10.1111/j.1095-8649.2010.02650.x; Huntingford FA, 1997, J FISH BIOL, V51, P1009, DOI 10.1111/j.1095-8649.1997.tb01539.x; Jacobsen JA, 2001, FISH RES, V52, P169, DOI 10.1016/S0165-7836(00)00255-1; Jonsson N, 2002, FRESHWATER BIOL, V47, P1391, DOI 10.1046/j.1365-2427.2002.00873.x; Jonsson N, 2003, J APPL ECOL, V40, P900, DOI 10.1046/j.1365-2664.2003.00851.x; Kallio-Nyberg I, 2006, FISH RES, V80, P295, DOI 10.1016/j.fishres.2006.03.026; Kearney M, 2010, PHILOS T R SOC B, V365, P3469, DOI 10.1098/rstb.2010.0034; Kohn F, 2007, J ANIM SCI, V85, P84, DOI 10.2527/jas.2006-271; Konishi S, 2008, SPRINGER SER STAT, P1, DOI 10.1007/978-0-387-71887-3; Kopp EB, 2009, EVOL APPL, V2, P132, DOI 10.1111/j.1752-4571.2008.00062.x; Kuparinen A, 2009, MAR ECOL PROG SER, V376, P245, DOI 10.3354/meps07789; Letcher BH, 2011, EVOL APPL, V4, P602, DOI 10.1111/j.1752-4571.2011.00184.x; Marco-Rius F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045528; Mccarthy JL, 2008, J FISH BIOL, V72, P1572, DOI 10.1111/j.1095-8649.2008.01820.x; Morinville GR, 2003, CAN J FISH AQUAT SCI, V60, P401, DOI [10.1139/f03-036, 10.1139/F03-036]; Morris MR, 2012, FUNCT ECOL, V26, P723, DOI 10.1111/j.1365-2435.2012.01983.x; Moyes K, 2009, J ANIM ECOL, V78, P406, DOI 10.1111/j.1365-2656.2008.01497.x; NAKANO S, 1995, J ANIM ECOL, V64, P75, DOI 10.2307/5828; Nicholson JK, 2004, NAT BIOTECHNOL, V22, P1268, DOI 10.1038/nbt1015; Peyronnet A, 2007, J FISH BIOL, V71, P684, DOI 10.1111/j.1095-8649.2007.01538.x; Pinheiro JC, 2009, MIXED EFFECTS MODELS; Regnier T, 2010, J COMP PHYSIOL B, V180, P25, DOI 10.1007/s00360-009-0385-x; Rifflart R, 2006, FISH RES, V78, P380, DOI 10.1016/j.fishres.2005.11.018; Rollinson N, 2010, EVOL ECOL RES, V12, P949; Rollinson N, 2011, OECOLOGIA, V166, P889, DOI 10.1007/s00442-011-1945-9; Rundle Howard D., 2004, P192; Saloniemi I, 2004, ICES J MAR SCI, V61, P782, DOI 10.1016/j.icesjms.2004.03.032; SCHLUTER D, 1994, SCIENCE, V266, P798, DOI 10.1126/science.266.5186.798; Schroder V, 2011, BIOL INVASIONS, V13, P203, DOI 10.1007/s10530-010-9802-z; Scott RD, 2012, MAR ECOL PROG SER, V450, P147, DOI 10.3354/meps09565; SHEARER WM, 1992, 188 ICES, P46; Stearns S., 1992, EVOLUTION LIFE HIST; Takahashi T, 2009, MOL ECOL, V18, P3110, DOI 10.1111/j.1365-294X.2009.04248.x; TAYLOR LR, 1977, NATURE, V265, P415, DOI 10.1038/265415a0; Thorpe JE, 1998, EVOL ECOL, V12, P581, DOI 10.1023/A:1022351814644; van de Pol M, 2012, METHODS ECOL EVOL, V3, P268, DOI 10.1111/j.2041-210X.2011.00160.x; Velasco G, 2007, J APPL ICHTHYOL, V23, P64, DOI 10.1111/j.1439-0426.2006.00793.x; von Bertalanffy L, 1938, HUM BIOL, V10, P181, DOI DOI 10.2307/41447359; WANG YG, 1995, CAN J FISH AQUAT SCI, V52, P1368, DOI 10.1139/f95-132; Wilson DS, 2004, TRENDS ECOL EVOL, V19, P245, DOI 10.1016/j.tree.2004.02.008; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Wysujack K, 2009, ECOL FRESHW FISH, V18, P52, DOI 10.1111/j.1600-0633.2008.00322.x; Zens MS, 2003, TRENDS ECOL EVOL, V18, P366, DOI 10.1016/S0169-5347(03)00096-X; Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x; Zuur Alain F., 2009, P1	81	9	10	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2013	8	4							e61744	10.1371/journal.pone.0061744	http://dx.doi.org/10.1371/journal.pone.0061744			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130DR	23613922	Green Published, gold, Green Submitted			2022-12-25	WOS:000317893400101
J	Bemelmans, AP; Duque, S; Riviere, C; Astord, S; Desrosiers, M; Marais, T; Sahel, JA; Voit, T; Barkats, M				Bemelmans, Alexis-Pierre; Duque, Sandra; Riviere, Christel; Astord, Stephanie; Desrosiers, Melissa; Marais, Thibault; Sahel, Jose-Alain; Voit, Thomas; Barkats, Martine			A Single Intravenous AAV9 Injection Mediates Bilateral Gene Transfer to the Adult Mouse Retina	PLOS ONE			English	Article							CONGENITAL AMAUROSIS; SUBRETINAL INJECTION; THERAPY; TRANSDUCTION; DELIVERY; VECTOR; MICE; EXPRESSION; SEROTYPE; TARGETS	Widespread gene delivery to the retina is an important challenge for the treatment of retinal diseases, such as retinal dystrophies. We and others have recently shown that the intravenous injection of a self-complementary (sc) AAV9 vector can direct efficient cell transduction in the central nervous system, in both neonatal and adult animals. We show here that the intravenous injection of scAAV9 encoding green fluorescent protein (GFP) resulted in gene transfer to all layers of the retina in adult mice, despite the presence of a mature blood-eye barrier. Cell morphology studies and double-labeling with retinal cell-specific markers showed that GFP was expressed in retinal pigment epithelium cells, photoreceptors, bipolar cells, Muller cells and retinal ganglion cells. The cells on the inner side of the retina, including retinal ganglion cells in particular, were transduced with the highest efficiency. Quantification of the cell population co-expressing GFP and Brn-3a showed that 45% of the retinal ganglion cells were efficiently transduced after intravenous scAAV9-GFP injection in adult mice. This study provides the first demonstration that a single intravenous scAAV9 injection can deliver transgenes to the retinas of both eyes in adult mice, suggesting that this vector serotype is able to cross mature blood-eye barriers. This intravascular gene transfer approach, by eliminating the potential invasiveness of ocular surgery, could constitute an alternative when fragility of the retina precludes subretinal or intravitreal injections of viral vectors, opening up new possibilities for gene therapy for retinal diseases.	[Bemelmans, Alexis-Pierre; Desrosiers, Melissa; Sahel, Jose-Alain] INSERM, U968, Paris, France; [Bemelmans, Alexis-Pierre; Desrosiers, Melissa; Sahel, Jose-Alain] Univ Paris 06, Inst Vis, UM80, Paris, France; [Bemelmans, Alexis-Pierre; Desrosiers, Melissa; Sahel, Jose-Alain] CNRS, UMR 7210, Paris, France; [Bemelmans, Alexis-Pierre] Inst Imagerie Biomed I2BM, Mol Imaging Res Ctr MIRCen, Fontenay Aux Roses, France; [Bemelmans, Alexis-Pierre] Inst Imagerie Biomed I2BM, Commissariat Energie Atom & Energies Alternat CEA, CNRS URA2210, Inst Imagerie Biomed I2BM,DSV, Fontenay Aux Roses, France; [Duque, Sandra; Astord, Stephanie; Marais, Thibault; Voit, Thomas; Barkats, Martine] Univ Paris 06, Inst Myol, UPMC AIM UMR S974 UM76, CNRS UMR 7215, Paris, France; [Riviere, Christel] Genethon, Evry, France; [Sahel, Jose-Alain] Ctr Hosp Natl Ophtalmol Quinze Vingts, INSERM DHOS CIC 503, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CEA; UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; CHNO des Quinze-Vingts; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Barkats, M (corresponding author), Univ Paris 06, Inst Myol, UPMC AIM UMR S974 UM76, CNRS UMR 7215, Paris, France.	m.barkats@institut-myologie.org	Sahel, Jose-Alain/F-3172-2017; Bemelmans, Alexis-Pierre/H-4476-2019	Sahel, Jose-Alain/0000-0002-4831-1153; Bemelmans, Alexis-Pierre/0000-0001-7605-5225; DESROSIERS, MELISSA/0000-0003-2776-9664	Universite Pierre et Marie Curie (UPMC); Institut National de la Sante et de la Recherche Medicale (INSERM); Centre National de la Recherche Scientifique (CNRS); Association Francaise contre les Myopathies (AFM)	Universite Pierre et Marie Curie (UPMC); Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies)	This work was supported by the Universite Pierre et Marie Curie (UPMC), the Institut National de la Sante et de la Recherche Medicale (INSERM), the Centre National de la Recherche Scientifique (CNRS), and the Association Francaise contre les Myopathies (AFM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aartsen WM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012387; Abouzeid H, 2006, ACTA OPHTHALMOL SCAN, V84, P597, DOI 10.1111/j.1600-0420.2006.00676.x; Acland GM, 2001, NAT GENET, V28, P92, DOI 10.1038/88327; Bainbridge JW, 2008, GENE THER, V15, P1191, DOI 10.1038/gt.2008.117; Bainbridge JWB, 2008, NEW ENGL J MED, V358, P2231, DOI 10.1056/NEJMoa0802268; Barkats M, 2007, WIDESPREAD GENE DELI; Bemelmans AP, 2005, J GENE MED, V7, P1367, DOI 10.1002/jgm.788; BENNETT J, 1994, INVEST OPHTH VIS SCI, V35, P2535; Bird AC, 2010, J CLIN INVEST, V120, P3033, DOI 10.1172/JCI42437; Bishop PN, 2002, EYE, V16, P454, DOI 10.1038/sj.eye.6700199; Bock F, 2007, INVEST OPHTH VIS SCI, V48, P2545, DOI 10.1167/iovs.06-0570; Bostick B, 2007, GENE THER, V14, P1605, DOI 10.1038/sj.gt.3303029; Boye SE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011306; Buch PK, 2008, GENE THER, V15, P849, DOI 10.1038/gt.2008.66; Cheng LY, 2005, RETINA-J RET VIT DIS, V25, P193, DOI 10.1097/00006982-200502000-00013; Cunha-Vaz JG, 1997, DOC OPHTHALMOL, V93, P149, DOI 10.1007/BF02569055; Dalkara D, 2011, GENE THER; Dalkara D, 2009, MOL THER, V17, P2096, DOI 10.1038/mt.2009.181; den Hollander AI, 2010, J CLIN INVEST, V120, P3042, DOI 10.1172/JCI42258; Dominguez E, 2011, HUM MOL GENET, V20, P681, DOI 10.1093/hmg/ddq514; Duque S, 2009, MOL THER, V17, P1187, DOI 10.1038/mt.2009.71; Foust KD, 2010, NAT BIOTECHNOL, V28, P271, DOI 10.1038/nbt.1610; Foust KD, 2009, NAT BIOTECHNOL, V27, P59, DOI 10.1038/nbt.1515; Gray SJ, 2011, MOL THER, V19, P1058, DOI 10.1038/mt.2011.72; Hauswirth WW, 2008, HUM GENE THER, V19, P979, DOI 10.1089/hum.2008.107; Hayworth CR, 2008, J TOXICOL ENV HEAL A, V71, P1582, DOI 10.1080/15287390802414190; Inagaki K, 2006, MOL THER, V14, P45, DOI 10.1016/j.ymthe.2006.03.014; Joussemet B, 2011, EXP EYE RES, V93, P491, DOI 10.1016/j.exer.2011.06.012; Klein RL, 2008, MOL THER, V16, P89, DOI 10.1038/sj.mt.6300331; Kolstad KD, 2010, HUM GENE THER, V21, P571, DOI 10.1089/hum.2009.194; Kotchey NM, 2011, MOL THER, V19, P1079, DOI 10.1038/mt.2011.3; Le Meur G, 2007, GENE THER, V14, P292, DOI 10.1038/sj.gt.3302861; LIU ISC, 1994, NEURON, V13, P377, DOI 10.1016/0896-6273(94)90354-9; Maguire AM, 2008, NEW ENGL J MED, V358, P2240, DOI 10.1056/NEJMoa0802315; Miyoshi H, 1997, P NATL ACAD SCI USA, V94, P10319, DOI 10.1073/pnas.94.19.10319; Nadal-Nicolas FM, 2009, INVEST OPHTH VIS SCI, V50, P3860, DOI 10.1167/iovs.08-3267; Pacak CA, 2006, CIRC RES, V99, pE3, DOI 10.1161/01.RES.0000237661.18885.f6; Pacak Christina A, 2008, Genet Vaccines Ther, V6, P13, DOI 10.1186/1479-0556-6-13; Pang JJ, 2008, INVEST OPHTH VIS SCI, V49, P4278, DOI 10.1167/iovs.07-1622; Park TK, 2009, GENE THER, V16, P916, DOI 10.1038/gt.2009.61; Passini MA, 2011, TRENDS MOL MED, V17, P259, DOI 10.1016/j.molmed.2011.01.002; Petrs-Silva H, 2009, MOL THER, V17, P463, DOI 10.1038/mt.2008.269; Rahim AA, 2011, FASEB J, V25, P3505, DOI 10.1096/fj.11-182311; Simonelli F, 2010, MOL THER, V18, P643, DOI 10.1038/mt.2009.277; Simons DL, 2011, P NATL ACAD SCI USA, V108, P6276, DOI 10.1073/pnas.1019222108; Stone EM, 1997, SCIENCE, V275, P668, DOI 10.1126/science.275.5300.668; Sun X, 2010, GENE THER, V17, P117, DOI 10.1038/gt.2009.104; Tamm ER, 2002, PROG RETIN EYE RES, V21, P395, DOI 10.1016/S1350-9462(02)00010-1; Valori CF, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000830; Williams DS, 2008, VISION RES, V48, P433, DOI 10.1016/j.visres.2007.08.015; Xu R, 2001, GENE THER, V8, P1323, DOI 10.1038/sj.gt.3301529; Yanez-Munoz RJ, 2006, NAT MED, V12, P348, DOI 10.1038/nm1365; Zincarelli C, 2008, MOL THER, V16, P1073, DOI 10.1038/mt.2008.76	53	12	14	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2013	8	4							e61618	10.1371/journal.pone.0061618	http://dx.doi.org/10.1371/journal.pone.0061618			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125TD	23613884	gold, Green Published, Green Submitted			2022-12-25	WOS:000317563300032
J	Jones-Davis, DM; Yang, M; Rider, E; Osbun, NC; da Gente, GJ; Li, J; Katz, AM; Weber, MD; Sen, S; Crawley, J; Sherr, EH				Jones-Davis, Dorothy M.; Yang, Mu; Rider, Eric; Osbun, Nathan C.; da Gente, Gilberto J.; Li, Jiang; Katz, Adam M.; Weber, Michael D.; Sen, Saunak; Crawley, Jacqueline; Sherr, Elliott H.			Quantitative Trait Loci for Interhemispheric Commissure Development and Social Behaviors in the BTBR T+ tf/J Mouse Model of Autism	PLOS ONE			English	Article							CORPUS-CALLOSUM; SPECTRUM DISORDERS; WHITE-MATTER; T+TF/J MICE; STRAINS; SOCIABILITY; RECURRENCE; PHENOTYPES; AGENESIS; DEFICITS	Background: Autism and Agenesis of the Corpus Callosum (AgCC) are interrelated behavioral and anatomic phenotypes whose genetic etiologies are incompletely understood. We used the BTBR T+ tf/ J (BTBR) strain, exhibiting fully penetrant AgCC, a diminished hippocampal commissure, and abnormal behaviors that may have face validity to autism, to study the genetic basis of these disorders. Methods: We generated 410 progeny from an F2 intercross between the BTBR and C57BL/ 6J strains. The progeny were phenotyped for social behaviors (as juveniles and adults) and commisural morphology, and genotyped using 458 markers. Quantitative trait loci (QTL) were identified using genome scans; significant loci were fine-mapped, and the BTBR genome was sequenced and analyzed to identify candidate genes. Results: Six QTL meeting genome-wide significance for three autism-relevant behaviors in BTBR were identified on chromosomes 1, 3, 9, 10, 12, and X. Four novel QTL for commissural morphology on chromosomes 4, 6, and 12 were also identified. We identified a highly significant QTL (LOD score = 20.2) for callosal morphology on the distal end of chromosome 4. Conclusions: We identified several QTL and candidate genes for both autism-relevant traits and commissural morphology in the BTBR mouse. Twenty-nine candidate genes were associated with synaptic activity, axon guidance, and neural development. This is consistent with a role for these processes in modulating white matter tract development and aspects of autism-relevant behaviors in the BTBR mouse. Our findings reveal candidate genes in a mouse model that will inform future human and preclinical studies of autism and AgCC.	[Jones-Davis, Dorothy M.; Rider, Eric; Osbun, Nathan C.; da Gente, Gilberto J.; Li, Jiang; Sherr, Elliott H.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Yang, Mu; Katz, Adam M.; Weber, Michael D.; Crawley, Jacqueline] NIMH, Lab Behav Neurosci, Intramural Res Program, NIH, Bethesda, MD 20892 USA; [Sen, Saunak] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); University of California System; University of California San Francisco	Sherr, EH (corresponding author), Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA.	sherre@neuropeds.ucsf.edu		Jones-Davis, Dorothy/0000-0001-7209-9183	Pfizer, Inc. [P0030953]; MH02179 from the National Institute of Mental Health Intramural Research Program [MH02179]; National Institutes of Health [K02NS052192, NS062173]; National Institute of General Medical Sciences/National Institutes of Health [K12GM081266]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM081266] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K02NS052192, R21NS062173] Funding Source: NIH RePORTER	Pfizer, Inc.(Pfizer); MH02179 from the National Institute of Mental Health Intramural Research Program; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by Grant P0030953 from Pfizer, Inc.(http://www.pfizer.com) to Dr. Elliott Sherr. Dr. Mathew Pletcher (employed by Pfizer, Inc.) provided suggestions in the design and interpretation of the study, and Dr. Nicholas Brandon (employed by Pfizer, Inc.) provided a critical reading of the manuscript. This work was also supported by Award MH02179 from the National Institute of Mental Health Intramural Research Program to Dr. Jacqueline Crawley and Dr. Mu Yang, National Institutes of Health Awards K02NS052192 and NS062173 to Dr.Elliott Sherr, and Award Number K12GM081266 from the National Institute of General Medical Sciences/National Institutes of Health (http://projectreporter.nih.gov/project_ info_ description.cfm? aid = 7869455& icde = 12962536& ddparam = & ddvalue = & ddsub = & cr = 443& csb = GNA& cs = ASC) to Dr. Dorothy Jones-Davis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander AL, 2007, NEUROIMAGE, V34, P61, DOI 10.1016/j.neuroimage.2006.08.032; American Psychiatric Association American Psychiatric Association Task Force on DSM-IV American Psychiatric Association Task Force on Nomenclature and Statistics, 1994, DIAGNOSTIC AND STATI, Vxxvii; Anitha A, 2008, AM J MED GENET B, V147B, P1019, DOI 10.1002/ajmg.b.30697; Barnea-Goraly N, 2004, BIOL PSYCHIAT, V55, P323, DOI 10.1016/j.biopsych.2003.10.022; Bolivar VJ, 2007, BEHAV BRAIN RES, V176, P21, DOI 10.1016/j.bbr.2006.09.007; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; Chadman KK, 2008, AUTISM RES, V1, P147, DOI 10.1002/aur.22; Constantino JN, 2010, AM J PSYCHIAT, V167, P1349, DOI 10.1176/appi.ajp.2010.09101470; Cooper GM, 2011, NAT REV GENET, V12, P628, DOI 10.1038/nrg3046; Fassio A, 2011, HUM MOL GENET, V20, P2297, DOI 10.1093/hmg/ddr122; Frazier TW, 2009, BIOL PSYCHIAT, V66, P935, DOI 10.1016/j.biopsych.2009.07.022; Fridley BL, 2011, EUR J HUM GENET, V19, P837, DOI 10.1038/ejhg.2011.57; Glass HC, 2008, AM J MED GENET A, V146A, P2495, DOI 10.1002/ajmg.a.32418; Hallmayer J., 2011, ARCH GEN PSYCHIAT; Keller TA, 2007, NEUROREPORT, V18, P23, DOI 10.1097/01.wnr.0000239965.21685.99; Kumar A, 2010, CEREB CORTEX, V20, P2103, DOI 10.1093/cercor/bhp278; Kumar RA, 2010, J MED GENET, V47, P81, DOI 10.1136/jmg.2008.065821; Lau YC, 2012, JOURNAL OF AUTISM AN; Le Roy I, 1998, BRAIN RES, V811, P173, DOI 10.1016/S0006-8993(98)00975-5; Livy DJ, 1997, EXP NEUROL, V146, P491, DOI 10.1006/exnr.1997.6564; McFarlane HG, 2008, GENES BRAIN BEHAV, V7, P152, DOI 10.1111/j.1601-183X.2007.00330.x; Moy SS, 2008, BEHAV BRAIN RES, V191, P118, DOI 10.1016/j.bbr.2008.03.015; Nishiyama T, 2009, J HUM GENET, V54, P721, DOI 10.1038/jhg.2009.105; Ozonoff S, 2011, PEDIATRICS, V128, pE488, DOI 10.1542/peds.2010-2825; Paul LK, 2007, NAT REV NEUROSCI, V8, P287, DOI 10.1038/nrn2107; Pearson BL, 2011, GENES BRAIN BEHAV, V10, P228, DOI 10.1111/j.1601-183X.2010.00659.x; Scattoni ML, 2011, GENES BRAIN BEHAV, V10, P44, DOI 10.1111/j.1601-183X.2010.00623.x; Sen S, 2001, GENETICS, V159, P371; Sen S, 2007, MAMM GENOME, V18, P87, DOI 10.1007/s00335-006-0090-y; Silverman JL, 2013, NEUROPHARMACOLOGY, V64, P268, DOI 10.1016/j.neuropharm.2012.07.013; Silverman JL, 2010, NEUROSCIENCE, V171, P1197, DOI 10.1016/j.neuroscience.2010.09.059; Silverman JL, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003501; Silverman JL, 2010, NAT REV NEUROSCI, V11, P490, DOI 10.1038/nrn2851; Team RDC, 2012, R LANG ENV STAT COMP; Wahlsten D, 2003, BRAIN RES, V971, P47, DOI 10.1016/S0006-8993(03)02354-0; Weinstein M, 2011, HUM BRAIN MAPP, V32, P534, DOI 10.1002/hbm.21042; Yang M, JOURNAL OF NEUROSCIE; Yang M, 2007, INT J DEV NEUROSCI, V25, P515, DOI 10.1016/j.ijdevneu.2007.09.008; Yang Mu, 2011, Curr Protoc Neurosci, VChapter 8, DOI 10.1002/0471142301.ns0826s56; Yang M, 2011, AUTISM RES, V4, P17, DOI 10.1002/aur.163; Yang M, 2009, EUR J NEUROSCI, V29, P1663, DOI 10.1111/j.1460-9568.2009.06714.x; Zahir FR, 2011, PEDIATR RES, V69, p92R, DOI 10.1203/PDR.0b013e318213565e	42	42	43	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2013	8	4							e61829	10.1371/journal.pone.0061829	http://dx.doi.org/10.1371/journal.pone.0061829			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	125TD	23613947	Green Submitted, Green Published, gold			2022-12-25	WOS:000317563300039
J	Gullingsrud, J; Saveria, T; Amos, E; Duffy, PE; Oleinikov, AV				Gullingsrud, Justin; Saveria, Tracy; Amos, Emily; Duffy, Patrick E.; Oleinikov, Andrew V.			Structure-Function-Immunogenicity Studies of PfEMP1 Domain DBL2 beta(PF11_0521), a Malaria Parasite Ligand for ICAM-1	PLOS ONE			English	Article							INTERCELLULAR-ADHESION MOLECULE-1; PLASMODIUM-FALCIPARUM; CRYSTAL-STRUCTURE; BINDING DOMAIN; IMMUNE EVASION; CYTOADHERENCE; RECEPTOR; PROTEIN; SEQUESTRATION; ERYTHROCYTES	Plasmodium falciparum virulence has been ascribed to its ability to sequester in deep vascular beds, mediated by the variant surface antigen family PfEMP1 binding endothelial receptors like ICAM-1. We previously observed that naturally-acquired antibodies that block a PfEMP1 domain, DBL2 beta of PF11_0521 allele, from binding to the human ICAM1 receptor, reduce the risk of malaria hospitalization in children. Here, we find that DBL2 beta(PF11_0521) binds ICAM-1 in the low nM range and relate the structure of this domain with its function and immunogenicity. We demonstrate that the interaction with ICAM-1 is not impaired by point mutations in the N-terminal subdomain or in the flexible Loop 4 of DBL2 beta(PF11_0521), although both substructures were previously implicated in binding ICAM-1. These data will help to refine the existing model of DBL beta::ICAM-1 interactions. Antibodies raised against full-length DBL2 beta(PF11_0521), but not truncated forms lacking the N terminal fragment, block its interaction with ICAM-1. Our data suggest that full length domain is optimal for displaying functional epitopes and has a broad surface of interaction with ICAM-1 that is not disrupted by individual amino acid substitutions at putative key residues. This information might be important for the future design of anti-malarial vaccines based on PfEMP1 antigens.	[Gullingsrud, Justin; Saveria, Tracy; Amos, Emily; Duffy, Patrick E.; Oleinikov, Andrew V.] Seattle Biomed Res Inst, Seattle, WA 98109 USA; [Duffy, Patrick E.] Univ Washington, Program Pathobiol, Dept Global Hlth, Seattle, WA 98195 USA; [Duffy, Patrick E.] NIAID, Lab Malaria Immunol & Vaccinol, NIH, Rockville, MD USA	Center for Infectious Disease Research; University of Washington; University of Washington Seattle; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Oleinikov, AV (corresponding author), Seattle Biomed Res Inst, 4 Nickerson St, Seattle, WA 98109 USA.	andrew.oleinikov@sbri.org			National Institutes of Health [1R21AI064503, 1R56AI083668, 1R01AI092120]; Foundation of the National Institutes of Health through the Grand Challenges in Global Health initiative [29202]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI092120, R56AI083668, R21AI064503] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation of the National Institutes of Health through the Grand Challenges in Global Health initiative; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work was supported by National Institutes of Health (http://www.nih.gov) [grants 1R21AI064503, 1R56AI083668, and 1R01AI092120 to AVO], and funded in part by the Foundation of the National Institutes of Health through the Grand Challenges in Global Health initiative (http://www.grandchallenges.org/Pages/default.aspx) [Grant No. 29202 to PED]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bengtsson A, 2013, J IMMUNOL, V190, P240, DOI 10.4049/jimmunol.1202578; Bertonati C, 2007, PROTEINS, V69, P215, DOI 10.1002/prot.21691; BIGGS BA, 1990, J EXP MED, V171, P1883, DOI 10.1084/jem.171.6.1883; Chakravorty SJ, 2008, BIOCHEM SOC T, V36, P221, DOI 10.1042/BST0360221; Deleage G, 1997, BIOCHIMIE, V79, P681, DOI 10.1016/S0300-9084(97)83524-9; Dondorp AM, 2008, TRANSFUS CLIN BIOL, V15, P56, DOI 10.1016/j.tracli.2008.04.013; Fried M, 1996, SCIENCE, V272, P1502, DOI 10.1126/science.272.5267.1502; Gardner JP, 1996, P NATL ACAD SCI USA, V93, P3503, DOI 10.1073/pnas.93.8.3503; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Gray C, 2003, MOL BIOCHEM PARASIT, V128, P187, DOI 10.1016/S0166-6851(03)00075-6; Higgins MK, 2008, J BIOL CHEM, V283, P21842, DOI 10.1074/jbc.C800086200; Howell DPG, 2008, MOL MICROBIOL, V67, P78, DOI 10.1111/j.1365-2958.2007.06019.x; Howell DPG, 2006, MOL BIOCHEM PARASIT, V148, P1, DOI 10.1016/j.molbiopara.2006.03.004; Hughes KR, 2010, MOL BIOCHEM PARASIT, V169, P71, DOI 10.1016/j.molbiopara.2009.09.007; Klein MM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000147; Lineweaver H, 1934, J AM CHEM SOC, V56, P658, DOI 10.1021/ja01318a036; McHenry AM, 2006, TRENDS BIOCHEM SCI, V31, P487, DOI 10.1016/j.tibs.2006.07.003; MILLER LH, 1994, SCIENCE, V264, P1878, DOI 10.1126/science.8009217; Newbold C, 1997, AM J TROP MED HYG, V57, P389, DOI 10.4269/ajtmh.1997.57.389; Ochola LB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014741; Oleinikov AV, 2008, J INFECT DIS, V197, P1119, DOI 10.1086/529526; Oleinikov AV, 2007, J INFECT DIS, V196, P155, DOI 10.1086/518513; Oleinikov AV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031011; Oleinikov AV, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000386; Rask TS, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000933; Singh K, 2008, NAT STRUCT MOL BIOL, V24, P24; Singh SK, 2006, NATURE, V439, P741, DOI 10.1038/nature04443; SMITH JD, 1995, CELL, V82, P101, DOI 10.1016/0092-8674(95)90056-X; Smith JD, 2000, P NATL ACAD SCI USA, V97, P1766, DOI 10.1073/pnas.040545897; Smith JD, 2000, MOL BIOCHEM PARASIT, V110, P293, DOI 10.1016/S0166-6851(00)00279-6; Springer AL, 2004, MOL BIOCHEM PARASIT, V137, P55, DOI 10.1016/j.molbiopara.2004.03.019; SU XZ, 1995, CELL, V82, P89, DOI 10.1016/0092-8674(95)90055-1; Tolia NH, 2005, CELL, V122, P183, DOI 10.1016/j.cell.2005.05.033; TURNER GDH, 1994, AM J PATHOL, V145, P1057; Wang W, 1999, BIOTECHNIQUES	35	16	16	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2013	8	4							e61323	10.1371/journal.pone.0061323	http://dx.doi.org/10.1371/journal.pone.0061323			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123JP	23593462	gold, Green Submitted, Green Published			2022-12-25	WOS:000317385300071
J	Teillet, A; Dybal, K; Kerry, BR; Miller, AJ; Curtis, RHC; Hedden, P				Teillet, Alice; Dybal, Katarzyna; Kerry, Brian R.; Miller, Anthony J.; Curtis, Rosane H. C.; Hedden, Peter			Transcriptional Changes of the Root-Knot Nematode Meloidogyne incognita in Response to Arabidopsis thaliana Root Signals	PLOS ONE			English	Article							POTATO CYST-NEMATODE; DIFFERENTIAL GENE-EXPRESSION; PLANT-PARASITIC NEMATODES; CELLULOSE-BINDING PROTEIN; 2ND-STAGE JUVENILES; EFFECTOR PROTEIN; IN-VITRO; HOST; IDENTIFICATION; SECRETION	Root-knot nematodes are obligate parasites that invade roots and induce the formation of specialized feeding structures. Although physiological and molecular changes inside the root leading to feeding site formation have been studied, very little is known about the molecular events preceding root penetration by nematodes. In order to investigate the influence of root exudates on nematode gene expression before plant invasion and to identify new genes potentially involved in parasitism, sterile root exudates from the model plant Arabidopsis thaliana were produced and used to treat Meloidogyne incognita pre-parasitic second-stage juveniles. After confirming the activity of A. thaliana root exudates (ARE) on M. incognita stylet thrusting, six new candidate genes identified by cDNA-AFLP were confirmed by qRT-PCR as being differentially expressed after incubation for one hour with ARE. Using an in vitro inoculation method that focuses on the events preceding the root penetration, we show that five of these genes are differentially expressed within hours of nematode exposure to A. thaliana roots. We also show that these genes are up-regulated post nematode penetration during migration and feeding site initiation. This study demonstrates that preceding root invasion plant-parasitic nematodes are able to perceive root signals and to respond by changing their behaviour and gene expression.	[Teillet, Alice; Dybal, Katarzyna; Kerry, Brian R.; Curtis, Rosane H. C.; Hedden, Peter] Rothamsted Res, Harpenden, Herts, England; [Teillet, Alice] Univ Wisconsin, Dept Plant Pathol, Madison, WI 53706 USA; [Miller, Anthony J.] John Innes Ctr, Norwich, Norfolk, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research; University of Wisconsin System; University of Wisconsin Madison; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Teillet, A (corresponding author), Rothamsted Res, Harpenden, Herts, England.	teillet@wisc.edu	Miller, Anthony John/B-5139-2008	Miller, Anthony John/0000-0003-0572-7607	Biotechnology and Biological Sciences Research Council of the United Kingdom [BB/F021577/1]; BBSRC [BBS/E/C/00005202, BB/F021577/1, BBS/E/C/00004967] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/C/00005202, BB/F021577/1, BBS/E/C/00004967] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council of the United Kingdom(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by grant BB/F021577/1 from the Biotechnology and Biological Sciences Research Council of the United Kingdom, which also provides strategic support to Rothamsted Research and to the John Innes Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad P, 2008, NAT BIOTECHNOL, V26, P909, DOI 10.1038/nbt.1482; Abad P, 2010, ADV BOT RES, V53, P147, DOI 10.1016/S0065-2296(10)53005-2; ATKINSON HJ, 1987, ANN APPL BIOL, V110, P105, DOI 10.1111/j.1744-7348.1987.tb03237.x; Bachem CWB, 1996, PLANT J, V9, P745, DOI 10.1046/j.1365-313X.1996.9050745.x; Barcala M, 2010, PLANT J, V61, P698, DOI 10.1111/j.1365-313X.2009.04098.x; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Bellafiore S, 2010, CURR OPIN PLANT BIOL, V13, P442, DOI 10.1016/j.pbi.2010.05.006; Bellafiore S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000192; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Blair L, 1999, NEMATOLOGY, V1, P103, DOI 10.1163/156854199507910; BYBD DW, 1983, J NEMATOL, V15, P142; Caillaud MC, 2008, J PLANT PHYSIOL, V165, P104, DOI 10.1016/j.jplph.2007.05.007; Curtis RHC, 1996, PARASITOLOGY, V113, P589, DOI 10.1017/S0031182000067640; Dalzell JJ, 2011, NEMATOLOGY, V13, P211, DOI 10.1163/138855410X516760; De Mendoza MEL, 2000, PARASITOLOGY, V120, P203, DOI 10.1017/S0031182099005326; Devine KJ, 1996, ANN APPL BIOL, V129, P323, DOI 10.1111/j.1744-7348.1996.tb05755.x; DIEZ JA, 1989, J CHEM ECOL, V15, P2445, DOI 10.1007/BF01020375; Ding X, 1998, MOL PLANT MICROBE IN, V11, P952, DOI 10.1094/MPMI.1998.11.10.952; Dodd AN, 2010, ANNU REV PLANT BIOL, V61, P593, DOI 10.1146/annurev-arplant-070109-104628; Dubreuil G, 2007, NEW PHYTOL, V176, P426, DOI 10.1111/j.1469-8137.2007.02181.x; Dubreuil G, 2011, INT J PARASITOL, V41, P385, DOI 10.1016/j.ijpara.2010.10.008; Ehwaeti ME, 1999, NEMATOLOGY, V1, P421, DOI 10.1163/156854199508315; Fuller VL, 2007, MOL PLANT PATHOL, V8, P595, DOI 10.1111/J.1364-3703.2007.00416.X; Gattiker Alexandre, 2002, Appl Bioinformatics, V1, P107; Gheysen G, 2011, CURR OPIN PLANT BIOL, V14, P415, DOI 10.1016/j.pbi.2011.03.012; Gleason CA, 2008, MOL PLANT MICROBE IN, V21, P576, DOI 10.1094/MPMI-21-5-0576; Gough C, 2011, MOL PLANT MICROBE IN, V24, P867, DOI 10.1094/MPMI-01-11-0019; Goverse A, 1999, MOL PLANT MICROBE IN, V12, P872, DOI 10.1094/MPMI.1999.12.10.872; GRUNDLER F, 1991, PARASITOLOGY, V103, P149, DOI 10.1017/S0031182000059394; Haegeman A, 2012, GENE, V492, P19, DOI 10.1016/j.gene.2011.10.040; Hamamouch N, 2011, MOL PLANT PATHOL, V12, P355, DOI 10.1111/j.1364-3703.2010.00675.x; Hammes UZ, 2005, MOL PLANT MICROBE IN, V18, P1247, DOI 10.1094/MPMI-18-1247; Hewezi T, 2010, PLANT PHYSIOL, V152, P968, DOI 10.1104/pp.109.150557; Hewezi T, 2008, PLANT CELL, V20, P3080, DOI 10.1105/tpc.108.063065; HO JY, 1992, PLANT J, V2, P971; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Huang GZ, 2005, INT J PARASITOL, V35, P685, DOI 10.1016/j.ijpara.2005.01.006; Huang GZ, 2003, MOL PLANT MICROBE IN, V16, P376, DOI 10.1094/MPMI.2003.16.5.376; HUSSEY RS, 1973, PLANT DIS REP, V57, P1025; Jammes F, 2005, PLANT J, V44, P447, DOI 10.1111/j.1365-313X.2005.02532.x; Jaouannet M, 2012, NEW PHYTOL, V194, P924, DOI 10.1111/j.1469-8137.2012.04164.x; Jaubert S, 2005, MOL PLANT MICROBE IN, V18, P1277, DOI 10.1094/MPMI-18-1277; Jaubert S, 2004, INT J PARASITOL, V34, P873, DOI 10.1016/j.ijpara.2004.02.008; Jaubert S, 2002, FEBS LETT, V522, P109, DOI 10.1016/S0014-5793(02)02906-X; Jones J, 2011, GENOMICS AND MOLECULAR GENETICS OF PLANT-NEMATODE INTERACTIONS, P1, DOI 10.1007/978-94-007-0434-3; Jones JT, 1997, PARASITOLOGY, V114, P309, DOI 10.1017/S0031182096008451; Koenning SR, 1999, J NEMATOL, V31, P587; Lee C, 2011, PLANT PHYSIOL, V155, P866, DOI 10.1104/pp.110.167197; Lopez de Mendoza M.E., 2002, International Journal of Nematology, V12, P149; Masler EP, 2007, J HELMINTHOL, V81, P421, DOI 10.1017/S0022149X07850243; MCCLURE MA, 1987, PHYTOPATHOLOGY, V77, P1463, DOI 10.1094/Phyto-77-1463; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Neveu C, 2003, MOL PLANT MICROBE IN, V16, P1077, DOI 10.1094/MPMI.2003.16.12.1077; Opperman CH, 2008, P NATL ACAD SCI USA, V105, P14802, DOI 10.1073/pnas.0805946105; Qin L, 2000, MOL PLANT MICROBE IN, V13, P830, DOI 10.1094/MPMI.2000.13.8.830; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Rosso M. N., 2009, Annual Review of Phytopathology, V47, P207, DOI 10.1146/annurev.phyto.112408.132605; Roze E, 2008, MOL PLANT PATHOL, V9, P1, DOI [10.1111/j.1364-3703.2007.00435.x, 10.1111/J.1364-3703.2007.00435.X]; Semblat JP, 2001, MOL PLANT MICROBE IN, V14, P72, DOI 10.1094/MPMI.2001.14.1.72; Shanmugam V, 2010, CELL MICROBIOL, V12, P1421, DOI 10.1111/j.1462-5822.2010.01479.x; Sheridan JP, 2004, J EXP BOT, V55, P751, DOI 10.1093/jxb/erh063; SIJMONS PC, 1991, PLANT J, V1, P245, DOI 10.1111/j.1365-313X.1991.00245.x; Smant G, 1997, PHYTOPATHOLOGY, V87, P839, DOI 10.1094/PHYTO.1997.87.8.839; Spiegel Y, 2003, PHYTOPATHOLOGY, V93, P127, DOI 10.1094/PHYTO.2003.93.1.127; Tocquin Pierre, 2003, BMC Plant Biology, V3, P2, DOI 10.1186/1471-2229-3-2; Trudgill DL, 2001, ANNU REV PHYTOPATHOL, V39, P53, DOI 10.1146/annurev.phyto.39.1.53; Vanholme B, 2004, GENE, V332, P13, DOI [10.1016/j.gene.2004.02.024, 10.1016/j.gnee.2004.02.024]; Vieira P, 2011, J EXP BOT, V62, P1241, DOI 10.1093/jxb/erq352; Wang CL, 2009, NEMATOLOGY, V11, P453, DOI 10.1163/156854109X447024; Weerasinghe RR, 2005, P NATL ACAD SCI USA, V102, P3147, DOI 10.1073/pnas.0407926102; WYSS U, 1992, NEMATOLOGICA, V38, P98, DOI 10.1163/187529292X00081; Yang SH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002973; Zhao XW, 2000, PHYTOPATHOLOGY, V90, P1239, DOI 10.1094/PHYTO.2000.90.11.1239	73	30	32	0	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2013	8	4							e61259	10.1371/journal.pone.0061259	http://dx.doi.org/10.1371/journal.pone.0061259			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123JP	23593446	Green Published, Green Submitted, gold			2022-12-25	WOS:000317385300068
J	Dekker, N; Bouma, A; Daemen, I; Klinkenberg, D; van Leengoed, L; Wagenaar, JA; Stegeman, A				Dekker, Niels; Bouma, Annemarie; Daemen, Ineke; Klinkenberg, Don; van Leengoed, Leo; Wagenaar, Jaap A.; Stegeman, Arjan			Effect of Spatial Separation of Pigs on Spread of Streptococcus suis Serotype 9	PLOS ONE			English	Article							AVIUM SUBSPECIES PARATUBERCULOSIS; BETWEEN-PEN TRANSMISSION; MOUTH-DISEASE-VIRUS; DAIRY-CATTLE; CAPSULAR TYPES; TYPE-2; HERD; STRAINS; PIGLETS; VACCINATION	The spread of an infectious agent in a population can be reduced by interfering in the infectiousness or susceptibility of individuals, and/or in their contact structure. The aim of this study was to quantify the effect of prevention of direct contact between infectious and susceptible pigs on the transmission of Streptococcus suis (S. suis). In three replicate experiments, S. suis-free pigs were housed in boxes either in pairs (25 pairs) or alone (15 pigs). The distance between the boxes was +/- 1 m. At 7 weeks of age, one pig of each pair was inoculated intranasally with S. suis serotype 9; the other pigs were exposed to S. suis by either direct (pairs) or indirect contact (individually housed pigs). Tonsillar brush and saliva swab samples from all pigs were collected regularly for 4 weeks post inoculation to monitor colonization with S. suis. All inoculated pigs became infected, and their pen mates became colonized within 2 days. Thirteen indirectly exposed pigs became positive within 725 days after exposure. The rate of direct transmission beta(dir) was estimated to be 3.58 per pig per day (95% CI: 2.29-5.60). The rate of indirect transmission increased in time, depending on the cumulative number of days pigs tested positive for the presence of S. suis. The estimate beta'(ind) was 0.001 (95% CI: 0.0006-0.0017) new infections per pig per day for each day that an infected pig was tested positive for S. suis. We conclude that prevention of direct contact reduces the rate at which susceptible pigs become colonized. Simulation studies using these parameters showed, however, that such intervention measure would not limit S. suis serotype 9 spread in a commercial pig farm to a relevant extent, implying that spatial separation of groups op pigs within a compartment would not be effective on a farm.	[Dekker, Niels; Bouma, Annemarie; Daemen, Ineke; Klinkenberg, Don; van Leengoed, Leo; Stegeman, Arjan] Univ Utrecht, Fac Vet Med, Dept Farm Anim Hlth, Utrecht, Netherlands; [Dekker, Niels; Wagenaar, Jaap A.] Univ Utrecht, Fac Vet Med, Dept Infect Dis & Immunol, Utrecht, Netherlands	Utrecht University; Utrecht University	Dekker, N (corresponding author), Univ Utrecht, Fac Vet Med, Dept Farm Anim Hlth, Utrecht, Netherlands.	c.n.t.dekker@uu.nl		Klinkenberg, Don/0000-0002-9449-6873	Utrecht University, The Netherlands	Utrecht University, The Netherlands(Netherlands Government)	This study was financially supported by Utrecht University, The Netherlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allgaier A, 2001, J CLIN MICROBIOL, V39, P445, DOI 10.1128/JCM.39.2.445-453.2001; BAILEY NTJ, 1975, MATH THEORY INFECT D, P81; Berthelot-Herault F, 2001, VET MICROBIOL, V82, P69, DOI 10.1016/S0378-1135(01)00376-5; BRISEBOIS LM, 1990, CAN J VET RES, V54, P174; Bunnik B, 2012, 13 INT S VET EP EC, V103; Bunnik B, 2012, 13 INT S VET EP EC, V376; Callens B, 2012, PREV VET MED, V106, P53, DOI 10.1016/j.prevetmed.2012.03.001; Cleveland-Nielsen A, 2002, PREV VET MED, V55, P121, DOI 10.1016/S0167-5877(02)00089-2; CLIFTONHADLEY FA, 1984, VET REC, V114, P584, DOI 10.1136/vr.114.24.584; CLIFTONHADLEY FA, 1984, VET REC, V114, P513, DOI 10.1136/vr.114.21.513; CLIFTONHADLEY FA, 1984, VET REC, V115, P562, DOI 10.1136/vr.115.22.562; Cloutier G, 2003, VET MICROBIOL, V97, P135, DOI 10.1016/j.vetmic.2003.09.018; Courcoul A, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-68; de Greeff A, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-161; De Jong MC, 1994, VACCINE, V128, P761; DEE SA, 1993, J AM VET MED ASSOC, V203, P295; Dekker CNT, 2012, VACCINE, V30, P1379, DOI 10.1016/j.vaccine.2011.12.035; DEVRIESE LA, 1991, VET MICROBIOL, V26, P141, DOI 10.1016/0378-1135(91)90050-P; Diekmann O., 2000, MATH EPIDEMIOLOGY IN; Dohoo I, 2007, VET EPIDEMIOLOGIC RE; Dore E, 2012, J VET INTERN MED, V26, P32, DOI 10.1111/j.1939-1676.2011.00854.x; Eble P, 2006, VET RES, V37, P647, DOI 10.1051/vetres:2006026; Ekkel ED, 1996, J ANIM SCI, V74, P2081; ENRIGHT MR, 1987, VET REC, V121, P132, DOI 10.1136/vr.121.6.132; Feberwee A, 2005, AVIAN PATHOL, V34, P355, DOI 10.1080/03079450500180770; FLORES JLM, 1993, CAN VET J, V34, P170; FRIEND TH, 1983, J ANIM SCI, V57, P1406, DOI 10.2527/jas1983.5761406x; Gottschalk M, 2000, VET MICROBIOL, V76, P259, DOI 10.1016/S0378-1135(00)00250-9; Hessel EF, 2006, J ANIM SCI, V84, P2847, DOI 10.2527/jas.2005-606; Higgins R, 2006, DIS SWINE, P769; Horvath G, 2000, DEUT TIERARZTL WOCH, V107, P364; JENSEN P, 1994, APPL ANIM BEHAV SCI, V41, P37, DOI 10.1016/0168-1591(94)90050-7; KOOPMAN JS, 1994, AM J PUBLIC HEALTH, V84, P836, DOI 10.2105/AJPH.84.5.836; Luque I, 2009, VET J VET J, V186, P396; Lurette A, 2008, VET RES, V39, DOI 10.1051/vetres:2008026; Lyte M, 2011, CELL TISSUE RES, V343, P23, DOI 10.1007/s00441-010-1050-0; Marce C, 2011, PREV VET MED, V100, P116, DOI 10.1016/j.prevetmed.2011.02.004; Marce C, 2010, J DAIRY SCI, V93, P4455, DOI 10.3168/jds.2010-3139; Naresh R, 2011, MICROBIOL-SGM, V157, P543, DOI 10.1099/mic.0.044594-0; Reina R, 2009, VET J, V182, P31, DOI 10.1016/j.tvjl.2008.05.008; ROBERTSON ID, 1989, VET REC, V124, P391, DOI 10.1136/vr.124.15.391; ROBERTSON ID, 1991, EPIDEMIOL INFECT, V107, P119, DOI 10.1017/S0950268800048743; Rostagno MH, 2009, FOODBORNE PATHOG DIS, V6, P767, DOI 10.1089/fpd.2009.0315; Schultsz C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033854; Silva LMG, 2006, VET MICROBIOL, V115, P117, DOI 10.1016/j.vetmic.2005.12.013; Smith HE, 1999, J CLIN MICROBIOL, V37, P3146, DOI 10.1128/JCM.37.10.3146-3152.1999; Staats JJ, 1997, VET RES COMMUN, V21, P381, DOI 10.1023/A:1005870317757; Swildens B, 2007, VET REC, V160, P619, DOI 10.1136/vr.160.18.619; Tarradas C, 2004, VET REC, V154, P665, DOI 10.1136/vr.154.21.665; Taylor D., 2006, DIS SWINE, P1075; Torremorell M, 2012, TRANSBOUND EMERG DIS, V59, P68, DOI 10.1111/j.1865-1682.2011.01300.x; Torremorell M, 1998, CAN J VET RES, V62, P21; van Bunnik BAD, 2012, PREV VET MED, V105, P315, DOI 10.1016/j.prevetmed.2012.03.007; Van Nes A, 1998, PREV VET MED, V33, P39, DOI 10.1016/S0167-5877(97)00058-5; van Roermund HJW, 2010, VACCINE, V28, P4452, DOI 10.1016/j.vaccine.2010.04.019; VANLEENGOED LAMG, 1987, VET QUART, V9, P111, DOI 10.1080/01652176.1987.9694087; Velthuis AGJ, 2007, EPIDEMIOL INFECT, V135, P202, DOI 10.1017/S095026880600673X; Velthuis AGJ, 2002, EPIDEMIOL INFECT, V128, P193, DOI 10.1017/S0950268801006707; Weesendorp E, 2011, PREV VET MED, V98, P152, DOI 10.1016/j.prevetmed.2010.11.010; Wisselink HJ, 2000, VET MICROBIOL, V74, P237, DOI 10.1016/S0378-1135(00)00188-7; Wisselink HJ, 1999, VET MICROBIOL, V67, P143, DOI 10.1016/S0378-1135(99)00036-X	61	26	27	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2013	8	4							e61339	10.1371/journal.pone.0061339	http://dx.doi.org/10.1371/journal.pone.0061339			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123IQ	23593467	Green Submitted, Green Published, gold			2022-12-25	WOS:000317382000048
J	Pawlus, MR; Wang, L; Hu, CJ				Pawlus, M. R.; Wang, L.; Hu, C-J			STAT3 and HIF1 alpha cooperatively activate HIF1 target genes in MDA-MB-231 and RCC4 cells	ONCOGENE			English	Article						cotranscriptional activation; HIF; hypoxia; STAT3; transcription	HYPOXIA-INDUCIBLE FACTOR-1; ENDOTHELIAL GROWTH-FACTOR; BREAST-CANCER CELLS; REGULATES VEGF EXPRESSION; SMOOTH-MUSCLE-CELLS; SIGNAL TRANSDUCER; TRANSCRIPTION FACTOR; METABOLIC SWITCH; SRC KINASE; KAPPA-B	Solid tumors often exhibit simultaneously inflammatory and hypoxic microenvironments. The 'signal transducer and activator of transcription-3' (STAT3)-mediated inflammatory response and the hypoxia-inducible factor (HIF)-mediated hypoxia response have been independently shown to promote tumorigenesis through the activation of HIF or STAT3 target genes and to be indicative of a poor prognosis in a variety of tumors. We report here for the first time that STAT3 is involved in the HIF1, but not HIF2-mediated hypoxic transcriptional response. We show that inhibiting STAT3 activity in MDA-MB-231 and RCC4 cells by a STAT3 inhibitor or STAT3 small interfering RNA significantly reduces the levels of HIF1, but not HIF2 target genes in spite of normal levels of hypoxia-inducible transcription factor 1 alpha (HIF1 alpha) and HIF2 alpha protein. Mechanistically, STAT3 activates HIF1 target genes by binding to HIF1 target gene promoters, interacting with HIF1a protein and recruiting coactivators CREB binding protein (CBP) and p300, and RNA polymerase II (Pol II) to form enhanceosome complexes that contain HIF1 alpha, STAT3, CBP, p300 and RNA Pol II on HIF1 target gene promoters. Functionally, the effect of STAT3 knockdown on proliferation, motility and clonogenic survival of tumor cells in vitro is phenocopied by HIF1 alpha knockdown in hypoxic cells, whereas STAT3 knockdown in normoxic cells also reduces cell proliferation, motility and clonogenic survival. This indicates that STAT3 works with HIF1 to activate HIF1 target genes and to drive HIF1-depedent tumorigenesis under hypoxic conditions, but also has HIF-independent activity in normoxic and hypoxic cells. Identifying the role of STAT3 in the hypoxia response provides further data supporting the effectiveness of STAT3 inhibitors in solid tumor treatment owing to their usefulness in inhibiting both the STAT3 and HIF1 pro-tumorigenic signaling pathways in some cancer types.	[Pawlus, M. R.; Hu, C-J] Univ Colorado, Grad Sch, Mol Biol Grad Program, Aurora, CO 80045 USA; [Wang, L.; Hu, C-J] Univ Colorado, Sch Dent Med, Dept Craniofacial Biol, Aurora, CO 80045 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Hu, CJ (corresponding author), Univ Colorado, Sch Dent Med, Dept Craniofacial Biol, Anschutz Med Campus, Aurora, CO 80045 USA.	Cheng-jun.hu@ucdenver.edu		Pawlus, Matthew/0000-0001-6007-7198; Hu, Cheng-Jun/0000-0003-0985-1285	National Cancer Institute [RO1CA134687]; Cancer Leagues of Colorado; NATIONAL CANCER INSTITUTE [P30CA046934, R01CA134687] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008730] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Leagues of Colorado; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Cancer Institute (RO1CA134687, Hu) and Cancer Leagues of Colorado (Hu).	Adachi M, 2012, ORAL ONCOL, V48, P1220, DOI 10.1016/j.oraloncology.2012.06.006; Arany Z, 1996, P NATL ACAD SCI USA, V93, P12969, DOI 10.1073/pnas.93.23.12969; Bai LF, 2012, INT J CANCER, V130, P2693, DOI 10.1002/ijc.26303; Bando H, 2003, BIOMED PHARMACOTHER, V57, P333, DOI 10.1016/S0753-3322(03)00098-2; Bartoli M, 2003, FASEB J, V17, P1562, DOI 10.1096/fj.02-1084fje; BelAiba RS, 2007, MOL BIOL CELL, V18, P4691, DOI 10.1091/mbc.E07-04-0391; Bowman T, 2000, ONCOGENE, V19, P2474, DOI 10.1038/sj.onc.1203527; Bromberg J, 2000, ONCOGENE, V19, P2468, DOI 10.1038/sj.onc.1203476; Carraro F, 2007, J CELL PHYSIOL, V211, P439, DOI 10.1002/jcp.20951; Demaria M, 2010, AGING-US, V2, P823, DOI 10.18632/aging.100232; Ebert BL, 1998, MOL CELL BIOL, V18, P4089, DOI 10.1128/MCB.18.7.4089; Finger EC, 2010, CANCER METAST REV, V29, P285, DOI 10.1007/s10555-010-9224-5; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Gao XL, 2012, MOL CELL, V45, P598, DOI 10.1016/j.molcel.2012.01.001; Gleadle JM, 1997, BLOOD, V89, P503, DOI 10.1182/blood.V89.2.503; Gomes NP, 2006, GENE DEV, V20, P601, DOI 10.1101/gad.1398206; Gordan JD, 2007, CANCER CELL, V11, P335, DOI 10.1016/j.ccr.2007.02.006; Grad JM, 2000, CURR OPIN ONCOL, V12, P543, DOI 10.1097/00001622-200011000-00006; Gray MJ, 2005, ONCOGENE, V24, P3110, DOI 10.1038/sj.onc.1208513; Horiguchi A, 2002, J UROLOGY, V168, P762, DOI 10.1016/S0022-5347(05)64741-6; Horiguchi A, 2010, BRIT J CANCER, V102, P1592, DOI 10.1038/sj.bjc.6605691; Horvath CM, 2000, TRENDS BIOCHEM SCI, V25, P496, DOI 10.1016/S0968-0004(00)01624-8; Hu CJ, 2007, MOL BIOL CELL, V18, P4528, DOI 10.1091/mbc.E06-05-0419; Hu CJ, 2003, MOL CELL BIOL, V23, P9361, DOI 10.1128/MCB.23.24.9361-9374.2003; Hu CJ, 2006, MOL CELL BIOL, V26, P3514, DOI 10.1128/MCB.26.9.3514-3526.2006; Indelicato M, 2010, J CELL PHYSIOL, V223, P359, DOI 10.1002/jcp.22041; Jung JE, 2005, FASEB J, V19, P1296, DOI 10.1096/fj.04-3099fje; Jung JE, 2008, EXP MOL MED, V40, P479, DOI 10.3858/emm.2008.40.5.479; Kaelin WG, 2011, COLD SH Q B, V76, P335, DOI 10.1101/sqb.2011.76.010975; Kang SH, 2010, NEUROSURGERY, V67, P1386, DOI 10.1227/NEU.0b013e3181f1c0cd; Keith B, 2012, NAT REV CANCER, V12, P9, DOI 10.1038/nrc3183; Kim HK, 1997, J BIOL CHEM, V272, P14571, DOI 10.1074/jbc.272.23.14571; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Lee MY, 2006, BREAST, V15, P187, DOI 10.1016/j.breast.2005.05.005; Liu T, 2012, INT J BIOCHEM CELL B, V44, P1337, DOI 10.1016/j.biocel.2012.04.017; Lum JJ, 2007, GENE DEV, V21, P1037, DOI 10.1101/gad.1529107; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Niu GL, 2002, ONCOGENE, V21, P2000, DOI 10.1038/sj.onc.1205260; Niu GL, 2008, MOL CANCER RES, V6, P1099, DOI 10.1158/1541-7786.MCR-07-2177; Noman MZ, 2009, J IMMUNOL, V182, P3510, DOI 10.4049/jimmunol.0800854; Oh MK, 2011, J BIOL CHEM, V286, P8857, DOI 10.1074/jbc.M110.150557; Papandreou I, 2006, CELL METAB, V3, P187, DOI 10.1016/j.cmet.2006.01.012; Paulson M, 1999, J BIOL CHEM, V274, P25343, DOI 10.1074/jbc.274.36.25343; Pawlus MR, 2012, MOL CELL BIOL, V32, P4595, DOI 10.1128/MCB.00724-12; Pham NA, 2009, INT J CANCER, V124, P280, DOI 10.1002/ijc.23912; Piperi C, 2011, CYTOKINE, V55, P387, DOI 10.1016/j.cyto.2011.05.012; Rathinavelu A, 2012, J CELL MOL MED, V16, P1750, DOI 10.1111/j.1582-4934.2011.01472.x; Raval RR, 2005, MOL CELL BIOL, V25, P5675, DOI 10.1128/MCB.25.13.5675-5686.2005; Ruas JL, 2010, J BIOL CHEM, V285, P2601, DOI 10.1074/jbc.M109.021824; Santra M, 2008, J NEUROCHEM, V105, P324, DOI 10.1111/j.1471-4159.2007.05134.x; Schuringa JJ, 2001, FEBS LETT, V495, P71, DOI 10.1016/S0014-5793(01)02354-7; Selvendiran K, 2009, INT J CANCER, V125, P2198, DOI 10.1002/ijc.24601; Semenza GL, 2012, CELL, V148, P399, DOI 10.1016/j.cell.2012.01.021; Squarize CH, 2006, NEOPLASIA, V8, P733, DOI 10.1593/neo.06274; Wang HB, 2012, AM J PATHOL, V180, P1243, DOI 10.1016/j.ajpath.2011.11.031; Warnecke C, 2004, FASEB J, V18, P1462, DOI 10.1096/fj.04-1640fje; Wei DY, 2003, ONCOGENE, V22, P319, DOI 10.1038/sj.onc.1206122; WENGER RH, 1995, J BIOL CHEM, V270, P27865, DOI 10.1074/jbc.270.46.27865; Yu H, 2004, NAT REV CANCER, V4, P97, DOI 10.1038/nrc1275; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Yuan ZL, 2005, SCIENCE, V307, P269, DOI 10.1126/science.1105166; Zia MK, 2007, INT J MOL MED, V20, P605	62	141	145	2	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 27	2014	33	13					1670	1679		10.1038/onc.2013.115	http://dx.doi.org/10.1038/onc.2013.115			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AE9QY	23604114	Green Accepted			2022-12-25	WOS:000334344700007
J	Li, H; Zhang, XY; Wu, TJ; Cheng, W; Liu, X; Jiang, TT; Wen, J; Li, J; Ma, QL; Hua, ZC				Li, Huang; Zhang, Xiang-Yu; Wu, Tuo-Jiang; Cheng, Wei; Liu, Xin; Jiang, Ting-Ting; Wen, Juan; Li, Jie; Ma, Qiao-Ling; Hua, Zi-Chun			Endoplasmic Reticulum Stress Regulates Rat Mandibular Cartilage Thinning under Compressive Mechanical Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEOMIC ANALYSIS; CONDYLAR CARTILAGE; SUBCHONDRAL BONE; OSTEOARTHRITIS; CHONDROCYTES; PROTECTS; FORCES; INJURY; CELLS; XBP1	Compressive mechanical stress-induced cartilage thinning has been characterized as a key step in the progression of temporomandibular joint diseases, such as osteoarthritis. However, the regulatory mechanisms underlying this loss have not been thoroughly studied. Here, we used an established animal model for loading compressive mechanical stress to induce cartilage thinning in vivo. The mechanically stressed mandibular chondrocytes were then isolated to screen potential candidates using a proteomics approach. A total of 28 proteins were identified that were directly or indirectly associated with endoplasmic reticulum stress, including protein disulfide-isomerase, calreticulin, translationally controlled tumor protein, and peptidylprolyl cis/trans-isomerase protein. The altered expression of these candidates was validated at both the mRNA and protein levels. The induction of endoplasmic reticulum stress by mechanical stress loading was confirmed by the activation of endoplasmic reticulum stress markers, the elevation of the cytoplasmic Ca2+ level, and the expansion of endoplasmic reticulum membranes. More importantly, the use of a selective inhibitor to block endoplasmic reticulum stress in vivo reduced the apoptosis observed at the early stages of mechanical stress loading and inhibited the proliferation observed at the later stages of mechanical stress loading. Accordingly, the use of the inhibitor significantly restored cartilage thinning. Taken together, these results demonstrated that endoplasmic reticulum stress is significantly activated in mechanical stress-induced mandibular cartilage thinning and, more importantly, that endoplasmic reticulum stress inhibition alleviates this loss, suggesting a novel pharmaceutical strategy for the treatment of mechanical stress-induced temporomandibular joint diseases.	[Li, Huang; Zhang, Xiang-Yu; Cheng, Wei; Liu, Xin; Jiang, Ting-Ting; Wen, Juan; Li, Jie; Ma, Qiao-Ling; Hua, Zi-Chun] Nanjing Univ, Sch Stomatol, Nanjing 210009, Jiangsu, Peoples R China; [Li, Huang; Zhang, Xiang-Yu; Cheng, Wei; Liu, Xin; Jiang, Ting-Ting; Wen, Juan; Li, Jie; Ma, Qiao-Ling; Hua, Zi-Chun] Nanjing Univ, State Key Lab Pharmaceut Biotechnol, Nanjing 210009, Jiangsu, Peoples R China; [Wu, Tuo-Jiang] Nanjing Med Univ, Stomatol Coll, Nanjing 210029, Jiangsu, Peoples R China	Nanjing University; Nanjing University; Nanjing Medical University	Li, H (corresponding author), Nanjing Univ, Sch Stomatol, 30 Zhongyang Rd, Nanjing 210009, Jiangsu, Peoples R China.	Lihuang76@nju.edu.cn; zchua@nju.edu.cn		Wen, Juan/0000-0001-9832-2056	National Natural Science Foundation of China; Nanjing Medical Science and Technique Development Foundation [81070807, 81200764, 81121062, 50973046]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Nanjing Medical Science and Technique Development Foundation	This work was supported by the National Natural Science Foundation of China and Nanjing Medical Science and Technique Development Foundation Contract Grants 81070807, 81200764, 81121062, and 50973046.	Boyce M, 2005, SCIENCE, V307, P935, DOI 10.1126/science.1101902; COPRAY JCVM, 1985, ARCH ORAL BIOL, V30, P305, DOI 10.1016/0003-9969(85)90002-0; Embree M, 2011, J DENT RES, V90, P1331, DOI 10.1177/0022034511421930; Gobom J, 2001, ANAL CHEM, V73, P434, DOI 10.1021/ac001241s; Habib H, 2005, J DENT RES, V84, P474, DOI 10.1177/154405910508400514; Hermansson M, 2004, J BIOL CHEM, V279, P43514, DOI 10.1074/jbc.M407041200; Jiao K, 2011, BONE, V48, P362, DOI 10.1016/j.bone.2010.09.010; Kiliaridis S, 1999, AM J ORTHOD DENTOFAC, V116, P121, DOI 10.1016/S0889-5406(99)70207-6; Kronfeld K, 2005, MOL CELL PROTEOMICS, V4, P1876, DOI 10.1074/mcp.M500194-MCP200; Kuroda S, 2009, OSTEOARTHR CARTILAGE, V17, P1408, DOI 10.1016/j.joca.2009.04.025; Lee JH, 2005, ARTHRITIS RHEUM-US, V52, P2386, DOI 10.1002/art.21215; Li H, 2010, J CELL PHYSIOL, V223, P610, DOI 10.1002/jcp.22052; MIKI T, 1987, CLIN ORTHOP RELAT R, P276; Millward-Sadler SJ, 1999, J CELL BIOL, V145, P183, DOI 10.1083/jcb.145.1.183; Mizoguchi I, 1996, ARCH ORAL BIOL, V41, P863, DOI 10.1016/S0003-9969(96)00021-0; Murray RC, 1999, J ORTHOPAED RES, V17, P725, DOI 10.1002/jor.1100170516; Roberts SR, 2001, J APPL PHYSIOL, V90, P1385, DOI 10.1152/jappl.2001.90.4.1385; Ruiz-Romero C, 2005, PROTEOMICS, V5, P3048, DOI 10.1002/pmic.200402106; Schroder M, 2008, CELL MOL LIFE SCI, V65, P862, DOI 10.1007/s00018-007-7383-5; Shaffer AL, 2004, IMMUNITY, V21, P81, DOI 10.1016/j.immuni.2004.06.010; SICHER H, 1947, Am J Orthod, V43, P123; Sohen Satoshi, 2001, Pathophysiology, V8, P93, DOI 10.1016/S0928-4680(01)00066-9; Sokka AL, 2007, J NEUROSCI, V27, P901, DOI 10.1523/JNEUROSCI.4289-06.2007; Sriburi R, 2004, J CELL BIOL, V167, P35, DOI 10.1083/jcb.200406136; Sriram D, 2009, J DENT RES, V88, P466, DOI 10.1177/0022034509336616; Suzuki S, 2004, J Orthod, V31, P138, DOI 10.1179/146531204225020436; Takebe K, 2011, INT J MOL MED, V27, P329, DOI 10.3892/ijmm.2010.588; Tasci A, 2011, J TISSUE ENG REGEN M, V5, P210, DOI 10.1002/term.307; Teramoto M, 2003, J BONE MINER METAB, V21, P276, DOI 10.1007/s00774-003-0421-y; Wadhwa S, 2008, J DENT EDUC, V72, P930; Wang XZ, 1996, MOL CELL BIOL, V16, P4273; Yang W, 2006, PROTEOMICS, V6, P2982, DOI 10.1002/pmic.200500036; Yu LR, 2000, ELECTROPHORESIS, V21, P3058, DOI 10.1002/1522-2683(20000801)21:14<3058::AID-ELPS3058>3.0.CO;2-U	33	51	54	2	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2013	288	25					18172	18183		10.1074/jbc.M112.407296	http://dx.doi.org/10.1074/jbc.M112.407296			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	168QZ	23603905	hybrid, Green Published			2022-12-25	WOS:000320721900022
J	Paulsel, AL; Merz, AJ; Nickerson, DP				Paulsel, Andrew L.; Merz, Alexey J.; Nickerson, Daniel P.			Vps9 Family Protein Muk1 Is the Second Rab5 Guanosine Nucleotide Exchange Factor in Budding Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EARLY ENDOCYTIC PATHWAY; MULTIVESICULAR BODY; SACCHAROMYCES-CEREVISIAE; BINDING-PROTEIN; MEMBRANE RECRUITMENT; VACUOLAR PROTEINS; FACTOR RECEPTOR; GAMMA-ADAPTIN; DOMAIN; GTPASES	VPS9 domains can act as guanosine nucleotide exchange factors (GEFs) against small G proteins of the Rab5 family. Saccharomyces cerevisiae vps9 Delta mutants have trafficking defects considerably less severe than multiple deletions of the three cognate Rab5 paralogs (Vps21, Ypt52, and Ypt53). Here, we show that Muk1, which also contains a VPS9 domain, acts as a second GEF against Vps21, Ypt52, and Ypt53. Muk1 is partially redundant with Vps9 in vivo, with vps9 Delta muk1 Delta double mutant cells displaying hypersensitivity to temperature and ionic stress, as well as profound impairments in endocytic and Golgi endosome trafficking, including defects in sorting through the multivesicular body. Cells lacking both Vps9 and Muk1 closely phenocopy double and triple knock-out strains lacking Rab5 paralogs. Microscopy and overexpression experiments demonstrate that Vps9 and Muk1 have distinct localization determinants. These experiments establish Muk1 as the second Rab5 GEF in budding yeast.	[Paulsel, Andrew L.; Merz, Alexey J.; Nickerson, Daniel P.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Merz, Alexey J.] Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Merz, AJ (corresponding author), Amer Canc Soc, Atlanta, GA 30329 USA.	merza@uw.edu; dpn2@uw.edu			National Institutes of Health [GM077349]; NIGMS, National Institutes of Health [T32 GM09270]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077349] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM077349.; Supported in part by NIGMS, National Institutes of Health Grant T32 GM09270.	Abdul-Ghani M, 2001, J BIOL CHEM, V276, P6225, DOI 10.1074/jbc.M009073200; Albert S, 2000, BIOL CHEM, V381, P453, DOI 10.1515/BC.2000.059; Babst M, 1997, EMBO J, V16, P1820, DOI 10.1093/emboj/16.8.1820; BANTA LM, 1988, J CELL BIOL, V107, P1369, DOI 10.1083/jcb.107.4.1369; Barbieri MA, 2003, J BIOL CHEM, V278, P32027, DOI 10.1074/jbc.M304324200; Barr F, 2010, CURR OPIN CELL BIOL, V22, P461, DOI 10.1016/j.ceb.2010.04.007; Barrowman J, 2003, NAT CELL BIOL, V5, P955, DOI 10.1038/ncb1103-955; Blumer J, 2013, J CELL BIOL, V200, P287, DOI 10.1083/jcb.201209113; Brett CL, 2008, J CELL BIOL, V182, P1141, DOI 10.1083/jcb.200801001; Bridges D, 2012, J BIOL CHEM, V287, P20913, DOI 10.1074/jbc.M111.334060; Burd CG, 1996, MOL CELL BIOL, V16, P2369; Cabrera M, 2013, J BIOL CHEM, V288, P5166, DOI 10.1074/jbc.M112.431536; Carney DS, 2006, TRENDS CELL BIOL, V16, P27, DOI 10.1016/j.tcb.2005.11.001; Chen LY, 2000, J CELL BIOL, V151, P731, DOI 10.1083/jcb.151.3.731; Cherfils J, 1999, TRENDS BIOCHEM SCI, V24, P306, DOI 10.1016/S0968-0004(99)01429-2; Collins RN, 2003, MOL CELL, V12, P1064, DOI 10.1016/S1097-2765(03)00445-3; Darsow T, 2000, METHOD ENZYMOL, V327, P95, DOI 10.1016/S0076-6879(00)27270-4; Davies BA, 2003, J BIOL CHEM, V278, P19826, DOI 10.1074/jbc.M301059200; Gueldener U, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.6.e23; Hama H, 1999, J BIOL CHEM, V274, P15284, DOI 10.1074/jbc.274.21.15284; Hirst J, 2000, J CELL BIOL, V149, P67, DOI 10.1083/jcb.149.1.67; HORAZDOVSKY BF, 1994, EMBO J, V13, P1297, DOI 10.1002/j.1460-2075.1994.tb06382.x; Horiuchi H, 1997, CELL, V90, P1149, DOI 10.1016/S0092-8674(00)80380-3; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Kajiho H, 2003, J CELL SCI, V116, P4159, DOI 10.1242/jcs.00718; Lachmann J, 2012, MOL BIOL CELL, V23, P2516, DOI 10.1091/mbc.E11-12-1030; Liu Y, 2011, MOL BIOL CELL, V22, P1575, DOI 10.1091/mbc.E10-08-0716; Lo SY, 2012, NAT STRUCT MOL BIOL, V19, P40, DOI 10.1038/nsmb.2162; MacDonald C, 2012, TRAFFIC, V13, P586, DOI 10.1111/j.1600-0854.2011.01326.x; Mattera R, 2003, EMBO J, V22, P78, DOI 10.1093/emboj/cdg015; McBride HM, 1999, CELL, V98, P377, DOI 10.1016/S0092-8674(00)81966-2; McNatt MW, 2007, MOL BIOL CELL, V18, P697, DOI 10.1091/mbc.E06-08-0663; Menant A, 2006, EMBO J, V25, P4436, DOI 10.1038/sj.emboj.7601330; Mizuno-Yamasaki E, 2010, DEV CELL, V18, P828, DOI 10.1016/j.devcel.2010.03.016; Nickerson Daniel P, 2006, J Cell Biol, V175, P715, DOI 10.1083/jcb.200606113; Nickerson DP, 2012, TRAFFIC, V13, P1411, DOI 10.1111/j.1600-0854.2012.01390.x; Nordmann M, 2010, CURR BIOL, V20, P1654, DOI 10.1016/j.cub.2010.08.002; Odorizzi G, 1998, CELL, V95, P847, DOI 10.1016/S0092-8674(00)81707-9; Oestreich AJ, 2007, MOL BIOL CELL, V18, P707, DOI 10.1091/mbc.E06-08-0680; Olsen B, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-141; Pan XJ, 2006, NATURE, V442, P303, DOI 10.1038/nature04847; Plemel RL, 2011, MOL BIOL CELL, V22, P1353, DOI 10.1091/mbc.E10-03-0260; RAYMOND CK, 1992, MOL BIOL CELL, V3, P1389, DOI 10.1091/mbc.3.12.1389; Reggiori F, 2001, EMBO J, V20, P5176, DOI 10.1093/emboj/20.18.5176; ROBINSON JS, 1988, MOL CELL BIOL, V8, P4936, DOI 10.1128/MCB.8.11.4936; Russell MRG, 2012, J CELL SCI, V125, P5208, DOI 10.1242/jcs.111310; Saito K, 2002, J BIOL CHEM, V277, P3412, DOI 10.1074/jbc.M106276200; Samanta MP, 2003, P NATL ACAD SCI USA, V100, P12579, DOI 10.1073/pnas.2132527100; Shiba Y, 2002, J BIOCHEM, V131, P327, DOI 10.1093/oxfordjournals.jbchem.a003107; SIKORSKI RS, 1989, GENETICS, V122, P19; SINGERKRUGER B, 1995, J CELL SCI, V108, P3509; SINGERKRUGER B, 1994, J CELL BIOL, V125, P283, DOI 10.1083/jcb.125.2.283; Sivars U, 2003, NATURE, V425, P856, DOI 10.1038/nature02057; Stawiecka-Mirota M, 2007, TRAFFIC, V8, P1280, DOI 10.1111/j.1600-0854.2007.00610.x; Tall GG, 2001, DEV CELL, V1, P73, DOI 10.1016/S1534-5807(01)00008-9; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; WEBB MR, 1992, P NATL ACAD SCI USA, V89, P4884, DOI 10.1073/pnas.89.11.4884; Weisman LS, 2006, NAT REV MOL CELL BIO, V7, P243, DOI 10.1038/nrm1892; Yoshimura S, 2010, J CELL BIOL, V191, P367, DOI 10.1083/jcb.201008051; Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684; Zhu YX, 2001, SCIENCE, V292, P1716, DOI 10.1126/science.1060896	61	29	29	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2013	288	25					18162	18171		10.1074/jbc.M113.457069	http://dx.doi.org/10.1074/jbc.M113.457069			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	168QZ	23612966	Green Published, hybrid			2022-12-25	WOS:000320721900021
J	Chew, YC; Adhikary, G; Xu, W; Wilson, GM; Eckert, RL				Chew, Yap Ching; Adhikary, Gautam; Xu, Wen; Wilson, Gerald M.; Eckert, Richard L.			Protein Kinase C delta Increases Kruppel-like Factor 4 Protein, which Drives Involucrin Gene Transcription in Differentiating Keratinocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN EPIDERMAL-KERATINOCYTES; DISTAL REGULATORY REGION; GREEN TEA POLYPHENOL; PROMOTER ACTIVITY; PKC-DELTA; IN-VIVO; EXPRESSION CLONING; CORNIFIED ENVELOPE; CORNEAL EPITHELIUM; P38-DELTA MAPK	KLF4 is a member of the Kruppel-like factor family of transcriptional regulators. KLF4 has been shown to be required for normal terminal differentiation of keratinocytes, but the molecular mechanism whereby KLF4 regulates genes associated with the differentiation process has not been studied. In the present study, we explore the impact of KLF4 on expression of involucrin, a gene that is specifically expressed in differentiated keratinocytes. KLF4 overexpression and knockdown studies show that involucrin mRNA and protein level correlates directly with KLF4 level. Moreover, studies of mutant KLF4 proteins indicate that transcriptionally inactive forms do not increase involucrin expression. PKC delta is a regulator of keratinocyte differentiation that increases expression of differentiation-associated target genes, including involucrin. Overexpression of KLF4 augments the PKC delta-dependent increase in involucrin expression, whereas KLF4 knockdown attenuates this response. The KLF4 induction of human involucrin (hINV) promoter activity is mediated via KLF4 binding to a GC-rich element located in the hINV promoter distal regulatory region, a region of the promoter required for in vivo involucrin expression. Mutation of the GC-rich element, an adjacent AP1 factor binding site, or both sites severely attenuates the response. Moreover, loss of KLF4 in an epidermal equivalent model of differentiation results in loss of hINV expression. These studies suggest that KLF4 is part of a multiprotein complex that interacts that the hINV promoter distal regulatory region to drive differentiation-dependent hINV gene expression in epidermis.	[Chew, Yap Ching; Adhikary, Gautam; Xu, Wen; Wilson, Gerald M.; Eckert, Richard L.] Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA; [Eckert, Richard L.] Univ Maryland, Sch Med, Dept Dermatol, Baltimore, MD 21201 USA; [Eckert, Richard L.] Univ Maryland, Sch Med, Dept Obstet & Gynecol & Reprod Sci, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Eckert, RL (corresponding author), Univ Maryland, Sch Med, Dept Biochem & Mol Biol, 108 N Greene St, Baltimore, MD 21201 USA.	reckert@umaryland.edu	Wilson, Gerald/AAF-3874-2019	Wilson, Gerald/0000-0002-1273-7507; Chew, Yap Ching/0000-0002-1686-6541	National Institutes of Health [R01 AR046494, R01 AR053851]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR053851, R01AR046494] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 AR046494 and R01 AR053851 (to R. L. E.).	Adhikary G, 2005, INVEST OPHTH VIS SCI, V46, P3109, DOI 10.1167/iovs.05-0053; Adhikary G, 2005, INVEST OPHTH VIS SCI, V46, P1219, DOI 10.1167/iovs.04-1285; Adhikary G, 2004, INVEST OPHTH VIS SCI, V45, P1080, DOI 10.1167/iovs.03-1180; Adhikary G, 2010, J INVEST DERMATOL, V130, P2017, DOI 10.1038/jid.2010.108; Alonso L, 2003, P NATL ACAD SCI USA, V100, P11830, DOI 10.1073/pnas.1734203100; APFEL C, 1992, P NATL ACAD SCI USA, V89, P7129, DOI 10.1073/pnas.89.15.7129; Balasubramanian S, 2004, J BIOL CHEM, V279, P24007, DOI 10.1074/jbc.M314331200; Balasubramanian S, 2002, J BIOL CHEM, V277, P1828, DOI 10.1074/jbc.M110376200; Balasubramanian S, 2007, TOXICOL APPL PHARM, V224, P214, DOI 10.1016/j.taap.2007.03.020; Balasubramanian S, 2006, J BIOL CHEM, V281, P36162, DOI 10.1074/jbc.M605368200; Banks EB, 1999, BIOCHEM J, V337, P507, DOI 10.1042/0264-6021:3370507; Banks EB, 1998, BIOCHEM J, V331, P61, DOI 10.1042/bj3310061; Black AR, 2001, J CELL PHYSIOL, V188, P143, DOI 10.1002/jcp.1111; BYRNE C, 1994, DEVELOPMENT, V120, P2369; Chen XM, 2003, J MOL BIOL, V326, P665, DOI 10.1016/S0022-2836(02)01449-3; Chew YC, 2011, J BIOL CHEM, V286, P28772, DOI 10.1074/jbc.M110.205245; Cordani N, 2011, ONCOGENE, V30, P922, DOI 10.1038/onc.2010.474; Crish JF, 2008, J INVEST DERMATOL, V128, P530, DOI 10.1038/sj.jid.5701049; Crish JF, 2006, J INVEST DERMATOL, V126, P305, DOI 10.1038/sj.jid.5700019; Crish JF, 2000, CARCINOGENESIS, V21, P1031, DOI 10.1093/carcin/21.5.1031; Crish JF, 1998, J BIOL CHEM, V273, P30460, DOI 10.1074/jbc.273.46.30460; CRISH JF, 1993, DIFFERENTIATION, V53, P191, DOI 10.1111/j.1432-0436.1993.tb00708.x; Crish JF, 2002, ONCOGENE, V21, P738, DOI 10.1038/sj.onc.1205038; Dai X, 2004, CURR OPIN GENET DEV, V14, P485, DOI 10.1016/j.gde.2004.07.002; Denning MF, 2000, EXP DERMATOL, V9, P192, DOI 10.1034/j.1600-0625.2000.009003192.x; DENNING MF, 1995, CELL GROWTH DIFFER, V6, P149; Deucher A, 2002, J BIOL CHEM, V277, P17032, DOI 10.1074/jbc.M109076200; Eckert RL, 2004, J INVEST DERMATOL, V123, P13, DOI 10.1111/j.0022-202X.2004.22723.x; ECKERT RL, 1993, J INVEST DERMATOL, V100, P613, DOI 10.1111/1523-1747.ep12472288; Efimova T, 2004, MOL CELL BIOL, V24, P8167, DOI 10.1128/MCB.24.18.8167-8183.2004; Efimova T, 2003, J BIOL CHEM, V278, P34277, DOI 10.1074/jbc.M302759200; Efimova T, 1998, J BIOL CHEM, V273, P24387, DOI 10.1074/jbc.273.38.24387; Efimova T, 2000, J BIOL CHEM, V275, P1601, DOI 10.1074/jbc.275.3.1601; Eftmova T, 2002, J BIOL CHEM, V277, P31753, DOI 10.1074/jbc.M205098200; Foster KW, 1999, CELL GROWTH DIFFER, V10, P423; GarrettSinha LA, 1996, J BIOL CHEM, V271, P31384, DOI 10.1074/jbc.271.49.31384; Jaubert J, 2004, J INVEST DERMATOL, V123, P313, DOI 10.1111/j.0022-202X.2004.23203.x; Jaubert J, 2003, DEVELOPMENT, V130, P2767, DOI 10.1242/dev.00477; Kaczynski J, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-206; KIKKAWA U, 1984, ADV CYCLIC NUCL PROT, V17, P437; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Kraft CA, 2007, ARCH DERMATOL RES, V299, P71, DOI 10.1007/s00403-006-0727-4; Ohba M, 1998, MOL CELL BIOL, V18, P5199, DOI 10.1128/MCB.18.9.5199; Patel S, 2006, P NATL ACAD SCI USA, V103, P18668, DOI 10.1073/pnas.0608658103; Pincelli C, 2010, J CELL PHYSIOL, V225, P310, DOI 10.1002/jcp.22275; Poumay Y, 2004, ARCH DERMATOL RES, V296, P203, DOI 10.1007/s00403-004-0507-y; RICE RH, 1977, CELL, V11, P417, DOI 10.1016/0092-8674(77)90059-9; RICE RH, 1979, CELL, V18, P681, DOI 10.1016/0092-8674(79)90123-5; Robinson NA, 1996, J INVEST DERMATOL, V107, P101, DOI 10.1111/1523-1747.ep12298323; Robinson NA, 1997, J BIOL CHEM, V272, P12035, DOI 10.1074/jbc.272.18.12035; Rowland BD, 2005, NAT CELL BIOL, V7, P1074, DOI 10.1038/ncb1314; Segre J, 2003, CURR OPIN CELL BIOL, V15, P778, DOI 10.1016/j.ceb.2003.10.001; Segre JA, 1999, NAT GENET, V22, P356, DOI 10.1038/11926; Steinert PM, 1997, J BIOL CHEM, V272, P2021, DOI 10.1074/jbc.272.3.2021; Sturniolo MT, 2005, ONCOGENE, V24, P2963, DOI 10.1038/sj.onc.1208392; Swamynathan SK, 2008, INVEST OPHTH VIS SCI, V49, P3360, DOI 10.1167/iovs.08-1811; Swamynathan SK, 2007, MOL CELL BIOL, V27, P182, DOI 10.1128/MCB.00846-06; Wei DY, 2006, CARCINOGENESIS, V27, P23, DOI 10.1093/carcin/bgi243; Welter JF, 1996, J BIOL CHEM, V271, P14727, DOI 10.1074/jbc.271.25.14727; WELTER JF, 1995, J BIOL CHEM, V270, P12614, DOI 10.1074/jbc.270.21.12614; Whitney EM, 2006, GENE EXPRESSION, V13, P85, DOI 10.3727/000000006783991908; Yoon HS, 2004, J BIOL CHEM, V279, P5035, DOI 10.1074/jbc.M307631200; Zhang WQ, 2000, J BIOL CHEM, V275, P18391, DOI 10.1074/jbc.C000062200; Zhu L, 2008, J INVEST DERMATOL, V128, P833, DOI 10.1038/sj.jid.5701103	64	29	29	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2013	288	24					17759	17768		10.1074/jbc.M113.477133	http://dx.doi.org/10.1074/jbc.M113.477133			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	164AH	23599428	Green Published, hybrid			2022-12-25	WOS:000320380600065
J	Leiba, J; Syson, K; Baronian, G; Zanella-Cleon, I; Kalscheuer, R; Kremer, L; Bornemann, S; Molle, V				Leiba, Jade; Syson, Karl; Baronian, Gregory; Zanella-Cleon, Isabelle; Kalscheuer, Rainer; Kremer, Laurent; Bornemann, Stephen; Molle, Virginie			Mycobacterium tuberculosis Maltosyltransferase GlgE, a Genetically Validated Antituberculosis Target, Is Negatively Regulated by Ser/Thr Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID SYNTHASE; PROTEIN SECONDARY STRUCTURE; ALPHA-GLUCAN; BACTERIAL GLYCOGEN; KINASES; BIOSYNTHESIS; EXPRESSION; GROWTH; SMEGMATIS; SURVIVAL	GlgE is a maltosyltransferase involved in the biosynthesis of alpha-glucans that has been genetically validated as a potential therapeutic target against Mycobacterium tuberculosis. Despite also making alpha-glucan, the GlgC/GlgA glycogen pathway is distinct and allosterically regulated. We have used a combination of genetics and biochemistry to establish how the GlgE pathway is regulated. M. tuberculosis GlgE was phosphorylated specifically by the Ser/Thr protein kinase PknB in vitro on one serine and six threonine residues. Furthermore, GlgE was phosphorylated in vivo when expressed in Mycobacterium bovis bacillus Calmette-Guerin (BCG) but not when all seven phosphorylation sites were replaced by Ala residues. The GlgE orthologues from Mycobacterium smegmatis and Streptomyces coelicolor were phosphorylated by the corresponding PknB orthologues in vitro, implying that the phosphorylation of GlgE is widespread among actinomycetes. PknB-dependent phosphorylation of GlgE led to a 2 orders of magnitude reduction in catalytic efficiency in vitro. The activities of phosphoablative and phosphomimetic GlgE derivatives, where each phosphorylation site was substituted with either Ala or Asp residues, respectively, correlated with negative phosphoregulation. Complementation studies of a M. smegmatis glgE mutant strain with these GlgE derivatives, together with both classical and chemical forward genetics, were consistent with flux through the GlgE pathway being correlated with GlgE activity. We conclude that the GlgE pathway appears to be negatively regulated in actinomycetes through the phosphorylation of GlgE by PknB, a mechanism distinct from that known in the classical glycogen pathway. Thus, these findings open new opportunities to target the GlgE pathway therapeutically.	[Leiba, Jade; Baronian, Gregory; Kremer, Laurent; Molle, Virginie] Univ Montpellier 2, CNRS, UMR 5235, Lab Dynam Interact Membranaires Normales & Pathol, F-34095 Montpellier 05, France; [Leiba, Jade; Baronian, Gregory; Kremer, Laurent; Molle, Virginie] Univ Montpellier I, CNRS, UMR 5235, Lab Dynam Interact Membranaires Normales & Pathol, F-34095 Montpellier 05, France; [Syson, Karl; Bornemann, Stephen] John Innes Ctr, Dept Biol Chem, Norwich NR4 7UH, Norfolk, England; [Zanella-Cleon, Isabelle] Univ Lyon 1, CNRS, BioSci IFR128, IBCP,UMR 5086,Lyon Gerland, F-69367 Lyon 07, France; [Kalscheuer, Rainer] Univ Dusseldorf, Inst Med Microbiol & Hosp Hyg, D-40225 Dusseldorf, Germany; [Kremer, Laurent] INSERM, F-34095 Montpellier 05, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Heinrich Heine University Dusseldorf; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier	Bornemann, S (corresponding author), John Innes Ctr, Dept Biol Chem, Norwich Res Pk, Norwich NR4 7UH, Norfolk, England.	stephen.bornemann@jic.ac.uk; virginie.molle@univ-montp2.fr	Bornemann, Stephen/K-2938-2012; Kremer, Laurent/M-4935-2017; Kalscheuer, Rainer/AAF-1381-2020; MOLLE, Virginie/D-4050-2019; Kalscheuer, Rainer/A-2852-2015	Bornemann, Stephen/0000-0001-5930-9473; Kremer, Laurent/0000-0002-6604-4458; Kalscheuer, Rainer/0000-0002-3378-2067; MOLLE, Virginie/0000-0002-6573-3411; Leiba, Jade/0000-0003-0584-9524	French National Research Agency [ANR-09-MIEN-004]; United Kingdom Biotechnology and Biological Sciences Research Council [BB/I012850/1, BB/J004561/1]; John Innes Foundation; Jurgen Manchot Foundation; Region Languedoc-Roussillon; University of Montpellier 1; Biotechnology and Biological Sciences Research Council [BBS/E/J/000C0647, BB/I012850/1] Funding Source: researchfish; BBSRC [BBS/E/J/000C0647, BB/I012850/1] Funding Source: UKRI	French National Research Agency(French National Research Agency (ANR)); United Kingdom Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); John Innes Foundation; Jurgen Manchot Foundation; Region Languedoc-Roussillon(Region OccitanieRegion Ile-de-France); University of Montpellier 1; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by in part grants from the French National Research Agency (Grant ANR-09-MIEN-004) (to V. M. and L. K.), the United Kingdom Biotechnology and Biological Sciences Research Council (Grant BB/I012850/1 and BB/J004561/1) and the John Innes Foundation (to S. B.), and the Jurgen Manchot Foundation (to R. K.).; Supported by the Region Languedoc-Roussillon and the University of Montpellier 1.	Av-Gay Y, 2000, TRENDS MICROBIOL, V8, P238, DOI 10.1016/S0966-842X(00)01734-0; Ballicora MA, 2003, MICROBIOL MOL BIOL R, V67, P213, DOI 10.1128/MMBR.67.2.213-225.2003; Barthe P, 2010, STRUCTURE, V18, P606, DOI 10.1016/j.str.2010.02.013; Barthe P, 2009, STRUCTURE, V17, P568, DOI 10.1016/j.str.2009.02.012; Belanger AE, 1999, J BACTERIOL, V181, P6670, DOI 10.1128/JB.181.21.6670-6678.1999; Canova MJ, 2008, PLASMID, V60, P149, DOI 10.1016/j.plasmid.2008.05.002; Canova MJ, 2009, J BACTERIOL, V191, P2876, DOI 10.1128/JB.01569-08; Chandra G, 2011, MICROBIOL-SGM, V157, P1565, DOI 10.1099/mic.0.044263-0; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Corrales RM, 2012, J BIOL CHEM, V287, P26187, DOI 10.1074/jbc.M112.373209; Dinadayala P, 2008, GLYCOBIOLOGY, V18, P502, DOI 10.1093/glycob/cwn031; Dye C, 2010, SCIENCE, V328, P856, DOI 10.1126/science.1185449; England P, 2009, FEBS LETT, V583, P301, DOI 10.1016/j.febslet.2008.12.036; Gagliardi MC, 2007, CELL MICROBIOL, V9, P2081, DOI 10.1111/j.1462-5822.2007.00940.x; Geurtsen J, 2009, J IMMUNOL, V183, P5221, DOI 10.4049/jimmunol.0900768; Hale KJ, 2002, NAT PROD REP, V19, P413, DOI 10.1039/b009211h; Jackson M, 2000, J BIOL CHEM, V275, P30092, DOI 10.1074/jbc.M004658200; Kalscheuer R, 2010, DRUG NEWS PERSPECT, V23, P619, DOI 10.1358/dnp.2010.23.10.1534855; Kalscheuer R, 2010, NAT CHEM BIOL, V6, P376, DOI 10.1038/nchembio.340; Kang CM, 2008, MICROBIOL-SGM, V154, P725, DOI 10.1099/mic.0.2007/014076-0; Kaur Devinder, 2009, Adv Appl Microbiol, V69, P23, DOI 10.1016/S0065-2164(09)69002-X; Mendes V, 2012, NAT PROD REP, V29, P834, DOI 10.1039/c2np20014g; Molle V, 2003, BIOCHEMISTRY-US, V42, P15300, DOI 10.1021/bi035150b; Molle V, 2006, J BIOL CHEM, V281, P30094, DOI 10.1074/jbc.M601691200; Molle V, 2010, MOL MICROBIOL, V78, P1591, DOI 10.1111/j.1365-2958.2010.07446.x; Molle V, 2010, PROTEOMICS, V10, P3910, DOI 10.1002/pmic.201000316; Molle V, 2010, MOL MICROBIOL, V75, P1064, DOI 10.1111/j.1365-2958.2009.07041.x; Noens EE, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-27; Papavinasasundaram KG, 2005, J BACTERIOL, V187, P5751, DOI 10.1128/JB.187.16.5751-5760.2005; Prisic S, 2010, P NATL ACAD SCI USA, V107, P7521, DOI 10.1073/pnas.0913482107; Sambou T, 2008, MOL MICROBIOL, V70, P762, DOI 10.1111/j.1365-2958.2008.06445.x; Shah IM, 2008, CELL, V135, P486, DOI 10.1016/j.cell.2008.08.039; Slama N, 2011, BIOCHEM BIOPH RES CO, V412, P401, DOI 10.1016/j.bbrc.2011.07.051; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Syson K, 2011, J BIOL CHEM, V286, P38298, DOI 10.1074/jbc.M111.279315; Veyron-Churlet R, 2004, MOL MICROBIOL, V54, P1161, DOI 10.1111/j.1365-2958.2004.04334.x; Veyron-Churlet R, 2010, J BIOL CHEM, V285, P12714, DOI 10.1074/jbc.M110.105189; Veyron-Churlet R, 2009, J BIOL CHEM, V284, P6414, DOI 10.1074/jbc.M806537200; Walburger A, 2004, SCIENCE, V304, P1800, DOI 10.1126/science.1099384; Wehenkel A, 2008, BBA-PROTEINS PROTEOM, V1784, P193, DOI 10.1016/j.bbapap.2007.08.006; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371	41	24	25	5	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2013	288	23					16546	16556		10.1074/jbc.M112.398503	http://dx.doi.org/10.1074/jbc.M112.398503			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	163ZU	23609448	Green Published, hybrid			2022-12-25	WOS:000320378900031
J	Xi, G; Shen, XC; Wai, C; Clemmons, DR				Xi, Gang; Shen, Xin-Chun; Wai, Christine; Clemmons, David R.			Recruitment of Nox4 to a Plasma Membrane Scaffold Is Required for Localized Reactive Oxygen Species Generation and Sustained Src Activation in Response to Insulin-like Growth Factor-I	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-TRANSDUCTION; PROTEIN; KINASE; H2O2; PHOSPHORYLATION; IDENTIFICATION; ASSOCIATION; BINDING; SHPS-1; SHC	Nox4-derived ROS is increased in response to hyperglycemia and is required for IGF-I-stimulated Src activation. This study was undertaken to determine the mechanism by which Nox4 mediates sustained Src activation. IGF-I stimulated sustained Src activation, which occurred primarily on the SHPS-1 scaffold protein. In vitro oxidation experiments indicated that Nox4-derived ROS was able to oxidize Src when they are in close proximity, and Src oxidation leads to its activation. Therefore we hypothesized that Nox4 recruitment to the plasma membrane scaffold SHPS-1 allowed localized ROS generation to mediate sustained Src oxidation and activation. To determine the mechanism of Nox4 recruitment, we analyzed the role of Grb2, a component of the SHPS-1 signaling complex. We determined that Nox4 Tyr-491 was phosphorylated after IGF-I stimulation and was responsible for Nox4 binding to the SH2 domain of Grb2. Overexpression of a Nox4 mutant, Y491F, prevented Nox4/Grb2 association. Importantly, it also prevented Nox4 recruitment to SHPS-1. The role of Grb2 was confirmed using a Pyk2 Y881F mutant, which blocked Grb2 recruitment to SHPS-1. Cells expressing this mutant had impaired Nox4 recruitment to SHPS-1. IGF-I-stimulated downstream signaling and biological actions were also significantly impaired in Nox4 Y491F-overexpressing cells. Disruption of Nox4 recruitment to SHPS-1 in aorta from diabetic mice inhibited IGF-I-stimulated Src oxidation and activation as well as cell proliferation. These findings provide insight into the mechanism by which localized Nox4-derived ROS regulates the sustained activity of a tyrosine kinase that is critical for mediating signal transduction and biological actions.	[Xi, Gang; Shen, Xin-Chun; Wai, Christine; Clemmons, David R.] Univ N Carolina, Sch Med, Dept Med, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Clemmons, DR (corresponding author), Univ N Carolina, Div Endocrinol, CB 7170,8024 Burnett Womack, Chapel Hill, NC 27599 USA.	david_clemmons@med.unc.edu			National Institutes of Health [AG02331]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034987] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG002331, R01AG002331] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant AG02331.	Basuroy S, 2009, AM J PHYSIOL-CELL PH, V296, pC422, DOI 10.1152/ajpcell.00381.2008; Block K, 2008, J BIOL CHEM, V283, P24061, DOI 10.1074/jbc.M803964200; Block K, 2009, P NATL ACAD SCI USA, V106, P14385, DOI 10.1073/pnas.0906805106; Chen K, 2008, J CELL BIOL, V181, P1129, DOI 10.1083/jcb.200709049; COURTNEIDGE SA, 1980, P NATL ACAD SCI-BIOL, V77, P3783, DOI 10.1073/pnas.77.7.3783; Czernichow S, 2009, AM J CLIN NUTR, V90, P329, DOI 10.3945/ajcn.2009.27635; Ellmark SHM, 2005, CARDIOVASC RES, V65, P495, DOI 10.1016/j.cardiores.2004.10.026; GOCKERMAN A, 1995, CIRC RES, V76, P514, DOI 10.1161/01.RES.76.4.514; Guo J, 2006, NEUROSCIENCE, V143, P827, DOI 10.1016/j.neuroscience.2006.08.031; Guo J, 2003, NEUROSCI LETT, V345, P101, DOI 10.1016/S0304-3940(03)00483-X; Helmcke I, 2009, ANTIOXID REDOX SIGN, V11, P1279, DOI [10.1089/ars.2008.2383, 10.1089/ARS.2008.2383]; Hilenski LL, 2004, ARTERIOSCL THROM VAS, V24, P677, DOI 10.1161/01.ATV.0000112024.13727.2c; Ikeda S, 2005, ARTERIOSCL THROM VAS, V25, P2295, DOI 10.1161/01.ATV.0000187472.55437.af; Kreuzer J, 2002, FASEB J, V16, P38, DOI 10.1096/fj.01-1036fje; Kris-Etherton PM, 2004, CIRCULATION, V110, P637, DOI 10.1161/01.CIR.0000137822.39831.F1; Krymskaya VP, 2004, FASEB J, V18, P428, DOI 10.1096/fj.04-2869fje; Kuroda J, 2005, GENES CELLS, V10, P1139, DOI 10.1111/j.1365-2443.2005.00907.x; Lieskovska J, 2006, J BIOL CHEM, V281, P25041, DOI 10.1074/jbc.M602866200; Ling Y, 2005, MOL BIOL CELL, V16, P3353, DOI 10.1091/mbc.E04-10-0918; Maile LA, 2008, DIABETES, V57, P2637, DOI 10.2337/db08-0326; Nam TJ, 2000, ENDOCRINOLOGY, V141, P1100, DOI 10.1210/en.141.3.1100; Radhakrishnan Y, 2008, J BIOL CHEM, V283, P16320, DOI 10.1074/jbc.M801687200; Rhee SG, 2006, SCIENCE, V312, P1882, DOI 10.1126/science.1130481; Sakellariou GK, 2013, ANTIOXID REDOX SIGN, V18, P603, DOI 10.1089/ars.2012.4623; Shen XC, 2010, CELL MOL LIFE SCI, V67, P3893, DOI 10.1007/s00018-010-0411-x; Shen XC, 2009, MOL CELL PROTEOMICS, V8, P1539, DOI 10.1074/mcp.M800543-MCP200; Sorenson CM, 2002, AM J PHYSIOL-RENAL, V283, pF1085, DOI 10.1152/ajprenal.00380.2001; SUNDARESAN M, 1995, SCIENCE, V270, P296, DOI 10.1126/science.270.5234.296; Toledano MB, 2010, CELL, V140, P454, DOI 10.1016/j.cell.2010.02.003; von Lohneysen K, 2010, MOL CELL BIOL, V30, P961, DOI 10.1128/MCB.01393-09; Woo HA, 2010, CELL, V140, P517, DOI 10.1016/j.cell.2010.01.009; Xi G, 2008, MOL ENDOCRINOL, V22, P2162, DOI 10.1210/me.2008-0079; Xi G, 2012, DIABETES, V61, P104, DOI 10.2337/db11-0990	33	32	33	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 31	2013	288	22					15641	15653		10.1074/jbc.M113.456046	http://dx.doi.org/10.1074/jbc.M113.456046			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	156LA	23612968	hybrid, Green Published			2022-12-25	WOS:000319822300021
J	Bernardi, JR; Ferreira, CF; Senter, G; Krolow, R; de Aguiar, BW; Portella, AK; Kauer-Sant'Anna, M; Kapczinski, F; Dalmaz, C; Goldani, MZ; Silveira, PP				Bernardi, Juliana R.; Ferreira, Charles F.; Senter, Gabrielle; Krolow, Rachel; de Aguiar, Bianca W.; Portella, Andre K.; Kauer-Sant'Anna, Marcia; Kapczinski, Flavio; Dalmaz, Carla; Goldani, Marcelo Z.; Silveira, Patricia P.			Early Life Stress Interacts with the Diet Deficiency of Omega-3 Fatty Acids during the Life Course Increasing the Metabolic Vulnerability in Adult Rats	PLOS ONE			English	Article							FATTY-ACID-COMPOSITION; NEONATAL MATERNAL SEPARATION; INSULIN-RESISTANCE; PALMITOLEIC ACID; GENE-EXPRESSION; DOCOSAHEXAENOIC ACID; CONTROLLED-TRIALS; SERUM-LIPIDS; PLASMA; OBESITY	Early stress can cause metabolic disorders in adulthood. Omega-3 polyunsaturated fatty acids (n-3 PUFAs) deficiency has also been linked to the development of metabolic disorders. The aim of this study was to assess whether an early stressful event such as maternal separation interacts with the nutritional availability of n-3 PUFAs during the life course on metabolic aspects. Litters were randomized into: maternal separated (MS) and non-handled (NH). The MS group was removed from their dam for 3 hours per day and put in an incubator at 32 degrees C on days 1 degrees to 10 degrees postnatal (PND). On PND 35, males were subdivided into diets that were adequate or deficient in n-3 PUFAs, and this intervention was applied during the subsequent 15 weeks. Animal's body weight and food consumption were measured weekly, and at the end of the treatment tissues were collected. MS was associated with increased food intake (p = 0.047) and weight gain (p = 0.012), but no differences were found in the NPY hypothalamic content between the groups. MS rats had also increased deposition of abdominal fat (p<0.001) and plasma triglycerides (p = 0.018) when compared to the NH group. Interactions between early life stress and n-3 PUFAs deficiency were found in plasma insulin (p = 0.033), HOMA index (p = 0.049), leptin (p = 0.010) and liver PEPCK expression (p = 0.050), in which the metabolic vulnerability in the MS group was aggravated by the n-3 PUFAs deficient diet exposure. This was associated with specific alterations in the peripheral fatty acid profile. Variations in the neonatal environment interact with nutritional aspects during the life course, such as n-3 PUFAs diet content, and persistently alter the metabolic vulnerability in adulthood.	[Bernardi, Juliana R.; Ferreira, Charles F.; Senter, Gabrielle; Portella, Andre K.; Goldani, Marcelo Z.; Silveira, Patricia P.] Univ Fed Rio Grande do Sul, Fac Med, HCPA, NESCA, Porto Alegre, RS, Brazil; [Ferreira, Charles F.; Dalmaz, Carla; Silveira, Patricia P.] Univ Fed Rio Grande do Sul, Inst Ciencias Basicas Saude, Programa Posgrad Neurociencias, Porto Alegre, RS, Brazil; [Krolow, Rachel; Dalmaz, Carla] Univ Fed Rio Grande do Sul, Inst Ciencias Basicas Saude, Dept Bioquim, Porto Alegre, RS, Brazil; [de Aguiar, Bianca W.; Kauer-Sant'Anna, Marcia; Kapczinski, Flavio] Univ Fed Rio Grande do Sul, Bipolar Disorders Program, HCPA, Porto Alegre, RS, Brazil; [de Aguiar, Bianca W.; Kauer-Sant'Anna, Marcia; Kapczinski, Flavio] Univ Fed Rio Grande do Sul, INCT Translat Med CNPq, HCPA, Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul	Silveira, PP (corresponding author), Univ Fed Rio Grande do Sul, Fac Med, HCPA, NESCA, Porto Alegre, RS, Brazil.	00032386@ufrgs.br	de Aguiar, Bianca Wollenhaupt/AAI-3522-2021; Portella, Andre Krumel/A-9333-2010; Kapczinski, Flavio/J-5803-2014; Ferreira, Charles Francisco F/B-5453-2015; Silveira, Patricia P/F-4897-2014; Silveira, Patricia/K-2364-2019; Ferreira, Charles Francisco/P-7568-2019; Kauer-Sant'Anna, Marcia/C-7399-2013; Bernardi, Juliana Rombaldi/U-8603-2019; Goldani, Marcelo Zubaran/U-8596-2019; Silveira, Patrícia P/A-7139-2011; Bernardi, Juliana Rombaldi/U-2198-2019; Kapczinski, Flávio/D-3175-2013; Bernardi, Juliana Rombaldi/P-4106-2015	de Aguiar, Bianca Wollenhaupt/0000-0002-8804-2664; Portella, Andre Krumel/0000-0003-3390-0016; Ferreira, Charles Francisco F/0000-0001-9777-7382; Silveira, Patricia P/0000-0001-8626-2519; Silveira, Patricia/0000-0001-8626-2519; Ferreira, Charles Francisco/0000-0001-9777-7382; Kauer-Sant'Anna, Marcia/0000-0003-2548-6230; Bernardi, Juliana Rombaldi/0000-0002-6803-4472; Kapczinski, Flávio/0000-0001-8738-856X; Krolow, Rachel/0000-0001-6217-1647	ARD/FAPERGS [10/0474-2]; PRONEM/FAPERGS; Universal National Counsel of Technological and Scientific Development (CNPq)- Brazil [478820/2010-0]; FIPE/HCPA [GPPG 09-410]; Foundation for the Coordination of Higher Education and Graduate Training (CAPES); INCT Translational Medicine (CNPq) [573671/2008-7]	ARD/FAPERGS; PRONEM/FAPERGS; Universal National Counsel of Technological and Scientific Development (CNPq)- Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FIPE/HCPA; Foundation for the Coordination of Higher Education and Graduate Training (CAPES); INCT Translational Medicine (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Financial support is from ARD/FAPERGS 2010 (Silveira PP, 10/0474-2) and PRONEM/FAPERGS; Universal National Counsel of Technological and Scientific Development (CNPq)- Brazil 2010 (Silveira PP, 478820/2010-0); FIPE/HCPA (GPPG 09-410); Foundation for the Coordination of Higher Education and Graduate Training (CAPES) and INCT Translational Medicine (CNPq) 573671/2008-7. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostoni C, 2010, EARLY HUM DEV, V86, pS3, DOI 10.1016/j.earlhumdev.2010.01.003; ANDERSON GJ, 1994, AM J CLIN NUTR, V59, P1338, DOI 10.1093/ajcn/59.6.1338; BLAKE WL, 1990, J NUTR, V120, P1727, DOI 10.1093/jn/120.12.1727; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bradley RL, 1999, DIABETES, V48, P272, DOI 10.2337/diabetes.48.2.272; Cancelas J, 2007, HORM METAB RES, V39, P823, DOI 10.1055/s-2007-991171; Chakravarty K, 2005, CRIT REV BIOCHEM MOL, V40, P129, DOI 10.1080/10409230590935479; Clark PM, 1998, EUR J PEDIATR, V157, pS7, DOI 10.1007/PL00014289; Clarke G, 2009, BEHAV BRAIN RES, V205, P319, DOI 10.1016/j.bbr.2009.07.008; De Pergola G, 2008, OBESITY, V16, P2405, DOI 10.1038/oby.2008.382; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; Dias JP, 2012, DIABETES OBES METAB, V14, P244, DOI 10.1111/j.1463-1326.2011.01521.x; Diehl LA, 2007, BRAIN RES, V1144, P107, DOI 10.1016/j.brainres.2007.01.084; Djousse L, 2012, CIRC-HEART FAIL, V5, P703, DOI 10.1161/CIRCHEARTFAILURE.112.967802; Djousse L, 2012, AM J CARDIOL, V110, P539, DOI 10.1016/j.amjcard.2012.04.027; Dupont JL, 2009, J NUTR, V139, P171, DOI 10.3945/jn.108.095810; Fabbrini E, 2009, P NATL ACAD SCI USA, V106, P15430, DOI 10.1073/pnas.0904944106; Gebauer SK, 2006, AM J CLIN NUTR, V83, p1526S, DOI 10.1093/ajcn/83.6.1526S; George ED, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-123; Gluckman PD, 2004, TRENDS ENDOCRIN MET, V15, P183, DOI 10.1016/j.tem.2004.03.002; Guo X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039286; Hartman L, 1973, Lab Pract, V22, P475; Hibbeln JR, 2006, AM J CLIN NUTR, V83, p1483S, DOI 10.1093/ajcn/83.6.1483S; Hodge AM, 2007, AM J CLIN NUTR, V86, P189, DOI 10.1093/ajcn/86.1.189; Jahng JW, 2011, HORM BEHAV, V59, P213, DOI 10.1016/j.yhbeh.2010.11.010; Jump DB, 1999, ANNU REV NUTR, V19, P63, DOI 10.1146/annurev.nutr.19.1.63; Kahl KG, 2012, EUR ARCH PSY CLIN N, V262, P313, DOI 10.1007/s00406-011-0277-4; Kamel MAEN, 2012, J DIABETES METAB, V3, DOI 10.4172/2155-6156.1000181; Kang J, 1999, KIDNEY INT, V56, P452, DOI 10.1046/j.1523-1755.1999.00562.x; Kaufman D, 2007, DIABETES, V56, P1382, DOI 10.2337/db06-1409; Kim HW, 2011, PROSTAG LEUKOTR ESS, V85, P361, DOI 10.1016/j.plefa.2011.08.002; Kim OY, 2013, NUTR METAB CARDIOVAS, V23, P366, DOI 10.1016/j.numecd.2011.06.006; Kotronen A, 2009, DIABETOLOGIA, V52, P684, DOI 10.1007/s00125-009-1282-2; Kozyrskyj AL, 2011, J DEV ORIG HLTH DIS, V2, P72, DOI 10.1017/S2040174410000723; KUHN CM, 1978, SCIENCE, V201, P1034, DOI 10.1126/science.684424; KUHN CM, 1990, DEV PSYCHOBIOL, V23, P395, DOI 10.1002/dev.420230503; Kurotani K, 2012, NUTR RES, V32, P669, DOI 10.1016/j.nutres.2012.07.004; Lee JH, 2007, NEUROSCI RES, V58, P32, DOI 10.1016/j.neures.2007.01.008; Lee MJ, 2007, J BIOL CHEM, V282, P72, DOI 10.1074/jbc.M609518200; Lemaitre-Delaunay D, 1999, J LIPID RES, V40, P1867; LEPAGE G, 1986, J LIPID RES, V27, P114; Lin PY, 2007, J CLIN PSYCHIAT, V68, P1056, DOI 10.4088/JCP.v68n0712; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lovejoy JC, 2001, METABOLISM, V50, P86, DOI 10.1053/meta.2001.19440; LUCAS F, 1989, PHYSIOL BEHAV, V45, P937, DOI 10.1016/0031-9384(89)90218-7; Malaisse WJ, 2009, INT J MOL MED, V24, P111, DOI 10.3892/ijmm_00000214; Marques AYC, 2011, REV NUTR, V24, P131, DOI 10.1590/S1415-52732011000100013; Martins JG, 2009, J AM COLL NUTR, V28, P525, DOI 10.1080/07315724.2009.10719785; Masuzaki H, 2001, SCIENCE, V294, P2166, DOI 10.1126/science.1066285; Mathieu G, 2008, PROSTAG LEUKOTR ESS, V78, P391, DOI 10.1016/j.plefa.2008.05.003; Mathieu G, 2011, PROSTAG LEUKOTR ESS, V85, P129, DOI 10.1016/j.plefa.2011.07.001; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; McEwen BS, 2002, NEUROBIOL AGING, V23, P921, DOI 10.1016/S0197-4580(02)00027-1; Mozaffarian D, 2010, AM J CLIN NUTR, V92, P1350, DOI 10.3945/ajcn.110.003970; Paillard F, 2008, NUTR METAB CARDIOVAS, V18, P436, DOI 10.1016/j.numecd.2007.02.017; Pan A, 2012, DIABETES CARE, V35, P1171, DOI 10.2337/dc11-2055; Patel PS, 2010, AM J CLIN NUTR, V92, P1214, DOI 10.3945/ajcn.2010.29182; Pfaffl MW, 2003, J TRACE ELEM MED BIO, V17, P97, DOI 10.1016/S0946-672X(03)80005-6; PLOTSKY PM, 1993, MOL BRAIN RES, V18, P195, DOI 10.1016/0169-328X(93)90189-V; Raposo HF, 2010, REV NUTR, V23, P871, DOI 10.1590/S1415-52732010000500017; Reynolds RM, 2013, PSYCHONEUROENDOCRINO, V38, P1, DOI 10.1016/j.psyneuen.2012.08.012; Rkhzay-Jaf J, 2012, CURR CARDIOVASC RISK, V6, P487, DOI 10.1007/s12170-012-0257-x; Ross BM, 2007, LIPIDS HEALTH DIS, V6, DOI 10.1186/1476-511X-6-21; Ryan JP, 2012, PSYCHOSOM MED, V74, P476, DOI 10.1097/PSY.0b013e31824d0865; Seckl JR, 2004, EUR J ENDOCRINOL, V151, pU49, DOI 10.1530/eje.0.151u049; Sener A, 2009, INT J MOL MED, V24, P125, DOI 10.3892/ijmm_00000215; Seppala J, 2012, J AFFECT DISORDERS, V136, P543, DOI 10.1016/j.jad.2011.10.032; Simopoulos AP, 2008, EXP BIOL MED, V233, P674, DOI 10.3181/0711-MR-311; Singh RB, 2004, BIOMED PHARMACOTHER, V58, pS56, DOI 10.1016/S0753-3322(04)80011-8; Soyalan B, 2011, EUR J NUTR, V50, P135, DOI 10.1007/s00394-010-0124-9; Straznicky NE, 2008, CURR HYPERTENS REP, V10, P440, DOI 10.1007/s11906-008-0083-1; Sutin AR, 2010, AGE, V32, P513, DOI 10.1007/s11357-010-9153-9; Tanaka S, 2012, BIOL PHARM BULL, V35, P184, DOI 10.1248/bpb.35.184; Tu WC, 2013, PROSTAG LEUKOTR ESS, V88, P53, DOI 10.1016/j.plefa.2012.04.005; Vanltallie TB, 2002, METABOLISM, V51, P40, DOI 10.1053/meta.2002.33191; VESSBY B, 1994, DIABETOLOGIA, V37, P1044, DOI 10.1007/s001250050215; VONSCHACKY C, 1985, J CLIN INVEST, V76, P1626, DOI 10.1172/JCI112147; Wang L, 2003, AM J CLIN NUTR, V78, P91; Wang Q, 1997, DIABETES, V46, P335, DOI 10.2337/diabetes.46.3.335; Warensjo E, 2005, DIABETOLOGIA, V48, P1999, DOI 10.1007/s00125-005-1897-x; Wree A, 2011, DIGESTION, V83, P124, DOI 10.1159/000318741; Yabaluri N, 2010, J BIOSCIENCES, V35, P473, DOI 10.1007/s12038-010-0052-0; Yoo SB, 2011, NEUROPEPTIDES, V45, P343, DOI 10.1016/j.npep.2011.07.005; Zhou L, 2007, CELL METAB, V6, P398, DOI 10.1016/j.cmet.2007.10.008	84	26	26	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2013	8	4							e62031	10.1371/journal.pone.0062031	http://dx.doi.org/10.1371/journal.pone.0062031			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IK	23614006	Green Submitted, Green Published, gold			2022-12-25	WOS:000317907200116
J	Guo, G; Kuai, D; Cai, S; Xue, NZ; Liu, YT; Hao, JH; Fan, YM; Jin, J; Mao, XG; Liu, BL; Zhong, CL; Zhang, X; Yue, Y; Liu, XD; Ma, N; Guo, YH				Guo, Geng; Kuai, Dong; Cai, Sang; Xue, Naizhao; Liu, Yueting; Hao, Jiehe; Fan, Yimin; Jin, Ji; Mao, Xinggang; Liu, Bolin; Zhong, Chengliang; Zhang, Xiang; Yue, Yi; Liu, Xiaodong; Ma, Ning; Guo, Yuhong			Knockdown of FRAT1 Expression by RNA Interference Inhibits Human Glioblastoma Cell Growth, Migration and Invasion	PLOS ONE			English	Article							BETA-CATENIN; MOLECULAR-CLONING; PATHWAY; AXIN; GBP; OVEREXPRESSION; RECONSTITUTION; PROTOONCOGENE; ACTIVATION; REGULATOR	Background: FRAT1 positively regulates the Wnt/beta-catenin signaling pathway by inhibiting GSK-3-mediated phosphorylation of beta-catenin. It was originally characterized as a protein frequently rearranged in advanced T cell lymphoma, but has recently also been identified as a proto-oncogene involved in tumorigenesis. Our previous studies showed that FRAT1 was dramatically overexpressed in gliomas and its expression level was significantly increased along with clinicopathological grades. Methods: In the current study, we used RT-PCR and Western blotting to assess the mRNA and protein levels of FRAT1 in three glioma cell lines. In addition, to evaluate its functional role in gliomas, we examined the effects of FRAT1 knockdown on proliferation, migration and invasion in vitro and tumor growth in vivo using glioblastoma U251 cells and RNAi. Results: FRAT1 was highly expressed in all three glioma cell lines. RNAi-mediated down-regulation of endogenous FRAT1 in human glioblastoma U251 cells resulted in suppression of cell proliferation, arrest of cell cycle, inhibition of cell migration and invasion in vitro. Moreover, FRAT1 depletion significantly impaired tumor xenograft growth in nude mice. Conclusions: Our results highlight the potential role of FRAT1 in tumorigenesis and progression of glioblastoma. These findings provide a biological basis for FRAT1 as a potential molecular marker for improved pathological grading and as a novel candidate therapeutic target for glioblastoma management.	[Guo, Geng; Kuai, Dong; Xue, Naizhao; Liu, Yueting; Hao, Jiehe; Fan, Yimin; Liu, Xiaodong; Ma, Ning; Guo, Yuhong] Shanxi Med Univ, Hosp 1, Dept Neurosurg, Taiyuan, Shanxi Province, Peoples R China; [Cai, Sang] 101 Hosp PLA, Inst Neurosurg, Wuxi, Jiangsu, Peoples R China; [Jin, Ji] Shanxi Med Univ, Taiyuan, Shanxi Province, Peoples R China; [Mao, Xinggang] PLA 254 Hosp, Dept Neurosurg, Tianjin, Peoples R China; [Mao, Xinggang; Liu, Bolin; Zhang, Xiang] Fourth Mil Med Univ, Xijing Hosp, Dept Neurosurg, Xian 710032, Shaanxi Provinc, Peoples R China; [Zhong, Chengliang] Tianjin Univ Tradit Chinese Med, Teaching Hosp 1, Clin Pharmacol Ctr, Tianjin, Peoples R China; [Yue, Yi] Shanxis Gen Hosp Chinese Peoples Armed Police For, Dept Neurosurg, Taiyuan, Shanxi Province, Peoples R China	Shanxi Medical University; Shanxi Medical University; Air Force Military Medical University; Tianjin University of Traditional Chinese Medicine	Guo, G (corresponding author), Shanxi Med Univ, Hosp 1, Dept Neurosurg, Taiyuan, Shanxi Province, Peoples R China.	guogenger@yahoo.com.cn	Mao, Xing-gang/GQP-3339-2022; guo, geng/M-4108-2014	Mao, Xing-gang/0000-0001-8505-1904; guo, geng/0000-0003-4197-0399	National Natural Science Foundation of China [81201991]; Basic Research Program of Shanxi Province of China [2012021035-5]; Foundation for Young Scholar of Shanxi Medical University [02201116]; Doctoral Foundation of First Hospital of Shanxi Medical University [YB1111]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Basic Research Program of Shanxi Province of China; Foundation for Young Scholar of Shanxi Medical University; Doctoral Foundation of First Hospital of Shanxi Medical University	This work was supported by the National Natural Science Foundation of China (No. 81201991), the Basic Research Program of Shanxi Province of China (No. 2012021035-5), the Foundation for Young Scholar of Shanxi Medical University (No. 02201116) and the Doctoral Foundation of First Hospital of Shanxi Medical University (No. YB1111). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baranes D, 1996, P NATL ACAD SCI USA, V93, P4706, DOI 10.1073/pnas.93.10.4706; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; DeAngelis LM, 2001, NEW ENGL J MED, V344, P114, DOI 10.1056/NEJM200101113440207; Farr GH, 2000, J CELL BIOL, V148, P691, DOI 10.1083/jcb.148.4.691; Ferkey DM, 2002, J BIOL CHEM, V277, P16147, DOI 10.1074/jbc.M112363200; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Fraser E, 2002, J BIOL CHEM, V277, P2176, DOI 10.1074/jbc.M109462200; Guo G, 2011, MED ONCOL, V28, P1, DOI 10.1007/s12032-009-9402-x; Guo G, 2010, BRAIN RES, V1320, P152, DOI 10.1016/j.brainres.2010.01.037; Hagen T, 2006, J BIOL CHEM, V281, P35021, DOI 10.1074/jbc.M607003200; Hess KR, 2004, CANCER, V101, P2293, DOI 10.1002/cncr.20621; Ille F, 2005, CELL MOL LIFE SCI, V62, P1100, DOI 10.1007/s00018-005-4552-2; Jonkers J, 1997, EMBO J, V16, P441, DOI 10.1093/emboj/16.3.441; Jonkers J, 1999, MECH DEVELOP, V88, P183, DOI 10.1016/S0925-4773(99)00187-2; Jonkers J, 1999, ONCOGENE, V18, P5982, DOI 10.1038/sj.onc.1202995; Li L, 1999, EMBO J, V18, P4233, DOI 10.1093/emboj/18.15.4233; Lin W, 2009, J CELL MOL MED, V13, P4608, DOI 10.1111/j.1582-4934.2008.00499.x; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Pelengaris S, 2002, NAT REV CANCER, V2, P764, DOI 10.1038/nrc904; Polakis P, 2000, GENE DEV, V14, P1837; Saitoh T, 2002, INT J ONCOL, V20, P785; Saitoh T, 2001, INT J ONCOL, V19, P311; Saitoh T, 2001, BIOCHEM BIOPH RES CO, V281, P815, DOI 10.1006/bbrc.2001.4421; Salic A, 2000, MOL CELL, V5, P523, DOI 10.1016/S1097-2765(00)80446-3; Sanson M, 2004, CURR OPIN ONCOL, V16, P607, DOI 10.1097/01.cco.0000142485.81849.cc; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Tolwinski NS, 2004, TRENDS GENET, V20, P177, DOI 10.1016/j.tig.2004.02.003; Valster A, 2005, METHODS, V37, P208, DOI 10.1016/j.ymeth.2005.08.001; Van Der Flier LG, 2007, GASTROENTEROLOGY, V132, P628, DOI 10.1053/j.gastro.2006.08.039; Wang Y, 2006, BRIT J CANCER, V94, P686, DOI 10.1038/sj.bjc.6602988; Wang YH, 2008, INT J CANCER, V123, P561, DOI 10.1002/ijc.23600; Yost C, 1998, CELL, V93, P1031, DOI 10.1016/S0092-8674(00)81208-8; Zhang Y, 2012, TUMOR BIOL, V33, P1437, DOI 10.1007/s13277-012-0394-3; Zhang Y, 2011, VIRCHOWS ARCH, V459, P255, DOI 10.1007/s00428-011-1135-5; Zhao C, 2007, CANCER CELL, V12, P528, DOI 10.1016/j.ccr.2007.11.003	37	26	28	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2013	8	4							e61206	10.1371/journal.pone.0061206	http://dx.doi.org/10.1371/journal.pone.0061206			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IK	23613813	Green Published, Green Submitted, gold			2022-12-25	WOS:000317907200039
J	Hennecke, K; Redeker, J; Kuhbier, JW; Strauss, S; Allmeling, C; Kasper, C; Reimers, K; Vogt, PM				Hennecke, Kathleen; Redeker, Joern; Kuhbier, Joern W.; Strauss, Sarah; Allmeling, Christina; Kasper, Cornelia; Reimers, Kerstin; Vogt, Peter M.			Bundles of Spider Silk, Braided into Sutures, Resist Basic Cyclic Tests: Potential Use for Flexor Tendon Repair	PLOS ONE			English	Article							DRAGLINE SILK; MECHANICAL-PROPERTIES; FIBERS; HUMIDITY; GROWTH; DESIGN	Repair success for injuries to the flexor tendon in the hand is often limited by the in vivo behaviour of the suture used for repair. Common problems associated with the choice of suture material include increased risk of infection, foreign body reactions, and inappropriate mechanical responses, particularly decreases in mechanical properties over time. Improved suture materials are therefore needed. As high-performance materials with excellent tensile strength, spider silk fibres are an extremely promising candidate for use in surgical sutures. However, the mechanical behaviour of sutures comprised of individual silk fibres braided together has not been thoroughly investigated. In the present study, we characterise the maximum tensile strength, stress, strain, elastic modulus, and fatigue response of silk sutures produced using different braiding methods to investigate the influence of braiding on the tensile properties of the sutures. The mechanical properties of conventional surgical sutures are also characterised to assess whether silk offers any advantages over conventional suture materials. The results demonstrate that braiding single spider silk fibres together produces strong sutures with excellent fatigue behaviour; the braided silk sutures exhibited tensile strengths comparable to those of conventional sutures and no loss of strength over 1000 fatigue cycles. In addition, the braiding technique had a significant influence on the tensile properties of the braided silk sutures. These results suggest that braided spider silk could be suitable for use as sutures in flexor tendon repair, providing similar tensile behaviour and improved fatigue properties compared with conventional suture materials.	[Hennecke, Kathleen; Redeker, Joern; Kuhbier, Joern W.; Strauss, Sarah; Allmeling, Christina; Reimers, Kerstin; Vogt, Peter M.] Hannover Med Sch, Dept Plast Hand & Reconstruct Surg, Hannover, Germany; [Kasper, Cornelia] Univ Nat Resources & Life Sci, Inst Appl Microbiol, Vienna, Austria	Hannover Medical School; University of Natural Resources & Life Sciences, Vienna	Reimers, K (corresponding author), Hannover Med Sch, Dept Plast Hand & Reconstruct Surg, Hannover, Germany.	Reimers.Kerstin@mh-hannover.de	Kasper, Cornelia/AAC-1924-2022; Vogt, Peter M./AAL-1332-2020	kasper, cornelia/0000-0003-2607-4326	REBIRTH cluster of excellence - "From Regenerative Biology to Reconstructive Therapy"	REBIRTH cluster of excellence - "From Regenerative Biology to Reconstructive Therapy"	Funding provided by REBIRTH cluster of excellence - "From Regenerative Biology to Reconstructive Therapy": financial support for purchasing the Instron testing system. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnarsson I, 2009, ZOOLOGY, V112, P325, DOI 10.1016/j.zool.2008.11.003; Allmeling C, 2008, CELL PROLIFERAT, V41, P408, DOI 10.1111/j.1365-2184.2008.00534.x; Allmeling C, 2006, J CELL MOL MED, V10, P770, DOI 10.1111/j.1582-4934.2006.tb00436.x; Bell FI, 2002, NATURE, V416, P37, DOI 10.1038/416037a; Blackledge TA, 2009, J EXP BIOL, V212, P1980, DOI 10.1242/jeb.028944; Boltz S, 2009, GESETZLICHE UNFALLVE; Brinkmann P, 2000, ORTHOPADISCHE BIOMEH, P147; Cunniff P.M., 1994, POLYM ADVAN TECHNOL, V5, P401; Dicko C, 2004, BIOMACROMOLECULES, V5, P2105, DOI 10.1021/bm034486y; Dona E, 2003, J HAND SURG-AM, V28A, P824, DOI 10.1016/S0363-5023(03)00305-8; Du N, 2006, BIOPHYS J, V91, P4528, DOI 10.1529/biophysj.106.089144; Emile O, 2006, NATURE, V440, P621, DOI 10.1038/440621a; FOELIX RF, 1996, BIOL SPIDERS, P3; Gellynck K, 2008, J MATER SCI-MATER M, V19, P2963, DOI 10.1007/s10856-007-3330-0; GOSLINE JM, 1984, NATURE, V309, P551, DOI 10.1038/309551a0; Gosline JM, 1999, J EXP BIOL, V202, P3295; Guinea GV, 2005, J EXP BIOL, V208, P25, DOI 10.1242/jeb.01344; Hakimi O, 2010, J BIOMED MATER RES A, V92A, P1366, DOI 10.1002/jbm.a.32462; James R, 2008, J HAND SURG-AM, V33A, P102, DOI 10.1016/j.jhsa.2007.09.007; Kennedy R, 2009, NY TIMES, pC1; Kitsis CK, 1998, J HAND SURG-BRIT EUR, V23B, P344, DOI 10.1016/S0266-7681(98)80055-7; Kuhbier JW, 2011, J BIOMED MATER RES B, V97B, P381, DOI 10.1002/jbm.b.31825; Kuhbier JW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012032; Leal-Egana A, 2010, BIOTECHNOL APPL BIOC, V55, P155, DOI 10.1042/BA20090229; Lister G D, 1977, J Hand Surg Am, V2, P441; Lu BY, 2010, BURNS, V36, P891, DOI 10.1016/j.burns.2009.12.001; Nockemann PF, 1992, CHIRURG NAHT, P1; Ortlepp CS, 2004, BIOMACROMOLECULES, V5, P727, DOI 10.1021/bm034269x; Perez-Rigueiro J, 2005, J EXP BIOL, V208, P2633, DOI 10.1242/jeb.01701; Rising A, 2011, CELL MOL LIFE SCI, V68, P169, DOI 10.1007/s00018-010-0462-z; Romer L, 2008, PRION, V2, P154; Schmit-Neuerburg KP, 2001, TSCHERNE UNFALLCHIRU, P581; Schunke M, 2000, FUNKTIONELLE ANATOMI, P81; Stephan C, 2008, OPER ORTHOPADE TRAUM, V20, P44, DOI 10.1007/s00064-008-1227-9; Vehoff T, 2007, BIOPHYS J, V93, P4425, DOI 10.1529/biophysj.106.099309; Vollrath F, 2000, J Biotechnol, V74, P67; Vollrath F, 2001, P ROY SOC B-BIOL SCI, V268, P2339, DOI 10.1098/rspb.2001.1590; Wang YZ, 2006, BIOMATERIALS, V27, P6064, DOI 10.1016/j.biomaterials.2006.07.008; Xia XX, 2010, P NATL ACAD SCI USA, V107, P14059, DOI 10.1073/pnas.1003366107	39	30	31	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2013	8	4							e61100	10.1371/journal.pone.0061100	http://dx.doi.org/10.1371/journal.pone.0061100			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IK	23613793	gold, Green Published, Green Submitted			2022-12-25	WOS:000317907200031
J	Liu, HB; Hunter, L; Keselj, V; Verspoor, K				Liu, Haibin; Hunter, Lawrence; Keselj, Vlado; Verspoor, Karin			Approximate Subgraph Matching-Based Literature Mining for Biomedical Events and Relations	PLOS ONE			English	Article							NATURAL-LANGUAGE PARSERS; EXTRACTION; CORPUS; TOOL	The biomedical text mining community has focused on developing techniques to automatically extract important relations between biological components and semantic events involving genes or proteins from literature. In this paper, we propose a novel approach for mining relations and events in the biomedical literature using approximate subgraph matching. Extraction of such knowledge is performed by searching for an approximate subgraph isomorphism between key contextual dependencies and input sentence graphs. Our approach significantly increases the chance of retrieving relations or events encoded within complex dependency contexts by introducing error tolerance into the graph matching process, while maintaining the extraction precision at a high level. When evaluated on practical tasks, it achieves a 51.12% F-score in extracting nine types of biological events on the GE task of the BioNLP-ST 2011 and an 84.22% F-score in detecting protein-residue associations. The performance is comparable to the reported systems across these tasks, and thus demonstrates the generalizability of our proposed approach.	[Liu, Haibin] Natl Lib Med, Natl Ctr Biotechnol Informat, Bethesda, MD 20894 USA; [Hunter, Lawrence] Univ Colorado, Sch Med, Aurora, CO USA; [Keselj, Vlado] Dalhousie Univ, Fac Comp Sci, Halifax, NS, Canada; [Verspoor, Karin] Natl ICT Australia, Victoria Res Lab, Melbourne, Vic, Australia	National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); University of Colorado System; University of Colorado Anschutz Medical Campus; Dalhousie University; NICTA	Liu, HB (corresponding author), Natl Lib Med, Natl Ctr Biotechnol Informat, Bethesda, MD 20894 USA.	Haibin.Liu@nih.gov	Verspoor, Karin/G-6034-2016	Verspoor, Karin/0000-0002-8661-1544; Hunter, Lawrence/0000-0003-1455-3370; Keselj, Vlado/0000-0001-8760-3223	National Library of Medicine Informatics Training grant [5T15LM009451]; National Institutes of Health [5R01LM009254, 5R01LM008111]; NIH, NLM; NATIONAL LIBRARY OF MEDICINE [T15LM009451, R01LM008111, R01LM009254] Funding Source: NIH RePORTER	National Library of Medicine Informatics Training grant; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH, NLM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This research was supported by the National Library of Medicine Informatics Training grant 5T15LM009451, and National Institutes of Health grants 5R01LM009254 and 5R01LM008111. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported in part by the Intramural Research Program of the NIH, NLM.	Airola A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S11-S2; Alpaydin E., 2004, INTRO MACHINE LEARNI; Ananiadou S, 2010, TRENDS BIOTECHNOL, V28, P381, DOI 10.1016/j.tibtech.2010.04.005; Bengoetxea E., 2002, THESIS ECOLE NATL SU; Bjorne J, 2009, P WORKSH CURR TRENDS, P10; Bjorne J., 2011, P DDIEXTRACTION 2011, P35; Bjorne J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S11-S4; Bui QC, 2012, BIOINFORMATICS; Bunescu R, 2005, ARTIF INTELL MED, V33, P139, DOI 10.1016/j.artmed.2004.07.016; Bunescu RC, 2005, P C HUM LANG TECHN E, P724, DOI DOI 10.3115/1220575.1220666; Buyko E., 2010, P 2010 C EMP METH NA, P982; Buyko Ekaterina, 2009, BIONLP 09 SHARED TAS; Clegg AB, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-24; Craven M, 1999, Proc Int Conf Intell Syst Mol Biol, P77; Dalkilic MM, 2008, FRONT BIOSCI-LANDMRK, V13, P3391; Ding J, 2002, Pac Symp Biocomput, P326; Erkan G., 2007, P 2007 JOINT C EMP M, P228; Fundel K, 2007, BIOINFORMATICS, V23, P365, DOI 10.1093/bioinformatics/btl616; Garey M.R., 1979, COMPUTERS INTRACTABI; Haghighi A.D., 2005, P C HUM LANG TECHN E, P387, DOI DOI 10.3115/1220575.1220624; Hoffmann R, 2011, P 49 ANN M ASS COMPU, P541; Jari Bjorne<spacing Tapio, 2011, P BIONLP SHAR TASK 2, P183; Kilicoglu H., 2011, P BIONLP SHAR TASK 2, P173; Kilicoglu H., 2009, P BIONLP 2009 WORKSH, P119, DOI [10.3115/1572340.1572361, DOI 10.3115/1572340.1572361]; Kilicoglu H, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S11-S7; Kim J., 2011, P BIONLP SHAR TASK 2, P1, DOI 10.1109/MWSCAS.2011.6026357; Kim JD, 2003, BIOINFORMATICS, V19, pi180, DOI 10.1093/bioinformatics/btg1023; Kim JH, 2009, ARTECH HSE METH BIOE, P1, DOI 10.1109/ICIMW.2009.5324773; Kim S, 2008, BIOINFORMATICS, V24, P118, DOI 10.1093/bioinformatics/btm544; Klein D, 2003, 41ST ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS, PROCEEDINGS OF THE CONFERENCE, P423, DOI 10.3115/1075096.1075150; Leiserson CE, 2001, INTRO ALGORITHMS; Liu H., 2011, P BIONLP SHAR TASK 2, P164; Liu H, 2010, P 4 INT S SEM MIN BI; Liu H, 2012, P AAAI 2012 FALL S I; Liu HB, 2012, J BIOMED SEMANT, V3, DOI 10.1186/2041-1480-3-3; Marneffe M-CDe, 2008, P WORKSH CROSS FRAM, P1, DOI [DOI 10.3115/1608858.1608859, 10.5555/1608858, DOI 10.5555/1608858]; McClosky D., 2011, P 49 ANN M ASS COMP, V1, P1626; McClosky D, 2008, P 46 ANN M ASS COMP, P101, DOI DOI 10.3115/1557690.1557717; McClosky D, 2011, P BIONLP SHAR TASK 2, P41; McClosky D, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S11-S9; McClosky David, 2010, HUMAN LANGUAGE TECHN, P28; Methods S, 2011, NONPARAMETRIC STAT T; Miwa Makoto, 2010, Journal of Bioinformatics and Computational Biology, V8, P131, DOI 10.1142/S0219720010004586; Miyao Y, 2009, BIOINFORMATICS, V25, P394, DOI 10.1093/bioinformatics/btn631; Mohler M, 2011, P 49 ANN M ASS COMPU, P752; Molla D, 2006, P HLT NAACL 2006 WOR, P37; Nagel K, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S8-S4; Nedellec C., 2005, P 4 LEARN LANG LOG W, P31; Nguyen Truc-Vien T, 2011, P ACL, P277; Pyysalo S, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-50; Qian LH, 2012, J BIOMED INFORM, V45, P535, DOI 10.1016/j.jbi.2012.02.004; Quirk C, 2011, P BIONLP SHAR TASK 2, P155; Ravikumar K, 2011, P 10 INT C MACH LEAR; Ravikumar Ke, 2012, J Biomed Semantics, V3 Suppl 3, pS2, DOI 10.1186/2041-1480-3-S3-S2; Riedel Sebastian, 2011, P BIONLP SHAR TASK 2, P46; Riedel Sebastian, 2011, P BIONLP SHAR TASK 2, P51; Rinaldi F, 2010, IEEE ACM T COMPUT BI, V7, P472, DOI 10.1109/TCBB.2010.50; SAGAE K, 2008, WORKSH AUT SYNT ANN; Segura-Bedmar I., 2011, CHALLENGE TASK DRUG, P1; Thomas P., 2011, P 1 CHALL TASK DRUG, P11; THOMAS PA, 2011, P BIONLP 2011 WORKSH, P1, DOI DOI 10.1007/978-1-60327-154-7_1; Tian YY, 2007, BIOINFORMATICS, V23, P232, DOI 10.1093/bioinformatics/btl571; Tikk D, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000837; Verspoor K, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-207; Verspoor KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032171; Vlachos A., 2011, P BIONLP SHAR TASK 2, P36; Wilbur J., 2007, P 2 BIOCREATIVE CHAL, P7; Xu Rong, 2009, P WORKSH CURR TRENDS, P63; Yeh A., 2000, P 18 C COMPUTATIONAL, P947, DOI [10.3115/992730.992783, DOI 10.3115/992730.992783]	69	24	25	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2013	8	4							e60954	10.1371/journal.pone.0060954	http://dx.doi.org/10.1371/journal.pone.0060954			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IK	23613763	Green Published, gold			2022-12-25	WOS:000317907200020
J	Martens-de Kemp, SR; Dalm, SU; Wijnolts, FMJ; Brink, A; Honeywell, RJ; Peters, GJ; Braakhuis, BJM; Brakenhoff, RH				Martens-de Kemp, Sanne R.; Dalm, Simone U.; Wijnolts, Fiona M. J.; Brink, Arjen; Honeywell, Richard J.; Peters, Godefridus J.; Braakhuis, Boudewijn J. M.; Brakenhoff, Ruud H.			DNA-Bound Platinum Is the Major Determinant of Cisplatin Sensitivity in Head and Neck Squamous Carcinoma Cells	PLOS ONE			English	Article							ADENOSINE-TRIPHOSPHATASE ATP7B; COPPER TRANSPORTER CTR1; LOCALLY ADVANCED HEAD; HUMAN OVARIAN; EXCISION-REPAIR; P53 MUTATIONS; EXPRESSION; RESISTANCE; CHEMOTHERAPY; LINES	Purpose: The combination of systemic cisplatin with local and regional radiotherapy as primary treatment of head and neck squamous cell carcinoma (HNSCC) leads to cure in approximately half of the patients. The addition of cisplatin has significant effects on outcome, but despite extensive research the mechanism underlying cisplatin response is still not well understood. Methods: We examined 19 HNSCC cell lines with variable cisplatin sensitivity. We determined the TP53 mutational status of each cell line and investigated the expression levels of 11 potentially relevant genes by quantitative real-time PCR. In addition, we measured cisplatin accumulation and retention, as well as the level of platinum-DNA adducts. Results: We found that the IC50 value was significantly correlated with the platinum-DNA adduct levels that accumulated during four hours of cisplatin incubation (p = 0.002). We could not find a significant correlation between cisplatin sensitivity and any of the other parameters tested, including the expression levels of established cisplatin influx and efflux transporters. Furthermore, adduct accumulation did not correlate with mRNA expression of the investigated influx pumps (CTR1 and OCT3) nor with that of the examined DNA repair genes (ATR, ATM, BRCA1, BRCA2 and ERCC1). Conclusion: Our findings suggest that the cisplatin-DNA adduct level is the most important determinant of cisplatin sensitivity in HNSCC cells. Imaging with radio-labeled cisplatin might have major associations with outcome.	[Martens-de Kemp, Sanne R.; Dalm, Simone U.; Wijnolts, Fiona M. J.; Brink, Arjen; Braakhuis, Boudewijn J. M.; Brakenhoff, Ruud H.] Vrije Univ Amsterdam, Med Ctr, Dept Otolaryngol Head Neck Surg, Amsterdam, Netherlands; [Honeywell, Richard J.; Peters, Godefridus J.] Vrije Univ Amsterdam, Med Ctr, Dept Med Oncol, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	Brakenhoff, RH (corresponding author), Vrije Univ Amsterdam, Med Ctr, Dept Otolaryngol Head Neck Surg, Amsterdam, Netherlands.	rh.brakenhoff@vumc.nl	Braakhuis, Boudewijn JM/B-4383-2008; Kemp, Sanne Martens-de/I-2060-2019; Peters, Godefridus J/C-7562-2013	Kemp, Sanne Martens-de/0000-0002-8889-1631; Dalm, Simone/0000-0002-6393-6901; Peters, Godefridus J/0000-0002-5447-2877				Aerts JL, 2004, BIOTECHNIQUES, V36, P84, DOI 10.2144/04361ST04; Agrawal N, 2011, SCIENCE, V333, P1154, DOI 10.1126/science.1206923; Andersson A, 1996, J PHARM SCI, V85, P824, DOI 10.1021/js960037a; Andrews GA, 2004, HEAD NECK-J SCI SPEC, V26, P870, DOI 10.1002/hed.20029; Bauer JA, 2005, MOL CANCER THER, V4, P1096, DOI 10.1158/1535-7163.MCT-05-0081; Bernier J, 2004, NEW ENGL J MED, V350, P1945, DOI 10.1056/NEJMoa032641; Bradford CR, 2003, HEAD NECK-J SCI SPEC, V25, P654, DOI 10.1002/hed.10274; Branch P, 2000, ONCOGENE, V19, P3138, DOI 10.1038/sj.onc.1203668; Burkitt K, 2007, CANCER LETT, V253, P131, DOI 10.1016/j.canlet.2007.01.017; Cabelguenne A, 2000, J CLIN ONCOL, V18, P1465, DOI 10.1200/JCO.2000.18.7.1465; de Winter JP, 2009, MUTAT RES-FUND MOL M, V668, P11, DOI 10.1016/j.mrfmmm.2008.11.004; Handra-Luca A, 2007, CLIN CANCER RES, V13, P3855, DOI 10.1158/1078-0432.CCR-07-0252; Hermsen MAJA, 1996, GENE CHROMOSOME CANC, V15, P1; Higashimoto M, 2003, INT J MOL MED, V11, P337; Hoebers FJP, 2006, INT J CANCER, V119, P750, DOI 10.1002/ijc.21919; Hoffmann TK, 2008, ORAL ONCOL; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Holzer AK, 2004, MOL PHARMACOL, V66, P817, DOI 10.1124/mol.104.001198; Ishida S, 2002, P NATL ACAD SCI USA, V99, P14298, DOI 10.1073/pnas.162491399; Jun HJ, 2008, BRIT J CANCER, V99, P167, DOI 10.1038/sj.bjc.6604464; Kalayda GV, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-175; Katano K, 2004, CLIN CANCER RES, V10, P4578, DOI 10.1158/1078-0432.CCR-03-0689; Katano K, 2002, CANCER RES, V62, P6559; Kelland L, 2007, NAT REV CANCER, V7, P573, DOI 10.1038/nrc2167; Komatsu M, 2000, CANCER RES, V60, P1312; Leemans CR, 2011, NAT REV CANCER, V11, P9, DOI 10.1038/nrc2982; LEVINE AJ, 1991, NATURE, V351, P453, DOI 10.1038/351453a0; Lin CJ, 2007, HEAD NECK-J SCI SPEC, V29, P163, DOI 10.1002/hed.20478; Lin XJ, 2002, MOL PHARMACOL, V62, P1154, DOI 10.1124/mol.62.5.1154; Lindenbergh-van der Plas M, 2011, CLIN CANCER RES, V17, P3733, DOI 10.1158/1078-0432.CCR-11-0183; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mandic R, 2005, CLIN CANCER RES, V11, P6845, DOI 10.1158/1078-0432.CCR-05-0378; Miyashita H, 2003, ORAL ONCOL, V39, P157, DOI 10.1016/S1368-8375(02)00038-6; Nakayama K, 2001, ONCOL REP, V8, P1285; Noordhuis P, 2008, BIOCHEM PHARMACOL, V76, P53, DOI 10.1016/j.bcp.2008.04.007; Rajan JV, 1996, P NATL ACAD SCI USA, V93, P13078, DOI 10.1073/pnas.93.23.13078; Reles A, 2001, CLIN CANCER RES, V7, P2984; Safaei R, 2004, CANCER CHEMOTH PHARM, V53, P239, DOI 10.1007/s00280-003-0736-3; Samimi G, 2004, CLIN CANCER RES, V10, P4661, DOI 10.1158/1078-0432.CCR-04-0137; Siddik ZH, 1998, CANCER RES, V58, P698; Snyder ER, 2007, CANCER LETT, V245, P75, DOI 10.1016/j.canlet.2005.12.028; Song IS, 2004, MOL CANCER THER, V3, P1543; STEENBERGEN RDM, 1995, CANCER RES, V55, P5465; Urien S, 2004, BRIT J CLIN PHARMACO, V57, P756, DOI 10.1111/j.1365-2125.2004.02082.x; van Zeeburg HJT, 2005, CANCER RES, V65, P1271, DOI 10.1158/0008-5472.CAN-04-3665; Wang D, 2005, NAT REV DRUG DISCOV, V4, P307, DOI 10.1038/nrd1691; WANG ZG, 1993, P NATL ACAD SCI USA, V90, P4907, DOI 10.1073/pnas.90.11.4907; Welters MJP, 1999, ANN ONCOL, V10, P97, DOI 10.1023/A:1008324803494; Yuan SSF, 1999, CANCER RES, V59, P3547	49	25	25	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2013	8	4							e61555	10.1371/journal.pone.0061555	http://dx.doi.org/10.1371/journal.pone.0061555			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IK	23613873	Green Published, Green Submitted, gold			2022-12-25	WOS:000317907200063
J	Martinez, D; Chaffiol, A; Voges, N; Gu, YQ; Anton, S; Rospars, JP; Lucas, P				Martinez, Dominique; Chaffiol, Antoine; Voges, Nicole; Gu, Yuqiao; Anton, Sylvia; Rospars, Jean-Pierre; Lucas, Philippe			Multiphasic On/Off Pheromone Signalling in Moths as Neural Correlates of a Search Strategy	PLOS ONE			English	Article							SEX-PHEROMONE; ANTENNAL-LOBE; OLFACTORY RECEPTORS; SILKWORM MOTH; UPWIND FLIGHT; SPHINX MOTH; ODOR; DROSOPHILA; NEURONS; RESPONSES	Insects and robots searching for odour sources in turbulent plumes face the same problem: the random nature of mixing causes fluctuations and intermittency in perception. Pheromone-tracking male moths appear to deal with discontinuous flows of information by surging upwind, upon sensing a pheromone patch, and casting crosswind, upon losing the plume. Using a combination of neurophysiological recordings, computational modelling and experiments with a cyborg, we propose a neuronal mechanism that promotes a behavioural switch between surge and casting. We show how multiphasic On/Off pheromone-sensitive neurons may guide action selection based on signalling presence or loss of the pheromone. A Hodgkin-Huxley-type neuron model with a small-conductance calcium-activated potassium (SK) channel reproduces physiological On/Off responses. Using this model as a command neuron and the antennae of tethered moths as pheromone sensors, we demonstrate the efficiency of multiphasic patterning in driving a robotic searcher toward the source. Taken together, our results suggest that multiphasic On/Off responses may mediate olfactory navigation and that SK channels may account for these responses.	[Martinez, Dominique; Voges, Nicole; Gu, Yuqiao] CNRS, Lab Lorrain Rech Informat & Ses Applicat LORIA, UMR7503, Vandoeuvre Les Nancy, France; [Chaffiol, Antoine; Gu, Yuqiao; Anton, Sylvia; Rospars, Jean-Pierre; Lucas, Philippe] INRA, UMR 1272, F-78026 Versailles, France; [Anton, Sylvia] Univ Angers, UPRES EA USC INRA 1330 2647, Lab Recepteurs & Canaux Ion Membranaires, Angers, France	Centre National de la Recherche Scientifique (CNRS); Universite de Lorraine; INRAE; UDICE-French Research Universities; Universite Paris Saclay; INRAE; Universite d'Angers	Martinez, D (corresponding author), CNRS, Lab Lorrain Rech Informat & Ses Applicat LORIA, UMR7503, Vandoeuvre Les Nancy, France.	dominique.martinez@loria.fr	Lucas, Philippe/I-6020-2016	Chaffiol, Antoine/0000-0001-7280-767X; voges, nicole/0000-0002-6324-2600	Agence Nationale de la Recherche, within the French-British ANR-BBSRC initiative [BSYS-006 "Pherosys'']; state program Investissements d'avenir [ANR-10-BINF-05 "Pherotaxis'']; European Bio-ICT convergence project [FP7-216916 "Neurochem'']	Agence Nationale de la Recherche, within the French-British ANR-BBSRC initiative(French National Research Agency (ANR)); state program Investissements d'avenir(French National Research Agency (ANR)); European Bio-ICT convergence project	This work was funded by the Agence Nationale de la Recherche, within the French-British ANR-BBSRC initiative (grant BSYS-006 "Pherosys''), by the state program Investissements d'avenir managed by ANR (grant ANR-10-BINF-05 "Pherotaxis''), and the European Bio-ICT convergence project (grant FP7-216916 "Neurochem''). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alperin S, 2003, THEORY SEARCH GAMES; Baker T. C., 1990, P 10 INT S OLF TAST; BAKER TC, 1988, J EXP BIOL, V137, P29; BAKER TC, 1987, PHYSIOL ENTOMOL, V12, P263, DOI 10.1111/j.1365-3032.1987.tb00751.x; Belmabrouk H, 2011, P NATL ACAD SCI USA, V108, P19790, DOI 10.1073/pnas.1112367108; Bhandawat V, 2010, J EXP BIOL, V213, P3625, DOI 10.1242/jeb.040402; Budick SA, 2006, J EXP BIOL, V209, P3001, DOI 10.1242/jeb.02305; Carde RT, 2012, J ANIM ECOL, V81, P268, DOI 10.1111/j.1365-2656.2011.01887.x; Chaffiol A, 2012, J EXP BIOL, V215, P1670, DOI 10.1242/jeb.066662; CHRISTENSEN TA, 1987, J COMP PHYSIOL A, V160, P553, DOI 10.1007/BF00611929; Dauwels J, 2009, NEURAL COMPUT, V21, P2152, DOI 10.1162/neco.2009.04-08-746; Gold JI, 2001, TRENDS COGN SCI, V5, P10, DOI 10.1016/S1364-6613(00)01567-9; Jarriault D, 2009, J EXP BIOL, V212, P1191, DOI 10.1242/jeb.024166; Kaissling KE, 1997, EXS, V84, P343; KANZAKI R, 1994, J COMP PHYSIOL A, V175, P1, DOI 10.1007/BF00217431; KANZAKI R, 1992, ZOOL SCI, V9, P515; KANZAKI R, 1991, J COMP PHYSIOL A, V169, P1, DOI 10.1007/BF00198168; Kanzaki R., 2007, INT C, V1301, P7, DOI [10.1016/j.ics.2006.12.037, DOI 10.1016/J.ICS.2006.12.037]; Kennedy JS, 1983, PHYSIOL ENTOMOL, V27, P58; Khawaled R, 1999, PFLUG ARCH EUR J PHY, V438, P314, DOI 10.1007/s004240050915; Kramer E, 1996, PHEROMONE RES NEW DI, P232; Kuwana Y, 1999, BIOSENS BIOELECTRON, V14, P195, DOI 10.1016/S0956-5663(98)00106-7; Lei Hong, 2009, Journal of Biology (London), V8, P21, DOI 10.1186/jbiol120; MAFRANETO A, 1994, NATURE, V369, P142, DOI 10.1038/369142a0; Marshall B, 2010, CHEM SENSES, V35, P613, DOI 10.1093/chemse/bjq050; Mercer AR, 2002, J NEUROPHYSIOL, V87, P2664, DOI 10.1152/jn.2002.87.6.2664; MULLER M, 1994, J COMP PHYSIOL A, V175, P525, DOI 10.1007/BF00199474; MURLIS J, 1992, ANNU REV ENTOMOL, V37, P505, DOI 10.1146/annurev.en.37.010192.002445; OLBERG RM, 1983, J COMP PHYSIOL, V152, P297, DOI 10.1007/BF00606236; Park KC, 2002, CHEM SENSES, V27, P343, DOI 10.1093/chemse/27.4.343; Peron S, 2009, NAT NEUROSCI, V12, P318, DOI 10.1038/nn.2259; Pouzat C, 2002, J NEUROSCI METH, V122, P43, DOI 10.1016/S0165-0270(02)00276-5; Rains GC, 2008, TRENDS BIOTECHNOL, V26, P288, DOI 10.1016/j.tibtech.2008.02.007; Reynolds AM, 2007, J THEOR BIOL, V245, P141, DOI 10.1016/j.jtbi.2006.10.007; Stocker M, 2004, NAT REV NEUROSCI, V5, P758, DOI 10.1038/nrn1516; Tichy H, 2005, EUR J NEUROSCI, V22, P3147, DOI 10.1111/j.1460-9568.2005.04501.x; Vergassola M, 2007, NATURE, V445, P406, DOI 10.1038/nature05464; Vickers NJ, 1996, J COMP PHYSIOL A, V178, P831, DOI 10.1007/BF00225831; VICKERS NJ, 1994, P NATL ACAD SCI USA, V91, P5756, DOI 10.1073/pnas.91.13.5756; Vickers NJ, 2001, NATURE, V410, P466, DOI 10.1038/35068559; WILLIS MA, 1991, J COMP PHYSIOL A, V169, P427; ZHANG HG, 1995, MOL PHARMACOL, V48, P835	43	16	16	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2013	8	4							e61220	10.1371/journal.pone.0061220	http://dx.doi.org/10.1371/journal.pone.0061220			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IK	23613816	Green Published, Green Submitted, gold			2022-12-25	WOS:000317907200041
J	Van Landeghem, S; Bjorne, J; Wei, CH; Hakala, K; Pyysalo, S; Ananiadou, S; Kao, HY; Lu, ZY; Salakoski, T; Van de Peer, Y; Ginter, F				Van Landeghem, Sofie; Bjorne, Jari; Wei, Chih-Hsuan; Hakala, Kai; Pyysalo, Sampo; Ananiadou, Sophia; Kao, Hung-Yu; Lu, Zhiyong; Salakoski, Tapio; Van de Peer, Yves; Ginter, Filip			Large-Scale Event Extraction from Literature with Multi-Level Gene Normalization	PLOS ONE			English	Article							DATABASE; TASK; ANNOTATION; NETWORKS; PROTEINS; ENSEMBL; SYSTEMS	Text mining for the life sciences aims to aid database curation, knowledge summarization and information retrieval through the automated processing of biomedical texts. To provide comprehensive coverage and enable full integration with existing biomolecular database records, it is crucial that text mining tools scale up to millions of articles and that their analyses can be unambiguously linked to information recorded in resources such as UniProt, KEGG, BioGRID and NCBI databases. In this study, we investigate how fully automated text mining of complex biomolecular events can be augmented with a normalization strategy that identifies biological concepts in text, mapping them to identifiers at varying levels of granularity, ranging from canonicalized symbols to unique gene and proteins and broad gene families. To this end, we have combined two state-of-the-art text mining components, previously evaluated on two community-wide challenges, and have extended and improved upon these methods by exploiting their complementary nature. Using these systems, we perform normalization and event extraction to create a large-scale resource that is publicly available, unique in semantic scope, and covers all 21.9 million PubMed abstracts and 460 thousand PubMed Central open access full-text articles. This dataset contains 40 million biomolecular events involving 76 million gene/protein mentions, linked to 122 thousand distinct genes from 5032 species across the full taxonomic tree. Detailed evaluations and analyses reveal promising results for application of this data in database and pathway curation efforts. The main software components used in this study are released under an open-source license. Further, the resulting dataset is freely accessible through a novel API, providing programmatic and customized access (http://www.evexdb.org/api/v001/). Finally, to allow for large-scale bioinformatic analyses, the entire resource is available for bulk download from http://evexdb.org/download/, under the Creative Commons -Attribution - Share Alike (CC BY-SA) license.	[Van Landeghem, Sofie; Van de Peer, Yves] VIB, Dept Plant Syst Biol, Ghent, Belgium; [Van Landeghem, Sofie; Van de Peer, Yves] Univ Ghent, Dept Plant Biotechnol & Bioinformat, B-9000 Ghent, Belgium; [Bjorne, Jari; Salakoski, Tapio] Turku Ctr Comp Sci, Turku, Finland; [Bjorne, Jari; Hakala, Kai; Salakoski, Tapio; Ginter, Filip] Univ Turku, Dept Informat Technol, SF-20500 Turku, Finland; [Wei, Chih-Hsuan; Lu, Zhiyong] Natl Lib Med, Natl Ctr Biotechnol Informat, Bethesda, MD 20894 USA; [Wei, Chih-Hsuan; Kao, Hung-Yu] Natl Cheng Kung Univ, Dept Comp Sci & Informat Engn, Tainan 70101, Taiwan; [Pyysalo, Sampo; Ananiadou, Sophia] Univ Manchester, Sch Comp Sci, Natl Ctr Text Min, Manchester, Lancs, England	Flanders Institute for Biotechnology (VIB); Ghent University; University of Turku; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); National Cheng Kung University; University of Manchester	Ginter, F (corresponding author), Univ Turku, Dept Informat Technol, SF-20500 Turku, Finland.	ginter@cs.utu.fi	Van de Peer, Yves/D-4388-2009; Lu, Zhiyong/H-3622-2016; Van de Peer, Yves/AAE-7666-2019	Van de Peer, Yves/0000-0003-4327-3730; Lu, Zhiyong/0000-0001-9998-916X; Van de Peer, Yves/0000-0003-4327-3730; Wei, Chih-Hsuan/0000-0001-5094-7321; Bjorne, Jari/0000-0003-1722-6404	Research Foundation Flanders; Intramural Research Program of the National Institutes of Health, the National Library of Medicine; Academy of Finland; UK Biotechnology and Biological Sciences Research Council; Ghent University (Multidisciplinary Research Partnership 'Bioinformatics: from nucleotides to networks'); BBSRC [BB/G53025X/1, BB/E004431/1, BB/G013160/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E004431/1, BB/G013160/1, BB/G53025X/1] Funding Source: researchfish; NATIONAL LIBRARY OF MEDICINE [ZIALM091813] Funding Source: NIH RePORTER	Research Foundation Flanders(FWO); Intramural Research Program of the National Institutes of Health, the National Library of Medicine; Academy of Finland(Academy of Finland); UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Ghent University (Multidisciplinary Research Partnership 'Bioinformatics: from nucleotides to networks')(Ghent University); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported by the Research Foundation Flanders (http://www.fwo.be/); the Intramural Research Program of the National Institutes of Health, the National Library of Medicine (http://irp.nih.gov/); the Academy of Finland (http://www.aka.fi); and the UK Biotechnology and Biological Sciences Research Council (http://www.bbsrc.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; SVL and YVdP acknowledge the support of Ghent University (Multidisciplinary Research Partnership 'Bioinformatics: from nucleotides to networks'). Computational resources were provided by CSC - IT Center for Science Ltd, Espoo, Finland.	Agarwal S, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-420; Ananiadou S, 2010, TRENDS BIOTECHNOL, V28, P381, DOI 10.1016/j.tibtech.2010.04.005; [Anonymous], 2006, P LREC; Apweiler R, 2011, NUCLEIC ACIDS RES, V39, pD214, DOI 10.1093/nar/gkq1020; Arighi CN, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S8-S1; Bada M, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-161; Bjorne J, 2010, P 2010 WORKSH BIOM N, P28; Bjorne J, 2012, P WORKSH BIOM NAT LA, P82; Bjorne J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S11-S4; Blake C, 2010, J BIOMED INFORM, V43, P173, DOI 10.1016/j.jbi.2009.11.001; Charniak E, 2005, P 43 ANN M ASS COMP, P173, DOI DOI 10.3115/1219840.1219862; Chen LF, 2005, BIOINFORMATICS, V21, P248, DOI 10.1093/bioinformatics/bth496; Cohen KB, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-492; Demir E, 2010, NAT BIOTECHNOL, V28, P935, DOI 10.1038/nbt.1666; Flicek P, 2011, NUCLEIC ACIDS RES, V39, pD800, DOI 10.1093/nar/gkq1064; Gerner M, 2012, BIOINFORMATICS, V28, P2154, DOI 10.1093/bioinformatics/bts332; Haibe-Kains B, 2012, NUCLEIC ACIDS RES, V40, pD866, DOI 10.1093/nar/gkr1050; Hearst MA, 2007, BIOINFORMATICS, V23, P2196, DOI 10.1093/bioinformatics/btm301; Hirschman L, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-S1-S1; Hoffmann R, 2004, NATURE GENETICS, V36; Hsu CN, 2008, BIOINFORMATICS, V24, pI286, DOI 10.1093/bioinformatics/btn183; Hucka M, 2003, BIOINFORMATICS, V19, P524, DOI 10.1093/bioinformatics/btg015; Kaewphan S, 2012, P BIOTXTM 2012; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kazama J, 2003, PROCEEDINGS OF THE 2003 CONFERENCE ON EMPIRICAL METHODS IN NATURAL LANGUAGE PROCESSING, P137; Kersey PJ, 2010, NUCLEIC ACIDS RES, V38, pD563, DOI 10.1093/nar/gkp871; Kim J., 2011, P BIONLP SHAR TASK 2, P1, DOI 10.1109/MWSCAS.2011.6026357; Kim JD, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S11-S1; Kim JD, 2011, COMPUT INTELL-US, V27, P513, DOI 10.1111/j.1467-8640.2011.00398.x; Krallinger M, 2008, GENOME BIOL, V9, DOI [10.1186/gb-2008-9-s2-s1, 10.1186/gb-2008-9-S2-S4, 10.1186/gb-2008-9-s2-s4, 10.1186/gb-2008-9-S2-S1]; Leaman Robert, 2008, Pac Symp Biocomput, P652; Leitner F, 2010, IEEE ACM T COMPUT BI, V7, P385, DOI 10.1109/TCBB.2010.61; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr201, 10.1093/nar/gkr931]; Lu ZY, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S8-S2; McClosky D., 2010, ANY DOMAIN PARSING A; Miwa M, 2012, BIOINFORMATICS, V28, P1759, DOI 10.1093/bioinformatics/bts237; Ohta T, 2011, P BIONLP WORKSH COMP, P105; Ohta T, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S5-P7; Ongenaert M, 2008, NUCLEIC ACIDS RES, V36, pD842, DOI 10.1093/nar/gkm788; Pyysalo S, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S11-S2; Rebholz-Schuhmann D, 2007, BIOINFORMATICS, V23, pE237, DOI 10.1093/bioinformatics/btl302; Rose PW, 2011, NUCLEIC ACIDS RES, V39, pD392, DOI 10.1093/nar/gkq1021; Sayers EW, 2012, NUCLEIC ACIDS RES, V40, pD13, DOI [10.1093/nar/gkr1184, 10.1093/nar/gks1189, 10.1093/nar/gky1069]; Stark C, 2011, NUCLEIC ACIDS RES, V39, pD698, DOI 10.1093/nar/gkq1116; Stenetorp P., 2011, P BIONLP SHARED TASK, P112; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Tanabe L, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-S1-S3; Van Landeghem S, 2011, P BIONLP 2011 WORKSH, P28; Van Landeghem Sofie, 2012, Advances in Bioinformatics, V2012, P582765, DOI 10.1155/2012/582765; Wei CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038460; Wei CH, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S8-S5	51	63	63	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2013	8	4							e55814	10.1371/journal.pone.0055814	http://dx.doi.org/10.1371/journal.pone.0055814			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IK	23613707	Green Published, Green Submitted, gold			2022-12-25	WOS:000317907200001
J	Zhu, T; Niu, DK				Zhu, Tao; Niu, Deng-Ke			Mechanisms of Intron Loss and Gain in the Fission Yeast Schizosaccharomyces	PLOS ONE			English	Article							SPLICEOSOMAL INTRONS; EVOLUTION; GENES; GENOME; CRYPTOCOCCUS; DROSOPHILA; SEQUENCE; ORIGIN; FUNGI; INTRONIZATION	The fission yeast, Schizosaccharomyces pombe, is an important model species with a low intron density. Previous studies showed extensive intron losses during its evolution. To test the models of intron loss and gain in fission yeasts, we conducted a comparative genomic analysis in four Schizosaccharomyces species. Both intronization and de-intronization were observed, although both were at a low frequency. A de-intronization event was caused by a degenerative mutation in the branch site. Four cases of imprecise intron losses were identified, indicating that genomic deletion is not a negligible mechanism of intron loss. Most intron losses were precise deletions of introns, and were significantly biased to the 3' sides of genes. Adjacent introns tended to be lost simultaneously. These observations indicated that the main force shaping the exon-intron structures of fission yeasts was precise intron losses mediated by reverse transcriptase. We found two cases of intron gains caused by tandem genomic duplication, but failed to identify the mechanisms for the majority of the intron gain events observed. In addition, we found that intron-lost and intron-gained genes had certain similar features, such as similar Gene Ontology categories and expression levels.	[Niu, Deng-Ke] Beijing Normal Univ, Coll Life Sci, MOE Key Lab Biodivers Sci & Ecol Engn, Beijing 100875, Peoples R China; Beijing Normal Univ, Coll Life Sci, Beijing Key Lab Gene Resource & Mol Dev, Beijing 100875, Peoples R China	Beijing Normal University; Beijing Normal University	Niu, DK (corresponding author), Beijing Normal Univ, Coll Life Sci, MOE Key Lab Biodivers Sci & Ecol Engn, Beijing 100875, Peoples R China.	dengkeniu@hotmail.com	Zhu, Tao/C-6183-2013; Niu, Deng-Ke/B-6007-2008; Zhu, Tao/D-7072-2016	Niu, Deng-Ke/0000-0003-4503-2658; Zhu, Tao/0000-0002-2358-6871	National Natural Science Foundation of China [31121003, 31071112]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (grant numbers 31121003 and 31071112). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belshaw R, 2006, HEREDITY, V96, P208, DOI 10.1038/sj.hdy.6800791; Carmel L, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-192; Carmel L, 2007, GENOME RES, V17, P1034, DOI 10.1101/gr.6438607; Cartegni L, 2002, NAT REV GENET, V3, P285, DOI 10.1038/nrg775; Catania F, 2008, PLOS BIOL, V6, P2354, DOI 10.1371/journal.pbio.0060283; Cho SC, 2004, GENOME RES, V14, P1207, DOI 10.1101/gr.2639304; Cohen NE, 2012, MOL BIOL EVOL, V29, P179, DOI 10.1093/molbev/msr192; Coulombe-Huntington J, 2007, MOL BIOL EVOL, V24, P2842, DOI 10.1093/molbev/msm235; Coulombe-Huntington J, 2007, GENOME RES, V17, P23, DOI 10.1101/gr.5703406; Croll D, 2012, GENOME BIOL EVOL, V4, P1148, DOI 10.1093/gbe/evs091; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Denoeud F, 2010, SCIENCE, V330, P1381, DOI 10.1126/science.1194167; Drabenstot SD, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng141; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Farlow A, 2011, TRENDS GENET, V27, P1, DOI 10.1016/j.tig.2010.10.004; Farlow A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000819; Fawcett JA, 2012, MOL BIOL EVOL, V29, P849, DOI 10.1093/molbev/msr254; Feiber AL, 2002, J MOL EVOL, V55, P401, DOI 10.1007/s00239-002-2336-y; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; FINK GR, 1987, CELL, V49, P5, DOI 10.1016/0092-8674(87)90746-X; Galagan JE, 2005, GENOME RES, V15, P1620, DOI 10.1101/gr.3767105; Gao X, 2009, P NATL ACAD SCI USA, V106, P20818, DOI 10.1073/pnas.0911093106; Hankeln T, 1997, GENE, V205, P151, DOI 10.1016/S0378-1119(97)00518-0; Irimia M, 2008, TRENDS GENET, V24, P378, DOI 10.1016/j.tig.2008.05.007; Jeffares DC, 2008, TRENDS GENET, V24, P375, DOI 10.1016/j.tig.2008.05.006; Jeffares DC, 2006, TRENDS GENET, V22, P16, DOI 10.1016/j.tig.2005.10.006; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Knowles DG, 2006, MOL BIOL EVOL, V23, P1548, DOI 10.1093/molbev/msl017; Li WL, 2009, SCIENCE, V326, P1260, DOI 10.1126/science.1179302; Lin HN, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-r41; Loh YH, 2008, MOL BIOL EVOL, V25, P526, DOI 10.1093/molbev/msm278; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Mourier T, 2003, SCIENCE, V300, P1393, DOI 10.1126/science.1080559; Ng MP, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-192; Nielsen CB, 2004, PLOS BIOL, V2, P2234, DOI 10.1371/journal.pbio.0020422; Niu DK, 2005, MOL BIOL EVOL, V22, P1475, DOI 10.1093/molbev/msi138; Rhind N, 2011, SCIENCE, V332, P930, DOI 10.1126/science.1203357; Rodriguez-Trelles F, 2006, ANNU REV GENET, V40, P47, DOI 10.1146/annurev.genet.40.110405.090625; Rogozin IB, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-11; Roy SW, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-192; Roy SW, 2006, GENOME RES, V16, P750, DOI 10.1101/gr.4845406; Roy SW, 2009, TRENDS GENET, V25, P67, DOI 10.1016/j.tig.2008.11.004; Roy SW, 2006, NAT REV GENET, V7, P211, DOI 10.1038/nrg1807; Roy SW, 2005, P NATL ACAD SCI USA, V102, P5773, DOI 10.1073/pnas.0500383102; Roy SW, 2005, P NATL ACAD SCI USA, V102, P713, DOI 10.1073/pnas.0408274102; Sharpton TJ, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r24; Szczesniak MW, 2011, MOL BIOL EVOL, V28, P33, DOI 10.1093/molbev/msq260; Torriani SFF, 2011, CURR BIOL, V21, P2017, DOI 10.1016/j.cub.2011.10.041; van der Burgt A, 2012, CURR BIOL, V22, P1260, DOI 10.1016/j.cub.2012.05.011; Wood V, 2002, NATURE, V415, P871, DOI 10.1038/nature724; Worden AZ, 2009, SCIENCE, V324, P268, DOI 10.1126/science.1167222; Yenerall P, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-29; Yenerall P, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-364; Zhang LY, 2010, J MOL EVOL, V71, P364, DOI 10.1007/s00239-010-9391-6; Zhu T, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-23; Zhu ZL, 2009, PLANT PHYSIOL, V151, P1943, DOI 10.1104/pp.109.142984	56	19	19	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2013	8	4							e61683	10.1371/journal.pone.0061683	http://dx.doi.org/10.1371/journal.pone.0061683			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IK	23613904	Green Published, gold, Green Submitted			2022-12-25	WOS:000317907200074
J	Birkholz, P				Birkholz, Peter			Modeling Consonant-Vowel Coarticulation for Articulatory Speech Synthesis	PLOS ONE			English	Article							MRI; TONGUE; CONSTRUCTION; SEQUENCES	A central challenge for articulatory speech synthesis is the simulation of realistic articulatory movements, which is critical for the generation of highly natural and intelligible speech. This includes modeling coarticulation, i.e., the context-dependent variation of the articulatory and acoustic realization of phonemes, especially of consonants. Here we propose a method to simulate the context-sensitive articulation of consonants in consonant-vowel syllables. To achieve this, the vocal tract target shape of a consonant in the context of a given vowel is derived as the weighted average of three measured and acoustically-optimized reference vocal tract shapes for that consonant in the context of the corner vowels /a/, /i/, and /u/. The weights are determined by mapping the target shape of the given context vowel into the vowel subspace spanned by the corner vowels. The model was applied for the synthesis of consonant-vowel syllables with the consonants /b/, /d/, /g/, /l/, /r/, /m/, /n/ in all combinations with the eight long German vowels. In a perception test, the mean recognition rate for the consonants in the isolated syllables was 82.4%. This demonstrates the potential of the approach for highly intelligible articulatory speech synthesis.	[Birkholz, Peter] Univ Hosp Aachen, Dept Phoniatr Pedaudiol & Commun Disorders, Aachen, Germany; [Birkholz, Peter] Rhein Westfal TH Aachen, Aachen, Germany	RWTH Aachen University; RWTH Aachen University Hospital; RWTH Aachen University	Birkholz, P (corresponding author), Univ Hosp Aachen, Dept Phoniatr Pedaudiol & Commun Disorders, Aachen, Germany.	pbirkholz@ukaachen.de			University Hospital Aachen, Germany	University Hospital Aachen, Germany	This study was funded by the University Hospital Aachen, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRY C, 1986, SPEECH COMMUN, V5, P97, DOI 10.1016/0167-6393(86)90032-4; Alwan A, 2011, SPEECH COMMUN, V53, P195, DOI 10.1016/j.specom.2010.09.001; Badin P, 2002, J PHONETICS, V30, P533, DOI 10.1006/jpho.2002.0166; Bavegard M, 1995, 4 EUR C SPEECH COMM, P1857; BEIER T, 1992, COMP GRAPH, V26, P35, DOI 10.1145/142920.134003; Birkholz P., 2011, STUDIENTEXTE SPRACHK, P47; Birkholz P., 2006, P 7 INT SEM SPEECH P, P493; Birkholz P, 2004, INTERSPEECH 04, P1125; Birkholz P., 2005, 3D ARTIKULATORISCHE; Birkholz P, 2006, INT CONF ACOUST SPEE, P873; Birkholz P, 2010, 11TH ANNUAL CONFERENCE OF THE INTERNATIONAL SPEECH COMMUNICATION ASSOCIATION 2010 (INTERSPEECH 2010), VOLS 1-2, P1017; Birkholz P, 2011, IEEE T AUDIO SPEECH, V19, P1422, DOI 10.1109/TASL.2010.2091632; Birkhoz P, 2007, IEEE T AUDIO SPEECH, V15, P1218, DOI 10.1109/TASL.2006.889731; Bresch E, 2009, IEEE T MED IMAGING, V28, P323, DOI 10.1109/TMI.2008.928920; Broersma M, 2010, SPEECH COMMUN, V52, P980, DOI 10.1016/j.specom.2010.08.010; BROWMAN CP, 1992, PHONETICA, V49, P155, DOI 10.1159/000261913; CARRE R, 1995, J PHONETICS, V23, P231, DOI 10.1016/S0095-4470(95)80045-X; DANG JW, 1994, J ACOUST SOC AM, V96, P2088, DOI 10.1121/1.410150; Dang JW, 2004, J ACOUST SOC AM, V115, P853, DOI 10.1121/1.1639325; EDWARDS J, 1990, J SPEECH HEAR RES, V33, P550, DOI 10.1044/jshr.3303.550; Engwall O, 2003, SPEECH COMMUN, V41, P303, DOI 10.1016/S0167-6393(02)00132-2; Engwall O., 1999, TMH QPSR, V1, P1; Flanagan J.L., 1965, SPEECH ANAL SYNTHESI; FOWLER CA, 1993, LANG SPEECH, V36, P171, DOI 10.1177/002383099303600304; GUENTHER FH, 1995, PSYCHOL REV, V102, P594, DOI 10.1037/0033-295X.102.3.594; Hillenbrand JM, 1999, J ACOUST SOC AM, V105, P3509, DOI 10.1121/1.424676; Howard IS, 2011, MOTOR CONTROL, V15, P85, DOI 10.1123/mcj.15.1.85; Hunt AJ, 1996, INT CONF ACOUST SPEE, P373, DOI 10.1109/ICASSP.1996.541110; KEWLEYPORT D, 1982, J ACOUST SOC AM, V72, P379, DOI 10.1121/1.388081; KLATT DH, 1987, J ACOUST SOC AM, V82, P737, DOI 10.1121/1.395275; Kroger BJ, 2009, SPEECH COMMUN, V51, P793, DOI 10.1016/j.specom.2008.08.002; Kroger BJ, 2004, HNO, V52, P837, DOI 10.1007/s00106-004-1097-x; KROGER BJ, 1993, PHONETICA, V50, P213; Kroger BJ, 2000, 5 SEM SPEECH PROD MO, P333; Kuhnert B., 1999, COARTICULATION THEOR, P1; LINDBLOM B, 1963, J ACOUST SOC AM, V35, P1773, DOI 10.1121/1.1918816; Lindblom B, 2012, J PHONETICS, V40, P1, DOI 10.1016/j.wocn.2011.09.005; Macaulay R, 1994, SOCIAL ART LANGUAGE; MAEDA S, 1990, NATO ADV SCI I D-BEH, V55, P131; Marin S, 2010, MOTOR CONTROL, V14, P380, DOI 10.1123/mcj.14.3.380; MERMELSTEIN P, 1973, J ACOUST SOC AM, V53, P1070, DOI 10.1121/1.1913427; NARAYANAN SS, 1995, J ACOUST SOC AM, V98, P1325, DOI 10.1121/1.413469; Narayanan SS, 1997, J ACOUST SOC AM, V101, P1064, DOI 10.1121/1.418030; Niebergall A, 2013, MAGN RESON MED, V69, P477, DOI 10.1002/mrm.24276; OHMAN SEG, 1967, J ACOUST SOC AM, V41, P310; Payan Y, 1997, SPEECH COMMUN, V22, P185, DOI 10.1016/S0167-6393(97)00019-8; Serrurier A, 2008, J ACOUST SOC AM, V123, P2335, DOI 10.1121/1.2875111; Shadle C. H., 2001, P 4 ISCA TUT RES WOR, P121; Sondhi M.M., 1983, PROC 11 ICA, P167; Stark J., 1999, P 14 INT C PHON SCI, P2279; Steiner I, 2012, J ACOUST SOC AM, V131, pEL106, DOI 10.1121/1.3675459; Stevens Kenneth N., 1998, ACOUSTIC PHONETICS; STEVENS KN, 1989, J PHONETICS, V17, P3, DOI 10.1016/S0095-4470(19)31520-7; Story BH, 2009, J ACOUST SOC AM, V126, P825, DOI 10.1121/1.3158816; SUSSMAN HM, 1991, J ACOUST SOC AM, V90, P1309, DOI 10.1121/1.401923; TITZE IR, 1989, SPEECH COMMUN, V8, P191, DOI 10.1016/0167-6393(89)90001-0; van den Doel K., 2006, 7 INT SEM SPEECH PRO; Wells J., 1992, SAMUCL037 PHON LING; WICKELGR.WA, 1969, PSYCHOL REV, V76, P1, DOI 10.1037/h0026823; Xu Y, 2006, ITAL J LINGUIST, V18, P125; Zen H, 2009, SPEECH COMMUN, V51, P1039, DOI 10.1016/j.specom.2009.04.004	61	80	80	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2013	8	4							e60603	10.1371/journal.pone.0060603	http://dx.doi.org/10.1371/journal.pone.0060603			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	130DR	23613734	Green Published, gold			2022-12-25	WOS:000317893400015
J	Dai, JP; Zhao, XF; Zeng, J; Wan, QY; Yang, JC; Li, WZ; Chen, XX; Wang, GF; Li, KS				Dai, Jian-Ping; Zhao, Xiang-Feng; Zeng, Jun; Wan, Qian-Ying; Yang, Jia-Cai; Li, Wei-Zhong; Chen, Xiao-Xuan; Wang, Ge-Fei; Li, Kang-Sheng			Drug Screening for Autophagy Inhibitors Based on the Dissociation of Beclin 1-Bcl2 Complex Using BiFC Technique and Mechanism of Eugenol on Anti-Influenza A Virus Activity	PLOS ONE			English	Article							INFLUENZA-A VIRUS; HMGB1 REGULATES AUTOPHAGY; CELL-DEATH; H5N1; REPLICATION; EXPRESSION; JNK	Autophagy is involved in many human diseases, such as cancer, cardiovascular disease and virus infection, including human immunodeficiency virus (HIV), hepatitis C virus (HCV), influenza A virus (IAV) and coxsackievirus B3/B4 (CVB3/B4), so a drug screening model targeting autophagy may be very useful for the therapy of these diseases. In our study, we established a drug screening model based on the inhibition of the dissociation of Beclin 1-Bcl2 heterodimer, an important negative regulator of autophagy, using bimolecular fluorescence complementation (BiFC) technique for developing novel autophagy inhibitors and anti-IAV agents. From 86 examples of traditional Chinese medicines, we found Syzygium aromaticum L. had the best activity. We then determined the anti-autophagy and anti-IAV activity of eugenol, the major active compound of Syzygium aromaticum L., and explored its mechanism of action. Eugenol could inhibit autophagy and IAV replication, inhibited the activation of ERK, p38MAPK and IKK/NF-kappa B signal pathways and antagonized the effects of the activators of these pathways. Eugenol also ameliorated the oxidative stress and inhibited the expressions of autophagic genes. We speculated that the mechanism underlying might be that eugenol inhibited the oxidative stress and the activation of ERK1/2, p38MAPK and IKK/NF-kB pathways, subsequently inhibited the dissociation of Beclin 1-Bcl2 heterodimer and autophagy, and finally impaired IAV replication. These results might conversely display the reasonableness of the design of our screening model. In conclusion, we have established a drug screening model for developing novel autophagy inhibitor, and find eugenol as a promising inhibitor for autophagy and IAV infection.	[Dai, Jian-Ping; Zhao, Xiang-Feng; Zeng, Jun; Wan, Qian-Ying; Yang, Jia-Cai; Chen, Xiao-Xuan; Wang, Ge-Fei; Li, Kang-Sheng] Shantou Univ Med Coll, Dept Microbiol & Immunol, Shantou, Guangdong, Peoples R China; [Li, Wei-Zhong] Univ Maryland, Dept Vet Med, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park	Wang, GF (corresponding author), Shantou Univ Med Coll, Dept Microbiol & Immunol, Shantou, Guangdong, Peoples R China.	gfwstdx@163.com; liksedustdx@163.com		Zeng, Jun/0000-0002-4317-2182; Li, Kangsheng/0000-0002-6981-9263; Li, Weizhong/0000-0002-8602-8375	National Natural Science Foundation of China [30972766, 31170852, 81001322, 81172795]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from The National Natural Science Foundation of China (30972766, 31170852, 81001322, 81172795). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Choi HJ, 2009, PHYTOMEDICINE, V16, P35, DOI 10.1016/j.phymed.2008.10.012; Copetti T, 2009, AUTOPHAGY, V5, P858, DOI 10.4161/auto.8822; Criollo A, 2010, EMBO J, V29, P619, DOI 10.1038/emboj.2009.364; Dai JP, 2009, J ORAL PATHOL MED, V38, P276, DOI 10.1111/j.1600-0714.2008.00738.x; Dai JP, 2012, J BIOMOL SCREEN, V17, P605, DOI 10.1177/1087057111435236; Gannage M, 2010, AUTOPHAGY, V6, P166, DOI 10.4161/auto.6.1.10624; Gannage M, 2009, CELL HOST MICROBE, V6, P367, DOI 10.1016/j.chom.2009.09.005; Geiler J, 2010, BIOCHEM PHARMACOL, V79, P413, DOI 10.1016/j.bcp.2009.08.025; Gregoire IP, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002422; Haider AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025818; Han NY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044057; Hariharan N, 2011, ANTIOXID REDOX SIGN, V14, P2179, DOI 10.1089/ars.2010.3488; Harris J, 2011, CYTOKINE, V56, P140, DOI 10.1016/j.cyto.2011.08.022; Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Kang R, 2011, CELL DEATH DIFFER, V18, P571, DOI 10.1038/cdd.2010.191; Kumar N, 2008, J VIROL, V82, P9880, DOI 10.1128/JVI.00909-08; Li DD, 2009, ONCOGENE, V28, P886, DOI 10.1038/onc.2008.441; Li XH, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1648; Liu AL, 2005, SCI CHINA SER C, V48, P1, DOI 10.1360/062004-69; Ma JH, 2011, J GENET GENOMICS, V38, P533, DOI 10.1016/j.jgg.2011.10.002; Maddry JA, 2011, J BIOMOL SCREEN, V16, P73, DOI 10.1177/1087057110384613; Magalhaes CB, J APPL PHYSL, V108, P845; Matarrese P, 2011, J CELL PHYSIOL, V226, P3368, DOI 10.1002/jcp.22696; Monteleone MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038948; Mueller Barbara, 2009, V189, P1, DOI 10.1007/978-3-540-79086-0_1; Munz C, 2011, VIRUSES-BASEL, V3, P1166, DOI 10.3390/v3071166; Nguyen JT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031006; Niso-Santano M, 2012, AUTOPHAGY, V8; Park KJ, 2009, BIOCHEM BIOPH RES CO, V382, P726, DOI 10.1016/j.bbrc.2009.03.095; Pattingre S, 2009, J BIOL CHEM, V284, P2719, DOI 10.1074/jbc.M805920200; Scherz-Shouval R, 2007, EMBO J, V26, P1749, DOI 10.1038/sj.emboj.7601623; Shaw ML, 2011, REV MED VIROL, V21, P358, DOI 10.1002/rmv.703; Shi CS, 2010, AUTOPHAGY, V6, P986, DOI 10.4161/auto.6.7.13288; Shih SR, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-13; Sinha S, 2008, ONCOGENE, V27, pS137, DOI 10.1038/onc.2009.51; Su CY, 2010, P NATL ACAD SCI USA, V107, P19151, DOI 10.1073/pnas.1013592107; Sun Y, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2001931; Tang DL, 2010, J CELL BIOL, V190, P881, DOI 10.1083/jcb.200911078; Tong SYC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021446; Vlahos R, 2012, TRENDS PHARMACOL SCI, V33, P3, DOI 10.1016/j.tips.2011.09.001; Yeh JL, 2001, INT J IMMUNOPATH PH, V24, P345; Zhao MY, 2011, BMB REP, V44, P601, DOI 10.5483/BMBRep.2011.44.9.601; Zhao Y, 2010, AUTOPHAGY, V6, P988, DOI 10.4161/auto.6.7.13289; Zhou Z, 2009, AUTOPHAGY, V5, P321, DOI 10.4161/auto.5.3.7406	45	80	85	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2013	8	4							e61026	10.1371/journal.pone.0061026	http://dx.doi.org/10.1371/journal.pone.0061026			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130DR	23613775	Green Submitted, gold, Green Published			2022-12-25	WOS:000317893400035
J	Delle Monache, S; Sanita, P; Trapasso, E; Ursino, MR; Dugo, P; Russo, M; Ferlazzo, N; Calapai, G; Angelucci, A; Navarra, M				Delle Monache, Simona; Sanita, Patrizia; Trapasso, Elena; Ursino, Maria Rita; Dugo, Paola; Russo, Marina; Ferlazzo, Nadia; Calapai, Gioacchino; Angelucci, Adriano; Navarra, Michele			Mechanisms Underlying the Anti-Tumoral Effects of Citrus bergamia Juice	PLOS ONE			English	Article							RADICAL-SCAVENGING ACTIVITY; INDUCED NEURITE OUTGROWTH; SIGNALING PATHWAYS; CANCER CELLS; BETA-CRYPTOXANTHIN; INDUCE APOPTOSIS; MAPK PATHWAY; COLON-CANCER; HUMAN BREAST; E-CADHERIN	Based on the growing deal of data concerning the biological activity of flavonoid-rich natural products, the aim of the present study was to explore in vitro the potential anti-tumoral activity of Citrus Bergamia (bergamot) juice (BJ), determining its molecular interaction with cancer cells. Here we show that BJ reduced growth rate of different cancer cell lines, with the maximal growth inhibition observed in neuroblastoma cells (SH-SY5Y) after 72 hs of exposure to 5% BJ. The SH-SY5Y antiproliferative effect elicited by BJ was not due to a cytotoxic action and it did not induce apoptosis. Instead, BJ stimulated the arrest in the G1 phase of cell cycle and determined a modification in cellular morphology, causing a marked increase of detached cells. The inhibition of adhesive capacity on different physiologic substrates and on endothelial cells monolayer were correlated with an impairment of actin filaments, a reduction in the expression of the active form of focal adhesion kinase (FAK) that in turn caused inhibition of cell migration. In parallel, BJ seemed to hinder the association between the neural cell adhesion molecule (NCAM) and FAK. Our data suggest a mechanisms through which BJ can inhibit important molecular pathways related to cancer-associated aggressive phenotype and offer new suggestions for further studies on the role of BJ in cancer treatment.	[Delle Monache, Simona; Sanita, Patrizia; Angelucci, Adriano] Univ Aquila, Dept Biotechnol & Appl Clin Sci, I-67100 Laquila, Italy; [Trapasso, Elena; Ursino, Maria Rita; Dugo, Paola; Russo, Marina; Ferlazzo, Nadia; Navarra, Michele] Univ Messina, Dept Drug Sci & Hlth Prod, Messina, Italy; [Calapai, Gioacchino] Univ Messina, Dept Clin & Expt Med, Messina, Italy; [Navarra, Michele] Carattere Sci Ctr Neurolesi Bonino Pulejo, Ist Ricovero & Cura, Messina, Italy	University of L'Aquila; University of Messina; University of Messina; IRCCS Bonino Pulejo	Navarra, M (corresponding author), Univ Messina, Dept Drug Sci & Hlth Prod, Messina, Italy.	mnavarra@unime.it	Calapai, Gioacchino/AAC-6377-2022; Russo, Marina/AAE-8094-2019; Angelucci, Adriano/B-7134-2013; Delle Monache, Simona/M-5618-2014	Russo, Marina/0000-0002-8229-1010; Angelucci, Adriano/0000-0002-8755-1889; Delle Monache, Simona/0000-0002-8153-915X; Navarra, Michele/0000-0002-6492-7820; Dugo, Paola/0000-0002-9432-1782; , Marina/0000-0001-7386-8036; Calapai, Gioacchino/0000-0001-8116-4821	Sicily Region [CUP G73F11000050004]	Sicily Region	Research was supported by a grant from Sicily Region (PO FESR Sicilia 2007/2013, CUP G73F11000050004 to MN, project "MEPRA'', N. 133 of Linea d'Intervento 4.1.1.1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelucci A, 2006, ENDOCR-RELAT CANCER, V13, P197, DOI 10.1677/erc.1.01100; Benavente-Garcia O, 2008, J AGR FOOD CHEM, V56, P6185, DOI 10.1021/jf8006568; Bohl M, 2007, BIOPHYS J, V93, P2767, DOI 10.1529/biophysj.107.107813; Broussard JA, 2008, CURR OPIN CELL BIOL, V20, P85, DOI 10.1016/j.ceb.2007.10.009; Caltagirone S, 2000, INT J CANCER, V87, P595, DOI 10.1002/1097-0215(20000815)87:4&lt;595::AID-IJC21&gt;3.0.CO;2-5; Cautela D, 2008, J AGR FOOD CHEM, V56, P5407, DOI 10.1021/jf8006823; Celano M, 2008, ENDOCR-RELAT CANCER, V15, P499, DOI 10.1677/ERC-07-0243; Chen YJ, 2009, J FOOD SCI, V74, pH162, DOI 10.1111/j.1750-3841.2009.01199.x; Conseil G, 1998, P NATL ACAD SCI USA, V95, P9831, DOI 10.1073/pnas.95.17.9831; Corasaniti MT, 2007, BRIT J PHARMACOL, V151, P518, DOI 10.1038/sj.bjp.0707237; Ditlevsen DK, 2010, ADV EXP MED BIOL, V663, P151, DOI 10.1007/978-1-4419-1170-4_10; Fresco P, 2010, CURR PHARM DESIGN, V16, P114, DOI 10.2174/138161210789941856; Gattuso Gianni, 2007, Infez Med, V15, P250; Ghadimi BM, 1999, EUR J CANCER, V35, P60, DOI 10.1016/S0959-8049(98)00344-X; Giganti Adeline, 2003, Prog Cell Cycle Res, V5, P511; Hanks SK, 1997, BIOESSAYS, V19, P137, DOI 10.1002/bies.950190208; Havsteen BH, 2002, PHARMACOL THERAPEUT, V96, P67, DOI 10.1016/S0163-7258(02)00298-X; Hirata A, 2005, ANTICANCER RES, V25, P3367; Hsiao YC, 2007, CHEM-BIOL INTERACT, V167, P193, DOI 10.1016/j.cbi.2007.02.012; Hwang SL, 2012, J AGR FOOD CHEM, V60, P877, DOI 10.1021/jf204452y; Iwashita K, 2000, BIOSCI BIOTECH BIOCH, V64, P1813, DOI 10.1271/bbb.64.1813; Johnson TR, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-148; Kim DI, 2008, CARCINOGENESIS, V29, P1701, DOI 10.1093/carcin/bgn055; Kim SW, 2011, BIOCHEM BIOPH RES CO, V415, P602, DOI 10.1016/j.bbrc.2011.10.115; Kleene R, 2010, J NEUROSCI, V30, P10784, DOI 10.1523/JNEUROSCI.0297-10.2010; Kohno H, 2001, CANCER LETT, V174, P141, DOI 10.1016/S0304-3835(01)00713-3; Lee DH, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/515901; Lee WR, 2002, BIOCHEM PHARMACOL, V63, P225, DOI 10.1016/S0006-2952(01)00876-0; Lee YC, 2011, MOL CELL BIOCHEM, V347, P103, DOI 10.1007/s11010-010-0618-z; Lehembre F, 2008, EMBO J, V27, P2603, DOI 10.1038/emboj.2008.178; Liu RH, 2004, J NUTR, V134, p3479S, DOI 10.1093/jn/134.12.3479S; Long DX, 2008, TOXICOL LETT, V181, P45, DOI 10.1016/j.toxlet.2008.06.871; Mariotti A, 2007, EXPERT OPIN INV DRUG, V16, P451, DOI 10.1517/13543784.16.4.451; Middleton E, 2000, PHARMACOL REV, V52, P673; Miyagi Y, 2000, NUTR CANCER, V36, P224, DOI 10.1207/S15327914NC3602_12; Molenaar JJ, 2008, CANCER RES, V68, P2599, DOI 10.1158/0008-5472.CAN-07-5032; Morley KL, 2007, CANCER LETT, V251, P168, DOI 10.1016/j.canlet.2006.11.016; Mutoh H, 2000, JPN J CANCER RES, V91, P686; Navarra M, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-602; Nazari M, 2011, EUR J PHARMACOL, V650, P526, DOI 10.1016/j.ejphar.2010.10.053; Pan MH, 2002, CARCINOGENESIS, V23, P1677, DOI 10.1093/carcin/23.10.1677; Picerno I, 2007, BIOGERONTOLOGY, V8, P111, DOI 10.1007/s10522-006-9040-z; Picerno P, 2011, NAT PROD COMMUN, V6, P951; POLLARD TD, 1986, BIOPHYS J, V49, P149, DOI 10.1016/S0006-3495(86)83630-X; Priyadarsini RV, 2010, EUR J PHARMACOL, V649, P84, DOI 10.1016/j.ejphar.2010.09.020; Rotelli AE, 2003, PHARMACOL RES, V48, P601, DOI 10.1016/S1043-6618(03)00225-1; Russo M, 2012, BIOCHEM PHARMACOL, V83, P6, DOI 10.1016/j.bcp.2011.08.010; Russo M, 2011, J SEP SCI, V34, P681, DOI 10.1002/jssc.201000844; Sawa T, 1999, J AGR FOOD CHEM, V47, P397, DOI 10.1021/jf980765e; So FV, 1996, NUTR CANCER, V26, P167, DOI 10.1080/01635589609514473; Spencer JPE, 2007, GENES NUTR, V2, P257, DOI 10.1007/s12263-007-0056-z; Surh YJ, 2003, NAT REV CANCER, V3, P768, DOI 10.1038/nrc1189; Tanaka T, 2000, INT J CANCER, V88, P146, DOI 10.1002/1097-0215(20001001)88:1&lt;146::AID-IJC23&gt;3.0.CO;2-I; Visa N, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000620; Yamazaki D, 2005, CANCER SCI, V96, P379, DOI 10.1111/j.1349-7006.2005.00062.x; Yoon KJ, 2009, CANCER BIOL THER, V8, P306, DOI 10.4161/cbt.8.4.7446	56	46	47	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2013	8	4							e61484	10.1371/journal.pone.0061484	http://dx.doi.org/10.1371/journal.pone.0061484			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130DR	23613861	Green Submitted, gold, Green Published			2022-12-25	WOS:000317893400068
J	Kalliokoski, T; Kramer, C; Vulpetti, A; Gedeck, P				Kalliokoski, Tuomo; Kramer, Christian; Vulpetti, Anna; Gedeck, Peter			Comparability of Mixed IC50 Data - A Statistical Analysis	PLOS ONE			English	Article							CSAR BENCHMARK EXERCISE; LIGAND; PHARMACOLOGY; PREDICTION; CHEMBL	The biochemical half maximal inhibitory concentration (IC50) is the most commonly used metric for on-target activity in lead optimization. It is used to guide lead optimization, build large-scale chemogenomics analysis, off-target activity and toxicity models based on public data. However, the use of public biochemical IC50 data is problematic, because they are assay specific and comparable only under certain conditions. For large scale analysis it is not feasible to check each data entry manually and it is very tempting to mix all available IC50 values from public database even if assay information is not reported. As previously reported for K-i database analysis, we first analyzed the types of errors, the redundancy and the variability that can be found in ChEMBL IC50 database. For assessing the variability of IC50 data independently measured in two different labs at least ten IC50 data for identical protein-ligand systems against the same target were searched in ChEMBL. As a not sufficient number of cases of this type are available, the variability of IC50 data was assessed by comparing all pairs of independent IC50 measurements on identical protein-ligand systems. The standard deviation of IC50 data is only 25% larger than the standard deviation of K-i data, suggesting that mixing IC50 data from different assays, even not knowing assay conditions details, only adds a moderate amount of noise to the overall data. The standard deviation of public ChEMBL IC50 data, as expected, resulted greater than the standard deviation of in-house intra-laboratory/inter-day IC50 data. Augmenting mixed public IC50 data by public K-i data does not deteriorate the quality of the mixed IC50 data, if the K-i is corrected by an offset. For a broad dataset such as ChEMBL database a K-i-IC50 conversion factor of 2 was found to be the most reasonable.	[Kalliokoski, Tuomo; Kramer, Christian; Vulpetti, Anna; Gedeck, Peter] Novartis Inst Biomed Res, Basel, Switzerland	Novartis	Kalliokoski, T (corresponding author), Novartis Inst Biomed Res, Basel, Switzerland.	tuomo.kalliokoski@novartis.com; Kramer_Christian@gmx.de	Gedeck, Peter/AAA-1746-2020; Kramer, Christian/A-6313-2012	Gedeck, Peter/0000-0002-4111-3162; Kramer, Christian/0000-0001-8663-5266; Kalliokoski, Tuomo/0000-0001-8037-2434; Vulpetti, Anna/0000-0002-3114-8679	Novartis Education Office	Novartis Education Office	TK and CK are Novartis Presidential Postdoctoral Fellows funded by Novartis Education Office. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bender A, 2007, CHEMMEDCHEM, V2, P861, DOI 10.1002/cmdc.200700026; Besnard J, 2012, NATURE, V492, P215, DOI 10.1038/nature11691; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Dunbar JB, 2011, J CHEM INF MODEL, V51, P2036, DOI 10.1021/ci200082t; Gaulton A, 2012, NUCLEIC ACIDS RES, V40, pD1100, DOI 10.1093/nar/gkr777; Hu Y, 2012, J CHEM INF MODEL, V52, P2550, DOI [10.1021/ci3003304, 10.1021/ci30033041]; Keiser MJ, 2007, NAT BIOTECHNOL, V25, P197, DOI 10.1038/nbt1284; Kirchmair J, 2012, J CHEM INF MODEL, V52, P617, DOI 10.1021/ci200542m; Kramer C, 2008, CHEMMEDCHEM, V3, P254, DOI 10.1002/cmdc.200700221; Kramer C, 2012, CURR TOP MED CHEM, V12, P1896, DOI 10.2174/156802612804547380; Kramer C, 2012, J MED CHEM, V55, P5165, DOI 10.1021/jm300131x; Liu TQ, 2007, NUCLEIC ACIDS RES, V35, pD198, DOI 10.1093/nar/gkl999; McCarren P, 2011, BIOORGAN MED CHEM, V19, P3173, DOI 10.1016/j.bmc.2011.03.066; Paolini GV, 2006, NAT BIOTECHNOL, V24, P805, DOI 10.1038/nbt1228; Sahoo PK, 2010, EUR J MED CHEM, V45, P909, DOI 10.1016/j.ejmech.2009.11.031; Schurer SC, 2013, J CHEM INF MODEL, V53, P27, DOI 10.1021/ci300403k; Smith RD, 2011, J CHEM INF MODEL, V51, P2115, DOI 10.1021/ci200269q; Team RC, 2012, R LANG ENV STAT COMP; Zdrazil B, 2012, MOL INFORM, V31, P599, DOI 10.1002/minf.201200059	19	164	166	4	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2013	8	4							e61007	10.1371/journal.pone.0061007	http://dx.doi.org/10.1371/journal.pone.0061007			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130DR	23613770	gold, Green Submitted, Green Published			2022-12-25	WOS:000317893400033
J	Meena, AS; Sharma, A; Kumari, R; Mohammad, N; Singh, SV; Bhat, MK				Meena, Avtar Singh; Sharma, Aanchal; Kumari, Ratna; Mohammad, Naoshad; Singh, Shivendra Vikram; Bhat, Manoj Kumar			Inherent and Acquired Resistance to Paclitaxel in Hepatocellular Carcinoma: Molecular Events Involved	PLOS ONE			English	Article							BREAST-CANCER CELLS; HEAT-SHOCK PROTEINS; DRUG-RESISTANCE; MULTIDRUG-RESISTANCE; INDUCED APOPTOSIS; P-GLYCOPROTEIN; OVARIAN-CANCER; CAVEOLIN-1; CHEMOTHERAPY; OVEREXPRESSION	Hepatocellular carcinoma (HCC) is a primary malignancy of the liver and is a major cause of cancer related deaths worldwide. Only 10 to 20% of HCC can be surgically excised. Therefore, chemotherapeutic intervention and treatment is essential for achieving favorable prognosis. However, therapeutic outcome of chemotherapy is generally poor owing to inherent resistance of cancer cells to the treatment or due to development of acquired resistance. To differentiate and delineate the molecular events, we developed drug resistant Hep3B cells (DRC) by treating cells with the increasing concentration of paclitaxel. We also developed a unique single cell clone of Hep3B cells (SCC) by selecting single cell colonies and screening them for resistant phenotype. Interestingly, both DRC and SCC were resistant to paclitaxel in comparison to parental Hep3B cells. We analyzed the contributory factors that may be involved in the development of resistance. As expected, level of P-glycoprotein (P-gp) was elevated in DRC. In addition, Caveolin-1 (Cav-1), Fatty acid synthase (FASN) and Cytochrome P450 (CYP450) protein levels were elevated in DRC whereas in SCC, FASN and CYP450 levels were elevated. Downregulation of these molecules by respective siRNAs and/or by specific pharmacological inhibitors resensitized cells to paclitaxel. Interestingly, these drug resistant cells were also less sensitive to vinblastine, doxorubicin and methotrexate with the exception of cisplatin. Our results suggested that differential levels of P-gp, Cav-1 and FASN play a major role in acquired resistant phenotype whereas FASN level was associated with the presentation of inherent resistant phenotype in HCC.	[Meena, Avtar Singh; Sharma, Aanchal; Kumari, Ratna; Mohammad, Naoshad; Singh, Shivendra Vikram; Bhat, Manoj Kumar] Natl Ctr Cell Sci, Pune, Maharashtra, India	Department of Biotechnology (DBT) India; National Centre for Cell Science, Pune (NCCS)	Bhat, MK (corresponding author), Natl Ctr Cell Sci, Pune, Maharashtra, India.	manojkbhat@nccs.res.in	Meena, Avtar Singh/AAG-4419-2021; Meena, Avtar S/AAZ-8213-2020; Muhammad, Naoshad/AAH-2147-2019	Muhammad, Naoshad/0000-0001-6924-7923; Singh, Shivendra Vikram/0000-0002-4153-8056; Meena, Avtar Singh/0000-0003-2213-2488	NCCS, DBT, India	NCCS, DBT, India	Intramural grant from NCCS, DBT, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrea F, 1997, CANCER RES, V57, P2388; Chhipa RR, 2007, EXP CELL RES, V313, P3945, DOI 10.1016/j.yexcr.2007.08.022; Cohen M, 2010, GYNECOL ONCOL, V119, P164, DOI 10.1016/j.ygyno.2010.05.027; Dai Z, 2004, CURR TOP MED CHEM, V4, P1347; Germann UA, 1998, CYTOTECHNOLOGY, V27, P31, DOI 10.1023/A:1008023629269; Gillet JP, 2011, P NATL ACAD SCI USA, V108, P18708, DOI 10.1073/pnas.1111840108; Gillet JP, 2010, METHODS MOL BIOL, V596, P47, DOI 10.1007/978-1-60761-416-6_4; Henley D, 2007, CANCER CHEMOTH PHARM, V59, P235, DOI 10.1007/s00280-006-0262-1; Hsu HS, 2011, CANCER-AM CANCER SOC, V117, P1516, DOI 10.1002/cncr.25599; HUTCHISON DJ, 1965, CANCER RES, V25, P1581; Landriscina M, 2010, GYNECOL ONCOL, V117, P177, DOI 10.1016/j.ygyno.2009.10.078; Lin DY, 1997, J GASTROEN HEPATOL, V12, pS319, DOI 10.1111/j.1440-1746.1997.tb00516.x; Liu HL, 2008, MOL CANCER THER, V7, P263, DOI 10.1158/1535-7163.MCT-07-0445; Mellor HR, 2008, PHARMACOLOGY, V81, P275, DOI 10.1159/000115967; Ofir R, 2002, CELL DEATH DIFFER, V9, P636, DOI 10.1038/sj.cdd.4401012; Ogu C C, 2000, Proc (Bayl Univ Med Cent), V13, P421; Ozlem DI, 2009, INT J HEMATOLOGY ONC, V19, P001; Pandey V, 2012, INT J CANCER, V130, P497, DOI 10.1002/ijc.26048; Patel VA, 2002, J BIOL CHEM, V277, P38915, DOI 10.1074/jbc.M206855200; Peetla C, 2010, MOL PHARMACEUT, V7, P2334, DOI 10.1021/mp100308n; Righetti SC, 2006, BBA-MOL CELL RES, V1763, P93, DOI 10.1016/j.bbamcr.2005.12.007; Seddon AM, 2009, CHEM SOC REV, V38, P2509, DOI 10.1039/b813853m; Selleri S, 2005, BRIT J DERMATOL, V153, P506, DOI 10.1111/j.1365-2133.2005.06746.x; Semela David, 2011, Ther Umsch, V68, P213, DOI 10.1024/0040-5930/a000153; Shajahan AN, 2007, J BIOL CHEM, V282, P5934, DOI 10.1074/jbc.M608857200; Sharma A, 2010, CANCER SCI, V101, P1186, DOI 10.1111/j.1349-7006.2010.01516.x; Szakacs G, 2006, NAT REV DRUG DISCOV, V5, P219, DOI 10.1038/nrd1984; Tang Y, 2012, MED ONCOL, V29, P977, DOI 10.1007/s12032-011-9900-5; Thomas S, 2011, CANCER RES, V71, P832, DOI 10.1158/0008-5472.CAN-10-0730; Tse EYT, 2012, J PATHOL, V226, P645, DOI 10.1002/path.3957; Wong Robert, 2011, Gastroenterol Hepatol (N Y), V7, P16; Xu Y, 2012, BIOSCI REP	32	62	64	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2013	8	4							e61524	10.1371/journal.pone.0061524	http://dx.doi.org/10.1371/journal.pone.0061524			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130DR	23613870	gold, Green Published, Green Submitted			2022-12-25	WOS:000317893400073
J	Schendzielorz, N; Oinas, JP; Myohanen, TT; Reenila, I; Raasmaja, A; Mannisto, PT				Schendzielorz, Nadia; Oinas, Juha-Pekka; Myohanen, Timo T.; Reenila, Ilkka; Raasmaja, Atso; Mannisto, Pekka T.			Catechol-O-Methyltransferase (COMT) Protein Expression and Activity after Dopaminergic and Noradrenergic Lesions of the Rat Brain	PLOS ONE			English	Article							METHYL-TRANSFERASE; NEURONS; NORADRENALINE; MICE; LOCALIZATION; ORGANIZATION; METABOLISM; MICROGLIA; SYSTEM; GENE	The occurrence of catechol-O-methyltransferase (COMT) in presynaptic neurons remains controversial. This study utilized dopaminergic and noradrenergic toxins to assess the presence of COMT in the presynaptic neurons originating from the substantia nigra, ventral tegmental area or locus coeruleus. Destruction of dopaminergic and noradrenergic neurons was assessed by measuring the dopamine and noradrenaline content in the projection areas of these neurons. Additionally, COMT protein expression and activity were examined in several projection areas to determine whether there are any changes in COMT values. Colocalization studies were done to identify COMT-containing postsynaptic neurons. Despite successful lesioning of dopaminergic and noradrenergic neurons, no changes in COMT protein expression or activity could be noted. These results strongly suggest that COMT is not present in presynaptic dopaminergic and noradrenergic neurons. There was a high colocalization of COMT with the GABAergic marker of short neurons both in the striatum and cortex but only a weak, if any, with the cholinergic marker in the cortex.	[Schendzielorz, Nadia; Oinas, Juha-Pekka; Myohanen, Timo T.; Reenila, Ilkka; Raasmaja, Atso; Mannisto, Pekka T.] Univ Helsinki, Fac Pharm, Div Pharmacol & Toxicol, Helsinki, Finland	University of Helsinki	Mannisto, PT (corresponding author), Univ Helsinki, Fac Pharm, Div Pharmacol & Toxicol, Helsinki, Finland.	Pekka.Mannisto@helsinki.fi	Myohanen, Timo/N-8438-2014; Raasmaja, Atso/AAL-9189-2020	Mannisto, Pekka/0000-0002-8708-1979; Reenila, Ilkka/0000-0002-9390-7351; Myohanen, Timo/0000-0002-9277-6687	Academy of Finland [131915]; Juselius Foundation	Academy of Finland(Academy of Finland); Juselius Foundation	Supported by a grant from the Academy of Finland (no. 131915) and Juselius Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airavaara M, 2006, SYNAPSE, V59, P321, DOI 10.1002/syn.20245; Chen JS, 2011, J BIOL CHEM, V286, P34752, DOI 10.1074/jbc.M111.262790; Cicchetti F, 2002, EUR J NEUROSCI, V15, P991, DOI 10.1046/j.1460-9568.2002.01938.x; CROSS AJ, 1978, PSYCHOPHARMACOLOGY, V59, P117, DOI 10.1007/BF00427744; CROUT JR, 1961, J PHARMACOL EXP THER, V132, P269; DAHLSTROM A, 1964, ACTA PHYSIOL SCAND, V62, P1; Helkamaa T, 2007, NEUROCHEM INT, V51, P412, DOI 10.1016/j.neuint.2007.04.020; HILLARP NA, 1966, PHARMACOL REV, V18, P727; HOUSER CR, 1983, BRAIN RES, V266, P97, DOI 10.1016/0006-8993(83)91312-4; Iversen L. L., 2009, INTRO NEUROPSYCHOPHA, P150; JAIMETCHEVERRY G, 1980, BRAIN RES, V188, P513, DOI 10.1016/0006-8993(80)90049-9; JARROTT B, 1971, J NEUROCHEM, V18, P1, DOI 10.1111/j.1471-4159.1971.tb00161.x; JARROTT B, 1971, J NEUROCHEM, V18, P17, DOI 10.1111/j.1471-4159.1971.tb00163.x; JONES BE, 1977, BRAIN RES, V127, P23, DOI 10.1016/0006-8993(77)90378-X; KAAKKOLA S, 1987, J NEURAL TRANSM, V69, P221, DOI 10.1007/BF01244343; Kaenmaki M, 2009, BRIT J PHARMACOL, V158, P1884, DOI 10.1111/j.1476-5381.2009.00494.x; KAPLAN GP, 1981, BRAIN RES, V204, P353, DOI 10.1016/0006-8993(81)90594-1; KARHUNEN T, 1995, NEUROSCI LETT, V187, P57, DOI 10.1016/0304-3940(95)11337-V; Kitamura Y, 2010, GLIA, V58, P1686, DOI 10.1002/glia.21040; LINDVALL O, 1974, ACTA PHYSIOL SCAND, P1; Mannisto PT, 1999, PHARMACOL REV, V51, P593; Matsumoto M, 2003, NEUROSCIENCE, V116, P127, DOI 10.1016/S0306-4522(02)00556-0; Motts SD, 2003, NEUROSC, V154, P186; Myohanen TT, 2012, J HISTOCHEM CYTOCHEM, V60, P706, DOI 10.1369/0022155412453051; Myohanen TT, 2010, J NEUROCHEM, V113, P1632, DOI 10.1111/j.1471-4159.2010.06723.x; REENILA I, 1995, J CHROMATOGR B, V663, P137, DOI 10.1016/0378-4347(94)00433-6; Reenila I, 1997, NEUROSCI LETT, V230, P155, DOI 10.1016/S0304-3940(97)00502-8; RIVETT AJ, 1983, J NEUROCHEM, V40, P215, DOI 10.1111/j.1471-4159.1983.tb12673.x; SACHS C, 1975, BRAIN RES, V99, P277, DOI 10.1016/0006-8993(75)90029-3; Silva C, 2009, J NEURAL TRANSM-SUPP, P185, DOI 10.1007/978-3-211-92660-4_15; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; TENHUNEN J, 1994, EUR J BIOCHEM, V223, P1049, DOI 10.1111/j.1432-1033.1994.tb19083.x	32	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2013	8	4							e61392	10.1371/journal.pone.0061392	http://dx.doi.org/10.1371/journal.pone.0061392			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130DR	23613844	Green Submitted, Green Published, gold			2022-12-25	WOS:000317893400060
J	Stone, R; Takimoto, T				Stone, Raychel; Takimoto, Toru			Critical Role of the Fusion Protein Cytoplasmic Tail Sequence in Parainfluenza Virus Assembly	PLOS ONE			English	Article							HEMAGGLUTININ-NEURAMINIDASE GLYCOPROTEIN; TEMPERATURE-SENSITIVE MUTANT; SENDAI-VIRUS; HN-GLYCOPROTEIN; TYPE-1; MATRIX; DOMAIN; GENE; RECOMBINANT; EXPRESSION	Interactions between viral glycoproteins, matrix protein and nucleocapsid sustain assembly of parainfluenza viruses at the plasma membrane. Although the protein interactions required for virion formation are considered to be highly specific, virions lacking envelope glycoprotein(s) can be produced, thus the molecular interactions driving viral assembly and production are still unclear. Sendai virus (SeV) and human parainfluenza virus type 1 (hPIV1) are highly similar in structure, however, the cytoplasmic tail sequences of the envelope glycoproteins (HN and F) are relatively less conserved. To unveil the specific role of the envelope glycoproteins in viral assembly, we created chimeric SeVs whose HN (rSeVhHN) or HN and F (rSeVh(HN+F)) were replaced with those of hPIV1. rSeVhHN grew as efficiently as wt SeV or hPIV1, suggesting that the sequence difference in HN does not have a significant impact on SeV replication and virion production. In sharp contrast, the growth of rSeVh(HN+F) was significantly impaired compared to rSeVhHN. rSeVh(HN+Fstail) which expresses a chimeric hPIV1 F with the SeV cytoplasmic tail sequence grew similar to wt SeV or rSeVhHN. Further analysis indicated that the F cytoplasmic tail plays a critical role in cell surface expression/accumulation of HN and F, as well as NP and M association at the plasma membrane. Trafficking of nucelocapsids in infected cells was not significantly affected by the origin of F, suggesting that F cytoplasmic tail is not involved in intracellular movement. These results demonstrate the role of the F cytoplasmic tail in accumulation of structural components at the plasma membrane assembly sites.	[Stone, Raychel; Takimoto, Toru] Univ Rochester, Sch Med & Dent, Dept Microbiol & Immunol, Rochester, NY 14642 USA	University of Rochester	Takimoto, T (corresponding author), Univ Rochester, Sch Med & Dent, Dept Microbiol & Immunol, Rochester, NY 14642 USA.	toru_takimoto@urmc.rochester.edu			National Institutes of Health [R01AI081779]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI081779] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grant R01AI081779. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali A, 2000, VIROLOGY, V276, P289, DOI 10.1006/viro.2000.0556; Battisti AJ, 2012, P NATL ACAD SCI USA, V109, P13996, DOI 10.1073/pnas.1210275109; BOUSSE T, 1994, VIROLOGY, V204, P506, DOI 10.1006/viro.1994.1564; Bousse T, 2002, J VIROL, V76, P8244, DOI 10.1128/JVI.76.16.8244-8251.2002; Bruce EA, 2012, BIOCHEM SOC T, V40, P1409, DOI 10.1042/BST20120166; Chambers R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010994; Coronel EC, 1999, J VIROL, V73, P7035, DOI 10.1128/JVI.73.8.7035-7038.1999; Coronel EC, 2001, J VIROL, V75, P1117, DOI 10.1128/JVI.75.3.1117-1123.2001; Fouillot-Coriou N, 2000, VIROLOGY, V270, P464, DOI 10.1006/viro.2000.0291; FUERST TR, 1986, P NATL ACAD SCI USA, V83, P8122, DOI 10.1073/pnas.83.21.8122; GORMAN WL, 1990, VIROLOGY, V175, P211, DOI 10.1016/0042-6822(90)90201-2; GORMAN WL, 1991, VIROLOGY, V183, P83, DOI 10.1016/0042-6822(91)90120-Z; Gosselin-Grenet AS, 2010, VIROLOGY, V405, P439, DOI 10.1016/j.virol.2010.06.030; HEGGENESS MH, 1982, P NATL ACAD SCI-BIOL, V79, P6232, DOI 10.1073/pnas.79.20.6232; HEWITT JA, 1977, J GEN VIROL, V34, P127, DOI 10.1099/0022-1317-34-1-127; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; KONDO T, 1993, J BIOL CHEM, V268, P21924; Li M, 2009, J VIROL, V83, P7261, DOI 10.1128/JVI.00421-09; Lyles D. S., 2007, FIELDS VIROLOGY, V1, P1364; MADDON PJ, 1986, CELL, V47, P333, DOI 10.1016/0092-8674(86)90590-8; MERSON JR, 1988, VIROLOGY, V167, P97, DOI 10.1016/0042-6822(88)90058-X; Oomens AGP, 2006, J VIROL, V80, P10465, DOI 10.1128/JVI.01439-06; Popa A, 2011, BIOCHEMISTRY-US, V50, P945, DOI 10.1021/bi101597k; PORTNER A, 1975, VIROLOGY, V67, P179, DOI 10.1016/0042-6822(75)90415-8; PORTNER A, 1981, VIROLOGY, V115, P375, DOI 10.1016/0042-6822(81)90118-5; PORTNER A, 1987, VIROLOGY, V158, P61, DOI 10.1016/0042-6822(87)90238-8; PORTNER A, 1974, J VIROL, V13, P298, DOI 10.1128/JVI.13.2.298-304.1974; ROUX L, 1982, CELL, V28, P293, DOI 10.1016/0092-8674(82)90347-6; SANDERSON CM, 1993, J VIROL, V67, P651, DOI 10.1128/JVI.67.2.651-663.1993; SANDERSON CM, 1994, J VIROL, V68, P69, DOI 10.1128/JVI.68.1.69-76.1994; Schmitt AP, 2005, J VIROL, V79, P2988, DOI 10.1128/JVI.79.5.2988-2997.2005; Schmitt AP, 1999, J VIROL, V73, P8703, DOI 10.1128/JVI.73.10.8703-8712.1999; Shaikh FY, 2012, MBIO, V3, DOI 10.1128/mBio.00270-11; STRICKER R, 1991, J GEN VIROL, V72, P1703, DOI 10.1099/0022-1317-72-7-1703; Takimoto T, 1998, J VIROL, V72, P9747, DOI 10.1128/JVI.72.12.9747-9754.1998; Takimoto T, 2004, VIRUS RES, V106, P133, DOI 10.1016/j.virusres.2004.08.010; Takimoto T, 2001, J VIROL, V75, P11384, DOI 10.1128/JVI.75.23.11384-11391.2001; TAKIMOTO T, 1994, VIRUS RES, V32, P85, DOI 10.1016/0168-1702(94)90063-9; TUFFEREAU C, 1985, J GEN VIROL, V66, P2313, DOI 10.1099/0022-1317-66-11-2313; Waning DL, 2002, J VIROL, V76, P9284, DOI 10.1128/JVI.76.18.9284-9297.2002; YOSHIDA T, 1979, VIROLOGY, V92, P139, DOI 10.1016/0042-6822(79)90220-4; YOSHIDA T, 1982, VIROLOGY, V120, P329, DOI 10.1016/0042-6822(82)90034-4; Zhan X, 2008, VACCINE, V26, P3480, DOI 10.1016/j.vaccine.2008.04.022	43	8	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2013	8	4							e61281	10.1371/journal.pone.0061281	http://dx.doi.org/10.1371/journal.pone.0061281			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123JP	23593451	gold, Green Published, Green Submitted			2022-12-25	WOS:000317385300069
J	Maes, E; Landuyt, B; Mertens, I; Schoofs, L				Maes, Evelyne; Landuyt, Bart; Mertens, Inge; Schoofs, Liliane			Interindividual Variation in the Proteome of Human Peripheral Blood Mononuclear Cells	PLOS ONE			English	Article							DIFFERENCE GEL-ELECTROPHORESIS; HUMAN CEREBROSPINAL-FLUID; QUANTITATIVE PROTEOMICS; RHEUMATOID-ARTHRITIS; BIOLOGICAL VARIATION; PLASMA PROTEOME	Peripheral blood mononuclear cells (PBMCs) are main actors in inflammatory processes and linked to many diseases, including rheumatoid arthritis, atherosclerosis, asthma, HIV and cancer. Moreover, they seem an interesting 'surrogate tissue' that can be used in biomarker discovery. In order to get a good experimental design for quantitative expression studies, the knowledge of the interindividual variation is an essential part. Therefore, PBMCs were isolated from 24 healthy volunteers (15 males, 9 females, ages 63-86) with no clinical signs of inflammation. The extracted proteins were separated using the two dimensional difference in gel electrophoresis technology (2D-DIGE), and the gel images were processed with the DeCyder 2D software. Protein spots present in at least 22 out of 24 healthy volunteers were selected for further statistical analysis. Determination of the coefficient of variation (CV) of the normalized spot volume values of these proteins, reveals that the total variation of the PBMC proteome varies between 12,99% to 148,45%, with a mean value of 28%. A supplemental look at the causes of technical variation showed that the isolation of PBMCs from whole blood is the factor which influences the experimental variance the most. This isolation should be handled with extra care and an additional washing step would be beneficial. Knowing the extent of variation, we show that at least 10 independent samples per group are needed to obtain statistical powerful data. This study demonstrates the importance of considering variance of a human population for a good experimental design for future protein profiling or biomarker studies.	[Maes, Evelyne; Landuyt, Bart; Schoofs, Liliane] Katholieke Univ Leuven, Res Grp Funct Genom & Prote, Louvain, Belgium; [Maes, Evelyne; Mertens, Inge] Flemish Inst Technol Res VITO, Mol, Belgium; [Mertens, Inge] CFP CeProMa, Antwerp, Belgium	KU Leuven; VITO	Maes, E (corresponding author), Katholieke Univ Leuven, Res Grp Funct Genom & Prote, Louvain, Belgium.	Evelyne.maes@bio.kuleuven.be	Mertens, Inge/N-9787-2018; schoofs, liliane/ABD-2943-2020; Maes, Evelyne/ABI-1790-2020; Schoofs, Liliane/F-2815-2010	Mertens, Inge/0000-0002-4888-3485; Schoofs, Liliane/0000-0002-1673-432X; Maes, Evelyne/0000-0002-1461-6039	Flemish Institute for Technological Research (VITO); Industrial Research Fund (KU Leuven) [IOFM/08/012 IOF/KP/09/003]; Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT) [SBO IWT 100042]	Flemish Institute for Technological Research (VITO); Industrial Research Fund (KU Leuven); Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT))	This work was supported by the Flemish Institute for Technological Research (VITO), the Industrial Research Fund (KU Leuven) (IOFM/08/012) (IOF/KP/09/003) and the Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT) (SBO IWT 100042). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson NL, 2010, CLIN CHEM, V56, P177, DOI 10.1373/clinchem.2009.126706; Brubaker AL, 2011, AGING DIS, V2, P346; Cairns DA, 2011, PROTEOMICS, V11, P1037, DOI 10.1002/pmic.201000579; Corzett TH, 2006, J PROTEOME RES, V5, P2611, DOI 10.1021/pr060100p; Corzett TH, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/258494; de RB, 2008, J PROTEOME RES, V7, P2280, DOI [10.1021/pr700714x, DOI 10.1021/PR700714X]; Dotzlaw H, 2004, BBA-PROTEINS PROTEOM, V1696, P121, DOI 10.1016/j.bbapap.2003.09.015; Foldi I, 2011, J PROTEOMICS, V74, P894, DOI 10.1016/j.jprot.2011.03.006; Hatsugai M, 2010, J GASTROENTEROL, V45, P488, DOI 10.1007/s00535-009-0183-y; Hryniewicz-Jankowska A, 2007, EXP BIOL MED, V232, P967; Hu Jianhua, 2005, Briefings in Functional Genomics & Proteomics, V3, P322, DOI 10.1093/bfgp/3.4.322; Hu Y, 2005, MOL CELL PROTEOMICS, V4, P2000, DOI 10.1074/mcp.M500207-MCP200; Hunt SMN, 2005, J PROTEOME RES, V4, P809, DOI 10.1021/pr049758y; Jin M, 2006, PROTEOME SCI, V4, DOI 10.1186/1477-5956-4-16; Karp NA, 2009, PROTEOMICS, V9, P388, DOI 10.1002/pmic.200800485; Levin Y, 2011, PROTEOMICS, V11, P2565, DOI 10.1002/pmic.201100033; Linton PJ, 2004, NAT IMMUNOL, V5, P133, DOI 10.1038/ni1033; Mazzola A, 2008, EUR J HEART FAIL, V10, P749, DOI 10.1016/j.ejheart.2008.06.003; Mesko B, 2011, TRENDS MOL MED, V17, P223, DOI 10.1016/j.molmed.2010.12.004; Molloy MP, 2003, PROTEOMICS, V3, P1912, DOI 10.1002/pmic.200300534; Reynolds JL, 2009, J CLIN IMMUNOL, V29, P646, DOI 10.1007/s10875-009-9309-5; Schulz M, 2007, J PROTEOME RES, V6, P3752, DOI 10.1021/pr070285f; Stoop MP, 2010, MOL CELL PROTEOMICS, V9, P2063, DOI 10.1074/mcp.M900877-MCP200; Vergara D, 2008, PROTEOMICS, V8, P2045, DOI 10.1002/pmic.200700726; Winkler W, 2008, MOL CELL PROTEOMICS, V7, P193, DOI 10.1074/mcp.M700137-MCP200; Yamakawa K, 2007, J ANDROL, V28, P858, DOI 10.2164/jandrol.107.002824; Zhang XQ, 2006, PROTEOMICS, V6, P5260, DOI 10.1002/pmic.200600006	27	23	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2013	8	4							e61933	10.1371/journal.pone.0061933	http://dx.doi.org/10.1371/journal.pone.0061933			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123JA	23613975	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000317383200063
J	Flegr, J; Preiss, M; Klose, J				Flegr, Jaroslav; Preiss, Marek; Klose, Jiri			Toxoplasmosis-Associated Difference in Intelligence and Personality in Men Depends on Their Rhesus Blood Group but Not ABO Blood Group	PLOS ONE			English	Article							LATENT TOXOPLASMOSIS; BEHAVIORAL-CHANGES; MOTOR-PERFORMANCE; FATAL ATTRACTION; RHD MOLECULE; GONDII; INFECTION; CAT; PHENOTYPE; PARASITE	Background: The parasite Toxoplasma gondii influences the behaviour of infected animals and probably also personality of infected humans. Subjects with a Rhesus-positive blood group are protected against certain behavioural effects associated with Toxoplasma infection, including the deterioration of reaction times and personality factor shift. Methodology/Principal Findings: Here, we searched for differences in the toxoplasmosis-associated effects between RhD-positive and RhD-negative subjects by testing 502 soldiers with two personality tests and two intelligence tests. The infected subjects expressed lower levels of all potentially pathognomic factors measured with the N-70 questionnaire and in neurasthenia measured with NEO-PI-R. The RhD-positive, Toxoplasma-infected subjects expressed lower while RhD-negative, Toxoplasma-infected subjects expressed higher intelligence than their Toxoplasma-free peers. The observed Toxoplasma-associated differences were always larger in RhD-negative than in RhD-positive subjects. Conclusions: RhD phenotype plays an important role in the strength and direction of association between latent toxoplasmosis and not only psychomotor performance, but also personality and intelligence.	[Flegr, Jaroslav] Charles Univ Prague, Fac Sci, Dept Biol, Prague, Czech Republic; [Preiss, Marek] Prague Psychiat Ctr, Dept Biochem & Brain Pathophysiol, Prague, Czech Republic; [Klose, Jiri] Mil Univ Hosp Prague, Cent Med Psychol Dept, Prague, Czech Republic	Charles University Prague; Military University Hospital Prague	Flegr, J (corresponding author), Charles Univ Prague, Fac Sci, Dept Biol, Prague, Czech Republic.	flegr@cesnet.cz	Preiss, Marek/AAG-9405-2020; Flegr, Jaroslav/A-1564-2008; Flegr, Jaroslav/AAG-7568-2021	Flegr, Jaroslav/0000-0002-0822-0126; Flegr, Jaroslav/0000-0002-0822-0126; Preiss, Marek/0000-0002-4463-6313	Grand Agency of the Czech Republic [P303/11/1398]; Charles University of Prague [GAUK 18810, UNCE 204004]	Grand Agency of the Czech Republic; Charles University of Prague	The authors' work was supported by the Grand Agency of the Czech Republic (Grant No. P303/11/1398) and Charles University of Prague (GAUK 18810, grant UNCE 204004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1958, STANDARD PROGR MATRI; Barnard C.J., 1990, PARASITISM HOST BEHA; Berdoy M, 2000, P ROY SOC B-BIOL SCI, V267, P1591, DOI 10.1098/rspb.2000.1182; Biver S, 2006, TRANSFUS CLIN BIOL, V13, P167, DOI 10.1016/j.tracli.2006.03.003; Carritt B, 1997, HUM MOL GENET, V6, P843, DOI 10.1093/hmg/6.6.843; CATTELL RB, 1972, AM J HUM GENET, V24, P485; Cernochova D, 2002, VIENNA MATRIX TEST; Flegel WA, 2006, TRANSFUS CLIN BIOL, V13, P4, DOI 10.1016/j.tracli.2006.02.011; Flegr J, 1996, PARASITOLOGY, V113, P49, DOI 10.1017/S0031182000066269; Flegr J, 1999, FOLIA PARASIT, V46, P22; Flegr J, 2008, NEUROENDOCRINOL LETT, V29, P475; Flegr J, 2007, SCHIZOPHRENIA BULL, V33, P757, DOI 10.1093/schbul/sbl074; Flegr J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049478; Flegr J, 2012, NEUROENDOCRINOL LETT, V33, P224; Flegr J, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001389; Flegr J, 2010, FOLIA PARASIT, V57, P143, DOI 10.14411/fp.2010.018; Flegr J, 2010, FOLIA PARASIT, V57, P81, DOI 10.14411/fp.2010.010; Flegr J, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-72; Formann AK., 1979, WIENER MATRIZEN TEST; Gaskell EA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004801; Gruswitz F, 2010, P NATL ACAD SCI USA, V107, P9638, DOI 10.1073/pnas.1003587107; HAY J, 1983, ANN TROP MED PARASIT, V77, P261, DOI 10.1080/00034983.1983.11811707; HAY J, 1984, Z PARASITENKD, V70, P575, DOI 10.1007/BF00926588; HAY J, 1985, Z PARASITENKD, V71, P459, DOI 10.1007/BF00928348; Hodkova H, 2007, PARASITOLOGY, V134, P1329, DOI 10.1017/S0031182007002673; House PK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023277; Hrda S, 2000, J PARASITOL, V86, P657, DOI 10.1645/0022-3395(2000)086[0657:TNOTGI]2.0.CO;2; Hrebickova M, 2002, CESK PSYCHOL, V46, P521; HUTCHISON WM, 1980, ANN TROP MED PARASIT, V74, P507, DOI 10.1080/00034983.1980.11687376; Kankova S, 2010, PARASITOLOGY, V137, P1773, DOI 10.1017/S0031182010000661; Kankova S, 2011, EXP PARASITOL, V128, P181, DOI 10.1016/j.exppara.2011.03.014; Kannan G, 2010, FOLIA PARASIT, V57, P151, DOI 10.14411/fp.2010.019; Kustu S, 2006, TRANSFUS CLIN BIOL, V13, P103, DOI 10.1016/j.tracli.2006.03.001; Lafferty KD, 2006, P ROY SOC B-BIOL SCI, V273, P2749, DOI 10.1098/rspb.2006.3641; Lindova J, 2012, EUR J PERSONALITY, V26, P285, DOI 10.1002/per.838; Lindova J, 2010, FOLIA PARASIT, V57, P136, DOI 10.14411/fp.2010.017; Ling VJ, 2011, J NERV MENT DIS, V199, P440, DOI 10.1097/NMD.0b013e318221416e; Moore J, 2005, BEHAV PROCESS, V68, P283, DOI 10.1016/j.beproc.2004.10.005; Novotna M, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-54; Novotna M, 2008, PARASITOLOGY, V135, P1253, DOI 10.1017/S003118200800485X; Otis A. S., 1954, OTIS QUICK SCORING M; Prandota J, 2012, NEUROINFLAMMATION PA; Prandota Joseph, 2004, Am J Ther, V11, P517, DOI 10.1097/01.mjt.0000140648.30948.bd; Prandota J, 2010, INT J NEUROSCI, V120, P81, DOI 10.3109/00207450903458647; Prandovszky E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023866; Rasch G, 1990, PROBABILISTIC MODELS; Raven J. C., 1947, ADV PROGR MATRICES; Raven J.C., 1958, ADV PROGR MATRICES, V2nd ed.; Rogers M, 2003, PERS INDIV DIFFER, V34, P1099, DOI 10.1016/S0191-8869(02)00101-0; Siegel S., 1988, NONPARAMETRIC STAT B, pXXIII; Skallova A, 2006, PARASITOLOGY, V133, P525, DOI 10.1017/S0031182006000886; Tenter AM, 2000, INT J PARASITOL, V30, P1217, DOI 10.1016/S0020-7519(00)00124-7; Thomas F, 2012, BIOL LETTERS, V8, P101, DOI 10.1098/rsbl.2011.0588; Vacir K, 1973, THESIS FACULTY PHILO; Vyas A, 2007, P NATL ACAD SCI USA, V104, P6442, DOI 10.1073/pnas.0608310104; Wagner FF, 2000, BLOOD, V95, P3662; Webster JP, 2007, SCHIZOPHRENIA BULL, V33, P752, DOI 10.1093/schbul/sbl073; Webster JP, 2010, FOLIA PARASIT, V57, P95, DOI 10.14411/fp.2010.012; Webster JP, 2001, MICROBES INFECT, V3, P1037, DOI 10.1016/S1286-4579(01)01459-9; WIENER AS, 1965, AM J HUM GENET, V17, P369; Wu KH, 2005, PERS INDIV DIFFER, V38, P797, DOI 10.1016/j.paid.2004.06.004; Xiao J, 2012, NEUROSCIENCE, V206, P39, DOI 10.1016/j.neuroscience.2011.12.051; Yazar S, 2006, J MED MICROBIOL, V55, P89, DOI 10.1099/jmm.0.46255-0; Yolken RH, 2009, PARASITE IMMUNOL, V31, P706, DOI 10.1111/j.1365-3024.2009.01131.x	64	21	21	0	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2013	8	4							e61272	10.1371/journal.pone.0061272	http://dx.doi.org/10.1371/journal.pone.0061272			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123IQ	23593448	Green Published, gold			2022-12-25	WOS:000317382000046
J	Bartolome, RA; Barderas, R; Torres, S; Fernandez-Acenero, MJ; Mendes, M; Garcia-Foncillas, J; Lopez-Lucendo, M; Casal, JI				Bartolome, R. A.; Barderas, R.; Torres, S.; Fernandez-Acenero, M. J.; Mendes, M.; Garcia-Foncillas, J.; Lopez-Lucendo, M.; Casal, J. I.			Cadherin-17 interacts with alpha 2 beta 1 integrin to regulate cell proliferation and adhesion in colorectal cancer cells causing liver metastasis	ONCOGENE			English	Article						Cadherin-17; alpha 2 beta 1 integrin; adhesion; proliferation; liver metastasis; colorectal cancer	INTESTINE-CADHERIN; LI-CADHERIN; MATRIX-METALLOPROTEINASE; HEPATOCELLULAR-CARCINOMA; DIAGNOSTIC MARKER; LYMPH-NODE; EXPRESSION; COMPLEX; INVASION; DISEASE	Liver metastasis is the major cause of death associated to colorectal cancer. Cadherin-17 (CDH17) is a non-classical, seven domain, cadherin lacking the conserved cytoplasmic domain of classical cadherins. CDH17 was overexpressed in highly metastatic human KM12SM and present in many other colorectal cancer cells. Using tissue microarrays, we observed a significant association between high expression of CDH17 with liver metastasis and poor survival of the patients. On the basis of these findings, we decided to study cellular functions and signaling mechanisms mediated by CDH17 in cancer cells. In this report, loss-of-function experiments demonstrated that CDH17 caused a significant increase in KM12SM cell adhesion and proliferation. Coimmunoprecipitation experiments demonstrated an interaction between CDH17 and alpha 2 beta 1 integrin with a direct effect on beta 1 integrin activation and talin recruitment. The formation of this complex, together with other proteins, was confirmed by mass spectrometry analysis. CDH17 modulated integrin activation and signaling to induce specific focal adhesion kinase and Ras activation, which led to the activation of extracellular signal-regulated kinase and Jun N-terminal kinase and the increase in cyclin D1 and proliferation. In vivo experiments showed that CDH17 silencing in KM12 cells suppressed tumor growth and liver metastasis after subcutaneous or intrasplenic inoculation in nude mice. Collectively, our data reveal a new function for CDH17, which is to regulate alpha 2 beta 1 integrin signaling in cell adhesion and proliferation in colon cancer cells for liver metastasis.	[Bartolome, R. A.; Barderas, R.; Torres, S.; Mendes, M.; Casal, J. I.] CSIC, CIB, Dept Cellular & Mol Med, Madrid 28040, Spain; [Fernandez-Acenero, M. J.] Fdn Jimenez Diaz, Dept Pathol, Madrid, Spain; [Garcia-Foncillas, J.] Fdn Jimenez Diaz, Dept Oncol, Madrid, Spain; [Lopez-Lucendo, M.] CSIC, CIB, Prote Core Facil, Madrid 28040, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB)	Casal, JI (corresponding author), CSIC, CIB, Dept Cellular & Mol Med, Ramiro De Maeztu 9, Madrid 28040, Spain.	icasal@cib.csic.es	Barderas, Rodrigo/K-3560-2014; Mendes, Marta L/P-4062-2018; Mendes, Marta/AAM-9766-2021; Aceñero, M Jesús Fernández/ABC-5904-2020; Casal, Ignacio/M-2312-2014; Bartolome, Ruben A/M-1873-2014	Barderas, Rodrigo/0000-0003-3539-7469; Mendes, Marta L/0000-0002-3528-7123; Mendes, Marta/0000-0002-3528-7123; Aceñero, M Jesús Fernández/0000-0002-2439-3553; Casal, Ignacio/0000-0003-1085-2840; Bartolome, Ruben A/0000-0002-3292-1491; J, Garcia-Foncillas/0000-0002-7591-8006	Asociacion Espanola Contra el Cancer (AECC); JAE-DOC/FSE Contract (CSIC); Ramon y Cajal program; ProteoRed; Juan de la Cierva program; Spanish Ministry of Science and Innovation [BIO2009-08818]; Comunidad de Madrid [S2010/BMD-2344/ Colomics2]	Asociacion Espanola Contra el Cancer (AECC); JAE-DOC/FSE Contract (CSIC); Ramon y Cajal program(Spanish Government); ProteoRed; Juan de la Cierva program; Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Comunidad de Madrid(Comunidad de Madrid)	We thank Prof John M Luk (Hong Kong University) by the kind supply of CDH17 antibody. RA Bartolome was supported by a grant to established research groups of the Asociacion Espanola Contra el Cancer (AECC). R Barderas was a recipient of a JAE-DOC/FSE Contract (CSIC) and is currently a fellow of the Ramon y Cajal program. S Torres was a recipient of a ProteoRed contract and Juan de la Cierva program. This research was supported by grant BIO2009-08818 from the Spanish Ministry of Science and Innovation, grant to established research groups (AECC) and grant S2010/BMD-2344/ Colomics2 from Comunidad de Madrid.	Barderas R, 2012, CANCER RES, V72, P2780, DOI 10.1158/0008-5472.CAN-11-4090; Bartolome RA, 2006, CANCER RES, V66, P248, DOI 10.1158/0008-5472.CAN-05-2489; Bartolome RA, 2004, CANCER RES, V64, P2534, DOI 10.1158/0008-5472.CAN-03-3398; BERNDORFF D, 1994, J CELL BIOL, V125, P1353, DOI 10.1083/jcb.125.6.1353; Berx G, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003129; CABANAS C, 1993, P NATL ACAD SCI USA, V90, P5838, DOI 10.1073/pnas.90.12.5838; Canonici A, 2008, INT J CANCER, V122, P572, DOI 10.1002/ijc.23164; Cavallaro U, 2004, NAT REV CANCER, V4, P118, DOI 10.1038/nrc1276; Elzagheid A, 2006, WORLD J GASTROENTERO, V12, P4304, DOI 10.3748/wjg.v12.i27.4304; Gessner R, 2000, ANN NY ACAD SCI, V915, P136; Grotzinger C, 2001, GUT, V49, P73, DOI 10.1136/gut.49.1.73; HERMISTON ML, 1995, SCIENCE, V270, P1203, DOI 10.1126/science.270.5239.1203; Higgins JMG, 1998, J CELL BIOL, V140, P197, DOI 10.1083/jcb.140.1.197; Hinoi T, 2002, GASTROENTEROLOGY, V123, P1565, DOI 10.1053/gast.2002.36598; Hintermann E, 2005, J BIOL CHEM, V280, P8004, DOI 10.1074/jbc.M406301200; Kreft B, 1997, J CELL BIOL, V136, P1109, DOI 10.1083/jcb.136.5.1109; Kwak JM, 2007, DIS COLON RECTUM, V50, P1873, DOI 10.1007/s10350-007-9034-1; Lawson C, 2012, J CELL BIOL, V196, P223, DOI 10.1083/jcb.201108078; Lee NP, 2010, BBA-REV CANCER, V1806, P138, DOI 10.1016/j.bbcan.2010.05.002; Liu LX, 2009, HEPATOLOGY, V50, P1453, DOI 10.1002/hep.23143; Luque-Garcia JL, 2010, PROTEOMICS, V10, P940, DOI 10.1002/pmic.200900441; Marchio S, 2012, EMBO MOL MED, V4, P1156, DOI 10.1002/emmm.201101164; MORIKAWA K, 1988, CANCER RES, V48, P1943; Nguyen DX, 2007, NAT REV GENET, V8, P341, DOI 10.1038/nrg2101; Park JH, 2011, HISTOPATHOLOGY, V58, P316, DOI 10.1111/j.1365-2559.2011.03746.x; Paschos KA, 2009, CELL SIGNAL, V21, P665, DOI 10.1016/j.cellsig.2009.01.006; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sleeman JP, 2000, RECENT RESULTS CANC, V157, P55; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; Streuli CH, 2009, J CELL SCI, V122, P171, DOI 10.1242/jcs.018945; Su MC, 2008, MODERN PATHOL, V21, P1379, DOI 10.1038/modpathol.2008.107; Takamura M, 2004, CANCER LETT, V212, P253, DOI 10.1016/j.canlet.2004.03.016; Takamura M, 2003, CANCER SCI, V94, P425, DOI 10.1111/j.1349-7006.2003.tb01459.x; Weinberg RA, 2007, BIOL CANC; Wells A, 2008, CLIN EXP METASTAS, V25, P621, DOI 10.1007/s10585-008-9167-1; Wendeler MW, 2006, CELL MOL LIFE SCI, V63, P1564, DOI 10.1007/s00018-006-6014-x; Wendeler MW, 2007, J MOL BIOL, V370, P220, DOI 10.1016/j.jmb.2007.04.062; Wendeler MW, 2004, EXP CELL RES, V294, P345, DOI 10.1016/j.yexcr.2003.11.022; Wong BW, 2003, BIOCHEM BIOPH RES CO, V311, P618, DOI 10.1016/j.bbrc.2003.10.032; Yoshimura K, 2009, CANCER RES, V69, P7320, DOI 10.1158/0008-5472.CAN-09-0315; Yu QF, 2010, J CANCER RES CLIN, V136, P1641, DOI 10.1007/s00432-010-0822-y	41	75	79	3	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 27	2014	33	13					1658	1669		10.1038/onc.2013.117	http://dx.doi.org/10.1038/onc.2013.117			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AE9QY	23604127				2022-12-25	WOS:000334344700006
J	Bayer, SB; Maghzal, G; Stocker, R; Hampton, MB; Winterbourn, CC				Bayer, Simone B.; Maghzal, Ghassan; Stocker, Roland; Hampton, Mark B.; Winterbourn, Christine C.			Neutrophil-mediated oxidation of erythrocyte peroxiredoxin 2 as a potential marker of oxidative stress in inflammation	FASEB JOURNAL			English	Article						hydrogen peroxide; antioxidant defense; NADPH oxidase	CHRONIC GRANULOMATOUS-DISEASE; NADPH OXIDASE ACTIVITY; HYDROGEN-PEROXIDE; LIPOPOLYSACCHARIDE; BINDING; CD14; MYELOPEROXIDASE; AUTOXIDATION; PROTEIN; MODEL	Peroxiredoxin 2 (Prx2) is an abundant thiol protein in erythrocytes. It is oxidized readily on exposure to hydrogen peroxide (H2O2) and provides antioxidant protection by cycling between its reduced and disulfide-bonded forms. To test whether Prx2 oxidation could occur in pathological situations where neutrophils are activated, we exposed human erythrocytes to stimulated neutrophils and measured Prx2 oxidation by immunoblotting of nonreducing gels. With phorbol myristate acetate, lipopolysaccharide or Staphylococcus aureus Prx2 dimer increased from <5% to up to 100% depending on neutrophil number and incubation time. Studies with inhibitors and myeloperoxidase-deficient neutrophils showed that H2O2 generated by the neutrophil NADPH oxidase was responsible. Prx2 oxidation was detected at erythrocyte:neutrophil ratios found in blood and reversed over time as the oxidative burst subsided. Acidotic conditions also increased erythrocyte Prx2 oxidation. In a mouse model of endotoxemia induced by lipopolysaccharide, oxidized Prx2 increased transiently from <1 to 15%, then reverted to baseline by 24 h. No increase was seen in mice lacking NADPH oxidase activity. These results indicate that erythrocyte Prx2 scavenges H2O2 produced during inflammation. Oxidized erythrocyte Prx2 could be a sensitive real-time marker of systemic neutrophil activation and an early indicator of inflammation and oxidative stress.Bayer, S.B., Maghzal, G., Stocker, R., Hampton, M.B., Winterbourn, C.C. Neutrophil-mediated oxidation of erythrocyte peroxiredoxin 2 as a potential marker of oxidative stress in inflammation.	[Bayer, Simone B.; Hampton, Mark B.; Winterbourn, Christine C.] Univ Otago Christchurch, Ctr Free Rad Res, Christchurch, New Zealand; [Bayer, Simone B.; Hampton, Mark B.; Winterbourn, Christine C.] Univ Otago Christchurch, Gravida Natl Res Ctr Growth & Dev, Dept Pathol, Christchurch, New Zealand; [Maghzal, Ghassan; Stocker, Roland] Univ Sydney, Ctr Vasc Res, Sch Med Sci Pathol, Sydney, NSW 2006, Australia; [Maghzal, Ghassan; Stocker, Roland] Univ Sydney, Bosch Inst, Sydney, NSW 2006, Australia; [Maghzal, Ghassan; Stocker, Roland] Victor Chang Cardiac Res Inst, Vasc Biol Div, Darlinghurst, NSW, Australia	University of Otago; University of Otago; University of Sydney; University of Sydney; Victor Chang Cardiac Research Institute	Hampton, MB (corresponding author), Univ Otago Christchurch, Dept Pathol, POB 4345, Christchurch, New Zealand.	hampton@otago.ac.nz; christine.winterbourn@otago.ac.nz	Hampton, Mark B/A-8490-2008; Stocker, Roland/AAV-4489-2021; maghzal, ghassan/A-9692-2015	Hampton, Mark B/0000-0002-7349-3729; Bayer, Simone/0000-0002-5880-2095	Health Research Council of New Zealand; National Research Centre for Growth and Development of New Zealand; National Health and Medical Research Council of Australia; Australian Research Council; University of Otago	Health Research Council of New Zealand(Health Research Council of New Zealand); National Research Centre for Growth and Development of New Zealand; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); University of Otago	This work was supported by the Health Research Council of New Zealand, the National Research Centre for Growth and Development of New Zealand, the National Health and Medical Research Council of Australia, the Australian Research Council, and a University of Otago Scholarship (to S. B.). The authors declare no conflicts of interest. S. B. B. carried out most of the experimental work and contributed to experimental design and preparation of the manuscript; M. B. H. and C. C. W. contributed to experimental design, interpretation, and manuscript preparation; G. M. carried out the mouse studies; R. S. advised on the mouse studies and the preparation of the manuscript.	AGAR NS, 1986, J CLIN INVEST, V77, P319, DOI 10.1172/JCI112294; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Bone RC, 1997, CHEST, V112, P235, DOI 10.1378/chest.112.1.235; BROWN JM, 1989, AM J PHYSIOL, V256, pH584, DOI 10.1152/ajpheart.1989.256.2.H584; BROWN WD, 1969, J BIOL CHEM, V244, P6696; Burtis C. A., 2000, TIETZ FUNDAMENTALS C, P734; DeCoursey TE, 2005, CELL MOL LIFE SCI, V62, P2173, DOI 10.1007/s00018-005-5177-1; Green Jessie N., 2007, V412, P319, DOI 10.1007/978-1-59745-467-4_21; HAILMAN E, 1994, J EXP MED, V179, P269, DOI 10.1084/jem.179.1.269; Hall A, 2009, FEBS J, V276, P2469, DOI 10.1111/j.1742-4658.2009.06985.x; JACKSON SH, 1995, J EXP MED, V182, P751, DOI 10.1084/jem.182.3.751; Johnson RM, 2005, FREE RADICAL BIO MED, V39, P1407, DOI 10.1016/j.freeradbiomed.2005.07.002; Kettle AJ, 1997, BIOCHEM J, V321, P503, DOI 10.1042/bj3210503; KETTLE AJ, 1994, J BIOL CHEM, V269, P17146; Lee TH, 2003, BLOOD, V101, P5033, DOI 10.1182/blood-2002-08-2548; Low FM, 2008, ANTIOXID REDOX SIGN, V10, P1621, DOI 10.1089/ars.2008.2081; Low FM, 2007, BLOOD, V109, P2611, DOI 10.1182/blood-2006-09-048728; Lundqvist H, 1996, J LEUKOCYTE BIOL, V59, P270, DOI 10.1002/jlb.59.2.270; MOORE RB, 1991, J BIOL CHEM, V266, P18964; Nauseef WM, 2007, IMMUNOL REV, V219, P88, DOI 10.1111/j.1600-065X.2007.00550.x; Peskin AV, 2007, J BIOL CHEM, V282, P11885, DOI 10.1074/jbc.M700339200; POLLOCK JD, 1995, NAT GENET, V9, P202, DOI 10.1038/ng0295-202; Remer KA, 2003, IMMUNOL LETT, V85, P75, DOI 10.1016/S0165-2478(02)00210-9; Rhee SG, 2011, ANTIOXID REDOX SIGN, V15, P781, DOI 10.1089/ars.2010.3393; Soler-Rodriguez AM, 2000, J IMMUNOL, V164, P2674, DOI 10.4049/jimmunol.164.5.2674; Stacey MM, 2009, FREE RADICAL BIO MED, V47, P1468, DOI 10.1016/j.freeradbiomed.2009.08.022; Troelstra A, 1999, J IMMUNOL, V162, P4220; Troelstra A, 1997, INFECT IMMUN, V65, P2272, DOI 10.1128/IAI.65.6.2272-2277.1997; VANASBECK BS, 1985, SCIENCE, V227, P756, DOI 10.1126/science.2982213; Wang YT, 2010, NAT MED, V16, P279, DOI 10.1038/nm.2092; WINTERBOURN CC, 1987, J CLIN INVEST, V80, P1486, DOI 10.1172/JCI113230; Winterbourn CC, 2013, ANTIOXID REDOX SIGN, V18, P642, DOI 10.1089/ars.2012.4827	32	31	33	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2013	27	8					3315	3322		10.1096/fj.13-227298	http://dx.doi.org/10.1096/fj.13-227298			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	292BT	23603832				2022-12-25	WOS:000329877600036
J	Schwappacher, R; Kilic, A; Kojonazarov, B; Lang, M; Diep, T; Zhuang, SH; Gawlowski, T; Schermuly, RT; Pfeifer, A; Boss, GR; Pilz, RB				Schwappacher, Raphaela; Kilic, Ana; Kojonazarov, Baktybek; Lang, Michaela; Diep, Thuan; Zhuang, Shunhui; Gawlowski, Thomas; Schermuly, Ralph T.; Pfeifer, Alexander; Boss, Gerry R.; Pilz, Renate B.			A Molecular Mechanism for Therapeutic Effects of cGMP-elevating Agents in Pulmonary Arterial Hypertension	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELLS; SOLUBLE GUANYLATE-CYCLASE; GENE-EXPRESSION; CYCLIC-GMP; INCREASED SUSCEPTIBILITY; NITRIC-OXIDE; MICE; ACTIVATION; PROLIFERATION; PENETRANCE	Pulmonary arterial hypertension (PAH) is a progressive, usually fatal disease with abnormal vascular remodeling. Pulmonary artery smooth muscle cells (PASMCs) from PAH patients are hyperproliferative and apoptosis-resistant and demonstrate decreased signaling in response to bone morphogenetic proteins (BMPs). Cyclic GMP-elevating agents are beneficial in PAH, but their mechanism(s) of action are incompletely understood. Here we show that BMP signaling via Smad1/5/8 requires cGMP-dependent protein kinase isotype I (PKGI) to maintain PASMCs in a differentiated, low proliferative state. BMP cooperation with cGMP/PKGI was crucial for transcription of contractile genes and suppression of pro-proliferative and anti-apoptotic genes. Lungs from mice with low or absent PKGI (Prkg1(+/-) and Prkg1(-/-) mice) exhibited impaired BMP signaling, decreased contractile gene expression, and abnormal vascular remodeling. Conversely, cGMP stimulation of PKGI restored defective BMP signaling in rats with hypoxia-induced PAH, consistent with cGMP-elevating agents reversing vascular remodeling in this PAH model. Our results provide a mechanism for the therapeutic effects of cGMP-elevating agents in PAH and suggest that combining them with BMP mimetics may provide a novel, disease-modifying approach to PAH therapy.	[Schwappacher, Raphaela; Diep, Thuan; Zhuang, Shunhui; Gawlowski, Thomas; Boss, Gerry R.; Pilz, Renate B.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Kilic, Ana; Pfeifer, Alexander] Univ Bonn, Inst Pharmacol & Toxicol, D-53113 Bonn, Germany; [Kojonazarov, Baktybek; Lang, Michaela; Schermuly, Ralph T.] Univ Giessen, D-35392 Giessen, Germany; [Kojonazarov, Baktybek; Lang, Michaela; Schermuly, Ralph T.] Marburg Lung Ctr, D-35392 Giessen, Germany	University of California System; University of California San Diego; University of Bonn; Justus Liebig University Giessen	Schwappacher, R (corresponding author), Univ Calif San Diego, Dept Med, 9500 Gilman Dr,Basic Sci Bldg,Rm 5076, La Jolla, CA 92093 USA.	rschwappacher@ucsd.edu		Schermuly, Ralph/0000-0002-5167-6970; Boss, Gerry/0000-0002-9758-8714	National Institutes of Health [R01-AR051300, NS047101]; Deutsche Forschungsgemeinschaft fellowship grant; BONFOR grant from the University of Bonn; Bayer-Schering; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR051300] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047101] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft fellowship grant(German Research Foundation (DFG)); BONFOR grant from the University of Bonn; Bayer-Schering(Bayer AG); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-AR051300 (to R. B. P.) and NS047101 (to the University of California San Diego Neuroscience Microscopy Facility). This work was also supported by a Deutsche Forschungsgemeinschaft fellowship grant (to R. S.) and a BONFOR grant from the University of Bonn (to A. K.). R. S. is an inventor on the patent "A method for restoring BMP-receptor signalling in a cell" (PCT/EP2009/001408, Germany). R. T. S. has received honoraria from Actelion, Pfizer, Bayer-Schering, Novartis and Solvay and research grant support from Bayer-Schering.	Abe K, 2010, CIRCULATION, V121, P2747, DOI 10.1161/CIRCULATIONAHA.109.927681; Atkinson C, 2002, CIRCULATION, V105, P1672, DOI 10.1161/01.CIR.0000012754.72951.3D; Baliga RS, 2008, AM J RESP CRIT CARE, V178, P861, DOI 10.1164/rccm.200801-121OC; Bao SL, 2004, ONCOGENE, V23, P5586, DOI 10.1038/sj.onc.1207753; Barford D, 2011, Q REV BIOPHYS, V44, P153, DOI 10.1017/S0033583510000259; Bauer NR, 2007, AM J PHYSIOL-LUNG C, V293, pL580, DOI 10.1152/ajplung.00281.2007; Beppu H, 2004, AM J PHYSIOL-LUNG C, V287, pL1241, DOI 10.1152/ajplung.00239.2004; Boerth NJ, 1997, J VASC RES, V34, P245, DOI 10.1159/000159231; Buis J, 2008, CELL, V135, P85, DOI 10.1016/j.cell.2008.08.015; Chen CN, 2013, VASC PHARMACOL, V58, P211, DOI 10.1016/j.vph.2012.09.001; Chiche JD, 1998, J BIOL CHEM, V273, P34263, DOI 10.1074/jbc.273.51.34263; Dey NB, 1998, CIRC RES, V82, P139; Dumitrascu R, 2006, CIRCULATION, V113, P286, DOI 10.1161/CIRCULATIONAHA.105.581405; Fantozzi I, 2005, EXP LUNG RES, V31, P783, DOI 10.1080/01902140500461026; Francis SH, 2010, PHARMACOL REV, V62, P525, DOI 10.1124/pr.110.002907; Frank DB, 2008, AM J PHYSIOL-LUNG C, V294, pL98, DOI 10.1152/ajplung.00034.2007; Geraci MW, 2001, CIRC RES, V88, P555, DOI 10.1161/01.RES.88.6.555; Hamid R, 2009, HUM MUTAT, V30, P649, DOI 10.1002/humu.20922; Hansmann G, 2008, J CLIN INVEST, V118, P1846, DOI 10.1172/JCI32503; Lagna G, 2007, J BIOL CHEM, V282, P37244, DOI 10.1074/jbc.M708137200; Lagna G, 2006, AM J PHYSIOL-LUNG C, V291, pL1059, DOI 10.1152/ajplung.00180.2006; Lang M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043433; Leoni AL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009298; Lincoln TM, 2006, FRONT BIOSCI-LANDMRK, V11, P356, DOI 10.2741/1803; Morrell NW, 2001, CIRCULATION, V104, P790, DOI 10.1161/hc3201.094152; Morty RE, 2007, ARTERIOSCL THROM VAS, V27, P1072, DOI 10.1161/ATVBAHA.107.141200; Neuman NA, 2009, J BIOL CHEM, V284, P13202, DOI 10.1074/jbc.M900282200; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Pfeifer A, 1998, EMBO J, V17, P3045, DOI 10.1093/emboj/17.11.3045; Rabinovitch M, 2008, J CLIN INVEST, V118, P2372, DOI 10.1172/JCI33452; Schermuly RT, 2011, NAT REV CARDIOL, V8, P443, DOI 10.1038/nrcardio.2011.87; Schwappacher R, 2009, EMBO J, V28, P1537, DOI 10.1038/emboj.2009.103; Sieber C, 2009, CYTOKINE GROWTH F R, V20, P343, DOI 10.1016/j.cytogfr.2009.10.007; Song YL, 2005, CIRCULATION, V112, P553, DOI 10.1161/CIRCULATIONAHA.104.492488; Stasch JP, 2011, CIRCULATION, V123, P2263, DOI 10.1161/CIRCULATIONAHA.110.981738; Tada Y, 2007, AM J PHYSIOL-LUNG C, V292, pL1556, DOI 10.1152/ajplung.00305.2006; Weissmann N, 2009, AM J PHYSIOL-LUNG C, V297, pL658, DOI 10.1152/ajplung.00189.2009; West J, 2004, CIRC RES, V94, P1109, DOI 10.1161/01.RES.0000126047.82846.20; Whitelaw NC, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-11-r111; Yang J, 2008, CIRC RES, V102, P1212, DOI 10.1161/CIRCRESAHA.108.173567; Yang J, 2010, CIRC RES, V107, P252, DOI 10.1161/CIRCRESAHA.109.209940; Yang XD, 2005, CIRC RES, V96, P1053, DOI 10.1161/01.RES.0000166926.54293.68; Yui PB, 2008, NAT CHEM BIOL, V4, P33, DOI 10.1038/nchembio.2007.54; Zhang S, 2003, AM J PHYSIOL-LUNG C, V285, pL740, DOI 10.1152/ajplung.00284.2002; Zhang T, 2007, J BIOL CHEM, V282, P33367, DOI 10.1074/jbc.M707186200; Zhao YDD, 2012, AM J PATHOL, V180, P2268, DOI 10.1016/j.ajpath.2012.02.016; Zhao YY, 2009, J CLIN INVEST, V119, P2009, DOI 10.1172/JCI33338; Zuckerbraun BS, 2010, CIRCULATION, V121, P98, DOI 10.1161/CIRCULATIONAHA.109.891077	48	19	19	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2013	288	23					16557	16566		10.1074/jbc.M113.458729	http://dx.doi.org/10.1074/jbc.M113.458729			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	163ZU	23612967	Green Published, hybrid			2022-12-25	WOS:000320378900032
J	Vu, TT; Stafford, AR; Leslie, BA; Kim, PY; Fredenburgh, JC; Weitz, JI				Vu, Trang T.; Stafford, Alan R.; Leslie, Beverly A.; Kim, Paul Y.; Fredenburgh, James C.; Weitz, Jeffrey I.			Batroxobin Binds Fibrin with Higher Affinity and Promotes Clot Expansion to a Greater Extent than Thrombin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VENOM PLASMINOGEN-ACTIVATOR; CRYSTAL-STRUCTURE; GAMMA-CHAIN; SERINE PROTEINASES; MOLECULAR-BASIS; BOUND THROMBIN; ANTITHROMBIN; INHIBITION; EXOSITES; SEQUENCE	Batroxobin is a thrombin-like serine protease from the venom of Bothrops atrox moojeni that clots fibrinogen. In contrast to thrombin, which releases fibrinopeptide A and B from the NH2 terminal domains of the A alpha -and B beta -chains of fibrinogen, respectively, batroxobin only releases fibrinopeptide A. Because the mechanism responsible for these differences is unknown, we compared the interactions of batroxobin and thrombin with the predominant gamma(A)/gamma(A) isoform of fibrin(ogen) and the gamma(A)/gamma' variant with an extended gamma-chain. Thrombin binds to the gamma'-chain and forms a higher affinity interaction with gamma(A)/gamma(A) -fibrin(ogen) than gamma(A)/gamma(A) -fibrin(ogen). In contrast, batroxobin binds both fibrin(ogen) isoforms with similar high affinity (K-d values of about 0.5 mu M) even though it does not interact with the gamma'-chain. The batroxobin-binding sites on fibrin(ogen) only partially overlap with those of thrombin because thrombin attenuates, but does not abrogate, the interaction of gamma(A)/gamma(A)-fibrinogen with batroxobin. Furthermore, although both thrombin and batroxobin bind to the central E-region of fibrinogen with a Kd value of 2-5 mu M, the alpha(17-51) and B beta(1-42) regions bind thrombin but not batroxobin. Once bound to fibrin, the capacity of batroxobin to promote fibrin accretion is 18-fold greater than that of thrombin, a finding that may explain the microvascular thrombosis that complicates envenomation by B. atrox moojeni. Therefore, batroxobin binds fibrin(ogen) in a manner distinct from thrombin, which may contribute to its higher affinity interaction, selective fibrinopeptide A release, and prothrombotic properties.	[Vu, Trang T.; Stafford, Alan R.; Leslie, Beverly A.; Kim, Paul Y.; Fredenburgh, James C.; Weitz, Jeffrey I.] McMaster Univ, Thrombosis & Atherosclerosis Res Inst, Hamilton, ON L8L 2X2, Canada; [Vu, Trang T.; Weitz, Jeffrey I.] McMaster Univ, Dept Med Sci, Hamilton, ON L8L 2X2, Canada; [Stafford, Alan R.; Leslie, Beverly A.; Kim, Paul Y.; Fredenburgh, James C.; Weitz, Jeffrey I.] McMaster Univ, Dept Med, Hamilton, ON L8L 2X2, Canada; [Weitz, Jeffrey I.] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8L 2X2, Canada	McMaster University; McMaster University; McMaster University; McMaster University	Weitz, JI (corresponding author), Thrombosis & Atherosclerosis Res Inst, 237 Barton St E, Hamilton, ON L8L 2X2, Canada.	weitzj@taari.ca	Weitz, Jeffrey/AAD-1929-2019; Kim, Paul/GYV-3258-2022	Weitz, Jeffrey/0000-0002-1092-7550; Kim, Paul/0000-0003-0943-4924	Canadian Institutes of Health Research [MOP 3992, MOP 102735, CTP 79846]; Heart and Stroke Foundation of Ontario [T4792, T4730]; Ontario Research and Development Challenge Fund	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Ontario Research and Development Challenge Fund(General Electric)	This work was supported in part by Canadian Institutes of Health Research Grants MOP 3992, MOP 102735, and CTP 79846, Heart and Stroke Foundation of Ontario Grants T4792 and T4730, and the Ontario Research and Development Challenge Fund.	Adams TE, 2006, ARTERIOSCL THROM VAS, V26, P1738, DOI 10.1161/01.ATV.0000228844.65168.d1; ARONSON DL, 1976, THROMB HAEMOSTASIS, V36, P9, DOI 10.1055/s-0038-1648004; Becker DL, 1999, J BIOL CHEM, V274, P6226, DOI 10.1074/jbc.274.10.6226; BLOMBACK B, 1978, NATURE, V275, P501, DOI 10.1038/275501a0; BODE W, 1989, EMBO J, V8, P3467, DOI 10.1002/j.1460-2075.1989.tb08511.x; Braud S, 2000, BIOCHIMIE, V82, P851, DOI 10.1016/S0300-9084(00)01178-0; Butantan-British Bothrops Systematics Project, 1996, Symposia of the Zoological Society of London, V70, P89; Castro HC, 2004, CELL MOL LIFE SCI, V61, P843, DOI 10.1007/s00018-003-3325-z; CHUNG DW, 1984, BIOCHEMISTRY-US, V23, P4232, DOI 10.1021/bi00313a033; Cooper AV, 2003, BLOOD, V102, P535, DOI 10.1182/blood-2002-10-3150; Di Cera E, 2001, ANN NY ACAD SCI, V936, P133; FORNACE AJ, 1984, J BIOL CHEM, V259, P2826; Fredenburgh JC, 2008, J BIOL CHEM, V283, P2470, DOI 10.1074/jbc.M707710200; Fredenburgh JC, 2004, BIOPHYS CHEM, V112, P277, DOI 10.1016/j.bpc.2004.07.031; Henschen-Edman AH, 1999, THROMB HAEMOSTASIS, V81, P81; Huntington JA, 2005, J THROMB HAEMOST, V3, P1861, DOI 10.1111/j.1538-7836.2005.01363.x; Isbister GK, 2010, SEMIN THROMB HEMOST, V36, P444, DOI 10.1055/s-0030-1254053; KOOPMAN J, 1992, J CLIN INVEST, V90, P238, DOI 10.1172/JCI115841; Kretz CA, 2010, THROMB HAEMOSTASIS, V103, P83, DOI 10.1160/TH09-04-0237; LATALLO ZS, 1983, THROMB HAEMOSTASIS, V50, P604; Liu S, 2011, STROKE, V42, P3277, DOI 10.1161/STROKEAHA.111.622753; LORD ST, 1995, J BIOL CHEM, V270, P24790, DOI 10.1074/jbc.270.42.24790; Lovely LP, 2003, SOUTH MED J, V96, P548, DOI 10.1097/01.SMJ.0000054567.79881.E9; Lovely RS, 2010, CLIN CHEM, V56, P781, DOI 10.1373/clinchem.2009.138347; Maroun RC, 2004, J MOL RECOGNIT, V17, P51, DOI 10.1002/jmr.644; Meh DA, 1996, J BIOL CHEM, V271, P23121, DOI 10.1074/jbc.271.38.23121; Moen JL, 2003, BLOOD, V102, P2466, DOI 10.1182/blood-2003-01-0204; Mosesson MW, 2007, THROMB HAEMOSTASIS, V98, P105, DOI 10.1160/Th07-04-0274; Mosesson MW, 2005, J THROMB HAEMOST, V3, P1894, DOI 10.1111/j.1538-7836.2005.01365.x; Mullin JL, 2000, J BIOL CHEM, V275, P25239, DOI 10.1074/jbc.M004142200; OLEXA SA, 1979, J BIOL CHEM, V254, P4925; Parry MAA, 1998, STRUCT FOLD DES, V6, P1195, DOI 10.1016/S0969-2126(98)00119-1; Pechik I, 2004, P NATL ACAD SCI USA, V101, P2718, DOI 10.1073/pnas.0303440101; Petrera NS, 2009, J BIOL CHEM, V284, P25620, DOI 10.1074/jbc.M109.000042; Pospisil CH, 2003, J BIOL CHEM, V278, P21584, DOI 10.1074/jbc.M300545200; Riedel T, 2011, BLOOD, V117, P1700, DOI 10.1182/blood-2010-08-300301; Rose T, 2003, J BIOL CHEM, V278, P11320, DOI 10.1074/jbc.M211820200; Schaefer AVL, 2006, BIOCHEMISTRY-US, V45, P4257, DOI 10.1021/bi0525730; Serrano SMT, 2005, TOXICON, V45, P1115, DOI 10.1016/j.toxicon.2005.02.020; Stocker K. F., 1998, HEMOSTASIS ANIMAL VE, P525; STONE SR, 1986, BIOCHEMISTRY-US, V25, P4622, DOI 10.1021/bi00364a025; van den Herik EG, 2011, THROMB HAEMOSTASIS, V105, P430, DOI 10.1160/TH10-09-0569; Vu TT, 2011, J BIOL CHEM, V286, P30314, DOI 10.1074/jbc.M111.253831; Wang J, 2010, ANN VASC SURG, V24, P876, DOI 10.1016/j.avsg.2010.03.030; WEISEL JW, 1993, J MOL BIOL, V232, P285, DOI 10.1006/jmbi.1993.1382; WEITZ JI, 1990, J CLIN INVEST, V86, P385, DOI 10.1172/JCI114723; White J, 2005, TOXICON, V45, P951, DOI 10.1016/j.toxicon.2005.02.030; Wolberg AS, 2012, CURR OPIN HEMATOL, V19, P349, DOI 10.1097/MOH.0b013e32835673c2; WOLFENSTEINTODEL C, 1980, P NATL ACAD SCI-BIOL, V77, P5069, DOI 10.1073/pnas.77.9.5069; Xu GL, 2007, BLOOD COAGUL FIBRIN, V18, P193, DOI 10.1097/MBC.0b013e328040c0f2; Zhang Y, 1997, J BIOL CHEM, V272, P20531, DOI 10.1074/jbc.272.33.20531	51	25	28	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2013	288	23					16862	16871		10.1074/jbc.M113.464750	http://dx.doi.org/10.1074/jbc.M113.464750			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	163ZU	23612970	hybrid, Green Published			2022-12-25	WOS:000320378900059
J	Schymeinsky, J; Mayer, H; Tomsic, C; Tilp, C; Schuetz, JD; Cui, YH; Wollin, L; Gantner, F; Erb, KJ				Schymeinsky, Juergen; Mayer, Hannah; Tomsic, Christopher; Tilp, Cornelia; Schuetz, John D.; Cui, Yunhai; Wollin, Lutz; Gantner, Florian; Erb, Klaus J.			The Absence of Mrp4 Has No Effect on the Recruitment of Neutrophils and Eosinophils into the Lung after LPS, Cigarette Smoke or Allergen Challenge	PLOS ONE			English	Article							MULTIDRUG-RESISTANCE PROTEINS; TNF-ALPHA PRODUCTION; PHOSPHODIESTERASE-4 INHIBITOR; AIRWAY HYPERRESPONSIVENESS; IN-VITRO; CAMP; TRANSPORTER; ROFLUMILAST; EXPRESSION; EFFLUX	The multidrug resistance protein 4 (Mrp4) is an ATP-binding cassette transporter that is capable of exporting the second messenger cAMP from cells, a process that might regulate cAMP-mediated anti-inflammatory processes. However, using LPS-or cigarette smoke (CS)-inflammation models, we found that neutrophil numbers in the bronchoalveolar lavage fluid (BALF) were similar in Mrp4(-/-) and Mrp4(+/+) mice treated with LPS or CS. Similarly, neutrophil numbers were not reduced in the BALF of LPS-challenged wt mice after treatment with 10 or 30 mg/kg of the Mrp1/4 inhibitor MK571. The absence of Mrp4 also had no impact on the influx of eosinophils or IL-4 and IL-5 levels in the BALF after OVA airway challenge in mice sensitized with OVA/alum. LPS-induced cytokine release in whole blood ex vivo was also not affected by the absence of Mrp4. These data clearly suggest that Mrp4 deficiency alone is not sufficient to reduce inflammatory processes in vivo. We hypothesized that in combination with PDE4 inhibitors, used at suboptimal concentrations, the anti-inflammatory effect would be more pronounced. However, LPS-induced neutrophil recruitment into the lung was no different between Mrp4(-/-) and Mrp4(+/+) mice treated with 3 mg/kg Roflumilast. Finally, the single and combined administration of 10 and 30 mg/kg MK571 and the specific breast cancer resistance protein (BCRP) inhibitor KO143 showed no reduction of LPS-induced TNF alpha release into the BALF compared to vehicle treated control animals. Similarly, LPS-induced TNFa release in murine whole blood of Mrp4(+/+) or Mrp4(-/-) mice was not reduced by KO143 (1, 10 mu M). Thus, BCRP seems not to be able to compensate for the absence or inhibition of Mrp4 in the used models. Taken together, our data suggest that Mrp4 is not essential for the recruitment of neutrophils into the lung after LPS or CS exposure or of eosinophils after allergen exposure.	[Schymeinsky, Juergen; Mayer, Hannah; Tomsic, Christopher; Tilp, Cornelia; Cui, Yunhai; Wollin, Lutz; Gantner, Florian; Erb, Klaus J.] Boehringer Ingelheim Pharma GmbH & Co KG, Resp Dis Res, Biberach, Germany; [Schuetz, John D.] St Jude Childrens Res Hosp, Dept Pharmaceut Sci, Memphis, TN 38105 USA	Boehringer Ingelheim; St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center	Schymeinsky, J (corresponding author), Boehringer Ingelheim Pharma GmbH & Co KG, Resp Dis Res, Biberach, Germany.	juergen.schymeinsky@boehringer-ingelheim.com	Schuetz, John D/N-2692-2018; Cui, Yunhai/AAP-7670-2021	Cui, Yunhai/0000-0003-4969-072X	National Institutes of Health (NIH) [2R0160904, P30CA21745, CA21865]; American Lebanese Associated Charities (ALSAC); Boehringer-Ingelheim Pharma GmbH Co KG	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lebanese Associated Charities (ALSAC)(American Lebanese Syrian Associated Charities (ALSAC)); Boehringer-Ingelheim Pharma GmbH Co KG(Boehringer Ingelheim)	John Schuetz has been funded by National Institutes of Health (NIH) grants 2R0160904, P30CA21745 and CA21865 and the American Lebanese Associated Charities (ALSAC). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have the following interests. JS, HM, C. Tomsic, C. Tilp, YC, LW, FG and KJE are employees of Boehringer-Ingelheim Pharma GmbH & Co KG which is a research-based pharmaceutical company that discovers, develops, manufactures, and markets prescription medicines for humans and animals. Boehringer-Ingelheim Pharma GmbH & Co KG provided funding for the experiments. Roflumilast was resynthesized at Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany. A semi-automatic cigarette lighter and smoke generator with an electronic timer was used to control the CS exposure (Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany). There are no further patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Allen JD, 2002, MOL CANCER THER, V1, P417; Andonegui G, 2003, J CLIN INVEST, V111, P1011, DOI 10.1172/JCI200316510; Barnes PJ, 2008, NAT REV IMMUNOL, V8, P183, DOI 10.1038/nri2254; Barnette MS, 1998, J PHARMACOL EXP THER, V284, P420; Beavo JA, 2002, NAT REV MOL CELL BIO, V3, P710, DOI 10.1038/nrm911; Beck-Schimmer B, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-61; Bickert T, 2009, INT ARCH ALLERGY IMM, V149, P219, DOI 10.1159/000199717; Borst P, 2000, JNCI-J NATL CANCER I, V92, P1295, DOI 10.1093/jnci/92.16.1295; Chen CA, 2005, BIOCHEM PHARMACOL, V70, P1088, DOI 10.1016/j.bcp.2005.06.019; Chen ZS, 2001, J BIOL CHEM, V276, P33747, DOI 10.1074/jbc.M104833200; Cheng JB, 1997, J PHARMACOL EXP THER, V280, P621; Ci L, 2007, MOL PHARMACOL, V71, P1591, DOI 10.1124/mol.106.031823; Davis TG, 2009, J PHARMACOL EXP THER, V330, P922, DOI 10.1124/jpet.109.152454; de Wolf CJF, 2007, FEBS J, V274, P439, DOI 10.1111/j.1742-4658.2006.05591.x; Duplantier AJ, 1996, J MED CHEM, V39, P120, DOI 10.1021/jm9505066; Essayan DM, 1999, BIOCHEM PHARMACOL, V57, P965, DOI 10.1016/S0006-2952(98)00331-1; Gloerich M, 2010, ANNU REV PHARMACOL, V50, P355, DOI 10.1146/annurev.pharmtox.010909.105714; Hara Y, 2011, J CLIN INVEST, V121, P2888, DOI 10.1172/JCI45023; Hatzelmann A, 2010, PULM PHARMACOL THER, V23, P235, DOI 10.1016/j.pupt.2010.03.011; Herbert C, 2008, CLIN EXP ALLERGY, V38, P847, DOI 10.1111/j.1365-2222.2008.02950.x; Kamenetsky M, 2006, J MOL BIOL, V362, P623, DOI 10.1016/j.jmb.2006.07.045; Kanehiro A, 2001, AM J RESP CRIT CARE, V163, P173, DOI 10.1164/ajrccm.163.1.2001118; Lee RJ, 2010, J CLIN INVEST, V120, P3137, DOI 10.1172/JCI42992; Leggas M, 2004, MOL CELL BIOL, V24, P7612, DOI 10.1128/MCB.24.17.7612-7621.2004; Li CY, 2007, CELL, V131, P940, DOI 10.1016/j.cell.2007.09.037; Lipworth BJ, 2005, LANCET, V365, P167, DOI 10.1016/S0140-6736(05)17708-3; Nies AT, 2004, NEUROSCIENCE, V129, P349, DOI 10.1016/j.neuroscience.2004.07.051; Page CP, 2011, HANDB EXP PHARMACOL, V204, P391, DOI 10.1007/978-3-642-17969-3_17; Peter D, 2011, BRIT J PHARMACOL, V162, P415, DOI 10.1111/j.1476-5381.2010.01035.x; Peters-Golden M, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.275pe37; Pick A, 2010, CHEMMEDCHEM, V5, P1498, DOI 10.1002/cmdc.201000216; Pierre S, 2009, NAT REV DRUG DISCOV, V8, P321, DOI 10.1038/nrd2827; PRABHAKAR U, 1994, INT J IMMUNOPHARMACO, V16, P805, DOI 10.1016/0192-0561(94)90054-X; Proskocil Becky J, 2005, Proc Am Thorac Soc, V2, P305, DOI 10.1513/pats.200504-038SR; Rees DC, 2009, NAT REV MOL CELL BIO, V10, P218, DOI 10.1038/nrm2646; Reid G, 2003, MOL PHARMACOL, V63, P1094, DOI 10.1124/mol.63.5.1094; Russel FGM, 2008, TRENDS PHARMACOL SCI, V29, P200, DOI 10.1016/j.tips.2008.01.006; Sassi Y, 2008, J CLIN INVEST, V118, P2747, DOI 10.1172/JCI35067; Sayner SL, 2011, AM J PHYSIOL-LUNG C, V300, pL667, DOI 10.1152/ajplung.00433.2010; SELDON PM, 1995, MOL PHARMACOL, V48, P747; Takenaka K, 2007, CANCER RES, V67, P6965, DOI 10.1158/0008-5472.CAN-06-4720; Van Aubel RAMH, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133595; van de Ven R, 2008, BLOOD, V112, P2353, DOI 10.1182/blood-2008-03-147850; van de Ven R, 2009, IMMUNOL LETT, V124, P81, DOI 10.1016/j.imlet.2009.04.007; Wollin L, 2006, PULM PHARMACOL THER, V19, P343, DOI 10.1016/j.pupt.2005.09.002; Wollin L, 2010, PULM PHARMACOL THER, V23, P345, DOI 10.1016/j.pupt.2010.03.008	46	3	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2013	8	4							e61193	10.1371/journal.pone.0061193	http://dx.doi.org/10.1371/journal.pone.0061193			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JR	23613808	Green Published, gold, Green Submitted			2022-12-25	WOS:000317911500022
J	Zhou, M; Rong, RC; Munro, D; Zhu, CX; Gao, X; Zhang, Q; Dong, QF				Zhou, Mi; Rong, Ruichen; Munro, Daniel; Zhu, Chunxia; Gao, Xiang; Zhang, Qi; Dong, Qunfeng			Investigation of the Effect of Type 2 Diabetes Mellitus on Subgingival Plaque Microbiota by High-Throughput 16S rDNA Pyrosequencing	PLOS ONE			English	Article							PUTATIVE PERIODONTAL PATHOGENS; INFLAMMATORY CYTOKINES; BACTERIAL DIVERSITY; JUVENILE DIABETICS; GLYCEMIC CONTROL; DENTAL-CARIES; DISEASE; PROFILES; PERIODONTOPATHOGENS; CAPNOCYTOPHAGA	Diabetes mellitus is a major risk factor for chronic periodontitis. We investigated the effects of type 2 diabetes on the subgingival plaque bacterial composition by applying culture-independent 16S rDNA sequencing to periodontal bacteria isolated from four groups of volunteers: non-diabetic subjects without periodontitis, non-diabetic subjects with periodontitis, type 2 diabetic patients without periodontitis, and type 2 diabetic patients with periodontitis. A total of 71,373 high-quality sequences were produced from the V1-V3 region of 16S rDNA genes by 454 pyrosequencing. Those 16S rDNA sequences were classified into 16 phyla, 27 classes, 48 orders, 85 families, 126 genera, and 1141 species-level OTUs. Comparing periodontally healthy samples with periodontitis samples identified 20 health-associated and 15 periodontitis-associated OTUs. In the subjects with healthy periodontium, the abundances of three genera (Prevotella, Pseudomonas, and Tannerella) and nine OTUs were significantly different between diabetic patients and their non-diabetic counterparts. In the subjects carrying periodontitis, the abundances of three phyla (Actinobacteria, Proteobacteria, and Bacteriodetes), two genera (Actinomyces and Aggregatibacter), and six OTUs were also significantly different between diabetics and non-diabetics. Our results show that type 2 diabetes mellitus could alter the bacterial composition in the subgingival plaque.	[Zhou, Mi; Zhu, Chunxia; Zhang, Qi] Wuhan Univ, State Key Lab Breeding Base Basic Sci Stomatol, Key Lab Oral Biomed, Minist Educ,Sch & Hosp Stomatol, Wuhan 430072, Hubei, Peoples R China; [Rong, Ruichen; Munro, Daniel; Gao, Xiang; Dong, Qunfeng] Univ N Texas, Dept Biol Sci, Denton, TX 76203 USA; [Zhang, Qi] Tongji Univ, Dept Endodont, Shanghai 200092, Peoples R China; [Dong, Qunfeng] Univ N Texas, Dept Comp Sci & Engn, Denton, TX 76203 USA	Wuhan University; University of North Texas System; University of North Texas Denton; Tongji University; University of North Texas System; University of North Texas Denton	Zhang, Q (corresponding author), Wuhan Univ, State Key Lab Breeding Base Basic Sci Stomatol, Key Lab Oral Biomed, Minist Educ,Sch & Hosp Stomatol, Wuhan 430072, Hubei, Peoples R China.	qizhang@tongji.edu.cn; Qunfeng.Dong@unt.edu		Munro, Daniel/0000-0002-0724-218X	National Natural Science Foundation of China [81070824]; Fundamental Research Funds for the Central Universities; Wuhan University [201001304275580]; Research Initiation Grant at University of North Texas; Howard Hughes Medical Institute	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Wuhan University; Research Initiation Grant at University of North Texas; Howard Hughes Medical Institute(Howard Hughes Medical Institute)	Funding for this study was provided by the National Natural Science Foundation of China (Grant No. 81070824), the Fundamental Research Funds for the Central Universities, and the PhD Candidates Self-research (Including 1+4) Program of Wuhan University (No. 201001304275580), the Research Initiation Grant at University of North Texas, and the undergraduate student research training grant to the University of North Texas from the Howard Hughes Medical Institute through the Precollege and Undergraduate Science Education Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022788; Alexandraki K, 2006, ANN NY ACAD SCI, V1084, P89, DOI 10.1196/annals.1372.039; Ashimoto A, 1996, ORAL MICROBIOL IMMUN, V11, P266, DOI 10.1111/j.1399-302X.1996.tb00180.x; Campus G, 2005, J PERIODONTOL, V76, P418, DOI 10.1902/jop.2005.76.3.418; Casarin RC, 2012, J PERIODONTAL RES; Chen T, 2010, DATABASE-OXFORD, DOI 10.1093/database/baq013; Colombo APV, 2012, J PERIODONTOL, V83, P1279, DOI 10.1902/jop.2012.110566; Colombo APV, 2009, J PERIODONTOL, V80, P1421, DOI 10.1902/jop.2009.090185; Dong Q, 2011, INVEST OPHTHALMOL VI; Dong QF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019709; Ebersole JL, 2008, J PERIODONTOL, V79, P637, DOI [10.1902/jop.2008.070455, 10.1902/jop.2008.070455 ]; Fettweis JM, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S8-S17; FICARA AJ, 1975, J PERIODONTAL RES, V10, P171, DOI 10.1111/j.1600-0765.1975.tb00022.x; Field CA, 2012, J PERIODONTAL RES, V47, P470, DOI 10.1111/j.1600-0765.2011.01455.x; Graves DT, 2011, J DENT RES, V90, P143, DOI 10.1177/0022034510385236; Griffen AL, 2012, ISME J, V6, P1176, DOI 10.1038/ismej.2011.191; Haffajee AD, 2004, J CLIN PERIODONTOL, V31, P996, DOI 10.1111/j.1600-051X.2004.00597.x; Hartroth B, 1999, ORAL MICROBIOL IMMUN, V14, P326, DOI 10.1034/j.1399-302X.1999.140510.x; Hawlena H, 2012, ISME J; Hintao J, 2007, ORAL MICROBIOL IMMUN, V22, P175, DOI 10.1111/j.1399-302X.2007.00341.x; HOLDEMAN LV, 1985, J PERIODONTAL RES, V20, P475, DOI 10.1111/j.1600-0765.1985.tb00830.x; Holt SC, 2005, PERIODONTOL 2000, V38, P72, DOI 10.1111/j.1600-0757.2005.00113.x; Hooda S, 2012, J NUTR, V142, P1259, DOI 10.3945/jn.112.158766; Human Microbiome Project Consortium, 2012, Nature, V486, P207, DOI 10.1038/nature11234; Johnson M, 2008, NUCLEIC ACIDS RES, V36, pW5, DOI 10.1093/nar/gkn201; Kardesler L, 2011, INFLAMM RES, V60, P143, DOI 10.1007/s00011-010-0248-7; Karima M, 2005, J LEUKOCYTE BIOL, V78, P862, DOI 10.1189/jlb.1004583; Kim TS, 2009, ARCH ORAL BIOL, V54, P223, DOI 10.1016/j.archoralbio.2008.10.005; King GL, 2008, J PERIODONTOL, V79, P1527, DOI 10.1902/jop.2008.080246; Kumar PS, 2005, J CLIN MICROBIOL, V43, P3944, DOI 10.1128/JCM.43.8.3944-3955.2005; Kumar PS, 2003, J DENT RES, V82, P338, DOI 10.1177/154405910308200503; Kumar PS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020956; Kunin V, 2010, ENVIRON MICROBIOL, V12, P118, DOI 10.1111/j.1462-2920.2009.02051.x; Lakschevitz F, 2011, CURR DIABETES REV, V7, P433, DOI 10.2174/157339911797579205; Lalla E, 2000, PERIODONTOL 2000, V23, P50, DOI 10.1034/j.1600-0757.2000.2230104.x; Lalla E, 2006, J CLIN PERIODONTOL, V33, P855, DOI 10.1111/j.1600-051X.2006.00996.x; Lalla E, 2011, NAT REV ENDOCRINOL, V7, P738, DOI 10.1038/nrendo.2011.106; Lazarevic V, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-523; Li C, 2012, J PERIODONTOL; Liljemark WF, 1996, CRIT REV ORAL BIOL M, V7, P180, DOI 10.1177/10454411960070020601; Liu B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037919; LOE H, 1993, DIABETES CARE, V16, P329, DOI 10.2337/diacare.16.1.329; Lozupone C, 2011, ISME J, V5, P169, DOI 10.1038/ismej.2010.133; Marette A, 2004, NES NUTR WS, V9, P141, DOI 10.1159/000080650; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; MASHIMO PA, 1983, J PERIODONTOL, V54, P420, DOI 10.1902/jop.1983.54.7.420; McMurdie PJ, 2012, BIOCOMPUT-PAC SYM, P235; Mealey BL, 2006, J PERIODONTOL, V77, P1289, DOI 10.1902/jop.2006.050459; Moter A, 1998, J CLIN MICROBIOL, V36, P1399, DOI 10.1128/JCM.36.5.1399-1403.1998; Nadkarni MA, 2012, EUR J CLIN MICROBIOL, V31, P2989, DOI 10.1007/s10096-012-1651-5; NELSON RG, 1990, DIABETES CARE, V13, P836, DOI 10.2337/diacare.13.8.836; Ohlrich Edward J, 2010, J Oral Microbiol, V2, DOI 10.3402/jom.v2i0.5818; Ohnishi T, 2009, J PERIODONTAL RES, V44, P43, DOI 10.1111/j.1600-0765.2007.01060.x; Oksanen J., 2017, R PACKAGE VERSION 26; Paster BJ, 2001, J BACTERIOL, V183, P3770, DOI 10.1128/JB.183.12.3770-3783.2001; Paster BJ, 2006, PERIODONTOL 2000, V42, P80, DOI 10.1111/j.1600-0757.2006.00174.x; Pihlstrom BL, 2005, LANCET, V366, P1809, DOI 10.1016/S0140-6736(05)67728-8; Preshaw PM, 2012, DIABETOLOGIA, V55, P21, DOI 10.1007/s00125-011-2342-y; Quast Christian, 2013, Nucleic Acids Res, V41, pD590, DOI 10.1093/nar/gks1219; Quince C, 2009, NAT METHODS, V6, P639, DOI [10.1038/NMETH.1361, 10.1038/nmeth.1361]; Salvi GE, 1997, J CLIN PERIODONTOL, V24, P8, DOI 10.1111/j.1600-051X.1997.tb01178.x; Salvi GE, 1997, J PERIODONTOL, V68, P127, DOI 10.1902/jop.1997.68.2.127; Sardi JCO, 2011, ARCH ORAL BIOL, V56, P1098, DOI 10.1016/j.archoralbio.2011.03.017; Sbordone L, 1998, J PERIODONTOL, V69, P120, DOI 10.1902/jop.1998.69.2.120; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Shaddox LM, 2012, J DENT RES, V91, P927, DOI 10.1177/0022034512456039; SHLOSSMAN M, 1990, J AM DENT ASSOC, V121, P532, DOI 10.14219/jada.archive.1990.0211; Shumway M, 2010, NUCLEIC ACIDS RES, V38, pD870, DOI 10.1093/nar/gkp1078; Socransky SS, 2005, PERIODONTOL 2000, V38, P135, DOI 10.1111/j.1600-0757.2005.00107.x; SOCRANSKY SS, 1979, ARCH MICROBIOL, V122, P29, DOI 10.1007/BF00408042; Socransky SS, 1998, J CLIN PERIODONTOL, V25, P134, DOI 10.1111/j.1600-051X.1998.tb02419.x; STACKEBRANDT E, 1994, INT J SYST BACTERIOL, V44, P846, DOI 10.1099/00207713-44-4-846; Tanner A C, 1986, Oral Microbiol Immunol, V1, P15; Taylor GW, 2008, ORAL DIS, V14, P191, DOI 10.1111/j.1601-0825.2008.01442.x; Taylor G W, 2001, Ann Periodontol, V6, P99, DOI 10.1902/annals.2001.6.1.99; Taylor GW, 1996, J PERIODONTOL, V67, P1085, DOI 10.1902/jop.1996.67.10s.1085; THORSTENSSON H, 1995, J CLIN PERIODONTOL, V22, P449, DOI 10.1111/j.1600-051X.1995.tb00176.x; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wolfe AJ, 2012, J CLIN MICROBIOL, V50, P1376, DOI 10.1128/JCM.05852-11; Yuan K, 2001, J PERIODONTAL RES, V36, P18, DOI 10.1034/j.1600-0765.2001.90613.x	80	78	86	2	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2013	8	4							e61516	10.1371/journal.pone.0061516	http://dx.doi.org/10.1371/journal.pone.0061516			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JR	23613868	Green Submitted, Green Published, gold			2022-12-25	WOS:000317911500045
J	Holmes, EH; Devalapally, H; Li, LB; Perdue, ML; Ostrander, GK				Holmes, Eric H.; Devalapally, Harikrishna; Li, Libin; Perdue, Michael L.; Ostrander, Gary K.			Permeability Enhancers Dramatically Increase Zanamivir Absolute Bioavailability in Rats: Implications for an Orally Bioavailable Influenza Treatment	PLOS ONE			English	Article							NEURAMINIDASE INHIBITORS; DESIGN; POTENT; PRODRUG	We have demonstrated that simple formulations composed of the parent drug in combination with generally regarded as safe (GRAS) permeability enhancers are capable of dramatically increasing the absolute bioavailability of zanamivir. This has the advantage of not requiring modification of the drug structure to promote absorption, thus reducing the regulatory challenges involved in conversion of an inhaled to oral route of administration of an approved drug. Absolute bioavailability increases of up to 24-fold were observed when Capmul MCM L8 (composed of mono-and diglycerides of caprylic/capric acids in glycerol) was mixed with 1.5 mg of zanamivir and administered intraduodenally to rats. Rapid uptake (t(max) of 5 min) and a C-max of over 7200 ng/mL was achieved. Variation of the drug load or amount of enhancer demonstrated a generally linear variation in absorption, indicating an ability to optimize a formulation for a desired outcome such as a targeted C-max for enzyme saturation. No absorption enhancement was observed when the enhancer was given 2 hr prior to drug administration, indicating, in combination with the observed t(max), that absorption enhancement is temporary. This property is significant and aligns well with therapeutic applications to limit undesirable drug-drug interactions, potentially due to the presence of other poorly absorbed polar drugs. These results suggest that optimal human oral dosage forms of zanamivir should be enteric-coated gelcaps or softgels for intraduodenal release. There continues to be a strong need and market for multiple neuraminidase inhibitors for influenza treatment. Creation of orally available formulations of inhibitor drugs that are currently administered intravenously or by inhalation would provide a significant improvement in treatment of influenza. The very simple GRAS formulation components and anticipated dosage forms would require low manufacturing costs and yield enhanced convenience. These results are being utilized to design prototype dosage forms for initial human pharmacokinetic studies.	[Holmes, Eric H.; Ostrander, Gary K.] Univ Hawaii, John A Burns Sch Med, Dept Cell & Mol Biol, Honolulu, HI 96822 USA; [Devalapally, Harikrishna; Li, Libin] Absorpt Syst LP, Exton, PA USA; [Perdue, Michael L.] FluSolut Consulting LLC, Hilo, HI USA	University of Hawaii System	Holmes, EH (corresponding author), Univ Hawaii, John A Burns Sch Med, Dept Cell & Mol Biol, Honolulu, HI 96822 USA.	eholmes3@hawaii.edu			National Center for Research Resources (NCRR) [P20RR016467]; National Institute of General Medical Sciences (NIGMS) [P20GM103466]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016467] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103466] Funding Source: NIH RePORTER	National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	EHH is supported in part by National Center for Research Resources (NCRR) Grant P20RR016467 and National Institute of General Medical Sciences (NIGMS) Grant P20GM103466. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki FY, 1999, CLIN PHARMACOKINET, V36, pV; Babu YS, 2000, J MED CHEM, V43, P3482, DOI 10.1021/jm0002679; Cass LMR, 1999, CLIN PHARMACOKINET, V36, P1, DOI 10.2165/00003088-199936001-00001; Centers for Disease Control and Prevention, 2009, 2008 2009 INFL SEAS; Chand P, 1997, J MED CHEM, V40, P4030, DOI 10.1021/jm970479e; COLMAN PM, 1994, PROTEIN SCI, V3, P1687, DOI 10.1002/pro.5560031007; Garcia-Sosa AT, 2008, J CHEM INF MODEL, V48, P2074, DOI 10.1021/ci800242z; Garman E., 2005, VIRAL MEMBRANE PROTE; Gupta SV, 2011, MOL PHARMACEUT, V8, P2358, DOI 10.1021/mp200291x; Kim CU, 1997, J AM CHEM SOC, V119, P681, DOI 10.1021/ja963036t; Li WX, 1998, ANTIMICROB AGENTS CH, V42, P647, DOI 10.1128/AAC.42.3.647; Liu KC, 2011, BIOORGAN MED CHEM, V19, P4796, DOI 10.1016/j.bmc.2011.06.080; Mendel DB, 1998, ANTIMICROB AGENTS CH, V42, P640, DOI 10.1128/AAC.42.3.640; Miller JM, 2010, MOL PHARMACEUT, V7, P1223, DOI 10.1021/mp100050d; Moscona A, 2005, NEW ENGL J MED, V353, P1363, DOI 10.1056/NEJMra050740; Nicholls H, 2006, PLOS BIOL, V4, P156, DOI 10.1371/journal.pbio.0040050; Russell RJ, 2006, NATURE, V443, P45, DOI 10.1038/nature05114; Sudbeck EA, 1997, J MOL BIOL, V267, P584, DOI 10.1006/jmbi.1996.0885; Varghese JN, 1998, STRUCT FOLD DES, V6, P735, DOI 10.1016/S0969-2126(98)00075-6; VONITZSTEIN M, 1993, NATURE, V363, P418, DOI 10.1038/363418a0	20	12	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2013	8	4							e61853	10.1371/journal.pone.0061853	http://dx.doi.org/10.1371/journal.pone.0061853			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IK	23613954	gold, Green Submitted, Green Published			2022-12-25	WOS:000317907200094
J	Plotnik, JM; Pokorny, JJ; Keratimanochaya, T; Webb, C; Beronja, HF; Hennessy, A; Hill, J; Hill, VJ; Kiss, R; Maguire, C; Melville, BL; Morrison, VMB; Seecoomar, D; Singer, B; Ukehaxhaj, J; Vlahakis, SK; Ylli, D; Clayton, NS; Roberts, J; Fure, EL; Duchatelier, AP; Getz, D				Plotnik, Joshua M.; Pokorny, Jennifer J.; Keratimanochaya, Titiporn; Webb, Christine; Beronja, Hana F.; Hennessy, Alice; Hill, James; Hill, Virginia J.; Kiss, Rebecca; Maguire, Caitlin; Melville, Beckett L.; Morrison, Violet M. B.; Seecoomar, Dannah; Singer, Benjamin; Ukehaxhaj, Jehona; Vlahakis, Sophia K.; Ylli, Dora; Clayton, Nicola S.; Roberts, John; Fure, Emilie L.; Duchatelier, Alicia P.; Getz, David			Visual Cues Given by Humans Are Not Sufficient for Asian Elephants (Elephas maximus) to Find Hidden Food	PLOS ONE			English	Article							EXPERIMENTER-GIVEN CUES; CHIMPANZEES PAN-TROGLODYTES; OBJECT-CHOICE TASKS; ORANGUTANS PONGO-PYGMAEUS; GORILLAS GORILLA-GORILLA; CONSPECIFIC SOCIAL CUES; HUMAN POINTING GESTURES; DOGS CANIS-FAMILIARIS; FACIAL CUES; COMPREHENSION	Recent research suggests that domesticated species - due to artificial selection by humans for specific, preferred behavioral traits - are better than wild animals at responding to visual cues given by humans about the location of hidden food. Although this seems to be supported by studies on a range of domesticated (including dogs, goats and horses) and wild (including wolves and chimpanzees) animals, there is also evidence that exposure to humans positively influences the ability of both wild and domesticated animals to follow these same cues. Here, we test the performance of Asian elephants (Elephas maximus) on an object choice task that provides them with visual-only cues given by humans about the location of hidden food. Captive elephants are interesting candidates for investigating how both domestication and human exposure may impact cue-following as they represent a non-domesticated species with almost constant human interaction. As a group, the elephants (n = 7) in our study were unable to follow pointing, body orientation or a combination of both as honest signals of food location. They were, however, able to follow vocal commands with which they were already familiar in a novel context, suggesting the elephants are able to follow cues if they are sufficiently salient. Although the elephants' inability to follow the visual cues provides partial support for the domestication hypothesis, an alternative explanation is that elephants may rely more heavily on other sensory modalities, specifically olfaction and audition. Further research will be needed to rule out this alternative explanation.	[Plotnik, Joshua M.; Clayton, Nicola S.] Univ Cambridge, Dept Psychol, Cambridge, England; [Plotnik, Joshua M.; Pokorny, Jennifer J.; Webb, Christine] Think Elephants Int, Stone Ridge, NY USA; [Plotnik, Joshua M.; Keratimanochaya, Titiporn; Roberts, John] Golden Triangle Asian Elephant Fdn, Chiang Saen, Chiang Rai, Thailand; [Pokorny, Jennifer J.] Univ Calif Davis, Ctr Mind & Brain, Davis, CA 95616 USA; [Webb, Christine] Columbia Univ, Dept Psychol, New York, NY 10027 USA; [Beronja, Hana F.; Hennessy, Alice; Hill, James; Hill, Virginia J.; Kiss, Rebecca; Maguire, Caitlin; Melville, Beckett L.; Morrison, Violet M. B.; Seecoomar, Dannah; Singer, Benjamin; Ukehaxhaj, Jehona; Vlahakis, Sophia K.; Ylli, Dora; Fure, Emilie L.; Duchatelier, Alicia P.; Getz, David] East Side Middle Sch, New York, NY USA	University of Cambridge; University of California System; University of California Davis; Columbia University	Plotnik, JM (corresponding author), Univ Cambridge, Dept Psychol, Cambridge, England.	Joshua.Plotnik@gmail.com		Plotnik, Joshua/0000-0002-7597-8818; Pokorny, Jennifer/0000-0001-8940-288X; Clayton, Nicola/0000-0003-1835-423X	Royal Society; British Academy; Minor International	Royal Society(Royal Society of London); British Academy; Minor International	JMP was supported by a Newton International Fellowship from the Royal Society and the British Academy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the mahouts and staff at GTAEF for their care of the elephants, as well as W.E. Heinecke and Minor International for supporting our research program. We also thank the National Research Council of Thailand (P. Panyawattanaporn and A. Vijit) for providing permission to conduct our work. This study was conducted as part of a new STEM learning initiative created by Think Elephants International, a non-profit foundation dedicated to giving young students an opportunity to become involved with scientific research as co-authors rather than as subjects or observers, participating in hypothesis development, experimental design, data analysis, and discussion. This study represents a collaboration between academics and middle school students and teachers aimed at promoting the study of animal behavior as a complement to endangered species conservation practice (http://www.thinkelephants.org).	Agnetta B., 2000, ANIMAL COGNITION, V3, P107, DOI [10.1007/s100710000070, DOI 10.1007/S100710000070, DOI 10.1177/0963721416667718]; ANDERSON JR, 1995, ANIM BEHAV, V49, P201, DOI 10.1016/0003-3472(95)80168-5; Arvidsson J, 2012, PHYSIOL BEHAV, V105, P809, DOI 10.1016/j.physbeh.2011.08.021; Barth J, 2005, ANIM COGN, V8, P84, DOI 10.1007/s10071-004-0235-x; Behne T, 2005, DEVELOPMENTAL SCI, V8, P492, DOI 10.1111/j.1467-7687.2005.00440.x; Byrnit JT, 2009, ANIM COGN, V12, P401, DOI 10.1007/s10071-008-0200-1; Byrnit JT, 2004, J COMP PSYCHOL, V118, P309, DOI 10.1037/0735-7036.118.3.309; Call J, 2004, J COMP PSYCHOL, V118, P232, DOI 10.1037/0735-7036.118.2.232; Call Josep, 1996, P371; Call J, 2000, ANIM COGN, V3, P23, DOI 10.1007/s100710050047; Call Josep., 2005, JOINT ATTENTION COMM, P45, DOI [10.1093/acprof:oso/9780199245635.003.0003, DOI 10.1093/ACPROF:OSO/9780199245635.003.0003]; Castellan NJ, 1988, NONPARAMETRIC STAT B; de Silva Shermin, 2011, BMC Ecology, V11, P17, DOI 10.1186/1472-6785-11-17; de Silva S, 2010, BEHAVIOUR, V147, P825, DOI 10.1163/000579510X495762; Douglas-Hamilton I., 1975, ELEPHANTS; Giret N, 2009, ANIM COGN, V12, P1, DOI 10.1007/s10071-008-0163-2; Hare B, 2005, TRENDS COGN SCI, V9, P439, DOI 10.1016/j.tics.2005.07.003; Hare B, 2005, CURR BIOL, V15, P226, DOI 10.1016/j.cub.2005.01.040; Hare B, 1999, J COMP PSYCHOL, V113, P173, DOI 10.1037/0735-7036.113.2.173; Hare B, 2001, Anim Cogn, V4, P269, DOI 10.1007/s100710100084; Hare B, 2002, SCIENCE, V298, P1634, DOI 10.1126/science.1072702; Herman LM, 1999, J COMP PSYCHOL, V113, P347, DOI 10.1037/0735-7036.113.4.347; Itakura S, 1996, CAH PSYCHOL COGN, V15, P103; Itakura S, 1998, J COMP PSYCHOL, V112, P119, DOI 10.1037/0735-7036.112.2.119; Kaminski J, 2005, ANIM BEHAV, V69, P11, DOI 10.1016/j.anbehav.2004.05.008; Lair R.C., 1997, GONE ASTRAY CARE MAN; LEUNG EHL, 1981, DEV PSYCHOL, V17, P215, DOI 10.1037/0012-1649.17.2.215; Lyn H, 2010, PSYCHOL SCI, V21, P360, DOI 10.1177/0956797610362218; Maros K, 2008, ANIM COGN, V11, P457, DOI 10.1007/s10071-008-0136-5; McComb K, 2000, ANIM BEHAV, V59, P1103, DOI 10.1006/anbe.2000.1406; Miklosi A, 2005, J COMP PSYCHOL, V119, P179, DOI 10.1037/0735-7036.119.2.179; Miklosi A, 2003, CURR BIOL, V13, P763, DOI 10.1016/S0960-9822(03)00263-X; Miklosi A, 1998, Anim Cogn, V1, P113, DOI 10.1007/s100710050016; Miklosi A, 2006, ANIM COGN, V9, P81, DOI 10.1007/s10071-005-0008-1; Moss C, 2012, AMBOSELI ELEPHANTS L; Mulcahy NJ, 2012, ANIM BEHAV, V83, P313, DOI 10.1016/j.anbehav.2011.11.019; Mulcahy NJ, 2009, J COMP PSYCHOL, V123, P304, DOI 10.1037/a0016222; Neiworth JJ, 2002, J COMP PSYCHOL, V116, P3, DOI 10.1037//0735-7036.116.1.3; Payne K, 2003, ANIMAL SOCIAL COMPLEXITY, P57; Peignot P, 1999, J COMP PSYCHOL, V113, P253, DOI 10.1037/0735-7036.113.3.253; Plotnik JM, 2006, P NATL ACAD SCI USA, V103, P17053, DOI 10.1073/pnas.0608062103; Plotnik JM, 2011, P NATL ACAD SCI USA, V108, P5116, DOI 10.1073/pnas.1101765108; Poole J.H., 1996, COMING AGE ELEPHANTS; Povinelli DJ, 1997, BRIT J DEV PSYCHOL, V15, P213, DOI 10.1111/j.2044-835X.1997.tb00735.x; Povinelli DJ, 1997, COGNITIVE DEV, V12, P327, DOI 10.1016/S0885-2014(97)90017-4; Proops L, 2010, ANIM BEHAV, V79, P1205, DOI 10.1016/j.anbehav.2010.02.015; Scheumann M, 2004, ANIM COGN, V7, P224, DOI 10.1007/s10071-004-0216-0; Schulte BA, 2000, ZOO BIOL, V19, P447, DOI 10.1002/1098-2361(2000)19:5&lt;447::AID-ZOO12&gt;3.0.CO;2-#; Smith BP, 2010, ANIM COGN, V13, P367, DOI 10.1007/s10071-009-0287-z; Sukumar R, 2003, LIVING ELEPHANTS EVO, Vxv; Tebbich S, 2007, ANIM COGN, V10, P225, DOI 10.1007/s10071-006-0061-4; Tornick JK, 2011, ANIM COGN, V14, P117, DOI 10.1007/s10071-010-0349-2; Tschudin A, 2001, J COMP PSYCHOL, V115, P100, DOI 10.1037//0735-7036.115.1.100; Udell M.A., 2008, ANIM BEHAV, V76, P1767, DOI DOI 10.1016/j.anbehav.2008.07.028; Viranyi Z, 2008, ANIM COGN, V11, P373, DOI 10.1007/s10071-007-0127-y; von Bayern AMP, 2009, CURR BIOL, V19, P602, DOI 10.1016/j.cub.2009.02.062	56	23	24	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2013	8	4							e61174	10.1371/journal.pone.0061174	http://dx.doi.org/10.1371/journal.pone.0061174			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IK	23613804	Green Published, gold, Green Submitted			2022-12-25	WOS:000317907200034
J	Song, MY; Su, HJ; Zhang, L; Ma, JL; Li, JY; Pan, KF; You, WC				Song, Ming-yang; Su, Hui-juan; Zhang, Lian; Ma, Jun-ling; Li, Ji-you; Pan, Kai-feng; You, Wei-cheng			Genetic Polymorphisms of miR-146a and miR-27a, H. pylori Infection, and Risk of Gastric Lesions in a Chinese Population	PLOS ONE			English	Article							INTESTINAL EPITHELIAL-CELLS; BREAST-CANCER CELLS; KAPPA-B; FUNCTIONAL POLYMORPHISM; MICRORNA NETWORKS; OXIDATIVE STRESS; EXPRESSION; PROHIBITIN; CARCINOMA; VARIANTS	Background: MicroRNAs (miRNAs) have been implicated in various human diseases. Single nucleotide polymorphisms SNPs) in inflammation-related miRNA may play an important role in Helicobacter pylori (H. pylori)-induced gastric lesions. To evaluate the associations between miRNA SNPs, H. pylori and gastric lesions, a population-based study was conducted in Linqu County, China. Methodology/Principal Findings: Based on serum miRNA array conducted in this population, two SNP loci (miR-146a rs2910164: G>C and miR-27a rs895819: T>C) were determined by polymerase chain reaction-restriction fragment length polymorphism in 2,380 participants with diverse gastric lesions. Using participants with superficial gastritis and mild chronic atrophic gastritis as the reference group, we found that rs2910164 CC carriers had a significantly increased risk of intestinal metaplasia [adjusted odds ratio (OR), 1.42; 95% confidence interval (CI), 1.03-1.97] and dysplasia (OR, 1.54; 95% CI, 1.05-2.25) compared to GG carriers, whereas no significant association was observed for rs895819. Stratified analysis by H. pylori infection indicated that rs2910164 C allele was associated with an increased risk of intestinal metaplasia and dysplasia only among individuals infected with H. pylori (CC vs. GG: OR, 1.53; 95% CI, 1.12-2.08, P for trend = 0.004). Participants who simultaneously carried variant alleles and H. pylori infection were more likely to develop intestinal metaplasia and dysplasia, although the interaction between genetic variants and H. pylori infection was not significant (P for interaction = 0.35 for rs2910164 and 0.92 for rs895819). Conclusions/Significance: These findings suggest that miR-146a rs2910164 polymorphism may contribute to the evolution of H. pylori-associated gastric lesions in this high-risk population.	[Song, Ming-yang; Su, Hui-juan; Zhang, Lian; Ma, Jun-ling; Pan, Kai-feng; You, Wei-cheng] Peking Univ, Canc Hosp & Inst, Dept Canc Epidemiol, Key Lab Carcinogenesis & Translat Res,Minist Educ, Beijing 100871, Peoples R China; [Li, Ji-you] Peking Univ, Canc Hosp & Inst, Dept Pathol, Beijing 100871, Peoples R China	Peking University; Peking University	Pan, KF (corresponding author), Peking Univ, Canc Hosp & Inst, Dept Canc Epidemiol, Key Lab Carcinogenesis & Translat Res,Minist Educ, Beijing 100871, Peoples R China.	pankaifeng2002@yahoo.com; weichengyou@yahoo.com		Pan, Kai-feng/0000-0002-3680-3126	National Basic Research Program of China (973 Program) [010CB529303]; A3 Foresight Program from Natural Science Foundation of China [30921140311]; National Natural Science Foundation of China [81171989]; Key International S&T Cooperation Project [2010DFB30310]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); A3 Foresight Program from Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key International S&T Cooperation Project	This work was supported by grants from the National Basic Research Program of China (973 Program: 2010CB529303), A3 Foresight Program from Natural Science Foundation of China (30921140311), National Natural Science Foundation of China (81171989), and the Key International S&T Cooperation Project (2010DFB30310). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn DH, 2012, MOL CARCINOGENESIS; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Alvarez-Garcia I, 2005, DEVELOPMENT, V132, P4653, DOI 10.1242/dev.02073; Arisawa T, 2007, DIGEST DIS SCI, V52, P1691, DOI 10.1007/s10620-006-9648-5; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bhaumik D, 2008, ONCOGENE, V27, P5643, DOI 10.1038/onc.2008.171; CORREA P, 1988, CANCER RES, V48, P3554; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Furukawa-Hibi Y, 2002, J BIOL CHEM, V277, P26729, DOI 10.1074/jbc.C200256200; Gonzalez CA, 2002, INT J CANCER, V100, P249, DOI 10.1002/ijc.10466; Guo H, 2010, FAM CANCER, V9, P599, DOI 10.1007/s10689-010-9370-5; Guttilla IK, 2009, J BIOL CHEM, V284, P23204, DOI 10.1074/jbc.M109.031427; Jazdzewski K, 2008, P NATL ACAD SCI USA, V105, P7269, DOI 10.1073/pnas.0802682105; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Liu T, 2009, CANCER LETT, V273, P233, DOI 10.1016/j.canlet.2008.08.003; Liu Z, 2010, MICROBES INFECT, V12, P854, DOI 10.1016/j.micinf.2010.06.002; Lu WL, 2005, CARCINOGENESIS, V26, P631, DOI 10.1093/carcin/bgh349; Ma YH, 2010, CANCER LETT, V298, P150, DOI 10.1016/j.canlet.2010.06.012; Okubo M, 2010, HELICOBACTER, V15, P524, DOI 10.1111/j.1523-5378.2010.00806.x; PARSONNET J, 1991, NEW ENGL J MED, V325, P1127, DOI 10.1056/NEJM199110173251603; Ryan BM, 2010, NAT REV CANCER, V10, P389, DOI 10.1038/nrc2867; Sharma A, 2004, P NATL ACAD SCI USA, V101, P17492, DOI 10.1073/pnas.0407536101; Song MY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033608; Sun QM, 2010, CANCER SCI, V101, P2241, DOI 10.1111/j.1349-7006.2010.01667.x; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Theiss AL, 2007, FASEB J, V21, P197, DOI 10.1096/fj.06-6801com; Theiss AL, 2009, MOL BIOL CELL, V20, P4412, DOI 10.1091/mbc.E09-05-0361; Theiss AL, 2009, GASTROENTEROLOGY, V137, P199, DOI 10.1053/j.gastro.2009.03.033; Wang J, 2012, MOL BIOL REP, V39, P4571, DOI 10.1007/s11033-011-1247-7; Xu B, 2010, PROSTATE, V70, P467, DOI 10.1002/pros.21080; Xu T, 2008, CARCINOGENESIS, V29, P2126, DOI 10.1093/carcin/bgn195; Yang Q, 2012, ONCOGENE; You WC, 1999, INT J CANCER, V83, P615, DOI 10.1002/(SICI)1097-0215(19991126)83:5&lt;615::AID-IJC8&gt;3.0.CO;2-L; YOU WC, 1993, CANCER RES, V53, P1317; Zeng HM, 2011, CANCER EPIDEM BIOMAR, V20, P2594, DOI 10.1158/1055-9965.EPI-11-0702; Zeng Y, 2010, WORLD J GASTROENTERO, V16, P3578, DOI 10.3748/wjg.v16.i28.3578; Zhang L, 1996, CANCER EPIDEM BIOMAR, V5, P627; Zhong S, 2012, MOL BIOL REPORTS; Zhou Y, 2012, J CANCER RES CLIN, V138, P939, DOI 10.1007/s00432-012-1164-8	39	24	27	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2013	8	4							e61250	10.1371/journal.pone.0061250	http://dx.doi.org/10.1371/journal.pone.0061250			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IK	23613822	gold, Green Submitted, Green Published			2022-12-25	WOS:000317907200043
J	Chang, HX; Kim, BJ; Kim, YS; Suarez, SS; Wu, MM				Chang, Haixin; Kim, Beum Jun; Kim, Yoon Soo; Suarez, Susan S.; Wu, Mingming			Different Migration Patterns of Sea Urchin and Mouse Sperm Revealed by a Microfluidic Chemotaxis Device	PLOS ONE			English	Article							CUMULUS CELLS; HUMAN SPERMATOZOA; FOLLICULAR-FLUID; PROGESTERONE; CHEMOATTRACTANT; CHANNEL; EGG; CAPACITATION; EXOCYTOSIS; MOTILITY	Chemotaxis refers to a process whereby cells move up or down a chemical gradient. Sperm chemotaxis is known to be a strategy exploited by marine invertebrates such as sea urchins to reach eggs efficiently in moving water. Less is understood about how or whether chemotaxis is used by mammalian sperm to reach eggs, where fertilization takes place within the confinement of a reproductive tract. In this report, we quantitatively assessed sea urchin and mouse sperm chemotaxis using a recently developed microfluidic model and high-speed imaging. Results demonstrated that sea urchin Arbacia punctulata sperm were chemotactic toward the peptide resact with high chemotactic sensitivity, with an average velocity V-x up the chemical gradient as high as 20% of its average speed (238 mu m/s), while mouse sperm displayed no statistically significant chemotactic behavior in progesterone gradients, which had been proposed to guide mammalian sperm toward eggs. This work demonstrates the validity of a microfluidic model for quantitative sperm chemotaxis studies, and reveals a biological insight that chemotaxis up a progesterone gradient may not be a universal strategy for mammalian sperm to reach eggs.	[Chang, Haixin; Suarez, Susan S.] Cornell Univ, Dept Biomed Sci, Ithaca, NY 14853 USA; [Kim, Beum Jun; Kim, Yoon Soo; Wu, Mingming] Cornell Univ, Dept Biol & Environm Engn, Ithaca, NY USA	Cornell University; Cornell University	Suarez, SS (corresponding author), Cornell Univ, Dept Biomed Sci, Ithaca, NY 14853 USA.	sss7@cornell.edu; mw272@cornell.edu	KIM, BEUM JUN/G-6829-2011; wu, mingming/GXN-1864-2022	KIM, BEUM JUN/0000-0003-1797-5026; 	Cornell Nanobiotechnology Center; Cornell NanoScale Science and Technology; National Institutes of Health (NIH) [R03 HD062471-01]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R03HD062471] Funding Source: NIH RePORTER	Cornell Nanobiotechnology Center; Cornell NanoScale Science and Technology; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by the Cornell Nanobiotechnology Center (www.nbtc.cornell.edu), the Cornell NanoScale Science and Technology (www.cnf.cornell.edu), and National Institutes of Health (NIH) R03 HD062471-01 (www.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Guidobaldi HA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003040; [Anonymous], 2004, CHEMOTAXIS, P409; Armon L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028359; BERG HC, 1975, ANNU REV BIOPHYS BIO, V4, P119, DOI 10.1146/annurev.bb.04.060175.001003; BRADEN AWH, 1954, EXP CELL RES, V7, P277, DOI 10.1016/0014-4827(54)90063-4; Chang HX, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.096578; Cheng SY, 2007, LAB CHIP, V7, P763, DOI 10.1039/b618463d; COHENDAYAG A, 1995, P NATL ACAD SCI USA, V92, P11039, DOI 10.1073/pnas.92.24.11039; Darszon A, 2006, REPRODUCTION, V131, P977, DOI 10.1530/rep.1.00612; DEMOTT RP, 1995, BIOL REPROD, V52, P1395, DOI 10.1095/biolreprod52.6.1395; Eisenbach M, 1999, REV REPROD, V4, P56, DOI 10.1530/revreprod/4.1.56; Eisenbach M, 1996, MOL MICROBIOL, V20, P903, DOI 10.1111/j.1365-2958.1996.tb02531.x; Fabro G, 2002, BIOL REPROD, V67, P1565, DOI 10.1095/biolreprod.102.006395; Fazeli A, 1999, BIOL REPROD, V60, P879, DOI 10.1095/biolreprod60.4.879; Gakamsky A, 2008, INT J DEV BIOL, V52, P481, DOI 10.1387/ijdb.072520ag; Gwathmey TM, 2006, BIOL REPROD, V75, P501, DOI 10.1095/biolreprod.106.053306; Gwathmey TM, 2003, BIOL REPROD, V69, P809, DOI 10.1095/biolreprod.102.010827; Haessler U, 2011, P NATL ACAD SCI USA, V108, P5614, DOI 10.1073/pnas.1014920108; Haessler U, 2009, BIOMED MICRODEVICES, V11, P827, DOI 10.1007/s10544-009-9299-3; Kaupp UB, 2008, ANNU REV PHYSIOL, V70, P93, DOI 10.1146/annurev.physiol.70.113006.100654; Kaupp UB, 2003, NAT CELL BIOL, V5, P109, DOI 10.1038/ncb915; Kim BJ, 2012, ANN BIOMED ENG, V40, P1316, DOI 10.1007/s10439-011-0489-9; Laboratory J, 1988, JAX NOTES, V1988, P434; Lishko PV, 2011, NATURE, V471, P387, DOI 10.1038/nature09767; Murase T, 1996, BIOCHEM J, V320, P1017, DOI 10.1042/bj3201017; Oren-Benaroya R, 2008, HUM REPROD, V23, P2339, DOI 10.1093/humrep/den265; OSMAN RA, 1989, BIOCHEM BIOPH RES CO, V160, P828, DOI 10.1016/0006-291X(89)92508-4; Pietschmann Catarina, 2009, MaxPlanckResearch, P17; RALT D, 1994, BIOL REPROD, V50, P774, DOI 10.1095/biolreprod50.4.774; RALT D, 1991, P NATL ACAD SCI USA, V88, P2840, DOI 10.1073/pnas.88.7.2840; Ren DJ, 2001, NATURE, V413, P603, DOI 10.1038/35098027; ROLDAN ERS, 1994, SCIENCE, V266, P1578, DOI 10.1126/science.7985030; Roussos ET, 2011, NAT REV CANCER, V11, P573, DOI 10.1038/nrc3078; Schuffner AA, 2002, MOL HUM REPROD, V8, P722, DOI 10.1093/molehr/8.8.722; SUAREZ SS, 1987, BIOL REPROD, V36, P1191, DOI 10.1095/biolreprod36.5.1191; Suarez SS, 2008, HUM REPROD UPDATE, V14, P647, DOI 10.1093/humupd/dmn029; Sun F, 2005, HUM REPROD, V20, P761, DOI 10.1093/humrep/deh657; Sun F, 2003, DEV BIOL, V255, P423, DOI 10.1016/S0012-1606(02)00090-8; Sutton KA, 2008, P NATL ACAD SCI USA, V105, P8661, DOI 10.1073/pnas.0800603105; Teves ME, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008211; Teves ME, 2006, FERTIL STERIL, V86, P745, DOI 10.1016/j.fertnstert.2006.02.080; Wang Y, 2001, GYNECOL ENDOCRINOL, V15, P286, DOI 10.1080/713602886; WARD GE, 1985, J CELL BIOL, V101, P2324, DOI 10.1083/jcb.101.6.2324; Wong K, 2008, J VIS EXP; Zimmer RK, 2011, P NATL ACAD SCI USA, V108, P13200, DOI 10.1073/pnas.1018666108	45	21	21	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2013	8	4							e60587	10.1371/journal.pone.0060587	http://dx.doi.org/10.1371/journal.pone.0060587			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130DR	23613731	gold, Green Submitted, Green Published			2022-12-25	WOS:000317893400014
J	Hao, YY; Zhang, LC; He, JR; Guo, Z; Ying, L; Xu, ZY; Zhang, JN; Lu, JX; Wang, Q				Hao, Yuanyuan; Zhang, Lichuan; He, Jiarui; Guo, Zhe; Ying, Li; Xu, Zhiyun; Zhang, Jianing; Lu, Jianxin; Wang, Qi			Functional Investigation of NCI-H460-Inducible Myofibroblasts on the Chemoresistance to VP-16 with a Microfluidic 3D Co-Culture Device	PLOS ONE			English	Article							CANCER-ASSOCIATED FIBROBLASTS; ENDOPLASMIC-RETICULUM STRESS; LUNG-CANCER; CHEMOTHERAPY RESISTANCE; ENDOTHELIAL-CELLS; UP-REGULATION; ACTIVATION; GRP78; APOPTOSIS; MICROENVIRONMENT	Fibroblasts, the major cell type in tumor stroma, are essential for tumor growth and survival, and represent an important therapeutic target for cancers. Here we presented a microfluidic co-culture device in which the three-dimensional (3D) matrix was employed to reconstruct an in vivo-like fibroblast-tumor cell microenvironment for investigation of the role of myofibroblasts induced by lung cancer cells in the chemoresistance to VP-16. Composed of a double-layer chip and an injection pump, the device houses fibroblasts and lung cancer cells co-cultured in 3D matrix and 2D mode to induce fibroblasts to become myofibroblasts with the supplement of the medium continuously. With this device, we verified that the cytokines secreted by lung cancer cells could effectively transform the fibroblasts into myofibroblasts. Moreover, compared to fibroblasts, the myofibroblasts showed higher resistance to anticancer drug VP-16. We also demonstrated that this kind of acquired resistance in myofibroblasts was associated with the expression of Glucose-regulated protein 78 (GP78). We concluded that this device allows for the assay to characterize various cellular events in a single device sequentially, facilitating a better understanding of the interactions among heterotypic cells in a sophisticated microenvironment.	[Hao, Yuanyuan; He, Jiarui; Guo, Zhe; Xu, Zhiyun] Dalian Med Univ, Dalian, Peoples R China; [Zhang, Lichuan] Dalian Univ, Affiliated Zhongshan Hosp, Dept Resp Med, Dalian 116012, Peoples R China; [Ying, Li; Wang, Qi] Dalian Med Univ, Hosp Affiliated 2, Dept Resp Med, Dalian, Peoples R China; [Zhang, Jianing] Dalian Med Univ, Inst Glycobiol, Dept Biochem, Dalian, Peoples R China; [Lu, Jianxin] Wenzhou Med Coll, Zhejiang Prov Key Lab Med Genet, Minist Educ, Key Lab Lab Med, Wenzhou, Zhejiang, Peoples R China	Dalian Medical University; Dalian University; Dalian Medical University; Dalian Medical University; Wenzhou Medical University	Lu, JX (corresponding author), Wenzhou Med Coll, Zhejiang Prov Key Lab Med Genet, Minist Educ, Key Lab Lab Med, Wenzhou, Zhejiang, Peoples R China.	jxlu313@163.com; wqdmu@yahoo.com.cn	He, Jiarui/AAF-7206-2020	He, Jiarui/0000-0003-4665-2306	National High-tech R&D Program (973 Program) [2012CB822103]; National Natural Science Foundation of China [91129733, 81071228]	National High-tech R&D Program (973 Program); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded by National High-tech R&D Program (973 Program, No. 2012CB822103) and National Natural Science Foundation of China (No. 91129733 and 81071228). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott A, 2003, NATURE, V424, P870, DOI 10.1038/424870a; Anderberg C, 2009, CANCER RES, V69, P369, DOI 10.1158/0008-5472.CAN-08-2724; Bhowmick NA, 2004, NATURE, V432, P332, DOI 10.1038/nature03096; Buess M, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r191; Califano R, 2012, DRUGS, V72, P471, DOI 10.2165/11597640-000000000-00000; De Wever O, 2003, J PATHOL, V200, P429, DOI 10.1002/path.1398; El-Ali J, 2006, NATURE, V442, P403, DOI 10.1038/nature05063; Ermakova SP, 2006, CANCER RES, V66, P9260, DOI 10.1158/0008-5472.CAN-06-1586; Fischbach C, 2009, P NATL ACAD SCI USA, V106, P399, DOI 10.1073/pnas.0808932106; Fu Y, 2007, CANCER RES, V67, P3734, DOI 10.1158/0008-5472.CAN-06-4594; Giannoni E, 2010, CANCER RES, V70, P6945, DOI 10.1158/0008-5472.CAN-10-0785; Gosky D, 2003, BIOCHEM BIOPH RES CO, V300, P327, DOI 10.1016/S0006-291X(02)02857-7; Hakanson M, 2011, INTEGR BIOL-UK, V3, P31, DOI 10.1039/c0ib00074d; Hande KR, 1998, EUR J CANCER, V34, P1514, DOI 10.1016/S0959-8049(98)00228-7; Herzog TJ, 2004, CLIN CANCER RES, V10, P7439, DOI 10.1158/1078-0432.CCR-04-0683; Hsu TH, 2011, LAB CHIP, V11, P1808, DOI 10.1039/c1lc20090a; Huang CP, 2009, LAB CHIP, V9, P1740, DOI 10.1039/b818401a; Kaji H, 2009, LAB CHIP, V9, P427, DOI 10.1039/b812510d; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Khademhosseini A, 2006, P NATL ACAD SCI USA, V103, P2480, DOI 10.1073/pnas.0507681102; Lee AS, 2001, TRENDS BIOCHEM SCI, V26, P504, DOI 10.1016/S0968-0004(01)01908-9; Loeffler M, 2006, J CLIN INVEST, V116, P1955, DOI 10.1172/JCI26532; Mark D, 2010, CHEM SOC REV, V39, P1153, DOI 10.1039/b820557b; Micke P, 2004, LUNG CANCER, V45, pS163, DOI 10.1016/j.lungcan.2004.07.977; Oh SR, 2008, J MICROMECH MICROENG, V18, DOI 10.1088/0960-1317/18/11/115025; Ranganathan AC, 2006, CANCER RES, V66, P1702, DOI 10.1158/0008-5472.CAN-05-3092; Rao RV, 2001, J BIOL CHEM, V276, P33869, DOI 10.1074/jbc.M102225200; Reddy RK, 2003, J BIOL CHEM, V278, P20915, DOI 10.1074/jbc.M212328200; Sasaki T, 2003, J BIOSCI BIOENG, V96, P76, DOI 10.1263/jbb.96.76; Tilles AW, 2001, BIOTECHNOL BIOENG, V73, P379, DOI 10.1002/bit.1071; Virrey JJ, 2008, MOL CANCER RES, V6, P1268, DOI 10.1158/1541-7786.MCR-08-0060; Walker GM, 2004, LAB CHIP, V4, P91, DOI 10.1039/b311214d; Wang Q, 2005, CANCER DETECT PREV, V29, P544, DOI 10.1016/j.cdp.2005.09.010; Wang SY, 2009, J PHARMACEUT BIOMED, V49, P806, DOI 10.1016/j.jpba.2008.12.021; West J, 2008, ANAL CHEM, V80, P4403, DOI 10.1021/ac800680j; Wong AP, 2008, BIOMATERIALS, V29, P1853, DOI 10.1016/j.biomaterials.2007.12.044; Ying-Yan W, 2008, BIOMED MICRODEVICES, V10, P429, DOI 10.1007/s10544-007-9152-5; Yu ZF, 1999, EXP NEUROL, V155, P302, DOI 10.1006/exnr.1998.7002; Zhang LC, 2010, ELECTROPHORESIS, V31, P3763, DOI 10.1002/elps.201000265; Zhao L, 2010, BIOMED MICRODEVICES, V12, P325, DOI 10.1007/s10544-009-9388-3	40	18	18	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2013	8	4							e61754	10.1371/journal.pone.0061754	http://dx.doi.org/10.1371/journal.pone.0061754			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130DR	23613925	Green Published, Green Submitted, gold			2022-12-25	WOS:000317893400102
J	Rivero-Juarez, A; Gonzalez, R; Camacho, A; Manzanares-Martin, B; Caruz, A; Martinez-Peinado, A; Torre-Cisneros, J; Pineda, JA; Pena, J; Rivero, A				Rivero-Juarez, Antonio; Gonzalez, Rafael; Camacho, Angela; Manzanares-Martin, Barbara; Caruz, Antonio; Martinez-Peinado, Antonio; Torre-Cisneros, Julian; Pineda, Juan A.; Pena, Jose; Rivero, Antonio			Natural Killer KIR3DS1 Is Closely Associated with HCV Viral Clearance and Sustained Virological Response in HIV/HCV Patients	PLOS ONE			English	Article							INTERFERON PLUS RIBAVIRIN; HEPATITIS-C; HLA-B; RECEPTOR GENES; IL28B GENOTYPE; CLASS-I; INNATE; KINETICS; HIV; PROGRESSION	Aim: To evaluate the influence of the presence of the killer cell immunoglobulin-like receptor (KIR) 3DS1 on HCV treatment response in HIV/HCV genotype 1 co-infected patients Methods: HIV/HCV co-infected patients were included. KIR3DS1, their specific HLA-B ligands and IL28B gene were genotyped. Reductions of plasma HCV RNA levels between baseline and week 1, week 2 and week 4 were analyzed for IL28B genotype and KIR3DS1 (HLA Bw4 or Bw6). Rapid and sustained virological response (RVR and SVR) rates were also analyzed. Results: Sixty HIV/HCV genotype 1 co-infected patients were included. Patients with KIR3DS1 and Bw4 had higher rates of HCV viral decline than those who were not carriers of KIR3DS1 (week1: p = 0.01; week2: p = 0.038; week 4: p = 0.03). Patients carrying KIR3DS1/Bw4 had higher rates of RVR and SVR than those who did not carry KIR3DS1 (RVR: 46.15% versus 17.02%, p = 0.012; SVR: 63.6% versus 13 26.5%, p = 0.031). With respect to patients carrying the IL28B-CC genotype, those with KIR3DS1/Bw4 had greater rates of HCV viral clearance (week1: p<0.001; week2: p = 0.01; week 4: p = 0.02), RVR (p = 0.015) and SVR (p = 0.029) than those not carrying KIR3DS1. Conclusion: Our results show that the KIR3DS1 genotype has a positive effect on HCV viral clearance during the first weeks of Peg-IFN/RBV treatment in HCV/HCV co-infected patients bearing genotype 1, and higher RVR and SVR rates.	[Rivero-Juarez, Antonio; Camacho, Angela; Torre-Cisneros, Julian; Rivero, Antonio] Hosp Univ Reina Sofia, Inst Maimonides Invest Biomed Cordoba IMIBIC, Infect Dis Unit, Cordoba, Spain; [Gonzalez, Rafael; Manzanares-Martin, Barbara; Pena, Jose] Hosp Univ Reina Sofia, Inst Maimonides Invest Biomed Cordoba IMIBIC, Serv Immunol, Cordoba, Spain; [Caruz, Antonio] Univ Jaen, Fac Sci, Immunogenet Unit, Jaen, Spain; [Martinez-Peinado, Antonio] Hosp Univ Reina Sofia, Inst Maimonides Invest Biomed Cordoba IMIBIC, Mol Genet Lab, Cordoba, Spain; [Pineda, Juan A.] Hosp Univ Valme, Infect Dis & Microbiol Unit, Seville, Spain	Universidad de Jaen; Hospital Valme	Rivero, A (corresponding author), Hosp Univ Reina Sofia, Inst Maimonides Invest Biomed Cordoba IMIBIC, Infect Dis Unit, Cordoba, Spain.	ariveror@gmail.com	Caruz, Antonio/N-5557-2014; Rivero, Antonio/ABE-5294-2020; Rivero-Juarez, Antonio/E-4528-2019; Pineda, Juan A./AAO-9312-2021; DE LA TORRE CISNEROS, JULIAN/AAL-5723-2021; Espejo, Angela Camacho/AAM-9991-2021	Caruz, Antonio/0000-0002-5788-7840; Rivero-Juarez, Antonio/0000-0002-5813-6889; Pineda, Juan A./0000-0002-3751-0296; Rivero, Antonio/0000-0001-5005-8268; Rivero Roman, Antonio/0000-0002-8643-4250	Fundacion Progreso y Salud, Consejeria de Salud de la Junta de Andalucia [PI-0036/2010, PI-0247-2010, PI-0208/2010, PI-0124/2008, PI-0293/2007, AI-0011-2010]; Spanish Health Ministry [ISCIII-RETIC RD06/006, PI10/0164, PI10/01232]; Ministry of Science, Spain [SAF-2005-06984]; Health Research Fund [FIS-PS09/00424]; Spanish Foundation for Research and prevention of AIDS [FIPSE-36536/05]; Instituto de Salud Carlos III [Programa-I3SNS]	Fundacion Progreso y Salud, Consejeria de Salud de la Junta de Andalucia(Junta de Andalucia); Spanish Health Ministry(Instituto de Salud Carlos IIISpanish Government); Ministry of Science, Spain; Health Research Fund(Instituto de Salud Carlos III); Spanish Foundation for Research and prevention of AIDS; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission)	This work was partly supported by grants from the Fundacion Progreso y Salud, Consejeria de Salud de la Junta de Andalucia (grants for health research projects: refs. PI-0036/2010, PI-0247-2010, PI-0208/2010, PI-0124/2008 and PI-0293/2007), the Spanish Health Ministry (ISCIII-RETIC RD06/006, and projects PI10/0164 and PI10/01232), Ministry of Science, Spain (SAF-2005-06984), Health Research Fund (FIS-PS09/00424) and the Spanish Foundation for Research and prevention of AIDS (FIPSE-36536/05). AR is the recipient of a research extension grant from the Fundacion Progreso y Salud, Consejeria de Salud de la Junta de Andalucia (Reference AI-0011-2010); JAP is the recipient of extension grant from the Instituto de Salud Carlos III (grant number Programa-I3SNS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlenstiel G, 2011, GASTROENTEROLOGY, V141, P1231, DOI 10.1053/j.gastro.2011.06.069; Alter G, 2007, J EXP MED, V204, P3027, DOI 10.1084/jem.20070695; Alter G, 2011, NATURE, V476, P96, DOI 10.1038/nature10237; Barbour JD, 2007, PLOS PATHOG, V3, P471, DOI 10.1371/journal.ppat.0030043; Biron CA, 1999, ANNU REV IMMUNOL, V17, P189, DOI 10.1146/annurev.immunol.17.1.189; Borrego F, 2002, MOL IMMUNOL, V38, P637, DOI 10.1016/S0161-5890(01)00107-9; Carr WH, 2007, J IMMUNOL, V178, P647, DOI 10.4049/jimmunol.178.2.647; Dieterich D, 2012, 19 C RETR OPP INF CR; Edlich B, 2012, HEPATOLOGY, V55, P39, DOI 10.1002/hep.24628; Foley BA, 2008, BLOOD, V112, P435, DOI 10.1182/blood-2008-01-132902; Gaudieri S, 2005, GENES IMMUN, V6, P683, DOI 10.1038/sj.gene.6364256; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; Gillespie G. E., 2007, Canadian Technical Report of Fisheries and Aquatic Sciences, V2707, P1; Golden-Mason L, 2011, HEPATOLOGY, V54, P1559, DOI 10.1002/hep.24556; Gomez-Lozano N, 2002, TISSUE ANTIGENS, V59, P184, DOI 10.1034/j.1399-0039.2002.590302.x; Hofmann WP, 2011, NAT REV GASTRO HEPAT, V8, P257, DOI 10.1038/nrgastro.2011.49; Khakoo SI, 2004, SCIENCE, V305, P872, DOI 10.1126/science.1097670; Knapp S, 2010, HEPATOLOGY, V51, P1168, DOI 10.1002/hep.23477; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Lopez-Vazquez A, 2005, J INFECT DIS, V192, P162, DOI 10.1086/430351; Martin MP, 2007, NAT GENET, V39, P733, DOI 10.1038/ng2035; Martin MP, 2002, NAT GENET, V31, P429, DOI 10.1038/ng934; Naggie S, 2012, HEPATOLOGY, V56, P444, DOI 10.1002/hep.25647; Neukam K, 2011, HIV MED, V12, P487, DOI 10.1111/j.1468-1293.2011.00912.x; Pineda JA, 2011, AIDS, V25, P1415, DOI 10.1097/QAD.0b013e328348a7ac; Pineda JA, 2010, CLIN INFECT DIS, V51, P788, DOI 10.1086/656235; Rivero-Juarez A, 2012, AIDS, V26, P1009, DOI 10.1097/QAD.0b013e3283528b1c; Rivero-Juarez A, 2012, J ANTIMICROB CHEMOTH, V67, P202, DOI 10.1093/jac/dkr439; Seden K, 2011, CURR OPIN HIV AIDS, V6, P514, DOI 10.1097/COH.0b013e32834b54dc; Soriano V, 2010, ANTIVIR RES, V85, P303, DOI 10.1016/j.antiviral.2009.10.021; Sulkowski M, 2012, 19 C RETR OPP INF CR; Suppiah V, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001092; Thompson AJ, 2010, GASTROENTEROLOGY, V139, P120, DOI 10.1053/j.gastro.2010.04.013; Urban TJ, 2010, HEPATOLOGY, V52, P1888, DOI 10.1002/hep.23912; Varchetta S, 2012, HEPATOLOGY, V56, P841, DOI 10.1002/hep.25723; Vidal-Castineira JR, 2010, J VIROL, V84, P475, DOI 10.1128/JVI.01285-09; Vivier E, 2011, SCIENCE, V331, DOI 10.1126/science.1198687	38	26	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2013	8	4							e61992	10.1371/journal.pone.0061992	http://dx.doi.org/10.1371/journal.pone.0061992			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130DR	23613999	Green Published, gold, Green Submitted			2022-12-25	WOS:000317893400141
J	Du, FK; Xu, F; Qu, H; Feng, SS; Tang, JJ; Wu, RL				Du, Fang K.; Xu, Fang; Qu, Hong; Feng, Sisi; Tang, Jijun; Wu, Rongling			Exploiting the Transcriptome of Euphrates Poplar, Populus euphratica (Salicaceae) to Develop and Characterize New EST-SSR Markers and Construct an EST-SSR Database	PLOS ONE			English	Article							EXPRESSED SEQUENCE TAGS; MICROSATELLITE MARKERS; IN-SILICO; GENETIC DIVERSITY; LINKAGE MAP; REPEATS; GENOME; POLYMORPHISM; DESERT; RICE	Background: Microsatellite markers or Simple Sequence Repeats (SSRs) are the most popular markers in population/conservation genetics. However, the development of novel microsatellite markers has been impeded by high costs, a lack of available sequence data and technical difficulties. New species-specific microsatellite markers were required to investigate the evolutionary history of the Euphratica tree, Populus euphratica, the only tree species found in the desert regions of Western China and adjacent Central Asian countries. Methodology/Principal Findings: A total of 94,090 non-redundant Expressed Sequence Tags (ESTs) from P. euphratica comprising around 63 Mb of sequence data were searched for SSRs. 4,202 SSRs were found in 3,839 ESTs, with 311 ESTs containing multiple SSRs. The most common motif types were trinucleotides (37%) and hexanucleotides (33%) repeats. We developed primer pairs for all of the identified EST-SSRs (eSSRs) and selected 673 of these pairs at random for further validation. 575 pairs (85%) gave successful amplification, of which, 464 (80.7%) were polymorphic in six to 24 individuals from natural populations across Northern China. We also tested the transferability of the polymorphic eSSRs to nine other Populus species. In addition, to facilitate the use of these new eSSR markers by other researchers, we mapped them onto Populus trichocarpa scaffolds in silico and compiled our data into a web-based database (http://202.205.131.253:8080/poplar/resources/static_page/index.html). Conclusions: The large set of validated eSSRs identified in this work will have many potential applications in studies on P. euphratica and other poplar species, in fields such as population genetics, comparative genomics, linkage mapping, QTL, and marker-assisted breeding. Their use will be facilitated by their incorporation into a user-friendly web-based database.	[Du, Fang K.; Xu, Fang; Feng, Sisi; Wu, Rongling] Beijing Forestry Univ, Coll Biol Sci & Biotechnol, Natl Engn Lab Tree Breeding, Ctr Computat Biol, Beijing, Peoples R China; [Qu, Hong] Peking Univ, Coll Life Sci, Ctr Bioinformat, Natl Lab Prot Engn & Plant Genet Engn, Beijing 100871, Peoples R China; [Tang, Jijun] Univ S Carolina, Dept Comp Sci & Engn, Columbia, SC 29208 USA	Beijing Forestry University; Peking University; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Du, FK (corresponding author), Beijing Forestry Univ, Coll Biol Sci & Biotechnol, Natl Engn Lab Tree Breeding, Ctr Computat Biol, Beijing, Peoples R China.	dufang325@gmail.com; RWU@hes.hmc.psu.edu	Tang, Jijun/ABH-6528-2020	Du, Fang/0000-0002-7377-5259	Fundamental Research Funds for the Central Universities [TD 2012-01]; Research Fund for the Doctoral Programme of Higher Education of China; Changjiang Scholars Award; "Thousand-person Plan" Award	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Research Fund for the Doctoral Programme of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Changjiang Scholars Award; "Thousand-person Plan" Award(Chinese Academy of Sciences)	This work is financially supported by Fundamental Research Funds for the Central Universities (TD 2012-01), the Research Fund for the Doctoral Programme of Higher Education of China to FKD; Changjiang Scholars Award and "Thousand-person Plan" Award to RLW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMOUR JAL, 1994, HUM MOL GENET, V3, P599, DOI 10.1093/hmg/3.4.599; Blenda A, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-132; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; Brandstrom M, 2008, GENOME RES, V18, P881, DOI 10.1101/gr.075242.107; Bruelheide H, 2003, PHYTOCOENOLOGIA, V33, P801, DOI 10.1127/0340-269X/2003/0033-0801; Cardle L, 2000, GENETICS, V156, P847; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; da Maia Luciano Carlos, 2008, Int J Plant Genomics, V2008, P412696, DOI 10.1155/2008/412696; Durand J, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-570; EDWARDS A, 1991, AM J HUM GENET, V49, P746; Fay MF, 1999, BIODIVERS CONSERV, V8, P769, DOI 10.1023/A:1008842230383; Feng SP, 2009, MOL BREEDING, V23, P85, DOI 10.1007/s11032-008-9216-0; Grover A, 2007, MOL GENET GENOMICS, V277, P469, DOI 10.1007/s00438-006-0204-y; Gu RS, 2004, TREE PHYSIOL, V24, P265, DOI 10.1093/treephys/24.3.265; Guichoux E, 2011, MOL ECOL RESOUR, V11, P591, DOI 10.1111/j.1755-0998.2011.03014.x; Gupta PK, 2003, MOL GENET GENOMICS, V270, P315, DOI 10.1007/s00438-003-0921-4; Hou H, 1985, PLANT RESOURCE ARID, P246; Huang Y, 2010, BIOINFORMATICS, V26, P680, DOI 10.1093/bioinformatics/btq003; JACOB HJ, 1991, CELL, V67, P213, DOI 10.1016/0092-8674(91)90584-L; Jayashree B., 2006, In Silico Biology, V6, P607; Kalia RK, 2011, EUPHYTICA, V177, P309, DOI 10.1007/s10681-010-0286-9; KANDPAL RP, 1994, P NATL ACAD SCI USA, V91, P88, DOI 10.1073/pnas.91.1.88; KANG JM, 1996, J FOR RES, V1, P27, DOI DOI 10.1007/BF02348336; Kantety RV, 2002, PLANT MOL BIOL, V48, P501, DOI 10.1023/A:1014875206165; KARAGYOZOV L, 1993, NUCLEIC ACIDS RES, V21, P3911, DOI 10.1093/nar/21.16.3911; Kelkar YD, 2010, GENOME BIOL EVOL, V2, P620, DOI 10.1093/gbe/evq046; KIJAS JMH, 1994, BIOTECHNIQUES, V16, P656; Li SX, 2011, MOL BREEDING, V27, P59, DOI 10.1007/s11032-010-9413-5; LITT M, 1989, AM J HUM GENET, V44, P397; McCouch SR, 2002, DNA RES, V9, P199, DOI 10.1093/dnares/9.6.199; Metzgar D, 2000, GENOME RES, V10, P72; Morgante M, 2002, NAT GENET, V30, P194, DOI 10.1038/ng822; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Poncet V, 2006, MOL GENET GENOMICS, V276, P436, DOI 10.1007/s00438-006-0153-5; Qiu LJ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-278; Qiu Q, 2011, TREE PHYSIOL, V31, P452, DOI 10.1093/treephys/tpr015; Rozen S, 2000, Methods Mol Biol, V132, P365; Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708; Scott KD, 2000, THEOR APPL GENET, V100, P723, DOI 10.1007/s001220051344; Sharma A., 1999, Annals of Forestry, V7, P1; Shirasawa K, 2010, THEOR APPL GENET, V121, P731, DOI 10.1007/s00122-010-1344-3; Smulders MJM, 2001, MOL ECOL NOTES, V1, P188, DOI 10.1046/j.1471-8278.2001.00071.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TAUTZ D, 1989, NUCLEIC ACIDS RES, V17, P6463, DOI 10.1093/nar/17.16.6463; Thiel T, 2003, THEOR APPL GENET, V106, P411, DOI 10.1007/s00122-002-1031-0; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Tuskan GA, 2004, CAN J FOREST RES, V34, P85, DOI [10.1139/x03-283, 10.1139/X03-283]; Ueno S, 2008, CONSERV GENET, V9, P1083, DOI 10.1007/s10592-007-9462-4; Ueno S, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-136; van der Schoot J, 2000, THEOR APPL GENET, V101, P317, DOI 10.1007/s001220051485; Varshney RK, 2005, TRENDS BIOTECHNOL, V23, P48, DOI 10.1016/j.tibtech.2004.11.005; Varshney RK, 2002, CELL MOL BIOL LETT, V7, P537; Victoria FC, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-15; Vonlanthen B, 2010, AM J BOT, V97, P234, DOI 10.3732/ajb.0800329; Wang J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026530; Watanabe S, 2000, PLANT CELL TISS ORG, V63, P199, DOI 10.1023/A:1010619503680; Xu F, 2013, MOL ECOL RESOUR, V13, P144, DOI 10.1111/1755-0998.12030; Yin TM, 2009, NEW PHYTOL, V181, P498, DOI 10.1111/j.1469-8137.2008.02663.x; Yu JK, 2004, MOL GENET GENOMICS, V271, P742, DOI 10.1007/s00438-004-1027-3; Zane L, 2002, MOL ECOL, V11, P1, DOI 10.1046/j.0962-1083.2001.01418.x; Zeng FJ, 2009, TREE PHYSIOL, V29, P1237, DOI 10.1093/treephys/tpp055	61	28	46	0	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2013	8	4							e61337	10.1371/journal.pone.0061337	http://dx.doi.org/10.1371/journal.pone.0061337			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123JA	23593466	Green Submitted, Green Published, gold			2022-12-25	WOS:000317383200053
J	Stanistreet, JE; Risch, D; Van Parijs, SM				Stanistreet, Joy E.; Risch, Denise; Van Parijs, Sofie M.			Passive Acoustic Tracking of Singing Humpback Whales (Megaptera novaeangliae) on a Northwest Atlantic Feeding Ground	PLOS ONE			English	Article							BALAENOPTERA-PHYSALUS; MORAY FIRTH; SONGS; MOVEMENTS; PACIFIC; SPACE; RADIO; SOUND; LOCALIZATION; WHISTLES	Passive acoustic tracking provides an unobtrusive method of studying the movement of sound-producing animals in the marine environment where traditional tracking methods may be costly or infeasible. We used passive acoustic tracking to characterize the fine-scale movements of singing humpback whales (Megaptera novaeangliae) on a northwest Atlantic feeding ground. Male humpback whales produce complex songs, a phenomenon that is well documented in tropical regions during the winter breeding season, but also occurs at higher latitudes during other times of year. Acoustic recordings were made throughout 2009 using an array of autonomous recording units deployed in the Stellwagen Bank National Marine Sanctuary. Song was recorded during spring and fall, and individual singing whales were localized and tracked throughout the array using a correlation sum estimation method on the time-synchronized recordings. Tracks were constructed for forty-three song sessions, revealing a high level of variation in movement patterns in both the spring and fall seasons, ranging from slow meandering to faster directional movement. Tracks were 30 min to 8 h in duration, and singers traveled distances ranging from 0.9 to 20.1 km. Mean swimming speed was 2.06 km/h (SD 0.95). Patterns and rates of movement indicated that most singers were actively swimming. In one case, two singers were tracked simultaneously, revealing a potential acoustic interaction. Our results provide a first description of the movements of singers on a northwest Atlantic feeding ground, and demonstrate the utility of passive acoustic tracking for studying the fine-scale movements of cetaceans within the behavioral context of their calls. These methods have further applications for conservation and management purposes, particularly by enhancing our ability to estimate cetacean densities using passive acoustic monitoring.	[Stanistreet, Joy E.; Van Parijs, Sofie M.] Northeast Fisheries Sci Ctr, Woods Hole, MA USA; [Stanistreet, Joy E.] Duke Univ, Marine Lab, Beaufort, NC 28516 USA; [Risch, Denise] Integrated Stat Inc, Woods Hole, MA USA	Duke University	Stanistreet, JE (corresponding author), Northeast Fisheries Sci Ctr, Woods Hole, MA USA.	joy.stanistreet@duke.edu	Risch, Denise/W-1070-2019	Risch, Denise/0000-0002-3719-7420; Stanistreet, Joy/0000-0002-1090-2169	National Oceanographic Partnership Program [N00014-07-1-1029]	National Oceanographic Partnership Program	This work was supported by grant number N00014-07-1-1029 from the National Oceanographic Partnership Program (http://www.nopp.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Au WWL, 2006, J ACOUST SOC AM, V120, P1103, DOI 10.1121/1.2211547; Barlow J, 2005, MAR MAMMAL SCI, V21, P429, DOI 10.1111/j.1748-7692.2005.tb01242.x; Baumgartner MF, 2008, J ACOUST SOC AM, V124, P1339, DOI 10.1121/1.2945155; Benhamou S, 2004, J THEOR BIOL, V229, P209, DOI 10.1016/j.jtbi.2004.03.016; Block BA, 2011, NATURE, V475, P86, DOI 10.1038/nature10082; Bunnefeld N, 2011, J ANIM ECOL, V80, P466, DOI 10.1111/j.1365-2656.2010.01776.x; Cagnacci F, 2010, PHILOS T R SOC B, V365, P2157, DOI 10.1098/rstb.2010.0107; Calenge C, 2006, ECOL MODEL, V197, P516, DOI 10.1016/j.ecolmodel.2006.03.017; Calenge C, 2009, ECOL INFORM, V4, P34, DOI 10.1016/j.ecoinf.2008.10.002; CATT DC, 1987, J ZOOL, V211, P681, DOI 10.1111/j.1469-7998.1987.tb04479.x; Charif RA, 2001, MAR MAMMAL SCI, V17, P751, DOI 10.1111/j.1748-7692.2001.tb01297.x; Cholewiak DM, 2008, THESIS CORNELL U; Clark Christopher W., 1996, Report of the International Whaling Commission, V46, P541; Clark CW, 2004, P ROY SOC B-BIOL SCI, V271, P1051, DOI 10.1098/rspb.2004.2699; Cooke Steven J., 2008, Endangered Species Research, V4, P165, DOI 10.3354/esr00063; Cortopassi KA, 2005, 2 INT WORKSH DET LOC; Croll DA, 2002, NATURE, V417, P809, DOI 10.1038/417809a; Darling JD, 2006, BEHAVIOUR, V143, P1051, DOI 10.1163/156853906778607381; Darling JD, 2001, MAR MAMMAL SCI, V17, P570, DOI 10.1111/j.1748-7692.2001.tb01005.x; Dawbin W.H., 1966, WHALES DOLPHINS PORP, P145; Dunn RA, 2009, J ACOUST SOC AM, V126, P1084, DOI 10.1121/1.3158929; Figueroa H, 2012, XBAT EXTENSIBLE BIOA; FRANKEL AS, 1995, CAN J ZOOL, V73, P1134, DOI 10.1139/z95-135; Gerrodette T, 2011, MAR MAMMAL SCI, V27, pE79, DOI 10.1111/j.1748-7692.2010.00438.x; Hansen BB, 2009, OIKOS, V118, P859, DOI 10.1111/j.1600-0706.2009.17098.x; Hastie GD, 2006, MAR BIOL, V148, P1181, DOI 10.1007/s00227-005-0143-x; Hatch LT, 2012, CONSERV BIOL, V26, P983, DOI 10.1111/j.1523-1739.2012.01908.x; Hebblewhite M, 2010, PHILOS T R SOC B, V365, P2303, DOI 10.1098/rstb.2010.0087; HELWEG DA, 1992, MARINE MAMMAL SENSORY SYSTEMS, P459; Hen I, 2004, J NEUROSCI METH, V133, P161, DOI 10.1016/j.jneumeth.2003.10.013; Janik VM, 2000, J COMP PHYSIOL A, V186, P673, DOI 10.1007/s003590000120; Kelly BP, 2010, POLAR BIOL, V33, P1095, DOI 10.1007/s00300-010-0796-x; Kusel ET, 2011, J ACOUST SOC AM, V129, P3610, DOI 10.1121/1.3583504; Li SH, 2009, J ACOUST SOC AM, V126, P468, DOI 10.1121/1.3147507; Marques Tiago A., 2011, Endangered Species Research, V13, P163, DOI 10.3354/esr00325; Marques TA, 2009, J ACOUST SOC AM, V125, P1982, DOI 10.1121/1.3089590; Marshell A, 2011, CORAL REEFS, V30, P631, DOI 10.1007/s00338-011-0770-2; Matthews CJD, 2011, POLAR BIOL, V34, P1091, DOI 10.1007/s00300-010-0958-x; MATTILA DK, 1987, J MAMMAL, V68, P880, DOI 10.2307/1381574; McCarthy TM, 2005, BIOL CONSERV, V124, P527, DOI 10.1016/j.biocon.2005.03.003; MCSWEENEY DJ, 1989, MAR MAMMAL SCI, V5, P139, DOI 10.1111/j.1748-7692.1989.tb00328.x; Mellinger DK, 2007, OCEANOGRAPHY, V20, P36, DOI 10.5670/oceanog.2007.03; Muanke PB, 2007, J ACOUST SOC AM, V121, P2049, DOI 10.1121/1.2532210; Noad MJ, 2007, MAR MAMMAL SCI, V23, P481, DOI 10.1111/j.1748-7692.2007.02414.x; OVERHOLTZ WJ, 1979, FISH B-NOAA, V77, P285; Parks SE, 2012, J ACOUST SOC AM, V131, P3173, DOI 10.1121/1.3688507; PAYNE RS, 1971, SCIENCE, V173, P585, DOI 10.1126/science.173.3997.585; Quick NJ, 2012, P ROY SOC B-BIOL SCI, V279, P2539, DOI 10.1098/rspb.2011.2537; R Development Core Team, 2012, R LANG ENV STAT COMP; Rankin S, 2005, J ACOUST SOC AM, V118, P3346, DOI 10.1121/1.2046747; Robbins J., 2007, THESIS U ST ANDREWS; Robinson WD, 2010, FRONT ECOL ENVIRON, V8, P354, DOI 10.1890/080179; Simard Y, 2008, J ACOUST SOC AM, V123, P4109, DOI 10.1121/1.2912453; Smith JN, 2008, ANIM BEHAV, V76, P467, DOI 10.1016/j.anbehav.2008.02.013; Sousa-Lima RS, 2009, PARK SCI, V26; Stimpert AK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051214; Tchamba MN, 1995, AFR J ECOL, V33, P335, DOI 10.1111/j.1365-2028.1995.tb01043.x; Thompson PM, 1996, J APPL ECOL, V33, P1572, DOI 10.2307/2404795; Turchin Peter, 1998; TYACK P, 1981, BEHAV ECOL SOCIOBIOL, V8, P105, DOI 10.1007/BF00300822; TYACK P, 1983, BEHAVIOUR, V83, P132, DOI 10.1163/156853982X00067; Van Parijs SM, 2004, ANIM BEHAV, V68, P89, DOI 10.1016/j.anbehav.2003.09.013; Van Parijs SM, 2009, MAR ECOL PROG SER, V395, P21, DOI 10.3354/meps08123; Van Parijs SM, 2006, ANIM BEHAV, V72, P1269, DOI 10.1016/j.anbehav.2006.03.026; Vu ET, 2012, AQUAT BIOL, V14, P175, DOI 10.3354/ab00390; WATKINS WA, 1981, DEEP-SEA RES, V28, P577, DOI 10.1016/0198-0149(81)90118-7; WHITEHEAD H, 1982, CAN J ZOOL, V60, P2203, DOI 10.1139/z82-282; WINN HE, 1978, MAR BIOL, V47, P97, DOI 10.1007/BF00395631; Wright AJ, 2010, J MAR BIOL ASSOC UK, V90, P1489, DOI 10.1017/S0025315410000913	69	27	28	1	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2013	8	4							e61263	10.1371/journal.pone.0061263	http://dx.doi.org/10.1371/journal.pone.0061263			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123IQ	23593447	Green Submitted, Green Published, gold			2022-12-25	WOS:000317382000045
J	Shafique, M; Meijerhof, T; Wilschut, J; de Haan, A				Shafique, Muhammad; Meijerhof, Tjarko; Wilschut, Jan; de Haan, Aalzen			Evaluation of an Intranasal Virosomal Vaccine against Respiratory Syncytial Virus in Mice: Effect of TLR2 and NOD2 Ligands on Induction of Systemic and Mucosal Immune Responses	PLOS ONE			English	Article							INFLUENZA SUBUNIT VACCINE; RECEPTOR AGONISTS; RSV INFECTION; CHOLERA-TOXIN; B-LYMPHOCYTES; BALB/C MICE; ADJUVANT; IGA; IMMUNOADJUVANT; PROTECTION	Introduction: RSV infection remains a serious threat to newborns and the elderly. Currently, there is no vaccine available to prevent RSV infection. A mucosal RSV vaccine would be attractive as it could induce mucosal as well as systemic antibodies, capable of protecting both the upper and lower respiratory tract. Previously, we reported on a virosomal RSV vaccine for intramuscular injection with intrinsic adjuvant properties mediated by an incorporated lipophilic Toll-like receptor 2 (TLR2) ligand. However, it has not been investigated whether this virosomal RSV vaccine candidate would be suitable for use in mucosal immunization strategies and if additional incorporation of other innate receptor ligands, like NOD2-ligand, could further enhance the immunogenicity and protective efficacy of the vaccine. Objective: To explore if intranasal (IN) immunization with a virosomal RSV vaccine, supplemented with TLR2 and/or NOD2-ligands, is an effective strategy to induce RSV-specific immunity. Methods: We produced RSV-virosomes carrying TLR2 (Pam(3)CSK(4)) and/or NOD2 (L18-MDP) ligands. We tested the immunopotentiating properties of these virosomes in vitro, using TLR2- and/or NOD2-ligand-responsive murine and human cell lines, and in vivo by assessing induction of protective antibody and cellular responses upon IN immunization of BALB/c mice. Results: Incorporation of Pam(3)CSK(4) and/or L18-MDP potentiates the capacity of virosomes to activate (antigen-presenting) cells in vitro, as demonstrated by NF-kappa B induction. In vivo, incorporation of Pam(3)CSK(4) in virosomes boosted serum IgG antibody responses and mucosal antibody responses after IN immunization. While L18-MDP alone was ineffective, incorporation of L18-MDP in Pam(3)CSK(4)-carrying virosomes further boosted mucosal antibody responses. Finally, IN immunization with adjuvanted virosomes, particularly Pam(3)CSK(4)/L18-MDP-adjuvanted-virosomes, protected mice against infection with RSV, without priming for enhanced disease. Conclusion: Mucosal immunization with RSV-virosomes, supplemented with incorporated TLR2- and/or NOD2-ligands, represents a promising approach to induce effective and safe RSV-specific immunity.	[de Haan, Aalzen] Univ Groningen, Univ Med Ctr Groningen, Dept Med Microbiol, Mol Virol Sect, NL-9713 AV Groningen, Netherlands; Univ Groningen, Groningen, Netherlands	University of Groningen; University of Groningen	de Haan, A (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Med Microbiol, Mol Virol Sect, NL-9713 AV Groningen, Netherlands.	aalzen.de.haan@umcg.nl		Shafique, Muhammad/0000-0003-0554-7622	Higher Education Commission (HEC), Government of Pakistan, under the HEC-NUFFIC overseas scholarship programme; Jan Kornelis de Cock stichting	Higher Education Commission (HEC), Government of Pakistan, under the HEC-NUFFIC overseas scholarship programme; Jan Kornelis de Cock stichting	This work was financially supported by the Higher Education Commission (HEC), Government of Pakistan, under the HEC-NUFFIC overseas scholarship programme, and by a grant from the "Jan Kornelis de Cock stichting." The funders had no role in study design, data collection and analysis or preparation of the manuscript.	Ainai A, 2010, J MED VIROL, V82, P476, DOI 10.1002/jmv.21694; Auci DL, 1998, IMMUNOL INVEST, V27, P105, DOI 10.3109/08820139809070894; Baca-Estrada ME, 2000, J BIOTECHNOL, V83, P91, DOI 10.1016/S0168-1656(00)00313-8; Borsutzky S, 2005, J IMMUNOL, V174, P6308, DOI 10.4049/jimmunol.174.10.6308; Caproni E, 2012, J IMMUNOL, V188, P3088, DOI 10.4049/jimmunol.1101764; Cashman SB, 2009, MOL IMMUNOL, V47, P365, DOI 10.1016/j.molimm.2009.09.007; Chabot SM, 2007, VACCINE, V25, P5348, DOI 10.1016/j.vaccine.2007.05.029; de Jonge J, 2007, BIOCHEM J, V405, P41, DOI 10.1042/BJ20061756; DEHAAN A, 1995, VACCINE, V13, P155, DOI 10.1016/0264-410X(95)93129-W; Dowell SF, 1996, J INFECT DIS, V174, P456, DOI 10.1093/infdis/174.3.456; Delgado MF, 2009, NAT MED, V15, P34, DOI 10.1038/nm.1894; Fukushima A, 1996, VACCINE, V14, P485, DOI 10.1016/0264-410X(95)00236-T; HALL CB, 1991, J INFECT DIS, V163, P693, DOI 10.1093/infdis/163.4.693; Hennessy EJ, 2010, NAT REV DRUG DISCOV, V9, P293, DOI 10.1038/nrd3203; HOLMGREN J, 1993, VACCINE, V11, P1179, DOI 10.1016/0264-410X(93)90039-Z; Huckriede A, 2005, VACCINE, V23, pS26, DOI 10.1016/j.vaccine.2005.04.026; Hussell T, 2002, CLIN EXP IMMUNOL, V130, P359, DOI 10.1046/j.1365-2249.2002.02038.x; Johnson TR, 2009, VACCINE, V27, P3045, DOI 10.1016/j.vaccine.2009.03.026; Kamphuis T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036812; KIM HW, 1969, AM J EPIDEMIOL, V89, P422, DOI 10.1093/oxfordjournals.aje.a120955; Kurt-Jones EA, 2000, NAT IMMUNOL, V1, P398, DOI 10.1038/80833; Lawson LB, 2011, CURR OPIN IMMUNOL, V23, P414, DOI 10.1016/j.coi.2011.03.009; Liang YM, 2011, CLIN IMMUNOL, V138, P33, DOI 10.1016/j.clim.2010.09.003; Littel-van den Hurk SV, 2007, REV MED VIROL, V17, P5, DOI 10.1002/rmv.518; Magalhaes JG, 2008, J IMMUNOL, V181, P7925, DOI 10.4049/jimmunol.181.11.7925; Murawski MR, 2009, J VIROL, V83, P1492, DOI 10.1128/JVI.00671-08; Nguyen DT, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001049; OGAWA T, 1989, INFECT IMMUN, V57, P3466, DOI 10.1128/IAI.57.11.3466-3471.1989; Ogra PL, 2001, CLIN MICROBIOL REV, V14, P430, DOI 10.1128/CMR.14.2.430-445.2001; Parker D, 2011, AM J RESP CELL MOL, V45, P189, DOI 10.1165/rcmb.2011-0011RT; Petterson T, 2011, J LEUKOCYTE BIOL, V89, P177, DOI 10.1189/jlb.0210061; Prince GA, 2001, VACCINE, V19, P2048, DOI 10.1016/S0264-410X(00)00417-5; Renegar KB, 2004, J IMMUNOL, V173, P1978, DOI 10.4049/jimmunol.173.3.1978; ROBERTS M, 1995, INFECT IMMUN, V63, P2100, DOI 10.1128/IAI.63.6.2100-2108.1995; Shafique M, 2012, VACCINE, V30, P597, DOI 10.1016/j.vaccine.2011.11.054; Stegmann T, 2010, VACCINE, V28, P5543, DOI 10.1016/j.vaccine.2010.06.041; Tada H, 2005, INFECT IMMUN, V73, P7967, DOI 10.1128/IAI.73.12.7967-7976.2005; Uehara A, 2005, CELL MICROBIOL, V7, P53, DOI 10.1111/j.1462-5822.2004.00433.x; Walsh EE, 2004, J INFECT DIS, V190, P373, DOI 10.1086/421524; Walsh EE, 2004, J INFECT DIS, V189, P233, DOI 10.1086/380907; Waris ME, 1996, J VIROL, V70, P2852, DOI 10.1128/JVI.70.5.2852-2860.1996; Yamamoto S, 1997, J EXP MED, V185, P1203, DOI 10.1084/jem.185.7.1203	42	31	31	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2013	8	4							e61287	10.1371/journal.pone.0061287	http://dx.doi.org/10.1371/journal.pone.0061287			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130FG	23593453	Green Published, gold, Green Submitted			2022-12-25	WOS:000317898000120
J	Langie, SAS; Achterfeldt, S; Gorniak, JP; Halley-Hogg, KJA; Oxley, D; van Schooten, FJ; Godschalk, RWL; McKay, JA; Mathers, JC				Langie, Sabine A. S.; Achterfeldt, Sebastian; Gorniak, Joanna P.; Halley-Hogg, Kirstin J. A.; Oxley, David; van Schooten, Frederik J.; Godschalk, Roger W. L.; McKay, Jill A.; Mathers, John C.			Maternal folate depletion and high-fat feeding from weaning affects DNA methylation and DNA repair in brain of adult offspring	FASEB JOURNAL			English	Article						epigenetics; base excision repair; developmental origin	OXIDATIVE STRESS; EPIGENETIC CHANGES; EXCISION-REPAIR; ALZHEIMERS-DISEASE; GENE-EXPRESSION; ACID TRANSPORT; DEFICIENT DIET; FOLIC-ACID; DAMAGE; COLON	The mechanisms through which environmental and dietary factors modulate DNA repair are still unclear but may include dysregulation of gene expression due to altered epigenetic markings. In a mouse model, we investigated the effect of maternal folate depletion during pregnancy and lactation, and high-fat feeding from weaning, on base excision repair (BER) and DNA methylation and expression of selected BER-related genes in the brain of adult offspring. While folate depletion did not affect BER activity of the mothers, BER increased in the offspring at weaning (P=0.052). In the long term, as observed in 6-mo-old offspring, the double insult, i.e., maternal low-folate supply and high-fat feeding from weaning, decreased BER activity significantly in the cortex, cerebellum, hippocampus, and subcortical regions (P0.017). This fall in BER activity was associated with small changes in methylation or expression of BER-related genes. Maternal folate depletion led to slightly increased oxidative DNA damage levels in subcortical regions of adult offspring, which may increase sensitivity to oxidative stress and predispose to neurological disorders. In summary, our data suggest that low-folate supply during early life may leave an epigenetic mark that can predispose the offspring to further dietary insults, causing adverse effects during adult life.Langie, S. A. S., Achterfeldt, S., Gorniak, J. P., Halley-Hogg, K. J. A., Oxley, D., van Schooten, F. J., Godschalk, R. W. L., McKay, J. A., Mathers, J. C. Maternal folate depletion and high-fat feeding from weaning affects DNA methylation and DNA repair in brain of adult offspring.	[Langie, Sabine A. S.; Achterfeldt, Sebastian; Gorniak, Joanna P.; Halley-Hogg, Kirstin J. A.; McKay, Jill A.; Mathers, John C.] Newcastle Univ, Human Nutr Res Ctr, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Langie, Sabine A. S.; Achterfeldt, Sebastian; Gorniak, Joanna P.; Halley-Hogg, Kirstin J. A.; Mathers, John C.] Newcastle Univ, Ctr Brain Ageing & Vital, Inst Ageing & Hlth, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [McKay, Jill A.] Newcastle Univ, Human Nutr Res Ctr, Inst Hlth & Soc, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Oxley, David] Babraham Inst, Prote Grp, Cambridge, England; [van Schooten, Frederik J.; Godschalk, Roger W. L.] Maastricht Univ, Dept Toxicol, Maastricht, Netherlands	Newcastle University - UK; Newcastle University - UK; Newcastle University - UK; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; Maastricht University	Langie, SAS (corresponding author), Flemisch Inst Technol Res VITO, Environm Risk & Hlth Unit, Boeretang 200, B-2400 Mol, Belgium.	sabine.langie@gmail.com	Langie, Sabine A/Q-2917-2017	Langie, Sabine A/0000-0003-3288-7331; McKay, Jill Ann/0000-0002-2711-0301; Mathers, John/0000-0003-3406-3002	Lifelong Health and Wellbeing cross council initiative by the UK Medical Research Council; Biotechnology and Biological Sciences Research Council (BBSRC); Engineering and Physical Sciences Research Council; Economic and Social Research Council; BBSRC [BB/G007993/1]; Biotechnology and Biological Sciences Research Council [BB/G007993/1] Funding Source: researchfish; Medical Research Council [G0700718] Funding Source: researchfish	Lifelong Health and Wellbeing cross council initiative by the UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The authors thank Hoffmann-La Roche (Basel, Switzerland) for supplying Ro 19-8022. Further thanks goes to Adele Kitching and Julie Wallace (Comparative Biology Centre, Newcastle University) for care of the animals, and Dr Long Xie and Sofia Lisanti for help with animal care and dissections. The Centre for Brain Aging and Vitality is funded through the Lifelong Health and Wellbeing cross council initiative by the UK Medical Research Council, Biotechnology and Biological Sciences Research Council (BBSRC), Engineering and Physical Sciences Research Council, and Economic and Social Research Council. The project was also funded by the BBSRC (BB/G007993/1). The authors declare no conflicts of interest.	Bagnyukova TV, 2008, BRAIN RES, V1237, P44, DOI 10.1016/j.brainres.2008.07.073; Basten GP, 2006, BRIT J CANCER, V94, P1942, DOI 10.1038/sj.bjc.6603197; Bert SA, 2013, CANCER CELL, V23, P9, DOI 10.1016/j.ccr.2012.11.006; Booth MJ, 2012, SCIENCE, V336, P934, DOI 10.1126/science.1220671; Branco MR, 2012, NAT REV GENET, V13, P7, DOI 10.1038/nrg3080; BRANDA RF, 1993, CANCER RES, V53, P5401; Chen KH, 2000, CARCINOGENESIS, V21, P1017, DOI 10.1093/carcin/21.5.1017; Choi SW, 1998, GUT, V43, P93, DOI 10.1136/gut.43.1.93; Chouliaras L, 2010, PROG NEUROBIOL, V90, P498, DOI 10.1016/j.pneurobio.2010.01.002; Collins AR, 2012, EUR J NUTR, V51, P261, DOI 10.1007/s00394-012-0318-4; Collins AR, 2000, FREE RADICAL RES, V32, P333, DOI 10.1080/10715760000300331; Dhikav V, 2011, DRUG AGING, V28, P1, DOI 10.2165/11586390-000000000-00000; Dobosy JR, 2008, PROSTATE, V68, P1187, DOI 10.1002/pros.20782; Doi A, 2009, NAT GENET, V41, P1350, DOI 10.1038/ng.471; Dudley KJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021662; Duthie SJ, 2011, J INHERIT METAB DIS, V34, P101, DOI 10.1007/s10545-010-9128-0; Duthie SJ, 2010, CANCER PREV RES, V3, P92, DOI 10.1158/1940-6207.CAPR-09-0231; Gallou-Kabani C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014398; Godschalk RWL, 1998, CARCINOGENESIS, V19, P819, DOI 10.1093/carcin/19.5.819; Gordon L, 2012, GENOME RES, V22, P1395, DOI 10.1101/gr.136598.111; Guintivano J, 2013, EPIGENETICS-US, V8, P290, DOI 10.4161/epi.23924; Hamilton JA, 2007, J MOL NEUROSCI, V33, P12, DOI 10.1007/s12031-007-0050-3; Hegde ML, 2012, MECH AGEING DEV, V133, P157, DOI 10.1016/j.mad.2012.01.005; HIETANEN E, 1990, INT J CANCER, V46, P640, DOI 10.1002/ijc.2910460415; Hsiao PJ, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-82; Jacob RA, 1998, J NUTR, V128, P1204, DOI 10.1093/jn/128.7.1204; JENNINGS E, 1995, MED HYPOTHESES, V45, P297, DOI 10.1016/0306-9877(95)90121-3; Kimura Y, 2012, AM J CLIN NUTR, V95, P1209, DOI 10.3945/ajcn.111.030817; Langie SAS, 2011, MUTAGENESIS, V26, P461, DOI 10.1093/mutage/ger005; Langie SAS, 2010, MUTAT RES-GEN TOX EN, V695, P75, DOI 10.1016/j.mrgentox.2009.12.005; Lillycrop KA, 2011, INT J OBESITY, V35, P72, DOI 10.1038/ijo.2010.122; Lucock M, 2000, MOL GENET METAB, V71, P121, DOI 10.1006/mgme.2000.3027; Mathers JC, 2007, CURR CANCER DRUG TAR, V7, P425; Mattson MP, 2003, AGEING RES REV, V2, P329, DOI 10.1016/S1568-1637(03)00013-8; Mckay JA, 2011, ACTA PHYSIOL, V202, P103, DOI 10.1111/j.1748-1716.2011.02278.x; McKay JA, 2011, MOL NUTR FOOD RES, V55, P1717, DOI 10.1002/mnfr.201100150; Mehler MF, 2008, PROG NEUROBIOL, V86, P305, DOI 10.1016/j.pneurobio.2008.10.001; Mitchell RW, 2011, PROSTAG LEUKOTR ESS, V85, P293, DOI 10.1016/j.plefa.2011.04.007; Munzel M, 2011, ANGEW CHEM INT EDIT, V50, P6460, DOI 10.1002/anie.201101547; Nabel CS, 2011, SCIENCE, V333, P1229, DOI 10.1126/science.1211917; Ochoa JJ, 2011, FREE RADICAL BIO MED, V50, P1053, DOI 10.1016/j.freeradbiomed.2011.02.004; Palou M, 2011, BRIT J NUTR, V106, P769, DOI 10.1017/S0007114511000973; Parra P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013005; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; Sadakane K, 2006, FOOD CHEM TOXICOL, V44, P1372, DOI 10.1016/j.fct.2006.03.002; Sibani S, 2002, CARCINOGENESIS, V23, P61, DOI 10.1093/carcin/23.1.61; Slim RM, 1996, J AM COLL NUTR, V15, P289; Sreekumar R, 2002, AM J PHYSIOL-ENDOC M, V282, pE1055, DOI 10.1152/ajpendo.00554.2001; Starlard-Davenport A, 2010, WORLD REV NUTR DIET, V101, P123, DOI 10.1159/000314517; Strakovsky RS, 2011, J PHYSIOL-LONDON, V589, P2707, DOI 10.1113/jphysiol.2010.203950; Unnikrishnan A, 2011, FREE RADICAL BIO MED, V50, P270, DOI 10.1016/j.freeradbiomed.2010.11.003; van den Hove DLA, 2012, CURR ALZHEIMER RES, V9, P545; Vogel U, 2003, FREE RADICAL RES, V37, P947, DOI 10.1080/1071576031000150779; Vucetic Z, 2010, ENDOCRINOLOGY, V151, P4756, DOI 10.1210/en.2010-0505; Waterland RA, 2004, NUTRITION, V20, P63, DOI 10.1016/j.nut.2003.09.011; Zawia NH, 2009, FREE RADICAL BIO MED, V46, P1241, DOI 10.1016/j.freeradbiomed.2009.02.006	56	56	57	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2013	27	8					3323	3334		10.1096/fj.12-224121	http://dx.doi.org/10.1096/fj.12-224121			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	292BT	23603834				2022-12-25	WOS:000329877600037
J	Chen, WZ; Zhou, ZR; Li, LS; Zhong, CQ; Zheng, XR; Wu, XR; Zhang, YY; Ma, H; Huang, DL; Li, WJ; Xia, ZP; Han, JH				Chen, Wanze; Zhou, Zhenru; Li, Lisheng; Zhong, Chuan-Qi; Zheng, Xinru; Wu, Xiurong; Zhang, Yingying; Ma, Huan; Huang, Deli; Li, Wenjuan; Xia, Zongping; Han, Jiahuai			Diverse Sequence Determinants Control Human and Mouse Receptor Interacting Protein 3 (RIP3) and Mixed Lineage Kinase domain-Like (MLKL) Interaction in Necroptotic Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROGRAMMED NECROSIS; CELL-DEATH; TNF-ALPHA; INFLAMMATION; APOPTOSIS; PHOSPHORYLATION; MACROPHAGES; DOWNSTREAM; INHIBITION; COMPLEXES	Receptor interacting protein 3 (RIP3) is a protein kinase essential for TNF-induced necroptosis. Phosphorylation on Ser227 in human RIP3 (hRIP3) is required for its interaction with human mixed lineage kinase domain-like (MLKL) in the necrosome, a signaling complex induced by TNF stimulation. RIP1 and RIP3 mediate necrosome aggregation leading to the formation of amyloid-like signaling complexes. We found that TNF induces Thr-231 and Ser-232 phosphorylation in mouse RIP3 (mRIP3) and this phosphorylation is required for mRIP3 to interact with mMLKL. Ser-232 in mRIP3 corresponds to Ser-227 in hRIP3, whereas Thr-231 is not conserved in hRIP3. Although the RIP3-MLKL interaction is required for necroptosis in both human and mouse cells, hRIP3 does not interact with mMLKL and mRIP3 cannot bind to hMLKL. The species specificity of the RIP3-MLKL interaction is primarily determined by the sequence differences in the phosphorylation sites and the flanking sequence around the phosphorylation sites in hRIP3 and mRIP3. It appears that the RIP3-MLKL interaction has been selected as an evolutionarily conserved mechanism in mediating necroptosis signaling despite that differing structural and mechanistic bases for this interaction emerged simultaneously in different organisms. In addition, we further revealed that the interaction of RIP3 with MLKL prevented massive abnormal RIP3 aggregation, and therefore should be crucial for formation of the amyloid signaling complex of necrosomes. We also found that the interaction between RIP3 and MLKL is required for the translocation of necrosomes to mitochondria-associated membranes. Our data demonstrate the importance of the RIP3-MLKL interaction in the formation of functional necrosomes and suggest that translocation of necrosomes to mitochondria-associated membranes is essential for necroptosis signaling.	[Chen, Wanze; Zhou, Zhenru; Li, Lisheng; Zhong, Chuan-Qi; Zheng, Xinru; Wu, Xiurong; Zhang, Yingying; Ma, Huan; Huang, Deli; Li, Wenjuan; Han, Jiahuai] Xiamen Univ, State Key Lab Cellular Stress Biol, Xiamen 361005, Fujian, Peoples R China; [Chen, Wanze; Zhou, Zhenru; Li, Lisheng; Zhong, Chuan-Qi; Zheng, Xinru; Wu, Xiurong; Zhang, Yingying; Ma, Huan; Huang, Deli; Li, Wenjuan; Han, Jiahuai] Xiamen Univ, Sch Life Sci, Xiamen 361005, Fujian, Peoples R China; [Xia, Zongping] Zhejiang Univ, Inst Life Sci, Hangzhou 310058, Zhejiang, Peoples R China	Xiamen University; Xiamen University; Zhejiang University	Han, JH (corresponding author), Xiamen Univ, State Key Lab Cellular Stress Biol, Xiamen 361005, Fujian, Peoples R China.	jhan@xmu.edu.cn	黄, 德力/GWU-7847-2022; Han, J/G-4671-2010; Zhang, Yingying/G-5244-2017	黄, 德力/0000-0002-6989-639X; Li, Lisheng/0000-0002-0793-272X; Chen, Wanze/0000-0002-7946-3336	973 program Grant [2009CB522201]; National Science Foundation of China [91029304, 31221065, 81061160512, 91229201]; 863 program Grant [2012AA02A201]; 111 Project [B12001]; Chinese National Scientific and Technological Major Project Grant [2013ZX10002002]; Open Research Fund of State Key Laboratory of Cellular Stress Biology, Xiamen University [SKLCSB2012KF003]	973 program Grant(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); 863 program Grant; 111 Project(Ministry of Education, China - 111 Project); Chinese National Scientific and Technological Major Project Grant; Open Research Fund of State Key Laboratory of Cellular Stress Biology, Xiamen University	This work was supported by 973 program Grant 2009CB522201, National Science Foundation of China Grants 91029304, 31221065, 81061160512, 91229201, 863 program Grant 2012AA02A201, 111 Project B12001, Chinese National Scientific and Technological Major Project Grant 2013ZX10002002, and Open Research Fund of State Key Laboratory of Cellular Stress Biology, Xiamen University Grant SKLCSB2012KF003.	Bertrand MJM, 2008, MOL CELL, V30, P689, DOI 10.1016/j.molcel.2008.05.014; Bonnet MC, 2011, IMMUNITY, V35, P572, DOI 10.1016/j.immuni.2011.08.014; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Ciarlo L, 2010, CELL DEATH DIFFER, V17, P1047, DOI 10.1038/cdd.2009.208; Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711; Fortes GB, 2012, BLOOD, V119, P2368, DOI 10.1182/blood-2011-08-375303; Friedman JR, 2011, SCIENCE, V334, P358, DOI 10.1126/science.1207385; Gunther C, 2011, NATURE, V477, P335, DOI 10.1038/nature10400; Han JH, 2011, NAT IMMUNOL, V12, P1143, DOI 10.1038/ni.2159; Hayashi T, 2009, TRENDS CELL BIOL, V19, P81, DOI 10.1016/j.tcb.2008.12.002; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; Kaiser WJ, 2011, NATURE, V471, P368, DOI 10.1038/nature09857; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Li JX, 2012, CELL, V150, P339, DOI 10.1016/j.cell.2012.06.019; Liedtke C, 2011, GASTROENTEROLOGY, V141, P2176, DOI 10.1053/j.gastro.2011.08.037; Lin J, 2013, CELL REP, V3, P200, DOI 10.1016/j.celrep.2012.12.012; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Murakami Y, 2012, P NATL ACAD SCI USA, V109, P14598, DOI 10.1073/pnas.1206937109; Oberst A, 2011, NATURE, V471, P363, DOI 10.1038/nature09852; Robinson N, 2012, NAT IMMUNOL, V13, P954, DOI 10.1038/ni.2397; Schneider-Brachert W, 2004, IMMUNITY, V21, P415, DOI 10.1016/j.immuni.2004.08.017; Sun LM, 2012, CELL, V148, P213, DOI 10.1016/j.cell.2011.11.031; Trichonas G, 2010, P NATL ACAD SCI USA, V107, P21695, DOI 10.1073/pnas.1009179107; Upton JW, 2012, CELL HOST MICROBE, V11, P290, DOI [10.1016/j.chom.2012.01.016, 10.1016/j.chom.2019.09.004]; Upton JW, 2010, CELL HOST MICROBE, V7, P302, DOI 10.1016/j.chom.2010.03.006; Wang L, 2008, CELL, V133, P693, DOI 10.1016/j.cell.2008.03.036; Wang ZG, 2012, CELL, V148, P228, DOI 10.1016/j.cell.2011.11.030; Welz PS, 2011, NATURE, V477, P330, DOI 10.1038/nature10273; Wieckowski MR, 2009, NAT PROTOC, V4, P1582, DOI 10.1038/nprot.2009.151; Wu XR, 2012, MOL CELL PROTEOMICS, V11, P1640, DOI 10.1074/mcp.M112.019091; Zhang DW, 2009, SCIENCE, V325, P332, DOI 10.1126/science.1172308; Zhang F, 2011, NAT BIOTECHNOL, V29, P149, DOI 10.1038/nbt.1775; Zhang HB, 2011, NATURE, V471, P373, DOI 10.1038/nature09878; Zhao J, 2012, P NATL ACAD SCI USA, V109, P5322, DOI 10.1073/pnas.1200012109	34	179	187	0	38	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2013	288	23					16247	16261		10.1074/jbc.M112.435545	http://dx.doi.org/10.1074/jbc.M112.435545			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	163ZU	23612963	Green Published, hybrid			2022-12-25	WOS:000320378900005
J	Frisz, JF; Klitzing, HA; Lou, KY; Hutcheon, ID; Weber, PK; Zimmerberg, J; Kraft, ML				Frisz, Jessica F.; Klitzing, Haley A.; Lou, Kaiyan; Hutcheon, Ian D.; Weber, Peter K.; Zimmerberg, Joshua; Kraft, Mary L.			Sphingolipid Domains in the Plasma Membranes of Fibroblasts Are Not Enriched with Cholesterol	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ION MASS-SPECTROMETRY; LIPID-MEMBRANES; INFLUENZA-VIRUS; PROTEINS; CELLS; RAFTS; ACTIN; HEMAGGLUTININ; ORGANIZATION; ADHESION	The plasma membranes of mammalian cells are widely expected to contain domains that are enriched with cholesterol and sphingolipids. In this work, we have used high-resolution secondary ion mass spectrometry to directly map the distributions of isotope-labeled cholesterol and sphingolipids in the plasma membranes of intact fibroblast cells. Although acute cholesterol depletion reduced sphingolipid domain abundance, cholesterol was evenly distributed throughout the plasma membrane and was not enriched within the sphingolipid domains. Thus, we rule out favorable cholesterol-sphingolipid interactions as dictating plasma membrane organization in fibroblast cells. Because the sphingolipid domains are disrupted by drugs that depolymerize the cells actin cytoskeleton, cholesterol must instead affect the sphingolipid organization via an indirect mechanism that involves the cytoskeleton.	[Frisz, Jessica F.; Klitzing, Haley A.; Kraft, Mary L.] Univ Illinois, Dept Chem, Urbana, IL 61801 USA; [Lou, Kaiyan; Kraft, Mary L.] Univ Illinois, Dept Chem & Biomol Engn, Urbana, IL 61801 USA; [Hutcheon, Ian D.; Weber, Peter K.] Lawrence Livermore Natl Lab, Glenn T Seaborg Inst, Livermore, CA 94551 USA; [Zimmerberg, Joshua] Eunice Kennedy Shriver NICHD, Program Phys Biol, NIH, Bethesda, MD 20892 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Kraft, ML (corresponding author), Univ Illinois, Dept Chem & Biomol Engn, 600 S Mathews Ave, Urbana, IL 61801 USA.	mlkraft@illinois.edu	Weber, Peter Kilian/AAP-9517-2020	Weber, Peter Kilian/0000-0001-6022-6050	Career Award at the Scientific Interface from the Burroughs Wellcome Fund; NICHD; National Institutes of Health; National Institutes of Health Training Program in the Chemistry-Biology Interface [T32 GM070421]; National Science Foundation [CHE-1058809]; Laboratory Directed Research and Development funding at the Lawrence Livermore National Laboratory; U.S. Department of Energy [DE-AC52-07NA27344]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001409] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM070421] Funding Source: NIH RePORTER; Direct For Mathematical & Physical Scien [1058809] Funding Source: National Science Foundation	Career Award at the Scientific Interface from the Burroughs Wellcome Fund(Burroughs Wellcome Fund); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Training Program in the Chemistry-Biology Interface(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Laboratory Directed Research and Development funding at the Lawrence Livermore National Laboratory; U.S. Department of Energy(United States Department of Energy (DOE)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported in part by a Career Award at the Scientific Interface from the Burroughs Wellcome Fund (to M. L. K.), the Intramural Program of the NICHD, National Institutes of Health, National Institutes of Health Training Program in the Chemistry-Biology Interface T32 GM070421 (to J. F. F.), National Science Foundation Grant CHE-1058809, and Laboratory Directed Research and Development funding at the Lawrence Livermore National Laboratory. Work at the Lawrence Livermore National Laboratory was performed under the auspices of U.S. Department of Energy Contract DE-AC52-07NA27344.	Altelaar AFM, 2006, ANAL CHEM, V78, P734, DOI 10.1021/ac0513111; Anderton CR, 2011, BBA-BIOMEMBRANES, V1808, P307, DOI 10.1016/j.bbamem.2010.09.016; Bezrukov L, 2009, ANAL BIOCHEM, V394, P171, DOI 10.1016/j.ab.2009.07.027; Dondoni A., 2000, ORG SYNTH, V77, P64; Eggeling C, 2009, NATURE, V457, P1159, DOI 10.1038/nature07596; Fan J, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.011908; Fan J, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.178102; Frisz JF, 2013, P NATL ACAD SCI USA, V110, pE613, DOI 10.1073/pnas.1216585110; GARNER P, 1988, J ORG CHEM, V53, P4395, DOI 10.1021/jo00253a039; Gheber LA, 1999, BIOPHYS J, V77, P3163, DOI 10.1016/S0006-3495(99)77147-X; Ghosal S, 2008, ANAL CHEM, V80, P5986, DOI 10.1021/ac8006279; Goswami D, 2008, CELL, V135, P1085, DOI 10.1016/j.cell.2008.11.032; Gowrishankar K, 2012, CELL, V149, P1353, DOI 10.1016/j.cell.2012.05.008; Hess ST, 2005, J CELL BIOL, V169, P965, DOI 10.1083/jcb.200412058; Klitzing Haley A, 2013, Methods Mol Biol, V950, P483, DOI 10.1007/978-1-62703-137-0_26; Kraft ML, 2006, SCIENCE, V313, P1948, DOI 10.1126/science.1130279; Kwik J, 2003, P NATL ACAD SCI USA, V100, P13964, DOI 10.1073/pnas.2336102100; Lavi Y, 2007, BIOPHYS J, V93, pL35, DOI 10.1529/biophysj.107.111567; Lechene CP, 2007, SCIENCE, V317, P1563, DOI 10.1126/science.1145557; Leslie M, 2011, SCIENCE, V334, P1046, DOI 10.1126/science.334.6059.1046-b; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Lozano MM, 2013, J AM CHEM SOC, V135, P5620, DOI 10.1021/ja310831m; Maxfield FR, 2006, CURR OPIN CELL BIOL, V18, P379, DOI 10.1016/j.ceb.2006.06.012; MCKENNIS H, 1948, J BIOL CHEM, V172, P313; McMahon G, 2006, APPL SURF SCI, V252, P6895, DOI 10.1016/j.apsusc.2006.02.170; Norman LL, 2010, CELL MOL BIOENG, V3, P151, DOI 10.1007/s12195-010-0119-x; Polozov IV, 2008, NAT CHEM BIOL, V4, P248, DOI 10.1038/nchembio.77; Ramprasad OG, 2007, CELL MOTIL CYTOSKEL, V64, P199, DOI 10.1002/cm.20176; Scheiffele P, 1997, EMBO J, V16, P5501, DOI 10.1093/emboj/16.18.5501; Sheng R, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2221; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Simons K, 2010, NAT REV MOL CELL BIO, V11, P688, DOI 10.1038/nrm2977; Steinhauser ML, 2012, NATURE, V481, P516, DOI 10.1038/nature10734; Turner MS, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.168301; Veatch SL, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.148101; Wang PY, 2005, SCIENCE, V307, P1472, DOI 10.1126/science.1107710; Wilson RL, 2012, BIOCONJUGATE CHEM, V23, P450, DOI 10.1021/bc200482z; Zidovetzki R, 2007, BBA-BIOMEMBRANES, V1768, P1311, DOI 10.1016/j.bbamem.2007.03.026	38	115	117	0	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2013	288	23					16855	16861		10.1074/jbc.M113.473207	http://dx.doi.org/10.1074/jbc.M113.473207			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	163ZU	23609440	Green Submitted, hybrid, Green Published			2022-12-25	WOS:000320378900058
J	Gari, RRS; Frey, NC; Mao, CF; Randall, LL; King, GM				Gari, Raghavendar Reddy Sanganna; Frey, Nathan C.; Mao, Chunfeng; Randall, Linda L.; King, Gavin M.			Dynamic Structure of the Translocon SecYEG in Membrane DIRECT SINGLE MOLECULE OBSERVATIONS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-TRANSLOCATION; ESCHERICHIA-COLI; LATERAL GATE; CHANNEL; SECA; COMPLEX; RESOLUTION; ATPASE	Purified SecYEG was reconstituted into liposomes and studied in near-native conditions using atomic force microscopy. These SecYEG proteoliposomes were active in translocation assays. Changes in the structure of SecYEG as a function of time were directly visualized. The dynamics observed were significant in magnitude (similar to 1-10 angstrom) and were attributed to the two large loops of SecY linking transmembrane helices 6-7 and 8-9. In addition, we identified a distribution between monomers and dimers of SecYEG as well as a smaller population of higher order oligomers. This work provides a new vista of the flexible and dynamic structure of SecYEG, an intricate and vital membrane protein.	[Gari, Raghavendar Reddy Sanganna; Frey, Nathan C.; King, Gavin M.] Univ Missouri, Dept Phys & Astron, Columbia, MO 65211 USA; [Mao, Chunfeng; Randall, Linda L.; King, Gavin M.] Univ Missouri, Dept Biochem, Columbia, MO 65211 USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	King, GM (corresponding author), Univ Missouri, Dept Phys & Astron, 223 Phys Bldg, Columbia, MO 65211 USA.	kinggm@missouri.edu	Frey, Nathan C./M-7197-2019	Frey, Nathan C./0000-0001-5291-6131; King, Gavin/0000-0002-5811-7012	National Science Foundation CAREER Award [1054832]; Burroughs Wellcome Fund Career Award at the Scientific Interface; National Institutes of Health [GM29798]; Hugo Wurdack Trust at the University of Missouri; Div Of Molecular and Cellular Bioscience [1054832] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM029798, R37GM029798] Funding Source: NIH RePORTER	National Science Foundation CAREER Award(National Science Foundation (NSF)); Burroughs Wellcome Fund Career Award at the Scientific Interface(Burroughs Wellcome Fund); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hugo Wurdack Trust at the University of Missouri; Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Science Foundation CAREER Award 1054832 (to G. M .K.), the Burroughs Wellcome Fund Career Award at the Scientific Interface (to G. M .K.), National Institutes of Health Grant GM29798 (to L. L .R.), and an endowment from the Hugo Wurdack Trust at the University of Missouri.	Bessonneau P, 2002, EMBO J, V21, P995, DOI 10.1093/emboj/21.5.995; BINNIG G, 1986, PHYS REV LETT, V56, P930, DOI 10.1103/PhysRevLett.56.930; Bippes CA, 2011, REP PROG PHYS, V74, DOI 10.1088/0034-4885/74/8/086601; Cannon KS, 2005, J CELL BIOL, V169, P219, DOI 10.1083/jcb.200412019; Dalal K, 2012, P NATL ACAD SCI USA, V109, P4104, DOI 10.1073/pnas.1117783109; Deville K, 2011, J BIOL CHEM, V286, P4659, DOI 10.1074/jbc.M110.175638; du Plessis DJF, 2009, J BIOL CHEM, V284, P15805, DOI 10.1074/jbc.M901855200; Duong F, 2003, EMBO J, V22, P4375, DOI 10.1093/emboj/cdg418; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Frauenfeld J, 2011, NAT STRUCT MOL BIOL, V18, P614, DOI 10.1038/nsmb.2026; Gumbart J, 2007, BIOCHEMISTRY-US, V46, P11147, DOI 10.1021/bi700835d; Howard J., 2001, MECH MOTOR PROTEINS; Kedrov A, 2011, EMBO J, V30, P4387, DOI 10.1038/emboj.2011.314; Luckey M., 2008, MEMBRANE STRUCTURAL; Manting EH, 2000, EMBO J, V19, P852, DOI 10.1093/emboj/19.5.852; Mao CF, 2009, J BACTERIOL, V191, P978, DOI 10.1128/JB.01321-08; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Mitra K, 2005, NATURE, V438, P318, DOI 10.1038/nature04133; Miyagi A, 2008, CHEMPHYSCHEM, V9, P1859, DOI 10.1002/cphc.200800210; Mori H, 2001, P NATL ACAD SCI USA, V98, P5128, DOI 10.1073/pnas.081617398; Muller DJ, 1999, BIOPHYS J, V76, P1101, DOI 10.1016/S0006-3495(99)77275-9; Muller DJ, 1997, BIOPHYS J, V73, P1633, DOI 10.1016/S0006-3495(97)78195-5; Muller DJ, 1998, FEBS LETT, V430, P105, DOI 10.1016/S0014-5793(98)00623-1; Nijeholt JALA, 2012, PHILOS T R SOC B, V367, P1016, DOI 10.1098/rstb.2011.0201; Papanikou E, 2007, NAT REV MICROBIOL, V5, P839, DOI 10.1038/nrmicro1771; Park E, 2012, ANNU REV BIOPHYS, V41, P21, DOI [10.1146/annurev-biophys-050511-102312, 10.1146/annurev-biophys-050511-402312]; Randall LL, 2002, CELL MOL LIFE SCI, V59, P1617, DOI 10.1007/PL00012488; Richter RP, 2006, LANGMUIR, V22, P3497, DOI 10.1021/la052687c; Rico F, 2011, NANO LETT, V11, P3983, DOI 10.1021/nl202351t; Rigaud JL, 2003, METHOD ENZYMOL, V372, P65; Schaap IAT, 2006, BIOPHYS J, V91, P1521, DOI 10.1529/biophysj.105.077826; Scheuring J, 2005, J MOL BIOL, V354, P258, DOI 10.1016/j.jmb.2005.09.058; Scheuring S, 2005, SCIENCE, V309, P484, DOI 10.1126/science.1110879; Scheuring S, 1999, EMBO J, V18, P4981, DOI 10.1093/emboj/18.18.4981; SHIBA K, 1984, EMBO J, V3, P631, DOI 10.1002/j.1460-2075.1984.tb01859.x; Shibata M, 2010, NAT NANOTECHNOL, V5, P208, DOI [10.1038/nnano.2010.7, 10.1038/NNANO.2010.7]; Shoemaker BA, 2000, P NATL ACAD SCI USA, V97, P8868, DOI 10.1073/pnas.160259697; Todd BA, 2001, SURF SCI, V491, P473, DOI 10.1016/S0039-6028(01)01313-9; Tsukazaki T, 2008, NATURE, V455, P988, DOI 10.1038/nature07421; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; Villarrubia JS, 1997, J RES NATL INST STAN, V102, P425, DOI 10.6028/jres.102.030; Zimmer J, 2008, NATURE, V455, P936, DOI 10.1038/nature07335	42	25	26	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2013	288	23					16848	16854		10.1074/jbc.M113.471870	http://dx.doi.org/10.1074/jbc.M113.471870			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	163ZU	23609442	Green Published, hybrid			2022-12-25	WOS:000320378900057
J	Olson, LJ; Orsi, R; Alculumbre, SG; Peterson, FC; Stigliano, ID; Parodi, AJ; D'Alessio, C; Dahms, NM				Olson, Linda J.; Orsi, Ramiro; Alculumbre, Solana G.; Peterson, Francis C.; Stigliano, Ivan D.; Parodi, Armando J.; D'Alessio, Cecilia; Dahms, Nancy M.			Structure of the Lectin Mannose 6-Phosphate Receptor Homology (MRH) Domain of Glucosidase II, an Enzyme That Regulates Glycoprotein Folding Quality Control in the Endoplasmic Reticulum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-SUBUNIT; OLIGOSACCHARIDE RECOGNITION; SCHIZOSACCHAROMYCES-POMBE; HUMAN OS-9; PROTEIN; CALNEXIN; GLUCOSYLATION; LOCALIZATION; DEGRADATION; ASSIGNMENT	Here we report for the first time the three-dimensional structure of a mannose 6-phosphate receptor homology (MRH) domain present in a protein with enzymatic activity, glucosidase II (GII). GII is involved in glycoprotein folding in the endoplasmic reticulum. GII removes the two innermost glucose residues from the Glc(3)Man(9)GlcNAc(2) transferred to nascent proteins and the glucose added by UDP-Glc:glycoprotein glucosyltransferase. GII is composed of a catalytic GII alpha subunit and a regulatory GII alpha subunit. GII beta participates in the endoplasmic reticulum localization of GII alpha and mediates in vivo enhancement of N-glycan trimming by GII through its C-terminal MRH domain. We determined the structure of a functional GII alpha MRH domain by NMR spectroscopy. It adopts a beta-barrel fold similar to that of other MRH domains, but its binding pocket is the most shallow known to date as it accommodates a single mannose residue. In addition, we identified a conserved residue outside the binding pocket (Trp-409) present in GII beta but not in other MRHs that influences GII glucose trimming activity.	[Olson, Linda J.; Peterson, Francis C.; Dahms, Nancy M.] Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA; [Orsi, Ramiro; Alculumbre, Solana G.; Stigliano, Ivan D.; Parodi, Armando J.; D'Alessio, Cecilia] Consejo Nacl Invest Cient & Tecn, Fdn Inst Leloir, RA-1405 Buenos Aires, DF, Argentina; [Orsi, Ramiro; Alculumbre, Solana G.; Stigliano, Ivan D.; Parodi, Armando J.; D'Alessio, Cecilia] Consejo Nacl Invest Cient & Tecn, Inst Invest Bioquim Buenos Aires, RA-1405 Buenos Aires, DF, Argentina; [D'Alessio, Cecilia] Univ Buenos Aires, Sch Sci, Buenos Aires, DF, Argentina	Medical College of Wisconsin; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Leloir Institute; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	D'Alessio, C (corresponding author), Consejo Nacl Invest Cient & Tecn, Inst Invest Bioquim Buenos Aires, Fdn Inst Leloir, Lab Glycobiol, Av Patricias Argentinas 435,C1405BWE, Buenos Aires, DF, Argentina.	cdalessio@leloir.org.ar; ndahms@mcw.edu		D'Alessio, Cecilia/0000-0001-7371-5080	National Institutes of Health [R01DK042667, GM44500]; Mizutani Foundation for Glycoscience Grant [10-0056]; Agencia Nacional de Promocion Cientifica y Tecnologica [PICT 2010-0734]; Howard Hughes Medical Institute; Consejo Nacional de Investigaciones Cientificas y Tecnicas [PIP-N824]; University of Buenos Aires [UBACYT-X290]; Advancing a Healthier Wisconsin program; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK042667] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044500] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mizutani Foundation for Glycoscience Grant; Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); University of Buenos Aires(University of Buenos Aires); Advancing a Healthier Wisconsin program; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01DK042667 (to N. M. D.) and GM44500 (to A. J. P.). This work was also supported by Mizutani Foundation for Glycoscience Grant 10-0056 (to N. M. D.), Agencia Nacional de Promocion Cientifica y Tecnologica Grant PICT 2010-0734 and the Howard Hughes Medical Institute (to A. P.), and Consejo Nacional de Investigaciones Cientificas y Tecnicas Grant PIP-N824 and University of Buenos Aires Grant UBACYT-X290 (to C. D.).; The BIAcore 3000 instrument was purchased through a grant from the Advancing a Healthier Wisconsin program. Acid alpha-glucosidase was generously provided by Dr. William Canfield. We thank Drs. J. J. Caramelo, L. Alonso, and G. Paris from the Fundacion Instituto Leloir for helpful discussions and advice with GII beta purification. UDP-[<SUP>14</SUP>C] Glc was efficiently synthesized by Susana Raffo. We also thank Dr. Jung-Ja Kim for critical reading of the manuscript.	Alfa C., 1993, EXPT FISSION YEAST L, P133; ALLEN HJ, 1976, CARBOHYD RES, V50, P121; Bartels C, 1996, J BIOMOL NMR, V7, P207, DOI 10.1007/BF00202037; BARTELS C, 1995, J BIOMOL NMR, V6, P1, DOI 10.1007/BF00417486; Bohnsack RN, 2009, J BIOL CHEM, V284, P35215, DOI 10.1074/jbc.M109.056184; Brown J, 2008, EMBO J, V27, P265, DOI 10.1038/sj.emboj.7601938; Castonguay AC, 2011, BBA-GEN SUBJECTS, V1810, P815, DOI 10.1016/j.bbagen.2011.06.016; Chavez CA, 2007, BIOCHEMISTRY-US, V46, P12604, DOI 10.1021/bi7011806; D'Alessio C, 1999, J BIOL CHEM, V274, P25899, DOI 10.1074/jbc.274.36.25899; D'Alessio C, 2010, SEMIN CELL DEV BIOL, V21, P491, DOI 10.1016/j.semcdb.2009.12.014; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Fernandez F, 1998, EMBO J, V17, P5877, DOI 10.1093/emboj/17.20.5877; FERNANDEZ FS, 1994, J BIOL CHEM, V269, P30701; Fujimori T, 2013, FEBS J, V280, P1563, DOI 10.1111/febs.12157; GRINNA LS, 1980, J BIOL CHEM, V255, P2255; HAMMOND C, 1994, P NATL ACAD SCI USA, V91, P913, DOI 10.1073/pnas.91.3.913; Hancock MK, 2002, J BIOL CHEM, V277, P47205, DOI 10.1074/jbc.M208534200; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Hosokawa N, 2009, J BIOL CHEM, V284, P17061, DOI 10.1074/jbc.M809725200; Hu D, 2009, GLYCOBIOLOGY, V19, P1127, DOI 10.1093/glycob/cwp104; JANNATIPOUR M, 1995, J BIOL CHEM, V270, P4845, DOI 10.1074/jbc.270.9.4845; Kamiya Y, 2012, BBA-GEN SUBJECTS, V1820, P1327, DOI 10.1016/j.bbagen.2011.12.017; Kim JJP, 2009, CURR OPIN STRUC BIOL, V19, P534, DOI 10.1016/j.sbi.2009.09.002; Kumari M, 2011, PHYS CHEM CHEM PHYS, V13, P6517, DOI 10.1039/c0cp02559c; Linge JP, 2003, PROTEINS, V50, P496, DOI 10.1002/prot.10299; Matsuyama A, 2006, NAT BIOTECHNOL, V24, P841, DOI 10.1038/nbt1222; Mikami K, 2010, GLYCOBIOLOGY, V20, P310, DOI 10.1093/glycob/cwp175; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Munro S, 2001, CURR BIOL, V11, pR499, DOI 10.1016/S0960-9822(01)00302-5; Myszka DG, 2000, METHOD ENZYMOL, V323, P325; Olson LJ, 2010, P NATL ACAD SCI USA, V107, P12493, DOI 10.1073/pnas.1004232107; Olson LJ, 2004, J BIOL CHEM, V279, P34000, DOI 10.1074/jbc.M404588200; Olson LJ, 2004, EMBO J, V23, P2019, DOI 10.1038/sj.emboj.7600215; Quan EM, 2008, MOL CELL, V32, P870, DOI 10.1016/j.molcel.2008.11.017; Quinn RP, 2009, GLYCOBIOLOGY, V19, P1408, DOI 10.1093/glycob/cwp087; Roberts DL, 1998, CELL, V93, P639, DOI 10.1016/S0092-8674(00)81192-7; Satoh T, 2010, MOL CELL, V40, P905, DOI 10.1016/j.molcel.2010.11.017; Schallus T, 2008, MOL BIOL CELL, V19, P3404, DOI 10.1091/mbc.E08-04-0354; Schrag JD, 2001, MOL CELL, V8, P633, DOI 10.1016/S1097-2765(01)00318-5; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Stigliano ID, 2011, MOL BIOL CELL, V22, P1810, DOI 10.1091/mbc.E11-01-0019; Stigliano ID, 2009, MOL BIOL CELL, V20, P3974, DOI 10.1091/mbc.E09-04-0316; Totani K, 2008, J AM CHEM SOC, V130, P2101, DOI 10.1021/ja077570k; Totani K, 2006, J BIOL CHEM, V281, P31502, DOI 10.1074/jbc.M605457200; Trombetta ES, 1996, J BIOL CHEM, V271, P27509, DOI 10.1074/jbc.271.44.27509; TROMBETTA SE, 1989, BIOCHEMISTRY-US, V28, P8108, DOI 10.1021/bi00446a022; Uson I, 2003, ACTA CRYSTALLOGR D, V59, P57, DOI 10.1107/S090744490201884X; Walker JM, 2002, PROTEIN PROTOCOLS HD, P803; Watanabe T, 2009, GLYCOBIOLOGY, V19, P834, DOI 10.1093/glycob/cwp061; Woods RJ, 1998, EUR J BIOCHEM, V258, P372, DOI 10.1046/j.1432-1327.1998.2580372.x; WRIGHT A, 1965, P NATL ACAD SCI USA, V54, P235, DOI 10.1073/pnas.54.1.235	53	23	23	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2013	288	23					16460	16475		10.1074/jbc.M113.450239	http://dx.doi.org/10.1074/jbc.M113.450239			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	163ZU	23609449	Green Published, hybrid			2022-12-25	WOS:000320378900023
J	Maehlen, MT; Provan, SA; de Rooy, DPC; van der Helm-van Mil, AHM; Krabben, A; Saxne, T; Lindqvist, E; Semb, AG; Uhlig, T; van der Heijde, D; Mero, IL; Olsen, IC; Kvien, TK; Lie, BA				Maehlen, Marthe T.; Provan, Sella A.; de Rooy, Diederik P. C.; van der Helm-van Mil, Annette H. M.; Krabben, Annemarie; Saxne, Tore; Lindqvist, Elisabet; Semb, Anne Grete; Uhlig, Till; van der Heijde, Desiree; Mero, Inger Lise; Olsen, Inge C.; Kvien, Tore K.; Lie, Benedicte A.			Associations between APOE Genotypes and Disease Susceptibility, Joint Damage and Lipid Levels in Patients with Rheumatoid Arthritis	PLOS ONE			English	Article							PREDICT RADIOGRAPHIC PROGRESSION; APOLIPOPROTEIN-E GENE; INFLAMMATION; DESTRUCTION; RISK; ATHEROSCLEROSIS; POLYMORPHISMS; VARIABLES; 10-YEAR; PROTEIN	Objective: Apolipoprotein E (APOE) genotypes are associated with cardiovascular disease (CVD) and lipid levels. In rheumatoid arthritis (RA), an association has been found with disease activity. We examined the associations between APOE genotypes and disease susceptibility and markers of disease severity in RA, including radiographic joint damage, inflammatory markers, lipid levels and cardiovascular markers. Method: A Norwegian cohort of 945 RA patients and 988 controls were genotyped for two APOE polymorphisms. We examined longitudinal associations between APOE genotypes and C-reactive protein (CRP), erythrocyte sedimentation rate (ESR) as well as hand radiographs (van der Heijde Sharp Score(SHS)) in 207 patients with 10 year longitudinal data. Lipid levels, cardiovascular markers and history of CVD were compared across genotypes in a cross sectional study of 136 patients. Longitudinal radiological data of cohorts from Lund and Leiden were available for replication. (N = 935, with 4799 radiographs). Results: In the Norwegian cohort, associations between APOE genotypes and total cholesterol (TC) and low-density lipoproteins (LDL) were observed (epsilon 2<epsilon 3/epsilon 3<epsilon 4, p = 0.03 and p = 0.02, respectively). No association was present for acute phase reactant or CVD markers, but a longitudinal linear association between APOE genotypes and radiographic joint damage was observed (p = 0.007). No association between APOE genotypes and the severity of joint destruction was observed in the Lund and Leiden cohorts, and a meta-analysis combining all data was negative. Conclusion: APOE genotypes are associated with lipid levels in patients with RA, and may contribute to dyslipidemia in some patients. APOE genotypes are not consistently associated with markers of inflammation or joint destruction in RA.	[Maehlen, Marthe T.; Mero, Inger Lise; Lie, Benedicte A.] Univ Oslo, Dept Med Genet, Oslo, Norway; [Maehlen, Marthe T.; Mero, Inger Lise; Lie, Benedicte A.] Oslo Univ Hosp, Oslo, Norway; [Maehlen, Marthe T.; Provan, Sella A.; Semb, Anne Grete; Uhlig, Till; van der Heijde, Desiree; Olsen, Inge C.; Kvien, Tore K.] Diakonhjemmet Hosp, Dept Rheumatol, Oslo, Norway; [de Rooy, Diederik P. C.; van der Helm-van Mil, Annette H. M.; Krabben, Annemarie; van der Heijde, Desiree] Leiden Univ, Med Ctr, Dept Rheumatol, Leiden, Netherlands; [Saxne, Tore; Lindqvist, Elisabet] Lund Univ, Dept Rheumatol, Lund, Sweden; [Mero, Inger Lise] Univ Oslo, Dept Neurol, Oslo, Norway	University of Oslo; University of Oslo; Diakonhjemmet Hospital; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Lund University; University of Oslo	Maehlen, MT (corresponding author), Univ Oslo, Dept Med Genet, Oslo, Norway.	marthemaehlen@gmail.com	emery, paul/B-3560-2013; Olsen, Inge Christoffer/R-9128-2019; van der Heijde, Désirée/I-6774-2019	Olsen, Inge Christoffer/0000-0001-6889-5873; van der Heijde, Désirée/0000-0002-5781-158X; Uhlig, Till/0000-0002-6881-9552; Provan, Sella/0000-0001-5442-902X; van der Helm - van Mil, Annette/0000-0001-8572-1437; Lindqvist, Elisabet/0000-0002-9937-6352	Southern and Eastern Health Region of Norway (Helse Sor Ost); Dutch Arthritis Foundation (Reumafonds); Dutch organization of Health research and development (Zon-MW)	Southern and Eastern Health Region of Norway (Helse Sor Ost); Dutch Arthritis Foundation (Reumafonds); Dutch organization of Health research and development (Zon-MW)(Netherlands Organization for Health Research and Development)	This work has been funded through grants from the Southern and Eastern Health Region of Norway (Helse Sor Ost). The work of AK and DPCdR is supported by grants of the Dutch Arthritis Foundation (Reumafonds). The work of AHMvdHvM is supported by the Dutch organization of Health research and development (Zon-MW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Belbin O, 2007, HUM MOL GENET, V16, P2199, DOI 10.1093/hmg/ddm171; Bennet AM, 2007, JAMA-J AM MED ASSOC, V298, P1300, DOI 10.1001/jama.298.11.1300; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Coto-Segura P, 2010, ARCH DERMATOL RES, V302, P145, DOI 10.1007/s00403-009-1002-2; de Rooy DPC, 2011, RHEUMATOLOGY, V50, P93, DOI 10.1093/rheumatology/keq230; DUPONT WD, 1990, CONTROL CLIN TRIALS, V11, P116, DOI 10.1016/0197-2456(90)90005-M; Fex E, 1996, BRIT J RHEUMATOL, V35, P1106; Furumoto H, 1997, ARCH DERMATOL RES, V289, P497, DOI 10.1007/s004030050229; Haavardsholm EA, 2008, ANN RHEUM DIS, V67, P794, DOI 10.1136/ard.2007.071977; Halvorsen EH, 2009, ANN RHEUM DIS, V68, P249, DOI 10.1136/ard.2008.094490; Head D, 2012, ARCH NEUROL-CHICAGO, V69, P636, DOI 10.1001/archneurol.2011.845; Hsu J. C, 1992, J COMPUTATIONAL STAT, V1, P151, DOI DOI 10.2307/1390839; Hubacek JA, 2010, HUM IMMUNOL, V71, P304, DOI 10.1016/j.humimm.2010.01.008; Klareskog L, 2009, LANCET, V373, P659, DOI 10.1016/S0140-6736(09)60008-8; Knevel R, 2012, ANN RHEUM DIS S1, V71, pA56; Koenig W, 1999, CIRCULATION, V99, P237, DOI 10.1161/01.CIR.99.2.237; Lebrec JJ, 2010, STAT APPL GENET MOL, V9, DOI 10.2202/1544-6115.1503; Mahley RW, 2000, ANNU REV GENOM HUM G, V1, P507, DOI 10.1146/annurev.genom.1.1.507; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; Marinou I, 2010, ANN RHEUM DIS, V69, P476, DOI 10.1136/ard.2009.117721; Mooyaart AL, 2011, DIABETOLOGIA, V54, P544, DOI 10.1007/s00125-010-1996-1; Odegard S, 2006, ARTHRITIS RHEUM, V54, P68, DOI 10.1002/art.21548; Postigo J, 2011, ARTHRITIS RHEUM-US, V63, P971, DOI 10.1002/art.30220; Provan SA, 2011, ANN RHEUM DIS, V70, P812, DOI 10.1136/ard.2010.141523; Provan SA, 2011, J RHEUMATOL, V38, P606, DOI 10.3899/jrheum.100689; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Semb AG, 2012, RHEUMATOLOG IN PRESS; SIDAK Z, 1967, J AM STAT ASSOC, V62, P626, DOI 10.2307/2283989; Slooter AJC, 2001, STROKE, V32, P1947, DOI 10.1161/hs0901.095377; Stevens Robert J., 2005, Expert Reviews in Molecular Medicine, V7, P1, DOI 10.1017/S1462399405009154; Syversen SW, 2008, ANN RHEUM DIS, V67, P212, DOI 10.1136/ard.2006.068247; Toms Tracey E, 2011, Open Cardiovasc Med J, V5, P64, DOI 10.2174/1874192401105010064; Toms TE, 2012, J RHEUMATOL, V39, P218, DOI 10.3899/jrheum.110683; Uhlig T, 1999, ANN RHEUM DIS, V58, P415, DOI 10.1136/ard.58.7.415; van der Heijde D, 2000, J RHEUMATOL, V27, P261; van der Helm-van Mil AHM, 2006, ARTHRITIS RHEUM-US, V54, P2028, DOI 10.1002/art.21872; van der Helm-van Mil AHM, 2010, RHEUMATOLOGY, V49, P1429, DOI 10.1093/rheumatology/keq013; Welsing PMJ, 2001, ARTHRITIS RHEUM, V44, P2009, DOI 10.1002/1529-0131(200109)44:9<2009::AID-ART349>3.0.CO;2-L; Wozniak MA, 2002, HEPATOLOGY, V36, P456, DOI 10.1053/jhep.2002.34745; Zhang HL, 2010, CLIN DEV IMMUNOL, DOI [10.1155/2010/186813, 10.1155/2010/459143]; Zhang HL, 2011, MEDIAT INFLAMM, V2011, DOI 10.1155/2011/949072	43	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2013	8	4							e60970	10.1371/journal.pone.0060970	http://dx.doi.org/10.1371/journal.pone.0060970			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IK	23613766	Green Published, gold, Green Submitted			2022-12-25	WOS:000317907200022
J	Rasteiro, R; Chikhi, L				Rasteiro, Rita; Chikhi, Lounes			Female and Male Perspectives on the Neolithic Transition in Europe: Clues from Ancient and Modern Genetic Data	PLOS ONE			English	Article							APPROXIMATE BAYESIAN COMPUTATION; LIKELIHOOD-BASED ESTIMATION; DEMIC DIFFUSION-MODEL; SEX-BIASED MIGRATION; POPULATION-GENETICS; 1ST FARMERS; STRONTIUM ISOTOPES; HUNTER-GATHERERS; NUCLEAR-DNA; ADMIXTURE	The arrival of agriculture into Europe during the Neolithic transition brought a significant shift in human lifestyle and subsistence. However, the conditions under which the spread of the new culture and technologies occurred are still debated. Similarly, the roles played by women and men during the Neolithic transition are not well understood, probably due to the fact that mitochondrial DNA (mtDNA) and Y chromosome (NRY) data are usually studied independently rather than within the same statistical framework. Here, we applied an integrative approach, using different model-based inferential techniques, to analyse published datasets from contemporary and ancient European populations. By integrating mtDNA and NRY data into the same admixture approach, we show that both males and females underwent the same admixture history and both support the demic diffusion model of Ammerman and Cavalli-Sforza. Similarly, the patterns of genetic diversity found in extant and ancient populations demonstrate that both modern and ancient mtDNA support the demic diffusion model. They also show that population structure and differential growth between farmers and hunter-gatherers are necessary to explain both types of data. However, we also found some differences between male and female markers, suggesting that the female effective population size was larger than that of the males, probably due to different demographic histories. We argue that these differences are most probably related to the various shifts in cultural practices and lifestyles that followed the Neolithic Transition, such as sedentism, the shift from polygyny to monogamy or the increase of patrilocality.	[Rasteiro, Rita; Chikhi, Lounes] Inst Gulbenkian Ciencias, Oeiras, Portugal; [Chikhi, Lounes] Univ Toulouse 3, CNRS, ENFA, EDB Lab Evolut & Diversite Biol,UMR 5174, Toulouse, France; [Chikhi, Lounes] Univ Toulouse, UPS, EDB Lab Evolut & Diversite Biol, Toulouse, France	Instituto Gulbenkian de Ciencia; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Ecole Nationale Formation Agronomique (ENSFEA); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Ecole Nationale Formation Agronomique (ENSFEA); Centre National de la Recherche Scientifique (CNRS)	Rasteiro, R (corresponding author), Univ Leicester, Dept Genet, Sch Hist Studies, Univ Rd, Leicester LE1 7RH, Leics, England.	rr147@le.ac.uk; chikhi@igc.gulbenkian.pt	Rasteiro, Rita/B-5079-2013	Rasteiro, Rita/0000-0002-4217-3060; Chikhi, Lounes/0000-0002-1140-0718	Fundacao para a Ciencia e Tecnologia (FCT, Portugal) [SFRH/BD/30821/2006]; CNRS (Centre National de la Recherche Scientifique, France); Laboratoire d'Excellence (LABEX) [ANR-10-LABX-41]; FCT [PTDC/BIA-BDE/71299/2008, H200741/re-equip/2005]; Toulouse [2010-P1038, 2012-P1244]; Fundação para a Ciência e a Tecnologia [PTDC/BIA-BDE/71299/2006, SFRH/BD/136590/2018] Funding Source: FCT	Fundacao para a Ciencia e Tecnologia (FCT, Portugal)(Portuguese Foundation for Science and Technology); CNRS (Centre National de la Recherche Scientifique, France)(Centre National de la Recherche Scientifique (CNRS)); Laboratoire d'Excellence (LABEX); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); Toulouse; Fundação para a Ciência e a Tecnologia	RR was funded by a Fundacao para a Ciencia e Tecnologia (FCT, Portugal, http://www.fct.pt) grant (ref. SFRH/BD/30821/2006). LC was partly funded by the CNRS (Centre National de la Recherche Scientifique, France), the "Laboratoire d'Excellence (LABEX, http://www6.inra.fr/labex-tulip_eng/layout/set/print)'' entitled TULIP (ANR-10-LABX-41) and the FCT grant PTDC/BIA-BDE/71299/2008. HPC resources from CALMIP (www.calmip.cict.fr), Toulouse (Grant 2010-P1038 and Grant 2012-P1244 to LC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors are grateful to C. van Schaik, A. Coutinho, G. Gomes, V. Sousa, J. Salmona, J. Alves, S. Davis and two anonymous reviewers for useful comments on earlier versions of this manuscript. Simulations were partly carried out using HPC resources from CALMIP (Toulouse, France) and from Instituto Gulbenkian de Ciencia (IGC, Oeiras, Portugal). We thus thank G. Gomes and P. Fernandes, respectively, for allowing us to use the HULK simulation server and HERMES HPC Centre (FCT grant H200741/re-equip/2005) at IGC. E. Danchin, C. Thebaud and B Crouau-Roy, A. Barelli are also thanked for their support.	AMMERMAN AJ, 1984, NEOLITHIC TRANSITION; Anderson CNK, 2005, BIOINFORMATICS, V21, P1733, DOI 10.1093/bioinformatics/bti154; Baker MJ, 2007, J LAW ECON ORGAN, V23, P208, DOI 10.1093/jleo/ewm009; Balanovsky O, 2011, MOL BIOL EVOL, V28, P2905, DOI 10.1093/molbev/msr126; Balaresque P, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000285; Balter M, 2009, SCIENCE, V325, P1189, DOI 10.1126/science.325_1189; Barbujani G, 1998, AM J HUM GENET, V62, P488, DOI 10.1086/301719; Barbujani G, 2006, HEREDITY, V97, P84, DOI 10.1038/sj.hdy.6800852; Beaumont MA, 2002, GENETICS, V162, P2025; Beaumont MA, 2008, SIMULATIONS GENETICS, P135; Beaumont MA, 2010, MOL ECOL, V19, P436, DOI 10.1111/j.1365-294X.2009.04515.x; Belle EMS, 2006, P ROY SOC B-BIOL SCI, V273, P1595, DOI 10.1098/rspb.2006.3494; Bellwood P., 2004, 1 FARMERS ORIGINS AG; Bellwood P, 2008, NEOLITHIC DEMOGRAPHIC TRANSITION AND ITS CONSEQUENCES, P13, DOI 10.1007/978-1-4020-8539-0_2; Bentley RA, 2008, ANTIQUITY, V82, P290, DOI 10.1017/S0003598X00096812; Bentley RA, 2012, P NATL ACAD SCI USA, V109, P9326, DOI 10.1073/pnas.1113710109; Bentley RA, 2009, HUM BIOL, V81, P159, DOI 10.3378/027.081.0304; Bentley RA, 2003, ANTIQUITY, V77, P63, DOI 10.1017/S0003598X00061342; Bentley RA, 2002, CURR ANTHROPOL, V43, P799, DOI 10.1086/344373; Blum MGB, 2010, STAT COMPUT, V20, P63, DOI 10.1007/s11222-009-9116-0; Bocquet-Appel JP, 2009, J ARCHAEOL SCI, V36, P807, DOI 10.1016/j.jas.2008.11.004; Bocquet-Appel JP, 2005, J ARCHAEOL SCI, V32, P1656, DOI 10.1016/j.jas.2005.05.006; Bocquet-Appel JP, 2002, CURR ANTHROPOL, V43, P637, DOI 10.1086/342429; Boric D, 2013, P NATL ACAD SCI USA, V110, P3298, DOI 10.1073/pnas.1211474110; Bramanti B, 2009, SCIENCE, V326, P137, DOI 10.1126/science.1176869; CavalliSforza LL, 1997, AM J HUM GENET, V61, P247, DOI 10.1016/S0002-9297(07)64303-1; Chikhi L, 1998, P NATL ACAD SCI USA, V95, P9053, DOI 10.1073/pnas.95.15.9053; Chikhi L, 2001, GENETICS, V158, P1347; Chikhi L, 2002, P NATL ACAD SCI USA, V99, P11008, DOI 10.1073/pnas.162158799; Chikhi L, 2005, ENCY GENETICS GENOMI; Chikhi L, 2009, HUM BIOL, V81, P639, DOI 10.3378/027.081.0612; Currat M, 2005, P ROY SOC B-BIOL SCI, V272, P679, DOI 10.1098/rspb.2004.2999; Dupanloup I, 2004, MOL BIOL EVOL, V21, P1361, DOI 10.1093/molbev/msh135; Dupanloup I, 2003, J MOL EVOL, V57, P85, DOI 10.1007/s00239-003-2458-x; Excoffier L, 2000, J HERED, V91, P506, DOI 10.1093/jhered/91.6.506; Fagundes NJR, 2007, P NATL ACAD SCI USA, V104, P17614, DOI 10.1073/pnas.0708280104; Fortunato L, 2011, HUM BIOL, V83, P87, DOI 10.3378/027.083.0106; Fortunato L, 2010, PHILOS T R SOC B, V365, P3913, DOI 10.1098/rstb.2010.0017; Galeta P, 2009, DOC PRAEHIST, V36, P139, DOI 10.4312/dp.36.8; Gamba C, 2012, MOL ECOL, V21, P45, DOI 10.1111/j.1365-294X.2011.05361.x; Gignoux CR, 2011, P NATL ACAD SCI USA, V108, P6044, DOI 10.1073/pnas.0914274108; Giovannini A, 2009, BIOINFORMATICS, V25, P1440, DOI 10.1093/bioinformatics/btp136; Gkiasta M, 2003, ANTIQUITY, V77, P45, DOI 10.1017/S0003598X00061330; Goldstein DB, 2002, ANNU REV GENOM HUM G, V3, P129, DOI 10.1146/annurev.genom.3.022502.103200; Gray RD, 2003, NATURE, V426, P435, DOI 10.1038/nature02029; Haak W, 2005, SCIENCE, V310, P1016, DOI 10.1126/science.1118725; Haak W, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000536; Haak W, 2008, P NATL ACAD SCI USA, V105, P18226, DOI 10.1073/pnas.0807592105; Lagerlof NP, 2010, J ECON GROWTH, V15, P235, DOI 10.1007/s10887-010-9056-8; Langella O, 2001, MOL ECOL NOTES, V1, P357, DOI 10.1046/j.1471-8278.2001.00099.x; Langergraber KE, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000973; Malmstrom H, 2009, CURR BIOL, V19, P1758, DOI 10.1016/j.cub.2009.09.017; Mithen S, 2007, PHILOS T R SOC B, V362, P705, DOI 10.1098/rstb.2006.2005; Pinhasi R, 2005, PLOS BIOL, V3, P2220, DOI 10.1371/journal.pbio.0030410; Pinhasi R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006747; Price TD, 2001, ANTIQUITY, V75, P593, DOI 10.1017/S0003598X00088827; Quintana-Murci L, 2008, P NATL ACAD SCI USA, V105, DOI 10.1073/pnas.0711467105; Rasteiro R, 2012, P ROY SOC B-BIOL SCI, V279, P2409, DOI 10.1098/rspb.2011.2323; Rasteiro R, 2009, J HUM GENET, V54, P349, DOI 10.1038/jhg.2009.39; Renfrew C, 1991, CAMB ARCHAEOL J, V1, P3, DOI DOI 10.1017/S0959774300000238; Richards M, 2000, AM J HUM GENET, V67, P1251, DOI 10.1016/S0002-9297(07)62954-1; Richards M, 2003, ANNU REV ANTHROPOL, V32, P135, DOI 10.1146/annurev.anthro.32.061002.093207; Richards M, 2002, AM J HUM GENET, V71, P1168, DOI 10.1086/342930; Rosser ZH, 2000, AM J HUM GENET, V67, P1526, DOI 10.1086/316890; Salzano FM, 2004, REV BIOL TROP, V52, P405; Semino O, 2000, SCIENCE, V290, P1155, DOI 10.1126/science.290.5494.1155; Shennan S, 2009, HUM BIOL, V81, P339, DOI 10.3378/027.081.0312; Sousa VC, 2009, GENETICS, V181, P1507, DOI 10.1534/genetics.108.098129; Tang H, 2002, GENETICS, V161, P447; Thomas MG, 2006, P ROY SOC B-BIOL SCI, V273, P2651, DOI 10.1098/rspb.2006.3627; Wilder JA, 2004, MOL BIOL EVOL, V21, P2047, DOI 10.1093/molbev/msh214; Wilkins JF, 2006, CURR OPIN GENET DEV, V16, P611, DOI 10.1016/j.gde.2006.10.004; ZVELEBIL M, 1988, ANTIQUITY, V62, P574, DOI 10.1017/S0003598X00074743	73	39	39	1	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2013	8	4							e60944	10.1371/journal.pone.0060944	http://dx.doi.org/10.1371/journal.pone.0060944			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	130IK	23613761	Green Submitted, Green Published, gold			2022-12-25	WOS:000317907200019
J	Sun, CQ; Heid, ME; Keyel, PA; Salter, RD				Sun, Chengqun; Heid, Michelle E.; Keyel, Peter A.; Salter, Russell D.			The Second Transmembrane Domain of P2X7 Contributes to Dilated Pore Formation	PLOS ONE			English	Article							HUMAN P2X(7) RECEPTOR; EXTRACELLULAR ATP; PERMEABILITY DYNAMICS; SYNAPTIC TERMINALS; ION-CHANNEL; POLYMORPHISM; CELLS; INTERLEUKIN-1-BETA; PANNEXIN-1; ACTIVATION	Activation of the purinergic receptor P2X7 leads to the cellular permeability of low molecular weight cations. To determine which domains of P2X7 are necessary for this permeability, we exchanged either the C-terminus or portions of the second transmembrane domain (TM2) with those in P2X1 or P2X4. Replacement of the C-terminus of P2X7 with either P2X1 or P2X4 prevented surface expression of the chimeric receptor. Similarly, chimeric P2X7 containing TM2 from P2X1 or P2X4 had reduced surface expression and no permeability to cationic dyes. Exchanging the N-terminal 10 residues or C-terminal 14 residues of the P2X7 TM2 with the corresponding region of P2X1 TM2 partially restored surface expression and limited pore permeability. To further probe TM2 structure, we replaced single residues in P2X7 TM2 with those in P2X1 or P2X4. We identified multiple substitutions that drastically changed pore permeability without altering surface expression. Three substitutions (Q332P, Y336T, and Y343L) individually reduced pore formation as indicated by decreased dye uptake and also reduced membrane blebbing in response to ATP exposure. Three others substitutions, V335T, S342G, and S342A each enhanced dye uptake, membrane blebbing and cell death. Our results demonstrate a critical role for the TM2 domain of P2X7 in receptor function, and provide a structural basis for differences between purinergic receptors.	[Sun, Chengqun; Heid, Michelle E.; Keyel, Peter A.; Salter, Russell D.] Univ Pittsburgh, Sch Med, Dept Immunol, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Salter, RD (corresponding author), Univ Pittsburgh, Sch Med, Dept Immunol, Pittsburgh, PA 15260 USA.	rds@pitt.edu		Salter, Russell/0000-0003-4553-2986	NIH [T32CA82084, T32AI089443, T32AI060525, AI072083, CA073743, P30CA047904]; NATIONAL CANCER INSTITUTE [P30CA047904, T32CA082084, P01CA073743] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI060525, R01AI072083, T32AI089443] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH grants T32CA82084 (PAK), T32AI089443 and T32AI060525 (MEH), AI072083 and CA073743 (RDS). The Center for Biologic Imaging is supported by NIH grant P30CA047904. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adinolfi E, 2002, BLOOD, V99, P706, DOI 10.1182/blood.V99.2.706; Andrei C, 2004, P NATL ACAD SCI USA, V101, P9745, DOI 10.1073/pnas.0308558101; Bradley HJ, 2011, J BIOL CHEM, V286, P8176, DOI 10.1074/jbc.M110.211284; BRETSCHNEIDER F, 1995, PFLUG ARCH EUR J PHY, V429, P691, DOI 10.1007/BF00373990; Browne LE, 2013, J NEUROSCI, V33, P3557, DOI 10.1523/JNEUROSCI.2235-12.2013; Bulanova E, 2005, J IMMUNOL, V174, P3880, DOI 10.4049/jimmunol.174.7.3880; Chaumont S, 2008, P NATL ACAD SCI USA, V105, P12063, DOI 10.1073/pnas.0803008105; Costa HM, 2011, PURINERG SIGNAL, V7, P7, DOI 10.1007/s11302-011-9215-1; Denlinger LC, 2003, J IMMUNOL, V171, P1304, DOI 10.4049/jimmunol.171.3.1304; Denlinger LC, 2006, CLIN CHEM, V52, P995, DOI 10.1373/clinchem.2005.065425; Duckwitz W, 2006, J BIOL CHEM, V281, P39561, DOI 10.1074/jbc.M606113200; Egan TM, 1998, J NEUROSCI, V18, P2350; Emmett DS, 2008, HEPATOLOGY, V47, P698, DOI 10.1002/hep.22035; Fernando SL, 2005, J INFECT DIS, V192, P149, DOI 10.1086/430622; Fernando SL, 2007, AM J RESP CRIT CARE, V175, P360, DOI 10.1164/rccm.200607-970OC; Gavala ML, 2008, J LEUKOCYTE BIOL, V84, P1159, DOI 10.1189/jlb.0907612; GIROLOMONI G, 1995, EUR J IMMUNOL, V25, P2163, DOI 10.1002/eji.1830250807; Gu B, 1998, BLOOD, V92, P946; Gu BJ, 2006, BLOOD, V107, P4946, DOI 10.1182/blood-2005-07-2994; Gu BJ, 2001, J BIOL CHEM, V276, P11135, DOI 10.1074/jbc.M010353200; Gudipaty L, 2001, AM J PHYSIOL-CELL PH, V280, pC943, DOI 10.1152/ajpcell.2001.280.4.C943; Gunosewoyo H, 2007, CURR MED CHEM, V14, P1505, DOI 10.2174/092986707780831023; Hillman KA, 2005, NEPHRON EXP NEPHROL, V101, pE24, DOI 10.1159/000086036; Hu HZ, 2001, J COMP NEUROL, V440, P299, DOI 10.1002/cne.1387; Jiang LH, 2001, J BIOL CHEM, V276, P14902, DOI 10.1074/jbc.M011327200; Jiang LH, 2005, AM J PHYSIOL-CELL PH, V289, pC1295, DOI 10.1152/ajpcell.00253.2005; Kawate T, 2009, NATURE, V460, P592, DOI 10.1038/nature08198; Khakh BS, 2005, J BIOL CHEM, V280, P6118, DOI 10.1074/jbc.M411324200; Khakh BS, 1999, NAT NEUROSCI, V2, P322, DOI 10.1038/7233; Kracun S, 2010, J BIOL CHEM, V285, P10110, DOI 10.1074/jbc.M109.089185; Lai CPK, 2007, CANCER RES, V67, P1545, DOI 10.1158/0008-5472.CAN-06-1396; Leon D, 2008, NEUROCHEM INT, V52, P1148, DOI 10.1016/j.neuint.2007.12.004; Li MF, 2008, NAT NEUROSCI, V11, P883, DOI 10.1038/nn.2151; Li MF, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1048; Li Q, 2003, J BIOL CHEM, V278, P47554, DOI 10.1074/jbc.M308306200; Locovei S, 2007, FEBS LETT, V581, P483, DOI 10.1016/j.febslet.2006.12.056; MacKenzie A, 2001, IMMUNITY, V15, P825, DOI 10.1016/S1074-7613(01)00229-1; Marin-Garcia P, 2008, NEUROSCIENCE, V151, P361, DOI 10.1016/j.neuroscience.2007.10.038; Marques-da-Silva C, 2011, BRIT J PHARM; Miras-Portugal MT, 2003, NEUROCHEM RES, V28, P1597, DOI 10.1023/A:1025690913206; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Ohlendorff SD, 2007, PHARMACOGENET GENOM, V17, P555, DOI 10.1097/FPC.0b013e3280951625; Pelegrin P, 2006, EMBO J, V25, P5071, DOI 10.1038/sj.emboj.7601378; Pelegrin P, 2009, PURINERG SIGNAL, V5, P129, DOI 10.1007/s11302-009-9141-7; Penuela S, 2007, J CELL SCI, V120, P3772, DOI 10.1242/jcs.009514; Petrilli V, 2007, CURR OPIN IMMUNOL, V19, P615, DOI 10.1016/j.coi.2007.09.002; Rassendren F, 1997, EMBO J, V16, P3446, DOI 10.1093/emboj/16.12.3446; Roger B, 2008, J NEUROSCI, V28, P6393, DOI 10.1523/JNEUROSCI.0696-08.2008; Samways DSK, 2008, J BIOL CHEM, V283, P5110, DOI 10.1074/jbc.M708713200; Saunders BM, 2003, J IMMUNOL, V171, P5442, DOI 10.4049/jimmunol.171.10.5442; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Shemon AN, 2006, J BIOL CHEM, V281, P2079, DOI 10.1074/jbc.M507816200; Shinozaki Y, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000103; Silberberg SD, 2005, J GEN PHYSIOL, V125, P347, DOI 10.1085/jgp.200409221; Sluyter R, 2004, J BIOL CHEM, V279, P44749, DOI 10.1074/jbc.M405631200; Smart ML, 2003, J BIOL CHEM, V278, P8853, DOI 10.1074/jbc.M211094200; Stokes L, 2010, FASEB J, V24, P2916, DOI 10.1096/fj.09-150862; Sugiyama T, 2010, INVEST OPHTH VIS SCI, V51, P3236, DOI 10.1167/iovs.09-4192; Suh BC, 2001, J IMMUNOL, V166, P6754, DOI 10.4049/jimmunol.166.11.6754; Sun CQ, 2010, PURINERG SIGNAL, V6, P31, DOI 10.1007/s11302-009-9168-9; Surprenant A, 1996, SCIENCE, V272, P735, DOI 10.1126/science.272.5262.735; Virginio C, 1999, NAT NEUROSCI, V2, P315, DOI 10.1038/7225; Wiley JS, 2003, J BIOL CHEM, V278, P17108, DOI 10.1074/jbc.M212759200; Zink D, 2003, METHODS, V29, P42, DOI 10.1016/S1046-2023(02)00289-X	64	25	25	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2013	8	4							e61886	10.1371/journal.pone.0061886	http://dx.doi.org/10.1371/journal.pone.0061886			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IK	23613968	gold, Green Accepted, Green Published			2022-12-25	WOS:000317907200100
J	Tseng, HK; Liu, CP; Ho, MW; Lu, PL; Lo, HJ; Lin, YH; Cho, WL; Chen, YC				Tseng, Hsiang-Kuang; Liu, Chang-Pan; Ho, Mao-Wang; Lu, Po-Liang; Lo, Hsiu-Jung; Lin, Yu-Hui; Cho, Wen-Long; Chen, Yee-Chun		Taiwan Infect Dis Study Network	Microbiological, Epidemiological, and Clinical Characteristics and Outcomes of Patients with Cryptococcosis in Taiwan, 1997-2010	PLOS ONE			English	Article							APPARENTLY IMMUNOCOMPETENT PATIENTS; IN-VITRO SUSCEPTIBILITIES; END-POINT DISTRIBUTIONS; GATTII SPECIES COMPLEX; HIV-INFECTED PATIENTS; AMPHOTERICIN-B; MOLECULAR EPIDEMIOLOGY; NEOFORMANS STRAINS; BRITISH-COLUMBIA; FUNGAL PATHOGEN	Background: Among members of Cryptococcus neoformans-Cryptococcus gattii species complex, C. neoformans is distributed worldwide whereas C. gattii is considered to be more prevalent in the subtropics and tropics including Taiwan. This nationwide study was undertaken to determine the distribution of genotypes, clinical characteristics and outcomes of 219 patients with proven cryptococcosis at 20 hospitals representative of all geographic areas in Taiwan during 1997-2010. Methods and Findings: Of 219 isolates analyzed, C. neoformans accounted for 210 isolates (95.9%); nine isolates were C. gattii (4.1%). The predominant genotype was VNI (206 isolates). The other genotypes included VNII (4 isolates), VGI (3 isolates) and VGII (6 isolates). Antifungal minimal inhibition concentrations higher than epidemiologic cutoff values (ECVs) were found in nine VNI isolates (7 for amphotericin B). HIV infection was the most common underlying condition (54/219, 24.6%). Among HIV-negative patients, liver diseases (HBV carrier or cirrhosis) were common (30.2%) and 15.4% did not have any underlying condition. Meningoencephalitis was the most common presentation (58.9%), followed by pulmonary infection (19.6%) and "others" (predominantly cryptococcemia) (18.7%). The independent risk factors for 10-week mortality, by multivariate analysis, were cirrhosis of liver (P = 0.014) and CSF cryptococcal antigen titer >= 512 (P = 0.020). All except one of 54 HIV-infected patients were infected by VNI genotype (98.1%). Of the 13 isolates of genotypes other than VNI, 12 (92.3%) were isolated from HIV-negative patients. HIV-infected patients compared to HIV-negative patients were more likely to have meningoencephalitis and serum cryptococcal antigen > 1:512. Patients infected with C. gattii compared to C. neoformans were younger, more likely to have meningoencephalitis (100% vs. 57%), reside in Central Taiwan (56% vs. 31%), and higher 10-week crude mortality (44.4% vs. 22.2%). Conclusions: Cryptococcus neoformans in Taiwan, more prevalent than C. gatii, has a predominant VNI genotype. Isolates with antifungal MIC higher than ECVs were rare.	[Tseng, Hsiang-Kuang; Cho, Wen-Long] Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan; [Tseng, Hsiang-Kuang; Liu, Chang-Pan] Mackay Mem Hosp, Dept Internal Med, Div Infect Dis, Taipei, Taiwan; [Ho, Mao-Wang] China Med Univ Hosp, Dept Internal Med, Div Infect Dis, Taichung, Taiwan; [Lu, Po-Liang] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Internal Med, Kaohsiung, Taiwan; [Lo, Hsiu-Jung] Natl Hlth Res Inst, Natl Inst Infect Dis & Vaccinol, Miaoli, Taiwan; [Lo, Hsiu-Jung] China Med Univ, Sch Dent, Taichung, Taiwan; [Lin, Yu-Hui] Taichung Vet Gen Hosp, Dept Med, Div Infect Dis, Taichung, Taiwan; [Tseng, Hsiang-Kuang; Liu, Chang-Pan; Cho, Wen-Long] Mackay Med Coll, Dept Med, New Taipei, Taiwan; [Chen, Yee-Chun] Natl Taiwan Univ Hosp, Dept Internal Med, Div Infect Dis, Taipei, Taiwan; [Chen, Yee-Chun] Coll Med, Taipei, Taiwan; [Tseng, Hsiang-Kuang; Liu, Chang-Pan] Mackay Med Nursing & Management Coll, Taipei, Taiwan	National Yang Ming Chiao Tung University; Mackay Memorial Hospital; China Medical University Taiwan; China Medical University Hospital - Taiwan; Kaohsiung Medical University; Kaohsiung Medical University Hospital; National Health Research Institutes - Taiwan; China Medical University Taiwan; Taichung Veterans General Hospital; Mackay Medical College; National Taiwan University; National Taiwan University Hospital; Mackay Junior College of Medicine, Nursing & Management	Cho, WL (corresponding author), Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan.	wenlong@ym.edu.tw; yeechunchen@gmail.com	Chen, Yee-Chun/AGW-7535-2022; Lu, Po-Liang/D-4499-2009; Lo, Hsiu-Jung/B-2658-2010	Chen, Yee-Chun/0000-0002-1816-9010; Lu, Po-Liang/0000-0002-7423-6783; 	National Science Council of Taiwan [NSC98-2314- B-002-066-MY3, NSC100-314- B-195-006, NSC100-2320- B-010 -011]; Department of Health, Taiwan [DOH100-TD- B-111-001]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Department of Health, Taiwan	This work was supported by grants NSC98-2314- B-002-066-MY3 (YCC), NSC100-314- B-195-006 (HKT), NSC100-2320- B-010 -011 (WLC) from the National Science Council of Taiwan, and DOH100-TD- B-111-001 (YCC) from the Department of Health, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antinori S, 2001, EUR J CLIN MICROBIOL, V20, P711, DOI 10.1007/s100960100616; Bicanic T, 2007, CLIN INFECT DIS, V45, P76, DOI 10.1086/518607; Byrnes EJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005851; Byrnes EJ, 2009, J INFECT DIS, V199, P1081, DOI 10.1086/597306; Campbell LT, 2005, EUKARYOT CELL, V4, P1403, DOI 10.1128/EC.4.8.1403-1409.2005; Olivares LRC, 2009, MED MYCOL, V47, P713, DOI 10.3109/13693780802559031; Chang WN, 2004, JPN J INFECT DIS, V57, P113; Chaturvedi V, 2011, TRENDS MICROBIOL, V19, P564, DOI 10.1016/j.tim.2011.07.010; Chau TTH, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-199; Chen JH, 2008, EMERG INFECT DIS, V14, P755, DOI 10.3201/eid1405.071312; Chen S, 2000, CLIN INFECT DIS, V31, P499, DOI 10.1086/313992; Chen YC, 2000, DIAGN MICR INFEC DIS, V36, P175, DOI 10.1016/S0732-8893(99)00137-6; Chen YC, 2012, MYCOPATHOLOGIA, V173, P329, DOI 10.1007/s11046-011-9471-1; Choi YH, 2010, FEMS YEAST RES, V10, P769, DOI 10.1111/j.1567-1364.2010.00648.x; Clinical and Laboratory Standards Institute, 2008, REF METH BROTH DIL A; Cogliati M, 2012, MYCOSES, V55, P262, DOI 10.1111/j.1439-0507.2011.02082.x; Desnos-Ollivier M, 2010, MBIO, V1, DOI 10.1128/mBio.00091-10; Dromer F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002870; Dromer F, 2007, PLOS MED, V4, P297, DOI 10.1371/journal.pmed.0040021; Escandon P, 2006, FEMS YEAST RES, V6, P625, DOI 10.1111/j.1567-1364.2006.00055.x; Espinel-Ingroff A, 2012, ANTIMICROB AGENTS CH, V56, P5898, DOI 10.1128/AAC.01115-12; Espinel-Ingroff A, 2012, ANTIMICROB AGENTS CH, V56, P3107, DOI 10.1128/AAC.06252-11; Feng XB, 2008, FEMS YEAST RES, V8, P930, DOI 10.1111/j.1567-1364.2008.00422.x; Harris J, 2012, MED MYCOL, V50, P113, DOI 10.3109/13693786.2011.607854; Jain N, 2005, J CLIN MICROBIOL, V43, P5733, DOI 10.1128/JCM.43.11.5733-5742.2005; Jean SS, 2002, QJM-INT J MED, V95, P511, DOI 10.1093/qjmed/95.8.511; Kidd SE, 2004, P NATL ACAD SCI USA, V101, P17258, DOI 10.1073/pnas.0402981101; Lee CK, 2011, THESIS NATL SUN YS U; Lee H, 2012, MOL MICROBIOL, V84, P130, DOI 10.1111/j.1365-2958.2012.08016.x; Liaw SJ, 2010, CLIN MICROBIOL INFEC, V16, P696, DOI 10.1111/j.1469-0691.2009.02930.x; Lui G, 2006, QJM-INT J MED, V99, P143, DOI 10.1093/qjmed/hcl014; MacDougall L, 2007, EMERG INFECT DIS, V13, P42, DOI 10.3201/eid1301.060827; Meyer W, 2003, EMERG INFECT DIS, V9, P189; Nucci M, 2008, CLIN INFECT DIS, V46, P1426, DOI 10.1086/587101; Okamoto K, 2010, EMERG INFECT DIS, V16, P1155, DOI 10.3201/eid1607.100106; Pappas PG, 2001, CLIN INFECT DIS, V33, P690, DOI 10.1086/322597; Sellers B, 2012, AM J MED SCI, V343, P510, DOI 10.1097/MAJ.0b013e3182464bc7; Shih CC, 2000, QJM-MON J ASSOC PHYS, V93, P245, DOI 10.1093/qjmed/93.4.245; Sionov E, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000848; Sorrell TC, 1996, J CLIN MICROBIOL, V34, P1253, DOI 10.1128/JCM.34.5.1253-1260.1996; Tay ST, 2010, MYCOSES, V53, P509, DOI 10.1111/j.1439-0507.2009.01750.x; Varma A, 2010, ANTIMICROB AGENTS CH, V54, P2303, DOI 10.1128/AAC.00153-10	42	48	53	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2013	8	4							e61921	10.1371/journal.pone.0061921	http://dx.doi.org/10.1371/journal.pone.0061921			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IK	23613973	Green Published, Green Submitted, gold			2022-12-25	WOS:000317907200104
J	Ahmed, Z; Douglas, MR; John, G; Berry, M; Logan, A				Ahmed, Zubair; Douglas, Michael R.; John, Gabrielle; Berry, Martin; Logan, Ann			AMIGO3 Is an NgR1/p75 Co-Receptor Signalling Axon Growth Inhibition in the Acute Phase of Adult Central Nervous System Injury	PLOS ONE			English	Article							MYELIN-ASSOCIATED GLYCOPROTEIN; RECEPTOR FAMILY-MEMBER; OPTIC-NERVE; NOGO RECEPTOR; NEURITE OUTGROWTH; SPINAL-CORD; CNS MYELIN; IN-VIVO; REGENERATION; EXPRESSION	Axon regeneration in the injured adult CNS is reportedly inhibited by myelin-derived inhibitory molecules, after binding to a receptor complex comprised of the Nogo-66 receptor (NgR1) and two transmembrane co-receptors p75/TROY and LINGO-1. However, the post-injury expression pattern for LINGO-1 is inconsistent with its proposed function. We demonstrated that AMIGO3 levels were significantly higher acutely than those of LINGO-1 in dorsal column lesions and reduced in models of dorsal root ganglion neuron (DRGN) axon regeneration. Similarly, AMIGO3 levels were raised in the retina immediately after optic nerve crush, whilst levels were suppressed in regenerating optic nerves, induced by intravitreal peripheral nerve implantation. AMIGO3 interacted functionally with NgR1-p75/TROY in non-neuronal cells and in brain lysates, mediating RhoA activation in response to CNS myelin. Knockdown of AMIGO3 in myelin-inhibited adult primary DRG and retinal cultures promoted disinhibited neurite growth when cells were stimulated with appropriate neurotrophic factors. These findings demonstrate that AMIGO3 substitutes for LINGO-1 in the NgR1-p75/TROY inhibitory signalling complex and suggests that the NgR1-p75/TROY-AMIGO3 receptor complex mediates myelin-induced inhibition of axon growth acutely in the CNS. Thus, antagonizing AMIGO3 rather than LINGO-1 immediately after CNS injury is likely to be a more effective therapeutic strategy for promoting CNS axon regeneration when combined with neurotrophic factor administration.	[Ahmed, Zubair; Douglas, Michael R.; John, Gabrielle; Berry, Martin; Logan, Ann] Univ Birmingham, Sch Clin & Expt Med, Neuropharmacol & Neurobiol Sect, Birmingham, W Midlands, England; [Douglas, Michael R.] Dudley Grp Hosp Natl Hlth Serv Fdn Trust, Russells Hall Hosp, Dept Neurol, Dudley, W Midlands, England	University of Birmingham; Russells Hall Hospital	Ahmed, Z (corresponding author), Univ Birmingham, Sch Clin & Expt Med, Neuropharmacol & Neurobiol Sect, Birmingham, W Midlands, England.	z.ahmed.1@bham.ac.uk	Ahmed, Zubair/AAN-1869-2021	Logan, Ann/0000-0003-3215-5042	University of Birmingham; Midlands Neuroscience Teaching and Research Fund; Wellcome Trust [092539/Z/10/Z]; Biotechnology and Biological Sciences Research Council [G181986]; Multiple Sclerosis Society of GB NI [207495]	University of Birmingham; Midlands Neuroscience Teaching and Research Fund; Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Multiple Sclerosis Society of GB NI	This work was supported by grants from the University of Birmingham (ZA), Midlands Neuroscience Teaching and Research Fund (MRD) and the Wellcome Trust (grant no. 092539/Z/10/Z to ZA; www.wellcome.ac.uk). The microarray data were extracted from a study supported by Biotechnology and Biological Sciences Research Council (AL and MB, grant no. G181986; www.bbsrc.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Control human brain tissue samples and associated clinical and neuropathological data were supplied by the UK Multiple Sclerosis Tissue Bank, funded by the Multiple Sclerosis Society of GB & NI, registered charity 207495.	Ahmed Z, 2005, MOL CELL NEUROSCI, V28, P64, DOI 10.1016/j.mcn.2004.08.013; Ahmed Z, 2006, FASEB J, V20, P1939, DOI 10.1096/fj.05-5339fje; Ahmed Z, 2006, BRAIN, V129, P1517, DOI 10.1093/brain/awl080; Ahmed Z, 2011, NEUROBIOL DIS, V41, P421, DOI 10.1016/j.nbd.2010.10.012; Ahmed Z, 2010, NEUROBIOL DIS, V39, P292, DOI 10.1016/j.nbd.2010.04.013; Ahmed Z, 2010, NEUROBIOL DIS, V37, P441, DOI 10.1016/j.nbd.2009.10.024; Ahmed Z, 2009, NEUROBIOL DIS, V36, P142, DOI 10.1016/j.nbd.2009.07.016; Ahmed Z, 2009, MOL CELL NEUROSCI, V42, P128, DOI 10.1016/j.mcn.2009.06.005; Benowitz LI, 2007, DEV NEUROBIOL, V67, P1148, DOI 10.1002/dneu.20515; Berry M, 1996, J NEUROCYTOL, V25, P147, DOI 10.1007/BF02284793; Berry M, 1999, J NEUROCYTOL, V28, P721, DOI 10.1023/A:1007086004022; Berry M, 2008, RESTOR NEUROL NEUROS, V26, P147; Domeniconi M, 2002, NEURON, V35, P283, DOI 10.1016/S0896-6273(02)00770-5; Douglas MR, 2009, BRAIN, V132, P3102, DOI 10.1093/brain/awp240; Filbin MT, 2003, NAT REV NEUROSCI, V4, P703, DOI 10.1038/nrn1195; Fischer D, 2004, J NEUROSCI, V24, P8726, DOI 10.1523/JNEUROSCI.2774-04.2004; Hunt D, 2002, J NEUROCYTOL, V31, P93, DOI 10.1023/A:1023941421781; Koprivica V, 2005, SCIENCE, V310, P106, DOI 10.1126/science.1115462; Kuja-Panula J, 2003, J CELL BIOL, V160, P963, DOI 10.1083/jcb.200209074; Kurimoto T, 2010, J NEUROSCI, V30, P15654, DOI 10.1523/JNEUROSCI.4340-10.2010; Lagord C, 2002, MOL CELL NEUROSCI, V20, P69, DOI 10.1006/mcne.2002.1121; Liu BP, 2002, SCIENCE, V297, P1190, DOI 10.1126/science.1073031; Logan A, 2006, BRAIN, V129, P490, DOI 10.1093/brain/awh706; Mi S, 2004, NAT NEUROSCI, V7, P221, DOI 10.1038/nn1188; Park JB, 2005, NEURON, V45, P345, DOI 10.1016/j.neuron.2004.12.040; Park KK, 2008, SCIENCE, V322, P963, DOI 10.1126/science.1161566; RAUVALA H, 1987, J BIOL CHEM, V262, P16625; Read ML, 2009, J GENE MED, V11, P523, DOI 10.1002/jgm.1321; Sandvig A, 2004, GLIA, V46, P225, DOI 10.1002/glia.10315; Shao ZH, 2005, NEURON, V45, P353, DOI 10.1016/j.neuron.2004.12.050; Suggate EL, 2009, MOL CELL NEUROSCI, V40, P451, DOI 10.1016/j.mcn.2009.01.004; Wang KC, 2002, NATURE, V420, P74, DOI 10.1038/nature01176	32	23	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2013	8	4							e61878	10.1371/journal.pone.0061878	http://dx.doi.org/10.1371/journal.pone.0061878			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130DR	23613963	Green Published, Green Submitted, gold			2022-12-25	WOS:000317893400126
J	Lo, JY; Brown, JQ; Dhar, S; Yu, B; Palmer, GM; Jokerst, NM; Ramanujam, N				Lo, Justin Y.; Brown, J. Quincy; Dhar, Sulochana; Yu, Bing; Palmer, Gregory M.; Jokerst, Nan M.; Ramanujam, Nirmala			Wavelength Optimization for Quantitative Spectral Imaging of Breast Tumor Margins	PLOS ONE			English	Article							TISSUE OPTICAL-PROPERTIES; INVERSE MODEL; CANCER; SPECTROSCOPY; THERAPY; SYSTEM	A wavelength selection method that combines an inverse Monte Carlo model of reflectance and a genetic algorithm for global optimization was developed for the application of spectral imaging of breast tumor margins. The selection of wavelengths impacts system design in cost, size, and accuracy of tissue quantitation. The minimum number of wavelengths required for the accurate quantitation of tissue optical properties is 8, with diminishing gains for additional wavelengths. The resulting wavelength choices for the specific probe geometry used for the breast tumor margin spectral imaging application were tested in an independent pathology-confirmed ex vivo breast tissue data set and in tissue-mimicking phantoms. In breast tissue, the optical endpoints (hemoglobin, beta-carotene, and scattering) that provide the contrast between normal and malignant tissue specimens are extracted with the optimized 8-wavelength set with <9% error compared to the full spectrum (450-600 nm). A multi-absorber liquid phantom study was also performed to show the improved extraction accuracy with optimization and without optimization. This technique for selecting wavelengths can be used for designing spectral imaging systems for other clinical applications.	[Lo, Justin Y.; Brown, J. Quincy; Yu, Bing; Ramanujam, Nirmala] Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA; [Dhar, Sulochana; Jokerst, Nan M.] Duke Univ, Dept Elect & Comp Engn, Durham, NC USA; [Palmer, Gregory M.] Duke Univ, Med Ctr, Dept Radiat Oncol, Durham, NC USA	Duke University; Duke University; Duke University	Lo, JY (corresponding author), Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA.	justin.lo@duke.edu	Brown, J. Quincy/F-6090-2012; Palmer, Gregory M/C-6910-2008; Ramanujam, Nimmi/AAA-7575-2021	Palmer, Gregory M/0000-0003-2955-8297; Ramanujam, Nimmi/0000-0001-7319-8415	National Institute of Biomedical Imaging and Bioengineering; NIH [BRP -1R01EB011574-01]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB011574] Funding Source: NIH RePORTER	National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by the Bioengineering Research Partnership grant from the National Institute of Biomedical Imaging and Bioengineering awarded to Dr. Nimmi Ramanujam, NIH BRP -1R01EB011574-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe O, 2005, LANCET, V366, P2087; Bender JE, 2009, IEEE T BIO-MED ENG, V56, P960, DOI 10.1109/TBME.2008.2005994; Bigio IJ, 2004, CANCER BIOL THER, V3, P259, DOI 10.4161/cbt.3.3.694; Brown JQ, 2009, CANCER RES, V69, P2919, DOI 10.1158/0008-5472.CAN-08-3370; Bydlon TM, 2010, OPT EXPRESS, V18, P8058, DOI 10.1364/OE.18.008058; Dhar Sulochana, 2012, Biomed Opt Express, V3, P3211, DOI 10.1364/BOE.3.003211; Dhar S, 2011, BIOMED CIRC SYST C, P440, DOI 10.1109/BioCAS.2011.6107822; Ferreira DS, 2011, BIOMED OPT EXPRESS, V2, P1703, DOI 10.1364/BOE.2.001703; Fu HL, 2010, OPT EXPRESS, V18, P12630, DOI 10.1364/OE.18.012630; Kennedy S, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2770; Lo JY, 2012, PROC SPIE, V8214, DOI 10.1117/12.909259; Lo JY, 2011, PROC SPIE, V7890, DOI 10.1117/12.873617; Lo JY, 2009, OPT EXPRESS, V17, P1372, DOI 10.1364/OE.17.001372; Mazhar A, 2010, J BIOMEDICAL OPTICS, V15; Palmer GM, 2006, APPL OPTICS, V45, P1072, DOI 10.1364/AO.45.001072; Palmer GM, 2006, APPL OPTICS, V45, P1062, DOI 10.1364/AO.45.001062; Phelps JE, 2010, OPT EXPRESS, V18, P18779, DOI 10.1364/OE.18.018779; Poggi MM, 2003, CANCER, V98, P697, DOI 10.1002/cncr.11580; Prahl S, 2005, MIE SCATTERING PROGR; Umeyama S, 2009, J BIOMEDICAL OPTICS, V14; Wilke LG, 2009, AM J SURG, V198, P566, DOI 10.1016/j.amjsurg.2009.06.018; Yu B, 2008, J BIOMED OPT, V13, DOI 10.1117/1.3041500	22	7	7	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2013	8	4							e61767	10.1371/journal.pone.0061767	http://dx.doi.org/10.1371/journal.pone.0061767			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130DR	23613927	Green Submitted, gold, Green Published			2022-12-25	WOS:000317893400103
J	MacLeod, MKL; David, A; Jin, NY; Noges, L; Wang, JR; Kappler, JW; Marrack, P				MacLeod, Megan K. L.; David, Alexandria; Jin, Niyun; Noges, Laura; Wang, Jieru; Kappler, John W.; Marrack, Philippa			Influenza Nucleoprotein Delivered with Aluminium Salts Protects Mice from an Influenza A Virus That Expresses an Altered Nucleoprotein Sequence	PLOS ONE			English	Article							T-CELL RESPONSES; TOXIC LYMPHOCYTES-T; B SURFACE-ANTIGEN; PANDEMIC H1N1; VACCINE; MEMORY; CHALLENGE; IMMUNITY; GENE; REPLICATION	Influenza virus poses a difficult challenge for protective immunity. This virus is adept at altering its surface proteins, the proteins that are the targets of neutralizing antibody. Consequently, each year a new vaccine must be developed to combat the current recirculating strains. A universal influenza vaccine that primes specific memory cells that recognise conserved parts of the virus could prove to be effective against both annual influenza variants and newly emergent potentially pandemic strains. Such a vaccine will have to contain a safe and effective adjuvant that can be used in individuals of all ages. We examine protection from viral challenge in mice vaccinated with the nucleoprotein from the PR8 strain of influenza A, a protein that is highly conserved across viral subtypes. Vaccination with nucleoprotein delivered with a universally used and safe adjuvant, composed of insoluble aluminium salts, provides protection against viruses that either express the same or an altered version of nucleoprotein. This protection correlated with the presence of nucleoprotein specific CD8 T cells in the lungs of infected animals at early time points after infection. In contrast, immunization with NP delivered with alum and the detoxified LPS adjuvant, monophosphoryl lipid A, provided some protection to the homologous viral strain but no protection against infection by influenza expressing a variant nucleoprotein. Together, these data point towards a vaccine solution for all influenza A subtypes.	[MacLeod, Megan K. L.; David, Alexandria; Jin, Niyun; Noges, Laura; Kappler, John W.; Marrack, Philippa] Natl Jewish Hlth, Howard Hughes Med Inst, Denver, CO USA; [MacLeod, Megan K. L.; David, Alexandria; Jin, Niyun; Noges, Laura; Kappler, John W.; Marrack, Philippa] Natl Jewish Hlth, Integrated Dept Immunol, Denver, CO USA; [Wang, Jieru] Natl Jewish Hlth, Dept Med, Denver, CO USA; [Kappler, John W.; Marrack, Philippa] Univ Colorado Denver, Sch Med, Program Biomol Struct, Aurora, CO USA; [Kappler, John W.] Univ Colorado Denver, Sch Med, Dept Med, Aurora, CO USA; [Marrack, Philippa] Univ Colorado Denver, Sch Med, Dept Biochem & Mol Genet, Aurora, CO USA	Howard Hughes Medical Institute; National Jewish Health; National Jewish Health; National Jewish Health; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	MacLeod, MKL (corresponding author), Natl Jewish Hlth, Howard Hughes Med Inst, Denver, CO USA.	megan.macleod@glasgow.ac.uk; marrackp@njhealth.org	Marrack, Philippa/AHE-6316-2022	Marrack, Philippa/0000-0003-1883-3687; MacLeod, Megan/0000-0003-1843-8580; Doepker, Laura/0000-0003-4514-5003	Howard Hughes Medical Institute; National Institutes of Health [AI-18785, AI-22295]; US Department of Defense [USAMRAMC: W81XWH-07-1-0550]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL113655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI022295, R01AI018785, R03AI101953, R56AI018785, R37AI018785] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Defense(United States Department of Defense); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Howard Hughes Medical Institute (http://www.hhmi.org); National Institutes of Health (AI-18785 and AI-22295) (http://www.nih.gov); US Department of Defense (USAMRAMC: W81XWH-07-1-0550) (http://www.defense.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrose CS, 2008, PEDIATR INFECT DIS J, V27, P744, DOI 10.1097/INF.0b013e318174e0f8; Belz GT, 2007, NAT IMMUNOL, V8, P1060, DOI 10.1038/ni1505; Brown LE, 2009, IMMUNOL CELL BIOL, V87, P300, DOI 10.1038/icb.2009.16; Carragher DM, 2008, J IMMUNOL, V181, P4168, DOI 10.4049/jimmunol.181.6.4168; Christensen JP, 2000, J VIROL, V74, P11690, DOI 10.1128/JVI.74.24.11690-11696.2000; Corti D, 2011, SCIENCE, V333, P850, DOI 10.1126/science.1205669; Cox MMJ, 2012, VACCINE, V30, P1759, DOI 10.1016/j.vaccine.2012.01.016; Crawford F, 1998, IMMUNITY, V8, P675, DOI 10.1016/S1074-7613(00)80572-5; de Wit E, 2004, VIRUS RES, V103, P155, DOI 10.1016/j.virusres.2004.02.028; ENDO A, 1991, J GEN VIROL, V72, P699, DOI 10.1099/0022-1317-72-3-699; Furuya Y, 2010, J VIROL, V84, P4212, DOI 10.1128/JVI.02508-09; Garcon N, 2012, EXPERT REV VACCINES, V11, P349, DOI [10.1586/erv.11.192, 10.1586/ERV.11.192]; Giannini SL, 2006, VACCINE, V24, P5937, DOI 10.1016/j.vaccine.2006.06.005; Grimm D, 2007, P NATL ACAD SCI USA, V104, P6806, DOI 10.1073/pnas.0701849104; Guo LN, 2010, ARCH VIROL, V155, P1765, DOI 10.1007/s00705-010-0756-3; Heiny AT, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001190; Hikono H, 2006, IMMUNOL REV, V211, P119, DOI 10.1111/j.0105-2896.2006.00385.x; Hohn H, 2002, CLIN EXP IMMUNOL, V129, P309, DOI 10.1046/j.1365-2249.2002.01841.x; KEES U, 1984, J EXP MED, V159, P365, DOI 10.1084/jem.159.2.365; Lambe T, 2012, PEDIATR INFECT DIS J, V31, pE86, DOI 10.1097/INF.0b013e318255e443; LaMere MW, 2011, J VIROL, V85, P5027, DOI 10.1128/JVI.00150-11; LaMere MW, 2011, J IMMUNOL, V186, P4331, DOI 10.4049/jimmunol.1003057; MacLeod MKL, 2011, P NATL ACAD SCI USA, V108, P7914, DOI 10.1073/pnas.1104588108; Marrack P, 2009, NAT REV IMMUNOL, V9, P287, DOI 10.1038/nri2510; McElhaney JE, 2006, J IMMUNOL, V176, P6333, DOI 10.4049/jimmunol.176.10.6333; MCKEE AS, 2010, BMC BIOL, V8, P36583, DOI DOI 10.1186/1741-7007-8-37; MCMICHAEL AJ, 1983, NEW ENGL J MED, V309, P13, DOI 10.1056/NEJM198307073090103; Medina RA, 2011, NAT REV MICROBIOL, V9, P590, DOI 10.1038/nrmicro2613; O'Hagan DT, 2012, VACCINE, V30, P4341, DOI 10.1016/j.vaccine.2011.09.061; Poland GA, 2007, VACCINE, V25, P3057, DOI 10.1016/j.vaccine.2007.01.050; Portela A, 2002, J GEN VIROL, V83, P723, DOI 10.1099/0022-1317-83-4-723; Price GE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013162; Rahman F, 2000, HEPATOLOGY, V31, P521, DOI 10.1002/hep.510310237; Richards KA, 2012, VACCINE; Schotsaert M, 2009, EXPERT REV VACCINES, V8, P499, DOI [10.1586/erv.09.6, 10.1586/ERV.09.6]; Sebastian R, 2008, VACCINE, V26, P1397, DOI 10.1016/j.vaccine.2007.11.090; SHU LL, 1993, J VIROL, V67, P2723, DOI 10.1128/JVI.67.5.2723-2729.1993; Tetsutani K, 2012, VACCINE; Thueng-In K, 2010, VACCINE, V28, P6765, DOI 10.1016/j.vaccine.2010.07.065; ULMER JB, 1993, SCIENCE, V259, P1745, DOI 10.1126/science.8456302; Wang MJ, 2007, VACCINE, V25, P2823, DOI 10.1016/j.vaccine.2006.12.038; Wei CJ, 2010, SCIENCE, V329, P1060, DOI 10.1126/science.1192517; Wilkinson TM, 2012, NAT MED, V18, P274, DOI 10.1038/nm.2612; YEWDELL JW, 1985, P NATL ACAD SCI USA, V82, P1785, DOI 10.1073/pnas.82.6.1785; Zehn D, 2010, J IMMUNOL, V184, P6320, DOI 10.4049/jimmunol.1000149; Zhou B, 2011, J VIROL, V85, P357, DOI 10.1128/JVI.01694-10	46	14	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2013	8	4							e61775	10.1371/journal.pone.0061775	http://dx.doi.org/10.1371/journal.pone.0061775			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130DR	23613928	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000317893400104
J	Qin, P; Wang, YP; Li, YY; Ma, BT; Li, SG				Qin, Peng; Wang, Yuping; Li, Yuanyuan; Ma, Bingtian; Li, Shigui			Analysis of Cytoplasmic Effects and Fine-Mapping of a Genic Male Sterile Line in Rice	PLOS ONE			English	Article							POLLEN EXINE FORMATION; AGRONOMIC TRAITS; ANTHER; PROTEIN; TRANSPORTER; COMPONENT; ENCODES; WALL	Cytoplasm has substantial genetic effects on progeny and is important for yield improvement in rice breeding. Studies on the cytoplasmic effects of cytoplasmic male sterility (CMS) show that most types of CMS have negative effects on yield-related traits and that these negative effects vary among CMS. Some types of genic male sterility (GMS), including photo-thermo sensitive male sterility (PTMS), have been widely used in rice breeding, but the cytoplasmic effects of GMS remain unknown. Here, we identified a GMS mutant line, h(2)s, which exhibited small, white anthers and failed to produce mature pollen. Unlike CMS, the h(2)s had significant positive cytoplasmic effects on the seed set rate, weight per panicle, yield, and general combining ability (GCA) for plant height, seed set rate, weight per panicle, and yield. These effects indicated that h(2)s cytoplasm may show promise for the improvement of rice yield. Genetic analysis suggested that the phenotype of h(2)s was controlled by a single recessive locus. We mapped h(2)s to a 152 kb region on chromosome 6, where 22 candidate genes were predicted. None of the 22 genes had previously been reported to be responsible for the phenotypes of h(2)s. Sequencing analysis showed a 12 bp deletion in the sixth exon of Loc_Os06g40550 in h(2)s in comparison to wild type, suggesting that Loc_Os06g40550 is the best candidate gene. These results lay a strong foundation for cloning of the H2S gene to elucidate the molecular mechanism of male reproduction.	[Qin, Peng; Wang, Yuping; Li, Yuanyuan; Ma, Bingtian; Li, Shigui] Sichuan Agr Univ, Rice Res Inst, Chengdu, Sichuan, Peoples R China; [Qin, Peng; Wang, Yuping; Li, Shigui] Sichuan Agr Univ, State Key Lab Hybrid Rice, Chengdu, Sichuan, Peoples R China	Sichuan Agricultural University; Sichuan Agricultural University	Li, SG (corresponding author), Sichuan Agr Univ, Rice Res Inst, Chengdu, Sichuan, Peoples R China.	lishigui@sicau.edu.cn	li, yuanyuan/GZA-4435-2022		National Natural Science Foundation of China [31025017, 30971763]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (31025017 and 30971763). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aya K, 2009, PLANT CELL, V21, P1453, DOI 10.1105/tpc.108.062935; Chandra-Shekara AC, 2007, EUPHYTICA, V153, P15, DOI 10.1007/s10681-006-9194-4; Chen CB, 2005, J INTEGR PLANT BIOL, V47, P734, DOI 10.1111/j.1744-7909.2005.00102.x; Chen JB, 2010, PLANT BREEDING, V129, P313, DOI 10.1111/j.1439-0523.2009.01689.x; Cheng MC, 2012, PLANT PHYSIOL, V158, P363, DOI 10.1104/pp.111.189738; Choi H, 2011, PLANT J, V65, P181, DOI 10.1111/j.1365-313X.2010.04412.x; Conchon S, 1999, EMBO J, V18, P3934, DOI 10.1093/emboj/18.14.3934; Ding JH, 2012, P NATL ACAD SCI USA, V109, P2654, DOI 10.1073/pnas.1121374109; Dou XY, 2011, J INTEGR PLANT BIOL, V53, P74, DOI 10.1111/j.1744-7909.2010.01010.x; Feng JiuHuan, 2001, Chinese Journal of Rice Science, V15, P21; Huang MD, 2009, PLANT PHYSIOL, V149, P694, DOI 10.1104/pp.108.131128; Ibl V, 2012, J PROTEOME RES, V11, P397, DOI 10.1021/pr200845n; Jung KH, 2006, PLANT CELL, V18, P3015, DOI 10.1105/tpc.106.042044; Lander ES, 1987, GENOMICS, V1, P1; Li H, 2011, PLANT PHYSIOL, V156, P615, DOI 10.1104/pp.111.175760; Li H, 2010, PLANT CELL, V22, P173, DOI 10.1105/tpc.109.070326; Li N, 2006, PLANT CELL, V18, P2999, DOI 10.1105/tpc.106.044107; Liu ZH, 2010, J INTEGR PLANT BIOL, V52, P670, DOI 10.1111/j.1744-7909.2010.00959.x; Lopez-Casado G, 2008, CURR OPIN PLANT BIOL, V11, P329, DOI 10.1016/j.pbi.2008.02.010; Marc A, 2006, International Patent International application, Patent No. [PCT/US2006/024273, 2006024273]; Ouyang S, 2007, NUCLEIC ACIDS RES, V35, pD883, DOI 10.1093/nar/gkl976; Quilichini TD, 2010, PLANT PHYSIOL, V154, P678, DOI 10.1104/pp.110.161968; Shi CH, 1998, SEED SCI TECHNOL, V26, P481; Shi J, 2011, PLANT CELL, V23, P2225, DOI 10.1105/tpc.111.087528; Tao DY, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-53; Tao DY, 2004, EUPHYTICA, V135, P129, DOI 10.1023/B:EUPH.0000009548.81467.73; Wang WenMing, 1997, Chinese Journal of Rice Science, V11, P65; Winter D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000718; [杨仕华 YANG Shi-hua], 2009, [杂交水稻, Hybrid Rice], V24, P5; YOUNG JB, 1990, EUPHYTICA, V48, P177, DOI 10.1007/BF00037198; Zhou H, 2012, CELL RES	31	4	5	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2013	8	4							e61719	10.1371/journal.pone.0061719	http://dx.doi.org/10.1371/journal.pone.0061719			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130DR	23613915	Green Published, gold, Green Submitted			2022-12-25	WOS:000317893400098
J	Asner, GP; Kellner, JR; Kennedy-Bowdoin, T; Knapp, DE; Anderson, C; Martin, RE				Asner, Gregory P.; Kellner, James R.; Kennedy-Bowdoin, Ty; Knapp, David E.; Anderson, Christopher; Martin, Roberta E.			Forest Canopy Gap Distributions in the Southern Peruvian Amazon	PLOS ONE			English	Article							TROPICAL RAIN-FOREST; SPECIES COMPOSITION; CARBON STOCKS; LIVE BIOMASS; DISTURBANCE; PATTERNS; DYNAMICS; GROWTH; ALLOCATION; RESPONSES	Canopy gaps express the time-integrated effects of tree failure and mortality as well as regrowth and succession in tropical forests. Quantifying the size and spatial distribution of canopy gaps is requisite to modeling forest functional processes ranging from carbon fluxes to species interactions and biological diversity. Using high-resolution airborne Light Detection and Ranging (LiDAR), we mapped and analyzed 5,877,937 static canopy gaps throughout 125,581 ha of lowland Amazonian forest in Peru. Our LiDAR sampling covered a wide range of forest physiognomies across contrasting geologic and topographic conditions, and on depositional floodplain and erosional terra firme substrates. We used the scaling exponent of the Zeta distribution (lambda) as a metric to quantify and compare the negative relationship between canopy gap frequency and size across sites. Despite variable canopy height and forest type, values of lambda were highly conservative (lambda (mean) = 1.83, s = 0.09), and little variation was observed regionally among geologic substrates and forest types, or at the landscape level comparing depositional-floodplain and erosional terra firme landscapes. lambda-values less than 2.0 indicate that these forests are subjected to large gaps that reset carbon stocks when they occur. Consistency of lambda-values strongly suggests similarity in the mechanisms of canopy failure across a diverse array of lowland forests in southwestern Amazonia.	[Asner, Gregory P.; Kennedy-Bowdoin, Ty; Knapp, David E.; Anderson, Christopher; Martin, Roberta E.] Carnegie Inst Sci, Dept Global Ecol, Stanford, CA USA; [Kellner, James R.] Univ Maryland, Dept Geog Sci, College Pk, MD 20742 USA	Carnegie Institution for Science; University System of Maryland; University of Maryland College Park	Asner, GP (corresponding author), Carnegie Inst Sci, Dept Global Ecol, Stanford, CA USA.	gpa@carnegiescience.edu	Asner, Gregory/G-9268-2013; Martin, Roberta/A-5073-2015	Asner, Gregory/0000-0001-7893-6421; Martin, Roberta/0000-0003-3509-8530; Anderson, Christopher/0000-0001-7392-4368	Government of Norway; Carnegie Institution for Science; John D. and Catherine T. MacArthur Foundation	Government of Norway; Carnegie Institution for Science; John D. and Catherine T. MacArthur Foundation	This study was supported by the John D. and Catherine T. MacArthur Foundation, the Government of Norway, and the Carnegie Institution for Science. The Carnegie Airborne Observatory is made possible by the Gordon and Betty Moore Foundation, Grantham Foundation for the Protection of the Environment, Avatar Alliance Foundation, W. M. Keck Foundation, Margaret A. Cargill Foundation, Mary Anne Nyburg Baker and G. Leonard Baker Jr., and William R. Hearst III. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACKERLY DD, 1995, ECOLOGY, V76, P1134, DOI 10.2307/1940921; Asner GP, 2012, BIOGEOSCIENCES, V9, P2683, DOI 10.5194/bg-9-2683-2012; Asner GP, 2004, ECOL APPL, V14, pS280; Asner GP, 2004, GLOBAL CHANGE BIOL, V10, P765, DOI 10.1111/j.1529-8817.2003.00756.x; Asner GP, 2013, P NATL ACAD SCI; Asner GP, 2007, J APPL REMOTE SENS, V1, DOI 10.1117/1.2794018; Asner GP, 2012, OECOLOGIA, V168, P1147, DOI 10.1007/s00442-011-2165-z; Asner GP, 2011, REMOTE SENS ENVIRON, V115, P3587, DOI 10.1016/j.rse.2011.08.020; Asner GP, 2011, ECOL APPL, V21, P85, DOI 10.1890/09-1999.1; Asner GP, 2011, NEW PHYTOL, V189, P999, DOI 10.1111/j.1469-8137.2010.03549.x; Asner GP, 2010, P NATL ACAD SCI USA, V107, P16738, DOI 10.1073/pnas.1004875107; Asner GP, 2009, ECOSYSTEMS, V12, P261, DOI 10.1007/s10021-008-9221-5; Baker TR, 2004, GLOBAL CHANGE BIOL, V10, P545, DOI 10.1111/j.1365-2486.2004.00751.x; Brokaw N. V. L., 1985, The ecology of natural disturbance and patch dynamics, P53; BROKAW NVL, 1982, BIOTROPICA, V14, P158, DOI 10.2307/2387750; BROKAW NVL, 1989, ECOLOGY, V70, P538, DOI 10.2307/1940196; BROKAW NVL, 1985, ECOLOGY, V66, P682, DOI 10.2307/1940529; CANHAM CD, 1988, ECOLOGY, V69, P786, DOI 10.2307/1941027; Chambers JQ, 2009, ECOL LETT, V12, pE22, DOI 10.1111/j.1461-0248.2009.01398.x; Chambers JQ, 2013, P NATL ACAD SCI; CLAUSET A, 2007, POWER LAW DISTRIBUTI; CONNELL JH, 1989, ECOLOGY, V70, P560, DOI 10.2307/1940205; Czaplewski RL, 1999, J FOREST, V97, P44; de Castilho CV, 2006, FOREST ECOL MANAG, V234, P85, DOI 10.1016/j.foreco.2006.06.024; DENSLOW JS, 1987, ANNU REV ECOL SYST, V18, P431, DOI 10.1146/annurev.es.18.110187.002243; Enquist BJ, 2002, SCIENCE, V295, P1517, DOI 10.1126/science.1066360; Feldpausch TR, 2012, BIOGEOSCIENCES, V9, P3381, DOI 10.5194/bg-9-3381-2012; Fisher JI, 2008, ECOL LETT, V11, P554, DOI 10.1111/j.1461-0248.2008.01169.x; Flores Sancho S, 2001, REV TRABAJOS INVESTI, V2, P21; Gloor M, 2009, GLOBAL CHANGE BIOL, V15, P2418, DOI 10.1111/j.1365-2486.2009.01891.x; GRACE J, 1995, SCIENCE, V270, P778, DOI 10.1126/science.270.5237.778; Higgins MA, 2012, REMOTE SENS-BASEL, V4, P2401, DOI 10.3390/rs4082401; Hubbell S. P., 1986, PLANT ECOL, P77; INGEMMET, 2000, MAP GEOL PER; Jansen PA, 2008, ECOLOGY, V89, P3490, DOI 10.1890/07-1682.1; Kellner JR, 2009, ECOL LETT, V12, P887, DOI 10.1111/j.1461-0248.2009.01345.x; Kellner JR, 2009, ECOL LETT, V12, P155, DOI 10.1111/j.1461-0248.2008.01274.x; Lertzman KP, 1996, ECOLOGY, V77, P1254, DOI 10.2307/2265594; Lewis SL, 2009, NATURE, V457, P1003, DOI 10.1038/nature07771; Lloyd J, 2009, ECOL LETT, V12, pE19, DOI 10.1111/j.1461-0248.2009.01326.x; Malhi Y, 2006, GLOBAL CHANGE BIOL, V12, P1107, DOI 10.1111/j.1365-2486.2006.01120.x; Malhi Y, 2009, GLOBAL CHANGE BIOL, V15, P1255, DOI 10.1111/j.1365-2486.2008.01780.x; Negron-Juarez RI, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL043733; NELSON BW, 1994, ECOLOGY, V75, P853, DOI 10.2307/1941742; Phillips OL, 1998, SCIENCE, V282, P439, DOI 10.1126/science.282.5388.439; Phillips OL, 2003, J ECOL, V91, P757, DOI 10.1046/j.1365-2745.2003.00815.x; Quesada C.A., 2009, BIOGEOSCI DISCUSS, V6, P3993, DOI DOI 10.5194/BGD-6-3993-2009; R Core Team, 2012, R LANG ENV STAT COMP; Rasanen ME, 1990, TERRA NOVA, V2, P320, DOI 10.1111/j.1365-3121.1990.tb00084.x; Regard V, 2009, GEOMORPHOLOGY, V107, P107, DOI 10.1016/j.geomorph.2008.12.003; Schieving F., 1998, PLATOS PLANT MATH ST; SOLE RV, 1995, J THEOR BIOL, V173, P31, DOI 10.1006/jtbi.1995.0040; ter Steege H, 2006, NATURE, V443, P444, DOI 10.1038/nature05134; TUOMISTO H, 1995, SCIENCE, V269, P63, DOI 10.1126/science.269.5220.63; Valladares F, 1997, OECOLOGIA, V111, P505, DOI 10.1007/s004420050264; West GB, 1997, SCIENCE, V276, P122, DOI 10.1126/science.276.5309.122; White EP, 2008, ECOLOGY, V89, P905, DOI 10.1890/07-1288.1; YOUNG TP, 1991, ECOLOGY, V72, P1464, DOI 10.2307/1941119	58	72	72	4	89	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2013	8	4							e60875	10.1371/journal.pone.0060875	http://dx.doi.org/10.1371/journal.pone.0060875			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125TD	23613748	gold, Green Submitted, Green Published			2022-12-25	WOS:000317563300009
J	Pan, Y; Liu, S; Wu, HF; Lv, J; Xu, XQ; Zhang, YF				Pan, Yu; Liu, Shuai; Wu, Haifei; Lv, Jing; Xu, Xiaoqian; Zhang, Yifan			Baculovirus as an Ideal Radionuclide Reporter Gene Vector: A New Strategy for Monitoring the Fate of Human Stem Cells In Vivo	PLOS ONE			English	Article							SODIUM-IODIDE SYMPORTER; UMBILICAL-CORD BLOOD; TRANSGENE EXPRESSION; PROTEIN EXPRESSION; TERATOMA FORMATION; BONE-MARROW; THERAPY; DELIVERY; DIFFERENTIATION; TRANSPLANTATION	Purpose: Radionuclide reporter gene imaging holds promise for non-invasive monitoring of transplanted stem cells. Thus, the feasibility of utilizing recombinant baculoviruses carrying the sodium iodide symporter (NIS) reporter gene in monitoring stem cell therapy by radionuclide imaging was explored in this study. Methods: Recombinant baculoviruses carrying NIS and green fluorescent protein (GFP) reporter genes (Bac-NIS and BacGFP) were constructed and used to infect human induced pluripotent stem cells (hiPSCs), human embryonic stem cells (hESCs) and human umbilical cord blood mesenchymal stem cells (hUCB-MSCs). Infection efficiency, total fluorescence intensity and duration of transgene expression were determined by flow cytometry. Cytotoxicity/ proliferative effects of baculovirus on hUCB-MSCs were assessed using CCK-8 assays. 125 I uptake and perchlorate inhibition assays were performed on Bac-NIS-infected hUCB-MSCs. Radionuclide imaging of mice transplanted with Bac-NIS-infected hUCB-MSCs was performed by NanoSPECT/ CT imaging. Results: Infection efficiencies of recombinant baculovirus in hESCs, hiPSCs and hUCB-MSCs increased with increasing MOIs (27.3%, 35.8% and 95.6%, respectively, at MOI = 800). Almost no cytotoxicity and only slight effects on hUCB-MSCs proliferation were observed. Obvious GFP expression (40.6%) remained at 8 days post-infection. The radioiodide was functionally accumulated by NIS gene products and specifically inhibited by perchlorate (ClO4 -). Radioiodide uptake, peaking at 30 min and gradually decreasing over time, significantly correlated with hUCB-MSCs cell number (R 2 = 0.994). Finally, radionuclide imaging showed Bac-NIS-infected hUCB-MSCs effectively accumulated radioiodide in vivo, which gradually weakened over time. Conclusion: Baculovirus as transgenic vector of radionuclide reporter gene imaging technology is a promising strategy for monitoring stem cell transplantation therapy.	[Pan, Yu; Liu, Shuai; Wu, Haifei; Lv, Jing; Zhang, Yifan] Shanghai Jiao Tong Univ, Ruijin Hosp, Sch Med, Dept Nucl Med, Shanghai 200030, Peoples R China; [Xu, Xiaoqian] Secondary Mil Med Univ, Changhai Hosp, Dept Hematol, Shanghai, Peoples R China	Shanghai Jiao Tong University; Naval Medical University	Zhang, YF (corresponding author), Shanghai Jiao Tong Univ, Ruijin Hosp, Sch Med, Dept Nucl Med, Shanghai 200030, Peoples R China.	zhangyifan1992@yahoo.com.cn	Zhang, Yifan/AGT-8799-2022	Yifan, Zhang/0000-0001-6488-6232; Pan, Yu/0000-0002-3917-8688				Acton PD, 2005, Q J NUCL MED MOL IM, V49, P349; Amit M, 2000, DEV BIOL, V227, P271, DOI 10.1006/dbio.2000.9912; Bai JZ, 2004, NEUROREPORT, V15, P1117, DOI 10.1097/00001756-200405190-00007; Barry FP, 2004, INT J BIOCHEM CELL B, V36, P568, DOI 10.1016/j.biocel.2003.11.001; Cao F, 2007, STEM CELLS DEV, V16, P883, DOI 10.1089/scd.2007.0160; Chen CY, 2011, BIOTECHNOL ADV, V29, P618, DOI 10.1016/j.biotechadv.2011.04.004; Chen CY, 2011, MOL PHARMACEUT, V8, P1505, DOI 10.1021/mp100368d; Chung JK, 2002, J NUCL MED, V43, P1188; D'Amour KA, 2006, NAT BIOTECHNOL, V24, P1392, DOI 10.1038/nbt1259; Dove A, 2002, NAT BIOTECHNOL, V20, P339, DOI 10.1038/nbt0402-339; Du J, 2010, J BIOSCI BIOENG, V109, P1, DOI 10.1016/j.jbiosc.2009.06.017; Fassas A, 2011, NEUROLOGY, V76, P1066, DOI 10.1212/WNL.0b013e318211c537; Hartley JL, 2006, CURR OPIN BIOTECH, V17, P359, DOI 10.1016/j.copbio.2006.06.011; HAYFLICK L, 1961, EXP CELL RES, V23, P14, DOI 10.1016/0014-4827(61)90059-3; Higuchi T, 2009, J NUCL MED, V50, P1088, DOI 10.2967/jnumed.108.060665; Ho YC, 2006, GENE THER, V13, P1471, DOI 10.1038/sj.gt.3302796; Ho YC, 2005, J GENE MED, V7, P860, DOI 10.1002/jgm.729; Hsu CS, 2004, BIOTECHNOL BIOENG, V88, P42, DOI 10.1002/bit.20213; Hu YC, 2008, CURR GENE THER, V8, P54, DOI 10.2174/156652308783688509; Hu YC, 2006, ADV VIRUS RES, V68, P287, DOI 10.1016/S0065-3527(06)68008-1; Hwang DW, 2008, EUR J NUCL MED MOL I, V35, P1887, DOI 10.1007/s00259-008-0751-z; Jin JL, 2013, CURR NEUROVASC RES, V10, P11, DOI 10.2174/156720213804805936; Kern S, 2006, STEM CELLS, V24, P1294, DOI 10.1634/stemcells.2005-0342; Kim YH, 2005, J NUCL MED, V46, P305; Kost TA, 2005, NAT BIOTECHNOL, V23, P567, DOI 10.1038/nbt1095; Lee AS, 2009, CELL CYCLE, V8, P2608, DOI 10.4161/cc.8.16.9353; Lin CY, 2011, BIOMATERIALS, V32, P6505, DOI 10.1016/j.biomaterials.2011.05.059; Lin Shih-Yeh, 2011, Recent Pat Biotechnol, V5, P1; Liu R, 2013, STEM CELLS DEV, V22, P1053, DOI 10.1089/scd.2012.0463; Lo WH, 2009, MOL THER, V17, P658, DOI 10.1038/mt.2009.13; Mahonen AJ, 2010, J BIOTECHNOL, V145, P111, DOI 10.1016/j.jbiotec.2009.11.003; Morizane A, 2010, J NEUROSCI RES, V88, P3467, DOI 10.1002/jnr.22515; Nicola JP, 2009, AM J PHYSIOL-CELL PH, V296, pC654, DOI 10.1152/ajpcell.00509.2008; Okita K, 2011, PHILOS T R SOC B, V366, P2198, DOI 10.1098/rstb.2011.0016; Pierro M, 2013, THORAX, V68, P475, DOI 10.1136/thoraxjnl-2012-202323; Pournasr B, 2011, STEM CELLS, V29, P1933, DOI 10.1002/stem.760; Shen HC, 2007, J GENE MED, V9, P470, DOI 10.1002/jgm.1037; Spitzweg C, 1998, J CLIN ENDOCR METAB, V83, P1746, DOI 10.1210/jc.83.5.1746; Strauer BE, 2002, CIRCULATION, V106, P1913, DOI 10.1161/01.CIR.0000034046.87607.1C; Sun N, 2010, CELL CYCLE, V9, P880, DOI 10.4161/cc.9.5.10827; Swijnenburg RJ, 2008, P NATL ACAD SCI USA, V105, P12991, DOI 10.1073/pnas.0805802105; Swijnenburg RJ, 2008, STEM CELLS DEV, V17, P1023, DOI 10.1089/scd.2008.0091; Sykova E, 2007, CELL DEATH DIFFER, V14, P1336, DOI 10.1038/sj.cdd.4402140; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; van der Bogt KEA, 2006, CELL CYCLE, V5, P2748, DOI 10.4161/cc.5.23.3533; Vayre L, 1999, EUR J ENDOCRINOL, V141, P382, DOI 10.1530/eje.0.1410382; Voltarelli JC, 2007, JAMA-J AM MED ASSOC, V297, P1568, DOI 10.1001/jama.297.14.1568; Watt SM, 2005, SEMIN FETAL NEONAT M, V10, P209, DOI 10.1016/j.siny.2005.02.001; WEISS SJ, 1984, ENDOCRINOLOGY, V114, P1090, DOI 10.1210/endo-114-4-1090; Wu JC, 2010, J NUCL MED, V51, p128S, DOI 10.2967/jnumed.109.068239; Wu Z, 2011, J GENET GENOMICS, V38, P13, DOI 10.1016/j.jcg.2010.12.006; Yan CH, 2013, MOL PHARMACEUT, V10, P142, DOI 10.1021/mp300261e; Yang SE, 2004, CYTOTHERAPY, V6, P476, DOI 10.1080/14653240410005041; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zeng JM, 2007, STEM CELLS, V25, P1055, DOI 10.1634/stemcells.2006-0616; Zhang XJ, 2006, ADV DRUG DELIVER REV, V58, P515, DOI 10.1016/j.addr.2006.03.006; Zhang X, 2013, CURR CANCER DRUG TAR, V13, P92, DOI 10.2174/156800913804486665; Zhou X, 2010, NUCL MED BIOL, V37, P299, DOI 10.1016/j.nucmedbio.2009.12.007	58	13	13	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2013	8	4							e61305	10.1371/journal.pone.0061305	http://dx.doi.org/10.1371/journal.pone.0061305			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125TD	23596521	Green Published, Green Submitted, gold			2022-12-25	WOS:000317563300028
J	Marron, AO; Akam, M; Walker, G				Marron, Alan O.; Akam, Michael; Walker, Giselle			A Duplex PCR-Based Assay for Measuring the Amount of Bacterial Contamination in a Nucleic Acid Extract from a Culture of Free-Living Protists	PLOS ONE			English	Article							QUANTIFICATION; DATABASE	Background: Cultures of heterotrophic protists often require co-culturing with bacteria to act as a source of nutrition. Such cultures will contain varying levels of intrinsic bacterial contamination that can interfere with molecular research and cause problems with the collection of sufficient material for sequencing. Measuring the levels of bacterial contamination for the purposes of molecular biology research is non-trivial, and can be complicated by the presence of a diverse bacterial flora, or by differences in the relative nucleic acid yield per bacterial or eukaryotic cell. Principal Findings: Here we describe a duplex PCR-based assay that can be used to measure the levels of contamination from marine bacteria in a culture of loricate choanoflagellates. By comparison to a standard culture of known target sequence content, the assay can be used to quantify the relative proportions of bacterial and choanoflagellate material in DNA or RNA samples extracted from a culture. We apply the assay to compare methods of purifying choanoflagellate cultures prior to DNA extraction, to determine their effectiveness in reducing bacterial contamination. Together with measurements of the total nucleic acid concentration, the assay can then be used as the basis for determining the absolute amounts of choanoflagellate DNA or RNA present in a sample. Conclusions: The assay protocol we describe here is a simple and relatively inexpensive method of measuring contamination levels in nucleic acid samples. This provides a new way to establish quantification and purification protocols for molecular biology and genomics in novel heterotrophic protist species. Guidelines are provided to develop a similar protocol for use with any protistan culture. This assay method is recommended where qPCR equipment is unavailable, where qPCR is not viable because of the nature of the bacterial contamination or starting material, or where prior sequence information is insufficient to develop qPCR protocols.	[Marron, Alan O.; Akam, Michael] Univ Cambridge, Dept Zool, Cambridge, England; [Walker, Giselle] Univ Otago, Dept Bot, Dunedin, New Zealand	University of Cambridge; University of Otago	Marron, AO (corresponding author), Univ Cambridge, Dept Zool, Cambridge, England.	am543@cam.ac.uk			Biotechnology and Biological Sciences Research Council [BB/E527604/1]; Fitzwilliam College, Cambridge; Leathersellers' Company Scholarship	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Fitzwilliam College, Cambridge; Leathersellers' Company Scholarship	AOM was supported by the Biotechnology and Biological Sciences Research Council Comparative Genomics training grant BB/E527604/1 and a Leathersellers' Company Scholarship awarded by Fitzwilliam College, Cambridge. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Baker GC, 2003, J MICROBIOL METH, V55, P541, DOI 10.1016/j.mimet.2003.08.009; Borneman J, 2000, APPL ENVIRON MICROB, V66, P4356, DOI 10.1128/AEM.66.10.4356-4360.2000; Bustin SA, 2000, J MOL ENDOCRINOL, V25, P169, DOI 10.1677/jme.0.0250169; Bustin Stephen A, 2004, J Biomol Tech, V15, P155; Carr M, 2008, P NATL ACAD SCI USA, V105, P16641, DOI 10.1073/pnas.0801667105; Doyle J. J., 1987, PHYTOCHEMISTRY B, V19, P11, DOI DOI 10.2307/4119796; Gong NP, 2010, J EXP BIOL, V213, P3575, DOI 10.1242/jeb.048496; Hodgetts J, 2009, APPL ENVIRON MICROB, V75, P2945, DOI 10.1128/AEM.02610-08; King N, 2009, EMERGING MODEL ORGAN; King N, 2008, NATURE, V451, P783, DOI 10.1038/nature06617; Klappenbach JA, 2001, NUCLEIC ACIDS RES, V29, P181, DOI 10.1093/nar/29.1.181; Leadbeater BSC, 2010, EUR J PROTISTOL, V46, P96, DOI 10.1016/j.ejop.2009.12.003; LEADBEATER BSC, 1979, PROTOPLASMA, V98, P241, DOI 10.1007/BF01281442; Lindstrom ES, 2002, J MICROBIOL METH, V49, P173, DOI 10.1016/S0167-7012(01)00366-9; Medina M, 2003, INT J ASTROBIOL, V2, P203, DOI [DOI 10.1017/S1473550403001551), 10.1017/S1473550403001551, DOI 10.1017/S1473550403001551]; MEDLIN L, 1988, GENE, V71, P491, DOI 10.1016/0378-1119(88)90066-2; Mohammadi T, 2003, J CLIN MICROBIOL, V41, P4796, DOI 10.1128/JCM.41.10.4796-4798.2003; Nagaraj SH, 2007, BRIEF BIOINFORM, V8, P6, DOI 10.1093/bib/bbl015; Rastogi G, 2010, J MICROBIOL METH, V83, P127, DOI 10.1016/j.mimet.2010.08.006; Rose JM, 2004, AQUAT MICROB ECOL, V34, P263, DOI 10.3354/ame034263; SAIKI RK, 1990, PCR PROTOCOLS GUIDE; Sanchez O, 2007, APPL ENVIRON MICROB, V73, P5962, DOI 10.1128/AEM.00817-07; Steenkamp ET, 2006, MOL BIOL EVOL, V23, P93, DOI 10.1093/molbev/msj011; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; VanGuilder HD, 2008, BIOTECHNIQUES, V44, P619, DOI 10.2144/000112776; Wilkens SL, 2012, J APPL MICROBIOL, V112, P346, DOI 10.1111/j.1365-2672.2011.05197.x; Wuyts J, 2002, NUCLEIC ACIDS RES, V30, P183, DOI 10.1093/nar/30.1.183; Yanez-Ruiz DR, 2007, BRIT J NUTR, V96, P861	29	3	3	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2013	8	4							e61732	10.1371/journal.pone.0061732	http://dx.doi.org/10.1371/journal.pone.0061732			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123JP	23593495	Green Submitted, Green Published, gold			2022-12-25	WOS:000317385300081
J	Boerlijst, MC; Oudman, T; de Roos, AM				Boerlijst, Maarten C.; Oudman, Thomas; de Roos, Andre M.			Catastrophic Collapse Can Occur without Early Warning: Examples of Silent Catastrophes in Structured Ecological Models	PLOS ONE			English	Article							REGIME SHIFTS; LEADING INDICATOR; VARIANCE; RECOVERY; SYSTEMS; SIGNALS; TIME	Catastrophic and sudden collapses of ecosystems are sometimes preceded by early warning signals that potentially could be used to predict and prevent a forthcoming catastrophe. Universality of these early warning signals has been proposed, but no formal proof has been provided. Here, we show that in relatively simple ecological models the most commonly used early warning signals for a catastrophic collapse can be silent. We underpin the mathematical reason for this phenomenon, which involves the direction of the eigenvectors of the system. Our results demonstrate that claims on the universality of early warning signals are not correct, and that catastrophic collapses can occur without prior warning. In order to correctly predict a collapse and determine whether early warning signals precede the collapse, detailed knowledge of the mathematical structure of the approaching bifurcation is necessary. Unfortunately, such knowledge is often only obtained after the collapse has already occurred.	[Boerlijst, Maarten C.; Oudman, Thomas; de Roos, Andre M.] Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, Amsterdam, Netherlands	University of Amsterdam	Boerlijst, MC (corresponding author), Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, Amsterdam, Netherlands.	M.C.Boerlijst@uva.nl	De Roos, Andre M./A-1590-2008	De Roos, Andre M./0000-0002-6944-2048				Biggs R, 2009, P NATL ACAD SCI USA, V106, P826, DOI 10.1073/pnas.0811729106; Carpenter SR, 2011, SCIENCE, V332, P1079, DOI 10.1126/science.1203672; Carpenter SR, 2006, ECOL LETT, V9, P308, DOI 10.1111/j.1461-0248.2005.00877.x; CASH JR, 1990, ACM T MATH SOFTWARE, V16, P201, DOI 10.1145/79505.79507; Contamin R, 2009, ECOL APPL, V19, P799, DOI 10.1890/08-0109.1; Dakos V, 2008, P NATL ACAD SCI USA, V105, P14308, DOI 10.1073/pnas.0802430105; Dakos V, 2012, ECOLOGY, V93, P264, DOI 10.1890/11-0889.1; Dakos V, 2010, THEOR ECOL-NETH, V3, P163, DOI 10.1007/s12080-009-0060-6; De Roos AM, 2002, P NATL ACAD SCI USA, V99, P12907, DOI 10.1073/pnas.192174199; Drake JM, 2010, NATURE, V467, P456, DOI 10.1038/nature09389; GARFINKEL A, 1992, SCIENCE, V257, P1230, DOI 10.1126/science.1519060; Guttal V, 2008, ECOL LETT, V11, P450, DOI 10.1111/j.1461-0248.2008.01160.x; Halley JM, 1996, TRENDS ECOL EVOL, V11, P33, DOI 10.1016/0169-5347(96)81067-6; Hastings A, 2010, ECOL LETT, V13, P464, DOI 10.1111/j.1461-0248.2010.01439.x; Holling C.S., 1973, Annual Rev Ecol Syst, V4, P1, DOI 10.1146/annurev.es.04.110173.000245; Kefi S, 2013, OIKOS, V122, P641, DOI 10.1111/j.1600-0706.2012.20838.x; MAY RM, 1977, NATURE, V269, P471, DOI 10.1038/269471a0; Persson L, 2007, SCIENCE, V316, P1743, DOI 10.1126/science.1141412; Scheffer M, 2009, NATURE, V461, P53, DOI 10.1038/nature08227; Seekell DA, 2011, AM NAT, V178, P442, DOI 10.1086/661898; van Kooten T, 2005, J THEOR BIOL, V237, P67, DOI 10.1016/j.jtbi.2005.03.032; van Nes EH, 2007, AM NAT, V169, P738, DOI 10.1086/516845; Vasseur DA, 2004, ECOLOGY, V85, P1146, DOI 10.1890/02-3122; Veraart AJ, 2012, NATURE, V481, P357, DOI 10.1038/nature10723; WISSEL C, 1984, OECOLOGIA, V65, P101, DOI 10.1007/BF00384470	25	68	69	3	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2013	8	4							e62033	10.1371/journal.pone.0062033	http://dx.doi.org/10.1371/journal.pone.0062033			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123JA	23593506	Green Published, gold, Green Submitted			2022-12-25	WOS:000317383200064
J	Verhagen, J; Burton, BR; Britton, GJ; Shepard, ER; Anderton, SM; Wraith, DC				Verhagen, Johan; Burton, Bronwen R.; Britton, Graham J.; Shepard, Ella R.; Anderton, Stephen M.; Wraith, David C.			Modification of the FoxP3 Transcription Factor Principally Affects Inducible T Regulatory Cells in a Model of Experimental Autoimmune Encephalomyelitis	PLOS ONE			English	Article							PROTEIN; EXPRESSION	T regulatory (Treg) cells expressing the transcription factor FoxP3 play a key role in protection against autoimmune disease. GFP-FoxP3 reporter mice have been used widely to study the induction, function and stability of both thymically- and peripherally-induced Treg cells. The N-terminal modification of FoxP3, however, affects its interaction with transcriptional co-factors; this can alter Treg cell development and function in certain self-antigen specific animal models. Interestingly, Treg cell function can be negatively or positively affected, depending on the nature of the model. In this study, we focused on the effect of the GFP-FoxP3 reporter on Treg cell development and function in the Tg4 mouse model. In this model, T cells express a transgenic T cell receptor (TCR) specific for the Myelin Basic Protein (MBP) peptide Ac1-9, making the animals susceptible to experimental autoimmune encephalomyelitis (EAE), a disease akin to multiple sclerosis in humans. Unlike diabetes-susceptible mice, Tg4 FoxP3(gfp) mice did not develop spontaneous autoimmune disease and did not demonstrate augmented susceptibility to induced disease. Concurrently, thymic generation of natural Treg cells was not negatively affected. The induction of FoxP3 expression in naive peripheral T cells was, however, significantly impaired as a result of the transgene. This study shows that the requirements for the interaction of FoxP3 with co-factors, which governs its regulatory ability, differ not only between natural and inducible Treg cells but also between animal models of diseases such as diabetes and EAE.	[Verhagen, Johan; Burton, Bronwen R.; Britton, Graham J.; Shepard, Ella R.; Wraith, David C.] Univ Bristol, Sch Cellular & Mol Med, Bristol, Avon, England; [Anderton, Stephen M.] Univ Edinburgh, Ctr Multiple Sclerosis Res, Ctr Inflammat Res, Queens Med Res Inst,Med Res Council, Edinburgh, Midlothian, Scotland; [Anderton, Stephen M.] Univ Edinburgh, Ctr Immunol Infect & Evolut, Queens Med Res Inst, Ctr Inflammat Res,Med Res Council, Edinburgh, Midlothian, Scotland	University of Bristol; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Edinburgh; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Edinburgh	Verhagen, J (corresponding author), Univ Bristol, Sch Cellular & Mol Med, Bristol, Avon, England.	Johan.Verhagen@bristol.ac.uk	Britton, Graham/CAI-2177-2022; Britton, Graham/V-1370-2019	Britton, Graham/0000-0003-4630-1223; Wraith, David/0000-0003-2147-5614; Verhagen, Johan/0000-0001-8414-1342	Wellcome Trust Program [091074/z/09/z]; MRC [G0801924, G0901697] Funding Source: UKRI; Medical Research Council [G0801924, G0901697] Funding Source: researchfish	Wellcome Trust Program(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The work was supported by Wellcome Trust Program, grant number 091074/z/09/z. (www.wellcome.ac.uk.) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akimova T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024226; Bettini ML, 2012, IMMUNITY, V36, P717, DOI 10.1016/j.immuni.2012.03.020; Bilate AM, 2012, ANNU REV IMMUNOL, V30, P733, DOI 10.1146/annurev-immunol-020711-075043; Brunkow ME, 2001, NAT GENET, V27, P68, DOI 10.1038/83784; Chatila TA, 2000, J CLIN INVEST, V106, pR75, DOI 10.1172/JCI11679; Chatila TA, 2012, IMMUNITY, V36, P693, DOI 10.1016/j.immuni.2012.05.011; Darce J, 2012, IMMUNITY, V36, P731, DOI 10.1016/j.immuni.2012.04.007; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Francisco LM, 2010, IMMUNOL REV, V236, P219, DOI 10.1111/j.1600-065X.2010.00923.x; Gavin M, 2003, CURR OPIN IMMUNOL, V15, P690, DOI 10.1016/j.coi.2003.09.011; Gavin MA, 2007, NATURE, V445, P771, DOI 10.1038/nature05543; Huynh KD, 2005, NAT REV GENET, V6, P410, DOI 10.1038/nrg1604; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Lehmann J, 2002, P NATL ACAD SCI USA, V99, P13031, DOI 10.1073/pnas.192162899; LIU GY, 1995, IMMUNITY, V3, P407, DOI 10.1016/1074-7613(95)90170-1; O'Connor RA, 2008, J IMMUNOL, V181, P3750, DOI 10.4049/jimmunol.181.6.3750; Rudra D, 2012, NAT IMMUNOL, V13, P1010, DOI 10.1038/ni.2402; Thornton AM, 2010, J IMMUNOL, V184, P3433, DOI 10.4049/jimmunol.0904028; Verhagen J, 2010, J IMMUNOL, V185, P7129, DOI 10.4049/jimmunol.1090105; Verhagen J, 2009, P NATL ACAD SCI USA, V106, P3306, DOI 10.1073/pnas.0803186106	20	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2013	8	4							e61334	10.1371/journal.pone.0061334	http://dx.doi.org/10.1371/journal.pone.0061334			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130FG	23593464	gold, Green Published, Green Submitted			2022-12-25	WOS:000317898000126
J	Erion, DM; Kotas, ME; McGlashon, J; Yonemitsu, S; Hsiao, JJ; Nagai, Y; Iwasaki, T; Murray, SF; Bhanot, S; Cline, GW; Samuel, VT; Shulman, GI; Gillum, MP				Erion, Derek M.; Kotas, Maya E.; McGlashon, Jacob; Yonemitsu, Shin; Hsiao, Jennifer J.; Nagai, Yoshio; Iwasaki, Takanori; Murray, Susan F.; Bhanot, Sanjay; Cline, Gary W.; Samuel, Varman T.; Shulman, Gerald I.; Gillum, Matthew P.			cAMP-responsive Element-binding Protein (CREB)-regulated Transcription Coactivator 2 (CRTC2) Promotes Glucagon Clearance and Hepatic Amino Acid Catabolism to Regulate Glucose Homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MODULATES GLUCONEOGENESIS; ENDOGENOUS GLUCAGON; INSULIN-RESISTANCE; TORC2; LIVER; HYPERGLYCEMIA; IMMUNONEUTRALIZATION; STREPTOZOTOCIN; SOMATOSTATIN; MAINTENANCE	cAMP-responsive element-binding protein (CREB)-regulated transcription coactivator 2 (CRTC2) regulates transcription of gluconeogenic genes by specifying targets for the transcription factor CREB in response to glucagon. We used an antisense oligonucleotide directed against CRTC2 in both normal rodents and in rodent models of increased gluconeogenesis to better understand the role of CRTC2 in metabolic disease. In the context of severe hyperglycemia and elevated hepatic glucose production, CTRC2 knockdown (KD) improved glucose homeostasis by reducing endogenous glucose production. Interestingly, despite the known role of CRTC2 in coordinating gluconeogenic gene expression, CRTC2KD in a rodent model of type 2 diabetes resulted in surprisingly little alteration of glucose production. However, CRTC2KD animals had elevated circulating concentrations of glucagon and a similar to 80% reduction in glucagon clearance. When this phenomenon was prevented with somatostatin or a glucagon-neutralizing antibody, endogenous glucose production was reduced by CRTC2 KD. Additionally, CRTC2 inhibition resulted in reduced expression of several glucagon-induced pyridoxal 5'-phosphate-dependent enzymes that convert amino acids to gluconeogenic intermediates, suggesting that it may control substrate availability as well as gluconeogenic gene expression. CRTC2 is an important regulator of gluconeogenesis with tremendous impact in models of elevated hepatic glucose production. Surprisingly, it is also part of a previously unidentified negative feedback loop that degrades glucagon and regulates amino acid metabolism to coordinately control glucose homeostasis in vivo.	[Erion, Derek M.; Yonemitsu, Shin; Hsiao, Jennifer J.; Nagai, Yoshio; Iwasaki, Takanori; Cline, Gary W.; Samuel, Varman T.; Shulman, Gerald I.] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06536 USA; [Erion, Derek M.; Shulman, Gerald I.] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06536 USA; [Kotas, Maya E.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06536 USA; [Erion, Derek M.; Shulman, Gerald I.] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06536 USA; [Samuel, Varman T.] Vet Affairs Med Ctr, West Haven, CT 06516 USA; [Murray, Susan F.; Bhanot, Sanjay] ISIS Pharmaceut, Carlsbad, CA 92008 USA; [McGlashon, Jacob; Gillum, Matthew P.] Univ Iowa, Carver Coll Med, Dept Neurol, Iowa City, IA 52242 USA	Yale University; Yale University; Yale University; Howard Hughes Medical Institute; Yale University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; Isis Pharmaceuticals Inc; University of Iowa	Gillum, MP (corresponding author), Univ Iowa, Carver Coll Med, Dept Neurol, 1000 ML,25 S Grand Ave, Iowa City, IA 52242 USA.	matthew-gillum@uiowa.edu	Shulman, Gerald I./P-7176-2019	Shulman, Gerald I./0000-0003-1529-5668; Gillum, Matthew/0000-0003-4893-012X	United States Public Health Service [R01 DK-40936, P30 DK-45735]; University of Iowa; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK045735, R01DK040936, U24DK059635] Funding Source: NIH RePORTER	United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); University of Iowa; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by United States Public Health Service Grants R01 DK-40936 and P30 DK-45735 (to G. I. S.) and the University of Iowa. S. F. M. and S. B. own stock and/or hold stock options in Isis Pharmaceuticals.	BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BRAND CL, 1995, AM J PHYSIOL-ENDOC M, V269, pE469, DOI 10.1152/ajpendo.1995.269.3.E469; BRAND CL, 1994, DIABETOLOGIA, V37, P985, DOI 10.1007/BF00400461; Burgess SC, 2007, CELL METAB, V5, P313, DOI 10.1016/j.cmet.2007.03.004; DEFRONZO RA, 1992, DIABETES CARE, V15, P318, DOI 10.2337/diacare.15.3.318; Dentin R, 2008, SCIENCE, V319, P1402, DOI 10.1126/science.1151363; Dentin R, 2007, NATURE, V449, P366, DOI 10.1038/nature06128; Erion DM, 2009, CELL METAB, V10, P499, DOI 10.1016/j.cmet.2009.10.007; Erion DM, 2009, P NATL ACAD SCI USA, V106, P11288, DOI 10.1073/pnas.0812931106; KOERKER DJ, 1974, SCIENCE, V184, P482, DOI 10.1126/science.184.4135.482; Koo SH, 2005, NATURE, V437, P1109, DOI 10.1038/nature03967; Le Lay J, 2009, CELL METAB, V10, P55, DOI 10.1016/j.cmet.2009.06.006; Liu Y, 2008, NATURE, V456, P269, DOI 10.1038/nature07349; MAGNUSSON I, 1992, J CLIN INVEST, V90, P1323, DOI 10.1172/JCI115997; Masiello P, 1998, DIABETES, V47, P224, DOI 10.2337/diabetes.47.2.224; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; Mu J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049572; Ravnskjaer K, 2007, EMBO J, V26, P2880, DOI 10.1038/sj.emboj.7601715; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; ROCHA DM, 1972, J CLIN INVEST, V51, P2346, DOI 10.1172/JCI107046; Saberi M, 2009, AM J PHYSIOL-ENDOC M, V297, pE1137, DOI 10.1152/ajpendo.00158.2009; Samuel VT, 2006, DIABETES, V55, P2042, DOI 10.2337/db05-0705; Samuel VT, 2009, P NATL ACAD SCI USA, V106, P12121, DOI 10.1073/pnas.0812547106; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Sloop KW, 2004, J CLIN INVEST, V113, P1571, DOI 10.1172/JCI200420911; Sorensen H, 2006, DIABETES, V55, P2843, DOI 10.2337/db06-0222; WAHREN J, 1976, LANCET, V2, P1213; Wang YG, 2010, P NATL ACAD SCI USA, V107, P3087, DOI 10.1073/pnas.0914897107; Watanabe C, 2012, DIABETES, V61, P74, DOI 10.2337/db11-0739; Yang JX, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-281	30	16	16	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 31	2013	288	22					16167	16176		10.1074/jbc.M113.460246	http://dx.doi.org/10.1074/jbc.M113.460246			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	156LA	23595987	Green Published, hybrid			2022-12-25	WOS:000319822300067
J	Lee, M; Choy, JC				Lee, Martin; Choy, Jonathan C.			Positive Feedback Regulation of Human Inducible Nitric-oxide Synthase Expression by Ras Protein S-Nitrosylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-KAPPA-B; CD8 T-CELLS; NEGATIVE-FEEDBACK; MOLECULAR-CLONING; MESSENGER-RNA; NO SYNTHASE; ALLOGENEIC RESPONSES; ACTIVATION; INDUCTION; PROMOTER	The production of nitric oxide (NO) by inducible NO synthase (iNOS) regulates many aspects of physiology and pathology. The expression of iNOS needs to be tightly regulated to balance the broad ranging properties of NO. We have investigated the feedback regulation of cytokine-induced iNOS expression by NO in human cells. The pharmacological inhibition of iNOS activity reduced iNOS protein levels in response to cytokine stimulation in a human epithelial cell line (A549 cells) as well as in primary human astrocytes and bronchial epithelial cells. The addition of exogenous NO using a NO donor prevented the reduction in iNOS levels caused by blockade of iNOS activity. Examination of signaling pathways affected by iNOS indicated that NO S-nitrosylated Ras. Transfection of cells with a S-nitrosylation-resistant Ras mutant reduced iNOS protein levels, indicating a role for this Ras modification in the amplification of iNOS levels. Further, the induction of iNOS protein levels correlated with the late activation of the phosphatidylinositol 3-kinase/Akt and mammalian target of rapamycin (mTOR) pathways, and inhibition of these signaling molecules reduced iNOS levels. Altogether, our findings reveal a previously unknown regulatory pathway that amplifies iNOS expression in human cells.	[Lee, Martin; Choy, Jonathan C.] Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada	Simon Fraser University	Choy, JC (corresponding author), Simon Fraser Univ, Dept Mol Biol & Biochem, 8888 Univ Dr, Burnaby, BC V5A 1S6, Canada.	jonathan.choy@sfu.ca		Choy, Jonathan/0000-0003-1837-8514	Natural Sciences and Engineering Research Council; Canadian Institutes for Health Research (CIHR) Training Grant in Transplantation; CIHR New Investigator award; Michael Smith Foundation for Health Research Scholar award	Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes for Health Research (CIHR) Training Grant in Transplantation(Canadian Institutes of Health Research (CIHR)); CIHR New Investigator award(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation for Health Research Scholar award(Michael Smith Foundation for Health Research)	This work was funded by a Natural Sciences and Engineering Research Council Discovery Grant (to J.C.C.).; Supported by a Canadian Institutes for Health Research (CIHR) Training Grant in Transplantation.; Recipient of CIHR New Investigator and Michael Smith Foundation for Health Research Scholar awards. To whom correspondence should be addressed: Dept. of Molecular Biology and Biochemistry, Simon Fraser University, 8888 University Dr., Burnaby, British Columbia V5A 1S6, Canada. Tel.: 778-782-8701; Fax: 778-782-5583; E-mail: jonathan.choy@sfu.ca.	Albakri QA, 1996, J BIOL CHEM, V271, P5414, DOI 10.1074/jbc.271.10.5414; Boese M, 1996, BRIT J PHARMACOL, V119, P707, DOI 10.1111/j.1476-5381.1996.tb15730.x; Bogdan CT, 2000, IMMUNOL REV, V173, P17, DOI 10.1034/j.1600-065X.2000.917307.x; BREDT DS, 1991, NATURE, V351, P714, DOI 10.1038/351714a0; Chang K, 2004, EXP MOL MED, V36, P311, DOI 10.1038/emm.2004.42; Chen SC, 2008, BIOCHEM BIOPH RES CO, V377, P1274, DOI 10.1016/j.bbrc.2008.10.144; Choy JC, 2009, AM J TRANSPLANT, V9, P2281, DOI 10.1111/j.1600-6143.2009.02771.x; Choy JC, 2007, P NATL ACAD SCI USA, V104, P1313, DOI 10.1073/pnas.0607731104; De Alba J, 1999, J NEUROCHEM, V72, P248, DOI 10.1046/j.1471-4159.1999.0720248.x; Deora AA, 2000, BIOCHEMISTRY-US, V39, P9901, DOI 10.1021/bi992954b; Deora AA, 1998, J BIOL CHEM, V273, P29923, DOI 10.1074/jbc.273.45.29923; Escalante NK, 2011, ARTERIOSCL THROM VAS, V31, P1177, DOI 10.1161/ATVBAHA.111.224162; Galijasevic S, 2003, P NATL ACAD SCI USA, V100, P14766, DOI 10.1073/pnas.2435008100; Ganster RW, 2001, P NATL ACAD SCI USA, V98, P8638, DOI 10.1073/pnas.151239498; GRISCAVAGE JM, 1993, J IMMUNOL, V151, P6329; Grumbach IM, 2005, J MOL CELL CARDIOL, V39, P595, DOI 10.1016/j.yjmcc.2005.06.012; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; Hinz B, 2000, BIOCHEM BIOPH RES CO, V271, P353, DOI 10.1006/bbrc.2000.2632; Ibiza S, 2008, P NATL ACAD SCI USA, V105, P10507, DOI 10.1073/pnas.0711062105; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Jin HK, 2009, BIOL PHARM BULL, V32, P988, DOI 10.1248/bpb.32.988; Kristof AS, 2006, J BIOL CHEM, V281, P23958, DOI 10.1074/jbc.M513918200; Kristof AS, 2001, J BIOL CHEM, V276, P8445, DOI 10.1074/jbc.M009563200; LANDER HM, 1995, J BIOL CHEM, V270, P7017, DOI 10.1074/jbc.270.13.7017; Lander HM, 1997, J BIOL CHEM, V272, P4323, DOI 10.1074/jbc.272.7.4323; Laplante M, 2009, J CELL SCI, V122, P3589, DOI 10.1242/jcs.051011; Lee Sunhee C., 1996, Methods (Orlando), V10, P31, DOI 10.1006/meth.1996.0075; Liu AC, 2012, J IMMUNOL, V188, P1544, DOI 10.4049/jimmunol.1102527; LOWENSTEIN CJ, 1992, P NATL ACAD SCI USA, V89, P6711, DOI 10.1073/pnas.89.15.6711; MARSDEN PA, 1992, FEBS LETT, V307, P287, DOI 10.1016/0014-5793(92)80697-F; Moncada S, 2006, BRIT J PHARMACOL, V147, pS193, DOI 10.1038/sj.bjp.0706458; Mott HR, 1997, BIOCHEMISTRY-US, V36, P3640, DOI 10.1021/bi962790o; MUHL H, 1995, J CLIN INVEST, V95, P1941, DOI 10.1172/JCI117876; Nathan C, 2011, CELL, V147, P257, DOI 10.1016/j.cell.2011.09.031; Nicholson S, 1996, J EXP MED, V183, P2293, DOI 10.1084/jem.183.5.2293; NISHIDA K, 1992, J CLIN INVEST, V90, P2092, DOI 10.1172/JCI116092; NUSSLER AK, 1992, J EXP MED, V176, P261, DOI 10.1084/jem.176.1.261; Oliveira CJR, 2008, NITRIC OXIDE-BIOL CH, V18, P241, DOI 10.1016/j.niox.2008.02.001; PADGETT EL, 1992, BIOCHEM BIOPH RES CO, V186, P775, DOI 10.1016/0006-291X(92)90813-Z; Pahan K, 2000, J NEUROCHEM, V74, P2288, DOI 10.1046/j.1471-4159.2000.0742288.x; Perez-Sala D, 2001, AM J PHYSIOL-RENAL, V280, pF466, DOI 10.1152/ajprenal.2001.280.3.F466; Poljakovic M, 2003, EUR J PHARMACOL, V469, P21, DOI 10.1016/S0014-2999(03)01716-3; Powell JD, 2010, IMMUNITY, V33, P301, DOI 10.1016/j.immuni.2010.09.002; Rahman MA, 2010, J BIOL CHEM, V285, P3806, DOI 10.1074/jbc.M109.059782; RODRIGUEZVICIANA P, 1994, NATURE, V370, P527, DOI 10.1038/370527a0; RodriguezViciana P, 1996, EMBO J, V15, P2442, DOI 10.1002/j.1460-2075.1996.tb00602.x; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; SCHNEEMANN M, 1993, J INFECT DIS, V167, P1358, DOI 10.1093/infdis/167.6.1358; Schneemann M, 2002, NAT IMMUNOL, V3, P102, DOI 10.1038/ni0202-102a; SESSA WC, 1992, J BIOL CHEM, V267, P15274; Shanshiashvili L, 2011, CELL BIOCHEM BIOPHYS, V59, P191, DOI 10.1007/s12013-010-9132-x; SHEFFLER LA, 1995, J IMMUNOL, V155, P886; STUEHR DJ, 1991, P NATL ACAD SCI USA, V88, P7773, DOI 10.1073/pnas.88.17.7773; Switzer CH, 2012, MOL CANCER RES, V10, P1203, DOI 10.1158/1541-7786.MCR-12-0124; Taylor BS, 1998, J BIOL CHEM, V273, P15148, DOI 10.1074/jbc.273.24.15148; Teng KK, 1999, J BIOL CHEM, V274, P37315, DOI 10.1074/jbc.274.52.37315; Tennyson AG, 2011, CHEM BIOL, V18, P1211, DOI 10.1016/j.chembiol.2011.09.009; THOMAS SM, 1992, CELL, V68, P1031, DOI 10.1016/0092-8674(92)90075-N; Thoreen CC, 2012, NATURE, V485, P109, DOI 10.1038/nature11083; Vaziri ND, 1999, HYPERTENSION, V34, P1237, DOI 10.1161/01.HYP.34.6.1237; von Rossum A, 2011, J BIOL CHEM, V286, P21137, DOI 10.1074/jbc.M110.197657; WEINBERG JB, 1995, BLOOD, V86, P1184; Williams JG, 2003, P NATL ACAD SCI USA, V100, P6376, DOI 10.1073/pnas.1037299100; XIE QW, 1992, SCIENCE, V256, P225, DOI 10.1126/science.1373522; XIE QW, 1993, J EXP MED, V177, P1779, DOI 10.1084/jem.177.6.1779; Yu ZY, 2006, J BIOL CHEM, V281, P9101, DOI 10.1074/jbc.M511049200; Yu ZY, 2005, AM J PHYSIOL-RENAL, V288, pF214, DOI 10.1152/ajprenal.00258.2004; Yuhanna IS, 1999, AM J RESP CELL MOL, V21, P629, DOI 10.1165/ajrcmb.21.5.3749	68	23	23	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 31	2013	288	22					15677	15686		10.1074/jbc.M113.475319	http://dx.doi.org/10.1074/jbc.M113.475319			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	156LA	23599434	Green Published, hybrid			2022-12-25	WOS:000319822300024
J	Chen, PR; Nogusa, S; Thapa, RJ; Shaller, C; Simmons, H; Peri, S; Adams, GP; Balachandran, S				Chen, Peirong; Nogusa, Shoko; Thapa, Roshan J.; Shaller, Calvin; Simmons, Heidi; Peri, Suraj; Adams, Gregory P.; Balachandran, Siddharth			Anti-CD70 Immunocytokines for Exploitation of Interferon-gamma-Induced RIP1-Dependent Necrosis in Renal Cell Carcinoma	PLOS ONE			English	Article							FACTOR-KAPPA-B; VESICULAR STOMATITIS-VIRUS; INNATE IMMUNITY; CD70; BORTEZOMIB; APOPTOSIS; ANTIBODY; IMMUNOTHERAPY; ACTIVATION; INHIBITOR	Metastatic renal cell carcinoma (RCC) is an incurable disease in clear need of new therapeutic interventions. In early-phase clinical trials, the cytokine IFN-gamma showed promise as a biotherapeutic for advanced RCC, but subsequent trials were less promising. These trials, however, focused on the indirect immunomodulatory properties of IFN-gamma, and its direct anti-tumor effects, including its ability to kill tumor cells, remains mostly unexploited. We have previously shown that IFN-gamma induces RIP1 kinase-dependent necrosis in cells lacking NF-kappa B survival signaling. RCC cells display basally-elevated NF-kappa B activity, and inhibiting NF-kappa B in these cells, for example by using the small-molecule proteasome blocker bortezomib, sensitizes them to RIP1-dependent necrotic death following exposure to IFN-gamma. While these observations suggest that IFN-gamma-mediated direct tumoricidal activity will have therapeutic benefit in RCC, they cannot be effectively exploited unless IFN-gamma is targeted to tumor cells in vivo. Here, we describe the generation and characterization of two novel 'immunocytokine' chimeric proteins, in which either human or murine IFN-gamma is fused to an antibody targeting the putative metastatic RCC biomarker CD70. These immunocytokines display high levels of species-specific IFN-gamma activity and selective binding to CD70 on human RCC cells. Importantly, the IFN-gamma immunocytokines function as well as native IFN-gamma in inducing RIP1-dependent necrosis in RCC cells, when deployed in the presence of bortezomib. These results provide a foundation for the in vivo exploitation of IFN-gamma-driven tumoricidal activity in RCC.	[Chen, Peirong; Nogusa, Shoko; Thapa, Roshan J.; Balachandran, Siddharth] Fox Chase Canc Ctr, Immune Cell Dev & Host Defense Program, Philadelphia, PA 19111 USA; [Shaller, Calvin; Simmons, Heidi; Adams, Gregory P.] Fox Chase Canc Ctr, Dev Therapeut Program, Philadelphia, PA 19111 USA; [Peri, Suraj] Fox Chase Canc Ctr, Dept Biostat & Bioinformat, Philadelphia, PA 19111 USA	Fox Chase Cancer Center; Fox Chase Cancer Center; Fox Chase Cancer Center	Balachandran, S (corresponding author), Fox Chase Canc Ctr, Immune Cell Dev & Host Defense Program, 7701 Burholme Ave, Philadelphia, PA 19111 USA.	Sid.balachandran@fcc.edu	Adams, Gregory/ABE-8245-2020		American Cancer Society Research Scholar Grant [RSG-09-195-01-MPC]; Fox Chase Cancer Center; NATIONAL CANCER INSTITUTE [T32CA009035] Funding Source: NIH RePORTER	American Cancer Society Research Scholar Grant(American Cancer Society); Fox Chase Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by an American Cancer Society Research Scholar Grant (RSG-09-195-01-MPC) to SB. Additional funds were provided by the Fox Chase Cancer Center via institutional support of the Kidney Cancer Keystone Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An JB, 2004, MOL CANCER THER, V3, P727; An JB, 2007, MOL CANCER THER, V6, P61, DOI 10.1158/1535-7163.MCT-06-0255; Balachandran S, 2004, NATURE, V432, P401, DOI 10.1038/nature03124; Balachandran S, 2004, CANCER CELL, V5, P51, DOI 10.1016/S1535-6108(03)00330-1; Balachandran Siddharth, 2007, V383, P277, DOI 10.1007/978-1-59745-335-6_18; Borst J, 2005, CURR OPIN IMMUNOL, V17, P275, DOI 10.1016/j.coi.2005.04.004; Boursalian TE, 2009, ADV EXP MED BIOL, V647, P108, DOI 10.1007/978-0-387-89520-8_7; Brooks AD, 2010, MOL CANCER RES, V8, P729, DOI 10.1158/1541-7786.MCR-10-0022; Chen D, 2011, CURR CANCER DRUG TAR, V11, P239, DOI 10.2174/156800911794519752; Chen DYT, 2011, MED CLIN N AM, V95, P179, DOI 10.1016/j.mcna.2010.08.021; Coppin C, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001425.pub2; Cvek B, 2011, CURR PHARM DESIGN, V17, P1483, DOI 10.2174/138161211796197124; Degterev A, 2013, CELL DEATH DIFFER, V20, P366, DOI 10.1038/cdd.2012.133; Degterev A, 2008, NAT CHEM BIOL, V4, P313, DOI 10.1038/nchembio.83; Diegmann J, 2005, EUR J CANCER, V41, P1794, DOI 10.1016/j.ejca.2005.05.005; Fernandez M, 2002, J VIROL, V76, P895, DOI 10.1128/JVI.76.2.895-904.2002; Ghetie V, 2002, IMMUNOL RES, V25, P97, DOI 10.1385/IR:25:2:097; Gleave ME, 1998, NEW ENGL J MED, V338, P1265, DOI 10.1056/NEJM199804303381804; Gumz ML, 2007, CLIN CANCER RES, V13, P4740, DOI 10.1158/1078-0432.CCR-07-0143; Hornick JL, 1998, CANCER BIOTHER RADIO, V13, P255, DOI 10.1089/cbr.1998.13.255; Hudes GR, 2009, CANCER, V115, P2313, DOI 10.1002/cncr.24239; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Junker K, 2005, J UROLOGY, V173, P2150, DOI 10.1097/01.ju.0000158121.49085.ba; Kovacs G, 1997, J PATHOL, V183, P131, DOI 10.1002/(SICI)1096-9896(199710)183:2<131::AID-PATH931>3.0.CO;2-G; KURZROCK R, 1985, CANCER RES, V45, P2866; Law CL, 2006, CANCER RES, V66, P2328, DOI 10.1158/0008-5472.CAN-05-2883; Ljungberg B, 2011, EUR UROL, V60, P615, DOI 10.1016/j.eururo.2011.06.049; Machida T, 1987, Gan To Kagaku Ryoho, V14, P440; Mazor Y, 2007, J IMMUNOL METHODS, V321, P41, DOI 10.1016/j.jim.2007.01.008; McEarchern JA, 2007, BLOOD, V109, P1185, DOI 10.1182/blood-2006-07-034017; Miller CHT, 2009, ANN NY ACAD SCI, V1182, P69, DOI 10.1111/j.1749-6632.2009.05069.x; Mizokami MM, 2003, HYBRIDOMA HYBRIDOM, V22, P197, DOI 10.1089/153685903322328929; Morais C, 2011, INT J BIOCHEM CELL B, V43, P1537, DOI 10.1016/j.biocel.2011.08.003; Oya M, 2001, ONCOGENE, V20, P3888, DOI 10.1038/sj.onc.1204525; Pal SK, 2010, TARGET ONCOL, V5, P131, DOI 10.1007/s11523-010-0145-6; Pasche N, 2012, DRUG DISCOV TODAY, V17, P583, DOI 10.1016/j.drudis.2012.01.007; Pirrotta MT, 2011, CURR MED CHEM, V18, P1651, DOI 10.2174/092986711795471293; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Roos FC, 2010, EMBO MOL MED, V2, P275, DOI 10.1002/emmm.201000081; Rosenblatt J, 2011, HEMATOL ONCOL CLIN N, V25, P793, DOI 10.1016/j.hoc.2011.04.010; Shanker A, 2008, JNCI-J NATL CANCER I, V100, P649, DOI 10.1093/jnci/djn113; Sharifi J, 2002, HYBRIDOMA HYBRIDOM, V21, P421, DOI 10.1089/153685902321043954; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Stojdl DF, 2003, CANCER CELL, V4, P263, DOI 10.1016/S1535-6108(03)00241-1; Stojdl DF, 2000, NAT MED, V6, P821, DOI 10.1038/77558; Storkel S, 1997, CANCER, V80, P987, DOI 10.1002/(SICI)1097-0142(19970901)80:5<987::AID-CNCR24>3.0.CO;2-R; Thapa RJ, 2011, MOL CELL BIOL, V31, P2934, DOI 10.1128/MCB.05445-11; THRASHBINGHAM CA, 1995, P NATL ACAD SCI USA, V92, P2854, DOI 10.1073/pnas.92.7.2854; WIRTH MP, 1993, UROL CLIN N AM, V20, P283; Xuan CY, 2010, BLOOD, V115, P2864, DOI 10.1182/blood-2009-10-250555; Yang CH, 2000, P NATL ACAD SCI USA, V97, P13631, DOI 10.1073/pnas.250477397; Younes HM, 2002, J PHARM SCI-US, V91, P2, DOI 10.1002/jps.10007	54	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2013	8	4							e61446	10.1371/journal.pone.0061446	http://dx.doi.org/10.1371/journal.pone.0061446			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IK	23613854	Green Published, gold, Green Submitted			2022-12-25	WOS:000317907200056
J	Kong, LB; Yang, CF; Yu, LF; Smith, W; Zhu, S; Zhu, JY; Zhu, QS				Kong, Lingbo; Yang, Chongfei; Yu, Lifeng; Smith, Wanli; Zhu, Shu; Zhu, Jinyu; Zhu, Qingsheng			Pyrroloquinoline Quinine Inhibits RANKL-Mediated Expression of NFATc1 in Part via Suppression of c-Fos in Mouse Bone Marrow Cells and Inhibits Wear Particle-Induced Osteolysis in Mice	PLOS ONE			English	Article							NUCLEAR-FACTOR; OSTEOCLAST DIFFERENTIATION; SIGNALING PATHWAYS; IN-VITRO; QUINONE; RECEPTOR; ACTIVATION; DERIVATIVES; TITANIUM	The effects of pyrroloquinoline quinine (PQQ) on RANKL-induced osteoclast differentiation and on wear particle-induced osteolysis were examined in this study. PQQ inhibited RANKL-mediated osteoclast differentiation in bone marrow macrophages (BMMs) in a dose-dependent manner without any evidence of cytotoxicity. The mRNA expression of c-Fos, NFATc1, and TRAP in RANKL-treated BMMs was inhibited by PQQ treatment. Moreover, RANKL-induced c-Fos and NFATc1 protein expression was suppressed by PQQ. PQQ additionally inhibited the bone resorptive activity of differentiated osteoclasts. Further a UHMWPE-induced murine calvaria erosion model study was performed to assess the effects of PQQ on wear particle-induced osteolysis in vivo. Mice treated with PQQ demonstrated marked attenuation of bone erosion based on Micro-CT and histologic analysis of calvaria. These results collectively suggested that PQQ demonstrated inhibitory effects on osteoclast differentiation in vitro and may suppress wear particle-induced osteolysis in vivo, indicating that PQQ may therefore serve as a useful drug in the prevention of bone loss.	[Kong, Lingbo; Yang, Chongfei; Yu, Lifeng; Zhu, Shu; Zhu, Jinyu; Zhu, Qingsheng] Fourth Mil Med Univ, Xijing Hosp, Inst Orthoped Surg, Xian 710032, Peoples R China; [Smith, Wanli] Univ Maryland, Sch Pharm, Dept Pharmaceut Sci, Baltimore, MD 21201 USA	Air Force Military Medical University; University System of Maryland; University of Maryland Baltimore	Zhu, QS (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Inst Orthoped Surg, Xian 710032, Peoples R China.	qingshengzhu@hotmail.co.uk	kong, lingbo/O-7491-2017		Fourth Military Medical University	Fourth Military Medical University	This work was supported in part by a grant-in-aid for scientific research from the Fourth Military Medical University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baxter RM, 2011, CLIN ORTHOP RELAT R, V469, P2308, DOI 10.1007/s11999-010-1713-x; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Childs LM, 2001, J BONE JOINT SURG AM, V83A, P1789, DOI 10.2106/00004623-200112000-00004; Chowanadisai W, 2010, J BIOL CHEM, V285, P142, DOI 10.1074/jbc.M109.030130; GALLOP PM, 1993, CONNECT TISSUE RES, V29, P153, DOI 10.3109/03008209309014242; GOLDRING SR, 1986, ARTHRITIS RHEUM-US, V29, P836, DOI 10.1002/art.1780290704; Greenfield EM, 2005, J BIOMED MATER RES B, V72B, P179, DOI 10.1002/jbm.b.30150; GRIGORIADIS AE, 1994, SCIENCE, V266, P443, DOI 10.1126/science.7939685; HAMAGISHI Y, 1990, J PHARMACOL EXP THER, V255, P980; HARRIS WH, 1995, CLIN ORTHOP RELAT R, P46; Hefferan TE, 2003, J APPL PHYSIOL, V95, P1775, DOI 10.1152/japplphysiol.00455.2002; HOBARA N, 1988, PHARMACOLOGY, V37, P264, DOI 10.1159/000138475; Hotokezaka H, 2002, J BIOL CHEM, V277, P47366, DOI 10.1074/jbc.M208284200; Ingham E, 2005, BIOMATERIALS, V26, P1271, DOI 10.1016/j.biomaterials.2004.04.035; JENSEN FE, 1994, NEUROSCIENCE, V62, P399, DOI 10.1016/0306-4522(94)90375-1; Kim K, 2005, J BIOL CHEM, V280, P35209, DOI 10.1074/jbc.M505815200; Kobayashi N, 2001, EMBO J, V20, P1271, DOI 10.1093/emboj/20.6.1271; Kumazawa T, 2007, INT J MOL MED, V19, P765; Kwak HB, 2010, BONE, V46, P724, DOI 10.1016/j.bone.2009.10.042; Masui T, 2005, BIOMATERIALS, V26, P1695, DOI 10.1016/j.biomaterials.2004.05.017; Matsuo K, 2004, J BIOL CHEM, V279, P26475, DOI 10.1074/jbc.M313973200; Merkel KD, 1999, AM J PATHOL, V154, P203, DOI 10.1016/S0002-9440(10)65266-2; Mitchell AE, 1999, ANAL BIOCHEM, V269, P317, DOI 10.1006/abio.1999.4039; Murase K, 2009, J BIOL CHEM, V290, P35209; Nakashima T, 2009, J CLIN IMMUNOL, V29, P555, DOI 10.1007/s10875-009-9316-6; Odkhuu E, 2012, IMMUNOL LETT, V142, P34, DOI 10.1016/j.imlet.2011.12.001; Rucker R, 2009, ALTERN MED REV, V14, P268; Sanchez RM, 2000, J NEUROSCI, V20, P2409; Schwarz EM, 2000, J ORTHOPAED RES, V18, P849, DOI 10.1002/jor.1100180602; Soysa NS, 2009, BIOCHEM BIOPH RES CO, V378, P1, DOI 10.1016/j.bbrc.2008.10.146; Suda T, 1999, ENDOCR REV, V20, P345, DOI 10.1210/er.20.3.345; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Tsutsumi R, 2008, J ORTHOP RES, V26, P1340, DOI 10.1002/jor.20620; Urakami T, 1997, J NUTR SCI VITAMINOL, V43, P19, DOI 10.3177/jnsv.43.19; Warashina H, 2003, BIOMATERIALS, V24, P3655, DOI 10.1016/S0142-9612(03)00120-0; Wei S, 2008, PATHOL RES PRACT, V204, P695, DOI 10.1016/j.prp.2008.07.002; XU F, 1993, BIOCHEM BIOPH RES CO, V193, P434, DOI 10.1006/bbrc.1993.1642; Zhao QX, 2010, INT J BIOCHEM CELL B, V42, P576, DOI 10.1016/j.biocel.2009.12.018	38	18	19	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2013	8	4							e61013	10.1371/journal.pone.0061013	http://dx.doi.org/10.1371/journal.pone.0061013			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IK	23613773	Green Published, gold, Green Submitted			2022-12-25	WOS:000317907200024
J	Mahawar, M; Rabadi, SM; Banik, S; Catlett, SV; Metzger, DW; Malik, M; Bakshi, CS				Mahawar, Manish; Rabadi, Seham M.; Banik, Sukalyani; Catlett, Sally V.; Metzger, Dennis W.; Malik, Meenakshi; Bakshi, Chandra Shekhar			Identification of a Live Attenuated Vaccine Candidate for Tularemia Prophylaxis	PLOS ONE			English	Article							VIRULENT TYPE-A; OUTER-MEMBRANE PROTEIN; FRANCISELLA-TULARENSIS; RESPIRATORY CHALLENGE; PURINE AUXOTROPH; O-ANTIGEN; MICE; STRAIN; PROTECTION; MUTANT	Francisella tularensis is the causative agent of a fatal human disease, tularemia. F. tularensis was used in bioweapon programs in the past and is now classified as a category A select agent owing to its possible use in bioterror attacks. Despite over a century since its discovery, an effective vaccine is yet to be developed. In this study four transposon insertion mutants of F. tularensis live vaccine strain (LVS) in Na/H antiporter (FTL_0304), aromatic amino acid transporter (FTL_0291), outer membrane protein A (OmpA)-like family protein (FTL_0325) and a conserved hypothetical membrane protein gene (FTL_0057) were evaluated for their attenuation and protective efficacy against F. tularensis SchuS4 strain. All four mutants were 100-1000 fold attenuated for virulence in mice than parental F. tularensis. Except for the FTL_0304, single intranasal immunization with the other three mutants provided 100% protection in BALB/c mice against intranasal challenge with virulent F. tularensis SchuS4. Differences in the protective ability of the FTL_0325 and FTL_0304 mutant which failed to provide protection against SchuS4 were investigated further. The results indicated that an early pro-inflammatory response and persistence in host tissues established a protective immunity against F. tularensis SchuS4 in the FTL_0325 immunized mice. No differences were observed in the levels of serum IgG antibodies amongst the two vaccinated groups. Recall response studies demonstrated that splenocytes from the FTL_0325 mutant immunized mice induced significantly higher levels of IFN-gamma and IL-17 cytokines than the FTL_0304 immunized counterparts indicating development of an effective memory response. Collectively, this study demonstrates that persistence of the vaccine strain together with its ability to induce an early pro-inflammatory innate immune response and strong memory responses can discriminate between successful and failed vaccinations against tularemia. This study describes a live attenuated vaccine which may prove to be an ideal vaccine candidate for prevention of respiratory tularemia.	[Mahawar, Manish; Metzger, Dennis W.; Bakshi, Chandra Shekhar] Albany Med Coll, Ctr Immunol & Microbial Dis, Albany, NY 12208 USA; [Rabadi, Seham M.; Banik, Sukalyani; Bakshi, Chandra Shekhar] New York Med Coll, Dept Microbiol & Immunol, Valhalla, NY 10595 USA; [Catlett, Sally V.; Malik, Meenakshi] Albany Coll Pharm & Hlth Sci, Albany, NY USA	Albany Medical College; New York Medical College; Albany College of Pharmacy & Health Sciences	Bakshi, CS (corresponding author), Albany Med Coll, Ctr Immunol & Microbial Dis, Albany, NY 12208 USA.	Shekhar_Bakshi@nymc.edu	Metzger, Dennis W/I-2771-2019; Malik, Meenakshi/F-1501-2015	Metzger, Dennis W/0000-0002-8000-9907; Malik, Meenakshi/0000-0003-0051-4485	New York Medical College; Albany College of Pharmacy and Health Sciences; National Institutes of Health [2P01AI056320, R56AI090072-02, R21AI075250-01A2]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI056320, R56AI090072, R21AI075250] Funding Source: NIH RePORTER	New York Medical College; Albany College of Pharmacy and Health Sciences; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in whole or in part, by National Institutes of Health Grants 2P01AI056320, R56AI090072-02 (CSB) and R21AI075250-01A2 (M. Malik) and startup funds from New York Medical College (CSB) and Albany College of Pharmacy and Health Sciences (MM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson H, 2006, J MED MICROBIOL, V55, P263, DOI 10.1099/jmm.0.46313-0; Bakshi CS, 2008, VACCINE, V26, P5276, DOI 10.1016/j.vaccine.2008.07.051; Bakshi CS, 2006, J BACTERIOL, V188, P6443, DOI 10.1128/JB.00266-06; BELL JF, 1955, J INFECT DIS, V97, P162, DOI 10.1093/infdis/97.2.162; Biennial Review, 2012, FED REGISTER, V77, P194; Bossi P, 2003, PRESSE MED, V32, P1126; Bury-Mone S, 2004, MOL MICROBIOL, V53, P623, DOI 10.1111/j.1365-2958.2004.04137.x; Chiavolini D, 2008, INFECT IMMUN, V76, P486, DOI 10.1128/IAI.00862-07; Cole LE, 2009, P NATL ACAD SCI USA, V106, P4343, DOI 10.1073/pnas.0813411106; Collazo CM, 2009, INFECT IMMUN, V77, P2010, DOI 10.1128/IAI.01322-08; Conlan J Wayne, 2004, Expert Rev Vaccines, V3, P307; Conlan JW, 2002, VACCINE, V20, P3465, DOI 10.1016/S0264-410X(02)00345-6; Cowley SC, 1996, MOL MICROBIOL, V20, P867, DOI 10.1111/j.1365-2958.1996.tb02524.x; Cronquist SD, 2004, DERMATOL CLIN, V22, P313, DOI 10.1016/j.det.2004.03.009; De Pascalis Roberto, 2012, PLoS Pathog, V8, pe1002494, DOI 10.1371/journal.ppat.1002494; Dennis DT, 2001, JAMA-J AM MED ASSOC, V285, P2763, DOI 10.1001/jama.285.21.2763; Eigelsbach H T, 1967, Med Ann Dist Columbia, V36, P282; El Sahly HM, 2009, VACCINE, V27, P4905, DOI 10.1016/j.vaccine.2009.06.036; FULOP M, 1995, VACCINE, V13, P1220, DOI 10.1016/0264-410X(95)00062-6; Griffin KF, 2007, FEMS IMMUNOL MED MIC, V49, P315, DOI 10.1111/j.1574-695X.2007.00219.x; Hickey AJ, 2011, VACCINE, V29, P6941, DOI 10.1016/j.vaccine.2011.07.075; HORNICK RB, 1966, BACTERIOL REV, V30, P532, DOI 10.1128/MMBR.30.3.532-538.1966; Huntley JF, 2008, INFECT IMMUN, V76, P3664, DOI 10.1128/IAI.00374-08; KADULL PJ, 1950, J IMMUNOL, V65, P425; Khader SA, 2010, VIRULENCE, V1, P423, DOI 10.4161/viru.1.5.12862; Kirimanjeswara GS, 2007, J IMMUNOL, V179, P532, DOI 10.4049/jimmunol.179.1.532; Kosono S, 2005, J BACTERIOL, V187, P5242, DOI 10.1128/JB.187.15.5242-5248.2005; KuoLee R, 2007, VACCINE, V25, P3781, DOI 10.1016/j.vaccine.2007.02.014; LANDAY ME, 1968, J BACTERIOL, V96, P804, DOI 10.1128/JB.96.3.804-810.1968; Li J, 2007, MICROBIOL-SGM, V153, P3141, DOI 10.1099/mic.0.2007/006460-0; Lin YY, 2009, IMMUNITY, V31, P799, DOI 10.1016/j.immuni.2009.08.025; Mahawar M, 2012, J BIOL CHEM, V287, P25216, DOI 10.1074/jbc.M112.367672; Melillo AA, 2010, J BIOL CHEM, V285, P27553, DOI 10.1074/jbc.M110.144394; Melillo AA, 2009, J BACTERIOL, V191, P6447, DOI 10.1128/JB.00534-09; Paranavitana C, 2010, J INTERF CYTOK RES, V30, P471, DOI 10.1089/jir.2009.0108; Pechous R, 2006, INFECT IMMUN, V74, P4452, DOI 10.1128/IAI.00666-06; Pechous RD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002487; Qin AP, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-69; Qin AP, 2009, INFECT IMMUN, V77, P152, DOI 10.1128/IAI.01113-08; Rawool DB, 2008, J IMMUNOL, V180, P5548, DOI 10.4049/jimmunol.180.8.5548; Rockx-Brouwer D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037752; Sammons-Jackson WL, 2008, DNA CELL BIOL, V27, P387, DOI 10.1089/dna.2007.0687; SASLAW S, 1961, AM J MED SCI, V242, P166, DOI 10.1097/00000441-196108000-00004; Sebastian S, 2009, VACCINE, V27, P597, DOI 10.1016/j.vaccine.2008.10.079; Shen H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013349; Sjostedt A, 2007, ANN NY ACAD SCI, V1105, P1, DOI 10.1196/annals.1409.009; Su JL, 2007, INFECT IMMUN, V75, P3089, DOI 10.1128/IAI.01865-06; Twine S, 2005, INFECT IMMUN, V73, P8345, DOI 10.1128/IAI.73.12.8345-8352.2005; Twine S, 2012, VACCINE, V30, P3634, DOI 10.1016/j.vaccine.2012.03.036; WAAG DM, 1995, CLIN DIAGN LAB IMMUN, V2, P143, DOI 10.1128/CDLI.2.2.143-148.1995; Weiss DS, 2007, P NATL ACAD SCI USA, V104, P6037, DOI 10.1073/pnas.0609675104	51	21	22	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2013	8	4							e61539	10.1371/journal.pone.0061539	http://dx.doi.org/10.1371/journal.pone.0061539			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IK	23613871	Green Published, gold, Green Submitted			2022-12-25	WOS:000317907200062
J	Branch, KR; Strote, J; Shuman, WP; Mitsumori, LM; Busey, JM; Rue, T; Caldwell, JH				Branch, Kelley R.; Strote, Jared; Shuman, William P.; Mitsumori, Lee M.; Busey, Janet M.; Rue, Tessa; Caldwell, James H.			Diagnostic Accuracy and Clinical Outcomes of ECG-Gated, Whole Chest CT in the Emergency Department	PLOS ONE			English	Article							TRIPLE RULE-OUT; COMPUTED-TOMOGRAPHY ANGIOGRAPHY; CORONARY-ANGIOGRAPHY; IMAGE QUALITY; CARDIAC CT; PAIN; RISK; PERFORMANCE; STANDARD; ARTERIES	Purpose: The purpose of this study was to assess the diagnostic accuracy and one year prognosis of whole chest, "multiple rule out" CT for coronary artery disease (CAD) in Emergency Department patients. Methods and Findings: One hundred and two Emergency Department patients at low to intermediate risk of acute coronary syndrome (ACS), pulmonary embolism and/or acute aortic syndrome underwent a research 64 channel ECG-gated, whole chest CT and a standard of care evaluation. Patients were classified with obstructive CAD with either a coronary CT stenosis greater than 50% or a non-evaluable coronary segment. SOC and 3 month follow up data were used to determine an adjudicated clinical diagnosis. The diagnostic ability of obstructive CAD on CT to identify clinical diagnoses was determined. Patients were followed up for 1 year for cardiac events. Seven (7%) patients were diagnosed with ACS. CT sensitivity to detect obstructive CAD in ACS patients was 100% (95% CI 65%, 100%), negative predictive value 100% (96%, 100%), specificity 88% (80%, 94%), and positive predictive value 39% (17%, 64%). Pulmonary embolism and acute aortic syndrome were not identified in any patients. No cardiac events occurred in patients without obstructive CAD over 1 year. Conclusions: Whole chest CT has high sensitivity and negative predictive value for ACS with excellent one year prognosis in patients without obstructive CAD on CT. The frequency of pulmonary embolism or acute aortic syndrome and the higher radiation dose suggest whole chest CT should be limited to select patients. ClinicalTrials.org #: NCT00855231	[Branch, Kelley R.; Caldwell, James H.] Univ Washington, Div Cardiol, Seattle, WA 98195 USA; [Strote, Jared] Univ Washington, Dept Emergency Med, Seattle, WA 98195 USA; [Shuman, William P.; Mitsumori, Lee M.; Busey, Janet M.; Caldwell, James H.] Univ Washington, Dept Radiol, Seattle, WA 98195 USA; [Rue, Tessa] Univ Washington, Dept Biostat, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Branch, KR (corresponding author), Univ Washington, Div Cardiol, Seattle, WA 98195 USA.	kbranch@u.washington.edu		Branch, Kelley/0000-0003-2362-6498	GE Healthcare; National Institutes of Health from the National Center for Research Resources (NCRR) [5KL2RR025015-02]; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR025015] Funding Source: NIH RePORTER	GE Healthcare(General ElectricGE Healthcare); National Institutes of Health from the National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Funders of this submission include 1) GE Healthcare http://www3.gehealthcare.com/en/Global_Gateway] and 2) National Institutes of Health [ Grant #Grant Number 5KL2RR025015-02 from the National Center for Research Resources (NCRR)]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AAPM-American Association of Physicists in Medicine, 2008, 96 AAPM TASK GROUP 2; Anderson JL, 2007, J AM COLL CARDIOL, V50, P652, DOI 10.1016/j.jacc.2007.02.028; Branch KR, 2012, ACAD RADIOL, V19, P265, DOI 10.1016/j.acra.2011.10.029; Branch KR, 2013, AM J ROENTG IN PRESS; Brown JE, 2002, ROSENS EMERGENCY MED, P162; Cerqueira MD, 2002, CIRCULATION, V105, P539, DOI 10.1161/hc0402.102975; Chang SA, 2008, AM HEART J, V156, P375, DOI 10.1016/j.ahj.2008.03.016; DALEN JE, 1975, PROG CARDIOVASC DIS, V17, P259, DOI 10.1016/S0033-0620(75)80017-X; DeFrance T, 2010, INT J CARDIOVAS IMAG, V26, P99, DOI 10.1007/s10554-009-9522-6; Durmus T, 2011, EUR RADIOL, V21, P1416, DOI 10.1007/s00330-011-2088-4; Earls JP, 2008, RADIOLOGY, V246, P742, DOI 10.1148/radiol.2463070989; Earls JP, 2010, RADIOL CLIN N AM, V48, P657, DOI 10.1016/j.rcl.2010.04.003; Einstein AJ, 2007, JAMA-J AM MED ASSOC, V298, P317, DOI 10.1001/jama.298.3.317; Gallagher MJ, 2007, ANN EMERG MED, V49, P125, DOI 10.1016/j.annemergmed.2006.06.043; Halpern EJ, 2009, ACAD RADIOL, V16, P1039, DOI 10.1016/j.acra.2009.03.013; Hamon M, 2006, J AM COLL CARDIOL, V48, P1896, DOI 10.1016/j.jacc.2006.08.028; Hirai N, 2008, RADIOLOGY, V248, P424, DOI 10.1148/radiol.2482071804; Hoffmann U, 2009, J AM COLL CARDIOL, V53, P1642, DOI 10.1016/j.jacc.2009.01.052; Johnson TRC, 2007, AM J ROENTGENOL, V188, P76, DOI 10.2214/AJR.05.1153; Krissak R, EUR J RADIOL; LaBounty TM, 2010, AM J CARDIOL, V106, P1663, DOI 10.1016/j.amjcard.2010.07.023; Ladapo JA, 2009, J AM COLL CARDIOL, V54, P2409, DOI 10.1016/j.jacc.2009.10.012; Lee HY, 2009, INT J CARDIOVAS IMAG, V25, P319, DOI 10.1007/s10554-008-9375-4; Madder RD, 2011, J CARDIOVASC COMPUT, V5, P165, DOI 10.1016/j.jcct.2011.03.008; May JM, 2009, AM J ROENTGENOL, V193, P150, DOI 10.2214/AJR.08.2021; Meijboom WB, 2007, HEART, V93, P1386, DOI 10.1136/hrt.2006.112771; Mullins MD, 2000, ARCH INTERN MED, V160, P293, DOI 10.1001/archinte.160.3.293; Pellikka PA, 2007, J AM SOC ECHOCARDIOG, V20, P1021, DOI 10.1016/j.echo.2007.07.003; Pope JH, 2000, NEW ENGL J MED, V342, P1163, DOI 10.1056/NEJM200004203421603; Rahmani N, 2009, ACAD RADIOL, V16, P604, DOI 10.1016/j.acra.2008.11.008; Rubinshtein R, 2007, AM J CARDIOL, V100, P1522, DOI 10.1016/j.amjcard.2007.06.052; Savino G, 2006, RADIOL MED, V111, P481, DOI 10.1007/s11547-006-0044-1; Schertler T, 2009, ACAD RADIOL, V16, P708, DOI 10.1016/j.acra.2009.01.014; Sebastia C, 1999, RADIOGRAPHICS, V19, P45, DOI 10.1148/radiographics.19.1.g99ja0945; Shapiro Michael D, 2009, J Cardiovasc Comput Tomogr, V3, P100, DOI 10.1016/j.jcct.2008.12.011; Shuman WP, 2008, RADIOLOGY, V248, P431, DOI 10.1148/radiol.2482072192; Shuman WP, 2010, AM J ROENTGENOL, V195, P923, DOI 10.2214/AJR.09.3972; Takakuwa KM, 2008, RADIOLOGY, V248, P438, DOI 10.1148/radiol.2482072169; White CS, 2005, AM J ROENTGENOL, V185, P533, DOI 10.2214/ajr.185.2.01850533; Wittram C, 2007, AM J ROENTGENOL, V188, P1255, DOI 10.2214/AJR.06.1104	40	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2013	8	4							e61121	10.1371/journal.pone.0061121	http://dx.doi.org/10.1371/journal.pone.0061121			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130DR	23613797	gold, Green Submitted, Green Published			2022-12-25	WOS:000317893400043
J	Lin, MH; Fu, JF; Liu, ST				Lin, Mei-Hui; Fu, Jen-Fen; Liu, Shih-Tung			A Repeat Sequence Causes Competition of ColE1-Type Plasmids	PLOS ONE			English	Article							ERWINIA-STEWARTII; DNA-REPLICATION; COPY NUMBER; PRIMER FORMATION; RIBONUCLEASE-H; ESCHERICHIA-COLI; CLONING VEHICLES; GENE-EXPRESSION; RNA PRIMER; PAR REGION	Plasmid pSW200 from Pantoea stewartii contains 41 copies of 15-bp repeats and has a replicon that is homologous to that of ColE1. Although deleting the repeats (pSW207) does not change the copy number and stability of the plasmid. The plasmid becomes unstable and is rapidly lost from the host when a homoplasmid with the repeats (pSW201) is present. Deleting the repeats is found to reduce the transcriptional activity of RNAIp and RNAIIp by about 30%, indicating that the repeats promote the transcription of RNAI and RNAII, and how the RNAI that is synthesized by pSW201 inhibits the replication of pSW207. The immunoblot analysis herein demonstrates that RNA polymerase beta subunit and sigma(70) in the lysate from Escherichia coli MG1655 bind to a biotin-labeled DNA probe that contains the entire sequence of the repeat region. Electrophoretic mobility shift assay also reveals that purified RNA polymerase shifts a DNA probe that contains four copies of the repeats. These results thus obtained reveal that RNA polymerase holoenzyme binds to the repeats. The repeats also exchange RNA polymerase with RNAIp and RNAIIp in vitro, revealing the mechanism by which the transcription is promoted. This investigation elucidates a mechanism by which a plasmid prevents the invasion of an incompatible plasmid and maintains its stability in the host cell during evolution.	[Lin, Mei-Hui] Chang Gung Univ, Coll Med, Dept Med Biotechnol & Lab Sci, Tao Yuan, Taiwan; [Fu, Jen-Fen] Chang Gung Mem Hosp, Dept Med Res, Kaohsiung, Taiwan; [Fu, Jen-Fen] Grad Inst Clin Med Sci Taoyuan, Tao Yuan, Taiwan; [Liu, Shih-Tung] Chang Gung Univ, Coll Med, Dept Microbiol & Immunol, Tao Yuan, Taiwan; [Lin, Mei-Hui; Liu, Shih-Tung] Chang Gung Univ, Res Ctr Pathogen Bacteria, Tao Yuan, Taiwan	Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University	Liu, ST (corresponding author), Chang Gung Univ, Coll Med, Dept Microbiol & Immunol, Tao Yuan, Taiwan.	cgliu@mail.cgu.edu.tw		Lin, Mei-Hui/0000-0002-3498-9377	Chang Gung Memorial Hospital [CMRPD1B0101, CMRPD190283]; National Science Council of the Republic of China, Taiwan [NSC 101-2320-B-182-014-MY3]	Chang Gung Memorial Hospital(Chang Gung Memorial Hospital); National Science Council of the Republic of China, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by grants from the Chang Gung Memorial Hospital (grant number CMRPD1B0101 and CMRPD190283) and from the National Science Council of the Republic of China, Taiwan (grant number NSC 101-2320-B-182-014-MY3). (The funders' websites are: http://web1.nsc.gov.tw/mp.aspx?mp=7, http://www.cgmh.org.tw/eng2002/index.asp.) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOLIVAR F, 1977, GENE, V2, P95, DOI 10.1016/0378-1119(77)90000-2; Bouet JY, 2007, MOL MICROBIOL, V65, P1405, DOI 10.1111/j.1365-2958.2007.05882.x; BOYER HW, 1969, J MOL BIOL, V41, P459, DOI 10.1016/0022-2836(69)90288-5; BROSIUS J, 1984, GENE, V27, P151, DOI 10.1016/0378-1119(84)90136-7; CESARENI G, 1991, TRENDS GENET, V7, P230, DOI 10.1016/0168-9525(91)90370-6; CHANG ACY, 1978, J BACTERIOL, V134, P1141, DOI 10.1128/JB.134.3.1141-1156.1978; Cooper TF, 2000, P NATL ACAD SCI USA, V97, P12643, DOI 10.1073/pnas.220077897; COPLIN DL, 1981, APPL ENVIRON MICROB, V42, P599, DOI 10.1128/AEM.42.4.599-604.1981; Corless CE, 2000, J CLIN MICROBIOL, V38, P1747, DOI 10.1128/JCM.38.5.1747-1752.2000; DITTA G, 1985, PLASMID, V13, P149, DOI 10.1016/0147-619X(85)90068-X; Field CM, 2011, J THEOR BIOL, V291, P119, DOI 10.1016/j.jtbi.2011.09.006; FREDERICK RD, 1986, PHYTOPATHOLOGY, V76, P1353, DOI 10.1094/Phyto-76-1353; Friehs K, 2004, ADV BIOCHEM ENG BIOT, V86, P47; Fu JF, 1998, PLASMID, V40, P100, DOI 10.1006/plas.1998.1350; FU JF, 1995, PLASMID, V34, P75, DOI 10.1006/plas.1995.9999; GENNARO ML, 1993, P NATL ACAD SCI USA, V90, P5529, DOI 10.1073/pnas.90.12.5529; GENNARO ML, 1986, J BACTERIOL, V168, P160, DOI 10.1128/jb.168.1.160-166.1986; GENNARO ML, 1988, J BACTERIOL, V170, P5709, DOI 10.1128/jb.170.12.5709-5717.1988; GUYER MS, 1980, COLD SPRING HARB SYM, V45, P135, DOI 10.1101/SQB.1981.045.01.022; Hayes F, 2003, SCIENCE, V301, P1496, DOI 10.1126/science.1088157; HENRIQUEZ V, 1993, GENE, V134, P93, DOI 10.1016/0378-1119(93)90179-7; ITOH T, 1980, P NATL ACAD SCI-BIOL, V77, P2450, DOI 10.1073/pnas.77.5.2450; ITOH T, 1982, NUCLEIC ACIDS RES, V10, P5949, DOI 10.1093/nar/10.19.5949; KADO CI, 1981, J BACTERIOL, V145, P1365, DOI 10.1128/JB.145.3.1365-1373.1981; Ke WJ, 2009, J BACTERIOL, V191, P4615, DOI 10.1128/JB.00255-09; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Lin MH, 2008, J BACTERIOL, V190, P3681, DOI 10.1128/JB.00846-07; Lin-Chao S, 1992, MOL MICROBIOL, V6, P3385, DOI 10.1111/j.1365-2958.1992.tb02206.x; MANEN D, 1990, MOL MICROBIOL, V4, P1839, DOI 10.1111/j.1365-2958.1990.tb02032.x; MASUKATA H, 1986, CELL, V44, P125, DOI 10.1016/0092-8674(86)90491-5; MASUKATA H, 1984, CELL, V36, P513, DOI 10.1016/0092-8674(84)90244-7; MASUKATA H, 1990, CELL, V62, P331, DOI 10.1016/0092-8674(90)90370-T; MECSAS J, 1991, J MOL BIOL, V220, P585, DOI 10.1016/0022-2836(91)90102-C; NAITO T, 1995, SCIENCE, V267, P897, DOI 10.1126/science.7846533; Naito Y, 1998, BIOL CHEM, V379, P429, DOI 10.1515/bchm.1998.379.4-5.429; Nordstrom K, 2003, PLASMID, V50, P95, DOI 10.1016/S0147-619X(03)00056-8; NORDSTROM K, 1989, ANNU REV GENET, V23, P37, DOI 10.1146/annurev.genet.23.1.37; NOVICK RP, 1987, MICROBIOL REV, V51, P381, DOI 10.1128/MMBR.51.4.381-395.1987; Paulsson J, 1998, J MOL BIOL, V279, P73, DOI 10.1006/jmbi.1998.1751; PEREZMARTIN J, 1994, MICROBIOL REV, V58, P268; Riethoven JJM, 2010, METHODS MOL BIOL, V674, P33, DOI 10.1007/978-1-60761-854-6_3; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schumacher MA, 2012, CURR OPIN STRUC BIOL, V22, P72, DOI 10.1016/j.sbi.2011.11.001; SELZER G, 1982, P NATL ACAD SCI-BIOL, V79, P7082, DOI 10.1073/pnas.79.23.7082; Sengupta M, 2011, INFECT IMMUN, V79, P2502, DOI 10.1128/IAI.00127-11; Stewart F.C., 1897, NY AGR EXP STN B, V130, P422; Summers D, 1998, MOL MICROBIOL, V29, P1137, DOI 10.1046/j.1365-2958.1998.01012.x; SUMMERS DK, 1991, TRENDS BIOTECHNOL, V9, P273, DOI 10.1016/0167-7799(91)90089-Z; TOMIZAWA J, 1981, P NATL ACAD SCI-BIOL, V78, P1421, DOI 10.1073/pnas.78.3.1421; TOMIZAWA J, 1982, CELL, V31, P575, DOI 10.1016/0092-8674(82)90313-0; TOMIZAWA JI, 1981, P NATL ACAD SCI-BIOL, V78, P6096, DOI 10.1073/pnas.78.10.6096; TUCKER WT, 1984, CELL, V38, P191, DOI 10.1016/0092-8674(84)90540-3; Wu YC, 2010, J BACTERIOL, V192, P3654, DOI 10.1128/JB.00095-10; Yeh HY, 2011, NUCLEIC ACIDS RES, V39, P913, DOI 10.1093/nar/gkq911	54	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2013	8	4							e61668	10.1371/journal.pone.0061668	http://dx.doi.org/10.1371/journal.pone.0061668			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130DR	23613898	Green Submitted, Green Published, gold			2022-12-25	WOS:000317893400087
J	Oey, M; Ross, IL; Stephens, E; Steinbeck, J; Wolf, J; Radzun, KA; Kugler, J; Ringsmuth, AK; Kruse, O; Hankamer, B				Oey, Melanie; Ross, Ian L.; Stephens, Evan; Steinbeck, Janina; Wolf, Juliane; Radzun, Khairul Adzfa; Kuegler, Johannes; Ringsmuth, Andrew K.; Kruse, Olaf; Hankamer, Ben			RNAi Knock-Down of LHCBM1, 2 and 3 Increases Photosynthetic H-2 Production Efficiency of the Green Alga Chlamydomonas reinhardtii	PLOS ONE			English	Article							LIGHT-HARVESTING COMPLEX; PHOTOSYSTEM-II; STATE TRANSITIONS; HYDROGEN PHOTOPRODUCTION; SOLAR-ENERGY; PROTEIN; GENE; ACCLIMATION; IDENTIFICATION; POLYPEPTIDES	Single cell green algae (microalgae) are rapidly emerging as a platform for the production of sustainable fuels. Solar-driven H-2 production from H2O theoretically provides the highest-efficiency route to fuel production in microalgae. This is because the H-2-producing hydrogenase (HYDA) is directly coupled to the photosynthetic electron transport chain, thereby eliminating downstream energetic losses associated with the synthesis of carbohydrate and oils (feedstocks for methane, ethanol and oil-based fuels). Here we report the simultaneous knock-down of three light-harvesting complex proteins (LHCMB1, 2 and 3) in the high H-2-producing Chlamydomonas reinhardtii mutant Stm6Glc4 using an RNAi triple knock-down strategy. The resultant Stm6Glc4L01 mutant exhibited a light green phenotype, reduced expression of LHCBM1 (20.6% +/- 0.27%), LHCBM2 (81.2% +/- 0.037%) and LHCBM3 (41.4% +/- 0.05%) compared to 100% control levels, and improved light to H-2 (180%) and biomass (165%) conversion efficiencies. The improved H-2 production efficiency was achieved at increased solar flux densities (450 instead of similar to 100 mu E m(-2) s(-1)) and high cell densities which are best suited for microalgae production as light is ideally the limiting factor. Our data suggests that the overall improved photon-to-H-2 conversion efficiency is due to: 1) reduced loss of absorbed energy by non-photochemical quenching (fluorescence and heat losses) near the photobioreactor surface; 2) improved light distribution in the reactor; 3) reduced photoinhibition; 4) early onset of HYDA expression and 5) reduction of O-2-induced inhibition of HYDA. The Stm6Glc4L01 phenotype therefore provides important insights for the development of high-efficiency photobiological H-2 production systems.	[Oey, Melanie; Ross, Ian L.; Stephens, Evan; Wolf, Juliane; Radzun, Khairul Adzfa; Ringsmuth, Andrew K.; Hankamer, Ben] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia; [Steinbeck, Janina] Univ Munster, Inst Plant Biol & Biotechnol, D-48149 Munster, Germany; [Kruse, Olaf] Univ Bielefeld, Ctr Biotechnol CeBiTec, Dept Algae Biotechnol & Bioenergy, D-33615 Bielefeld, Germany; [Kuegler, Johannes] Karlsruhe Inst Technol, Inst Proc Engn Life Sci, Sect Tech Biol 2, D-76021 Karlsruhe, Germany; [Ringsmuth, Andrew K.] Univ Queensland, ARC Ctr Engn Quantum Syst, Brisbane, Qld, Australia; [Radzun, Khairul Adzfa] Univ Teknol MARA, Fac Sci Appl, Shah Alam, Selangor, Malaysia	University of Queensland; University of Munster; University of Bielefeld; Helmholtz Association; Karlsruhe Institute of Technology; University of Queensland; Universiti Teknologi MARA	Hankamer, B (corresponding author), Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia.	b.hankamer@imb.uq.edu.au	Oey, Melanie/N-9517-2019; Wolf, Juliane/V-9228-2019; Kruse, Olaf/O-1127-2015; Wolf, Juliane/B-7921-2016; Ross, Ian/A-8622-2011; Stephens, Evan/K-1690-2014; Hankamer, Ben D/C-9688-2015; Oey, Melanie/H-3873-2016	Oey, Melanie/0000-0001-9290-0580; Wolf, Juliane/0000-0002-7825-3118; Wolf, Juliane/0000-0002-7825-3118; Ross, Ian/0000-0002-2389-4292; Stephens, Evan/0000-0001-8390-7246; Hankamer, Ben D/0000-0001-9284-4929; Oey, Melanie/0000-0001-9290-0580; Kruse, Olaf/0000-0001-9874-382X; RADZUN, KHAIRUL ADZFA/0000-0002-0270-6942; Ringsmuth, Andrew/0000-0002-2984-8860	Pacific Seeds; Advanta India; Pacific Seeds and Advanta India Limited;  [LP0883380];  [BH011372]	Pacific Seeds; Advanta India; Pacific Seeds and Advanta India Limited; ; 	This project was supported by Grants LP0883380 and BH011372 and had financial support from Pacific Seeds (http://www.pacificseeds.com.au) and Advanta India (http://www.advantaindia.com). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Funding was received from Pacific Seeds and Advanta India Limited. For complete transparency BH and OK would like to declare that they are Directors of the Solar Biofuels Consortium (www.solarbiofuels.org) a collaborative agreement between member parties which is focused on developing high efficiency microalgal biofuel systems. The University of Queensland has filed a Provisional Patent Application. There are no further patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Ahn TK, 2008, SCIENCE, V320, P794, DOI 10.1126/science.1154800; Alados I, 1996, AGR FOREST METEOROL, V78, P121, DOI 10.1016/0168-1923(95)02245-7; [Anonymous], 2010, REF SOL SPECTR IRR A; Asamizu E, 1999, DNA Res, V6, P369, DOI 10.1093/dnares/6.6.369; BARBER J, 1992, TRENDS BIOCHEM SCI, V17, P61, DOI 10.1016/0968-0004(92)90503-2; Bassi R, 1997, PHYSIOL PLANTARUM, V100, P769, DOI 10.1034/j.1399-3054.1997.1000404.x; Beckmann J, 2009, J BIOTECHNOL, V142, P70, DOI 10.1016/j.jbiotec.2009.02.015; BP 2011, 2011, STAT REV WORLD EN 20; British Petroleum (BP), 2010, STAT REV WORLD EN 20; Chisti Y, 2007, BIOTECHNOL ADV, V25, P294, DOI 10.1016/j.biotechadv.2007.02.001; Damkjaer JT, 2009, PLANT CELL, V21, P3245, DOI 10.1105/tpc.108.064006; DEBUCHY R, 1989, EMBO J, V8, P2803, DOI 10.1002/j.1460-2075.1989.tb08426.x; Dittami SM, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-365; Doebbe A, 2007, J BIOTECHNOL, V131, P27, DOI 10.1016/j.jbiotec.2007.05.017; Drop B, 2011, J BIOL CHEM, V286, P44878, DOI 10.1074/jbc.M111.301101; Dubelaar GBJ, 2000, SCI MAR, V64, P135, DOI 10.3989/scimar.2000.64n2135; Elrad D, 2002, PLANT CELL, V14, P1801, DOI 10.1105/tpc.002154; Ferrante P, 2012, J BIOL CHEM; Fouchard S, 2005, APPL ENVIRON MICROB, V71, P6199, DOI 10.1128/AEM.71.10.6199-6205.2005; Ghirardi ML, 2007, ANNU REV PLANT BIOL, V58, P71, DOI 10.1146/annurev.arplant.58.032806.103848; Gomiero T, 2010, J AGR ENVIRON ETHIC, V23, P403, DOI 10.1007/s10806-009-9218-x; Hankamer B, 1997, EUR J BIOCHEM, V243, P422, DOI 10.1111/j.1432-1033.1997.0422a.x; Harris EH, 1989, CHLAMYDOMONAS SOURCE, P25, DOI [DOI 10.1016/B978-0-12-326880-8.50007-9, DOI 10.1126/SCIENCE.246.4936.1503-A]; Horton P, 2008, FEBS J, V275, P1069, DOI 10.1111/j.1742-4658.2008.06263.x; IEA (International Energy Agency), 2009, WORLD EN OUTL 2009, DOI DOI 10.1787/WEO-2009-EN; Ihalainen JA, 2000, BIOCHEMISTRY-US, V39, P8625, DOI 10.1021/bi0007369; Iwai M, 2008, PLANT CELL, V20, P2177, DOI 10.1105/tpc.108.059352; Jans F, 2008, P NATL ACAD SCI USA, V105, P20546, DOI 10.1073/pnas.0806896105; KNOETZEL J, 1992, EUR J BIOCHEM, V206, P209, DOI 10.1111/j.1432-1033.1992.tb16918.x; Kosourov S, 2005, PHOTOSYNTH RES, V85, P295, DOI 10.1007/s11120-005-5105-0; Kosourov SN, 2011, INT J HYDROGEN ENERG, V36, P2044, DOI 10.1016/j.ijhydene.2010.10.041; Kruse O, 2005, PHOTOCH PHOTOBIO SCI, V4, P957, DOI 10.1039/b506923h; Kruse O, 2005, J BIOL CHEM, V280, P34170, DOI 10.1074/jbc.M503840200; Kruse O, 2010, CURR OPIN BIOTECH, V21, P238, DOI 10.1016/j.copbio.2010.03.012; Makarova VV, 2007, PHOTOSYNTH RES, V94, P79, DOI 10.1007/s11120-007-9219-4; Melis A, 2001, PLANT PHYSIOL, V127, P740, DOI 10.1104/pp.127.3.740; Melis A, 2000, PLANT PHYSIOL, V122, P127, DOI 10.1104/pp.122.1.127; Melis A, 2009, PLANT SCI, V177, P272, DOI 10.1016/j.plantsci.2009.06.005; Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609; Murphy TE, 2011, J QUANT SPECTROSC RA, V112, P2826, DOI 10.1016/j.jqsrt.2011.08.012; Mus F, 2007, J BIOL CHEM, V282, P25475, DOI 10.1074/jbc.M701415200; Mussgnug JH, 2007, PLANT BIOTECHNOL J, V5, P802, DOI 10.1111/j.1467-7652.2007.00285.x; Neilson JAD, 2010, PHOTOSYNTH RES, V106, P57, DOI 10.1007/s11120-010-9576-2; Perrine Z, 2012, ALGAL RES, V1, P134, DOI 10.1016/j.algal.2012.07.002; Pimentel D, 2009, HUM ECOL, V37, P1, DOI 10.1007/s10745-009-9215-8; Polle JEW, 2003, PLANTA, V217, P49, DOI 10.1007/s00425-002-0968-1; Polle JEW, 2002, INT J HYDROGEN ENERG, V27, P1257, DOI 10.1016/S0360-3199(02)00116-7; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; Pulz O, 2004, APPL MICROBIOL BIOT, V65, P635, DOI 10.1007/s00253-004-1647-x; Rohr J, 2004, PLANT J, V40, P611, DOI 10.1111/j.1365-313X.2004.02227.x; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Schonfeld C, 2004, J BIOL CHEM, V279, P50366, DOI 10.1074/jbc.M408477200; Smil Vaclav, 2008, ENERGY NATURE SOC GE; Stephens E, 2010, NAT BIOTECHNOL, V28, P126, DOI 10.1038/nbt0210-126; Takahashi H, 2006, P NATL ACAD SCI USA, V103, P477, DOI 10.1073/pnas.0509952103; Takahashi Y, 2004, BIOCHEMISTRY-US, V43, P7816, DOI 10.1021/bi035988z; Tokutsu R, 2004, PLANT CELL PHYSIOL, V45, P138, DOI 10.1093/pcp/pch013; Tokutsu R, 2009, J BIOL CHEM, V284, P7777, DOI 10.1074/jbc.M809360200; Tyystjarvi E, 2008, COORDIN CHEM REV, V252, P361, DOI 10.1016/j.ccr.2007.08.021; Vass I, 2012, BBA-BIOENERGETICS, V1817, P209, DOI 10.1016/j.bbabio.2011.04.014; Zienkiewicz M, 2012, PLANTA, V235, P279, DOI 10.1007/s00425-011-1505-x	61	68	74	0	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2013	8	4							e61375	10.1371/journal.pone.0061375	http://dx.doi.org/10.1371/journal.pone.0061375			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130DR	23613840	gold, Green Published, Green Submitted			2022-12-25	WOS:000317893400058
J	Pietrzyk, AJ; Bujacz, A; Mueller-Dieckmann, J; Lochynska, M; Jaskolski, M; Bujacz, G				Pietrzyk, Agnieszka J.; Bujacz, Anna; Mueller-Dieckmann, Jochen; Lochynska, Malgorzata; Jaskolski, Mariusz; Bujacz, Grzegorz			Two Crystal Structures of Bombyx mori Lipoprotein 3-Structural Characterization of a New 30-kDa Lipoprotein Family Member	PLOS ONE			English	Article							PROTEIN GENES; SILKWORM; HEMOLYMPH; BINDING; SEQUENCE; IDENTIFICATION; APOPTOSIS; DELIVERY; SYSTEM; GENOME	The 30-kDa family of lipoproteins from insect hemolymph has been the focus of a number of studies over the last few years. Recently, four crystal structures of Bombyx mori lipoprotein 7 have been determined. Here we report two crystal structures of another member of the 30-kDa lipoprotein family, Bombyx mori lipoprotein 3 (Bmlp3). The protein was isolated from its natural source, mulberry silkworm hemolymph. It crystallized in two different crystal forms, Bmlp3-p21 (space group P2(1)) and Bmlp3-c2 (space group C2). The crystal structures were solved by molecular replacement using the coordinates of Bmlp7 as a starting model. The crystals of Bmlp3-p21 diffracted X-rays to 2.4 angstrom resolution and of Bmlp3-c2 to 2.1 angstrom resolution. Bmlp3 has an overall fold characteristic of 30-kDa lipoproteins, with a VHS-type N-terminal domain and beta-trefoil C-terminal domain. Structural comparison of Bmlp3 and Bmlp7 shows that the loops present in the C-terminal domain are flexible and participate in dimer formation. Additionally, new putative binding sites of Bmlp3 have been analyzed in detail and the electrostatic potential of the protein surface at physiological pH 7.4 conditions has been calculated. The results of these calculations are the starting point for an explanation of the recently reported cell-penetrating properties of the 30-kDa lipoproteins.	[Pietrzyk, Agnieszka J.; Jaskolski, Mariusz; Bujacz, Grzegorz] Polish Acad Sci, Inst Bioorgan Chem, Ctr Biocrystallog Res, Poznan, Poland; [Bujacz, Anna; Bujacz, Grzegorz] Lodz Univ Technol, Inst Tech Biochem, Fac Biotechnol & Food Sci, Lodz, Poland; [Mueller-Dieckmann, Jochen] Univ Hamburg, Bioctr Klein Flottbeck, Hamburg, Germany; [Lochynska, Malgorzata] Inst Nat Fibers & Med Plants, Poznan, Poland; [Jaskolski, Mariusz] Adam Mickiewicz Univ, Fac Chem, Dept Crystallog, PL-60780 Poznan, Poland	Polish Academy of Sciences; Institute of Bioorganic Chemistry of the Polish Academy of Sciences; Lodz University of Technology; University of Hamburg; Institute of Natural Fibres & Medicinal Plants; Adam Mickiewicz University	Bujacz, G (corresponding author), Polish Acad Sci, Inst Bioorgan Chem, Ctr Biocrystallog Res, Poznan, Poland.	grzegorz.bujacz@p.lodz.pl	Pietrzyk-Brzezinska, Agnieszka J./M-3560-2018; Bujacz, Anna/M-4464-2018; Łochyńska, Małgorzata/C-7129-2016; Bujacz, Grzegorz/M-4446-2018	Pietrzyk-Brzezinska, Agnieszka J./0000-0003-1565-7307; Bujacz, Anna/0000-0002-0808-1349; Łochyńska, Małgorzata/0000-0001-8796-204X; Bujacz, Grzegorz/0000-0002-3787-7522; Jaskolski, Mariusz/0000-0003-1587-6489	European Union within the European Regional Development Fund; European Community's Seventh Framework Programme (FP7) [227764]; National Science Centre [2011/03/B/NZ1/01238]	European Union within the European Regional Development Fund; European Community's Seventh Framework Programme (FP7); National Science Centre(National Science Centre, Poland)	This work was supported in part by the European Union within the European Regional Development Fund and by grant 2011/03/B/NZ1/01238 from the National Science Centre to GB. The screening for crystallization conditions at the High Throughput Crystallization (HTX) Facility, EMBL Hamburg, Germany, was funded from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement no 227764 (P CUBE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; CHEN Y L, 1990, Journal of Sericultural Science of Japan, V59, P202; Choi SS, 2002, BIOTECHNOL PROGR, V18, P874, DOI 10.1021/bp020001q; Couble P, 2008, INSECT BIOCHEM MOLEC, V38, P1035, DOI [10.1016/j.ibmb.2009.01.004, 10.1016/j.ibmb.2008.11.004]; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FRANKEL AD, 1988, CELL, V55, P1189, DOI 10.1016/0092-8674(88)90263-2; GAMO T, 1978, INSECT BIOCHEM, V8, P457, DOI 10.1016/0020-1790(78)90059-8; Goldsmith MR, 2005, ANNU REV ENTOMOL, V50, P71, DOI 10.1146/annurev.ento.50.071803.130456; Hildebrand J.G., 1980, RECEPTORS NEUROTRANS, P261; Huang BD, 2009, OMICS, V13, P325, DOI 10.1089/omi.2009.0045; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kaplan IM, 2005, J CONTROL RELEASE, V102, P247, DOI 10.1016/j.jconrel.2004.10.018; Kim EJ, 2001, BIOCHEM BIOPH RES CO, V285, P224, DOI 10.1006/bbrc.2001.5148; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Lundberg M, 2001, NAT BIOTECHNOL, V19, P713, DOI 10.1038/90741; Maki N, 2001, INSECT BIOCHEM MOLEC, V31, P407, DOI 10.1016/S0965-1748(00)00135-1; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mita K, 2004, DNA RES, V11, P27, DOI 10.1093/dnares/11.1.27; MORI S, 1991, BIOCHIM BIOPHYS ACTA, V1090, P129, DOI 10.1016/0167-4781(91)90048-Q; Mueller U, 2012, J SYNCHROTRON RADIAT, V19, P442, DOI 10.1107/S0909049512006395; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Pakkianathan BC, 2012, BMC BIOCHEM, V13, DOI 10.1186/1471-2091-13-5; Park JH, 2012, BIOMATERIALS, V33, P9127, DOI 10.1016/j.biomaterials.2012.08.063; Pietrzyk AJ, 2012, ACTA CRYSTALLOGR D, V68, P1140, DOI 10.1107/S0907444912021555; Pietrzyk AJ, 2011, ACTA CRYSTALLOGR F, V67, P372, DOI 10.1107/S1744309110054564; Rhee WJ, 2000, BIOCHEM BIOPH RES CO, V271, P186, DOI 10.1006/bbrc.2000.2592; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Schwarze SR, 2000, TRENDS CELL BIOL, V10, P290, DOI 10.1016/S0962-8924(00)01771-2; Sun Q, 2007, INSECT SCI, V14, P5, DOI 10.1111/j.1744-7919.2007.00121.x; Tomita M, 2003, NAT BIOTECHNOL, V21, P52, DOI 10.1038/nbt771; Ujita M, 2005, BIOSCI BIOTECH BIOCH, V69, P1178, DOI 10.1271/bbb.69.1178; Ujita M, 2002, BIOSCI BIOTECH BIOCH, V66, P2264, DOI 10.1271/bbb.66.2264; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; WANG XY, 1989, GENE, V80, P259, DOI 10.1016/0378-1119(89)90290-4; WYATT GR, 1956, J GEN PHYSIOL, V39, P853, DOI 10.1085/jgp.39.6.853; Xia QY, 2004, SCIENCE, V306, P1937, DOI 10.1126/science.1102210; Yang JP, 2011, J STRUCT BIOL, V175, P97, DOI 10.1016/j.jsb.2011.04.003; Zhang Y, 2012, FUNCT INTEGR GENOMIC, V12, P705, DOI 10.1007/s10142-012-0281-4; Zhang ZM, 2011, BIOINFORMATICS, V27, P2083, DOI 10.1093/bioinformatics/btr331	49	5	6	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2013	8	4							e61303	10.1371/journal.pone.0061303	http://dx.doi.org/10.1371/journal.pone.0061303			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130DR	23613829	gold, Green Published, Green Submitted			2022-12-25	WOS:000317893400055
J	Costard, S; Jones, BA; Martinez-Lopez, B; Mur, L; de la Torre, A; Martinez, M; Sanchez-Vizcaino, F; Sanchez-Vizcaino, JM; Pfeiffer, DU; Wieland, B				Costard, Solenne; Jones, Bryony Anne; Martinez-Lopez, Beatriz; Mur, Lina; de la Torre, Ana; Martinez, Marta; Sanchez-Vizcaino, Fernando; Sanchez-Vizcaino, Jose-Manuel; Pfeiffer, Dirk Udo; Wieland, Barbara			Introduction of African Swine Fever into the European Union through Illegal Importation of Pork and Pork Products	PLOS ONE			English	Article							QUANTITATIVE ASSESSMENT; MOUTH-DISEASE; VIRUS; SPREAD; RISKS	Transboundary animal diseases can have very severe socio-economic impacts when introduced into new regions. The history of disease incursions into the European Union suggests that initial outbreaks were often initiated by illegal importation of meat and derived products. The European Union would benefit from decision-support tools to evaluate the risk of disease introduction caused by illegal imports in order to inform its surveillance strategy. However, due to the difficulty in quantifying illegal movements of animal products, very few studies of this type have been conducted. Using African swine fever as an example, this work presents a novel risk assessment framework for disease introduction into the European Union through illegal importation of meat and products. It uses a semi-quantitative approach based on factors that likely influence the likelihood of release of contaminated smuggled meat and products, and subsequent exposure of the susceptible population. The results suggest that the European Union is at non-negligible risk of African swine fever introduction through illegal importation of pork and products. On a relative risk scale with six categories from negligible to very high, five European Union countries were estimated at high (France, Germany, Italy and United Kingdom) or moderate (Spain) risk of African swine fever release, five countries were at high risk of exposure if African swine fever were released (France, Italy, Poland, Romania and Spain) and ten countries had a moderate exposure risk (Austria, Bulgaria, Germany, Greece, Hungary, Latvia, Lithuania, Portugal, Sweden and United Kingdom). The approach presented here and results obtained for African swine fever provide a basis for the enhancement of risk-based surveillance systems and disease prevention programmes in the European Union.	[Costard, Solenne; Jones, Bryony Anne; Pfeiffer, Dirk Udo; Wieland, Barbara] Royal Vet Coll, Vet Epidemiol & Publ Hlth Grp, Hatfield, Herts, England; [Martinez-Lopez, Beatriz; Mur, Lina; Martinez, Marta; Sanchez-Vizcaino, Fernando; Sanchez-Vizcaino, Jose-Manuel] Univ Complutense Madrid, VISAVET Ctr, Madrid, Spain; [Martinez-Lopez, Beatriz; Mur, Lina; Martinez, Marta; Sanchez-Vizcaino, Fernando; Sanchez-Vizcaino, Jose-Manuel] Univ Complutense Madrid, Sch Vet, Dept Anim Hlth, Madrid, Spain; [de la Torre, Ana; Martinez, Marta] Anim Hlth Res Ctr, Madrid, Spain; [Martinez-Lopez, Beatriz] IREC CSIC UCLM JCCM, Ciudad Real, Spain; [Wieland, Barbara] Swiss Agcy Dev & Cooperat, Ulaanbaatar, Mongolia	University of London; University of London Royal Veterinary College; Complutense University of Madrid; Complutense University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigacion en Recursos Cinegeticos (IREC); Universidad de Castilla-La Mancha	Costard, S (corresponding author), EpiX Analyt, Boulder, CO USA.	scostard@epixanalytics.com	studies, IT VISAVET Account for bibliometric/C-3115-2014; Sánchez-Vizcaíno, José Manuel/G-6299-2015; Mur, Lina/AAC-8860-2022; de la Torre, Ana/AAH-5383-2019; Lopez, Beatriz Martinez/AAE-6692-2021; Aviles, Marta Martínez/P-5821-2014; Wieland, Barbara/AAC-1263-2019; Pfeiffer, Dirk U/C-5002-2009	studies, IT VISAVET Account for bibliometric/0000-0003-3319-0050; Sánchez-Vizcaíno, José Manuel/0000-0002-1502-8968; de la Torre, Ana/0000-0003-4560-5196; Aviles, Marta Martínez/0000-0002-7880-3829; Wieland, Barbara/0000-0003-4020-9186; Pfeiffer, Dirk U/0000-0001-7000-0530; Sanchez-Vizcaino, Fernando/0000-0002-1655-8290; Jones, Bryony/0000-0003-4383-2504	project ASFRISK (EC) [211691]	project ASFRISK (EC)	This work was funded by the project ASFRISK (EC, FP7-KBBE-2007-1, Project #211691). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, TRENDS ORGAN CRIME, V13, P219, DOI 10.1007/s12117-010-9102-0; Beltran Alcrudo D, 2008, AFRICAN SWINE FEVER; Boklund A, 2004, PREV VET MED, V66, P49, DOI 10.1016/j.prevetmed.2004.08.004; Boklund A, 2005, ACTA VETERINARIA SCA, V100, P5; Bosch J, 2012, FOLIA ZOOL, V61, P138, DOI 10.25225/fozo.v61.i2.a7.2012; Brand C, 2011, MSC CONTROL OF INFEC; Bronsvoort BMD, 2008, PREV VET MED, V85, P226, DOI 10.1016/j.prevetmed.2008.01.013; Brown S, 2010, BSC VETERINARY SCIEN; Costard S, 2009, PHILOS T R SOC B, V364, P2683, DOI 10.1098/rstb.2009.0098; European Commission, 2007, THE NEW ANIMAL HEALT; European Commission, 2009, TRADE AND IMPORTS OF; [European Commission Eurostat. European health interview survey (EHIS)], 2011, EUROSTAT; Frey HC, 2002, RISK ANAL, V22, P553; Gardner Ian A., 2002, Animal Health Research Reviews, V3, P43; Hartnett E, 2007, RISK ANAL, V27, P187, DOI 10.1111/j.1539-6924.2006.00869.x; Jenks G.F., 1967, INT YB CARTOGR, V7, P186; Lubisi BA, 2009, TRANSBOUND EMERG DIS, V56, P178, DOI 10.1111/j.1865-1682.2009.01078.x; Lyra TMP, 2006, REV SCI TECH OIE, V25, P93; Malczewski J, 1999, GIS MULTICRITERIA DE; Moennig V, 2003, VET J, V165, P11, DOI 10.1016/S1090-0233(02)00112-0; Mur L, 2012, TRANSBOUND EMERG DIS, V59, P134, DOI 10.1111/j.1865-1682.2011.01253.x; Nigsch A, 2013, PREV VET MED, V108, P262, DOI 10.1016/j.prevetmed.2012.11.003; OIE, 2012, WORLD ANIMAL HEALTH; Oravainen J, 2011, POSSIBLE ROUTES OF E; Paton DJ, 2003, RES VET SCI, V75, P169, DOI 10.1016/S0034-5288(03)00076-6; Pharo HJ, 2002, NEW ZEAL VET J, V50, P46, DOI 10.1080/00480169.2002.36250; Polese A, 2012, SUBVERTING BORDERS: DOING RESEARCH ON SMUGGLING AND SMALL-SCALE TRADE, P21; Quinn JA, 2010, BSC VETERINARY SCIEN; Rowlands RJ, 2008, EMERG INFECT DIS, V14, P1870, DOI 10.3201/eid1412.080591; Saaty T., 1980, THE ANALYTIC HIERARC; Saaty TL, 2008, RACSAM REV R ACAD A, V102, P251, DOI 10.1007/BF03191825; Sanchez Botija C, 1966, Bull Off Int Epizoot, V66, P699; Sanchez-Vizcaino JM, 2012, TRANSBOUND EMERG DIS, V59, P27, DOI 10.1111/j.1865-1682.2011.01293.x; Shields R, 2007, INDEPENDENT; Simeon-Negrin RE, 2002, TRENDS IN EMERGING VIRAL INFECTIONS OF SWINE, P125; Vannier P, 2010, EFSA J, V8, DOI 10.2903/j.efsa.2010.1556; Wieland B, 2011, PREV VET MED, V99, P4, DOI 10.1016/j.prevetmed.2011.01.001; Wooldridge M, 2006, REV SCI TECH OIE, V25, P105, DOI 10.20506/rst.25.1.1651	38	59	61	1	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2013	8	4							e61104	10.1371/journal.pone.0061104	http://dx.doi.org/10.1371/journal.pone.0061104			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125TD	23613795	Green Submitted, gold, Green Published, Green Accepted			2022-12-25	WOS:000317563300021
J	Gao, DC; Zhang, L; Dhillon, R; Hong, TT; Shaw, RM; Zhu, JH				Gao, Danchen; Zhang, Li; Dhillon, Ranvir; Hong, Ting-Ting; Shaw, Robin M.; Zhu, Jianhua			Dynasore Protects Mitochondria and Improves Cardiac Lusitropy in Langendorff Perfused Mouse Heart	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; ACUTE MYOCARDIAL-INFARCTION; CYTOSOLIC FREE CALCIUM; OXIDATIVE STRESS; DIASTOLIC DYSFUNCTION; RAT CARDIOMYOCYTES; FREE-RADICALS; FAILURE; HYPOXIA; MECHANISMS	Background: Heart failure due to diastolic dysfunction exacts a major economic, morbidity and mortality burden in the United States. Therapeutic agents to improve diastolic dysfunction are limited. It was recently found that Dynamin related protein 1 (Drp1) mediates mitochondrial fission during ischemia/reperfusion (I/R) injury, whereas inhibition of Drp1 decreases myocardial infarct size. We hypothesized that Dynasore, a small noncompetitive dynamin GTPase inhibitor, could have beneficial effects on cardiac physiology during I/R injury. Methods and Results: In Langendorff perfused mouse hearts subjected to I/R (30 minutes of global ischemia followed by 1 hour of reperfusion), pretreatment with 1 mu M Dynasore prevented I/R induced elevation of left ventricular end diastolic pressure (LVEDP), indicating a significant and specific lusitropic effect. Dynasore also decreased cardiac troponin I efflux during reperfusion and reduced infarct size. In cultured adult mouse cardiomyocytes subjected to oxidative stress, Dynasore increased cardiomyocyte survival and viability identified by trypan blue exclusion assay and reduced cellular Adenosine triphosphate(ATP) depletion. Moreover, in cultured cells, Dynasore pretreatment protected mitochondrial fragmentation induced by oxidative stress. Conclusion: Dynasore protects cardiac lusitropy and limits cell damage through a mechanism that maintains mitochondrial morphology and intracellular ATP in stressed cells. Mitochondrial protection through an agent such as Dynasore can have clinical benefit by positively influencing the energetics of diastolic dysfunction.	[Gao, Danchen; Zhang, Li; Zhu, Jianhua] Zhejiang Univ, Coll Med, Affiliated Hosp 1, Dept Cardiol, Hangzhou 310003, Zhejiang, Peoples R China; [Dhillon, Ranvir; Hong, Ting-Ting; Shaw, Robin M.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA; [Shaw, Robin M.] Univ Calif San Francisco, Dept Med, Div Cardiol, San Francisco, CA 94143 USA	Zhejiang University; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Shaw, RM (corresponding author), Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA.	shawrm@medicine.ucsf.edu; zjh_john@medmail.com.cn		Shaw, Robin/0000-0001-7429-6092	National Institutes of Health [R01HL094414]; Science Technology Department of Zhejiang Province, China [2011R10069]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R00HL109075, R01HL094414, K99HL109075] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Science Technology Department of Zhejiang Province, China; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health [Grant R01HL094414] (RMS) (http://grants.nih.gov/grants/about_grants.htm). This work was supported by Science Technology Department of Zhejiang Province, China[2011R10069] (DCG) (http://www.zjkjt.gov.cn/html/node05/detail0502/2011/0502_22744.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMSTRONG SC, 1991, J MOL CELL CARDIOL, V23, P1001, DOI 10.1016/0022-2828(91)91636-6; ARROYO CM, 1987, FEBS LETT, V221, P101, DOI 10.1016/0014-5793(87)80360-5; Babuin L, 2005, CAN MED ASSOC J, V173, P1191, DOI 10.1503/cmaj/051291; BOLLI R, 1988, J CLIN INVEST, V82, P476, DOI 10.1172/JCI113621; Brady NR, 2006, BBA-BIOENERGETICS, V1757, P667, DOI 10.1016/j.bbabio.2006.04.011; Brooks C, 2009, J CLIN INVEST, V119, P1275, DOI 10.1172/JCI37829; Bursi F, 2006, JAMA-J AM MED ASSOC, V296, P2209, DOI 10.1001/jama.296.18.2209; Chatterjee K, 2007, J MOL CELL CARDIOL, V43, P327, DOI 10.1016/j.yjmcc.2007.06.005; Cho DH, 2009, SCIENCE, V324, P102, DOI 10.1126/science.1171091; CORRALDEBRINSKI M, 1991, JAMA-J AM MED ASSOC, V266, P1812, DOI 10.1001/jama.266.13.1812; Fitzgibbons TP, 2009, CARDIOL REV, V17, P51, DOI 10.1097/CRD.0b013e318194527d; GOTTLIEB RA, 1994, J CLIN INVEST, V94, P1621, DOI 10.1172/JCI117504; Griffiths EJ, 1998, CARDIOVASC RES, V39, P423, DOI 10.1016/S0008-6363(98)00104-7; Griffiths EJ, 2000, CELL CALCIUM, V27, P87, DOI 10.1054/ceca.1999.0094; Guo R, 2009, J MOL CELL CARDIOL, V47, P228, DOI 10.1016/j.yjmcc.2009.03.018; Halestrap AP, 2004, CARDIOVASC RES, V61, P372, DOI 10.1016/S0008-6363(03)00533-9; Holloway C, 2011, FASEB J, V25, P3130, DOI 10.1096/fj.11-183426; Hong TT, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000312; Ingwall JS, 2009, CARDIOVASC RES, V81, P412, DOI 10.1093/cvr/cvn301; Jezek P, 2009, INT J BIOCHEM CELL B, V41, P1790, DOI 10.1016/j.biocel.2009.02.014; Kacimi R, 2000, CARDIOVASC RES, V46, P139, DOI 10.1016/S0008-6363(00)00007-9; Karliner JS, 2001, J MOL CELL CARDIOL, V33, P1713, DOI 10.1006/jmcc.2001.1429; Kjaergaard J, 2006, EUR J APPL PHYSIOL, V98, P411, DOI 10.1007/s00421-006-0299-1; Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; MURPHY E, 1991, CIRC RES, V68, P1250, DOI 10.1161/01.RES.68.5.1250; Murphy E, 2008, PHYSIOL REV, V88, P581, DOI 10.1152/physrev.00024.2007; O'Connell Timothy D, 2007, Methods Mol Biol, V357, P271; Ong SB, 2010, CIRCULATION, V121, P2012, DOI 10.1161/CIRCULATIONAHA.109.906610; Ouzounian M, 2008, NAT CLIN PRACT CARD, V5, P375, DOI 10.1038/ncpcardio1245; Paolocci N, 2006, J PHARMACOL EXP THER, V317, P506, DOI 10.1124/jpet.105.099168; Prasad SB, 2011, AM J CARDIOL, V108, P348, DOI 10.1016/j.amjcard.2011.03.051; Sharikabad MN, 2009, AM J PHYSIOL-HEART C, V296, pH787, DOI 10.1152/ajpheart.00796.2008; Smyth JW, 2010, J CLIN INVEST, V120, P266, DOI 10.1172/JCI39740; Song X, 2003, ACTA PHYSIOL SCAND, V177, P459, DOI 10.1046/j.1365-201X.2003.01068.x; STEENBERGEN C, 1987, CIRC RES, V60, P700, DOI 10.1161/01.RES.60.5.700; Sutherland FJ, 2003, CLIN EXP PHARMACOL P, V30, P867, DOI 10.1046/j.1440-1681.2003.03925.x; Weinbrenner C, 2004, CARDIOVASC RES, V61, P591, DOI 10.1016/j.cardiores.2003.10.008; Wolff RA, 2000, J MOL CELL CARDIOL, V32, P225, DOI 10.1006/jmcc.1999.1074; Wood P, 2011, CAN J CARDIOL, V27, P302, DOI 10.1016/j.cjca.2011.02.008; Yang EH, 2006, CURR PROB CARDIOLOGY, V31, P769, DOI 10.1016/j.cpcardiol.2006.08.004; Zhao TC, 2000, CIRCULATION, V102, P902; Zhou YY, 2000, AM J PHYSIOL-HEART C, V279, pH429; Zile MR, 2002, CIRCULATION, V105, P1503, DOI 10.1161/hc1202.105290; Zile MR, 2002, CIRCULATION, V105, P1387, DOI 10.1161/hc1102.105289	45	72	74	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2013	8	4							e60967	10.1371/journal.pone.0060967	http://dx.doi.org/10.1371/journal.pone.0060967			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125TD	23596510	gold, Green Published, Green Submitted			2022-12-25	WOS:000317563300011
J	Gribble, SM; Wiseman, FK; Clayton, S; Prigmore, E; Langley, E; Yang, FT; Maguire, S; Fu, BY; Rajan, D; Sheppard, O; Scott, C; Hauser, H; Stephens, PJ; Stebbings, LA; Ng, BL; Fitzgerald, T; Quail, MA; Banerjee, R; Rothkamm, K; Tybulewicz, VLJ; Fisher, EMC; Carter, NP				Gribble, Susan M.; Wiseman, Frances K.; Clayton, Stephen; Prigmore, Elena; Langley, Elizabeth; Yang, Fengtang; Maguire, Sean; Fu, Beiyuan; Rajan, Diana; Sheppard, Olivia; Scott, Carol; Hauser, Heidi; Stephens, Philip J.; Stebbings, Lucy A.; Ng, Bee Ling; Fitzgerald, Tomas; Quail, Michael A.; Banerjee, Ruby; Rothkamm, Kai; Tybulewicz, Victor L. J.; Fisher, Elizabeth M. C.; Carter, Nigel P.			Massively Parallel Sequencing Reveals the Complex Structure of an Irradiated Human Chromosome on a Mouse Background in the Tc1 Model of Down Syndrome	PLOS ONE			English	Article							FLOW KARYOTYPE; GENE; HUMAN-CHROMOSOME-21; REARRANGEMENTS; IMPAIRMENTS; PLASTICITY; PROTEINS; DOSAGE	Down syndrome (DS) is caused by trisomy of chromosome 21 (Hsa21) and presents a complex phenotype that arises from abnormal dosage of genes on this chromosome. However, the individual dosage-sensitive genes underlying each phenotype remain largely unknown. To help dissect genotype - phenotype correlations in this complex syndrome, the first fully transchromosomic mouse model, the Tc1 mouse, which carries a copy of human chromosome 21 was produced in 2005. The Tc1 strain is trisomic for the majority of genes that cause phenotypes associated with DS, and this freely available mouse strain has become used widely to study DS, the effects of gene dosage abnormalities, and the effect on the basic biology of cells when a mouse carries a freely segregating human chromosome. Tc1 mice were created by a process that included irradiation microcell-mediated chromosome transfer of Hsa21 into recipient mouse embryonic stem cells. Here, the combination of next generation sequencing, array-CGH and fluorescence in situ hybridization technologies has enabled us to identify unsuspected rearrangements of Hsa21 in this mouse model; revealing one deletion, six duplications and more than 25 de novo structural rearrangements. Our study is not only essential for informing functional studies of the Tc1 mouse but also (1) presents for the first time a detailed sequence analysis of the effects of gamma radiation on an entire human chromosome, which gives some mechanistic insight into the effects of radiation damage on DNA, and (2) overcomes specific technical difficulties of assaying a human chromosome on a mouse background where highly conserved sequences may confound the analysis. Sequence data generated in this study is deposited in the ENA database, Study Accession number: ERP000439.	[Gribble, Susan M.; Clayton, Stephen; Prigmore, Elena; Langley, Elizabeth; Yang, Fengtang; Maguire, Sean; Fu, Beiyuan; Rajan, Diana; Scott, Carol; Hauser, Heidi; Stephens, Philip J.; Stebbings, Lucy A.; Ng, Bee Ling; Fitzgerald, Tomas; Quail, Michael A.; Banerjee, Ruby; Carter, Nigel P.] Wellcome Trust Sanger Inst, Cambridge, England; [Wiseman, Frances K.; Sheppard, Olivia; Fisher, Elizabeth M. C.] UCL Inst Neurol, Dept Neurodegenerat Dis, London, England; [Tybulewicz, Victor L. J.] MRC Natl Inst Med Res, London, England; [Rothkamm, Kai] Hlth Protect Agcy, Ctr Radiat Chem & Environm Hazards Chilton, Didcot, Oxon, England	Wellcome Trust Sanger Institute; University of London; University College London; MRC National Institute for Medical Research; Health Protection Agency	Gribble, SM (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Cambridge, England.	smg@sanger.ac.uk	Rothkamm, Kai/A-2164-2014; Fisher, Elizabeth MC/C-2168-2008; Yang, Fan/GYU-4249-2022; Wiseman, Frances K/M-4701-2014; Quail, michael/ABE-6131-2020	Rothkamm, Kai/0000-0001-7414-5729; Fisher, Elizabeth MC/0000-0003-2850-9936; Tybulewicz, Victor/0000-0003-2439-0798; Wiseman, Frances/0000-0001-9323-3548; Sheppard, Olivia/0000-0001-5636-3925; Fitzgerald, Tomas/0000-0002-2370-8496; Yang, Fengtang/0000-0002-3573-2354	Wellcome Trust [WT098051, WT080174MA]; Medical Research Council [U117527252]; MRC [MC_U117527252, G0601056] Funding Source: UKRI; Medical Research Council [G0601056, MC_U117527252] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by The Wellcome Trust [grant number WT098051 and grant number WT080174MA], and by the Medical Research Council programme number U117527252. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alford KA, 2010, BLOOD, V115, P2928, DOI 10.1182/blood-2009-06-227629; Besson V, 2007, HUM MOL GENET, V16, P2040, DOI 10.1093/hmg/ddm152; Campbell PJ, 2008, NAT GENET, V40, P722, DOI 10.1038/ng.128; Chang KT, 2009, P NATL ACAD SCI USA, V106, P17117, DOI 10.1073/pnas.0904397106; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Duchon A, 2008, GENETICS, V180, P51, DOI 10.1534/genetics.108.092312; Duchon A, 2011, MAMM GENOME, V22, P674, DOI 10.1007/s00335-011-9356-0; Dunlevy L, 2010, CARDIOVASC RES, V88, P287, DOI 10.1093/cvr/cvq193; Elagib KE, 2003, BLOOD, V101, P4333, DOI 10.1182/blood-2002-09-2708; Fiegler H, 2007, NAT PROTOC, V2, P577, DOI 10.1038/nprot.2007.53; Galante M, 2009, HUM MOL GENET, V18, P1449, DOI 10.1093/hmg/ddp055; Gardiner K, 2006, BEHAV GENET, V36, P439, DOI 10.1007/s10519-006-9051-1; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; Kozarewa I, 2009, NAT METHODS, V6, P291, DOI [10.1038/nmeth.1311, 10.1038/NMETH.1311]; Lee JA, 2007, CELL, V131, P1235, DOI 10.1016/j.cell.2007.11.037; Li ZY, 2007, HUM MOL GENET, V16, P1359, DOI 10.1093/hmg/ddm086; Lobrich M, 1995, P NATL ACAD SCI USA, V92, P12050, DOI 10.1073/pnas.92.26.12050; Morice E, 2008, LEARN MEMORY, V15, P492, DOI 10.1101/lm.969608; Ng BL, 2007, CYTOM PART A, V71A, P410, DOI 10.1002/cyto.a.20394; Ng BL, 2006, CYTOM PART A, V69A, P1028, DOI 10.1002/cyto.a.20330; O'Doherty A, 2005, SCIENCE, V309, P2033, DOI 10.1126/science.1114535; Povirk LR, 2006, DNA REPAIR, V5, P1199, DOI 10.1016/j.dnarep.2006.05.016; Prandini P, 2007, AM J HUM GENET, V81, P252, DOI 10.1086/519248; Quail MA, 2008, NAT METHODS, V5, P1005, DOI 10.1038/nmeth.1270; RABBITTS P, 1995, NAT GENET, V9, P369, DOI 10.1038/ng0495-369; RASHEED S, 1974, CANCER, V33, P1027, DOI 10.1002/1097-0142(197404)33:4<1027::AID-CNCR2820330419>3.0.CO;2-Z; REEVES RH, 1994, P NATL ACAD SCI USA, V91, P5359, DOI 10.1073/pnas.91.12.5359; Reinholdt LG, 2011, MAMM GENOME, V22, P685, DOI 10.1007/s00335-011-9357-z; Reynolds LE, 2010, NATURE, V465, P813, DOI 10.1038/nature09106; Rogers MA, 2006, INT REV CYTOL, V251, P209, DOI 10.1016/S0074-7696(06)51006-X; Rothkamm K, 2001, CANCER RES, V61, P3886; Sheppard O, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.06.025; Sherman SL, 2007, MENT RETARD DEV D R, V13, P221, DOI 10.1002/mrdd.20157; Shibuya K, 2004, BIOCHEM BIOPH RES CO, V319, P1181, DOI 10.1016/j.bbrc.2004.05.094; Tybulewicz VLJ, 2006, HUM MOL GENET, V15, pR103, DOI 10.1093/hmg/ddl179; United Nations Scientific Committee on the Effects of Atomic Radiation (UNSCEAR), 2000, UNSCEAR 2000 GEN ASS, VII; Wang Y, 2010, GENE, V451, P23, DOI 10.1016/j.gene.2009.11.006; WEITZNER JM, 1990, AM FAM PHYSICIAN, V41, P1197; Wilson MD, 2008, SCIENCE, V322, P434, DOI 10.1126/science.1160930; Wiseman FK, 2009, HUM MOL GENET, V18, pR75, DOI 10.1093/hmg/ddp010; Yahya-Graison EA, 2007, AM J HUM GENET, V81, P475, DOI 10.1086/520000; Yu T, 2010, HUM MOL GENET, V19, P2780, DOI 10.1093/hmg/ddq179; Zhang F, 2009, TRENDS GENET, V25, P298, DOI 10.1016/j.tig.2009.05.005	43	67	68	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2013	8	4							e60482	10.1371/journal.pone.0060482	http://dx.doi.org/10.1371/journal.pone.0060482			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125TD	23596509	Green Published, Green Submitted, gold			2022-12-25	WOS:000317563300006
J	Rousk, K; DeLuca, TH; Rousk, J				Rousk, Kathrin; DeLuca, Thomas H.; Rousk, Johannes			The Cyanobacterial Role in the Resistance of Feather Mosses to Decomposition-Toward a New Hypothesis	PLOS ONE			English	Article							NITROGEN-FIXATION; LEUCINE INCORPORATION; LITTER DECOMPOSITION; SOIL; BRYOPHYTE; TOXICITY; ECOTOXICOLOGY; COMMUNITIES; TOLERANCE; THYMIDINE	Cyanobacteria-plant symbioses play an important role in many ecosystems due to the fixation of atmospheric nitrogen (N) by the cyanobacterial symbiont. The ubiquitous feather moss Pleurozium schreberi (Brid.) Mitt. is colonized by cyanobacteria in boreal systems with low N deposition. Here, cyanobacteria fix substantial amounts of N-2 and represent a potential N source. The feather moss appears to be resistant to decomposition, which could be partly a result of toxins produced by cyanobacteria. To assess how cyanobacteria modulated the toxicity of moss, we measured inhibition of bacterial growth. Moss with varying numbers of cyanobacteria was added to soil bacteria to test the inhibition of their growth using the thymidine incorporation technique. Moss could universally inhibit bacterial growth, but moss toxicity did not increase with N-2 fixation rates (numbers of cyanobacteria). Instead, we see evidence for a negative relationship between moss toxicity to bacteria and N-2 fixation, which could be related to the ecological mechanisms that govern the cyanobacteria - moss relationship. We conclude that cyanobacteria associated with moss do not contribute to the resistance to decomposition of moss, and from our results emerges the question as to what type of relationship the moss and cyanobacteria share.	[Rousk, Kathrin; DeLuca, Thomas H.] Bangor Univ, Sch Environm Nat Resources & Geog, Bangor, Gwynedd, Wales; [DeLuca, Thomas H.] Univ Washington, Sch Environm & Forest Sci, Seattle, WA 98195 USA; [Rousk, Johannes] Lund Univ, Lund, Sweden	Bangor University; University of Washington; University of Washington Seattle; Lund University	Rousk, J (corresponding author), Lund Univ, Lund, Sweden.	Johannes.rousk@biol.lu.se	Rousk, Johannes/E-9741-2010; Rousk, Kathrin/H-8836-2013; DeLuca, Thomas/GYU-3468-2022; DeLuca, Thomas Henry/B-4547-2012	Rousk, Johannes/0000-0002-4985-7262; Rousk, Kathrin/0000-0003-3140-9864; DeLuca, Thomas Henry/0000-0003-1561-9597	Swedish Research Council (Vetenskapsradet) [621-2011-5719]; UK Natural Environment Research Council; Bangor University, UK	Swedish Research Council (Vetenskapsradet)(Swedish Research Council); UK Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Bangor University, UK	Funding provided by Swedish Research Council (Vetenskapsradet) grant # 621-2011-5719, the UK Natural Environment Research Council, and Bangor University, UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann K, 2012, ECOSYSTEMS, V15, P986, DOI 10.1007/s10021-012-9562-y; Adams DG, 2008, J EXP BOT, V59, P1047, DOI 10.1093/jxb/ern005; Alden L, 2001, APPL ENVIRON MICROB, V67, P1830, DOI 10.1128/AEM.67.4.1830-1838.2001; BAATH E, 1992, SOIL BIOL BIOCHEM, V24, P1157, DOI 10.1016/0038-0717(92)90066-7; Baath E, 2001, SOIL BIOL BIOCHEM, V33, P1571, DOI 10.1016/S0038-0717(01)00073-6; Brandt KK, 2004, FEMS MICROBIOL ECOL, V49, P229, DOI 10.1016/j.femsec.2004.03.006; Brandt KK, 2009, ENVIRON SCI TECHNOL, V43, P2963, DOI 10.1021/es803546y; Cox PA, 2005, P NATL ACAD SCI USA, V102, P5074, DOI 10.1073/pnas.0501526102; Croisier E, 2010, PHYTOCHEMISTRY, V71, P574, DOI 10.1016/j.phytochem.2009.12.004; DeLuca TH, 2002, NATURE, V419, P917, DOI 10.1038/nature01051; DeLuca TH, 2008, SCIENCE, V320, P1181, DOI 10.1126/science.1154836; DeLuca TH, 2007, OECOLOGIA, V152, P121, DOI 10.1007/s00442-006-0626-6; Demoling LA, 2008, APPL SOIL ECOL, V38, P34, DOI 10.1016/j.apsoil.2007.08.008; Demoling LA, 2009, SOIL BIOL BIOCHEM, V41, P840, DOI 10.1016/j.soilbio.2009.02.001; Eskelinen O, 2002, ANN ZOOL FENN, V39, P49; Fenton NJ, 2010, PLANT SOIL, V336, P499, DOI 10.1007/s11104-010-0506-z; Grman E, 2012, ECOLOGY, V93, P711, DOI 10.1890/11-1358.1; Gundale MJ, 2011, GLOBAL CHANGE BIOL, V17, P2743, DOI 10.1111/j.1365-2486.2011.02407.x; Hobbie SE, 1996, ECOL MONOGR, V66, P503, DOI 10.2307/2963492; Jones MLM, 2004, PLANT BIOLOGY, V6, P598, DOI 10.1055/s-2004-821004; Kaasalainen U, 2012, P NATL ACAD SCI USA, V109, P5886, DOI 10.1073/pnas.1200279109; Kahru A, 2008, SENSORS-BASEL, V8, P5153, DOI 10.3390/s8085153; Kiers ET, 2008, ANNU REV ECOL EVOL S, V39, P215, DOI 10.1146/annurev.ecolsys.39.110707.173423; Lang SI, 2009, J ECOL, V97, P886, DOI 10.1111/j.1365-2745.2009.01538.x; Matsui K, 2006, CURR OPIN PLANT BIOL, V9, P274, DOI 10.1016/j.pbi.2006.03.002; MEEKS JC, 1985, PLANTA, V164, P406, DOI 10.1007/BF00402954; Meeks JC, 2002, MICROBIOL MOL BIOL R, V66, P94, DOI 10.1128/MMBR.66.1.94-121.2002; Meeks JC, 2009, MICROBIOL MONOGR, V8, P181, DOI 10.1007/7171_2007_101; Ore S, 2010, ENVIRON SCI TECHNOL, V44, P9201, DOI 10.1021/es1026294; PRINS HHT, 1982, OIKOS, V38, P374, DOI 10.2307/3544680; Rai AN, 2000, NEW PHYTOL, V147, P449, DOI 10.1046/j.1469-8137.2000.00720.x; Rousk J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034197; Rousk J, 2011, SOIL BIOL BIOCHEM, V43, P1881, DOI 10.1016/j.soilbio.2011.05.007; SCHOLLHORN R, 1967, P NATL ACAD SCI USA, V58, P213, DOI 10.1073/pnas.58.1.213; Smith S.E., 2008, MYCORRHIZAL SYMBIOSI, V3rd ed; STEINBERG NA, 1991, J BACTERIOL, V173, P7324, DOI 10.1128/jb.173.22.7324-7329.1991; SWAIN T., 1959, Journal of the Science of Food and Agriculture, V10, P63, DOI 10.1002/jsfa.2740100110; Tamm CO, 1991, NITROGEN IN TERRESTR; Vanderpoorten A, 2009, INTRODUCTION TO BRYO; vanGestel CAM, 1996, ECOTOXICOLOGY, V5, P217, DOI 10.1007/BF00118992; Wernegreen JJ, 2004, PLOS BIOL, V2, P307, DOI 10.1371/journal.pbio.0020068; Zackrisson O, 2004, ECOLOGY, V85, P3327, DOI 10.1890/04-0461	42	10	11	4	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2013	8	4							e62058	10.1371/journal.pone.0062058	http://dx.doi.org/10.1371/journal.pone.0062058			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125TD	23614013	Green Published, Green Submitted, gold			2022-12-25	WOS:000317563300049
J	Pietkiewicz, S; Sohn, D; Piekorz, RP; Grether-Beck, S; Budach, W; Sabapathy, K; Janicke, RU				Pietkiewicz, Sabine; Sohn, Dennis; Piekorz, Roland P.; Grether-Beck, Susanne; Budach, Wilfried; Sabapathy, Kanaga; Jaenicke, Reiner U.			Oppositional Regulation of Noxa by JNK1 and JNK2 during Apoptosis Induced by Proteasomal Inhibitors	PLOS ONE			English	Article							ACTIVATING TRANSCRIPTION FACTOR-3; BH3-ONLY PROTEIN NOXA; CELL-DEATH; GLUCOCORTICOID-RECEPTOR; GENE-EXPRESSION; BCL-2 FAMILY; C-MYC; MEDIATED APOPTOSIS; BORTEZOMIB; INDUCTION	Proteasome inhibitors (PIs) potently induce apoptosis in a variety of tumor cells, but the underlying mechanisms are not fully elucidated. Comparing PI-induced apoptosis susceptibilities of various mouse embryonic fibroblast (MEF) lines differing in their c-jun N-terminal kinase (JNK) 1 and 2 status, we show that several hallmarks of apoptosis were most rapidly detectable in JNK2-/- cells, whereas they appeared only delayed and severely reduced in their intensities in cells expressing JNK2. Consistent with our finding that PI-induced apoptosis requires de novo protein synthesis, the proteasomal inhibitor MG-132 induced expression of the BH3-only protein Noxa at the transcriptional level in a JNK1-dependent, but JNK2-opposing manner. As the knockdown of Noxa blocked only the rapid PI-induced apoptosis of JNK2-/- cells, but not the delayed death occurring in JNK1-/- and JNK1+/+ cells, our data uncover a novel PI-induced apoptosis pathway that is regulated by the JNK1/2-dependent expression of Noxa. Furthermore, several transcription factors known to modulate Noxa expression including ATF3, ATF4, c-Jun, c-Myc, HIF1 alpha, and p53 were found upregulated following MG-132 exposure. From those, only knockdown of c-Myc rescued JNK2-/- cells from PI-induced apoptosis, however, without affecting expression of Noxa. Together, our data not only show that a rapid execution of PI-induced apoptosis requires JNK1 for upregulation of Noxa via an as yet unknown transcription factor, but also that JNK2 controls this event in an oppositional manner.	[Pietkiewicz, Sabine; Sohn, Dennis; Budach, Wilfried; Jaenicke, Reiner U.] Univ Dusseldorf, Lab Mol Radiooncol, Clin & Policlin Radiat Therapy & Radiooncol, D-40225 Dusseldorf, Germany; [Piekorz, Roland P.] Univ Dusseldorf, Inst Biochem & Mol Biol 2, D-40225 Dusseldorf, Germany; [Grether-Beck, Susanne] IUF Leibniz Res Inst Environm Med, Dusseldorf, Germany; [Sabapathy, Kanaga] Natl Canc Ctr, Humphrey Oei Inst Canc Res, Div Cellular & Mol Res, Singapore, Singapore	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Leibniz Institut fur Umweltmedizinische Forschung (IUF); National Cancer Centre Singapore (NCCS)	Janicke, RU (corresponding author), Univ Dusseldorf, Lab Mol Radiooncol, Clin & Policlin Radiat Therapy & Radiooncol, D-40225 Dusseldorf, Germany.	janicke@uni-duesseldorf.de			Deutsche Forschungsgemeinschaft [SFB 728, JA 1060/3-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by grants from the Deutsche Forschungsgemeinschaft to RUJ (SFB 728 and JA 1060/3-1). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams J, 2004, NAT REV CANCER, V4, P349, DOI 10.1038/nrc1361; Adams KW, 2007, J BIOL CHEM, V282, P6192, DOI 10.1074/jbc.M610643200; Ahmed SU, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007305; An JB, 2004, MOL CANCER THER, V3, P727; An WG, 2000, LEUKEMIA, V14, P1276, DOI 10.1038/sj.leu.2401812; Bjorkblom B, 2008, J BIOL CHEM, V283, P19704, DOI 10.1074/jbc.M707744200; Breitschopf K, 2000, J BIOL CHEM, V275, P21648, DOI 10.1074/jbc.M001083200; Chang LF, 2006, CELL, V124, P601, DOI 10.1016/j.cell.2006.01.021; Chauhan D, 2004, BLOOD, V104, P2458, DOI 10.1182/blood-2004-02-0547; Chen SQ, 2010, CANCER RES, V70, P4318, DOI 10.1158/0008-5472.CAN-09-4428; Dhanasekaran DN, 2008, ONCOGENE, V27, P6245, DOI 10.1038/onc.2008.301; Fennell DA, 2008, ONCOGENE, V27, P1189, DOI 10.1038/sj.onc.1210744; Fribley A, 2004, MOL CELL BIOL, V24, P9695, DOI 10.1128/MCB.24.22.9695-9704.2004; Fribley AM, 2006, J BIOL CHEM, V281, P31440, DOI 10.1074/jbc.M604356200; Hideshima T, 2003, BLOOD, V101, P1530, DOI 10.1182/blood-2002-08-2543; Itoh M, 2002, MOL ENDOCRINOL, V16, P2382, DOI 10.1210/me.2002-0144; Johnson TR, 2003, ONCOGENE, V22, P4953, DOI 10.1038/sj.onc.1206656; Kim JY, 2004, J EXP MED, V199, P113, DOI 10.1084/jem.20030613; Kuroda J, 2010, MOL CANCER RES, V8, P994, DOI 10.1158/1541-7786.MCR-10-0040; Lassot I, 2001, MOL CELL BIOL, V21, P2192, DOI 10.1128/MCB.21.6.2192-2202.2001; Lauricella M, 2006, APOPTOSIS, V11, P607, DOI 10.1007/s10495-006-4689-y; Liu J, 2004, MOL CELL BIOL, V24, P10844, DOI 10.1128/MCB.24.24.10844-10856.2004; Liu M, 2007, J BIOL CHEM, V282, P17581, DOI 10.1074/jbc.M702206200; Lopes UG, 1997, J BIOL CHEM, V272, P12893, DOI 10.1074/jbc.272.20.12893; Lynch JT, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-38; Meriin AB, 1998, J BIOL CHEM, V273, P6373, DOI 10.1074/jbc.273.11.6373; Mitsiades N, 2002, P NATL ACAD SCI USA, V99, P14374, DOI 10.1073/pnas.202445099; Mitsiades N, 2003, BLOOD, V101, P2377, DOI 10.1182/blood-2002-06-1768; Naik E, 2007, J CELL BIOL, V176, P415, DOI 10.1083/jcb.200608070; Navon A, 2009, J BIOL CHEM, V284, P33713, DOI 10.1074/jbc.R109.018481; Neise D, 2010, CELL CYCLE, V9, P3575, DOI 10.4161/cc.9.17.12799; Nijhawan D, 2003, GENE DEV, V17, P1475, DOI 10.1101/gad.1093903; Nikiforov MA, 2007, P NATL ACAD SCI USA, V104, P19488, DOI 10.1073/pnas.0708380104; Nikrad M, 2005, MOL CANCER THER, V4, P443; Noguchi K, 1999, J BIOL CHEM, V274, P32580, DOI 10.1074/jbc.274.46.32580; Oda E, 2000, SCIENCE, V288, P1053, DOI 10.1126/science.288.5468.1053; Perez-Galan P, 2006, BLOOD, V107, P257, DOI 10.1182/blood-2005-05-2091; Ploner C, 2008, ONCOGENE, V27, pS84, DOI 10.1038/onc.2009.46; Podar K, 2008, ONCOGENE, V27, P721, DOI 10.1038/sj.onc.1210679; Qin JZ, 2005, CANCER RES, V65, P6282, DOI 10.1158/0008-5472.CAN-05-0676; Russo A, 2010, CURR CANCER DRUG TAR, V10, P55, DOI 10.2174/156800910790980250; Sabapathy K, 2004, MOL CELL, V15, P713, DOI 10.1016/j.molcel.2004.08.028; Sakurai T, 2006, P NATL ACAD SCI USA, V103, P10544, DOI 10.1073/pnas.0603499103; She QB, 2002, ONCOGENE, V21, P1580, DOI 10.1038/sj.onc.1205239; She QB, 2002, CANCER RES, V62, P1343; Shringarpure R, 2006, BRIT J HAEMATOL, V134, P145, DOI 10.1111/j.1365-2141.2006.06132.x; Snyder CM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007059; Sohn D, 2006, MOL CELL BIOL, V26, P1967, DOI 10.1128/MCB.26.5.1967-1978.2006; Spohn D, 2010, MOL PHARMACOL, V78, P865, DOI 10.1124/mol.110.067637; Strasser A, 2011, EMBO J, V30, P3667, DOI 10.1038/emboj.2011.307; Tafolla E, 2005, J BIOL CHEM, V280, P19992, DOI 10.1074/jbc.M500331200; Tani E, 2001, FEBS LETT, V504, P53, DOI 10.1016/S0014-5793(01)02770-3; Tournier C, 2000, SCIENCE, V288, P870, DOI 10.1126/science.288.5467.870; Turchi L, 2008, CELL DEATH DIFFER, V15, P1472, DOI 10.1038/cdd.2008.74; Veschini L, 2007, BLOOD, V109, P2565, DOI 10.1182/blood-2006-06-032664; Wallace AD, 2001, J BIOL CHEM, V276, P42714, DOI 10.1074/jbc.M106033200; Wang Q, 2009, P NATL ACAD SCI USA, V106, P2200, DOI 10.1073/pnas.0807611106; Weston CR, 2007, CURR OPIN CELL BIOL, V19, P142, DOI 10.1016/j.ceb.2007.02.001; Yang X, 2003, CELL DEATH DIFFER, V10, P400, DOI 10.1038/cj.cdd.4401182; Yuan BZ, 2009, ONCOGENE, V28, P3775, DOI 10.1038/onc.2009.240; Zhong SP, 2009, P NATL ACAD SCI USA, V106, P12682, DOI 10.1073/pnas.0904843106; Zhu HB, 2005, ONCOGENE, V24, P4993, DOI 10.1038/sj.onc.1208683; Zimmermann J, 2000, ONCOGENE, V19, P2913, DOI 10.1038/sj.onc.1203606	63	13	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2013	8	4							e61438	10.1371/journal.pone.0061438	http://dx.doi.org/10.1371/journal.pone.0061438			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123JA	23593480	Green Published, gold, Green Submitted			2022-12-25	WOS:000317383200057
J	Kanak, DJ; Rose, GM; Zaveri, HP; Patrylo, PR				Kanak, Daniel J.; Rose, Gregory M.; Zaveri, Hitten P.; Patrylo, Peter R.			Altered Network Timing in the CA3-CA1 Circuit of Hippocampal Slices from Aged Mice	PLOS ONE			English	Article							GAMMA-OSCILLATIONS; RAT HIPPOCAMPUS; NEURONS; INTERNEURONS; CALCIUM; CELL; CA3; AFTERHYPERPOLARIZATION; REACTIVATION; MECHANISMS	Network patterns are believed to provide unique temporal contexts for coordinating neuronal activity within and across different regions of the brain. Some of the characteristics of network patterns modeled in vitro are altered in the CA3 or CA1 subregions of hippocampal slices from aged mice. CA3-CA1 network interactions have not been examined previously. We used slices from aged and adult mice to model spontaneous sharp wave ripples and carbachol-induced gamma oscillations, and compared measures of CA3-CA1 network timing between age groups. Coherent sharp wave ripples and gamma oscillations were evident in the CA3-CA1 circuit in both age groups, but the relative timing of activity in CA1 stratum pyramidale was delayed in the aged. In another sample of aged slices, evoked Schaffer collateral responses were attenuated in CA3 (antidromic spike amplitude) and CA1 (orthodromic field EPSP slope). However, the amplitude and timing of spontaneous sharp waves recorded in CA1 stratum radiatum were similar to adults. In both age groups unit activity recorded juxtacellularly from unidentified neurons in CA1 stratum pyramidale and stratum oriens was temporally modulated by CA3 ripples. However, aged neurons exhibited reduced spike probability during the early cycles of the CA3 ripple oscillation. These findings suggest that aging disrupts the coordination of patterned activity in the CA3-CA1 circuit.	[Kanak, Daniel J.; Rose, Gregory M.; Patrylo, Peter R.] So Illinois Univ, Sch Med, Dept Physiol, Carbondale, IL 62901 USA; [Rose, Gregory M.; Patrylo, Peter R.] So Illinois Univ, Sch Med, Dept Anat, Carbondale, IL 62901 USA; [Kanak, Daniel J.; Rose, Gregory M.; Patrylo, Peter R.] So Illinois Univ, Ctr Integrated Res Cognit & Neural Sci, Carbondale, IL 62901 USA; [Zaveri, Hitten P.] Yale Univ, Dept Neurol, New Haven, CT USA	Southern Illinois University System; Southern Illinois University; Southern Illinois University System; Southern Illinois University; Southern Illinois University System; Southern Illinois University; Yale University	Kanak, DJ (corresponding author), So Illinois Univ, Sch Med, Dept Physiol, Carbondale, IL 62901 USA.	djkanak@yahoo.com			Southern Illinois Univsersity's Center for Integrated Research in Cognitive & Neural Sciences; Center for Alzheimer's Disease and Related Disorders	Southern Illinois Univsersity's Center for Integrated Research in Cognitive & Neural Sciences; Center for Alzheimer's Disease and Related Disorders	This work was supported by funds from Southern Illinois Univsersity's Center for Integrated Research in Cognitive & Neural Sciences and Center for Alzheimer's Disease and Related Disorders. The funders had no role in study design, data collection, analysis, decision to publish, or preparation of the manuscript.	Barnes C. A., 2000, Neural Plasticity, V7, P167, DOI 10.1155/NP.2000.167; BARNES CA, 1992, HIPPOCAMPUS, V2, P457, DOI 10.1002/hipo.450020413; Baude A, 2007, CEREB CORTEX, V17, P2094, DOI 10.1093/cercor/bhl117; Berens P, 2009, J STAT SOFTW, V31, P1, DOI 10.18637/jss.v031.i10; Both M, 2008, HIPPOCAMPUS, V18, P899, DOI 10.1002/hipo.20446; BRAGIN A, 1995, J NEUROSCI, V15, P47; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; BUZSAKI G, 1983, BRAIN RES REV, V6, P139, DOI 10.1016/0165-0173(83)90037-1; BUZSAKI G, 1989, NEUROSCIENCE, V31, P551, DOI 10.1016/0306-4522(89)90423-5; CHROBAK JJ, 1994, J NEUROSCI, V14, P6160; Colgin LL, 2009, NATURE, V462, P353, DOI 10.1038/nature08573; Csicsvari J, 2003, NEURON, V37, P311, DOI 10.1016/S0896-6273(02)01169-8; Csicsvari J, 1999, J NEUROSCI, V19, P274, DOI 10.1523/JNEUROSCI.19-01-00274.1999; Disterhoft JF, 1996, LIFE SCI, V59, P413, DOI 10.1016/0024-3205(96)00320-7; Driver JE, 2007, EUR J NEUROSCI, V26, P1280, DOI 10.1111/j.1460-9568.2007.05705.x; Ego-Stengel V, 2010, HIPPOCAMPUS, V20, P1, DOI 10.1002/hipo.20707; Fisahn A, 1998, NATURE, V394, P186, DOI 10.1038/28179; Girardeau G, 2009, NAT NEUROSCI, V12, P1222, DOI 10.1038/nn.2384; HASSELMO ME, 1995, J NEUROSCI, V15, P5249; Heistek TS, 2010, FRONT CELL NEUROSCI, V4, DOI 10.3389/fncel.2010.00018; Hermann D, 2009, NEUROSCIENCE, V162, P1081, DOI 10.1016/j.neuroscience.2009.05.044; Klausberger T, 2004, NAT NEUROSCI, V7, P41, DOI 10.1038/nn1159; Kubota D, 2003, J NEUROPHYSIOL, V89, P81, DOI 10.1152/jn.00542.2002; LANDFIELD PW, 1984, SCIENCE, V226, P1089, DOI 10.1126/science.6494926; Lu CB, 2011, NEUROBIOL AGING, V32, P956, DOI 10.1016/j.neurobiolaging.2009.05.006; Maccaferri G, 2000, J PHYSIOL-LONDON, V524, P91, DOI 10.1111/j.1469-7793.2000.t01-3-00091.x; Maier N, 2003, J PHYSIOL-LONDON, V550, P873, DOI 10.1113/jphysiol.2003.044602; Montgomery SM, 2007, P NATL ACAD SCI USA, V104, P14495, DOI 10.1073/pnas.0701826104; Mott DD, 2011, NEUROBIOL AGING; Nadasdy Z, 1999, J NEUROSCI, V19, P9497; Nakashiba T, 2009, NEURON, V62, P781, DOI 10.1016/j.neuron.2009.05.013; Nicholson DA, 2004, J NEUROSCI, V24, P7648, DOI 10.1523/JNEUROSCI.1725-04.2004; Potier B, 2006, NEUROSCIENCE, V142, P187, DOI 10.1016/j.neuroscience.2006.06.040; Randall AD, 2012, NEUROBIOL AGING, V33, P2715, DOI 10.1016/j.neurobiolaging.2011.12.030; Sametsky EA, 2010, NEUROBIOL AGING, V31, P813, DOI 10.1016/j.neurobiolaging.2008.05.029; Shi L, 2004, J COMP NEUROL, V478, P282, DOI 10.1002/cne.20303; SIK A, 1993, EUR J NEUROSCI, V5, P1719, DOI 10.1111/j.1460-9568.1993.tb00239.x; Stanley DP, 2004, J NEUROCHEM, V89, P204, DOI 10.1111/j.1471-4159.2004.02318.x; Stanley EM, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.12.014; Thibault O, 1996, SCIENCE, V272, P1017, DOI 10.1126/science.272.5264.1017; Tombaugh GC, 2005, J NEUROSCI, V25, P2609, DOI 10.1523/JNEUROSCI.5023-04.2005; Tukker JJ, 2007, J NEUROSCI, V27, P8184, DOI 10.1523/JNEUROSCI.1685-07.2007; Vela J, 2003, J NEUROCHEM, V85, P368, DOI 10.1046/j.1471-4159.2003.01681.x; Verkhratsky A, 1998, TRENDS NEUROSCI, V21, P2, DOI 10.1016/S0166-2236(97)01156-9; Vreugdenhil M, 2005, NEUROSCIENCE, V132, P1151, DOI 10.1016/j.neuroscience.2005.01.025; Wierenga CJ, 2003, J NEUROPHYSIOL, V90, P811, DOI 10.1152/jn.00865.2002; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517; YLINEN A, 1995, J NEUROSCI, V15, P30	48	16	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2013	8	4							e61364	10.1371/journal.pone.0061364	http://dx.doi.org/10.1371/journal.pone.0061364			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130FG	23593474	gold, Green Published, Green Submitted			2022-12-25	WOS:000317898000129
J	Sroubek, J; Krishnan, Y; McDonald, TV				Sroubek, Jakub; Krishnan, Yamini; McDonald, Thomas V.			Sequence and structure-specific elements of HERG mRNA determine channel synthesis and trafficking efficiency	FASEB JOURNAL			English	Article						codon-usage; KCNH2; LQTS; SNP; protein translation	LONG QT SYNDROME; SECONDARY STRUCTURE; PROTEIN-KINASE; SYNONYMOUS MUTATIONS; ESCHERICHIA-COLI; GC-CONTENT; CODON; TRANSLATION; POLYMORPHISM; MECHANISMS	Human ether-a-gogo-related gene (HERG) encodes a potassium channel that is highly susceptible to deleterious mutations resulting in susceptibility to fatal cardiac arrhythmias. Most mutations adversely affect HERG channel assembly and trafficking. Why the channel is so vulnerable to missense mutations is not well understood. Since nothing is known of how mRNA structural elements factor in channel processing, we synthesized a codon-modified HERG cDNA (HERG-CM) where the codons were synonymously changed to reduce GC content, secondary structure, and rare codon usage. HERG-CM produced typical I-Kr-like currents; however, channel synthesis and processing were markedly different. Translation efficiency was reduced for HERG-CM, as determined by heterologous expression, in vitro translation, and polysomal profiling. Trafficking efficiency to the cell surface was greatly enhanced, as assayed by immunofluorescence, subcellular fractionation, and surface labeling. Chimeras of HERG-NT/CM indicated that trafficking efficiency was largely dependent on 5 sequences, while translation efficiency involved multiple areas. These results suggest that HERG translation and trafficking rates are independently governed by noncoding information in various regions of the mRNA molecule. Noncoding information embedded within the mRNA may play a role in the pathogenesis of hereditary arrhythmia syndromes and could provide an avenue for targeted therapeutics.	[Sroubek, Jakub; Krishnan, Yamini; McDonald, Thomas V.] Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY USA; [McDonald, Thomas V.] Albert Einstein Coll Med, Dept Med, Wilf Family Cardiovasc Res Ctr, Bronx, NY USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	McDonald, TV (corresponding author), 1300 Morris Pk Ave,Forchheimer G35, Bronx, NY 10461 USA.	tom.mcdonald@einstein.yu.edu			U.S. National Institutes of Health/National Heart, Lung, and Blood Institute [F30HL096279, R01HL077929]; American Heart Association [11GRNT5480008]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F30HL096279] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007288] Funding Source: NIH RePORTER	U.S. National Institutes of Health/National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Drs. Charles Rubin, John Warner, and Umadas Maitra for thoughtful discussion and advice. This work was supported in part by grants from the U.S. National Institutes of Health/National Heart, Lung, and Blood Institute (F30HL096279 to Y.K. and R01HL077929 to T. V. M.) and the American Heart Association (11GRNT5480008 to T.V.M.).	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Anderson CL, 2006, CIRCULATION, V113, P365, DOI 10.1161/CIRCULATIONAHA.105.570200; Banasavadi-Siddegowda YK, 2011, J BIOL CHEM, V286, P43071, DOI 10.1074/jbc.M111.269993; Barc Julien, 2011, J Am Coll Cardiol, V57, P40, DOI 10.1016/j.jacc.2010.08.621; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartoszewski RA, 2010, J BIOL CHEM, V285, P28741, DOI 10.1074/jbc.M110.154575; Bernardi G, 2000, GENE, V241, P3, DOI 10.1016/S0378-1119(99)00485-0; Buchan JR, 2007, BIOL CELL, V99, P475, DOI 10.1042/BC20070037; Capon F, 2004, HUM MOL GENET, V13, P2361, DOI 10.1093/hmg/ddh273; Chen J, 2009, AM J PHYSIOL-HEART C, V296, pH1244, DOI 10.1152/ajpheart.01252.2008; Crotti L, 2005, CIRCULATION, V112, P1251, DOI 10.1161/CIRCULATIONAHA.105.549071; Delisle BP, 2005, MOL PHARMACOL, V68, P233, DOI 10.1124/mol.105.012914; Delisle BP, 2003, J BIOL CHEM, V278, P35749, DOI 10.1074/jbc.M305787200; DESMIT MH, 1990, P NATL ACAD SCI USA, V87, P7668, DOI 10.1073/pnas.87.19.7668; Dittmar KA, 2006, PLOS GENET, V2, P2107, DOI 10.1371/journal.pgen.0020221; Duan JB, 2003, HUM MOL GENET, V12, P205, DOI 10.1093/hmg/ddg055; Ficker E, 2003, CIRC RES, V92, pE87, DOI 10.1161/01.RES.0000079028.31393.15; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Fraser CS, 2009, PROG MOL BIOL TRANSL, V90, P1, DOI 10.1016/S1877-1173(09)90001-1; Fullerton SM, 2001, MOL BIOL EVOL, V18, P1139, DOI 10.1093/oxfordjournals.molbev.a003886; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Goldenberg I, 2008, J AM COLL CARDIOL, V51, P2291, DOI 10.1016/j.jacc.2008.02.068; Gruber AR, 2008, NUCLEIC ACIDS RES, V36, pW70, DOI 10.1093/nar/gkn188; Handa V, 2003, NUCLEIC ACIDS RES, V31, P6243, DOI 10.1093/nar/gkg818; Hurt CM, 2000, J BIOL CHEM, V275, P35424, DOI 10.1074/jbc.M006241200; IKEMURA T, 1982, J MOL BIOL, V158, P573, DOI 10.1016/0022-2836(82)90250-9; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; Komar AA, 1999, FEBS LETT, V462, P387, DOI 10.1016/S0014-5793(99)01566-5; Komar AA, 2009, TRENDS BIOCHEM SCI, V34, P16, DOI 10.1016/j.tibs.2008.10.002; Kozak M, 2005, GENE, V361, P13, DOI 10.1016/j.gene.2005.06.037; Krishnan Y, 2012, BBA-MOL CELL RES, V1823, P1273, DOI 10.1016/j.bbamcr.2012.05.012; Kudla G, 2006, PLOS BIOL, V4, P933, DOI 10.1371/journal.pbio.0040180; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Li Q, 2004, J NEUROSCI, V24, P4070, DOI 10.1523/JNEUROSCI.0346-04.2004; Li Y, 2008, J MEMBRANE BIOL, V223, P107, DOI 10.1007/s00232-008-9118-4; Lu JL, 2008, J MOL BIOL, V384, P73, DOI 10.1016/j.jmb.2008.08.089; Mahoney SJ, 2009, PROG MOL BIOL TRANSL, V90, P53, DOI 10.1016/S1877-1173(09)90002-3; McDonald TV, 1997, NATURE, V388, P289, DOI 10.1038/40882; Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609; Moss AJ, 2005, J CLIN INVEST, V115, P2018, DOI 10.1172/JCI25537; Nakamura Y, 2000, NUCLEIC ACIDS RES, V28, P292, DOI 10.1093/nar/28.1.292; Pager CT, 2009, PROG MOL BIOL TRANSL, V90, P187, DOI 10.1016/S1877-1173(09)90005-9; Rasband W., 2006, IMAGEJ; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Romiguier J, 2010, GENOME RES, V20, P1001, DOI 10.1101/gr.104372.109; Saenen JB, 2008, J MOL CELL CARDIOL, V44, P633, DOI 10.1016/j.yjmcc.2008.01.006; SANGUINETTI MC, 1995, CELL, V81, P299, DOI 10.1016/0092-8674(95)90340-2; Sauna ZE, 2011, NAT REV GENET, V12, P683, DOI 10.1038/nrg3051; Saunders R, 2010, NUCLEIC ACIDS RES, V38, P6719, DOI 10.1093/nar/gkq495; Schulze-Bahr E, 2008, PROG BIOPHYS MOL BIO, V98, P289, DOI 10.1016/j.pbiomolbio.2009.01.008; Schwartz PJ, 2006, J INTERN MED, V259, P39, DOI 10.1111/j.1365-2796.2005.01583.x; Sesti F, 2000, P NATL ACAD SCI USA, V97, P10613, DOI 10.1073/pnas.180223197; SHARP PM, 1988, NUCLEIC ACIDS RES, V16, P8207, DOI 10.1093/nar/16.17.8207; Sobczak K, 2003, NUCLEIC ACIDS RES, V31, P5469, DOI 10.1093/nar/gkg766; Takyar S, 2005, CELL, V120, P49, DOI 10.1016/j.cell.2004.11.042; Thomas D, 2003, CARDIOVASC RES, V60, P235, DOI 10.1016/j.cardiores.2003.08.002; VARENNE S, 1984, J MOL BIOL, V180, P549, DOI 10.1016/0022-2836(84)90027-5; Walker VE, 2007, J BIOL CHEM, V282, P23509, DOI 10.1074/jbc.M701006200; Walker VE, 2010, J BIOL CHEM, V285, P3319, DOI 10.1074/jbc.M109.024000; Wan Y, 2011, NAT REV GENET, V12, P641, DOI 10.1038/nrg3049; Wang XD, 2006, CELL, V127, P803, DOI 10.1016/j.cell.2006.09.043; WARMKE JW, 1994, P NATL ACAD SCI USA, V91, P3438, DOI 10.1073/pnas.91.8.3438; Wen JD, 2008, NATURE, V452, P598, DOI 10.1038/nature06716; Zhang G, 2009, NAT STRUCT MOL BIOL, V16, P274, DOI 10.1038/nsmb.1554; Zhou ZF, 1998, J BIOL CHEM, V273, P21061, DOI 10.1074/jbc.273.33.21061; Zumwalt M, 2007, RNA BIOL, V4, P93, DOI 10.4161/rna.4.2.5039	67	5	6	1	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2013	27	8					3039	3053		10.1096/fj.12-227009	http://dx.doi.org/10.1096/fj.12-227009			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	292BT	23608144	Green Published			2022-12-25	WOS:000329877600012
J	Liu, J; Wang, Y; Li, L; Zhou, L; Wei, HB; Zhou, QX; Liu, J; Wang, WC; Ji, L; Shan, PP; Wang, Y; Yang, YY; Jung, SY; Zhang, P; Wang, CG; Long, WW; Zhang, BH; Li, XT				Liu, Jiang; Wang, Ying; Li, Lei; Zhou, Li; Wei, Haibin; Zhou, Qingxia; Liu, Jian; Wang, Weicang; Ji, Lei; Shan, Peipei; Wang, Yan; Yang, Yuanyuan; Jung, Sung Yun; Zhang, Pei; Wang, Chuangui; Long, Weiwen; Zhang, Bianhong; Li, Xiaotao			Site-specific Acetylation of the Proteasome Activator REG gamma Directs Its Heptameric Structure and Functions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CREB-BINDING PROTEIN; LYSINE ACETYLATION; POSTTRANSLATIONAL MODIFICATIONS; TRANSCRIPTIONAL REGULATION; CELL-CYCLE; DEGRADATION; P300; PA28-GAMMA; INHIBITORS; MICE	The proteasome activator REG gamma has been reported to promote degradation of steroid receptor coactivator-3 and cyclin-dependent kinase inhibitors p21, p16, and p19 in a ubiquitin- and ATP-independent manner. A recent comparative analysis of REG gamma expression in mouse and human tissues reveals a unique pattern of REG gamma in specific cell types, suggesting undisclosed functions and biological importance of this molecule. Despite the emerging progress made in REG gamma-related studies, how REG gamma function is regulated remains to be explored. In this study, we report for the first time that REG gamma can be acetylated mostly on its lysine 195 (Lys-195) residue by CREB binding protein (CBP), which can be reversed by sirtuin 1 (SIRT1) in mammalian cells. Site-directed mutagenesis abrogated acetylation at Lys-195 and significantly attenuated the capability of REG gamma to degrade its target substrates, p21 and hepatitis C virus core protein. Mechanistically, acetylation at Lys-195 is important for the interactions between REG gamma monomers and ultimately influences REG gamma heptamerization. Biological analysis of cells containing REG gamma-WT or REG gamma-K195R mutant indicates an impact of acetylation on REG gamma-mediated regulation of cell proliferation and cell cycle progression. These findings reveal a previously unknown mechanism in the regulation of REG gamma assembly and activity, suggesting a potential venue for the intervention of the ubiquitin-independent REG gamma proteasome activity.	[Liu, Jiang; Wang, Ying; Li, Lei; Zhou, Li; Wei, Haibin; Zhou, Qingxia; Wang, Weicang; Ji, Lei; Shan, Peipei; Wang, Yan; Yang, Yuanyuan; Wang, Chuangui; Zhang, Bianhong; Li, Xiaotao] E China Normal Univ, Inst Biomed Sci, Sch Life Sci, Shanghai Key Lab Regulatory Biol, Shanghai 200241, Peoples R China; [Liu, Jiang; Wang, Ying] Hangzhou Normal Univ, Sch Med, Inst Aging Res, Hangzhou 310036, Zhejiang, Peoples R China; [Liu, Jiang; Wang, Ying; Liu, Jian; Jung, Sung Yun; Long, Weiwen; Li, Xiaotao] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Zhang, Pei] Second Chengdu Municipal Hosp, Dept Pathol, Chengdu 610017, Sichuan, Peoples R China	East China Normal University; Hangzhou Normal University; Baylor College of Medicine	Zhang, BH (corresponding author), E China Normal Univ, Inst Biomed Sci, Sch Life Sci, 500 Dongchuan Rd, Shanghai 200241, Peoples R China.	bhzhang@bio.ecnu.edu.cn; xiaotaol@bcm.edu	Wang, Weicang/K-7618-2017	Wang, Weicang/0000-0002-2722-507X; Liu, Jian/0000-0002-1447-0973; Jung, Sung Yun/0000-0003-1521-7977	Excellent East China Normal University Ph.D. student award; National Institutes of Health Grant [1R01CA131914]; Norman Hackerman Advanced Research Program [1082318401, PN004949-0012-2009]; Pilot/Feasibility Program of the Diabetes & Endocrinology Research Center at Baylor College of Medicine [P30-DK079638]; National Natural Science Foundation of China [81261120555, 30870503, 81071657, 31100946, 31200878]; Science and Technology Commission of Shanghai Municipality [11DZ2260300, 10JC1404200, 11ZR1410000, 12ZR1409300]; National Basic Research Program [2009CB918402, 2011CB504200]; NATIONAL CANCER INSTITUTE [R01CA131914] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079638] Funding Source: NIH RePORTER	Excellent East China Normal University Ph.D. student award; National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Norman Hackerman Advanced Research Program; Pilot/Feasibility Program of the Diabetes & Endocrinology Research Center at Baylor College of Medicine; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); National Basic Research Program(National Basic Research Program of China); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by an Excellent East China Normal University Ph.D. student award (to J. L.). This work was also supported by National Institutes of Health Grant 1R01CA131914, Norman Hackerman Advanced Research Program Grants 1082318401 and PN004949-0012-2009), and the Pilot/Feasibility Program of the Diabetes & Endocrinology Research Center (P30-DK079638) at Baylor College of Medicine. This work was supported in part by National Natural Science Foundation of China Grants 81261120555, 30870503, 81071657, 31100946, and 31200878; Science and Technology Commission of Shanghai Municipality Grants 11DZ2260300, 10JC1404200, 11ZR1410000, and 12ZR1409300; and National Basic Research Program Grants 2009CB918402 and 2011CB504200.	Avalos JL, 2005, MOL CELL, V17, P855, DOI 10.1016/j.molcel.2005.02.022; Barton LF, 2004, J IMMUNOL, V172, P3948, DOI 10.4049/jimmunol.172.6.3948; Blackwell JS, 2007, J BIOL CHEM, V282, P20142, DOI 10.1074/jbc.M701989200; Chan HM, 2001, J CELL SCI, V114, P2363; Chen XY, 2007, MOL CELL, V26, P843, DOI 10.1016/j.molcel.2007.05.022; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Deng QD, 2005, CANCER RES, V65, P8298, DOI 10.1158/0008-5472.CAN-05-0054; DUBIEL W, 1992, J BIOL CHEM, V267, P22369; Furumai R, 2001, P NATL ACAD SCI USA, V98, P87, DOI 10.1073/pnas.011405598; Glozak MA, 2005, GENE, V363, P15, DOI 10.1016/j.gene.2005.09.010; Guo P, 2009, J BIOL CHEM, V284, P18184, DOI 10.1074/jbc.M109.007096; He J, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-75; Jones JD, 2011, PROTEOMICS, V11, P3012, DOI 10.1002/pmic.201000812; Kanai K, 2011, J MOL ENDOCRINOL, V47, P119, DOI 10.1530/JME-11-0044; Kang SA, 2010, BIOCHEM PHARMACOL, V80, P867, DOI 10.1016/j.bcp.2010.04.026; Kasper LH, 2006, MOL CELL BIOL, V26, P789, DOI 10.1128/MCB.26.3.789-809.2006; Kawai Y, 2011, J BIOL CHEM, V286, P7629, DOI 10.1074/jbc.M110.208173; Kingsley-Kallesen ML, 1999, J BIOL CHEM, V274, P34020, DOI 10.1074/jbc.274.48.34020; Knowlton JR, 1997, NATURE, V390, P639, DOI 10.1038/37670; Kouzarides T, 2000, EMBO J, V19, P1176, DOI 10.1093/emboj/19.6.1176; Kramer OH, 2006, GENE DEV, V20, P473, DOI 10.1101/gad.364306; Li J, 2001, EMBO J, V20, P3359, DOI 10.1093/emboj/20.13.3359; Li J, 2001, BIOCHIMIE, V83, P373, DOI 10.1016/S0300-9084(01)01236-6; Li XT, 2007, MOL CELL, V26, P831, DOI 10.1016/j.molcel.2007.05.028; Li XT, 2006, CELL, V124, P381, DOI 10.1016/j.cell.2005.11.037; Liu JA, 2010, J CELL SCI, V123, P4076, DOI 10.1242/jcs.067405; Liu X, 2008, NATURE, V451, P846, DOI 10.1038/nature06546; MA CP, 1992, J BIOL CHEM, V267, P10515; Manohar M, 2009, J BIOL CHEM, V284, P23312, DOI 10.1074/jbc.M109.003202; Mao I, 2008, Cell Mol Life Sci, V65, P3971, DOI 10.1007/s00018-008-8291-z; Mariadason JM, 2008, EPIGENETICS-US, V3, P28, DOI 10.4161/epi.3.1.5736; Molloy D, 2006, VIROLOGY, V355, P115, DOI 10.1016/j.virol.2006.05.004; Moriishi K, 2003, J VIROL, V77, P10237, DOI 10.1128/JVI.77.19.10237-10249.2003; Murata S, 1999, J BIOL CHEM, V274, P38211, DOI 10.1074/jbc.274.53.38211; Nakagawa T, 2011, J CELL SCI, V124, P833, DOI 10.1242/jcs.081067; Nie J, 2010, FEBS LETT, V584, P3021, DOI 10.1016/j.febslet.2010.05.034; Roessler M, 2006, MOL CELL PROTEOMICS, V5, P2092, DOI 10.1074/mcp.M600118-MCP200; Shikama N, 2003, EMBO J, V22, P5175, DOI 10.1093/emboj/cdg502; Sun YL, 2007, MOL CELL BIOL, V27, P8502, DOI 10.1128/MCB.01382-07; Thompson PR, 2004, NAT STRUCT MOL BIOL, V11, P308, DOI 10.1038/nsmb740; Vo N, 2001, J BIOL CHEM, V276, P13505, DOI 10.1074/jbc.R000025200; Wang F, 2012, ONCOGENE, V31, P1546, DOI 10.1038/onc.2011.347; Weinberg WC, 2002, CRIT REV ORAL BIOL M, V13, P453, DOI 10.1177/154411130201300603; Whitby FG, 2000, NATURE, V408, P115, DOI 10.1038/35040607; Wu Y, 2011, CELL RES, V21, P807, DOI 10.1038/cr.2011.57; Xin FX, 2012, BIOINFORMATICS, V28, P2905, DOI 10.1093/bioinformatics/bts541; XIONG Y, 1993, NATURE, V366, P701, DOI 10.1038/366701a0; Yang XJ, 2008, MOL CELL, V31, P449, DOI 10.1016/j.molcel.2008.07.002; Yu GW, 2010, J MOL CELL BIOL, V2, P192, DOI 10.1093/jmcb/mjq009; Zhang Z, 2008, EMBO J, V27, P852, DOI 10.1038/emboj.2008.25; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689	51	15	18	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2013	288	23					16567	16578		10.1074/jbc.M112.437129	http://dx.doi.org/10.1074/jbc.M112.437129			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	163ZU	23612972	Green Published, hybrid			2022-12-25	WOS:000320378900033
J	Zhao, WT; Zhou, CF; Li, XB; Zhang, YF; Fan, L; Pelletier, J; Fang, J				Zhao, Wen-Ting; Zhou, Cheng-Fu; Li, Xue-Bing; Zhang, Yun-Fang; Fan, Li; Pelletier, Jerry; Fang, Jing			The von Hippel-Lindau Protein pVHL Inhibits Ribosome Biogenesis and Protein Synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR PROTEIN; HUMAN BREAST-CANCER; TRANSLATION INITIATION; NUCLEAR EXPORT; PRE-RIBOSOMES; RNA SYNTHESIS; SUBUNITS; NETWORK; GROWTH; CELLS	pVHL, the product of von Hippel-Lindau (VHL) tumor suppressor gene, functions as the substrate recognition component of an E3-ubiquitin ligase complex that targets hypoxia inducible factor alpha (HIF-alpha) for ubiquitination and degradation. Besides HIF-alpha, pVHL also interacts with other proteins and has multiple functions. Here, we report that pVHL inhibits ribosome biogenesis and protein synthesis. We find that pVHL associates with the 40S ribosomal protein S3 (RPS3) but does not target it for destruction. Rather, the pVHL-RPS3 association interferes with the interaction between RPS3 and RPS2. Expression of pVHL also leads to nuclear retention of pre-40S ribosomal subunits, diminishing polysomes and 18S rRNA levels. We also demonstrate that pVHL suppresses both cap-dependent and cap-independent protein synthesis. Our findings unravel a novel function of pVHL and provide insight into the regulation of ribosome biogenesis by the tumor suppressor pVHL.	[Zhao, Wen-Ting; Li, Xue-Bing; Zhang, Yun-Fang; Fan, Li; Fang, Jing] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Key Lab Nutr & Metab, Shanghai 200031, Peoples R China; [Zhou, Cheng-Fu] Fudan Univ, Sch Med, Zhongshan Hosp, Dept Surg, Shanghai 200030, Peoples R China; [Pelletier, Jerry] McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Fudan University; McGill University	Fang, J (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Key Lab Nutr & Metab, Shanghai 200031, Peoples R China.	jfang@sibs.ac.cn			Natural Science Foundation of China [30970586, 31270829]; Innovation Program of Chinese Academy of Sciences Grant [KSCX2-EW-R-09]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovation Program of Chinese Academy of Sciences Grant	This work was supported by Natural Science Foundation of China Grants 30970586 and 31270829 and the Innovation Program of Chinese Academy of Sciences Grant KSCX2-EW-R-09.	Albanese V, 2010, J CELL BIOL, V189, P69, DOI 10.1083/jcb.201001054; Belin S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007147; Bordeleau ME, 2008, J CLIN INVEST, V118, P2651, DOI 10.1172/JCI34753; Bordeleau ME, 2006, NAT CHEM BIOL, V2, P213, DOI 10.1038/nchembio776; Brandenburger Y, 2001, FASEB J, V15, P2051, DOI 10.1096/fj.00-0853fje; Bulygin K, 2005, BIOCHEMISTRY-US, V44, P2153, DOI 10.1021/bi0487802; Campbell MG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016194; Carron C, 2011, NUCLEIC ACIDS RES, V39, P280, DOI 10.1093/nar/gkq734; CAVANAUGH AH, 1995, NATURE, V374, P177, DOI 10.1038/374177a0; Chitalia VC, 2008, NAT CELL BIOL, V10, P1208, DOI 10.1038/ncb1781; Davidowitz EJ, 2001, MOL CELL BIOL, V21, P865, DOI 10.1128/MCB.21.3.865-874.2001; Fatica A, 2002, CURR OPIN CELL BIOL, V14, P313, DOI 10.1016/S0955-0674(02)00336-8; Ferreira-Cerca S, 2005, MOL CELL, V20, P263, DOI 10.1016/j.molcel.2005.09.005; Ferreira-Cerca S, 2007, MOL CELL, V28, P446, DOI 10.1016/j.molcel.2007.09.029; Frew IJ, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.124pe30; Fromont-Racine M, 2003, GENE, V313, P17, DOI 10.1016/S0378-1119(03)00629-2; Grandi P, 2002, MOL CELL, V10, P105, DOI 10.1016/S1097-2765(02)00579-8; Granneman S, 2010, EMBO J, V29, P2026, DOI 10.1038/emboj.2010.86; Grosfeld A, 2007, J BIOL CHEM, V282, P13264, DOI 10.1074/jbc.M611648200; HADJIOLOVA KV, 1993, EUR J BIOCHEM, V212, P211, DOI 10.1111/j.1432-1033.1993.tb17652.x; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Hergovich A, 2003, NAT CELL BIOL, V5, P64, DOI 10.1038/ncb899; Kaelin WG, 2008, NAT REV CANCER, V8, P865, DOI 10.1038/nrc2502; Kaelin WG, 2007, ANNU REV PATHOL-MECH, V2, P145, DOI 10.1146/annurev.pathol.2.010506.092049; Kim WY, 2004, J CLIN ONCOL, V22, P4991, DOI 10.1200/JCO.2004.05.061; Lafontaine DLJ, 2001, NAT REV MOL CELL BIO, V2, P514, DOI 10.1038/35080045; Lee S, 1999, MOL CELL BIOL, V19, P1486; Lewis MD, 2003, ONCOGENE, V22, P3992, DOI 10.1038/sj.onc.1206683; Mekhail K, 2006, CELL CYCLE, V5, P2401, DOI 10.4161/cc.5.20.3387; Milkereit P, 2003, NUCLEIC ACIDS RES, V31, P799, DOI 10.1093/nar/gkg165; Montanaro L, 2012, BBA-REV CANCER, V1825, P101, DOI 10.1016/j.bbcan.2011.10.006; Nemoto N, 2010, J BIOL CHEM, V285, P32200, DOI 10.1074/jbc.M110.146662; O'Donohue MF, 2010, J CELL BIOL, V190, P853, DOI 10.1083/jcb.201005117; Ohh M, 1998, MOL CELL, V1, P959, DOI 10.1016/S1097-2765(00)80096-9; Okuda H, 2001, J BIOL CHEM, V276, P43611, DOI 10.1074/jbc.M107880200; Perreault A, 2008, NUCLEIC ACIDS RES, V36, P6132, DOI 10.1093/nar/gkn625; Rouquette J, 2005, EMBO J, V24, P2862, DOI 10.1038/sj.emboj.7600752; Ruggero D, 2003, NAT REV CANCER, V3, P179, DOI 10.1038/nrc1015; Schafer T, 2003, EMBO J, V22, P1370, DOI 10.1093/emboj/cdg121; Schmidt EV, 1999, ONCOGENE, V18, P2988, DOI 10.1038/sj.onc.1202751; Soudet J, 2010, EMBO J, V29, P80, DOI 10.1038/emboj.2009.307; Strunk BS, 2011, SCIENCE, V333, P1449, DOI 10.1126/science.1208245; Thoma CR, 2007, NAT CELL BIOL, V9, P588, DOI 10.1038/ncb1579; Trere D, 2004, J HISTOCHEM CYTOCHEM, V52, P1601, DOI 10.1369/jhc.4A6454.2004; van Riggelen J, 2010, NAT REV CANCER, V10, P301, DOI 10.1038/nrc2819; Yan B, 2011, BIOCHEM BIOPH RES CO, V409, P315, DOI 10.1016/j.bbrc.2011.05.012; Yang H, 2007, MOL CELL, V28, P15, DOI 10.1016/j.molcel.2007.09.010; Zemp I, 2009, J CELL BIOL, V185, P1167, DOI 10.1083/jcb.200904048	48	14	15	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2013	288	23					16588	16597		10.1074/jbc.M113.455121	http://dx.doi.org/10.1074/jbc.M113.455121			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	163ZU	23612971	hybrid, Green Published			2022-12-25	WOS:000320378900035
J	Chen, XL; Zhou, XY; Xi, L; Li, JX; Zhao, RY; Ma, N; Zhao, LJ				Chen, Xiaoli; Zhou, Xiaoyang; Xi, Lin; Li, Junxiang; Zhao, Ruiyan; Ma, Nan; Zhao, Liangjun			Roles of DgBRC1 in Regulation of Lateral Branching in Chrysanthemum (Dendranthema xgrandiflora cv. Jinba)	PLOS ONE			English	Article							AGROBACTERIUM-MEDIATED TRANSFORMATION; AXILLARY BUD OUTGROWTH; APICAL-DOMINANCE; ACTS DOWNSTREAM; CYTOKININ CONCENTRATION; ARABIDOPSIS-THALIANA; RMS1 MUTANT; FLORAL DIP; TCP DOMAIN; AUXIN	The diverse plasticity of plant architecture is largely determined by shoot branching. Shoot branching is an event regulated by multiple environmental, developmental and hormonal stimuli through triggering lateral bud response. After perceiving these signals, the lateral buds will respond and make a decision on whether to grow out. TCP transcriptional factors, BRC1/TB1/FC1, were previously proven to be involved in local inhibition of shoot branching in Arabidopsis, pea, tomato, maize and rice. To investigate the function of BRC1, we isolated the BRC1 homolog from chrysanthemum. There were two transcripts of DgBRC1 coming from two alleles in one locus, both of which complemented the multiple branches phenotype of Arabidopsis brc1-1, indicating that both are functionally conserved. DgBRC1 was mainly expressed in dormant axillary buds, and down-regulated at the bud activation stage, and up-regulated by higher planting densities. DgBRC1 transcripts could respond to apical auxin supply and polar auxin transport. Moreover, we found that the acropetal cytokinin stream promoted branch outgrowth whether or not apical auxin was present. Basipetal cytokinin promoted outgrowth of branches in the absence of apical auxin, while strengthening the inhibitory effects on lower buds in the presence of apical auxin. The influence of auxin and strigolactons (SLs) on the production of cytokinin was investigated, we found that auxin locally down-regulated biosynthesis of cytokinin in nodes, SLs also down-regulated the biosynthesis of cytokinin, the interactions among these phytohormones need further investigation.	[Chen, Xiaoli; Zhou, Xiaoyang; Xi, Lin; Li, Junxiang; Zhao, Ruiyan; Ma, Nan; Zhao, Liangjun] China Agr Univ, Dept Ornamental Hort & Landscape Architecture, Beijing 100094, Peoples R China	China Agricultural University	Zhao, LJ (corresponding author), China Agr Univ, Dept Ornamental Hort & Landscape Architecture, Beijing 100094, Peoples R China.	zhaolj5073@sina.com	ma, nan/AAF-6968-2020	ma, nan/0000-0003-4006-1003; Xi, Lin/0000-0002-6811-9505	China 863 Program [2011AA10020801]; China Scholarship Council (CSC)	China 863 Program(National High Technology Research and Development Program of China); China Scholarship Council (CSC)(China Scholarship Council)	This work was supported by the China 863 Program (2011AA10020801) (http://www.863.gov.cn/) and the China Scholarship Council (CSC) (http://www.csc.edu.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar-Martinez JA, 2007, PLANT CELL, V19, P458, DOI 10.1105/tpc.106.048934; Agusti J, 2011, P NATL ACAD SCI USA, V108, P20242, DOI 10.1073/pnas.1111902108; ALI A, 1971, CAN J BOTANY, V49, P1727, DOI 10.1139/b71-243; Amor S, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-571; Ando S, 2005, PHYSIOL MOL PLANT P, V67, P59, DOI 10.1016/j.pmpp.2005.09.005; Arite T, 2007, PLANT J, V51, P1019, DOI 10.1111/j.1365-313X.2007.03210.x; Arite T, 2009, PLANT CELL PHYSIOL, V50, P1416, DOI 10.1093/pcp/pcp091; Balla J, 2011, PLANT J, V65, P571, DOI 10.1111/j.1365-313X.2010.04443.x; BANGERTH F, 1994, PLANTA, V194, P439, DOI 10.1007/BF00197546; Bennett T, 2006, CURR BIOL, V16, P553, DOI 10.1016/j.cub.2006.01.058; Beveridge CA, 1997, PLANT PHYSIOL, V115, P1251, DOI 10.1104/pp.115.3.1251; Beveridge CA, 1996, PLANT PHYSIOL, V110, P859, DOI 10.1104/pp.110.3.859; Bishopp A, 2011, CURR OPIN PLANT BIOL, V14, P10, DOI 10.1016/j.pbi.2010.08.014; Booker J, 2005, DEV CELL, V8, P443, DOI 10.1016/j.devcel.2005.01.009; Booker J, 2004, CURR BIOL, V14, P1232, DOI 10.1016/j.cub.2004.06.061; Booker J, 2003, PLANT CELL, V15, P495, DOI 10.1105/tpc.007542; Braun N, 2012, PLANT PHYSIOL, V158, P225, DOI 10.1104/pp.111.182725; Brewer PB, 2013, MOL PLANT, V6, P18, DOI 10.1093/mp/sss130; Brewer PB, 2009, PLANT PHYSIOL, V150, P482, DOI 10.1104/pp.108.134783; Broholm SK, 2008, P NATL ACAD SCI USA, V105, P9117, DOI 10.1073/pnas.0801359105; CASAL JJ, 1986, ENVIRON EXP BOT, V26, P365, DOI 10.1016/0098-8472(86)90024-9; Chapman MA, 2008, MOL BIOL EVOL, V25, P1260, DOI 10.1093/molbev/msn001; Chatfield SP, 2000, PLANT J, V24, P159, DOI 10.1046/j.1365-313x.2000.00862.x; CLINE MG, 1991, BOT REV, V57, P318, DOI 10.1007/BF02858771; Cline MG, 1997, AM J BOT, V84, P1064, DOI 10.2307/2446149; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Crawford S, 2010, DEVELOPMENT, V137, P2905, DOI 10.1242/dev.051987; Cubas P, 1999, PLANT J, V18, P215, DOI 10.1046/j.1365-313X.1999.00444.x; DAVIES CR, 1966, SCIENCE, V151, P468, DOI 10.1126/science.151.3709.468; Doebley J, 1997, NATURE, V386, P485, DOI 10.1038/386485a0; DOEBLEY J, 1995, GENETICS, V141, P333; Domagalska MA, 2011, NAT REV MOL CELL BIO, V12, P211, DOI 10.1038/nrm3088; Drummond RSM, 2009, PLANT PHYSIOL, V151, P1867, DOI 10.1104/pp.109.146720; Dun EA, 2013, MOL PLANT, V6, P128, DOI 10.1093/mp/sss131; Dun EA, 2009, PLANT CELL, V21, P3459, DOI 10.1105/tpc.109.069013; Dun EA, 2009, TRENDS PLANT SCI, V14, P364, DOI 10.1016/j.tplants.2009.04.003; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eklof S, 1997, PLANT CELL PHYSIOL, V38, P225, DOI 10.1093/oxfordjournals.pcp.a029157; Ferguson BJ, 2009, PLANT PHYSIOL, V149, P1929, DOI 10.1104/pp.109.135475; Finlayson SA, 2007, PLANT CELL PHYSIOL, V48, P667, DOI 10.1093/pcp/pcm044; Finlayson SA, 2010, PLANT PHYSIOL, V152, P1914, DOI 10.1104/pp.109.148833; Foo E, 2001, PLANT PHYSIOL, V126, P203, DOI 10.1104/pp.126.1.203; Franklin KA, 2005, ANN BOT-LONDON, V96, P169, DOI 10.1093/aob/mci165; GARRISON R, 1955, AM J BOT, V42, P257, DOI 10.2307/2438561; GOLDSMITH MHM, 1977, ANNU REV PLANT PHYS, V28, P439, DOI 10.1146/annurev.pp.28.060177.002255; Gomez-Roldan V, 2008, NATURE, V455, P189, DOI 10.1038/nature07271; Greb T, 2003, GENE DEV, V17, P1175, DOI 10.1101/gad.260703; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Han BH, 2007, SCI HORTIC-AMSTERDAM, V115, P70, DOI 10.1016/j.scienta.2007.07.012; Hayward A, 2009, PLANT PHYSIOL, V151, P400, DOI 10.1104/pp.109.137646; HILLMAN JR, 1977, PLANTA, V134, P191, DOI 10.1007/BF00384970; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Howarth DG, 2006, P NATL ACAD SCI USA, V103, P9101, DOI 10.1073/pnas.0602827103; Jiang BB, 2010, PLANT MOL BIOL REP, V28, P144, DOI 10.1007/s11105-009-0130-3; Jones B, 2010, PLANT CELL ONLINE; Kalousek P., 2010, Acta Universitatis Agriculturae et Silviculturae Mendelianae Brunensis, V58, P79; Kapulnik Y, 2011, J EXP BOT, V62, P2915, DOI 10.1093/jxb/erq464; Kebrom TH, 2010, PLANT SIGNAL BEHAV, V5, P317, DOI 10.4161/psb.5.3.11186; Kebrom TH, 2006, PLANT PHYSIOL, V140, P1109, DOI 10.1104/pp.105.074856; Kertesz S, 2006, NUCLEIC ACIDS RES, V34, P6147, DOI 10.1093/nar/gkl737; Koroleva OA, 2005, PLANT J, V41, P162, DOI 10.1111/j.1365-313X.2004.02281.x; Kosugi S, 1997, PLANT CELL, V9, P1607, DOI 10.1105/tpc.9.9.1607; Kudo T, 2010, J INTEGR PLANT BIOL, V52, P53, DOI 10.1111/j.1744-7909.2010.00898.x; Laufs P, 1998, PLANT CELL, V10, P1375, DOI 10.1105/tpc.10.8.1375; Li CJ, 1999, PHYSIOL PLANTARUM, V106, P415, DOI 10.1034/j.1399-3054.1999.106409.x; Liang JL, 2010, J EXP BOT, V61, P3069, DOI 10.1093/jxb/erq133; Luo D, 1996, NATURE, V383, P794, DOI 10.1038/383794a0; Luo D, 1999, CELL, V99, P367, DOI 10.1016/S0092-8674(00)81523-8; Martin-Trillo M, 2011, PLANT J, V67, P701, DOI 10.1111/j.1365-313X.2011.04629.x; Martin-Trillo M, 2010, TRENDS PLANT SCI, V15, P31, DOI 10.1016/j.tplants.2009.11.003; McSteen P, 2005, ANNU REV PLANT BIOL, V56, P353, DOI 10.1146/annurev.arplant.56.032604.144122; Minakuchi K, 2010, PLANT CELL PHYSIOL, V51, P1127, DOI 10.1093/pcp/pcq083; MORRIS DA, 1972, J EXP BOT, V23, P346, DOI 10.1093/jxb/23.2.346; Mueller D, 2011, ANN BOT-LONDON, V107, P1203, DOI 10.1093/aob/mcr069; Muller D, 2006, PLANT CELL, V18, P586, DOI 10.1105/tpc.105.038745; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nath U, 2003, SCIENCE, V299, P1404, DOI 10.1126/science.1079354; Nicholas K.B., 1997, EMBNEW NEWS, V4, P14, DOI DOI 10.11118/ACTAUN201361041061; Nordstrom A, 2004, P NATL ACAD SCI USA, V101, P8039, DOI 10.1073/pnas.0402504101; Ongaro V, 2008, J EXP BOT, V59, P67, DOI 10.1093/jxb/erm134; Palatnik JF, 2003, NATURE, V425, P257, DOI 10.1038/nature01958; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Prusinkiewicz P, 2009, P NATL ACAD SCI USA, V106, P17431, DOI 10.1073/pnas.0906696106; Qin Lian-Ju, 2004, Zhiwu Shengli yu Fenzi Shengwuxue Xuebao, V30, P523; Rasmussen A, 2012, PLANT PHYSL; Renton M, 2012, NEW PHYTOL, V194, P704, DOI 10.1111/j.1469-8137.2012.04093.x; SACHS T, 1967, AM J BOT, V54, P136, DOI 10.2307/2440896; SHEIN T, 1972, ANN BOT-LONDON, V36, P791, DOI 10.1093/oxfordjournals.aob.a084635; Simons JL, 2007, PLANT PHYSIOL, V143, P697, DOI 10.1104/pp.106.087957; SMITH H, 1995, ANNU REV PLANT PHYS, V46, P289, DOI 10.1146/annurev.pp.46.060195.001445; Snow M., 1942, NEW PHYTOL, V41, P13, DOI 10.1111/j.1469-8137.1942.tb07058.x; Snowden KC, 2005, PLANT CELL, V17, P746, DOI 10.1105/tpc.104.027714; Sorefan K, 2003, GENE DEV, V17, P1469, DOI 10.1101/gad.256603; Stirnberg P, 2002, DEVELOPMENT, V129, P1131; Stirnberg P, 2007, PLANT J, V50, P80, DOI 10.1111/j.1365-313X.2007.03032.x; Suzuki T, 2001, PLANT CELL PHYSIOL, V42, P37, DOI 10.1093/pcp/pce011; Takeda T, 2003, PLANT J, V33, P513, DOI 10.1046/j.1365-313X.2003.01648.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tanaka M, 2006, PLANT J, V45, P1028, DOI 10.1111/j.1365-313X.2006.02656.x; Tantikanjana T, 2001, GENE DEV, V15, P1577, DOI 10.1101/gad.887301; Thimann KV, 1933, P NATL ACAD SCI USA, V19, P714, DOI 10.1073/pnas.19.7.714; Turnbull CGN, 1997, PLANTA, V202, P271, DOI 10.1007/s004250050128; Umehara M, 2008, NATURE, V455, P195, DOI 10.1038/nature07272; VARAGONA MJ, 1992, PLANT CELL, V4, P1213, DOI 10.1105/tpc.4.10.1213; Wang C, 2004, J BEIJING FORESTRY U, V26, P91; Whipple CJ, 2011, P NATL ACAD SCI; WICKSON M, 1958, PHYSIOL PLANTARUM, V11, P62, DOI 10.1111/j.1399-3054.1958.tb08426.x; Yang F, 2012, PLANT J, V71, P61, DOI 10.1111/j.1365-313X.2012.04970.x; Yu J, 2012, ACTA HORTICULTURAE S, V39, P712; Zhang XR, 2006, NAT PROTOC, V1, P641, DOI 10.1038/nprot.2006.97	110	24	31	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2013	8	4							e61717	10.1371/journal.pone.0061717	http://dx.doi.org/10.1371/journal.pone.0061717			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IK	23613914	Green Published, Green Submitted, gold			2022-12-25	WOS:000317907200077
J	Gustafson-Wagner, E; Stipp, CS				Gustafson-Wagner, Elisabeth; Stipp, Christopher S.			The CD9/CD81 Tetraspanin Complex and Tetraspanin CD151 Regulate alpha 3 beta 1 Integrin-Dependent Tumor Cell Behaviors by Overlapping but Distinct Mechanisms	PLOS ONE			English	Article							BREAST-CANCER; PROSTATE-CANCER; KERATINOCYTE POLARIZATION; ALPHA-6-BETA-4 INTEGRIN; MAJOR CD9; IN-VIVO; PROTEIN; CD81; EXPRESSION; MEMBRANE	Integrin alpha 3 beta 1 potently promotes cell motility on its ligands, laminin-332 and laminin-511, and this may help to explain why alpha 3 beta 1 has repeatedly been linked to breast carcinoma progression and metastasis. The pro-migratory functions of alpha 3 beta 1 depend strongly on lateral interactions with cell surface tetraspanin proteins. Tetraspanin CD151 interacts directly with the alpha 3 integrin subunit and links alpha 3 beta 1 integrin to other tetraspanins, including CD9 and CD81. Loss of CD151 disrupts alpha 3 beta 1 association with other tetraspanins and impairs alpha 3 beta 1-dependent motility. However, the extent to which tetraspanins other than CD151 are required for specific alpha 3 beta 1 functions is unclear. To begin to clarify which aspects of alpha 3 beta 1 function require which tetraspanins, we created breast carcinoma cells depleted of both CD9 and CD81 by RNA interference. Silencing both of these closely related tetraspanins was required to uncover their contributions to alpha 3 beta 1 function. We then directly compared our CD9/CD81-silenced cells to CD151-silenced cells. Both CD9/CD81-silenced cells and CD151-silenced cells showed delayed alpha 3 beta 1-dependent cell spreading on laminin-332. Surprisingly, however, once fully spread, CD9/CD81-silenced cells, but not CD151-silenced cells, displayed impaired alpha 3 beta 1-dependent directed motility and altered front-rear cell morphology. Also unexpectedly, the CD9/CD81 complex, but not CD151, was required to promote alpha 3 beta 1 association with PKC alpha in breast carcinoma cells, and a PKC inhibitor mimicked aspects of the CD9/CD81-silenced cell motility defect. Our data reveal overlapping, but surprisingly distinct contributions of specific tetraspanins to alpha 3 beta 1 integrin function. Importantly, some of CD9/CD81's alpha 3 beta 1 regulatory functions may not require CD9/CD81 to be physically linked to alpha 3 beta 1 by CD151.	[Gustafson-Wagner, Elisabeth; Stipp, Christopher S.] Univ Iowa, Dept Biol, Iowa City, IA 52242 USA; [Stipp, Christopher S.] Univ Iowa, Dept Mol Physiol & Biophys, Iowa City, IA USA; [Stipp, Christopher S.] Univ Iowa, Holden Comprehens Canc Ctr, Iowa City, IA USA	University of Iowa; University of Iowa; University of Iowa	Stipp, CS (corresponding author), Univ Iowa, Dept Biol, Iowa City, IA 52242 USA.	christopher-stipp@uiowa.edu			National Institutes of Health [R01 CA136664]; American Cancer Society [119840-PF-10-139-01-CSM]; NATIONAL CANCER INSTITUTE [R01CA136664] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health R01 CA136664 (to CSS) and American Cancer Society Postdoctoral Fellowship 119840-PF-10-139-01-CSM (to EAGW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldwin G, 2008, J BIOL CHEM, V283, P35445, DOI 10.1074/jbc.M806394200; Berditchevski F, 2001, J CELL SCI, V114, P4143; Bryce NS, 2005, CURR BIOL, V15, P1276, DOI 10.1016/j.cub.2005.06.043; Cailleteau L, 2010, J CELL SCI, V123, P2491, DOI 10.1242/jcs.058875; Castro-Sanchez L, 2010, EUR J CELL BIOL, V89, P843, DOI 10.1016/j.ejcb.2010.07.004; Chang YG, 2007, J CELL SCI, V120, P3053, DOI 10.1242/jcs.006361; Charrin S, 2003, BIOCHEM J, V373, P409, DOI 10.1042/BJ20030343; Charrin S, 2001, J BIOL CHEM, V276, P14329, DOI 10.1074/jbc.M011297200; Charrin S, 2009, BIOCHEM J, V420, P133, DOI 10.1042/BJ20082422; Choma DP, 2007, J INVEST DERMATOL, V127, P31, DOI 10.1038/sj.jid.5700505; Clark KL, 2001, J IMMUNOL, V167, P5115, DOI 10.4049/jimmunol.167.9.5115; Deng XY, 2012, NEOPLASIA, V14, P678, DOI 10.1593/neo.12922; Frank DE, 2004, J CELL SCI, V117, P1351, DOI 10.1242/jcs.01003; FUKUDOME K, 1992, J VIROL, V66, P1394, DOI 10.1128/JVI.66.3.1394-1401.1992; Furuya M, 2005, CANCER RES, V65, P2617, DOI 10.1158/0008-5472.CAN-04-3123; Garcia-Lopez MA, 2005, J INVEST DERMATOL, V125, P1001, DOI 10.1111/j.0022-202X.2005.23882.x; Gu JG, 2001, J BIOL CHEM, V276, P27090, DOI 10.1074/jbc.M102284200; Guo WJ, 2006, CELL, V126, P489, DOI 10.1016/j.cell.2006.05.047; Hemler ME, 2008, NAT REV DRUG DISCOV, V7, P747, DOI 10.1038/nrd2659; Humphries JD, 2006, J CELL SCI, V119, P3901, DOI 10.1242/jcs.03098; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Jiang Y, 2005, CLIN EXP METASTAS, V22, P369, DOI 10.1007/s10585-005-8186-4; Kazarov AR, 2002, J CELL BIOL, V158, P1299, DOI 10.1083/jcb.200204056; Kim J, 2011, ONCOGENE, V30, P323, DOI 10.1038/onc.2010.415; Kohmo S, 2010, CANCER RES, V70, P8025, DOI 10.1158/0008-5472.CAN-10-0996; Lamar JM, 2008, CANCER RES, V68, P7371, DOI 10.1158/0008-5472.CAN-08-1080; Lamb LE, 2011, CANCER RES, V71, P2739, DOI 10.1158/0008-5472.CAN-10-2745; Li Q, 2013, ONCOGENE, V32, P1772, DOI 10.1038/onc.2012.205; Lipscomb EA, 2005, CANCER METAST REV, V24, P413, DOI 10.1007/s10555-005-5133-4; Lonne GK, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-76; Margadant C, 2010, FASEB J, V24, P4133, DOI 10.1096/fj.09-151449; Mitchell K, 2010, CANCER RES, V70, P6359, DOI 10.1158/0008-5472.CAN-09-4283; Mitsuzuka K, 2005, J BIOL CHEM, V280, P35545, DOI 10.1074/jbc.M505630200; Nagle RB, 2011, PROSTATE CANCER, V2011, DOI 10.1155/2011/249290; Nishiuchi R, 2005, P NATL ACAD SCI USA, V102, P1939, DOI 10.1073/pnas.0409493102; Owens DM, 2003, J CELL SCI, V116, P3783, DOI 10.1242/jcs.00725; Owens DM, 2001, CANCER RES, V61, P5248; Pellinen T, 2012, J CELL SCI, V125, P649, DOI 10.1242/jcs.090704; Powner D, 2011, BIOCHEM SOC T, V39, P563, DOI 10.1042/BST0390563; Quast T, 2011, BLOOD, V118, P1818, DOI 10.1182/blood-2010-12-326595; Raymond K, 2007, MOL BIOL CELL, V18, P4210, DOI 10.1091/mbc.E06-08-0720; Ren BG, 2007, J NATL CANCER I, V99, P868, DOI 10.1093/jnci/djk199; Sadej R, 2010, CANCER RES, V70, P6059, DOI 10.1158/0008-5472.CAN-09-3497; Sadej R, 2009, MOL CANCER RES, V7, P787, DOI 10.1158/1541-7786.MCR-08-0574; Schmelz M, 2002, NEOPLASIA, V4, P243, DOI 10.1038/sj.neo.7900223; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Serru V, 1999, BIOCHEM J, V340, P103, DOI 10.1042/0264-6021:3400103; Sroka IC, 2010, J CELL PHYSIOL, V224, P283, DOI 10.1002/jcp.22149; Stipp CS, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399409001355; Stipp CS, 2003, J CELL BIOL, V163, P1167, DOI 10.1083/jcb.200309113; Stipp CS, 2001, J BIOL CHEM, V276, P40545, DOI 10.1074/jbc.M107338200; Stipp CS, 2001, J BIOL CHEM, V276, P4853, DOI 10.1074/jbc.M009859200; Subbaram S, 2011, EXPERT OPIN THER TAR, V15, P1197, DOI 10.1517/14728222.2011.609557; Takeda Y, 2008, J BIOL CHEM, V283, P26089, DOI 10.1074/jbc.M801902200; Takeda Y, 2007, BLOOD, V109, P1524, DOI 10.1182/blood-2006-08-041970; Wang HX, 2011, BIOCHEM SOC T, V39, P547, DOI 10.1042/BST0390547; WEITZMAN JB, 1993, J BIOL CHEM, V268, P8651; Weitzman JB, 1996, CELL ADHES COMMUN, V4, P41, DOI 10.3109/15419069609010762; Winterwood NE, 2006, MOL BIOL CELL, V17, P2707, DOI 10.1091/mbc.E05-11-1042; Yamada M, 2008, FEBS J, V275, P3335, DOI 10.1111/j.1742-4658.2008.06481.x; Yanez-Mo M, 2009, TRENDS CELL BIOL, V19, P434, DOI 10.1016/j.tcb.2009.06.004; Yang XWH, 2008, CANCER RES, V68, P3204, DOI 10.1158/0008-5472.CAN-07-2949; Yang XWH, 2012, J CELL SCI, V125, P1478, DOI 10.1242/jcs.093963; Yang XWH, 2010, CANCER RES, V70, P2256, DOI 10.1158/0008-5472.CAN-09-4032; Yang XW, 2004, J CELL BIOL, V167, P1231, DOI 10.1083/jcb.200404100; Yauch RL, 2000, J BIOL CHEM, V275, P9230, DOI 10.1074/jbc.275.13.9230; Yauch RL, 1998, MOL BIOL CELL, V9, P2751, DOI 10.1091/mbc.9.10.2751; Yurchenco PD, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004911; Zevian CS, 2011, THESIS U IOWA; Zevian S, 2011, J BIOL CHEM, V286, P7496, DOI 10.1074/jbc.M110.173583; Zhang XA, 2001, MOL BIOL CELL, V12, P351, DOI 10.1091/mbc.12.2.351; Zhang XA, 2001, J BIOL CHEM, V276, P25005, DOI 10.1074/jbc.M102156200; Zhou H, 2005, J BIOL CHEM, V280, P10624, DOI 10.1074/jbc.M411900200; Ziober BL, 1999, CELL GROWTH DIFFER, V10, P479; Zoller M, 2009, NAT REV CANCER, V9, P40, DOI 10.1038/nrc2543	75	28	31	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2013	8	4							e61834	10.1371/journal.pone.0061834	http://dx.doi.org/10.1371/journal.pone.0061834			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IK	23613949	gold, Green Published, Green Submitted			2022-12-25	WOS:000317907200092
J	Molina-Lopez, RA; Casal, J; Darwich, L				Molina-Lopez, Rafael A.; Casal, Jordi; Darwich, Laila			Final Disposition and Quality Auditing of the Rehabilitation Process in Wild Raptors Admitted to a Wildlife Rehabilitation Centre in Catalonia, Spain, during a Twelve Year Period (1995-2007)	PLOS ONE			English	Article							MORTALITY; MORBIDITY; VIRGINIA; PREVALENCE; CALIFORNIA; REPTILES	Background: Variability in reporting and classification methods in previous published data of the final dispositions in the rehabilitation of wild raptors makes use of this data limited in trying to audit the quality of the rehabilitation process. Crude as well as stratified disposition rates are needed if quality auditing of the rehabilitation process is to be adequately performed. Methodology: Final dispositions of 6221 hospitalized wild raptors admitted at a wildlife rehabilitation centre (WRC) of Catalonia during 1995-2007 were analyzed. These dispositions were calculated as the euthanasia (Er), unassisted mortality (Mr), release (Rr) and captivity rates (Cr)., time to death (Td) for dead and euthanized raptors, and length of stay for released (Tr) raptors was estimated. Stratified analyses by main causes of admission and clinical signs were performed. Results: The disposition for the total population were: Er = 30.6%, Mr = 19.1%, Rr = 47.2%, and Cr = 3%. By main causes of admission, Er was higher in the trauma category (34.2%), whereas Mr was found similar between trauma (37.4%) and nontrauma categories (34.8%). The highest Rr was observed for the orphaned group (77.9%). Furthermore, Cr was low in all the categories (, 4%). By clinical signs, the highest Er was found in animals suffering musculoskeletal (37.9%) or skin (32.3%) lesions; Mr was high in infectious/parasitic diseases (66.7%) and in case of neurological symptoms (64.5%). The euthanized birds had a median Td = 1 day (P-10 = 0-P-90 = 59) for both trauma and non-trauma categories, and Td = 36 days for the orphaned young group (P-10= 0; P-90 = 596). The median Td in the unassisted dead birds was 2 days for all the categories (P-10 = 0-P-90 = 31). Finally, the median Tr in the centre was variable among categories. Conclusions/Significance: Reporting of final dispositions in wildlife rehabilitation should include the crude and stratified rates (Er, Mr, Rr, and Cr), by causes and clinical presentation, as well as Td and Tr, to allow meaningful auditing of the rehabilitation process quality.	[Molina-Lopez, Rafael A.] Catalan Wildlife Serv Forestal Catalana, Ctr Fauna Salvatge Torreferrussa, Barcelona, Spain; [Molina-Lopez, Rafael A.; Casal, Jordi; Darwich, Laila] Univ Autonoma Barcelona, Fac Vet, Dept Sanit & Anat Anim, E-08193 Barcelona, Spain; [Casal, Jordi; Darwich, Laila] UAB IRTA, Ctr Recerca Sanit Anim CReSA, Barcelona, Spain	Autonomous University of Barcelona; IRTA	Molina-Lopez, RA (corresponding author), Catalan Wildlife Serv Forestal Catalana, Ctr Fauna Salvatge Torreferrussa, Barcelona, Spain.	rafael.molina@gencat.cat	Casal, Jordi/F-3020-2016; Darwich, Laila/F-5330-2016	Casal, Jordi/0000-0002-6909-9366; Darwich, Laila/0000-0001-9027-9452; Molina Lopez, Rafael/0000-0002-9043-2346	Catalan Wildlife-Service and Forestal Catalana	Catalan Wildlife-Service and Forestal Catalana	The study has been supported by the Catalan Wildlife-Service and Forestal Catalana. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arent L, 2001, RECONDITIONING RAPTO, P32; Black PA, 2011, J AVIAN MED SURG, V25, P192, DOI 10.1647/2010-024.1; Braun JP, 2010, ANASTH INTENSIVMED, V51, pS809, DOI 10.3205/000111; Brown JD, 2002, J WILDLIFE DIS, V38, P699, DOI 10.7589/0090-3558-38.4.699; Cabezon O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029549; COOPER J E, 1987, Journal of Raptor Research, V21, P21; Cooper JE, 2006, IN PRACTICE, V28, P2, DOI 10.1136/inpract.28.1.2; Deem SL, 1998, J ZOO WILDLIFE MED, V29, P160; Duke G.E., 1981, Raptor Research, V15, P97; FIX AS, 1990, J WILDLIFE DIS, V26, P18, DOI 10.7589/0090-3558-26.1.18; Garcia RE, 2001, REV MED CHILE, V129, P825; Harris S, 2005, PRACTICAL WILDLIFE CARE, 2ND EDITION, P159; Hartup BK, 1996, J WILDLIFE DIS, V32, P109, DOI 10.7589/0090-3558-32.1.109; Jiménez Paneque Rosa E, 2004, Rev Cubana Salud Pública, V30, P0; Kelly TR, 2003, J WILDLIFE DIS, V39, P467, DOI 10.7589/0090-3558-39.2.467; Kirkwood James K., 2003, P1; Kotter T, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-21; Komnenou AT, 2005, J ZOO WILDLIFE MED, V36, P222, DOI 10.1638/04-061.1; Kramer JL, 1997, J RAPTOR RES, V31, P327; Lawrence J, 1997, THESIS U TENNESSEE; Martinez Climent Jose Antonio, 2001, Biota (Race), V2, P163; Miller EA., 2012, MINIMUM STANDARDS WI, P116; Millsap Brian A., 2007, P437; Molina-Lopez RA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024603; Morishita TY, 1998, J AVIAN MED SURG, V12, P78; OECD, 2011, AV LENGTH STAY HOSP; Punch P, 2001, AUST VET J, V79, P747, DOI 10.1111/j.1751-0813.2001.tb10890.x; Redig Patrick T., 2007, P411; REDIG PT, 1995, T N AM WILDL NAT RES, P162; Ress S, 2004, J RAPTOR RES, V38, P77; Richards J, 2005, J ZOO WILDLIFE MED, V36, P485, DOI 10.1638/04-075.1; Rodriguez B, 2010, J RAPTOR RES, V44, P30, DOI 10.3356/JRR-09-40.1; Simo MR, 2010, CIR ESPAN, V88, P81, DOI 10.1016/j.ciresp.2010.03.021; Samour JH, 2003, J AVIAN MED SURG, V17, P136, DOI 10.1647/2001-047; Sleeman JM, 2003, J AVIAN MED SURG, V17, P33, DOI 10.1647/1082-6742(2003)017[0033:CWMANP]2.0.CO;2; Sleeman Jonathan M., 2008, P97; Smith WA, 2002, J ZOO WILDLIFE MED, V33, P228, DOI 10.1638/1042-7260(2002)033[0228:SICWSP]2.0.CO;2; Alvarez JS, 2007, AN MED INTERN, V24, P517; Weiner BJ, 2006, HEALTH SERV RES, V41, P307, DOI 10.1111/j.1475-6773.2005.00483.x; Woodford MH, 2000, QUARANTINE HLTH SCRE, P87; World Health Organization, 2004, ICD 10 INT STAT CLAS, V2, P125	41	23	23	2	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2013	8	4							e60242	10.1371/journal.pone.0060242	http://dx.doi.org/10.1371/journal.pone.0060242			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IK	23613722	Green Published, Green Submitted, gold			2022-12-25	WOS:000317907200005
J	Rodrigues, R; Grosso, AR; Moita, L				Rodrigues, Raquel; Grosso, Ana Rita; Moita, Luis			Genome-Wide Analysis of Alternative Splicing during Dendritic Cell Response to a Bacterial Challenge	PLOS ONE			English	Article							GENE-EXPRESSION; MESSENGER-RNA; IN-VITRO; MATURATION; ACTIVATION; DIFFERENTIATION; SIGNATURES; PHOSPHATASE; PATHOGENS; MIGRATION	The immune system relies on the plasticity of its components to produce appropriate responses to frequent environmental challenges. Dendritic cells (DCs) are critical initiators of innate immunity and orchestrate the later and more specific adaptive immunity. The generation of diversity in transcriptional programs is central for effective immune responses. Alternative splicing is widely considered a key generator of transcriptional and proteomic complexity, but its role has been rarely addressed systematically in immune cells. Here we used splicing-sensitive arrays to assess genome-wide gene-and exon-level expression profiles in human DCs in response to a bacterial challenge. We find widespread alternative splicing events and splicing factor transcriptional signatures induced by an E. coli challenge to human DCs. Alternative splicing acts in concert with transcriptional modulation, but these two mechanisms of gene regulation affect primarily distinct functional gene groups. Alternative splicing is likely to have an important role in DC immunobiology because it affects genes known to be involved in DC development, endocytosis, antigen presentation and cell cycle arrest.	[Rodrigues, Raquel; Grosso, Ana Rita; Moita, Luis] Univ Lisbon, Fac Med, Inst Mol Med, P-1699 Lisbon, Portugal	Universidade de Lisboa	Moita, L (corresponding author), Univ Lisbon, Fac Med, Inst Mol Med, P-1699 Lisbon, Portugal.	lmoita@fm.ul.pt	Grosso, Ana Rita/I-6656-2013; Rodrigues, Raquel/GZM-7677-2022; Moita, Luis/HCI-2793-2022; Moita, Luis F./L-1296-2013	Grosso, Ana Rita/0000-0001-6974-4209; Moita, Luis/0000-0003-0707-315X; Moita, Luis F./0000-0003-0707-315X; Rodrigues, Raquel/0000-0002-7557-1815	Fundacao Luso-Americana para o Desenvolvimento; Fundacao para a Ciencia e a Tecnologia [PTDC/SAU-MII/100780/2008]	Fundacao Luso-Americana para o Desenvolvimento; Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission)	LFM receives support from Fundacao Luso-Americana para o Desenvolvimento (http://www.flad.pt/) and Fundacao para a Ciencia e a Tecnologia (http://alfa.fct.mctes.pt/); (PTDC/SAU-MII/100780/2008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi H, 2002, J BIOL CHEM, V277, P34264, DOI 10.1074/jbc.M204277200; Affymetrix Website, ALT TRANSCR AN METH; Ahn JH, 2002, BLOOD, V100, P1742, DOI 10.1182/blood.V100.5.1742.h81702001742_1742_1754; Akasaki K, 2004, ARCH BIOCHEM BIOPHYS, V425, P147, DOI 10.1016/j.abb.2004.02.042; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bertho N, 2002, INT IMMUNOL, V14, P935, DOI 10.1093/intimm/dxf058; CAUX C, 1994, J EXP MED, V180, P1263, DOI 10.1084/jem.180.4.1263; Cecchini MJ, 2011, BIOCHEM J, V434, P297, DOI 10.1042/BJ20101210; Cella M, 1999, J EXP MED, V189, P821, DOI 10.1084/jem.189.5.821; Conboy CM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001061; de la Grange P, 2010, NUCLEIC ACIDS RES, V38, P2825, DOI 10.1093/nar/gkq008; Dietz AB, 2000, BIOCHEM BIOPH RES CO, V275, P731, DOI 10.1006/bbrc.2000.3372; Doidge R, 2012, BIOCHEM SOC T, V40, P896, DOI 10.1042/BST20120074; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Gao JL, 2010, BIOCHEM BIOPH RES CO, V402, P588, DOI 10.1016/j.bbrc.2010.09.133; Gardina PJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-325; Gillett A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007773; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Granucci F, 2001, NAT IMMUNOL, V2, P882, DOI 10.1038/ni0901-882; Granucci F, 2001, EUR J IMMUNOL, V31, P2539, DOI 10.1002/1521-4141(200109)31:9<2539::AID-IMMU2539>3.0.CO;2-9; Grosso AR, 2008, NUCLEIC ACIDS RES, V36, P4823, DOI 10.1093/nar/gkn463; GYURIS J, 1993, CELL, V75, P791, DOI 10.1016/0092-8674(93)90498-F; HANNON GJ, 1994, P NATL ACAD SCI USA, V91, P1731, DOI 10.1073/pnas.91.5.1731; Heufler C, 1996, EUR J IMMUNOL, V26, P659, DOI 10.1002/eji.1830260323; Huang Q, 2001, SCIENCE, V294, P870, DOI 10.1126/science.294.5543.870; Hubbard TJP, 2007, NUCLEIC ACIDS RES, V35, pD610, DOI 10.1093/nar/gkl996; Ip JY, 2007, RNA, V13, P563, DOI 10.1261/rna.457207; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Jin W, 2001, NAT GENET, V29, P389, DOI 10.1038/ng766; Johnson LN, 2002, PHARMACOL THERAPEUT, V93, P113, DOI 10.1016/S0163-7258(02)00181-X; Ju XS, 2003, EUR J CELL BIOL, V82, P75, DOI 10.1078/0171-9335-00294; Karolchik D, 2008, NUCLEIC ACIDS RES, V36, pD773, DOI 10.1093/nar/gkm966; Kim H, 2002, J AM CHEM SOC, V124, P4934, DOI 10.1021/ja012102a; Kim JH, 2005, GENE THER, V12, P1517, DOI 10.1038/sj.gt.3302584; Kiss T, 2004, J CELL SCI, V117, P5949, DOI 10.1242/jcs.01487; Kzhyshkowska J, 2010, THESCIENTIFICWORLDJO, V10, P2039, DOI 10.1100/tsw.2010.189; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Le Naour F, 2001, J BIOL CHEM, V276, P17920, DOI 10.1074/jbc.M100156200; Lewis BP, 2003, P NATL ACAD SCI USA, V100, P189, DOI 10.1073/pnas.0136770100; Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260; Loya CM, 2010, GENE DEV, V24, P625, DOI 10.1101/gad.1907710; Lynch KW, 2004, NAT REV IMMUNOL, V4, P931, DOI 10.1038/nri1497; McIlroy D, 2005, J LEUKOCYTE BIOL, V78, P794, DOI 10.1189/jlb.0105029; Medzhitov R, 1997, CELL, V91, P295, DOI 10.1016/S0092-8674(00)80412-2; Meijer HA, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm830; Mittal S, 2011, MOL BIOL CELL, V22, P748, DOI 10.1091/mbc.E10-11-0898; Moura-Alves P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019829; Okamoto K, 2006, BIOCHEM BIOPH RES CO, V351, P216, DOI 10.1016/j.bbrc.2006.10.022; Olex AL, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-41; Penna G, 2002, HUM IMMUNOL, V63, P1164, DOI 10.1016/S0198-8859(02)00755-3; Pierre P, 1997, NATURE, V388, P787, DOI 10.1038/42039; Piqueras B, 2006, BLOOD, V107, P2613, DOI 10.1182/blood-2005-07-2965; Pulendran B, 2001, SCIENCE, V293, P253, DOI 10.1126/science.1062060; Purdom E, 2008, BIOINFORMATICS, V24, P1707, DOI 10.1093/bioinformatics/btn284; Rescigno M, 1998, J EXP MED, V188, P2175, DOI 10.1084/jem.188.11.2175; Salomonis N, 2010, P NATL ACAD SCI USA, V107, P10514, DOI 10.1073/pnas.0912260107; Saltzman AL, 2008, MOL CELL BIOL, V28, P4320, DOI 10.1128/MCB.00361-08; Schoeters E, 2006, TOXICOL APPL PHARM, V216, P131, DOI 10.1016/j.taap.2006.04.009; Severa M, 2006, J LEUKOCYTE BIOL, V79, P1286, DOI 10.1189/jlb.1205742; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Soreq L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002392; Soreq L, 2012, NEURODEGENER DIS, V10, P203, DOI 10.1159/000332598; Tang HL, 1999, SCIENCE, V284, P819, DOI 10.1126/science.284.5415.819; Trombetta ES, 2005, ANNU REV IMMUNOL, V23, P975, DOI 10.1146/annurev.immunol.22.012703.104538; Tureci O, 2003, FASEB J, V17, P836, DOI 10.1096/fj.02-0724com; Ueno H, 2007, IMMUNOL REV, V219, P118, DOI 10.1111/j.1600-065X.2007.00551.x; Vizzardelli C, 2006, EUR J IMMUNOL, V36, P1504, DOI 10.1002/eji.200535488; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Watts C, 2012, BBA-PROTEINS PROTEOM, V1824, P14, DOI 10.1016/j.bbapap.2011.07.006; Zilliox MJ, 2006, P NATL ACAD SCI USA, V103, P3363, DOI 10.1073/pnas.0511345103	72	20	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2013	8	4							e61975	10.1371/journal.pone.0061975	http://dx.doi.org/10.1371/journal.pone.0061975			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IK	23613991	Green Published, Green Submitted, gold			2022-12-25	WOS:000317907200113
J	Rozsypal, J; Kostal, V; Zahradnickova, H; Simek, P				Rozsypal, Jan; Kostal, Vladimir; Zahradnickova, Helena; Simek, Petr			Overwintering Strategy and Mechanisms of Cold Tolerance in the Codling Moth (Cydia pomonella)	PLOS ONE			English	Article							SEASONAL-VARIATION; BARK BEETLE; DIAPAUSE; HARDINESS; LARVAE; LEPIDOPTERA; SURVIVAL; ACCUMULATION; COLEOPTERA; PROTEINS	Background: The codling moth (Cydia pomonella) is a major insect pest of apples worldwide. Fully grown last instar larvae overwinter in diapause state. Their overwintering strategies and physiological principles of cold tolerance have been insufficiently studied. No elaborate analysis of overwintering physiology is available for European populations. Principal Findings: We observed that codling moth larvae of a Central European population prefer to overwinter in the microhabitat of litter layer near the base of trees. Reliance on extensive supercooling, or freeze-avoidance, appears as their major strategy for survival of the winter cold. The supercooling point decreases from approximately -15.3 degrees C during summer to -26.3 degrees C during winter. Seasonal extension of supercooling capacity is assisted by partial dehydration, increasing osmolality of body fluids, and the accumulation of a complex mixture of winter specific metabolites. Glycogen and glutamine reserves are depleted, while fructose, alanine and some other sugars, polyols and free amino acids are accumulated during winter. The concentrations of trehalose and proline remain high and relatively constant throughout the season, and may contribute to the stabilization of proteins and membranes at subzero temperatures. In addition to supercooling, overwintering larvae acquire considerable capacity to survive at subzero temperatures, down to -15 degrees C, even in partially frozen state. Conclusion: Our detailed laboratory analysis of cold tolerance, and whole-winter survival assays in semi-natural conditions, suggest that the average winter cold does not represent a major threat for codling moth populations. More than 83% of larvae survived over winter in the field and pupated in spring irrespective of the overwintering microhabitat (cold-exposed tree trunk or temperature-buffered litter layer).	[Rozsypal, Jan; Kostal, Vladimir; Zahradnickova, Helena; Simek, Petr] Acad Sci Czech Republ, Inst Entomol, Ctr Biol, CR-37005 Ceske Budejovice, Czech Republic; [Rozsypal, Jan; Kostal, Vladimir] Univ South Bohemia, Fac Sci, Ceske Budejovice, Czech Republic	Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; University of South Bohemia Ceske Budejovice	Kostal, V (corresponding author), Acad Sci Czech Republ, Inst Entomol, Ctr Biol, Branisovska 31, CR-37005 Ceske Budejovice, Czech Republic.	kostal@entu.cas.cz	Zahradnickova, Helena/H-1863-2014; Rozsypal, Jan/H-6294-2014; Kostal, Vladimir/G-6688-2014; Simek, Petr/H-4126-2014; Simek, Petr/AAE-9176-2021	Rozsypal, Jan/0000-0002-7925-7401; Kostal, Vladimir/0000-0002-4994-5123; Simek, Petr/0000-0003-2754-6372	Ministry of Education, Youth and Sports of the Czech Republic [KONTAKT II LH12103]	Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic)	This work was supported by the Ministry of Education, Youth and Sports of the Czech Republic grant KONTAKT II LH12103. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Audermard H., 1991, TORTRICID PESTS THEI, P327; BALE JS, 1993, FUNCT ECOL, V7, P751; BALE JS, 1987, J INSECT PHYSIOL, V33, P899, DOI 10.1016/0022-1910(87)90001-1; Barnes M.M., 1991, TORTRICID PESTS THEI, P313; BROWN JJ, 1980, J INSECT PHYSIOL, V26, P487, DOI 10.1016/0022-1910(80)90121-3; BUEDING E, 1964, J BIOL CHEM, V239, P4018; CARPENTER JF, 1988, CRYOBIOLOGY, V25, P244, DOI 10.1016/0011-2240(88)90032-6; CHEN CP, 1991, ECOL ENTOMOL, V16, P155, DOI 10.1111/j.1365-2311.1991.tb00204.x; Denlinger D.L., 1991, P174; Ding L, 2003, J INSECT PHYSIOL, V49, P1153, DOI 10.1016/j.jinsphys.2003.08.012; Dorn S, 1999, AGR ECOSYST ENVIRON, V73, P111, DOI 10.1016/S0167-8809(99)00020-1; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Duman JG, 2004, J INSECT PHYSIOL, V50, P259, DOI 10.1016/j.jinsphys.2003.12.003; Duman JG, 2001, ANNU REV PHYSIOL, V63, P327, DOI 10.1146/annurev.physiol.63.1.327; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fukova I, 2005, GENOME, V48, P1083, DOI 10.1139/G05-063; GEHRKEN U, 1985, J INSECT PHYSIOL, V31, P909, DOI 10.1016/0022-1910(85)90024-1; Gessner MO, 2005, METHODS STUDY LITTER, P103; GLEN DM, 1978, ANN APPL BIOL, V90, P133, DOI 10.1111/j.1744-7348.1978.tb02620.x; Gould E, 1941, J ECON ENTOMOL, V34, P445, DOI 10.1093/jee/34.3.445; Headlee TJ, 1930, N J AGR EXPT STA ANN, V1930, P142; Hodkova M, 1997, CRYOBIOLOGY, V34, P70, DOI 10.1006/cryo.1996.1985; HODKOVA M, 1994, ENTOMOL EXP APPL, V70, P237, DOI 10.1007/BF02380557; JEGEN G., 1922, Landwirtschaftliches Jahrbuch der Schweiz, V36, P83; Khani Abbas, 2007, Pakistan Journal of Biological Sciences, V10, P2591, DOI 10.3923/pjbs.2007.2591.2594; Khani A, 2007, EUR J ENTOMOL, V104, P385, DOI 10.14411/eje.2007.057; Khani A, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.8301; Kostal V, 2000, EUR J ENTOMOL, V97, P433, DOI 10.14411/eje.2000.066; Kostal V, 2004, PHYSIOL ENTOMOL, V29, P344, DOI 10.1111/j.0307-6962.2004.00396.x; Kostal V, 2011, J INSECT PHYSIOL, V57, P1136, DOI 10.1016/j.jinsphys.2011.03.011; Kostal V, 2012, P NATL ACAD SCI USA, V109, P3270, DOI 10.1073/pnas.1119986109; Kostal V, 2011, P NATL ACAD SCI USA, V108, P13041, DOI 10.1073/pnas.1107060108; Kot J, 1958, EKOLOGIA POLSKA SE B, V4, P173; Le Roux EJ, 1959, REP POMOL FRUIT GROW, V1959, P45; Lee R.E. Jr, 1991, P17; Lee Richard E. Jr, 2010, P3, DOI 10.1017/CBO9780511675997.002; Ma RY, 2006, ENVIRON ENTOMOL, V35, P881, DOI 10.1603/0046-225X-35.4.881; MacLELLAN C. R., 1959, CAN ADIAN ENT?, V91, P673; MacLELLAN C. R., 1958, CANADIAN ENT, V90, P18; MACLELLAN C. R., 1960, CANADIAN ENT, V92, P469; MACPHEE AW, 1964, CAN ENTOMOL, V96, P617, DOI 10.4039/Ent96617-4; MAILLOUX M., 1960, Report. pomol. Soc. Quebec, P45; MAILLOUX M., 1963, Ann. ent. Soc. Quebec, V8, P48; Miller F., 1956, ZEMEDELSKA ENTOMOLOG; Neven LG, 1999, CRYOBIOLOGY, V38, P43, DOI 10.1006/cryo.1998.2140; Newcomer EJ, 1920, J ECON ENTOMOL, V13, P441, DOI 10.1093/jee/13.6.441; PETERSON DM, 1968, J INSECT PHYSIOL, V14, P519, DOI 10.1016/0022-1910(68)90067-X; PULLIN AS, 1991, PHYSIOL ENTOMOL, V16, P447, DOI 10.1111/j.1365-3032.1991.tb00584.x; Pullin AS, 1996, EUR J ENTOMOL, V93, P121; RAYMOND JA, 1977, P NATL ACAD SCI USA, V74, P2589, DOI 10.1073/pnas.74.6.2589; RUDOLPH AS, 1986, ARCH BIOCHEM BIOPHYS, V245, P134, DOI 10.1016/0003-9861(86)90197-9; Sateyev AF, 1963, T I BOT AN KAZ ALMA, V17, P189; Sato H, 1964, SOC PLANT PROTECT NO, V15, P113; Sformo T, 2010, J EXP BIOL, V213, P502, DOI 10.1242/jeb.035758; SIEBER R, 1980, ENTOMOL EXP APPL, V28, P204, DOI 10.1007/BF00287130; Sinclair BJ, 1999, EUR J ENTOMOL, V96, P157; SOLOMON ME, 1976, J APPL ECOL, V13, P341, DOI 10.2307/2401784; SOMME L, 1982, COMP BIOCHEM PHYS A, V73, P519, DOI 10.1016/0300-9629(82)90260-2; Storey K.B., 1991, P64; STOREY KB, 1988, PHYSIOL REV, V68, P27, DOI 10.1152/physrev.1988.68.1.27; TELFER WH, 1991, ANNU REV ENTOMOL, V36, P205, DOI 10.1146/annurev.en.36.010191.001225; TOBA H H, 1991, Journal of the Entomological Society of British Columbia, V88, P22; Vesala L, 2012, J EXP BIOL, V215, P2891, DOI 10.1242/jeb.069948; Watanabe M, 2002, EUR J ENTOMOL, V99, P5, DOI 10.14411/eje.2002.002; Willett MJ, 2009, HORTTECHNOLOGY, V19, P633, DOI 10.21273/HORTSCI.19.3.633; WILLIAMS DG, 1982, J AUST ENTOMOL SOC, V21, P1; ZACHARIASSEN KE, 1985, PHYSIOL REV, V65, P799, DOI 10.1152/physrev.1985.65.4.799; Zachariassen KE, 2000, CRYOBIOLOGY, V41, P257, DOI 10.1006/cryo.2000.2289	68	66	73	0	93	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2013	8	4							e61745	10.1371/journal.pone.0061745	http://dx.doi.org/10.1371/journal.pone.0061745			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IK	23613923	Green Published, Green Submitted, gold			2022-12-25	WOS:000317907200082
J	Boudiaf-Benmammar, C; Cresteil, T; Melki, R				Boudiaf-Benmammar, Chafika; Cresteil, Thierry; Melki, Ronald			The Cytosolic Chaperonin CCT/TRiC and Cancer Cell Proliferation	PLOS ONE			English	Article							CYTOPLASMIC CHAPERONIN; MOLECULAR CHAPERONES; EUKARYOTIC CHAPERONIN; NASCENT CHAIN; HUMAN LIVER; IN-VIVO; PROTEIN; TUBULIN; COMPLEX; BINDING	The molecular chaperone CCT/TRiC plays a central role in maintaining cellular proteostasis as it mediates the folding of the major cytoskeletal proteins tubulins and actins. CCT/TRiC is also involved in the oncoprotein cyclin E, the Von Hippel-Lindau tumour suppressor protein, cyclin B and p21(ras) folding which strongly suggests that it is involved in cell proliferation and tumor genesis. To assess the involvement of CCT/TRiC in tumor genesis, we quantified its expression levels and activity in 18 cancer, one non-cancer human cell lines and a non-cancer human liver. We show that the expression levels of CCT/TRiC in cancer cell lines are higher than that in normal cells. However, CCT/TRiC activity does not always correlate with its expression levels. We therefore documented the expression levels of CCT/TRiC modulators and partners PhLP3, Hop/P60, prefoldin and Hsc/Hsp70. Our analysis reveals a functional interplay between molecular chaperones that might account for a precise modulation of CCT/TRiC activity in cell proliferation through changes in the cellular levels of prefoldin and/or Hsc/p70 and CCT/TRiC client protein availability. Our observation and approaches bring novel insights in the role of CCT/TRiC-mediated protein folding machinery in cancer cell development.	[Boudiaf-Benmammar, Chafika; Melki, Ronald] CNRS, Lab Enzymol & Biochim Struct, Gif Sur Yvette, France; [Cresteil, Thierry] CNRS, Inst Chim Subst Nat, Gif Sur Yvette, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Melki, R (corresponding author), CNRS, Lab Enzymol & Biochim Struct, Gif Sur Yvette, France.	ronald.melki@lebs.cnrs-gif.fr	Cresteil, Thierry/L-3641-2019		French Ministry of Education, Research and Technology; Algerian Ministry of Higher Education and Research; Centre National de la Recherche Scientifique; University Paris Sud	French Ministry of Education, Research and Technology; Algerian Ministry of Higher Education and Research; Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); University Paris Sud	This work was supported by the French Ministry of Education, Research and Technology, the Algerian Ministry of Higher Education and Research, the Centre National de la Recherche Scientifique and the University Paris Sud. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagatell R, 2004, MOL CANCER THER, V3, P1021; Bigotti MG, 2008, ARCH BIOCHEM BIOPHYS, V474, P331, DOI 10.1016/j.abb.2008.03.015; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Broadley SA, 2009, FEBS LETT, V583, P2647, DOI 10.1016/j.febslet.2009.04.029; Cuellar J, 2008, NAT STRUCT MOL BIOL, V15, P858, DOI 10.1038/nsmb.1464; DARNBROUGH C, 1973, J MOL BIOL, V76, P379; Fan CY, 2003, CELL STRESS CHAPERON, V8, P309, DOI 10.1379/1466-1268(2003)008<0309:MFROHF>2.0.CO;2; GAO YI, 1993, MOL CELL BIOL, V13, P2478, DOI 10.1128/MCB.13.4.2478; GAO YJ, 1992, CELL, V69, P1043, DOI 10.1016/0092-8674(92)90622-J; Gebauer M, 1998, J BIOL CHEM, V273, P29475, DOI 10.1074/jbc.273.45.29475; GEORGOPOULOS CP, 1973, J MOL BIOL, V76, P45, DOI 10.1016/0022-2836(73)90080-6; Hansen WJ, 1999, J CELL BIOL, V145, P265, DOI 10.1083/jcb.145.2.265; Hansen WJ, 2002, MOL CELL BIOL, V22, P1947, DOI 10.1128/MCB.22.6.1947-1960.2002; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; HEMMINGSEN SM, 1988, NATURE, V333, P330, DOI 10.1038/333330a0; Kampinga HH, 2009, CELL STRESS CHAPERON, V14, P105, DOI 10.1007/s12192-008-0068-7; KUBOTA H, 1995, EUR J BIOCHEM, V230, P3, DOI 10.1111/j.1432-1033.1995.0003i.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Liu XQ, 2005, MOL CELL BIOL, V25, P4993, DOI 10.1128/MCB.25.12.4993-5010.2005; Mahalingam D, 2009, BRIT J CANCER, V100, P1523, DOI 10.1038/sj.bjc.6605066; MELKI R, 1993, J CELL BIOL, V122, P1301, DOI 10.1083/jcb.122.6.1301; Melki R, 1997, BIOCHEMISTRY-US, V36, P5817, DOI 10.1021/bi962830o; Melville MW, 2003, MOL CELL BIOL, V23, P3141, DOI 10.1128/MCB.23.9.3141-3151.2003; Miyoshi N, 2010, ANN SURG ONCOL, V17, P3030, DOI 10.1245/s10434-010-1138-5; ROTHMAN JE, 1989, CELL, V59, P591, DOI 10.1016/0092-8674(89)90005-6; Sonnier M, 1998, EUR J BIOCHEM, V251, P893, DOI 10.1046/j.1432-1327.1998.2510893.x; Spiess C, 2004, TRENDS CELL BIOL, V14, P598, DOI 10.1016/j.tcb.2004.09.015; STERNLICHT H, 1993, P NATL ACAD SCI USA, V90, P9422, DOI 10.1073/pnas.90.20.9422; Stirling PC, 2006, NAT STRUCT MOL BIOL, V13, P865, DOI 10.1038/nsmb1153; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Vieira I, 1996, EUR J BIOCHEM, V238, P476, DOI 10.1111/j.1432-1033.1996.0476z.x; Walter S, 2002, ANGEW CHEM INT EDIT, V41, P1098, DOI 10.1002/1521-3773(20020402)41:7<1098::AID-ANIE1098>3.0.CO;2-9; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Won KA, 1998, MOL CELL BIOL, V18, P7584, DOI 10.1128/MCB.18.12.7584; YAFFE MB, 1992, NATURE, V358, P245, DOI 10.1038/358245a0; Yokota S, 1999, J BIOL CHEM, V274, P37070, DOI 10.1074/jbc.274.52.37070; Zhang JJ, 2010, NATURE, V463, P379, DOI 10.1038/nature08701	38	49	51	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2013	8	4							e60895	10.1371/journal.pone.0060895	http://dx.doi.org/10.1371/journal.pone.0060895			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130DR	23613750	Green Published, gold, Green Submitted			2022-12-25	WOS:000317893400025
J	Chen, KD; Goto, S; Hsu, LW; Lin, TY; Nakano, T; Lai, CY; Chang, YC; Weng, WT; Kuo, YR; Wang, CC; Cheng, YF; Ma, YY; Lin, CC; Chen, CL				Chen, Kuang-Den; Goto, Shigeru; Hsu, Li-Wen; Lin, Tzu-Yang; Nakano, Toshiaki; Lai, Chia-Yun; Chang, Yen-Chen; Weng, Wei-Teng; Kuo, Yur-Ren; Wang, Chih-Chi; Cheng, Yu-Fan; Ma, Yen-Ying; Lin, Chih-Che; Chen, Chao-Long			Identification of miR-27b as a Novel Signature from the mRNA Profiles of Adipose-Derived Mesenchymal Stem Cells Involved in the Tolerogenic Response	PLOS ONE			English	Article							FACTOR-I; STROMAL CELLS; HOMING FACTOR; LIVER; TISSUE; SDF-1; FACTOR-1-ALPHA; MOBILIZATION; SDF-1-ALPHA; REGULATORS	Adipose-derived mesenchymal stem cells (adipose-derived MSCs, ASCs) possess the ability to differentiate into multiple tissue types and have immune-modulatory properties similar to those of MSCs from other origins. However, the regulation of the MSC-elicited immune-modulatory activity by specific microRNA (miRNA) mechanisms remains unexplored. Gene expression profiling with knowledge-based functional enrichment analysis is an appropriate approach for unraveling these mechanisms. This tool can be used to examine the transcripts and miRNA regulators that differentiate the rat tolerogenic orthotopic liver transplantation (OLT; DA liver into PVG) and rejection OLT (DA liver into LEW) models. In both models, the rejection reaction was observed on postoperative day 7 similar to 14 (rejection phase) but was overcome only by the PVG recipients. Thus, the global gene expression patterns of ASCs from spontaneously tolerant (PVG) and acute rejecting (LEW) rats in response to LPS activation were compared. In this study, we performed miRNA enrichment analysis based on the analysis of pathway, gene ontology (GO) terms and transcription factor binding site (TFBS) motif annotations. We found that the top candidate, miR-27, was specifically enriched and had the highest predicted frequency. We also identified a greater than 3-fold increase of miR-27b expression in the ASCs of tolerant recipients (DA to PVG) compared to those of rejecting recipients (DA to LEW) during the rejection phase in the rat OLT model. Furthermore, our data showed that miR-27b knockdown has a positive influence on the allosuppressive activity that inhibits T-cell proliferation. We found that miR-27 knockdown significantly induced the expression of CXCL12 in cultured ASCs and the expression of CXCL12 was responsible for the miR-27b antagomir-mediated inhibition of T-cell proliferation. These results, which through a series of comprehensive miRNA enrichment analyses, might be relevant for stem cell-based therapeutic applications in immunosuppressive function using ASCs.	[Chen, Kuang-Den; Goto, Shigeru; Hsu, Li-Wen; Lin, Tzu-Yang; Nakano, Toshiaki; Lai, Chia-Yun; Chang, Yen-Chen; Wang, Chih-Chi; Lin, Chih-Che; Chen, Chao-Long] Kaohsiung Chang Gung Mem Hosp, Ctr Translat Res Biomed Sci, Liver Transplantat Program, Kaohsiung, Taiwan; [Chen, Kuang-Den; Goto, Shigeru; Hsu, Li-Wen; Lin, Tzu-Yang; Nakano, Toshiaki; Lai, Chia-Yun; Chang, Yen-Chen; Wang, Chih-Chi; Lin, Chih-Che; Chen, Chao-Long] Kaohsiung Chang Gung Mem Hosp, Dept Surg, Kaohsiung, Taiwan; [Chen, Kuang-Den; Goto, Shigeru; Hsu, Li-Wen; Lin, Tzu-Yang; Nakano, Toshiaki; Lai, Chia-Yun; Chang, Yen-Chen; Wang, Chih-Chi; Lin, Chih-Che; Chen, Chao-Long] Chang Gung Univ, Coll Med, Dept Surg, Kaohsiung, Taiwan; [Goto, Shigeru] Iwao Hosp, Yufuin, Japan; [Hsu, Li-Wen] Natl Cheng Kung Univ, Dept Chem, Tainan 70101, Taiwan; [Nakano, Toshiaki] Kaohsiung Chang Gung Mem Hosp, Grad Inst Clin Med Sci, Kaohsiung, Taiwan; [Nakano, Toshiaki; Kuo, Yur-Ren; Cheng, Yu-Fan; Ma, Yen-Ying] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan; [Kuo, Yur-Ren] Kaohsiung Chang Gung Mem Hosp, Dept Plast & Reconstruct Surg, Kaohsiung, Taiwan; [Cheng, Yu-Fan] Kaohsiung Chang Gung Mem Hosp, Dept Diagnost Radiol, Kaohsiung, Taiwan; [Ma, Yen-Ying] Kaohsiung Chang Gung Mem Hosp, Dept Obstet & Gynecol, Kaohsiung, Taiwan	Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University; National Cheng Kung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital	Chen, CL (corresponding author), Kaohsiung Chang Gung Mem Hosp, Ctr Translat Res Biomed Sci, Liver Transplantat Program, Kaohsiung, Taiwan.	clchen@adm.cgmh.org.tw		Nakano, Toshiaki/0000-0003-3701-3449; Chen, Kuang-Den/0000-0003-2982-1286	National Science Council of Taiwan [NSC101-2314-B-182A-031-MY3, NSC101-2320-B-182-037-MY3]; Chang Gung Memorial Hospital of Taiwan [CMRPG891062, CMRPG8A0431, CMRPG891301, CMRPG8A0631]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Chang Gung Memorial Hospital of Taiwan(Chang Gung Memorial Hospital)	This work was supported in part by grants from the National Science Council (NSC101-2314-B-182A-031-MY3 to C.L. Chen; NSC101-2320-B-182-037-MY3 to T. Nakano) and the Chang Gung Memorial Hospital (CMRPG891062 and CMRPG8A0431 to C.L. Chen; CMRPG891301 to K.D. Chen; CMRPG8A0631 to K.W. Chiu) of Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Augello A, 2007, ARTHRITIS RHEUM-US, V56, P1175, DOI 10.1002/art.22511; Beyth S, 2005, BLOOD, V105, P2214, DOI 10.1182/blood-2004-07-2921; Burger JA, 2002, LEUKEMIA LYMPHOMA, V43, P461, DOI 10.1080/10428190290011921; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Corcione A, 2006, BLOOD, V107, P367, DOI 10.1182/blood-2005-07-2657; Elkon R, 2003, GENOME RES, V13, P773, DOI 10.1101/gr.947203; Elmadbouh I, 2007, J MOL CELL CARDIOL, V42, P792, DOI 10.1016/j.yjmcc.2007.02.001; Flicek P, 2008, NUCLEIC ACIDS RES, V36, pD707, DOI 10.1093/nar/gkm988; Gangaraju VK, 2009, NAT REV MOL CELL BIO, V10, P116, DOI 10.1038/nrm2621; Ghadge SK, 2011, PHARMACOL THERAPEUT, V129, P97, DOI 10.1016/j.pharmthera.2010.09.011; Ghannam S, 2010, STEM CELL RES THER, V1, DOI 10.1186/scrt2; Hannoush EJ, 2011, J TRAUMA, V71, P283, DOI 10.1097/TA.0b013e318222f380; Honczarenko M, 2006, STEM CELLS, V24, P1030, DOI 10.1634/stemcells.2005-0319; Huang CY, 2011, AM J PHYSIOL-HEART C, V301, pH1496, DOI 10.1152/ajpheart.00365.2011; Jin SZ, 2009, WORLD J GASTROENTERO, V15, P2657, DOI 10.3748/wjg.15.2657; Jung YJ, 2006, STEM CELLS DEV, V15, P687, DOI 10.1089/scd.2006.15.687; Keating A, 2008, CELL STEM CELL, V2, P106, DOI 10.1016/j.stem.2008.01.007; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Lau TT, 2011, EXPERT OPIN BIOL TH, V11, P189, DOI 10.1517/14712598.2011.546338; Li Y, 2007, BIOCHEM BIOPH RES CO, V356, P780, DOI 10.1016/j.bbrc.2007.03.049; Liu Y, 2011, STEM CELLS, V29, P2077, DOI 10.1002/stem.764; Lu MH, 2012, BIOCHEM BIOPH RES CO, V421, P389, DOI 10.1016/j.bbrc.2012.04.027; Martin D, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-12-r101; McIntosh K, 2006, STEM CELLS, V24, P1246, DOI 10.1634/stemcells.2005-0235; Nauta AJ, 2006, J IMMUNOL, V177, P2080, DOI 10.4049/jimmunol.177.4.2080; Petit I, 2002, NAT IMMUNOL, V3, P687, DOI 10.1038/ni813; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Rusca Nicole, 2011, Mol Biol Int, V2011, P437301, DOI 10.4061/2011/437301; Saxena A, 2008, CIRCULATION, V117, P2224, DOI 10.1161/CIRCULATIONAHA.107.694992; Schuh A, 2008, BASIC RES CARDIOL, V103, P69, DOI 10.1007/s00395-007-0685-9; Shamir R, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-232; Swenson ES, 2008, LIVER INT, V28, P308, DOI 10.1111/j.1478-3231.2007.01659.x; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Tang JM, 2010, MOL CELL BIOCHEM, V339, P107, DOI 10.1007/s11010-009-0374-0; Tang Junming, 2008, Interact Cardiovasc Thorac Surg, V7, P767, DOI 10.1510/icvts.2007.169896; Tang JM, 2009, EUR J CARDIO-THORAC, V36, P644, DOI 10.1016/j.ejcts.2009.04.052; Tili E, 2007, J IMMUNOL, V179, P5082, DOI 10.4049/jimmunol.179.8.5082; Ulitsky I, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq570; Wang FF, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-52; Yamaguchi J, 2003, CIRCULATION, V107, P1322, DOI 10.1161/01.CIR.0000055313.77510.22; Yanez R, 2006, STEM CELLS, V24, P2582, DOI 10.1634/stemcells.2006-0228; Zernecke A, 2008, CIRC RES, V102, P209, DOI 10.1161/CIRCRESAHA.107.160697; Zhang M, 2007, FASEB J, V21, P3197, DOI 10.1096/fj.06-6558com; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	44	18	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2013	8	4							e60492	10.1371/journal.pone.0060492	http://dx.doi.org/10.1371/journal.pone.0060492			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130DR	23613728	gold, Green Published, Green Submitted			2022-12-25	WOS:000317893400011
J	Lee, J; Lee, J; Park, MK; Lim, MA; Park, EM; Kim, EK; Yang, EJ; Lee, SY; Jhun, JY; Park, SH; Kim, HY; Cho, ML				Lee, Jaeseon; Lee, Jennifer; Park, Mi-Kyung; Lim, Mi-Ae; Park, Eun-Mi; Kim, Eun-kyung; Yang, Eun-Ji; Lee, Seon-Yeong; Jhun, Joo-Yeon; Park, Sung-Hwan; Kim, Ho-Youn; Cho, Mi-La			Interferon Gamma Suppresses Collagen-Induced Arthritis by Regulation of Th17 through the Induction of Indoleamine-2,3-Deoxygenase	PLOS ONE			English	Article							INDOLEAMINE 2,3-DIOXYGENASE EXPRESSION; TUMOR-INDUCED TOLERANCE; IFN-GAMMA; T-CELLS; TRYPTOPHAN CATABOLISM; RHEUMATOID-ARTHRITIS; SYNOVIAL FIBROBLASTS; IDO EXPRESSION; CUTTING EDGE; MICE	C57BL/6 mice are known to be resistant to the development of collagen-induced arthritis (CIA). However, they show a severe arthritic phenotype when the Ifng gene is deleted. Although it has been proposed that IFN-gamma suppresses inflammation in CIA via suppressing Th17 which is involved in the pathogenesis of CIA, the exact molecular mechanism of the Th17 regulation by IFN-gamma is poorly understood. This study was conducted to 1) clarify that arthritogenic condition of IFN-gamma knockout (KO) mice is dependent on the disinhibition of Th17 and 2) demonstrate that IFN-gamma-induced indoleamine2,3-dioxgenase (IDO) is engaged in the regulation of Th17. The results showed that the IFN-gamma KO mice displayed increased levels of IL-17 producing T cells and the exacerbation of arthritis. Also, production of IL-17 by the splenocytes of the IFN-gamma KO mice was increased when cultured with type II collagen. When Il17 was deleted from the IFN-gamma KO mice, only mild arthritis developed without any progression of the arthritis score. The proportion of CD44(high) CD62L(low) memory-like T cells were elevated in the spleen, draining lymph node and mesenteric lymph node of IFN-c KO CIA mice. Meanwhile, CD44(low) CD62L(high) naive T cells were increased in IFN-gamma and IL-17 double KO CIA mice. When Th17 polarized CD4+ T cells of IFN-gamma KO mice were co-cultured with their own antigen presenting cells (APCs), a greater increase in IL-17 production was observed than in co-culture of the cells from wild type mice. In contrast, when APCs from IFN-gamma KO mice were pretreated with IFN-gamma, there was a significant reduction in IL-17 in the co-culture system. Of note, pretreatment of 1-methyl- DL-tryptophan, a specific inhibitor of IDO, abolished the inhibitory effects of IFN-gamma. Given that IFN-gamma is a potent inducer of IDO in APCs, these results suggest that IDO is involved in the regulation of IL-17 by IFN-gamma.	[Lee, Jaeseon; Lee, Jennifer; Park, Mi-Kyung; Lim, Mi-Ae; Park, Eun-Mi; Kim, Eun-kyung; Yang, Eun-Ji; Lee, Seon-Yeong; Jhun, Joo-Yeon; Park, Sung-Hwan; Kim, Ho-Youn; Cho, Mi-La] Catholic Univ Korea, Catholic Res Inst Med Sci, Rheumatism Res Ctr, Seoul, South Korea	Catholic University of Korea	Cho, ML (corresponding author), Catholic Univ Korea, Catholic Res Inst Med Sci, Rheumatism Res Ctr, Seoul, South Korea.	iammila@catholic.ac.kr			National Research Foundation (NRF); Korean government (MEST) [2012M3A9C6049783]	National Research Foundation (NRF); Korean government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This research was supported by the Bio & Medical Technology Development Program of the National Research Foundation (NRF) and funded by the Korean government (MEST) (No. 2012M3A9C6049783). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beutelspacher SC, 2006, AM J TRANSPLANT, V6, P1320, DOI 10.1111/j.1600-6143.2006.01324.x; Chen SY, 2011, HUM GENE THER, V22, P145, DOI 10.1089/hum.2009.217; Chen WJ, 2011, NAT IMMUNOL, V12, P809, DOI 10.1038/ni.2088; Chu CQ, 2007, ARTHRITIS RHEUM, V56, P1145, DOI 10.1002/art.22453; Chu CQ, 2003, ANN RHEUM DIS, V62, P983, DOI 10.1136/ard.62.10.983; Criado G, 2009, ARTHRITIS RHEUM-US, V60, P1342, DOI 10.1002/art.24446; Curti A, 2009, BLOOD, V113, P2394, DOI 10.1182/blood-2008-07-144485; Ferber IA, 1996, J IMMUNOL, V156, P5; Guedez YB, 2001, ARTHRITIS RHEUM, V44, P2413, DOI 10.1002/1529-0131(200110)44:10<2413::AID-ART406>3.0.CO;2-E; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Ikemoto T, 2013, PANCREAS, V42, P130, DOI 10.1097/MPA.0b013e3182575e4a; Inglis JJ, 2008, NAT PROTOC, V3, P612, DOI 10.1038/nprot.2008.19; Irmler I, 2007, Z RHEUMATOL, V66, P17; Kelchtermans H, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2787; LEMMEL EM, 1988, RHEUMATOL INT, V8, P87, DOI 10.1007/BF00271840; ManourySchwartz B, 1997, J IMMUNOL, V158, P5501; Mellor AL, 2003, J IMMUNOL, V171, P1652, DOI 10.4049/jimmunol.171.4.1652; Mellor AL, 2004, NAT REV IMMUNOL, V4, P762, DOI 10.1038/nri1457; Munn DH, 2007, J CLIN INVEST, V117, P1147, DOI 10.1172/JCI31178; Munn DH, 2006, CURR OPIN IMMUNOL, V18, P220, DOI 10.1016/j.coi.2006.01.002; Munn DH, 2005, IMMUNITY, V22, P633, DOI 10.1016/j.immuni.2005.03.013; Munn DH, 1999, J EXP MED, V189, P1363, DOI 10.1084/jem.189.9.1363; Murphy WJ, 1998, J CLIN INVEST, V102, P1742, DOI 10.1172/JCI3906; Odemuyiwa SO, 2004, J IMMUNOL, V173, P5909, DOI 10.4049/jimmunol.173.10.5909; Page CE, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2960; Park MK, 2011, EXP MOL MED, V43, P446, DOI 10.3858/emm.2011.43.8.050; Sarkar S, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2838; Schroecksnadel K, 2006, CLIN RHEUMATOL, V25, P334, DOI 10.1007/s10067-005-0056-6; Schurgers E, 2011, J INTERF CYTOK RES, V31, P917, DOI 10.1089/jir.2011.0056; Sun JY, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-82; TAKAHASHI N, 1986, J IMMUNOL, V137, P3544; Wainwright DA, 2012, CLIN CANCER RES, V18, P6110, DOI 10.1158/1078-0432.CCR-12-2130; Wang SH, 1999, EUR J IMMUNOL, V29, P3782, DOI 10.1002/(SICI)1521-4141(199911)29:11<3782::AID-IMMU3782>3.0.CO;2-B; Wang ZJ, 2006, J CLIN INVEST, V116, P2434, DOI 10.1172/JCI25826; Yadav MC, 2007, GLIA, V55, P1385, DOI 10.1002/glia.20544; Yan YP, 2010, J IMMUNOL, V185, P5953, DOI 10.4049/jimmunol.1001628; Yang XP, 2011, NAT IMMUNOL, V12, P247, DOI 10.1038/ni.1995; Zhang HL, 2012, J NEUROIMMUNOL, V246, P18, DOI 10.1016/j.jneuroim.2012.02.011	38	42	46	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2013	8	4							e60900	10.1371/journal.pone.0060900	http://dx.doi.org/10.1371/journal.pone.0060900			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130DR	23613752	Green Submitted, Green Published, gold			2022-12-25	WOS:000317893400026
J	Miaskowski, C; Dodd, M; Paul, SM; West, C; Hamolsky, D; Abrams, G; Cooper, BA; Elboim, C; Neuhaus, J; Schmidt, BL; Smoot, B; Aouizerat, BE				Miaskowski, Christine; Dodd, Marylin; Paul, Steven M.; West, Claudia; Hamolsky, Deborah; Abrams, Gary; Cooper, Bruce A.; Elboim, Charles; Neuhaus, John; Schmidt, Brian L.; Smoot, Betty; Aouizerat, Bradley E.			Lymphatic and Angiogenic Candidate Genes Predict the Development of Secondary Lymphedema following Breast Cancer Surgery	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; ANTIINFLAMMATORY CYTOKINE GENES; RISK-FACTORS; TRANSCRIPTION FACTOR; SLEEP DISTURBANCE; EARLY-DIAGNOSIS; VEGF-D; MUTATIONS; FOXC2; NEUROPILINS	The purposes of this study were to evaluate for differences in phenotypic and genotypic characteristics in women who did and did not develop lymphedema (LE) following breast cancer treatment. Breast cancer patients completed a number of self-report questionnaires. LE was evaluated using bioimpedance spectroscopy. Genotyping was done using a custom genotyping array. No differences were found between patients with (n = 155) and without LE (n = 387) for the majority of the demographic and clinical characteristics. Patients with LE had a significantly higher body mass index, more advanced disease and a higher number of lymph nodes removed. Genetic associations were identified for four genes (i.e., lymphocyte cytosolic protein 2 (rs315721), neuropilin-2 (rs849530), protein tyrosine kinase (rs158689), vascular cell adhesion molecule 1 (rs3176861)) and three haplotypes (i.e., Forkhead box protein C2 (haplotype A03), neuropilin-2 (haplotype F03), vascular endothelial growth factor-C (haplotype B03)) involved in lymphangiogensis and angiogenesis. These genetic associations suggest a role for a number of lymphatic and angiogenic genes in the development of LE following breast cancer treatment.	[Miaskowski, Christine; Dodd, Marylin; Paul, Steven M.; West, Claudia] Univ Calif San Francisco, Dept Physiol Nursing, San Francisco, CA 94143 USA; [Hamolsky, Deborah] Univ Calif San Francisco, Dept Physiol Nursing, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA USA; [Abrams, Gary] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA; [Cooper, Bruce A.] Univ Calif San Francisco, Dept Community Hlth Syst, San Francisco, CA USA; [Elboim, Charles] Redwood Reg Med Grp, Santa Rosa, CA USA; [Neuhaus, John] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Schmidt, Brian L.] NYU, Dept Oral & Maxillofacial Surg, New York, NY USA; [Smoot, Betty] Univ Calif San Francisco, Dept Phys Therapy & Rehabil Sci, San Francisco, CA USA; [Aouizerat, Bradley E.] Univ Calif San Francisco, Inst Human Genet, Dept Physiol Nursing, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; New York University; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Miaskowski, C (corresponding author), Univ Calif San Francisco, Dept Physiol Nursing, San Francisco, CA 94143 USA.	chris.miaskowski@nursing.ucsf.edu	Paul, Steve/ABE-5400-2020	Schmidt, Brian/0000-0002-2409-8984	National Cancer Institute [CA107091, CA118658]; National Institute of Nursing Research [NR0101282]; National Institutes of Health (NIH) Roadmap for Medical Research Grant [KL2 RR624130]; NIH/NCRR UCSF-CTSI Grant [UL1 RR024131]; NATIONAL CANCER INSTITUTE [R01CA118658, R01CA107091] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024131] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Nursing Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); National Institutes of Health (NIH) Roadmap for Medical Research Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NCRR UCSF-CTSI Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This study was funded by grants from the National Cancer Institute (CA107091 and CA118658) and the National Institute of Nursing Research (NR0101282). Dr. Miaskowski is an American Cancer Society Clinical Research Professor. Dr. Bradley Aouizerat was funded through the National Institutes of Health (NIH) Roadmap for Medical Research Grant (KL2 RR624130). This project was supported by NIH/NCRR UCSF-CTSI Grant Number UL1 RR024131. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abtahian F, 2003, SCIENCE, V299, P247, DOI 10.1126/science.1079477; Achen MG, 1998, P NATL ACAD SCI USA, V95, P548, DOI 10.1073/pnas.95.2.548; Ahmed RL, 2011, BREAST CANCER RES TR, V130, P981, DOI 10.1007/s10549-011-1667-z; Alitalo K, 2011, NAT MED, V17, P1371, DOI 10.1038/nm.2545; Armer JM, 2010, CANCER EPIDEM BIOMAR, V19, P2715, DOI 10.1158/1055-9965.EPI-10-0962; Bagri A, 2009, CLIN CANCER RES, V15, P1860, DOI 10.1158/1078-0432.CCR-08-0563; Bell R, 2001, HUM GENET, V108, P546, DOI 10.1007/s004390100528; Brunner F, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-92; Butler MG, 2009, BIRTH DEFECTS RES C, V87, P222, DOI 10.1002/bdrc.20155; Chen CY, 2005, WORLD J SURG, V29, P271, DOI 10.1007/s00268-004-7818-1; Cieza Alarcos, 2006, BMC Med Res Methodol, V6, P36, DOI 10.1186/1471-2288-6-36; Conde L, 2006, NUCLEIC ACIDS RES, V34, pW621, DOI 10.1093/nar/gkl071; Connell F, 2008, ANN NY ACAD SCI, V1131, P140, DOI 10.1196/annals.1413.013; Cornish BH, 2001, LYMPHOLOGY, V34, P2; Cornish BH, 2000, ANN NY ACAD SCI, V904, P571; Dagenais SL, 2004, GENE EXPR PATTERNS, V4, P611, DOI 10.1016/j.modgep.2004.07.004; Dhruva A, 2012, J PAIN SYMPTOM MANAG, V44, P215, DOI 10.1016/j.jpainsymman.2011.08.010; Dominick SA, 2012, J CANC SURVIV; Fang JM, 2000, AM J HUM GENET, V67, P1382, DOI 10.1086/316915; Ferrell Robert E., 2008, Lymphatic Research and Biology, V6, P69, DOI 10.1089/lrb.2007.1022; Finegold DN, 2012, CLIN CANCER RES, V18, P2382, DOI 10.1158/1078-0432.CCR-11-2303; Finegold David N., 2008, Lymphatic Research and Biology, V6, P65, DOI 10.1089/lrb.2008.1524; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Ghalamkarpour A, 2009, J MED GENET, V46, P399, DOI 10.1136/jmg.2008.064469; Hajjami HME, 2008, HISTOCHEM CELL BIOL, V130, P1063, DOI 10.1007/s00418-008-0525-5; Halder I, 2008, HUM MUTAT, V29, P648, DOI 10.1002/humu.20695; Hattersley AT, 2005, LANCET, V366, P1315, DOI 10.1016/S0140-6736(05)67531-9; Hayes S, 2005, BREAST CANCER RES TR, V89, P221, DOI 10.1007/s10549-004-2045-x; Hoggart CJ, 2003, AM J HUM GENET, V72, P1492, DOI 10.1086/375613; Illi J, 2012, CYTOKINE, V58, P437, DOI 10.1016/j.cyto.2012.02.015; Irrthum A, 2003, AM J HUM GENET, V72, P1470, DOI 10.1086/375614; Joukov V, 1996, EMBO J, V15, P290; Jurisic G, 2009, CELL TISSUE RES, V335, P97, DOI 10.1007/s00441-008-0644-2; Karkkainen MJ, 2001, P NATL ACAD SCI USA, V98, P12677, DOI 10.1073/pnas.221449198; Karnofsky D, 1977, PERFORMANCE SCALE; KARNOFSKY DA, 1948, CANCER-AM CANCER SOC, V1, P634, DOI 10.1002/1097-0142(194811)1:4<634::AID-CNCR2820010410>3.0.CO;2-L; Karpanen T, 2006, FASEB J, V20, P1462, DOI 10.1096/fj.05-5646com; Kerjaschki D, 2004, J AM SOC NEPHROL, V15, P603, DOI 10.1097/01.ASN.0000113316.52371.2E; Kwan ML, 2010, ARCH SURG-CHICAGO, V145, P1055, DOI 10.1001/archsurg.2010.231; Lee J, 1996, P NATL ACAD SCI USA, V93, P1988, DOI 10.1073/pnas.93.5.1988; MacLean Charles D, 2006, BMC Fam Pract, V7, P50, DOI 10.1186/1471-2296-7-50; McCann B, 2012, J PAIN, V13, P425, DOI 10.1016/j.jpain.2011.02.358; Mellor RH, 2007, CIRCULATION, V115, P1912, DOI 10.1161/CIRCULATIONAHA.106.675348; Miaskowski C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040560; Michael S, 2011, BREAST CANCER-TOKYO, V18, P174, DOI 10.1007/s12282-010-0246-1; Norman SA, 2010, CANCER EPIDEM BIOMAR, V19, P2734, DOI 10.1158/1055-9965.EPI-09-1245; Olszewski Waldemar L, 2003, Lymphat Res Biol, V1, P235, DOI 10.1089/153968503768330265; Orlandini M, 1996, P NATL ACAD SCI USA, V93, P11675, DOI 10.1073/pnas.93.21.11675; Petrova TV, 2004, NAT MED, V10, P974, DOI 10.1038/nm1094; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Rockson Stanley G., 2009, Lymphatic Research and Biology, V7, P97, DOI 10.1089/lrb.2009.7202; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; Saito Y, 2006, CIRCULATION, V114, P1177, DOI 10.1161/CIRCULATIONAHA.105.602953; Sangha O, 2003, ARTHRIT RHEUM-ARTHR, V49, P156, DOI 10.1002/art.10993; Schulte-Merker S, 2011, J CELL BIOL, V193, P607, DOI 10.1083/jcb.201012094; Sebzda E, 2006, DEV CELL, V11, P349, DOI 10.1016/j.devcel.2006.07.007; Smith SK, 2009, CANCER-AM CANCER SOC, V115, P3312, DOI 10.1002/cncr.24391; SPSS, 2010, IBM SPSS WIND VERS 1; StataCorp, 2005, STAT STAT SOFTW REL; Staton CA, 2007, J PATHOL, V212, P237, DOI 10.1002/path.2182; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Tammela T, 2010, CELL, V140, P460, DOI 10.1016/j.cell.2010.01.045; Tian C, 2008, HUM MOL GENET, V17, pR143, DOI 10.1093/hmg/ddn268; Traboulsi EI, 2002, AM J OPHTHALMOL, V134, P592, DOI 10.1016/S0002-9394(02)01642-2; Wang YD, 2010, GENE DEV, V24, P2115, DOI 10.1101/gad.1955910; Yamada Y, 1997, GENOMICS, V42, P483, DOI 10.1006/geno.1997.4774; Yuan L, 2002, DEVELOPMENT, V129, P4797	67	68	71	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2013	8	4							e60164	10.1371/journal.pone.0060164	http://dx.doi.org/10.1371/journal.pone.0060164			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130DR	23613720	Green Published, gold			2022-12-25	WOS:000317893400007
J	Clitherow, LR; Carrivick, JL; Brown, LE				Clitherow, Leonie R.; Carrivick, Jonathan L.; Brown, Lee E.			Food Web Structure in a Harsh Glacier-Fed River	PLOS ONE			English	Article							MACROINVERTEBRATE COMMUNITY STRUCTURE; ORGANIC-MATTER; BODY-SIZE; BENTHIC ALGAE; FRESH-WATERS; STREAM; ECOSYSTEM; VISUALIZATION; BIODIVERSITY; ASSEMBLAGES	Glacier retreat is occurring across the world, and associated river ecosystems are expected to respond more rapidly than those in flowing waters in other regions. The river environment directly downstream of a glacier snout is characterised by extreme low water temperature and unstable channel sediments but these habitats may become rarer with widespread glacier retreat. In these extreme environments food web dynamics have been little studied, yet they could offer opportunities to test food web theories using highly resolved food webs owing to their low taxonomic richness. This study examined the interactions of macroinvertebrate and diatom taxa in the Odenwinkelkees river, Austrian central Alps between 2006 and 2011. The webs were characterised by low taxon richness (13-22), highly connected individuals (directed connectance up to 0.19) and short mean food chain length (2.00-2.36). The dominant macroinvertebrates were members of the Chironomidae genus Diamesa and had an omnivorous diet rich in detritus and diatoms as well as other Chironomidae. Simuliidae (typically detritivorous filterers) had a diet rich in diatoms but also showed evidence of predation on Chironomidae larvae. Food webs showed strong species-averaged and individual size structuring but mass-abundance scaling coefficients were larger than those predicted by metabolic theory, perhaps due to a combination of spatial averaging effects of patchily distributed consumers and resources, and/or consumers deriving unquantified resources from microorganisms attached to the large amounts of ingested rock fragments. Comparison of food web structural metrics with those from 62 published river webs suggest these glacier-fed river food web properties were extreme but in line with general food web scaling predictions, a finding which could prove useful to forecast the effects of anticipated future glacier retreat on the structure of aquatic food webs.	[Clitherow, Leonie R.] Univ Leeds, Fac Biol Sci Water Leeds, Leeds, W Yorkshire, England; [Carrivick, Jonathan L.; Brown, Lee E.] Univ Leeds, Sch Geog Water Leeds, Leeds, W Yorkshire, England	University of Leeds; University of Leeds	Brown, LE (corresponding author), Univ Leeds, Sch Geog Water Leeds, Leeds, W Yorkshire, England.	l.brown@leeds.ac.uk		Carrivick, Jonathan/0000-0002-9286-5348; Brown, Lee/0000-0002-2420-0088	Santander Full Fee Masters Scholarship; Royal Society [2006/R4]; Royal Geographical Society-Institute of British Geographers; Royal Institute of Chartered Surveyors [GFG 39/08]; University of Leeds Academic Fund for Learning and Teaching	Santander Full Fee Masters Scholarship; Royal Society(Royal Society of London); Royal Geographical Society-Institute of British Geographers; Royal Institute of Chartered Surveyors; University of Leeds Academic Fund for Learning and Teaching	LRC was funded by the Santander Full Fee Masters Scholarship. Field work funding was provided to LEB by the Royal Society (International Outgoing Grant 2006/R4) and to LEB and JLC by the Royal Geographical Society-Institute of British Geographers with the Royal Institute of Chartered Surveyors (GFG 39/08) and the University of Leeds Academic Fund for Learning and Teaching (2008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation or the manuscript.	Batagelj V, 2004, MATH VIS, P77; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Brown LE, 2003, ARCT ANTARCT ALP RES, V35, P313, DOI 10.1657/1523-0430(2003)035[0313:ASHCAA]2.0.CO;2; Brown LE, 2007, GLOBAL CHANGE BIOL, V13, P958, DOI 10.1111/j.1365-2486.2007.01341.x; Brown LE, 2012, GLOBAL CHANGE BIOL, V18, P2195, DOI 10.1111/j.1365-2486.2012.02675.x; Brown LE, 2011, J ANIM ECOL, V80, P884, DOI 10.1111/j.1365-2656.2011.01814.x; Cadbury SL, 2008, RIVER RES APPL, V24, P68, DOI 10.1002/rra.1048; Carrivick JL, GEOMORPHOLOGY; CLOSS GP, 1994, ECOL MONOGR, V64, P1, DOI 10.2307/2937053; Cohen JE, 2009, P NATL ACAD SCI USA, V106, P22335, DOI 10.1073/pnas.0910582106; DAVIES RW, 1970, CAN J ZOOLOG, V48, P519, DOI 10.1139/z70-087; De Nooy W., 2005, EXPLORATORY SOCIAL N; Dickson NE, 2012, J HYDROL, V464, P505, DOI 10.1016/j.jhydrol.2012.07.044; Dunne JA, 2002, P NATL ACAD SCI USA, V99, P12917, DOI 10.1073/pnas.192407699; Epler JH, 2001, IDENTIFICATION MANUA; Fureder L, 2003, INT REV HYDROBIOL, V88, P314, DOI 10.1002/iroh.200390028; Fureder L, 2001, FRESHWATER BIOL, V46, P1673, DOI 10.1046/j.1365-2427.2001.00862.x; Gesierich Doris, 2004, Berichte des Naturwissenschaftlich-Medizinischen Vereins in Innsbruck, V91, P7; Gilljam D, 2011, ADV ECOL RES, V45, P67, DOI 10.1016/B978-0-12-386475-8.00003-4; Hall RO, 2000, ECOLOGY, V81, P3445, DOI 10.1890/0012-9658(2000)081[3445:OMFISF]2.0.CO;2; Hannah DM, 2007, AQUAT CONSERV, V17, P636, DOI 10.1002/aqc.800; Hieber M, 2001, ARCT ANTARCT ALP RES, V33, P447, DOI 10.2307/1552555; Hillebrand H, 1999, J PHYCOL, V35, P403, DOI 10.1046/j.1529-8817.1999.3520403.x; Hodson A, 2008, ECOL MONOGR, V78, P41, DOI 10.1890/07-0187.1; Hudson LN, 2013, METHODS ECOL EVOL, V4, P99, DOI 10.1111/2041-210X.12005; Ilg C, 2006, FRESHWATER BIOL, V51, P840, DOI 10.1111/j.1365-2427.2006.01533.x; Ings TC, 2009, J ANIM ECOL, V78, P253, DOI 10.1111/j.1365-2656.2008.01460.x; Jaarsma NG, 1998, NEW ZEAL J MAR FRESH, V32, P271, DOI 10.1080/00288330.1998.9516825; Jacobsen D, 2012, NAT CLIM CHANGE, V2, P361, DOI [10.1038/nclimate1435, 10.1038/NCLIMATE1435]; Jonsson T, 2005, ADV ECOL RES, V36, P1, DOI 10.1016/S0065-2504(05)36001-6; Krammer K, 2007, SUSSWASSERFLORA MITT; Krammer K, 2007, SUSSWASSERFLORA MITT; Krammer K, 2004, SUSSWASSERFLORA MITT; Krammer K, 2008, BACILLARIOPHYCEAE, V2; KREBS C J, 1972, P694; Lavandier P., 1983, P81; Layer K, 2010, ADV ECOL RES, V42, P265, DOI 10.1016/S0065-2504(10)42005-X; Ledger ME, NATURE CLIMATE CHANG; Lods-Crozet B, 2001, FRESHWATER BIOL, V46, P1641, DOI 10.1046/j.1365-2427.2001.00850.x; Logue JB, 2004, LIMNOL OCEANOGR, V49, P2001, DOI 10.4319/lo.2004.49.6.2001; Maiolini B, 2001, FRESHWATER BIOL, V46, P1625, DOI 10.1046/j.1365-2427.2001.00849.x; Milner AM, 2009, HYDROL PROCESS, V23, P62, DOI 10.1002/hyp.7197; MILNER AM, 1994, FRESHWATER BIOL, V32, P295, DOI 10.1111/j.1365-2427.1994.tb01127.x; Milner AM, 2001, FRESHWATER BIOL, V46, P1833, DOI 10.1046/j.1365-2427.2001.00861.x; Muhlfeld CC, 2011, CLIMATIC CHANGE, V106, P337, DOI 10.1007/s10584-011-0057-1; Neutel AM, 2007, NATURE, V449, P599, DOI 10.1038/nature06154; NOLTE U, 1990, FRESHWATER BIOL, V24, P443, DOI 10.1111/j.1365-2427.1990.tb00723.x; O'Gorman EJ, 2012, ADV ECOL RES, V47, P81, DOI 10.1016/B978-0-12-398315-2.00002-8; Parker SM, 2006, FRESHWATER BIOL, V51, P1249, DOI 10.1111/j.1365-2427.2006.01567.x; Pederson GT, 2010, CLIMATIC CHANGE, V98, P133, DOI 10.1007/s10584-009-9642-y; Petchey OL, 1999, NATURE, V402, P69, DOI 10.1038/47023; PIMM SL, 1982, FOOD WEBS; PLATT T, 1977, HELGOLAND WISS MEER, V30, P575, DOI 10.1007/BF02207862; Post DM, 2002, TRENDS ECOL EVOL, V17, P269, DOI 10.1016/S0169-5347(02)02455-2; Rall BC, 2012, PHILOS T R SOC B, V367, P2923, DOI 10.1098/rstb.2012.0242; Robinson CT, 2001, FRESHWATER BIOL, V46, P1663, DOI 10.1046/j.1365-2427.2001.00851.x; ROCHA O, 1985, J PLANKTON RES, V7, P279, DOI 10.1093/plankt/7.2.279; Rott E, 2006, HYDROBIOLOGIA, V562, P195, DOI 10.1007/s10750-005-1811-z; Round FE, 2007, DIATOMS BIOL MORPHOL; Sabo JL, 2010, SCIENCE, V330, P965, DOI 10.1126/science.1196005; SCHMID P. E., 1993, WASSER ABWASSER S3, V93, P1; Schmid-Araya JM, 2002, ECOLOGY, V83, P1271, DOI 10.1890/0012-9658(2002)083[1271:TIOMIF]2.0.CO;2; Seitz G, 1998, BAYERISCHES LANDESAM, V77, P140; Sharp M, 1999, GEOLOGY, V27, P107, DOI 10.1130/0091-7613(1999)027<0107:WBPAGB>2.3.CO;2; SICKOGOAD LM, 1984, LIMNOL OCEANOGR, V29, P1170, DOI 10.4319/lo.1984.29.6.1170; SMOCK LA, 1980, FRESHWATER BIOL, V10, P375, DOI 10.1111/j.1365-2427.1980.tb01211.x; Snook DL, 2001, FRESHWATER BIOL, V46, P1609, DOI 10.1046/j.1365-2427.2001.00848.x; Stephens D.W., 1986, pi; Straile D, 2005, AQUATIC FOOD WEBS: AN ECOSYSTEM APPROACH, P41; Sun J, 2003, J PLANKTON RES, V25, P1331, DOI 10.1093/plankt/fbg096; Thompson RM, 2005, OIKOS, V108, P137, DOI 10.1111/j.0030-1299.2005.11600.x; Thompson RM, 2003, ECOLOGY, V84, P145, DOI 10.1890/0012-9658(2003)084[0145:IOSFWO]2.0.CO;2; Thompson RM, 2012, FRESHWATER BIOL, V57, P1329, DOI 10.1111/j.1365-2427.2012.02808.x; Townsend CR, 1998, ECOL LETT, V1, P200; Tscherko D, 2003, EUR J SOIL SCI, V54, P685, DOI 10.1046/j.1351-0754.2003.0570.x; WARD JV, 1994, FRESHWATER BIOL, V32, P277, DOI 10.1111/j.1365-2427.1994.tb01126.x; WARINGER J, 1997, ATLAS OSTERREICHISCH; Williams RJ, 2002, P NATL ACAD SCI USA, V99, P12913, DOI 10.1073/pnas.192448799; Winterbourn MJ, 2008, HYDROBIOLOGIA, V603, P211, DOI 10.1007/s10750-007-9273-0; Woodward G, 2005, AQUATIC FOOD WEBS: AN ECOSYSTEM APPROACH, P51; Woodward G, 2005, ADV ECOL RES, V36, P85, DOI 10.1016/S0065-2504(05)36002-8; Woodward G, 2001, J ANIM ECOL, V70, P273, DOI 10.1046/j.1365-2656.2001.00497.x; Woodward G, 2012, PHILOS T R SOC B, V367, P2990, DOI 10.1098/rstb.2012.0245; Woodward G, 2010, ADV ECOL RES, V42, P71, DOI 10.1016/S0065-2504(10)42002-4; Woodward G, 2009, FRESHWATER BIOL, V54, P2171, DOI 10.1111/j.1365-2427.2008.02081.x; Woodward Guy, 2007, P98, DOI 10.1017/CBO9780511611223.007; Yoon I, 2004, P SOC PHOTO-OPT INS, V5295, P124, DOI 10.1117/12.526956; Yvon-Durocher G, 2008, CENT EUR J BIOL, V3, P91, DOI 10.2478/s11535-008-0004-y; Zah R, 2001, FRESHWATER BIOL, V46, P1597, DOI 10.1046/j.1365-2427.2001.00847.x; Zah R, 2001, FRESHWATER BIOL, V46, P871, DOI 10.1046/j.1365-2427.2001.00720.x	90	40	41	2	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2013	8	4							e60899	10.1371/journal.pone.0060899	http://dx.doi.org/10.1371/journal.pone.0060899			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125TD	23613751	gold, Green Submitted, Green Published			2022-12-25	WOS:000317563300010
J	Lee, CS; Gregson, DB; Church, D; Laupland, KB; Eckhardt, R; Ross, T; Chan, W; Pillai, DR				Lee, Clara S.; Gregson, Daniel B.; Church, Deirdre; Laupland, Kevin B.; Eckhardt, Rose; Ross, Terry; Chan, Wilson; Pillai, Dylan R.			Population-Based Laboratory Surveillance of Imported Malaria in Metropolitan Calgary, 2000-2011	PLOS ONE			English	Article							CHEMOPROPHYLAXIS; TRAVELERS	Increased travel leads to a heightened risk of imported infectious diseases. Patterns of immigration to countries like Canada have changed such that countries of malaria endemicity are frequented in larger numbers. In keeping with the changes in travel patterns and immigration, the major metropolitan city of Calgary has seen a dramatic rise in malaria incidence over the last decade. Fuelling this rise in Calgary has been the apparent complacence with prophylaxis in individuals visiting friends and relatives and potentially inadequate public health intervention in areas of the city with increased immigration and lower socioeconomic status.	[Lee, Clara S.; Gregson, Daniel B.; Church, Deirdre; Laupland, Kevin B.; Ross, Terry; Chan, Wilson; Pillai, Dylan R.] Calgary Lab Serv, Calgary, AB, Canada; [Gregson, Daniel B.; Church, Deirdre; Chan, Wilson; Pillai, Dylan R.] Univ Calgary, Dept Pathol & Lab Med & Med, Calgary, AB, Canada; [Gregson, Daniel B.; Church, Deirdre; Laupland, Kevin B.; Pillai, Dylan R.] Univ Calgary, Dept Microbiol Immunol & Infect Dis, Calgary, AB, Canada; [Eckhardt, Rose] St Michaels Hosp, Li Ka Shing Knowledge Inst, Keenan Res Ctr, Toronto, ON M5B 1W8, Canada	University of Calgary; University of Calgary; University of Calgary; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto	Pillai, DR (corresponding author), Calgary Lab Serv, Calgary, AB, Canada.	drpillai@ucalgary.ca	Laupland, Kevin/AAG-3656-2020; Laupland, kevin/AAJ-6339-2020	Laupland, kevin/0000-0002-1205-5354	Calgary Laboratory Services	Calgary Laboratory Services	Funding for this study was provided by Calgary Laboratory Services (DRP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bacaner N, 2004, JAMA-J AM MED ASSOC, V291, P2856, DOI 10.1001/jama.291.23.2856; Checkley AM, 2012, BMJ-BRIT MED J, V27, P344; Church DL, 2003, ARCH PATHOL LAB MED, V127, P687; Citizenship and Immigration Canada, 2011, SUMM TABL PERM TEMP; Eckhardt R, 2012, EMERG INFECT DIS, V18, P775, DOI 10.3201/eid1805.110602; Farcas GA, 2003, AM J TROP MED HYG, V69, P589, DOI 10.4269/ajtmh.2003.69.6.0690589; Joshi MS, 2010, ETHNIC HEALTH, V15, P365, DOI 10.1080/13557851003729098; Loutan L, 2003, INT J ANTIMICROB AG, V21, P158, DOI 10.1016/S0924-8579(02)00367-9; MacLean JD, 2004, EMERG INFECT DIS, V10, P1195; MacMullin G, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-148; Mali Sonja, 2012, Morbidity and Mortality Weekly Report, V61, P1; Monge-Maillo B, 2012, MEDITERR J HEMATOL I, V4, DOI 10.4084/MJHID.2012.014; Muentener P, 1999, B WORLD HEALTH ORGAN, V77, P560; Nilles EJ, 2012, AM J EMERG MED, V30, P972, DOI 10.1016/j.ajem.2011.06.016; Millet JP, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-56; Pistone T, 2007, T ROY SOC TROP MED H, V101, P990, DOI 10.1016/j.trstmh.2007.05.009; Public Health Agency of Canada, 2009, CAN REC PREV TREAT S, V35S1; Romi R, 2001, J TRAVEL MED, V8, P6, DOI 10.2310/7060.2001.5140; Schlagenhauf P, 2008, CLIN MICROBIOL REV, V21, P466, DOI 10.1128/CMR.00059-07; Schlagenhauf P, 2010, CLIN INFECT DIS, V50, P826, DOI 10.1086/650575; Shahinas D, 2010, EMERG INFECT DIS, V16, P1608, DOI [10.3201/eid1610.100427, 10.3201/eid1610.100116]; Shokoples SE, 2009, J CLIN MICROBIOL, V47, P975, DOI 10.1128/JCM.01858-08; Statistics Canada, 2011, CENS POP DWELL COUNT; Statistics Canada, POP DWELL COUNTS CAN; Wesolowski A, 2012, SCIENCE, V338, P267, DOI 10.1126/science.1223467; World health organization (WHO), 2013, GUID TREATM MAL	26	20	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2013	8	4							e60751	10.1371/journal.pone.0060751	http://dx.doi.org/10.1371/journal.pone.0060751			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125TD	23613742	Green Published, gold			2022-12-25	WOS:000317563300007
J	Anagrius, C; Lore, B; Jensen, JS				Anagrius, Carin; Lore, Britta; Jensen, Jorgen Skov			Treatment of Mycoplasma genitalium. Observations from a Swedish STD Clinic	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; NONGONOCOCCAL URETHRITIS; AZITHROMYCIN; WOMEN; ASSOCIATION; PERSISTENCE; PREVALENCE; CERVICITIS; INFECTION; CHLAMYDIA	Objectives: To evaluate therapy for Mycoplasma genitalium infection with doxycycline or azithromycin 1 g compared to five days of azithromycin (total dose 1.5 g). Methods: A retrospective case study was performed among patients attending the STD-clinic in Falun, Sweden 1998-2005. All patients with a positive PCR test for M. genitalium were routinely offered a test of cure (toc). Response to doxycycline for 9 days, azithromycin 1 g single dose and extended azithromycin (500 mg on day 1 followed by 250 mg o.d. for 4 days) was determined. In patients with treatment failure after azithromycin, macrolide resistance was monitored before and after treatment. Furthermore, the rate of macrolide resistance was monitored for positive specimens available from 2006-2011. Results: The eradication rate after doxycycline was 43% (48% for women and 38% for men), for azithromycin 1 g 91% (96% for women and 88% for men) and for extended azithromycin 99% (100% for women and 93% for men). Macrolide resistance developed in 7/7 examined (100%) of those testing positive after azithromycin 1 g, but in none of those treated with extended azithromycin. Macrolide resistance before treatment increased from 0% in 2006 and 2007 to 18% in 2011. Conclusions: These findings confirm the results from other studies showing that doxycycline is inefficient in eradicating M. genitalium. Although azithromycin 1 g was not significantly less efficient than extended dosage, it was associated with selection of macrolide resistant M. genitalium strains and should not be used as first line therapy for M. genitalium. Monitoring of M. genitalium macrolide resistance should be encouraged.	[Anagrius, Carin] Falu Lasarett, Dept Venereol, Falun, Sweden; [Lore, Britta] Falu Lasarett, Dept Clin Microbiol, Falun, Sweden; [Jensen, Jorgen Skov] Statens Serum Inst, DK-2300 Copenhagen, Denmark	Falun Hospital; Falun Hospital; Statens Serum Institut	Anagrius, C (corresponding author), Falu Lasarett, Dept Venereol, Falun, Sweden.	carin.anagrius@telia.com	Jensen, Jørgen Skov/H-5159-2019	Jensen, Jørgen Skov/0000-0002-7464-7435	Centre for Clinical research, County Council of Dalarna	Centre for Clinical research, County Council of Dalarna	The Centre for Clinical research, County Council of Dalarna. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anagrius C, 2005, SEX TRANSM INFECT, V81, P458, DOI 10.1136/sti.2004.012062; Andersen B, 2007, SEX TRANSM INFECT, V83, P237, DOI 10.1136/sti.2006.022970; Bjornelius E, 2007, SEX TRANSM INFECT, V84, P72, DOI [10.1136/ti.2007.027375, 10.1136/sti.2007.027375]; Bradshaw CS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003618; Cohen CR, 2005, SEX TRANSM INFECT, V81, P463, DOI 10.1136/sti.2005.015701; Cohen CR, 2002, LANCET, V359, P765, DOI 10.1016/S0140-6736(02)07848-0; Falk L, 2005, SEX TRANSM INFECT, V81, P73, DOI 10.1136/sti.2004.010439; Falk L, 2003, SEX TRANSM INFECT, V79, P318, DOI 10.1136/sti.79.4.318; FitzGerald M, 1996, INT J STD AIDS, V7, P298, DOI 10.1258/0956462961917861; Gesink DC, 2012, INT J CIRCUMPOL HEAL, V71, DOI 10.3402/ijch.v71i0.18203; Hamasuna R, 2011, SEX TRANSM INFECT, V87, pA302, DOI 10.1136/sextrans-2011-050108.492; Hamasuna R, 2009, ANTIMICROB AGENTS CH, V53, P4938, DOI 10.1128/AAC.00724-09; Hjorth SV, 2006, J CLIN MICROBIOL, V44, P2078, DOI 10.1128/JCM.00003-06; Jensen JS, 2008, CLIN INFECT DIS, V47, P1546, DOI 10.1086/593188; JENSEN JS, 1991, J CLIN MICROBIOL, V29, P46, DOI 10.1128/JCM.29.1.46-50.1991; Jensen JS, 2003, J CLIN MICROBIOL, V41, P261, DOI 10.1128/JCM.41.1.261-266.2003; Jernberg E, 2008, INT J STD AIDS, V19, P676, DOI 10.1258/ijsa.2008.008038; Maeda S, 2001, SEX TRANSM DIS, V28, P472, DOI 10.1097/00007435-200108000-00010; Manhart LE, 2003, J INFECT DIS, V187, P650, DOI 10.1086/367992; Manhart LE, 2013, CLIN INFECT DIS, V56, P934, DOI 10.1093/cid/cis1022; Mena LA, 2009, CLIN INFECT DIS, V48, P1649, DOI 10.1086/599033; Moi Harald, 2011, Tidsskr Nor Laegeforen, V131, P673, DOI 10.4045/tidsskr.10.1224; Nilsson AC, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-93; Oakeshott P, 2010, CLIN INFECT DIS, V51, P1160, DOI 10.1086/656739; Schwebke JR, 2011, CLIN INFECT DIS, V52, P163, DOI 10.1093/cid/ciq074; Taylor-Robinson D, 2000, VENEREOLOGY, V13, P119; Taylor-Robinson D, 2011, CLIN MICROBIOL REV, V24, P498, DOI 10.1128/CMR.00006-11; TULLY JG, 1981, LANCET, V1, P1288; TULLY JG, 1983, INT J SYST BACTERIOL, V33, P387, DOI 10.1099/00207713-33-2-387; Twin J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035593; Waites KB, 2009, ANTIMICROB AGENTS CH, V53, P2139, DOI 10.1128/AAC.00090-09; Wikstrom A, 2006, SEX TRANSM INFECT, V82, P276, DOI 10.1136/sti.2005.018598; Workowski Kimberly A, 2010, MMWR Recomm Rep, V59, P1	33	87	88	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2013	8	4							e61481	10.1371/journal.pone.0061481	http://dx.doi.org/10.1371/journal.pone.0061481			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130FG	23593483	Green Published, Green Submitted, gold			2022-12-25	WOS:000317898000133
J	Matias, MG; Coleman, RA; Hochuli, DF; Underwood, AJ				Matias, Miguel G.; Coleman, Ross A.; Hochuli, Dieter F.; Underwood, Antony J.			Macrofaunal Responses to Edges Are Independent of Habitat-Heterogeneity in Experimental Landscapes	PLOS ONE			English	Article							CORALLINE ALGAL TURF; ECOLOGICAL BOUNDARIES; STRUCTURAL COMPLEXITY; SEAGRASS LANDSCAPES; PATCH SIZE; ASSEMBLAGES; COMMUNITY; FISH; AREA; COLONIZATION	assemblages respond to them. Every edge between two contrasting habitats has characteristics governed by the composition of adjoining habitats and/or by the nature of any transitions between them. To develop better explanatory theory, we examined the extent to which edges act independently of the composition of the surrounding landscape and to which transitions between different types of habitats affect assemblages. Using experimental landscapes, we measured the responses of assemblages of marine molluscs colonising different experimental landscapes constructed with different compositions (i.e. different types of habitats within the landscape) and different types of transitions between habitats (i.e. sharp vs gradual). Edge effects (i.e. proximity to the edge of the landscape) were independent of the internal composition of experimental landscape; fewer species were found near the edges of landscapes. These reductions may be explained by differences in differential larval settlement between edges and interiors of experimental landscapes. We also found that the sharpness of transitions influenced the magnitude of interactions in the different types of habitats in experimental landscapes, most probably due to the increased number of species in areas of transition between two habitats. Our experiments allowed the effects of composition and transitions between habitats to be disentangled from those of proximity to edges of landscapes. Understanding and making predictions about the responses by species to edges depends on understanding not only the nature of transitions across boundaries, but also the landscape in which the edges are embedded.	[Matias, Miguel G.; Coleman, Ross A.; Underwood, Antony J.] Univ Sydney, Sch Biol Sci, Ctr Res Ecol Impacts Coastal Cities, Marine Ecol Labs A11, Sydney, NSW 2006, Australia; [Hochuli, Dieter F.] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia	University of Sydney; University of Sydney	Matias, MG (corresponding author), Univ Evora, Rui Nabeiro Biodivers Chair, CIBIO, Casa Cordovil,Rua Doutor Joaquim Henrique da Fons, Evora, Portugal.	mail.miguelmatias@gmail.com	Matias, Miguel G/D-4294-2019; Hochuli, Dieter/E-5023-2010; Coleman, Ross/B-1314-2008	Matias, Miguel G/0000-0001-9198-2051; Hochuli, Dieter/0000-0002-6673-4475; Coleman, Ross/0000-0003-4136-5914	FundaAxiApoundo o para a CiAancia e Tecnologia (FCT) [SFRH/BD/27506/2006]; Australian Research Council; EICC	FundaAxiApoundo o para a CiAancia e Tecnologia (FCT); Australian Research Council(Australian Research Council); EICC	This work was supported by funds from the FundaA xi A o pound o para a CiAancia e Tecnologia (FCT) SFRH/BD/27506/2006 to MGM, by grants from the Australian Research Council to AJU and additional funds from the EICC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKIOKA H, 1999, PHYCOL RES, V47, P199, DOI DOI 10.1046/J.1440-1835.1999.00164.X; Allen T. F. H., 1982, HIERARCHY PERSPECTIV; Anderson MJ, 1999, OECOLOGIA, V118, P87, DOI 10.1007/s004420050706; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Attrill MJ, 2000, ECOGRAPHY, V23, P114, DOI 10.1034/j.1600-0587.2000.230112.x; Barnes RSK, 1998, J MAR BIOL ASSOC UK, V78, P377, DOI 10.1017/S0025315400041515; BEESLEY PL, 1998, FAUNA AUSTR B, V5, P565; Bell SS, 1999, ECOSYSTEMS, V2, P493, DOI 10.1007/s100219900097; BENEDETTICECCHI L, 1993, J EXP MAR BIOL ECOL, V169, P15, DOI 10.1016/0022-0981(93)90040-U; Bologna PAX, 1999, J EXP MAR BIOL ECOL, V242, P21, DOI 10.1016/S0022-0981(99)00092-1; Bologna PAX, 2000, ESTUARIES, V23, P449, DOI 10.2307/1353138; Bologna PAX, 2002, ESTUARIES, V25, P1033, DOI 10.1007/BF02691350; Bostrom C, 2006, ESTUAR COAST SHELF S, V68, P383, DOI 10.1016/j.ecss.2006.01.026; Bulling M, 2008, OECOLOGIA, V158, P511, DOI 10.1007/s00442-008-1160-5; Cadenasso ML, 2003, BIOSCIENCE, V53, P750, DOI 10.1641/0006-3568(2003)053[0750:AFFATO]2.0.CO;2; Connolly RM, 2006, ESTUAR COAST SHELF S, V68, P433, DOI 10.1016/j.ecss.2006.01.023; Donovan TM, 1997, ECOLOGY, V78, P2064, DOI 10.1890/0012-9658(1997)078[2064:VILSEE]2.0.CO;2; Drew CA, 2008, MAR ECOL PROG SER, V362, P233, DOI 10.3354/meps07430; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; FARRELL TM, 1989, J EXP MAR BIOL ECOL, V128, P57, DOI 10.1016/0022-0981(89)90092-0; Forbes AE, 2002, OIKOS, V96, P433, DOI 10.1034/j.1600-0706.2002.960305.x; FORMAN RTT, 1995, LANDSCAPE ECOL, V10, P133, DOI 10.1007/BF00133027; Godbold JA, 2011, P ROY SOC B-BIOL SCI, V278, P2510, DOI 10.1098/rspb.2010.2414; Gonzalez A, 1998, SCIENCE, V281, P2045, DOI 10.1126/science.281.5385.2045; Goodsell PJ, 2008, MAR BIOL, V154, P117, DOI 10.1007/s00227-008-0906-2; Goodwin BJ, 2002, OIKOS, V99, P552, DOI 10.1034/j.1600-0706.2002.11824.x; Hovel KA, 2002, J EXP MAR BIOL ECOL, V271, P75, DOI 10.1016/S0022-0981(02)00043-6; Jelbart JE, 2006, MAR ECOL PROG SER, V319, P93, DOI 10.3354/meps319093; Johnson MP, 2003, ECOL LETT, V6, P126, DOI 10.1046/j.1461-0248.2003.00404.x; KELAHER B, 2001, J MAR BIOL ASSOC UK, V81, P1; Kelaher BP, 2005, AUSTRAL ECOL, V30, P40, DOI 10.1046/j.1442-9993.2004.01420.x; Kelaher BP, 2003, OECOLOGIA, V135, P431, DOI 10.1007/s00442-003-1196-5; KOTLIAR NB, 1990, OIKOS, V59, P253, DOI 10.2307/3545542; Lahti DC, 2001, BIOL CONSERV, V99, P365, DOI 10.1016/S0006-3207(00)00222-6; Lilley SA, 2006, OECOLOGIA, V148, P672, DOI 10.1007/s00442-006-0411-6; Macreadie PI, 2010, ECOLOGY, V91, P2013, DOI 10.1890/08-1890.1; Macreadie PI, 2009, CONSERV BIOL, V23, P644, DOI 10.1111/j.1523-1739.2008.01130.x; Matias MG, 2010, AUSTRAL ECOL, V35, P743, DOI 10.1111/j.1442-9993.2009.02081.x; Matias MG, 2007, J ANIM ECOL, V76, P986, DOI 10.1111/j.1365-2656.2007.01277.x; Matias MG, 2011, MAR ECOL PROG SER, V437, P135, DOI 10.3354/meps09273; Matias MG, 2010, ECOLOGY, V91, P1908, DOI 10.1890/09-1083.1; MCGUINNESS KA, 1986, J EXP MAR BIOL ECOL, V104, P97, DOI 10.1016/0022-0981(86)90099-7; Monteiro SM, 2002, J EXP MAR BIOL ECOL, V270, P171, DOI 10.1016/S0022-0981(02)00020-5; MULLINEAUX LS, 1990, LIMNOL OCEANOGR, V35, P409, DOI 10.4319/lo.1990.35.2.0409; MURCIA C, 1995, TRENDS ECOL EVOL, V10, P58, DOI 10.1016/S0169-5347(00)88977-6; Olabarria C, 2002, OECOLOGIA, V132, P159, DOI 10.1007/s00442-002-0940-6; Olabarria C, 2002, J EXP MAR BIOL ECOL, V274, P121, DOI 10.1016/S0022-0981(02)00201-0; Olabarria C, 2001, J MAR BIOL ASSOC UK, V81, P961, DOI 10.1017/S0025315401004908; OSMAN RW, 1977, ECOL MONOGR, V47, P37, DOI 10.2307/1942223; Pittman SJ, 2004, MAR ECOL PROG SER, V283, P233, DOI 10.3354/meps283233; Ricklefs RE, 1999, J ANIM ECOL, V68, P1142, DOI 10.1046/j.1365-2656.1999.00358.x; Ries L, 2004, ANNU REV ECOL EVOL S, V35, P491, DOI 10.1146/annurev.ecolsys.35.112202.130148; Sanchez-Jerez P, 1999, ACTA OECOL, V20, P391, DOI 10.1016/S1146-609X(99)00128-9; SCHOENER A, 1981, AM NAT, V118, P339, DOI 10.1086/283827; Sirota L, 2006, MAR ECOL PROG SER, V326, P115, DOI 10.3354/meps326115; Smith TB, 1997, SCIENCE, V276, P1855, DOI 10.1126/science.276.5320.1855; Smith TM, 2010, J ANIM ECOL, V79, P275, DOI 10.1111/j.1365-2656.2009.01605.x; Srivastava DS, 2004, TRENDS ECOL EVOL, V19, P379, DOI 10.1016/j.tree.2004.04.010; STEWART JG, 1982, PAC SCI, V36, P45; Strayer DL, 2003, BIOSCIENCE, V53, P723, DOI 10.1641/0006-3568(2003)053[0723:ACOEB]2.0.CO;2; Tanner JE, 2006, ESTUAR COAST SHELF S, V68, P404, DOI 10.1016/j.ecss.2006.01.029; Tanner JE, 2005, AUSTRAL ECOL, V30, P210, DOI 10.1111/j.1442-9993.2005.01438.x; Tanner JE, 2003, OIKOS, V100, P517, DOI 10.1034/j.1600-0706.2003.12060.x; Turner MG, 2005, ANNU REV ECOL EVOL S, V36, P319, DOI 10.1146/annurev.ecolsys.36.102003.152614; TURNER MG, 1989, ANNU REV ECOL SYST, V20, P171, DOI 10.1146/annurev.es.20.110189.001131; Tuya F, 2008, ESTUAR COAST SHELF S, V78, P774, DOI 10.1016/j.ecss.2008.02.017; Underwood A.J., 1997, EXPT ECOLOGY THEIR L, DOI DOI 10.1017/CBO9780511806407; Underwood AJ, 2006, J EXP MAR BIOL ECOL, V330, P221, DOI 10.1016/j.jembe.2005.12.029; UNDERWOOD AJ, 1983, J EXP MAR BIOL ECOL, V66, P169, DOI 10.1016/0022-0981(83)90038-2; Yarrow MM, 2007, ECOSYSTEMS, V10, P462, DOI 10.1007/s10021-007-9036-9	70	7	7	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2013	8	4							e61349	10.1371/journal.pone.0061349	http://dx.doi.org/10.1371/journal.pone.0061349			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130FG	23593471	Green Submitted, Green Published, gold			2022-12-25	WOS:000317898000127
J	Lee, M; Dworkin, AM; Gildea, D; Trivedi, NS; Moorhead, GB; Crawford, NPS				Lee, M.; Dworkin, A. M.; Gildea, D.; Trivedi, N. S.; Moorhead, G. B.; Crawford, N. P. S.		NISC Comparative Sequencing Progra	RRP1B is a metastasis modifier that regulates the expression of alternative mRNA isoforms through interactions with SRSF1	ONCOGENE			English	Article						Metastasis; RRP1B; germline modifiers; RNA-seq; alternative splicing; breast cancer	SPLICE-SITE SELECTION; CANCER; PROTEINS; IDENTIFICATION; PATTERNS; SEQUENCE	RRP1B (ribosomal RNA processing 1 homolog B) was first identified as a metastasis susceptibility gene in breast cancer through its ability to modulate gene expression in a manner that can be used to accurately predict prognosis in breast cancer. However, the mechanism(s) by which RRP1B modulates gene expression is currently unclear. Many RRP1B binding candidates are involved in alternative splicing, a mechanism of gene expression regulation that is increasingly recognized to be involved in cancer progression and metastasis. One such target is SRSF1 (serine/arginine-rich splicing factor 1) (SF2/ASF, splicing factor 2/alternative splicing factor), an essential splicing regulator that also functions as an oncoprotein. Earlier studies demonstrated that splicing and transcription occur concurrently and are coupled processes. Given that RRP1B regulates transcriptional activity, we hypothesized that RRP1B also regulates the expression of alternative mRNA isoforms through its interaction with SRSF1. Interaction between RRP1B and SRSF1 was verified by coimmunoprecipitation and coimmunofluorescence. Treatment of cells with transcriptional inhibitors significantly increased this interaction, demonstrating that the association of these two proteins is transcriptionally regulated. To assess the role of RRP1B in the regulation of alternative isoform expression, RNA-sequencing data were generated from control and Rrp1b-knockdown cells. Knockdown of Rrp1b induced a significant change in isoform expression in over 600 genes compared with control cell lines. This was verified by quantitative reverse-transcription PCR using isoform-specific primers. Pathway enrichment analyses identified cell cycle and checkpoint regulation to be those most affected by Rrp1b knockdown. These data suggest that RRP1B suppresses metastatic progression by altering the transcriptome through its interaction with splicing regulators such as SRSF1.	[Lee, M.; Dworkin, A. M.; Crawford, N. P. S.] NHGRI, Canc Genet Branch, NIH, Bethesda, MD 20892 USA; [Gildea, D.; Trivedi, N. S.; NISC Comparative Sequencing Progra] NHGRI, Genome Technol Branch, NIH, Bethesda, MD 20892 USA; [Moorhead, G. B.] Univ Calgary, Dept Biol Sci, Calgary, AB, Canada	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Calgary	Crawford, NPS (corresponding author), NHGRI, Canc Genet Branch, NIH, MSC 8000,50 South Dr,Bldg 50,Room 5154, Bethesda, MD 20892 USA.	crawforn@mail.nih.gov			Intramural Research Program of the National Human Genome Research Institute; National Institutes of Health, USA; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIBHG000196, ZIAHG200380] Funding Source: NIH RePORTER	Intramural Research Program of the National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by the Intramural Research Program of the National Human Genome Research Institute, National Institutes of Health, USA. We thank Stephen Wincovitch and Sujata Bupp for technical assistance, and Drs Kent Hunter, Tom Misteli and Larry Brody for critical review of the manuscript.	Albulescu LO, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002530; Alexander RD, 2010, MOL CELL, V40, P582, DOI 10.1016/j.molcel.2010.11.005; Arhin GK, 2002, NUCLEIC ACIDS RES, V30, P1842, DOI 10.1093/nar/30.8.1842; ASLAKSON CJ, 1992, CANCER RES, V52, P1399; BAGGA PS, 1995, NUCLEIC ACIDS RES, V23, P1625, DOI 10.1093/nar/23.9.1625; Baumli S, 2010, CHEM BIOL, V17, P931, DOI 10.1016/j.chembiol.2010.07.012; Bensaude O, 2011, TRANSCR-AUSTIN, V2, P103, DOI 10.4161/trns.2.3.16172; Chamousset D, 2010, MOL BIOL CELL, V21, P4212, DOI 10.1091/mbc.E10-04-0287; Crawford NPS, 2007, PLOS GENET, V3, P2296, DOI 10.1371/journal.pgen.0030214; Crawford NPS, 2009, J BIOL CHEM, V284, P28660, DOI 10.1074/jbc.M109.023457; Du KY, 1998, J BIOL CHEM, V273, P35208, DOI 10.1074/jbc.273.52.35208; Grosso AR, 2008, EMBO REP, V9, P1087, DOI 10.1038/embor.2008.189; Hsieh SM, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2412; Hui LJ, 2004, ONCOGENE, V23, P3013, DOI 10.1038/sj.onc.1207362; Ip JY, 2011, GENOME RES, V21, P390, DOI 10.1101/gr.111070.110; Karni R, 2007, NAT STRUCT MOL BIOL, V14, P185, DOI 10.1038/nsmb1209; Kim E, 2008, TRENDS GENET, V24, P7, DOI 10.1016/j.tig.2007.10.001; KRAINER AR, 1990, CELL, V62, P35, DOI 10.1016/0092-8674(90)90237-9; Lee JH, 2008, CANCER RES, V68, P639, DOI 10.1158/0008-5472.CAN-07-2632; Lemischka IR, 2006, CELL CYCLE, V5, P347, DOI 10.4161/cc.5.4.2424; Luco RF, 2010, SCIENCE, V327, P996, DOI 10.1126/science.1184208; Nurtdinov RN, 2003, HUM MOL GENET, V12, P1313, DOI 10.1093/hmg/ddg137; Oesterreich FC, 2010, MOL CELL, V40, P571, DOI 10.1016/j.molcel.2010.11.004; Pei XF, 2004, IN VITRO CELL DEV-AN, V40, P14; Piva F, 2009, BIOINFORMATICS, V25, P1211, DOI 10.1093/bioinformatics/btp124; Puig O, 2007, NUCLEIC ACIDS RES, V35, P5874, DOI 10.1093/nar/gkm505; Ramaswamy S, 2003, NAT GENET, V33, P49, DOI 10.1038/ng1060; Roberts A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-r22; Thorsen K, 2008, MOL CELL PROTEOMICS, V7, P1214, DOI 10.1074/mcp.M700590-MCP200; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; TRASK DK, 1988, P NATL ACAD SCI USA, V85, P1417, DOI 10.1073/pnas.85.5.1417; Umehara H, 2003, BIOCHEM BIOPH RES CO, V301, P324, DOI 10.1016/S0006-291X(02)03017-6; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Vargas DY, 2011, CELL, V147, P1054, DOI 10.1016/j.cell.2011.10.024; Venables JP, 2004, CANCER RES, V64, P7647, DOI 10.1158/0008-5472.CAN-04-1910; Venables JP, 2006, BIOESSAYS, V28, P378, DOI 10.1002/bies.20390; Venables JP, 2009, NAT STRUCT MOL BIOL, V16, P670, DOI 10.1038/nsmb.1608; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang GS, 2007, NAT REV GENET, V8, P749, DOI 10.1038/nrg2164; Wang ZN, 2003, CANCER RES, V63, P655; WU JY, 1993, CELL, V75, P1061, DOI 10.1016/0092-8674(93)90316-I; Xu Q, 2003, NUCLEIC ACIDS RES, V31, P5635, DOI 10.1093/nar/gkg786; Yeo G, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r74; Yeo GW, 2005, P NATL ACAD SCI USA, V102, P2850, DOI 10.1073/pnas.0409742102; ZAHLER AM, 1993, SCIENCE, V260, P219, DOI 10.1126/science.8385799; ZUO P, 1993, EMBO J, V12, P4727, DOI 10.1002/j.1460-2075.1993.tb06161.x	47	16	18	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 3	2014	33	14					1818	1827		10.1038/onc.2013.133	http://dx.doi.org/10.1038/onc.2013.133			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AE9RE	23604122	Green Accepted			2022-12-25	WOS:000334345500008
J	Liu, J; Mei, ZQ; Li, NN; Qi, YT; Xu, YJ; Shi, YG; Wang, F; Lei, JL; Gao, N				Liu, Jing; Mei, Ziqing; Li, Ningning; Qi, Yutao; Xu, Yanji; Shi, Yigong; Wang, Feng; Lei, Jianlin; Gao, Ning			Structural Dynamics of the MecA-ClpC Complex A TYPE II AAA(+) PROTEIN UNFOLDING MACHINE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATP-FUELED MACHINES; ELECTRON-MICROSCOPY; NUCLEOTIDE-BINDING; CRYSTAL-STRUCTURE; ADAPTER PROTEIN; PLUS PROTEIN; CRYOELECTRON MICROGRAPHS; DISAGGREGATING MACHINE; CONFORMATIONAL-CHANGES; REGULATED PROTEOLYSIS	The MecA-ClpC complex is a bacterial type II AAA(+) molecular machine responsible for regulated unfolding of substrates, such as transcription factors ComK and ComS, and targeting them to ClpP for degradation. The six subunits of the MecA-ClpC complex form a closed barrel-like structure, featured with three stacked rings and a hollow passage, where substrates are threaded and translocated through successive pores. Although the general concepts of how polypeptides are unfolded and translocated by internal pore loops of AAA(+) proteins have long been conceived, the detailed mechanistic model remains elusive. With cryoelectron microscopy, we captured four different structures of the MecA-ClpC complexes. These complexes differ in the nucleotide binding states of the two AAA(+) rings and therefore might presumably reflect distinctive, representative snapshots from a dynamic unfolding cycle of this hexameric complex. Structural analysis reveals that nucleotide binding and hydrolysis modulate the hexameric complex in a number of ways, including the opening of the N-terminal ring, the axial and radial positions of pore loops, the compactness of the C-terminal ring, as well as the relative rotation between the two nucleotide-binding domain rings. More importantly, our structural and biochemical data indicate there is an active allosteric communication between the two AAA(+) rings and suggest that concerted actions of the two AAA(+) rings are required for the efficiency of the substrate unfolding and translocation. These findings provide important mechanistic insights into the dynamic cycle of the MecA-ClpC unfoldase and especially lay a foundation toward the complete understanding of the structural dynamics of the general type II AAA(+) hexamers.	[Liu, Jing; Li, Ningning; Xu, Yanji; Shi, Yigong; Lei, Jianlin; Gao, Ning] Tsinghua Univ, Sch Life Sci, Minist Educ, Struct Biol Ctr,Key Lab Prot Sci, Beijing 100084, Peoples R China; [Mei, Ziqing; Qi, Yutao; Shi, Yigong; Wang, Feng] Tsinghua Univ, Tsinghua Peking Ctr Life Sci, Beijing 100084, Peoples R China; [Shi, Yigong] Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China	Tsinghua University; Tsinghua University; Tsinghua University	Wang, F (corresponding author), Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China.	wfeng@tsinghua.edu.cn; jllei@tsinghuae.du.cn; ninggao@tsinghua.edu.cn	Wang, Feng/AAC-6221-2022; Gao, Ning/J-9623-2012; Gao, Ning/AAK-2214-2020; Mei, Ziqing/AHD-6788-2022	Wang, Feng/0000-0002-9403-4337; Gao, Ning/0000-0003-3067-9993; Gao, Ning/0000-0003-3067-9993; Mei, Ziqing/0000-0001-8554-6309; Li, Ningning/0000-0001-8601-5171; Shi, Yigong/0000-0003-2030-168X	Ministry of Science and Technology of China [2010CB912402, 2013CB910404, 2010CB912401, 2009CB918801]; National Natural Science Foundation of China [31100524, 31270764, 30888001]; Tsinghua-Peking Center for Life Sciences; China Postdoctoral Science Foundation [023201058]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tsinghua-Peking Center for Life Sciences; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by Ministry of Science and Technology of China Grants 2010CB912402 and 2013CB910404 (to N. G.), 2010CB912401 (to J. L.), and 2009CB918801 (to Y. S.), National Natural Science Foundation of China Grants 31100524 (to Z. M.), 31270764 (to F. W.), and 30888001 (to Y. S.), postdoctoral fellowships from Tsinghua-Peking Center for Life Sciences (to Z. M.), and China Postdoctoral Science Foundation Grant 023201058 (to Z. M.).	Andersson FI, 2006, J BIOL CHEM, V281, P5468, DOI 10.1074/jbc.M509661200; Fernandez-Higuero JA, 2011, J BIOL CHEM, V286, P25547, DOI 10.1074/jbc.M111.231365; Beuron F, 2006, EMBO J, V25, P1967, DOI 10.1038/sj.emboj.7601055; Biter AB, 2012, P NATL ACAD SCI USA, V109, P12515, DOI 10.1073/pnas.1207040109; Bohon J, 2008, STRUCTURE, V16, P1157, DOI 10.1016/j.str.2008.04.016; Bolon DN, 2004, MOL CELL, V16, P343, DOI 10.1016/j.molcel.2004.10.001; Burton RE, 2001, EMBO J, V20, P3092, DOI 10.1093/emboj/20.12.3092; Chan KY, 2011, STRUCTURE, V19, P1211, DOI 10.1016/j.str.2011.07.017; Chang LF, 2012, NAT STRUCT MOL BIOL, V19, P268, DOI 10.1038/nsmb.2237; COOK PF, 1982, BIOCHEMISTRY-US, V21, P5794, DOI 10.1021/bi00266a011; DeLaBarre B, 2005, J MOL BIOL, V347, P437, DOI 10.1016/j.jmb.2005.01.060; DeLaBarre B, 2003, NAT STRUCT BIOL, V10, P856, DOI 10.1038/nsb972; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Doyle SM, 2007, NAT STRUCT MOL BIOL, V14, P114, DOI 10.1038/nsmb1198; Effantin G, 2010, STRUCTURE, V18, P553, DOI 10.1016/j.str.2010.02.016; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Furst J, 2003, EMBO J, V22, P4365, DOI 10.1093/emboj/cdg420; Glover JR, 1998, CELL, V94, P73, DOI 10.1016/S0092-8674(00)81223-4; Glynn SE, 2009, CELL, V139, P744, DOI 10.1016/j.cell.2009.09.034; Gottesman S, 2003, ANNU REV CELL DEV BI, V19, P565, DOI 10.1146/annurev.cellbio.19.110701.153228; Guo FS, 2002, J BIOL CHEM, V277, P46743, DOI 10.1074/jbc.M207796200; Gur E, 2011, NAT REV MICROBIOL, V9, P839, DOI 10.1038/nrmicro2669; Hanson PI, 2005, NAT REV MOL CELL BIO, V6, P519, DOI 10.1038/nrm1684; Hattendorf DA, 2002, P NATL ACAD SCI USA, V99, P2732, DOI 10.1073/pnas.261693199; Hattendorf DA, 2002, EMBO J, V21, P12, DOI 10.1093/emboj/21.1.12; Heymann JB, 2007, J STRUCT BIOL, V157, P3, DOI 10.1016/j.jsb.2006.06.006; Hinnerwisch J, 2005, CELL, V121, P1029, DOI 10.1016/j.cell.2005.04.012; Hoskins JR, 2009, P NATL ACAD SCI USA, V106, P22233, DOI 10.1073/pnas.0911937106; Joshi SA, 2004, NAT STRUCT MOL BIOL, V11, P404, DOI 10.1038/nsmb752; Kim YI, 2001, NAT STRUCT BIOL, V8, P230, DOI 10.1038/84967; Kirstein J, 2006, EMBO J, V25, P1481, DOI 10.1038/sj.emboj.7601042; Kirstein J, 2009, NAT REV MICROBIOL, V7, P589, DOI 10.1038/nrmicro2185; Lee S, 2003, CELL, V115, P229, DOI 10.1016/S0092-8674(03)00807-9; Lee S, 2007, MOL CELL, V25, P261, DOI 10.1016/j.molcel.2007.01.002; Lee S, 2010, P NATL ACAD SCI USA, V107, P8135, DOI 10.1073/pnas.1003572107; Lei JL, 2005, J STRUCT BIOL, V150, P69, DOI 10.1016/j.jsb.2005.01.002; Lenzen CU, 1998, CELL, V94, P525, DOI 10.1016/S0092-8674(00)81593-7; LEVCHENKO I, 1995, GENE DEV, V9, P2399, DOI 10.1101/gad.9.19.2399; Li GT, 2012, P NATL ACAD SCI USA, V109, P3737, DOI 10.1073/pnas.1200255109; Li JZ, 2002, J MOL BIOL, V318, P1127, DOI 10.1016/S0022-2836(02)00188-2; Martin A, 2005, NATURE, V437, P1115, DOI 10.1038/nature04031; Martin A, 2008, NAT STRUCT MOL BIOL, V15, P1147, DOI 10.1038/nsmb.1503; Martin A, 2008, MOL CELL, V29, P441, DOI 10.1016/j.molcel.2008.02.002; Mei ZQ, 2009, J BIOL CHEM, V284, P34366, DOI 10.1074/jbc.M109.053017; Mogk A, 2008, BIOCHEM SOC T, V36, P120, DOI 10.1042/BST0360120; Persuh M, 1999, MOL MICROBIOL, V33, P886, DOI 10.1046/j.1365-2958.1999.01544.x; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Prepiak P, 2007, MOL CELL, V26, P639, DOI 10.1016/j.molcel.2007.05.011; Pruteanu M, 2009, RES MICROBIOL, V160, P677, DOI 10.1016/j.resmic.2009.08.012; Rath BK, 2004, J STRUCT BIOL, V145, P84, DOI 10.1016/j.jsb.2003.11.015; Rouiller I, 2002, NAT STRUCT BIOL, V9, P950, DOI 10.1038/nsb872; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sauer RT, 2011, ANNU REV BIOCHEM, V80, P587, DOI 10.1146/annurev-biochem-060408-172623; Scheres SHW, 2012, J MOL BIOL, V415, P406, DOI 10.1016/j.jmb.2011.11.010; Schlee S, 2001, J MOL BIOL, V306, P889, DOI 10.1006/jmbi.2001.4455; Schlieker C, 2004, NAT STRUCT MOL BIOL, V11, P607, DOI 10.1038/nsmb787; Schlothauer T, 2003, P NATL ACAD SCI USA, V100, P2306, DOI 10.1073/pnas.0535717100; Schmidt R, 2009, RES MICROBIOL, V160, P629, DOI 10.1016/j.resmic.2009.08.018; Shaikh TR, 2008, NAT PROTOC, V3, P1941, DOI 10.1038/nprot.2008.156; Siddiqui SM, 2004, GENE DEV, V18, P369, DOI 10.1101/gad.1170304; Singh SK, 2001, J BIOL CHEM, V276, P29420, DOI 10.1074/jbc.M103489200; Trabuco LG, 2008, STRUCTURE, V16, P673, DOI 10.1016/j.str.2008.03.005; Turgay K, 1998, EMBO J, V17, P6730; Wang F, 2011, NATURE, V471, P331, DOI 10.1038/nature09780; Wang F, 2009, J BIOL CHEM, V284, P34376, DOI 10.1074/jbc.M109.053033; Watanabe Y, 2005, J BIOL CHEM, V280, P24562, DOI 10.1074/jbc.M414623200; Wendler P, 2007, CELL, V131, P1366, DOI 10.1016/j.cell.2007.10.047; Wendler P, 2009, MOL CELL, V34, P81, DOI 10.1016/j.molcel.2009.02.026; WICKNER S, 1994, P NATL ACAD SCI USA, V91, P12218, DOI 10.1073/pnas.91.25.12218; Xia D, 2004, J STRUCT BIOL, V146, P166, DOI 10.1016/j.jsb.2003.11.025; Yu RC, 1998, NAT STRUCT BIOL, V5, P803, DOI 10.1038/1843; Zhang XD, 2000, MOL CELL, V6, P1473, DOI 10.1016/S1097-2765(00)00143-X	76	17	18	0	46	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2013	288	24					17597	17608		10.1074/jbc.M113.458752	http://dx.doi.org/10.1074/jbc.M113.458752			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	164AH	23595989	Green Published, hybrid			2022-12-25	WOS:000320380600051
J	Chen, KQ; Liu, MY; Liu, Y; Wang, CY; Yoshimura, T; Gong, WH; Le, YY; Tessarollo, L; Wang, JM				Chen, Keqiang; Liu, Mingyong; Liu, Ying; Wang, Chunyan; Yoshimura, Teizo; Gong, Wanghua; Le, Yingying; Tessarollo, Lino; Wang, Ji Ming			Signal Relay by CC Chemokine Receptor 2 (CCR2) and Formylpeptide Receptor 2 (Fpr2) in the Recruitment of Monocyte-derived Dendritic Cells in Allergic Airway Inflammation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOLL-LIKE RECEPTORS; INDUCED PULMONARY INFLAMMATION; ANTIMICROBIAL-PEPTIDE; EPITHELIAL-CELLS; BLOOD MONOCYTES; BONE-MARROW; DISEASE; LUNG; RESPONSES; MIGRATION	Chemoattractant receptors regulate leukocyte accumulation at sites of inflammation. In allergic airway inflammation, although a chemokine receptor CCR2 was implicated in mediating monocyte- derived dendritic cell (DC) recruitment into the lung, we previously also discovered reduced accumulation of DCs in the inflamed lung in mice deficient in formylpeptide receptor Fpr2 (Fpr2(-/-)). We therefore investigated the role of Fpr2 in the trafficking of monocyte- derived DCs in allergic airway inflammation in cooperation with CCR2. We report that in allergic airway inflammation, CCR2 mediated the recruitment of monocyte- derived DCs to the perivascular region, and Fpr2 was required for further migration of the cells into the bronchiolar area. We additionally found that the bronchoalveolar lavage liquid from mice with airway inflammation contained both the CCR2 ligand CCL2 and an Fpr2 agonist CRAMP. Furthermore, similar to Fpr2(-/-) mice, in the inflamed airway of CRAMP(-/-) mice, DC trafficking into the peribronchiolar areas was diminished. Our study demonstrates that the interaction of CCR2 and Fpr2 with their endogenous ligands sequentially mediates the trafficking of DCs within the inflamed lung.	[Chen, Keqiang; Liu, Mingyong; Liu, Ying; Wang, Chunyan; Yoshimura, Teizo; Wang, Ji Ming] NCI, Mol Immunoregulat Lab, Canc & Inflammat Program, Ctr Canc Res,NIH, Frederick, MD 21702 USA; [Tessarollo, Lino] NCI, Mouse Canc Genet Program, Ctr Canc Res, NIH, Frederick, MD 21702 USA; [Gong, Wanghua] SAIC Frederick, Frederick, MD 21702 USA; [Le, Yingying] Chinese Acad Sci, Inst Nutr Sci, Shanghai 200031, Peoples R China	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Chinese Academy of Sciences	Wang, JM (corresponding author), Frederick Natl Lab Canc Res, Ctr Canc Res, Canc & Inflammat Program, Mol Immunoregulat Lab, Bldg 560,Rm 31-76, Frederick, MD 21702 USA.	wangji@mail.nih.gov	Le, Yingying/L-9785-2017	Le, Yingying/0000-0002-7990-3899; Yoshimura, Teizo/0000-0002-3853-2075	Frederick National Laboratory for Cancer Research, National Institutes of Health [HHSN261200800001E]; NCI, National Institutes of Health; NATIONAL CANCER INSTITUTE [ZIABC010725, ZIABC010015, ZICBC011265] Funding Source: NIH RePORTER	Frederick National Laboratory for Cancer Research, National Institutes of Health; NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by Frederick National Laboratory for Cancer Research, National Institutes of Health Contract HHSN261200800001E. This work was also supported by the Intramural Research Program of the NCI, National Institutes of Health.	Alves JC, 2009, P NATL ACAD SCI USA, V106, P4018, DOI 10.1073/pnas.0900196106; Bals R, 1998, P NATL ACAD SCI USA, V95, P9541, DOI 10.1073/pnas.95.16.9541; Bracke KR, 2007, CLIN EXP ALLERGY, V37, P1467, DOI 10.1111/j.1365-2222.2007.02808.x; Bracke KR, 2006, J IMMUNOL, V177, P4350, DOI 10.4049/jimmunol.177.7.4350; Buyukozturk S, 2004, TOHOKU J EXP MED, V204, P209, DOI 10.1620/tjem.204.209; Chaudhuri N, 2005, CLIN SCI, V109, P125, DOI 10.1042/CS20050044; Chen KQ, 2007, INT IMMUNOPHARMACOL, V7, P1271, DOI 10.1016/j.intimp.2007.05.016; Chen KQ, 2010, J IMMUNOL, V184, P3331, DOI 10.4049/jimmunol.0903022; Chen KQ, 2006, J BIOL CHEM, V281, P3651, DOI 10.1074/jbc.M508125200; Chou RC, 2010, IMMUNITY, V33, P266, DOI 10.1016/j.immuni.2010.07.018; Dominguez PM, 2010, IMMUNOL REV, V234, P90, DOI 10.1111/j.0105-2896.2009.00876.x; Eisenbarth SC, 2002, J EXP MED, V196, P1645, DOI 10.1084/jem.20021340; Fox JM, 2011, BLOOD, V117, P1851, DOI 10.1182/blood-2010-05-287474; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Geissmann F, 2008, IMMUNOL CELL BIOL, V86, P398, DOI 10.1038/icb.2008.19; Hajishengallis G, 2008, P NATL ACAD SCI USA, V105, P13532, DOI 10.1073/pnas.0803852105; Holt PG, 2004, CURR OPIN ALLERGY CL, V4, P39, DOI 10.1097/01.all.0000113677.18759.dc; Hu JY, 2001, J LEUKOCYTE BIOL, V70, P155; Kaisho T, 2003, CURR MOL MED, V3, P373, DOI 10.2174/1566524033479726; Kessel CHG, 2008, MUCOSAL IMMUNOL, V1, P442, DOI 10.1038/mi.2008.39; Kovach MA, 2012, J IMMUNOL, V189, P304, DOI 10.4049/jimmunol.1103196; Kurosaka K, 2005, J IMMUNOL, V174, P6257, DOI 10.4049/jimmunol.174.10.6257; Lambrecht BN, 2009, IMMUNITY, V31, P412, DOI 10.1016/j.immuni.2009.08.008; Lambrecht BN, 2003, NAT REV IMMUNOL, V3, P994, DOI 10.1038/nri1249; Le YY, 2002, TRENDS IMMUNOL, V23, P541, DOI 10.1016/S1471-4906(02)02316-5; Lee EC, 2001, GENOMICS, V73, P56, DOI 10.1006/geno.2000.6451; Maharshak N, 2010, WORLD J GASTROENTERO, V16, P3258, DOI 10.3748/wjg.v16.i26.3258; McDonald B, 2010, SCIENCE, V330, P362, DOI 10.1126/science.1195491; McKimmie CS, 2009, BLOOD, V113, P4224, DOI 10.1182/blood-2008-08-174698; Myou S, 2003, J EXP MED, V198, P1573, DOI 10.1084/jem.20030298; Nakano H, 2009, NAT IMMUNOL, V10, P394, DOI 10.1038/ni.1707; Ozseker F, 2006, INT IMMUNOPHARMACOL, V6, P1569, DOI 10.1016/j.intimp.2006.05.006; Park JS, 2004, J BIOL CHEM, V279, P7370, DOI 10.1074/jbc.M306793200; Pease JE, 2011, BIOCHEM J, V434, P11, DOI 10.1042/BJ20101132; Pelchen-Matthews A, 1999, IMMUNOL REV, V168, P33, DOI 10.1111/j.1600-065X.1999.tb01281.x; Provoost S, 2012, J ALLERGY CLIN IMMUN, V129, P483, DOI 10.1016/j.jaci.2011.07.051; Randolph GJ, 2005, SPRINGER SEMIN IMMUN, V26, P273, DOI 10.1007/s00281-004-0168-0; Randolph GJ, 1999, IMMUNITY, V11, P753, DOI 10.1016/S1074-7613(00)80149-1; Ritter U, 2004, J LEUKOCYTE BIOL, V76, P472, DOI 10.1189/jlb.0104037; Robays LJ, 2007, J IMMUNOL, V178, P5305, DOI 10.4049/jimmunol.178.8.5305; Sadik CD, 2012, J LEUKOCYTE BIOL, V91, P207, DOI 10.1189/jlb.0811402; Serbina NV, 2006, NAT IMMUNOL, V7, P311, DOI 10.1038/ni1309; Shao GH, 2011, AM J RESP CELL MOL, V44, P264, DOI 10.1165/rcmb.2010-0246RC; Sica A, 1997, J EXP MED, V185, P969, DOI 10.1084/jem.185.5.969; Sozzani S, 2005, CYTOKINE GROWTH F R, V16, P581, DOI 10.1016/j.cytogfr.2005.04.008; Takahashi M, 2009, J IMMUNOL, V183, P3463, DOI 10.4049/jimmunol.0802812; Ungaro R, 2009, AM J PHYSIOL-GASTR L, V296, pG1167, DOI 10.1152/ajpgi.90496.2008; Wu TL, 2007, J CLIN LAB ANAL, V21, P367, DOI 10.1002/jcla.20197; Yang D, 2000, J EXP MED, V192, P1069, DOI 10.1084/jem.192.7.1069; Ye RD, 2009, PHARMACOL REV, V61, P119, DOI 10.1124/pr.109.001578	50	39	41	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2013	288	23					16262	16273		10.1074/jbc.M113.450635	http://dx.doi.org/10.1074/jbc.M113.450635			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	163ZU	23603910	hybrid, Green Published			2022-12-25	WOS:000320378900006
J	Chung, S; Miller, JT; Lapkouski, M; Tian, L; Yang, W; Le Grice, SFJ				Chung, Suhman; Miller, Jennifer T.; Lapkouski, Mikalai; Tian, Lan; Yang, Wei; Le Grice, Stuart F. J.			Examining the Role of the HIV-1 Reverse Transcriptase p51 Subunit in Positioning and Hydrolysis of RNA/DNA Hybrids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONNECTION DOMAIN; CRYSTAL-STRUCTURE; COMPLEX; N348I; MUTAGENESIS; MUTATIONS; 3'-AZIDO-3'-DEOXYTHYMIDINE; RESISTANCE; INHIBITORS; SUBDOMAIN	Recent crystallographic analysis of p66/p51 human immuno-deficiency virus (HIV) type 1 reverse transcriptase (RT) complexed with a non-polypurine tract RNA/DNA hybrid has illuminated novel and important contacts between structural elements at the C terminus of the noncatalytic p51 subunit and the nucleic acid duplex in the vicinity of the ribonuclease H (RNase H) active site. In particular, a short peptide spanning residues Phe-416-Pro-421 was shown to interact with theDNA strand, cross the minor groove of the helix, and then form Van der Waals contacts with the RNA strand adjacent to the scissile phosphate. At the base of the adjoining alpha-helix M', Tyr-427 forms a hydrogen bond with Asn-348, the latter of which, when mutated to Ile, is implicated in resistance to both nucleoside and non-nucleoside RT inhibitors. Based on our structural data, we analyzed the role of the p51 C terminus by evaluating selectively mutated p66/p51 heterodimers carrying (i) p51 truncations that encroach on alpha-M', (ii) alterations that interrupt the Asn-348-Tyr- 427 interaction, and (iii) alanine substitutions throughout the region Phe-416-Pro-421. Collectively, our data support the notion that the p51 C terminus makes an important contribution toward hybrid binding and orienting the RNA strand for catalysis at the RNase H active site.	[Chung, Suhman; Miller, Jennifer T.; Le Grice, Stuart F. J.] NCI, Natl Inst Hlth, Ctr Canc Res, RT Biochem Sect,HIV Drug Resistance Program, Frederick, MD 21702 USA; [Lapkouski, Mikalai; Tian, Lan; Yang, Wei] NIDDK, Natl Inst Hlth, Mol Biol Lab, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Le Grice, SFJ (corresponding author), NCI, Natl Inst Hlth, Ctr Canc Res, RT Biochem Sect,HIV Drug Resistance Program, Frederick, MD 21702 USA.	legrices@mail.nih.gov	Yang, Wei/D-4926-2011; Yang, Wei/ABB-4785-2020	Yang, Wei/0000-0002-3591-2195; Yang, Wei/0000-0002-3591-2195	NIDDK, National Institutes of Health; NCI, National Institutes of Health; NATIONAL CANCER INSTITUTE [ZIABC010494, ZIABC011443] Funding Source: NIH RePORTER	NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by the Intramural Research Programs of the NIDDK and NCI, respectively, of the National Institutes of Health (to W.Y. and S.F.J.L.G.)	Arts EJ, 1996, J BIOL CHEM, V271, P9054, DOI 10.1074/jbc.271.15.9054; Bauman JD, 2008, NUCLEIC ACIDS RES, V36, P5083, DOI 10.1093/nar/gkn464; Cameron CE, 1997, P NATL ACAD SCI USA, V94, P6700, DOI 10.1073/pnas.94.13.6700; Chung SM, 2012, J BIOL CHEM, V287, P4066, DOI 10.1074/jbc.M111.314781; Das K, 2011, J MED CHEM, V54, P2727, DOI 10.1021/jm101536x; DING J, 1995, STRUCTURE, V3, P365, DOI 10.1016/S0969-2126(01)00168-X; Ehteshami M, 2008, J BIOL CHEM, V283, P22222, DOI 10.1074/jbc.M803521200; Hachiya A, 2008, J VIROL, V82, P3261, DOI 10.1128/JVI.01154-07; Harris D, 1998, BIOCHEMISTRY-US, V37, P5903, DOI 10.1021/bi9728452; Himmel DM, 2006, ACS CHEM BIOL, V1, P702, DOI 10.1021/cb600303y; Hsiou Y, 1996, STRUCTURE, V4, P853, DOI 10.1016/S0969-2126(96)00091-3; Huang HF, 1998, SCIENCE, V282, P1669, DOI 10.1126/science.282.5394.1669; JACQUES PS, 1994, J BIOL CHEM, V269, P1388; Julias JG, 2003, J VIROL, V77, P8548, DOI 10.1128/JVI.77.15.8548-8554.2003; Kim S, 2010, J MOL BIOL, V395, P995, DOI 10.1016/j.jmb.2009.11.072; Kirschberg TA, 2008, BIOORG MED CHEM LETT, V18, P1131, DOI 10.1016/j.bmcl.2007.11.127; KOHLSTAEDT LA, 1992, SCIENCE, V256, P1783, DOI 10.1126/science.1377403; Lapkouski M, 2013, NAT STRUCT MOL BIOL, V20, P230, DOI 10.1038/nsmb.2485; LEGRICE SFJ, 1988, EMBO J, V7, P2547, DOI 10.1002/j.1460-2075.1988.tb03103.x; LEGRICE SFJ, 1991, EMBO J, V10, P3905, DOI 10.1002/j.1460-2075.1991.tb04960.x; Nikolenko GN, 2007, P NATL ACAD SCI USA, V104, P317, DOI 10.1073/pnas.0609642104; Nowotny M, 2005, CELL, V121, P1005, DOI 10.1016/j.cell.2005.04.024; Nowotny M, 2007, MOL CELL, V28, P264, DOI 10.1016/j.molcel.2007.08.015; Phillips Kevin, 2011, Curr Protoc Mol Biol, VChapter 10, DOI 10.1002/0471142727.mb1028s94; Rausch JW, 2002, BIOCHEMISTRY-US, V41, P4856, DOI 10.1021/bi015970t; REN JS, 1995, STRUCTURE, V3, P915, DOI 10.1016/S0969-2126(01)00226-X; Sarafianos SG, 2001, EMBO J, V20, P1449, DOI 10.1093/emboj/20.6.1449; Schuckmann MM, 2010, J BIOL CHEM, V285, P38700, DOI 10.1074/jbc.M110.153783; VERONESE FD, 1986, SCIENCE, V231, P1289, DOI 10.1126/science.2418504; WANG J, 1994, P NATL ACAD SCI USA, V91, P7242, DOI 10.1073/pnas.91.15.7242; Wendeler M, 2008, ACS CHEM BIOL, V3, P635, DOI 10.1021/cb8001039; Yap SH, 2007, PLOS MED, V4, P1887, DOI 10.1371/journal.pmed.0040335	32	16	16	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 31	2013	288	22					16177	16184		10.1074/jbc.M113.465641	http://dx.doi.org/10.1074/jbc.M113.465641			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	156LA	23595992	Green Published, hybrid			2022-12-25	WOS:000319822300068
J	Brosnahan, AJ; Merriman, JA; Salgado-Pabon, W; Ford, B; Schlievert, PM				Brosnahan, Amanda J.; Merriman, Joseph A.; Salgado-Pabon, Wilmara; Ford, Bradley; Schlievert, Patrick M.			Enterococcus faecalis Inhibits Superantigen Toxic Shock Syndrome Toxin-1-Induced Interleukin-8 from Human Vaginal Epithelial Cells through Tetramic Acids	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED-DISEASES; CULTIVATION-INDEPENDENT METHODS; STAPHYLOCOCCUS-AUREUS; MICROBIAL COMMUNITIES; GLYCEROL MONOLAURATE; BIOLOGICAL-ACTIVITY; HYDROGEN-PEROXIDE; REUTERICYCLIN; TRANSMISSION; WOMEN	The vaginal mucosa can be colonized by many bacteria including commensal organisms and potential pathogens, such as Staphylococcus aureus. Some strains of S. aureus produce the superantigen toxic shock syndrome toxin-1, which can penetrate the vaginal epithelium to cause toxic shock syndrome. We have observed that a female was mono-colonized with Enterococcus faecalis vaginally as tested in aerobic culture, even upon repeated culture for six months, suggesting this organism was negatively influencing colonization by other bacteria. In recent studies, we demonstrated an "outside-in" mechanism of cytokine signaling and consequent inflammation that facilitates the ability of potential pathogens to initiate infection from mucosal surfaces. Thus, we hypothesized that this strain of E. faecalis may make anti-inflammatory factors which block disease progression of more pathogenic organisms. E. faecalis MN1 inhibited interleukin-8 production from human vaginal epithelial cells in response to the vaginal pathogens Candida albicans, Gardnerella vaginalis, and Neisseria gonorrhoeae, as well as to toxic shock syndrome toxin-1. We further demonstrated that this organism secretes two tetramic acid compounds which appear responsible for inhibition of interleukin-8 production, as well as inhibition of T cell proliferation due to toxic shock syndrome toxin-1. Microbicides that include anti-inflammatory molecules, such as these tetramic acid compounds naturally produced by E. faecalis MN1, may be useful in prevention of diseases that develop from vaginal infections.	[Brosnahan, Amanda J.; Schlievert, Patrick M.] Univ Minnesota, Sch Med, Dept Microbiol, Minneapolis, MN 55455 USA; [Merriman, Joseph A.; Salgado-Pabon, Wilmara; Schlievert, Patrick M.] Univ Iowa, Dept Microbiol, Carver Coll Med, Iowa City, IA 52242 USA; [Ford, Bradley] Univ Iowa, Dept Pathol, Carver Coll Med, Iowa City, IA 52242 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Iowa; University of Iowa	Schlievert, PM (corresponding author), Univ Minnesota, Sch Med, Dept Microbiol, Minneapolis, MN 55455 USA.	patrick-schlievert@uiowa.edu	; Salgado-Pabon, Wilmara/N-9443-2018	Ford, Bradley/0000-0002-7871-7955; Schlievert, Patrick/0000-0001-8314-9369; Salgado-Pabon, Wilmara/0000-0003-0854-1568	United States Public Health Service from the National Institute of Allergy and Infectious Diseases [AI074283]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI074283] Funding Source: NIH RePORTER	United States Public Health Service from the National Institute of Allergy and Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by United States Public Health Service research grant AI074283 from the National Institute of Allergy and Infectious Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonio MAD, 1999, J INFECT DIS, V180, P1950, DOI 10.1086/315109; Boonanantanasarn K, 2012, INFECT IMMUN, V80, P3545, DOI 10.1128/IAI.00479-12; Boris S, 2000, MICROBES INFECT, V2, P543, DOI 10.1016/S1286-4579(00)00313-0; Broekaert IJ, 2007, PEDIATR RES, V62, P139, DOI 10.1203/PDR.0b013e31809fd85e; Brosnahan AJ, 2011, FEBS J, V278, P4649, DOI 10.1111/j.1742-4658.2011.08151.x; Brosnahan AJ, 2009, J IMMUNOL, V182, P2364, DOI 10.4049/jimmunol.0803283; Brosnahan AJ, 2008, BIOCHEMISTRY-US, V47, P12995, DOI 10.1021/bi801468w; Brown CJ, 2007, J MED MICROBIOL, V56, P271, DOI 10.1099/jmm.0.46607-0; Chavez V, 2007, GENETICS, V176, P1567, DOI 10.1534/genetics.107.072587; Coolen MJL, 2005, APPL ENVIRON MICROB, V71, P8729, DOI 10.1128/AEM.71.12.8729-8737.2005; Fichorova RN, 2001, J INFECT DIS, V184, P418, DOI 10.1086/322047; Galvin SR, 2004, NAT REV MICROBIOL, V2, P33, DOI 10.1038/nrmicro794; Ganzle MG, 2004, APPL MICROBIOL BIOT, V64, P326, DOI 10.1007/s00253-003-1536-8; Ganzle MG, 2003, APPL ENVIRON MICROB, V69, P1305, DOI 10.1128/AEM.69.2.1305-1307.2003; Ganzle MG, 2000, APPL ENVIRON MICROB, V66, P4325, DOI 10.1128/AEM.66.10.4325-4333.2000; HALBERT CL, 1992, J VIROL, V66, P2125, DOI 10.1128/JVI.66.4.2125-2134.1992; Hill JE, 2005, AM J OBSTET GYNECOL, V193, P682, DOI 10.1016/j.ajog.2005.02.094; Holtzel A, 2000, ANGEW CHEM INT EDIT, V39, P2766; Huycke MM, 2002, CARCINOGENESIS, V23, P529, DOI 10.1093/carcin/23.3.529; Kaufmann GF, 2005, P NATL ACAD SCI USA, V102, P309, DOI 10.1073/pnas.0408639102; Kiyono T, 1998, NATURE, V396, P84, DOI 10.1038/23962; KREISWIRTH BN, 1987, MOL GEN GENET, V208, P84, DOI 10.1007/BF00330426; LAGA M, 1993, AIDS, V7, P95, DOI 10.1097/00002030-199301000-00015; Li QS, 2009, NATURE, V458, P1034, DOI 10.1038/nature07831; Lowery CA, 2009, J AM CHEM SOC, V131, P14473, DOI 10.1021/ja9056079; Peterson ML, 2006, BIOCHEMISTRY-US, V45, P2387, DOI 10.1021/bi051992u; Peterson ML, 2005, INFECT IMMUN, V73, P2164, DOI 10.1128/IAI.73.4.2164-2174.2005; Plummer FA, 1998, AIDS RES HUM RETROV, V14, pS5; POINDEXTER NJ, 1985, J INFECT DIS, V151, P65, DOI 10.1093/infdis/151.1.65; REDONDOLOPEZ V, 1990, REV INFECT DIS, V12, P856; Schlievert PM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040350; SCHLIEVERT PM, 1988, METHOD ENZYMOL, V165, P339; SCHLIEVERT PM, 1982, ANN INTERN MED, V96, P937, DOI 10.7326/0003-4819-96-6-937; SCHLIEVERT PM, 1981, J INFECT DIS, V143, P509, DOI 10.1093/infdis/143.4.509; Strandberg KL, 2009, CLIN INFECT DIS, V49, P1711, DOI 10.1086/644614; Wannamaker LW, 1988, BACTERIAL TOXINS, P267; Witcher KJ, 1996, CLIN DIAGN LAB IMMUN, V3, P10, DOI 10.1128/CDLI.3.1.10-13.1996; Zhou X, 2004, MICROBIOL-SGM, V150, P2565, DOI 10.1099/mic.0.26905-0; Zhou Xiaoping, 2007, U S Forest Service Pacific Northwest Research Station General Technical Report PNW-GTR, P1	39	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2013	8	4							e61255	10.1371/journal.pone.0061255	http://dx.doi.org/10.1371/journal.pone.0061255			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JR	23613823	Green Published, Green Submitted, gold			2022-12-25	WOS:000317911500025
J	Kannathasan, S; Murugananthan, A; Rajeshkannan, N; de Silva, NR				Kannathasan, Selvam; Murugananthan, Arumugam; Rajeshkannan, Nadarajah; de Silva, Nilanthi Renuka			A Simple Intervention to Prevent Cutaneous Larva Migrans among Devotees of the Nallur Temple in Jaffna, Sri Lanka	PLOS ONE			English	Article							ALBENDAZOLE; BRAZIL	Background: A cross sectional study conducted during the annual festival at Nallur temple in Jaffna, Sri Lanka, in 2010, showed that the prevalence of cutaneous larva migrants (CLM) among the devotees who performed the side roll ritual was 58.2% (95% CI: 51.2%-65.0%). Objective: To test the hypothesis that the deworming stray dogs around the temple premises effectively reduces the prevalence of CLM among devotees. Methodology/Principal Findings: All stray dogs (8) in the vicinity of the temple were treated, with mebendazole (100 mg) crushed and filled into sausages, 10 days before the commencement of festival in 2011. The same procedure was repeated a week later to ensure complete coverage. A cross-sectional study was conducted among 200 systematically selected devotees in August 2011 using an interviewer-administered questionnaire and the clinical examination of the skin. Baermann's technique was used for the recovery of nematode larvae from 40 soil samples collected from the temple premises. Ten samples of dog faeces collected from the same premises were also examined for nematode eggs. Prevalence of CLM among devotees in 2010 (Pre intervention) and 2011(Post intervention) were compared to test the hypothesis. Prevalence of CLM declined from 58% to 8% (Chi-square = 112.90, p<0.001) following the intervention. None of the subjects practiced new precautionary measures compared to the previous year. Soil and fecal samples were negative for parasites. Conclusions/Significance: Regular dog deworming is an important and effective method for the prevention of CLM among the devotees doing side roll ritual and represents a pragmatic intervention that municipal authorities could perform on annual basis.	[Kannathasan, Selvam; Murugananthan, Arumugam] Univ Jaffna, Fac Med, Dept Pathol, Div Parasitol, Jaffna, Sri Lanka; [Rajeshkannan, Nadarajah] Univ Jaffna, Fac Med, Dept Community Med, Jaffna, Sri Lanka; [de Silva, Nilanthi Renuka] Univ Kelaniya, Fac Med, Dept Parasitol, Ragama, Sri Lanka	University Jaffna; University Jaffna; University Kelaniya	Kannathasan, S (corresponding author), Univ Jaffna, Fac Med, Dept Pathol, Div Parasitol, Jaffna, Sri Lanka.	selvamkannathasan@gmail.com	Nadarajah, Rajeshkannan/AFS-0100-2022	Nadarajah, Rajeshkannan/0000-0001-9045-3369				Boggild AK, 2006, J TRAVEL MED, V13, P138, DOI 10.1111/j.1708-8305.2006.00032.x; Caumes E, 2003, FUND CLIN PHARMACOL, V17, P213, DOI 10.1046/j.1472-8206.2003.00172.x; Chopra S, 2009, MANSONS TROPICAL DIS, P333; Feldmeier H, 2012, EUR J CLIN MICROBIOL, V31, P915, DOI 10.1007/s10096-011-1404-x; Heukelbach J, 2008, ANN TROP MED PARASIT, V102, P53, DOI 10.1179/136485908X252205; Heukelbach J, 2004, INT J DERMATOL, V43, P511, DOI 10.1111/j.1365-4632.2004.02152.x; Heukelbach J, 2008, LANCET INFECT DIS, V8, P302, DOI 10.1016/S1473-3099(08)70098-7; Kannathasan S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030516; Kim Tae-Heung, 2006, Korean Journal of Parasitology, V44, P145, DOI 10.3347/kjp.2006.44.2.145; Miro G, 2007, PARASITOL RES, V100, P317, DOI 10.1007/s00436-006-0258-0; SANGUIGNI S, 1990, T ROY SOC TROP MED H, V84, P831, DOI 10.1016/0035-9203(90)90099-Z; Veraldi S, 1999, EUR J DERMATOL, V9, P352	12	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2013	8	4							e61816	10.1371/journal.pone.0061816	http://dx.doi.org/10.1371/journal.pone.0061816			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IK	23613943	Green Published, Green Submitted, gold			2022-12-25	WOS:000317907200089
J	Spoletini, M; Zampetti, S; Campagna, G; Marandola, L; Capizzi, M; Buzzetti, R				Spoletini, Marialuisa; Zampetti, Simona; Campagna, Giuseppe; Marandola, Lidia; Capizzi, Marco; Buzzetti, Raffaella		IMDIAB Study Grp	Temporal Trends of HLA, CTLA-4 and PTPN22 Genotype Frequencies among Type 1 Diabetes in Continental Italy	PLOS ONE			English	Article							HIGH-RISK; TYROSINE-PHOSPHATASE; RISING INCIDENCE; GENE REGION; CHILDHOOD; DISEASE; ONSET; SUSCEPTIBILITY; INDIVIDUALS; VARIANT	The incidence of type 1 diabetes has, progressively, increased worldwide over the last decades and also in Continental Italian population. Previous studies performed in northern European countries, showed, alongside a general increase in the disease incidence, a decreasing frequency of the highest risk HLA genotype in type 1 diabetes populations, thus emphasizing the role of environmental factors. The aim of the study was to evaluate whether a decreasing trend of high risk HLA, CTLA-4 and PTPN22 genotypes would be present in type 1 diabetes subjects of Continental Italy, a country considered at low incidence of the disease compared to northern European populations. N = 765 type 1 diabetes patients diagnosed from 1980 to 2012 in Lazio region were included. For HLA, CTLA-4 and PTPN22 temporal trend evaluation, subjects were subdivided into groups of years according to age at diagnosis. All subjects were typed for HLA-DRB1 and DQB1 by a reverse line blot. The CT60 polymorphism of the CTLA4 and C1858T of the PTPN22 gene were genotyped using ABI PRISM 7900HT (n = 419 and n = 364 respectively). HLA genotypes were divided in high, moderate and low risk categories. The proportion of the HLA risk categories was not statistically different over the three decades in subjects with age of onset,15 years and >= 15 years. The genotype distribution of CT60 polymorphism of CTLA4 gene did not show any change in the frequencies during time. The analysis of the PTPN22 C1858T variant revealed, instead, that the frequency of CT+TT susceptibility genotypes decreased during time (23.9% vs 13.6%, p = 0.017). We can hypothesize that the pressure of the diabetogenic environment could be milder and therefore not sufficient to reduce the need of a strong genetic background (HLA) "to precipitate'' diabetes; the increased pressure of the environment could have, instead, some effects on minor susceptibility genes in our population.	[Spoletini, Marialuisa; Zampetti, Simona; Campagna, Giuseppe; Marandola, Lidia; Capizzi, Marco; Buzzetti, Raffaella] Univ Roma La Sapienza, Dept Expt Med, I-00185 Rome, Italy; [IMDIAB Study Grp] Univ Campus Biomed, Dept Endocrinol, Rome, Italy	Sapienza University Rome; University Campus Bio-Medico - Rome Italy	Buzzetti, R (corresponding author), Univ Roma La Sapienza, Dept Expt Med, I-00185 Rome, Italy.	raffaella.buzzetti@uniroma1.it	Buzzetti, Raffaella/K-3090-2016; CAMPAGNA, GIUSEPPE/AAT-2796-2020	Buzzetti, Raffaella/0000-0003-1490-6041; CAMPAGNA, GIUSEPPE/0000-0002-1884-9171	Diabetes, Endocrinology and Metabolism (DEM) Foundation	Diabetes, Endocrinology and Metabolism (DEM) Foundation	This work was supported by Diabetes, Endocrinology and Metabolism (DEM) Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awa WL, 2010, EUR J ENDOCRINOL, V163, P97, DOI 10.1530/EJE-09-0921; Bizzarri C, 2010, DIABETES CARE, V33, P1962, DOI [10.2337/dc10-0814, 10.2337/dc10-1168]; Bottini N, 2004, NAT GENET, V36, P337, DOI 10.1038/ng1323; Buzzetti R, 2004, DIABETES-METAB RES, V20, P137, DOI 10.1002/dmrr.426; Catanzariti L, 2009, DIABETIC MED, V26, P596, DOI 10.1111/j.1464-5491.2009.02737.x; Dahlquist GG, 2011, DIABETES CARE, V34, P1754, DOI 10.2337/dc11-0056; Dang MN, 2013, DIABETES-METAB RES, V29, P8, DOI 10.1002/dmrr.2375; Ehehalt S, 2012, EXP CLIN ENDOCR DIAB, V120, P441, DOI 10.1055/s-0032-1309045; Fourlanos S, 2008, DIABETES CARE, V31, P1546, DOI 10.2337/dc08-0239; Gale EAM, 2002, DIABETES, V51, P3353, DOI 10.2337/diabetes.51.12.3353; Gale EAM, 2002, DIABETOLOGIA, V45, P588, DOI 10.1007/s00125-002-0801-1; Ghazarian L, 2012, CELL MOL LIFE SCI; Gillespie KM, 2004, LANCET, V364, P1699, DOI 10.1016/S0140-6736(04)17357-1; Harjutsalo V, 2005, DIABETES, V54, P563, DOI 10.2337/diabetes.54.2.563; Hermann R, 2004, DIABETES-METAB RES, V20, P322, DOI 10.1002/dmrr.455; Hermann R, 2003, DIABETOLOGIA, V46, P420, DOI 10.1007/s00125-003-1045-4; Knip M, 2005, DIABETES, V54, pS125, DOI 10.2337/diabetes.54.suppl_2.S125; Knip M, 2011, HORM RES PAEDIAT, V76, P57, DOI 10.1159/000329169; Nistico L, 1996, HUM MOL GENET, V5, P1075, DOI 10.1093/hmg/5.7.1075; Noble JA, 1996, AM J HUM GENET, V59, P1134; Palmer Jerry P., 2004, Diabetes, V53, P250; Patterson CC, 2009, LANCET, V373, P2027, DOI 10.1016/S0140-6736(09)60568-7; Petrone A, 2005, DIABETES-METAB RES, V21, P271, DOI 10.1002/dmrr.549; Petrone A, 2005, THYROID, V15, P232, DOI 10.1089/thy.2005.15.232; Petrone A, 2008, DIABETES CARE, V31, P1214, DOI 10.2337/dc07-1158; Petrone A, 2008, DIABETES CARE, V31, P534, DOI 10.2337/dc07-1457; Pitkaniemi J, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-5; Resic-Lindehammer S, 2008, ACTA DIABETOL, V45, P231, DOI 10.1007/s00592-008-0048-5; Steck AK, 2011, DIABETES, V60, P1045, DOI 10.2337/db10-1419; Ueda H, 2003, NATURE, V423, P506, DOI 10.1038/nature01621; Vehik K, 2008, DIABETES CARE, V31, P1392, DOI 10.2337/dc07-2210; Vehik K, 2011, DIABETES-METAB RES, V27, P3, DOI 10.1002/dmrr.1141; Washington RE, 2012, PEDIAT DIABETES	33	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2013	8	4							e61331	10.1371/journal.pone.0061331	http://dx.doi.org/10.1371/journal.pone.0061331			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IK	23613833	Green Published, Green Submitted, gold			2022-12-25	WOS:000317907200048
J	Doll, VM; Ehling-Schulz, M; Vogelmann, R				Doll, Viktoria M.; Ehling-Schulz, Monika; Vogelmann, Roger			Concerted Action of Sphingomyelinase and Non-Hemolytic Enterotoxin in Pathogenic Bacillus cereus	PLOS ONE			English	Article							3 EXOPROTEIN COMPONENTS; PORE-FORMING TOXIN; PHOSPHOLIPASE-C; NHE ENTEROTOXIN; STAPHYLOCOCCUS-AUREUS; NUCLEOTIDE-SEQUENCE; HEMOLYSIN BL; BETA-TOXIN; VIRULENCE; INSECTS	Bacillus cereus causes food poisoning and serious non-gastrointestinal-tract infections. Non-hemolytic enterotoxin (Nhe), which is present in most B. cereus strains, is considered to be one of the main virulence factors. However, a B. cereus DnheBC mutant strain lacking Nhe is still cytotoxic to intestinal epithelial cells. In a screen for additional cytotoxic factors using an in vitro model for polarized colon epithelial cells we identified B. cereus sphingomyelinase (SMase) as a strong inducer of epithelial cell death. Using single and double deletion mutants of sph, the gene encoding for SMase, and nheBC in B. cereus we demonstrated that SMase is an important factor for B. cereus cytotoxicity in vitro and pathogenicity in vivo. SMase substantially complemented Nhe induced cytotoxicity in vitro. In addition, SMase but not Nhe contributed significantly to the mortality rate of larvae in vivo in the insect model Galleria mellonella. Our study suggests that the role of B. cereus SMase as a secreted virulence factor for in vivo pathogenesis has been underestimated and that Nhe and SMase complement each other significantly to cause full B. cereus virulence hence disease formation.	[Doll, Viktoria M.] Tech Univ Munich, Abt Mikrobiol, ZIEL, Freising Weihenstephan, Germany; [Ehling-Schulz, Monika] Vet Univ Vienna, Dept Pathobiol, A-1030 Vienna, Austria; [Vogelmann, Roger] Heidelberg Univ, Univ Med Mannheim, Dept Internal Med 2, Mannheim, Germany	Technical University of Munich; University of Veterinary Medicine Vienna; Ruprecht Karls University Heidelberg	Vogelmann, R (corresponding author), Heidelberg Univ, Univ Med Mannheim, Dept Internal Med 2, Mannheim, Germany.	roger.vogelmann@medma.uni-heidelberg.de	Ehling-Schulz, Monika/J-3592-2014	Ehling-Schulz, Monika/0000-0001-7384-0594	German Research Foundation (Deutsche Forschungsgemeinschaft) [GRK 1482]; German Ministry of Economics and Technology (via AiF); FEI (Forschungskreis der Ernahrungsindustrie e.V., Bonn) [AiF 17506 N]; TUM Graduate School at Technische Universitat Munchen, Germany; 2nd Dept. of Internal Medicine; Klinikum rechts der Isar, Munich; Siegfried Scherer; Lehrstuhl fur Mikrobielle Okologie; Department fur Grundlagen der Biowissenschaften; Technische Universitat Munchen, Weihenstephan, Germany	German Research Foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); German Ministry of Economics and Technology (via AiF)(Federal Ministry for Economic Affairs and Energy (BMWi)); FEI (Forschungskreis der Ernahrungsindustrie e.V., Bonn); TUM Graduate School at Technische Universitat Munchen, Germany; 2nd Dept. of Internal Medicine; Klinikum rechts der Isar, Munich; Siegfried Scherer; Lehrstuhl fur Mikrobielle Okologie; Department fur Grundlagen der Biowissenschaften; Technische Universitat Munchen, Weihenstephan, Germany	This work was supported by the German Research Foundation (Deutsche Forschungsgemeinschaft) grant GRK 1482, in part by the German Ministry of Economics and Technology (via AiF) and the FEI (Forschungskreis der Ernahrungsindustrie e.V., Bonn), project AiF 17506 N, the TUM Graduate School at Technische Universitat Munchen, Germany and the generous financial support from Roland M. Schmid, 2nd Dept. of Internal Medicine, Klinikum rechts der Isar, Munich and Siegfried Scherer, Lehrstuhl fur Mikrobielle Okologie, Department fur Grundlagen der Biowissenschaften, Technische Universitat Munchen, Weihenstephan, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ago H, 2006, J BIOL CHEM, V281, P16157, DOI 10.1074/jbc.M601089200; Arnesen LPS, 2008, FEMS MICROBIOL REV, V32, P579, DOI 10.1111/j.1574-6976.2008.00112.x; BASHFORD CL, 1986, J BIOL CHEM, V261, P9300; Beecher DJ, 2000, INFECT IMMUN, V68, P5269, DOI 10.1128/IAI.68.9.5269-5276.2000; Beecher DJ, 2000, MICROBIOL-UK, V146, P3033, DOI 10.1099/00221287-146-12-3033; Bottone EJ, 2010, CLIN MICROBIOL REV, V23, P382, DOI 10.1128/CMR.00073-09; Christenson JC, 1999, AM J INFECT CONTROL, V27, P543, DOI 10.1016/S0196-6553(99)70034-9; Christie R. N. E. Atkins, 1944, AUSTRALIAN JOUR EXP BIOL AND MED SCI, V22, P197; CROWELL KM, 1989, TOXICON, V27, P531, DOI 10.1016/0041-0101(89)90114-1; Didier A, 2012, INFECT IMMUN, V80, P832, DOI 10.1128/IAI.05681-11; Dierick K, 2005, J CLIN MICROBIOL, V43, P4277, DOI 10.1128/JCM.43.8.4277-4279.2005; Dietrich R, 2005, APPL ENVIRON MICROB, V71, P8214, DOI 10.1128/AEM.71.12.8214-8220.2005; Duc LH, 2004, APPL ENVIRON MICROB, V70, P2161, DOI 10.1128/AEM.70.4.2161-2171.2004; Ehling-Schulz M, 2005, APPL ENVIRON MICROB, V71, P105, DOI 10.1128/AEM.71.1.105-113.2005; Ehling-Schulz M, 2005, MICROBIOL-SGM, V151, P183, DOI 10.1099/mic.0.27607-0; Ehling-Schulz M, 2004, MOL NUTR FOOD RES, V48, P479, DOI 10.1002/mnfr.200400055; Ehling-Schulz M, 2012, WOODHEAD PUBL FOOD S, P63; Ehling-Schulz M, 2006, FEMS MICROBIOL LETT, V260, P232, DOI 10.1111/j.1574-6968.2006.00320.x; Fagerlund A, 2008, MICROBIOL-SGM, V154, P693, DOI 10.1099/mic.0.2007/014134-0; Fedhila S, 2002, J BACTERIOL, V184, P3296, DOI 10.1128/JB.184.12.3296-3304.2002; Fedhila S, 2010, J INVERTEBR PATHOL, V103, P24, DOI 10.1016/j.jip.2009.09.005; Frenzel E, 2012, MOL MICROBIOL, V85, P67, DOI 10.1111/j.1365-2958.2012.08090.x; GILMORE MS, 1989, J BACTERIOL, V171, P744, DOI 10.1128/jb.171.2.744-753.1989; Gohar M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002793; GRANUM PE, 1993, FEMS MICROBIOL LETT, V110, P97, DOI [10.1016/0378-1097(93)90248-Z, 10.1111/j.1574-6968.1993.tb06301.x]; Guillemet E, 2010, J BACTERIOL, V192, P286, DOI 10.1128/JB.00264-09; Guinebretiere MH, 2002, J CLIN MICROBIOL, V40, P3053, DOI 10.1128/JCM.40.8.3053-3056.2002; Haug TM, 2010, J MEMBRANE BIOL, V237, P1, DOI 10.1007/s00232-010-9298-6; Hoa NT, 2000, APPL ENVIRON MICROB, V66, P5241, DOI 10.1128/AEM.66.12.5241-5247.2000; Huseby M, 2007, J BACTERIOL, V189, P8719, DOI 10.1128/JB.00741-07; IKEZAWA H, 1980, ARCH BIOCHEM BIOPHYS, V199, P572, DOI 10.1016/0003-9861(80)90315-X; Kavanagh K, 2004, FEMS MICROBIOL REV, V28, P101, DOI 10.1016/j.femsre.2003.09.002; Kelley JM, 2013, TRANSFUSION, V53, P394, DOI 10.1111/j.1537-2995.2012.03723.x; Klein G, 2011, J FOOD PROTECT, V74, P1189, DOI 10.4315/0362-028X.JFP-10-574; Kolesnick RN, 2000, J CELL PHYSIOL, V184, P285; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lang SH, 2003, J BIOL CHEM, V278, P38167, DOI 10.1074/jbc.M303544200; Lindback T, 2004, MICROBIOL-SGM, V150, P3959, DOI 10.1099/mic.0.27359-0; Lindback T, 2010, INFECT IMMUN, V78, P3813, DOI 10.1128/IAI.00247-10; Lucking G, 2009, MICROBIOL-SGM, V155, P922, DOI 10.1099/mic.0.024125-0; Lund T, 2000, MOL MICROBIOL, V38, P254, DOI 10.1046/j.1365-2958.2000.02147.x; Lund T, 1996, FEMS MICROBIOL LETT, V141, P151, DOI 10.1016/0378-1097(96)00208-X; MCDONEL JL, 1980, PHARMACOL THERAPEUT, V10, P617, DOI 10.1016/0163-7258(80)90031-5; Minnaard J, 2007, INT J FOOD MICROBIOL, V116, P197, DOI 10.1016/j.ijfoodmicro.2006.12.013; Moravek M, 2006, FEMS MICROBIOL LETT, V257, P293, DOI 10.1111/j.1574-6968.2006.00185.x; Mukherjee K, 2010, APPL ENVIRON MICROB, V76, P310, DOI 10.1128/AEM.01301-09; Nakatsuji T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014797; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Nishiwaki H, 2004, EUR J BIOCHEM, V271, P601, DOI 10.1111/j.1432-1033.2003.03962.x; Oda M, 2013, BIOCHEM BIOPH RES CO, V431, P164, DOI 10.1016/j.bbrc.2013.01.002; Oda M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038054; Oda M, 2010, BBA-BIOMEMBRANES, V1798, P1073, DOI 10.1016/j.bbamem.2010.03.004; PEZARD C, 1991, INFECT IMMUN, V59, P3472, DOI 10.1128/IAI.59.10.3472-3477.1991; Pomerantsev AP, 2003, INFECT IMMUN, V71, P6591, DOI 10.1128/IAI.71.11.6591-6606.2003; Ramarao N, 2012, JOVE-J VIS EXP, DOI 10.3791/4392; Rasko DA, 2011, NEW ENGL J MED, V365, P709, DOI 10.1056/NEJMoa1106920; Salamitou S, 2000, MICROBIOL-UK, V146, P2825, DOI 10.1099/00221287-146-11-2825; Sambrook J, 2001, MOL CLONING LAB MANU; Schierack P, 2007, VET IMMUNOL IMMUNOP, V118, P1, DOI 10.1016/j.vetimm.2007.03.006; TAMURA HO, 1994, TOXICON, V32, P629, DOI 10.1016/0041-0101(94)90211-9; Tran SL, 2011, CELL MICROBIOL, V13, P92, DOI 10.1111/j.1462-5822.2010.01522.x; Usui K, 2009, MICROB PATHOGENESIS, V46, P59, DOI 10.1016/j.micpath.2008.10.010; Walev I, 1996, INFECT IMMUN, V64, P2974, DOI 10.1128/IAI.64.8.2974-2979.1996; WALTERS JB, 1983, J INSECT PHYSIOL, V29, P417, DOI 10.1016/0022-1910(83)90069-0; Whitehead RH, 2008, J GASTROEN HEPATOL, V23, P1119, DOI 10.1111/j.1440-1746.2008.05308.x; YAMADA A, 1988, EUR J BIOCHEM, V175, P213, DOI 10.1111/j.1432-1033.1988.tb14186.x	66	48	51	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2013	8	4							e61404	10.1371/journal.pone.0061404	http://dx.doi.org/10.1371/journal.pone.0061404			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130DR	23613846	Green Published, Green Submitted, gold			2022-12-25	WOS:000317893400062
J	Hamilton, WB; Kaji, K; Kunath, T				Hamilton, William B.; Kaji, Keisuke; Kunath, Tilo			ERK2 Suppresses Self-Renewal Capacity of Embryonic Stem Cells, but Is Not Required for Multi-Lineage Commitment	PLOS ONE			English	Article							MOUSE EMBRYOS; C-FOS; KINASE PHOSPHATASE-1; PLURIPOTENTIAL CELLS; RAT BLASTOCYSTS; ES CELLS; EXPRESSION; PROTEIN; NETWORK; NANOG	Activation of the FGF-ERK pathway is necessary for naive mouse embryonic stem (ES) cells to exit self-renewal and commit to early differentiated lineages. Here we show that genetic ablation of Erk2, the predominant ERK isozyme expressed in ES cells, results in hyper-phosphorylation of ERK1, but an overall decrease in total ERK activity as judged by substrate phosphorylation and immediate-early gene (IEG) induction. Normal induction of this subset of canonical ERK targets, as well as p90RSK phosphorylation, was rescued by transgenic expression of either ERK1 or ERK2 indicating a degree of functional redundancy. In contrast to previously published work, Erk2-null ES cells exhibited no detectable defect in lineage specification to any of the three germ layers when induced to differentiate in either embryoid bodies or in defined neural induction conditions. However, under self-renewing conditions Erk2-null ES cells express increased levels of the pluripotency-associated transcripts, Nanog and Tbx3, a decrease in Nanog-GFP heterogeneity, and exhibit enhanced self-renewal in colony forming assays. Transgenic add-back of ERK2 is capable of restoring normal pluripotent gene expression and self-renewal capacity. We show that ERK2 contributes to the destabilization of ES cell self-renewal by reducing expression of pluripotency genes, such as Nanog, but is not specifically required for the early stages of germ layer specification.	[Hamilton, William B.; Kaji, Keisuke; Kunath, Tilo] Univ Edinburgh, MRC Ctr Regenerat Med, Edinburgh, Midlothian, Scotland	University of Edinburgh	Hamilton, WB (corresponding author), Univ Edinburgh, MRC Ctr Regenerat Med, Edinburgh, Midlothian, Scotland.	william.hamilton@sund.ku.dk; tilo.kunath@ed.ac.uk		Kaji, Keisuke/0000-0001-5946-8415; Kunath, Tilo/0000-0002-8805-7356; Hamilton, William B/0000-0003-2029-1944	School of Biological Sciences, University of Edinburgh; Scottish Funding Council and Parkinson's UK; Medical Research Council [G0700711B, MR/J012831/1, MR/K017276/1] Funding Source: researchfish; Parkinson&quot;s UK [K-1205, F-0902] Funding Source: researchfish; MRC [MR/J012831/1, MR/K017276/1] Funding Source: UKRI	School of Biological Sciences, University of Edinburgh; Scottish Funding Council and Parkinson's UK; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Parkinson&quot;s UK(Parkinson&apos;s UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	WBH was supported by a studentship from the School of Biological Sciences, University of Edinburgh, and the work was funded by the Scottish Funding Council and Parkinson's UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arman E, 1998, P NATL ACAD SCI USA, V95, P5082, DOI 10.1073/pnas.95.9.5082; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Brondello JM, 1997, J BIOL CHEM, V272, P1368, DOI 10.1074/jbc.272.2.1368; Brondello JM, 1999, SCIENCE, V286, P2514, DOI 10.1126/science.286.5449.2514; Brook FA, 1997, P NATL ACAD SCI USA, V94, P5709, DOI 10.1073/pnas.94.11.5709; Buehr M, 2008, CELL, V135, P1287, DOI 10.1016/j.cell.2008.12.007; Burdon T, 1999, DEV BIOL, V210, P30, DOI 10.1006/dbio.1999.9265; Canham MA, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000379; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Chazaud C, 2006, DEV CELL, V10, P615, DOI 10.1016/j.devcel.2006.02.020; Cheng AM, 1998, CELL, V95, P793, DOI 10.1016/S0092-8674(00)81702-X; Choudhury GG, 2001, J BIOL CHEM, V276, P35636, DOI 10.1074/jbc.M100946200; Dalby KN, 1998, J BIOL CHEM, V273, P1496, DOI 10.1074/jbc.273.3.1496; Davies OR, 2013, CELL REP, V3, P472, DOI 10.1016/j.celrep.2013.01.017; De Cesare D, 1998, P NATL ACAD SCI USA, V95, P12202, DOI 10.1073/pnas.95.21.12202; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; FELDMAN B, 1995, SCIENCE, V267, P246, DOI 10.1126/science.7809630; Fischer AM, 2005, IMMUNITY, V23, P431, DOI 10.1016/j.immuni.2005.08.013; Gurtu V, 1996, BIOCHEM BIOPH RES CO, V229, P295, DOI 10.1006/bbrc.1996.1795; HOOPER M, 1987, NATURE, V326, P292, DOI 10.1038/326292a0; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Kholodenko BN, 2010, NAT REV MOL CELL BIO, V11, P414, DOI 10.1038/nrm2901; Kiyatkin A, 2009, METHODS MOL BIOL, V536, P149, DOI 10.1007/978-1-59745-542-8_17; Kunath T, 2007, DEVELOPMENT, V134, P2895, DOI 10.1242/dev.02880; Li P, 2008, CELL, V135, P1299, DOI 10.1016/j.cell.2008.12.006; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Murphy LO, 2002, NAT CELL BIOL, V4, P556, DOI 10.1038/ncb822; Najm FJ, 2011, CELL STEM CELL, V8, P318, DOI 10.1016/j.stem.2011.01.016; Nakakuki T, 2010, CELL, V141, P884, DOI 10.1016/j.cell.2010.03.054; Nichols J, 2009, NAT MED, V15, P814, DOI 10.1038/nm.1996; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Niwa H, 2009, NATURE, V460, P118, DOI 10.1038/nature08113; ROBERTSON E, 1986, NATURE, V323, P445, DOI 10.1038/323445a0; ROGERS S, 1986, SCIENCE, V234, P364, DOI 10.1126/science.2876518; Saba-El-Leil MK, 2003, EMBO REP, V4, P964, DOI 10.1038/sj.embor.embor939; Santos SDM, 2007, NAT CELL BIOL, V9, P324, DOI 10.1038/ncb1543; Silva J, 2008, CELL, V132, P532, DOI 10.1016/j.cell.2008.02.006; Singh AM, 2007, STEM CELLS, V25, P2534, DOI 10.1634/stemcells.2007-0126; Tsakiridis A, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp640; van den Berg DLC, 2010, CELL STEM CELL, V6, P369, DOI 10.1016/j.stem.2010.02.014; Voisin L, 2010, MOL CELL BIOL, V30, P2918, DOI 10.1128/MCB.00131-10; White J, 2005, STEM CELL REV, V1, P131, DOI 10.1385/SCR:1:2:131; Wilder PJ, 1997, DEV BIOL, V192, P614, DOI 10.1006/dbio.1997.8777; Yao Y, 2003, P NATL ACAD SCI USA, V100, P12759, DOI 10.1073/pnas.2134254100; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; YUAN HB, 1995, GENE DEV, V9, P2635, DOI 10.1101/gad.9.21.2635	51	22	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2013	8	4							e60907	10.1371/journal.pone.0060907	http://dx.doi.org/10.1371/journal.pone.0060907			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130DR	23613754	Green Submitted, Green Published, gold			2022-12-25	WOS:000317893400028
J	Holmes, LV; Strain, L; Staniforth, SJ; Moore, I; Marchbank, K; Kavanagh, D; Goodship, JA; Cordell, HJ; Goodship, THJ				Holmes, Lucy V.; Strain, Lisa; Staniforth, Scott J.; Moore, Iain; Marchbank, Kevin; Kavanagh, David; Goodship, Judith A.; Cordell, Heather J.; Goodship, Timothy H. J.			Determining the Population Frequency of the CFHR3/CFHR1 Deletion at 1q32	PLOS ONE			English	Article							HEMOLYTIC-UREMIC SYNDROME; COMPLEMENT-FACTOR-H; GENOME-WIDE ASSOCIATION; MACULAR DEGENERATION; CFHR1-CFHR3 DELETION; AFRICAN-AMERICANS; IGA NEPHROPATHY; CFH SNP; GENES; DISEASES	In this study we have used multiplex ligation-dependent probe amplification (MLPA) to measure the copy number of CFHR3 and CFHR1 in DNA samples from 238 individuals from the UK and 439 individuals from the HGDP-CEPH Human Genome Diversity Cell Line Panel. We have then calculated the allele frequency and frequency of homozygosity for the copy number polymorphism represented by the CFHR3/CFHR1 deletion. There was a highly significant difference between geographical locations in both the allele frequency (X-2 = 127.7, DF = 11, P-value = 4.97x10(-22)) and frequency of homozygosity (X-2 = 142.3, DF = 22, P-value = 1.33x10(-19)). The highest frequency for the deleted allele (54.7%) was seen in DNA samples from Nigeria and the lowest (0%) in samples from South America and Japan. The observed frequencies in conjunction with the known association of the deletion with AMD, SLE and IgA nephropathy is in keeping with differences in the prevalence of these diseases in African and European Americans. This emphasises the importance of identifying copy number polymorphism in disease.	[Holmes, Lucy V.; Staniforth, Scott J.; Moore, Iain; Marchbank, Kevin; Kavanagh, David; Goodship, Judith A.; Cordell, Heather J.; Goodship, Timothy H. J.] Newcastle Univ, Inst Genet & Cellular Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Strain, Lisa] Newcastle Tyne Hosp NHS Fdn Trust, Northern Mol Genet Serv, Newcastle Upon Tyne, Tyne & Wear, England	Newcastle University - UK; Newcastle Upon Tyne Hospitals NHS Foundation Trust	Goodship, THJ (corresponding author), Newcastle Univ, Inst Genet & Cellular Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	t.h.j.goodship@ncl.ac.uk	Kavanagh, David/E-8498-2011; Rosby, Lucy Victoria/N-3458-2018	Kavanagh, David/0000-0003-4718-0072; marchbank, kevin james/0000-0003-1312-5411; Cordell, Heather/0000-0002-1879-5572	UK Medical Research Council [G0701325]; Northern Counties Kidney Research Fund; Wellcome Trust grant [076113/C/04/Z]; Juvenile Diabetes Research Foundation grant [WT061858]; National Institute of Health Research of England; Medical Research Council [G0701325] Funding Source: researchfish; MRC [G0701325] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Northern Counties Kidney Research Fund; Wellcome Trust grant(Wellcome Trust); Juvenile Diabetes Research Foundation grant(Juvenile Diabetes Research Foundation); National Institute of Health Research of England(National Institute for Health Research (NIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Funding for this study was provided by the UK Medical Research Council (G0701325) and the Northern Counties Kidney Research Fund. We acknowledge use of DNA from The UK Blood Services collection of Common Controls (UKBS collection), funded by the Wellcome Trust grant 076113/C/04/Z, by the Juvenile Diabetes Research Foundation grant WT061858, and by the National Institute of Health Research of England. The collection was established as part of the Wellcome Trust Case-Control Consortium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge use of DNA from The UK Blood Services collection of Common Controls (UKBS collection), funded by the Wellcome Trust grant 076113/C/04/Z, by the Juvenile Diabetes Research Foundation grant WT061858, and by the National Institute of Health Research of England. The collection was established as part of the Wellcome Trust Case-Control Consortium. We thank Dr Howard Cann (Centre d'Etude du Polymorphisme Humaine (CEPH), Paris, France) for his critical appraisal of this manuscript.	Abarrategui-Garrido C, 2009, BLOOD, V114, P4261, DOI 10.1182/blood-2009-05-223834; [Anonymous], 2007, NATURE, V447, P661; Cann HM, 2002, SCIENCE, V296, P261; Danchenko N, 2006, LUPUS, V15, P308, DOI 10.1191/0961203306lu2305xx; Davila S, 2010, NAT GENET, V42, P772, DOI 10.1038/ng.640; Diaz-Guillen MA, 1999, IMMUNOGENETICS, V49, P549, DOI 10.1007/s002510050534; Dishaw LJ, 2005, IMMUNOGENETICS, V57, P535, DOI 10.1007/s00251-005-0005-1; Dragon-Durey MA, 2009, J MED GENET, V46, P447, DOI 10.1136/jmg.2008.064766; Ermini L, 2012, IMMUNOBIOLOGY, V217, P265, DOI 10.1016/j.imbio.2011.07.020; FEIFEL E, 1992, IMMUNOGENETICS, V36, P104, DOI 10.1007/BF00215286; Francis NJ, 2012, BLOOD, V119, P591, DOI 10.1182/blood-2011-03-339903; Gharavi AG, 2011, NAT GENET, V43, P321, DOI 10.1038/ng.787; Hageman GS, 2006, ANN MED, V38, P592, DOI 10.1080/07853890601097030; Heinen S, 2009, BLOOD, V114, P2439, DOI 10.1182/blood-2009-02-205641; Henn BM, 2012, P NATL ACAD SCI USA, V109, P17758, DOI 10.1073/pnas.1212380109; Henn BM, 2011, P NATL ACAD SCI USA, V108, P5154, DOI 10.1073/pnas.1017511108; Hughes AE, 2006, NAT GENET, V38, P1173, DOI 10.1038/ng1890; Hughes AE, 2010, NAT GENET, V42, P555, DOI 10.1038/ng0710-555; JENNETTE JC, 1985, KIDNEY INT, V28, P944, DOI 10.1038/ki.1985.222; Jozsi M, 2008, TRENDS IMMUNOL, V29, P380, DOI 10.1016/j.it.2008.04.008; Jozsi M, 2008, BLOOD, V111, P1512, DOI 10.1182/blood-2007-09-109876; Kemper C, 2000, EXP CLIN IMMUNOGENET, V17, P55, DOI 10.1159/000019124; Kimura Y, 2004, J IMMUNOL, V173, P1118, DOI 10.4049/jimmunol.173.2.1118; Kiryluk K, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002765; Klein R, 2011, ARCH OPHTHALMOL-CHIC, V129, P75, DOI 10.1001/archophthalmol.2010.318; Krushkal J, 1998, J MOL EVOL, V47, P625, DOI 10.1007/PL00013152; Leban N, 2012, INT J IMMUNOGENET, V39, P110, DOI 10.1111/j.1744-313X.2011.01071.x; Lupski JR, 2007, NEW ENGL J MED, V356, P1169, DOI 10.1056/NEJMcibr067658; Lupski JR, 2005, PLOS GENET, V1, P627, DOI 10.1371/journal.pgen.0010049; Male DA, 2000, MOL IMMUNOL, V37, P41, DOI 10.1016/S0161-5890(00)00024-9; Malik TH, 2012, J AM SOC NEPHROL, V23, P1155, DOI 10.1681/ASN.2012020166; McVey M, 2008, TRENDS GENET, V24, P529, DOI 10.1016/j.tig.2008.08.007; Moore I, 2010, BLOOD, V115, P379, DOI 10.1182/blood-2009-05-221549; Newport M, 2007, NAT GENET, V39, P1329, DOI 10.1038/ng.2007.17; Nonaka M, 2006, IMMUNOGENETICS, V58, P701, DOI 10.1007/s00251-006-0142-1; Pickrell JK, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2140; Raychaudhuri S, 2010, NAT GENET, V42, P553, DOI 10.1038/ng0710-553; Schouten JP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf056; Silver KL, 2010, CELL MICROBIOL, V12, P1036, DOI 10.1111/j.1462-5822.2010.01492.x; Sivakumaran TA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025598; Spencer KL, 2008, HUM MOL GENET, V17, P971, DOI 10.1093/hmg/ddm369; Sun GN, 2010, FUNCT INTEGR GENOMIC, V10, P577, DOI 10.1007/s10142-010-0182-3; Tishkoff SA, 2009, SCIENCE, V324, P1035, DOI 10.1126/science.1172257; Venables JP, 2006, PLOS MED, V3, P1957, DOI 10.1371/journal.pmed.0030431; Zakharia F, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-12-r141; Zhao J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002079; Zipfel PF, 2007, PLOS GENET, V3, P387, DOI 10.1371/journal.pgen.0030041; Zipfel PF, 1999, IMMUNOPHARMACOLOGY, V42, P53, DOI 10.1016/S0162-3109(99)00015-6	48	75	77	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2013	8	4							e60352	10.1371/journal.pone.0060352	http://dx.doi.org/10.1371/journal.pone.0060352			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130DR	23613724	Green Published, Green Submitted, gold			2022-12-25	WOS:000317893400008
J	Sousounis, K; Looso, M; Maki, N; Ivester, CJ; Braun, T; Tsonis, PA				Sousounis, Konstantinos; Looso, Mario; Maki, Nobuyasu; Ivester, Clifford J.; Braun, Thomas; Tsonis, Panagiotis A.			Transcriptome Analysis of Newt Lens Regeneration Reveals Distinct Gradients in Gene Expression Patterns	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; KAPPA-B ACTIVATION; MESSENGER-RNA; CELL-CYCLE; RIBOSOMAL-RNA; TUMOR-SUPPRESSOR; BINDING PROTEIN; DNA-DAMAGE; MICROTUBULE NUCLEATION; POLYADENYLATION FACTOR	Regeneration of the lens in newts is quite a unique process. The lens is removed in its entirety and regeneration ensues from the pigment epithelial cells of the dorsal iris via transdifferentiation. The same type of cells from the ventral iris are not capable of regenerating a lens. It is, thus, expected that differences between dorsal and ventral iris during the process of regeneration might provide important clues pertaining to the mechanism of regeneration. In this paper, we employed next generation RNA-seq to determine gene expression patterns during lens regeneration in Notophthalmus viridescens. The expression of more than 38,000 transcripts was compared between dorsal and ventral iris. Although very few genes were found to be dorsal- or ventral-specific, certain groups of genes were up-regulated specifically in the dorsal iris. These genes are involved in cell cycle, gene regulation, cytoskeleton and immune response. In addition, the expression of six highly regulated genes, TBX5, FGF10, UNC5B, VAX2, NR2F5, and NTN1, was verified using qRT-PCR. These graded gene expression patterns provide insight into the mechanism of lens regeneration, the markers that are specific to dorsal or ventral iris, and layout a map for future studies in the field.	[Sousounis, Konstantinos; Maki, Nobuyasu; Ivester, Clifford J.; Tsonis, Panagiotis A.] Univ Dayton, Dept Biol, Dayton, OH 45469 USA; [Sousounis, Konstantinos; Maki, Nobuyasu; Ivester, Clifford J.; Tsonis, Panagiotis A.] Univ Dayton, Ctr Tissue Regenerat & Engn Dayton, Dayton, OH 45469 USA; [Looso, Mario] Max Planck Inst Heart & Lung Res, Dept Bioinformat, Bad Nauheim, Germany; [Braun, Thomas] Max Planck Inst Heart & Lung Res, Dept Cardiac Dev & Remodeling, Bad Nauheim, Germany	University of Dayton; University of Dayton; Max Planck Society; Max Planck Society	Braun, T (corresponding author), Max Planck Inst Heart & Lung Res, Dept Cardiac Dev & Remodeling, Bad Nauheim, Germany.	thomas.braun@mpi-bn.mpg.de; ptsonis1@udayton.edu	Braun, Thomas/B-2310-2008	Braun, Thomas/0000-0002-6165-4804; Looso, Mario/0000-0003-1495-9530; Sousounis, Konstantinos/0000-0002-5577-6207	National Institutes of Health [EY10540]; NATIONAL EYE INSTITUTE [R01EY010540] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Institutes of Health grant EY10540. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afrakhte M, 1998, BIOCHEM BIOPH RES CO, V249, P505, DOI 10.1006/bbrc.1998.9170; Akhmanova A, 2001, CELL, V104, P923, DOI 10.1016/S0092-8674(01)00288-4; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ansari KI, 2010, FEBS J, V277, P1790, DOI 10.1111/j.1742-4658.2010.07606.x; Azuma M, 2006, J BIOL CHEM, V281, P13309, DOI 10.1074/jbc.M601892200; Baddour JA, 2012, BIRTH DEFECTS RES C, V96, P1, DOI 10.1002/bdrc.21006; Bai SW, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-54; Barbieri AM, 1999, P NATL ACAD SCI USA, V96, P10729, DOI 10.1073/pnas.96.19.10729; Bochman ML, 2009, MICROBIOL MOL BIOL R, V73, P652, DOI 10.1128/MMBR.00019-09; Brede G, 2002, NUCLEIC ACIDS RES, V30, P5301, DOI 10.1093/nar/gkf648; Bruckskotten M, 2012, NUCLEIC ACIDS RES, V40, pD895, DOI 10.1093/nar/gkr873; Cao R, 2004, CURR OPIN GENET DEV, V14, P155, DOI 10.1016/j.gde.2004.02.001; Casco-Robles MM, 2011, NAT PROTOC, V6, P600, DOI 10.1038/nprot.2011.334; Casenghi M, 2003, DEV CELL, V5, P113, DOI 10.1016/S1534-5807(03)00193-X; Cazalla D, 2005, MOL CELL BIOL, V25, P2969, DOI 10.1128/MCB.25.8.2969-2980.2005; Champion EA, 2008, MOL CELL BIOL, V28, P6547, DOI 10.1128/MCB.00906-08; Charroux B, 2000, J CELL BIOL, V148, P1177, DOI 10.1083/jcb.148.6.1177; CHAUDHARY N, 1991, P NATL ACAD SCI USA, V88, P8189, DOI 10.1073/pnas.88.18.8189; Chen HJ, 2006, GENE DEV, V20, P1933, DOI 10.1101/gad.1411206; Chen LH, 2005, EMBO J, V24, P3411, DOI 10.1038/sj.emboj.7600812; Chumnarnsilpa S, 2009, P NATL ACAD SCI USA, V106, P13719, DOI 10.1073/pnas.0812383106; Collart MA, 2012, GENE, V492, P42, DOI 10.1016/j.gene.2011.09.033; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cowper AE, 2001, J BIOL CHEM, V276, P48908, DOI 10.1074/jbc.M103967200; Damianov A, 2006, BIOL CHEM, V387, P1455, DOI 10.1515/BC.2006.182; Dantzig JA, 2006, ANN NY ACAD SCI, V1080, P1, DOI 10.1196/annals.1380.002; Del Rio-Tsonis K, 1998, J IMMUNOL, V161, P6819; Denslow SA, 2007, ONCOGENE, V26, P5433, DOI 10.1038/sj.onc.1210611; Ding JQ, 2006, HUM MOL GENET, V15, P1451, DOI 10.1093/hmg/ddl069; Ding JQ, 2002, J CELL BIOL, V158, P427, DOI 10.1083/jcb.200202055; Doyon Y, 2004, CURR OPIN GENET DEV, V14, P147, DOI 10.1016/j.gde.2004.02.009; DRAETTA G, 1988, CELL, V54, P17, DOI 10.1016/0092-8674(88)90175-4; EGUCHI G, 1971, DEV GROWTH DIFFER, V13, P337; EGUCHI G, 1963, EMBRYOLOGIA, V8, P45, DOI 10.1111/j.1440-169X.1963.tb00185.x; Euskirchen G, 2012, J BIOL CHEM, V287, P30897, DOI 10.1074/jbc.R111.309302; Faigle W, 1998, J CELL BIOL, V141, P1121, DOI 10.1083/jcb.141.5.1121; Friesen WJ, 2002, J BIOL CHEM, V277, P8243, DOI 10.1074/jbc.M109984200; GALAKTIONOV K, 1991, CELL, V67, P1181, DOI 10.1016/0092-8674(91)90294-9; GIGUERE V, 1987, NATURE, V330, P624, DOI 10.1038/330624a0; Godwin JW, 2010, MECH DEVELOP, V127, P321, DOI 10.1016/j.mod.2010.04.004; Gomez TS, 2009, DEV CELL, V17, P699, DOI 10.1016/j.devcel.2009.09.009; Gray JX, 1996, J IMMUNOL, V157, P5438; Grogg MW, 2005, NATURE, V438, P858, DOI 10.1038/nature04175; GU Y, 1992, EMBO J, V11, P3995, DOI 10.1002/j.1460-2075.1992.tb05493.x; Guarguaglini G, 2005, MOL BIOL CELL, V16, P1095, DOI 10.1091/mbc.E04-10-0939; Gudi R, 2006, ONCOGENE, V25, P3458, DOI 10.1038/sj.onc.1209381; Gumienny TL, 2001, CELL, V107, P27, DOI 10.1016/S0092-8674(01)00520-7; Guo QB, 1998, P NATL ACAD SCI USA, V95, P9172, DOI 10.1073/pnas.95.16.9172; Hamaguchi N, 2007, BIOCHEM BIOPH RES CO, V361, P270, DOI 10.1016/j.bbrc.2007.06.132; Hannedouche S, 2011, NATURE, V475, P524, DOI 10.1038/nature10280; Hart MJ, 1996, EMBO J, V15, P2997, DOI 10.1002/j.1460-2075.1996.tb00663.x; Hata A, 1998, GENE DEV, V12, P186, DOI 10.1101/gad.12.2.186; HENGLEIN B, 1994, P NATL ACAD SCI USA, V91, P5490, DOI 10.1073/pnas.91.12.5490; Henry JJ, 2010, PROG RETIN EYE RES, V29, P543, DOI 10.1016/j.preteyeres.2010.07.002; HIROSE T, 1995, BIOCHEM BIOPH RES CO, V211, P83, DOI 10.1006/bbrc.1995.1781; Ho TH, 2004, EMBO J, V23, P3103, DOI 10.1038/sj.emboj.7600300; Hu DL, 2003, J BIOL CHEM, V278, P8623, DOI 10.1074/jbc.M210057200; Huang SC, 2012, MOL CELL BIOL, V32, P513, DOI 10.1128/MCB.06423-11; Imokawa Y, 2003, CURR BIOL, V13, P877, DOI 10.1016/S0960-9822(03)00294-X; Jurica MS, 2002, RNA, V8, P426, DOI 10.1017/S1355838202021088; Katahira J, 2012, BBA-GENE REGUL MECH, V1819, P507, DOI 10.1016/j.bbagrm.2011.12.001; KAUFMAN PD, 1995, CELL, V81, P1105, DOI 10.1016/S0092-8674(05)80015-7; Khan JA, 2011, GENE THER, V18, P437, DOI 10.1038/gt.2010.155; Khan P, 2002, DEV BIOL, V250, P383, DOI 10.1006/dbio.2002.0801; Kim JW, 2000, NUCLEIC ACIDS RES, V28, P3666, DOI 10.1093/nar/28.18.3666; Kimura Y, 2003, J IMMUNOL, V170, P2331, DOI 10.4049/jimmunol.170.5.2331; Kondo S, 2007, MOL CELL BIOL, V27, P1716, DOI 10.1128/MCB.01552-06; Kotlajich MV, 2008, MOL CELL, V32, P162, DOI 10.1016/j.molcel.2008.10.008; Krock BL, 2008, J CELL SCI, V121, P1907, DOI 10.1242/jcs.029397; Kruse SW, 2008, PLOS BIOL, V6, P2002, DOI 10.1371/journal.pbio.0060227; Lauper N, 1998, ONCOGENE, V17, P2637, DOI 10.1038/sj.onc.1202477; Leconte L, 2004, J BIOL CHEM, V279, P47272, DOI 10.1074/jbc.M406624200; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu QH, 2000, GENE DEV, V14, P1448; Looso M, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-2-r16; Louis-Dit-Picard H, 2012, NAT GENET, V44, P456, DOI 10.1038/ng.2218; Luo HBR, 1999, RNA, V5, P893, DOI 10.1017/S1355838299990520; Makarev E, 2007, FEBS LETT, V581, P1865, DOI 10.1016/j.febslet.2007.03.082; MANGELSDORF DJ, 1990, NATURE, V345, P224, DOI 10.1038/345224a0; Mastellos D, 2001, J IMMUNOL, V166, P2479, DOI 10.4049/jimmunol.166.4.2479; McLean JR, 2011, CRIT REV BIOCHEM MOL, V46, P118, DOI 10.3109/10409238.2010.541420; McNally KP, 2000, J CELL SCI, V113, P1623; Mehta GD, 2012, BBA-MOL CELL RES, V1823, P1324, DOI 10.1016/j.bbamcr.2012.05.027; Meng W, 2008, CELL, V135, P948, DOI 10.1016/j.cell.2008.09.040; Merkle CJ, 2003, J BIOL CHEM, V278, P30051, DOI 10.1074/jbc.M211591200; Merrill AE, 2009, AM J HUM GENET, V84, P542, DOI 10.1016/j.ajhg.2009.03.015; Moore PA, 1999, SCIENCE, V285, P260, DOI 10.1126/science.285.5425.260; Moshous D, 2001, CELL, V105, P177, DOI 10.1016/S0092-8674(01)00309-9; Myhre S, 2006, BIOINFORMATICS, V22, P2020, DOI 10.1093/bioinformatics/btl334; Nachury MV, 2007, CELL, V129, P1201, DOI 10.1016/j.cell.2007.03.053; Neubauer G, 1998, NAT GENET, V20, P46, DOI 10.1038/1700; Niwa R, 2002, CELL, V108, P233, DOI 10.1016/S0092-8674(01)00638-9; Oh SH, 2002, J COMP NEUROL, V448, P399, DOI 10.1002/cne.10265; Olson JK, 2004, J IMMUNOL, V173, P3916, DOI 10.4049/jimmunol.173.6.3916; ORAND MG, 1992, DEV BIOL, V154, P37, DOI 10.1016/0012-1606(92)90045-I; Page-McCaw PS, 1999, RNA, V5, P1548, DOI 10.1017/S1355838299991938; Pardo R, 2010, MOL BRAIN, V3, DOI 10.1186/1756-6606-3-17; Pfeiffer JR, 2011, MOL CELL BIOL, V31, P277, DOI 10.1128/MCB.00775-10; PINES J, 1989, CELL, V58, P833, DOI 10.1016/0092-8674(89)90936-7; Prescott JE, 2001, J BIOL CHEM, V276, P48276, DOI 10.1074/jbc.M107357200; Raemaekers T, 2003, J CELL BIOL, V162, P1017, DOI 10.1083/jcb.200302129; Riento K, 2003, NAT REV MOL CELL BIO, V4, P446, DOI 10.1038/nrm1128; Rohrmoser M, 2007, MOL CELL BIOL, V27, P3682, DOI 10.1128/MCB.00172-07; RUBEN SM, 1992, GENE DEV, V6, P745, DOI 10.1101/gad.6.5.745; Ryan K, 2004, RNA, V10, P565, DOI 10.1261/rna.5214404; Rytkonen AK, 2006, FEBS J, V273, P2984, DOI 10.1111/j.1742-4658.2006.05310.x; Sarkissian M, 1996, J BIOL CHEM, V271, P31106, DOI 10.1074/jbc.271.49.31106; SCEARCE LM, 1993, J BIOL CHEM, V268, P8855; Schilders G, 2007, NUCLEIC ACIDS RES, V35, P2564, DOI 10.1093/nar/gkm082; SCHMID RM, 1991, NATURE, V352, P733, DOI 10.1038/352733a0; Schuler H, 2008, FEBS J, V275, P59, DOI 10.1111/j.1742-4658.2007.06171.x; Scorilas A, 2001, BRIT J CANCER, V85, P190, DOI 10.1054/bjoc.2001.1885; Sivaram MVS, 2009, EMBO J, V28, P902, DOI 10.1038/emboj.2009.38; Smythe WR, 1999, LUNG CANCER-J IASLC, V24, P157, DOI 10.1016/S0169-5002(99)00032-X; Sousounis K, 2013, MOL VIS, V19, P135; Spassov DS, 2002, GENE, V299, P195, DOI 10.1016/S0378-1119(02)01060-0; Stewart-Hutchinson PJ, 2008, EXP CELL RES, V314, P1892, DOI 10.1016/j.yexcr.2008.02.022; Stillwell EE, 2004, CELL CYCLE, V3, P923; STRACKE ML, 1992, J BIOL CHEM, V267, P2524; Strom M, 2002, J BIOL CHEM, V277, P25423, DOI 10.1074/jbc.M202574200; SU LK, 1993, SCIENCE, V262, P1734, DOI 10.1126/science.8259519; Sweet T, 2008, J CELL PHYSIOL, V214, P381, DOI 10.1002/jcp.21204; TAKAGAKI Y, 1992, J BIOL CHEM, V267, P23471; Takemaru KI, 2003, NATURE, V422, P905, DOI 10.1038/nature01570; Tanaka EM, 1997, J CELL BIOL, V136, P155, DOI 10.1083/jcb.136.1.155; TASSAN JP, 1995, EMBO J, V14, P5608, DOI 10.1002/j.1460-2075.1995.tb00248.x; Teigelkamp S, 1998, RNA, V4, P127; Thompson HM, 2002, CURR BIOL, V12, P2111, DOI 10.1016/S0960-9822(02)01390-8; Tooley J, 2011, CHROMOSOME RES, V19, P377, DOI 10.1007/s10577-010-9180-5; Trompouki E, 2003, NATURE, V424, P793, DOI 10.1038/nature01803; Tsonis PA, 2011, NAT PROTOC, V6, P593, DOI 10.1038/nprot.2011.341; van der Waal MS, 2012, EXP CELL RES, V318, P1407, DOI 10.1016/j.yexcr.2012.03.015; VAUGHAN KT, 1995, J CELL BIOL, V131, P1507, DOI 10.1083/jcb.131.6.1507; Vlach J, 2008, P NATL ACAD SCI USA, V105, P10565, DOI 10.1073/pnas.0801765105; Wade C, 2001, MOL CELL BIOL, V21, P8638, DOI 10.1128/MCB.21.24.8638-8650.2001; Wang H, 2008, BIOCHEM BIOPH RES CO, V370, P594, DOI 10.1016/j.bbrc.2008.03.152; Welch MD, 1997, J CELL BIOL, V138, P375, DOI 10.1083/jcb.138.2.375; Westendorf JM, 1998, MOL BIOL CELL, V9, P437, DOI 10.1091/mbc.9.2.437; Will CL, 2002, EMBO J, V21, P4978, DOI 10.1093/emboj/cdf480; Woodings JA, 2003, BIOCHEM J, V371, P463, DOI 10.1042/BJ20021962; Wozniak MJ, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-35; Yamada T, 1977, Monogr Dev Biol, V13, P1; Yang HH, 2012, CELL, V151, P111, DOI 10.1016/j.cell.2012.07.036; Ye J, 2000, MOL CELL, V6, P1355, DOI 10.1016/S1097-2765(00)00133-7; Yik JHN, 2003, MOL CELL, V12, P971, DOI 10.1016/S1097-2765(03)00388-5; Yoshinaga S, 2012, J NEUROSCI, V32, P11643, DOI 10.1523/JNEUROSCI.0738-12.2012; Yu N, 2009, J DERMATOL SCI, V56, P113, DOI 10.1016/j.jdermsci.2009.08.003; Zhang YJ, 2002, J BIOL CHEM, V277, P17906, DOI 10.1074/jbc.M200348200; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhou H, 2004, J IMMUNOL, V172, P2559, DOI 10.4049/jimmunol.172.4.2559; Zhu B, 2005, MOL CELL, V20, P601, DOI 10.1016/j.molcel.2005.09.025	151	28	29	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2013	8	4							e61445	10.1371/journal.pone.0061445	http://dx.doi.org/10.1371/journal.pone.0061445			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130DR	23613853	Green Published, gold, Green Submitted			2022-12-25	WOS:000317893400066
J	Matthews, GV; Ali, RJ; Avihingsanon, A; Amin, J; Hammond, R; Bowden, S; Lewin, SR; Sasadeusz, J; Littlejohn, M; Locarnini, SL; Ruxrungtham, K; Dore, GJ				Matthews, Gail V.; Ali, Rachel J.; Avihingsanon, Anchalee; Amin, Janaki; Hammond, Rachel; Bowden, Scott; Lewin, Sharon R.; Sasadeusz, Joe; Littlejohn, Margaret; Locarnini, Stephen L.; Ruxrungtham, Kiat; Dore, Gregory J.			Quantitative HBsAg and HBeAg Predict Hepatitis B Seroconversion after Initiation of HAART in HIV-HBV Coinfected Individuals	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; E-ANTIGEN SEROCONVERSION; SURFACE-ANTIGEN; PEGINTERFERON ALPHA-2A; VIROLOGICAL RESPONSE; ADEFOVIR DIPIVOXIL; NATURAL-HISTORY; THERAPY; LAMIVUDINE; COMBINATION	Objective: Anti-HBe seroconversion and HBsAg loss are important therapeutic endpoints in patients with hepatitis B virus (HBV) infection. Quantitative measures of hepatitis B surface antigen (qHBsAg) and e antigen (qHBeAg) have been identified as potentially useful indicators of therapeutic response in HBV monoinfection. The aim of this study was to examine serological change including quantitative biomarkers in HIV-HBV coinfected patients initiating HBV active antiretroviral therapy (ART). Methods: HIV-HBV coinfected individuals from Thailand were followed for up to 168 weeks post ART. Rates and associations of qualitative serological change were determined. Longitudinal changes in qHBsAg and qHBeAg were measured and their utility as predictors of response examined. Results: Forty seven patients were included of whom 27 (57%) were HBeAg positive at baseline. Median CD4 count was 48 cells/mm(3). Over a median follow-up of 108 weeks 48% (13/27) lost HBeAg, 12/27 (44%) achieved anti-HBe seroconversion and 13% (6/47) HBsAg loss. Anti-HBe seroconversion was associated with higher baseline ALT (p = 0.034), lower qHBsAg (p = 0.015), lower qHBeAg (p = 0.031) and greater HBV DNA decline to week 24 (p = 0.045). Sensitivity and specificity for qHBsAg and qHBeAg decline of >0.5 log at week 12 and >1.0 log at week 24 were high for both anti-HBe seroconversion and HBsAg loss. Conclusions: Rates of serological change in these HIV-HBV coinfected individuals with advanced immunodeficiency initiating HBV-active ART were high. Baseline and on treatment factors were identified that were associated with a greater likelihood of subsequent anti-HBe seroconversion, including both quantitative HBsAg and HBeAg, suggesting these biomarkers may have utility in this clinical setting.	[Matthews, Gail V.; Ali, Rachel J.; Amin, Janaki; Dore, Gregory J.] Univ New S Wales, Kirby Inst, Sydney, NSW, Australia; [Avihingsanon, Anchalee; Ruxrungtham, Kiat] Chulongkorn Univ, Dept Med, Thai Red Cross AIDS Res Ctr, HIV NAT, Bangkok, Thailand; [Hammond, Rachel; Bowden, Scott; Littlejohn, Margaret; Locarnini, Stephen L.] Victorian Infect Dis Reference Lab, Melbourne, Vic, Australia; [Lewin, Sharon R.] Monash Univ, Dept Med, Melbourne, Vic 3004, Australia; [Lewin, Sharon R.] Alfred Hosp, Infect Dis Unit, Melbourne, Vic, Australia; [Lewin, Sharon R.] Burnet Inst, Ctr Virol, Melbourne, Vic, Australia; [Sasadeusz, Joe] Royal Melbourne Hosp, Melbourne, Vic, Australia	University of New South Wales Sydney; Kirby Institute; Chulalongkorn University; Thai Red Cross Society; Victorian Infectious Diseases Reference Laboratory; Monash University; Florey Institute of Neuroscience & Mental Health; Burnet Institute; Royal Melbourne Hospital	Matthews, GV (corresponding author), Univ New S Wales, Kirby Inst, Sydney, NSW, Australia.	gmatthews@kirby.unsw.edu.au	Lewin, Sharon/Z-3297-2019; matthews, gail/AFL-8501-2022; matthews, gail/AAG-8626-2022; Dore, Gregory John/ABD-5665-2021	Dore, Gregory John/0000-0002-4741-2622; Littlejohn, Margaret/0000-0002-8206-2664; Matthews, Gail/0000-0002-1048-6396; Amin, Janaki/0000-0003-2161-9366; Ruxrungtham, Kiat/0000-0001-7348-2352; Lewin, Sharon Ruth/0000-0002-0330-8241	Gilead sciences; Gilead; MSD; Merck; BMS; Roche; Melbourne Health; Receipt of Intellectual Property Rights/Patent Holder; National Research University Project of CHE [HR1161A]; Ministry of Education; GlaxoSmithKline; Janssen	Gilead sciences(Gilead Sciences); Gilead(Gilead Sciences); MSD; Merck(Merck & Company); BMS(Bristol-Myers Squibb); Roche(Roche Holding); Melbourne Health; Receipt of Intellectual Property Rights/Patent Holder; National Research University Project of CHE; Ministry of Education; GlaxoSmithKline(GlaxoSmithKline); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc)	Gilead sciences provided unrestricted grant support to complete quantitative testing for this study. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journals policy and declare the following conflicts. Matthews GV: Grant funding: Gilead, MSD, Speakers bureau: Gilead, Roche, MSD, BMS, Janssen, Travel support: Janssen, MSD. Ali RJ: None. Avihingsanon A: None. Lewin SR: Grant funding: Gilead and Merck; Paid consultant and speaker: Gilead, Viiv Healthcare; Advisory Board: Gilead and Merck. Sasadeusz J: Gilead: research funding, meeting sponsorship, Merck: research funding, meeting sponsorship, BMS: research funding, Roche: research funding, paid speaker, advisory board. Hammond R: None. Bowden S: Speaker with honorarium for Gilead, Bristol-Myers Squibb, Roche and Merck. Littlejohn M: None. Locarnini S: Royalties - "Melbourne Health; Receipt of Intellectual Property Rights/Patent Holder -" Melbourne Health; Consulting Fees (eg. Advisory Boards) - Evivar Pty Ltd, Gilead, Bristol-Myers Squibb; Fees for Non-CME Services Received Directly from a Commercial Interest or their Agent -Bristol-Myers Squibb, Merck Sharpe and Dohme Pty Ltd. Ruxrungtham K has been awarded Senior Researcher Scholar, Thai Research Fund; The National Research University Project of CHE (HR1161A), Ministry of Education; and the Professional Research Team Strengthening Fund, from the National Science and Technology Development Agency (NSTDA), BIOTEC, Ministry of Science and Technology; Thailand. He has also served as a consultant for Merck, and Tibotec. He has been a speaker with honorarium for Bristol-Myers Squibb, Merck, Roche, Jensen-Cilag, GlaxoSmithKline, and GPO. Dore GJ: Board membership: Roche, Merck, Janssen, Gilead, BMS; Honoraria: Roche, Merck, Janssen, Gilead, BMS; Research grants: Roche, Merck, Janssen, Gilead, BMS; Scholarship: Roche, Merck, Janssen. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Ayihingsanon A, 2010, ANTIVIR THER, V15, P917, DOI 10.3851/IMP1645; BODSWORTH NJ, 1991, J INFECT DIS, V163, P1138, DOI 10.1093/infdis/163.5.1138; Brunetto MR, 2009, HEPATOLOGY, V49, P1141, DOI 10.1002/hep.22760; Cai W, 2010, J CLIN VIROL, V48, P22, DOI 10.1016/j.jcv.2010.02.014; Chang TT, 2006, NEW ENGL J MED, V354, P1001, DOI 10.1056/NEJMoa051285; Chen CH, 2004, EUR J GASTROEN HEPAT, V16, P1213, DOI 10.1097/00042737-200411000-00021; de Vries-Sluijs TEMS, 2010, GASTROENTEROLOGY, V139, P1934, DOI 10.1053/j.gastro.2010.08.045; Gane E, 2010, 61 ANN M AM ASS STUD; Heathcote EJ, 2011, GASTROENTEROLOGY, V140, P132, DOI 10.1053/j.gastro.2010.10.011; JANSSEN HLA, 1994, ANTIVIR RES, V23, P251, DOI 10.1016/0166-3542(94)90022-1; Jung YK, 2010, J CLIN GASTROENTEROL, V44, P653, DOI 10.1097/MCG.0b013e3181d52946; Lai CL, 1998, NEW ENGL J MED, V339, P61, DOI 10.1056/NEJM199807093390201; Lau GKK, 2005, NEW ENGL J MED, V352, P2682, DOI 10.1056/NEJMoa043470; Lee JM, 2011, HEPATOLOGY, V53, P1486, DOI 10.1002/hep.24221; Leung NWY, 2001, HEPATOLOGY, V33, P1527, DOI 10.1053/jhep.2001.25084; Liaw YF, 2003, J GASTROEN HEPATOL, V18, P246, DOI 10.1046/j.1440-1746.2003.02976.x; Marcellin P, 2003, NEW ENGL J MED, V348, P808, DOI 10.1056/NEJMoa020681; Matthews GV, 2008, HEPATOLOGY, V48, P1062, DOI 10.1002/hep.22462; Maylin S, 2012, AIDS, V26, P939, DOI 10.1097/QAD.0b013e328352224d; Miailhes P, 2007, CLIN INFECT DIS, V45, P624, DOI 10.1086/520752; Moucari R, 2009, HEPATOLOGY, V49, P1151, DOI 10.1002/hep.22744; Piratvisuth T, 2011, HEPATOL INT; Reijnders JGP, 2011, J HEPATOL, V54, P449, DOI 10.1016/j.jhep.2010.07.046; Thibault V, 2011, ANTIVIR THER, V16, P199, DOI 10.3851/IMP1723; Thio CL, 2002, LANCET, V360, P1921, DOI 10.1016/S0140-6736(02)11913-1; Thompson AJV, 2010, HEPATOLOGY, V51, P1933, DOI 10.1002/hep.23571; Werle-Lapostolle B, 2004, GASTROENTEROLOGY, V126, P1750, DOI 10.1053/j.gastro.2004.03.018; Yuen MF, 2003, GUT, V52, P416, DOI 10.1136/gut.52.3.416	28	37	38	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2013	8	4							e61297	10.1371/journal.pone.0061297	http://dx.doi.org/10.1371/journal.pone.0061297			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JB	23593455	Green Published, Green Submitted, gold			2022-12-25	WOS:000317909600102
J	Yu, YL; Chou, RH; Liang, JH; Chang, WJ; Su, KJ; Tseng, YJ; Huang, WC; Wang, SC; Hung, MC				Yu, Yung-Luen; Chou, Ruey-Hwang; Liang, Jia-Hong; Chang, Wei-Jung; Su, Kuo-Jung; Tseng, Yen-Ju; Huang, Wei-Chien; Wang, Shao-Chun; Hung, Mien-Chie			Targeting the EGFR/PCNA Signaling Suppresses Tumor Growth of Triple-Negative Breast Cancer Cells with Cell-Penetrating PCNA Peptides	PLOS ONE			English	Article							NUCLEAR ANTIGEN PCNA; INVASIVE DUCTAL CARCINOMA; FACTOR RECEPTOR; TYROSINE PHOSPHORYLATION; PROGNOSTIC-FACTOR; EXPRESSION; TRANSLOCATION; ANGIOGENESIS; REPLICATION; COMBINATION	Tyrosine 211 (Y211) phosphorylation of proliferation cell nuclear antigen (PCNA) coincides with pronounced cancer cell proliferation and correlates with poor survival of breast cancer patients. In epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI)-resistant cells, both nuclear EGFR (nEGFR) expression and PCNA Y211 phosphorylation are increased. Moreover, the resistance to EGFR TKI is a major clinical problem in treating EGFR-overexpressing triple-negative breast cancer (TNBC). Thus, effective treatment to combat resistance is urgently needed. Here, we show that treatment of cell-penetrating PCNA peptide (CPPP) inhibits growth and induces apoptosis of human TNBC cells. The Y211F CPPP specifically targets EGFR and competes directly for PCNA tyrosine Y211 phosphorylation and prevents nEGFR from binding PCNA in vivo; it also suppresses tumor growth by sensitizing EGFR TKI resistant cells, which have enhanced nEGFR function and abrogated classical EGFR membrane signaling. Furthermore, we identify an active motif of CPPP, RFLNFF (RF6 CPPP), which is necessary and sufficient to inhibit TKI-resistant TNBC cell growth of orthotopic implanted tumor in mice. Finally, the activity of its synthetic retro-inverted derivative, D-RF6 CPPP, on an equimolar basis, is more potent than RF6 CPPP. Our study reveals a drug candidate with translational potential for the future development of safe and effective therapeutic for EGFR TKI resistance in TNBC.	[Yu, Yung-Luen; Chou, Ruey-Hwang; Liang, Jia-Hong; Chang, Wei-Jung; Su, Kuo-Jung; Tseng, Yen-Ju; Huang, Wei-Chien; Hung, Mien-Chie] China Med Univ, Grad Inst Canc Biol, Taichung, Taiwan; [Yu, Yung-Luen; Chou, Ruey-Hwang; Liang, Jia-Hong; Chang, Wei-Jung; Su, Kuo-Jung; Tseng, Yen-Ju; Huang, Wei-Chien; Hung, Mien-Chie] China Med Univ, Ctr Mol Med, Taichung, Taiwan; [Yu, Yung-Luen; Chou, Ruey-Hwang] Asia Univ, Dept Biotechnol, Taichung, Taiwan; [Su, Kuo-Jung] China Med Univ, PhD Program Canc Biol & Drug Discovery, Taichung, Taiwan; [Wang, Shao-Chun] Univ Cincinnati, Coll Med, Dept Canc & Cell Biol, Cincinnati, OH USA; [Hung, Mien-Chie] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA	China Medical University Taiwan; China Medical University Taiwan; Asia University Taiwan; China Medical University Taiwan; University System of Ohio; University of Cincinnati; University of Texas System; UTMD Anderson Cancer Center	Yu, YL (corresponding author), China Med Univ, Grad Inst Canc Biol, Taichung, Taiwan.	ylyu@mail.cmu.edu.tw; mhung@mdanderson.org	Chou, Ruey-Hwang/K-8541-2013; Hung, Mien-Chie/ABD-5911-2021; Wang, Shao-Chun/P-9904-2019; Huang, Wei-Chien/H-3126-2019; Huang, Wei-Chien/D-1740-2012	Chou, Ruey-Hwang/0000-0002-2297-2180; Hung, Mien-Chie/0000-0003-4317-4740; Wang, Shao-Chun/0000-0002-5477-1682; Huang, Wei-Chien/0000-0001-6467-8716; Huang, Wei-Chien/0000-0001-6467-8716	National Institutes of Health [RO1 CA109311, PO1 CA099031, DMR-101-115, NSC99-2320-B-039-030-MY3, NSC99-2632-B-039-001-MY3, NSC101-2321-B-039, NSC101-2311-B-039-001, NSC101-2320-B-039-048, NSC102-2911-I-002-303, NHRI-EX102-10245BI, DOH102-TD-B-111-004, DOH102-TD-C-111-005, CMU100-N2-09]; NATIONAL CANCER INSTITUTE [P01CA099031, R01CA109311] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the following grants: National Institutes of Health (RO1 CA109311 and PO1 CA099031), DMR-101-115, NSC99-2320-B-039-030-MY3, NSC99-2632-B-039-001-MY3, NSC101-2321-B-039, NSC101-2311-B-039-001, NSC101-2320-B-039-048, NSC102-2911-I-002-303, NHRI-EX102-10245BI, DOH102-TD-B-111-004, DOH102-TD-C-111-005, CMU100-N2-09. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AALTOMAA S, 1993, ANTICANCER RES, V13, P533; Baselga J, 2005, J CLIN ONCOL, V23, P5323, DOI 10.1200/JCO.2005.08.326; Bitler BG, 2009, CLIN CANCER RES, V15, P100, DOI 10.1158/1078-0432.CCR-08-1745; Bukholm IRK, 2003, J CLIN PATHOL, V56, P368, DOI 10.1136/jcp.56.5.368; Cardo-Vila M, 2010, P NATL ACAD SCI USA, V107, P5118, DOI 10.1073/pnas.0915146107; Chen YT, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0017876, 10.1371/journal.pone.0021428, 10.1371/journal.pone.0017844, 10.1371/journal.pone.0024144, 10.1371/journal.pone.0027163, 10.1371/journal.pone.0027333]; Chu JS, 1998, CANCER LETT, V131, P145, DOI 10.1016/S0304-3835(98)00118-9; Foulkes WD, 2010, NEW ENGL J MED, V363, P1938, DOI 10.1056/NEJMra1001389; Fulda S, 2002, NAT MED, V8, P808, DOI 10.1038/nm735; Grossi F, 2003, EUR J CANCER, V39, P1242, DOI 10.1016/S0959-8049(03)00232-6; Heimann R, 1997, CANCER J, V3, P224; Huang WC, 2011, J BIOL CHEM, V286, P20558, DOI 10.1074/jbc.M111.240796; Huo LF, 2010, P NATL ACAD SCI USA, V107, P16125, DOI 10.1073/pnas.1000743107; Johnson DG, 1999, ANNU REV PHARMACOL, V39, P295, DOI 10.1146/annurev.pharmtox.39.1.295; Kato, 1999, Breast Cancer, V6, P370, DOI 10.1007/BF02966456; Kato T, 2003, BRIT J CANCER, V88, P1900, DOI 10.1038/sj.bjc.6600921; Korsching E, 2008, J CLIN PATHOL, V61, P553, DOI 10.1136/jcp.2008.055475; Lee JS, 2001, ANAL QUANT CYTOL, V23, P161; Li C, 2009, ONCOGENE, V28, P3801, DOI 10.1038/onc.2009.234; Lin SY, 2001, NAT CELL BIOL, V3, P802, DOI 10.1038/ncb0901-802; Liu XJ, 2008, NAT MED, V14, P1325, DOI 10.1038/nm.1883; Lo HW, 2005, CANCER RES, V65, P338; Maga G, 2003, J CELL SCI, V116, P3051, DOI 10.1242/jcs.00653; Metzger O, 2012, J CLIN ONCOL, V30, P1879, DOI 10.1200/JCO.2011.38.2010; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; Paunesku T, 2001, INT J RADIAT BIOL, V77, P1007, DOI 10.1080/09553000110069335; Pero SC, 2007, BRIT J CANCER, V96, P1520, DOI 10.1038/sj.bjc.6603732; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Psyrri A, 2005, CLIN CANCER RES, V11, P5856, DOI 10.1158/1078-0432.CCR-05-0420; Snyder EL, 2004, PLOS BIOL, V2, P186, DOI 10.1371/journal.pbio.0020036; Tachibana KEK, 2005, J PATHOL, V205, P123, DOI 10.1002/path.1708; Taghibiglou C, 2009, NAT MED, V15, P1399, DOI 10.1038/nm.2064; TAHAN SR, 1993, CANCER, V71, P3552, DOI 10.1002/1097-0142(19930601)71:11<3552::AID-CNCR2820711115>3.0.CO;2-N; Tan AR, 2004, J CLIN ONCOL, V22, P3080, DOI 10.1200/JCO.2004.08.189; Tsurimoto T, 1998, BBA-GENE STRUCT EXPR, V1443, P23, DOI 10.1016/S0167-4781(98)00204-8; Wang SC, 2006, NAT CELL BIOL, V8, P1359, DOI 10.1038/ncb1501; Wang SC, 2009, CLIN CANCER RES, V15, P6484, DOI 10.1158/1078-0432.CCR-08-2813; Wheeler DL, 2010, NAT REV CLIN ONCOL, V7, P493, DOI 10.1038/nrclinonc.2010.97; Xia WY, 2009, MOL CARCINOGEN, V48, P610, DOI 10.1002/mc.20504; Yu YL, 2012, J BIOL CHEM; Zhao HJ, 2011, MOL CANCER THER, V10, P29, DOI 10.1158/1535-7163.MCT-10-0778	41	52	57	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2013	8	4							e61362	10.1371/journal.pone.0061362	http://dx.doi.org/10.1371/journal.pone.0061362			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130FG	23593472	Green Published, Green Submitted, gold			2022-12-25	WOS:000317898000128
J	Casanovas-Vilar, I; van Dam, J				Casanovas-Vilar, Isaac y; van Dam, Jan			Conservatism and Adaptability during Squirrel Radiation: What Is Mandible Shape Telling Us?	PLOS ONE			English	Article							GEOMETRIC MORPHOMETRICS; MASTICATORY APPARATUS; JAW MUSCLES; PHYLOGENY; RODENTIA; EVOLUTION; ECOLOGY; SKULL; PERCIFORMES; MORPHOLOGY	Both functional adaptation and phylogeny shape the morphology of taxa within clades. Herein we explore these two factors in an integrated way by analyzing shape and size variation in the mandible of extant squirrels using landmark-based geometric morphometrics in combination with a comparative phylogenetic analysis. Dietary specialization and locomotion were found to be reliable predictors of mandible shape, with the prediction by locomotion probably reflecting the underlying diet. In addition a weak but significant allometric effect could be demonstrated. Our results found a strong phylogenetic signal in the family as a whole as well as in the main clades, which is in agreement with the general notion of squirrels being a conservative group. This fact does not preclude functional explanations for mandible shape, but rather indicates that ancient adaptations kept a prominent role, with most genera having diverged little from their ancestral clade morphologies. Nevertheless, certain groups have evolved conspicuous adaptations that allow them to specialize on unique dietary resources. Such adaptations mostly occurred in the Callosciurinae and probably reflect their radiation into the numerous ecological niches of the tropical and subtropical forests of Southeastern Asia. Our dietary reconstruction for the oldest known fossil squirrels (Eocene, 36 million years ago) show a specialization on nuts and seeds, implying that the development from protrogomorphous to sciuromorphous skulls was not necessarily related to a change in diet.	[Casanovas-Vilar, Isaac y; van Dam, Jan] Univ Autonoma Barcelona, Inst Catala Paleontol Miquel Crusafont, Cerdanyola Del Valles, Spain; [van Dam, Jan] Univ Utrecht, Dept Earth Sci, Utrecht, Netherlands	Autonomous University of Barcelona; Institut Catala de Paleontologia Miquel Crusafont (ICP); Utrecht University	Casanovas-Vilar, I (corresponding author), Univ Autonoma Barcelona, Inst Catala Paleontol Miquel Crusafont, Cerdanyola Del Valles, Spain.	isaac.casanovas@icp.cat	Casanovas-Vilar, Isaac/J-2517-2012	Casanovas-Vilar, Isaac/0000-0001-7092-9622; van Dam, Jan/0000-0002-2748-3722	Ministerio de Economia y Competitividad [CGL2010-21672/BTE, CGL2011-27343]; Generalitat de Catalunya, project [2009 SGR 754]; SYNTHESYS Project from the European Community Research Infrastructure [NL-TAF-4084]	Ministerio de Economia y Competitividad(Spanish Government); Generalitat de Catalunya, project(Generalitat de Catalunya); SYNTHESYS Project from the European Community Research Infrastructure	Ministerio de Economia y Competitividad, projects (CGL2010-21672/BTE, CGL2011-27343) and research contract to ICV (JCI2010-08241), as well as Generalitat de Catalunya, project (2009 SGR 754), and the SYNTHESYS Project from the European Community Research Infrastructure (NL-TAF-4084) to ICV supported this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DC, 2004, ITAL J ZOOL, V71, P5, DOI 10.1080/11250000409356545; BALL SS, 1995, J MORPHOL, V224, P265, DOI 10.1002/jmor.1052240303; BELK M C, 1991, Mammalian Species, P1, DOI 10.2307/3504191; Blomberg SP, 2002, J EVOLUTION BIOL, V15, P899, DOI 10.1046/j.1420-9101.2002.00472.x; Bookstein F. L., 1997, MORPHOMETRIC TOOLS L; Cardini A, 2003, SYST BIOL, V52, P186, DOI 10.1080/10635150390192807; Casanovas-Vilar I, 2009, PALEONTOLOGIA EVOLUC, V3, P41; Caumul R, 2005, EVOLUTION, V59, P2460; CIFELLI RL, 1986, J MAMMAL, V67, P274, DOI 10.2307/1380880; Corti M, 1996, NATO ADV SCI INST SE, V284, P303; Cox PG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036299; CUENCA G, 1994, GEOBIOS-LYON, V27, P353, DOI 10.1016/S0016-6995(94)80183-5; de Bruijn Hans, 1999, P271; Demeter A, 1996, NATO ADV SCI INST SE, V284, P359; den Tex RJ, 2010, MOL PHYLOGENET EVOL, V55, P711, DOI 10.1016/j.ympev.2009.12.023; Drake AG, 2008, P ROY SOC B-BIOL SCI, V275, P71, DOI 10.1098/rspb.2007.1169; DRUZINSKY RE, 1995, J MORPHOL, V226, P79, DOI 10.1002/jmor.1052260106; EMMONS LH, 1980, ECOL MONOGR, V50, P31, DOI 10.2307/2937245; EMMONS LH, 1990, NEOTROPICAL RAINFORE; Emry R.J., 1984, P23; Emry RJ, 1996, J VERTEBR PALEONTOL, V16, P775, DOI 10.1080/02724634.1996.10011366; Emry RJ., 1982, SMITHSONIAN CONTRIBU, V47, P1, DOI [10.5479/si.00810266.47.1, DOI 10.5479/si.00810266.47.1]; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Flynn Lawrence J., 2003, Deinsea (Rotterdam), V10, P183; Freeman PW, 2008, J ZOOL, V275, P418, DOI 10.1111/j.1469-7998.2008.00459.x; GOODALL C, 1991, J ROY STAT SOC B MET, V53, P285, DOI 10.1111/j.2517-6161.1991.tb01825.x; GOULD SJ, 1975, AM ZOOL, V15, P351; Handley C.O. Jr., 1976, Science Bull Brigham Young Univ ( Biol), V20, P1; Hautier L, 2012, J MORPHOL, V273, P1319, DOI 10.1002/jmor.20061; Hautier L, 2009, NATURWISSENSCHAFTEN, V96, P725, DOI 10.1007/s00114-009-0519-8; Helgen KM, 2009, J MAMMAL, V90, P270, DOI 10.1644/07-MAMM-A-309.1; Klingenberg CP, 2011, MOL ECOL RESOUR, V11, P353, DOI 10.1111/j.1755-0998.2010.02924.x; Klingenberg CP, 2010, SYST BIOL, V59, P245, DOI 10.1093/sysbio/syp106; Klingenberg CP, 1996, BIOL J LINN SOC, V59, P143; Klingenberg CP, 2001, GENETICS, V157, P785; KORTH W W, 1992, Annals of Carnegie Museum, V61, P69; Korth W.W., 1994, TERTIARY RECORD RODE; Koyabu DB, 2009, J ZOOL, V279, P372, DOI 10.1111/j.1469-7998.2009.00629.x; Koyabu DB, 2009, J HUM EVOL, V56, P525, DOI 10.1016/j.jhevol.2008.12.009; Loy A, 1998, J MORPHOL, V237, P137, DOI 10.1002/(SICI)1097-4687(199808)237:2<137::AID-JMOR5>3.0.CO;2-Z; Lucas P., 2004, DENT FUNCTIONAL MORP; Lucas PW, 2000, ANN BOT-LONDON, V86, P913, DOI 10.1006/anbo.2000.1261; MacKinnon K.S., 1978, Malayan Nature Journal, V30, P593; MacLeod N., 2002, MORPHOLOGY SHAPE PHY; MADDISON WP, 1991, SYST ZOOL, V40, P304, DOI 10.2307/2992324; Maddison WP, 2007, MESQUITE 2 74 AMODUL; McKenna MC, 1997, CLASSIFICATION MAMMA; Mercer JM, 2003, SCIENCE, V299, P1568, DOI 10.1126/science.1079705; Michaux J, 2007, J ZOOL SYST EVOL RES, V45, P263, DOI 10.1111/j.1439-0469.2006.00390.x; Michaux J, 2008, MAMMALIA, V72, P286, DOI 10.1515/MAMM.2008.049; Monteiro LR, 1999, SYST BIOL, V48, P192, DOI 10.1080/106351599260526; Monteiro LR, 2003, J ZOOL, V261, P47, DOI 10.1017/S0952836903003893; Nicola PA, 2003, BIOL J LINN SOC, V80, P385, DOI 10.1046/j.1095-8312.2003.00245.x; Nogueira MR, 2005, J ZOOL, V266, P355, DOI 10.1017/S0952836905007053; Payne J. B., 1980, MALAYAN FOREST PRIMA, P261; Payne JB, 1979, THESIS U CAMBRIDGE C; PILBEAM D, 1974, SCIENCE, V186, P892, DOI 10.1126/science.186.4167.892; Promel HJ, 2002, STEINER TREE PROBLEM; Renaud S, 2007, ZOOL SCR, V36, P525, DOI 10.1111/j.1463-6409.2007.00297.x; Rohlf FJ, 2006, EVOLUTION, V60, P1509, DOI 10.1111/j.0014-3820.2006.tb01229.x; Rohlf F. James, 2002, Systematics Association Special Volume Series, V64, P175; Rohlf FJ, 2006, TPSDIG VER 2 16; Roth VL, 1996, AM ZOOL, V36, P14; Samuels JX, 2009, ZOOL J LINN SOC-LOND, V156, P864, DOI 10.1111/j.1096-3642.2009.00502.x; Singleton M, 2004, J ANTHROPOL SCI, V82, P27; Steppan SJ, 2004, MOL PHYLOGENET EVOL, V30, P703, DOI 10.1016/S1055-7903(03)00204-5; SWEET SS, 1980, AM ZOOL, V20, P643; Swiderski DL, 2010, EVOL BIOL, V37, P1, DOI 10.1007/s11692-010-9081-8; Thorington RW, 1996, J MORPHOL, V230, P145, DOI 10.1002/(SICI)1097-4687(199611)230:2<145::AID-JMOR3>3.0.CO;2-G; THORINGTON RWJ, 2012, SQUIRRELS WORLD; Velhagen WA, 1997, J MORPHOL, V232, P107, DOI 10.1002/(SICI)1097-4687(199705)232:2<107::AID-JMOR1>3.0.CO;2-7; Vinyard CJ, 2003, AM J PHYS ANTHROPOL, V120, P153, DOI 10.1002/ajpa.10129; Walston J, 2008, IUCN RED LIST THREAT; Wilson D. E., 2005, MAMMAL SPECIES WORLD; Zahler P, 2003, J MAMMAL, V84, P480, DOI 10.1644/1545-1542(2003)084<0480:EFDSOP>2.0.CO;2; Zelditch M.L., 2004, GEOMETRIC MORPHOMETR, DOI DOI 10.1016/B978-0-12-778460-1.X5000-5	76	40	41	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2013	8	4							e61298	10.1371/journal.pone.0061298	http://dx.doi.org/10.1371/journal.pone.0061298			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RK	23593456	gold, Green Published, Green Submitted			2022-12-25	WOS:000319108100082
J	Lu, R; Pal, J; Buon, L; Nanjappa, P; Shi, J; Fulciniti, M; Tai, YT; Guo, L; Yu, M; Gryaznov, S; Munshi, NC; Shammas, MA				Lu, R.; Pal, J.; Buon, L.; Nanjappa, P.; Shi, J.; Fulciniti, M.; Tai, Y-T; Guo, L.; Yu, M.; Gryaznov, S.; Munshi, N. C.; Shammas, M. A.			Targeting homologous recombination and telomerase in Barrett's adenocarcinoma: impact on telomere maintenance, genomic instability and tumor growth	ONCOGENE			English	Article						homologous recombination; telomerase; telomeres; Barrett's adenocarcinoma	LASER CAPTURE MICRODISSECTION; QUADRUPLEX-INTERACTIVE AGENT; MULTIPLE-MYELOMA CELLS; DNA-DAMAGE RESPONSE; TO-END FUSIONS; LEUKEMIA-CELLS; IMMORTAL CELLS; IN-VIVO; TELOMESTATIN SOT-095; MAMMALIAN TELOMERES	Homologous recombination (HR), a mechanism to accurately repair DNA in normal cells, is deregulated in cancer. Elevated/deregulated HR is implicated in genomic instability and telomere maintenance, which are critical lifelines of cancer cells. We have previously shown that HR activity is elevated and significantly contributes to genomic instability in Barrett's esophageal adenocarcinoma (BAC). The purpose of this study was to evaluate therapeutic potential of HR inhibition, alone and in combination with telomerase inhibition, in BAC. We demonstrate that telomerase inhibition in BAC cells increases HR activity, RAD51 expression, and association of RAD51 to telomeres. Suppression of HR leads to shorter telomeres as well as markedly reduced genomic instability in BAC cells over time. Combination of HR suppression (whether transgenic or chemical) with telomerase inhibition, causes a significant increase in telomere attrition and apoptotic death in all BAC cell lines tested, relative to either treatment alone. A subset of treated cells also stain positive for beta-galactosidase, indicating senescence. The combined treatment is also associated with decline in S-phase and a strong G2/M arrest, indicating massive telomere attrition. In a subcutaneous tumor model, the combined treatment resulted in the smallest tumors, which were even smaller (P - 0.001) than those that resulted from either treatment alone. Even the tumors removed from these mice had significantly reduced telomeres and evidence of apoptosis. We therefore conclude that although telomeres are elongated by telomerase, elevated RAD51/HR assist in their maintenance/ stabilization in BAC cells. Telomerase inhibitor prevents telomere elongation but induces RAD51/HR, which contributes to telomere maintenance/ stabilization and prevention of apoptosis, reducing the efficacy of treatment. Combining HR inhibition with telomerase renders telomeres more vulnerable to degradation and significantly increases/ expedites their attrition, leading to apoptosis. We therefore demonstrate that a therapy targeting HR and telomerase has the potential to prevent both tumor growth and genomic evolution in BAC.	[Lu, R.; Pal, J.; Buon, L.; Nanjappa, P.; Shi, J.; Fulciniti, M.; Tai, Y-T; Munshi, N. C.; Shammas, M. A.] Harvard Dana Farber Canc Inst, Dept Adult Oncol, Boston, MA USA; [Lu, R.; Pal, J.; Buon, L.; Nanjappa, P.; Shi, J.; Fulciniti, M.; Tai, Y-T; Munshi, N. C.; Shammas, M. A.] VA Hlth Care Syst, Boston, MA USA; [Lu, R.; Guo, L.; Yu, M.] Fudan Univ, Dept Clin Lab, Shanghai Canc Ctr, Shanghai 200433, Peoples R China; [Lu, R.; Guo, L.; Yu, M.] Shanghai Med Sch, Shanghai, Peoples R China; [Shi, J.; Fulciniti, M.; Tai, Y-T; Munshi, N. C.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Gryaznov, S.] Geron Corp, Dept Nucle Acid Chem, Menlo Pk, CA USA	Fudan University; Harvard University; Harvard Medical School; Geron Corporation	Shammas, MA (corresponding author), Harvard Dana Farber Canc Inst, Dept Adult Oncol, 1400 VFW Pkwy,Bldg 3,Room 2A111, West Roxbury, MA 02132 USA.	Masood_Shammas@DFCI.Harvard.Edu	Munshi, Nikhil/ABE-2338-2021	Shi, Jialan/0000-0001-5642-5436	National Cancer Institute [R01CA125711]; Department of Veterans Affairs Merit Review Awards; National Institutes of Health [RO1-1375555, P50-100007, PO1-78378]; NATIONAL CANCER INSTITUTE [P01CA155258, R01CA125711] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Veterans Affairs Merit Review Awards(US Department of Veterans Affairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We are grateful to Dr David G Beer, Department of Surgery, University of Michigan, Ann Arbor, MI, USA, for providing FLO-1 cells. This work was supported in part by grants from National Cancer Institute R01CA125711 to MAS, from the Department of Veterans Affairs Merit Review Awards (to NCM) and from the National Institutes of Health Grants RO1-1375555, P50-100007 and PO1-78378 to NCM.	Abdallah P, 2009, NAT CELL BIOL, V11, P988, DOI 10.1038/ncb1911; Aggarwal S, 2000, NEOPLASIA, V2, P346, DOI 10.1038/sj.neo.7900097; Akiyama M, 2003, CANCER RES, V63, P6187; ALLSHIRE RC, 1988, NATURE, V332, P656, DOI 10.1038/332656a0; Badie S, 2010, NAT STRUCT MOL BIOL, V17, P1461, DOI 10.1038/nsmb.1943; Bechter OE, 1998, CANCER RES, V58, P4918; BLACKBURN EH, 1989, GENOME, V31, P553, DOI 10.1139/g89-104; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; BRYAN TM, 1995, EMBO J, V14, P4240, DOI 10.1002/j.1460-2075.1995.tb00098.x; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Cerone MA, 2001, HUM MOL GENET, V10, P1945, DOI 10.1093/hmg/10.18.1945; Collins K, 2000, CURR OPIN CELL BIOL, V12, P378, DOI 10.1016/S0955-0674(00)00103-4; COUNTER CM, 1992, EMBO J, V11, P1921, DOI 10.1002/j.1460-2075.1992.tb05245.x; DAY JP, 1993, ENVIRON MOL MUTAGEN, V22, P245, DOI 10.1002/em.2850220411; DELANGE T, 1990, MOL CELL BIOL, V10, P518, DOI 10.1128/MCB.10.2.518; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Ducray C, 1999, ONCOGENE, V18, P4211, DOI 10.1038/sj.onc.1202797; Dunham MA, 2000, NAT GENET, V26, P447, DOI 10.1038/82586; Engelhardt M, 1998, ONCOL REP, V5, P1043; Fu WM, 1999, J BIOL CHEM, V274, P7264, DOI 10.1074/jbc.274.11.7264; Ganapathipillai SS, 2008, CANCER RES, V68, P5769, DOI 10.1158/0008-5472.CAN-08-1269; Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; HARLEY CB, 1991, MUTAT RES, V256, P271, DOI 10.1016/0921-8734(91)90018-7; Henson JD, 2002, ONCOGENE, V21, P598, DOI 10.1038/sj.onc.1205058; Ijpma AS, 2003, MOL BIOL CELL, V14, P987, DOI 10.1091/mbc.02-04-0057; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Lord RVN, 2000, J GASTROINTEST SURG, V4, P135, DOI 10.1016/S1091-255X(00)80049-9; McEachern MJ, 2000, ANNU REV GENET, V34, P331, DOI 10.1146/annurev.genet.34.1.331; Morrish TA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000357; MOYZIS RK, 1988, P NATL ACAD SCI USA, V85, P6622, DOI 10.1073/pnas.85.18.6622; Munshi NC, 2004, BLOOD, V103, P1799, DOI 10.1182/blood-2003-02-0402; Nakajima A, 2003, LEUKEMIA, V17, P560, DOI 10.1038/sj.leu.2402825; Ogunwobi OO, 2008, AM J GASTROENTEROL, V103, P825, DOI 10.1111/j.1572-0241.2007.01773.x; Opitz OG, 2001, J CLIN INVEST, V108, P725, DOI 10.1172/JCI11909; Pal J, 2011, ONCOGENE, V30, P3585, DOI 10.1038/onc.2011.83; Pal J, 2012, CANCER GENOM PROTEOM, V9, P55; Pierce AJ, 1999, GENE DEV, V13, P2633, DOI 10.1101/gad.13.20.2633; Seimiya H, 2002, MOL CANCER THER, V1, P657; Shammas MA, 2008, LEUKEMIA, V22, P1410, DOI 10.1038/leu.2008.81; Shammas MA, 1999, ONCOGENE, V18, P6191, DOI 10.1038/sj.onc.1203069; Shammas MA, 2004, GASTROENTEROLOGY, V126, P1337, DOI 10.1053/j.gastro.2004.01.026; Shammas MA, 2004, EXP CELL RES, V295, P204, DOI 10.1016/j.yexcr.2004.01.003; Shammas MA, 2004, CLIN CANCER RES, V10, P770, DOI 10.1158/1078-0432.CCR-0793-03; Shammas MA, 2003, MOL CANCER THER, V2, P825; Shammas MA, 2008, CLIN CANCER RES, V14, P4971, DOI 10.1158/1078-0432.CCR-08-0473; Shammas MA, 2006, BLOOD, V108, P2804, DOI 10.1182/blood-2006-05-022814; Shammas MA, 2005, MOL CANCER, V4, DOI 10.1186/1476-4598-4-24; Shammas MA, 2011, METHODS MOL BIOL, V755, P181, DOI 10.1007/978-1-61779-163-5_14; Shammas MA, 2009, BLOOD, V113, P2290, DOI 10.1182/blood-2007-05-089193; Shay JW, 1996, TRENDS GENET, V12, P129, DOI 10.1016/0168-9525(96)30018-8; Shay JW, 1997, J CELL PHYSIOL, V173, P266, DOI 10.1002/(SICI)1097-4652(199711)173:2<266::AID-JCP33>3.0.CO;2-B; Shay JW, 1997, EUR J CANCER, V33, P787, DOI 10.1016/S0959-8049(97)00062-2; Shi J, 2006, CYTOM PART A, V69A, P1193, DOI 10.1002/cyto.a.20345; Sumi M, 2004, INT J ONCOL, V24, P1481; Tauchi T, 2003, ONCOGENE, V22, P5338, DOI 10.1038/sj.onc.1206833; van Steensel B, 1998, CELL, V92, P401, DOI 10.1016/S0092-8674(00)80932-0; Wai Lin Kah, 2004, MedGenMed, V6, P19; Wallweber G, 2003, BIOCHEMISTRY-US, V42, P589, DOI 10.1021/bi026914a	59	30	31	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 20	2014	33	12					1495	1505		10.1038/onc.2013.103	http://dx.doi.org/10.1038/onc.2013.103			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AD4TS	23604115	Green Accepted, Green Submitted			2022-12-25	WOS:000333244200003
J	Suh, YH; Park, JY; Park, S; Jou, I; Roche, PA; Roche, KW				Suh, Young Ho; Park, Ji-Young; Park, Sangwook; Jou, Ilo; Roche, Paul A.; Roche, Katherine W.			Regulation of Metabotropic Glutamate Receptor 7 (mGluR7) Internalization and Surface Expression by Ser/Thr Protein Phosphatase 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERINE/THREONINE PHOSPHATASES; INTERACTING PROTEINS; SYNAPTIC PLASTICITY; PKC PHOSPHORYLATION; CATALYTIC SUBUNIT; NERVOUS-SYSTEM; OKADAIC ACID; CALYCULIN-A; S6 KINASE; 2A	The metabotropic glutamate receptor type 7 (mGluR7) is the predominant group III mGluR in the presynaptic active zone, where it serves as an autoreceptor to inhibit neurotransmitter release. Our previous studies show that PKC phosphorylation of mGluR7 on Ser-862 is a key mechanism controlling constitutive and activity-dependent surface expression of mGluR7 by regulating a competitive interaction of calmodulin and protein interacting with C kinase (PICK1). As receptor phosphorylation and dephosphorylation are tightly coordinated through the precise action of protein kinases and phosphatases, dephosphorylation by phosphatases is likely to play an active role in governing the activity-dependent or agonist-induced changes in mGluR7 receptor surface expression. In the present study, we find that the serine/threonine protein phosphatase 1 (PP1) has a crucial role in the constitutive and agonist-induced dephosphorylation of Ser-862 on mGluR7. Treatment of neurons with PP1 inhibitors leads to a robust increase in Ser-862 phosphorylation and increased surface expression of mGluR7. In addition, Ser-862 phosphorylation of both mGluR7a and mGluR7b is a target of PP1. Interestingly, agonist-induced dephosphorylation of mGluR7 is regulated by PP1, whereas NMDA-mediated activity-induced dephosphorylation is not, illustrating there are multiple signaling pathways that affect receptor phosphorylation and trafficking. Importantly, PP1 gamma 1 regulates agonist-dependent Ser-862 dephosphorylation and surface expression of mGluR7.	[Suh, Young Ho; Park, Ji-Young; Park, Sangwook; Jou, Ilo] Ajou Univ, Sch Med, Dept Pharmacol, Suwon 443721, South Korea; [Suh, Young Ho; Park, Ji-Young; Park, Sangwook; Jou, Ilo] Ajou Univ, Sch Med, Chron Inflammatory Dis Res Ctr, Suwon 443721, South Korea; [Suh, Young Ho; Roche, Paul A.] NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA; [Suh, Young Ho; Roche, Katherine W.] NINDS, Receptor Biol Sect, NIH, Bethesda, MD 20892 USA	Ajou University; Ajou University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Roche, KW (corresponding author), NINDS, Receptor Biol Sect, NIH, Porter Neurosci Res Ctr, Bldg 35,Rm 2C903, Bethesda, MD 20892 USA.	rochek@ninds.nih.gov	Roche, Katherine/W-9893-2019; Suh, Young Ho/AAJ-6405-2021	Suh, Young Ho/0000-0003-3979-1615; Roche, Paul/0000-0002-8949-9172; Roche, Katherine/0000-0001-7282-6539	NINDS, National Institutes of Health, Intramural Research Program; NCI, National Institutes of Health, Intramural Research Program; Ajou University School of Medicine; Basic Science Research Program through the National Research Foundation of Korea [2011-0011694]; Medical Research Center Program through the National Research Foundation of Korea [NRF-2012R1A5A048183]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003036, ZIANS002994] Funding Source: NIH RePORTER	NINDS, National Institutes of Health, Intramural Research Program; NCI, National Institutes of Health, Intramural Research Program; Ajou University School of Medicine; Basic Science Research Program through the National Research Foundation of Korea(National Research Foundation of Korea); Medical Research Center Program through the National Research Foundation of Korea(National Research Foundation of Korea); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the NINDS, National Institutes of Health, Intramural Research Program (to K. W. R.), the NCI, National Institutes of Health, Intramural Research Program (to P. A. R.), the new faculty research fund of the Ajou University School of Medicine, and the Basic Science Research Program (2011-0011694) and Medical Research Center Program (NRF-2012R1A5A048183) through the National Research Foundation of Korea.	Bockaert J, 2010, ANNU REV PHARMACOL, V50, P89, DOI 10.1146/annurev.pharmtox.010909.105705; Boger DL, 2001, J AM CHEM SOC, V123, P4161, DOI 10.1021/ja010195q; Cohen PTW, 2002, J CELL SCI, V115, P241; Conn PJ, 1997, ANNU REV PHARMACOL, V37, P205, DOI 10.1146/annurev.pharmtox.37.1.205; Corti C, 1998, EUR J NEUROSCI, V10, P3629, DOI 10.1046/j.1460-9568.1998.00371.x; Croci C, 2003, J BIOL CHEM, V278, P50682, DOI 10.1074/jbc.M305764200; Dev KK, 2000, J NEUROSCI, V20, P7252; Egloff MP, 1997, EMBO J, V16, P1876, DOI 10.1093/emboj/16.8.1876; El Far O, 2002, BIOCHEM J, V365, P329, DOI 10.1042/BJ20020481; Enz R, 2003, BIOCHEM J, V372, P183, DOI 10.1042/BJ20021750; Enz R, 2002, J NEUROCHEM, V81, P1130, DOI 10.1046/j.1471-4159.2002.00922.x; Fagni L, 2004, SEMIN CELL DEV BIOL, V15, P289, DOI 10.1016/j.semcdb.2003.12.018; Flor PJ, 1997, NEUROPHARMACOLOGY, V36, P153, DOI 10.1016/S0028-3908(96)00176-1; Herzig S, 2000, PHYSIOL REV, V80, P173, DOI 10.1152/physrev.2000.80.1.173; ISHIHARA H, 1989, BIOCHEM BIOPH RES CO, V159, P871, DOI 10.1016/0006-291X(89)92189-X; Kinoshita A, 1998, J COMP NEUROL, V393, P332; Koss DJ, 2007, J NEUROCHEM, V102, P1009, DOI 10.1111/j.1471-4159.2007.04579.x; KREIENBUHL P, 1992, BLOOD, V80, P2911; Lavezzari G, 2007, NEUROPHARMACOLOGY, V52, P100, DOI 10.1016/j.neuropharm.2006.07.011; Lee HK, 2006, PHARMACOL THERAPEUT, V112, P810, DOI 10.1016/j.pharmthera.2006.06.003; Lee JH, 2008, P NATL ACAD SCI USA, V105, P12575, DOI 10.1073/pnas.0712033105; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; Millward TA, 1999, TRENDS BIOCHEM SCI, V24, P186, DOI 10.1016/S0968-0004(99)01375-4; Munton RP, 2004, FEBS LETT, V567, P121, DOI 10.1016/j.febslet.2004.03.121; Pelkey KA, 2005, NEURON, V46, P89, DOI 10.1016/j.neuron.2005.02.011; Pelkey KA, 2007, NEUROPHARMACOLOGY, V52, P108, DOI 10.1016/j.neuropharm.2006.07.020; Pelkey KA, 2008, NEURON, V60, P980, DOI 10.1016/j.neuron.2008.11.018; Peterson RT, 1999, P NATL ACAD SCI USA, V96, P4438, DOI 10.1073/pnas.96.8.4438; Petritsch C, 2000, GENE DEV, V14, P3093, DOI 10.1101/gad.854200; Schwartz N, 2009, NEURON, V62, P655, DOI 10.1016/j.neuron.2009.05.007; Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006; Shi Y, 2010, P NATL ACAD SCI USA, V107, P16315, DOI 10.1073/pnas.1011706107; Shibasaki F, 2002, J BIOCHEM, V131, P1, DOI 10.1093/oxfordjournals.jbchem.a003063; Shigemoto R, 1997, J NEUROSCI, V17, P7503, DOI 10.1523/jneurosci.17-19-07503.1997; Shigemoto R, 1996, NATURE, V381, P523, DOI 10.1038/381523a0; Strack S, 1999, J COMP NEUROL, V413, P373; Suh YH, 2008, NEURON, V58, P736, DOI 10.1016/j.neuron.2008.03.028; Suh YH, 2010, NAT NEUROSCI, V13, P338, DOI 10.1038/nn.2488; Walsh AH, 1997, FEBS LETT, V416, P230, DOI 10.1016/S0014-5793(97)01210-6; Westphal RS, 1999, SCIENCE, V285, P93, DOI 10.1126/science.285.5424.93; Winder DG, 2001, NAT REV NEUROSCI, V2, P461, DOI 10.1038/35081514; Zhang J, 1996, BIOCHEMISTRY-US, V35, P6276, DOI 10.1021/bi952954l	42	20	20	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2013	288	24					17544	17551		10.1074/jbc.M112.439513	http://dx.doi.org/10.1074/jbc.M112.439513			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	164AH	23612982	Green Published, hybrid			2022-12-25	WOS:000320380600045
J	Sachelaru, I; Petriman, NA; Kudva, R; Kuhn, P; Welte, T; Knapp, B; Drepper, F; Warscheid, B; Koch, HG				Sachelaru, Ilie; Petriman, Narcis Adrian; Kudva, Renuka; Kuhn, Patrick; Welte, Thomas; Knapp, Bettina; Drepper, Friedel; Warscheid, Bettina; Koch, Hans-Georg			YidC Occupies the Lateral Gate of the SecYEG Translocon and Is Sequentially Displaced by a Nascent Membrane Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-RECOGNITION PARTICLE; ESCHERICHIA-COLI REQUIRES; BACTERIAL SRP RECEPTOR; CONDUCTING CHANNEL; TRANSLATING RIBOSOME; PERIPLASMIC DOMAIN; CYTOPLASMIC MEMBRANE; BINDING-SITES; CROSS-LINKING; IN-VIVO	Most membrane proteins are co-translationally inserted into the lipid bilayer via the universally conserved SecY complex and they access the lipid phase presumably via a lateral gate in SecY. In bacteria, the lipid transfer of membrane proteins from the SecY channel is assisted by the SecY-associated protein YidC, but details on the SecY-YidC interaction are unknown. By employing an in vivo and in vitro site-directed cross-linking approach, we have mapped the SecY-YidC interface and found YidC in contact with all four transmembrane domains of the lateral gate. This interaction did not require the SecDFYajC complex and was not influenced by SecA binding to SecY. In contrast, ribosomes dissociated the YidC contacts to lateral gate helices 2b and 8. The major contact between YidC and the lateral gate was lost in the presence of ribosome nascent chains and new SecY-YidC contacts appeared. These data demonstrate that the SecY-YidC interaction is influenced by nascent-membrane-induced lateral gate movements.	[Sachelaru, Ilie; Petriman, Narcis Adrian; Kudva, Renuka; Kuhn, Patrick; Welte, Thomas; Koch, Hans-Georg] Univ Freiburg, Inst Biochem & Mol Biol, ZBMZ, D-79104 Freiburg, Germany; [Sachelaru, Ilie; Petriman, Narcis Adrian; Kudva, Renuka; Kuhn, Patrick; Knapp, Bettina; Drepper, Friedel; Warscheid, Bettina] Univ Freiburg, Fak Biol, D-79104 Freiburg, Germany; [Kudva, Renuka; Koch, Hans-Georg] Univ Freiburg, Spemann Grad Sch Biol & Med SGBM, D-79104 Freiburg, Germany; [Drepper, Friedel; Warscheid, Bettina] Univ Freiburg, Zentrum Biol Signalstudien, BIOSS Ctr Biol Signalling Studies, D-79104 Freiburg, Germany	University of Freiburg; University of Freiburg; University of Freiburg; University of Freiburg	Koch, HG (corresponding author), Univ Freiburg, Inst Biochem & Mol Biol, Stefan Meier Str 17, D-79104 Freiburg, Germany.	Hans-Georg.Koch@biochemie.uni-freiburg.de		Petriman, Narcis Adrian/0000-0002-3189-7530; Kudva, Renuka/0000-0003-0426-3716; Warscheid, Bettina/0000-0001-5096-1975; Drepper, Friedel/0000-0002-2043-5795; Welte, Thomas/0000-0003-4583-9216	Deutsche Forschungsgemeinschaft [FOR929, FOR 967, GRK1478]; Excellence Initiative of the German Federal and State Governments EXC [294]; FF-Nord Foundation Fellowship; European Union	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Excellence Initiative of the German Federal and State Governments EXC; FF-Nord Foundation Fellowship; European Union(European Commission)	This work was supported by the Deutsche Forschungsgemeinschaft Grants FOR929, FOR 967, and GRK1478 (to H.G.K.), grants from the Excellence Initiative of the German Federal and State Governments EXC 294 BIOSS Centre for Biological Signaling Studies (to B.W.) and GSC-4 Spemann Graduate School for Biology and Medicine (to H.G.K.), a FF-Nord Foundation Fellowship (to T.W.), and an Erasmus Fellowship of the European Union (to N.P.).	Angelini S, 2005, EMBO REP, V6, P476, DOI 10.1038/sj.embor.7400385; Angelini S, 2006, J CELL BIOL, V174, P715, DOI 10.1083/jcb.200606093; BABA T, 1990, J BACTERIOL, V172, P7005, DOI 10.1128/jb.172.12.7005-7010.1990; Beck K, 2001, EMBO REP, V2, P709, DOI 10.1093/embo-reports/kve154; Becker T, 2009, SCIENCE, V326, P1369, DOI 10.1126/science.1178535; Boy D, 2009, MOL BIOL CELL, V20, P1804, DOI 10.1091/mbc.E08-08-0886; Braig D, 2009, J MOL BIOL, V390, P401, DOI 10.1016/j.jmb.2009.04.061; Breyton C, 2002, NATURE, V418, P662, DOI 10.1038/nature00827; Chen MY, 2005, BIOCHEMISTRY-US, V44, P10741, DOI 10.1021/bi047418k; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Dalal K, 2012, P NATL ACAD SCI USA, V109, P4104, DOI 10.1073/pnas.1117783109; Dalbey RE, 2011, ANNU REV BIOCHEM, V80, P161, DOI 10.1146/annurev-biochem-060409-092524; DARKEN MA, 1964, PHARMACOL REV, V16, P223; Das S, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.182931; du Plessis DJF, 2009, J BIOL CHEM, V284, P15805, DOI 10.1074/jbc.M901855200; Duong F, 1997, EMBO J, V16, P4871, DOI 10.1093/emboj/16.16.4871; Egea PF, 2010, P NATL ACAD SCI USA, V107, P17182, DOI 10.1073/pnas.1012556107; Frauenfeld J, 2011, NAT STRUCT MOL BIOL, V18, P614, DOI 10.1038/nsmb.2026; Funes S, 2009, P NATL ACAD SCI USA, V106, P6656, DOI 10.1073/pnas.0809951106; Gumbart J, 2009, STRUCTURE, V17, P1453, DOI 10.1016/j.str.2009.09.010; Haider S, 2006, BIOCHEMISTRY-US, V45, P13018, DOI 10.1021/bi061013d; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Hizlan D, 2012, CELL REPORTS, V1, P21, DOI 10.1016/j.celrep.2011.11.003; Hou B, 2012, MOL CELL, V48, P398, DOI 10.1016/j.molcel.2012.08.023; Houben ENG, 2004, EMBO REP, V5, P970, DOI 10.1038/sj.embor.7400261; Kaufmann A, 1999, BIOCHEMISTRY-US, V38, P9115, DOI 10.1021/bi990539d; Koch HG, 2002, J BIOL CHEM, V277, P5715, DOI 10.1074/jbc.C100683200; Kohler R, 2009, MOL CELL, V34, P344, DOI 10.1016/j.molcel.2009.04.019; Kuhn P, 2011, TRAFFIC, V12, P563, DOI 10.1111/j.1600-0854.2011.01167.x; Lotz M, 2008, J MOL BIOL, V375, P901, DOI 10.1016/j.jmb.2007.10.089; Luirink J, 2005, ANNU REV MICROBIOL, V59, P329, DOI 10.1146/annurev.micro.59.030804.121246; MATSUYAMA S, 1993, EMBO J, V12, P265, DOI 10.1002/j.1460-2075.1993.tb05652.x; Mitra K, 2005, NATURE, V438, P318, DOI 10.1038/nature04133; Mori H, 2006, P NATL ACAD SCI USA, V103, P16159, DOI 10.1073/pnas.0606390103; Nagamori S, 2004, J CELL BIOL, V165, P53, DOI 10.1083/jcb.200402067; Niemann M, 2013, MOL CELL PROTEOMICS, V12, P515, DOI 10.1074/mcp.M112.023093; Nijeholt JALA, 2011, J BIOL CHEM, V286, P43881, DOI 10.1074/jbc.M111.297507; Nishiyama KI, 1996, CELL, V85, P71, DOI 10.1016/S0092-8674(00)81083-1; Nouwen N, 2002, MOL MICROBIOL, V44, P1397, DOI 10.1046/j.1365-2958.2002.02972.x; Oliver DC, 2008, J BIOL CHEM, V283, P5208, DOI 10.1074/jbc.M708936200; Park E, 2012, J CELL BIOL, V198, P881, DOI 10.1083/jcb.201205140; Park E, 2012, ANNU REV BIOPHYS, V41, P21, DOI [10.1146/annurev-biophys-050511-102312, 10.1146/annurev-biophys-050511-402312]; POGLIANO JA, 1994, EMBO J, V13, P554, DOI 10.1002/j.1460-2075.1994.tb06293.x; Ravaud S, 2008, ACTA CRYSTALLOGR F, V64, P144, DOI 10.1107/S1744309108002364; Ryu YH, 2006, NAT METHODS, V3, P263, DOI 10.1038/NMETH864; Samuelson JC, 2000, NATURE, V406, P637, DOI 10.1038/35020586; Scotti PA, 2000, EMBO J, V19, P542, DOI 10.1093/emboj/19.4.542; Seidelt B, 2009, SCIENCE, V326, P1412, DOI 10.1126/science.1177662; Serek J, 2004, EMBO J, V23, P294, DOI 10.1038/sj.emboj.7600063; Stiegler N, 2011, J MOL BIOL, V406, P362, DOI 10.1016/j.jmb.2010.12.036; Tsukazaki T, 2008, NATURE, V455, P988, DOI 10.1038/nature07421; Tsukazaki T, 2011, NATURE, V474, P235, DOI 10.1038/nature09980; Urbanus ML, 2001, EMBO REP, V2, P524, DOI 10.1093/embo-reports/kve108; van Bloois E, 2008, FEBS LETT, V582, P1419, DOI 10.1016/j.febslet.2008.02.082; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; van der Laan M, 2004, J CELL BIOL, V165, P213, DOI 10.1083/jcb.200402100; Wagner S, 2008, J BIOL CHEM, V283, P17881, DOI 10.1074/jbc.M801481200; Welte T, 2012, MOL BIOL CELL, V23, P464, DOI 10.1091/mbc.E11-07-0590; Xie K, 2006, BIOCHEMISTRY-US, V45, P13401, DOI 10.1021/bi060826z; Zimmer J, 2008, NATURE, V455, P936, DOI 10.1038/nature07335	61	74	75	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2013	288	23					16295	16307		10.1074/jbc.M112.446583	http://dx.doi.org/10.1074/jbc.M112.446583			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	163ZU	23609445	hybrid, Green Published			2022-12-25	WOS:000320378900009
J	Harmel, J; Ruzzenente, B; Terzioglu, M; Spahr, H; Falkenberg, M; Larsson, NG				Harmel, Julia; Ruzzenente, Benedetta; Terzioglu, Mugen; Spahr, Henrik; Falkenberg, Maria; Larsson, Nils-Goran			The Leucine-rich Pentatricopeptide Repeat-containing Protein (LRPPRC) Does Not Activate Transcription in Mammalian Mitochondria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA; IN-VIVO; DOMAIN; GENE; TRANSLATION; BINDING; MTDNA; POLYADENYLATION; IDENTIFICATION; CONTRIBUTES	Regulation of mtDNA expression is critical for controlling oxidative phosphorylation capacity and has been reported to occur at several different levels in mammalian mitochondria. LRPPRC (leucine-rich pentatricopeptide repeat-containing protein) has a key role in this regulation and acts at the post-transcriptional level to stabilize mitochondrial mRNAs, to promote mitochondrial mRNA polyadenylation, and to coordinate mitochondrial translation. However, recent studies have suggested that LRPPRC may have an additional intramitochondrial role by directly interacting with the mitochondrial RNA polymerase POLRMT to stimulate mtDNA transcription. In this study, we have further examined the intramitochondrial roles for LRPPRC by creating bacterial artificial chromosome transgenic mice with moderately increased LRPPRC expression and heterozygous Lrpprc knock-out mice with moderately decreased LRPPRC expression. Variation of LRPPRC levels in mice in vivo, occurring within a predicted normal physiological range, strongly affected the levels of an unprocessed mitochondrial precursor transcript (ND5-cytochrome b) but had no effect on steady-state levels of mitochondrial transcripts or de novo transcription of mtDNA. We further assessed the role of LRPPRC in mitochondrial transcription by performing size exclusion chromatography and immunoprecipitation experiments in human cell lines and mice, but we found no interaction between LRPPRC and POLRMT. Furthermore, addition of purified LRPPRC to a recombinant human in vitro transcription system did not activate mtDNA transcription. On the basis of these data, we conclude that LRPPRC does not directly regulate mtDNA transcription but rather acts as a post-transcriptional regulator of mammalian mtDNA expression.	[Harmel, Julia; Ruzzenente, Benedetta; Terzioglu, Mugen; Spahr, Henrik; Larsson, Nils-Goran] Max Planck Inst Biol Ageing, Dept Mitochondrial Biol, D-50931 Cologne, Germany; [Falkenberg, Maria] Univ Gothenburg, Inst Biomed, SE-40530 Gothenburg, Sweden; [Larsson, Nils-Goran] Karolinska Inst, Dept Lab Med, SE-17177 Stockholm, Sweden	Max Planck Society; University of Gothenburg; Karolinska Institutet	Larsson, NG (corresponding author), Max Planck Inst Biol Ageing, Dept Mitochondrial Biol, Joseph Stelzmann Str 9B, D-50931 Cologne, Germany.	larsson@age.mpg.de	Ruzzenente, Benedetta/H-4793-2017; Larsson, Nils-Göran/GVS-5578-2022	Ruzzenente, Benedetta/0000-0001-7366-114X; Larsson, Nils-Göran/0000-0001-5100-996X; Terzioglu, Mugen/0000-0003-0872-3046	European Research Council advanced investigator grant; Swedish Research Council; Swedish Cancer Foundation; European Research Council starting independent investigator grant	European Research Council advanced investigator grant(European Research Council (ERC)); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Foundation; European Research Council starting independent investigator grant	The work was supported by a European Research Council advanced investigator grant (to N.-G.L.) and by Swedish Research Council grants, the Swedish Cancer Foundation, and a European Research Council starting independent investigator grant (to M.F.).	Barkan A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002910; Bogenhagen DF, 2008, J BIOL CHEM, V283, P3665, DOI 10.1074/jbc.M708444200; Bratic A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002324; Camara Y, 2011, CELL METAB, V13, P527, DOI 10.1016/j.cmet.2011.04.002; Chujo T, 2012, NUCLEIC ACIDS RES, V40, P8033, DOI 10.1093/nar/gks506; Cooper MP, 2008, J BIOL CHEM, V283, P31960, DOI 10.1074/jbc.M805431200; Cooper MP, 2006, GENE DEV, V20, P2996, DOI 10.1101/gad.1483906; Davies SMK, 2012, FEBS LETT, V586, P3555, DOI 10.1016/j.febslet.2012.07.043; Davies SMK, 2009, FEBS LETT, V583, P1853, DOI 10.1016/j.febslet.2009.04.048; Ekstrand MI, 2004, HUM MOL GENET, V13, P935, DOI 10.1093/hmg/ddh109; Falkenberg M, 2002, NAT GENET, V31, P289, DOI 10.1038/ng909; Falkenberg M, 2007, ANNU REV BIOCHEM, V76, P679, DOI 10.1146/annurev.biochem.76.060305.152028; Gaspari M, 2004, EMBO J, V23, P4606, DOI 10.1038/sj.emboj.7600465; Hallberg BM, 2011, NAT STRUCT MOL BIOL, V18, P1179, DOI 10.1038/nsmb.2167; Holzmann J, 2008, CELL, V135, P462, DOI 10.1016/j.cell.2008.09.013; Larsson NG, 2010, ANNU REV BIOCHEM, V79, P683, DOI 10.1146/annurev-biochem-060408-093701; Liu LJ, 2011, J BIOL CHEM, V286, P41253, DOI 10.1074/jbc.M111.276121; Liu LY, 2002, GENOMICS, V79, P124, DOI 10.1006/geno.2001.6679; Mancebo R, 2001, MOL CELL BIOL, V21, P3462, DOI 10.1128/MCB.21.10.3462-3471.2001; Metodiev MD, 2009, CELL METAB, V9, P386, DOI 10.1016/j.cmet.2009.03.001; Mili S, 2003, MOL CELL BIOL, V23, P4972, DOI 10.1128/MCB.23.14.4972-4982.2003; Mili S, 2001, MOL CELL BIOL, V21, P7307, DOI 10.1128/MCB.21.21.7307-7319.2001; PARISI MA, 1991, SCIENCE, V252, P965, DOI 10.1126/science.2035027; Park CB, 2007, CELL, V130, P273, DOI 10.1016/j.cell.2007.05.046; Rackham O, 2009, NUCLEIC ACIDS RES, V37, P5859, DOI 10.1093/nar/gkp627; Ruzzenente B, 2012, EMBO J, V31, P443, DOI 10.1038/emboj.2011.392; Sasarman F, 2010, MOL BIOL CELL, V21, P1315, DOI 10.1091/mbc.E10-01-0047; Schmitz-Linneweber C, 2008, TRENDS PLANT SCI, V13, P663, DOI 10.1016/j.tplants.2008.10.001; Shi YH, 2012, P NATL ACAD SCI USA, V109, P16510, DOI 10.1073/pnas.1119738109; Sondheimer N, 2010, BIOCHEMISTRY-US, V49, P7467, DOI 10.1021/bi1008479; Spahr H, 2012, P NATL ACAD SCI USA, V109, P15253, DOI 10.1073/pnas.1210688109; Sterky FH, 2010, BIOCHEM BIOPH RES CO, V398, P759, DOI 10.1016/j.bbrc.2010.07.019; Tiranti V, 1997, HUM MOL GENET, V6, P615, DOI 10.1093/hmg/6.4.615; Topisirovic I, 2009, MOL CELL BIOL, V29, P1152, DOI 10.1128/MCB.01532-08; Wong TS, 2009, NUCLEIC ACIDS RES, V37, P6765, DOI 10.1093/nar/gkp750; Xu F, 2008, BIOCHEM J, V416, P15, DOI 10.1042/BJ20080847; Xu FH, 2004, BIOCHEM J, V382, P331, DOI 10.1042/BJ20040469; Zehrmann A, 2011, RNA BIOL, V8, P67, DOI 10.4161/rna.8.1.14298	38	21	21	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 31	2013	288	22					15510	15519		10.1074/jbc.M113.471649	http://dx.doi.org/10.1074/jbc.M113.471649			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	156LA	23599432	hybrid, Green Published			2022-12-25	WOS:000319822300009
J	Wang, X; Singh, S; Jung, HY; Yang, GJ; Jun, S; Sastry, KJ; Park, JI				Wang, Xin; Singh, Shailbala; Jung, Hae-Yun; Yang, Guojun; Jun, Sohee; Sastry, K. Jagannadha; Park, Jae-Il			HIV-1 Vpr Protein Inhibits Telomerase Activity via the EDD-DDB1-VPRBP E3 Ligase Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; REVERSE-TRANSCRIPTASE; ENZYME APOBEC3G; CELL-CYCLE; INFECTION; EXPRESSION; GENE; VIF; DEGRADATION; INDUCTION	Viral pathogens utilize host cell machinery for their benefits. Herein, we identify that HIV-1 Vpr (viral protein R) negatively modulates telomerase activity. Telomerase enables stem and cancer cells to evade cell senescence by adding telomeric sequences to the ends of chromosomes. We found that Vpr inhibited telomerase activity by down-regulating TERT protein, a catalytic subunit of telomerase. As a molecular adaptor, Vpr enhanced the interaction between TERT and the VPRBP substrate receptor of the DYRK2-associated EDD-DDB1-VPRBP E3 ligase complex, resulting in increased ubiquitination of TERT. In contrast, the Vpr mutant identified in HIV-1-infected long-term nonprogressors failed to promote TERT destabilization. Our results suggest that Vpr inhibits telomerase activity by hijacking the host E3 ligase complex, and we propose the novel molecular mechanism of telomerase deregulation in possibly HIV-1 pathogenesis.	[Wang, Xin; Jung, Hae-Yun; Jun, Sohee; Park, Jae-Il] Univ Texas MD Anderson Canc Ctr, Dept Expt Radiat Oncol, Houston, TX 77030 USA; [Singh, Shailbala; Yang, Guojun; Sastry, K. Jagannadha] Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA; [Park, Jae-Il] Univ Texas MD Anderson Canc Ctr, Program Canc Biol, Houston, TX 77030 USA; [Park, Jae-Il] Univ Texas Houston, Hlth Sci Ctr, Grad Sch Biomed Sci, Houston, TX 77030 USA; [Park, Jae-Il] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; UTMD Anderson Cancer Center	Park, JI (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Expt Radiat Oncol, 1515 Holcombe Blvd, Houston, TX 77030 USA.	jaeil@mdanderson.org	park, jaeil/AAS-5894-2021	PARK, JAE-IL/0000-0002-0737-2654; Jung, Hae-Yun/0000-0001-9467-2219; Sastry, Jagannadha/0000-0002-6987-4422	Duncan Family Institute research program grant; University Cancer Foundation Grant [IRG-08-061-01]; American Association for Cancer Research-Pancreatic Cancer Action Network [11-20-25-PARK]; Center for Stem Cell and Developmental Biology transformative pilot grant; Metastasis Research Center grant; University of Texas MD Anderson Cancer Center; National Institutes of Health through The University of Texas MD Anderson Cancer Center [CA016672]; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER	Duncan Family Institute research program grant; University Cancer Foundation Grant; American Association for Cancer Research-Pancreatic Cancer Action Network; Center for Stem Cell and Developmental Biology transformative pilot grant; Metastasis Research Center grant; University of Texas MD Anderson Cancer Center; National Institutes of Health through The University of Texas MD Anderson Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a Duncan Family Institute research program grant; University Cancer Foundation Grant IRG-08-061-01; American Association for Cancer Research-Pancreatic Cancer Action Network Grant 11-20-25-PARK; and a Center for Stem Cell and Developmental Biology transformative pilot grant, an institutional research grant, a new faculty support grant, a Metastasis Research Center grant, the Specialized Program of Research Excellence (SPORE) in Ovarian Cancer, research grant from The University of Texas MD Anderson Cancer Center. DNA sequencing and other core facilities were supported by National Institutes of Health Grant CA016672 through The University of Texas MD Anderson Cancer Center.	Armstrong L, 2005, STEM CELLS, V23, P516, DOI 10.1634/stemcells.2004-0269; Artandi SE, 2002, P NATL ACAD SCI USA, V99, P8191, DOI 10.1073/pnas.112515399; Autexier C, 2006, ANNU REV BIOCHEM, V75, P493, DOI 10.1146/annurev.biochem.75.103004.142412; Ballon G, 2001, J INFECT DIS, V183, P417, DOI 10.1086/318072; Belzile JP, 2007, PLOS PATHOG, V3, P882, DOI 10.1371/journal.ppat.0030085; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; Bostik P, 2002, J INFECT DIS, V185, P999, DOI 10.1086/339412; Cech TR, 2004, CELL, V116, P273, DOI 10.1016/S0092-8674(04)00038-8; Deeks SG, 2011, ANNU REV MED, V62, P141, DOI 10.1146/annurev-med-042909-093756; Fauce SR, 2008, J IMMUNOL, V181, P7400, DOI 10.4049/jimmunol.181.10.7400; Franzese O, 2007, J MED VIROL, V79, P639, DOI 10.1002/jmv.20855; Gonzalez-Suarez E, 2002, MOL CELL BIOL, V22, P7291, DOI 10.1128/MCB.22.20.7291-7301.2002; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; Hrecka K, 2011, NATURE, V474, P658, DOI 10.1038/nature10195; Huang J, 2008, ONCOGENE, V27, P4056, DOI 10.1038/onc.2008.44; Imamura S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003364; Jager S, 2012, NATURE, V481, P371, DOI 10.1038/nature10693; Jung HY, 2013, J BIOL CHEM, V288, P7252, DOI 10.1074/jbc.M112.416792; Kogan M, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-25; Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117; Le Rouzic E, 2008, J BIOL CHEM, V283, P21686, DOI 10.1074/jbc.M710298200; Le Rouzic E, 2007, CELL CYCLE, V6, P182, DOI 10.4161/cc.6.2.3732; Lum JJ, 2003, J CLIN INVEST, V111, P1547, DOI 10.1172/JCI200316233; Maddika S, 2009, NAT CELL BIOL, V11, P409, DOI 10.1038/ncb1848; Margottin F, 1998, MOL CELL, V1, P565, DOI 10.1016/S1097-2765(00)80056-8; Mariani R, 2003, CELL, V114, P21, DOI 10.1016/S0092-8674(03)00515-4; Marin M, 2003, NAT MED, V9, P1398, DOI 10.1038/nm946; Meyerson M, 1997, CELL, V90, P785, DOI 10.1016/S0092-8674(00)80538-3; Morellet N, 2003, J MOL BIOL, V327, P215, DOI 10.1016/S0022-2836(03)00060-3; Park JI, 2009, NATURE, V460, P66, DOI 10.1038/nature08137; Reynoso R, 2006, AIDS RES HUM RETROV, V22, P425, DOI 10.1089/aid.2006.22.425; Roshal M, 2003, J BIOL CHEM, V278, P25879, DOI 10.1074/jbc.M303948200; Sheehy AM, 2003, NAT MED, V9, P1404, DOI 10.1038/nm945; SHIPPENLENTZ D, 1990, SCIENCE, V247, P546, DOI 10.1126/science.1689074; Stewart SA, 2002, P NATL ACAD SCI USA, V99, P12606, DOI 10.1073/pnas.182407599; Tan L, 2007, J VIROL, V81, P10822, DOI 10.1128/JVI.01380-07; Wang B, 1996, VIROLOGY, V223, P224, DOI 10.1006/viro.1996.0471; Yang CB, 2008, STEM CELLS, V26, P850, DOI 10.1634/stemcells.2007-0677; Yu XH, 2003, SCIENCE, V302, P1056, DOI 10.1126/science.1089591; Zhang LQ, 1997, VIROLOGY, V228, P340, DOI 10.1006/viro.1996.8378; ZHAO LJ, 1994, J BIOL CHEM, V269, P15577	41	28	31	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 31	2013	288	22					15474	15480		10.1074/jbc.M112.416735	http://dx.doi.org/10.1074/jbc.M112.416735			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	156LA	23612978	Green Published, hybrid			2022-12-25	WOS:000319822300006
J	Bell, D; Lambourne, A; Percival, F; Laverty, AA; Ward, DK				Bell, Derek; Lambourne, Adrian; Percival, Frances; Laverty, Anthony A.; Ward, David K.			Consultant Input in Acute Medical Admissions and Patient Outcomes in Hospitals in England: A Multivariate Analysis	PLOS ONE			English	Article							QUALITY-OF-CARE; MORTALITY; WEEKENDS; VOLUME; IMPACT	Recent recommendations for physicians in the UK outline key aspects of care that should improve patient outcomes and experience in acute hospital care. Included in these recommendations are Consultant patterns of work to improve timeliness of clinical review and improve continuity of care. This study used a contemporaneous validated survey compared with clinical outcomes derived from Hospital Episode Statistics, between April 2009 and March 2010 from 91 acute hospital sites in England to evaluate systems of consultant cover for acute medical admissions. Clinical outcomes studied included adjusted case fatality rates (aCFR), including the ratio of weekend to weekday mortality, length of stay and readmission rates. Hospitals that had an admitting Consultant presence within the Acute Medicine Unit (AMU, or equivalent) for a minimum of 4 hours per day (65% of study group) had a lower aCFR compared with hospitals that had Consultant presence for less than 4 hours per day (p<0.01) and also had a lower 28 day re-admission rate (p<0.01). An 'all inclusive' pattern of Consultant working, incorporating all the guideline recommendations and which included the minimum Consultant presence of 4 hours per day (29%) was associated with reduced excess weekend mortality (p<0.05). Hospitals with >40 acute medical admissions per day had a lower aCFR compared to hospitals with fewer than 40 admissions per day (p<0.03) and had a lower 7 day re-admission rate (p<0.02). This study is the first large study to explore the potential relationships between systems of providing acute medical care and clinical outcomes. The results show an association between well-designed systems of Consultant working practices, which promote increased patient contact, and improved patient outcomes in the acute hospital setting.	[Bell, Derek] Univ London Imperial Coll Sci Technol & Med, London, England; [Lambourne, Adrian; Percival, Frances] pH Associates Ltd, Marlow, Bucks, England; [Laverty, Anthony A.] Univ London Imperial Coll Sci Technol & Med, Dept Primary Care & Publ Hlth, London, England; [Ward, David K.] Queen Elizabeth Hosp, South London Healthcare NHS Trust, Woolwich, England	Imperial College London; Imperial College London	Bell, D (corresponding author), Univ London Imperial Coll Sci Technol & Med, London, England.	d.bell@imperial.ac.uk		Bell, Derek/0000-0002-9944-1097; Laverty, Anthony/0000-0003-1318-8439	independent consultancy pH associates	independent consultancy pH associates	This study was supported by an independent consultancy pH associates, the employer of A Lambourne and F Percival. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.	*AC MED TASKF, 2007, AC MED CAR RIGHT PER; Aylin P, 2010, QUAL SAF HEALTH CARE, V19, P213, DOI 10.1136/qshc.2008.028639; Bell CM, 2001, NEW ENGL J MED, V345, P663, DOI 10.1056/NEJMsa003376; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cram P, 2004, AM J MED, V117, P151, DOI 10.1016/j.amjmed.2004.02.035; Dr Foster Intelligence, 2011, INS YOUR HOSP FOST H, P19; Joynt KE, 2011, ANN INTERN MED, V154, P94, DOI 10.7326/0003-4819-154-2-201101180-00008; McQuillan P, 1998, BMJ-BRIT MED J, V316, P1853; Moore S, 2006, CLIN MED, V6, P286, DOI 10.7861/clinmedicine.6-3-286; National Confidential Enquiry into Patient Outcome and Death, 2007, EMERGENCY ADMISSIONS; National Confidential Enquiry into Patient Outcome and Death (NCEPOD), 2005, AC PROBL REP NAT CON; NHS Staff - 2001-2011, 2001, MED DENT DET VIEW NH; NHS-London, 2011, AD EM SERV AC MED EM; Office for National Statistics, 2014, SUP OUTP AR; Payne RA, 2012, HLTH STAT Q      SPR; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Ross JS, 2010, NEW ENGL J MED, V362, P1110, DOI 10.1056/NEJMsa0907130; Royal College of Physicians (London), 2010, EV CONS INP AC MED A; Schmulewitz L, 2005, CLIN MED, V5, P621, DOI 10.7861/clinmedicine.5-6-621; Scott I, 2009, INT J QUAL HEALTH C, V21, P397, DOI 10.1093/intqhc/mzp045; Seward E, 2003, CLIN MED, V3, P425, DOI 10.7861/clinmedicine.3-5-425	21	53	53	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2013	8	4							e61476	10.1371/journal.pone.0061476	http://dx.doi.org/10.1371/journal.pone.0061476			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IK	23613858	Green Published, Green Submitted, gold			2022-12-25	WOS:000317907200058
J	O'Callaghan, MJ; Hannah, DM; Boomer, I; Williams, M; Sadler, JP				O'Callaghan, Matt J.; Hannah, David M.; Boomer, Ian; Williams, Mike; Sadler, Jon P.			Responses to River Inundation Pressures Control Prey Selection of Riparian Beetles	PLOS ONE			English	Article							STABLE-ISOTOPE ANALYSES; GROUND BEETLE; CONSERVATION VALUE; AQUATIC INSECTS; COLEOPTERA-CHRYSOMELIDAE; ASSEMBLAGE STRUCTURE; TROPHIC STRUCTURE; SEDIMENTS ERS; FLOOD PLAINS; FOOD WEBS	Background: Riparian habitats are subjected to frequent inundation (flooding) and are characterised by food webs that exhibit variability in aquatic/terrestrial subsidies across the ecotone. The strength of this subsidy in active riparian floodplains is thought to underpin local biodiversity. Terrestrial invertebrates dominate the fauna, exhibiting traits that allow exploitation of variable aquatic subsidies while reducing inundation pressures, leading to inter-species micro-spatial positioning. The effect these strategies have on prey selection is not known. This study hypothesised that plasticity in prey choice from either aquatic or terrestrial sources is an important trait linked to inundation tolerance and avoidance. Method/Principal Findings: We used hydrological, isotopic and habitat analyses to investigate the diet of riparian Coleoptera in relation to inundation risk and relative spatial positioning in the floodplain. The study examined patch scale and longitudinal changes in utilisation of the aquatic subsidy according to species traits. Prey sourced from terrestrial or emerging/stranded aquatic invertebrates varied in relation to traits for inundation avoidance or tolerance strategies. Traits that favoured rapid dispersal corresponded with highest proportions of aquatic prey, with behavioural traits further predicting uptake. Less able dispersers showed minimal use of aquatic subsidy and switched to a terrestrial diet under moderate inundation pressures. All trait groups showed a seasonal shift in diet towards terrestrial prey in the early spring. Prey selection became exaggerated towards aquatic prey in downstream samples. Conclusions/Significance: Our results suggest that partitioning of resources and habitat creates overlapping niches that increase the processing of external subsidies in riparian habitats. By demonstrating functional complexity, this work advances understanding of floodplain ecosystem processes and highlights the importance of hydrological variability. With an increasing interest in reconnecting rivers to their floodplains, these invertebrates represent a key functional element in ensuring that such reconnections have demonstrable ecological value.	[O'Callaghan, Matt J.; Hannah, David M.; Boomer, Ian; Sadler, Jon P.] Univ Birmingham, Sch Geog Earth & Environm Sci, Birmingham, W Midlands, England; [Williams, Mike] Environm Agcy, Exeter, Devon, England	University of Birmingham	O'Callaghan, MJ (corresponding author), Univ Birmingham, Sch Geog Earth & Environm Sci, Birmingham, W Midlands, England.	m.j.ocallaghan@bham.ac.uk; j.p.sadler@bham.ac.uk	Boomer, Ian D/C-5154-2009; Hannah, David M./B-9221-2015	Boomer, Ian D/0000-0003-1276-2179; Hannah, David M./0000-0003-1714-1240; Sadler, Jonathan/0000-0003-0443-4458	Environment Agency, England; Wales	Environment Agency, England; Wales	This research was funded by the Environment Agency, England and Wales. The funders has no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adis J, 2002, FRESHWATER BIOL, V47, P711, DOI 10.1046/j.1365-2427.2002.00892.x; ANDERSEN J, 1985, OIKOS, V44, P499, DOI 10.2307/3565791; ANDERSEN J, 1968, Norsk Entomologisk Tidsskrift, V15, P115; Andersen J, 2005, BIODIVERS CONSERV, V14, P3497, DOI 10.1007/s10531-004-0825-6; ANDERSEN J, 1988, ENTOMOL GEN, V13, P47; Andersen J, 2006, J INSECT BEHAV, V19, P545, DOI 10.1007/s10905-006-9036-1; [Anonymous], 2010, R LANG ENV STAT COMP; Bastow JL, 2002, OECOLOGIA, V131, P261, DOI 10.1007/s00442-002-0879-7; Bates AJ, 2007, EUR J ENTOMOL, V104, P479, DOI 10.14411/eje.2007.068; Bates AJ, 2007, BIODIVERS CONSERV, V16, P1491, DOI 10.1007/s10531-006-9028-7; Bates AJ, 2006, OECOLOGIA, V150, P50, DOI 10.1007/s00442-006-0508-y; Bates Adam J., 2009, Terrestrial Arthropod Reviews, V2, P77, DOI 10.1163/187498309X455052; Bates AJ, 2005, ECOLOGY CONSERVATION; Baxter CV, 2005, FRESHWATER BIOL, V50, P201, DOI 10.1111/j.1365-2427.2004.01328.x; Bennett PM, 2009, ENTOMOL SCI, V12, P17, DOI 10.1111/j.1479-8298.2009.00308.x; Bonn A, 2002, RIVER RES APPL, V18, P43, DOI 10.1002/rra.632; Brasington J, 2000, EARTH SURF PROC LAND, V25, P973, DOI 10.1002/1096-9837(200008)25:9<973::AID-ESP111>3.0.CO;2-Y; Briers RA, 2005, ECOGRAPHY, V28, P165, DOI 10.1111/j.0906-7590.2005.04020.x; Burdon FJ, 2008, FRESHWATER BIOL, V53, P330, DOI 10.1111/j.1365-2427.2007.01897.x; Burt TP, 2005, PROG PHYS GEOG, V29, P297, DOI 10.1191/0309133305pp450ra; Church M, 1983, INT ASS SEDIMENTOLOG, V169-180; Collier KJ, 2002, FRESHWATER BIOL, V47, P1651, DOI 10.1046/j.1365-2427.2002.00903.x; Cornwell WK, 2006, ECOLOGY, V87, P1465, DOI 10.1890/0012-9658(2006)87[1465:ATTFHF]2.0.CO;2; CRAIG H, 1957, GEOCHIM COSMOCHIM AC, V12, P133, DOI 10.1016/0016-7037(57)90024-8; Cremona F, 2010, HYDROBIOLOGIA, V647, P51, DOI 10.1007/s10750-009-9798-5; Davies M. J., 1953, Entomologist's Monthly Magazine, V89, P18; Desender K, 1989, ECOMORPHOLOGICAL ADA, P309; Easterling DR, 2000, SCIENCE, V289, P2068, DOI 10.1126/science.289.5487.2068; Eyre MD, 2002, AQUAT CONSERV, V12, P553, DOI 10.1002/aqc.519; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fowler J., 1998, PRACTICAL STAT FIELD, P130; Gerisch M, 2011, ZOOKEYS, P353, DOI 10.3897/zookeys.100.1427; Gratton C, 2006, OECOLOGIA, V147, P615, DOI 10.1007/s00442-005-0322-y; Greenwood MJ, 2008, ECOLOGY, V89, P1489, DOI 10.1890/07-0749.1; Gurnell A, 2009, AQUAT SCI, V71, P253, DOI 10.1007/s00027-009-9186-2; Hammond P.M., 1998, UK FLOODPLAINS, P237; Henshall SE, 2011, ECOHYDROLOGY, V4, P512, DOI 10.1002/eco.188; Hering D, 2004, RIVER RES APPL, V20, P445, DOI 10.1002/rra.759; Hering D, 1997, OECOLOGIA, V111, P261, DOI 10.1007/s004420050234; Hering Daniel, 1995, Archiv fuer Hydrobiologie Supplementband, V101, P439; Hood-Nowotny R, 2007, ENTOMOL EXP APPL, V124, P3, DOI 10.1111/j.1570-7458.2007.00572.x; Jackson AL, 2011, J ANIM ECOL, V80, P595, DOI 10.1111/j.1365-2656.2011.01806.x; Jardine TD, 2008, FRESHWATER BIOL, V53, P2192, DOI 10.1111/j.1365-2427.2008.02044.x; Kato C, 2004, ECOL RES, V19, P633, DOI 10.1111/j.1440-1703.2004.00678.x; Klaar MJ, 2009, RIVER RES APPL, V25, P1331, DOI 10.1002/rra.1235; Kocarek Petr, 2001, Biological Rhythm Research, V32, P431, DOI 10.1076/brhm.32.4.431.1333; Laize CLR, 2010, J HYDROL, V389, P186, DOI 10.1016/j.jhydrol.2010.05.048; Lambeets K, 2009, BIOL CONSERV, V142, P625, DOI 10.1016/j.biocon.2008.11.015; Lambeets K, 2008, BIODIVERS CONSERV, V17, P3133, DOI 10.1007/s10531-007-9313-0; Lambeets K, 2008, J ANIM ECOL, V77, P1162, DOI 10.1111/j.1365-2656.2008.01443.x; Lavers D, 2010, J HYDROL, V395, P242, DOI 10.1016/j.jhydrol.2010.10.036; Layman CA, 2007, ECOLOGY, V88, P42, DOI 10.1890/0012-9658(2007)88[42:CSIRPF]2.0.CO;2; Luff ML, 2007, CARABIDAE GROUND BEE; Lundgren JG, 2009, BIOCONTROL SCI TECHN, V19, P327, DOI 10.1080/09583150802696533; Lytle DA, 2008, P ROY SOC B-BIOL SCI, V275, P453, DOI 10.1098/rspb.2007.1157; MARIOTTI A, 1983, NATURE, V303, P685, DOI 10.1038/303685a0; Mccluney KE, 2012, FRESHWATER BIOL, V57, P91, DOI 10.1111/j.1365-2427.2011.02698.x; McCullagh P., 1989, GEN LINEAR MODELS, V(2nd), DOI [10.1007/978-1-4899-3242-6, https://doi.org/10.1007/978-1-4899-3242-6, DOI 10.1007/978-1-4899-3242-6]; McCutchan JH, 2003, OIKOS, V102, P378, DOI 10.1034/j.1600-0706.2003.12098.x; Mims MC, 2012, ECOLOGY, V93, P35, DOI 10.1890/11-0370.1; Mitsch WJ, 2000, ECOL ECON, V35, P25, DOI 10.1016/S0921-8009(00)00165-8; Nakano S, 2001, P NATL ACAD SCI USA, V98, P166, DOI 10.1073/pnas.98.1.166; O'Callaghan MJ, 2011, CONTROLS DISTRIBUTIO; Paetzold A, 2005, ECOSYSTEMS, V8, P748, DOI 10.1007/s10021-005-0004-y; Paetzold A, 2005, J N AM BENTHOL SOC, V24, P395, DOI 10.1899/04-049.1; Paetzold A, 2008, J APPL ECOL, V45, P894, DOI 10.1111/j.1365-2664.2008.01463.x; Paetzold A, 2006, FRESHWATER BIOL, V51, P1103, DOI 10.1111/j.1365-2427.2006.01559.x; Palmer MA, 2005, J APPL ECOL, V42, P208, DOI 10.1111/j.1365-2664.2005.01004.x; Parmesan C, 2000, B AM METEOROL SOC, V81, P443, DOI 10.1175/1520-0477(2000)081<0443:IOEWAC>2.3.CO;2; Parnell A., 2008, SIAR STABLE ISOTOPE; Parnell AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009672; Petersen I, 2004, J APPL ECOL, V41, P934, DOI 10.1111/j.0021-8901.2004.00942.x; PETERSON BJ, 1987, ANNU REV ECOL SYST, V18, P293, DOI 10.1146/annurev.es.18.110187.001453; Poff NL, 1997, BIOSCIENCE, V47, P769, DOI 10.2307/1313099; Post DM, 2007, OECOLOGIA, V152, P179, DOI 10.1007/s00442-006-0630-x; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.1890/0012-9658(2002)083[0703:USITET]2.0.CO;2; Ribera I, 2001, ECOLOGY, V82, P1112, DOI 10.1890/0012-9658(2001)082[1112:EOLDAS]2.0.CO;2; Richardson JS, 2010, RIVER RES APPL, V26, P55, DOI 10.1002/rra.1283; Sadler J, 2008, HYDROECOLOGY ECOHYDR, P37; Sadler JP, 2004, BIOL CONSERV, V118, P41, DOI 10.1016/j.biocon.2003.07.007; Soreide JE, 2006, MAR ECOL PROG SER, V328, P17, DOI 10.3354/meps328017; Tallamy DW, 1996, ENVIRON ENTOMOL, V25, P1167, DOI 10.1093/ee/25.5.1167; Thiele H. -U., 1977, CARABID BEETLES THEI, DOI 10.1007/978-3-642-81154-8; Tockner K, 2002, ENVIRON CONSERV, V29, P308, DOI 10.1017/S037689290200022X; Tockner K, 2006, SPEC PUBL INT ASS SE, V36, P339; van der Nat D, 2003, FRESHWATER BIOL, V48, P1799, DOI 10.1046/j.1365-2427.2003.01126.x; van der Nat D, 2002, ECOSYSTEMS, V5, P636, DOI 10.1007/s10021-002-0170-0; Van Looy K, 2005, RIVER RES APPL, V21, P1133, DOI 10.1002/rra.872; Vander Zanden MJ, 2001, LIMNOL OCEANOGR, V46, P2061; Ward JV, 2002, FRESHWATER BIOL, V47, P517, DOI 10.1046/j.1365-2427.2002.00893.x; Winterbourn MJ, 1985, MISCELLANEOUS PUBLIC, V83; Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x	92	17	18	2	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2013	8	4							e61866	10.1371/journal.pone.0061866	http://dx.doi.org/10.1371/journal.pone.0061866			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IK	23613958	Green Published, gold, Green Submitted			2022-12-25	WOS:000317907200096
J	Tisell, A; Leinhard, OD; Warntjes, JBM; Aalto, A; Smedby, O; Landtblom, AM; Lundberg, P				Tisell, Anders; Leinhard, Olof Dahlqvist; Warntjes, Jan Bertus Marcel; Aalto, Anne; Smedby, Orjan; Landtblom, Anne-Marie; Lundberg, Peter			Increased Concentrations of Glutamate and Glutamine in Normal-Appearing White Matter of Patients with Multiple Sclerosis and Normal MR Imaging Brain Scans	PLOS ONE			English	Article							MAGNETIC-RESONANCE-SPECTROSCOPY; METABOLITE CONCENTRATIONS; DIAGNOSTIC-CRITERIA; IN-VIVO; MS; LESIONS; NEURODEGENERATION; QUANTIFICATION; DISABILITY; FRACTION	In Multiple Sclerosis (MS) the relationship between disease process in normal-appearing white matter (NAWM) and the development of white matter lesions is not well understood. In this study we used single voxel proton 'Quantitative Magnetic Resonance Spectroscopy' (qMRS) to characterize the NAWM and thalamus both in atypical 'Clinically Definite MS' (CDMS) patients, MRIneg (N = 15) with very few lesions (two or fewer lesions), and in typical CDMS patients, MRIpos (N = 20) with lesions, in comparison with healthy control subjects (N = 20). In addition, the metabolite concentrations were also correlated with extent of brain atrophy measured using Brain Parenchymal Fraction (BPF) and severity of the disease measured using 'Multiple Sclerosis Severity Score' (MSSS). Elevated concentrations of glutamate and glutamine (Glx) were observed in both MS groups (MRIneg 8.12 mM, p<0.001 and MRIpos 7.96 mM p<0.001) compared to controls, 6.76 mM. Linear regressions of Glx and total creatine (tCr) with MSSS were 0.16 +/- 0.06 mM/MSSS (p=0.02) for Glx and 0.06 +/- 0.03 mM/MSSS (p=0.04) for tCr, respectively. Moreover, linear regressions of tCr and myo-Inositol (mIns) with BPF were -6.22 +/- 1.63 mM/BPF (p<0.001) for tCr and -7.71 +/- 2.43 mM/BPF (p = 0.003) for mIns. Furthermore, the MRIpos patients had lower N-acetylaspartate and N-acetylaspartate-glutamate (tNA) and elevated mIns concentrations in NAWM compared to both controls (tNA: p=0.04 mIns p<0.001) and MRIneg (tNA: p= 0.03, mIns: p=0.002). The results suggest that Glx may be an important marker for pathology in non-lesional white matter in MS. Moreover, Glx is related to the severity of MS independent of number of lesions in the patient. In contrast, increased glial density indicated by increased mIns and decreased neuronal density indicated by the decreased tNA, were only observed in NAWM of typical CDMS patients with white matter lesions.	[Tisell, Anders; Leinhard, Olof Dahlqvist; Warntjes, Jan Bertus Marcel; Aalto, Anne; Smedby, Orjan; Landtblom, Anne-Marie; Lundberg, Peter] Linkoping Univ, Ctr Med Image Sci & Visualizat CMIV, Linkoping, Sweden; [Tisell, Anders; Leinhard, Olof Dahlqvist; Lundberg, Peter] Linkoping Univ, Dept Med & Hlth Sci IMH, Dept Radiat Phys UHL, Cty Council Ostergotland, Linkoping, Sweden; [Warntjes, Jan Bertus Marcel] Linkoping Univ, IMH, Linkoping, Sweden; [Aalto, Anne] Linkoping Univ, IMH, Dept Radiol, Vasterv Hosp, Linkoping, Sweden; [Smedby, Orjan; Lundberg, Peter] Linkoping Univ, IMH, Dept Radiol UHL, Cty Council Ostergotland, Linkoping, Sweden; [Landtblom, Anne-Marie] Linkoping Univ, Neurol Clin LiM, Div Neurosci, Dept Clin & Expt Med IKE,Cty Council Ostergotland, Linkoping, Sweden	Linkoping University; City Council Ostergotland; Linkoping University; Linkoping University; Linkoping University; City Council Ostergotland; Linkoping University; City Council Ostergotland; Linkoping University	Tisell, A (corresponding author), Linkoping Univ, Ctr Med Image Sci & Visualizat CMIV, Linkoping, Sweden.	anders.tisell@liu.se	Lundberg, Peter/AGD-9679-2022; Dahlqvist Leinhard, Olof/K-4228-2013	Dahlqvist Leinhard, Olof/0000-0002-6189-0807; Landtblom, Anne-Marie/0000-0001-9567-470X; Smedby, Orjan/0000-0002-7750-1917	National Research Council (VR/NT); County Council of Ostergotland (ALF)	National Research Council (VR/NT)(Swedish Research Council); County Council of Ostergotland (ALF)	This study was supported by grants form The National Research Council (VR/NT) and the County Council of Ostergotland (ALF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barkhof F, 2002, CURR OPIN NEUROL, V15, P239, DOI 10.1097/00019052-200206000-00003; Bjartmar C, 2002, ANN NEUROL, V51, P51, DOI 10.1002/ana.10052; Bjartmar C, 2001, NEUROLOGY, V57, P1248, DOI 10.1212/WNL.57.7.1248; BRAND A, 1993, DEV NEUROSCI-BASEL, V15, P289, DOI 10.1159/000111347; Caramanos Z, 2005, BRAIN, V128, P2483, DOI 10.1093/brain/awh640; Ernst T, 1993, J MAGNETIC RESONAN B, V102; Fu Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006705; Geurts JJG, 2004, J MAGN RESON IMAGING, V20, P366, DOI 10.1002/jmri.20138; Gustafsson MC, 2007, AM J NEURORADIOL, V28, P1306, DOI 10.3174/ajnr.A0580; Kidd D, 1999, BRAIN, V122, P17, DOI 10.1093/brain/122.1.17; Kreis R, 2004, NMR BIOMED, V17, P361, DOI 10.1002/nbm.891; Lassmann H, 2004, J NEUROL, V251, P2, DOI 10.1007/s00415-004-1402-3; Laule C, 2004, J NEUROL, V251, P284, DOI 10.1007/s00415-004-0306-6; Leary SM, 1999, J NEUROL, V246, P1023, DOI 10.1007/s004150050507; Martola J, 2010, NEURORADIOLOGY, V52, P109, DOI 10.1007/s00234-009-0593-9; Matthews PM, 1998, SEMIN NEUROL, V18, P327, DOI 10.1055/s-2008-1040884; Matute C, 2006, GLIA, V53, P212, DOI 10.1002/glia.20275; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; Minneboo A, 2009, MULT SCLER, V15, P632, DOI 10.1177/1352458509102617; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; PROVENCHER SW, 1993, MAGNET RESON MED, V30, P672, DOI 10.1002/mrm.1910300604; Rudick RA, 1999, NEUROLOGY, V53, P1698, DOI 10.1212/WNL.53.8.1698; Scahill RI, 2003, ARCH NEUROL-CHICAGO, V60, P989, DOI 10.1001/archneur.60.7.989; Srinivasan R, 2005, BRAIN, V128, P1016, DOI 10.1093/brain/awh467; Tisell A, 2013, MAGN RESON MED, V70, P905, DOI 10.1002/mrm.24554; Trapp BD, 1998, NEW ENGL J MED, V338, P278, DOI 10.1056/NEJM199801293380502; Trapp BD, 1999, NEUROSCIENTIST, V5, P48, DOI 10.1177/107385849900500107; URENJAK J, 1993, J NEUROSCI, V13, P981, DOI 10.1523/jneurosci.13-03-00981.1993; Vagberg M, 2013, AM J NEURORADIOL, V34, P498, DOI 10.3174/ajnr.A3262; Vercellino M, 2009, J NEUROPATH EXP NEUR, V68, P489, DOI 10.1097/NEN.0b013e3181a19a5a; Vrenken H, 2006, AM J NEURORADIOL, V27, P2005; Vrenken H, 2005, MAGNET RESON MED, V53, P256, DOI 10.1002/mrm.20366; West J, 2012, EUR RADIOL, V22, P998, DOI 10.1007/s00330-011-2336-7	34	52	52	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2013	8	4							e61817	10.1371/journal.pone.0061817	http://dx.doi.org/10.1371/journal.pone.0061817			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IK	23613944	gold, Green Published, Green Submitted			2022-12-25	WOS:000317907200090
J	Moreno-Delafuente, A; Garzo, E; Moreno, A; Fereres, A				Moreno-Delafuente, Ana; Garzo, Elisa; Moreno, Aranzazu; Fereres, Alberto			A Plant Virus Manipulates the Behavior of Its Whitefly Vector to Enhance Its Transmission Efficiency and Spread	PLOS ONE			English	Article							MYZUS-PERSICAE HOMOPTERA; LEAF CURL VIRUS; BEMISIA-TABACI; FEEDING-BEHAVIOR; APHID VECTORS; INSECT VECTOR; ALEYRODIDAE; INFECTION; BIOTYPES; TOSPOVIRUS	Plant viruses can produce direct and plant-mediated indirect effects on their insect vectors, modifying their life cycle, fitness and behavior. Viruses may benefit from such changes leading to enhanced transmission efficiency and spread. In our study, female adults of Bemisia tabaci were subjected to an acquisition access period of 72 h in Tomato yellow leaf curl virus (TYLCV)-infected and non-infected tomato plants to obtain viruliferous and non-viruliferous whiteflies, respectively. Insects that were exposed to virus-infected plants were checked by PCR to verify their viruliferous status. Results of the Ethovision video tracking bioassays indicated that TYLCV induced an arrestant behavior of B. tabaci, as viruliferous whitefly adults remained motionless for more time and moved slower than non-viruliferous whiteflies after their first contact with eggplant leaf discs. In fact, Electrical Penetration Graphs showed that TYLCV-viruliferous B. tabaci fed more often from phloem sieve elements and made a larger number of phloem contacts (increased number of E1, E2 and sustained E2 per insect, p < 0.05) in eggplants than non-viruliferous whiteflies. Furthermore, the duration of the salivation phase in phloem sieve elements (E1) preceding sustained sap ingestion was longer in viruliferous than in non-viruliferous whiteflies (p < 0.05). This particular probing behavior is known to significantly enhance the inoculation efficiency of TYLCV by B. tabaci. Our results show evidence that TYLCV directly manipulates the settling, probing and feeding behavior of its vector B. tabaci in a way that enhances virus transmission efficiency and spread. Furthermore, TYLCV-B. tabaci interactions are mutually beneficial to both the virus and its vector because B. tabaci feeds more efficiently after acquisition of TYLCV. This outcome has clear implications in the epidemiology and management of the TYLCV-B. tabaci complex.	[Moreno-Delafuente, Ana; Garzo, Elisa; Moreno, Aranzazu; Fereres, Alberto] CSIC, Inst Ciencias Agr ICA, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Ciencias Agrarias (ICA)	Fereres, A (corresponding author), CSIC, Inst Ciencias Agr ICA, Madrid, Spain.	a.fereres@csic.es	Fereres, Alberto/F-2990-2011; Fereres, Alberto/G-6542-2012; Moreno, Aránzazu/F-9309-2015; Fereres, Alberto/F-8206-2013; Fereres, Alberto/GZG-4690-2022; Garzo, Elisa/G-3047-2015	Fereres, Alberto/0000-0001-6012-3270; Fereres, Alberto/0000-0001-6012-3270; Moreno, Aránzazu/0000-0003-1394-3123; Garzo, Elisa/0000-0001-8626-5832; Moreno-Delafuente, Ana/0000-0001-7784-9828	Spanish Ministry of Science and Innovation [AGL2010-22196-C02-01]; Fundacion La Caixa	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fundacion La Caixa(La Caixa Foundation)	The present work received financial support from the Spanish Ministry of Science and Innovation (Research Grant AGL2010-22196-C02-01). First author was supported by Fundacion La Caixa Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abacus Concepts INC, 1989, STAT VIEW 2; Backus EA, 2007, ANN ENTOMOL SOC AM, V100, P296, DOI 10.1603/0013-8746(2007)100[296:LHHMFO]2.0.CO;2; Bosque-Perez NA, 2011, VIRUS RES, V159, P201, DOI 10.1016/j.virusres.2011.04.020; BROWN JK, 1995, ANNU REV ENTOMOL, V40, P511, DOI 10.1146/annurev.en.40.010195.002455; Brown JK, 2002, ADV BOT RES, V36, P65, DOI 10.1016/S0065-2296(02)36059-2; COHEN S, 1966, PHYTOPATHOLOGY, V56, P1127; COHEN S., 1964, ENTOMOL EXP APPL, V7, P155, DOI 10.1007/BF00305053; Czosnek H, 1997, ARCH VIROL, V142, P1391, DOI 10.1007/s007050050168; Czosnek H, 2012, J INTEGR AGR, V11, P225, DOI 10.1016/S2095-3119(12)60007-0; Dalton R, 2006, NATURE, V443, P898, DOI 10.1038/443898a; De Barro PJ, 2011, ANNU REV ENTOMOL, V56, P1, DOI 10.1146/annurev-ento-112408-085504; Donaldson JR, 2007, ENVIRON ENTOMOL, V36, P918, DOI 10.1603/0046-225X(2007)36[918:AEOSVO]2.0.CO;2; Eigenbrode SD, 2002, P ROY SOC B-BIOL SCI, V269, P455, DOI 10.1098/rspb.2001.1909; FERERES A, 1989, ENVIRON ENTOMOL, V18, P388, DOI 10.1093/ee/18.3.388; Fereres A, 2009, VIRUS RES, V141, P158, DOI 10.1016/j.virusres.2008.10.020; FORBES AR, 1969, CAN ENTOMOL, V101, P31, DOI 10.4039/Ent10131-1; Frolich DR, 1999, MOL ECOL, V8, P1593; Ghanim M, 2000, J VIROL, V74, P4738, DOI 10.1128/JVI.74.10.4738-4745.2000; Ghanim M, 1998, VIROLOGY, V240, P295, DOI 10.1006/viro.1997.8937; GRIMSTAD PR, 1980, J MED ENTOMOL, V17, P1, DOI 10.1093/jmedent/17.1.1; Hodge S, 2008, ENVIRON ENTOMOL, V37, P1573, DOI 10.1603/0046-225X-37.6.1573; Hogenhout SA, 2008, ANNU REV PHYTOPATHOL, V46, P327, DOI 10.1146/annurev.phyto.022508.092135; Ingwell LL, 2012, SCI REP-UK, V2, DOI 10.1038/srep00578; Irwin ME, 2007, APHIDS AS CROP PESTS, P153, DOI 10.1079/9780851998190.0153; Jeger MJ, 2004, PHYSIOL ENTOMOL, V29, P291, DOI 10.1111/j.0307-6962.2004.00394.x; Jiang YX, 1999, J ECON ENTOMOL, V92, P357, DOI 10.1093/jee/92.2.357; Jiang YX, 2000, ANN ENTOMOL SOC AM, V93, P573, DOI 10.1603/0013-8746(2000)093[0573:CBWHAF]2.0.CO;2; Jiu M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000182; Johnson DD, 1999, ENTOMOL EXP APPL, V92, P257, DOI 10.1023/A:1003844802227; Rodriguez-Lopez MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033064; Liu SS, 2012, J INTEGR AGR, V11, P176, DOI 10.1016/S2095-3119(12)60002-1; Luan JB, 2013, ECOL LETT, V16, P390, DOI 10.1111/ele.12055; Mann RS, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002610; Mauck K, 2012, FUNCT ECOL, V26, P1162, DOI 10.1111/j.1365-2435.2012.02026.x; McKenzie CL, 2012, J ECON ENTOMOL, V105, P753, DOI 10.1603/EC11337; Medeiros RB, 2004, J VIROL, V78, P4976, DOI 10.1128/JVI.78.10.4976-4982.2004; Morilla G, 2005, PHYTOPATHOLOGY, V95, P1089, DOI 10.1094/PHYTO-95-1089; Noldus Information Technology, 2009, ETH XT REF MAN VERS; Noldus LPJJ, 2002, COMPUT ELECTRON AGR, V35, P201, DOI 10.1016/S0168-1699(02)00019-4; Olmos A, 1999, NUCLEIC ACIDS RES, V27, P1564, DOI 10.1093/nar/27.6.1564; Olmos A, 1996, NUCLEIC ACIDS RES, V24, P2192, DOI 10.1093/nar/24.11.2192; Platt KB, 1997, AM J TROP MED HYG, V57, P119, DOI 10.4269/ajtmh.1997.57.119; PRADO E, 1994, ENTOMOL EXP APPL, V72, P157, DOI 10.1007/BF02383550; Pusag JCA, 2012, J INSECT PHYSL; Richards O.W., 1977, IMMS GEN TXB ENTOMOL, V1; Rodriguez-Lopez MJ, 2011, PHYTOPATHOLOGY, V101, P1191, DOI 10.1094/PHYTO-01-11-0028; Rubinstein G, 1997, J GEN VIROL, V78, P2683, DOI 10.1099/0022-1317-78-10-2683; Sarria E, 2009, COMPUT ELECTRON AGR, V67, P35, DOI 10.1016/j.compag.2009.02.006; Shrestha A, 2012, ENTOMOL EXP APPL, V145, P260, DOI 10.1111/eea.12011; SPILLER NJ, 1990, ENTOMOL EXP APPL, V55, P101, DOI 10.1007/BF00352570; SPSS Inc, 2010, IBM STAT SPSS 19 0 P; Stafford CA, 2011, P NATL ACAD SCI USA, V108, P9350, DOI 10.1073/pnas.1100773108; Sun DB, 2011, B ENTOMOL RES, V101, P211, DOI 10.1017/S0007485310000416; Tjallingii W.F., 1990, P89; Wang J, 2012, ENTOMOL EXP APPL, V144, P191, DOI 10.1111/j.1570-7458.2012.01278.x; Zhang T, 2012, MOL ECOL, V21, P1294, DOI 10.1111/j.1365-294X.2012.05457.x	56	144	153	3	124	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2013	8	4							e61543	10.1371/journal.pone.0061543	http://dx.doi.org/10.1371/journal.pone.0061543			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130DR	23613872	Green Published, Green Submitted, gold			2022-12-25	WOS:000317893400074
J	White, MT; Bejon, P; Olotu, A; Griffin, JT; Riley, EM; Kester, KE; Ockenhouse, CF; Ghani, AC				White, Michael T.; Bejon, Philip; Olotu, Ally; Griffin, Jamie T.; Riley, Eleanor M.; Kester, Kent E.; Ockenhouse, Christian F.; Ghani, Azra C.			The Relationship between RTS,S Vaccine-Induced Antibodies, CD4(+) T Cell Responses and Protection against Plasmodium falciparum Infection	PLOS ONE			English	Article							PHASE 2A TRIAL; CANDIDATE MALARIA VACCINE; CIRCUMSPOROZOITE PROTEIN; NAIVE ADULTS; DOUBLE-BLIND; EFFICACY; SAFETY; IMMUNIZATION; CHILDREN; IMMUNITY	Vaccination with the pre-erythrocytic malaria vaccine RTS,S induces high levels of antibodies and CD4(+) T cells specific for the circumsporozoite protein (CSP). Using a biologically-motivated mathematical model of sporozoite infection fitted to data from malaria-naive adults vaccinated with RTS, S and subjected to experimental P. falciparum challenge, we characterised the relationship between antibodies, CD4(+) T cell responses and protection from infection. Both anti-CSP antibody titres and CSP-specific CD4(+) T cells were identified as immunological surrogates of protection, with RTS,S induced anti-CSP antibodies estimated to prevent 32% (95% confidence interval (CI) 24%-41%) of infections. The addition of RTS,S induced CSP-specific CD4(+) T cells was estimated to increase vaccine efficacy against infection to 40% (95% CI, 34%-48%). This protective efficacy is estimated to result from a 96.1% (95% CI, 93.4%-97.8%) reduction in the liver-to-blood parasite inoculum, indicating that in volunteers who developed P. falciparum infection, a small number of parasites (often the progeny of a single surviving sporozoite) are responsible for breakthrough blood-stage infections.	[White, Michael T.; Griffin, Jamie T.; Ghani, Azra C.] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, MRC Ctr Outbreak Anal & Modelling, London, England; [Bejon, Philip; Olotu, Ally] Kenya Govt Med Res Ctr, Kilifi, Kenya; [Bejon, Philip] Univ Oxford, Ctr Clin Vaccinol & Trop Med, Oxford, England; [Riley, Eleanor M.] Univ London London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Dept Immunol & Infect, London WC1E 7HT, England; [Kester, Kent E.; Ockenhouse, Christian F.] Walter Reed Army Inst Res, Silver Spring, MD USA	Imperial College London; Kenya Medical Research Institute; University of Oxford; University of London; London School of Hygiene & Tropical Medicine; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR)	White, MT (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, MRC Ctr Outbreak Anal & Modelling, London, England.	m.white08@imperial.ac.uk	Ghani, Azra/B-8560-2009; Riley, Eleanor/AAL-1382-2020; Kester, Kent/AAF-8235-2020; Riley, Eleanor M/C-8960-2013	Riley, Eleanor/0000-0003-3447-3570; Kester, Kent/0000-0002-5056-0802; Riley, Eleanor M/0000-0003-3447-3570; White, Michael/0000-0002-7472-4138; Ghani, Azra/0000-0002-0007-4910	MRC Centre; MRC [G1002624]; Wellcome Trust; MVI/PATH; EviMalaR network; Bill and Melinda Gates Foundation Vaccine Modelling Initiative; Medical Research Council [MR/K010174/1B, MR/K010174/1, G1002284, G1002624, G0600719B] Funding Source: researchfish; MRC [G1002284, MR/K010174/1] Funding Source: UKRI	MRC Centre(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); MVI/PATH; EviMalaR network; Bill and Melinda Gates Foundation Vaccine Modelling Initiative; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	MTW was supported by an MRC Centre studentship. PB is funded by an MRC Fellowship G1002624). AO is funded by a Wellcome Trust Strategic Award. JTG is funded by an MRC Fellowship. EMR acknowledges funding from MVI/PATH, the MRC and the EviMalaR network (EU FP7). ACG acknowledges support from the Bill and Melinda Gates Foundation Vaccine Modelling Initiative and MRC Centre funding. The analysis was conducted following a call for proposals initiated and facilitated by GSK Biologicals. Employees of GSK Biologicals reviewed and commented on early draft manuscripts, but were not involved in the final approval of the manuscript. GSK Biologicals did not fund the investigators to undertake the analysis. GSK funded transport expenses for the investigators to attend a meeting to discuss their progress. GSK had no role in study design, data collection or the final decision to publish.	Abdulla S, 2008, NEW ENGL J MED, V359, P2533, DOI 10.1056/NEJMoa0807773; Alonso PL, 2004, LANCET, V364, P1411, DOI 10.1016/S0140-6736(04)17223-1; Ansong D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018891; Aponte JJ, 2007, LANCET, V370, P1543, DOI 10.1016/S0140-6736(07)61542-6; Asante KP, 2011, LANCET INFECT DIS, V11, P741, DOI 10.1016/S1473-3099(11)70100-1; BEIER JC, 1991, AM J TROP MED HYG, V44, P564, DOI 10.4269/ajtmh.1991.44.564; BEIER MS, 1992, AM J TROP MED HYG, V47, P195; Bejon P, 2005, J INFECT DIS, V191, P619, DOI 10.1086/427243; Bejon P, 2008, NEW ENGL J MED, V359, P2521, DOI 10.1056/NEJMoa0807381; Bejon P, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-104; Bejon P, 2009, INFECT IMMUN, V77, P1917, DOI 10.1128/IAI.01358-08; Bojang KA, 2001, LANCET, V358, P1927, DOI 10.1016/S0140-6736(01)06957-4; Bosman A, 2007, AM J TROP MED HYG, V77, P193, DOI 10.4269/ajtmh.2007.77.193; Flaxman AD, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000328; GRECO WR, 1995, PHARMACOL REV, V47, P331; Hanke T, 1998, VACCINE, V16, P439, DOI 10.1016/S0264-410X(97)00226-0; Heppner DG, 2005, VACCINE, V23, P2243, DOI 10.1016/j.vaccine.2005.01.042; Hermsen CC, 2004, AM J TROP MED HYG, V71, P196, DOI 10.4269/ajtmh.2004.71.2.0700196; Hermsen CC, 2001, MOL BIOCHEM PARASIT, V118, P247, DOI 10.1016/S0166-6851(01)00379-6; Hill AVS, 2006, NAT REV IMMUNOL, V6, P21, DOI 10.1038/nri1746; John CC, 2005, AM J TROP MED HYG, V73, P222, DOI 10.4269/ajtmh.2005.73.222; Kester KE, 2008, VACCINE, V26, P2191, DOI 10.1016/j.vaccine.2008.02.048; Kester KE, 2009, J INFECT DIS, V200, P337, DOI 10.1086/600120; Lell B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007611; Lumsden JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020775; Medica DL, 2005, INFECT IMMUN, V73, P4363, DOI 10.1128/IAI.73.7.4363-4369.2005; MELLOUK S, 1990, B WORLD HEALTH ORGAN, V68, P52; MURPHY JR, 1989, J CLIN MICROBIOL, V27, P1434, DOI 10.1128/JCM.27.7.1434-1437.1989; Olotu A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025786; Olotu A, 2011, LANCET INFECT DIS, V11, P102, DOI 10.1016/S1473-3099(10)70262-0; Olotu AI, 2010, J INFECT DIS, V201, P970, DOI 10.1086/651025; Owusu-Agyei S, 2009, PLOS ONE, V4; Polhemus ME, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006465; PRENTICE RL, 1989, STAT MED, V8, P431, DOI 10.1002/sim.4780080407; Qin L, 2007, J INFECT DIS, V196, P1304, DOI 10.1086/522428; RENIA L, 1991, P NATL ACAD SCI USA, V88, P7963, DOI 10.1073/pnas.88.18.7963; RILEY EM, 1990, T ROY SOC TROP MED H, V84, P648, DOI 10.1016/0035-9203(90)90133-Y; Schwenk R, 2003, PARASITE IMMUNOL, V25, P17, DOI 10.1046/j.1365-3024.2003.00495.x; SMITH PG, 1984, INT J EPIDEMIOL, V13, P87, DOI 10.1093/ije/13.1.87; Sun PF, 2003, J IMMUNOL, V171, P6961, DOI 10.4049/jimmunol.171.12.6961; The RTS SCTP, 2011, NEW ENGLAND J MED, V10; White MT, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-82; WHO, 2011, WORLD MALARIA REPORT 2011, P1	43	104	106	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2013	8	4							e61395	10.1371/journal.pone.0061395	http://dx.doi.org/10.1371/journal.pone.0061395			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130DR	23613845	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000317893400061
J	Winsor, TS; Bartkowiak, B; Bennett, CB; Greenleaf, AL				Winsor, Tiffany Sabin; Bartkowiak, Bartlomiej; Bennett, Craig B.; Greenleaf, Arno L.			A DNA Damage Response System Associated with the phosphoCTD of Elongating RNA Polymerase II	PLOS ONE			English	Article							TERMINAL REPEAT DOMAIN; DOUBLE-STRAND BREAKS; CTD KINASE; INTERACTING DOMAIN; IONIZING-RADIATION; TRANSCRIPTION; GENOME; PHOSPHORYLATION; REPAIR; GENES	RNA polymerase II translocates across much of the genome and since it can be blocked by many kinds of DNA lesions, detects DNA damage proficiently; it thereby contributes to DNA repair and to normal levels of DNA damage resistance. However, the components and mechanisms that respond to polymerase blockage are largely unknown, except in the case of UV-induced damage that is corrected by nucleotide excision repair. Because elongating RNAPII carries with it numerous proteins that bind to its hyperphosphorylated CTD, we tested for effects of interfering with this binding. We find that expressing a decoy CTD-carrying protein in the nucleus, but not in the cytoplasm, leads to reduced DNA damage resistance. Likewise, inducing aberrant phosphorylation of the CTD, by deleting CTK1, reduces damage resistance and also alters rates of homologous recombination-mediated repair. In line with these results, extant data sets reveal a remarkable, highly significant overlap between phosphoCTD-associating protein genes and DNA damage-resistance genes. For one well-known phosphoCTD-associating protein, the histone methyltransferase Set2, we demonstrate a role in DNA damage resistance, and we show that this role requires the phosphoCTD binding ability of Set2; surprisingly, Set2's role in damage resistance does not depend on its catalytic activity. To explain all of these observations, we posit the existence of a CTD-Associated DNA damage Response (CAR) system, organized around the phosphoCTD of elongating RNAPII and comprising a subset of phosphoCTD-associating proteins.	[Winsor, Tiffany Sabin; Bartkowiak, Bartlomiej; Bennett, Craig B.; Greenleaf, Arno L.] Duke Univ, Med Ctr, Dept Biochem, Duke Ctr RNA Biol, Durham, NC 27710 USA	Duke University	Greenleaf, AL (corresponding author), Duke Univ, Med Ctr, Dept Biochem, Duke Ctr RNA Biol, Durham, NC 27710 USA.	arno@biochem.duke.edu			National Institutes of Healht [GM040505]; Duke School of Medicine Bridging; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040505] Funding Source: NIH RePORTER	National Institutes of Healht; Duke School of Medicine Bridging; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Healht grant GM040505 and in part by Duke School of Medicine Bridging Funds, both to ALG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SH, 2004, MOL CELL, V13, P67, DOI 10.1016/S1097-2765(03)00492-1; Anindya R, 2007, MOL CELL, V28, P386, DOI 10.1016/j.molcel.2007.10.008; Barbera MA, 2006, P NATL ACAD SCI USA, V103, P12819, DOI 10.1073/pnas.0605778103; Bartkowiak B, 2011, GENET RES INT, V2011, DOI 10.4061/2011/623718; Bartkowiak B, 2010, GENE DEV, V24, P2303, DOI 10.1101/gad.1968210; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Bennett CB, 2001, NAT GENET, V29, P426, DOI 10.1038/ng778; Boone C, 2007, NAT REV GENET, V8, P437, DOI 10.1038/nrg2085; Bouchard WJ, 2003, EXP HEMATOL, V31, P446, DOI 10.1016/S0301-472X(03)00083-3; Buratowski S, 2009, MOL CELL, V36, P541, DOI 10.1016/j.molcel.2009.10.019; Carty SM, 2002, MOL CELL PROTEOMICS, V1, P598, DOI 10.1074/mcp.M200029-MCP200; Chinchilla K, 2012, EUKARYOT CELL, V11, P417, DOI 10.1128/EC.05320-11; Cho EJ, 2001, GENE DEV, V15, P3319, DOI 10.1101/gad.935901; Coic E, 2008, GENETICS, V179, P199, DOI 10.1534/genetics.108.087189; Dantzer F, 2006, METHOD ENZYMOL, V409, P493, DOI 10.1016/S0076-6879(05)09029-4; Derheimer FA, 2007, P NATL ACAD SCI USA, V104, P12778, DOI 10.1073/pnas.0705317104; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Duina AA, 2004, MOL CELL BIOL, V24, P561, DOI 10.1128/MCB.24.2.561-572.2004; Egloff S, 2008, TRENDS GENET, V24, P280, DOI 10.1016/j.tig.2008.03.008; Game JC, 2003, RADIAT RES, V160, P14, DOI 10.1667/RR3019; Gandhi M, 2012, P NATL ACAD SCI USA, V109, P9454, DOI 10.1073/pnas.1205759109; Grasso CS, 2012, NATURE, V487, P239, DOI 10.1038/nature11125; Hall BM, 2009, BIOINFORMATICS, V25, P1564, DOI 10.1093/bioinformatics/btp253; Hanawalt PC, 2008, NAT REV MOL CELL BIO, V9, P958, DOI 10.1038/nrm2549; Harreman M, 2009, P NATL ACAD SCI USA, V106, P20705, DOI 10.1073/pnas.0907052106; Ho Y, 1997, P NATL ACAD SCI USA, V94, P581, DOI 10.1073/pnas.94.2.581; Jeong SJ, 2005, J MICROBIOL, V43, P516; Juhlin C, 2006, ENDOCR-RELAT CANCER, V13, P509, DOI 10.1677/erc.1.01058; Kanagaraj R, 2010, NUCLEIC ACIDS RES, V38, P8131, DOI 10.1093/nar/gkq697; Kim M, 2004, NATURE, V432, P517, DOI 10.1038/nature03041; Kizer KO, 2005, MOL CELL BIOL, V25, P3305, DOI 10.1128/MCB.25.8.3305-3316.2005; LEA DE, 1949, J GENET, V49, P264, DOI 10.1007/BF02986080; LEE JM, 1991, GENE EXPRESSION, V1, P149; LEE JM, 1989, P NATL ACAD SCI USA, V86, P3624, DOI 10.1073/pnas.86.10.3624; Lettier G, 2006, PLOS GENET, V2, P1773, DOI 10.1371/journal.pgen.0020194; Li M, 2005, P NATL ACAD SCI USA, V102, P17636, DOI 10.1073/pnas.0506350102; Li M, 2006, J BIOMOL NMR, V36, P5, DOI 10.1007/s10858-005-4690-8; Li XL, 2005, CELL, V122, P365, DOI 10.1016/j.cell.2005.06.008; Lindsey-Boltz LA, 2007, P NATL ACAD SCI USA, V104, P13213, DOI 10.1073/pnas.0706316104; MALONE RE, 1983, MOL GEN GENET, V189, P405, DOI 10.1007/BF00325902; MALONE RE, 1984, GENETICS, V107, P33; Mischo HE, 2011, MOL CELL, V41, P21, DOI 10.1016/j.molcel.2010.12.007; MORELAND RB, 1985, P NATL ACAD SCI USA, V82, P6561, DOI 10.1073/pnas.82.19.6561; Morris DP, 1999, J BIOL CHEM, V274, P31583, DOI 10.1074/jbc.274.44.31583; Pan XW, 2006, CELL, V124, P1069, DOI 10.1016/j.cell.2005.12.036; Pankotai T, 2012, NAT STRUCT MOL BIOL, V19, P276, DOI 10.1038/nsmb.2224; Phatnani HP, 2006, GENE DEV, V20, P2922, DOI 10.1101/gad.1477006; Phatnani HP, 2004, BIOCHEMISTRY-US, V43, P15702, DOI 10.1021/bi048364h; Qiu HF, 2009, MOL CELL, V33, P752, DOI 10.1016/j.molcel.2009.02.018; Skaar DA, 2002, CHARACTERIZATION CTD; Sordet O, 2010, CELL CYCLE, V9, P274, DOI 10.4161/cc.9.2.10506; Srividya I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031288; St Charles J, 2012, GENETICS, V190, P1267, DOI 10.1534/genetics.111.137927; Strahl BD, 2002, MOL CELL BIOL, V22, P1298, DOI 10.1128/MCB.22.5.1298-1306.2002; Svejstrup JQ, 2010, TRENDS BIOCHEM SCI, V35, P333, DOI 10.1016/j.tibs.2010.02.001; Ursic D, 2004, NUCLEIC ACIDS RES, V32, P2441, DOI 10.1093/nar/gkh561; Westmoreland TJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005830; Westmoreland TJ, 2004, EUKARYOT CELL, V3, P430, DOI 10.1128/EC.3.2.430-446.2004; Winzeler E A, 2000, Novartis Found Symp, V229, P105; Wong JMS, 2001, MOL GEN GENET, V264, P842; Wu J, 2010, BIOCHEM BIOPH RES CO, V397, P117, DOI 10.1016/j.bbrc.2010.05.081	61	19	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2013	8	4							e60909	10.1371/journal.pone.0060909	http://dx.doi.org/10.1371/journal.pone.0060909			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130DR	23613755	Green Submitted, Green Published, gold			2022-12-25	WOS:000317893400029
J	Bax, ML; Buffiere, C; Hafnaoui, N; Gaudichon, C; Savary-Auzeloux, I; Dardevet, D; Sante-Lhoutellier, V; Remond, D				Bax, Marie-Laure; Buffiere, Caroline; Hafnaoui, Noureddine; Gaudichon, Claire; Savary-Auzeloux, Isabelle; Dardevet, Dominique; Sante-Lhoutellier, Veronique; Remond, Didier			Effects of Meat Cooking, and of Ingested Amount, on Protein Digestion Speed and Entry of Residual Proteins into the Colon: A Study in Minipigs	PLOS ONE			English	Article							AMINO-ACIDS; IN-VITRO; METABOLIC UTILIZATION; ILEAL DIGESTIBILITY; NITROGEN-BALANCE; DIETARY PROTEINS; HUMANS; CONSUMPTION; CARNOSINE; QUALITY	The speed of protein digestion impacts on postprandial protein anabolism. After exercise or in the elderly, fast proteins stimulate protein synthesis more efficiently than slow proteins. It has been shown that meat might be a source of fast proteins. However, cooking temperature, acting on the macrostructure and microstructure of the meat could affect both the speed, and efficiency, of protein digestion. This study aims to evaluate, in vivo, the effect of meat cooking on digestion parameters, in the context of a complete meal. Six minipigs fitted with an ileal cannula and an arterial catheter were used. In order to measure the true ileal digestibility, tested meat was obtained from a calf, the muscle proteins of which were intrinsically labelled with N-15-amino acids. Three cooking temperatures (60, 75 and 95 degrees C; core temperature for 30 min), and three levels of intake (1, 1.45, and 1.90 g protein/kg body weight) were tested. Following meat ingestion, ileal digesta and arterial blood were collected over a 9-h period. The speed of digestion, evaluated from the kinetics of amino acid appearance in blood within the first 3 h, was greater for the cooking temperature of 75 degrees C, than for 60 or 95 degrees C. The true ileal digestibility, which averaged 95%, was not affected by cooking temperature or by the level of meat intake. The amino acid composition of the digesta flowing at the ileum was not affected by cooking temperature. These results show that cooking temperature can modulate the speed of meat protein digestion, without affecting the efficiency of the small intestinal digestion, and consequently the entry of meat protein residues into the colon.	[Bax, Marie-Laure; Buffiere, Caroline; Hafnaoui, Noureddine; Savary-Auzeloux, Isabelle; Dardevet, Dominique; Remond, Didier] Univ Auvergne, Clermont Univ, Unite Nutr Humaine, Clermont Ferrand, France; [Bax, Marie-Laure; Buffiere, Caroline; Hafnaoui, Noureddine; Savary-Auzeloux, Isabelle; Dardevet, Dominique; Remond, Didier] CRNH Auvergne, UNH UMR1019, INRA, Clermont Ferrand, France; [Bax, Marie-Laure; Sante-Lhoutellier, Veronique] INRA, Qualite Prod Anim UR370, F-63122 St Genes Champanelle, France; [Gaudichon, Claire] CRNH Ile France, INRA, AgroParisTech, Nutr Physiol & Ingest Behav UMR914, Paris, France	Universite Clermont Auvergne (UCA); INRAE; INRAE; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Remond, D (corresponding author), Univ Auvergne, Clermont Univ, Unite Nutr Humaine, Clermont Ferrand, France.	didier.remond@clermont.inra.fr	Sante-Lhoutellier, Veronique/M-8831-2017; Rémond, Didier/G-3550-2013	Sante-Lhoutellier, Veronique/0000-0003-2149-7661; Remond, Didier/0000-0003-4430-0067; GAUDICHON, Claire/0000-0002-0983-4760; Dardevet, Dominique/0000-0001-7320-9970; Savary-Auzeloux, Isabelle/0000-0002-3298-9787	French Research National Agency [ANR-09-ALIA-008-01]; European fund for regional development (FEDER); Auvergne regional council; EU [COST FA 1005]	French Research National Agency(French National Research Agency (ANR)); European fund for regional development (FEDER)(European Commission); Auvergne regional council(Region Auvergne-Rhone-Alpes); EU(European Commission)	The authors are grateful to the French Research National Agency (ANR-09-ALIA-008-01 Program PRONUTRIAL (2010-2013)), the European fund for regional development (FEDER), and the Auvergne regional council for their financial supports. The authors are participants of the EU funded COST action INFOGEST (COST FA 1005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DD, 2011, OBES REV, V12, pe472, DOI 10.1111/j.1467-789X.2010.00785.x; Barbe F, 2013, FOOD CHEM, V136, P1203, DOI 10.1016/j.foodchem.2012.09.022; Bauchart C, 2007, BRIT J NUTR, V98, P1187, DOI 10.1017/S0007114507761810; Bauchart C, 2007, J NUTR, V137, P589, DOI 10.1093/jn/137.3.589; Bax ML, 2012, J AGR FOOD CHEM, V60, P2569, DOI 10.1021/jf205280y; Bingham SA, 2002, J NUTR, V132, p3522S, DOI 10.1093/jn/132.11.3522S; Boirie Y, 1997, P NATL ACAD SCI USA, V94, P14930, DOI 10.1073/pnas.94.26.14930; Bos C, 2005, AM J CLIN NUTR, V81, P87; Bos C, 2007, J NUTR, V137, P594, DOI 10.1093/jn/137.3.594; Chan DSM, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0020456, 10.1371/journal.pone.0027218]; Dangin M, 2003, J PHYSIOL-LONDON, V549, P635, DOI 10.1113/jphysiol.2002.036897; de Vrese M, 2000, J NUTR, V130, P2026, DOI 10.1093/jn/130.8.2026; Gaudichon C, 2002, GASTROENTEROLOGY, V123, P50, DOI 10.1053/gast.2002.34233; Gausseres N, 1997, J NUTR, V127, P1160, DOI 10.1093/jn/127.6.1160; Hess V, 2000, BRIT J NUTR, V83, P123, DOI 10.1017/S0007114500000167; Lacroix M, 2006, AM J CLIN NUTR, V84, P1070, DOI 10.1093/ajcn/84.5.1070; Leterme P, 1996, J NUTR, V126, P2188, DOI 10.1093/jn/126.9.2188; Magee EA, 2000, AM J CLIN NUTR, V72, P1488; Mariotti F, 1999, J NUTR, V129, P1992, DOI 10.1093/jn/129.11.1992; Mariotti F, 2001, J NUTR, V131, P1706, DOI 10.1093/jn/131.6.1706; Park YJ, 2005, J AGR FOOD CHEM, V53, P4736, DOI 10.1021/jf047934h; Remond D, 2007, AM J CLIN NUTR, V85, P1286, DOI 10.1093/ajcn/85.5.1286; Remond D, 2009, J NUTR, V139, P720, DOI 10.3945/jn.108.101675; ROWAN AM, 1994, BRIT J NUTR, V71, P29, DOI 10.1079/BJN19940108; Santarelli RL, 2008, NUTR CANCER, V60, P131, DOI 10.1080/01635580701684872; Sante-Lhoijtellier V, 2008, J AGR FOOD CHEM, V56, P1488, DOI 10.1021/jf072999g; SCHMITZ M, 1991, J NUTR, V121, P1575, DOI 10.1093/jn/121.10.1575; SILVESTER KR, 1995, NUTR CANCER, V24, P279, DOI 10.1080/01635589509514417; Symons TB, 2009, J AM DIET ASSOC, V109, P1582, DOI 10.1016/j.jada.2009.06.369; Tabatabaei SM, 2011, EUR J CLIN NUTR, V65, P668, DOI 10.1038/ejcn.2011.17; WAYLER A, 1983, J NUTR, V113, P2485, DOI 10.1093/jn/113.12.2485; West DWD, 2011, AM J CLIN NUTR, V94, P795, DOI 10.3945/ajcn.111.013722; World Cancer Research Fund and American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P; YOUNG VR, 1975, J NUTR, V105, P534, DOI 10.1093/jn/105.5.534	34	77	78	4	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2013	8	4							e61252	10.1371/journal.pone.0061252	http://dx.doi.org/10.1371/journal.pone.0061252			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123JP	23593443	Green Published, Green Submitted, gold			2022-12-25	WOS:000317385300066
J	Odell, AF; Odell, LR; Askham, JM; Alogheli, H; Ponnambalam, S; Hollstein, M				Odell, Adam F.; Odell, Luke R.; Askham, Jon M.; Alogheli, Hiba; Ponnambalam, Sreenivasan; Hollstein, Monica			A Novel p53 Mutant Found in Iatrogenic Urothelial Cancers Is Dysfunctional and Can Be Rescued by a Second-site Global Suppressor Mutation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOUSE EMBRYONIC FIBROBLASTS; ARISTOLOCHIC ACID; TP53 MUTATIONS; DNA-BINDING; WILD-TYPE; PATTERNS; ETIOLOGY; INSIGHTS; CELLS; GAIN	Exposure to herbal remedies containing the carcinogen aristolochic acid (AA) has been widespread in some regions of the world. Rare A -> T TP53 mutations were recently discovered in AA-associated urothelial cancers. The near absence of these mutations among all other sequenced human tumors suggests that they could be biologically silent. There are no cell banks with established lines derived from human tumors with which to explore the influence of the novel mutants on p53 function and cellular behavior. To investigate their impact, we generated isogenic mutant clones by integrase-mediated cassette exchange at the p53 locus of platform (null) murine embryonic fibroblasts and kidney epithelial cells. Common tumor mutants (R248W, R273C) were compared with the AA-associated mutants N131Y, R249W, and Q104L. Assays of cell proliferation, migration, growth in soft agar, apoptosis, senescence, and gene expression revealed contrasting outcomes on cellular behavior following introduction of N131Y or Q104L. The N131Y mutant demonstrated a phenotype akin to common tumor mutants, whereas Q104L clone behavior resembled that of cells with wild-type p53. Wild-type p53 responses were restored in double-mutant cells harboring N131Y and N239Y, a second-site rescue mutation, suggesting that pharmaceutical reactivation of p53 function in tumors expressing N131Y could have therapeutic benefit. N131Y is likely to contribute directly to tumor phenotype and is a promising candidate biomarker of AA exposure and disease. Rare mutations thus do not necessarily point to sites where amino acid exchanges are phenotypically neutral. Encounter with mutagenic insults targeting cryptic sites can reveal specific signature hotspots.	[Odell, Adam F.; Askham, Jon M.; Hollstein, Monica] Univ Leeds, Fac Med & Hlth, Leeds LS2 9JT, W Yorkshire, England; [Odell, Luke R.; Alogheli, Hiba] Uppsala Univ, Dept Med Chem, Div Organ Pharmaceut Chem, S-75123 Uppsala, Sweden; [Ponnambalam, Sreenivasan] Univ Leeds, Sch Mol & Cellular Biol, Leeds LS2 9JT, W Yorkshire, England; [Hollstein, Monica] German Canc Res Ctr, Dept C016, D-69120 Heidelberg, Germany	University of Leeds; Uppsala University; University of Leeds; Helmholtz Association; German Cancer Research Center (DKFZ)	Odell, AF (corresponding author), Univ Leeds, LIGHT Lab, Fac Med & Hlth, Clarendon Way, Leeds LS2 9JT, W Yorkshire, England.	a.f.odell@leeds.ac.uk; m.hollstein@dkfz.de		Ponnambalam, Sreenivasan/0000-0002-4452-7619	Yorkshire Cancer Research Grant [L351]; White Rose University Consortium Grant; Deutsches Krebsforschungszentrum (German Cancer Research Center)	Yorkshire Cancer Research Grant; White Rose University Consortium Grant; Deutsches Krebsforschungszentrum (German Cancer Research Center)	This work was supported by Yorkshire Cancer Research Grant L351 (to M. H.), a White Rose University Consortium Grant (to A. F. O. and M. H.), and the Deutsches Krebsforschungszentrum (German Cancer Research Center).	Baroni TE, 2004, P NATL ACAD SCI USA, V101, P4930, DOI 10.1073/pnas.0401162101; Besaratinia A, 2010, FASEB J, V24, P2612, DOI 10.1096/fj.10-157263; Brosh R, 2009, NAT REV CANCER, V9, P701, DOI 10.1038/nrc2693; Chen CH, 2012, P NATL ACAD SCI USA, V109, P8241, DOI 10.1073/pnas.1119920109; Danziger SA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000498; Freed-Pastor WA, 2012, GENE DEV, V26, P1268, DOI 10.1101/gad.190678.112; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Hainaut P., 2006, 25 YEARS P53 RES; Hollstein M., 2013, P53 CLIN, V2013, P95; Hollstein M., 2013, MUTAT RES; Hussain SP, 2007, ONCOGENE, V26, P2166, DOI 10.1038/sj.onc.1210279; Joerger AC, 2006, P NATL ACAD SCI USA, V103, P15056, DOI 10.1073/pnas.0607286103; Joerger AC, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000919; Kato S, 2003, P NATL ACAD SCI USA, V100, P8424, DOI 10.1073/pnas.1431692100; Lai MN, 2010, JNCI-J NATL CANCER I, V102, P179, DOI 10.1093/jnci/djp467; Liu ZP, 2004, P NATL ACAD SCI USA, V101, P2963, DOI 10.1073/pnas.0308607101; Luo JL, 2001, ONCOGENE, V20, P320, DOI 10.1038/sj.onc.1204080; Mathew R, 2008, METHOD ENZYMOL, V446, P77, DOI 10.1016/S0076-6879(08)01605-4; Merabet A, 2010, BIOCHEM J, V427, P225, DOI 10.1042/BJ20091888; Nedelko T, 2009, INT J CANCER, V124, P987, DOI 10.1002/ijc.24006; Nikolova PV, 1998, P NATL ACAD SCI USA, V95, P14675, DOI 10.1073/pnas.95.25.14675; Olivier M, 2012, NAT REV CANCER, V12, P503, DOI 10.1038/nrc3311; Olivier M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001008; Oren M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001107; Otsuka K, 2007, INT J CANCER, V121, P559, DOI 10.1002/ijc.22724; Petitjean A, 2007, HUM MUTAT, V28, P622, DOI 10.1002/humu.20495; Schetter AJ, 2012, P NATL ACAD SCI USA, V109, P7955, DOI 10.1073/pnas.1205457109; Song H, 2007, NAT CELL BIOL, V9, P573, DOI 10.1038/ncb1571; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Wei QX, 2012, NAT PROTOC, V7, P1145, DOI 10.1038/nprot.2012.042; Wei QX, 2011, CELL CYCLE, V10, P1261, DOI 10.4161/cc.10.8.15303; Whibley C, 2010, J BIOL CHEM, V285, P11326, DOI 10.1074/jbc.M109.064444	32	10	12	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 7	2013	288	23					16704	16714		10.1074/jbc.M112.443168	http://dx.doi.org/10.1074/jbc.M112.443168			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	163ZU	23612969	Green Published, hybrid			2022-12-25	WOS:000320378900045
J	Tosato, V; Sidari, S; Bruschi, CV				Tosato, Valentina; Sidari, Sabrina; Bruschi, Carlo V.			Bridge-Induced Chromosome Translocation in Yeast Relies upon a Rad54/Rdh54-Dependent, Pol32-Independent Pathway	PLOS ONE			English	Article							STRAND BREAK REPAIR; PROSTATE-CANCER CELLS; SACCHAROMYCES-CEREVISIAE; HOMOLOGOUS RECOMBINATION; DNA-REPAIR; ILLEGITIMATE RECOMBINATION; MEIOTIC RECOMBINATION; HYPER-RECOMBINATION; SHUTTLE VECTORS; MITOTIC GROWTH	While in mammalian cells the genetic determinism of chromosomal translocation remains unclear, the yeast Saccharomyces cerevisiae has become an ideal model system to generate ad hoc translocations and analyze their cellular and molecular outcome. A linear DNA cassette carrying a selectable marker flanked by perfect homologies to two chromosomes triggers a bridge-induced translocation (BIT) in budding yeast, with variable efficiency. A postulated two-step process to produce BIT translocants is based on the cooperation between the Homologous Recombination System (HRS) and Break-Induced Replication (BIR); however, a clear indication of the molecular factors underlying the genetic mechanism is still missing. In this work we provide evidence that BIT translocation is elicited by the Rad54 helicase and completed by a Pol32-independent replication pathway. Our results demonstrate also that Rdh54 is involved in the stability of the translocants, suggesting a mitotic role in chromosome pairing and segregation. Moreover, when RAD54 is over-expressed, an ensemble of secondary rearrangements between repeated DNA tracts arise after the initial translocation event, leading to severe aneuploidy with loss of genetic material, which prompts the identification of fragile sites within the yeast genome.	[Tosato, Valentina; Sidari, Sabrina; Bruschi, Carlo V.] Int Ctr Genet Engn & Biotechnol, Yeast Mol Genet Lab, I-34012 Trieste, Italy	International Center for Genetic Engineering & Biotechnology (ICGEB)	Tosato, V (corresponding author), Int Ctr Genet Engn & Biotechnol, Yeast Mol Genet Lab, Padriciano 99, I-34012 Trieste, Italy.	tosato@icgeb.org						Ajima J, 2002, MUTAT RES-FUND MOL M, V504, P157, DOI 10.1016/S0027-5107(02)00089-1; Avet-Loiseau H, 2011, J CLIN ONCOL, V29, P1893, DOI 10.1200/JCO.2010.32.8435; Ben Aroya S, 2005, DNA REPAIR, V4, P409, DOI 10.1016/j.dnarep.2004.08.003; Bristow RG, 2007, RADIOTHER ONCOL, V83, P220, DOI 10.1016/j.radonc.2007.04.016; Brusa G, 2007, ONCOL REP, V18, P1427; BRUSCHI CV, 1988, CURR GENET, V14, P191, DOI 10.1007/BF00376739; Bugreev DV, 2006, NATURE, V442, P590, DOI 10.1038/nature04889; Campsteijn C, 2007, PLOS GENET, V3, P947, DOI 10.1371/journal.pgen.0030092; Chan CY, 2011, MOL GENET GENOMICS, V285, P471, DOI 10.1007/s00438-011-0619-y; Cheng TH, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.24.e108; Chi P, 2009, DNA REPAIR, V8, P279, DOI 10.1016/j.dnarep.2008.10.012; CHRISTIANSON TW, 1992, GENE, V110, P119, DOI 10.1016/0378-1119(92)90454-W; Fan R, 2004, CANCER RES, V64, P8526, DOI 10.1158/0008-5472.CAN-04-1601; Gostissa M, 2011, ANNU REV IMMUNOL, V29, P319, DOI 10.1146/annurev-immunol-031210-101329; Hoang ML, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001228; HOFFMAN CS, 1987, GENE, V57, P267, DOI 10.1016/0378-1119(87)90131-4; Huang HJ, 1998, ONCOGENE, V16, P2311, DOI 10.1038/sj.onc.1200202; IVANOV EL, 1992, GENETICS, V132, P651; Kaiser C, 1994, METHODS YEAST GENETI, P179; Kamisugi Y, 2012, NUCLEIC ACIDS RES, V40, P3496, DOI 10.1093/nar/gkr1272; Kim PM, 2002, NUCLEIC ACIDS RES, V30, P2727, DOI 10.1093/nar/gkf413; Klein HL, 1997, GENETICS, V147, P1533; Klemke M, 2011, CANCER GENET-NY, V204, P334, DOI 10.1016/j.cancergen.2011.05.001; Klutstein M, 2008, GENETICS, V178, P2389, DOI 10.1534/genetics.108.086777; Kobayashi T, 2011, CELL MOL LIFE SCI, V68, P1395, DOI 10.1007/s00018-010-0613-2; Lenstra TL, 2012, NUCLEUS-AUSTIN, V3, P213, DOI 10.4161/nucl.19513; Li X, 2007, NUCLEIC ACIDS RES, V35, P4124, DOI 10.1093/nar/gkm412; Lim DS, 1996, MOL CELL BIOL, V16, P7133; LUDWIG DL, 1993, GENE, V132, P33, DOI 10.1016/0378-1119(93)90511-Z; Lydeard JR, 2007, NATURE, V448, P820, DOI 10.1038/nature06047; Manthey GM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007488; Matsuda M, 1999, ONCOGENE, V18, P3427, DOI 10.1038/sj.onc.1202692; Matsui SI, 2005, CANCER GENET CYTOGEN, V159, P18, DOI 10.1016/j.cancergencyto.2004.09.010; Miyagawa K, 2002, EMBO J, V21, P175, DOI 10.1093/emboj/21.1.175; Morrow DM, 1997, GENETICS, V147, P371; Nikitin D, 2008, P NATL ACAD SCI USA, V105, P9703, DOI 10.1073/pnas.0800464105; Nimonkar AV, 2007, J BIOL CHEM, V282, P30776, DOI 10.1074/jbc.M704767200; Petukhova G, 2000, GENE DEV, V14, P2206, DOI 10.1101/gad.826100; Poitras JL, 2011, CANCER GENET-NY, V204, P68, DOI 10.1016/j.cancergen.2010.12.005; Putnam CD, 2009, NATURE, V460, P984, DOI 10.1038/nature08217; Rossi B, 2010, GENETICS, V186, P775, DOI 10.1534/genetics.110.120683; Rothstein R, 1995, GENOME RES, V5, P421, DOI 10.1101/gr.5.5.421; SCHIESTL RH, 1994, MOL CELL BIOL, V14, P4493, DOI 10.1128/MCB.14.7.4493; Schmuckli-Maurer J, 2003, NUCLEIC ACIDS RES, V31, P1013, DOI 10.1093/nar/gkg190; Shah PP, 2010, MOL CELL, V39, P862, DOI 10.1016/j.molcel.2010.08.028; Shinohara M, 2000, P NATL ACAD SCI USA, V97, P10814, DOI 10.1073/pnas.97.20.10814; Signon L, 2001, MOL CELL BIOL, V21, P2048, DOI 10.1128/MCB.21.6.2048-2056.2001; Sikdar N, 2009, CELL CYCLE, V8, P3199, DOI 10.4161/cc.8.19.9752; SIKORSKI RS, 1989, GENETICS, V122, P19; Smirnova M, 2004, J BIOL CHEM, V279, P24081, DOI 10.1074/jbc.M402719200; Smith CE, 2009, MOL CELL BIOL, V29, P1432, DOI 10.1128/MCB.01469-08; Smith S, 2005, DNA REPAIR, V4, P606, DOI 10.1016/j.dnarep.2005.01.004; Storici F, 1999, YEAST, V15, P271, DOI 10.1002/(SICI)1097-0061(19990315)15:4<271::AID-YEA371>3.0.CO;2-U; Symington LS, 2002, MICROBIOL MOL BIOL R, V66, P630, DOI 10.1128/MMBR.66.4.630-670.2002; Teicher BA, 2011, ANN SAUDI MED, V31, P174, DOI 10.4103/0256-4947.78206; Tosato V, 2005, CHROMOSOMA, V114, P15, DOI 10.1007/s00412-005-0332-x; Tosato V, 2009, CHROMOSOMA, V118, P179, DOI 10.1007/s00412-008-0187-z; Trigueros S, 2002, J BIOL CHEM, V277, P37207, DOI 10.1074/jbc.M206663200; Tsuzuki T, 1996, P NATL ACAD SCI USA, V93, P6236, DOI 10.1073/pnas.93.13.6236; Veronese ML, 1996, CANCER RES, V56, P728; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; Waghmare SK, 2003, BIOTECHNIQUES, V34, P1024, DOI 10.2144/03345rr02; Wang YC, 2008, FRONT BIOSCI-LANDMRK, V13, P2091, DOI 10.2741/2826; Yamaguchi-Iwai Y, 1998, MOL CELL BIOL, V18, P6430, DOI 10.1128/MCB.18.11.6430; Yu SL, 2011, J BIOTECHNOL, V154, P21, DOI 10.1016/j.jbiotec.2011.03.023; Zhang Y, 2010, ADV IMMUNOL, V106, P93, DOI 10.1016/S0065-2776(10)06004-9	66	8	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2013	8	4							e60926	10.1371/journal.pone.0060926	http://dx.doi.org/10.1371/journal.pone.0060926			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IK	23613757	Green Published, Green Submitted, gold			2022-12-25	WOS:000317907200016
J	Venters, SJ; Mikawa, T; Hyer, J				Venters, Sara J.; Mikawa, Takashi; Hyer, Jeanette			Central and Peripheral Retina Arise through Distinct Developmental Paths	PLOS ONE			English	Article							OPTIC VESICLE; TRANSCRIPTION FACTORS; CHICK-EMBRYO; EYE MORPHOGENESIS; VERTEBRATE RETINA; RETROVIRUS VECTOR; PROGENITOR CELLS; GENE-EXPRESSION; NEURAL RETINA; DIFFERENTIATION	In the mature eye, three distinct tissue fates, retina, ciliary body, and iris, arrange with a strict linear organization along the central (back) to peripheral (front) axis. The establishment of this topographical relationship within the optic vesicle is not well understood. We use a targeted vital labeling strategy to test the derivation of mature eye tissues from the optic vesicle of the chick embryo. Fate mapping uncovers two distinct origins of the neural retina. Contrary to expectations, the central neural retina has a discrete origin within the posterior optic vesicle. The peripheral retina derives from the distal optic vesicle, sharing a common origin with more peripheral tissue fates. This study identifies for the first time two distinct retinal sub-domains, central and peripheral, which arise during embryogenesis. Identification of these discrete retinal compartments provides a framework for understanding functional and disease processes throughout retinal tissue.	[Venters, Sara J.; Hyer, Jeanette] Univ Calif San Francisco, Dept Neurosurg, San Francisco, CA 94143 USA; [Hyer, Jeanette] Univ Calif San Francisco, Dept Ophthalmol, San Francisco, CA USA; [Venters, Sara J.; Mikawa, Takashi] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Hyer, J (corresponding author), Univ Calif San Francisco, Dept Neurosurg, San Francisco, CA 94143 USA.	jeanette.hyer@ucsf.edu			NIH [R37HL078921, R01HL112268];  [060720]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL112268, R01HL092429, R37HL078921] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	TMMS award 060720 to JH, Research to Prevent Blindness unrestricted grant to the Univ of CA. Dept. of Ophthalmology, NIH R37HL078921 and NIH R01HL112268 to TM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler R, 2000, PROG RETIN EYE RES, V19, P529, DOI 10.1016/S1350-9462(00)00008-2; Agathocleous M, 2009, ANNU REV CELL DEV BI, V25, P45, DOI 10.1146/annurev.cellbio.042308.113259; Azuma N, 2005, HUM MOL GENET, V14, P1059, DOI 10.1093/hmg/ddi098; Bellairs R., 2005, ATLAS CHICK DEV, DOI DOI 10.1016/C2010-0-65149-2; Braisted JE, 1997, DEV BIOL, V191, P14, DOI 10.1006/dbio.1997.8706; Bulchand S, 2001, MECH DEVELOP, V100, P165, DOI 10.1016/S0925-4773(00)00515-3; Chapman SC, 2001, DEV DYNAM, V220, P284, DOI 10.1002/1097-0177(20010301)220:3<284::AID-DVDY1102>3.0.CO;2-5; Davis N, 2009, DEV BIOL, V333, P132, DOI 10.1016/j.ydbio.2009.06.023; DOUGHERTY JP, 1986, MOL CELL BIOL, V6, P4387, DOI 10.1128/MCB.6.12.4387; DUTTING D, 1995, DEV BIOL, V167, P263, DOI 10.1006/dbio.1995.1022; FEKETE DM, 1994, DEV BIOL, V166, P666, DOI 10.1006/dbio.1994.1346; Hagglund AC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023387; HILFER SR, 1980, ANAT REC, V197, P423; HILL RE, 1991, NATURE, V354, P522, DOI 10.1038/354522a0; Hirashima M, 2008, DEV BIOL, V317, P620, DOI 10.1016/j.ydbio.2008.03.010; HOLT CE, 1993, J NEUROBIOL, V24, P1400, DOI 10.1002/neu.480241011; Ishii Y, 2009, DEVELOPMENT, V136, P2579, DOI 10.1242/dev.031344; Kawaue T, 2012, BIOL OPEN, V1, P1083, DOI 10.1242/bio.20121396; Kim HT, 2012, MOL CELLS, V33, P317, DOI 10.1007/s10059-012-0030-5; Kubota R, 2004, DEV DYNAM, V229, P529, DOI 10.1002/dvdy.20000; Kwan KM, 2012, DEVELOPMENT, V139, P359, DOI 10.1242/dev.071407; Lee HY, 2005, DEV BIOL, V284, P464, DOI 10.1016/j.ydbio.2005.06.010; Li Z, 2000, DEV DYNAM, V219, P391, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1063>3.0.CO;2-G; Liem KF, 1997, CELL, V91, P127, DOI 10.1016/S0092-8674(01)80015-5; Link B A, 2001, Prog Brain Res, V131, P565; Livesey FJ, 2001, NAT REV NEUROSCI, V2, P109, DOI 10.1038/35053522; Marquardt T, 2001, CELL, V105, P43, DOI 10.1016/S0092-8674(01)00295-1; MATSUNO T, 1992, NEUROSCI RES, V15, P96, DOI 10.1016/0168-0102(92)90022-5; McCabe KL, 1999, DEVELOPMENT, V126, P5713; Michaelides M, 2012, BRIT J OPHTHALMOL, V96, P917, DOI 10.1136/bjophthalmol-2011-300994; MIKAWA T, 1991, EXP CELL RES, V195, P516, DOI 10.1016/0014-4827(91)90404-I; Momose T, 1999, DEV GROWTH DIFFER, V41, P335; Mori M, 2002, INVEST OPHTH VIS SCI, V43, P1384; Peters MA, 2002, DEV BIOL, V251, P59, DOI 10.1006/dbio.2002.0791; Philips GT, 2005, DEV BIOL, V279, P308, DOI 10.1016/j.ydbio.2004.12.018; Porter FD, 1997, DEVELOPMENT, V124, P2935; SCHMITT EA, 1994, J COMP NEUROL, V344, P532, DOI 10.1002/cne.903440404; Schulte D, 2005, J NEUROSCI, V25, P2823, DOI 10.1523/JNEUROSCI.2037-04.2005; Shin SK, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-57; Swift S, 2001, Curr Protoc Immunol, VChapter 10, DOI 10.1002/0471142735.im1017cs31; Uemonsa T, 2002, DEV BIOL, V248, P319, DOI 10.1006/dbio.2002.0737; Venters SJ, 2008, DEV DYNAM, V237, P3260, DOI 10.1002/dvdy.21766; Venters SJ, 2011, MOL VIS, V17, P3347; Wehman AM, 2005, DEV BIOL, V281, P53, DOI 10.1016/j.ydbio.2005.02.010; Wilson SI, 2008, NEURON, V59, P413, DOI 10.1016/j.neuron.2008.07.020; Yang HJ, 2009, DEV DYNAM, V238, P2823, DOI 10.1002/dvdy.22116; YOUNG RW, 1985, DEV BRAIN RES, V21, P229, DOI 10.1016/0165-3806(85)90211-1; Zhao LY, 2010, MECH DEVELOP, V127, P62, DOI 10.1016/j.mod.2009.10.006; Zuber ME, 2003, DEVELOPMENT, V130, P5155, DOI 10.1242/dev.00723	49	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2013	8	4							e61422	10.1371/journal.pone.0061422	http://dx.doi.org/10.1371/journal.pone.0061422			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130DR	23613848	Green Submitted, Green Published, gold			2022-12-25	WOS:000317893400063
J	Zhang, JY; Wang, JHC				Zhang, Jianying; Wang, James H. -C.			Human Tendon Stem Cells Better Maintain Their Stemness in Hypoxic Culture Conditions	PLOS ONE			English	Article							OXYGEN-TENSION; IN-VITRO; ENGINEERED TENDON; INDUCIBLE FACTORS; TISSUE FORMATION; DIFFERENTIATION; PROLIFERATION; REPAIR; PLURIPOTENCY; CONSTRUCTS	Tissues and organs in vivo are under a hypoxic condition; that is, the oxygen tension is typically much lower than in ambient air. However, the effects of such a hypoxic condition on tendon stem cells, a recently identified tendon cell, remain incompletely defined. In cell culture experiments, we subjected human tendon stem cells (hTSCs) to a hypoxic condition with 5% O-2, while subjecting control cells to a normaxic condition with 20% O-2. We found that hTSCs at 5% O-2 had significantly greater cell proliferation than those at 20% O-2. Moreover, the expression of two stem cell marker genes, Nanog and Oct-4, was upregulated in the cells cultured in 5% O-2. Finally, in cultures under 5% O-2, more hTSCs expressed the stem cell markers nucleostemin, Oct-4, Nanog and SSEA-4. In an in vivo experiment, we found that when both cell groups were implanted with tendon-derived matrix, more tendon-like structures formed in the 5% O-2 treated hTSCs than in 20% O-2 treated hTSCs. Additionally, when both cell groups were implanted with Matrigel, the 5% O-2 treated hTSCs showed more extensive formation of fatty, cartilage-like and bone-like tissues than the 20% O-2 treated cells. Together, the findings of this study show that oxygen tension is a niche factor that regulates the stemness of hTSCs, and that less oxygen is better for maintaining hTSCs in culture and expanding them for cell therapy of tendon injuries.	[Wang, James H. -C.] Univ Pittsburgh, MechanoBiol Lab, Dept Orthopaed Surg, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Dept Bioengn, MechanoBiol Lab, Pittsburgh, PA USA; Univ Pittsburgh, Dept Mech Engn & Mat Sci, MechanoBiol Lab, Pittsburgh, PA USA; Univ Pittsburgh, Dept Phys Med & Rehabil, MechanoBiol Lab, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Wang, JHC (corresponding author), Univ Pittsburgh, MechanoBiol Lab, Dept Orthopaed Surg, Pittsburgh, PA 15213 USA.	wanghc@pitt.edu			National Institutes of Health [AR049921, AR06139]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR060920, R01AR049921] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This project was funded by National Institutes of Health grants AR049921 and AR06139. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awad HA, 2003, J ORTHOP RES, V21, P420, DOI 10.1016/S0736-0266(02)00163-8; Bi YM, 2007, NAT MED, V13, P1219, DOI 10.1038/nm1630; Butler DL, 2008, J ORTHOP RES, V26, P1, DOI 10.1002/jor.20456; Cao YL, 2002, PLAST RECONSTR SURG, V110, P1280, DOI 10.1097/01.PRS.0000025290.49889.4D; Cui L, 2004, J HISTOCHEM CYTOCHEM, V52, P1447, DOI 10.1369/jhc.3A6241.2004; D'Ippolito G, 2006, BONE, V39, P513, DOI 10.1016/j.bone.2006.02.061; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P1269, DOI 10.1038/nbt.1502; Forristal CE, 2010, REPRODUCTION, V139, P85, DOI 10.1530/REP-09-0300; Gang EJ, 2007, BLOOD, V109, P1743, DOI 10.1182/blood-2005-11-010504; Grayson WL, 2007, BIOCHEM BIOPH RES CO, V358, P948, DOI 10.1016/j.bbrc.2007.05.054; Grayson WL, 2006, J CELL PHYSIOL, V207, P331, DOI 10.1002/jcp.20571; Greco SJ, 2007, STEM CELLS, V25, P3143, DOI 10.1634/stemcells.2007-0351; Grimshaw MJ, 2000, OSTEOARTHR CARTILAGE, V8, P386, DOI 10.1053/joca.1999.0314; Harris MT, 2004, J ORTHOP RES, V22, P998, DOI 10.1016/j.orthres.2004.02.012; Henderson JK, 2002, STEM CELLS, V20, P329, DOI 10.1634/stemcells.20-4-329; Ivanovic Z, 2009, J CELL PHYSIOL, V219, P271, DOI 10.1002/jcp.21690; Keith B, 2007, CELL, V129, P465, DOI 10.1016/j.cell.2007.04.019; Lavrentieva A, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-18; Lee WYW, 2012, TISSUE ENG PT A, V18, P484, DOI [10.1089/ten.TEA.2011.0130, 10.1089/ten.tea.2011.0130]; Lennon DP, 2001, J CELL PHYSIOL, V187, P345, DOI 10.1002/jcp.1081; Liu HF, 2008, BIOMATERIALS, V29, P662, DOI 10.1016/j.biomaterials.2007.10.035; Pan GJ, 2007, CELL RES, V17, P42, DOI 10.1038/sj.cr.7310125; Pesce M, 2001, STEM CELLS, V19, P271, DOI 10.1634/stemcells.19-4-271; Risbud MV, 2007, SPINE, V32, P2537, DOI 10.1097/BRS.0b013e318158dea6; Rui YF, 2010, TISSUE ENG PT A, V16, P1549, DOI 10.1089/ten.TEA.2009.0529; Tsai RYL, 2002, GENE DEV, V16, P2991, DOI 10.1101/gad.55671; Zhang JY, 2011, BIOMATERIALS, V32, P6972, DOI 10.1016/j.biomaterials.2011.05.088; Zhang JY, 2010, J ORTHOP RES, V28, P639, DOI 10.1002/jor.21046; Zhang JY, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-10; Zhang JY, 2010, J ORTHOP RES, V28, P198, DOI 10.1002/jor.20962	30	51	52	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2013	8	4							e61424	10.1371/journal.pone.0061424	http://dx.doi.org/10.1371/journal.pone.0061424			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130DR	23613849	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000317893400064
J	Zhao, YL; Yan, H; Marshall, RJ; Dang, SN; Yang, RH; Li, Q; Qin, XY				Zhao, Yaling; Yan, Hong; Marshall, Roger J.; Dang, Shaonong; Yang, Ruihai; Li, Qiang; Qin, Xueying			Trends in Population Blood Pressure and Prevalence, Awareness, Treatment, and Control of Hypertension among Middle-Aged and Older Adults in a Rural Area of Northwest China from 1982 to 2010	PLOS ONE			English	Article							COOPERATIVE MEDICAL SCHEME; MANAGEMENT; HEALTH; INTERVENTIONS; BARRIERS; URBAN	Objectives: To assess trends in average blood pressure levels and prevalence, awareness, treatment, and control of hypertension among adults in a rural area of Northwest China, and to determine associated risk factors. Methods: Four cross-sectional population-based surveys were conducted between 1982 and 2010 among randomly selected adults in rural areas of Hanzhong, in Northwest China. Data on blood pressure, body mass index, family history of hypertension, and socio-demographic and lifestyle characteristics were collected in similar way by trained investigators in four surveys. Data of 8575 participants aged 35-64 years was analyzed. Averages and proportions were adjusted for age and sex. Results: Average blood pressure in the population has increased since 1982 from 76.9 mm Hg to 79.6 mm Hg in 2010 (diastolic) and from 120.9 to 129.7 mm Hg (systolic). Prevalence of hypertension increased from 18.4% in 1982 to 30.5% in 2010, and awareness of hypertension increased from 16.8% to 38.4% in 2010. Treatment of hypertension increased from 1.0% in 1982 to 17.4% in 2010, and control of hypertension increased from 0.1% in 1982 to 3.5% in 2010. All these gradients were statistically significant (P<0.01 for trend). Population blood pressure and prevalence, awareness and treatment of hypertension were positively associated with increasing age, body mass index and having family history of hypertension. Conclusions: Average blood pressure levels and the prevalence, awareness, treatment and control of hypertension among adults in rural areas of Hanzhong have increased since 1982. However, awareness, treatment and control rates remain low. Public health programs and practical strategies are required to improve prevention and control of hypertension in rural Northwest China. In particular, attention should be given to the elderly and obese, and to those with a family history of hypertension, while raising awareness and treatment among younger adults.	[Zhao, Yaling; Yan, Hong; Dang, Shaonong; Li, Qiang] Xi An Jiao Tong Univ, Coll Med, Dept Publ Hlth, Xian 710049, Shaanxi, Peoples R China; [Marshall, Roger J.] Univ Auckland, Sch Populat Hlth, Epidemiol & Biostat Sect, Auckland 1, New Zealand; [Yang, Ruihai] Hanzhong Peoples Hosp, Dept Cardiovasc Dis, Hanzhong, Shaanxi, Peoples R China; [Qin, Xueying] Peking Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Beijing 100871, Peoples R China	Xi'an Jiaotong University; University of Auckland; Peking University	Yan, H (corresponding author), Xi An Jiao Tong Univ, Coll Med, Dept Publ Hlth, Xian 710049, Shaanxi, Peoples R China.	xjtu_yh.paper@yahoo.com	Shaonong, Dang/J-7421-2019	Shaonong, Dang/0000-0002-6980-8169; Marshall, Roger/0000-0001-8278-167X	China Medical Board [08-925]	China Medical Board	This work was supported by the China Medical Board (Grant No. 08-925, http://www.chinamedicalboard.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajay Vamadevan S, 2011, J Diabetes Sci Technol, V5, P778; Andersen UO, 2004, BLOOD PRESSURE, V13, P176, DOI 10.1080/08037050410015006; Babiarz KS, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c5617; Bosworth HB, 2009, ANN INTERN MED, V151, P687, DOI 10.7326/0003-4819-151-10-200911170-00148; Chobanian AV., 2003, HYPERTENSION, V42, P1206, DOI [10.1161/01.HYP.0000107251, DOI 10.1161/01.HYP.9.2_PT_2.II36, DOI 10.1161/01.HYP.0000107251.49515.C2]; Cifkova R, 2010, J HYPERTENS, V28, P2196, DOI 10.1097/HJH.0b013e32833d4451; Dai BZ, 2011, GERIATR GERONTOL INT, V11, P239, DOI 10.1111/j.1447-0594.2011.00702.x; De Henauw S, 1998, J HYPERTENS, V16, P277; Dick Jonathan J, 2011, J Diabetes Sci Technol, V5, P1246; Dickinson HO, 2006, J HYPERTENS, V24, P215, DOI 10.1097/01.hjh.0000199800.72563.26; Dong GH, 2008, INDIAN J MED RES, V128, P122; Du SF, 2002, PUBLIC HEALTH NUTR, V5, P169, DOI 10.1079/PHN2001290; Egan BM, 2010, JAMA-J AM MED ASSOC, V303, P2043, DOI 10.1001/jama.2010.650; Erdine S, 2004, CLIN EXP HYPERTENS, V26, P731, DOI 10.1081/CEH-200032144; Fezeu L, 2010, J EPIDEMIOL COMMUN H, V64, P360, DOI 10.1136/jech.2008.086355; Forman JP, 2009, JAMA-J AM MED ASSOC, V302, P401, DOI 10.1001/jama.2009.1060; Guessous I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039877; Guo FJ, 2012, J AM COLL CARDIOL, V60, P599, DOI 10.1016/j.jacc.2012.04.026; Ibrahim MM, 2012, LANCET, V380, P611, DOI 10.1016/S0140-6736(12)60861-7; Kearney PM, 2004, J HYPERTENS, V22, P11, DOI 10.1097/00004872-200401000-00003; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3; Law MR, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1665; Leeder S, 2004, RACE TIME CHALLENGE; Liu ZQ, 2009, AM J HYPERTENS, V22, P929, DOI 10.1038/ajh.2009.134; Logan AG, 2007, AM J HYPERTENS, V20, P942, DOI 10.1016/j.amjhyper.2007.03.020; Ma WJ, 2012, AM J HYPERTENS, V25, P590, DOI 10.1038/ajh.2012.11; Margolius D, 2010, AM J MANAG CARE, V16, P648; McAlister FA, 2011, CAN MED ASSOC J, V183, P1007, DOI 10.1503/cmaj.101767; Meng XJ, 2011, J HYPERTENS, V29, P1303, DOI 10.1097/HJH.0b013e328347f79e; Ng SW, 2009, SOC SCI MED, V68, P1305, DOI 10.1016/j.socscimed.2009.01.035; Nguyen QN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042825; Ogedegbe G, 2008, J CLIN HYPERTENS, V10, P644, DOI 10.1111/j.1751-7176.2008.08329.x; Pereira M, 2012, BLOOD PRESSURE, V21, P220, DOI 10.3109/08037051.2012.666380; Pereira M, 2009, J HYPERTENS, V27, P963, DOI 10.1097/HJH.0b013e3283282f65; Roark RF, 2011, AM HEART J, V162, P405, DOI 10.1016/j.ahj.2011.06.010; Sjol A, 1998, INT J EPIDEMIOL, V27, P614, DOI 10.1093/ije/27.4.614; Vaidya Abhinav, 2012, Indian Heart J, V64, P128, DOI 10.1016/S0019-4832(12)60045-5; Wang Hui-Jun, 2011, Zhonghua Yu Fang Yi Xue Za Zhi, V45, P318; Wang LX, 2004, MED PRIN PRACT, V13, P282, DOI 10.1159/000079528; World Health Organization, 2005, WHO GLOB REP PREV CH; Xi B, 2012, INT J CARDIOL, V158, P326, DOI 10.1016/j.ijcard.2012.04.140; Yang JM, 2010, HYPERTENS RES, V33, P331, DOI 10.1038/hr.2009.235; Zhang Bing, 2011, Zhonghua Yu Fang Yi Xue Za Zhi, V45, P330	43	31	36	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2013	8	4							e61779	10.1371/journal.pone.0061779	http://dx.doi.org/10.1371/journal.pone.0061779			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130DR	23613932	Green Published, Green Submitted, gold			2022-12-25	WOS:000317893400106
J	Eldred, KC; Palmiter, RD				Eldred, Kiara C.; Palmiter, Richard D.			Amphetamine-Induced Sensitization Has Little Effect on Multiple Learning Paradigms and Fails to Rescue Mice with a Striatal Learning Defect	PLOS ONE			English	Article							INDUCED STRUCTURAL PLASTICITY; NUCLEUS-ACCUMBENS NEURONS; VENTRAL TEGMENTAL AREA; SYNAPTIC PLASTICITY; DOPAMINE NEURONS; BEHAVIORAL SENSITIZATION; NMDA-RECEPTORS; REPEATED EXPOSURE; COCAINE EXPOSURE; AMPA RECEPTORS	Behavioral sensitization to psychostimulants such as amphetamine (AMPH) is associated with synaptic modifications that are thought to underlie learning and memory. Because AMPH enhances extracellular dopamine in the striatum where dopamine and glutamate signaling are essential for learning, one might expect that the molecular and morphological changes that occur in the striatum in response to AMPH, including changes in synaptic plasticity, would affect learning. To ascertain whether AMPH sensitization affects learning, we tested wild-type mice and mice lacking NMDA receptor signaling in striatal medium spiny neurons in several different learning tests (motor learning, Pavlovian association, U-maze escape test with strategy shifting) with or without prior sensitization to AMPH. Prior sensitization had minimal effect on learning in any of these paradigms in wild-type mice and failed to restore learning in mutant mice, despite the fact that the mutant mice became sensitized by the AMPH treatment. We conclude that the changes in synaptic plasticity and many other signaling events that occur in response to AMPH sensitization are dissociable from those involved in learning the tasks used in our experiments.	[Eldred, Kiara C.; Palmiter, Richard D.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Eldred, Kiara C.; Palmiter, Richard D.] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Palmiter, RD (corresponding author), Univ Washington, Dept Biochem, Seattle, WA 98195 USA.	palmiter@uw.edu		Eldred, Kiara/0000-0002-4067-8639	Howard Hughes Medical Institute (HHMI)	Howard Hughes Medical Institute (HHMI)(Howard Hughes Medical Institute)	All funding was received from Howard Hughes Medical Institute (HHMI) URL: http://www.hhmi.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bamford NS, 2008, NEURON, V58, P89, DOI 10.1016/j.neuron.2008.01.033; Bellone C, 2006, NAT NEUROSCI, V9, P636, DOI 10.1038/nn1682; Beutler LR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028168; Beutler LR, 2011, P NATL ACAD SCI USA, V108, P4206, DOI 10.1073/pnas.1101424108; Boudreau AC, 2007, J NEUROSCI, V27, P10621, DOI 10.1523/JNEUROSCI.2163-07.2007; Carelli RM, 2003, J NEUROSCI, V23, P11214; Chen BT, 2008, NEURON, V59, P288, DOI 10.1016/j.neuron.2008.05.024; Conrad KL, 2008, NATURE, V454, P118, DOI 10.1038/nature06995; Daberkow DP, 2013, J NEUROSCI, V33, P452, DOI 10.1523/JNEUROSCI.2136-12.2013; Dang MT, 2006, P NATL ACAD SCI USA, V103, P15254, DOI 10.1073/pnas.0601758103; Darvas M, 2010, J NEUROSCI, V30, P1158, DOI 10.1523/JNEUROSCI.4576-09.2010; Darvas M, 2009, P NATL ACAD SCI USA, V106, P14664, DOI 10.1073/pnas.0907299106; Day JJ, 2007, NAT NEUROSCI, V10, P1020, DOI 10.1038/nn1923; DICHIARA G, 1988, P NATL ACAD SCI USA, V85, P5274; Engblom D, 2008, NEURON, V59, P497, DOI 10.1016/j.neuron.2008.07.010; Featherstone RE, 2008, BEHAV BRAIN RES, V189, P170, DOI 10.1016/j.bbr.2007.12.032; Ferrario CR, 2007, EUR NEUROPSYCHOPHARM, V17, P352, DOI 10.1016/j.euroneuro.2006.08.005; Girault JA, 2007, CURR OPIN PHARMACOL, V7, P77, DOI 10.1016/j.coph.2006.08.012; Harmer CJ, 1999, NEUROSCIENCE, V90, P119, DOI 10.1016/S0306-4522(98)00464-3; Harris GC, 2003, NEUROPSYCHOPHARMACOL, V28, P73, DOI 10.1038/sj.npp.1300011; Hyman SE, 2006, ANNU REV NEUROSCI, V29, P565, DOI 10.1146/annurev.neuro.29.051605.113009; Jedynak JP, 2007, EUR J NEUROSCI, V25, P847, DOI 10.1111/j.1460-9568.2007.05316.x; Kalivas PW, 2009, NAT REV NEUROSCI, V10, P561, DOI 10.1038/nrn2515; KALIVAS PW, 1993, J NEUROSCI, V13, P266; KALIVAS PW, 1993, J PHARMACOL EXP THER, V267, P486; Kasanetz F, 2010, SCIENCE, V328, P1709, DOI 10.1126/science.1187801; Kourrich S, 2007, J NEUROSCI, V27, P7921, DOI 10.1523/JNEUROSCI.1859-07.2007; Kourrich S, 2012, J NEUROSCI, V32, P6578, DOI 10.1523/JNEUROSCI.6391-11.2012; Koya E, 2009, NAT NEUROSCI, V12, P1069, DOI 10.1038/nn.2364; Li YL, 2004, EUR J NEUROSCI, V20, P1647, DOI 10.1111/j.1460-9568.2004.03612.x; Lorrain DS, 2000, BEHAV BRAIN RES, V107, P9, DOI 10.1016/S0166-4328(99)00109-6; Luscher C, 2011, NEURON, V69, P650, DOI 10.1016/j.neuron.2011.01.017; Luo Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012141; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Mameli M, 2011, NAT NEUROSCI, V14, P414, DOI 10.1038/nn.2763; Martin M, 2006, NAT NEUROSCI, V9, P868, DOI 10.1038/nn1713; Nocjar C, 2002, BEHAV BRAIN RES, V128, P189, DOI 10.1016/S0166-4328(01)00321-7; Ohtsuka N, 2008, P NATL ACAD SCI USA, V105, P12961, DOI 10.1073/pnas.0806180105; Olausson P, 2006, J NEUROSCI, V26, P9196, DOI 10.1523/JNEUROSCI.1124-06.2006; Palmiter RD, 2011, NEUROSCIENCE, V198, P213, DOI 10.1016/j.neuroscience.2011.06.089; Pan WX, 2005, J NEUROSCI, V25, P6235, DOI 10.1523/JNEUROSCI.1478-05.2005; Parker JG, 2011, J NEUROSCI, V31, P11362, DOI 10.1523/JNEUROSCI.2411-11.2011; Parker JG, 2010, P NATL ACAD SCI USA, V107, P13491, DOI 10.1073/pnas.1007827107; Parkinson JA, 2002, BEHAV BRAIN RES, V137, P149, DOI 10.1016/S0166-4328(02)00291-7; Pascoli V, 2012, NATURE, V481, P71, DOI 10.1038/nature10709; PIAZZA PV, 1989, SCIENCE, V245, P1511, DOI 10.1126/science.2781295; Quintana A, 2012, NAT NEUROSCI, V15, P1547, DOI 10.1038/nn.3239; ROBINSON TE, 1988, BRAIN RES, V462, P211, DOI 10.1016/0006-8993(88)90549-5; Robinson TE, 2003, ANNU REV PSYCHOL, V54, P25, DOI 10.1146/annurev.psych.54.101601.145237; Robison AJ, 2011, NAT REV NEUROSCI, V12, P623, DOI 10.1038/nrn3111; Roesch MR, 2007, J NEUROSCI, V27, P245, DOI 10.1523/JNEUROSCI.4080-06.2007; Russo SJ, 2010, TRENDS NEUROSCI, V33, P267, DOI 10.1016/j.tins.2010.02.002; Saddoris MP, 2011, EUR J NEUROSCI, V33, P2274, DOI 10.1111/j.1460-9568.2011.07683.x; Schoenbaum G, 2005, CEREB CORTEX, V15, P1162, DOI 10.1093/cercor/bhh216; Schultz W, 2007, TRENDS NEUROSCI, V30, P203, DOI 10.1016/j.tins.2007.03.007; Steketee JD, 2011, PHARMACOL REV, V63, P348, DOI 10.1124/pr.109.001933; Stipanovich A, 2008, NATURE, V453, P879, DOI 10.1038/nature06994; Stuber GD, 2008, SCIENCE, V321, P1690, DOI 10.1126/science.1160873; Tzschentke TM, 2007, ADDICT BIOL, V12, P227, DOI 10.1111/j.1369-1600.2007.00070.x; Ungless MA, 2001, NATURE, V411, P583, DOI 10.1038/35079077; Vashchinkina E, 2012, J NEUROSCI, V32, P5310, DOI 10.1523/JNEUROSCI.4697-11.2012; Vezina P, 2000, PSYCHOPHARMACOLOGY, V151, P184, DOI 10.1007/s002130000463; Wang LP, 2011, NEURON, V72, P1055, DOI 10.1016/j.neuron.2011.10.019; Wheeler RA, 2009, NEUROPHARMACOLOGY, V56, P149, DOI 10.1016/j.neuropharm.2008.06.028; Wickens JR, 2009, BEHAV BRAIN RES, V199, P119, DOI 10.1016/j.bbr.2008.10.030; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406; Wolf ME, 2010, NEUROSCI BIOBEHAV R, V35, P185, DOI 10.1016/j.neubiorev.2010.01.013; Wolf ME, 2004, NEUROPHARMACOLOGY, V47, P61, DOI 10.1016/j.neuropharm.2004.07.006; Wyvell CL, 2001, J NEUROSCI, V21, P7831, DOI 10.1523/JNEUROSCI.21-19-07831.2001; Zweifel LS, 2008, NEURON, V59, P486, DOI 10.1016/j.neuron.2008.05.028; Zweifel LS, 2009, P NATL ACAD SCI USA, V106, P7281, DOI 10.1073/pnas.0813415106	71	6	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2013	8	4							e59964	10.1371/journal.pone.0059964	http://dx.doi.org/10.1371/journal.pone.0059964			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125TD	23596507	gold, Green Published, Green Submitted			2022-12-25	WOS:000317563300003
J	Singer, AC; Jarhult, JD; Grabic, R; Khan, GA; Fedorova, G; Fick, J; Lindberg, RH; Bowes, MJ; Olsen, B; Soderstrom, H				Singer, Andrew C.; Jarhult, Josef D.; Grabic, Roman; Khan, Ghazanfar A.; Fedorova, Ganna; Fick, Jerker; Lindberg, Richard H.; Bowes, Michael J.; Olsen, Bjorn; Soderstrom, Hanna			Compliance to Oseltamivir among Two Populations in Oxfordshire, United Kingdom Affected by Influenza A(H1N1)pdm09, November 2009-A Waste Water Epidemiology Study	PLOS ONE			English	Article							ANTIVIRAL DRUG OSELTAMIVIR; TAMIFLU; ILLICIT; SCHOOL; LOADS	Antiviral provision remains the focus of many pandemic preparedness plans, however, there is considerable uncertainty regarding antiviral compliance rates. Here we employ a waste water epidemiology approach to estimate oseltamivir (Tamiflu (R)) compliance. Oseltamivir carboxylate (oseltamivir's active metabolite) was recovered from two waste water treatment plant (WWTP) catchments within the United Kingdom at the peak of the autumnal wave of the 2009 Influenza A (H1N1)pdm09 pandemic. Predictions of oseltamivir consumption from detected levels were compared with two sources of national government statistics to derive compliance rates. Scenario and sensitivity analysis indicated between 3-4 and 120-154 people were using oseltamivir during the study period in the two WWTP catchments and a compliance rate between 45-60%. With approximately half the collected antivirals going unused, there is a clear need to alter public health messages to improve compliance. We argue that a near real-time understanding of drug compliance at the scale of the waste water treatment plant (hundreds to millions of people) can potentially help public health messages become more timely, targeted, and demographically sensitive, while potentially leading to less mis- and un-used antiviral, less wastage and ultimately a more robust and efficacious pandemic preparedness plan.	[Singer, Andrew C.; Bowes, Michael J.] NERC Ctr Ecol & Hydrol, Wallingford, Oxon, England; [Jarhult, Josef D.; Olsen, Bjorn] Uppsala Univ, Dept Med Sci, Infect Dis Sect, Uppsala, Sweden; [Grabic, Roman; Khan, Ghazanfar A.; Fedorova, Ganna; Fick, Jerker; Lindberg, Richard H.; Soderstrom, Hanna] Umea Univ, Dept Chem, Umea, Sweden; [Grabic, Roman; Fedorova, Ganna] Univ South Bohemia Ceske Budejovice, Fac Fisheries & Protect Waters, South Bohemian Res Ctr Aquaculture & Biodivers Hy, Vodnany, Czech Republic; [Olsen, Bjorn] Linnaeus Univ, Sch Nat Sci, Sect Zoonot Ecol & Epidemiol, Kalmar, Sweden	UK Centre for Ecology & Hydrology (UKCEH); Uppsala University; Umea University; University of South Bohemia Ceske Budejovice; Linnaeus University	Singer, AC (corresponding author), NERC Ctr Ecol & Hydrol, Wallingford, Oxon, England.	acsi@ceh.ac.uk	Jarhult, Josef D./ABE-8149-2020; Grabic, Roman/AAF-5412-2021; Fedorova, Ganna/F-8268-2015; Berglund Fick, Jerker/HDO-5788-2022; Bowes, Mike/E-1528-2011; Lindberg, Richard/C-8882-2013; Grabic, Roman/B-1289-2013; Singer, Andrew/B-3398-2010	Jarhult, Josef D./0000-0002-7075-1059; Grabic, Roman/0000-0002-0935-2075; Bowes, Mike/0000-0002-0673-1934; Grabic, Roman/0000-0002-0935-2075; Fick, Jerker/0000-0002-3949-7371; Soderstrom, Hanna/0000-0003-1341-7879; Singer, Andrew/0000-0003-4705-6063; Olsen, Bjorn/0000-0002-4646-691X	Swedish Research Council Formas; Natural Environment Research Council-Knowledge Transfer (PREPARE) Initiative contract [NE/F009216/1]; Ministry of Education, Youth and Sports of the Czech Republic CENAKVA [CZ.1.05/2.1.00/01.0024]; Grant Agency of the University of South Bohemia [047/2010/Z]; NERC [NE/F009216/1, NE/F009410/1] Funding Source: UKRI; Natural Environment Research Council [ceh010023, NE/F009410/1, NE/F009216/1] Funding Source: researchfish	Swedish Research Council Formas(Swedish Research CouncilSwedish Research Council Formas); Natural Environment Research Council-Knowledge Transfer (PREPARE) Initiative contract; Ministry of Education, Youth and Sports of the Czech Republic CENAKVA; Grant Agency of the University of South Bohemia; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The authors received funding for the collection and analysis from the Swedish Research Council Formas, the Natural Environment Research Council-Knowledge Transfer (PREPARE) Initiative contract NE/F009216/1, the Ministry of Education, Youth and Sports of the Czech Republic CENAKVA No. CZ.1.05/2.1.00/01.0024 and the Grant Agency of the University of South Bohemia No. 047/2010/Z. The authors received in-kind support from G. F. F. Hoffman - La Roche Ltd. through donated deuterated OC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accinelli C, 2010, CHEMOSPHERE, V81, P436, DOI 10.1016/j.chemosphere.2010.06.074; Accinelli C, 2010, CHEMOSPHERE, V79, P891, DOI 10.1016/j.chemosphere.2010.02.022; Azuma T, 2012, ENV SCI TECHNOL; Brewer AJ, 2012, ENVIRON SCI TECHNOL, V46, P8305, DOI 10.1021/es202447r; Brooks-Pollock E, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-68; Carrasco LR, 2011, J R SOC INTERFACE, V8, P1307, DOI 10.1098/rsif.2010.0715; Fick J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000986; Health Protection Agency (HPA), 2010, EP REP PAND H1N1 200; Kaiser L, 2003, ARCH INTERN MED, V163, P1667, DOI 10.1001/archinte.163.14.1667; Khan GA, 2012, J PHARMACEUT BIOMED, V66, P24, DOI 10.1016/j.jpba.2012.02.011; Kitching A, 2009, EUROSURVEILLANCE, V14, P2; Leknes H, 2012, SCI TOTAL ENVIRON, V414, P632, DOI 10.1016/j.scitotenv.2011.11.004; Ort C, 2006, WATER SCI TECHNOL, V54, P169, DOI 10.2166/wst.2006.591; Ort C, 2010, ENVIRON SCI TECHNOL, V44, P6289, DOI 10.1021/es100778d; Prasse C, 2010, ENVIRON SCI TECHNOL, V44, P1728, DOI 10.1021/es903216p; Rogers Simon, 2011, GUARDIAN; Sacca ML, 2009, CHEMOSPHERE, V75, P28, DOI 10.1016/j.chemosphere.2008.11.060; Singer AC, 2008, ENVIRON HEALTH PERSP, V116, P1563, DOI 10.1289/ehp.11310; Singer AC, 2007, ENVIRON HEALTH PERSP, V115, P102, DOI 10.1289/ehp.9574; Singer AC, 2011, ENVIRON HEALTH PERSP, V119, P1084, DOI 10.1289/ehp.1002757; Slater FR, 2011, FEMS MICROBIOL LETT, V315, P17, DOI 10.1111/j.1574-6968.2010.02163.x; SMITH A, 2009, EURO SURVEILL, V14; Soderstrom H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006064; Straub JO, 2009, ECOTOX ENVIRON SAFE, V72, P1625, DOI 10.1016/j.ecoenv.2008.09.011; Strong M, 2010, EUROSURVEILLANCE, V15, P16; Takanami R., 2012, Journal of Water and Environment Technology, V10, P57, DOI 10.2965/jwet.2012.57; Tilston NL, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-650; TuTiempo.net, 2009, CLIM BENS; U.K. Cabinet Office, 2012, NAT RISK REG CIV EM; United Kingdom Cabinet Office, 2010, NAT RISK REG CIV EM; van Nuijs ALN, 2012, J HAZARD MATER, V239, P19, DOI 10.1016/j.jhazmat.2012.04.030; van Velzen E, 2011, Scott Med J, V56, P120, DOI 10.1258/smj.2010.010017; Wallensten A, 2009, EUROSURVEILLANCE, V14, P6; World Health Organization (WHO), 2010, WHO REC POSTP PER PA; Yu HJ, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4779	35	23	24	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2013	8	4							e60221	10.1371/journal.pone.0060221	http://dx.doi.org/10.1371/journal.pone.0060221			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125TD	23613721	Green Published, Green Accepted, gold			2022-12-25	WOS:000317563300004
J	Undrovinas, A; Maltsev, VA; Sabbah, HN				Undrovinas, Albertas; Maltsev, Victor A.; Sabbah, Hani N.			Calpain Inhibition Reduces Amplitude and Accelerates Decay of the Late Sodium Current in Ventricular Myocytes from Dogs with Chronic Heart Failure	PLOS ONE			English	Article							INTRACELLULAR CALCIUM; ANTIANGINAL AGENT; CANINE MODEL; CA CURRENT; CHANNEL; PROTEOLYSIS; ANKYRIN; ARRHYTHMIAS; RANOLAZINE; MECHANISM	Calpain is an intracellular Ca2+ -activated protease that is involved in numerous Ca2+ dependent regulation of protein function in many cell types. This paper tests a hypothesis that calpains are involved in Ca2+ -dependent increase of the late sodium current (I-NaL) in failing heart. Chronic heart failure (HF) was induced in 2 dogs by multiple coronary artery embolization. Using a conventional patch-clamp technique, the whole-cell INaL was recorded in enzymatically isolated ventricular cardiomyocytes (VCMs) in which INaL was activated by the presence of a higher (1 mu M) intracellular [Ca2+] in the patch pipette. Cell suspensions were exposed to a cell-permeant calpain inhibitor MDL-28170 for 1-2 h before INaL recordings. The numerical excitation-contraction coupling (ECC) model was used to evaluate electrophysiological effects of calpain inhibition in silico. MDL caused acceleration of INaL decay evaluated by the two-exponential fit (tau(1)= 42 +/- 3.0 ms tau(2) = 435 +/- 27 ms, n = 6, in MDL vs. tau(1)= 52 +/- 2.1 ms tau(2) = 605 +/- 26 control no vehicle, n = 11, and vs. tau(1)= 52 +/- 2.8 ms tau(2) = 583 +/- 37 ms n = 7, control with vehicle, P<0.05 ANOVA). MDL significantly reduced I-NaL density recorded at -30 mV (0.488 +/- 0.03, n = 12, in control no vehicle, 0.4502 +/- 0.0210, n = 9 in vehicle vs. 0.166 +/- 0.05pA/pF, n = 5, in MDL). Our measurements of current-voltage relationships demonstrated that the INaL density was decreased by MDL in a wide range of potentials, including that for the action potential plateau. At the same time the membrane potential dependency of the steady-state activation and inactivation remained unchanged in the MDL-treated VCMs. Our ECC model predicted that calpain inhibition greatly improves myocyte function by reducing the action potential duration and intracellular diastolic Ca2+ accumulation in the pulse train. Conclusions: Calpain inhibition reverses INaL changes in failing dog ventricular cardiomyocytes in the presence of high intracellular Ca2+. Specifically it decreases INaL density and accelerates INaL kinetics resulting in improvement of myocyte electrical response and Ca2+ handling as predicted by our in silico simulations.	[Undrovinas, Albertas; Sabbah, Hani N.] Henry Ford Hosp, Dept Internal Med, Detroit, MI 48202 USA; [Maltsev, Victor A.] NIA, Intramural Res Program, Baltimore, MD 21224 USA	Henry Ford Health System; Henry Ford Hospital; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Undrovinas, A (corresponding author), Henry Ford Hosp, Dept Internal Med, Detroit, MI 48202 USA.	adas7247@yahoo.com	Maltsev, Victor/AAY-9460-2020	Maltsev, Victor/0000-0002-3832-791X	National Heart, Lung, and Blood Institute [HL-53819, HL-074238]; American Heart Association [0350472Z]; Intramural Research Program of the National Institute on Aging; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL053819] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association(American Heart Association); Intramural Research Program of the National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by National Heart, Lung, and Blood Institute Grants HL-53819 and HL-074238, by a grant-in-aid from the American Heart Association (0350472Z; to AU), and, in part, by the Intramural Research Program of the National Institute on Aging (to VM; the numerical modeling part). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abriel H, 2005, TRENDS CARDIOVAS MED, V15, P35, DOI 10.1016/j.tcm.2005.01.001; Antzelevitch C, 2004, CIRCULATION, V110, P904, DOI 10.1161/01.CIR.0000139333.83620.5D; BELLES B, 1988, PFLUG ARCH EUR J PHY, V412, P554, DOI 10.1007/BF00582548; BELLES B, 1988, PFLUG ARCH EUR J PHY, V411, P353, DOI 10.1007/BF00587713; Bukowska A, 2010, CARDIOVASC THER, P1755; Carragher NO, 2006, CURR PHARM DESIGN, V12, P615, DOI 10.2174/138161206775474314; Chauhan VS, 2000, CIRC RES, V86, P441, DOI 10.1161/01.RES.86.4.441; Hanna RA, 2008, NATURE, V456, P409, DOI 10.1038/nature07451; Hein S, 2000, CARDIOVASC RES, V45, P273, DOI 10.1016/S0008-6363(99)00268-0; Heling A, 2000, CIRC RES, V86, P846, DOI 10.1161/01.RES.86.8.846; JANUARY CT, 1992, ANN NY ACAD SCI, V644, P23, DOI 10.1111/j.1749-6632.1992.tb30999.x; KAMEYAMA M, 1985, PFLUG ARCH EUR J PHY, V405, P285, DOI 10.1007/BF00582573; Malhotra JD, 2000, J BIOL CHEM, V275, P11383, DOI 10.1074/jbc.275.15.11383; Maltsev VA, 2006, CARDIOVASC RES, V69, P116, DOI 10.1016/j.cardiores.2005.08.015; Maltsev VA, 2002, CELL MOL LIFE SCI, V59, P1561, DOI 10.1007/s00018-002-8529-0; Maltsev VA, 1998, CIRCULATION, V98, P2545, DOI 10.1161/01.CIR.98.23.2545; Maltsev VA, 2008, PROG BIOPHYS MOL BIO, V96, P421, DOI 10.1016/j.pbiomolbio.2007.07.010; Maltsev VA, 2008, AM J PHYSIOL-HEART C, V294, pH1597, DOI 10.1152/ajpheart.00484.2007; Maltsev VA, 2007, EUR J HEART FAIL, V9, P219, DOI 10.1016/j.ejheart.2006.08.007; MATHIAS RT, 1990, BIOPHYS J, V58, P759, DOI 10.1016/S0006-3495(90)82418-8; Matsumura Y, 2001, J MOL CELL CARDIOL, V33, P1133, DOI 10.1006/jmcc.2001.1373; Mishra S, 2011, AM J PHYSIOL-HEART C, V301, pH1596, DOI 10.1152/ajpheart.00948.2009; Mohler PJ, 2003, NATURE, V421, P634, DOI 10.1038/nature01335; Noble D, 2006, HEART, V92, P1, DOI 10.1136/hrt.2005.078782; OLIVA C, 1988, BIOPHYS J, V54, P791, DOI 10.1016/S0006-3495(88)83017-0; Patterson C, 2011, CIRC RES, V109, P453, DOI 10.1161/CIRCRESAHA.110.239749; PUSCH M, 1988, PFLUG ARCH EUR J PHY, V411, P204, DOI 10.1007/BF00582316; SABBAH HN, 1992, EUR HEART J, V13, P1562, DOI 10.1093/oxfordjournals.eurheartj.a060102; SABBAH HN, 1991, AM J PHYSIOL, V260, pH1379, DOI 10.1152/ajpheart.1991.260.4.H1379; Scirica BM, 2007, CIRCULATION, V116, P1647, DOI 10.1161/CIRCULATIONAHA.107.724880; Sossalla S, 2008, J MOL CELL CARDIOL, V14, P14; Tsuji T, 2001, AM J PHYSIOL-HEART C, V281, pH1286, DOI 10.1152/ajpheart.2001.281.3.H1286; Undrovinas Albertas, 2008, Cardiovascular & Hematological Agents in Medicinal Chemistry, V6, P348, DOI 10.2174/187152508785909447; Undrovinas Albertas I, 2006, J Cardiovasc Electrophysiol, V17 Suppl 1, pS169; Undrovinas NA, 2010, J PHYSIOL SCI, V60, P245, DOI 10.1007/s12576-010-0092-0; Urthaler F, 1997, CARDIOVASC RES, V35, P60, DOI 10.1016/S0008-6363(97)00099-0; Wagner S, 2006, J CLIN INVEST, V22, P22; Wingo TL, 2004, NAT STRUCT MOL BIOL, V11, P219, DOI 10.1038/nsmb737; Winslow RL, 1999, CIRC RES, V84, P571, DOI 10.1161/01.RES.84.5.571; YOSHIDA K, 1995, CIRC RES, V77, P603, DOI 10.1161/01.RES.77.3.603	40	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2013	8	4							e54436	10.1371/journal.pone.0054436	http://dx.doi.org/10.1371/journal.pone.0054436			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125TD	23596505	gold, Green Submitted, Green Published			2022-12-25	WOS:000317563300001
J	Occella, C; Bleidl, D; Nozza, P; Mascelli, S; Raso, A; Gimelli, G; Gimelli, S; Tassano, E				Occella, Corrado; Bleidl, Dario; Nozza, Paolo; Mascelli, Samantha; Raso, Alessandro; Gimelli, Giorgio; Gimelli, Stefania; Tassano, Elisa			Identification of an Interstitial 18p11.32-p11.31 Duplication Including the EMILIN2 Gene in a Family with Porokeratosis of Mibelli	PLOS ONE			English	Article							DISSEMINATED SUPERFICIAL POROKERATOSIS; ACTINIC POROKERATOSIS; LOCUS; KERATINOCYTES; APOPTOSIS; PSORIASIS; 18P11.3; PCR	Porokeratosis is a rare disease of epidermal keratinization characterized by the histopathological feature of the cornoid lamella, a column of tightly fitted parakeratocytic cells, whose etiology is still unclear. Porokeratosis of Mibelli is a subtype of porokeratosis presenting a single plaque or a small number of plaques of variable size located unilaterally on limbs. It frequently appears in childhood and occurs with a higher incidence in males. Cytogenetic analyses were performed in all members of the family on lesioned and uninvolved skin. An array-CGH analysis was also performed utilizing the Human Genome CGH Microarray Kit G3 400 with 5.3 KB overall median probe spacing. Gene expression was performed on skin fibroblasts. In this study, we describe a Caucasian healthy 4-year-old child and his father showing features of porokeratosis of Mibelli. Array-CGH analysis revealed an interstitial 429.5 Kb duplication of chromosome 18p11.32-p11.3 containing four genes, namely: SMCHD1, EMILIN2, LPIN2, and MYOM1 both in patient and his father. EMILIN2 resulted overexpressed on skin fibroblasts. Also other members of this family, without evident signs of porokeratosis, carried the same duplication. Among these genes, we focused our attention on elastin microfibril interfacer 2 (EMILIN2) gene. Apoptosis plays a fundamental role in maintaining epidermal homeostasis, balancing keratinocytes proliferation, and forming the stratum corneum. EMILIN2 is known to trigger the apoptosis of different cell lines negatively affecting cell survival. It is expressed in the skin. We could speculate that the duplication and overexpression of EMILIN2 cause an abnormal apoptosis of epidermal keratinocytes and alter the process of keratinization, even if other epigenetic and genetic factors could also be involved. Our results could contribute to a better understanding of the pathogenesis of porokeratosis of Mibelli.	[Occella, Corrado; Bleidl, Dario] Ist Giannina Gaslini, Unita Operat Dermatol, I-16148 Genoa, Italy; [Nozza, Paolo] Ist Giannina Gaslini, Unita Operat Anat Patol, I-16148 Genoa, Italy; [Mascelli, Samantha; Raso, Alessandro] Ist Giannina Gaslini, Unita Operat Neurochirurg, I-16148 Genoa, Italy; [Gimelli, Giorgio; Tassano, Elisa] Ist Giannina Gaslini, Lab Citogenet, Unita Operat Semplice, I-16148 Genoa, Italy; [Gimelli, Stefania] Univ Hosp Geneva, Serv Genet Med, Geneva, Switzerland	University of Genoa; IRCCS Istituto Giannina Gaslini; University of Genoa; IRCCS Istituto Giannina Gaslini; University of Genoa; IRCCS Istituto Giannina Gaslini; University of Genoa; IRCCS Istituto Giannina Gaslini; University of Geneva	Tassano, E (corresponding author), Ist Giannina Gaslini, Lab Citogenet, Unita Operat Semplice, I-16148 Genoa, Italy.	eli.tassano@gmail.com	Nozza, Paolo/AAC-5901-2022; Tassano, Elisa/AAB-1108-2020	Tassano, Elisa/0000-0003-2037-0554; Nozza, Paolo/0000-0002-7595-1420				ANDERSON DE, 1969, ARCH DERMATOL, V99, P408, DOI 10.1001/archderm.99.4.408; Andrews GC, 1937, ARCH DERMATOL SYPH, V36, P1111; Arranz-Salas I, 2003, J CUTAN PATHOL, V30, P455, DOI 10.1034/j.1600-0560.2003.00097.x; Asumalahti K, 2003, J INVEST DERMATOL, V121, P735, DOI 10.1046/j.1523-1747.2003.12483.x; Braghetta P, 2004, MATRIX BIOL, V22, P549, DOI 10.1016/j.matbio.2003.10.005; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Cao HM, 2012, CLIN EXP DERMATOL, V37, P672, DOI 10.1111/j.1365-2230.2012.04380.x; CHERNOSKY ME, 1986, ARCH DERMATOL, V122, P869, DOI 10.1001/archderm.122.8.869; GUSS SB, 1971, ARCH DERMATOL, V104, P366, DOI 10.1001/archderm.104.4.366; Hivnor C, 2004, J CUTAN PATHOL, V31, P657, DOI 10.1111/j.0303-6987.2004.00247.x; Itsara A, 2009, AM J HUM GENET, V84, P148, DOI 10.1016/j.ajhg.2008.12.014; JURECKA W, 1991, J AM ACAD DERMATOL, V24, P96, DOI 10.1016/0190-9622(91)70019-X; Kothny-Wilkes G, 1998, J BIOL CHEM, V273, P29247, DOI 10.1074/jbc.273.44.29247; Milanetto M, 2008, DEV DYNAM, V237, P222, DOI 10.1002/dvdy.21402; Mongiat M, 2007, MOL CELL BIOL, V27, P7176, DOI 10.1128/MCB.00696-07; Palleschi GM, 2008, J CUTAN PATHOL, V35, P253, DOI 10.1111/j.1600-0560.2007.00787.x; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Raso A, 2011, J CLIN LAB ANAL, V25, P389, DOI 10.1002/jcla.20489; SEHGAL VN, 1967, DERMATOLOGICA, V134, P219, DOI 10.1159/000254297; Sertznig P, 2012, J EUR ACAD DERMATOL, V26, P404, DOI 10.1111/j.1468-3083.2011.04275.x; Shen CS, 2002, BRIT J DERMATOL, V147, P498, DOI 10.1046/j.1365-2133.2002.04853.x; Wei S, 2010, CLIN EXP DERMATOL, V35, P664, DOI 10.1111/j.1365-2230.2010.03844.x; Wei SC, 2004, J INVEST DERMATOL, V123, P872, DOI 10.1111/j.0022-202X.2004.23455.x; Zhang SQ, 2012, NAT GENET, V44, P1156, DOI 10.1038/ng.2409; Zhang ZH, 2008, J CUTAN PATHOL, V35, P1058, DOI 10.1111/j.1600-0560.2008.01026.x; Zogopoulos G, 2007, HUM GENET, V122, P345, DOI 10.1007/s00439-007-0404-5	26	8	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2013	8	4							e61311	10.1371/journal.pone.0061311	http://dx.doi.org/10.1371/journal.pone.0061311			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123IQ	23593459	gold, Green Published, Green Submitted			2022-12-25	WOS:000317382000047
J	Sokolova, EA; Malkova, NA; Korobko, DS; Rozhdestvenskii, AS; Kakulya, AV; Khanokh, EV; Delov, RA; Platonov, FA; Popova, TY; Aref'eva, EG; Zagorskaya, NN; Alifirova, VM; Titova, MA; Smagina, IV; El'chaninova, SA; Popovtseva, AV; Puzyrev, VP; Kulakova, OG; Tsareva, EY; Favorova, OO; Shchur, SG; Lashch, NY; Popova, NF; Popova, EV; Gusev, EI; Boyko, AN; Aulchenko, YS; Filipenko, ML				Sokolova, Ekaterina Alekseevna; Malkova, Nadezhda Alekseevna; Korobko, Denis Sergeevich; Rozhdestvenskii, Aleksey Sergeevich; Kakulya, Anastasia Vladimirovna; Khanokh, Elena Vladimirovna; Delov, Roman Andreevich; Platonov, Fedor Alekseevich; Popova, Tatyana Yegorovna; Aref'eva, Elena Gennadievna; Zagorskaya, Natalia Nikolaevna; Alifirova, Valentina Mikhailovna; Titova, Marina Andreevna; Smagina, Inna Vadimovna; El'chaninova, Svetlana Alksandrovna; Popovtseva, Anna Valentinovna; Puzyrev, Valery Pavlovich; Kulakova, Olga Georgievna; Tsareva, Ekaterina Yur'evna; Favorova, Olga Olegovna; Shchur, Sergei Gennadievich; Lashch, Natalia Yurievna; Popova, Natalia Fyodorovna; Popova, Ekaterina Valerievna; Gusev, Evgenii Ivanovich; Boyko, Aleksey Nikolaevich; Aulchenko, Yurii Sergeevich; Filipenko, Maxim Leonidovich			Association of SNPs of CD40 Gene with Multiple Sclerosis in Russians	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SYSTEMIC-LUPUS-ERYTHEMATOSUS; RISK; SUSCEPTIBILITY; LIGAND; POLYMORPHISMS; METAANALYSIS; VARIANTS; DISEASE; LOCUS	Multiple sclerosis (MS) is a serious, incurable neurological disease. In 2009, the ANZgene studies detected the suggestive association of located upstream of CD40 gene in chromosome 20q13 (p = 1.3x10(-7)). Identification of the causal variant(s) in the CD40 locus leads to a better understanding of the mechanism underlying the development of autoimmune pathologies. We determined the genotypes of rs6074022, rs1883832, rs1535045, and rs11086996 in patients with MS (n = 1684) and in the control group (n = 879). Two SNPs were significantly associated with MS: rs6074022 (additive model C allele OR = 1.27, 95% CI = [1.12-1.45], p= 3x10(-4)) and rs1883832 (additive model T allele OR = 1.20, 95% CI = [1.05-1.38], p= 7x10(-3)). In the meta-analysis of our results and the results of four previous studies, we obtain the association p-value of 2.34x10(-12), which confirmed the association between MS and rs6074022 at a genome-wide significant level. Next, we demonstrated that the model including rs6074022 only sufficiently described the association. From our analysis, we can speculate that the association between rs1883832 and MS was induced by LD, whereas rs6074022 was a marker in stronger LD with the functional variant or was the functional variant itself. Our results indicated that the functional variants were located in the upstream region of the gene CD40 and were in higher LD with rs6074022 than LD with rs1883832.	[Sokolova, Ekaterina Alekseevna; Aulchenko, Yurii Sergeevich; Filipenko, Maxim Leonidovich] Russian Acad Sci, Inst Chem Biol & Fundamental Med, Pharmacogen Grp, Siberian Div, Novosibirsk, Russia; [Malkova, Nadezhda Alekseevna; Korobko, Denis Sergeevich] Novosibirsk Reg State Clin Hosp, Multiple Sclerosis Ctr, Novosibirsk, Russia; [Rozhdestvenskii, Aleksey Sergeevich; Delov, Roman Andreevich] Omsk State Med Acad, Dept Neurol Postgrad Educ, Omsk, Russia; [Kakulya, Anastasia Vladimirovna] Omsk Reg Clin Hosp, Omsk, Russia; [Khanokh, Elena Vladimirovna] Clin Diagnost Ctr, Budgetary Healthcare Facil Omsk Reg, Omsk, Russia; [Platonov, Fedor Alekseevich] Minist Hlth Republ Sakha, Republican Hosp 2, Multiple Sclerosis Ctr, Yakutsk, Russia; [Popova, Tatyana Yegorovna] North Eastern Fed Univ, Dept Neurol, Med Univ, Yakutsk, Russia; [Aref'eva, Elena Gennadievna; Zagorskaya, Natalia Nikolaevna] Kemerovo Reg Clin Hosp, State Budget Inst Healthcare, Kemerovo, Russia; [Alifirova, Valentina Mikhailovna; Titova, Marina Andreevna] Siberian State Med Univ, Dept Neurol & Neurosurg, Fed Agcy Hlth & Social Dev, Tomsk, Russia; [Smagina, Inna Vadimovna] Terr Clin Hosp, Barnaul, Russia; [Smagina, Inna Vadimovna; El'chaninova, Svetlana Alksandrovna; Popovtseva, Anna Valentinovna] Altai State Med Univ, Dept Nervous Dis, Barnaul, Russia; [Puzyrev, Valery Pavlovich] Russian Acad Med Sci, Russian Acad Med Sci Facil, Res Inst Med Genet, Siberian Div, Tomsk, Russia; [Kulakova, Olga Georgievna; Tsareva, Ekaterina Yur'evna; Favorova, Olga Olegovna; Shchur, Sergei Gennadievich; Lashch, Natalia Yurievna; Popova, Natalia Fyodorovna; Popova, Ekaterina Valerievna; Gusev, Evgenii Ivanovich; Boyko, Aleksey Nikolaevich] Russian Natl Res Med Univ, Dept Neurol & Neurosurg, Moscow, Russia; [Shchur, Sergei Gennadievich; Lashch, Natalia Yurievna; Popova, Natalia Fyodorovna; Popova, Ekaterina Valerievna; Gusev, Evgenii Ivanovich; Boyko, Aleksey Nikolaevich] 11th City Hosp Moscow, MMSC, Moscow, Russia; [Aulchenko, Yurii Sergeevich] Russian Acad Sci, Inst Cytol & Genet, Lab Genet Recombinat & Segregat, Siberian Branch, Novosibirsk 630090, Russia	Institute of Chemical Biology & Fundamental Medicine, Siberian Branch of the RAS; Russian Academy of Sciences; Omsk State Medical University; North-Eastern Federal University in Yakutsk; Siberian State Medical University; Altai State Medical University; Russian Academy of Medical Sciences; Russian Academy of Sciences; Tomsk National Research Medical Center; Research Institute of Medical Genetics - Tomsk; Pirogov Russian National Research Medical University; Russian Academy of Sciences; Institute of Cytology & Genetics ICG SB RAS	Sokolova, EA (corresponding author), Russian Acad Sci, Inst Chem Biol & Fundamental Med, Pharmacogen Grp, Siberian Div, Novosibirsk, Russia.	sokolovaea2608@gmail.ru	Puzyrev, Valery P/S-3144-2016; Rozhdestvensky, Alexey/AAH-9681-2020; Kulakova, Olga/S-1426-2019; Popova, Tatiana/P-4515-2014; Boyko, Alexey N/Z-2106-2018; Tsareva, Ekaterina/AAO-6978-2020; Platonov, Fedor/K-8010-2017; Delov, Roman/AAH-6657-2020; Korobko, Denis/ABA-7214-2021; I.V., Smagina/S-4084-2016; Puzyrev, Valery P/A-7925-2014; Favorova, Olga O/U-7912-2017; Sokolova, Ekaterina Alekseevna/F-2859-2013; Malkova, Nadezhda/I-1650-2017; Aulchenko, Yurii/M-8270-2013	Puzyrev, Valery P/0000-0002-2113-4556; Popova, Tatiana/0000-0003-1062-1540; Tsareva, Ekaterina/0000-0003-2535-9450; Korobko, Denis/0000-0002-7938-3782; I.V., Smagina/0000-0002-7947-4529; Aulchenko, Yurii/0000-0002-7899-1575; Delov, Roman/0000-0003-4708-5737; Alifirova, Valentina/0000-0002-4140-3223; Boyko, Alexei/0000-0003-3306-9541; Ekaterina, Sokolova/0000-0002-4852-5661; Favorova, Olga/0000-0002-5271-6698; Kulakova, Olga/0000-0002-5321-3101; Rozhdestvensky, Alexey/0000-0002-2065-4699; Popova, Ekaterina V/0000-0003-2676-452X	Ministry of Education and Science of Russian Federation [2012-1.5-12-000-1002-010, 8490]; Presidium SBRAS [91]	Ministry of Education and Science of Russian Federation(Ministry of Education and Science, Russian Federation); Presidium SBRAS	The study was supported by The Ministry of Education and Science of Russian Federation, project number 2012-1.5-12-000-1002-010 (government contract number 8490) and the grant of Presidium SBRAS (number 91). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aulchenko YS, 2008, NAT GENET, V40, P1402, DOI 10.1038/ng.251; Bahlo M, 2009, NAT GENET, V41, P824, DOI 10.1038/ng.396; Balasa B, 1997, J IMMUNOL, V159, P4620; Baranzini SE, 2009, HUM MOL GENET, V18, P767, DOI 10.1093/hmg/ddn388; Barbe-Tuana FM, 2006, DIABETES, V55, P2437, DOI 10.2337/db05-1673; Blanco-Kelly F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011520; Briggs FBS, 2011, GENES IMMUN, V12, P615, DOI 10.1038/gene.2011.34; Chen FL, 2012, RHEUMATOLOGY, V51, P47, DOI 10.1093/rheumatology/ker345; Comabella M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003490; De Jager PL, 2009, NAT GENET, V41, P776, DOI 10.1038/ng.401; Denfeld RW, 1996, EUR J IMMUNOL, V26, P2329, DOI 10.1002/eji.1830261009; Diekstra FP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035333; DURIE FH, 1993, SCIENCE, V261, P1328, DOI 10.1126/science.7689748; Gerritse K, 1996, P NATL ACAD SCI USA, V93, P2499, DOI 10.1073/pnas.93.6.2499; Grammer AC, 2003, J CLIN INVEST, V112, P1506, DOI 10.1172/JCI200319301; Hafler DA, 2007, NEW ENGL J MED, V357, P851, DOI 10.1056/NEJMoa073493; Jacobson EM, 2005, ENDOCRINOLOGY, V146, P2684, DOI 10.1210/en.2004-1617; Jakkula E, 2010, AM J HUM GENET, V86, P285, DOI 10.1016/j.ajhg.2010.01.017; Kyburz D, 2000, ARTHRITIS RHEUM, V43, P2571, DOI 10.1002/1529-0131(200011)43:11<2571::AID-ANR26>3.0.CO;2-4; Liu RP, 2012, MOL BIOL REP, V39, P6915, DOI 10.1007/s11033-012-1518-y; MacDonald AS, 2002, J IMMUNOL, V168, P537, DOI 10.4049/jimmunol.168.2.537; Martinelli-Boneschi F, 2012, MULT SCLER J, V18, P1384, DOI 10.1177/1352458512439118; Matesanz F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036140; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; Newport M, 2007, NAT GENET, V39, P1329, DOI 10.1038/ng.2007.17; Nieters A, 2011, INT J CANCER, V128, P1481, DOI 10.1002/ijc.25420; Nischwitz S, 2010, J NEUROIMMUNOL, V227, P162, DOI 10.1016/j.jneuroim.2010.06.003; Orozco G, 2010, ANN RHEUM DIS, V69, P813, DOI 10.1136/ard.2009.109579; Patsopoulos NA, 2011, ANN NEUROL, V70, P897, DOI 10.1002/ana.22609; Peters AL, 2008, BLOOD, V112, P1863, DOI 10.1182/blood-2008-02-138925; Pineda B, 2011, OSTEOPOROSIS INT, V22, P1451, DOI 10.1007/s00198-010-1324-0; Sanna S, 2010, NAT GENET, V42, P495, DOI 10.1038/ng.584; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Skibola CF, 2008, BLOOD, V111, P4348, DOI 10.1182/blood-2007-09-112144; Toubi E, 2004, AUTOIMMUNITY, V37, P457, DOI 10.1080/08916930400002386; Vazgiourakis VM, 2011, ANN RHEUM DIS, V70, P2184, DOI 10.1136/ard.2010.146530; Zhou ZQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018795	37	24	26	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2013	8	4							e61032	10.1371/journal.pone.0061032	http://dx.doi.org/10.1371/journal.pone.0061032			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JR	23613777	Green Submitted, Green Published, gold			2022-12-25	WOS:000317911500015
J	Anbalagan, S; Chaussee, MS				Anbalagan, Srivishnupriya; Chaussee, Michael S.			Transcriptional Regulation of a Bacteriophage Encoded Extracellular DNase (Spd-3) by Rgg in Streptococcus pyogenes	PLOS ONE			English	Article							GROUP-A STREPTOCOCCUS; SEROTYPE M3 STRAIN; GENOME SEQUENCE; PROPHAGE INDUCTION; GENE-EXPRESSION; VIRULENCE; IDENTIFICATION; INFECTIONS; PATHOGENESIS; EMERGENCE	The Streptococcus pyogenes transcriptional regulator Rgg controls the expression of virulence-associated genes encoded both within the core genome and within horizontally transmissible DNA such as temperate bacteriophage. Previously, we showed that Rgg binds to the non-coding DNA upstream of the bacteriophage gene encoding an extracellular DNase Spd-3. In the current study, we further characterized Rgg-mediated regulation of spd-3 expression. Two spd-3 transcripts were identified by northern blotting. The 5' ends were 27 and 594 nucleotides upstream of the start codon as determined with primer extension analysis and 5' RACE (rapid amplification of c-DNA ends), respectively. Results obtained with gel shift assays showed that purified Rgg bound specifically to non-coding DNA containing the promoters of both transcripts. Transcriptional fusion analyses confirmed the presence of Rgg-repressible promoters within these DNA regions. In addition, repression was associated with direct DNA binding by Rgg as determined with chromatin immunoprecipitation (ChIP) coupled with quantitative PCR (qPCR). The results show that the chromosomally encoded transcriptional regulator, Rgg, directly represses both bacteriophage promoters controlling the expression of Spd-3. The results provide new information regarding the regulation of prophage encoded virulence factors of S. pyogenes and highlight the complex evolutionary history of S. pyogenes and temperate bacteriophage.	[Anbalagan, Srivishnupriya; Chaussee, Michael S.] Univ S Dakota, Sanford Sch Med, Div Basic Biomed Sci, Vermillion, SD 57069 USA	University of South Dakota	Chaussee, MS (corresponding author), Univ S Dakota, Sanford Sch Med, Div Basic Biomed Sci, Vermillion, SD 57069 USA.	Michael.Chaussee@usd.edu			Sanford School of Medicine of the University of South Dakota; National Institutes of Health [2 P20 RR016479]; INBRE Program of the National Center for Research Resources; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016479] Funding Source: NIH RePORTER	Sanford School of Medicine of the University of South Dakota; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); INBRE Program of the National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Funding was provided by the Sanford School of Medicine of the University of South Dakota and by National Institutes of Health grant 2 P20 RR016479 from the INBRE Program of the National Center for Research Resources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amulic B, 2011, CURR BIOL, V21, pR297, DOI 10.1016/j.cub.2011.03.021; Anbalagan S, 2012, J BACTERIOL, V194, P3961, DOI 10.1128/JB.06709-11; Anbalagan S, 2011, J BACTERIOL, V193, P4933, DOI 10.1128/JB.00429-11; Aziz RK, 2008, EMERG INFECT DIS, V14, P1511, DOI 10.3201/eid1410.071660; Banks DJ, 2003, INFECT IMMUN, V71, P7079, DOI 10.1128/IAI.71.12.7079-7086.2003; Banks DJ, 2002, TRENDS MICROBIOL, V10, P515, DOI 10.1016/S0966-842X(02)02461-7; Beres SB, 2002, P NATL ACAD SCI USA, V99, P10078, DOI 10.1073/pnas.152298499; Beres SB, 2010, P NATL ACAD SCI USA, V107, P4371, DOI 10.1073/pnas.0911295107; Broudy TB, 2002, INFECT IMMUN, V70, P2805, DOI 10.1128/IAI.70.6.2805-2811.2002; Buchanan JT, 2006, CURR BIOL, V16, P396, DOI 10.1016/j.cub.2005.12.039; Carroll RK, 2011, J CLIN INVEST, V121, P1956, DOI 10.1172/JCI45169; Chaussee MS, 1996, J INFECT DIS, V173, P901, DOI 10.1093/infdis/173.4.901; Chaussee MS, 1999, INFECT IMMUN, V67, P1715; Chaussee MS, 2003, J BACTERIOL, V185, P6016, DOI 10.1128/JB.185.20.6016-6024.2003; Chaussee MS, 2001, INFECT IMMUN, V69, P822, DOI 10.1128/IAI.69.2.822-831.2001; Cunningham MW, 2000, CLIN MICROBIOL REV, V13, P470, DOI 10.1128/CMR.13.3.470-511.2000; Dmitriev AV, 2006, J BACTERIOL, V188, P7230, DOI 10.1128/JB.00877-06; Federle MJ, 2012, VIRULENCE, V3, P92, DOI 10.4161/viru.3.1.18652; Ferretti JJ, 2004, INDIAN J MED RES, V119, P1; Ferretti JJ, 2001, P NATL ACAD SCI USA, V98, P4658, DOI 10.1073/pnas.071559398; Kinkel TL, 2008, INFECT IMMUN, V76, P3451, DOI 10.1128/IAI.00343-08; Loughman JA, 2006, EMBO J, V25, P5414, DOI 10.1038/sj.emboj.7601393; Lyon WR, 1998, EMBO J, V17, P6263, DOI 10.1093/emboj/17.21.6263; McShan WM, 2008, J BACTERIOL, V190, P7773, DOI 10.1128/JB.00672-08; Medini D, 2005, CURR OPIN GENET DEV, V15, P589, DOI 10.1016/j.gde.2005.09.006; Musser JM, 2009, J CLIN INVEST, V119, P2455, DOI 10.1172/JCI38095; Neely MN, 1998, MOL MICROBIOL, V28, P1255, DOI 10.1046/j.1365-2958.1998.00890.x; Olsen RJ, 2012, J INFECT DIS, V205, P1719, DOI 10.1093/infdis/jir825; Proft T, 1999, J EXP MED, V189, P89, DOI 10.1084/jem.189.1.89; Shelburne SA, 2011, MOL MICROBIOL, V82, P1481, DOI 10.1111/j.1365-2958.2011.07902.x; STEVENS DL, 1992, CLIN INFECT DIS, V14, P2, DOI 10.1093/clinids/14.1.2; Sumby P, 2005, P NATL ACAD SCI USA, V102, P1679, DOI 10.1073/pnas.0406641102; Uchiyama S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002736; Wagner PL, 2001, J BACTERIOL, V183, P2081, DOI 10.1128/JB.183.6.2081-2085.2001; Waldor MK, 2005, CURR OPIN MICROBIOL, V8, P459, DOI 10.1016/j.mib.2005.06.001; WANNAMAKER LW, 1958, J EXP MED, V107, P797, DOI 10.1084/jem.107.6.797; WINTER JE, 1964, J BIOL CHEM, V239, P215; ZABRISKIE JB, 1964, J EXP MED, V119, P761, DOI 10.1084/jem.119.5.761	38	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2013	8	4							e61312	10.1371/journal.pone.0061312	http://dx.doi.org/10.1371/journal.pone.0061312			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IK	23613830	Green Submitted, gold, Green Published			2022-12-25	WOS:000317907200046
J	Broering, TJ; Wang, HY; Boatright, NK; Wang, Y; Baptista, K; Shayan, G; Garrity, KA; Kayatekin, C; Bosco, DA; Matthews, CR; Ambrosino, DM; Xu, ZS; Babcock, GJ				Broering, Teresa J.; Wang, Hongyan; Boatright, Naomi K.; Wang, Yang; Baptista, Katherine; Shayan, Gilda; Garrity, Kerry A.; Kayatekin, Can; Bosco, Daryl A.; Matthews, C. Robert; Ambrosino, Donna M.; Xu, Zuoshang; Babcock, Gregory J.			Identification of Human Monoclonal Antibodies Specific for Human SOD1 Recognizing Distinct Epitopes and Forms of SOD1	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; CU,ZN SUPEROXIDE-DISMUTASE; FREE-ENERGY SURFACE; MUTANT SOD1; WILD-TYPE; HEXANUCLEOTIDE REPEAT; TRANSGENIC MICE; FAMILIAL ALS; DISEASE; PROTEIN	Mutations in the gene encoding human SOD1 (hSOD1) can cause amyotrophic lateral sclerosis (ALS) yet the mechanism by which mutant SOD1 can induce ALS is not fully understood. There is currently no cure for ALS or treatment that significantly reduces symptoms or progression. To develop tools to understand the protein conformations present in mutant SOD1-induced ALS and as possible immunotherapy, we isolated and characterized eleven unique human monoclonal antibodies specific for hSOD1. Among these, five recognized distinct linear epitopes on hSOD1 that were not available in the properly-folded protein but were available on forms of protein with some degree of misfolding. The other six antibodies recognized conformation-dependent epitopes that were present in the properly-folded protein with two different recognition profiles: three could bind hSOD1 dimer or monomer and the other three were specific for hSOD1 dimer only. Antibodies with the capacity to bind hSOD1 monomer were able to prevent increased hydrophobicity when mutant hSOD1 was exposed to increased temperature and EDTA, suggesting that the antibodies stabilized the native structure of hSOD1. Two antibodies were tested in a G93A mutant hSOD1 transgenic mouse model of ALS but did not yield a statistically significant increase in overall survival. It may be that the two antibodies selected for testing in the mouse model were not effective for therapy or that the model and/or route of administration were not optimal to produce a therapeutic effect. Therefore, additional testing will be required to determine therapeutic potential for SOD1 mutant ALS and potentially some subset of sporadic ALS.	[Broering, Teresa J.; Boatright, Naomi K.; Wang, Yang; Baptista, Katherine; Shayan, Gilda; Garrity, Kerry A.; Ambrosino, Donna M.; Babcock, Gregory J.] Univ Massachusetts, Sch Med, Boston, MA 02125 USA; [Wang, Hongyan; Kayatekin, Can; Bosco, Daryl A.; Matthews, C. Robert; Xu, Zuoshang] Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA USA; [Bosco, Daryl A.] Univ Massachusetts, Sch Med, Dept Neurol, Worcester, MA USA; [Xu, Zuoshang] Univ Massachusetts, Sch Med, Dept Cell Biol, Worcester, MA 01655 USA; [Xu, Zuoshang] Univ Massachusetts, Sch Med, Neurosci Program, Worcester, MA USA	University of Massachusetts System; University of Massachusetts Boston; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Broering, TJ (corresponding author), AbVitro Inc, Boston, MA USA.	teresa.broering@gmail.com	Kayatekin, Can/B-6618-2009	Kayatekin, Can/0000-0002-4367-9645	MassBiologics; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS067206] Funding Source: NIH RePORTER	MassBiologics; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was primarily funded by MassBiologics. Experiments were designed and conducted by authors employed by MassBiologics and Dr. Broering, an employee of MassBiologics, prepared the first draft of the manuscript. All authors reviewed the manuscript for accuracy. The funders had a role in study design, data collection and data analysis.	Babcock GJ, 2006, INFECT IMMUN, V74, P6339, DOI 10.1128/IAI.00982-06; Banci L, 2009, P NATL ACAD SCI USA, V106, P6980, DOI 10.1073/pnas.0809845106; BENSIMON G, 1994, NEW ENGL J MED, V330, P585, DOI 10.1056/NEJM199403033300901; Bosco DA, 2010, NAT NEUROSCI, V13, P1396, DOI 10.1038/nn.2660; Broering TJ, 2009, J VIROL, V83, P12473, DOI 10.1128/JVI.01138-09; Brotherton TE, 2012, P NATL ACAD SCI USA, V109, P5505, DOI 10.1073/pnas.1115009109; Bruijn LI, 1997, NEURON, V18, P327, DOI 10.1016/S0896-6273(00)80272-X; Chattopadhyay M, 2009, ANTIOXID REDOX SIGN, V11, P1603, DOI [10.1089/ars.2009.2536, 10.1089/ARS.2009.2536]; Cudkowicz ME, 1997, ANN NEUROL, V41, P210, DOI 10.1002/ana.410410212; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; Delrieu J, 2012, J NEUROCHEM, V120, P186, DOI 10.1111/j.1471-4159.2011.07458.x; Forsberg K, 2011, ACTA NEUROPATHOL, V121, P623, DOI 10.1007/s00401-011-0805-3; Forsberg K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011552; Galaleldeen A, 2009, ARCH BIOCHEM BIOPHYS, V492, P40, DOI 10.1016/j.abb.2009.09.020; Grad LI, 2011, P NATL ACAD SCI USA, V108, P16398, DOI 10.1073/pnas.1102645108; Gros-Louis F, 2010, J NEUROCHEM, V113, P1188, DOI 10.1111/j.1471-4159.2010.06683.x; Guareschi S, 2012, P NATL ACAD SCI USA, V109, P5074, DOI 10.1073/pnas.1115402109; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Gurney ME, 1996, ANN NEUROL, V39, P147, DOI 10.1002/ana.410390203; Kayatekin C, 2010, J MOL BIOL, V398, P320, DOI 10.1016/j.jmb.2010.02.034; Kayatekin C, 2008, J MOL BIOL, V384, P540, DOI 10.1016/j.jmb.2008.09.045; Kerman A, 2010, ACTA NEUROPATHOL, V119, P335, DOI 10.1007/s00401-010-0646-5; Lang LS, 2012, P NATL ACAD SCI USA, V109, P17868, DOI 10.1073/pnas.1201795109; Liu HN, 2012, J NEUROSCI, V32, P8791, DOI 10.1523/JNEUROSCI.5053-11.2012; Lonberg N, 2005, NAT BIOTECHNOL, V23, P1117, DOI 10.1038/nbt1135; Ludolph AC, 2010, AMYOTROPH LATERAL SC, V11, P38, DOI 10.3109/17482960903545334; Pokrishevsky E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035050; Rakhit R, 2004, J BIOL CHEM, V279, P15499, DOI 10.1074/jbc.M313295200; Rakhit R, 2007, NAT MED, V13, P754, DOI 10.1038/nm1559; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Rothstein JD, 2009, ANN NEUROL, V65, pS3, DOI 10.1002/ana.21543; Rowland LP, 2001, NEW ENGL J MED, V344, P1688, DOI 10.1056/NEJM200105313442207; Scott S, 2008, AMYOTROPH LATERAL SC, V9, P4, DOI 10.1080/17482960701856300; Strange RW, 2006, J MOL BIOL, V356, P1152, DOI 10.1016/j.jmb.2005.11.081; Svensson AKE, 2006, J MOL BIOL, V364, P1084, DOI 10.1016/j.jmb.2006.09.005; Svensson AKE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010064; Takeuchi S, 2010, J NEUROPATH EXP NEUR, V69, P1044, DOI 10.1097/NEN.0b013e3181f4a90a; Urushitani M, 2006, NAT NEUROSCI, V9, P108, DOI 10.1038/nn1603; Urushitani M, 2007, P NATL ACAD SCI USA, V104, P2495, DOI 10.1073/pnas.0606201104; van Blitterswijk M, 2011, AMYOTROPH LATERAL SC, V12, P430, DOI 10.3109/17482968.2011.585163; Ve Velde C., 2008, P NATL ACAD SCI USA, V105, P4022, DOI [DOI 10.1073/PNAS.0712209105, 10.1073/pnas.0712209105]; Wang HY, 2008, J BIOL CHEM, V283, P15845, DOI 10.1074/jbc.M800834200; Watanabe M, 2001, NEUROBIOL DIS, V8, P933, DOI 10.1006/nbdi.2001.0443; Wilcox KC, 2009, J BIOL CHEM, V284, P13940, DOI 10.1074/jbc.M809687200; WONG PC, 1995, NEURON, V14, P1105, DOI 10.1016/0896-6273(95)90259-7; Xia XG, 2005, J NEUROCHEM, V92, P362, DOI 10.1111/j.1471-4159.2004.02860.x	47	13	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2013	8	4							e61210	10.1371/journal.pone.0061210	http://dx.doi.org/10.1371/journal.pone.0061210			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IK	23613814	gold, Green Published, Green Submitted			2022-12-25	WOS:000317907200040
J	Hanna, SK; Miller, RJ; Muller, EB; Nisbet, RM; Lenihan, HS				Hanna, Shannon K.; Miller, Robert J.; Muller, Erik B.; Nisbet, Roger M.; Lenihan, Hunter S.			Impact of Engineered Zinc Oxide Nanoparticles on the Individual Performance of Mytilus galloprovincialis	PLOS ONE			English	Article							EDULIS-L BIVALVIA; BRACKISH WATER; MUSSEL; NANOMATERIALS; CALIFORNIA; TOXICITY; GROWTH; ACCUMULATION; ENVIRONMENT; METABOLISM	The increased use of engineered nanoparticles (ENPs) in consumer products raises the concern of environmental release and subsequent impacts in natural communities. We tested for physiological and demographic impacts of ZnO, a prevalent metal oxide ENP, on the mussel Mytilus galloprovincialis. We exposed mussels of two size classes, <4.5 and >= 4.5 cm shell length, to 0.1-2 mg l(-1) ZnO ENPs in seawater for 12 wk, and measured the effect on mussel respiration, accumulation of Zn, growth, and survival. After 12 wk of exposure to ZnO ENPs, respiration rates of mussels increased with ZnO concentration. Mussels had up to three fold more Zn in tissues than control groups after 12 wk of exposure, but patterns of Zn accumulation varied with mussel size and Zn concentrations. Small mussels accumulated Zn 10 times faster than large mussels at 0.5 mg l(-1), while large mussels accumulated Zn four times faster than small mussels at 2 mg l(-1). Mussels exposed to 2 mg l(-1) ZnO grew 40% less than mussels in our control group for both size classes. Survival significantly decreased only in groups exposed to the highest ZnO concentration (2 mg l(-1)) and was lower for small mussels than large. Our results indicate that ZnO ENPs are toxic to mussels but at levels unlikely to be reached in natural marine waters.	[Hanna, Shannon K.; Lenihan, Hunter S.] Univ Calif Santa Barbara, Bren Sch Environm Sci & Management, Santa Barbara, CA 93106 USA; [Miller, Robert J.; Muller, Erik B.] Univ Calif Santa Barbara, Inst Marine Sci, Santa Barbara, CA 93106 USA; [Nisbet, Roger M.] Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara	Hanna, SK (corresponding author), Univ Calif Santa Barbara, Bren Sch Environm Sci & Management, Santa Barbara, CA 93106 USA.	hanna.shannonk@gmail.com	Nisbet, Roger M/B-6951-2014	Muller, Erik/0000-0003-2300-0727; Miller, Robert/0000-0002-8350-3759	National Science Foundation; Environmental Protection Agency [DBI 0830117]; MRSEC Program of the National Science Foundation [DMR 1121053]	National Science Foundation(National Science Foundation (NSF)); Environmental Protection Agency(United States Environmental Protection Agency); MRSEC Program of the National Science Foundation(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This material is based upon work supported by the National Science Foundation and the Environmental Protection Agency under Cooperative Agreement Number DBI 0830117. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the author(s) and do not necessarily reflect the views of the National Science Foundation or the Environmental Protection Agency. This work has not been subjected to EPA review and no official endorsement should be inferred. The Materials Research Lab Shared Experimental Facilities are supported by the MRSEC Program of the National Science Foundation under Award No. DMR 1121053, a member of the NSF-funded Materials Research Facilities Network. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adami G, 2002, CHEMOSPHERE, V48, P671, DOI 10.1016/S0045-6535(02)00196-0; Adams LK, 2006, WATER RES, V40, P3527, DOI 10.1016/j.watres.2006.08.004; AKBERALI HB, 1982, COMP BIOCHEM PHYS C, V72, P149, DOI 10.1016/0306-4492(82)90223-4; Anandraj A, 2002, COMP BIOCHEM PHYS C, V132, P355, DOI 10.1016/S1532-0456(02)00081-9; Blackmore G, 2004, J EXP MAR BIOL ECOL, V307, P91, DOI 10.1016/j.jembe.2004.01.021; Blanchette CA, 2007, J EXP MAR BIOL ECOL, V340, P126, DOI 10.1016/j.jembe.2006.09.022; BROWN BE, 1972, MAR BIOL, V16, P108; BURBIDGE FJ, 1994, ARCH ENVIRON CON TOX, V26, P466, DOI 10.1007/BF00214148; Buschbaum C, 2001, J SEA RES, V45, P27, DOI 10.1016/S1385-1101(00)00061-7; Byers JE, 2006, TRENDS ECOL EVOL, V21, P493, DOI 10.1016/j.tree.2006.06.002; Coe WR, 1942, J EXP ZOOL, V90, P1, DOI 10.1002/jez.1400900102; Denis L, 1999, AQUAT LIVING RESOUR, V12, P279, DOI 10.1016/S0990-7440(00)86639-5; Ferry JL, 2009, NAT NANOTECHNOL, V4, P441, DOI [10.1038/NNANO.2009.157, 10.1038/nnano.2009.157]; Franklin NM, 2007, ENVIRON SCI TECHNOL, V41, P8484, DOI 10.1021/es071445r; GEORGE SG, 1980, J MAR BIOL ASSOC UK, V60, P575, DOI 10.1017/S0025315400040273; Godwin HA, 2009, ENVIRON SCI TECHNOL, V43, P6453, DOI 10.1021/es8034544; Gottschalk F, 2009, ENVIRON SCI TECHNOL, V43, P9216, DOI 10.1021/es9015553; Griffitt RJ, 2007, ENVIRON SCI TECHNOL, V41, P8178, DOI 10.1021/es071235e; HAVEN DS, 1966, LIMNOL OCEANOGR, V11, P487, DOI 10.4319/lo.1966.11.4.0487; HIETANEN B, 1988, ANN ZOOL FENN, V25, P341; HIETANEN B, 1988, ANN ZOOL FENN, V25, P349; Hull MS, 2011, ENVIRON SCI TECHNOL, V45, P6592, DOI 10.1021/es200809c; Jager T, 2005, FUNCT ECOL, V19, P136, DOI 10.1111/j.0269-8463.2005.00941.x; Jager T, 2010, ECOTOXICOLOGY, V19, P351, DOI 10.1007/s10646-009-0417-z; Kadar E, 2010, ANAL BIOANAL CHEM, V396, P657, DOI 10.1007/s00216-009-3191-0; Keller AA, 2010, ENVIRON SCI TECHNOL, V44, P1962, DOI 10.1021/es902987d; Klaine SJ, 2008, ENVIRON TOXICOL CHEM, V27, P1825, DOI 10.1897/08-090.1; KRAAK MHS, 1994, ENVIRON POLLUT, V84, P139, DOI 10.1016/0269-7491(94)90096-5; LOBEL PB, 1982, MAR BIOL, V66, P145, DOI 10.1007/BF00397187; LOBEL PB, 1982, MAR POLLUT BULL, V13, P320, DOI 10.1016/0025-326X(82)90396-4; Miller RJ, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030321, 10.1371/journal.pone.0033885]; Miller RJ, 2010, ENVIRON SCI TECHNOL, V44, P7329, DOI 10.1021/es100247x; Montes MO, 2012, J HAZARD MATER, V225, P139, DOI 10.1016/j.jhazmat.2012.05.009; Muller EB, 2010, ECOTOXICOLOGY, V19, P38, DOI 10.1007/s10646-009-0384-4; Nel A, 2006, SCIENCE, V311, P622, DOI 10.1126/science.1114397; PAINE RT, 1966, AM NAT, V100, P65, DOI 10.1086/282400; PAINE RT, 1976, ECOLOGY, V57, P858, DOI 10.2307/1941053; Pitkethly MJ, 2004, MATER TODAY, V7, P20, DOI 10.1016/S1369-7021(04)00627-3; Scown TM, 2010, CRIT REV TOXICOL, V40, P653, DOI 10.3109/10408444.2010.494174; Suchanek TH, 1986, ECOLOGY ROCKY COASTS; Thomas CR, 2011, ACS NANO, V5, P13, DOI 10.1021/nn1034857; Wallace WG, 2003, MAR ECOL PROG SER, V249, P183, DOI 10.3354/meps249183; Zhu XS, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/19/195103; Zhu XS, 2009, J NANOPART RES, V11, P67, DOI 10.1007/s11051-008-9426-8	44	46	46	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2013	8	4							e61800	10.1371/journal.pone.0061800	http://dx.doi.org/10.1371/journal.pone.0061800			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IK	23613941	Green Published, gold			2022-12-25	WOS:000317907200088
J	Lambreva, MD; Giardi, MT; Rambaldi, I; Antonacci, A; Pastorelli, S; Bertalan, I; Husu, I; Johanningmeier, U; Rea, G				Lambreva, Maya D.; Giardi, Maria Teresa; Rambaldi, Irene; Antonacci, Amina; Pastorelli, Sandro; Bertalan, Ivo; Husu, Ivan; Johanningmeier, Udo; Rea, Giuseppina			A Powerful Molecular Engineering Tool Provided Efficient Chlamydomonas Mutants as Bio-Sensing Elements for Herbicides Detection	PLOS ONE			English	Article							PHOTOSYSTEM-II; D1 PROTEIN; REINHARDTII; DESIGN; SUPERSENSITIVITY; VALIDATION; EXPRESSION; RESISTANCE; BIOSENSOR; ALGAE	This study was prompted by increasing concerns about ecological damage and human health threats derived by persistent contamination of water and soil with herbicides, and emerging of bio-sensing technology as powerful, fast and efficient tool for the identification of such hazards. This work is aimed at overcoming principal limitations negatively affecting the whole-cell-based biosensors performance due to inadequate stability and sensitivity of the bio-recognition element. The novel bio-sensing elements for the detection of herbicides were generated exploiting the power of molecular engineering in order to improve the performance of photosynthetic complexes. The new phenotypes were produced by an in vitro directed evolution strategy targeted at the photosystem II (PSII) D1 protein of Chlamydomonas reinhardtii, using exposures to radical-generating ionizing radiation as selection pressure. These tools proved successful to identify D1 mutations conferring enhanced stability, tolerance to free-radical-associated stress and competence for herbicide perception. Long-term stability tests of PSII performance revealed the mutants capability to deal with oxidative stress-related conditions. Furthermore, dose-response experiments indicated the strains having increased sensitivity or resistance to triazine and urea type herbicides with I-50 values ranging from 6x10(-8) M to 2x10(-6) M. Besides stressing the relevance of several amino acids for PSII photochemistry and herbicide sensing, the possibility to improve the specificity of whole-cell-based biosensors, via coupling herbicide-sensitive with herbicide-resistant strains, was verified.	[Lambreva, Maya D.; Giardi, Maria Teresa; Rambaldi, Irene; Antonacci, Amina; Pastorelli, Sandro; Husu, Ivan; Rea, Giuseppina] CNR, Inst Crystallog, Rome, Italy; [Bertalan, Ivo; Johanningmeier, Udo] Univ Halle Wittenberg, Inst Plant Physiol, D-06108 Halle, Saale, Germany	Consiglio Nazionale delle Ricerche (CNR); Istituto Di Cristallografia (IC-CNR); Martin Luther University Halle Wittenberg	Lambreva, MD (corresponding author), CNR, Inst Crystallog, Rome, Italy.	maya.lambreva@ic.cnr.it	Antonacci, Amina/I-4374-2012; REA, GIUSEPPINA/B-9479-2015; Lambreva, Maya Dimova/D-6917-2017	Antonacci, Amina/0000-0002-3245-3739; REA, GIUSEPPINA/0000-0001-7353-727X; Lambreva, Maya Dimova/0000-0001-5750-0899; Giardi, Maria Teresa/0000-0002-7401-5905	FP7-SME-2008-1 SENSBIOSYN project [232082]; FILAS Microbiosis project [POR FESR-LAZIO 2007.2013]; CMST COST TD1102 Action PHOTOTECH	FP7-SME-2008-1 SENSBIOSYN project; FILAS Microbiosis project; CMST COST TD1102 Action PHOTOTECH	This research was performed within the FP7-SME-2008-1 SENSBIOSYN project (ID: 232082, http://www.sensbiosyn.com), FILAS Microbiosis project (POR FESR-LAZIO 2007.2013) and the CMST COST TD1102 Action PHOTOTECH (http://www.phototech.eu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen DJ, 2001, TRENDS PLANT SCI, V6, P36, DOI 10.1016/S1360-1385(00)01808-2; Bhalla V, 2011, J ELECTROANAL CHEM, V657, P84, DOI 10.1016/j.jelechem.2011.03.026; Brayner R, 2011, ANAL BIOANAL CHEM, V401, P581, DOI 10.1007/s00216-011-5107-z; Broser M, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.215970; Buonasera K, 2010, J AGR FOOD CHEM, V58, P5982, DOI 10.1021/jf9027602; Cano JB, 2011, RECENT PATENTS SPACE, V1, P18; Chalifour Annie, 2009, Toxicological and Environmental Chemistry, V91, P1315, DOI 10.1080/02772240802590293; Del Carlo M., 2010, BIOANAL REV, V1, P159; Dewez D, 2008, ENVIRON POLLUT, V151, P93, DOI 10.1016/j.envpol.2007.03.002; Giardi MT, 2009, BIOSENS BIOELECTRON, V25, P294, DOI 10.1016/j.bios.2009.07.003; Goho S, 2000, P ROY SOC B-BIOL SCI, V267, P123, DOI 10.1098/rspb.2000.0976; Harris E. H., 1989, CHLAMYDOMONAS SOURCE; Hema R, 2007, PLANTA, V226, P655, DOI 10.1007/s00425-007-0514-2; Hernandez-Allica J, 2011, HERBICIDES AND ENVIRONMENT, P433; Hoshino T, 2012, BIORESOURCE TECHNOL, V120, P233, DOI 10.1016/j.biortech.2012.06.011; Huner NPA, 1998, TRENDS PLANT SCI, V3, P224, DOI 10.1016/S1360-1385(98)01248-5; Johanningmeier U, 2000, PESTIC BIOCHEM PHYS, V66, P9, DOI 10.1006/pest.1999.2455; JOHANNINGMEIER U, 1993, PLANT MOL BIOL, V22, P91, DOI 10.1007/BF00038998; Kern J, 2007, PHOTOSYNTH RES, V94, P183, DOI 10.1007/s11120-007-9201-1; Lazar D, 2006, FUNCT PLANT BIOL, V33, P9, DOI 10.1071/FP05095; Lefevre F, 2012, LAB CHIP, V12, P787, DOI 10.1039/c2lc20998e; Maly J, 2005, BIOSENS BIOELECTRON, V21, P923, DOI 10.1016/j.bios.2005.02.013; Mayfield SP, 2007, CURR OPIN BIOTECH, V18, P126, DOI 10.1016/j.copbio.2007.02.001; Melis A, 1998, J APPL PHYCOL, V10, P515, DOI 10.1023/A:1008076231267; Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609; Mulo P, 2012, BBA-BIOENERGETICS, V1817, P247, DOI 10.1016/j.bbabio.2011.04.011; Oettmeier W, 1999, CELL MOL LIFE SCI, V55, P1255, DOI 10.1007/s000180050370; Podola B, 2005, J APPL PHYCOL, V17, P261, DOI 10.1007/s10811-005-4945-5; Preiss S, 2001, EUR J BIOCHEM, V268, P4562, DOI 10.1046/j.1432-1327.2001.02383.x; Rasala BA, 2010, PLANT BIOTECHNOL J, V8, P719, DOI 10.1111/j.1467-7652.2010.00503.x; Rea G, 2011, HERBICIDES, THEORY AND APPLICATIONS, P93; Rea G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016216; Rea G, 2009, PROTEIN SCI, V18, P2139, DOI 10.1002/pro.228; Rouillon R, 2006, BIOTECHNOL INTELL UN, P166, DOI 10.1007/978-0-387-36672-2_15; Sanche L, 2002, MASS SPECTROM REV, V21, P349, DOI 10.1002/mas.10034; Shitanda I, 2009, ELECTROCHIM ACTA, V54, P4933, DOI 10.1016/j.electacta.2009.04.005; Singh A, 2011, APPL ENERG, V88, P3548, DOI 10.1016/j.apenergy.2010.12.012; Strasser R.J., 2000, PROBING PHOTOSYNTHES, P445; Wilski S, 2006, PESTIC BIOCHEM PHYS, V84, P157, DOI 10.1016/j.pestbp.2005.07.001; Yang WW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032300	40	14	14	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2013	8	4							e61851	10.1371/journal.pone.0061851	http://dx.doi.org/10.1371/journal.pone.0061851			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IK	23613953	gold, Green Published, Green Submitted			2022-12-25	WOS:000317907200093
J	Majeske, AJ; Bayne, CJ; Smith, LC				Majeske, Audrey J.; Bayne, Christopher J.; Smith, L. Courtney			Aggregation of Sea Urchin Phagocytes Is Augmented In Vitro by Lipopolysaccharide	PLOS ONE			English	Article							STRONGYLOCENTROTUS-PURPURATUS; ECHINOID PHAGOCYTES; IMMUNE-RESPONSE; BACTERIAL CLEARANCE; COELOMIC ELEMENTS; PRIMARY CULTURE; COMPLEMENT; CELOMOCYTES; EXPRESSION; DIVERSITY	Development of protocols and media for culturing immune cells from marine invertebrates has not kept pace with advancements in mammalian immune cell culture, the latter having been driven by the need to understand the causes of and develop therapies for human and animal diseases. However, expansion of the aquaculture industry and the diseases that threaten these systems creates the need to develop cell and tissue culture methods for marine invertebrates. Such methods will enable us to better understand the causes of disease outbreaks and to develop means to avoid and remedy epidemics. We report a method for the short-term culture of phagocytes from the purple sea urchin, Strongylocentrotus purpuratus, by modifying an approach previously used to culture cells from another sea urchin species. The viability of cultured phagocytes from the purple sea urchin decreases from 91.6% to 57% over six days and phagocyte morphology changes from single cells to aggregates leading to the formation of syncytia-like structures. This process is accelerated in the presence of lipopolysaccharide suggesting that phagocytes are capable of detecting this molecular pattern in culture conditions. Sea urchin immune response proteins, called Sp185/333, are expressed on the surface of a subset of phagocytes and have been associated with syncytia-like structures. We evaluated their expression in cultured phagocytes to determine their possible role in cell aggregation and in the formation of syncytia-like structures. Between 0 and 3 hr, syncytia-like structures were observed in cultures when only similar to 10% of the cells were positive for Sp185/333 proteins. At 24 hr, similar to 90% of the nuclei were Sp185/333-positive when all of the phagocytes had aggregated into syncytia-like structures. Consequently, we conclude that the Sp185/333 proteins do not have a major role in initiating the aggregation of cultured phagocytes, however the Sp185/333 proteins are associated with the clustered nuclei within the syncytia-like structures.	[Majeske, Audrey J.; Smith, L. Courtney] Washington Univ, Dept Biol Sci, Washington, DC USA; [Bayne, Christopher J.] Oregon State Univ, Dept Zool, Corvallis, OR 97331 USA	Oregon State University	Smith, LC (corresponding author), Washington Univ, Dept Biol Sci, Washington, DC USA.	csmith@gwu.edu		Majeske, Audrey/0000-0002-2178-5869; Smith, L Courtney/0000-0001-7099-7852	National Science Foundation [MCB 04-24235, MCB 07-44999]; Department of Biological Sciences and Columbian College of Arts and Sciences, George Washington University	National Science Foundation(National Science Foundation (NSF)); Department of Biological Sciences and Columbian College of Arts and Sciences, George Washington University	This work was supported by National Science Foundation awards (MCB 04-24235 and MCB 07-44999) to LCS. Travel funding and educational support for AJM was provided by the Department of Biological Sciences and Columbian College of Arts and Sciences, George Washington University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes DW, 2004, CYTOTECHNOLOGY, V46, P123, DOI 10.1007/s10616-005-1719-5; BERTHEUSSEN K, 1979, EXP CELL RES, V120, P373, DOI 10.1016/0014-4827(79)90397-5; BERTHEUSSEN K, 1978, EXP CELL RES, V111, P401, DOI 10.1016/0014-4827(78)90185-4; BERTHEUSSEN K, 1981, DEV COMP IMMUNOL, V5, P557, DOI 10.1016/S0145-305X(81)80030-4; BERTHEUSSEN K, 1982, DEV COMP IMMUNOL, V6, P635; BERTHEUSSEN K, 1981, DEV COMP IMMUNOL, V5, P241, DOI 10.1016/0145-305X(81)90031-8; BOOLOOTIAN RA, 1959, J EXP ZOOL, V140, P207, DOI 10.1002/jez.1401400203; Brockton V, 2008, J CELL SCI, V121, P339, DOI 10.1242/jcs.012096; Buckley KM, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00136; Chen SN, 1995, COA FISHERIES SERIES, V53, P1; Clow LA, 2000, IMMUNOGENETICS, V51, P1021, DOI 10.1007/s002510000233; Cross PS, 1999, DEV COMP IMMUNOL, V23, P429, DOI 10.1016/S0145-305X(99)00022-1; D'Andrea-Winslow L, 2012, INTEGR ZOOL, V7, P61, DOI [10.1111/j.1749-4877.2012.00276.x, 10.1111/j.1749-4877.2011.00279.x]; DANDREA L, 1994, J CELL SCI, V107, P2081; DANSOHKAWA M, 1993, J EXP ZOOL, V267, P67, DOI 10.1002/jez.1402670110; Dheilly NM, 2011, IMMUNOL CELL BIOL, P1; Dheilly NM, 2009, J IMMUNOL, V182, P2203, DOI 10.4049/jimmunol.07012766; EDDS KT, 1979, J CELL BIOL, V83, P109, DOI 10.1083/jcb.83.1.109; EDDS KT, 1977, J CELL BIOL, V73, P479, DOI 10.1083/jcb.73.2.479; ELLENDER RD, 1992, J CRUSTACEAN BIOL, V12, P178, DOI 10.2307/1549072; Ernst SG, 1997, AM ZOOL, V37, P250; Ghosh J, 2011, DEV COMP IMMUNOL, V35, P959, DOI 10.1016/j.dci.2010.12.009; Ghosh J, 2010, DEV COMP IMMUNOL, V34, P235, DOI 10.1016/j.dci.2009.10.008; GILLMAN T, 1966, NATURE, V209, P263, DOI 10.1038/209263a0; Gross PS, 2000, IMMUNOGENETICS, V51, P1034, DOI 10.1007/s002510000234; Henson JH, 1999, MOL BIOL CELL, V10, P4075, DOI 10.1091/mbc.10.12.4075; Hibino T, 2006, DEV BIOL, V300, P349, DOI 10.1016/j.ydbio.2006.08.065; Hillier BJ, 2003, J CELL BIOL, V160, P597, DOI 10.1083/jcb.200210053; JOHNSON PT, 1969, J INVERTEBR PATHOL, V13, P25, DOI 10.1016/0022-2011(69)90236-5; JOHNSON PT, 1969, J INVERTEBR PATHOL, V13, P42, DOI 10.1016/0022-2011(69)90237-7; Majeske A, 2013, J INNATE IMMUN, DOI [10.1177/1753425912473850, DOI 10.1177/1753425912473850]; Marino R, 2002, IMMUNOGENETICS, V53, P1055, DOI 10.1007/s00251-001-0421-9; Metchnikoff E., 1893, LECT COMP PATHOLOGY; MEYER FP, 1991, J ANIM SCI, V69, P4201, DOI 10.2527/1991.69104201x; Mothersill C, 2000, AQUATIC INVERTEBRATE; Nair SV, 2005, PHYSIOL GENOMICS, V22, P33, DOI 10.1152/physiolgenomics.00052.2005; PLYTYCZ B, 1993, DEV COMP IMMUNOL, V17, P283, DOI 10.1016/0145-305X(93)90047-T; Rinkevich B, 2005, MAR BIOTECHNOL, V7, P429, DOI 10.1007/s10126-004-0108-y; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Smith LC, 2010, ADV EXP MED BIOL, V708, P260; Smith LC, 1996, J IMMUNOL, V156, P593; SMITH LC, 1994, ANN NY ACAD SCI, V712, P213, DOI 10.1111/j.1749-6632.1994.tb33575.x; SMITH LC, 1995, DEV COMP IMMUNOL, V19, P217, DOI 10.1016/0145-305X(95)00009-I; Smith LC, 2012, FRONT IMMUNOL, V3, P1, DOI [10.3339/fimmu.2012,00070, DOI 10.3339/FIMMU.2012.00070]; Smith V., 1981, INVERTEBRATE BLOOD C, VVolume 2, P513; Sodergren E, 2006, SCIENCE, V314, P941, DOI 10.1126/science.1133609; Soderhall I, 2005, J IMMUNOL, V174, P6153, DOI 10.4049/jimmunol.174.10.6153; Terwilliger DP, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-16; Terwilliger DP, 2006, PHYSIOL GENOMICS, V26, P134, DOI 10.1152/physiolgenomics.00011.2006; Walton A, 1999, FISH SHELLFISH IMMUN, V9, P181, DOI 10.1006/fsim.1998.0184; Whittaker CA, 2006, DEV BIOL, V300, P252, DOI 10.1016/j.ydbio.2006.07.044; YUI MA, 1983, BIOL BULL-US, V165, P473, DOI 10.2307/1541213	52	36	36	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2013	8	4							e61419	10.1371/journal.pone.0061419	http://dx.doi.org/10.1371/journal.pone.0061419			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IK	23613847	gold, Green Published			2022-12-25	WOS:000317907200053
J	Pathania, S; Randhawa, V; Bagler, G				Pathania, Shivalika; Randhawa, Vinay; Bagler, Ganesh			Prospecting for Novel Plant-Derived Molecules of Rauvolfia serpentina as Inhibitors of Aldose Reductase, a Potent Drug Target for Diabetes and Its Complications	PLOS ONE			English	Article							RAUWOLFIA-SERPENTINA; DOCKING; DYNAMICS; DISCOVERY; DATABASE; OPTIMIZATION; SIMULATIONS; EPALRESTAT; NEUROPATHY; DESIGN	Aldose Reductase (AR) is implicated in the development of secondary complications of diabetes, providing an interesting target for therapeutic intervention. Extracts of Rauvolfia serpentina, a medicinal plant endemic to the Himalayan mountain range, have been known to be effective in alleviating diabetes and its complications. In this study, we aim to prospect for novel plant-derived inhibitors from R. serpentina and to understand structural basis of their interactions. An extensive library of R. serpentina molecules was compiled and computationally screened for inhibitory action against AR. The stability of complexes, with docked leads, was verified using molecular dynamics simulations. Two structurally distinct plant-derived leads were identified as inhibitors: indobine and indobinine. Further, using these two leads as templates, 16 more leads were identified through ligand-based screening of their structural analogs, from a small molecules database. Thus, we obtained plant-derived indole alkaloids, and their structural analogs, as potential AR inhibitors from a manually curated dataset of R. serpentina molecules. Indole alkaloids reported herein, as a novel structural class unreported hitherto, may provide better insights for designing potential AR inhibitors with improved efficacy and fewer side effects.	[Pathania, Shivalika; Randhawa, Vinay; Bagler, Ganesh] CSIR, Inst Himalayan Bioresource Technol, Div Biotechnol, Palampur, Himachal Prades, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Himalayan Bioresource Technology (IHBT)	Bagler, G (corresponding author), CSIR, Inst Himalayan Bioresource Technol, Div Biotechnol, Palampur, Himachal Prades, India.	bagler@ihbt.res.in	Bagler, Ganesh/A-1102-2009	Bagler, Ganesh/0000-0003-1924-6070; Randhawa, Vinay/0000-0002-5070-6218				Akileshwari C, 2012, EXP DIABETES RES, DOI 10.1155/2012/147965; Alexiou P, 2009, CURR MED CHEM, V16, P734, DOI 10.2174/092986709787458362; Alonso H, 2006, MED RES REV, V26, P531, DOI 10.1002/med.20067; [Anonymous], 2012, DATABASE ANTIDIABETI; Azmi MB, 2012, J FOOD DRUG ANAL, V20, P484, DOI 10.6227/jfda.2012200208; Barnes EC, 2012, ORG BIOMOL CHEM, V10, P4015, DOI 10.1039/c2ob00029f; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Berendsen HJC, 1981, INTERMOLECULAR FORCE, P331, DOI [DOI 10.1007/978-94-015-7658-1_21, 10.1007/978-94-015-7658-1_21]; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Buckingham J., 2011, DICT NATURAL PRODUCT; Cereto-Massague A, 2012, BIOINFORMATICS, V28, P1661, DOI 10.1093/bioinformatics/bts249; Cole JC, 2005, PROTEINS, V60, P325, DOI 10.1002/prot.20497; Cordell G. A., 1998, ALKALOIDS; Costantino L, 2002, BIOORGAN MED CHEM, V10, P3923, DOI 10.1016/S0968-0896(02)00318-8; Costantino L, 1999, AID MED2 3 0 CO, P2; Dey A, 2011, J MED PLANTS RES, V5, P144; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Foppiano M, 1997, LANCET, V349, P399, DOI 10.1016/S0140-6736(97)80018-9; Giannoukakis Nick, 2003, Curr Opin Investig Drugs, V4, P1233; GOOD A. C., 1996, REV COMPUTATIONAL CH, P67, DOI [DOI 10.1002/9780470125847.CH2, 10.1002/9780470125847]; Haider SI, 1986, EXTENDED STUDIES ALK; Hess B, 1997, AID JCC4 3 0 CO, P2; Hotta N, 1996, J DIABETES COMPLICAT, V10, P168, DOI 10.1016/1056-8727(96)00113-4; Howard EI, 2004, PROTEINS, V55, P792, DOI 10.1002/prot.20015; Huang N, 2006, J MED CHEM, V49, P6789, DOI 10.1021/jm0608356; Hung HY, 2012, NAT PROD REP, V29, P580, DOI 10.1039/c2np00074a; INDIA HERBS, 2002, CARD SYST SUPP; Irwin JJ, 2005, J CHEM INF MODEL, V45, P177, DOI 10.1021/ci049714+; KADOR PF, 1985, J MED CHEM, V28, P841, DOI 10.1021/jm00145a001; KINOSHITA JH, 1990, EXP EYE RES, V50, P567, DOI 10.1016/0014-4835(90)90096-D; Kitchen DB, 2004, NAT REV DRUG DISCOV, V3, P935, DOI 10.1038/nrd1549; Kraemer O, 2004, PROTEINS, V55, P814, DOI 10.1002/prot.20057; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Lengauer T, 2004, DRUG DISCOV TODAY, V9, P27, DOI 10.1016/S1359-6446(04)02939-3; Lipinski CA, 2000, J PHARMACOL TOX MET, V44, P235, DOI 10.1016/S1056-8719(00)00107-6; Logendra S, 2006, PHYTOCHEMISTRY, V67, P1539, DOI 10.1016/j.phytochem.2006.05.015; Manske R.H.F., 1965, ALKALOIDS CHEM PHYSL; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Morris Garrett M, 2008, Curr Protoc Bioinformatics, VChapter 8, DOI 10.1002/0471250953.bi0814s24; Naeem S, 2012, BIOORGAN MED CHEM, V20, P1251, DOI 10.1016/j.bmc.2011.12.033; Nikolova N, 2004, QSAR COMB SCI, V22, P1006, DOI 10.1002/qsar.200330831; O'Boyle NM, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-33; Oates PJ, 2008, CURR DRUG TARGETS, V9, P14, DOI 10.2174/138945008783431781; Pant KK, 2008, SCI WORLD, V6, P58, DOI DOI 10.3126/SW.V6I6.2635; Puppala M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031399; Qiu LX, 2012, EXP DIABETES RES, DOI 10.1155/2012/789730; Qureshi SA, 2009, INT J PHARMACOL, V5, P323, DOI 10.3923/ijp.2009.323.326; Ramunno A, 2012, EUR J MED CHEM, V51, P216, DOI 10.1016/j.ejmech.2012.02.045; Randhawa V, 2012, OMICS, V16, P513, DOI 10.1089/omi.2011.0160; Rastelli G, 2002, BIOORGAN MED CHEM, V10, P1437, DOI 10.1016/S0968-0896(01)00410-2; Rodrigo R, 1965, ALKALOIDS CHEM PHYSL; Rosen J, 2009, J MED CHEM, V52, P1953, DOI 10.1021/jm801514w; Sakkiah S, 2012, J MOL MODEL, V18, P3267, DOI 10.1007/s00894-011-1247-5; Saraswat M, 2008, ASIA PAC J CLIN NUTR, V17, P558; Schemmel KE, 2010, J DIABETES COMPLICAT, V24, P354, DOI 10.1016/j.jdiacomp.2009.07.005; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Scott WRP, 1999, J PHYS CHEM A, V103, P3596, DOI 10.1021/jp984217f; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Srivastava SK, 2011, CHEM-BIOL INTERACT, V191, P330, DOI 10.1016/j.cbi.2011.02.023; Srivastava SK, 2005, ENDOCR REV, V26, P380, DOI 10.1210/er.2004-0028; STEELE JW, 1993, DRUG AGING, V3, P532, DOI 10.2165/00002512-199303060-00007; Tang WH, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00087; Triballeau N, 2005, J MED CHEM, V48, P2534, DOI 10.1021/jm049092j; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; van Dieren S, 2010, EUR J CARDIOV PREV R, V17, pS3, DOI 10.1097/01.hjr.0000368191.86614.5a; Villacanas O, 2002, J BIOMOL STRUCT DYN, V20, P347, DOI 10.1080/07391102.2002.10506853; Wang ZG, 2009, J MOL GRAPH MODEL, V28, P162, DOI 10.1016/j.jmgm.2009.06.003; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Xie HZ, 2009, BIOORG MED CHEM LETT, V19, P1944, DOI 10.1016/j.bmcl.2009.02.049; Yabe-Nishimura C, 1998, PHARMACOL REV, V50, P21; Yap BK, 2012, J MOL MODEL, V18, P3639, DOI 10.1007/s00894-012-1368-5; Zaidi SSA, 1986, STUDIES ALKALOIDAL C	73	34	35	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2013	8	4							e61327	10.1371/journal.pone.0061327	http://dx.doi.org/10.1371/journal.pone.0061327			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IK	23613832	Green Published, gold, Green Submitted			2022-12-25	WOS:000317907200047
J	Poletti, P; Melegaro, A; Ajelli, M; del Fava, E; Guzzetta, G; Faustini, L; Tomba, GS; Lopalco, P; Rizzo, C; Merler, S; Manfredi, P				Poletti, Piero; Melegaro, Alessia; Ajelli, Marco; del Fava, Emanuele; Guzzetta, Giorgio; Faustini, Luca; Tomba, Giampaolo Scalia; Lopalco, Pierluigi; Rizzo, Caterina; Merler, Stefano; Manfredi, Piero			Perspectives on the Impact of Varicella Immunization on Herpes Zoster. A Model-Based Evaluation from Three European Countries	PLOS ONE			English	Article							UNITED-STATES; POSTHERPETIC NEURALGIA; VACCINATION PROGRAMS; PROTECTIVE IMMUNITY; SOCIAL CONTACTS; ECONOMIC BURDEN; OKA STRAIN; LONG-TERM; EPIDEMIOLOGY; CHILDREN	The introduction of mass vaccination against Varicella-Zoster-Virus (VZV) is being delayed in many European countries because of, among other factors, the possibility of a large increase in Herpes Zoster (HZ) incidence in the first decades after the initiation of vaccination, due to the expected decline of the boosting of Cell Mediated Immunity caused by the reduced varicella circulation. A multi-country model of VZV transmission and reactivation, is used to evaluate the possible impact of varicella vaccination on HZ epidemiology in Italy, Finland and the UK. Despite the large uncertainty surrounding HZ and vaccine-related parameters, surprisingly robust medium-term predictions are provided, indicating that an increase in HZ incidence is likely to occur in countries where the incidence rate is lower in absence of immunization, possibly due to a higher force of boosting (e.g. Finland), whereas increases in HZ incidence might be minor where the force of boosting is milder (e.g. the UK). Moreover, a convergence of HZ post vaccination incidence levels in the examined countries is predicted despite different initial degrees of success of immunization policies. Unlike previous model-based evaluations, our investigation shows that after varicella immunization an increase of HZ incidence is not a certain fact, rather depends on the presence or absence of factors promoting a strong boosting intensity and which might or not be heavily affected by changes in varicella circulation due to mass immunization. These findings might explain the opposed empirical evidences observed about the increases of HZ in sites where mass varicella vaccination is ongoing.	[Poletti, Piero; Ajelli, Marco; Guzzetta, Giorgio; Merler, Stefano] Bruno Kessler Fdn, Ctr Informat Technol, Trento, Italy; [Poletti, Piero; Melegaro, Alessia] Bocconi Univ, DONDENA Ctr Res Social Dynam, Milan, Italy; [del Fava, Emanuele] Univ Hasselt, Ctr Stat, Diepenbeek, Belgium; [Faustini, Luca] ISTAT Reg Off Tuscany, Florence, Italy; [Tomba, Giampaolo Scalia] Univ Roma Tor Vergata, Dept Math, Rome, Italy; [Lopalco, Pierluigi] European Ctr Dis Prevent & Control, Stockholm, Sweden; [Rizzo, Caterina] Ist Super Sanita, Natl Ctr Epidemiol Surveillance & Hlth Promot, I-00161 Rome, Italy; [Manfredi, Piero] Univ Pisa, Dept Stat & Math Appl Econ, Pisa, Italy	Fondazione Bruno Kessler; Bocconi University; Hasselt University; University of Rome Tor Vergata; European Centre for Disease Prevention & Control; Istituto Superiore di Sanita (ISS); University of Pisa	Poletti, P (corresponding author), Bruno Kessler Fdn, Ctr Informat Technol, Trento, Italy.	poletti@fbk.eu	Rizzo, Caterina/H-4092-2012; Lopalco, Pier Luigi/AAB-7035-2019; Del Fava, Emanuele/D-6181-2014; Ajelli, Marco/AAX-1113-2020; merler, stefano/I-3557-2017	Rizzo, Caterina/0000-0002-5583-7508; Lopalco, Pier Luigi/0000-0002-3181-8054; Del Fava, Emanuele/0000-0001-7352-8525; Ajelli, Marco/0000-0003-1753-4749; merler, stefano/0000-0002-5117-0611; Melegaro, Alessia/0000-0003-2221-8898; Guzzetta, Giorgio/0000-0002-9296-9470; Poletti, Piero/0000-0001-5453-5199	ECDC [GRANT/2009/002]; EU [231807]	ECDC; EU(European Commission)	PP, GG, PM, AM would like to thank the ECDC GRANT/2009/002 project for research funding. MA and SM would like to thank the EU FP7 EPIWORK project (contract no. 231807) for research funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfonsi V, 2011, HEALTH POLICY, V103, P176, DOI 10.1016/j.healthpol.2011.10.002; Amanna IJ, 2007, NEW ENGL J MED, V357, P1903, DOI 10.1056/NEJMoa066092; ANDERSON R M, 1991; [Anonymous], 1995, CONTROL COMMUNICABLE; ASANO Y, 1985, PEDIATRICS, V75, P667; Asano Y, 1996, J INFECT DIS, V174, pS310, DOI 10.1093/infdis/174.Supplement_3.S310; ASANO Y, 1994, PEDIATRICS, V94, P524; Bilcke J, 2012, EPIDEMIOL INFECT, V140, P2096, DOI 10.1017/S0950268811002640; Black S, 2008, J INFECT DIS, V197, pS139, DOI 10.1086/522124; Brisson M, 2000, VACCINE, V18, P2775, DOI 10.1016/S0264-410X(00)00100-6; Brisson M, 2002, VACCINE, V20, P2500, DOI 10.1016/S0264-410X(02)00180-9; Brisson M, 2000, EPIDEMIOL INFECT, V125, P651, DOI 10.1017/S0950268800004714; Brisson M, 2010, VACCINE, V28, P3385, DOI 10.1016/j.vaccine.2010.02.079; Chaves SS, 2007, NEW ENGL J MED, V356, P1121, DOI 10.1056/NEJMoa064040; Civen R, 2009, PEDIATR INFECT DIS J, V28, P954, DOI 10.1097/INF.0b013e3181a90b16; d'Onofrio A, 2011, J THEOR BIOL, V273, P63, DOI 10.1016/j.jtbi.2010.12.029; de Melker H, 2006, VACCINE, V24, P3946, DOI 10.1016/j.vaccine.2006.02.017; Fumanelli L, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002673; Gaillat J, 2011, CLIN INFECT DIS, V53, P405, DOI 10.1093/cid/cir436; Gialloreti LE, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-230; Goeyvaerts N, 2010, J R STAT SOC C-APPL, V59, P255, DOI 10.1111/j.1467-9876.2009.00693.x; Guris D, 2008, J INFECT DIS, V197, pS71, DOI 10.1086/522156; Hambleton S, 2008, J INFECT DIS, V197, pS196, DOI 10.1086/522131; Hata A, 2011, INFECTION, V39, P537, DOI 10.1007/s15010-011-0162-0; Heininger U, 2006, LANCET, V368, P1365, DOI 10.1016/S0140-6736(06)69561-5; Heyman DL, 2008, CONTROL COMMUNICABLE; HOPESIMPSON RE, 1965, P ROY SOC MED, V58, P9, DOI 10.1177/003591576505800106; Iozzi F, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001021; Karhunen M, 2010, EPIDEMIOL INFECT, V138, P469, DOI 10.1017/S0950268809990768; Kretzschmar M, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000291; Larussa P, 2000, PEDIATR INFECT DIS J, V19, P1037, DOI 10.1097/00006454-200011000-00002; Leung J, 2011, CLIN INFECT DIS, V52, P332, DOI 10.1093/cid/ciq077; Levin MJ, 1998, J INFECT DIS, V178, pS109, DOI 10.1086/514264; Liu JZ, 2012, J R SOC INTERFACE, V9, P68, DOI 10.1098/rsif.2011.0001; Lu P, 2001, AM J PREV MED, V40, pe1; Lua PJ, 2009, VACCINE, V27, P882, DOI 10.1016/j.vaccine.2008.11.077; Marin M, 2008, PEDIATRICS, V122, pE744, DOI 10.1542/peds.2008-0567; Marino S, 2008, J THEOR BIOL, V254, P178, DOI 10.1016/j.jtbi.2008.04.011; Melegaro A, 2011, EPIDEMICS-NETH, V3, P143, DOI 10.1016/j.epidem.2011.04.001; Michalik DE, 2008, J INFECT DIS, V197, P944, DOI 10.1086/529043; Nardone A, 2007, VACCINE, V25, P7866, DOI 10.1016/j.vaccine.2007.07.036; Nguyen HQ, 2005, NEW ENGL J MED, V352, P450, DOI 10.1056/NEJMoa042271; Ogunjimi B, 2011, VIRAL IMMUNOL, V24, P151, DOI 10.1089/vim.2010.0031; Oxman MN, 2009, J AM OSTEOPATH ASSOC, V109, pS13; Ramet J, 2007, INT J INFECT DIS, V11, pS49, DOI 10.1016/S1201-9712(07)60022-8; Reynolds MA, 2008, J INFECT DIS, V197, pS224, DOI 10.1086/522162; Sanford M, 2010, DRUG AGING, V27, P159, DOI 10.2165/10489140-000000000-00000; Schuette MC, 1999, B MATH BIOL, V61, P1031, DOI 10.1006/bulm.1999.0126; Seward JF, 2008, J INFECT DIS, V197, pS82, DOI 10.1086/522145; Seward JF, 2004, JAMA-J AM MED ASSOC, V292, P704, DOI 10.1001/jama.292.6.704; Seward JF, 2002, JAMA-J AM MED ASSOC, V287, P606, DOI 10.1001/jama.287.5.606; Shapiro ED, 2011, J INFECT DIS, V203, P312, DOI 10.1093/infdis/jiq052; Sharrar RG, 2000, VACCINE, V19, P916, DOI 10.1016/S0264-410X(00)00297-8; Statistical Office of the European Commission (Eurostat), DAT THEM; Thomas SL, 2002, LANCET, V360, P678, DOI 10.1016/S0140-6736(02)09837-9; van Hoek AJ, 2012, VACCINE, V30, P1225, DOI 10.1016/j.vaccine.2011.11.026; van Hoek AJ, 2011, VACCINE, V29, P2411, DOI 10.1016/j.vaccine.2011.01.037; Vazquez M, 2001, NEW ENGL J MED, V344, P955, DOI 10.1056/NEJM200103293441302; Wallinga J, 2006, AM J EPIDEMIOL, V164, P936, DOI 10.1093/aje/kwj317; Zagheni E, 2008, AM J EPIDEMIOL, V168, P1082, DOI 10.1093/aje/kwn220	60	54	55	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2013	8	4							e60732	10.1371/journal.pone.0060732	http://dx.doi.org/10.1371/journal.pone.0060732			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IK	23613740	Green Published, Green Submitted, gold			2022-12-25	WOS:000317907200011
J	Tan, JL; Li, QX; Ciccotosto, GD; Crouch, PJ; Culvenor, JG; White, AR; Evin, G				Tan, Jiang-Li; Li, Qiao-Xin; Ciccotosto, Giuseppe D.; Crouch, Peter John; Culvenor, Janetta Gladys; White, Anthony Robert; Evin, Genevieve			Mild Oxidative Stress Induces Redistribution of BACE1 in Non-Apoptotic Conditions and Promotes the Amyloidogenic Processing of Alzheimer's Disease Amyloid Precursor Protein	PLOS ONE			English	Article							BETA-SECRETASE ACTIVITY; FACTOR-KAPPA-B; A-BETA; UP-REGULATION; DIFFERENTIAL REGULATION; REDOX REGULATION; GENE-EXPRESSION; GAMMA-SECRETASE; SORTING SIGNAL; APP	BACE1 is responsible for beta-secretase cleavage of the amyloid precursor protein (APP), which represents the first step in the production of amyloid beta (A beta) peptides. Previous reports, by us and others, have indicated that the levels of BACE1 protein and activity are increased in the brain cortex of patients with Alzheimer's disease (AD). The association between oxidative stress (OS) and AD has prompted investigations that support the potentiation of BACE1 expression and enzymatic activity by OS. Here, we have established conditions to analyse the effects of mild, non-lethal OS on BACE1 in primary neuronal cultures, independently from apoptotic mechanisms that were shown to impair BACE1 turnover. Six-hour treatment of mouse primary cortical cells with 10-40 mu M hydrogen peroxide did not significantly compromise cell viability but it did produce mild oxidative stress (mOS), as shown by the increased levels of reactive radical species and activation of p38 stress kinase. The endogenous levels of BACE1 mRNA and protein were not significantly altered in these conditions, whereas a toxic H2O2 concentration (100 mu M) caused an increase in BACE1 protein levels. Notably, mOS conditions resulted in increased levels of the BACE1 C-terminal cleavage product of APP, beta-CTF. Subcellular fractionation techniques showed that mOS caused a major rearrangement of BACE1 localization from light to denser fractions, resulting in an increased distribution of BACE1 in fractions containing APP and markers for trans-Golgi network and early endosomes. Collectively, these data demonstrate that mOS does not modify BACE1 expression but alters BACE1 subcellular compartmentalization to favour the amyloidogenic processing of APP, and thus offer new insight in the early molecular events of AD pathogenesis.	[Tan, Jiang-Li; Ciccotosto, Giuseppe D.; Crouch, Peter John; Culvenor, Janetta Gladys; White, Anthony Robert; Evin, Genevieve] Univ Melbourne, Dept Pathol, Parkville, Vic 3052, Australia; [Li, Qiao-Xin; Ciccotosto, Giuseppe D.; Crouch, Peter John; Culvenor, Janetta Gladys; White, Anthony Robert; Evin, Genevieve] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Div Mental Hlth, Neuropathol Lab, Parkville, Vic 3052, Australia; [Ciccotosto, Giuseppe D.] Univ Melbourne, Mol Sci & Biotechnol Inst BIO21, Parkville, Vic 3052, Australia	University of Melbourne; Florey Institute of Neuroscience & Mental Health; University of Melbourne; University of Melbourne	Evin, G (corresponding author), Univ Melbourne, Dept Pathol, Parkville, Vic 3052, Australia.	gmevin@unimelb.edu.au	Evin, Genevieve M/E-5891-2013; White, Anthony/P-5596-2016	Crouch, Peter/0000-0002-7777-4747; White, Anthony/0000-0003-1802-9891	Australian NHMRC; Judith Jane Mason & Harold Stannett Williams Memorial Foundation	Australian NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Judith Jane Mason & Harold Stannett Williams Memorial Foundation	This work was supported in part by the Australian NHMRC and the Judith Jane Mason & Harold Stannett Williams Memorial Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apelt J, 2004, INT J DEV NEUROSCI, V22, P475, DOI 10.1016/j.ijdevneu.2004.07.006; Borghi R, 2007, NEUROBIOL AGING, V28, P1009, DOI 10.1016/j.neurobiolaging.2006.05.004; Bose A, 2011, BRAIN PATHOL, V21, P189, DOI 10.1111/j.1750-3639.2010.00437.x; Bourne KZ, 2007, J NEUROSCI RES, V85, P1194, DOI 10.1002/jnr.21252; Chami L, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-52; Chami L, 2012, J BIOL CHEM, V287, P24573, DOI 10.1074/jbc.M111.333054; Chen CH, 2011, INT J NEUROPSYCHOPH, V18, P1, DOI DOI 10.1017/S1461145711000149; Chiarugi P, 2008, MOL CELLS, V26, P329; Clarke P, 2009, NAT REV MICROBIOL, V7, P144, DOI 10.1038/nrmicro2071; Cole SL, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-22; Der SD, 1997, P NATL ACAD SCI USA, V94, P3279, DOI 10.1073/pnas.94.7.3279; Ding QX, 2007, CURR ALZHEIMER RES, V4, P73, DOI 10.2174/156720507779939788; Ferreiro E, 2012, Int J Cell Biol, V2012, P735206, DOI 10.1155/2012/735206; Fukumoto H, 2002, ARCH NEUROL-CHICAGO, V59, P1381, DOI 10.1001/archneur.59.9.1381; Fukumoto H, 2004, AM J PATHOL, V164, P719, DOI 10.1016/S0002-9440(10)63159-8; GANDY SE, 1992, J NEUROCHEM, V58, P383, DOI 10.1111/j.1471-4159.1992.tb09322.x; Giannoni E, 2008, CELL DEATH DIFFER, V15, P867, DOI 10.1038/cdd.2008.3; Giliberto L, 2009, J BIOL CHEM, V284, P9027, DOI 10.1074/jbc.M805685200; Guglielmotto M, 2009, J NEUROCHEM, V108, P1045, DOI 10.1111/j.1471-4159.2008.05858.x; Hattori C, 2006, J NEUROSCI RES, V84, P912, DOI 10.1002/jnr.20981; He XY, 2005, J BIOL CHEM, V280, P11696, DOI 10.1074/jbc.M411296200; He XY, 2002, FEBS LETT, V524, P183, DOI 10.1016/S0014-5793(02)03052-1; Holsinger RMD, 2002, ANN NEUROL, V51, P783, DOI 10.1002/ana.10208; Hussain I, 1999, MOL CELL NEUROSCI, V14, P419, DOI 10.1006/mcne.1999.0811; Jo DG, 2010, NEUROBIOL AGING, V31, P917, DOI 10.1016/j.neurobiolaging.2008.07.003; Kaether C, 2004, J CELL BIOL, V167, P809, DOI 10.1083/jcb.200410090; Kalvodova L, 2005, J BIOL CHEM, V280, P36815, DOI 10.1074/jbc.M504484200; Kang EL, 2010, J BIOL CHEM, V285, P24108, DOI 10.1074/jbc.M109.092742; Kao SC, 2004, J BIOL CHEM, V279, P1942, DOI 10.1074/jbc.M309219200; Koh YH, 2005, J BIOL CHEM, V280, P32499, DOI 10.1074/jbc.M506199200; Kudo T, 2006, BIOCHEM BIOPH RES CO, V344, P525, DOI 10.1016/j.bbrc.2006.03.173; Kumar S, 2003, NAT REV DRUG DISCOV, V2, P717, DOI 10.1038/nrd1177; Kwak YD, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-17; Li QX, 1999, J NEUROCHEM, V72, P2479, DOI 10.1046/j.1471-4159.1999.0722479.x; Li R, 2004, P NATL ACAD SCI USA, V101, P3632, DOI 10.1073/pnas.0205689101; Lin XL, 2000, P NATL ACAD SCI USA, V97, P1456, DOI 10.1073/pnas.97.4.1456; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lovell MA, 1997, NEUROBIOL AGING, V18, P457, DOI 10.1016/S0197-4580(97)00108-5; Lovell MA, 2007, J NEUROSCI RES, V85, P3036, DOI 10.1002/jnr.21346; McGrath LT, 2001, QJM-MON J ASSOC PHYS, V94, P485, DOI 10.1093/qjmed/94.9.485; McLean CA, 1999, ANN NEUROL, V46, P860, DOI 10.1002/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M; Mouton-Liger F, 2012, BBA-MOL BASIS DIS, V1822, P885, DOI 10.1016/j.bbadis.2012.01.009; Nunomura A, 2001, J NEUROPATH EXP NEUR, V60, P759, DOI 10.1093/jnen/60.8.759; Nural-Guvener HF, 2012, NEUROSCI LETT, DOI 10.1016/j.neulet.2012.10.051; O'Connor T, 2008, NEURON, V60, P988, DOI 10.1016/j.neuron.2008.10.047; Pastorino L, 2002, MOL CELL NEUROSCI, V19, P175, DOI 10.1006/mcne.2001.1065; Quiroz-Baez R, 2009, NEUROCHEM INT, V55, P662, DOI 10.1016/j.neuint.2009.06.012; Radak Z, 2011, MOL ASPECTS MED, V32, P305, DOI 10.1016/j.mam.2011.10.010; Riddell DR, 2001, CURR BIOL, V11, P1288, DOI 10.1016/S0960-9822(01)00394-3; Salminen A, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-41; Sannerud R, 2011, P NATL ACAD SCI USA, V108, pE559, DOI 10.1073/pnas.1100745108; Santosa C, 2011, NEUROBIOL DIS, V43, P176, DOI 10.1016/j.nbd.2011.03.009; Scheper W, 2011, AUTOPHAGY, V7, P910, DOI 10.4161/auto.7.8.15761; Shiba T, 2004, TRAFFIC, V5, P437, DOI 10.1111/j.1600-0854.2004.00188.x; Sinha S, 1999, NATURE, V402, P537, DOI 10.1038/990114; Stockley JH, 2006, FEBS LETT, V580, P6550, DOI 10.1016/j.febslet.2006.10.076; Su JH, 1997, BRAIN RES, V774, P193, DOI 10.1016/S0006-8993(97)81703-9; Sultana R, 2010, J ALZHEIMERS DIS, V19, P341, DOI 10.3233/JAD-2010-1222; Sun X, 2006, P NATL ACAD SCI USA, V103, P18727, DOI 10.1073/pnas.0606298103; Tamagno E, 2005, J NEUROCHEM, V92, P628, DOI 10.1111/j.1471-4159.2004.02895.x; Tamagno E, 2002, NEUROBIOL DIS, V10, P279, DOI 10.1006/nbdi.2002.0515; Tamagno E, 2008, J NEUROCHEM, V104, P683, DOI 10.1111/j.1471-4159.2007.05072.x; Tamagno E, 2012, NEUROTOX RES, V22, P208, DOI 10.1007/s12640-011-9283-6; Tamagno E, 2009, NEUROBIOL AGING, V30, P1563, DOI 10.1016/j.neurobiolaging.2007.12.015; Tan JG, 2012, J NEUROCHEM, V120, P869, DOI 10.1111/j.1471-4159.2011.07623.x; Tesco G, 2007, NEURON, V54, P721, DOI 10.1016/j.neuron.2007.05.012; Tong Y, 2005, J NEURAL TRANSM, V112, P455, DOI 10.1007/s00702-004-0255-3; Tun H, 2002, J MOL NEUROSCI, V19, P31, DOI 10.1007/s12031-002-0007-5; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Velliquette RA, 2005, J NEUROSCI, V25, P10874, DOI 10.1523/JNEUROSCI.2350-05.2005; Villemagne VL, 2011, ANN NEUROL, V69, P181, DOI 10.1002/ana.22248; von Arnim CAF, 2004, J CELL SCI, V117, P5437, DOI 10.1242/jcs.01422; Wahle T, 2005, MOL CELL NEUROSCI, V29, P453, DOI 10.1016/j.mcn.2005.03.014; Wahle T, 2006, J NEUROSCI, V26, P12838, DOI 10.1523/JNEUROSCI.1982-06.2006; Walker KR, 2012, J NEUROSCI, V32, P10423, DOI 10.1523/JNEUROSCI.5491-11.2012; Walter J, 2001, J BIOL CHEM, V276, P14634, DOI 10.1074/jbc.M011116200; Wang H, 1999, FREE RADICAL BIO MED, V27, P612, DOI 10.1016/S0891-5849(99)00107-0; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Xiong K, 2007, EXP BRAIN RES, V181, P435, DOI 10.1007/s00221-007-0943-y; Xue SF, 2006, NEUROSCI LETT, V405, P231, DOI 10.1016/j.neulet.2006.07.013; Yang LB, 2003, NAT MED, V9, P3, DOI 10.1038/nm0103-3; Yoon CH, 2009, P NATL ACAD SCI USA, V106, P7852, DOI 10.1073/pnas.0812148106; Zhang X, 2007, J BIOL CHEM, V282, P10873, DOI 10.1074/jbc.M608856200; Zhang Y, 2010, J CEREBR BLOOD F MET, V30, P566, DOI 10.1038/jcbfm.2009.228; Zhong ZY, 2007, ARCH GEN PSYCHIAT, V64, P718, DOI 10.1001/archpsyc.64.6.718; Zou L, 2007, CELL RES, V17, P389, DOI 10.1038/cr.2007.5	86	12	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2013	8	4							e61246	10.1371/journal.pone.0061246	http://dx.doi.org/10.1371/journal.pone.0061246			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IK	23613819	Green Published, gold			2022-12-25	WOS:000317907200042
J	Jiang, L; Lan, T; Chen, YC; Sang, JR; Li, YY; Wu, M; Tao, Y; Wang, Y; Qian, H; Gu, L				Jiang, Lu; Lan, Ting; Chen, Yongchang; Sang, Jianrong; Li, Yueying; Wu, Min; Tao, Yan; Wang, Ying; Qian, Hai; Gu, Luo			PKG II Inhibits EGF/EGFR-Induced Migration of Gastric Cancer Cells	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; CYCLIC-GMP; EGF RECEPTOR; SIGNAL-TRANSDUCTION; PHOSPHORYLATION; PROLIFERATION; MECHANISMS; LIGANDS; NETWORK; BIOLOGY	Background: Our previous research results showed that Type II cGMP dependent protein kinase (PKG II) could block the activation of epidermal growth factor receptor (EGFR) and consequently inhibit the proliferation and the related MAPK/ERK-mediated signal transduction of gastric cancer cell line BGC-823, suggesting that PKG II might inhibit other EGFR-triggered signal transduction pathways and related biological activities of gastric cancer cells. This paper was designed to investigate the potential inhibition of PKG II on EGF/EGFR-induced migration activity and the related signal transduction pathways. Methodology/Principal Findings: In gastric cancer cell line AGS, expression and activity of PKG II were increased by infecting the cells with adenoviral construct encoding PKG II cDNA (Ad-PKG II) and treating the cells with cGMP analogue 8-pCPT-cGMP. Phosphorylation of proteins was detected by Western Blotting and active small G protein Ras and Rac1 was measured by "Pull-down" method. Cell migration activity was detected with trans-well equipment. Binding between PKG II and EGFR was detected with Co-IP. The results showed EGF stimulated migration of AGS cell and the effect was related to PLC gamma 1 and ERK-mediated signal transduction pathways. PKG II inhibited EGF-induced migration activity and blocked EGF-initiated signal transduction of PLC gamma 1 and MAPK/ERK-mediated pathways through preventing EGF-induced Tyr 992 and Tyr 1068 phosphorylation of EGFR. PKG II bound with EGFR and caused threonine phosphorylation of it. Conclusion/Significance: Our results systemically confirms the inhibition of PKG II on EGF-induced migration and related signal transduction of PLC gamma 1 and MAPK/ERK-mediated pathways, indicating that PKG II has a fargoing inhibition on EGF/EGFR related signal transduction and biological activities of gastric cancer cells through phosphorylating EGFR and blocking the activation of it.	[Jiang, Lu; Lan, Ting; Chen, Yongchang; Sang, Jianrong; Li, Yueying; Wu, Min; Tao, Yan; Wang, Ying; Qian, Hai] Jiangsu Univ, Sch Med Sci & Lab Med, Dept Physiol, Zhenjiang, Jiangsu, Peoples R China; [Gu, Luo] Nanjing Med Univ, Dept Physiol, Nanjing, Jiangsu, Peoples R China	Jiangsu University; Nanjing Medical University	Chen, YC (corresponding author), Jiangsu Univ, Sch Med Sci & Lab Med, Dept Physiol, Zhenjiang, Jiangsu, Peoples R China.	ycchen54@ujs.edu.cn	Lan, Ting/GWV-2392-2022		National Natural Science Foundation of China [81272755, 31040002, 81001100, 31100974]; Jiangsu University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu University	This study was supported by the National Natural Science Foundation of China, No. 81272755, No. 31040002, No. 81001100 and No. 31100974; The Innovation Grant of Jiangsu University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen YC, 2010, MOL MED REP, V3, P361, DOI 10.3892/mmr_00000266; Cook ALM, 2004, CELL SIGNAL, V16, P253, DOI 10.1016/S0898-6568(03)00134-7; Fallahian F, 2011, FEBS J, V278, P3360, DOI 10.1111/j.1742-4658.2011.08260.x; GAMM DM, 1995, J BIOL CHEM, V270, P27380, DOI 10.1074/jbc.270.45.27380; Hofmann F, 2005, J BIOL CHEM, V280, P1, DOI 10.1074/jbc.R400035200; Hou YL, 2006, CANCER LETT, V240, P60, DOI 10.1016/j.canlet.2005.08.035; Hu TH, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-236; Hu ZZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038777; Krishnan S, 2003, FRONT BIOSCI-LANDMRK, V8, pE1, DOI 10.2741/895; LIN CR, 1986, CELL, V44, P839, DOI 10.1016/0092-8674(86)90006-1; Merla Amartej, 2012, Chemother Res Pract, V2012, P387172, DOI 10.1155/2012/387172; Morandell S, 2008, PROTEOMICS, V8, P4383, DOI 10.1002/pmic.200800204; Nie HG, 2009, J PHYSIOL-LONDON, V587, P2663, DOI 10.1113/jphysiol.2009.170324; Nogami M, 2003, FEBS LETT, V536, P71, DOI 10.1016/S0014-5793(03)00013-9; Normanno N, 2003, ENDOCR-RELAT CANCER, V10, P1, DOI 10.1677/erc.0.0100001; Olayioye MA, 2000, EMBO J, V19, P3159, DOI 10.1093/emboj/19.13.3159; Orstavik S, 1997, GENOMICS, V42, P311, DOI 10.1006/geno.1997.4743; Orstavik S, 1996, BIOCHEM BIOPH RES CO, V220, P759, DOI 10.1006/bbrc.1996.0477; Quatrale AE, 2011, FRONT BIOSCI-LANDMRK, V16, P1962, DOI 10.2741/3833; Rangaswami H, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001423; Rangaswami H, 2009, J BIOL CHEM, V284, P14796, DOI 10.1074/jbc.M806486200; Ray RM, 2007, CELL MOTIL CYTOSKEL, V64, P143, DOI 10.1002/cm.20172; Rooij J, 1997, ONCOGENE, V14, P623; Sharma SV, 2007, NAT REV CANCER, V7, P169, DOI 10.1038/nrc2088; Swartling FJ, 2009, ONCOGENE, V28, P3121, DOI 10.1038/onc.2009.168; THEROUX SJ, 1992, MOL ENDOCRINOL, V6, P1849, DOI 10.1210/me.6.11.1849; Wells A, 1999, INT J BIOCHEM CELL B, V31, P637, DOI 10.1016/S1357-2725(99)00015-1; Wieduwilt MJ, 2008, CELL MOL LIFE SCI, V65, P1566, DOI 10.1007/s00018-008-7440-8; Wu Y, 2012, ONCOL REP, V27, P553, DOI 10.3892/or.2011.1507; Xie ZJ, 2010, BIOCHEM BIOPH RES CO, V399, P425, DOI 10.1016/j.bbrc.2010.07.098; Yang SQ, 2008, J JIANGSU U, V18, P1; Yarden Y, 2001, EUR J CANCER, V37, pS3	32	31	32	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2013	8	4							e61674	10.1371/journal.pone.0061674	http://dx.doi.org/10.1371/journal.pone.0061674			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130DR	23613900	gold, Green Submitted, Green Published			2022-12-25	WOS:000317893400089
J	Qin, D; Trenkwalder, T; Lee, S; Chillo, O; Deindl, E; Kupatt, C; Hinkel, R				Qin, Di; Trenkwalder, Teresa; Lee, Seungmin; Chillo, Omary; Deindl, Elisabeth; Kupatt, Christian; Hinkel, Rabea			Early Vessel Destabilization Mediated by Angiopoietin-2 and Subsequent Vessel Maturation via Angiopoietin-1 Induce Functional Neovasculature after Ischemia	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; CELL-PROLIFERATION; TUMOR ANGIOGENESIS; MOUSE MODEL; VEGF; ARTERIOGENESIS; TIE2; NEOVASCULARIZATION; RECRUITMENT; PERFUSION	Background: We assessed whether Angiopoietin-2 (Ang2), a Tie2 ligand and partial antagonist of Angiopoietin-1 (Ang1), is required for early vessel destabilization during postischemic angiogenesis, when combined with vascular growth factors. Methods: In vitro, matrigel co-cultures assessed endothelial-cell tube formation and pericyte recruitment after stimulation of VEGF-A, Apelin (APLN), Ang1 with or without Ang2. In a murine hindlimb ischemia model, adeno-associated virus (rAAV, 3 x 10(12) virusparticles) transduction of VEGF-A, APLN and Ang1 with or without Ang2 (continuous or early expression d0-3) was performed intramuscularly (d-14). Femoral artery ligation was performed at d0, followed by laser doppler perfusion meassurements (LDI) 7 and 14. At d7 (early timepoint) and d14 (late timepoint), histological analysis of capillary/muscle fiber ratio (CMF-R, PECAM-1) and pericyte/capillary ratio (PC-R, NG2) was performed. Results: In vitro, VEGF-A, APLN and Ang1 induced ring formation, but only APLN and Ang1 recruited pericytes. Ang2 did not affect tube formation by APLN, but reduced pericyte recruitment after APLN or Ang1 overexpression. In vivo, rAAV. VEGF-A did not alter LDI-perfusion at d14, consistent with an impaired PC-R despite a rise in CMF-R. rAAV. APLN improved perfusion at d14, with or without continuous Ang2, increasing CMF-R and PC-R. rAAV. Ang1 improved perfusion at d14, when combined with rAAV. Ang2 (d0-3), accompanied by an increased CMF-R and PC-R. Conclusion: The combination of early vessel destabilization (Ang2 d0-3) and continuous Ang1 overexpression improves hindlimb perfusion, pointing to the importance of early vessel destabilization and subsequent vessel maturation for enhanced therapeutic neovascularization.	[Qin, Di; Trenkwalder, Teresa; Lee, Seungmin; Kupatt, Christian; Hinkel, Rabea] Med Klin & Poliklin 1, Klinikum Grosshadern, Munich, Germany; [Qin, Di] Jilin Univ, Dept Senile Dis, China Japan Union Hosp, Changchun 130023, Jilin, Peoples R China; [Trenkwalder, Teresa; Chillo, Omary; Deindl, Elisabeth] Ludwig Maximilians Univ Munchen, Walter Brendel Ctr Expt Med, Munich, Germany; [Kupatt, Christian; Hinkel, Rabea] DZHK German Ctr Cardiovasc Res, Munich, Germany	University of Munich; Jilin University; University of Munich; German Centre for Cardiovascular Research	Hinkel, R (corresponding author), Med Klin & Poliklin 1, Klinikum Grosshadern, Munich, Germany.	rabea.hinkel@med.uni-muenchen.de	Hinkel, Rabea/I-9165-2014; Deindl, Elisabeth/A-2511-2013	Hinkel, Rabea/0000-0002-2936-0400; Chillo, Omary/0000-0002-0364-9804; Kupatt, Christian/0000-0002-3611-1218	Deutsche Forschungsgemeinschaft [KU 1019/11-2]; FoFoLe grant	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); FoFoLe grant	This work was in part supported by Deutsche Forschungsgemeinschaft Grant KU 1019/11-2 to CK and a FoFoLe grant to TT. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Malak NA, 2008, BLOOD, V111, P4145, DOI 10.1182/blood-2007-08-110338; Abe M, 2003, BIOCHEM BIOPH RES CO, V306, P10, DOI 10.1016/S0006-291X(03)00903-3; Arsic N, 2003, MOL THER, V7, P450, DOI 10.1016/S1525-0016(03)00034-0; Asahara T, 1998, CIRC RES, V83, P233, DOI 10.1161/01.RES.83.3.233; Couffinhal T, 1998, AM J PATHOL, V152, P1667; Dor Y, 2002, EMBO J, V21, P1939, DOI 10.1093/emboj/21.8.1939; Fagiani E, 2011, CANCER RES, V71, P5717, DOI 10.1158/0008-5472.CAN-10-4635; Felcht M, 2012, J CLIN INVEST, V122, P1991, DOI 10.1172/JCI58832; Gao GP, 2002, P NATL ACAD SCI USA, V99, P11854, DOI 10.1073/pnas.182412299; Greenberg JI, 2008, NATURE, V456, P809, DOI 10.1038/nature07424; Helisch A, 2006, ARTERIOSCL THROM VAS, V26, P520, DOI 10.1161/01.ATV.0000202677.55012.a0; Hinkel R, 2011, EXPERT OPIN BIOL TH, V11, P723, DOI 10.1517/14712598.2011.570749; Holash J, 1999, ONCOGENE, V18, P5356, DOI 10.1038/sj.onc.1203035; Jain RK, 2003, NAT MED, V9, P685, DOI 10.1038/nm0603-685; Karvinen H, 2010, CURR OPIN PHARMACOL, V10, P208, DOI 10.1016/j.coph.2010.01.004; Kidoya H, 2012, J BIOCHEM, V152, P125, DOI 10.1093/jb/mvs071; Kidoya H, 2010, BLOOD, V115, P3166, DOI 10.1182/blood-2009-07-232306; Kobayashi H, 2006, BLOOD, V108, P1260, DOI 10.1182/blood-2005-09-012807; Koblizek TI, 1998, CURR BIOL, V8, P529, DOI 10.1016/S0960-9822(98)70205-2; Kupatt C, 2010, J AM COLL CARDIOL, V56, P414, DOI 10.1016/j.jacc.2010.03.050; Limbourg A, 2009, NAT PROTOC, V4, P1737, DOI 10.1038/nprot.2009.185; Pagel JI, 2012, THROMB HAEMOSTASIS, V107, P562, DOI 10.1160/TH11-07-0490; Raake PW, 2008, GENE THER, V15, P12, DOI 10.1038/sj.gt.3303035; Reiss Y, 2007, CIRC RES CIRCRESAHA; Saharinen P, 2008, NAT CELL BIOL, V10, P527, DOI 10.1038/ncb1715; Sandhu R, 2004, CARDIOVASC RES, V64, P115, DOI 10.1016/j.cardiores.2004.05.013; Scharpfenecker M, 2005, J CELL SCI, V118, P771, DOI 10.1242/jcs.01653; Scholz D, 2002, J MOL CELL CARDIOL, V34, P775, DOI 10.1006/jmcc.2002.2013; Smith AH, 2012, J AM COLL CARDIOL, V59, P1320, DOI 10.1016/j.jacc.2011.12.025; Thomas M, 2009, ANGIOGENESIS, V12, P125, DOI 10.1007/s10456-009-9147-3; Yla-Herttuala S, 2007, J AM COLL CARDIOL, V49, P1015, DOI 10.1016/j.jacc.2006.09.053; Zhu WH, 2003, J VASC RES, V40, P140, DOI 10.1159/000070711	32	37	45	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2013	8	4							e61831	10.1371/journal.pone.0061831	http://dx.doi.org/10.1371/journal.pone.0061831			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130DR	23613948	Green Submitted, Green Published, gold			2022-12-25	WOS:000317893400115
J	Vinaik, R; Kozlov, G; Gehring, K				Vinaik, Roohi; Kozlov, Guennadi; Gehring, Kalle			Structure of the Non-Catalytic Domain of the Protein Disulfide Isomerase-Related Protein (PDIR) Reveals Function in Protein Binding	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; SYSTEM; FAMILY; ERP57	Protein disulfide isomerases comprise a large family of enzymes responsible for catalyzing the proper oxidation and folding of newly synthesized proteins in the endoplasmic reticulum (ER). Protein disulfide isomerase-related (PDIR) protein (also known as PDIA5) is a specialized member that participates in the folding of alpha(1)-antitrypsin and N-linked glycoproteins. Here, the crystal structure of the non-catalytic domain of PDIR was determined to 1.5 angstrom resolution. The structure adopts a thioredoxin-like fold stabilized by a structural disulfide bridge with a positively charged binding surface for interactions with the ER chaperones, calreticulin and ERp72. Crystal contacts between molecules potentially mimic the interactions of PDIR with misfolded substrate proteins. The results suggest that the non-catalytic domain of PDIR plays a key role in the recognition of protein partners and substrates.	[Vinaik, Roohi; Kozlov, Guennadi; Gehring, Kalle] McGill Univ, Dept Biochem, Grp Rech Axe Struct Prot, Montreal, PQ, Canada	McGill University	Gehring, K (corresponding author), McGill Univ, Dept Biochem, Grp Rech Axe Struct Prot, Montreal, PQ, Canada.	kalle.gehring@mcgill.ca	Gehring, Kalle/I-4403-2013; Gehring, Kalle/N-2945-2019	Gehring, Kalle/0000-0001-6500-1184; Gehring, Kalle/0000-0001-6500-1184	NSERC [RGPIN 233873]; Natural Sciences and Engineering Research Council of Canada (NSERC); National Science Foundation [DMR 0225180]; National Institutes of Health [RR-01646]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001646] Funding Source: NIH RePORTER	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This study was funded by NSERC grant RGPIN 233873 to KG. RV acknowledges fellowship from Natural Sciences and Engineering Research Council of Canada (NSERC). Data acquisition for the native crystal at the Macromolecular Diffraction (MacCHESS) facility at the Cornell High Energy Synchrotron Source (CHESS) was supported by the National Science Foundation award DMR 0225180 and the National Institutes of Health award RR-01646. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Denisov AY, 2009, FEBS J, V276, P1440, DOI 10.1111/j.1742-4658.2009.06884.x; Dong G, 2009, IMMUNITY, V30, P21, DOI 10.1016/j.immuni.2008.10.018; Ellgaard L, 2005, EMBO REP, V6, P28, DOI 10.1038/sj.embor.7400311; Ellgaard L, 2002, J MOL BIOL, V322, P773, DOI 10.1016/S0022-2836(02)00812-4; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Frickel EM, 2002, P NATL ACAD SCI USA, V99, P1954, DOI 10.1073/pnas.042699099; Goddard T.D., SPARKY 3; Gulerez IE, 2012, ACTA CRYSTALLOGR F, V68, P378, DOI 10.1107/S1744309112005866; Hatahet F, 2009, ANTIOXID REDOX SIGN, V11, P2807, DOI 10.1089/ARS.2009.2466; HAYANO T, 1995, FEBS LETT, V372, P210, DOI 10.1016/0014-5793(95)00996-M; HENDRICKSON WA, 1990, EMBO J, V9, P1665, DOI 10.1002/j.1460-2075.1990.tb08287.x; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Horibe T, 2004, FEBS LETT, V566, P311, DOI 10.1016/j.febslet.2004.03.103; Horibe T, 2004, J BIOL CHEM, V279, P4604, DOI 10.1074/jbc.M310922200; Jansen G, 2012, MOL CELL PROTEOMICS, V11, P710, DOI 10.1074/mcp.M111.016550; Kozlov G, 2006, STRUCTURE, V14, P1331, DOI 10.1016/j.str.2006.06.019; Kozlov G, 2010, J BIOL CHEM, V285, P35551, DOI 10.1074/jbc.M110.160101; Kozlov G, 2010, FEBS J, V277, P3924, DOI 10.1111/j.1742-4658.2010.07793.x; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Maattanen P, 2006, BIOCHEM CELL BIOL, V84, P881, DOI 10.1139/O06-186; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Nguyen VD, 2008, J MOL BIOL, V383, P1144, DOI 10.1016/j.jmb.2008.08.085; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tian G, 2006, CELL, V124, P61, DOI 10.1016/j.cell.2005.10.044; Villani GRD, 2012, J INHERIT METAB DIS, V35, P479, DOI 10.1007/s10545-011-9403-8; Walker KW, 1997, J BIOL CHEM, V272, P8845	30	15	15	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2013	8	4							e62021	10.1371/journal.pone.0062021	http://dx.doi.org/10.1371/journal.pone.0062021			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130DR	23614004	Green Published, gold, Green Submitted			2022-12-25	WOS:000317893400146
J	Yang, J; Fan, J; Li, Y; Li, FH; Chen, PK; Fan, YB; Xia, XF; Wong, ST				Yang, Jian; Fan, Jing; Li, Ying; Li, Fuhai; Chen, Peikai; Fan, Yubo; Xia, Xiaofeng; Wong, Stephen T.			Genome-Wide RNAi Screening Identifies Genes Inhibiting the Migration of Glioblastoma Cells	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; CELLULAR MOTILITY; MESSENGER-RNA; FILAMIN-A; IN-VIVO; INTERFERENCE; PROTEIN; EXPRESSION; TWINFILIN	Glioblastoma Multiforme (GBM) cells are highly invasive, infiltrating into the surrounding normal brain tissue, making it impossible to completely eradicate GBM tumors by surgery or radiation. Increasing evidence also shows that these migratory cells are highly resistant to cytotoxic reagents, but decreasing their migratory capability can re-sensitize them to chemotherapy. These evidences suggest that the migratory cell population may serve as a better therapeutic target for more effective treatment of GBM. In order to understand the regulatory mechanism underlying the motile phenotype, we carried out a genome-wide RNAi screen for genes inhibiting the migration of GBM cells. The screening identified a total of twenty-five primary hits; seven of them were confirmed by secondary screening. Further study showed that three of the genes, FLNA, KHSRP and HCFC1, also functioned in vivo, and knocking them down caused multifocal tumor in a mouse model. Interestingly, two genes, KHSRP and HCFC1, were also found to be correlated with the clinical outcome of GBM patients. These two genes have not been previously associated with cell migration.	[Yang, Jian; Fan, Jing; Li, Ying; Li, Fuhai; Chen, Peikai; Fan, Yubo; Xia, Xiaofeng; Wong, Stephen T.] Weill Cornell Med Coll, Methodist Hosp, Res Inst, Dept Syst Med & Bioengn, Houston, TX USA	Cornell University; The Methodist Hospital System; The Methodist Hospital - Houston	Xia, XF (corresponding author), Weill Cornell Med Coll, Methodist Hosp, Res Inst, Dept Syst Med & Bioengn, Houston, TX USA.	xxia@tmhs.org; stwong@tmhs.org	Chen, Peikai/ABB-3740-2021	Chen, Peikai/0000-0003-1880-0893				Ali N, 2009, BLOOD, V113, P3690, DOI 10.1182/blood-2008-10-176396; Boettcher M, 2010, CURR GENOMICS, V11, P162, DOI 10.2174/138920210791110988; Briata P, 2005, MOL CELL, V20, P891, DOI 10.1016/j.molcel.2005.10.021; Choudhury Y, 2012, J CLIN INVEST, V122, P4059, DOI 10.1172/JCI62925; Demuth T, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-54; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Franz CM, 2002, DEV CELL, V2, P153, DOI 10.1016/S1534-5807(02)00120-X; Gherzi R, 2007, PLOS BIOL, V5, P82, DOI 10.1371/journal.pbio.0050005; Giese A, 2003, J CLIN ONCOL, V21, P1624, DOI 10.1200/JCO.2003.05.063; Guilini C, 2010, AM J PHYSIOL-HEART C, V298, pH844, DOI 10.1152/ajpheart.00898.2009; Guthrie B L, 1990, Neurosurg Clin N Am, V1, P37; Kanu OO, 2009, EXPERT OPIN THER TAR, V13, P701, DOI [10.1517/14728220902942348 , 10.1517/14728220902942348]; KLEIHUES P, 2000, WHO CLASSIFICATION T, V1; Ko J, 2004, FASEB J, V18, P890, DOI 10.1096/fj.03-0867fje; Kowanetz M, 2010, P NATL ACAD SCI USA, V107, P21248, DOI 10.1073/pnas.1015855107; Lefranc F, 2005, J CLIN ONCOL, V23, P2411, DOI 10.1200/JCO.2005.03.089; Loftus JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039818; Lu R, 1998, J VIROL, V72, P6291, DOI 10.1128/JVI.72.8.6291-6297.1998; Mariani L, 2001, J NEURO-ONCOL, V53, P161, DOI 10.1023/A:1012253317934; Meacham CE, 2009, NAT GENET, V41, P1133, DOI 10.1038/ng.451; Megalizzi V, 2007, NEOPLASIA, V9, P358, DOI 10.1593/neo.07130; Mohr S, 2010, ANNU REV BIOCHEM, V79, P37, DOI 10.1146/annurev-biochem-060408-092949; Morita I, 2008, J BIOCHEM, V143, P719, DOI 10.1093/jb/mvm221; Palmgren S, 2002, J CELL SCI, V115, P881; Penas-Prado M, 2012, HAND CLINIC, V105, P485, DOI 10.1016/B978-0-444-53502-3.00004-5; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Pollard TD, 2003, NATURE, V422, P741, DOI 10.1038/nature01598; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Robertson SP, 2003, NAT GENET, V33, P487, DOI 10.1038/ng1119; Santarosa M, 2010, CELL CYCLE, V9, P4666, DOI 10.4161/cc.9.23.14022; Seo M, 2010, FASEB J, V24, P464, DOI 10.1096/fj.09-137562; Sheen VL, 2002, HUM MOL GENET, V11, P2845, DOI 10.1093/hmg/11.23.2845; Silva JM, 2008, SCIENCE, V319, P617, DOI 10.1126/science.1149185; Sims D, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-10-r104; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Vartiainen MK, 2003, J BIOL CHEM, V278, P34347, DOI 10.1074/jbc.M303642200; Vicente-Manzanares M, 2005, J CELL SCI, V118, DOI 10.1242/jcs.02662; Westbrook TF, 2005, CELL, V121, P837, DOI 10.1016/j.cell.2005.03.033; WILSON AC, 1993, CELL, V74, P115, DOI 10.1016/0092-8674(93)90299-6; Xu YJ, 2010, J EXP MED, V207, P2421, DOI 10.1084/jem.20100433; Yang I, 2009, NAT REV CLIN ONCOL, V6, P648, DOI 10.1038/nrclinonc.2009.150; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0	43	21	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2013	8	4							e61915	10.1371/journal.pone.0061915	http://dx.doi.org/10.1371/journal.pone.0061915			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123JP	23593504	gold, Green Published, Green Submitted			2022-12-25	WOS:000317385300090
J	Lo, PHY; Urabe, Y; Kumar, V; Tanikawa, C; Koike, K; Kato, N; Miki, D; Chayama, K; Kubo, M; Nakamura, Y; Matsuda, K				Lo, Paulisally Hau Yi; Urabe, Yuji; Kumar, Vinod; Tanikawa, Chizu; Koike, Kazuhiko; Kato, Naoya; Miki, Daiki; Chayama, Kazuaki; Kubo, Michiaki; Nakamura, Yusuke; Matsuda, Koichi			Identification of a Functional Variant in the MICA Promoter Which Regulates MICA Expression and Increases HCV-Related Hepatocellular Carcinoma Risk	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; CHRONIC HEPATITIS-B; TRANSCRIPTIONAL REGULATION; SUSCEPTIBILITY LOCUS; CHAIN-A; EPIDEMIOLOGY; JAPANESE; GENE; POLYMORPHISM	Hepatitis C virus (HCV) infection is the major cause of hepatocellular carcinoma (HCC) in Japan. We previously identified the association of SNP rs2596542 in the 5' flanking region of the MHC class I polypeptide-related sequence A (MICA) gene with the risk of HCV-induced HCC. In the current study, we performed detailed functional analysis of 12 candidate SNPs in the promoter region and found that a SNP rs2596538 located at 2.8 kb upstream of the MICA gene affected the binding of a nuclear protein(s) to the genomic segment including this SNP. By electrophoretic mobility shift assay (EMSA) and chromatin immunoprecipitation (ChIP) assay, we identified that transcription factor Specificity Protein 1 (SP1) can bind to the protective G allele, but not to the risk A allele. In addition, reporter construct containing the G allele was found to exhibit higher transcriptional activity than that containing the A allele. Moreover, SNP rs2596538 showed stronger association with HCV-induced HCC (P = 1.82 x 10(-5) and OR = 1.34) than the previously identified SNP rs2596542. We also found significantly higher serum level of soluble MICA (sMICA) in HCV-induced HCC patients carrying the G allele than those carrying the A allele (P = 0.00616). In summary, we have identified a functional SNP that is associated with the expression of MICA and the risk for HCV-induced HCC.	[Lo, Paulisally Hau Yi; Urabe, Yuji; Kumar, Vinod; Tanikawa, Chizu; Nakamura, Yusuke; Matsuda, Koichi] Univ Tokyo, Inst Med Sci, Mol Med Lab, Ctr Human Genome, Tokyo, Japan; [Urabe, Yuji; Miki, Daiki; Chayama, Kazuaki] Hiroshima Univ, Grad Sch Biomed Sci, Dept Med, Div Frontier Med Sci,Programs Biomed Res, Hiroshima, Japan; [Urabe, Yuji; Miki, Daiki; Chayama, Kazuaki] Hiroshima Univ, Grad Sch Biomed Sci, Dept Mol Sci, Div Frontier Med Sci,Programs Biomed Res, Hiroshima, Japan; [Koike, Kazuhiko] Univ Tokyo, Dept Gastroenterol, Grad Sch Med, Tokyo, Japan; [Kato, Naoya] Univ Tokyo, Inst Med Sci, Unit Dis Control Genome Med, Tokyo, Japan; [Miki, Daiki; Chayama, Kazuaki; Kubo, Michiaki] Inst Phys & Chem Res RIKEN, Ctr Genom Med, Kanagawa, Japan; [Nakamura, Yusuke] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Nakamura, Yusuke] Univ Chicago, Dept Surg, Chicago, IL 60637 USA; [Nakamura, Yusuke] Univ Chicago, Ctr Personalized Therapeut, Chicago, IL 60637 USA	University of Tokyo; Hiroshima University; Hiroshima University; University of Tokyo; University of Tokyo; RIKEN; University of Chicago; University of Chicago; University of Chicago	Matsuda, K (corresponding author), Univ Tokyo, Inst Med Sci, Mol Med Lab, Ctr Human Genome, Tokyo, Japan.	koichima@ims.u-tokyo.ac.jp	Miki, Daiki/L-5069-2018; Kubo, Michiaki/N-7947-2015; Kumar, Vinod/ABC-4866-2020; Matsuda, Koichi/D-4597-2011	Miki, Daiki/0000-0002-6505-9826; Kumar, Vinod/0000-0002-2775-6049; Chayama, Kazuaki/0000-0002-5530-5341; Matsuda, Koichi/0000-0001-7292-2686	Ministry of Education, Culture, Sports, Science and Technology of the Japanese government; Ministry of Health, Labour, and Welfare of the Japanese government; Grants-in-Aid for Scientific Research [25670369] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of the Japanese government(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour, and Welfare of the Japanese government; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Ministry of Education, Culture, Sports, Science and Technology of the Japanese government, the Ministry of Health, Labour, and Welfare of the Japanese government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Andresen L, 2007, J IMMUNOL, V179, P8235, DOI 10.4049/jimmunol.179.12.8235; ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; Barrett Jeffrey C, 2009, Cold Spring Harb Protoc, V2009, DOI 10.1101/pdb.ip71; Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727; Cabibbo G, 2010, EUR REV MED PHARMACO, V14, P352; Chung TW, 2004, FASEB J, V18, P1123, DOI 10.1096/fj.03-1429fje; Fassio E, 2010, ANN HEPATOL, V9, pS119, DOI 10.1016/S1665-2681(19)31736-3; Hata J, 2007, HUM MOL GENET, V16, P630, DOI 10.1093/hmg/ddm005; Jinushi M, 2003, INT J CANCER, V104, P354, DOI 10.1002/ijc.10966; KADONAGA JT, 1986, P NATL ACAD SCI USA, V83, P5889, DOI 10.1073/pnas.83.16.5889; Kamatani Y, 2009, NAT GENET, V41, P591, DOI 10.1038/ng.348; Kim JR, 2004, INT J BIOCHEM CELL B, V36, P2293, DOI 10.1016/j.biocel.2004.04.022; Kohga K, 2008, CANCER SCI, V99, P1643, DOI 10.1111/j.1349-7006.2008.00859.x; Komatsu-Wakui M, 2001, TISSUE ANTIGENS, V57, P1, DOI 10.1034/j.1399-0039.2001.057001001.x; Kumar V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044743; Kumar V, 2011, NAT GENET, V43, P455, DOI 10.1038/ng.809; Lee S, 2001, VIROLOGY, V283, P167, DOI 10.1006/viro.2001.0892; Mbarek H, 2011, HUM MOL GENET, V20, P3884, DOI 10.1093/hmg/ddr301; McGlynn KA, 2011, CLIN LIVER DIS, V15, P223, DOI 10.1016/j.cld.2011.03.006; Miki D, 2011, NAT GENET, V43, P797, DOI 10.1038/ng.876; Nakamura Yusuke, 2007, Clin Adv Hematol Oncol, V5, P696; Negro F, 2011, LIVER INT, V31, P1, DOI 10.1111/j.1478-3231.2011.02537.x; Ota M, 1997, TISSUE ANTIGENS, V49, P448, DOI 10.1111/j.1399-0039.1997.tb02778.x; Ou DP, 2007, INT J CANCER, V120, P1208, DOI 10.1002/ijc.22452; Rodriguez-Rodero S, 2007, EUR J IMMUNOL, V37, P1938, DOI 10.1002/eji.200737031; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Sun DH, 2011, CELL BIOL INT, V35, P569, DOI 10.1042/CBI20100431; Suske G, 1999, GENE, V238, P291, DOI 10.1016/S0378-1119(99)00357-1; Tanikawa C, 2012, NAT GENET, V44, P430, DOI 10.1038/ng.1109; Tse KP, 2011, HUM MOL GENET, V20, P2889, DOI 10.1093/hmg/ddr191; Umemura T, 2009, J GASTROENTEROL, V44, P102, DOI 10.1007/s00535-008-2251-0; Urabe Y, 2013, J HEPATOL; Venkataraman GM, 2007, J IMMUNOL, V178, P961, DOI 10.4049/jimmunol.178.2.961; Waldhauer I, 2008, CANCER RES, V68, P6368, DOI 10.1158/0008-5472.CAN-07-6768; Yu FL, 2005, J HEPATOL, V42, P520, DOI 10.1016/j.jhep.2004.11.031; Zhang C, 2009, CANCER IMMUNOL IMMUN, V58, P1275, DOI 10.1007/s00262-008-0645-8; Zhang HX, 2010, NAT GENET, V42, P755, DOI 10.1038/ng.638	38	48	50	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2013	8	4							e61279	10.1371/journal.pone.0061279	http://dx.doi.org/10.1371/journal.pone.0061279			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123JA	23593449	Green Published, Green Submitted, gold			2022-12-25	WOS:000317383200048
J	Wu, K; Liu, J; Tseng, SF; Gore, C; Ning, Z; Sharifi, N; Fazli, L; Gleave, M; Kapur, P; Xiao, G; Sun, X; Oz, OK; Min, W; Alexandrakis, G; Yang, CR; Hsieh, CL; Wu, HC; He, D; Xie, D; Hsieh, JT				Wu, K.; Liu, J.; Tseng, S-F; Gore, C.; Ning, Z.; Sharifi, N.; Fazli, L.; Gleave, M.; Kapur, P.; Xiao, G.; Sun, X.; Oz, O. K.; Min, W.; Alexandrakis, G.; Yang, C-R; Hsieh, C-L; Wu, H-C; He, D.; Xie, D.; Hsieh, J-T			The role of DAB2IP in androgen receptor activation during prostate cancer progression	ONCOGENE			English	Article						prostate cancer; DAB2IP; androgen receptor; Src; genomic pathway	ABERRANT PROMOTER METHYLATION; PROTEIN HDAB2IP GENE; SERINE 81 PHOSPHORYLATION; BREAST-CANCER; CELL-GROWTH; SH3 DOMAINS; TRANSCRIPTION; KINASE; TUMOR; LOCALIZATION	Altered androgen-receptor (AR) expression and/ or constitutively active AR are commonly associated with prostate cancer (PCa) progression. Targeting AR remains a focal point for designing new strategy of PCa therapy. Here, we have shown that DAB2IP, a novel tumor suppressor in PCa, can inhibit AR-mediated cell growth and gene activation in PCa cells via distinct mechanisms. DAB2IP inhibits the genomic pathway by preventing AR nuclear translocation or phosphorylation and suppresses the non-genomic pathway via its unique functional domain to inactivate c-Src. Also, DAB2IP is capable of suppressing AR activation in an androgen-independent manner. In addition, DAB2IP can inhibit several AR splice variants showing constitutive activity in PCa cells. In DAB2IP(-/-)mice, the prostate gland exhibits hyperplastic epithelia, in which AR becomes more active. Consistently, DAB2IP expression inversely correlates with AR activation status particularly in recurrent or metastatic PCa patients. Taken together, DAB2IP is a unique intrinsic AR modulator in normal cells, and likely can be further developed into a therapeutic agent for PCa.	[Wu, K.; Gore, C.; Hsieh, J-T] Univ Texas SW Med Ctr Dallas, Dept Urol, Dallas, TX 75390 USA; [Wu, K.; Ning, Z.; He, D.] Xi An Jiao Tong Univ, Affiliated Hosp 1, Sch Med, Dept Urol, Xian, Shaanxi, Peoples R China; [Liu, J.; Sun, X.; Oz, O. K.] Univ Texas SW Med Ctr Dallas, Dept Radiol, Dallas, TX 75390 USA; [Tseng, S-F; Alexandrakis, G.] Univ Texas Arlington, Dept Bioengn, Arlington, TX 76019 USA; [Sharifi, N.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Div Hematol Oncol, Dallas, TX 75390 USA; [Fazli, L.; Gleave, M.] Univ British Columbia, Vancouver Prostate Ctr, Vancouver, BC, Canada; [Kapur, P.] Univ Texas SW Med Ctr Dallas, Dept Pathol, Dallas, TX 75390 USA; [Xiao, G.] Univ Texas SW Med Ctr Dallas, Dept Clin Sci, Dallas, TX 75390 USA; [Min, W.] Yale Univ, Sch Med, Interdept Program Vasc Biol & Transplant, New Haven, CT USA; [Min, W.] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA; [Yang, C-R; Wu, H-C] China Med Univ Hosp, Dept Urol, Taichung, Taiwan; [Hsieh, C-L; Hsieh, J-T] China Med Univ Hosp, Grad Inst Canc Biol, Taichung, Taiwan; [Hsieh, C-L] China Med Univ Hosp, Ctr Mol Med, Taichung, Taiwan; [Hsieh, C-L] Asia Univ, Dept Biotechnol, Taichung, Taiwan; [Wu, H-C] China Med Univ, Sch Med, Taichung, Taiwan; [Xie, D.] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Canc Res Inst, Dept Gen Surg, Wuhan 430074, Hubei, Peoples R China	University of Texas System; University of Texas Southwestern Medical Center Dallas; Xi'an Jiaotong University; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Arlington; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of British Columbia; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Yale University; Yale University; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; Asia University Taiwan; China Medical University Taiwan; Huazhong University of Science & Technology	Hsieh, JT (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Urol, J8-134,5323 Harry Hines Blvd, Dallas, TX 75390 USA.	dxxie@tjh.tjmu.edu.cn; jt.hsieh@utsouthwestern.edu	Oz, Orhan/GVT-7264-2022	Gleave, Martin/0000-0003-4235-0167	United States Army [W81XWH-04-1-0222 (JTH)]; National Natural Science Foundation of China [NSFC 81202014]	United States Army(United States Department of DefenseUnited States Army); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	We thank Dr Jiang Min for editorial assistant and Rui Li for technical support. This work is supported in part by United States Army Grant W81XWH-04-1-0222 (JTH) and the National Natural Science Foundation of China (NSFC 81202014 to KW).	Araujo JC, 2012, CANCER-AM CANCER SOC, V118, P63, DOI 10.1002/cncr.26204; Brooke GN, 2009, CURR GENOMICS, V10, P18, DOI 10.2174/138920209787581307; Cai HJ, 2011, CANCER RES, V71, P862, DOI 10.1158/0008-5472.CAN-10-1605; Cao WH, 2000, J BIOL CHEM, V275, P38131, DOI 10.1074/jbc.C000592200; Chen H, 2005, J BIOL CHEM, V280, P22437, DOI 10.1074/jbc.M501379200; Chen H, 2003, J BIOL CHEM, V278, P3121, DOI 10.1074/jbc.M208230200; Chen SY, 2012, J BIOL CHEM, V287, P8571, DOI 10.1074/jbc.M111.325290; Craft N, 1999, NAT MED, V5, P280, DOI 10.1038/6495; Debes JD, 2004, NEW ENGL J MED, V351, P1488, DOI 10.1056/NEJMp048178; Dote H, 2004, CLIN CANCER RES, V10, P2082, DOI 10.1158/1078-0432.CCR-03-0236; Dote H, 2005, BRIT J CANCER, V92, P1117, DOI 10.1038/sj.bjc.6602458; Duggan D, 2007, JNCI-J NATL CANCER I, V99, P1836, DOI 10.1093/jnci/djm250; Feldman BJ, 2001, NAT REV CANCER, V1, P34, DOI 10.1038/35094009; Gioeli D, 2006, MOL ENDOCRINOL, V20, P503, DOI 10.1210/me.2005-0351; Gordon V, 2010, MOL ENDOCRINOL, V24, P2267, DOI 10.1210/me.2010-0238; Guo ZY, 2009, CANCER RES, V69, P2305, DOI 10.1158/0008-5472.CAN-08-3795; Harvey JM, 1999, J CLIN ONCOL, V17, P1474, DOI 10.1200/JCO.1999.17.5.1474; Heinlein CA, 2004, ENDOCR REV, V25, P276, DOI 10.1210/er.2002-0032; Hu R, 2009, CANCER RES, V69, P16, DOI 10.1158/0008-5472.CAN-08-2764; Huggins C, 1941, CANCER RES, V1, P293; Kesler CT, 2007, MOL ENDOCRINOL, V21, P2071, DOI 10.1210/me.2007-0240; Mayer BJ, 2001, J CELL SCI, V114, P1253; McKenna NJ, 1999, ENDOCR REV, V20, P321, DOI 10.1210/er.20.3.321; Min J, 2010, NAT MED, V16, P286, DOI 10.1038/nm.2100; Min W, 2008, CIRC RES, V102, P840, DOI 10.1161/CIRCRESAHA.107.168153; Qiu GH, 2007, J HEPATOL, V46, P655, DOI 10.1016/j.jhep.2006.11.012; Shang YF, 2002, MOL CELL, V9, P601, DOI 10.1016/S1097-2765(02)00471-9; Sun SH, 2010, J CLIN INVEST, V120, P2715, DOI 10.1172/JCI41824; Tatarov O, 2009, CLIN CANCER RES, V15, P3540, DOI 10.1158/1078-0432.CCR-08-1857; Verras M, 2004, CANCER RES, V64, P8860, DOI 10.1158/0008-5472.CAN-04-2370; Vidal M, 2001, CRIT REV ONCOL HEMAT, V40, P175, DOI 10.1016/S1040-8428(01)00142-1; VISAKORPI T, 1995, NAT GENET, V9, P401, DOI 10.1038/ng0495-401; Wang QB, 2005, MOL CELL, V19, P631, DOI 10.1016/j.molcel.2005.07.018; Wang QB, 2007, MOL CELL, V27, P380, DOI 10.1016/j.molcel.2007.05.041; Wang Z, 2002, J BIOL CHEM, V277, P12622, DOI 10.1074/jbc.M110568200; Watson PA, 2010, P NATL ACAD SCI USA, V107, P16759, DOI 10.1073/pnas.1012443107; Wen Y, 2000, CANCER RES, V60, P6841; Wright CD, 2008, CIRC RES, V103, P992, DOI 10.1161/CIRCRESAHA.108.176024; Xie DX, 2010, P NATL ACAD SCI USA, V107, P2485, DOI 10.1073/pnas.0908133107; Xie DX, 2009, P NATL ACAD SCI USA, V106, P19878, DOI 10.1073/pnas.0908458106; Yang CS, 2005, MOL CELL BIOL, V25, P1298, DOI 10.1128/MCB.25.4.1298-1308.2005; Yano M, 2005, INT J CANCER, V113, P59, DOI 10.1002/ijc.20531; Yu EY, 2009, CLIN CANCER RES, V15, P7421, DOI 10.1158/1078-0432.CCR-09-1691; Zhou XE, 2010, J BIOL CHEM, V285, P9161, DOI 10.1074/jbc.M109.085779	44	32	36	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 10	2014	33	15					1954	1963		10.1038/onc.2013.143	http://dx.doi.org/10.1038/onc.2013.143			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AE9RK	23604126				2022-12-25	WOS:000334346300008
J	Yu, M; Trobridge, P; Wang, Y; Kanngurn, S; Morris, SM; Knoblaugh, S; Grady, WM				Yu, M.; Trobridge, P.; Wang, Y.; Kanngurn, S.; Morris, S. M.; Knoblaugh, S.; Grady, W. M.			Inactivation of TGF-beta signaling and loss of PTEN cooperate to induce colon cancer in vivo	ONCOGENE			English	Article						colon cancer; transforming growth factor-beta; PTEN; p21(Cip1)	RECEPTOR-TYPE-II; COLORECTAL-CANCER; TUMOR-SUPPRESSOR; MICROSATELLITE INSTABILITY; CELL-PROLIFERATION; APC MUTATION; GROWTH; GENE; EXPRESSION; PATHWAY	The accumulation of genetic and epigenetic alterations mediates colorectal cancer (CRC) formation by deregulating key signaling pathways in cancer cells. In CRC, one of the most commonly inactivated signaling pathways is the transforming growth factor-beta (TGF-beta) signaling pathway, which is often inactivated by mutations of TGF-beta type II receptor (TGFBR2). Another commonly deregulated pathway in CRC is the phosphoinositide-3-kinase (PI3K)-AKT pathway. Phosphatase and tensin homolog deleted on chromosome 10 (PTEN) is an important negative regulator of PI3K-AKT signaling and is silenced in similar to B30% of CRC. The combination of TGFBR2 inactivation and loss of PTEN is particularly common in microsatellite-unstable CRCs. Consequently, we determined in vivo if deregulation of these two pathways cooperates to affect CRC formation by analyzing tumors arising in mice that lack Tgfbr2 and/or Pten specifically in the intestinal epithelium. We found that lack of Tgfbr2 (Tgfbr2(IEKO)) alone is not sufficient for intestinal tumor formation and lack of Pten (Pten(IEKO)) alone had a weak effect on intestinal tumor induction. However, the combination of Tgfbr2 inactivation with Pten loss (Pten(IEKO); Tgfbr(2IEKO)) led to malignant tumors in both the small intestine and colon in 86% of the mice and to metastases in 8% of the tumor-bearing mice. Moreover, these tumors arose via a beta-catenin-independent mechanism. Inactivation of TGF-beta signaling and loss of Pten in the tumors led to increased cell proliferation, decreased apoptosis and decreased expression of cyclin-dependent kinase inhibitors. Thus, inactivation of TGF-beta signaling and loss of PTEN cooperate to drive intestinal cancer formation and progression by suppressing cell cycle inhibitors.	[Yu, M.; Trobridge, P.; Kanngurn, S.; Morris, S. M.; Grady, W. M.] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98109 USA; [Wang, Y.] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; [Wang, Y.; Grady, W. M.] Univ Washington, Sch Med, Dept Med, Seattle, WA 98195 USA; [Kanngurn, S.] Prince Songkla Univ, Dept Pathol, Hat Yai, Thailand; [Knoblaugh, S.] Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Prince of Songkla University; Fred Hutchinson Cancer Center	Grady, WM (corresponding author), Fred Hutchinson Canc Res Ctr, Div Clin Res, 1100 Fairview Ave North,Mailstop D4-100, Seattle, WA 98109 USA.	wgrady@fhcrc.org			NIH [RO1CA115513, P30CA15704, UO1CA152756, U54CA143862, P01CA077852]; Burroughs Wellcome Fund Translational Research Award for Clinician Scientist (WMG); Interdisciplinary Training in Cancer Research Grant [T32 CA080416]; NATIONAL CANCER INSTITUTE [P30CA015704, U54CA143862, U01CA152756, T32CA080416, P01CA077852, R01CA115513] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund Translational Research Award for Clinician Scientist (WMG); Interdisciplinary Training in Cancer Research Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Support for these studies was provided by the NIH (RO1CA115513, P30CA15704, UO1CA152756, U54CA143862, and P01CA077852 WMG), a Burroughs Wellcome Fund Translational Research Award for Clinician Scientist (WMG), and an Interdisciplinary Training in Cancer Research Grant (T32 CA080416 SMM).	Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; Akhurst RJ, 2001, TRENDS CELL BIOL, V11, pS44, DOI 10.1016/S0962-8924(01)82259-5; Alimonti A, 2010, J CLIN INVEST, V120, P681, DOI 10.1172/JCI40535; Bakin AV, 2000, J BIOL CHEM, V275, P36803, DOI 10.1074/jbc.M005912200; Bauer J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039381; Bierie B, 2006, NAT REV CANCER, V6, P506, DOI 10.1038/nrc1926; Biswas S, 2004, CANCER RES, V64, P4687, DOI 10.1158/0008-5472.CAN-03-3255; Byun DS, 2011, AM J PHYSIOL-GASTR L, V301, pG856, DOI 10.1152/ajpgi.00178.2011; Chen CN, 2005, J CLIN ONCOL, V23, P7286, DOI 10.1200/JCO.2004.00.2253; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Chittenden TW, 2008, GENOMICS, V91, P508, DOI 10.1016/j.ygeno.2008.03.002; Chu IM, 2008, NAT REV CANCER, V8, P253, DOI 10.1038/nrc2347; Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a; DATTO MB, 1995, J BIOL CHEM, V270, P28623, DOI 10.1074/jbc.270.48.28623; Di Cristofano A, 2000, CELL, V100, P387, DOI 10.1016/S0092-8674(00)80674-1; Engelman JA, 2009, NAT REV CANCER, V9, P550, DOI 10.1038/nrc2664; Fearon ER., ANN REV PATHOL, V6, P479; Glick AB, 1996, CANCER RES, V56, P3645; Gomes LR, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-26; Grady WM, 2008, GASTROENTEROLOGY, V135, P1079, DOI 10.1053/j.gastro.2008.07.076; Grady William M., 2008, P889; Grady WM, 1998, CANCER RES, V58, P3101; Grady WM, 2006, INT J CANCER, V118, P600, DOI 10.1002/ijc.21399; Grady WM, 1999, CANCER RES, V59, P320; He XC, 2004, NAT GENET, V36, P1117, DOI 10.1038/ng1430; Ise K, 2000, ONCOGENE, V19, P2951, DOI 10.1038/sj.onc.1203600; Jaiswal BS, 2009, CANCER CELL, V16, P463, DOI 10.1016/j.ccr.2009.10.016; Jass JR, 2007, HISTOPATHOLOGY, V50, P113, DOI 10.1111/j.1365-2559.2006.02549.x; Jung B, 2004, GASTROENTEROLOGY, V126, P654, DOI 10.1053/j.gastro.2004.01.008; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Langlois MJ, 2009, FASEB J, V23, P1835, DOI 10.1096/fj.08-123125; Lee MH, 2001, CELL MOL LIFE SCI, V58, P1907, DOI 10.1007/PL00000826; Lesche R, 2002, GENESIS, V32, P148, DOI 10.1002/gene.10036; LEVY DB, 1994, CANCER RES, V54, P5953; Leystra AA, 2012, CANCER RES, V72, P2931, DOI 10.1158/0008-5472.CAN-11-4097; Liang J, 2002, NAT MED, V8, P1153, DOI 10.1038/nm761; Liu PX, 2009, NAT REV DRUG DISCOV, V8, P627, DOI 10.1038/nrd2926; Liu XQ, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.221697; Luo J, 2003, CANCER CELL, V4, P257, DOI 10.1016/S1535-6108(03)00248-4; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Majumder PK, 2008, CANCER CELL, V14, P146, DOI 10.1016/j.ccr.2008.06.002; Marsh V, 2008, NAT GENET, V40, P1436, DOI 10.1038/ng.256; Massague J, 2000, CELL, V103, P295, DOI 10.1016/S0092-8674(00)00121-5; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; MOSES HL, 1990, CELL, V63, P245, DOI 10.1016/0092-8674(90)90155-8; Muncan V, 2006, MOL CELL BIOL, V26, P8418, DOI 10.1128/MCB.00821-06; Munoz NM, 2006, CANCER RES, V66, P9837, DOI 10.1158/0008-5472.CAN-06-0890; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Naguib A, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-123; Panopoulou E, 2005, CANCER RES, V65, P1877, DOI 10.1158/0008-5472.CAN-04-2828; Parsons DW, 2005, NATURE, V436, P792, DOI 10.1038/436792a; Philp AJ, 2001, CANCER RES, V61, P7426; Pritchard CC, 2011, GUT, V60, P116, DOI 10.1136/gut.2009.206250; Roy HK, 2002, CARCINOGENESIS, V23, P201, DOI 10.1093/carcin/23.1.201; Samowitz WS, 1999, CANCER RES, V59, P1442; Shen WH, 2007, CELL, V128, P157, DOI 10.1016/j.cell.2006.11.042; Shin I, 2001, MOL BIOL CELL, V12, P3328, DOI 10.1091/mbc.12.11.3328; Shin KH, 2001, CANCER LETT, V174, P189, DOI 10.1016/S0304-3835(01)00691-7; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Song MS, 2012, NAT REV MOL CELL BIO, V13, P283, DOI 10.1038/nrm3330; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; SU LK, 1992, SCIENCE, V256, P668, DOI 10.1126/science.1350108; Trobridge P, 2009, GASTROENTEROLOGY, V136, P1680, DOI 10.1053/j.gastro.2009.01.066; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901; Wielenga VJM, 1999, AM J PATHOL, V154, P515, DOI 10.1016/S0002-9440(10)65297-2; Yilmaz M, 2010, MOL CANCER RES, V8, P629, DOI 10.1158/1541-7786.MCR-10-0139; Young LC, 2008, BRIT J DERMATOL, V158, P59, DOI 10.1111/j.1365-2133.2007.08249.x; Zhou XP, 2002, AM J PATHOL, V161, P439, DOI 10.1016/S0002-9440(10)64200-9	69	57	58	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 20	2014	33	12					1538	1547		10.1038/onc.2013.102	http://dx.doi.org/10.1038/onc.2013.102			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AD4TS	23604118	Green Accepted			2022-12-25	WOS:000333244200007
J	Ma, B; Zhong, LL; van Blitterswijk, CA; Post, JN; Karperien, M				Ma, Bin; Zhong, Leilei; van Blitterswijk, Clemens A.; Post, Janine N.; Karperien, Marcel			T Cell Factor 4 Is a Pro-catabolic and Apoptotic Factor in Human Articular Chondrocytes by Potentiating Nuclear Factor kappa B Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MATRIX-METALLOPROTEINASE 13; GENE-EXPRESSION; TRANSCRIPTION; ACTIVATION; KINASE; PHENOTYPE; CARTILAGE; PROMOTER; COLLAGEN; DOMAIN	T cell factor/lymphoid enhancer factor (TCF/LEF) transcription factors are downstream effectors of Wnt/beta-catenin signaling, which has been implicated in the development and progression of osteoarthritis (OA). This study aimed to investigate the role of TCF/LEF transcription factors in human articular chondrocytes. Primary human osteoarthritic cartilage predominantly expressed TCF4 and to a lesser extent, LEF1 and TCF3 mRNA. Overexpression of TCF4, but not of TCF3 or LEF1, induced MMP-1, -3, and -13 expression and generic MMP activity in human chondrocytes. This was due to potentiating NF-kappa B signaling by a protein-protein interaction between TCF4 and NF-kappa B p65 activating established NF-kappa B target genes such as MMPs and IL-6. LEF1 competed with TCF4 for binding to NF-kappa B p65. I kappa B-alpha was able to counteract the effect of TCF4 on NF-kappa B target gene expression. Finally, we showed that TCF4 mRNA expression was elevated in OA cartilage compared with healthy cartilage and induced chondrocyte apoptosis at least partly through activating caspase 3/7. Our findings suggest that increased TCF4 expression may contribute to cartilage degeneration in OA by augmenting NF-kappa B signaling.	[Ma, Bin; Zhong, Leilei; Post, Janine N.; Karperien, Marcel] Univ Twente, Dept Dev BioEngn, NL-7522 NB Enschede, Netherlands; [van Blitterswijk, Clemens A.] Univ Twente, Dept Tissue Regenerat, NL-7522 NB Enschede, Netherlands	University of Twente; University of Twente	Karperien, M (corresponding author), Univ Twente, Dept Dev BioEngn, Drienerlolaan 5, NL-7522 NB Enschede, Netherlands.	b.j.karperien@utwente.nl	Ma, Bin/B-4239-2015; Post, Janine N./E-9983-2011; Karperien, Marcel/R-3270-2018	Ma, Bin/0000-0001-5744-9667; Post, Janine N./0000-0002-6645-6583; Karperien, Marcel/0000-0003-0751-0604; van Blitterswijk, Clemens/0000-0003-2371-4615	BioMedical Materials Institute [P2.02]; Dutch Ministry of Economic Affairs, Agriculture, and Innovation	BioMedical Materials Institute; Dutch Ministry of Economic Affairs, Agriculture, and Innovation	This work was supported by the Project P2.02 OAcontrol of the research program of the BioMedical Materials Institute, co-funded by the Dutch Ministry of Economic Affairs, Agriculture, and Innovation.	Billinghurst RC, 1997, J CLIN INVEST, V99, P1534, DOI 10.1172/JCI119316; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Furia B, 2002, J BIOL CHEM, V277, P4973, DOI 10.1074/jbc.M107848200; Hayashida M, 2009, ARTHRITIS RHEUM-US, V60, P708, DOI 10.1002/art.24332; Hecht A, 2003, J BIOL CHEM, V278, P3776, DOI 10.1074/jbc.M210081200; HISCOTT J, 1993, MOL CELL BIOL, V13, P6231, DOI 10.1128/MCB.13.10.6231; Hovanes K, 2001, NAT GENET, V28, P53, DOI 10.1038/88264; Huang H, 2008, CURR OPIN CELL BIOL, V20, P119, DOI 10.1016/j.ceb.2008.01.009; Hurlstone A, 2002, EMBO J, V21, P2303, DOI 10.1093/emboj/21.10.2303; Hwang SG, 2004, J BIOL CHEM, V279, P26597, DOI 10.1074/jbc.M401401200; Ishiguro N, 1999, ARTHRITIS RHEUM, V42, P129, DOI 10.1002/1529-0131(199901)42:1<129::AID-ANR16>3.0.CO;2-4; Kim SJ, 2003, BIOCHEM BIOPH RES CO, V303, P206, DOI 10.1016/S0006-291X(03)00305-X; Kim SJ, 2002, J BIOL CHEM, V277, P33501, DOI 10.1074/jbc.M202862200; Kuhn K, 2001, ARTHRITIS RHEUM-US, V44, P1644, DOI 10.1002/1529-0131(200107)44:7<1644::AID-ART287>3.0.CO;2-S; Lark MW, 1997, J CLIN INVEST, V100, P93, DOI 10.1172/JCI119526; Liacini A, 2002, MATRIX BIOL, V21, P251, DOI 10.1016/S0945-053X(02)00007-0; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Ma B, 2012, ARTHRITIS RHEUM-US, V64, P2589, DOI 10.1002/art.34425; Marr RA, 2004, J MOL NEUROSCI, V22, P5, DOI 10.1385/JMN:22:1-2:5; Mengshol JA, 2000, ARTHRITIS RHEUM, V43, P801, DOI 10.1002/1529-0131(200004)43:4<801::AID-ANR10>3.0.CO;2-4; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Nalesso G, 2011, J CELL BIOL, V193, P551, DOI 10.1083/jcb.201011051; Raymond L, 2007, OSTEOARTHR CARTILAGE, V15, P431, DOI 10.1016/j.joca.2006.09.011; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Valenta T, 2003, NUCLEIC ACIDS RES, V31, P2369, DOI 10.1093/nar/gkg346; Vanden Berghe W, 1999, J BIOL CHEM, V274, P32091, DOI 10.1074/jbc.274.45.32091; Wan FY, 2007, CELL, V131, P927, DOI 10.1016/j.cell.2007.10.009; Wan FY, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000067; Yuasa T, 2008, LAB INVEST, V88, P264, DOI 10.1038/labinvest.3700747; Yun K, 2007, BIOCHEM BIOPH RES CO, V364, P1009, DOI 10.1016/j.bbrc.2007.10.121; Yun K, 2007, BIOCHEM BIOPH RES CO, V357, P589, DOI 10.1016/j.bbrc.2007.03.170; Yun K, 2009, J IMMUNOL, V183, P5129, DOI 10.4049/jimmunol.0802744; Zhu M, 2009, J BONE MINER RES, V24, P12, DOI 10.1359/JBMR.080901	34	47	52	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2013	288	24					17552	17558		10.1074/jbc.M113.453985	http://dx.doi.org/10.1074/jbc.M113.453985			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	164AH	23603903	Green Published, hybrid			2022-12-25	WOS:000320380600046
J	Bianchin, MM; Velasco, TR; Coimbra, ER; Gargaro, AC; Escorsi-Rosset, SR; Wichert-Ana, L; Terra, VC; Alexandre, V; Araujo, D; dos Santos, AC; Fernandes, RMF; Assirati, JA; Carlotti, CG; Leite, JP; Takayanagui, OM; Markowitsch, HJ; Sakamoto, AC				Bianchin, Marino M.; Velasco, Tonicarlo R.; Coimbra, Erica R.; Gargaro, Ana C.; Escorsi-Rosset, Sara R.; Wichert-Ana, Lauro; Terra, Vera C.; Alexandre, Veriano, Jr.; Araujo, David, Jr.; dos Santos, Antonio Carlos; Fernandes, Regina M. F.; Assirati, Joao A., Jr.; Carlotti, Carlos G., Jr.; Leite, Joao P.; Takayanagui, Osvaldo M.; Markowitsch, Hans J.; Sakamoto, Americo C.			Cognitive and Surgical Outcome in Mesial Temporal Lobe Epilepsy Associated with Hippocampal Sclerosis Plus Neurocysticercosis: A Cohort Study	PLOS ONE			English	Article							DUAL PATHOLOGY; CALCIFIED NEUROCYSTICERCOSIS; PERILESIONAL GLIOSIS; LESIONS; SURGERY; IMPAIRMENT; BRAZIL; MANIFESTATIONS; PERFORMANCE; DEMENTIA	Background: Where neurocysticercosis (NCC) is endemic, chronic calcified neurocysticercosis (cNCC) can be observed in patients with mesial temporal lobe epilepsy associated with hippocampal sclerosis (MTLE-HS). Considering that both disorders cause recurrent seizures or cognitive impairment, we evaluated if temporal lobectomy is cognitively safe and effective for seizure control in MTLE-HS plus cNCC. Methods: Retrospective cohort study of neuropsychological profile and surgical outcome of 324 MTLE-HS patients submitted to temporal lobectomy, comparing the results according to the presence or absence of cNCC. Findings: cNCC occurred in 126 (38.9%) of our MTLE-HS patients, a frequency higher than expected, more frequently in women than in men (O.R. = 1.66; 95% C. I. = 1.05-2.61; p = 0.03). Left-side (but not right side) surgery caused impairment in selected neuropsychological tests, but this impairment was not accentuated by the presence of cNCC. Ninety-four (74.6%) patients with MTLE-HS plus cNCC and 153 patients (77.3%) with MTLE-HS alone were Engel class I after surgery (O.R. = 1.16; 95% C. I. = 0.69-1.95; p = 0.58). However, the chances of Engel class IA were significantly lower in MTLE-HS plus cNCC than in patients with MTLE-HS alone (31.7% versus 48.5%; O.R. = 2.02; 95% C. I. = 1.27-3.23; p = 0.003). Patients with MTLE-HS plus cNCC showed higher rates of Engel class ID (15.1% versus 6.6%; O.R. = 2.50; 95% C. I. = 1.20-5.32; p = 0.012). Interpretation: cNCC can be highly prevalent among MTLE-HS patients living in areas where neurocysticercosis is endemic, suggesting a cause-effect relationship between the two diseases. cNCC does not add further risk for cognitive decline after surgery in MTLE-HS patients. The rates of Engel class I outcome were very similar for the two groups; however, MTLE-HS plus cNCC patients achieved Engel IA status less frequently, and Engel ID status more frequently. Temporal lobectomy can be safely performed in most patients with MTLE-HS plus cNCC without affecting cognitive outcome. Long-term surgical seizure control in MTLE-HS plus cNCC is still satisfactory, as long as selected patients remain under medication.	[Bianchin, Marino M.; Velasco, Tonicarlo R.; Coimbra, Erica R.; Gargaro, Ana C.; Escorsi-Rosset, Sara R.; Wichert-Ana, Lauro; Terra, Vera C.; Alexandre, Veriano, Jr.; Sakamoto, Americo C.] Univ Sao Paulo, Ctr Epilepsy Surg CIREP, Hosp Clin Ribeirao Preto, Dept Neurol,Ribeirao Preto Sch Med, Sao Paulo, Brazil; [Bianchin, Marino M.] Univ Fed Rio Grande do Sul, Div Neurol, Hosp Clin Porto Alegre, Porto Alegre, RS, Brazil; [Araujo, David, Jr.; dos Santos, Antonio Carlos] Univ Sao Paulo, Dept Radiol, Ribeirao Preto Sch Med, Sao Paulo, Brazil; [Fernandes, Regina M. F.; Leite, Joao P.; Takayanagui, Osvaldo M.; Sakamoto, Americo C.] Univ Sao Paulo, Dept Neurosci & Behav, Ribeirao Preto Sch Med, Sao Paulo, Brazil; [Assirati, Joao A., Jr.; Carlotti, Carlos G., Jr.] Univ Sao Paulo Ribeirao Preto, Dept Surg & Anat, Ribeirao Preto Sch Med, Neurosurg Div, Sao Paulo, Brazil; [Markowitsch, Hans J.] Univ Bielefeld, Arbeitseinheit Physiol Psychol, D-33615 Bielefeld, Germany	Universidade de Sao Paulo; Universidade Federal do Rio Grande do Sul; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; University of Bielefeld	Bianchin, MM (corresponding author), Univ Sao Paulo, Ctr Epilepsy Surg CIREP, Hosp Clin Ribeirao Preto, Dept Neurol,Ribeirao Preto Sch Med, Sao Paulo, Brazil.	mmbianchin@hotmail.com	Bianchin, Marino/V-5956-2019; Velasco, Tonicarlo R/Q-2170-2016; Takayanagui, Osvaldo M/C-8159-2013; Leite, Joao/B-9070-2012; Wichert-Ana, Lauro/C-8373-2012; Sakamoto, Americo C/H-5311-2012; Carlotti, Carlos G/C-1608-2012	Velasco, Tonicarlo R/0000-0001-7756-8882; Takayanagui, Osvaldo M/0000-0002-8190-0275; Leite, Joao/0000-0003-0558-3519; Wichert-Ana, Lauro/0000-0003-2059-5120; Carlotti, Carlos G/0000-0002-7055-0564; Terra, Vera/0000-0002-4246-970X	Brazilian Government research grant agency FAPESP/CINAPCE; Brazilian Government research grant agency CNPq [306644/2010-0, 483108/2010-3]; Brazilian Government research grant agency FAPERGS/CNPq/PRONEM	Brazilian Government research grant agency FAPESP/CINAPCE; Brazilian Government research grant agency CNPq; Brazilian Government research grant agency FAPERGS/CNPq/PRONEM	This study was fully supported by Brazilian Government research grant agencies FAPESP/CINAPCE (http://www.fapesp.br), CNPq (http://www.cnpq.br) grants #306644/2010-0 and #483108/2010-3, and FAPERGS/CNPq/PRONEM (http://www.fapergs.rs.gov.br). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agapejev S, 2003, ARQ NEURO-PSIQUIAT, V61, P822, DOI 10.1590/S0004-282X2003000500022; Agapejev Svetlana, 1996, Revista do Instituto de Medicina Tropical de Sao Paulo, V38, P207, DOI 10.1590/S0036-46651996000300008; Bianchin MM, 2010, NEUROLOGY, V75, P1028, DOI 10.1212/WNL.0b013e3181f00328; Bianchin MM, 2010, EPILEPSIA, V51, P2359, DOI 10.1111/j.1528-1167.2010.02735.x; Bianchin MM, 2012, PATHOG GLOB HEALTH, V106, P280, DOI 10.1179/2047773212Y.0000000027; Bianchin MM, 2006, LANCET NEUROL, V5, P20, DOI 10.1016/S1474-4422(05)70269-6; Bigel MG, 2001, EPILEPSY BEHAV, V2, P37, DOI 10.1006/ebeh.2000.0146; Boppre MCP, 2001, EPILEPSY BEHAV, V2, P558, DOI 10.1006/ebeh.2001.0270; Carabin H, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001152; CASCINO GD, 1993, EPILEPSY RES, V14, P175, DOI 10.1016/0920-1211(93)90022-Y; Chimelli L, 1998, ARQ NEURO-PSIQUIAT, V56, P577, DOI 10.1590/S0004-282X1998000400010; Coyle CM, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001500; Croker C, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001480; de Andrade DC, 2010, NEUROLOGY, V74, P1288, DOI 10.1212/WNL.0b013e3181d9eda6; de Boer HM, 2008, EPILEPSY BEHAV, V12, P540, DOI 10.1016/j.yebeh.2007.12.019; Del Brutto OH, 2001, NEUROLOGY, V57, P177, DOI 10.1212/WNL.57.2.177; Del Brutto OH, 2012, SCI WORLD J, DOI 10.1100/2012/159821; Engel J, 2001, NEUROSCIENTIST, V7, P340, DOI 10.1177/107385840100700410; Engel J, 2012, JAMA-J AM MED ASSOC, V307, P922, DOI 10.1001/jama.2012.220; Forlenza OV, 1997, J NEUROL NEUROSUR PS, V62, P612, DOI 10.1136/jnnp.62.6.612; Gupta RK, 1999, LANCET, V354, P44, DOI 10.1016/S0140-6736(99)00881-8; HAUSER WA, 1998, EPILEPSY COMPREHENSI, P47; Helmstaedter C, 2003, ANN NEUROL, V54, P425, DOI 10.1002/ana.10692; Helmstaedter C, 2004, EPILEPSY BEHAV, V5, pS45, DOI 10.1016/j.yebeh.2003.11.006; Ives-Deliperi VL, 2012, EPILEPSY BEHAV, V24, P194, DOI 10.1016/j.yebeh.2012.04.115; Leite JP, 2000, NEUROLOGY, V55, P1485, DOI 10.1212/WNL.55.10.1485; LEVESQUE MF, 1991, J NEUROSURG, V75, P364, DOI 10.3171/jns.1991.75.3.0364; Li LM, 1999, BRAIN, V122, P799, DOI 10.1093/brain/122.5.799; Martin R, 1999, NEUROLOGY, V53, P709, DOI 10.1212/WNL.53.4.709; Nash TE, 2004, NEUROLOGY, V62, P1934, DOI 10.1212/01.WNL.0000129481.12067.06; Nash TE, 2011, NAT REV NEUROL, V7, P584, DOI 10.1038/nrneurol.2011.135; Ngugi AK, 2011, NEUROLOGY, V77, P1005, DOI 10.1212/WNL.0b013e31822cfc90; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; Pradhan S, 2000, ANN NEUROL, V48, P181, DOI 10.1002/1531-8249(200008)48:2&lt;181::AID-ANA7&gt;3.0.CO;2-C; RANGEL R, 1987, AM J TROP MED HYG, V36, P387, DOI 10.4269/ajtmh.1987.36.387; Rathore C, 2012, EPILEPSIA, V53, pe60, DOI 10.1111/j.1528-1167.2011.03386.x; Rodrigues CL, 2012, NEUROLOGY, V78, P861, DOI 10.1212/WNL.0b013e31824c46d1; Serpa JA, 2011, MEDICINE, V90, P81, DOI 10.1097/MD.0b013e318206d13e; Spencer S, 2008, LANCET NEUROL, V7, P525, DOI 10.1016/S1474-4422(08)70109-1; Stern Y, 2009, NEUROPSYCHOLOGIA, V47, P2015, DOI 10.1016/j.neuropsychologia.2009.03.004; Terra-Bustamante VC, 2005, J NEUROL NEUROSUR PS, V76, P1080, DOI 10.1136/jnnp.2004.048934; Velasco TR, 2006, J NEUROL NEUROSUR PS, V77, P485, DOI 10.1136/jnnp.2005.078675; Wallin MT, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001493; Wehner T, 2011, PEDIATR NEUROL, V44, P52, DOI 10.1016/j.pediatrneurol.2010.07.003; Wichert-Ana L, 2004, ARCH NEUROL-CHICAGO, V61, P1117, DOI 10.1001/archneur.61.7.1117; Wiebe S, 2001, NEW ENGL J MED, V345, P311, DOI 10.1056/NEJM200108023450501	46	23	23	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2013	8	4							e60949	10.1371/journal.pone.0060949	http://dx.doi.org/10.1371/journal.pone.0060949			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JR	23613762	Green Submitted, gold, Green Published			2022-12-25	WOS:000317911500010
J	Kundu, M; Kuzin, A; Lin, TY; Lee, CH; Brody, T; Odenwald, WF				Kundu, Mukta; Kuzin, Alexander; Lin, Tzu-Yang; Lee, Chi-Hon; Brody, Thomas; Odenwald, Ward F.			cis-Regulatory Complexity within a Large Non-Coding Region in the Drosophila Genome	PLOS ONE			English	Article							CONSERVED SEQUENCE BLOCK; TRANSCRIPTION FACTOR; DEVELOPMENTAL ENHANCERS; EXPRESSION; POU; VERTEBRATE; DNA; SPECIFICATION; BINDING; IDENTIFICATION	Analysis of cis-regulatory enhancers has revealed that they consist of clustered blocks of highly conserved sequences. Although most characterized enhancers reside near their target genes, a growing number of studies have shown that enhancers located over 50 kb from their minimal promoter(s) are required for appropriate gene expression and many of these 'long-range' enhancers are found in genomic regions that are devoid of identified exons. To gain insight into the complexity of Drosophila cis-regulatory sequences within exon-poor regions, we have undertaken an evolutionary analysis of 39 of these regions located throughout the genome. This survey revealed that within these genomic expanses, clusters of conserved sequence blocks (CSBs) are positioned once every 1.1 kb, on average, and that a typical cluster contains multiple (5 to 30 or more) CSBs that have been maintained for at least 190 My of evolutionary divergence. As an initial step toward assessing the cis-regulatory activity of conserved clusters within gene-free genomic expanses, we have tested the in-vivo enhancer activity of 19 consecutive CSB clusters located in the middle of a 115 kb gene-poor region on the 3 rd chromosome. Our studies revealed that each cluster functions independently as a specific spatial/temporal enhancer. In total, the enhancers possess a diversity of regulatory functions, including dynamically activating expression in defined patterns within subsets of cells in discrete regions of the embryo, larvae and/or adult. We also observed that many of the enhancers are multifunctional-that is, they activate expression during multiple developmental stages. By extending these results to the rest of the Drosophila genome, which contains over 70,000 non-coding CSB clusters, we suggest that most function as enhancers.	[Kundu, Mukta; Kuzin, Alexander; Brody, Thomas; Odenwald, Ward F.] NINDS, Neural Cell Fate Determinants Sect, NIH, Bethesda, MD 20892 USA; [Lin, Tzu-Yang; Lee, Chi-Hon] NICHHD, Sect Neuronal Connect, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Brody, T (corresponding author), NINDS, Neural Cell Fate Determinants Sect, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA.	brodyt@ninds.nih.gov; odenwaldw@ninds.nih.gov	Lin, Tzu-Yang/U-6553-2018	Lin, Tzu-Yang/0000-0002-1968-177X; Lee, Chi-Hon/0000-0002-6138-711X	National Institutes of Health (NIH), US government; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008776, ZIAHD008913] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS009413, ZIANS002820] Funding Source: NIH RePORTER	National Institutes of Health (NIH), US government(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health (NIH), US government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON MG, 1995, GENE DEV, V9, P123, DOI 10.1101/gad.9.1.123; Bachmann Andre, 2008, V420, P61, DOI 10.1007/978-1-59745-583-1_4; Bejerano G, 2005, NAT METHODS, V2, P535, DOI 10.1038/nmeth0705-535; Brody T, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r75; Brody T, 2012, DEV DYNAM, V241, P169, DOI 10.1002/dvdy.22728; Campos-Ortega J.A., 2013, EMBRYONIC DEV DROSOP; Certel K, 2000, DEVELOPMENT, V127, P3173; Certel SJ, 2004, DEVELOPMENT, V131, P5429, DOI 10.1242/dev.01418; Chen ML, 2001, EUR J IMMUNOL, V31, P1696, DOI 10.1002/1521-4141(200106)31:6<1696::AID-IMMU1696>3.3.CO;2-E; de la Calle-Mustienes E, 2005, GENOME RES, V15, P1061, DOI 10.1101/gr.4004805; Evans NC, 2012, CURR TOP DEV BIOL, V98, P97, DOI 10.1016/B978-0-12-386499-4.00004-5; Frankel N, 2010, NATURE, V466, P490, DOI 10.1038/nature09158; Fujioka M, 1999, DEVELOPMENT, V126, P2527; Fujioka M, 2012, DEV BIOL, V362, P309, DOI 10.1016/j.ydbio.2011.12.001; Gao SY, 2008, NEURON, V60, P328, DOI 10.1016/j.neuron.2008.08.010; Groth AC, 2004, GENETICS, V166, P1775, DOI 10.1534/genetics.166.4.1775; Hardison RC, 2000, TRENDS GENET, V16, P369, DOI 10.1016/S0168-9525(00)02081-3; HARTENSTEIN V, 1984, ROUX ARCH DEV BIOL, V193, P308, DOI 10.1007/BF00848159; Hasegawa E, 2011, DEVELOPMENT, V138, P983, DOI 10.1242/dev.058370; Hirono K, 2012, GENE EXPR PATTERNS, V12, P11, DOI 10.1016/j.gep.2011.10.001; Ho MCW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016283; Inbal A, 2003, DEVELOPMENT, V130, P2467, DOI 10.1242/dev.00475; JACK J, 1991, DEVELOPMENT, V113, P735; Jareborg N, 1999, GENOME RES, V9, P815, DOI 10.1101/gr.9.9.815; Ji YB, 2006, GENETICS, V172, P1621, DOI 10.1534/genetics.105.045641; Kambadur R, 1998, GENE DEV, V12, P246, DOI 10.1101/gad.12.2.246; Komiyama T, 2003, CELL, V112, P157, DOI 10.1016/S0092-8674(03)00030-8; Komiyama T, 2007, CELL, V128, P399, DOI 10.1016/j.cell.2006.12.028; Kuo CL, 1998, P NATL ACAD SCI USA, V95, P3839, DOI 10.1073/pnas.95.7.3839; Kuzin A, 2012, GENE EXPR PATTERNS, V12, P261, DOI 10.1016/j.gep.2012.05.004; Kuzin A, 2011, MECH DEVELOP, V128, P165, DOI 10.1016/j.mod.2011.02.001; Kuzin A, 2009, GENE EXPR PATTERNS, V9, P65, DOI 10.1016/j.gep.2008.10.005; Kvon EZ, 2012, GENE DEV, V26, P908, DOI 10.1101/gad.188052.112; Kwon D, 2009, DEVELOPMENT, V136, P3067, DOI 10.1242/dev.036426; Lai EC, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-r42; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Liu F, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002796; Loots G, 2007, BIOINFORMATICS, V23, P122, DOI 10.1093/bioinformatics/btl546; Luo JN, 2012, CELL MOL LIFE SCI, V69, P471, DOI 10.1007/s00018-011-0789-0; Maeso I, 2012, GENOME RES, V22, P642, DOI 10.1101/gr.132233.111; Markstein M, 2008, NAT GENET, V40, P476, DOI 10.1038/ng.101; Meier S, 2006, MECH DEVELOP, V123, P76, DOI 10.1016/j.mod.2005.09.004; Miele L, 2011, P NATL ACAD SCI USA, V108, P14715, DOI 10.1073/pnas.1110570108; Miller SW, 2009, DEV BIOL, V329, P386, DOI 10.1016/j.ydbio.2009.02.009; Nobrega MA, 2003, SCIENCE, V302, P413, DOI 10.1126/science.1088328; Odenwald WF, 2005, P NATL ACAD SCI USA, V102, P14700, DOI 10.1073/pnas.0506915102; Ovcharenko I, 2005, GENOME RES, V15, P137, DOI 10.1101/gr.3015505; Panne D, 2008, CURR OPIN STRUC BIOL, V18, P236, DOI 10.1016/j.sbi.2007.12.002; Papatsenko D, 2009, NUCLEIC ACIDS RES, V37, P5665, DOI 10.1093/nar/gkp619; PATEL NH, 1994, METHOD CELL BIOL, V44, P445, DOI 10.1016/S0091-679X(08)60927-9; Pennacchio LA, 2006, NATURE, V444, P499, DOI 10.1038/nature05295; Perry MW, 2011, P NATL ACAD SCI USA, V108, P13570, DOI 10.1073/pnas.1109873108; Pfeiffer BD, 2008, P NATL ACAD SCI USA, V105, P9715, DOI 10.1073/pnas.0803697105; Rebeiz M, 2011, P NATL ACAD SCI USA, V108, P10036, DOI 10.1073/pnas.1105937108; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Sotillos S, 2010, DEV BIOL, V340, P571, DOI 10.1016/j.ydbio.2010.02.015; Spitz F, 2012, NAT REV GENET, V13, P613, DOI 10.1038/nrg3207; Thomas S, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-r43; Yavatkar AS, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-106	59	5	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2013	8	4							e60137	10.1371/journal.pone.0060137	http://dx.doi.org/10.1371/journal.pone.0060137			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JR	23613719	gold, Green Submitted, Green Published			2022-12-25	WOS:000317911500006
J	Northington, RM; Webster, JR; Benfield, EF; Cheever, BM; Niederlehner, BR				Northington, Robert M.; Webster, Jackson R.; Benfield, Ernest F.; Cheever, Beth M.; Niederlehner, Barbara R.			Ecosystem Function in Appalachian Headwater Streams during an Active Invasion by the Hemlock Woolly Adelgid	PLOS ONE			English	Article							FORESTED WATERSHEDS; NUTRIENT DYNAMICS; PRIMARY PRODUCERS; NITROGEN; MORTALITY; IMPACTS; INFESTATION; METABOLISM; PERIPHYTON; RIPARIAN	Forested ecosystems in the southeastern United States are currently undergoing an invasion by the hemlock woolly adelgid (HWA). Previous studies in this area have shown changes to forest structure, decreases in canopy cover, increases in organic matter, and changes to nutrient cycling on the forest floor and soil. Here, we were interested in how the effects of canopy loss and nutrient leakage from terrestrial areas would translate into functional changes in streams draining affected watersheds. We addressed these questions in HWA-infested watersheds at the Coweeta Hydrologic Laboratory in North Carolina. Specifically, we measured stream metabolism (gross primary production and ecosystem respiration) and nitrogen uptake from 2008 to 2011 in five streams across the Coweeta basin. Over the course of our study, we found no change to in-stream nutrient concentrations. While canopy cover decreased annually in these watersheds, this change in light penetration did not translate to higher rates of in-stream primary production during the summer months of our study. We found a trend towards greater heterotrophy within our watersheds, where in-stream respiration accounted for a much larger component of net ecosystem production than GPP. Additionally, increases in rhododendron cover may counteract changes in light and nutrient availability that occurred with hemlock loss. The variability in our metabolic and uptake parameters suggests an actively-infested ecosystem in transition between steady states.	[Northington, Robert M.; Webster, Jackson R.; Benfield, Ernest F.; Cheever, Beth M.; Niederlehner, Barbara R.] Virginia Polytech Inst & State Univ, Dept Biol Sci, Blacksburg, VA 24061 USA	Virginia Polytechnic Institute & State University	Northington, RM (corresponding author), Virginia Polytech Inst & State Univ, Dept Biol Sci, Blacksburg, VA 24061 USA.	rnorthin@vt.edu		Webster, Jackson/0000-0002-2649-0867; Niederlehner, Barbara/0000-0002-6933-336X	National Science Foundation [DEB-02218001]; Long Term Ecological Research Program [DEB-0823293]; United States Forest Service; Direct For Biological Sciences [0823293] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Long Term Ecological Research Program; United States Forest Service(United States Department of Agriculture (USDA)United States Forest Service); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was supported by a National Science Foundation award DEB-02218001 and DEB-0823293 from the Long Term Ecological Research Program to the Coweeta LTER Program at the University of Georgia. Any opinions, findings, conclusions, or recommendations expressed in the material are those of the authors and do not necessarily reflect the views of the National Science Foundation or the University of Georgia. Funding was also provided by a grant from the United States Forest Service. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan J, 2007, STREAM ECOLOGY; APHA AWWA WEF, 2005, STANDARD METHODS EXA, V21, P4; AUMEN NG, 1990, J N AM BENTHOL SOC, V9, P95; BILBY RE, 1980, ECOLOGY, V61, P1107, DOI 10.2307/1936830; Bott Thomas L., 2007, P663, DOI 10.1016/B978-012332908-0.50040-1; Bunn SE, 1999, FRESHWATER BIOL, V41, P333, DOI 10.1046/j.1365-2427.1999.00434.x; Clapcott JE, 2010, J N AM BENTHOL SOC, V29, P546, DOI 10.1899/09-040.1; Ehrenfeld JG, 2010, ANNU REV ECOL EVOL S, V41, P59, DOI 10.1146/annurev-ecolsys-102209-144650; Elliott KJ, 2008, PLANT ECOL, V197, P155, DOI 10.1007/s11258-007-9352-3; Elliott KJ, 2011, FOREST ECOL MANAG, V261, P900, DOI 10.1016/j.foreco.2010.03.010; Ellison AM, 2005, FRONT ECOL ENVIRON, V3, P479, DOI 10.1890/1540-9295(2005)003[0479:LOFSCF]2.0.CO;2; Elser JJ, 2007, ECOL LETT, V10, P1135, DOI 10.1111/j.1461-0248.2007.01113.x; ELWOOD JW, 1981, ECOLOGY, V62, P146, DOI 10.2307/1936678; England LE, 2004, FRESHWATER BIOL, V49, P721, DOI 10.1111/j.1365-2427.2004.01219.x; Eshleman KN, 1998, WATER RESOUR RES, V34, P2005, DOI 10.1029/98WR01198; Fellows CS, 2006, ECOSYSTEMS, V9, P788, DOI 10.1007/s10021-006-0005-5; Fitzpatrick MC, 2012, ECOL APPL, V22, P472, DOI 10.1890/11-0009.1; Ford CR, 2007, ECOL APPL, V17, P1156, DOI 10.1890/06-0027; Ford CR, 2012, OIKOS, V121, P523, DOI 10.1111/j.1600-0706.2011.19622.x; Gordon ND, 2004, STREAM HYDROLOGY INT; Grace M. R., 2006, STREAM METABOLISM PE; GRIMM N B, 1986, Journal of the North American Benthological Society, V5, P2, DOI 10.2307/1467743; Hall RO, 2003, LIMNOL OCEANOGR, V48, P1120, DOI 10.4319/lo.2003.48.3.1120; Hensel DR, 2006, ENVIRON SCI TECHNOL, V40, P4066, DOI 10.1021/es051650b; HILL WR, 1995, ECOLOGY, V76, P1297, DOI 10.2307/1940936; Kiffney PM, 2003, J APPL ECOL, V40, P1060, DOI 10.1111/j.1365-2664.2003.00855.x; Knoepp JD, 2011, SOIL SCI SOC AM J, V75, P1935, DOI 10.2136/sssaj2010.0409; Krapfl KJ, 2011, J TORREY BOT SOC, V138, P93, DOI 10.3159/10-RA-031.1; Lamberti GA, 1997, J N AM BENTHOL SOC, V16, P95, DOI 10.2307/1468241; Larned ST, 2010, J N AM BENTHOL SOC, V29, P182, DOI 10.1899/08-063.1; Lewis GP, 2007, FOREST ECOL MANAG, V238, P199, DOI 10.1016/j.foreco.2006.10.013; LOWE R L, 1986, Journal of the North American Benthological Society, V5, P221, DOI 10.2307/1467709; MORKESKI K, 2007, THESIS VIRGINIA POLY; Mulholland PJ, 2010, J N AM BENTHOL SOC, V29, P100, DOI 10.1899/08-035.1; Mulholland PJ, 2002, J N AM BENTHOL SOC, V21, P544, DOI 10.2307/1468429; Mulholland PJ, 2001, FRESHWATER BIOL, V46, P1503, DOI 10.1046/j.1365-2427.2001.00773.x; Nuckolls AE, 2009, ECOSYSTEMS, V12, P179, DOI 10.1007/s10021-008-9215-3; Orwig DA, 1998, J TORREY BOT SOC, V125, P60, DOI 10.2307/2997232; Paradis A, 2008, MITIG ADAPT STRAT GL, V13, P541, DOI 10.1007/s11027-007-9127-0; Riscassi AL, 2009, J GEOPHYS RES-BIOGEO, V114, DOI 10.1029/2008JG000860; Roberts BJ, 2007, J GEOPHYS RES-BIOGEO, V112, DOI 10.1029/2007JG000422; Roberts SW, 2009, ENVIRON MANAGE, V44, P335, DOI 10.1007/s00267-009-9317-5; Rowell TJ, 2008, J FRESHWATER ECOL, V23, P33, DOI 10.1080/02705060.2008.9664555; Simberloff D, 2011, BIOL INVASIONS, V13, P1255, DOI 10.1007/s10530-011-9956-3; Small MJ, 2005, J TORREY BOT SOC, V132, P458, DOI 10.3159/1095-5674(2005)132[458:CIAHFF]2.0.CO;2; Stadler B, 2006, ECOLOGY, V87, P1792, DOI 10.1890/0012-9658(2006)87[1792:TEOEAN]2.0.CO;2; Stanley EH, 2010, J N AM BENTHOL SOC, V29, P67, DOI 10.1899/08-027.1; Strayer DL, 2006, TRENDS ECOL EVOL, V21, P645, DOI 10.1016/j.tree.2006.07.007; Swank WT, 1997, GLOBAL BIOGEOCHEM CY, V11, P657, DOI 10.1029/97GB01752; Swank WT, 1988, ECOL STUD, V66, P52; Tank JL, 2000, LIMNOL OCEANOGR, V45, P1013, DOI 10.4319/lo.2000.45.5.1013; Townsend PA, 2004, ECOL APPL, V14, P504, DOI 10.1890/02-5356; Valett HM, 2008, ECOLOGY, V89, P3515, DOI 10.1890/07-1003.1; Valett HM, 2002, ECOLOGY, V83, P2888, DOI 10.1890/0012-9658(2002)083[2888:SNUFSA]2.0.CO;2; Wallace JB, 2001, INT REV HYDROBIOL, V86, P501, DOI 10.1002/1522-2632(200107)86:4/5<501::AID-IROH501>3.0.CO;2-8; Ward JSJS., 2004, NATP0304 USDA FOR SE; Warren DR, 2008, FOREST ECOL MANAG, V256, P808, DOI 10.1016/j.foreco.2008.05.038; Warren DR, 2007, EARTH SURF PROC LAND, V32, P1154, DOI 10.1002/esp.1548; Webster JR, 2012, AM MIDL NAT, V168, P112, DOI 10.1674/0003-0031-168.1.112; Webster J.R., 2000, VERHANDLUNGEN INT VE, V27, P1337, DOI DOI 10.1080/03680770.1998.11901453; Webster Jackson R., 2007, P169, DOI 10.1016/B978-012332908-0.50010-3; WEBSTER JR, 1991, INT VER THEOR ANGEW, V24, P1681; Young RG, 2008, J N AM BENTHOL SOC, V27, P605, DOI 10.1899/07-121.1; Zar JH, 1999, BIOSTATISTICAL ANAL	64	8	8	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2013	8	4							e61171	10.1371/journal.pone.0061171	http://dx.doi.org/10.1371/journal.pone.0061171			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JR	23613803	gold, Green Published			2022-12-25	WOS:000317911500021
J	Zhang, K; Lu, K; Qu, CM; Liang, Y; Wang, R; Chai, YR; Li, JN				Zhang, Kai; Lu, Kun; Qu, Cunmin; Liang, Ying; Wang, Rui; Chai, Yourong; Li, Jiana			Gene Silencing of BnTT10 Family Genes Causes Retarded Pigmentation and Lignin Reduction in the Seed Coat of Brassica napus	PLOS ONE			English	Article							PROANTHOCYANIDIN BIOSYNTHESIS; LACCASE; SEQUENCE; INHERITANCE; CARINATA; ENCODES; COLOR; LINES; L.	Yellow-seed (i.e., yellow seed coat) is one of the most important agronomic traits of Brassica plants, which is correlated with seed oil and meal qualities. Previous studies on the Brassicaceae, including Arabidopsis and Brassica species, proposed that the seed-color trait is correlative to flavonoid and lignin biosynthesis, at the molecular level. In Arabidopsis thaliana, the oxidative polymerization of flavonoid and biosynthesis of lignin has been demonstrated to be catalyzed by laccase 15, a functional enzyme encoded by the AtTT10 gene. In this study, eight Brassica TT10 genes (three from B. napus, three from B. rapa and two from B. oleracea) were isolated and their roles in flavonoid oxidation/polymerization and lignin biosynthesis were investigated. Based on our phylogenetic analysis, these genes could be divided into two groups with obvious structural and functional differentiation. Expression studies showed that Brassica TT10 genes are active in developing seeds, but with differential expression patterns in yellow-and black-seeded near-isogenic lines. For functional analyses, three black-seeded B. napus cultivars were chosen for transgenic studies. Transgenic B. napus plants expressing antisense TT10 constructs exhibited retarded pigmentation in the seed coat. Chemical composition analysis revealed increased levels of soluble proanthocyanidins, and decreased extractable lignin in the seed coats of these transgenic plants compared with that of the controls. These findings indicate a role for the Brassica TT10 genes in proanthocyanidin polymerization and lignin biosynthesis, as well as seed coat pigmentation in B. napus.	[Zhang, Kai; Lu, Kun; Qu, Cunmin; Liang, Ying; Wang, Rui; Chai, Yourong; Li, Jiana] Southwest Univ, Chongqing Rapeseed Engn & Technol Res Ctr, Chongqing, Peoples R China; [Zhang, Kai; Lu, Kun; Qu, Cunmin; Liang, Ying; Wang, Rui; Chai, Yourong; Li, Jiana] Southwest Univ, Engn Res Ctr South Upland Agr, Minist Educ, Chongqing, Peoples R China; [Zhang, Kai; Lu, Kun; Qu, Cunmin; Liang, Ying; Wang, Rui; Chai, Yourong; Li, Jiana] Southwest Univ, Coll Agron & Biotechnol, Chongqing, Peoples R China	Southwest University - China; Southwest University - China; Southwest University - China	Chai, YR (corresponding author), Southwest Univ, Chongqing Rapeseed Engn & Technol Res Ctr, Chongqing, Peoples R China.	chaiyourong1@163.com; ljn1950@swu.edu.cn	Lu, Kun/C-2597-2008	Lu, Kun/0000-0003-1370-8633; Qu, Cunmin/0000-0003-2413-2350	National Natural Science Foundation of China [31071450, 31171619, 31101175, 31171177]; "111" Project [B12006]; Fundamental Research Funds for the Central Universities [XDJK2012A009]; Specialized Research Fund for the Doctoral Program of Higher Education of China [20100182120016]; Chongqing Program for Key Science and Technology Project [2009AB1030]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); "111" Project(Ministry of Education, China - 111 Project); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Chongqing Program for Key Science and Technology Project	This work was supported by National Natural Science Foundation of China [31071450, 31171619, 31101175 and 31171177, http://www.nsfc.gov.cn], the "111" Project [B12006, http://www.moe.edu.cn], the Fundamental Research Funds for the Central Universities [XDJK2012A009, http://www.moe.edu.cn], the Specialized Research Fund for the Doctoral Program of Higher Education of China [20100182120016, http://www.moe.edu.cn], and the Chongqing Program for Key Science and Technology Project [2009AB1030, http://www.ctin.ac.cn]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhov L, 2009, BOTANY, V87, P616, DOI 10.1139/B09-036; Burbulis N, 2005, CAN J PLANT SCI, V85, P109, DOI 10.4141/P04-030; Cardoza V, 2003, PLANT CELL REP, V21, P599, DOI 10.1007/s00299-002-0560-y; Chai YR, 2009, MOL GENET GENOMICS, V281, P109, DOI 10.1007/s00438-008-0399-1; Dalzell SA, 1998, J SCI FOOD AGR, V78, P405, DOI [10.1002/(SICI)1097-0010(199811)78:3<405::AID-JSFA133>3.0.CO;2-G, 10.1002/(SICI)1097-0010(199811)78:3&lt;405::AID-JSFA133&gt;3.0.CO;2-G]; Debeaujon I, 2001, PLANT CELL, V13, P853, DOI 10.1105/tpc.13.4.853; Dixon RA, 2005, NEW PHYTOL, V165, P9, DOI 10.1111/j.1469-8137.2004.01217.x; El-Mezawy A, 2009, BIOTECHNOL LETT, V31, P1961, DOI 10.1007/s10529-009-0098-y; Fu FY, 2007, GENOME, V50, P840, DOI 10.1139/G07-068; Hatfield R, 2005, CROP SCI, V45, P832, DOI 10.2135/cropsci2004.0238; JEFFERSON RA, 1987, EMBO J, V6, P3901; Kitamura S, 2004, PLANT J, V37, P104, DOI 10.1046/j.1365-313X.2003.01943.x; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Kumar SVS, 2003, BIOTECHNOL BIOENG, V83, P386, DOI 10.1002/bit.10681; Lai DY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028676; Liang MX, 2006, PLANTA, V224, P1185, DOI 10.1007/s00425-006-0300-6; Lise J., 2011, BMC PROCBIOMED CENT, V5, DOI [10.1186/1753-6561-5-S7-O39, DOI 10.1186/1753-6561-5-S7-O39]; Liu XP, 2005, PLANT BREEDING, V124, P9, DOI 10.1111/j.1439-0523.2004.01051.x; Lu K, 2008, THEOR APPL GENET, V117, P963, DOI 10.1007/s00122-008-0836-x; Marles MAS, 2004, J SCI FOOD AGR, V84, P251, DOI 10.1002/jsfa.1621; Marles MAS, 2003, PHYTOCHEMISTRY, V62, P663, DOI 10.1016/S0031-9422(02)00488-0; Mayer AM, 2002, PHYTOCHEMISTRY, V60, P551, DOI 10.1016/S0031-9422(02)00171-1; McCaig BC, 2005, PLANTA, V221, P619, DOI 10.1007/s00425-004-1472-6; Meng JL, 1998, EUPHYTICA, V103, P329, DOI 10.1023/A:1018646223643; MORRISON IM, 1972, J SCI FOOD AGR, V23, P455, DOI 10.1002/jsfa.2740230405; Mun JH, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-r111; Nakamura K, 2005, CELL MOL LIFE SCI, V62, P2050, DOI 10.1007/s00018-004-5076-x; Nesi N, 2009, PLANT CELL REP, V28, P601, DOI 10.1007/s00299-008-0667-x; Pourcel L, 2005, PLANT CELL, V17, P2966, DOI 10.1105/tpc.105.035154; Pourcel L, 2007, TRENDS PLANT SCI, V12, P29, DOI 10.1016/j.tplants.2006.11.006; Routaboul JM, 2006, PLANTA, V224, P96, DOI 10.1007/s00425-005-0197-5; SAGHAIMAROOF MA, 1984, P NATL ACAD SCI-BIOL, V81, P8014, DOI 10.1073/pnas.81.24.8014; STAFFORD HA, 1988, PHYTOCHEMISTRY, V27, P1, DOI 10.1016/0031-9422(88)80583-1; STRINGAM GR, 1974, P 4 INT RAP C GIESS, P99; Tang ZL, 1997, PLANT BREEDING, V116, P471, DOI 10.1111/j.1439-0523.1997.tb01033.x; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; U. N., 1935, Japanese Journal of Botany, V7, P389; Xie DY, 2005, PHYTOCHEMISTRY, V66, P2127, DOI 10.1016/j.phytochem.2005.01.008; Zhao J, 2010, PLANT PHYSIOL, V153, P437, DOI 10.1104/pp.110.155432	39	32	37	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2013	8	4							e61247	10.1371/journal.pone.0061247	http://dx.doi.org/10.1371/journal.pone.0061247			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JR	23613820	gold, Green Submitted, Green Published			2022-12-25	WOS:000317911500024
J	Merk, H; Kuhlmann-Berenzon, S; Bexelius, C; Sandin, S; Litton, JE; Linde, A; Nyren, O				Merk, Hanna; Kuhlmann-Berenzon, Sharon; Bexelius, Christin; Sandin, Sven; Litton, Jan-Eric; Linde, Annika; Nyren, Olof			The Validity of Self-Initiated, Event-Driven Infectious Disease Reporting in General Population Cohorts	PLOS ONE			English	Article							INFLUENZA-LIKE ILLNESS; SURVEILLANCE; HEALTH; NETHERLANDS; NONRESPONSE; RETENTION; SEASONS; DESIGN; RATES; YOUNG	Background: The 2009/2010 pandemic influenza highlighted the need for valid and timely incidence data. In 2007 we started the development of a passive surveillance scheme based on passive follow-up of representative general population cohorts. Cohort members are asked to spontaneously report all instances of colds and fevers as soon as they occur for up to 9 months. Suspecting that compliance might be poor, we aimed to assess the validity of self-initiated, event-driven outcome reporting over long periods. Methods: During two 8 week periods in 2008 and 2009, 2376 and 2514 cohort members in Stockholm County were sent one-week recall questionnaires, which served as reference method. Results: The questionnaires were completed by 88% and 86% of the cohort members. Whilst the false positive proportion (1-specificity) in the reporting was low (upper bound of the 95% confidence interval [CI] <= 2% in each season), the false negative proportion (failure to report, 1-sensitivity) was considerable (60% [95% CI 52%-67%] in each season). Still, the resulting epidemic curves for influenza-like illness compared well with those from existing General Practitioner-based sentinel surveillance in terms of shape, timing of peak, and year-to-year variation. This suggested that the error was fairly constant. Conclusions: Passive long-term surveillance through self-initiated, event-driven outcome reporting underestimates incidence rates of common upper respiratory tract infections. However, because underreporting appears predictable, simple corrections could potentially restore validity.	[Merk, Hanna; Bexelius, Christin; Sandin, Sven; Litton, Jan-Eric; Nyren, Olof] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Merk, Hanna; Kuhlmann-Berenzon, Sharon; Linde, Annika] Swedish Inst Commun Dis Control, Dept Anal & Prevent, Solna, Sweden; [Bexelius, Christin] OptumInsight, Stockholm, Sweden; [Nyren, Olof] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37212 USA	Karolinska Institutet; Optum; Vanderbilt University	Merk, H (corresponding author), Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden.	hanna.merk@smi.se	Kühlmann-Berenzon, Sharon/J-1554-2019; Sandin, Sven/L-5357-2015; Sandin, Sven/ABE-2959-2021	Kühlmann-Berenzon, Sharon/0000-0002-8138-1196; Sandin, Sven/0000-0001-6994-4884; Sandin, Sven/0000-0001-6994-4884	European Union [EPIWORK 231807]; Strategic Research Program in Epidemiology at Karolinska Institutet; Swedish Institute for Communicable Disease Control	European Union(European Commission); Strategic Research Program in Epidemiology at Karolinska Institutet; Swedish Institute for Communicable Disease Control	This work was supported by the European Union Seventh Framework Programme (grant number EPIWORK 231807) (http://cordis.europa.eu/fp7/home_en.html); the Strategic Research Program in Epidemiology at Karolinska Institutet (http://ki.se/ki/jsp/polopoly.jsp?d=34466 & l=en); and the Swedish Institute for Communicable Disease Control (http://smi.se/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti A., 2013, CATEGORICAL DATA ANA, V3rd; Altman DG., 1991, PRACTICAL STAT MED R, p[203, 531]; Arkema A, 2008, EISS WEEKLY ELECT B; Bexelius C, 2010, EUR J EPIDEMIOL, V25, P693, DOI 10.1007/s10654-010-9484-y; Biemer PP, 2003, INTRO SURVEY QUALITY, P132; Broberg E, 2011, WEEKLY INFLUENZA SUR; Brytting M, 2008, INFLUENZA ANN REPORT; Brytting M, 2011, INFLUENZA ANN REPORT; Chatfield C, 2004, ANAL TIME SERIES INT, P155; Eaker S, 1998, AM J EPIDEMIOL, V147, P74; Ebell MH, 2011, ANN FAM MED, V9, P69, DOI 10.1370/afm.1192; Friesema IHM, 2009, VACCINE, V27, P6353, DOI 10.1016/j.vaccine.2009.05.042; Gibson RS, 2005, PRINCIPLES NUTR ASSE, P152; Kirkwood B, 2003, ESSENTIAL MED STAT, P240; Kirkwood BR, 2003, ESSENTIAL MED STAT, P153; Littman AJ, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-99; Marquet RL, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-242; May L, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-242; Paget J, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-141; Parrella A, 2009, AUST FAM PHYSICIAN, V38, P932; Radler BT, 2010, J AGING HEALTH, V22, P307, DOI 10.1177/0898264309358617; RODGERS A, 1995, THROMB HAEMOSTASIS, V73, P167; Ronmark EP, 2009, RESP MED, V103, P1807, DOI 10.1016/j.rmed.2009.07.014; Roy Sharon L., 2006, Journal of Water and Health, V4, P31, DOI 10.2166/wh.2006.017; SOGAARD AJ, 2004, INT J EQUITY HEALTH, V3, DOI DOI 10.1186/1475-9276-3-3; Tolonen H, 2006, EUR J EPIDEMIOL, V21, P409, DOI 10.1007/s10654-006-9019-8; Walker J, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-156; Wheeler JG, 1999, BMJ-BRIT MED J, V318, P1046, DOI 10.1136/bmj.318.7190.1046	28	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2013	8	4							e61644	10.1371/journal.pone.0061644	http://dx.doi.org/10.1371/journal.pone.0061644			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IK	23613891	Green Published, Green Submitted, gold			2022-12-25	WOS:000317907200068
J	Ngamjariyawat, A; Turpaev, K; Vasylovska, S; Kozlova, EN; Welsh, N				Ngamjariyawat, Anongnad; Turpaev, Kyril; Vasylovska, Svitlana; Kozlova, Elena N.; Welsh, Nils			Co-Culture of Neural Crest Stem Cells (NCSC) and Insulin Producing Beta-TC6 Cells Results in Cadherin Junctions and Protection against Cytokine-Induced Beta-Cell Death	PLOS ONE			English	Article							BOUNDARY CAP; KAPPA-B; DIFFERENTIATION; ACTIVATION; RESPONSES; ISLETS; KINASE; WNT	Purpose: Transplantation of pancreatic islets to Type 1 diabetes patients is hampered by inflammatory reactions at the transplantation site leading to dysfunction and death of insulin producing beta-cells. Recently we have shown that co-transplantation of neural crest stem cells (NCSCs) together with the islet cells improves transplantation outcome. The aim of the present investigation was to describe in vitro interactions between NCSCs and insulin producing beta-TC6 cells that may mediate protection against cytokine-induced beta-cell death. Procedures: Beta-TC6 and NCSC cells were cultured either alone or together, and either with or without cell culture inserts. The cultures were then exposed to the pro-inflammatory cytokines IL-1 beta and IFN-gamma for 48 hours followed by analysis of cell death rates (flow cytometry), nitrite production (Griess reagent), protein localization (immunofluorescence) and protein phosphorylation (flow cytometry). Results: We observed that beta-TC6 cells co-cultured with NCSCs were protected against cytokine-induced cell death, but not when separated by cell culture inserts. This occurred in parallel with (i) augmented production of nitrite from beta-TC6 cells, indicating that increased cell survival allows a sustained production of nitric oxide; (ii) NCSC-derived laminin production; (iii) decreased phospho-FAK staining in beta-TC6 cell focal adhesions, and (iv) decreased beta-TC6 cell phosphorylation of ERK(T202/Y204), FAK(Y397) and FAK(Y576). Furthermore, co-culture also resulted in cadherin and beta-catenin accumulations at the NCSC/beta-TC6 cell junctions. Finally, the gap junction inhibitor carbenoxolone did not affect cytokine-induced beta-cell death during co-culture with NCSCs. Conclusion: In summary, direct contacts, but not soluble factors, promote improved beta-TC6 viability when co-cultured with NCSCs. We hypothesize that cadherin junctions between NCSC and beta-TC6 cells promote powerful signals that maintain beta-cell survival even though ERK and FAK signaling are suppressed. It may be that future strategies to improve islet transplantation outcome may benefit from attempts to increase beta-cell cadherin junctions to neighboring cells.	[Ngamjariyawat, Anongnad; Vasylovska, Svitlana; Kozlova, Elena N.] Uppsala Univ, Dept Neurosci, Uppsala, Sweden; [Turpaev, Kyril; Welsh, Nils] Uppsala Univ, Dept Med Cell Biol, Uppsala, Sweden; [Turpaev, Kyril; Welsh, Nils] Uppsala Univ, Sci Life Lab SciLifeLab, Uppsala, Sweden; [Turpaev, Kyril] Russian Acad Sci, Ctr Theoret Problems Physicochem Pharmacol, Moscow, Russia	Uppsala University; Uppsala University; SciLifeLab; Uppsala University; Center for Theoretical Problems of Physicochemical Pharmacology of the Russian Academy of Sciences; Russian Academy of Sciences	Kozlova, EN (corresponding author), Uppsala Univ, Dept Neurosci, Uppsala, Sweden.	Elena.Kozlova@neuro.uu.se; nils.welsh@mcb.uu.se		Kozlova, Elena/0000-0002-2234-0079	Swedish Research Council [2010-11564-15-3, K2011-62X-20716-04-6]; Swedish Diabetes Association; family Ernfors Foundation; Barndiabetesfonden; Novo-Nordisk Foundation; Stiftelsen Olle Engkvist Byggare; Signhild Engkvist Stiftelse; Swedish Institute [00613/2011]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Diabetes Association; family Ernfors Foundation; Barndiabetesfonden; Novo-Nordisk Foundation(Novo Nordisk Foundation); Stiftelsen Olle Engkvist Byggare(Swedish Research Council); Signhild Engkvist Stiftelse; Swedish Institute	This work was supported in part by the Swedish Research Council (2010-11564-15-3, (NW), and K2011-62X-20716-04-6 (EK)), the Swedish Diabetes Association (NW), the family Ernfors Foundation (NW), Barndiabetesfonden (NW), the Novo-Nordisk Foundation (NW), Stiftelsen Olle Engkvist Byggare (EK), Signhild Engkvist Stiftelse (EK) and the Swedish Institute's Visby program 00613/2011 (EK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldskogius H, 2009, STEM CELLS, V27, P1592, DOI 10.1002/stem.77; Banerjee M, 2012, MOL CELL ENDOCRINOL, V355, P78, DOI 10.1016/j.mce.2012.01.020; Chapman Harold A, 2012, Proc Am Thorac Soc, V9, P89, DOI 10.1513/pats.201112-053AW; Curchoe CL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013890; Dahl U, 1996, DEVELOPMENT, V122, P2895; Davalli AM, 1996, DIABETES, V45, P1161, DOI 10.2337/diabetes.45.9.1161; Eizirik DL, 2001, DIABETOLOGIA, V44, P2115, DOI 10.1007/s001250100021; Flodstrom M, 1996, FEBS LETT, V385, P4, DOI 10.1016/0014-5793(96)00337-7; Grouwels G, 2012, DIABETOLOGIA, V55, P2016, DOI 10.1007/s00125-012-2542-0; Hauge-Evans AC, 1999, DIABETES, V48, P1402, DOI 10.2337/diabetes.48.7.1402; Herzig M, 2007, ONCOGENE, V26, P2290, DOI 10.1038/sj.onc.1210029; Heuberger J, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002915; Hjerling-Leffler J, 2005, DEVELOPMENT, V132, P2623, DOI 10.1242/dev.01852; Iwashita J, 2011, BIOSCI BIOTECH BIOCH, V75, P688, DOI 10.1271/bbb.100830; Johansson JK, 2010, GENESIS, V48, P374, DOI 10.1002/dvg.20628; Kilkenny DM, 2008, MOL ENDOCRINOL, V22, P196, DOI 10.1210/me.2007-0241; Kleber M, 2005, J CELL BIOL, V169, P309, DOI 10.1083/jcb.200411095; Klee P, 2011, J CLIN INVEST, V121, P4870, DOI 10.1172/JCI40509; Kozlova EN, 2009, NEUROREPORT, V20, P833, DOI 10.1097/WNR.0b013e32832b8e20; Kozlova EN, 2005, PANCREAS, V31, P380, DOI 10.1097/01.mpa.0000181489.35022.4a; Krishnamurthy M, 2008, J CELL COMMUN SIGNAL, V2, P67, DOI 10.1007/s12079-008-0030-6; Larsen CM, 1998, J BIOL CHEM, V273, P15294, DOI 10.1074/jbc.273.24.15294; Li J, 2007, GLIA, V55, P93, DOI 10.1002/glia.20427; Mokhtari D, 2009, AM J PHYSIOL-ENDOC M, V297, pE1067, DOI 10.1152/ajpendo.00212.2009; Moore Robert, 2004, Birth Defects Res C Embryo Today, V72, P140, DOI 10.1002/bdrc.20014; Nekrep N, 2008, DEVELOPMENT, V135, P2151, DOI 10.1242/dev.015859; Ngamjariyawat A, 2012, PANCREAS, V41, P490, DOI 10.1097/MPA.0b013e31823fcf2a; Olerud J, 2009, DIABETOLOGIA, V52, P2594, DOI 10.1007/s00125-009-1544-z; Parnaud G, 2006, DIABETES, V55, P1413, DOI 10.2337/db05-1388; Parnaud G, 2011, ENDOCRINOLOGY, V152, P4601, DOI 10.1210/en.2011-1286; Ryan EA, 2005, DIABETES, V54, P2060, DOI 10.2337/diabetes.54.7.2060; Stipp CS, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399409001355; Suarez-Pinzon W, 1999, DIABETES, V48, P21, DOI 10.2337/diabetes.48.1.21; Uno S, 2007, DIABETOLOGIA, V50, P596, DOI 10.1007/s00125-006-0569-9; Welsh N, 1996, J BIOL CHEM, V271, P8307, DOI 10.1074/jbc.271.14.8307	35	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2013	8	4							e61828	10.1371/journal.pone.0061828	http://dx.doi.org/10.1371/journal.pone.0061828			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IK	23613946	Green Published, Green Submitted, gold			2022-12-25	WOS:000317907200091
J	Rajput, S; Kumar, BNP; Sarkar, S; Das, S; Azab, B; Santhekadur, PK; Das, SK; Emdad, L; Sarkar, D; Fisher, PB; Mandal, M				Rajput, Shashi; Kumar, B. N. Prashanth; Sarkar, Siddik; Das, Subhasis; Azab, Belal; Santhekadur, Prasanna K.; Das, Swadesh K.; Emdad, Luni; Sarkar, Devanand; Fisher, Paul B.; Mandal, Mahitosh			Targeted Apoptotic Effects of Thymoquinone and Tamoxifen on XIAP Mediated Akt Regulation in Breast Cancer	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; TYROSINE KINASE INHIBITOR; KAPPA-B ACTIVATION; ESTROGEN-RECEPTOR; TUMOR-GROWTH; PROTEIN-KINASE; CELL-DEATH; IN-VITRO; SUPPRESSION; EXPRESSION	X-linked inhibitor of apoptosis protein (XIAP) is constitutively expressed endogenous inhibitor of apoptosis, exhibit its antiapoptotic effect by inactivating key caspases such as caspase-3, caspase-7 and caspase-9 and also play pivotal role in rendering cancer chemoresistance. Our studies showed the coadministration of TQ and TAM resulting in a substantial increase in breast cancer cell apoptosis and marked inhibition of cell growth both in vitro and in vivo. Anti-angiogenic and anti-invasive potential of TQ and TAM was assessed through in vitro studies. This novel combinatorial regimen leads to regulation of multiple cell signaling targets including inactivation of Akt and XIAP degradation. At molecular level, TQ and TAM synergistically lowers XIAP expression resulting in binding and activation of caspase-9 in apoptotic cascade, and interfere with cell survival through PI3-K/Akt pathway by inhibiting Akt phosphorylation. Cleaved caspase-9 further processes other intracellular death substrates such as PARP thereby shifting the balance from survival to apoptosis, indicated by rise in the sub-G(1) cell population. This combination also downregulates the expression of Akt-regulated downstream effectors such as Bcl-xL, Bcl-2 and induce expression of Bax, AIF, cytochrome C and p-27. Consistent with these results, overexpression studies further confirmed the involvement of XIAP and its regulatory action on Akt phosphorylation along with procaspase-9 and PARP cleavage in TQ-TAM coadministrated induced apoptosis. The ability of TQ and TAM in inhibiting XIAP was confirmed through siRNA-XIAP cotransfection studies. This novel modality may be a promising tool in breast cancer treatment.	[Rajput, Shashi; Kumar, B. N. Prashanth; Das, Subhasis; Mandal, Mahitosh] Indian Inst Technol, Sch Med Sci & Technol, Kharagpur 721302, W Bengal, India; [Sarkar, Siddik; Azab, Belal; Santhekadur, Prasanna K.; Das, Swadesh K.; Emdad, Luni; Sarkar, Devanand; Fisher, Paul B.] Virginia Commonwealth Univ, VCU Massey Canc Ctr, VCU Inst Mol Genet, Sch Med,Dept Human & Mol Genet, Richmond, VA USA	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Kharagpur; Virginia Commonwealth University	Mandal, M (corresponding author), Indian Inst Technol, Sch Med Sci & Technol, Kharagpur 721302, W Bengal, India.	mahitosh@smst.iitkgp.ernet.in	Santhekadur, Prasanna/O-7006-2019; Bhusetty Nagesh, Prashanth Kumar/ABH-4999-2020; Mandal, Mahitosh/GMW-6195-2022; JAIN, SHASHI/N-8877-2017; DAS, SUBHASIS/O-8421-2017; Azab, Belal/AAJ-5652-2021; jain, shashi/AAF-4706-2020	Santhekadur, Prasanna/0000-0003-3338-375X; Bhusetty Nagesh, Prashanth Kumar/0000-0003-3518-405X; Mandal, Mahitosh/0000-0003-3861-3323; JAIN, SHASHI/0000-0001-9428-0135; DAS, SUBHASIS/0000-0003-1032-4407; Azab, Belal/0000-0003-0293-6489; jain, shashi/0000-0001-9428-0135; Sarkar, Siddik/0000-0002-3694-8915	Department of Biotechnology (DBT); Council of Scientific and Industrial Research (CSIR); Department of Science and Technology (DST), India; Council of Scientific and Industrial Research (CSIR), India; U.S. Department of Defense (DoD) [W81XWH-11-1-0186]; National Institutes of Health National Cancer Institute grant [5 R01 CA097318, 1 R01 CA127641, 1 R01 CA138540]; NATIONAL CANCER INSTITUTE [R01CA127641, R01CA097318, R01CA138540] Funding Source: NIH RePORTER	Department of Biotechnology (DBT)(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India); Department of Science and Technology (DST), India(Department of Science & Technology (India)); Council of Scientific and Industrial Research (CSIR), India(Council of Scientific & Industrial Research (CSIR) - India); U.S. Department of Defense (DoD)(United States Department of Defense); National Institutes of Health National Cancer Institute grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by grants from the Department of Biotechnology (DBT: http://dbtindia.nic.in/index.asp), Council of Scientific and Industrial Research (CSIR: http://csirhrdg.res.in/) and Department of Science and Technology (DST: http://www.dst.gov.in/), India. Shashi Rajput and B. N. Prashanth Kumar are the recipients of a Research fellowship from the Council of Scientific and Industrial Research (CSIR), India. Siddik Sarkar is a postdoctoral scientist in Cancer Research sponsored by the U.S. Department of Defense (DoD Award W81XWH-11-1-0186). Support from National Institutes of Health National Cancer Institute grants 5 R01 CA097318 and 1 R01 CA127641 to PBF and 1 R01 CA138540 to DS is also acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberg UWN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025720; Aird KM, 2008, MOL CANCER THER, V7, P38, DOI 10.1158/1535-7163.MCT-07-0370; Asselin E, 2001, CANCER RES, V61, P1862; Barnes CJ, 2003, MOL CANCER THER, V2, P345; Becker M, 2005, MOL CANCER THER, V4, P151; Das S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046641; Dash R, 2008, MOL CELL BIOCHEM, V311, P111, DOI 10.1007/s11010-008-9702-z; Dorai T, 2004, CANCER LETT, V215, P129, DOI 10.1016/j.canlet.2004.07.013; Emdad L, 2009, P NATL ACAD SCI USA, V106, P21300, DOI 10.1073/pnas.0910936106; Fisher B, 2006, JNCI-J NATL CANCER I, V98, P643, DOI 10.1093/jnci/djj168; Franke TF, 2003, ONCOGENE, V22, P8983, DOI 10.1038/sj.onc.1207115; Franke TF, 1997, NATURE, V390, P116, DOI 10.1038/36442; Gagnon V, 2008, APOPTOSIS, V13, P259, DOI 10.1007/s10495-007-0165-6; Gali-Muhtasib H, 2004, INT J ONCOL, V25, P857; Gali-Muhtasib H, 2006, INT J BIOCHEM CELL B, V38, P1249, DOI 10.1016/j.biocel.2005.10.009; Gurung RL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012124; HARAN EF, 1994, CANCER RES, V54, P5511; Hawkins RA, 2000, BREAST, V9, P96, DOI 10.1054/brst.2000.0140; Hlobilkova A, 2006, ANTICANCER RES, V26, P1015; Hosseinzadeh H, 2004, PHYTOMEDICINE, V11, P56, DOI 10.1078/0944-7113-00376; Hussain AR, 2010, J PATHOL, V222, P180, DOI 10.1002/path.2747; Jordan NJ, 2004, BREAST CANCER RES TR, V87, P167, DOI 10.1023/B:BREA.0000041623.21338.47; JORDAN VC, 1992, CANCER, V70, P977; KATO S, 1995, SCIENCE, V270, P1491, DOI 10.1126/science.270.5241.1491; Koren J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035566; Li CX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027053; Liu Y, 2012, MOL CANCER THER, V11, P45, DOI 10.1158/1535-7163.MCT-11-0578; Lupu R, 1996, BREAST CANCER RES TR, V38, P57, DOI 10.1007/BF01803784; Mandal M, 1999, BIOCHEM BIOPH RES CO, V260, P775, DOI 10.1006/bbrc.1999.0966; Mandal M, 2008, CANCER-AM CANCER SOC, V112, P2088, DOI 10.1002/cncr.23410; Mandlekar S, 2001, APOPTOSIS, V6, P469, DOI 10.1023/A:1012437607881; Mimeault M, 2007, MOL CANCER THER, V6, P967, DOI 10.1158/1535-7163.MCT-06-0648; Murphy DA, 2006, AM J PATHOL, V169, P1875, DOI 10.2353/ajpath.2006.050711; Pap M, 1998, J BIOL CHEM, V273, P19929, DOI 10.1074/jbc.273.32.19929; Perez-Tenorio G, 2002, BRIT J CANCER, V86, P540, DOI 10.1038/sj.bjc.6600126; PERRY RR, 1995, ANN SURG ONCOL, V2, P238, DOI 10.1007/BF02307030; Rajput S, 2012, EUR J CANCER PREV, V21, P205, DOI 10.1097/CEJ.0b013e32834a7f0c; Reddy KB, 2007, INT J ONCOL, V30, P971; Ren Y, 2003, ANTICANCER RES, V23, P3231; Salami S, 2003, CLIN BIOCHEM, V36, P247, DOI 10.1016/S0009-9120(03)00007-9; Santhekadur PK, 2011, J BIOL CHEM; Sarkar D, 2008, CANCER RES, V68, P1478, DOI 10.1158/0008-5472.CAN-07-6164; Sarkar S, 2011, J CELL PHYSIOL, V226, P375, DOI 10.1002/jcp.22343; Sarkar S, 2010, CANCER BIOL THER, V9, P592, DOI 10.4161/cbt.9.8.11103; Sethi G, 2008, MOL CANCER RES, V6, P1059, DOI 10.1158/1541-7786.MCR-07-2088; Shoieb AM, 2003, INT J ONCOL, V22, P107; Somanath PR, 2006, CELL CYCLE, V5, P512, DOI 10.4161/cc.5.5.2538; Venkatesan P, 2011, BIOMATERIALS, V32, P3794, DOI 10.1016/j.biomaterials.2011.01.027; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Weng SC, 2008, MOL CANCER THER, V7, P800, DOI 10.1158/1535-7163.MCT-07-0434; Yi TF, 2008, MOL CANCER THER, V7, P1789, DOI 10.1158/1535-7163.MCT-08-0124; Younes MN, 2005, CANCER RES, V65, P4716, DOI 10.1158/0008-5472.CAN-04-4196	52	90	91	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2013	8	4							e61342	10.1371/journal.pone.0061342	http://dx.doi.org/10.1371/journal.pone.0061342			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IK	23613836	Green Published, gold			2022-12-25	WOS:000317907200050
J	Sayeed, S; Barnes, I; Cairns, BJ; Finlayson, A; Ali, R				Sayeed, Shameq; Barnes, Isobel; Cairns, Benjamin J.; Finlayson, Alexander; Ali, Raghib			Childhood Cancer Incidence in British Indians & Whites in Leicester, 1996-2008	PLOS ONE			English	Article							SOUTH ASIAN POPULATION; UNITED-KINGDOM; ETHNIC-GROUP; UK; BREAST; DEPRIVATION; SURVIVAL; LEUKEMIA; RISK	Background: South Asians in England have an increased risk of childhood cancer but incidence by their individual ethnicities using self-assigned ethnicity is unknown. Our objective was to compare the incidence of childhood cancer in British Indians and Whites in Leicester, which has virtually complete, self-assigned, ethnicity data and the largest population of Indians in England. Methods: We obtained data on all cancer registrations from 1996 to 2008 for Leicester with ethnicity obtained by linkage to the Hospital Episodes Statistics database. Age-standardised incidence rates were calculated for childhood cancers in Indians and Whites as well as rate ratios, adjusted for age. Results: There were 33 cancers registered among Indian children and 39 among White children. The incidence rate for Indians was greater compared to Whites for all cancers combined (RR 1.82 (95% CI 1.14 to 2.89); p = 0.01), with some evidence of increased risk of leukaemia (RR 2.20 (0.95 to 5.07); p = 0.07), lymphoma (RR 3.96 (0.99 to 15.84); p = 0.04) and central nervous system tumours (RR 2.70 (1.00 to 7.26); p = 0.05). Rates were also higher in British Indian children compared to children in India. Conclusions: British Indian children in Leicester had an increased risk of developing cancer compared to White children, largely due to a higher incidence of central nervous system and haematological malignancies.	[Sayeed, Shameq; Barnes, Isobel; Cairns, Benjamin J.; Ali, Raghib] Univ Oxford, Canc Epidemiol Unit, Oxford, England; [Finlayson, Alexander] INDOX Canc Res Network, Canc Epidemiol Unit, Oxford, England; [Ali, Raghib] United Arab Emirates Univ, Fac Med & Hlth Sci, Al Ain, U Arab Emirates	University of Oxford; University of Oxford; United Arab Emirates University	Ali, R (corresponding author), Univ Oxford, Canc Epidemiol Unit, Richard Doll Bldg, Oxford, England.	raghib.ali@ndm.ox.ac.uk		Cairns, Benjamin/0000-0001-7994-8213	Cancer Research United Kingdom; Medical Research Council [G0700474] Funding Source: researchfish; MRC [G0700474] Funding Source: UKRI	Cancer Research United Kingdom(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Funded by a program grant from Cancer Research United Kingdom to the Cancer Epidemiology Unit. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali R, 2010, BRIT J CANCER, V103, P143, DOI 10.1038/sj.bjc.6605744; Ali R, 2012, GUT; [Anonymous], 1992, INT STAT CLASS DIS R; Bell A, 2004, 6 SURVEY PARENTS 3 4; Bhopal R, 2004, J EPIDEMIOL COMMUN H, V58, P441, DOI 10.1136/jech.2003.013466; Cancer Research UK, 2008, CANCERSTATS CHILDH C; Chaturvedi N, 2001, INT J EPIDEMIOL, V30, P925, DOI 10.1093/ije/30.5.925; Cummins C, 1999, J PUBLIC HEALTH MED, V21, P401, DOI 10.1093/pubmed/21.4.401; Cummins C, 2001, BRIT J CANCER, V84, P1215, DOI 10.1054/bjoc.2001.1775; Curado MP, 2007, CANC INCIDENCE 5 CON, VIX; Downing A, 2011, ETHNIC HEALTH, V16, P201, DOI 10.1080/13557858.2011.561301; Eden T, 2010, CANCER TREAT REV, V36, P286, DOI 10.1016/j.ctrv.2010.02.004; Flavell KJ, 2001, BRIT J CANCER, V85, P350, DOI 10.1054/bjoc.2001.1872; International Commission on Radiological Protection, 1998, GEN SUSC CANC; Jack RH, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-281; Kelly YJ, 2006, PEDIATRICS, V118, pE1428, DOI 10.1542/peds.2006-0714; Martin-Cordero C, 2003, J ENZYM INHIB MED CH, V18, P505, DOI 10.1080/14756360310001613085; McKinney PA, 2003, EUR J CANCER, V39, P92, DOI 10.1016/S0959-8049(02)00488-4; McNally RJQ, 2001, LEUKEMIA, V15, P1612, DOI 10.1038/sj.leu.2402252; Murdoch University, 2009, CONS END RES GLOB PR; Noble M, 2008, ENGLISH INDICES DEPR; *OFF NAT STAT, 2001, UK CENS; Office for National Statistics, 2003, ETHN GROUP STAT GUID; Office for National Statistics, 2011, POP EST ETHN GROUP E; Office of National Statistics, 2012, DEATH REG SUMM TABL; Office of Registrar General, 2001, 2001 CENS IND; Parkin D., 2002, IARC PUBL, V8; Policy Research Centre, 2010, MUSL LEIC; Pollock AM, 1997, J PUBLIC HEALTH MED, V19, P288, DOI 10.1093/oxfordjournals.pubmed.a024632; POWELL JE, 1994, ARCH DIS CHILD, V71, P398, DOI 10.1136/adc.71.5.398; Rastogi T, 2008, INT J EPIDEMIOL, V37, P147, DOI 10.1093/ije/dym219; Segi M., 1960, CANC MORTALITY SELEC; Shah A, 2007, BRIT J CANCER, V97, P1009, DOI 10.1038/sj.bjc.6603946; Simmons D, 1997, BRIT J NUTR, V78, P5, DOI 10.1079/BJN19970114; Spector LG, 2005, CANCER EPIDEM BIOMAR, V14, P651, DOI 10.1158/1055-9965.EPI-04-0602; Steliarova-Foucher E, 2005, CANCER-AM CANCER SOC, V103, P1457, DOI 10.1002/cncr.20910; STILLER CA, 1991, BRIT J CANCER, V64, P543, DOI 10.1038/bjc.1991.347; Swaminathan R, 2010, CANCER EPIDEMIOL, V34, P107, DOI 10.1016/j.canep.2009.11.006; van Laar M, 2010, BRIT J CANCER, V103, P1448, DOI 10.1038/sj.bjc.6605903; Winter H, 1999, BRIT J CANCER, V79, P645, DOI 10.1038/sj.bjc.6690102	40	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2013	8	4							e61881	10.1371/journal.pone.0061881	http://dx.doi.org/10.1371/journal.pone.0061881			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IK	23613964	Green Submitted, Green Published, gold			2022-12-25	WOS:000317907200098
J	Ceola, S; Hodl, I; Adlboller, M; Singer, G; Bertuzzo, E; Mari, L; Botter, G; Waringer, J; Battin, TJ; Rinaldo, A				Ceola, Serena; Hoedl, Iris; Adlboller, Martina; Singer, Gabriel; Bertuzzo, Enrico; Mari, Lorenzo; Botter, Gianluca; Waringer, Johann; Battin, Tom J.; Rinaldo, Andrea			Hydrologic Variability Affects Invertebrate Grazing on Phototrophic Biofilms in Stream Microcosms	PLOS ONE			English	Article							CURRENT VELOCITY; FLOW REGIMES; PERIPHYTON; ARCHITECTURE; HERBIVORY; RESPONSES; ECOSYSTEM; GRAZERS; DAMS	The temporal variability of streamflow is known to be a key feature structuring and controlling fluvial ecological communities and ecosystem processes. Although alterations of streamflow regime due to habitat fragmentation or other anthropogenic factors are ubiquitous, a quantitative understanding of their implications on ecosystem structure and function is far from complete. Here, by experimenting with two contrasting flow regimes in stream microcosms, we provide a novel mechanistic explanation for how fluctuating flow regimes may affect grazing of phototrophic biofilms (i.e., periphyton) by an invertebrate species (Ecdyonurus sp.). In both flow regimes light availability was manipulated as a control on autotroph biofilm productivity and grazer activity, thereby allowing the test of flow regime effects across various ratios of biofilm biomass to grazing activity. Average grazing rates were significantly enhanced under variable flow conditions and this effect was highest at intermediate light availability. Our results suggest that stochastic flow regimes, characterised by suitable fluctuations and temporal persistence, may offer increased windows of opportunity for grazing under favourable shear stress conditions. This bears important implications for the development of comprehensive schemes for water resources management and for the understanding of trophic carbon transfer in stream food webs.	[Ceola, Serena; Bertuzzo, Enrico; Mari, Lorenzo; Rinaldo, Andrea] Ecole Polytech Fed Lausanne, Lab Ecohydrol ECHO IEE ENAC, Lausanne, Switzerland; [Ceola, Serena] Univ Bologna, Dipartimento Ingn Civile Chim Ambientale & Mat, Bologna, Italy; [Hoedl, Iris; Adlboller, Martina; Singer, Gabriel; Waringer, Johann; Battin, Tom J.] Univ Vienna, Dept Limnol, Vienna, Austria; [Mari, Lorenzo] Politecn Milan, Dipartimento Elettron Informaz & Bioingn, I-20133 Milan, Italy; [Botter, Gianluca; Rinaldo, Andrea] Univ Padua, Dipartimento Ingn Civile Edile & Ambientale, Padua, Italy; [Battin, Tom J.] WasserCluster Lunz, Interuniv Ctr Aquat Ecosyst Res, Lunz Am See, Austria	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Bologna; University of Vienna; Polytechnic University of Milan; University of Padua	Rinaldo, A (corresponding author), Ecole Polytech Fed Lausanne, Lab Ecohydrol ECHO IEE ENAC, Lausanne, Switzerland.	andrea.rinaldo@epfl.ch	Bertuzzo, Enrico/U-7129-2017; Ceola, Serena/ABB-3364-2020; Ceola, Serena/AFP-3009-2022; Mari, Lorenzo/M-8528-2015; Singer, Gabriel/C-6285-2012	Bertuzzo, Enrico/0000-0001-5872-0666; Ceola, Serena/0000-0003-1757-509X; Ceola, Serena/0000-0003-1757-509X; Mari, Lorenzo/0000-0003-1326-9992; Singer, Gabriel/0000-0002-7389-9788; Waringer, Johann/0000-0002-0114-1636	European Research Council (ERC) [RINEC-227612]; SFN/FNS project (Swiss National Science Foundation) [200021_124930/1]; Fonds zur Foerderung der Wissenschaftlichen Forschung (the Austrian Science Fund) [START Y420-B17];  [CPDA105501]; Austrian Science Fund (FWF) [Y 420] Funding Source: researchfish	European Research Council (ERC)(European Research Council (ERC)European Commission); SFN/FNS project (Swiss National Science Foundation); Fonds zur Foerderung der Wissenschaftlichen Forschung (the Austrian Science Fund)(Austrian Science Fund (FWF)); ; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	SC, EB, LM and AR gratefully acknowledge the support provided by European Research Council (ERC) advanced grant program through the project RINEC-227612 and by SFN/FNS project (Swiss National Science Foundation 200021_124930/1). TJB acknowledges financial support from Fonds zur Foerderung der Wissenschaftlichen Forschung (the Austrian Science Fund) (START Y420-B17). GB acknowledges funding from the research grant CPDA105501. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan J D, 2007, STREAM ECOLOGY STRUC, V2nd; Arthington AH, 2006, ECOL APPL, V16, P1311, DOI 10.1890/1051-0761(2006)016[1311:TCOPEF]2.0.CO;2; Battin TJ, 2003, NATURE, V426, P439, DOI 10.1038/nature02152; Battin TJ, 2003, APPL ENVIRON MICROB, V69, P5443, DOI 10.1128/AEM.69.9.5443-5452.2003; Battin TJ, 2008, NAT GEOSCI, V1, P95, DOI 10.1038/ngeo101; Benton TG, 2007, TRENDS ECOL EVOL, V22, P516, DOI 10.1016/j.tree.2007.08.003; Botter G, 2007, WATER RESOUR RES, V43, DOI 10.1029/2006WR005397; Botter G, 2007, WATER RESOUR RES, V43, DOI 10.1029/2006WR005043; Botter G, 2010, WATER RESOUR RES, V46, DOI 10.1029/2009WR008523; Botter G, 2007, WATER RESOUR RES, V43, DOI 10.1029/2007WR006162; Ceola S, 2010, WATER RESOUR RES, V46, DOI 10.1029/2010WR009102; Cross WF, 2008, BIOTROPICA, V40, P477, DOI 10.1111/j.1744-7429.2007.00388.x; Feminella JW, 1995, J N AM BENTHOL SOC, V14, P465, DOI 10.2307/1467536; HARKER JE, 1953, J EXP BIOL, V30, P525; Hart DD, 1999, ANNU REV ECOL SYST, V30, P363, DOI 10.1146/annurev.ecolsys.30.1.363; Hauer F.R., 2007, METHODS STREAM ECOLO; HILL WR, 1995, ECOLOGY, V76, P1297, DOI 10.2307/1940936; Hondzo M, 2002, WATER RESOUR RES, V38, DOI 10.1029/2002WR001409; Ings NL, 2012, FRESHWATER BIOL, V57, P2526, DOI 10.1111/fwb.12025; Jaschinski S, 2010, MAR ECOL PROG SER, V401, P77, DOI 10.3354/meps08412; Kupferberg SJ, 2012, CONSERV BIOL, V26, P513, DOI 10.1111/j.1523-1739.2012.01837.x; LAMBERTI GA, 1985, FRESHWATER BIOL, V15, P21, DOI 10.1111/j.1365-2427.1985.tb00693.x; LAMBERTI GA, 1989, ECOLOGY, V70, P1840, DOI 10.2307/1938117; LANCASTER J, 1993, J N AM BENTHOL SOC, V12, P385, DOI 10.2307/1467619; Lancaster J, 2006, FRESHWATER BIOL, V51, P1053, DOI 10.1111/j.1365-2427.2006.01554.x; Lawrence JR, 2002, MICROB ECOL, V44, P199, DOI 10.1007/s00248-001-1064-y; Legendre P., 1998, NUMERICAL ECOLOGY, V24; Leopold L.B., 1992, FLUVIAL PROCESSES GE; Lytle DA, 2004, TRENDS ECOL EVOL, V19, P94, DOI 10.1016/j.tree.2003.10.002; Malmqvist B, 1996, OECOLOGIA, V108, P450, DOI 10.1007/BF00333721; Meissner K, 2009, ANN ZOOL FENN, V46, P193, DOI 10.5735/086.046.0304; Moog O, 2002, FAUNA AQUATICA AUSTR; Muneepeerakul R, 2008, NATURE, V453, P220, DOI 10.1038/nature06813; Poff NL, 2007, P NATL ACAD SCI USA, V104, P5732, DOI 10.1073/pnas.0609812104; Poff NL, 2006, GEOMORPHOLOGY, V79, P264, DOI 10.1016/j.geomorph.2006.06.032; Poff NL, 1997, BIOSCIENCE, V47, P769, DOI 10.2307/1313099; POFF NL, 1995, OIKOS, V72, P179, DOI 10.2307/3546220; POFF NL, 1992, OIKOS, V65, P465, DOI 10.2307/3545564; Power ME, 2008, ECOL MONOGR, V78, P263, DOI 10.1890/06-0902.1; POWER ME, 1995, GEOMORPHOLOGY, V13, P301, DOI 10.1016/0169-555X(95)00039-8; POWER ME, 1995, BIOSCIENCE, V45, P159, DOI 10.2307/1312555; Rodriguez-Iturbe I, 1999, P ROY SOC A-MATH PHY, V455, P3789, DOI 10.1098/rspa.1999.0477; Rodriguez-Iturbe I., 1997, FRACTAL RIVER BASINS; Rodriguez-Iturbe I, 2009, WATER RESOUR RES, V45, DOI 10.1029/2008WR007124; Rodruiguez-Iturbe I., 2004, ECOHYDROLOGY WATER C, DOI 10.1017/CBO9780511535727; Sabo JL, 2010, SCIENCE, V330, P965, DOI 10.1126/science.1196005; Sabo JL, 2009, ANN NY ACAD SCI, V1162, P187, DOI 10.1111/j.1749-6632.2009.04445.x; Schmedtje U, 1995, THESIS U INNSBRUCK A; Sommer U, 1999, ECOL LETT, V2, P65, DOI 10.1046/j.1461-0248.1999.22052.x; STATZNER B, 1989, FRESHWATER BIOL, V21, P445, DOI 10.1111/j.1365-2427.1989.tb01377.x; STEELE JH, 1962, LIMNOL OCEANOGR, V7, P137, DOI 10.4319/lo.1962.7.2.0137; STEELE JH, 1962, LIMNOL OCEANOGR, V7, P42, DOI 10.4319/lo.1962.7.1.0042; Stevenson R.J, 1996, ALGAL ECOLOGY FRESHW; Toffolon M, 2010, WATER RESOUR RES, V46, DOI 10.1029/2009WR008234; Trent M., 2011, LIMNOL OCEANOGR, V1, P147, DOI [10.1215/21573698-1498042, DOI 10.1215/21573698-1498042]; Uthermol H., 1958, MITTEILINGEN INTERNA, V9, P1, DOI [10.1080/0 5384680.1958.11904091, DOI 10.1080/05384680.1958.11904091]; VANNOTE RL, 1980, CAN J FISH AQUAT SCI, V37, P130, DOI 10.1139/f80-017; Vogel S, 1994, LIFE MOVING FLUIDS; Wellnitz TA, 2000, LIMNOL OCEANOGR, V45, P64, DOI 10.4319/lo.2000.45.1.0064; Wellnitz TA, 2001, LANDSCAPE ECOL, V16, P111, DOI 10.1023/A:1011114414898; Wellnitz TA, 1998, FRESHWATER BIOL, V39, P135, DOI 10.1046/j.1365-2427.1998.00270.x; Wellnitz T, 2006, FRESHWATER BIOL, V51, P2114, DOI 10.1111/j.1365-2427.2006.01644.x; Wootton JT, 1996, SCIENCE, V273, P1558, DOI 10.1126/science.273.5281.1558; Zolezzi G, 2011, ECOHYDROLOGY, V4, P564, DOI 10.1002/eco.132	64	38	39	1	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2013	8	4							e60629	10.1371/journal.pone.0060629	http://dx.doi.org/10.1371/journal.pone.0060629			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130DR	23613735	Green Published, Green Submitted, gold			2022-12-25	WOS:000317893400016
J	Chang, CL; Semyonov, J; Cheng, PJ; Huang, SY; Park, JI; Tsai, HJ; Lin, CY; Grutzner, F; Soong, YK; Cai, JJ; Hsu, SYT				Chang, Chia Lin; Semyonov, Jenia; Cheng, Po Jen; Huang, Shang Yu; Park, Jae Il; Tsai, Huai-Jen; Lin, Cheng-Yung; Gruetzner, Frank; Soong, Yung Kuei; Cai, James J.; Hsu, Sheau Yu Teddy			Widespread Divergence of the CEACAM/PSG Genes in Vertebrates and Humans Suggests Sensitivity to Selection	PLOS ONE			English	Article							PREGNANCY-SPECIFIC BETA-1-GLYCOPROTEIN; IMMUNOGLOBULIN-LIKE RECEPTOR; COPY-NUMBER VARIATION; EVOLUTIONARY DYNAMICS; NEISSERIA-GONORRHOEAE; MOLECULAR EVOLUTION; POSITIVE SELECTION; NATURAL-SELECTION; MATERNAL BLOOD; FAMILY	In mammals, carcinoembryonic antigen cell adhesion molecules (CEACAMs) and pregnancy-specific glycoproteins (PSGs) play important roles in the regulation of pathogen transmission, tumorigenesis, insulin signaling turnover, and fetal-maternal interactions. However, how these genes evolved and to what extent they diverged in humans remain to be investigated specifically. Based on syntenic mapping of chordate genomes, we reveal that diverging homologs with a prototypic CEACAM architecture-including an extracellular domain with immunoglobulin variable and constant domain-like regions, and an intracellular domain containing ITAM motif-are present from cartilaginous fish to humans, but are absent in sea lamprey, cephalochordate or urochordate. Interestingly, the CEACAM/PSG gene inventory underwent radical divergence in various vertebrate lineages: from zero in avian species to dozens in therian mammals. In addition, analyses of genetic variations in human populations showed the presence of various types of copy number variations (CNVs) at the CEACAM/PSG locus. These copy number polymorphisms have 3-80% frequency in select populations, and encompass single to more than six PSG genes. Furthermore, we found that CEACAM/PSG genes contain a significantly higher density of nonsynonymous single nucleotide polymorphism (SNP) compared to the chromosome average, and many CEACAM/PSG SNPs exhibit high population differentiation. Taken together, our study suggested that CEACAM/PSG genes have had a more dynamic evolutionary history in vertebrates than previously thought. Given that CEACAM/PSGs play important roles in maternal-fetal interaction and pathogen recognition, these data have laid the groundwork for future analysis of adaptive CEACAM/PSG genotype-phenotypic relationships in normal and complicated pregnancies as well as other etiologies.	[Chang, Chia Lin; Cheng, Po Jen; Huang, Shang Yu; Soong, Yung Kuei] Chang Gung Univ, Chang Gung Mem Hosp, Linkou Med Ctr, Dept Obstet & Gynecol, Tao Yuan, Taiwan; [Semyonov, Jenia; Park, Jae Il; Hsu, Sheau Yu Teddy] Stanford Univ, Sch Med, Dept Obstet & Gynecol, Reprod Biol & Stem Cell Res Program, Stanford, CA 94305 USA; [Tsai, Huai-Jen; Lin, Cheng-Yung] Natl Taiwan Univ, Inst Mol & Cellular Biol, Taipei 10764, Taiwan; [Gruetzner, Frank] Univ Adelaide, Sch Mol & Biomed Sci, Discipline Genet, Adelaide, SA, Australia; [Cai, James J.] Texas A&M Univ, Dept Vet Integrat Biosci, College Stn, TX USA	Chang Gung Memorial Hospital; Chang Gung University; Stanford University; National Taiwan University; University of Adelaide; Texas A&M University System; Texas A&M University College Station	Chang, CL (corresponding author), Chang Gung Univ, Chang Gung Mem Hosp, Linkou Med Ctr, Dept Obstet & Gynecol, Tao Yuan, Taiwan.	amego@cgmh.org.tw	Grutzner, Frank/AAD-5834-2020; Grutzner, Frank/ABB-2820-2021; Cai, James/C-4928-2008	Grutzner, Frank/0000-0002-3088-7314; Cai, James/0000-0002-8081-6725	National Health Research Institute, Taiwan [NHRI-Ex98-9822SIsimilar toNHRI-Ex100-9822SI]; New Century Health Care Promotion Foundation, Taipei, Taiwan [NCHCPF-94001]; NIH [RO1 DK70652]; Australian Research Council [DP0664267]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK070652] Funding Source: NIH RePORTER	National Health Research Institute, Taiwan(National Health Research Institutes - Taiwan); New Century Health Care Promotion Foundation, Taipei, Taiwan; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Australian Research Council(Australian Research Council); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors acknowledge the support of National Health Research Institute, Taiwan (NHRI-Ex98-9822SI similar to NHRI-Ex100-9822SI, CLC), New Century Health Care Promotion Foundation, Taipei, Taiwan (NCHCPF-94001, CLC), NIH (RO1 DK70652, SYH), and the Australian Research Council (DP0664267, FG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abi-Rached L, 2005, J EXP MED, V201, P1319, DOI 10.1084/jem.20042558; Aitman TJ, 2006, NATURE, V439, P851, DOI 10.1038/nature04489; Akey JM, 2009, GENOME RES, V19, P711, DOI 10.1101/gr.086652.108; Amigo J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-428; ANTHONY F, 1983, ANN CLIN BIOCHEM, V20, P26, DOI 10.1177/000456328302000104; Barreiro LB, 2008, NAT GENET, V40, P340, DOI 10.1038/ng.78; Barrett Jeffrey C, 2009, Cold Spring Harb Protoc, V2009, DOI 10.1101/pdb.ip71; Beauchemin N, 1999, EXP CELL RES, V252, P243; BOHN H, 1974, ARCH GYNAKOL, V217, P209, DOI 10.1007/BF02570647; Cann HM, 2002, SCIENCE, V296, P261; Chan CHF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001353; Chang CL, 2008, 41 ANN M SOC STUD RE; Chen DS, 1995, P NATL ACAD SCI USA, V92, P12095, DOI 10.1073/pnas.92.26.12095; Chen T, 2001, J BIOL CHEM, V276, P17413, DOI 10.1074/jbc.M010609200; CHEVINSKY AH, 1991, SEMIN SURG ONCOL, V7, P162, DOI 10.1002/ssu.2980070309; Colobran R, 2010, CLIN EXP IMMUNOL, V162, P41, DOI 10.1111/j.1365-2249.2010.04224.x; Conrad DF, 2010, NAT GENET, V42, P385, DOI 10.1038/ng.564; Demuth JP, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000085; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eichler EE, 2001, TRENDS GENET, V17, P661, DOI 10.1016/S0168-9525(01)02492-1; FELSENSTEIN J, 1988, ANNU REV GENET, V22, P521, DOI 10.1146/annurev.ge.22.120188.002513; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Finkenzeller D, 2000, MOL CELL BIOL, V20, P7140, DOI 10.1128/MCB.20.19.7140-7145.2000; Finkenzeller D, 2003, MOL CELL BIOL, V23, P272, DOI 10.1128/MCB.23.1.272-279.2003; Fu WQ, 2010, AM J HUM GENET, V87, P494, DOI 10.1016/j.ajhg.2010.09.006; Gibbons A, 2010, SCIENCE, V329, P740, DOI 10.1126/science.329.5993.740; GOLD P, 1965, J EXP MED, V121, P439, DOI 10.1084/jem.121.3.439; GORDON YB, 1977, LANCET, V1, P331; Gray-Owen SD, 2006, NAT REV IMMUNOL, V6, P433, DOI 10.1038/nri1864; Gu ZL, 2003, NATURE, V421, P63, DOI 10.1038/nature01198; Ha CT, 2010, BIOL REPROD, V83, P27, DOI 10.1095/biolreprod.109.082412; Hahn MW, 2007, PLOS GENET, V3, P2135, DOI 10.1371/journal.pgen.0030197; Hao L, 2005, GENE, V347, P149, DOI 10.1016/j.gene.2004.12.012; Hastings PJ, 2009, NAT REV GENET, V10, P551, DOI 10.1038/nrg2593; Hogan L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034291; Horst AK, 2006, J CLIN INVEST, V116, P1596, DOI 10.1172/JCI24340; Huang J, 1999, J CELL SCI, V112, P4193; Jaillon O, 2004, NATURE, V431, P946, DOI 10.1038/nature03025; Jakobsson M, 2008, NATURE, V451, P998, DOI 10.1038/nature06742; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Kammerer R, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-196; Kammerer R, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-12; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Kuespert K, 2006, CURR OPIN CELL BIOL, V18, P565, DOI 10.1016/j.ceb.2006.08.008; Larsen MH, 2012, INFECT GENET EVOL; Leung N, 2006, ONCOGENE, V25, P5527, DOI 10.1038/sj.onc.1209541; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Lisboa FA, 2011, J BIOL CHEM, V286, P7577, DOI 10.1074/jbc.M110.161810; Locke DP, 2006, AM J HUM GENET, V79, P275, DOI 10.1086/505653; LUPSKI JR, 1991, CELL, V66, P219, DOI 10.1016/0092-8674(91)90613-4; Malmberg KJ, 2011, IMMUNITY, V35, P653, DOI 10.1016/j.immuni.2011.11.007; McCaw SE, 2003, MOL MICROBIOL, V49, P623, DOI 10.1046/j.1365-2958.2003.03591.x; McLellan AS, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-4; Nagaishi T, 2006, IMMUNITY, V25, P769, DOI 10.1016/j.immuni.2006.08.026; Nei M, 2010, ANNU REV GENOM HUM G, V11, P265, DOI 10.1146/annurev-genom-082908-150129; Niimura Y, 2006, J HUM GENET, V51, P505, DOI 10.1007/s10038-006-0391-8; Niimura Yoshihito, 2009, Human Genomics, V4, P107; Nikolaidis N, 2005, IMMUNOGENETICS, V57, P151, DOI 10.1007/s00251-004-0764-0; Pang AW, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-r52; Park H, 2010, NAT GENET, V42, P400, DOI 10.1038/ng.555; Perry GH, 2007, NAT GENET, V39, P1256, DOI 10.1038/ng2123; Pickrell JK, 2009, GENOME RES, V19, P826, DOI 10.1101/gr.087577.108; Poy MN, 2002, NAT GENET, V30, P270, DOI 10.1038/ng840; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Rosenberg NA, 2006, ANN HUM GENET, V70, P841, DOI 10.1111/j.1469-1809.2006.00285.x; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Saraiva LR, 2007, GENOME RES, V17, P1448, DOI 10.1101/gr.6553207; Scally A, 2012, NATURE, V483, P169, DOI 10.1038/nature10842; Schaffer AA, 2001, NUCLEIC ACIDS RES, V29, P2994, DOI 10.1093/nar/29.14.2994; Schmitter T, 2004, J EXP MED, V199, P35, DOI 10.1084/jem.20030204; Semyonov J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001903; Shrestha Sadeep, 2010, BMC Res Notes, V3, P74, DOI 10.1186/1756-0500-3-74; SMITH GP, 1976, SCIENCE, V191, P528, DOI 10.1126/science.1251186; Sulem P, 2007, NAT GENET, V39, P1443, DOI 10.1038/ng.2007.13; TAMSEN L, 1983, J PERINAT MED, V11, P19, DOI 10.1515/jpme.1983.11.1.19; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tan KM, 2002, EMBO J, V21, P2076, DOI 10.1093/emboj/21.9.2076; Tishkoff SA, 2007, NAT GENET, V39, P31, DOI 10.1038/ng1946; Uhrberg M, 2005, EUR J IMMUNOL, V35, P10, DOI 10.1002/eji.200425743; Varki A, 2010, P NATL ACAD SCI USA, V107, P8939, DOI 10.1073/pnas.0914634107; Wagner A, 2000, NAT GENET, V24, P355, DOI 10.1038/74174; Wallis OC, 2001, J MOL ENDOCRINOL, V26, P249, DOI 10.1677/jme.0.0260249; Wang XX, 2012, P NATL ACAD SCI USA, V109, P9935, DOI 10.1073/pnas.1119459109; Wong KK, 2007, AM J HUM GENET, V80, P91, DOI 10.1086/510560; WURZ H, 1981, J PERINAT MED, V9, P67, DOI 10.1515/jpme.1981.9.2.67; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yokoyama S, 2007, ONCOGENE, V26, P7637, DOI 10.1038/sj.onc.1210577; Zhao LL, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-61	88	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2013	8	4							e61701	10.1371/journal.pone.0061701	http://dx.doi.org/10.1371/journal.pone.0061701			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130DR	23613906	Green Published, Green Submitted, gold			2022-12-25	WOS:000317893400094
J	Globisch, C; Krishnamani, V; Deserno, M; Peter, C				Globisch, Christoph; Krishnamani, Venkatramanan; Deserno, Markus; Peter, Christine			Optimization of an Elastic Network Augmented Coarse Grained Model to Study CCMV Capsid Deformation	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; CHLOROTIC MOTTLE VIRUS; PARTICLE MESH EWALD; FORCE-FIELD; MECHANICAL-PROPERTIES; COMPUTER-SIMULATION; TERTIARY STRUCTURE; SINGLE-PARAMETER; VIRAL CAPSIDS; IN-VITRO	The major protective coat of most viruses is a highly symmetric protein capsid that forms spontaneously from many copies of identical proteins. Structural and mechanical properties of such capsids, as well as their self-assembly process, have been studied experimentally and theoretically, including modeling efforts by computer simulations on various scales. Atomistic models include specific details of local protein binding but are limited in system size and accessible time, while coarse grained (CG) models do get access to longer time and length scales but often lack the specific local interactions. Multi-scale models aim at bridging this gap by systematically connecting different levels of resolution. Here, a CG model for CCMV (Cowpea Chlorotic Mottle Virus), a virus with an icosahedral shell of 180 identical protein monomers, is developed, where parameters are derived from atomistic simulations of capsid protein dimers in aqueous solution. In particular, a new method is introduced to combine the MARTINI CG model with a supportive elastic network based on structural fluctuations of individual monomers. In the parametrization process, both network connectivity and strength are optimized. This elastic-network optimized CG model, which solely relies on atomistic data of small units (dimers), is able to correctly predict inter-protein conformational flexibility and properties of larger capsid fragments of 20 and more subunits. Furthermore, it is shown that this CG model reproduces experimental (Atomic Force Microscopy) indentation measurements of the entire viral capsid. Thus it is shown that one obvious goal for hierarchical modeling, namely predicting mechanical properties of larger protein complexes from models that are carefully parametrized on elastic properties of smaller units, is achievable.	[Globisch, Christoph; Peter, Christine] Max Planck Inst Polymer Res MPIP, Mainz, Germany; [Krishnamani, Venkatramanan; Deserno, Markus] Carnegie Mellon Univ, Dept Phys, Pittsburgh, PA 15213 USA	Max Planck Society; Carnegie Mellon University	Peter, C (corresponding author), Max Planck Inst Polymer Res MPIP, Mainz, Germany.	peter@mpip-mainz.mpg.de	Deserno, Markus/P-1699-2014; Krishnamani, Venkatramanan/J-7535-2016	Deserno, Markus/0000-0001-5692-1595; 	Volkwagen Foundation within the framework of the program "New Conceptual Approaches to Modeling and Simulation of Complex Systems"; German Science Foundation within the Emmy Noether Program	Volkwagen Foundation within the framework of the program "New Conceptual Approaches to Modeling and Simulation of Complex Systems"; German Science Foundation within the Emmy Noether Program	The authors are grateful to the Volkwagen Foundation for supporting their project within the framework of the program "New Conceptual Approaches to Modeling and Simulation of Complex Systems" (www.volkswagenstiftung.de). CP also gratefully acknowledges financial support from the German Science Foundation within the Emmy Noether Program (www.dfg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arkhipov A, 2009, BIOPHYS J, V97, P2061, DOI 10.1016/j.bpj.2009.07.039; Atilgan AR, 2001, BIOPHYS J, V80, P505, DOI 10.1016/S0006-3495(01)76033-X; Ayton GS, 2007, CURR OPIN STRUC BIOL, V17, P192, DOI 10.1016/j.sbi.2007.03.004; Bahar I, 2005, CURR OPIN STRUC BIOL, V15, P586, DOI 10.1016/j.sbi.2005.08.007; Bahar I, 1999, J MOL BIOL, V285, P1023, DOI 10.1006/jmbi.1998.2371; Bahar I, 1997, FOLD DES, V2, P173, DOI 10.1016/S1359-0278(97)00024-2; Barrett CP, 2004, ACTA CRYSTALLOGR D, V60, P2280, DOI 10.1107/S0907444904019171; Bereau T, 2012, J CHEM THEORY COMPUT, V8, P3750, DOI 10.1021/ct200888u; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Berendsen HJC, 1981, INTERMOLECULAR FORCE, P331, DOI [DOI 10.1007/978-94-015-7658-1_21, 10.1007/978-94-015-7658-1_21]; Borhani DW, 2012, J COMPUT AID MOL DES, V26, P15, DOI 10.1007/s10822-011-9517-y; Bowman GR, 2011, J AM CHEM SOC, V133, P664, DOI 10.1021/ja106936n; BRUNGER AT, 1985, P NATL ACAD SCI USA, V82, P8458, DOI 10.1073/pnas.82.24.8458; Bucher D, 2010, J GEN PHYSL; Carloni P, 2002, ACCOUNTS CHEM RES, V35, P455, DOI 10.1021/ar010018u; CASPAR DLD, 1962, COLD SPRING HARB SYM, V27, P1, DOI 10.1101/sqb.1962.027.001.005; Cuendet MA, 2008, BIOPHYS J, V95, P3575, DOI 10.1529/biophysj.108.131383; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Durrant JD, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-71; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; FLORY PJ, 1976, P ROY SOC LOND A MAT, V351, P351, DOI 10.1098/rspa.1976.0146; HAGLER AT, 1978, P NATL ACAD SCI USA, V75, P554, DOI 10.1073/pnas.75.2.554; Haliloglu T, 1997, PHYS REV LETT, V79, P3090, DOI 10.1103/PhysRevLett.79.3090; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hess B, 2008, J CHEM THEORY COMPUT, V4, P116, DOI 10.1021/ct700200b; Jensen MO, 2012, SCIENCE, V336, P229, DOI 10.1126/science.1216533; KARPLUS M, 1990, NATURE, V347, P631, DOI 10.1038/347631a0; Karplus M, 2002, NAT STRUCT BIOL, V9, P646, DOI 10.1038/nsb0902-646; Karplus M, 2005, P NATL ACAD SCI USA, V102, P6679, DOI 10.1073/pnas.0408930102; Kerssemakers JWJ, 2006, NATURE, V442, P709, DOI 10.1038/nature04928; Krishnamani V, 2012, BIOCHEMISTRY-US, V51, P1061, DOI 10.1021/bi201770y; Krishnamani V, 2012, BIOCHEMISTRY-US, V51, P1051, DOI 10.1021/bi201769z; LEVITT M, 1975, NATURE, V253, P694, DOI 10.1038/253694a0; Lindorff-Larsen K, 2011, SCIENCE, V334, P517, DOI 10.1126/science.1208351; Lodola A, 2009, BIOCHEM SOC T, V37, P363, DOI 10.1042/BST0370363; Lyman E, 2008, BIOPHYS J, V95, P4183, DOI 10.1529/biophysj.108.139733; Marrink SJ, 2007, J PHYS CHEM B, V111, P7812, DOI 10.1021/jp071097f; Marrink SJ, 2004, J PHYS CHEM B, V108, P750, DOI 10.1021/jp036508g; MCCAMMON JA, 1977, NATURE, V267, P585, DOI 10.1038/267585a0; MCCAMMON JA, 1977, NATURE, V268, P765, DOI 10.1038/268765a0; Menikarachchi LC, 2010, CURR TOP MED CHEM, V10, P46, DOI 10.2174/156802610790232297; Michel JP, 2006, P NATL ACAD SCI USA, V103, P6184, DOI 10.1073/pnas.0601744103; Ming DM, 2003, BIOPHYS J, V85, P27, DOI 10.1016/S0006-3495(03)74451-8; Monticelli L, 2008, J CHEM THEORY COMPUT, V4, P819, DOI 10.1021/ct700324x; Oostenbrink C, 2004, J COMPUT CHEM, V25, P1656, DOI 10.1002/jcc.20090; Periole X, 2007, J AM CHEM SOC, V129, P10126, DOI 10.1021/ja0706246; Periole X, 2009, J CHEM THEORY COMPUT, V5, P2531, DOI 10.1021/ct9002114; Ponder JW, 2003, ADV PROTEIN CHEM, V66, P27; Risselada HJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038302; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Salsbury FR, 2010, CURR OPIN PHARMACOL, V10, P738, DOI 10.1016/j.coph.2010.09.016; Seo M, 2012, J CHEM THEORY COMPUT, V8, P1774, DOI 10.1021/ct200876v; Shaik S, 2010, CHEM REV, V110, P949, DOI 10.1021/cr900121s; Shen JW, 2011, J CHEM THEORY COMPUT, V7, P1916, DOI 10.1021/ct2001396; Shen TY, 2002, ACCOUNTS CHEM RES, V35, P332, DOI 10.1021/ar010025i; Shimamura T, 2010, SCIENCE, V328, P470, DOI 10.1126/science.1186303; Shinoda W, 2012, CURR OPIN STRUC BIOL, V22, P175, DOI 10.1016/j.sbi.2012.01.011; Sotomayor M, 2007, SCIENCE, V316, P1144, DOI 10.1126/science.1137591; Speir JA, 2006, J VIROL, V80, P3582, DOI 10.1128/JVI.80.7.3582-3591.2006; SPEIR JA, 1995, STRUCTURE, V3, P63, DOI 10.1016/S0969-2126(01)00135-6; Splettstoesser T, 2011, PROTEINS, V79, P2033, DOI 10.1002/prot.23017; Tama F, 2005, J MOL BIOL, V345, P299, DOI 10.1016/j.jmb.2004.10.054; Tang JH, 2006, J STRUCT BIOL, V154, P59, DOI 10.1016/j.jsb.2005.10.013; Tirion MM, 1996, PHYS REV LETT, V77, P1905, DOI 10.1103/PhysRevLett.77.1905; Tozzini V, 2005, CURR OPIN STRUC BIOL, V15, P144, DOI 10.1016/j.sbi.2005.02.005; Van Gunsteren WF, 1988, MOL SIMULAT, V1, P173, DOI 10.1080/08927028808080941; Voth G. A., 2008, COARSE GRAINING COND; Wang YM, 2004, J STRUCT BIOL, V147, P302, DOI 10.1016/j.jsb.2004.01.005; ZHAO XX, 1995, VIROLOGY, V207, P486, DOI 10.1006/viro.1995.1108; Zink M, 2009, BIOPHYS J, V96, P1350, DOI 10.1016/j.bpj.2008.11.028; Zlotnick A, 2000, VIROLOGY, V277, P450, DOI 10.1006/viro.2000.0619	71	36	36	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2013	8	4							e60582	10.1371/journal.pone.0060582	http://dx.doi.org/10.1371/journal.pone.0060582			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130DR	23613730	Green Published, Green Submitted, gold			2022-12-25	WOS:000317893400013
J	Kim, K; Carp, J; Fitzgerald, KD; Taylor, SF; Weissman, DH				Kim, Kamin; Carp, Joshua; Fitzgerald, Kate D.; Taylor, Stephan F.; Weissman, Daniel H.			Neural Congruency Effects in the Multi-Source Interference Task Vanish in Healthy Youth after Controlling for Conditional Differences in Mean RT	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; RESPONSE CONFLICT; BRAIN; TIME; FMRI; FDR	According to the conflict monitoring model of cognitive control, reaction time (RT) in distracter interference tasks (e.g., the Stroop task) is a more precise index of response conflict than stimulus congruency (incongruent vs. congruent). The model therefore predicts that RT should be a reliable predictor of activity in regions of the posterior medial frontal cortex (pMFC) that are posited to detect response conflict. In particular, pMFC activity should be (a) greater in slow-RT than in fast-RT trials within a given task condition (e.g., congruent) and (b) equivalent in RT-matched trials from different conditions (i.e., congruent and incongruent trials). Both of these effects have been observed in functional magnetic resonance imaging (MRI) studies of adults. However, neither effect was observed in a recent study of healthy youth, suggesting that (a) the model does not accurately describe the relationship between RT and pMFC activity in this population or (b) the recent study was characterized by high variability due to a relatively small sample size. To distinguish between these possibilities, we asked a relatively large group of healthy youth (n = 28) to perform a distracter interference task - the multi-source interference task (MSIT) - while we recorded their brain activity with functional MRI. In this relatively large sample, both of the model's predictions were confirmed. We conclude that the model accurately describes the relationship between pMFC activity and RT in healthy youth, but that additional research is needed to determine whether processes unrelated to response conflict contribute to this relationship.	[Kim, Kamin; Carp, Joshua; Weissman, Daniel H.] Univ Michigan, Dept Psychol, Ann Arbor, MI 48109 USA; [Fitzgerald, Kate D.; Taylor, Stephan F.] Univ Michigan, Dept Psychiat, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Kim, K (corresponding author), Univ Michigan, Dept Psychol, Ann Arbor, MI 48109 USA.	kaminkim@umich.edu; danweiss@umich.edu	Fitzgerald, Kate D./AAV-7278-2020	Kim, Kamin/0000-0002-4616-0646; Taylor, Stephan/0000-0001-8777-4292	Graduate Student Research Fellowship from the University of Michigan's Institute of Human Adjustment; National Defense Science and Engineering Graduate Fellowship; Dana Foundation; National Alliance for Research on Schizophrenia and Depression; Todd Ouida Clinical Scholars Award; National Institute of Mental Health [K23-MH082176]; University of Michigan; NATIONAL INSTITUTE OF MENTAL HEALTH [K23MH082176] Funding Source: NIH RePORTER	Graduate Student Research Fellowship from the University of Michigan's Institute of Human Adjustment; National Defense Science and Engineering Graduate Fellowship; Dana Foundation; National Alliance for Research on Schizophrenia and Depression(NARSAD); Todd Ouida Clinical Scholars Award; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); University of Michigan(University of Michigan System); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported by a Graduate Student Research Fellowship to Kamin Kim from the University of Michigan's Institute of Human Adjustment and by a National Defense Science and Engineering Graduate Fellowship to Joshua Carp. This research was also supported by funding to Kate Fitzgerald from the Dana Foundation, the National Alliance for Research on Schizophrenia and Depression, the Todd Ouida Clinical Scholars Award, and the National Institute of Mental Health (K23-MH082176). Finally, this research was supported by startup funds provided to Daniel H. Weissman by the University of Michigan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banich MT, 2000, J COGNITIVE NEUROSCI, V12, P988, DOI 10.1162/08989290051137521; Barch DM, 2001, CEREB CORTEX, V11, P837, DOI 10.1093/cercor/11.9.837; BENCH CJ, 1993, NEUROPSYCHOLOGIA, V31, P907, DOI 10.1016/0028-3932(93)90147-R; Binder JR, 2005, NEUROIMAGE, V27, P677, DOI 10.1016/j.neuroimage.2005.04.029; Blakemore SJ, 2006, J CHILD PSYCHOL PSYC, V47, P296, DOI 10.1111/j.1469-7610.2006.01611.x; Botvinick MM, 2004, TRENDS COGN SCI, V8, P539, DOI 10.1016/j.tics.2004.10.003; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Bunge SA, 2002, NEUROIMAGE, V17, P1562, DOI 10.1006/nimg.2002.1252; Bush G, 2003, MOL PSYCHIATR, V8, P60, DOI 10.1038/sj.mp.4001217; Carp J, 2012, NEUROIMAGE, V59, P853, DOI 10.1016/j.neuroimage.2011.07.064; Carp J, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00231; Chee MWL, 2008, J NEUROSCI, V28, P5519, DOI 10.1523/JNEUROSCI.0733-08.2008; Chumbley J, 2010, NEUROIMAGE, V49, P3057, DOI 10.1016/j.neuroimage.2009.10.090; Chumbley JR, 2009, NEUROIMAGE, V44, P62, DOI 10.1016/j.neuroimage.2008.05.021; Church JA, 2010, HUM BRAIN MAPP, V31, P852, DOI 10.1002/hbm.21036; Critchley HD, 2003, BRAIN, V126, P2139, DOI 10.1093/brain/awg216; Dosenbach NUF, 2006, NEURON, V50, P799, DOI 10.1016/j.neuron.2006.04.031; Fan J, 2008, CEREB CORTEX, V18, P796, DOI 10.1093/cercor/bhm125; Fitzgerald KD, 2010, NEUROIMAGE, V49, P3463, DOI 10.1016/j.neuroimage.2009.11.004; Grinband J, 2011, NEUROIMAGE, V57, P303, DOI 10.1016/j.neuroimage.2010.12.027; HU XP, 1995, MAGNET RESON MED, V34, P201, DOI 10.1002/mrm.1910340211; Kaufman J, 1997, J AM ACAD CHILD PSY, V36, P980, DOI 10.1097/00004583-199707000-00021; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; Lund TE, 2005, NEUROIMAGE, V26, P960, DOI 10.1016/j.neuroimage.2005.02.021; Mostofsky SH, 2002, BIOL PSYCHIAT, V52, P785, DOI 10.1016/S0006-3223(02)01412-9; Mulert C, 2005, INT J PSYCHOPHYSIOL, V56, P65, DOI 10.1016/j.ijpsycho.2004.10.002; Murtha S, 1996, HUM BRAIN MAPP, V4, P103, DOI 10.1002/(SICI)1097-0193(1996)4:2<103::AID-HBM2>3.0.CO;2-7; Nee DE, 2007, COGN AFFECT BEHAV NE, V7, P1, DOI 10.3758/CABN.7.1.1; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pfeuffer J, 2002, MAGN RESON MED, V47, P344, DOI 10.1002/mrm.10065; Poldrack Russell A, 2002, Top Magn Reson Imaging, V13, P61, DOI 10.1097/00002142-200202000-00005; Prado J, 2011, NEUROIMAGE, V54, P541, DOI 10.1016/j.neuroimage.2010.08.022; Qiu MG, 2011, BRAIN TOPOGR, V24, P243, DOI 10.1007/s10548-010-0168-4; SHUE KL, 1992, BRAIN COGNITION, V20, P104, DOI 10.1016/0278-2626(92)90064-S; van Veen V, 2001, NEUROIMAGE, V14, P1302, DOI 10.1006/nimg.2001.0923; Weissman DH, 2006, NAT NEUROSCI, V9, P971, DOI 10.1038/nn1727; Yarkoni T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004257; Yeung N, 2004, PSYCHOL REV, V111, P931, DOI [10.1037/0033-295X.111.4.931, 10.1037/0033-295x.111.4.931]; Yeung N, 2011, NEUROIMAGE, V57, P316, DOI 10.1016/j.neuroimage.2011.04.029	39	2	2	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2013	8	4							e60710	10.1371/journal.pone.0060710	http://dx.doi.org/10.1371/journal.pone.0060710			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	130DR	23613739	Green Published, Green Submitted, gold			2022-12-25	WOS:000317893400019
J	Klein, SL; Neilson, KM; Orban, J; Yaklichkin, S; Hoffbauer, J; Mood, K; Daar, IO; Moody, SA				Klein, Steven L.; Neilson, Karen M.; Orban, John; Yaklichkin, Sergey; Hoffbauer, Jennifer; Mood, Kathy; Daar, Ira O.; Moody, Sally A.			Conserved Structural Domains in FoxD4L1, a Neural Forkhead Box Transcription Factor, Are Required to Repress or Activate Target Genes	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; WINGED HELIX GENES; DNA-BINDING; DIFFERENTIAL EXPRESSION; COMPACTED CHROMATIN; IN-VITRO; XENOPUS; CREST; FOX; ECTODERM	FoxD4L1 is a forkhead transcription factor that expands the neural ectoderm by down-regulating genes that promote the onset of neural differentiation and up-regulating genes that maintain proliferative neural precursors in an immature state. We previously demonstrated that binding of Grg4 to an Eh-1 motif enhances the ability of FoxD4L1 to down-regulate target neural genes but does not account for all of its repressive activity. Herein we analyzed the protein sequence for additional interaction motifs and secondary structure. Eight conserved motifs were identified in the C-terminal region of fish and frog proteins. Extending the analysis to mammals identified a high scoring motif downstream of the Eh-1 domain that contains a tryptophan residue implicated in protein-protein interactions. In addition, secondary structure prediction programs predicted an alpha-helical structure overlapping with amphibian-specific Motif 6 in Xenopus, and similarly located alpha-helical structures in other vertebrate FoxD proteins. We tested functionality of this site by inducing a glutamine-to-proline substitution expected to break the predicted alpha-helical structure; this significantly reduced FoxD4L1's ability to repress zic3 and irx1. Because this mutation does not interfere with Grg4 binding, these results demonstrate that at least two regions, the Eh-1 motif and a more C-terminal predicted alpha-helical/Motif 6 site, additively contribute to repression. In the N-terminal region we previously identified a 14 amino acid motif that is required for the up-regulation of target genes. Secondary structure prediction programs predicted a short beta-strand separating two acidic domains. Mutant constructs show that the beta-strand itself is not required for transcriptional activation. Instead, activation depends upon a glycine residue that is predicted to provide sufficient flexibility to bring the two acidic domains into close proximity. These results identify conserved predicted motifs with secondary structures that enable FoxD4L1 to carry out its essential functions as both a transcriptional repressor and activator of neural genes.	[Klein, Steven L.; Neilson, Karen M.; Hoffbauer, Jennifer; Moody, Sally A.] George Washington Univ, Sch Med & Hlth Sci, Dept Anat & Regenerat Biol, Washington, DC 20052 USA; [Orban, John] Univ Maryland, Inst Biosci & Biotechnol Res, Dept Chem & Biochem, Rockville, MD USA; [Yaklichkin, Sergey] Univ Penn, Penn Ctr Bioinformat, Philadelphia, PA 19104 USA; [Mood, Kathy; Daar, Ira O.] NCI, Lab Cell & Dev Signaling, NIH, Frederick, MD 21701 USA	George Washington University; University of Pennsylvania; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Moody, SA (corresponding author), George Washington Univ, Sch Med & Hlth Sci, Dept Anat & Regenerat Biol, Washington, DC 20052 USA.	samoody@gwu.edu	Moody, Sally A./AAI-3660-2020	Moody, Sally A./0000-0003-4192-1087; Daar, Ira/0000-0003-2657-526X	George Washington University School of Medicine; National Science Foundation [MCB-1121711]; Intramural Research Program of the National Institutes of Health, National Cancer Institute [ZIA BC01000617]; National Science Foundation; NATIONAL CANCER INSTITUTE [ZIABC010958, ZIABC010006] Funding Source: NIH RePORTER	George Washington University School of Medicine; National Science Foundation(National Science Foundation (NSF)); Intramural Research Program of the National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported in part by facilitating funds from the George Washington University School of Medicine (SAM), National Science Foundation grant MCB-1121711 (SAM), and the Intramural Research Program of the National Institutes of Health, National Cancer Institute project number ZIA BC01000617 (IOD). Dr Klein (TM) s efforts were supported by the National Science Foundation while working at the Foundation. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of the National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angerer LM, 2011, DEVELOPMENT, V138, P3613, DOI 10.1242/dev.058172; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Bornberg-Bauer E, 1998, NUCLEIC ACIDS RES, V26, P2740, DOI 10.1093/nar/26.11.2740; Carlsson P, 2002, DEV BIOL, V250, P1, DOI 10.1006/dbio.2002.0780; Cirillo LA, 2002, MOL CELL, V9, P279, DOI 10.1016/S1097-2765(02)00459-8; DIRKSEN ML, 1995, DEV GENET, V17, P107, DOI 10.1002/dvg.1020170203; Dottori M, 2001, DEVELOPMENT, V128, P4127; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Fetka I, 2000, MECH DEVELOP, V93, P49, DOI 10.1016/S0925-4773(00)00265-3; Freyaldenhoven BS, 2002, GENE, V294, P131, DOI 10.1016/S0378-1119(02)00702-3; Gomez-Skarmeta JL, 1999, MECH DEVELOP, V80, P15, DOI 10.1016/S0925-4773(98)00190-7; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; Hannenhalli S, 2009, NAT REV GENET, V10, P233, DOI 10.1038/nrg2523; HATINI V, 1994, J NEUROBIOL, V25, P1293, DOI 10.1002/neu.480251010; Herrera E, 2004, DEVELOPMENT, V131, P5727, DOI 10.1242/dev.01431; Hromas R, 1999, CELL TISSUE RES, V297, P371, DOI 10.1007/s004410051365; Imai KS, 2002, DEVELOPMENT, V129, P3441; Jackson Brian C., 2010, Human Genomics, V4, P345; Jimenez G, 1997, GENE DEV, V11, P3072, DOI 10.1101/gad.11.22.3072; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; KAESTNER KH, 1995, J BIOL CHEM, V270, P30029, DOI 10.1074/jbc.270.50.30029; Katoh M, 2004, INT J ONCOL, V25, P1495; Knoepfler PS, 1999, NUCLEIC ACIDS RES, V27, P3752, DOI 10.1093/nar/27.18.3752; Kos R, 2001, DEVELOPMENT, V128, P1467; Labosky PA, 1998, MECH DEVELOP, V76, P185, DOI 10.1016/S0925-4773(98)00105-1; Lee HC, 2009, DEV BIOL, V336, P232, DOI 10.1016/j.ydbio.2009.10.001; Mariani FV, 1998, DEVELOPMENT, V125, P5019; Marsden I, 1998, J MOL BIOL, V278, P293, DOI 10.1006/jmbi.1998.1703; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Miller M, 2009, CURR PROTEIN PEPT SC, V10, P244, DOI 10.2174/138920309788452164; MOODY SA, 1987, DEV BIOL, V119, P560, DOI 10.1016/0012-1606(87)90059-5; Moody SA, 2000, METH MOL B, V135, P331; Moody SA, 1999, ADV MOLEC BIOL, P355; Neilson KM, 2012, DEV BIOL, V365, P363, DOI 10.1016/j.ydbio.2012.03.004; Nieuwkoop P.D., 1967, NORMAL TABLE XENOPUS; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Odenthal J, 1998, DEV GENES EVOL, V208, P245, DOI 10.1007/s004270050179; Pohl BS, 2005, GENE, V344, P21, DOI 10.1016/j.gene.2004.09.037; Pohl BS, 2002, MECH DEVELOP, V111, P181, DOI 10.1016/S0925-4773(01)00617-7; Pohl BS, 2001, MECH DEVELOP, V103, P93, DOI 10.1016/S0925-4773(01)00334-3; Pollastri G, 2005, BIOINFORMATICS, V21, P1719, DOI 10.1093/bioinformatics/bti203; PTASHNE M, 1988, NATURE, V335, P683, DOI 10.1038/335683a0; Sasai N, 2001, DEVELOPMENT, V128, P2525; SASAKI H, 1993, DEVELOPMENT, V118, P47; Schuddekopf K, 1996, P NATL ACAD SCI USA, V93, P9661, DOI 10.1073/pnas.93.18.9661; Sekiya T, 2007, MOL CELL, V28, P291, DOI 10.1016/j.molcel.2007.10.002; Sive Hazel L., 2000, EARLY DEV XENOPUS LA; SMITH LD, 1991, METHOD CELL BIOL, V36, P45; Solter M, 1999, MECH DEVELOP, V89, P161, DOI 10.1016/S0925-4773(99)00195-1; Suda Y, 1999, DEVELOPMENT, V126, P743; Sullivan SA, 2001, DEV BIOL, V232, P439, DOI 10.1006/dbio.2001.0191; Takahashi H, 2009, DEV BIOL, V331, P300, DOI 10.1016/j.ydbio.2009.05.549; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tuteja G, 2007, CELL, V130, DOI 10.1016/j.cell.2007.09.005; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wijchers PJEC, 2006, BIOCHEM J, V397, P233, DOI 10.1042/BJ20060387; Wu SCY, 1998, MECH DEVELOP, V70, P3, DOI 10.1016/S0925-4773(97)00157-3; Yaklichkin S, 2007, J BIOL CHEM, V282, P2548, DOI 10.1074/jbc.M607412200; Yaklichkin S, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-201; Yan B, 2010, DEV DYNAM, V239, P3467, DOI 10.1002/dvdy.22485; Yan B, 2009, DEV BIOL, V329, P80, DOI 10.1016/j.ydbio.2009.02.019; Yu JK, 2002, DEV DYNAM, V225, P289, DOI 10.1002/dvdy.10173; Zaret KS, 2008, COLD SH Q B, V73, P119, DOI 10.1101/sqb.2008.73.040; Zaret KS, 2011, GENE DEV, V25, P2227, DOI 10.1101/gad.176826.111; Zaret KS, 2002, NAT REV GENET, V3, P499, DOI 10.1038/nrg837	66	8	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2013	8	4							e61845	10.1371/journal.pone.0061845	http://dx.doi.org/10.1371/journal.pone.0061845			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130DR	23610594	gold, Green Published			2022-12-25	WOS:000317893400118
J	Soares, D; Bierman, HS				Soares, Daphne; Bierman, Hilary S.			Aerial Jumping in the Trinidadian Guppy (Poecilia reticulata)	PLOS ONE			English	Article							LIFE-HISTORY EVOLUTION; PIKE ESOX-LUCIUS; ARCHER FISH; PARALLEL EVOLUTION; START PERFORMANCE; GENE FLOW; DISPERSAL; KINEMATICS; WATER; POPULATIONS	Many fishes are able to jump out of the water and launch themselves into the air. Such behavior has been connected with prey capture, migration and predator avoidance. We found that jumping behavior of the guppy Poecilia reticulata is not associated with any of the above. The fish jump spontaneously, without being triggered by overt sensory cues, is not migratory and does not attempt to capture aerial food items. Here, we use high speed video imaging to analyze the kinematics of the jumping behavior P. reticulata. Fish jump from a still position by slowly backing up while using its pectoral fins, followed by strong body trusts which lead to launching into the air several body lengths. The liftoff phase of the jump is fast and fish will continue with whole body thrusts and tail beats, even when out of the water. This behavior occurs when fish are in a group or in isolation. Geography has had substantial effects on guppy evolution, with waterfalls reducing gene flow and constraining dispersal. We suggest that jumping has evolved in guppies as a behavioral phenotype for dispersal.	[Soares, Daphne; Bierman, Hilary S.] Univ Maryland, Dept Biol, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park	Soares, D (corresponding author), Univ Maryland, Dept Biol, College Pk, MD 20742 USA.	daph@umd.edu			Marine Biological Laboratory, Woods Hole MA	Marine Biological Laboratory, Woods Hole MA	Work was supported by a 2011 summer fellowship to DS from the Marine Biological Laboratory, Woods Hole MA 02543, www.mbl.edu (no grant #). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander HJ, 2006, EVOLUTION, V60, P2352, DOI 10.1111/j.0014-3820.2006.tb01870.x; Barson NJ, 2009, J EVOLUTION BIOL, V22, P485, DOI 10.1111/j.1420-9101.2008.01675.x; Becher SA, 2000, J FISH BIOL, V56, P241, DOI 10.1111/j.1095-8649.2000.tb02103.x; BENGTSSON BO, 1978, J THEOR BIOL, V73, P439, DOI 10.1016/0022-5193(78)90151-0; Breden F, 1999, MOL PHYLOGENET EVOL, V12, P95, DOI 10.1006/mpev.1998.0600; Breder C. M., 1937, Science New York N S, V86, P420, DOI 10.1126/science.86.2236.420; CARLQUIS.S, 1966, Q REV BIOL, V41, P247, DOI 10.1086/405054; Carlquist S, 1965, ISLAND LIFE NATURAL; Chappell M, 2004, PHYSIOL BIOCHEM ZOOL, V77, P27, DOI 10.1086/378920; CHESSER RK, 1986, EVOLUTION, V40, P616, DOI 10.1111/j.1558-5646.1986.tb00512.x; COMINS HN, 1980, J THEOR BIOL, V82, P205, DOI 10.1016/0022-5193(80)90099-5; CRESPI BJ, 1990, AM NAT, V135, P48, DOI 10.1086/285031; Crispo E, 2006, MOL ECOL, V15, P49, DOI 10.1111/j.1365-294X.2005.02764.x; Croft DP, 2003, OECOLOGIA, V137, P62, DOI 10.1007/s00442-003-1268-6; DAVENPORT J, 1994, REV FISH BIOL FISHER, V4, P184, DOI 10.1007/BF00044128; Dieckmann U, 1999, TRENDS ECOL EVOL, V14, P88, DOI 10.1016/S0169-5347(98)01571-7; Domenici P, 1997, J EXP BIOL, V200, P1165; EATON RC, 1977, J EXP BIOL, V66, P65; ELSHOUD GCA, 1985, ZOOMORPHOLOGY, V105, P240, DOI 10.1007/BF00311967; ENDLER JA, 1995, TRENDS ECOL EVOL, V10, P22, DOI 10.1016/S0169-5347(00)88956-9; Ferriere R, 2000, TRENDS ECOL EVOL, V15, P5, DOI 10.1016/S0169-5347(99)01757-7; FRANK SA, 1986, J THEOR BIOL, V122, P303, DOI 10.1016/S0022-5193(86)80122-9; FRITH HR, 1995, J EXP BIOL, V198, P1863; Gibb AC, 2011, J EXP ZOOL PART A, V315A, P649, DOI 10.1002/jez.711; GILLIAM JF, 1993, ECOLOGY, V74, P1856, DOI 10.2307/1939943; Hale ME, 2002, EVOLUTION, V56, P993; HAMILTON WD, 1977, NATURE, V269, P578, DOI 10.1038/269578a0; Hendry AP, 2006, J EVOLUTION BIOL, V19, P741, DOI 10.1111/j.1420-9101.2005.01061.x; Houde A.E., 1997, SEX COLOR MATE CHOIC; Hubbs C.L., 1933, PAPERS MICHIGAN ACAD, V17, P575; Hyatt K, 1971, ANAL SOME SELECTED A; JOHNSON ML, 1990, ANNU REV ECOL SYST, V21, P449, DOI 10.1146/annurev.ecolsys.21.1.449; JOHNSON TP, 1995, J EXP BIOL, V198, P2165; Johnson TP, 1998, J EXP BIOL, V201, P2045; KALLEBERG HARRY, 1958, REPT INST FRESHWATER RES DROTTNINGHOLM, V39, P55; KAWACHI K, 1993, J THEOR BIOL, V163, P145, DOI 10.1006/jtbi.1993.1113; Kondratieff MC, 2006, T AM FISH SOC, V135, P361, DOI 10.1577/T04-210.1; Lauritzen DV, 2010, BIOINSPIR BIOMIM, V5, DOI 10.1088/1748-3182/5/3/035006; Liao JC, 2007, PHILOS T R SOC B, V362, P1973, DOI 10.1098/rstb.2007.2082; Lowry D, 2005, ENVIRON BIOL FISH, V73, P453, DOI 10.1007/s10641-005-3214-4; MAGURRAN AE, 2005, EVOLUTIONARY ECOLOGY; O'Steen S, 2002, EVOLUTION, V56, P776, DOI 10.1554/0014-3820(2002)056[0776:REOEAI]2.0.CO;2; RAYNER JMV, 1986, ENDEAVOUR, V10, P58, DOI 10.1016/0160-9327(86)90131-6; REZNICK DA, 1990, NATURE, V346, P357, DOI 10.1038/346357a0; Reznick DN, 1996, AM NAT, V147, P319, DOI 10.1086/285854; REZNICK DN, 1987, EVOLUTION, V41, P1370, DOI 10.1111/j.1558-5646.1987.tb02474.x; Reznick DN, 1997, SCIENCE, V275, P1934, DOI 10.1126/science.275.5308.1934; ROFF DA, 1990, ECOL MONOGR, V60, P389, DOI 10.2307/1943013; Rossel S, 2002, J EXP BIOL, V205, P3321; Saidel WM, 2004, ENVIRON BIOL FISH, V71, P63, DOI 10.1023/B:EBFI.0000043153.38418.cd; Schriefer JE, 2004, J EXP BIOL, V207, P535, DOI 10.1242/jeb.00789; Shih AM, 2010, IFMBE PROC, V31, P48, DOI 10.1007/978-3-642-14515-5_13; Suk HY, 2009, HEREDITY, V102, P425, DOI 10.1038/hdy.2009.7; Sulak KJ, 2002, J APPL ICHTHYOL, V18, P617, DOI 10.1046/j.1439-0426.2002.00401.x; Timmermans PJA, 2000, NETH J ZOOL, V50, P411, DOI 10.1163/156854200506053; Trewick SA, 2000, J BIOGEOGR, V27, P1189, DOI 10.1046/j.1365-2699.2000.00492.x; Turesson H, 2009, J EXP BIOL, V212, P2925, DOI 10.1242/jeb.032953; van Oosterhout C, 2006, EVOLUTION, V60, P2562, DOI 10.1111/j.0014-3820.2006.tb01890.x; Walker JA, 2005, FUNCT ECOL, V19, P808, DOI 10.1111/j.1365-2435.2005.01033.x; WIEST FC, 1995, J ZOOL, V236, P571, DOI 10.1111/j.1469-7998.1995.tb02733.x; Wohl S, 2007, J EXP BIOL, V210, P311, DOI 10.1242/jeb.02646; ZAHL PA, 1977, COPEIA, P791; Zimmerman E.C., 1948, INSECTS HAWAII, VVolume 7	63	15	15	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2013	8	4							e61617	10.1371/journal.pone.0061617	http://dx.doi.org/10.1371/journal.pone.0061617			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130DR	23613883	Green Submitted, gold, Green Published			2022-12-25	WOS:000317893400081
J	Torrado, E; Fountain, JJ; Robinson, RT; Martino, CA; Pearl, JE; Rangel-Moreno, J; Tighe, M; Dunn, R; Cooper, AM				Torrado, Egidio; Fountain, Jeffrey J.; Robinson, Richard T.; Martino, Cynthia A.; Pearl, John E.; Rangel-Moreno, Javier; Tighe, Michael; Dunn, Robert; Cooper, Andrea M.			Differential and Site Specific Impact of B Cells in the Protective Immune Response to Mycobacterium tuberculosis in the Mouse	PLOS ONE			English	Article							FC-GAMMA RECEPTORS; ENTERICA SEROVAR TYPHIMURIUM; DEFICIENT MICE; IN-VIVO; ACQUIRED-RESISTANCE; INFECTION; MACROPHAGES; ANTIBODIES; PROGRESSION; ACTIVATION	Cell-mediated immune responses are known to be critical for control of mycobacterial infections whereas the role of B cells and humoral immunity is unclear. B cells can modulate immune responses by secretion of immunoglobulin, production of cytokines and antigen-presentation. To define the impact of B cells in the absence of secreted immunoglobulin, we analyzed the progression of Mycobacterium tuberculosis (Mtb) infection in mice that have B cells but which lack secretory immunoglobulin (AID(-/-)mu S-/- mice). AID(-/-)mu S-/- mice accumulated a population of activated B cells in the lungs when infected and were more susceptible to aerosol Mtb when compared to wild type (C57BL/6) mice or indeed mice that totally lack B cells. The enhanced susceptibility of AID(-/-)mu S-/- mice was not associated with defective T cell activation or expression of a type 1 immune response. While delivery of normal serum to AID(-/-)mu S-/- mice did not reverse susceptibility, susceptibility in the spleen was dependent upon the presence of B cells and susceptibility in the lungs of AID(-/-)mu S-/- mice was associated with elevated expression of the cytokines IL-6, GM-CSF, IL-10 and molecules made by alternatively activated macrophages. Blocking of IL-10 signaling resulted in reversal of susceptibility in the spleens and lungs of AID(-/-)mu S-/- mice. These data support the hypothesis that B cells can modulate immunity to Mtb in an organ specific manner via the modulation of cytokine production and macrophage activation.	[Torrado, Egidio; Fountain, Jeffrey J.; Robinson, Richard T.; Martino, Cynthia A.; Pearl, John E.; Tighe, Michael; Cooper, Andrea M.] Trudeau Inst Inc, Saranac Lake, NY USA; [Rangel-Moreno, Javier] Univ Rochester, Med Ctr, Dept Med, Div Allergy Immunol & Rheumatol, Rochester, NY 14642 USA; [Dunn, Robert] Biogen Idec Inc, Cambridge, MA USA; [Dunn, Robert] Biogen Idec Inc, San Diego, CA USA	Trudeau Institute; University of Rochester; Biogen; Biogen	Cooper, AM (corresponding author), Trudeau Inst Inc, POB 59, Saranac Lake, NY USA.	acooper@trudeauinstitute.org	Torrado, Egídio/T-5156-2018	Torrado, Egídio/0000-0002-7462-8234; Rangel-Moreno, Javier/0000-0002-9738-1182; Cooper, Andrea/0000-0001-6050-3863; Fountain, Jeffrey/0000-0001-9473-7705; Pearl, John/0000-0001-7496-6367; Robinson, Richard/0000-0002-4699-515X	Trudeau Institute, Inc.; NIAID, NIH [AI46530, AI0691121, AI067723]; ALA DeSouza award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI067723, P01AI046530] Funding Source: NIH RePORTER	Trudeau Institute, Inc.; NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); ALA DeSouza award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Work supported by Trudeau Institute, Inc., NIAID, NIH awards AI46530, AI0691121, AI067723 and an ALA DeSouza award - all to AMC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard C, 2009, IMMUNOL CELL BIOL, V87, P279, DOI 10.1038/icb.2009.14; Ahuja A, 2007, J IMMUNOL, V179, P3351, DOI 10.4049/jimmunol.179.5.3351; Baumgarth N, 2008, CURR TOP MICROBIOL, V319, P41; Beamer GL, 2008, J IMMUNOL, V181, P5545, DOI 10.4049/jimmunol.181.8.5545; Boes M, 1998, J IMMUNOL, V160, P4776; Bosio CM, 2000, J IMMUNOL, V164, P6417, DOI 10.4049/jimmunol.164.12.6417; Carragher DM, 2008, J IMMUNOL, V181, P4168, DOI 10.4049/jimmunol.181.6.4168; Chan AC, 2010, NAT REV IMMUNOL, V10, P301, DOI 10.1038/nri2761; Cooper AM, 2009, ANNU REV IMMUNOL, V27, P393, DOI 10.1146/annurev.immunol.021908.132703; Crawford A, 2006, J IMMUNOL, V176, P3498, DOI 10.4049/jimmunol.176.6.3498; Culkin SJ, 1997, J IMMUNOL, V158, P3277; Dorner T, 2007, IMMUNITY, V27, P384, DOI 10.1016/j.immuni.2007.09.002; Edwards JCW, 2006, NAT REV IMMUNOL, V6, P394, DOI 10.1038/nri1838; El Kasmi KC, 2008, NAT IMMUNOL, V9, P1399, DOI 10.1038/ni.1671; Gillan V, 2005, INT IMMUNOL, V17, P373, DOI 10.1093/intimm/dxh217; Gray D, 2007, EUR J IMMUNOL, V37, P3304, DOI 10.1002/eji.200737728; Hamel K, 2008, J IMMUNOL, V180, P4994, DOI 10.4049/jimmunol.180.7.4994; Hooper LV, 2001, SCIENCE, V292, P1115, DOI 10.1126/science.1058709; Huber VC, 2001, J IMMUNOL, V166, P7381, DOI 10.4049/jimmunol.166.12.7381; Ichinohe T, 2011, P NATL ACAD SCI USA, V108, P5354, DOI 10.1073/pnas.1019378108; Johnson CM, 1997, TUBERCLE LUNG DIS, V78, P257, DOI 10.1016/S0962-8479(97)90006-X; Khader SA, 2005, J IMMUNOL, V175, P788, DOI 10.4049/jimmunol.175.2.788; Kima PE, 2000, J EXP MED, V191, P1063, DOI 10.1084/jem.191.6.1063; Kumazaki K, 2007, J IMMUNOL, V178, P2192, DOI 10.4049/jimmunol.178.4.2192; Lang R, 2002, J IMMUNOL, V169, P2253, DOI 10.4049/jimmunol.169.5.2253; Langhorne J, 1998, P NATL ACAD SCI USA, V95, P1730, DOI 10.1073/pnas.95.4.1730; Lund FE, 2006, J IMMUNOL, V176, P6147, DOI 10.4049/jimmunol.176.10.6147; Lund FE, 2010, NAT REV IMMUNOL, V10, P236, DOI 10.1038/nri2729; Lund Frances E., 2005, V8, P25; Maartens G, 2007, LANCET, V370, P2030, DOI 10.1016/S0140-6736(07)61262-8; MacMicking JD, 1997, P NATL ACAD SCI USA, V94, P5243, DOI 10.1073/pnas.94.10.5243; MacMicking JD, 2003, SCIENCE, V302, P654, DOI 10.1126/science.1088063; Maglione PJ, 2008, J IMMUNOL, V180, P3329, DOI 10.4049/jimmunol.180.5.3329; Maglione PJ, 2007, J IMMUNOL, V178, P7222, DOI 10.4049/jimmunol.178.11.7222; Mastroeni P, 2000, INFECT IMMUN, V68, P46, DOI 10.1128/IAI.68.1.46-53.2000; Menager N, 2007, IMMUNOLOGY, V120, P424, DOI 10.1111/j.1365-2567.2006.02527.x; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Murray PJ, 1997, J IMMUNOL, V158, P315; Qualls JE, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000955; Redford PS, 2010, EUR J IMMUNOL, V40, P2200, DOI 10.1002/eji.201040433; Roberts AD, 2002, METHOD MICROBIOL, V32, P433; Schreiber T, 2009, J IMMUNOL, V183, P1301, DOI 10.4049/jimmunol.0803567; Seder RA, 2000, NATURE, V406, P793, DOI 10.1038/35021239; Serreze DV, 2011, DIABETES, V60, P2914, DOI 10.2337/db11-0705; Stephens R, 2006, PARASITE IMMUNOL, V28, P25, DOI 10.1111/j.1365-3024.2006.00767.x; Su H, 1997, INFECT IMMUN, V65, P1993, DOI 10.1128/IAI.65.6.1993-1999.1997; Teitelbaum R, 1998, P NATL ACAD SCI USA, V95, P15688, DOI 10.1073/pnas.95.26.15688; Turner J, 2002, J IMMUNOL, V169, P6343, DOI 10.4049/jimmunol.169.11.6343; Turner J, 2001, EXP GERONTOL, V36, P537, DOI 10.1016/S0531-5565(00)00257-6; Uppington H, 2006, IMMUNOLOGY, V119, P147, DOI 10.1111/j.1365-2567.2006.02416.x; Vordermeier HM, 1996, CLIN EXP IMMUNOL, V106, P312, DOI 10.1046/j.1365-2249.1996.d01-845.x; Williams A, 2004, IMMUNOLOGY, V111, P328, DOI 10.1111/j.1365-2567.2004.01809.x; Woelbing F, 2006, J EXP MED, V203, P177, DOI 10.1084/jem.20052288; Wojciechowski W, 2009, IMMUNITY, V30, P421, DOI 10.1016/j.immuni.2009.01.006; Yang X, 1998, J IMMUNOL, V161, P1439; Yoneto T, 2001, J IMMUNOL, V166, P6236, DOI 10.4049/jimmunol.166.10.6236	56	41	43	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2013	8	4							e61681	10.1371/journal.pone.0061681	http://dx.doi.org/10.1371/journal.pone.0061681			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130DR	23613902	Green Published, Green Submitted, gold			2022-12-25	WOS:000317893400090
J	Tougeron, D; Maby, P; Elie, N; Fauquembergue, E; Le Pessot, F; Cornic, M; Sabourin, JC; Michel, P; Frebourg, T; Latouche, JB				Tougeron, David; Maby, Pauline; Elie, Nicolas; Fauquembergue, Emilie; Le Pessot, Florence; Cornic, Marie; Sabourin, Jean-Christophe; Michel, Pierre; Frebourg, Thierry; Latouche, Jean-Baptiste			Regulatory T Lymphocytes Are Associated with Less Aggressive Histologic Features in Microsatellite-Unstable Colorectal Cancers	PLOS ONE			English	Article							TUMOR-INFILTRATING LYMPHOCYTES; PROGNOSTIC-FACTOR; HIGH PREVALENCE; INSTABILITY; CELLS; CARCINOMAS; EXPRESSION; DEFICIENT; APOPTOSIS; SURVIVAL	Background: Colorectal cancers (CRCs) with microsatellite instability (MSI) are associated with a good prognosis and a high density of tumor-infiltrating lymphocytes (TILs). We have undertaken to determine the link between TIL densities and MSI CRC histologic features. Patients and Methods: Using tissue microarrays, T-cell sub-population infiltration, including T cells (CD3), cytotoxic T cells (CD8) and regulatory T cells (FoxP3) were studied in 86 MSI CRCs. We separately analyzed TILs of the stromal and epithelial compartments in the tumor center, the tumoral invasion margin and associated normal tissue. Results: For FoxP3+ TIL density in the tumor center stromal compartment, we found a strong negative correlation with T4 stage (p = 0.01), node invasion (p<0.001) and VELIPI (vascular emboli, lymphatic invasion and perinervous invasion) criteria (p = 0.002). Conclusion: The strong correlation between regulatory T cell density and the absence of VELIPI criteria suggests that this sub-group of T cells is preferentially associated with less invasive tumors.	[Tougeron, David; Maby, Pauline; Fauquembergue, Emilie; Sabourin, Jean-Christophe; Michel, Pierre; Frebourg, Thierry; Latouche, Jean-Baptiste] Rouen Univ Hosp, Inst Med Res, Fac Med, Inserm,U1079, Rouen, France; [Tougeron, David; Michel, Pierre] Rouen Univ Hosp, Dept Gastroenterol, Rouen, France; [Tougeron, David] Univ Poitiers Hosp, Dept Gastroenterol, Poitiers, France; [Tougeron, David] Univ Poitiers, EA 4331, Lab Inflammat Tissus Epitheliaux & Cytokines, Poitiers, France; [Elie, Nicolas] Univ Caen, CMABIO, F-14032 Caen, France; [Le Pessot, Florence; Sabourin, Jean-Christophe] Rouen Univ Hosp, Dept Pathol, Rouen, France; [Cornic, Marie] Ctr Henri Becquerel, Dept Pathol, F-76038 Rouen, France	CHU de Rouen; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU de Rouen; CHU Poitiers; Universite de Poitiers; Universite de Poitiers; Universite de Caen Normandie; CHU de Rouen; UNICANCER; Centre Henri Becquerel	Tougeron, D (corresponding author), Rouen Univ Hosp, Inst Med Res, Fac Med, Inserm,U1079, Rouen, France.	davidtougeron@hotmail.fr	Frebourg, Thierry/AAK-8390-2020; tougeron, david/ABF-3217-2020; Elie, Nicolas/ABC-4069-2020	tougeron, david/0000-0002-8065-9635; Elie, Nicolas/0000-0001-5772-8252; Frebourg, Thierry/0000-0003-0399-4007; Latouche, Jean-Baptiste/0000-0003-4802-5429	Inserm - Haute-Normandie Region; Ligue Contre le Cancer de Seine-Maritime	Inserm - Haute-Normandie Region; Ligue Contre le Cancer de Seine-Maritime	Financial support was received from Inserm - Haute-Normandie Region (P. Maby's salary), and Ligue Contre le Cancer de Seine-Maritime (reagents). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaltonen LA, 1998, NEW ENGL J MED, V338, P1481, DOI 10.1056/NEJM199805213382101; Baker K, 2007, EUR J CANCER, V43, P624, DOI 10.1016/j.ejca.2006.11.012; Benatti P, 2005, CLIN CANCER RES, V11, P8332, DOI 10.1158/1078-0432.CCR-05-1030; Blatner NR, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004566; Buhard O, 2006, J CLIN ONCOL, V24, P241, DOI 10.1200/JCO.2005.02.7227; Chaput N, 2009, GUT, V58, P520, DOI 10.1136/gut.2008.158824; Clarke SL, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000129; Diederichsen ACP, 2003, CANCER IMMUNOL IMMUN, V52, P423, DOI 10.1007/s00262-003-0388-5; Dolcetti R, 1999, AM J PATHOL, V154, P1805, DOI 10.1016/S0002-9440(10)65436-3; Drescher KM, 2009, FAM CANCER, V8, P231, DOI 10.1007/s10689-009-9233-0; Frey DM, 2010, INT J CANCER, V126, P2635, DOI 10.1002/ijc.24989; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Gray RG, 2000, LANCET, V355, P1588; Greenson JK, 2009, AM J SURG PATHOL, V33, P126, DOI 10.1097/PAS.0b013e31817ec2b1; Gryfe R, 2000, NEW ENGL J MED, V342, P69, DOI 10.1056/NEJM200001133420201; Guidoboni M, 2001, AM J PATHOL, V159, P297, DOI 10.1016/S0002-9440(10)61695-1; Katz SC, 2009, ANN SURG ONCOL, V16, P2524, DOI 10.1245/s10434-009-0585-3; Koch M, 2006, ANN SURG, V244, P986, DOI 10.1097/01.sla.0000247058.43243.7b; Le Gouvello S, 2008, GUT, V57, P772, DOI 10.1136/gut.2007.123794; Ling Khoon Lin, 2007, Cancer Immun, V7, P7; Loddenkemper C, 2006, J TRANSL MED, V4, DOI 10.1186/1479-5876-4-52; Lugli A, 2009, BRIT J CANCER, V101, P1382, DOI 10.1038/sj.bjc.6605318; Mantovani A, 2010, ANN MED, V42, P161, DOI 10.3109/07853890903405753; Michael-Robinson JM, 2001, GUT, V48, P360, DOI 10.1136/gut.48.3.360; Michel S, 2010, INT J CANCER, V127, P889, DOI 10.1002/ijc.25106; Mlecnik B, 2011, J CLIN ONCOL, V29, P610, DOI 10.1200/JCO.2010.30.5425; Naito Y, 1998, CANCER RES, V58, P3491; Nosho K, 2010, J PATHOL, V222, P350, DOI 10.1002/path.2774; Pages F, 2005, NEW ENGL J MED, V353, P2654, DOI 10.1056/NEJMoa051424; Phillips SM, 2004, BRIT J SURG, V91, P469, DOI 10.1002/bjs.4472; Prall F, 2004, HUM PATHOL, V35, P808, DOI 10.1016/j.humpath.2004.01.022; Radoja S, 2001, J IMMUNOL, V167, P5042, DOI 10.4049/jimmunol.167.9.5042; Salama P, 2009, J CLIN ONCOL, V27, P186, DOI 10.1200/JCO.2008.18.7229; Schwitalle Y, 2008, GASTROENTEROLOGY, V134, P988, DOI 10.1053/j.gastro.2008.01.015; Sinicrope FA, 2009, GASTROENTEROLOGY, V137, P1270, DOI 10.1053/j.gastro.2009.06.053; Smyrk TC, 2001, CANCER, V91, P2417, DOI 10.1002/1097-0142(20010615)91:12<2417::AID-CNCR1276>3.3.CO;2-L; Takemoto N, 2004, JPN J CLIN ONCOL, V34, P90, DOI 10.1093/jjco/hyh018; Tosolini M, 2011, CANCER RES, V71, P1263, DOI 10.1158/0008-5472.CAN-10-2907; Tougeron D, 2009, MODERN PATHOL, V22, P1186, DOI 10.1038/modpathol.2009.80; von Boehmer H, 2005, NAT IMMUNOL, V6, P338, DOI 10.1038/ni1180; Ye SW, 2006, J CLIN IMMUNOL, V26, P447, DOI 10.1007/s10875-006-9040-4	41	22	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2013	8	4							e61001	10.1371/journal.pone.0061001	http://dx.doi.org/10.1371/journal.pone.0061001			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125TD	23613769	Green Published, Green Submitted, gold			2022-12-25	WOS:000317563300015
J	Takemoto, K				Takemoto, Kazuhiro			Does Habitat Variability Really Promote Metabolic Network Modularity?	PLOS ONE			English	Article							ESCHERICHIA-COLI; EVOLUTION; RECONSTRUCTION; EVOLVABILITY; ORGANIZATION; ECOLOGY; SYSTEMS; WORLD	The hypothesis that variability in natural habitats promotes modular organization is widely accepted for cellular networks. However, results of some data analyses and theoretical studies have begun to cast doubt on the impact of habitat variability on modularity in metabolic networks. Therefore, we re-evaluated this hypothesis using statistical data analysis and current metabolic information. We were unable to conclude that an increase in modularity was the result of habitat variability. Although horizontal gene transfer was also considered because it may contribute for survival in a variety of environments, closely related to habitat variability, and is known to be positively correlated with network modularity, such a positive correlation was not concluded in the latest version of metabolic networks. Furthermore, we demonstrated that the previously observed increase in network modularity due to habitat variability and horizontal gene transfer was probably due to a lack of available data on metabolic reactions. Instead, we determined that modularity in metabolic networks is dependent on species growth conditions. These results may not entirely discount the impact of habitat variability and horizontal gene transfer. Rather, they highlight the need for a more suitable definition of habitat variability and a more careful examination of relationships of the network modularity with horizontal gene transfer, habitats, and environments.	[Takemoto, Kazuhiro] Kyushu Inst Technol, Dept Biosci & Bioinformat, Iizuka, Fukuoka, Japan; [Takemoto, Kazuhiro] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama, Japan	Kyushu Institute of Technology; Japan Science & Technology Agency (JST)	Takemoto, K (corresponding author), Kyushu Inst Technol, Dept Biosci & Bioinformat, Iizuka, Fukuoka, Japan.	takemoto@bio.kyutech.ac.jp	Takemoto, Kazuhiro/H-2915-2019	Takemoto, Kazuhiro/0000-0002-6355-1366	Japan Science and Technology Agency (JST) Precursory Research for Embryonic Science and Technology (PRESTO) program	Japan Science and Technology Agency (JST) Precursory Research for Embryonic Science and Technology (PRESTO) program	This work was supported by the Japan Science and Technology Agency (JST) Precursory Research for Embryonic Science and Technology (PRESTO) program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn YY, 2010, NATURE, V466, P761, DOI 10.1038/nature09182; Arita M, 2004, P NATL ACAD SCI USA, V101, P1543, DOI 10.1073/pnas.0306458101; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Becker E, 2012, BIOINFORMATICS, V28, P84, DOI 10.1093/bioinformatics/btr621; Brandes U, 2008, IEEE T KNOWL DATA EN, V20, P172, DOI 10.1109/TKDE.2007.190689; Caspi R, 2012, NUCLEIC ACIDS RES, V40, pD742, DOI 10.1093/nar/gkr1014; Chave Jerome, 2013, Ecology Letters, V16, P4, DOI 10.1111/ele.12048; Clauset A, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.066111; Cordero OX, 2009, P NATL ACAD SCI USA, V106, P21748, DOI 10.1073/pnas.0907584106; Danon L, 2005, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2005/09/P09008; Fortunato S, 2007, P NATL ACAD SCI USA, V104, P36, DOI 10.1073/pnas.0605965104; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Freilich S, 2010, NUCLEIC ACIDS RES, V38, P3857, DOI 10.1093/nar/gkq118; Freilich S, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000690; Freilich S, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r61; Guimera R, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.025101; Guimera R, 2005, NATURE, V433, P895, DOI 10.1038/nature03288; Hansen TF, 2003, BIOSYSTEMS, V69, P83, DOI 10.1016/S0303-2647(02)00132-6; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Hickey DA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-117; Hintze A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040023; Hirschman L, 2008, OMICS, V12, P129, DOI 10.1089/omi.2008.0016; Hofman JM, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.258701; Holme P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019759; Holme P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016605; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kashtan N, 2005, P NATL ACAD SCI USA, V102, P13773, DOI 10.1073/pnas.0503610102; Khersonsky O, 2010, ANNU REV BIOCHEM, V79, P471, DOI 10.1146/annurev-biochem-030409-143718; Kreimer A, 2008, P NATL ACAD SCI USA, V105, P6976, DOI 10.1073/pnas.0712149105; Lawrence JG, 1996, GENETICS, V143, P1843; Lee SH, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/3/033032; Levy R, 2012, ADV EXP MED BIOL, V751, P329, DOI 10.1007/978-1-4614-3567-9_15; Lipson H, 2002, EVOLUTION, V56, P1549, DOI 10.1111/j.0014-3820.2002.tb01466.x; Ma HW, 2003, BIOINFORMATICS, V19, P270, DOI 10.1093/bioinformatics/19.2.270; Ma HW, 2003, BIOINFORMATICS, V19, P1423, DOI 10.1093/bioinformatics/btg177; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Mazurie A, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-59; Minnhagen P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001690; Nakamura Y, 2004, NAT GENET, V36, P760, DOI 10.1038/ng1381; Nam H, 2012, SCIENCE, V337, P1101, DOI 10.1126/science.1216861; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Pal C, 2005, NAT GENET, V37, P1372, DOI 10.1038/ng1686; Parter M, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-169; Patrick WM, 2007, MOL BIOL EVOL, V24, P2716, DOI 10.1093/molbev/msm204; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Raymond J, 2006, SCIENCE, V311, P1764, DOI 10.1126/science.1118439; Reichardt J, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.016110; Robertson CE, 2005, CURR OPIN MICROBIOL, V8, P638, DOI 10.1016/j.mib.2005.10.003; Shou C, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001050; Sole RV, 2008, J R SOC INTERFACE, V5, P129, DOI 10.1098/rsif.2007.1108; Stelzer M, 2011, INTEGR BIOL-UK, V3, P1071, DOI 10.1039/c1ib00008j; Takemoto K, 2012, METABOLITES, V2, P429, DOI 10.3390/metabo2030429; Takemoto K, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.036107; Takemoto K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025874; Takemoto K, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-98; Takemoto K, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-303; Wagner A, 2001, P ROY SOC B-BIOL SCI, V268, P1803, DOI 10.1098/rspb.2001.1711; Yang AS, 2001, EVOL DEV, V3, P59, DOI 10.1046/j.1525-142x.2001.003002059.x; Zhao J, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-386; Zhou WD, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-181	60	14	14	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2013	8	4							e61348	10.1371/journal.pone.0061348	http://dx.doi.org/10.1371/journal.pone.0061348			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123JP	23593470	Green Published, Green Submitted, gold			2022-12-25	WOS:000317385300073
J	Moreno, A; Soleto, I; Garcia-Sanz, P; Moreno-Bueno, G; Palmero, I				Moreno, A.; Soleto, I.; Garcia-Sanz, P.; Moreno-Bueno, G.; Palmero, I.			ING4 regulates a secretory phenotype in primary fibroblasts with dual effects on cell proliferation and tumor growth	ONCOGENE			English	Article						ING4; p53; tumor suppression; secretory phenotype	SUPPRESSOR PROTEIN ING4; SENESCENCE; CANCER; GENES; P53; ACETYLATION; INHIBITOR; STRESS; TUMORIGENESIS; ANGIOGENESIS	ING proteins have an essential role in the control of a variety of cellular functions whose deregulation is associated with tumor formation and dissemination, such as proliferation, apoptosis, senescence or invasion. Accordingly, loss of function of ING proteins is a frequent event in many types of human tumors. In this report, we have studied the function of ING4, a member of the ING family of tumor suppressors, in the context of normal, non-transformed primary fibroblasts. We show that ING4 negatively regulates cell proliferation in this cell type. The antiproliferative action of ING4 requires its ability to recognize chromatin marks, it is p53-dependent at least in part, and it is lost in an ING4 cancer-associated mutant. Gene expression analysis shows that ING4 regulates the expression and release of soluble factors of the chemokine family. The secretory phenotype regulated by ING4 in primary fibroblasts displays a selective paracrine effect on proliferation, fostering the division of tumor cells, while inhibiting division in primary fibroblasts. Consistently, ING4-expressing fibroblasts promoted tumor growth in vivo in co-injection tumorigenesis assays. Collectively, our results show that ING4 not only can regulate the proliferation of primary non-transformed human fibroblasts, but also orchestrates a secretory phenotype in these cells that promotes tumor cell proliferation in vitro and in vivo. These findings support a critical role for ING4 expression in normal cells in the non-cell-autonomous regulation of tumor growth.	[Moreno, A.; Soleto, I.; Garcia-Sanz, P.; Moreno-Bueno, G.; Palmero, I.] CSIC UAM, Inst Invest Biomed Alberto Sols, E-28029 Madrid, Spain; [Garcia-Sanz, P.; Moreno-Bueno, G.] Univ Autonoma Madrid, IdiPAZ Inst Invest Sanitaria La Paz, Dept Bioquim, Madrid, Spain; [Garcia-Sanz, P.; Moreno-Bueno, G.] Fdn MD Anderson Int, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); Autonomous University of Madrid; University of Texas System; UTMD Anderson Cancer Center	Palmero, I (corresponding author), CSIC UAM, Inst Invest Biomed Alberto Sols, Arturo Duperier 4, E-28029 Madrid, Spain.	ipalmero@iib.uam.es	Moreno-Bueno, Gema/K-9354-2016; Palmero, Ignacio/B-4346-2013; soleto, irene/AAF-8123-2019	Moreno-Bueno, Gema/0000-0002-5030-6687; soleto, irene/0000-0002-8005-2411	Spanish Ministry of Science and Innovation [SAF2009-09031, SAF2012-32117]; Madrid Regional Government [S2010/BMD-2303];  [SAF2010-20175]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Madrid Regional Government; 	We thank R Gomis, J Massague, G Peters, D Peeper and A Cano for providing cell lines and reagents, V Miguel for help in some experiments and I Peruzza for technical assistance. This work was supported by grants from the Spanish Ministry of Science and Innovation to IP (SAF2009-09031 and SAF2012-32117) and GM-B (SAF2010-20175), and from the Madrid Regional Government (S2010/BMD-2303) to GM-B.	Abad M, 2011, AGING CELL, V10, P158, DOI 10.1111/j.1474-9726.2010.00651.x; Acosta JC, 2008, CELL CYCLE, V7, P2956, DOI 10.4161/cc.7.19.6780; Acosta JC, 2008, CELL, V133, P1006, DOI 10.1016/j.cell.2008.03.038; Aguissa-Toure AH, 2011, CELL MOL LIFE SCI, V68, P45, DOI 10.1007/s00018-010-0509-1; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Chicas A, 2010, CANCER CELL, V17, P376, DOI 10.1016/j.ccr.2010.01.023; Chien YC, 2011, GENE DEV, V25, P2125, DOI 10.1101/gad.17276711; Coles AH, 2010, P NATL ACAD SCI USA, V107, P11423, DOI 10.1073/pnas.0912116107; Coles AH, 2009, J CELL PHYSIOL, V218, P45, DOI 10.1002/jcp.21583; Colla S, 2007, BLOOD, V110, P4464, DOI 10.1182/blood-2007-02-074617; Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003; Coppe JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144; Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301; Doyon Y, 2006, MOL CELL, V21, P51, DOI 10.1016/j.molcel.2005.12.007; Erez N, 2010, CANCER CELL, V17, P135, DOI 10.1016/j.ccr.2009.12.041; Garkavtsev I, 2004, NATURE, V428, P328, DOI 10.1038/nature02329; Goeman F, 2005, MOL CELL BIOL, V25, P422, DOI 10.1128/MCB.25.1.422-431.2005; Gomez-Cabello D, 2010, CANCER RES, V70, P1866, DOI 10.1158/0008-5472.CAN-09-2088; Hung T, 2009, MOL CELL, V33, P248, DOI 10.1016/j.molcel.2008.12.016; Jafarnejad SM, 2012, CANCER METAST REV, V31, P55, DOI 10.1007/s10555-011-9329-5; Kim S, 2004, P NATL ACAD SCI USA, V101, P16251, DOI 10.1073/pnas.0407158101; Krtolica A, 2001, P NATL ACAD SCI USA, V98, P12072, DOI 10.1073/pnas.211053698; Kuilman T, 2008, CELL, V133, P1019, DOI 10.1016/j.cell.2008.03.039; Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610; Kuilman T, 2009, NAT REV CANCER, V9, P81, DOI 10.1038/nrc2560; Larrieu D, 2009, EMBO REP, V10, P1168, DOI 10.1038/embor.2009.180; Lazennec G, 2010, TRENDS MOL MED, V16, P133, DOI 10.1016/j.molmed.2010.01.003; Li J, 2008, CARCINOGENESIS, V29, P1373, DOI 10.1093/carcin/bgn086; Liu F, 2011, NAT CELL BIOL, V13, P254, DOI 10.1038/ncb2167; Menendez C, 2009, CURR DRUG TARGETS, V10, P406, DOI 10.2174/138945009788185077; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Moreno A, 2010, CARCINOGENESIS, V31, P1932, DOI 10.1093/carcin/bgq171; Nozell S, 2008, MOL CELL BIOL, V28, P6632, DOI 10.1128/MCB.00697-08; Palmero I, 2002, ONCOGENE, V21, P2939, DOI 10.1038/sj/onc/1205371; Pedeux R, 2005, MOL CELL BIOL, V25, P6639, DOI 10.1128/MCB.25.15.6639-6648.2005; Pena PV, 2006, NATURE, V442, P100, DOI 10.1038/nature04814; Perkins ND, 2012, NAT REV CANCER, V12, P121, DOI 10.1038/nrc3204; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Shen JC, 2007, CANCER RES, V67, P2552, DOI 10.1158/0008-5472.CAN-06-3870; Shiseki M, 2003, CANCER RES, V63, P2373; Tapia C, 2011, HUM PATHOL, V42, P983, DOI 10.1016/j.humpath.2010.10.012; Wong RPC, 2011, NUCLEIC ACIDS RES, V39, P3632, DOI 10.1093/nar/gkq1337; Ythier D, 2008, INT J CANCER, V123, P1483, DOI 10.1002/ijc.23790	43	15	15	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 10	2014	33	15					1945	1953		10.1038/onc.2013.145	http://dx.doi.org/10.1038/onc.2013.145			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AE9RK	23604125				2022-12-25	WOS:000334346300007
J	Sarkari, F; Wheaton, K; La Delfa, A; Mohamed, M; Shaikh, F; Khatun, R; Arrowsmith, CH; Frappier, L; Saridakis, V; Sheng, Y				Sarkari, Feroz; Wheaton, Keith; La Delfa, Anthony; Mohamed, Majda; Shaikh, Faryal; Khatun, Rahima; Arrowsmith, Cheryl H.; Frappier, Lori; Saridakis, Vivian; Sheng, Yi			Ubiquitin-specific Protease 7 Is a Regulator of Ubiquitin-conjugating Enzyme UbE2E1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE H2B; HAUSP; P53; DOMAIN; USP7; DEUBIQUITINATION; LOCALIZATION; INHIBITION; ACTIVATION; EXPRESSION	Ubiquitin-specific protease 7 (USP7) is a deubiquitinating enzyme found in all eukaryotes that catalyzes the removal of ubiquitin from specific target proteins. Here, we report that UbE2E1, an E2 ubiquitin conjugation enzyme with a unique N-terminal extension, is a novel USP7-interacting protein. USP7 forms a complex with UbE2E1 in vitro and in vivo through the ASTSUSP7 binding motif within its N-terminal extension in an identical manner with other known USP7 binding proteins. We show that USP7 attenuates UbE2E1-mediated ubiquitination, an effect that requires the N-terminal ASTS sequence of UbE2E1 as well as the catalytic activity of USP7. Additionally, USP7 is critical in maintaining the steady state levels of UbE2E1 in cells. This study reveals a new cellular mechanism that couples the opposing activities of the ubiquitination machinery and a deubiquitinating enzyme to maintain and modulate the dynamic balance of the ubiquitin-proteasome system.	[Sarkari, Feroz; Wheaton, Keith; La Delfa, Anthony; Mohamed, Majda; Shaikh, Faryal; Khatun, Rahima; Saridakis, Vivian; Sheng, Yi] York Univ, Dept Biol, Toronto, ON M3J 1P3, Canada; [Arrowsmith, Cheryl H.] Univ Hlth Network, Ontario Canc Inst, Div Canc Genom & Prote, Toronto, ON M5G 1L7, Canada; [Frappier, Lori] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada	York University - Canada; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto	Saridakis, V (corresponding author), York Univ, Dept Biol, Life Sci Bldg,Rm 327A,4700 Keele St, Toronto, ON M3J 1P3, Canada.	vsaridak@yorku.ca; yisheng@yorku.ca	Wheaton, Keith/AAF-1561-2021	Arrowsmith, Cheryl/0000-0002-4971-3250	Canadian Institutes of Health Research (CIHR) [106583]; York University; Natural Science and Engineering Research Council of Canada Undergraduate Student Research Assistantship; York University James Wu Research Internship; Canada Foundation for Innovation (CFI) Leaders Opportunity Fund Program; Ontario Research Fund Research Infrastructure Program (ORF-RI); United States Department of Energy, Office of Biological and Environmental Research [DE-AC02-06CH11357]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); York University; Natural Science and Engineering Research Council of Canada Undergraduate Student Research Assistantship(Natural Sciences and Engineering Research Council of Canada (NSERC)); York University James Wu Research Internship; Canada Foundation for Innovation (CFI) Leaders Opportunity Fund Program; Ontario Research Fund Research Infrastructure Program (ORF-RI); United States Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE))	This work was supported by Operating Grant 106583 from the Canadian Institutes of Health Research (CIHR) (to V. S. and Y. S.) as well as York University startup funds (to V. S. and Y. S.).; Supported by a Natural Science and Engineering Research Council of Canada Undergraduate Student Research Assistantship and a York University James Wu Research Internship.; We thank Dr. Bert Vogelstein for generously providing the HCT116 USP7<SUP>-/-</SUP> and the HCT116 parental cell lines. We thank Dr. Sirano Dhe-Paganon from Structural Genomics Consortium (SGC) Toronto for the HECT domain E3 ligase constructs (NEDD-4L and ITCH). Infrastructure was funded by the Canada Foundation for Innovation (CFI) Leaders Opportunity Fund Program and the Ontario Research Fund Research Infrastructure Program (ORF-RI). Results shown in this study are derived from work performed at Argonne National Laboratory, Structural Biology Center at the Advanced Photon Source. The Argonne National Laboratory is operated by the University of Chicago, Argonne, LLC, for the United States Department of Energy, Office of Biological and Environmental Research under Contract DE-AC02-06CH11357.	Anan T, 1998, GENES CELLS, V3, P751, DOI 10.1046/j.1365-2443.1998.00227.x; BANERJEE A, 1993, J BIOL CHEM, V268, P5668; Block K, 2005, CELL CYCLE, V4, P1421, DOI 10.4161/cc.4.10.2054; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Cummins JM, 2004, CELL CYCLE, V3, P689, DOI 10.4161/cc.3.6.924; David Y, 2010, J BIOL CHEM, V285, P8595, DOI 10.1074/jbc.M109.089003; Debonneville C, 2004, MOL CELL BIOL, V24, P2397, DOI 10.1128/MCB.24.6.2397-2409.2004; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Faustrup H, 2009, J CELL BIOL, V184, P13, DOI 10.1083/jcb.200807137; Fotia AB, 2006, INT J BIOCHEM CELL B, V38, P472, DOI 10.1016/j.biocel.2005.11.006; Jin JP, 2007, NATURE, V447, P1135, DOI 10.1038/nature05902; Jones TA, 1997, METHOD ENZYMOL, V277, P173, DOI 10.1016/S0076-6879(97)77012-5; Khoronenkova SV, 2013, NUCLEIC ACIDS RES, V41, P1750, DOI 10.1093/nar/gks1359; Lee HR, 2011, NAT STRUCT MOL BIOL, V18, P1336, DOI 10.1038/nsmb.2142; Li MY, 2002, NATURE, V416, P648, DOI 10.1038/nature737; MEREDITH M, 1994, VIROLOGY, V200, P457, DOI 10.1006/viro.1994.1209; Nakada S, 2010, NATURE, V466, P941, DOI 10.1038/nature09297; Nathan JA, 2008, TRAFFIC, V9, P1130, DOI 10.1111/j.1600-0854.2008.00747.x; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Oh YM, 2007, BIOCHEM BIOPH RES CO, V357, P615, DOI 10.1016/j.bbrc.2007.03.193; Park YC, 2000, CELL, V101, P777, DOI 10.1016/S0092-8674(00)80889-2; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Plafker KS, 2009, BIOCHEMISTRY-US, V48, P3527, DOI 10.1021/bi801971m; Qing P, 2011, J CELL BIOCHEM, V112, P3856, DOI 10.1002/jcb.23317; Saridakis V, 2005, MOL CELL, V18, P25, DOI 10.1016/j.molcel.2005.02.029; Sarkari F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016598; Sarkari F, 2010, J MOL BIOL, V402, P825, DOI 10.1016/j.jmb.2010.08.017; Sarkari F, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000624; Schwartz AL, 2009, ANNU REV PHARMACOL, V49, P73, DOI 10.1146/annurev.pharmtox.051208.165340; Seol JH, 1999, GENE DEV, V13, P1614, DOI 10.1101/gad.13.12.1614; SEUFERT W, 1990, EMBO J, V9, P543, DOI 10.1002/j.1460-2075.1990.tb08141.x; Sheng Y, 2006, NAT STRUCT MOL BIOL, V13, P285, DOI 10.1038/nsmb1067; Sheng Y, 2012, MOL CELL PROTEOMICS, V11, P329, DOI 10.1074/mcp.O111.013706; Song MS, 2008, NATURE, V455, P813, DOI 10.1038/nature07290; Summers MK, 2008, MOL CELL, V31, P544, DOI 10.1016/j.molcel.2008.07.014; Tang J, 2006, NAT CELL BIOL, V8, P855, DOI 10.1038/ncb1442; van der Knaap JA, 2005, MOL CELL, V17, P695, DOI 10.1016/j.molcel.2005.02.013; van Wijk SJL, 2010, FASEB J, V24, P981, DOI 10.1096/fj.09-136259; van Wijk SJL, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.55; Yamanaka A, 2000, MOL BIOL CELL, V11, P2821, DOI 10.1091/mbc.11.8.2821; Zhu B, 2005, MOL CELL, V20, P601, DOI 10.1016/j.molcel.2005.09.025	41	31	31	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2013	288	23					16975	16985		10.1074/jbc.M113.469262	http://dx.doi.org/10.1074/jbc.M113.469262			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	163ZU	23603909	Green Published, hybrid			2022-12-25	WOS:000320378900069
J	Barrero, MJ; Sese, B; Marti, M; Belmonte, JCI				Barrero, Maria J.; Sese, Borja; Marti, Merce; Izpisua Belmonte, Juan Carlos			Macro Histone Variants Are Critical for the Differentiation of Human Pluripotent Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INACTIVE X-CHROMOSOME; STEM-CELLS; GENERATION; EFFICIENT; CHROMATIN; BINDING; DOMAIN	We have previously shown that macro histone variants (macroH2A) are expressed at low levels in stem cells and are up-regulated during differentiation. Here we show that the knockdown of macro histone variants impaired the in vitro and in vivo differentiation of human pluripotent cells, likely through defects in the silencing of pluripotency-related genes. ChIP experiments showed that during differentiation macro histone variants are recruited to the regulatory regions of pluripotency and developmental genes marked with H3K27me3 contributing to the silencing of these genes.	[Barrero, Maria J.; Sese, Borja; Marti, Merce; Izpisua Belmonte, Juan Carlos] Ctr Regenerat Med Barcelona, Barcelona 08003, Spain; [Izpisua Belmonte, Juan Carlos] Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Centro de Medicina Regenerativa de Barcelona; University of Barcelona; Salk Institute	Belmonte, JCI (corresponding author), Ctr Regenerat Med Barcelona, Barcelona 08003, Spain.	belmonte@salk.edu	Barrero, Maria J./Q-1785-2017	Barrero, Maria J./0000-0002-5990-7040; Sese, Borja/0000-0001-8554-897X	Ministerio de Ciencia e Innovacion of Spain (MICINN) [RYC-2007-01510, SAF2009-08588]; Ramon y Cajal program; Formacion de Personal Investigador (FPI); Ministerio de Ciencia e Innovacion of Spain (MICINN); G. Harold and Leila Y. Mathers Charitable Foundation; The Leona M. and Harry B. Helmsley Charitable Trust; ISCIII-TERCEL-MINECO; CIBER; Fundacion Cellex	Ministerio de Ciencia e Innovacion of Spain (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Ramon y Cajal program(Spanish Government); Formacion de Personal Investigador (FPI)(Spanish Government); Ministerio de Ciencia e Innovacion of Spain (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); G. Harold and Leila Y. Mathers Charitable Foundation; The Leona M. and Harry B. Helmsley Charitable Trust; ISCIII-TERCEL-MINECO; CIBER; Fundacion Cellex(Foundation CELLEX)	This work was supported by Ministerio de Ciencia e Innovacion of Spain (MICINN) Grants RYC-2007-01510 and SAF2009-08588 (to M.J.B.).; 1 Supported in part by the Ramon y Cajal program.; 2 Recipient of a Formacion de Personal Investigador (FPI) predoctoral fellowship from Ministerio de Ciencia e Innovacion of Spain (MICINN).; 3 Work in the laboratory of J.C.I.B. was supported by the G. Harold and Leila Y. Mathers Charitable Foundation, The Leona M. and Harry B. Helmsley Charitable Trust, ISCIII-TERCEL-MINECO, CIBER, and Fundacion Cellex. To whom correspondence should be addressed. E-mail: belmonte@salk.edu.	Aasen T, 2008, NAT BIOTECHNOL, V26, P1276, DOI 10.1038/nbt.1503; Ahmad K, 2002, MOL CELL, V9, P1191, DOI 10.1016/S1097-2765(02)00542-7; Angelov D, 2003, MOL CELL, V11, P1033, DOI 10.1016/S1097-2765(03)00100-X; Barrero M. J., 2013, CELL REP, VS2211-1247, P00105; Barrero MJ, 2012, COMP FUNCT GENOM, DOI 10.1155/2012/434529; Boue S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012664; Buschbeck M, 2009, NAT STRUCT MOL BIOL, V16, P1074, DOI 10.1038/nsmb.1665; Chadwick BP, 2001, HUM MOL GENET, V10, P1101, DOI 10.1093/hmg/10.10.1101; Chakravarthy S, 2005, MOL CELL BIOL, V25, P7616, DOI 10.1128/MCB.25.17.7616-7624.2005; Costanzi C, 1998, NATURE, V393, P599, DOI 10.1038/31275; Creppe C, 2012, MOL CELL BIOL, V32, P1442, DOI 10.1128/MCB.06323-11; Csankovszki G, 1999, NAT GENET, V22, P323, DOI 10.1038/11887; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; Faast R, 2001, CURR BIOL, V11, P1183, DOI 10.1016/S0960-9822(01)00329-3; Gamble MJ, 2010, CELL CYCLE, V9, P2568, DOI 10.4161/cc.9.13.12144; Gamble MJ, 2010, GENE DEV, V24, P21, DOI 10.1101/gad.1876110; Kapoor A, 2010, NATURE, V468, P1105, DOI 10.1038/nature09590; Karras GI, 2005, EMBO J, V24, P1911, DOI 10.1038/sj.emboj.7600664; Keller G, 2005, GENE DEV, V19, P1129, DOI 10.1101/gad.1303605; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Pan GJ, 2007, CELL STEM CELL, V1, P299, DOI 10.1016/j.stem.2007.08.003; Pasini D, 2007, MOL CELL BIOL, V27, P3769, DOI 10.1128/MCB.01432-06; Pasque V, 2012, J CELL SCI, V125, P6094, DOI 10.1242/jcs.113019; Pasque V, 2011, EMBO J, V30, P2373, DOI 10.1038/emboj.2011.144; PEHRSON JR, 1992, SCIENCE, V257, P1398; Polo JM, 2010, NAT BIOTECHNOL, V28, P848, DOI 10.1038/nbt.1667; Raya A, 2008, COLD SH Q B, V73, P127, DOI 10.1101/sqb.2008.73.038; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Sporn JC, 2009, ONCOGENE, V28, P3423, DOI 10.1038/onc.2009.26; SULLIVAN KF, 1994, J CELL BIOL, V127, P581, DOI 10.1083/jcb.127.3.581; Terme JM, 2011, J BIOL CHEM, V286, P35347, DOI 10.1074/jbc.M111.281923	31	28	28	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 31	2013	288	22					16110	16116		10.1074/jbc.M113.466144	http://dx.doi.org/10.1074/jbc.M113.466144			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	156LA	23595991	Green Published, hybrid			2022-12-25	WOS:000319822300061
J	Fukuda, R; Suico, MA; Koyama, K; Omachi, K; Kai, Y; Matsuyama, S; Mitsutake, K; Taura, M; Morino-Koga, S; Shuto, T; Kai, H				Fukuda, Ryosuke; Suico, Mary Ann; Koyama, Kosuke; Omachi, Kohei; Kai, Yukari; Matsuyama, Shingo; Mitsutake, Kazunori; Taura, Manabu; Morino-Koga, Saori; Shuto, Tsuyoshi; Kai, Hirofumi			Mild Electrical Stimulation at 0.1-ms Pulse Width Induces p53 Protein Phosphorylation and G(2) Arrest in Human Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; DNA-DAMAGE; P53-DEPENDENT APOPTOSIS; INFLAMMATORY RESPONSE; CYCLE CHECKPOINTS; LIPID RAFTS; P38 MAPK; ACTIVATION; HYPERTHERMIA; SUPPRESSOR	Exogenous low-intensity electrical stimulation has been used for treatment of various intractable diseases despite the dearth of information on the molecular underpinnings of its effects. Our work and that of others have demonstrated that applied electrical stimulation at physiological strength or mild electrical stimulation (MES) activates the PI3K-Akt pathway, but whether MES activates other molecules remains unknown. Considering that MES is a form of physiological stress, we hypothesized that it can activate the tumor suppressor p53, which is a key modulator of the cell cycle and apoptosis in response to cell stresses. The potential response of p53 to an applied electrical current of low intensity has not been investigated. Here, we show that p53 was transiently phosphorylated at Ser-15 in epithelial cells treated with an imperceptible voltage (1 V/cm) and a 0.1-ms pulse width. MES-induced p53 phosphorylation was inhibited by pretreatment with a p38 MAPK inhibitor and transfection of dominant-negative mutants of p38, MKK3b, and MKK6b, implying the involvement of the p38 MAPK signaling pathway. Furthermore, MES treatment enhanced p53 transcriptional function and increased the expression of p53 target genes p21, BAX, PUMA, NOXA, and IRF9. Importantly, MES treatment triggered G(2) cell cycle arrest, but not cell apoptosis. MES treatment had no effect on the cell cycle in HCT116 p53(-/-) cells, suggesting a dependence on p53. These findings identify some molecular targets of electrical stimulation and incorporate the p38-p53 signaling pathway among the transduction pathways that MES affects.	[Fukuda, Ryosuke; Suico, Mary Ann; Koyama, Kosuke; Omachi, Kohei; Kai, Yukari; Matsuyama, Shingo; Taura, Manabu; Morino-Koga, Saori; Shuto, Tsuyoshi; Kai, Hirofumi] Kumamoto Univ, Grad Sch Pharmaceut Sci, Dept Mol Med, Kumamoto 8620973, Japan; [Mitsutake, Kazunori] Kumamoto Univ, Grad Sch Sci & Technol, Kumamoto 8620973, Japan	Kumamoto University; Kumamoto University	Kai, H (corresponding author), Kumamoto Univ, Grad Sch Pharmaceut Sci, Dept Mol Med, 5-1 Oe Honmachi, Kumamoto 8620973, Japan.	hirokai@gpo.kumamoto-u.ac.jp	Taura, Manabu/Y-6844-2019; Omachi, Kohei/ABB-2844-2020; Omachi, Kohei/GPX-9286-2022	Taura, Manabu/0000-0001-9577-8007; Shuto, Tsuyoshi/0000-0003-1275-4988; Suico, Mary Ann/0000-0002-6751-8352; Omachi, Kohei/0000-0002-0160-3271	Ministry of Education, Science, Sports, and Culture (MEXT) of Japan [22390015, 23590082]	Ministry of Education, Science, Sports, and Culture (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grants-in-aid for Science Research 22390015 (to H. K.) and 23590082 (to M. A. S.) from the Ministry of Education, Science, Sports, and Culture (MEXT) of Japan.	AGARWAL ML, 1995, P NATL ACAD SCI USA, V92, P8493, DOI 10.1073/pnas.92.18.8493; Ainsworth L, 2006, PAIN, V120, P182, DOI 10.1016/j.pain.2005.10.030; Balakatounis Konstantine C, 2008, Eplasty, V8, pe28; Banin S, 1998, SCIENCE, V281, P1674, DOI 10.1126/science.281.5383.1674; BASSETT CAL, 1993, J CELL BIOCHEM, V51, P387, DOI 10.1002/jcb.2400510402; Beebe SJ, 2003, FASEB J, V17, P1493, DOI 10.1096/fj.02-0859fje; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Clotet J, 2006, EMBO J, V25, P2338, DOI 10.1038/sj.emboj.7601095; Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301; Cucullo L, 2005, GLIA, V51, P65, DOI 10.1002/glia.20188; Duan Y, 2008, P NATL ACAD SCI USA, V105, P11418, DOI 10.1073/pnas.0804954105; Feng LJ, 2006, CELL CYCLE, V5, P2812, DOI 10.4161/cc.5.23.3526; Freund A, 2011, EMBO J, V30, P1536, DOI 10.1038/emboj.2011.69; Fuchs SY, 1998, P NATL ACAD SCI USA, V95, P10541, DOI 10.1073/pnas.95.18.10541; Griffin Michelle, 2011, Eplasty, V11, pe34; Gu G, 2011, J INT MED RES, V39, P1783, DOI 10.1177/147323001103900521; Hirao A, 2000, SCIENCE, V287, P1824, DOI 10.1126/science.287.5459.1824; Hoeferlin L Alexis, 2011, Genes Cancer, V2, P889, DOI 10.1177/1947601911432495; Kai H, 2009, INT J HYPERTHER, V25, P655, DOI 10.3109/02656730903039605; Kirson ED, 2004, CANCER RES, V64, P3288, DOI 10.1158/0008-5472.CAN-04-0083; Kirson ED, 2007, P NATL ACAD SCI USA, V104, P10152, DOI 10.1073/pnas.0702916104; Kishi H, 2001, J BIOL CHEM, V276, P39115, DOI 10.1074/jbc.M105134200; Koga T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043852; Komarova EA, 2005, FASEB J, V19, P1030, DOI 10.1096/fj.04-3213fje; Kondo T, 2013, NEUROREPORT, V24, P68, DOI 10.1097/WNR.0b013e32835c7df2; Kondo T, 2012, DIABETES, V61, P838, DOI 10.2337/db11-1098; Kondo T, 2010, OBES RES CLIN PRACT, V4, pE101, DOI 10.1016/j.orcp.2009.09.007; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Lambert S, 2008, J CELL PHYSIOL, V217, P834, DOI 10.1002/jcp.21563; Liu G, 2009, J IMMUNOL, V182, P5063, DOI 10.4049/jimmunol.0803526; Lowe SW, 2000, CARCINOGENESIS, V21, P485, DOI 10.1093/carcin/21.3.485; Mayr M, 2002, FASEB J, V16, P1423, DOI 10.1096/fj.02-0042fje; McCaig CD, 2005, PHYSIOL REV, V85, P943, DOI 10.1152/physrev.00020.2004; Menendez D, 2009, NAT REV CANCER, V9, P724, DOI 10.1038/nrc2730; Miyakoda M, 2002, ONCOGENE, V21, P1090, DOI 10.1038/sj.onc.1205196; MIYASHITA T, 1995, CELL, V80, P293; Morino S, 2008, J PHARMACOL SCI, V108, P222, DOI 10.1254/jphs.08180SC; Morino S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004068; Morino-Koga S, 2013, J CELL PHYSIOL, V228, P439, DOI 10.1002/jcp.24149; Muller-Ladner U, 2000, ARTHRITIS RES, V2, P175, DOI 10.1186/ar84; Munoz-Fontela C, 2008, J EXP MED, V205, P1929, DOI 10.1084/jem.20080383; Murphy SH, 2011, P NATL ACAD SCI USA, V108, P17117, DOI 10.1073/pnas.1114420108; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; Nigro JM, 1997, CANCER RES, V57, P3635; Oba M, 2008, INT J ONCOL, V32, P1317; Oba M, 2010, J SURG RES, V162, P213, DOI 10.1016/j.jss.2009.03.093; Oda E, 2000, SCIENCE, V288, P1053, DOI 10.1126/science.288.5468.1053; Saretzki G, 1999, ONCOGENE, V18, P5148, DOI 10.1038/sj.onc.1202898; Seegers JC, 2001, MED HYPOTHESES, V57, P224, DOI 10.1054/mehy.2001.1292; Sen N, 2012, TRANSCR-AUSTIN, V3, P119, DOI 10.4161/trns.20094; Sersa G, 2008, EJSO-EUR J SURG ONC, V34, P232, DOI 10.1016/j.ejso.2007.05.016; She QB, 2000, J BIOL CHEM, V275, P20444, DOI 10.1074/jbc.M001020200; Sherr CJ, 2000, CURR OPIN GENET DEV, V10, P94, DOI 10.1016/S0959-437X(99)00038-6; Shuto T, 2001, P NATL ACAD SCI USA, V98, P8774, DOI 10.1073/pnas.151236098; Simelyte E, 2005, ARTHRITIS RHEUM-US, V52, P1876, DOI 10.1002/ART.21099; Suico MA, 2004, J BIOL CHEM, V279, P19091, DOI 10.1074/jbc.M312439200; Svirskis D, 2010, J CONTROL RELEASE, V146, P6, DOI 10.1016/j.jconrel.2010.03.023; Taura M, 2008, MOL CELL BIOL, V28, P6557, DOI 10.1128/MCB.01202-08; Taura M, 2011, NUCLEIC ACIDS RES, V39, P76, DOI 10.1093/nar/gkq762; Thornton TM, 2009, INT J BIOL SCI, V5, P44, DOI 10.7150/ijbs.5.44; Utz KS, 2010, NEUROPSYCHOLOGIA, V48, P2789, DOI 10.1016/j.neuropsychologia.2010.06.002; Vousden KH, 2009, NAT REV CANCER, V9, P691, DOI 10.1038/nrc2715; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Yano S, 2011, J PHARMACOL SCI, V115, P94, DOI 10.1254/jphs.10185SC; Yugawa T, 2007, MOL CELL BIOL, V27, P3732, DOI 10.1128/MCB.02119-06; Zhao M, 2006, NATURE, V442, P457, DOI 10.1038/nature04925	66	14	16	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 31	2013	288	22					16117	16126		10.1074/jbc.M112.442442	http://dx.doi.org/10.1074/jbc.M112.442442			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	156LA	23599430	hybrid, Green Published			2022-12-25	WOS:000319822300062
J	Mansour, MK; Tam, JM; Khan, NS; Seward, M; Davids, PJ; Puranam, S; Sokolovska, A; Sykes, DB; Dagher, Z; Becker, C; Tanne, A; Reedy, JL; Stuart, LM; Vyas, JM				Mansour, Michael K.; Tam, Jenny M.; Khan, Nida S.; Seward, Michael; Davids, Peter J.; Puranam, Sravanthi; Sokolovska, Anna; Sykes, David B.; Dagher, Zeina; Becker, Christine; Tanne, Antoine; Reedy, Jennifer L.; Stuart, Lynda M.; Vyas, Jatin M.			Dectin-1 Activation Controls Maturation of beta-1,3-Glucan-containing Phagosomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INVASIVE FUNGAL-INFECTIONS; BETA-GLUCAN RECOGNITION; CANDIDA-ALBICANS; RECEPTOR DECTIN-1; LECTIN RECEPTORS; HOST-DEFENSE; SYK KINASE; MACROPHAGES; CARD9; EPIDEMIOLOGY	Elimination of fungal pathogens by phagocytes requires phagosome maturation, a process that involves the recruitment and fusion of intracellular proteins. The role of Dectin-1, a beta-1,3-glucan receptor, critical for fungal recognition and triggering of Th17 responses, to phagosomal maturation has not been defined. We show that GFP-Dectin-1 translocates to the fungal phagosome, but its signal decays after 2 h. Inhibition of acidification results in retention of GFP-Dectin-1 to phagosome membranes highlighting the requirement for an acidic pH. Following beta-1,3-glucan recognition, GFP-Dectin-1 undergoes tyrosine phosphorylation by Src kinases with subsequent Syk activation. Our results demonstrate that Syk is activated independently of intraphagosomal pH. Inhibition of Src or Syk results in prolonged retention of GFP-Dectin-1 to the phagosome signifying a link between Syk and intraphagosomal pH. beta-1,3-glucan phagosomes expressing a signaling incompetent Dectin-1 failed to mature as demonstrated by prolonged Dectin-1 retention, presence of Rab5B, failure to acquire LAMP-1 and inability to acidify. Phagosomes containing Candida albicans also require Dectin-1-dependent Syk activation for phagosomal maturation. Taken together, these results support a model where Dectin-1 not only controls internalization of beta-1,3-glucan containing cargo and triggers proinflammatory cytokines, but also acts as a master regulator for subsequent phagolysosomal maturation through Syk activation.	[Mansour, Michael K.; Tam, Jenny M.; Khan, Nida S.; Seward, Michael; Davids, Peter J.; Puranam, Sravanthi; Dagher, Zeina; Reedy, Jennifer L.; Vyas, Jatin M.] Massachusetts Gen Hosp, Dept Med, Div Infect Dis, Boston, MA 02114 USA; [Sokolovska, Anna; Becker, Christine; Tanne, Antoine; Stuart, Lynda M.] Massachusetts Gen Hosp, Dept Pediat, Boston, MA 02114 USA; [Sykes, David B.] Massachusetts Gen Hosp, Div Hematol & Oncol, Boston, MA 02114 USA; [Mansour, Michael K.; Tam, Jenny M.; Sykes, David B.; Reedy, Jennifer L.; Vyas, Jatin M.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Davids, Peter J.] Bowdoin Coll, Brunswick, ME 04011 USA; [Puranam, Sravanthi] MIT, Cambridge, MA 02143 USA; [Stuart, Lynda M.] Broad Inst MIT & Harvard Univ, Cambridge, MA 02143 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Bowdoin College; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Vyas, JM (corresponding author), Massachusetts Gen Hosp, Dept Med, Div Infect Dis, 55 Fruit St,Gray Jackson Bldg Room 504, Boston, MA 02114 USA.	jvyas@partners.org	Vyas, Jatin/Q-1627-2016	Vyas, Jatin/0000-0002-9985-9565; Seward, Michael/0000-0002-4813-6308	National Institutes of Health [NIAID T32-AI007061-35, NIAID R01AI079198, NIAID 1R01AI092084]; Leukemia & Lymphoma Society; Alex's Lemonade Stand Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI079198, T32AI007061, R01AI092084] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia & Lymphoma Society(Leukemia and Lymphoma Society); Alex's Lemonade Stand Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants NIAID T32-AI007061-35 (to M. K. M. and J. L. R.), NIAID R01AI079198 (to L. M. S.), and NIAID 1R01AI092084 (to J. M. V.).; Supported by The Leukemia & Lymphoma Society and Alex's Lemonade Stand Foundation.	Arendrup MC, 2010, CURR OPIN CRIT CARE, V16, P445, DOI 10.1097/MCC.0b013e32833e84d2; Artavanis-Tsakonas K, 2006, P NATL ACAD SCI USA, V103, P15945, DOI 10.1073/pnas.0607528103; Brown GD, 2001, NATURE, V413, P36, DOI 10.1038/35092620; Brown GD, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004404; Brown J, 2007, PROTEIN SCI, V16, P1042, DOI 10.1110/ps.072791207; Carvalho A, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00156; Carvalho A, 2012, CELL MOL IMMUNOL, V9, P276, DOI 10.1038/cmi.2012.1; Chai LYA, 2011, J INFECT DIS, V203, P736, DOI 10.1093/infdis/jiq102; De Luca A, 2012, J CLIN INVEST, V122, P1816, DOI 10.1172/JCI60862; Dennehy KM, 2008, EUR J IMMUNOL, V38, P500, DOI 10.1002/eji.200737741; Dennehy KM, 2009, EUR J IMMUNOL, V39, P1379, DOI 10.1002/eji.200838543; Esteban A, 2011, P NATL ACAD SCI USA, V108, P14270, DOI 10.1073/pnas.1111415108; Fernandez-Arenas E, 2007, MOL CELL PROTEOMICS, V6, P460, DOI 10.1074/mcp.M600210-MCP200; Ferwerda B, 2009, NEW ENGL J MED, V361, P1760, DOI 10.1056/NEJMoa0901053; Goodridge HS, 2007, J IMMUNOL, V178, P3107, DOI 10.4049/jimmunol.178.5.3107; Goodridge HS, 2009, IMMUNOL REV, V230, P38, DOI 10.1111/j.1600-065X.2009.00793.x; Goodridge HS, 2009, J IMMUNOL, V182, P1146, DOI 10.4049/jimmunol.182.2.1146; Gringhuis SI, 2009, NAT IMMUNOL, V10, P203, DOI 10.1038/ni.1692; Gross O, 2006, NATURE, V442, P651, DOI 10.1038/nature04926; Heinsbroek SEM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000218; Hise AG, 2009, CELL HOST MICROBE, V5, P487, DOI 10.1016/j.chom.2009.05.002; Huang HB, 2012, J IMMUNOL, V189, P312, DOI 10.4049/jimmunol.1200603; Husebye H, 2010, IMMUNITY, V33, P583, DOI 10.1016/j.immuni.2010.09.010; Kasperkovitz PV, 2010, J IMMUNOL, V185, P7614, DOI 10.4049/jimmunol.1002760; Kerrigan AM, 2010, IMMUNOL REV, V234, P335, DOI 10.1111/j.0105-2896.2009.00882.x; LeibundGut-Landmann S, 2012, CURR OPIN IMMUNOL, V24, P449, DOI 10.1016/j.coi.2012.04.007; Levitz SM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000758; Ma J, 2012, J BIOL CHEM, V287, P34149, DOI 10.1074/jbc.M112.382812; Neofytos D, 2010, TRANSPL INFECT DIS, V12, P220, DOI 10.1111/j.1399-3062.2010.00492.x; Osorio F, 2008, EUR J IMMUNOL, V38, P3274, DOI 10.1002/eji.200838950; Pappas PG, 2010, CLIN INFECT DIS, V50, P1101, DOI 10.1086/651262; Rai MN, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002863; Reid DM, 2009, CURR OPIN IMMUNOL, V21, P30, DOI 10.1016/j.coi.2009.01.003; Rogers NC, 2005, IMMUNITY, V22, P507, DOI 10.1016/j.immuni.2005.03.004; Saijo S, 2007, NAT IMMUNOL, V8, P39, DOI 10.1038/ni1425; Segal BH, 2009, NEW ENGL J MED, V360, P1870, DOI 10.1056/NEJMra0808853; Skrzypek F, 2009, MICROBES INFECT, V11, P661, DOI 10.1016/j.micinf.2009.03.010; Strasser D, 2012, IMMUNITY, V36, P32, DOI 10.1016/j.immuni.2011.11.015; Stuart LM, 2007, NATURE, V445, P95, DOI 10.1038/nature05380; Tam JM, 2012, INTEGR BIOL-UK, V4, P220, DOI 10.1039/c2ib00089j; Taylor PR, 2007, NAT IMMUNOL, V8, P31, DOI 10.1038/ni1408; Underhill DM, 2012, NAT REV IMMUNOL, V12, P492, DOI 10.1038/nri3244; Underhill DM, 2005, BLOOD, V106, P2543, DOI 10.1182/blood-2005-03-1239; West AP, 2011, NATURE, V472, P476, DOI 10.1038/nature09973; Wilkinson B, 2006, J BIOL CHEM, V281, P20842, DOI 10.1074/jbc.M600627200; Zanoni I, 2011, CELL, V147, P868, DOI 10.1016/j.cell.2011.09.051	46	57	58	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 31	2013	288	22					16043	16054		10.1074/jbc.M113.473223	http://dx.doi.org/10.1074/jbc.M113.473223			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	156LA	23609446	Green Published, hybrid			2022-12-25	WOS:000319822300055
J	Deo, AJ; Goldszer, IM; Li, SY; DiBitetto, JV; Henteleff, R; Sampson, A; Lewis, DA; Penzes, P; Sweet, RA				Deo, Anthony J.; Goldszer, Isaac M.; Li, Siyu; DiBitetto, James V.; Henteleff, Ruth; Sampson, Allan; Lewis, David A.; Penzes, Peter; Sweet, Robert A.			PAK1 Protein Expression in the Auditory Cortex of Schizophrenia Subjects	PLOS ONE			English	Article							DENDRITIC SPINE DENSITY; CORTICAL PYRAMIDAL NEURONS; PREFRONTAL CORTEX; KINASE; SPINOPHILIN; MECHANISMS; DEFICITS; MORPHOGENESIS; EFFECTOR; VOLUME	Deficits in auditory processing are among the best documented endophenotypes in schizophrenia, possibly due to loss of excitatory synaptic connections. Dendritic spines, the principal post-synaptic target of excitatory projections, are reduced in schizophrenia. p21-activated kinase 1 (PAK1) regulates both the actin cytoskeleton and dendritic spine density, and is a downstream effector of both kalirin and CDC42, both of which have altered expression in schizophrenia. This study sought to determine if there is decreased auditory cortex PAK1 protein expression in schizophrenia through the use of quantitative western blots of 25 schizophrenia subjects and matched controls. There was no significant change in PAK1 level detected in the schizophrenia subjects in our cohort. PAK1 protein levels within subject pairs correlated positively with prior measures of total kalirin protein in the same pairs. PAK1 level also correlated with levels of a marker of dendritic spines, spinophilin. These latter two findings suggest that the lack of change in PAK1 level in schizophrenia is not due to limited sensitivity of our assay to detect meaningful differences in PAK1 protein expression. Future studies are needed to evaluate whether alterations in PAK1 phosphorylation states, or alterations in protein expression of other members of the PAK family, are present in schizophrenia.	[Deo, Anthony J.; Goldszer, Isaac M.; DiBitetto, James V.; Henteleff, Ruth; Lewis, David A.; Sweet, Robert A.] Univ Pittsburgh, Sch Med, Dept Psychiat, Translat Neurosci Program, Pittsburgh, PA 15213 USA; [Deo, Anthony J.] Univ Pittsburgh, Sch Med, Phys Scientist Training Program, Pittsburgh, PA USA; [Li, Siyu; Sampson, Allan] Univ Pittsburgh, Dept Stat, Pittsburgh, PA USA; [Lewis, David A.] Univ Pittsburgh, Dept Neurosci, Pittsburgh, PA USA; [Penzes, Peter] Northwestern Univ, Dept Physiol, Feinberg Sch Med, Chicago, IL 60611 USA; [Penzes, Peter] Northwestern Univ, Dept Psychiat & Behav Sci, Feinberg Sch Med, Chicago, IL 60611 USA; [Sweet, Robert A.] Univ Pittsburgh, Sch Med, Dept Neurol, Pittsburgh, PA 15261 USA; [Sweet, Robert A.] VA Pittsburgh Healthcare Syst, VISN Mental Illness Res Educ & Clin Ctr 4, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Pittsburgh Healthcare System	Sweet, RA (corresponding author), Univ Pittsburgh, Sch Med, Dept Psychiat, Translat Neurosci Program, Pittsburgh, PA 15213 USA.	sweetra@upmc.edu	Lewis, David A/G-4053-2014; Penzes, Peter/L-3987-2016	Lewis, David A/0000-0002-3225-6778; Penzes, Peter/0000-0001-5449-1640	National Institutes of Mental Health [MH071533, MH084053, MH071316]; Doris Duke Charitable Foundation; Johnson & Johnson Pharmaceutical Research and Development; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH097216, R01MH071316, P50MH084053, R01MH071533] Funding Source: NIH RePORTER	National Institutes of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); Johnson & Johnson Pharmaceutical Research and Development(Johnson & JohnsonJohnson & Johnson USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by grants MH071533, MH084053 and MH071316 from the National Institutes of Mental Health. Anthony Deo was supported by a Clinical Research Fellow grant from the Doris Duke Charitable Foundation to the University of Pittsburgh School of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Allan R. Sampson is a paid statistical consultant on design and analysis issues to Johnson & Johnson Pharmaceutical Research and Development. This does not alter his adherence to all the PLOS ONE policies on sharing data and materials.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Allen PB, 1997, P NATL ACAD SCI USA, V94, P9956, DOI 10.1073/pnas.94.18.9956; Aspromonte J, 2008, BIOL PSYCHIAT, V63, p248S; Asrar S, 2009, NEUROPHARMACOLOGY, V56, P73, DOI 10.1016/j.neuropharm.2008.06.055; Bishop AL, 2000, BIOCHEM J, V348, P241, DOI 10.1042/0264-6021:3480241; Bokoch GM, 2003, ANNU REV BIOCHEM, V72, P743, DOI 10.1146/annurev.biochem.72.121801.161742; Combeau G, 2012, J BIOL CHEM, V287, P30084, DOI 10.1074/jbc.M112.355073; Deo AJ, 2011, NEUROBIOL DIS; Edwards DC, 1999, NAT CELL BIOL, V1, P253, DOI 10.1038/12963; Garey LJ, 1998, J NEUROL NEUROSUR PS, V65, P446, DOI 10.1136/jnnp.65.4.446; Glantz LA, 2000, ARCH GEN PSYCHIAT, V57, P65, DOI 10.1001/archpsyc.57.1.65; Hayashi K, 2002, MOL CELL NEUROSCI, V20, P579, DOI 10.1006/mcne.2002.1144; Hayashi K, 2007, DEV NEUROBIOL, V67, P655, DOI 10.1002/dneu.20363; Hayashi ML, 2004, NEURON, V42, P773, DOI 10.1016/j.neuron.2004.05.003; Hill JJ, 2006, MOL PSYCHIATR, V11, P557, DOI 10.1038/sj.mp.4001792; Holtmaat AJGD, 2005, NEURON, V45, P279, DOI 10.1016/j.neuron.2005.01.003; Honea R, 2005, AM J PSYCHIAT, V162, P2233, DOI 10.1176/appi.ajp.162.12.2233; Huang WN, 2011, MOL CELL BIOL, V31, P388, DOI 10.1128/MCB.00969-10; Javitt DC, 2000, CLIN NEUROPHYSIOL, V111, P1733, DOI 10.1016/S1388-2457(00)00377-1; JAVITT DC, 1994, BRAIN RES, V667, P192, DOI 10.1016/0006-8993(94)91496-6; Javitt DC, 1997, J ABNORM PSYCHOL, V106, P315, DOI 10.1037/0021-843X.106.2.315; Kreis P, 2007, J BIOL CHEM, V282, P21497, DOI 10.1074/jbc.M703298200; Leitman DI, 2005, BIOL PSYCHIAT, V58, P56, DOI 10.1016/j.biopsych.2005.02.034; Liu BH, 2007, NAT NEUROSCI, V10, P1594, DOI 10.1038/nn2012; Majewska AK, 2006, J NEUROSCI, V26, P3021, DOI 10.1523/JNEUROSCI.4454-05.2006; McCarley RW, 1999, BIOL PSYCHIAT, V45, P1099, DOI 10.1016/S0006-3223(99)00018-9; Mulle JG, 2010, AM J HUM GENET, V87, P229, DOI 10.1016/j.ajhg.2010.07.013; Muly EC, 2004, J COMP NEUROL, V469, P185, DOI 10.1002/cne.11001; Ojima H, 1991, CEREB CORTEX, V1, P80, DOI 10.1093/cercor/1.1.80; Oka T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021405; Okamoto KI, 2004, NAT NEUROSCI, V7, P1104, DOI 10.1038/nn1311; Oswald AMM, 2006, CURR OPIN NEUROBIOL, V16, P371, DOI 10.1016/j.conb.2006.06.015; Penzes P, 2001, NEURON, V29, P229, DOI 10.1016/S0896-6273(01)00193-3; Rabiner CA, 2005, NEUROSCIENTIST, V11, P148, DOI 10.1177/1073858404271250; Rubio MD, 2012, BIOL PSYCHIAT, V71, P906, DOI 10.1016/j.biopsych.2012.02.006; Sweet RA, 2004, BIOL PSYCHIAT, V55, P1128, DOI 10.1016/j.biopsych.2004.03.002; Sweet RA, 2003, NEUROPSYCHOPHARMACOL, V28, P599, DOI 10.1038/sj.npp.1300120; Sweet RA, 2007, BIOL PSYCHIAT, V61, P854, DOI 10.1016/j.biopsych.2006.07.033; Sweet RA, 2009, NEUROPSYCHOPHARMACOL, V34, P374, DOI 10.1038/npp.2008.67; Tang Y, 2004, CEREB CORTEX, V14, P215, DOI 10.1093/cercor/bhg121; WALLACE MN, 1991, EXP BRAIN RES, V86, P527; Xie Z, 2007, NEURON, V56, P640, DOI 10.1016/j.neuron.2007.10.005; Zhang HY, 2005, J NEUROSCI, V25, P3379, DOI 10.1523/JNEUROSCI.3553-04.2005; Zuo Y, 2005, NEURON, V46, P181, DOI 10.1016/j.neuron.2005.04.001	44	10	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2013	8	4							e59458	10.1371/journal.pone.0059458	http://dx.doi.org/10.1371/journal.pone.0059458			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JR	23613712	gold, Green Published, Green Submitted, Green Accepted			2022-12-25	WOS:000317911500002
J	Antelis, JM; Montesano, L; Ramos-Murguialday, A; Birbaumer, N; Minguez, J				Antelis, Javier M.; Montesano, Luis; Ramos-Murguialday, Ander; Birbaumer, Niels; Minguez, Javier			On the Usage of Linear Regression Models to Reconstruct Limb Kinematics from Low Frequency EEG Signals	PLOS ONE			English	Article							2-DIMENSIONAL MOVEMENT TRAJECTORIES; BRAIN-COMPUTER INTERFACE; GRASP; POTENTIALS; DIRECTION; REACH; MEG	Several works have reported on the reconstruction of 2D/3D limb kinematics from low-frequency EEG signals using linear regression models based on positive correlation values between the recorded and the reconstructed trajectories. This paper describes the mathematical properties of the linear model and the correlation evaluation metric that may lead to a misinterpretation of the results of this type of decoders. Firstly, the use of a linear regression model to adjust the two temporal signals (EEG and velocity profiles) implies that the relevant component of the signal used for decoding (EEG) has to be in the same frequency range as the signal to be decoded (velocity profiles). Secondly, the use of a correlation to evaluate the fitting of two trajectories could lead to overly-optimistic results as this metric is invariant to scale. Also, the correlation has a non-linear nature that leads to higher values for sinus/cosinus-like signals at low frequencies. Analysis of these properties on the reconstruction results was carried out through an experiment performed in line with previous studies, where healthy participants executed predefined reaching movements of the hand in 3D space. While the correlations of limb velocity profiles reconstructed from low-frequency EEG were comparable to studies in this domain, a systematic statistical analysis revealed that these results were not above the chance level. The empirical chance level was estimated using random assignments of recorded velocity profiles and EEG signals, as well as combinations of randomly generated synthetic EEG with recorded velocity profiles and recorded EEG with randomly generated synthetic velocity profiles. The analysis shows that the positive correlation results in this experiment cannot be used as an indicator of successful trajectory reconstruction based on a neural correlate. Several directions are herein discussed to address the misinterpretation of results as well as the implications on previous invasive and non-invasive works.	[Antelis, Javier M.; Montesano, Luis] Univ Zaragoza, Aragon Inst Engn Res I3A, Zaragoza, Aragon, Spain; [Ramos-Murguialday, Ander; Birbaumer, Niels; Minguez, Javier] Univ Tubingen, Inst Med Psychol & Behav Neurobiol, Tubingen, Germany; [Ramos-Murguialday, Ander] TECNALIA, Hlth Technol, San Sebastian, Basque Country, Spain; [Birbaumer, Niels] Osped San Camilo, Ist Ricovero & Cura Carattere Sci, Venice, Lido, Italy; [Minguez, Javier] BitBrain Technol, Zaragoza, Spain	University of Zaragoza; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; IRCCS Ospedale San Camillo	Antelis, JM (corresponding author), Univ Zaragoza, Aragon Inst Engn Res I3A, Zaragoza, Aragon, Spain.	antelis@unizar.es	Antelis, Javier M./W-3381-2019	Antelis, Javier M./0000-0003-3377-0813; Birbaumer, Niels/0000-0002-6786-5127; Ramos-Murguialday, Dr. Ander/0000-0002-1549-4029; Minguez Zafra, Javier/0000-0002-2957-0133	Spanish projects HYPER-C [SD2009-00067, DPI2009-4732-C 02-01, DPI2011-25892]; Deutsche Forschungsgemeinschaft; German Ministry of Education and Research; Bernstein Centers [01GQ0761]; BMBF [58416SV3783]; EU HUMOUR-IC [T-2008-231724]	Spanish projects HYPER-C; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Bernstein Centers; BMBF(Federal Ministry of Education & Research (BMBF)); EU HUMOUR-IC	This work has been partly supported by the Spanish projects HYPER-C SD2009-00067, DPI2009-4732-C 02-01, DPI2011-25892, the Deutsche Forschungsgemeinschaft, the German Ministry of Education and Research, Bernstein Centers 01GQ0761, BMBF 58416SV3783 and the EU HUMOUR-IC T-2008-231724. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya S, 2010, J NEURAL ENG, V7, DOI [10.1088/1741-2560/7/4/046002, 10.2202/1553-3840.1324]; Agashe HA, 2011, IEEE ENG MED BIO, P5444, DOI 10.1109/IEMBS.2011.6091389; Antelis J. M., 2011, INT J BIOELECTROMAGN, V13, P112; Bradberry TJ, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/5/058002; Bradberry TJ, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/3/036010; Bradberry TJ, 2010, J NEUROSCI, V30, P3432, DOI 10.1523/JNEUROSCI.6107-09.2010; Bradberry TJ, 2009, NEUROIMAGE, V47, P1691, DOI 10.1016/j.neuroimage.2009.06.023; Carmena JM, 2003, PLOS BIOL, V1, P193, DOI 10.1371/journal.pbio.0000042; Chao ZC, 2010, FRONTIERS NEUROENGIN, V3; Colebatch JG, 2007, MOVEMENT DISORD, V22, P601, DOI 10.1002/mds.21323; Cui RQ, 1999, BRAIN TOPOGR, V11, P233; Doud AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026322; Georgopoulos AP, 2005, EXP BRAIN RES, V167, P132, DOI 10.1007/s00221-005-0028-8; Hochberg LR, 2012, NATURE, V485, P372, DOI 10.1038/nature11076; Jankelowitz SK, 2002, EXP BRAIN RES, V147, P98, DOI 10.1007/s00221-002-1220-8; Jerbi K, 2011, IRBM, V32, P8, DOI 10.1016/j.irbm.2010.12.004; Kim HK, 2006, IEEE T BIO-MED ENG, V53, P1164, DOI 10.1109/TBME.2006.870235; Kim SP, 2005, EURASIP J APPL SIG P, V2005, P3113, DOI 10.1155/ASP.2005.3113; Lebedev MA, 2006, TRENDS NEUROSCI, V29, P536, DOI 10.1016/j.tins.2006.07.004; Lew Eileen, 2012, Front Neuroeng, V5, P13, DOI 10.3389/fneng.2012.00013; Lv J, 2010, BIOMED ENG ONLINE, V9, DOI 10.1186/1475-925X-9-64; McFarland DJ, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/3/036007; Mulliken GH, 2008, J NEUROSCI, V28, P12913, DOI 10.1523/JNEUROSCI.1463-08.2008; Niazi IK, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/6/066009; Ofner P, 2012, IEEE ENG MED BIO, P6406, DOI 10.1109/EMBC.2012.6347460; Paninski L, 2004, J NEUROSCI, V24, P8551, DOI 10.1523/JNEUROSCI.0919-04.2004; Pascual-Marqui RD, 2002, METHOD FIND EXP CLIN, V24, P5; Pistohl T, 2008, J NEUROSCI METH, V167, P105, DOI 10.1016/j.jneumeth.2007.10.001; Poli R, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/5/058001; Presacco A, 2011, J NEUROPHYSIOLOGY; Proakis J. G., 1996, DIGIT SIGNAL PROCESS; Rickert J, 2005, J NEUROSCI, V25, P8815, DOI 10.1523/JNEUROSCI.0816-05.2005; Saleh M, 2010, J NEUROSCI, V30, P17079, DOI 10.1523/JNEUROSCI.2558-10.2010; Schalk G, 2007, J NEURAL ENG, V4, P264, DOI 10.1088/1741-2560/4/3/012; Serruya MD, 2002, NATURE, V416, P141, DOI 10.1038/416141a; Taylor DM, 2002, SCIENCE, V296, P1829, DOI 10.1126/science.1070291; Toda A, 2011, NEUROIMAGE, V54, P892, DOI 10.1016/j.neuroimage.2010.09.057; Waldert S, 2008, J NEUROSCI, V28, P1000, DOI 10.1523/JNEUROSCI.5171-07.2008; Waldert S, 2009, J PHYSIOL-PARIS, V103, P244, DOI 10.1016/j.jphysparis.2009.08.007; Wang YJ, 2009, LECT NOTES ARTIF INT, V5638, P437, DOI 10.1007/978-3-642-02812-0_52; Wolpaw JR, 2010, J MOTOR BEHAV, V42, P351, DOI 10.1080/00222895.2010.526471; Wolpaw JR, 2004, P NATL ACAD SCI USA, V101, P17849, DOI 10.1073/pnas.0403504101; Yeom HG, 2011, P 5 INT BRAIN COMP I, P32; Yuan H, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/2/026001; Zhuang J, 2010, IEEE T BIO-MED ENG, V57, P1774, DOI 10.1109/TBME.2010.2047015	45	69	69	3	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2013	8	4							e61976	10.1371/journal.pone.0061976	http://dx.doi.org/10.1371/journal.pone.0061976			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IK	23613992	Green Submitted, Green Published, gold			2022-12-25	WOS:000317907200114
J	Huang, BX; Kim, HY				Huang, Bill X.; Kim, Hee-Yong			Effective Identification of Akt Interacting Proteins by Two-Step Chemical Crosslinking, Co-Immunoprecipitation and Mass Spectrometry	PLOS ONE			English	Article							CELL-SURVIVAL; KINASE-B; TFII-I; PROTEOMICS; PHOSPHORYLATION; INHIBITION; COMPLEXES; TARGET; DIFFERENTIATION; ACTIVATION	Akt is a critical protein for cell survival and known to interact with various proteins. However, Akt binding partners that modulate or regulate Akt activation have not been fully elucidated. Identification of Akt-interacting proteins has been customarily achieved by co-immunoprecipitation combined with western blot and/or MS analysis. An intrinsic problem of the method is loss of interacting proteins during procedures to remove non-specific proteins. Moreover, antibody contamination often interferes with the detection of less abundant proteins. Here, we developed a novel two-step chemical crosslinking strategy to overcome these problems which resulted in a dramatic improvement in identifying Akt interacting partners. Akt antibody was first immobilized on protein A/G beads using disuccinimidyl suberate and allowed to bind to cellular Akt along with its interacting proteins. Subsequently, dithiobis[succinimidylpropionate], a cleavable crosslinker, was introduced to produce stable complexes between Akt and binding partners prior to the SDS-PAGE and nanoLC-MS/MS analysis. This approach enabled identification of ten Akt partners from cell lysates containing as low as 1.5 mg proteins, including two new potential Akt interacting partners. None of these but one protein was detectable without crosslinking procedures. The present method provides a sensitive and effective tool to probe Akt-interacting proteins. This strategy should also prove useful for other protein interactions, particularly those involving less abundant or weakly associating partners.	[Huang, Bill X.; Kim, Hee-Yong] NIAAA, Lab Mol Signaling, NIH, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)	Kim, HY (corresponding author), NIAAA, Lab Mol Signaling, NIH, Bethesda, MD USA.	hykim@nih.gov			Intramural Research Program of National Institute of Alcohol Abuse and Alcoholism, NIH; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000284] Funding Source: NIH RePORTER	Intramural Research Program of National Institute of Alcohol Abuse and Alcoholism, NIH; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This research was supported by the Intramural Research Program of National Institute of Alcohol Abuse and Alcoholism, NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn JY, 2006, EMBO J, V25, P2083, DOI 10.1038/sj.emboj.7601111; Amoresana A, 2010, J PROTEOME RES, V9, P2042, DOI 10.1021/pr9011156; Archakov AI, 2003, PROTEOMICS, V3, P380, DOI 10.1002/pmic.200390053; Aslan JE, 2009, MOL CELL, V34, P497, DOI 10.1016/j.molcel.2009.04.011; Basso AD, 2002, J BIOL CHEM, V277, P39858, DOI 10.1074/jbc.M206322200; Blagoev B, 2003, NAT BIOTECHNOL, V21, P315, DOI 10.1038/nbt790; Brazil DP, 2001, TRENDS BIOCHEM SCI, V26, P657, DOI 10.1016/S0968-0004(01)01958-2; Casteel DE, 2002, J BIOL CHEM, V277, P32003, DOI 10.1074/jbc.M112332200; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Ding ZY, 2006, P NATL ACAD SCI USA, V103, P15014, DOI 10.1073/pnas.0606917103; Du KY, 2005, ONCOGENE, V24, P7401, DOI 10.1038/sj.onc.1209099; Free R Benjamin, 2009, Curr Protoc Neurosci, VChapter 5, DOI 10.1002/0471142301.ns0528s46; Gandhi TKB, 2006, NAT GENET, V38, P285, DOI 10.1038/ng1747; Gingras AC, 2007, NAT REV MOL CELL BIO, V8, P645, DOI 10.1038/nrm2208; Gottschalk A, 2005, EMBO J, V24, P2566, DOI 10.1038/sj.emboj.7600741; Harlow E., 1999, USING ANTIBODIES LAB; Huang BX, 2006, MOL CELL PROTEOMICS, V5, P1045, DOI 10.1074/mcp.M600026-MCP200; Huang BX, 2011, J CELL BIOL, V192, P979, DOI 10.1083/jcb.201005100; Huang BX, 2004, J AM SOC MASS SPECTR, V15, P1237, DOI 10.1016/j.jasms.2004.05.004; Kocher T, 2007, NAT METHODS, V4, P807, DOI 10.1038/NMETH1093; Lau J, 2006, MOL CELL BIOCHEM, V286, P17, DOI 10.1007/s11010-005-9006-5; Lee YJ, 2008, MOL BIOSYST, V4, P816, DOI 10.1039/b801810c; Li YY, 2010, P NATL ACAD SCI USA, V107, P18832, DOI 10.1073/pnas.1008678107; Liu MY, 2002, CANCER RES, V62, P6475; Ma H, 2012, J PROTEOMICS, V75, P2601, DOI 10.1016/j.jprot.2012.03.009; Moresco JJ, 2010, J PROTEOMICS, V73, P2198, DOI 10.1016/j.jprot.2010.05.008; Novina CD, 1999, MOL CELL BIOL, V19, P5014; Oti M, 2006, J MED GENET, V43, DOI 10.1136/jmg.2006.041376; PHIZICKY EM, 1995, MICROBIOL REV, V59, P94, DOI 10.1128/MMBR.59.1.94-123.1995; Porter GW, 2006, SEMIN CANCER BIOL, V16, P193, DOI 10.1016/j.semcancer.2006.03.003; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Selbach M, 2006, NAT METHODS, V3, P981, DOI 10.1038/nmeth972; Sinha D, 2004, J BIOL CHEM, V279, P10962, DOI 10.1074/jbc.M312048200; Sinz A, 2006, MASS SPECTROM REV, V25, P663, DOI 10.1002/mas.20082; Sun LG, 2004, J CELL SCI, V117, P3021, DOI 10.1242/jcs.01142; Trinkle-Mulcahy L, 2008, J CELL BIOL, V183, P223, DOI 10.1083/jcb.200805092; Vandermoere F, 2007, MOL CELL PROTEOMICS, V6, P114, DOI 10.1074/mcp.M600335-MCP200; Vandermoere F, 2006, J BIOL CHEM, V281, P14307, DOI 10.1074/jbc.M510003200; Vasilescu J, 2006, CURR OPIN BIOTECH, V17, P394, DOI 10.1016/j.copbio.2006.06.008; Walther TC, 2010, J CELL BIOL, V190, P491, DOI 10.1083/jcb.201004052; Wepf A, 2009, NAT METHODS, V6, P203, DOI [10.1038/NMETH.1302, 10.1038/nmeth.1302]; Xiao L, 2010, CELL DEATH DIFFER, V17, P1448, DOI 10.1038/cdd.2010.16; Yang W, 2008, PROTEOMICS, V8, P832, DOI 10.1002/pmic.200700650; Zhou T, 2003, DEV CELL, V5, P127, DOI 10.1016/S1534-5807(03)00186-2; Zieske LR, 2006, J EXP BOT, V57, P1501, DOI 10.1093/jxb/erj168	45	32	33	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2013	8	4							e61430	10.1371/journal.pone.0061430	http://dx.doi.org/10.1371/journal.pone.0061430			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IK	23613850	gold, Green Submitted, Green Published			2022-12-25	WOS:000317907200054
J	Fattouh, R; Guo, CH; Lam, GY; Gareau, MG; Ngan, BY; Glogauer, M; Muise, AM; Brumell, JH				Fattouh, Ramzi; Guo, Cong-Hui; Lam, Grace Y.; Gareau, Melanie G.; Ngan, Bo-Yee; Glogauer, Michael; Muise, Aleixo M.; Brumell, John H.			Rac2-Deficiency Leads to Exacerbated and Protracted Colitis in Response to Citrobacter rodentium Infection	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; NADPH OXIDASE; INTESTINAL INFLAMMATION; ULCERATIVE-COLITIS; MURINE NEUTROPHILS; RAC2 MUTATION; GTPASE RAC2; CHEMOTAXIS; ACTIVATION; SUPEROXIDE	Recent genetic-based studies have implicated a number of immune-related genes in the pathogenesis of inflammatory bowel disease (IBD). Our recent genetic studies showed that RAC2 is associated with human IBD; however, its role in disease pathogenesis is unclear. Given Rac2's importance in various fundamental immune cell processes, we investigated whether a defect in Rac2 may impair host immune responses in the intestine and promote disease in the context of an infection-based (Citrobacter rodentium) model of colitis. In response to infection, Rac2(-/-) mice showed i) worsened clinical symptoms (days 13-18), ii) increased crypt hyperplasia at days 11 and 22 (a time when crypt hyperplasia was largely resolved in wildtype mice; WT), and iii) marked mononuclear cell infiltration characterized by higher numbers of T (CD3(+)) cells (day 22), compared to WT-infected mice. Moreover, splenocytes harvested from infected Rac2(-/-) mice and stimulated in vitro with C. rodentium lysate produced considerably higher levels of interferon-gamma and interleukin-17A. The augmented responses observed in Rac2(-/-) mice did not appear to stem from Rac2's role in NADPH oxidase-driven reactive oxygen species production as no differences in crypt hyperplasia, nor inflammation, were observed in infected NOX2(-/-) mice compared to WT. Collectively, our findings demonstrate that Rac2(-/-) mice develop more severe disease when subjected to a C. rodentium-induced model of infectious colitis, and suggest that impaired Rac2 function may promote the development of IBD in humans.	[Fattouh, Ramzi; Guo, Cong-Hui; Lam, Grace Y.; Gareau, Melanie G.; Muise, Aleixo M.; Brumell, John H.] Hosp Sick Children, Cell Biol Program, Toronto, ON M5G 1X8, Canada; [Ngan, Bo-Yee] Hosp Sick Children, Dept Pathol, Toronto, ON M5G 1X8, Canada; [Glogauer, Michael] Univ Toronto, Fac Dent, Toronto, ON, Canada; [Muise, Aleixo M.] Univ Toronto, Hosp Sick Children, Dept Pediat, Div Gastroenterol Hepatol & Nutr, Toronto, ON M5G 1X8, Canada; [Muise, Aleixo M.; Brumell, John H.] Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A1, Canada; [Muise, Aleixo M.; Brumell, John H.] Hosp Sick Children, Sickkids IBD Ctr, Toronto, ON M5G 1X8, Canada; [Brumell, John H.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto	Brumell, JH (corresponding author), Hosp Sick Children, Cell Biol Program, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	john.brumell@sickkids.ca	Glogauer, Michael/D-2504-2011	Glogauer, Michael/0000-0002-6248-5977; Lam, Grace/0000-0002-7366-193X; Fattouh, Ramzi/0000-0001-6573-6367	Canadian Institutes of Health Research (MOP) [97756]; Hospital for Sick Children; Ontario Ministry of Research and Innovation; CDHNF/NASPGHAN George Ferry young Investigator Development Award; CIHR [MOP119457]; Canadian Association of Gastroenterology; Crohn's and Colitis Foundation of Canada	Canadian Institutes of Health Research (MOP)(Canadian Institutes of Health Research (CIHR)); Hospital for Sick Children(University of Toronto); Ontario Ministry of Research and Innovation(Ministry of Research and Innovation, Ontario); CDHNF/NASPGHAN George Ferry young Investigator Development Award; CIHR(Canadian Institutes of Health Research (CIHR)); Canadian Association of Gastroenterology; Crohn's and Colitis Foundation of Canada	This work was supported by an operating grant from the Canadian Institutes of Health Research (MOP#97756) to JHB and AM and by a Trainee Start-up Fund Award from the Hospital for Sick Children to RF. AMM is supported by an Early Researcher Award from the Ontario Ministry of Research and Innovation and a CDHNF/NASPGHAN George Ferry young Investigator Development Award, and funded by a CIHR Operating Grant (MOP119457). RF is currently supported by a post-doctoral fellowship award from the CIHR in partnership with the Canadian Association of Gastroenterology and the Crohn's and Colitis Foundation of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambruso DR, 2000, P NATL ACAD SCI USA, V97, P4654, DOI 10.1073/pnas.080074897; Anderson CA, 2011, NAT GENET, V43, P246, DOI 10.1038/ng.764; Bao SS, 2011, IMMUNOL CELL BIOL, V89, P853, DOI 10.1038/icb.2011.4; Bokoch GM, 2005, TRENDS CELL BIOL, V15, P163, DOI 10.1016/j.tcb.2005.01.002; BOKOCH GM, 1995, TRENDS CELL BIOL, V5, P109, DOI 10.1016/S0962-8924(00)88960-6; Cho JH, 2011, GASTROENTEROLOGY, V140, P1704, DOI 10.1053/j.gastro.2011.02.046; Conway KL, 2012, J IMMUNOL, V189, P3631, DOI 10.4049/jimmunol.1103746; Cosnes J, 2011, GASTROENTEROLOGY, V140, P1785, DOI 10.1053/j.gastro.2011.01.055; Croker BA, 2002, IMMUNOL CELL BIOL, V80, P231, DOI 10.1046/j.1440-1711.2002.01077.x; Croker BA, 2002, J IMMUNOL, V168, P3376, DOI 10.4049/jimmunol.168.7.3376; Dumont C, 2009, BLOOD, V113, P3990, DOI 10.1182/blood-2008-09-181180; Filippi MD, 2004, NAT IMMUNOL, V5, P744, DOI 10.1038/ni1081; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Gu Y, 2003, SCIENCE, V302, P445, DOI 10.1126/science.1088485; HEYWORTH PG, 1994, J BIOL CHEM, V269, P30749; Kaniuk NA, 2010, METHODS MOL BIOL, V648, P175, DOI 10.1007/978-1-60761-756-3_11; KNAUS UG, 1991, SCIENCE, V254, P1512, DOI 10.1126/science.1660188; Koh ALY, 2005, CELL IMMUNOL, V235, P92, DOI 10.1016/j.cellimm.2005.07.005; Krieglstein CF, 2001, J EXP MED, V194, P1207, DOI 10.1084/jem.194.9.1207; Kurkchubasche AG, 2001, J PEDIATR-US, V139, P141, DOI 10.1067/mpd.2001.114718; Lebeis SL, 2007, J IMMUNOL, V179, P566, DOI 10.4049/jimmunol.179.1.566; Lefrancois L, 2001, Curr Protoc Immunol, VChapter 3, DOI 10.1002/0471142735.im0319s17; Li BY, 2000, SCIENCE, V288, P2219, DOI 10.1126/science.288.5474.2219; Li SJ, 2002, J IMMUNOL, V169, P5043, DOI 10.4049/jimmunol.169.9.5043; Lores P, 1997, ONCOGENE, V15, P601, DOI 10.1038/sj.onc.1201378; Muise AM, 2007, CURR BIOL, V17, P1212, DOI 10.1016/j.cub.2007.06.013; Muise AM, 2011, GUT; QUINN MT, 1993, J BIOL CHEM, V268, P20983; Ramaswamy M, 2007, J IMMUNOL, V179, P6384, DOI 10.4049/jimmunol.179.10.6384; Roberts AW, 1999, IMMUNITY, V10, P183, DOI 10.1016/S1074-7613(00)80019-9; Routes JM, 2009, JAMA-J AM MED ASSOC, V302, P2465, DOI 10.1001/jama.2009.1806; Snow AL, 2010, IMMUNOL REV, V236, P68, DOI 10.1111/j.1600-065X.2010.00917.x; Spehlmann ME, 2009, J IMMUNOL, V183, P3332, DOI 10.4049/jimmunol.0900600; Sun CX, 2004, BLOOD, V104, P3758, DOI 10.1182/blood-2004-03-0781; Vermeire S, 2011, CURR OPIN GASTROEN, V27, P32, DOI 10.1097/MOG.0b013e3283412e87; Walmsley MJ, 2003, SCIENCE, V302, P459, DOI 10.1126/science.1089709; Wheeler AP, 2006, J CELL SCI, V119, P2749, DOI 10.1242/jcs.03024; Williams DA, 2000, BLOOD, V96, P1646; Yamauchi A, 2005, J BIOL CHEM, V280, P953, DOI 10.1074/jbc.M408820200; Yamauchi A, 2004, J IMMUNOL, V173, P5971, DOI 10.4049/jimmunol.173.10.5971; Yu H, 2001, J EXP MED, V194, P915, DOI 10.1084/jem.194.7.915; Zhang H, 2009, J IMMUNOL, V183, P2718, DOI 10.4049/jimmunol.0900849	42	17	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2013	8	4							e61629	10.1371/journal.pone.0061629	http://dx.doi.org/10.1371/journal.pone.0061629			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130DR	23613889	Green Submitted, Green Published, gold			2022-12-25	WOS:000317893400084
J	Hoog, JL; Huisman, SM; Brunner, D; Antony, C				Hoeoeg, Johanna L.; Huisman, Stephen M.; Brunner, Damian; Antony, Claude			Electron Tomography Reveals Novel Microtubule Lattice and Microtubule Organizing Centre Defects in plus TIP Mutants	PLOS ONE			English	Article							SPINDLE POLE BODY; SEPTATION INITIATION NETWORK; ADENOMATOUS POLYPOSIS-COLI; FISSION YEAST; SCHIZOSACCHAROMYCES-POMBE; CELL-CYCLE; SACCHAROMYCES-CEREVISIAE; END-TRACKING; CYTOPLASMIC MICROTUBULES; INTERPHASE MICROTUBULES	Mal3p and Tip1p are the fission yeast (Schizosaccharomyces pombe) homologues of EB1 and CLIP-170, two conserved microtubule plus end tracking proteins (+TIPs). These proteins are crucial regulators of microtubule dynamics. Using electron tomography, we carried out a high-resolution analysis of the phenotypes caused by mal3 and tip1 deletions. We describe the 3-dimensional microtubule organization, quantify microtubule end structures and uncover novel defects of the microtubule lattices. We also reveal unexpected structural modifications of the spindle pole bodies (SPBs), the yeast microtubule organizing centers. In both mutants we observe an increased SPB volume and a reduced number of MT/SPB attachments. The discovered defects alter previous interpretations of the mutant phenotypes and provide new insights into the molecular functions of the two protein families.	[Hoeoeg, Johanna L.] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; [Hoeoeg, Johanna L.] Univ Colorado, Dept Mol Cellular & Dev Biol, Lab Struct Cells & Mol 3D, Boulder, CO 80309 USA; [Hoeoeg, Johanna L.; Huisman, Stephen M.; Brunner, Damian; Antony, Claude] European Mol Biol Lab, D-69012 Heidelberg, Germany; [Huisman, Stephen M.; Brunner, Damian] Univ Zurich, Inst Mol Life Sci, CH-8006 Zurich, Switzerland	University of Oxford; University of Colorado System; University of Colorado Boulder; European Molecular Biology Laboratory (EMBL); University of Zurich	Hoog, JL (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, S Parks Rd, Oxford OX1 3RE, England.	johanna.hoog@path.ox.ac.uk	antony, claude/K-5342-2013; Brunner, Damian/F-2024-2011	Hoog, Johanna/0000-0003-2162-3816; Huisman, Stephen/0000-0002-1658-8350; Brunner, Damian/0000-0001-5250-492X	European Community [MEST-CT-2004-504640]; EMBO; Deutsche Forschungsgemeinschaft (DFG) within 7th European Community Framework Programme; National Institutes of Health Biotechnology Resources grant [RR000592]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR000592] Funding Source: NIH RePORTER	European Community(European Commission); EMBO(European Molecular Biology Organization (EMBO)); Deutsche Forschungsgemeinschaft (DFG) within 7th European Community Framework Programme(German Research Foundation (DFG)); National Institutes of Health Biotechnology Resources grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	J.L.H. was first supported by a Marie Curie Early Stage Research Training Fellowship of the European Community's Sixth Framework Programme (FP6) under contract number MEST-CT-2004-504640, then EMBO postdoctoral fellowship followed by Sir Henry Wellcome postdoctoral fellowship. S. M. H. was supported by Deutsche Forschungsgemeinschaft (DFG) followed by a Marie Curie Intra European fellowship within the 7th European Community Framework Programme. This work was also supported by National Institutes of Health Biotechnology Resources grant RR000592 to Andreas Hoenger. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhmanova A, 2008, NAT REV MOL CELL BIO, V9, P309, DOI 10.1038/nrm2369; Askham JM, 2002, MOL BIOL CELL, V13, P3627, DOI 10.1091/mbc.E02-01-0061; Beinhauer JD, 1997, J CELL BIOL, V139, P717, DOI 10.1083/jcb.139.3.717; BERLIN V, 1990, J CELL BIOL, V111, P2573, DOI 10.1083/jcb.111.6.2573; Berrueta L, 1998, P NATL ACAD SCI USA, V95, P10596, DOI 10.1073/pnas.95.18.10596; Bieling P, 2007, NATURE, V450, P1100, DOI 10.1038/nature06386; Bridge AJ, 1998, GENE DEV, V12, P927, DOI 10.1101/gad.12.7.927; Brunner D, 2000, CELL, V102, P695, DOI 10.1016/S0092-8674(00)00091-X; Busch KE, 2004, CURR BIOL, V14, P548, DOI 10.1016/j.cub.2004.03.029; Carvalho P, 2004, DEV CELL, V6, P815, DOI 10.1016/j.devcel.2004.05.001; Chang L, 2000, P NATL ACAD SCI USA, V97, P5249, DOI 10.1073/pnas.97.10.5249; Cuschieri L, 2006, MOL BIOL CELL, V17, P4420, DOI 10.1091/mbc.E06-03-0245; des Georges A, 2008, NAT STRUCT MOL BIOL, V15, P1102, DOI 10.1038/nsmb.1482; Ding R, 1997, MOL BIOL CELL, V8, P1461, DOI 10.1091/mbc.8.8.1461; Dixit R, 2009, P NATL ACAD SCI USA, V106, P492, DOI 10.1073/pnas.0807614106; Hoog JL, 2007, METHOD CELL BIOL, V79, P145, DOI 10.1016/S0091-679X(06)79006-9; Hoog JL, 2007, DEV CELL, V12, P349, DOI 10.1016/j.devcel.2007.01.020; Hoog JL, 2011, J CELL SCI, V124, P693, DOI 10.1242/jcs.072967; Katsuki M, 2009, J BIOL CHEM, V284, P29246, DOI 10.1074/jbc.C109.052159; Krapp A, 2001, CURR BIOL, V11, P1559, DOI 10.1016/S0960-9822(01)00478-X; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Liakopoulos D, 2003, CELL, V112, P561, DOI 10.1016/S0092-8674(03)00119-3; Lin HJ, 2001, J CELL BIOL, V155, P1173, DOI 10.1083/jcb.200108119; Louie RK, 2004, J CELL SCI, V117, P1117, DOI 10.1242/jcs.00939; Maekawa H, 2003, EMBO J, V22, P438, DOI 10.1093/emboj/cdg063; Maurer SP, 2011, P NATL ACAD SCI USA, V108, P3988, DOI 10.1073/pnas.1014758108; McIntosh JR, 2009, J MOL BIOL, V394, P177, DOI 10.1016/j.jmb.2009.09.033; Moore JK, 2006, MOL BIOL CELL, V17, P178, DOI 10.1091/mbc.e05-06-0565; Morrell JL, 2004, CURR BIOL, V14, P579, DOI 10.1016/j.cub.2004.03.036; Morrison EE, 2007, CELL MOL LIFE SCI, V64, P307, DOI 10.1007/s00018-007-6360-3; Morrison EE, 1998, ONCOGENE, V17, P3471, DOI 10.1038/sj.onc.1202247; NURSE P, 1980, GENETICS, V96, P627; O'Toole ET, 1999, MOL BIOL CELL, V10, P2017, DOI 10.1091/mbc.10.6.2017; QUINLAN RA, 1980, J CELL SCI, V46, P341; Rehberg M, 2002, MOL BIOL CELL, V13, P2301, DOI 10.1091/mbc.E02-01-0054; Sandblad L, 2006, CELL, V127, P1415, DOI 10.1016/j.cell.2006.11.025; Sawin KE, 2004, CURR BIOL, V14, P763, DOI 10.1016/j.cub.2004.03.042; Sawin KE, 2006, YEAST, V23, P1001, DOI 10.1002/yea.1404; Tallada VA, 2009, J CELL BIOL, V185, P875, DOI 10.1083/jcb.200812108; Uzawa S, 2004, MOL BIOL CELL, V15, P5219, DOI 10.1091/mbc.E04-03-0255; Vaughan KT, 2005, J CELL BIOL, V171, P197, DOI 10.1083/jcb.200509150; Yan XM, 2006, MOL BIOL CELL, V17, P634, DOI 10.1091/mbc.E05-08-0810; Yang XM, 2009, J BIOL CHEM, V284, P28775, DOI 10.1074/jbc.M109.017681; Zimmerman S, 2005, MOL BIOL CELL, V16, P2719, DOI 10.1091/mbc.E04-08-0676	44	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2013	8	4							e61698	10.1371/journal.pone.0061698	http://dx.doi.org/10.1371/journal.pone.0061698			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130DR	23613905	Green Published, Green Submitted, gold			2022-12-25	WOS:000317893400092
J	Kleinsteuber, K; Heesch, K; Schattling, S; Kohns, M; Sander-Julch, C; Walzl, G; Hesseling, A; Mayatepek, E; Fleischer, B; Marx, FM; Jacobsen, M				Kleinsteuber, Katja; Heesch, Kerrin; Schattling, Stefanie; Kohns, Malte; Sander-Juelch, Claudia; Walzl, Gerhard; Hesseling, Anneke; Mayatepek, Ertan; Fleischer, Bernhard; Marx, Florian M.; Jacobsen, Marc			Decreased Expression of miR-21, miR-26a, miR-29a, and miR-142-3p in CD4(+) T Cells and Peripheral Blood from Tuberculosis Patients	PLOS ONE			English	Article							INTERFERON-GAMMA; ACTIVE TUBERCULOSIS; IMMUNE-RESPONSE; TH17 CELLS; C-MYC; INFECTION; MICRORNA; PROTECTION; DISEASE; PTEN	The vast majority of Mycobacterium tuberculosis (M. tuberculosis) infected individuals are protected from developing tuberculosis and T cells are centrally involved in this process. MicroRNAs (miRNA) regulate T-cell functions and are biomarker candidates of disease susceptibility and treatment efficacy in M. tuberculosis infection. We determined the expression profile of 29 selected miRNAs in CD4(+) T cells from tuberculosis patients and contacts with latent M. tuberculosis infection (LTBI). These analyses showed lower expression of miR-21, miR-26a, miR-29a, and miR-142-3p in CD4(+) T cells from tuberculosis patients. Whole blood miRNA candidate analyses verified decreased expression of miR-26a, miR-29a, and miR-142-3p in children with tuberculosis as compared to healthy children with LTBI. Despite marked variances between individual donor samples, trends of increased miRNA candidate expression during treatment and recovery were observed. Functional in vitro analysis identified increased miR-21 and decreased miR-26a expression after re-stimulation of T cells. In vitro polarized Interleukin-17 positive T-cell clones showed activation-dependent miR-29a up-regulation. In order to characterize the role of miR-29a (a described suppressor of Interferon-c in tuberculosis), we analyzed M. tuberculosis specific Interferon-gamma expressing T cells in children with tuberculosis and healthy contacts but detected no correlation between miR-29a and Interferon-gamma expression. Suppression of miR-29a in primary human T cells by antagomirs indicated no effect on Interferon-gamma expression after in vitro activation. Finally, classification of miRNA targets revealed only a moderate overlap between the candidates. This may reflect differential roles of miR-21, miR-26a, miR-29a, and miR-142-3p in T-cell immunity against M. tuberculosis infection and disease.	[Kleinsteuber, Katja; Heesch, Kerrin; Schattling, Stefanie; Sander-Juelch, Claudia; Fleischer, Bernhard; Jacobsen, Marc] Bernhard Nocht Inst Trop Med, Dept Immunol, D-20359 Hamburg, Germany; [Kohns, Malte; Mayatepek, Ertan; Jacobsen, Marc] Univ Childrens Hosp, Dept Gen Pediat Neonatol Pediat Cardiol, Dusseldorf, Germany; [Hesseling, Anneke] Univ Stellenbosch, Fac Hlth Sci, Desmond Tutu Tb Ctr, Dept Paediat & Child Hlth, Cape Town, South Africa; [Walzl, Gerhard] Univ Stellenbosch, Div Mol Biol & Human Genet, MRC Ctr Mol & Cellular Biol, Fac Hlth Sci,DST & NRF Ctr Excellence Biomed TB R, Cape Town, South Africa; [Marx, Florian M.] Charite, Dept Pediat Pneumol & Immunol, D-13353 Berlin, Germany	Bernhard Nocht Institut fur Tropenmedizin; University of Hamburg; University Medical Center Hamburg-Eppendorf; Stellenbosch University; Stellenbosch University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Jacobsen, M (corresponding author), Bernhard Nocht Inst Trop Med, Dept Immunol, Bernhard Nocht Str 74, D-20359 Hamburg, Germany.	marc.jacobsen@med.uni-duesseldorf.de	Marx, Florian/AAD-7148-2019; Walzl, Gerhard/N-6371-2016	Marx, Florian/0000-0003-4630-4598; Jacobsen, Marc/0000-0002-4703-5652; Walzl, Gerhard/0000-0003-2487-125X	German Leprosy; TB relief association (DAHW); Deutsche Forschungsgemeinschaft (DFG) [JA 1479/3-1]	German Leprosy; TB relief association (DAHW); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This study was supported by the German Leprosy and TB relief association (DAHW), project: TB Biomarkers and by the Deutsche Forschungsgemeinschaft (DFG), project: Immunpolarization in childhood TB (JA 1479/3-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baltimore D, 2008, NAT IMMUNOL, V9, P839, DOI 10.1038/ni.f.209; Basile JI, 2011, J INFECT DIS, V204, P1054, DOI 10.1093/infdis/jir460; Buckler JL, 2008, IMMUNOL REV, V224, P239, DOI 10.1111/j.1600-065X.2008.00650.x; Buckler JL, 2006, J IMMUNOL, V177, P4262, DOI 10.4049/jimmunol.177.7.4262; Buechner J, 2011, DIFFERENTIATION, V81, P25, DOI 10.1016/j.diff.2010.09.184; Bui Thi V, 2010, Genes Cancer, V1, P568; Chang TC, 2008, NAT GENET, V40, P43, DOI 10.1038/ng.2007.30; Chen XC, 2010, AM J RESP CRIT CARE, V181, P734, DOI 10.1164/rccm.200909-1463OC; COOPER AM, 1993, J EXP MED, V178, P2243, DOI 10.1084/jem.178.6.2243; Curtale G, 2010, BLOOD, V115, P265, DOI 10.1182/blood-2009-06-225987; Darrah PA, 2007, NAT MED, V13, P843, DOI 10.1038/nm1592; Day CL, 2011, J IMMUNOL, V187, P2222, DOI 10.4049/jimmunol.1101122; Dorhoi A, 2011, IMMUNOL REV, V240, P235, DOI 10.1111/j.1600-065X.2010.00994.x; FLYNN JL, 1993, J EXP MED, V178, P2249, DOI 10.1084/jem.178.6.2249; Haasch D, 2002, CELL IMMUNOL, V217, P78, DOI 10.1016/S0008-8749(02)00506-3; Harari A, 2011, NAT MED, V17, P372, DOI 10.1038/nm.2299; Huang GC, 2012, J BIOL CHEM, V287, P23196, DOI 10.1074/jbc.M112.351940; Jacobsen M, 2006, METHOD INFORM MED, V45, P557, DOI 10.1055/s-0038-1634118; Jacobsen M, 2005, J INFECT DIS, V192, P1211, DOI 10.1086/444428; Jacobsen M, 2011, CLIN MICROBIOL INFEC, V17, P1323, DOI 10.1111/j.1469-0691.2010.03326.x; Jurado JO, 2012, J LEUKOCYTE BIOL, V91, P991, DOI 10.1189/jlb.1211619; Kleinsteuber K, 2012, BLOOD, V120, P4374, DOI 10.1182/blood-2011-11-392738; Kumar NP, 2011, CLIN VACCINE IMMUNOL, V18, P1856, DOI 10.1128/CVI.05366-11; Kumar P, 2005, NUCLEIC ACIDS RES, V33, P2707, DOI 10.1093/nar/gki568; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Li QJ, 2007, CELL, V129, P147, DOI 10.1016/j.cell.2007.03.008; Lindenstrom T, 2009, J IMMUNOL, V182, P8047, DOI 10.4049/jimmunol.0801592; Lu LF, 2009, IMMUNITY, V30, P80, DOI 10.1016/j.immuni.2008.11.010; Lu TX, J IMMUNOL; Ma F, 2011, NAT IMMUNOL, V12, P861, DOI 10.1038/ni.2073; Marin ND, 2012, CLIN VACCINE IMMUNOL, V19, P1667, DOI 10.1128/CVI.00390-12; Mattes J, 2009, P NATL ACAD SCI USA, V106, P18704, DOI 10.1073/pnas.0905063106; Mott JL, 2010, J CELL BIOCHEM, V110, P1155, DOI 10.1002/jcb.22630; Mueller H, 2008, CYTOKINE, V43, P143, DOI 10.1016/j.cyto.2008.05.002; O'Connell RM, 2010, NAT REV IMMUNOL, V10, P111, DOI 10.1038/nri2708; Ottenhoff THM, 2003, ADV EXP MED BIOL, V531, P279; Rossi RL, 2011, NAT IMMUNOL, V12, P796, DOI 10.1038/ni.2057; Steiner DF, 2011, IMMUNITY, V35, P169, DOI 10.1016/j.immuni.2011.07.009; Sun W, 2010, ANNU REV BIOMED ENG, V12, P1, DOI 10.1146/annurev-bioeng-070909-105314; Tili Esmerina, 2008, Int J Med Sci, V5, P73; Wei B, 2010, CELL MOL IMMUNOL, V7, P175, DOI 10.1038/cmi.2010.19; Wozniak TM, 2010, INFECT IMMUN, V78, P4187, DOI 10.1128/IAI.01392-09	42	64	72	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2013	8	4							e61609	10.1371/journal.pone.0061609	http://dx.doi.org/10.1371/journal.pone.0061609			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130DR	23613882	gold, Green Submitted, Green Published			2022-12-25	WOS:000317893400080
J	Myking, S; Boyd, HA; Myhre, R; Feenstra, B; Jugessur, A; Pay, ASD; Ostensen, IHG; Morken, NH; Busch, T; Ryckman, KK; Geller, F; Magnus, P; Gjessing, HK; Melbye, M; Jacobsson, B; Murray, JC				Myking, Solveig; Boyd, Heather A.; Myhre, Ronny; Feenstra, Bjarke; Jugessur, Astanand; Pay, Aase S. Devold; Ostensen, Ingrid H. G.; Morken, Nils-Halvdan; Busch, Tamara; Ryckman, Kelli K.; Geller, Frank; Magnus, Per; Gjessing, Hakon K.; Melbye, Mads; Jacobsson, Bo; Murray, Jeffrey C.			X-Chromosomal Maternal and Fetal SNPs and the Risk of Spontaneous Preterm Delivery in a Danish/Norwegian Genome-Wide Association Study	PLOS ONE			English	Article							TRANSMISSION/DISEQUILIBRIUM TEST; NORWEGIAN MOTHER; GESTATIONAL-AGE; BIRTH-WEIGHT; CHILD COHORT; GENE; LINKAGE; FAMILY; DISEQUILIBRIUM; SUSCEPTIBILITY	Background: Recent epidemiological studies suggest that the maternal genome is an important contributor to spontaneous preterm delivery (PTD). There is also a significant excess of males among preterm born infants, which may imply an X-linked mode of inheritance for a subset of cases. To explore this, we examined the effect of maternal and fetal X-chromosomal single nucleotide polymorphisms (SNPs) on the risk of PTD in two independent genome-wide association studies and one replication study. Methods: Participants were recruited from the Danish National Birth Cohort and the Norwegian Mother and Child cohort studies. Data from these two populations were first analyzed independently, and then combined in a meta-analysis. Overall, we evaluated 12,211 SNPs in 1,535 case-mother dyads and 1,487 control-mother dyads. Analyses were done using a hybrid design that combines case-mother dyads and control-mother dyads, as implemented in the Haplin statistical software package. A sex-stratified analysis was performed for the fetal SNPs. In the replication study, 10 maternal and 16 fetal SNPs were analyzed using case-parent triads from independent studies of PTD in the United States, Argentina and Denmark. Results: In the meta-analysis, the G allele at the maternal SNP rs2747022 in the FERM domain containing 7 gene (FRMD7) increased the risk of spontaneous PTD by 1.2 (95% confidence interval (CI): 1.1, 1.4). Although an association with this SNP was confirmed in the replication study, it was no longer statistically significant after a Bonferroni correction for multiple testing. Conclusion: We did not find strong evidence in our data to implicate X-chromosomal SNPs in the etiology of spontaneous PTD. Although non-significant after correction for multiple testing, the mother's G allele at rs2747022 in FRMD7 increased the risk of spontaneous PTD across all populations in this study, thus warranting further investigation in other populations.	[Myking, Solveig; Myhre, Ronny; Jugessur, Astanand; Pay, Aase S. Devold; Ostensen, Ingrid H. G.; Magnus, Per; Gjessing, Hakon K.; Jacobsson, Bo] Norwegian Inst Publ Hlth, Div Epidemiol, Dept Genes & Environm, Oslo, Norway; [Boyd, Heather A.; Feenstra, Bjarke; Geller, Frank; Melbye, Mads] Statens Serum Inst, Dept Epidemiol Res, DK-2300 Copenhagen, Denmark; [Jugessur, Astanand] Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; [Pay, Aase S. Devold] Oslo Univ Hosp, Women & Childrens Div, Dept Obstet & Gynecol, Oslo, Norway; [Morken, Nils-Halvdan; Gjessing, Hakon K.] Univ Bergen, Dept Publ Hlth & Primary Hlth Care, Bergen, Norway; [Morken, Nils-Halvdan] Haukeland Hosp, Dept Obstet & Gynecol, N-5021 Bergen, Norway; [Jacobsson, Bo] Sahlgrens Univ Hosp, Inst Hlth Women & Children, Dept Obstet & Gynecol, Gothenburg, Sweden; [Busch, Tamara; Ryckman, Kelli K.; Murray, Jeffrey C.] Univ Iowa, Dept Pediat, Carver Coll Med, Iowa City, IA 52242 USA; [Ryckman, Kelli K.; Murray, Jeffrey C.] Univ Iowa, Coll Publ Hlth, Dept Epidemiol, Iowa City, IA USA	Norwegian Institute of Public Health (NIPH); Statens Serum Institut; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Oslo; University of Bergen; University of Bergen; Haukeland University Hospital; Sahlgrenska University Hospital; University of Iowa; University of Iowa	Jacobsson, B (corresponding author), Norwegian Inst Publ Hlth, Div Epidemiol, Dept Genes & Environm, Oslo, Norway.	bo.jacobsson@obgyn.gu.se	Jacobsson, Bo/O-8007-2014; Pay, Aase Serine Devold/AAO-8849-2020	Jacobsson, Bo/0000-0001-5079-2374; Pay, Aase Serine Devold/0000-0001-6361-5983; melbye, mads/0000-0001-8264-6785; Ryckman, Kelli/0000-0002-9496-4147; Feenstra, Bjarke/0000-0003-1478-649X; Geller, Frank/0000-0002-9238-3269; Boyd, Heather/0000-0001-6849-9985	National Institutes of Health (NIH) [HD52953, HD57192]; Danish National Research Foundation; Danish Pharmacists' Fund; Egmont Foundation; March of Dimes Birth Defects Foundation; Augustinus Foundation; Health Fund of the Danish Health Insurance Societies; Gene Environment Association Studies (GENEVA) under GEI; Danish Medical Research Council; Lundbeck Foundation; GENEVA Coordinating Center [U01 HG004446]; NIH GEI [U01HG004438, U01HG04424]; NIH contract "High throughput genotyping for studying the genetic contributions to human disease" [HHSN268200782096C]; Norwegian Ministry of Health; Ministry of Education and Research; NIH/NIEHS [NO-ES-75558]; NIH/NINDS [1 UO1 NS 047537-01]; Norwegian Research Council/FUGE [151918/S10]; Norwegian Research Council [FUGE 183220/S10, FRIMEDKLI-05 ES236011]; Swedish government [ALFGBG-136431]; Sahlgrenska University Hospital, Sahlgrenska Academy, Gothenburg, Sweden; Swedish Medical Society, Stockholm, Sweden [2008-21198]; Jane and Dan Olsson Research Foundation, Gothenburg, Sweden; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD057192, R01HD052953] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004446, U01HG004424, U01HG004438] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES005605] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS047537] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Danish National Research Foundation(Danmarks Grundforskningsfond); Danish Pharmacists' Fund; Egmont Foundation; March of Dimes Birth Defects Foundation(March of Dimes); Augustinus Foundation; Health Fund of the Danish Health Insurance Societies; Gene Environment Association Studies (GENEVA) under GEI; Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Lundbeck Foundation(Lundbeckfonden); GENEVA Coordinating Center; NIH GEI; NIH contract "High throughput genotyping for studying the genetic contributions to human disease"(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Norwegian Ministry of Health; Ministry of Education and Research; NIH/NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Norwegian Research Council/FUGE(Research Council of Norway); Norwegian Research Council(Research Council of NorwayEuropean Commission); Swedish government; Sahlgrenska University Hospital, Sahlgrenska Academy, Gothenburg, Sweden; Swedish Medical Society, Stockholm, Sweden; Jane and Dan Olsson Research Foundation, Gothenburg, Sweden; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institutes of Health (NIH) [grant numbers HD52953, HD57192 to J.C.M.]. The DNBC was established with the support of a major grant from the Danish National Research Foundation. Additional support for the DNBC has been provided by the Danish Pharmacists' Fund, the Egmont Foundation, the March of Dimes Birth Defects Foundation, the Augustinus Foundation and the Health Fund of the Danish Health Insurance Societies. The generation of GWAS genotype data for the DNBC samples was funded as part of the Gene Environment Association Studies (GENEVA) under GEI. Other support came from the Danish Medical Research Council and the Lundbeck Foundation. Assistance with phenotype harmonization and genotype cleaning, as well as with general study coordination, was provided by the GENEVA Coordinating Center (U01 HG004446). Assistance with data cleaning was provided by the National Center for Biotechnology Information (NCBI). Funding support for genotyping, which was performed at the Johns Hopkins University Center for Inherited Disease Research (CIDR) and the Broad Institute of MIT and Harvard, was provided by the NIH GEI (U01HG004438 for CIDR; U01HG04424 for Broad) and the NIH contract "High throughput genotyping for studying the genetic contributions to human disease" (HHSN268200782096C for CIDR only). The Norwegian Mother and Child Cohort Study (MoBa) is supported by the Norwegian Ministry of Health and the Ministry of Education and Research, NIH/NIEHS (contract no. NO-ES-75558), NIH/NINDS (grant no. 1 UO1 NS 047537-01), and the Norwegian Research Council/FUGE (grant no. 151918/S10). Support also came from the Norwegian Research Council (FUGE 183220/S10, FRIMEDKLI-05 ES236011); Swedish government grants to researchers in the public health service (ALF) (ALFGBG-136431); Sahlgrenska University Hospital, Sahlgrenska Academy, Gothenburg, Sweden; the Swedish Medical Society, Stockholm, Sweden (2008-21198); and the Jane and Dan Olsson Research Foundation, Gothenburg, Sweden. The MoBa samples were genotyped at the genotyping core facility at Oslo University Hospital, Norway. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BERKOWITZ GS, 1993, EPIDEMIOL REV, V15, P414, DOI 10.1093/oxfordjournals.epirev.a036128; Betts-Henderson J, 2010, HUM MOL GENET, V19, P342, DOI 10.1093/hmg/ddp500; Blencowe H, 2012, LANCET, V379, P2162, DOI 10.1016/S0140-6736(12)60820-4; Born TL, 2000, J BIOL CHEM, V275, P41529; Boyd HA, 2009, AM J EPIDEMIOL, V170, P1358, DOI 10.1093/aje/kwp324; BRY K, 1995, ACTA PAEDIATR, V84, P233, DOI 10.1111/j.1651-2227.1995.tb13620.x; Carlini L, 2002, GYNECOL OBSTET INVES, V53, P174, DOI 10.1159/000058370; Chung RH, 2007, AM J HUM GENET, V80, P59, DOI 10.1086/510630; Clausson B, 2000, BRIT J OBSTET GYNAEC, V107, P375, DOI 10.1111/j.1471-0528.2000.tb13234.x; Cooperstock M, 1996, OBSTET GYNECOL, V88, P189, DOI 10.1016/0029-7844(96)00106-8; Ding J, 2006, AM J HUM GENET, V79, P567, DOI 10.1086/507609; Ferrante MI, 2001, GENE, V275, P217, DOI 10.1016/S0378-1119(01)00659-X; Fisher R.A., 1958, STAT METHODS RES WOR; Gjessing HK, 2006, ANN HUM GENET, V70, P382, DOI 10.1111/j.1469-1809.2005.00218.x; Gjessing HK, 2010, HAPLIN ANAL CASE PAR; Gudmundsson J, 2008, NAT GENET, V40, P281, DOI 10.1038/ng.89; Ho GYF, 2000, AM J HUM GENET, V66, P1158, DOI 10.1086/302822; Horvath S, 2000, AM J HUM GENET, V66, P1161, DOI 10.1086/302823; Jugessur A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039240; Kistka ZAF, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2007.12.014; Knapp M, 2001, THEOR POPUL BIOL, V60, P141, DOI 10.1006/tpbi.2001.1540; LEVITON A, 1993, DEV MED CHILD NEUROL, V35, P553; Lin PI, 2007, AM J HUM GENET, V80, P531, DOI 10.1086/512133; Lunde A, 2007, AM J EPIDEMIOL, V165, P734, DOI 10.1093/aje/kwk107; Magnus P, 2006, INT J EPIDEMIOL, V35, P1146, DOI 10.1093/ije/dyl170; MCGREGOR JA, 1992, AM J PERINAT, V9, P43, DOI 10.1055/s-2007-994668; Morken Nils-Halvdan, 2008, BMC Womens Health, V8, P16, DOI 10.1186/1472-6874-8-16; Moster D, 2008, NEW ENGL J MED, V359, P262, DOI 10.1056/NEJMoa0706475; Nemeth AH, 1999, GENOMICS, V60, P320, DOI 10.1006/geno.1999.5929; Nobrega MA, 2003, SCIENCE, V302, P413, DOI 10.1126/science.1088328; Olsen J, 2001, SCAND J PUBLIC HEALT, V29, P300, DOI 10.1177/14034948010290040201; Piton A, 2011, MOL PSYCHIATR, V16, P867, DOI 10.1038/mp.2010.54; Piton A, 2008, HUM MOL GENET, V17, P3965, DOI 10.1093/hmg/ddn300; Ronningen KS, 2006, EUR J EPIDEMIOL, V21, P619, DOI 10.1007/s10654-006-9041-x; Su MT, 2011, FERTIL STERIL, V96, P1435, DOI 10.1016/j.fertnstert.2011.09.030; Svensson AC, 2009, AM J EPIDEMIOL, V170, P1365, DOI 10.1093/aje/kwp328; Tarpey P, 2006, NAT GENET, V38, P1242, DOI 10.1038/ng1893; Treloar S A, 2000, Twin Res, V3, P80, DOI 10.1375/twin.3.2.80; van der Zanden LFM, 2011, NAT GENET, V43, P48, DOI 10.1038/ng.721; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Zeitlin J, 2002, HUM REPROD, V17, P2762, DOI 10.1093/humrep/17.10.2762; Zhang L, 2008, GENET EPIDEMIOL, V32, P370, DOI 10.1002/gepi.20311; Zhang L, 2009, AM J HUM GENET, V84, P431, DOI 10.1016/j.ajhg.2009.02.010	44	22	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2013	8	4							e61781	10.1371/journal.pone.0061781	http://dx.doi.org/10.1371/journal.pone.0061781			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130DR	23613933	Green Submitted, gold, Green Published			2022-12-25	WOS:000317893400107
J	Sato, S; Sesay, AK; Holder, AA				Sato, Shigeharu; Sesay, Abdul K.; Holder, Anthony A.			The Unique Structure of the Apicoplast Genome of the Rodent Malaria Parasite Plasmodium chabaudi chabaudi	PLOS ONE			English	Article							PLASTID-LIKE DNA; FALCIPARUM	The apicoplast, a non-photosynthetic plastid of apicomplexan species, has an extremely reduced but highly conserved genome. Here, the apicoplast genome of the rodent malaria parasite Plasmodium chabaudi chabaudi (Pcc) isolate CB was characterized. Although the set of genes in the genome is identical, the copy number of some tRNA genes differs between Pcc and other Plasmodium species because the Pcc DNA has only one rRNA/tRNA gene cluster, which is normally duplicated in other species. The location of the duplicated trnR(ACG) and trnM implies that one of the duplicated clusters in the ancestral molecule has been lost due to an intramolecular recombination event. The Pcc DNA occurs in two isoforms with an internal inversion between them. The presence of a unique variant in the duplicated trnT gene suggests that the two isoforms are interconvertible. This is the first report of the complete nucleotide sequence of a Plasmodium apicoplast DNA.	[Sato, Shigeharu; Holder, Anthony A.] MRC Natl Inst Med Res, Div Parasitol, London, England; [Sesay, Abdul K.] MRC Natl Inst Med Res, Div Syst Biol, Genom Facil, London, England	MRC National Institute for Medical Research; MRC National Institute for Medical Research	Sato, S (corresponding author), MRC Natl Inst Med Res, Div Parasitol, London, England.	ssato@nimr.mrc.ac.uk	Holder, Anthony A/A-7554-2013; Sato, Shigeharu/K-9464-2013	Holder, Anthony A/0000-0002-8490-6058; Sato, Shigeharu/0000-0001-9559-7580; Sato, Shigeharu/0000-0003-2738-430X	British Medical Research Council [U117532067, U117584270]; MRC [MC_U117532072] Funding Source: UKRI; Medical Research Council [MC_U117532072, U117584270] Funding Source: researchfish	British Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by British Medical Research Council (File References U117532067 and U117584270). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arisue N, 2012, MOL BIOL EVOL, V29, P2095, DOI 10.1093/molbev/mss082; Green BR, 2011, PLANT J, V66, P34, DOI 10.1111/j.1365-313X.2011.04541.x; Kohler S, 1997, SCIENCE, V275, P1485, DOI 10.1126/science.275.5305.1485; Kozarewa I, 2009, NAT METHODS, V6, P291, DOI [10.1038/nmeth.1311, 10.1038/NMETH.1311]; McFadden GI, 1996, NATURE, V381, P482, DOI 10.1038/381482a0; PREISER P, 1995, NUCLEIC ACIDS RES, V23, P4329, DOI 10.1093/nar/23.21.4329; Sato S, 2011, CELL MOL LIFE SCI, V68, P1285, DOI 10.1007/s00018-011-0646-1; Williamson DH, 2002, MOL MICROBIOL, V45, P533, DOI 10.1046/j.1365-2958.2002.03033.x; Wilson RJM, 1996, J MOL BIOL, V261, P155, DOI 10.1006/jmbi.1996.0449; Yeh E, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001138	10	7	7	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2013	8	4							e61778	10.1371/journal.pone.0061778	http://dx.doi.org/10.1371/journal.pone.0061778			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130DR	23613931	Green Submitted, Green Published, gold			2022-12-25	WOS:000317893400105
J	Thorpe, SD; Nagel, T; Carroll, SF; Kelly, DJ				Thorpe, Stephen D.; Nagel, Thomas; Carroll, Simon F.; Kelly, Daniel J.			Modulating Gradients in Regulatory Signals within Mesenchymal Stem Cell Seeded Hydrogels: A Novel Strategy to Engineer Zonal Articular Cartilage	PLOS ONE			English	Article							CYCLIC HYDROSTATIC-PRESSURE; DYNAMIC COMPRESSION; FUNCTIONAL-PROPERTIES; CHONDROGENIC PHENOTYPE; MECHANICAL STIMULATION; TISSUE DIFFERENTIATION; LOADING IMPROVES; PROGENITOR CELLS; GENE-EXPRESSION; MATRIX	Engineering organs and tissues with the spatial composition and organisation of their native equivalents remains a major challenge. One approach to engineer such spatial complexity is to recapitulate the gradients in regulatory signals that during development and maturation are believed to drive spatial changes in stem cell differentiation. Mesenchymal stem cell (MSC) differentiation is known to be influenced by both soluble factors and mechanical cues present in the local microenvironment. The objective of this study was to engineer a cartilaginous tissue with a native zonal composition by modulating both the oxygen tension and mechanical environment thorough the depth of MSC seeded hydrogels. To this end, constructs were radially confined to half their thickness and subjected to dynamic compression (DC). Confinement reduced oxygen levels in the bottom of the construct and with the application of DC, increased strains across the top of the construct. These spatial changes correlated with increased glycosaminoglycan accumulation in the bottom of constructs, increased collagen accumulation in the top of constructs, and a suppression of hypertrophy and calcification throughout the construct. Matrix accumulation increased for higher hydrogel cell seeding densities; with DC further enhancing both glycosaminoglycan accumulation and construct stiffness. The combination of spatial confinement and DC was also found to increase proteoglycan-4 (lubricin) deposition toward the top surface of these tissues. In conclusion, by modulating the environment through the depth of developing constructs, it is possible to suppress MSC endochondral progression and to engineer tissues with zonal gradients mimicking certain aspects of articular cartilage.	[Thorpe, Stephen D.; Nagel, Thomas; Carroll, Simon F.; Kelly, Daniel J.] Trinity Coll Dublin, Trinity Biomed Sci Inst, Trinity Ctr Bioengn, Dublin, Ireland; [Thorpe, Stephen D.; Nagel, Thomas; Carroll, Simon F.; Kelly, Daniel J.] Trinity Coll Dublin, Sch Engn, Dept Mech & Mfg Engn, Dublin, Ireland	Trinity College Dublin; Trinity College Dublin	Kelly, DJ (corresponding author), Trinity Coll Dublin, Trinity Biomed Sci Inst, Trinity Ctr Bioengn, Dublin, Ireland.	kellyd9@tcd.ie	Nagel, Thomas/T-8805-2019; Thorpe, Stephen/C-1656-2018; Nagel, Thomas/E-9966-2017	Nagel, Thomas/0000-0001-8459-4616; Thorpe, Stephen/0000-0002-4707-7756; Nagel, Thomas/0000-0001-8459-4616; Kelly, Daniel/0000-0003-4091-0992	Science Foundation Ireland [08/Y15/B1336]; European Research Council [258463]	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); European Research Council(European Research Council (ERC)European Commission)	Funding was provided by Science Foundation Ireland (President of Ireland Young Researcher Award: 08/Y15/B1336) and the European Research Council (StemRepair Project number 258463). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKIZUKI S, 1986, J ORTHOPAED RES, V4, P379, DOI 10.1002/jor.1100040401; Albro MB, 2011, J BIOMECH, V44, P1654, DOI 10.1016/j.jbiomech.2011.03.026; Albro MB, 2008, J BIOMECH, V41, P3152, DOI 10.1016/j.jbiomech.2008.08.023; Angele P, 2004, BIORHEOLOGY, V41, P335; Angele P, 2003, J ORTHOPAED RES, V21, P451, DOI 10.1016/S0736-0266(02)00230-9; Baker BM, 2011, TISSUE ENG PT A, V17, P1445, DOI [10.1089/ten.TEA.2010.0535, 10.1089/ten.tea.2010.0535]; Baumgartner L, 2010, J BIOMED MATER RES A, V93A, P930, DOI 10.1002/jbm.a.32577; Bian LM, 2012, TISSUE ENG PT A, V18, P715, DOI [10.1089/ten.tea.2011.0455, 10.1089/ten.TEA.2011.0455]; BROCKLEHURST R, 1984, J BONE JOINT SURG AM, V66A, P95, DOI 10.2106/00004623-198466010-00013; Buckley CT, 2010, OSTEOARTHR CARTILAGE, V18, P1345, DOI 10.1016/j.joca.2010.07.004; Buckley CT, 2012, TISSUE ENG PT A, V18, P382, DOI [10.1089/ten.tea.2011.0145, 10.1089/ten.TEA.2011.0145]; Buckley CT, 2009, TISSUE ENG PT A, V15, P3213, DOI [10.1089/ten.tea.2008.0531, 10.1089/ten.TEA.2008.0531]; Buckley CT, 2009, J MECH BEHAV BIOMED, V2, P512, DOI 10.1016/j.jmbbm.2008.12.007; Campbell JJ, 2006, BIORHEOLOGY, V43, P455; Candrian C, 2008, ARTHRITIS RHEUM-US, V58, P197, DOI 10.1002/art.23155; CARTER DR, 1988, J ORTHOP RES, V6, P736, DOI 10.1002/jor.1100060517; Connelly JT, 2010, TISSUE ENG PT A, V16, P1913, DOI [10.1089/ten.tea.2009.0561, 10.1089/ten.TEA.2009.0561]; Demarteau O, 2003, BIOCHEM BIOPH RES CO, V310, P580, DOI 10.1016/j.bbrc.2003.09.099; Farrell MJ, 2012, EUR CELLS MATER, V23, P425, DOI 10.22203/eCM.v023a33; Gannon AR, 2012, OSTEOARTHR CARTILAGE, V20, P1417, DOI 10.1016/j.joca.2012.08.005; Goerke UJ, 2010, J BIOMECH ENG-T ASME, V132, DOI 10.1115/1.4001312; Gu WY, 2003, J BIOMECH, V36, P593, DOI 10.1016/S0021-9290(02)00437-2; Hall BK, 2005, BONES CARTILAGE DEV, Vxxviii; Haugh MG, 2011, TISSUE ENG PT A, V17, P3085, DOI 10.1089/ten.tea.2011.0198; Huang AH, 2010, EUR CELLS MATER, V19, P72, DOI 10.22203/eCM.v019a08; Huang AH, 2010, J BIOMECH, V43, P128, DOI 10.1016/j.jbiomech.2009.09.018; Huang CYC, 2004, STEM CELLS, V22, P313, DOI 10.1634/stemcells.22-3-313; Hwang NS, 2007, FEBS LETT, V581, P4172, DOI 10.1016/j.febslet.2007.07.049; Ignat'eva NY, 2007, J ANAL CHEM+, V62, P51, DOI 10.1134/S106193480701011X; Kafienah W, 2003, METH MOL B, V238, P217; Kanichai M, 2008, J CELL PHYSIOL, V216, P708, DOI 10.1002/jcp.21446; Kelly DJ, 2010, BIRTH DEFECTS RES C, V90, P75, DOI 10.1002/bdrc.20173; Khan WS, 2010, KNEE, V17, P369, DOI 10.1016/j.knee.2009.12.003; Kim TK, 2003, OSTEOARTHR CARTILAGE, V11, P653, DOI 10.1016/S1063-4584(03)00120-1; KIM YJ, 1988, ANAL BIOCHEM, V174, P168, DOI 10.1016/0003-2697(88)90532-5; Kisiday JD, 2009, TISSUE ENG PT A, V15, P2817, DOI [10.1089/ten.tea.2008.0357, 10.1089/ten.TEA.2008.0357]; Klein TJ, 2003, OSTEOARTHR CARTILAGE, V11, P595, DOI 10.1016/S1063-4584(03)00090-6; Krinner A, 2009, CELL PROLIFERAT, V42, P471, DOI 10.1111/j.1365-2184.2009.00621.x; Kupcsik L, 2010, TISSUE ENG PT A, V16, P1845, DOI [10.1089/ten.tea.2009.0531, 10.1089/ten.TEA.2009.0531]; Laasanen MS, 2003, BIORHEOLOGY, V40, P133; Lecocq M, 2008, EQUINE VET J, V40, P442, DOI 10.2746/042516408X297453; Lee CSD, 2007, BIOMATERIALS, V28, P2987, DOI 10.1016/j.biomaterials.2007.02.035; Li JT, 2011, CELL TISSUE RES, V345, P357, DOI [10.1007/s00441-011-1212-8, 10.1007/s00441-011-1220-8]; Lion A, 1997, ACTA MECH, V123, P1, DOI 10.1007/BF01178397; Liu YR, 2012, TISSUE ENG PT A, V18, P1531, DOI [10.1089/ten.tea.2011.0575, 10.1089/ten.TEA.2011.0575]; Mauck RL, 2007, BIOMECH MODEL MECHAN, V6, P113, DOI 10.1007/s10237-006-0042-1; Mauck RL, 2003, J BIOMECH ENG-T ASME, V125, P602, DOI 10.1115/1.1611512; Meyer EG, 2011, J MECH BEHAV BIOMED, V4, P1257, DOI 10.1016/j.jmbbm.2011.04.012; Meyer EG, 2010, J BIOMECH, V43, P2516, DOI 10.1016/j.jbiomech.2010.05.020; Miyanishi K, 2006, TISSUE ENG, V12, P1419, DOI 10.1089/ten.2006.12.1419; Mow V, 2002, ANNU REV BIOMED ENG, V4, P175, DOI 10.1146/annurev.bioeng.4.110701.120309; Mow V.C., 2001, BASIC BIOMECHANICS M, P60; Nagel T, 2012, TISSUE EN A IN PRESS; Ng KW, 2006, BIORHEOLOGY, V43, P497; Ng KW, 2009, TISSUE ENG PT A, V15, P2315, DOI 10.1089/ten.tea.2008.0391; Ng KW, 2005, J ORTHOP RES, V23, P134, DOI 10.1016/j.orthres.2004.05.015; Nguyen LH, 2011, BIOMATERIALS, V32, P6946, DOI 10.1016/j.biomaterials.2011.06.014; Nguyen LH, 2011, BIOMATERIALS, V32, P1327, DOI 10.1016/j.biomaterials.2010.10.009; Pattappa G, 2013, TISSUE ENG PART C-ME, V19, DOI [10.1089/ten.tec.2011.0734, 10.1089/ten.TEC.2011.0734]; Pattappa G, 2011, J CELL PHYSIOL, V226, P2562, DOI 10.1002/jcp.22605; PAUWELS F, 1960, Z Anat Entwicklungsgesch, V121, P478, DOI 10.1007/BF00523401; Pelttari K, 2009, SWISS MED WKLY, V139, P602, DOI smw-12742; Prendergast PJ, 1997, J BIOMECH, V30, P539, DOI 10.1016/S0021-9290(96)00140-6; Schinagl RM, 1997, J ORTHOPAED RES, V15, P499, DOI 10.1002/jor.1100150404; Sengers BG, 2005, J BIOMECH ENG-T ASME, V127, P758, DOI 10.1115/1.1993664; Sharma B, 2007, TISSUE ENG, V13, P405, DOI 10.1089/ten.2006.0068; Sheehy EJ, 2013, ACTA BIOMATER, V9, P5484, DOI 10.1016/j.actbio.2012.11.008; Sheehy EJ, 2012, BIOCHEM BIOPH RES CO, V417, P305, DOI 10.1016/j.bbrc.2011.11.105; Sheehy EJ, 2011, J TISSUE ENG REGEN M, V5, P747, DOI 10.1002/term.385; Steward AJ, 2012, ACTA BIOMATER, V8, P2153, DOI 10.1016/j.actbio.2012.03.016; Storn R, 1997, J GLOBAL OPTIM, V11, P341, DOI 10.1023/A:1008202821328; Thorpe SD, 2008, BIOCHEM BIOPH RES CO, V377, P458, DOI 10.1016/j.bbrc.2008.09.154; Thorpe SD, 2012, J BIOMECH, V45, P2483, DOI 10.1016/j.jbiomech.2012.07.024; Thorpe SD, 2010, ANN BIOMED ENG, V38, P2896, DOI 10.1007/s10439-010-0059-6; Vinardell T, 2012, EUR CELLS MATER, V23, P121, DOI 10.22203/eCM.v023a09; Vinatier C, 2009, CURR STEM CELL RES T, V4, P318, DOI 10.2174/157488809789649205; Woodfield TBF, 2005, TISSUE ENG, V11, P1297, DOI 10.1089/ten.2005.11.1297; Zhou SD, 2004, ARTHRITIS RHEUM-US, V50, P3915, DOI 10.1002/art.20675	78	56	58	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2013	8	4							e60764	10.1371/journal.pone.0060764	http://dx.doi.org/10.1371/journal.pone.0060764			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130DR	23613745	Green Published, gold			2022-12-25	WOS:000317893400021
J	Aksnes, H; Osberg, C; Arnesen, T				Aksnes, Henriette; Osberg, Camilla; Arnesen, Thomas			N-Terminal Acetylation by NatC Is Not a General Determinant for Substrate Subcellular Localization in Saccharomyces cerevisiae	PLOS ONE			English	Article							GENOME-WIDE SCREEN; ALPHA-ACETYLATION; GTPASE ARL3P; PROTEIN; YEAST; ACETYLTRANSFERASE; COMPLEX; IDENTIFICATION; MITOCHONDRIAL; REQUIRES	N-terminal acetylation has been suggested to play a role in the subcellular targeting of proteins, in particular those acetylated by the N-terminal acetyltransferase complex NatC. Based on previous positional proteomics data revealing N-terminal acetylation status and the predicted NAT substrate classes, we selected 13 suitable NatC substrates for subcellular localization studies in Saccharomyces cerevisiae. Fluorescence microscopy analysis of GFP-tagged candidates in the presence or absence of the NatC catalytic subunit Naa30 (Mak3) revealed unaltered localization patterns for all 13 candidates, thus arguing against a general role for the N-terminal acetyl group as a localization determinant. Furthermore, all organelle-localized substrates indicated undisrupted structures, thus suggesting that absence of NatC acetylation does not have a vast effect on organelle morphology in yeast.	[Aksnes, Henriette; Osberg, Camilla; Arnesen, Thomas] Univ Bergen, Dept Mol Biol, Bergen, Norway; [Arnesen, Thomas] Haukeland Hosp, Dept Surg, N-5021 Bergen, Norway	University of Bergen; University of Bergen; Haukeland University Hospital	Arnesen, T (corresponding author), Univ Bergen, Dept Mol Biol, Bergen, Norway.	Thomas.Arnesen@mbi.uib.no	Arnesen, Thomas/J-7139-2017; Aksnes, Henriette/AAD-6290-2020; Arnesen, Thomas/Q-8117-2019	Arnesen, Thomas/0000-0002-3005-147X; Aksnes, Henriette/0000-0003-4968-2324; Arnesen, Thomas/0000-0002-3005-147X; Osberg, Camilla/0000-0003-0249-0536	Bergen Research Foundation; Research Council of Norway [197136]; Norwegian Cancer Society	Bergen Research Foundation; Research Council of Norway(Research Council of Norway); Norwegian Cancer Society(Norwegian Cancer Society)	This work was supported by The Bergen Research Foundation, the Research Council of Norway (Grant 197136 to T. A) and the Norwegian Cancer Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AITCHISON JD, 1995, J CELL BIOL, V131, P1133, DOI 10.1083/jcb.131.5.1133; Amberg DC, 2006, CSH PROTOC, V2006; Arnesen T, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001074; Arnesen T, 2009, P NATL ACAD SCI USA, V106, P8157, DOI 10.1073/pnas.0901931106; Behnia R, 2004, NAT CELL BIOL, V6, P405, DOI 10.1038/ncb1120; Behnia R, 2007, J CELL BIOL, V176, P255, DOI 10.1083/jcb.200607151; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; Caesar R, 2006, EUKARYOT CELL, V5, P368, DOI 10.1128/EC.5.2.368-378.2006; Caesar R, 2004, J BIOL CHEM, V279, P38532, DOI 10.1074/jbc.M402939200; Chacinska A, 2009, CELL, V138, P628, DOI 10.1016/j.cell.2009.08.005; Ciechanover A, 2004, TRENDS CELL BIOL, V14, P103, DOI 10.1016/j.tcb.2004.01.004; Coulton AT, 2010, J CELL SCI, V123, P3235, DOI 10.1242/jcs.069971; DASCHER C, 1991, MOL CELL BIOL, V11, P872, DOI 10.1128/MCB.11.2.872; De Hertogh Benoit, 2002, Funct Integr Genomics, V2, P154; Fleischer TC, 2006, GENE DEV, V20, P1294, DOI 10.1101/gad.1422006; Forte GMA, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001073; Frohlich F, 2009, J CELL BIOL, V185, P1227, DOI 10.1083/jcb.200811081; Geissenhoner A, 2004, MOL CELL BIOL, V24, P10300, DOI 10.1128/MCB.24.23.10300-10312.2004; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Hwang CS, 2010, SCIENCE, V327, P973, DOI 10.1126/science.1183147; Koffel R, 2005, MOL CELL BIOL, V25, P1655, DOI 10.1128/MCB.25.5.1655-1668.2005; Kondo-Okamoto N, 2008, EMBO REP, V9, P63, DOI 10.1038/sj.embor.7401113; Lai TP, 2009, TRAFFIC, V10, P1243, DOI 10.1111/j.1600-0854.2009.00956.x; Lalo D, 1996, J BIOL CHEM, V271, P21062, DOI 10.1074/jbc.271.35.21062; Lin CW, 1996, MOL CELL BIOL, V16, P6436; Losev E, 2006, NATURE, V441, P1002, DOI 10.1038/nature04717; Mackin NA, 2004, MOL BIOL CELL, V15, P1904, DOI 10.1091/mbc.E04-01-0004; Murthi A, 2005, GENETICS, V170, P1553, DOI 10.1534/genetics.105.043620; NOSKOV V, 1994, NUCLEIC ACIDS RES, V22, P1527, DOI 10.1093/nar/22.9.1527; Ostrowicz CW, 2008, AUTOPHAGY, V4, P5, DOI 10.4161/auto.5054; Outten CE, 2004, J BIOL CHEM, V279, P7785, DOI 10.1074/jbc.M312421200; Park HO, 1997, P NATL ACAD SCI USA, V94, P4463, DOI 10.1073/pnas.94.9.4463; Polevoda B, 2003, J BIOL CHEM, V278, P30686, DOI 10.1074/jbc.M304690200; Polevoda B, 2001, J BIOL CHEM, V276, P20154, DOI 10.1074/jbc.M011440200; PREUSS D, 1992, MOL BIOL CELL, V3, P789, DOI 10.1091/mbc.3.7.789; Scott DC, 2011, SCIENCE, V334, P674, DOI 10.1126/science.1209307; Setty SRG, 2004, NAT CELL BIOL, V6, P414, DOI 10.1038/ncb1121; Shibata Y, 2009, ANNU REV CELL DEV BI, V25, P329, DOI 10.1146/annurev.cellbio.042308.113324; Singer JM, 2003, P NATL ACAD SCI USA, V100, P7644, DOI 10.1073/pnas.1232343100; Starheim KK, 2012, TRENDS BIOCHEM SCI, V37, P152, DOI 10.1016/j.tibs.2012.02.003; Starheim KK, 2009, MOL CELL BIOL, V29, P3569, DOI 10.1128/MCB.01909-08; Stradalova V, 2009, J CELL SCI, V122, P2887, DOI 10.1242/jcs.051227; TERCERO JC, 1992, J BIOL CHEM, V267, P20277; Van Damme P, 2012, P NATL ACAD SCI USA, V109, P12449, DOI 10.1073/pnas.1210303109; Van Damme P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002169; van Welsem T, 2008, MOL CELL BIOL, V28, P3861, DOI 10.1128/MCB.02050-07; Vogt N, 2008, MOL BIOL CELL, V19, P4554, DOI 10.1091/mbc.E07-12-1266; Wang XR, 2004, GENETICS, V168, P547, DOI 10.1534/genetics.104.028803	48	18	18	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2013	8	4							e61012	10.1371/journal.pone.0061012	http://dx.doi.org/10.1371/journal.pone.0061012			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125TD	23613772	Green Submitted, gold, Green Published			2022-12-25	WOS:000317563300016
J	Muehsam, D; Lalezari, P; Lekhraj, R; Abruzzo, P; Bolotta, A; Marini, M; Bersani, F; Aicardi, G; Pilla, A; Casper, D				Muehsam, David; Lalezari, Parviz; Lekhraj, Rukmani; Abruzzo, Provvidenza; Bolotta, Alessandra; Marini, Marina; Bersani, Ferdinando; Aicardi, Giorgio; Pilla, Arthur; Casper, Diana			Non-Thermal Radio Frequency and Static Magnetic Fields Increase Rate of Hemoglobin Deoxygenation in a Cell-Free Preparation	PLOS ONE			English	Article							PULSED ELECTROMAGNETIC-FIELDS; POSTOPERATIVE PAIN; BINDING-KINETICS; THERMAL NOISE; LORENTZ MODEL; DOUBLE-BLIND; OXYGEN; DIFFERENTIATION; PROLIFERATION; SPECTROSCOPY	The growing body of clinical and experimental data regarding electromagnetic field (EMF) bioeffects and their therapeutic applications has contributed to a better understanding of the underlying mechanisms of action. This study reports that two EMF modalities currently in clinical use, a pulse-modulated radiofrequency (PRF) signal, and a static magnetic field (SMF), applied independently, increased the rate of deoxygenation of human hemoglobin (Hb) in a cell-free assay. Deoxygenation of Hb was initiated using the reducing agent dithiothreitol (DTT) in an assay that allowed the time for deoxygenation to be controlled (from several min to several hours) by adjusting the relative concentrations of DTT and Hb. The time course of Hb deoxygenation was observed using visible light spectroscopy. Exposure for 10-30 min to either PRF or SMF increased the rate of deoxygenation occurring several min to several hours after the end of EMF exposure. The sensitivity and biochemical simplicity of the assay developed here suggest a new research tool that may help to further the understanding of basic biophysical EMF transduction mechanisms. If the results of this study were to be shown to occur at the cellular and tissue level, EMF-enhanced oxygen availability would be one of the mechanisms by which clinically relevant EMF-mediated enhancement of growth and repair processes could occur.	[Muehsam, David; Lekhraj, Rukmani; Casper, Diana] Albert Einstein Coll Med, Dept Neurosurg, Bronx, NY 10467 USA; [Muehsam, David; Lalezari, Parviz; Lekhraj, Rukmani; Casper, Diana] Montefiore Med Ctr, Bronx, NY 10467 USA; [Lalezari, Parviz] Albert Einstein Coll Med, Dept Pathol & Med, Bronx, NY 10467 USA; [Muehsam, David; Aicardi, Giorgio] Univ Bologna, Dept Human & Gen Physiol, Bologna, Italy; [Pilla, Arthur] Columbia Univ, Dept Biomed Engn, New York, NY USA; [Abruzzo, Provvidenza; Bolotta, Alessandra; Marini, Marina] Univ Bologna, Dept Histol Embryol & Appl Biol, Bologna, Italy; [Bersani, Ferdinando] Univ Bologna, Dept Phys, I-40126 Bologna, Italy; [Bersani, Ferdinando; Aicardi, Giorgio] Univ Bologna, Interdept Ctr L Galvani, Bologna, Italy; [Pilla, Arthur] Mt Sinai Sch Med, Dept Orthoped, New York, NY USA	Yeshiva University; Albert Einstein College of Medicine; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; University of Bologna; Columbia University; University of Bologna; University of Bologna; University of Bologna; Icahn School of Medicine at Mount Sinai	Muehsam, D (corresponding author), Albert Einstein Coll Med, Dept Neurosurg, Bronx, NY 10467 USA.	davmumu@yahoo.com	Marini, Marina/Y-6191-2019; Marini, Marina/B-1490-2012; Abruzzo, Provvidenza Maria/G-7009-2015	Marini, Marina/0000-0003-1932-7380; Marini, Marina/0000-0003-1932-7380; Abruzzo, Provvidenza Maria/0000-0001-5242-9448; AICARDI, GIORGIO/0000-0002-7451-3883	Ivivi Health Sciences, LLC, USA; Ivivi Health Sciences	Ivivi Health Sciences, LLC, USA; Ivivi Health Sciences	This work was supported in part by Ivivi Health Sciences, LLC, USA (www.ivivihealthsciences.com). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; David Muehsam was a paid consultant for Ivivi Health Sciences, LLC, USA, for a portion of the duration of this study. Rukmani Lekhraj and Diana Casper received a portion of their salaries for other studies funded by Ivivi Health Sciences during the time of this study, but received no financial support for their contributions to this study. Arthur Pilla was a paid consultant for Ivivi Health Sciences LLC for the duration of this study. None of the other authors in this study received financial support or have other competing interests. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	BENESCH RE, 1973, ANAL BIOCHEM, V55, P245, DOI 10.1016/0003-2697(73)90309-6; Binhi VN, 2007, ELECTROMAGN BIOL MED, V26, P45, DOI 10.1080/15368370701205677; Bitterman H, 2007, ISR MED ASSOC J, V9, P874; Cheng GZ, 2011, NITRIC OXIDE-BIOL CH, V25, P316, DOI 10.1016/j.niox.2011.05.009; CLOSS GL, 1969, J AM CHEM SOC, V91, P4552, DOI 10.1021/ja01044a043; Diniz P, 2002, NITRIC OXIDE-BIOL CH, V7, P18, DOI 10.1016/S1089-8603(02)00004-6; Eccles NK, 2005, J ALTERN COMPLEM MED, V11, P495, DOI 10.1089/acm.2005.11.495; Fitzsimmons RJ, 2008, J ORTHOP RES, V26, P854, DOI 10.1002/jor.20590; Frauenfelder H, 2009, P NATL ACAD SCI USA, V106, P5129, DOI 10.1073/pnas.0900336106; Heden P, 2008, AESTHET PLAST SURG, V32, P660, DOI 10.1007/s00266-008-9169-z; HERZFELD J, 1990, HEMOGLOBIN, V14, P399, DOI 10.3109/03630269009032000; Iwasaka M, 2001, IEEE T MAGN, V37, P2906, DOI 10.1109/20.951343; Magazu S, 2010, J PHYS CHEM B, V114, P12144, DOI 10.1021/jp104226p; Milweski S, 2006, DUMMERSTORF, V49, P219; Mousavy SJ, 2009, INT J BIOL MACROMOL, V44, P278, DOI 10.1016/j.ijbiomac.2009.01.001; Muehsam DJ, 2009, BIOELECTROMAGNETICS, V30, P476, DOI 10.1002/bem.20493; Muehsam DJ, 2009, BIOELECTROMAGNETICS, V30, P462, DOI 10.1002/bem.20494; Muehsam DJ, 1996, BIOELECTROMAGNETICS, V17, P89, DOI 10.1002/(SICI)1521-186X(1996)17:2<89::AID-BEM3>3.0.CO;2-1; Najjar SS, 2005, J CARDIOVASC MAGN R, V7, P657, DOI 10.1081/JCMR-200065610; Nelson FR, 2012, RHEUMATOL INT; Papassotiriou I, 1998, BRIT J HAEMATOL, V102, P1165, DOI 10.1046/j.1365-2141.1998.00886.x; PAULING L, 1977, P NATL ACAD SCI USA, V74, P2612, DOI 10.1073/pnas.74.7.2612; Pilla AA, 1999, BIOELECTROCH BIOENER, V48, P27, DOI 10.1016/S0302-4598(98)00148-2; Pilla AA, 2006, BIOL MED ASPECTS ELE, P351; Pilla A, 2011, BBA-GEN SUBJECTS, V1810, P1236, DOI 10.1016/j.bbagen.2011.10.001; Pilla AA, 2012, BIOCHEM BIOPH RES CO, V426, P330, DOI 10.1016/j.bbrc.2012.08.078; Rasouli J, 2012, NEUROSCI LETT, V519, P4, DOI 10.1016/j.neulet.2012.03.089; Roche CJ, 2006, J BIOL CHEM, V281, P38757, DOI 10.1074/jbc.M608835200; Rohde C, 2010, PLAST RECONSTR SURG, V125, P1620, DOI 10.1097/PRS.0b013e3181c9f6d3; Royer WE, 1996, P NATL ACAD SCI USA, V93, P14526, DOI 10.1073/pnas.93.25.14526; Sakhnini L, 2001, EUR BIOPHYS J BIOPHY, V30, P467, DOI 10.1007/s002490100171; Salvay AG, 2003, BIOPHYS J, V84, P564, DOI 10.1016/S0006-3495(03)74876-0; Shalaby TE, 2006, ROM J BIOPHYS, V16, P169; Sosa M, 2005, BIOELECTROMAGNETICS, V26, P564, DOI 10.1002/bem.20132; Strauch B, 2007, PLAST RECONSTR SURG, V120, P425, DOI 10.1097/01.prs.0000267700.15452.d0; Strauch B, 2006, J HAND SURG-AM, V31A, P1131, DOI 10.1016/j.jhsa.2006.03.024; Tandara AA, 2004, WORLD J SURG, V28, P294, DOI 10.1007/s00268-003-7400-2; Tao R, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.011905; Timmel CR, 1998, MOL PHYS, V95, P71, DOI 10.1080/00268979809483134	39	8	10	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2013	8	4							e61752	10.1371/journal.pone.0061752	http://dx.doi.org/10.1371/journal.pone.0061752			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123JP	23593496	gold, Green Published			2022-12-25	WOS:000317385300082
J	Gagnon, K; Rothausler, E; Syrjanen, A; Yli-Renko, M; Jormalainen, V				Gagnon, Karine; Rothausler, Eva; Syrjanen, Anneli; Yli-Renko, Maria; Jormalainen, Veijo			Seabird Guano Fertilizes Baltic Sea Littoral Food Webs	PLOS ONE			English	Article							FUCUS-VESICULOSUS; TEMPORAL-CHANGES; ISOTOPE RATIOS; CORMORANTS; NITROGEN; IMPACT; DIET; DELTA-N-15; CONSUMER; CARBON	Nutrient enrichment in coastal marine systems can have profound impacts on trophic networks. In the Baltic Sea, the population of Great Cormorant (Phalacrocorax carbo sinensis) has increased nearly exponentially since the mid-1990s, and colonies of these seabirds can be important sources of nitrogen enrichment for nearby benthic communities due to guano runoff. In this study we used stable isotope analyses and diet mixing models to determine the extent of nitrogen enrichment from cormorant colonies, as well as to examine any possible changes in herbivore diet preferences due to enrichment. We found significantly higher levels of delta N-15 in samples from colony islands than control islands for producers (the dominant macroalga Fucus vesiculosus, filamentous algae, and periphyton) and herbivores, as well as a positive correlation between enrichment and nest density in colony sites. We also found that enrichment increased over the breeding season of the cormorants, with higher enrichment in late summer than early summer. While the amount of total nitrogen did not differ between colony and control sites, the amount of guano-based nitrogen in algae was >50% in most sites, indicating high nitrogen enrichment from colonies. Herbivores (the isopod Idotea balthica and the gastropod Theodoxus fluviatilis) preferred feeding upon the dominant macroalga Fucus vesiculosus rather than on filamentous algae or periphyton in both control and colony, and there was a significant increase in periphyton consumption near colony sites. Overall, guano from cormorant colonies seems to have effects on both producers and herbivores, as well as the potential to modify algae-herbivore interactions.	[Gagnon, Karine; Rothausler, Eva; Syrjanen, Anneli; Yli-Renko, Maria; Jormalainen, Veijo] Univ Turku, Dept Biol, Sect Ecol, SF-20500 Turku, Finland	University of Turku	Gagnon, K (corresponding author), Univ Turku, Dept Biol, Sect Ecol, SF-20500 Turku, Finland.	karine.gagnon@utu.fi	Gagnon, Karine/O-1514-2013; Jormalainen, Veijo/B-2073-2008	Gagnon, Karine/0000-0002-0971-7740; Jormalainen, Veijo/0000-0001-6346-2585; Rothausler, Eva/0000-0002-3185-4290	Academy of Finland [251102]	Academy of Finland(Academy of Finland)	This study was funded by the Academy of Finland (project # 251102). The funding agency had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aita MN, 2011, J PLANKTON RES, V33, P1629, DOI 10.1093/plankt/fbr070; [Anonymous], 2006, SAS MIXED MODELS; Axelsson L, 2000, EUR J PHYCOL, V35, P53, DOI 10.1080/09670260010001735621; Berlow EL, 2004, J ANIM ECOL, V73, P585, DOI 10.1111/j.0021-8790.2004.00833.x; Bostrom MK, 2012, ICES J MAR SCI, V69, P175, DOI 10.1093/icesjms/fss002; Caut S, 2009, J APPL ECOL, V46, P443, DOI 10.1111/j.1365-2664.2009.01620.x; Davis AM, 2012, FRESHWATER BIOL, V57, P2156, DOI 10.1111/j.1365-2427.2012.02858.x; Doucette JL, 2011, ECOL APPL, V21, P2987, DOI 10.1890/10-2384.1; Ducrotoy JP, 2008, MAR POLLUT BULL, V57, P8, DOI 10.1016/j.marpolbul.2008.04.030; Dunne JA, 2004, MAR ECOL PROG SER, V273, P291, DOI 10.3354/meps273291; Engstrom H, 2001, ECOGRAPHY, V24, P127, DOI 10.1034/j.1600-0587.2001.240203.x; Gillies CL, 2012, ESTUAR COAST SHELF S, V97, P44, DOI 10.1016/j.ecss.2011.11.003; Glahn JF, 1995, COLON WATERBIRD, V18, P168, DOI 10.2307/1521537; GREMILLET D, 1995, MAR ECOL PROG SER, V121, P1, DOI 10.3354/meps121001; Gruner DS, 2008, ECOL LETT, V11, P740, DOI 10.1111/j.1461-0248.2008.01192.x; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Halpern BS, 2007, CONSERV BIOL, V21, P1301, DOI 10.1111/j.1523-1739.2007.00752.x; Hanson CE, 2010, AQUAT BOT, V93, P114, DOI 10.1016/j.aquabot.2010.04.004; Heck KL, 2007, ESTUAR COAST, V30, P371, DOI 10.1007/BF02819384; Hemmi A, 2005, AQUAT ECOL, V39, P201, DOI 10.1007/s10452-004-3526-z; Hemmi A, 2002, ECOLOGY, V83, P1052, DOI 10.2307/3071913; Honkanen T, 2005, OECOLOGIA, V144, P196, DOI 10.1007/s00442-005-0053-0; Jormalainen V, 2001, MAR ECOL PROG SER, V220, P219, DOI 10.3354/meps220219; Jormalainen V, 2008, OECOLOGIA, V155, P559, DOI 10.1007/s00442-007-0939-0; Kolb GS, 2010, MAR ECOL PROG SER, V417, P287, DOI 10.3354/meps08791; Kolb GS, 2010, ECOSYSTEMS, V13, P353, DOI 10.1007/s10021-010-9323-8; Korpinen S, 2008, ESTUAR COAST SHELF S, V78, P437, DOI 10.1016/j.ecss.2008.01.005; Korpinen S, 2007, J EXP MAR BIOL ECOL, V343, P52, DOI 10.1016/j.jembe.2006.11.012; Lehikoinen A, 2006, ORNIS FENNICA, V83, P34; Lehikoinen A, 2011, BOREAL ENVIRON RES, V16, P61; Lotze HK, 2006, SCIENCE, V312, P1806, DOI 10.1126/science.1128035; Malm T, 1999, MAR ECOL PROG SER, V188, P63, DOI 10.3354/meps188063; McCutchan JH, 2003, OIKOS, V102, P378, DOI 10.1034/j.1600-0706.2003.12098.x; Mercado JM, 2009, ESTUAR COAST SHELF S, V85, P449, DOI 10.1016/j.ecss.2009.09.005; Mizota C, 2012, ATMOS ENVIRON, V57, P29, DOI 10.1016/j.atmosenv.2012.02.007; Myers RA, 2003, NATURE, V423, P280, DOI 10.1038/nature01610; OLEARY MH, 1992, PLANT CELL ENVIRON, V15, P1099, DOI 10.1111/j.1365-3040.1992.tb01660.x; Osterblom H, 2007, ECOSYSTEMS, V10, P877, DOI 10.1007/s10021-007-9069-0; Parnell AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009672; Post DM, 2007, OECOLOGIA, V152, P179, DOI 10.1007/s00442-006-0630-x; Ridgway MS, 2010, J GREAT LAKES RES, V36, P93, DOI 10.1016/j.jglr.2009.10.002; Shurin JB, 2002, ECOL LETT, V5, P785, DOI 10.1046/j.1461-0248.2002.00381.x; Sieben K, 2011, J EXP MAR BIOL ECOL, V397, P79, DOI 10.1016/j.jembe.2010.11.020; SMITH JS, 1995, MAR ECOL PROG SER, V124, P189, DOI 10.3354/meps124189; Suominen T, 2007, EXPOSURE FINNISH COA, V13, P7; Syvaranta J, 2011, AQUAT SCI, V73, P79, DOI 10.1007/s00027-010-0161-8; Syvitski JPM, 2005, SCIENCE, V308, P376, DOI 10.1126/science.1109454; Vander Zanden MJ, 2001, LIMNOL OCEANOGR, V46, P2061; Vanderklift MA, 2003, OECOLOGIA, V136, P169, DOI 10.1007/s00442-003-1270-z; VANEERDEN MR, 1995, ARDEA, V83, P61; Wainright SC, 1998, MAR BIOL, V131, P63, DOI 10.1007/s002270050297; WOOTTON JT, 1991, J EXP MAR BIOL ECOL, V151, P139, DOI 10.1016/0022-0981(91)90121-C; Worm B, 2000, LIMNOL OCEANOGR, V45, P339, DOI 10.4319/lo.2000.45.2.0339; ZELICKMAN EA, 1972, MAR BIOL, V17, P265, DOI 10.1007/BF00366302	54	34	34	1	113	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2013	8	4							e61284	10.1371/journal.pone.0061284	http://dx.doi.org/10.1371/journal.pone.0061284			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123JA	23593452	Green Published, gold, Green Submitted			2022-12-25	WOS:000317383200049
J	Thio, CLP; Yusof, R; Abdul-Rahman, PSA; Karsani, SA				Thio, Christina Li-Ping; Yusof, Rohana; Abdul-Rahman, Puteri Shafinaz Akmar; Karsani, Saiful Anuar			Differential Proteome Analysis of Chikungunya Virus Infection on Host Cells	PLOS ONE			English	Article							UBIQUITIN-PROTEASOME PATHWAY; GENE-EXPRESSION; INDIAN-OCEAN; IDENTIFICATION; PROTEINS; BIOSYNTHESIS; RNA	Background: Chikungunya virus (CHIKV) is an emerging mosquito-borne alphavirus that has caused multiple unprecedented and re-emerging outbreaks in both tropical and temperate countries. Despite ongoing research efforts, the underlying factors involved in facilitating CHIKV replication during early infection remains ill-characterized. The present study serves to identify host proteins modulated in response to early CHIKV infection using a proteomics approach. Methodology and Principal Findings: The whole cell proteome profiles of CHIKV-infected and mock control WRL-68 cells were compared and analyzed using two-dimensional gel electrophoresis (2-DGE). Fifty-three spots were found to be differentially modulated and 50 were successfully identified by MALDI-TOF/TOF. Eight were significantly up-regulated and 42 were down-regulated. The mRNA expressions of 15 genes were also found to correlate with the corresponding protein expression. STRING network analysis identified several biological processes to be affected, including mRNA processing, translation, energy production and cellular metabolism, ubiquitin-proteasome pathway (UPP) and cell cycle regulation. Conclusion/Significance: This study constitutes a first attempt to investigate alteration of the host cellular proteome during early CHIKV infection. Our proteomics data showed that during early infection, CHIKV affected the expression of proteins that are involved in mRNA processing, host metabolic machinery, UPP, and cyclin-dependent kinase 1 (CDK1) regulation (in favour of virus survival, replication and transmission). While results from this study complement the proteomics results obtained from previous late host response studies, functional characterization of these proteins is warranted to reinforce our understanding of their roles during early CHIKV infection in humans.	[Thio, Christina Li-Ping; Karsani, Saiful Anuar] Univ Malaya, Fac Sci, Inst Biol Sci, Kuala Lumpur, Malaysia; [Yusof, Rohana; Abdul-Rahman, Puteri Shafinaz Akmar] Univ Malaya, Fac Med, Dept Mol Med, Kuala Lumpur, Malaysia; [Abdul-Rahman, Puteri Shafinaz Akmar; Karsani, Saiful Anuar] Univ Malaya, Fac Med, Med Biotechnol Lab, Ctr Prote Res, Kuala Lumpur, Malaysia; [Thio, Christina Li-Ping; Yusof, Rohana; Karsani, Saiful Anuar] Univ Malaya, Drug Design & Dev Res Grp, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Malaya; Universiti Malaya; Universiti Malaya	Thio, CLP (corresponding author), Univ Malaya, Fac Sci, Inst Biol Sci, Kuala Lumpur, Malaysia.	christinathio86@gmail.com; saiful72@um.edu.my	Rahman, Puteri Shafinaz Akmar Binti Abdul/B-9511-2010; SA, karsani/B-9667-2010; YUSOF, ROHANA/B-9589-2010	Rahman, Puteri Shafinaz Akmar Binti Abdul/0000-0002-1818-4552; SA, karsani/0000-0003-1617-9554; YUSOF, ROHANA/0000-0002-6591-3236	Postgraduate Researh Fund [PV088/2012A]; University Malaya Research Grant [RG013-09AFR]	Postgraduate Researh Fund; University Malaya Research Grant	This work was supported by the Postgraduate Researh Fund (Grant no.: PV088/2012A) and the University Malaya Research Grant (Grant no.: RG013-09AFR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abere B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034800; Bentinger M, 2010, BIOCHEM BIOPH RES CO, V396, P74, DOI 10.1016/j.bbrc.2010.02.147; Brehin AC, 2008, VIROLOGY, V371, P185, DOI 10.1016/j.virol.2007.09.028; Canela N, 2003, J BIOL CHEM, V278, P1158, DOI 10.1074/jbc.M207497200; Christensen BC, 2011, JNCI-J NATL CANCER I, V103, DOI 10.1093/jnci/djq497; Chua K B, 2010, Med J Malaysia, V65, P277; DAHL HHM, 1987, J BIOL CHEM, V262, P7398; Dahlan HM, 2012, J NUTR BIOCHEM, V23, P741, DOI 10.1016/j.jnutbio.2011.03.018; Dhanwani R, 2011, PROTEOMICS, V11, P1936, DOI 10.1002/pmic.201000500; Dinh PX, 2011, J VIROL, V85, P9459, DOI 10.1128/JVI.05179-11; Gao G, 2006, CAN J PHYSIOL PHARM, V84, P5, DOI 10.1139/y05-144; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Guo Y, 2008, ACTA BIOCH BIOPH SIN, V40, P11; Kanlaya R, 2010, J PROTEOME RES, V9, P4960, DOI 10.1021/pr100219y; Krasner R, 2009, MICROBIAL CHALLENGE; Krecic AM, 1999, CURR OPIN CELL BIOL, V11, P363, DOI 10.1016/S0955-0674(99)80051-9; Krejbich-Trotot P, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-432; Krejbich-Trotot P, 2011, FASEB J, V25, P314, DOI 10.1096/fj.10-164178; Kushner DB, 2003, P NATL ACAD SCI USA, V100, P15764, DOI 10.1073/pnas.2536857100; Lam S K, 2001, Southeast Asian J Trop Med Public Health, V32, P447; Leong WF, 2006, CELL MICROBIOL, V8, P565, DOI 10.1111/j.1462-5822.2005.00644.x; Li HP, 1999, J VIROL, V73, P772, DOI 10.1128/JVI.73.1.772-777.1999; Lindqvist A, 2009, J CELL BIOL, V185, P193, DOI 10.1083/jcb.200812045; McInerney GM, 2005, MOL BIOL CELL, V16, P3753, DOI 10.1091/mbc.E05-02-0124; Njenga MK, 2008, J GEN VIROL, V89, P2754, DOI 10.1099/vir.0.2008/005413-0; Nkoghe D, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001517; Noisakran S, 2008, BIOCHEM BIOPH RES CO, V372, P67, DOI 10.1016/j.bbrc.2008.04.165; Noridah O, 2007, Med J Malaysia, V62, P323; Ozden S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000527; Pastorino B, 2009, MOL CELL PROTEOMICS, V8, P1623, DOI 10.1074/mcp.M800565-MCP200; Pattanakitsakul S, 2007, J PROTEOME RES, V6, P4592, DOI 10.1021/pr070366b; Poggioli GJ, 2002, J VIROL, V76, P2585, DOI 10.1128/JVI.76.6.2585-2594.2002; Rajapakse S, 2010, T ROY SOC TROP MED H, V104, P89, DOI 10.1016/j.trstmh.2009.07.031; Ray RB, 1997, J BIOL CHEM, V272, P10983; Salvador B, 2009, VIROLOGY, V393, P33, DOI 10.1016/j.virol.2009.07.013; Schang LM, 2004, BBA-PROTEINS PROTEOM, V1697, P197, DOI 10.1016/j.bbapap.2003.11.024; Schuffenecker I, 2006, PLOS MED, V3, P1058, DOI 10.1371/journal.pmed.0030263; Sourisseau M, 2007, PLOS PATHOG, V3, P804, DOI 10.1371/journal.ppat.0030089; Tan EC, 2012, PLANT CELL TISS ORG, V111, P219, DOI 10.1007/s11240-012-0188-8; Tchankouo-Nguetcheu S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013149; Volk SM, 2010, J VIROL, V84, P6497, DOI 10.1128/JVI.01603-09; von Mering C, 2003, NUCLEIC ACIDS RES, V31, P258, DOI 10.1093/nar/gkg034; White LK, 2011, J VIROL, V85, P606, DOI 10.1128/JVI.00767-10; Yan JX, 2000, ELECTROPHORESIS, V21, P3666, DOI 10.1002/1522-2683(200011)21:17<3666::AID-ELPS3666>3.0.CO;2-6	44	33	35	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2013	8	4							e61444	10.1371/journal.pone.0061444	http://dx.doi.org/10.1371/journal.pone.0061444			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123IQ	23593481	gold, Green Published, Green Submitted			2022-12-25	WOS:000317382000049
J	Xue, Y; Ha, Y				Xue, Yi; Ha, Ya			Large Lateral Movement of Transmembrane Helix S5 Is Not Required for Substrate Access to the Active Site of Rhomboid Intramembrane Protease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERINE PROTEASES; CRYSTAL-STRUCTURE; MOLECULAR RULERS; STRUCTURAL BASIS; GLPG; FAMILY; PROTEOLYSIS; MECHANISM; ACTIVATION; MEMBRANE	Rhomboids represent an evolutionarily ancient protease family. Unlike most other proteases, they are polytopic membrane proteins and specialize in cleaving transmembrane protein substrates. The polar active site of rhomboid protease is embedded in the membrane and normally closed. For the bacterial rhomboid GlpG, it has been proposed that one of the transmembrane helices (S5) of the protease can rotate to open a lateral gate, enabling substrate to enter the protease from inside the membrane. Here, we studied the conformational change in GlpG by solving the cocrystal structure of the protease with a mechanism-based inhibitor. We also examined the lateral gating model by cross-linking S5 to a neighboring helix (S2). The crystal structure shows that inhibitor binding displaces a capping loop (L5) from the active site but causes only minor shifts in the transmembrane helices. Cross-linking S5 and S2, which not only restricts the lateral movement of S5 but also prevents substrate from passing between the two helices, does not hinder the ability of the protease to cleave a membrane protein substrate in detergent solution and in reconstituted membrane vesicles. Taken together, these data suggest that a large lateral movement of the S5 helix is not required for substrate access to the active site of rhomboid protease.	[Xue, Yi; Ha, Ya] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA	Yale University	Ha, Y (corresponding author), Yale Univ, Sch Med, Dept Pharmacol, 333 Cedar St, New Haven, CT 06520 USA.	ya.ha@yale.edu			National Institutes of Health Grant [GM082839]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM082839] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM082839 (to Y. H.).	Adrain C, 2012, SCIENCE, V335, P225, DOI 10.1126/science.1214400; Adrain C, 2011, EMBO REP, V12, P421, DOI 10.1038/embor.2011.50; Baker RP, 2007, P NATL ACAD SCI USA, V104, P8257, DOI 10.1073/pnas.0700814104; Baker RP, 2006, PLOS PATHOG, V2, P922, DOI 10.1371/journal.ppat.0020113; Baker RP, 2012, NAT CHEM BIOL, V8, P759, DOI [10.1038/NCHEMBIO.1021, 10.1038/nchembio.1021]; Ben-Shem A, 2007, P NATL ACAD SCI USA, V104, P462, DOI 10.1073/pnas.0609773104; Brooks CL, 2011, J MOL BIOL, V407, P687, DOI 10.1016/j.jmb.2011.01.046; Buguliskis JS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000858; Chao JR, 2008, NATURE, V452, P98, DOI 10.1038/nature06604; Cipolat S, 2006, CELL, V126, P163, DOI 10.1016/j.cell.2006.06.021; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fersht A., 1999, STRUCTURE MECH PROTE, DOI 10.1142/10574; Green NS, 2001, PROTEIN SCI, V10, P1293, DOI 10.1110/ps.51201; Ha Y, 2009, SEMIN CELL DEV BIOL, V20, P240, DOI 10.1016/j.semcdb.2008.11.006; Koonin EV, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-3-r19; Lemberg MK, 2007, GENOME RES, V17, P1634, DOI 10.1101/gr.6425307; Lemieux MJ, 2007, P NATL ACAD SCI USA, V104, P750, DOI 10.1073/pnas.0609981104; Loo TW, 2001, J BIOL CHEM, V276, P36877, DOI 10.1074/jbc.C100467200; Maegawa S, 2005, BIOCHEMISTRY-US, V44, P13543, DOI 10.1021/bi051363k; Maegawa S, 2007, MOL MICROBIOL, V64, P435, DOI 10.1111/j.1365-2958.2007.05679.x; McIlwain DR, 2012, SCIENCE, V335, P229, DOI 10.1126/science.1214448; McQuibban GA, 2003, NATURE, V423, P537, DOI 10.1038/nature01633; O'Donnell RA, 2006, J CELL BIOL, V174, P1023, DOI 10.1083/jcb.200604136; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; SAEZ R, 1985, FEBS LETT, V179, P311, DOI 10.1016/0014-5793(85)80541-X; Santos JM, 2011, SCIENCE, V331, P473, DOI 10.1126/science.1199284; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Stevenson LG, 2007, P NATL ACAD SCI USA, V104, P1003, DOI 10.1073/pnas.0608140104; Strisovsky K, 2009, MOL CELL, V36, P1048, DOI 10.1016/j.molcel.2009.11.006; THORNTON JM, 1981, J MOL BIOL, V151, P261, DOI 10.1016/0022-2836(81)90515-5; Urban S, 2001, CELL, V107, P173, DOI 10.1016/S0092-8674(01)00525-6; Vinothkumar KR, 2010, EMBO J, V29, P3797, DOI 10.1038/emboj.2010.243; Wang YC, 2007, J MOL BIOL, V374, P1104, DOI 10.1016/j.jmb.2007.10.014; Wang YC, 2007, P NATL ACAD SCI USA, V104, P2098, DOI 10.1073/pnas.0611080104; Wang YC, 2006, NATURE, V444, P179, DOI 10.1038/nature05255; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; Wu ZR, 2006, NAT STRUCT MOL BIOL, V13, P1084, DOI 10.1038/nsmb1179; Xue Y, 2012, BIOCHEMISTRY-US, V51, P3723, DOI 10.1021/bi300368b; Xue Y, 2012, J BIOL CHEM, V287, P3099, DOI 10.1074/jbc.M111.310482; Zettl M, 2011, CELL, V145, P79, DOI 10.1016/j.cell.2011.02.047	40	24	24	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2013	288	23					16645	16654		10.1074/jbc.M112.438127	http://dx.doi.org/10.1074/jbc.M112.438127			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	163ZU	23609444	Green Published, hybrid			2022-12-25	WOS:000320378900040
J	Yar, S; Chowdhury, SAK; Davis, RT; Kobayashi, M; Monasky, MM; Rajan, S; Wolska, BM; Gaponenko, V; Kobayashi, T; Wieczorek, DF; Solaro, RJ				Yar, Sumeyye; Chowdhury, Shamim A. K.; Davis, Robert T., III; Kobayashi, Minae; Monasky, Michelle M.; Rajan, Sudarsan; Wolska, Beata M.; Gaponenko, Vadim; Kobayashi, Tomoyoshi; Wieczorek, David F.; Solaro, R. John			Conserved Asp-137 Is Important for both Structure and Regulatory Functions of Cardiac alpha-Tropomyosin (alpha-TM) in a Novel Transgenic Mouse Model Expressing alpha-TM-D137L	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUSCLE THIN-FILAMENTS; LIGHT-CHAIN PHOSPHORYLATION; COILED-COIL; TROPONIN-I; DILATED CARDIOMYOPATHY; REDUCTIVE ALKYLATION; BETA-TROPOMYOSIN; LYSINE RESIDUES; STRIATED-MUSCLE; MOLECULAR-BASIS	alpha-Tropomyosin (alpha-TM) has a conserved, charged Asp-137 residue located in the hydrophobic core of its coiled-coil structure, which is unusual in that the residue is found at a position typically occupied by a hydrophobic residue. Asp-137 is thought to destabilize the coiled-coil and so impart structural flexibility to the molecule, which is believed to be crucial for its function in the heart. Aprevious in vitro study indicated that the conversion of Asp-137 to a more typical canonical Leu alters flexibility of TM and affects its in vitro regulatory functions. However, the physiological importance of the residue Asp-137 and altered TM flexibility is unknown. In this study, we further analyzed structural properties of the alpha-TM-D137L variant and addressed the physiological importance of TM flexibility in cardiac function in studies with a novel transgenic mouse model expressing alpha-TM-D137L in the heart. Our NMR spectroscopy data indicated that the presence of D137L introduced long range rearrangements in TM structure. Differential scanning calorimetry measurements demonstrated that alpha-TM-D137L has higher thermal stability compared with alpha-TM, which correlated with decreased flexibility. Hearts of transgenic mice expressing alpha-TM-D137L showed systolic and diastolic dysfunction with decreased myofilament Ca2(+) sensitivity and cardiomyocyte contractility without changes in intracellular Ca2(+) transients or post-translational modifications of major myofilament proteins. Weconclude that conversion of the highly conserved Asp137 to Leu results in loss of flexibility of TM that is important for its regulatory functions in mouse hearts. Thus, our results provide insight into the link between flexibility of TM and its function in ejecting hearts.	[Yar, Sumeyye; Gaponenko, Vadim] Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL 60612 USA; [Yar, Sumeyye; Chowdhury, Shamim A. K.; Davis, Robert T., III; Kobayashi, Minae; Monasky, Michelle M.; Wolska, Beata M.; Kobayashi, Tomoyoshi; Solaro, R. John] Univ Illinois, Dept Physiol & Biophys, Chicago, IL 60612 USA; [Wolska, Beata M.] Univ Illinois, Dept Med, Chicago, IL 60612 USA; [Wolska, Beata M.; Kobayashi, Tomoyoshi; Solaro, R. John] Univ Illinois, Cardiovasc Res Ctr, Chicago, IL 60612 USA; [Rajan, Sudarsan; Wieczorek, David F.] Univ Cincinnati, Coll Med, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH 45267 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University System of Ohio; University of Cincinnati	Solaro, RJ (corresponding author), Univ Illinois, Dept Physiol & Biophys, 835 S Wolcott Ave,M-C 901, Chicago, IL 60612 USA.	solarorj@uic.edu	Yar, Sumeyye/F-4992-2015; Monasky, Michelle/B-4273-2009; Gaponenko, Vadim/K-9729-2019	Yar, Sumeyye/0000-0002-1592-2361; Monasky, Michelle/0000-0003-3205-2254; Gaponenko, Vadim/0000-0002-7891-9223	National Institutes of Health [PO1 HL62426, R01 CA135341, RO1 HL081680]; American Heart Association Predoctoral Fellowship [12PRE9260034]; NATIONAL CANCER INSTITUTE [R01CA135341] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081680, T32HL007692, P01HL062426] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Predoctoral Fellowship(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants PO1 HL62426 (Project 1) (to R.J.S.), R01 CA135341 (to V.G.), and RO1 HL081680 (to D.F.W.). This work was also supported by American Heart Association Predoctoral Fellowship 12PRE9260034 (to S.Y.).	BRANDT PW, 1990, J MOL BIOL, V212, P473, DOI 10.1016/0022-2836(90)90326-H; Chen YD, 2004, BIOCHEMISTRY-US, V43, P11491, DOI 10.1021/bi049186v; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dubois E, 2011, EUR HEART J, V32, P115, DOI 10.1093/eurheartj/ehq108; FABIATO A, 1988, METHODS ENZYMOL, V157, P378; Gaffin RD, 2011, J MOL CELL CARDIOL, V51, P812, DOI 10.1016/j.yjmcc.2011.07.026; GERKEN TA, 1982, J BIOL CHEM, V257, P2894; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; GODT RE, 1982, J GEN PHYSIOL, V80, P279, DOI 10.1085/jgp.80.2.279; HASELGROVE JC, 1973, COLD SPRING HARB SYM, V37, P341, DOI 10.1101/SQB.1973.037.01.044; Heller MJ, 2003, J BIOL CHEM, V278, P41742, DOI 10.1074/jbc.M303408200; James J, 2011, J BIOL CHEM, V286, P9913, DOI 10.1074/jbc.R110.171801; Kirk JA, 2009, CIRC RES, V105, P1232, DOI 10.1161/CIRCRESAHA.109.205427; Kobayashi T, 2009, J BIOL CHEM, V284, P20052, DOI 10.1074/jbc.M109.001396; Korte FS, 2005, AM J PHYSIOL-HEART C, V289, pH801, DOI 10.1152/ajpheart.01227.2004; Kremneva E, 2004, BIOPHYS J, V87, P3922, DOI 10.1529/biophysj.104.048793; Krenz M, 2004, J AM COLL CARDIOL, V44, P2390, DOI 10.1016/j.jacc.2004.09.044; Kurinov IV, 2000, BIOCHEM BIOPH RES CO, V275, P549, DOI 10.1006/bbrc.2000.3329; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Lehman W, 2000, J MOL BIOL, V302, P593, DOI 10.1006/jmbi.2000.4080; Loong CKP, 2012, FEBS LETT, V586, P3503, DOI 10.1016/j.febslet.2012.08.005; Louch WE, 2011, J MOL CELL CARDIOL, V51, P288, DOI 10.1016/j.yjmcc.2011.06.012; MCKILLOP DFA, 1993, BIOPHYS J, V65, P693, DOI 10.1016/S0006-3495(93)81110-X; MEANS GE, 1968, BIOCHEMISTRY-US, V7, P2192, DOI 10.1021/bi00846a023; MONTEIRO PB, 1994, J BIOL CHEM, V269, P10461; Mudalige WAKA, 2009, J MOL BIOL, V389, P575, DOI 10.1016/j.jmb.2009.04.027; Muthuchamy M, 1995, J BIOL CHEM, V270, P30593, DOI 10.1074/jbc.270.51.30593; NADALGINARD B, 1989, J CLIN INVEST, V84, P1693, DOI 10.1172/JCI114351; Nagueh SF, 2009, EUR J ECHOCARDIOGR, V10, P165, DOI 10.1093/ejechocard/jep007; Nevzorov IA, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.209353; Nitanai Y, 2007, ADV EXP MED BIOL, V592, P137; Nixon BR, 2013, ARCH BIOCHEM BIOPHYS, V535, P30, DOI 10.1016/j.abb.2012.11.010; PARRY DAD, 1973, J MOL BIOL, V75, P33, DOI 10.1016/0022-2836(73)90527-5; POTEKHIN SA, 1982, J MOL BIOL, V159, P519, DOI 10.1016/0022-2836(82)90299-6; Rajan S, 2007, CIRC RES, V101, P205, DOI 10.1161/CIRCRESAHA.107.148379; Rayment I, 1997, METHOD ENZYMOL, V276, P171, DOI 10.1016/S0076-6879(97)76058-0; Schulz EM, 2012, J BIOL CHEM, V287, P44478, DOI 10.1074/jbc.M112.402040; Scruggs SB, 2011, ARCH BIOCHEM BIOPHYS, V510, P129, DOI 10.1016/j.abb.2011.02.013; Scruggs SB, 2009, J BIOL CHEM, V284, P5097, DOI 10.1074/jbc.M807414200; Singh A, 2006, STRUCTURE, V14, P43, DOI 10.1016/j.str.2005.09.016; Singh A, 2003, BIOCHEMISTRY-US, V42, P14114, DOI 10.1021/bi0348462; Solaro RJ, 2013, CIRC RES, V112, P355, DOI 10.1161/CIRCRESAHA.112.268672; Solaro RJ, 2009, J PHYSIOL-LONDON, V587, P3, DOI 10.1113/jphysiol.2008.166751; Straussman R, 2007, J MOL BIOL, V366, P1232, DOI 10.1016/j.jmb.2006.11.083; STURTEVANT JM, 1991, BIOPOLYMERS, V31, P489, DOI 10.1002/bip.360310504; SUBRAMANIAM A, 1991, J BIOL CHEM, V266, P24613; Sumida JP, 2008, J BIOL CHEM, V283, P6728, DOI 10.1074/jbc.M707485200; Sun YB, 2010, J MOL CELL CARDIOL, V48, P859, DOI 10.1016/j.yjmcc.2009.11.019; Vibert P, 1997, J MOL BIOL, V266, P8, DOI 10.1006/jmbi.1996.0800; Warren CM, 2008, PROTEOMICS, V8, P100, DOI 10.1002/pmic.200700772; Warren CM, 2003, ANAL BIOCHEM, V320, P149, DOI 10.1016/S0003-2697(03)00350-6; Wider G, 1999, CURR OPIN STRUC BIOL, V9, P594, DOI 10.1016/S0959-440X(99)00011-1; WILLIAMS DL, 1981, BIOCHEMISTRY-US, V20, P3856, DOI 10.1021/bi00516a029; Wolska BM, 1996, AM J PHYSIOL-HEART C, V271, pH1250, DOI 10.1152/ajpheart.1996.271.3.H1250; Wolska BM, 1998, CIRCULATION, V98, P465; Yuan C, 2008, AM J PHYSIOL-HEART C, V295, pH647, DOI 10.1152/ajpheart.00357.2008	56	21	21	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2013	288	23					16235	16246		10.1074/jbc.M113.458695	http://dx.doi.org/10.1074/jbc.M113.458695			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	163ZU	23609439	hybrid, Green Published			2022-12-25	WOS:000320378900004
J	Ward, T; Wang, M; Liu, X; Wang, ZK; Xia, P; Chu, YJ; Wang, XW; Liu, LF; Jiang, K; Yu, HJ; Yan, MM; Wang, JY; Hill, DL; Huang, YJ; Zhu, TG; Yao, XB				Ward, Tarsha; Wang, Ming; Liu, Xing; Wang, Zhikai; Xia, Peng; Chu, Youjun; Wang, Xiwei; Liu, Lifang; Jiang, Kai; Yu, Huijuan; Yan, Maomao; Wang, Jianyu; Hill, Donald L.; Huang, Yuejia; Zhu, Tongge; Yao, Xuebiao			Regulation of a Dynamic Interaction between Two Microtubule-binding Proteins, EB1 and TIP150, by the Mitotic p300/CBP-associated Factor (PCAF) Orchestrates Kinetochore Microtubule Plasticity and Chromosome Stability during Mitosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLUS-END TRACKING; SPINDLE; PHOSPHORYLATION; ACETYLATION; SEGREGATION; ATTACHMENT; FORMS; PRC1; LINK; KMN	The microtubule cytoskeleton network orchestrates cellular dynamics and chromosome stability in mitosis. Although tubulin acetylation is essential for cellular plasticity, it has remained elusive how kinetochore microtubule plus-end dynamics are regulated by p300/CBP-associated factor (PCAF) acetylation in mitosis. Here, we demonstrate that the plus-end tracking protein, TIP150, regulates dynamic kinetochore-microtubule attachments by promoting the stability of spindle microtubule plus-ends. Suppression of TIP150 by siRNA results in metaphase alignment delays and perturbations in chromosome biorientation. TIP150 is a tetramer that binds an end-binding protein (EB1) dimer through the C-terminal domains, and overexpression of the C-terminal TIP150 or disruption of the TIP150-EB1 interface by a membrane-permeable peptide perturbs chromosome segregation. Acetylation of EB1-PCAF regulates the TIP150 interaction, and persistent acetylation perturbs EB1-TIP150 interaction and accurate metaphase alignment, resulting in spindle checkpoint activation. Suppression of the mitotic checkpoint serine/threonine protein kinase, BubR1, overrides mitotic arrest induced by impaired EB1-TIP150 interaction, but cells exhibit whole chromosome aneuploidy. Thus, the results identify a mechanism by which the TIP150-EB1 interaction governs kinetochore microtubule plus-end plasticity and establish that the temporal control of the TIP150-EB1 interaction by PCAF acetylation ensures chromosome stability in mitosis.	[Ward, Tarsha; Wang, Ming; Liu, Xing; Wang, Zhikai; Xia, Peng; Chu, Youjun; Wang, Xiwei; Liu, Lifang; Jiang, Kai; Yu, Huijuan; Yan, Maomao; Wang, Jianyu; Hill, Donald L.; Huang, Yuejia; Zhu, Tongge; Yao, Xuebiao] Anhui Key Lab Cellular Dynam & Chem Biol, Anhui MSM Joint Res Grp Cellular Dynam, Hefei 230026, Anhui, Peoples R China; [Ward, Tarsha; Wang, Ming; Liu, Xing; Wang, Zhikai; Xia, Peng; Chu, Youjun; Wang, Xiwei; Liu, Lifang; Jiang, Kai; Yu, Huijuan; Yan, Maomao; Wang, Jianyu; Hill, Donald L.; Huang, Yuejia; Zhu, Tongge; Yao, Xuebiao] Univ Sci & Technol China, Hefei 230026, Anhui, Peoples R China; [Ward, Tarsha; Liu, Xing; Wang, Zhikai; Chu, Youjun; Wang, Xiwei; Jiang, Kai; Yu, Huijuan; Yan, Maomao; Hill, Donald L.; Huang, Yuejia; Zhu, Tongge; Yao, Xuebiao] Morehouse Sch Med, Dept Physiol, Atlanta, GA 30310 USA; [Ward, Tarsha; Liu, Xing; Wang, Zhikai; Chu, Youjun; Wang, Xiwei; Jiang, Kai; Yu, Huijuan; Yan, Maomao; Hill, Donald L.; Huang, Yuejia; Zhu, Tongge; Yao, Xuebiao] Morehouse Sch Med, Mol Imaging Core, Atlanta, GA 30310 USA; [Liu, Lifang] Airforce Gen Hosp, Beijing 100036, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Morehouse School of Medicine; Morehouse School of Medicine	Yao, XB (corresponding author), Anhui Key Lab Cellular Dynam & Chem Biol, Anhui MSM Joint Res Grp Cellular Dynam, Hefei 230026, Anhui, Peoples R China.	yaoxb@ustc.edu.cn	Yao, Xuebiao/P-5771-2014; liu, li/HGC-0900-2022; Liu, Xing/H-2989-2018	Liu, Xing/0000-0002-7480-5085; Wang, Ming/0000-0002-7000-1063; Xia, Peng/0000-0002-5419-7756	National Institutes of Health [DK56292, CA164133, G12RR03034, UL1RR025008, CA132389]; Chinese 973 Project [2010CB912103, 2012CB917204, 2012CB945002, 2002CB713700]; Chinese Academy of Science [KSCX2-YW-H-10]; Anhui Province Key Project Grant [08040102005]; International Collaboration Grant [2009DFA31010]; Chinese Natural Science Foundation [90508002, 91129714, 31071184, 81270466, 90913016, MOE20113402130010]; Chinese Postdoctoral Fellowship [2012M510210]; Fundamental Research Funds for Central Universities Grants [WK2060190018, WK2340000021]; NATIONAL CANCER INSTITUTE [R01CA164133, P20CA132389] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025008, G12RR003034] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056292] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [S21MD000101] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chinese 973 Project(National Basic Research Program of China); Chinese Academy of Science(Chinese Academy of Sciences); Anhui Province Key Project Grant; International Collaboration Grant; Chinese Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Chinese Postdoctoral Fellowship; Fundamental Research Funds for Central Universities Grants; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported, in whole or in part, by National Institutes of Health Grants DK56292, CA164133, G12RR03034, UL1RR025008, and CA132389. This work was also supported by Chinese 973 Project Grants 2010CB912103, 2012CB917204, 2012CB945002, and 2002CB713700; Chinese Academy of Science Grant KSCX2-YW-H-10; Anhui Province Key Project Grant 08040102005; International Collaboration Grant 2009DFA31010; Chinese Natural Science Foundation Grants 90508002, 91129714, 31071184, 81270466, 90913016, and MOE20113402130010, Chinese Postdoctoral Fellowship 2012M510210; and Fundamental Research Funds for Central Universities Grants WK2060190018 and WK2340000021.	Akhmanova A, 2008, NAT REV MOL CELL BIO, V9, P309, DOI 10.1038/nrm2369; [Anonymous], CELL, V112, P407; Bieling P, 2007, NATURE, V450, P1100, DOI 10.1038/nature06386; Cheeseman IM, 2008, NAT REV MOL CELL BIO, V9, P33, DOI 10.1038/nrm2310; Cheeseman IM, 2006, CELL, V127, P983, DOI 10.1016/j.cell.2006.09.039; Choi E, 2009, EMBO J, V28, P2077, DOI 10.1038/emboj.2009.123; Chu LL, 2012, J MOL CELL BIOL, V4, P331, DOI 10.1093/jmcb/mjs023; Chu YJ, 2011, J MOL CELL BIOL, V3, P260, DOI 10.1093/jmcb/mjq037; Dixit R, 2010, METHOD CELL BIOL, V95, P543, DOI 10.1016/S0091-679X(10)95027-9; Du J, 2008, ONCOGENE, V27, P4107, DOI 10.1038/onc.2008.34; Fodde R, 2001, NAT CELL BIOL, V3, P433, DOI 10.1038/35070129; Fu CH, 2007, CELL RES, V17, P449, DOI 10.1038/cr.2007.32; Gordon DJ, 2012, NAT REV GENET, V13, P189, DOI 10.1038/nrg3123; Huang YJ, 2012, J BIOL CHEM, V287, P1500, DOI 10.1074/jbc.M111.277194; Jiang K, 2009, EMBO REP, V10, P857, DOI 10.1038/embor.2009.94; Kim HS, 2011, CANCER CELL, V20, P487, DOI 10.1016/j.ccr.2011.09.004; Kops GJPL, 2009, BIOCHEM SOC T, V37, P971, DOI 10.1042/BST0370971; Lampson MA, 2005, NAT CELL BIOL, V7, P93, DOI 10.1038/ncb1208; Liu J, 2009, J BIOL CHEM, V284, P23059, DOI 10.1074/jbc.M109.009670; Lou Y, 2004, J BIOL CHEM, V279, P20049, DOI 10.1074/jbc.M314205200; MITCHISON TJ, 1989, J CELL BIOL, V109, P637, DOI 10.1083/jcb.109.2.637; Nakamura T, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120117; Santaguida S, 2009, EMBO J, V28, P2511, DOI 10.1038/emboj.2009.173; Siegel JJ, 2012, ANNU REV CELL DEV BI, V28, P189, DOI 10.1146/annurev-cellbio-101011-155807; SU LK, 1995, CANCER RES, V55, P2972; Wang HM, 2004, J BIOL CHEM, V279, P54590, DOI 10.1074/jbc.M407588200; Wang XW, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.406652; Xia P, 2012, P NATL ACAD SCI USA, V109, P16564, DOI 10.1073/pnas.1202639109; Yao XB, 2000, NAT CELL BIOL, V2, P484, DOI 10.1038/35019518; Yao XB, 2009, CELL RES, V19, P152, DOI 10.1038/cr.2009.7; Zhang LY, 2011, J BIOL CHEM, V286, P3033, DOI 10.1074/jbc.M110.165340; Zhao LL, 2010, J BIOL CHEM, V285, P2488, DOI 10.1074/jbc.M109.042614; Zhou RH, 2003, MOL BIOL CELL, V14, P1097, DOI 10.1091/mbc.E02-07-0425	33	23	25	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 31	2013	288	22					15771	15785		10.1074/jbc.M112.448886	http://dx.doi.org/10.1074/jbc.M112.448886			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	156LA	23595990	hybrid, Green Published			2022-12-25	WOS:000319822300032
J	Cotterell, J; Sharpe, J				Cotterell, James; Sharpe, James			Mechanistic Explanations for Restricted Evolutionary Paths That Emerge from Gene Regulatory Networks	PLOS ONE			English	Article							FITNESS LANDSCAPES; ROBUSTNESS; EPISTASIS; PROTEIN; SHAPES	The extent and the nature of the constraints to evolutionary trajectories are central issues in biology. Constraints can be the result of systems dynamics causing a non-linear mapping between genotype and phenotype. How prevalent are these developmental constraints and what is their mechanistic basis? Although this has been extensively explored at the level of epistatic interactions between nucleotides within a gene, or amino acids within a protein, selection acts at the level of the whole organism, and therefore epistasis between disparate genes in the genome is expected due to their functional interactions within gene regulatory networks (GRNs) which are responsible for many aspects of organismal phenotype. Here we explore epistasis within GRNs capable of performing a common developmental function - converting a continuous morphogen input into discrete spatial domains. By exploring the full complement of GRN wiring designs that are able to perform this function, we analyzed all possible mutational routes between functional GRNs. Through this study we demonstrate that mechanistic constraints are common for GRNs that perform even a simple function. We demonstrate a common mechanistic cause for such a constraint involving complementation between counter-balanced gene-gene interactions. Furthermore we show how such constraints can be bypassed by means of "permissive" mutations that buffer changes in a direct route between two GRN topologies that would normally be unviable. We show that such bypasses are common and thus we suggest that unlike what was observed in protein sequence-function relationships, the "tape of life" is less reproducible when one considers higher levels of biological organization.	[Cotterell, James; Sharpe, James] Ctr Genom Regulat CRG, EMBL CRG Syst Biol Res Unit, Barcelona, Spain; [Cotterell, James] MRC Human Genet Unit, Dev Biol Sect, Edinburgh, Midlothian, Scotland; [Sharpe, James] Ctr Genom Regulat CRG, ICREA Prof, Barcelona, Spain	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); ICREA	Cotterell, J (corresponding author), Ctr Genom Regulat CRG, EMBL CRG Syst Biol Res Unit, Barcelona, Spain.	james.cotterell@crg.es; james.sharpe@crg.es	Sharpe, James/L-1150-2014; Sharpe, James/AAB-7948-2019	Sharpe, James/0000-0002-1434-9743; 	ICREA Funding Source: Custom	ICREA(ICREA)		Basu S, 2005, NATURE, V434, P1130, DOI 10.1038/nature03461; Beerenwinkel N, 2007, STAT SINICA, V17, P1317; Beerenwinkel N, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-60; Bridgham JT, 2009, NATURE, V461, P515, DOI 10.1038/nature08249; Bridgham JT, 2006, SCIENCE, V312, P97, DOI 10.1126/science.1123348; Ciliberti S, 2007, P NATL ACAD SCI USA, V104, P13591, DOI 10.1073/pnas.0705396104; Ciliberti S, 2007, PLOS COMPUT BIOL, V3, P164, DOI 10.1371/journal.pcbi.0030015; Cotterell J, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.74; Entus Robert, 2007, Syst Synth Biol, V1, P119, DOI 10.1007/s11693-007-9008-6; Gavrilets S, 2004, FITNESS LANDSCAPES O; Gould S. J., 1989, WONDERFUL LIFE BURGE; Greber D, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq671; Janssens H, 2013, DEV BIOL, V13, P00015; Kondrashov AS, 2002, P NATL ACAD SCI USA, V99, P14878, DOI 10.1073/pnas.232565499; Lunzer M, 2005, SCIENCE, V310, P499, DOI 10.1126/science.1115649; Lynch M, 2007, NAT REV GENET, V8, P803, DOI 10.1038/nrg2192; Manu, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000303; Manu, 2009, PLOS BIOL, V7, P3; Miller SP, 2006, SCIENCE, V314, P458, DOI 10.1126/science.1133479; Orr HA, 2005, NAT REV GENET, V6, P119, DOI 10.1038/nrg1523; Ortlund EA, 2007, SCIENCE, V317, P1544, DOI 10.1126/science.1142819; Phillips PC, 2008, NAT REV GENET, V9, P855, DOI 10.1038/nrg2452; Phillips PC, 1998, GENETICS, V149, P1167; Poelwijk FJ, 2007, NATURE, V445, P383, DOI 10.1038/nature05451; Prusinkiewicz P, 2007, SCIENCE, V316, P1452, DOI 10.1126/science.1140429; REINITZ J, 1995, MECH DEVELOP, V49, P133, DOI 10.1016/0925-4773(94)00310-J; SCHUSTER P, 1994, P ROY SOC B-BIOL SCI, V255, P279, DOI 10.1098/rspb.1994.0040; SMITH JM, 1970, NATURE, V225, P563, DOI 10.1038/225563a0; Sohka T, 2009, P NATL ACAD SCI USA, V106, P10135, DOI 10.1073/pnas.0901246106; Surkova S, 2013, DEV BIOL, V13, P00013; Van Nimwegen E, 2000, B MATH BIOL, V62, P799, DOI 10.1006/bulm.2000.0180; van Nimwegen E, 1999, P NATL ACAD SCI USA, V96, P9716, DOI 10.1073/pnas.96.17.9716; Weinreich DM, 2006, SCIENCE, V312, P111, DOI 10.1126/science.1123539; Whibley AC, 2006, SCIENCE, V313, P963, DOI 10.1126/science.1129161	34	6	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2013	8	4							e61178	10.1371/journal.pone.0061178	http://dx.doi.org/10.1371/journal.pone.0061178			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IK	23613807	Green Published, gold			2022-12-25	WOS:000317907200037
J	Palmer, SR; Miller, JH; Abranches, J; Zeng, L; Lefebure, T; Richards, VP; Lemos, JA; Stanhope, MJ; Burne, RA				Palmer, Sara R.; Miller, James H.; Abranches, Jacqueline; Zeng, Lin; Lefebure, Tristan; Richards, Vincent P.; Lemos, Jose A.; Stanhope, Michael J.; Burne, Robert A.			Phenotypic Heterogeneity of Genomically-Diverse Isolates of Streptococcus mutans	PLOS ONE			English	Article							COLLAGEN-BINDING PROTEIN; BIOFILM FORMATION; STRESS TOLERANCE; VIRULENCE TRAITS; OXIDATIVE STRESS; CARIES-FREE; COMPETENCE DEVELOPMENT; EXTRACELLULAR DNA; GENOME SEQUENCE; ORAL BACTERIA	High coverage, whole genome shotgun (WGS) sequencing of 57 geographically- and genetically-diverse isolates of Streptococcus mutans from individuals of known dental caries status was recently completed. Of the 57 sequenced strains, fifteen isolates, were selected based primarily on differences in gene content and phenotypic characteristics known to affect virulence and compared with the reference strain UA159. A high degree of variability in these properties was observed between strains, with a broad spectrum of sensitivities to low pH, oxidative stress (air and paraquat) and exposure to competence stimulating peptide (CSP). Significant differences in autolytic behavior and in biofilm development in glucose or sucrose were also observed. Natural genetic competence varied among isolates, and this was correlated to the presence or absence of competence genes, comCDE and comX, and to bacteriocins. In general strains that lacked the ability to become competent possessed fewer genes for bacteriocins and immunity proteins or contained polymorphic variants of these genes. WGS sequence analysis of the pan-genome revealed, for the first time, components of a Type VII secretion system in several S. mutans strains, as well as two putative ORFs that encode possible collagen binding proteins located upstream of the cnm gene, which is associated with host cell invasiveness. The virulence of these particular strains was assessed in a wax-worm model. This is the first study to combine a comprehensive analysis of key virulence-related phenotypes with extensive genomic analysis of a pathogen that evolved closely with humans. Our analysis highlights the phenotypic diversity of S. mutans isolates and indicates that the species has evolved a variety of adaptive strategies to persist in the human oral cavity and, when conditions are favorable, to initiate disease.	[Palmer, Sara R.; Zeng, Lin; Burne, Robert A.] Univ Florida, Dept Oral Biol, Gainesville, FL 32610 USA; [Lefebure, Tristan] Univ Lyon, CNRS, Villeurbanne, France; [Lefebure, Tristan] Univ Lyon, Villeurbanne, France; [Lefebure, Tristan; Richards, Vincent P.; Stanhope, Michael J.] Cornell Univ, Coll Vet Med, Ithaca, NY 14853 USA; [Miller, James H.; Abranches, Jacqueline; Lemos, Jose A.] Univ Rochester, Med Ctr, Ctr Oral Biol, Rochester, NY 14642 USA; [Abranches, Jacqueline; Lemos, Jose A.] Univ Rochester, Med Ctr, Dept Microbiol & Immunol, Rochester, NY 14642 USA	State University System of Florida; University of Florida; Centre National de la Recherche Scientifique (CNRS); Cornell University; University of Rochester; University of Rochester	Burne, RA (corresponding author), Univ Florida, Dept Oral Biol, Gainesville, FL 32610 USA.	rburne@dental.ufl.edu	Zeng, Lin/L-5931-2019; Lefebure, Tristan/A-6489-2009; Richards, Vincent/AAV-1816-2021; Richards, Vince/AAO-4261-2020	Lefebure, Tristan/0000-0003-3923-8166; Zeng, Lin/0000-0002-9269-2707; Lemos, Jose/0000-0003-0791-5863; Burne, Robert/0000-0002-4234-0316; Richards, Vincent/0000-0002-9309-6595	NIH [NIDAID RO1 AI073368, NIDCR R01 DE013239, NIDCR T90 DE021990]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073368] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE012236, R01DE013239, T90DE021990] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This research was funded by the following NIH grants: NIDAID RO1 AI073368, NIDCR R01 DE013239, and NIDCR T90 DE021990. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah AM, 2007, NAT REV MICROBIOL, V5, P883, DOI 10.1038/nrmicro1773; Abranches J, 2009, ORAL MICROBIOL IMMUN, V24, P141, DOI 10.1111/j.1399-302X.2008.00487.x; Abranches J, 2011, INFECT IMMUN, V79, P2277, DOI 10.1128/IAI.00767-10; Ahn SJ, 2007, J BACTERIOL, V189, P8519, DOI 10.1128/JB.01180-07; Ahn SJ, 2007, J BACTERIOL, V189, P6293, DOI 10.1128/JB.00546-07; Ahn SJ, 2006, J BACTERIOL, V188, P6877, DOI 10.1128/JB.00536-06; Ahn SJ, 2010, MICROBIOL-SGM, V156, P3136, DOI 10.1099/mic.0.039586-0; Ahn SJ, 2006, INFECT IMMUN, V74, P1631, DOI 10.1128/IAI.74.3.1631-1642.2006; Aikawa C, 2012, J BACTERIOL, V194, P2754, DOI 10.1128/JB.00350-12; Ajdic D, 2002, P NATL ACAD SCI USA, V99, P14434, DOI 10.1073/pnas.172501299; Argimon S, 2011, J CLIN MICROBIOL, V49, P984, DOI 10.1128/JCM.01993-10; Banas JA, 2003, CRIT REV ORAL BIOL M, V14, P89, DOI 10.1177/154411130301400203; BELLI WA, 1991, APPL ENVIRON MICROB, V57, P1134, DOI 10.1128/AEM.57.4.1134-1138.1991; BENDER GR, 1986, INFECT IMMUN, V53, P331, DOI 10.1128/IAI.53.2.331-338.1986; Bhagwat SP, 2001, FEMS MICROBIOL LETT, V205, P225, DOI 10.1016/S0378-1097(01)00471-2; Biswas I, 2008, J BACTERIOL, V190, P68, DOI 10.1128/JB.00990-07; BOWDEN GHW, 1990, J DENT RES, V69, P1205, DOI 10.1177/00220345900690051701; Bowen WH, 2011, CARIES RES, V45, P69, DOI 10.1159/000324598; Bradshaw DJ, 1996, MICROBIOL-UK, V142, P623, DOI 10.1099/13500872-142-3-623; Brady LJ, 2010, MOL MICROBIOL, V77, P276, DOI 10.1111/j.1365-2958.2010.07212.x; Burne R A, 2012, Adv Dent Res, V24, P77, DOI 10.1177/0022034512449462; Burts ML, 2005, P NATL ACAD SCI USA, V102, P1169, DOI 10.1073/pnas.0405620102; Burts ML, 2008, MOL MICROBIOL, V69, P736, DOI 10.1111/j.1365-2958.2008.06324.x; Cornejo OE, 2013, MOL BIOL EVOL; Cvitkovitch DG, 2003, J CLIN INVEST, V112, P1626, DOI 10.1172/JCI200320430; Dewhirst FE, 2010, J BACTERIOL, V192, P5002, DOI 10.1128/JB.00542-10; Do T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009073; Dufour D, 2011, J BACTERIOL, V193, P6552, DOI 10.1128/JB.05968-11; Engelberg-Kulka H, 2006, PLOS GENET, V2, P1518, DOI 10.1371/journal.pgen.0020135; Federle MJ, 2012, MOL MICROBIOL; Fujita H, 2011, CARIES RES, V45, P524, DOI 10.1159/000331920; Hale JDF, 2005, J BACTERIOL, V187, P5036, DOI 10.1128/JB.187.14.5036-5039.2005; HANADA N, 1989, INFECT IMMUN, V57, P2079, DOI 10.1128/IAI.57.7.2079-2085.1989; Higuchi M, 1999, J BACTERIOL, V181, P5940, DOI 10.1128/JB.181.19.5940-5947.1999; Hossain MS, 2012, J BACTERIOL; Jenkinson HF, 2011, ENVIRON MICROBIOL, V13, P3077, DOI 10.1111/j.1462-2920.2011.02573.x; Kesavalu L, 2012, J DENT RES, V91, P255, DOI 10.1177/0022034511435101; Khalichi P, 2004, BIOMATERIALS, V25, P5467, DOI 10.1016/j.biomaterials.2003.12.056; Klein MI, 2006, J CLIN MICROBIOL, V44, P3015, DOI 10.1128/JCM.02024-05; Klein MN, 2004, J CLIN MICROBIOL, V42, P4620, DOI 10.1128/JCM.42.10.4620-4626.2004; Kleinberg I, 2002, CRIT REV ORAL BIOL M, V13, P108, DOI 10.1177/154411130201300202; Koo H, 2010, J BACTERIOL, V192, P3024, DOI 10.1128/JB.01649-09; Kreulen CM, 1997, J DENT CHILD, V64, P107; Kuramitsu HK, 2007, MICROBIOL MOL BIOL R, V71, P653, DOI 10.1128/MMBR.00024-07; Lembo FL, 2007, ORAL MICROBIOL IMMUN, V22, P313, DOI 10.1111/j.1399-302X.2007.00361.x; Lemme A, 2011, J BACTERIOL, V193, P1863, DOI 10.1128/JB.01363-10; Lemos JAC, 2005, CURR ISSUES MOL BIOL, V7, P95; Lemos JA, 2008, MICROBIOL-SGM, V154, P3247, DOI 10.1099/mic.0.2008/023770-0; Levine M, 2011, INT J DENT, V2011, DOI 10.1155/2011/953412; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Li YH, 2001, J BACTERIOL, V183, P897, DOI 10.1128/JB.183.3.897-908.2001; Li YH, 2008, MICROBIOL-SGM, V154, P3256, DOI 10.1099/mic.0.2008/019455-0; LINZER R, 1987, INFECT IMMUN, V55, P3006, DOI 10.1128/IAI.55.12.3006-3010.1987; LITTLETON J, 1993, AM J PHYS ANTHROPOL, V92, P427, DOI 10.1002/ajpa.1330920403; LOESCHE WJ, 1986, MICROBIOL REV, V50, P353, DOI 10.1128/MMBR.50.4.353-380.1986; Loo CY, 2000, J BACTERIOL, V182, P1374, DOI 10.1128/JB.182.5.1374-1382.2000; LUKACS JR, 1992, AM J PHYS ANTHROPOL, V87, P133, DOI 10.1002/ajpa.1330870202; MACRINA FL, 1978, INFECT IMMUN, V20, P296, DOI 10.1128/IAI.20.1.296-302.1978; MACRINA FL, 1991, INFECT IMMUN, V59, P1535, DOI 10.1128/IAI.59.4.1535-1543.1991; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; MARQUIS RE, 1995, J IND MICROBIOL, V15, P198, DOI 10.1007/BF01569826; Marri PR, 2006, MOL BIOL EVOL, V23, P2379, DOI 10.1093/molbev/msl115; Marsh PD, 2003, MICROBIOL-SGM, V149, P279, DOI 10.1099/mic.0.26082-0; Martin B, 2006, TRENDS MICROBIOL, V14, P339, DOI 10.1016/j.tim.2006.06.007; Martin V, 1997, ADV EXP MED BIOL, V418, P669; Mashburn-Warren L, 2010, MOL MICROBIOL, V78, P589, DOI 10.1111/j.1365-2958.2010.07361.x; Mattos-Graner RO, 2004, J CLIN MICROBIOL, V42, P4586, DOI 10.1128/JCM.42.10.4586-4592.2004; Merritt J, 2012, MOL ORAL MICROBIOL, V27, P57, DOI 10.1111/j.2041-1014.2011.00634.x; Montanaro L, 2011, INT J ARTIF ORGANS, V34, P824, DOI 10.5301/ijao.5000051; MUNRO C, 1991, INFECT IMMUN, V59, P2316, DOI 10.1128/IAI.59.7.2316-2323.1991; Nakano K, 2010, ARCH ORAL BIOL, V55, P34, DOI 10.1016/j.archoralbio.2009.11.008; Nakano K, 2006, J CLIN MICROBIOL, V44, P3313, DOI 10.1128/JCM.00377-06; Nakano K, 2010, J PHARMACOL SCI, V113, P120, DOI 10.1254/jphs.09R24FM; Nakano K, 2009, FUTURE MICROBIOL, V4, P891, DOI [10.2217/fmb.09.64, 10.2217/FMB.09.64]; Napimoga MH, 2004, J MED MICROBIOL, V53, P697, DOI 10.1099/jmm.0.05512-0; Narisawa N, 2011, J BACTERIOL, V193, P5147, DOI 10.1128/JB.05240-11; Nomura R, 2012, MOL ORAL MICROBIOL, V27, P308, DOI 10.1111/j.2041-1014.2012.00649.x; OGIER JA, 1990, ARCH ORAL BIOL, V35, pS25, DOI 10.1016/0003-9969(90)90127-V; Okinaga T, 2010, J BACTERIOL, V192, P1844, DOI 10.1128/JB.01667-09; Ouyang J, 2010, ANTIMICROB AGENTS CH, V54, P3895, DOI 10.1128/AAC.01802-09; PERRY D, 1989, INFECT IMMUN, V57, P805, DOI 10.1128/IAI.57.3.805-809.1989; Perry JA, 2009, FEMS MICROBIOL LETT, V299, P261, DOI 10.1111/j.1574-6968.2009.01758.x; Petersen FC, 2006, MOL MICROBIOL, V61, P1322, DOI 10.1111/j.1365-2958.2006.05312.x; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Phattarataratip E, 2011, MOL ORAL MICROBIOL, V26, P187, DOI 10.1111/j.2041-1014.2011.00607.x; Pieralisi FJS, 2010, INT J DENT, V2010, DOI 10.1155/2010/824976; Pizzo G, 2007, CLIN ORAL INVEST, V11, P189, DOI 10.1007/s00784-007-0111-6; Rice KC, 2003, MOL MICROBIOL, V50, P729, DOI 10.1046/j.1365-2958.2003.t01-1-03720.x; Rodriguez-Moya J, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-256; Sato Y, 2004, J DENT RES, V83, P534, DOI 10.1177/154405910408300705; Schneewind O, 2012, PHILOS T R SOC B, V367, P1123, DOI 10.1098/rstb.2011.0210; SCHROEDER VA, 1989, INFECT IMMUN, V57, P3560, DOI 10.1128/IAI.57.11.3560-3569.1989; Seaton K, 2011, J BACTERIOL, V193, P862, DOI 10.1128/JB.01257-10; Senadheera D, 2008, ADV EXP MED BIOL, V631, P178, DOI 10.1007/978-0-387-78885-2_12; Shibata Y, 2005, INFECT IMMUN, V73, P3512, DOI 10.1128/IAI.73.6.3512-3520.2005; Shibata Y, 2003, J CLIN MICROBIOL, V41, P4107, DOI 10.1128/JCM.41.9.4107-4112.2003; Song LF, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-128; Tamesada M, 2004, J DENT RES, V83, P874, DOI 10.1177/154405910408301110; UEDA S, 1988, MOL MICROBIOL, V2, P135, DOI 10.1111/j.1365-2958.1988.tb00014.x; van der Ploeg JR, 2005, J BACTERIOL, V187, P3980, DOI 10.1128/JB.187.12.3980-3989.2005; Vengadesan K, 2011, PROTEIN SCI, V20, P759, DOI 10.1002/pro.613; Waterhouse JC, 2007, ORAL MICROBIOL IMMUN, V22, P103, DOI 10.1111/j.1399-302X.2007.00330.x; Waterhouse JC, 2006, MICROBIOL-SGM, V152, P1777, DOI 10.1099/mic.0.28647-0; Way SS, 2005, INFECT IMMUN, V73, P6151, DOI 10.1128/IAI.73.9.6151-6153.2005; Wen ZT, 2004, J BACTERIOL, V186, P2682, DOI 10.1128/JB.186.9.2682-2691.2004; Wen ZT, 2002, APPL ENVIRON MICROB, V68, P1196, DOI 10.1128/AEM.68.3.1196-1203.2002; Willems RJL, 2011, FEMS MICROBIOL REV, V35, P872, DOI 10.1111/j.1574-6976.2011.00284.x; Wu CG, 2010, APPL ENVIRON MICROB, V76, P5815, DOI 10.1128/AEM.03079-09; Wunder D, 2000, ORAL DIS, V6, P289; Zeng L, 2009, J BACTERIOL, V191, P2153, DOI 10.1128/JB.01641-08; Zhang L, 2009, ORAL MICROBIOL IMMUN, V24, P197, DOI 10.1111/j.1399-302X.2008.00495.x	112	58	60	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2013	8	4							e61358	10.1371/journal.pone.0061358	http://dx.doi.org/10.1371/journal.pone.0061358			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130DR	23613838	Green Submitted, gold, Green Published			2022-12-25	WOS:000317893400056
J	Kumar, R; Raghava, GPS				Kumar, Ravi; Raghava, Gajendra P. S.			Hybrid Approach for Predicting Coreceptor Used by HIV-1 from Its V3 Loop Amino Acid Sequence	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; GP120 ENVELOPE GLYCOPROTEIN; SUPPORT VECTOR MACHINE; SUBCELLULAR-LOCALIZATION; DIPEPTIDE COMPOSITION; GENOTYPIC PREDICTION; USAGE PREDICTION; SUBTYPE-D; PHENOTYPE; PROTEIN	Background : HIV-1 infects the host cell by interacting with the primary receptor CD4 and a coreceptor CCR5 or CXCR4. Maraviroc, a CCR5 antagonist binds to CCR5 receptor. Thus, it is important to identify the coreceptor used by the HIV strains dominating in the patient. In past, a number of experimental assays and in-silico techniques have been developed for predicting the coreceptor tropism. The prediction accuracy of these methods is excellent when predicting CCR5(R5) tropic sequences but is relatively poor for CXCR4(X4) tropic sequences. Therefore, any new method for accurate determination of coreceptor usage would be of paramount importance to the successful management of HIV-infected individuals. Results: The dataset used in this study comprised 1799 R5-tropic and 598 X4-tropic third variable (V3) sequences of HIV-1. We compared the amino acid composition of both types of V3 sequences and observed that certain types of residues, e. g., Asparagine and Isoleucine, were preferred in R5-tropic sequences whereas residues like Lysine, Arginine, and Tryptophan were preferred in X4-tropic sequences. Initially, Support Vector Machine-based models were developed using amino acid composition, dipeptide composition, and split amino acid composition, which achieved accuracy up to 90%. We used BLAST to discriminate R5-and X4-tropic sequences and correctly predicted 93.16% of R5-and 75.75% of X4-tropic sequences. In order to improve the prediction accuracy, a Hybrid model was developed that achieved 91.66% sensitivity, 81.77% specificity, 89.19% accuracy and 0.72 Matthews Correlation Coefficient. The performance of our models was also evaluated on an independent dataset (256 R5-and 81 X4-tropic sequences) and achieved maximum accuracy of 84.87% with Matthews Correlation Coefficient 0.63. Conclusion: This study describes a highly efficient method for predicting HIV-1 coreceptor usage from V3 sequences. In order to provide a service to the scientific community, a webserver HIVcoPred was developed(http://www.imtech.res.in/raghava/hivcopred/) for predicting the coreceptor usage.	[Kumar, Ravi; Raghava, Gajendra P. S.] CSIR, Inst Microbial Technol, Bioinformat Ctr, Chandigarh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH)	Raghava, GPS (corresponding author), CSIR, Inst Microbial Technol, Bioinformat Ctr, Chandigarh, India.	raghava@imtech.res.in	Raghava, Gajendra P.S./AAA-2413-2022; Raghava, Gajendra/B-1717-2009	Raghava, Gajendra P.S./0000-0002-8902-2876; , Ravi Kumar/0000-0001-9310-1940				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Baldi P, 2000, BIOINFORMATICS, V16, P412, DOI 10.1093/bioinformatics/16.5.412; Berger EA, 1999, ANNU REV IMMUNOL, V17, P657, DOI 10.1146/annurev.immunol.17.1.657; Bhasin M, 2004, NUCLEIC ACIDS RES, V32, pW414, DOI 10.1093/nar/gkh350; Bhasin M, 2004, J BIOL CHEM, V279, P23262, DOI 10.1074/jbc.M401932200; Boisvert S, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-110; Chauhan JS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-301; Chauhan JS, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-434; Chen C, 2009, PROTEIN PEPTIDE LETT, V16, P27, DOI 10.2174/092986609787049420; CHOU KC, 1995, CRIT REV BIOCHEM MOL, V30, P275, DOI 10.3109/10409239509083488; Cocchi F, 1996, NAT MED, V2, P1244, DOI 10.1038/nm1196-1244; Cormier EG, 2002, J VIROL, V76, P8953, DOI 10.1128/JVI.76.17.8953-8957.2002; DEJONG JJ, 1992, J VIROL, V66, P6777, DOI 10.1128/JVI.66.11.6777-6780.1992; Dimonte S, 2011, RETROVIROL, V12, P8, DOI DOI 10.1186/1742-4690-8-33; Ding H, 2009, PROTEIN PEPTIDE LETT, V16, P351, DOI 10.2174/092986609787848045; Dorr P, 2005, ANTIMICROB AGENTS CH, V49, P4721, DOI 10.1128/AAC.49.11.4721-4732.2005; Dybowski JN, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000743; FOUCHIER RAM, 1992, J VIROL, V66, P3183, DOI 10.1128/JVI.66.5.3183-3187.1992; FOUCHIER RAM, 1995, J CLIN MICROBIOL, V33, P906, DOI 10.1128/JCM.33.4.906-911.1995; Garg A, 2005, J BIOL CHEM, V280, P14427, DOI 10.1074/jbc.M411789200; Gorry PR, 2005, CURR HIV RES, V3, P53, DOI 10.2174/1570162052772951; Grivel JC, 2000, J VIROL, V74, P5347, DOI 10.1128/JVI.74.11.5347-5351.2000; Hartley O, 2005, AIDS RES HUM RETROV, V21, P171, DOI 10.1089/aid.2005.21.171; Hoffman NG, 2002, J VIROL, V76, P3852, DOI 10.1128/JVI.76.8.3852-3864.2002; Huang CC, 2005, SCIENCE, V310, P1025, DOI 10.1126/science.1118398; Huang W, 2008, J VIROL, V82, P5584, DOI 10.1128/JVI.02676-07; Huang W, 2007, J VIROL, V81, P7885, DOI 10.1128/JVI.00218-07; Jensen MA, 2006, J VIROL, V80, P4698, DOI 10.1128/JVI.80.10.4698-4704.2006; Jensen MA, 2003, J VIROL, V77, P13376, DOI 10.1128/JVI.77.24.13376-13388.2003; Joachims T, 1999, ADVANCES IN KERNEL METHODS, P169; Kumar M, 2006, J BIOL CHEM, V281, P5357, DOI 10.1074/jbc.M511061200; Kumar M, 2008, PROTEINS, V71, P189, DOI 10.1002/prot.21677; Kumar M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-22; Kumar Ravi, 2011, BMC Res Notes, V4, P237, DOI 10.1186/1756-0500-4-237; Lamers SL, 2008, IEEE ACM T COMPUT BI, V5, P291, DOI 10.1109/TCBB.2007.1074; Lengauer T, 2007, NAT BIOTECHNOL, V25, P1407, DOI 10.1038/nbt1371; Masso M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-494; Mefford ME, 2008, AIDS RES HUM RETROV, V24, P1215, DOI 10.1089/aid.2008.0009; Monno L, 2011, ANTIMICROB AGENTS CH, V55, P5078, DOI 10.1128/AAC.00743-11; Moore JP, 2004, AIDS RES HUM RETROV, V20, P111, DOI 10.1089/088922204322749567; Pastore C, 2006, J VIROL, V80, P750, DOI 10.1128/JVI.80.2.750-758.2006; Pillai S, 2003, AIDS RES HUM RETROV, V19, P145, DOI 10.1089/088922203762688658; Polzer S, 2001, GLYCOBIOLOGY, V11, P11, DOI 10.1093/glycob/11.1.11; Prosperi MCF, 2009, AIDS RES HUM RETROV, V25, P305, DOI 10.1089/aid.2008.0039; Raghava GPS, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-59; Raymond S, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-56; Raymond S, 2010, J CLIN VIROL, V47, P126, DOI 10.1016/j.jcv.2009.11.018; Regoes RR, 2005, TRENDS MICROBIOL, V13, P269, DOI 10.1016/j.tim.2005.04.005; Resch W, 2001, VIROLOGY, V288, P51, DOI 10.1006/viro.2001.1087; Rose JD, 2009, CURR OPIN HIV AIDS, V4, P136, DOI 10.1097/COH.0b013e328322f973; Rupp D, 2010, JAIDS-J ACQ IMM DEF, V53, P412, DOI 10.1097/QAI.0b013e3181c9f53f; Sander O, 2007, PLOS COMPUT BIOL, V3, P555, DOI 10.1371/journal.pcbi.0030058; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Schuitemaker Hanneke, 2005, Methods Mol Biol, V304, P327; Sharp PM, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a006841; SHIODA T, 1992, P NATL ACAD SCI USA, V89, P9434, DOI 10.1073/pnas.89.20.9434; Shoombuatong W, 2012, COMPUT BIOL MED, V42, P885, DOI 10.1016/j.compbiomed.2012.06.011; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Sing T, 2007, ANTIVIR THER, V12, P1097; Thielen A, 2010, J INFECT DIS, V202, P1435, DOI 10.1086/656600; Trouplin V, 2001, J VIROL, V75, P251, DOI 10.1128/JVI.75.1.251-259.2001; Vacic V, 2006, BIOINFORMATICS, V22, P1536, DOI 10.1093/bioinformatics/btl151; Vapnik V. N., 1998, NATURE STAT LEARNING; Wasmuth JC, 2012, EXPERT OPIN DRUG SAF, V11, P161, DOI 10.1517/14740338.2012.640670; Whitcomb JM, 2007, ANTIMICROB AGENTS CH, V51, P566, DOI 10.1128/AAC.00853-06; Xu SG, 2007, J MICROBIOL, V45, P441; Yamaguchi-Kabata Y, 2004, J MOL EVOL, V58, P333, DOI 10.1007/s00239-003-2555-x; Zaitseva M, 2003, BBA-BIOMEMBRANES, V1614, P51, DOI 10.1016/S0005-2736(03)00162-7	68	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2013	8	4							e61437	10.1371/journal.pone.0061437	http://dx.doi.org/10.1371/journal.pone.0061437			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125TD	23596523	Green Published, Green Submitted, gold			2022-12-25	WOS:000317563300030
J	Zhang, C; Wang, XX; Wang, ZP; Niu, WB; Zhu, BC; Xia, GL				Zhang, Cheng; Wang, Xiaoxia; Wang, Zhengpin; Niu, Wanbao; Zhu, Baochang; Xia, Guoliang			Effect of Different Culture Systems and 3, 5, 3 '-Triiodothyronine/Follicle-Stimulating Hormone on Preantral Follicle Development in Mice	PLOS ONE			English	Article							X-LINKED INHIBITOR; RAT GRANULOSA-CELLS; NECROSIS-FACTOR-ALPHA; IN-VITRO CULTURE; GROWTH-FACTOR-I; STIMULATING-HORMONE; OOCYTE MATURATION; EMBRYO DEVELOPMENT; APOPTOSIS PROTEIN; GENE-EXPRESSION	The mechanical method to isolate preantral follicle has been reported for many years. However, the culture systems in vitro are still unstable. The aim of this study was to analyze the effect of the culture system of mice preantral follicles on the follicular development in vitro. The results showed that the 96-well plate system was the most effective method for mice follicle development in vitro (volume change: 51.71%; survival rate: 89%, at day 4). Follicle-stimulating hormone (FSH) and Thyroid hormone (TH) are important for normal follicular development and dysregulation of hormones are related with impaired follicular development. To determine the effect of hormone on preantral follicular development, we cultured follicle with hormones in the 96-well plate culture system and found that FSH significantly increased preantral follicular growth on day 4. The FSH-induced growth action was markedly enhanced by T-3 although T-3 was ineffective alone. We also demonstrated by QRT-PCR that T-3 significantly enhanced FSH-induced up-regulation of Xiap mRNA level. Meanwhile, Bad, cell death inducer, was markedly down-regulated by the combination of hormones. Moreover, QRT-PCR results were also consistent with protein regulation which detected by Western Blotting analysis. Taken together, the findings of the present study demonstrate that 96-well plate system is an effective method for preantral follicle development in vitro. Moreover, these results provide insights on the role of thyroid hormone in increasing FSH-induced preantral follicular development, which mediated by up-regulating Xiap and down-regulating Bad.	[Zhang, Cheng; Wang, Xiaoxia; Zhu, Baochang] Capital Normal Univ, Coll Life Sci, Beijing, Peoples R China; [Wang, Zhengpin; Niu, Wanbao; Xia, Guoliang] China Agr Univ, State Key Lab Agrobiotechnol, Coll Biol Sci, Beijing 100094, Peoples R China; [Wang, Xiaoxia] Beijing Agr Univ, Anim Sci & Technol Coll, Beijing 100094, Peoples R China	Capital Normal University; China Agricultural University; Beijing University of Agriculture	Zhang, C (corresponding author), Capital Normal Univ, Coll Life Sci, Beijing, Peoples R China.	zhch8012@163.com; glxiachina@sohu.com	Wang, Zhengpin/AAM-3021-2020	Wang, Zhengpin/0000-0001-5388-1516; Xia, Guoliang/0000-0003-3674-0142	Innovation Team on Nutrition & Feedstuff in Poultry, Beijing, China [PXM2012_014207_0001666]	Innovation Team on Nutrition & Feedstuff in Poultry, Beijing, China	This work was supported in part by a grant (PXM2012_014207_0001666) from the Innovation Team on Nutrition & Feedstuff in Poultry, Beijing, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Anckaert E, 2009, BIOL REPROD, V81, P666, DOI 10.1095/biolreprod.109.076810; Asselin E, 2001, ENDOCRINOLOGY, V142, P2451, DOI 10.1210/en.142.6.2451; Cecconi S, 1999, ENDOCRINOLOGY, V140, P1783, DOI 10.1210/en.140.4.1783; Cecconi S, 2004, FERTIL STERIL, V81, P919, DOI 10.1016/j.fertnstert.2003.11.014; Choi J, 2008, CRYOBIOLOGY, V57, P209, DOI 10.1016/j.cryobiol.2008.08.004; Cortvrindt R, 1997, HUM REPROD, V12, P759, DOI 10.1093/humrep/12.4.759; Cortvrindt R, 1996, HUM REPROD, V11, P2656; Cortvrindt R, 1998, HUM REPROD, V13, P1292, DOI 10.1093/humrep/13.5.1292; Demeestere I, 2005, REPRODUCTION, V130, P147, DOI 10.1530/rep.1.00648; Demeestere I, 2004, BIOL REPROD, V70, P1664, DOI 10.1095/biolreprod.103.023317; Demeestere I, 2002, HUM REPROD, V17, P2152, DOI 10.1093/humrep/17.8.2152; Eppig JJ, 1996, MOL REPROD DEV, V44, P260, DOI 10.1002/(SICI)1098-2795(199606)44:2&lt;260::AID-MRD17&gt;3.0.CO;2-6; Erbach GT, 1995, HUM REPROD, V10, P3248, DOI 10.1093/oxfordjournals.humrep.a135897; Ezzoukhry Z, 2011, MOL PHARMACOL, V79, P997, DOI 10.1124/mol.110.070565; GERHARD I, 1991, HUM REPROD, V6, P338, DOI 10.1093/oxfordjournals.humrep.a137335; Hara S, 2011, BIOL REPROD, V85, P895, DOI 10.1095/biolreprod.111.090738; Hashimoto A, 2005, J BIOL CHEM, V280, P26225, DOI 10.1074/jbc.M409363200; Hekman M, 2006, J BIOL CHEM, V281, P17321, DOI 10.1074/jbc.M600292200; Hsu SY, 1997, TRENDS ENDOCRIN MET, V8, P207, DOI 10.1016/S1043-2760(97)00036-2; Jiang JY, 1999, J REPROD FERTIL, V116, P19, DOI 10.1530/jrf.0.1160019; Jiang JY, 2000, J REPROD FERTIL, V119, P193, DOI 10.1530/reprod/119.2.193; Jiang JY, 2003, FRONT BIOSCI-LANDMRK, V8, pD222, DOI 10.2741/949; Kobayashi N, 2009, ENDOCRINOLOGY, V150, P5566, DOI 10.1210/en.2009-0262; Lee S, 2004, J VET MED SCI, V66, P63, DOI 10.1292/jvms.66.63; Li J, 1998, ENDOCRINOLOGY, V139, P1321, DOI 10.1210/en.139.3.1321; Lima IMT, 2012, CELL TISSUE RES, V348, P225, DOI 10.1007/s00441-012-1361-4; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mao JD, 2002, BIOL REPROD, V67, P1197, DOI 10.1095/biolreprod67.4.1197; Metoki T, 2008, ZYGOTE, V16, P239, DOI 10.1017/S0967199408004711; MILLER KF, 1987, GAMETE RES, V17, P57, DOI 10.1002/mrd.1120170107; Moriishi K, 2002, VIROLOGY, V292, P258, DOI 10.1006/viro.2001.1206; Mueller A, 2009, HUM REPROD, V24, P2924, DOI 10.1093/humrep/dep285; Mufti AR, 2007, ARCH BIOCHEM BIOPHYS, V463, P168, DOI 10.1016/j.abb.2007.01.033; Orisaka M, 2006, MOL ENDOCRINOL, V20, P2456, DOI 10.1210/me.2005-0357; Otsuki J, 2007, FERTIL STERIL, V88, P741, DOI 10.1016/j.fertnstert.2006.11.144; Park KE, 2012, REPROD SCI; PELUSO JJ, 1978, J REPROD FERTIL, V54, P275, DOI 10.1530/jrf.0.0540275; Phillipps HR, 2011, REPRODUCTION, V142, P855, DOI 10.1530/REP-11-0177; Rocha RMP, 2013, DOMEST ANIM ENDOCRIN, V44, P1, DOI 10.1016/j.domaniend.2012.07.001; Segers I, 2008, BIOL REPROD, V78, P859, DOI 10.1095/biolreprod.107.062539; Sensintaffar J, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-11; Smitz J, 1998, HUM REPROD, V13, P927, DOI 10.1093/humrep/13.4.927; STANDEVEN RM, 1969, J ENDOCRINOL, V43, P217, DOI 10.1677/joe.0.0430217; TISDALL DJ, 1995, J MOL ENDOCRINOL, V15, P273, DOI 10.1677/jme.0.0150273; Torkin R, 2005, MOL CANCER THER, V4, P1; Van Soom A, 2001, REPROD DOMEST ANIM, V36, P169, DOI 10.1046/j.1439-0531.2001.d01-32.x; Wan XY, 2011, TOXICOL IND HEALTH, V27, P637, DOI 10.1177/0748233710395345; Wang JW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045043; Wang YF, 2002, BIOL REPROD, V66, P1672, DOI 10.1095/biolreprod66.6.1672; Xiao CW, 2001, ENDOCRINOLOGY, V142, P557, DOI 10.1210/en.142.2.557; Xu GX, 2012, THERANOSTICS, V2, P734, DOI 10.7150/thno.4290; Zhang C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042406; Zhang Cheng, 2011, Front Biosci (Elite Ed), V3, P1401	53	23	25	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2013	8	4							e61947	10.1371/journal.pone.0061947	http://dx.doi.org/10.1371/journal.pone.0061947			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125TD	23596531	gold, Green Published, Green Submitted			2022-12-25	WOS:000317563300045
J	Daugherty, A; Rateri, DL; Howatt, DA; Charnigo, R; Cassis, LA				Daugherty, Alan; Rateri, Debra L.; Howatt, Deborah A.; Charnigo, Richard; Cassis, Lisa A.			PD123319 Augments Angiotensin II-Induced Abdominal Aortic Aneurysms through an AT2 Receptor-Independent Mechanism	PLOS ONE			English	Article							E-DEFICIENT MICE; TYPE-2 RECEPTOR; ATHEROSCLEROTIC LESIONS; AT(1A) RECEPTOR; APOE(-/-) MICE; BLOOD-PRESSURE; NULL MICE; SYSTEM; ATHEROGENESIS; ANTAGONISM	Background: AT2 receptors have an unclear function on development of abdominal aortic aneurysms (AAAs), although a pharmacological approach using the AT2 receptor antagonist PD123319 has implicated a role. The purpose of the present study was to determine the role of AT2 receptors in AngII-induced AAAs using a combination of genetic and pharmacological approaches. We also defined effects of AT2 receptors in AngII-induced atherosclerosis and thoracic aortic aneurysms. Methods and Results: Male AT2 receptor wild type (AT2 +/y) and deficient (AT2 -/y) mice in an LDL receptor -/- background were fed a saturated-fat enriched diet, and infused with either saline or AngII (500 ng/kg/min). AT2 receptor deficiency had no significant effect on systolic blood pressure during AngII-infusion. While AngII infusion induced AAAs, AT2 receptor deficiency did not significantly affect either maximal width of the suprarenal aorta or incidence of AAAs. The AT2 receptor antagonist PD123319 (3 mg/kg/day) and AngII were co-infused into male LDL receptor -/- mice that were either AT2 +/y or -/y. PD123319 had no significant effect on systolic blood pressure in either wild type or AT2 receptor deficient mice. Consistent with our previous findings, PD123319 increased AngII-induced AAAs. However, this effect of PD123319 occurred irrespective of AT2 receptor genotype. Neither AT2 receptor deficiency nor PD123319 had any significant effect on AngII-induced thoracic aortic aneurysms or atherosclerosis. Conclusions: AT2 receptor deficiency does not affect AngII-induced AAAs, thoracic aortic aneurysms and atherosclerosis. PD123319 augments AngII-induced AAAs through an AT2 receptor-independent mechanism.	[Cassis, Lisa A.] Univ Kentucky, Dept Mol & Biomed Pharmacol, Lexington, KY USA	University of Kentucky		Alan.Daugherty@uky.edu	Daugherty, Alan/C-8282-2009	Daugherty, Alan/0000-0003-2093-3775	National Institutes of Health [HL062846]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062846] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Institutes of Health (HL062846). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akishita M, 2000, CIRCULATION, V102, P1684, DOI 10.1161/01.CIR.102.14.1684; Akishita M, 1999, BIOCHEM BIOPH RES CO, V261, P345, DOI 10.1006/bbrc.1999.1027; Bruemmer D, 2003, J CLIN INVEST, V112, P1318, DOI 10.1172/JCI200318141; Carey RM, 2000, HYPERTENSION, V35, P155, DOI 10.1161/01.HYP.35.1.155; Cassis LA, 2007, ARTERIOSCL THROM VAS, V27, P380, DOI 10.1161/01.ATV.0000254680.71485.92; Clere N, 2010, INT J CANCER, V127, P2279, DOI 10.1002/ijc.25234; DAUGHERTY A, 1994, ARTERIOSCLER THROMB, V14, P2017, DOI 10.1161/01.ATV.14.12.2017; Daugherty A, 1999, ANN NY ACAD SCI, V892, P108, DOI 10.1111/j.1749-6632.1999.tb07789.x; Daugherty A, 2000, J CLIN INVEST, V105, P1605, DOI 10.1172/JCI7818; Daugherty A, 2005, METHODS, V36, P129, DOI 10.1016/j.ymeth.2004.11.008; Daugherty A, 2004, CIRCULATION, V110, P3849, DOI 10.1161/01.CIR.0000150540.54220.C4; Daugherty A, 2001, BRIT J PHARMACOL, V134, P865, DOI 10.1038/sj.bjp.0704331; DAUGHERTY A, 2009, J VIS EXP, V1291; Daugherty A, 2011, J ZHEJIANG UNIV-SC B, V12, P624, DOI 10.1631/jzus.B1101002; Daugherty Alan, 2003, Methods Mol Biol, V209, P293; Daugherty A, 2010, CLIN SCI, V118, P681, DOI 10.1042/CS20090372; DUDLEY DT, 1991, MOL PHARMACOL, V40, P360; Habashi JP, 2011, SCIENCE, V332, P361, DOI 10.1126/science.1192152; Habashi JP, 2006, SCIENCE, V312, P117, DOI 10.1126/science.1124287; HEIN L, 1995, NATURE, V377, P744, DOI 10.1038/377744a0; Henriques TA, 2004, ENDOCRINOLOGY, V145, P3866, DOI 10.1210/en.2003-1615; ICHIKI T, 1995, NATURE, V377, P748, DOI 10.1038/377748a0; Iwai M, 2005, CIRCULATION, V112, P1636, DOI 10.1161/CIRCULATIONAHA.104.525550; Johansson ME, 2005, J HYPERTENS, V23, P1541, DOI 10.1097/01.hjh.0000174078.95745.77; Koitka A, 2010, DIABETOLOGIA, V53, P584, DOI 10.1007/s00125-009-1619-x; Lu H, 2012, BRIT J PHARMACOL, V165, P2000, DOI 10.1111/j.1476-5381.2011.01712.x; Okui S, 2012, EUR J PHARMACOL, V685, P149, DOI 10.1016/j.ejphar.2012.04.027; Praddaude F, 2009, EXP EYE RES, V89, P109, DOI 10.1016/j.exer.2009.02.020; Rateri DL, 2011, AM J PATHOL, V179, P1542, DOI 10.1016/j.ajpath.2011.05.049; Rateri DL, 2011, CIRC RES, V108, P574, DOI 10.1161/CIRCRESAHA.110.222844; Ruan XP, 1999, J AM SOC NEPHROL, V10, P2620; Sales VL, 2005, CIRCULATION, V112, P3328, DOI 10.1161/CIRCULATIONAHA.105.541714; Saraff K, 2003, ARTERIOSCL THROM VAS, V23, P1621, DOI 10.1161/01.ATV.0000085631.76095.64; Tanaka M, 1999, BIOCHEM BIOPH RES CO, V258, P194, DOI 10.1006/bbrc.1999.0500; Tesanovic S, 2010, ARTERIOSCL THROM VAS, V30, P1606, DOI 10.1161/ATVBAHA.110.204453; Tiyerili V, 2012, J MOL CELL CARDIOL, V52, P630, DOI 10.1016/j.yjmcc.2011.12.007; Tsutsumi Y, 1999, J CLIN INVEST, V104, P925, DOI 10.1172/JCI7886; Wang M, 2008, CIRCULATION, V117, P1302, DOI 10.1161/CIRCULATIONAHA.107.731398; Wang Y. X., 2006, HDB MOUSE MODELS CAR, V125; Wang YX, 2001, AM J PATHOL, V159, P1455, DOI 10.1016/S0002-9440(10)62532-1; Weiss D, 2001, CIRCULATION, V103, P448; Yayama K, 2006, HYPERTENSION, V48, P958, DOI 10.1161/01.HYP.0000244108.30909.27	42	26	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2013	8	4							e61849	10.1371/journal.pone.0061849	http://dx.doi.org/10.1371/journal.pone.0061849			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123JP	23593499	Green Submitted, Green Published, gold			2022-12-25	WOS:000317385300085
J	Wu, S; Ju, GQ; Du, T; Zhu, YJ; Liu, GH				Wu, Shuai; Ju, Guan-Qun; Du, Tao; Zhu, Ying-Jian; Liu, Guo-Hua			Microvesicles Derived from Human Umbilical Cord Wharton's Jelly Mesenchymal Stem Cells Attenuate Bladder Tumor Cell Growth In Vitro and In Vivo	PLOS ONE			English	Article							HORIZONTAL TRANSFER; CANCER; TRANSFORMATION; PROLIFERATION; MEDIATORS; KI-67; INHIBITION; CARCINOMAS; PREDICTOR; MICRORNAS	Several studies suggest that mesenchymal stem cells (MSCs) possess antitumor properties; however, the exact mechanisms remain unclear. Recently, microvesicles (MVs) are considered as a novel avenue intercellular communication, which may be a mediator in MSCs-related antitumor effect. In the present study, we evaluated whether MVs derived from human umbilical cord Wharton's jelly mesenchymal stem cells (hWJMSCs) may inhibit bladder tumor T24 cells growth using cell culture and the BALB/c nu/nu mice xenograft model. CCK-8 assay and Ki-67 immunostaining were performed to estimate cell proliferation in vitro and in vivo. Flow cytometry and TUNEL assay were used to assess cell cycle and apoptosis. To study the conceivable mechanism by which hWJMSC-MVs attenuate bladder tumor T24 cells, we estimated the expression of Akt/p-Akt, p-p53, p21 and cleaved Caspase 3 by Western blot technique after exposing T24 cells to hWJMSC-MVs for 24, 48 and 72h. Our data indicated that hWJMSC-MVs can inhibit T24 cells proliferative viability via cell cycle arrest and induce apoptosis in T24 cells in vitro and in vivo. This study showed that hWJMSC-MVs down-regulated phosphorylation of Akt protein kinase and up-regulated cleaved Caspase 3 during the process of anti-proliferation and pro-apoptosis in T24 cells. These results demonstrate that hWJMSC-MVs play a vital role in hWJMSC-induced antitumor effect and may be a novel tool for cancer therapy as a new mechanism of cell-to-cell communication.	[Wu, Shuai; Ju, Guan-Qun; Du, Tao; Zhu, Ying-Jian; Liu, Guo-Hua] Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 1, Dept Urol, Shanghai 200030, Peoples R China; [Wu, Shuai] Qingdao Municipal Hosp, Dept Urol, Qingdao, Shandong, Peoples R China	Shanghai Jiao Tong University; Qingdao Municipal Hospital	Zhu, YJ (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 1, Dept Urol, Shanghai 200030, Peoples R China.	zhuyingjian72_sjtu@126.com; liuguohua_sjtu@163.com			Research Program of Science and Technology Commission of Shanghai Municipality [10411967200]; Shanghai Song-Jiang Health Bureau [2011PD06]; National Natural Science Foundation of China [81170642]; Shanghai Shen Kang Plat-Form Grant [SHDC12007206]	Research Program of Science and Technology Commission of Shanghai Municipality; Shanghai Song-Jiang Health Bureau; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Shen Kang Plat-Form Grant	This study is supported by grants from the Research Program of Science and Technology Commission of Shanghai Municipality (10411967200) and Shanghai Song-Jiang Health Bureau (2011PD06) and National Natural Science Foundation of China (81170642) and Shanghai Shen Kang Plat-Form Grant (SHDC12007206). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Nedawi K, 2009, CELL CYCLE, V8, P2014, DOI 10.4161/cc.8.13.8988; Ayuzawa R, 2009, CANCER LETT, V280, P31, DOI 10.1016/j.canlet.2009.02.011; Bernardo ME, 2007, CANCER RES, V67, P9142, DOI 10.1158/0008-5472.CAN-06-4690; Bouffi C, 2009, RHEUMATOLOGY, V48, P1185, DOI 10.1093/rheumatology/kep162; Bruno S, 2009, J AM SOC NEPHROL, V20, P1053, DOI 10.1681/ASN.2008070798; Camussi G, 2011, AM J CANCER RES, V1, P98; Castellana D, 2010, THROMB RES, V125, pS84, DOI 10.1016/S0049-3848(10)70021-9; Chen X, 2012, TRENDS CELL BIOL; Cocucci E, 2009, TRENDS CELL BIOL, V19, P43, DOI 10.1016/j.tcb.2008.11.003; Collino F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011803; Conde-Vancells J, 2008, J PROTEOME RES, V7, P5157, DOI 10.1021/pr8004887; Deregibus MC, 2007, BLOOD, V110, P2440, DOI 10.1182/blood-2007-03-078709; Djouad F, 2003, BLOOD, V102, P3837, DOI 10.1182/blood-2003-04-1193; Endl E, 2000, EXP CELL RES, V257, P231, DOI 10.1006/excr.2000.4888; Fonsato V, 2012, STEM CELLS, V30, P1985, DOI 10.1002/stem.1161; Frankel LB, 2008, J BIOL CHEM, V283, P1026, DOI 10.1074/jbc.M707224200; Ganta C, 2009, CANCER RES, V69, P1815, DOI 10.1158/0008-5472.CAN-08-2750; Gatti S, 2011, NEPHROL DIAL TRANSPL, V26, P1474, DOI 10.1093/ndt/gfr015; Gauthaman K, 2012, J CELL BIOCHEM, V113, P2027, DOI 10.1002/jcb.24073; Gerdes J, 1990, Semin Cancer Biol, V1, P199; GERDES J, 1984, J IMMUNOL, V133, P1710; GERDES J, 1983, INT J CANCER, V31, P13, DOI 10.1002/ijc.2910310104; He J, 2012, NEPHROLOGY CARLTON; Hossain A, 2006, MOL CELL BIOL, V26, P8191, DOI 10.1128/MCB.00242-06; Kang SG, 2008, CHILD NERV SYST, V24, P293, DOI 10.1007/s00381-007-0515-2; Khakoo AY, 2006, J EXP MED, V203, P1235, DOI 10.1084/jem.20051921; Kim JW, 2005, CLIN CANCER RES, V11, P1010; Klopp AH, 2011, STEM CELLS, V29, P11, DOI 10.1002/stem.559; Li L, 2011, J CELL PHYSIOL, V226, P1860, DOI 10.1002/jcp.22511; Li L, 2011, ACTA BIOCH BIOPH SIN, V43, P143, DOI 10.1093/abbs/gmq118; Lim PK, 2011, CANCER RES, V71, P1550, DOI 10.1158/0008-5472.CAN-10-2372; Lu LL, 2006, HAEMATOLOGICA, V91, P1017; Lu YR, 2008, CANCER BIOL THER, V7, P245, DOI 10.4161/cbt.7.2.5296; Majore I, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-6; Margulis V, 2006, CLIN CANCER RES, V12, P7369, DOI 10.1158/1078-0432.CCR-06-1472; Mathivanan S, 2010, J PROTEOMICS, V73, P1907, DOI 10.1016/j.jprot.2010.06.006; Muralidharan-Chari V, 2010, J CELL SCI, V123, P1603, DOI 10.1242/jcs.064386; O'Day E, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2484; Otsu K, 2009, BLOOD, V113, P4197, DOI 10.1182/blood-2008-09-176198; Pap E, 2011, ADV EXP MED BIOL, V714, P183, DOI 10.1007/978-94-007-0782-5_10; Polgar J, 2005, J THROMB HAEMOST, V3, P1590, DOI 10.1111/j.1538-7836.2005.01373.x; Quesenberry PJ, 2010, EXP HEMATOL, V38, P581, DOI 10.1016/j.exphem.2010.03.021; Ramachandran S, 2012, WIRES RNA, V3, P286, DOI 10.1002/wrna.115; Ratajczak J, 2006, LEUKEMIA, V20, P1487, DOI 10.1038/sj.leu.2404296; Ratajczak J, 2006, LEUKEMIA, V20, P847, DOI 10.1038/sj.leu.2404132; Rosland GV, 2009, CANCER RES, V69, P5331, DOI 10.1158/0008-5472.CAN-08-4630; Rubio D, 2008, EXP CELL RES, V314, P691, DOI 10.1016/j.yexcr.2007.11.017; Sarkar A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007140; Secchiero P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011140; Simons M, 2009, CURR OPIN CELL BIOL, V21, P575, DOI 10.1016/j.ceb.2009.03.007; Spaeth EL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004992; Stepan A, 2011, ROM J MORPHOL EMBRYO, V52, P653; Sugino T, 2011, MED MOL MORPHOL, V44, P146, DOI 10.1007/s00795-010-0517-0; TOMAYKO MM, 1989, CANCER CHEMOTH PHARM, V24, P148, DOI 10.1007/BF00300234; Torsvik A, 2012, CANC TREATMENT REV; Tsai KS, 2011, GASTROENTEROLOGY, V141, P1046, DOI 10.1053/j.gastro.2011.05.045; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; WANG Y, 1995, NATURE, V376, P88, DOI 10.1038/376088a0; Yu ZR, 2008, J CELL BIOL, V182, P509, DOI 10.1083/jcb.200801079; Zhu SM, 2008, CELL RES, V18, P350, DOI 10.1038/cr.2008.24; Zhu W, 2011, CELL CYCLE, V10, DOI 10.4161/cc.10.18.17638; Zhu W, 2012, CANCER LETT, V315, P28, DOI 10.1016/j.canlet.2011.10.002	62	93	108	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2013	8	4							e61366	10.1371/journal.pone.0061366	http://dx.doi.org/10.1371/journal.pone.0061366			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123JP	23593475	Green Submitted, Green Published, gold			2022-12-25	WOS:000317385300074
J	Yu, Y; Li, Y; Wang, W; Jin, MH; Du, ZJ; Li, YB; Duan, JC; Yu, YB; Sun, ZW				Yu, Yang; Li, Yang; Wang, Wen; Jin, Minghua; Du, Zhongjun; Li, Yanbo; Duan, Junchao; Yu, Yongbo; Sun, Zhiwei			Acute Toxicity of Amorphous Silica Nanoparticles in Intravenously Exposed ICR Mice	PLOS ONE			English	Article							SIZE-DEPENDENT CYTOTOXICITY; OXIDATIVE STRESS; EXTRAMEDULLARY HEMATOPOIESIS; INTRATRACHEAL INSTILLATION; SIO2 NANOPARTICLES; CARBON NANOTUBES; IN-VITRO; CELLS; RATS; PARTICLES	This study aimed to evaluate the acute toxicity of intravenously administrated amorphous silica nanoparticles (SNPs) in mice. The lethal dose, 50 (LD50), of intravenously administrated SNPs was calculated in mice using Dixon's up-and-down method (262.45 +/- 33.78 mg/kg). The acute toxicity was evaluated at 14 d after intravenous injection of SNPs at 29.5, 103.5 and 177.5 mg/kg in mice. A silicon content analysis using ICP-OES found that SNPs mainly distributed in the resident macrophages of the liver (10.24% ID/g), spleen (34.78% ID/g) and lung (1.96% ID/g). TEM imaging showed only a small amount in the hepatocytes of the liver and in the capillary endothelial cells of the lung and kidney. The levels of serum LDH, AST and ALT were all elevated in the SNP treated groups. A histological examination showed lymphocytic infiltration, granuloma formation, and hydropic degeneration in liver hepatocytes; megakaryocyte hyperplasia in the spleen; and pneumonemia and pulmonary interstitial thickening in the lung of the SNP treated groups. A CD68 immunohistochemistry stain indicated SNPs induced macrophage proliferation in the liver and spleen. The results suggest injuries induced by the SNPs in the liver, spleen and lungs. Mononuclear phagocytic cells played an important role in the injury process.	[Yu, Yang; Li, Yanbo; Duan, Junchao; Yu, Yongbo; Sun, Zhiwei] Capital Med Univ, Sch Publ Hlth, Beijing, Peoples R China; [Li, Yang; Wang, Wen; Jin, Minghua; Du, Zhongjun; Sun, Zhiwei] Jilin Univ, Sch Publ Hlth, Changchun 130023, Jilin, Peoples R China	Capital Medical University; Jilin University	Sun, ZW (corresponding author), Capital Med Univ, Sch Publ Hlth, Beijing, Peoples R China.	zwsun@ccmu.edu.cn	Yu, Yongbo/AAE-9353-2019		National Natural Science Foundation of China [81230065, 81172704]; Funding Project for Academic Human Resources Development of Beijing Education Committee [PHR201006110]; Innovative Team Project of Beijing Education Committee [PHR201107116]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Funding Project for Academic Human Resources Development of Beijing Education Committee; Innovative Team Project of Beijing Education Committee	This work was supported by National Natural Science Foundation of China (No. 81230065, No. 81172704), http://www.nsfc.gov.cn/Portal0/default152.htm; Funding Project for Academic Human Resources Development of Beijing Education Committee (PHR201006110) and Innovative Team Project of Beijing Education Committee (PHR201107116), http://www.bjedu.gov.cn/publish/portal0/tab40/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arts JHE, 2008, INHAL TOXICOL, V20, P935, DOI [10.1080/08958370802105371, 10.1080/08958370802105371 ]; Chekman I S, 2008, Lik Sprava, P104; Chen M, 2005, EXP CELL RES, V305, P51, DOI 10.1016/j.yexcr.2004.12.021; Cho MJ, 2009, TOXICOL LETT, V189, P177, DOI 10.1016/j.toxlet.2009.04.017; Cho WS, 2007, TOXICOL LETT, V175, P24, DOI 10.1016/j.toxlet.2007.09.008; Cosgrove BD, 2008, HEPATOLOGY, V48, P276, DOI 10.1002/hep.22335; DIXON WJ, 1965, J AM STAT ASSOC, V60, P967, DOI 10.2307/2283398; Eom HJ, 2009, TOXICOL IN VITRO, V23, P1326, DOI 10.1016/j.tiv.2009.07.010; Gluhcheva Y, 2012, J TOXICOL ENV HEAL A, V75, P1418, DOI 10.1080/15287394.2012.721176; Hiller DB, 2010, REGION ANESTH PAIN M, V35, P140, DOI 10.1097/AAP.0b013e3181c6f5aa; Iqbal MP, 2012, BMC CARDIOVASC DISOR, V12, DOI 10.1186/1471-2261-12-94; Koch CA, 2003, MAYO CLIN PROC, V78, P1223, DOI 10.4065/78.10.1223; Kwon JT, 2009, J OCCUP HEALTH, V51, P423, DOI 10.1539/joh.L8159; Lam CW, 2004, TOXICOL SCI, V77, P126, DOI 10.1093/toxsci/kfg243; Li Y, 2011, TOXICOL IN VITRO, V25, P1343, DOI 10.1016/j.tiv.2011.05.003; Liu TL, 2012, BIOMATERIALS, V33, P2399, DOI 10.1016/j.biomaterials.2011.12.008; Liu TL, 2011, BIOMATERIALS, V32, P1657, DOI 10.1016/j.biomaterials.2010.10.035; MOVAT HZ, 1965, J CELL BIOL, V27, P531, DOI 10.1083/jcb.27.3.531; Nabeshi H, 2012, NANOTECHNOLOGY, V23, DOI 10.1088/0957-4484/23/4/045101; Napierska D, 2010, PART FIBRE TOXICOL, V7, DOI 10.1186/1743-8977-7-39; Napierska D, 2009, SMALL, V5, P846, DOI 10.1002/smll.200800461; Nel A, 2006, SCIENCE, V311, P622, DOI 10.1126/science.1114397; Nishimori H, 2009, EUR J PHARM BIOPHARM, V72, P626, DOI 10.1016/j.ejpb.2009.03.007; Nishimori H, 2009, EUR J PHARM BIOPHARM, V72, P496, DOI 10.1016/j.ejpb.2009.02.005; Osmond-McLeod MJ, 2011, PART FIBRE TOXICOL, V8, DOI 10.1186/1743-8977-8-15; Park EJ, 2009, TOXICOL LETT, V184, P18, DOI 10.1016/j.toxlet.2008.10.012; Sayes CM, 2010, INHAL TOXICOL, V22, P348, DOI 10.3109/08958370903359992; Shi YL, 2010, J TOXICOL ENV HEAL A, V73, P748, DOI 10.1080/15287391003614042; Sohaebuddin SK, 2010, PART FIBRE TOXICOL, V7, DOI 10.1186/1743-8977-7-22; Sun L, 2011, TOXICOL IN VITRO, V25, P1619, DOI 10.1016/j.tiv.2011.06.012; Tseng MT, 2012, TOXICOL APPL PHARM, V260, P173, DOI 10.1016/j.taap.2012.02.008; Xie GP, 2010, ARCH TOXICOL, V84, P183, DOI 10.1007/s00204-009-0488-x; Yang XF, 2010, PART FIBRE TOXICOL, V7, DOI 10.1186/1743-8977-7-1; YARRINGTON JT, 1992, FUND APPL TOXICOL, V18, P247, DOI 10.1016/0272-0590(92)90053-K; Ye YY, 2010, TOXICOL IN VITRO, V24, P751, DOI 10.1016/j.tiv.2010.01.001	35	106	114	0	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2013	8	4							e61346	10.1371/journal.pone.0061346	http://dx.doi.org/10.1371/journal.pone.0061346			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123JP	23593469	Green Published, Green Submitted, gold			2022-12-25	WOS:000317385300072
J	Leelaram, MN; Bhat, AG; Godbole, AA; Bhat, RS; Manjunath, R; Nagaraja, V				Leelaram, Majety Naga; Bhat, Anuradha Gopal; Godbole, Adwait Anand; Bhat, Rajeshwari Subray; Manjunath, Ramanathapuram; Nagaraja, Valakunja			Type IA topoisomerase inhibition by clamp closure	FASEB JOURNAL			English	Article						DNA cleavage-religation; enzyme-DNA heterocatenane; monoclonal antibody; mycobacteria	MYCOBACTERIAL DNA GYRASE; MONOCLONAL-ANTIBODY; SMEGMATIS; ENZYME; MECHANISM; CLEAVAGE; TUBERCULOSIS; SEQUENCE; POISONS; BINDING	Bacterial DNA topoisomerase I (topoI) catalyzes relaxation of negatively supercoiled DNA. The enzyme alters DNA topology through protein-operated DNA gate, switching between open and closed conformations during its reaction. We describe the mechanism of inhibition of Mycobacterium smegmatis and Mycobacterium tuberculosis topoI by monoclonal antibodies (mAbs) that bind with high affinity and inhibit at 10-50 nM concentration. Unlike other inhibitors of topoisomerases, the mAbs inhibited several steps of relaxation reaction, namely DNA binding, cleavage, strand passage, and enzyme-DNA dissociation. The enhanced religation of the cleaved DNA in presence of the mAb indicated closing of the enzyme DNA gate. The formation of enzyme-DNA heterocatenane in the presence of the mAbs as a result of closing the gate could be inferred by the salt resistance of the complex, visualized by atomic force microscopy and confirmed by fluorescence measurements. Locking the enzyme-DNA complex as a closed clamp restricted the movements of the DNA gate, affecting all of the major steps of the relaxation reaction. Enzyme trapped on DNA in closed clamp conformation formed roadblock for the elongating DNA polymerase. The unusual multistep inhibition of mycobacterial topoisomerases may facilitate lead molecule development, and the mAbs would also serve as valuable tools to probe the enzyme mechanism.	[Leelaram, Majety Naga; Bhat, Anuradha Gopal; Godbole, Adwait Anand; Bhat, Rajeshwari Subray; Nagaraja, Valakunja] Indian Inst Sci, Dept Microbiol & Cell Biol, Bangalore 560012, Karnataka, India; [Manjunath, Ramanathapuram] Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India; [Nagaraja, Valakunja] Indian Inst Sci, Jawaharlal Nehru Ctr Adv Sci Res, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore; Indian Institute of Science (IISC) - Bangalore; Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR); Indian Institute of Science (IISC) - Bangalore	Nagaraja, V (corresponding author), Indian Inst Sci, Dept Microbiol & Cell Biol, Bangalore 560012, Karnataka, India.	vraj@mcbl.iisc.ernet.in	Godbole, Adwait/AAM-5736-2021; Godbole, Adwait/V-5526-2018	Majety, Naga Leelaram/0000-0003-2884-4654	Centre of Excellence from the Department of Biotechnology, Government of India	Centre of Excellence from the Department of Biotechnology, Government of India	The authors thank H. K. Majumder (Indian Institute of Chemical Biology) for the kinetoplast DNA; S. Chatterjee and T. K. Kundu (Jawaharlal Nehru Centre for Advanced Scientific Research, Bangalore, India) for atomic force microscopy; the Molecular Biophysics Unit, of the Indian Institute of Science for fluorescence spectrometery; and N. S. Srilatha for surface plasmon resonance spectroscopy. P. Tare is acknowledged for primer extension experiments and T. Bhowmick for discussions. Technical assistance was provided by S. M. Hegde and B. Mallick. Members of the V.N. laboratory are thanked for the reagents, discussions, and critical reading of the manuscript. This work is supported by Centre of Excellence grant in tuberculosis research (to V.N.) from the Department of Biotechnology, Government of India. V. N. is a J. C. Bose Fellow of Department of Science and Technology, Government of India.	BERNARD P, 1993, J MOL BIOL, V234, P534, DOI 10.1006/jmbi.1993.1609; Bhaduri T, 1998, NUCLEIC ACIDS RES, V26, P1668, DOI 10.1093/nar/26.7.1668; Bhaduri T, 1998, J BIOL CHEM, V273, P13925, DOI 10.1074/jbc.273.22.13925; Bhat AG, 2009, J MOL BIOL, V393, P788, DOI 10.1016/j.jmb.2009.08.064; BROWN PO, 1981, P NATL ACAD SCI-BIOL, V78, P843, DOI 10.1073/pnas.78.2.843; BROWN PO, 1979, SCIENCE, V206, P1081, DOI 10.1126/science.227059; CARROLL SB, 1982, P NATL ACAD SCI-BIOL, V79, P7233, DOI 10.1073/pnas.79.23.7233; Changela A, 2001, NATURE, V411, P1077, DOI 10.1038/35082615; Chen A Y, 1994, Adv Pharmacol, V29B, P245; CHEN AY, 1994, ANNU REV PHARMACOL, V34, P191, DOI 10.1146/annurev.pa.34.040194.001203; Cheng BK, 2007, J ANTIMICROB CHEMOTH, V59, P640, DOI 10.1093/jac/dkl556; Classen S, 2003, P NATL ACAD SCI USA, V100, P10629, DOI 10.1073/pnas.1832879100; Drlica K, 2008, ANTIMICROB AGENTS CH, V52, P385, DOI 10.1128/AAC.01617-06; Feinberg H, 1999, NAT STRUCT BIOL, V6, P918; FROELICHAMMON SJ, 1995, J BIOL CHEM, V270, P21429, DOI 10.1074/jbc.270.37.21429; Garnier T, 2003, P NATL ACAD SCI USA, V100, P7877, DOI 10.1073/pnas.1130426100; GELLERT M, 1981, ANNU REV BIOCHEM, V50, P879, DOI 10.1146/annurev.bi.50.070181.004311; Godbole AA, 2012, ARCH BIOCHEM BIOPHYS, V528, P197, DOI 10.1016/j.abb.2012.10.004; GUILHOT C, 1994, J BACTERIOL, V176, P535, DOI 10.1128/JB.176.2.535-539.1994; HOOPER DC, 1991, NEW ENGL J MED, V324, P384, DOI 10.1056/NEJM199102073240606; Jain P, 2006, J MOL BIOL, V357, P1409, DOI 10.1016/j.jmb.2006.01.079; Jensen LH, 2000, J BIOL CHEM, V275, P2137, DOI 10.1074/jbc.275.3.2137; Leelaram MN, 2012, FEBS J, V279, P55, DOI 10.1111/j.1742-4658.2011.08398.x; Leelaram MN, 2010, J IMMUNOL METHODS, V357, P26, DOI 10.1016/j.jim.2010.03.008; Leelaram MN, 2009, TUBERCULOSIS, V89, P256, DOI 10.1016/j.tube.2009.05.004; Li ZY, 2001, MOL CELL, V7, P301, DOI 10.1016/S1097-2765(01)00178-2; LIMA CD, 1994, NATURE, V367, P138, DOI 10.1038/367138a0; LIU LF, 1989, ANNU REV BIOCHEM, V58, P351, DOI 10.1146/annurev.bi.58.070189.002031; Manjunatha UH, 2005, NUCLEIC ACIDS RES, V33, P3085, DOI 10.1093/nar/gki622; Manjunatha UH, 2001, EUR J BIOCHEM, V268, P2038, DOI 10.1046/j.1432-1327.2001.02077.x; Mansoor SE, 2002, BIOCHEMISTRY-US, V41, P2475, DOI 10.1021/bi011198i; Mansoor SE, 2010, BIOCHEMISTRY-US, V49, P9722, DOI 10.1021/bi100907m; Maxwell A, 1997, TRENDS MICROBIOL, V5, P102, DOI 10.1016/S0966-842X(96)10085-8; MAXWELL A, 1993, MOL MICROBIOL, V9, P681, DOI 10.1111/j.1365-2958.1993.tb01728.x; Nagaraja V, 2002, CURR PHARM DESIGN, V8, P1995, DOI 10.2174/1381612023393567; Nitiss John L, 2002, Curr Opin Investig Drugs, V3, P1512; ORLOWSKI R, 1990, VIROLOGY, V176, P638, DOI 10.1016/0042-6822(90)90036-Q; Philipp WJ, 1996, P NATL ACAD SCI USA, V93, P3132, DOI 10.1073/pnas.93.7.3132; ROCA J, 1992, CELL, V71, P833, DOI 10.1016/0092-8674(92)90558-T; ROCA J, 1994, P NATL ACAD SCI USA, V91, P1781, DOI 10.1073/pnas.91.5.1781; Sassetti CM, 2003, P NATL ACAD SCI USA, V100, P12989, DOI 10.1073/pnas.2134250100; Sikder D, 2001, J MOL BIOL, V312, P347, DOI 10.1006/jmbi.2001.4942; Unniraman S, 2002, J BACTERIOL, V184, P5449, DOI 10.1128/JB.184.19.5449-5456.2002; VIZAN JL, 1991, EMBO J, V10, P467, DOI 10.1002/j.1460-2075.1991.tb07969.x; Xiao H, 2003, P NATL ACAD SCI USA, V100, P3239, DOI 10.1073/pnas.0736401100	45	16	16	1	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2013	27	8					3030	3038		10.1096/fj.12-226118	http://dx.doi.org/10.1096/fj.12-226118			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	292BT	23612788				2022-12-25	WOS:000329877600011
J	Gillis, J; Schipper-Krom, S; Juenemann, K; Gruber, A; Coolen, S; van den Nieuwendijk, R; van Veen, H; Overkleeft, H; Goedhart, J; Kampinga, HH; Reits, EA				Gillis, Judith; Schipper-Krom, Sabine; Juenemann, Katrin; Gruber, Anna; Coolen, Silvia; van den Nieuwendijk, Rian; van Veen, Henk; Overkleeft, Hermen; Goedhart, Joachim; Kampinga, Harm H.; Reits, Eric A.			The DNAJB6 and DNAJB8 Protein Chaperones Prevent Intracellular Aggregation of Polyglutamine Peptides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIFETIME IMAGING MICROSCOPY; BULBAR MUSCULAR-ATROPHY; HEAT-SHOCK PROTEINS; EXPANDED POLYGLUTAMINE; MOLECULAR CHAPERONES; ANDROGEN RECEPTOR; PROTEOLYTIC CLEAVAGE; NUCLEAR INCLUSIONS; MUTANT HUNTINGTIN; MAMMALIAN-CELLS	Fragments of proteins containing an expanded polyglutamine (polyQ) tract are thought to initiate aggregation and toxicity in at least nine neurodegenerative diseases, including Huntington's disease. Because proteasomes appear unable to digest the polyQ tract, which can initiate intracellular protein aggregation, preventing polyQ peptide aggregation by chaperones should greatly improve polyQ clearance and prevent aggregate formation. Here we expressed polyQ peptides in cells and show that their intracellular aggregation is prevented by DNAJB6 and DNAJB8, members of the DNAJ (Hsp40) chaperone family. In contrast, HSPA/Hsp70 and DNAJB1, also members of the DNAJ chaperone family, did not prevent peptide-initiated aggregation. Intriguingly, DNAJB6 and DNAJB8 also affected the soluble levels of polyQ peptides, indicating that DNAJB6 and DNAJB8 inhibit polyQ peptide aggregation directly. Together with recent data showing that purified DNAJB6 can suppress fibrillation of polyQ peptides far more efficiently than polyQ expanded protein fragments in vitro, we conclude that the mechanism of DNAJB6 and DNAJB8 is suppression of polyQ protein aggregation by directly binding the polyQ tract.	[Gillis, Judith; Schipper-Krom, Sabine; Juenemann, Katrin; Gruber, Anna; Coolen, Silvia; van Veen, Henk; Reits, Eric A.] Univ Amsterdam, Acad Med Ctr, Dept Cell Biol & Histol, NL-1105 AZ Amsterdam, Netherlands; [van den Nieuwendijk, Rian; Overkleeft, Hermen] Leiden Univ, Dept Bioorgan Synth, NL-2333 CC Leiden, Netherlands; [Goedhart, Joachim] Leiden Univ, Swammerdam Inst Life Sci, NL-1090 GE Leiden, Netherlands; [Kampinga, Harm H.] Univ Med Ctr Groningen, Dept Cell Biol, NL-9713 AV Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University - Excl LUMC; University of Groningen	Reits, EA (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Cell Biol & Histol, Meibergdreef 15, NL-1105 AZ Amsterdam, Netherlands.	e.a.reits@amc.uva.nl	Coolen, Silvia/ABD-4352-2020	Coolen, Silvia/0000-0003-1902-5227; Goedhart, Joachim/0000-0002-0630-3825; Kampinga, Harm/0000-0002-8966-8466; Overkleeft, Herman/0000-0001-6976-7005	VENI Grant [91646038]; VIDI Grant from NWO-Zon-MW [91796315]; Hersenstichting; Agentschap.nl Grant [IOP IGE07004]	VENI Grant; VIDI Grant from NWO-Zon-MW; Hersenstichting; Agentschap.nl Grant	This work was supported by VENI Grant 91646038 and VIDI Grant 91796315 from NWO-Zon-MW and by a grant from the Hersenstichting (to E. R.), and by Agentschap.nl Grant IOP IGE07004 (to H. H. K.).	Bailey CK, 2002, HUM MOL GENET, V11, P515, DOI 10.1093/hmg/11.5.515; Carra S, 2008, J BIOL CHEM, V283, P1437, DOI 10.1074/jbc.M706304200; Chai YH, 2002, P NATL ACAD SCI USA, V99, P9310, DOI 10.1073/pnas.152101299; Chai YH, 1999, HUM MOL GENET, V8, P673, DOI 10.1093/hmg/8.4.673; Chuang JZ, 2002, J BIOL CHEM, V277, P19831, DOI 10.1074/jbc.M109613200; Cooper JK, 1998, HUM MOL GENET, V7, P783, DOI 10.1093/hmg/7.5.783; Cummings CJ, 1998, NAT GENET, V19, P148, DOI 10.1038/502; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Durrenberger PF, 2009, J NEUROSCI RES, V87, P238, DOI 10.1002/jnr.21819; Ellerby LM, 1999, J NEUROCHEM, V72, P185, DOI 10.1046/j.1471-4159.1999.0720185.x; Esser C, 2004, BBA-MOL CELL RES, V1695, P171, DOI 10.1016/j.bbamcr.2004.09.020; Fink AL, 1999, PHYSIOL REV, V79, P425, DOI 10.1152/physrev.1999.79.2.425; Goti D, 2004, J NEUROSCI, V24, P10266, DOI 10.1523/JNEUROSCI.2734-04.2004; Graham RK, 2006, CELL, V125, P1179, DOI 10.1016/j.cell.2006.04.026; Haacke A, 2006, HUM MOL GENET, V15, P555, DOI 10.1093/hmg/ddi472; Hageman J, 2010, MOL CELL, V37, P355, DOI 10.1016/j.molcel.2010.01.001; Hageman J, 2009, CELL STRESS CHAPERON, V14, P1, DOI 10.1007/s12192-008-0060-2; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Holmberg CI, 2004, EMBO J, V23, P4307, DOI 10.1038/sj.emboj.7600426; Ikeda H, 1996, NAT GENET, V13, P196, DOI 10.1038/ng0696-196; Iwata A, 2009, J BIOL CHEM, V284, P9796, DOI 10.1074/jbc.M809739200; Jana NR, 2005, J BIOL CHEM, V280, P11635, DOI 10.1074/jbc.M412042200; JOHNSON ES, 1995, J BIOL CHEM, V270, P17442, DOI 10.1074/jbc.270.29.17442; Kampinga HH, 2010, NAT REV MOL CELL BIO, V11, P579, DOI 10.1038/nrm2941; KAMPINGA HH, 1993, J CELL SCI, V104, P11; Kazantsev A, 1999, P NATL ACAD SCI USA, V96, P11404, DOI 10.1073/pnas.96.20.11404; Kim S, 2002, NAT CELL BIOL, V4, P826, DOI 10.1038/ncb863; LIBEREK K, 1991, P NATL ACAD SCI USA, V88, P2874, DOI 10.1073/pnas.88.7.2874; Lippincott-Schwartz J, 2001, NAT REV MOL CELL BIO, V2, P444, DOI 10.1038/35073068; Lunkes A, 2002, MOL CELL, V10, P259, DOI 10.1016/S1097-2765(02)00602-0; Marsh JL, 2000, HUM MOL GENET, V9, P13, DOI 10.1093/hmg/9.1.13; Martin BR, 2005, NAT BIOTECHNOL, V23, P1308, DOI 10.1038/nbt1136; Matsumoto G, 2006, J BIOL CHEM, V281, P4477, DOI 10.1074/jbc.M509201200; Merry DE, 1998, HUM MOL GENET, V7, P693, DOI 10.1093/hmg/7.4.693; Miyawaki A, 2003, DEV CELL, V4, P295, DOI 10.1016/S1534-5807(03)00060-1; Nollen EAA, 1999, MOL CELL BIOL, V19, P2069; Orr HT, 2007, ANNU REV NEUROSCI, V30, P575, DOI 10.1146/annurev.neuro.29.051605.113042; Qiu XB, 2006, CELL MOL LIFE SCI, V63, P2560, DOI 10.1007/s00018-006-6192-6; Raspe M, 2009, J CELL SCI, V122, P3262, DOI 10.1242/jcs.045567; Reits E, 2003, IMMUNITY, V18, P97, DOI 10.1016/S1074-7613(02)00511-3; Reits EAJ, 2001, NAT CELL BIOL, V3, pE145, DOI 10.1038/35078615; Rousseau E, 2009, J BIOL CHEM, V284, P1917, DOI 10.1074/jbc.M806256200; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; Stenoien DL, 1999, HUM MOL GENET, V8, P731, DOI 10.1093/hmg/8.5.731; Suhr ST, 2001, J CELL BIOL, V153, P283, DOI 10.1083/jcb.153.2.283; Tsai J, 1996, J BIOL CHEM, V271, P9347, DOI 10.1074/jbc.271.16.9347; van Munster EB, 2005, ADV BIOCHEM ENG BIOT, V95, P143; Van Munster EB, 2004, J MICROSC-OXFORD, V213, P29, DOI 10.1111/j.1365-2818.2004.01249.x; van Munster EB, 2004, CYTOM PART A, V58A, P185, DOI 10.1002/cyto.a.20013; Venkatraman P, 2004, MOL CELL, V14, P95, DOI 10.1016/S1097-2765(04)00151-0; Vos MJ, 2008, BIOCHEMISTRY-US, V47, P7001, DOI 10.1021/bi800639z; Wanker EE, 1999, METHOD ENZYMOL, V309, P375; Wilburn B, NEURON, V70, P427; Wyttenbach A, 2000, P NATL ACAD SCI USA, V97, P2898, DOI 10.1073/pnas.97.6.2898; Young JE, 2007, J BIOL CHEM, V282, P30150, DOI 10.1074/jbc.M705265200	55	83	85	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2013	288	24					17225	17237		10.1074/jbc.M112.421685	http://dx.doi.org/10.1074/jbc.M112.421685			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	164AH	23612975	Green Published, hybrid			2022-12-25	WOS:000320380600019
J	Ramanagoudr-Bhojappa, R; Chib, S; Byrd, AK; Aarattuthodiyil, S; Pandey, M; Patel, SS; Raney, KD				Ramanagoudr-Bhojappa, Ramanagouda; Chib, Shubeena; Byrd, Alicia K.; Aarattuthodiyil, Suja; Pandey, Manjula; Patel, Smita S.; Raney, Kevin D.			Yeast Pif1 Helicase Exhibits a One-base-pair Stepping Mechanism for Unwinding Duplex DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-STRANDED-DNA; REPLICATION FORK PROGRESSION; SACCHAROMYCES-CEREVISIAE; MITOCHONDRIAL-DNA; FUNCTIONAL INTERACTION; TURNOVER KINETICS; BINDING-PROTEIN; PCRA HELICASE; TRANSLOCATION; PROCESSIVITY	Kinetic analysis of the DNA unwinding and translocation activities of helicases is necessary for characterization of the biochemical mechanism(s) for this class of enzymes. Saccharomyces cerevisiae Pif1 helicase was characterized using presteady state kinetics to determine rates of DNA unwinding, displacement of streptavidin from biotinylated DNA, translocation on single-stranded DNA (ssDNA), and ATP hydrolysis activities. Unwinding of substrates containing varying duplex lengths was fit globally to a model for stepwise unwinding and resulted in an unwinding rate of similar to 75 bp/s and a kinetic step size of 1 base pair. Pif1 is capable of displacing streptavidin from biotinylated oligonucleotides with a linear increase in the rates as the length of the oligonucleotides increased. The rate of translocation on ssDNA was determined by measuring dissociation from varying lengths of ssDNA and is essentially the same as the rate of unwinding of dsDNA, making Pif1 an active helicase. The ATPase activity of Pif1 on ssDNA was determined using fluorescently labeled phosphate-binding protein to measure the rate of phosphate release. The quantity of phosphate released corresponds to a chemical efficiency of 0.84 ATP/nucleotides translocated. Hence, when all of the kinetic data are considered, Pif1 appears to move along DNA in single nucleotide or base pair steps, powered by hydrolysis of 1 molecule of ATP.	[Ramanagoudr-Bhojappa, Ramanagouda; Chib, Shubeena; Byrd, Alicia K.; Aarattuthodiyil, Suja; Raney, Kevin D.] Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Little Rock, AR 72205 USA; [Pandey, Manjula; Patel, Smita S.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem & Mol Biol, Piscataway, NJ 08854 USA	University of Arkansas System; University of Arkansas Medical Sciences; Rutgers State University New Brunswick; Rutgers State University Medical Center	Raney, KD (corresponding author), 4301 W Markham St,Slot 516, Little Rock, AR 72205 USA.	raneykevind@uams.edu	Aarattuthodiyil, Suja/W-2167-2019; Ramanagoudr Bhojappa, Ramanagouda/ABG-3444-2021	Ramanagoudr Bhojappa, Ramanagouda/0000-0002-3122-3827; Byrd, Alicia/0000-0001-5484-0759	National Institutes of Health [R01 GM098922]; Translational Research Institute (TRI) [UL1TR000039]; NIH National Center for Research Resources (NCRR); National Center for Advancing Translational Sciences (NCATS);  [GM51966]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000039] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051966, R01GM098922, R37GM051966] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Translational Research Institute (TRI); NIH National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Advancing Translational Sciences (NCATS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); ; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM098922 (to K. D. R.), Translational Research Institute (TRI) grant UL1TR000039 through the NIH National Center for Research Resources (NCRR) and National Center for Advancing Translational Sciences (NCATS), and GM51966 (to S. S. P.).	Ali JA, 1997, SCIENCE, V275, P377, DOI 10.1126/science.275.5298.377; Barranco-Medina S, 2010, BIOCHEMISTRY-US, V49, P8445, DOI 10.1021/bi100984j; Bochman ML, 2010, DNA REPAIR, V9, P237, DOI 10.1016/j.dnarep.2010.01.008; Boule JB, 2005, NATURE, V438, P57, DOI 10.1038/nature04091; Boule JB, 2007, NUCLEIC ACIDS RES, V35, P5809, DOI 10.1093/nar/gkm613; BRUNE M, 1994, BIOCHEMISTRY-US, V33, P8262, DOI 10.1021/bi00193a013; Budd ME, 2006, MOL CELL BIOL, V26, P2490, DOI 10.1128/MCB.26.7.2490-2500.2006; Byrd AK, 2004, NAT STRUCT MOL BIOL, V11, P531, DOI 10.1038/nsmb774; Byrd AK, 2012, J MOL BIOL, V420, P141, DOI 10.1016/j.jmb.2012.04.007; Cheng X, 2007, MITOCHONDRION, V7, P211, DOI 10.1016/j.mito.2006.11.023; Cheng X, 2010, EUR J CELL BIOL, V89, P742, DOI 10.1016/j.ejcb.2010.06.008; Dhakal S, 2013, NUCLEIC ACIDS RES, V41, P3915, DOI 10.1093/nar/gkt038; Dillingham MS, 2000, BIOCHEMISTRY-US, V39, P205, DOI 10.1021/bi992105o; Eoff RL, 2006, NAT STRUCT MOL BIOL, V13, P242, DOI 10.1038/nsmb1055; Eoff RL, 2010, BIOCHEMISTRY-US, V49, P4543, DOI 10.1021/bi100061v; Fairman-Williams ME, 2010, CURR OPIN STRUC BIOL, V20, P313, DOI 10.1016/j.sbi.2010.03.011; FOURY F, 1983, P NATL ACAD SCI-BIOL, V80, P5345, DOI 10.1073/pnas.80.17.5345; FOURY F, 1985, EMBO J, V4, P3525, DOI 10.1002/j.1460-2075.1985.tb04112.x; Galletto R, 2013, NUCLEIC ACIDS RES, V41, P4613, DOI 10.1093/nar/gkt117; He XP, 2012, STRUCTURE, V20, P1189, DOI 10.1016/j.str.2012.04.013; Ivessa AS, 2000, CELL, V100, P479, DOI 10.1016/S0092-8674(00)80683-2; Ivessa AS, 2003, MOL CELL, V12, P1525, DOI 10.1016/S1097-2765(03)00456-8; Ivessa AS, 2002, GENE DEV, V16, P1383, DOI 10.1101/gad.982902; Johnson KA, 2009, METHOD ENZYMOL, V467, P601, DOI 10.1016/S0076-6879(09)67023-3; LAHAYE A, 1993, J BIOL CHEM, V268, P26155; Lane AN, 2008, NUCLEIC ACIDS RES, V36, P5482, DOI 10.1093/nar/gkn517; Lee JY, 2006, CELL, V127, P1349, DOI 10.1016/j.cell.2006.10.049; Levin MK, 2004, J BIOL CHEM, V279, P26005, DOI 10.1074/jbc.M403257200; Lohman TM, 1996, ANNU REV BIOCHEM, V65, P169, DOI 10.1146/annurev.bi.65.070196.001125; Lucius AL, 2004, J MOL BIOL, V339, P731, DOI 10.1016/j.jmb.2004.04.009; Lucius AL, 2003, BIOPHYS J, V85, P2224, DOI 10.1016/S0006-3495(03)74648-7; Lucius AL, 2002, J MOL BIOL, V324, P409, DOI 10.1016/S0022-2836(02)01067-7; Manosas M, 2010, NUCLEIC ACIDS RES, V38, P5518, DOI 10.1093/nar/gkq273; Myung K, 2001, NATURE, V411, P1073, DOI 10.1038/35082608; Noirot-Gros MF, 2002, MOL GENET GENOMICS, V267, P391, DOI 10.1007/s00438-002-0670-9; O'Rourke TW, 2002, MOL CELL BIOL, V22, P4086, DOI 10.1128/MCB.22.12.4086-4093.2002; Paeschke K, 2011, CELL, V145, P678, DOI 10.1016/j.cell.2011.04.015; Rad B, 2012, P NATL ACAD SCI USA, V109, P1443, DOI 10.1073/pnas.1119952109; Rajagopal V, 2010, J BIOL CHEM, V285, P17821, DOI 10.1074/jbc.M110.114785; Ramanagoudr-Bhojappa R, 2013, NUCLEIC ACIDS RES, V41, P1029, DOI 10.1093/nar/gks1088; Ribeyre C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000475; ROMAN LJ, 1992, J BIOL CHEM, V267, P4207; Rossi ML, 2008, J BIOL CHEM, V283, P27483, DOI 10.1074/jbc.M804550200; Saikrishnan K, 2009, CELL, V137, P849, DOI 10.1016/j.cell.2009.03.036; Salins LLE, 2004, SENSOR ACTUAT B-CHEM, V97, P81, DOI 10.1016/j.snb.2003.07.019; Sarlos K, 2012, P NATL ACAD SCI USA, V109, P9804, DOI 10.1073/pnas.1114468109; SCHULZ VP, 1994, CELL, V76, P145, DOI 10.1016/0092-8674(94)90179-1; Sikora B, 2006, J BIOL CHEM, V281, P36110, DOI 10.1074/jbc.M604412200; Soultanas P, 1999, NUCLEIC ACIDS RES, V27, P1421, DOI 10.1093/nar/27.6.1421; Tackett AJ, 2001, BIOCHEMISTRY-US, V40, P543, DOI 10.1021/bi002122+; Tomko EJ, 2007, MOL CELL, V26, P335, DOI 10.1016/j.molcel.2007.03.024; VANDYCK E, 1992, EMBO J, V11, P3421, DOI 10.1002/j.1460-2075.1992.tb05421.x; Velankar SS, 1999, CELL, V97, P75, DOI 10.1016/S0092-8674(00)80716-3; Wang QX, 2010, NUCLEIC ACIDS RES, V38, P1312, DOI 10.1093/nar/gkp1118; Yang Y, 2008, NUCLEIC ACIDS RES, V36, P1976, DOI 10.1093/nar/gkm1174; Zhou JQ, 2000, SCIENCE, V289, P771, DOI 10.1126/science.289.5480.771	56	42	46	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 31	2013	288	22					16185	16195		10.1074/jbc.M113.470013	http://dx.doi.org/10.1074/jbc.M113.470013			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	156LA	23596008	Green Published, hybrid			2022-12-25	WOS:000319822300069
J	Le Roux, X; Schmid, B; Poly, F; Barnard, RL; Niklaus, PA; Guillaumaud, N; Habekost, M; Oelmann, Y; Philippot, L; Salles, JF; Schloter, M; Steinbeiss, S; Weigelt, A				Le Roux, Xavier; Schmid, Bernhard; Poly, Franck; Barnard, Romain L.; Niklaus, Pascal A.; Guillaumaud, Nadine; Habekost, Maike; Oelmann, Yvonne; Philippot, Laurent; Salles, Joana Falcao; Schloter, Michael; Steinbeiss, Sibylle; Weigelt, Alexandra			Soil Environmental Conditions and Microbial Build-Up Mediate the Effect of Plant Diversity on Soil Nitrifying and Denitrifying Enzyme Activities in Temperate Grasslands	PLOS ONE			English	Article							AMMONIA-OXIDIZING BACTERIA; SPECIES RICHNESS; ELEVATED CO2; CURRENT KNOWLEDGE; NITROUS-OXIDE; BIODIVERSITY; COMMUNITIES; ABUNDANCE; DENITRIFICATION; NITRIFICATION	Random reductions in plant diversity can affect ecosystem functioning, but it is still unclear which components of plant diversity (species number - namely richness, presence of particular plant functional groups, or particular combinations of these) and associated biotic and abiotic drivers explain the observed relationships, particularly for soil processes. We assembled grassland communities including 1 to 16 plant species with a factorial separation of the effects of richness and functional group composition to analyze how plant diversity components influence soil nitrifying and denitrifying enzyme activities (NEA and DEA, respectively), the abundance of nitrifiers (bacterial and archaeal amoA gene number) and denitrifiers (nirK, nirS and nosZ gene number), and key soil environmental conditions. Plant diversity effects were largely due to differences in functional group composition between communities of identical richness (number of sown species), though richness also had an effect per se. NEA was positively related to the percentage of legumes in terms of sown species number, the additional effect of richness at any given legume percentage being negative. DEA was higher in plots with legumes, decreased with increasing percentage of grasses, and increased with richness. No correlation was observed between DEA and denitrifier abundance. NEA increased with the abundance of ammonia oxidizing bacteria. The effect of richness on NEA was entirely due to the build-up of nitrifying organisms, while legume effect was partly linked to modified ammonium availability and nitrifier abundance. Richness effect on DEA was entirely due to changes in soil moisture, while the effects of legumes and grasses were partly due to modified nitrate availability, which influenced the specific activity of denitrifiers. These results suggest that plant diversity-induced changes in microbial specific activity are important for facultative activities such as denitrification, whereas changes in microbial abundance play a major role for non-facultative activities such as nitrification.	[Le Roux, Xavier; Poly, Franck; Guillaumaud, Nadine; Salles, Joana Falcao] Univ Lyon 1, CNRS, INRA,USC INRA 1364, Microbial Ecol Ctr,UMR CNRS 5557, F-69622 Villeurbanne, France; [Schmid, Bernhard] Univ Zurich, Inst Evolutionary Biol & Environm Studies, Zurich, Switzerland; [Barnard, Romain L.; Niklaus, Pascal A.] Swiss Fed Inst Technol, Inst Plant Sci, Zurich, Switzerland; [Habekost, Maike; Steinbeiss, Sibylle] Max Planck Inst Biogeochem, D-07745 Jena, Germany; [Oelmann, Yvonne] Univ Tubingen, Tubingen, Germany; [Philippot, Laurent] INRA, Lab Microbiol Sols, F-21034 Dijon, France; [Schloter, Michael] Helmholtz Zentrum Munchen, Res Unit Environm Genom, Neuherberg, Germany; [Weigelt, Alexandra] Univ Jena, Inst Ecol, Jena, Germany	INRAE; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); VetAgro Sup; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; Max Planck Society; Eberhard Karls University of Tubingen; INRAE; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Friedrich Schiller University of Jena	Le Roux, X (corresponding author), Univ Lyon 1, CNRS, INRA,USC INRA 1364, Microbial Ecol Ctr,UMR CNRS 5557, F-69622 Villeurbanne, France.	Xavier.le-roux@univ-lyon1.fr	Salles, Joana Falcao/AAG-7070-2020; Schloter, 1Michael/H-9151-2013; Oelmann, Yvonne/J-8730-2016; Schmid, Bernhard/C-8625-2009; Philippot, Laurent/G-5598-2011; Falcao Salles, Joana/A-7313-2008; Niklaus, Pascal A/G-5786-2010; Barnard, Romain L./G-8190-2011	Salles, Joana Falcao/0000-0003-4317-7263; Oelmann, Yvonne/0000-0003-3513-6568; Schmid, Bernhard/0000-0002-8430-3214; Philippot, Laurent/0000-0003-3461-4492; Falcao Salles, Joana/0000-0003-4317-7263; Niklaus, Pascal A/0000-0002-2360-1357; Barnard, Romain L./0000-0002-6440-1159; LE ROUX, Xavier/0000-0001-9695-0825	Deutsche Forschungsgemeinschaft (DFG) [FOR 456]; Friedrich Schiller University of Jena; Max Planck Society; French ANR "Biodiversite" programme; Swiss Science Foundation [31-65224-01]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Friedrich Schiller University of Jena; Max Planck Society(Max Planck Society); French ANR "Biodiversite" programme(French National Research Agency (ANR)); Swiss Science Foundation(Swiss National Science Foundation (SNSF))	The Jena Experiment is funded by the Deutsche Forschungsgemeinschaft (DFG, FOR 456) with additional support from the Friedrich Schiller University of Jena and the Max Planck Society. This work is a part of the DISCOVER project funded by the French ANR "Biodiversite" programme. B Schmid was additionally funded by the Swiss Science Foundation (grant number 31-65224-01). These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan E, 2013, OECOLOGIA, V173, P223, DOI 10.1007/s00442-012-2589-0; Attard E, 2011, GLOBAL CHANGE BIOL, V17, P1975, DOI 10.1111/j.1365-2486.2010.02340.x; Balvanera P, 2006, ECOL LETT, V9, P1146, DOI 10.1111/j.1461-0248.2006.00963.x; Barnard R, 2006, FUNCT ECOL, V20, P557, DOI 10.1111/j.1365-2435.2006.01146.x; Baudoin E, 2009, SOIL BIOL BIOCHEM, V41, P1703, DOI 10.1016/j.soilbio.2009.05.015; Bremer C, 2009, FEMS MICROBIOL ECOL, V70, P377, DOI 10.1111/j.1574-6941.2009.00732.x; Caldeira MC, 2001, ECOL LETT, V4, P439, DOI 10.1046/j.1461-0248.2001.00238.x; Cardinale BJ, 2006, NATURE, V443, P989, DOI 10.1038/nature05202; Chung HG, 2007, GLOBAL CHANGE BIOL, V13, P980, DOI 10.1111/j.1365-2486.2007.01313.x; Corre MD, 2002, SOIL BIOL BIOCHEM, V34, P445, DOI 10.1016/S0038-0717(01)00198-5; Craine JM, 2002, FUNCT ECOL, V16, P563, DOI 10.1046/j.1365-2435.2002.00660.x; Dollhopf SL, 2005, APPL ENVIRON MICROB, V71, P240, DOI 10.1128/AEM.71.1.240-246.2005; FIRESTONE MK, 1980, SCIENCE, V208, P749, DOI 10.1126/science.208.4445.749; Hector A, 2007, NATURE, V448, P188, DOI 10.1038/nature05947; Henry S, 2006, APPL ENVIRON MICROB, V72, P5181, DOI 10.1128/AEM.00231-06; Hooper D, 1997, SCIENCE, V302, P1512; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Hungate BA, 2003, SCIENCE, V302, P1512, DOI 10.1126/science.1091390; Konneke M, 2005, NATURE, V437, P543, DOI 10.1038/nature03911; Lamb EG, 2011, PLANT SOIL, V338, P483, DOI 10.1007/s11104-010-0560-6; Le Roux X, 2003, OECOLOGIA, V137, P417, DOI 10.1007/s00442-003-1367-4; Le Roux X, 2008, ISME J, V2, P221, DOI 10.1038/ismej.2007.109; Leininger S, 2006, NATURE, V442, P806, DOI 10.1038/nature04983; LEROUX X, 1995, J GEOPHYS RES-ATMOS, V100, P23133, DOI 10.1029/95JD01923; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; Malchair S, 2010, SOIL BIOL BIOCHEM, V42, P1944, DOI 10.1016/j.soilbio.2010.07.006; MALLARINO AP, 1990, GRASS FORAGE SCI, V45, P393, DOI 10.1111/j.1365-2494.1990.tb01964.x; McClain ME, 2003, ECOSYSTEMS, V6, P301, DOI 10.1007/s10021-003-0161-9; McGill BM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011618; Mulder CPH, 2002, OECOLOGIA, V133, P412, DOI 10.1007/s00442-002-1043-0; Naeem S, 2003, ECOL LETT, V6, P567, DOI 10.1046/j.1461-0248.2003.00471.x; Niklaus PA, 2007, ECOLOGY, V88, P3153, DOI 10.1890/06-2100.1; Niklaus PA, 2001, OECOLOGIA, V127, P540, DOI 10.1007/s004420000612; Niklaus PA, 2006, PLANT SOIL, V282, P83, DOI 10.1007/s11104-005-5230-8; Oelmann Y, 2007, SOIL SCI SOC AM J, V71, P720, DOI 10.2136/sssaj2006.0205; Palmborg C, 2005, OIKOS, V110, P271, DOI 10.1111/j.0030-1299.2005.13673.x; Patra AK, 2005, ECOL MONOGR, V75, P65, DOI 10.1890/03-0837; Patra AK, 2006, ENVIRON MICROBIOL, V8, P1005, DOI 10.1111/j.1462-2920.2006.00992.x; Petersen DG, 2012, ENVIRON MICROBIOL, V14, P993, DOI 10.1111/j.1462-2920.2011.02679.x; Phillips CJ, 2000, APPL ENVIRON MICROB, V66, P5410, DOI 10.1128/AEM.66.12.5410-5418.2000; PROSSER JI, 1989, ADV MICROB PHYSIOL, V30, P125; Reich PB, 2004, P NATL ACAD SCI USA, V101, P10101, DOI 10.1073/pnas.0306602101; Robson TM, 2007, SOIL BIOL BIOCHEM, V39, P930, DOI 10.1016/j.soilbio.2006.11.004; Roscher C, 2005, ECOL LETT, V8, P419, DOI 10.1111/j.1461-0248.2005.00736.x; Roscher C, 2004, BASIC APPL ECOL, V5, P107, DOI 10.1078/1439-1791-00216; Rosenfeld JS, 2002, CONSERV BIOL, V16, P837, DOI 10.1046/j.1523-1739.2002.01080.x; Rosenkranz S, 2012, SOIL BIOL BIOCHEM, V48, P78, DOI 10.1016/j.soilbio.2012.01.008; Salles JF, 2009, ECOLOGY, V90, P3324, DOI 10.1890/09-0188.1; Salles JF, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00209; Scherer-Lorenzen M, 2003, ECOLOGY, V84, P1539, DOI 10.1890/0012-9658(2003)084[1539:TROPDA]2.0.CO;2; Schimel JP, 2004, ECOLOGY, V85, P591, DOI 10.1890/03-8002; Schmid B, 2002, MG POP BIOL, V33, P120; Spehn EM, 2005, ECOL MONOGR, V75, P37, DOI 10.1890/03-4101; Sutton-Grier AE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016584; Tiedje J.M., 1988, BIOL ANAEROB MICROOR, V717, P179; Tilman D, 1997, SCIENCE, V277, P1300, DOI 10.1126/science.277.5330.1300	56	63	63	4	193	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2013	8	4							e61069	10.1371/journal.pone.0061069	http://dx.doi.org/10.1371/journal.pone.0061069			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IK	23613785	Green Published, Green Submitted, gold			2022-12-25	WOS:000317907200029
J	Nishimura, R; Nishioka, S; Fujisawa, I; Shiku, H; Shimada, M; Sekiguchi, S; Fujimori, K; Ushiyama, A; Matsue, T; Ohuchi, N; Satomi, S; Goto, M				Nishimura, Ryuichi; Nishioka, Sho; Fujisawa, Ikuma; Shiku, Hitoshi; Shimada, Miki; Sekiguchi, Satoshi; Fujimori, Keisei; Ushiyama, Akira; Matsue, Tomokazu; Ohuchi, Noriaki; Satomi, Susumu; Goto, Masafumi			Tacrolimus Inhibits the Revascularization of Isolated Pancreatic Islets	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; MEDIATED INFLAMMATORY REACTION; CELL BIOLOGY; TRANSPLANTATION; ANGIOGENESIS; BETA; RAPAMYCIN; CULTURE; SYSTEM; IMMUNOSUPPRESSION	Aims: Immunosuppressive drugs could be crucial factors for a poor outcome after islet allotransplantation. Unlike rapamycin, the effects of tacrolimus, the current standard immunosuppressant used in islet transplantation, on graft revascularization remain unclear. We examined the effects of tacrolimus on islet revascularization using a highly sensitive imaging system, and analyzed the gene expression in transplanted islets by introducing laser microdissection techniques. Methods: Islets isolated from C57BL/6-Tg (CAG-EGFP) mice were transplanted into the nonmetallic dorsal skinfold chamber on the recipients. Balb/c athymic mice were used as recipients and were divided into two groups: including a control group (n = 9) and tacrolimus-treated group (n = 7). The changes in the newly-formed vessels surrounding the islet grafts were imaged and semi-quantified using multi-photon laser-scanning microscopy and a Volocity system. Gene expression in transplanted islets was analyzed by the BioMark dynamic system. Results: The revascularization process was completed within 14 days after pancreatic islet transplantation at subcutaneous sites. The newly-formed vascular volume surrounding the transplanted islets in the tacrolimus-treated group was significantly less than that in the control group (p<0.05). Although the expression of Vegfa (p<0.05) and Ccnd1 (p<0.05) was significantly upregulated in the tacrolimus-treated group compared with that of the control group, no differences were observed between the groups in terms of other types of gene expression. Conclusions: The present study demonstrates that tacrolimus inhibits the revascularization of isolated pancreatic islets without affecting the characteristics of the transplanted grafts. Further refinements of this immunosuppressive regimen, especially regarding the revascularization of islet grafts, could improve the outcome of islet allotransplantation.	[Nishimura, Ryuichi; Sekiguchi, Satoshi; Fujimori, Keisei; Ohuchi, Noriaki; Satomi, Susumu; Goto, Masafumi] Tohoku Univ, Div Adv Surg Sci & Technol, Sendai, Miyagi 980, Japan; [Nishioka, Sho; Fujisawa, Ikuma; Shiku, Hitoshi] Tohoku Univ, Grad Sch Environm Studies, Sendai, Miyagi 980, Japan; [Shimada, Miki] Tohoku Univ Hosp, Dept Pharmaceut Sci, Sendai, Miyagi, Japan; [Ushiyama, Akira] Natl Inst Publ Hlth, Dept Environm Hlth, Wako, Saitama 3510197, Japan; [Matsue, Tomokazu] Tohoku Univ, WorldPremier InternationalRes Ctr Initiat, Adv Inst Mat Res, Sendai, Miyagi 980, Japan; [Goto, Masafumi] Tohoku Univ, New Ind Creat Hatchery Ctr, Sendai, Miyagi 980, Japan	Tohoku University; Tohoku University; Tohoku University; National Institute of Public Health - Japan; Tohoku University; Tohoku University	Goto, M (corresponding author), Tohoku Univ, Div Adv Surg Sci & Technol, Sendai, Miyagi 980, Japan.	gotokichi@aol.com	Goto, Masafumi/GPF-7677-2022; Matsue, Tomokazu/CAF-0782-2022; Matsue, Tomokazu/F-9688-2010; Ushiyama, Akira/AAT-5226-2020		Takeda Science Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Japanese Ministry of Health, Welfare and Labor [20120101]; Grants-in-Aid for Scientific Research [25460185] Funding Source: KAKEN	Takeda Science Foundation(Takeda Science Foundation (TSF)); Mochida Memorial Foundation for Medical and Pharmaceutical Research; Japanese Ministry of Health, Welfare and Labor(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study has been supported by grants from the Japanese Grant-in-Aid for Scientific Research (B), the Takeda Science Foundation, the Mochida Memorial Foundation for Medical and Pharmaceutical Research, and the Japanese Ministry of Health, Welfare and Labor (20120101). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSSON A, 1989, DIABETES, V38, P192, DOI 10.2337/diab.38.1.S192; Aronovitz A, 2008, J INVEST MED, V56, P985, DOI 10.2310/JIM.0b013e31818ce763; Bayne K, 1996, Physiologist, V39, P208; Cantaluppi V, 2006, AM J TRANSPLANT, V6, P2601, DOI 10.1111/j.1600-6143.2006.01534.x; Cross SE, 2007, DIABETOLOGIA, V50, P1423, DOI 10.1007/s00125-007-0670-8; Deryugina EI, 2002, CANCER RES, V62, P580; Goto M, 2005, TRANSPLANT P, V37, P1313, DOI 10.1016/j.transproceed.2005.01.074; Goto M, 2004, TRANSPLANTATION, V78, P1367, DOI 10.1097/01.TP.0000140882.53773.DC; Goto M, 2004, TRANSPLANTATION, V77, P741, DOI 10.1097/01.TP.0000114872.26990.4F; Goto M, 2010, TRANSPL P, V42, P2040, DOI 10.1016/j.transproceed.2010.05.101; Goto M, 2008, XENOTRANSPLANTATION, V15, P225, DOI 10.1111/j.1399-3089.2008.00482.x; Guba M, 2002, NAT MED, V8, P128, DOI 10.1038/nm0202-128; Henriksnas J, 2012, DIABETES, V61, P665, DOI 10.2337/db10-0895; Ichii H, 2005, AM J TRANSPLANT, V5, P21, DOI 10.1111/j.1600-6143.2005.00698.x; Johansson A, 2009, TRANSPL INT, V22, P1182, DOI 10.1111/j.1432-2277.2009.00939.x; Lai Y, 2005, TRANSPLANTATION, V79, P1530, DOI 10.1097/01.TP.0000163506.40189.65; Lopez-Talavera JC, 2004, ENDOCRINOLOGY, V145, P467, DOI 10.1210/en.2003-1070; Maeda A, 2003, TRANSPLANTATION, V75, P1409, DOI 10.1097/01.TP.0000061770.39569.7F; MENDOLA JF, 1994, TRANSPLANTATION, V57, P725, DOI 10.1097/00007890-199403150-00015; Menger MD, 2001, WORLD J SURG, V25, P509, DOI 10.1007/s002680020345; Merchant FA, 1997, TRANSPLANTATION, V63, P1652, DOI 10.1097/00007890-199706150-00020; Mita A, 2010, CELL TRANSPLANT, V19, P1537, DOI 10.3727/096368910X516600; Nishimura R, 2011, TRANSPL P, V43, P3239, DOI 10.1016/j.transproceed.2011.09.095; Olsson R, 2006, TRANSPLANTATION, V82, P340, DOI 10.1097/01.tp.0000229418.60236.87; Reffet S, 2006, DIABETES METAB, V32, P523, DOI 10.1016/S1262-3636(06)72805-1; Ryan EA, 2005, DIABETES, V54, P2060, DOI 10.2337/diabetes.54.7.2060; SANDBERG JO, 1995, TRANSPLANTATION, V59, P1665, DOI 10.1097/00007890-199506270-00004; Shapiro AMJ, 2005, THER DRUG MONIT, V27, P35, DOI 10.1097/00007691-200502000-00008; Shapiro AMJ, 2005, TRANSPLANTATION, V79, P1304, DOI 10.1097/01.TP.0000157300.53976.2A; Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401; Singh RP, 2008, CURR OPIN ORGAN TRAN, V13, P79, DOI 10.1097/MOT.0b013e3282f2fd91; Speier S, 2008, NAT PROTOC, V3, P1278, DOI 10.1038/nprot.2008.118; Speier S, 2008, NAT MED, V14, P574, DOI 10.1038/nm1701; Stallone G, 2005, NEW ENGL J MED, V352, P1317, DOI 10.1056/NEJMoa042831; Sutherland DER, 2008, TRANSPLANTATION, V86, P1799, DOI 10.1097/TP.0b013e31819143ec; Turgut B, 2011, CURR EYE RES, V36, P34, DOI 10.3109/02713683.2010.516620; Ushiyama A, 2004, MICROVASC RES, V68, P147, DOI 10.1016/j.mvr.2004.05.004; VAJKOCZY P, 1995, AM J PATHOL, V146, P1397; Vasir B, 2000, DIABETOLOGIA, V43, P763, DOI 10.1007/s001250051374; Watanabe H, 2003, SURG TODAY, V33, P854, DOI 10.1007/s00595-003-2609-0; Zhang N, 2004, DIABETES, V53, P963, DOI 10.2337/diabetes.53.4.963; Zhang N, 2006, DIABETES, V55, P2429, DOI 10.2337/db06-0173	42	26	27	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2013	8	4							e56799	10.1371/journal.pone.0056799	http://dx.doi.org/10.1371/journal.pone.0056799			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IK	23613708	gold, Green Submitted, Green Published			2022-12-25	WOS:000317907200002
J	Zhai, RR; Feng, Y; Zhan, XD; Shen, XH; Wu, WM; Yu, P; Zhang, YX; Chen, DB; Wang, HM; Lin, ZC; Cao, LY; Cheng, SH				Zhai, Rongrong; Feng, Yue; Zhan, Xiaodeng; Shen, Xihong; Wu, Weiming; Yu, Ping; Zhang, Yingxin; Chen, Daibo; Wang, Huimin; Lin, Zechuan; Cao, Liyong; Cheng, Shihua			Identification of Transcriptome SNPs for Assessing Allele-Specific Gene Expression in a Super-Hybrid Rice Xieyou9308	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION; MAIZE; DNA; 5-METHYLCYTOSINE; EVOLUTION; PATTERNS; INSIGHTS; LINES; CIS	Hybridization, a common process in nature, can give rise to a vast reservoir of allelic variants. Combination of these allelic variants may result in novel patterns of gene action and is thought to contribute to heterosis. In this study, we analyzed genome-wide allele-specific gene expression (ASGE) in the super-hybrid rice variety Xieyou9308 using RNA sequencing technology (RNA-Seq). We identified 9325 reliable single nucleotide polymorphisms (SNPs) distributed throughout the genome. Nearly 68% of the identified polymorphisms were CT and GA SNPs between R9308 and Xieqingzao B, suggesting the existence of DNA methylation, a heritable epigenetic mark, in the parents and their F-1 hybrid. Of 2793 identified transcripts with consistent allelic biases, only 480 (17%) showed significant allelic biases during tillering and/or heading stages, implying that trans effects may mediate most transcriptional differences in hybrid offspring. Approximately 67% and 62% of the 480 transcripts showed R9308 allelic expression biases at tillering and heading stages, respectively. Transcripts with higher levels of gene expression in R9308 also exhibited R9308 allelic biases in the hybrid. In addition, 125 transcripts were identified with significant allelic expression biases at both stages, of which 74% showed R9308 allelic expression biases. R9308 alleles may tend to preserve their characteristic states of activity in the hybrid and may play important roles in hybrid vigor at both stages. The allelic expression of 355 transcripts was highly stage-specific, with divergent allelic expression patterns observed at different developmental stages. Many transcripts associated with stress resistance were differently regulated in the F-1 hybrid. The results of this study may provide valuable insights into molecular mechanisms of heterosis.	[Zhai, Rongrong; Feng, Yue; Zhan, Xiaodeng; Shen, Xihong; Wu, Weiming; Yu, Ping; Zhang, Yingxin; Chen, Daibo; Lin, Zechuan; Cao, Liyong; Cheng, Shihua] China Natl Rice Res Inst, State Key Lab Rice Biol, Hangzhou, Zhejiang, Peoples R China; [Wang, Huimin] Shenyang Agr Univ, Coll Agron, Shenyang, Liaoning, Peoples R China	Chinese Academy of Agricultural Sciences; China National Rice Research Institute, CAAS; Shenyang Agricultural University	Cao, LY (corresponding author), China Natl Rice Res Inst, State Key Lab Rice Biol, Hangzhou, Zhejiang, Peoples R China.	caolycgf@mail.hz.zj.cn; shcheng@mail.hz.zj.cn	wang, huimin/HDM-8421-2022		Chinese Natural Science Foundation [31071398]; National Program on Super Rice Breeding, Ministry of Agriculture	Chinese Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National Program on Super Rice Breeding, Ministry of Agriculture	This work was supported by a grant from the Chinese Natural Science Foundation(31071398), and a grant from the National Program on Super Rice Breeding, Ministry of Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold ML, 2004, MOL ECOL, V13, P997, DOI 10.1111/j.1365-294X.2004.02145.x; Birchler JA, 2003, PLANT CELL, V15, P2236, DOI 10.1105/tpc.151030; Bird A, 2007, NATURE, V447, P396, DOI 10.1038/nature05913; Bransteitter R, 2003, P NATL ACAD SCI USA, V100, P4102, DOI 10.1073/pnas.0730835100; Cheng SH, 2007, J INTEGR PLANT BIOL, V49, P805, DOI [10.1111/j.1744-7909.2007.00514.x, 10.1111/j.1672-9072.2007.00514.x]; Chodavarapu RK, 2012, P NATL ACAD SCI USA, V109, P12040, DOI 10.1073/pnas.1209297109; Cowles CR, 2002, NAT GENET, V32, P432, DOI 10.1038/ng992; Guo M, 2004, PLANT CELL, V16, P1707, DOI 10.1105/tpc.022087; He GM, 2010, PLANT CELL, V22, P17, DOI 10.1105/tpc.109.072041; Hegarty MJ, 2005, NEW PHYTOL, V165, P411, DOI 10.1111/j.1469-8137.2004.01253.x; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Morgan HD, 2004, J BIOL CHEM, V279, P52353, DOI 10.1074/jbc.M407695200; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Pant PVK, 2006, GENOME RES, V16, P331, DOI 10.1101/gr.4559106; Pastinen T, 2010, NAT REV GENET, V11, P533, DOI 10.1038/nrg2815; Rieseberg LH, 1997, ANNU REV ECOL SYST, V28, P359, DOI 10.1146/annurev.ecolsys.28.1.359; Rieseberg LH, 2003, SCIENCE, V301, P1211, DOI 10.1126/science.1086949; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Shen YJ, 2012, COMP BIOCHEM PHYS C, V155, P102, DOI 10.1016/j.cbpc.2011.03.012; Singh N, 2012, PLOS ONE, V7, P36875; Springer NM, 2007, PLANT CELL, V19, P2391, DOI 10.1105/tpc.107.052258; Springer NM, 2007, GENOME RES, V17, P264, DOI 10.1101/gr.5347007; Stupar RM, 2006, GENETICS, V173, P2199, DOI 10.1534/genetics.106.060699; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Swanson-Wagner RA, 2006, P NATL ACAD SCI USA, V103, P6805, DOI 10.1073/pnas.0510430103; Tirosh I, 2009, SCIENCE, V324, P659, DOI 10.1126/science.1169766; Wittkopp PJ, 2004, NATURE, V430, P85, DOI 10.1038/nature02698; Yan H, 2002, SCIENCE, V297, P1143, DOI 10.1126/science.1072545; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; YEBRA MJ, 1995, BIOCHEMISTRY-US, V34, P14752, DOI 10.1021/bi00045a016; Zhang X, 2009, GENETICS, V182, P943, DOI 10.1534/genetics.109.103499; Zhuang Y, 2007, GENETICS, V177, P1987, DOI 10.1534/genetics.107.080325	32	12	15	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2013	8	4							e60668	10.1371/journal.pone.0060668	http://dx.doi.org/10.1371/journal.pone.0060668			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IK	23613738	gold, Green Submitted, Green Published			2022-12-25	WOS:000317907200010
J	Bourque, SL; Kuny, S; Reyes, LM; Davidge, ST; Sauve, Y				Bourque, Stephane L.; Kuny, Sharee; Reyes, Laura M.; Davidge, Sandra T.; Sauve, Yves			Prenatal Hypoxia Is Associated with Long-Term Retinal Dysfunction in Rats	PLOS ONE			English	Article							CHRONIC PLACENTAL INSUFFICIENCY; RICH LABORATORY RODENT; LOW-BIRTH-WEIGHT; ARVICANTHIS-NILOTICUS; GROWTH RESTRICTION; B-WAVE; AGE; DEGENERATION; ELECTRORETINOGRAPHY; EXPRESSION	Background: Intra-uterine growth restriction (IUGR) has been associated with increased predisposition to age-related complications. We tested the hypothesis that rat offspring models of IUGR would exhibit exacerbated, age-related retinal dysfunction. Methods: Female Sprague-Dawley rats (maintained at 11.5% O-2 from gestational day 15 to 21 to induce IUGR) and control offspring (maintained at 21% O-2 throughout pregnancy) had retinal function assessed at 2 months (young) and 14 months of age (aged) with electroretinogram (ERG) recordings. Retinal anatomy was assessed by immunofluorescence. Results: Deficits in rod-driven retina function were observed in aged IUGR offspring, as evidenced by reduced amplitudes of dark-adapted mixed a-wave V-max (by 49.3%, P<0.01), b-wave V-max (by 42.1%, P < 0.001) and dark-adapted peak oscillatory potentials (by 42.3%, P<0.01). In contrast to the rod-driven defects specific to aged IUGR offspring, light adapted ERG recordings revealed cone defects in young animals, that were stationary until old age. At 2 months, IUGR offspring had amplitude reductions for both b-wave (V-max by 46%, P<0.01) and peak oscillatory potential (V-max by 38%, P<0.05). Finally, defects in cone-driven responses were further confirmed by reduced maximal photopic flicker amplitudes at 2 (by 42%, P, 0.001) and 14 months (by 34%, P = 0.06) and critical flicker fusion frequencies at 14 months (Control: 42+/-1 Hz, IUGR: 35+/-2 Hz, P<0.05). These functional changes were not paralleled by anatomical losses in IUGR offspring retinas. Conclusions: These data support that the developing retina is sensitive to stressors, and that pathways governing cone-and rod-driven function differ in their susceptibilities. In the case of prenatal hypoxia, cone-and rod-driven dysfunction manifest at young and old ages, respectively. We must, therefore, take into account the specific impact that fetal programming might exert on age-related retinal dystrophies when considering related diagnoses and therapeutic applications.	[Bourque, Stephane L.; Reyes, Laura M.; Davidge, Sandra T.] Univ Alberta, Dept Obstet & Gynecol, Edmonton, AB, Canada; [Kuny, Sharee; Sauve, Yves] Univ Alberta, Dept Ophthalmol, Edmonton, AB, Canada; [Reyes, Laura M.; Davidge, Sandra T.; Sauve, Yves] Univ Alberta, Dept Physiol, Edmonton, AB, Canada; [Bourque, Stephane L.; Reyes, Laura M.; Davidge, Sandra T.] Women & Childrens Hlth Res Inst, Edmonton, AB, Canada	University of Alberta; University of Alberta; University of Alberta	Sauve, Y (corresponding author), Univ Alberta, Dept Ophthalmol, Edmonton, AB, Canada.	ysauve@ualberta.ca	Reyes, Laura M./AAA-1581-2019	Reyes, Laura M./0000-0003-4207-0480; Bourque, Stephane/0000-0001-6375-7404; Davidge, Sandra/0000-0002-5559-4905	Alberta Innovates Health Solutions [200800242]; Canadian Institutes of Health Research [MOP77648]; Alberta Innovates [201201139, 201100397] Funding Source: researchfish	Alberta Innovates Health Solutions; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Innovates	This work is supported by grants from Alberta Innovates Health Solutions (#200800242 to YS; http://www.aihealthsolutions.ca/), and the Canadian Institutes of Health Research (MOP77648 to SD; http://www.cihr-irsc.gc.ca/e/193.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baehr W, 2009, VISION RES, V49, P2636, DOI 10.1016/j.visres.2009.04.008; BIRCH DG, 1992, ARCH OPHTHALMOL-CHIC, V110, P1571, DOI 10.1001/archopht.1992.01080230071024; Bui BV, 2002, INVEST OPHTH VIS SCI, V43, P805; BURGESS P, 1991, BRIT J OPHTHALMOL, V75, P84, DOI 10.1136/bjo.75.2.84; Calkins K, 2011, CURR PROB PEDIATR AD, V41, P158, DOI 10.1016/j.cppeds.2011.01.001; DOWDESWELL HJ, 1995, BRIT J OPHTHALMOL, V79, P447, DOI 10.1136/bjo.79.5.447; FLEDELIUS HC, 1980, ACTA OPHTHALMOL, V58, P889; Forte JD, 2008, J NEUROSCI METH, V169, P191, DOI 10.1016/j.jneumeth.2007.12.007; Freund PR, 2011, DOC OPHTHALMOL, V122, P177, DOI 10.1007/s10633-011-9273-2; Gaillard F, 2008, J COMP NEUROL, V510, P525, DOI 10.1002/cne.21798; Gilmour GS, 2008, VISION RES, V48, P2723, DOI 10.1016/j.visres.2008.09.004; Hanitzsch R, 2004, GRAEF ARCH CLIN EXP, V242, P784, DOI 10.1007/s00417-004-0919-6; Jackson GR, 2002, AGEING RES REV, V1, P381, DOI 10.1016/S1568-1637(02)00007-7; Jackson GR, 1999, VISION RES, V39, P3975, DOI 10.1016/S0042-6989(99)00092-9; Klein R, 2010, ARCH OPHTHALMOL-CHIC, V128, P750, DOI 10.1001/archophthalmol.2010.92; Kuny S, 2012, INVEST OPHTH VIS SCI, V53, P664, DOI 10.1167/iovs.11-8418; Lewis GP, 2002, INVEST OPHTH VIS SCI, V43, P2412; LI Y, 1995, J NEUROL SCI, V128, P134, DOI 10.1016/0022-510X(94)00228-G; Loeliger M, 2005, INVEST OPHTH VIS SCI, V46, P3300, DOI 10.1167/iovs.04-1357; Loeliger M, 2004, INVEST OPHTH VIS SCI, V45, P2361, DOI 10.1167/iovs.03-1349; Owsley C, 2011, VISION RES, V51, P1610, DOI 10.1016/j.visres.2010.10.020; Punzo C, 2012, J BIOL CHEM, V287, P1642, DOI 10.1074/jbc.R111.304428; Reese BE, 2011, VISION RES, V51, P613, DOI 10.1016/j.visres.2010.07.010; Rueda-Clausen CF, 2011, CARDIOVASC RES, V90, P285, DOI 10.1093/cvr/cvq363; Sancho-Pelluz J, 2008, MOL NEUROBIOL, V38, P253, DOI 10.1007/s12035-008-8045-9; SLAUGHTER MM, 1981, SCIENCE, V211, P182, DOI 10.1126/science.6255566; STOCKTON RA, 1989, J GEN PHYSIOL, V93, P101, DOI 10.1085/jgp.93.1.101; Suckow AA, 2005, LAB RAT; Weymouth AE, 2008, PROG RETIN EYE RES, V27, P1, DOI 10.1016/j.preteyeres.2007.09.003; Williams SJ, 2005, AM J PHYSIOL-REG I, V288, pR360, DOI 10.1152/ajpregu.00178.2004	30	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2013	8	4							e61861	10.1371/journal.pone.0061861	http://dx.doi.org/10.1371/journal.pone.0061861			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130DR	23610595	Green Submitted, Green Published, gold			2022-12-25	WOS:000317893400121
J	Gu, JH; Ge, JB; Li, M; Xu, HD; Wu, F; Qin, ZH				Gu, Jin-Hua; Ge, Jian-Bin; Li, Mei; Xu, Hai-Dong; Wu, Feng; Qin, Zheng-Hong			Poloxamer 188 Protects Neurons against Ischemia/Reperfusion Injury through Preserving Integrity of Cell Membranes and Blood Brain Barrier	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; CEREBRAL-ARTERY OCCLUSION; SURFACTANT POLOXAMER-188; UP-REGULATION; MUSCLE; RECOVERY; NECROSIS; PERMEABILITY; EXPRESSION; EDEMA	Poloxamer 188 (P188), a multiblock copolymer surfactant, has been shown to protect against ischemic tissue injury of cardiac muscle, testes and skeletal muscle, but the mechanisms have not been fully understood. In this study, we explored whether P188 had a protective effect against cerebral ischemia/reperfusion injury and its underlying mechanisms. The in vivo results showed that P188 significantly reduced the infarct volume, ameliorated the brain edema and neurological symptoms 24 h after ischemia/reperfusion. In the long-term outcome study, P188 markedly alleviated brain atrophy and motor impairments and increased survival rate in 3 weeks of post stroke period. Additionally, P188 protected cultured hippucampal HT22 cells against oxygen-glucose deprivation and reoxygenation (OGD/R) injury. The ability in membrane sealing was assessed with two fluorescent membrane-impermeant dyes. The results showed that P188 treatment significantly reduced the PI-positive cells following ischemia/reperfusion injury and repaired the HT22 cell membrane rupture induced by Triton X-100. In addition, P188 inhibited ischemia/reperfusion-induced activation of matrix metalloproteinase (MMP)-9 and leakage of Evans blue. Therefore, the present study concludes that P188 can protect against cerebral ischemia/reperfusion injury, and the protection involves multi-mechanisms in addition to the membrane resealing.	[Gu, Jin-Hua; Ge, Jian-Bin; Li, Mei; Xu, Hai-Dong; Wu, Feng; Qin, Zheng-Hong] Soochow Univ, Sch Pharmaceut Sci, Dept Pharmacol, Suzhou, Peoples R China; [Gu, Jin-Hua; Ge, Jian-Bin; Li, Mei; Xu, Hai-Dong; Wu, Feng; Qin, Zheng-Hong] Soochow Univ, Sch Pharmaceut Sci, Lab Aging & Nervous Dis, Suzhou, Peoples R China; [Gu, Jin-Hua; Wu, Feng] Nantong Univ Med Coll, Dept Pharmacol, Nantong, Peoples R China; [Ge, Jian-Bin] Second Peoples Hosp Nantong, Nantong, Peoples R China	Soochow University - China; Soochow University - China; Nantong University	Qin, ZH (corresponding author), Soochow Univ, Sch Pharmaceut Sci, Dept Pharmacol, Suzhou, Peoples R China.	zhqin5@hotmail.com	Xu, Haidong/Q-1095-2019		Natural Science Foundation of China [30930035]; Priority Academic Program Development of Jiangsu Higher Education Institutes; Jiangsu Province's Outstanding Medical Academic Leader Program [LJ201139]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutes; Jiangsu Province's Outstanding Medical Academic Leader Program	This work was supported by the grant from the Natural Science Foundation of China (number 30930035), the Priority Academic Program Development of Jiangsu Higher Education Institutes and the Jiangsu Province's Outstanding Medical Academic Leader Program (number LJ201139). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bond M, 1998, FEBS LETT, V435, P29, DOI 10.1016/S0014-5793(98)01034-5; Borgens RB, 2004, J NEUROSCI RES, V76, P141, DOI 10.1002/jnr.20053; Cadichon SB, 2007, J NEUROSURG, V106, P36, DOI 10.3171/ped.2007.106.1.36; Cevik IU, 2003, CELL DEATH DIFFER, V10, P928, DOI 10.1038/sj.cdd.4401250; Clark WM, 1997, NEUROL RES, V19, P641; COLBASSANI HJ, 1989, STROKE, V20, P1241, DOI 10.1161/01.STR.20.9.1241; Curry DJ, 2004, NEUROSURGERY, V55, P943, DOI 10.1227/01.NEU.0000137890.29862.2C; Donnan GA, 2008, LANCET, V371, P1612, DOI 10.1016/S0140-6736(08)60694-7; Farina AR, 1999, CELL GROWTH DIFFER, V10, P353; Follis F, 1996, J INVEST SURG, V9, P149, DOI 10.3109/08941939609012466; Frim DM, 2004, NEUROREPORT, V15, P171, DOI 10.1097/00001756-200401190-00033; Gaymalov ZZ, 2009, BIOMATERIALS, V30, P1232, DOI 10.1016/j.biomaterials.2008.10.064; Gertz K, 2006, CIRC RES, V99, P1132, DOI 10.1161/01.RES.0000250175.14861.77; Greenebaum B, 2004, BURNS, V30, P539, DOI 10.1016/j.burns.2004.02.009; Kilinc D, 2008, EXP NEUROL, V212, P422, DOI 10.1016/j.expneurol.2008.04.025; Kilinc D, 2009, EXP NEUROL, V219, P553, DOI 10.1016/j.expneurol.2009.07.014; LEE RC, 1992, P NATL ACAD SCI USA, V89, P4524, DOI 10.1073/pnas.89.10.4524; Li C-H, 2011, CHINESE PHARMACOL B, V26, P10; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; Marks Jeremy D., 2001, FASEB Journal, V15, P1107; Maskarinec SA, 2005, ANN NY ACAD SCI, V1066, P310, DOI 10.1196/annals.1363.018; Matsuura K, 1997, J NEUROSCI METH, V73, P45, DOI 10.1016/S0165-0270(96)02211-X; Mdzinarishvili A, 2007, NEUROSCIENCE, V144, P217, DOI 10.1016/j.neuroscience.2006.08.037; Murphy AD, 2010, PLAST RECONSTR SURG, V125, P1651, DOI 10.1097/PRS.0b013e3181ccdbef; PADANILAM JT, 1994, ANN NY ACAD SCI, V720, P111, DOI 10.1111/j.1749-6632.1994.tb30439.x; Palmer JS, 1998, J UROLOGY, V159, P2136, DOI 10.1016/S0022-5347(01)63295-6; Polavarapu R, 2005, J NEUROSCI, V25, P10094, DOI 10.1523/JNEUROSCI.3382-05.2005; SCHAER GL, 1994, CIRCULATION, V90, P2964, DOI 10.1161/01.CIR.90.6.2964; Serbest G, 2005, J NEUROTRAUM, V22, P119, DOI 10.1089/neu.2005.22.119; Serbest G, 2006, FASEB J, V20, P308, DOI 10.1096/fj.05-4024fje; Singh-Joy SD, 2008, INT J TOXICOL, V27, P93, DOI 10.1080/10915810802244595; UYAMA O, 1988, J CEREBR BLOOD F MET, V8, P282, DOI 10.1038/jcbfm.1988.59; Walters TJ, 2011, J TRAUMA, V70, P1192, DOI 10.1097/TA.0b013e318217879a; Whalen MJ, 2008, J CEREBR BLOOD F MET, V28, P490, DOI 10.1038/sj.jcbfm.9600544	34	52	56	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2013	8	4							e61641	10.1371/journal.pone.0061641	http://dx.doi.org/10.1371/journal.pone.0061641			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130DR	23613890	Green Published, gold, Green Submitted			2022-12-25	WOS:000317893400085
J	Li, YJ; Yuan, Y; Tao, K; Wang, X; Xiao, Q; Huang, ZL; Zhong, L; Cao, WX; Wen, JP; Feng, WL				Li, Yajuan; Yuan, Ying; Tao, Kun; Wang, Xin; Xiao, Qing; Huang, Zhenglan; Zhong, Liang; Cao, Weixi; Wen, Jianping; Feng, Wenli			Inhibition of BCR/ABL Protein Expression by miR-203 Sensitizes for Imatinib Mesylate	PLOS ONE			English	Article							CHRONIC MYELOID-LEUKEMIA; SMALL INTERFERING RNA; ABL GENE-EXPRESSION; CANCER; MICRORNAS; CELLS; PROLIFERATION; RESISTANCE	Selective inhibition of BCR/ABL expression by RNA interference has been demonstrated as an effective strategy in CML treatment and a reversal to imatinib resistance. microRNAs (miRNAs) are small regulatory RNAs involved in post-transcriptional gene regulation. miR-203 is supposed to directly regulate ABL and BCR/ABL expression, however, the role of miR-203 in imatinib-resistant cells is not clear. Here, we report that overexpression of miR-203 in BaF3-BCR/ABL cells with T315I mutant inhibited cell growth and colony formation ability. Furthermore, miR-203 increased sensitivity to imatinib in BaF3-BCR/ABL(T315I) cells, thereby antagonizing the main mechanism of resistance to imatinib.	[Li, Yajuan; Huang, Zhenglan; Zhong, Liang; Cao, Weixi; Feng, Wenli] Chongqing Med Univ, Minist Educ, Key Lab Lab Med Diagnost, Chongqing, Peoples R China; [Li, Yajuan; Huang, Zhenglan; Zhong, Liang; Cao, Weixi; Feng, Wenli] Chongqing Med Univ, Minist Educ, Dept Clin Hematol, Chongqing, Peoples R China; [Yuan, Ying] Chongqing Med Univ, Affiliated Hosp 1, Dept Gen Surg, Chongqing, Peoples R China; [Tao, Kun] Chongqing Med Univ, Dept Immunol, Chongqing, Peoples R China; [Wang, Xin; Xiao, Qing] Chongqing Med Univ, Affiliated Hosp 1, Dept Hematol, Chongqing, Peoples R China; [Wen, Jianping] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON L8S 4L8, Canada	Chongqing Medical University; Chongqing Medical University; Chongqing Medical University; Chongqing Medical University; Chongqing Medical University; McMaster University	Feng, WL (corresponding author), Chongqing Med Univ, Minist Educ, Key Lab Lab Med Diagnost, Chongqing, Peoples R China.	fengwlcqmu@sina.com			Doctor Foundation of school of Medical Lab Science, Chongqing Medical University	Doctor Foundation of school of Medical Lab Science, Chongqing Medical University	This work was supported by the Doctor Foundation of school of Medical Lab Science, Chongqing Medical University to Yajuan Li. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2001, CELL, V107, P823, DOI 10.1016/S0092-8674(01)00616-X; Bo JJ, 2011, FEBS J, V278, P786, DOI 10.1111/j.1742-4658.2010.07997.x; Bueno MJ, 2008, CANCER CELL, V13, P496, DOI 10.1016/j.ccr.2008.04.018; Chekulaeva M, 2009, CURR OPIN CELL BIOL, V21, P452, DOI 10.1016/j.ceb.2009.04.009; Druker BJ, 2003, EXPERT OPIN PHARMACO, V4, P963, DOI 10.1517/14656566.4.6.963; Garzon R, 2006, TRENDS MOL MED, V12, P580, DOI 10.1016/j.molmed.2006.10.006; Goldman JM, 2003, NEW ENGL J MED, V349, P1451, DOI 10.1056/NEJMra020777; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538; Bueno MJ, 2008, CELL CYCLE, V7, P3143, DOI 10.4161/cc.7.20.6833; Koldehoff M, 2010, HAEMATOL-HEMATOL J, V95, P388, DOI 10.3324/haematol.2009.016063; Lee YS, 2006, CURR OPIN INVEST DR, V7, P560; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; Peng Z, 2011, ONCOL REP, V25, P1381, DOI 10.3892/or.2011.1197; Scherr M, 2003, BLOOD, V101, P1566, DOI 10.1182/blood-2002-06-1685; Shah NP, 2004, SCIENCE, V305, P399, DOI 10.1126/science.1099480; Sonkoly E, 2010, J INVEST DERMATOL, V130, P124, DOI 10.1038/jid.2009.294; Viticchie G, 2011, CELL CYCLE, V10, P1121, DOI 10.4161/cc.10.7.15180; Wang V, 2009, BIODRUGS, V23, P15, DOI 10.2165/00063030-200923010-00002; Wilda M, 2002, ONCOGENE, V21, P5716, DOI 10.1038/sj.onc.1205653; Wohlbold L, 2003, BLOOD, V102, P2236, DOI 10.1182/blood-2002-12-3899	20	30	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2013	8	4							e61858	10.1371/journal.pone.0061858	http://dx.doi.org/10.1371/journal.pone.0061858			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130DR	23613955	Green Published, gold, Green Submitted			2022-12-25	WOS:000317893400120
J	Umapathy, NS; Kaczmarek, E; Fatteh, N; Burns, N; Lucas, R; Stenmark, KR; Verin, AD; Gerasimovskaya, EV				Umapathy, Nagavedi Siddaramappa; Kaczmarek, Elzbieta; Fatteh, Nooreen; Burns, Nana; Lucas, Rudolf; Stenmark, Kurt R.; Verin, Alexander D.; Gerasimovskaya, Evgenia V.			Adenosine A1 Receptors Promote Vasa Vasorum Endothelial Cell Barrier Integrity via G(i) and Akt-Dependent Actin Cytoskeleton Remodeling	PLOS ONE			English	Article							PHENOTYPIC HETEROGENEITY; ADENOSINE RECEPTORS; GAP FORMATION; HYPOXIA; PERMEABILITY; LUNG; ACTIVATION; TNF; ATP; ENHANCEMENT	Background: In a neonatal model of hypoxic pulmonary hypertension, a dramatic pulmonary artery adventitial thickening, accumulation of inflammatory cells in the adventitial compartment, and angiogenic expansion of the vasa vasorum microcirculatory network are observed. These pathophysiological responses suggest that rapidly proliferating vasa vasorum endothelial cells (VVEC) may exhibit increased permeability for circulating blood cells and macromolecules. However, the molecular mechanisms underlying these observations remain unexplored. Some reports implicated extracellular adenosine in the regulation of vascular permeability under hypoxic and inflammatory conditions. Thus, we aimed to determine the role of adenosine in barrier regulation of VVEC isolated from the pulmonary arteries of normoxic (VVEC-Co) or chronically hypoxic (VVEC-Hyp) neonatal calves. Principal Findings: We demonstrate via a transendothelial electrical resistance measurement that exogenous adenosine significantly enhanced the barrier function in VVEC-Co and, to a lesser extent, in VVEC-Hyp. Our data from a quantitative reverse transcription polymerase chain reaction show that both VVEC-Co and VVEC-Hyp express all four adenosine receptors (A1, A2A, A2B, and A3), with the highest expression level of A1 receptors (A1Rs). However, A1R expression was significantly lower in VVEC-Hyp compared to VVEC-Co. By using an A1R-specific agonist/antagonist and siRNA, we demonstrate that A1Rs are mostly responsible for adenosine-induced enhancement in barrier function. Adenosine-induced barrier integrity enhancement was attenuated by pretreatment of VVEC with pertussis toxin and GSK690693 or LY294002, suggesting the involvement of Gi proteins and the PI3K-Akt pathway. Moreover, we reveal a critical role of actin cytoskeleton in VVEC barrier regulation by using specific inhibitors of actin and microtubule polymerization. Further, we show that adenosine pretreatment blocked the tumor necrosis factor alpha (TNF-alpha)-induced permeability in VVEC-Co, validating its anti-inflammatory effects. Conclusions: We demonstrate for the first time that stimulation of A1Rs enhances the barrier function in VVEC by activation of the Gi/PI3K/Akt pathway and remodeling of actin microfilament.	[Umapathy, Nagavedi Siddaramappa; Fatteh, Nooreen; Lucas, Rudolf; Verin, Alexander D.] Georgia Regents Univ, Vasc Biol Ctr, Augusta, GA 30912 USA; [Umapathy, Nagavedi Siddaramappa; Lucas, Rudolf; Verin, Alexander D.] Georgia Regents Univ, Div Pulm Med, Augusta, GA USA; [Kaczmarek, Elzbieta] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Ctr Vasc Biol Res,Dept Surg, Boston, MA 02215 USA; [Burns, Nana; Stenmark, Kurt R.; Gerasimovskaya, Evgenia V.] Univ Colorado, Dept Pediat, Aurora, CO USA; [Lucas, Rudolf] Georgia Regents Univ, Dept Pharmacol & Toxicol, Augusta, GA USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University of Colorado System; University of Colorado Anschutz Medical Campus; University System of Georgia; Augusta University	Umapathy, NS (corresponding author), Georgia Regents Univ, Vasc Biol Ctr, Augusta, GA 30912 USA.	usiddaramappa@georgiahealth.edu	stenmark, kurt/AFI-6776-2022; stenmark, kurt/AAH-3124-2022; Lucas, Rudolf/ABA-3011-2020		NSU (Biomedical Research Grant, American Lung Association, Southeast); ADV (NHLBI) [HL 083327]; EVG (NHLBI) [086783]; EK (NHLBI) [HL106227]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094609, R01HL114887, R21HL106227, R01HL083327, R01HL086783] Funding Source: NIH RePORTER	NSU (Biomedical Research Grant, American Lung Association, Southeast); ADV (NHLBI); EVG (NHLBI); EK (NHLBI); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported, in part, by grants, NSU (Biomedical Research Grant, American Lung Association, Southeast), ADV (NHLBI # HL 083327), EVG (NHLBI # 086783), and EK (NHLBI # HL106227). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aird WC, 2007, CIRC RES, V100, P158, DOI 10.1161/01.RES.0000255691.76142.4a; Aird WC, 2007, CIRC RES, V100, P174, DOI 10.1161/01.RES.0000255690.03436.ae; BARGER AC, 1984, NEW ENGL J MED, V310, P175, DOI 10.1056/NEJM198401193100307; Birukova AA, 2004, MICROVASC RES, V67, P64, DOI 10.1016/j.mvr.2003.09.007; Birukova AA, 2007, FASEB J, V21, P2776, DOI 10.1096/fj.06-7660com; Budhiraja R, 2004, CIRCULATION, V109, P159, DOI 10.1161/01.CIR.0000102381.57477.50; Burnstock G, 2006, PHARMACOL REV, V58, P58, DOI 10.1124/pr.58.1.5; Creighton J, 2011, FASEB J, V25, P3356, DOI 10.1096/fj.10-179218; Eckle T, 2008, BLOOD, V111, P2024, DOI 10.1182/blood-2007-10-117044; Eltzschig HK, 2004, BLOOD, V104, P3986, DOI 10.1182/blood-2004-06-2066; Eltzschig HK, 2003, J EXP MED, V198, P783, DOI 10.1084/jem.20030891; Enomoto A, 2005, DEV CELL, V9, P389, DOI 10.1016/j.devcel.2005.08.001; Erlinge D, 2008, PURINERG SIGNAL, V4, P1, DOI 10.1007/s11302-007-9078-7; Finigan JH, 2005, J BIOL CHEM, V280, P17286, DOI 10.1074/jbc.M412427200; Fredholm BB, 2001, PHARMACOL REV, V53, P527; Frid MG, 2009, AM J PHYSIOL-LUNG C, V297, pL1059, DOI 10.1152/ajplung.90611.2008; Frid MG, 2006, AM J PATHOL, V168, P659, DOI 10.2353/ajpath.2006.050599; Friedl J, 2002, BLOOD, V100, P1334, DOI 10.1182/blood.V100.4.1334.h81602001334_1334_1339; GARCIA JGN, 1995, J INVEST MED, V43, P117; Gerasimovskaya EV, 2008, ANGIOGENESIS, V11, P169, DOI 10.1007/s10456-007-9087-8; Gessi S, 2011, EXPERT OPIN INV DRUG, V20, P1591, DOI 10.1517/13543784.2011.627853; Hasegawa T, 2008, CIRC RES, V103, P1410, DOI 10.1161/CIRCRESAHA.108.180059; Hasko G, 2004, TRENDS IMMUNOL, V25, P33, DOI 10.1016/j.it.2003.11.003; Hayden MR, 2004, CARDIOVASC DIABETOL, V3, DOI 10.1186/1475-2840-3-1; Heller AR, 2007, EUR J ANAESTH, V24, P258, DOI 10.1017/S026502150600144X; Henttinen T, 2003, J BIOL CHEM, V278, P24888, DOI 10.1074/jbc.M300779200; Jacobson JR, 2006, AM J PHYSIOL-LUNG C, V291, pL289, DOI 10.1152/ajplung.00343.2005; Kiemer AK, 2002, CIRC RES, V90, P874, DOI 10.1161/01.RES.0000017068.58856.F3; Kolosova IA, 2005, CIRC RES, V97, P115, DOI 10.1161/01.RES.0000175561.55761.69; Komarova Y, 2010, ANNU REV PHYSIOL, V72, P463, DOI 10.1146/annurev-physiol-021909-135833; Linden J, 2001, ANNU REV PHARMACOL, V41, P775, DOI 10.1146/annurev.pharmtox.41.1.775; Liu F, 2002, FASEB J, V16, P950, DOI 10.1096/fj.01-0870com; Liu FQ, 2008, EXP CELL RES, V314, P1327, DOI 10.1016/j.yexcr.2008.01.007; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu Q, 2010, AM J PHYSIOL-LUNG C, V298, pL755, DOI 10.1152/ajplung.00330.2009; Maggiorini M, 2006, CARDIOVASC RES, V72, P41, DOI 10.1016/j.cardiores.2006.07.004; Mehta D, 2006, PHYSIOL REV, V86, P279, DOI 10.1152/physrev.00012.2005; Merighi S, 2003, PHARMACOL THERAPEUT, V100, P31, DOI 10.1016/S0163-7258(03)00084-6; Morote-Garcia JC, 2008, BLOOD, V111, P5571, DOI 10.1182/blood-2007-11-126763; MULLIGAN MS, 1993, AM J PATHOL, V142, P1739; Nakav S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002107; Narravula S, 2000, J IMMUNOL, V165, P5262, DOI 10.4049/jimmunol.165.9.5262; Ngamsri KC, 2010, J IMMUNOL, V185, P4374, DOI 10.4049/jimmunol.1000433; Park SW, 2010, J PHARMACOL EXP THER, V333, P736, DOI 10.1124/jpet.110.166884; PATY PSK, 1992, AM J PHYSIOL, V262, pH771, DOI 10.1152/ajpheart.1992.262.3.H771; Petrache I, 2003, AM J RESP CELL MOL, V28, P574, DOI 10.1165/rcmb.2002-0075OC; Rajsheker S, 2010, CURR OPIN PHARMACOL, V10, P191, DOI 10.1016/j.coph.2009.11.005; Sahara M, 2007, CIRCULATION, V115, P509, DOI 10.1161/CIRCULATIONAHA.106.655837; Sayner SL, 2011, AM J PHYSIOL-LUNG C, V300, pL667, DOI 10.1152/ajplung.00433.2010; Singleton PA, 2009, CIRC RES, V104, P978, DOI 10.1161/CIRCRESAHA.108.193367; Soon E, 2010, CIRCULATION, V122, P921, DOI 10.1161/CIRCULATIONAHA.109.933762; Srinivas SP, 2004, EXP EYE RES, V79, P543, DOI 10.1016/j.exer.2004.06.027; STENMARK KR, 1991, AM J PHYSIOL, V261, P97, DOI 10.1152/ajplung.1991.261.4.L97; Stenmark KR, 2006, CIRC RES, V99, P675, DOI 10.1161/01.RES.0000243584.45145.3f; Taylor CT, 1998, GASTROENTEROLOGY, V114, P657, DOI 10.1016/S0016-5085(98)70579-7; Thompson LF, 2004, J EXP MED, V200, P1395, DOI 10.1084/Jem.20040915; Tilley SL, 2000, J CLIN INVEST, V105, P361, DOI 10.1172/JCI8253; Tsutsui S, 2004, J NEUROSCI, V24, P1521, DOI 10.1523/JNEUROSCI.4271-03.2004; TUDER RM, 1994, AM J PATHOL, V144, P275; Tuder RM, 2007, J MOL MED, V85, P1317, DOI 10.1007/s00109-007-0280-4; Umapathy NS, 2010, VASC PHARMACOL, V52, P199, DOI 10.1016/j.vph.2009.12.008; Umapathy NS, 2010, J CELL PHYSIOL, V223, P215, DOI 10.1002/jcp.22029; Vandenbroucke E, 2008, ANN NY ACAD SCI, V1123, P134, DOI 10.1196/annals.1420.016; VERIN AD, 1995, AM J PHYSIOL-LUNG C, V269, pL99, DOI 10.1152/ajplung.1995.269.1.L99; Wojciak-Stothard B, 2006, AM J PHYSIOL-LUNG C, V290, pL1173, DOI 10.1152/ajplung.00309.2005; Woodward HN, 2009, AM J PHYSIOL-LUNG C, V297, pL954, DOI 10.1152/ajplung.00038.2009; Xing JJ, 2010, MICROVASC RES, V79, P56, DOI 10.1016/j.mvr.2009.11.006; Yegutkin GG, 2011, ANGIOGENESIS, V14, P503, DOI 10.1007/s10456-011-9234-0; Yildiz G, 2007, EUR J PHARMACOL, V556, P144, DOI 10.1016/j.ejphar.2006.11.008; Yu X, 2012, J MOL CELL CARDIOL, V53, P848, DOI 10.1016/j.yjmcc.2012.10.002; Zimmermann H, 2000, N-S ARCH PHARMACOL, V362, P299, DOI 10.1007/s002100000309	71	27	27	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2013	8	4							e59733	10.1371/journal.pone.0059733	http://dx.doi.org/10.1371/journal.pone.0059733			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130DR	23613714	Green Submitted, gold, Green Published			2022-12-25	WOS:000317893400003
J	Luo, QX; Dong, YY; Chen, HJ; Gao, HC				Luo, Qixia; Dong, Yangyang; Chen, Haijiang; Gao, Haichun			Mislocalization of Rieske Protein PetA Predominantly Accounts for the Aerobic Growth Defect of tat Mutants in Shewanella oneidensis	PLOS ONE			English	Article							ARGININE TRANSLOCATION PATHWAY; GREEN FLUORESCENT PROTEIN; ESCHERICHIA-COLI; DEPENDENT TRANSLOCATION; TRANSPORT-SYSTEM; FE/S PROTEIN; GENOME; EXPORT; GENES; MR-1	Shewanella oneidensis exhibits a remarkable versatility in respiration, which largely relies on its various respiratory pathways. Most of these pathways are composed of secretory terminal reductases and multiple associated electron transport proteins that contain cofactors such as Fe-S, molybdopterin, and NiFe. The majority of these cofactors are inserted enzymatically in the cytoplasm, and thus are substrates of the twin-arginine translocation (Tat) protein export system, which transports fully folded proteins. Using genomic array footprinting, we discovered that loss of TatA or TatC caused a reduction in the growth rate of S. oneidensis under aerobic conditions. Mutational analysis of the predicted Tat substrates revealed that PetA, the Rieske Fe-S subunit of the ubiquinol-cytochrome c reductase, predominantly dictates the aerobic growth defect of tat mutants in S. oneidensis. In addition, evidence is presented that the signal sequence in PetA appears to be resistant to cleavage after the protein is inserted into the cytoplasmic membrane.	[Gao, Haichun] Zhejiang Univ, Inst Microbiol, Hangzhou 310003, Zhejiang, Peoples R China; Zhejiang Univ, Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Gao, HC (corresponding author), Zhejiang Univ, Inst Microbiol, Hangzhou 310003, Zhejiang, Peoples R China.	haichung@zju.edu.cn	Gao, Haichun/AFU-4588-2022; Chen, Haijiang/D-1893-2009; Gao, Haichun/A-2160-2014	Gao, Haichun/0000-0002-2647-6563; Gao, Haichun/0000-0002-2647-6563	Major State Basic Research Development Program (973 Program) [2010CB833803]; National Natural Science Foundation of China [31270097]; Natural Science Foundation of Zhejiang province [R3110096]; Major Program of Science and Technology Department of Zhejiang [2009C12061]	Major State Basic Research Development Program (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang province(Natural Science Foundation of Zhejiang Province); Major Program of Science and Technology Department of Zhejiang	This research was supported by Major State Basic Research Development Program (973 Program: 2010CB833803), National Natural Science Foundation of China (31270097), and Natural Science Foundation of Zhejiang province (R3110096) and Major Program of Science and Technology Department of Zhejiang (2009C12061) to HG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXEYEV MF, 1995, GENE, V160, P59, DOI 10.1016/0378-1119(95)00141-R; Bachmann J, 2006, FEBS J, V273, P4817, DOI 10.1111/j.1742-4658.2006.05480.x; Bagos PG, 2010, BIOINFORMATICS, V26, P2811, DOI 10.1093/bioinformatics/btq530; Barnett JP, 2008, J BIOL CHEM, V283, P2534, DOI 10.1074/jbc.M708134200; Bendtsen JD, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-167; Bijlsma JJE, 2007, APPL ENVIRON MICROB, V73, P1514, DOI 10.1128/AEM.01900-06; Biswas L, 2009, J BACTERIOL, V191, P5921, DOI 10.1128/JB.00642-09; Blaudeck N, 2005, J BIOL CHEM, V280, P3426, DOI 10.1074/jbc.M411210200; Brown RN, 2010, J PROTEOME RES, V9, P4454, DOI 10.1021/pr100215h; Chang CY, 2011, MICROBIOL-SGM, V157, P3079, DOI 10.1099/mic.0.052449-0; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; De Buck E, 2005, BIOCHEM BIOPH RES CO, V331, P1413, DOI 10.1016/j.bbrc.2005.04.060; De Buck E, 2008, TRENDS MICROBIOL, V16, P442, DOI 10.1016/j.tim.2008.06.004; De Buck E, 2007, FEBS LETT, V581, P259, DOI 10.1016/j.febslet.2006.12.022; Dilks K, 2003, J BACTERIOL, V185, P1478, DOI 10.1128/JB.185.4.1478-1483.2003; Ding ZY, 2003, J BACTERIOL, V185, P760, DOI 10.1128/JB.185.3.760-771.2003; Dreusch A, 1997, BBA-BIOENERGETICS, V1319, P311, DOI 10.1016/S0005-2728(96)00174-0; Elias DA, 2005, PROTEOMICS, V5, P3120, DOI 10.1002/pmic.200401140; Feilmeier BJ, 2000, J BACTERIOL, V182, P4068, DOI 10.1128/JB.182.14.4068-4076.2000; Fredrickson JK, 2008, NAT REV MICROBIOL, V6, P592, DOI 10.1038/nrmicro1947; Frobel J, 2012, PHILOS T R SOC B, V367, P1029, DOI 10.1098/rstb.2011.0202; Gao HC, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-42; Gao HC, 2007, APPL ENVIRON MICROB, V73, P563, DOI 10.1128/AEM.01771-06; Gao HC, 2010, MICROB BIOTECHNOL, V3, P455, DOI 10.1111/j.1751-7915.2010.00181.x; Gao HC, 2009, ISME J, V3, P966, DOI 10.1038/ismej.2009.40; Gao HC, 2004, J BACTERIOL, V186, P7796, DOI 10.1128/JB.186.22.7796-7803.2004; Gonzalez ET, 2007, APPL ENVIRON MICROB, V73, P3779, DOI 10.1128/AEM.02999-06; Gralnick JA, 2005, MOL MICROBIOL, V56, P1347, DOI 10.1111/j.1365-2958.2005.04628.x; Groh JL, 2005, APPL ENVIRON MICROB, V71, P7064, DOI 10.1128/AEM.71.11.7064-7074.2005; Hatzixanthis K, 2003, MOL MICROBIOL, V49, P1377, DOI 10.1046/j.1365-2958.2003.03642.x; Heidelberg JF, 2002, NAT BIOTECHNOL, V20, P1118, DOI 10.1038/nbt749; Heidrich C, 2001, MOL MICROBIOL, V41, P167, DOI 10.1046/j.1365-2958.2001.02499.x; Hinsley AP, 2001, FEBS LETT, V497, P45, DOI 10.1016/S0014-5793(01)02428-0; Ignatova Z, 2002, BIOCHEM BIOPH RES CO, V291, P146, DOI 10.1006/bbrc.2002.6420; Jack RL, 2001, J BACTERIOL, V183, P1801, DOI 10.1128/JB.183.5.1801-1804.2001; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lee PA, 2006, ANNU REV MICROBIOL, V60, P373, DOI 10.1146/annurev.micro.60.080805.142212; Liang YL, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-291; Lindenstrauss U, 2010, FEBS LETT, V584, P3644, DOI 10.1016/j.febslet.2010.07.039; McDonough JA, 2005, J BACTERIOL, V187, P7667, DOI 10.1128/JB.187.22.7667-7679.2005; Meyer TE, 2004, OMICS, V8, P57, DOI 10.1089/153623104773547499; Molik S, 2001, J BIOL CHEM, V276, P42761, DOI 10.1074/jbc.M106690200; Molzen TE, 2011, INFECT IMMUN, V79, P288, DOI 10.1128/IAI.00631-10; Nijeholt JALA, 2012, PHILOS T R SOC B, V367, P1016, DOI 10.1098/rstb.2011.0201; Palmer T, 2012, NAT REV MICROBIOL, V10, P483, DOI 10.1038/nrmicro2814; Papanikou E, 2007, NAT REV MICROBIOL, V5, P839, DOI 10.1038/nrmicro1771; Pickering BS, 2010, J BACTERIOL, V192, P5173, DOI 10.1128/JB.00206-10; Rajashekara G, 2009, FOODBORNE PATHOG DIS, V6, P935, DOI 10.1089/fpd.2009.0298; Rodrigue A, 1999, J BIOL CHEM, V274, P13223, DOI 10.1074/jbc.274.19.13223; Romine MF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-S1-S1; Rose RW, 2002, MOL MICROBIOL, V45, P943, DOI 10.1046/j.1365-2958.2002.03090.x; Sauve V, 2007, J BIOL CHEM, V282, P23194, DOI 10.1074/jbc.M701602200; Serres MH, 2006, J BACTERIOL, V188, P4601, DOI 10.1128/JB.01787-05; Stanley NR, 2001, J BACTERIOL, V183, P139, DOI 10.1128/JB.183.1.139-144.2001; Thomas JD, 2001, MOL MICROBIOL, V39, P47, DOI 10.1046/j.1365-2958.2001.02253.x; TRUMPOWER BL, 1990, MICROBIOL REV, V54, P101, DOI 10.1128/MMBR.54.2.101-129.1990; Widdick DA, 2011, MOL MICROBIOL, V80, P1395, DOI 10.1111/j.1365-2958.2011.07656.x; Wu L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021479	59	47	47	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2013	8	4							e62064	10.1371/journal.pone.0062064	http://dx.doi.org/10.1371/journal.pone.0062064			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123JA	23593508	Green Published, gold, Green Submitted			2022-12-25	WOS:000317383200065
J	Teh, HF; Neoh, BK; Hong, MPL; Low, JYS; Ng, TLM; Ithnin, N; Thang, YM; Mohamed, M; Chew, FT; Yusof, HM; Kulaveerasingam, H; Appleton, DR				Teh, Huey Fang; Neoh, Bee Keat; Hong, May Ping Li; Low, Jaime Yoke Sum; Ng, Theresa Lee Mei; Ithnin, Nalisha; Thang, Yin Mee; Mohamed, Mohaimi; Chew, Fook Tim; Yusof, Hirzun Mohd; Kulaveerasingam, Harikrishna; Appleton, David R.			Differential Metabolite Profiles during Fruit Development in High-Yielding Oil Palm Mesocarp	PLOS ONE			English	Article							FATTY-ACID SYNTHESIS; BRASSICA-NAPUS L.; PLANT METABOLOMICS; ELAEIS-GUINEENSIS; FUNCTIONAL GENOMICS; DEVELOPING SEEDS; REVEALS; CARBON; GENES; OLIVE	To better understand lipid biosynthesis in oil palm mesocarp, in particular the differences in gene regulation leading to and including de novo fatty acid biosynthesis, a multi-platform metabolomics technology was used to profile mesocarp metabolites during six critical stages of fruit development in comparatively high- and low-yielding oil palm populations. Significantly higher amino acid levels preceding lipid biosynthesis and nucleosides during lipid biosynthesis were observed in a higher yielding commercial palm population. Levels of metabolites involved in glycolysis revealed interesting divergence of flux towards glycerol-3-phosphate, while carbon utilization differences in the TCA cycle were proven by an increase in malic acid/citric acid ratio. Apart from insights into the regulation of enhanced lipid production in oil palm, these results provide potentially useful metabolite yield markers and genes of interest for use in breeding programmes.	[Teh, Huey Fang; Neoh, Bee Keat; Hong, May Ping Li; Low, Jaime Yoke Sum; Ng, Theresa Lee Mei; Ithnin, Nalisha; Thang, Yin Mee; Yusof, Hirzun Mohd; Kulaveerasingam, Harikrishna; Appleton, David R.] Univ Putra Malaysia, Sime Darby Technol Ctr, Lebuh Silikon, Serdang, Selangor, Malaysia; [Mohamed, Mohaimi] Sime Darby Res, Banting, Selangor, Malaysia; [Chew, Fook Tim] Natl Univ Singapore, Fac Sci, Dept Biol Sci, Singapore 117548, Singapore	Universiti Putra Malaysia; National University of Singapore	Teh, HF (corresponding author), Univ Putra Malaysia, Sime Darby Technol Ctr, Lebuh Silikon, Serdang, Selangor, Malaysia.	teh.huey.fang@simedarby.com	Chew, Fook Tim/E-7259-2010; Neoh, Bee Keat/H-4445-2016	Chew, Fook Tim/0000-0003-1337-5146; Neoh, Bee Keat/0000-0002-6973-696X	National Science Foundation (NSF) [MCB 0455318, MCB 0920663, DBI 0521587]; Kansas INBRE (National Institutes of Health (NIH) Grant from the INBRE program of the National Center for Research Resources) [P20 RR16475]; NSF EPSCoR grant [EPS-0236913]; Kansas Technology Enterprise Corporation; Kansas State University; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016475] Funding Source: NIH RePORTER	National Science Foundation (NSF)(National Science Foundation (NSF)); Kansas INBRE (National Institutes of Health (NIH) Grant from the INBRE program of the National Center for Research Resources)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF EPSCoR grant; Kansas Technology Enterprise Corporation; Kansas State University; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Instrument acquisition and method development at KLRC was supported by National Science Foundation (NSF) grants MCB 0455318, MCB 0920663, and DBI 0521587, Kansas INBRE (National Institutes of Health (NIH) Grant P20 RR16475 from the INBRE program of the National Center for Research Resources), NSF EPSCoR grant EPS-0236913, Kansas Technology Enterprise Corporation, and Kansas State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Troncoso-Ponce MA, 2010, PLANT PHYSIOL BIOCH, V48, P961, DOI 10.1016/j.plaphy.2010.09.012; Basiron Y, 2007, EUR J LIPID SCI TECH, V109, P289, DOI 10.1002/ejlt.200600223; Billotte N, 2010, THEOR APPL GENET, V120, P1673, DOI 10.1007/s00122-010-1284-y; Bourgis F, 2011, P NATL ACAD SCI USA, V108, P12527, DOI 10.1073/pnas.1106502108; De Vos RCH, 2007, NAT PROTOC, V2, P778, DOI 10.1038/nprot.2007.95; Devaiah SP, 2006, PHYTOCHEMISTRY, V67, P1907, DOI 10.1016/j.phytochem.2006.06.005; DONAIRE JP, 1975, PHYTOCHEMISTRY, V14, P1167, DOI 10.1016/S0031-9422(00)98588-1; Fait A, 2008, PLANT PHYSIOL, V148, P730, DOI 10.1104/pp.108.120691; Fiehn O, 2000, NAT BIOTECHNOL, V18, P1157, DOI 10.1038/81137; Galla G, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-128; Hajduch M, 2007, J PROTEOME RES, V6, P3232, DOI 10.1021/pr070149a; Hajduch M, 2011, PROTEOMICS, V11, P1619, DOI 10.1002/pmic.201000644; Hayden DM, 2011, PLANT J, V67, P1018, DOI 10.1111/j.1365-313X.2011.04654.x; Kulaveerasingam H, UNPUB; Liu P, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-132; Low ETL, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-62; MACLELLAN M, 1983, J AM OIL CHEM SOC, V60, P368, DOI 10.1007/BF02543520; Matthes M, 2001, THEOR APPL GENET, V102, P971, DOI 10.1007/s001220000491; Mayes S, 2000, HEREDITY, V85, P288, DOI 10.1046/j.1365-2540.2000.00758.x; Murphy DJ., 2009, LIPID TECH, V21, P257, DOI DOI 10.1002/LITE.200900067; Okoye M., 2009, AM EURASIAN J SCI RE, V4, P59; Osorio S, 2011, PLANT PHYSIOL, V157, P405, DOI 10.1104/pp.111.175463; Osuji G. O., 2010, INT J BIOTECHNOLOGY, V3, P455; Pleite R, 2005, J EXP BOT, V56, P1297, DOI 10.1093/jxb/eri130; Ramli US, 2005, FEBS J, V272, P5764, DOI 10.1111/j.1742-4658.2005.04964.x; Rival A, 2010, OCL OILS FAT CROP LI, V17, P368, DOI 10.1051/ocl.2010.0341; Sambanthamurthi R, 2000, PROG LIPID RES, V39, P507, DOI 10.1016/S0163-7827(00)00015-1; SAMBANTHAMURTHI R, 1987, PLANT SCI, V51, P97, DOI 10.1016/0168-9452(87)90225-1; San CT, 2005, MOL BIOL REP, V32, P227, DOI 10.1007/s11033-005-3142-6; Schauer N, 2006, TRENDS PLANT SCI, V11, P508, DOI 10.1016/j.tplants.2006.08.007; Seng TY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026593; Smirnoff N, 2001, ANNU REV PLANT PHYS, V52, P437, DOI 10.1146/annurev.arplant.52.1.437; SMITH RG, 1992, PLANT PHYSIOL, V98, P1233, DOI 10.1104/pp.98.4.1233; Soga Tomoyoshi, 2007, V358, P129, DOI 10.1007/978-1-59745-244-1_8; Sumner LW, 2003, PHYTOCHEMISTRY, V62, P817, DOI 10.1016/S0031-9422(02)00708-2; Tran LSP, 2010, FUNCT INTEGR GENOMIC, V10, P447, DOI 10.1007/s10142-010-0178-z; Tranbarger TJ, 2011, PLANT PHYSIOL, V156, P564, DOI 10.1104/pp.111.175141; Troncoso-Ponce MA, 2011, PLANT J, V68, P1014, DOI 10.1111/j.1365-313X.2011.04751.x; Vigeolas H, 2004, PLANTA, V219, P827, DOI 10.1007/s00425-004-1273-y; Vigeolas H, 2007, PLANT BIOTECHNOL J, V5, P431, DOI 10.1111/j.1467-7652.2007.00252.x; Weselake RJ, 2009, BIOTECHNOL ADV, V27, P866, DOI 10.1016/j.biotechadv.2009.07.001; Wu XL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-469; Zrenner R, 2006, ANNU REV PLANT BIOL, V57, P805, DOI 10.1146/annurev.arplant.57.032905.105421	43	35	37	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2013	8	4							e61344	10.1371/journal.pone.0061344	http://dx.doi.org/10.1371/journal.pone.0061344			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123JA	23593468	Green Published, Green Submitted, gold			2022-12-25	WOS:000317383200054
J	Peterson, CL; Kaufmann, GS; Vandello, C; Richardson, ML				Peterson, Cheryl L.; Kaufmann, Gregory S.; Vandello, Christopher; Richardson, Matthew L.			Parent Genotype and Environmental Factors Influence Introduction Success of the Critically Endangered Savannas Mint (Dicerandra immaculata var. savannarum)	PLOS ONE			English	Article							POPULATION VIABILITY ANALYSIS; LAKE WALES RIDGE; BIODIVERSITY HOTSPOTS; ERYNGIUM-CUNEIFOLIUM; SPATIAL-DISTRIBUTION; COMMUNITY STRUCTURE; FLORIDA; FIRE; PLANT; MICROHABITAT	Species previously unknown to science are continually discovered and some of these species already face extinction at the time of their discovery. Conserving new and rare species in these cases becomes a trial-and-error process and conservationists will attempt to manage them by using knowledge of closely related species, or those that fill the same ecological niche, and then adapting the management program as needed. Savannas Mint (Dicerandra immaculata Lakela var. savannarum Huck) is a perennial plant that was discovered in Florida scrub habitat at two locations in 1995, but is nearly extinct at these locations. We tested whether shade, leaf litter, propagation method, parent genotype, parent collection site, planting date, and absorbent granules influenced survival, reproduction, and recruitment of Savannas Mint in a population of 1,614 plants that we introduced between June 2006 and July 2009 into a state protected site. Survival and reproduction of introduced plants, and recruitment of new plants, was higher in microhabitats in full sun and no leaf litter and lower in partially shaded habitats. The two sites from which parent plants were collected differentially influenced survival and reproduction of introduced plants. These differences in survival and reproduction are likely due to underlying genetic differences. Differential survival of progeny from different parent genotypes further supports the idea that underlying genetics is an important consideration when restoring plant populations. The most successful progeny of parent genotypes had survival rates nearly 12 times higher than the least successful progeny. We speculate that many of these environmental and genetic factors are likely to influence allopatric congeners and other critically endangered gap specialists that grow in Florida scrub and our results can be used to guide their conservation.	[Peterson, Cheryl L.] Bok Tower Gardens, Rare Plant Conservat Program, Lake Wales, FL USA; [Kaufmann, Gregory S.] Bur Nat & Cultural Resources, Florida Dept Environm Protect, Florida Pk Serv, Tallahassee, FL USA; [Vandello, Christopher] Florida Pk Serv, Florida Dept Environm Protect, Jensen Beach, FL USA; [Richardson, Matthew L.] ARS, USDA, US Hort Res Lab, Subtrop Insects Res Unit, Ft Pierce, FL USA	United States Department of Agriculture (USDA)	Peterson, CL (corresponding author), Bok Tower Gardens, Rare Plant Conservat Program, Lake Wales, FL USA.	cpeterson@boktower.org			U.S. Fish and Wildlife Service [1448-40181-00-G-003]; Florida Department of Agriculture and Consumer Services, Division of Plant Industry [011298, 013924, 014879]	U.S. Fish and Wildlife Service(US Fish & Wildlife Service); Florida Department of Agriculture and Consumer Services, Division of Plant Industry	This research was funded by grants from the U.S. Fish and Wildlife Service (grant agreement 1448-40181-00-G-003; http://www.fws.gov/southeast/) and the Florida Department of Agriculture and Consumer Services, Division of Plant Industry (contract #011298, #013924 and #014879; http://www.freshfromflorida.com/pi/) to CLP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON SS, 1989, ECOLOGY, V70, P1048, DOI 10.2307/1941373; CHRISTMAN S P, 1990, Florida Scientist, V53, P52; Crutsinger GM, 2006, SCIENCE, V313, P966, DOI 10.1126/science.1128326; Defler Thomas R., 2010, Primate Conservation, V25, P1, DOI 10.1896/052.025.0101; Dobson AP, 1997, SCIENCE, V275, P550, DOI 10.1126/science.275.5299.550; Estill James C., 2001, Castanea, V66, P3; Evans MEK, 2008, POPUL ECOL, V50, P53, DOI 10.1007/s10144-007-0060-6; FALK DA, 1992, RHODORA, V94, P287; Florida Natural Areas Inventory (FNAI), 2010, GUIDE NATURAL COMMUN, P69; Gigon A, 1996, J VEG SCI, V7, P29, DOI 10.2307/3236413; GORDON DR, 1994, NAT AREA J, V14, P31; Gutterman Yitzchak, 2000, Plant Species Biology, V15, P113, DOI 10.1046/j.1442-1984.2000.00032.x; HARTNETT DC, 1989, AM J BOT, V76, P361, DOI 10.2307/2444605; Huck R. B., 1997, Edinburgh Journal of Botany, V54, P217; Huck RB, 2001, NOVON, V11, P417, DOI 10.2307/3393153; HUCK RB, 1989, SYST BOT, V14, P197, DOI 10.2307/2418906; Johnson MTJ, 2006, ECOL LETT, V9, P24, DOI 10.1111/j.1461-0248.2005.00833.x; Joppa LN, 2011, P NATL ACAD SCI USA, V108, P13171, DOI 10.1073/pnas.1109389108; Joppa LN, 2011, P ROY SOC B-BIOL SCI, V278, P554, DOI 10.1098/rspb.2010.1004; Kephart SR, 1997, AM J BOT, V84, P179, DOI 10.2307/2446079; Kron P, 2006, SEX PLANT REPROD, V19, P125, DOI 10.1007/s00497-006-0028-2; Maunder M., 2004, EX SITU PLANT CONSER; Menges Eric S., 1999, P7; Menges ES, 2006, BIOL CONSERV, V127, P115, DOI 10.1016/j.biocon.2005.08.002; Menges ES, 1998, ECOL APPL, V8, P935, DOI 10.1890/1051-0761(1998)008[0935:IEOFAM]2.0.CO;2; Menges ES, 2004, ECOL MONOGR, V74, P79, DOI 10.1890/03-4029; Menges ES, 1999, J TORREY BOT SOC, V126, P24, DOI 10.2307/2997252; Menges ES, 1996, AM J BOT, V83, P185, DOI 10.2307/2445937; MENGES ES, 1992, B TORREY BOT CLUB, V119, P308, DOI 10.2307/2996762; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Oliveira LO, 2007, AM J BOT, V94, P1017, DOI 10.3732/ajb.94.6.1017; Peterson CL, 2008, GLOBAL REINTRODUCTIO; Pinhal D, 2012, MAR BIOL, V159, P829, DOI 10.1007/s00227-011-1858-5; Quintana-Ascencio PF, 2003, CONSERV BIOL, V17, P433, DOI 10.1046/j.1523-1739.2003.01431.x; Richardson ML, 2013, PLANT ECOL, V214, P443, DOI 10.1007/s11258-013-0181-2; Richardson ML, 2011, AM J BOT, V98, P1595, DOI 10.3732/ajb.1100018; SAS Institute, 2011, SAS STAT US GUID PER; Sokal RR., 2012, BIOMETRY PRINCIPLES; Sorrie Bruce A., 2001, Castanea, V66, P50; ZONA S, 1986, SIDA Contributions to Botany, V11, P417	40	5	7	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2013	8	4							e61429	10.1371/journal.pone.0061429	http://dx.doi.org/10.1371/journal.pone.0061429			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JB	23593479	Green Submitted, gold, Green Published			2022-12-25	WOS:000317909600112
J	Veldhuizen, EJA; Brouwer, EC; Schneider, VAF; Fluit, AC				Veldhuizen, Edwin J. A.; Brouwer, Ellen C.; Schneider, Viktoria A. F.; Fluit, Ad C.			Chicken Cathelicidins Display Antimicrobial Activity against Multiresistant Bacteria without Inducing Strong Resistance	PLOS ONE			English	Article							ANTIBACTERIAL PEPTIDES; ESCHERICHIA-COLI; IDENTIFICATION; PR-39	The increased prevalence of multidrug-resistant (MDR) bacteria in combination with the relatively limited development of new antibiotics presents a serious threat to public health. In chicken, especially Extended-Spectrum beta-Lactamase (ESBL) carrying Enterobacteriaceae are often asymptomatically present but can infect humans. Due to their broad range antimicrobial activity cathelicidins and other host defence peptides, are considered to be an attractive alternative to conventional antibiotics. In this study, the antimicrobial activity of three chicken cathelicidins against a broad array of multidrug resistant bacteria was determined. All three peptides showed high antibacterial activity independent of the presence of MDR characteristics. Induction experiments using S. aureus and K. pneumoniae showed that although an increase in resistance was initially observed, susceptibility towards chicken cathelicidins remained high and no major resistance was developed. The combined results underline the potential of chicken cathelicidins as a new alternative to antibiotics.	[Veldhuizen, Edwin J. A.; Schneider, Viktoria A. F.] Univ Utrecht, Fac Vet Med, Div Mol Host Def, Dept Infect Dis & Immunol, Utrecht, Netherlands; [Brouwer, Ellen C.; Fluit, Ad C.] Univ Med Ctr Utrecht, Dept Med Microbiol, Utrecht, Netherlands	Utrecht University; Utrecht University; Utrecht University Medical Center	Veldhuizen, EJA (corresponding author), Univ Utrecht, Fac Vet Med, Div Mol Host Def, Dept Infect Dis & Immunol, Utrecht, Netherlands.	E.J.A.Veldhuizen@uu.nl		Stronks, Karien/0000-0002-0921-2232; Kunst, Anton/0000-0002-3313-5273	SEED grant from the Infection & Immunity Center Utrecht of the University Medical Center Utrecht; University of Utrecht	SEED grant from the Infection & Immunity Center Utrecht of the University Medical Center Utrecht; University of Utrecht	The study was partly funded by a SEED grant from the Infection & Immunity Center Utrecht of the University Medical Center Utrecht and University of Utrecht. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Achanta M, 2012, J ANIM SCI BIOTECHNO, V3, DOI 10.1186/2049-1891-3-15; BELDEN WJ, 1994, INFECT IMMUN, V62, P5095, DOI 10.1128/IAI.62.11.5095-5101.1994; BOMAN HG, 1993, INFECT IMMUN, V61, P2978, DOI 10.1128/IAI.61.7.2978-2984.1993; Bommineni YR, 2007, FEBS J, V274, P418, DOI 10.1111/j.1742-4658.2006.05589.x; Clinical and Laboratory Standards Institute (CLSI), 2012, M100S22 CLSI; Fluit AC, 2012, CLIN MICROBIOL INFEC, V18, P735, DOI 10.1111/j.1469-0691.2012.03846.x; Goitsuka R, 2007, P NATL ACAD SCI USA, V104, P15063, DOI 10.1073/pnas.0707037104; Gould IM, 2012, INT J ANTIMICROB AG, V39, P96, DOI 10.1016/j.ijantimicag.2011.09.028; Guina T, 2000, J BACTERIOL, V182, P4077, DOI 10.1128/JB.182.14.4077-4086.2000; Guo L, 1998, CELL, V95, P189, DOI 10.1016/S0092-8674(00)81750-X; Kai-Larsen Y, 2008, FRONT BIOSCI, V13, P3760, DOI 10.2741/2964; Kondo N, 2001, ANTIMICROB AGENTS CH, V45, P815, DOI 10.1128/AAC.45.3.815-824.2001; Koprivnjak T, 2011, CELL MOL LIFE SCI, V68, P2243, DOI 10.1007/s00018-011-0716-4; Peschel A, 2002, TRENDS MICROBIOL, V10, P179, DOI 10.1016/S0966-842X(02)02333-8; Shafer WM, 1998, P NATL ACAD SCI USA, V95, P1829, DOI 10.1073/pnas.95.4.1829; Shi JH, 1996, ANTIMICROB AGENTS CH, V40, P115, DOI 10.1128/AAC.40.1.115; Thomassin JL, 2012, INFECT IMMUN, V80, P483, DOI 10.1128/IAI.05674-11; van Dijk A, 2005, VET IMMUNOL IMMUNOP, V106, P321, DOI 10.1016/j.vetimm.2005.03.003; van Dijk A, 2011, VET MICROBIOL, V153, P27, DOI 10.1016/j.vetmic.2011.03.028; van Dijk A, 2009, MOL IMMUNOL, V46, P2465, DOI 10.1016/j.molimm.2009.05.019; Veldhuizen EJA, 2008, MOL IMMUNOL, V45, P386, DOI 10.1016/j.molimm.2007.06.001; Wayne P.A., 2009, M07A8 CLIN LAB STAND; Woodford N, 2011, FEMS MICROBIOL REV, V35, P736, DOI 10.1111/j.1574-6976.2011.00268.x; Xiao YJ, 2009, J INNATE IMMUN, V1, P268, DOI 10.1159/000174822; Xiao YJ, 2006, J BIOL CHEM, V281, P2858, DOI 10.1074/jbc.M507180200	25	35	36	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2013	8	4							e61964	10.1371/journal.pone.0061964	http://dx.doi.org/10.1371/journal.pone.0061964			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JR	23874765	Green Published, gold, Green Submitted			2022-12-25	WOS:000317911500074
J	Kumar, R; Chaterjee, P; Sharma, PK; Singh, AK; Gupta, A; Gill, K; Tripathi, M; Dey, AB; Dey, S				Kumar, Rahul; Chaterjee, Prasun; Sharma, Prakash K.; Singh, Abhay K.; Gupta, Abhishek; Gill, Kamaldeep; Tripathi, Manjari; Dey, Aparajit B.; Dey, Sharmistha			Sirtuin1: A Promising Serum Protein Marker for Early Detection of Alzheimer's Disease	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; CALORIE RESTRICTION; NEURODEGENERATION; PLASMA; BLOOD	Sirtuin (SIRT) pathway has a crucial role in Alzheimer's disease (AD). The present study evaluated the alterations in serum sirtuin1 (SIRT1) concentration in healthy individuals (young and old) and patients with AD and mild cognitive impairment (MCI). Blood samples were collected from 40 AD and 9 MCI patients as cases and 22 young healthy adults and 22 healthy elderly individuals as controls. Serum SIRT1 was estimated by Surface Plasmon Resonance (SPR), Western Blot and Enzyme Linked Immunosorbent Assay (ELISA). A significant (p < 0.0001) decline in SIRT1 concentration was observed in patients with AD (2.27 +/- 0.46 ng/mu l) and MCI (3.64 +/- 0.15 ng/mu l) compared to healthy elderly individuals (4.82 +/- 0.4 ng/mu l). The serum SIRT1 concentration in healthy elderly was also significantly lower (p < 0.0001) compared to young healthy controls (8.16 +/- 0.87 ng/mu l). This study, first of its kind, has demonstrated, decline in serum concentration of SIRT1 in healthy individuals as they age. In patients with AD and MCI the decline was even more pronounced, which provides an opportunity to develop this protein as a predictive marker of AD in early stages with suitable cut off values.	[Kumar, Rahul; Singh, Abhay K.; Gupta, Abhishek; Gill, Kamaldeep; Dey, Sharmistha] All India Inst Med Sci, Dept Biophys, New Delhi 110029, India; [Chaterjee, Prasun; Sharma, Prakash K.; Dey, Aparajit B.] All India Inst Med Sci, Dept Geriatr Med, New Delhi 110029, India; [Tripathi, Manjari] All India Inst Med Sci, Dept Neurol, New Delhi 110029, India	All India Institute of Medical Sciences (AIIMS) New Delhi; All India Institute of Medical Sciences (AIIMS) New Delhi; All India Institute of Medical Sciences (AIIMS) New Delhi	Dey, S (corresponding author), All India Inst Med Sci, Dept Biophys, New Delhi 110029, India.	sharmistha_d@hotmail.com	Kumar, Rahul/AGB-1290-2022; Ferosekhan, Shajahan/E-5051-2010; Kothari, Dushyant/G-3646-2013	Kumar, Rahul/0000-0002-3603-7572; Kumar, Prakash/0000-0002-8230-2867; GUPTA, ABHISHEK/0000-0003-1056-8479; Gupta, Subodh/0000-0002-9420-480X; Ferosekhan, Shajahan/0000-0003-4662-8306; Kothari, Dushyant/0000-0003-0448-4164; Jadhao, Sanjay/0000-0003-2859-8529	Council of Scientific and Industrial Research	Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India)	Authors acknowledge Council of Scientific and Industrial Research for the fellowship of Rahul kumar. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albani D, 2010, J ALZHEIMERS DIS, V19, P11, DOI 10.3233/JAD-2010-1215; Anderson NL, 2002, MOL CELL PROTEOMICS, V1, P845, DOI 10.1074/mcp.R200007-MCP200; [Anonymous], 2010, PREV IMP COSTS SERV; Bonda DJ, 2011, LANCET NEUROL, V10, P275, DOI 10.1016/S1474-4422(11)70013-8; Donmez G, 2010, CELL, V142, P320, DOI 10.1016/j.cell.2010.06.020; FLICKER C, 1991, NEUROLOGY, V41, P1006, DOI 10.1212/WNL.41.7.1006; Guarente L, 2008, CELL, V132, P171, DOI 10.1016/j.cell.2008.01.007; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; JORM AF, 1991, EUR ARCH PSY CLIN N, V240, P218, DOI 10.1007/BF02189530; Julien C, 2009, J NEUROPATH EXP NEUR, V68, P48, DOI 10.1097/NEN.0b013e3181922348; Kemnitz JW, 2011, ILAR J, V52, P66, DOI 10.1093/ilar.52.1.66; Kim D, 2007, EMBO J, V26, P3169, DOI 10.1038/sj.emboj.7601758; Luis CA, 2009, AGING NEUROPSYCHOL C, V16, P203, DOI 10.1080/13825580802411766; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Nakahata Y, 2008, CELL, V134, P329, DOI 10.1016/j.cell.2008.07.002; Patel NV, 2005, NEUROBIOL AGING, V26, P995, DOI 10.1016/j.neurobiolaging.2004.09.014; Petersen RC, 1995, NEUROLOGIST, V1, P326; Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583; Prinzen C, 2005, FASEB J, V19, P1522, DOI 10.1096/fj.04-3619fje; Qin WP, 2006, J BIOL CHEM, V281, P21745, DOI 10.1074/jbc.M602909200; Rahul Kumar, 2012, International Journal of Molecular Biology, V3, P49; Schneider P, 2009, CNS NEUROSCI THER, V15, P358, DOI 10.1111/j.1755-5949.2009.00104.x; TAYLOR WH, 1969, BRIT J ANAESTH, V41, P227, DOI 10.1093/bja/41.3.227; Thadikkaran L, 2005, PROTEOMICS, V5, P3019, DOI 10.1002/pmic.200402053; Vlassenko AG, 2010, P NATL ACAD SCI USA, V107, P17763, DOI 10.1073/pnas.1010461107	26	107	111	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2013	8	4							e61560	10.1371/journal.pone.0061560	http://dx.doi.org/10.1371/journal.pone.0061560			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130DR	24040333	Green Published, gold, Green Submitted			2022-12-25	WOS:000317893400075
J	Gao, XM; Zhao, YJ; Yang, XJ; Sun, SC				Gao, Xianming; Zhao, Yujie; Yang, Xuejun; Sun, Shucun			Linking Trait Differences to Community Dynamics: Evidence from Eupatorium adenophorum and Co-Occurring Native Species during a Three-Year Succession	PLOS ONE			English	Article							ALIEN INVASIVE PLANTS; RESOURCE-USE; IMPACTS; LEAF; ECOLOGY; HERBIVORY; PHENOLOGY; DOMINANCE; FRAMEWORK; RESPONSES	Trait differences between invasive and native species are believed to be closely related to whether the former are successful. However, few studies have measured trait differences between invasive and native species directly under field conditions or during long term experiments. We examined the phenological pattern, plant height and biomass accumulation and allocation of Crofton weed (Eupatorium adenophorum Spreng.) and co-occurring native species in a community during a three-year succession. The phenological pattern of Crofton weed differed from that of co-occurring native species. Crofton weed had longer vegetative stage (when resources were more available), a higher biomass accumulation and a higher above/below-ground ratio compared to native species. Crofton weed was shorter than grasses and two forbs (Artemisia tangutica and Cynoglossum amabile) during its first year of growth, but was significantly taller than all other species during subsequent years. The dominance (calculated as the importance value) of Crofton weed was the highest among all other species and continually increased over time while the dominance of co-occurring native species decreased. This study provides direct field evidence that trait differences are important to plant invasion.	[Gao, Xianming; Zhao, Yujie; Yang, Xuejun] Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China; [Zhao, Yujie] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Sun, Shucun] Chinese Acad Sci, Chengdu Inst Biol, ECORES Lab, Chengdu, Sichuan, Peoples R China	Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Chengdu Institute of Biology, CAS	Gao, XM (corresponding author), Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China.	xmgao@ibcas.ac.cn	Yang, Xuejun/B-4718-2014	Yang, Xuejun/0000-0002-8595-545X	National Basic Research and Development Program of China [2009CB112000]; key project of the Chinese Academy of Science [KSCX1-SW-13-03-06]; National Nature Science Foundation of China [30670333]	National Basic Research and Development Program of China(National Basic Research Program of China); key project of the Chinese Academy of Science(Chinese Academy of Sciences); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was financially supported by the National Basic Research and Development Program of China (2009CB112000), the key project of the Chinese Academy of Science (KSCX1-SW-13-03-06) and National Nature Science Foundation of China (30670333). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews AC, 1979, P 7 AS PAC WEED SCI, P351; Augspurger CK, 2008, OECOLOGIA, V156, P281, DOI 10.1007/s00442-008-1000-7; Barney JN, 2009, PLANT ECOL, V202, P275, DOI 10.1007/s11258-008-9481-3; Baruch Z, 1999, OECOLOGIA, V121, P183, DOI 10.1007/s004420050920; Cadotte MW, 2002, ECOSCIENCE, V9, P397, DOI 10.1080/11956860.2002.11682727; Cleland EE, 2011, NEW PHYTOL, V189, P649, DOI 10.1111/j.1469-8137.2010.03607.x; Coleman HM, 2007, BIOL INVASIONS, V9, P65, DOI 10.1007/s10530-006-9008-6; COLEY PD, 1983, ECOL MONOGR, V53, P209, DOI 10.2307/1942495; Crawley MJ, 1996, PHILOS T R SOC B, V351, P1251, DOI 10.1098/rstb.1996.0108; Cronk QCB, 1995, PLANT INVADERS THREA; CURTIS JT, 1951, ECOLOGY, V32, P476, DOI 10.2307/1931725; Daehler CC, 2003, ANNU REV ECOL EVOL S, V34, P183, DOI 10.1146/annurev.ecolsys.34.011802.132403; Dassonville N, 2008, OECOLOGIA, V157, P131, DOI 10.1007/s00442-008-1054-6; Dietz H, 2006, ECOLOGY, V87, P1359, DOI 10.1890/0012-9658(2006)87[1359:RTCPCD]2.0.CO;2; Ehrenfeld JG, 2003, ECOSYSTEMS, V6, P503, DOI 10.1007/s10021-002-0151-3; Evans RD, 2001, ECOL APPL, V11, P1301, DOI 10.1890/1051-0761(2001)011[1301:EPIAND]2.0.CO;2; Field CB, 2007, AR4 CLIMATE CHANGE 2007: IMPACTS, ADAPTATION, AND VULNERABILITY, P617; Funk JL, 2007, NATURE, V446, P1079, DOI 10.1038/nature05719; Garnier E, 2007, ANN BOT-LONDON, V99, P967, DOI 10.1093/aob/mcl215; Godoy O, 2009, ANN BOT-LONDON, V103, P485, DOI 10.1093/aob/mcn232; Grotkopp E, 2002, AM NAT, V159, P396, DOI 10.1086/338995; Hamilton MA, 2005, ECOL LETT, V8, P1066, DOI 10.1111/j.1461-0248.2005.00809.x; Harper J. L., 1977, Population biology of plants.; Hina Fatimah, 2009, Advances in Environmental Biology, V3, P150; Ishii H, 2010, ECOL RES, V25, P715, DOI 10.1007/s11284-009-0668-4; KLUGE RL, 1991, AGR ECOSYST ENVIRON, V37, P187, DOI 10.1016/0167-8809(91)90146-O; Kolar CS, 2001, TRENDS ECOL EVOL, V16, P199, DOI 10.1016/S0169-5347(01)02101-2; Kudo G, 1996, ECOL RES, V11, P283, DOI 10.1007/BF02347785; Lavorel S, 2002, FUNCT ECOL, V16, P545, DOI 10.1046/j.1365-2435.2002.00664.x; Levine JM, 2003, P ROY SOC B-BIOL SCI, V270, P775, DOI 10.1098/rspb.2003.2327; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; Manea A, 2011, OECOLOGIA, V165, P735, DOI 10.1007/s00442-010-1765-3; Moles AT, 2008, J ECOL, V96, P13, DOI 10.1111/j.1365-2745.2007.01332.x; MURPHY J, 1962, ANAL CHIM ACTA, V26, P31; Olden JD, 2003, AM NAT, V162, P442, DOI 10.1086/378212; Page AL., 1982, CHEM MICROBIOLOGICAL, V15, P99, DOI DOI 10.2134/AGRONMONOGR9.2.2ED; Pimentel D, 2005, ECOL ECON, V52, P273, DOI 10.1016/j.ecolecon.2004.10.002; Rejmanek M., 2005, INVASIVE ALIEN SPECI; Scharfy D, 2011, NEW PHYTOL, V189, P818, DOI 10.1111/j.1469-8137.2010.03531.x; Seabloom EW, 2003, P NATL ACAD SCI USA, V100, P13384, DOI 10.1073/pnas.1835728100; SHARMA K C, 1977, Nepalese Journal of Agriculture, V12, P135; Smith MD, 2001, INT J PLANT SCI, V162, P785, DOI 10.1086/320774; Suding KN, 2008, GLOBAL CHANGE BIOL, V14, P1125, DOI 10.1111/j.1365-2486.2008.01557.x; Suttle KB, 2007, SCIENCE, V315, P640, DOI 10.1126/science.1136401; Tao ZG, 2002, SICHUAN ANIM VET SCI, V29, P25; Thompson K, 1995, ECOGRAPHY, V18, P390, DOI 10.1111/j.1600-0587.1995.tb00142.x; van der Wal R, 2008, GLOBAL CHANGE BIOL, V14, P1428, DOI 10.1111/j.1365-2486.2008.01576.x; van Kleunen M, 2010, ECOL LETT, V13, P235, DOI 10.1111/j.1461-0248.2009.01418.x; VITOUSEK PM, 1994, ECOLOGY, V75, P1861, DOI 10.2307/1941591; VITOUSEK PM, 1990, OIKOS, V57, P7, DOI 10.2307/3565731; Waser NM., 2006, PLANT POLLINATOR INT; Weigelt A, 2002, BASIC APPL ECOL, V3, P85, DOI 10.1078/1439-1791-00080; Weiher E., 1999, ECOLOGICAL ASSEMBLY; Westoby M, 1998, PLANT SOIL, V199, P213, DOI 10.1023/A:1004327224729; Wilcove DS, 1998, BIOSCIENCE, V48, P607, DOI 10.2307/1313420; Wilsey BJ, 2006, OECOLOGIA, V150, P300, DOI 10.1007/s00442-006-0515-z; Wolkovich EM, 2011, FRONT ECOL ENVIRON, V9, P287, DOI 10.1890/100033; Xu CY, 2007, OECOLOGIA, V154, P11, DOI 10.1007/s00442-007-0807-y; Zheng YL, 2009, PLANT ECOL, V203, P263, DOI 10.1007/s11258-008-9544-5; Zhu L, 2007, LANDSCAPE ECOL, V22, P1143, DOI 10.1007/s10980-007-9096-4	60	51	56	2	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e50247	10.1371/journal.pone.0050247	http://dx.doi.org/10.1371/journal.pone.0050247			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23613942	Green Published, gold			2022-12-25	WOS:000314610600002
J	Zhao, QH; Guo, QH; Li, F; Zhou, Y; Wang, B; Hong, Z				Zhao, Qianhua; Guo, Qihao; Li, Fang; Zhou, Yan; Wang, Bei; Hong, Zhen			The Shape Trail Test: Application of a New Variant of the Trail Making Test	PLOS ONE			English	Article							NORMATIVE DATA; ELDERLY-PEOPLE; AGE; EQUIVALENCE; EDUCATION; VALIDITY; PROJECT; NORMS	Objective: The Trail making test (TMT) is culture-loaded because of reliance on the Latin alphabet, limiting its application in Eastern populations. The Shape Trail Test (STT) has been developed as a new variant. This study is to examine the applicability of the STT in a senile Chinese population and to evaluate its potential advantages and disadvantages. Method: A total of 2470 participants were recruited, including 1151 cognitively normal control (NC), 898 amnestic mild cognitive impairment (aMCI), and 421 mild Alzheimer disease (AD) patients. Besides the STT, the Mini mental state examination and a comprehensive neuropsychological battery involving memory, language, attention, executive function and visuospatial ability were administered to all the participants. In a subgroup of 100 NC and 50 AD patients, both the STT and the Color Trail Test (CTT) were performed. Results: In NC, the time consumed for Part A and B (STT-A and STT-B) significantly correlated with age and negatively correlated with education (p<0.01). STT-A and B significantly differed among the AD, aMCI and NC. The number that successfully connected within one minute in Part B (STT-B-1 min) correlated well with STT-B (r = 0.71, p<0.01) and distinguished well among NC, aMCI and AD. In the receiver operating characteristic curve analysis, the AUCs (area under the curve) for STT-A, STT-B, and STT-B-1min in identifying AD were 0.698, 0.694 and 0.709, respectively. The STT correlated with the CTT, but the time for completion was longer. Conclusion: The TMT is a sensitive test of visual search and sequencing. The STT is a meaningful attempt to develop a "culture-fair" variant of the TMT in addition to the CTT.	[Zhao, Qianhua; Guo, Qihao; Zhou, Yan; Wang, Bei; Hong, Zhen] Fudan Univ, Huashan Hosp, Dept Neurol, Shanghai 200433, Peoples R China; [Li, Fang] Capital Med Univ, Fuxing Hosp, Dept Gerontol, Beijing, Peoples R China	Fudan University; Capital Medical University	Guo, QH (corresponding author), Fudan Univ, Huashan Hosp, Dept Neurol, Shanghai 200433, Peoples R China.	dr.guoqihao@126.com; lifangwa@sina.com	Stefanadis, Christodoulos/ABH-2232-2020	Stefanadis, Christodoulos/0000-0001-5974-6454	Science and Technology Commission of Shanghai Municipality, China [09DZ1950400, 08411951000]; National Natural Science Foundation of China [81200835]	Science and Technology Commission of Shanghai Municipality, China(Science & Technology Commission of Shanghai Municipality (STCSM)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was funded by the Science and Technology Commission of Shanghai Municipality, China (09DZ1950400, 08411951000) and National Natural Science Foundation of China (81200835). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander NB, 2005, J GERONTOL A-BIOL, V60, P1558, DOI 10.1093/gerona/60.12.1558; Arbuthnott K, 2000, J CLIN EXP NEUROPSYC, V22, P518, DOI 10.1076/1380-3395(200008)22:4;1-0;FT518; Ashendorf L, 2008, ARCH CLIN NEUROPSYCH, V23, P129, DOI 10.1016/j.acn.2007.11.005; Barncord S W, 2001, Appl Neuropsychol, V8, P99, DOI 10.1207/S15324826AN0802_4; DAVIES ADM, 1968, J CLIN PSYCHOL, V24, P98; Drane DL, 2002, NEUROPSY NEUROPSY BE, V15, P39; Dugbartey AT, 2000, ARCH CLIN NEUROPSYCH, V15, P425, DOI 10.1016/S0887-6177(99)00034-7; Elkin-Frankston S, 2007, ARCH CLIN NEUROPSYCH, V22, P631, DOI 10.1016/j.acn.2007.04.004; Fernandez AL, 2008, SCAND J PSYCHOL, V49, P239, DOI 10.1111/j.1467-9450.2008.00637.x; Hartman-Maeir A, 2008, BRAIN INJURY, V22, P994, DOI 10.1080/02699050802491305; Hashimoto R, 2006, PSYCHIAT CLIN NEUROS, V60, P422, DOI 10.1111/j.1440-1819.2006.01526.x; Hester RL, 2005, CLIN NEUROPSYCHOL, V19, P45, DOI 10.1080/13854040490524137; KENNEDY KJ, 1981, PERCEPT MOTOR SKILL, V52, P671, DOI 10.2466/pms.1981.52.2.671; Kortte Kathleen Bechtold, 2002, Appl Neuropsychol, V9, P106, DOI 10.1207/S15324826AN0902_5; Lee TMC, 2000, J CLIN EXP NEUROPSYC, V22, P529, DOI 10.1076/1380-3395(200008)22:4;1-0;FT529; Lee TMC, 2000, J CLIN EXP NEUROPSYC, V22, P772, DOI 10.1076/jcen.22.6.772.954; Lu JC, 2006, CHIN J CLIN PSYCHOL, V14, P118; Lu L, 2000, Appl Neuropsychol, V7, P243, DOI 10.1207/S15324826AN0704_6; Lu Lei, 2002, Appl Neuropsychol, V9, P219, DOI 10.1207/S15324826AN0904_4; Martin TA, 2003, APPL NEUROPSYCHOL, V10, P163, DOI 10.1207/S15324826AN1003_05; Moll J, 2002, ARQ NEURO-PSIQUIAT, V60, P900, DOI 10.1590/S0004-282X2002000600002; Oosterman JM, 2010, CLIN NEUROPSYCHOL, V24, P203, DOI 10.1080/13854040903482848; Pena-Casanova J, 2009, ARCH CLIN NEUROPSYCH, V24, P321, DOI 10.1093/arclin/acp038; Petersen R. C., 1999, ARCH NEUROL-CHICAGO, V56, P6; Ruffolo LF, 2000, CLIN NEUROPSYCHOL, V14, P223, DOI 10.1076/1385-4046(200005)14:2;1-Z;FT223; Sanchez-Cubillo I, 2009, J INT NEUROPSYCH SOC, V15, P438, DOI 10.1017/S1355617709090626; Seo EH, 2006, INT J GERIATR PSYCH, V21, P844, DOI 10.1002/gps.1570; Spreen O, 1998, COMPENDIUM NEUROPSYC; Tombaugh TN, 2004, ARCH CLIN NEUROPSYCH, V19, P203, DOI 10.1016/S0887-6177(03)00039-8	29	170	179	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e57333	10.1371/journal.pone.0057333	http://dx.doi.org/10.1371/journal.pone.0057333			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	093IE	23613798	gold, Green Published, Green Submitted			2022-12-25	WOS:000315184200244
J	Zhang, HX; Zhang, ML; Sanderson, SC				Zhang, Hong-Xiang; Zhang, Ming-Li; Sanderson, Stewart C.			Retreating or Standing: Responses of Forest Species and Steppe Species to Climate Change in Arid Eastern Central Asia	PLOS ONE			English	Article							GENETIC-STRUCTURE; POPULATION-GROWTH; GLACIAL REFUGIA; PHYLOGEOGRAPHY; FUTURE; MITOCHONDRIAL; TIANSHAN; MAXIMUM; ZONE; BIODIVERSITY	Background: The temperature in arid Eastern Central Asia is projected to increase in the future, accompanied by increased variability of precipitation. To investigate the impacts of climate change on plant species in this area, we selected two widespread species as candidates, Clematis sibirica and C. songorica, from montane coniferous forest and arid steppe habitats respectively. Methodology/Principal Findings: We employed a combined approach of molecular phylogeography and species distribution modelling (SDM) to predict the future responses of these two species to climate change, utilizing evidence of responses from the past. Genetic data for C. sibirica shows a significant phylogeographical signal (N-ST > F-ST, P<0.05) and demographic contraction during the glacial-interglacial cycles in the Pleistocene. This forest species would likely experience range reduction, though without genetic loss, in the face of future climate change. In contrast, SDMs predict that C. songorica, a steppe species, should maintain a consistently stable potential distribution under the Last Glacial Maximum (LGM) and the future climatic conditions referring to its existing potential distribution. Molecular results indicate that the presence of significant phylogeographical signal in this steppe species is rejected and this species contains a high level of genetic differentiation among populations in cpDNA, likely benefiting from stable habitats over a lengthy time period. Conclusions/Significance: Evidence from the molecular phylogeography of these two species, the forest species is more sensitive to past climate changes than the steppe species. SDMs predict that the forest species will face the challenge of potential range contraction in the future more than the steppe species. This provides a perspective on ecological management in arid Eastern Central Asia, indicating that increased attention should be paid to montane forest species, due to their high sensitivity to disturbance.	[Zhang, Hong-Xiang; Zhang, Ming-Li] Chinese Acad Sci, Key Lab Biogeog & Bioresource Arid Land, Xinjiang Inst Ecol & Geog, Urumqi, Peoples R China; [Zhang, Hong-Xiang] Univ Chinese Acad Sci, Beijing, Peoples R China; [Zhang, Ming-Li] Chinese Acad Sci, Inst Bot, Beijing, Peoples R China; [Sanderson, Stewart C.] US Forest Serv, Shrub Sci Lab, Intermt Res Stn, USDA, Provo, UT USA	Chinese Academy of Sciences; Xinjiang Institute of Ecology & Geography, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Institute of Botany, CAS; United States Department of Agriculture (USDA); United States Forest Service	Zhang, ML (corresponding author), Chinese Acad Sci, Key Lab Biogeog & Bioresource Arid Land, Xinjiang Inst Ecol & Geog, Urumqi, Peoples R China.	zhangml@ibcas.ac.cn			CAS Important Direction for Knowledge Innovation Project [KZCX2-EW-305]; Xinjiang Institute of Ecology and Geography, Chinese Academy of Sciences	CAS Important Direction for Knowledge Innovation Project; Xinjiang Institute of Ecology and Geography, Chinese Academy of Sciences(Chinese Academy of Sciences)	This study was funded by CAS Important Direction for Knowledge Innovation Project (No. KZCX2-EW-305), and the Xinjiang Institute of Ecology and Geography, Chinese Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsos IG, 2012, P ROY SOC B-BIOL SCI, V279, P2042, DOI 10.1098/rspb.2011.2363; Avise JC, 2009, J BIOGEOGR, V36, P3, DOI 10.1111/j.1365-2699.2008.02032.x; Balint M, 2011, NAT CLIM CHANGE, V1, P313, DOI 10.1038/NCLIMATE1191; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Beatty GE, 2013, J BIOGEOGR, V40, P335, DOI 10.1111/j.1365-2699.2012.02789.x; Beatty GE, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-29; Bellard C, 2012, ECOL LETT, V15, P365, DOI 10.1111/j.1461-0248.2011.01736.x; Bohner J, 2005, BOREAS, V34, P220, DOI 10.1080/03009480510012917; Bosboom RE, 2011, PALAEOGEOGR PALAEOCL, V299, P385, DOI 10.1016/j.palaeo.2010.11.019; Braconnot P, 2007, CLIM PAST, V3, P261, DOI 10.5194/cp-3-261-2007; Byrne M, 2008, MOL ECOL, V17, P4398, DOI 10.1111/j.1365-294X.2008.03899.x; Collins WD, 2006, J CLIMATE, V19, P2122, DOI 10.1175/JCLI3761.1; Comes HP, 1998, TRENDS PLANT SCI, V3, P432, DOI 10.1016/S1360-1385(98)01327-2; Cordellier M, 2009, MOL ECOL, V18, P534, DOI 10.1111/j.1365-294X.2008.04042.x; Cox CB, 2010, BIOGEOGRAPHY AN ECOL; Desamore A, 2012, J BIOGEOGR, V39, P574, DOI 10.1111/j.1365-2699.2011.02622.x; Desamore A, 2012, GLOBAL CHANGE BIOL, V18, P2915, DOI 10.1111/j.1365-2486.2012.02752.x; Doyle J. J., 1987, PHYTOCHEMISTRY B, V19, P11, DOI DOI 10.2307/4119796; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Dupanloup I, 2008, MOL ECOL, V11, P2571; Espindola A, 2012, ECOL LETT, V15, P649, DOI 10.1111/j.1461-0248.2012.01779.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fang XM, 2002, CHINESE SCI BULL, V47, P1381, DOI 10.1360/02tb9305; Fehrer J, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-239; FORMAN RTT, 1995, LANDSCAPE ECOL, V10, P133, DOI 10.1007/BF00133027; Fu YX, 1997, GENETICS, V147, P915; Ge XJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043717; Graham MH, 2003, ECOLOGY, V84, P2809, DOI 10.1890/02-3114; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; HARPENDING HC, 1994, HUM BIOL, V66, P591; Hasumi H, 2004, K 1 COUPLED GCM MIRO; Hesse PP, 2004, QUATERN INT, V118, P87, DOI 10.1016/S1040-6182(03)00132-0; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Hu RJ, 2004, PHYSICAL GEOGRAPHY O; Hu XS, 1999, GENETICS, V152, P441; Hughes L, 2003, AUSTRAL ECOL, V28, P423, DOI 10.1046/j.1442-9993.2003.01300.x; Iwasaki T, 2012, J PLANT RES, V125, P207, DOI 10.1007/s10265-011-0428-8; Keppel G, 2012, GLOBAL ECOL BIOGEOGR, V21, P393, DOI 10.1111/j.1466-8238.2011.00686.x; Lawing AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028554; Lessa EP, 2003, P NATL ACAD SCI USA, V100, P10331, DOI 10.1073/pnas.1730921100; Lioubimtseva E, 2009, J ARID ENVIRON, V73, P963, DOI 10.1016/j.jaridenv.2009.04.022; LOISELLE BA, 1995, AM J BOT, V82, P1420, DOI 10.2307/2445869; Ma Shao-Bin, 2002, Acta Botanica Yunnanica, V24, P569; Malhi Y, 2008, SCIENCE, V319, P169, DOI 10.1126/science.1146961; Measey GJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026606; Miller MP, 2005, J HERED, V96, P722, DOI 10.1093/jhered/esi119; Pachauri R.K, 2007, CONTRIBUTION WORKING, P104, DOI DOI 10.1017/CBO9780511546013; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Pearson RG, 2006, TRENDS ECOL EVOL, V21, P111, DOI 10.1016/j.tree.2005.11.022; Petit RJ, 2008, SCIENCE, V320, P1450, DOI 10.1126/science.1155457; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Pons O, 1996, GENETICS, V144, P1237; Ramos ACS, 2007, ANN BOT-LONDON, V100, P1219, DOI 10.1093/aob/mcm221; Richardson JE, 2001, SCIENCE, V293, P2242, DOI 10.1126/science.1061421; Sang T, 1997, AM J BOT, V84, P1120, DOI 10.2307/2446155; Schneider S, 1999, GENETICS, V152, P1079; Shi YF, 2006, THE QUATERNARY GLACI; SWOFFORD DL, 2002, PAUP PHYLOGENETIC AN; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Thuiller W, 2005, P NATL ACAD SCI USA, V102, P8245, DOI 10.1073/pnas.0409902102; Wang W.T., 2001, FLORA CHINA, V6, P333; Wang W, 2009, PERSPECT PLANT ECOL, V11, P81, DOI 10.1016/j.ppees.2009.01.001; Wang WT, 1980, RANUNCULACEAE FLORA, P33; Wen Q.Z., 1993, CHINESE GEOGR SCI, V3, P147; White T., 1990, PCR PROTOCOLS GUIDE, P315; Widmer A, 2001, TRENDS ECOL EVOL, V16, P267, DOI 10.1016/S0169-5347(01)02163-2; WOLFE KH, 1987, P NATL ACAD SCI USA, V84, P9054, DOI 10.1073/pnas.84.24.9054; Xu XK, 2010, BOREAS, V39, P215, DOI 10.1111/j.1502-3885.2009.00118.x; Yang FS, 2008, MOL ECOL, V17, P5135, DOI 10.1111/j.1365-294X.2008.03976.x; Zhang HX, 2012, PALAEOGEOGR PALAEOCL, V353, P93, DOI 10.1016/j.palaeo.2012.07.013; Zhang HX, 2012, J SYST EVOL, V50, P295, DOI 10.1111/j.1759-6831.2012.00198.x; Zhang QA, 2010, MOL PHYLOGENET EVOL, V57, P1091, DOI 10.1016/j.ympev.2010.10.003; Zhang YJ, 2008, GENETICA, V134, P353, DOI 10.1007/s10709-008-9243-0	75	69	70	0	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2013	8	4							e61954	10.1371/journal.pone.0061954	http://dx.doi.org/10.1371/journal.pone.0061954			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125TD	23894405	Green Published, gold, Green Submitted			2022-12-25	WOS:000317563300046
J	Berneman, A; Montout, L; Goyard, S; Chamond, N; Cosson, A; d'Archivio, S; Gouault, N; Uriac, P; Blondel, A; Minoprio, P				Berneman, Armand; Montout, Lory; Goyard, Sophie; Chamond, Nathalie; Cosson, Alain; d'Archivio, Simon; Gouault, Nicolas; Uriac, Philippe; Blondel, Arnaud; Minoprio, Paola			Combined Approaches for Drug Design Points the Way to Novel Proline Racemase Inhibitor Candidates to Fight Chagas' Disease	PLOS ONE			English	Article							TRYPANOSOMA-CRUZI INFECTION; IN-VITRO; DOCKING; DISCRIMINATION; ACTIVATION; RECEPTOR; HOST; VIVO	Chagas' disease is caused by Trypanosoma cruzi, a protozoan transmitted to humans by blood-feeding insects, blood transfusion or congenitally. Previous research led us to discover a parasite proline racemase (TcPRAC) and to establish its validity as a target for the design of new chemotherapies against the disease, including its chronic form. A known inhibitor of proline racemases, 2-pyrrolecarboxylic acid (PYC), is water-insoluble. We synthesized soluble pyrazole derivatives, but they proved weak or inactive TcPRAC inhibitors. TcPRAC catalytic site is too small and constrained when bound to PYC to allow efficient search for new inhibitors by virtual screening. Forty-nine intermediate conformations between the opened enzyme structure and the closed liganded one were built by calculating a transition path with a method we developed. A wider range of chemical compounds could dock in the partially opened intermediate active site models in silico. Four models were selected for known substrates and weak inhibitors could dock in them and were used to screen chemical libraries. Two identified soluble compounds, (E)-4-oxopent-2-enoic acid (OxoPA) and its derivative (E)-5-bromo-4-oxopent-2-enoic acid (Br-OxoPA), are irreversible competitive inhibitors that presented stronger activity than PYC on TcPRAC. We show here that increasing doses of OxoPA and Br-OxoPA hamper T. cruzi intracellular differentiation and fate in mammalian host cells. Our data confirm that through to their binding mode, these molecules are interesting and promising as lead compounds for the development of chemotherapies against diseases where active proline racemases play essential roles.	[Berneman, Armand; Goyard, Sophie; Chamond, Nathalie; Cosson, Alain; d'Archivio, Simon; Minoprio, Paola] Inst Pasteur, Dept Infect & Epidemiol, Lab Proc Infect Trypanosomatides, Paris, France; [Montout, Lory; Blondel, Arnaud] Inst Pasteur, Dept Biol Struct & Chim, CNRS UMR 3528, Unite Bioinformat Struct, Paris, France; [Gouault, Nicolas; Uriac, Philippe] Univ Rennes 1, UMR Sci Chim Rennes 6226, Equipe Prod Nat Synth & Chim Med, Rennes, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Universite de Rennes	Minoprio, P (corresponding author), Inst Pasteur, Dept Infect & Epidemiol, Lab Proc Infect Trypanosomatides, Paris, France.	paola.minoprio@pasteur.fr	Chamond, Nathalie/C-5907-2018	Berneman, Zwi/0000-0002-9133-4588; Chamond, Nathalie/0000-0002-0518-2929; Goyard, Sophie/0000-0002-8937-2796; Minoprio, Paola/0000-0002-1659-833X; GOUAULT, Nicolas/0000-0002-5527-8566; Adachi-Mejia, Anna/0000-0001-5980-3850	Fonds dedies [17]; sanofi-aventis/Ministere de la Recherche/Institut Pasteur; Fondation pour la Recherche Medicale (FRM) [DCM20111223751]	Fonds dedies; sanofi-aventis/Ministere de la Recherche/Institut Pasteur(Sanofi-AventisMinistry of Research, France); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale)	The work was supported by Fonds dedies n<SUP>o</SUP> 17, sanofi-aventis/Ministere de la Recherche/Institut Pasteur and Fondation pour la Recherche Medicale (FRM) project N<SUP>o</SUP>DCM20111223751. SD'A is a fellow from DIM, "Domaine d'Interet Majeur, maladies infectieuses, parasitaires et nosocomiales emergentes", Conseil Regional Ile de France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABAGYAN R, 1994, J COMPUT CHEM, V15, P488, DOI 10.1002/jcc.540150503; Appel A, 2011, NATURE, V480, pS40, DOI 10.1038/480S40a; Aznar C, 2004, MEM I OSWALDO CRUZ, V99, P805, DOI 10.1590/S0074-02762004000800004; Berneman A., 2010, J MICROBIAL BIOCH TE, V2, P139; Blondel A, 1999, J MOL BIOL, V291, P101, DOI 10.1006/jmbi.1999.2879; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Bryan MA, 2010, INFECT IMMUN, V78, P810, DOI 10.1128/IAI.00926-09; Buschiazzo A, 2006, P NATL ACAD SCI USA, V103, P1705, DOI 10.1073/pnas.0509010103; CDCP, 2007, BLOOD DON SCREEN CHA; CDCP, 2006, CHAG DIS ORG TRANSPL; Chamond N, 2005, MOL MICROBIOL, V58, P46, DOI 10.1111/j.1365-2958.2005.04808.x; Chamond N., 2002, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V2, P247, DOI 10.2174/1568008023340604; Chamond N, 2003, J BIOL CHEM, V278, P15484, DOI 10.1074/jbc.M210830200; Chamond N, 2009, MOL BIOCHEM PARASIT, V165, P170, DOI 10.1016/j.molbiopara.2009.02.002; CORSANO S, 1958, ANN CHIM-ROME, V48, P140; Coura JR, 2002, MEM I OSWALDO CRUZ, V97, P3, DOI 10.1590/S0074-02762002000100001; Coutinho L, 2009, MEM I OSWALDO CRUZ, V104, P1055, DOI 10.1590/S0074-02762009000800001; da Silva CF, 2008, ANTIMICROB AGENTS CH, V52, P3307, DOI 10.1128/AAC.00038-08; de Souza EM, 2003, CELL TISSUE RES, V314, P223, DOI 10.1007/s00441-003-0782-5; DOCAMPO R, 1990, CHEM-BIOL INTERACT, V73, P1, DOI 10.1016/0009-2797(90)90106-W; Fatin-Rouge N, 2000, J AM CHEM SOC, V122, P10810, DOI 10.1021/ja001089b; FISCHER S, 1992, CHEM PHYS LETT, V194, P252, DOI 10.1016/0009-2614(92)85543-J; Garraud O, 2007, Travel Med Infect Dis, V5, P110, DOI 10.1016/j.tmaid.2006.01.010; Gouault N, 2004, J ENZYM INHIB MED CH, V19, P475, DOI 10.1080/14756360412331280536; Goytia M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000885; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Janin YL, 2010, MINIREVIEWS ORGANIC, V7, P342; KEENAN MV, 1974, BIOCHEM BIOPH RES CO, V57, P500, DOI 10.1016/0006-291X(74)90960-7; KUBOTA H, 1992, J IMMUNOL, V149, P1143; Kwong AD, 2011, NAT BIOTECHNOL, V29, P993, DOI 10.1038/nbt.2020; Laine E, 2010, P NATL ACAD SCI USA, V107, P11277, DOI 10.1073/pnas.0914611107; Lee GM, 2009, SCIENCE, V324, P213, DOI 10.1126/science.1169378; Manaev YA, 1982, CHEM ABSTR, V2298, P71993; Manaev YA., 1982, J GEN CHEM USSR, V52, P2291; Maya JD, 2003, BIOCHEM PHARMACOL, V65, P999, DOI 10.1016/S0006-2952(02)01663-5; Molecular-Networks-Inspiring-Chemical-Discovery website, 2013, CORNIA FAST GEN HIGH; Morel CM, 2007, NATURE, V449, P180, DOI 10.1038/449180a; O'Connell D, 2007, NATURE, V449, P157, DOI 10.1038/449157a; Osorio L, 2012, MICROBES INFECT, V14, P1390, DOI 10.1016/j.micinf.2012.09.003; Rarey M, 1996, J MOL BIOL, V261, P470, DOI 10.1006/jmbi.1996.0477; Reina-San-Martin B, 2000, PARASITOL TODAY, V16, P62, DOI 10.1016/S0169-4758(99)01591-4; Robertson JG, 2005, BIOCHEMISTRY-US, V44, P5561, DOI 10.1021/bi050247e; Salvatella R, 2007, MEM I OSWALDO CRUZ, V102, P39, DOI 10.1590/S0074-02762007005000105; Schaefer M, 1996, J PHYS CHEM-US, V100, P1578, DOI 10.1021/jp9521621; Singh J, 2011, NAT REV DRUG DISCOV, V10, P307, DOI 10.1038/nrd3410; Taly A, 2011, J MOL GRAPH MODEL, V30, P100, DOI 10.1016/j.jmgm.2011.06.008; WHO web site, 2013, RES PRIOR CHAG DIS	48	22	23	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2013	8	4							e60955	10.1371/journal.pone.0060955	http://dx.doi.org/10.1371/journal.pone.0060955			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130DR	23613764	Green Published, gold			2022-12-25	WOS:000317893400031
J	Zhang, XY; Sun, Q; Shan, M; Niu, M; Liu, T; Xia, BS; Liang, XS; Wei, W; Sun, SS; Zhang, YX; Liu, XS; Song, QB; Yang, YM; Ma, YY; Liu, Y; Yang, L; Ren, YL; Zhang, GQ; Pang, D				Zhang, Xianyu; Sun, Qian; Shan, Ming; Niu, Ming; Liu, Tong; Xia, Bingshu; Liang, Xiaoshuan; Wei, Wei; Sun, Shanshan; Zhang, Youxue; Liu, Xiaolong Sean; Song, Qingbin; Yang, Yanmei; Ma, Yuyan; Liu, Yang; Yang, Long; Ren, Yanlv; Zhang, Guoqiang; Pang, Da			Promoter Hypermethylation of ARID1A Gene Is Responsible for Its Low mRNA Expression in Many Invasive Breast Cancers	PLOS ONE			English	Article							CLEAR-CELL CARCINOMA; SOMATIC MUTATIONS; SWI/SNF COMPLEXES; PROTEIN P270; EPIGENETICS; COMPONENT	ARID1A (AT-rich interactive domain 1A) has recently been identified as a tumor suppressor gene. Its mRNA expression is significantly low in many breast cancers; this is often associated with more aggressive phenotypes. However, the underlying molecular mechanism for its low expression has not been fully understood. This study was undertaken to evaluate the contribution of gene copy number variation, mutations, promoter methylation and histone modification to ARID1A's low expression. 38 pairs of breast invasive ductal carcinomas and their normal breast tissue counterparts from the same patients were randomly selected for gene expression and copy number variation detection. Promoter methylation and histone modification levels were evaluated by MeDIP-qPCR and ChIP-qPCR, respectively. PCR product Sanger sequencing was carried out to detect the exon mutation rate. Twenty-two out of 38 invasive ductal carcinomas in the study (57.9%) revealed ARID1A mRNA low expression by realtime RT-PCR. The relative promoter methylation level was, significantly higher in ARID1A mRNA low expression group compared with its high expression group (p<0.001). In the low expression group, nineteen out of 22 invasive ductal carcinomas (86.4%) exhibited ARID1A promoter hypermthylation. In addition, the promoter hypermethylation was accompanied with repressive histone modification (H3K27Me3). Although five out of 38 invasive ductal carcinomas (13.2%) exhibited loss of ARID1A gene copy number by realtime PCR and nine exon novel mutations are seen from eight out of 33 invasive ductal carcinomas (24.2%), there was no statistically significant difference in both ARID1A mRNA low and high expression groups (p = 0.25, and p = 0.68, respectively). We demonstrate that promoter hypermethylation was the main culprit for ARID1A mRNA low expression in invasive ductal carcinomas. The influence of mutation and copy number variation on the expression were statistically insignificant at mRNA level, and were, therefore, not considered the main causes for ARID1A mRNA low expression in invasive breast cancer.	[Zhang, Xianyu; Sun, Qian; Shan, Ming; Niu, Ming; Liu, Tong; Xia, Bingshu; Liang, Xiaoshuan; Wei, Wei; Sun, Shanshan; Zhang, Youxue; Ren, Yanlv; Zhang, Guoqiang; Pang, Da] Harbin Med Univ, Dept Breast Surg, Affiliated Hosp 3, Harbin, Heilongjiang, Peoples R China; [Liu, Xiaolong Sean] Harbin Med Univ, Dept Pathol, Affiliated Hosp 3, Harbin, Heilongjiang, Peoples R China; [Song, Qingbin] Mt Sinai Sch Med, Dept Med, New York, NY USA; [Yang, Yanmei; Ma, Yuyan; Pang, Da] Heilongjiang Inst Canc Res, Key Lab, Harbin, Heilongjiang, Peoples R China; [Yang, Long] Life Technol Corp, ICFC Custom Serv, Beijing, Peoples R China	Harbin Medical University; Harbin Medical University; Icahn School of Medicine at Mount Sinai; Thermo Fisher Scientific	Pang, D (corresponding author), Harbin Med Univ, Dept Breast Surg, Affiliated Hosp 3, Harbin, Heilongjiang, Peoples R China.	pangda@ems.hrbmu.edu.cn	Zhang, Guo-Qiang/AAG-6817-2019; Liu, Wei/N-4465-2017	Zhang, Guo-Qiang/0000-0001-6439-019X; LIU, TONG/0000-0001-9234-1328; Liu, Wei/0000-0001-9819-3178; Wu, Chongming/0000-0003-2898-370X	National Natural Science Foundation of China [81172498/H1622]; Harbin Science and Technology bureau [2011RFXYS056]; Postgraduate Innovation Research Fund of Heilongjiang Province [YJSCX2011-332-HLJ]; Research initiation Fund of the Third Affiliated Hospital of Harbin Medical University [JJ2010-24]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Harbin Science and Technology bureau; Postgraduate Innovation Research Fund of Heilongjiang Province; Research initiation Fund of the Third Affiliated Hospital of Harbin Medical University	This work was supported by National Natural Science Foundation of China (81172498/H1622), Harbin Science and Technology bureau (2011RFXYS056), Postgraduate Innovation Research Fund of Heilongjiang Province (YJSCX2011-332-HLJ) and Research initiation Fund of the Third Affiliated Hospital of Harbin Medical University (JJ2010-24). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cornen S., 2012, ONCOGENE; Dallas PB, 2000, MOL CELL BIOL, V20, P3137, DOI 10.1128/MCB.20.9.3137-3146.2000; Dallas PB, 1998, MOL CELL BIOL, V18, P3596, DOI 10.1128/MCB.18.6.3596; DeCristofaro MF, 2001, J CELL PHYSIOL, V186, P136; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Feinberg AP, 2004, NAT REV CANCER, V4, P143, DOI 10.1038/nrc1279; Guichard C, 2012, NAT GENET, V44, P694, DOI 10.1038/ng.2256; Jones S, 2012, HUM MUTAT, V33, P100, DOI 10.1002/humu.21633; Jones S, 2010, SCIENCE, V330, P228, DOI 10.1126/science.1196333; Katagiri A, 2012, MODERN PATHOL, V25, P282, DOI 10.1038/modpathol.2011.161; Luo B, 2008, P NATL ACAD SCI USA, V105, P20380, DOI 10.1073/pnas.0810485105; Mamo A, 2012, ONCOGENE, V31, P2090, DOI 10.1038/onc.2011.386; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Nagl NG, 2005, CANCER RES, V65, P9236, DOI 10.1158/0008-5472.CAN-05-1225; Nagl NG, 2007, EMBO J, V26, P752, DOI 10.1038/sj.emboj.7601541; Shain AH, 2012, P NATL ACAD SCI USA, V109, pE252, DOI 10.1073/pnas.1114817109; Tsai HC, 2011, CELL RES, V21, P502, DOI 10.1038/cr.2011.24; Wang XM, 2004, INT J CANCER, V112, P636, DOI 10.1002/ijc.20450; Wiegand KC, 2011, J PATHOL, V224, P328, DOI 10.1002/path.2911; Wiegand KC, 2010, NEW ENGL J MED, V363, P1532, DOI 10.1056/NEJMoa1008433; Zhang XY, 2012, CANCER EPIDEMIOL, V36, P288, DOI 10.1016/j.canep.2011.07.006	21	709	730	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2013	8	1							e53931	10.1371/journal.pone.0053931	http://dx.doi.org/10.1371/journal.pone.0053931			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076FX	23349767	Green Published, Green Submitted, gold			2022-12-25	WOS:000313943000021
J	Wang, FQ; Wang, L; Xu, ZY; Liang, GL				Wang, Fuqiang; Wang, Ling; Xu, Zhiyang; Liang, Gaolin			Identification and Analysis of Multi-Protein Complexes in Placenta	PLOS ONE			English	Article							INTRAUTERINE GROWTH RESTRICTION; NATIVE GEL-ELECTROPHORESIS; PLASMA-MEMBRANE; PROTEOMIC ANALYSIS; PROTEASOME; UBIQUITINATION; DEGRADATION; PREECLAMPSIA; HOMEOSTASIS; EXPRESSION	Placental malfunction induces pregnancy disorders which contribute to life-threatening complications for both the mother and the fetus. Identification and characterization of placental multi-protein complexes is an important step to integratedly understand the protein-protein interaction networks in placenta which determine placental function. In this study, blue native/sodium dodecyl sulfate polyacrylamide gel electrophoresis (BN/SDS-PAGE) and Liquid chromatography-tandem mass spectrometry (LC-MS/MS) were used to screen the multi-protein complexes in placenta. 733 unique proteins and 34 known and novel heterooligomeric multi-protein complexes including mitochondrial respiratory chain complexes, integrin complexes, proteasome complexes, histone complex, and heat shock protein complexes were identified. A novel protein complex, which involves clathrin and small conductance calcium-activated potassium (SK) channel protein 2, was identified and validated by antibody based gel shift assay, co-immunoprecipitation and immunouorescence staining. These results suggest that BN/SDS-PAGE, when integrated with LC-MS/MS, is a very powerful and versatile tool for the investigation of placental protein complexes. This work paves the way for deeper functional characterization of the placental protein complexes associated with pregnancy disorders.	[Wang, Fuqiang; Liang, Gaolin] Univ Sci & Technol China, Dept Chem, CAS Key Lab Soft Matter Chem, Hefei 230026, Anhui, Peoples R China; [Wang, Fuqiang; Wang, Ling; Xu, Zhiyang] Nanjing Med Univ, Anal Ctr, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Nanjing Medical University	Liang, GL (corresponding author), Univ Sci & Technol China, Dept Chem, CAS Key Lab Soft Matter Chem, Hefei 230026, Anhui, Peoples R China.	gliang@ustc.edu.cn	Wang, Jing/G-5261-2018; Liang, Gaolin/F-1786-2010; Tian, Jie/H-1190-2011; Liang, Jimin/B-5394-2014; Wang, Fu/S-7955-2017; li, xiu/GXV-1745-2022; Chen, Xiaoyuan/D-1860-2014; Life, MC/M-9554-2013	Liang, Gaolin/0000-0002-6159-9999; Tian, Jie/0000-0003-0498-0432; Liang, Jimin/0000-0003-1428-5804; Wang, Fu/0000-0001-9222-0833; Chen, Xiaoyuan/0000-0002-9622-0870; Xia, Qingyou/0000-0002-9263-2886; Wang, Fuqiang/0000-0002-7777-3541; Song, Xinxing/0000-0001-8649-4096	National Natural Science Foundation of China [21175122, 91127036]; Nanjing Medical University [2011NJMU269, 2011NJMU270]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Nanjing Medical University	This work was supported by the National Natural Science Foundation of China (Grants 21175122 and 91127036) and Technology Development Key Project Fund of Nanjing Medical University (Grants 2011NJMU269 and 2011NJMU270). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abell AN, 2011, CELL STEM CELL, V8, P525, DOI 10.1016/j.stem.2011.03.008; Alberts B, 1998, CELL, V92, P291, DOI 10.1016/S0092-8674(00)80922-8; CARVER W, 1995, J CELL PHYSIOL, V165, P425, DOI 10.1002/jcp.1041650224; Chenette EJ, 2012, NAT CELL BIOL, V14, P566; Cox B, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.012526; CRAIG EA, 1993, MICROBIOL REV, V57, P402, DOI 10.1128/MMBR.57.2.402-414.1993; DAMSKY CH, 1994, DEVELOPMENT, V120, P3657; Ekambaram P, 2011, INDIAN J BIOCHEM BIO, V48, P243; Eubel H, 2005, PLANT METHODS, V1, DOI 10.1186/1746-4811-1-11; Feikova S, 2000, NEOPLASMA, V47, P212; Garnica AD, 1996, J AM COLL NUTR, V15, P206; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Gerke V, 2002, PHYSIOL REV, V82, P331, DOI 10.1152/physrev.00030.2001; Hayes MJ, 2004, TRAFFIC, V5, P571, DOI 10.1111/j.1600-0854.2004.00210.x; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Ito T, 2000, P NATL ACAD SCI USA, V97, P1143, DOI 10.1073/pnas.97.3.1143; Johnstone ED, 2011, PROTEOMICS, V11, P4077, DOI 10.1002/pmic.201000505; Katz A, 2007, MOL CELL PROTEOMICS, V6, P1459, DOI 10.1074/mcp.M700002-MCP200; Lafond J, 2006, INT REV CYTOL, V250, P109, DOI 10.1016/S0074-7696(06)50004-X; Lemarie A, 2011, ONCOGENE, V30, P3985, DOI 10.1038/onc.2011.167; LEWIS PN, 1976, CAN J BIOCHEM CELL B, V54, P641, DOI 10.1139/o76-093; Li XW, 2009, J PROTEOME RES, V8, P3475, DOI 10.1021/pr900101d; Lipkowitz S, 2003, BREAST CANCER RES, V5, P8, DOI 10.1186/bcr541; Liu K, 2009, MOL CELL PROTEOMICS, V8, P495, DOI 10.1074/mcp.M800250-MCP200; Mari G, 2007, CLIN OBSTET GYNECOL, V50, P497, DOI 10.1097/GRF.0b013e31804c96a9; Marin R, 2008, PLACENTA, V29, P671, DOI 10.1016/j.placenta.2008.06.003; Pedarzani P, 2008, CELL MOL LIFE SCI, V65, P3196, DOI 10.1007/s00018-008-8216-x; Powe CE, 2011, CIRCULATION, V123, P2856, DOI 10.1161/CIRCULATIONAHA.109.853127; Reisinger Veronika, 2007, Proteomics, V7 Suppl 1, P6, DOI 10.1002/pmic.200700205; Robinson JM, 2008, PLACENTA, V29, P135, DOI 10.1016/j.placenta.2007.12.005; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Schmitt HP, 2006, MED HYPOTHESES, V67, P311, DOI 10.1016/j.mehy.2006.02.023; Smart EJ, 2004, P NATL ACAD SCI USA, V101, P3450, DOI 10.1073/pnas.0400441101; Soltys BJ, 1996, EXP CELL RES, V222, P16, DOI 10.1006/excr.1996.0003; Streicher WW, 2009, BIOCHEMISTRY-US, V48, P2788, DOI 10.1021/bi8019959; Thorn SR, 2011, SEMIN REPROD MED, V29, P225, DOI 10.1055/s-0031-1275516; Ueki H, 2012, SCI REP-UK, V2, DOI 10.1038/srep00827; Van Blerkom J, 2009, SEMIN CELL DEV BIOL, V20, P354, DOI 10.1016/j.semcdb.2008.12.005; Wang HX, 2006, J CELL PHYSIOL, V206, P616, DOI 10.1002/jcp.20508; Williamson R, 2002, J NEUROSCI, V22, P10, DOI 10.1523/JNEUROSCI.22-01-00010.2002; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Yang T, 2002, CELL, V110, P489, DOI 10.1016/S0092-8674(02)00872-3; Zhang HJ, 2012, DEVELOPMENT, V139, P2071, DOI 10.1242/dev.077347; Zhang Q, 2010, PROTEOM CLIN APPL, V4, P538, DOI 10.1002/prca.200900048; Zhang Y, 2008, PROTEOMICS, V8, P4344, DOI 10.1002/pmic.200800294	46	311	332	16	131	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2013	8	4							e62988	10.1371/journal.pone.0062988	http://dx.doi.org/10.1371/journal.pone.0062988			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181JC	23638173	Green Published, gold, Green Submitted			2022-12-25	WOS:000321662800072
J	Wang, F; Song, XX; Li, XJ; Xin, J; Wang, SX; Yang, WD; Wang, J; Wu, KC; Chen, XY; Liang, JM; Tian, J; Cao, F				Wang, Fu; Song, Xinxing; Li, Xiujuan; Xin, Jing; Wang, Shenxu; Yang, Weidong; Wang, Jing; Wu, Kaichun; Chen, Xiaoyuan; Liang, Jimin; Tian, Jie; Cao, Feng			Noninvasive Visualization of MicroRNA-16 in the Chemoresistance of Gastric Cancer Using a Dual Reporter Gene Imaging System	PLOS ONE			English	Article							DRUG-RESISTANCE; MAPK PATHWAYS; CELLS; CHEMOTHERAPY; ACTIVATION	MicroRNAs (miRNAs) have been implicated to play a central role in the development of drug resistance in a variety of malignancies. However, many studies were conducted at the in vitro level and could not provide the in vivo information on the functions of miRNAs in the anticancer drug resistance. Here, we introduced a dual reporter gene imaging system for noninvasively monitoring the kinetic expression of miRNA-16 during chemoresistance in gastric cancer both in vitro and in vivo. Human sodium iodide symporter (hNIS) and firefly luciferase (Fluc) genes were linked to form hNIS/Fluc double fusion reporter gene and then generate human gastric cancer cell line NF-3xmir16 and its multidrug resistance cell line NF-3xmir16/VCR. Radioiodide uptake and Fluc luminescence signals in vitro correlated well with viable cell numbers. The luciferase activities and radioiodide uptake in NF-3xmir16 cells were remarkably repressed by exogenous or endogenous miRNA-16. The NF-3xmir16/VCR cells showed a significant increase of I-131 uptake and luminescence intensity compared to NF-3xmir16 cells. The radioactivity from in vivo Tc-99m-pertechnetate imaging and the intensity from bioluminescence imaging were also increased in NF-3xmir16/VCR compared with that in NF-3xmir16 tumor xenografts. Furthermore, using this reporter gene system, we found that etoposide (VP-16) and 5-fluorouracil (5-FU) activated miRNA-16 expression in vitro and in vivo, and the upregulation of miRNA-16 is p38MAPK dependent but NF-kappa B independent. This dual imaging reporter gene may be served as a novel tool for in vivo imaging of microRNAs in the chemoresistance of cancers, as well as for early detection and diagnosis in clinic.	[Wang, Fu; Xin, Jing; Liang, Jimin] Xidian Univ, Sch Life Sci & Technol, Xian, Shaanxi, Peoples R China; [Wang, Fu; Song, Xinxing; Li, Xiujuan; Wang, Shenxu; Cao, Feng] Fourth Mil Med Univ, Xijing Hosp, Dept Cardiol, Xian 710032, Shaanxi, Peoples R China; [Wang, Fu; Song, Xinxing; Li, Xiujuan; Wang, Shenxu; Cao, Feng] Fourth Mil Med Univ, Xijing Hosp, Xian 710032, Shaanxi, Peoples R China; [Yang, Weidong; Wang, Jing] Fourth Mil Med Univ, Xijing Hosp, Dept Nucl Med, Xian 710032, Shaanxi, Peoples R China; [Wu, Kaichun] Fourth Mil Med Univ, Xijing Hosp, Dept Digest Dis, Xian 710032, Shaanxi, Peoples R China; [Chen, Xiaoyuan] Natl Inst Biomed Imaging & Bioengn, Lab Mol Imaging & Nanomed, NIH, Bethesda, MD USA; [Tian, Jie] Chinese Acad Sci, Inst Automat, Beijing, Peoples R China	Xidian University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; National Institutes of Health (NIH) - USA; NIH National Institute of Biomedical Imaging & Bioengineering (NIBIB); Chinese Academy of Sciences; Institute of Automation, CAS	Liang, JM (corresponding author), Xidian Univ, Sch Life Sci & Technol, Xian, Shaanxi, Peoples R China.	jimleung@mail.xidian.edu.cn; tian@ieee.org; wind8828@gmail.com	Wang, Jing/G-5261-2018; Liang, Gaolin/F-1786-2010; Tian, Jie/H-1190-2011; Liang, Jimin/B-5394-2014; Wang, Fu/S-7955-2017; li, xiu/GXV-1745-2022; Chen, Xiaoyuan/D-1860-2014; Life, MC/M-9554-2013	Liang, Gaolin/0000-0002-6159-9999; Tian, Jie/0000-0003-0498-0432; Liang, Jimin/0000-0003-1428-5804; Wang, Fu/0000-0001-9222-0833; Chen, Xiaoyuan/0000-0002-9622-0870; Xia, Qingyou/0000-0002-9263-2886; Wang, Fuqiang/0000-0002-7777-3541; Song, Xinxing/0000-0001-8649-4096	Program of the National Basic Research and Development Program of China (973) [2012CB518101, 2011CB707702]; National Natural Science Foundation of China [81090272, 81090274, 81227901]; China Department of Education [2010CXTD01]; 863 Program of China [2012AA02A603]; National Key Technology Support Program [2012BAI23B06]	Program of the National Basic Research and Development Program of China (973)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Department of Education; 863 Program of China(National High Technology Research and Development Program of China); National Key Technology Support Program(National Key Technology R&D Program)	This work was supported by the Program of the National Basic Research and Development Program of China (973) under Grant No. 2012CB518101, 2011CB707702, the National Natural Science Foundation of China under Grant Nos. 81090272, 81090274, 81227901, Innovation Team Development Grant by China Department of Education (2010CXTD01), 863 Program of China (2012AA02A603) and the National Key Technology Support Program under Grant No. 2012BAI23B06. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen KE, 2010, MOL CANCER THER, V9, P3126, DOI 10.1158/1535-7163.MCT-10-0397; Baguley BC, 2010, MOL BIOTECHNOL, V46, P308, DOI 10.1007/s12033-010-9321-2; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Blasberg RG, 2002, J CELL BIOCHEM, P172, DOI 10.1002/jcb.10433; Boldt S, 2002, CARCINOGENESIS, V23, P1831, DOI 10.1093/carcin/23.11.1831; Broxterman HJ, 2009, DRUG RESIST UPDATE, V12, P114, DOI 10.1016/j.drup.2009.07.001; Chung JK, 2002, J NUCL MED, V43, P1188; Cunningham D, 2006, NEW ENGL J MED, V355, P11, DOI 10.1056/NEJMoa055531; Fang JY, 2005, LANCET ONCOL, V6, P322, DOI 10.1016/S1470-2045(05)70168-6; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Jo MH, 2012, BIOMATERIALS, V33, P6456, DOI 10.1016/j.biomaterials.2012.05.057; Kang JH, 2008, J NUCL MED, V49, p164S, DOI 10.2967/jnumed.107.045955; Kang WJ, 2012, BIOMATERIALS, V33, P6430, DOI 10.1016/j.biomaterials.2012.05.056; Kim JK, 2012, BIOMATERIALS, V33, P207, DOI 10.1016/j.biomaterials.2011.09.023; Li F, 2010, BBA-REV CANCER, V1805, P167, DOI 10.1016/j.bbcan.2010.01.002; Ma J, 2010, CANCER GENE THER, V17, P523, DOI 10.1038/cgt.2010.18; Mansouri A, 2003, J BIOL CHEM, V278, P19245, DOI 10.1074/jbc.M208134200; Massoud TF, 2003, GENE DEV, V17, P545, DOI 10.1101/gad.1047403; Rivera F, 2007, CANCER TREAT REV, V33, P315, DOI 10.1016/j.ctrv.2007.01.004; Sarkar FH, 2010, DRUG RESIST UPDATE, V13, P57, DOI 10.1016/j.drup.2010.02.001; TROPPMAIR J, 1994, J BIOL CHEM, V269, P7030; Wang F, 2011, EUR J NUCL MED MOL I, V38, P1572, DOI 10.1007/s00259-011-1786-0; Xia L, 2008, INT J CANCER, V123, P372, DOI 10.1002/ijc.23501; Yang SY, 2011, INT J ONCOL, V38, P1695, DOI 10.3892/ijo.2011.982; Zheng TS, 2010, INT J CANCER, V126, P2, DOI 10.1002/ijc.24782	25	311	332	16	131	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2013	8	4							e61792	10.1371/journal.pone.0061792	http://dx.doi.org/10.1371/journal.pone.0061792			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IK	23638173	gold, Green Submitted, Green Published			2022-12-25	WOS:000317907200086
J	Wang, F; Hu, CM; Hua, XT; Song, L; Xia, QY				Wang, Fei; Hu, Cuimei; Hua, Xiaoting; Song, Liang; Xia, Qingyou			Translationally Controlled Tumor Protein, a Dual Functional Protein Involved in the Immune Response of the Silkworm, Bombyx mori	PLOS ONE			English	Article							HISTAMINE-RELEASING FACTOR; DROSOPHILA-MELANOGASTER; PATHOGEN RECOGNITION; CELL-PROLIFERATION; SCAVENGER RECEPTOR; INNATE IMMUNITY; PHAGE DISPLAY; TCTP; IDENTIFICATION; INFECTION	Insect gut immunity is the first line of defense against oral infection. Although a few immune-related molecules in insect intestine has been identified by genomics or proteomics approach with comparison to well-studied tissues, such as hemolymph or fat body, our knowledge about the molecular mechanism underlying the gut immunity which would involve a variety of unidentified molecules is still limited. To uncover additional molecules that might take part in pathogen recognition, signal transduction or immune regulation in insect intestine, a T7 phage display cDNA library of the silkworm midgut is constructed. By use of different ligands for biopanning, Translationally Controlled Tumor Protein (TCTP) has been selected. BmTCTP is produced in intestinal epithelial cells and released into the gut lumen. The protein level of BmTCTP increases at the early time points during oral microbial infection and declines afterwards. In vitro binding assay confirms its activity as a multi-ligand binding molecule and it can further function as an opsonin that promotes the phagocytosis of microorganisms. Moreover, it can induce the production of anti-microbial peptide via a signaling pathway in which ERK is required and a dynamic tyrosine phosphorylation of certain cytoplasmic membrane protein. Taken together, our results characterize BmTCTP as a dual-functional protein involved in both the cellular and the humoral immune response of the silkworm, Bombyx mori.	[Wang, Fei; Hu, Cuimei; Hua, Xiaoting; Song, Liang; Xia, Qingyou] Southwest Univ, State Key Lab Silkworm Genome Biol, Chongqing, Peoples R China	Southwest University - China	Xia, QY (corresponding author), Southwest Univ, State Key Lab Silkworm Genome Biol, Chongqing, Peoples R China.	xiaqy@swu.edu.cn	Wang, Jing/G-5261-2018; Liang, Gaolin/F-1786-2010; Tian, Jie/H-1190-2011; Liang, Jimin/B-5394-2014; Wang, Fu/S-7955-2017; li, xiu/GXV-1745-2022; Chen, Xiaoyuan/D-1860-2014; Life, MC/M-9554-2013	Liang, Gaolin/0000-0002-6159-9999; Tian, Jie/0000-0003-0498-0432; Liang, Jimin/0000-0003-1428-5804; Wang, Fu/0000-0001-9222-0833; Chen, Xiaoyuan/0000-0002-9622-0870; Xia, Qingyou/0000-0002-9263-2886; Wang, Fuqiang/0000-0002-7777-3541; Song, Xinxing/0000-0001-8649-4096	National Basic Research Program of China [2012CB114600]; Natural Science Foundation of China [31201854]; Fundamental Research Funds for the Central Universities [XDJK2009B033]	National Basic Research Program of China(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the grant of "National Basic Research Program of China'' (http://www.973.gov.cn/Default_3.aspx) (2012CB114600), "Natural Science Foundation of China'' (http://www.nsfc.gov.cn/Portal0/default152.htm) (31201854) and "Fundamental Research Funds for the Central Universities'' (XDJK2009B033). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Amson R, 2012, NAT MED, V18, P91, DOI 10.1038/nm.2546; Amzallag N, 2004, J BIOL CHEM, V279, P46104, DOI 10.1074/jbc.M404850200; Aoun RB, 2011, J INNATE IMMUN, V3, P52, DOI 10.1159/000321554; Chen SH, 2007, MOL BIOL CELL, V18, P2525, DOI 10.1091/mbc.E07-02-0188; Chen TS, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-16; Chung YSA, 2011, J BIOL CHEM, V286, P26524, DOI 10.1074/jbc.M110.214007; Cronin SJF, 2009, SCIENCE, V325, P340, DOI 10.1126/science.1173164; Davis MM, 2012, J INNATE IMMUN, V4, P273, DOI 10.1159/000332947; Dong YM, 2006, PLOS BIOL, V4, P1137, DOI 10.1371/journal.pbio.0040229; Govind S, 2008, INSECT SCI, V15, P29, DOI 10.1111/j.1744-7917.2008.00185.x; Ha EM, 2005, SCIENCE, V310, P847, DOI 10.1126/science.1117311; He NH, 2005, ANTIVIR RES, V66, P39, DOI 10.1016/j.antiviral.2004.12.010; Hsu YC, 2007, NATURE, V445, P785, DOI 10.1038/nature05528; Hu XL, 2012, MOL BIOL REP, V39, P3427, DOI 10.1007/s11033-011-1114-6; Huang JX, 2012, ANTIMICROB AGENTS CH, V56, P4569, DOI 10.1128/AAC.00567-12; Huang LL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008098; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Jung J, 2004, J BIOL CHEM, V279, P49868, DOI 10.1074/jbc.M400895200; Kashiwakura JI, 2012, J CLIN INVEST, V122, P218, DOI 10.1172/JCI59072; Kim CH, 2010, J BIOL CHEM, V285, P25243, DOI 10.1074/jbc.M110.134940; Kocks C, 2005, CELL, V123, P335, DOI 10.1016/j.cell.2005.08.034; Lee JM, 2004, COMP BIOCHEM PHYS B, V139, P35, DOI 10.1016/j.cbpc.2004.06.004; MACDONALD SM, 1995, SCIENCE, V269, P688, DOI 10.1126/science.7542803; Meyvis Y, 2009, INT J PARASITOL, V39, P1205, DOI 10.1016/j.ijpara.2009.02.017; Nayak S, 2010, FISH SHELLFISH IMMUN, V29, P544, DOI 10.1016/j.fsi.2010.05.010; Nehme NT, 2007, PLOS PATHOG, V3, P1694, DOI 10.1371/journal.ppat.0030173; Nie ZM, 2010, MOL BIOL REP, V37, P2621, DOI 10.1007/s11033-009-9787-9; Niikura M, 2004, POULTRY SCI, V83, P1117, DOI 10.1093/ps/83.7.1117; Nupan B, 2011, DEV COMP IMMUNOL, V35, P469, DOI 10.1016/j.dci.2010.11.016; Ochiai M, 2000, J BIOL CHEM, V275, P4995, DOI 10.1074/jbc.275.7.4995; Oliveira GD, 2012, SCIENCE, V335, P856, DOI 10.1126/science.1209678; Pan MH, 2010, TISSUE CELL, V42, P42, DOI 10.1016/j.tice.2009.07.002; Panrat T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033291; Pauchet Y, 2009, J BIOL CHEM, V284, P2214, DOI 10.1074/jbc.M806204200; Pauchet Y, 2008, J PROTEOME RES, V7, P1629, DOI 10.1021/pr7006208; PEARSON A, 1995, P NATL ACAD SCI USA, V92, P4056, DOI 10.1073/pnas.92.9.4056; Ponnuvel KM, 2003, J VIROL, V77, P10725, DOI 10.1128/JVI.77.19.10725-10729.2003; Popova-Butler A, 2009, J INSECT PHYSIOL, V55, P264, DOI 10.1016/j.jinsphys.2008.12.008; Povelones M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002023; Rinnerthaler M, 2006, BBA-BIOENERGETICS, V1757, P631, DOI 10.1016/j.bbabio.2006.05.022; Shitomi Y, 2006, J BIOCHEM, V139, P223, DOI 10.1093/jb/mvj024; Song KH, 2008, J INSECT PHYSIOL, V54, P1271, DOI 10.1016/j.jinsphys.2008.06.010; Sunagar SG, 2011, J INSECT PHYSIOL, V57, P1707, DOI 10.1016/j.jinsphys.2011.09.009; Thaw P, 2001, NAT STRUCT BIOL, V8, P701, DOI 10.1038/90415; Tonganunt M, 2008, FISH SHELLFISH IMMUN, V25, P633, DOI 10.1016/j.fsi.2008.08.006; Venugopal T, 2005, COMP BIOCHEM PHYS B, V142, P8, DOI 10.1016/j.cbpc.2005.04.011; Vonakis BM, 2008, BLOOD, V111, P1789, DOI 10.1182/blood-2007-07-104364; Wang F, 2009, EUR J IMMUNOL, V39, P254, DOI 10.1002/eji.200838472; Wang LH, 2006, IMMUNOBIOLOGY, V211, P251, DOI 10.1016/j.imbio.2006.01.001; Watson FL, 2005, SCIENCE, V309, P1874, DOI 10.1126/science.1116887; Wu S, 2010, DEV COMP IMMUNOL, V34, P1191, DOI 10.1016/j.dci.2010.06.013; Yang Y, 2005, ONCOGENE, V24, P4778, DOI 10.1038/sj.onc.1208666; Zhang J, 2012, P NATL ACAD SCI USA, V109, pE926, DOI 10.1073/pnas.1106300109; Zhang S, 2011, COMP FUNCT GENOM, DOI 10.1155/2011/876064	55	311	332	16	131	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2013	8	7							e69284	10.1371/journal.pone.0069284	http://dx.doi.org/10.1371/journal.pone.0069284			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	187PW	23638173	Green Submitted, Green Published, gold			2022-12-25	WOS:000322132100052
J	Wang, FQ; Wang, L; Shi, ZH; Liang, GL				Wang, Fuqiang; Wang, Ling; Shi, Zhonghua; Liang, Gaolin			Comparative N-Glycoproteomic and Phosphoproteomic Profiling of Human Placental Plasma Membrane between Normal and Preeclampsia Pregnancies with High-Resolution Mass Spectrometry	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTOR; LATE-ONSET PREECLAMPSIA; UTERINE ARTERY DOPPLER; METASTASIS SUPPRESSOR; SIGNALING NETWORKS; QUANTITATIVE PROTEOMICS; TROPHOBLAST INVASION; IN-VITRO; EXPRESSION; KISS-1	Preeclampsia is a serious complication of pregnancy, which affects 2-8% of all pregnancies and is one of the leading causes of maternal and perinatal mortality and morbidity worldwide. To better understand the molecular mechanisms involved in pathological development of placenta in preeclampsia, we used high-resolution LC-MS/MS technologies to construct a comparative N-glycoproteomic and phosphoproteomic profiling of human placental plasma membrane in normal and preeclamptic pregnancies. A total of 1027 N-glyco-and 2094 phospho-sites were detected in human placental plasma membrane, and 5 N-glyco-and 38 phospho-proteins, respectively, with differentially expression were definitively identified between control and preeclamptic placental plasma membrane. Further bioinformatics analysis indicated that these differentially expressed proteins correlate with several specific cellular processes occurring during pathological changes of preeclamptic placental plasma membrane.	[Wang, Fuqiang; Liang, Gaolin] Univ Sci & Technol China, Dept Chem, CAS Key Lab Soft Matter Chem, Hefei, Anhui, Peoples R China; [Wang, Fuqiang; Wang, Ling; Shi, Zhonghua] Nanjing Med Univ, State Key Lab Reprod Med, Anal Ctr, Nanjing, Jiangsu, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Nanjing Medical University	Liang, GL (corresponding author), Univ Sci & Technol China, Dept Chem, CAS Key Lab Soft Matter Chem, Hefei, Anhui, Peoples R China.	gliang@ustc.edu.cn	Wang, Jing/G-5261-2018; Liang, Gaolin/F-1786-2010; Tian, Jie/H-1190-2011; Liang, Jimin/B-5394-2014; Wang, Fu/S-7955-2017; li, xiu/GXV-1745-2022; Chen, Xiaoyuan/D-1860-2014; Life, MC/M-9554-2013	Liang, Gaolin/0000-0002-6159-9999; Tian, Jie/0000-0003-0498-0432; Liang, Jimin/0000-0003-1428-5804; Wang, Fu/0000-0001-9222-0833; Chen, Xiaoyuan/0000-0002-9622-0870; Xia, Qingyou/0000-0002-9263-2886; Wang, Fuqiang/0000-0002-7777-3541; Song, Xinxing/0000-0001-8649-4096	National Natural Science Foundation of China [21175122, 91127036]; Technology Development Key Project Fund of Nanjing Medical University [2011NJMU269, 2011NJMU270]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Technology Development Key Project Fund of Nanjing Medical University	This work was supported by the National Natural Science Foundation of China (Grants 21175122 and 91127036) and Technology Development Key Project Fund of Nanjing Medical University (Grants 2011NJMU269 and 2011NJMU270). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beck BH, 2010, EUR J CANCER, V46, P1283, DOI 10.1016/j.ejca.2010.02.023; Bilban M, 2004, J CELL SCI, V117, P1319, DOI 10.1242/jcs.00971; Blagoev B, 2004, NAT BIOTECHNOL, V22, P1139, DOI 10.1038/nbt1005; Boersema PJ, 2009, NAT PROTOC, V4, P484, DOI 10.1038/nprot.2009.21; Cartwright JE, 2012, J ENDOCRINOL, V214, P79, DOI 10.1530/JOE-12-0091; Crispi F, 2008, ULTRASOUND OBST GYN, V31, P303, DOI 10.1002/uog.5184; Danussi C, 2012, CANCER PREV RES, V5, P1131, DOI 10.1158/1940-6207.CAPR-12-0076-T; Danussi C, 2011, J CELL BIOL, V195, P131, DOI 10.1083/jcb.201008013; Duley L, 2009, SEMIN PERINATOL, V33, P130, DOI 10.1053/j.semperi.2009.02.010; Eastabrook G, 2011, BEST PRACT RES CL OB, V25, P435, DOI 10.1016/j.bpobgyn.2011.01.005; Fleischer S, 1974, Methods Enzymol, V31, P6; Hiden U, 2007, REV ENDOCR METAB DIS, V8, P31, DOI 10.1007/s11154-007-9030-8; Huppertz B, 2008, HYPERTENSION, V51, P970, DOI 10.1161/HYPERTENSIONAHA.107.107607; Ilic D, 2001, AM J PATHOL, V159, P93, DOI 10.1016/S0002-9440(10)61677-X; Janneau JL, 2002, J CLIN ENDOCR METAB, V87, P5336, DOI 10.1210/jc.2002-021093; Kotani M, 2001, J BIOL CHEM, V276, P34631, DOI 10.1074/jbc.M104847200; Kratchmarova I, 2005, SCIENCE, V308, P1472, DOI 10.1126/science.1107627; Li CF, 2012, PLACENTA, V33, P47, DOI 10.1016/j.placenta.2011.10.008; Mead EJ, 2007, BRIT J PHARMACOL, V151, P1143, DOI 10.1038/sj.bjp.0707295; MEEKINS JW, 1994, BRIT J OBSTET GYNAEC, V101, P669, DOI 10.1111/j.1471-0528.1994.tb13182.x; Ohtaki T, 2001, NATURE, V411, P613, DOI 10.1038/35079135; Oudejans CBM, 2007, HUM GENET, V120, P607, DOI 10.1007/s00439-006-0259-1; Park DW, 2012, AM J REPROD IMMUNOL, V67, P132, DOI 10.1111/j.1600-0897.2011.01073.x; Ping C, 2007, SCI CHINA SER C, V50, P731, DOI 10.1007/s11427-007-0103-4; Plasencia W, 2008, ULTRASOUND OBST GYN, V32, P138, DOI 10.1002/uog.5402; Qiao Chong, 2005, Zhonghua Fu Chan Ke Za Zhi, V40, P585; [乔宠 Qiao Chong], 2003, [中国实用妇科与产科杂志, Chineses Journal of Practical Gynecology and Obstetrics], V19, P289; Qin HQ, 2013, CHEM COMMUN, V49, P5162, DOI 10.1039/c3cc41479e; Raymond D, 2011, OBSTET GYNECOL SURV, V66, P497, DOI 10.1097/OGX.0b013e3182331028; Roseweir AK, 2012, PLACENTA, V33, P408, DOI 10.1016/j.placenta.2012.02.001; Sibai B, 2005, LANCET, V365, P785, DOI 10.1016/S0140-6736(05)71003-5; Staun-Ram Elsebeth, 2004, Reprod Biol Endocrinol, V2, P59, DOI 10.1186/1477-7827-2-59; Takino T, 2003, ONCOGENE, V22, P4617, DOI 10.1038/sj.onc.1206542; Tena-Sempere M, 2008, NAT MED, V14, P1196, DOI 10.1038/nm1108-1196; Thelemann A, 2005, MOL CELL PROTEOMICS, V4, P356, DOI 10.1074/mcp.M400118-MCP200; Vazquez-Alaniz F, 2011, EUR J OBSTET GYN R B, V159, P67, DOI 10.1016/j.ejogrb.2011.07.019; von Dadelszen P, 2003, HYPERTENS PREGNANCY, V22, P143, DOI 10.1081/PRG-120021060; Walker JJ, 2000, LANCET, V356, P1260, DOI 10.1016/S0140-6736(00)02800-2; Wolf-Yadlin A, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100094; Xu B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016046; Xu P, 2001, BIOL REPROD, V65, P240, DOI 10.1095/biolreprod65.1.240; Yan CH, 2001, J BIOL CHEM, V276, P1164, DOI 10.1074/jbc.M008681200; Zhang Y, 2005, MOL CELL PROTEOMICS, V4, P1240, DOI 10.1074/mcp.M500089-MCP200	43	311	332	16	131	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2013	8	11							e80480	10.1371/journal.pone.0080480	http://dx.doi.org/10.1371/journal.pone.0080480			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255RX	23638173	Green Published, Green Submitted, gold			2022-12-25	WOS:000327258600065
J	Wang, FP; Li, L; Li, J; Wang, JY; Wang, LY; Jiang, W				Wang, Fu-ping; Li, Lei; Li, Jing; Wang, Ji-yao; Wang, Ling-yan; Jiang, Wei			RETRACTED: High Mobility Group Box-1 Promotes the Proliferation and Migration of Hepatic Stellate Cells via TLR4-Dependent Signal Pathways of PI3K/Akt and JNK (Retracted article. See vol. 14, 2019)	PLOS ONE			English	Article; Retracted Publication							GLYCATION END-PRODUCTS; RECEPTOR 4; LIVER FIBROSIS; KAPPA-B; HMGB1; PROTEIN; RAT; EXPRESSION; APOPTOSIS; INFLAMMATION	Background: The migration of hepatic stellate cells (HSCs) is essential to the hepatic fibrotic response, and recently High-mobility group box 1 (HMGB1) has been shown up-regulated during liver fibrosis. Nevertheless, whether HMGB1 can modulate the proliferation and migration of HSCs is poorly understood, as well as the involved intracellular signaling. In this study, we examined the effect of HMGB1 on proliferation, migration, pro-fibrotic function of HSCs and investigated whether toll-like family of receptor 4 (TLR4) dependent signal pathway is involved in the intracellular signaling regulation. Methodology/Principal Findings: Modified transwell chamber system to mimic the space of Disse was used to evaluate the migration of human primary HSCs, and the protein expressions of related signal factors were evaluated by western blot. Cell proliferation was analyzed by MTT assay, the pro-fibrotic functions of HSCs by qRT-PCR and ELISA respectively. Recombinant human HMGB1 could significantly promote migration of HSCs under both haptotactic and chemotactic stimulation, especially the latter. Human TLR4 neutralizing antibody could markedly inhibit HMGB1-induced migration of HSCs. HMGB1 could enhance the phosphorylation of JNK and PI3K/Akt, and TLR4 neutralizing antibody inhibited HMGB1-enhanced phosphorylation of JNK and PI3K/Akt and activation of NF-kappa B. JNK inhibitor (SP600125) and PI3K inhibitor (LY 294002) significantly inhibited HMGB1-induced proliferation and migration of HSCs, and also reduced HMGB1-enhanced related collagen expressions and pro-fibrotic cytokines production. Conclusions/Significance: HMGB1 could significantly enhance migration of HSCs in vitro, and TLR4-dependent JNK and PI3K/Akt signal pathways are involved in the HMGB1-induced proliferation, migration and pro-fibrotic effects of HSCs, which indicates HMGB1 might be an effective target to treat liver fibrosis.	[Wang, Fu-ping; Li, Lei; Wang, Ji-yao; Jiang, Wei] Fudan Univ, Zhongshan Hosp, Dept Gastroenterol, Shanghai 200433, Peoples R China; [Li, Jing] Tongji Univ, Tongji Hosp, Dept Gastroenterol, Shanghai 200092, Peoples R China; [Wang, Ling-yan] Fudan Univ, Zhongshan Hosp, Biomed Res Ctr, Shanghai 200433, Peoples R China	Fudan University; Tongji University; Fudan University	Jiang, W (corresponding author), Fudan Univ, Zhongshan Hosp, Dept Gastroenterol, Shanghai 200433, Peoples R China.	jiang.wei@zs-hospital.sh.cn	Wang, Jing/G-5261-2018; Liang, Gaolin/F-1786-2010; Tian, Jie/H-1190-2011; Liang, Jimin/B-5394-2014; Wang, Fu/S-7955-2017; li, xiu/GXV-1745-2022; Chen, Xiaoyuan/D-1860-2014; Life, MC/M-9554-2013	Liang, Gaolin/0000-0002-6159-9999; Tian, Jie/0000-0003-0498-0432; Liang, Jimin/0000-0003-1428-5804; Wang, Fu/0000-0001-9222-0833; Chen, Xiaoyuan/0000-0002-9622-0870; Xia, Qingyou/0000-0002-9263-2886; Wang, Fuqiang/0000-0002-7777-3541; Song, Xinxing/0000-0001-8649-4096	National Nature Science Foundation of China [30300151, 81070341]; Shanghai Nature Science Foundation [09ZR1406000]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Nature Science Foundation	This study is supported by grants from the National Nature Science Foundation of China (No. 30300151 &81070341, http://www.nsfc.gov.cn) and Shanghai Nature Science Foundation (No. 09ZR1406000, http://www.stcsm.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson U, 2011, ANNU REV IMMUNOL, V29, P139, DOI 10.1146/annurev-immunol-030409-101323; Bai D, 2009, INT J CANCER, V125, P2863, DOI 10.1002/ijc.24748; Beaulieu JM, 2007, TRENDS PHARMACOL SCI, V28, P166, DOI 10.1016/j.tips.2007.02.006; Brenner DA, 2000, J HEPATOL, V32, P32, DOI 10.1016/S0168-8278(00)80413-4; Chen GQ, 2004, J INTERF CYTOK RES, V24, P329, DOI 10.1089/107999004323142187; Chen XL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050668; Dolcet X, 2005, VIRCHOWS ARCH, V446, P475, DOI 10.1007/s00428-005-1264-9; Fehrenbach H, 2001, HEPATOLOGY, V34, P943, DOI 10.1053/jhep.2001.28788; Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003; Hamada N, 2008, AM J RESP CELL MOL, V39, P440, DOI 10.1165/rcmb.2007-0330OC; He ZY, 2009, J RECEPT SIG TRANSD, V29, P119, DOI 10.1080/10799890902845690; Ilmakunnas M, 2008, LIVER TRANSPLANT, V14, P1517, DOI 10.1002/lt.21573; Inoue R, 2005, BRIT J PHARMACOL, V146, P633, DOI 10.1038/sj.bjp.0706373; Iredale JP, 2007, J CLIN INVEST, V117, P539, DOI 10.1172/JCI30542; Ito I, 2007, J BIOL CHEM, V282, P16336, DOI 10.1074/jbc.M608467200; Kao YH, 2008, TRANSPL P, V40, P2704, DOI 10.1016/j.transproceed.2008.07.055; Kim CH, 2010, INT J ONCOL, V36, P117, DOI 10.3892/ijo_00000482; Kim DE, 2012, BIOCHEM BIOPH RES CO, V421, P436, DOI 10.1016/j.bbrc.2012.03.131; Kim SY, 2012, BIOCHEM BIOPH RES CO, V419, P466, DOI 10.1016/j.bbrc.2012.02.015; Lang A, 2000, J HEPATOL, V33, P49, DOI 10.1016/S0168-8278(00)80159-2; Lange SS, 2008, P NATL ACAD SCI USA, V105, P10320, DOI 10.1073/pnas.0803181105; Li L, 2012, LIVER INT, V32, P1093, DOI 10.1111/j.1478-3231.2012.02809.x; Lin YL, 2009, J GASTROEN HEPATOL, V24, P453, DOI 10.1111/j.1440-1746.2008.05573.x; Lohwasser C, 2009, WORLD J GASTROENTERO, V15, P5789, DOI 10.3748/wjg.15.5789; Ma JJ, 2009, LIVER INT, V29, P567, DOI 10.1111/j.1478-3231.2009.01981.x; Mitola S, 2006, J IMMUNOL, V176, P12, DOI 10.4049/jimmunol.176.1.12; Nogueira-Machado JA, 2011, EXPERT OPIN THER TAR, V15, P1023, DOI 10.1517/14728222.2011.575360; Novo E, 2012, J PATHOL, V226, P588, DOI 10.1002/path.3005; Paik YH, 2003, HEPATOLOGY, V37, P1043, DOI 10.1053/jhep.2003.50182; Pradere JP, 2010, SEMIN LIVER DIS, V30, P232, DOI 10.1055/s-0030-1255353; Rauvala H, 2010, BBA-GENE REGUL MECH, V1799, P164, DOI 10.1016/j.bbagrm.2009.11.012; Reif S, 2003, J BIOL CHEM, V278, P8083, DOI 10.1074/jbc.M212927200; Reyes-Gordillo K, 2011, AM J PATHOL, V178, P2100, DOI 10.1016/j.ajpath.2011.01.025; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Schnabl B, 2008, BIOCHEM BIOPH RES CO, V375, P210, DOI 10.1016/j.bbrc.2008.07.150; Seki E, 2007, NAT MED, V13, P1324, DOI 10.1038/nm1663; Sims GP, 2010, ANNU REV IMMUNOL, V28, P367, DOI 10.1146/annurev.immunol.021908.132603; Son G, 2009, HEPATOLOGY, V50, P1512, DOI 10.1002/hep.23186; Tang XM, 2009, BIOL PHARM BULL, V32, P963, DOI 10.1248/bpb.32.963; Tsung A, 2007, J EXP MED, V204, P2913, DOI 10.1084/jem.20070247; Uyama N, 2012, LAB INVEST, V92, P57, DOI 10.1038/labinvest.2011.150; Vinas O, 2003, HEPATOLOGY, V38, P919, DOI 10.1053/jhep.2003.50392; Wang X, 2011, J HEPATOL, V55, P379, DOI 10.1016/j.jhep.2010.10.040; Xia JR, 2008, INT J MOL SCI, V9, P638, DOI 10.3390/ijms9040638; Yamada S, 2007, CLIN CHIM ACTA, V375, P36, DOI 10.1016/j.cca.2006.07.019; Yang CQ, 2003, GASTROENTEROLOGY, V124, P147, DOI 10.1053/gast.2003.50012; Yang J, 2012, MOL BIOL REP, V39, P3361, DOI 10.1007/s11033-011-1106-6; Yang LC, 2012, LEUKEMIA LYMPHOMA, V53, P315, DOI 10.3109/10428194.2011.616962	48	311	332	16	131	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2013	8	5							e64373	10.1371/journal.pone.0064373	http://dx.doi.org/10.1371/journal.pone.0064373			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146HW	23638173	Green Published, gold			2022-12-25	WOS:000319081900089
